PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Dai, L; Defee, MR; Cao, YY; Wen, JL; Wen, XF; Noverr, MC; Qin, ZQ				Dai, Lu; Defee, Michael R.; Cao, Yueyu; Wen, Jiling; Wen, Xiaofei; Noverr, Mairi C.; Qin, Zhiqiang			Lipoteichoic Acid (LTA) and Lipopolysaccharides (LPS) from Periodontal Pathogenic Bacteria Facilitate Oncogenic Herpesvirus Infection within Primary Oral Cells	PLOS ONE			English	Article							SARCOMA-ASSOCIATED-HERPESVIRUS; ACTIVE ANTIRETROVIRAL THERAPY; HUMAN-IMMUNODEFICIENCY-VIRUS; RESISTANT STAPHYLOCOCCUS-AUREUS; KAPPA-B ACTIVATION; DE-NOVO INFECTION; KAPOSIS-SARCOMA; PORPHYROMONAS-GINGIVALIS; HEPARAN-SULFATE; REACTIVE OXYGEN	Kaposi's sarcoma (KS) remains the most common tumor arising in patients with HIV/AIDS, and involvement of the oral cavity represents one of the most common clinical manifestations of this tumor. HIV infection incurs an increased risk for periodontal diseases and oral carriage of a variety of bacteria. Whether interactions involving pathogenic bacteria and oncogenic viruses in the local environment facilitate replication or maintenance of these viruses in the oral cavity remains unknown. In the current study, our data indicate that pretreatment of primary human oral fibroblasts with two prototypical pathogen-associated molecular patterns (PAMPs) produced by oral pathogenic bacteria-lipoteichoic acid (LTA) and lipopolysaccharide (LPS), increase KSHV entry and subsequent viral latent gene expression during de novo infection. Further experiments demonstrate that the underlying mechanisms induced by LTA and/or LPS include upregulation of cellular receptor, increasing production of reactive oxygen species (ROS), and activating intracellular signaling pathways such as MAPK and NF-kappa B, and all of which are closely associated with KSHV entry or gene expression within oral cells. Based on these findings, we hope to provide the framework of developing novel targeted approaches for treatment and prevention of oral KSHV infection and KS development in high-risk HIV-positive patients.	[Dai, Lu; Cao, Yueyu; Qin, Zhiqiang] Tongji Univ, East Hosp, Sch Med, Res Ctr Translat Med, Shanghai 200092, Peoples R China; [Dai, Lu; Cao, Yueyu; Qin, Zhiqiang] Tongji Univ, East Hosp, Sch Med, Key Lab Arrhythmias, Shanghai 200092, Peoples R China; [Qin, Zhiqiang] Louisiana State Univ, Hlth Sci Ctr, Louisiana Canc Res Ctr, Dept Microbiol Immunol Parasitol, New Orleans, LA USA; [Dai, Lu] Louisiana State Univ, Hlth Sci Ctr, Louisiana Canc Res Ctr, Dept Med, New Orleans, LA USA; [Defee, Michael R.] Med Univ S Carolina, Dept Oral Hlth Sci, Charleston, SC 29425 USA; [Noverr, Mairi C.] Louisiana State Univ, Hlth Sci Ctr, Louisiana Canc Res Ctr, Dept Oral & Craniofacial Biol, New Orleans, LA USA; [Wen, Jiling; Wen, Xiaofei] Tongji Univ, East Hosp, Sch Med, Dept Urol, Shanghai 200092, Peoples R China	Tongji University; Tongji University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Medical University of South Carolina; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Tongji University	Qin, ZQ (corresponding author), Tongji Univ, East Hosp, Sch Med, Res Ctr Translat Med, Shanghai 200092, Peoples R China.	zqin@lsuhsc.edu		Noverr, Mairi/0000-0002-8812-1450	Center for Biomedical Research Excellence Award [P20-RR021970]; SOM Research Enhancement Funding [5497400038]; Ladies Leukemia League Grant; National Natural Science Foundation of China [81272191]; NNSF for Young Scientists of China [81101791]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021970] Funding Source: NIH RePORTER	Center for Biomedical Research Excellence Award; SOM Research Enhancement Funding; Ladies Leukemia League Grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NNSF for Young Scientists of China; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by grants from a Center for Biomedical Research Excellence Award (P20-RR021970 to ZQ), the SOM Research Enhancement Funding (5497400038 to ZQ), the Ladies Leukemia League Grant (2014-2015 to ZQ), the National Natural Science Foundation of China (81272191 to ZQ), and the NNSF for Young Scientists of China (81101791 to ZQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abend JR, 2012, J VIROL, V86, P11663, DOI 10.1128/JVI.01147-12; Adang LA, 2006, J VIROL, V80, P10073, DOI 10.1128/JVI.01156-06; Akula SM, 2003, J VIROL, V77, P7978, DOI 10.1128/JVI.77.14.7978-7990.2003; Akula SM, 2002, CELL, V108, P407, DOI 10.1016/S0092-8674(02)00628-1; [Anonymous], J PERIODONTAL RES; [Anonymous], CLIN ORAL INVESTIG; [Anonymous], ACTA ODONTOL SCAND; Ballestas ME, 1999, SCIENCE, V284, P641, DOI 10.1126/science.284.5414.641; BEAZLEY VCC, 1980, SCAND J DENT RES, V88, P193; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Birkmann A, 2001, J VIROL, V75, P11583, DOI 10.1128/JVI.75.23.11583-11593.2001; Bonnet F, 2004, CANCER-AM CANCER SOC, V101, P317, DOI 10.1002/cncr.20354; Bostanci N, 2012, FEMS MICROBIOL LETT, V333, P1, DOI 10.1111/j.1574-6968.2012.02579.x; Bottero V, 2013, J VIROL, V87, P1733, DOI 10.1128/JVI.02958-12; Casper C, 2004, JAIDS-J ACQ IMM DEF, V35, P233, DOI 10.1097/00126334-200403010-00003; Cassai E, 2003, J CLIN PERIODONTOL, V30, P184, DOI 10.1034/j.1600-051X.2003.00220.x; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Cole J, 2013, CURR HIV-AIDS REP, V10, P244, DOI 10.1007/s11904-013-0161-0; Dai L, 2012, CANCER LETT, V318, P214, DOI 10.1016/j.canlet.2011.12.019; Defee MR, 2011, AM J CANCER RES, V1, P687; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Dukers NHTM, 2000, AM J EPIDEMIOL, V151, P213, DOI 10.1093/oxfordjournals.aje.a010195; Flaitz CM, 1997, ORAL SURG ORAL MED O, V83, P259, DOI 10.1016/S1079-2104(97)90014-7; Garrigues HJ, 2008, J VIROL, V82, P1570, DOI 10.1128/JVI.01673-07; Gorsky M, 2000, ORAL SURG ORAL MED O, V90, P612, DOI 10.1067/moe.2000.109518; Gregory SM, 2009, P NATL ACAD SCI USA, V106, P11725, DOI 10.1073/pnas.0905316106; Griffen AL, 2012, ISME J, V6, P1176, DOI 10.1038/ismej.2011.191; Griffen AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019051; Groome MJ, 2012, PAEDIATR INT CHILD H, V32, P140, DOI 10.1179/1465328111Y.0000000044; Guo SJ, 2000, J CLIN PERIODONTOL, V27, P769, DOI 10.1034/j.1600-051x.2000.027010769.x; Jain S, 2010, PERIODONTOL 2000, V54, P53, DOI 10.1111/j.1600-0757.2009.00333.x; Jones KS, 2005, J VIROL, V79, P12692, DOI 10.1128/JVI.79.20.12692-12702.2005; Kaleeba JAR, 2006, SCIENCE, V311, P1921, DOI 10.1126/science.1120878; Kim H, 2014, INFLAMM RES, V63, P419, DOI 10.1007/s00011-014-0714-8; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Lager I, 2003, ORAL SURG ORAL MED O, V96, P701, DOI 10.1016/S1079-2104(03)00370-6; Lagos D, 2008, CELL HOST MICROBE, V4, P470, DOI 10.1016/j.chom.2008.09.012; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lebbe Celeste, 2008, Transplant Rev (Orlando), V22, P252, DOI 10.1016/j.trre.2008.05.004; Lee JK, 2009, J ENDODONT, V35, P212, DOI 10.1016/j.joen.2008.10.018; Lee JM, 2012, PPAR RES, V2012, DOI 10.1155/2012/687570; Lester SN, 2014, J MOL BIOL, V426, P1246, DOI 10.1016/j.jmb.2013.11.024; Ma Q, 2013, ANTIOXID REDOX SIGN, V18, P80, DOI 10.1089/ars.2012.4584; Mataftsi M, 2011, ORAL DIS, V17, P13, DOI 10.1111/j.1601-0825.2010.01727.x; Miller CS, 2006, J CLIN MICROBIOL, V44, P2409, DOI 10.1128/JCM.00256-06; Morath S, 2005, J ENDOTOXIN RES, V11, P348, DOI 10.1179/096805105X67328; Mutig N, 2013, MOL IMMUNOL, V56, P720, DOI 10.1016/j.molimm.2013.07.007; Nakou M, 1997, ANAEROBE, V3, P97, DOI 10.1006/anae.1997.0081; Nogueira G, 2014, J PERIODONTOL, V85, pE18, DOI 10.1902/jop.2013.120735; Offermann MK, 1996, TRENDS MICROBIOL, V4, P419, DOI 10.1016/0966-842X(96)84953-5; Osmond DH, 2002, JAMA-J AM MED ASSOC, V287, P221, DOI 10.1001/jama.287.2.221; Pak F, 2005, J CUTAN PATHOL, V32, P21, DOI 10.1111/j.0303-6987.2005.00256.x; Paramonov N, 2001, EUR J BIOCHEM, V268, P4698, DOI 10.1046/j.1432-1327.2001.02397.x; Paramonov NA, 2009, J BACTERIOL, V191, P5272, DOI 10.1128/JB.00019-09; Patton LL, 2000, ORAL SURG ORAL MED O, V89, P299, DOI 10.1016/S1079-2104(00)70092-8; Pauk J, 2000, NEW ENGL J MED, V343, P1369, DOI 10.1056/NEJM200011093431904; Phiri Reality, 2010, J Int Acad Periodontol, V12, P98; Qin ZQ, 2013, J VIROL, V87, P621, DOI 10.1128/JVI.01441-12; Qin ZQ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000742; Ramirez-Amador V, 2009, J ORAL PATHOL MED, V38, P328, DOI 10.1111/j.1600-0714.2008.00740.x; Rappocciolo G, 2006, J IMMUNOL, V176, P1741, DOI 10.4049/jimmunol.176.3.1741; Reddi HV, 2004, J VIROL, V78, P8909, DOI 10.1128/JVI.78.16.8909-8916.2004; Rohrmus B, 2000, LANCET, V356, P2160, DOI 10.1016/S0140-6736(00)03503-0; Sadagopan S, 2007, J VIROL, V81, P3949, DOI 10.1128/JVI.02333-06; Saygun I, 2005, J PERIODONTAL RES, V40, P187, DOI 10.1111/j.1600-0765.2005.00790.x; Schlafer S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-66; Seaberg EC, 2010, CANCER-AM CANCER SOC, V116, P5507, DOI 10.1002/cncr.25530; Shadyab AH, 2012, HIV MED, V13, P319, DOI 10.1111/j.1468-1293.2011.00978.x; Sharma-Walia N, 2005, J VIROL, V79, P10308, DOI 10.1128/JVI.79.16.10308-10329.2005; Siqueira Jr José F., 2007, Braz. Dent. J., V18, P267, DOI 10.1590/S0103-64402007000400001; Slots Jorgen, 2011, J Calif Dent Assoc, V39, P393; Slots J, 2010, PERIODONTOL 2000, V53, P89, DOI 10.1111/j.1600-0757.2009.00325.x; Vanni T, 2006, CANCER TREAT REV, V32, P445, DOI 10.1016/j.ctrv.2006.06.001; West J, 2008, J VIROL, V82, P5440, DOI 10.1128/JVI.02590-07; Whitelock JM, 2005, CHEM REV, V105, P2745, DOI 10.1021/cr010213m; Ye FC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002054; Yu XL, 2014, J VIROL, V88, P4466, DOI 10.1128/JVI.03326-13; ZAMBON JJ, 1990, J PERIODONTOL, V61, P699, DOI 10.1902/jop.1990.61.11.699; Zeymn A, 2007, ADV EXP MED BIOL, V598, P342	79	22	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e101326	10.1371/journal.pone.0101326	http://dx.doi.org/10.1371/journal.pone.0101326			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971655	Green Published, Green Submitted, gold			2022-12-27	WOS:000338512200113
J	Sirvent, P; Douillard, A; Galbes, O; Ramonatxo, C; Py, G; Candau, R; Lacampagne, A				Sirvent, Pascal; Douillard, Aymerick; Galbes, Olivier; Ramonatxo, Christelle; Py, Guillaume; Candau, Robin; Lacampagne, Alain			Effects of Chronic Administration of Clenbuterol on Contractile Properties and Calcium Homeostasis in Rat Extensor Digitorum Longus Muscle	PLOS ONE			English	Article							SARCOPLASMIC-RETICULUM FUNCTION; CA2+ RELEASE CHANNELS; SKELETAL-MUSCLE; RYANODINE RECEPTOR; SOLEUS MUSCLE; EXERCISE PERFORMANCE; CARDIAC-MUSCLE; HEART-FAILURE; MDX MICE; FIBERS	Clenbuterol, a beta 2-agonist, induces skeletal muscle hypertrophy and a shift from slow-oxidative to fast-glycolytic muscle fiber type profile. However, the cellular mechanisms of the effects of chronic clenbuterol administration on skeletal muscle are not completely understood. As the intracellular Ca2+ concentration must be finely regulated in many cellular processes, the aim of this study was to investigate the effects of chronic clenbuterol treatment on force, fatigue, intracellular calcium (Ca2+) homeostasis and Ca2+-dependent proteolysis in fast-twitch skeletal muscles (the extensor digitorum longus, EDL, muscle), as they are more sensitive to clenbuterol-induced hypertrophy. Male Wistar rats were chronically treated with 4 mg.kg(-1) clenbuterol or saline vehicle (controls) for 21 days. Confocal microscopy was used to evaluate sarcoplasmic reticulum Ca2+ load, Ca2+-transient amplitude and Ca2+ spark properties. EDL muscles from clenbuterol-treated animals displayed hypertrophy, a shift from slow to fast fiber type profile and increased absolute force, while the relative force remained unchanged and resistance to fatigue decreased compared to control muscles from rats treated with saline vehicle. Compared to control animals, clenbuterol treatment decreased Ca2+-transient amplitude, Ca2+ spark amplitude and frequency and the sarcoplasmic reticulum Ca2+ load was markedly reduced. Conversely, calpain activity was increased by clenbuterol chronic treatment. These results indicate that chronic treatment with clenbuterol impairs Ca2+ homeostasis and this could contribute to the remodeling and functional impairment of fast-twitch skeletal muscle.	[Sirvent, Pascal] Blaise Pascal Univ, Clermont Univ, Lab Adaptat Metab Exercice Condit Physiol & Patho, EA 3533, BP 80026, F-80026 Aubiere, France; [Sirvent, Pascal; Galbes, Olivier; Ramonatxo, Christelle; Lacampagne, Alain] Univ Montpellier 2, Univ Montpellier 1, INSERM, U1046, F-34295 Montpellier, France; [Sirvent, Pascal; Galbes, Olivier; Ramonatxo, Christelle; Lacampagne, Alain] CHRU Montpellier, F-34295 Montpellier, France; [Sirvent, Pascal; Douillard, Aymerick; Galbes, Olivier; Ramonatxo, Christelle; Py, Guillaume; Candau, Robin] Univ Montpellier, Natl Inst Agron Res INRA, UMR Muscular Dynam & Metab 866, F-34059 Montpellier, France	Universite Clermont Auvergne (UCA); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; INRAE; Universite de Montpellier	Sirvent, P (corresponding author), Blaise Pascal Univ, Clermont Univ, Lab Adaptat Metab Exercice Condit Physiol & Patho, EA 3533, BP 80026, F-80026 Aubiere, France.	Pascal.sirvent@univ-bpclermont.fr	Lacampagne, Alain/S-3719-2016; Ramonatxo, Christelle/B-2929-2017	Lacampagne, Alain/0000-0003-0264-1787; Ramonatxo, Christelle/0000-0001-6112-0864; candau, robin/0000-0002-5930-8750	World Anti Doping Agency; French Ministry of youth and sports; Fondation of Francaise des Jeux; Ministere de la Recherche et de la Technologie	World Anti Doping Agency; French Ministry of youth and sports; Fondation of Francaise des Jeux; Ministere de la Recherche et de la Technologie	This work was supported by World Anti Doping Agency (http://www.wada-ama.org/en/), French Ministry of youth and sports (http://www.sports.gouv.fr/), Fondation of Francaise des Jeux (http://www.groupefdj.com/fr). Drs Olivier Galbes and A Douillard held a graduate fellowship from the Ministere de la Recherche et de la Technologie (http://www.enseignementsup-recherche.gouv.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker AJ, 1998, AM J PHYSIOL-CELL PH, V274, pC1718, DOI 10.1152/ajpcell.1998.274.6.C1718; BARDSLEY RG, 1992, BIOCHIMIE, V74, P267, DOI 10.1016/0300-9084(92)90125-X; Berchtold MW, 2000, PHYSIOL REV, V80, P1215, DOI 10.1152/physrev.2000.80.3.1215; Burniston JG, 2007, MUSCLE NERVE, V35, P217, DOI 10.1002/mus.20684; Burniston JG, 2005, J APPL PHYSIOL, V98, P1379, DOI 10.1152/japplphysiol.00642.2004; Burniston JG, 2002, J APPL PHYSIOL, V93, P1824, DOI 10.1152/japplphysiol.00139.2002; Cancelliero KM, 2008, BRAZ J MED BIOL RES, V41, P1054, DOI 10.1590/S0100-879X2008001200003; Castle A, 2001, LIFE SCI, V69, P599, DOI 10.1016/S0024-3205(01)01149-3; Cheng H, 1999, BIOPHYS J, V76, P606, DOI 10.1016/S0006-3495(99)77229-2; Cheranov SY, 2002, J PHYSIOL-LONDON, V544, P71, DOI 10.1113/jphysiol.2002.025197; DiFranco M, 2008, P NATL ACAD SCI USA, V105, P14698, DOI 10.1073/pnas.0802217105; Divet A, 2002, PFLUG ARCH EUR J PHY, V444, P634, DOI 10.1007/s00424-002-0854-5; Douillard A, 2012, CLIN EXP PHARMACOL P, V39, P364, DOI 10.1111/j.1440-1681.2012.05677.x; Douillard A, 2011, CAN J PHYSIOL PHARM, V89, P117, DOI [10.1139/Y10-114, 10.1139/y10-114]; Duncan ND, 2000, CLIN SCI, V98, P339, DOI 10.1042/CS19990069; EDELSTEIN CL, 1995, P NATL ACAD SCI USA, V92, P7662, DOI 10.1073/pnas.92.17.7662; EMERY PW, 1984, BIOSCIENCE REP, V4, P83, DOI 10.1007/BF01120827; GILCHRIST JSC, 1992, J BIOL CHEM, V267, P20857; Gokhin DS, 2014, MOL BIOL CELL, V25, P852, DOI 10.1091/mbc.E13-10-0608; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Harcourt LJ, 2007, NEUROMUSCULAR DISORD, V17, P47, DOI 10.1016/j.nmd.2006.08.012; Head SI, 2011, CLIN EXP PHARMACOL P, V38, P638, DOI 10.1111/j.1440-1681.2011.05574.x; Hinkle RT, 2002, MUSCLE NERVE, V25, P729, DOI 10.1002/mus.10092; Hoshino D, 2012, AM J PHYSIOL-REG I, V302, pR373, DOI 10.1152/ajpregu.00183.2011; Ingalls CP, 1996, J APPL PHYSIOL, V80, P795, DOI 10.1152/jappl.1996.80.3.795; Kabbara AA, 1999, J PHYSIOL-LONDON, V519, P169, DOI 10.1111/j.1469-7793.1999.0169o.x; Kabbara AA, 1999, CELL CALCIUM, V25, P227, DOI 10.1054/ceca.1999.0023; Laver DR, 2007, CLIN EXP PHARMACOL P, V34, P889, DOI 10.1111/j.1440-1681.2007.04708.x; Laver DR, 2007, BIOPHYS J, V92, P3541, DOI 10.1529/biophysj.106.099028; Lunde PK, 2001, CIRC RES, V88, P1299, DOI 10.1161/hh1201.092041; MALTIN CA, 1993, CLIN SCI, V84, P651, DOI 10.1042/cs0840651; MENDEZ J, 1960, METABOLISM, V9, P184; Murphy RM, 2013, J PHYSIOL-LONDON, V591, P719, DOI 10.1113/jphysiol.2012.243279; Murphy RM, 2010, CLIN EXP PHARMACOL P, V37, P385, DOI 10.1111/j.1440-1681.2009.05310.x; Rajab P, 2000, AM J PHYSIOL-REG I, V279, pR1076, DOI 10.1152/ajpregu.2000.279.3.R1076; Raynaud F, 2004, EXP CELL RES, V298, P48, DOI 10.1016/j.yexcr.2004.03.053; Reiken S, 2003, J CELL BIOL, V160, P919, DOI 10.1083/jcb.200211012; Ricart-Firinga C, 2000, AM J PHYSIOL-CELL PH, V278, pC582, DOI 10.1152/ajpcell.2000.278.3.C582; Ryall JG, 2008, PHARMACOL THERAPEUT, V120, P219, DOI 10.1016/j.pharmthera.2008.06.003; Ryall JG, 2002, AM J PHYSIOL-REG I, V283, pR1386, DOI 10.1152/ajpregu.00324.2002; Sirvent P, 2005, BIOCHEM BIOPH RES CO, V329, P1067, DOI 10.1016/j.bbrc.2005.02.070; Smith WN, 2002, J APPL PHYSIOL, V92, P941, DOI 10.1152/japplphysiol.00576.2001; Sneddon AA, 2000, AM J PHYSIOL-ENDOC M, V279, pE188, DOI 10.1152/ajpendo.2000.279.1.E188; Song LS, 1997, J PHYSIOL-LONDON, V505, P665, DOI 10.1111/j.1469-7793.1997.665ba.x; Soppa GKR, 2005, AM J PHYSIOL-HEART C, V288, pH1468, DOI 10.1152/ajpheart.00624.2004; Teng YD, 2006, NEUROSCI LETT, V397, P155, DOI 10.1016/j.neulet.2005.12.007; TORGAN CE, 1995, J APPL PHYSIOL, V79, P163, DOI 10.1152/jappl.1995.79.1.163; Verburg E, 2009, AM J PHYSIOL-CELL PH, V296, pC1115, DOI 10.1152/ajpcell.00008.2009; Ward CW, 2003, FASEB J, V17, P1517, DOI 10.1096/fj.02-1083fje; WATERFIELD CJ, 1995, EUR J PHARM-ENVIRON, V293, P141, DOI 10.1016/0926-6917(95)00010-0; Yimlamai T, 2005, J APPL PHYSIOL, V99, P71, DOI 10.1152/japplphysiol.00448.2004; ZEMAN RJ, 1988, AM J PHYSIOL, V254, pE726, DOI 10.1152/ajpendo.1988.254.6.E726	52	19	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100281	10.1371/journal.pone.0100281	http://dx.doi.org/10.1371/journal.pone.0100281			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971566	Green Submitted, gold, Green Published			2022-12-27	WOS:000338512200023
J	Xie, Y; Wang, BB; Li, FC; Ma, L; Ni, M; Shen, WD; Hong, FS; Li, B				Xie, Yi; Wang, Binbin; Li, Fanchi; Ma, Lie; Ni, Min; Shen, Weide; Hong, Fashui; Li, Bing			Molecular Mechanisms of Reduced Nerve Toxicity by Titanium Dioxide Nanoparticles in the Phoxim-Exposed Brain of Bombyx mori	PLOS ONE			English	Article							ACETYLCHOLINESTERASE GENES; OXIDATIVE STRESS; EXPRESSION; APOPTOSIS; MITOCHONDRIA; SILKWORM; REMEDIATION; NANO-TIO2; PROTEINS; TISSUES	Bombyx mori (B. mori), silkworm, is one of the most important economic insects in the world, while phoxim, an organophosphorus (OP) pesticide, impact its economic benefits seriously. Phoxim exposure can damage the brain, fatbody, midgut and haemolymph of B. mori. However the metabolism of proteins and carbohydrates in phoxim-exposed B. mori can be improved by Titanium dioxide nanoparticles (TiO2 NPs). In this study, we explored whether TiO2 NPs treatment can reduce the phoxim-induced brain damage of the 5th larval instar of B. mori. We observed that TiO2 NPs pretreatments significantly reduced the mortality of phoxim-exposed larva and relieved severe brain damage and oxidative stress under phoxim exposure in the brain. The treatments also relieved the phoxim-induced increases in the contents of acetylcholine (Ach), glutamate (Glu) and nitric oxide (NO) and the phoxim-induced decreases in the contents of norepinephrine (NE), Dopamine (DA), and 5-hydroxytryptamine (5-HT), and reduced the inhibition of acetylcholinesterase (AChE), Na+/K+-ATPase, Ca2+-ATPase, and Ca2+/Mg2+-ATPase activities and the activation of total nitric oxide synthase (TNOS) in the brain. Furthermore, digital gene expression profile (DGE) analysis and real time quantitative PCR (qRT-PCR) assay revealed that TiO2 NPs pretreatment inhibited the up-regulated expression of ace1, cytochrome c, caspase-9, caspase-3, Bm109 and down-regulated expression of BmIap caused by phoxim; these genes are involved in nerve conduction, oxidative stress and apoptosis. TiO2 NPs pretreatment also inhibited the down-regulated expression of H+ transporting ATP synthase and vacuolar ATP synthase under phoxim exposure, which are involved in ion transport and energy metabolism. These results indicate that TiO2 NPs pretreatment reduced the phoxim-induced nerve toxicity in the brain of B. mori.	[Xie, Yi; Wang, Binbin; Li, Fanchi; Ma, Lie; Ni, Min; Shen, Weide; Hong, Fashui; Li, Bing] Soochow Univ, Sch Basic Med & Biol Sci, Suzhou, Jiangsu, Peoples R China; [Xie, Yi; Wang, Binbin; Li, Fanchi; Ma, Lie; Ni, Min; Shen, Weide; Li, Bing] Soochow Univ, Natl Engn Lab Modern Silk, Suzhou, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China	Hong, FS (corresponding author), Soochow Univ, Sch Basic Med & Biol Sci, Suzhou, Jiangsu, Peoples R China.	hongfsh_cn@sina.com; lib@suda.edu.cn	li, bing/GWQ-9617-2022		National High Technology Research and Development Program of China (863 Program) [2013AA102507]; transformation project of agriculture scientific and technological achievements [2013GB2C100180]; national cocoons silk development funds; Priority Academic Program Development of Jiangsu Higher Education Institutions; Doctoral Fund of Ministry of Education of China [20113201110008]; China Agriculture Research System [CARS-22-ZJ0305]; Science & Technology support Program of Suzhou [ZXS2012005, SNG201352]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); transformation project of agriculture scientific and technological achievements; national cocoons silk development funds; Priority Academic Program Development of Jiangsu Higher Education Institutions; Doctoral Fund of Ministry of Education of China(Ministry of Education, China); China Agriculture Research System; Science & Technology support Program of Suzhou	This work was supported by the National High Technology Research and Development Program of China (863 Program) (Grant No. 2013AA102507), the transformation project of agriculture scientific and technological achievements (2013GB2C100180), the projects sponsored by the national cocoons silk development funds in 2014, the Priority Academic Program Development of Jiangsu Higher Education Institutions, the Doctoral Fund of Ministry of Education of China (20113201110008), the China Agriculture Research System (CARS-22-ZJ0305), and the Science & Technology support Program of Suzhou (ZXS2012005, SNG201352). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALRAJHI DH, 1990, PESTIC BIOCHEM PHYS, V37, P116, DOI 10.1016/0048-3575(90)90116-J; Asmann YW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-531; Astiz M, 2009, ECOTOX ENVIRON SAFE, V72, P2025, DOI 10.1016/j.ecoenv.2009.05.001; Azuma M, 1998, J EXP BIOL, V201, P479; Brini M, 2009, PHYSIOL REV, V89, P1341, DOI 10.1152/physrev.00032.2008; Carlson K, 1999, TOXICOL APPL PHARM, V160, P33, DOI 10.1006/taap.1999.8741; Chernyak BV, 2006, BBA-BIOENERGETICS, V1757, P525, DOI 10.1016/j.bbabio.2006.02.019; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Esterkin CR, 2005, AICHE J, V51, P2298, DOI 10.1002/aic.10472; FOURNIER D, 1994, COMP BIOCHEM PHYS C, V108, P19, DOI 10.1016/1367-8280(94)90084-1; Fu W, 2013, NEUROSCIENCE, V250, P520, DOI 10.1016/j.neuroscience.2013.07.029; Gu ZY, 2013, BOMBYX MORI CHEMOSPH, V96, P33; Higarashi MM, 2002, CATAL TODAY, V76, P201, DOI 10.1016/S0920-5861(02)00219-5; Hong FH, 2005, BIOL TRACE ELEM RES, V104, P249, DOI 10.1385/BTER:104:3:249; Hu RP, 2011, J HAZARD MATER, V191, P32, DOI 10.1016/j.jhazmat.2011.04.027; Hu RP, 2010, BIOMATERIALS, V31, P8043, DOI 10.1016/j.biomaterials.2010.07.011; Huang QH, 2001, BBA-MOL CELL RES, V1499, P191, DOI 10.1016/S0167-4889(00)00105-1; Konstantinou IK, 2004, APPL CATAL B-ENVIRON, V49, P1, DOI 10.1016/j.apcatb.2003.11.010; Kopecka-Pilarczyk J, 2010, J FISH BIOL, V76, P716, DOI 10.1111/j.1095-8649.2009.02503.x; Lee KS, 2005, INSECT BIOCHEM MOLEC, V35, P73, DOI 10.1016/j.ibmb.2004.09.008; Li B, 2013, J AGR FOOD CHEM, V61, P12238, DOI 10.1021/jf4039259; Li B, 2012, CHEMOSPHERE, V89, P609, DOI 10.1016/j.chemosphere.2012.05.061; Li B, 2010, AFR J BIOTECHNOL, V9, P8477; Meneses A, 2012, REV NEUROSCIENCE, V23, P543, DOI 10.1515/revneuro-2012-0060; Mohammadi R, 2013, BIOL TRACE ELEM RES, V152, P403, DOI 10.1007/s12011-013-9631-x; Nath BS, 1999, ECOTOX ENVIRON SAFE, V42, P157, DOI 10.1006/eesa.1998.1735; Nishijima T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029977; Nordlund J, 2012, LEUKEMIA, V26, P1218, DOI 10.1038/leu.2011.358; Park SY, 2012, COMP BIOCHEM PHYS C, V156, P187, DOI 10.1016/j.cbpc.2012.06.003; Peng GD, 2011, PESTIC BIOCHEM PHYS, V101, P154, DOI 10.1016/j.pestbp.2011.08.010; Prast H, 2001, PROG NEUROBIOL, V64, P51, DOI 10.1016/S0301-0082(00)00044-7; Sinha K, 2013, ARCH TOXICOL, V87, P1157, DOI 10.1007/s00204-013-1034-4; Stadtman ER, 2003, AMINO ACIDS, V25, P207, DOI 10.1007/s00726-003-0011-2; Stennicke HR, 1999, J BIOL CHEM, V274, P8359, DOI 10.1074/jbc.274.13.8359; Su JJ, 2014, ENVIRON TOXICOL, V29, P1355, DOI 10.1002/tox.21866; Tambunan J, 1998, GENE, V212, P287, DOI 10.1016/S0378-1119(98)00126-7; Tokiwa H, 1999, FREE RADICAL BIO MED, V27, P1251, DOI 10.1016/S0891-5849(99)00156-2; Wang YH, 2013, PESTIC BIOCHEM PHYS, V105, P13, DOI 10.1016/j.pestbp.2012.11.001; Wu WX, 2011, J INSECT PHYSIOL, V57, P723, DOI 10.1016/j.jinsphys.2011.02.008; Yang ZP, 1998, J PHYSIOLOGY-PARIS, V92, P157, DOI 10.1016/S0928-4257(98)80002-8; Yano M, 2007, EXP CELL RES, V313, P3767, DOI 10.1016/j.yexcr.2007.07.031; Yu QY, 2011, J ECON ENTOMOL, V104, P101, DOI 10.1603/EC10260; Zamzami N, 2005, CELL DEATH DIFFER, V12, P1478, DOI 10.1038/sj.cdd.4401682; Zhang Y, 2007, NUCLEIC ACIDS RES, V35, pW152, DOI 10.1093/nar/gkm381; Zheng L, 2005, BIOL TRACE ELEM RES, V104, P83, DOI 10.1385/BTER:104:1:083	45	24	29	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e101062	10.1371/journal.pone.0101062	http://dx.doi.org/10.1371/journal.pone.0101062			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971466	Green Published, gold, Green Submitted			2022-12-27	WOS:000338512200086
J	Music, N; Reber, AJ; Lipatov, AS; Kamal, RP; Blanchfield, K; Wilson, JR; Donis, RO; Katz, JM; York, IA				Music, Nedzad; Reber, Adrian J.; Lipatov, Aleksandr S.; Kamal, Ram P.; Blanchfield, Kristy; Wilson, Jason R.; Donis, Ruben O.; Katz, Jacqueline M.; York, Ian A.			Influenza Vaccination Accelerates Recovery of Ferrets from Lymphopenia	PLOS ONE			English	Article							HEMAGGLUTINATION-INHIBITING ANTIBODY; A H1N1; VIRUS-INFECTION; MONOCLONAL-ANTIBODIES; HOSPITALIZED-PATIENTS; RELATIVE LYMPHOPENIA; SEASONAL INFLUENZA; GLOBAL BURDEN; UNITED-STATES; MOUSE MODEL	Ferrets are a useful animal model for human influenza virus infections, since they closely mimic the pathogenesis of influenza viruses observed in humans. However, a lack of reagents, especially for flow cytometry of immune cell subsets, has limited research in this model. Here we use a panel of primarily species cross-reactive antibodies to identify ferret T cells, cytotoxic T lymphocytes (CTL), B cells, and granulocytes in peripheral blood. Following infection with seasonal H3N2 or H1N1pdm09 influenza viruses, these cell types showed rapid and dramatic changes in frequency, even though clinically the infections were mild. The loss of B cells and CD4 and CD8 T cells, and the increase in neutrophils, were especially marked 1 - 2 days after infection, when about 90% of CD8+ T cells disappeared from the peripheral blood. The different virus strains led to different kinetics of leukocyte subset alterations. Vaccination with homologous vaccine reduced clinical symptoms slightly, but led to a much more rapid return to normal leukocyte parameters. Assessment of clinical symptoms may underestimate the effectiveness of influenza vaccine in restoring homeostasis.	[Music, Nedzad; Reber, Adrian J.; Lipatov, Aleksandr S.; Kamal, Ram P.; Blanchfield, Kristy; Wilson, Jason R.; Donis, Ruben O.; Katz, Jacqueline M.; York, Ian A.] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	York, IA (corresponding author), Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA 30333 USA.	ite1@cdc.gov	York, Ian/X-9351-2019	York, Ian/0000-0002-3478-3344	Centers for Disease Control and Prevention	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The source of funding for this work was the Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, Wkly Epidemiol Rec, V85, P402; AULITZKY WE, 1991, ANN HEMATOL, V62, P25, DOI 10.1007/BF01714980; Banner D, 2012, J INFECT DEV COUNTR, V6, P465; Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Belser JA, 2011, DIS MODEL MECH, V4, P575, DOI 10.1242/dmm.007823; Bergman Hagit, 2011, Open Respir Med J, V5, P19, DOI 10.2174/1874306401105010019; Bouvier NM, 2010, VIRUSES-BASEL, V2, P1530, DOI 10.3390/v20801530; Brown C, 2006, LAB ANIMAL, V35, P23, DOI 10.1038/laban0206-23; Carrero JA, 2004, J EXP MED, V200, P535, DOI 10.1084/jem.20040769; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P1071; Chaussee MS, 2011, VACCINE, V29, P3773, DOI 10.1016/j.vaccine.2011.03.031; Clark NM, 2011, SEMIN RESP CRIT CARE, V32, P373, DOI 10.1055/s-0031-1283278; Coskun O, 2010, J CLIN VIROL, V47, P388, DOI 10.1016/j.jcv.2010.01.007; Coudeville L, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-18; Cunha BA, 2010, INFECT DIS CLIN N AM, V24, P203, DOI 10.1016/j.idc.2009.10.001; Cunha BA, 2009, CLIN INFECT DIS, V49, P1454, DOI 10.1086/644496; Dhanoa A, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-501; Dondi E, 2004, J IMMUNOL, V173, P3740, DOI 10.4049/jimmunol.173.6.3740; Goldberg L, 2011, PEDIATR INFECT DIS J, V30, P530, DOI 10.1097/INF.0b013e31821810ff; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; Houser KV, 2013, J VIROL, V87, P1261, DOI 10.1128/JVI.02625-12; Huang SSH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027512; Huber VC, 2010, J VIROL, V84, P4105, DOI 10.1128/JVI.02621-09; Ibrahim HM, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/148725; Ishigaki H, 2011, PEDIATR INT, V53, P669, DOI 10.1111/j.1442-200X.2011.03324.x; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Kanchana S, 2013, AM J TROP MED HYG, V88, P461, DOI 10.4269/ajtmh.12-0132; Lee N, 2012, ANTIVIR THER, V17, P143, DOI 10.3851/IMP2059; Lee SE, 2008, VACCINE, V26, P3383, DOI 10.1016/j.vaccine.2008.04.041; Lowen AC, 2006, P NATL ACAD SCI USA, V103, P9988, DOI 10.1073/pnas.0604157103; Lu XH, 1999, J VIROL, V73, P5903, DOI 10.1128/JVI.73.7.5903-5911.1999; Maher JA, 2004, LAB ANIMAL, V33, P50, DOI 10.1038/laban1004-50; Maines TR, 2012, J INFECT DIS, V205, P474, DOI 10.1093/infdis/jir768; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Martel CJM, 2009, VET IMMUNOL IMMUNOP, V132, P109, DOI 10.1016/j.vetimm.2009.05.011; Matsuoka Yumiko, 2009, Curr Protoc Microbiol, VChapter 15, DOI [10.1002/9780471729259.mc15g03s13, 10.1002/9780471729259.mc15g02s13]; McCullers JA, 2002, J INFECT DIS, V186, P341, DOI 10.1086/341462; MEIKLEJOHN G, 1952, AM J HYG, V55, P1; Merekoulias G, 2010, PLOS CURR, V2, DOI [10.1371/currents.rrn1154, DOI 10.1371/CURRENTS.RRN1154]; Mina MJ, 2013, J INFECT DIS, V208, P1281, DOI 10.1093/infdis/jit317; Monto AS, 2004, INT CONGR SER, V1263, P3, DOI 10.1016/j.ics.2004.02.049; Moore DM, 2000, SCHALMS VET HEMATOLO, P1096; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; Pearce MB, 2012, J VIROL, V86, P7118, DOI 10.1128/JVI.00674-12; Pedersen LG, 2002, VET IMMUNOL IMMUNOP, V88, P111, DOI 10.1016/S0165-2427(02)00139-3; Pillet S, 2009, CURR TOP MICROBIOL, V330, P73; POTTER CW, 1979, BRIT MED BULL, V35, P69, DOI 10.1093/oxfordjournals.bmb.a071545; REED L. J., 1938, AMER JOUR HYG, V27, P493; REUMAN PD, 1989, J VIROL METHODS, V24, P27, DOI 10.1016/0166-0934(89)90004-9; Rimmelzwaan GF, 2003, AVIAN DIS, V47, P931, DOI 10.1637/0005-2086-47.s3.931; Russell S M, 1977, Dev Biol Stand, V39, P397; Rutigliano JA, 2008, J IMMUNOL METHODS, V336, P71, DOI 10.1016/j.jim.2008.04.003; Smith W, 1933, LANCET, V2, P66, DOI 10.1016/S0140-6736(00)78541-2; Svitek N, 2008, VIROLOGY, V376, P53, DOI 10.1016/j.virol.2008.02.035; Tumpey TM, 2000, J VIROL, V74, P6105, DOI 10.1128/JVI.74.13.6105-6116.2000; World Health Organization, 2011, MAN LAB DIAGN VIR SU	60	24	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100926	10.1371/journal.pone.0100926	http://dx.doi.org/10.1371/journal.pone.0100926			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968319	Green Published, Green Submitted, gold			2022-12-27	WOS:000338280800083
J	Breton, CV; Siegmund, KD; Joubert, BR; Wang, XH; Qui, WL; Carey, V; Nystad, W; Haberg, SE; Ober, C; Nicolae, D; Barnes, KC; Martinez, F; Liu, A; Lemanske, R; Strunk, R; Weiss, S; London, S; Gilliland, F; Raby, B				Breton, Carrie V.; Siegmund, Kimberly D.; Joubert, Bonnie R.; Wang, Xinhui; Qui, Weiliang; Carey, Vincent; Nystad, Wenche; Haberg, Siri E.; Ober, Carole; Nicolae, Dan; Barnes, Kathleen C.; Martinez, Fernando; Liu, Andy; Lemanske, Robert; Strunk, Robert; Weiss, Scott; London, Stephanie; Gilliland, Frank; Raby, Benjamin		Asthma BRIDGE Consortium	Prenatal Tobacco Smoke Exposure Is Associated with Childhood DNA CpG Methylation	PLOS ONE			English	Article							MATERNAL SMOKING; NICOTINE DEPENDENCE; AMINOPEPTIDASE-P; SMOOTH-MUSCLE; LUNG-FUNCTION; ASTHMA; PREGNANCY; CHILDREN; COHORT; FRMD4A	Background: Smoking while pregnant is associated with a myriad of negative health outcomes in the child. Some of the detrimental effects may be due to epigenetic modifications, although few studies have investigated this hypothesis in detail. Objectives: To characterize site-specific epigenetic modifications conferred by prenatal smoking exposure within asthmatic children. Methods: Using Illumina HumanMethylation27 microarrays, we estimated the degree of methylation at 27,578 distinct DNA sequences located primarily in gene promoters using whole blood DNA samples from the Childhood Asthma Management Program (CAMP) subset of Asthma BRIDGE childhood asthmatics (n = 527) ages 5-12 with prenatal smoking exposure data available. Using beta-regression, we screened loci for differential methylation related to prenatal smoke exposure, adjusting for gender, age and clinical site, and accounting for multiple comparisons by FDR. Results: Of 27,578 loci evaluated, 22,131 (80%) passed quality control assessment and were analyzed. Sixty-five children (12%) had a history of prenatal smoke exposure. At an FDR of 0.05, we identified 19 CpG loci significantly associated with prenatal smoke, of which two replicated in two independent populations. Exposure was associated with a 2% increase in mean CpG methylation in FRMD4A (p = 0.01) and Cllorf52 (p = 0.001) compared to no exposure. Four additional genes, XPNPEP1, PPEF2, SMPD3 and CRYGN, were nominally associated in at least one replication group. Conclusions: These data suggest that prenatal exposure to tobacco smoke is associated with reproducible epigenetic changes that persist well into childhood. However, the biological significance of these altered loci remains unknown.	[Breton, Carrie V.; Siegmund, Kimberly D.; Wang, Xinhui; Gilliland, Frank] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Joubert, Bonnie R.; London, Stephanie] NIEHS, Div Intramural Res, NIH, Dept Hlth & Human Serv, Res Triangle Pk, NC 27709 USA; [Qui, Weiliang; Carey, Vincent; Weiss, Scott; Raby, Benjamin] Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Div Network Med,Dept Med, Boston, MA 02115 USA; [Nystad, Wenche; Haberg, Siri E.] Norwegian Inst Publ Hlth, Oslo, Norway; [Ober, Carole; Nicolae, Dan] Univ Chicago, Chicago, IL 60637 USA; [Barnes, Kathleen C.] Johns Hopkins Univ, Baltimore, MD USA; [Martinez, Fernando] Univ Arizona, Arizona Resp Ctr, Tucson, AZ 85721 USA; [Liu, Andy] Natl Jewish Hlth, Denver, CO USA; [Lemanske, Robert] Univ Wisconsin, Madison, WI USA; [Strunk, Robert] Washington Univ, Sch Med, St Louis, MT USA	University of Southern California; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Harvard University; Brigham & Women's Hospital; Harvard Medical School; Norwegian Institute of Public Health (NIPH); University of Chicago; Johns Hopkins University; University of Arizona; National Jewish Health; University of Wisconsin System; University of Wisconsin Madison; Washington University (WUSTL)	Breton, CV (corresponding author), Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA.	Breton@usc.edu	Raby, Benjamin/AAK-3866-2021; London, Stephanie/C-3734-2019	London, Stephanie/0000-0003-4911-5290; Joubert, Bonnie/0000-0001-7952-1180; Ober, Carole/0000-0003-4626-9809; Nicolae, Dan/0000-0002-0918-4630	National Heart, Lung and Blood Institute, National Institutes of Health [U01 HL075419, U01 HL65899, P01 HL083069 R01 HL 086601]; NIEHS [5P30ES007048, 1K01ES017801]; Division of Intramural Research, National Institute of Environmental Health Sciences, National Institutes of Health, Dept of Health and Human Services, US; Norwegian Ministry of Health; Ministry of Education and Research; NIH/NIEHS [NO-ES-75558]; NIH/NINDS [1 UO1 NS 047537-01]; Norwegian Research Council/FUGE [151918/S10]; Mary Beryl Patch Turnbull Scholar Program;  [5RC2HL101543-02]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL065899, R01HL086601, U01HL075419, RC2HL101543, R01HL118455, P01HL083069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI095230] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K01ES017801, P30ES007048, ZIAES049019] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS047537] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Division of Intramural Research, National Institute of Environmental Health Sciences, National Institutes of Health, Dept of Health and Human Services, US; Norwegian Ministry of Health; Ministry of Education and Research; NIH/NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Norwegian Research Council/FUGE(Research Council of Norway); Mary Beryl Patch Turnbull Scholar Program; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The CAMP Genetics Ancillary Study is supported by U01 HL075419, U01 HL65899, P01 HL083069 R01 HL 086601, from the National Heart, Lung and Blood Institute, National Institutes of Health. The methylation data described here was funded by 5RC2HL101543-02 and NIEHS grants 5P30ES007048 and 1K01ES017801. Also supported in part by the Division of Intramural Research, National Institute of Environmental Health Sciences, National Institutes of Health, Dept of Health and Human Services, US. The Norwegian Mother and Child Cohort Study is supported by the Norwegian Ministry of Health and the Ministry of Education and Research, NIH/NIEHS (contract no NO-ES-75558), NIH/NINDS (grant no. 1 UO1 NS 047537-01), and the Norwegian Research Council/FUGE (grant no. 151918/S10). KCB was supported in part by the Mary Beryl Patch Turnbull Scholar Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SS, 2004, J APPL PHYSIOL, V96, P1701, DOI 10.1152/japplphysiol.01129.2003; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Buchser WJ, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.52; Burke H, 2012, PEDIATRICS, V129, P735, DOI 10.1542/peds.2011-2196; Cohen RT, 2010, J ALLERGY CLIN IMMUN, V126, P491, DOI 10.1016/j.jaci.2010.06.016; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Edelmann SL, 2011, BLOOD, V118, pE40, DOI 10.1182/blood-2011-03-342261; Eskenazi B, 1999, ENVIRON HEALTH PERSP, V107, P991, DOI 10.1289/ehp.99107991; Ferrari SLP, 2004, J APPL STAT, V31, P799, DOI 10.1080/0266476042000214501; Finkelstein JB, 2006, J NATL CANCER I, V98, P1360, DOI 10.1093/jnci/djj427; Gilliland FD, 2001, AM J RESP CRIT CARE, V163, P429, DOI 10.1164/ajrccm.163.2.2006009; Goldie SJ, 2012, CANCER RES, V72, P3424, DOI 10.1158/0008-5472.CAN-12-0423; Graw J, 2009, EXP EYE RES, V88, P173, DOI 10.1016/j.exer.2008.10.011; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86; Ikenouchi J, 2010, P NATL ACAD SCI USA, V107, P748, DOI 10.1073/pnas.0908423107; Jauniaux E, 2007, EARLY HUM DEV, V83, P699, DOI 10.1016/j.earlhumdev.2007.07.016; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Joubert BR, 2012, ENVIRON HEALTH PERSP, V120, P1425, DOI 10.1289/ehp.1205412; Kim WJ, 2008, BLOOD, V111, P4716, DOI 10.1182/blood-2007-10-113068; King GG, 1999, RESP PHYSIOL, V118, P1, DOI 10.1016/S0034-5687(99)00076-6; Kutuzov MA, 2010, INT J BIOCHEM CELL B, V42, P1816, DOI 10.1016/j.biocel.2010.07.014; Kvalvik LG, 2012, PEDIATR RES, V72, P101, DOI 10.1038/pr.2012.36; La Corte AIC, 2008, J RENIN-ANGIO-ALDO S, V9, P221, DOI 10.1177/1470320308096405; Lambert JC, 2012, MOL PSYCHIATR, DOI 10. 1038/mp. 2012. 75; Li X, 2008, J BIOL CHEM, V283, P22858, DOI 10.1074/jbc.M710274200; Li YF, 2000, AM J RESP CRIT CARE, V162, P2097, DOI 10.1164/ajrccm.162.6.2004178; Midttun O, 2009, RAPID COMMUN MASS SP, V23, P1371, DOI 10.1002/rcm.4013; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; O'Callaghan FV, 2009, AUST NZ J PUBL HEAL, V33, P371, DOI 10.1111/j.1753-6405.2009.00410.x; Plume Jeffrey M., 2012, Frontiers in Genetics, V3, P12, DOI 10.3389/fgene.2012.00012; Rydell M, 2012, BRIT J PSYCHIAT, V200, P202, DOI 10.1192/bjp.bp.111.100123; Sadikovic B, 2007, TOXICOL APPL PHARM, V225, P300, DOI 10.1016/j.taap.2007.08.013; Sprinkle TJ, 2000, ARCH BIOCHEM BIOPHYS, V378, P51, DOI 10.1006/abbi.2000.1792; Stoffel W, 2005, P NATL ACAD SCI USA, V102, P4554, DOI 10.1073/pnas.0406380102; Stoffel W, 2007, AM J PATHOL, V171, P153, DOI 10.2353/ajpath.2007.061285; SUTER MA, 2012, MOL HUM REPROD; Timms AE, 2013, JAMA PSYCHIAT, V70, P582, DOI 10.1001/jamapsychiatry.2013.1195; Triche TJ, 2013, NUCL ACIDS IN PRESS; Wang Lei, 2008, Birth Defects Research, V84, P54, DOI 10.1002/bdrc.20114; Wang T, 2010, AM J RESP CELL MOL, V42, P442, DOI 10.1165/rcmb.2008-0402OC; Wu CJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007994; Yoon D, 2012, HUM GENET, V131, P1009, DOI 10.1007/s00439-011-1102-x; 1999, CONTROL CLIN TRIALS, V20, P91; 2000, N ENGL J MED, V343, P1054	45	83	84	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e99716	10.1371/journal.pone.0099716	http://dx.doi.org/10.1371/journal.pone.0099716			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964093	Green Published, gold			2022-12-27	WOS:000338709500015
J	Sloff, M; de Vries, R; Geutjes, P; in't Hout, J; Ritskes-Hoitinga, M; Oosterwijk, E; Feitz, W				Sloff, Marije; de Vries, Rob; Geutjes, Paul; in't Hout, Joanna; Ritskes-Hoitinga, Merel; Oosterwijk, Egbert; Feitz, Wout			Tissue Engineering in Animal Models for Urinary Diversion: A Systematic Review	PLOS ONE			English	Article							BLADDER REGENERATION; MACROPHAGE PHENOTYPE; CONDUIT; COMPLICATIONS; AUGMENTATION; IMPLANTATION; METAANALYSIS; CYSTECTOMY; SCAFFOLDS; OUTCOMES	Tissue engineering and regenerative medicine (TERM) approaches may provide alternatives for gastrointestinal tissue in urinary diversion. To continue to clinically translatable studies, TERM alternatives need to be evaluated in (large) controlled and standardized animal studies. Here, we investigated all evidence for the efficacy of tissue engineered constructs in animal models for urinary diversion. Studies investigating this subject were identified through a systematic search of three different databases (PubMed, Embase and Web of Science). From each study, animal characteristics, study characteristics and experimental outcomes for meta-analyses were tabulated. Furthermore, the reporting of items vital for study replication was assessed. The retrieved studies (8 in total) showed extreme heterogeneity in study design, including animal models, biomaterials and type of urinary diversion. All studies were feasibility studies, indicating the novelty of this field. None of the studies included appropriate control groups, i. e. a comparison with the classical treatment using GI tissue. The meta-analysis showed a trend towards successful experimentation in larger animals although no specific animal species could be identified as the most suitable model. Larger animals appear to allow a better translation to the human situation, with respect to anatomy and surgical approaches. It was unclear whether the use of cells benefits the formation of a neo urinary conduit. The reporting of the methodology and data according to standardized guidelines was insufficient and should be improved to increase the value of such publications. In conclusion, animal models in the field of TERM for urinary diversion have probably been chosen for reasons other than their predictive value. Controlled and comparative long term animal studies, with adequate methodological reporting are needed to proceed to clinical translatable studies. This will aid in good quality research with the reduction in the use of animals and an increase in empirical evidence of biomedical research.	[Sloff, Marije; Geutjes, Paul; Oosterwijk, Egbert; Feitz, Wout] Radboud Univ Nijmegen Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Urol, Nijmegen, Netherlands; [de Vries, Rob; Ritskes-Hoitinga, Merel] Radboud Univ Nijmegen Med Ctr, Cent Anim Lab, SYRCLE SYstemat Review Ctr Lab Anim Experimentat, Nijmegen, Netherlands; [in't Hout, Joanna] Radboud Univ Nijmegen Med Ctr, Dept Hlth Evidence, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Sloff, M (corresponding author), Radboud Univ Nijmegen Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Urol, Nijmegen, Netherlands.	marije.sloff@radboudumc.nl	Oosterwijk, Egbert/P-5466-2014; Geutjes, P.J./L-4320-2015; Feitz, W.F.J./H-8028-2014; Ritskes-Hoitinga, J./H-8083-2014; IntHout, Joanna/A-1863-2016; Ritskes-Hoitinga, Merel/GLT-8517-2022; Vries, R.B.M./L-4732-2015	IntHout, Joanna/0000-0002-6127-0747; Ritskes-Hoitinga, Merel/0000-0001-5315-284X; 	Fonds NutsOhra: Kunststoma [1102-56]	Fonds NutsOhra: Kunststoma	This work is funded by Fonds NutsOhra: Kunststoma 1102-56(http://www.stichtingnutsohra.nl/). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264; Basu J, 2010, TISSUE ENG PART A, V18, P1025; Beiko DT, 2004, J UROLOGY, V171, P2438, DOI 10.1097/01.ju.0000125001.56045.6c; Bertram T, 2009, FASEB J, V23; Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040; ClinicalTrials.gov, 2014, INC UR DIV US AUT NE; De Filippo RE, 2002, J UROLOGY, V168, P1789, DOI 10.1016/S0022-5347(05)64414-X; De Filippo R, 2009, J UROLOGY, V181, P267, DOI 10.1016/S0022-5347(09)60763-1; De Vries RB, 2011, LAB ANIM, V45, P168; de Vries RBM, 2012, TISSUE ENG PART B-RE, V18, P427, DOI [10.1089/ten.TEB.2012.0059, 10.1089/ten.teb.2012.0059]; DORFLINGER T, 1985, NEUROUROL URODYNAM, V4, P47, DOI 10.1002/nau.1930040108; Drewa T, 2007, TRANSPL P, V39, P1647, DOI 10.1016/j.transproceed.2007.02.092; Drewa T, 2006, TRANSPLANT P, V38, P133, DOI 10.1016/j.transproceed.2005.11.086; Drewa T, 2012, NAT REV UROL, V9, P561, DOI 10.1038/nrurol.2012.158; Evans K, 2005, J UROLOGY, V173, P858, DOI 10.1097/01.ju.0000152578.07262.1c; Geutjes P, 2012, J UROLOGY, V188, P653, DOI 10.1016/j.juro.2012.03.119; GROVER PK, 1994, MINER ELECTROL METAB, V20, P361; Hautmann RE, 2003, J UROLOGY, V169, P834, DOI 10.1097/01.ju.0000029010.97686.eb; Hautmann RE, 2011, NAT REV UROL, V8, P667, DOI 10.1038/nrurol.2011.147; Hooijmans CR, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001482; Hooijmans CR, 2010, LAB ANIM-UK, V44, P170, DOI 10.1258/la.2010.009117; Hooijmans CR, 2010, ATLA-ALTERN LAB ANIM, V38, P167, DOI 10.1177/026119291003800208; Kaefer M, 1998, J UROLOGY, V160, P2187, DOI 10.1016/S0022-5347(01)62290-0; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kim BS, 2000, WORLD J UROL, V18, P2, DOI 10.1007/s003450050002; Kloskowski T, 2012, J TISSUE ENG REGEN M, V6, P23; Knapp G, 2003, STAT MED, V22, P2693, DOI 10.1002/sim.1482; Knight J, 2003, NATURE, V422, P554, DOI 10.1038/422554a; Lee YS, 2009, KOREAN J UROL, V50, P282; Leenaars M, 2012, LAB ANIM-UK, V46, P24, DOI 10.1258/la.2011.011087; Liao WB, 2013, J SURG RES, V182, P185, DOI 10.1016/j.jss.2012.10.024; National Cancer Institute, 2010, NIH PUBL; Nieuwenhuijzen JA, 2008, EUR UROL, V53, P834, DOI 10.1016/j.eururo.2007.09.008; Nordgren A, 2004, BIOMATERIALS, V25, P1723, DOI 10.1016/S0142-9612(03)00506-4; Nuininga JE, 2004, BIOMATERIALS, V25, P1657, DOI 10.1016/S0142-9612(03)00519-2; Orabi H, 2013, EUR UROL, V63, P531, DOI 10.1016/j.eururo.2012.07.041; Pannek J, 1998, UROL INT, V60, P1; Probst M, 2000, BJU INT, V85, P362, DOI 10.1046/j.1464-410x.2000.00442.x; R Core Team, 2012, R LANG ENV STAT COMP; Raya-Rivera A, 2011, LANCET, V377, P1175, DOI 10.1016/S0140-6736(10)62354-9; Roosen A, 2012, BJU INT, V109, P6, DOI 10.1111/j.1464-410X.2011.10494.x; Roth CC, 2011, BJU INT, V108, P148, DOI 10.1111/j.1464-410X.2010.09757.x; Rucker G, 2009, STAT MED, V28, P721, DOI 10.1002/sim.3511; Sievert KD, 2006, WORLD J UROL, V24, P101, DOI 10.1007/s00345-006-0052-8; Vesterinen HM, 2014, J NEUROSCI METH, V221, P92, DOI 10.1016/j.jneumeth.2013.09.010; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Wood MW, 2007, AATEX, V14, P303; Zhang YY, 2004, TISSUE ENG, V10, P181, DOI 10.1089/107632704322791835	49	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e98734	10.1371/journal.pone.0098734	http://dx.doi.org/10.1371/journal.pone.0098734			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964011	gold, Green Published, Green Submitted			2022-12-27	WOS:000338709500005
J	Stoof, SP; van der Klis, FRM; van Rooijen, DM; Knol, MJ; Sanders, EAM; Berbers, GAM				Stoof, Susanne P.; van der Klis, Fiona R. M.; van Rooijen, Debbie M.; Knol, Mirjam J.; Sanders, Elisabeth A. M.; Berbers, Guy A. M.			Timing of an Adolescent Booster after Single Primary Meningococcal Serogroup C Conjugate Immunization at Young Age; An Intervention Study among Dutch Teenagers	PLOS ONE			English	Article							NEISSERIA-MENINGITIDIS; UNITED-KINGDOM; GLYCOCONJUGATE VACCINE; IMMUNOLOGICAL MEMORY; POLYSACCHARIDE VACCINE; MULTIPLEX IMMUNOASSAY; SERUM ANTIBODIES; PRIMARY SCHEDULE; IMMUNE-RESPONSE; CLINICAL-TRIAL	Background: Meningococcal serogroup C (MenC) specific antibody levels decline rapidly after a single primary MenC conjugate (MenCC) vaccination in preschool children. A second MenCC vaccination during (pre) adolescence might attain longer lasting individual and herd protection. We aimed to establish an appropriate age for a (pre) adolescent MenCC booster vaccination. Methods: A phase-IV trial with healthy 10-year-olds (n = 91), 12-year-olds (n = 91) and 15-year-olds (n = 86) who were primed with a MenCC vaccine nine years earlier. All participants received a booster vaccination with the same vaccine. Serum bactericidal antibody assay titers (SBA, using baby rabbit complement), MenC-polysaccharide (MenC-PS) specific IgG, IgG subclass and avidity and tetanus-specific IgG levels were measured prior to (T0) and 1 month (T1) and 1 year (T2) after the booster. An SBA titer >= 8 was the correlate of protection. Results: 258 (96.3%) participants completed all three study visits. At T0, 19% of the 10-year-olds still had an SBA titer >= 8, compared to 34% of the 12-year-olds (P = 0.057) and 45% of the 15-year-olds (P<0.001). All participants developed high SBA titers (GMTs>30,000 in all age groups) and MenC-PS specific IgG levels at T1. IgG levels mainly consisted of IgG1, but the contribution of IgG2 increased with age. At T2, 100% of participants still had an SBA titer >= 8, but the 15-year-olds showed the highest protective antibody levels and the lowest decay. Conclusion: Nine years after primary MenCC vaccination adolescents develop high protective antibody levels in response to a booster and are still sufficiently protected one year later. Our results suggest that persistence of individual - and herd - protection increases with the age at which an adolescent booster is administered.	[Stoof, Susanne P.; van der Klis, Fiona R. M.; van Rooijen, Debbie M.; Knol, Mirjam J.; Berbers, Guy A. M.] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands; [Stoof, Susanne P.; Sanders, Elisabeth A. M.] Univ Med Ctr, Wilhelmina Childrens Hosp, Dept Immunol & Infect Dis, Utrecht, Netherlands	Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis	Stoof, SP (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands.	susanne.stoof@rivm.nl; guy.berbers@rivm.nl			Dutch Ministry of Health	Dutch Ministry of Health	This study was funded by the Dutch Ministry of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Baxter kindly provided the vaccines.	Andrews N, 2003, CLIN DIAGN LAB IMMUN, V10, P780, DOI 10.1128/CDLI.10.5.780-786.2003; [Anonymous], VACC SCHED; Borrow R, 2005, VACCINE, V23, P2222, DOI 10.1016/j.vaccine.2005.01.051; Borrow R, 2003, INFECT IMMUN, V71, P5549, DOI 10.1128/IAI.71.10.5549-5555.2003; Borrow R, 2010, CLIN VACCINE IMMUNOL, V17, P154, DOI 10.1128/CVI.00384-09; Christensen H, 2010, LANCET INFECT DIS, V10, P853, DOI 10.1016/S1473-3099(10)70251-6; de Voer RM, 2008, CLIN VACCINE IMMUNOL, V15, P1188, DOI 10.1128/CVI.00478-07; de Voer RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023497; de Voer RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012144; de Voer RM, 2009, VACCINE, V27, P6974, DOI 10.1016/j.vaccine.2009.09.082; de Whalley PCS, 2013, ARCH DIS CHILD, V98, P686, DOI 10.1136/archdischild-2013-303893; de Whalley PCS, 2011, PEDIATR INFECT DIS J, V30, pE203, DOI 10.1097/INF.0b013e318224fb14; Diez-Domingo J, 2010, PEDIATR INFECT DIS J, V29, P148, DOI 10.1097/INF.0b013e3181b9a831; Findlow H, 2012, PEDIATR INFECT DIS J, V31, P616, DOI 10.1097/INF.0b013e31824f34e6; Goldblatt D, 2002, J INFECT DIS, V185, P397, DOI 10.1086/338474; Harris SL, 2007, CLIN VACCINE IMMUNOL, V14, P397, DOI 10.1128/CVI.00241-06; Jafri RZ, 2013, POPUL HEALTH METR, V11, DOI 10.1186/1478-7954-11-17; Kelly DF, 2009, IMMUNOLOGY, V127, P134, DOI 10.1111/j.1365-2567.2008.02934.x; Khatami A, 2011, CLIN VACCINE IMMUNOL, V18, P2038, DOI 10.1128/CVI.05354-11; Khatami A, 2011, PEDIATR INFECT DIS J, V30, P197, DOI 10.1097/INF.0b013e3181f728fd; Lal G, 2004, CLIN DIAGN LAB IMMUN, V11, P272, DOI 10.1128/CDLI.11.2.272-279.2004; Maiden MCJ, 2008, J INFECT DIS, V197, P737, DOI 10.1086/527401; Maiden MCJ, 2002, LANCET, V359, P1829, DOI 10.1016/S0140-6736(02)08679-8; Maslanka SE, 1997, CLIN DIAGN LAB IMMUN, V4, P156, DOI 10.1128/CDLI.4.2.156-167.1997; Neppelenbroek SE, 2003, DAS GOED GEDAAN REPO; Newcombe RG, 1998, STAT MED, V17, P857, DOI 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E; Perrett KP, 2010, CLIN INFECT DIS, V50, P1601, DOI 10.1086/652765; Richmond P, 2001, J INFECT DIS, V183, P160, DOI 10.1086/317646; Rohner GB, 2008, J IMMUNOL, V180, P2165, DOI 10.4049/jimmunol.180.4.2165; Snape MD, 2008, BRIT MED J, V336, P1487, DOI 10.1136/bmj.39563.545255.AE; Snape MD, 2006, CLIN INFECT DIS, V43, P1387, DOI 10.1086/508776; Snape MD, 2005, PEDIATR INFECT DIS J, V24, P128, DOI 10.1097/01.inf.0000151029.58752.27; Trotter CL, 2009, EXPERT REV VACCINES, V8, P851, DOI [10.1586/erv.09.48, 10.1586/ERV.09.48]; Trotter CL, 2005, AM J EPIDEMIOL, V162, P89, DOI 10.1093/aje/kwi160; Trotter CL, 2004, LANCET, V364, P365, DOI 10.1016/S0140-6736(04)16725-1; van der Klis FRM, 2009, NETH J MED, V67, P301; van Gageldonk PGM, 2008, J IMMUNOL METHODS, V335, P79, DOI 10.1016/j.jim.2008.02.018; van Lier EA, 2013, VACCINATIEGRAAD RIJK; van't Klooster T, 2013, NATL IMMUNISATION PR, V201001002; Vickers DM, 2013, VACCINE	40	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100651	10.1371/journal.pone.0100651	http://dx.doi.org/10.1371/journal.pone.0100651			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963638	gold, Green Published, Green Submitted			2022-12-27	WOS:000338709500072
J	Xu, XY; Kong, H; Song, RX; Zhai, YH; Wu, XF; Ai, WS; Liu, HB				Xu, Xue-Ying; Kong, Hong; Song, Rui-Xiang; Zhai, Yu-Han; Wu, Xiao-Fei; Ai, Wen-Si; Liu, Hong-Bo			The Effectiveness of Noninvasive Biomarkers to Predict Hepatitis B-Related Significant Fibrosis and Cirrhosis: A Systematic Review and Meta-Analysis of Diagnostic Test Accuracy	PLOS ONE			English	Article							PLATELET RATIO INDEX; CHRONIC VIRAL-HEPATITIS; LIVER FIBROSIS; ASPARTATE-AMINOTRANSFERASE; BIOCHEMICAL MARKERS; INFECTED PATIENTS; BIOPSY; ELASTOGRAPHY; MODELS; EPIDEMIOLOGY	Noninvasive biomarkers have been developed to predict hepatitis B virus (HBV)-related fibrosis owing to the significant limitations of liver biopsy. Those biomarkers were initially derived from evaluation of hepatitis C virus (HCV)-related fibrosis, and their accuracy among HBV-infected patients was under constant debate. A systematic review was conducted on records in PubMed, EMBASE and the Cochrane Library electronic databases, up until April 1st, 2013, in order to systematically assess the effectiveness and accuracy of these biomarkers for predicting HBV-related fibrosis. The questionnaire for quality assessment of diagnostic accuracy studies (QUADAS) was used. Out of 115 articles evaluated for eligibility, 79 studies satisfied the pre-determined inclusion criteria for meta-analysis. Eventually, our final data set for the meta-analysis contained 30 studies. The areas under the SROC curve for APRI, FIB-4, and FibroTest of significant fibrosis were 0.77, 0.75, and 0.84, respectively. For cirrhosis, the areas under the SROC curve for APRI, FIB-4 and FibroTest were 0.75, 0.87, and 0.90, respectively. The heterogeneity of FIB-4 and FibroTest were not statistically significant. The heterogeneity of APRI for detecting significant fibrosis was affected by median age (P = 0.0211), and for cirrhosis was affected by etiology (P = 0.0159). Based on the analysis we claim that FibroTest has excellent diagnostic accuracy for identification of HBV-related significant fibrosis and cirrhosis. FIB-4 has modest benefits and may be suitable for wider scope implementation.	[Xu, Xue-Ying; Zhai, Yu-Han; Wu, Xiao-Fei; Ai, Wen-Si; Liu, Hong-Bo] China Med Univ, Sch Publ Hlth, Shenyang, Peoples R China; [Kong, Hong] China Med Univ, Shengjing Hosp, Dept Clin Lab, Shenyang, Peoples R China; [Song, Rui-Xiang] Changhai Hosp, Dept Urinary Surg, Shanghai, Peoples R China	China Medical University; China Medical University; Naval Medical University	Liu, HB (corresponding author), China Med Univ, Sch Publ Hlth, Shenyang, Peoples R China.	hbliu@mail.cmu.edu.cn			National Natural Science Foundation Grant in China [71073176]	National Natural Science Foundation Grant in China(National Natural Science Foundation of China (NSFC))	This research was supported by a National Natural Science Foundation Grant in China (No. 71073176) awarded to H.B.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basar O, 2013, CLIN RES HEPATOL GAS, V37, P152, DOI 10.1016/j.clinre.2012.07.003; BATTS KP, 1995, AM J SURG PATHOL, V19, P1409, DOI 10.1097/00000478-199512000-00007; BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Bonnard P, 2010, AM J TROP MED HYG, V82, P454, DOI 10.4269/ajtmh.2010.09-0088; Bottero J, 2009, J HEPATOL, V50, P1074, DOI 10.1016/j.jhep.2009.01.022; Bravo AA, 2001, NEW ENGL J MED, V344, P495, DOI 10.1056/NEJM200102153440706; Chrysanthos NV, 2006, EUR J GASTROEN HEPAT, V18, P389, DOI 10.1097/00042737-200604000-00012; Colloredo G, 2003, J HEPATOL, V39, P239, DOI 10.1016/S0168-8278(03)00191-0; Corradi F, 2009, DIGEST LIVER DIS, V41, P217, DOI 10.1016/j.dld.2008.06.009; Custer B, 2004, J CLIN GASTROENTEROL, V38, pS158, DOI 10.1097/00004836-200411003-00008; Deeks JJ, 2001, BRIT MED J, V323, P157, DOI 10.1136/bmj.323.7305.157; Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Doust JA, 2004, ARCH INTERN MED, V164, P1978, DOI 10.1001/archinte.164.18.1978; Dukic V, 2003, BIOMETRICS, V59, P936, DOI 10.1111/j.0006-341X.2003.00108.x; Amorim TGF, 2012, ANN HEPATOL, V11, P855; Gui Hong-Lian, 2008, Zhonghua Gan Zang Bing Za Zhi, V16, P897; Gumusay O, 2013, HEPATOL RES, V43, P228, DOI 10.1111/j.1872-034X.2012.01057.x; Guzelbulut F, 2012, TURK J GASTROENTEROL, V23, P353, DOI 10.4318/tjg.2012.0348; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Imbert-Bismut F, 2001, LANCET, V357, P1069, DOI 10.1016/S0140-6736(00)04258-6; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Jin WW, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-14; Kim BK, 2007, LIVER INT, V27, P969, DOI 10.1111/j.1478-3231.2007.01519.x; Kim BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041964; Kim BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035825; Kim BK, 2010, LIVER INT, V30, P546, DOI 10.1111/j.1478-3231.2009.02192.x; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Lesmana CRA, 2011, J CLIN PATHOL, V64, P916, DOI 10.1136/jclinpath-2011-200044; Liaw YF, 2004, NEW ENGL J MED, V351, P1521, DOI 10.1056/NEJMoa033364; Lin ZH, 2011, HEPATOLOGY, V53, P726, DOI 10.1002/hep.24105; Liu HB, 2011, CLIN CHIM ACTA, V412, P33, DOI 10.1016/j.cca.2010.08.032; Liu HB, 2007, CLIN BIOCHEM, V40, P562, DOI 10.1016/j.clinbiochem.2007.01.022; Liu XD, 2012, WORLD J GASTROENTERO, V18, P2784, DOI 10.3748/wjg.v18.i22.2784; Martinez SM, 2011, ALIMENT PHARM THER, V33, P138, DOI 10.1111/j.1365-2036.2010.04500.x; Miailhes P, 2011, J VIRAL HEPATITIS, V18, P61, DOI 10.1111/j.1365-2893.2010.01275.x; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; MOSES LE, 1993, STAT MED, V12, P1293, DOI 10.1002/sim.4780121203; Myers RP, 2003, J HEPATOL, V39, P222, DOI 10.1016/S0168-8278(03)00171-5; Park MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055759; Poynard T, 2007, BMC GASTROENTEROL, V7, DOI 10.1186/1471-230X-7-40; Reitsma JB, 2005, J CLIN EPIDEMIOL, V58, P982, DOI 10.1016/j.jclinepi.2005.02.022; SCHEUER PJ, 1991, J HEPATOL, V13, P372, DOI 10.1016/0168-8278(91)90084-O; Sebastiani G, 2011, ALIMENT PHARM THER, V34, P1202, DOI 10.1111/j.1365-2036.2011.04861.x; Sebastiani G, 2007, WORLD J GASTROENTERO, V13, P525, DOI 10.3748/wjg.v13.i4.525; Seto WK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023077; Shaheen AAM, 2007, AM J GASTROENTEROL, V102, P2589, DOI 10.1111/j.1572-0241.2007.01466.x; Shin WG, 2008, DIGEST LIVER DIS, V40, P267, DOI 10.1016/j.dld.2007.10.011; Sterling RK, 2010, CLIN GASTROENTEROL H, V8, P1070, DOI 10.1016/j.cgh.2010.08.004; Stibbe KJM, 2011, SCAND J GASTROENTERO, V46, P962, DOI 10.3109/00365521.2011.574725; Strader DB, 2004, HEPATOLOGY, V39, P1147, DOI 10.1002/hep.20119; Ucar F, 2013, EUR J GASTROENTEROL; Walter SD, 2002, STAT MED, V21, P1237, DOI 10.1002/sim.1099; Wang H, 2013, J VIRAL HEPATITIS, V20, pe3, DOI 10.1111/jvh.12010; Wang Y, 2013, HEPATOL RES, V43, P441, DOI 10.1111/j.1872-034X.2012.01094.x; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Wu SD, 2010, WORLD J GASTROENTERO, V16, P501, DOI 10.3748/wjg.v16.i4.501; Yu MW, 1997, AM J EPIDEMIOL, V145, P1039, DOI 10.1093/oxfordjournals.aje.a009060; Zhang Yu-feng, 2010, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V24, P215; Zhou K, 2010, J GASTROEN HEPATOL, V25, P1569, DOI 10.1111/j.1440-1746.2010.06383.x; Zhu X, 2011, DIGEST DIS SCI, V56, P2742, DOI 10.1007/s10620-011-1659-1	61	32	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100182	10.1371/journal.pone.0100182	http://dx.doi.org/10.1371/journal.pone.0100182			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964038	Green Published, gold, Green Submitted			2022-12-27	WOS:000338709500032
J	Liu, QL; Li, SY; Quan, H; Li, JW				Liu, Qilin; Li, Sheyu; Quan, Heng; Li, Jianwei			Vitamin B-12 Status in Metformin Treated Patients: Systematic Review	PLOS ONE			English	Review							DIABETIC-PATIENTS; SERUM CONCENTRATIONS; HOMOCYSTEINE LEVELS; B-12 DEFICIENCY; INCREASED RISK; TERM TREATMENT; FOLIC-ACID; TYPE-2; MALABSORPTION; WOMEN	Objective: Randomized controlled trials and observational studies have yielded inconsistent results on the effects of metformin on vitamin B-12 reduction. We therefore performed a systematic review to analyze the effects of metformin on vitamin B-12 concentration. Methods: PubMed, Medline, Embase, and the Cochrane central registry of controlled trials were searched to identify randomized controlled trials and observational studies exploring the association between metformin and vitamin B-12 concentration in patients with type 2 diabetes mellitus or polycystic ovary syndrome. The main outcome measure was changes in serum vitamin B-12 concentration after 6-208 weeks of treatment with metformin, as compared with placebo or other anti-hyperglycemic therapy. Results: Six randomized controlled trials met the inclusion criteria. Serum vitamin B-12 concentrations were significantly lower in patients treated with metformin than in those who received placebo or rosiglitazone (mean difference [MD], -53.93 pmol/L; 95% confidence interval [CI], -81.44 to -26.42 pmol/L, P = 0.0001). Subgroup analysis identified four trials in which patients received a lower dose of metformin (<2000 mg/d) and two in which they received a higher dose (>= 2000 mg/d), with MDs in vitamin B-12 concentration after metformin treatment of -37.99 pmol/L (95% CI, -57.44 to -18.54 pmol/L, P = 0.0001) and -78.62 pmol/L (95% CI, -106.37 to -50.86 pmol/L, P<0.00001), respectively. Conclusions: The reduction of vitamin B-12 may be induced by metformin in a dose dependent manner.	[Liu, Qilin; Li, Sheyu; Quan, Heng; Li, Jianwei] Sichuan Univ, West China Hosp, Dept Endocrinol & Metab, Chengdu 610064, Peoples R China	Sichuan University	Li, JW (corresponding author), Sichuan Univ, West China Hosp, Dept Endocrinol & Metab, Chengdu 610064, Peoples R China.	jerryli678@yahoo.com	Li, Sheyu/O-3242-2016	Li, Sheyu/0000-0003-0060-0287	National Natural Science Foundation of China [30600293]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by grant from the National Natural Science Foundation of China, No. 30600293 (Jianwei Li) (http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JF, 1983, DIABETOLOGIA, V24, P16, DOI 10.1007/BF00275941; [Anonymous], 2016, NEWCASTLEOTTAWA SCAL; Atwell C, 2012, J INVEST MED, V60, P435; Bauman WA, 2000, DIABETES CARE, V23, P1227, DOI 10.2337/diacare.23.9.1227; Buvat DR, 2004, AM FAM PHYSICIAN, V69, P264; CALLAGHAN TS, 1980, BRIT MED J, V280, P1214, DOI 10.1136/bmj.280.6225.1214; Calvo C, 2010, J INVEST MED, V58, P215; Carlsen SM, 2007, ACTA OBSTET GYN SCAN, V86, P145, DOI 10.1080/00016340600855946; CARPENTIER JL, 1976, DIABETES METAB, V2, P187; CASPARY WF, 1977, DIABETOLOGIA, V13, P187, DOI 10.1007/BF01219698; CASPARY WF, 1971, DIABETOLOGIA, V7, P379, DOI 10.1007/BF01219474; Chen S, 2012, BRIT J DIABETES VASC, V12, P189, DOI DOI 10.1177/1474651412454924; de Groot-Kamphuis DM, 2013, NETH J MED, V71, P386; de Jager J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2181; Farvid MS, 2012, CLIN CHEM LAB MED, V50, pA48; Filioussi Kalitsa, 2003, Aust Fam Physician, V32, P383; Gastaldi G, 2011, DIABETOLOGIA, V54, pS500; Greibe E, 2013, NUTRIENTS, V5, P2475, DOI 10.3390/nu5072475; Hermann LS, 2004, BRIT J DIABETES VASC, V4, P401; Hoogeveen EK, 1998, ARTERIOSCL THROM VAS, V18, P133, DOI 10.1161/01.ATV.18.1.133; Kilicdag EB, 2005, HUM REPROD, V20, P894, DOI 10.1093/humrep/deh700; Kos E, 2012, ENDOCR PRACT, V18, P179, DOI 10.4158/EP11009.OR; Kulambil Padinjakara RN, 2009, DIABETIC MED, V26, P46; La Marca A, 2005, EUR J OBSTET GYN R B, V121, P3, DOI 10.1016/j.ejogrb.2004.09.015; Leung S, 2010, CLIN BIOCHEM, V43, P759, DOI 10.1016/j.clinbiochem.2010.02.011; Liu KW, 2006, AGE AGEING, V35, P200, DOI 10.1093/ageing/afj042; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Moore EM, 2013, DIABETES CARE, V36, P2981, DOI 10.2337/dc13-0229; Morrison CL, 2013, DIABETIC MED, V30, P22; Nag S, 2012, DIABETIC MED, V29, P173; Narayanan RP, 2012, DIABETIC MED, V29, P72; Nervo M, 2011, REV ASSOC MED BRAS, V57, P46, DOI 10.1590/S0104-42302011000100015; Nurpeisov V, 2012, J AM GERIATR SOC, V60, pS36; Obeid R, 2013, BIOCHIMIE, V95, P1056, DOI 10.1016/j.biochi.2012.10.028; Pflipsen MC, 2009, J AM BOARD FAM MED, V22, P528, DOI 10.3122/jabfm.2009.05.090044; Plodkowski RA, 2010, J AM GERIATR SOC, V58, P185; Pongchaidecha Manat, 2004, Journal of the Medical Association of Thailand, V87, P780; Prabhu M, 2010, INDIAN J PHARM SCI, V72, P280; Radfar M, 2011, INT J CLIN PHARM-NET, V33, P339; Rajendran R, 2011, DIABETIC MED, V28, P136; Reinstatler L, 2012, DIABETES CARE, V35, P327, DOI 10.2337/dc11-1582; Sahin M, 2007, J DIABETES COMPLICAT, V21, P118, DOI 10.1016/j.jdiacomp.2005.10.005; Sato Y, 2013, ENDOCR J, V60, P1275, DOI 10.1507/endocrj.EJ13-0332; Tal S, 2010, J AM GERIATR SOC, V58, P523, DOI 10.1111/j.1532-5415.2010.02721.x; Ting RZW, 2006, ARCH INTERN MED, V166, P1975, DOI 10.1001/archinte.166.18.1975; TOMKIN GH, 1973, BRIT MED J, V3, P673, DOI 10.1136/bmj.3.5882.673; TOMKIN GH, 1971, BMJ-BRIT MED J, V2, P685, DOI 10.1136/bmj.2.5763.685; Toth C, 2009, J PERIPHER NERV SYST, V14, P245; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Vischer UM, 2009, DIABETOLOGIA, V52, pS352; Vrbikova J, 2002, EXP CLIN ENDOCR DIAB, V110, P74, DOI 10.1055/s-2002-23489; Wile DJ, 2010, DIABETES CARE, V33, P156, DOI 10.2337/dc09-0606; Wolever TMS, 2000, NUTR RES, V20, P1447, DOI 10.1016/S0271-5317(00)80025-1; Wulffele MG, 2003, J INTERN MED, V254, P455, DOI 10.1046/j.1365-2796.2003.01213.x	55	76	79	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100379	10.1371/journal.pone.0100379	http://dx.doi.org/10.1371/journal.pone.0100379			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959880	Green Submitted, gold, Green Published			2022-12-27	WOS:000338633900042
J	Zhang, HX; Wu, J; Yu, LP				Zhang, Hongxiu; Wu, Jie; Yu, Lipeng			Association of Gln27Glu and Arg16Gly Polymorphisms in Beta2-Adrenergic Receptor Gene with Obesity Susceptibility: A Meta-Analysis	PLOS ONE			English	Article							BODY-MASS INDEX; BETA(2)-ADRENOCEPTOR GENE; BETA-2-ADRENERGIC RECEPTOR; LONGITUDINAL CHANGES; WOMEN; RISK; VARIANT; BETA-2; ADRB2; HYPERTRIGLYCERIDEMIA	Background: The beta2-adrenergic receptor (ADRB2) gene polymorphism has been implicated in susceptibility to obesity, but study results are still controversial. Objective: The present meta-analysis is performed to determine whether there are any associations between the Gln27Glu (rs1042714) or the Arg16Gly (rs1042713) polymorphisms in ADRB2 and obesity susceptibility. Methods: The PubMed (1950-2014), Embase (1974-2014), and China National Knowledge Infrastructure (CNKI, 1994-2014) databases were searched using the search terms ("Beta2-adrenergic receptor'', "beta 2-adrenergic receptor'' or "ADRB2''), "polymorphism,'' and "obesity''. Fixed-or random-effects pooled measures were determined on the bias of heterogeneity tests across studies. Publication bias was examined by Egger's test and the modified Begg's test. Results: Eighteen published articles were selected for meta-analysis. Overall analyses showed that rs1042714 (Gln27Glu) was associated with significantly increased obesity risk in the heterozygote model (Gln/Glu vs. Gln/Gln: OR: 1.16, 95% CI: 1.04-1.30, I-2= 49%, P = 0.009) and the dominant model (Gln/Glu + Glu/Glu vs. Gln/Gln: OR: 1.2, 95% CI: 1.00-1.44, I-2 = 55%, P = 0.04), whereas no significant association was found in the other models for rs1042714. Also, no significant association was found between the rs1042713 (Arg16Gly) gene polymorphism and the risk of obesity in all genetic models. In addition, neither rs1042713 (Arg16Gly) nor rs1042714 (Gln27Glu) showed any significant association with obesity susceptibility when the population were stratified based on gender. Conclusion: Our meta-analysis revealed that the rs1042714 (Gln27Glu) polymorphism is associated with obesity susceptibility. However, our results do not support an association between rs1042713 (Arg16Gly) polymorphisms and obesity in the populations investigated. This conclusion warrants confirmation by more case-control and cohort studies.	[Zhang, Hongxiu; Wu, Jie] Nanjing Med Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Nanjing, Jiangsu, Peoples R China; [Wu, Jie] Nanjing Med Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Yu, Lipeng] Nanjing Med Univ, Affiliated Hosp 1, Dept Orthopaed, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Zhang, HX (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Nanjing, Jiangsu, Peoples R China.	hongxiuz@hotmail.com			Priority Academic Program Development of Jiangsu Higher Education Institutions; Jiangsu Province Foundation for Women's Health [F201201]; Jiangsu Women and Children Health Hospital [FXK201201]; Jiangsu Health International Exchange Program sponsorship of Jiangsu Province Department of Health [JSH-2010-004]	Priority Academic Program Development of Jiangsu Higher Education Institutions; Jiangsu Province Foundation for Women's Health; Jiangsu Women and Children Health Hospital; Jiangsu Health International Exchange Program sponsorship of Jiangsu Province Department of Health	Funding for this project was provided by grants from the Priority Academic Program Development of Jiangsu Higher Education Institutions, the Jiangsu Province Foundation for Women's Health (F201201), and the Jiangsu Women and Children Health Hospital (FXK201201), and the Jiangsu Health International Exchange Program sponsorship of Jiangsu Province Department of Health (JSH-2010-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeli CB, 2011, OBESITY, V19, P1244, DOI 10.1038/oby.2010.325; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Caramelli D, 2012, PLOS ONE, V7; Carlsson M, 2001, DIABETOLOGIA, V44, P629, DOI 10.1007/s001250051670; Chou YC, 2012, PEDIATR INT, V54, P111, DOI 10.1111/j.1442-200X.2011.03516.x; de Oliveira CM, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-32; Echwald SM, 1998, DIABETES, V47, P1657, DOI 10.2337/diabetes.47.10.1657; Ehrenborg E, 2000, J INTERN MED, V247, P651, DOI 10.1046/j.1365-2796.2000.00669.x; Ellsworth DL, 2005, OBES RES, V13, P519, DOI 10.1038/oby.2005.55; Ellsworth DL, 2002, INT J OBESITY, V26, P928, DOI 10.1038/sj.ijo.0802020; Gjesing AP, 2007, DIABETOLOGIA, V50, P563, DOI 10.1007/s00125-006-0578-8; Sanchez JLG, 2003, CLIN ENDOCRINOL, V59, P476, DOI 10.1046/j.1365-2265.2003.01871.x; Hayakawa T, 2000, METABOLISM, V49, P1215, DOI 10.1053/meta.2000.8622; Hellstrom L, 1999, J INTERN MED, V245, P253, DOI 10.1046/j.1365-2796.1999.0437e.x; Ishiyama-Shigemoto S, 1999, DIABETOLOGIA, V42, P98, DOI 10.1007/s001250051120; Iwamoto N, 2001, CLIN CHIM ACTA, V314, P85, DOI 10.1016/S0009-8981(01)00633-7; Jalba MS, 2008, OBESITY, V16, P2096, DOI 10.1038/oby.2008.327; Kim SH, 2002, METABOLISM, V51, P833, DOI 10.1053/meta.2002.33347; Kortner B, 1999, INT J OBESITY, V23, P1099, DOI 10.1038/sj.ijo.0801063; Large V, 1997, J CLIN INVEST, V100, P3005, DOI 10.1172/JCI119854; Lee S, 2011, ASIA PAC J CLIN NUTR, V20, P563; Liu Zhao-qian, 2007, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V32, P359; Malczewska-Malec M, 2003, MED SCI MONITOR, V9, pCR225; Martinez JA, 2003, J NUTR, V133, P2549, DOI 10.1093/jn/133.8.2549; Masuo K, 2006, AM J HYPERTENS, V19, P1084, DOI 10.1016/j.amjhyper.2006.02.015; Matsuoka H, 2004, ACTA PAEDIATR, V93, P430, DOI 10.1080/08035250410023764; Mattevi VS, 2006, AM J HUM BIOL, V18, P182, DOI 10.1002/ajhb.20486; Meirhaeghe A, 2000, INT J OBESITY, V24, P382, DOI 10.1038/sj.ijo.0801168; Mori Y, 1999, BIOCHEM BIOPH RES CO, V258, P138, DOI 10.1006/bbrc.1999.0607; Naka I OJ, 2013, LIPIDS HLTH DIS, V12, P1; Oberkofler H, 2000, INT J OBESITY, V24, P388, DOI 10.1038/sj.ijo.0801180; OConnell D, 2019, NEWCASTLE OTTAWA SCA; Pereira TV, 2011, OBESITY, V19, P1523, DOI 10.1038/oby.2010.322; Phares DA, 2004, OBES RES, V12, P807, DOI 10.1038/oby.2004.97; Rauhio A, 2013, MATURITAS, V76, P165, DOI 10.1016/j.maturitas.2013.07.004; REIHSAUS E, 1993, AM J RESP CELL MOL, V8, P334, DOI 10.1165/ajrcmb/8.3.334; Ruiz JR, 2011, OBESITY, V19, P212, DOI 10.1038/oby.2010.130; Sakane N, 1999, LANCET, V353, P1976, DOI 10.1016/S0140-6736(05)77192-0; Speakman JR, 2004, J NUTR, V134, p2090S, DOI 10.1093/jn/134.8.2090S; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Terra SG, 2005, INT J OBESITY, V29, P746, DOI 10.1038/sj.ijo.0802978; Ukkola O, 2000, METABOLISM, V49, P1063, DOI 10.1053/meta.2000.7708; Wu Hong-Mei, 2009, Sichuan Da Xue Xue Bao Yi Xue Ban, V40, P1056; ZAMBONI P, 1954, Arch Sci Biol (Bologna), V38, P575	44	16	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100489	10.1371/journal.pone.0100489	http://dx.doi.org/10.1371/journal.pone.0100489			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24960039	Green Published, Green Submitted, gold			2022-12-27	WOS:000338633900051
J	Carethers, JM; Murali, B; Yang, B; Doctolero, RT; Tajima, A; Basa, R; Smith, EJ; Lee, M; Janke, R; Ngo, T; Tejada, R; Ji, M; Kinseth, M; Cabrera, BL; Miyai, K; Keku, TO; Martin, CF; Galanko, JA; Sandler, RS; McGuire, KL				Carethers, John M.; Murali, Bhavya; Yang, Bing; Doctolero, Ryan T.; Tajima, Akihiro; Basa, Ranor; Smith, E. Julieta; Lee, Monte; Janke, Ryan; Ngo, Tina; Tejada, Ruth; Ji, Ming; Kinseth, Matthew; Cabrera, Betty L.; Miyai, Katsumi; Keku, Temitope O.; Martin, Christopher F.; Galanko, Joseph A.; Sandler, Robert S.; McGuire, Kathleen L.			Influence of Race on Microsatellite Instability and CD8(+) T Cell Infiltration in Colon Cancer	PLOS ONE			English	Article							COLORECTAL-CANCER; AFRICAN-AMERICANS; PATHOGENESIS; STATISTICS; TUMORS	African American patients with colorectal cancer show higher mortality than their Caucasian counterparts. Biology might play a partial role, and prior studies suggest a higher prevalence for microsatellite instability (MSI) among cancers from African Americans, albeit patients with MSI cancers have improved survival over patients with non-MSI cancers, counter to the outcome observed for African American patients. CD8(+) T cell infiltration of colon cancer is postively correlated with MSI tumors, and is also related to improved outcome. Here, we utilized a 503-person, population-based colon cancer cohort comprising 45% African Americans to determine, under blinded conditions from all epidemiological data, the prevalence of MSI and associated CD8(+) T cell infiltration within the cancers. Among Caucasian cancers, 14% were MSI, whereas African American cancers demonstrated 7% MSI (P = 0.009). Clinically, MSI cancers between races were similar; among microsatellite stable cancers, African American patients were younger, female, and with proximal cancers. CD8(+) T cells were higher in MSI cancers (88.0 vs 30.4/hpf, P<0.0001), but was not different between races. Utilizing this population-based cohort, African American cancers show half the MSI prevalence of Caucasians without change in CD8(+) T cell infiltration which may contribute towards their higher mortality from colon cancer.	[Carethers, John M.] Univ Michigan, Dept Internal Med, Div Gastroenterol, Ann Arbor, MI 48109 USA; [Murali, Bhavya; Yang, Bing; Basa, Ranor; Lee, Monte; Janke, Ryan; Ngo, Tina; Tejada, Ruth; Kinseth, Matthew; McGuire, Kathleen L.] San Diego State Univ, Inst Mol Biol, Dept Biol, San Diego, CA 92182 USA; [Ji, Ming] San Diego State Univ, Grad Sch Publ Hlth, San Diego, CA 92182 USA; [Carethers, John M.; Doctolero, Ryan T.; Tajima, Akihiro; Smith, E. Julieta; Cabrera, Betty L.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Miyai, Katsumi] Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA; [Carethers, John M.] Univ Calif San Diego, Moores Canc Ctr, San Diego, CA 92103 USA; [Keku, Temitope O.; Martin, Christopher F.; Sandler, Robert S.] Univ N Carolina, Dept Med, Chapel Hill, NC USA; [Galanko, Joseph A.; Sandler, Robert S.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA	University of Michigan System; University of Michigan; California State University System; San Diego State University; California State University System; San Diego State University; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Carethers, JM (corresponding author), Univ Michigan, Dept Internal Med, Div Gastroenterol, Ann Arbor, MI 48109 USA.	jcarethe@umich.edu	Tajima, Akihiro/AAK-8017-2020; Tajima, Akihiro/AAF-4912-2020	Tajima, Akihiro/0000-0003-4008-5048; Basa, Ranor/0000-0001-8412-8770	National Cancer Institute [U54CA132384, U54CA132379];  [R01 DK067287];  [U01 CA162147];  [P30 DK034987]; NATIONAL CANCER INSTITUTE [U54CA132384, U54CA132379] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034987] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded in part by the National Cancer Institute Comprehensive Partnerships to Reduce Cancer Health Disparities (CPRCHD) grants U54CA132384 and U54CA132379, and by grants R01 DK067287, U01 CA162147, and P30 DK034987. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashktorab H, 2003, CLIN CANCER RES, V9, P1112; Baker K, 2009, CANCER IMMUNOL IMMUN, V58, P135, DOI 10.1007/s00262-008-0534-1; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; Carethers J M, 1999, J Assoc Acad Minor Phys, V10, P59; Carethers JM, 2004, GASTROENTEROLOGY, V126, P394, DOI 10.1053/j.gastro.2003.12.023; Carethers JM, 2005, NAT CLIN PRACT GASTR, V2, P352, DOI 10.1038/ncpgasthep0241; Carethers JM, 2014, GASTROENTEROLOGY, V146, P602, DOI 10.1053/j.gastro.2014.01.041; Carethers JM, 2011, GASTROENTEROLOGY, V141, P411, DOI 10.1053/j.gastro.2011.06.029; DeSantis C, 2013, CA-CANCER J CLIN, V63, P151, DOI 10.3322/caac.21173; Devaraj B, 2010, J GASTROINTEST SURG, V14, P1521, DOI 10.1007/s11605-010-1340-6; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Garcia M, 2012, GASTROENTEROLOGY, V143, P48, DOI 10.1053/j.gastro.2012.03.034; Grady WM, 2008, GASTROENTEROLOGY, V135, P1079, DOI 10.1053/j.gastro.2008.07.076; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Lee SY, 2012, DIGEST DIS SCI, V57, P72, DOI 10.1007/s10620-011-1825-5; Leggett B, 2010, GASTROENTEROLOGY, V138, P2088, DOI 10.1053/j.gastro.2009.12.066; Lieberman DA, 2008, JAMA-J AM MED ASSOC, V300, P1417, DOI 10.1001/jama.300.12.1417; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Popat S, 2005, J CLIN ONCOL, V23, P609, DOI 10.1200/JCO.2005.01.086; Ribic CM, 2003, NEW ENGL J MED, V349, P247, DOI 10.1056/NEJMoa022289; Satia JA, 2005, CANCER EPIDEM BIOMAR, V14, P429, DOI 10.1158/1055-9965.EPI-04-0486; Schwitalle Y, 2008, GASTROENTEROLOGY, V134, P988, DOI 10.1053/j.gastro.2008.01.015; Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220; Tseng-Rogenski SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050616	24	63	63	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100461	10.1371/journal.pone.0100461	http://dx.doi.org/10.1371/journal.pone.0100461			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956473	Green Submitted, Green Published, gold			2022-12-27	WOS:000338917900054
J	Almarza, G; Sanchez, F; Barrantes, FJ				Almarza, Gonzalo; Sanchez, Francisco; Barrantes, Francisco J.			Transient Cholesterol Effects on Nicotinic Acetylcholine Receptor Cell-Surface Mobility	PLOS ONE			English	Article							SINGLE-PARTICLE TRACKING; LIPID RAFTS; PROTEIN HETEROGENEITY; LATERAL DIFFUSION; DYNAMICS; ORGANIZATION; ACTIN; SITES; MAINTENANCE; CLUSTERS	To what extent do cholesterol-rich lipid platforms modulate the supramolecular organization of the nicotinic acetylcholine receptor (AChR)? To address this question, the dynamics of AChR particles at high density and its cholesterol dependence at the surface of mammalian cells were studied by combining total internal reflection fluorescence microscopy and single-particle tracking. AChR particles tagged with a monovalent ligand, fluorescent alpha-bungarotoxin (alpha BTX), exhibited two mobile pools: i) a highly mobile one undergoing simple Brownian motion (16%) and ii) one with restricted motion (similar to 50%), the rest being relatively immobile (similar to 44%). Depletion of membrane cholesterol by methyl-alpha-cyclodextrin increased the fraction of the first pool to 22% and 33% after 15 and 40 min, respectively; the pool undergoing restricted motion diminished from 50% to 44% and 37%, respectively. Monoclonal antibody binding results in AChR crosslinking-internalization after 2 h; here, antibody binding immobilized within minutes similar to 20% of the totally mobile AChR. This proportion dramatically increased upon cholesterol depletion, especially during the initial 10 min (83.3%). Thus, antibody crosslinking and cholesterol depletion exhibited a mutually synergistic effect, increasing the average lifetime of cell-surface AChRs similar to 10 s to similar to 20 s. The instantaneous (microscopic) diffusion coefficient D2-4 of the AChR obtained from the MSD analysis diminished from similar to 0.001 mu m(2) s(-1) to similar to 0.0001-0.00033 mu m(2) s(-1) upon cholesterol depletion, similar to 30% of all particles falling into the stationary mode. Thus, muscle-type AChR exhibits heterogeneous motional regimes at the cell surface, modulated by the combination of intrinsic (its supramolecular organization) and extrinsic (membrane cholesterol content) factors.	[Barrantes, Francisco J.] Pontifical Catholic Univ Argentina UCA, Biomed Res Inst, Mol Neurobiol Lab, Buenos Aires, DF, Argentina; Natl Sci & Tech Res Council Argentina CONICET, Buenos Aires, DF, Argentina	Pontifical Catholic University of Argentina	Barrantes, FJ (corresponding author), Pontifical Catholic Univ Argentina UCA, Biomed Res Inst, Mol Neurobiol Lab, Buenos Aires, DF, Argentina.	rtfjb1@yahoo.com	Barrantes, Francisco J./HCH-0258-2022	Barrantes, Francisco J./0000-0002-4745-681X; Sanchez, Francisco/0000-0002-8795-168X	PICT from FONCYT [2008-1003, 2011-0604]; Ministry of Science and Technology of Argentina; PIP from the National Scientific and Technical Research Council of Argentina (CONICET) [112-201101-01023]	PICT from FONCYT; Ministry of Science and Technology of Argentina; PIP from the National Scientific and Technical Research Council of Argentina (CONICET)	Grants PICT 2008-1003 and 2011-0604 from FONCYT, Ministry of Science and Technology of Argentina and PIP No. No 112-201101-01023 from the National Scientific and Technical Research Council of Argentina (CONICET) to FJB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaaboune M, 1999, SCIENCE, V286, P503, DOI 10.1126/science.286.5439.503; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; AXELROD D, 1980, P NATL ACAD SCI-BIOL, V77, P4823, DOI 10.1073/pnas.77.8.4823; Axelrod D, 2001, TRAFFIC, V2, P764, DOI 10.1034/j.1600-0854.2001.21104.x; Baier CJ, 2010, EUR BIOPHYS J BIOPHY, V39, P213, DOI 10.1007/s00249-009-0521-2; BARRANTES FJ, 1989, CRIT REV BIOCHEM MOL, V24, P437, DOI 10.3109/10409238909086961; Barrantes FJ, 2004, BRAIN RES REV, V47, P71, DOI 10.1016/j.brainresrev.2004.06.008; BARRANTES FJ, 1979, ANNU REV BIOPHYS BIO, V8, P287, DOI 10.1146/annurev.bb.08.060179.001443; Barrantes FJ, 2007, J NEUROCHEM, V103, P72, DOI 10.1111/j.1471-4159.2007.04719.x; Barrantes FJ, 2010, SUBCELL BIOCHEM, V51, P467, DOI 10.1007/978-90-481-8622-8_17; BLOCH RJ, 1989, EXP CELL RES, V182, P583, DOI 10.1016/0014-4827(89)90261-9; Borroni V, 2007, MOL MEMBR BIOL, V24, P1, DOI 10.1080/09687860600903387; Bruneau EG, 2006, DEVELOPMENT, V133, P4485, DOI 10.1242/dev.02619; Bruses JL, 2001, J NEUROSCI, V21, P504, DOI 10.1523/JNEUROSCI.21-02-00504.2001; Burli T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011507; Campagna JA, 2006, NEUROSCIENCE, V138, P123, DOI 10.1016/j.neuroscience.2005.11.019; Choquet D, 2003, NAT REV NEUROSCI, V4, P251, DOI 10.1038/nrn1077; CRIADO M, 1982, BIOCHEMISTRY-US, V21, P3622, DOI 10.1021/bi00258a015; Dai ZS, 2000, J CELL BIOL, V150, P1321, DOI 10.1083/jcb.150.6.1321; Dedecker P, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.12.126008; Feder TJ, 1996, BIOPHYS J, V70, P2767, DOI 10.1016/S0006-3495(96)79846-6; Fernandes CC, 2010, J NEUROSCI, V30, P8841, DOI 10.1523/JNEUROSCI.6236-09.2010; GETIS A, 1987, ECOLOGY, V68, P473, DOI 10.2307/1938452; Gomez-Varela D, 2013, J NEUROSCI, V 33, P17062, DOI 10.1523/JNEUROSCI.1482-13.2013; Greenfield D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000137; Gupta GD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006768; Henriques R, 2010, NAT METHODS, V7, P339, DOI 10.1038/nmeth0510-339; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Jaqaman K, 2008, NAT METHODS, V5, P695, DOI 10.1038/nmeth.1237; Kellner RR, 2007, NEUROSCIENCE, V144, P135, DOI 10.1016/j.neuroscience.2006.08.071; Kenworthy AK, 2004, J CELL BIOL, V165, P735, DOI 10.1083/jcb.200312170; Kiskowski MA, 2009, BIOPHYS J, V97, P1095, DOI 10.1016/j.bpj.2009.05.039; Kumari S, 2008, J CELL BIOL, V181, P1179, DOI 10.1083/jcb.200709086; KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0; LEE GM, 1991, P NATL ACAD SCI USA, V88, P6274, DOI 10.1073/pnas.88.14.6274; LEIBEL WS, 1987, BIOCHIM BIOPHYS ACTA, V897, P249, DOI 10.1016/0005-2736(87)90421-4; MARSH D, 1978, P NATL ACAD SCI USA, V75, P4329, DOI 10.1073/pnas.75.9.4329; McCann CM, 2008, NAT NEUROSCI, V11, P807, DOI 10.1038/nn.2145; Nishimura SY, 2006, BIOPHYS J, V90, P927, DOI 10.1529/biophysj.105.070524; Niv H, 2002, J CELL BIOL, V157, P865, DOI 10.1083/jcb.200202009; O'Connell KMS, 2005, J CELL SCI, V118, P2155, DOI 10.1242/jcs.02348; Oliferenko S, 1999, J CELL BIOL, V146, P843, DOI 10.1083/jcb.146.4.843; Orr G, 2005, BIOPHYS J, V89, P1362, DOI 10.1529/biophysj.104.056192; Owen DM, 2010, J BIOPHOTONICS, V3, P446, DOI 10.1002/jbio.200900089; Pediconi MF, 2004, NEUROSCIENCE, V128, P239, DOI 10.1016/j.neuroscience.2004.06.007; Perry GLW, 2006, PLANT ECOL, V187, P59, DOI 10.1007/s11258-006-9133-4; Perry GLW, 2004, ENVIRON MODELL SOFTW, V19, P559, DOI 10.1016/j.envsoft.2003.07.004; Piguet J, 2011, J BIOL CHEM, V286, P363, DOI 10.1074/jbc.M110.139782; PUMPLIN DW, 1989, J CELL BIOL, V109, P739, DOI 10.1083/jcb.109.2.739; Qian H, 1991, BIOPHYS J, V60, P910, DOI 10.1016/S0006-3495(91)82125-7; RIPLEY BD, 1977, J ROY STAT SOC B MET, V39, P172; RIPLEY BD, 1979, J ROY STAT SOC B MET, V41, P368; Roccamo AM, 1999, EUR J NEUROSCI, V11, P1615, DOI 10.1046/j.1460-9568.1999.00574.x; Rossy J, 2014, HISTOCHEM CELL BIOL; Rossy J, 2013, NAT IMMUNOL, V14, P82, DOI 10.1038/ni.2488; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; SAXTON MJ, 1995, BIOPHYS J, V69, P389, DOI 10.1016/S0006-3495(95)79911-8; Saxton MJ, 1997, BIOPHYS J, V72, P1744, DOI 10.1016/S0006-3495(97)78820-9; Sengupta P, 2013, NAT PROTOC, V8, P345, DOI 10.1038/nprot.2013.005; Sengupta P, 2011, NAT METHODS, V8, P969, DOI [10.1038/nmeth.1704, 10.1038/NMETH.1704]; Serge A, 2008, NAT METHODS, V5, P687, DOI 10.1038/nmeth.1233; Shvartsman DE, 2006, TRAFFIC, V7, P917, DOI 10.1111/j.1600-0854.2006.00437.x; Sieber JJ, 2007, SCIENCE, V317, P1072, DOI 10.1126/science.1141727; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SIMONS K, 1988, BIOCHEMISTRY-US, V27, P6197, DOI 10.1021/bi00417a001; Simonson PD, 2010, BIOPHYS J, V99, pL81, DOI 10.1016/j.bpj.2010.08.076; Stetzkowski-Marden F, 2006, J LIPID RES, V47, P2121, DOI 10.1194/jlr.M600182-JLR200; Tejedor V, 2010, BIOPHYS J, V98, P1364, DOI 10.1016/j.bpj.2009.12.4282; Veatch SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031457; Vrljic M, 2005, BIOPHYS J, V88, P334, DOI 10.1529/biophsj.104.045989; Williamson DJ, 2011, NAT IMMUNOL, V12, P655, DOI 10.1038/ni.2049; Willmann R, 2006, EMBO J, V25, P4050, DOI 10.1038/sj.emboj.7601288; Zhu D, 2006, J NEUROSCI, V26, P4841, DOI 10.1523/JNEUROSCI.2807-05.2006	73	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100346	10.1371/journal.pone.0100346	http://dx.doi.org/10.1371/journal.pone.0100346			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971757	Green Published, gold			2022-12-27	WOS:000338512200026
J	Chen, LZ; Li, XY; Huang, H; Xing, W; Guo, W; He, J; Sun, ZY; Luo, AX; Liang, HP; Hu, J; Xu, X; Xu, YS; Wang, ZG				Chen, Li-zhao; Li, Xiang-yun; Huang, Hong; Xing, Wei; Guo, Wei; He, Jing; Sun, Zhi-ya; Luo, An-xiong; Liang, Hua-ping; Hu, Jing; Xu, Xiang; Xu, Yun-sheng; Wang, Zheng-guo			SUMO-2 Promotes mRNA Translation by Enhancing Interaction between eIF4E and eIF4G	PLOS ONE			English	Article							INITIATION-FACTOR 4E; UBIQUITIN-CONJUGATING ENZYME; PROTEIN-SYNTHESIS; GENE-EXPRESSION; PHAS-I; PHOSPHORYLATION; SUMOYLATION; INSULIN; BINDING; IDENTIFICATION	Small ubiquitin-like modifier (SUMO) proteins regulate many important eukaryotic cellular processes through reversible covalent conjugation to target proteins. In addition to its many well-known biological consequences, like subcellular translocation of protein, subnuclear structure formation, and modulation of transcriptional activity, we show here that SUMO-2 also plays a role in mRNA translation. SUMO-2 promoted formation of the active eukaryotic initiation factor 4F (eIF4F) complex by enhancing interaction between Eukaryotic Initiation Factor 4E (eIF4E) and Eukaryotic Initiation Factor 4G (eIF4G), and induced translation of a subset of proteins, such as cyclinD1 and c-myc, which essential for cell proliferation and apoptosis. As expected, overexpression of SUMO-2 can partially cancel out the disrupting effect of 4EGI-1, a small molecule inhibitor of eIF4E/eIF4G interaction, on formation of the eIF4F complex, translation of the cap-dependent protein, cell proliferation and apoptosis. On the other hand, SUMO-2 knockdown via shRNA partially impaired cap-dependent translation and cell proliferation and promoted apoptosis. These results collectively suggest that SUMO-2 conjugation plays a crucial regulatory role in protein synthesis. Thus, this report might contribute to the basic understanding of mammalian protein translation and sheds some new light on the role of SUMO in this process.	[Chen, Li-zhao; Li, Xiang-yun; Huang, Hong; Xing, Wei; Guo, Wei; Liang, Hua-ping; Xu, Xiang] Third Mil Med Univ, Inst Surg Res, State Key Lab Trauma Burn & Combined Injury, Dept 1, Chongqing, Peoples R China; [Chen, Li-zhao; Li, Xiang-yun; Huang, Hong; Xing, Wei; Guo, Wei; He, Jing; Sun, Zhi-ya; Luo, An-xiong; Liang, Hua-ping; Xu, Xiang; Wang, Zheng-guo] Third Mil Med Univ, Daping Hosp, Chongqing, Peoples R China; [Chen, Li-zhao] Third Mil Med Univ, Inst Surg Res, Dept Neurosurg, Chongqing, Peoples R China; [Li, Xiang-yun; He, Jing; Sun, Zhi-ya; Luo, An-xiong; Xu, Xiang] Third Mil Med Univ, Inst Surg Res, Cell Based Biotherapy Ctr, Chongqing, Peoples R China; [Wang, Zheng-guo] Third Mil Med Univ, Inst Surg Res, State Key Lab Trauma Burn & Combined Injury, Dept 4, Chongqing, Peoples R China; [Hu, Jing] Univ Pittsburgh, Sch Med, Inst Canc, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA; [Xu, Yun-sheng] Wenzhou Med Coll, Affiliated Hosp 1, Dept Dermatol, Wenzhou, Zhejiang, Peoples R China	Army Medical University; Army Medical University; Army Medical University; Army Medical University; Army Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Wenzhou Medical University	Xu, X (corresponding author), Third Mil Med Univ, Inst Surg Res, State Key Lab Trauma Burn & Combined Injury, Dept 1, Chongqing, Peoples R China.	xiangxu@ymail.com; xuyunsh@sohu.com; wangzhg@cae.cn	Hu, Jing/M-3130-2014; xu, xiang/L-2579-2014	Huang, Hong/0000-0001-7688-3506; xu, xiang/0000-0002-1026-2210	National Natural Science Foundation of China (NSFC) [81172988, 30970651, 30972800]; National Natural Science Foundation of Chongqing [CSTC, 2014yykfB0196]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Chongqing	This study was supported by the National Natural Science Foundation of China (NSFC, No. 81172988; No. 30970651; 30972800) and the National Natural Science Foundation of Chongqing (No. CSTC, 2014yykfB0196). But The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALKHODAIRY F, 1995, J CELL SCI, V108, P475; Bischof O, 2007, CELL CYCLE, V6, P677, DOI 10.4161/cc.6.6.4021; Bohren KM, 2004, J BIOL CHEM, V279, P27233, DOI 10.1074/jbc.M402273200; Chen LJ, 2002, TOXICOL SCI, V69, P149, DOI 10.1093/toxsci/69.1.149; Fan SQ, 2010, NEOPLASIA, V12, P346, DOI 10.1593/neo.10144; Finkbeiner E, 2011, EMBO J, V30, P1067, DOI 10.1038/emboj.2011.33; FREDERICKSON RM, 1991, MOL CELL BIOL, V11, P2896, DOI 10.1128/MCB.11.5.2896; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; GRAVES LM, 1995, P NATL ACAD SCI USA, V92, P7222, DOI 10.1073/pnas.92.16.7222; Gutierrez GJ, 2006, TRENDS BIOCHEM SCI, V31, P324, DOI 10.1016/j.tibs.2006.04.001; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; HAYSTEAD TAJ, 1994, J BIOL CHEM, V269, P23185; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Johnson ES, 1997, J BIOL CHEM, V272, P26799, DOI 10.1074/jbc.272.43.26799; JOSHIBARVE S, 1990, J BIOL CHEM, V265, P2979; Kamitani T, 1998, J BIOL CHEM, V273, P11349, DOI 10.1074/jbc.273.18.11349; Kim KI, 2006, MOL CELLS, V22, P247; Lapenta V, 1997, GENOMICS, V40, P362, DOI 10.1006/geno.1996.4556; Lee JS, 2004, GASTROENTEROLOGY, V127, pS51, DOI 10.1053/j.gastro.2004.09.015; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; LIN TA, 1994, SCIENCE, V266, P653, DOI 10.1126/science.7939721; MADER S, 1995, BIOCHIMIE, V77, P40, DOI 10.1016/0300-9084(96)88102-8; MAKKINJE A, 1995, J BIOL CHEM, V270, P14824, DOI 10.1074/jbc.270.24.14824; McDoniels-Silvers AL, 2002, CLIN CANCER RES, V8, P1127; Meinecke I, 2007, P NATL ACAD SCI USA, V104, P5073, DOI 10.1073/pnas.0608773104; Mo YY, 2005, ONCOGENE, V24, P2677, DOI 10.1038/sj.onc.1208210; Moerke NJ, 2007, CELL, V128, P257, DOI 10.1016/j.cell.2006.11.046; MORLEY SJ, 1993, BIOCHIMIE, V75, P985, DOI 10.1016/0300-9084(93)90149-M; Mukhopadhyay D, 2007, TRENDS BIOCHEM SCI, V32, P286, DOI 10.1016/j.tibs.2007.05.002; Nie M, 2006, NUCLEIC ACIDS RES, V34, P5528, DOI 10.1093/nar/gkl584; Owerbach D, 2005, BIOCHEM BIOPH RES CO, V337, P517, DOI 10.1016/j.bbrc.2005.09.090; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; PFAHL M, 1990, METHOD ENZYMOL, V189, P256; RINKERSCHAEFFER CW, 1992, J BIOL CHEM, V267, P10659; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Sarge KD, 2009, TRENDS BIOCHEM SCI, V34, P200, DOI 10.1016/j.tibs.2009.01.004; Scheper GC, 2002, EUR J BIOCHEM, V269, P5350, DOI 10.1046/j.1432-1033.2002.03291.x; Seeler JS, 2007, CURR TOP MICROBIOL, V313, P49; SEUFERT W, 1995, NATURE, V373, P78, DOI 10.1038/373078a0; Shayeghi M, 1997, NUCLEIC ACIDS RES, V25, P1162, DOI 10.1093/nar/25.6.1162; Wang J, 2007, BIOCHEM BIOPH RES CO, V363, P63, DOI 10.1016/j.bbrc.2007.08.125; Wang LM, 2004, ONCOL REP, V11, P1319; Wilson VG, 2008, EXPERT REV PROTEOMIC, V5, P121, DOI 10.1586/14789450.5.1.121; Xu XA, 2010, J BIOL CHEM, V285, P18139, DOI 10.1074/jbc.C110.131599; Xu X, 2010, EMBO REP, V11, P299, DOI 10.1038/embor.2010.18; Yang W, 2009, BIOCHEM BIOPH RES CO, V382, P215, DOI 10.1016/j.bbrc.2009.03.013	48	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100457	10.1371/journal.pone.0100457	http://dx.doi.org/10.1371/journal.pone.0100457			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971752	Green Accepted, gold, Green Published			2022-12-27	WOS:000338512200034
J	Dougherty, MJ; Tran, HM; Stavila, V; Knierim, B; George, A; Auer, M; Adams, PD; Hadi, MZ				Dougherty, Michael J.; Tran, Huu M.; Stavila, Vitalie; Knierim, Bernhard; George, Anthe; Auer, Manfred; Adams, Paul D.; Hadi, Masood Z.			Cellulosic Biomass Pretreatment and Sugar Yields as a Function of Biomass Particle Size	PLOS ONE			English	Article							IONIC LIQUID PRETREATMENT; ENZYMATIC-HYDROLYSIS; LIGNIN CONTENT; DECONSTRUCTION; CELLULASE; ACID; BETA	Three lignocellulosic pretreatment techniques (ammonia fiber expansion, dilute acid and ionic liquid) are compared with respect to saccharification efficiency, particle size and biomass composition. In particular, the effects of switchgrass particle size (32-200) on each pretreatment regime are examined. Physical properties of untreated and pretreated samples are characterized using crystallinity, surface accessibility measurements and scanning electron microscopy (SEM) imaging. At every particle size tested, ionic liquid (IL) pretreatment results in greater cell wall disruption, reduced crystallinity, increased accessible surface area, and higher saccharification efficiencies compared with dilute acid and AFEX pretreatments. The advantages of using IL pretreatment are greatest at larger particle sizes (>75 mu m).	[Dougherty, Michael J.; Tran, Huu M.; Knierim, Bernhard; George, Anthe; Auer, Manfred; Adams, Paul D.; Hadi, Masood Z.] Joint BioEnergy Inst, Emeryville, CA USA; [Dougherty, Michael J.; Tran, Huu M.; Stavila, Vitalie; George, Anthe; Hadi, Masood Z.] Sandia Natl Labs, Livermore, CA USA; [Knierim, Bernhard; Auer, Manfred; Adams, Paul D.] Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA USA; [Adams, Paul D.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; United States Department of Energy (DOE); Sandia National Laboratories; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Hadi, MZ (corresponding author), NASA, Ames Res Ctr, Space BioSci Div, Synthet Biol Program, Moffett Field, CA 94035 USA.	Masood.Hadi@NASA.gov	Stavila, Vitalie/B-6464-2008; Adams, Paul David/A-1977-2013	Stavila, Vitalie/0000-0003-0981-0432; Adams, Paul David/0000-0001-9333-8219	U. S. Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-AC02-05CH11231]	U. S. Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE))	This work was part of the DOE Joint BioEnergy Institute (http://www.jbei.org) supported by the U. S. Department of Energy, Office of Science, Office of Biological and Environmental Research, through contract DE-AC02-05CH11231 between Lawrence Berkeley National Laboratory and the U. S. Department of Energy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora R, 2010, BIOENERG RES, V3, P134, DOI 10.1007/s12155-010-9087-1; Balan V, 2009, METHODS MOL BIOL, V581, P61, DOI 10.1007/978-1-60761-214-8_5; Berlin A, 2006, J BIOTECHNOL, V125, P198, DOI 10.1016/j.jbiotec.2006.02.021; Blanch HW, 2011, BIOTECHNOL J, V6, P1086, DOI 10.1002/biot.201000180; Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023; Carroll A, 2009, ANNU REV PLANT BIOL, V60, P165, DOI 10.1146/annurev.arplant.043008.092125; Cheng G, 2012, J PHYS CHEM B, V116, P10049, DOI 10.1021/jp304538v; Chundawat SPS, 2007, BIOTECHNOL BIOENG, V96, P219, DOI 10.1002/bit.21132; Chundawat SPS, 2011, ANNU REV CHEM BIOMOL, V2, P121, DOI 10.1146/annurev-chembioeng-061010-114205; Dasari RK, 2007, APPL BIOCHEM BIOTECH, V137, P289, DOI 10.1007/s12010-007-9059-x; Klein-Marcuschamer D, 2011, BIOFUEL BIOPROD BIOR, V5, P562, DOI 10.1002/bbb.303; Kumar R, 2009, BIORESOURCE TECHNOL, V100, P3948, DOI 10.1016/j.biortech.2009.01.075; Li CL, 2011, BIORESOURCE TECHNOL, V102, P6928, DOI 10.1016/j.biortech.2011.04.005; Li CL, 2010, BIORESOURCE TECHNOL, V101, P4900, DOI 10.1016/j.biortech.2009.10.066; Liu HB, 2012, J PHYS CHEM B, V116, P8131, DOI 10.1021/jp301673h; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Papa G, 2012, BIORESOURCE TECHNOL, V117, P352, DOI 10.1016/j.biortech.2012.04.065; Sluiter A., 2008, LAB ANAL PROCED, V1617, P1; Studer MH, 2011, P NATL ACAD SCI USA, V108, P6300, DOI 10.1073/pnas.1009252108; Yeh AI, 2010, CARBOHYD POLYM, V79, P192, DOI 10.1016/j.carbpol.2009.07.049; Zhang YHP, 2004, BIOTECHNOL BIOENG, V88, P797, DOI 10.1002/bit.20282	21	21	21	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100836	10.1371/journal.pone.0100836	http://dx.doi.org/10.1371/journal.pone.0100836			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971883	Green Submitted, gold, Green Published			2022-12-27	WOS:000338512200067
J	Pedersen, RO; Sandel, B; Svenning, JC				Pedersen, Rasmus Ostergaard; Sandel, Brody; Svenning, Jens-Christian			Macroecological Evidence for Competitive Regional-Scale Interactions between the Two Major Clades of Mammal Carnivores (Feliformia and Caniformia)	PLOS ONE			English	Article							AMERICAN BIOTIC INTERCHANGE; SPATIAL AUTOCORRELATION; LATE-PLEISTOCENE; EVOLUTION; HISTORY; NICHE; SYSTEMATICS; DIVERSITY; RICHNESS; PATTERNS	Geographical gradients in species diversity are often explained by environmental factors such as climate and productivity. Biotic interactions play a key role in evolutionary diversification and may therefore also affect diversity patterns, but this has rarely been assessed. Here, we investigate whether negative competitive interactions shape the diversity patterns of the two major mammalian clades of carnivores, the suborders Caniformia (dogs and allies) and Feliformia (cats and allies) within the order Carnivora. We specifically test for a negative effect of feliform species richness on caniform species richness by a natural experiment, The Great American Interchange, which due to biogeographic lineage history and climate patterns caused tropical South America to be colonized by most caniform families, but only one feliform family. To this end we used regression modelling to investigate feliform and caniform richness patterns and their determinants with emphasis on contrasting the Old and New World tropics. We find that feliform richness is elevated in the Old World Tropics, while caniform richness is elevated in the New World Tropics. Models based on environmental variables alone underpredict caniform richness and overpredict feliform richness in the New World and vice versa in the Old World. We further show that models including feliform richness as a predictor for caniform species richness significantly improve predictions at the continental scale, albeit not at finer scales. Our results are consistent with a negative effect of feliforms on regional-scale caniform diversification within the tropics, probably indicating that niche space occupancy by the one clade constrains diversification in the other in the build-up of regional faunas, while negative interactions at smaller scales may be unimportant due to niche differentiation within the regional faunas.	[Pedersen, Rasmus Ostergaard; Sandel, Brody; Svenning, Jens-Christian] Aarhus Univ, Dept Biosci, Sect Ecoinformat & Biodivers, Aarhus, Denmark	Aarhus University	Pedersen, RO (corresponding author), Aarhus Univ, Dept Biosci, Sect Ecoinformat & Biodivers, Aarhus, Denmark.	rasmus.oestergaard.pedersen@gmail.com	Pedersen, Rasmus Ø/AAA-2520-2020; Svenning, Jens-Christian/C-8977-2012	Pedersen, Rasmus Ø/0000-0001-8538-8646; Svenning, Jens-Christian/0000-0002-3415-0862	HISTFUNC (Macroecological studies of long-term HISTorical constraints on FUNCtional diversity and ecosystem functioning across continents) project (ERC (European Research Council)) [310886]	HISTFUNC (Macroecological studies of long-term HISTorical constraints on FUNCtional diversity and ecosystem functioning across continents) project (ERC (European Research Council))	This article is a contribution of the HISTFUNC (Macroecological studies of long-term HISTorical constraints on FUNCtional diversity and ecosystem functioning across continents) project (ERC (European Research Council) Starting Grant 310886 to J. -C. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, HEXAGON BINNING OVER; [Anonymous], 2014, R LANG ENV STAT COMP; Barycka E, 2007, MAMM BIOL, V72, P257, DOI 10.1016/j.mambio.2006.10.011; Berta A, 1998, EVOLUTION TERTIARY M, V1, P243; BIVAND R., 2014, SPDEP SPATIAL DEPEND; Bivand R, 2012, SPDEP SPATIAL DEPEND; Bjornstad O. N., 2013, NCF SPATIAL NONPARAM; Buckley LB, 2010, P ROY SOC B-BIOL SCI, V277, P2131, DOI 10.1098/rspb.2010.0179; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Calix M., 2018, EUROPEAN RED LIST SA; Diniz JAF, 2003, GLOBAL ECOL BIOGEOGR, V12, P53, DOI 10.1046/j.1466-822X.2003.00322.x; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Fukami T, 2007, NATURE, V446, P436, DOI 10.1038/nature05629; Hijmans R.J., 2019, GEOGRAPHIC DATA ANAL; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Jetz W, 2002, SCIENCE, V297, P1548, DOI 10.1126/science.1072779; Kissling WD, 2007, P ROY SOC B-BIOL SCI, V274, P799, DOI 10.1098/rspb.2006.0311; Kissling WD, 2008, GLOBAL ECOL BIOGEOGR, V17, P59, DOI 10.1111/j.1466-8238.2007.00334.x; Kok OB, 2004, BIOL J LINN SOC, V83, P527, DOI 10.1111/j.1095-8312.2004.00409.x; Kurten B., 1980, PLEISTOCENE MAMMALS; KurtUn B., 1968, PLEISTOCENE MAMMALS; Laliberte AS, 2004, BIOSCIENCE, V54, P123, DOI 10.1641/0006-3568(2004)054[0123:RCONAC]2.0.CO;2; Macdonald D, 2001, NEW ENCY MAMMALS; Moreno-Rueda G, 2009, ECOL RES, V24, P335, DOI 10.1007/s11284-008-0509-x; Murphy KM, 1998, URSUS-SERIES, V10, P55; Palomares F, 1999, AM NAT, V153, P492, DOI 10.1086/303189; Pinzon JE, 2005, INTERD MATH SCI, V5, P167; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Sandom C, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3254; Sommer R, 2005, MAMM BIOL, V70, P227, DOI 10.1016/j.mambio.2004.12.001; Sommer RS, 2006, J ZOOL, V269, P7, DOI 10.1111/j.1469-7998.2005.00040.x; Tucker C.J., 2004, GLOBAL INVENTORY MOD; Tucker CJ, 2005, INT J REMOTE SENS, V26, P4485, DOI 10.1080/01431160500168686; Van Valkenburgh B, 1999, ANNU REV EARTH PL SC, V27, P463, DOI 10.1146/annurev.earth.27.1.463; Van Valkenburgh B, 2007, INTEGR COMP BIOL, V47, P147, DOI 10.1093/icb/icm016; VANVALKENBURGH B, 1991, PALEOBIOLOGY, V17, P340, DOI 10.1017/S0094837300010691; Veron G, 2004, MOL PHYLOGENET EVOL, V30, P582, DOI 10.1016/S1055-7903(03)00229-X; Wang SW, 2009, J ZOOL, V277, P275, DOI 10.1111/j.1469-7998.2008.00537.x; Webb SD, 2006, ANN MO BOT GARD, V93, P245; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wiens JJ, 2011, PHILOS T R SOC B, V366, P2336, DOI 10.1098/rstb.2011.0059; Wisz MS, 2013, BIOL REV, V88, P15, DOI 10.1111/j.1469-185X.2012.00235.x; Woodburne MO, 2010, J MAMM EVOL, V17, P245, DOI 10.1007/s10914-010-9144-8	43	12	12	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100553	10.1371/journal.pone.0100553	http://dx.doi.org/10.1371/journal.pone.0100553			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971629	Green Published, gold			2022-12-27	WOS:000338512200040
J	Afshar, AS; Xu, J; Goutsias, J				Afshar, Ali Sobhi; Xu, Joseph; Goutsias, John			Integrative Identification of Deregulated MiRNA/TF-Mediated Gene Regulatory Loops and Networks in Prostate Cancer	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; EPITHELIAL-MESENCHYMAL TRANSITION; SET ENRICHMENT ANALYSIS; TUMOR-SUPPRESSOR P53; TRANSCRIPTION FACTOR; MICRORNA EXPRESSION; RECEPTOR EXPRESSION; C-MYC; COMBINATORIAL REGULATION; TMPRSS2-ERG FUSION	MicroRNAs (miRNAs) have attracted a great deal of attention in biology and medicine. It has been hypothesized that miRNAs interact with transcription factors (TFs) in a coordinated fashion to play key roles in regulating signaling and transcriptional pathways and in achieving robust gene regulation. Here, we propose a novel integrative computational method to infer certain types of deregulated miRNA-mediated regulatory circuits at the transcriptional, post-transcriptional and signaling levels. To reliably predict miRNA-target interactions from mRNA/miRNA expression data, our method collectively utilizes sequence-based miRNA-target predictions obtained from several algorithms, known information about mRNA and miRNA targets of TFs available in existing databases, certain molecular structures identified to be statistically over-represented in gene regulatory networks, available molecular subtyping information, and state-of-the-art statistical techniques to appropriately constrain the underlying analysis. In this way, the method exploits almost every aspect of extractable information in the expression data. We apply our procedure on mRNA/miRNA expression data from prostate tumor and normal samples and detect numerous known and novel miRNA-mediated deregulated loops and networks in prostate cancer. We also demonstrate instances of the results in a number of distinct biological settings, which are known to play crucial roles in prostate and other types of cancer. Our findings show that the proposed computational method can be used to effectively achieve notable insights into the poorly understood molecular mechanisms of miRNA-mediated interactions and dissect their functional roles in cancer in an effort to pave the way for miRNA-based therapeutics in clinical settings.	[Afshar, Ali Sobhi; Xu, Joseph; Goutsias, John] Johns Hopkins Univ, Whitaker Biomed Engn Inst, Baltimore, MD 21218 USA	Johns Hopkins University	Goutsias, J (corresponding author), Johns Hopkins Univ, Whitaker Biomed Engn Inst, Baltimore, MD 21218 USA.	goutsias@jhu.edu			National Science Foundation (NSF) [CCF-0849907, CCF-1217213]	National Science Foundation (NSF)(National Science Foundation (NSF))	This work was funded by the National Science Foundation (NSF) Grants CCF-0849907 and CCF-1217213. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U., 2006, INTRO SYSTEMS BIOL D; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Artmann S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038365; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Becker LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048474; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boldrup Linda, 2012, J Carcinog, V11, P18, DOI 10.4103/1477-3163.104007; Brase JC, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-507; BROWN MB, 1975, BIOMETRICS, V31, P987, DOI 10.2307/2529826; Chakraborty S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-236; Chakraborty S, 2012, BIOINFORMATICS, V28, P799, DOI 10.1093/bioinformatics/bts022; Chang LW, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-84; Chaux A, 2011, AM J SURG PATHOL, V35, P1014, DOI 10.1097/PAS.0b013e31821e8761; Chen CY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S41; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Cheng C, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002190; Chinnaiyan AM, 2008, NEOPLASIA, V10, P177, DOI 10.1593/neo.07822; Cooper SJ, 2010, ONCOGENE, V29, P2905, DOI 10.1038/onc.2010.64; Copland JA, 2003, ONCOGENE, V22, P8053, DOI 10.1038/sj.onc.1206835; Cui QH, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100089; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; Demichelis F, 2013, NAT MED, V19, P966, DOI 10.1038/nm.3285; Dhasarathy A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026514; Dong M, 2007, J CLIN INVEST, V117, P206, DOI 10.1172/JCI29293; Dong QC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010147; Elliott RL, 2005, J CLIN ONCOL, V23, P2078, DOI 10.1200/JCO.2005.02.047; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Finger EC, 2008, CARCINOGENESIS, V29, P528, DOI 10.1093/carcin/bgm289; Fisher RA, 1990, STAT METHODS EXPT DE; Gennarino VA, 2012, GENOME RES, V22, P1163, DOI 10.1101/gr.130435.111; Gennarino VA, 2011, GENE, V480, P51, DOI 10.1016/j.gene.2011.03.005; Gordon KJ, 2008, CARCINOGENESIS, V29, P252, DOI 10.1093/carcin/bgm249; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hammell M, 2010, SEMIN CELL DEV BIOL, V21, P738, DOI 10.1016/j.semcdb.2010.01.004; Heinrich EM, 2013, FEBS LETT, V587, P2405, DOI 10.1016/j.febslet.2013.06.008; Hsu CW, 2008, PROTEOMICS, V8, P1975, DOI 10.1002/pmic.200701004; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kasinski AL, 2011, NAT REV CANCER, V11, P849, DOI 10.1038/nrc3166; Kossenkov A, 2003, BIOINFORMATICS, V19, P675, DOI 10.1093/bioinformatics/btg056; Kost JT, 2002, STAT PROBABIL LETT, V60, P183, DOI 10.1016/S0167-7152(02)00310-3; Kumar M, 2011, ONCOGENE, V30, P843, DOI 10.1038/onc.2010.457; Kumar-Sinha C, 2008, NAT REV CANCER, V8, P497, DOI 10.1038/nrc2402; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Le TD, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-92; Lee JY, 2006, P NATL ACAD SCI USA, V103, P6055, DOI 10.1073/pnas.0510607103; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; Li J, 2012, BIOINFORMATICS, V28, pI509, DOI 10.1093/bioinformatics/bts387; Li YW, 2012, EPIGENETICS-US, V7, P940, DOI 10.4161/epi.21236; Liang H, 2007, RNA, V13, P1402, DOI 10.1261/rna.634607; Liu YC, 2012, BIOCHEM BIOPH RES CO, V417, P371, DOI 10.1016/j.bbrc.2011.11.119; Lopez-Serra P, 2012, ONCOGENE, V31, P1609, DOI 10.1038/onc.2011.354; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Lujambio A, 2007, CANCER RES, V67, P1424, DOI 10.1158/0008-5472.CAN-06-4218; Medici D, 2008, MOL BIOL CELL, V19, P4875, DOI 10.1091/mbc.E08-05-0506; Medina PP, 2010, NATURE, V467, P86, DOI 10.1038/nature09284; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Miyazono K, 2009, P JPN ACAD B-PHYS, V85, P314, DOI 10.2183/pjab.85.314; Mogilyansky E, 2013, CELL DEATH DIFFER, V20, P1603, DOI 10.1038/cdd.2013.125; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Obad S, 2011, NAT GENET, V43, P371, DOI 10.1038/ng.786; Olive V, 2013, IMMUNOL REV, V253, P158, DOI 10.1111/imr.12054; Osada H, 2011, CANCER SCI, V102, P9, DOI 10.1111/j.1349-7006.2010.01707.x; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Park SY, 2012, BIOCHEM BIOPH RES CO, V420, P350, DOI 10.1016/j.bbrc.2012.03.001; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Re A, 2009, MOL BIOSYST, V5, P854, DOI 10.1039/b900177h; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; Saito T, 2010, NEW BIOTECHNOL, V27, P243, DOI 10.1016/j.nbt.2010.02.016; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Sass S, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-136; Schaefer A, 2008, UROL ONCOL, V28, P4; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Setty M, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.37; Shalgi R, 2007, PLOS COMPUT BIOL, V3, P1291, DOI 10.1371/journal.pcbi.0030131; Shi J, 2007, CURR BIOINFORM, V2, P133, DOI 10.2174/157489307780618231; Shi XB, 2011, PROSTATE, V71, P538, DOI 10.1002/pros.21270; Sikand K, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-21; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Speier W, 2012, BIOINFORMATICS, V28, P2858, DOI 10.1093/bioinformatics/bts530; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Su NF, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-150; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sumazin P, 2011, CELL, V147, P370, DOI 10.1016/j.cell.2011.09.041; Sun C, 2008, ONCOGENE, V27, P5348, DOI 10.1038/onc.2008.183; Sun JC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002488; Sun YM, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-6; Szczyrba J, 2010, MOL CANCER RES, V8, P529, DOI 10.1158/1541-7786.MCR-09-0443; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tong AW, 2009, CANCER GENE THER, V16, P206, DOI 10.1038/cgt.2008.77; Tran DH, 2010, BIOINFORMATION, V4, P371, DOI 10.6026/97320630004371; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; Tsang JS, 2010, MOL CELL, V38, P140, DOI 10.1016/j.molcel.2010.03.007; Turley RS, 2007, CANCER RES, V67, P1090, DOI 10.1158/0008-5472.CAN-06-3117; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Vlachos IS, 2013, CLIN BIOCHEM, V46, P879, DOI 10.1016/j.clinbiochem.2013.03.006; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wach S, 2012, INT J CANCER, V130, P611, DOI 10.1002/ijc.26064; Wang J, 2010, NUCLEIC ACIDS RES, V38, pD119, DOI 10.1093/nar/gkp803; Wang LL, 2011, GENOMICS, V98, P1, DOI 10.1016/j.ygeno.2011.04.006; Wels C, 2011, J INVEST DERMATOL, V131, P1877, DOI 10.1038/jid.2011.142; WESTBERG M, 1985, J ROY STAT SOC D-STA, V34, P287; Wingender E, 2008, BRIEF BIOINFORM, V9, P326, DOI 10.1093/bib/bbn016; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Xu JZ, 2008, RNA, V14, P1276, DOI 10.1261/rna.997708; Yan ZY, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks395; Yu H, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-61; Zacher B, 2012, BIOINFORMATICS, V28, P1714, DOI 10.1093/bioinformatics/bts257; Zhou YM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-396	123	25	24	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100806	10.1371/journal.pone.0100806	http://dx.doi.org/10.1371/journal.pone.0100806			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968068	Green Published, gold, Green Submitted			2022-12-27	WOS:000338280800070
J	Ferrari, N; Mohammed, ZMA; Nixon, C; Mason, SM; Mallon, E; McMillan, DC; Morris, JS; Cameron, ER; Edwards, J; Blyth, K				Ferrari, Nicola; Mohammed, Zahra M. A.; Nixon, Colin; Mason, Susan M.; Mallon, Elizabeth; McMillan, Donald C.; Morris, Joanna S.; Cameron, Ewan R.; Edwards, Joanne; Blyth, Karen			Expression of RUNX1 Correlates with Poor Patient Prognosis in Triple Negative Breast Cancer	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; TARGETED THERAPIES; TUMOR PROGRESSION; EPITHELIAL-CELLS; IDENTIFICATION; LEUKEMIA; SUBTYPES; PROLIFERATION; INHIBITION; PROTEINS	The RUNX1 transcription factor is widely recognised for its tumour suppressor effects in leukaemia. Recently a putative link to breast cancer has started to emerge, however the function of RUNX1 in breast cancer is still unknown. To investigate if RUNX1 expression was important to clinical outcome in primary breast tumours a tissue microarray (TMA) containing biopsies from 483 patients with primary operable invasive ductal breast cancer was stained by immunohistochemistry. RUNX1 was associated with progesterone receptor (PR)-positive tumours (P < 0.05), more tumour CD4+(P < 0.05) and CD8+(P < 0.01) T-lymphocytic infiltrate, increased tumour CD138+plasma cell (P < 0.01) and more CD68+macrophage infiltrate (P < 0.001). RUNX1 expression did not influence outcome of oestrogen receptor (ER)-positive or HER2-positive disease, however on univariate analysis a high RUNX1 protein was significantly associated with poorer cancer-specific survival in patients with ER-negative (P < 0.05) and with triple negative (TN) invasive breast cancer (P < 0.05). Furthermore, multivariate Cox regression analysis of cancer-specific survival showed a trend towards significance in ER-negative patients (P < 0.1) and was significant in triple negative patients (P < 0.05). Of relevance, triple negative breast cancer currently lacks good biomarkers and patients with this subtype do not benefit from the option of targeted therapy unlike patients with ER-positive or HER2-positive disease. Using multivariate analysis RUNX1 was identified as an independent prognostic marker in the triple negative subgroup. Overall, our study identifies RUNX1 as a new prognostic indicator correlating with poor prognosis specifically in the triple negative subtype of human breast cancer.	[Ferrari, Nicola; Nixon, Colin; Mason, Susan M.; Blyth, Karen] Canc Res UK Beatson Inst, Transgen Models Lab, Glasgow, Lanark, Scotland; [Mohammed, Zahra M. A.; McMillan, Donald C.] Univ Glasgow, Coll Med Vet & Life Sci, Acad Unit Surg, Glasgow, Lanark, Scotland; [Mallon, Elizabeth] So Gen Hosp, Univ Pathol Unit, Glasgow G51 4TF, Lanark, Scotland; [Morris, Joanna S.; Cameron, Ewan R.] Univ Glasgow, Sch Vet Med, Glasgow, Lanark, Scotland; [Edwards, Joanne] Univ Glasgow, Inst Canc Sci, Glasgow, Lanark, Scotland	Beatson Institute; University of Glasgow; University of Glasgow; University of Glasgow; University of Glasgow	Blyth, K (corresponding author), Canc Res UK Beatson Inst, Transgen Models Lab, Glasgow, Lanark, Scotland.	K.Blyth@beatson.gla.ac.uk	Ferrari, Nicola/AAO-6180-2020; Edwards, Joanne/J-1903-2015	Ferrari, Nicola/0000-0001-7925-8335; Edwards, Joanne/0000-0002-7192-6906; Blyth, Karen/0000-0002-9304-439X; McMillan, Donald/0000-0003-4260-5334; Mason, Susan/0000-0002-3327-7693	Cancer Research UK	Cancer Research UK(Cancer Research UK)	This work was funded by Cancer Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Fatah TMA, 2013, ANN ONCOL, V24, P2801, DOI 10.1093/annonc/mdt277; Arnedos M, 2012, THER ADV MED ONCOL, V4, P195, DOI 10.1177/1758834012444711; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Blyth K, 2005, NAT REV CANCER, V5, P376, DOI 10.1038/nrc1607; Chimge NO, 2013, ONCOGENE, V32, P2121, DOI 10.1038/onc.2012.328; Chuang LSH, 2013, INT J CANCER, V132, P1260, DOI 10.1002/ijc.27964; Cunningham L, 2012, P NATL ACAD SCI USA, V109, P14592, DOI 10.1073/pnas.1200037109; Diaz N, 2006, CLIN CANCER RES, V12, P20, DOI 10.1158/1078-0432.CCR-04-1749; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Gluz O, 2009, ANN ONCOL, V20, P1913, DOI 10.1093/annonc/mdp492; Gorczynski MJ, 2007, CHEM BIOL, V14, P1186, DOI 10.1016/j.chembiol.2007.09.006; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Higgins MJ, 2011, J CLIN INVEST, V121, P3797, DOI 10.1172/JCI57152; Hoi CSL, 2010, MOL CELL BIOL, V30, P2518, DOI 10.1128/MCB.01308-09; Janes KA, 2011, CELL CYCLE, V10, P3461, DOI 10.4161/cc.10.20.18029; Kadota M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009201; Karn T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028403; Keita M, 2013, CELL CYCLE, V12, P972, DOI 10.4161/cc.23963; Kirkegaard T, 2006, HISTOPATHOLOGY, V48, P787, DOI 10.1111/j.1365-2559.2006.02412.x; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lam K, 2012, FRONT BIOSCI-LANDMRK, V17, P1120, DOI 10.2741/3977; Lehmann BD, 2014, J PATHOL, V232, P142, DOI 10.1002/path.4280; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Mohammed ZMA, 2013, BRIT J CANCER, V109, P1676, DOI 10.1038/bjc.2013.493; Mohammed ZMA, 2012, BRIT J CANCER, V107, P864, DOI 10.1038/bjc.2012.347; Mohammed ZMA, 2013, HUM PATHOL, V44, P1688, DOI 10.1016/j.humpath.2012.11.023; Mohammed ZMA, 2012, HISTOPATHOLOGY, V61, P675, DOI 10.1111/j.1365-2559.2012.04280.x; Mohammed ZMA, 2012, HISTOPATHOLOGY, V61, P283, DOI 10.1111/j.1365-2559.2012.04244.x; Rody A, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3035; Scheitz CJF, 2013, J CELL BIOCHEM, V114, P985, DOI 10.1002/jcb.24453; Scheitz CJF, 2012, EMBO J, V31, P4124, DOI 10.1038/emboj.2012.270; Taneja P, 2010, CLIN MED INSIGHTS-ON, V4, P15; Taniuchi I, 2012, EMBO J, V31, P4098, DOI 10.1038/emboj.2012.282; Thibodeaux CA, 2009, BREAST CANCER RES TR, V116, P281, DOI 10.1007/s10549-008-0127-x; Wang LX, 2011, P NATL ACAD SCI USA, V108, pE803, DOI 10.1073/pnas.1103423108; Wong WF, 2012, J IMMUNOL, V188, P5408, DOI 10.4049/jimmunol.1102991; Wotton S, 2002, CANCER RES, V62, P7181; Yeh HY, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-70; Zhou L, 2013, HUM PATHOL, V44, P2180, DOI 10.1016/j.humpath.2013.03.021	40	55	56	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100759	10.1371/journal.pone.0100759	http://dx.doi.org/10.1371/journal.pone.0100759			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967588	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000338280800064
J	Jin, ZN; Pu, LM; Sun, L; Chen, WJ; Nan, N; Li, H; Zhu, HG; Yang, XM; Wang, NN; Hui, J; Zhang, YR; Zhou, Q; Zhao, F; Yang, F; Shi, XH; Zhu, XQ; Yang, YG; Zhang, WD; Zheng, CG; Li, X; Yang, D; Jia, RF; Meng, S; Yang, Z				Jin, Zening; Pu, Lianmei; Sun, Liang; Chen, Weijun; Nan, Nan; Li, Hong; Zhu, Huagang; Yang, Xinmiao; Wang, Nana; Hui, Juan; Zhang, Yurong; Zhou, Qin; Zhao, Fan; Yang, Fan; Shi, Xiaohong; Zhu, Xiaoquan; Yang, Yige; Zhang, Wandong; Zheng, Chenguang; Li, Xiang; Yang, Duo; Jia, Ruofei; Meng, Shuai; Yang, Ze			Identification of Susceptibility Variants in ADIPOR1 Gene Associated with Type 2 Diabetes, Coronary Artery Disease and the Comorbidity of Type 2 Diabetes and Coronary Artery Disease	PLOS ONE			English	Article							ADIPONECTIN RECEPTOR 1; OVEREXPRESSION; PHENOTYPES; LOCUS	Objective: Adiponectin receptor 1 (encoded by ADIPOR1) is one of the major adiponectin receptors, and plays an important role in glucose and lipid metabolism. However, few studies have reported simultaneous associations between ADIPOR1 variants and type 2 diabetes (T2D), coronary artery disease (CAD) and T2D with CAD. Based on the "common soil'' hypothesis, we investigated whether ADIPOR1 polymorphisms contributed to the etiology of T2D, CAD, or T2D with CAD in a Northern Han Chinese population. Methods: Our multi-disease comparison study enrolled 657 subjects, including 165 with T2D, 173 with CAD, 174 with both T2D and CAD (T2D+CAD), and 145 local healthy controls. Six ADIPOR1 single nucleotide polymorphisms (SNPs) were genotyped and their association with disease risk was analyzed. Results: Multi-case-control comparison identified two ADIPOR1 variants: rs3737884-G, which was simultaneously associated with an increased risk of T2D, CAD, and T2D+CAD (P-value range, 9.80 x 10(-5)-6.30 x 10(-4); odds ratio (OR) range: 1.96-2.42) and 16850797-C, which was separately associated with T2D and T2D+CAD (P-value range: 0.007-0.014; OR range: 1.71-1.77). The risk genotypes of both rs3737884 and 16850797 were consistently associated with common metabolic phenotypes in all three diseases (P-value range: 4.81 x 10(-42)-0.001). We observed an increase in the genetic dose-dependent cumulative risk with increasing risk allele numbers in T2D, CAD and T2D+CAD (P-trend from 1.35 x 10(-5)-0.002). Conclusions: Our results suggest that ADIPOR1 risk polymorphisms are a strong candidate for the " common soil'' hypothesis and could partially contribute to disease susceptibility to T2D, CAD, and T2D with CAD in the Northern Han Chinese population.	[Jin, Zening; Pu, Lianmei; Li, Hong; Zhu, Huagang; Li, Xiang; Yang, Duo; Jia, Ruofei; Meng, Shuai] Capital Med Univ, Beijing Inst Heart Lung & Blood Vessels, Anzhen Hosp, Dept Emergency Med, Beijing, Peoples R China; [Sun, Liang; Wang, Nana; Hui, Juan; Zhang, Yurong; Zhao, Fan; Yang, Fan; Shi, Xiaohong; Zhu, Xiaoquan; Yang, Yige; Yang, Ze] Beijing Hosp, Key Lab Geriatr, Beijing, Peoples R China; [Sun, Liang; Wang, Nana; Hui, Juan; Zhang, Yurong; Zhao, Fan; Yang, Fan; Shi, Xiaohong; Zhu, Xiaoquan; Yang, Yige; Yang, Ze] Chinese Minist Hlth, Beijing Inst Geriatr, Beijing, Peoples R China; [Chen, Weijun] Capital Med Univ, Beijing Ditan Hosp, Dept Cardiol, Beijing, Peoples R China; [Nan, Nan] Capital Med Univ, Beijing Anzhen Hosp, Beijing Inst Heart Lung & Blood Vessels, Dept Cardiol, Beijing, Peoples R China; [Yang, Xinmiao] Capital Med Univ, Beijing You An Hosp, Dept Funct Tests, Beijing, Peoples R China; [Zhou, Qin] Jiangbin Hosp, Dept Neurol, Nanning, Peoples R China; [Zhang, Wandong] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada; [Zheng, Chenguang] Guangxi Zhuang Autonomous Region Women & Children, Dept Cardiac Surg, Nanning, Peoples R China	Capital Medical University; Beijing Hospital; Capital Medical University; Capital Medical University; Capital Medical University; National Research Council Canada	Yang, Z (corresponding author), Beijing Hosp, Key Lab Geriatr, Beijing, Peoples R China.	yang.ze@live.cn		Zhang, Wandong/0000-0001-6412-8124	Natural Science Foundation of China [30972709, 81061120527, 81241082, 81370445]; Beijing Hospital [BJ-2010-30]; Ministry of Health [10120101]; National Department Public Benefit Research Foundation by Ministry of Health P. R. China [201302008]; National Program from Ministry of Scientific Technology of China, Beijing Nova Program [2012BAI10B01, Z121107002512058]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Hospital; Ministry of Health; National Department Public Benefit Research Foundation by Ministry of Health P. R. China; National Program from Ministry of Scientific Technology of China, Beijing Nova Program	This study was funded by the Natural Science Foundation of China (30972709, 81061120527, 81241082, 81370445), the major funding from Beijing Hospital (BJ-2010-30), funding from the key project of clinical disciplines at the subordinate hospital, Ministry of Health (10120101), National Department Public Benefit Research Foundation by Ministry of Health P. R. China (201302008) and 12th 5-year National Program from Ministry of Scientific Technology (2012BAI10B01) of China, Beijing Nova Program (Z121107002512058). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Alobeidy BF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066976; [Anonymous], 2008, DIABETIC MED, V25, P400, DOI 10.1111/j.1464-5491.2008.02396.x; Damcott CM, 2005, DIABETES, V54, P2245, DOI 10.2337/diabetes.54.7.2245; Kim JT, 2009, CLIN ENDOCRINOL, V70, P66, DOI 10.1111/j.1365-2265.2008.03296.x; LOPAREV VN, 1991, J VIROL METHODS, V34, P105, DOI 10.1016/0166-0934(91)90126-K; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Luo NL, 2012, DIABETES, V61, pA415; Luo NL, 2013, ATHEROSCLEROSIS, V228, P124, DOI 10.1016/j.atherosclerosis.2013.02.026; Mather KJ, 2012, DIABETIC MED, V29, P1579, DOI 10.1111/j.1464-5491.2012.03662.x; Mente A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066808; Patel SA, 2012, ENDOCRINOLOGY, V153, P5231, DOI 10.1210/en.2012-1368; Qi L, 2007, DIABETES, V56, P1586, DOI 10.2337/db06-1447; Soccio T, 2006, DIABETES, V55, P2763, DOI 10.2337/db06-0613; STERN MP, 1995, DIABETES, V44, P369, DOI 10.2337/diabetes.44.4.369; Wang F, 2011, NAT GENET, V43, P345, DOI 10.1038/ng.783; Wang M, 2013, ATHEROSCLEROSIS, V229, P62, DOI 10.1016/j.atherosclerosis.2013.01.017; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557	18	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100339	10.1371/journal.pone.0100339	http://dx.doi.org/10.1371/journal.pone.0100339			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967709	Green Published, Green Submitted, gold			2022-12-27	WOS:000338280800036
J	Yrttiaho, S; Forssman, L; Kaatiala, J; Leppanen, JM				Yrttiaho, Santeri; Forssman, Linda; Kaatiala, Jussi; Leppanen, Jukka M.			Developmental Precursors of Social Brain Networks: The Emergence of Attentional and Cortical Sensitivity to Facial Expressions in 5 to 7 Months Old Infants	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; HUMAN AMYGDALA; FEARFUL FACES; RESPONSES; DISCRIMINATION; EMOTION; RECOGNITION; PERCEPTION; GAZE; SPECIALIZATION	Biases in attention towards facial cues during infancy may have an important role in the development of social brain networks. The current study used a longitudinal design to examine the stability of infants' attentional biases towards facial expressions and to elucidate how these biases relate to emerging cortical sensitivity to facial expressions. Event-related potential (ERP) and attention disengagement data were acquired in response to the presentation of fearful, happy, neutral, and phase-scrambled face stimuli from the same infants at 5 and 7 months of age. The tendency to disengage from faces was highly consistent across both ages. However, the modulation of this behavior by fearful facial expressions was uncorrelated between 5 and 7 months. In the ERP data, fear-sensitive activity was observed over posterior scalp regions, starting at the latency of the N290 wave. The scalp distribution of this sensitivity to fear in ERPs was dissociable from the topography of face-sensitive modulation within the same latency range. While attentional bias scores were independent of co-registered ERPs, attention bias towards fearful faces at 5 months of age predicted the fear-sensitivity in ERPs at 7 months of age. The current results suggest that the attention bias towards fear could be involved in the developmental tuning of cortical networks for social signals of emotion.	[Yrttiaho, Santeri; Forssman, Linda; Kaatiala, Jussi; Leppanen, Jukka M.] Univ Tampere, Sch Med, Tampere Ctr Child Hlth Res, FIN-33101 Tampere, Finland	Tampere University	Yrttiaho, S (corresponding author), Univ Tampere, Sch Med, Tampere Ctr Child Hlth Res, FIN-33101 Tampere, Finland.	santeri.yrttiaho@uta.fi		Forssman, Linda/0000-0003-0208-4212; Yrttiaho, Santeri/0000-0002-5724-1222	European Research Council [283763]; Academy of Finland [218284]	European Research Council(European Research Council (ERC)European Commission); Academy of Finland(Academy of Finland)	This research was supported by grants from the European Research Council (# 283763) and the Academy of Finland (# 218284) (http://erc.europa.eu/) (http://www.aka.fi/en-GB/A/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASLIN RN, 1975, PERCEPT PSYCHOPHYS, V17, P293, DOI 10.3758/BF03203214; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Bickart KC, 2011, NAT NEUROSCI, V14, P163, DOI 10.1038/nn.2724; Blau VC, 2007, BEHAV BRAIN FUNCT, V3; Block J., 1971, LIVES TIME; Borghans L, 2008, J HUM RESOUR, V43, P972; Bornstein MH, 2003, DEVELOPMENTAL SCI, V6, P585, DOI 10.1111/1467-7687.00314; BORNSTEIN MH, 1986, CHILD DEV, V57, P87, DOI 10.1111/j.1467-8624.1986.tb00009.x; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Cheour M., 2007, INFANT EEG EVENT REL, P19; Coch D., 2012, HDB EVENT RELATED PO, P475; Colombo J, 2012, HDB PSYCHOL, V6, P61; COURCHESNE E, 1981, CHILD DEV, V52, P804, DOI 10.2307/1129080; Csibra G., 2008, HDB DEV COGNITIVE NE, V2nd ed., P247; CZIGLER I, 1992, PSYCHOPHYSIOLOGY, V29, P471, DOI 10.1111/j.1469-8986.1992.tb01722.x; de Gelder BC, 2003, P NATL ACAD SCI USA, V100, P13105, DOI 10.1073/pnas.1735530100; de Haan M, 2004, J CHILD PSYCHOL PSYC, V45, P1209, DOI 10.1111/j.1469-7610.2004.00320.x; de Haan M, 2003, INT J PSYCHOPHYSIOL, V51, P45, DOI 10.1016/S0167-8760(03)00152-1; de Haan M, 2002, J COGNITIVE NEUROSCI, V14, P199, DOI 10.1162/089892902317236849; Deffke I, 2007, NEUROIMAGE, V35, P1495, DOI 10.1016/j.neuroimage.2007.01.034; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; desHaan M., 2007, INFANT EEG EVENT REL, P78; Farroni T, 2002, P NATL ACAD SCI USA, V99, P9602, DOI 10.1073/pnas.152159999; Farroni T, 2007, EUR J DEV PSYCHOL, V4, P2, DOI 10.1080/17405620601046832; Forssman L, 2014, J CHILD PSYCHOL PSYC, V55, P793, DOI 10.1111/jcpp.12181; GOREN CC, 1975, PEDIATRICS, V56, P544; GREENOUGH WT, 1987, CHILD DEV, V58, P539, DOI 10.2307/1130197; Grossmann T, 2011, DEV COGN NEUROS-NETH, V1, P57, DOI 10.1016/j.dcn.2010.07.001; Grossmann T, 2009, J COGNITIVE NEUROSCI, V21, P2276, DOI 10.1162/jocn.2009.21188; Halgren E, 2000, CEREB CORTEX, V10, P69, DOI 10.1093/cercor/10.1.69; Halit H, 2004, J CHILD PSYCHOL PSYC, V45, P1228, DOI 10.1111/j.1469-7610.2004.00321.x; Halit H, 2003, NEUROIMAGE, V19, P1180, DOI 10.1016/S1053-8119(03)00076-4; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Hoehl S, 2010, DEVELOPMENTAL SCI, V6, P813; Hoehl S, 2008, CHILD DEV, V79, P1752, DOI 10.1111/j.1467-8624.2008.01223.x; Jacques C, 2007, NEUROIMAGE, V36, P863, DOI 10.1016/j.neuroimage.2007.04.016; Johnson MH, 2005, NAT REV NEUROSCI, V6, P766, DOI 10.1038/nrn1766; Jones W, 2013, NATURE, V504, P427, DOI 10.1038/nature12715; Kaatiala J, 2014, BEHAV RES METHODS, V46, P745, DOI 10.3758/s13428-013-0404-4; Kobiella A, 2008, COGNITION EMOTION, V22, P134, DOI 10.1080/02699930701394256; KUCHUK A, 1986, CHILD DEV, V57, P1054; Leppanen JM, 2007, CHILD DEV, V78, P232, DOI 10.1111/j.1467-8624.2007.00994.x; Leppanen JM, 2015, BEHAV RES METHODS, V47, P538, DOI 10.3758/s13428-014-0473-z; Leppanen JM, 2011, J CHILD PSYCHOL PSYC, V52, P1144, DOI 10.1111/j.1469-7610.2011.02391.x; Leppanen JM, 2009, NAT REV NEUROSCI, V10, P37, DOI 10.1038/nrn2554; Leventon JS, 2013, DEVELOPMENTAL SCI, V16, P485, DOI 10.1111/desc.12041; May PJC, 2010, PSYCHOPHYSIOLOGY, V47, P66, DOI 10.1111/j.1469-8986.2009.00856.x; Morris JS, 1996, NATURE, V383, P812, DOI 10.1038/383812a0; Morris JS, 1998, BRAIN, V121, P47, DOI 10.1093/brain/121.1.47; MORTON J, 1991, PSYCHOL REV, V98, P164, DOI 10.1037/0033-295X.98.2.164; Nelson CA, 1996, DEV PSYCHOBIOL, V29, P577; NELSON CA, 1991, DEV PSYCHOL, V27, P50, DOI 10.1037/0012-1649.27.1.50; Pazo-Alvarez P, 2003, BIOL PSYCHOL, V63, P199, DOI 10.1016/S0301-0511(03)00049-8; Peltola MJ, 2013, INFANCY, V18, P905, DOI 10.1111/infa.12013; Peltola MJ, 2009, SOC COGN AFFECT NEUR, V4, P134, DOI 10.1093/scan/nsn046; Pessoa L, 2010, NAT REV NEUROSCI, V11, P773, DOI 10.1038/nrn2920; Peykarjou S, 2013, DEV NEUROPSYCHOL, V38, P272, DOI 10.1080/87565641.2013.786719; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Pihko E, 1999, NEUROREPORT, V10, P901, DOI 10.1097/00001756-199904060-00002; Rellecke J, 2013, BRAIN TOPOGR, V26, P62, DOI 10.1007/s10548-012-0261-y; Rigato S, 2010, SOC COGN AFFECT NEUR, V5, P88, DOI 10.1093/scan/nsp037; Rossion B, 1999, BIOL PSYCHOL, V50, P173, DOI 10.1016/S0301-0511(99)00013-7; Spearman C, 1904, AM J PSYCHOL, V15, P72, DOI 10.2307/1412159; Taaseh N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023369; Taylor MJ, 2001, COGNITIVE BRAIN RES, V10, P333, DOI 10.1016/S0926-6410(00)00051-3; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P454, DOI 10.1006/nimg.2001.0979; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Vuilleumier P, 2003, NAT NEUROSCI, V6, P624, DOI 10.1038/nn1057; Whalen PJ, 2001, EMOTION, V1, P70, DOI 10.1037/1528-3542.1.1.70; Zald DH, 2003, BRAIN RES REV, V41, P88, DOI 10.1016/S0165-0173(02)00248-5	70	29	30	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100811	10.1371/journal.pone.0100811	http://dx.doi.org/10.1371/journal.pone.0100811			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK2WP	24968161	Green Submitted, Green Published, gold			2022-12-27	WOS:000338280800071
J	Johnson, J; Sharman, Z; Vissandjee, B; Stewart, DE				Johnson, Joy; Sharman, Zena; Vissandjee, Bilkis; Stewart, Donna E.			Does a Change in Health Research Funding Policy Related to the Integration of Sex and Gender Have an Impact?	PLOS ONE			English	Article							BIOMEDICAL-RESEARCH; CLINICAL-TRIALS; WOMEN; NIH; INCLUSION; BIAS; RAMIFICATIONS	We analyzed the impact of a requirement introduced in December 2010 that all applicants to the Canadian Institutes of Health Research indicate whether their research designs accounted for sex or gender. We aimed to inform research policy by understanding the extent to which applicants across health research disciplines accounted for sex and gender. We conducted a descriptive statistical analysis to identify trends in application data from three research funding competitions (December 2010, June 2011, and December 2011) (N = 1459). We also conducted a qualitative thematic analysis of applicants' responses. Here we show that the proportion of applicants responding affirmatively to the questions on sex and gender increased over time (48% in December 2011, compared to 26% in December 2010). Biomedical researchers were least likely to report accounting for sex and gender. Analysis by discipline-specific peer review panel showed variation in the likelihood that a given panel will fund grants with a stated focus on sex or gender. These findings suggest that mandatory questions are one way of encouraging the uptake of sex and gender in health research, yet there remain persistent disparities across disciplines. These disparities represent opportunities for policy intervention by health research funders.	[Johnson, Joy; Sharman, Zena] Univ British Columbia, CIHR Inst Gender & Hlth, Vancouver, BC V5Z 1M9, Canada; [Vissandjee, Bilkis] Univ Montreal, Fac Nursing, Montreal, PQ, Canada; [Stewart, Donna E.] Univ Toronto, Toronto, ON, Canada; [Stewart, Donna E.] Univ Hlth Network, Toronto, ON, Canada	University of British Columbia; Universite de Montreal; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Sharman, Z (corresponding author), Univ British Columbia, CIHR Inst Gender & Hlth, Vancouver, BC V5Z 1M9, Canada.	zsharman@exchange.ubc.ca	Stewart, Donna Eileen E/J-2844-2016	Stewart, Donna Eileen E/0000-0002-8157-7746; Johnson, Joy/0000-0003-4767-6692	The CIHR Institute of Gender and Health (IGH)	The CIHR Institute of Gender and Health (IGH)(Canadian Institutes of Health Research (CIHR))	The CIHR Institute of Gender and Health (IGH) funded this study. The funder provided support in the form of salaries for authors JJ, and ZS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. BV and DES are former IGH board members.	American Association of University Women, 2010, WHY SO FEW WOM SCI T; [Anonymous], 2007, INCLUSION POLITICS D; Beery AK, 2011, NEUROSCI BIOBEHAV R, V35, P565, DOI 10.1016/j.neubiorev.2010.07.002; Blauwet LA, 2007, MAYO CLIN PROC, V82, P166; Canadian Institutes of Health Research, 2012, GEND SEX HLTH RES GU; Canadian Institutes of Health Research, 2013, AB US; CIHR Institute of Gender and Health, 2012, WHAT DIFF SEX GEND M; Clayton JA, 2014, NATURE, V509, P282, DOI 10.1038/509282a; Dhruva SS, 2011, JAMA-J AM MED ASSOC, V305, P1197, DOI 10.1001/jama.2011.347; Fausto-Sterling A, 2005, SIGNS, V30, P1491, DOI 10.1086/424932; Foulkes MA, 2011, J WOMENS HEALTH, V20, P829, DOI 10.1089/jwh.2010.2527; Geller SE, 2011, J WOMENS HEALTH, V20, P315, DOI 10.1089/jwh.2010.2469; Gendered Innovations, SEX GEND AN POL MAJ; Health Canada, 2010, HLTH PORTF SEX GEND; Heidari S, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-11; Holden C, 2008, SCIENCE, V322, P219, DOI 10.1126/science.322.5899.219; Institute of Medicine, 2012, SEX SPEC REP SCI RES; Jagsi R, 2011, ACAD MED, V86, P1415, DOI 10.1097/ACM.0b013e3182305aa6; Johnson J. L., 2013, Canadian Journal of Public Health, V104, pe80; Johnson JL, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-14; Keuken DG, 2007, INT J EQUITY HEALTH, V6, P13, DOI [10.1186/1475-9276-6-13., DOI 10.1186/1475-9276-6-13]; Krieger N, 2003, INT J EPIDEMIOL, V32, P652, DOI 10.1093/ije/dyg156; Lawrence K, 2007, GENDER MED, V4, pS96, DOI 10.1016/S1550-8579(07)80050-7; Natural Sciences and Engineering Research Council, 2010, WOM SCI ENG CAN; Obias-Manno D, 2007, J WOMENS HEALTH, V16, P807, DOI 10.1089/jwh.2006.0135; Oertelt-Prigione S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-70; Pohlhaus JR, 2011, ACAD MED, V86, P759, DOI 10.1097/ACM.0b013e31821836ff; Polit DF, 2009, INT J NURS STUD, V46, P1102, DOI 10.1016/j.ijnurstu.2009.02.002; Prins MH, 2007, GENDER MED, V4, pS106, DOI 10.1016/S1550-8579(07)80051-9; Ritz SA, 2014, FASEB J, V28, P4, DOI 10.1096/fj.13-233395; Rogers WA, 2008, MAYO CLIN PROC, V83, P536, DOI 10.4065/83.5.536; Schiebinger L, 2014, NATURE, V507, P9, DOI 10.1038/507009a; Sharman Z, 2012, SOC SCI MED, V74, P1812, DOI 10.1016/j.socscimed.2011.08.039; Shen H, 2013, NATURE, V495, P22, DOI [10.1038/495022a, 10.1038/495021a]; Taylor HA, 2008, CLIN TRIALS, V5, P140, DOI 10.1177/1740774508089457; Tingen CM, 2010, WOMENS HEALTH, V6, P511, DOI 10.2217/WHE.10.45; Wald C, 2010, SCIENCE, V327, P1571, DOI 10.1126/science.327.5973.1571; Wizemann TM, 2001, EXPLORING BIOL CONTR; Yang YS, 2009, J WOMENS HEALTH, V18, P303, DOI 10.1089/jwh.2008.0971	39	43	43	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e99900	10.1371/journal.pone.0099900	http://dx.doi.org/10.1371/journal.pone.0099900			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK8WO	24964040	Green Published, gold			2022-12-27	WOS:000338709500023
J	Lind, KR; Sizmur, T; Benomar, S; Miller, A; Cademartiri, L				Lind, Kara R.; Sizmur, Tom; Benomar, Saida; Miller, Anthony; Cademartiri, Ludovico			LEGO (R) Bricks as Building Blocks for Centimeter-Scale Biological Environments: The Case of Plants	PLOS ONE			English	Article							ROOT-SYSTEM ARCHITECTURE; CELL-CULTURE; SOIL; GROWTH	LEGO bricks are commercially available interlocking pieces of plastic that are conventionally used as toys. We describe their use to build engineered environments for cm-scale biological systems, in particular plant roots. Specifically, we take advantage of the unique modularity of these building blocks to create inexpensive, transparent, reconfigurable, and highly scalable environments for plant growth in which structural obstacles and chemical gradients can be precisely engineered to mimic soil.	[Lind, Kara R.; Sizmur, Tom; Benomar, Saida; Miller, Anthony; Cademartiri, Ludovico] Iowa State Univ, Dept Mat Sci & Engn, Ames, IA 50011 USA; [Sizmur, Tom; Benomar, Saida; Cademartiri, Ludovico] Iowa State Univ, US Dept Energy, Ames Lab, Ames, IA USA; [Miller, Anthony] Iowa State Univ, Dept Agron, Ames, IA USA; [Cademartiri, Ludovico] Iowa State Univ, Dept Chem & Biol Engn, Ames, IA USA	Iowa State University; Iowa State University; United States Department of Energy (DOE); Ames National Laboratory; Iowa State University; Iowa State University	Cademartiri, L (corresponding author), Iowa State Univ, Dept Mat Sci & Engn, Ames, IA 50011 USA.	lcademar@iastate.edu	Cademartiri, Ludovico/A-4142-2008; Sizmur, Tom/F-4532-2018	Cademartiri, Ludovico/0000-0001-8805-9434; Sizmur, Tom/0000-0001-9835-7195	Iowa State University	Iowa State University	The work was funded by Iowa State University through a startup grant to LC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen M, 2011, EXP MATH, V20, P145, DOI 10.1080/10586458.2011.564539; Balvin M, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.078301; Bengough AG, 2010, MICROSC RES TECHNIQ, V73, P27, DOI 10.1002/jemt.20749; Clark KA, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-8; de Dorlodot S, 2007, TRENDS PLANT SCI, V12, P474, DOI 10.1016/j.tplants.2007.08.012; Derda R, 2009, P NATL ACAD SCI USA, V106, P18457, DOI 10.1073/pnas.0910666106; Downie H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044276; EMMERICH WE, 1991, CROP SCI, V31, P454, DOI 10.2135/cropsci1991.0011183X003100020046x; FAO, 2009, FOOD BAL SHEETS; Fiorani F, 2013, ANNU REV PLANT BIOL, V64, P267, DOI 10.1146/annurev-arplant-050312-120137; Gilroy S, 2008, PLANT TROPISMS; Grossmann G, 2011, PLANT CELL, V23, P4234, DOI 10.1105/tpc.111.092577; Hargreaves CE, 2009, PLANT SOIL, V316, P285, DOI 10.1007/s11104-008-9780-4; Hulme SE, 2007, LAB CHIP, V7, P1515, DOI 10.1039/b707861g; Ingram PA, 2012, PHILOS T R SOC B, V367, P1559, DOI 10.1098/rstb.2011.0241; Krysan P, 2004, PLANT PHYSIOL, V135, P1162, DOI 10.1104/pp.104.040774; Lucchetta EM, 2005, NATURE, V434, P1134, DOI 10.1038/nature03509; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; LYNCH J, 1995, PLANT PHYSIOL, V109, P7, DOI 10.1104/pp.109.1.7; Massa GD, 2003, PLANT J, V33, P435, DOI 10.1046/j.1365-313X.2003.01637.x; McNamara S, 1999, ASEE ANN C; Meier M, 2010, LAB CHIP, V10, P2147, DOI 10.1039/c004629a; Nunan N, 2002, MICROBIAL ECOL, V44, P296, DOI 10.1007/s00248-002-2021-0; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; PARASHAR A, 2011, APPL PHYS LETT, V98; Poorter H, 2012, FUNCTIONAL PLANT BIO; Ray DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066428; Sizmur T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096730; Sultan SE, 2000, TRENDS PLANT SCI, V5, P537, DOI 10.1016/S1360-1385(00)01797-0; The LEGO Group, 2013, LEG GROUP CO PROF; Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361; Tracy SR, 2010, J EXP BOT, V61, P311, DOI 10.1093/jxb/erp386; Whalley WR, 2013, PLANT SOIL, V364, P171, DOI 10.1007/s11104-012-1342-0; Whitesides G, 2012, FRUGAL WAY PROMISE C; Whitesides GM, 2013, LAB CHIP, V13, P11, DOI 10.1039/c2lc90109a; Young IM, 2004, SCIENCE, V304, P1634, DOI 10.1126/science.1097394; Zhang HM, 1998, SCIENCE, V279, P407, DOI 10.1126/science.279.5349.407	37	12	12	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100867	10.1371/journal.pone.0100867	http://dx.doi.org/10.1371/journal.pone.0100867			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963716	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000338709500092
J	Moller, AP; Bonisoli-Alquati, A; Mousseau, TA; Rudolfsen, G				Moller, Anders Pape; Bonisoli-Alquati, Andrea; Mousseau, Timothy A.; Rudolfsen, Geir			Aspermy, Sperm Quality and Radiation in Chernobyl Birds	PLOS ONE			English	Article							SWALLOWS HIRUNDO-RUSTICA; REACTIVE OXYGEN; BARN SWALLOWS; DNA-DAMAGE; OXIDATIVE STRESS; MICROSATELLITE MUTATIONS; IONIZING-RADIATION; SOCIAL-STATUS; COMET ASSAY; COMPETITION	Background: Following the Chernobyl nuclear power plant accident, large amounts of radionuclides were emitted and spread in the environment. Animals living in such contaminated areas are predicted to suffer fitness costs including reductions in the quality and quantity of gametes. Methodology/Principal Findings: We studied whether aspermy and sperm quality were affected by radioactive contamination by examining ejaculates from wild caught birds breeding in areas varying in background radiation level by more than three orders of magnitude around Chernobyl, Ukraine. The frequency of males with aspermy increased logarithmically with radiation level. While 18.4% of males from contaminated areas had no sperm that was only the case for 3.0% of males from uncontaminated control areas. Furthermore, there were negative relationships between sperm quality as reflected by reduced sperm velocity and motility, respectively, and radiation. Conclusions/Significance: Our results suggest that radioactive contamination around Chernobyl affects sperm production and quality. We are the first to report an interspecific difference in sperm quality in relation to radioactive contamination.	[Moller, Anders Pape] Univ Paris 11, CNRS, UMR 8079, Lab Ecol Systemat & Evolut, F-91405 Orsay, France; [Bonisoli-Alquati, Andrea; Mousseau, Timothy A.] Univ S Carolina, Dept Biol Sci, Columbia, SC USA; [Rudolfsen, Geir] Univ Tromso, Dept Arctic & Marine Biol, Tromso, Norway	AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; UiT The Arctic University of Tromso	Moller, AP (corresponding author), Univ Paris 11, CNRS, UMR 8079, Lab Ecol Systemat & Evolut, Batiment 362, F-91405 Orsay, France.	anders.moller@u-psud.fr	Mousseau, Timothy A/A-1253-2011; Alquati, Andrea Bonisoli/S-2082-2017; Rudolfsen, Geir/ABD-7777-2020; Moller, Anders/O-6665-2016	Alquati, Andrea Bonisoli/0000-0002-9255-7556; Moller, Anders/0000-0003-3739-4675; Rudolfsen, Geir/0000-0001-7984-8458; Mousseau, Timothy/0000-0002-2235-4868	CNRS (France); University of South Carolina College of Arts Sciences; NATO; Fulbright Program; Samuel Freeman Charitable Trust; National Geographic Society; Norwegian Radiation Protection Authority	CNRS (France)(Centre National de la Recherche Scientifique (CNRS)); University of South Carolina College of Arts Sciences; NATO(NATO (North Atlantic Treaty Organisation)); Fulbright Program; Samuel Freeman Charitable Trust; National Geographic Society(National Geographic Society); Norwegian Radiation Protection Authority	We are grateful for logistic help during our visit to Ukraine from G. Milinevsky, L. Milinevski, I. Chizchevsky, A. Peklo, A. Rozhok, I. Kozeretska, S. Taykova, W. Mardal and E. Flensted-Jensen. We received funding from the CNRS (France), University of South Carolina College of Arts & Sciences, NATO, the Fulbright Program, the Samuel Freeman Charitable Trust, the National Geographic Society and Norwegian Radiation Protection Authority in support of this research. Support and sperm tracking equipment was kindly provided by Ivar Folstad, University of Tromso.	Agarwal A, 2006, FERTIL STERIL, V86, P878, DOI 10.1016/j.fertnstert.2006.02.111; Aitken RJ, 1998, J CELL SCI, V111, P645; Aitken RJ, 1998, BIOL REPROD, V59, P1037, DOI 10.1095/biolreprod59.5.1037; AITKEN RJ, 1987, J REPROD FERTIL, V81, P459; ASH P, 1980, BRIT J RADIOL, V53, P271, DOI 10.1259/0007-1285-53-628-271; BIRIOUKOV A, 1993, ARCH ANDROLOGY, V30, P99, DOI 10.3109/01485019308987741; Birkhead TR, 1999, P ROY SOC B-BIOL SCI, V266, P1759, DOI 10.1098/rspb.1999.0843; Birkhead TR, 1998, SPERM COMPETITION SE; Bonisoli-Alquati A, 2010, COMP BIOCHEM PHYS C, V151, P271, DOI 10.1016/j.cbpc.2009.11.006; Bonisoli-Alquati A, 2010, COMP BIOCHEM PHYS A, V155, P205, DOI 10.1016/j.cbpa.2009.10.041; CHEKHOVICH AV, 1993, GENETIKA+, V29, P312; CLIFTON DK, 1983, J ANDROL, V4, P387; Cornwallis CK, 2007, AM NAT, V170, P758, DOI 10.1086/521955; Cornwallis CK, 2006, EVOLUTION, V60, P1486, DOI 10.1111/j.0014-3820.2006.tb01227.x; DEWSBURY DA, 1982, AM NAT, V119, P601, DOI 10.1086/283938; Ellegren H, 2000, TRENDS GENET, V16, P551, DOI 10.1016/S0168-9525(00)02139-9; European Union, 1998, EU PUBL EUR; Fischbein A, 1997, ENVIRON HEALTH PERSP, V105, P1445, DOI 10.2307/3433648; Folstad I, 1997, BEHAV ECOL, V8, P109, DOI 10.1093/beheco/8.1.109; Frenzilli G, 2001, MUTAT RES-GEN TOX EN, V491, P139, DOI 10.1016/S1383-5718(01)00136-X; Frenzilli G, 1998, MUTAT RES-GEN TOX EN, V415, P151, DOI 10.1016/S1383-5718(98)00060-6; Furitsu K, 2005, MUTAT RES-GEN TOX EN, V581, P69, DOI 10.1016/j.mrgentox.2004.11.002; Gage MJG, 2004, CURR BIOL, V14, P44, DOI 10.1016/j.cub.2003.12.028; Garcia O, 2005, MUTAT RES-GEN TOX EN, V565, P191, DOI 10.1016/j.mrgentox.2004.10.001; Gaschak S. P., 2008, Radiatsionnaya Biologiya Radioekologiya, V48, P28; Gelman A., 2007, DATA ANAL USING REGR; Gemignani F, 1999, MUTAT RES-GEN TOX EN, V446, P245, DOI 10.1016/S1383-5718(99)00194-1; Goncharov NP, 1998, INT J ANDROL, V21, P271; Helfenstein F, 2010, ECOL LETT, V13, P213, DOI 10.1111/j.1461-0248.2009.01419.x; Hermosell IG, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0530; Hinton TG, 2007, HEALTH PHYS, V93, P427, DOI 10.1097/01.HP.0000281179.03443.2e; Hunter FM, 2002, CURR BIOL, V12, P121, DOI 10.1016/S0960-9822(01)00647-9; International Atomic Energy Agency, 1992, EFF ION RAD PLANTS A; JONES R, 1973, PROC R SOC SER B-BIO, V184, P103, DOI 10.1098/rspb.1973.0035; Kleven O, 2009, EVOLUTION, V63, P2466, DOI 10.1111/j.1558-5646.2009.00725.x; Lanzafame FM, 2009, REPROD BIOMED ONLINE, V19, P638, DOI 10.1016/j.rbmo.2009.09.014; Laskemoen T, 2008, J AVIAN BIOL, V39, P322, DOI 10.1111/j.0908-8857.2008.04178.x; Laskemoen T, 2010, BEHAV ECOL SOCIOBIOL, V64, P1473, DOI 10.1007/s00265-010-0962-8; Levitan DR, 2000, P ROY SOC B-BIOL SCI, V267, P531, DOI 10.1098/rspb.2000.1032; Lifjeld JT, 2007, J AVIAN BIOL, V38, P267, DOI 10.1111/j.2007.0908-8857.04126.x; Mahfouz R, 2010, FERTIL STERIL, V94, P2141, DOI 10.1016/j.fertnstert.2009.12.030; Malo AF, 2005, BIOL REPROD, V72, P822, DOI 10.1095/biolreprod.104.036368; Meeks HN, 2007, ENVIRON TOXICOL CHEM, V26, P361, DOI 10.1897/06-346R.1; MEISTRICH ML, 1982, J ANDROL, V3, P58; MEISTRICH ML, 1985, RADIAT RES, V102, P138, DOI 10.2307/3576437; Mikkelsen RB, 2003, ONCOGENE, V22, P5734, DOI 10.1038/sj.onc.1206663; Moller AP, 2008, MUTAT RES-GEN TOX EN, V650, P210, DOI 10.1016/j.mrgentox.2007.12.006; Moller AP, 2007, BIOLOGY LETT, V3, P483, DOI 10.1098/rsbl.2007.0226; Moller AP, 2007, BIOL LETTERS, V3, P414, DOI 10.1098/rsbl.2007.0136; Moller AP, 2009, J EVOLUTION BIOL, V22, P334, DOI 10.1111/j.1420-9101.2008.01650.x; Moller AP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035223; Moller AP, 2005, P ROY SOC B-BIOL SCI, V272, P247, DOI 10.1098/rspb.2004.2914; Moller AP, 2003, EVOLUTION, V57, P2139, DOI 10.1554/03-051; Moller AP, 2001, EVOLUTION, V55, P2097; Parker GA, 2010, BIOL REV, V85, P897, DOI 10.1111/j.1469-185X.2010.00140.x; Pizzari T, 2007, P ROY SOC B-BIOL SCI, V274, P853, DOI 10.1098/rspb.2006.0080; Pomerantseva MD, 1997, MUTAT RES-FUND MOL M, V381, P97, DOI 10.1016/S0027-5107(97)00155-3; Prise KM, 2006, OCCUP MED-OXFORD, V56, P156, DOI 10.1093/occmed/kql010; Rowe M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015720; ROWLEY MJ, 1974, RADIAT RES, V59, P665, DOI 10.2307/3574084; Rudolfsen G, 2006, P ROY SOC B-BIOL SCI, V273, P325, DOI 10.1098/rspb.2005.3305; Rudolfsen G, 2008, AQUAC RES, V39, P212, DOI 10.1111/j.1365-2109.2007.01863.x; Ryabokon NI, 2006, RADIAT ENVIRON BIOPH, V45, P167, DOI 10.1007/s00411-006-0054-3; Sakharov IY, 1996, ANDROLOGIA, V28, P259; SAS, 2012, JMP VERS 10 0; Sawyer DE, 2003, MUTAT RES-FUND MOL M, V529, P21, DOI 10.1016/S0027-5107(03)00101-5; Sawyer DE, 2001, REDOX REP, V6, P182, DOI 10.1179/135100001101536157; Svensson L.A., 2006, IDENTIFICATION GUIDE; Tremellen K, 2008, HUM REPROD UPDATE, V14, P243, DOI 10.1093/humupd/dmn004; Tunc O, 2009, REPROD BIOMED ONLINE, V18, P761, DOI 10.1016/S1472-6483(10)60024-7; UNSCEAR, 2008, EFF ATOM RAD SOUR EF, V1, P1; WARD JF, 1994, RADIAT RES, V138, pS85, DOI 10.2307/3578769; Wedell N, 2002, TRENDS ECOL EVOL, V17, P313, DOI 10.1016/S0169-5347(02)02533-8; Wickliffe JK, 2003, ENVIRON MOL MUTAGEN, V42, P11, DOI 10.1002/em.10170; Yumura Y, 2009, INT J UROL, V16, P202, DOI 10.1111/j.1442-2042.2008.02213.x; ZALATA A, 1995, HUM REPROD, V10, P1444, DOI 10.1093/HUMREP/10.6.1444	76	17	18	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100296	10.1371/journal.pone.0100296	http://dx.doi.org/10.1371/journal.pone.0100296			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963711	Green Submitted, Green Published, gold			2022-12-27	WOS:000338709500038
J	Shimoni, R; Pham, K; Yassin, M; Ludford-Menting, MJ; Gu, M; Russell, SM				Shimoni, Raz; Pham, Kim; Yassin, Mohammed; Ludford-Menting, Mandy J.; Gu, Min; Russell, Sarah M.			Normalized Polarization Ratios for the Analysis of Cell Polarity	PLOS ONE			English	Article							T-LYMPHOCYTE DIVISION; ASYMMETRIC DIVISION; MICROSCOPY; TIME; STEM; SEGREGATION; IMMUNITY; SYSTEM	The quantification and analysis of molecular localization in living cells is increasingly important for elucidating biological pathways, and new methods are rapidly emerging. The quantification of cell polarity has generated much interest recently, and ratiometric analysis of fluorescence microscopy images provides one means to quantify cell polarity. However, detection of fluorescence, and the ratiometric measurement, is likely to be sensitive to acquisition settings and image processing parameters. Using imaging of EGFP-expressing cells and computer simulations of variations in fluorescence ratios, we characterized the dependence of ratiometric measurements on processing parameters. This analysis showed that image settings alter polarization measurements; and that clustered localization is more susceptible to artifacts than homogeneous localization. To correct for such inconsistencies, we developed and validated a method for choosing the most appropriate analysis settings, and for incorporating internal controls to ensure fidelity of polarity measurements. This approach is applicable to testing polarity in all cells where the axis of polarity is known.	[Shimoni, Raz; Pham, Kim; Gu, Min; Russell, Sarah M.] Swinburne Univ Technol, Fac Sci Engn & Technol, Ctr Microphoton, Hawthorn, Vic 3122, Australia; [Yassin, Mohammed; Ludford-Menting, Mandy J.; Russell, Sarah M.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3052, Australia; [Shimoni, Raz; Pham, Kim; Yassin, Mohammed; Ludford-Menting, Mandy J.; Russell, Sarah M.] Peter MacCallum Canc Ctr, Immune Signalling Lab, East Melbourne, Vic, Australia	Swinburne University of Technology; Peter Maccallum Cancer Center; University of Melbourne; Peter Maccallum Cancer Center	Russell, SM (corresponding author), Swinburne Univ Technol, Fac Sci Engn & Technol, Ctr Microphoton, Hawthorn, Vic 3122, Australia.	sarah.russell@petermac.org	Gu, Min/B-6627-2008; Russell, Sarah M/B-9341-2009	Russell, Sarah M/0000-0001-5826-9641	National Health and Medical Research Foundation [1020234, 620500]; Australian Research Council [FT0990405]; Human Frontiers Science Program [RGP0049/2007]	National Health and Medical Research Foundation; Australian Research Council(Australian Research Council); Human Frontiers Science Program(Human Frontier Science Program)	This work was supported by the National Health and Medical Research Foundation, https://www.nhmrc.gov.au/, 1020234, 620500; the Australian Research Council, http://www.arc.gov.au/, FT0990405; and the Human Frontiers Science Program, http://www.hfsp.org/, RGP0049/2007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRESENHAM JE, 1965, IBM SYST J, V4, P25, DOI 10.1147/sj.41.0025; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Chang JT, 2011, IMMUNITY, V34, P492, DOI 10.1016/j.immuni.2011.03.017; Couturier L, 2013, CURR BIOL, V23, P588, DOI 10.1016/j.cub.2013.03.002; Dalton CM, 2013, J CELL SCI, V126, P2955, DOI 10.1242/jcs.128744; Day D, 2009, IMMUNOL CELL BIOL, V87, P154, DOI 10.1038/icb.2008.79; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Filby A, 2011, CYTOM PART A, V79A, P496, DOI 10.1002/cyto.a.21091; Frigault MM, 2009, J CELL SCI, V122, P753, DOI 10.1242/jcs.033837; Guberman JM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000233; Habib SJ, 2013, SCIENCE, V339, P1445, DOI 10.1126/science.1231077; Hawkins ED, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2796; Huh D, 2011, P NATL ACAD SCI USA, V108, P15004, DOI 10.1073/pnas.1013171108; Villalta JI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019031; King CG, 2012, IMMUNITY, V37, P709, DOI 10.1016/j.immuni.2012.06.021; Knoblich JA, 2010, NAT REV MOL CELL BIO, V11, P849, DOI 10.1038/nrm3010; Lehmussola A, 2007, IEEE T MED IMAGING, V26, P1010, DOI 10.1109/TMI.2007.896925; Martin-Belmonte F, 2012, NAT REV CANCER, V12, P23, DOI 10.1038/nrc3169; Melichar HJ, 2011, IMMUNOL CELL BIOL, V89, P549, DOI 10.1038/icb.2010.122; Moreau HD, 2012, IMMUNITY; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Oliaro J, 2010, J IMMUNOL, V185, P367, DOI 10.4049/jimmunol.0903627; Pang Z, 2012, J MICROSC-OXFORD, V246, P1, DOI [10.1111/j.1365-2818.2011.03581.x, 10.1111/j.1365-2818.201.1.03581.x]; Pawley JB, 2006, HDB BIOL CONFOCAL MI, p[xxviii, 985]; Pham K, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00026; Pham K, 2013, IMMUNOL CELL BIOL, V91, P70, DOI 10.1038/icb.2012.49; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Ramsbottom KM, 2014, J IMMUNOL, V192, P553, DOI 10.4049/jimmunol.1302197; Restifo NP, 2013, CURR OPIN IMMUNOL; Roybal KT, 2013, IMMUNOL REV, V256, P133, DOI 10.1111/imr.12103; Rujano MA, 2006, PLOS BIOL, V4, P2325, DOI 10.1371/journal.pbio.0040417; Russell S, 2008, J CELL SCI, V121, P131, DOI 10.1242/jcs.021253; Shimoni R, 2013, BIOINFORMATICS, V29, P817, DOI 10.1093/bioinformatics/btt035; Skamagki M, 2013, CELL REP, V3, P442, DOI 10.1016/j.celrep.2013.01.006; St Johnston D, 2010, CELL, V141, P757, DOI 10.1016/j.cell.2010.05.011; Summers HD, 2011, NAT NANOTECHNOL, V6, P170, DOI [10.1038/nnano.2010.277, 10.1038/NNANO.2010.277]; Ting SB, 2012, BLOOD, V119, P2510, DOI 10.1182/blood-2011-11-393272; Waters JC, 2009, J CELL BIOL, V185, P1135, DOI 10.1083/jcb.200903097; Wu MF, 2007, CELL STEM CELL, V1, P541, DOI 10.1016/j.stem.2007.08.009; Yan Y, 2013, ACS NANO, V7, P5558, DOI 10.1021/nn401800u; Yang Y H, 2001, Brief Bioinform, V2, P341, DOI 10.1093/bib/2.4.341	41	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e99885	10.1371/journal.pone.0099885	http://dx.doi.org/10.1371/journal.pone.0099885			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963926	gold, Green Published			2022-12-27	WOS:000338709500022
J	Stotland, NE; Sutton, P; Trowbridge, J; Atchley, DS; Conry, J; Trasande, L; Gerbert, B; Charlesworth, A; Woodruff, TJ				Stotland, Naomi E.; Sutton, Patrice; Trowbridge, Jessica; Atchley, Dylan S.; Conry, Jeanne; Trasande, Leonardo; Gerbert, Barbara; Charlesworth, Annemarie; Woodruff, Tracey J.			Counseling Patients on Preventing Prenatal Environmental Exposures - A Mixed- Methods Study of Obstetricians	PLOS ONE			English	Article							BISPHENOL-A; CHEMICALS; PHTHALATE; DISPARITIES; EXPERIENCE; POLLUTION	Objective: Describe the attitudes, beliefs, and practices of U. S. obstetricians on the topic of prenatal environmental exposures. Study Design: A national online survey of American Congress of Obstetricians and Gynecologists (ACOG) fellows and 3 focus groups of obstetricians. Results: We received 2,514 eligible survey responses, for a response rate of 14%. The majority (78%) of obstetricians agreed that they can reduce patient exposures to environmental health hazards by counseling patients; but 50% reported that they rarely take an environmental health history; less than 20% reported routinely asking about environmental exposures commonly found in pregnant women in the U.S.; and only 1 in 15 reported any training on the topic. Barriers to counseling included: a lack of knowledge of and uncertainty about the evidence; concerns that patients lack the capacity to reduce harmful exposures; and fear of causing anxiety among patients. Conclusion: U.S. obstetricians in our study recognized the potential impact of the environment on reproductive health, and the role that physicians could play in prevention, but reported numerous barriers to counseling patients. Medical education and training, evidence-based guidelines, and tools for communicating risks to patients are needed to support the clinical role in preventing environmental exposures that threaten patient health.	[Stotland, Naomi E.; Sutton, Patrice; Trowbridge, Jessica; Atchley, Dylan S.; Charlesworth, Annemarie; Woodruff, Tracey J.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA; [Conry, Jeanne] Amer Coll Congress Obstetricians & Gynecologists, Washington, DC USA; [Conry, Jeanne] Roseville Sacramento Kaiser Permanente, Sacramento, CA USA; [Trasande, Leonardo] NYU, New York, NY USA; [Gerbert, Barbara] Univ Calif San Francisco, Sch Dent, Div Behav Sci Professionalism & Eth, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Kaiser Permanente; New York University; University of California System; University of California San Francisco	Stotland, NE (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA.	stotlandn@obgyn.ucsf.edu	Trasande, Leonardo/ABE-6339-2020	Woodruff, Tracey/0000-0003-3622-1297	National Institute for Environmental Health Sciences [ES018135]; United States Environmental Protection Agency STAR [RD83467801]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P20ES018135] Funding Source: NIH RePORTER	National Institute for Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); United States Environmental Protection Agency STAR(United States Environmental Protection Agency); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Financial support for this survey was provided to UCSF Program on Reproductive Health and the Environment by: New York Community Trust, Passport Foundation, Johnson Family Foundation, the National Institute for Environmental Health Sciences (ES018135) and United States Environmental Protection Agency STAR (RD83467801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamkiewicz G, 2011, AM J PUBLIC HEALTH, V101, pS238, DOI 10.2105/AJPH.2011.300119; Adams C, 2011, J HEALTH SOC BEHAV, V52, P180, DOI 10.1177/0022146510395593; Adler NE, 2009, MILBANK Q, V87, P49, DOI 10.1111/j.1468-0009.2009.00547.x; Altman RG, 2008, J HEALTH SOC BEHAV, V49, P417, DOI 10.1177/002214650804900404; Amer Soc Reprod Med, 2013, FERTIL STERIL, V100, P931, DOI 10.1016/j.fertnstert.2013.08.043; American Congress of Gynecologists and Gynecologists, 2008, 2008 SOC SURV ACOG F; Bellingham M, 2013, SCI ADVISORY COMMITT; California Environmental Protection Agency Office of Environmental Health Hazard Assessment Reproductive and Cancer Hazard Branch, 2007, OCC HLTH HAZ RISK AS; Chenseng L., 2006, ENVIRON HEALTH PERSP, V114, P260, DOI DOI 10.1289/ehp.8418; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; Gee GC, 2004, ENVIRON HEALTH PERSP, V112, P1645, DOI 10.1289/ehp.7074; Grandjean P, 2008, BASIC CLIN PHARMACOL, V102, P73, DOI 10.1111/j.1742-7843.2007.00114.x; HEMMINKI K, 1985, TERATOGEN CARCIN MUT, V5, P251, DOI 10.1002/tcm.1770050405; Ji K, 2010, ENVIRON RES, V110, P375, DOI 10.1016/j.envres.2010.02.008; Kimmel CA, 1984, RELIABILITY EXPT STU; Lubick N, 2011, ENVIRON HEALTH PERSP, V119, pA437; Miller WL, 1999, DOING QUALITATIVE RE; Morello-Frosch R, 2011, HEALTH AFFAIR, V30, P879, DOI 10.1377/hlthaff.2011.0153; Morello-Frosch R, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-6; National Research Council (U.S.) Committee on Developmental Toxicology National Research Council (U.S.) Commission on Life Sciences, 2000, SCI FRONT DEV TOX RI; NEMEC MD, 2006, SIGNIFICANCE RELIABI; Newbold R, 2010, ENV IMPACTS REPROD H; NISBET ICT, 1983, CHEM HAZARDS HUMAN R; Raffensperger C., 1999, PROTECTING PUBLIC HL; Rayburn W, 2011, OBSTETRICIAN GYNECOL; Reuben S. H., 2010, REDUCING ENV CANC RI; Rice P., 1999, QUALITATIVE RES METH; Rudel RA, 2011, ENVIRON HEALTH PERSP, V119, P914, DOI 10.1289/ehp.1003170; Sathyanarayana S, 2013, J EXPO SCI ENV EPID, V23, P378, DOI 10.1038/jes.2013.9; Sathyanarayana S, 2012, AM J OBSTET GYNECOL, V207, P463, DOI 10.1016/j.ajog.2012.02.004; Smith-Spangler C, 2012, ANN INTERN MED, V157, P348, DOI 10.7326/0003-4819-157-5-201209040-00007; Strauss A., 2007, BASICS QUALITATIVE R; Sutton P, 2012, AM J OBSTET GYNECOL, V207, P164, DOI 10.1016/j.ajog.2012.01.034; Trasande L, 2006, J URBAN HEALTH, V83, P760, DOI 10.1007/s11524-006-9071-4; U. S. Environmental Protection Agency, 2007, OFF POLL PREV TOX PR; UCSF Program on Reproductive Health and the Environment, 2012, PROF STAT DAT; US Environmental Protection Agency, 2011, TSCA CHEM SUBST INV; Vogel SA, 2011, HEALTH AFFAIR, V30, P898, DOI 10.1377/hlthaff.2011.0211; Wilson MP, 2009, ENVIRON HEALTH PERSP, V117, P1202, DOI 10.1289/ehp.0800404; Woodruff TJ, 2003, ENVIRON HEALTH PERSP, V111, P942, DOI 10.1289/ehp.5317; Woodruff TJ, 2008, FERTIL STERIL, V89, P281, DOI [10.1016/j.fertnstert.2007.10.002, 10.1016/j.fertnstert.2008.01.065]; Woodruff TJ, 2011, HEALTH AFFAIR, V30, P931, DOI 10.1377/hlthaff.2010.1219; Woodruff TJ, 2011, ENVIRON HEALTH PERSP, V119, P878, DOI 10.1289/ehp.1002727; Wu N, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-4	44	46	46	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e98771	10.1371/journal.pone.0098771	http://dx.doi.org/10.1371/journal.pone.0098771			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK8WO	24964083	gold, Green Published			2022-12-27	WOS:000338709500006
J	Aho, J; Hakim, A; Vuylsteke, B; Semde, G; Gbais, HG; Diarrassouba, M; Thiam, M; Laga, M				Aho, Josephine; Hakim, Avi; Vuylsteke, Bea; Semde, Gisele; Gbais, Honorat G.; Diarrassouba, Mamadou; Thiam, Marguerite; Laga, Marie			Exploring Risk Behaviors and Vulnerability for HIV among Men Who Have Sex with Men in Abidjan, Cote d'Ivoire: Poor Knowledge, Homophobia and Sexual Violence	PLOS ONE			English	Article							INTERNALIZED HOMOPHOBIA; HUMAN-RIGHTS; INFECTION; DEPRESSION; PREVALENCE; TRANSMISSION; METAANALYSIS; PREVENTION; HIV/AIDS; AFRICA	Men who have sex with men (MSM) are at high risk of HIV. Few data are available on MSM and HIV-related risk behaviors in West Africa. We aimed to describe risk behaviors and vulnerability among MSM in Abidjan, Cote d'Ivoire. We conducted a cross-sectional respondent-driven sampling survey with 601 MSM in 2011-2012. Sociodemographic and behavioural data as well as data related to emotional state and stigma were collected. Population estimates with 95% confidence intervals were produced. Survey weighted logistic regression was used to assess factors associated with inconsistent condom use in the prior 12 months. Most MSM were 24 years of age or younger (63.9%) and had attained at least primary education (84.4%). HIV risk behaviors such as low condom and water-based lubricant use, high numbers of male and female sex partners, and sex work were frequently reported as well as verbal, physical and sexual abuse. Inconsistent condom use during anal sex with a male partner in the prior 12 months was reported by 66.0% of the MSM and was positively associated with history of forced sex, alcohol consumption, having a regular partner and a casual partner, having bought sex, and self-perception of low HIV risk. MSM in Abidjan exhibit multiple and frequent HIV-related risk behaviors. To address those behaviours, a combination of individual but also structural interventions will be needed given the context of stigma, homophobia and violence.	[Aho, Josephine; Vuylsteke, Bea; Laga, Marie] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Hakim, Avi] Ctr Dis Control & Prevent, Atlanta, GA USA; [Semde, Gisele] Family Hlth Int 360, Kinshasa, DEM REP CONGO; [Gbais, Honorat G.] Family Hlth Int 360, Abidjan, Cote Ivoire; [Diarrassouba, Mamadou] Ctr Dis Control & Prevent, Abidjan, Cote Ivoire; [Thiam, Marguerite] Minist Hlth & Fight AIDS, Program Highly Vulnerable Populat, Abidjan, Cote Ivoire	Institute of Tropical Medicine (ITM); Centers for Disease Control & Prevention - USA	Aho, J (corresponding author), Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium.	joseaho@yahoo.ca			US President's Emergency Plan for AIDS Relief; US Centers for Disease Control and Prevention (CDC); Canadian Institutes for Health Research	US President's Emergency Plan for AIDS Relief(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); US Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	The survey was funded by the US President's Emergency Plan for AIDS Relief and the US Centers for Disease Control and Prevention (CDC). CDC was involved in the study design but not directly with the study participants. JA is a recipient of a postdoctoral fellowship by the Canadian Institutes for Health Research.	Alvy LM, 2011, AIDS BEHAV, V15, P1171, DOI 10.1007/s10461-010-9678-z; Arnold MP, 2013, AIDS BEHAV, V17, pS4, DOI 10.1007/s10461-012-0324-9; Baggaley RF, 2010, INT J EPIDEMIOL, V39, P1048, DOI 10.1093/ije/dyq057; Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Baral S, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-36; Baral S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004997; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Calzavara LM, 2012, AIDS BEHAV, V16, P633, DOI 10.1007/s10461-010-9879-5; Chapman J, 2011, AIDS CARE, V23, P449, DOI 10.1080/09540121.2010.507758; Creswell J.W., 2007, DESIGNING CONDUCTING; Diaz Rafael M, 2004, Cultur Divers Ethnic Minor Psychol, V10, P255, DOI 10.1037/1099-9809.10.3.255; Hakim A, 2013, HIV PREVALENCE ASS R; Heckathorn DD, 2007, SOCIOL METHODOL, V37, P151, DOI 10.1111/j.1467-9531.2007.00188.x; Heckathorn DD, 2011, SOCIOL METHODOL, V41, P355, DOI 10.1111/j.1467-9531.2011.01244.x; Huebner DM, 2002, AM J COMMUN PSYCHOL, V30, P327, DOI 10.1023/A:1015325303002; Jin FY, 2010, AIDS, V24, P907, DOI 10.1097/QAD.0b013e3283372d90; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Lane T, 2011, AIDS BEHAV, V15, P626, DOI 10.1007/s10461-009-9598-y; Merrigan M, 2011, SEX TRANSM INFECT, V87, P65, DOI 10.1136/sti.2008.034991; Ministere de la Sante A et de la Lutte contre le Sida [Co A te d'Ivoire] & Institut National de la Statistique (INS) MEASURE DHS, 2013, ENQ DEM SANT IND MUL; Ministere de la Santeet de la Lutte contre le Sida de Cote d'Ivoire INdlS Measure DHS ICF International, 2012, ENQ DEM SANT IND MUL; Monahan PO, 2009, J GEN INTERN MED, V24, P189, DOI 10.1007/s11606-008-0846-z; Rebe KB, 2011, SAMJ S AFR MED J, V101, P708; Salganik MJ, 2006, J URBAN HEALTH, V83, pI98, DOI 10.1007/s11524-006-9106-x; Smith AD, 2009, LANCET, V374, P416, DOI 10.1016/S0140-6736(09)61118-1; Tucker A, 2013, AIDS CARE; van Griensven F, 2009, CURR OPIN HIV AIDS, V4, P300, DOI 10.1097/COH.0b013e32832c3bb3; Voisin D. R., 2012, J ADOLESCENCE; Vu L, 2012, AIDS BEHAV, V16, P717, DOI 10.1007/s10461-011-9948-4; Vuylsteke B, 2012, SEX TRANSM INFECT, V88, P288, DOI 10.1136/sextrans-2011-050276	30	43	43	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e99591	10.1371/journal.pone.0099591	http://dx.doi.org/10.1371/journal.pone.0099591			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK7UT	24959923	gold, Green Published, Green Submitted			2022-12-27	WOS:000338633900010
J	Dohn, MN; Pilkington, H				Dohn, Michael N.; Pilkington, Hugo			Sharing Medicine: The Candidacy of Medicines and Other Household Items for Sharing, Dominican Republic	PLOS ONE			English	Article							PRESCRIPTION-MEDICATION; ADVERTISEMENTS; COMMODITIES; EXCHANGE; EXPOSURE; SMOKING; GIFTS	Background: People share medicines and problems can result from this behavior. Successful interventions to change sharing behavior will require understanding people's motives and purposes for sharing medicines. Better information about how medicines fit into the gifting and reciprocity system could be useful in designing interventions to modify medicine sharing behavior. However, it is uncertain how people situate medicines among other items that might be shared. This investigation is a descriptive study of how people sort medicines and other shareable items. Methods and Findings: This study in the Dominican Republic examined how a convenience sample (31 people) sorted medicines and rated their shareability in relation to other common household items. We used non-metric multidimensional scaling to produce association maps in which the distances between items offer a visual representation of the collective opinion of the participants regarding the relationships among the items. In addition, from a pile sort constrained by four categories of whether sharing or loaning the item was acceptable (on a scale from not shareable to very shareable), we assessed the degree to which the participants rated the medicines as shareable compared to other items. Participants consistently grouped medicines together in all pile sort activities; yet, medicines were mixed with other items when rated by their candidacy to be shared. Compared to the other items, participants had more variability of opinion as to whether medicines should be shared. Conclusions: People think of medicines as a distinct group, suggesting that interventions might be designed to apply to medicines as a group. People's differing opinions as to whether it was appropriate to share medicines imply a degree of uncertainty or ambiguity that health promotion interventions might exploit to alter attitudes and behaviors. These findings have implications for the design of health promotion interventions to impact medicine sharing behavior.	[Dohn, Michael N.] Nica Episcopal Esperanza & Caridad, Community Hlth, San Pedro De Macoris, Dominican Rep; [Dohn, Michael N.] Soc Anglican Missionaries & Senders, Ambridge, PA USA; [Pilkington, Hugo] Univ Paris 08, Dept Geog, St Denis, France; [Pilkington, Hugo] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	Universite Paris-VIII; University of London; London School of Hygiene & Tropical Medicine	Dohn, MN (corresponding author), Wright State Univ, Boonshoft Sch Med, Dept Community Hlth, Ctr Global Hlth, Dayton, OH 45435 USA.	michael.dohn@wright.edu		Pilkington, Hugo/0000-0002-8245-2806				Amare G, 1997, E AFR MED J, V74, P362; [Anonymous], MED ANTHR Q; Appadurai A., 1986, SOCIAL LIFE THINGS; Arnett JJ, 1998, TOB CONTROL, V7, P129, DOI 10.1136/tc.7.2.129; BERNARD HR, 2006, RES METHODS CULTURAL, P299; Bernard HR, 2006, RES METHODS ANTHR, P649; CARRIER J, 1991, SOCIOL FORUM, V6, P119, DOI 10.1007/BF01112730; Daniel KL, 2003, PEDIATRICS, V111, P1167; DARNELL JC, 1986, J AM GERIATR SOC, V34, P1; DiMatteo MR, 2004, MED CARE, V42, P200, DOI 10.1097/01.mlr.0000114908.90348.f9; Dohn MN, 2007, AM J TROP MED HYG, V77, P40; Dohn MN, 2012, J RELIG HLTH, V51; Dumit Joseph, 2010, Anthropol Med, V17, P245, DOI 10.1080/13648470.2010.493708; Ellis J, 2009, AUST FAM PHYSICIAN, V38, P816; FOSTER GM, 1961, AM ANTHROPOL, V63, P1173, DOI 10.1525/aa.1961.63.6.02a00020; Garnier LM, 2010, J CLIN PSYCHIAT, V71, P262, DOI 10.4088/JCP.09m05189ecr; Goldsworthy RC, 2008, AM J PUBLIC HEALTH, V98, P1115, DOI 10.2105/AJPH.2007.123257; Goldsworthy RC, 2009, J ADOLESCENT HEALTH, V45, P634, DOI 10.1016/j.jadohealth.2009.06.002; Goulding E, 2011, IRISH J MED SCI, V180, P687, DOI 10.1007/s11845-011-0698-0; Green J, 2005, PRINCIPLES SOCIAL RE, P23; Haynes RB, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000011.pub3; Holloway K., 2011, WORLD MED SITUATION; Kirkwood B. R., 2003, MED STAT; Kleinman Arthur, 1995, WRITING MARGIN DISCO; Lapavitsas C, 2004, SCI SOC, V68, P33, DOI 10.1521/siso.68.1.33.25757; Leeson PT, 2008, J LEGAL STUD, V37, P161, DOI 10.1086/588262; Mauss M, 1950, ESSAI SER DON; McCabe SE, 2005, ADDICT BEHAV, V30, P1342, DOI 10.1016/j.addbeh.2005.01.012; Mitchell AA, 2008, AM J PUBLIC HEALTH, V98, P1926, DOI 10.2105/AJPH.2008.144261; Nutbeam D, 2006, HLTH PROMOTION THEOR, P24; Page RM, 2009, J PEDIATR HEALTH CAR, V23, P150, DOI 10.1016/j.pedhc.2008.01.006; Petersen EE, 2008, J WOMENS HEALTH, V17, P1073, DOI 10.1089/jwh.2007.0769; Pierce JP, 1999, TOB CONTROL, V8, P37, DOI 10.1136/tc.8.1.37; Planta MB, 2007, J AM BOARD FAM MED, V20, P533, DOI 10.3122/jabfm.2007.06.070019; Pool R, 2005, MED ANTHROPOL, P88; Pool R, 2005, MED ANTHROPOL, P39; Radyowijati A, 2003, SOC SCI MED, V57, P733, DOI 10.1016/S0277-9536(02)00422-7; Rosner B., 2010, FUNDAMENTALS BIOSTAT; Rouse Carolyn, 2010, Anthropol Med, V17, P187, DOI 10.1080/13648470.2010.493602; Rus A., 2008, ANTHROPOL NOTEB, V14, P81; Tanne JH, 1996, BRIT MED J, V313, P1349, DOI 10.1136/bmj.313.7069.1349a; van der Geest S, 1990, HLTH POLICY PLANNING, V5, P182; van der Geest S, 2006, J ETHNOBIOL ETHNOMED, V2, DOI 10.1186/1746-4269-2-48; vanderGeest S, 1996, ANNU REV ANTHROPOL, V25, P153, DOI 10.1146/annurev.anthro.25.1.153; Ward L, 2011, J URBAN HEALTH, V88, P997, DOI 10.1007/s11524-011-9589-y; Whyte SR, 2002, SOCIAL LIVES MED	46	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e101007	10.1371/journal.pone.0101007	http://dx.doi.org/10.1371/journal.pone.0101007			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK6BK	24971939	Green Published, Green Submitted, gold			2022-12-27	WOS:000338512200083
J	Piyatrakul, P; Yang, M; Putranto, RA; Pirrello, J; Dessailly, F; Hu, SN; Summo, M; Theeravatanasuk, K; Leclercq, J; Kuswanhadi; Montoro, P				Piyatrakul, Piyanuch; Yang, Meng; Putranto, Riza-Arief; Pirrello, Julien; Dessailly, Florence; Hu, Songnian; Summo, Marilyne; Theeravatanasuk, Kannikar; Leclercq, Julie; Kuswanhadi; Montoro, Pascal			Sequence and Expression Analyses of Ethylene Response Factors Highly Expressed in Latex Cells from Hevea brasiliensis	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; END RULE PATHWAY; RUBBER-TREE; TRANSCRIPTION FACTORS; SUBMERGENCE TOLERANCE; AP2/ERF SUPERFAMILY; FREEZING TOLERANCE; GENE-EXPRESSION; FUNCTIONAL-ANALYSIS; NATURAL VARIATION	The AP2/ERF superfamily encodes transcription factors that play a key role in plant development and responses to abiotic and biotic stress. In Hevea brasiliensis, ERF genes have been identified by RNA sequencing. This study set out to validate the number of HbERF genes, and identify ERF genes involved in the regulation of latex cell metabolism. A comprehensive Hevea transcriptome was improved using additional RNA reads from reproductive tissues. Newly assembled contigs were annotated in the Gene Ontology database and were assigned to 3 main categories. The AP2/ERF superfamily is the third most represented compared with other transcription factor families. A comparison with genomic scaffolds led to an estimation of 114 AP2/ERF genes and 1 soloist in Hevea brasiliensis. Based on a phylogenetic analysis, functions were predicted for 26 HbERF genes. A relative transcript abundance analysis was performed by real-time RT-PCR in various tissues. Transcripts of ERFs from group I and VIII were very abundant in all tissues while those of group VII were highly accumulated in latex cells. Seven of the thirty-five ERF expression marker genes were highly expressed in latex. Subcellular localization and transactivation analyses suggested that HbERF-VII candidate genes encoded functional transcription factors.	[Piyatrakul, Piyanuch; Putranto, Riza-Arief; Pirrello, Julien; Dessailly, Florence; Summo, Marilyne; Leclercq, Julie; Montoro, Pascal] Ctr Int Rech Agron Dev, Unite Mixte Rech Ameliorat Genet & Adaptat Plante, Montpellier, France; [Piyatrakul, Piyanuch; Theeravatanasuk, Kannikar] Rubber Res Inst, Dept Agr, Bangkok, Thailand; [Yang, Meng; Hu, Songnian] Chinese Acad Sci, Beijing Inst Genom, Beijing, Peoples R China; [Putranto, Riza-Arief] Indonesian Biotechnol Res Inst Estate Crops, Bogor, Indonesia; [Kuswanhadi] Indonesian Rubber Res Inst, Sembawa Res Ctr, Palembang, Indonesia	CIRAD; Universite de Montpellier; Ministry of Agriculture & Cooperatives - Thailand; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Riset Perkebunan Nusantara; Indonesian Rubber Research Institute (IRRI)	Montoro, P (corresponding author), Ctr Int Rech Agron Dev, Unite Mixte Rech Ameliorat Genet & Adaptat Plante, Montpellier, France.	pascal.montoro@cirad.fr	Summo, Marilyne/AAR-1367-2021; Pirrello, Julien/AAI-1692-2020; Putranto, Riza-Arief/X-3130-2019; Leclercq, Julie/B-2147-2012; Hu, Songnian/C-6509-2013	Summo, Marilyne/0000-0002-9308-974X; Pirrello, Julien/0000-0002-5725-885X; Putranto, Riza-Arief/0000-0002-1327-1200; Hu, Songnian/0000-0003-3966-3111; Leclercq, Julie/0000-0001-8110-3762; , Meng/0000-0002-2672-3069	Rubber Research Institute of Thailand; Institut Francais du Caoutchouc; Michelin company; Socfinco company; SIPH company	Rubber Research Institute of Thailand; Institut Francais du Caoutchouc; Michelin company; Socfinco company; SIPH company	This work was supported by the Rubber Research Institute of Thailand, the Institut Francais du Caoutchouc, and the Michelin, Socfinco and SIPH companies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Blanco C, 2005, PLANT PHYSIOL, V139, P1304, DOI 10.1104/pp.105.068510; [Anonymous], SURVEY BRANCH SUPPOR; Argout X, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-512; Azar S, 2012, FACTEURS TRANSCRIPTI; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bailey-Serres J, 2012, TRENDS PLANT SCI, V17, P129, DOI 10.1016/j.tplants.2011.12.004; Bleecker AB, 2000, ANNU REV CELL DEV BI, V16, P1, DOI 10.1146/annurev.cellbio.16.1.1; Byrne M, 1997, THEOR APPL GENET, V95, P975, DOI 10.1007/s001220050650; Cai HB, 2008, TROPICAL AGR SCI TEC, V31, P424; CAZAUX E, 1995, PLANT CELL TISS ORG, V41, P211, DOI 10.1007/BF00045084; Cernac A, 2004, PLANT J, V40, P575, DOI 10.1111/j.1365-313X.2004.02235.x; Chaabouni S, 2009, J EXP BOT, V60, P1349, DOI 10.1093/jxb/erp009; Chen YY, 2012, MOL BIOL REP, V39, P3713, DOI 10.1007/s11033-011-1146-y; Chow KS, 2007, J EXP BOT, V58, P2429, DOI 10.1093/jxb/erm093; Chow KS, 2012, J EXP BOT, V63, P1863, DOI 10.1093/jxb/err363; Chrestin H, 1997, EUPHYTICA, V96, P77, DOI 10.1023/A:1002950300536; Chrestin H., 1989, PHYSL RUBBER TREE LA, P431; CHYE ML, 1992, PLANT MOL BIOL, V19, P473, DOI 10.1007/BF00023395; D'Auzac J., 1989, PHYSL RUBBER TREE LA; Dietz KJ, 2010, PROTOPLASMA, V245, P3, DOI 10.1007/s00709-010-0142-8; Duan CF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-30; Duan C, 2010, TREE PHYSIOL, V30, P1349, DOI 10.1093/treephys/tpq066; Dufayard JF, 2005, BIOINFORMATICS, V21, P2596, DOI 10.1093/bioinformatics/bti325; Dusotoit-Coucaud A, 2010, TREE PHYSIOL, V30, P1586, DOI 10.1093/treephys/tpq088; Dusotoit-Coucaud A, 2010, PLANT CELL PHYSIOL, V51, P1878, DOI 10.1093/pcp/pcq151; Dusotoit-Coucaud A, 2009, ANN BOT-LONDON, V104, P635, DOI 10.1093/aob/mcp150; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Etchells JP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002997; Fujimoto SY, 2000, PLANT CELL, V12, P393, DOI 10.1105/tpc.12.3.393; Fukao T, 2006, PLANT CELL, V18, P2021, DOI 10.1105/tpc.106.043000; Fukao T, 2013, CURR OPIN PLANT BIOL, V16, P196, DOI 10.1016/j.pbi.2013.02.003; Fukao T, 2012, PLANT PHYSIOL, V160, P1795, DOI 10.1104/pp.112.207738; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Gebelin V, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-18; Gery C, 2011, PLANT SCI, V180, P12, DOI 10.1016/j.plantsci.2010.07.010; Gibbs DJ, 2011, NATURE, V479, P415, DOI 10.1038/nature10534; GIDROL X, 1994, J BIOL CHEM, V269, P9278; GIDROL X, 1988, PLANT PHYSIOL, V86, P899, DOI 10.1104/pp.86.3.899; Girardi CL, 2013, SCI HORTIC-AMSTERDAM, V151, P112, DOI 10.1016/j.scienta.2012.12.017; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Han KH, 2000, TREE PHYSIOL, V20, P503; Hattori Y, 2009, NATURE, V460, P1026, DOI 10.1038/nature08258; Hess N, 2011, PHYSIOL PLANTARUM, V143, P41, DOI 10.1111/j.1399-3054.2011.01486.x; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Hinz M, 2010, PLANT PHYSIOL, V153, P757, DOI 10.1104/pp.110.155077; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jacob J.L., 1989, PHYSL RUBBER TREE LA, P101; Johnson PR, 1998, ANNU REV GENET, V32, P227, DOI 10.1146/annurev.genet.32.1.227; Khandelwal A, 2008, PLANT PHYSIOL, V148, P2050, DOI 10.1104/pp.108.128488; Ko JH, 2003, PLANT MOL BIOL, V53, P479, DOI 10.1023/B:PLAN.0000019119.66643.5d; Krishnaswamy S, 2011, PLANT MOL BIOL, V75, P107, DOI 10.1007/s11103-010-9711-7; Kuswanhadi, 2010, J RUBBER RES, V13, P185; LATCHMAN DS, 1993, INT J EXP PATHOL, V74, P417; Lertpanyasampatha M, 2012, PLANTA, V236, P437, DOI 10.1007/s00425-012-1622-1; Li DJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-192; Li HY, 2008, J EXP BOT, V59, P3997, DOI 10.1093/jxb/ern241; Licausi F, 2013, J INTEGR PLANT BIOL, V55, P31, DOI 10.1111/jipb.12011; Licausi F, 2011, NATURE, V479, P419, DOI 10.1038/nature10536; Licausi F, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-719; Licausi F, 2010, PLANT J, V62, P302, DOI 10.1111/j.1365-313X.2010.04149.x; Liengprayoon S, 2011, PHYTOCHEMISTRY, V72, P1902, DOI 10.1016/j.phytochem.2011.04.023; Mituyama T, 2009, NUCLEIC ACIDS RES, V37, pD89, DOI 10.1093/nar/gkn805; Moffat CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035995; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Navarro M, 2009, J EXP BOT, V60, P2713, DOI 10.1093/jxb/erp129; Pan L, 2001, FEBS LETT, V508, P375, DOI 10.1016/S0014-5793(01)03098-8; Papdi C, 2008, PLANT PHYSIOL, V147, P528, DOI 10.1104/pp.108.116897; Park HY, 2011, BIOCHEM BIOPH RES CO, V414, P135, DOI 10.1016/j.bbrc.2011.09.039; Pennycooke JC, 2008, PLANT MOL BIOL, V67, P483, DOI 10.1007/s11103-008-9333-5; Perata P, 2007, TRENDS PLANT SCI, V12, P43, DOI 10.1016/j.tplants.2006.12.005; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Pirrello J, 2006, PLANT CELL PHYSIOL, V47, P1195, DOI 10.1093/pcp/pcj084; Pirrello J, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-190; Piyatrakul P, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-244; PUJADERENAUD V, 1994, PLANT PHYSIOL, V105, P127, DOI 10.1104/pp.105.1.127; Qin F, 2004, PLANT CELL PHYSIOL, V45, P1042, DOI 10.1093/pcp/pch118; Rahman AYA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-75; Rashotte AM, 2006, P NATL ACAD SCI USA, V103, P11081, DOI 10.1073/pnas.0602038103; Rombauts S, 1999, NUCLEIC ACIDS RES, V27, P295, DOI 10.1093/nar/27.1.295; Sakuma Y, 2002, BIOCHEM BIOPH RES CO, V290, P998, DOI 10.1006/bbrc.2001.6299; Sambrook J., 2002, MOL CLONING LAB MANU; Sasidharan R, 2011, PLANT CELL, V23, P4173, DOI 10.1105/tpc.111.093880; Schlereth A, 2010, NATURE, V464, P913, DOI 10.1038/nature08836; Schmitz AJ, 2013, NEW PHYTOL, V198, P1060, DOI 10.1111/nph.12202; Shi XL, 2012, J EXP BOT, V63, P973, DOI 10.1093/jxb/err325; Stockinger EJ, 2007, PLANT J, V51, P308, DOI 10.1111/j.1365-313X.2007.0141.x; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tang CR, 2010, PLANT CELL ENVIRON, V33, P1708, DOI 10.1111/j.1365-3040.2010.02175.x; Thevenin J, 2012, NEW PHYTOL, V193, P504, DOI 10.1111/j.1469-8137.2011.03936.x; To A, 2012, PLANT CELL, V24, P5007, DOI 10.1105/tpc.112.106120; Triwitayakorn K, 2011, DNA RES, V18, P471, DOI 10.1093/dnares/dsr034; Tungngoen K, 2009, PLANT PHYSIOL, V151, P843, DOI 10.1104/pp.109.140228; Tupy J., 1989, PHYSL RUBBER TREE LA, P179; Venkatachalam P, 2009, MOL BIOTECHNOL, V41, P42, DOI 10.1007/s12033-008-9095-y; Walley JW, 2007, PLOS GENET, V3, P1800, DOI 10.1371/journal.pgen.0030172; Wilson K, 1996, PLANT CELL, V8, P659, DOI 10.1105/tpc.8.4.659; Wu H., 2010, CHINESE AGR SCI B, V5; Xia ZH, 2011, PLANT MOL BIOL, V77, P299, DOI 10.1007/s11103-011-9811-z; Zhang CH, 2012, GENET MOL RES, V11, P4789, DOI 10.4238/2012.October.17.6; Zhang H, 2011, NUCLEIC ACIDS RES, V39, pD1114, DOI 10.1093/nar/gkq1141; Zhen Y, 2008, MOL BIOL EVOL, V25, P2547, DOI 10.1093/molbev/msn196; Zhu JH, 2009, PLANT SIGNAL BEHAV, V4, P1072, DOI 10.4161/psb.4.11.9738; Zhu L, 2013, PLANT PHYSIOL, V161, P904, DOI 10.1104/pp.112.204487; Zhuang J, 2008, BIOCHEM BIOPH RES CO, V371, P468, DOI 10.1016/j.bbrc.2008.04.087	104	31	36	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e99367	10.1371/journal.pone.0099367	http://dx.doi.org/10.1371/journal.pone.0099367			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971876	Green Submitted, Green Published, gold			2022-12-27	WOS:000338512200010
J	Zhang, Y; Tian, XY; Ji, H; Guan, XY; Xu, W; Dong, B; Zhao, M; Wei, M; Ye, CX; Sun, Y; Yuan, XS; Yang, C; Hao, CY				Zhang, Yi; Tian, Xiuyun; Ji, Hong; Guan, Xiaoya; Xu, Wei; Dong, Bin; Zhao, Min; Wei, Meng; Ye, Chunxiang; Sun, Yuan; Yuan, Xiaosun; Yang, Chen; Hao, Chunyi			Expression of SATB1 Promotes the Growth and Metastasis of Colorectal Cancer	PLOS ONE			English	Article							MAR-BINDING PROTEIN; T-CELL DEVELOPMENT; VEGF-B; PROGNOSTIC-SIGNIFICANCE; GENE-EXPRESSION; MULTIPLE GENES; GASTRIC-CANCER; DIFFERENTIATION; OVEREXPRESSION; ANGIOGENESIS	Special AT-rich sequence-binding protein-1 (SATB1) has been identified as a genome organizer that reprograms chromatin organization and transcription profiles. SATB1 promotes tumor growth and metastasis in breast cancer and is associated with poor prognosis in several cancer types. The association between SATB1 and colorectal cancer (CRC) has not been studied intensively. Therefore, this study aimed to investigate the effect of SATB1 on CRC growth and metastasis in vitro and in vivo and its correlation with overall survival and clinicopathological factors in CRC patients. Stable SATB1 knockdown and SATB1-overexpressing cell lines were established. SATB1 knockdown decreased cell growth, colony formation, migration, and invasion and increased apoptosis in CRC cells in vitro (p < 0.05), whereas SATB1 overexpression had the opposite effect. SATB1 overexpression increased tumor growth and metastasis to lung and liver in vivo by using xenograft animal models (p < 0.05). Thus, SATB1 promoted an aggressive CRC phenotype in vitro and in vivo. Immunohistochemical analysis of 560 CRC specimens showed that SATB1 expression was significantly higher in CRC tissues than in matched non-tumor mucosa (p < 0.001). In addition, SATB1 expression was significantly higher in patients with poorly differentiated tumors, higher invasion depth, distant metastasis, and advanced TNM stage. SATB1-positive patients had a poorer prognosis than SATB1-negative patients, and SATB1 was identified as an independent prognostic factor for CRC (p = 0.009). Strikingly, we also evaluated SATB2 expression in CRC and found that SATB2 was more abundantly expressed in non-cancerous mucosa compared to colorectal cancer tissues (p < 0.001). However, SATB2 expression had no influence on prognosis of CRC patients (p = 0.836). SATB1 expression was significantly associated with shorter survival time either in SATB2-positive patients or in SATB2-negative patients (p < 0.001). In conclusion, our findings indicated an important role for SATB1 in CRC tumorigenesis and metastasis. Therefore, SATB1 may represent an important prognostic biomarker and therapeutic target for CRC.	[Zhang, Yi; Tian, Xiuyun; Guan, Xiaoya; Xu, Wei; Wei, Meng; Ye, Chunxiang; Sun, Yuan; Yuan, Xiaosun; Hao, Chunyi] Peking Univ, Key Lab Carcinogenesis & Translat Res, Dept Hepatopancreato Biliary Surg, Sch Oncol,Canc Hosp & Inst,Minist Educ, Beijing 100871, Peoples R China; [Zhang, Yi; Ji, Hong] Aerosp Ctr Hosp, Dept Gereol, Beijing, Peoples R China; [Dong, Bin; Zhao, Min] Peking Univ, Key Lab Carcinogenesis & Translat Res, Canc Hosp & Inst, Sch Oncol,Ctr Lab,Minist Educ, Beijing 100871, Peoples R China; [Yang, Chen] Peking Univ, Key Lab Carcinogenesis & Translat Res, Canc Hosp & Inst, Sch Oncol,Etiol Lab,Minist Educ, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University	Hao, CY (corresponding author), Peking Univ, Key Lab Carcinogenesis & Translat Res, Dept Hepatopancreato Biliary Surg, Sch Oncol,Canc Hosp & Inst,Minist Educ, Beijing 100871, Peoples R China.	haochunyi@126.com			National Natural Science funding [81272765]; Capital Characteristic Clinical Application Research [Z121107001012083]; Capital Medical Development Fund [2009-2095]; Beijing Municipal Natural Science Foundation [7122030]; Beijing's Outstanding Talents Subsidy Scheme (215 Program) [2009-2-18]; Special Project of Beijing "Tens, Hundreds and Thousands" Health Talentsand funding from the Beijing Cancer Hospital [10-04]	National Natural Science funding(National Natural Science Foundation of China (NSFC)); Capital Characteristic Clinical Application Research; Capital Medical Development Fund; Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation); Beijing's Outstanding Talents Subsidy Scheme (215 Program); Special Project of Beijing "Tens, Hundreds and Thousands" Health Talentsand funding from the Beijing Cancer Hospital	This study was supported by National Natural Science funding (No: 81272765), Capital Characteristic Clinical Application Research (No: Z121107001012083), the Key Project of Capital Medical Development Fund (No: 2009-2095), Beijing Municipal Natural Science Foundation (No: 7122030), Beijing's Outstanding Talents Subsidy Scheme (215 Program, No: 2009-2-18), Special Project of Beijing "Tens, Hundreds and Thousands" Health Talentsand funding from the Beijing Cancer Hospital (No: 10-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlfors H, 2010, BLOOD, V116, P1443, DOI 10.1182/blood-2009-11-252205; Alvarez JD, 2000, GENE DEV, V14, P521; Berx G, 2001, BREAST CANCER RES, V3, P289, DOI 10.1186/bcr309; Boye K, 2010, AM J PATHOL, V176, P528, DOI 10.2353/ajpath.2010.090526; Burute M, 2012, IMMUNOL CELL BIOL, V90, P852, DOI 10.1038/icb.2012.28; Cai ST, 2003, NAT GENET, V34, P42, DOI 10.1038/ng1146; Chang C, 2001, TRENDS CELL BIOL, V11, pS37, DOI 10.1016/S0962-8924(01)82222-4; Chen HX, 2011, J DERMATOL SCI, V64, P39, DOI 10.1016/j.jdermsci.2011.06.007; Cheng C, 2010, APMIS, V118, P855, DOI 10.1111/j.1600-0463.2010.02673.x; Darrington E, 2012, ASIAN J ANDROL, V14, P745, DOI 10.1038/aja.2011.197; DICKINSON LA, 1992, CELL, V70, P631, DOI 10.1016/0092-8674(92)90432-C; Dobreva G, 2003, GENE DEV, V17, P3048, DOI 10.1101/gad.1153003; Eberhard J, 2012, BRIT J CANCER, V106, P931, DOI 10.1038/bjc.2012.34; Fang XF, 2013, WORLD J GASTROENTERO, V19, P2331, DOI 10.3748/wjg.v19.i15.2331; FOSTER JH, 1984, SEMIN LIVER DIS, V4, P170, DOI 10.1055/s-2008-1040656; Garrett SC, 2006, J BIOL CHEM, V281, P677, DOI 10.1074/jbc.R500017200; Han HJ, 2008, NATURE, V452, P187, DOI 10.1038/nature06781; Jia XQ, 2011, CHINESE MED J-PEKING, V124, P3794, DOI 10.3760/cma.j.issn.0366-6999.2011.22.034; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Leask A, 2006, J CELL SCI, V119, P4803, DOI 10.1242/jcs.03270; Lu XM, 2010, ONCOL REP, V24, P981, DOI 10.3892/or_00000945; Mahmoud N, 2010, DIS COLON RECTUM, V53, P1080, DOI 10.1007/DCR.0b013e3181dcadbc; MASSAGUE J, 1992, CANCER SURV, V12, P81; Meng WJ, 2012, INT J COLORECTAL DIS, V27, P143, DOI 10.1007/s00384-011-1302-9; Meng WJ, 2011, MED HYPOTHESES, V76, P277, DOI 10.1016/j.mehy.2010.10.022; Naito T, 2011, INT IMMUNOL, V23, P661, DOI 10.1093/intimm/dxr078; Nie H, 2005, J IMMUNOL, V174, P4745, DOI 10.4049/jimmunol.174.8.4745; Nodin B, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-115; Notani D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000296; Olofsson B, 1998, P NATL ACAD SCI USA, V95, P11709, DOI 10.1073/pnas.95.20.11709; Potter E, 1999, ENDOCR REV, V20, P207, DOI 10.1210/er.20.2.207; Qi W, 2005, AM J PHYSIOL-RENAL, V288, pF800, DOI 10.1152/ajprenal.00179.2004; Salven P, 1998, AM J PATHOL, V153, P103, DOI 10.1016/S0002-9440(10)65550-2; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Wang S, 2009, J PATHOL, V219, P114, DOI 10.1002/path.2575; Xu L, 1997, CYTOGENET CELL GENET, V77, P205, DOI 10.1159/000134577; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084; Zhang F, 2009, P NATL ACAD SCI USA, V106, P6152, DOI 10.1073/pnas.0813061106; Zhang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0047902; Zhao XD, 2010, ORL-J OTO-RHIN-LARYN, V72, P1, DOI 10.1159/000264777	40	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100413	10.1371/journal.pone.0100413	http://dx.doi.org/10.1371/journal.pone.0100413			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971456	Green Submitted, Green Published, gold			2022-12-27	WOS:000338512200030
J	Adeloye, D				Adeloye, Davies			An Estimate of the Incidence and Prevalence of Stroke in Africa: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							SUB-SAHARAN AFRICA; NEUROLOGICAL DISORDERS; CASE-FATALITY; RISK-FACTORS; COMMUNITY; BURDEN; EPIDEMIOLOGY; URBAN; POPULATION; DISEASE	Background: Stroke is increasingly becoming a challenging public health issue in Africa, and the non-availability of data has limited research output and consequently the response to this burden. This study aimed to estimate the incidence and prevalence of stroke in Africa in 2009 towards improved policy response and management of the disease in the region. Methods: A systematic search of Medline, EMBASE and Global Health for original population-based or hospital-based studies on stroke was conducted. A random effect meta-analysis was conducted on crude stroke incidence and prevalence rates, and a meta-regression-like epidemiological model was applied on all data points. The fitted curve generated from the model was used to estimate incident cases of stroke and number of stroke survivors in Africa at midpoints of the United Nation population 5-year age groups for the year 2009. Results: The literature search yielded a total of 1227 studies. 19 studies from 10 African countries were selected. 483 thousand new stroke cases among people aged 15 years or more were estimated in Africa in 2009, equivalent to 81.2 (13.2-94.9)/100,000 person years. A total of 1.89 million stroke survivors among people aged 15 years or more were estimated in Africa in 2009, with a prevalence of 317.3 (314.0-748.2)/100000 population. Comparable figures for the year 2013 based on the same rates would amount to 535 thousand (87.0-625.3) new stroke cases and 2.09 million (2.06-4.93) stroke survivors, suggesting an increase of 10.8% and 9.6% of incident stroke cases and stroke survivors respectively, attributable to population growth and ageing between 2009 and 2013. Conclusion: The findings of this review suggest the burden of stroke in Africa is high and still increasing. There is need for more research on stroke and other vascular risk factors towards instituting appropriate policy, and effective preventive and management measures.	Univ Edinburgh, Sch Med, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland	University of Edinburgh	Adeloye, D (corresponding author), Univ Edinburgh, Sch Med, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland.	Davies.Adeloye@ed.ac.uk	Adeloye, Davies/AAB-6302-2022	Adeloye, Davies/0000-0003-1316-8139				Adoukonou TA, 2010, REV NEUROL-FRANCE, V166, P882, DOI 10.1016/j.neurol.2010.06.004; AHO K, 1980, B WORLD HEALTH ORGAN, V58, P113; [Anonymous], 1988, J CLIN EPIDEMIOL, V41, P105, DOI 10.1016/0895-4356(88)90084-4; [Anonymous], GLOB BURD DIS GBD 20; ASHOK PP, 1986, J NEUROL NEUROSUR PS, V49, P519, DOI 10.1136/jnnp.49.5.519; Beaglehole R, 2011, LANCET, V378, P449, DOI 10.1016/S0140-6736(11)60879-9; Bennett DA, 2012, NEUROEPIDEMIOLOGY, V38, P30, DOI 10.1159/000334744; Bonita R, 2003, LANCET NEUROL, V2, P592, DOI 10.1016/S1474-4422(03)00524-6; Chan KY, 2012, J GLOB HEALTH, V2, P20101, DOI DOI 10.7189/J0GH.02.020101; Chin JH, 2012, NEUROLOGY, V78, P1007, DOI 10.1212/WNL.0b013e318248df95; Connor MD, 2004, STROKE, V35, P627, DOI 10.1161/01.STR.0000117096.61838.C7; Connor MD, 2007, LANCET NEUROL, V6, P269, DOI 10.1016/S1474-4422(07)70002-9; Cossi MJ, 2012, CEREBROVASC DIS, V33, P166, DOI 10.1159/000334195; Damasceno A, 2010, STROKE, V41, P2463, DOI 10.1161/STROKEAHA.110.594275; Danesi M, 2007, NEUROEPIDEMIOLOGY, V28, P216, DOI 10.1159/000108114; Danesi MA, 2013, J NEUROL SCI, V331, P43, DOI 10.1016/j.jns.2013.04.026; Dewhurst F, 2013, ACTA NEUROL SCAND, V127, P198, DOI 10.1111/j.1600-0404.2012.01709.x; El Tallawy HNA, 2013, NEUROPSYCH DIS TREAT, V9, P767, DOI 10.2147/NDT.S36956; ELZUNNI S, 1995, ANN SAUDI MED, V15, P367, DOI 10.5144/0256-4947.1995.367; Farghaly WMA, 2013, NEUROPSYCH DIS TREAT, V9, P1785, DOI 10.2147/NDT.S48322; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7; HATANO S, 1976, B WORLD HEALTH ORGAN, V54, P541; Johnston SC, 2009, LANCET NEUROL, V8, P345, DOI 10.1016/S1474-4422(09)70023-7; JOUBERT J, 1991, S AFR MED J, V80, P567; Kandil MR., 2006, EGYPT J NEUROL PSYCH, V43, P593; Kengne AP, 2006, INT J STROKE, V1, P180, DOI 10.1111/j.1747-4949.2006.00064.x; Khedr EM, 2013, NEUROEPIDEMIOLOGY, V40, P288, DOI 10.1159/000346270; Kolapo KO, 2011, TROP MED INT HEALTH, V16, P707, DOI 10.1111/j.1365-3156.2011.02759.x; Lemogoum D, 2005, AM J PREV MED, V29, P95, DOI 10.1016/j.amepre.2005.07.025; Matenga J, 1997, S AFR MED J, V87, P606; Mathers CD., 2005, UNCERTAINTY DATA AVA; Matuja W, 2004, TROP DOCT, V34, P144, DOI 10.1177/004947550403400305; Mensah GA, 2008, HEART, V94, P697, DOI 10.1136/hrt.2007.127753; Mensah George A, 2003, Ethn Dis, V13, pS4; Nyame P K, 1994, West Afr J Med, V13, P183; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Olubunmi O, 2007, BENIN J POSTGRADUATE, V9; OSUNTOKUN BO, 1987, ACTA NEUROL SCAND, V75, P13, DOI 10.1111/j.1600-0404.1987.tb07883.x; OSUNTOKUN BO, 1979, STROKE, V10, P205, DOI 10.1161/01.STR.10.2.205; Owolabi M, 2012, NEUR C 64 AM AC NEUR; ROMDHANE NA, 1993, NEUROEPIDEMIOLOGY, V12, P285, DOI 10.1159/000110330; ROSMAN KD, 1986, STROKE, V17, P667, DOI 10.1161/01.STR.17.4.667; Strong K, 2007, LANCET NEUROL, V6, P182, DOI 10.1016/S1474-4422(07)70031-5; Sudlow CLM, 1996, STROKE, V27, P550, DOI 10.1161/01.STR.27.3.550; TEKLEHAIMANOT R, 1990, NEUROEPIDEMIOLOGY, V9, P263, DOI 10.1159/000110783; Truelsen T., 2006, GLOBAL BURDEN CEREBR; Truelsen T, 2010, LANCET NEUROL, V9, P755, DOI 10.1016/S1474-4422(10)70161-7; United Nations, 2013, WORLD POP AG 2013; Wahab KW, 2008, INT J STROKE, V3, P290, DOI 10.1111/j.1747-4949.2008.00217.x; WALKER R, 1994, T ROY SOC TROP MED H, V88, P609, DOI 10.1016/0035-9203(94)90193-7; Walker RW, 2013, SAMJ S AFR MED J, V103, P107, DOI [10.7196/samj.5793, 10.7196/SAMJ.5793]; Walker R, 2010, LANCET NEUROL, V9, P786, DOI 10.1016/S1474-4422(10)70144-7; Walker RW, 2000, LANCET, V355, P1684, DOI 10.1016/S0140-6736(00)02240-6; World Bank, 2013, WORLD BANK LIST EC; World Bank, 2014, POV EQ DAT; World Health Organization, 1990, STROK EV REG DAT C 4; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20	59	82	82	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100724	10.1371/journal.pone.0100724	http://dx.doi.org/10.1371/journal.pone.0100724			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967899	Green Published, Green Submitted, gold			2022-12-27	WOS:000338280800058
J	Hsieh, TC; Lin, CY; Bennett, DJ; Wu, E; Wu, JM				Hsieh, Tze-Chen; Lin, Chia-Yi; Bennett, Dylan John; Wu, Erxi; Wu, Joseph M.			Biochemical and Cellular Evidence Demonstrating AKT-1 as a Binding Partner for Resveratrol Targeting Protein NQO2	PLOS ONE			English	Article							QUINONE REDUCTASE 2; FAST INTERACTION REFINEMENT; PROSTATE-CANCER CELLS; PHOSPHOINOSITIDE 3-KINASE; CYCLIN D1; AFFINITY-CHROMATOGRAPHY; MOLECULAR DOCKING; TUMOR SUPPRESSION; WEB SERVER; PATHWAY	Background: AKT plays an important role in the control of cell proliferation and survival. Aberrant activation of AKT frequently occurs in human cancers making it an attractive drug targets and leading to the synthesis of numerous AKT inhibitors as therapeutic candidates. Less is known regarding proteins that control AKT. We recently reported that quinone reductase 2 (NQO2) inhibited AKT activity, by unknown mechanisms. Methodology/Principal Findings: In this study, molecular modeling was used to query interaction between NQO2 and AKT. We found that pleckstrin homology (PH) and kinase domains of AKT bind to chains A and B of NQO2. Pull-down and deletion assays revealed that PH domain of AKT is essential for interaction with NQO2. Modeling analysis further revealed that kinase domain of AKT binds NQO2 in the vicinity of asparagine 161 located in the resveratrol-binding domain of NQO2. In studies to test whether exposure to resveratrol potentiates or diminishes AKT binding to NQO2, we showed that pre-binding by resveratrol in wild type but not histidine-161 (N161H) mutant NQO2 significantly affected this interaction. To obtain information on interplay between resveratrol and AKT, resveratrol affinity chromatography was performed. AKT binds with high affinity to the column suggesting that it is a target of resveratrol. The half-life of AKT mRNA decreased from similar to 4 h in control cells to similar to 1 h in NQO2-knockdown cells. The inhibition of AKT by resveratrol was attenuated in NQO2-expressing relative to NQO2-knockdown cells. Conclusion/Significance: Both NQO2 and AKT are targets of resveratrol; NQO2: AKT interaction is a novel physiological regulator of AKT activation/function.	[Hsieh, Tze-Chen; Bennett, Dylan John; Wu, Joseph M.] New York Med Coll, Dept Biochem & Mol Biol, Valhalla, NY 10595 USA; [Lin, Chia-Yi] Natl Taiwan Univ, Genome & Syst Biol Degree Program, Taipei 10764, Taiwan; [Wu, Erxi] N Dakota State Univ, Dept Pharmaceut Sci, Fargo, ND 58105 USA	New York Medical College; National Taiwan University; North Dakota State University Fargo	Hsieh, TC (corresponding author), New York Med Coll, Dept Biochem & Mol Biol, Valhalla, NY 10595 USA.	Tze-chen_Hsieh@nymc.edu		Wu, Erxi/0000-0002-1680-3639	Intramural Sponsored Research Program of New York Medical College [49-432-1, 49-466-1]	Intramural Sponsored Research Program of New York Medical College	This research was supported by the Intramural Sponsored Research Program of New York Medical College to T. C. H. (49-432-1 and 49-466-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alt JR, 2000, GENE DEV, V14, P3102, DOI 10.1101/gad.854900; Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Andrusier N, 2007, PROTEINS, V69, P139, DOI 10.1002/prot.21495; Aziz MH, 2006, MOL CANCER THER, V5, P1335, DOI 10.1158/1535-7163.MCT-05-0526; Barnett SF, 2005, BIOCHEM J, V385, P399, DOI 10.1042/BJ20041140; Benitez DA, 2007, BRIT J CANCER, V96, P1595, DOI 10.1038/sj.bjc.6603755; Blando J, 2009, AM J PATHOL, V174, P1869, DOI 10.2353/ajpath.2009.080055; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Buryanovskyy L, 2004, BIOCHEMISTRY-US, V43, P11417, DOI 10.1021/bi049162o; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Chan T O, 2001, Sci STKE, V2001, ppe1, DOI 10.1126/stke.2001.66.pe1; Davies MA, 1999, CANCER RES, V59, P2551; Davies MA, 1998, CANCER RES, V58, P5285; de Souza PL, 2009, CURR CANCER DRUG TAR, V9, P163, DOI 10.2174/156800909787581006; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Galetic I, 1999, PHARMACOL THERAPEUT, V82, P409, DOI 10.1016/S0163-7258(98)00071-0; Gill C, 2007, PROSTATE, V67, P1641, DOI 10.1002/pros.20653; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Hsieh TC, 2008, ANTICANCER RES, V28, P29; Hsieh TC, 2012, CARCINOGENESIS, V33, P670, DOI 10.1093/carcin/bgs016; Hsieh TC, 2011, INT J CANCER, V129, P2732, DOI 10.1002/ijc.25930; Hsieh TC, 2009, ASIAN J ANDROL, V11, P653, DOI 10.1038/aja.2009.56; Hsieh TC, 2009, ANTICANCER RES, V29, P3011; Huang BX, 2011, J CELL BIOL, V192, P979, DOI 10.1083/jcb.201005100; Hudson TS, 2007, CANCER RES, V67, P8396, DOI 10.1158/0008-5472.CAN-06-4069; Jetzt A, 2003, CANCER RES, V63, P6697; Li RL, 2009, CLIN CANCER RES, V15, P3568, DOI 10.1158/1078-0432.CCR-08-0826; Luo Y, 2005, MOL CANCER THER, V4, P977, DOI 10.1158/1535-7163.MCT-05-0005; Mashiach E, 2008, NUCLEIC ACIDS RES, V36, pW229, DOI 10.1093/nar/gkn186; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rix U, 2007, BLOOD, V110, P4055, DOI 10.1182/blood-2007-07-102061; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.0.CO;2-Y; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Sexton E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-45; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tovchigrechko A, 2005, PROTEINS, V60, P296, DOI 10.1002/prot.20573; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang ZR, 2006, BIOCHEM BIOPH RES CO, V346, P367, DOI 10.1016/j.bbrc.2006.05.156; Wang ZR, 2004, BIOCHEM BIOPH RES CO, V323, P743, DOI 10.1016/j.bbrc.2004.08.174; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Winger JA, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-7	44	23	23	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e101070	10.1371/journal.pone.0101070	http://dx.doi.org/10.1371/journal.pone.0101070			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968355	gold, Green Published, Green Submitted			2022-12-27	WOS:000338280800103
J	Karatas, OF; Guzel, E; Suer, I; Ekici, ID; Caskurlu, T; Creighton, CJ; Ittmann, M; Ozen, M				Karatas, Omer Faruk; Guzel, Esra; Suer, Ilknur; Ekici, Isin D.; Caskurlu, Turhan; Creighton, Chad J.; Ittmann, Michael; Ozen, Mustafa			miR-1 and miR-133b Are Differentially Expressed in Patients with Recurrent Prostate Cancer	PLOS ONE			English	Article							RADICAL PROSTATECTOMY; BIOCHEMICAL RELAPSE; COLORECTAL-CANCER; TUMOR-SUPPRESSOR; GENE-EXPRESSION; PROGNOSTIC MARKER; DOWN-REGULATION; MICRORNA; PROGRESSION; METASTASIS	Prostate cancer (PCa) is currently the most frequently diagnosed malignancy in the western countries. It is more prevalent in older men with 75% of the incident cases above 65 years old. After radical prostatectomy, approximately 30% of men develop clinical recurrence with elevated serum prostate-specific antigen levels. Therefore, it is important to unravel the molecular mechanisms underlying PCa progression to develop novel diagnostic/therapeutic approaches. In this study, it is aimed to compare the microRNA (miRNA) profile of recurrent and non-recurrent prostate tumor tissues to explore the possible involvement of miRNAs in PCa progression. Total RNA from 41 recurrent and 41 non-recurrent PCa tissue samples were used to investigate the miRNA signature in PCa specimens. First of all, 20 recurrent and 20 non-recurrent PCa samples were profiled using miRNA microarray chips. Of the differentially expressed miRNAs, miR-1, miR-133b and miR-145* were selected for further validation with qRT-PCR in a different set of 21 recurrent and 21 non-recurrent PCa samples. Data were statistically analyzed using two-sided Student's t-test, Pearson Correlation test, Receiver operating characteristic analysis. Our results demonstrated that miR-1 and mir-133b have been significantly downregulated in recurrent PCa specimens in comparison to non-recurrent PCa samples and have sufficient power to distinguish recurrent specimens from non-recurrent ones on their own. Here, we report that the relative expression of miR-1 and mir-133b have been significantly reduced in recurrent PCa specimens in comparison to non-recurrent PCa samples, which can serve as novel biomarkers for prediction of PCa progression.	[Karatas, Omer Faruk; Guzel, Esra; Suer, Ilknur; Ozen, Mustafa] Istanbul Univ, Cerrahpasa Med Sch, Dept Med Genet, Istanbul, Turkey; [Karatas, Omer Faruk] Erzurum Tech Univ, Dept Mol Biol & Genet, Erzurum, Turkey; [Guzel, Esra; Ozen, Mustafa] Biruni Univ, Istanbul, Turkey; [Ekici, Isin D.] Yeditepe Univ, Dept Med Pathol, Istanbul, Turkey; [Caskurlu, Turhan] Goztepe Educ & Res Hosp, Dept Urol, Istanbul, Turkey; [Creighton, Chad J.] Baylor Coll Med, Div Biostat, Houston, TX 77030 USA; [Ittmann, Michael; Ozen, Mustafa] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Ittmann, Michael; Ozen, Mustafa] Michael E DeBakey VAMC, Houston, TX USA	Istanbul University; Istanbul University - Cerrahpasa; Erzurum Technical University; Biruni University; Yeditepe University; Istanbul Goztepe Training and Research Hospital; Baylor College of Medicine; Baylor College of Medicine	Ozen, M (corresponding author), Istanbul Univ, Cerrahpasa Med Sch, Dept Med Genet, Istanbul, Turkey.	mozen@bcm.edu	Guzel, Esra/AAB-8509-2019; Karatas, Omer/I-5103-2013; Suer, Ilknur/AAY-8643-2020	Suer, Ilknur/0000-0003-1954-4190; Ozen, Mustafa/0000-0002-6142-5294; Guzel Tanoglu, Esra/0000-0002-0909-8935; Karatas, Omer/0000-0002-0379-2088; Dogan Ekici, Asiye Isin/0000-0003-4062-9519	Scientific and Technological Research Council of Turkey (TUBITAK) [108S051]; United States' National Institute of Health [P30 CA125123]; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER	Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); United States' National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by The Scientific and Technological Research Council of Turkey (TUBITAK) (grant number 108S051), as well as in part by the United States' National Institute of Health (CJC and MI, grant P30 CA125123). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcakaya P, 2011, INT J ONCOL, V39, P311, DOI 10.3892/ijo.2011.1043; Amling CL, 2000, J UROLOGY, V164, P101, DOI 10.1016/S0022-5347(05)67457-5; Baranwal S, 2010, INT J CANCER, V126, P1283, DOI 10.1002/ijc.25014; Barron N, 2012, PROSTATE, V72, P1193, DOI 10.1002/pros.22469; Bhatnagar N, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.85; Brookman-Amissah N, 2007, CANCER GENET CYTOGEN, V179, P118, DOI 10.1016/j.cancergencyto.2007.08.017; Bruce Justine Yang, 2012, Clin Adv Hematol Oncol, V10, P716; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Chatterton Z, 2010, EPIGENOMICS-UK, V2, P697, DOI 10.2217/EPI.10.39; Chen YP, 2008, J BIOL CHEM, V283, P17969, DOI 10.1074/jbc.M802917200; Cooper CS, 2007, NAT CLIN PRACT UROL, V4, P677, DOI 10.1038/ncpuro0946; Duan FT, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-164; Fendler A, 2011, INT J ONCOL, V39, P1183, DOI 10.3892/ijo.2011.1128; Gallagher RP, 1998, CAN MED ASSOC J, V159, P807; Han M, 2003, J UROLOGY, V169, P517, DOI 10.1016/S0022-5347(05)63946-8; Hudson RS, 2012, NUCLEIC ACIDS RES, V40, P3689, DOI 10.1093/nar/gkr1222; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Jansen FH, 2009, EUR UROL, V55, P563, DOI 10.1016/j.eururo.2008.11.040; Jung SJ, 2011, KOREAN J UROL, V52, P607, DOI 10.4111/kju.2011.52.9.607; Karatas OF, 2013, MOL BIOL REP, V40, P4619, DOI 10.1007/s11033-013-2555-x; Kurdistani SK, 2007, BRIT J CANCER, V97, P1, DOI 10.1038/sj.bjc.6603844; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Leone V, 2011, J CLIN ENDOCR METAB, V96, pE1388, DOI 10.1210/jc.2011-0345; Li X, 2014, CLIN CANC RES; Liang JJ, 2010, CANCER EPIDEM BIOMAR, V19, P2598, DOI 10.1158/1055-9965.EPI-10-0405; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long Q, 2011, AM J PATHOL, V179, P46, DOI 10.1016/j.ajpath.2011.03.008; Lughezzani G, 2010, EUR UROL, V58, P687, DOI 10.1016/j.eururo.2010.07.034; Majid S, 2010, CANCER-AM CANCER SOC, V116, P5637, DOI 10.1002/cncr.25488; Maqbool R., 2014, CELL TISSUE RES; Miyake H, 2013, INT J UROL, V20, P301, DOI 10.1111/j.1442-2042.2012.03175.x; Nohata N, 2012, ONCOTARGET, V3, P9; Oh SY, 2012, J SURG RES, V172, P102, DOI 10.1016/j.jss.2010.07.015; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Sevli S, 2010, PROSTATE CANCER P D, V13, P208, DOI 10.1038/pcan.2010.21; Spahn M, 2010, INT J CANCER, V127, P394, DOI 10.1002/ijc.24715; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Townley-Tilson WHD, 2010, INT J BIOCHEM CELL B, V42, P1252, DOI 10.1016/j.biocel.2009.03.002; Voorhoeve PM, 2007, BBA-REV CANCER, V1775, P274, DOI 10.1016/j.bbcan.2006.11.003; Yang F, 2013, INT J CLIN EXP PATHO, V6, P2846	40	68	70	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e98675	10.1371/journal.pone.0098675	http://dx.doi.org/10.1371/journal.pone.0098675			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967583	Green Published, gold, Green Submitted			2022-12-27	WOS:000338280800004
J	Li, WY; Wang, X; Li, R; Li, WQ; Chen, KM				Li, Wen-Yan; Wang, Xiang; Li, Ri; Li, Wen-Qiang; Chen, Kun-Ming			Genome-Wide Analysis of the NADK Gene Family in Plants	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; SACCHAROMYCES-CEREVISIAE; PHYLOGENETIC ANALYSIS; KINASE-ACTIVITY; CYANIDIOSCHYZON-MEROLAE; REGULATORY ELEMENTS; OXIDATIVE STRESS; EVOLUTION; IDENTIFICATION; REVEALS	Background: NAD(H) kinase (NADK) is the key enzyme that catalyzes de novo synthesis of NADP(H) from NAD(H) for NADP(H)-based metabolic pathways. In plants, NADKs form functional subfamilies. Studies of these families in Arabidopsis thaliana indicate that they have undergone considerable evolutionary selection; however, the detailed evolutionary history and functions of the various NADKs in plants are not clearly understood. Principal Findings: We performed a comparative genomic analysis that identified 74 NADK gene homologs from 24 species representing the eight major plant lineages within the supergroup Plantae: glaucophytes, rhodophytes, chlorophytes, bryophytes, lycophytes, gymnosperms, monocots and eudicots. Phylogenetic and structural analysis classified these NADK genes into four well-conserved subfamilies with considerable variety in the domain organization and gene structure among subfamily members. In addition to the typical NAD_kinase domain, additional domains, such as adenylate kinase, dual-specificity phosphatase, and protein tyrosine phosphatase catalytic domains, were found in subfamily II. Interestingly, NADKs in subfamily III exhibited low sequence similarity (similar to 30%) in the kinase domain within the subfamily and with the other subfamilies. These observations suggest that gene fusion and exon shuffling may have occurred after gene duplication, leading to specific domain organization seen in subfamilies II and III, respectively. Further analysis of the exon/intron structures showed that single intron loss and gain had occurred, yielding the diversified gene structures, during the process of structural evolution of NADK family genes. Finally, both available global microarray data analysis and qRT-RCR experiments revealed that the NADK genes in Arabidopsis and Oryza sativa show different expression patterns in different developmental stages and under several different abiotic/biotic stresses and hormone treatments, underscoring the functional diversity and functional divergence of the NADK family in plants. Conclusions: These findings will facilitate further studies of the NADK family and provide valuable information for functional validation of this family in plants.	[Li, Wen-Yan; Wang, Xiang; Li, Ri; Li, Wen-Qiang; Chen, Kun-Ming] Northwest A&F Univ, Coll Life Sci, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Chen, KM (corresponding author), Northwest A&F Univ, Coll Life Sci, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.	kunmingchen@nwsuaf.edu.cn	Chen, Kun-Ming/AAU-6087-2021	Chen, Kun-Ming/0000-0002-0016-9995	National Natural Science Foundation of China [31270299]; State Key Laboratory of Crop Stress Biology for Arid Areas, NWAFU [CSBAAZD1301]; NWAFU [2014YB033]; Program for New Century Excellent Talents in University of China [NCET-11-0440]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Crop Stress Biology for Arid Areas, NWAFU; NWAFU; Program for New Century Excellent Talents in University of China(Program for New Century Excellent Talents in University (NCET))	This research was supported by grants from the National Natural Science Foundation of China (grant number 31270299), the Basic Scientific Fund of The State Key Laboratory of Crop Stress Biology for Arid Areas, NWAFU (CSBAAZD1301), the Basic Scientific Fund of NWAFU (2014YB033), and the Program for New Century Excellent Talents in University of China (NCET-11-0440). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JM, 1980, BIOCHEMISTRY-US, V19, P3113, DOI 10.1021/bi00554a043; Ando T, 2011, J BIOL CHEM, V286, P29984, DOI 10.1074/jbc.M111.249011; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Banks JA, 2011, SCIENCE, V332, P960, DOI 10.1126/science.1203810; Barbier G, 2005, PLANT PHYSIOL, V137, P460, DOI 10.1104/pp.104.051169; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Berrin JG, 2005, MOL GENET GENOMICS, V273, P10, DOI 10.1007/s00438-005-1113-1; Bieganowski P, 2006, J BIOL CHEM, V281, P22439, DOI 10.1074/jbc.M513919200; Blanc G, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-5-r39; Blanc G, 2010, PLANT CELL, V22, P2943, DOI 10.1105/tpc.110.076406; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Chai MF, 2006, PLANT J, V47, P665, DOI 10.1111/j.1365-313X.2006.02816.x; Chai MF, 2005, PLANT MOL BIOL, V59, P553, DOI 10.1007/s11103-005-6802-y; Chehab EW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001904; [周丛义 Congyi Zhou], 2010, [植物学报, Chinese Bulletin of Botany], V45, P615; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Delumeau O, 2000, PLANT CELL ENVIRON, V23, P329, DOI 10.1046/j.1365-3040.2000.00545.x; Derelle E, 2006, P NATL ACAD SCI USA, V103, P11647, DOI 10.1073/pnas.0604795103; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Garavaglia S, 2004, J BIOL CHEM, V279, P40980, DOI 10.1074/jbc.M406586200; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Grose JH, 2006, P NATL ACAD SCI USA, V103, P7601, DOI 10.1073/pnas.0602494103; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Harding SA, 1997, EMBO J, V16, P1137, DOI 10.1093/emboj/16.6.1137; Hardison RC, 1996, P NATL ACAD SCI USA, V93, P5675, DOI 10.1073/pnas.93.12.5675; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jones CD, 2005, P NATL ACAD SCI USA, V102, P11373, DOI 10.1073/pnas.0503528102; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kaessmann H, 2010, GENOME RES, V20, P1313, DOI 10.1101/gr.101386.109; Kawai S, 2000, BIOCHEM BIOPH RES CO, V276, P57, DOI 10.1006/bbrc.2000.3433; Kawai S, 2005, J BIOL CHEM, V280, P39200, DOI 10.1074/jbc.M506426200; Kawai S, 2001, EUR J BIOCHEM, V268, P4359, DOI 10.1046/j.1432-1327.2001.02358.x; Kawai S, 2001, FEMS MICROBIOL LETT, V200, P181, DOI 10.1111/j.1574-6968.2001.tb10712.x; Kawai S, 2008, BIOSCI BIOTECH BIOCH, V72, P919, DOI 10.1271/bbb.70738; Kolkman JA, 2001, NAT BIOTECHNOL, V19, P423, DOI 10.1038/88084; Labesse G, 2002, TRENDS BIOCHEM SCI, V27, P273, DOI 10.1016/S0968-0004(02)02093-5; Lee TH, 2013, NUCLEIC ACIDS RES, V41, pD1152, DOI 10.1093/nar/gks1104; Lerner F, 2001, BIOCHEM BIOPH RES CO, V288, P69, DOI 10.1006/bbrc.2001.5735; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Li WY, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-90; Li YF, 2006, ACTA BIOCH BIOPH SIN, V38, P293, DOI 10.1111/j.1745-7270.2006.00162.x; Liu JY, 2005, J MOL BIOL, V354, P289, DOI 10.1016/j.jmb.2005.09.026; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Ma QC, 2008, BIODATA MIN, V1, DOI 10.1186/1756-0381-1-4; Magadum S, 2013, J GENET, V92, P155, DOI 10.1007/s12041-013-0212-8; Matsuzaki M, 2004, NATURE, V428, P653, DOI 10.1038/nature02398; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Morgante M, 2005, NAT GENET, V37, P997, DOI 10.1038/ng1615; Mori S, 2005, BIOCHEM BIOPH RES CO, V327, P500, DOI 10.1016/j.bbrc.2004.11.163; Mori S, 2001, ACTA CRYSTALLOGR D, V57, P1319, DOI 10.1107/S0907444901011362; Oganesyan V, 2005, ACTA CRYSTALLOGR F, V61, P640, DOI 10.1107/S1744309105019780; Outten CE, 2003, EMBO J, V22, P2015, DOI 10.1093/emboj/cdg211; Pain J, 2010, J BIOL CHEM, V285, P39409, DOI 10.1074/jbc.M110.178947; Palenik B, 2007, P NATL ACAD SCI USA, V104, P7705, DOI 10.1073/pnas.0611046104; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Pollak N, 2007, J BIOL CHEM, V282, P33562, DOI 10.1074/jbc.M704442200; Price DC, 2012, SCIENCE, V335, P843, DOI 10.1126/science.1213561; Puranik S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064594; Raffaelli N, 2004, BIOCHEMISTRY-US, V43, P7610, DOI 10.1021/bi049650w; Ralph SG, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-484; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Retief J D, 2000, Methods Mol Biol, V132, P243; Rogozin IB, 2003, CURR BIOL, V13, P1512, DOI 10.1016/S0960-9822(03)00558-X; Rombauts S, 1999, NUCLEIC ACIDS RES, V27, P295, DOI 10.1093/nar/27.1.295; Ruiz JM, 2002, PHYTOCHEMISTRY, V59, P473, DOI 10.1016/S0031-9422(01)00481-2; Sagi M, 2006, PLANT PHYSIOL, V141, P336, DOI 10.1104/pp.106.078089; Schaller A, 2009, PHYTOCHEMISTRY, V70, P1532, DOI 10.1016/j.phytochem.2009.07.032; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Shi F, 2005, FEBS J, V272, P3337, DOI 10.1111/j.1742-4658.2005.04749.x; Shi F, 2009, ACTA BIOCH BIOPH SIN, V41, P352, DOI 10.1093/abbs/gmp029; Shianna KV, 2006, MITOCHONDRION, V6, P94, DOI 10.1016/j.mito.2006.02.003; Singh R, 2007, J BACTERIOL, V189, P6665, DOI 10.1128/JB.00555-07; Stephan C, 2000, INT J BIOCHEM CELL B, V32, P855, DOI 10.1016/S1357-2725(00)00032-7; Strand MK, 2003, EUKARYOT CELL, V2, P809, DOI 10.1128/EC.2.4.809-820.2003; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Turner WL, 2004, PLANT PHYSIOL, V135, P1243, DOI 10.1104/pp.104.040428; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Van de Peer Y, 2009, TRENDS PLANT SCI, V14, P680, DOI 10.1016/j.tplants.2009.09.001; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Waller JC, 2010, PLANTA, V231, P305, DOI 10.1007/s00425-009-1047-7; Wang GF, 2013, INT J MOL SCI, V14, P9440, DOI 10.3390/ijms14059440; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wasternack C, 2013, ANN BOT-LONDON, V111, P1021, DOI 10.1093/aob/mct067; Wilkerson MD, 2009, BRIEF BIOINFORM, V10, P631, DOI 10.1093/bib/bbp051; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Worden AZ, 2009, SCIENCE, V324, P268, DOI 10.1126/science.1167222; Wu LL, 2011, J NUCL AGR SCI, V25; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672; ZAGDANSKA B, 1990, ACTA BIOCHIM POL, V37, P385; Zhang GY, 2012, NAT BIOTECHNOL, V30, P549, DOI 10.1038/nbt.2195; Zhang Z, 2004, GENETICS, V166, P1995, DOI 10.1534/genetics.166.4.1995; Zhang ZM, 2003, BIOINFORMATICS, V19, P307, DOI 10.1093/bioinformatics/19.2.307	106	24	24	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e101051	10.1371/journal.pone.0101051	http://dx.doi.org/10.1371/journal.pone.0101051			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968225	Green Submitted, Green Published, gold			2022-12-27	WOS:000338280800101
J	Mishra, NK; Chang, J; Zhao, PX				Mishra, Nitish K.; Chang, Junil; Zhao, Patrick X.			Prediction of Membrane Transport Proteins and Their Substrate Specificities Using Primary Sequence Information	PLOS ONE			English	Article							SUPPORT VECTOR MACHINES; HIDDEN MARKOV-MODELS; SUBCELLULAR LOCATIONS; PSI-BLAST; CLASSIFICATION; NETWORKS; RESIDUES; DATABASE; RATES	Background: Membrane transport proteins (transporters) move hydrophilic substrates across hydrophobic membranes and play vital roles in most cellular functions. Transporters represent a diverse group of proteins that differ in topology, energy coupling mechanism, and substrate specificity as well as sequence similarity. Among the functional annotations of transporters, information about their transporting substrates is especially important. The experimental identification and characterization of transporters is currently costly and time-consuming. The development of robust bioinformatics-based methods for the prediction of membrane transport proteins and their substrate specificities is therefore an important and urgent task. Results: Support vector machine (SVM)-based computational models, which comprehensively utilize integrative protein sequence features such as amino acid composition, dipeptide composition, physico-chemical composition, biochemical composition, and position-specific scoring matrices (PSSM), were developed to predict the substrate specificity of seven transporter classes: amino acid, anion, cation, electron, protein/mRNA, sugar, and other transporters. An additional model to differentiate transporters from non-transporters was also developed. Among the developed models, the biochemical composition and PSSM hybrid model outperformed other models and achieved an overall average prediction accuracy of 76.69% with a Mathews correlation coefficient (MCC) of 0.49 and a receiver operating characteristic area under the curve (AUC) of 0.833 on our main dataset. This model also achieved an overall average prediction accuracy of 78.88% and MCC of 0.41 on an independent dataset. Conclusions: Our analyses suggest that evolutionary information (i.e., the PSSM) and the AAIndex are key features for the substrate specificity prediction of transport proteins. In comparison, similarity-based methods such as BLAST, PSI-BLAST, and hidden Markov models do not provide accurate predictions for the substrate specificity of membrane transport proteins. TrSSP: The Transporter Substrate Specificity Prediction Server, a web server that implements the SVM models developed in this paper, is freely available at http://bioinfo.noble.org/TrSSP.	[Mishra, Nitish K.; Chang, Junil; Zhao, Patrick X.] Samuel Roberts Noble Fdn Inc, Div Plant Biol, Ardmore, OK 73401 USA	Noble Research Institute	Zhao, PX (corresponding author), Samuel Roberts Noble Fdn Inc, Div Plant Biol, Ardmore, OK 73401 USA.	pzhao@noble.org	Mishra, Nitish Kumar/D-5577-2009; Mishra, Nitish/AAR-3757-2021	Chang, Junil/0000-0002-4765-5157; Zhao, Patrick Xuechun/0000-0002-3460-5564	National Science Foundation [0960897]; Samuel Roberts Noble Foundation; Div Of Biological Infrastructure [0960897] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Samuel Roberts Noble Foundation; Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation award #0960897 to PXZ and The Samuel Roberts Noble Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024039; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Barghash A, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-343; Benedito VA, 2010, PLANT PHYSIOL, V152, P1716, DOI 10.1104/pp.109.148684; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Chen SA, 2011, BIOINFORMATICS, V27, P2062, DOI 10.1093/bioinformatics/btr340; CHOTHIA C, 1975, NATURE, V254, P304, DOI 10.1038/254304a0; Chou KC, 2000, BIOCHEM BIOPH RES CO, V278, P477, DOI 10.1006/bbrc.2000.3815; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Gromiha MM, 2006, NUCLEIC ACIDS RES, V34, pW70, DOI 10.1093/nar/gkl043; Gromiha MM, 2006, J CHEM INF MODEL, V46, P1503, DOI 10.1021/ci050417u; Gromiha MM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-135; Gromiha MM, 1999, BIOPHYS CHEM, V77, P49, DOI 10.1016/S0301-4622(99)00010-1; Joachims T, 1999, ADVANCES IN KERNEL METHODS, P169; Kawashima S, 2008, NUCLEIC ACIDS RES, V36, pD202, DOI 10.1093/nar/gkm998; KROGH A, 1994, J MOL BIOL, V235, P1501, DOI 10.1006/jmbi.1994.1104; Kumar Manish, 2008, In Silico Biology, V8, P121; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lata S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S19; Lee TJ, 2008, BIOINFORMATICS, V24, pI259, DOI 10.1093/bioinformatics/btn180; Li HQ, 2008, BIOINFORMATICS, V24, P1129, DOI 10.1093/bioinformatics/btn099; Li HQ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-418; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lin HH, 2006, PROTEINS, V62, P218, DOI 10.1002/prot.20605; Mishra NK, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S48; Mishra NK, 2007, PROTEIN PEPTIDE LETT, V14, P575; Mishra NK, 2011, LETT DRUG DES DISCOV, V8, P223; Ou YY, 2010, PROTEINS, V78, P1789, DOI 10.1002/prot.22694; Park KJ, 2003, BIOINFORMATICS, V19, P1656, DOI 10.1093/bioinformatics/btg222; Park Y, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-302; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Saier MH, 2014, NUCLEIC ACIDS RES, V42, pD251, DOI 10.1093/nar/gkt1097; Schaadt NS, 2010, J CHEM INF MODEL, V50, P1899, DOI 10.1021/ci100243m; Schaffer AA, 1999, BIOINFORMATICS, V15, P1000; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Vapnik V., 2013, NATURE STAT LAERNING; Zavaljevski N, 2002, BIOINFORMATICS, V18, P689, DOI 10.1093/bioinformatics/18.5.689	39	65	66	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100278	10.1371/journal.pone.0100278	http://dx.doi.org/10.1371/journal.pone.0100278			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968309	gold, Green Submitted, Green Published			2022-12-27	WOS:000338280800032
J	Soneson, C; Gerster, S; Delorenzi, M				Soneson, Charlotte; Gerster, Sarah; Delorenzi, Mauro			Batch Effect Confounding Leads to Strong Bias in Performance Estimates Obtained by Cross-Validation	PLOS ONE			English	Article							GENE-EXPRESSION DATA; ERROR ESTIMATION; MICROARRAY DATA; PREDICTION; SELECTION; HETEROGENEITY; REMOVAL; GENOME	Background: With the large amount of biological data that is currently publicly available, many investigators combine multiple data sets to increase the sample size and potentially also the power of their analyses. However, technical differences ("batch effects'') as well as differences in sample composition between the data sets may significantly affect the ability to draw generalizable conclusions from such studies. Focus: The current study focuses on the construction of classifiers, and the use of cross-validation to estimate their performance. In particular, we investigate the impact of batch effects and differences in sample composition between batches on the accuracy of the classification performance estimate obtained via cross-validation. The focus on estimation bias is a main difference compared to previous studies, which have mostly focused on the predictive performance and how it relates to the presence of batch effects. Data: We work on simulated data sets. To have realistic intensity distributions, we use real gene expression data as the basis for our simulation. Random samples from this expression matrix are selected and assigned to group 1 (e.g., 'control') or group 2 (e.g., 'treated'). We introduce batch effects and select some features to be differentially expressed between the two groups. We consider several scenarios for our study, most importantly different levels of confounding between groups and batch effects. Methods: We focus on well-known classifiers: logistic regression, Support Vector Machines (SVM), k-nearest neighbors (kNN) and Random Forests (RF). Feature selection is performed with the Wilcoxon test or the lasso. Parameter tuning and feature selection, as well as the estimation of the prediction performance of each classifier, is performed within a nested cross-validation scheme. The estimated classification performance is then compared to what is obtained when applying the classifier to independent data.	[Soneson, Charlotte; Gerster, Sarah; Delorenzi, Mauro] SIB, Lausanne, Switzerland; [Delorenzi, Mauro] Univ Lausanne, Ludwig Ctr Canc Res, Lausanne, Switzerland; [Delorenzi, Mauro] Univ Lausanne, Dept Oncol, Lausanne, Switzerland	Swiss Institute of Bioinformatics; University of Lausanne; University of Lausanne	Soneson, C (corresponding author), SIB, Lausanne, Switzerland.	charlotte.soneson@isb-sib.ch	Soneson, Charlotte/J-6740-2019	Soneson, Charlotte/0000-0003-3833-2169	Swiss National Science Foundation (SNF) [320030_ 135421]; Fondation Medic	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Fondation Medic	This work was supported in part by the Swiss National Science Foundation (SNF, http://www.snf.ch/E/, grant No. 320030_ 135421) and by Fondation Medic (grant to MD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey JM, 2007, NAT GENET, V39, P807, DOI 10.1038/ng0707-807; Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101; Ambroise C, 2002, P NATL ACAD SCI USA, V99, P6562, DOI 10.1073/pnas.102102699; Ben-Hur A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000173; Benito M, 2004, BIOINFORMATICS, V20, P105, DOI 10.1093/bioinformatics/btg385; Bernau C, 2009, 076 LMU; Boulesteix AL, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-85; Brazma A, 2003, NUCLEIC ACIDS RES, V31, P68, DOI 10.1093/nar/gkg091; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brown PO, 1999, NAT GENET, V21, P33, DOI 10.1038/4462; Budinska E, 2013, J PATHOL, V231, P63, DOI 10.1002/path.4212; Chen C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017238; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Gagnon-Bartsch JA, 2012, BIOSTATISTICS, V13, P539, DOI 10.1093/biostatistics/kxr034; James G., 2017, INTRO STAT LEARNING, V8th ed.; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kerr M K, 2001, Biostatistics, V2, P183, DOI 10.1093/biostatistics/2.2.183; Kim JH, 2009, COMPUT STAT DATA AN, V53, P3735, DOI 10.1016/j.csda.2009.04.009; Lazar C, 2013, BRIEF BIOINFORM, V14, P469, DOI 10.1093/bib/bbs037; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; Lukk M, 2010, NAT BIOTECHNOL, V28, P322, DOI 10.1038/nbt0410-322; Luo J, 2010, PHARMACOGENOMICS J, V10, P278, DOI 10.1038/tpj.2010.57; Meyer D., 2012, E1071 MISC FUNCTIONS; Molinaro AM, 2005, BIOINFORMATICS, V21, P3301, DOI 10.1093/bioinformatics/bti499; Parker HS, 2012, STAT APPL GENET MOL, V11, DOI 10.1515/1544-6115.1766; R Core Team, 2021, R LANGUAGE ENV STAT; Radmacher MD, 2002, J COMPUT BIOL, V9, P505, DOI 10.1089/106652702760138592; Sadanandam A, 2013, NAT MED, V19, P619, DOI 10.1038/nm.3175; Scherer A, 2009, WILEY SERIES PROBABI; Shi LM, 2010, NAT BIOTECHNOL, V28, P827, DOI 10.1038/nbt.1665; Sims AH, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-42; Slawski M, 2009, CMA SYNTHESIS MICROA; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Van Cutsem E, 2009, J CLIN ONCOL, V27, P3117, DOI 10.1200/JCO.2008.21.6663; Varma S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-91; Venables WN., 2002, MODERN APPL STAT S, V4; Wood IA, 2007, BIOINFORMATICS, V23, P1363, DOI 10.1093/bioinformatics/btm117; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	41	29	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100335	10.1371/journal.pone.0100335	http://dx.doi.org/10.1371/journal.pone.0100335			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967636	Green Published, Green Submitted, gold			2022-12-27	WOS:000338280800035
J	Zhu, CG; Yang, G; An, KN; Huang, JP				Zhu, Chenge; Yang, Guang; An, Kenan; Huang, Jiping			The Leverage Effect on Wealth Distribution in a Controllable Laboratory Stock Market	PLOS ONE			English	Article							COMPLEX ADAPTIVE SYSTEM; PHASE-TRANSITIONS; HERD BEHAVIOR; MINORITY GAME	Wealth distribution has always been an important issue in our economic and social life, since it affects the harmony and stabilization of the society. Under the background of widely used financial tools to raise leverage these years, we studied the leverage effect on wealth distribution of a population in a controllable laboratory market in which we have conducted several human experiments, and drawn the conclusion that higher leverage leads to a higher Gini coefficient in the market. A higher Gini coefficient means the wealth distribution among a population becomes more unequal. This is a result of the ascending risk with growing leverage level in the market plus the diversified trading abilities and risk preference of the participants. This work sheds light on the effects of leverage and its related regulations, especially its impact on wealth distribution. It also shows the capability of the method of controllable laboratory markets which could be helpful in several fields of study such as economics, econophysics and sociology.	[Huang, Jiping] Fudan Univ, Dept Phys, Shanghai 200433, Peoples R China; Fudan Univ, State Key Lab Surface Phys, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Huang, JP (corresponding author), Fudan Univ, Dept Phys, Shanghai 200433, Peoples R China.	jphuang@fudan.edu.cn			National Natural Science Foundation of China [11222544]; Program for New Century Excellent Talents in University [NCET-12-0121]; Shanghai Rising-Star Program [12QA1400200]; Shanghai Key Laboratory of Financial Information Technology (Shanghai University of Finance and Economics)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Shanghai Rising-Star Program; Shanghai Key Laboratory of Financial Information Technology (Shanghai University of Finance and Economics)	This work is supported by the National Natural Science Foundation of China under Grant No. 11222544 (http://www.nsfc.gov.cn/), by the Program for New Century Excellent Talents in University (NCET-12-0121) (http://www.moe.edu.cn/), by the Shanghai Rising-Star Program (No. 12QA1400200) (http://www.stcsm.gov.cn/), and by Shanghai Key Laboratory of Financial Information Technology (Shanghai University of Finance and Economics) (http://www.shufe.edu.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian T, 2010, J FINANC INTERMED, V19, P418, DOI 10.1016/j.jfi.2008.12.002; Agnello L, 2012, APPL ECON LETT, V19, P1627, DOI 10.1080/13504851.2011.648315; An KN, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2013-40640-y; ARTHUR WB, 1994, AM ECON REV, V84, P406; BAXTER ND, 1967, J FINANC, V22, P395, DOI 10.2307/2978892; Blair MM, 2010, VANDERBILT PUBLIC LA, V10-40, P225; Carmassi J, 2009, JCMS-J COMMON MARK S, V47, P977, DOI 10.1111/j.1468-5965.2009.02031.x; Challet D, 1997, PHYSICA A, V246, P407, DOI 10.1016/S0378-4371(97)00419-6; CHRISTIE AA, 1982, J FINANC ECON, V10, P407, DOI 10.1016/0304-405X(82)90018-6; Cont R, 2000, MACROECON DYN, V4, P170; Farmer JD, 2002, IND CORP CHANGE, V11, P895, DOI 10.1093/icc/11.5.895; Feldman T, 2011, J ECON BUS, V63, P431, DOI 10.1016/j.jeconbus.2010.03.002; Geanakoplos J, 2010, NBER MACROEC ANN-SER, V24, P1; Gini C, 1912, ITALIAN VARIABILIT M; Gini C., 1997, RIV POLIT ECON, V87, P769; HAMEL G, 1993, HARVARD BUS REV, V71, P75; Jin HQ, 2013, MATH FINANC, V23, P122, DOI 10.1111/j.1467-9965.2011.00490.x; Kumhof M, 2011, LEVERAGING INEQUALIT, P189; Lang L, 1996, J FINANC ECON, V40, P3, DOI 10.1016/0304-405X(95)00842-3; Laureti P, 2004, PHYSICA A, V331, P651, DOI 10.1016/j.physa.2003.07.002; Liang Y, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.012809; Platkowski T, 2003, PHYSICA A, V323, P726, DOI 10.1016/S0378-4371(03)00048-7; Savit R, 1999, PHYS REV LETT, V82, P2203, DOI 10.1103/PhysRevLett.82.2203; Song KY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033588; Stockhammer E, 2013, FINANCIALIZATION INC, P98; Thurner S, 2012, QUANT FINANC, V12, P695, DOI 10.1080/14697688.2012.674301; Wang W, 2009, P NATL ACAD SCI USA, V106, P8423, DOI 10.1073/pnas.0811782106; Yeung CH, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.026107; Zhao L, 2011, P NATL ACAD SCI USA, V108, P15058, DOI 10.1073/pnas.1105239108	29	4	4	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100681	10.1371/journal.pone.0100681	http://dx.doi.org/10.1371/journal.pone.0100681			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK2WP	24968222	Green Submitted, Green Published, gold			2022-12-27	WOS:000338280800051
J	Inoue, T; Hagiyama, M; Yoneshige, A; Kato, T; Enoki, E; Maenishi, O; Chikugo, T; Kimura, M; Satou, T; Ito, A				Inoue, Takao; Hagiyama, Man; Yoneshige, Azusa; Kato, Takashi; Enoki, Eisuke; Maenishi, Osamu; Chikugo, Takaaki; Kimura, Masatomo; Satou, Takao; Ito, Akihiko			Increased Ectodomain Shedding of Cell Adhesion Molecule 1 from Pancreatic Islets in Type 2 Diabetic Pancreata: Correlation with Hemoglobin A1c Levels	PLOS ONE			English	Article							PROTEIN-KINASE-C; INDUCED INSULIN-SECRETION; GLUCAGON-LIKE PEPTIDE-1; GENE-EXPRESSION; MELLITUS; APOPTOSIS; ALPHA; RISK; GLUCOTOXICITY; PATHOGENESIS	Pulmonary emphysema and type 2 diabetes mellitus (T2DM), both caused by lifestyle factors, frequently concur. Respectively, the diseases affect lung alveolar and pancreatic islet cells, which express cell adhesion molecule 1 (CADM1), an immunoglobulin superfamily member. Protease-mediated ectodomain shedding of full-length CADM1 produces C-terminal fragments (CTFs) with proapoptotic activity. In emphysematous lungs, the CADM1 shedding rate and thus the level of CTFs in alveolar cells increase. In this study, CADM1 expression in islet cells was examined by western blotting. Protein was extracted from formalin-fixed, paraffin-embedded sections of pancreata isolated from patients with T2DM (n = 12) or from patients without pancreatic disease (n = 8) at autopsy. After adjusting for the number of islet cells present in the adjacent section, we found that full-length CADM1 decreased in T2DM islets, while ectodomain shedding increased. Hemoglobin A1c levels, measured when patients were alive, correlated inversely with full-length CADM1 levels (P = 0.041) and positively with ectodomain shedding rates (P = 0.001). In immunofluorescence images of T2DM islet cells, CADM1 was detected in the cytoplasm, but not on the cell membrane. Consistently, when MIN6-m9 mouse beta cells were treated with phorbol ester and trypsin to induce shedding, CADM1 immunostaining was diffuse in the cytoplasm. When a form of CTFs was exogenously expressed in MIN6-m9 cells, it localized diffusely in the cytoplasm and increased the number of apoptotic cells. These results suggest that increased CADM1 ectodomain shedding contributes to blood glucose dysregulation in T2DM by decreasing full-length CADM1 and producing CTFs that accumulate in the cytoplasm and promote apoptosis of beta cells. Thus, this study has identified a molecular alteration shared by pulmonary emphysema and T2DM.	[Inoue, Takao; Hagiyama, Man; Yoneshige, Azusa; Kato, Takashi; Enoki, Eisuke; Maenishi, Osamu; Chikugo, Takaaki; Kimura, Masatomo; Satou, Takao; Ito, Akihiko] Kinki Univ, Fac Med, Dept Pathol, Osaka, Japan	Kindai University (Kinki University)	Ito, A (corresponding author), Kinki Univ, Fac Med, Dept Pathol, Osaka, Japan.	aito@med.kindai.ac.jp			Japan Society for the Promotion of Science Kakenhi [24659184, 24890274, 25860302, 24590492]; Japan Diabetes Foundation; Grants-in-Aid for Scientific Research [26860268] Funding Source: KAKEN	Japan Society for the Promotion of Science Kakenhi(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Diabetes Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Japan Society for the Promotion of Science Kakenhi (24659184 to TI, 24890274 and 25860302 to MH, and 24590492 to AI), and a grant from Japan Diabetes Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bensellam M, 2012, MOL CELL ENDOCRINOL, V364, P1, DOI 10.1016/j.mce.2012.08.003; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Carpenter L, 2004, DIABETES, V53, P53, DOI 10.2337/diabetes.53.1.53; CLARK A, 1988, DIABETES RES CLIN EX, V9, P151; Das Evcimen N, 2007, PHARMACOL RES, V55, P498, DOI 10.1016/j.phrs.2007.04.016; Del Prato S, 2009, DIABETIC MED, V26, P1185, DOI 10.1111/j.1464-5491.2009.02847.x; Erhardt L, 2009, ATHEROSCLEROSIS, V205, P23, DOI 10.1016/j.atherosclerosis.2009.01.007; Fogel AI, 2010, J BIOL CHEM, V285, P34864, DOI 10.1074/jbc.M110.120865; GANESAN S, 1990, P NATL ACAD SCI USA, V87, P9893, DOI 10.1073/pnas.87.24.9893; Geraldes P, 2010, CIRC RES, V106, P1319, DOI 10.1161/CIRCRESAHA.110.217117; Gunton JE, 2005, CELL, V122, P337, DOI 10.1016/j.cell.2005.05.027; Hagiyama M, 2009, AM J PATHOL, V174, P2278, DOI 10.2353/ajpath.2009.080743; Henquin JC, 2011, DIABETOLOGIA, V54, P1720, DOI 10.1007/s00125-011-2118-4; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; ISHIHARA H, 1993, DIABETOLOGIA, V36, P1139, DOI 10.1007/BF00401058; Ito A, 2003, LAB INVEST, V83, P1175, DOI 10.1097/01.LAB.0000081391.28136.80; Ito A, 2003, BLOOD, V101, P2601, DOI 10.1182/blood-2002-07-2265; Ito A, 2007, HEPATOLOGY, V45, P684, DOI 10.1002/hep.21501; Ito A, 2012, ISLETS, V4, DOI 10.4161/isl.18675; Kilimnik G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027445; KLOPPEL G, 1985, SURV SYN PATHOL RES, V4, P110; Kohutek ZA, 2009, J NEUROSCI, V29, P4605, DOI 10.1523/JNEUROSCI.5126-08.2009; Koma YI, 2008, GASTROENTEROLOGY, V134, P1544, DOI 10.1053/j.gastro.2008.01.081; Kong L, 2011, ACTA DIABETOL, V48, P61, DOI 10.1007/s00592-010-0226-0; Kumar V, 2009, ROBBINS COTRAN PATHO; Kuramochi M, 2001, NAT GENET, V27, P427, DOI 10.1038/86934; Manson JE, 2000, AM J MED, V109, P538, DOI 10.1016/S0002-9343(00)00568-4; Marchetti P, 2004, J CLIN ENDOCR METAB, V89, P5535, DOI 10.1210/jc.2004-0150; MEDA P, 1991, EXP CELL RES, V192, P469, DOI 10.1016/0014-4827(91)90066-4; Mimae T, 2014, THORAX, V69, P223, DOI 10.1136/thoraxjnl-2013-203867; Mimae T, 2012, CLIN CANCER RES, V18, P945, DOI 10.1158/1078-0432.CCR-11-1946; Minakata Y, 2008, INTERNAL MED, V47, P77, DOI 10.2169/internalmedicine.47.0489; Minami K, 2000, AM J PHYSIOL-ENDOC M, V279, pE773, DOI 10.1152/ajpendo.2000.279.4.E773; Mirrakhimov AE, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-132; Nagara Y, 2012, BIOCHEM BIOPH RES CO, V417, P462, DOI 10.1016/j.bbrc.2011.11.140; NAUCK M, 1986, DIABETOLOGIA, V29, P46, DOI 10.1007/BF02427280; NAUCK MA, 1993, J CLIN INVEST, V91, P301, DOI 10.1172/JCI116186; Rana JS, 2004, DIABETES CARE, V27, P2478, DOI 10.2337/diacare.27.10.2478; Ravier MA, 2005, DIABETES, V54, P1798, DOI 10.2337/diabetes.54.6.1798; REAVEN GM, 1987, J CLIN ENDOCR METAB, V64, P106, DOI 10.1210/jcem-64-1-106; Rodriguez-Rigueiro T, 2011, PROTEOMICS, V11, P2555, DOI 10.1002/pmic.201000809; Sakuraba H, 2002, DIABETOLOGIA, V45, P85, DOI 10.1007/s125-002-8248-z; Sakurai-Yageta M, 2009, BIOCHEM BIOPH RES CO, V390, P977, DOI 10.1016/j.bbrc.2009.10.088; Schafer SA, 2011, DIABETES RES CLIN PR, V93, pS9, DOI 10.1016/S0168-8227(11)70008-0; Sharma G, 2011, ENDOCRINOLOGY, V152, P3030, DOI 10.1210/en.2011-0091; Tattikota SG, 2014, CELL METAB, V19, P122, DOI 10.1016/j.cmet.2013.11.015; Toft-Nielsen MB, 2001, J CLIN ENDOCR METAB, V86, P3717, DOI 10.1210/jc.86.8.3717; Tuder RM, 2012, J CLIN INVEST, V122, P2749, DOI 10.1172/JCI60324; van de Bunt M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055272; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Walter RE, 2003, AM J RESP CRIT CARE, V167, P911, DOI 10.1164/rccm.2203022; Warwar N, 2006, DIABETES, V55, P590, DOI 10.2337/diabetes.55.03.06.db05-0001; Zhao HL, 2010, PANCREAS, V39, P843, DOI 10.1097/MPA.0b013e3181d12613	53	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100988	10.1371/journal.pone.0100988	http://dx.doi.org/10.1371/journal.pone.0100988			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964098	Green Submitted, Green Published, gold			2022-12-27	WOS:000338709500106
J	Wiener, M; Thompson, JC; Coslett, HB				Wiener, Martin; Thompson, James C.; Coslett, H. Branch			Continuous Carryover of Temporal Context Dissociates Response Bias from Perceptual Influence for Duration	PLOS ONE			English	Article							PSYCHOMETRIC FUNCTION; INTRINSIC MODELS; TIME PERCEPTION; INTERVAL; BISECTION; IDENTIFICATION; DISTORTIONS; INFORMATION; INTEGRATION; JUDGMENT	Recent experimental evidence suggests that the perception of temporal intervals is influenced by the temporal context in which they are presented. A longstanding example is the time-order-error, wherein the perception of two intervals relative to one another is influenced by the order in which they are presented. Here, we test whether the perception of temporal intervals in an absolute judgment task is influenced by the preceding temporal context. Human subjects participated in a temporal bisection task with no anchor durations (partition method). Intervals were demarcated by a Gaussian blob (visual condition) or burst of white noise (auditory condition) that persisted for one of seven logarithmically spaced sub-second intervals. Crucially, the order in which stimuli were presented was first-order counterbalanced, allowing us to measure the carryover effect of every successive combination of intervals. The results demonstrated a number of distinct findings. First, the perception of each interval was biased by the prior response, such that each interval was judged similarly to the preceding trial. Second, the perception of each interval was also influenced by the prior interval, such that perceived duration shifted away from the preceding interval. Additionally, the effect of decision bias was larger for visual intervals, whereas auditory intervals engendered greater perceptual carryover. We quantified these effects by designing a biologically-inspired computational model that measures noisy representations of time against an adaptive memory prior while simultaneously accounting for uncertainty, consistent with a Bayesian heuristic. We found that our model could account for all of the effects observed in human data. Additionally, our model could only accommodate both carryover effects when uncertainty and memory were calculated separately, suggesting separate neural representations for each. These findings demonstrate that time is susceptible to similar carryover effects as other basic stimulus attributes, and that the brain rapidly adapts to temporal context.	[Wiener, Martin; Coslett, H. Branch] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Wiener, Martin; Thompson, James C.] George Mason Univ, Dept Psychol, Fairfax, VA 22030 USA	University of Pennsylvania; George Mason University	Wiener, M (corresponding author), Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA.	mwiener@gmu.edu			George Mason University Libraries Open Access publishing Fund	George Mason University Libraries Open Access publishing Fund	Publication of this article was funded in part by the George Mason University Libraries Open Access publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acerbi L, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002771; Aguirre GK, 2011, NEUROIMAGE, V56, P1293, DOI 10.1016/j.neuroimage.2011.02.005; Agus TR, 2010, NEURON, V66, P610, DOI 10.1016/j.neuron.2010.04.014; Allman MJ, 2012, BRAIN, V135, P656, DOI 10.1093/brain/awr210; Bao M, 2012, P NATL ACAD SCI USA, V109, P5898, DOI 10.1073/pnas.1113503109; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; Brown GDA, 2005, J EXP PSYCHOL HUMAN, V31, P919, DOI 10.1037/0096-1523.31.5.919; Burr D, 2007, NAT NEUROSCI, V10, P423, DOI 10.1038/nn1874; Cicchini GM, 2012, J NEUROSCI, V32, P1056, DOI 10.1523/JNEUROSCI.3411-11.2012; Cravo AM, 2013, J NEUROSCI, V33, P4002, DOI 10.1523/JNEUROSCI.4675-12.2013; Droit-Volet S, 2013, NEUROPSYCHOLOGIA, V51, P220, DOI 10.1016/j.neuropsychologia.2012.09.023; Dyjas O, 2012, ATTEN PERCEPT PSYCHO, V74, P1819, DOI 10.3758/s13414-012-0362-4; Ferris SJ, 2001, PERCEPTION, V30, P1363, DOI 10.1068/p2917; Fruend I, 2011, J VISION, V11, DOI 10.1167/11.6.16; GESCHEIDER GA, 1988, ANNU REV PSYCHOL, V39, P169, DOI 10.1146/annurev.psych.39.1.169; GIBBON J, 1984, ANN NY ACAD SCI, V423, P52, DOI 10.1111/j.1749-6632.1984.tb23417.x; Gilden DL, 2001, PSYCHOL REV, V108, P33, DOI 10.1037/0033-295X.108.1.33; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; He JF, 1997, J NEUROSCI, V17, P2615; HELLSTROM A, 1985, PSYCHOL BULL, V97, P35, DOI 10.1037/0033-2909.97.1.35; Heron J, 2012, P ROY SOC B-BIOL SCI, V279, P690, DOI 10.1098/rspb.2011.1131; Hollingworth H. L., 1910, J PHILOS PSYCHOL SCI, V7, P461, DOI [10.2307/2012819, DOI 10.2307/2012819]; IVRY RB, 1995, J EXP PSYCHOL HUMAN, V21, P3, DOI 10.1037/0096-1523.21.1.3; Ivry RB, 2008, TRENDS COGN SCI, V12, P273, DOI 10.1016/j.tics.2008.04.002; Jazayeri M, 2010, NAT NEUROSCI, V13, P1020, DOI 10.1038/nn.2590; Johnston A, 2006, CURR BIOL, V16, P472, DOI 10.1016/j.cub.2006.01.032; Jones M, 2006, J EXP PSYCHOL LEARN, V32, P316, DOI 10.1037/0278-7393.32.3.316; Jones MR, 2005, PERCEPT PSYCHOPHYS, V67, P398, DOI 10.3758/BF03193320; Kahn DA, 2010, J VISION, V10, DOI 10.1167/10.10.12; Kelly A, 2001, Q J EXP PSYCHOL-A, V54, P805, DOI 10.1080/02724980042000327; Klampfl S, 2012, J NEUROPHYSIOL, V108, P1366, DOI 10.1152/jn.00935.2011; Kopec CD, 2010, BRAIN COGNITION, V74, P262, DOI 10.1016/j.bandc.2010.08.006; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Kwon OS, 2013, P NATL ACAD SCI USA, V110, pE1064, DOI 10.1073/pnas.1214869110; Leon MI, 2003, NEURON, V38, P317, DOI 10.1016/S0896-6273(03)00185-5; Li Y, 2013, P NATL ACAD SCI USA, V110, P17154, DOI 10.1073/pnas.1310666110; Los S.A., 2010, ATTENTION TIME, P289, DOI [10.1093/acprof:oso/9780199563456.003.0021, DOI 10.1093/ACPROF:OSO/9780199563456.001.0001]; Matell MS, 2004, COGNITIVE BRAIN RES, V21, P139, DOI 10.1016/j.cogbrainres.2004.06.012; Matthews WJ, 2013, COGNITIVE PSYCHOL, V66, P259, DOI 10.1016/j.cogpsych.2013.01.001; Matthews WJ, 2009, Q J EXP PSYCHOL, V62, P2014, DOI 10.1080/17470210802649285; Matthews WJ, 2009, JUDGM DECIS MAK, V4, P64; Merchant H, 2013, ANNU REV NEUROSCI, V36, P313, DOI 10.1146/annurev-neuro-062012-170349; MORI S, 1995, PERCEPT PSYCHOPHYS, V57, P1065, DOI 10.3758/BF03205465; Palmer J, 2005, J VISION, V5, P376, DOI 10.1167/5.5.1; Pariyadath V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049362; Peirce JW, 2009, FRONT NEUROINFORM, V2, DOI 10.3389/neuro.11.010.2008; Pestilli F, 2011, NEURON, V72, P832, DOI 10.1016/j.neuron.2011.09.025; Petzschner FH, 2011, J NEUROSCI, V31, P17220, DOI 10.1523/JNEUROSCI.2028-11.2011; Raviv O, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002731; Rohenkohl G, 2012, J NEUROSCI, V32, P8424, DOI 10.1523/JNEUROSCI.0804-12.2012; Shi ZH, 2013, TRENDS COGN SCI, V17, P556, DOI 10.1016/j.tics.2013.09.009; Shuler MG, 2006, SCIENCE, V311, P1606, DOI 10.1126/science.1123513; Simen P, 2011, J NEUROSCI, V31, P9238, DOI 10.1523/JNEUROSCI.3121-10.2011; Spencer RMC, 2009, PHILOS T R SOC B, V364, P1853, DOI 10.1098/rstb.2009.0024; Stewart N, 2005, PSYCHOL REV, V112, P881, DOI 10.1037/0033-295X.112.4.881; Summerfield C, 2011, NEURON, V71, P725, DOI 10.1016/j.neuron.2011.06.022; Taatgen N, 2011, MEM COGNITION, V39, P1546, DOI 10.3758/s13421-011-0113-0; Ulanovsky N, 2004, J NEUROSCI, V24, P10440, DOI 10.1523/JNEUROSCI.1905-04.2004; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P579, DOI 10.3758/BF03196615; WEARDEN JH, 1995, Q J EXP PSYCHOL-B, V48, P289; WEARDEN JH, 1991, Q J EXP PSYCHOL-B, V43, P59; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1314, DOI 10.3758/BF03194545; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Wiener M, 2012, J NEUROSCI, V32, P12258, DOI 10.1523/JNEUROSCI.2511-12.2012; Wiener M, 2010, NEUROIMAGE, V49, P1728, DOI 10.1016/j.neuroimage.2009.09.064; Wilson RC, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003150	66	31	32	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100803	10.1371/journal.pone.0100803	http://dx.doi.org/10.1371/journal.pone.0100803			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK8WO	24963624	gold, Green Published, Green Submitted			2022-12-27	WOS:000338709500081
J	Fujimaki, T; Saiki, S; Tashiro, E; Yamada, D; Kitagawa, M; Hattori, N; Imoto, M				Fujimaki, Takahiro; Saiki, Shinji; Tashiro, Etsu; Yamada, Daisuke; Kitagawa, Mitsuhiro; Hattori, Nobutaka; Imoto, Masaya			Identification of Licopyranocoumarin and Glycyrurol from Herbal Medicines as Neuroprotective Compounds for Parkinson's Disease	PLOS ONE			English	Article							COMPLEX-I DEFICIENCY; SUBSTANTIA-NIGRA; DOPAMINERGIC-NEURONS; MITOCHONDRIAL DYSFUNCTION; ANTIOXIDANT ACTIVITY; OXIDATIVE STRESS; PARS COMPACTA; SH-SY5Y CELLS; MOUSE MODEL; MPTP MODEL	In the course of screening for the anti-Parkinsonian drugs from a library of traditional herbal medicines, we found that the extracts of choi-joki-to and daio-kanzo-to protected cells from MPP+-induced cell death. Because choi-joki-to and daio-kanzo-to commonly contain the genus Glycyrrhiza, we isolated licopyranocoumarin (LPC) and glycyrurol (GCR) as potent neuroprotective principals from Glycyrrhiza. LPC and GCR markedly blocked MPP+-induced neuronal PC12D cell death and disappearance of mitochondrial membrane potential, which were mediated by JNK. LPC and GCR inhibited MPP+-induced JNK activation through the suppression of reactive oxygen species (ROS) generation, thereby inhibiting MPP+-induced neuronal PC12D cell death. These results indicated that LPC and GCR derived from choi-joki-to and daio-kanzo-to would be promising drug leads for PD treatment in the future.	[Fujimaki, Takahiro; Tashiro, Etsu; Kitagawa, Mitsuhiro; Imoto, Masaya] Keio Univ, Fac Sci & Technol, Dept Biosci & Informat, Yokohama, Kanagawa 223, Japan; [Saiki, Shinji; Yamada, Daisuke; Hattori, Nobutaka] Juntendo Univ, Sch Med, Dept Neurol, Bunkyo Ku, Tokyo 113, Japan	Keio University; Juntendo University	Hattori, N (corresponding author), Juntendo Univ, Sch Med, Dept Neurol, Bunkyo Ku, Tokyo 113, Japan.	nhattori@juntendo.ac.jp; imoto@bio.keio.ac.jp	Saiki, Shinji/ABC-8214-2021; Hattori, Nobutaka/ACR-0069-2022	Saiki, Shinji/0000-0002-9732-8488; Tashiro, Etsu/0000-0003-4533-623X	Health Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare of Japan; Grants-in-Aid for Scientific Research [23102006, 26350974] Funding Source: KAKEN	Health Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Health Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare of Japan. The extract powder of 128 traditional herbal (kampo) medicines (The Kampo, TJ-1 similar to 3, TJ-5 similar to 12, TJ-14 similar to 41, TJ-43, TJ-45 similar to 48, TJ-50 similar to 93, TJ-95 similar to 128, TJ-133 similar to 138) and powder of Glycyrrhiza were kindly donated from Tsumura Corporation (Tokyo, Japan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam ZI, 1997, J NEUROCHEM, V69, P1196, DOI 10.1046/j.1471-4159.1997.69031196.x; Asl MN, 2008, PHYTOTHER RES, V22, P709, DOI 10.1002/ptr.2362; Bae N, 2011, J ETHNOPHARMACOL, V134, P313, DOI 10.1016/j.jep.2010.12.016; Beal MF, 2001, NAT REV NEUROSCI, V2, P325, DOI 10.1038/35072550; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; BINDOFF LA, 1989, LANCET, V2, P49, DOI 10.1016/S0140-6736(89)90291-2; BURNS RS, 1983, P NATL ACAD SCI-BIOL, V80, P4546, DOI 10.1073/pnas.80.14.4546; Cao BY, 2010, J ETHNOPHARMACOL, V131, P122, DOI 10.1016/j.jep.2010.06.009; Chung V, 2006, MOVEMENT DISORD, V21, P1709, DOI 10.1002/mds.21008; COHEN G, 1984, EUR J PHARMACOL, V106, P209, DOI 10.1016/0014-2999(84)90700-3; DAVIS GC, 1979, PSYCHIAT RES, V1, P249, DOI 10.1016/0165-1781(79)90006-4; Dawson TM, 2002, NAT NEUROSCI, V5, P1058, DOI 10.1038/nn941; DEXTER DT, 1989, J NEUROCHEM, V52, P381, DOI 10.1111/j.1471-4159.1989.tb09133.x; Doo AR, 2010, J ETHNOPHARMACOL, V131, P433, DOI 10.1016/j.jep.2010.07.008; Eberhardt O, 2003, TOXICOL LETT, V139, P135, DOI 10.1016/S0378-4274(02)00428-9; Esteves ARF, 2008, MITOCHONDRION, V8, P219, DOI 10.1016/j.mito.2008.03.004; Fernandez-Puntero B, 2001, BIOL PHARM BULL, V24, P777, DOI 10.1248/bpb.24.777; Floor E, 1998, J NEUROCHEM, V70, P268; Hanawa N, 2008, J BIOL CHEM, V283, P13565, DOI 10.1074/jbc.M708916200; Hasegawa A, 2002, JPN J PHARMACOL, V89, P164, DOI 10.1254/jjp.89.164; Hashimoto R., 2012, EVID-BASED COMPL ALT, V2012, DOI DOI 10.1155/2012/693717; HATANO T, 1989, CHEM PHARM BULL, V37, P3005, DOI 10.1248/cpb.37.3005; HEIKKILA RE, 1984, SCIENCE, V224, P1451, DOI 10.1126/science.6610213; HEIKKILA RE, 1984, NATURE, V311, P467, DOI 10.1038/311467a0; Hunot S, 2004, P NATL ACAD SCI USA, V101, P665, DOI 10.1073/pnas.0307453101; Iizuka A, 2000, J Atheroscler Thromb, V6, P49; Infanger DW, 2006, ANTIOXID REDOX SIGN, V8, P1583, DOI 10.1089/ars.2006.8.1583; Jin H, 2013, BIOCH BIOPHYSICA ACT; Kasai A, 2008, BIOL PHARM BULL, V31, P838, DOI 10.1248/bpb.31.838; KATOHSEMBA R, 1987, J NEUROSCI RES, V17, P36, DOI 10.1002/jnr.490170106; Kawatani M, 2003, EXP CELL RES, V286, P57, DOI 10.1016/S0014-4827(03)00098-3; Kim SY, 2007, NEUROSCI LETT, V413, P132, DOI 10.1016/j.neulet.2006.11.074; Klintworth H, 2007, TOXICOL SCI, V97, P149, DOI 10.1093/toxsci/kfm029; Kobayashi K, 2002, BIOL PHARM BULL, V25, P1108, DOI 10.1248/bpb.25.1108; Kong XC, 2011, BRAIN RES, V1383, P99, DOI 10.1016/j.brainres.2011.01.093; Kumazawa S, 2002, J AGR FOOD CHEM, V50, P373, DOI 10.1021/jf010938r; Li XF, 2011, BRAIN RES, V1382, P9, DOI 10.1016/j.brainres.2011.01.015; Lin X, 2009, FEBS J, V276, P2022, DOI 10.1111/j.1742-4658.2009.06938.x; Manyam B V, 1999, Adv Neurol, V80, P565; Martinez TN, 2012, ANTIOXID REDOX SIGN, V16, P920, DOI 10.1089/ars.2011.4033; Mielke K, 2000, PROG NEUROBIOL, V61, P45, DOI 10.1016/S0301-0082(99)00042-8; Newhouse K, 2004, TOXICOL SCI, V79, P137, DOI 10.1093/toxsci/kfh089; Ng TB, 2000, LIFE SCI, V66, P709, DOI 10.1016/S0024-3205(99)00642-6; Nishimura K, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1093/ecam/nen082; Oi H, 2002, P NATL ACAD SCI USA, V99, P3042, DOI 10.1073/pnas.052709499; Park SW, 2011, NEUROSCI RES, V69, P283, DOI 10.1016/j.neures.2011.01.004; Park SW, 2004, NEUROSCI LETT, V363, P243, DOI 10.1016/j.neulet.2004.03.072; Parker WD, 2008, BRAIN RES, V1189, P215, DOI 10.1016/j.brainres.2007.10.061; Parker WD, 1998, AM J HUM GENET, V62, P758, DOI 10.1086/301812; Saporito MS, 1999, J PHARMACOL EXP THER, V288, P421; Sawada M, 2006, J NEURAL TRANSM-SUPP, P373; SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x; Seaton TA, 1997, BRAIN RES, V777, P110; Smigrodzki R, 2004, NEUROBIOL AGING, V25, P1273, DOI 10.1016/j.neurobiolaging.2004.02.020; Song JX, 2012, J ETHNOPHARMACOL, V139, P698, DOI 10.1016/j.jep.2011.12.030; Swerdlow RH, 1999, BIOCHEM BIOPH RES CO, V261, P701, DOI 10.1006/bbrc.1999.1095; Tao WW, 2012, FITOTERAPIA, V83, P422, DOI 10.1016/j.fitote.2011.12.010; Tatton WG, 2003, ANN NEUROL, V53, pS61, DOI 10.1002/ana.10489; Testa CM, 2005, MOL BRAIN RES, V134, P109, DOI 10.1016/j.molbrainres.2004.11.007; Trimmer PA, 2004, J NEUROCHEM, V88, P800, DOI 10.1046/j.1471-4159.2003.02168.x; Tsukamoto S, 2005, BIOL PHARM BULL, V28, P2000, DOI 10.1248/bpb.28.2000; Vladimirov Iu A, 1991, Biull Eksp Biol Med, V112, P472; Voss T, 2008, CURR NEUROL NEUROSCI, V8, P304, DOI 10.1007/s11910-008-0047-5; Xia XG, 2001, P NATL ACAD SCI USA, V98, P10433, DOI 10.1073/pnas.181182298; Yang LC, 2009, J NEUROCHEM, V109, P1427, DOI 10.1111/j.1471-4159.2009.06074.x; Yao S, 2006, J CHROMATOGR A, V1115, P64, DOI 10.1016/j.chroma.2006.02.071; Yurekli VA, 2013, CELL MOL NEUROBIOL, V33, P205, DOI 10.1007/s10571-012-9886-3; Zhou JJ, 2013, BRAIN RES, V1508, P53, DOI 10.1016/j.brainres.2013.02.049	68	16	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100395	10.1371/journal.pone.0100395	http://dx.doi.org/10.1371/journal.pone.0100395			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24960051	Green Submitted, gold, Green Published			2022-12-27	WOS:000338633900044
J	Pinzon, NE; Stroo, E; 't Hart, BA; Bol, JGJM; Drukarch, B; Bauer, J; van Dam, AM				Pinzon, Nathaly Espitia; Stroo, Esther; 't Hart, Bert A.; Bol, John G. J. M.; Drukarch, Benjamin; Bauer, Jan; van Dam, Anne-Marie			Tissue Transglutaminase in Marmoset Experimental Multiple Sclerosis: Discrepancy between White and Grey Matter	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CELL-ADHESION; CROSS-LINKING; DIFFERENTIAL EXPRESSION; CORTICAL-LESIONS; MATRIX PROTEINS; FIBRONECTIN; INTEGRIN; PATHOLOGY; DISEASE	Infiltration of leukocytes is a major pathological event in white matter lesion formation in the brain of multiple sclerosis (MS) patients. In grey matter lesions, less infiltration of these cells occur, but microglial activation is present. Thus far, the interaction of beta-integrins with extracellular matrix proteins, e.g. fibronectin, is considered to be of importance for the influx of immune cells. Recent in vitro studies indicate a possible role for the enzyme tissue Transglutaminase (TG2) in mediating cell adhesion and migration. In the present study we questioned whether TG2 is present in white and grey matter lesions observed in the marmoset model for MS. To this end, immunohistochemical studies were performed. We observed that TG2, expressed by infiltrating monocytes in white matter lesions co-expressed beta(1)-integrin and is located in close apposition to deposited fibronectin. These data suggest an important role for TG2 in the adhesion and migration of infiltrating monocytes during white matter lesion formation. Moreover, in grey matter lesions, TG2 is mainly present in microglial cells together with some beta(1)-integrin, whereas fibronectin is absent in these lesions. These data imply an alternative role for microglial-derived TG2 in grey matter lesions, e.g. cell proliferation. Further research should clarify the functional role of TG2 in monocytes or microglial cells in MS lesion formation.	[Pinzon, Nathaly Espitia; Stroo, Esther; Bol, John G. J. M.; Drukarch, Benjamin; van Dam, Anne-Marie] Vrije Univ Amsterdam Med Ctr, Neurosci Campus Amsterdam, Dept Anat & Neurosci, Amsterdam, Netherlands; ['t Hart, Bert A.] Biomed Primate Res Ctr, Dept Immunobiol, Rijswijk, Netherlands; ['t Hart, Bert A.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, Groningen, Netherlands; [Bauer, Jan] Ctr Brain Res, Dept Neuroimmunol, Vienna, Austria	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Groningen	van Dam, AM (corresponding author), Vrije Univ Amsterdam Med Ctr, Neurosci Campus Amsterdam, Dept Anat & Neurosci, Amsterdam, Netherlands.	amw.vandam@vumc.nl	; Bauer, Jan/F-5429-2011	Drukarch, Benjamin/0000-0002-2417-8888; Bauer, Jan/0000-0001-5802-8047	Dutch Stichting MS Research [09-693MS]	Dutch Stichting MS Research	The present study was supported by the Dutch Stichting MS Research (project 09-693MS, received by: NEP & AMD). http://msresearch.nl/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimov SS, 2000, J CELL BIOL, V148, P825, DOI 10.1083/jcb.148.4.825; Akimov SS, 2001, J CELL SCI, V114, P2989; Akimov SS, 2001, BLOOD, V98, P1567, DOI 10.1182/blood.V98.5.1567; Bauer M, 2009, P NATL ACAD SCI USA, V106, P1920, DOI 10.1073/pnas.0808909106; Belkin AM, 2011, FEBS J, V278, P4704, DOI 10.1111/j.1742-4658.2011.08346.x; Bo L, 2003, MULT SCLER, V9, P323, DOI 10.1191/1352458503ms917oa; Bo L, 2009, ACTA NEUROL SCAND, V120, P51, DOI 10.1111/j.1600-0404.2009.01216.x; Bo L, 1996, J NEUROPATH EXP NEUR, V55, P1060, DOI 10.1097/00005072-199655100-00006; BO L, 1994, J NEUROIMMUNOL, V51, P135, DOI 10.1016/0165-5728(94)90075-2; Brosnan CF, 2013, GLIA, V61, P453, DOI 10.1002/glia.22443; BRUCK W, 1995, ANN NEUROL, V38, P788, DOI 10.1002/ana.410380514; Caccamo D, 2010, AMINO ACIDS, V38, P653, DOI 10.1007/s00726-009-0428-3; Calabrese M, 2010, NEUROLOGY, V75, P1234, DOI 10.1212/WNL.0b013e3181f5d4da; Colak G, 2012, NEUROBIOL DIS, V45, P1042, DOI 10.1016/j.nbd.2011.12.023; Collighan RJ, 2009, AMINO ACIDS, V36, P659, DOI 10.1007/s00726-008-0190-y; Dal Bianco A, 2008, ANN NEUROL, V63, P174, DOI 10.1002/ana.21240; de Graaf WL, 2013, EUR RADIOL, V23, P528, DOI 10.1007/s00330-012-2619-7; de Jager M, 2013, NEUROBIOL AGING, V34, P1159, DOI 10.1016/j.neurobiolaging.2012.10.005; DSOUZA SE, 1991, TRENDS BIOCHEM SCI, V16, P246, DOI 10.1016/0968-0004(91)90096-E; ELICES MJ, 1990, CELL, V60, P577, DOI 10.1016/0092-8674(90)90661-W; Engel C, 2007, J NEUROL, V254, P30, DOI 10.1007/s00415-007-2009-2; Falasca L, 2005, J IMMUNOL, V174, P7330, DOI 10.4049/jimmunol.174.11.7330; Falasca L, 2008, J IMMUNOL, V180, P2616, DOI 10.4049/jimmunol.180.4.2616; Fesus L, 2002, TRENDS BIOCHEM SCI, V27, P534, DOI 10.1016/S0968-0004(02)02182-5; Gaudry CA, 1999, EXP CELL RES, V252, P104, DOI 10.1006/excr.1999.4633; Gold R, 2006, BRAIN, V129, P1953, DOI 10.1093/brain/awl075; Gray E, 2008, BRAIN PATHOL, V18, P86, DOI 10.1111/j.1750-3639.2007.00110.x; Haanstra KG, 2013, J IMMUNOL, V190, P1961, DOI 10.4049/jimmunol.1202490; Hafler DA, 2004, J CLIN INVEST, V113, P788, DOI 10.1172/JCI200421357; Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0; Hodrea J, 2010, IMMUNOL LETT, V130, P74, DOI 10.1016/j.imlet.2009.12.010; Hwang IK, 2009, BRAIN RES, V1263, P134, DOI 10.1016/j.brainres.2009.01.038; Imai Y, 2002, GLIA, V40, P164, DOI 10.1002/glia.10149; Imai Y, 1996, BIOCHEM BIOPH RES CO, V224, P855, DOI 10.1006/bbrc.1996.1112; Johnson GVW, 1997, BRAIN RES, V751, P323, DOI 10.1016/S0006-8993(96)01431-X; Junn E, 2003, P NATL ACAD SCI USA, V100, P2047, DOI 10.1073/pnas.0438021100; Kap YS, 2008, J IMMUNOL, V180, P1326, DOI 10.4049/jimmunol.180.3.1326; Kim SY, 1999, J BIOL CHEM, V274, P30715, DOI 10.1074/jbc.274.43.30715; Kooi EJ, 2012, NEUROLOGY, V79, P1369, DOI 10.1212/WNL.0b013e31826c1b1c; Korn T, 2008, J NEUROL, V255, P2, DOI 10.1007/s00415-008-6001-2; Lassmann H, 2014, GLIA, P1; Lassmann H, 2007, BRAIN PATHOL, V17, P210, DOI 10.1111/j.1750-3639.2007.00064.x; Lesort M, 1999, J NEUROCHEM, V73, P2018; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; LORAND L, 1988, P NATL ACAD SCI USA, V85, P1057, DOI 10.1073/pnas.85.4.1057; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Lucchinetti CF, 1996, BRAIN PATHOL, V6, P259, DOI 10.1111/j.1750-3639.1996.tb00854.x; MEHTA K, 1986, CANCER RES, V46, P1388; Mix E, 2010, PROG NEUROBIOL, V92, P386, DOI 10.1016/j.pneurobio.2010.06.005; Nasu-Tada K, 2005, GLIA, V52, P98, DOI 10.1002/glia.20224; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Oh K, 2012, CLIN IMMUNOL, V145, P122, DOI 10.1016/j.clim.2012.08.009; Papadopoulos D, 2009, BRAIN PATHOL, V19, P238, DOI 10.1111/j.1750-3639.2008.00177.x; Park KC, 2004, BIOCHEM BIOPH RES CO, V323, P1055, DOI 10.1016/j.bbrc.2004.08.204; Peterson JW, 2001, ANN NEUROL, V50, P389, DOI 10.1002/ana.1123; Petzold A, 2002, BRAIN, V125, P1462, DOI 10.1093/brain/awf165; PIERSCHBACHER M, 1983, P NATL ACAD SCI-BIOL, V80, P1224, DOI 10.1073/pnas.80.5.1224; Politis M, 2012, NEUROLOGY, V79, P523, DOI 10.1212/WNL.0b013e3182635645; Popescu BFG, 2012, ANNU REV PATHOL-MECH, V7, P185, DOI 10.1146/annurev-pathol-011811-132443; Rawji KS, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/948976; Reynolds R, 2011, ACTA NEUROPATHOL, V122, P155, DOI 10.1007/s00401-011-0840-0; Ruan QM, 2007, FRONT BIOSCI-LANDMRK, V12, P891, DOI 10.2741/2111; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; Schonrock LM, 1998, NEUROPATH APPL NEURO, V24, P320; SEIVING B, 1991, EUR J HAEMATOL, V46, P263; Seta N, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/820827; SOBEL RA, 1989, AM J PATHOL, V135, P161; Sriram S, 2011, J NEUROIMMUNOL, V239, P13, DOI 10.1016/j.jneuroim.2011.08.012; Stadelmann C, 2008, J NEUROL, V255, P12, DOI 10.1007/s00415-008-1003-7; Stadelmann C, 2011, CURR OPIN NEUROL, V24, P224, DOI 10.1097/WCO.0b013e328346056f; Stys PK, 2012, NAT REV NEUROSCI, V13, P507, DOI 10.1038/nrn3275; Szondy Z, 2003, P NATL ACAD SCI USA, V100, P7812, DOI 10.1073/pnas.0832466100; 't Hart BA, 1998, AM J PATHOL, V153, P649, DOI 10.1016/S0002-9440(10)65606-4; 't Hart BA, 2011, TRENDS MOL MED, V17, P119, DOI 10.1016/j.molmed.2010.11.006; 't Hart BA, 2009, J NEUROPATH EXP NEUR, V68, P341, DOI 10.1097/NEN.0b013e31819f1d24; THOMAZY V, 1989, CELL TISSUE RES, V255, P215; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; van der Valk P, 2000, NEUROPATH APPL NEURO, V26, P2, DOI 10.1046/j.1365-2990.2000.00217.x; van Horssen J, 2005, J NEUROPATH EXP NEUR, V64, P722, DOI 10.1097/01.jnen.0000173894.09553.13; Horssen J, 2007, J NEUROCHEM, V103, P1293, DOI 10.1111/j.1471-4159.2007.04897.x; van Strien ME, 2011, BRAIN PATHOL, V21, P44, DOI 10.1111/j.1750-3639.2010.00428.x; Vercellino M, 2007, J NEUROPATH EXP NEUR, V66, P732, DOI 10.1097/nen.0b013e31812571b0; Vercellino M, 2009, J NEUROPATH EXP NEUR, V68, P489, DOI 10.1097/NEN.0b013e3181a19a5a; Wang Z, 2010, J BIOL CHEM, V285, P40212, DOI 10.1074/jbc.M110.123703; WEINSHENKER BG, 1989, BRAIN, V112, P133, DOI 10.1093/brain/112.1.133; Wilhelmus MMM, 2008, EUR J PHARMACOL, V585, P464, DOI 10.1016/j.ejphar.2008.01.059; Zemskov EA, 2006, FRONT BIOSCI-LANDMRK, V11, P1057, DOI 10.2741/1863	88	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100574	10.1371/journal.pone.0100574	http://dx.doi.org/10.1371/journal.pone.0100574			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959868	Green Submitted, Green Published, gold			2022-12-27	WOS:000338633900058
J	Zhang, N; Shu, HY; Huang, TT; Zhang, QL; Li, D; Zhang, GQ; Peng, XY; Liu, CF; Luo, WF; Hu, LF				Zhang, Ning; Shu, Hai-Yang; Huang, Tingting; Zhang, Qi-Lin; Li, Da; Zhang, Guan-Qun; Peng, Xiao-Yan; Liu, Chun-Feng; Luo, Wei-Feng; Hu, Li-Fang			Nrf2 Signaling Contributes to the Neuroprotective Effects of Urate against 6-OHDA Toxicity	PLOS ONE			English	Article							TRANSCRIPTION FACTOR NRF2; URIC-ACID; PARKINSONS-DISEASE; SUBSTANTIA-NIGRA; PATHWAY; KEAP1; DEGRADATION; PROTECTION; LIGASE; CELLS	Background: Mounting evidence shows that urate may become a biomarker of Parkinson's disease (PD) diagnosis and prognosis and a neuroprotectant candidate for PD therapy. However, the cellular and molecular mechanisms underlying its neuroprotective actions remain poorly understood. Results: In this study, we showed that urate pretreatment protected dopaminergic cell line (SH-SY5Y and MES23.5) against 6-hydroxydopamine (6-OHDA)- and hydrogen peroxide-induced cell damage. Urate was found to be accumulated into SH-SY5Y cells after 30 min treatment. Moreover, urate induced NF-E2-related factor 2 (Nrf2) accumulation by inhibiting its ubiquitinationa and degradation, and also promoted its nuclear translocation; however, it did not modulate Nrf2 mRNA level or Kelch-like ECH-associated protein 1 (Keap1) expression. In addition, urate markedly up-regulated the transcription and protein expression of gamma-glutamate-cysteine ligase catalytic subunit (gamma-GCLC) and heme oxygenase-1 (HO-1), both of which are controlled by Nrf2 activity. Furthermore, Nrf2 knockdown by siRNA abolished the intracellular glutathione augmentation and the protection exerted by urate pretreatment. Conclusion: Our findings demonstrated that urate treatment may result in Nrf2-targeted anti-oxidant genes transcription and expression by reducing Nrf2 ubiquitination and degradation and promoting its nuclear translocation, and thus offer neuroprotection on dopaminergic cells against oxidative stresses.	[Zhang, Ning; Shu, Hai-Yang; Huang, Tingting; Zhang, Qi-Lin; Li, Da; Zhang, Guan-Qun; Peng, Xiao-Yan; Liu, Chun-Feng; Luo, Wei-Feng; Hu, Li-Fang] Soochow Univ, Affiliated Hosp 2, Jiangsu Key Lab Translat Res & Therapy Neuropsych, Dept Neurol, Suzhou, Jiangsu, Peoples R China; [Zhang, Ning; Huang, Tingting; Liu, Chun-Feng; Luo, Wei-Feng; Hu, Li-Fang] Soochow Univ, Inst Neurosci, Suzhou, Jiangsu, Peoples R China; [Hu, Li-Fang] Soochow Univ, Dept Pharmacol, Suzhou, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China	Luo, WF (corresponding author), Soochow Univ, Affiliated Hosp 2, Jiangsu Key Lab Translat Res & Therapy Neuropsych, Dept Neurol, Suzhou, Jiangsu, Peoples R China.	lwfwxx@126.com; hulifang@suda.edu.cn	Hu, Li-Fang/S-3153-2019; Hu, Li-Fang/ABD-9621-2021	Hu, Li-Fang/0000-0001-8326-7779; Hu, Li-Fang/0000-0001-8326-7779; Liu, Chun-Feng/0000-0002-8364-0219	National Natural Science Foundation of China [81171212]; Natural Science Foundation of Jiangsu Province, China [BK2010229, BK2010228]; Suzhou Technology Support Program [SS201112]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province); Suzhou Technology Support Program	This work was supported by grants from National Natural Science Foundation of China (81171212), Natural Science Foundation of Jiangsu Province, China (BK2010229, BK2010228) and also Suzhou Technology Support Program (SS201112). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annanmaki T, 2008, PARKINSONISM RELAT D, V14, P576, DOI 10.1016/j.parkreldis.2007.11.001; Ansari N, 2011, EUR J PHARMACOL, V658, P84, DOI 10.1016/j.ejphar.2011.02.028; Aoyama K, 2011, NEUROSCIENCE, V181, P206, DOI 10.1016/j.neuroscience.2011.02.047; Tobon-Velasco JC, 2012, FREE RADICAL BIO MED, V53, P1024, DOI 10.1016/j.freeradbiomed.2012.06.040; Chen PC, 2009, P NATL ACAD SCI USA, V106, P2933, DOI 10.1073/pnas.0813361106; CHURCH WH, 1994, BRAIN RES BULL, V33, P419, DOI 10.1016/0361-9230(94)90285-2; Cipriani S, 2012, J NEUROCHEM, V123, P172, DOI 10.1111/j.1471-4159.2012.07820.x; CRAWFORD GD, 1992, J NEUROSCI, V12, P3392; Dimitroula HV, 2008, NEUROLOGIST, V14, P238, DOI 10.1097/NRL.0b013e31815c666b; Du YZ, 2007, GLIA, V55, P463, DOI 10.1002/glia.20472; Enomoto A, 2002, NATURE, V417, P447, DOI 10.1038/nature742; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Gong L, 2012, J NEUROCHEM, V123, P876, DOI 10.1111/jnc.12038; Guerreiro S, 2009, J NEUROCHEM, V109, P1118, DOI 10.1111/j.1471-4159.2009.06040.x; Gunjima K, 2014, J CELL BIOCHEM, V115, P151, DOI 10.1002/jcb.24643; Itoh K, 2003, GENES CELLS, V8, P379, DOI 10.1046/j.1365-2443.2003.00640.x; Jakel RJ, 2007, BRAIN RES, V1144, P192, DOI 10.1016/j.brainres.2007.01.131; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Li Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035122; Mahajan M, 2009, INDIAN J CLIN BIOCHE, V24, P205, DOI 10.1007/s12291-009-0038-6; PROCTOR P, 1970, NATURE, V228, P868, DOI 10.1038/228868a0; Ramsey CP, 2007, J NEUROPATH EXP NEUR, V66, P75, DOI 10.1097/nen.0b013e31802d6da9; Sautin YY, 2008, NUCLEOS NUCLEOT NUCL, V27, P608, DOI 10.1080/15257770802138558; Schwarzschild MA, 2008, ARCH NEUROL-CHICAGO, V65, P716, DOI 10.1001/archneur.2008.65.6.nct70003; Spector R, 2006, PHARM RES-DORDR, V23, P2515, DOI 10.1007/s11095-006-9091-5; Stewart D, 2003, J BIOL CHEM, V278, P2396, DOI 10.1074/jbc.M209195200; Tobon-Velasco JC, 2013, TOXICOLOGY, V304, P109, DOI 10.1016/j.tox.2012.12.011; Yeum KJ, 2004, ARCH BIOCHEM BIOPHYS, V430, P97, DOI 10.1016/j.abb.2004.03.006; Yu JJ, 2012, J BIOCHEM MOL TOXIC, V26, P264, DOI 10.1002/jbt.21417; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zhang DD, 2006, DRUG METAB REV, V38, P769, DOI 10.1080/03602530600971974; Zhu TG, 2012, NEUROSCI LETT, V506, P175, DOI 10.1016/j.neulet.2011.10.075	32	38	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100286	10.1371/journal.pone.0100286	http://dx.doi.org/10.1371/journal.pone.0100286			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959672	Green Submitted, Green Published, gold			2022-12-27	WOS:000338633900037
J	Browne, JA; Harris, A; Leir, SH				Browne, James A.; Harris, Ann; Leir, Shih-Hsing			An Optimized Protocol for Isolating Primary Epithelial Cell Chromatin for ChIP	PLOS ONE			English	Article							CYSTIC-FIBROSIS	A critical part of generating robust chromatin immunoprecipitation (ChIP) data is the optimization of chromatin purification and size selection. This is particularly important when ChIP is combined with next-generation sequencing (ChIP-seq) to identify targets of DNA-binding proteins, genome-wide. Current protocols refined by the ENCODE consortium generally use a two-step cell lysis procedure that is applicable to a wide variety of cell types. However, the isolation and size selection of chromatin from primary human epithelial cells may often be particularly challenging. These cells tend to form sheets of formaldehyde cross-linked material in which cells are resistant to membrane lysis, nuclei are not released and subsequent sonication produces extensive high molecular weight contamination. Here we describe an optimized protocol to prepare high quality ChIP-grade chromatin from primary human bronchial epithelial cells. The ENCODE protocol was used as a starting point to which we added the following key steps to separate the sheets of formaldehyde-fixed cells prior to lysis. (1) Incubation of the formaldehyde-fixed adherent cells in Trypsin-EDTA (0.25% room temperature) for no longer than 5 min. (2) Equilibration of the fixed cells in detergent-free lysis buffers prior to each lysis step. (3) The addition of 0.5% Triton X-100 to the complete cell membrane lysis buffer. (4) Passing the cell suspension (in complete cell membrane lysis buffer) through a 25-gauge needle followed by continuous agitation on ice for 35 min. Each step of the modified protocol was documented by light microscopy using the Methyl Green-Pyronin dual dye, which stains cytoplasm red (Pyronin) and the nuclei grey-blue (Methyl green). This modified method is reproducibly effective at producing high quality sheared chromatin for ChIP and is equally applicable to other epithelial cell types.	[Browne, James A.; Harris, Ann; Leir, Shih-Hsing] Lurie Childrens Res Ctr, Human Mol Genet Program, Chicago, IL 60611 USA; [Browne, James A.; Harris, Ann; Leir, Shih-Hsing] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA; [Harris, Ann] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center	Leir, SH (corresponding author), Lurie Childrens Res Ctr, Human Mol Genet Program, Chicago, IL 60611 USA.	s-leir@northwestern.edu	Leir, Shih-Hsing/AAG-1086-2019; Leir, Shih-Hsing/O-6739-2019	Leir, Shih-Hsing/0000-0001-9524-3379; Browne, James/0000-0002-6473-3567	National Institutes of Health [R01HD068901, R01HL094585, R01HL117843]; Cystic Fibrosis Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD068901] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094585] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	All the funding sources were from the National Institutes of Health (R01HD068901, R01HL094585, R01HL117843 (PI: A. H.)) and the Cystic Fibrosis Foundation (www.cff.org) (PI: A. H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	COLEMAN L, 1991, J CELL SCI, V98, P85; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; FOGH J, 1977, J NATL CANCER I, V58, P209, DOI 10.1093/jnci/58.2.209; HARRIS A, 1989, J CELL SCI, V92, P687; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; KAPUSCINSKI J, 1987, CYTOMETRY, V8, P129, DOI 10.1002/cyto.990080205; KURNICK NB, 1952, STAIN TECHNOL, V27, P233, DOI 10.3109/10520295209105083; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Marconett CN, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003513; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; SHEN RQ, 1994, AM J PHYSIOL, V266, pL493, DOI 10.1152/ajplung.1994.266.5.L493; Weinmann AS, 2002, METHODS, V26, P37, DOI 10.1016/S1046-2023(02)00006-3	12	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100099	10.1371/journal.pone.0100099	http://dx.doi.org/10.1371/journal.pone.0100099			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971909	Green Submitted, Green Published, gold			2022-12-27	WOS:000338512200019
J	Chen, JW; Xie, ZR; Wu, YH				Chen, Jiawen; Xie, Zhong-Ru; Wu, Yinghao			Computational Modeling of the Interplay between Cadherin-Mediated Cell Adhesion and Wnt Signaling Pathway	PLOS ONE			English	Article							BETA-CATENIN; ALPHA-CATENIN; COMPLEX; ROLES; APC; CONVERGENCE; PRINCIPLES; MUTATIONS; STABILITY; CLUSTERS	Wnt signaling and cadherin-mediated adhesion have been implicated in both processes of embryonic development and the progression of carcinomas. Recent experimental studies revealed that Wnt signaling and cadherin-mediated cell adhesion have close crosstalk with each other. A comprehensive model that investigates the dynamic balance of beta-catenins in Wnt signaling and cell adhesion will improve our understanding to embryonic development and carcinomas. We constructed a network model to evaluate the dynamic interplay between adhesion and Wnt signaling. The network is decomposed into three interdependent modules: the cell adhesion, the degradation circle and the transcriptional regulation. In the cell adhesion module, we consider the effect of cadherin's lateral clustering. We found adhesion negatively contributes to Wnt signaling through competition for cytoplasmic beta-catenins. In the network of degradation circle, we incorporated features from various existing models. Our simulations reproduced the most recent experimental phenomena with semi-quantitative accuracy. Finally, in the transcriptional regulation module, we developed a function selection strategy to analyze the outcomes of genetic feedback loops in modulating the gene expression of Wnt targets. The specific cellular phenomena such as cadherin switch and Axin oscillation were archived and their biological insights were discussed. Our model provides the theoretical basis of how spatial organization regulates the dynamics of cellular signaling pathways. We suggest that cell adhesion affects Wnt signaling in both negative and positive ways. Cadherins can inhibit Wnt signaling not only in a way as a stoichiometric binding partner of beta-catenins that sequesters them from signaling, but also in a way through their clustering to impacts the rate at which beta-catenins are involved in the destruction loop. Additionally, cadherin clustering increases the phosphorylation rate of beta-catenins and promotes its signaling in nucleus.	[Chen, Jiawen; Xie, Zhong-Ru; Wu, Yinghao] Yeshiva Univ, Albert Einstein Coll Med, Dept Syst & Computat Biol, Bronx, NY 10033 USA	Yeshiva University; Albert Einstein College of Medicine	Wu, YH (corresponding author), Yeshiva Univ, Albert Einstein Coll Med, Dept Syst & Computat Biol, Bronx, NY 10033 USA.	yinghao.wu@einstein.yu.edu	Xie, Paul Zhongru/O-3547-2014	Xie, Paul Zhongru/0000-0002-1539-5100	Albert Einstein College of Medicine	Albert Einstein College of Medicine	YW was supported by a start-up grant from Albert Einstein College of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aulehla A, 2003, DEV CELL, V4, P395, DOI 10.1016/S1534-5807(03)00055-8; Bienz M, 2005, CURR BIOL, V15, pR64, DOI 10.1016/j.cub.2004.12.058; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Quang BAT, 2013, CURR BIOL, V23, P2197, DOI 10.1016/j.cub.2013.09.015; Brembeck FH, 2004, GENE DEV, V18, P2225, DOI 10.1101/gad.317604; Buske P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001045; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Cebecauer M, 2010, J CELL SCI, V123, P309, DOI 10.1242/jcs.061739; Cho KH, 2006, FEBS LETT, V580, P3665, DOI 10.1016/j.febslet.2006.05.053; Choi HJ, 2006, J BIOL CHEM, V281, P1027, DOI 10.1074/jbc.M511338200; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Curtis MW, 2008, CELL COMMUN ADHES, V15, P365, DOI 10.1080/15419060802460748; Daugherty RL, 2007, PHYSIOLOGY, V22, P303, DOI 10.1152/physiol.00020.2007; Davidson G, 2010, TRENDS CELL BIOL, V20, P453, DOI 10.1016/j.tcb.2010.05.002; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Fagotto F, 2013, EMBO REP, V14, P422, DOI 10.1038/embor.2013.45; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Goentoro L, 2009, MOL CELL, V36, P872, DOI 10.1016/j.molcel.2009.11.017; Grigoryan T, 2008, GENE DEV, V22, P2308, DOI 10.1101/gad.1686208; Harrison OJ, 2011, STRUCTURE, V19, P244, DOI 10.1016/j.str.2010.11.016; Hartman NC, 2011, CURR OPIN CELL BIOL, V23, P370, DOI 10.1016/j.ceb.2011.05.003; Hayward P, 2008, DEVELOPMENT, V135, P411, DOI 10.1242/dev.000505; Hernandez AR, 2012, SCIENCE, V338, P1337, DOI 10.1126/science.1228734; Heuberger J, 2010, COLD SPRING HARBOR P, P2; HINCK L, 1994, J CELL BIOL, V125, P1327, DOI 10.1083/jcb.125.6.1327; Hong S, 2010, P NATL ACAD SCI USA, V107, P3528, DOI 10.1073/pnas.0911027107; Howard S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023899; Hu TH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-236; Ishiyama Noboru, 2012, Subcell Biochem, V60, P39, DOI 10.1007/978-94-007-4186-7_3; Ishiyama N, 2010, CELL, V141, P117, DOI 10.1016/j.cell.2010.01.017; Kam Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004580; Kim D, 2007, ONCOGENE, V26, P4571, DOI 10.1038/sj.onc.1210230; Kim SE, 2013, SCIENCE, V340, P867, DOI 10.1126/science.1232389; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Kogan Y, 2012, BIOCHEM J, V444, P115, DOI 10.1042/BJ20111887; Kruger Roland, 2004, Genome Inform, V15, P138; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Lloyd-Lewis B, 2013, WIRES SYST BIOL MED, V5, P391, DOI 10.1002/wsbm.1221; Lustig B, 2003, J CANCER RES CLIN, V129, P199, DOI 10.1007/s00432-003-0431-0; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; MacDonald BT, 2012, COLD SPRING HARB PER, V4; Maher MT, 2009, J CELL BIOL, V186, P219, DOI 10.1083/jcb.200811108; McGuffee SR, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000694; Micalizzi DS, 2010, J MAMMARY GLAND BIOL, V15, P117, DOI 10.1007/s10911-010-9178-9; Mirams GR, 2012, J THEOR BIOL, V312, P143, DOI 10.1016/j.jtbi.2012.08.002; Mirams GR, 2010, J MATH BIOL, V60, P131, DOI 10.1007/s00285-009-0262-y; Mosimann C, 2009, NAT REV MOL CELL BIO, V10, P276, DOI 10.1038/nrm2654; Moussavi-Baygi R, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002049; Nanes BA, 2012, J CELL BIOL, V199, P365, DOI 10.1083/jcb.201205029; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Patel SD, 2003, CURR OPIN STRUC BIOL, V13, P690, DOI 10.1016/j.sbi.2003.10.007; Pronobis MI, 2012, CURR BIOL, V22, pR137, DOI 10.1016/j.cub.2012.01.002; Ramis-Conde I, 2008, BIOPHYS J, V95, P155, DOI 10.1529/biophysj.107.114678; Roberts DM, 2011, MOL BIOL CELL, V22, P1845, DOI 10.1091/mbc.E10-11-0871; Schmitz Y, 2011, J THEOR BIOL, V279, P132, DOI 10.1016/j.jtbi.2011.03.018; Seidensticker MJ, 2000, BBA-MOL CELL RES, V1495, P168, DOI 10.1016/S0167-4889(99)00158-5; Shapiro L, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003053; Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002; Sun J., 2007, J CHEM PHYS, V127; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Tan CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031882; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; van Leeuwen IMM, 2009, CELL PROLIFERAT, V42, P617, DOI 10.1111/j.1365-2184.2009.00627.x; Leeuwen IMM, 2007, J THEOR BIOL, V247, P77, DOI 10.1016/j.jtbi.2007.01.019; Wawra C, 2007, FEBS LETT, V581, P4043, DOI 10.1016/j.febslet.2007.07.043; Weis W. I., 2013, COLD SPRING HARBOR P, V5; Willert K, 1999, GENE DEV, V13, P1768, DOI 10.1101/gad.13.14.1768; Wu YH, 2011, NATURE, V475, P510, DOI 10.1038/nature10183; Wu YH, 2010, P NATL ACAD SCI USA, V107, P17592, DOI 10.1073/pnas.1011247107; Xie ZR, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4863992; Xing Y, 2003, GENE DEV, V17, P2753, DOI 10.1101/gad.1142603; Yuan JM, 2008, PROTEIN SCI, V17, P2156, DOI 10.1110/ps.037325.108; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540	74	17	17	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100702	10.1371/journal.pone.0100702	http://dx.doi.org/10.1371/journal.pone.0100702			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967587	gold, Green Published, Green Submitted			2022-12-27	WOS:000338280800054
J	Liu, ZY; Wei, WJ; Bai, LJ; Dai, RW; You, YB; Chen, SJ; Tian, J				Liu, Zhenyu; Wei, Wenjuan; Bai, Lijun; Dai, Ruwei; You, Youbo; Chen, Shangjie; Tian, Jie			Exploring the Patterns of Acupuncture on Mild Cognitive Impairment Patients Using Regional Homogeneity	PLOS ONE			English	Article							FMRI CONNECTIVITY ANALYSIS; HUMAN BRAIN; ALZHEIMERS-DISEASE; FUNCTIONAL CONNECTIVITY; NETWORK; STIMULATION; DEFAULT; MODULATION	Purpose: To investigate the different responses to acupuncture in MCI patients and age-matched healthy subjects reflected by the Regional Homogeneity (ReHo) indices. Methods: The experiment was performed at the acupoint KI3 in 12 MCI patients and 12 healthy controls, respectively. A novel non-repeated event-related (NRER) fMRI design paradigm was applied to separately detect neural activities related to different stages of acupuncture (pre-acupuncture resting state, needling manipulation and post-acupuncture resting state). ReHo values were calculated for MCI patients and healthy controls in pre-and post-acupuncture resting state. Then, a two-way ANCOVA with repeated measures with post-hoc two sample t-tests was performed to explore the different responses to acupuncture in the two groups. Results: The ANCOVA revealed a significant main effect of group, but no significant main effect of acupuncture and interactions between group and acupuncture. During the pre-acupuncture resting state, ReHo values increased in the precentral gyrus (PCG), superior frontal gyrus (SFG), and insula (INS) and decreased mainly in middle temporal gyrus (MTG), parahippocampal (PHIP) and cingulate cortex in MCI patients compared with healthy controls. Furthermore, we found that the regions including precuneus (PCUN), and cingulate cortex showed increased ReHo values for MCI patients following acupuncture. For healthy controls, the medial frontal gyrus, PCG, anterior cingulate cortex (ACC) and INS showed enhanced ReHo values following acupuncture. During the post-acupuncture resting state, MCI patients showed increased ReHo values mainly in the MTG, superior parietal lobule (SPL), middle frontal gyrus (MFG), supramarginal (SMG), and PCG, and decreased ReHo values mainly in the frontal regions, PHIP, and posterior cingulated cortex (PCC) compared to healthy controls. Conclusion: Though we found some ReHo changes between MCI patients and healthy controls, the two-way ANCOVA results showed no significant effects after multiple corrections. Further study is needed to reveal the real acupuncture effects on MCI patients.	[Liu, Zhenyu; Wei, Wenjuan; Bai, Lijun; Dai, Ruwei; You, Youbo; Tian, Jie] Chinese Acad Sci, Inst Automat, Key Lab Mol Imaging & Funct Imaging, Beijing, Peoples R China; [Chen, Shangjie] Southern Med Univ, Baoan Hosp, Dept Acupuncture & Massage, Shenzhen, Peoples R China; [Tian, Jie] Xidian Univ, Sch Life Sci & Technol, Life Sci Res Ctr, Xian, Shaanxi, Peoples R China	Chinese Academy of Sciences; Institute of Automation, CAS; Southern Medical University - China; Xidian University	Bai, LJ (corresponding author), Chinese Acad Sci, Inst Automat, Key Lab Mol Imaging & Funct Imaging, Beijing, Peoples R China.	bailj4152615@gmail.com; tian@ieee.org	Bai, Lijun/C-5119-2015; Liu, Zhenyu/G-8444-2018; Tian, Jie/H-1190-2011; tian, jie/M-6336-2013	Bai, Lijun/0000-0001-8790-5424; Liu, Zhenyu/0000-0001-7559-8519; Tian, Jie/0000-0003-0498-0432; 	National Basic Research Program of China (973 Program) [2011CB707700]; National Natural Science Foundation of China [81227901, 61231004, 30970771, 81000640, 81171314, 30970769, 81071217]; Fundamental Research Funds for the Central Universities [2011JBM226]; NIH [R01HD046526, R01HD060595]; Beijing Nova program [Z111101054511116]; Beijing Natural Science Foundation [4122082]; Fellowship for Young International Scientists of the Chinese Academy of Sciences [2010Y2GA03]; Chinese Academy of Sciences Visiting Professorship for Senior International Scientists [2012T1G0036, 2010T2G36, 2012T1G0039]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD046526, R01HD060595] Funding Source: NIH RePORTER	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beijing Nova program(Beijing Municipal Science & Technology Commission); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Fellowship for Young International Scientists of the Chinese Academy of Sciences; Chinese Academy of Sciences Visiting Professorship for Senior International Scientists; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This paper is supported by the National Basic Research Program of China (973 Program) under grant 2011CB707700 (http://www.973.gov.cn/Default_3. aspx), the National Natural Science Foundation of China under grant no. 81227901, 61231004, 30970771, 81000640, 81171314, 30970769, 81071217 (http://www. nsfc.gov.cn/Portal0/default152.htm), the Fundamental Research Funds for the Central Universities (2011JBM226) and NIH (R01HD046526 & R01HD060595), the Beijing Nova program (grant number Z111101054511116), and Beijing Natural Science Foundation (grant number 4122082), the Fellowship for Young International Scientists of the Chinese Academy of Sciences under grant no. 2010Y2GA03, the Chinese Academy of Sciences Visiting Professorship for Senior International Scientists under grant no. 2012T1G0036, 2010T2G36, 2012T1G0039. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Bai F, 2008, NEUROSCI LETT, V438, P111, DOI 10.1016/j.neulet.2008.04.021; Bai LJ, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-73; Bai LJ, 2010, J MAGN RESON IMAGING, V31, P71, DOI 10.1002/jmri.22006; Bai LJ, 2009, CURR MED IMAGING REV, V5, P167, DOI 10.2174/157340509789000589; Bai LJ, 2009, HUM BRAIN MAPP, V30, P3445, DOI 10.1002/hbm.20769; Bai LJ, 2009, PROG NAT SCI-MATER, V19, P827, DOI 10.1016/j.pnsc.2008.09.009; Bai LJ, 2009, BRAIN RES, V1279, P37, DOI 10.1016/j.brainres.2009.04.056; Beijing Shanghai and Nanjing College of Traditional Chinese Medicine. Acupuncture Institute of the Academy of Traditional Chinese Medicine, 1980, ESS CHIN AC; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Dhond RP, 2008, PAIN, V136, P407, DOI 10.1016/j.pain.2008.01.011; Enck P, 2010, AUTON NEUROSCI-BASIC, V157, P68, DOI 10.1016/j.autneu.2010.03.005; Fang JL, 2009, HUM BRAIN MAPP, V30, P1196, DOI 10.1002/hbm.20583; Feng YY, 2012, MAGN RESON IMAGING, V30, P672, DOI 10.1016/j.mri.2012.01.003; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Goddard G, 2005, J PAIN, V6, P237, DOI 10.1016/j.jpain.2004.12.009; Grady CL, 2001, BRAIN, V124, P739, DOI 10.1093/brain/124.4.739; Grundman M, 2004, ARCH NEUROL-CHICAGO, V61, P59, DOI 10.1001/archneur.61.1.59; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; Horwitz B, 1995, NEUROREPORT, V6, P2287, DOI 10.1097/00001756-199511270-00005; Hui KKS, 2005, NEUROIMAGE, V27, P479, DOI 10.1016/j.neuroimage.2005.04.037; Hui KKS, 2000, HUM BRAIN MAPP, V9, P13, DOI 10.1002/(SICI)1097-0193(2000)9:1<13::AID-HBM2>3.0.CO;2-F; Ikonomovic MD, 2003, J ALZHEIMERS DIS, V5, P39, DOI 10.3233/JAD-2003-5106; Kaptchuk TJ, 2002, ANN INTERN MED, V136, P374, DOI 10.7326/0003-4819-136-5-200203050-00010; Kendall M.G., 1990, RANK CORRELATION MET, V5th; Kiviniemi V, 2008, HUM BRAIN MAPP, V29, P810, DOI 10.1002/hbm.20582; Kong J, 2007, J ALTERN COMPLEM MED, V13, P1059, DOI 10.1089/acm.2007.0524; Liu HH, 2006, NEUROREPORT, V17, P19, DOI 10.1097/01.wnr.0000195666.22714.35; Luijpen MW, 2004, NEUROREHAB NEURAL RE, V18, P166, DOI 10.1177/0888439004268785; Mayer DJ, 2000, ANNU REV MED, V51, P49, DOI 10.1146/annurev.med.51.1.49; Molsberger AF, 2010, PAIN, V151, P146, DOI 10.1016/j.pain.2010.06.036; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Napadow V, 2005, HUM BRAIN MAPP, V24, P193, DOI 10.1002/hbm.20081; NIH, 1998, JAMA; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Paakki JJ, 2010, BRAIN RES, V1321, P169, DOI 10.1016/j.brainres.2009.12.081; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Qi ZG, 2010, NEUROIMAGE, V50, P48, DOI 10.1016/j.neuroimage.2009.12.025; Qin W, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-55; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Wu T, 2009, HUM BRAIN MAPP, V30, P1502, DOI 10.1002/hbm.20622; Yoo SS, 2004, NEUROIMAGE, V22, P932, DOI 10.1016/j.neuroimage.2004.02.017; Yu DH, 2012, NMR BIOMED, V25, P806, DOI 10.1002/nbm.1796; Yu JC, 2006, NEUROL RES, V28, P97, DOI 10.1179/016164106X91951; Yuan YG, 2008, J AFFECT DISORDERS, V111, P145, DOI 10.1016/j.jad.2008.02.016; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zhang ZQ, 2012, NEUROIMAGE, V59, P1429, DOI 10.1016/j.neuroimage.2011.08.049; Zhong CG, 2012, J MAGN RESON IMAGING, V35, P572, DOI 10.1002/jmri.22887; Zhou YL, 2008, ACUPUNCTURE ELECTRO, V33, P9, DOI 10.3727/036012908803861186; Zhu L, 1954, NEW ACUPUNCTURE XIN; Zuo XN, 2013, NEUROIMAGE, V65, P374, DOI 10.1016/j.neuroimage.2012.10.017	52	10	16	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e99335	10.1371/journal.pone.0099335	http://dx.doi.org/10.1371/journal.pone.0099335			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968124	Green Submitted, Green Published, gold			2022-12-27	WOS:000338280800010
J	Putila, J; Guo, NL				Putila, Joseph; Guo, Nancy Lan			Combining COPD with Clinical, Pathological and Demographic Information Refines Prognosis and Treatment Response Prediction of Non-Small Cell Lung Cancer	PLOS ONE			English	Article							COMORBIDITY INDEX; SURVIVAL; VALIDATION; SMOKING; PREVALENCE; MORBIDITY; SMOKERS; MODEL; STAGE	Background: Accurate assessment of a patient's risk of recurrence and treatment response is an important prerequisite of personalized therapy in lung cancer. This study extends a previously described non-small cell lung cancer prognostic model by the addition of chemotherapy and co-morbidities through the use of linked SEER-Medicare data. Methodology/Principal Findings: Data on 34,203 lung adenocarcinoma and 26,967 squamous cell lung carcinoma patients were used to determine the contribution of Chronic Obstructive Pulmonary Disease (COPD) to prognostication in 30 treatment combinations. A Cox model including COPD was estimated on 1,000 bootstrap samples, with the resulting model assessed on ROC, Brier Score, Harrell's C, and Nagelkerke's R-2 metrics in order to evaluate improvements in prognostication over a model without COPD. The addition of COPD to the model incorporating cancer stage, age, gender, race, and tumor grade was shown to improve prognostication in multiple patient groups. For lung adenocarcinoma patients, there was an improvement on the prognostication in the overall patient population and in patients without receiving chemotherapy, including those receiving surgery only. For squamous cell carcinoma, an improvement on prognostication was seen in both the overall patient population and in patients receiving multiple types of chemotherapy. COPD condition was able to stratify patients receiving the same treatments into significantly (log-rank p<0.05) different prognostic groups, independent of cancer stage. Conclusion/Significance: Combining patient information on COPD, cancer stage, age, gender, race, and tumor grade could improve prognostication and prediction of treatment response in individual non-small cell lung cancer patients. This model enables refined prognosis and estimation of clinical outcome of comprehensive treatment regimens, providing a useful tool for personalized clinical decision-making.	[Putila, Joseph; Guo, Nancy Lan] W Virginia Univ, Sch Publ Hlth, Mary Babb Randolph Canc Ctr, Dept Environm & Occupat Hlth Sci, Morgantown, WV 26506 USA	West Virginia University	Guo, NL (corresponding author), W Virginia Univ, Sch Publ Hlth, Mary Babb Randolph Canc Ctr, Dept Environm & Occupat Hlth Sci, Morgantown, WV 26506 USA.	lguo@hsc.wvu.edu			National Institutes of Health (NIH) [R01/R56LM009500];  [NCRRP20 RR16440]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104942] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM009500, R56LM009500] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by NCRRP20 RR16440 Stimulus Grant (PD: Dr. Nancy Guo) (http://recovery.nih.gov/Stories/ViewStory.aspx?id=449) and National Institutes of Health (NIH) R01/R56LM009500 (PI: Dr. Nancy Guo) (http://www.nlm.nih.gov/ep/AwardsShortTerm.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2013, CANC FACTS FIGURES 2; Bach PB, 1999, NEW ENGL J MED, V341, P1198, DOI 10.1056/NEJM199910143411606; Birim O, 2006, J THORAC CARDIOV SUR, V132, P491, DOI 10.1016/j.jtcvs.2006.04.010; Bryant A, 2007, CHEST, V132, P185, DOI 10.1378/chest.07-0442; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Dehing-Oberije C, 2008, INT J RADIAT ONCOL, V70, P1039, DOI 10.1016/j.ijrobp.2007.07.2323; Dehing-Oberije C, 2009, INT J RADIAT ONCOL, V74, P355, DOI 10.1016/j.ijrobp.2008.08.052; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; DHoore W, 1996, J CLIN EPIDEMIOL, V49, P1429, DOI 10.1016/S0895-4356(96)00271-5; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Engels EA, 2008, EXPERT REV ANTICANC, V8, P605, DOI 10.1586/14737140.8.4.605; General thoracic surgery, 2009, GEN THORACIC SURG; Guo L, 2006, CLIN CANCER RES, V12, P3344, DOI 10.1158/1078-0432.CCR-05-2336; Guo NL, 2009, LUNG CANCER, V66, P386, DOI 10.1016/j.lungcan.2009.02.012; Guo NL, 2008, CLIN CANCER RES, V14, P8213, DOI 10.1158/1078-0432.CCR-08-0095; Hoffman PC, 2000, LANCET, V355, P479, DOI 10.1016/S0140-6736(00)82038-3; Houghton AM, 2008, NAT MED, V14, P1023, DOI 10.1038/nm1008-1023; Janssen-Heijnen MLG, 2004, THORAX, V59, P602, DOI 10.1136/thx.2003.018044; Janssen-Heijnen MLG, 1998, LUNG CANCER, V21, P105, DOI 10.1016/S0169-5002(98)00039-7; Karoor V, 2012, CANCER PREV RES, V5, P1061, DOI 10.1158/1940-6207.CAPR-12-0069-T; Kenfield SA, 2008, TOB CONTROL, V17, P198, DOI 10.1136/tc.2007.022582; Kiri VA, 2010, PRIM CARE RESP J, V19, P57, DOI 10.4104/pcrj.2009.00048; Klabunde CN, 2007, ANN EPIDEMIOL, V17, P584, DOI 10.1016/j.annepidem.2007.03.011; Klabunde CN, 2000, J CLIN EPIDEMIOL, V53, P1258, DOI 10.1016/S0895-4356(00)00256-0; Kratz JR, 2012, LANCET, V379, P823, DOI 10.1016/S0140-6736(11)61941-7; Morth C, 2014, LUNG CANC; NARUKE T, 1988, J THORAC CARDIOV SUR, V96, P440; Papi A, 2004, THORAX, V59, P679, DOI 10.1136/thx.2003.018291; Putila JJ, 2012, THESIS; Putila J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017493; Rancati T, 2003, RADIOTHER ONCOL, V67, P275, DOI 10.1016/S0167-8140(03)00119-1; SEER, 2010, SURV EP END RES SEER; Sorenson S, 2001, ACTA ONCOL, V40, P327; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Tammemagi CM, 2004, CHEST, V125, P27, DOI 10.1378/chest.125.1.27; Tammemagi CM, 2003, INT J CANCER, V103, P792, DOI 10.1002/ijc.10882; Thorpe Kenneth E, 2003, Health Aff (Millwood), VSuppl Web Exclusives, pW3; Wan YW, 2012, LUNG CANCER, V76, P98, DOI 10.1016/j.lungcan.2011.09.016; Wan YW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012222; Warren JL, 2002, MED CARE, V40, P3; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; Yao HW, 2009, CURR OPIN PHARMACOL, V9, P375, DOI 10.1016/j.coph.2009.06.009; Young RP, 2009, EUR RESPIR J, V34, P380, DOI 10.1183/09031936.00144208	43	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100994	10.1371/journal.pone.0100994	http://dx.doi.org/10.1371/journal.pone.0100994			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967586	Green Published, Green Submitted, gold			2022-12-27	WOS:000338280800094
J	Vassilakopoulou, M; Togun, T; Dafni, U; Cheng, H; Bordeaux, J; Neumeister, VM; Bobos, M; Pentheroudakis, G; Skarlos, DV; Pectasides, D; Kotoula, V; Fountzilas, G; Rimm, DL; Psyrri, A				Vassilakopoulou, Maria; Togun, Taiwo; Dafni, Urania; Cheng, Huan; Bordeaux, Jennifer; Neumeister, Veronique M.; Bobos, Mattheos; Pentheroudakis, George; Skarlos, Dimosthenis V.; Pectasides, Dimitrios; Kotoula, Vassiliki; Fountzilas, George; Rimm, David L.; Psyrri, Amanda			In Situ Quantitative Measurement of HER2mRNA Predicts Benefit from Trastuzumab-Containing Chemotherapy in a Cohort of Metastatic Breast Cancer Patients	PLOS ONE			English	Article							POLYMERASE CHAIN-REACTION; ADJUVANT TRASTUZUMAB; MONOCLONAL-ANTIBODY; GENE AMPLIFICATION; PROGNOSTIC-FACTOR; AMERICAN-SOCIETY; HYBRIDIZATION; EXPRESSION; HER-2/NEU; RECEPTOR	Background: We sought to determine the predictive value of in situ mRNA measurement compared to traditional methods cohort of trastuzumab-treated metastatic breast cancer patients. Methods: A tissue microarray composed of 149, classified as HER2-positive, metastatic breast cancers treated with various trastuzumab-containing chemotherapy regimens was constructed. HER2 intracellular domain(ICD), HER2 extracellular domain(ECD) and HER2 mRNA were assessed using AQUA. For HER2 protein evaluation, CB11 was used to measure ICD and SP3 to measure ECD of the HER2 receptor. In addition, HER2 mRNA status was assessed using RNAscope assay ERRB2 probe. Kaplan - Meier estimates were used for depicting time-to-event endpoints. Multivariate Cox regression models with backward elimination were used to assess the performance of markers as predictors of TTP and OS, after adjusting for important covariates. Results: HER2 mRNA was correlated with ICD HER2, as measured by CB11 HER2, with ECD HER2 as measured by SP3 (Pearson's Correlation Coefficient, r = 0.66 and 0.51 respectively) and with FISH HER2 (Spearman's Correlation Coefficient, r = 0.75). All markers, HER2 mRNA, ICD HER2 and ECD HER2, along with FISH HER2, were found prognostic for OS (Log-rank p = 0.007, 0.005, 0.009 and 0.043 respectively), and except for FISH HER2, they were also prognostic for TTP Log-rank p = 0.036, 0.068 and 0.066 respectively) in this trastuzumab-treated cohort. Multivariate analysis showed that in the presence of pre-specified set of prognostic factors, among all biomarkers only ECD HER2, as measured by SP3, is strong prognostic factor for both TTP (HR = 0.54, 95% CI: 0.31-0.93, p = 0.027) and OS (HR = 0.39, 95% CI: 0.22-0.70, p = 0.002). Conclusions: The expression of HER2 ICD and ECD as well as HER2 mRNA levels was significantly associated with TTP and OS in this trastuzumab-treated metastatic cohort. In situ assessment of HER2 mRNA has the potential to identify breast cancer patients who derive benefit from Trastuzumab treatment.	[Vassilakopoulou, Maria; Cheng, Huan; Bordeaux, Jennifer; Neumeister, Veronique M.; Rimm, David L.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Togun, Taiwo] Yale Univ, Sch Publ Hlth, Dept Biostat, New Haven, CT USA; [Dafni, Urania] Univ Athens, Sch Nursing, Lab Biostat, Athens, Greece; [Bobos, Mattheos; Kotoula, Vassiliki; Fountzilas, George] Aristotle Univ Thessaloniki, Sch Med, Hellen Fdn Canc Res, Mol Oncol Lab, GR-54006 Thessaloniki, Greece; [Pentheroudakis, George] Ioannina Univ Hosp, Dept Med Oncol, Ioannina, Greece; [Skarlos, Dimosthenis V.] Metropolitan Hosp, Dept Med Oncol 2, Piraeus, Greece; [Pectasides, Dimitrios] Hippokrateion Hosp, Dept Internal Med 2, Oncol Sect, Athens, Greece; [Kotoula, Vassiliki] Aristotle Univ Thessaloniki, Sch Med, Dept Pathol, Thessaloniki, Greece; [Fountzilas, George] Aristotle Univ Thessaloniki, Sch Med, Dept Med Oncol, Papageorgiou Hosp, Thessaloniki, Greece; [Psyrri, Amanda] Univ Athens, Sch Med, Dept Internal Med 2, Div Oncol,Attikon Univ Hosp, GR-11527 Athens, Greece	Yale University; Yale University; National & Kapodistrian University of Athens; Aristotle University of Thessaloniki; University Hospital Ioannina; Hippokration General Hospital; Aristotle University of Thessaloniki; Aristotle University of Thessaloniki; Papageorgiou Hospital; Athens Medical School; National & Kapodistrian University of Athens; University Hospital Attikon	Psyrri, A (corresponding author), Univ Athens, Sch Med, Dept Internal Med 2, Div Oncol,Attikon Univ Hosp, GR-11527 Athens, Greece.	dpsyrri@med.uoa.gr	Bobos, Mattheos/L-5702-2019; Fountzilas, George/ABF-2139-2020; Dafni, Ourania/AAH-4453-2019	Bobos, Mattheos/0000-0001-5662-9201; Dafni, Ourania/0000-0003-4367-4497; Rimm, David/0000-0001-5820-4397; Fountzilas, George/0000-0001-8045-2186	National Cancer Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was supported by the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandra S, 2007, J CLIN PATHOL, V60, P1001, DOI 10.1136/jcp.2006.040287; Benohr P, 2005, ANTICANCER RES, V25, P1895; Bogaerts J, 2006, NAT CLIN PRACT ONCOL, V3, P540, DOI 10.1038/ncponc0591; Bordeaux J, 2010, BIOTECHNIQUES, V48, P197, DOI 10.2144/000113382; Camp RL, 2002, NAT MED, V8, P1323, DOI 10.1038/nm791; Chia S, 2008, J CLIN ONCOL, V26, P5697, DOI 10.1200/JCO.2007.15.8659; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Cianciulli AM, 2002, CANCER GENET CYTOGEN, V133, P66, DOI 10.1016/S0165-4608(01)00559-3; Cronin M, 2004, AM J PATHOL, V164, P35, DOI 10.1016/S0002-9440(10)63093-3; Dabbs DJ, 2011, J CLIN ONCOL, V29, P4279, DOI 10.1200/JCO.2011.34.7963; Dekker TJA, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3208; Di Leo A, 2002, ONCOLOGY-BASEL, V63, P25, DOI 10.1159/000066204; Dvorak L, 2013, APPL IMMUNOHISTO M M, V21, P196, DOI 10.1097/PAI.0b013e3182632ff5; Fountzilas G, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-212; Gjerdrum LM, 2004, J MOL DIAGN, V6, P42, DOI 10.1016/S1525-1578(10)60490-4; Hayes DF, 2006, J CLIN ONCOL, V24, P4056, DOI 10.1200/JCO.2006.07.5143; Hicks DG, 2005, HUM PATHOL, V36, P250, DOI 10.1016/j.humpath.2004.11.010; Murphy CG, 2010, ONCOLOGY-NY, V24, P410; Nahta R, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1612; Nunes CB, 2008, J CLIN PATHOL, V61, P934, DOI 10.1136/jcp.2007.053892; Paik S, 2002, JNCI-J NATL CANCER I, V94, P852, DOI 10.1093/jnci/94.11.852; Paik S, 2008, NEW ENGL J MED, V358, P1409, DOI 10.1056/NEJMc0801440; Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985; Pauletti G, 2000, J CLIN ONCOL, V18, P3651, DOI 10.1200/JCO.2000.18.21.3651; Perez EA, 2002, MAYO CLIN PROC, V77, P148; Perez EA, 2012, JNCI-J NATL CANCER I, V104, P159, DOI 10.1093/jnci/djr490; Razis E, 2011, BREAST CANCER RES TR, V128, P447, DOI 10.1007/s10549-011-1572-5; Robert N, 2006, J CLIN ONCOL, V24, P2786, DOI 10.1200/JCO.2005.04.1764; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Saini KS, 2011, BREAST, V20, pS20, DOI 10.1016/S0960-9776(11)70289-2; Scaltriti M, 2007, J NATL CANCER I, V99, P628, DOI 10.1093/jnci/djk134; Slamon D, 2001, SEMIN ONCOL, V28, P13, DOI 10.1053/sonc.2001.22812; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Thomson TA, 2001, MODERN PATHOL, V14, P1079, DOI 10.1038/modpathol.3880440; Tsang RY, 2012, BRIT J CANCER, V106, P6, DOI 10.1038/bjc.2011.516; Valero V, 2011, J CLIN ONCOL, V29, P149, DOI 10.1200/JCO.2010.28.6450; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.20.3.719; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002; Wludarski S, 2008, APPL IMMUNOHISTO M M, P466; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; ZABRECKY JR, 1991, J BIOL CHEM, V266, P1716	43	19	19	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e99131	10.1371/journal.pone.0099131	http://dx.doi.org/10.1371/journal.pone.0099131			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968015	Green Submitted, Green Published, gold			2022-12-27	WOS:000338280800009
J	Wang, CH; Chen, CL; More, SV; Hsiao, PW; Hung, WC; Li, WS				Wang, Chie-Hong; Chen, Chia-Ling; More, Shivaji V.; Hsiao, Pei-Wen; Hung, Wen-Chun; Li, Wen-Shan			The Tetraindole SK228 Reverses the Epithelial-to-Mesenchymal Transition of Breast Cancer Cells by Up-Regulating Members of the miR-200 Family	PLOS ONE			English	Article							E-CADHERIN; TRANSCRIPTIONAL REPRESSOR; ZEB1; MICRORNA; INVASIVENESS; EXPRESSION; INVASION; METASTASIS; TARGETS; GROWTH	The results of recent studies have shown that metastasis, the most common malignancy and primary cause of mortality promoted by breast cancer in women, is associated with the epithelial-to-mesenchymal transition (EMT). The results of the current study show that SK228, a novel indole containing substance, exhibits anti-cancer activity. In addition, the effects of SK228 on the regulation of EMT in breast cancer cells as well as the underlying mechanism have been explored. SK228 was observed to induce a fibroblastoid to epithelial-like change in the appearance of various breast cancer cell lines and to suppress the migration and invasion of these cancer cells in vitro. Moreover, expression of E-cadherin was found to increase following SK228 treatment whereas ZEB1 expression was repressed. Expression of other major EMT inducers, including ZEB2, Slug and Twist1, is also repressed by SK228 as a consequence of up-regulation of members of the miR-200 family, especially miR-200c. The results of animal studies demonstrate that SK228 treatment leads to effective suppression of breast cancer growth and metastasis in vivo. The observations made in this investigation show that SK228 reverses the EMT process in breast cancer cells via an effect on the miR-200c/ZEB1/E-cadherin signalling pathway. In addition, the results of a detailed analysis of the in vivo anti-cancer activities of SK228, carried out using a breast cancer xenograft animal model, show that this substance is a potential chemotherapeutic agent for the treatment of breast cancer.	[Wang, Chie-Hong; Chen, Chia-Ling; More, Shivaji V.; Li, Wen-Shan] Acad Sinica, Inst Chem, Taipei, Taiwan; [Wang, Chie-Hong] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung 80424, Taiwan; [Hung, Wen-Chun] Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan; [Hsiao, Pei-Wen] Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan; [Li, Wen-Shan] Natl Sun Yat Sen Univ, Doctoral Degree Program Marine Biotechnol, Kaohsiung 80424, Taiwan	Academia Sinica - Taiwan; National Sun Yat Sen University; National Health Research Institutes - Taiwan; Academia Sinica - Taiwan; National Sun Yat Sen University	Hung, WC (corresponding author), Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan.	hung1228@nhri.org.tw; wenshan@gate.sinica.edu.tw	Li, Wen-Shan/F-1972-2015; Hung, Wen-Chun/F-4846-2011; Hsiao, Pei-Wen/V-5653-2018	Li, Wen-Shan/0000-0002-8359-4582; Wang, Chie-Hong/0000-0003-0774-5323; Hsiao, Pei-Wen/0000-0002-3589-6754	Academia Sinica; National Science Council [101-2113-M-001-009-MY2]	Academia Sinica(Academia Sinica - Taiwan); National Science Council(Ministry of Science and Technology, Taiwan)	The authors are grateful for funding of this study provided by the Academia Sinica and the National Science Council (101-2113-M-001-009-MY2; http://web1.nsc.gov.tw/mp.aspx?mp=1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner K, 2007, ONCOGENE, V26, P6979, DOI 10.1038/sj.onc.1210508; Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Beaver LM, 2012, TOXICOL APPL PHARM, V263, P345, DOI 10.1016/j.taap.2012.07.007; Berx G, 1995, EMBO J, V14, P6107, DOI 10.1002/j.1460-2075.1995.tb00301.x; Blick T, 2010, J MAMMARY GLAND BIOL, V15, P235, DOI 10.1007/s10911-010-9175-z; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Casas E, 2011, CANCER RES, V71, P245, DOI 10.1158/0008-5472.CAN-10-2330; Cochrane DR, 2010, J ONCOL, V2010, DOI 10.1155/2010/821717; Cochrane DR, 2009, MOL CANCER THER, V8, P1055, DOI 10.1158/1535-7163.MCT-08-1046; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Guaita S, 2002, J BIOL CHEM, V277, P39209, DOI 10.1074/jbc.M206400200; Hajra KM, 2002, CANCER RES, V62, P1613; Hazan RB, 2000, J CELL BIOL, V148, P779, DOI 10.1083/jcb.148.4.779; Heldin CH, 2012, FEBS LETT, V586, P1959, DOI 10.1016/j.febslet.2012.02.037; Howe EN, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2867; Huang SM, 2012, INT J CANCER, V131, P722, DOI 10.1002/ijc.26401; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Jansson MD, 2012, MOL ONCOL, V6, P590, DOI 10.1016/j.molonc.2012.09.006; Korpal M, 2008, RNA BIOL, V5, P115, DOI 10.4161/rna.5.3.6558; Korsching E, 2005, J PATHOL, V206, P451, DOI 10.1002/path.1797; Li WS, 2012, J MED CHEM, V55, P1583, DOI 10.1021/jm2013425; Li YW, 2010, PHARM RES-DORDR, V27, P1027, DOI 10.1007/s11095-010-0105-y; Li YW, 2009, CANCER RES, V69, P6704, DOI 10.1158/0008-5472.CAN-09-1298; Lim YY, 2013, J CELL SCI, V126, P2256, DOI 10.1242/jcs.122275; NIETO MA, 1994, SCIENCE, V264, P835, DOI 10.1126/science.7513443; Oliveri P, 2008, P NATL ACAD SCI USA, V105, P5955, DOI 10.1073/pnas.0711220105; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Sarrio D, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-74; Siitonen SM, 1996, AM J CLIN PATHOL, V105, P394; Spaderna S, 2008, CANCER RES, V68, P537, DOI 10.1158/0008-5472.CAN-07-5682; Sreekumar Rahul, 2011, Frontiers in Genetics, V2, P58, DOI 10.3389/fgene.2011.00058; Takeyama Y, 2010, CANCER LETT, V296, P216, DOI 10.1016/j.canlet.2010.04.008; Tellez CS, 2011, CANCER RES, V71, P3087, DOI 10.1158/0008-5472.CAN-10-3035; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Wu W, 2010, DRUGS R&D, V10, P1, DOI 10.2165/11537800-000000000-00000	40	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e101088	10.1371/journal.pone.0101088	http://dx.doi.org/10.1371/journal.pone.0101088			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967704	Green Published, Green Submitted, gold			2022-12-27	WOS:000338280800106
J	Abdulmawjood, A; Grabowski, N; Fohler, S; Kittler, S; Nagengast, H; Klein, G				Abdulmawjood, Amir; Grabowski, Nils; Fohler, Svenja; Kittler, Sophie; Nagengast, Helga; Klein, Guenter			Development of Loop-Mediated Isothermal Amplification (LAMP) Assay for Rapid and Sensitive Identification of Ostrich Meat	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; SALMON SALMO-SALAR; LINKED-IMMUNOSORBENT-ASSAY; CYTOCHROME-B GENE; MITOCHONDRIAL-DNA; RFLP ANALYSIS; PCR; PRODUCTS	Animal species identification is one of the primary duties of official food control. Since ostrich meat is difficult to be differentiated macroscopically from beef, therefore new analytical methods are needed. To enforce labeling regulations for the authentication of ostrich meat, it might be of importance to develop and evaluate a rapid and reliable assay. In the present study, a loop-mediated isothermal amplification (LAMP) assay based on the cytochrome b gene of the mitochondrial DNA of the species Struthio camelus was developed. The LAMP assay was used in combination with a real-time fluorometer. The developed system allowed the detection of 0.01% ostrich meat products. In parallel, a direct swab method without nucleic acid extraction using the HYPLEX LPTV buffer was also evaluated. This rapid processing method allowed detection of ostrich meat without major incubation steps. In summary, the LAMP assay had excellent sensitivity and specificity for detecting ostrich meat and could provide a sampling-to-result identification-time of 15 to 20 minutes.	[Abdulmawjood, Amir; Grabowski, Nils; Fohler, Svenja; Kittler, Sophie; Nagengast, Helga; Klein, Guenter] Univ Vet Med, Inst Food Qual & Food Safety, Hannover, Germany	University of Veterinary Medicine Hannover, Foundation	Abdulmawjood, A (corresponding author), Univ Vet Med, Inst Food Qual & Food Safety, Hannover, Germany.	amir.abdulmawjood@tiho-hannover.de	Klein, Günter/G-5321-2013; Abdulmawjood, Amir/C-6083-2015; Grabowski, Nils Th. T/D-8542-2015; Abdulmawjood, Amir/AAL-5523-2020	Klein, Günter/0000-0003-1931-2701; Abdulmawjood, Amir/0000-0001-5189-8381; Grabowski, Nils Th. T/0000-0003-0440-9594; Woudstra, Svenja/0000-0003-4668-1799				Abdulmawjood A, 2012, MEAT SCI, V91, P272, DOI 10.1016/j.meatsci.2012.02.001; Abdulmawjood A, 2003, J FOOD SCI, V68, P1757, DOI 10.1111/j.1365-2621.2003.tb12324.x; Abdulmawjood A, 2002, J FOOD SCI, V67, P1688, DOI 10.1111/j.1365-2621.2002.tb08706.x; Abdulmawjood A, 2001, J FOOD SCI, V66, P1287, DOI 10.1111/j.1365-2621.2001.tb15203.x; Carney BL, 1997, CAN J FISH AQUAT SCI, V54, P940, DOI 10.1139/cjfas-54-4-940; Carrera E, 1996, J FOOD PROTECT, V59, P521, DOI 10.4315/0362-028X-59.5.521; Carrera E, 1998, J FOOD PROTECT, V61, P482, DOI 10.4315/0362-028X-61.4.482; Carrera E, 1999, ARCH LEBENSMITTELHYG, V50, P76; Cespedes A, 1999, J FOOD PROTECT, V62, P1178, DOI 10.4315/0362-028X-62.10.1178; Curtis KA, 2008, J VIROL METHODS, V151, P264, DOI 10.1016/j.jviromet.2008.04.011; D'Amato Maria Eugenia, 2013, Investig Genet, V4, P6, DOI 10.1186/2041-2223-4-6; Kiddle G, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-15; Kistner C, 2004, STRAUSSE ZUCHT HALTU; Niessen L, 2013, FOOD MICROBIOL, V36, P191, DOI 10.1016/j.fm.2013.04.017; Njiru ZK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001572; Ram JL, 1996, J AGR FOOD CHEM, V44, P2460, DOI 10.1021/jf950822t; Rigaa A, 1997, HEREDITY, V79, P380, DOI 10.1038/sj.hdy.6882370; Tartaglia M, 1998, J FOOD PROTECT, V61, P513, DOI 10.4315/0362-028X-61.5.513; WILSON AC, 1985, BIOL J LINN SOC, V26, P375, DOI 10.1111/j.1095-8312.1985.tb02048.x; Yoshizaki G, 1997, J FISH BIOL, V51, P193, DOI 10.1006/jfbi.1997.0428	20	61	65	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100717	10.1371/journal.pone.0100717	http://dx.doi.org/10.1371/journal.pone.0100717			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963709	gold, Green Published, Green Submitted			2022-12-27	WOS:000338709500074
J	Leite, RN; Kolokotronis, SO; Almeida, FC; Werneck, FP; Rogers, DS; Weksler, M				Leite, Rafael N.; Kolokotronis, Sergios-Orestis; Almeida, Francisca C.; Werneck, Fernanda P.; Rogers, Duke S.; Weksler, Marcelo			In the Wake of Invasion: Tracing the Historical Biogeography of the South American Cricetid Radiation (Rodentia, Sigmodontinae)	PLOS ONE			English	Article							LOWER MIOCENE COMMUNITIES; DISPERSAL-VICARIANCE ANALYSIS; BIOTIC INTERCHANGE; NEOTROPICAL PALEOBOTANY; MIDDLE MIOCENE; PHYLOGENETIC ESTIMATION; DIVERSIFICATION RATES; CENTRAL ARGENTINA; FAUNAL TURNOVER; MUROID RODENTS	The Great American Biotic Interchange (GABI) was greatly influenced by the completion of the Isthmus of Panama and impacted the composition of modern faunal assemblages in the Americas. However, the contribution of preceding events has been comparatively less explored, even though early immigrants in the fossil records are evidence for waif dispersals. The cricetid rodents of the subfamily Sigmodontinae are a classic example of a species-rich South American radiation resulting from an early episode of North American invasion. Here, we provide a temporal and spatial framework to address key aspects of the historical biogeography and diversification of this diverse mammal group by using mitochondrial and nuclear DNA datasets coupled with methods of divergence time estimation, ancestral area reconstruction and comparative phylogenetics. Relaxed-clock time estimates indicate that divergence of the Sigmodontinae began in the middle-late Miocene (ca. 12-9 Ma). Dispersal-vicariance analyses point to the arrival of a single lineage of northern invaders with a widespread ancestral distribution and imply that the initial differentiation between Central and South America gave rise to the most basal groups within the subfamily. These two major clades diversified in the late Miocene followed by the radiation of main tribes until the early Pliocene. Within the Oryzomyalia, tribes diverged initially in eastern South America whereas multiple dispersals into the Andes promoted further diversification of the majority of modern genera. A comparatively uniform background tempo of diversification explains the species richness of sigmodontines across most nodes, except for two akodontine genera with recent increases in diversification rates. The bridging of the Central American seaway and episodes of low sea levels likely facilitated the invasion of South America long before the onset of the post-Isthmian phase of the GABI.	[Leite, Rafael N.; Rogers, Duke S.] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA; [Leite, Rafael N.; Werneck, Fernanda P.] Inst Nacl de Pesquisas da Amazonia, Manaus, Amazonas, Brazil; [Kolokotronis, Sergios-Orestis] Fordham Univ, Dept Biol Sci, Bronx, NY 10458 USA; [Almeida, Francisca C.] Univ Barcelona, Dept Genet, Barcelona, Spain; [Rogers, Duke S.] Brigham Young Univ, Monte L Bean Life Sci Museum, Provo, UT 84602 USA; [Weksler, Marcelo] Univ Fed Estado Rio de Janeiro, Dept Zool, Rio De Janeiro, Brazil	Brigham Young University; Institute Nacional de Pesquisas da Amazonia; Fordham University; University of Barcelona; Brigham Young University; Universidade Federal do Estado do Rio de Janeiro	Leite, RN (corresponding author), Brigham Young Univ, Dept Biol, Provo, UT 84602 USA.	rnleite@gmail.com	Almeida, Francisca Cunha/E-5849-2016; Leite, Rafael N./O-1216-2013; Kolokotronis, Sergios-Orestis/GWM-5773-2022; Kolokotronis, Sergios-Orestis/A-1910-2009; Weksler, Marcelo/A-7420-2010; Werneck, Fernanda P./J-9629-2013	Almeida, Francisca Cunha/0000-0001-6003-4657; Leite, Rafael N./0000-0002-3945-1007; Kolokotronis, Sergios-Orestis/0000-0003-3309-8465; Kolokotronis, Sergios-Orestis/0000-0003-3309-8465; Weksler, Marcelo/0000-0001-8111-4779; Werneck, Fernanda P./0000-0002-8779-2607	CAPES [BEX 1861/07-7]; BYU Graduate Student Society; Julia Greenwell scholarship from the College of Life Sciences; Monte L. Bean Life Science Museum; American Society of Mammalogists; Idea Wild; CNPq [BJT-374307/2012-1, 481286/2011-0]; FCA to the Juan de la Cierva Fellowship, Ministry of Science and Innovation; FAPERJ [E-26/110.505/2012, E-26/101.950/2012]; National Science Foundation (NSF) [DDIG/DEB1115208]	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); BYU Graduate Student Society; Julia Greenwell scholarship from the College of Life Sciences; Monte L. Bean Life Science Museum; American Society of Mammalogists; Idea Wild; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FCA to the Juan de la Cierva Fellowship, Ministry of Science and Innovation; FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); National Science Foundation (NSF)(National Science Foundation (NSF))	RNL was supported by CAPES (BEX 1861/07-7), BYU Graduate Student Society, Julia Greenwell scholarship from the College of Life Sciences, Monte L. Bean Life Science Museum, American Society of Mammalogists Grants-in-Aid, and Idea Wild. FPW is thankful to CNPq's Science Without Borders Program (BJT-374307/2012-1) and FCA to the Juan de la Cierva Fellowship, Ministry of Science and Innovation. MW was supported by FAPERJ (E-26/110.505/2012 and E-26/101.950/2012) and CNPq (481286/2011-0). Additional support was provided to RNL and DSR from the National Science Foundation (NSF) (DDIG/DEB1115208). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alfaro ME, 2009, P NATL ACAD SCI USA, V106, P13410, DOI 10.1073/pnas.0811087106; Ali JR, 2012, J BIOGEOGR, V39, P431, DOI 10.1111/j.1365-2699.2011.02674.x; Almeida FC, 2007, MOL PHYLOGENET EVOL, V42, P449, DOI 10.1016/j.ympev.2006.07.005; Almendra Ana Laura, 2012, P203; Bacon CD, 2013, BOT J LINN SOC, V171, P287, DOI 10.1111/j.1095-8339.2012.01281.x; BASKIN JA, 1978, J MAMMAL, V59, P125, DOI 10.2307/1379882; Battistuzzi FU, 2010, MOL BIOL EVOL, V27, P1289, DOI 10.1093/molbev/msq014; Bermingham E, 1998, MOL ECOL, V7, P499, DOI 10.1046/j.1365-294x.1998.00358.x; Burnham RJ, 1999, ANN MO BOT GARD, V86, P546, DOI 10.2307/2666185; Campbell KE, 2010, J S AM EARTH SCI, V29, P619, DOI 10.1016/j.jsames.2009.11.007; Carleton Michael D., 1999, American Museum Novitates, V3256, P1; Cione Alberto L., 2007, Asociacion Paleontologica Argentina Publicacion Especial, V11, P257; Coates AG, 2004, GEOL SOC AM BULL, V116, P1327, DOI 10.1130/B25275.1; COATES AG, 1992, GEOL SOC AM BULL, V104, P814, DOI 10.1130/0016-7606(1992)104<0814:COTIOP>2.3.CO;2; Cody S, 2010, ECOGRAPHY, V33, P326, DOI 10.1111/j.1600-0587.2010.06327.x; Cole M., 1986, SAVANNAS BIOGEOGRAPH; COLINVAUX P, 1997, CENTRAL AM NATURAL C, P123; Collins LS, 1996, GEOLOGY, V24, P687, DOI 10.1130/0091-7613(1996)024<0687:TLMPIS>2.3.CO;2; Cusimano N, 2010, SYST BIOL, V59, P458, DOI 10.1093/sysbio/syq032; D'Elia G, 2003, CLADISTICS, V19, P307, DOI 10.1016/S0748-3007(03)00071-9; D'Elía Guillermo, 2007, Gayana (Concepc.), V71, P187; Da Silva JMC, 2002, BIOSCIENCE, V52, P225, DOI 10.1641/0006-3568(2002)052[0225:BPACIT]2.0.CO;2; DEBRUIJN H, 1970, PROC K NED AKAD B-PH, V73, P535; deGamero MLD, 1996, PALAEOGEOGR PALAEOCL, V123, P385, DOI 10.1016/0031-0182(96)00115-0; Dowler RC, 2000, ORYX, V34, P109, DOI 10.1046/j.1365-3008.2000.00104.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; DUQUECARO H, 1990, PALAEOGEOGR PALAEOCL, V77, P203, DOI 10.1016/0031-0182(90)90178-A; Engel SR, 1998, MOL BIOL EVOL, V15, P35, DOI 10.1093/oxfordjournals.molbev.a025845; Fabre PH, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-88; Farris DW, 2011, GEOLOGY; Felsenstein J, 1996, MOL BIOL EVOL, V13, P93, DOI 10.1093/oxfordjournals.molbev.a025575; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Freudenthal Matthijs, 1998, Treballs del Museu de Geologia de Barcelona, V7, P11; GRAHAM A, 1988, ANN MO BOT GARD, V75, P1467, DOI 10.2307/2399296; GRAHAM A, 1988, ANN MO BOT GARD, V75, P1440, DOI 10.2307/2399295; GRAHAM A, 1989, ANN MO BOT GARD, V76, P50, DOI 10.2307/2399342; GRAHAM A, 1987, AM J BOT, V74, P1519, DOI 10.2307/2444046; Graham A, 1997, SYST BOT, V22, P139, DOI 10.2307/2419682; HAQ BU, 1987, SCIENCE, V235, P1156, DOI 10.1126/science.235.4793.1156; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; HERSHKOVITZ P, 1969, Q REV BIOL, V44, P1, DOI 10.1086/405975; Hershkovitz P, 1966, PARASITES PANAMA, P725; HIRSCHFELD SE, 1976, J PALEONTOL, V50, P433; Ho SYW, 2009, SYST BIOL, V58, P367, DOI 10.1093/sysbio/syp035; HOORN C, 1995, GEOLOGY, V23, P237, DOI 10.1130/0091-7613(1995)023<0237:ATAACF>2.3.CO;2; Iturralde-Vinent MA, 1999, B AM MUS NAT HIST, P1; Jacobs LL, 1984, J VERTEBR PALEONTOL, V55, P265; Jansa SA, 2004, MOL PHYLOGENET EVOL, V31, P256, DOI 10.1016/j.ympev.2003.07.002; Janssen T, 2004, BOT J LINN SOC, V146, P385, DOI 10.1111/j.1095-8339.2004.00345.x; John CM, 2011, EARTH PLANET SC LETT, V304, P455, DOI 10.1016/j.epsl.2011.02.013; John CM, 2004, GEOLOGY, V32, P829, DOI 10.1130/G20580.1; Jombart T, 2010, BIOINFORMATICS, V26, P1907, DOI 10.1093/bioinformatics/btq292; Kelt DA, 2010, J MAMMAL, V91, P1524, DOI 10.1644/10-MAMM-A-306.1; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kirby MX, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002791; Kirby MX, 2005, PALAEOGEOGR PALAEOCL, V228, P193, DOI 10.1016/j.palaeo.2005.06.002; Korth W.W., 1994, TERTIARY RECORD RODE; MARSHALL LG, 1982, SCIENCE, V215, P1351, DOI 10.1126/science.215.4538.1351; MARSHALL LG, 1979, PALEOBIOLOGY, V5, P126, DOI 10.1017/S0094837300006412; MARSHALL LG, 1988, AM SCI, V76, P380; Martinez JJ, 2012, ACTA THERIOL, V57, P277, DOI 10.1007/s13364-011-0070-9; Maslin MA, 1998, QUATERNARY SCI REV, V17, P411, DOI 10.1016/S0277-3791(97)00047-4; McCafferty WP, 1998, J N AM BENTHOL SOC, V17, P1, DOI 10.2307/1468048; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; Montes C, 2012, GEOL SOC AM BULL, V124, P780, DOI 10.1130/B30528.1; Montes C, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB008959; Morgan G, 2005, IDEA OF A EUROPEAN SUPERSTATE: PUBLIC JUSTIFICATION AND EUROPEAN INTEGRATION, P45; Musser GG, 2005, MAMMAL SPECIES WORLD, P1; Nasif Norma L., 2009, Ser. correl. geol., V25, P105; Pacheco V, 2003, PHYLOGENETIC ANAL TH; Parada A, 2013, MOL PHYLOGENETICS EV; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paradis E, 2006, ANAL PHYLOGENETICS E; PATTERSON B, 1968, Q REV BIOL, V43, P409, DOI 10.1086/405916; Porter ML, 2005, MOL PHYLOGENET EVOL, V37, P355, DOI 10.1016/j.ympev.2005.06.021; Poux C, 2006, SYST BIOL, V55, P228, DOI 10.1080/10635150500481390; Prevosti FJ, 2009, PALAEOGEOGR PALAEOCL, V280, P543, DOI 10.1016/j.palaeo.2009.05.021; R Development Core Team, 2012, R LANG ENV STAT COMP; Rabosky DL, 2006, EVOL BIOINFORM, V2, P247; Rambaut A., 2007, TRACE 1 4; Reig O.A., 1981, Monographiae Naturae, P1; Reig O.A., 1978, Publicaciones del Museo Municipal de Ciencias Naturales "Lorenzo Scaglia", V2, P164; REIG OA, 1980, J ZOOL, V192, P257; REIG OA, 1984, REV BRAS GENET, V7, P333; Reig OA, 1975, ACTA CIENT VENEZ, V26, P7; Retallack GJ, 2007, PALAIOS, V22, P667, DOI 10.2110/palo.2006.p06-130r; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Pinto-Sanchez NR, 2012, MOL PHYLOGENET EVOL, V62, P954, DOI 10.1016/j.ympev.2011.11.022; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Ronquist F, 1997, SYST BIOL, V46, P195, DOI 10.2307/2413643; Rowe DL, 2010, J BIOGEOGR, V37, P305, DOI 10.1111/j.1365-2699.2009.02190.x; Sarmiento G., 1975, J BIOGEOGR, V2, P233, DOI DOI 10.2307/3037998; SARMIENTO G., 1976, EVOLUTION DESERT BIO, P65; Savage J.M., 1974, Contributions Sci, VNo. 260, P1; Schenk JJ, 2013, SYST BIOL, V62, P837, DOI 10.1093/sysbio/syt050; Simpson G. G., 1969, BIOGEOGRAPHY ECOLOGY, V19, P879; SIMPSON GEORGE GAYLORD, 1950, AMER SCIENTIST, V38, P361; Smith BT, 2010, ECOGRAPHY, V33, P333, DOI 10.1111/j.1600-0587.2009.06335.x; Smith MF, 1999, BIOL J LINN SOC, V50, P149; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stehli F. G, 1985, GREAT AM BIOTIC INTE; Steppan SJ, 2004, SYST BIOL, V53, P533, DOI 10.1080/10635150490468701; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thorne JL, 2002, SYST BIOL, V51, P689, DOI 10.1080/10635150290102456; Tomassini RL, 2013, J S AM EARTH SCI, V48, P31, DOI 10.1016/j.jsames.2013.08.002; Turvey ST, 2012, MAMM BIOL, V77, P404, DOI 10.1016/j.mambio.2012.03.005; Upham NS, 2012, MOL PHYLOGENET EVOL, V63, P417, DOI 10.1016/j.ympev.2012.01.020; Vanzolini P.E., 1985, Topics in Geobiology, V4, P475; Verzi DH, 2008, PALAEOGEOGR PALAEOCL, V267, P284, DOI 10.1016/j.palaeo.2008.07.003; Vilela JF, 2013, J ZOOLOGICAL SYSTEMA; Voss Robert S., 1993, American Museum Novitates, V3073, P1; VRBA ES, 1992, J MAMMAL, V73, P1, DOI 10.2307/1381862; WEBB S D, 1976, Paleobiology, V2, P220; Webb SD, 2006, ANN MO BOT GARD, V93, P245; WEBB SD, 1991, PALEOBIOLOGY, V17, P266, DOI 10.1017/S0094837300010605; WEBB SD, 1978, ANNU REV ECOL SYST, V9, P393, DOI 10.1146/annurev.es.09.110178.002141; Weir JT, 2009, P NATL ACAD SCI USA, V106, P21737, DOI 10.1073/pnas.0903811106; Weksler M, 2003, MOL PHYLOGENET EVOL, V29, P331, DOI 10.1016/S1055-7903(03)00132-5; WHITMORE FC, 1965, SCIENCE, V148, P180, DOI 10.1126/science.148.3667.180; Woodburne M.O., 2006, ADV LATE TERTIARY VE, V4, P73; Woodburne MO, 2010, J MAMM EVOL, V17, P245, DOI 10.1007/s10914-010-9144-8; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Yu Y., 2013, RASP RECONSTRUCT ANC; Yu Y, 2010, MOL PHYLOGENET EVOL, V56, P848, DOI 10.1016/j.ympev.2010.04.011; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zeh JA, 2003, MOL ECOL, V12, P2759, DOI 10.1046/j.1365-294X.2003.01914.x	129	57	64	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100687	10.1371/journal.pone.0100687	http://dx.doi.org/10.1371/journal.pone.0100687			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963664	Green Submitted, Green Published, gold			2022-12-27	WOS:000338709500073
J	Brambila-Tapia, AJL; Armenta-Medina, D; Rivera-Gomez, N; Perez-Rueda, E				Leticia Brambila-Tapia, Aniel Jessica; Armenta-Medina, Dagoberto; Rivera-Gomez, Nancy; Perez-Rueda, Ernesto			Main Functions and Taxonomic Distribution of Virulence Genes in Brucella melitensis 16 M	PLOS ONE			English	Article							B-MELITENSIS; MICE; MUTANTS; MUTAGENESIS; INFECTION; SURVIVAL; IDENTIFICATION; PERSISTENCE; EXPRESSION; PATHOGEN	Many virulence genes have been detected in attenuated mutants of Brucella melitensis 16 M; nevertheless, a complete report of these genes, including the main Cluster of Orthologous Groups (COG) represented as well as the taxonomical distribution among all complete bacterial and archaeal genomes, has not been analyzed. In this work a total of 160 virulence genes that have been reported in attenuated mutants in B. melitensis were included and analyzed. Additionally, we obtained 250 B. melitensis randomly selected genes as a reference group for the taxonomical comparisons. The COGs and the taxonomical distribution profile for 789 nonredundant bacterial and archaeal genomes were obtained and compared with the whole-genome COG distribution and with the 250 randomly selected genes, respectively. The main COGs associated with virulence genes corresponded to the following: intracellular trafficking, secretion and vesicular transport (U); cell motility (N); nucleotide transport and metabolism (F); transcription (K); and cell wall/membrane/envelope biogenesis (M). In addition, we found that virulence genes presented a higher proportion of orthologs in the Euryarchaeota and Proteobacteria phyla, with a significant decrease in Chlamydiae, Bacteroidetes, Tenericutes, Firmicutes and Thermotogae. In conclusion, we found that genes related to specific functions are more relevant to B. melitensis virulence, with the COG U the most significant. Additionally, the taxonomical distribution of virulence genes highlights the importance of these genes in the related Proteobacteria, being less relevant in distant groups of organisms with the exception of Euryarchaeota.	[Leticia Brambila-Tapia, Aniel Jessica; Armenta-Medina, Dagoberto; Rivera-Gomez, Nancy; Perez-Rueda, Ernesto] Univ Nacl Autonoma Mexico, Dept Ingn Celular & Biocatalisis, Inst Biotecnol, Cuernavaca 62191, Morelos, Mexico	Universidad Nacional Autonoma de Mexico	Brambila-Tapia, AJL (corresponding author), Univ Nacl Autonoma Mexico, Dept Ingn Celular & Biocatalisis, Inst Biotecnol, Cuernavaca 62191, Morelos, Mexico.	anieljessica@hotmail.com; erueda@ibt.unam.mx	Brambila-Tapia, Aniel Jessica Leticia/AAG-8886-2020; Perez-Rueda, Ernesto/D-7468-2016	Perez-Rueda, Ernesto/0000-0002-6879-0673; Brambila-Tapia, Aniel Jessica Leticia/0000-0002-6455-3662	Consejo Nacional de Ciencia y Tecnologia (CONACYT); DGAPA-UNAM [IN-204714]; CONACYT [155116]	Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); DGAPA-UNAM(Universidad Nacional Autonoma de Mexico); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The authors thank the Consejo Nacional de Ciencia y Tecnologia (CONACYT) for the postdoctoral scholarship granted to A.J.L. Brambila-Tapia. Support from DGAPA-UNAM (IN-204714) and CONACYT (155116) is also gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldi Pablo C, 2013, Recent Pat Antiinfect Drug Discov, V8, P18; Crawford RM, 1996, INFECT IMMUN, V64, P2188, DOI 10.1128/IAI.64.6.2188-2192.1996; De Iannino NI, 1998, J BACTERIOL, V180, P4392; Delory M, 2006, J BACTERIOL, V188, P7707, DOI 10.1128/JB.00644-06; Dokuzoguz B, 2005, J INFECTION, V50, P41, DOI 10.1016/j.jinf.2004.02.005; Edmonds MD, 2002, VET MICROBIOL, V88, P205, DOI 10.1016/S0378-1135(02)00110-4; Fretin D, 2005, CELL MICROBIOL, V7, P687, DOI 10.1111/j.1462-5822.2005.00502.x; Guzman-Verri C, 2002, P NATL ACAD SCI USA, V99, P12375, DOI 10.1073/pnas.192439399; Haine V, 2006, J BACTERIOL, V188, P1615, DOI 10.1128/JB.188.4.1615-1619.2006; Haine V, 2005, INFECT IMMUN, V73, P5578, DOI 10.1128/IAI.73.9.5578-5586.2005; He YQ, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00002; Janga SC, 2004, NUCLEIC ACIDS RES, V32, P5392, DOI 10.1093/nar/gkh882; Lestrate P, 2000, MOL MICROBIOL, V38, P543, DOI 10.1046/j.1365-2958.2000.02150.x; Lestrate P, 2003, INFECT IMMUN, V71, P7053, DOI 10.1128/IAI.71.12.7053-7060.2003; LeVier K, 2000, SCIENCE, V287, P2492, DOI 10.1126/science.287.5462.2492; Mirabella A, 2012, MICROBIOL-SGM, V158, P2642, DOI 10.1099/mic.0.060863-0; Nijskens C, 2008, MICROB PATHOGENESIS, V45, P134, DOI 10.1016/j.micpath.2008.04.005; Novichkov PS, 2004, J BACTERIOL, V186, P6575, DOI 10.1128/JB.186.19.6575-6585.2004; Petersen E, 2011, J BACTERIOL, V193, P5683, DOI 10.1128/JB.00428-11; Rajashekara G, 2006, INFECT IMMUN, V74, P2925, DOI 10.1128/IAI.74.5.2925-2936.2006; Rajashekara G, 2008, J BACTERIOL, V190, P6243, DOI 10.1128/JB.00520-08; Rarnbow-Larsen AA, 2008, J BACTERIOL, V190, P3274, DOI 10.1128/JB.01915-07; Troy SB, 2005, MEDICINE, V84, P174, DOI 10.1097/01.md.0000165659.20988.25; Uzureau S, 2007, J BACTERIOL, V189, P6035, DOI 10.1128/JB.00265-07; Uzureau S, 2010, J PROTEOME RES, V9, P3200, DOI 10.1021/pr100068p; Wang Z, 2013, CLIN VACCINE IMMUNOL, V20, P174, DOI 10.1128/CVI.00573-12; Wu QM, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-102; Zhang XL, 2009, INT J BIOL SCI, V5, P570; Zygmunt MS, 2006, MICROBES INFECT, V8, P2849, DOI 10.1016/j.micinf.2006.09.002	29	10	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100349	10.1371/journal.pone.0100349	http://dx.doi.org/10.1371/journal.pone.0100349			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964015	gold, Green Submitted, Green Published			2022-12-27	WOS:000338709500041
J	Utter, B; Deutsch, DR; Schuch, R; Winer, BY; Verratti, K; Bishop-Lilly, K; Sozhamannan, S; Fischetti, VA				Utter, Bryan; Deutsch, Douglas R.; Schuch, Raymond; Winer, Benjamin Y.; Verratti, Kathleen; Bishop-Lilly, Kim; Sozhamannan, Shanmuga; Fischetti, Vincent A.			Beyond the Chromosome: The Prevalence of Unique Extra-Chromosomal Bacteriophages with Integrated Virulence Genes in Pathogenic Staphylococcus aureus	PLOS ONE			English	Article							CHEMOTAXIS INHIBITORY PROTEIN; BACILLUS-ANTHRACIS; MOLECULAR CHARACTERIZATION; COMPLEMENT INHIBITOR; GENOMIC ANALYSIS; IMMUNE EVASION; PHAGE; EXPRESSION; EVOLUTION; TRANSDUCTION	In Staphylococcus aureus, the disease impact of chromosomally integrated prophages on virulence is well described. However, the existence of extra-chromosomal prophages, both plasmidial and episomal, remains obscure. Despite the recent explosion in bacterial and bacteriophage genomic sequencing, studies have failed to specifically focus on extra-chromosomal elements. We selectively enriched and sequenced extra-chromosomal DNA from S. aureus isolates using Roche-454 technology and uncovered evidence for the widespread distribution of multiple extra-chromosomal prophages (ExP Phi s) throughout both antibiotic-sensitive and -resistant strains. We completely sequenced one such element comprised of a 43.8 kbp, circular ExP Phi (designated Phi BU01) from a vancomycin-intermediate S. aureus (VISA) strain. Assembly and annotation of Phi BU01 revealed a number of putative virulence determinants encoded within a bacteriophage immune evasion cluster (IEC). Our identification of several potential ExP Phi s and mobile genetic elements (MGEs) also revealed numerous putative virulence factors and antibiotic resistance genes. We describe here a previously unidentified level of genetic diversity of stealth extra-chromosomal elements in S. aureus, including phages with a larger presence outside the chromosome that likely play a prominent role in pathogenesis and strain diversity driven by horizontal gene transfer (HGT).	[Utter, Bryan; Deutsch, Douglas R.; Schuch, Raymond; Winer, Benjamin Y.; Fischetti, Vincent A.] Rockefeller Univ, Lab Bacterial Pathogenesis & Immunol, New York, NY 10021 USA; [Verratti, Kathleen; Bishop-Lilly, Kim; Sozhamannan, Shanmuga] Henry M Jackson Fdn, Bethesda, MD USA; [Verratti, Kathleen; Bishop-Lilly, Kim; Sozhamannan, Shanmuga] Naval Med Res Ctr Frederick, Ft Detrick, MD USA	Rockefeller University; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; Naval Medical Research Center (NMRC)	Utter, B (corresponding author), Rockefeller Univ, Lab Bacterial Pathogenesis & Immunol, 1230 York Ave, New York, NY 10021 USA.	butter@rockefeller.edu	Sozhamannan, Shanmuga/AGF-2410-2022; Sozhamannan, Shanmuga/AAN-7809-2020	Sozhamannan, Shanmuga/0000-0002-6762-7874; Winer, Benjamin/0000-0001-7895-2544	USPHS [AI-057472]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI070084, R01AI057472] Funding Source: NIH RePORTER	USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by USPHS grant AI-057472 to VAF from the National Institute of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bae T, 2006, MOL MICROBIOL, V62, P1035, DOI 10.1111/j.1365-2958.2006.05441.x; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; BETLEY MJ, 1985, SCIENCE, V229, P185, DOI 10.1126/science.3160112; Bokarewa MI, 2006, INT J BIOCHEM CELL B, V38, P504, DOI 10.1016/j.biocel.2005.07.005; Bonilla CY, 2012, J BACTERIOL, V194, P5110, DOI 10.1128/JB.00958-12; Cao R, 2012, APPL ENVIRON MICROB, V78, P4942, DOI 10.1128/AEM.00803-12; Casjens S, 2003, MOL MICROBIOL, V49, P277, DOI 10.1046/j.1365-2958.2003.03580.x; Casjens S, 2000, MOL MICROBIOL, V35, P490, DOI 10.1046/j.1365-2958.2000.01698.x; CHINAULT AC, 1979, GENE, V5, P111; Chung M, 2000, MICROB DRUG RESIST, V6, P189, DOI 10.1089/mdr.2000.6.189; de Haas CJC, 2004, J EXP MED, V199, P687, DOI 10.1084/jem.20031636; Euler CW, REVERSAL MUTAT UNPUB; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Gilmer DB, 2013, ANTIMICROB AGENTS CH, V57, P2743, DOI 10.1128/AAC.02526-12; Goerke C, 2004, J INFECT DIS, V189, P724, DOI 10.1086/381502; Goerke C, 2006, MOL MICROBIOL, V61, P1673, DOI 10.1111/j.1365-2958.2006.05354.x; Han CS, 2006, J BACTERIOL, V188, P3382, DOI 10.1128/JB.188.9.3382-3390.2006; Haraldsen JD, 2003, MOL MICROBIOL, V48, P811, DOI 10.1046/j.1365-2958.2003.03471.x; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; IKEDA H, 1968, COLD SPRING HARB SYM, V33, P791, DOI 10.1101/SQB.1968.033.01.091; Kahankova J, 2010, ENVIRON MICROBIOL, V12, P2527, DOI 10.1111/j.1462-2920.2010.02226.x; Kaneko J, 1998, GENE, V215, P57, DOI 10.1016/S0378-1119(98)00278-9; Kiel JL, 2008, FOLIA MICROBIOL, V53, P472, DOI 10.1007/s12223-008-0074-2; KIRBY JE, 1994, J BACTERIOL, V176, P2068, DOI 10.1128/jb.176.7.2068-2081.1994; Klumpp Jochen, 2012, Bacteriophage, V2, P190; Kos VN, 2012, MBIO, V3, DOI 10.1128/mBio.00112-12; KUNKEL B, 1990, GENE DEV, V4, P525, DOI 10.1101/gad.4.4.525; Kwan T, 2005, P NATL ACAD SCI USA, V102, P5174, DOI 10.1073/pnas.0501140102; Lawrence JG, 2001, TRENDS MICROBIOL, V9, P535, DOI 10.1016/S0966-842X(01)02198-9; Lindsay JA, 1998, MOL MICROBIOL, V29, P527, DOI 10.1046/j.1365-2958.1998.00947.x; Lindsay JA, 2004, TRENDS MICROBIOL, V12, P378, DOI 10.1016/j.tim.2004.06.004; Lindsay Jodi A., 2006, Functional & Integrative Genomics, V6, P186, DOI 10.1007/s10142-005-0019-7; Liu L, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/251364; LOCHHEAD AG, 1952, J BACTERIOL, V63, P219, DOI 10.1128/JB.63.2.219-226.1952; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Matos RC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003539; McCarthy AJ, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00006; McCarthy AJ, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-104; Mobberley JM, 2008, J VIROL, V82, P6618, DOI 10.1128/JVI.00140-08; Moore PCL, 2001, J CLIN MICROBIOL, V39, P2760, DOI 10.1128/JCM.39.8.2760-2767.2001; Read TD, 2000, NUCLEIC ACIDS RES, V28, P1397, DOI 10.1093/nar/28.6.1397; Rokop ME, 2004, MOL MICROBIOL, V52, P1757, DOI 10.1111/j.1365-2958.2004.04091.x; Romero P, 2009, J BACTERIOL, V191, P4854, DOI 10.1128/JB.01272-08; Rooijakkers SHM, 2005, NAT IMMUNOL, V6, P920, DOI 10.1038/ni1235; Rooijakkers SHM, 2006, CELL MICROBIOL, V8, P1282, DOI 10.1111/j.1462-5822.2006.00709.x; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Scharn CR, 2013, ANTIMICROB AGENTS CH, V57, P5233, DOI 10.1128/AAC.01058-13; Schuch R, 2006, J BACTERIOL, V188, P3037, DOI 10.1128/JB.188.8.3037-3051.2006; Schuch R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006532; Shambrook J, 2001, MOL CLONING LAB MANU; Shearer JES, 2011, G3-GENES GENOM GENET, V1, P581, DOI 10.1534/g3.111.000760; Sozhamannan S, 2008, APPL ENVIRON MICROB, V74, P6792, DOI 10.1128/AEM.01124-08; Tao LA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000888; THORNE CB, 1968, BACTERIOL REV, V32, P358, DOI 10.1128/MMBR.32.4_Pt_1.358-361.1968; van Wamel WJB, 2006, J BACTERIOL, V188, P1310, DOI 10.1128/JB.188.4.1310-1315.2006; VERA T, 1968, AM J VET RES, V29, P1059; WALKER DH, 1976, J VIROL, V19, P271, DOI 10.1128/JVI.19.1.271-274.1976; Xia GQ, 2014, INFECT GENET EVOL, V21, P593, DOI 10.1016/j.meegid.2013.04.022; Zabala B, 2009, APPL ENVIRON MICROB, V75, P1697, DOI 10.1128/AEM.01995-08	61	31	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100502	10.1371/journal.pone.0100502	http://dx.doi.org/10.1371/journal.pone.0100502			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963913	gold, Green Published, Green Submitted			2022-12-27	WOS:000338709500058
J	Yu, CJ; Fan, LL; Wu, Q; Fu, KH; Gao, SG; Wang, M; Gao, JX; Li, YQ; Chen, J				Yu, Chuanjin; Fan, Lili; Wu, Qiong; Fu, Kehe; Gao, Shigang; Wang, Meng; Gao, Jinxin; Li, Yaqian; Chen, Jie			Biological Role of Trichoderma harzianum-Derived Platelet-Activating Factor Acetylhydrolase (PAF-AH) on Stress Response and Antagonism	PLOS ONE			English	Article							PROTEOMIC ANALYSIS; GENE-EXPRESSION; BIOCONTROL; A(2)	We investigated the properties of platelet-activating factor acetylhydrolase (PAF-AH) derived from Trichoderma harzianum. The enzyme, comprised of 572 amino acids, shares high homology with PAF-AH proteins from T. koningii and other microbial species. The optimum enzymatic activity of PAF-AH occurred at pH 6 in the absence of Ca2+ and it localized in the cytoplasm, and we observed the upregulation of PAF-AH expression in response to carbon starvation and strong heat shock. Furthermore, PAF-AH knockout transformant growth occurred more slowly than wild type cells and over-expression strains grown in SM medium at 37 degrees C and 42 degrees C. In addition, PAF-AH expression significantly increased under a series of maize root induction assay. Eicosanoic acid and ergosterol levels decreased in the PAF-AH knockouts compared to wild type cells, as revealed by GC/MS analysis. We also determined stress responses mediated by PAF-AH were related to proteins HEX1, Cu/Zn superoxide dismutase, and cytochrome c. Finally, PAF-AH exhibited antagonistic activity against Rhizoctonia solani in plate confrontation assays. Our results indicate PAF-AH may play an important role in T. harzianum stress response and antagonism under diverse environmental conditions.	[Yu, Chuanjin; Fan, Lili; Wu, Qiong; Fu, Kehe; Gao, Shigang; Wang, Meng; Gao, Jinxin; Li, Yaqian; Chen, Jie] Shanghai Jiao Tong Univ, Sch Agr & Biol, Dept Resource & Environm Sci, Shanghai 200030, Peoples R China; [Yu, Chuanjin; Fan, Lili; Wu, Qiong; Fu, Kehe; Gao, Shigang; Wang, Meng; Gao, Jinxin; Li, Yaqian; Chen, Jie] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Chen, J (corresponding author), Shanghai Jiao Tong Univ, Sch Agr & Biol, Dept Resource & Environm Sci, Shanghai 200030, Peoples R China.	jiechen59@gmail.com	Gao, Jinxin/AAG-8521-2020	Gao, Jinxin/0000-0001-5429-7442	National Natural Science Foundation of China [30971949, 31270155, 31171798]; China Agriculture Research System Project [CARS-02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Agriculture Research System Project	The work was supported by a grant from the National Natural Science Foundation of China ( Nos. 30971949, 31270155, 31171798) and China Agriculture Research System Project (CARS-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu IA, 2010, BBA-PROTEINS PROTEOM, V1804, P263, DOI 10.1016/j.bbapap.2009.11.005; Agbagwa IO, 2012, GENET MOL RES, V11, P4632, DOI 10.4238/2012.September.14.1; Ait-Lahsen H, 2001, APPL ENVIRON MICROB, V67, P5833, DOI 10.1128/AEM.67.12.5833-5839.2001; Basu S, 2010, MOL CELLS, V30, P383, DOI 10.1007/s10059-010-0157-1; Benitez T, 2004, INT MICROBIOL, V7, P249; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Dan P, 2012, EUR J PHARMACOL, V691, P1, DOI 10.1016/j.ejphar.2012.07.023; Druzhinina IS, 2011, NAT REV MICROBIOL, V9, P749, DOI 10.1038/nrmicro2637; Dubey MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036152; Foulks JM, 2008, FREE RADICAL BIO MED, V45, P434, DOI 10.1016/j.freeradbiomed.2008.04.034; Fu KH, 2012, MICROBIOL RES, V167, P536, DOI 10.1016/j.micres.2012.02.002; Harman GE, 2004, NAT REV MICROBIOL, V2, P43, DOI 10.1038/nrmicro797; Jeffries TW, 2000, ADV APPL MICROBIOL, V47, P221, DOI 10.1016/S0065-2164(00)47006-1; Karasawa K, 2006, BBA-MOL CELL BIOL L, V1761, P1359, DOI 10.1016/j.bbalip.2006.06.017; Kirschnek S, 2006, INFECT IMMUN, V74, P850, DOI 10.1128/IAI.74.2.850-860.2006; Kono N, 2008, J BIOL CHEM, V283, P1628, DOI 10.1074/jbc.M708622200; Kudo I, 2002, PROSTAG OTH LIPID M, V68-9, P3, DOI 10.1016/S0090-6980(02)00020-5; Kunitake E, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-46; Leslie CC, 1997, J BIOL CHEM, V272, P16709, DOI 10.1074/jbc.272.27.16709; Lindner SC, 2009, J LEUKOCYTE BIOL, V86, P389, DOI 10.1189/jlb.1008591; Liu JD, 2013, J APPL MICROBIOL, V114, P482, DOI 10.1111/jam.12046; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Montero-Barrientos M, 2008, FUNGAL GENET BIOL, V45, P1506, DOI 10.1016/j.fgb.2008.09.003; Moretti-Almeida G, 2013, FEBS LETT; Nakahama T, 2010, FUNGAL GENET BIOL, V47, P318, DOI 10.1016/j.fgb.2009.12.011; Nakayashiki H, 2005, FUNGAL GENET BIOL, V42, P275, DOI 10.1016/j.fgb.2005.01.002; Parti RP, 2010, AM J RESP CELL MOL, V42, P415, DOI 10.1165/rcmb.2009-0110OC; Pliego C, 2009, FUNGAL GENET BIOL, V46, P137, DOI 10.1016/j.fgb.2008.11.009; Rohrich CR, 2013, CHEM BIODIVERS, V10, P787, DOI 10.1002/cbdv.201200339; Shoresh M, 2010, ANNU REV PHYTOPATHOL, V48, P21, DOI 10.1146/annurev-phyto-073009-114450; Sobhanian H, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-19; Soragni E, 2001, EMBO J, V20, P5079, DOI 10.1093/emboj/20.18.5079; Suarez MB, 2005, FUNGAL GENET BIOL, V42, P924, DOI 10.1016/j.fgb.2005.08.002; Tang J, 2010, CAN J MICROBIOL, V56, P121, DOI 10.1139/W09-110; Tjoelker LW, 2000, BBA-MOL CELL BIOL L, V1488, P102, DOI 10.1016/S1388-1981(00)00114-1; Viterbo A, 2002, ANTON LEEUW INT J G, V81, P549, DOI 10.1023/A:1020553421740; Wang B, 2009, CHEMOSPHERE, V74, P1400, DOI 10.1016/j.chemosphere.2008.11.027; Zeilinger S, 1999, FUNGAL GENET BIOL, V26, P131, DOI 10.1006/fgbi.1998.1111; Zhang Q, 2009, ACTA PHARMACOL SIN, V30, P1674, DOI 10.1038/aps.2009.173	39	11	12	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100367	10.1371/journal.pone.0100367	http://dx.doi.org/10.1371/journal.pone.0100367			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964161	Green Published, gold, Green Submitted			2022-12-27	WOS:000338709500044
J	Yang, JH; Liu, JW; Liu, J; Li, WY; Li, XY; He, Y; Ye, L				Yang, Jinghui; Liu, Jianwei; Liu, Jing; Li, Wenyuan; Li, Xiaoying; He, Yao; Ye, Ling			Genetic Association Study with Metabolic Syndrome and Metabolic-Related Traits in a Cross-Sectional Sample and a 10-Year Longitudinal Sample of Chinese Elderly Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; PANCREATIC BETA-CELLS; INSULIN-RESISTANCE; SUSCEPTIBILITY LOCI; MESSENGER-RNA; INSIG2 GENE; RISK LOCI; TYPE-2; OBESITY; POLYMORPHISM	Background: The metabolic syndrome (MetS) has been known as partly heritable, while the number of genetic studies on MetS and metabolic-related traits among Chinese elderly was limited. Methods: A cross-sectional analysis was performed among 2 014 aged participants from September 2009 to June 2010 in Beijing, China. An additional longitudinal study was carried out among the same study population from 2001 to 2010. Biochemical profile and anthropometric parameters of all the participants were measured. The associations of 23 SNPs located within 17 candidate genes (MTHFR, PPAR gamma, LPL, INSIG, TCF7L2, FTO, KCNJ11, JAZF1, CDKN2A/B, ADIPOQ, WFS1, CDKAL1, IGF2BP2, KCNQ1, MTNR1B, IRS1, ACE) with overweight and obesity, diabetes, metabolic phenotypes, and MetS were examined in both studies. Results: In this Chinese elderly population, prevalence of overweight, central obesity, diabetes, dyslipidemia, hypertension, and MetS were 48.3%, 71.0%, 32.4%, 75.7%, 68.3% and 54.5%, respectively. In the cross-sectional analyses, no SNP was found to be associated with MetS. Genotype TT of SNP rs4402960 within the gene IGF2BP2 was associated with overweight (odds ratio (OR) = 0.479, 95% confidence interval (CI): 0.316-0.724, p = 0.001) and genotype CA of SNP rs1801131 within the gene MTHFR was associated with hypertension (OR = 1.560, 95% CI: 1.194-2.240, p = 0.001). However, these associations were not observed in the longitudinal analyses. Conclusions: The associations of SNP rs4402960 with overweight as well as the association of SNP rs1801131 with hypertension were found to be statistically significant. No SNP was identified to be associated with MetS in our study with statistical significance.	[Yang, Jinghui; Liu, Jianwei; Liu, Jing; Li, Xiaoying; He, Yao; Ye, Ling] Gen Hosp Peoples Liberat Army, Inst Geriatr, Beijing, Peoples R China; [Yang, Jinghui; Liu, Jianwei; Liu, Jing; He, Yao; Ye, Ling] Gen Hosp Peoples Liberat Army, Beijing Key Lab Aging & Geriatr, Beijing, Peoples R China; [Li, Wenyuan] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Li, Xiaoying] Gen Hosp Peoples Liberat Army, Dept Geriatr Cardiol, Beijing, Peoples R China	Harvard University; Harvard T.H. Chan School of Public Health	He, Y (corresponding author), Gen Hosp Peoples Liberat Army, Inst Geriatr, Beijing, Peoples R China.	yhe301@x263.net; lye301@gmail.com	Li, Wenyuan/AAD-4648-2019; Li, Wenyuan/GOG-9505-2022	Li, Wenyuan/0000-0001-6196-9964; He, Yao/0000-0001-6205-7895	Beijing Municipal Science and Technology Commission [D121100004912003]; Special Research Fund of the Ministry of Health of China [201002011]; National Natural Science Foundation of China [21071150, 81072355]	Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission); Special Research Fund of the Ministry of Health of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Beijing Municipal Science and Technology Commission (No. D121100004912003), Special Research Fund of the Ministry of Health of China (No. 201002011), the National Natural Science Foundation of China (No. 21071150 and No. 81072355). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; [Anonymous], IDF CONS WORLDW DEF; Bellia A, 2009, NUTR METAB CARDIOVAS, V19, P455, DOI 10.1016/j.numecd.2008.11.002; Boes E, 2008, OBESITY, V16, P827, DOI 10.1038/oby.2007.132; Bosy-Westphal A, 2007, INT J OBESITY, V31, P784, DOI 10.1038/sj.ijo.0803481; Bouatia-Naji N, 2009, NAT GENET, V41, P89, DOI 10.1038/ng.277; Ciullo M, 2008, DIABETES, V57, P783, DOI 10.2337/db07-0970; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Gavin JR, 1997, DIABETES CARE, V20, P1183; Groenewoud MJ, 2008, DIABETOLOGIA, V51, P1659, DOI 10.1007/s00125-008-1083-z; HAFFNER SM, 1992, DIABETES, V41, P715, DOI 10.2337/diabetes.41.6.715; He Y, 2006, J VASC SURG, V44, P333, DOI 10.1016/j.jvs.2006.03.032; Henneman P, 2008, J MED GENET, V45, P572, DOI 10.1136/jmg.2008.058388; Herbert A, 2006, SCIENCE, V312, P279, DOI 10.1126/science.1124779; Hu C, 2009, DIABETOLOGIA, V52, P1322, DOI 10.1007/s00125-009-1335-6; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; Kumar J, 2007, CLIN GENET, V71, P415, DOI 10.1111/j.1399-0004.2007.00795.x; Li X, 2009, OBESITY, V17, P729, DOI 10.1038/oby.2008.593; Liu Y, 2009, DIABETOLOGIA, V52, P1315, DOI 10.1007/s00125-009-1375-y; MacDonald PE, 2002, J BIOL CHEM, V277, P44938, DOI 10.1074/jbc.M205532200; MacDonald PE, 2001, MOL ENDOCRINOL, V15, P1423, DOI 10.1210/me.15.8.1423; Markan S, 2007, MOL CELL BIOCHEM, V302, P125, DOI 10.1007/s11010-007-9434-5; Neyroud N, 1997, NAT GENET, V15, P186, DOI 10.1038/ng0297-186; Nielsen J, 1999, MOL CELL BIOL, V19, P1262; Oki K, 2009, BRIT J NUTR, V101, P322, DOI 10.1017/S0007114508006557; Palmer ND, 2008, DIABETES, V57, P1093, DOI 10.2337/db07-1169; Pollex RL, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-80; Prokopenko I, 2009, NAT GENET, V41, P77, DOI 10.1038/ng.290; Rong R, 2009, DIABETES, V58, P478, DOI 10.2337/db08-0877; Rosskopf D, 2007, SCIENCE, V315, P187, DOI DOI 10.1126/science.1130571; Rung J, 2009, NAT GENET, V41, P1110, DOI 10.1038/ng.443; Salonen JT, 2007, AM J HUM GENET, V81, P338, DOI 10.1086/520599; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Smith AJP, 2007, INT J OBESITY, V31, P1753, DOI 10.1038/sj.ijo.0803645; Steinthorsdottir V, NET GENET, V39, P770; Takeuchi F, 2009, DIABETES, V58, P1690, DOI 10.2337/db08-1494; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Timpson NJ, 2009, DIABETES, V58, P505, DOI 10.2337/db08-0906; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; Weisberg I, 1998, MOL GENET METAB, V64, P169, DOI 10.1006/mgme.1998.2714; WHO/IASO/IOTF, 2000, ASIA PACIFIC PERSPEC; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Yabe D, 2003, P NATL ACAD SCI USA, V100, P3155, DOI 10.1073/pnas.0130116100; Yabe D, 2002, P NATL ACAD SCI USA, V99, P12753, DOI 10.1073/pnas.162488899; Yang WS, 2007, AM J CLIN NUTR, V86, P509, DOI 10.1093/ajcn/86.2.509; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Yu W, 2012, DIABETOLOGIA, V55, P2655, DOI 10.1007/s00125-012-2636-8; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zhang M, 2005, J GEN PHYSIOL, V126, P353, DOI 10.1085/jgp.200509312	54	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100548	10.1371/journal.pone.0100548	http://dx.doi.org/10.1371/journal.pone.0100548			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959828	Green Submitted, Green Published, gold			2022-12-27	WOS:000338633900056
J	Yi, W; Tian, Q; Dai, ZP; Liu, XH				Yi, Wei; Tian, Qing; Dai, Zhipeng; Liu, Xiaohu			Mechanical Behaviour of Umbrella-Shaped, Ni-Ti Memory Alloy Femoral Head Support Device during Implant Operation: A Finite Element Analysis Study	PLOS ONE			English	Article							EARLY OSTEONECROSIS; OSTEOTOMY; MODEL	A new instrument used for treating femoral head osteonecrosis was recently proposed: the umbrella-shaped, Ni-Ti memory femoral head support device. The device has an efficacy rate of 82.35%. Traditional radiographic study provides limited information about the mechanical behaviour of the support device during an implant operation. Thus, this study proposes a finite element analysis method, which includes a 3-step formal head model construction scheme and a unique material assignment strategy for evaluating mechanical behaviour during an implant operation. Four different scenarios with different constraints, initial positions and bone qualities are analyzed using the simulation method. The max radium of the implanted device was consistent with observation data, which confirms the accuracy of the proposed method. To ensure that the device does not unexpectedly open and puncture the femoral head, the constraint on the impact device should be strong. The initial position of sleeve should be in the middle to reduce the damage to the decompression channel. The operation may fail because of poor bone quality caused by severe osteoporosis. The proposed finite element analysis method has proven to be an accurate tool for studying the mechanical behaviour of umbrella-shaped, Ni-Ti memory alloy femoral head support device during an implant operation. The 3-step construct scheme can be implemented with any kind of bone structure meshed with multiple element types.	[Yi, Wei; Liu, Xiaohu] Huazhong Univ Sci & Technol, Dept Mech, Wuhan 430074, Hubei, Peoples R China; [Tian, Qing; Dai, Zhipeng] Huazhong Univ Sci & Technol, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Liu, XH (corresponding author), Huazhong Univ Sci & Technol, Dept Mech, Wuhan 430074, Hubei, Peoples R China.	xhliu@mail.hust.edu.cn		Liu, Xiaohu/0000-0002-8973-438X	National Natural Science Foundation of China [11172110]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China through the project No. 11172110. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge JM, 2004, J BONE JOINT SURG AM, V86A, P1955, DOI 10.2106/00004623-200409000-00014; Auricchio F, 1997, COMPUT METHOD APPL M, V143, P175, DOI 10.1016/S0045-7825(96)01147-4; Brinson L.C., 1993, J INTEL MAT SYST STR, V4, P229, DOI [10.1177/1045389X9300400213, DOI 10.1177/1045389X9300400213]; Burgers TA, 2008, J BIOMECH, V41, P1077, DOI 10.1016/j.jbiomech.2007.11.018; Christ D, 2009, INT J SOLIDS STRUCT, V46, P3694, DOI 10.1016/j.ijsolstr.2009.06.017; Gao XJ, 2000, INT J PLASTICITY, V16, P1345, DOI 10.1016/S0749-6419(00)00013-9; Gibson Lorna J, 1999, CELLULAR SOLIDS STRU, DOI DOI 10.1017/CBO9781139878326; Kainuma R, 1986, MECH ALL ROUND SHAPE, P717; KOO KH, 1995, J BONE JOINT SURG BR, V77B, P870, DOI 10.1302/0301-620X.77B6.7593097; Lutz A, 2011, BIOMECH MODEL MECHAN, V10, P627, DOI 10.1007/s10237-010-0261-3; Marker DR, 2008, J BONE JOINT SURG AM, V90A, P175, DOI 10.2106/JBJS.H.00671; MULLER I, 1979, ARCH RATION MECH AN, V70, P61, DOI 10.1007/BF00276382; Necchi S, 2008, INT ENDOD J, V41, P939, DOI 10.1111/j.1365-2591.2008.01454.x; Plakseychuk AY, 2003, J BONE JOINT SURG AM, V85A, P589, DOI 10.2106/00004623-200304000-00001; Shuler MS, 2007, J ARTHROPLASTY, V22, P26, DOI 10.1016/j.arth.2006.03.007; SUGIOKA Y, 1992, CLIN ORTHOP RELAT R, P111; SUN QP, 1993, J MECH PHYS SOLIDS, V41, P1, DOI 10.1016/0022-5096(93)90060-S; TANAKA K, 1986, RES MECH, V18, P251; Wang Y, 2009, J ARTHROPLASTY, V24, P1006, DOI 10.1016/j.arth.2008.07.010; Yu X., 2013, 2013 S DESIGN TEST I, P1; Zhao G, 2010, J BONE JOINT SURG BR, V92B, P781, DOI 10.1302/0301-620X.92B6.23621	21	0	2	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100765	10.1371/journal.pone.0100765	http://dx.doi.org/10.1371/journal.pone.0100765			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24960038	Green Published, gold, Green Submitted			2022-12-27	WOS:000338633900083
J	Cao, DP; Liu, Y; Walker, WB; Li, JH; Wang, GR				Cao, Depan; Liu, Yang; Walker, William B.; Li, Jianhong; Wang, Guirong			Molecular Characterization of the Aphis gossypii Olfactory Receptor Gene Families	PLOS ONE			English	Article							DROSOPHILA ODORANT RECEPTORS; LIGAND-BINDING CORE; CHEMORECEPTOR SUPERFAMILY; MEMBRANE TOPOLOGY; HOST LOCATION; PEA APHID; EXPRESSION; IDENTIFICATION; ALIGNMENT; PROTEINS	The cotton aphid, Aphis gossypii Glover, is a polyphagous pest that inflicts great damage to cotton yields worldwide. Antennal olfaction, which is extremely important for insect survival, mediates key behaviors such as host preference, mate choice, and oviposition site selection. In insects, odor detection is mediated by odorant receptors (ORs) and ionotropic receptors (IRs), which ensure the specificity of the olfactory sensory neuron responses. In this study, our aim is to identify chemosensory receptors in the cotton aphid genome, as a means to uncover olfactory encoding of the polyphagous feeding habits as well as to aid the discovery of new targets for behavioral interference. We identified a total of 45 candidate ORs and 14 IRs in the cotton aphid genome. Among the candidate AgoORs, 9 are apparent pseudogenes, while 19 can be clustered with ORs from the pea aphid, forming 16 AgoOR/ApOR orthologous subgroups. Among the candidate IRs, we identified homologs of the two highly conserved co-receptors IR8a and IR25a; no AgoIR retain the complete glutamic acid binding domain, suggesting that putative AgoIRs bind different ligands. Our results provide the necessary information for functional characterization of the chemosensory receptors of A. gossypii, with potential for new or refined applications of semiochemicals-based control of this pest insect.	[Cao, Depan; Li, Jianhong] Huazhong Agr Univ, Coll Plant Sci & Technol, Lab Pesticide, Wuhan, Peoples R China; [Cao, Depan; Liu, Yang; Wang, Guirong] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Walker, William B.] Swedish Univ Agr Sci, Dept Plant Protect Biol, Chem Ecol Res Grp, Alnarp, Sweden	Huazhong Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Swedish University of Agricultural Sciences	Li, JH (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Lab Pesticide, Wuhan, Peoples R China.	jianhl@mail.hzau.edu.cn; grwang@ippcaas.cn		Liu, Yang/0000-0002-3424-7111	National Basic Research Program of China (973 Program) [2012CB114104]; National Natural Science Foundation of China [31230062, 31201578]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China (973 Program, 2012CB114104), National Natural Science Foundation of China (31230062, to G. W. and 31201578, to Y.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Bargmann CI, 2006, NATURE, V444, P295, DOI 10.1038/nature05402; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Berlocher SH, 2002, ANNU REV ENTOMOL, V47, P773, DOI 10.1146/annurev.ento.47.091201.145312; Birkett MA, 2000, P NATL ACAD SCI USA, V97, P9329, DOI 10.1073/pnas.160241697; Bohbot J, 2007, INSECT MOL BIOL, V16, P525, DOI 10.1111/j.1365-2583.2007.00748.x; Bruce TJA, 2005, TRENDS PLANT SCI, V10, P269, DOI 10.1016/j.tplants.2005.04.003; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; Croset V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001064; Dahanukar A, 2007, NEURON, V56, P503, DOI 10.1016/j.neuron.2007.10.024; Ferrari J, 2008, EVOLUTION, V62, P2508, DOI 10.1111/j.1558-5646.2008.00468.x; Gao Q, 1999, GENOMICS, V60, P31, DOI 10.1006/geno.1999.5894; Gereau R.W., 2008, GLUTAMATE RECEPTORS; Hegde M, 2011, J CHEM ECOL, V37, P741, DOI 10.1007/s10886-011-9980-x; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; Jones WD, 2005, CURR BIOL, V15, pR119, DOI 10.1016/j.cub.2005.02.007; Kent LB, 2008, CHEM SENSES, V33, P79, DOI 10.1093/chemse/bjm067; Kim HY, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0024749, 10.1371/journal.pone.0019867]; Koczor S, 2010, PEST MANAG SCI, V66, P1374, DOI 10.1002/ps.2030; Krieger J, 2003, J COMP PHYSIOL A, V189, P519, DOI 10.1007/s00359-003-0427-x; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Krzywinski J, 2001, SYST BIOL, V50, P540, DOI 10.1080/106351501750435095; Kwon JY, 2007, P NATL ACAD SCI USA, V104, P3574, DOI 10.1073/pnas.0700079104; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048260; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lundin C, 2007, FEBS LETT, V581, P5601, DOI 10.1016/j.febslet.2007.11.007; Madden DR, 2002, NAT REV NEUROSCI, V3, P91, DOI 10.1038/nrn725; Mayer ML, 2006, J NEUROSCI, V26, P2852, DOI 10.1523/JNEUROSCI.0123-06.2005; Quiroz A, 1998, J CHEM ECOL, V24, P113, DOI 10.1023/A:1022393029987; Rebora M, 2009, MICRON, V40, P571, DOI 10.1016/j.micron.2009.03.001; Robertson HM, 2010, INSECT MOL BIOL, V19, P121, DOI 10.1111/j.1365-2583.2009.00979.x; Robertson HM, 2006, GENOME RES, V16, P1395, DOI 10.1101/gr.5057506; Rutzler M, 2005, J COMP PHYSIOL A, V191, P777, DOI 10.1007/s00359-005-0044-y; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Schirmer S, 2008, EUR J ENTOMOL, V105, P121, DOI 10.14411/eje.2008.017; Smadja C, 2009, MOL BIOL EVOL, V26, P2073, DOI 10.1093/molbev/msp116; Smart R, 2008, INSECT BIOCHEM MOLEC, V38, P770, DOI 10.1016/j.ibmb.2008.05.002; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van Naters WV, 2006, NATURE, V444, P302, DOI 10.1038/nature05403; Via S, 2002, AM NAT, V159, pS76, DOI 10.1086/338374; Via S, 2008, MOL ECOL, V17, P4334, DOI 10.1111/j.1365-294X.2008.03921.x; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wanner KW, 2007, INSECT MOL BIOL, V16, P107, DOI 10.1111/j.1365-2583.2007.00708.x; Webster B, 2008, J CHEM ECOL, V34, P1153, DOI 10.1007/s10886-008-9510-7; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Wistrand M, 2006, PROTEIN SCI, V15, P509, DOI 10.1110/ps.051745906; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Yao CA, 2005, J NEUROSCI, V25, P8359, DOI 10.1523/JNEUROSCI.2432-05.2005; Zhu JW, 2005, J CHEM ECOL, V31, P1733, DOI 10.1007/s10886-005-5923-8; Zwiebel LJ, 2004, INSECT BIOCHEM MOLEC, V34, P645, DOI 10.1016/j.ibmb.2004.03.017	54	46	51	5	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e101187	10.1371/journal.pone.0101187	http://dx.doi.org/10.1371/journal.pone.0101187			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971460	Green Submitted, gold, Green Published			2022-12-27	WOS:000338512200102
J	Chi, H; Hsu, CH; Chang, JH; Chiu, NC; Hung, HY; Kao, HA; Weng, LC; Huang, FY; Chiu, YY; Chang, LY; Huang, LM				Chi, Hsin; Hsu, Chyong-Hsin; Chang, Jui-Hsing; Chiu, Nan-Chang; Hung, Han-Yang; Kao, Hsin-An; Weng, Li-Chuan; Huang, Fu-Yuan; Chiu, Yu-Ying; Chang, Luan-Yin; Huang, Li-Min			A Novel Six Consecutive Monthly Doses of Palivizumab Prophylaxis Protocol for the Prevention of Respiratory Syncytial Virus Infection in High-Risk Preterm Infants in Taiwan	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; PREMATURE-INFANTS; CHILDREN; HOSPITALIZATIONS; REHOSPITALIZATION; COST; PHARMACOKINETICS; EPIDEMIOLOGY; DISEASE; SAFETY	Background: Respiratory syncytial virus (RSV) circulates year round in Taiwan. A novel six consecutive monthly doses of palivizumab for RSV prevention protocol has been approved for high risk preterm infants since December 2010. This study aimed to determine the clinical effectiveness and safety of this novel protocol for the prevention of RSV infection. Methods: From April 2011 to March 2013, we enrolled infants born at <= 28 weeks gestation and infants born at <= 35 weeks gestation with chronic lung disease (CLD) who received palivizumab prophylaxis as study group and followed up for 12 months. Historic control, those who were born and followed up between July 2000 and June 2008, were retrieved for propensity score matching. Primary endpoint was RSV-related hospitalization, and secondary endpoints included the length of hospital stay and intensive care unit (ICU) care. Results: We enrolled 127 infants (108 infants born at <= 28 weeks and 19 infants born at 29-35 weeks with CLD). They completed 6-dose palivizumab as scheduled. Among the study group, the RSV-related hospitalizations were 2 (1.6%) within 6 months and 5 (3.9%) within 12 months after discharge. We matched 127 infants in the control group with 127 infants in the study group by propensity score matching. The reduction of RSV-related hospitalization rates were 86% (10.2% vs 1.6%, p = 0.002) within 6 months after discharge and 78% (15.7% vs 3.9%, p = 0.004) within 12 months after discharge. Compared to the control group, the rate of ICU care significantly decreased from 7.1% to 0.8% (p = 0.024) within 6 months after discharge and from 7.9% to 0.8% (p = 0.014) within 12 months after discharge. Adverse events were recorded in 6.4% injections. Conclusions: Six monthly intramuscular administration of palivizumab is effective for prevention of RSV hospitalization in regions with no single seasonal peak of RSV infection such as Taiwan.	[Chi, Hsin; Hsu, Chyong-Hsin; Chang, Jui-Hsing; Chiu, Nan-Chang; Hung, Han-Yang; Kao, Hsin-An; Huang, Fu-Yuan] Mackay Mem Hosp, Dept Pediat, Taipei, Taiwan; [Chi, Hsin; Chang, Luan-Yin; Huang, Li-Min] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Chi, Hsin; Chiu, Nan-Chang] Mackay Jr Coll Med Nursing & Management, Dept Nursing, Taipei, Taiwan; [Chi, Hsin] Mackay Med Coll, Dept Med, New Taipei City, Taiwan; [Weng, Li-Chuan] Mackay Mem Hosp, Dept Med Res, Tamsui, Taiwan; [Chiu, Yu-Ying] Mackay Mem Hosp, Dept Clin Virol Lab Med, Tamsui, Taiwan; [Chang, Luan-Yin; Huang, Li-Min] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Pediat, Taipei 10764, Taiwan	Mackay Memorial Hospital; National Taiwan University; Mackay Junior College of Medicine, Nursing & Management; Mackay Medical College; Mackay Memorial Hospital; Mackay Memorial Hospital; National Taiwan University; National Taiwan University Hospital	Huang, LM (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan.	lmhuang@ntu.edu.tw		CHANG, LUAN-YIN/0000-0003-2632-1956; HUANG, LI-MIN/0000-0002-9291-260X	Mackay Memorial Hospital, Taipei, Taiwan [MMH 9944, MMH 10038]; Taiwan Foundation of Prematurity	Mackay Memorial Hospital, Taipei, Taiwan; Taiwan Foundation of Prematurity	This study was supported by grants MMH 9944 and MMH 10038 from Mackay Memorial Hospital, Taipei, Taiwan and grants from the Taiwan Foundation of Prematurity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson JS, 2003, PEDIATRICS, V112, P1442; Austin PC, 2008, PHARMACOEPIDEM DR S, V17, P1218, DOI 10.1002/pds.1674; Bocchini JA, 2009, PEDIATRICS, V124, P1216, DOI [10.1542/peds.2009-1806, 10.1542/peds.2009-2345]; Bont L, 2011, PEDIATR INFECT DIS J, V30, P785, DOI 10.1097/INF.0b013e31821fef9e; Boyce TG, 2000, J PEDIATR-US, V137, P865, DOI 10.1067/mpd.2000.110531; Carbonell-Estrany X, 2000, PEDIATR INFECT DIS J, V19, P592, DOI 10.1097/00006454-200007000-00002; Chan PWK, 2002, PEDIATR PULM, V34, P47, DOI 10.1002/ppul.10095; Chew FT, 1998, EPIDEMIOL INFECT, V121, P121, DOI 10.1017/S0950268898008905; Chi H, 2011, J FORMOS MED ASSOC, V110, P388, DOI 10.1016/S0929-6646(11)60057-0; Cilla G, 2006, EPIDEMIOL INFECT, V134, P506, DOI 10.1017/S0950268805005571; ElHassan NO, 2006, ARCH PEDIAT ADOL MED, V160, P1070, DOI 10.1001/archpedi.160.10.1070; Frogel M, 2008, J PERINATOL, V28, P511, DOI 10.1038/jp.2008.28; Fryzek JP, 2011, ADV THER, V28, P195, DOI 10.1007/s12325-010-0106-6; Grimaldi M, 2007, PEDIATR PULM, V42, P189, DOI 10.1002/ppul.20503; Groothius JR, 2001, PEDIATR INFECT DIS J, V20, P628, DOI 10.1097/00006454-200106000-00018; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Hall CB, 2010, MANDELL DOUGLAS BENN, P2207; Halsey NA, 1998, PEDIATRICS, V102, P1211, DOI 10.1542/peds.102.5.1211; Joffe S, 1999, PEDIATRICS, V104, P894, DOI 10.1542/peds.104.4.894; Johnson S, 1997, J INFECT DIS, V176, P1215, DOI 10.1086/514115; Lee Jian-Te, 2007, Journal of Microbiology Immunology and Infection, V40, P293; Loscertales MP, 2002, PEDIATR INFECT DIS J, V21, P148, DOI 10.1097/00006454-200202000-00013; Meissner HC, 2004, PEDIATRICS, V114, P1082, DOI 10.1542/peds.2004-1300; Mitchell I, 2011, PEDIATR INFECT DIS J, V30, P651, DOI 10.1097/INF.0b013e31821146f7; Mullooly JP, 2007, VACCINE, V25, P846, DOI 10.1016/j.vaccine.2006.09.041; Null D, 1998, PEDIATRICS, V102, P531, DOI 10.1542/peds.102.3.531; Pedraz C, 2003, PEDIATR INFECT DIS J, V22, P823, DOI 10.1097/01.inf.0000086403.50417.7c; Robbie GJ, 2012, ANTIMICROB AGENTS CH, V56, P4927, DOI 10.1128/AAC.06446-11; Romero JR, 2003, PEDIATR INFECT DIS J, V22, pS46, DOI 10.1097/00006454-200302001-00007; Rossi GA, 2007, EUR J PEDIATR, V166, P1267, DOI 10.1007/s00431-007-0418-y; Saez-Llorens X, 2004, PEDIATR INFECT DIS J, V23, P707, DOI 10.1097/01.inf.0000133165.85909.08; Shay DK, 1999, JAMA-J AM MED ASSOC, V282, P1440, DOI 10.1001/jama.282.15.1440; Simoes EAF, 1999, LANCET, V354, P847, DOI 10.1016/S0140-6736(99)80040-3; Singleton R, 2003, PEDIATR INFECT DIS J, V22, P540, DOI 10.1097/00006454-200306000-00010; Sommer Constanze, 2011, Open Microbiol J, V5, P144, DOI 10.2174/1874285801105010144; Stensballe LG, 2003, PEDIATR INFECT DIS J, V22, pS21, DOI 10.1097/00006454-200302001-00004; Tsai HP, 2001, J CLIN MICROBIOL, V39, P111, DOI 10.1128/JCM.39.1.111-118.2001; Underwood MA, 2007, J PERINATOL, V27, P614, DOI 10.1038/sj.jp.7211801; Wegner S, 2004, PEDIATRICS, V114, P1612, DOI 10.1542/peds.2004-0959; Yusuf S, 2007, EPIDEMIOL INFECT, V135, P1077, DOI 10.1017/S095026880600776X	40	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100981	10.1371/journal.pone.0100981	http://dx.doi.org/10.1371/journal.pone.0100981			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971565	Green Published, Green Submitted, gold			2022-12-27	WOS:000338512200079
J	Dennis, FE; Fujii, Y; Haga, K; Damanka, S; Lartey, B; Agbemabiese, CA; Ohta, N; Armah, GE; Katayama, K				Dennis, Francis E.; Fujii, Yoshiki; Haga, Kei; Damanka, Susan; Lartey, Belinda; Agbemabiese, Chantal A.; Ohta, Nobuo; Armah, George E.; Katayama, Kazuhiko			Identification of Novel Ghanaian G8P[6] Human-Bovine Reassortant Rotavirus Strain by Next Generation Sequencing	PLOS ONE			English	Article							GROUP-A ROTAVIRUS; WHOLE-GENOME ANALYSIS; CLOSE RELATIONSHIP; G8 ROTAVIRUSES; GENOTYPES; DIARRHEA; REVEALS; GENE; CLASSIFICATION; VACCINE	Group A rotaviruses (RVAs) are the most important etiological agent of acute gastroenteritis in children <5 years of age worldwide. The monovalent rotavirus vaccine Rotarix was introduced into the national Expanded Programme on Immunization (EPI) in Ghana in May 2012. However, there is a paucity of genetic and phylogenetic data on the complete genomes of human RVAs in circulation pre-vaccine introduction. The common bovine rotavirus VP7 genotype G8 has been sporadically detected in Ghanaian children, usually in combination with the VP4 genotype P[6]. To investigate the genomic constellations and phylogeny of RVA strains in circulation prior to vaccine introduction, the full genomes of two unusual G8P[6] strains, GH018-08 and GH019-08, detected during burden of disease surveillance, were characterized by Illumina MiSeq sequencing. The Ghanaian isolates, GH018-08 and GH019-08, exhibited the unusual, previously unreported genotype constellation G8-P[6]-I2-R2-C2-M2-A2-N2-T2-E2-H3. Phylogenetic analyses confirmed that 10 out of the 11 genes of GH018-08 and GH019-08 were identical/nearly identical, with significant variation detected only in their VP1 genes, and clearly established the occurrence of multiple independent interspecies transmission and reassortment events between co-circulating bovine/ovine/caprine rotaviruses and human DS-1-like RVA strains. These findings highlight the contribution of reassortment and interspecies transmission events to the high rotavirus diversity in this region of Africa, and justify the need for simultaneous monitoring of animal and human rotavirus strains.	[Dennis, Francis E.; Ohta, Nobuo] Tokyo Med & Dent Univ, Dept Environm Parasitol, Tokyo, Japan; [Dennis, Francis E.; Fujii, Yoshiki; Haga, Kei; Katayama, Kazuhiko] Natl Inst Infect Dis, Dept Virol 2, Lab Gastroenteritis Viruses, Musashimurayama, Tokyo, Japan; [Dennis, Francis E.; Damanka, Susan; Lartey, Belinda; Agbemabiese, Chantal A.; Armah, George E.] Univ Ghana, Coll Hlth Sci, Noguchi Mem Inst Med Res, Dept Electron Microscopy & Histopathol, Legon, Ghana	Tokyo Medical & Dental University (TMDU); National Institute of Infectious Diseases (NIID); University of Ghana	Katayama, K (corresponding author), Natl Inst Infect Dis, Dept Virol 2, Lab Gastroenteritis Viruses, Musashimurayama, Tokyo, Japan.	katayama@nih.go.jp	Fujii, Yoshiki/GOE-3566-2022	Agbemabiese, Chantal/0000-0003-1862-9408; Katayama, Kazuhiko/0000-0002-7692-1151	Ministry of Health, Labour and Welfare, Japan	Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was funded by Grants-in-Aid for Research on Emerging and Re-emerging Infectious Diseases by the Ministry of Health, Labour and Welfare, Japan (KK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adah MI, 2003, J CLIN MICROBIOL, V41, P3945, DOI 10.1128/JCM.41.8.3945-3950.2003; Alkan F, 2010, VET MICROBIOL, V141, P231, DOI 10.1016/j.vetmic.2009.09.016; Armah GE, 2001, J MED VIROL, V63, P67, DOI 10.1002/1096-9071(200101)63:1&lt;67::AID-JMV1010&gt;3.0.CO;2-T; Armah GE, 2003, J CLIN MICROBIOL, V41, P2317, DOI 10.1128/JCM.41.6.2317-2322.2003; Armah GE, 2010, J INFECT DIS, V202, pS64, DOI 10.1086/653571; Asmah RH, 2001, J CLIN MICROBIOL, V39, P1981, DOI 10.1128/JCM.39.5.1981-1984.2001; Banyai K, 2010, INFECT GENET EVOL, V10, P1140, DOI 10.1016/j.meegid.2010.05.001; Barro M, 2005, P NATL ACAD SCI USA, V102, P4114, DOI 10.1073/pnas.0408376102; Binka E, 2011, PEDIATR INFECT DIS J, V30, P716, DOI 10.1097/INF.0b013e318223bd85; BROWNING GF, 1992, ARCH VIROL, V125, P121, DOI 10.1007/BF01309632; Chege GK, 2005, VACCINE, V23, P1522, DOI 10.1016/j.vaccine.2004.06.055; Chen YD, 2008, VIROLOGY, V375, P361, DOI 10.1016/j.virol.2008.01.003; Cunliffe NA, 2000, VIROLOGY, V274, P309, DOI 10.1006/viro.2000.0456; Enweronu-Laryea CC, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-287; Esona MD, 2009, J MED VIROL, V81, P937, DOI 10.1002/jmv.21468; Estes M.K., 2001, FIELDS VIROLOGY, V2., P1747; Estes MK, 1996, J INFECT DIS, V174, pS37, DOI 10.1093/infdis/174.Supplement_1.S37; Estes MK, 2007, FIELDS VIROLOGY, P1917; Fodha I, 2005, J VET MED B, V52, P49, DOI 10.1111/j.1439-0450.2004.00810.x; Ghosh S, 2007, ARCH VIROL, V152, P423, DOI 10.1007/s00705-006-0848-2; Ghosh S, 2011, J GEN VIROL, V92, P2201, DOI 10.1099/vir.0.033001-0; Ghosh S, 2011, J MED VIROL, V83, P367, DOI 10.1002/jmv.21974; Ghosh S, 2010, J GEN VIROL, V91, P2367, DOI 10.1099/vir.0.022244-0; GORZIGLIA M, 1988, J VIROL, V62, P2978, DOI 10.1128/JVI.62.8.2978-2984.1988; Heiman EM, 2008, J VIROL, V82, P11106, DOI 10.1128/JVI.01402-08; Heylen E, 2013, INFECT GENET EVOL, V13, P27, DOI 10.1016/j.meegid.2012.08.019; Iturriza-Gomara M, 2011, EPIDEMIOL INFECT, V139, P895, DOI 10.1017/S0950268810001810; Jayaram H, 2004, VIRUS RES, V101, P67, DOI 10.1016/j.virusres.2003.12.007; Jere KC, 2014, INFECT GENET EVOL, V21, P58, DOI 10.1016/j.meegid.2013.10.002; Jere KC, 2012, VET MICROBIOL, V159, P245, DOI 10.1016/j.vetmic.2012.03.040; Jere KC, 2011, INFECT GENET EVOL, V11, P2072, DOI 10.1016/j.meegid.2011.09.023; Kirkwood CD, 1996, ARCH VIROL, V141, P587, DOI 10.1007/BF01718319; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Maes P, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-238; Martella V, 2010, VET MICROBIOL, V140, P246, DOI 10.1016/j.vetmic.2009.08.028; Matthijnssens J, 2008, J GEN VIROL, V89, P2630, DOI 10.1099/vir.0.2008/003780-0; Matthijnssens J, 2008, ARCH VIROL, V153, P1621, DOI 10.1007/s00705-008-0155-1; Matthijnssens J, 2008, J VIROL, V82, P3204, DOI 10.1128/JVI.02257-07; Matthijnssens J, 2006, J CLIN MICROBIOL, V44, P1801, DOI 10.1128/JCM.44.5.1801-1809.2006; Matthijnssens J, 2011, ARCH VIROL, V156, P1397, DOI 10.1007/s00705-011-1006-z; Matthijnssens J, 2010, MOL BIOL EVOL, V27, P2431, DOI 10.1093/molbev/msq137; Matthijnssens J, 2009, FUTURE MICROBIOL, V4, P1303, DOI [10.2217/fmb.09.96, 10.2217/FMB.09.96]; Midgley SE, 2012, VET MICROBIOL, V156, P238, DOI 10.1016/j.vetmic.2011.10.027; Monini M, 2008, VET MICROBIOL, V129, P384, DOI 10.1016/j.vetmic.2007.11.036; Mwenda JM, 2010, J INFECT DIS, V202, pS5, DOI 10.1086/653557; NAKAGOMI O, 1989, MOL CELL PROBE, V3, P251, DOI 10.1016/0890-8508(89)90006-6; NAKAGOMI T, 1989, J VIROL, V63, P1431, DOI 10.1128/JVI.63.3.1431-1434.1989; Nakagomi T, 2013, J GEN VIROL, V94, P1273, DOI 10.1099/vir.0.050625-0; Nielsen NM, 2005, J CLIN VIROL, V34, P13, DOI 10.1016/j.jcv.2004.12.017; Page N, 2010, J MED VIROL, V82, P2073, DOI 10.1002/jmv.21912; Patel MM, 2011, PEDIATR INFECT DIS J, V30, pS1, DOI 10.1097/INF.0b013e3181fefa1f; Rahman M, 2007, J VIROL, V81, P2382, DOI 10.1128/JVI.01622-06; Rippinger CM, 2010, VIROLOGY, V405, P201, DOI 10.1016/j.virol.2010.06.005; Santos N, 2008, J CLIN MICROBIOL, V46, P462, DOI 10.1128/JCM.01361-07; Seheri M, 2014, PEDIATR INFECT DIS J, V33, pS76, DOI 10.1097/INF.0000000000000053; SUZUKI Y, 1993, J CLIN MICROBIOL, V31, P3046, DOI 10.1128/JCM.31.11.3046-3049.1993; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tapia MD, 2012, VACCINE, V30, pA79, DOI 10.1016/j.vaccine.2012.01.022; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; Todd S, 2010, J INFECT DIS, V202, pS34, DOI 10.1086/653555; Trojnar E, 2013, J GEN VIROL, V94, P136, DOI 10.1099/vir.0.047381-0; World Health Organization, 2002, GEN PROT HOSP BAS SU; Wu HX, 1998, J MED VIROL, V55, P168, DOI 10.1002/(SICI)1096-9071(199806)55:2&lt;168::AID-JMV14&gt;3.0.CO;2-E	63	54	55	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100699	10.1371/journal.pone.0100699	http://dx.doi.org/10.1371/journal.pone.0100699			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971993	Green Submitted, Green Published, gold			2022-12-27	WOS:000338512200052
J	Liu, C; Zhan, XL; Xiao, ZM; Fan, Q; Deng, L; Cui, MX; Xiong, CX; Xue, JB; Xie, XT				Liu, Chong; Zhan, Xinli; Xiao, Zengming; Fan, Qie; Deng, Li; Cui, Mingxing; Xiong, Chunxiang; Xue, Jingbo; Xie, Xiangtao			Transcript Levels of Major Interleukins in Relation to the Clinicopathological Profile of Patients with Tuberculous Intervertebral Discs and Healthy Controls	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; SPINAL TUBERCULOSIS; PLEURAL EFFUSIONS; PULMONARY TUBERCULOSIS; T-CELLS; MACROPHAGES; EXPRESSION; CYTOKINES; NICOTINE; DIFFERENTIATION	Objectives: The purpose of the present study was to simultaneously examine the transcript levels of a large number of interleukins (ILs; IL-9, IL-10, IL-12, IL-13, IL-16, IL-17, IL-18, IL-26, and IL-27) and investigate their correlation with the clinicopathological profiles of patients with tuberculous intervertebral discs. Methods: Clinical data were collected from 150 patients participating in the study from January 2013 to December 2013. mRNA expression levels in 70 tuberculous, 70 herniated, and 10 control intervertebral disc specimens were determined by real-time polymerase chain reaction. Results: IL-10, IL-16, IL-17, IL-18, and IL-27 displayed stronger expression in tuberculous spinal disc tissue than in normal intervertebral disc tissue (P < 0.05). Our results illustrated multiple correlations among IL-10, IL-16, IL-17, IL-18, and IL-27 mRNA expression in tuberculous samples. Smoking habits were found to have a positive correlation with IL-17 transcript levels and a negative correlation with IL-10 transcript levels (P < 0.05). Pain intensity, symptom duration, C-reactive protein levels, and the erythrocyte sedimentation rate exhibited multiple correlations with the transcript levels of several ILs (P < 0.05). Conclusions: The experimental data imply a double-sided effect on the activity of ILs in tuberculous spinal intervertebral discs, suggesting that they may be involved in intervertebral discs destruction. Our findings also suggest that smoking may affect the intervertebral discs destruction process of spinal tuberculosis. However, further studies are necessary to elucidate the exact role of ILs in the intervertebral discs destruction process of spinal tuberculosis.	[Liu, Chong; Zhan, Xinli; Xiao, Zengming; Fan, Qie; Deng, Li; Cui, Mingxing; Xiong, Chunxiang; Xue, Jingbo; Xie, Xiangtao] Guangxi Med Univ, Affiliated Hosp 1, Spine & Osteopathy Ward, Nanning, Guangxi, Peoples R China	Guangxi Medical University	Zhan, XL (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Spine & Osteopathy Ward, Nanning, Guangxi, Peoples R China.	3cstar@163.com		, Qie/0000-0001-6391-4342				Aicher A, 2003, CIRCULATION, V107, P604, DOI 10.1161/01.CIR.0000047279.42427.6D; Alawneh KM, 2014, BIOL-TARGETS THER, V8, P193, DOI 10.2147/BTT.S59574; Chang JC, 1996, THORAX, V51, P306, DOI 10.1136/thx.51.3.306; Cheng L, 2013, INJURY, V44, P1805, DOI 10.1016/j.injury.2013.04.010; Cho H, 2005, INFECT IMMUN, V73, P1367, DOI 10.1128/IAI.73.3.1367-1376.2005; Coad M, 2010, VET RES, V41, DOI 10.1051/vetres/2009062; Commins SP, 2010, J ALLERGY CLIN IMMUN, V125, pS53, DOI 10.1016/j.jaci.2009.07.008; Duanmu H, 2010, ZHONGHUA JIE HE HE H, V25, P3; ElAhmady O, 1997, ANN CLIN BIOCHEM, V34, P160, DOI 10.1177/000456329703400205; Flynn JL, 2011, MUCOSAL IMMUNOL, V4, P271, DOI 10.1038/mi.2011.14; Garg RK, 2011, J SPINAL CORD MED, V34, P440, DOI 10.1179/2045772311Y.0000000023; Gergert V Ia, 1995, Vestn Ross Akad Med Nauk, P33; Guinet E, 2004, IMMUNOL LETT, V95, P45, DOI 10.1016/j.imlet.2004.06.003; Guo Li-Xin, 2010, Zhongguo Gu Shang, V23, P200; Ibrahim L, 2013, IMMUNOL INVEST, V42, P122, DOI 10.3109/08820139.2012.736116; Inoue H, 2008, BONE, V42, P1102, DOI 10.1016/j.bone.2008.01.031; Jo EK, 2003, CURR OPIN INFECT DIS, V16, P205, DOI 10.1097/00001432-200306000-00004; Joosten LAB, 1999, INFLAMM RES, V48, P48, DOI 10.1007/s000110050396; Kozakiewicz L, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003472; LAFOND EM, 1958, J BONE JOINT SURG AM, V40, P346, DOI 10.2106/00004623-195840020-00008; Matsuzaki Goro, 2011, Nihon Rinsho, V69, P1368; Vo N, 2011, J ORTHOP RES, V29, P1585, DOI 10.1002/jor.21417; Nouri-Shirazi M, 2003, IMMUNOLOGY, V109, P365, DOI 10.1046/j.1365-2567.2003.01655.x; O'Shea MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097366; Ortner D. J., 2003, IDENTIFICATION PATHO, DOI DOI 10.1016/B978-012528628-2/50057-0; Palle Lalitha, 2010, Indian J Radiol Imaging, V20, P279, DOI 10.4103/0971-3026.73544; Qin XJ, 2005, EUR RESPIR J, V25, P605, DOI 10.1183/09031936.05.00090804; Reichmann MT, 2014, BMJ CASE REP 2014, V2014; Rovina N, 2013, CYTOKINE, V63, P166, DOI 10.1016/j.cyto.2013.04.017; Sharma S, 2001, ASIAN PAC J ALLERGY, V19, P213; Shigenaga T, 2001, IMMUNOLOGY, V102, P466, DOI 10.1046/j.1365-2567.2001.01195.x; Si JW, 2012, ARCH ORTHOP TRAUM SU, V132, P941, DOI 10.1007/s00402-012-1506-7; Skvortsova L A, 2003, Probl Tuberk Bolezn Legk, P9; Smith RE, 1997, J LEUKOCYTE BIOL, V62, P612, DOI 10.1002/jlb.62.5.612; Steinbock RT, 1976, PALEOPATHOLOGICAL DI, P374; Tsarouhas A, 2011, EUR SPINE J, V20, P781, DOI 10.1007/s00586-010-1573-9; Tsuzaki M, 2003, J ORTHOP RES, V21, P256, DOI 10.1016/S0736-0266(02)00141-9; Valdes L, 2013, RESP CARE; Valsalan R, 2012, INDIAN J ORTHOP, V46, P138, DOI 10.4103/0019-5413.93673; van Zyl-Smit RN, 2013, CIGARETTE SMOKE IMPA; Wang B, 2011, TURK NEUROSURG, V21, P575, DOI [10.5137/1019-5149.JTN .4639-11.1, 10.5137/1019-5149.JTN.4639-11.1]; Wilson M, 1998, INFECT IMMUN, V66, P2401, DOI 10.1128/IAI.66.6.2401-2409.1998; Witchell J, 2010, VET IMMUNOL IMMUNOP, V138, P79, DOI 10.1016/j.vetimm.2010.07.004; Yang WB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040450; Ye ZJ, 2012, AM J RESP CRIT CARE, V185, P660, DOI 10.1164/rccm.201107-1198OC; Ye ZJ, 2011, CLIN VACCINE IMMUNOL, V18, P1608, DOI 10.1128/CVI.05214-11	46	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e101324	10.1371/journal.pone.0101324	http://dx.doi.org/10.1371/journal.pone.0101324			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971599	Green Published, Green Submitted, gold			2022-12-27	WOS:000338512200112
J	Park, SY; Jung, HY; Gwak, JM; Jung, N; Cho, NY; Kang, GH				Park, So Yeon; Jung, Hae Yoen; Gwak, Jae Moon; Jung, Namhee; Cho, Nam-Yun; Kang, Gyeong Hoon			Alu and LINE-1 Hypomethylation Is Associated with HER2 Enriched Subtype of Breast Cancer	PLOS ONE			English	Article							CARCINOMA IN-SITU; ELEMENT 1 HYPOMETHYLATION; DNA METHYLATION PATTERNS; HORMONE-RECEPTOR STATUS; POOR-PROGNOSIS; CHROMOSOMAL INSTABILITY; MOLECULAR SUBTYPES; FAMILY-HISTORY; TUMOR; PROFILES	The changes in DNA methylation status in cancer cells are characterized by hypermethylation of promoter CpG islands and diffuse genomic hypomethylation. Alu and long interspersed nucleotide element-1 (LINE-1) are non-coding genomic repetitive sequences and methylation of these elements can be used as a surrogate marker for genome-wide methylation status. This study was designed to evaluate the changes of Alu and LINE-1 hypomethylation during breast cancer progression from normal to pre-invasive lesions and invasive breast cancer (IBC), and their relationship with characteristics of IBC. We analyzed the methylation status of Alu and LINE-1 in 145 cases of breast samples including normal breast tissue, atypical ductal hyperplasia/flat epithelial atypia (ADH/FEA), ductal carcinoma in situ (DCIS) and IBC, and another set of 129 cases of IBC by pyrosequencing. Alu methylation showed no significant changes during multistep progression of breast cancer, although it tended to decrease during the transition from DCIS to IBC. In contrast, LINE-1 methylation significantly decreased from normal to ADH/FEA, while it was similar in ADH/FEA, DCIS and IBC. In IBC, Alu hypomethylation correlated with negative estrogen receptor (ER) status, and LINE-1 hypomethylation was associated with negative ER status, ERBB2 (HER2) amplification and p53 overexpression. Alu and LINE-1 methylation status was significantly different between breast cancer subtypes, and the HER2 enriched subtype had lowest methylation levels. In survival analyses, low Alu methylation status tended to be associated with poor disease-free survival of the patients. Our findings suggest that LINE-1 hypomethylation is an early event and Alu hypomethylation is probably a late event during breast cancer progression, and prominent hypomethylation of Alu and LINE-1 in HER2 enriched subtype may be related to chromosomal instability of this specific subtype.	[Park, So Yeon; Gwak, Jae Moon; Kang, Gyeong Hoon] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul, South Korea; [Park, So Yeon; Jung, Hae Yoen; Gwak, Jae Moon] Seoul Natl Univ, Bundang Hosp, Dept Pathol, Songnam, Gyeonggi, South Korea; [Jung, Namhee; Cho, Nam-Yun; Kang, Gyeong Hoon] Seoul Natl Univ, Canc Res Inst, Lab Epigenet, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Kang, GH (corresponding author), Seoul Natl Univ, Coll Med, Dept Pathol, Seoul, South Korea.	ghkang@snu.ac.kr	Kang, Gyeong Hoon/F-1051-2010	Kang, Gyeong Hoon/0000-0003-2380-6675; Park, So Yeon/0000-0002-0299-7268	National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea [0720540]; Priority Research Centers Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2009-0093820]; National Research Foundation of Korea (NRF) by the Korea government (MSIP) [2011-0030049]	National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Priority Research Centers Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(National Research Foundation of Korea); National Research Foundation of Korea (NRF) by the Korea government (MSIP)	This study was supported by a grant from the National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea (0720540), by a Priority Research Centers Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science and Technology (2009-0093820), and by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. 2011-0030049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allred DC, 2008, CLIN CANCER RES, V14, P370, DOI 10.1158/1078-0432.CCR-07-1127; Bae JM, 2012, INT J CANCER, V131, P1323, DOI 10.1002/ijc.27369; Bediaga NG, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2721; Bloushtain-Qimron N, 2008, P NATL ACAD SCI USA, V105, P14076, DOI 10.1073/pnas.0805206105; Chalitchagorn K, 2004, ONCOGENE, V23, P8841, DOI 10.1038/sj.onc.1208137; Costello JF, 2000, NAT GENET, V24, P132, DOI 10.1038/72785; Delgado-Cruzata L, 2014, EPIGENETICS-US, V9, P243, DOI 10.4161/epi.26880; Ellsworth RE, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-297; Erbas B, 2006, BREAST CANCER RES TR, V97, P135, DOI 10.1007/s10549-005-9101-z; Feng W, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1762; Fiegl H, 2006, CANCER RES, V66, P29, DOI 10.1158/0008-5472.CAN-05-2508; Garcia JM, 2004, GENE CHROMOSOME CANC, V41, P117, DOI 10.1002/gcc.20062; Goel A, 2010, GASTROENTEROLOGY, V138, P1854, DOI 10.1053/j.gastro.2010.01.035; Holm K, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2590; Hormozdiari F, 2011, GENOME RES, V21, P840, DOI 10.1101/gr.115956.110; Ikeda K, 2013, ANN THORAC SURG, V96, P1790, DOI 10.1016/j.athoracsur.2013.06.035; Isola J, 1999, CLIN CANCER RES, V5, P4140; Iwagami S, 2013, ANN SURG, V257, P449, DOI 10.1097/SLA.0b013e31826d8602; Kamalakaran S, 2011, MOL ONCOL, V5, P77, DOI 10.1016/j.molonc.2010.11.002; Karpf AR, 2005, CANCER RES, V65, P8635, DOI 10.1158/0008-5472.CAN-05-1961; Kim BH, 2009, VIRCHOWS ARCH, V455, P343, DOI 10.1007/s00428-009-0829-4; Kitkumthorn N, 2011, CLIN EPIGENETICS, V2, P315, DOI 10.1007/s13148-011-0032-8; Kwon HJ, 2010, VIRCHOWS ARCH, V457, P433, DOI 10.1007/s00428-010-0958-9; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee HS, 2009, CLIN CANCER RES, V15, P812, DOI 10.1158/1078-0432.CCR-08-0266; Lengauer C, 1997, P NATL ACAD SCI USA, V94, P2545, DOI 10.1073/pnas.94.6.2545; Ogino S, 2013, JNCI-J NATL CANCER I, V105, P130, DOI 10.1093/jnci/djs482; Ogino S, 2008, J NATL CANCER I, V100, P1734, DOI 10.1093/jnci/djn359; Park SY, 2011, VIRCHOWS ARCH, V458, P73, DOI 10.1007/s00428-010-1013-6; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Rodriguez J, 2006, CANCER RES, V66, P8462, DOI 10.1158/0008-5472.CAN-06-0293; Ronneberg JA, 2011, MOL ONCOL, V5, P61, DOI 10.1016/j.molonc.2010.11.004; Saito K, 2010, CLIN CANCER RES, V16, P2418, DOI 10.1158/1078-0432.CCR-09-2819; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sorlie T, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-127; Sunami E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018884; van Hoesel AQ, 2012, BREAST CANCER RES TR, V134, P1103, DOI 10.1007/s10549-012-2038-0; Vincent-Salomon A, 2008, CLIN CANCER RES, V14, P1956, DOI 10.1158/1078-0432.CCR-07-1465; Voduc KD, 2010, J CLIN ONCOL, V28, P1684, DOI 10.1200/JCO.2009.24.9284; Widschwendter M, 2004, CANCER RES, V64, P3807, DOI 10.1158/0008-5472.CAN-03-3852; Yeon S, 2012, MODERN PATHOL, V25, P185, DOI 10.1038/modpathol.2011.160; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5	42	56	58	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100429	10.1371/journal.pone.0100429	http://dx.doi.org/10.1371/journal.pone.0100429			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971511	Green Published, gold, Green Submitted			2022-12-27	WOS:000338512200031
J	Beckham, Y; Vasquez, RJ; Stricker, J; Sayegh, K; Campillo, C; Gardel, ML				Beckham, Yvonne; Vasquez, Robert J.; Stricker, Jonathan; Sayegh, Kareem; Campillo, Clement; Gardel, Margaret L.			Arp2/3 Inhibition Induces Amoeboid-Like Protrusions in MCF10A Epithelial Cells by Reduced Cytoskeletal-Membrane Coupling and Focal Adhesion Assembly	PLOS ONE			English	Article							MIGRATION; LAMELLIPODIA; COMPLEX; DYNAMICS; TENSION; GROWTH; FIBROBLASTS; EXTENSION; MOTILITY; VINCULIN	Here we demonstrate that Arp2/3 regulates a transition between mesenchymal and amoeboid protrusions in MCF10A epithelial cells. Using genetic and pharmacological means, we first show Arp2/3 inhibition impairs directed cell migration. Arp2/3 inhibition results in a dramatically impaired cell adhesion, causing deficient cell attachment and spreading to ECM as well as an 8-fold decrease in nascent adhesion assembly at the leading edge. While Arp2/3 does not play a significant role in myosin-dependent adhesion growth, mature focal adhesions undergo large scale movements against the ECM suggesting reduced coupling to the ECM. Cell edge protrusions occur at similar rates when Arp2/3 is inhibited but their morphology is dramatically altered. Persistent lamellipodia are abrogated and we observe a markedly increased incidence of blebbing and unstable pseuodopods. Micropipette-aspiration assays indicate that Arp2/3-inhibited cells have a weak coupling between the cell cortex and the plasma membrane, and suggest a potential mechanism for increased pseudopod and bleb formation. Pseudopods are not sensitive to reduced in formin or myosin II activity. Collectively, these results indicate that Arp2/3 is not necessary for rapid protrusion of the cell edge but plays a crucial role in assembling focal adhesions required for its stabilization.	[Beckham, Yvonne; Gardel, Margaret L.] Univ Chicago, Med Ctr, Inst Biophys Dynam, Chicago, IL 60637 USA; [Vasquez, Robert J.] Univ Chicago, Med Ctr, Dept Pediat, Sect Hematol Oncol & Stem Cell Transplantat, Chicago, IL 60637 USA; [Stricker, Jonathan; Sayegh, Kareem; Gardel, Margaret L.] Univ Chicago, James Franck Inst, Chicago, IL 60637 USA; [Stricker, Jonathan; Sayegh, Kareem; Gardel, Margaret L.] Univ Chicago, Dept Phys, Chicago, IL 60637 USA; [Campillo, Clement] Inst Curie, Ctr Rech, Lab Physicochim, Paris, France; [Campillo, Clement] Univ Evry Val dEssonne, Lab Anal & Modelisat Biol & Environm, Evry, France	University of Chicago; University of Chicago Medical Center; University of Chicago; University of Chicago Medical Center; University of Chicago; University of Chicago; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; Universite Paris Saclay; CEA; CY Cergy Paris Universite; Centre National de la Recherche Scientifique (CNRS)	Gardel, ML (corresponding author), Univ Chicago, Med Ctr, Inst Biophys Dynam, Chicago, IL 60637 USA.	gardel@uchicago.edu	Campillo, Clément/AAE-5395-2019; vasquez, robert/G-9016-2013	Campillo, Clément/0000-0003-4698-8643; vasquez, robert/0000-0002-5321-2846	Packard Foundation Grant	Packard Foundation Grant	Packard Foundation Grant. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aratyn-Schaus Y, 2010, CURR BIOL, V20, P1145, DOI 10.1016/j.cub.2010.05.049; Bergert M, 2012, P NATL ACAD SCI USA, V109, P14434, DOI 10.1073/pnas.1207968109; Bryce NS, 2005, CURR BIOL, V15, P1276, DOI 10.1016/j.cub.2005.06.043; Chang C, 2001, TRENDS CELL BIOL, V11, pS37, DOI 10.1016/S0962-8924(01)82222-4; Charras G, 2008, NAT REV MOL CELL BIO, V9, P730, DOI 10.1038/nrm2453; Charras GT, 2008, BIOPHYS J, V94, P1836, DOI 10.1529/biophysj.107.113605; Choi CK, 2008, NAT CELL BIOL, V109, P14434; DAI JW, 1995, BIOPHYS J, V68, P988, DOI 10.1016/S0006-3495(95)80274-2; DeMali KA, 2002, J CELL BIOL, V159, P881, DOI 10.1083/jcb.200206043; Di Nardo A, 2005, P NATL ACAD SCI USA, V102, P16263, DOI 10.1073/pnas.0508228102; Diz-Munoz A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000544; Fackler OT, 2008, J CELL BIOL, V181, P879, DOI 10.1083/jcb.200802081; Gardel M. L., 2010, ANNU REV CELL DEV BI, V26; Gardel ML, 2008, J CELL BIOL, V183, P999, DOI 10.1083/jcb.200810060; Gupton SL, 2005, J CELL BIOL, V168, P619, DOI 10.1083/jcb.200406063; Hochmuth RM, 2000, J BIOMECH, V33, P15, DOI 10.1016/S0021-9290(99)00175-X; Iwasa JH, 2007, CURR BIOL, V17, P395, DOI 10.1016/j.cub.2007.02.012; Lacayo CI, 2007, PLOS BIOL, V5, P2035, DOI 10.1371/journal.pbio.0050233; Lammermann T, 2009, CURR OPIN CELL BIOL, V21, P636, DOI 10.1016/j.ceb.2009.05.003; Laukaitis CM, 2001, J CELL BIOL, V153, P1427, DOI 10.1083/jcb.153.7.1427; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Merkel R, 2000, BIOPHYS J, V79, P707, DOI 10.1016/S0006-3495(00)76329-6; Nicholson-Dykstra SM, 2008, CELL MOTIL CYTOSKEL, V65, P904, DOI 10.1002/cm.20312; Nolen BJ, 2009, NATURE, V460, P1031, DOI 10.1038/nature08231; Oakes PW, 2012, J CELL BIOL, V196, P363, DOI 10.1083/jcb.201107042; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Poincloux R, 2011, P NATL ACAD SCI USA, V108, P1943, DOI 10.1073/pnas.1010396108; Raucher D, 2000, J CELL BIOL, V148, P127, DOI 10.1083/jcb.148.1.127; Rizvi SA, 2009, CHEM BIOL, V16, P1158, DOI 10.1016/j.chembiol.2009.10.006; Saarikangas J, 2010, PHYSIOL REV, V90, P259, DOI 10.1152/physrev.00036.2009; Suraneni P, 2012, J CELL BIOL, V197, P239, DOI 10.1083/jcb.201112113; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Thievessen I, 2013, J CELL BIOL, V202, P163, DOI 10.1083/jcb.201303129; Vicente-Manzanares M, 2009, J CELL SCI, V122, P199, DOI 10.1242/jcs.018564; Wehrle-Haller B, 2012, CURR OPIN CELL BIOL, V24, P569, DOI 10.1016/j.ceb.2012.06.010; Wu CY, 2013, J CELL BIOL, V203, P907, DOI 10.1083/jcb.201306032; Wu CY, 2012, CELL, V148, P973, DOI 10.1016/j.cell.2011.12.034	38	27	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100943	10.1371/journal.pone.0100943	http://dx.doi.org/10.1371/journal.pone.0100943			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967897	gold, Green Published, Green Submitted			2022-12-27	WOS:000338280800088
J	Flehmig, G; Scholz, M; Kloting, N; Fasshauer, M; Tonjes, A; Stumvoll, M; Youn, BS; Bluher, M				Flehmig, Gesine; Scholz, Markus; Kloeting, Nora; Fasshauer, Mathias; Toenjes, Anke; Stumvoll, Michael; Youn, Byung-Soo; Blueher, Matthias			Identification of Adipokine Clusters Related to Parameters of Fat Mass, Insulin Sensitivity and Inflammation	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; BONE MORPHOGENETIC PROTEIN-7; IMPAIRED GLUCOSE REGULATION; ADIPOSE-TISSUE DYSFUNCTION; VASPIN GENE-EXPRESSION; METABOLIC SYNDROME; HUMAN OBESITY; WEIGHT-LOSS; VISCERAL ADIPOSITY; BROWN ADIPOGENESIS	In obesity, elevated fat mass and ectopic fat accumulation are associated with changes in adipokine secretion, which may link obesity to inflammation and the development of insulin resistance. However, relationships among individual adipokines and between adipokines and parameters of obesity, glucose metabolism or inflammation are largely unknown. Serum concentrations of 20 adipokines were measured in 141 Caucasian obese men (n = 67) and women (n = 74) with a wide range of body weight, glycemia and insulin sensitivity. Unbiased, distance-based hierarchical cluster analyses were performed to recognize patterns among adipokines and their relationship with parameters of obesity, glucose metabolism, insulin sensitivity and inflammation. We identified two major adipokine clusters related to either (1) body fat mass and inflammation (leptin, ANGPTL3, DLL1, chemerin, Nampt, resistin) or insulin sensitivity/hyperglycemia, and lipid metabolism (vaspin, clusterin, glypican 4, progranulin, ANGPTL6, GPX3, RBP4, DLK1, SFRP5, BMP7, adiponectin, CTRP3 and 5, omentin). In addition, we found distinct adipokine clusters in subgroups of patients with or without type 2 diabetes (T2D). Logistic regression analyses revealed ANGPTL6, DLK1, Nampt and progranulin as strongest adipokine correlates of T2D in obese individuals. The panel of 20 adipokines predicted T2D compared to a combination of HbA1c, HOMA-IR and fasting plasma glucose with lower sensitivity (78% versus 91%) and specificity (76% versus 94%). Therefore, adipokine patterns may currently not be clinically useful for the diagnosis of metabolic diseases. Whether adipokine patterns are relevant for the predictive assessment of intervention outcomes needs to be further investigated.	[Flehmig, Gesine; Fasshauer, Mathias; Toenjes, Anke; Stumvoll, Michael; Blueher, Matthias] Univ Leipzig, Dept Med, D-04109 Leipzig, Germany; [Scholz, Markus] Univ Leipzig, Inst Med Informat Stat & Epidemiol, D-04109 Leipzig, Germany; [Kloeting, Nora] Univ Leipzig, IFB ObesityDis, Jr Res Grp Anim Models, D-04109 Leipzig, Germany; [Youn, Byung-Soo] Korea Univ, Coll Life Sci & Biotechnol, AdipoGen, Seoul, South Korea; [Youn, Byung-Soo] Univ Ulsan, Immunomodulat Res Ctr, Ulsan 680749, South Korea	Leipzig University; Leipzig University; Leipzig University; Korea University; University of Ulsan	Youn, BS (corresponding author), OsteoNeuroGen, 40 MiKeum RO, Songnam, Kyunggi Do, South Korea.	byung4jc@gmail.com; bluma@medizin.uni-leipzig.de	Stumvoll, Michael/ABE-1121-2021	Stumvoll, Michael/0000-0001-6225-8240	Kompetenznetz Adipositas (Competence network for Obesity) - Federal Ministry of Education and Research (German Obesity Biomaterial Bank); Deutsche Forschungsgemeinschaft [SFB 1052/1]; Helmholtz Alliance ICEMED - Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Networking Fund of the Helmholtz Association	Kompetenznetz Adipositas (Competence network for Obesity) - Federal Ministry of Education and Research (German Obesity Biomaterial Bank); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Helmholtz Alliance ICEMED - Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Networking Fund of the Helmholtz Association	This work was supported by the Kompetenznetz Adipositas (Competence network for Obesity) funded by the Federal Ministry of Education and Research (German Obesity Biomaterial Bank; FKZ 01GI1128), a grant from Deutsche Forschungsgemeinschaft, the SFB 1052/1: "Obesity mechanisms'' (project B01) (both to MB), and by the Helmholtz Alliance ICEMED - Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Networking Fund of the Helmholtz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2000, ANNU REV PHYSIOL, V62, P413, DOI 10.1146/annurev.physiol.62.1.413; Amato MC, 2010, DIABETES CARE, V33, P920, DOI 10.2337/dc09-1825; Azuma K, 2003, OBES RES, V11, P997, DOI 10.1038/oby.2003.137; Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4; Batista CMDS, 2007, DIABETES, V56, P1655, DOI 10.2337/db06-1506; Berndt J, 2005, DIABETES, V54, P2911, DOI 10.2337/diabetes.54.10.2911; Bluher M, 2013, BEST PRACT RES CL EN, V27, P163, DOI 10.1016/j.beem.2013.02.005; Bluher M, 2012, DIABETES CARE, V35, P342, DOI 10.2337/dc11-1267; Bluhre M, 2009, EXP CLIN ENDOCR DIAB, V117, P241, DOI 10.1055/s-0029-1192044; Bozaoglu K, 2007, ENDOCRINOLOGY, V148, P4687, DOI 10.1210/en.2007-0175; Chakaroun R, 2012, METABOLISM, V61, P706, DOI 10.1016/j.metabol.2011.10.008; Dallmeier D, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-28; Fasshauer M, 2002, BIOCHEM BIOPH RES CO, V290, P1084, DOI 10.1006/bbrc.2001.6307; Ferrannini E, 1997, J CLIN INVEST, V100, P1166, DOI 10.1172/JCI119628; Fruhbeck G, 2009, TRENDS PHARMACOL SCI, V30, P387, DOI 10.1016/j.tips.2009.05.003; Goralski KB, 2007, J BIOL CHEM, V282, P28175, DOI 10.1074/jbc.M700793200; Graham TE, 2006, NEW ENGL J MED, V354, P2552, DOI 10.1056/NEJMoa054862; Hida K, 2005, P NATL ACAD SCI USA, V102, P10610, DOI 10.1073/pnas.0504703102; Hoofnagle AN, 2010, ARTERIOSCL THROM VAS, V30, P2528, DOI 10.1161/ATVBAHA.110.212894; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hu WJ, 2013, J CLIN ENDOCR METAB, V98, P290, DOI 10.1210/jc.2012-2466; Janke J, 2006, DIABETES, V55, P2805, DOI 10.2337/db06-0616; Kadoglou NPE, 2011, EXP CLIN ENDOCR DIAB, V119, P63, DOI 10.1055/s-0030-1265174; Kadoglou NPE, 2011, CLIN CHIM ACTA, V412, P48, DOI 10.1016/j.cca.2010.09.012; Karelis AD, 2008, DIABETOLOGIA, V51, P1752, DOI 10.1007/s00125-008-1038-4; Kengne AP, 2014, LANCET DIABETES ENDO, V2, P19, DOI 10.1016/S2213-8587(13)70103-7; Kettaneh A, 2006, METABOLISM, V55, P1171, DOI 10.1016/j.metabol.2006.04.015; Kloeting N, 2007, CELL METAB, V6, P79, DOI 10.1016/j.cmet.2007.06.002; Kloting N, 2010, AM J PHYSIOL-ENDOC M, V299, pE506, DOI 10.1152/ajpendo.00586.2009; Kloting N, 2006, BIOCHEM BIOPH RES CO, V339, P430, DOI 10.1016/j.bbrc.2005.11.039; Kuk JL, 2006, OBESITY, V14, P336, DOI 10.1038/oby.2006.43; Laudes M, 2010, HORM METAB RES, V42, P268, DOI 10.1055/s-0029-1243638; Lee JA, 2011, ENDOCR J, V58, P639, DOI 10.1507/endocrj.K11E-073; Lehr S, 2012, PROTEOM CLIN APPL, V6, P91, DOI 10.1002/prca.201100052; Moreno-Navarrete JM, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-27; Mather KJ, 2008, DIABETES, V57, P980, DOI 10.2337/db07-1419; Matsubara T, 2012, CELL METAB, V15, P38, DOI 10.1016/j.cmet.2011.12.002; Meisinger C, 2010, DIABETIC MED, V27, P360, DOI 10.1111/j.1464-5491.2009.02905.x; Montagne CT, 2000, DIABETES, V49, P883, DOI 10.2337/diabetes.49.6.883; O'Connell J, 2011, J CLIN ENDOCR METAB, V96, pE680, DOI 10.1210/jc.2010-2026; Orlik B, 2014, CLIN ENDOCRINOL, V81, P529, DOI 10.1111/cen.12381; Park H, 2012, J HUM NUTR DIET, V25, P300, DOI 10.1111/j.1365-277X.2012.01262.x; Rasouli N, 2007, DIABETES OBES METAB, V9, P1, DOI 10.1111/j.1463-1326.2006.00590.x; Spranger J, 2003, LANCET, V361, P226, DOI 10.1016/S0140-6736(03)12255-6; Stefan N, 2007, DIABETES CARE, V30, P1173, DOI 10.2337/dc06-2342; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Tan BK, 2008, DIABETES, V57, P1501, DOI 10.2337/db08-0127; Tan BK, 2013, J CLIN ENDOCR METAB, V98, pE1891, DOI 10.1210/jc.2013-2227; Tan BK, 2010, DIABETES, V59, P3023, DOI 10.2337/db10-0124; Tan BK, 2009, DIABETES, V58, P1971, DOI 10.2337/db08-1528; Tonjes A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013911; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Tuomilehto J, 2003, DIABETES CARE, V26, P61; Turer AT, 2012, DIABETOLOGIA, V55, P2319, DOI 10.1007/s00125-012-2598-x; Ussar S, 2012, DIABETES, V61, P2289, DOI 10.2337/db11-1395; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; van Vliet-Ostaptchouk JV, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-9; Vangipurapu J, 2011, DIABETOLOGIA, V54, P540, DOI 10.1007/s00125-010-1966-7; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Wittamer V, 2003, J EXP MED, V198, P977, DOI 10.1084/jem.20030382; Ye RS, 2013, MOL METAB, V2, P133, DOI 10.1016/j.molmet.2013.04.001; Yoo HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055744; Youn B, 2007, DIABETES, V57, P372, DOI DOI 10.2337/DB07-1045); Youn BS, 2009, DIABETES, V58, P627, DOI 10.2337/db08-1147; Zeng J, 2011, DIABETES RES CLIN PR, V93, pE21, DOI 10.1016/j.diabres.2011.03.010; Zhang HB, 2010, MOL CELL BIOL, V30, P4224, DOI 10.1128/MCB.00363-10	66	96	101	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e99785	10.1371/journal.pone.0099785	http://dx.doi.org/10.1371/journal.pone.0099785			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968098	Green Published, Green Submitted, gold			2022-12-27	WOS:000338280800020
J	Jambhekar, A; Emerman, AB; Schweidenback, CTH; Blower, MD				Jambhekar, Ashwini; Emerman, Amy B.; Schweidenback, Caterina T. H.; Blower, Michael D.			RNA Stimulates Aurora B Kinase Activity during Mitosis	PLOS ONE			English	Article							CHROMOSOMAL PASSENGER COMPLEX; MAJOR DEVELOPMENTAL TRANSITION; EARLY XENOPUS-EMBRYOS; MITOTIC SPINDLE; MESSENGER-RNA; BINDING-PROTEIN; IMPORTIN-BETA; EGG EXTRACTS; CAENORHABDITIS-ELEGANS; MICROTUBULE DYNAMICS	Accurate chromosome segregation is essential for cell viability. The mitotic spindle is crucial for chromosome segregation, but much remains unknown about factors that regulate spindle assembly. Recent work implicates RNA in promoting proper spindle assembly independently of mRNA translation; however, the mechanism by which RNA performs this function is currently unknown. Here, we show that RNA regulates both the localization and catalytic activity of the mitotic kinase, Aurora-B (AurB), which is present in a ribonucleoprotein (RNP) complex with many mRNAs. Interestingly, AurB kinase activity is reduced in Xenopus egg extracts treated with RNase, and its activity is stimulated in vitro by RNA binding. Spindle assembly defects following RNase-treatment are partially rescued by inhibiting MCAK, a microtubule depolymerase that is inactivated by AurB-dependent phosphorylation. These findings implicate AurB as an important RNA-dependent spindle assembly factor, and demonstrate a translation-independent role for RNA in stimulating AurB.	[Jambhekar, Ashwini; Emerman, Amy B.; Schweidenback, Caterina T. H.; Blower, Michael D.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Jambhekar, Ashwini; Emerman, Amy B.; Schweidenback, Caterina T. H.; Blower, Michael D.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Blower, MD (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	blower@molbio.mgh.harvard.edu		Jambhekar, Ashwini/0000-0003-1078-6601; Blower, Michael/0000-0002-5037-1972	National Institutes of Health (NIH) [RO1GM086434]; Burroughs Wellcome Fund Career Award in the Biomedical Sciences; National Science Foundation (NSF) GRFP; NIH [F32 GM090533]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM090533, R01GM086434] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Career Award in the Biomedical Sciences(Burroughs Wellcome Fund); National Science Foundation (NSF) GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded the following grants: National Institutes of Health (NIH) RO1 (RO1GM086434) (M. D. B.), Burroughs Wellcome Fund Career Award in the Biomedical Sciences (M. D. B.), National Science Foundation (NSF) GRFP (A. E.), and NIH F32 GM090533 (C. T. H. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5; Audhya A, 2005, J CELL BIOL, V171, P267, DOI 10.1083/jcb.200506124; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Baltz AG, 2012, MOL CELL, V46, P674, DOI 10.1016/j.molcel.2012.05.021; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; Blower MD, 2005, CELL, V121, P223, DOI 10.1016/j.cell.2005.02.016; Blower MD, 2007, J CELL BIOL, V179, P1365, DOI 10.1083/jcb.200705163; Bolton MA, 2002, MOL BIOL CELL, V13, P3064, DOI 10.1091/mbc.E02-02-0092; Carmena M, 2012, NAT REV MOL CELL BIO, V13, P789, DOI 10.1038/nrm3474; Castello A, 2013, NAT PROTOC, V8, P491, DOI 10.1038/nprot.2013.020; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Chan FL, 2012, P NATL ACAD SCI USA, V109, P1979, DOI 10.1073/pnas.1108705109; Ciesla J, 2006, ACTA BIOCHIM POL, V53, P11; Cimini D, 2007, CELL CYCLE, V6, P1558, DOI 10.4161/cc.6.13.4452; Darnell RB, 2010, WIRES RNA, V1, P266, DOI 10.1002/wrna.31; Davidovich C, 2013, NAT STRUCT MOL BIOL, V20, P1250, DOI 10.1038/nsmb.2679; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; EARNSHAW WC, 1991, CHROMOSOMA, V100, P139, DOI 10.1007/BF00337241; Edwards NS, 2005, MOL BIOL CELL, V16, P1800, DOI 10.1091/mbc.e04-09-0788; Eliscovich C, 2008, NAT CELL BIOL, V10, P858, DOI 10.1038/ncb1746; Ferri F, 2009, NUCLEIC ACIDS RES, V37, P5071, DOI 10.1093/nar/gkp529; Gadde S, 2004, CURR BIOL, V14, pR797, DOI 10.1016/j.cub.2004.09.021; Gadea BB, 2006, P NATL ACAD SCI USA, V103, P4493, DOI 10.1073/pnas.0600702103; Gent JI, 2012, ANNU REV GENET, V46, P443, DOI 10.1146/annurev-genet-110711-155419; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; Groen AC, 2009, MOL BIOL CELL, V20, P2766, DOI 10.1091/mbc.E09-01-0043; Groisman I, 2000, CELL, V103, P435, DOI 10.1016/S0092-8674(00)00135-5; Gruss OJ, 2001, CELL, V104, P83, DOI 10.1016/S0092-8674(01)00193-3; Hafner M, 2013, RNA, V19, P613, DOI 10.1261/rna.036491.112; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hannak E, 2006, NAT PROTOC, V1, P2305, DOI 10.1038/nprot.2006.396; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hussain S, 2009, J CELL BIOL, V186, P27, DOI 10.1083/jcb.200810180; Ince-Dunn G, 2012, NEURON, V75, P1067, DOI 10.1016/j.neuron.2012.07.009; KARSENTI E, 1984, J CELL BIOL, V99, pS47, DOI 10.1083/jcb.99.1.47s; Kelly AE, 2007, DEV CELL, V12, P31, DOI 10.1016/j.devcel.2006.11.001; KENNEDY MC, 1992, P NATL ACAD SCI USA, V89, P11730, DOI 10.1073/pnas.89.24.11730; Kim Y, 2008, J CELL BIOL, V181, P411, DOI 10.1083/jcb.200802189; Kingsley EP, 2007, EVOL DEV, V9, P527, DOI 10.1111/j.1525-142X.2007.00194.x; Klein UR, 2006, MOL BIOL CELL, V17, P2547, DOI 10.1091/mbc.E05-12-1133; Knowlton AL, 2006, CURR BIOL, V16, P1705, DOI 10.1016/j.cub.2006.07.057; Koffa MD, 2006, CURR BIOL, V16, P743, DOI 10.1016/j.cub.2006.03.056; Kwon SC, 2013, NAT STRUCT MOL BIOL, V20, P1122, DOI 10.1038/nsmb.2638; Lambert JD, 2002, NATURE, V420, P682, DOI 10.1038/nature01241; Lan WJ, 2004, CURR BIOL, V14, P273, DOI 10.1016/j.cub.2004.01.055; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Makino DL, 2013, NATURE, V495, P70, DOI 10.1038/nature11870; MITCHISON T, 1984, NATURE, V312, P232, DOI 10.1038/312232a0; Mitchison TJ, 2005, MOL BIOL CELL, V16, P3064, DOI 10.1091/mbc.E05-02-0174; Nachury MV, 2001, CELL, V104, P95, DOI 10.1016/S0092-8674(01)00194-5; NAGY E, 1995, J BIOL CHEM, V270, P2755, DOI 10.1074/jbc.270.6.2755; Nakano M, 2008, DEV CELL, V14, P507, DOI 10.1016/j.devcel.2008.02.001; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; NEWPORT J, 1982, CELL, V30, P687, DOI 10.1016/0092-8674(82)90273-2; Ohi R, 2004, MOL BIOL CELL, V15, P2895, DOI 10.1091/mbc.E04-02-0082; Rabinowitz JS, 2010, DEVELOPMENT, V137, P4039, DOI 10.1242/dev.055269; RAFF JW, 1990, DEVELOPMENT, V110, P1249; Ribbeck K, 2006, MOL BIOL CELL, V17, P2646, DOI 10.1091/mbc.E05-12-1178; Rosasco-Nitcher SE, 2008, SCIENCE, V319, P469, DOI 10.1126/science.1148980; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Sampath SC, 2004, CELL, V118, P187, DOI 10.1016/j.cell.2004.06.026; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Sharp JA, 2011, MOL BIOL CELL, V22, P4312, DOI 10.1091/mbc.E11-07-0629; Sillje HHW, 2006, CURR BIOL, V16, P731, DOI 10.1016/j.cub.2006.02.070; Squirrell JM, 2006, MOL BIOL CELL, V17, P336, DOI 10.1091/mbc.E05-09-0874; Tan MH, 2013, GENOME RES, V23, P201, DOI 10.1101/gr.141424.112; Tournebize R, 2000, NAT CELL BIOL, V2, P13, DOI 10.1038/71330; Tseng BS, 2010, DEV CELL, V18, P903, DOI 10.1016/j.devcel.2010.05.018; Walczak CE, 1996, CELL, V84, P37, DOI 10.1016/S0092-8674(00)80991-5; Wiese C, 2001, SCIENCE, V291, P653, DOI 10.1126/science.1057661; Wong LH, 2007, GENOME RES, V17, P1146, DOI 10.1101/gr.6022807; Zhang X, 2007, MOL BIOL CELL, V18, P3264, DOI 10.1091/mbc.E07-01-0086; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011	77	34	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100748	10.1371/journal.pone.0100748	http://dx.doi.org/10.1371/journal.pone.0100748			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968351	Green Published, Green Submitted, gold			2022-12-27	WOS:000338280800063
J	Mac Sharry, J; Shalaby, KH; Marchica, C; Farahnak, S; Chieh-Li, T; Lapthorne, S; Qureshi, ST; Shanahan, F; Martin, JG				Mac Sharry, John; Shalaby, Karim H.; Marchica, Cinzia; Farahnak, Soroor; Chieh-Li, Tien; Lapthorne, Susan; Qureshi, Salman T.; Shanahan, Fergus; Martin, James G.			Concomitant Exposure to Ovalbumin and Endotoxin Augments Airway Inflammation but Not Airway Hyperresponsiveness in a Murine Model of Asthma	PLOS ONE			English	Article							KAPPA-B ACTIVATION; ALLERGIC-ASTHMA; MESSENGER-RNA; T-CELLS; LUNG INFLAMMATION; BINDING-PROTEIN; DENDRITIC CELLS; RESPONSES; EXPRESSION; IL-5	Varying concentrations of lipopolysaccharide (LPS) in ovalbumin (OVA) may influence the airway response to allergic sensitization and challenge. We assessed the contribution of LPS to allergic airway inflammatory responses following challenge with LPS-rich and LPS-free commercial OVA. BALB/c mice were sensitized with LPS-rich OVA and alum and then underwent challenge with the same OVA (10 mu g intranasally) or an LPS-free OVA. Following challenge, bronchoalveolar lavage (BAL), airway responsiveness to methacholine and the lung regulatory T cell population (Treg) were assessed. Both OVA preparations induced BAL eosinophilia but LPS-rich OVA also evoked BAL neutrophilia. LPS-free OVA increased interleukin (IL)-2, IL-4 and IL-5 whereas LPS-rich OVA additionally increased IL-1 beta, IL-12, IFN-gamma, TNF-alpha and KC. Both OVA-challenged groups developed airway hyperresponsiveness. TLR4-deficient mice challenged with either OVA preparation showed eosinophilia but not neutrophilia and had increased IL-5. Only LPS-rich OVA challenged mice had increased lung Tregs and LPS-rich OVA also induced in vitro Treg differentiation. LPS-rich OVA also induced a Th1 cytokine response in human peripheral blood mononuclear cells. We conclude that LPS-rich OVA evokes mixed Th1, Th2 and innate immune responses through the TLR-4 pathway, whereas LPS-free OVA evokes only a Th2 response. Contaminating LPS is not required for induction of airway hyperresponsiveness but amplifies the Th2 inflammatory response and is a critical mediator of the neutrophil, Th1 and T regulatory cell responses to OVA.	[Shalaby, Karim H.; Marchica, Cinzia; Farahnak, Soroor; Chieh-Li, Tien; Qureshi, Salman T.; Martin, James G.] McGill Univ, Meakins Christie Labs, Dept Med, Montreal, PQ, Canada; [Mac Sharry, John; Lapthorne, Susan; Shanahan, Fergus] Natl Univ Ireland Univ Coll Cork, Sch Med, Alimentary Pharmabiot Ctr, Cork, Ireland	McGill University; University College Cork	Martin, JG (corresponding author), McGill Univ, Meakins Christie Labs, Dept Med, Montreal, PQ, Canada.	james.martin@mcgill.ca	Shanahan, Fergus/ABF-2390-2020; Sharry, John A Mac/M-7209-2017	Shanahan, Fergus/0000-0003-0467-0936; Sharry, John A Mac/0000-0002-9528-6261; Martin, James/0000-0001-7574-5363	Science Foundation of Ireland; Walton Fellowship; Short term travel fellowship (STTF); Canadian Thoracic Society	Science Foundation of Ireland(Science Foundation Ireland); Walton Fellowship(Science Foundation Ireland); Short term travel fellowship (STTF); Canadian Thoracic Society	This study was supported by the Science Foundation of Ireland research grants, Walton Fellowship and Short term travel fellowship (STTF), awarded to J.G. Martin and J. Mac Sharry, respectively. K. H. Shalaby was supported by a studentship from the Canadian Thoracic Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bortolatto J, 2008, CLIN EXP ALLERGY, V38, P1668, DOI 10.1111/j.1365-2222.2008.03036.x; BOZIC CR, 1994, J BIOL CHEM, V269, P29355; Chapman TJ, 2013, J IMMUNOL, V191, P4423, DOI 10.4049/jimmunol.1300042; Corry DB, 1996, J EXP MED, V183, P109, DOI 10.1084/jem.183.1.109; de Boer JD, 2013, AM J RESP CELL MOL, V48, P382, DOI 10.1165/rcmb.2012-0331OC; de Lafaille MAC, 2008, IMMUNITY, V29, P114, DOI 10.1016/j.immuni.2008.05.010; Dong L, 2009, J ASTHMA, V46, P229, DOI 10.1080/02770900802610050; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Ewart SL, 2000, AM J RESP CELL MOL, V23, P537, DOI 10.1165/ajrcmb.23.4.4199; Franchi L, 2009, IMMUNOL REV, V227, P106, DOI 10.1111/j.1600-065X.2008.00734.x; HAMID Q, 1991, INT ARCH ALLER A IMM, V94, P169, DOI 10.1159/000235353; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Holt PG, 2005, J ALLERGY CLIN IMMUN, V116, P16, DOI 10.1016/j.jaci.2005.04.017; KUNG TT, 1995, AM J RESP CELL MOL, V13, P360, DOI 10.1165/ajrcmb.13.3.7654390; Lambrecht BN, 2005, ALLERGY, V60, P271, DOI 10.1111/j.1398-9995.2005.00708.x; Lewkowich IP, 2005, J EXP MED, V202, P1549, DOI 10.1084/jem.20051506; Li JJ, 2010, J IMMUNOL, V185, P4401, DOI 10.4049/jimmunol.1001039; Lundblad LKA, 2007, EUR RESPIR J, V30, P805, DOI 10.1183/09031936.00091307; Machida I, 2004, J IMMUNOL, V172, P1833, DOI 10.4049/jimmunol.172.3.1833; MALO JL, 1992, J ALLERGY CLIN IMMUN, V90, P937, DOI 10.1016/0091-6749(92)90466-F; Morgan RK, 2007, J IMMUNOL, V178, P8081, DOI 10.4049/jimmunol.178.12.8081; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; O'Carroll C, 2014, J IMMUNOL, V192, P427, DOI 10.4049/jimmunol.1301722; OKAYAMA Y, 1995, J IMMUNOL, V155, P1796; Olivenstein R, 1999, J ALLERGY CLIN IMMUN, V103, P238, DOI 10.1016/S0091-6749(99)70497-5; Peters M, 2010, IMMUNOL CELL BIOL, V88, P537, DOI 10.1038/icb.2010.3; Piggott DA, 2005, J CLIN INVEST, V115, P459, DOI 10.1172/JCI200522462; Poynter ME, 2004, J IMMUNOL, V173, P7003, DOI 10.4049/jimmunol.173.11.7003; Poynter ME, 2003, J IMMUNOL, V170, P6257, DOI 10.4049/jimmunol.170.12.6257; Shainheit MG, 2008, J IMMUNOL, V181, P8559, DOI 10.4049/jimmunol.181.12.8559; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Strickland DH, 2006, J EXP MED, V203, P2649, DOI 10.1084/jem.20060155; Strohmeier GR, 2001, J IMMUNOL, V166, P2063, DOI 10.4049/jimmunol.166.3.2063; Tan AM, 2010, J IMMUNOL, V184, P3535, DOI 10.4049/jimmunol.0900340; Thomas CJ, 2002, FEBS LETT, V531, P184, DOI 10.1016/S0014-5793(02)03499-3; Tsuchiya K, 2012, AM J PHYSIOL-LUNG C, V303, pL54, DOI 10.1152/ajplung.00208.2011; von Mutius Erika, 2007, Proc Am Thorac Soc, V4, P212, DOI 10.1513/pats.200701-028AW; W KL, 2007, ENDOTOXINS PYROGENS; Watanabe J, 2003, J BIOL CHEM, V278, P42361, DOI 10.1074/jbc.M307752200; Whitehead GS, 2013, ENV HLTH PERSPECTIVE; Wills-Karp M, 2001, J ALLERGY CLIN IMMUN, V107, P9, DOI 10.1067/mai.2001.112265; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Wilson RH, 2009, AM J RESP CRIT CARE, V180, P720, DOI 10.1164/rccm.200904-0573OC	46	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e98648	10.1371/journal.pone.0098648	http://dx.doi.org/10.1371/journal.pone.0098648			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968337	Green Published, Green Submitted, gold			2022-12-27	WOS:000338280800003
J	Panek, J; El Alaoui, H; Mone, A; Urbach, S; Demettre, E; Texier, C; Brun, C; Zanzoni, A; Peyretaillade, E; Parisot, N; Lerat, E; Peyret, P; Delbac, F; Biron, DG				Panek, Johan; El Alaoui, Hicham; Mone, Anne; Urbach, Serge; Demettre, Edith; Texier, Catherine; Brun, Christine; Zanzoni, Andreas; Peyretaillade, Eric; Parisot, Nicolas; Lerat, Emmanuelle; Peyret, Pierre; Delbac, Frederic; Biron, David G.			Hijacking of Host Cellular Functions by an Intracellular Parasite, the Microsporidian Anncaliia algerae	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; TRANSPOSABLE ELEMENTS; BRACHIOLA-ALGERAE; AEDES-AEGYPTI; AMINO-ACIDS; GENOME; PROTEOMICS; PATHOGEN; IDENTIFICATION; ANNOTATION	Intracellular pathogens including bacteria, viruses and protozoa hijack host cell functions to access nutrients and to bypass cellular defenses and immune responses. These strategies have been acquired through selective pressure and allowed pathogens to reach an appropriate cellular niche for their survival and growth. To get new insights on how parasites hijack host cellular functions, we developed a SILAC (Stable Isotope Labeling by Amino Acids in Cell culture) quantitative proteomics workflow. Our study focused on deciphering the cross-talk in a host-parasite association, involving human foreskin fibroblasts (HFF) and the microsporidia Anncaliia algerae, a fungus related parasite with an obligate intracellular lifestyle and a strong host dependency. The host-parasite cross-talk was analyzed at five post-infection times 1, 6, 12 and 24 hours post-infection (hpi) and 8 days post-infection (dpi). A significant up-regulation of four interferon-induced proteins with tetratricopeptide repeats IFIT1, IFIT2, IFIT3 and MX1 was observed at 8 dpi suggesting a type 1 interferon (IFN) host response. Quantitative alteration of host proteins involved in biological functions such as signaling (STAT1, Ras) and reduction of the translation activity (EIF3) confirmed a host type 1 IFN response. Interestingly, the SILAC approach also allowed the detection of 148 A. algerae proteins during the kinetics of infection. Among these proteins many are involved in parasite proliferation, and an over-representation of putative secreted effectors proteins was observed. Finally our survey also suggests that A. algerae could use a transposable element as a lure strategy to escape the host innate immune system.	[Panek, Johan; El Alaoui, Hicham; Mone, Anne; Texier, Catherine; Delbac, Frederic; Biron, David G.] Univ Blaise Pascal, Clermont Univ, Lab Microorganismes Genome & Environm, Clermont Ferrand, France; [Panek, Johan; El Alaoui, Hicham; Mone, Anne; Texier, Catherine; Delbac, Frederic; Biron, David G.] CNRS, UMR 6023, LMGE, Aubiere, France; [Urbach, Serge] CNRS, UMR 5203, Montpellier, France; [Demettre, Edith] CNRS, UMS 3426, Montpellier, France; [Brun, Christine; Zanzoni, Andreas] INSERM, UMR1090, TAGC, F-13258 Marseille, France; [Brun, Christine; Zanzoni, Andreas] Aix Marseille Univ, UMR1090, TAGC, Marseille, France; [Brun, Christine] CNRS, Marseille, France; [Peyretaillade, Eric; Parisot, Nicolas; Peyret, Pierre] Univ Auvergne, Clermont Univ, IUT, UFR Pharm, Clermont Ferrand, France; [Peyretaillade, Eric; Parisot, Nicolas; Peyret, Pierre] Univ Auvergne, Clermont Univ, EA 4678, Clermont Ferrand, France; [Lerat, Emmanuelle] Univ Lyon 1, CNRS, UMR5558, Lab Biometrie & Biol Evolut, F-69622 Villeurbanne, France	Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup	El Alaoui, H (corresponding author), Univ Blaise Pascal, Clermont Univ, Lab Microorganismes Genome & Environm, Clermont Ferrand, France.	Hicham.EL_ALAOUI@univ-bpclermont.fr; david.biron1@univ-bpclermont.fr	Zanzoni, Andreas/I-1664-2019; Brun, Christine/B-4922-2008; Zanzoni, Andreas/D-2188-2012; Parisot, Nicolas/C-8116-2012	Zanzoni, Andreas/0000-0002-4818-6161; Brun, Christine/0000-0002-5563-6765; Zanzoni, Andreas/0000-0002-4818-6161; Parisot, Nicolas/0000-0001-5217-8415; El Alaoui, Hicham/0000-0003-1926-0905; PEYRET, Pierre/0000-0003-3114-0586; Panek, Johan/0000-0002-6026-9875; LERAT, Emmanuelle/0000-0001-6757-8796	Centre National de la Recherche Scientifique (France) (CNRS SILACFOOD); Ministere de l'Education Nationale de l'Enseignement Superieur et de la Recherche (France)	Centre National de la Recherche Scientifique (France) (CNRS SILACFOOD); Ministere de l'Education Nationale de l'Enseignement Superieur et de la Recherche (France)	This work was funded by a grant, Projets Exploratoires Pluridisciplinaires (PEPS) from the Centre National de la Recherche Scientifique (France) (CNRS SILACFOOD). J. P. was supported by a scholarship from the Ministere de l'Education Nationale de l'Enseignement Superieur et de la Recherche (France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baudry C, 2009, GENE DEV, V23, P2478, DOI 10.1101/gad.547309; Belkorchia A, 2008, PARASITOL INT, V57, P62, DOI 10.1016/j.parint.2007.09.002; Biemont C, 2010, GENETICS, V186, P1085, DOI 10.1534/genetics.110.124180; Biron DG, 2013, J EXP BIOL, V216, P148, DOI 10.1242/jeb.073825; Biron DG, 2011, GENETICS AND EVOLUTION OF INFECTIOUS DISEASES, P263, DOI 10.1016/B978-0-12-384890-1.00011-X; Biron DG, 2005, INT J PARASITOL, V35, P1385, DOI 10.1016/j.ijpara.2005.05.015; Biron DG, 2005, TRENDS PARASITOL, V21, P162, DOI 10.1016/j.pt.2005.02.009; Capella-Gutierrez S, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-47; Carrero JA, 2013, INT IMMUNOL, V25, P663, DOI 10.1093/intimm/dxt050; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dean CB, 2007, LIFETIME DATA ANAL, V13, P497, DOI 10.1007/s10985-007-9065-x; Dimmer EC, 2012, NUCLEIC ACIDS RES, V40, pD565, DOI 10.1093/nar/gkr1048; Duncan AB, 2012, ECOL EVOL, V2, P681, DOI 10.1002/ece3.199; Gomez D, 2003, J IMMUNOL, V170, P5373, DOI 10.4049/jimmunol.170.11.5373; Gonzalez J, 2008, PLOS BIOL, V6, P2109, DOI 10.1371/journal.pbio.0060251; Hughes C, 2012, TRENDS BIOTECHNOL, V30, P668, DOI 10.1016/j.tibtech.2012.09.007; Hui DJ, 2005, J BIOL CHEM, V280, P3433, DOI 10.1074/jbc.M406700200; Jimenez-Mateos EM, 2006, BIOCHEM J, V397, P53, DOI 10.1042/BJ20060205; Kapitonov VV, 2005, PLOS BIOL, V3, P998, DOI 10.1371/journal.pbio.0030181; Katinka MD, 2001, NATURE, V414, P450, DOI 10.1038/35106579; Kostourou V, 2002, BRIT J CANCER, V87, P673, DOI 10.1038/sj.bjc.6600518; Kucerova Z, 2004, J EUKARYOT MICROBIOL, V51, P339, DOI 10.1111/j.1550-7408.2004.tb00577.x; Lafferty KD, 2006, P NATL ACAD SCI USA, V103, P11211, DOI 10.1073/pnas.0604755103; Lerat E, 2007, J MOL EVOL, V65, P215, DOI 10.1007/s00239-007-9001-4; MARGOS G, 1992, PARASITOL RES, V78, P168, DOI 10.1007/BF00931661; Mehta A, 2008, FEBS J, V275, P3731, DOI 10.1111/j.1742-4658.2008.06528.x; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Motylewska E, 2013, ENDOKRYNOL POL, V64, P368, DOI 10.5603/EP.2013.0020; Munday DC, 2012, PROTEOMICS, V12, P666, DOI 10.1002/pmic.201100488; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427; Pardue ML, 2003, ANNU REV GENET, V37, P485, DOI 10.1146/annurev.genet.38.072902.093115; Patramool S, 2012, PROTEOMICS, V12, P3510, DOI 10.1002/pmic.201200300; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Petrak J, 2008, PROTEOMICS, V8, P1744, DOI 10.1002/pmic.200700919; Peyretaillade E, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2156; Peyretaillade E, 2011, RES MICROBIOL, V162, P598, DOI 10.1016/j.resmic.2011.03.004; Peyretaillade E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-607; Pichyangkul S, 2004, J IMMUNOL, V172, P4926, DOI 10.4049/jimmunol.172.8.4926; Prajapati SK, 2013, BLOOD CELL MOL DIS, V51, P195, DOI 10.1016/j.bcmd.2013.06.003; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Saha S, 2006, J GEN VIROL, V87, P3285, DOI 10.1099/vir.0.82107-0; Scanlon M, 2004, J EUKARYOT MICROBIOL, V51, P81, DOI 10.1111/j.1550-7408.2004.tb00166.x; SchmidHempel P, 2011, EVOLUTIONARY PARASITOLOGY: THE INTEGRATED STUDY OF INFECTIONS, IMMUNOLOGY, ECOLOGY, AND GENETICS, P1; Sibley LD, 2011, IMMUNOL REV, V240, P72, DOI 10.1111/j.1600-065X.2010.00990.x; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Stawowczyk M, 2011, J BIOL CHEM, V286, P7257, DOI 10.1074/jbc.M110.207068; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Streit A, 2000, NATURE, V406, P74, DOI 10.1038/35017617; Texier C, 2010, CURR OPIN MICROBIOL, V13, P443, DOI 10.1016/j.mib.2010.05.005; VAVRA J, 1970, J PROTOZOOL, V17, P240, DOI 10.1111/j.1550-7408.1970.tb02365.x; Vavra J, 2013, ADV PARASIT, V82, P253, DOI 10.1016/B978-0-12-407706-5.00004-6; Vincendeau P, 2003, TRENDS PARASITOL, V19, P9, DOI 10.1016/S1471-4922(02)00010-7; Visvesvara GS, 2005, FOLIA PARASIT, V52, P83, DOI 10.14411/fp.2005.011; Volff JN, 2006, BIOESSAYS, V28, P913, DOI 10.1002/bies.20452; Wastling JM, 2012, PARASITOLOGY, V139, P1103, DOI 10.1017/S0031182012000716; Weber B, 2009, CELL SIGNAL, V21, P1513, DOI 10.1016/j.cellsig.2009.05.011; Weiske J, 2006, J BIOL CHEM, V281, P27356, DOI 10.1074/jbc.M513452200; Zhou X, 2013, INT J BIOL SCI, V9, P200, DOI 10.7150/ijbs.5613	61	17	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100791	10.1371/journal.pone.0100791	http://dx.doi.org/10.1371/journal.pone.0100791			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967735	Green Published, Green Submitted, gold			2022-12-27	WOS:000338280800067
J	Stokes, AN; Ducey, PK; Neuman-Lee, L; Hanifin, CT; French, SS; Pfrender, ME; Brodie, ED; Brodie, ED				Stokes, Amber N.; Ducey, Peter K.; Neuman-Lee, Lorin; Hanifin, Charles T.; French, Susannah S.; Pfrender, Michael E.; Brodie, Edmund D., III; Brodie, Edmund D., Jr.			Confirmation and Distribution of Tetrodotoxin for the First Time in Terrestrial Invertebrates: Two Terrestrial Flatworm Species (Bipalium adventitium and Bipalium kewense)	PLOS ONE			English	Article							ROUGH-SKIN NEWT; TARICHA-GRANULOSA; EGGS; TRICLADIDA; PREDATION; BLOCKAGE; INCREASE; BEHAVIOR; ECOLOGY	The potent neurotoxin tetrodotoxin (TTX) is known from a diverse array of taxa, but is unknown in terrestrial invertebrates. Tetrodotoxin is a low molecular weight compound that acts by blocking voltage-gated sodium channels, inducing paralysis. However, the origins and ecological functions of TTX in most taxa remain mysterious. Here, we show that TTX is present in two species of terrestrial flatworm (Bipalium adventitium and Bipalium kewense) using a competitive inhibition enzymatic immunoassay to quantify the toxin and high phase liquid chromatography to confirm the presence. We also investigated the distribution of TTX throughout the bodies of the flatworms and provide evidence suggesting that TTX is used during predation to subdue large prey items. We also show that the egg capsules of B. adventitium have TTX, indicating a further role in defense. These data suggest a potential route for TTX bioaccumulation in terrestrial systems.	[Stokes, Amber N.] Calif State Univ, Dept Biol, Bakersfield, CA 93311 USA; [Ducey, Peter K.] SUNY Coll Cortland, Dept Biol Sci, Cortland, NY 13045 USA; [Neuman-Lee, Lorin; French, Susannah S.; Brodie, Edmund D., Jr.] Utah State Univ, Dept Biol, Logan, UT 84322 USA; [Hanifin, Charles T.] Utah State Univ Uintah Basin, Dept Biol, Vernal, UT USA; [Pfrender, Michael E.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Brodie, Edmund D., III] Univ Virginia, Mt Lake Biol Stn, Charlottesville, VA USA; [Brodie, Edmund D., III] Univ Virginia, Dept Biol, Charlottesville, VA USA	California State University System; California State University Bakersfield; State University of New York (SUNY) System; SUNY Cortland; Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University; University of Notre Dame; University of Virginia; University of Virginia	Stokes, AN (corresponding author), Calif State Univ, Dept Biol, Bakersfield, CA 93311 USA.	astokes2@csub.edu	Pfrender, Micheal E./C-5065-2019	Neuman-Lee, Lorin/0000-0002-0225-5686	Utah State University, SUNY Cortland, NSF [DEB-0922251]; Division Of Environmental Biology [0922216] Funding Source: National Science Foundation	Utah State University, SUNY Cortland, NSF; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Utah State University, SUNY Cortland, NSF: DEB-0922251 to ME Pfrender, ED Brodie, Jr, and ED Brodie III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRODIE ED, 1968, COPEIA, P307; Cardall BL, 2004, TOXICON, V44, P933, DOI 10.1016/j.toxicon.2004.09.006; DINDAL DL, 1970, AM MIDL NAT, V83, P635, DOI 10.2307/2423970; Ducey PK, 2005, PEDOBIOLOGIA, V49, P367, DOI 10.1016/j.pedobi.2005.04.002; Ducey PK, 1999, AM MIDL NAT, V141, P305, DOI 10.1674/0003-0031(1999)141[0305:LPAPHP]2.0.CO;2; Fernandes MC, 2001, BELG J ZOOL, V131, P173; Fiore C, 2004, BEHAV PROCESS, V67, P327, DOI 10.1016/j.beproc.2004.06.001; FUHRMAN FA, 1969, J AGR FOOD CHEM, V17, P417, DOI 10.1021/jf60163a043; Gall BG, 2012, TOXICON, V60, P1057, DOI 10.1016/j.toxicon.2012.07.017; Hanifin CT, 2008, PLOS BIOL, V6, P471, DOI 10.1371/journal.pbio.0060060; Hanifin CT, 2003, J CHEM ECOL, V29, P1729, DOI 10.1023/A:1024885824823; Hanifin CT, 2002, TOXICON, V40, P1149, DOI 10.1016/S0041-0101(02)00115-0; KAO CY, 1966, PHARMACOL REV, V18, P997; MATSUMURA K, 1995, APPL ENVIRON MICROB, V61, P3468, DOI 10.1128/AEM.61.9.3468-3470.1995; MIYAZAWA K, 1987, TOXICON, V25, P975, DOI 10.1016/0041-0101(87)90160-7; Miyazawa K, 2001, J TOXICOL-TOXIN REV, V20, P11, DOI 10.1081/TXR-100103081; NARAHASH.T, 1967, SCIENCE, V156, P976, DOI 10.1126/science.156.3777.976; NARAHASHI T, 1964, J GEN PHYSIOL, V47, P965, DOI 10.1085/jgp.47.5.965; OGREN RE, 1995, HYDROBIOLOGIA, V305, P105, DOI 10.1007/BF00036370; Ritson-Williams R, 2005, PNAS, P3176; SHEUMACK DD, 1984, TOXICON, V22, P811, DOI 10.1016/0041-0101(84)90164-8; Shimizu C, 1982, MAR SCI MON, V16, P560; Stokes AN, 2012, BIOL PROCED ONLINE, V14, DOI 10.1186/1480-9222-14-3; Stokes AN, 2011, AM MIDL NAT, V165, P389, DOI 10.1674/0003-0031-165.2.389; Williams BL, 2010, MAR DRUGS, V8, P381, DOI 10.3390/md8030381; Zaborski ER, 2002, AM MIDL NAT, V148, P401, DOI 10.1674/0003-0031(2002)148[0401:OOFBBT]2.0.CO;2	26	38	39	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100718	10.1371/journal.pone.0100718	http://dx.doi.org/10.1371/journal.pone.0100718			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963791	Green Submitted, Green Published, gold			2022-12-27	WOS:000338709500075
J	Zhang, B; Nardi, F; Hull-Sanders, H; Wan, XW; Liu, YH				Zhang, Bin; Nardi, Francesco; Hull-Sanders, Helen; Wan, Xuanwu; Liu, Yinghong			The Complete Nucleotide Sequence of the Mitochondrial Genome of Bactrocera minax (Diptera: Tephritidae)	PLOS ONE			English	Article							DIRECTIONAL MUTATION PRESSURE; TRANSFER-RNA; GENE REARRANGEMENTS; CONTROL REGION; COMPOSITIONAL HETEROGENEITY; DORSALIS DIPTERA; WING-SHAPE; EVOLUTION; DNA; LEPIDOPTERA	The complete 16,043 bp mitochondrial genome (mitogenome) of Bactrocera minax (Diptera: Tephritidae) has been sequenced. The genome encodes 37 genes usually found in insect mitogenomes. The mitogenome information for B. minax was compared to the homologous sequences of Bactrocera oleae, Bactrocera tryoni, Bactrocera philippinensis, Bactrocera carambolae, Bactrocera papayae, Bactrocera dorsalis, Bactrocera correcta, Bactrocera cucurbitae and Ceratitis capitata. The analysis indicated the structure and organization are typical of, and similar to, the nine closely related species mentioned above, although it contains the lowest genome-wide A+T content (67.3%). Four short intergenic spacers with a high degree of conservation among the nine tephritid species mentioned above and B. minax were observed, which also have clear counterparts in the control regions (CRs). Correlation analysis among these ten tephritid species revealed close positive correlation between the A+T content of zero-fold degenerate sites (P-OFD), the ratio of nucleotide substitution frequency at P-OFD sites to all degenerate sites (zero-fold degenerate sites, two-fold degenerate sites and four-fold degenerate sites) and amino acid sequence distance (ASD) were found. Further, significant positive correlation was observed between the A+T content of four-fold degenerate sites (P-4FD) and the ratio of nucleotide substitution frequency at P-4FD sites to all degenerate sites; however, we found significant negative correlation between ASD and the A+T content of P-4FD, and the ratio of nucleotide substitution frequency at P-4FD sites to all degenerate sites. A higher nucleotide substitution frequency at non-synonymous sites compared to synonymous sites was observed in nad4, the first time that has been observed in an insect mitogenome. A poly(T) stretch at the 5' end of the CR followed by a [TA(A)](n)-like stretch was also found. In addition, a highly conserved G+A-rich sequence block was observed in front of the poly(T) stretch among the ten tephritid species and two tandem repeats were present in the CR.	[Zhang, Bin] Qingdao Agr Univ, Coll Agron & Plant Protect, Key Lab Integrated Pest Management Shandong Prov, Qingdao, Peoples R China; [Liu, Yinghong] Southwest Univ, Chongqing Key Lab Entomol & Pest Control Engn, Coll Plant Protect, Chongqing, Peoples R China; [Wan, Xuanwu] Sichuan Plant Protect Stn, Chengdu, Peoples R China; [Nardi, Francesco] Univ Siena, Dept Evolutionary Biol, I-53100 Siena, Italy; [Hull-Sanders, Helen] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA	Qingdao Agricultural University; Southwest University - China; University of Siena; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Liu, YH (corresponding author), Southwest Univ, Chongqing Key Lab Entomol & Pest Control Engn, Coll Plant Protect, Chongqing, Peoples R China.	yhliu@swu.edu.cn	liu, ying/GXF-4294-2022; LIU, YING/GZL-7252-2022	Nardi, Francesco/0000-0003-0271-9855	Taishan Mountain Scholar Constructive Engineering Foundation of Shandong, China; Startup Fund for Distinguished Scholars Qingdao Agricultural University, China [631316]	Taishan Mountain Scholar Constructive Engineering Foundation of Shandong, China; Startup Fund for Distinguished Scholars Qingdao Agricultural University, China	This work was supported in part by the Taishan Mountain Scholar Constructive Engineering Foundation of Shandong, China and the Startup Fund for Distinguished Scholars (No. 631316) supported by Qingdao Agricultural University, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allwood AJ, 1999, RAFFLES B ZOOL, P1; [Anonymous], FRUIT FLIES EC IMPOR; Beckenbach AT, 2012, GENOME BIOL EVOL, V4, P89, DOI 10.1093/gbe/evr131; Beckenbach AT, 2009, GENOME BIOL EVOL, V1, P278, DOI 10.1093/gbe/evp027; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Boykin LM, J APPL ENTO IN PRESS; Cameron SL, 2004, CLADISTICS, V20, P534, DOI 10.1111/j.1096-0031.2004.00040.x; Cameron SL, 2007, J MOL EVOL, V65, P589, DOI 10.1007/s00239-007-9042-8; Cameron SL, 2007, SYST ENTOMOL, V32, P40, DOI 10.1111/j.1365-3113.2006.00355.x; Cameron SL, 2014, ANNU REV ENTOMOL, V59, P95, DOI 10.1146/annurev-ento-011613-162007; Cameron SL, 2012, MOL PHYLOGENET EVOL, V65, P163, DOI 10.1016/j.ympev.2012.05.034; Cameron SL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-394; Castro LR, 2002, MOL BIOL EVOL, V19, P1100, DOI 10.1093/oxfordjournals.molbev.a004168; Cha SY, 2007, GENE, V392, P206, DOI 10.1016/j.gene.2006.12.031; Collins TM, 2005, SYST BIOL, V54, P493, DOI 10.1080/10635150590947339; Dowton M, 2009, MOL BIOL EVOL, V26, P1607, DOI 10.1093/molbev/msp072; DREW RAI, 1979, J AUST ENTOMOL SOC, V18, P71; Fenn JD, 2007, INSECT MOL BIOL, V16, P239, DOI 10.1111/j.1365-2583.2006.00721.x; Fenn JD, 2008, MOL PHYLOGENET EVOL, V49, P59, DOI 10.1016/j.ympev.2008.07.004; Friedrich M, 2003, MOL PHYLOGENET EVOL, V26, P502, DOI 10.1016/S1055-7903(02)00335-4; Hong GY, 2009, ACTA BIOCH BIOPH SIN, V41, P446, DOI 10.1093/abbs/gmp030; HUGHES AL, 1989, P NATL ACAD SCI USA, V86, P958, DOI 10.1073/pnas.86.3.958; Inohira K, 1997, MOL BIOL EVOL, V14, P814, DOI 10.1093/oxfordjournals.molbev.a025822; JERMIIN LS, 1994, J MOL EVOL, V39, P160; JERMIIN LS, 1994, J MOL EVOL, V38, P282, DOI 10.1007/BF00176090; Jose MS, 2013, ANN ENTOMOL SOC AM, V106, P684, DOI 10.1603/AN13017; Kim I, 2005, GENE, V353, P155, DOI 10.1016/j.gene.2005.04.019; Krosch MN, 2013, SYST ENTOMOL, V38, P2, DOI 10.1111/j.1365-3113.2012.00643.x; Lessinger AC, 2000, INSECT MOL BIOL, V9, P521, DOI 10.1046/j.1365-2583.2000.00215.x; Lewis DL, 1995, INSECT MOL BIOL, V4, P263, DOI 10.1111/j.1365-2583.1995.tb00032.x; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Ma C, 2012, MOL ECOL, V21, P4344, DOI 10.1111/j.1365-294X.2012.05684.x; Moriyama EN, 1997, J MOL EVOL, V45, P378, DOI 10.1007/PL00006243; Nardi F, 2003, SCIENCE, V299, P1887, DOI 10.1126/science.1078607; Nardi F, 2003, INSECT MOL BIOL, V12, P605, DOI 10.1046/j.1365-2583.2003.00445.x; Nardi F, 2010, MOL PHYLOGENET EVOL, V57, P678, DOI 10.1016/j.ympev.2010.08.008; Nei M., 1987, MOL EVOLUTIONARY GEN; Nelson LA, 2012, GENE, V511, P131, DOI 10.1016/j.gene.2012.09.103; Ohtsuki T, 2002, FEBS LETT, V514, P37, DOI 10.1016/S0014-5793(02)02328-1; OSAWA S, 1992, MICROBIOL REV, V56, P229, DOI 10.1128/MMBR.56.1.229-264.1992; Rieger M, 2006, CITRUS LEMON LIME OR; SACCONE C, 1991, EUR J BIOCHEM, V195, P151, DOI 10.1111/j.1432-1033.1991.tb15688.x; Salvato P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-331; Schutze MK, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-130; Shao R, 2001, MOL BIOL EVOL, V18, P858, DOI 10.1093/oxfordjournals.molbev.a003867; Shao RF, 2009, GENOME RES, V19, P904, DOI 10.1101/gr.083188.108; Sheffield NC, 2009, SYST BIOL, V58, P381, DOI 10.1093/sysbio/syp037; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Song HJ, 2010, SYST ENTOMOL, V35, P429, DOI 10.1111/j.1365-3113.2009.00517.x; Song N, 2009, ACTA BIOCH BIOPH SIN, V41, P206, DOI 10.1093/abbs/gmp003; STANTON DJ, 1994, GENETICS, V137, P233; Steffen P, 2006, BIOINFORMATICS, V22, P500, DOI 10.1093/bioinformatics/btk010; Stewart JB, 2006, GENOME, V49, P815, DOI 10.1139/G06-037; Stewart JB, 2005, GENOME, V48, P46, DOI 10.1139/G04-090; Stewart JB, 2003, MOL PHYLOGENET EVOL, V26, P513, DOI 10.1016/S1055-7903(02)00421-9; SUEOKA N, 1992, J MOL EVOL, V34, P95, DOI 10.1007/BF00182387; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TANAKA T, 1989, MOL BIOL EVOL, V6, P447; Thompson P. C., 1998, INT J N AM DIPTERIST; Wan X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042056; Wang M, 2011, VIRUS GENES, V42, P245, DOI 10.1007/s11262-011-0574-z; Wang Xing-Jian, 1995, Entomological Knowledge, V32, P310; WHITE IM, 1992, B ENTOMOL RES, V82, P275, DOI 10.1017/S0007485300051828; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Yang L, 2009, MOL BIOL REP, V36, P1441, DOI 10.1007/s11033-008-9334-0; Yu DJ, 2007, GENE, V396, P66, DOI 10.1016/j.gene.2007.02.023; Zhang DX, 1997, BIOCHEM SYST ECOL, V25, P99, DOI 10.1016/S0305-1978(96)00042-7; ZHANG DX, 1995, J MOL EVOL, V40, P382, DOI 10.1007/BF00164024; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	71	30	33	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100558	10.1371/journal.pone.0100558	http://dx.doi.org/10.1371/journal.pone.0100558			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964138	Green Submitted, gold, Green Published			2022-12-27	WOS:000338709500061
J	Abu Sadat, M; Jeon, J; Mir, AA; Choi, J; Choi, J; Lee, YH				Abu Sadat, Md.; Jeon, Junhyun; Mir, Albely Afifa; Choi, Jaeyoung; Choi, Jaehyuk; Lee, Yong-Hwan			Regulation of Cellular Diacylglycerol through Lipid Phosphate Phosphatases Is Required for Pathogenesis of the Rice Blast Fungus, Magnaporthe oryzae	PLOS ONE			English	Article							PROTEIN-KINASE-C; SIGNAL-TRANSDUCTION; APPRESSORIUM FORMATION; MEMBRANE-PROTEIN; GENETIC-ANALYSIS; GRISEA; SEQUENCE; IDENTIFICATION; PATHOGENICITY; ACID	Considering implication of diacylglycerol in both metabolism and signaling pathways, maintaining proper levels of diacylglycerol (DAG) is critical to cellular homeostasis and development. Except the PIP2-PLC mediated pathway, metabolic pathways leading to generation of DAG converge on dephosphorylation of phosphatidic acid catalyzed by lipid phosphate phosphatases. Here we report the role of such enzymes in a model plant pathogenic fungus, Magnaporthe oryzae. We identified five genes encoding putative lipid phosphate phosphatases (MoLPP1 to MoLPP5). Targeted disruption of four genes (except MoLPP4) showed that MoLPP3 and MoLPP5 are required for normal progression of infection-specific development and proliferation within host plants, whereas MoLPP1 and MoLPP2 are indispensable for fungal pathogenicity. Reintroduction of MoLPP3 and MoLPP5 into individual deletion mutants restored all the defects. Furthermore, exogenous addition of saturated DAG not only restored defect in appressorium formation but also complemented reduced virulence in both mutants. Taken together, our data indicate differential roles of lipid phosphate phosphatase genes and requirement of proper regulation of cellular DAGs for fungal development and pathogenesis.	[Abu Sadat, Md.; Jeon, Junhyun; Mir, Albely Afifa; Choi, Jaeyoung; Lee, Yong-Hwan] Seoul Natl Univ, Plant Genom & Breeding Inst, Dept Agr Biotechnol, Seoul, South Korea; [Abu Sadat, Md.; Jeon, Junhyun; Mir, Albely Afifa; Choi, Jaeyoung; Choi, Jaehyuk; Lee, Yong-Hwan] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea; [Choi, Jaehyuk; Lee, Yong-Hwan] Seoul Natl Univ, Ctr Fungal Pathogenesis, Plant Genom & Breeding Inst, Seoul, South Korea; [Lee, Yong-Hwan] Seoul Natl Univ, Ctr Fungal Genet Resources, Plant Genom & Breeding Inst, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Lee, YH (corresponding author), Seoul Natl Univ, Plant Genom & Breeding Inst, Dept Agr Biotechnol, Seoul, South Korea.	yonglee@snu.ac.kr	Choi, Jaeyoung/H-8665-2013; Choi, Jaeyoung/T-5932-2019	Choi, Jaeyoung/0000-0003-2206-4593; Choi, Jaeyoung/0000-0003-2206-4593	National Research Foundation of Korea - Korea government [2008-0061897, 2013-003196]; Next-Generation BioGreen 21 Program of Rural Development Administration in Korea [PJ00821201]; Brain Korea 21 Program	National Research Foundation of Korea - Korea government(National Research Foundation of KoreaKorean Government); Next-Generation BioGreen 21 Program of Rural Development Administration in Korea; Brain Korea 21 Program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was supported by the National Research Foundation of Korea grant funded by the Korea government (2008-0061897 and 2013-003196), and the Next-Generation BioGreen 21 Program of Rural Development Administration in Korea (PJ00821201). Sadat is grateful for a graduate fellowship through the Brain Korea 21 Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez FJ, 2007, EUKARYOT CELL, V6, P755, DOI 10.1128/EC.00008-07; Athenstaedt K, 1999, EUR J BIOCHEM, V266, P1, DOI 10.1046/j.1432-1327.1999.00822.x; Baker B, 1997, SCIENCE, V276, P726, DOI 10.1126/science.276.5313.726; Balhadere PV, 1999, MOL PLANT MICROBE IN, V12, P129, DOI 10.1094/MPMI.1999.12.2.129; BELL RM, 1980, ANNU REV BIOCHEM, V49, P459, DOI 10.1146/annurev.bi.49.070180.002331; BOURETT TM, 1990, CAN J BOT, V68, P329, DOI 10.1139/b90-044; Carrasco S, 2007, TRENDS BIOCHEM SCI, V32, P27, DOI 10.1016/j.tibs.2006.11.004; Chi MH, 2009, PLANT PATHOLOGY J, V25, P108, DOI 10.5423/PPJ.2009.25.1.108; Choi J, 2007, MOL MICROBIOL, V66, P826, DOI 10.1111/j.1365-2958.2007.05971.x; Choi J, 2013, NUCLEIC ACIDS RES, V41, pD714, DOI 10.1093/nar/gks1163; Choi J, 2011, FUNGAL GENET BIOL, V48, P445, DOI 10.1016/j.fgb.2011.01.001; D'Souza CA, 2001, FEMS MICROBIOL REV, V25, P349, DOI 10.1111/j.1574-6976.2001.tb00582.x; Deacon EM, 2002, J CELL SCI, V115, P983; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; DeZwaan TM, 1999, PLANT CELL, V11, P2013, DOI 10.1105/tpc.11.10.2013; Ghannoum MA, 2000, CLIN MICROBIOL REV, V13, P122, DOI 10.1128/CMR.13.1.122-143.2000; Goff SA, 2005, SCIENCE, V309, P879; Goldston AM, 2012, TRENDS PARASITOL, V28, P417, DOI 10.1016/j.pt.2012.07.002; Gomez-Fernandez JC, 2007, CHEM PHYS LIPIDS, V148, P1, DOI 10.1016/j.chemphyslip.2007.04.003; Goni FM, 1999, PROG LIPID RES, V38, P1, DOI 10.1016/S0163-7827(98)00021-6; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; HOWARD RJ, 1991, P NATL ACAD SCI USA, V88, P11281, DOI 10.1073/pnas.88.24.11281; Ile KE, 2012, DEVELOPMENT, V139, P2535, DOI 10.1242/dev.077289; Jenkins GM, 1997, J BIOL CHEM, V272, P32566, DOI 10.1074/jbc.272.51.32566; Jeon J, 2008, MOL PLANT MICROBE IN, V21, P525, DOI 10.1094/MPMI-21-5-0525; Jia YJ, 2003, FEBS LETT, V552, P240, DOI 10.1016/S0014-5793(03)00931-1; Kankanala P, 2007, PLANT CELL, V19, P706, DOI 10.1105/tpc.106.046300; Kim S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-104; Klose J, 2004, MOL MICROBIOL, V52, P823, DOI 10.1111/j.1365-2958.2004.04019.x; Koga H, 2004, PHYSIOL MOL PLANT P, V64, P67, DOI 10.1016/j.pmpp.2004.07.002; LEE YH, 1993, PLANT CELL, V5, P693, DOI 10.1105/tpc.5.6.693; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; Nanjundan M, 2003, AM J PHYSIOL-LUNG C, V284, pL1, DOI 10.1152/ajplung.00029.2002; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; Paradis S, 2011, PLANT PHYSIOL BIOCH, V49, P357, DOI 10.1016/j.plaphy.2011.01.010; Park G, 2002, MOL PLANT MICROBE IN, V15, P183, DOI 10.1094/MPMI.2002.15.3.183; Park SY, 2010, PLANT PATHOLOGY J, V26, P313, DOI 10.5423/PPJ.2010.26.4.313; PATTON JL, 1992, J BACTERIOL, V174, P7180, DOI 10.1128/jb.174.22.7180-7184.1992; PESSIN MS, 1989, J BIOL CHEM, V264, P8729; Pettitt TR, 1997, J BIOL CHEM, V272, P17354, DOI 10.1074/jbc.272.28.17354; Pierrugues O, 2001, J BIOL CHEM, V276, P20300, DOI 10.1074/jbc.M009726200; Rho HS, 2009, MOL PLANT PATHOL, V10, P337, DOI [10.1111/J.1364-3703.2009.00536.X, 10.1111/j.1364-3703.2009.00536.x]; Rhome R, 2009, ANNU REV MICROBIOL, V63, P119, DOI 10.1146/annurev.micro.091208.073431; Sambrook J., 2001, MOL CLONING LAB MANU; Sciorra VA, 1999, BIOCHIM BIOPHYS ACTA, V1582, P45; Shea JM, 2006, CURR OPIN MICROBIOL, V9, P352, DOI 10.1016/j.mib.2006.06.003; Siafakas AR, 2006, EUKARYOT CELL, V5, P488, DOI 10.1128/EC.5.3.488-498.2006; Spiegel S, 1996, CURR OPIN CELL BIOL, V8, P159, DOI 10.1016/S0955-0674(96)80061-5; Stukey J, 1997, PROTEIN SCI, V6, P469; Talbot NJ, 2003, ANNU REV MICROBIOL, V57, P177, DOI 10.1146/annurev.micro.57.030502.090957; Talbot NJ, 2001, ADV BOT RES, V34, P263, DOI 10.1016/S0065-2296(01)34011-9; Thines E, 1997, FEMS MICROBIOL LETT, V156, P91, DOI 10.1016/S0378-1097(97)00407-2; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toke DA, 1998, J BIOL CHEM, V273, P3278, DOI 10.1074/jbc.273.6.3278; Toke DA, 1998, J BIOL CHEM, V273, P14331, DOI 10.1074/jbc.273.23.14331; Torres MA, 2006, PLANT PHYSIOL, V141, P373, DOI 10.1104/pp.106.079467; Urban M, 1999, EMBO J, V18, P512, DOI 10.1093/emboj/18.3.512; VALENT B, 1991, ANNU REV PHYTOPATHOL, V29, P443, DOI 10.1146/annurev.py.29.090191.002303; Villalba F, 2008, FUNGAL GENET BIOL, V45, P68, DOI 10.1016/j.fgb.2007.06.006; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; Wakelam MJO, 1998, BBA-MOL CELL BIOL L, V1436, P117, DOI 10.1016/S0005-2760(98)00123-4; Wang ZY, 2007, MOL PLANT MICROBE IN, V20, P475, DOI 10.1094/MPMI-20-5-0475; Wang ZY, 2003, MOL MICROBIOL, V47, P1601, DOI 10.1046/j.1365-2958.2003.03412.x; Wojtaszek P, 1997, BIOCHEM J, V322, P681, DOI 10.1042/bj3220681; Xu JR, 1996, GENE DEV, V10, P2696, DOI 10.1101/gad.10.21.2696; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001; Zhang N, 1996, GENETICS, V143, P1231	69	9	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100726	10.1371/journal.pone.0100726	http://dx.doi.org/10.1371/journal.pone.0100726			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959955	Green Submitted, Green Published, gold			2022-12-27	WOS:000338633900076
J	Chiu, CL; Aguilar, JS; Tsai, CY; Wu, GK; Gratton, E; Digman, MA				Chiu, Chi-Li; Aguilar, Jose S.; Tsai, Connie Y.; Wu, GuiKai; Gratton, Enrico; Digman, Michelle A.			Nanoimaging of Focal Adhesion Dynamics in 3D	PLOS ONE			English	Article							IMAGE CORRELATION SPECTROSCOPY; CELL-MIGRATION; PAXILLIN; ACTIN; TURNOVER; TRACKING; INVASION; REVEALS	Organization and dynamics of focal adhesion proteins have been well characterized in cells grown on two-dimensional (2D) cell culture surfaces. However, much less is known about the dynamic association of these proteins in the 3D microenvironment. Limited imaging technologies capable of measuring protein interactions in real time and space for cells grown in 3D is a major impediment in understanding how proteins function under different environmental cues. In this study, we applied the nano-scale precise imaging by rapid beam oscillation (nSPIRO) technique and combined the scaning-fluorescence correlation spectroscopy (sFCS) and the number and molecular brightness (N&B) methods to investigate paxillin and actin dynamics at focal adhesions in 3D. Both MDA-MB-231 cells and U2OS cells produce elongated protrusions with high intensity regions of paxillin in cell grown in 3D collagen matrices. Using sFCS we found higher percentage of slow diffusing proteins at these focal spots, suggesting assembling/disassembling processes. In addition, the N&B analysis shows paxillin aggregated predominantly at these focal contacts which are next to collagen fibers. At those sites, actin showed slower apparent diffusion rate, which indicated that actin is either polymerizing or binding to the scaffolds in these locals. Our findings demonstrate that by multiplexing these techniques we have the ability to spatially and temporally quantify focal adhesion assembly and disassembly in 3D space and allow the understanding tumor cell invasion in a more complex relevant environment.	[Chiu, Chi-Li; Gratton, Enrico; Digman, Michelle A.] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92717 USA; [Tsai, Connie Y.; Wu, GuiKai] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA; [Aguilar, Jose S.; Gratton, Enrico; Digman, Michelle A.] Univ Calif Irvine, Fluorescence Dynam Lab, Dept Biomed Engn, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Digman, MA (corresponding author), Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92717 USA.	mdigman@uci.edu		, Michelle/0000-0003-4611-7100	W.M. Keck Foundation [50242]; W.M. Keck Nanoimaging Lab at UCI; National Institutes of Health [P50 GM076516]; National Institute of General Medical Sciences [8 P41 GM103540-27]; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076516] Funding Source: NIH RePORTER	W.M. Keck Foundation(W.M. Keck Foundation); W.M. Keck Nanoimaging Lab at UCI; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by the W.M. Keck Foundation (Award 50242), The W.M. Keck Nanoimaging Lab at UCI, The National Institutes of Health P50 GM076516, and National Institute of General Medical Sciences (8 P41 GM103540-27). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; Deakin NO, 2011, MOL BIOL CELL, V22, P327, DOI 10.1091/mbc.E10-09-0790; Digman MA, 2005, BIOPHYS J, V89, P1317, DOI 10.1529/biophysj.105.062836; Digman MA, 2008, BIOPHYS J, V94, P2819, DOI 10.1529/biophysj.107.104984; Digman MA, 2008, BIOPHYS J, V94, P2320, DOI 10.1529/biophysj.107.114645; Digman MA, 2009, P NATL ACAD SCI USA, V106, P2170, DOI 10.1073/pnas.0806036106; Fraley SI, 2011, NAT CELL BIOL, V13, P5, DOI 10.1038/ncb0111-5; Fraley SI, 2010, NAT CELL BIOL, V12, P598, DOI 10.1038/ncb2062; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036; Geiger B, 2001, CURR OPIN CELL BIOL, V13, P584, DOI 10.1016/S0955-0674(00)00255-6; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Harunaga JS, 2011, MATRIX BIOL; Hayakawa K, 2008, J CELL SCI, V121, P496, DOI 10.1242/jcs.022053; Hebert B, 2005, BIOPHYS J, V88, P3601, DOI 10.1529/biophysj.104.054874; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Kis-Petikova K, 2004, MICROSC RES TECHNIQ, V63, P34, DOI 10.1002/jemt.10417; Kraning-Rush CM, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015009; Kubow Kristopher E, 2011, Nat Cell Biol, V13, P3, DOI 10.1038/ncb0111-3; Kuo JC, 2011, NAT CELL BIOL, V13, P383, DOI 10.1038/ncb2216; Lanzano L, 2011, J BIOPHOTONICS, V4, P415, DOI 10.1002/jbio.201100002; Levi V, 2005, BIOPHYS J, V88, P2919, DOI 10.1529/biophysj.104.044230; Maskarinec SA, 2009, P NATL ACAD SCI USA, V106, P22108, DOI 10.1073/pnas.0904565106; McGrath JL, 1998, BIOPHYS J, V75, P2070, DOI 10.1016/S0006-3495(98)77649-0; Meyer AS, 2012, J CELL BIOL, V197, P721, DOI 10.1083/jcb.201201003; Miron-Mendoza M, 2010, BIOMATERIALS, V31, P6425, DOI 10.1016/j.biomaterials.2010.04.064; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Pathak A, 2011, INTEGR BIOL CAMB; Poincloux R, 2011, P NATL ACAD SCI USA, V108, P1943, DOI 10.1073/pnas.1010396108; Rhee S, 2009, EXP MOL MED, V41, P858, DOI 10.3858/emm.2009.41.12.096; Rossow M, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3088203; Rossow MJ, 2010, NAT PROTOC, V5, P1761, DOI 10.1038/nprot.2010.122; Schaller MD, 2001, ONCOGENE, V20, P6459, DOI 10.1038/sj.onc.1204786; Tanner K, 2009, BIOPHYS J, V97, P2098, DOI 10.1016/j.bpj.2009.06.052; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Wolf K, 2009, SEMIN CELL DEV BIOL, V20, P931, DOI 10.1016/j.semcdb.2009.08.005; Yu XZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030605	38	20	20	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e99896	10.1371/journal.pone.0099896	http://dx.doi.org/10.1371/journal.pone.0099896			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959851	Green Published, gold			2022-12-27	WOS:000338633900016
J	Erb, A; Althaus, M				Erb, Alexandra; Althaus, Mike			Actions of Hydrogen Sulfide on Sodium Transport Processes across Native Distal Lung Epithelia (Xenopus laevis)	PLOS ONE			English	Article							CL-SECRETION; CHANNELS; PROTECTS; INJURY; EXPRESSION; CLEARANCE; NYSTATIN; EDEMA; CELLS; H2S	Hydrogen sulfide (H2S) is well known as a highly toxic environmental chemical threat. Prolonged exposure to H2S can lead to the formation of pulmonary edema. However, the mechanisms of how H2S facilitates edema formation are poorly understood. Since edema formation can be enhanced by an impaired clearance of electrolytes and, consequently, fluid across the alveolar epithelium, it was questioned whether H2S may interfere with transepithelial electrolyte absorption. Electrolyte absorption was electrophysiologically measured across native distal lung preparations (Xenopus laevis) in Ussing chambers. The exposure of lung epithelia to H2S decreased net transepithelial electrolyte absorption. This was due to an impairment of amiloride-sensitive sodium transport. H2S inhibited the activity of the Na+/K+-ATPase as well as lidocaine-sensitive potassium channels located in the basolateral membrane of the epithelium. Inhibition of these transport molecules diminishes the electrochemical gradient which is necessary for transepithelial sodium absorption. Since sodium absorption osmotically facilitates alveolar fluid clearance, interference of H2S with the epithelial transport machinery provides a mechanism which enhances edema formation in H2S-exposed lungs.	[Erb, Alexandra; Althaus, Mike] Univ Giessen, Inst Anim Physiol, D-35390 Giessen, Germany	Justus Liebig University Giessen	Althaus, M (corresponding author), Univ Giessen, Inst Anim Physiol, D-35390 Giessen, Germany.	mike.althaus@bio.uni-giessen.de		Althaus, Mike/0000-0002-3554-7538	German Research Foundation (DFG) [AL1453/1-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work has been funded by a grant from the German Research Foundation (DFG) No. AL1453/1-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althaus M, 2012, BRIT J PHARMACOL, V166, P1946, DOI 10.1111/j.1476-5381.2012.01909.x; Althaus M, 2011, PULM MED, V2011, DOI 10.1155/2011/830320; Althaus M, 2011, AM J RESP CELL MOL, V44, P53, DOI 10.1165/2009-0335OC; Berger J, 2011, AM J PHYSIOL-REG I, V300, pR616, DOI 10.1152/ajpregu.00464.2010; Cao H, 2014, TOXICOL LETT, V224, P387, DOI 10.1016/j.toxlet.2013.11.008; Egli M, 2004, J PHYSIOL-LONDON, V560, P857, DOI 10.1113/jphysiol.2004.066704; Esechie A, 2009, BRIT J PHARMACOL, V158, P1442, DOI 10.1111/j.1476-5381.2009.00411.x; Faller S, 2012, MED GAS RES, V2, DOI 10.1186/2045-9912-2-26; Faller S, 2010, ANESTHESIOLOGY, V113, P104, DOI 10.1097/ALN.0b013e3181de7107; FISCHER H, 1989, AM J PHYSIOL, V256, pC764, DOI 10.1152/ajpcell.1989.256.4.C764; FISCHER H, 1990, PFLUG ARCH EUR J PHY, V416, P62, DOI 10.1007/BF00370222; Francis RC, 2011, ANESTHESIOLOGY, V115, P1012, DOI 10.1097/ALN.0b013e31823306cf; Fronius M, 2003, J MEMBRANE BIOL, V195, P43, DOI 10.1007/s00232-003-2043-7; Fronius Martin, 2013, Curr Mol Pharmacol, V6, P13; Guidotti TL, 2010, INT J TOXICOL, V29, P569, DOI 10.1177/1091581810384882; Guidotti TL, 1996, OCCUP MED-OXFORD, V46, P367, DOI 10.1093/occmed/46.5.367; Jain L, 2001, AM J PHYSIOL-LUNG C, V280, pL646, DOI 10.1152/ajplung.2001.280.4.L646; KOEFOEDJOHNSEN V, 1958, ACTA PHYSIOL SCAND, V42, P298, DOI 10.1111/j.1748-1716.1958.tb01563.x; Kolluru GK, 2013, REDOX BIOL, V1, P313, DOI 10.1016/j.redox.2013.05.001; LEWIS SA, 1977, J GEN PHYSIOL, V70, P427, DOI 10.1085/jgp.70.4.427; Madurga A, 2014, AM J PHYSL LUNG CELL; MEBAN C, 1973, J ANAT, V114, P235; Mimoun S, 2012, ANTIOXID REDOX SIGN, V17, P1, DOI 10.1089/ars.2011.4186; OLVER RE, 1986, J PHYSIOL-LONDON, V376, P321, DOI 10.1113/jphysiol.1986.sp016156; Otulakowski G, 2010, ANESTHESIOLOGY, V113, P4, DOI 10.1097/ALN.0b013e3181dec00e; Rashid S, 2013, BRIT J PHARMACOL, V168, P1902, DOI 10.1111/bph.12084; REIFFENSTEIN RJ, 1992, ANNU REV PHARMACOL, V32, P109, DOI 10.1146/annurev.pa.32.040192.000545; RUSSELL JM, 1977, J MEMBRANE BIOL, V37, P137, DOI 10.1007/BF01940929; Sommer D, 2007, RESP PHYSIOL NEUROBI, V158, P97, DOI 10.1016/j.resp.2007.03.016; Sznajder JI, 2002, J APPL PHYSIOL, V93, P1860, DOI 10.1152/japplphysiol.00022.2002; Vadivel A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090965; Wang R, 2012, PHYSIOL REV, V92, P791, DOI 10.1152/physrev.00017.2011; Ware LB, 2001, AM J RESP CRIT CARE, V163, P1376, DOI 10.1164/ajrccm.163.6.2004035	33	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100971	10.1371/journal.pone.0100971	http://dx.doi.org/10.1371/journal.pone.0100971			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24960042	Green Published, Green Submitted, gold			2022-12-27	WOS:000338633900108
J	Houle, B; Clark, SJ; Gomez-Olive, FX; Kahn, K; Tollman, SM				Houle, Brian; Clark, Samuel J.; Gomez-Olive, F. Xavier; Kahn, Kathleen; Tollman, Stephen M.			The Unfolding Counter-Transition in Rural South Africa: Mortality and Cause of Death, 1994-2009	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; EPIDEMIOLOGIC TRANSITION; ADULT MORTALITY; HEALTH-CARE; AGINCOURT HEALTH; LIFE EXPECTANCY; SCALE-UP; POPULATION; HIV; LEVEL	The HIV pandemic has led to dramatic increases and inequalities in adult mortality, and the diffusion of antiretroviral treatment, together with demographic and socioeconomic shifts in sub-Saharan Africa, has further changed mortality patterns. We describe all-cause and cause-specific mortality patterns in rural South Africa, analyzing data from the Agincourt health and socio-demographic surveillance system from 1994 to 2009 for those aged 5 years and older. Mortality increased during that period, particularly after 2002 for ages 30-69. HIV/AIDS and TB deaths increased and recently plateaued at high levels in people under age 60. Noncommunicable disease deaths increased among those under 60, and recently also increased among those over 60. There was an inverse gradient between mortality and household SES, particularly for deaths due to HIV/AIDS and TB and noncommunicable diseases. A smaller and less consistent gradient emerged for deaths due to other communicable diseases. Deaths due to injuries remained an important mortality risk for males but did not vary by SES. Rural South Africa continues to have a high burden of HIV/AIDS and TB mortality while deaths from noncommunicable diseases have increased, and both of these cause-categories show social inequalities in mortality.	[Houle, Brian; Clark, Samuel J.] Univ Washington, Dept Sociol, Seattle, WA 98195 USA; [Houle, Brian; Clark, Samuel J.; Kahn, Kathleen; Tollman, Stephen M.] Univ Colorado, Inst Behav Sci, Boulder, CO 80309 USA; [Clark, Samuel J.; Gomez-Olive, F. Xavier; Kahn, Kathleen; Tollman, Stephen M.] Univ Witwatersrand, Fac Hlth Sci, Wits Rural Publ Hlth & Hlth Transit Res Unit Agin, MRC,Sch Publ Hlth, Johannesburg, South Africa; [Kahn, Kathleen; Tollman, Stephen M.] Umea Univ, Ctr Global Hlth Res, Umea, Sweden; [Clark, Samuel J.; Gomez-Olive, F. Xavier; Kahn, Kathleen; Tollman, Stephen M.] INDEPTH Network, Accra, Ghana; [Clark, Samuel J.] ALPHA Network, London, England	University of Washington; University of Washington Seattle; University of Colorado System; University of Colorado Boulder; University of Witwatersrand; Umea University; INDEPTH Network	Houle, B (corresponding author), Univ Washington, Dept Sociol, Seattle, WA 98195 USA.	brian.houle@colorado.edu	Gómez-Olivé, Francesc Xavier/AAP-7673-2021; Clark, Samuel J/A-8419-2009	Gómez-Olivé, Francesc Xavier/0000-0002-4876-0848; Clark, Samuel J/0000-0002-4929-6231; Kahn, Kathleen/0000-0003-3339-3931; Tollman, Stephen/0000-0003-0744-7588; Houle, Brian/0000-0003-2157-3118	Wellcome Trust, UK [058893/Z/99/A, 069683/Z/02/Z]; Medical Research Council; University of the Witwatersrand; Anglo-American Chairman's Fund, South Africa; Andrew W. Mellon Foundation; William and Flora Hewlett Foundation; National Institutes of Health (NIH) from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [K01 HD057246]; National Institute on Aging (NIA), USA [R24 AG032112]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [5R24 HD066613-03]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K01HD057246, R01HD054511, R24HD066613, R01HD070936, R24HD042828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R24AG032112] Funding Source: NIH RePORTER	Wellcome Trust, UK(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of the Witwatersrand; Anglo-American Chairman's Fund, South Africa; Andrew W. Mellon Foundation; William and Flora Hewlett Foundation; National Institutes of Health (NIH) from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Institute on Aging (NIA), USA; Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Thanks are due to key funding partners of the MRC/Wits Rural Public Health and Health Transitions Research Unit who have enabled the ongoing Agincourt health and socio-demographic surveillance system: the Wellcome Trust grants 058893/Z/99/A and 069683/Z/02/Z, UK; the Medical Research Council, University of the Witwatersrand, and Anglo-American Chairman's Fund, South Africa; the Andrew W. Mellon Foundation, the William and Flora Hewlett Foundation, and the National Institutes of Health (NIH) grants K01 HD057246 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and R24 AG032112 from the National Institute on Aging (NIA), USA. Partial support for this research came from a Eunice Kennedy Shriver National Institute of Child Health and Human Development research infrastructure grant, 5R24 HD066613-03, to the University of Colorado Population Center in the Institute of Behavioral Science at the University of Colorado Boulder and the National Institute on Aging (NIA), USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjuik M, 2006, B WORLD HEALTH ORGAN, V84, P181, DOI 10.2471/BLT.05.026492; Allison P. D., 1995, SURVIVAL ANAL USING; Allison P.D., 1984, EVENT HIST ANAL REGR; Atun R, 2012, LANCET, V380, P2044, DOI 10.1016/S0140-6736(12)61460-3; Barnighausen T, 2008, J HUM HYPERTENS, V22, P236, DOI 10.1038/sj.jhh.1002308; Bor J, 2013, SCIENCE, V339, P961, DOI 10.1126/science.1230413; Byass P, 2006, SCAND J PUBLIC HEALT, V34, P26, DOI 10.1080/14034940510032202; Byass P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000325; Clark SJ, 2007, SCAND J PUBLIC HEALT, V35, P35, DOI 10.1080/14034950701355619; Clark SJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001409; Collinson MA, 2006, J ETHN MIGR STUD, V32, P633, DOI 10.1080/13691830600610023; Collinson MA, 2010, GLOBAL HEALTH ACTION, V3, DOI 10.3402/gha.v3i0.5080; Cornell M, 2010, AIDS, V24, P2263, DOI 10.1097/QAD.0b013e32833d45c5; Desmond C, 2000, S AFRICAN J INT AFFA, V7, P39; Frenk J, 1991, Health Transit Rev, V1, P21; Geneau R, 2010, LANCET, V376, P1689, DOI 10.1016/S0140-6736(10)61414-6; Gomez-Olive FX, 2009, WITS AIDS RES S; Gomez-Olive FX, 2013, AIDS CARE; Goudge J, 2007, SCAND J PUBLIC HEALT, V35, P181, DOI 10.1080/14034950701355551; Goudge J, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-75; Goudge J, 2009, TROP MED INT HEALTH, V14, P458, DOI 10.1111/j.1365-3156.2009.02256.x; Gwatkin DR, 1999, LANCET, V354, P586, DOI 10.1016/S0140-6736(99)02108-X; Herbst AJ, 2009, B WORLD HEALTH ORGAN, V87, P754, DOI 10.2471/BLT.08.058982; Hontelez Jan A C, 2012, AIDS, V26 Suppl 1, pS19; Hosegood V, 2004, AIDS, V18, P663, DOI 10.1097/00002030-200403050-00011; Houle B, 2013, INT J EPIDE IN PRESS; INDEPTH, 2005, MEAS HLTH EQ SMALL A; Jahn A, 2008, LANCET, V371, P1603, DOI 10.1016/S0140-6736(08)60693-5; Joint United Nations Programme on HIV/AIDS, 2010, GLOB REP UNAIDS REP; Kahn K, 2000, TROP MED INT HEALTH, V5, P824, DOI 10.1046/j.1365-3156.2000.00638.x; Kahn K, 2006, AGING SUBSAHARAN AFR, P166; Kahn K, 2005, MEASURING HLTH EQUIT; Kahn K, 2007, SCAND J PUBLIC HEALT, V35, P8, DOI 10.1080/14034950701505031; Kahn K, 2007, SCAND J PUBLIC HEALT, V35, P26, DOI 10.1080/14034950701355668; Kahn K, 2012, INT J EPIDEMIOL, V41, P988, DOI 10.1093/ije/dys115; Karim SSA, 2009, LANCET, V374, P921, DOI 10.1016/S0140-6736(09)60916-8; Klausner JD, 2011, JAIDS-J ACQ IMM DEF, V56, P292, DOI 10.1097/QAI.0b013e3182067d99; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mayosi BM, 2009, LANCET, V374, P934, DOI 10.1016/S0140-6736(09)61087-4; Mills EJ, 2011, ANN INTERN MED, V155, P209, DOI 10.7326/0003-4819-155-4-201108160-00358; Mishra V, 2007, AIDS, V21, pS17, DOI 10.1097/01.aids.0000300532.51860.2a; Moshabela Mosa, 2011, Afr J AIDS Res, V10, P393, DOI 10.2989/16085906.2011.646654; Negin Joel, 2012, AIDS, V26 Suppl 1, pS55; Nikoi CA, 2009, ASS SOCIOECONOMIC ST; Olshansky S. J., 1998, World Health Statistics Quarterly, V51, P207; OLSHANSKY SJ, 1986, MILBANK Q, V64, P355, DOI 10.2307/3350025; Omran A. R., 1998, World Health Statistics Quarterly, V51, P99; OMRAN AR, 1971, MILBANK MEML FUND Q, V49, P509, DOI 10.2307/3349375; Palloni A, 2011, INT HDB ADULT MORTAL; Patterson LR, 2011, PRIME AGE ADULT MORT; PRESTON SH, 1975, POP STUD-J DEMOG, V29, P231, DOI 10.2307/2173509; Reniers G, 2009, AIDS, V23, P511, DOI 10.1097/QAD.0b013e32832403d0; ROGERS RG, 1987, SOC BIOL, V34, P234; Rogers RG, 2005, HDB POPULATION, P283; Salomon JA, 2002, POPUL DEV REV, V28, P205, DOI 10.1111/j.1728-4457.2002.00205.x; Sankoh O, 2012, INT J EPIDEMIOL, V41, P579, DOI 10.1093/ije/dys081; Sartorius B, 2013, GEOSPATIAL HEALTH, V7, P237, DOI 10.4081/gh.2013.83; Snow RC, 2010, AIDS CARE, V22, P1060, DOI 10.1080/09540120903193641; StataCorp L, 2007, STAT DAT AN STAT SOF; Tollman SM, 1999, AIDS, V13, P1091, DOI 10.1097/00002030-199906180-00013; Tollman SM, 2008, LANCET, V372, P893, DOI 10.1016/S0140-6736(08)61399-9; Twine R, 2007, SCAND J PUBLIC HEALT, V35, P118, DOI 10.1080/14034950701430008; United Nations General Assembly, 2010, KEEP PROM UN ACH MIL; Vallin Jacques, 2004, SPECIAL COLLECTION, V2, P11, DOI [10.4054/DemRes.2004.S2.2, DOI 10.4054/DEMRES.2004.S2.2]	64	33	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100420	10.1371/journal.pone.0100420	http://dx.doi.org/10.1371/journal.pone.0100420			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK7UT	24959714	Green Submitted, Green Published, gold			2022-12-27	WOS:000338633900046
J	Pletnev, S; Shcherbakova, DM; Subach, OM; Pletneva, NV; Malashkevich, VN; Almo, SC; Dauter, Z; Verkhusha, VV				Pletnev, Sergei; Shcherbakova, Daria M.; Subach, Oksana M.; Pletneva, Nadya V.; Malashkevich, Vladimir N.; Almo, Steven C.; Dauter, Zbigniew; Verkhusha, Vladislav V.			Orange Fluorescent Proteins: Structural Studies of LSSmOrange, PSmOrange and PSmOrange2	PLOS ONE			English	Article							LARGE STOKES SHIFT; MONOMERIC RED; ZOANTHUS SP; FRET; VARIANT; PHOTOCONVERSION; CHROMOPHORE; REFINEMENT; PATHWAYS; DYNAMICS	A structural analysis of the recently developed orange fluorescent proteins with novel phenotypes, LSSmOrange (lambda(ex)/lambda(em) at 437/572 nm), PSmOrange (lambda(ex)/lambda(em) at 548/565 nm and for photoconverted form at 636/662 nm) and PSmOrange2 (lambda(ex)/lambda(em) at 546/561 nm and for photoconverted form at 619/651 nm), is presented. The obtained crystallographic structures provide an understanding of how the ensemble of a few key mutations enabled special properties of the orange FPs. While only a single Ile161Asp mutation, enabling excited state proton transfer, is critical for LSSmOrange, other substitutions provide refinement of its special properties and an exceptional 120 nm large Stokes shift. Similarly, a single Gln64Leu mutation was sufficient to cause structural changes resulting in photoswitchability of PSmOrange, and only one additional substitution (Phe65Ile), yielding PSmOrange2, was enough to greatly decrease the energy of photoconversion and increase its efficiency of photoswitching. Fluorescence of photoconverted PSmOrange and PSmOrange2 demonstrated an unexpected bathochromic shift relative to the fluorescence of classic red FPs, such as DsRed, eqFP578 and zFP574. The structural changes associated with this fluorescence shift are of considerable value for the design of advanced far-red FPs. For this reason the chromophore transformations accompanying photoconversion of the orange FPs are discussed.	[Pletnev, Sergei] Leidos Biomed Res Inc, Basic Res Program, Argonne, IL 60439 USA; [Pletnev, Sergei; Dauter, Zbigniew] NCI, Macromol Crystallog Lab, Argonne, IL USA; [Shcherbakova, Daria M.; Subach, Oksana M.; Verkhusha, Vladislav V.] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10467 USA; [Malashkevich, Vladimir N.; Almo, Steven C.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10467 USA; [Pletneva, Nadya V.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia; [Subach, Oksana M.] Moscow Inst Phys & Technol, Dept Nano Bio Informat & Cognit Technol, Moscow, Russia	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Moscow Institute of Physics & Technology	Pletnev, S (corresponding author), Leidos Biomed Res Inc, Basic Res Program, Argonne, IL 60439 USA.	pletnevs@mail.nih.gov; vladislav.verkhusha@einstein.yu.edu	Verkhusha, Vladislav/AAU-7784-2020; Subach, Oksana (Gritsenko)/K-7086-2014; Pletneva, Nadya/F-7839-2014	Verkhusha, Vladislav/0000-0002-2083-8121; Zucker-Scharff, Thomas/0000-0002-1790-7405; Pletneva, Nadya/0000-0001-9681-4022	US Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; National Cancer Institute, NIH [HHSN261200800001E]; NIH [GM073913, CA164468]; Albert Einstein Cancer Center [CA013330]; New York Structural Genomics Research Center; Russian Science Foundation [14-14-00281]; NATIONAL CANCER INSTITUTE [P30CA013330, R01CA164468] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM111244, R01GM073913] Funding Source: NIH RePORTER	US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albert Einstein Cancer Center; New York Structural Genomics Research Center; Russian Science Foundation(Russian Science Foundation (RSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Use of the Advanced Photon Source was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract No. W-31-109-Eng-38. The authors thank Rafael Toro for help with the crystallization screening and X29 beamline staff at NSLS for help with data collection. This work was supported in part with Federal funds from the National Cancer Institute, NIH, under contract HHSN261200800001E, the Intramural Research Program of the NIH, the NIH grants GM073913 and CA164468 (to VVV), the Albert Einstein Cancer Center grant CA013330, the New York Structural Genomics Research Center (to SCA), and by a grant from the Russian Science Foundation 14-14-00281. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does the mention of trade names, commercial products or organizations imply endorsement by the US Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agmon N, 2005, BIOPHYS J, V88, P2452, DOI 10.1529/biophysj.104.055541; Ai HW, 2008, NAT METHODS, V5, P401, DOI [10.1038/nmeth.1207, 10.1038/NMETH.1207]; Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chattoraj M, 1996, P NATL ACAD SCI USA, V93, P8362, DOI 10.1073/pnas.93.16.8362; Chudakov DM, 2007, NAT PROTOC, V2, P2024, DOI 10.1038/nprot.2007.291; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Habuchi S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003944; Henderson JN, 2009, J AM CHEM SOC, V131, P13212, DOI 10.1021/ja904665x; Hoi H, 2013, CHEM BIOL, V20, P1296, DOI 10.1016/j.chembiol.2013.08.008; Hoi HF, 2010, J MOL BIOL, V401, P776, DOI 10.1016/j.jmb.2010.06.056; Karasawa S, 2004, BIOCHEM J, V381, P307, DOI 10.1042/BJ20040321; Kikuchi A, 2008, BIOCHEMISTRY-US, V47, P11573, DOI 10.1021/bi800727v; Kogure T, 2006, NAT BIOTECHNOL, V24, P577, DOI 10.1038/nbt1207; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lippincott-Schwartz J, 2009, TRENDS CELL BIOL, V19, P555, DOI 10.1016/j.tcb.2009.09.003; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McKinney SA, 2009, NAT METHODS, V6, P131, DOI [10.1038/NMETH.1296, 10.1038/nmeth.1296]; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patterson GH, 1997, BIOPHYS J, V73, P2782, DOI 10.1016/S0006-3495(97)78307-3; Piatkevich KD, 2010, J AM CHEM SOC, V132, P10762, DOI 10.1021/ja101974k; Piatkevich KD, 2010, P NATL ACAD SCI USA, V107, P5369, DOI 10.1073/pnas.0914365107; Pletnev S, 2012, J MOL BIOL, V417, P144, DOI 10.1016/j.jmb.2012.01.044; Pletneva N, 2006, ACTA CRYSTALLOGR D, V62, P527, DOI 10.1107/S0907444906007852; Pletneva NV, 2007, RUSS J BIOORG CHEM+, V33, P390, DOI 10.1134/S1068162007040048; Pletneva NV, 2013, ACTA CRYSTALLOGR D, V69, P1005, DOI 10.1107/S0907444913004034; Pletneva NV, 2011, PROTEIN SCI, V20, P1265, DOI 10.1002/pro.654; Remington SJ, 2005, BIOCHEMISTRY-US, V44, P202, DOI 10.1021/bi048383r; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Shagin DA, 2004, MOL BIOL EVOL, V21, P841, DOI 10.1093/molbev/msh079; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shcherbakova DM, 2012, ANGEW CHEM INT EDIT, V51, P10724, DOI 10.1002/anie.201200408; Shcherbakova DM, 2012, J AM CHEM SOC, V134, P7913, DOI 10.1021/ja3018972; Shu XK, 2006, BIOCHEMISTRY-US, V45, P9639, DOI 10.1021/bi060773l; Strack RL, 2008, NAT METHODS, V5, P955, DOI 10.1038/nmeth.1264; Strack RL, 2009, BIOCHEMISTRY-US, V48, P8279, DOI 10.1021/bi900870u; Strack RL, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-32; Subach OM, 2012, J AM CHEM SOC, V134, P14789, DOI 10.1021/ja3034137; Subach OM, 2011, NAT METHODS, V8, P771, DOI 10.1038/nmeth.1664; Tsutsui H, 2008, NAT METHODS, V5, P683, DOI 10.1038/nmeth.1235; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Violot S, 2009, J AM CHEM SOC, V131, P10356, DOI 10.1021/ja903695n; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu B, 2011, CURR OPIN CELL BIOL, V23, P310, DOI 10.1016/j.ceb.2010.12.004; Yarbrough D, 2001, P NATL ACAD SCI USA, V98, P462, DOI 10.1073/pnas.98.2.462; Zapata-Hommer O, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-5	52	15	17	4	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e99136	10.1371/journal.pone.0099136	http://dx.doi.org/10.1371/journal.pone.0099136			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24960050	Green Published, gold, Green Submitted			2022-12-27	WOS:000338633900003
J	Tossavainen, H; Kukkurainen, S; Maatta, JAE; Kahkonen, N; Pihlajamaa, T; Hytonen, VP; Kulomaa, MS; Permi, P				Tossavainen, Helena; Kukkurainen, Sampo; Maatta, Juha A. E.; Kahkonen, Niklas; Pihlajamaa, Tero; Hytonen, Vesa P.; Kulomaa, Markku S.; Permi, Perttu			Chimeric Avidin - NMR Structure and Dynamics of a 56 kDa Homotetrameric Thermostable Protein	PLOS ONE			English	Article							MAGNETIC-RESONANCE RELAXATION; GROUP HYDROGEN-EXCHANGE; MODEL-FREE APPROACH; BIOTIN-BINDING; TEMPERATURE-DEPENDENCE; BACKBONE DYNAMICS; ROTATIONAL DIFFUSION; MOLECULAR-DYNAMICS; THERMAL-STABILITY; ORDER PARAMETERS	Chimeric avidin (ChiAVD) is a product of rational protein engineering remarkably resistant to heat and harsh conditions. In quest of the fundamentals behind factors affecting stability we have elucidated the solution NMR spectroscopic structure of the biotin-bound form of ChiAVD and characterized the protein dynamics through N-15 relaxation and hydrogen/deuterium (H/D) exchange of this and the biotin-free form. To surmount the challenges arising from the very large size of the protein for NMR spectroscopy, we took advantage of its high thermostability. Conventional triple resonance experiments for fully protonated proteins combined with methyl-detection optimized experiments acquired at 58 degrees C were adequate for the structure determination of this 56 kDa protein. The model-free parameters derived from the N-15 relaxation data reveal a remarkably rigid protein at 58 degrees C in both the biotin-bound and the free forms. The H/D exchange experiments indicate a notable increase in hydrogen protection upon biotin binding.	[Tossavainen, Helena; Pihlajamaa, Tero; Permi, Perttu] Univ Helsinki, Inst Biotechnol, Program Struct Biol & Biophys, Helsinki, Finland; [Kukkurainen, Sampo; Maatta, Juha A. E.; Kahkonen, Niklas; Hytonen, Vesa P.; Kulomaa, Markku S.] Univ Tampere, Inst Biomed Technol, FIN-33101 Tampere, Finland; [Kukkurainen, Sampo; Maatta, Juha A. E.; Kahkonen, Niklas; Hytonen, Vesa P.; Kulomaa, Markku S.] Tampere Univ Hosp, Tampere, Finland; [Maatta, Juha A. E.; Kahkonen, Niklas; Hytonen, Vesa P.; Kulomaa, Markku S.] BioMediTech, Tampere, Finland; [Kukkurainen, Sampo; Maatta, Juha A. E.; Hytonen, Vesa P.] Fimlab Labs, Tampere, Finland	University of Helsinki; Tampere University; Tampere University; Tampere University Hospital	Permi, P (corresponding author), Univ Helsinki, Inst Biotechnol, Program Struct Biol & Biophys, Helsinki, Finland.	Perttu.Permi@helsinki.fi	Määttä, Juha/A-6629-2016; Hytonen, Vesa P./E-8855-2013	Määttä, Juha/0000-0003-3885-6149; Hytonen, Vesa P./0000-0002-9357-1480; Kukkurainen, Sampo/0000-0002-0635-784X	Academy of Finland [259447, 136288, 140978]; Sigrid Juselius Foundation; Tampere Graduate Program in Biomedicine and Biotechnology	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Tampere Graduate Program in Biomedicine and Biotechnology	Funding provided by Academy of Finland (www.aka.fi) grants 259447 (PP), 136288, 140978 (VPH), Sigrid Juselius Foundation (www.sigridjuselius.fi): PP & VPH and Tampere Graduate Program in Biomedicine and Biotechnology (www.uta.fi/bmt/tgpbb: SK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKKE M, 1993, J AM CHEM SOC, V115, P9832, DOI 10.1021/ja00074a073; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Celej MS, 2004, BIOCHEM BIOPH RES CO, V325, P922, DOI 10.1016/j.bbrc.2004.10.118; Chang SL, 2005, J MAGN RESON, V174, P43, DOI 10.1016/j.jmr.2005.01.008; Chivers CE, 2010, NAT METHODS, V7, P391, DOI [10.1038/nmeth.1450, 10.1038/NMETH.1450]; CONNELLY GP, 1993, PROTEINS, V17, P87, DOI 10.1002/prot.340170111; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DIAMANDIS EP, 1991, CLIN CHEM, V37, P625; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620; Eisenberg-Domovich Y, 2005, ACTA CRYSTALLOGR D, V61, P528, DOI 10.1107/S0907444905003914; Gonzalez M, 1999, BIOMOL ENG, V16, P67, DOI 10.1016/S1050-3862(99)00041-8; Goto NK, 1999, J BIOMOL NMR, V13, P369, DOI 10.1023/A:1008393201236; Heikkinen JJ, 2011, ACS APPL MATER INTER, V3, P2240, DOI 10.1021/am200272u; Heikkinen JJ, 2011, COLLOID SURFACE B, V87, P409, DOI 10.1016/j.colsurfb.2011.05.052; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hytonen VP, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-28; Hytonen VP, 2005, PROTEINS, V61, P597, DOI 10.1002/prot.20604; Hytonen VP, 2005, J BIOL CHEM, V280, P10228, DOI 10.1074/jbc.M414196200; Hytonen VP, 2004, J BIOL CHEM, V279, P9337, DOI 10.1074/jbc.M310989200; Hytonen VR, 2004, BIOCHEM J, V384, P385, DOI 10.1042/BJ20041114; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Laitinen OH, 2006, CELL MOL LIFE SCI, V63, P2992, DOI 10.1007/s00018-006-6288-z; Laitinen OH, 2002, BIOCHEM J, V363, P609, DOI 10.1042/0264-6021:3630609; Laitinen OH, 2001, J BIOL CHEM, V276, P8219, DOI 10.1074/jbc.M007930200; Laitinen OH, 2007, TRENDS BIOTECHNOL, V25, P269, DOI 10.1016/j.tibtech.2007.04.001; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; LIVNAH O, 1993, P NATL ACAD SCI USA, V90, P5076, DOI 10.1073/pnas.90.11.5076; Lopez-Mendez B, 2006, J AM CHEM SOC, V128, P13112, DOI 10.1021/ja061136l; Maatta JAE, 2011, BIOTECHNOL BIOENG, V108, P481, DOI 10.1002/bit.22962; Mantylahti S, 2010, J BIOMOL NMR, V47, P183, DOI 10.1007/s10858-010-9422-z; MARION D, 1989, J MAGN RESON, V85, P393, DOI 10.1016/0022-2364(89)90152-2; MCCOY MA, 1992, J AM CHEM SOC, V114, P2108, DOI 10.1021/ja00032a026; Morin S, 2009, BIOPHYS J, V96, P4681, DOI 10.1016/j.bpj.2009.02.068; Pawley NH, 2002, J MOL BIOL, V324, P991, DOI 10.1016/S0022-2836(02)01146-4; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SANO T, 1995, P NATL ACAD SCI USA, V92, P3180, DOI 10.1073/pnas.92.8.3180; Savard PY, 2006, BIOCHEMISTRY-US, V45, P11414, DOI 10.1021/bi060414q; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Seewald MJ, 2000, PROTEIN SCI, V9, P1177, DOI 10.1110/ps.9.6.1177; SKELTON NJ, 1992, J MOL BIOL, V227, P1100, DOI 10.1016/0022-2836(92)90524-N; Spyracopoulos L, 2001, BIOCHEMISTRY-US, V40, P12541, DOI 10.1021/bi010903k; Tjandra N, 1996, J BIOMOL NMR, V8, P273, DOI 10.1007/BF00410326; Torchia DA, 2011, J MAGN RESON, V212, P1, DOI 10.1016/j.jmr.2011.07.010; Tossavainen H, 2013, BIOMOL NMR ASSIGN, V7, P35, DOI 10.1007/s12104-012-9371-4; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; Wang TZ, 2003, J AM CHEM SOC, V125, P8639, DOI 10.1021/ja034077+; Wilchek M, 1999, BIOMOL ENG, V16, P1; Williams DH, 2006, J MOL BIOL, V355, P760, DOI 10.1016/j.jmb.2005.11.015; Wurtz P, 2006, J BIOMOL NMR, V36, P12, DOI 10.1007/s10858-006-9056-3; Yang DW, 1996, J MOL BIOL, V263, P369, DOI 10.1006/jmbi.1996.0581	57	1	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100564	10.1371/journal.pone.0100564	http://dx.doi.org/10.1371/journal.pone.0100564			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959850	Green Submitted, Green Published, gold			2022-12-27	WOS:000338633900057
J	Zhou, Y; Ni, HP; Balint, K; Sanzari, JK; Dentchev, T; Diffenderfer, ES; Wilson, JM; Cengel, KA; Weissman, D				Zhou, Yu; Ni, Houping; Balint, Klara; Sanzari, Jenine K.; Dentchev, Tzvete; Diffenderfer, Eric S.; Wilson, Jolaine M.; Cengel, Keith A.; Weissman, Drew			Ionizing Radiation Selectively Reduces Skin Regulatory T Cells and Alters Immune Function	PLOS ONE			English	Article							DNA-PKCS; IN-VIVO; DOSE DISTRIBUTION; UV-RADIATION; IRRADIATION; THERAPY; PROTON; SYSTEM; RESISTANCE; TOLERANCE	The skin serves multiple functions that are critical for life. The protection from pathogens is achieved by a complicated interaction between aggressive effectors and controlling functions that limit damage. Inhomogeneous radiation with limited penetration is used in certain types of therapeutics and is experienced with exposure to solar particle events outside the protection of the Earth's magnetic field. This study explores the effect of ionizing radiation on skin immune function. We demonstrate that radiation, both homogeneous and inhomogeneous, induces inflammation with resultant specific loss of regulatory T cells from the skin. This results in a hyper-responsive state with increased delayed type hypersensitivity in vivo and CD4(+) T cell proliferation in vitro. The effects of inhomogeneous radiation to the skin of astronauts or as part of a therapeutic approach could result in an unexpected enhancement in skin immune function. The effects of this need to be considered in the design of radiation therapy protocols and in the development of countermeasures for extended space travel.	[Zhou, Yu; Ni, Houping; Balint, Klara; Weissman, Drew] Univ Penn, Dept Med, Div Infect Dis, Philadelphia, PA 19104 USA; [Sanzari, Jenine K.; Diffenderfer, Eric S.; Wilson, Jolaine M.; Cengel, Keith A.] Univ Penn, Dept Radiat Oncol, Philadelphia, PA USA; [Dentchev, Tzvete] Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Weissman, D (corresponding author), Univ Penn, Dept Med, Div Infect Dis, Philadelphia, PA 19104 USA.	dreww@mail.med.upenn.edu	Balint, Klara/ABB-8816-2021	Balint, Klara/0000-0002-1540-1988	National Space Biomedical Research Institute through National Aeronautics and Space Administration [NCC 9-58]	National Space Biomedical Research Institute through National Aeronautics and Space Administration	This work was supported by a grant from the National Space Biomedical Research Institute through National Aeronautics and Space Administration NCC 9-58. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinelli S, 2003, NUCL INSTRUM METH A, V506, P250, DOI 10.1016/S0168-9002(03)01368-8; Ariotti N, 2012, MOL BIOL CELL, V23, P1826, DOI 10.1091/mbc.E11-10-0847; Ariotti S, 2012, P NATL ACAD SCI USA, V109, P19739, DOI 10.1073/pnas.1208927109; Ariotti S, 2012, ADV IMMUNOL, V114, P203, DOI 10.1016/B978-0-12-396548-6.00008-1; AWWAD M, 1988, CANCER IMMUNOL IMMUN, V26, P55; Balogh A, 2013, INFLAMM RES, V62, P201, DOI 10.1007/s00011-012-0567-y; Balter S, 2010, RADIOLOGY, V254, P326, DOI 10.1148/radiol.2542082312; Burzyn D, 2013, NAT IMMUNOL, V14, P1007, DOI 10.1038/ni.2683; Cao MD, 2011, INT J RADIAT BIOL, V87, P71, DOI 10.3109/09553002.2010.518208; Cengel KA, 2010, RADIAT ENVIRON BIOPH, V49, P715, DOI 10.1007/s00411-010-0315-z; Chen KL, 2010, POULTRY SCI, V89, P887, DOI 10.3382/ps.2009-00524; DUNN PL, 1991, J LEUKOCYTE BIOL, V49, P388, DOI 10.1002/jlb.49.4.388; EKKEL ED, 1995, J ANIM SCI, V73, P1544; EKKEL ED, 1995, VET QUART, V17, P143, DOI 10.1080/01652176.1995.9694554; Franco D, 2009, DNA REPAIR, V8, P813, DOI 10.1016/j.dnarep.2009.03.007; Geherin SA, 2012, J IMMUNOL, V188, P6027, DOI 10.4049/jimmunol.1102639; Gleason NR, 1999, SURG ENDOSC-ULTRAS, V13, P1032, DOI 10.1007/s004649901163; Gridley DS, 2011, IN VIVO, V25, P871; Gridley DS, 2010, TECHNOL CANCER RES T, V9, P637, DOI 10.1177/153303461000900612; Hagelstrom RT, 2008, ONCOGENE, V27, P6761, DOI 10.1038/onc.2008.276; Halliday GM, 2012, J DERMATOL SCI, V66, P176, DOI 10.1016/j.jdermsci.2011.12.009; Hart PH, 2011, NAT REV IMMUNOL, V11, P584, DOI 10.1038/nri3045; Hauswald H, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-118; Hernandez A, 2005, VET IMMUNOL IMMUNOP, V104, P45, DOI 10.1016/j.vetimm.2004.10.006; Hong A, 2012, CANCER J, V18, P203, DOI 10.1097/PPO.0b013e31824b241a; Hu SW, 2009, HEALTH PHYS, V96, P465, DOI 10.1097/01.HP.0000339020.92837.61; Ikushima H, 2011, INT J RADIAT ONCOL, V79, P473, DOI 10.1016/j.ijrobp.2009.11.009; Juzeniene A, 2009, J PHOTOCH PHOTOBIO B, V96, P93, DOI 10.1016/j.jphotobiol.2009.04.009; Kachikwu EL, 2011, INT J RADIAT ONCOL, V81, P1128, DOI 10.1016/j.ijrobp.2010.09.034; Kim MHY, 2009, HEALTH PHYS, V97, P68, DOI 10.1097/01.HP.0000346799.65001.9c; Kohnke M, 2012, CHEM BIOL, V19, P866, DOI 10.1016/j.chembiol.2012.05.019; Komatsu N, 2007, P NATL ACAD SCI USA, V104, P8959, DOI 10.1073/pnas.0702004104; Kupper TS, 2004, NAT REV IMMUNOL, V4, P211, DOI 10.1038/nri1310; Li MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085665; Liston A, 2014, NAT REV IMMUNOL, V14, P154, DOI 10.1038/nri3605; Loser K, 2012, J INVEST DERMATOL, V132, P864, DOI 10.1038/jid.2011.375; Massimino S, 2003, J VET INTERN MED, V17, P835, DOI 10.1892/0891-6640(2003)017&lt;0835:EOAADO&gt;2.3.CO;2; McFarland HI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039092; Nelson C, 2010, INT J RADIAT ONCOL, V76, P1578, DOI 10.1016/j.ijrobp.2009.08.002; NISCO SJ, 1995, TRANSPLANTATION, V59, P1444, DOI 10.1097/00007890-199505270-00015; Norval M, 2011, PHOTOCHEM PHOTOBIOL, V87, P965, DOI 10.1111/j.1751-1097.2011.00969.x; Pathania S, 2011, VACCINE, V29, P7296, DOI 10.1016/j.vaccine.2011.07.065; Pustisek N, 2011, COLLEGIUM ANTROPOL, V35, P339; Qu YY, 2010, CELL MOL IMMUNOL, V7, P419, DOI 10.1038/cmi.2010.45; Qu YY, 2010, RADIAT RES, V173, P148, DOI 10.1667/RR0978.1; Romero-Weaver AL, 2013, RADIAT RES, V180, P177, DOI 10.1667/RR3055.1; Romero-Weaver AL, 2013, ASTROBIOLOGY, V13, P570, DOI 10.1089/ast.2012.0916; Sanzari JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071757; Seo HW, 2012, BMC VET RES, V8, P1, DOI 10.1186/1746-6148-8-194; Sklar LR, 2013, PHOTOCH PHOTOBIO SCI, V12, P54, DOI 10.1039/c2pp25152c; Suchin EJ, 2001, J IMMUNOL, V166, P973, DOI 10.4049/jimmunol.166.2.973; Tomura M, 2010, J CLIN INVEST, V120, P883, DOI 10.1172/JCI40926; Ullrich SE, 2012, J INVEST DERMATOL, V132, P896, DOI 10.1038/jid.2011.405; Walser PJ, 2012, CELL, V150, P752, DOI 10.1016/j.cell.2012.06.042; Williams ES, 2009, CANCER RES, V69, P2100, DOI 10.1158/0008-5472.CAN-08-2854; Wilson JM, 2011, RADIAT RES, V176, P649, DOI 10.1667/RR2541.1; Wood KJ, 2003, NAT REV IMMUNOL, V3, P199, DOI 10.1038/nri1027; Worbs T, 2006, J EXP MED, V203, P519, DOI 10.1084/jem.20052016	58	10	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100800	10.1371/journal.pone.0100800	http://dx.doi.org/10.1371/journal.pone.0100800			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959865	Green Submitted, Green Published, gold			2022-12-27	WOS:000338633900088
J	Pritchett, J; Athwal, VS; Harvey, E; Martin, K; Llewellyn, J; Ireland, P; Nicolaides, A; Humphries, MJ; Bobola, N; Hanley, NA; Hanley, KP				Pritchett, James; Athwal, Varinder S.; Harvey, Emma; Martin, Katherine; Llewellyn, Jessica; Ireland, Philip; Nicolaides, Alexander; Humphries, Martin J.; Bobola, Nicoletta; Hanley, Neil A.; Hanley, Karen Piper			Epimorphin Alters the Inhibitory Effects of SOX9 on Mmp13 in Activated Hepatic Stellate Cells	PLOS ONE			English	Article							LIVER FIBROSIS; MORPHOGENIC PROTEIN; GENE-EXPRESSION; OSTEOPONTIN; RECOVERY; DEACTIVATION; HEPATOCYTES; DEGRADATION; PROGRESSION; RESOLUTION	Background and Aims: Liver fibrosis is a major cause of morbidity and mortality. It is characterised by excessive extracellular matrix (ECM) deposition from activated hepatic stellate cells (HSCs). Although potentially reversible, treatment remains limited. Understanding how ECM influences the pathogenesis of the disease may provide insight into novel therapeutic targets for the disease. The extracellular protein Epimorphin (EPIM) has been implicated in tissue repair mechanisms in several tissues, partially, through its ability to manipulate proteases. In this study, we have identified that EPIM modulates the ECM environment produced by activated hepatic stellate cells (HSCs), in part, through down-regulation of pro-fibrotic Sex-determining region Y-box 9 (SOX9). Methods: Influence of EPIM on ECM was investigated in cultured primary rat HSCs. Activated HSCs were treated with recombinant EPIM or SOX9 siRNA. Core fibrotic factors were evaluated by immunoblotting, qPCR and chromatin immunoprecipitation (ChIP). Results: During HSC activation EPIM became significantly decreased in contrast to pro-fibrotic markers SOX9, Collagen type 1 (COL1), and alpha-Smooth muscle actin (alpha-SMA). Treatment of activated HSCs with recombinant EPIM caused a reduction in alpha-SMA, SOX9, COL1 and Osteopontin (OPN), while increasing expression of the collagenase matrix metalloproteinase 13 (MMP13). Sox9 abrogation in activated HSCs increased EPIM and MMP13 expression. Conclusion: These data provide evidence for EPIM and SOX9 functioning by mutual negative feedback to regulate attributes of the quiescent or activated state of HSCs. Further understanding of EPIM's role may lead to opportunities to modulate SOX9 as a therapeutic avenue for liver fibrosis.	[Pritchett, James; Athwal, Varinder S.; Harvey, Emma; Martin, Katherine; Llewellyn, Jessica; Ireland, Philip; Nicolaides, Alexander; Hanley, Neil A.; Hanley, Karen Piper] Univ Manchester, Manchester Acad Hlth Sci Ctr, Ctr Endocrinol & Diabet, Manchester, Lancs, England; [Bobola, Nicoletta] Univ Manchester, Manchester Acad Hlth Sci Ctr, Sch Dent, Manchester, Lancs, England; [Pritchett, James; Athwal, Varinder S.; Martin, Katherine; Llewellyn, Jessica; Hanley, Neil A.; Hanley, Karen Piper] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Biomed Res Ctr, Manchester, Lancs, England; [Humphries, Martin J.] Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Manchester, Lancs, England	University of Manchester; University of Manchester; University of Manchester; University of Manchester	Hanley, KP (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Ctr Endocrinol & Diabet, Manchester, Lancs, England.	karen.piperhanley@manchester.ac.uk	Piper Hanley, Karen/O-8676-2015; Pritchett, James/C-2532-2008	Piper Hanley, Karen/0000-0001-9473-9647; Pritchett, James/0000-0003-2620-7061; Hanley, Neil/0000-0003-3234-4038; Llewellyn, Jessica/0000-0003-0359-6711; Humphries, Martin/0000-0002-4331-6967	Medical Research Council (MRC) [MR/J003352/1]; Manchester Biomedical Research Centre; Wellcome Trust [WT088566MA]; Biological & Biotechnological Sciences Research Council (BBSRC); Medical Research Council [MR/K003194/1, MR/J003352/1, 1233455] Funding Source: researchfish; MRC [MR/J003352/1, MR/K003194/1] Funding Source: UKRI	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); Biological & Biotechnological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Medical Research Council (MRC; KPH, MR/J003352/1; VSA and KM are MRC Clinical Training Fellows); the Manchester Biomedical Research Centre; the Wellcome Trust (NAH, WT088566MA) and the Biological & Biotechnological Sciences Research Council (BBSRC; studentship to EH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cohen-Naftaly Michal, 2011, Therap Adv Gastroenterol, V4, P391, DOI 10.1177/1756283X11413002; Donaldson IJ, 2012, NUCLEIC ACIDS RES, V40, P3990, DOI 10.1093/nar/gkr1240; Endo H, 2011, PATHOBIOLOGY, V78, P239, DOI 10.1159/000328841; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Friedman SL, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004700; Friedman SL, 2003, J HEPATOL, V38, pS38, DOI 10.1016/S0168-8278(02)00429-4; FRIEDMAN SL, 1989, J BIOL CHEM, V264, P10756; Gaca MDA, 2003, MATRIX BIOL, V22, P229, DOI 10.1016/S0945-053X(03)00017-9; Hanley KP, 2008, J BIOL CHEM, V283, P14063, DOI 10.1074/jbc.M707390200; Hanley KP, 2010, J ENDOCRINOL, V207, P151, DOI 10.1677/JOE-10-0120; Hattori T, 2010, DEVELOPMENT, V137, P901, DOI 10.1242/dev.045203; HIRAI Y, 1993, BIOCHEM BIOPH RES CO, V191, P1332, DOI 10.1006/bbrc.1993.1363; HIRAI Y, 1992, CELL, V69, P471, DOI 10.1016/0092-8674(92)90448-L; Hirose M, 1996, BIOCHEM BIOPH RES CO, V225, P155, DOI 10.1006/bbrc.1996.1146; Huang WB, 2010, CLIN CHIM ACTA, V411, P675, DOI 10.1016/j.cca.2010.01.029; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; IREDALE JP, 1992, J CLIN INVEST, V90, P282, DOI 10.1172/JCI115850; Iredale JP, 2001, SEMIN LIVER DIS, V21, P427, DOI 10.1055/s-2001-17557; Jia Y, 2011, J CELL PHYSL; Jia YL, 2011, HEPATOLOGY, V54, P1808, DOI 10.1002/hep.24562; Kim EJ, 2011, MOL THER, V19, P355, DOI 10.1038/mt.2010.262; Kisseleva T, 2012, P NATL ACAD SCI USA, V109, P9448, DOI 10.1073/pnas.1201840109; Kossakowska AE, 1998, AM J PATHOL, V153, P1895, DOI 10.1016/S0002-9440(10)65703-3; Miura K, 2007, J HEPATOL, V47, P834, DOI 10.1016/j.jhep.2007.07.024; Nishimura R, 2012, J BIOL CHEM, V287, P33179, DOI 10.1074/jbc.M111.337063; Oakley F, 2005, GASTROENTEROLOGY, V128, P108, DOI 10.1053/j.gastro.2004.10.003; Pritchett J, 2012, HEPATOLOGY, V56, P1108, DOI 10.1002/hep.25758; Pritchett J, 2011, TRENDS MOL MED, V17, P166, DOI 10.1016/j.molmed.2010.12.001; Radisky DC, 2003, TRENDS CELL BIOL, V13, P426, DOI 10.1016/S0962-8924(03)00146-6; Radisky DC, 2009, NAT REV MOL CELL BIO, V10, P228, DOI 10.1038/nrm2633; Rowe C, 2013, HEPATOLOGY, V58, P799, DOI 10.1002/hep.26414; Segawa D, 2005, J GASTROEN HEPATOL, V20, P1769, DOI 10.1111/j.1440-1746.2005.03944.x; Shimada H, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S12; Smart DE, 2006, HEPATOLOGY, V44, P1432, DOI 10.1002/hep.21436; Sohara N, 2002, J HEPATOL, V37, P214, DOI 10.1016/S0168-8278(02)00103-4; Syn WK, 2011, HEPATOLOGY, V53, P106, DOI 10.1002/hep.23998; Terasaki Y, 2000, AM J RESP CELL MOL, V23, P168, DOI 10.1165/ajrcmb.23.2.3973; Troeger JS, 2012, GASTROENTEROLOGY, V143, P1073, DOI 10.1053/j.gastro.2012.06.036; Watanabe S, 1998, BIOCHEM BIOPH RES CO, V250, P486, DOI 10.1006/bbrc.1998.9339; Watanabe T, 2000, J HEPATOL, V33, P224, DOI 10.1016/S0168-8278(00)80363-3; Xie H, 2007, DIGEST LIVER DIS, V39, P167, DOI 10.1016/j.dld.2006.10.015; Yamada M, 2010, LAB INVEST, V90, P867, DOI 10.1038/labinvest.2010.50; Yoshino R, 2006, HEPATOL RES, V34, P238, DOI 10.1016/j.hepres.2005.12.011; Zhao L, 2008, INT J CLIN PRACT, V62, P1056, DOI 10.1111/j.1742-1241.2007.01368.x; Zhou J, 2011, PLOS ONE, V5, pe9732; Zhou JN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009732	46	13	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100091	10.1371/journal.pone.0100091	http://dx.doi.org/10.1371/journal.pone.0100091			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971829	Green Published, gold, Green Accepted			2022-12-27	WOS:000338512200018
J	Rusan, ZM; Kingsford, OA; Tanouye, MA				Rusan, Zeid M.; Kingsford, Olivia A.; Tanouye, Mark A.			Modeling Glial Contributions to Seizures and Epileptogenesis: Cation-Chloride Cotransporters in Drosophila melanogaster	PLOS ONE			English	Article							K-CL COTRANSPORTER; GIANT FIBER SYSTEM; EXPRESSION; BRAIN; SUSCEPTIBILITY; GENE; DISRUPTION; MUTATIONS; EPILEPSY; MUTANTS	Flies carrying a kcc loss-of-function mutation are more seizure-susceptible than wild-type flies. The kcc gene is the highly conserved Drosophila melanogaster ortholog of K+/Cl- cotransporter genes thought to be expressed in all animal cell types. Here, we examined the spatial and temporal requirements for kcc loss-of-function to modify seizure-susceptibility in flies. Targeted RNA interference (RNAi) of kcc in various sets of neurons was sufficient to induce severe seizure-sensitivity. Interestingly, kcc RNAi in glia was particularly effective in causing seizure-sensitivity. Knockdown of kcc in glia or neurons during development caused a reduction in seizure induction threshold, cell swelling, and brain volume increase in 24-48 hour old adult flies. Third instar larval peripheral nerves were enlarged when kcc RNAi was expressed in neurons or glia. Results suggest that a threshold of K+/Cl- cotransport dysfunction in the nervous system during development is an important determinant of seizure-susceptibility in Drosophila. The findings presented are the first attributing a causative role for glial cation-chloride cotransporters in seizures and epileptogenesis. The importance of elucidating glial cell contributions to seizure disorders and the utility of Drosophila models is discussed.	[Rusan, Zeid M.; Tanouye, Mark A.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Kingsford, Olivia A.; Tanouye, Mark A.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Tanouye, Mark A.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Rusan, ZM (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	rusanz@anesthesia.ucsf.edu			McKnight Foundation; National Institutes of Health [NS31231]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031231] Funding Source: NIH RePORTER	McKnight Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by awards from the McKnight Foundation and the National Institutes of Health (NS31231) to M.A.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MJ, 2007, GENES BRAIN BEHAV, V6, P347, DOI 10.1111/j.1601-183X.2006.00263.x; Allen M.J., 2010, COLD SPRING HARB PRO, V2010; Allen MJ, 2006, SEMIN CELL DEV BIOL, V17, P31, DOI 10.1016/j.semcdb.2005.11.011; Ben-Ari Y, 2012, NEUROSCIENTIST, V18, P467, DOI 10.1177/1073858412438697; Benarroch EE, 2013, NEUROLOGY, V80, P756, DOI 10.1212/WNL.0b013e318283bb1c; Benesova J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029725; Blaesse P, 2009, NEURON, V61, P820, DOI 10.1016/j.neuron.2009.03.003; Boettger T, 2003, EMBO J, V22, P5422, DOI 10.1093/emboj/cdg519; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brink DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037876; Byun N, 2007, NEUROBIOL DIS, V28, P39, DOI 10.1016/j.nbd.2007.06.014; Chvatal A, 2000, PROG BRAIN RES, V125, P199; Colmenero-Flores JM, 2007, PLANT J, V50, P278, DOI 10.1111/j.1365-313X.2007.03048.x; Cruz-Rangel S, 2011, AM J PHYSIOL-CELL PH, V301, pC601, DOI 10.1152/ajpcell.00070.2011; D'Ambrosio R, 2004, PHARMACOL THERAPEUT, V103, P95, DOI 10.1016/j.pharmthera.2004.05.004; Desalvo MK, 2011, GLIA, V59, P1322, DOI 10.1002/glia.21147; Devinsky O, 2013, TRENDS NEUROSCI, V36, P174, DOI 10.1016/j.tins.2012.11.008; Edwards TN, 2012, J COMP NEUROL, V520, P2067, DOI 10.1002/cne.23071; Featherstone DE, 2011, GLIA, V59, P1351, DOI 10.1002/glia.21085; Filippov V, 2003, INSECT MOL BIOL, V12, P319, DOI 10.1046/j.1365-2583.2003.00415.x; Gagnon KB, 2013, AM J PHYSIOL-CELL PH, V304, pC693, DOI 10.1152/ajpcell.00350.2012; Gagnon KBE, 2007, CELL PHYSIOL BIOCHEM, V20, P121, DOI 10.1159/000104160; Hartenstein V, 2011, GLIA, V59, P1237, DOI 10.1002/glia.21162; Hebert SC, 2004, PFLUG ARCH EUR J PHY, V447, P580, DOI 10.1007/s00424-003-1066-3; Hekmat-Scafe DS, 2006, J NEUROSCI, V26, P8943, DOI 10.1523/JNEUROSCI.4998-05.2006; Hekmat-Scafe DS, 2010, GENETICS, V184, P171, DOI 10.1534/genetics.109.109074; Hochman DW, 2012, EPILEPSIA, V53, P18, DOI 10.1111/j.1528-1167.2012.03471.x; Hubner CA, 2001, NEURON, V30, P515, DOI 10.1016/S0896-6273(01)00297-5; Jayakumar AR, 2011, J NEUROCHEM, V117, P437, DOI 10.1111/j.1471-4159.2011.07211.x; Jayakumar AR, 2010, METAB BRAIN DIS, V25, P31, DOI 10.1007/s11011-010-9180-3; Kahle KT, 2008, NAT CLIN PRACT NEURO, V4, P490, DOI 10.1038/ncpneuro0883; Kahle KT, 2010, BBA-MOL BASIS DIS, V1802, P1150, DOI 10.1016/j.bbadis.2010.07.009; Kuebler D, 2000, J NEUROPHYSIOL, V83, P998, DOI 10.1152/jn.2000.83.2.998; Lee J, 2002, J NEUROSCI, V22, P11065; Lee J, 2006, J NEUROPHYSIOL, V96, P2465, DOI 10.1152/jn.00499.2006; Leiserson WM, 2011, GLIA, V59, P1312, DOI 10.1002/glia.21132; Leiserson WM, 2011, GLIA, V59, P320, DOI 10.1002/glia.21103; MacAulay N, 2012, NEUROCHEM RES, V37, P2299, DOI 10.1007/s11064-012-0731-3; Marchi N, 2007, EPILEPSIA, V48, P732, DOI 10.1111/j.1528-1167.2007.00988.x; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Melom JE, 2013, J NEUROSCI, V33, P1169, DOI 10.1523/JNEUROSCI.3920-12.2013; Park JH, 1996, J MEMBRANE BIOL, V149, P161, DOI 10.1007/s002329900016; Parker L, 2011, INT REV NEUROBIOL, V99, P1, DOI 10.1016/B978-0-12-387003-2.00001-X; Pasantes-Morales H, 2006, CONTRIB NEPHROL, V152, P221, DOI 10.1159/000096326; PAVLIDIS P, 1995, J NEUROSCI, V15, P5810; Phelan P, 1996, J NEUROSCI, V16, P1101; Ringel F, 2008, NEUROSCI LETT, V442, P219, DOI 10.1016/j.neulet.2008.07.017; Seifert G, 2010, BRAIN RES REV, V63, P212, DOI 10.1016/j.brainresrev.2009.10.004; Stork Tobias, 2012, Cold Spring Harb Protoc, V2012, P1, DOI 10.1101/pdb.top067587; Sun QF, 2010, AM J PHYSIOL-CELL PH, V298, pC26, DOI 10.1152/ajpcell.00376.2009; Tornberg J, 2005, EUR J NEUROSCI, V21, P1327, DOI 10.1111/j.1460-9568.2005.03959.x; Woo NS, 2002, HIPPOCAMPUS, V12, P258, DOI 10.1002/hipo.10014; Zdebik AA, 2011, J PHYSIOL-LONDON, V589, P5903, DOI 10.1113/jphysiol.2011.221754	53	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e101117	10.1371/journal.pone.0101117	http://dx.doi.org/10.1371/journal.pone.0101117			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971529	gold, Green Published, Green Submitted			2022-12-27	WOS:000338512200095
J	Su, XL; Yao, J; Jiang, Y; Li, J; Han, JF; Sun, WD				Su, Xueli; Yao, Jun; Jiang, Yan; Li, Jie; Han, Jianfeng; Sun, Weidong			Promising Antibody Testing Strategies for Early Infant HIV Infection Diagnosis in China	PLOS ONE			English	Article							IMMUNODEFICIENCY; CHILDREN; PROGRESSION; RECOMBINANT; MORTALITY; AFRICA	Background: In China, 1.1% of people living with HIV were transmitted vertically, causing a heavy burden on families and society. Early infant diagnosis (EID) is critical for improving neonatal survival. The purpose of this study is to suggest improvement in antibody testing strategies with dried blood spots (DBSs) for EID in China through analysis of anti-HIV seroreversion of infants. Methods: A total of 280 infants born to HIV infected mothers in four diverse provinces of China where multiple subtypes coexist were enrolled. The status of the infants' infection was determined by HIV antibody enzyme immunoassay and Western blot analysis at >= 18 months of age or by convincing clinical and epidemiologic data for deceased infants. A total of 1028 DBSs were collected during follow-up, which were tested to obtain anti-HIV signal to cut-off ratio (S/CO) data. Results: For uninfected infants, anti-HIV S/CO decreased with age. Seropositivity percentage declined most rapidly at 6 months to 9 months of age and 98.7% children seroreverted by 12 months of age. For most infected infants, minimum S/CO values were obtained at <= 6 months of age. Antibody negative predictive value was 100% at >= 6 months of age. An S/CO increase >= 1.86 after three months follow-up can determine HIV infection. S/CO threshold of 3.17 can differentiate infected from uninfected infants for exposed kids at 9 months or older with sensitivity as 100% and specificity >= 94.2%. Significance: Suggestions obtained through studying seroreversion data of Chinese HIV-exposed infants help improve antibody strategies for HIV EID in China. The infection can be determined as early as 3 months of age and excluded as early as 6 months of age.	[Su, Xueli; Sun, Weidong] Beijing Ctr Dis Control & Prevent, Beijing, Peoples R China; [Yao, Jun; Jiang, Yan; Han, Jianfeng] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Natl HIV HCV Reference Lab, Beijing, Peoples R China; [Li, Jie] Kunming Ctr Dis Control & Prevent, Kunming, Peoples R China	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention	Yao, J (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Natl HIV HCV Reference Lab, Beijing, Peoples R China.	yaojuncdc@163.com; jiangyan03@263.net			National Natural Science Foundation of China [81302440]; Ministry of Science and Technology of China [2004BA719A03]; Clinton Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Clinton Foundation	The work was supported by National Natural Science Foundation of China (Grant No. 81302440), 'State Tenth 5 Year Plan' from Ministry of Science and Technology of China (Grant No. 2004BA719A03) and Clinton Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chaisomchit Sumonta, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P270; CHANTRY CJ, 1995, PEDIATR INFECT DIS J, V14, P382, DOI 10.1097/00006454-199505000-00009; Garcia F, 2012, IMMUNOTHERAPY-UK, V4, P245, DOI [10.2217/IMT.12.2, 10.2217/imt.12.2]; Graf M, 1998, AIDS RES HUM RETROV, V14, P285, DOI 10.1089/aid.1998.14.285; Gray L, 2001, PEDIATRICS, V108, P116, DOI 10.1542/peds.108.1.116; Han JF, 2009, THESIS CHINESE CTR D; Li QR, 2005, INFECT DIS INFO, V18, P156; Li QR, 2005, CHIN J AIDS STD, V11, P393; Li QR, 2005, CHIN J AIDS STD, V11, P397; Little K, 2007, CURR HIV RES, V5, P139, DOI 10.2174/157016207780077002; Menzies NA, 2009, PEDIATR INFECT DIS J, V28, P819, DOI 10.1097/INF.0b013e3181a3954b; Ministry of Health of the People&#x27; s Republic of China, 2012, 2012 CHIN AIDS RESP; MOODLEY D, 1995, PEDIATR INFECT DIS J, V14, P850, DOI 10.1097/00006454-199510000-00006; Mphatswe W, 2007, AIDS, V21, P1253, DOI 10.1097/QAD.0b013e3281a3bec2; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Okamoto Y, 1997, MICROBIOL IMMUNOL, V41, P131, DOI 10.1111/j.1348-0421.1997.tb01178.x; PALASANTHIRAN P, 1994, J INFECT DIS, V170, P1593, DOI 10.1093/infdis/170.6.1593; Pan PinLiang, 1999, Chinese Journal of Virology, V15, P97; Piyasirisilp S, 2000, J VIROL, V74, P11286, DOI 10.1128/JVI.74.23.11286-11295.2000; Prendergast A, 2008, HIV WOM CHILDR SESS; Read JS, 2007, PEDIATRICS, V120, pE1547, DOI 10.1542/peds.2007-2951; Sohn AH, 2009, PEDIATR INFECT DIS J, V28, P273, DOI 10.1097/INF.0b013e31818e03b4; Stevens W, 2008, Open AIDS J, V2, P17, DOI 10.2174/1874613600802010017; Su L, 2000, J VIROL, V74, P11367, DOI 10.1128/JVI.74.23.11367-11376.2000; Su Ling, 1997, Chinese Journal of Virology, V13, P265; Violari A, 2007, 4 INT AIDS SOC C HIV; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; WHO Technical Reference Group, 2008, PAED HIV ART CAR GUI; Xing H, 1999, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V13, P157	29	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e99935	10.1371/journal.pone.0099935	http://dx.doi.org/10.1371/journal.pone.0099935			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971594	Green Published, Green Submitted, gold			2022-12-27	WOS:000338512200016
J	Gao, F; Li, FH; Tan, J; Yan, JP; Sun, HL				Gao, Fei; Li, Fenghui; Tan, Jie; Yan, Jingping; Sun, Huiling			Bacterial Community Composition in the Gut Content and Ambient Sediment of Sea Cucumber Apostichopus japonicus Revealed by 16S rRNA Gene Pyrosequencing	PLOS ONE			English	Article							SULFATE-REDUCING BACTERIA; GRADIENT GEL-ELECTROPHORESIS; AEROBIC CULTURABLE BACTERIA; MARINE-SEDIMENTS; ORGANIC-MATTER; ONEIROPHANTA-MUTABILIS; ABYSSAL HOLOTHURIANS; DIVERSITY; AQUACULTURE; MICROBIOTA	The composition of the bacterial communities in the contents of the foregut and hindgut of the sea cucumber Apostichopus japonicus and in the ambient surface sediment was surveyed by 16S rRNA gene 454-pyrosequencing. A total of 188,623 optimized reads and 15,527 operational taxonomic units (OTUs) were obtained from the ten gut contents samples and four surface sediment samples. The sequences in the sediments, foregut contents, and hindgut contents were assigned to 38.0 +/- 4.7, 31.2 +/- 6.2 and 27.8 +/- 6.5 phyla, respectively. The bacterial richness and Shannon diversity index were both higher in the ambient sediments than in the gut contents. Proteobacteria was the predominant phylum in both the gut contents and sediment samples. The predominant classes in the foregut, hindgut, and ambient sediment were Holophagae and Gammaproteobacteria, Deltaproteobacteria and Gammaproteobacteria, and Gammaproteobacteria and Deltaproteobacteria, respectively. The potential probiotics, including sequences related to Bacillus, lactic acid bacteria (Lactobacillus, Lactococcus, and Streptococcus) and Pseudomonas were detected in the gut of A. japonicus. Principle component analysis and heatmap figure showed that the foregut, hindgut, and ambient sediment respectively harbored different characteristic bacterial communities. Selective feeding of A. japonicus may be the primary source of the different bacterial communities between the foregut contents and ambient sediments.	[Gao, Fei; Li, Fenghui; Tan, Jie; Yan, Jingping; Sun, Huiling] Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Key Lab Sustainable Dev Marine Fisheries, Qingdao, Peoples R China	Chinese Academy of Fishery Sciences; Yellow Sea Fisheries Research Institute, CAFS	Sun, HL (corresponding author), Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Key Lab Sustainable Dev Marine Fisheries, Qingdao, Peoples R China.	sunhl@ysfri.ac.cn			National Science Foundation of China [41106145]; National Key Technology Research and Development Program [2011BAD13B02]; National High Technology Research and Development Program of China (863 program) [2012AA10A412]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology Research and Development Program(National Key Technology R&D Program); National High Technology Research and Development Program of China (863 program)(National High Technology Research and Development Program of China)	This work was supported by National Science Foundation of China (No. 41106145), National Key Technology Research and Development Program (Nos. 2011BAD13B02) and the National High Technology Research and Development Program of China (863 program, No. 2012AA10A412). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsson TR, 2012, J ALLERGY CLIN IMMUN, V129, P434, DOI 10.1016/j.jaci.2011.10.025; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Amaro T, 2009, DEEP-SEA RES PT I, V56, P1834, DOI 10.1016/j.dsr.2009.05.014; AMON R M W, 1991, Marine Ecology, V12, P163, DOI 10.1111/j.1439-0485.1991.tb00250.x; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Balcazar JL, 2006, VET MICROBIOL, V114, P173, DOI 10.1016/j.vetmic.2006.01.009; Barlocher F, 1978, RECENT ADV AQUATIC M, P35; Cypionka H, 2000, ANNU REV MICROBIOL, V54, P827, DOI 10.1146/annurev.micro.54.1.827; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; DEMING JW, 1982, APPL ENVIRON MICROB, V44, P1222, DOI 10.1128/AEM.44.5.1222-1230.1982; Droge S, 2005, J GEN APPL MICROBIOL, V51, P57, DOI 10.2323/jgam.51.57; Gao F., 2010, J FISH SCI CHINA, V17, P672, DOI [10.3724/SP.J.1011.2010.01351, DOI 10.3724/SP.J.1011.2010.01351]; Gao F, 2008, COMP BIOCHEM PHYS B, V150, P255, DOI 10.1016/j.cbpb.2008.03.011; Gao F, 2014, J OCEAN U CHINA, V13, P303, DOI 10.1007/s11802-014-2078-7; Gao Fei, 2010, Journal of Fisheries of China, V34, P760, DOI 10.3724/SP.J.1231.2010.06768; GEBHART CJ, 1993, INT J SYST BACTERIOL, V43, P533, DOI 10.1099/00207713-43-3-533; GERLACH SA, 1978, OECOLOGIA, V33, P55, DOI 10.1007/BF00376996; GIBSON GR, 1988, J APPL BACTERIOL, V65, P241, DOI 10.1111/j.1365-2672.1988.tb01891.x; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; HAMMOND LS, 1983, MAR ECOL PROG SER, V10, P297, DOI 10.3354/meps010297; Han SF, 2010, AQUAC RES, V42, P47, DOI 10.1111/j.1365-2109.2010.02543.x; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Irianto A., 2002, J FISH DIS, V25, P1, DOI DOI 10.1046/J.1365-2761.2002.00375.X; JORGENSEN BB, 1982, NATURE, V296, P643, DOI 10.1038/296643a0; Kjelleberg S., 1993, STARVATION BACTERIA, P55, DOI DOI 10.1007/978-1-4899-2439-1_3; Kuhnigk T, 1996, SYST APPL MICROBIOL, V19, P139, DOI 10.1016/S0723-2020(96)80039-7; Leloup J, 2009, ENVIRON MICROBIOL, V11, P1278, DOI 10.1111/j.1462-2920.2008.01855.x; Li Bin, 2010, Marine Sciences (Beijing), V34, P64; Liao Y., 1997, FAUNA CHINA ECHINODE; LOPEZ GR, 1987, Q REV BIOL, V62, P235, DOI 10.1086/415511; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; McElroy S, 1990, SPC BECHE DEMER INF, V2, P2; Michio K, 2003, MAR POLLUT BULL, V47, P118, DOI 10.1016/S0025-326X(02)00411-3; MORIARTY DJW, 1982, AUST J MAR FRESH RES, V33, P255, DOI 10.1071/MF9820255; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Navarro PG, 2013, MAR BIOL, V160, P2957, DOI 10.1007/s00227-013-2286-5; PHILLIPS NW, 1984, B MAR SCI, V35, P283; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Ringo E, 2010, AQUACULT NUTR, V16, P117, DOI 10.1111/j.1365-2095.2009.00731.x; Roberts D, 2001, PROG OCEANOGR, V50, P443, DOI 10.1016/S0079-6611(01)00065-9; Roeselers G, 2011, ISME J, DOI [10.1038/ismej.2011.1038, DOI 10.1038/ISMEJ.2011.1038]; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SLOAN NA, 1980, MAR ECOL PROG SER, V2, P257, DOI 10.3354/meps002257; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Sun Yi, 1989, Oceanologia et Limnologia Sinica, V20, P300; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Uthicke S, 1999, J EXP MAR BIOL ECOL, V236, P69, DOI 10.1016/S0022-0981(98)00190-7; Vaz-Moreira I, 2011, ANTON LEEUW INT J G, V100, P245, DOI 10.1007/s10482-011-9583-0; Verschuere L, 2000, MICROBIOL MOL BIOL R, V64, P655, DOI 10.1128/MMBR.64.4.655-671.2000; Wang J, 2011, APPL MICROBIOL BIOT, V90, P2015, DOI 10.1007/s00253-011-3217-3; Wang YB, 2008, AQUACULTURE, V281, P1, DOI 10.1016/j.aquaculture.2008.06.002; WardRainey N, 1996, J EXP MAR BIOL ECOL, V203, P11, DOI 10.1016/0022-0981(96)02566-X; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Witbaard R, 2001, PROG OCEANOGR, V50, P423, DOI 10.1016/S0079-6611(01)00064-7; Wu SG, 2013, WORLD J MICROB BIOT, V29, P1585, DOI 10.1007/s11274-013-1322-4; Wu SG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040727, 10.1371/journal.pone.0030440]; YINGST JY, 1976, J EXP MAR BIOL ECOL, V23, P55, DOI 10.1016/0022-0981(76)90085-X; Yu Y, 2012, EUR J SOIL BIOL, V49, P12, DOI 10.1016/j.ejsobi.2011.08.006; Zhang B., 1995, MAR SCI-CHINA, V3, P11; [张文姬 ZHANG Wenji], 2011, [食品工业科技, Science & Technology of Food Industry], V32, P149; Zhang XC, 2013, J GEN APPL MICROBIOL, V59, P1; Zhang XC, 2012, J GEN APPL MICROBIOL, V58, P447, DOI 10.2323/jgam.58.447	64	64	68	2	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100092	10.1371/journal.pone.0100092	http://dx.doi.org/10.1371/journal.pone.0100092			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967593	gold, Green Published, Green Submitted			2022-12-27	WOS:000338280800024
J	Pettersson, LME; Geremia, NM; Ying, ZX; Verge, VMK				Pettersson, Lina M. E.; Geremia, Nicole M.; Ying, Zhengxin; Verge, Valerie M. K.			Injury-Associated PACAP Expression in Rat Sensory and Motor Neurons Is Induced by Endogenous BDNF	PLOS ONE			English	Article							CYCLASE-ACTIVATING POLYPEPTIDE; NERVE GROWTH-FACTOR; DORSAL-ROOT GANGLIA; P75 NEUROTROPHIN RECEPTOR; SCIATIC-NERVE; SPINAL-CORD; MESSENGER-RNA; AXONAL REGENERATION; COLUMN NUCLEI; UP-REGULATION	Peripheral nerve injury results in dramatic upregulation in pituitary adenylate cyclase activating polypeptide (PACAP) expression in adult rat dorsal root ganglia and spinal motor neurons mirroring that described for the neurotrophin brain derived neurotrophic factor (BDNF). Thus, we posited that injury-associated alterations in BDNF expression regulate the changes in PACAP expression observed in the injured neurons. The role of endogenous BDNF in induction and/or maintenance of PACAP mRNA expression in injured adult rat motor and sensory neurons was examined by intrathecally infusing or intraperitoneally injecting BDNF-specific antibodies or control IgGs immediately at the time of L4-L6 spinal nerve injury, or in a delayed fashion one week later for 3 days followed by analysis of impact on PACAP expression. PACAP mRNA in injured lumbar sensory and motor neurons was detected using in situ hybridization, allowing quantification of relative changes between experimental groups, with ATF-3 immunofluorescence serving to identify the injured subpopulation of motor neurons. Both the incidence and level of PACAP mRNA expression were dramatically reduced in injured sensory and motor neurons in response to immediate intrathecal anti-BDNF treatment. In contrast, neither intraperitoneal injections nor delayed intrathecal infusions of anti-BDNF had any discernible impact on PACAP expression. This impact on PACAP expression in response to BDNF immunoneutralization in DRG was confirmed using qRT-PCR or by using BDNF selective siRNAs to reduce neuronal BDNF expression. Collectively, our findings support that endogenous injury-associated BDNF expression is critically involved in induction, but not maintenance, of injury-associated PACAP expression in sensory and motor neurons.	[Pettersson, Lina M. E.] Univ Saskatchewan, CMSNRC, Saskatoon, SK, Canada; Univ Saskatchewan, Dept Anat & Cell Biol, Saskatoon, SK, Canada	University of Saskatchewan; University of Saskatchewan	Pettersson, LME (corresponding author), Lund Univ, Dept Expt Med Sci, Neuronano Res Ctr, BMC F10, Lund, Sweden.	Lina.Pettersson@med.lu.se	Ying, Zhengxin/A-8953-2011; Geremia, Nicole/AAC-3285-2021	Pettersson, Lina/0000-0002-6847-8823	Canadian Institutes of Health Research [MOP74747, ROP102801]; Saskatchewan Health Research Foundation PDF; University of Saskatchewan College of Medicine Scholarship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Saskatchewan Health Research Foundation PDF; University of Saskatchewan College of Medicine Scholarship	Support was contributed by: The Canadian Institutes of Health Research # MOP74747 and # ROP102801 to VMKV, the Saskatchewan Health Research Foundation PDF to LMEP & the University of Saskatchewan College of Medicine Scholarship to NMG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Majed AA, 2000, EUR J NEUROSCI, V12, P4381, DOI 10.1046/j.1460-9568.2000.01341.x; Apfel SC, 1996, MOL CELL NEUROSCI, V7, P134, DOI 10.1006/mcne.1996.0010; Armstrong BD, 2008, NEUROSCIENCE, V151, P63, DOI 10.1016/j.neuroscience.2007.09.084; Baker-Herman TL, 2004, NAT NEUROSCI, V7, P48, DOI 10.1038/nn1166; BOULDIN TW, 1991, J NEUROPATH EXP NEUR, V50, P719, DOI 10.1097/00005072-199111000-00004; Boyd JG, 2001, J NEUROBIOL, V49, P314, DOI 10.1002/neu.10013; Boyd JG, 2002, EUR J NEUROSCI, V15, P613, DOI 10.1046/j.1460-9568.2002.01891.x; Buck CR, 2000, J COMP NEUROL, V416, P309, DOI 10.1002/(SICI)1096-9861(20000117)416:3<309::AID-CNE3>3.0.CO;2-U; Cellerino A, 2003, J COMP NEUROL, V467, P97, DOI 10.1002/cne.10908; Deng YS, 1999, NEUROTOX RES, V1, P311, DOI 10.1007/BF03033260; Dun NJ, 1996, NEUROSCIENCE, V73, P677, DOI 10.1016/0306-4522(96)00057-7; ERNFORS P, 1990, NEURON, V5, P511, DOI 10.1016/0896-6273(90)90090-3; Frechilla D, 2001, NEUROREPORT, V12, P919, DOI 10.1097/00001756-200104170-00011; FUNAKOSHI H, 1993, J CELL BIOL, V123, P455, DOI 10.1083/jcb.123.2.455; Geremia NM, 2010, EXP NEUROL, V223, P128, DOI 10.1016/j.expneurol.2009.07.022; GIUFFRIDA R, 1992, J COMP NEUROL, V316, P206, DOI 10.1002/cne.903160206; Guirland C, 2003, J NEUROSCI, V23, P2274; Hammarberg H, 2000, J COMP NEUROL, V426, P587, DOI 10.1002/1096-9861(20001030)426:4<587::AID-CNE7>3.0.CO;2-R; Hanani M, 2005, BRAIN RES REV, V48, P457, DOI 10.1016/j.brainresrev.2004.09.001; Hannibal J, 2002, J COMP NEUROL, V453, P389, DOI 10.1002/cne.10418; HURLEY JD, 1995, ENDOCRINOLOGY, V136, P550, DOI 10.1210/en.136.2.550; Jongsma H, 2001, NEUROREPORT, V12, P2215, DOI 10.1097/00001756-200107200-00034; Jongsma H, 2000, BRAIN RES, V853, P186, DOI 10.1016/S0006-8993(99)02233-7; Jongsma Wallin H, 2002, THESIS; Karchewski LA, 2002, EUR J NEUROSCI, V16, P1449, DOI 10.1046/j.1460-9568.2002.02205.x; Karchewski LA, 1999, J COMP NEUROL, V413, P327, DOI 10.1002/(SICI)1096-9861(19991018)413:2<327::AID-CNE11>3.0.CO;2-3; Kimura H, 2004, REGUL PEPTIDES, V123, P135, DOI 10.1016/j.regpep.2004.04.020; Kobayashi NR, 1997, J NEUROSCI, V17, P9583; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; Li WP, 1999, NEUROSCI LETT, V260, P49, DOI 10.1016/S0304-3940(98)00958-6; Lindwall C, 2004, MOL CELL NEUROSCI, V27, P267, DOI 10.1016/j.mcn.2004.07.001; Mabuchi T, 2004, J NEUROSCI, V24, P7283, DOI 10.1523/JNEUROSCI.0983-04.2004; MAISONPIERRE PC, 1991, GENOMICS, V10, P558, DOI 10.1016/0888-7543(91)90436-I; Mamounas LA, 2000, J NEUROSCI, V20, P771, DOI 10.1523/JNEUROSCI.20-02-00771.2000; Michael GJ, 1999, EUR J NEUROSCI, V11, P3539, DOI 10.1046/j.1460-9568.1999.00767.x; MOLLER K, 1993, NEUROSCIENCE, V57, P725, DOI 10.1016/0306-4522(93)90018-B; MULDER H, 1994, NEUROSCIENCE, V63, P307, DOI 10.1016/0306-4522(94)90025-6; Narita M, 1996, EUR J PHARMACOL, V311, P121, DOI 10.1016/0014-2999(96)00359-7; Ohsawa M, 2002, PAIN, V100, P27, DOI 10.1016/S0304-3959(02)00207-5; Pettersson LME, 2004, EUR J NEUROSCI, V20, P1838, DOI 10.1111/j.1460-9568.2004.03644.x; Pettersson LME, 2004, J COMP NEUROL, V471, P85, DOI 10.1002/cne.20015; Shortland PJ, 2006, EUR J NEUROSCI, V23, P365, DOI 10.1111/j.1460-9568.2005.04568.x; Somogyvari-Vigh A, 2004, CURR PHARM DESIGN, V10, P2861, DOI 10.2174/1381612043383548; Song XY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001707; Suarez V, 2006, EUR J NEUROSCI, V24, P1555, DOI 10.1111/j.1460-9568.2006.05029.x; Thompson SWN, 1999, P NATL ACAD SCI USA, V96, P7714, DOI 10.1073/pnas.96.14.7714; Tonra JR, 1998, J NEUROSCI, V18, P4374; Tsujino H, 2000, MOL CELL NEUROSCI, V15, P170, DOI 10.1006/mcne.1999.0814; Vaudry D, 2000, PHARMACOL REV, V52, P269; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370; VERGE VMK, 1995, J NEUROSCI, V15, P2081, DOI 10.1523/JNEUROSCI.15-03-02081.1995; Villuendas G, 2001, MOL BRAIN RES, V94, P59, DOI 10.1016/S0169-328X(01)00177-2; Wallin HJ, 2003, NEUROSCIENCE, V120, P325, DOI 10.1016/S0306-4522(03)00118-0; Wallin HJ, 2001, EUR J NEUROSCI, V14, P267, DOI 10.1046/j.0953-816x.2001.01641.x; Waschek JA, 2002, DEV NEUROSCI-BASEL, V24, P14, DOI 10.1159/000064942; WETMORE C, 1995, J COMP NEUROL, V353, P143, DOI 10.1002/cne.903530113; Woolf CJ, 1996, PHILOS T ROY SOC B, V351, P441, DOI 10.1098/rstb.1996.0040; Xu XJ, 1996, NEUROSCIENCE, V72, P801, DOI 10.1016/0306-4522(96)00006-1; YAN Q, 1988, NEURON, V1, P335; Zhang JY, 2000, EUR J NEUROSCI, V12, P4171, DOI 10.1046/j.1460-9568.2000.01312.x; Zhang Q, 1995, BRAIN RES, V705, P149, DOI 10.1016/0006-8993(95)01150-1; Zhang YH, 2008, J PHYSIOL-LONDON, V586, P3113, DOI 10.1113/jphysiol.2008.152439; Zhang YZ, 1998, NEUROREPORT, V9, P2833, DOI 10.1097/00001756-199808240-00027; Zhang YZ, 1996, NEUROSCIENCE, V74, P1099, DOI 10.1016/S0306-4522(96)00168-6; Zhou XF, 2005, NEUROSCIENCE, V132, P591, DOI 10.1016/j.neuroscience.2004.12.034; Zhou XF, 1999, EUR J NEUROSCI, V11, P1711, DOI 10.1046/j.1460-9568.1999.00589.x; Zhou XF, 1999, NEUROSCIENCE, V92, P841, DOI 10.1016/S0306-4522(99)00027-5; Zhou XF, 2000, EUR J NEUROSCI, V12, P100, DOI 10.1046/j.1460-9568.2000.00884.x	68	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100730	10.1371/journal.pone.0100730	http://dx.doi.org/10.1371/journal.pone.0100730			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968020	Green Published, gold, Green Submitted			2022-12-27	WOS:000338280800059
J	Waseda, Y; Doyama, H; Inaki, N; Nakanishi, H; Yoshida, N; Tsuji, S; Takemura, K; Yamada, S; Okada, T				Waseda, Yohei; Doyama, Hisashi; Inaki, Noriyuki; Nakanishi, Hiroyoshi; Yoshida, Naohiro; Tsuji, Shigetsugu; Takemura, Kenichi; Yamada, Shinya; Okada, Toshihide			Does Laparoscopic and Endoscopic Cooperative Surgery for Gastric Submucosal Tumors Preserve Residual Gastric Motility? Results of a Retrospective Single-Center Study	PLOS ONE			English	Article							LOCAL RESECTION; WEDGE RESECTION; DISTAL GASTRECTOMY; LYMPHADENECTOMY; CANCER; GIST	Background: Laparoscopic and endoscopic cooperative surgery (LECS) is a minimally invasive surgical technique used to resect gastric submucosal tumors with intraluminal growth. Endoscopic submucosal dissection is used to determine the appropriate resection line from within the stomach lumen as it minimizes the stomach wall resection area and prevents postoperative stomach deformity. Although LECS is intended to preserve gastric function, few reports have evaluated postoperative residual gastric motility. Therefore, we conducted a retrospective analysis of patients who underwent LECS to determine the effects of LECS on residual gastric motility. Methods: Twenty-two patients underwent endoscopy 3 to 12 months after LECS. Patients were evaluated for endoscopic evidence of gastric motility disorder, namely food residue and occurrence/exacerbation of reflux esophagitis. We considered patients with new onset of gastric symptoms and endoscopic evidence of gastric motility disorder to have clinically relevant gastric motility disorder. We described patient characteristics, tumor location, and surgical findings. Results: Two of 22 patients developed clinically relevant gastric motility disorder after LECS. In one of these patients, the symptoms were not severe; only one had reduced dietary intake and had lost weight. We identified clinically relevant gastric motility disorder in two patients with gastrointestinal stromal tumors located in the lesser curvature of the stomach. The major axis of these two tumors was 34 mm and 38 mm. Conclusions: Many patients did not have clinically relevant gastric motility disorder after LECS. Further investigation is required to identify predisposing factors for gastric motility disorder.	[Waseda, Yohei; Doyama, Hisashi; Nakanishi, Hiroyoshi; Yoshida, Naohiro; Tsuji, Shigetsugu; Takemura, Kenichi; Yamada, Shinya] Ishikawa Prefectural Cent Hosp, Dept Gastroenterol, Kanazawa, Ishikawa, Japan; [Inaki, Noriyuki] Ishikawa Prefectural Cent Hosp, Dept Surg Gastroenterol, Kanazawa, Ishikawa, Japan; [Okada, Toshihide] Ishikawa Prefectural Cent Hosp, Dept Gen Med, Kanazawa, Ishikawa, Japan	Ishikawa Prefectural Central Hospital; Ishikawa Prefectural Central Hospital; Ishikawa Prefectural Central Hospital	Waseda, Y (corresponding author), Ishikawa Prefectural Cent Hosp, Dept Gastroenterol, 2-1 Kuratsukihigashi, Kanazawa, Ishikawa, Japan.	wsdyhi@gmail.com	Inaki, Noriyuki/B-4361-2018	Inaki, Noriyuki/0000-0002-4241-5015				BarNatan M, 1996, AM J SURG, V172, P24, DOI 10.1016/S0002-9610(96)00048-7; Choi SM, 2007, EJSO-EUR J SURG ONC, V33, P444, DOI 10.1016/j.ejso.2006.11.003; FUKUMOTO S, 1987, Gastroenterologia Japonica, V22, P1; Gotoda Takuji, 2005, Clin Gastroenterol Hepatol, V3, pS71, DOI 10.1016/S1542-3565(05)00251-X; Hiki N, 2008, SURG ENDOSC, V22, P1729, DOI 10.1007/s00464-007-9696-8; Ishikawa K, 2006, SURG LAPARO ENDO PER, V16, P82, DOI 10.1097/00129689-200604000-00005; Kang WM, 2013, WORLD J GASTROENTERO, V19, P5720, DOI 10.3748/wjg.v19.i34.5720; Kawahira H, 2012, HEPATO-GASTROENTEROL, V59, P415, DOI 10.5754/hge11456; Kitano S, 2005, SURG CLIN N AM, V85, P151, DOI 10.1016/j.suc.2004.09.004; Kubota K, 2011, SURG TODAY, V41, P680, DOI 10.1007/s00595-010-4329-6; Lee JH, 2003, J LAPAROENDOSC ADV A, V13, P349, DOI 10.1089/109264203322656397; Ludwig K, 2002, SURG ENDOSC, V16, P1561, DOI 10.1007/s00464-001-9224-1; Lundell LR, 1999, GUT, V45, P172, DOI 10.1136/gut.45.2.172; Nishida T, 2008, INT J CLIN ONCOL, V13, P416, DOI 10.1007/s10147-008-0798-7; OHASHI S, 1995, SURG ENDOSC-ULTRAS, V9, P169; Ohgami M, 1999, WORLD J SURG, V23, P187, DOI 10.1007/PL00013167; Seto Y, 1999, BRIT J SURG, V86, P526, DOI 10.1046/j.1365-2168.1999.01069.x; Seto Y, 2001, AM J SURG, V182, P498, DOI 10.1016/S0002-9610(01)00747-4; Tomita R, 2000, WORLD J SURG, V24, P1250, DOI 10.1007/s002680010248; Tomita R, 2006, WORLD J SURG, V30, P205, DOI 10.1007/s00268-005-7979-6; Tsujimoto H, 2012, WORLD J SURG, V36, P327, DOI 10.1007/s00268-011-1387-x; Ueda E, 2002, SURG TODAY, V32, P305, DOI 10.1007/s005950200043	22	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e101337	10.1371/journal.pone.0101337	http://dx.doi.org/10.1371/journal.pone.0101337			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968310	Green Published, Green Submitted, gold			2022-12-27	WOS:000338280800122
J	Arai, T				Arai, Takaomi			Salmon Migration Patterns Revealed the Temporal and Spatial Fluctuations of the Radiocesium Levels in Terrestrial and Ocean Environments	PLOS ONE			English	Article							NUCLEAR-POWER-PLANT; FUKUSHIMA-DERIVED RADIONUCLIDES; CS-137; I-131	The disabling of the Fukushima Daiichi Nuclear Power Plant (F1NPP) resulted in the release of radionuclides, including Cs-134 and Cs-137, into the air and the ocean. The unpredicted nuclear accident is of global concern for human health and the ecosystem. Although investigations of radionuclides in environments were performed shortly after the accident started, the temporal and spatial impacts and fluctuations on the releasing radionuclides to natural environment remain unclear. I focused on salmon, which migrate from inland to the open ocean globally, to reveal the three-year (May 2011 to February 2014) fluctuations and accumulations of Cs-134 and Cs-137 from terrestrial to open ocean environments after the F1NPP accident. The Cs-134 and Cs-137 concentrations in six salmonids exhibited lower temporal variations for three years after the F1NPP accident, suggesting that these radionuclides are widely distributed and these radionuclides remain in the natural environment globally with less convergence. The accumulation patterns were significantly different among the different salmon species. Fluvial (freshwater residence) type salmons exhibited significantly higher accumulation in Cs-134 (25.3-40.2 Bq kg(-1) in mean) and Cs-137 (41.4-51.7 Bq kg(-1) in mean) than did the anadromous (sea-run) type salmons (0.64-8.03 Bq kg(-1) in mean Cs-134 and 0.42-10.2 Bq kg(-1) in mean Cs-137) suggesting widespread contamination in terrestrial environments versus the coastal and open ocean environments. Salmonids are the most highly migratory animals and are characterised by their strong tendency to return home to their natal site for reproduction. Salmonids have a potential to be a good indicator as an effective monitoring animal.	Univ Malaysia Terengganu, Inst Oceanog & Environm, Kuala Terengganu, Terengganu, Malaysia	Universiti Malaysia Terengganu	Arai, T (corresponding author), Univ Malaysia Terengganu, Inst Oceanog & Environm, Kuala Terengganu, Terengganu, Malaysia.	arai@umt.edu.my	Arai, Takaomi/AAX-2641-2021	Arai, Takaomi/0000-0001-9440-7933				Buesseler K, 2011, ENVIRON SCI TECHNOL, V45, P9931, DOI 10.1021/es202816c; Buesseler KO, 2012, P NATL ACAD SCI USA, V109, P5984, DOI 10.1073/pnas.1120794109; Chino M, 2011, J NUCL SCI TECHNOL, V48, P1129, DOI 10.3327/jnst.48.1129; du Bois PB, 2012, J ENVIRON RADIOACTIV, V114, P2, DOI 10.1016/j.jenvrad.2011.11.015; Estournel C, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2012JC007933; Harte J., 1991, TOXICS A Z GUIDE EVE; Ikeuchi Y, 2003, DEEP-SEA RES PT II, V50, P2713, DOI 10.1016/S0967-0645(03)00143-7; Japanese Ministry of Agriculture Forestry and Fisheries, 2014, RES INSP RAD MAT FIS; Kawamura H, 2011, J NUCL SCI TECHNOL, V48, P1349, DOI 10.3327/jnst.48.1349; Madigan DJ, 2012, P NATL ACAD SCI USA, V109, P9483, DOI 10.1073/pnas.1204859109; Masson O, 2011, ENVIRON SCI TECHNOL, V45, P7670, DOI 10.1021/es2017158; McDowall R.M., 1988, DIADROMY FISHES MIGR; Miyazawa Y, 2013, BIOGEOSCIENCES, V10, P2349, DOI 10.5194/bg-10-2349-2013; Mizuno T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01742; Nakanishi T, 2010, J RADIOANAL NUCL CH, V283, P831, DOI 10.1007/s10967-009-0422-y; Nelson J. S., 1976, FISHES WORLD; Povinec PP, 2004, J ENVIRON RADIOACTIV, V76, P113, DOI 10.1016/j.jenvrad.2004.03.022; Tsumune D, 2012, J ENVIRON RADIOACTIV, V111, P100, DOI 10.1016/j.jenvrad.2011.10.007; Yasunari TJ, 2011, P NATL ACAD SCI USA, V108, P19530, DOI 10.1073/pnas.1112058108	19	5	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100779	10.1371/journal.pone.0100779	http://dx.doi.org/10.1371/journal.pone.0100779			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964195	Green Published, gold, Green Submitted			2022-12-27	WOS:000338709500080
J	Baalbergen, E; Helwerda, R; Schelfhorst, R; Cajas, RFC; van Moorsel, CHM; Kundrata, R; Welter-Schultes, FW; Giokas, S; Schilthuizen, M				Baalbergen, Els; Helwerda, Renate; Schelfhorst, Rense; Cajas, Ruth F. Castillo; van Moorsel, Coline H. M.; Kundrata, Robin; Welter-Schultes, Francisco W.; Giokas, Sinos; Schilthuizen, Menno			Predator-Prey Interactions between Shell-Boring Beetle Larvae and Rock-Dwelling Land Snails	PLOS ONE			English	Article							SPECIES GASTROPODA; CLAUSILIIDAE; EVOLUTION; PULMONATA; ALBINARIA; BEHAVIOR	Drilus beetle larvae (Coleoptera: Elateridae) are specialized predators of land snails. Here, we describe various aspects of the predator-prey interactions between multiple Drilus species attacking multiple Albinaria (Gastropoda: Clausiliidae) species in Greece. We observe that Drilus species may be facultative or obligate Albinaria-specialists. We map geographically varying predation rates in Crete, where on average 24% of empty shells carry fatal Drilus bore holes. We also provide first-hand observations and video-footage of prey entry and exit strategies of the Drilus larvae, and evaluate the potential mutual evolutionary impacts. We find limited evidence for an effect of shell features and snail behavioral traits on inter-and intraspecifically differing predation rates. We also find that Drilus predators adjust their predation behavior based on specific shell traits of the prey. In conclusion, we suggest that, with these baseline data, this interesting predator-prey system will be available for further, detailed more evolutionary ecology studies.	[Baalbergen, Els; Helwerda, Renate; Schelfhorst, Rense; Schilthuizen, Menno] Nat Biodivers Ctr, Focus Grp Character Evolut, Leiden, Netherlands; [Cajas, Ruth F. Castillo; Schilthuizen, Menno] Univ Groningen, Ctr Ecol & Evolutionary Studies, Groningen, Netherlands; [Cajas, Ruth F. Castillo] Univ Wurzburg, Dept Anim Ecol & Trop Biol, D-97070 Wurzburg, Germany; [van Moorsel, Coline H. M.] St Antonius Hosp, Nieuwegein, Netherlands; [van Moorsel, Coline H. M.; Schilthuizen, Menno] Leiden Univ, Inst Biol Leiden, Leiden, Netherlands; [Kundrata, Robin] Palacky Univ, Dept Zool, CR-77147 Olomouc, Czech Republic; [Welter-Schultes, Francisco W.] Univ Gottingen, Zool Inst Univ, D-37073 Gottingen, Germany; [Giokas, Sinos] Univ Patras, Dept Biol, Patras, Greece	Naturalis Biodiversity Center; University of Groningen; University of Wurzburg; St. Antonius Hospital Utrecht; Leiden University; Leiden University - Excl LUMC; Palacky University Olomouc; University of Gottingen; University of Patras	Schilthuizen, M (corresponding author), Nat Biodivers Ctr, Focus Grp Character Evolut, Leiden, Netherlands.	menno.schilthuizen@naturalis.nl	Giokas, Sinos/C-3752-2008; KUNDRATA, Robin/AAI-5445-2021	Giokas, Sinos/0000-0003-2809-1605; Kundrata, Robin/0000-0001-9397-1030; Welter-Schultes, Francisco/0000-0002-6808-0049	NWO-ALW [819.01.012]; Jan-Joost ter Pelkwijkfonds; Uyttenboogaart-Eliasen Fonds; Kees Bakker award; Evangelisches Studienwerk	NWO-ALW(Netherlands Organization for Scientific Research (NWO)); Jan-Joost ter Pelkwijkfonds; Uyttenboogaart-Eliasen Fonds; Kees Bakker award; Evangelisches Studienwerk	Funding for this study came from NWO-ALW (grant 819.01.012, awarded to M.S.), the Jan-Joost ter Pelkwijkfonds (awarded to E.B, R.S., and R.H.), the Uyttenboogaart-Eliasen Fonds (awarded to M.S.), the Kees Bakker award (awarded to R.H.), and a doctoral fellowship to F.W.-S. from the Evangelisches Studienwerk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baalbergen E, 2013, THESIS LEIDEN U; DeWitt TJ, 2000, EVOL ECOL RES, V2, P129; Giokas S, 2002, MALACOLOGIA, V44, P33; GITTENBERGER E, 1991, BIOL J LINN SOC, V43, P263, DOI 10.1111/j.1095-8312.1991.tb00598.x; GOODFRIEND GA, 1986, SYST ZOOL, V35, P204, DOI 10.2307/2413431; KEMPERMAN T C M, 1988, Basteria, V52, P77; Konuma J, 2007, AM NAT, V170, P90, DOI 10.1086/518182; Kundrata R, 2011, ZOOL SCR, V40, P364, DOI 10.1111/j.1463-6409.2011.00476.x; Liew TS, 2014, PEERJ, V2, DOI 10.7717/peerj.329; Mesher CS, 2008, SPECIES PHYLOGENY EV, V1, P129; Nordsieck Hartmut, 1999, Mitteilungen der Deutschen Malakozoologischen Gesellschaft, V62-63, P1; Orstan Aydin, 1999, Schriften zur Malakozoologie aus dem Haus der Natur-Cismar, V13, P31; Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012; R Core Team, 2012, R LANG ENV STAT COMP; Roth, 1855, MALAKOZOOLOGISCHE BL, V2, P17; Schilthuizen M., 1994, Bios (Thessaloniki), V2, P177; Schilthuizen M, 1994, THESIS LEIDEN U; Schilthuizen M, 2006, EVOLUTION, V60, P1851, DOI 10.1554/06-114.1; van Moorsel CHM, 2000, MOL PHYLOGENET EVOL, V17, P200, DOI 10.1006/mpev.2000.0826; Vermeij G.J, 1987, EVOLUTION ESCALATION; Vermeij GJ, 2011, PALEONTOL RES, V15, P54, DOI 10.2517/1342-8144-15.2.054; VERMEIJ GJ, 1979, EVOLUTION, V33, P686, DOI 10.1111/j.1558-5646.1979.tb04721.x; Welter-Schultes FW, 2010, ARCH MOLLUSKENKD, V139, P143, DOI 10.1127/arch.moll/1869-0963/139/143-245; Welter-Schultes F.W., 2012, EUROPEAN NON MARINE	24	22	23	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100366	10.1371/journal.pone.0100366	http://dx.doi.org/10.1371/journal.pone.0100366			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964101	Green Published, Green Submitted, gold			2022-12-27	WOS:000338709500043
J	Mendoza, E; Colomb, J; Rybak, J; Pfluger, HJ; Zars, T; Scharff, C; Brembs, B				Mendoza, Ezequiel; Colomb, Julien; Rybak, Juergen; Pflueger, Hans-Joachim; Zars, Troy; Scharff, Constance; Brembs, Bjoern			Drosophila FoxP Mutants Are Deficient in Operant Self-Learning	PLOS ONE			English	Article							BASAL GANGLIA CIRCUITS; PROTEIN-KINASE-C; ADENYLYL-CYCLASE; VISUAL-SYSTEM; SEVERE SPEECH; ZEBRA FINCH; TERM-MEMORY; GENE; EVOLUTION; LANGUAGE	Intact function of the Forkhead Box P2 (FOXP2) gene is necessary for normal development of speech and language. This important role has recently been extended, first to other forms of vocal learning in animals and then also to other forms of motor learning. The homology in structure and in function among the FoxP gene members raises the possibility that the ancestral FoxP gene may have evolved as a crucial component of the neural circuitry mediating motor learning. Here we report that genetic manipulations of the single Drosophila orthologue, dFoxP, disrupt operant self-learning, a form of motor learning sharing several conceptually analogous features with language acquisition. Structural alterations of the dFoxP locus uncovered the role of dFoxP in operant self-learning and habit formation, as well as the dispensability of dFoxP for operant world-learning, in which no motor learning occurs. These manipulations also led to subtle alterations in the brain anatomy, including a reduced volume of the optic glomeruli. RNAi-mediated interference with dFoxP expression levels copied the behavioral phenotype of the mutant flies, even in the absence of mRNA degradation. Our results provide evidence that motor learning and language acquisition share a common ancestral trait still present in extant invertebrates, manifest in operant self-learning. This 'deep' homology probably traces back to before the split between vertebrate and invertebrate animals.	[Mendoza, Ezequiel; Scharff, Constance] Free Univ Berlin, Inst Biol Behav Biol, Berlin, Germany; [Colomb, Julien; Pflueger, Hans-Joachim; Brembs, Bjoern] Free Univ Berlin, Inst Biol Neurobiol, Berlin, Germany; [Rybak, Juergen] Max Planck Inst Chem Ecol, Jena, Germany; [Zars, Troy] Univ Missouri, Columbia, MO USA; [Brembs, Bjoern] Univ Regensburg, Inst Zool Neurogenet, D-93053 Regensburg, Germany	Free University of Berlin; Free University of Berlin; Max Planck Society; University of Missouri System; University of Missouri Columbia; University of Regensburg	Brembs, B (corresponding author), Free Univ Berlin, Inst Biol Neurobiol, Berlin, Germany.	bjoern@brembs.net	mendoza, ezequiel/AAZ-7613-2020; Scharff, Constance/HHN-0673-2022; Colomb, Julien/H-4927-2019; Brembs, Björn/A-9970-2008; Rybak, Jürgen/G-9143-2014	Colomb, Julien/0000-0002-3127-5520; Brembs, Björn/0000-0001-7824-7650; Rybak, Jürgen/0000-0003-0571-9957; Zars, Troy/0000-0003-4114-9322; Mendoza, Ezequiel/0000-0003-4963-519X	FU Berlin; DFG [BR 1892/6-1, BR 1892/7-1]	FU Berlin; DFG(German Research Foundation (DFG))	This study was funded by the research commission of the FU Berlin (to HJP and CS) and the DFG (BR 1892/6-1 and BR 1892/7-1 to BB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS TW, 1991, J NEUROSCI, V11, P2655; Bacon C, 2012, HUM GENET, V131, P1687, DOI 10.1007/s00439-012-1193-z; Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; Berwick RC, 2013, TRENDS COGN SCI, V17, P89, DOI 10.1016/j.tics.2012.12.002; Bolhuis JJ, 2010, NAT REV NEUROSCI, V11, P747, DOI 10.1038/nrn2931; Bowers JM, 2012, DIS MARKERS, V33, P251, DOI [10.3233/DMA-2012-0919, 10.1155/2012/456787]; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brembs B, 2000, LEARN MEMORY, V7, P104, DOI 10.1101/lm.7.2.104; Brembs B, 2008, CURR BIOL, V18, P1168, DOI 10.1016/j.cub.2008.07.041; Brembs B, 2007, J NEUROSCI, V27, P11122, DOI 10.1523/JNEUROSCI.2704-07.2007; Brembs B, 2006, LEARN MEMORY, V13, P629, DOI 10.1101/lm.319406; Brembs B, 2011, BEHAV PROCESS, V87, P157, DOI 10.1016/j.beproc.2011.02.005; Brembs Bjoern, 2008, J Vis Exp, DOI 10.3791/731; Brembs B, 2009, CURR BIOL, V19, P1351, DOI 10.1016/j.cub.2009.06.014; Callaway E, 2011, NATURE, DOI [10.1038/nature.2011.9395., DOI 10.1038/NATURE.2011.9395]; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chae WJ, 2006, P NATL ACAD SCI USA, V103, P9631, DOI 10.1073/pnas.0600225103; Chiang AS, 2011, CURR BIOL, V21, P1, DOI 10.1016/j.cub.2010.11.056; Chien WH, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-23; CHOMSKY N, 1959, LANGUAGE, V35, P26, DOI 10.2307/411334; Chu CY, 2006, PLOS BIOL, V4, P1122, DOI 10.1371/journal.pbio.0040210; Colomb Julien, 2010, Communicative & Integrative Biology, V3, P142; Corballis MC, 2009, ANN NY ACAD SCI, V1156, P19, DOI 10.1111/j.1749-6632.2009.04423.x; Costa RM, 2011, CURR OPIN NEUROBIOL, V21, P579, DOI 10.1016/j.conb.2011.05.004; Crespi B, 2008, BEHAV BRAIN SCI, V31, P241, DOI 10.1017/S0140525X08004214; Crespi B, 2010, P NATL ACAD SCI USA, V107, P1736, DOI 10.1073/pnas.0906080106; DasGupta S, 2014, SCIENCE, V344, P901, DOI 10.1126/science.1252114; Drier EA, 2002, NAT NEUROSCI, V5, P316, DOI 10.1038/nn820; DUERR JS, 1982, P NATL ACAD SCI-BIOL, V79, P3646, DOI 10.1073/pnas.79.11.3646; Santos ME, 2011, MOL BIOL EVOL, V28, P237, DOI 10.1093/molbev/msq182; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Enard W, 2011, CURR OPIN NEUROBIOL, V21, P415, DOI 10.1016/j.conb.2011.04.008; Enard W, 2009, CELL, V137, P961, DOI 10.1016/j.cell.2009.03.041; Engel JE, 1996, J NEUROSCI, V16, P3486; Engel JE, 2009, NEUROBIOL LEARN MEM, V92, P166, DOI 10.1016/j.nlm.2008.08.003; Fee MS, 2014, CURR OPIN NEUROBIOL, V25, P194, DOI 10.1016/j.conb.2014.01.012; Feenders G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001768; Fisher SE, 2009, TRENDS GENET, V25, P166, DOI 10.1016/j.tig.2009.03.002; French CA, 2012, MOL PSYCHIATR, V17, P1077, DOI 10.1038/mp.2011.105; Fukaya T, 2012, MOL CELL, V48, P825, DOI 10.1016/j.molcel.2012.09.024; Gabut M, 2011, CELL, V147, P132, DOI 10.1016/j.cell.2011.08.023; Gervasi N, 2010, NEURON, V65, P516, DOI 10.1016/j.neuron.2010.01.014; Gong XH, 2004, AM J MED GENET B, V127B, P113, DOI 10.1002/ajmg.b.20162; GOTZ KG, 1964, KYBERNETIK, V2, P77, DOI 10.1007/BF00288561; Groszer M, 2008, CURR BIOL, V18, P354, DOI 10.1016/j.cub.2008.01.060; Guo A, 1996, LEARN MEMORY, V3, P49, DOI 10.1101/lm.3.1.49; Haesler S, 2007, PLOS BIOL, V5, P2885, DOI 10.1371/journal.pbio.0050321; Hamdan FF, 2010, AM J HUM GENET, V87, P671, DOI 10.1016/j.ajhg.2010.09.017; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; Horn D, 2011, MOL SYNDROMOL, V2, P213, DOI 10.1159/000330916; Kane NS, 1997, NEURON, V18, P307, DOI 10.1016/S0896-6273(00)80270-6; Keene AC, 2007, NAT REV NEUROSCI, V8, P341, DOI 10.1038/nrn2098; Kiya T, 2008, INSECT MOL BIOL, V17, P53, DOI 10.1111/j.1365-2583.2008.00775.x; Konopka G, 2009, NATURE, V462, P213, DOI 10.1038/nature08549; Kurt S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033130; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Lawton KJ, 2014, BEHAV BRAIN RES, V268, P213, DOI 10.1016/j.bbr.2014.04.009; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Li H, 2005, BRAIN DEV-JPN, V27, P207, DOI 10.1016/j.braindev.2004.06.002; Li SR, 2004, MOL CELL BIOL, V24, P809, DOI 10.1128/MCB.24.2.809-822.2004; Li T, 2013, WORLD J BIOL PSYCHIA, V14, P146, DOI 10.3109/15622975.2011.615860; Liu G, 2006, NATURE, V439, P551, DOI 10.1038/nature04381; Lorenzetti FD, 2008, NEURON, V59, P815, DOI 10.1016/j.neuron.2008.07.019; Maguire LP, 2004, REV SCI INSTRUM, V75, P3077, DOI 10.1063/1.1786331; Margulies C, 2005, CURR BIOL, V15, pR700, DOI 10.1016/j.cub.2005.08.024; MARLER P, 1991, TRENDS NEUROSCI, V14, P199, DOI 10.1016/0166-2236(91)90106-5; Maye A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000443; McCarthy-Jones S, 2014, J PSYCHIATR RES, V50, P66, DOI 10.1016/j.jpsychires.2013.11.012; Mooney R, 2004, ANN NY ACAD SCI, V1016, P476, DOI 10.1196/annals.1298.011; Naour P, 2009, DEV PRIMATOL-PROG PR, P1, DOI 10.1007/978-0-387-89462-1; Newbury DF, 2010, NEURON, V68, P309, DOI 10.1016/j.neuron.2010.10.001; Palumbo O, 2013, GENE, V516, P107, DOI 10.1016/j.gene.2012.12.073; Pflugfelder GO, 1998, BEHAV BRAIN RES, V95, P3, DOI 10.1016/S0166-4328(97)00204-0; Ponton F, 2011, J INSECT PHYSIOL, V57, P840, DOI 10.1016/j.jinsphys.2011.03.014; Reimers-Kipping S, 2011, NEUROSCIENCE, V175, P75, DOI 10.1016/j.neuroscience.2010.11.042; Rochefort C, 2011, SCIENCE, V334, P385, DOI 10.1126/science.1207403; Rybak J, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00030; Sakaguchi H, 1997, NEUROREPORT, V8, P2645, DOI 10.1097/00001756-199708180-00002; Scharff C, 2011, PHILOS T R SOC B, V366, P2124, DOI 10.1098/rstb.2011.0001; Schulz SB, 2010, GENES BRAIN BEHAV, V9, P732, DOI 10.1111/j.1601-183X.2010.00607.x; Seki Y, 2010, J NEUROPHYSIOL, V104, P1007, DOI 10.1152/jn.00249.2010; Skinner B. F., 1957, VERBAL BEHAV; Spaniel F, 2011, NEUROSCI LETT, V493, P131, DOI 10.1016/j.neulet.2011.02.024; Spiteri E, 2007, AM J HUM GENET, V81, P1144, DOI 10.1086/522237; STEKLIS HD, 1976, ANN NY ACAD SCI, V280, P445, DOI 10.1111/j.1749-6632.1976.tb25508.x; Strausfeld NJ, 2007, J COMP NEUROL, V500, P166, DOI 10.1002/cne.21196; Takahashi H, 2009, ADV EXP MED BIOL, V665, P117; Tang SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014455; Teramitsu I, 2008, CURR BIOL, V18, pR335, DOI 10.1016/j.cub.2008.02.048; Toma C, 2013, PSYCHIAT GENET, V23, P82, DOI 10.1097/YPG.0b013e32835d6fc6; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Ueda A, 2012, J NEUROGENET, V26, P64, DOI 10.3109/01677063.2011.652752; Vernes SC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002145; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Wei F, 2002, NEURON, V36, P713, DOI 10.1016/S0896-6273(02)01019-X; WOLF R, 1991, J COMP PHYSIOL A, V169, P699; Wong ST, 1999, NEURON, V23, P787, DOI 10.1016/S0896-6273(01)80036-2; Yoshida Y, 2003, NEUROREPORT, V14, P645, DOI 10.1097/00001756-200303240-00025; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672; Zars T, 2000, LEARN MEMORY, V7, P18, DOI 10.1101/lm.7.1.18	100	23	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100648	10.1371/journal.pone.0100648	http://dx.doi.org/10.1371/journal.pone.0100648			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964149	Green Published, gold, Green Submitted			2022-12-27	WOS:000338709500071
J	Minodier, L; Arena, C; Heuze, G; Ruello, M; Amoros, JP; Souty, C; Varesi, L; Falchi, A				Minodier, Laetitia; Arena, Christophe; Heuze, Guillaume; Ruello, Marc; Amoros, Jean Pierre; Souty, Cecile; Varesi, Laurent; Falchi, Alessandra			Epidemiology and Viral Etiology of the Influenza-Like Illness in Corsica during the 2012-2013 Winter: An Analysis of Several Sentinel Surveillance Systems	PLOS ONE			English	Article							RESPIRATORY VIRUSES; COMMUNICABLE DISEASES; VACCINATION COVERAGE; B VIRUSES; H1N1; COINFECTION; EXPERIENCE; ONTARIO; FRANCE; A/H1N1	Influenza-like illness (ILI) surveillance is important to identify circulating and emerging/reemerging strains and unusual epidemiological trends. The present study aimed to give an accurate picture of the 2012-2013 ILI outbreak in Corsica by combining data from several surveillance systems: general practice, emergency general practice, hospital emergency units, intensive care units, and nursing homes. Twenty-eight respiratory viruses were retrospectively investigated from patients in general practice with ILI. Sequence analysis of the genetic changes in the hemagglutinin gene of influenza viruses (A(H1N1)pdm2009, A(H3N2) and B) was performed. The trends in ILI/influenza consultation rates and the relative illness ratios (RIRs) of having an ILI consultation were estimated by age group for the different surveillance systems analyzed. Of the 182 ILI patients enrolled by general practitioners, 57.7% tested positive for influenza viruses. Phylogenetic analyses suggested a genetic drift for influenza B and A(H3N2) viruses. The ILI/influenza surveillance systems showed similar trends and were well correlated. In accordance with virological data, the RIRs of having an ILI consultation were highest among the young (<15 years old) and decreased with age. No clusters of acute respiratory illness were declared by the sentinel nursing homes. This study is noteworthy in that it is the first extensive description of the 2012-2013 ILI outbreak in Corsica as monitored through several surveillance systems. To improve ILI surveillance in Corsica, a consortium that links together the complementary regional surveillance ILI systems described here is being implemented.	[Minodier, Laetitia; Arena, Christophe; Amoros, Jean Pierre; Varesi, Laurent; Falchi, Alessandra] Univ Corse, Virol Lab, EA7310, INSERM, Corte, France; [Arena, Christophe] Observ Reg Sante Corse, Ajaccio, France; [Heuze, Guillaume; Ruello, Marc] Cellule Inst Natl Veille Sanit Reg, Ajaccio, France; [Souty, Cecile] Univ Paris 06, Sorbonne Univ, UMRS 1136, Inst Pierre Louis Epidemiol & Sante Publ, Paris, France; [Souty, Cecile] Inst Pierre Louis Epidemiol & Sante Publ, INSERM, UMRS 1136, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Institute of Public Health Surveillance; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Minodier, L (corresponding author), Univ Corse, Virol Lab, EA7310, INSERM, Corte, France.	minodier@univ-corse.fr	FALCHI, Alessandra/AAQ-8039-2020	Alessandra, FALCHI/0000-0003-0799-1460	Contrat Plan Etat Region	Contrat Plan Etat Region	The research was supported by the Contrat Plan Etat Region 2007-2013 funding. All the funding or sources of support had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, Wkly Epidemiol Rec, V84, P361; Bentsen B G, 1986, Scand J Prim Health Care, V4, P43, DOI 10.3109/02813438609013970; Bragstad K, 2013, EURO SURVEILL, V18; BRESLOW NE, 1980, STATISTICAL METHODS, V1, P1; Byarugaba DK, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-11; Carrat F, 1999, CLIN INFECT DIS, V28, P283, DOI 10.1086/515117; COSTAGLIOLA D, 1994, EUR J EPIDEMIOL, V10, P475, DOI 10.1007/BF01719680; COSTAGLIOLA D, 1991, AM J PUBLIC HEALTH, V81, P97, DOI 10.2105/AJPH.81.1.97; ECDC, 2013, INFL VIR CHAR; Esper FP, 2011, J INFECTION, V63, P260, DOI 10.1016/j.jinf.2011.04.004; Falchi A, 2008, J CLIN VIROL, V41, P148, DOI 10.1016/j.jcv.2007.11.003; Falchi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024471; Falsey AR, 2014, J INFECT DIS; Fantoni A, 2013, J MED VIROLOGY; Flahault A, 2006, STAT METHODS MED RES, V15, P413, DOI 10.1177/0962280206071639; Friesema IHM, 2009, VACCINE, V27, P6353, DOI 10.1016/j.vaccine.2009.05.042; Gandhi A, 2012, J CLIN VIROL, V55, P343, DOI 10.1016/j.jcv.2012.08.020; Gault G, 2009, J PUBLIC HEALTH-UK, V31, P286, DOI 10.1093/pubmed/fdp020; Guthmann JP, 2012, VACCINE, V30, P995, DOI 10.1016/j.vaccine.2011.12.011; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Hershenson M. B., 2010, The picornaviruses, P369, DOI 10.1128/ISBN978-1-55581-603-2.23; Horm SV, 2013, EMERG INFECT DIS, V19, P305, DOI 10.3201/eid1902.121201; Huo X, 2012, J MED VIROL, V84, P1980, DOI 10.1002/jmv.23401; Josseran L, 2006, Euro Surveill, V11, P11, DOI 10.2807/esm.11.12.00668-en; Kelvin DJ, 2013, J INFECT DEV COUNTR, V7, P299, DOI 10.3855/jidc.3544; Kissling E, 2013, EURO SURVEILL, V18; Lemaitre M, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-162; Longtin J, 2010, J AM GERIATR SOC, V58, P2036, DOI 10.1111/j.1532-5415.2010.03091.x; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Nakoune E, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-49; Peci A, 2013, INFLUENZA OTHER RESP, V7, P559, DOI 10.1111/j.1750-2659.2012.00418.x; R Development Core Team, 2011, LANG ENV STAT COMP, DOI 10.1007/978-3-540-74686-7; Ren L, 2009, CLIN MICROBIOL INFEC, V15, P1146, DOI 10.1111/j.1469-0691.2009.02746.x; reseau Sentinelles US Inserm UMPC, 2011, ANN REP ACT 2011; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thiberville SD, 2012, J MED VIROL, V84, P1071, DOI 10.1002/jmv.23265; Turbelin C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065919; VALLERON AJ, 1986, AM J PUBLIC HEALTH, V76, P1289, DOI 10.2105/AJPH.76.11.1289; Vaux S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-159; Venter M, 2012, J INFECT DIS, V206, pS166, DOI 10.1093/infdis/jis539; WILSON IA, 1990, ANNU REV IMMUNOL, V8, P737, DOI 10.1146/annurev.iy.08.040190.003513	41	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100388	10.1371/journal.pone.0100388	http://dx.doi.org/10.1371/journal.pone.0100388			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959929	Green Published, gold, Green Submitted			2022-12-27	WOS:000338633900043
J	Obermeyer, AC; Capehart, SL; Jarman, JB; Francis, MB				Obermeyer, Allie C.; Capehart, Stacy L.; Jarman, John B.; Francis, Matthew B.			Multivalent Viral Capsids with Internal Cargo for Fibrin Imaging	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; COMBINATORIAL LIBRARIES; CONTRAST AGENT; PEPTIDE; NANOPARTICLES; PROTEIN; POLYMERIZATION; BINDING; SURFACE; BACTERIOPHAGE-MS2	Thrombosis is the cause of many cardiovascular syndromes and is a significant contributor to life-threatening diseases, such as myocardial infarction and stroke. Thrombus targeted imaging agents have the capability to provide molecular information about pathological clots, potentially improving detection, risk stratification, and therapy of thrombosis-related diseases. Nanocarriers are a promising platform for the development of molecular imaging agents as they can be modified to have external targeting ligands and internal functional cargo. In this work, we report the synthesis and use of chemically functionalized bacteriophage MS2 capsids as biomolecule-based nanoparticles for fibrin imaging. The capsids were modified using an oxidative coupling reaction, conjugating similar to 90 copies of a fibrin targeting peptide to the exterior of each protein shell. The ability of the multivalent, targeted capsids to bind fibrin was first demonstrated by determining the impact on thrombin-mediated clot formation. The modified capsids out-performed the free peptides and were shown to inhibit clot formation at effective concentrations over ten-fold lower than the monomeric peptide alone. The installation of near-infrared fluorophores on the interior surface of the capsids enabled optical detection of binding to fibrin clots. The targeted capsids bound to fibrin, exhibiting higher signal-to-background than control, non-targeted MS2-based nanoagents. The in vitro assessment of the capsids suggests that fibrin-targeted MS2 capsids could be used as delivery agents to thrombi for diagnostic or therapeutic applications.	[Obermeyer, Allie C.; Capehart, Stacy L.; Jarman, John B.; Francis, Matthew B.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Francis, Matthew B.] Lawrence Berkeley Natl Labs, Div Mat Sci, Berkeley, CA USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Francis, MB (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	mbfrancis@berkeley.edu	Obermeyer, Allie/P-9227-2016	Obermeyer, Allie/0000-0003-2412-2021	DOD Breast Cancer Research Program [BC061995]; NSF; UC Berkeley Chemical Biology Graduate Program [1 T32 GMO66698]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066698] Funding Source: NIH RePORTER	DOD Breast Cancer Research Program(United States Department of Defense); NSF(National Science Foundation (NSF)); UC Berkeley Chemical Biology Graduate Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	These studies were generously supported by the DOD Breast Cancer Research Program (BC061995). ACO and SLC were supported by graduate research fellowships from the NSF. The UC Berkeley Chemical Biology Graduate Program (Training Grant 1 T32 GMO66698) is acknowledged for their support of ACO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aruva MR, 2006, J NUCL MED, V47, P155; Ashley CE, 2011, ACS NANO, V5, P5729, DOI 10.1021/nn201397z; Behrens CR, 2011, J AM CHEM SOC, V133, P16398, DOI 10.1021/ja2033298; Binz HK, 2004, NAT BIOTECHNOL, V22, P575, DOI 10.1038/nbt962; Binz HK, 2003, J MOL BIOL, V332, P489, DOI 10.1016/S0022-2836(03)00896-9; Carrico ZM, 2008, CHEM COMMUN, P1205, DOI 10.1039/b717826c; Chacko AM, 2011, CURR OPIN COLLOID IN, V16, P215, DOI 10.1016/j.cocis.2011.01.008; Choudhury RP, 2009, ARTERIOSCL THROM VAS, V29, P983, DOI 10.1161/ATVBAHA.108.165498; Choudhury RP, 2004, NAT REV DRUG DISCOV, V3, P913, DOI 10.1038/nrd1548; Comellas-Aragones M, 2011, SOFT MATTER, V7, P11380, DOI 10.1039/c1sm06123b; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Farkas ME, 2013, MOL PHARMACEUT, V10, P69, DOI 10.1021/mp3003754; Garimella PD, 2011, J AM CHEM SOC, V133, P14704, DOI 10.1021/ja204516p; Gestwicki JE, 2002, J AM CHEM SOC, V124, P14922, DOI 10.1021/ja027184x; Hood CA, 2008, J PEPT SCI, V14, P97, DOI 10.1002/psc.921; Hooker JM, 2004, J AM CHEM SOC, V126, P3718, DOI 10.1021/ja031790q; HUI KY, 1983, SCIENCE, V222, P1129, DOI 10.1126/science.6648524; Jayagopal A, 2007, BIOCONJUGATE CHEM, V18, P1424, DOI 10.1021/bc070020r; JOHNSON P, 1965, BIOCHIM BIOPHYS ACTA, V102, P467, DOI 10.1016/0926-6585(65)90137-8; Kamaly N, 2010, INT J MOL SCI, V11, P1759, DOI 10.3390/ijms11041759; Kickhoefer VA, 2005, P NATL ACAD SCI USA, V102, P4348, DOI 10.1073/pnas.0500929102; Kitagawa T, 2012, MOL IMAGING BIOL, V14, P315, DOI 10.1007/s11307-011-0495-1; KNIGHT LC, 1988, J NUCL MED, V29, P494; Kodadek T, 2006, MOL BIOSYST, V2, P25, DOI 10.1039/b514349g; Kolodziej AF, 2012, BIOCONJUGATE CHEM, V23, P548, DOI 10.1021/bc200613e; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LATALLO ZS, 1962, AM J PHYSIOL, V202, P681, DOI 10.1152/ajplegacy.1962.202.4.681; LAUDANO AP, 1978, P NATL ACAD SCI USA, V75, P3085, DOI 10.1073/pnas.75.7.3085; Lee CC, 2005, NAT BIOTECHNOL, V23, P1517, DOI 10.1038/nbt1171; Lee LA, 2006, NANOMED-NANOTECHNOL, V2, P137, DOI 10.1016/j.nano.2006.07.009; Li D, 2010, CIRC-CARDIOVASC IMAG, V3, P464, DOI 10.1161/CIRCIMAGING.109.896654; Li F, 2009, SMALL, V5, P718, DOI 10.1002/smll.200801303; Manchester M, 2006, ADV DRUG DELIVER REV, V58, P1505, DOI 10.1016/j.addr.2006.09.014; MASTICO RA, 1993, J GEN VIROL, V74, P541, DOI 10.1099/0022-1317-74-4-541; McCarthy JR, 2008, ADV DRUG DELIVER REV, V60, P1241, DOI 10.1016/j.addr.2008.03.014; McCarthy JR, 2010, CURR CARDIOVASC IMAG, V3, P42, DOI 10.1007/s12410-009-9002-3; McCarthy JR, 2011, NANOMEDICINE-UK, V6, P1291, DOI [10.2217/NNM.11.128, 10.2217/nnm.11.128]; McCarthy JR, 2009, BIOCONJUGATE CHEM, V20, P1251, DOI 10.1021/bc9001163; Meldrum T, 2010, J AM CHEM SOC, V132, P5936, DOI 10.1021/ja100319f; Nahrendorf M, 2009, JACC-CARDIOVASC IMAG, V2, P1213, DOI 10.1016/j.jcmg.2009.04.016; Overoye-Chan K, 2008, J AM CHEM SOC, V130, P6025, DOI 10.1021/ja800834y; Parrott MC, 2009, J AM CHEM SOC, V131, P2906, DOI 10.1021/ja8078175; Peter K, 2000, CIRCULATION, V101, P1158, DOI 10.1161/01.CIR.101.10.1158; Plummer EM, 2012, NANOMEDICINE-UK, V7, P877, DOI [10.2217/nnm.11.185, 10.2217/NNM.11.185]; Pokorski JK, 2011, CHEMBIOCHEM, V12, P2441, DOI 10.1002/cbic.201100469; Pratt KP, 1997, P NATL ACAD SCI USA, V94, P7176, DOI 10.1073/pnas.94.14.7176; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Santoro SW, 2002, NAT BIOTECHNOL, V20, P1044, DOI 10.1038/nbt742; Sanz J, 2008, NATURE, V451, P953, DOI 10.1038/nature06803; Sigal GB, 1996, J AM CHEM SOC, V118, P3789, DOI 10.1021/ja953729u; Soon ASC, 2011, BIOMATERIALS, V32, P4406, DOI 10.1016/j.biomaterials.2011.02.050; Terashima M, 2011, BIOMATERIALS, V32, P1430, DOI 10.1016/j.biomaterials.2010.09.029; Thakur ML, 2000, J NUCL MED, V41, P161; Tong GJ, 2009, J AM CHEM SOC, V131, P11174, DOI 10.1021/ja903857f; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Uchida M, 2006, J AM CHEM SOC, V128, P16626, DOI 10.1021/ja0655690; Uchida M, 2011, ACS NANO, V5, P2493, DOI 10.1021/nn102863y; Udugamasooriya DG, 2008, J AM CHEM SOC, V130, P5744, DOI 10.1021/ja711193x; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; Watson JW, 2011, BIOCHEMISTRY-US, V50, P9923, DOI 10.1021/bi201406c; Wei B, 2009, BIOMED PHARMACOTHER, V63, P313, DOI 10.1016/j.biopha.2008.07.086; Woller EK, 2003, J AM CHEM SOC, V125, P8820, DOI 10.1021/ja0352496; Yang Z, 2000, P NATL ACAD SCI USA, V97, P14156, DOI 10.1073/pnas.97.26.14156; Yildiz I, 2011, CURR OPIN BIOTECH, V22, P901, DOI 10.1016/j.copbio.2011.04.020; Yu X, 2000, MAGNET RESON MED, V44, P867, DOI 10.1002/1522-2594(200012)44:6<867::AID-MRM7>3.0.CO;2-P	65	20	20	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100678	10.1371/journal.pone.0100678	http://dx.doi.org/10.1371/journal.pone.0100678			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24960118	gold, Green Published, Green Submitted			2022-12-27	WOS:000338633900068
J	Parkunan, SM; Astley, R; Callegan, MC				Parkunan, Salai Madhumathi; Astley, Roger; Callegan, Michelle C.			Role of TLR5 and Flagella in Bacillus Intraocular Infection	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSE; STAPHYLOCOCCUS-AUREUS VIRULENCE; TOLL-LIKE RECEPTORS; BACTERIAL ENDOPHTHALMITIS; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; INFLAMMATORY RESPONSES; CEREUS INFECTION; BARRIER FUNCTION; HEMOLYSIN BL	B. cereus possesses flagella which allow the organism to migrate within the eye during a blinding form of intraocular infection called endophthalmitis. Because flagella is a ligand for Toll-like receptor 5 (TLR5), we hypothesized that TLR5 contributed to endophthalmitis pathogenesis. Endophthalmitis was induced in C57BL/6J and TLR5-/- mice by injecting 100 CFU of B. cereus into the mid-vitreous. Eyes were analyzed for intraocular bacterial growth, retinal function, and inflammation by published methods. Purified B. cereus flagellin was also injected into the mid-vitreous of wild type C57BL/6J mice and inflammation was analyzed. TLR5 activation by B. cereus flagellin was also analyzed in vitro. B. cereus grew rapidly and at similar rates in infected eyes of C57BL/6J and TLR5-/- mice. A significant loss in retinal function in both groups of mice was observed at 8 and 12 hours postinfection. Retinal architecture disruption and acute inflammation (neutrophil infiltration and proinflammatory cytokine concentrations) increased and were significant at 8 and 12 hours postinfection. Acute inflammation was comparable in TLR5-/- and C57BL/6J mice. Physiological concentrations of purified B. cereus flagellin caused significant inflammation in C57BL/6J mouse eyes, but not to the extent of that observed during active infection. Purified B. cereus flagellin was a weak agonist for TLR5 in vitro. These results demonstrated that the absence of TLR5 did not have a significant effect on the evolution of B. cereus endophthalmitis. This disparity may be due to sequence differences in important TLR5 binding domains in B. cereus flagellin or the lack of flagellin monomers in the eye to activate TLR5 during infection. Taken together, these results suggest a limited role for flagellin/TLR5 interactions in B. cereus endophthalmitis. Based on this and previous data, the importance of flagella in this disease lies in its contribution to the motility of the organism within the eye during infection.	[Parkunan, Salai Madhumathi; Callegan, Michelle C.] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73190 USA; [Astley, Roger; Callegan, Michelle C.] Univ Oklahoma, Hlth Sci Ctr, Dept Ophthalmol, Oklahoma City, OK 73190 USA; [Callegan, Michelle C.] Dean A McGee Eye Inst, Oklahoma City, OK USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Callegan, MC (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73190 USA.	michelle-callegan@ouhsc.edu		Astley, Roger/0000-0002-2243-119X	National Institutes of Health (NIH) [R01EY012985]; NIH CORE Grant [P30EY012191]; National Center for Research Resources COBRE Grant [P20RR017703]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017703] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY021725, R01EY012985] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH CORE Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources COBRE Grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by National Institutes of Health (NIH) Grant R01EY012985 (to MCC, http://www.nih.gov). The authors' research is also supported in part by NIH CORE Grant P30EY012191 (Robert E. Anderson, OUHSC), National Center for Research Resources COBRE Grant P20RR017703 (Robert E. Anderson, OUHSC), and an unrestricted grant to the Dean A. McGee Eye Institute from Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen-Nissen E, 2005, P NATL ACAD SCI USA, V102, P9247, DOI 10.1073/pnas.0502040102; Andersen-Nissen E, 2007, J IMMUNOL, V178, P4717, DOI 10.4049/jimmunol.178.8.4717; Beecher DJ, 2000, INFECT IMMUN, V68, P5269, DOI 10.1128/IAI.68.9.5269-5276.2000; BERGER SA, 1983, J CLIN MICROBIOL, V18, P974, DOI 10.1128/JCM.18.4.974-975.1983; BOOTH MC, 1995, INVEST OPHTH VIS SCI, V36, P1828; Booth MC, 1997, INFECT IMMUN, V65, P1550, DOI 10.1128/IAI.65.4.1550-1556.1997; Bottone EJ, 2010, CLIN MICROBIOL REV, V23, P382, DOI 10.1128/CMR.00073-09; BRYCE EA, 1993, INFECT CONT HOSP EP, V14, P459, DOI 10.1086/646779; Callegan MC, 1999, INFECT IMMUN, V67, P3348, DOI 10.1128/IAI.67.7.3348-3356.1999; Callegan MC, 2005, INVEST OPHTH VIS SCI, V46, P3233, DOI 10.1167/iovs.05-0410; Callegan MC, 1999, INFECT IMMUN, V67, P3357, DOI 10.1128/IAI.67.7.3357-3366.1999; Callegan MC, 2003, INFECT IMMUN, V71, P3116, DOI 10.1128/IAI.71.6.3116-3124.2003; Callegan MC, 2002, INFECT IMMUN, V70, P5381, DOI 10.1128/IAI.70.10.5381-5389.2002; Callegan MC, 2002, CLIN MICROBIOL REV, V15, P111, DOI 10.1128/CMR.15.1.111-124.2002; Callegan MC, 2002, DNA CELL BIOL, V21, P367, DOI 10.1089/10445490260099647; Callegan MC, 2007, PROG RETIN EYE RES, V26, P189, DOI 10.1016/j.preteyeres.2006.12.001; Callegan MC, 2006, INVEST OPHTH VIS SCI, V47, P4461, DOI 10.1167/iovs.06-0301; Campodonico VL, 2010, INFECT IMMUN, V78, P746, DOI 10.1128/IAI.00806-09; Chang JH, 2006, BRIT J OPHTHALMOL, V90, P103, DOI 10.1136/bjo.2005.072686; Cullender TC, 2013, CELL HOST MICROBE, V14, P571, DOI 10.1016/j.chom.2013.10.009; Das T, 1999, BRIT J OPHTHALMOL, V83, P1050, DOI 10.1136/bjo.83.9.1050; de Vos AF, 2009, J IMMUNOL, V183, P533, DOI 10.4049/jimmunol.0802189; DEPAMPHI.ML, 1971, J BACTERIOL, V105, P376, DOI 10.1128/JB.105.1.376-383.1971; Dolan SA, 2012, INFECT CONT HOSP EP, V33, P666, DOI 10.1086/666334; Donnelly MA, 2002, J BIOL CHEM, V277, P40456, DOI 10.1074/jbc.M206851200; Fournier B, 2009, INFECT IMMUN, V77, P4121, DOI 10.1128/IAI.00656-09; Gao N, 2011, INVEST OPHTH VIS SCI, V52, P3074, DOI 10.1167/iovs.10-5928; Ghelardi E, 2002, J BACTERIOL, V184, P6424, DOI 10.1128/JB.184.23.6424-6433.2002; Guttenplan SB, 2013, MOL MICROBIOL, V87, P211, DOI 10.1111/mmi.12103; Hawn TR, 2007, J IMMUNOL, V179, P6981, DOI 10.4049/jimmunol.179.10.6981; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hernaiz C, 2003, CLIN MICROBIOL INFEC, V9, P973, DOI 10.1046/j.1469-0691.2003.00682.x; Hozono Y, 2006, BIOCHEM BIOPH RES CO, V347, P238, DOI 10.1016/j.bbrc.2006.06.088; Hsueh PR, 1999, J CLIN MICROBIOL, V37, P2280, DOI 10.1128/JCM.37.7.2280-2284.1999; Im J, 2009, MOL IMMUNOL, V47, P614, DOI 10.1016/j.molimm.2009.09.004; Ivanova N, 2003, NATURE, V423, P87, DOI 10.1038/nature01582; Jarchum I, 2011, INFECT IMMUN, V79, P1498, DOI 10.1128/IAI.01196-10; JETT BD, 1995, INVEST OPHTH VIS SCI, V36, P9; JETT BD, 1992, INFECT IMMUN, V60, P2445, DOI 10.1128/IAI.60.6.2445-2452.1992; Kalpoe JS, 2008, J HOSP INFECT, V68, P341, DOI 10.1016/j.jhin.2008.01.017; Kojima K, 2008, BRIT J OPHTHALMOL, V92, P411, DOI 10.1136/bjo.2007.128322; Kumar A, 2007, INVEST OPHTH VIS SCI, V48, P4664, DOI 10.1167/iovs.07-0473; Kumar A, 2010, J INFECT DIS, V201, P255, DOI 10.1086/649589; Kumar MV, 2004, J NEUROIMMUNOL, V153, P7, DOI 10.1016/j.jneuroim.2004.04.018; Lai MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072047; Lambiase A, 2011, CLIN SCI, V120, P441, DOI 10.1042/CS20100425; Lin X, 2012, NEUROL SCI, P1; McCole DF, 2003, CURR OPIN GASTROEN, V19, P578, DOI 10.1097/00001574-200311000-00011; Meredith T A, 1996, Trans Am Ophthalmol Soc, V94, P241; Morris AE, 2009, AM J PHYSIOL-LUNG C, V297, pL1112, DOI 10.1152/ajplung.00155.2009; MOTZEL SL, 1991, J CLIN MICROBIOL, V29, P2566, DOI 10.1128/JCM.29.11.2566-2570.1991; Moyer AL, 2009, INVEST OPHTH VIS SCI, V50, P3783, DOI 10.1167/iovs.08-3051; Novosad BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028619; Ramadan RT, 2008, INVEST OPHTH VIS SCI, V49, P4482, DOI 10.1167/iovs.08-2085; Ramadan RT, 2006, CURR EYE RES, V31, P955, DOI 10.1080/02713680600976925; Redfern RL, 2011, EXP EYE RES, V92, P209, DOI 10.1016/j.exer.2010.12.005; Sadaka A, 2012, PROG RETIN EYE RES, V31, P316, DOI 10.1016/j.preteyeres.2012.03.004; Salvetti S, 2007, MICROBIOL-SGM, V153, P2541, DOI 10.1099/mic.0.2006/005553-0; Sanders DSA, 2005, J CLIN PATHOL, V58, P568, DOI 10.1136/jcp.2004.021840; Sanders ME, 2011, INVEST OPHTH VIS SCI, V52, P865, DOI 10.1167/iovs.10-5513; Sanders ME, 2008, CLIN OPHTHALMOL, V2, P793; Senesi S, 2002, MICROBIOL-SGM, V148, P1785, DOI 10.1099/00221287-148-6-1785; Senesi S, 2010, RES MICROBIOL, V161, P743, DOI 10.1016/j.resmic.2010.10.007; Shah GK, 2000, OPHTHALMOLOGY, V107, P486, DOI 10.1016/S0161-6420(99)00139-6; Smith K, 2003, POETRY REV, V93, P5; Sun Y, 2010, J IMMUNOL, V185, P4272, DOI 10.4049/jimmunol.1000874; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wiskur BJ, 2008, INVEST OPHTH VIS SCI, V49, P1480, DOI 10.1167/iovs.07-1303; Yang JY, 2014, J INNATE IMMUN, V6, P47, DOI 10.1159/000351476; Yoshino Y, 2013, LIFE SCI, V92, P211, DOI 10.1016/j.lfs.2012.11.017; Yoshizumi MO, 1998, RETINA-J RET VIT DIS, V18, P130, DOI 10.1097/00006982-199818020-00006; Zhang F., 2013, DEP SYST NETW WORKSH, P1; Zhang J, 2003, INVEST OPHTH VIS SCI, V44, P4247, DOI 10.1167/iovs.03-0219	73	24	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100543	10.1371/journal.pone.0100543	http://dx.doi.org/10.1371/journal.pone.0100543			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959742	gold, Green Published, Green Submitted			2022-12-27	WOS:000338633900055
J	Lim, YF; Lentle, RG; Janssen, PWM; Williams, MAK; de Loubens, C; Mansel, BW; Chambers, P				Lim, Yuen Feung; Lentle, Roger G.; Janssen, Patrick W. M.; Williams, Martin A. K.; de Loubens, Clement; Mansel, Bradley W.; Chambers, Paul			Determination of Villous Rigidity in the Distal Ileum of the Possum (Trichosurus vulpecula)	PLOS ONE			English	Article							SMALL-INTESTINE; ABSORPTION; DIGESTA; MOTILITY; MARKER; SYSTEM; MUCINS; LAYERS; FLOW; DOG	We investigated the passive mechanical properties of villi in ex vivo preparations of sections of the wall of the distal ileum from the brushtail possum (Trichosurus vulpecula) by using a flow cell to impose physiological and supra-physiological levels of shear stress on the tips of villi. We directly determined the stress applied from the magnitude of the local velocities in the stress inducing flow and additionally mapped the patterns of flow around isolated villi by tracking the trajectories of introduced 3 mu m microbeads with bright field micro particle image velocimetry (mPIV). Ileal villi were relatively rigid along their entire length (mean 550 mu m), and exhibited no noticeable bending even at flow rates that exceeded calculated normal physiological shear stress (>0.5 mPa). However, movement of villus tips indicated that the whole rigid structure of a villus could pivot about the base, likely from laxity at the point of union of the villous shaft with the underlying mucosa. Flow moved upward toward the tip on the upper portions of isolated villi on the surface facing the flow and downward toward the base on the downstream surface. The fluid in sites at distances greater than 150 mu m below the villous tips was virtually stagnant indicating that significant convective mixing in the lower intervillous spaces was unlikely. Together the findings indicate that mixing and absorption is likely to be confined to the tips of villi under conditions where the villi and intestinal wall are immobile and is unlikely to be greatly augmented by passive bending of the shafts of villi.	[Lim, Yuen Feung; Lentle, Roger G.; Janssen, Patrick W. M.; de Loubens, Clement] Massey Univ, Inst Food Nutr & Human Hlth, Palmerston North, New Zealand; [Williams, Martin A. K.; Mansel, Bradley W.] Massey Univ, Inst Fundamental Sci, Palmerston North, New Zealand; [Lentle, Roger G.; Williams, Martin A. K.] Massey Univ, Riddet Inst, Palmerston North, New Zealand; [Williams, Martin A. K.; Mansel, Bradley W.] MacDiarmid Inst Adv Mat & Nanotechnol, Wellington, New Zealand; [Chambers, Paul] Massey Univ, Inst Vet Anim & Biomed Sci, Palmerston North, New Zealand	Massey University; Massey University; Massey University; Victoria University Wellington; Massey University	Lentle, RG (corresponding author), Massey Univ, Inst Food Nutr & Human Hlth, Palmerston North, New Zealand.	r.g.lentle@massey.ac.nz	de Loubens, Clement/N-2116-2015	de Loubens, Clement/0000-0002-4988-9168; Mansel, Bradley/0000-0003-4484-2093	Dick & Mary Earle PhD Food Research Fund	Dick & Mary Earle PhD Food Research Fund	This study was funded by the Dick & Mary Earle PhD Food Research Fund administered by the Riddet Institute, New Zealand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN A, 1993, PHYSIOL REV, V73, P823, DOI 10.1152/physrev.1993.73.4.823; BUENO L, 1975, J PHYSIOL-LONDON, V249, P69, DOI 10.1113/jphysiol.1975.sp011003; Corfield AP, 2001, FRONT BIOSCI-LANDMRK, V6, pD1321, DOI 10.2741/Corfield; DANIEL H, 1989, AM J PHYSIOL, V257, pG489, DOI 10.1152/ajpgi.1989.257.4.G489; DANIELSEN EM, 1982, BIOCHEM J, V202, P647, DOI 10.1042/bj2020647; DAVIDSON GP, 1977, J CLIN INVEST, V60, P1402, DOI 10.1172/JCI108901; GROVUM WL, 1973, BRIT J NUTR, V29, P13, DOI 10.1079/BJN19730072; Gruzdkov AA, 1989, MEMBRANE DIGESTION N, P228; GULDNER FH, 1972, Z ZELLFORSCH MIK ANA, V135, P349, DOI 10.1007/BF00307181; Ham AW, 1969, HISTOLOGY; HOLZHEIMER G, 1989, AM J PHYSIOL, V256, pG188, DOI 10.1152/ajpgi.1989.256.1.G188; Hosoyamada Y, 2005, ANAT EMBRYOL, V210, P1, DOI 10.1007/s00429-005-0011-y; Hosoyamada Y, 2007, ARCH HISTOL CYTOL, V70, P107, DOI 10.1679/aohc.70.107; Hulls C, 2012, J COMP PHYSIOL B, V182, P287, DOI 10.1007/s00360-011-0610-2; Janssen P. W. M., 2013, NEW ADV GASTROINTEST, V10, P219, DOI DOI 10.1007/978-94-007-6561-0_12; KARARLI TT, 1995, BIOPHARM DRUG DISPOS, V16, P351, DOI 10.1002/bdd.2510160502; KEANE RD, 1990, MEAS SCI TECHNOL, V1, P1202, DOI 10.1088/0957-0233/1/11/013; KING CE, 1945, AM J PHYSIOL, V143, P325, DOI 10.1152/ajplegacy.1945.143.3.325; Kuzmuk KN, 2005, J NUTR, V135, P1940, DOI 10.1093/jn/135.8.1940; Lentle RG, 2005, J COMP PHYSIOL B, V175, P337, DOI 10.1007/s00360-005-0490-4; Lentle RG, 2013, NEUROGASTROENTEROLOG, V25, P881; LEVITT MD, 1990, J CLIN INVEST, V86, P1540, DOI 10.1172/JCI114873; Lim YF, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.1008; MAILMAN D, 1990, AM J PHYSIOL, V258, pG238, DOI 10.1152/ajpgi.1990.258.2.G238; MAURY J, 1995, EUR J BIOCHEM, V228, P323; Pappenheimer JR, 2001, J MEMBRANE BIOL, V184, P233, DOI 10.1007/s00232-001-0094-1; Pappenheimer JR, 2001, J MEMBRANE BIOL, V179, P185, DOI 10.1007/s002320010047; Prasad AK, 2000, CURR SCI INDIA, V79, P51; Raffel M., 1998, EXP FLUID MECH; Robbe C, 2003, J BIOL CHEM, V278, P46337, DOI 10.1074/jbc.M302529200; RYU KH, 1982, AM J PHYSIOL, V242, pG364, DOI 10.1152/ajpgi.1982.242.4.G364; Santiago JG, 1998, EXP FLUIDS, V25, P316, DOI 10.1007/s003480050235; Thielicke W, 2013, COMMUNICATION; Thielicke W, 2013, PIVLAB TIME RESOLVED; Tietjens O, 1935, B AM MATH SOC, V41, P173; Wang YX, 2010, PHILOS T R SOC A, V368, P2863, DOI 10.1098/rsta.2010.0090; WEINSTEIN LD, 1969, ARCH SURG-CHICAGO, V99, P560; WESTERGAARD H, 1974, J CLIN INVEST, V54, P718, DOI 10.1172/JCI107810; WOMACK WA, 1988, GASTROENTEROLOGY, V94, P977, DOI 10.1016/0016-5085(88)90556-2	39	6	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100140	10.1371/journal.pone.0100140	http://dx.doi.org/10.1371/journal.pone.0100140			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956476	Green Published, gold, Green Submitted			2022-12-27	WOS:000338917900027
J	Ezzatizadeh, V; Sandi, C; Sandi, M; Anjomani-Virmouni, S; Al-Mahdawi, S; Pook, MA				Ezzatizadeh, Vahid; Sandi, Chiranjeevi; Sandi, Madhavi; Anjomani-Virmouni, Sara; Al-Mahdawi, Sahar; Pook, Mark A.			MutL alpha Heterodimers Modify the Molecular Phenotype of Friedreich Ataxia	PLOS ONE			English	Article							DNA MISMATCH REPAIR; GAA TRIPLET-REPEAT; MISSENSE MUTATIONS; PARENTAL GENDER; RNA-POLYMERASE; STICKY DNA; TRANSCRIPTION; INSTABILITY; EXPANSION; FRATAXIN	Background: Friedreich ataxia (FRDA), the most common autosomal recessive ataxia disorder, is caused by a dynamic GAA repeat expansion mutation within intron 1 of FXN gene, resulting in down-regulation of frataxin expression. Studies of cell and mouse models have revealed a role for the mismatch repair (MMR) MutS-heterodimer complexes and the PMS2 component of the MutL alpha complex in the dynamics of intergenerational and somatic GAA repeat expansions: MSH2, MSH3 and MSH6 promote GAA repeat expansions, while PMS2 inhibits GAA repeat expansions. Methodology/Principal Findings: To determine the potential role of the other component of the MutL alpha complex, MLH1, in GAA repeat instability in FRDA, we have analyzed intergenerational and somatic GAA repeat expansions from FXN transgenic mice that have been crossed with Mlh1 deficient mice. We find that loss of Mlh1 activity reduces both intergenerational and somatic GAA repeat expansions. However, we also find that loss of either Mlh1 or Pms2 reduces FXN transcription, suggesting different mechanisms of action for Mlh1 and Pms2 on GAA repeat expansion dynamics and regulation of FXN transcription. Conclusions/Significance: Both MutL alpha components, PMS2 and MLH1, have now been shown to modify the molecular phenotype of FRDA. We propose that upregulation of MLH1 or PMS2 could be potential FRDA therapeutic approaches to increase FXN transcription.	[Ezzatizadeh, Vahid; Sandi, Chiranjeevi; Sandi, Madhavi; Anjomani-Virmouni, Sara; Al-Mahdawi, Sahar; Pook, Mark A.] Brunel Univ London, Sch Hlth Sci & Social Care, Div Biosci, Uxbridge, Middx, England	Brunel University	Pook, MA (corresponding author), Brunel Univ London, Sch Hlth Sci & Social Care, Div Biosci, Uxbridge, Middx, England.	Mark.Pook@brunel.ac.uk			European Union [242193/EFACTS]; Wellcome Trust [089757]; GoFAR; Ataxia UK; FARA	European Union(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); GoFAR; Ataxia UK; FARA	The research leading to these results has received funding from the European Union Seventh Framework Programme [FP7/2007-2013] under grant agreement number 242193/EFACTS (CS, MS), the Wellcome Trust [089757] (SA), GoFAR, Ataxia UK and FARA (VE) to MAP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mahdawi S, 2004, GENOMICS, V84, P301, DOI 10.1016/j.ygeno.2004.04.003; Al-Mahdawi S, 2008, HUM MOL GENET, V17, P735, DOI 10.1093/hmg/ddm346; Al-Mahdawi S, 2006, GENOMICS, V88, P580, DOI 10.1016/j.ygeno.2006.06.015; Al-Mahdawi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074956; BAKER SM, 1995, CELL, V82, P309, DOI 10.1016/0092-8674(95)90318-6; Belvederesi L, 2006, EUR J HUM GENET, V14, P853, DOI 10.1038/sj.ejhg.5201628; Bourn RL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047085; Bradley JL, 2000, HUM MOL GENET, V9, P275, DOI 10.1093/hmg/9.2.275; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Campuzano V, 1997, HUM MOL GENET, V6, P1771, DOI 10.1093/hmg/6.11.1771; Castel AL, 2010, NAT REV MOL CELL BIO, V11, P165, DOI 10.1038/nrm2854; Chahwan R, 2012, J EXP MED, V209, P671, DOI 10.1084/jem.20111531; Chandok GS, 2012, NUCLEIC ACIDS RES, V40, P3964, DOI 10.1093/nar/gks021; Chang DK, 2000, J BIOL CHEM, V275, P18424, DOI 10.1074/jbc.M001140200; Clark RM, 2007, HUM GENET, V120, P633, DOI 10.1007/s00439-006-0249-3; Davis TW, 1998, CANCER RES, V58, P767; De Biase I, 2007, GENOMICS, V90, P1, DOI 10.1016/j.ygeno.2007.04.001; De Blase I, 2007, ANN NEUROL, V61, P55, DOI 10.1002/ana.21052; De Michele G, 1998, HUM MOL GENET, V7, P1901, DOI 10.1093/hmg/7.12.1901; Delatycki MB, 1998, J MED GENET, V35, P713, DOI 10.1136/jmg.35.9.713; Denver DR, 2006, GENETICS, V174, P57, DOI 10.1534/genetics.106.059840; Du JT, 2012, J BIOL CHEM, V287, P29861, DOI 10.1074/jbc.M112.391961; Edelmann W, 1996, CELL, V85, P1125, DOI 10.1016/S0092-8674(00)81312-4; Ellison AR, 2004, NUCLEIC ACIDS RES, V32, P5321, DOI 10.1093/nar/gkh855; Ezzatizadeh V, 2012, NEUROBIOL DIS, V46, P165, DOI 10.1016/j.nbd.2012.01.002; Frizzell A, 2014, CELL REP, V6, P827, DOI 10.1016/j.celrep.2014.01.034; Gibson SL, 2006, CANCER LETT, V244, P195, DOI 10.1016/j.canlet.2005.12.009; Grabczyk E, 2000, NUCLEIC ACIDS RES, V28, P2815, DOI 10.1093/nar/28.14.2815; Grabczyk E, 2007, NUCLEIC ACIDS RES, V35, P5351, DOI 10.1093/nar/gkm589; Groh M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004318; Hsieh P, 2008, MECH AGEING DEV, V129, P391, DOI 10.1016/j.mad.2008.02.012; Jun SH, 2006, FEBS J, V273, P1609, DOI 10.1111/j.1742-4658.2006.05190.x; Kobayashi Katsutoshi, 2005, Hum Cell, V18, P103; Koeppen AH, 2011, J NEUROL SCI, V303, P1, DOI 10.1016/j.jns.2011.01.010; Kuehner JN, 2011, NAT REV MOL CELL BIO, V12, P283, DOI 10.1038/nrm3098; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Lin YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046807; Martini E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002305; MELLON I, 1989, NATURE, V342, P95, DOI 10.1038/342095a0; Mellon I, 1996, SCIENCE, V272, P557, DOI 10.1126/science.272.5261.557; Michalowski J, 2001, ONCOGENE, V20, P5856, DOI 10.1038/sj.onc.1204721; Monros E, 1997, AM J HUM GENET, V61, P101, DOI 10.1086/513887; Montermini L, 1997, HUM MOL GENET, V6, P1261, DOI 10.1093/hmg/6.8.1261; Moyer MP, 1996, IN VITRO CELL DEV-AN, V32, P315; Pandolfo M, 2002, ADV EXP MED BIOL, V516, P99; Pandolfo M, 2009, J NEUROL, V256, P3, DOI 10.1007/s00415-009-1002-3; Pianese L, 1997, AM J HUM GENET, V60, P460; Pianese L, 2004, J NEUROL NEUROSUR PS, V75, P1061, DOI 10.1136/jnnp.2003.028605; Pinto RM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003930; Sakamoto N, 1999, MOL CELL, V3, P465, DOI 10.1016/S1097-2765(00)80474-8; Sandi C, 2011, NEUROBIOL DIS, V42, P496, DOI 10.1016/j.nbd.2011.02.016; Saveliev A, 2003, NATURE, V422, P909, DOI 10.1038/nature01596; Schulz JB, 2009, NAT REV NEUROL, V5, P222, DOI 10.1038/nrneurol.2009.26; Tomassini B, 2012, HUM MOL GENET, V21, P2855, DOI 10.1093/hmg/dds110; Vetcher AA, 2002, J BIOL CHEM, V277, P39217, DOI 10.1074/jbc.M205209200; Wells RD, 2008, FASEB J, V22, P1625, DOI 10.1096/fj.07-097857; Zhang Y, 2009, CURR GENOMICS, V10, P250, DOI 10.2174/138920209788488544	58	18	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100523	10.1371/journal.pone.0100523	http://dx.doi.org/10.1371/journal.pone.0100523			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971578	Green Published, gold, Green Submitted			2022-12-27	WOS:000338512200039
J	Wang, YD; Li, XR; Yuan, YW; Patel, MS				Wang, Yadong; Li, Xiangrui; Yuan, Yiwen; Patel, Mohamed S.			A Multi-Method Approach to Curriculum Development for In-Service Training in China's Newly Established Health Emergency Response Offices	PLOS ONE			English	Article							SYSTEM	Objective: To describe an innovative approach for developing and implementing an in-service curriculum in China for staff of the newly established health emergency response offices (HEROs), and that is generalisable to other settings. Methods: The multi-method training needs assessment included reviews of the competency domains needed to implement the International Health Regulations (2005) as well as China's policies and emergency regulations. The review, iterative interviews and workshops with experts in government, academia, the military, and with HERO staff were reviewed critically by an expert technical advisory panel. Findings: Over 1600 participants contributed to curriculum development. Of the 18 competency domains identified as essential for HERO staff, nine were developed into priority in-service training modules to be conducted over 2.5 weeks. Experts from academia and experienced practitioners prepared and delivered each module through lectures followed by interactive problem-solving exercises and desktop simulations to help trainees apply, experiment with, and consolidate newly acquired knowledge and skills. Conclusion: This study adds to the emerging literature on China's enduring efforts to strengthen its emergency response capabilities since the outbreak of SARS in 2003. The multi-method approach to curriculum development in partnership with senior policy-makers, researchers, and experienced practitioners can be applied in other settings to ensure training is responsive and customized to local needs, resources and priorities. Ongoing curriculum development should reflect international standards and be coupled with the development of appropriate performance support systems at the workplace for motivating staff to apply their newly acquired knowledge and skills effectively and creatively.	[Wang, Yadong] Capital Med Univ, Sch Hlth Management & Educ, Beijing, Peoples R China; [Li, Xiangrui] Beijing Canc Hosp, Beijing, Peoples R China; [Yuan, Yiwen] Peking Univ, Hosp 3, Beijing 100871, Peoples R China; [Patel, Mohamed S.] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia	Capital Medical University; Peking University; Peking University; Australian National University	Wang, YD (corresponding author), Capital Med Univ, Sch Hlth Management & Educ, Beijing, Peoples R China.	yadong61@ccmu.edu.cn		Patel, Mahomed/0000-0001-7671-1114	China's National Health and Family Planning Commission [201002028]; China Office of the World Health Organisation	China's National Health and Family Planning Commission; China Office of the World Health Organisation	The project was funded through China's National Health and Family Planning Commission's "Special Fund for Health Scientific Research in the Public Interest [201002028]", in collaboration with the China Office of the World Health Organisation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, ORD STAT COUNC PEOPL; [Anonymous], 2007, ORD PRES PEOPL REP C; Archer F, 2007, PREHOSP DISASTER MED, V22, P120, DOI 10.1017/S1049023X00004490; Cai Wu., 2006, WORK HARD CREATE FAV; Chan LH, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000266; Chevalier R, 2003, PERFORMANCE IMPROVEM, V42, P9, DOI [DOI 10.1002/PFI.4930420504, 10.1002/pfi.4930420504]; Daily E, 2013, WHITE PAPER IDENTIFY; FitzGerald G, 2010, PREHOSP DISASTER MED, V25, P4; Gao L, 2011, J ADULT ED HEBEI U, V13, P21; Hipgrave David, 2011, J Glob Health, V1, P224; Hu G-q, 2008, J CENTRAL S U MED SC, V10, P947; Ingelfinger JR, 2008, NEW ENGL J MED, V359, P2745, DOI 10.1056/NEJMp0808410; Kirkpatrick DL, 2006, EVALUATING TRAINING, V3rd; L-m Un, 2006, J PUBLIC HLTH PREVEN, V17, P10; Liu Y-G, 2006, GUIDELINES RAINING H; Ministry of Health, 2004, MAJ POINTS WORK HLTH; Ministry of Health of the People's Republic of China, 2006, 2006 2010 NAT HLTH E; Morrison GR, 2010, DESIGNING EFFECTIVE; Ning N, 2008, CHINESE HLTH EC, V307, P66; Parry S, 1996, TRAINING MAGAZINE, V33, P48; Shultz J, 2013, WHITE PAPER SETTING; Wang C, 2010, PUBLIC HEALTH, V124, P339, DOI 10.1016/j.puhe.2010.02.020; Wang CJ, 2008, PUBLIC HEALTH, V122, P471, DOI 10.1016/j.puhe.2007.08.006; Wang LD, 2008, LANCET, V372, P1598, DOI 10.1016/S0140-6736(08)61365-3; Wang LD, 2007, LANCET, V369, P691, DOI 10.1016/S0140-6736(07)60316-X; Wang Z, 2005, J HULUNBEIER COLL, V6; WHO, 2010, IHR MON FRAM CHECKL; Xue L, 2011, CHINA EMERGENCY MANA, V8, P12; Zhang LL, 2012, LANCET, V379, P853, DOI 10.1016/S0140-6736(11)61876-X	29	3	3	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100892	10.1371/journal.pone.0100892	http://dx.doi.org/10.1371/journal.pone.0100892			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971602	gold, Green Published, Green Submitted			2022-12-27	WOS:000338512200072
J	Elks, PM; van der Vaart, M; van Hensbergen, V; Schutz, E; Redd, MJ; Murayama, E; Spaink, HP; Meijer, AH				Elks, Philip M.; van der Vaart, Michiel; van Hensbergen, Vincent; Schutz, Esther; Redd, Michael J.; Murayama, Emi; Spaink, Herman P.; Meijer, Annemarie H.			Mycobacteria Counteract a TLR-Mediated Nitrosative Defense Mechanism in a Zebrafish Infection Model	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; TUMOR-NECROSIS-FACTOR; HUMAN ALVEOLAR MACROPHAGES; OXIDATIVE STRESS-RESPONSE; TOLL-LIKE RECEPTORS; REACTIVE OXYGEN; HOST-DEFENSE; TUBERCULOUS-GRANULOMAS; ARGININE METABOLISM; TYROSINE NITRATION	Pulmonary tuberculosis (TB), caused by the intracellular bacterial pathogen Mycobacterium tuberculosis (Mtb), is a major world health problem. The production of reactive nitrogen species (RNS) is a potent cytostatic and cytotoxic defense mechanism against intracellular pathogens. Nevertheless, the protective role of RNS during Mtb infection remains controversial. Here we use an anti-nitrotyrosine antibody as a readout to study nitration output by the zebrafish host during early mycobacterial pathogenesis. We found that recognition of Mycobacterium marinum, a close relative of Mtb, was sufficient to induce a nitrosative defense mechanism in a manner dependent on MyD88, the central adaptor protein in Toll like receptor (TLR) mediated pathogen recognition. However, this host response was attenuated by mycobacteria via a virulence mechanism independent of the well-characterized RD1 virulence locus. Our results indicate a mechanism of pathogenic mycobacteria to circumvent host defense in vivo. Shifting the balance of host-pathogen interactions in favor of the host by targeting this virulence mechanism may help to alleviate the problem of infection with Mtb strains that are resistant to multiple drug treatments.	[Elks, Philip M.; van der Vaart, Michiel; van Hensbergen, Vincent; Schutz, Esther; Spaink, Herman P.; Meijer, Annemarie H.] Leiden Univ, Inst Biol, Leiden, South Holland, Netherlands; [Elks, Philip M.] Univ Sheffield, Bateson Ctr, Sheffield, S Yorkshire, England; [Elks, Philip M.] Univ Sheffield, Dept Infect & Immun, Sheffield, S Yorkshire, England; [Redd, Michael J.] Univ Utah, Dept Oncol Sci, Salt Lake City, UT USA; [Murayama, Emi] Inst Pasteur, Unite Macrophages & Dev Immun, Paris, France; [Murayama, Emi] Inst Pasteur, Ctr Natl Rech Sci, Unite Rech Associee 2578, Paris, France	Leiden University; Leiden University - Excl LUMC; University of Sheffield; University of Sheffield; Utah System of Higher Education; University of Utah; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Meijer, AH (corresponding author), Leiden Univ, Inst Biol, Leiden, South Holland, Netherlands.	a.h.meijer@biology.leidenuniv.nl	Spaink, Herman P./S-3586-2017; Meijer, Annemarie/W-3726-2019	Spaink, Herman P./0000-0003-4128-9501; Meijer, Annemarie H./0000-0002-1325-0725; van der Vaart, Michiel/0000-0003-0828-7088; van Hensbergen, Vincent/0000-0002-6316-3400; Murayama, Emi/0000-0002-5311-1594; Elks, Philip/0000-0003-1683-0749	European Respiratory Society Fellowship (LTRF fellowship) [176-2011]; University of Sheffield Vice-Chancellor's Fellowship; European Commission [LSHG-CT-2003-503496]; Netherlands Ministry of Economic Affairs; Ministry of Education, Culture and Science; European Commission 7th framework project ZF-HEALTH [HEALTH-F4-2010-242048]; Leiden University Fund (LUF)	European Respiratory Society Fellowship (LTRF fellowship); University of Sheffield Vice-Chancellor's Fellowship; European Commission(European CommissionEuropean Commission Joint Research Centre); Netherlands Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); European Commission 7th framework project ZF-HEALTH; Leiden University Fund (LUF)	P.M.E. is the recipient of a European Respiratory Society Fellowship (LTRF fellowship n degrees 176-2011). P.M.E. is further funded by a University of Sheffield Vice-Chancellor's Fellowship. The identification of the mpx-/-spotless mutant used in this study was supported by the European Commission through a FP6 Integrated Project ZF-MODELS grant (LSHG-CT-2003-503496) to P. Herbomel (Institut Pasteur, Paris). A.H.M, M.vdV., and H.P.S. are funded by the Smart Mix Program of the Netherlands Ministry of Economic Affairs and the Ministry of Education, Culture and Science. This work is further supported by the European Commission 7th framework project ZF-HEALTH (HEALTH-F4-2010-242048), and by the Leiden University Fund (LUF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LB, 1997, TUBERCLE LUNG DIS, V78, P237, DOI 10.1016/S0962-8479(97)90004-6; Aston C, 1998, AM J RESP CRIT CARE, V157, P1943, DOI 10.1164/ajrccm.157.6.9705028; Azad AK, 2012, INFECT IMMUN, V80, P3343, DOI 10.1128/IAI.00443-12; BAGGIOLINI M, 1992, FEBS LETT, V307, P97, DOI 10.1016/0014-5793(92)80909-Z; Benard EL, 2012, JOVE-J VIS EXP, DOI 10.3791/3781; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Bryk R, 2002, SCIENCE, V295, P1073, DOI 10.1126/science.1067798; Burgess A, 2010, P NATL ACAD SCI USA, V107, P12564, DOI 10.1073/pnas.0914191107; Buxade M, 2012, J EXP MED, V209, P379, DOI 10.1084/jem.20111569; Cambier CJ, 2014, NATURE, V505, P218, DOI 10.1038/nature12799; Cardona PJ, 2001, SCAND J IMMUNOL, V53, P65, DOI 10.1046/j.1365-3083.2001.00842.x; Chakravortty D, 2003, MICROBES INFECT, V5, P621, DOI 10.1016/S1286-4579(03)00096-0; Chan ED, 2001, AM J RESP CELL MOL, V25, P606, DOI 10.1165/ajrcmb.25.5.4487; CHAN J, 1995, INFECT IMMUN, V63, P736, DOI 10.1128/IAI.63.2.736-740.1995; CHAN J, 1992, J EXP MED, V175, P1111, DOI 10.1084/jem.175.4.1111; Chawla M, 2012, MOL MICROBIOL, V85, P1148, DOI 10.1111/j.1365-2958.2012.08165.x; Clay H, 2008, IMMUNITY, V29, P283, DOI 10.1016/j.immuni.2008.06.011; Clay H, 2007, CELL HOST MICROBE, V2, P29, DOI 10.1016/j.chom.2007.06.004; Cooper AM, 2000, INFECT IMMUN, V68, P1231, DOI 10.1128/IAI.68.3.1231-1234.2000; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; de Oliveira S, 2013, J IMMUNOL, V190, P4349, DOI 10.4049/jimmunol.1203266; DEGROOTE MA, 1995, CLIN INFECT DIS, V21, pS162, DOI 10.1093/clinids/21.Supplement_2.S162; Deng Q, 2013, J LEUKOCYTE BIOL, V93, P761, DOI 10.1189/jlb.1012534; Ehrt S, 2009, CELL MICROBIOL, V11, P1170, DOI 10.1111/j.1462-5822.2009.01335.x; Elks PM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003789; Elks PM, 2011, BLOOD, V118, P712, DOI 10.1182/blood-2010-12-324186; Flynn JL, 2011, MUCOSAL IMMUNOL, V4, P271, DOI 10.1038/mi.2011.14; Forlenza M, 2008, MOL IMMUNOL, V45, P3178, DOI 10.1016/j.molimm.2008.02.025; Gao LY, 2004, MOL MICROBIOL, V53, P1677, DOI 10.1111/j.1365-2958.2004.04261.x; Gay NJ, 2011, TRENDS IMMUNOL, V32, P104, DOI 10.1016/j.it.2010.12.005; Gengenbacher M, 2012, FEMS MICROBIOL REV, V36, P514, DOI 10.1111/j.1574-6976.2012.00331.x; Goldberg DE, 2012, CELL, V148, P1271, DOI 10.1016/j.cell.2012.02.021; Guinn KM, 2004, MOL MICROBIOL, V51, P359, DOI 10.1046/j.1365-2958.2003.03844.x; Hall C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-42; Hall CJ, 2012, CELL STEM CELL, V10, P198, DOI 10.1016/j.stem.2012.01.007; Idh J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039891; Jagannath C, 1998, NITRIC OXIDE-BIOL CH, V2, P174, DOI 10.1006/niox.1998.9999; JONES GS, 1990, J INFECT DIS, V162, P700, DOI 10.1093/infdis/162.3.700; Koul A, 2011, NATURE, V469, P483, DOI 10.1038/nature09657; Krutzik SR, 2004, SEMIN IMMUNOL, V16, P35, DOI 10.1016/j.smim.2003.10.005; Kumar A, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411002079; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lau YL, 1998, CLIN INFECT DIS, V26, P226, DOI 10.1086/517036; Le Guyader D, 2008, BLOOD, V111, P132, DOI 10.1182/blood-2007-06-095398; LEE J, 1992, J BIOL CHEM, V267, P16283; Lee WL, 2009, MOL MICROBIOL, V71, P583, DOI 10.1111/j.1365-2958.2008.06548.x; Lepiller S, 2007, FREE RADICAL BIO MED, V43, P619, DOI 10.1016/j.freeradbiomed.2007.05.025; Lepiller S, 2009, GENE, V445, P58, DOI 10.1016/j.gene.2009.05.016; Long R, 1999, ANTIMICROB AGENTS CH, V43, P403, DOI 10.1128/AAC.43.2.403; Loynes CA, 2010, J LEUKOCYTE BIOL, V87, P203, DOI 10.1189/jlb.0409255; MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243; Masaki T, 2013, CELL, V152, P51, DOI 10.1016/j.cell.2012.12.014; Mattila JT, 2013, J IMMUNOL, V191, P773, DOI 10.4049/jimmunol.1300113; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; MORENO C, 1989, CLIN EXP IMMUNOL, V76, P240; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Nathan C, 2002, AM J RESP CRIT CARE, V166, P130, DOI 10.1164/rccm.2205016; Nicholson S, 1996, J EXP MED, V183, P2293, DOI 10.1084/jem.183.5.2293; PACELLI R, 1995, J EXP MED, V182, P1469, DOI 10.1084/jem.182.5.1469; Pagan-Ramos E, 1998, J BACTERIOL, V180, P4856; Parikka M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002944; Peranzoni E, 2007, IMMUNOBIOLOGY, V212, P795, DOI 10.1016/j.imbio.2007.09.008; Peyssonnaux C, 2005, J CLIN INVEST, V115, P1806, DOI 10.1172/JCI23865; Pfeiffer S, 2001, J BIOL CHEM, V276, P34051, DOI 10.1074/jbc.M100585200; RAMAKRISHNAN L, 1994, INFECT IMMUN, V62, P3222, DOI 10.1128/IAI.62.8.3222-3229.1994; Ramakrishnan L, 2013, ADV EXP MED BIOL, V783, P251, DOI 10.1007/978-1-4614-6111-1_13; Renshaw SA, 2006, BLOOD, V108, P3976, DOI 10.1182/blood-2006-05-024075; Rich EA, 1997, TUBERCLE LUNG DIS, V78, P247, DOI 10.1016/S0962-8479(97)90005-8; Roca FJ, 2013, CELL, V153, P521, DOI 10.1016/j.cell.2013.03.022; Rockett KA, 1998, INFECT IMMUN, V66, P5314, DOI 10.1128/IAI.66.11.5314-5321.1998; Sampson JB, 1998, ARCH BIOCHEM BIOPHYS, V356, P207, DOI 10.1006/abbi.1998.0772; Stoop EJM, 2011, DIS MODEL MECH, V4, P526, DOI 10.1242/dmm.006676; Swaim LE, 2006, INFECT IMMUN, V74, P6108, DOI 10.1128/IAI.00887-06; Tobin DM, 2010, CELL, V140, P717, DOI 10.1016/j.cell.2010.02.013; Toossi Zahra, 2000, Archivum Immunologiae et Therapiae Experimentalis, V48, P513; Trivedi A, 2012, ADV MICROB PHYSIOL, V60, P263, DOI 10.1016/B978-0-12-398264-3.00004-8; Ulrichs T, 2006, J PATHOL, V208, P261, DOI 10.1002/path.1906; van der Sar AM, 2009, MOL IMMUNOL, V46, P2317, DOI 10.1016/j.molimm.2009.03.024; van der Vaart Michiel, 2012, Adv Hematol, V2012, P159807, DOI 10.1155/2012/159807; van der Vaart M, 2013, DIS MODEL MECH, V6, P841, DOI 10.1242/dmm.010843; VazquezTorres A, 1996, INFECT IMMUN, V64, P3127, DOI 10.1128/IAI.64.8.3127-3133.1996; Vergne I, 2004, ANNU REV CELL DEV BI, V20, P367, DOI 10.1146/annurev.cellbio.20.010403.114015; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; Volkman HE, 2010, SCIENCE, V327, P466, DOI 10.1126/science.1179663; Volkman HE, 2004, PLOS BIOL, V2, P1946, DOI 10.1371/journal.pbio.0020367; Voskuil MI, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00105; Walmsley SR, 2005, J EXP MED, V201, P105, DOI 10.1084/jem.20040624; Wu GY, 1998, BIOCHEM J, V336, P1, DOI 10.1042/bj3360001; Yang CT, 2012, CELL HOST MICROBE, V12, P301, DOI 10.1016/j.chom.2012.07.009; Yang Chul-Su, 2009, Immune Netw, V9, P46, DOI 10.4110/in.2009.9.2.46; ZHANG YH, 1993, J CLIN INVEST, V91, P2076, DOI 10.1172/JCI116430	93	22	23	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100928	10.1371/journal.pone.0100928	http://dx.doi.org/10.1371/journal.pone.0100928			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967596	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000338280800084
J	Hochman, EY; Vaidya, AR; Fellows, LK				Hochman, Eldad Yitzhak; Vaidya, Avinash Rao; Fellows, Lesley K.			Evidence for a Role for the Dorsal Anterior Cingulate Cortex in Disengaging from an Incorrect Action	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; ERROR-DETECTION; FRONTAL-CORTEX; RESPONSE CONFLICT; FINGER MOVEMENTS; BRAIN ACTIVITY; NEURAL SYSTEM; MOTOR CORTEX; NEGATIVITY; COMPONENTS	Adjusting for an error requires both disengaging from the wrong course of action and initiating a corrective response. The dorsal anterior cingulate cortex (dACC) has been implicated in both these processes in the decision-making and action monitoring literatures. Here, we aimed to distinguish between these putative functions with a variant of the Eriksen flanker task that manipulated response requirements (i.e. one or two finger responses). We found that two event-related potentials originating from the dACC (error-related negativity (ERN) and anterior N2) only reflected the representation of the incorrect response: these waveforms were larger when the incorrect response involved two fingers rather than one finger. The increase in ERN magnitude was also accompanied by a reduction in spontaneous error corrections. These results argue that activity in the dACC reflects a process involved in disengaging from an ongoing incorrect action, clearing the way for the correct response.	[Hochman, Eldad Yitzhak; Vaidya, Avinash Rao; Fellows, Lesley K.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada	McGill University	Vaidya, AR (corresponding author), McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada.	avinash.vaidya@mail.mcgill.ca	Vaidya, Avinash/H-7034-2019; Fellows, Lesley K/B-1778-2018	Vaidya, Avinash/0000-0001-5423-5655; Fellows, Lesley/0000-0002-9144-092X	Jeanne Timmins Costello Fellowship; CIHR [MOP 119291]	Jeanne Timmins Costello Fellowship; CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported by a Jeanne Timmins Costello Fellowship to EYH and an operating grant from CIHR (MOP 119291). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander WH, 2011, NAT NEUROSCI, V14, P1338, DOI 10.1038/nn.2921; Baillet S, 2001, IEEE SIGNAL PROC MAG, V18, P14, DOI 10.1109/79.962275; BERNSTEIN PS, 1995, J EXP PSYCHOL HUMAN, V21, P1312, DOI 10.1037/0096-1523.21.6.1312; Bonini F, 2014, SCIENCE, V343, P888, DOI 10.1126/science.1247412; Boorman ED, 2013, J NEUROSCI, V33, P2242, DOI 10.1523/JNEUROSCI.3022-12.2013; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Burle B, 2008, J COGNITIVE NEUROSCI, V20, P1637, DOI 10.1162/jocn.2008.20110; Camille N, 2011, J NEUROSCI, V31, P15048, DOI 10.1523/JNEUROSCI.3164-11.2011; Carbonnell L, 2006, BRAIN RES, V1095, P124, DOI 10.1016/j.brainres.2006.04.004; Coles MGH, 2001, BIOL PSYCHOL, V56, P173, DOI 10.1016/S0301-0511(01)00076-X; Dechent P, 2003, HUM BRAIN MAPP, V18, P272, DOI 10.1002/hbm.10084; DEHAENE S, 1994, PSYCHOL SCI, V5, P303, DOI 10.1111/j.1467-9280.1994.tb00630.x; Destrieux C, 2010, NEUROIMAGE, V53, P1, DOI 10.1016/j.neuroimage.2010.06.010; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; Falkenstein M, 1996, INT CONGR SER, V1099, P579; Fiehler K, 2005, PSYCHOPHYSIOLOGY, V42, P72, DOI 10.1111/j.1469-8986.2005.00265.x; Fleming SM, 2010, P NATL ACAD SCI USA, V107, P6005, DOI 10.1073/pnas.0910380107; Forster SE, 2011, J COGNITIVE NEUROSCI, V23, P923, DOI 10.1162/jocn.2010.21458; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Gehring WJ, 2000, NAT NEUROSCI, V3, P516, DOI 10.1038/74899; Gramfort A, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-45; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Grinband J, 2011, NEUROIMAGE, V57, P303, DOI 10.1016/j.neuroimage.2010.12.027; Hajcak G, 2003, PSYCHOPHYSIOLOGY, V40, P895, DOI 10.1111/1469-8986.00107; Hayden BY, 2011, NAT NEUROSCI, V14, P933, DOI 10.1038/nn.2856; Hochman EY, 2012, CEREB CORTEX; Indovina I, 2001, NEUROIMAGE, V13, P1027, DOI 10.1006/nimg.2001.0776; Kleinschmidt A, 1997, EUR J NEUROSCI, V9, P2178, DOI 10.1111/j.1460-9568.1997.tb01384.x; Kolling N, 2012, SCIENCE, V336, P95, DOI 10.1126/science.1216930; Kybic J, 2005, IEEE T MED IMAGING, V24, P12, DOI 10.1109/TMI.2004.837363; LOGAN GD, 1984, PSYCHOL REV, V91, P295, DOI 10.1037/0033-295X.91.3.295; Luu P., 2000, DETERMINATION GEODES, P1; Maier ME, 2012, PSYCHOPHYSIOLOGY, V49, P899, DOI 10.1111/j.1469-8986.2012.01373.x; Miller KJ, 2009, J NEUROSCI, V29, P3132, DOI 10.1523/JNEUROSCI.5506-08.2009; Modirrousta M, 2008, J NEUROSCI, V28, P14000, DOI 10.1523/JNEUROSCI.4450-08.2008; Nieuwenhuis S, 2003, COGN AFFECT BEHAV NE, V3, P17, DOI 10.3758/CABN.3.1.17; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Olvet DM, 2009, PSYCHOPHYSIOLOGY, V46, P957, DOI 10.1111/j.1469-8986.2009.00848.x; Overbeek TJM, 2005, J PSYCHOPHYSIOL, V19, P319, DOI 10.1027/0269-8803.19.4.319; PAUS T, 1991, BRAIN, V114, P2051, DOI 10.1093/brain/114.5.2051; Procyk E, 2000, NAT NEUROSCI, V3, P502, DOI 10.1038/74880; Quilodran R, 2008, NEURON, V57, P314, DOI 10.1016/j.neuron.2007.11.031; Rabbitt P, 2002, Q J EXP PSYCHOL-A, V55, P1081, DOI 10.1080/02724980244000080; Rodriguez-Fornells A, 2002, J NEUROSCI, V22, P9990; Roger C, 2010, NEUROIMAGE, V51, P391, DOI 10.1016/j.neuroimage.2010.02.005; Rudebeck PH, 2008, J NEUROSCI, V28, P13775, DOI 10.1523/JNEUROSCI.3541-08.2008; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; Scheffers MK, 2000, J EXP PSYCHOL HUMAN, V26, P141, DOI 10.1037/0096-1523.26.1.141; Shenhav A, 2013, NEURON, V79, P217, DOI 10.1016/j.neuron.2013.07.007; Sheth SA, 2012, NATURE, V488, P218, DOI 10.1038/nature11239; Srinivasan L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055247; Stuss DT, 2007, PHILOS T R SOC B, V362, P901, DOI 10.1098/rstb.2007.2096; Stuss DT, 1995, ANN NY ACAD SCI, V769, P191, DOI 10.1111/j.1749-6632.1995.tb38140.x; Swick D, 2002, P NATL ACAD SCI USA, V99, P16354, DOI 10.1073/pnas.252521499; Tadel F, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/879716; van Veen V, 2002, J COGNITIVE NEUROSCI, V14, P593, DOI 10.1162/08989290260045837; Vidal F, 2000, BIOL PSYCHOL, V51, P109, DOI 10.1016/S0301-0511(99)00032-0; Wessel JR, 2014, CORTEX, V50, P45, DOI 10.1016/j.cortex.2013.09.002; Wiecki TV, 2013, PSYCHOL REV, V120, P329, DOI 10.1037/a0031542; Yeung N, 2004, PSYCHOL REV, V111, P931, DOI 10.1037/0033-295x.111.4.931; Yeung N, 2012, PHILOS T R SOC B, V367, P1310, DOI 10.1098/rstb.2011.0416	63	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e101126	10.1371/journal.pone.0101126	http://dx.doi.org/10.1371/journal.pone.0101126			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968256	Green Published, Green Submitted, gold			2022-12-27	WOS:000338280800112
J	O'Donnell, JJ; Birukova, AA; Beyer, EC; Birukov, KG				O'Donnell, James J., III; Birukova, Anna A.; Beyer, Eric C.; Birukov, Konstantin G.			Gap Junction Protein Connexin43 Exacerbates Lung Vascular Permeability	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; DIFFERENTIAL REGULATION; BARRIER FUNCTION; EXPRESSION; LIPOPOLYSACCHARIDE; INFLAMMATION; ACTIVATION; STRETCH; INJURY; RHO	Increased vascular permeability causes pulmonary edema that impairs arterial oxygenation and thus contributes to morbidity and mortality associated with Acute Respiratory Distress Syndrome and sepsis. Although components of intercellular adhesive and tight junctions are critical for maintaining the endothelial barrier, there has been limited study of the roles of gap junctions and their component proteins (connexins). Since connexins can modulate inflammatory signaling in other systems, we hypothesized that connexins may also regulate pulmonary endothelial permeability. The relationships between connexins and the permeability response to inflammatory stimuli were studied in cultured human pulmonary endothelial cells. Prolonged treatment with thrombin, lipopolysaccharide, or pathological cyclic stretch increased levels of mRNA and protein for the major connexin, connexin43 (Cx43). Thrombin and lipopolysaccharide both increased intercellular communication assayed by transfer of microinjected Lucifer yellow. Although thrombin decreased transendothelial resistance in these cells, the response was attenuated by pretreatment with the connexin inhibitor carbenoxolone. Additionally, the decreases of transendothelial resistance produced by either thrombin or lipopolysaccharide were attenuated by reducing Cx43 expression by siRNA knockdown. Both carbenoxolone and Cx43 knockdown also abrogated thrombin-induced phosphorylation of myosin light chain. Taken together, these data suggest that increased lung vascular permeability induced by inflammatory conditions may be amplified via increased expression of Cx43 and intercellular communication among pulmonary endothelial cells.	[O'Donnell, James J., III; Birukova, Anna A.; Birukov, Konstantin G.] Univ Chicago, Dept Med, Sect Pulm & Crit Care, Chicago, IL 60637 USA; [O'Donnell, James J., III; Birukova, Anna A.; Birukov, Konstantin G.] Univ Chicago, Dept Med, Lung Injury Ctr, Chicago, IL 60637 USA; [Beyer, Eric C.] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Birukov, KG (corresponding author), Univ Chicago, Dept Med, Sect Pulm & Crit Care, 5841 S Maryland Ave, Chicago, IL 60637 USA.	kbirukov@medicine.bsd.uchicago.edu	Birukov, Konstantin/FJB-5755-2022	Beyer, Eric/0000-0001-8044-1356	National Institutes of Health [NHLBI HL089257]; NIH [NHLBI HL087823];  [T32HL007605];  [HL59199]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076259, T32HL007605, R01HL089257, R01HL059199, R01HL087823] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding sources that supported this work include: T32HL007605, HL59199, National Institutes of Health NHLBI HL089257, and NIH NHLBI HL087823. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2012, AM J PHYSIOL-LUNG C, V303, pL634, DOI 10.1152/ajplung.00195.2012; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Baker SM, 2008, FEBS LETT, V582, P4039, DOI 10.1016/j.febslet.2008.10.043; Bastarache JA, 2006, SEMIN RESP CRIT CARE, V27, P365, DOI 10.1055/s-2006-948290; Birukov KG, 2003, AM J PHYSIOL-LUNG C, V285, pL785, DOI 10.1152/ajplung.00336.2002; Birukov KG, 2013, COMPR PHYSIOL, V3, P429, DOI 10.1002/cphy.c100066; Birukova AA, 2004, MICROVASC RES, V67, P64, DOI 10.1016/j.mvr.2003.09.007; Birukova AA, 2006, AM J PATHOL, V168, P1749, DOI 10.2353/ajpath.2006.050431; Birukova AA, 2008, AM J PHYSIOL-LUNG C, V295, pL612, DOI 10.1152/ajplung.90236.2008; Birukova AA, 2007, AM J PHYSIOL-LUNG C, V292, pL924, DOI 10.1152/ajplung.00395.2006; Birukova AA, 2007, AM J PHYSIOL-LUNG C, V293, pL199, DOI 10.1152/ajplung.00020.2007; Birukova AA, 2012, J CELL PHYSIOL, V227, P3405, DOI 10.1002/jcp.24041; Birukova AA, 2012, AM J PHYSIOL-LUNG C, V302, pL965, DOI 10.1152/ajplung.00292.2011; Birukova AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030957; Bolon ML, 2007, J CELL PHYSIOL, V211, P159, DOI 10.1002/jcp.20928; Chadjichristos CE, 2010, CIRCULATION, V121, P123, DOI 10.1161/CIRCULATIONAHA.109.867176; Davey A, 2011, EUR RESPIR J, V38, P959, DOI 10.1183/09031936.00032111; De Vuyst E, 2007, MOL BIOL CELL, V18, P34, DOI 10.1091/mbc.E06-03-0182; Fernandez-Cobo M, 1999, CYTOKINE, V11, P216, DOI 10.1006/cyto.1998.0422; Fernandez-Cobo M, 1998, SHOCK, V10, P97, DOI 10.1097/00024382-199808000-00003; Gemel J, 2012, J MEMBRANE BIOL, V245, P231, DOI 10.1007/s00232-012-9444-4; Harris AL, 2001, Q REV BIOPHYS, V34, P325, DOI 10.1017/S0033583501003705; Harris AL, 2007, PROG BIOPHYS MOL BIO, V94, P120, DOI 10.1016/j.pbiomolbio.2007.03.011; JARA PI, 1995, P NATL ACAD SCI USA, V92, P7011, DOI 10.1073/pnas.92.15.7011; Juszczak GR, 2009, PROG NEURO-PSYCHOPH, V33, P181, DOI 10.1016/j.pnpbp.2008.12.014; Kwak BR, 2003, CIRCULATION, V107, P1033, DOI 10.1161/01.CIR.0000051364.70064.D1; LARSON DM, 1990, CIRC RES, V66, P1074, DOI 10.1161/01.RES.66.4.1074; Lim PK, 2011, CANCER RES, V71, P1550, DOI 10.1158/0008-5472.CAN-10-2372; Lucas R, 2009, BIOCHEM PHARMACOL, V77, P1763, DOI 10.1016/j.bcp.2009.01.014; LUM H, 1994, AM J PHYSIOL, V267, pL223, DOI 10.1152/ajplung.1994.267.3.L223; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Meliton AY, 2013, AM J PHYSIOL-LUNG C, V304, pL689, DOI 10.1152/ajplung.00047.2013; Nagasawa K, 2006, J CELL PHYSIOL, V208, P123, DOI 10.1002/jcp.20647; Parthasarathi K, 2006, J CLIN INVEST, V116, P2193, DOI 10.1172/JCI26605; Parthasarathi K, 2012, AM J PHYSIOL-LUNG C, V303, pL33, DOI 10.1152/ajplung.00219.2011; Rignault S, 2007, SHOCK, V28, P78, DOI 10.1097/shk.0b013e3180310bd1; Salameh A, 2013, BBA-BIOMEMBRANES, V1828, P147, DOI 10.1016/j.bbamem.2011.12.030; Sarieddine MZR, 2009, J CELL MOL MED, V13, P4560, DOI 10.1111/j.1582-4934.2008.00654.x; Seminario-Vidal L, 2009, J BIOL CHEM, V284, P20638, DOI 10.1074/jbc.M109.004762; Starosta V, 2012, AM J RESP CELL MOL, V46, P331, DOI 10.1165/rcmb.2011-0153OC; Tyml K, 2011, CAN J PHYSIOL PHARM, V89, P1, DOI 10.1139/y10-099; Wong CW, 2006, NAT MED, V12, P950, DOI 10.1038/nm1441; Yeager M, 2007, CURR OPIN CELL BIOL, V19, P521, DOI 10.1016/j.ceb.2007.09.001; Zhou XH, 2012, FRONT BIOSCI-LANDMRK, V17, P2278, DOI 10.2741/4051; Ziliene Violeta, 2004, Medicina (Kaunas), V40, P1124	45	50	51	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100931	10.1371/journal.pone.0100931	http://dx.doi.org/10.1371/journal.pone.0100931			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967639	Green Published, gold, Green Submitted			2022-12-27	WOS:000338280800085
J	Walters, RD; McSwiggen, DT; Goodrich, JA; Kugel, JF				Walters, Ryan D.; McSwiggen, David T.; Goodrich, James A.; Kugel, Jennifer F.			Selection and Characterization of a DNA Aptamer That Can Discriminate between cJun/cJun and cJun/cFos	PLOS ONE			English	Article							NF-KAPPA-B; ACTIVATE INTERLEUKIN-2 TRANSCRIPTION; RNA APTAMER; C-JUN; IN-VITRO; AP-1; BINDING; COACTIVATOR; SPECIFICITY; HOMODIMERS	The AP-1 family of transcriptional activators plays pivotal roles in regulating a wide range of biological processes from the immune response to tumorigenesis. Determining the roles of specific AP-1 dimers in cells, however, has remained challenging because common molecular biology techniques are unable to distinguish between the role of, for example, cJun/cJun homodimers versus cJun/cFos heterodimers. Here we used SELEX (systematic evolution of ligands by exponential enrichment) to identify and characterize DNA aptamers that are > 100-fold more specific for binding cJun/cJun compared to cJun/cFos, setting the foundation to investigate the biological functions of different AP-1 dimer compositions.	[Walters, Ryan D.; McSwiggen, David T.; Goodrich, James A.; Kugel, Jennifer F.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Goodrich, JA (corresponding author), Univ Colorado, Dept Chem & Biochem, Campus Box 215, Boulder, CO 80309 USA.	james.goodrich@colorado.edu; jennifer.kugel@colorado.edu			Department of Defense [BC074015]; National Institutes of Health [R01 GM055235, T32 GM08759]; Undergraduate Research Opportunities Program at the University of Colorado, Boulder; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008759] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Undergraduate Research Opportunities Program at the University of Colorado, Boulder; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by grant BC074015 from the Department of Defense, and R01 GM055235 from the National Institutes of Health. RDW was supported in part by National Institutes of Health Training Grant T32 GM08759. DTS was supported by the Undergraduate Research Opportunities Program at the University of Colorado, Boulder. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakiri L, 2002, MOL CELL BIOL, V22, P4952, DOI 10.1128/MCB.22.13.4952-4964.2002; Balasubramanian B, 1998, P NATL ACAD SCI USA, V95, P9738, DOI 10.1073/pnas.95.17.9738; Behre G, 1999, J BIOL CHEM, V274, P4939, DOI 10.1074/jbc.274.8.4939; Brody E N, 2000, J Biotechnol, V74, P5, DOI 10.1016/S1389-0352(99)00004-5; Chen SY, 2006, ONCOGENE, V25, P7212, DOI 10.1038/sj.onc.1209705; Chinenov Y, 2001, ONCOGENE, V20, P2438, DOI 10.1038/sj.onc.1204385; Cho JS, 2004, MOL CELLS, V18, P17; Darty K, 2009, BIOINFORMATICS, V25, P1974, DOI 10.1093/bioinformatics/btp250; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Fan XC, 2004, P NATL ACAD SCI USA, V101, P6934, DOI 10.1073/pnas.0401523101; Fennewald SM, 2007, J GEN VIROL, V88, P981, DOI 10.1099/vir.0.82499-0; Ferguson HA, 2001, NUCLEIC ACIDS RES, V29, part. no., DOI 10.1093/nar/29.20.e98; Grondin B, 2007, MOL CELL BIOL, V27, P2919, DOI 10.1128/MCB.00936-06; Hettinger K, 2007, CELL DEATH DIFFER, V14, P218, DOI 10.1038/sj.cdd.4401946; Huang DB, 2003, P NATL ACAD SCI USA, V100, P9268, DOI 10.1073/pnas.1632011100; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kim Loree J., 2000, BMC Immunology, V1, P1, DOI 10.1186/1471-2172-1-1; KROEGER PE, 1994, MOL CELL BIOL, V14, P7592, DOI 10.1128/MCB.14.11.7592; Lebruska LL, 1999, BIOCHEMISTRY-US, V38, P3168, DOI 10.1021/bi982515x; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; Nguyen TN, 2010, MOL IMMUNOL, V47, P2314, DOI 10.1016/j.molimm.2010.05.287; Nimjee SM, 2005, ANNU REV MED, V56, P555, DOI 10.1146/annurev.med.56.062904.144915; Park MW, 2005, BIOCHEM BIOPH RES CO, V330, P11, DOI 10.1016/j.bbrc.2005.02.119; Reiter NJ, 2008, NUCLEIC ACIDS RES, V36, P1227, DOI 10.1093/nar/gkm1141; Shi H, 2007, P NATL ACAD SCI USA, V104, P3742, DOI 10.1073/pnas.0607805104; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; van Dam H, 2001, ONCOGENE, V20, P2453, DOI 10.1038/sj.onc.1204239; Walters RD, 2013, MOL IMMUNOL, V56, P48, DOI 10.1016/j.molimm.2013.03.022; Wisniewska MB, 2007, J MOL BIOL, V371, P569, DOI 10.1016/j.jmb.2007.05.079; Zhao XC, 2006, NUCLEIC ACIDS RES, V34, P3755, DOI 10.1093/nar/gkl470; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	32	7	8	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e101015	10.1371/journal.pone.0101015	http://dx.doi.org/10.1371/journal.pone.0101015			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968026	Green Published, Green Submitted, gold			2022-12-27	WOS:000338280800099
J	Lee, KM; Cho, WK; Yu, J; Son, M; Choi, H; Min, K; Lee, YW; Kim, KH				Lee, Kyung-Mi; Cho, Won Kyong; Yu, Jisuk; Son, Moonil; Choi, Hoseong; Min, Kyunghun; Lee, Yin-Won; Kim, Kook-Hyung			A Comparison of Transcriptional Patterns and Mycological Phenotypes following Infection of Fusarium graminearum by Four Mycoviruses	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; CHESTNUT BLIGHT FUNGUS; HOST; GENE; REVEALS	Many fungi-infecting viruses, which are termed mycoviruses, have been identified, and most do not cause any visible symptoms. Some mycoviruses, however, can attenuate the virulence of the infected fungi, a phenomenon referred to as hypovirulence. To study fungus responses to virus infection, we established a model system composed of Fusarium graminearum and four mycoviruses including FgV1 (Fusarium graminearum virus 1), FgV2, FgV3, and FgV4. FgV1 and FgV2 infections caused several phenotypic alterations in F. graminearum including abnormal colony morphology, defects in perithecium development, and reductions in growth rate, conidiation, and virulence. In contrast, FgV3 and FgV4 infections did not cause any phenotypic change. An RNA-Seq-based analysis of the host transcriptome identified four unique Fusarium transcriptomes, one for each of the four mycoviruses. Unexpectedly, the fungal host transcriptome was more affected by FgV1 and FgV4 infections than by FgV2 and FgV3 infections. Gene ontology (GO) enrichment analysis revealed that FgV1 and FgV3 infections resulted in down-regulation of host genes required for cellular transport systems. FgV4 infection reduced the expression of genes involved in RNA processing and ribosome assembly. We also found 12 genes that were differentially expressed in response to all four mycovirus infections. Unfortunately, functions of most of these genes are still unknown. Taken together, our analysis provides further detailed insights into the interactions between mycoviruses and F. graminearum.	[Kim, Kook-Hyung] Seoul Natl Univ, Ctr Fungal Pathogenesis, Dept Agr Biotechnol, Seoul, South Korea; Seoul Natl Univ, Res Inst Agr & Life Sci, Coll Agr & Life Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Kim, KH (corresponding author), Seoul Natl Univ, Ctr Fungal Pathogenesis, Dept Agr Biotechnol, Seoul, South Korea.	kookkim@snu.ac.kr	Cho, Won Kyong/I-5098-2012	Cho, Won Kyong/0000-0002-8416-5173; Min, Kyunghun/0000-0002-2682-4660; Son, Moonil/0000-0002-1325-2085	Center for Fungal Pathogenesis - Ministry of Education, Science, and Technology (MEST) [2011-0000959]; Next-Generation BioGreen 21 Program [PJ00819801]; Rural Development Administration, Republic of Korea; MEST	Center for Fungal Pathogenesis - Ministry of Education, Science, and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); Next-Generation BioGreen 21 Program(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea); MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by a grant from the Center for Fungal Pathogenesis (No. 2011-0000959) funded by the Ministry of Education, Science, and Technology (MEST) and by a grant from the Next-Generation BioGreen 21 Program (No. PJ00819801), Rural Development Administration, Republic of Korea. KM Lee, WK Cho, J Yu, and M Son were supported by research fellowships from the MEST through the Brain Korea 21 Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TD, 2004, J VIROL, V78, P4145, DOI 10.1128/JVI.78.8.4145-4155.2004; Babu MM, 2004, CURR OPIN STRUC BIOL, V14, P283, DOI 10.1016/j.sbi.2004.05.004; Chang S-S, 2012, ANN REV MICROBIOL; Cho WK, 2013, ADV VIRUS RES, V86, P273, DOI 10.1016/B978-0-12-394315-6.00010-6; Cho WK, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-173; Chu YM, 2004, VIRUS GENES, V28, P135, DOI 10.1023/B:VIRU.0000012270.67302.35; Chu YM, 2002, APPL ENVIRON MICROB, V68, P2529, DOI 10.1128/AEM.68.5.2529-2534.2002; Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; Compel P, 1999, VIRUS GENES, V18, P49, DOI 10.1023/A:1008069318838; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cuomo CA, 2007, SCIENCE, V317, P1400, DOI 10.1126/science.1143708; Darissa O, 2012, EUR J PLANT PATHOL, V134, P181, DOI 10.1007/s10658-012-9977-5; Darissa O, 2011, ARCH VIROL, V156, P647, DOI 10.1007/s00705-010-0904-9; Delmas S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002875; Desjardins AE, 2007, INT J FOOD MICROBIOL, V119, P47, DOI 10.1016/j.ijfoodmicro.2007.07.024; Guldener U, 2006, NUCLEIC ACIDS RES, V34, pD456, DOI 10.1093/nar/gkj026; Hammond TM, 2008, EUKARYOT CELL, V7, P350, DOI 10.1128/EC.00356-07; Kanematsu S, 2010, PHYTOPATHOLOGY, V100, P922, DOI 10.1094/PHYTO-100-9-0922; Kwon SJ, 2009, VIRUS RES, V144, P96, DOI 10.1016/j.virusres.2009.04.004; Lee KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021629; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; Nogawa M, 1996, BIOSCI BIOTECH BIOCH, V60, P784, DOI 10.1271/bbb.60.784; Pearson MN, 2009, MOL PLANT PATHOL, V10, P115, DOI 10.1111/j.1364-3703.2008.00503.x; Segers GC, 2006, EUKARYOT CELL, V5, P896, DOI 10.1128/EC.00373-05; Soanes DM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002514; Son H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002310; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Yu J, 2011, PLANT PATHOLOGY J, V27, P285, DOI 10.5423/PPJ.2011.27.3.285; Yu J, 2009, ARCH VIROL, V154, P1855, DOI 10.1007/s00705-009-0507-5; Zhang XM, 2008, J VIROL, V82, P2613, DOI 10.1128/JVI.02324-07	30	37	38	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100989	10.1371/journal.pone.0100989	http://dx.doi.org/10.1371/journal.pone.0100989			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964178	gold, Green Submitted, Green Published			2022-12-27	WOS:000338709500107
J	Schaudinn, C; Stoodley, P; Hall-Stoodley, L; Gorur, A; Remis, J; Wu, S; Auer, M; Hertwig, S; Guerrero-Given, D; Hu, FZ; Ehrlich, GD; Costerton, JW; Robinson, DH; Webster, P				Schaudinn, Christoph; Stoodley, Paul; Hall-Stoodley, Luanne; Gorur, Amita; Remis, Jonathan; Wu, Siva; Auer, Manfred; Hertwig, Stefan; Guerrero-Given, Debbie; Hu, Fen Ze; Ehrlich, Garth D.; Costerton, John William; Robinson, Douglas H.; Webster, Paul			Death and Transfiguration in Static Staphylococcus epidermidis Cultures	PLOS ONE			English	Article							POLYSACCHARIDE INTERCELLULAR ADHESIN; TARGETED OLIGONUCLEOTIDE PROBES; IN-SITU HYBRIDIZATION; BIOFILM FORMATION; BINDING; ACCUMULATION; POPULATIONS; MICROSCOPY; ORGANISMS; BACTERIA	The overwhelming majority of bacteria live in slime embedded microbial communities termed biofilms, which are typically adherent to a surface. However, when several Staphylococcus epidermidis strains were cultivated in static liquid cultures, macroscopic aggregates were seen floating within the broth and also sedimented at the test tube bottom. Light-and electron microscopy revealed that early-stage aggregates consisted of bacteria and extracellular matrix, organized in sheet-like structures. Perpendicular under the sheets hung a network of periodically arranged, bacteria-associated strands. During the extended cultivation, the strands of a subpopulation of aggregates developed into cross-connected wall-like structures, in which aligned bacteria formed the walls. The resulting architecture had a compartmentalized appearance. In late-stage cultures, the wall-associated bacteria disintegrated so that, henceforth, the walls were made of the coalescing remnants of lysed bacteria, while the compartment-like organization remained intact. At the same time, the majority of strand-containing aggregates with associated culturable bacteria continued to exist. These observations indicate that some strains of Staphylococcus epidermidis are able to build highly sophisticated structures, in which a subpopulation undergoes cell lysis, presumably to provide continued access to nutrients in a nutrient-limited environment, whilst maintaining structural integrity.	[Schaudinn, Christoph] Robert Koch Inst, Ctr Biol Threats & Special Pathogens, Berlin, Germany; [Stoodley, Paul; Hall-Stoodley, Luanne] Dept Microbial Infect & Immun, Columbus, OH USA; [Stoodley, Paul; Hall-Stoodley, Luanne] Dept Orthoped, Columbus, OH USA; [Gorur, Amita; Remis, Jonathan; Wu, Siva; Auer, Manfred] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Hertwig, Stefan] Fed Inst Risk Assessment, Dept Biol Safety, Berlin, Germany; [Guerrero-Given, Debbie] Max Planck Florida Inst, Jupiter, FL USA; [Hu, Fen Ze; Ehrlich, Garth D.; Costerton, John William] Drexel Univ, Coll Med, Ctr Genom Sci, Philadelphia, PA 19104 USA; [Hu, Fen Ze; Ehrlich, Garth D.; Costerton, John William] Drexel Univ, Coll Med, Ctr Adv Microbial Proc, Inst Mol Med & Infect Dis,Dept Microbiol & Immuno, Philadelphia, PA 19104 USA; [Robinson, Douglas H.] DeNovo Biol LLC, Arlington, VA USA; [Webster, Paul] Univ So Calif, Ctr Electron Microscopy & Microanal, Los Angeles, CA USA; [Webster, Paul] Oak Crest Inst Sci, Pasadena, CA USA	Robert Koch Institute; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Federal Institute for Risk Assessment; Max Planck Society; Drexel University; Drexel University; University of Southern California	Schaudinn, C (corresponding author), Robert Koch Inst, Ctr Biol Threats & Special Pathogens, Berlin, Germany.	schaudinnc@rki.de	Stoodley, Paul/E-5079-2013; Hall-Stoodley, Luanne/AAF-1925-2020	Stoodley, Paul/0000-0001-6069-273X; Ehrlich, Garth/0000-0003-1140-6594; Webster, Paul/0000-0002-1980-6931	Office of Biological and Environmental Research of the US Department of Energy [DE-AC02-05CH11231]; NIDCD [5 P-30 DC006276-03]; National Science Foundation (NSF) [0722354]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC006276] Funding Source: NIH RePORTER	Office of Biological and Environmental Research of the US Department of Energy(United States Department of Energy (DOE)); NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	J. P. Remis and M. Auer acknowledge support by the Office of Biological and Environmental Research of the US Department of Energy under contract number DE-AC02-05CH11231. Furthermore, the authors would like to express gratitude to the House Research Institute (Los Angeles) for funding this project in part, and for the generosity of the Ahmanson Foundation in supporting the Ahmanson Imaging Core. Grants from the NIDCD (5 P-30 DC006276-03) and the National Science Foundation (NSF #0722354) also supported the Ahmanson Imaging Core where a substantial part of this work was performed. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allesen-Holm M, 2006, MOL MICROBIOL, V59, P1114, DOI 10.1111/j.1365-2958.2005.05008.x; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Baum MM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-103; Bayles KW, 2007, NAT REV MICROBIOL, V5, P721, DOI 10.1038/nrmicro1743; Bockelmann U, 2002, J MICROBIOL METH, V49, P75, DOI 10.1016/S0167-7012(01)00354-2; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Cafiso V, 2004, CLIN MICROBIOL INFEC, V10, P1081, DOI 10.1111/j.1469-0691.2004.01024.x; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; COSTERTON JW, 1997, ADV DENT RES, V11, P192; Dice B, 2009, BIOFOULING, V25, P367, DOI 10.1080/08927010902803297; EMERMAN M, 1982, J HISTOCHEM CYTOCHEM, V30, P395, DOI 10.1177/30.4.7061831; Felek S, 2008, MICROBIOL-SGM, V154, P1802, DOI 10.1099/mic.0.2007/010918-0; Gerke C, 1998, J BIOL CHEM, V273, P18586, DOI 10.1074/jbc.273.29.18586; Handke LD, 2004, J MED MICROBIOL, V53, P367, DOI 10.1099/jmm.0.05372-0; Hunter RC, 2005, J BACTERIOL, V187, P7619, DOI 10.1128/JB.187.22.7619-7630.2005; JARLOV JO, 1992, J MED MICROBIOL, V37, P195, DOI 10.1099/00222615-37-3-195; Mack D, 1996, J BACTERIOL, V178, P175, DOI 10.1128/jb.178.1.175-183.1996; Marsh EJ, 2003, FEMS MICROBIOL LETT, V228, P203, DOI 10.1016/S0378-1097(03)00752-3; Monds RD, 2009, TRENDS MICROBIOL, V17, P73, DOI 10.1016/j.tim.2008.11.001; Moscoso M, 2006, J BACTERIOL, V188, P7785, DOI 10.1128/JB.00673-06; Okajima Y, 2006, INVEST OPHTH VIS SCI, V47, P2971, DOI 10.1167/iovs.05-1172; Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182; Palsdottir H, 2009, J BACTERIOL, V191, P2077, DOI 10.1128/JB.01333-08; Rani SA, 2005, ANTIMICROB AGENTS CH, V49, P728, DOI 10.1128/AAC.49.2.728-732.2005; Rickard AH, 2003, TRENDS MICROBIOL, V11, P94, DOI 10.1016/S0966-842X(02)00034-3; Robinson DH, 2005, MED HYPOTHESES, V64, P177, DOI 10.1016/j.mehy.2004.04.023; Rohde H, 2007, BIOMATERIALS, V28, P1711, DOI 10.1016/j.biomaterials.2006.11.046; RUPP ME, 1992, INFECT IMMUN, V60, P4322, DOI 10.1128/IAI.60.10.4322-4327.1992; Shapiro JA, 1998, ANNU REV MICROBIOL, V52, P81, DOI 10.1146/annurev.micro.52.1.81; Stoodley P, 1999, J APPL MICROBIOL, V85, p19S, DOI 10.1111/j.1365-2672.1998.tb05279.x; Thar R, 2002, APPL ENVIRON MICROB, V68, P6310, DOI 10.1128/AEM.68.12.6310-6320.2002; WALLNER G, 1993, CYTOMETRY, V14, P136, DOI 10.1002/cyto.990140205; Webster P, 2004, BIOFILMS, V1, P165, DOI DOI 10.1017/S1479050504001425; Wimpenny J, 2000, FEMS MICROBIOL REV, V24, P661, DOI 10.1111/j.1574-6976.2000.tb00565.x	35	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100002	10.1371/journal.pone.0100002	http://dx.doi.org/10.1371/journal.pone.0100002			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964210	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000338709500026
J	Sung, HY; Choi, EN; Lyu, D; Mook-Jung, I; Ahn, JH				Sung, Hye Youn; Choi, Eun Nam; Lyu, Dahyun; Mook-Jung, Inhee; Ahn, Jung-Hyuck			Amyloid Beta-Mediated Epigenetic Alteration of Insulin-Like Growth Factor Binding Protein 3 Controls Cell Survival in Alzheimer's Disease	PLOS ONE			English	Article							ABERRANT PROMOTER METHYLATION; MAMMARY EPITHELIAL-CELLS; FACTOR-I; PRECURSOR PROTEIN; EXPRESSION; APOPTOSIS; IGFBP-3; CANCER; SERUM; BRAIN	Swedish double mutation (KM670/671NL) of amyloid precursor protein (APP) is reported to increase toxic amyloid b (Ab) production via aberrant cleavage at the beta-secretase site and thereby cause early-onset Alzheimer's disease (AD). However, the underlying molecular mechanisms leading to AD pathogenesis remains largely unknown. Previously, our transcriptome sequence analyses revealed global expressional modifications of over 600 genes in APP-Swedish mutant-expressing H4 (H4sw) cells compared to wild type H4 cells. Insulin-like growth factor binding protein 3 (IGFBP3) is one gene that showed significantly decreased mRNA expression in H4-sw cells. In this study, we investigated the functional role of IGFBP3 in AD pathogenesis and elucidated the mechanisms regulating its expression. We observed decreased IGFBP3 expression in the H4-sw cell line as well as the hippocampus of AD model transgenic mice. Treatment with exogenous IGFBP3 protein inhibited A beta(1-42)-induced cell death and caspase-3 activity, whereas siRNA-mediated suppression of IGFBP3 expression induced cell death and caspase-3 cleavage. In primary hippocampal neurons, administration of IGFBP3 protein blocked apoptotic cell death due to A beta(1-42) toxicity. These data implicate a protective role for IGFBP3 against A beta(1-42)-mediated apoptosis. Next, we investigated the regulatory mechanisms of IGFBP3 expression in AD pathogenesis. We observed abnormal IGFBP3 hypermethylation within the promoter CpG island in H4-sw cells. Treatment with the DNA methyltransferase inhibitor 5-aza-29-deoxycytidine restored IGFBP3 expression at both the mRNA and protein levels. Chronic exposure to A beta(1-42) induced IGFBP3 hypermethylation at CpGs, particularly at loci 2164 and 2173, and subsequently suppressed IGFBP3 expression. Therefore, we demonstrate that expression of anti-apoptotic IGFBP3 is regulated by epigenetic DNA methylation, suggesting a mechanism that contributes to AD pathogenesis.	[Sung, Hye Youn; Choi, Eun Nam; Lyu, Dahyun; Ahn, Jung-Hyuck] Ewha Womans Univ, Sch Med, Dept Biochem, Seoul, South Korea; [Ahn, Jung-Hyuck] Ewha Womans Univ, Tissue Injury Def Res Ctr, Sch Med, Seoul, South Korea; [Mook-Jung, Inhee] Seoul Natl Univ, Coll Med, Dept Biochem & Biomed Sci, Seoul, South Korea	Ewha Womans University; Ewha Womans University; Seoul National University (SNU)	Ahn, JH (corresponding author), Ewha Womans Univ, Sch Med, Dept Biochem, Seoul, South Korea.	ahnj@ewha.ac.kr		Ahn, Jung-Hyuck/0000-0001-9589-3881	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2011-0013882]; National Research Foundation of Korea (NRF) grant - Korea government (MSIP) [2012R1A5A2A32671867]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2012R1A1A2004214]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; National Research Foundation of Korea (NRF) grant - Korea government (MSIP); Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2011-0013882) and this work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. 2012R1A5A2A32671867). This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2012R1A1A2004214). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAXTER RC, 1994, ENDOCRINOLOGY, V134, P848, DOI 10.1210/en.134.2.848; Borchelt DR, 1998, BRAIN PATHOL, V8, P735, DOI 10.1111/j.1750-3639.1998.tb00198.x; Butt AJ, 2004, J CLIN ENDOCR METAB, V89, P1950, DOI 10.1210/jc.2003-030914; CAI XD, 1993, SCIENCE, V259, P514, DOI 10.1126/science.8424174; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Carro E, 2006, NEUROBIOL AGING, V27, P1250, DOI 10.1016/j.neurobiolaging.2005.06.015; Chae SS, 2010, J NEUROSCI RES, V88, P1926, DOI 10.1002/jnr.22356; Chang YS, 2002, CLIN CANCER RES, V8, P3669; Chen UL, 2009, BIOCHEM BIOPH RES CO, V378, P57, DOI 10.1016/j.bbrc.2008.10.173; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Dar AA, 2010, J INVEST DERMATOL, V130, P2071, DOI 10.1038/jid.2010.70; Duron E, 2012, J CLIN ENDOCR METAB, V97, P4673, DOI 10.1210/jc.2012-2063; Firth SM, 2002, ENDOCRINOLOGY, V143, P1669, DOI 10.1210/en.143.5.1669; Fuso A, 2005, MOL CELL NEUROSCI, V28, P195, DOI 10.1016/j.mcn.2004.09.007; Granata R, 2007, J THROMB HAEMOST, V5, P835, DOI 10.1111/j.1538-7836.2007.02431.x; Granata R, 2004, FASEB J, V18, P1456, DOI 10.1096/fj.04-1618fje; Hanafusa T, 2002, CANCER LETT, V176, P149, DOI 10.1016/S0304-3835(01)00736-4; Ikonen M, 2003, P NATL ACAD SCI USA, V100, P13042, DOI 10.1073/pnas.2135111100; Jogie-Brahim S, 2009, ENDOCR REV, V30, P417, DOI 10.1210/er.2008-0028; Kennedy BP, 2004, J NEURAL TRANSM, V111, P547, DOI 10.1007/s00702-003-0096-5; Kimberly WT, 2001, J BIOL CHEM, V276, P40288, DOI 10.1074/jbc.C100447200; Leibowitz BJ, 2009, J CELL PHYSIOL, V220, P182, DOI 10.1002/jcp.21748; Martin JL, 2009, J BIOL CHEM, V284, P25542, DOI 10.1074/jbc.M109.007120; Martin JL, 2003, J BIOL CHEM, V278, P2969, DOI 10.1074/jbc.M210739200; Mustafa A, 1999, DEMENT GERIATR COGN, V10, P446, DOI 10.1159/000017188; Niikura T, 2001, J NEUROSCI, V21, P1902, DOI 10.1523/JNEUROSCI.21-06-01902.2001; Nishijima T, 2010, NEURON, V67, P834, DOI 10.1016/j.neuron.2010.08.007; Rensink AAM, 2002, ACTA NEUROPATHOL, V104, P525, DOI 10.1007/s00401-002-0585-x; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Shin J, 2010, BMB REP, V43, P704, DOI [10.3858/BMBRep.2010.43.10.704, 10.5483/BMBRep.2010.43.10.704]; Takahashi T, 2006, INT J CANCER, V118, P924, DOI 10.1002/ijc.21453; THAM A, 1993, J NEURAL TRANSM-PARK, V5, P165, DOI 10.1007/BF02257671; Tomii K, 2007, INT J CANCER, V120, P566, DOI 10.1002/ijc.22341; Torng PL, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-120; Vardy ERLC, 2007, J ALZHEIMERS DIS, V12, P285; Watanabe T, 2005, J AM GERIATR SOC, V53, P1748, DOI 10.1111/j.1532-5415.2005.53524.x; West RL, 1995, J MOL NEUROSCI, V6, P141, DOI 10.1007/BF02736773; Wiley A, 2006, INT J GYNECOL CANCER, V16, P210, DOI 10.1111/j.1525-1438.2006.00299.x; Yamada PM, 2009, AM J PHYSIOL-CELL PH, V296, pC954, DOI 10.1152/ajpcell.00598.2008; Yamashita S, 2006, CANCER SCI, V97, P64, DOI 10.1111/j.1349-7006.2006.00136.x; Yun SM, 2013, NEUROBIOL AGING, V34, P650, DOI 10.1016/j.neurobiolaging.2012.08.005	41	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e99047	10.1371/journal.pone.0099047	http://dx.doi.org/10.1371/journal.pone.0099047			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964199	gold, Green Submitted, Green Published			2022-12-27	WOS:000338709500008
J	Roy, A; Tesauro, C; Frohlich, R; Hede, MS; Nielsen, MJ; Kjeldsen, E; Bonven, B; Stougaard, M; Gromova, I; Knudsen, BR				Roy, Amit; Tesauro, Cinzia; Frohlich, Rikke; Hede, Marianne S.; Nielsen, Maria J.; Kjeldsen, Eigil; Bonven, Bjarne; Stougaard, Magnus; Gromova, Irina; Knudsen, Birgitta R.			Decreased Camptothecin Sensitivity of the Stem-Cell-Like Fraction of Caco2 Cells Correlates with an Altered Phosphorylation Pattern of Topoisomerase I	PLOS ONE			English	Article							METASTATIC COLORECTAL-CANCER; PROTEIN-KINASE-C; TUMOR-INITIATING CELLS; SODIUM-BUTYRATE; LYMPHOMA-CELLS; LUNG-CANCER; DNA; RESISTANCE; LINE; IDENTIFICATION	The CD44+ and CD44- subpopulations of the colorectal cancer cell line Caco2 were analyzed separately for their sensitivities to the antitumor drug camptothecin. CD44+ cells were less sensitive to camptothecin than CD44- cells. The relative resistance of CD44+ cells was correlated with (i) reduced activity of the nuclear enzyme topoisomerase I and (ii) insensitivity of this enzyme to camptothecin when analyzed in extracts. In contrast, topoisomerase I activity was higher in extracts from CD44- cells and the enzyme was camptothecin sensitive. Topoisomerase I from the two subpopulations were differentially phosphorylated in a manner that appeared to determine the drug sensitivity and activity of the enzyme. This finding was further supported by the fact that phosphorylation of topoisomerase I in CD44+ cell extract by protein kinase CK2 converted the enzyme to a camptothecin sensitive, more active form mimicking topoisomerase I in extracts from CD44- cells. Conversely, dephosphorylation of topoisomerase I in extracts from CD44- cells rendered the enzyme less active and camptothecin resistant. These findings add to our understanding of chemotherapy resistance in the Caco2 CD44+ cancer stem cell model.	[Roy, Amit; Tesauro, Cinzia; Frohlich, Rikke; Nielsen, Maria J.; Bonven, Bjarne; Knudsen, Birgitta R.] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark; [Hede, Marianne S.] Zymonostics ApS, Aarhus, Denmark; [Kjeldsen, Eigil] Aarhus Univ Hosp, Cancercytogenet Sect, Hemodiagnost Lab, DK-8000 Aarhus, Denmark; [Stougaard, Magnus] Aarhus Univ Hosp, Dept Pathol, DK-8000 Aarhus, Denmark; [Gromova, Irina] Danish Canc Soc, Danish Canc Res Ctr, Genome Integr Unit, Copenhagen, Denmark	Aarhus University; Aarhus University; Aarhus University; Danish Cancer Society	Knudsen, BR (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark.	brk@mb.au.dk		Stougaard, Magnus/0000-0001-7456-902X; Knudsen, Birgitta Ruth/0000-0002-3484-3802; Tesauro, Cinzia/0000-0003-2986-9618; Gromova, Irina/0000-0003-4357-5958	Carlsberg Foundation; Danish Cancer Society; Aase og Ejnar Danielsens Foundation; Fabrikant Einar Willumsens Mindelegat; Friedrich Wilhelm Frank & Hustru Angelina Franks Mindelegat; Arvid Nilssons Foundation; Minister Erna Hamiltons Legat for Videnskab og Kunst; Familien Erichsens Mindefond; Karen Elise Jensen's Foundation; Dagmar Marshall's Foundation; Einar Hansen & Vera Hansen's Foundation; Harboe Foundation; Louis Hansen's Foundation; Horslev Foundation; Kobmand Sven Hansen & hustru Ina Hansen's Foundation; Emil Hertz & hustru Inger Hertz' Foundation; Civilingenior Frode Nygaard's Foundation; Kong Christian den Tiende's Foundation; Gangsted Foundation; KU's Foundation for Cancer research; Ludvig og Franciska Andersen's Foundation; Frimodt-Heineke's Foundation; Familien Hede Nielsens Foundation; Marie & M. B. Richters Foundation; Lykfeldts legat; Fhv. Dir. Leo Nielsen og Hustru Karen Margrethe Nielsens Legat for Laegevidenskabelig Grundforskning	Carlsberg Foundation(Carlsberg Foundation); Danish Cancer Society(Danish Cancer Society); Aase og Ejnar Danielsens Foundation; Fabrikant Einar Willumsens Mindelegat; Friedrich Wilhelm Frank & Hustru Angelina Franks Mindelegat; Arvid Nilssons Foundation; Minister Erna Hamiltons Legat for Videnskab og Kunst; Familien Erichsens Mindefond; Karen Elise Jensen's Foundation; Dagmar Marshall's Foundation; Einar Hansen & Vera Hansen's Foundation; Harboe Foundation; Louis Hansen's Foundation; Horslev Foundation; Kobmand Sven Hansen & hustru Ina Hansen's Foundation; Emil Hertz & hustru Inger Hertz' Foundation; Civilingenior Frode Nygaard's Foundation; Kong Christian den Tiende's Foundation; Gangsted Foundation; KU's Foundation for Cancer research; Ludvig og Franciska Andersen's Foundation; Frimodt-Heineke's Foundation; Familien Hede Nielsens Foundation; Marie & M. B. Richters Foundation; Lykfeldts legat; Fhv. Dir. Leo Nielsen og Hustru Karen Margrethe Nielsens Legat for Laegevidenskabelig Grundforskning	This research was supported by the Carlsberg Foundation (post doc grant for AR), the Danish Cancer Society, Aase og Ejnar Danielsens Foundation, the Fabrikant Einar Willumsens Mindelegat, the Friedrich Wilhelm Frank & Hustru Angelina Franks Mindelegat, the Arvid Nilssons Foundation, the Minister Erna Hamiltons Legat for Videnskab og Kunst, the Familien Erichsens Mindefond, Karen Elise Jensen's Foundation, Dagmar Marshall's Foundation, Dir. Einar Hansen & Vera Hansen's Foundation, The Harboe Foundation, Louis Hansen's Foundation, The Horslev Foundation, Kobmand Sven Hansen & hustru Ina Hansen's Foundation, Dir. Emil Hertz & hustru Inger Hertz' Foundation, Civilingenior Frode Nygaard's Foundation, Kong Christian den Tiende's Foundation, The Gangsted Foundation, KU's Foundation for Cancer research, Ludvig og Franciska Andersen's Foundation, Frimodt-Heineke's Foundation, the Familien Hede Nielsens Foundation, the Marie & M. B. Richters Foundation, the Lykfeldts legat, the Fhv. Dir. Leo Nielsen og Hustru Karen Margrethe Nielsens Legat for Laegevidenskabelig Grundforskning. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah LN, 2013, CLIN TRANSL MED, V2, DOI 10.1186/2001-1326-2-3; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alison MR, 2011, J PATHOL, V223, P147, DOI 10.1002/path.2793; Andersen FF, 2009, ACS NANO, V3, P4043, DOI 10.1021/nn9012912; [Anonymous], ANN SURG ONCOL, V15, P2027; AUGERON C, 1984, CANCER RES, V44, P3961; Bandyopadhyay K, 2007, BIOCHEMISTRY-US, V46, P14325, DOI 10.1021/bi7013618; Bandyopadhyay K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050427; Bandyopadhyay K, 2011, BIOCHEMISTRY-US, V50, P704, DOI 10.1021/bi101110e; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Beretta GL, 2006, CURR MED CHEM, V13, P3291, DOI 10.2174/092986706778773121; Beretta GL, 2013, CURR MED CHEM, V20, P1541; Burgess DJ, 2008, P NATL ACAD SCI USA, V105, P9053, DOI 10.1073/pnas.0803513105; CARDELLINI E, 1993, BIOCHEM J, V291, P303, DOI 10.1042/bj2910303; CELIS JE, 2006, CELL BIOL LAB HDB, P165; Christiansen K, 1996, ANN NY ACAD SCI, V803, P50, DOI 10.1111/j.1749-6632.1996.tb26376.x; CODERONI S, 1990, INT J BIOCHEM, V22, P737, DOI 10.1016/0020-711X(90)90009-R; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Douillard JY, 2000, LANCET, V355, P1041, DOI 10.1016/S0140-6736(00)02034-1; Emmink BL, 2011, GASTROENTEROLOGY, V141, P269, DOI 10.1053/j.gastro.2011.03.052; ENG WK, 1988, MOL PHARMACOL, V34, P755; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Gerrits CJH, 1997, BRIT J CANCER, V76, P952, DOI 10.1038/bjc.1997.491; Goldberg RM, 2004, J CLIN ONCOL, V22, P23, DOI 10.1200/JCO.2004.09.046; Gongora C, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-64; Grivicich I, 2001, BRAZ J MED BIOL RES, V34, P1087, DOI 10.1590/S0100-879X2001000900001; Gromov P, 2006, CELL BIOL, P527; Gromov P, 2008, MOL ONCOL, V2, P368, DOI 10.1016/j.molonc.2008.09.003; Hann CL, 1998, J BIOL CHEM, V273, P31519, DOI 10.1074/jbc.273.47.31519; HERTZBERG RP, 1990, J BIOL CHEM, V265, P19287; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Jansen WJM, 1997, INT J CANCER, V70, P335, DOI 10.1002/(SICI)1097-0215(19970127)70:3<335::AID-IJC15>3.0.CO;2-E; Juul S, 2011, ACS NANO, V5, P8305, DOI 10.1021/nn203012q; KAISERMAN HB, 1988, BIOCHEMISTRY-US, V27, P3216, DOI 10.1021/bi00409a014; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; KJELDSEN E, 1988, J BIOL CHEM, V263, P3912; Knudsen BR, 1996, J CHROMATOGR B, V684, P307, DOI 10.1016/0378-4347(96)00152-1; Kondo T, 2004, P NATL ACAD SCI USA, V101, P781, DOI 10.1073/pnas.0307618100; Kowalska-Loth B, 2003, MOL BIOL REP, V30, P107, DOI 10.1023/A:1023942226954; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Leppard JB, 2005, CHROMOSOMA, V114, P75, DOI 10.1007/s00412-005-0345-5; Li XG, 1997, BIOCHEM PHARMACOL, V53, P1019, DOI 10.1016/S0006-2952(96)00899-4; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; MADELAINE I, 1993, BIOCHEM PHARMACOL, V45, P339, DOI 10.1016/0006-2952(93)90069-9; Moisan F, 2006, BRIT J CANCER, V95, P906, DOI 10.1038/sj.bjc.6603361; Moreau LC, 2013, ANTICANCER RES, V33, P1765; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; Pommier Y, 1999, DRUG RESIST UPDATE, V2, P307, DOI 10.1054/drup.1999.0102; POMMIER Y, 1990, J BIOL CHEM, V265, P9418; POMMIER Y, 1993, CANCER CHEMOTH PHARM, V32, P103, DOI 10.1007/BF00685611; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Proszek J, 2014, SENSORS-BASEL, V14, P1195, DOI 10.3390/s140101195; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rossi F, 1996, NATURE, V381, P80, DOI 10.1038/381080a0; SAMUELS DS, 1989, FEBS LETT, V259, P57, DOI 10.1016/0014-5793(89)81493-0; Sell S, 2010, AM J PATHOL, V176, P2584, DOI 10.2353/ajpath.2010.091064; Setoguchi T, 2004, CELL CYCLE, V3, P414; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; SORENSEN M, 1995, BRIT J CANCER, V72, P399, DOI 10.1038/bjc.1995.345; Soret J, 2003, CANCER RES, V63, P8203; SOULEIMANI A, 1993, FEBS LETT, V326, P45, DOI 10.1016/0014-5793(93)81758-R; St-Amant C, 2006, BIOCHEM CELL BIOL, V84, P55, DOI 10.1139/O05-157; STARON K, 1994, CARCINOGENESIS, V15, P2953, DOI 10.1093/carcin/15.12.2953; STARON K, 1995, BBA-GENE STRUCT EXPR, V1260, P35, DOI 10.1016/0167-4781(94)00175-3; Staron K, 1996, ANN NY ACAD SCI, V803, P321, DOI 10.1111/j.1749-6632.1996.tb26406.x; Stougaard M, 2009, ACS NANO, V3, P223, DOI 10.1021/nn800509b; Strumberg D, 2000, MOL CELL BIOL, V20, P3977, DOI 10.1128/MCB.20.11.3977-3987.2000; SUGIMOTO Y, 1990, CANCER RES, V50, P6925; Tesauro C, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-100; TSAO YP, 1993, CANCER RES, V53, P5908; TURMAN MA, 1993, BIOCHEM MED METAB B, V50, P210, DOI 10.1006/bmmb.1993.1063; Wolpin BM, 2008, GASTROENTEROLOGY, V134, P1296, DOI 10.1053/j.gastro.2008.02.098; Yu DH, 2004, J BIOL CHEM, V279, P51851, DOI 10.1074/jbc.M404396200	73	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e99628	10.1371/journal.pone.0099628	http://dx.doi.org/10.1371/journal.pone.0099628			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24960044	Green Published, Green Submitted, gold			2022-12-27	WOS:000338633900011
J	Terami, N; Ogawa, D; Tachibana, H; Hatanaka, T; Wada, J; Nakatsuka, A; Eguchi, J; Horiguchi, CS; Nishii, N; Yamada, H; Takei, K; Makino, H				Terami, Naoto; Ogawa, Daisuke; Tachibana, Hiromi; Hatanaka, Takashi; Wada, Jun; Nakatsuka, Atsuko; Eguchi, Jun; Horiguchi, Chikage Sato; Nishii, Naoko; Yamada, Hiroshi; Takei, Kohji; Makino, Hirofumi			Long-Term Treatment with the Sodium Glucose Cotransporter 2 Inhibitor, Dapagliflozin, Ameliorates Glucose Homeostasis and Diabetic Nephropathy in db/db Mice	PLOS ONE			English	Article							SGLT2 INHIBITOR; PANCREATIC-FUNCTION; OXIDATIVE STRESS; RENAL INJURY; MELLITUS; RATS; INFLAMMATION; COMPLICATIONS; HYPERGLYCEMIA; ACTIVATION	Inhibition of sodium glucose cotransporter 2 (SGLT2) has been reported as a new therapeutic strategy for treating diabetes. However, the effect of SGLT2 inhibitors on the kidney is unknown. In addition, whether SGLT2 inhibitors have an anti-inflammatory or antioxidative stress effect is still unclear. In this study, to resolve these issues, we evaluated the effects of the SGLT2 inhibitor, dapagliflozin, using a mouse model of type 2 diabetes and cultured proximal tubular epithelial (mProx24) cells. Male db/db mice were administered 0.1 or 1.0 mg/kg of dapagliflozin for 12 weeks. Body weight, blood pressure, blood glucose, hemoglobin A1c, albuminuria and creatinine clearance were measured. Mesangial matrix accumulation and interstitial fibrosis in the kidney and pancreatic beta-cell mass were evaluated by histological analysis. Furthermore, gene expression of inflammatory mediators, such as osteopontin, monocyte chemoattractant protein-1 and transforming growth factor-beta, was evaluated by quantitative reverse transcriptase-PCR. In addition, oxidative stress was evaluated by dihydroethidium and NADPH oxidase 4 staining. Administration of 0.1 or 1.0 mg/kg of dapagliflozin ameliorated hyperglycemia, beta-cell damage and albuminuria in db/db mice. Serum creatinine, creatinine clearance and blood pressure were not affected by administration of dapagliflozin, but glomerular mesangial expansion and interstitial fibrosis were suppressed in a dose-dependent manner. Dapagliflozin treatment markedly decreased macrophage infiltration and the gene expression of inflammation and oxidative stress in the kidney of db/db mice. Moreover, dapagliflozin suppressed the high-glucose-induced gene expression of inflammatory cytokines and oxidative stress in cultured mProx24 cells. These data suggest that dapagliflozin ameliorates diabetic nephropathy by improving hyperglycemia along with inhibiting inflammation and oxidative stress.	[Terami, Naoto; Ogawa, Daisuke; Tachibana, Hiromi; Hatanaka, Takashi; Wada, Jun; Nakatsuka, Atsuko; Eguchi, Jun; Horiguchi, Chikage Sato; Nishii, Naoko; Makino, Hirofumi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Med & Clin Sci, Okayama, Japan; [Ogawa, Daisuke] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Diabet Nephropathy, Okayama, Japan; [Yamada, Hiroshi; Takei, Kohji] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neurochem, Okayama, Japan	Okayama University; Okayama University; Okayama University	Ogawa, D (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Med & Clin Sci, Okayama, Japan.	daiogawa@md.okayama-u.ac.jp	WADA, Jun/B-2023-2011; Yamada, Hiroshi/AGZ-4497-2022; Nakatsuka, Atsuko/L-2765-2017; YAMADA, Hiroshi/B-2251-2011	WADA, Jun/0000-0003-1468-5170; Yamada, Hiroshi/0000-0002-9328-3446; YAMADA, Hiroshi/0000-0002-9328-3446; Takei, Kohji/0000-0002-6555-9425	Ministry of Education, Culture, Sports, Science and Technology [25461223, 24790927]; Ministry of Health, Labour and Welfare of Japan; Naito Foundation; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Naito Foundation(Naito Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF))	This study was supported in part by Grant-in-Aid for Scientific Research (C) to D. Ogawa (25461223) and Grant-in-Aid for Young Scientists (B) to C. Sato Horiguchi (24790927) from the Ministry of Education, Culture, Sports, Science and Technology, and by Grant-in-Aid for Diabetic Nephropathy and Nephrosclerosis Research from the Ministry of Health, Labour and Welfare of Japan. This work was also supported by the Naito Foundation and the Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouchie A, 2013, NAT BIOTECHNOL, V31, P469, DOI 10.1038/nbt0613-469; Chao EC, 2010, NAT REV DRUG DISCOV, V9, P551, DOI 10.1038/nrd3180; Chen L, 2012, CURR MOL MED, V12, P995, DOI 10.2174/156652412802480970; Chen LH, 2013, DIABETES OBES METAB, V15, P392, DOI 10.1111/dom.12064; Cherney DZI, 2014, CIRCULATION, V129, P587, DOI 10.1161/CIRCULATIONAHA.113.005081; DeFronzo RA, 2013, DIABETES CARE; Forbes JM, 2013, PHYSIOL REV, V93, P137, DOI 10.1152/physrev.00045.2011; Fujimori Y, 2008, J PHARMACOL EXP THER, V327, P268, DOI 10.1124/jpet.108.140210; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Gilbertson DT, 2005, J AM SOC NEPHROL, V16, P3736, DOI 10.1681/ASN.2005010112; Han SP, 2008, DIABETES, V57, P1723, DOI 10.2337/db07-1472; HEDIGER MA, 1994, PHYSIOL REV, V74, P993, DOI 10.1152/physrev.1994.74.4.993; Jurczak MJ, 2011, DIABETES, V60, P890, DOI 10.2337/db10-1328; Kanwar YS, 2011, ANNU REV PATHOL-MECH, V6, P395, DOI 10.1146/annurev.pathol.4.110807.092150; Kodera R, 2011, DIABETOLOGIA, V54, P965, DOI 10.1007/s00125-010-2028-x; Kojima N, 2013, J PHARMACOL EXP THER, V345, P464, DOI 10.1124/jpet.113.203869; Macdonald FR, 2010, DIABETES OBES METAB, V12, P1004, DOI 10.1111/j.1463-1326.2010.01291.x; Matsushita Y, 2011, DIABETES, V60, P960, DOI 10.2337/db10-1361; Nagata T, 2013, BRIT J PHARMACOL, V170, P519, DOI 10.1111/bph.12269; Navarro-Gonzalez JF, 2011, NAT REV NEPHROL, V7, P327, DOI 10.1038/nrneph.2011.51; Ogawa D, 2011, EXP DIABETES RES, DOI 10.1155/2011/534872; Ohga S, 2007, AM J PHYSIOL-RENAL, V292, pF1141, DOI 10.1152/ajprenal.00288.2005; Okada S, 2003, DIABETES, V52, P2586, DOI 10.2337/diabetes.52.10.2586; Plosker GL, 2012, DRUGS, V72, P2289, DOI 10.2165/11209910-000000000-00000; Tachibana H, 2012, J AM SOC NEPHROL, V23, P1835, DOI 10.1681/ASN.2012010022; Tahara A, 2013, EUR J PHARMACOL, V715, P246, DOI 10.1016/j.ejphar.2013.05.014; Vallon V, 2013, AM J PHYSIOL-RENAL, V304, pF156, DOI 10.1152/ajprenal.00409.2012; Vlassara H, 2012, J GERONTOL A-BIOL, V67, P1410, DOI 10.1093/gerona/gls195; Whaley JM, 2012, DIABET METAB SYND OB, V5, P135, DOI 10.2147/DMSO.S22503; Wright EM, 2001, AM J PHYSIOL-RENAL, V280, pF10, DOI 10.1152/ajprenal.2001.280.1.F10	30	210	229	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100777	10.1371/journal.pone.0100777	http://dx.doi.org/10.1371/journal.pone.0100777			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24960177	Green Submitted, gold, Green Published			2022-12-27	WOS:000338633900084
J	Xiao, GH; Xia, CL; Yang, J; Liu, JQ; Du, HZ; Kang, XJ; Lin, YY; Guan, RH; Yan, PK; Tang, SS				Xiao, Guohong; Xia, Chenglai; Yang, Jie; Liu, Jianqiao; Du, Hongzi; Kang, Xiangjin; Lin, Yuyi; Guan, Ronghua; Yan, Pengke; Tang, Shengsong			MiR-133b Regulates the Expression of the Actin Protein TAGLN2 during Oocyte Growth and Maturation: A Potential Target for Infertility Therapy	PLOS ONE			English	Article							GENE-EXPRESSION; MICRORNAS; PROLIFERATION; CELLS	Infertility is an area of increasing in life science research. Although follicular maturation disorders and anovulation are the primary causations of infertility, its molecular mechanism is not well understood. Recent research has shown that microRNAs (miRNAs) might play an important role in the regulation of ovarian follicle development and maturation. In this study, the expression of miRNAs in metaphase I (MI) oocytes treated with or without insulin-like growth factor 1 (IGF-1) was observed by microRNA microarray analysis. Results show that 145 miRNAs were up-regulated and 200 miRNAs were down-regulated in MI oocytes after IGF-1 treatment. MiR-133b, which was up-regulated more than 30-fold, was chosen for further research. As a potential target of miR133b, transgelin 2 (TAGLN2) gene was down-regulated, at both transcription and translation levels, in miR-133b- over-expressed 293T cells, but TAGLN2 was up-regulated when the expression of miR-133b was inhibited. Furthermore, the expression level of TAGLN2 in the ovaries of 8-week-old mice was higher than that observed in 4-week-old mice. Immunofluorescence experiments showed that TAGLN2 was located in the cytoplasm. In general, our results indicate that miR-133b may play important roles in the growth and maturation of oocytes by regulating its potential target, TAGLN2, at both transcription and translation levels. Therefore, our research provides a potential new target for infertility therapy.	[Xiao, Guohong; Tang, Shengsong] Univ South China, Dept Pathol, Hengyang, Peoples R China; [Xiao, Guohong; Xia, Chenglai; Yang, Jie; Liu, Jianqiao; Du, Hongzi; Kang, Xiangjin; Lin, Yuyi; Guan, Ronghua; Yan, Pengke] Guangzhou Med Univ, Affiliated Hosp 3, Guangzhou, Guangdong, Peoples R China; [Xiao, Guohong; Yang, Jie; Liu, Jianqiao; Du, Hongzi; Kang, Xiangjin; Lin, Yuyi; Guan, Ronghua] Guangdong Prov Key Lab Reprod Med, Guangzhou, Guangdong, Peoples R China; [Tang, Shengsong] Hunan Univ Arts & Sci, Ctr Life Sci, Changde, Peoples R China	University of South China; Guangzhou Medical University; Hunan University of Arts & Science	Tang, SS (corresponding author), Univ South China, Dept Pathol, Hengyang, Peoples R China.	tangss111@163.com			Technology Innovation Platform in Hunan [09K072, 12K120]	Technology Innovation Platform in Hunan	This study was supported by Open Fund of Technology Innovation Platform in Hunan (No. 09K072, 12K120). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assou S, 2013, HUM REPROD, V28, P3038, DOI 10.1093/humrep/det321; Bachelot A, 2002, ENDOCRINOLOGY, V143, P4104, DOI 10.1210/en.2002-220087; Carletti MZ, 2010, BIOL REPROD, V83, P286, DOI 10.1095/biolreprod.109.081448; Chang RJ, 2013, MOL CELL ENDOCRINOL, V373, P51, DOI 10.1016/j.mce.2012.07.011; Coyral-Castel S, 2012, THERIOGENOLOGY, V77, P1822, DOI 10.1016/j.theriogenology.2011.12.028; da Silveira Juliano C, 2012, Biol Reprod, V86, P71, DOI 10.1095/biolreprod.111.093252; Dai AY, 2013, FEBS LETT, V587, P2474, DOI 10.1016/j.febslet.2013.06.023; Hennebold JD, 2004, HUM REPROD UPDATE, V10, P227, DOI 10.1093/humupd/dmh017; Hidalgo GD, 2011, FERTIL STERIL, V96, P700, DOI 10.1016/j.fertnstert.2011.06.052; HWANG HW, 2007, BRIT J CANCER, V94, P776; Jansson MD, 2012, MOL ONCOL, V6, P590, DOI 10.1016/j.molonc.2012.09.006; Kim YJ, 2013, HUM REPROD, V28, P3050, DOI 10.1093/humrep/det338; Lehrbach NJ, 2012, RNA, V18, P2220, DOI 10.1261/rna.035402.112; Lei L, 2010, MOL CELL ENDOCRINOL, V315, P63, DOI 10.1016/j.mce.2009.09.021; Li XJ, 2010, J REPROD CONTRACEPTI, V21, P27; Liang M, 2013, MOL CELL ENDOCRINOL, V370, P119, DOI 10.1016/j.mce.2013.02.014; Luense LJ, 2009, TRENDS ENDOCRIN MET, V20, P265, DOI 10.1016/j.tem.2009.05.001; Ma XH, 2006, J BIOL CHEM, V281, P9351, DOI 10.1074/jbc.M511512200; Murchison EP, 2007, GENE DEV, V21, P682, DOI 10.1101/gad.1521307; Nogueira D, 2012, SEMIN REPROD MED, V30, P199, DOI 10.1055/s-0032-1311522; Nohata N, 2011, ONCOTARGET, V2, P29; Otsuka M, 2008, J CLIN INVEST, V118, P1944, DOI 10.1172/JCI33680; Otsuka M, 2007, IMMUNITY, V27, P123, DOI 10.1016/j.immuni.2007.05.014; Panguluri SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008760; Sohel MMH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078505; Sucharov C, 2008, J MOL CELL CARDIOL, V45, P185, DOI 10.1016/j.yjmcc.2008.04.014; Suh N, 2010, CURR BIOL, V20, P271, DOI 10.1016/j.cub.2009.12.044; Tang F, 2007, GENE DEV, V21, P644, DOI 10.1101/gad.418707; Velazquez MA, 2012, THERIOGENOLOGY, V78, P517, DOI 10.1016/j.theriogenology.2012.02.034; Williams AH, 2009, CURR OPIN CELL BIOL, V21, P461, DOI 10.1016/j.ceb.2009.01.029; Xu YW, 2011, J ASSIST REPROD GEN, V28, P559, DOI 10.1007/s10815-011-9590-0; Yang SH, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.107730; Yao GD, 2010, MOL ENDOCRINOL, V24, P540, DOI 10.1210/me.2009-0432; Zhang Q, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054250, 10.1371/journal.pone.0059667]	34	29	34	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100751	10.1371/journal.pone.0100751	http://dx.doi.org/10.1371/journal.pone.0100751			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959893	gold, Green Published, Green Submitted			2022-12-27	WOS:000338633900081
J	Blasi, F; Cesana, G; Conti, S; Chiodini, V; Aliberti, S; Fornari, C; Mantovani, LG				Blasi, Francesco; Cesana, Giancarlo; Conti, Sara; Chiodini, Virginio; Aliberti, Stefano; Fornari, Carla; Mantovani, Lorenzo Giovanni			The Clinical and Economic Impact of Exacerbations of Chronic Obstructive Pulmonary Disease: A Cohort of Hospitalized Patients	PLOS ONE			English	Article							COPD EXACERBATIONS; MORTALITY; SPIROMETRY; OUTCOMES; COSTS	Background: Chronic Obstructive Pulmonary Disease (COPD) is a common disease with significant health and economic consequences. This study assesses the burden of COPD in the general population, and the influence of exacerbations (E-COPD) on disease progression and costs. Methods: This is a secondary data analysis of healthcare administrative databases of the region of Lombardy, in northern Italy. The study included >= 40 year-old patients hospitalized for a severe E-COPD (index event) during 2006. Patients were classified in relation to the number and type of E-COPD experienced in a three-year pre-index period. Subjects were followed up until December 31st, 2009, collecting data on healthcare resource use and vital status. Results: 15857 patients were enrolled -9911 males, mean age: 76 years (SD 10). Over a mean follow-up time of 2.4 years (1.36), 81% of patients had at least one E-COPD with an annual rate of 3.2 exacerbations per person-year and an all-cause mortality of 47%. A history of exacerbation influenced the occurrence of new E-COPD and mortality after discharge for an E-COPD. On average, the healthcare system spent 6725(sic) per year per person (95% CI 6590-6863). Occurrence and type of exacerbations drove the direct healthcare cost. Less than one quarter of patients presented claims for pulmonary function tests. Conclusions: COPD imposes a substantial burden on healthcare systems, mainly attributable to the type and occurrence of E-COPD, or in other words, to the exacerbator phenotypes. A more tailored approach to the management of COPD patients is required.	[Blasi, Francesco] Univ Milan, Osped Maggiore Policlin, IRCCS Fdn Ca Granda, Dept Pathophysiol & Transplantat, Milan, Italy; [Cesana, Giancarlo; Conti, Sara; Chiodini, Virginio; Fornari, Carla; Mantovani, Lorenzo Giovanni] Univ Milano Bicocca, CESP, Res Ctr Publ Hlth, Dept Stat & Quantitat Methods, Monza, Italy; [Aliberti, Stefano] Univ Milano Bicocca, AO San Gerardo, Dept Hlth Sci, Resp Unit, Monza, Italy; [Mantovani, Lorenzo Giovanni] Univ Napoli Federico II, Naples, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Milano-Bicocca; University of Milano-Bicocca; University of Naples Federico II	Fornari, C (corresponding author), Univ Milano Bicocca, CESP, Res Ctr Publ Hlth, Dept Stat & Quantitat Methods, Monza, Italy.	carla.fornari@unimib.it	BLASI, FRANCESCO B/O-5885-2017; Aliberti, Stefano/AAL-8032-2021; Aliberti, Stefano/K-9115-2016; Mantovani, Lorenzo Giovanni/AAC-4263-2021; Conti, Sara/J-4891-2019	BLASI, FRANCESCO B/0000-0002-2285-9970; Aliberti, Stefano/0000-0002-0090-4531; Aliberti, Stefano/0000-0002-0090-4531; Conti, Sara/0000-0002-5774-3740; Fornari, Carla/0000-0002-9609-9556; Mantovani, Lorenzo Giovanni/0000-0003-3866-8199	Nycomed-Takeda SpA	Nycomed-Takeda SpA	Nycomed-Takeda SpA funded this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Moreover, this does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Abramson MJ, 2010, MED J AUSTRALIA, V193, P104, DOI 10.5694/j.1326-5377.2010.tb03817.x; Almagro P, 2002, CHEST, V2002, P5; [Anonymous], 2008, WORLD HLTH STAT 2008; Bang H, 2000, BIOMETRIKA, V87, P329, DOI 10.1093/biomet/87.2.329; Bertella E, 2013, MULTIDISCIP RESP MED, V8, DOI 10.1186/2049-6958-8-24; Calverley PMA, 2009, LANCET, V374, P685, DOI 10.1016/S0140-6736(09)61255-1; Cazzola M, 2008, EUR RESPIR J, V31, P416, DOI 10.1183/09031936.00099306; Celli B, 2009, AM J RESP CRIT CARE, V180, P948, DOI 10.1164/rccm.200906-0876OC; Celli BR, 2004, EUROPEAN RESP J, V23, P942; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Dal Negro Roberto, 2008, Int J Chron Obstruct Pulmon Dis, V3, P1; Dalal Anand A, 2010, Int J Chron Obstruct Pulmon Dis, V5, P341, DOI 10.2147/COPD.S13771; Donaldson GC, 2010, CHEST, V137, P1091, DOI 10.1378/chest.09-2029; Groenewegen KH, 2003, CHEST, V124, P459, DOI 10.1378/chest.124.2.459; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Johnson AK, 2008, CHRONIC OBSTRUCTIVE, P15; Lokke A, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004069; Mapel DW, 2012, PHARMACOECONOMICS, V30, P869, DOI 10.2165/11633330-000000000-00000; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Monteagudo M, 2011, ARCH BRONCONEUMOL, V47, P226, DOI 10.1016/j.arbres.2010.10.009; Pasquale MK, 2012, INT J CHRONIC OBSTR, V7, P757, DOI 10.2147/COPD.S36997; Patel IS, 2002, THORAX, V57, P759, DOI 10.1136/thorax.57.9.759; Press W, 2007, GLOBAL SURVEILLANCE; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rodriguez-Roisin R, 2006, THORAX, V61, P535, DOI 10.1136/thx.2005.041863; Seemungal Terence A R, 2009, Int J Chron Obstruct Pulmon Dis, V4, P203; Simoens S, 2007, INT J CLIN PRACT, V61, P200, DOI 10.1111/j.1742-1241.2006.01240.x; Soler-Cataluna JJ, 2005, THORAX, V60, P925, DOI 10.1136/thx.2005.040527; Suissa S, 2012, THORAX, V67, P957, DOI 10.1136/thoraxjnl-2011-201518; Toy EL, 2010, COPD, V7, P214, DOI 10.3109/15412555.2010.481697; Yu Andrew P, 2011, J Med Econ, V14, P315, DOI 10.3111/13696998.2011.576295	31	72	72	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e101228	10.1371/journal.pone.0101228	http://dx.doi.org/10.1371/journal.pone.0101228			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971791	Green Published, Green Submitted, gold			2022-12-27	WOS:000338512200106
J	Lisboa, FJG; Peres-Neto, PR; Chaer, GM; Jesus, ED; Mitchell, RJ; Chapman, SJ; Berbara, RLL				Goncalves Lisboa, Francy Junio; Peres-Neto, Pedro R.; Chaer, Guilherme Montandon; Jesus, Ederson da Conceicao; Mitchell, Ruth Joy; Chapman, Stephen James; Louro Berbara, Ricardo Luis			Much beyond Mantel: Bringing Procrustes Association Metric to the Plant and Soil Ecologist's Toolbox	PLOS ONE			English	Article							MICROBIAL COMMUNITY STRUCTURE; AMAZONIAN RAIN-FOREST; CO-INERTIA ANALYSIS; VEGETATION COMPOSITION; BACTERIAL COMMUNITY; FLORISTIC VARIATION; MYCORRHIZAL FUNGI; BETA DIVERSITY; ENVIRONMENT; CHEMISTRY	The correlation of multivariate data is a common task in investigations of soil biology and in ecology in general. Procrustes analysis and the Mantel test are two approaches that often meet this objective and are considered analogous in many situations especially when used as a statistical test to assess the statistical significance between multivariate data tables. Here we call the attention of ecologists to the advantages of a less familiar application of the Procrustean framework, namely the Procrustean association metric (a vector of Procrustean residuals). These residuals represent differences in fit between multivariate data tables regarding homologous observations (e. g., sampling sites) that can be used to estimate local levels of association (e. g., some groups of sites are more similar in their association between biotic and environmental features than other groups of sites). Given that in the Mantel framework, multivariate information is translated into a pairwise distance matrix, we lose the ability to contrast homologous data points across dimensions and data matrices after their fit. In this paper, we attempt to familiarize ecologists with the benefits of using these Procrustean residual differences to further gain insights about the processes underlying the association among multivariate data tables using real and hypothetical examples.	[Goncalves Lisboa, Francy Junio; Louro Berbara, Ricardo Luis] Univ Fed Rural Rio de Janeiro, Inst Agron, Dept Soil Sci, Seropedica, RJ, Brazil; [Peres-Neto, Pedro R.] Univ Quebec Montreal, Canada Res Chair Spatial Modelling & Biodivers, Quebec City, PQ, Canada; [Chaer, Guilherme Montandon; Jesus, Ederson da Conceicao] Embrapa Agrobiol, Seropedica, RJ, Brazil; [Goncalves Lisboa, Francy Junio; Mitchell, Ruth Joy; Chapman, Stephen James] James Hutton Inst, Aberdeen, Scotland	Instituto Agronomico de Campinas (IAC); Universidade Federal Rural do Rio de Janeiro (UFRRJ); University of Quebec; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); James Hutton Institute	Lisboa, FJG (corresponding author), Univ Fed Rural Rio de Janeiro, Inst Agron, Dept Soil Sci, Seropedica, RJ, Brazil.	agrolisboa@gmail.com	Mitchell, Ruth/F-4159-2010; Berbara, Ricardo L.L./F-6672-2012; berbara, ricardo l/AAE-4318-2020; Jesus, Ederson/AAC-5305-2019; Chaer, Guilherme Montandon/B-1241-2013; Chapman, Stephen James/B-3599-2010	Mitchell, Ruth/0000-0001-8151-2769; Berbara, Ricardo L.L./0000-0002-3649-9443; berbara, ricardo l/0000-0002-9133-7754; Chaer, Guilherme Montandon/0000-0003-0734-2866; Chapman, Stephen James/0000-0003-3397-3418; Peres Neto, Pedro/0000-0002-5629-8067	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [CNPq-563304/2010-3, 562955/2010-0]; Fundacao de Amparo a Pesquisa de Minas Gerais [FAPEMIG CRA-APQ-00001-11]; Inter-American Institute for Global Change Research [IAI-CRN II-021]; CAPES/EMBRAPA (Carbioma)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Inter-American Institute for Global Change Research; CAPES/EMBRAPA (Carbioma)	This work was carried out with the aid of a grant from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq-563304/2010-3 and 562955/2010-0), Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG CRA-APQ-00001-11), and the Inter-American Institute for Global Change Research (IAI-CRN II-021). Francy Lisboa greatly acknowledges a research scholarship from CAPES/EMBRAPA (Carbioma) and Dr. Beata Madari. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon R, 2008, OIKOS, V117, P1796, DOI 10.1111/j.0030-1299.2008.16987.x; Artz RRE, 2006, SOIL BIOL BIOCHEM, V38, P2958, DOI 10.1016/j.soilbio.2006.04.017; Burkle L, 2009, OIKOS, V118, P1816, DOI 10.1111/j.1600-0706.2009.17740.x; Castillo-Monroy AP, 2011, J VEG SCI, V22, P165, DOI 10.1111/j.1654-1103.2010.01236.x; Chaer GM, 2009, SOIL SCI SOC AM J, V73, P1327, DOI 10.2136/sssaj2008.0276; Dijksterhuis G. B., 1991, FOOD QUAL PREFER, V3, P67; DOLEDEC S, 1994, FRESHWATER BIOL, V31, P277, DOI 10.1111/j.1365-2427.1994.tb01741.x; Dray S, 2003, ECOSCIENCE, V10, P110, DOI 10.1080/11956860.2003.11682757; Dumbrell AJ, 2010, ISME J, V4, P337, DOI 10.1038/ismej.2009.122; Fitzsimons MS, 2008, OECOLOGIA, V158, P117, DOI 10.1007/s00442-008-1117-8; Gower J.C., 1971, MATH ARCHAEOLOGICAL, P138; Grayston SJ, 2004, APPL SOIL ECOL, V25, P63, DOI 10.1016/S0929-1393(03)00098-2; Griffith DA, 2006, ECOLOGY, V87, P2603, DOI 10.1890/0012-9658(2006)87[2603:SMIETF]2.0.CO;2; Hirst CN, 2007, DIVERS DISTRIB, V13, P361, DOI 10.1111/j.1472-4642.2007.00307.x; JACKSON DA, 1995, ECOSCIENCE, V2, P297, DOI 10.1080/11956860.1995.11682297; Jesus ED, 2009, ISME J, V3, P1004, DOI 10.1038/ismej.2009.47; Kang SH, 2004, SOIL SCI, V169, P55, DOI 10.1097/01.ss.0000112014.97541.ba; Kuehnelt-Leddihn ER, 2007, MENACE HERD PROCRUST; Landeiro VL, 2012, ECOL INDIC, V23, P366, DOI 10.1016/j.ecolind.2012.04.023; Legendre P, 2005, ECOL MONOGR, V75, P435, DOI 10.1890/05-0549; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Legendre P, 2012, NUMERICAL ECOLOGY, P516; Lisboa FJG, 2013, PLANT SOIL, V367, P551, DOI 10.1007/s11104-012-1491-1; MANTEL N, 1967, CANCER RES, V27, P209; Merila P, 2010, APPL SOIL ECOL, V46, P259, DOI 10.1016/j.apsoil.2010.08.003; Mitchell RJ, 2010, PLANT SOIL, V333, P417, DOI 10.1007/s11104-010-0357-7; Mitchell RJ, 2012, PLANT SOIL, V351, P355, DOI 10.1007/s11104-011-0968-7; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; Peixoto RS, 2010, ANTON LEEUW INT J G, V98, P403, DOI 10.1007/s10482-010-9454-0; Peres-Neto PR, 2001, OECOLOGIA, V129, P169, DOI 10.1007/s004420100720; Pomara LY, 2012, BIOTROPICA, V44, P545, DOI 10.1111/j.1744-7429.2011.00851.x; Poos MS, 2012, ECOL INDIC, V18, P82, DOI 10.1016/j.ecolind.2011.10.008; Poulsen AD, 2006, BIOTROPICA, V38, P468, DOI 10.1111/j.1744-7429.2006.00168.x; Powers JS, 2009, FOREST ECOL MANAG, V258, P959, DOI 10.1016/j.foreco.2008.10.036; Singh BK, 2006, EUR J SOIL SCI, V57, P72, DOI 10.1111/j.1365-2389.2005.00781.x; Singh BK, 2008, ENVIRON MICROBIOL, V10, P534, DOI 10.1111/j.1462-2920.2007.01474.x; Siqueira T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043626; TENBERGE JMF, 1993, BRIT J MATH STAT PSY, V46, P119; ter Braak CJF, 2004, ECOLOGY, V85, P834, DOI 10.1890/03-0021; Thioulouse J, 2004, ECOLOGY, V85, P272, DOI 10.1890/02-0605; Trivedi MR, 2008, BIOL CONSERV, V141, P1665, DOI 10.1016/j.biocon.2008.04.008; Tuomisto H, 2003, J ECOL, V91, P743, DOI 10.1046/j.1365-2745.2003.00802.x; Tuomisto H, 2003, ECOL APPL, V13, P352, DOI 10.1890/1051-0761(2003)013[0352:LFPWSH]2.0.CO;2; Tuomisto H, 2003, SCIENCE, V299, P241, DOI 10.1126/science.1078037; Tuomisto H, 2006, ECOLOGY, V87, P2697, DOI 10.1890/0012-9658(2006)87[2697:AOEBDU]2.0.CO;2; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; Vinten AJA, 2011, J MICROBIOL METH, V85, P190, DOI 10.1016/j.mimet.2011.03.001; Zheng YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063375	48	46	46	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e101238	10.1371/journal.pone.0101238	http://dx.doi.org/10.1371/journal.pone.0101238			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971901	gold, Green Published, Green Submitted			2022-12-27	WOS:000338512200107
J	Niikura, T; Kita, Y; Abe, Y				Niikura, Takako; Kita, Yoshiko; Abe, Yoichiro			SUMO3 Modification Accelerates the Aggregation of ALS-Linked SOD1 Mutants	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; GLUTAMATE TRANSPORTER EAAT2; SPINAL-CORD; PROTEIN SUMOYLATION; UBIQUITIN; NEURONS; TDP-43; IDENTIFICATION; MECHANISMS; INCLUSIONS	Mutations in superoxide dismutase 1 (SOD1) are a major cause of familial amyotrophic lateral sclerosis (ALS), whereby the mutant proteins misfold and aggregate to form intracellular inclusions. We report that both small ubiquitin-like modifier (SUMO) 1 and SUMO2/3 modify ALS-linked SOD1 mutant proteins at lysine 75 in a motoneuronal cell line, the cell type affected in ALS. In these cells, SUMO1 modification occurred on both lysine 75 and lysine 9 of SOD1, and modification of ALS-linked SOD1 mutant proteins by SUMO3, rather than by SUMO1, significantly increased the stability of the proteins and accelerated intracellular aggregate formation. These findings suggest the contribution of sumoylation, particularly by SUMO3, to the protein aggregation process underlying the pathogenesis of ALS.	[Niikura, Takako] Sophia Univ, Fac Sci & Technol, Dept Informat & Commun Sci, Tokyo 102, Japan; [Kita, Yoshiko; Abe, Yoichiro] Keio Univ, Sch Med, Dept Pharmacol, Tokyo 160, Japan	Sophia University; Keio University	Niikura, T (corresponding author), Sophia Univ, Fac Sci & Technol, Dept Informat & Commun Sci, Tokyo 102, Japan.	niikura@sophia.ac.jp	Abe, Yoichiro/J-5576-2013; Abe, Yoichiro/AAN-8801-2020	Abe, Yoichiro/0000-0001-6163-8794; Abe, Yoichiro/0000-0001-6163-8794	Japan Society for the Promotion of Science [15590908]; Keio Gijuku Academic Development funds	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Keio Gijuku Academic Development funds	This work was supported by grants from Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research (C) (15590908, http://www.jsps.go.jp) to TN and Keio Gijuku Academic Development funds (no number, http://www.med.keio.ac.jp/research/) to TN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bento-Abreu A, 2010, EUR J NEUROSCI, V31, P2247, DOI 10.1111/j.1460-9568.2010.07260.x; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Cimarosti H, 2012, J CEREBR BLOOD F MET, V32, P17, DOI 10.1038/jcbfm.2011.146; Datwyler AL, 2011, J CEREBR BLOOD F MET, V31, P2152, DOI 10.1038/jcbfm.2011.112; Dorval V, 2006, J BIOL CHEM, V281, P9919, DOI 10.1074/jbc.M510127200; Dorval V, 2007, BBA-MOL CELL RES, V1773, P694, DOI 10.1016/j.bbamcr.2007.03.017; Fei EK, 2006, BIOCHEM BIOPH RES CO, V347, P406, DOI 10.1016/j.bbrc.2006.06.092; Foran E, 2011, GLIA, V59, P1719, DOI 10.1002/glia.21218; Gibb SL, 2007, J BIOL CHEM, V282, P32480, DOI 10.1074/jbc.M704314200; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; Hay RT, 2007, TRENDS CELL BIOL, V17, P370, DOI 10.1016/j.tcb.2007.08.002; Huang C, 2009, EMBO J, V28, P2748, DOI 10.1038/emboj.2009.210; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Ling SC, 2013, NEURON, V79, P416, DOI 10.1016/j.neuron.2013.07.033; Liu DX, 1999, FASEB J, V13, P2318, DOI 10.1096/fasebj.13.15.2318; McFadden K, 2005, J NEUROPATH EXP NEUR, V64, P545, DOI 10.1093/jnen/64.6.545; Melchior F, 2000, ANNU REV CELL DEV BI, V16, P591, DOI 10.1146/annurev.cellbio.16.1.591; Nakamura T, 2012, EXP NEUROL, V238, P12, DOI 10.1016/j.expneurol.2012.06.032; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Obata Y, 2005, J NEUROSCI RES, V81, P720, DOI 10.1002/jnr.20594; Parakh S, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/408681; Pedrioli PGA, 2006, NAT METHODS, V3, P533, DOI 10.1038/NMETH891; Praefcke GJK, 2012, TRENDS BIOCHEM SCI, V37, P23, DOI 10.1016/j.tibs.2011.09.002; Renton AE, 2014, NAT NEUROSCI, V17, P17, DOI 10.1038/nn.3584; Rosas-Acosta G, 2005, MOL CELL PROTEOMICS, V4, P56, DOI 10.1074/mcp.M400149-MCP200; Rothstein JD, 2009, ANN NEUROL, V65, pS3, DOI 10.1002/ana.21543; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Sarge KD, 2011, INT REV CEL MOL BIO, V288, P167, DOI 10.1016/B978-0-12-386041-5.00004-2; Seyfried NT, 2010, MOL CELL PROTEOMICS, V9, P705, DOI 10.1074/mcp.M800390-MCP200; Shaw BF, 2007, TRENDS BIOCHEM SCI, V32, P78, DOI 10.1016/j.tibs.2006.12.005; SHAW PJ, 1995, ANN NEUROL, V38, P691, DOI 10.1002/ana.410380424; Sreedharan J, 2013, ANN NEUROL, V74, P309, DOI 10.1002/ana.24012; Su HL, 2002, GENE, V296, P65, DOI 10.1016/S0378-1119(02)00843-0; Tempe D, 2008, BIOCHEM SOC T, V36, P874, DOI 10.1042/BST0360874; Tohgi H, 1999, NEUROSCI LETT, V260, P204, DOI 10.1016/S0304-3940(98)00986-0; Van Deerlin VM, 2008, LANCET NEUROL, V7, P409, DOI 10.1016/S1474-4422(08)70071-1; Wang Z, 2013, SPINAL CORD, V51, P139, DOI 10.1038/sc.2012.100; Wilkinson KA, 2010, BIOCHEM J, V428, P133, DOI 10.1042/BJ20100158; Woo CH, 2010, CURR OPIN PHARMACOL, V10, P146, DOI 10.1016/j.coph.2009.12.001; Wykoff DD, 2005, MOL CELL PROTEOMICS, V4, P73, DOI 10.1074/mcp.M400166-MCP200; Zhou WD, 2004, J BIOL CHEM, V279, P32262, DOI 10.1074/jbc.M404173200	41	22	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e101080	10.1371/journal.pone.0101080	http://dx.doi.org/10.1371/journal.pone.0101080			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971881	Green Published, gold, Green Submitted			2022-12-27	WOS:000338512200090
J	Taylor, L; Vasudevan, SR; Jones, CI; Gibbins, JM; Churchill, GC; Campbell, RD; Coxon, CH				Taylor, Lewis; Vasudevan, Sridhar R.; Jones, Chris I.; Gibbins, Jonathan M.; Churchill, Grant C.; Campbell, R. Duncan; Coxon, Carmen H.			Discovery of Novel GPVI Receptor Antagonists by Structure-Based Repurposing	PLOS ONE			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; PLATELET GLYCOPROTEIN VI; END-POINT REDUCTION; CARDIOVASCULAR MORBIDITY; LOSARTAN INTERVENTION; DISEASE; AGGREGATION; ACTIVATION; ASPIRIN; STROKE	Inappropriate platelet aggregation creates a cardiovascular risk that is largely managed with thienopyridines and aspirin. Although effective, these drugs carry risks of increased bleeding and drug 'resistance', underpinning a drive for new antiplatelet agents. To discover such drugs, one strategy is to identify a suitable druggable target and then find small molecules that modulate it. A good and unexploited target is the platelet collagen receptor, GPVI, which promotes thrombus formation. To identify inhibitors of GPVI that are safe and bioavailable, we docked a FDA-approved drug library into the GPVI collagen-binding site in silico. We now report that losartan and cinanserin inhibit GPVI-mediated platelet activation in a selective, competitive and dose-dependent manner. This mechanism of action likely underpins the cardioprotective effects of losartan that could not be ascribed to its antihypertensive effects. We have, therefore, identified small molecule inhibitors of GPVI-mediated platelet activation, and also demonstrated the utility of structure-based repurposing.	[Taylor, Lewis; Campbell, R. Duncan; Coxon, Carmen H.] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; [Vasudevan, Sridhar R.; Churchill, Grant C.] Univ Oxford, Dept Pharmacol, Oxford, England; [Jones, Chris I.; Gibbins, Jonathan M.] Univ Reading, Sch Biol Sci, Inst Cardiovasc & Metab Res, Reading, Berks, England	University of Oxford; University of Oxford; University of Reading	Coxon, CH (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Le Gros Clark Bldg,South Pk Rd, Oxford, England.	carmen.coxon@imm.ox.ac.uk	Vasudevan, Sridhar/B-1841-2015	Vasudevan, Sridhar/0000-0003-0516-2984; Jones, Chris/0000-0001-7537-1509; Gibbins, Jonathan/0000-0002-0372-5352	BHF Centre for Research Excellence (Oxford) [RE/08/004]; BHF [RG/05/007]; Biotechnology and Biological Sciences Research Council [BB/G008523/1] Funding Source: researchfish; British Heart Foundation [RG/09/011/28094] Funding Source: researchfish; BBSRC [BB/G008523/1] Funding Source: UKRI	BHF Centre for Research Excellence (Oxford); BHF(British Heart Foundation); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the BHF Centre for Research Excellence (Oxford), grant number: RE/08/004 and the BHF, grant number RG/05/007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Tamimi M, 2012, BLOOD, V119, P4311, DOI 10.1182/blood-2011-10-386607; Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Ballester PJ, 2012, J R SOC INTERFACE; Belhassen L, 2003, J AM COLL CARDIOL, V41, P1198, DOI 10.1016/S0735-1097(03)00048-2; BHF, 2009, BHF COR HEART DIS ST; Bostrom J, 2003, J MOL GRAPH MODEL, V21, P449, DOI 10.1016/S1093-3263(02)00204-8; Bousser MG, 2011, LANCET, V377, P2013, DOI 10.1016/S0140-6736(11)60600-4; Chen LL, 2005, J VIROL, V79, P7095, DOI 10.1128/JVI.79.11.7095-7103.2005; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Feher G, 2009, CLIN GENET, V75, P1, DOI 10.1111/j.1399-0004.2008.01105.x; Franchini M, 2009, EUR J INTERN MED, V20, P733, DOI 10.1016/j.ejim.2009.09.005; Gibbins JM, 2004, J CELL SCI, V117, P3415, DOI 10.1242/jcs.01325; Gibbins JM, 1997, FEBS LETT, V413, P255, DOI 10.1016/S0014-5793(97)00926-5; Goebel S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066960; Grothusen C, 2007, ARTERIOSCL THROM VAS, V27, P1184, DOI 10.1161/ATVBAHA.106.138693; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guerra JI, 2000, REV ESP CARDIOL, V53, P525, DOI 10.1016/S0300-8932(00)75123-2; Horii K, 2006, BLOOD, V108, P936, DOI 10.1182/blood-2006-01-010215; Huang RL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001862; Julius S, 2004, LANCET, V363, P2022, DOI 10.1016/S0140-6736(04)16451-9; Katritch V, 2010, J MED CHEM, V53, P1799, DOI 10.1021/jm901647p; Kehoe PG, 2012, J ALZHEIMERS DIS, V30, pS251, DOI 10.3233/JAD-2012-111376; Kjeldsen SE, 2002, JAMA-J AM MED ASSOC, V288, P1491, DOI 10.1001/jama.288.12.1491; Kleinschnitz C, 2007, CIRCULATION, V115, P2323, DOI 10.1161/CIRCULATIONAHA.107.691279; Konstam MA, 2009, LANCET, V374, P1840, DOI 10.1016/S0140-6736(09)61913-9; Lepantalo A, 2006, THROMB HAEMOSTASIS, V95, P253, DOI 10.1160/TH05-07-0516; Lindholm LH, 2002, LANCET, V359, P1004, DOI 10.1016/S0140-6736(02)08090-X; Maree AO, 2005, J THROMB HAEMOST, V3, P2340, DOI 10.1111/j.1538-7836.2005.01555.x; Massberg S, 2003, FASEB J, V17, P397, DOI 10.1096/f.03-0464.fje; McGann M, 2011, J CHEM INF MODEL, V51, P578, DOI 10.1021/ci100436p; Michelson AD, 2010, NAT REV DRUG DISCOV, V9, P154, DOI 10.1038/nrd2957; Mizushima T, 2011, J BIOCHEM, V149, P499, DOI 10.1093/jb/mvr032; Murad JP, 2012, J CARDIOVASC PHARM T, V17, P308, DOI 10.1177/1074248411425491; Murad JP, 2011, J CARDIOVASC PHARM T; Muzard J, 2009, FEBS J, V276, P4207, DOI 10.1111/j.1742-4658.2009.07129.x; NIH, 2012, RESC REP DRUGS; O'Connor MN, 2006, J THROMB HAEMOST, V4, P869, DOI 10.1111/j.1538-7836.2005.01764.x; O'Donnell CJ, 2001, CIRCULATION, V103, P3051, DOI 10.1161/01.CIR.103.25.3051; Ono K, 2010, J MED CHEM, V53, P2087, DOI 10.1021/jm901534d; Poole A, 1997, EMBO J, V16, P2333, DOI 10.1093/emboj/16.9.2333; Pugh N, 2010, BLOOD, V115, P5069, DOI 10.1182/blood-2010-01-260778; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Shoichet BK, 2004, NATURE, V432, P862, DOI 10.1038/nature03197; Shoichet BK, 2006, DRUG DISCOV TODAY, V11, P607, DOI 10.1016/j.drudis.2006.05.014; Smethurst PA, 2004, BLOOD, V103, P903, DOI 10.1182/blood-2003-01-0308; Sollier CBD, 2009, CEREBROVASC DIS, V28, P505, DOI 10.1159/000236915; Stoll G, 2008, BLOOD, V112, P3555, DOI 10.1182/blood-2008-04-144758; Ungerer M, 2011, CIRCULATION, V123, P1891, DOI 10.1161/CIRCULATIONAHA.110.980623; Varenhorst C, 2009, EUR HEART J, V30, P1744, DOI 10.1093/eurheartj/ehp157; Yang QG, 2008, CHEM PHARM BULL, V56, P1400, DOI 10.1248/cpb.56.1400; Yeung J, 2012, J BLOOD MED, V3, P33, DOI 10.2147/JBM.S25421	51	20	23	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e101209	10.1371/journal.pone.0101209	http://dx.doi.org/10.1371/journal.pone.0101209			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971515	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000338512200103
J	Achhra, AC; Boyd, MA; Law, MG; Matthews, GV; Kelleher, AD; Cooper, DA				Achhra, Amit C.; Boyd, Mark A.; Law, Matthew G.; Matthews, Gail V.; Kelleher, Anthony D.; Cooper, David A.			Moving Away from Ritonavir, Abacavir, Tenofovir, and Efavirenz (RATE) - Agents That Concern Prescribers and Patients: A Feasibility Study and Call for a Trial	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; BOOSTED-PROTEASE INHIBITOR; PLUS RALTEGRAVIR; ANTIRETROVIRAL TREATMENT; SPARING REGIMEN; VIROLOGICAL SUPPRESSION; HIV-1-INFECTED PATIENTS; RANDOMIZED-TRIAL; SALVAGE THERAPY; DUAL THERAPY	Objectives: Regimens sparing RATE (ritonavir, abacavir, tenofovir, efavirienz) agents might have better long-term safety. We conducted a feasibility exercise to assess the potential for a randomised trial evaluating RATE-sparing regimens. Design: Observational. Methods: We first calculated RATE-sparing options available to an average patient receiving RATE agents. We reviewed treatment history and all resistance assays from patients attending the St. Vincent's Hospital (Sydney) clinic and receiving >= 2 RATE agents (n = 120). A viable RATE-sparing regimen with 2 or 3 fully-active agents was constructed from the following six 'safer' agents: rilpivirine or etravirine; atazanavir; raltegravir; maraviroc; and lamivudine. Activity for each drug was predicted as 1 (full-activity), 0.5 or 0 (no activity) using the Stanford mutation database. The utility of maraviroc was calculated assuming both maraviroc activity and inactivity where unknown. The analysis was restricted to regimens for which supporting evidence was identified in the literature or conference proceedings. Finally, we calculated the proportion of patients in the nationally representative Australian HIV Observational Database (AHOD) cohort receiving >= 2 RATE agents (n = 1473) to measure the potential population-level uptake of RATE-sparing agents. Results: Assuming full maraviroc activity, 117(97.5%) and 107(89.2%) individuals had at least one option with 2 or 3 active RATE-sparing agents, respectively. Assuming no maraviroc activity this decreased to 113(94.2%) and 104(86.7%), respectively. In AHOD, 837(56.8%) patients were receiving >= 2 RATE agents. Conclusion: Feasible treatment switch options sparing RATE agents exist for the majority of patients. Understanding the pros and cons of switching stable patients onto new RATE-sparing regimens requires evidence derived from randomised controlled trials.	[Achhra, Amit C.; Boyd, Mark A.; Law, Matthew G.; Matthews, Gail V.; Kelleher, Anthony D.; Cooper, David A.] UNSW Australia, Kirby Inst, Sydney, NSW, Australia	University of New South Wales Sydney; Kirby Institute	Achhra, AC (corresponding author), UNSW Australia, Kirby Inst, Sydney, NSW, Australia.	aachhra@kirby.unsw.edu.au	matthews, gail/AAG-8626-2022; matthews, gail/AFL-8501-2022	Matthews, Gail/0000-0002-1048-6396; Law, Matthew/0000-0002-3540-8837; Boyd, Mark/0000-0002-6848-3307	Gilead Australia Fellowship awarded; Asia Pacific HIV Observational Database; Foundation for AIDS Research; amfAR; U.S. National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIAID) [U01-AI069907]; Merck Sharp Dohme; Gilead Sciences; Bristol-Myers Squibb; Boehringer Ingelheim; ViiV Australia; Janssen-Cilag; Australian Government Department of Health and Ageing; Faculty of Medicine; University of New South Wales; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069907] Funding Source: NIH RePORTER	Gilead Australia Fellowship awarded; Asia Pacific HIV Observational Database; Foundation for AIDS Research; amfAR; U.S. National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Merck Sharp Dohme(Merck & Company); Gilead Sciences(Gilead Sciences); Bristol-Myers Squibb(Bristol-Myers Squibb); Boehringer Ingelheim(Boehringer Ingelheim); ViiV Australia; Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); Faculty of Medicine; University of New South Wales; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project was funded by the Gilead Australia Fellowship awarded to Amit C Achhra. The Australian HIV Observational Database is funded as part of the Asia Pacific HIV Observational Database, a program of The Foundation for AIDS Research, amfAR, and is supported in part by a grant from the U.S. National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIAID) (Grant No. U01-AI069907) and by unconditional grants from Merck Sharp & Dohme; Gilead Sciences; Bristol-Myers Squibb; Boehringer Ingelheim; ViiV Australia; Janssen-Cilag. The Kirby Institute is funded by the Australian Government Department of Health and Ageing, and is affiliated with the Faculty of Medicine, The University of New South Wales. The content of this publication is solely the responsibility of the authors and does not necessarily represent the official views of any of the institutions mentioned above. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach CJ, 2011, FUTURE VIROL, V6, P157, DOI 10.2217/FVL.10.89; Achhra AC, 2013, AIDS RES THER, V10, DOI 10.1186/1742-6405-10-33; Allavena C, 2009, HIV CLIN TRIALS, V10, P337, DOI 10.1310/hct1005-337; Australian HIV Observational Database, 2002, HIV Med, V3, P28; Bedimo R, 2011, RADAR STUDY RALTEGRA; Boyd MA, 2013, LANCET, V381, P2091, DOI 10.1016/S0140-6736(13)61164-2; Cahn P, 2013, 14 EUR AIDS C BRUSS; Calin R, 2013, 7 INT AIDS SOC C HIV; Calza L, 2012, HIV CLIN TRIALS, V13, P189, DOI 10.1310/hct1304-189; Carey D, 2012, JAIDS-J ACQ IMM DEF, V60, P143, DOI 10.1097/QAI.0b013e318252f97e; Carr A, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001240; Casado JL, 2013, AIDS RES HUM RETROV, V29, P588, DOI 10.1089/aid.2012.0280; Choi AI, 2011, AIDS, V25, P1289, DOI 10.1097/QAD.0b013e328347fa16; Ciccarelli N, 2011, NEUROLOGY, V76, P1403, DOI 10.1212/WNL.0b013e31821670fb; Cordery DV, 2010, ANTIVIR THER, V15, P1035, DOI 10.3851/IMP1647; Costagliola Dominique, 2010, Curr HIV/AIDS Rep, V7, P127, DOI 10.1007/s11904-010-0047-3; Cotte L, 2013, IAS 2013 KAUL LUMP M; D argolis, 2014, 21 C RETR OPP INF BO; Di Giambenedetto S, 2013, J ANTIMICROB CHEMOTH, V68, P1364, DOI 10.1093/jac/dkt007; Gazzard B, 2011, AIDS, V25, P2249, DOI 10.1097/QAD.0b013e32834c4c06; Gupta Shaili, 2009, J Int Assoc Physicians AIDS Care (Chic), V8, P87, DOI 10.1177/1545109709332471; Hill A, 2009, HIV MED, V10, P527, DOI 10.1111/j.1468-1293.2009.00724.x; Imaz A, 2011, J ANTIMICROB CHEMOTH, V66, P358, DOI 10.1093/jac/dkq432; Imaz A, 2009, JAIDS-J ACQ IMM DEF, V52, P382, DOI 10.1097/QAI.0b013e3181b17f53; Jansen A, 2013, HIV MED, V14, P449, DOI 10.1111/hiv.12029; Katlama C, 2014, J ANTIMICROB CHEMOTH; Kozal MJ, 2012, HIV CLIN TRIALS, V13, P119, DOI 10.1310/hct1303-119; Mills A, 2013, JAIDS-J ACQ IMM DEF, V62, P164, DOI 10.1097/QAI.0b013e31827b51b5; Monteiro P, 2014, J ANTIMICROB CHEMOTH, V69, P742, DOI 10.1093/jac/dkt406; Nozza S, 2011, JAIDS-J ACQ IMM DEF, V56, pE113, DOI 10.1097/QAI.0b013e31820a9ae4; Ofotokun I, 2012, AIDS RES HUM RETROV, V28, P1196, DOI 10.1089/aid.2011.0336; Orrell C, 2013, ETRAVIRINE 200 MG TW; Paton N, 2013, 7 IAS C HIV PATH TRE; Raffi F, 2014, 21 C RETR OPP INF BO; Squires KE, 2012, HIV CLIN TRIALS, V13, P233, DOI 10.1310/hct1305-233; Stanford University, 2013, HIV DRUG RES DAT HIV; Taiwo B, 2011, AIDS, V25, P2113, DOI 10.1097/QAD.0b013e32834bbaa9; Taiwo B, 2010, DRUGS, V70, P1629, DOI 10.2165/11538020-000000000-00000; Tashima K, 2013, 20 C RETR OPP INF AT; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Tu E, 2013, J CLIN MICROBIOL, V51, P2063, DOI 10.1128/JCM.00510-13; van Leth F, 2004, PLOS MED, V1, P64, DOI 10.1371/journal.pmed.0010019; Ward DJ, 2013, 53 INT C ANT AG CHEM; Wilkin TJ, 2009, J INFECT DIS, V199, P866, DOI 10.1086/597119	44	3	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e99530	10.1371/journal.pone.0099530	http://dx.doi.org/10.1371/journal.pone.0099530			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968324	Green Submitted, Green Published, gold			2022-12-27	WOS:000338280800013
J	Baig, SA; Sheng, TT; Sun, C; Xue, XQ; Tan, LS; Xu, XH				Baig, Shams Ali; Sheng, TianTian; Sun, Chen; Xue, XiaoQin; Tan, LiSha; Xu, XinHua			Arsenic Removal from Aqueous Solutions Using Fe3O4-HBC Composite: Effect of Calcination on Adsorbents Performance	PLOS ONE			English	Article							METAL-IONS; MECHANICAL-PROPERTIES; CONTAMINATED WATER; ADSORPTION; IRON; SORPTION; TEMPERATURE; OXIDE; NANOPARTICLES; MAGNETITE	The presence of elevated concentration of arsenic in water sources is considered to be health hazard globally. Calcination process is known to change the surface efficacy of the adsorbent. In current study, five adsorbent composites: uncalcined and calcined Fe3O4-HBC prepared at different temperatures (400 degrees C and 1000 degrees C) and environment (air and nitrogen) were investigated for the adsorptive removal of As(V) and As(III) from aqueous solutions determining the influence of solution's pH, contact time, temperature, arsenic concentration and phosphate anions. Characterizations from FTIR, XRD, HT-XRD, BET and SEM analyses revealed that the Fe3O4-HBC composite at higher calcination temperature under nitrogen formed a new product (fayalite, Fe2SiO4) via phase transformation. In aqueous medium, ligand exchange between arsenic and the effective sorbent site (=FeOOH) was established from the release of hydroxyl group. Langmuir model suggested data of the five adsorbent composites follow the order: Fe3O4-HBC-1000 degrees C(N-2)>Fe3O4-HBC (uncalcined)>Fe3O4-HBC-400 degrees C(N-2)>Fe3O4-HBC-400 degrees C(air)>Fe3O4-HBC-1000 degrees C(air) and the maximum As(V) and As(III) adsorption capacities were found to be about 3.35 mg g(-1) and 3.07 mg g(-1), respectively. The adsorption of As(V) and As(III) remained stable in a wider pH range (4-10) using Fe3O4-HBC-1000 degrees C(N-2). Additionally, adsorption data fitted well in pseudo-second-order (R-2>0.99) rather than pseudo-first-order kinetics model. The adsorption of As(V) and As(III) onto adsorbent composites increase with increase in temperatures indicating that it is an endothermic process. Phosphate concentration (0.01 mM or higher) strongly inhibited As(V) and As(III) removal through the mechanism of competitive adsorption. This study suggests that the selective calcination process could be useful to improve the adsorbent efficiency for enhanced arsenic removal from contaminated water.	[Baig, Shams Ali; Sheng, TianTian; Sun, Chen; Xue, XiaoQin; Tan, LiSha; Xu, XinHua] Zhejiang Univ, Coll Environm & Resource Sci, Dept Environm Engn, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Xu, XH (corresponding author), Zhejiang Univ, Coll Environm & Resource Sci, Dept Environm Engn, Hangzhou 310003, Zhejiang, Peoples R China.	xuxinhua@zju.edu.cn	Xu, Xinhua/ABG-6289-2021	Xu, Xinhua/0000-0001-7139-1246	National Natural Science Foundation [21277119]; Science and Technology Project of Zhejiang Province, China [2012C23061]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Science and Technology Project of Zhejiang Province, China	The authors acknowledge the financial support of the National Natural Science Foundation (No. 21277119) and the Science and Technology Project of Zhejiang Province, China (No. 2012C23061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badruzzaman M, 2004, WATER RES, V38, P4002, DOI 10.1016/j.watres.2004.07.007; Baig SA, 2015, CLEAN-SOIL AIR WATER, V43, P13, DOI 10.1002/clen.201200466; Baig SA, 2013, ECOL ENG, V60, P345, DOI 10.1016/j.ecoleng.2013.09.001; Chandra V, 2010, ACS NANO, V4, P3979, DOI 10.1021/nn1008897; Chowdhury SR, 2010, J ENVIRON MANAGE, V91, P2238, DOI 10.1016/j.jenvman.2010.06.003; Diaz-Parralejo A, 2010, J NON-CRYST SOLIDS, V356, P175, DOI 10.1016/j.jnoncrysol.2009.11.007; Feng LY, 2012, J HAZARD MATER, V217, P439, DOI 10.1016/j.jhazmat.2012.03.073; Gerente C, 2010, CHEM ENG J, V158, P593, DOI 10.1016/j.cej.2010.02.005; Goldberg S, 2002, SOIL SCI SOC AM J, V66, P413, DOI 10.2136/sssaj2002.0413; Gupta K, 2012, J COLLOID INTERF SCI, V377, P269, DOI 10.1016/j.jcis.2012.01.066; Haarhoff J, 2010, WATER SA, V36, P97; Hering JG, 1996, J AM WATER WORKS ASS, V88, P155; Ho YS, 2000, WATER RES, V34, P735, DOI 10.1016/S0043-1354(99)00232-8; Ho YS, 2004, SCIENTOMETRICS, V59, P171, DOI 10.1023/B:SCIE.0000013305.99473.cf; Ho YS, 2002, PROCESS BIOCHEM, V37, P1421, DOI 10.1016/S0032-9592(02)00036-5; Johnson MC, 2007, MAT SCI ENG A-STRUCT, V456, P58, DOI 10.1016/j.msea.2006.11.106; Katsoyiannis IA, 2002, WATER RES, V36, P5141, DOI 10.1016/S0043-1354(02)00236-1; Kolodynska D, 2012, CHEM ENG J, V197, P295, DOI 10.1016/j.cej.2012.05.025; Kurtoglu ME, 2011, J AM CERAM SOC, V94, P1101, DOI 10.1111/j.1551-2916.2010.04218.x; Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004; Luo XB, 2012, CHEM ENG J, V187, P45, DOI 10.1016/j.cej.2012.01.073; Mahmood T, 2012, CHEM ENG J, V192, P90, DOI 10.1016/j.cej.2012.03.048; McNeill LS, 1997, J AM WATER WORKS ASS, V89, P75; Meng XG, 2002, TOXICOL LETT, V133, P103, DOI 10.1016/S0378-4274(02)00080-2; Michel R, 2013, CERAM INT, V39, P5287, DOI 10.1016/j.ceramint.2012.12.031; Mohan D, 2007, J HAZARD MATER, V142, P1, DOI 10.1016/j.jhazmat.2007.01.006; Mucke A, 2003, J AFR EARTH SCI, V36, P55, DOI 10.1016/S0899-5362(03)00015-0; Rehman K, 2012, METALLOMICS, V4, P881, DOI 10.1039/c2mt00181k; Sakthivel R, 2011, POWDER TECHNOL, V208, P747, DOI 10.1016/j.powtec.2011.01.010; Seco-Reigosa N, 2013, ENVIRON SCI POLLUT R, P1; Shahar A, 2008, EARTH PLANET SC LETT, V268, P330, DOI 10.1016/j.epsl.2008.01.026; Shan C, 2013, WATER RES, V47, P3411, DOI 10.1016/j.watres.2013.03.035; Sheng TT, 2014, ARAB J CHEM, V7, P27, DOI 10.1016/j.arabjc.2013.05.032; Tian Y, 2011, J HAZARD MATER, V193, P10, DOI 10.1016/j.jhazmat.2011.04.093; WEBER TW, 1974, AICHE J, V20, P228, DOI 10.1002/aic.690200204; Weng CH, 2013, ULTRASON SONOCHEM, V20, P970, DOI 10.1016/j.ultsonch.2012.09.014; Wu K, 2013, CHEM ENG J, V226, P393, DOI 10.1016/j.cej.2013.04.076; Yue X, 2011, J HAZARD MATER, V190, P553, DOI 10.1016/j.jhazmat.2011.03.076; Zhang M, 2013, BIORESOURCE TECHNOL, V130, P457, DOI 10.1016/j.biortech.2012.11.132; Zhang W, 2004, MINER ENG, V17, P517, DOI 10.1016/j.mineng.2003.11.020	40	41	43	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100704	10.1371/journal.pone.0100704	http://dx.doi.org/10.1371/journal.pone.0100704			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967645	Green Submitted, gold, Green Published			2022-12-27	WOS:000338280800055
J	Chen, CJ; Huang, YC; Su, LH; Wu, TL; Huang, SH; Chien, CC; Chen, PY; Lu, MC; Ko, WC				Chen, Chih-Jung; Huang, Yhu-Chering; Su, Lin-Hui; Wu, Tsu-Lan; Huang, Shu-Huan; Chien, Chun-Chih; Chen, Po-Yen; Lu, Min-Chi; Ko, Wen-Chien			Molecular Epidemiology and Antimicrobial Resistance of Methicillin-Resistant Staphylococcus aureus Bloodstream Isolates in Taiwan, 2010	PLOS ONE			English	Article							RAPID IDENTIFICATION; COMMUNITY; INFECTIONS; MRSA; MEC; VIRULENCE; CHILDREN; SPREAD	The information of molecular characteristics and antimicrobial susceptibility pattern of methicillin-resistant Staphylococcus aureus (MRSA) is essential for control and treatment of diseases caused by this medically important pathogen. A total of 577 clinical MRSA bloodstream isolates from six major hospitals in Taiwan were determined for molecular types, carriage of Panton-Valentine leukocidin (PVL) and sasX genes and susceptibilities to 9 non-beta-lactam antimicrobial agents. A total of 17 genotypes were identified in 577 strains by pulsotyping. Five major pulsotypes, which included type A (26.2%, belonging to sequence type (ST) 239, carrying type III staphylococcal chromosomal cassette mec (SCCmec), type F (18.9%, ST5-SCCmecII), type C (18.5%, ST59-SCCmecIV), type B (12.0%, ST239-SCCmecIII) and type D (10.9%, ST59-SCCmecV(T)/IV), prevailed in each of the six sampled hospitals. PVL and sasX genes were respectively carried by ST59-type D strains and ST239 strains with high frequencies (93.7% and 99.1%, respectively) but rarely detected in strains of other genotypes. Isolates of different genotypes and from different hospitals exhibited distinct antibiograms. Multi-resistance to >= 3 non-beta- lactams was more common in ST239 isolates (100%) than in ST59 isolates (97.2%, P = 0.0347) and ST59 isolates (8.2%, P < 0.0001). Multivariate analysis further indicated that the genotype, but not the hospital, was an independent factor associated with muti-resistance of the MRSA strains. In conclusion, five common MRSA clones with distinct antibiograms prevailed in the major hospitals in Taiwan in 2010. The antimicrobial susceptibility pattern of invasive MRSA was mainly determined by the clonal distribution.	[Chen, Chih-Jung; Huang, Yhu-Chering] Chang Gung Mem Hosp Linkou, Div Pediat Infect Dis, Taoyuan, Taiwan; [Chen, Chih-Jung; Huang, Yhu-Chering] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Su, Lin-Hui; Wu, Tsu-Lan] Chang Gung Mem Hosp Linkou, Dept Lab Med, Taoyuan, Taiwan; [Huang, Shu-Huan] Chang Gung Mem Hosp, Dept Lab Med, Keelung, Taiwan; [Chien, Chun-Chih] Chang Gung Mem Hosp, Dept Lab Med, Kaohsiung, Taiwan; [Chen, Po-Yen] Taichung Vet Gen Hosp, Dept Pediat, Taichung, Taiwan; [Lu, Min-Chi] Chung Shan Med Univ Hosp, Dept Med, Taichung, Taiwan; [Ko, Wen-Chien] Natl Cheng Kung Univ Hosp, Dept Med, Tainan 70428, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Taichung Veterans General Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; National Cheng Kung University; National Cheng Kung University Hospital	Huang, YC (corresponding author), Chang Gung Mem Hosp Linkou, Div Pediat Infect Dis, Taoyuan, Taiwan.	ychuang@adm.cgmh.org.tw	Ko, Wen-Chien/ABG-4316-2020	Ko, Wen-Chien/0000-0001-7497-149X	Chang Gung Memorial Hospital [CMRPG 490132]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was supported by grants from Chang Gung Memorial Hospital (CMRPG 490132). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1961, BMJ-BRIT MED J, V1, P113; Ayliffe GAJ, 1997, CLIN INFECT DIS, V24, pS74, DOI 10.1093/clinids/24.Supplement_1.S74; Boyce JM, 1998, JAMA-J AM MED ASSOC, V279, P623, DOI 10.1001/jama.279.8.623; Boyle-Vavra S, 2005, J CLIN MICROBIOL, V43, P4719, DOI 10.1128/JCM.43.9.4719-4730.2005; CAFFERKEY MT, 1985, LANCET, V2, P705; CHANG S-C, 1988, Taiwan yixuehui zazhi, V87, P157; Chang SC, 1997, INT J ANTIMICROB AG, V8, P109, DOI 10.1016/S0924-8579(96)00360-3; Chen CB, 2010, J HOSP INFECT, V74, P238, DOI 10.1016/j.jhin.2009.10.026; Chen CJ, 2009, DIAGN MICR INFEC DIS, V65, P199, DOI 10.1016/j.diagmicrobio.2009.05.020; Chen CJ, 2005, PEDIATR INFECT DIS J, V24, P40, DOI 10.1097/01.inf.0000148926.11227.1c; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; de Sousa MA, 2004, FEMS IMMUNOL MED MIC, V40, P101, DOI 10.1016/S0928-8244(03)00370-5; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Denis O, 2009, J ANTIMICROB CHEMOTH, V64, P1299, DOI 10.1093/jac/dkp345; Grim SA, 2005, PHARMACOTHERAPY, V25, P253, DOI 10.1592/phco.25.2.253.56956; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Ho PL, 2009, DIAGN MICR INFEC DIS, V64, P131, DOI 10.1016/j.diagmicrobio.2009.01.030; Hsueh PR, 2002, EMERG INFECT DIS, V8, P132; Huang YC, 2008, CLIN MICROBIOL INFEC, V14, P1167, DOI 10.1111/j.1469-0691.2008.02115.x; Huang YH, 2007, CLIN MICROBIOL INFEC, V13, P717, DOI 10.1111/j.1469-0691.2007.01718.x; Huang YC, 2004, J CLIN MICROBIOL, V42, P307, DOI 10.1128/JCM.42.1.307-310.2004; Huang YC, 2011, INT J ANTIMICROB AG, V38, P2, DOI 10.1016/j.ijantimicag.2011.01.011; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Li M, 2012, NAT MED, V18, P816, DOI 10.1038/nm.2692; Li M, 2009, P NATL ACAD SCI USA, V106, P5883, DOI 10.1073/pnas.0900743106; Liu C, 2011, CLIN INFECT DIS, V53, P319, DOI [10.1093/cid/cir353, 10.1093/cid/ciq146]; Martinez-Aguilar G, 2003, PEDIATR INFECT DIS J, V22, P593, DOI 10.1097/00006454-200307000-00006; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; Oliveira DC, 2002, ANTIMICROB AGENTS CH, V46, P2155, DOI 10.1128/AAC.46.7.2155-2161.2002; Otto M, 2012, VIRULENCE, V3, P521, DOI 10.4161/viru.21523; Otto M, 2011, NAT MED, V17, P169, DOI 10.1038/nm0211-169; PAVILLARD R, 1982, MED J AUSTRALIA, V1, P451, DOI 10.5694/j.1326-5377.1982.tb132413.x; Regev-Yochay G, 2005, EMERG INFECT DIS, V11, P453, DOI 10.3201/eid1103.040470; Seybold U, 2006, CLIN INFECT DIS, V42, P647, DOI 10.1086/499815; Witte Wolfgang, 1997, Clin Microbiol Infect, V3, P414, DOI 10.1111/j.1469-0691.1997.tb00277.x; Wu Kun-Chan, 2002, Journal of Microbiology Immunology and Infection, V35, P53; Zetola N, 2005, LANCET INFECT DIS, V5, P275, DOI 10.1016/S1473-3099(05)70112-2	37	22	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e101184	10.1371/journal.pone.0101184	http://dx.doi.org/10.1371/journal.pone.0101184			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967822	Green Published, Green Submitted, gold			2022-12-27	WOS:000338280800117
J	Choe, R; Putt, ME; Carlile, PM; Durduran, T; Giammarco, JM; Busch, DR; Jung, KW; Czerniecki, BJ; Tchou, J; Feldman, MD; Mies, C; Rosen, MA; Schnall, MD; DeMichele, A; Yodh, AG				Choe, Regine; Putt, Mary E.; Carlile, Peter M.; Durduran, Turgut; Giammarco, Joseph M.; Busch, David R.; Jung, Ki Won; Czerniecki, Brian J.; Tchou, Julia; Feldman, Michael D.; Mies, Carolyn; Rosen, Mark A.; Schnall, Mitchell D.; DeMichele, Angela; Yodh, Arjun G.			Optically Measured Microvascular Blood Flow Contrast of Malignant Breast Tumors	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; NEOADJUVANT CHEMOTHERAPY RESPONSE; PRIMARY MEDICAL THERAPY; COLOR DOPPLER; GLUCOSE-METABOLISM; CANCER; SPECTROSCOPY; MAMMOGRAPHY; OXYGEN; BENIGN	Microvascular blood flow contrast is an important hemodynamic and metabolic parameter with potential to enhance in vivo breast cancer detection and therapy monitoring. Here we report on non-invasive line-scan measurements of malignant breast tumors with a hand-held optical probe in the remission geometry. The probe employs diffuse correlation spectroscopy (DCS), a near-infrared optical method that quantifies deep tissue microvascular blood flow. Tumor-to-normal perfusion ratios are derived from thirty-two human subjects. Mean (95% confidence interval) tumor-to-normal ratio using surrounding normal tissue was 2.25 (1.92-2.63); tumor-to-normal ratio using normal tissues at the corresponding tumor location in the contralateral breast was 2.27 (1.94-2.66), and using normal tissue in the contralateral breast was 2.27 (1.90-2.70). Thus, the mean tumor-to-normal ratios were significantly different from unity irrespective of the normal tissue chosen, implying that tumors have significantly higher blood flow than normal tissues. Therefore, the study demonstrates existence of breast cancer contrast in blood flow measured by DCS. The new, optically accessible cancer contrast holds potential for cancer detection and therapy monitoring applications, and it is likely to be especially useful when combined with diffuse optical spectroscopy/tomography.	[Choe, Regine; Carlile, Peter M.; Jung, Ki Won] Univ Rochester, Dept Biomed Engn, Rochester, NY 14627 USA; [Putt, Mary E.] Univ Penn, Dept Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Durduran, Turgut] ICFO Inst Ciencies Foton, Castelldefels, Barcelona, Spain; [Giammarco, Joseph M.] Eastern Univ, Dept Phys & Astron, St Davids, PA USA; [Busch, David R.; Yodh, Arjun G.] Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA; [Busch, David R.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Czerniecki, Brian J.; Tchou, Julia] Hosp Univ Penn, Dept Surg, Philadelphia, PA 19104 USA; [Feldman, Michael D.; Mies, Carolyn] Hosp Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Rosen, Mark A.; Schnall, Mitchell D.] Hosp Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA; [DeMichele, Angela] Hosp Univ Penn, Dept Med Hematol Oncol, Philadelphia, PA 19104 USA	University of Rochester; University of Pennsylvania; Barcelona Institute of Science & Technology; Universitat Politecnica de Catalunya; Institut de Ciencies Fotoniques (ICFO); University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Choe, R (corresponding author), Univ Rochester, Dept Biomed Engn, Rochester, NY 14627 USA.	Regine_Choe@urmc.rochester.edu	Busch, David R/B-5543-2013; Durduran, Turgut/N-7768-2015	Busch, David R/0000-0002-9488-944X; Durduran, Turgut/0000-0001-5838-1027; Jung, Ki Won/0000-0001-9847-3532; Choe, Regine/0000-0001-5851-4504	NIH [K99/R00-CA126187, R01-EB002109]; NHLBI [HL007915]; Thrasher Early Career Award [P41-RR002305]; Fundacio Cellex Barcelona; Marie Curie IRG (FP7); LASERLAB Europe; Ministerio de Economia y Competitividad (PHOTOSTROKE)(Durduran); NATIONAL CANCER INSTITUTE [R00CA126187, K99CA126187] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002305] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072338, R01NS060653] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Thrasher Early Career Award; Fundacio Cellex Barcelona(Foundation CELLEXEuropean Commission); Marie Curie IRG (FP7); LASERLAB Europe; Ministerio de Economia y Competitividad (PHOTOSTROKE)(Durduran); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by NIH K99/R00-CA126187 (Choe), R01-EB002109 (Yodh), NHLBI HL007915, Thrasher Early Career Award (Busch), P41-RR002305 (Reddy-Yodh), Fundacio Cellex Barcelona, Marie Curie IRG (RTPAMON, FP7), LASERLAB Europe (BIOPTHICAL), Ministerio de Economia y Competitividad (PHOTOSTROKE)(Durduran). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEANEY RP, 1984, LANCET, V1, P131; Busch DR, 2013, PET CLIN, V8, P345, DOI 10.1016/j.cpet.2013.04.004; Busch DR, 2014, ACAD RADIOL, V21, P151, DOI 10.1016/j.acra.2013.10.009; Carp SA, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2397572; Carp SA, 2013, BIOMED OPT EXPRESS, V4, P2911, DOI 10.1364/BOE.4.002911; Cerussi A, 2007, P NATL ACAD SCI USA, V104, P4014, DOI 10.1073/pnas.0611058104; Cerussi AE, 2011, PHILOS T R SOC A, V369, P4512, DOI 10.1098/rsta.2011.0279; Cerussi Albert E, 2010, Acad Radiol, V17, P1031, DOI 10.1016/j.acra.2010.05.002; Chance B, 2005, ACAD RADIOL, V12, P925, DOI 10.1016/j.acra.2005.04.016; Choe R, 2005, MED PHYS, V32, P1128, DOI 10.1118/1.1869612; Choe R, 2012, IEEE J SEL TOP QUANT, V18, P1367, DOI 10.1109/JSTQE.2011.2177963; Choe R, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3103325; Cochet A, 2012, J NUCL MED, V53, P512, DOI 10.2967/jnumed.111.096834; Colak SB, 1999, IEEE J SEL TOP QUANT, V5, P1143, DOI 10.1109/2944.796341; Corlu A, 2007, OPT EXPRESS, V15, P6696, DOI 10.1364/OE.15.006696; COSGROVE DO, 1990, RADIOLOGY, V176, P175, DOI 10.1148/radiology.176.1.2191364; Dehghani H, 2003, APPL OPTICS, V42, P3117, DOI 10.1364/AO.42.003117; Delille JP, 2002, RADIOLOGY, V223, P558, DOI 10.1148/radiol.2232010428; Diop M, 2011, BIOMED OPT EXPRESS, V2, P2068, DOI 10.1364/BOE.2.002068; Doughty JC, 1996, BRIT J SURG, V83, P1128, DOI 10.1002/bjs.1800830830; Dunnwald LK, 2008, J CLIN ONCOL, V26, P4449, DOI 10.1200/JCO.2007.15.4385; Dunnwald LK, 2005, CANCER-AM CANCER SOC, V103, P680, DOI 10.1002/cncr.20831; Durduran T, 2005, OPT LETT, V30, P2915, DOI 10.1364/OL.30.002915; Durduran T, 2002, PHYS MED BIOL, V47, P2847, DOI 10.1088/0031-9155/47/16/302; Durduran T, 2010, REP PROG PHYS, V73, DOI 10.1088/0034-4885/73/7/076701; Durduran T, 2004, THESIS U PENNSYLVANI; Eby PR, 2008, ACAD RADIOL, V15, P1246, DOI 10.1016/j.acra.2008.03.019; Enfield LC, 2011, TECHNOL CANCER RES T, V10, P533, DOI 10.1177/153303461101000604; Enfield LC, 2007, APPL OPTICS, V46, P3628, DOI 10.1364/AO.46.003628; Enfield LC, 2009, TARGET ONCOL, V4, P219, DOI 10.1007/s11523-009-0115-z; Fang QQ, 2011, RADIOLOGY, V258, P89, DOI 10.1148/radiol.10082176; Flexman ML, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.9.096012; Franceschini MA, 1997, P NATL ACAD SCI USA, V94, P6468, DOI 10.1073/pnas.94.12.6468; Grosenick D, 2005, PHYS MED BIOL, V50, P2429, DOI 10.1088/0031-9155/50/11/001; Grosenick D, 2005, PHYS MED BIOL, V50, P2451, DOI 10.1088/0031-9155/50/11/002; Hagen A, 2009, OPT EXPRESS, V17, P17016, DOI 10.1364/OE.17.017016; Hajihashemi MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045714; Hentschel M, 2007, NUCL MED COMMUN, V28, P789, DOI 10.1097/MNM.0b013e3282e2a880; Huber KE, 2009, SEMIN RADIAT ONCOL, V19, P204, DOI 10.1016/j.semradonc.2009.05.004; Intes X, 2005, ACAD RADIOL, V12, P934, DOI 10.1016/j.acra.2005.05.006; Jain V, 2014, J CEREBR BLOOD F MET, V34, P380, DOI 10.1038/jcbfm.2013.214; Jakubowski DB, 2004, J BIOMED OPT, V9, P230, DOI 10.1117/1.1629681; Jiang H, 2001, IEEE T MED IMAGING, V20, P1334, DOI 10.1109/42.974928; Jiang SD, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.7.076011; Jiang SD, 2009, RADIOLOGY, V252, P551, DOI 10.1148/radiol.2522081202; Kawashima M, 2012, J MAGN RESON IMAGING, V35, P436, DOI 10.1002/jmri.22882; KEDAR RP, 1994, RADIOLOGY, V190, P825, DOI 10.1148/radiology.190.3.8115634; Krak N, 2008, MOL IMAGING BIOL, V10, P356, DOI 10.1007/s11307-008-0163-2; Leff DR, 2008, BREAST CANCER RES TR, V108, P9, DOI 10.1007/s10549-007-9582-z; Leproux A, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3485; Madjar H, 1997, GYNECOL ONCOL, V64, P392, DOI 10.1006/gyno.1996.4585; Makkat S, 2008, RADIOLOGY, V249, P471, DOI 10.1148/radiol.2492071147; Mankoff DA, 2003, J NUCL MED, V44, P1806; Mankoff DA, 2002, NUCL MED BIOL, V29, P719, DOI 10.1016/S0969-8051(02)00333-5; Mankoff DA, 2002, J NUCL MED, V43, P500; Mann RM, 2008, EUR RADIOL, V18, P1307, DOI 10.1007/s00330-008-0863-7; Mincey BA, 2004, MAYO CLIN PROC, V79, P810; Ntziachristos V, 2002, NEOPLASIA, V4, P347, DOI 10.1038/sj.neo.7900244; Pakalniskis MG, 2011, RADIOLOGY, V259, P365, DOI 10.1148/radiol.11100699; Pinheiro J, 2001, MIXED EFFECTS MODELS; Poellinger A, 2012, J BIOPHOTONICS, V5, P815, DOI 10.1002/jbio.201200123; Poellinger A, 2011, RADIOLOGY, V258, P409, DOI 10.1148/radiol.10100258; Pogue BW, 2001, RADIOLOGY, V218, P261, DOI 10.1148/radiology.218.1.r01ja51261; Roblyer D, 2011, P NATL ACAD SCI USA, V108, P14626, DOI 10.1073/pnas.1013103108; Santoro Y, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3638135; Schmitz CH, 2005, APPL OPTICS, V44, P2140, DOI 10.1364/AO.44.002140; Sehgal CM, 2006, J MAMMARY GLAND BIOL, V11, P113, DOI 10.1007/s10911-006-9018-0; Shah N, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2070147; Soliman H, 2010, CLIN CANCER RES, V16, P2605, DOI 10.1158/1078-0432.CCR-09-1510; Specht JM, 2010, CLIN CANCER RES, V16, P2803, DOI 10.1158/1078-0432.CCR-10-0026; Spinelli L, 2005, PHYS MED BIOL, V50, P2489, DOI 10.1088/0031-9155/50/11/004; Tanamai W, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3028012; Tiling R, 2001, EUR J NUCL MED, V28, P711, DOI 10.1007/s002590100539; Tozaki M, 2011, ACTA RADIOL, V52, P706, DOI 10.1258/ar.2011.110039; Tromberg BJ, 2000, NEOPLASIA, V2, P26, DOI 10.1038/sj.neo.7900082; Tromberg BJ, 2005, BREAST CANCER RES, V7, P279, DOI 10.1186/bcr1358; Ueda S, 2012, CANCER RES, V72, P4318, DOI 10.1158/0008-5472.CAN-12-0056; Vaupel P, 2005, ADV EXP MED BIOL, V566, P333; WILSON CBJH, 1992, CANCER RES, V52, P1592; Xu RX, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1837; Yang WT, 2002, J ULTRAS MED, V21, P1227, DOI 10.1023/A:1016580715595; Yu GQ, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1884603; Zhou C, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2798595; Zhu Q, 2005, RADIOLOGY, V237, P57, DOI 10.1148/radiol.2371041236; Zhu QN, 2005, NEOPLASIA, V7, P263, DOI 10.1593/neo.04526; Zhu Q, 2008, NEOPLASIA, V10, P1028, DOI 10.1593/neo.08602; Zhu Q, 2013, RADIOLOGY, V266, P433, DOI 10.1148/radiol.12112415; Zhu Q, 2010, RADIOLOGY, V256, P367, DOI 10.1148/radiol.10091237	88	31	31	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e99683	10.1371/journal.pone.0099683	http://dx.doi.org/10.1371/journal.pone.0099683			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967878	Green Submitted, Green Published, gold			2022-12-27	WOS:000338280800018
J	McKinley, SA; Chen, A; Shi, F; Wang, SM; Mucha, PJ; Forest, MG; Lai, SK				McKinley, Scott A.; Chen, Alex; Shi, Feng; Wang, Simi; Mucha, Peter J.; Forest, M. Gregory; Lai, Samuel K.			Modeling Neutralization Kinetics of HIV by Broadly Neutralizing Monoclonal Antibodies in Genital Secretions Coating the Cervicovaginal Mucosa	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; SEXUAL TRANSMISSION; VAGINAL FLUID; BINDING; DIFFUSION; MACAQUES; EPITOPE; STOICHIOMETRY; PROTECTION; INFECTION	Eliciting broadly neutralizing antibodies (bnAb) in cervicovaginal mucus (CVM) represents a promising "first line of defense'' strategy to reduce vaginal HIV transmission. However, it remains unclear what levels of bnAb must be present in CVM to effectively reduce infection. We approached this complex question by modeling the dynamic tally of bnAb coverage on HIV. This analysis introduces a critical, timescale-dependent competition: to protect, bnAb must accumulate at sufficient stoichiometry to neutralize HIV faster than virions penetrate CVM and reach target cells. We developed a model that incorporates concentrations and diffusivities of HIV and bnAb in semen and CVM, kinetic rates for binding (k(on)) and unbinding (k(off)) of select bnAb, and physiologically relevant thicknesses of CVM and semen layers. Comprehensive model simulations lead to robust conclusions about neutralization kinetics in CVM. First, due to the limited time virions in semen need to penetrate CVM, substantially greater bnAb concentrations than in vitro estimates must be present in CVM to neutralize HIV. Second, the model predicts that bnAb with more rapid k(on), almost independent of k(off), should offer greater neutralization potency in vivo. These findings suggest the fastest arriving virions at target cells present the greatest likelihood of infection. It also implies the marked improvements in in vitro neutralization potency of many recently discovered bnAb may not translate to comparable reduction in the bnAb dose needed to confer protection against initial vaginal infections. Our modeling framework offers a valuable tool to gaining quantitative insights into the dynamics of mucosal immunity against HIV and other infectious diseases.	[McKinley, Scott A.] Univ Florida, Dept Math, Gainesville, FL 32611 USA; [Chen, Alex; Shi, Feng; Wang, Simi; Mucha, Peter J.; Forest, M. Gregory] Univ N Carolina, Dept Math, Chapel Hill, NC USA; [Chen, Alex; Shi, Feng; Wang, Simi; Mucha, Peter J.; Forest, M. Gregory] Univ N Carolina, Dept Appl Phys Sci, Chapel Hill, NC USA; [Chen, Alex] Stat & Appl Math Sci Inst, Res Triangle Pk, NC USA; [Lai, Samuel K.] Univ N Carolina, Eshelman Sch Pharm, Div Mol Pharmaceut, Chapel Hill, NC USA; [Forest, M. Gregory; Lai, Samuel K.] Univ N Carolina, UNC NCSU Joint Dept Biomed Engn, Chapel Hill, NC USA	State University System of Florida; University of Florida; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; North Carolina State University; University of North Carolina Chapel Hill	McKinley, SA (corresponding author), Univ Florida, Dept Math, Gainesville, FL 32611 USA.	scott.mckinley@ufl.edu; lai@unc.edu	Shi, Feng/H-9103-2019	Shi, Feng/0000-0001-5369-6695; Lai, Samuel/0000-0003-4721-528X	National Institutes of Health [R21AI093242, U19AI096398]; National Science Foundation [DMS-1122483, DMS-1100281, DMS-0645369, DMS-1127914]; CAREER Award [DMR-1151477]; Eshelman School of Pharmacy and Lineburger Cancer Center at University of North Carolina-Chapel Hill; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410, R21AI093242, U19AI096398] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); CAREER Award; Eshelman School of Pharmacy and Lineburger Cancer Center at University of North Carolina-Chapel Hill; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health grants R21AI093242 (S.K.L) and U19AI096398 (S.K.L.), National Science Foundation DMS-1122483 (G.F.), DMS-1100281 (G.F.), DMS-0645369 (P.J.M.), DMS-1127914 (A.C.) and CAREER Award DMR-1151477 (S.K.L), and startup funds from the Eshelman School of Pharmacy and Lineburger Cancer Center at University of North Carolina-Chapel Hill (S.K.L.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burton DR, 2001, CURR TOP MICROBIOL, V260, P109; Chakraborty H, 2001, AIDS, V15, P621, DOI 10.1097/00002030-200103300-00012; Chen L, 2009, SCIENCE, V326, P1123, DOI 10.1126/science.1175868; Cone R., 1999, MUCOSAL IMMUNOLOGY, P43; Diskin R, 2011, SCIENCE, V334, P1289, DOI 10.1126/science.1213782; Du SX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020927; Fouts TR, 1997, J VIROL, V71, P2779, DOI 10.1128/JVI.71.4.2779-2785.1997; Geonnotti AR, 2006, BIOPHYS J, V91, P2121, DOI 10.1529/biophysj.106.086322; Gupta P, 1997, J VIROL, V71, P6271, DOI 10.1128/JVI.71.8.6271-6275.1997; Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433; Hu JJ, 2000, J VIROL, V74, P6087, DOI 10.1128/JVI.74.13.6087-6095.2000; Jamison P L, 1988, J Sex Res, V24, P177, DOI 10.1080/00224498809551408; Kovacs JM, 2012, P NATL ACAD SCI USA, V109, P12111, DOI 10.1073/pnas.1204533109; Lai BE, 2009, BIOPHYS J, V97, P2379, DOI 10.1016/j.bpj.2009.08.010; Lai SK, 2010, P NATL ACAD SCI USA, V107, P598, DOI 10.1073/pnas.0911748107; Lai SK, 2009, J VIROL, V83, P11196, DOI 10.1128/JVI.01899-08; Lai SK, 2009, ADV DRUG DELIVER REV, V61, P86, DOI 10.1016/j.addr.2008.09.012; LAYNE SP, 1992, VIROLOGY, V189, P695, DOI 10.1016/0042-6822(92)90593-E; Magnus C, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002900; Magnus C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000713; Maher D, 2005, P NATL ACAD SCI USA, V102, P11504, DOI 10.1073/pnas.0500848102; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; McGhee JerryR., 1994, HDB MUCOSAL IMMUNOLO, P127, DOI 10.1016/b978-0-12-524730-6; MCLAIN L, 1994, J GEN VIROL, V75, P1457, DOI 10.1099/0022-1317-75-6-1457; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; Norris J.R., 1998, CAMBRIDGE SERIES STA; NORVELL MK, 1984, J REPROD MED, V29, P269; Olmsted SS, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-79; Olmsted SS, 2001, BIOPHYS J, V81, P1930, DOI 10.1016/S0006-3495(01)75844-4; Owen DH, 1999, CONTRACEPTION, V59, P91, DOI 10.1016/S0010-7824(99)00010-4; Parren PWHI, 1998, J VIROL, V72, P3512, DOI 10.1128/JVI.72.5.3512-3519.1998; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Pendergrass PB, 2003, GYNECOL OBSTET INVES, V55, P110, DOI 10.1159/000070184; Rehan N, 1975, Fertil Steril, V26, P492; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Ruprecht CR, 2011, J EXP MED, V208, P439, DOI 10.1084/jem.20101907; SALTZMAN WM, 1994, BIOPHYS J, V66, P508, DOI 10.1016/S0006-3495(94)80802-1; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Schonning K, 1999, J VIROL, V73, P8364; SCHUMACHER GFB, 1988, HUM REPROD, V3, P289, DOI 10.1093/oxfordjournals.humrep.a136698; Shattock RJ, 2003, NAT REV MICROBIOL, V1, P25, DOI 10.1038/nrmicro729; Shukair SA, 2012, MUCOSAL IMMUNOL; Steckbeck JD, 2005, J VIROL, V79, P12311, DOI 10.1128/JVI.79.19.12311-12320.2005; STONE A, 1959, AM J OBSTET GYNECOL, V78, P279, DOI 10.1016/0002-9378(59)90173-5; USALA SJ, 1989, J REPROD MED, V34, P292; van Gils MJ, 2013, VIROLOGY, V435, P46, DOI 10.1016/j.virol.2012.10.004; VANCOTT TC, 1994, J IMMUNOL, V153, P449; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang Y.Y., 2014, MUCOSAL IMMUNOL; Watkins JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018207; Wu H, 2005, J MOL BIOL, V350, P126, DOI 10.1016/j.jmb.2005.04.049; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Yang XZ, 2005, J VIROL, V79, P3500, DOI 10.1128/JVI.79.6.3500-3508.2005; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817	60	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100598	10.1371/journal.pone.0100598	http://dx.doi.org/10.1371/journal.pone.0100598			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967706	Green Submitted, Green Published, gold			2022-12-27	WOS:000338280800046
J	Metzler-Zebeli, BU; Deckardt, K; Schollenberger, M; Rodehutscord, M; Zebeli, Q				Metzler-Zebeli, Barbara U.; Deckardt, Kathrin; Schollenberger, Margit; Rodehutscord, Markus; Zebeli, Qendrim			Lactic Acid and Thermal Treatments Trigger the Hydrolysis of Myo-Inositol Hexakisphosphate and Modify the Abundance of Lower Myo-Inositol Phosphates in Barley (Hordeum vulgare L.)	PLOS ONE			English	Article							MILK-FAT CONTENT; LIQUID FEED; PHYTIC ACID; GASTROINTESTINAL ECOLOGY; PHOSPHORUS DIGESTIBILITY; INOSITOL PHOSPHATES; MICROBIAL PHYTASE; RESISTANT STARCH; FORMIC-ACID; WHEAT	Barley is an important source of dietary minerals, but it also contains myo-inositol hexakisphosphate (InsP(6)) that lowers their absorption. This study evaluated the effects of increasing concentrations (0.5, 1, and 5%, vol/vol) of lactic acid (LA), without or with an additional thermal treatment at 55 degrees C (LA-H), on InsP(6) hydrolysis, formation of lower phosphorylated myo-inositol phosphates, and changes in chemical composition of barley grain. Increasing LA concentrations and thermal treatment linearly reduced (P<0.001) InsP(6)-phosphate (InsP(6)-P) by 0.5 to 1 g compared to the native barley. In particular, treating barley with 5% LA-H was the most efficient treatment to reduce the concentrations of InsP(6)-P, and stimulate the formation of lower phosphorylated myo-inositol phosphates such as myo-inositol tetraphosphate (InsP(4)) and myo-inositol pentaphosphates (InsP(5)). Also, LA and thermal treatment changed the abundance of InsP(4) and InsP(5) isomers with Ins(1,2,5,6)P-4 and Ins(1,2,3,4,5)P-5 as the dominating isomers with 5% LA, 1% LA-H and 5% LA-H treatment of barley, resembling to profiles found when microbial 6-phytase is applied. Treating barley with LA at room temperature (22 degrees C) increased the concentration of resistant starch and dietary fiber but lowered those of total starch and crude ash. Interestingly, total phosphorus (P) was only reduced (P<0.05) in barley treated with LA-H but not after processing of barley with LA at room temperature. In conclusion, LA and LA-H treatment may be effective processing techniques to reduce InsP(6) in cereals used in animal feeding with the highest degradation of InsP(6) at 5% LA-H. Further in vivo studies are warranted to determine the actual intestinal P availability and to assess the impact of changes in nutrient composition of LA treated barley on animal performance.	[Metzler-Zebeli, Barbara U.; Deckardt, Kathrin; Zebeli, Qendrim] Vetmeduni Vienna, Dept Farm Anim & Vet Publ Hlth, Inst Anim Nutr & Funct Plant Cpds, Vienna, Austria; [Metzler-Zebeli, Barbara U.] Vetmeduni Vienna, Dept Farm Anim & Vet Publ Hlth, Univ Clin Swine, Vienna, Austria; [Schollenberger, Margit; Rodehutscord, Markus] Univ Hohenheim, Inst Anim Nutr, Stuttgart, Germany	University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; University Hohenheim	Zebeli, Q (corresponding author), Vetmeduni Vienna, Dept Farm Anim & Vet Publ Hlth, Inst Anim Nutr & Funct Plant Cpds, Vienna, Austria.	Qendrim.Zebeli@vetmeduni.ac.at		Zebeli, Qendrim/0000-0001-5188-9004; Rodehutscord, Markus/0000-0003-3156-7889				Afify AMR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025512; Agger J, 2011, NEW BIOTECHNOL, V28, P125, DOI 10.1016/j.nbt.2010.09.012; [Anonymous], 1997, HDB LANDW VERS UNT; Ariza A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065062; Baik BK, 2008, J CEREAL SCI, V48, P233, DOI 10.1016/j.jcs.2008.02.002; Beal JD, 2005, J SCI FOOD AGR, V85, P433, DOI 10.1002/jsfa.2013; Bergman EL, 1999, J CEREAL SCI, V29, P261, DOI 10.1006/jcrs.1999.0239; Blaabjerg K, 2012, J ANIM SCI, V90, P206, DOI 10.2527/jas.53920; Blaabjerg K, 2011, J ANIM SCI, V89, P3153, DOI 10.2527/jas.2010-3358; Blaabjerg K, 2010, ANIMAL, V4, P876, DOI 10.1017/S1751731110000054; Bohn L, 2008, J ZHEJIANG UNIV-SC B, V9, P165, DOI 10.1631/jzus.B0710640; Canibe N, 2008, LIVEST SCI, V114, P251, DOI 10.1016/j.livsci.2007.05.002; Canibe N, 2003, J ANIM SCI, V81, P2019; de Lange CFM, 2010, LIVEST SCI, V134, P124, DOI 10.1016/j.livsci.2010.06.117; Deckardt K, 2014, STARCH-STARKE, V66, P558, DOI 10.1002/star.201300200; Deckardt K, 2013, NUTRIENTS, V5, P1970, DOI 10.3390/nu5061970; Dionisio G, 2007, PLANT BIOTECHNOL J, V5, P325, DOI 10.1111/j.1467-7652.2007.00244.x; Egli I, 2002, J FOOD SCI, V67, P3484, DOI 10.1111/j.1365-2621.2002.tb09609.x; Esmaeilipour O, 2012, ANIM FEED SCI TECH, V175, P168, DOI 10.1016/j.anifeedsci.2012.05.007; Fredlund K, 1997, J CEREAL SCI, V25, P83, DOI 10.1006/jcrs.1996.0070; Greiner R, 2000, J CEREAL SCI, V31, P127, DOI 10.1006/jcrs.1999.0254; Greiner R, 2007, PROTEIN J, V26, P577, DOI 10.1007/s10930-007-9100-5; Haraldsson AK, 2004, J SCI FOOD AGR, V84, P653, DOI 10.1002/jsfa.1724; Heo JM, 2013, J ANIM PHYSIOL AN N, V97, P207, DOI 10.1111/j.1439-0396.2012.01284.x; Holopainen-Mantila U, 2013, BIORESOURCE TECHNOL, V138, P156, DOI 10.1016/j.biortech.2013.03.152; Hurrell RF, 2004, INT J VITAM NUTR RES, V74, P445, DOI 10.1024/0300-9831.74.6.445; Iqbal S, 2012, J ANIM SCI, V90, P3143, DOI 10.2527/jas.2011-3983; Iqbal S, 2012, ANIM FEED SCI TECH, V172, P141, DOI 10.1016/j.anifeedsci.2011.12.024; Iqbal S, 2010, J DAIRY SCI, V93, P5147, DOI 10.3168/jds.2010-3118; Iqbal S, 2009, J DAIRY SCI, V92, P6023, DOI 10.3168/jds.2009-2380; Jarrett JP, 2014, J DAIRY SCI, V97, P411, DOI 10.3168/jds.2013-7124; Kiarie E, 2013, NUTR RES REV, V26, P71, DOI 10.1017/S0954422413000048; Leenhardt F, 2005, J AGR FOOD CHEM, V53, P98, DOI 10.1021/jf049193q; March JG, 1998, ANAL CHIM ACTA, V367, P63, DOI 10.1016/S0003-2670(98)00164-0; Sanz-Penella JM, 2012, J AGR FOOD CHEM, V60, P11787, DOI 10.1021/jf3034013; Pable A, 2014, J FOOD BIOCHEM, V38, P18, DOI 10.1111/jfbc.12020; PHILLIPPY BQ, 1988, ANAL BIOCHEM, V175, P162, DOI 10.1016/0003-2697(88)90374-0; Plumed-Ferrer C, 2009, J APPL MICROBIOL, V106, P351, DOI 10.1111/j.1365-2672.2008.03938.x; Pontoppidan K, 2007, ANIM FEED SCI TECH, V132, P137, DOI 10.1016/j.anifeedsci.2006.03.008; Proulx AK, 2007, J AGR FOOD CHEM, V55, P2749, DOI 10.1021/jf0630015; Raboy V, 2003, PHYTOCHEMISTRY, V64, P1033, DOI 10.1016/S0031-9422(03)00446-1; Regmi PR, 2011, J NUTR, V141, P1273, DOI 10.3945/jn.111.140509; Rutherfurd SM, 2014, J ANIM SCI, V92, P189, DOI 10.2527/jas.2013-6923; Sandberg AS, 1999, AM J CLIN NUTR, V70, P240; Sandberg AS, 2002, FOOD PHYTATES, P139; SANDBERG AS, 1991, ADV EXP MED BIOL, V289, P499; Selvendran R R, 1987, Adv Food Res, V31, P117; Shastak Y, 2012, POULTRY SCI, V91, P2201, DOI 10.3382/ps.2011-02063; Shen YR, 2005, J AGR FOOD CHEM, V53, P853, DOI 10.1021/jf049116v; Skoglund E, 1997, J AGR FOOD CHEM, V45, P431, DOI 10.1021/jf9603238; STEWART A, 1988, PLANT PHYSIOL, V86, P93, DOI 10.1104/pp.86.1.93; TABEKHIA MM, 1980, J FOOD SCI, V45, P406, DOI 10.1111/j.1365-2621.1980.tb02631.x; Tanaka T, 2010, J VET MED SCI, V72, P827, DOI 10.1292/jvms.09-0490; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Willamil J, 2011, ARCH ANIM NUTR, V65, P431, DOI 10.1080/1745039X.2011.623047; Zebeli Q, 2007, J DAIRY SCI, V90, P1929, DOI 10.3168/jds.2006-354	56	28	29	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e101166	10.1371/journal.pone.0101166	http://dx.doi.org/10.1371/journal.pone.0101166			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967651	Green Submitted, Green Published, gold			2022-12-27	WOS:000338280800115
J	Wang, X; Bai, TT; Liu, SN; Pan, H; Wang, BB				Wang, Xi; Bai, Tingting; Liu, Shengnan; Pan, Hong; Wang, Binbin			Association between Thrombophilia Gene Polymorphisms and Preeclampsia: A Meta-Analysis	PLOS ONE			English	Article							FACTOR-V-LEIDEN; PREGNANCY-INDUCED HYPERTENSION; ACTIVATED PROTEIN-C; METHYLENETETRAHYDROFOLATE REDUCTASE; PROTHROMBIN-GENE; INHERITED THROMBOPHILIAS; HEMOSTATIC ABNORMALITIES; VENOUS THROMBOSIS; HIGH PREVALENCE; RISK-FACTORS	Objective: To estimate the relationship between the risk of preeclampsia and two thrombophilia gene single-nucleotide polymorphisms (SNPs), the factor V G1691A SNP and the prothrombin G20210A SNP. Date Sources: A systematic search of the English-language literature up to November 2012 was performed using Medline and EMBASE. Search terms included "preeclampsia,'' "thrombophilia,'' "factor V Leiden,'' "prothrombin gene 20210,'' and their combinations. Result(s): Thirty-seven studies with 5048 preeclampsia patients and 6796 controls were included in the meta-analysis. We found that the prothrombin G20210A polymorphism was associated with an increased risk of all preeclampsia (pooled odds ratio (OR) = 1.81, 95% confidence interval (CI) 1.25-2.63) and severe preeclampsia (pooled OR = 3.02, 95%CI 2.06-4.45). Meanwhile, the pooled OR for the association between factor V Leiden and all preeclampsia was 1.60 (95%CI 1.28-2.00) and 2.45 (95%CI 1.63-3.69) for the cases of severe preeclampsia. Conclusion(s): This meta-analysis supports that the factor V G1691A SNP and the prothrombin G20210A SNP are associated with an increased risk for both preeclampsia overall and severe preeclampsia.	[Wang, Xi; Bai, Tingting; Liu, Shengnan; Wang, Binbin] Peking Union Med Coll, Grad Sch, Beijing 100021, Peoples R China; [Wang, Xi; Bai, Tingting; Liu, Shengnan; Pan, Hong; Wang, Binbin] Natl Res Inst Family Planning, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; National Research Institute for Family Planning - China	Wang, BB (corresponding author), Peking Union Med Coll, Grad Sch, Beijing 100021, Peoples R China.	wbbahu@163.com		Wang, Binbin/0000-0002-1597-5930	Knowledge Innovation Program of The Chinese Academy of Sciences [KSCX2-EW-R-06]	Knowledge Innovation Program of The Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the Knowledge Innovation Program of The Chinese Academy of Sciences (KSCX2-EW-R-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2011, J OBSTET GYNAECOL RE, V37, P1335, DOI 10.1111/j.1447-0756.2010.01523.x; Alfirevic Z, 2001, OBSTET GYNECOL, V97, P753, DOI 10.1016/S0029-7844(01)01190-5; Arngrimsson R, 1997, AM J HUM GENET, V61, P354, DOI 10.1086/514843; Best LG, 2009, HYPERTENS PREGNANCY, V28, P85, DOI 10.1080/10641950802419887; Currie L, 2002, BJOG-INT J OBSTET GY, V109, P191, DOI 10.1016/S1470-0328(02)00373-7; D'Elia AV, 2002, GYNECOL OBSTET INVES, V53, P84, DOI 10.1159/000052998; DAHLBACK B, 1994, HAEMOSTASIS, V24, P139; Dalmaz CA, 2006, BLOOD CELL MOL DIS, V37, P107, DOI 10.1016/j.bcmd.2006.07.005; Davalos IP, 2005, BLOOD CELL MOL DIS, V35, P66, DOI 10.1016/j.bcmd.2005.03.008; De Groot CJM, 1999, AM J OBSTET GYNECOL, V181, P975, DOI 10.1016/S0002-9378(99)70335-2; Demir SC, 2006, SAUDI MED J, V27, P1161; Dissanayake VHW, 2012, J OBSTET GYNAECOL RE, V38, P1168, DOI 10.1111/j.1447-0756.2012.01846.x; DizonTownson DS, 1996, AM J OBSTET GYNECOL, V175, P902, DOI 10.1016/S0002-9378(96)80022-6; Driul L, 2005, INT J GYNECOL OBSTET, V88, P265, DOI 10.1016/j.ijgo.2004.12.013; Dudding T, 2008, J THROMB HAEMOST, V6, P1868, DOI 10.1111/j.1538-7836.2008.03134.x; Fabbro D, 2003, GYNECOL OBSTET INVES, V56, P17, DOI 10.1159/000072326; Faisel F, 2004, EUR J HUM GENET, V12, P187, DOI 10.1038/sj.ejhg.5201124; Gant NF, 1996, INT J GYNECOL OBSTET, V53, P175; Gerhardt A, 2005, J THROMB HAEMOST, V3, P686, DOI 10.1111/j.1538-7836.2005.01226.x; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; Higgins JR, 2000, GYNECOL OBSTET INVES, V50, P254, DOI 10.1159/000010326; Hiltunen LM, 2009, THROMB RES, V124, P167, DOI 10.1016/j.thromres.2008.11.012; Hira B, 2003, BJOG-INT J OBSTET GY, V110, P327, DOI 10.1016/S1470-0328(02)01590-2; Kahn SR, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.09.023; Kim YJ, 2001, AM J OBSTET GYNECOL, V184, P1211, DOI 10.1067/mob.2001.110411; Kobashi G, 1999, SEMIN THROMB HEMOST, V25, P487, DOI 10.1055/s-2007-994955; Koleva R, 2005, Akush Ginekol (Sofiia), V44, P18; Kupferminc MJ, 2000, ACTA OBSTET GYN SCAN, V79, P963, DOI 10.1034/j.1600-0412.2000.079011963.x; Kupferminc MJ, 2000, OBSTET GYNECOL, V96, P45, DOI 10.1016/S0029-7844(00)00861-9; Kupferminc MJ, 1999, NEW ENGL J MED, V340, P9, DOI 10.1056/NEJM199901073400102; Lin J, 2005, OBSTET GYNECOL, V105, P182, DOI 10.1097/01.AOG.0000146250.85561.e9; Lindoff C, 1997, AM J OBSTET GYNECOL, V176, P457, DOI 10.1016/S0002-9378(97)70515-5; Livingston JC, 2001, AM J OBSTET GYNECOL, V185, P153, DOI 10.1067/mob.2001.114691; Malek-Khosravi S, 2012, J THROMB THROMBOLYS, V33, P109, DOI 10.1007/s11239-011-0653-y; Mello G, 2005, HYPERTENSION, V46, P1270, DOI 10.1161/01.HYP.0000188979.74172.4d; Mello G, 1999, HAEMOSTASIS, V29, P197; Mimuro S, 1998, AUST NZ J OBSTET GYN, V38, P200, DOI 10.1111/j.1479-828X.1998.tb03002.x; Morrison ER, 2002, THROMB HAEMOSTASIS, V87, P779, DOI 10.1055/s-0037-1613083; O'Shaughnessy KM, 1999, HYPERTENSION, V33, P1338, DOI 10.1161/01.HYP.33.6.1338; Poort SR, 1996, BLOOD, V88, P3698, DOI 10.1182/blood.V88.10.3698.bloodjournal88103698; Prasmusinto D, 2004, EUR J OBSTET GYN R B, V112, P162, DOI 10.1016/S0301-2115(03)00314-2; Preston FE, 1996, LANCET, V348, P913, DOI 10.1016/S0140-6736(96)04125-6; Prochazka M, 2003, Ceska Gynekol, V68, P162; Rigo J, 2000, HYPERTENS PREGNANCY, V19, P163, DOI 10.1081/PRG-100100132; Salanti G, 2005, GENET MED, V7, P13, DOI 10.1097/01.GIM.0000151839.12032.1A; Dusse LMS, 2007, EUR J OBSTET GYN R B, V134, P20, DOI 10.1016/j.ejogrb.2006.09.006; Seremak-Mrozikiewicz A, 2010, J THROMB THROMBOLYS, V30, P97, DOI 10.1007/s11239-009-0432-1; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Tempfer CB, 2004, J SOC GYNECOL INVEST, V11, P227, DOI 10.1016/j.jsgi.2003.12.002; van Pampus MG, 1999, AM J OBSTET GYNECOL, V180, P1146, DOI 10.1016/S0002-9378(99)70608-3; von Tempelhoff GF, 2000, THROMB RES, V100, P363, DOI 10.1016/S0049-3848(00)00312-1; Wilson ML, 2003, OBSTET GYNECOL SURV, V58, P39, DOI 10.1097/00006254-200301000-00022; Yalinkaya A, 2006, ANN SAUDI MED, V26, P105, DOI 10.5144/0256-4947.2006.105	53	21	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100789	10.1371/journal.pone.0100789	http://dx.doi.org/10.1371/journal.pone.0100789			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967675	Green Submitted, gold, Green Published			2022-12-27	WOS:000338280800066
J	Feng, ST; Li, JG; Luo, YJ; Yin, TH; Cai, HS; Wang, Y; Dong, Z; Shuai, XT; Li, ZP				Feng, Shi-Ting; Li, Jingguo; Luo, Yanji; Yin, Tinghui; Cai, Huasong; Wang, Yong; Dong, Zhi; Shuai, Xintao; Li, Zi-Ping			pH-Sensitive Nanomicelles for Controlled and Efficient Drug Delivery to Human Colorectal Carcinoma LoVo Cells	PLOS ONE			English	Article							PHARMACEUTICAL NANOCARRIERS; COPOLYMER MICELLES; POLYMERIC MICELLES; IRON-OXIDE; CANCER; TUMOR; NANOPARTICLES; PACLITAXEL; SYSTEMS; RELEASE	Background: The triblock copolymers PEG-P(Asp-DIP)-P(Lys-Ca) (PEALCa) of polyethylene glycol (PEG), poly(N-(N', N'-diisopropylaminoethyl) aspartamide) (P(Asp-DIP)), and poly (lysine-cholic acid) (P(Lys-Ca)) were synthesized as a pH-sensitive drug delivery system. In neutral aqueous environment such as physiological environment, PEALCa can self-assemble into stable vesicles with a size around 50-60 nm, avoid uptake by the reticuloendothelial system (RES), and encase the drug in the core. However, the PEALCa micelles disassemble and release drug rapidly in acidic environment that resembles lysosomal compartments. Methodology/Principal Findings: The anticancer drug Paclitaxel (PTX) and hydrophilic superparamagnetic iron oxide (SPIO) were encapsulated inside the core of the PEALCa micelles and used for potential cancer therapy. Drug release study revealed that PTX in the micelles was released faster at pH 5.0 than at pH 7.4. Cell culture studies showed that the PTX-SPIO-PEALCa micelle was effectively internalized by human colon carcinoma cell line (LoVo cells), and PTX could be embedded inside lysosomal compartments. Moreover, the human colorectal carcinoma (CRC) LoVo cells delivery effect was verified in vivo by magnetic resonance imaging (MRI) and histology analysis. Consequently effective suppression of CRC LoVo cell growth was evaluated. Conclusions/Significance: These results indicated that the PTX-SPION-loaded pH-sensitive micelles were a promising MRI-visible drug release system for colorectal cancer therapy.	[Feng, Shi-Ting; Luo, Yanji; Cai, Huasong; Dong, Zhi; Li, Zi-Ping] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Radiol, Guangzhou 510275, Guangdong, Peoples R China; [Li, Jingguo; Wang, Yong; Shuai, Xintao] Sun Yat Sen Univ, Sch Chem & Chem Engn, Minist Educ, PCFM Lab, Guangzhou 510275, Guangdong, Peoples R China; [Yin, Tinghui] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Med Ultrason, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Li, ZP (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Radiol, Guangzhou 510275, Guangdong, Peoples R China.	liziping163@163.com	Shuai, Xintao/C-5819-2008; Li, Jingguo/E-7523-2015; 庭辉, 尹/I-5114-2014	Shuai, Xintao/0000-0003-4271-0310; Yin, Tinghui/0000-0003-4201-3953; Wang, Yong/0000-0002-8349-7555	National Natural Science Foundation of China [81000626]; Zhujiang Scientific and Technological New Star Foundation [2012J2200084]; Fundamental Research Funds for the Central Universities [10ykpy11]; Natural Science Foundation of Guangdong Province [S2013010016004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhujiang Scientific and Technological New Star Foundation; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was supported by: 1. National Natural Science Foundation of China (81000626); 2. Zhujiang Scientific and Technological New Star Foundation (2012J2200084); 3. Fundamental Research Funds for the Central Universities (10ykpy11); 4. Natural Science Foundation of Guangdong Province (S2013010016004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Lorenzo C, 2008, MINI-REV MED CHEM, V8, P1065, DOI 10.2174/138955708785909952; Byrne JD, 2008, ADV DRUG DELIVER REV, V60, P1615, DOI 10.1016/j.addr.2008.08.005; Chang GT, 2010, MACROMOL BIOSCI, V10, P1248, DOI 10.1002/mabi.201000117; Chen YT, 2012, INT J NANOMED, V7, P359, DOI 10.2147/IJN.S24083; Chen YB, 2007, CHINESE MED J-PEKING, V120, P703, DOI 10.1097/00029330-200704020-00017; Dai J, 2011, ANGEW CHEM INT EDIT, V50, P9404, DOI 10.1002/anie.201103806; Foersch S, 2012, DIGEST DIS, V30, P469, DOI 10.1159/000341692; Gao GH, 2010, SMALL, V6, P1201, DOI 10.1002/smll.200902317; Hawkins MJ, 2008, ADV DRUG DELIVER REV, V60, P876, DOI 10.1016/j.addr.2007.08.044; Hu YQ, 2007, POLYMER, V48, P3437, DOI 10.1016/j.polymer.2007.04.011; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Ju CY, 2013, J PHARM SCI-US, V102, P2707, DOI 10.1002/jps.23649; Khemtong C, 2009, CANCER RES, V69, P1651, DOI 10.1158/0008-5472.CAN-08-3231; Klaikherd A, 2009, J AM CHEM SOC, V131, P4830, DOI 10.1021/ja809475a; Lee ES, 2003, J CONTROL RELEASE, V90, P363, DOI 10.1016/S0168-3659(03)00205-0; Lee ES, 2008, J CONTROL RELEASE, V132, P164, DOI 10.1016/j.jconrel.2008.05.003; Lee JH, 2007, NAT MED, V13, P95, DOI [10.1038/nm1467, 10.20659/jfp.13.1_95]; Liao CD, 2011, EUR J RADIOL, V80, P699, DOI 10.1016/j.ejrad.2010.08.005; Liu J, 2010, CARBOHYD POLYM, V82, P432, DOI 10.1016/j.carbpol.2010.04.084; Luo JT, 2009, BIOMACROMOLECULES, V10, P900, DOI 10.1021/bm801423p; Lutz JF, 2006, BIOMACROMOLECULES, V7, P3132, DOI 10.1021/bm0607527; Lynn DM, 2001, J AM CHEM SOC, V123, P8155, DOI 10.1021/ja016288p; Mei L, 2009, J PHARM SCI-US, V98, P2040, DOI 10.1002/jps.21581; Mi Y, 2011, BIOMATERIALS, V32, P4058, DOI 10.1016/j.biomaterials.2011.02.022; Mo R, 2011, BIOMATERIALS, V32, P4609, DOI 10.1016/j.biomaterials.2011.03.005; Nasongkla N, 2006, NANO LETT, V6, P2427, DOI 10.1021/nl061412u; Otsuka H, 2003, ADV DRUG DELIVER REV, V55, P403, DOI 10.1016/S0169-409X(02)00226-0; Panchagnula R, 1998, INT J PHARMACEUT, V172, P1, DOI 10.1016/S0378-5173(98)00188-4; Ranganathan R, 2012, INT J NANOMED, V7, P1043, DOI 10.2147/IJN.S25182; Savic R, 2003, SCIENCE, V300, P615, DOI 10.1126/science.1078192; Sawant RM, 2006, BIOCONJUGATE CHEM, V17, P943, DOI 10.1021/bc060080h; Torchilin V, 2009, EUR J PHARM BIOPHARM, V71, P431, DOI 10.1016/j.ejpb.2008.09.026; Wang WW, 2012, ADV MATER, V24, P115, DOI 10.1002/adma.201104066; Wu H, 2013, BIOMATERIALS, V34, P1213, DOI 10.1016/j.biomaterials.2012.08.072; Yang R, 2009, INT J PHARMACEUT, V371, P142, DOI 10.1016/j.ijpharm.2008.12.007; Yang XQ, 2010, BIOCONJUGATE CHEM, V21, P496, DOI 10.1021/bc900422j; Yin HQ, 2008, J CONTROL RELEASE, V126, P130, DOI 10.1016/j.jconrel.2007.11.014	37	41	41	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100732	10.1371/journal.pone.0100732	http://dx.doi.org/10.1371/journal.pone.0100732			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964012	Green Published, Green Submitted, gold			2022-12-27	WOS:000338709500077
J	Lu, XD; Zhang, DY; Li, SP; Su, YP; Liang, QJ; Meng, HY; Shen, SD; Fan, YL; Liu, CM; Zhang, CY				Lu, Xiaoduo; Zhang, Dongyuan; Li, Shipeng; Su, Yanping; Liang, Qiuju; Meng, Hongyan; Shen, Songdong; Fan, Yunliu; Liu, Chunming; Zhang, Chunyi			FtsHi4 Is Essential for Embryogenesis Due to Its Influence on Chloroplast Development in Arabidopsis	PLOS ONE			English	Article							PHOTOSYSTEM-II REPAIR; THYLAKOID MEMBRANE; EMBRYO DEVELOPMENT; GENE-EXPRESSION; CHLOROPHYLL FLUORESCENCE; PLANT DEVELOPMENT; LEAF VARIEGATION; SEED DEVELOPMENT; PROTEIN IMPORT; D1 PROTEIN	Chloroplast formation is associated with embryo development and seedling growth. However, the relationship between chloroplast differentiation and embryo development remains unclear. Five FtsHi genes that encode proteins with high similarity to FtsH proteins, but lack Zn2+-binding motifs, are present in the Arabidopsis genome. In this study, we showed that T-DNA insertion mutations in the Arabidopsis FtsHi4 gene resulted in embryo arrest at the globular-to-heart-shaped transition stage. Transmission electron microscopic analyses revealed abnormal plastid differentiation with a severe defect in thylakoid formation in the mutant embryos. Immunocytological studies demonstrated that FtsHi4 localized in chloroplasts as a thylakoid membrane-associated protein, supporting its essential role in thylakoid membrane formation. We further showed that FtsHi4 forms protein complexes, and that there was a significant reduction in the accumulation of D2 and PsbO (two photosystem II proteins) in mutant ovules. The role of FtsHi4 in chloroplast development was confirmed using an RNA-interfering approach. Additionally, mutations in other FtsHi genes including FtsHi1, FtsHi2, and FtsHi5 caused phenotypic abnormalities similar to ftshi4 with respect to plastid differentiation during embryogenesis. Taken together, our data suggest that FtsHi4, together with FtsHi1, FtsHi2, and FtsHi5 are essential for chloroplast development in Arabidopsis.	[Lu, Xiaoduo; Li, Shipeng] Qilu Normal Univ, Dept Life Sci, Jinan, Peoples R China; [Zhang, Dongyuan] Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Qingdao, Peoples R China; [Su, Yanping; Shen, Songdong] Soochow Univ, Sch Biol & Basic Med Sci, Suzhou, Peoples R China; [Liang, Qiuju; Meng, Hongyan; Fan, Yunliu; Zhang, Chunyi] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China; [Liang, Qiuju; Fan, Yunliu; Zhang, Chunyi] Natl Key Facil Crop Gene Resources & Genet Improv, Beijing, Peoples R China; [Liu, Chunming] Chinese Acad Sci, Inst Bot, Beijing, Peoples R China	Qilu Normal University; Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS; Soochow University - China; Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS; Chinese Academy of Sciences; Institute of Botany, CAS	Zhang, CY (corresponding author), Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China.	zhangchunyi@caas.cn	Liu, Chun-Ming/G-1006-2010; 刘, 春明/GLU-4320-2022; Shen, Songdong/G-9385-2011	Liu, Chun-Ming/0000-0002-7271-362X; 刘, 春明/0000-0002-7271-362X; Shen, Songdong/0000-0002-5731-1681	National Science Foundation of China [31071077]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Science Foundation of China (grant number 31071077 to C. Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam Z, 2011, PLANT MOL BIOL, V76, P221, DOI 10.1007/s11103-010-9693-5; Aluru MR, 2006, J EXP BOT, V57, P1871, DOI 10.1093/jxb/erj008; Asakura Y, 2004, PLANT CELL, V16, P201, DOI 10.1105/tpc.014787; Bailey S, 2002, J BIOL CHEM, V277, P2006, DOI 10.1074/jbc.M105878200; BARKAN A, 1993, PLANT CELL, V5, P389, DOI 10.1105/tpc.5.4.389; Berleth T, 2002, ARABIDOPSIS BOOK; Chaudhury AM, 2001, ANNU REV CELL DEV BI, V17, P677, DOI 10.1146/annurev.cellbio.17.1.677; Chen M, 2000, PLANT J, V22, P303, DOI 10.1046/j.1365-313x.2000.00738.x; Chen M, 2010, CELL, V141, P1230, DOI 10.1016/j.cell.2010.05.007; Chi W, 2008, PLANT PHYSIOL, V147, P573, DOI 10.1104/pp.108.116194; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Colombo M, 2008, PLANT J, V54, P1037, DOI 10.1111/j.1365-313X.2008.03485.x; CONSTANTINE NT, 1994, J VIROL METHODS, V47, P153, DOI 10.1016/0166-0934(94)90074-4; Drescher A, 2000, PLANT J, V22, P97, DOI 10.1046/j.1365-313x.2000.00722.x; Gao ZP, 2011, PLANT PHYSIOL, V157, P1733, DOI 10.1104/pp.111.184762; Garcion C, 2006, PLANT J, V48, P895, DOI 10.1111/j.1365-313X.2006.02922.x; Huang XZ, 2009, CELL RES, V19, P1205, DOI 10.1038/cr.2009.84; Hust B, 2006, PLANT BIOLOGY, V8, P18, DOI 10.1055/s-2005-873044; Ito K, 2005, ANNU REV MICROBIOL, V59, P211, DOI 10.1146/annurev.micro.59.030804.121316; Jurgens G, 2001, EMBO J, V20, P3609, DOI 10.1093/emboj/20.14.3609; Kadirjan-Kalbach DK, 2012, PLANT J, V72, P856, DOI 10.1111/tpj.12001; Kim HU, 2004, PLANT PHYSIOL, V134, P1206, DOI 10.1104/pp.103.035832; Kim J, 2009, PLANT CELL, V21, P1669, DOI 10.1105/tpc.108.063784; KITAJIMA M, 1975, BIOCHIM BIOPHYS ACTA, V376, P105, DOI 10.1016/0005-2728(75)90209-1; Klostermann E, 2002, BIOCHEM J, V368, P777, DOI 10.1042/BJ20021291; Kovacheva S, 2005, PLANT J, V41, P412, DOI 10.1111/j.1365-313X.2004.02307.x; KRAUSE GH, 1991, ANNU REV PLANT PHYS, V42, P313, DOI 10.1146/annurev.pp.42.060191.001525; Kwon KC, 2008, PLANT J, V55, P428, DOI 10.1111/j.1365-313X.2008.03523.x; Leister D, 2003, TRENDS GENET, V19, P47, DOI 10.1016/S0168-9525(02)00003-3; Lennartz K, 2001, PLANT CELL, V13, P2539, DOI 10.1105/tpc.13.11.2539; Liang QJ, 2010, PHYSIOL PLANTARUM, V140, P380, DOI 10.1111/j.1399-3054.2010.01407.x; Lindahl M, 2000, PLANT CELL, V12, P419, DOI 10.1105/tpc.12.3.419; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu XD, 2008, CELL RES, V18, P589, DOI 10.1038/cr.2008.44; MANSFIELD SG, 1991, CAN J BOT, V69, P461, DOI 10.1139/b91-063; McElver J, 2001, GENETICS, V159, P1751; Meurer J, 1998, EMBO J, V17, P5286, DOI 10.1093/emboj/17.18.5286; Motohashi K, 2001, P NATL ACAD SCI USA, V98, P11224, DOI 10.1073/pnas.191282098; Nickelsen J, 2013, ANNU REV PLANT BIOL, V64, P609, DOI 10.1146/annurev-arplant-050312-120124; Nixon PJ, 2010, ANN BOT-LONDON, V106, P1, DOI 10.1093/aob/mcq059; Nixon PJ, 2005, J EXP BOT, V56, P357, DOI 10.1093/jxb/eri021; OELMULLER R, 1989, PLANT MOL BIOL, V13, P223, DOI 10.1007/BF00016140; Ostersetzer O, 1997, PLANT CELL, V9, P957, DOI 10.1105/tpc.9.6.957; Peng LW, 2006, PLANT CELL, V18, P955, DOI 10.1105/tpc.105.037689; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Roy LM, 1998, J CELL BIOL, V141, P385, DOI 10.1083/jcb.141.2.385; Ruuska SA, 2004, PLANT PHYSIOL, V136, P2700, DOI 10.1104/pp.104.047977; Sakamoto W, 2003, PLANT CELL, V15, P2843, DOI 10.1105/tpc.017319; Sakamoto W, 2002, GENES CELLS, V7, P769, DOI 10.1046/j.1365-2443.2002.00558.x; SANTOS D, 1975, J BACTERIOL, V124, P1502, DOI 10.1128/JB.124.3.1502-1507.1975; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Sinvany-Villalobo G, 2004, PLANT PHYSIOL, V135, P1336, DOI 10.1104/pp.104.043299; Sokolenko A, 2002, CURR GENET, V41, P291, DOI 10.1007/s00294-002-0309-8; Sundberg E, 1997, PLANT CELL, V9, P717, DOI 10.1105/tpc.9.5.717; Takechi K, 2000, PLANT CELL PHYSIOL, V41, P1334, DOI 10.1093/pcp/pcd067; TAYLOR WC, 1989, ANNU REV PLANT PHYS, V40, P211, DOI 10.1146/annurev.pp.40.060189.001235; TOMOYASU T, 1993, J BACTERIOL, V175, P1352, DOI 10.1128/JB.175.5.1352-1357.1993; Tzafrir I, 2003, NUCLEIC ACIDS RES, V31, P90, DOI 10.1093/nar/gkg028; Uwer U, 1998, PLANT CELL, V10, P1277, DOI 10.1105/tpc.10.8.1277; Wagner R, 2012, PHYSIOL PLANTARUM, V145, P203, DOI 10.1111/j.1399-3054.2011.01548.x; Xu XM, 2004, P NATL ACAD SCI USA, V101, P9143, DOI 10.1073/pnas.0400799101; Yoshioka M, 2010, J BIOL CHEM, V285, P41972, DOI 10.1074/jbc.M110.117432; Yu B., 2004, PLANT CELL PHYSL, V45, P503, DOI 10.1093/pcp/pch064; Yu F, 2005, PLANT PHYSIOL, V138, P1957, DOI 10.1104/pp.105.061234; Yu F, 2004, PLANT J, V37, P864, DOI 10.1111/j.1365-313X.2003.02014.x; Zaltsman A, 2005, PLANT CELL, V17, P2782, DOI 10.1105/tpc.105.035071; Zelisko A, 2005, P NATL ACAD SCI USA, V102, P13699, DOI 10.1073/pnas.0503472102; Zhang LX, 1999, J BIOL CHEM, V274, P16062, DOI 10.1074/jbc.274.23.16062	68	21	26	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e99741	10.1371/journal.pone.0099741	http://dx.doi.org/10.1371/journal.pone.0099741			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964212	Green Published, gold			2022-12-27	WOS:000338709500017
J	Chiang, EPI; Tsai, SY; Kuo, YH; Pai, MH; Chiu, HL; Rodriguez, RL; Tang, FY				Chiang, En-Pei Isabel; Tsai, Shu-Yao; Kuo, Yueh-Hsiung; Pai, Man-Hui; Chiu, Hsi-Lin; Rodriguez, Raymond L.; Tang, Feng-Yao			Caffeic Acid Derivatives Inhibit the Growth of Colon Cancer: Involvement of the PI3-K/Akt and AMPK Signaling Pathways	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; PHENETHYL ESTER CAPE; COLORECTAL-CANCER; TUMOR-GROWTH; CYCLIN D1; EXPRESSION; CELLS; ENERGY; CONSUMPTION; PROGRESSION	Background: The aberrant regulation of phosphatidylinositide 3-kinases (PI3-K)/Akt, AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (m-TOR) signaling pathways in cancer has prompted significant interest in the suppression of these pathways to treat cancer. Caffeic acid (CA) has been reported to possess important anti-inflammatory actions. However, the molecular mechanisms by which CA derivatives including caffeic acid phenethyl ester (CAPE) and caffeic acid phenylpropyl ester (CAPPE), exert inhibitory effects on the proliferation of human colorectal cancer (CRC) cells have yet to be elucidated. Methodology/Principal Findings: CAPE and CAPPE were evaluated for their ability to modulate these signaling pathways and suppress the proliferation of CRC cells both in vitro and in vivo. Anti-cancer effects of these CA derivatives were measured by using proliferation assays, cell cycle analysis, western blotting assay, reporter gene assay and immunohistochemical (IHC) staining assays both in vitro and in vivo. This study demonstrates that CAPE and CAPPE exhibit a dose-dependent inhibition of proliferation and survival of CRC cells through the induction of G(0)/G(1) cell cycle arrest and augmentation of apoptotic pathways. Consumption of CAPE and CAPPE significantly inhibited the growth of colorectal tumors in a mouse xenograft model. The mechanisms of action included a modulation of PI3-K/Akt, AMPK and m-TOR signaling cascades both in vitro and in vivo. In conclusion, the results demonstrate novel anti-cancer mechanisms of CA derivatives against the growth of human CRC cells. Conclusions: CA derivatives are potent anti-cancer agents that augment AMPK activation and promote apoptosis in human CRC cells. The structure of CA derivatives can be used for the rational design of novel inhibitors that target human CRC cells.	[Chiang, En-Pei Isabel] Natl Chung Hsing Univ, Dept Food Sci & Biotechnol, Taichung 40227, Taiwan; [Chiang, En-Pei Isabel] Natl Chung Hsing Univ, NCHU UCD Plant & Food Biotechnol Program, Taichung 40227, Taiwan; [Chiang, En-Pei Isabel] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung 40227, Taiwan; [Tsai, Shu-Yao] Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung, Taiwan; [Kuo, Yueh-Hsiung; Chiu, Hsi-Lin] China Med Univ, Dept Chinese Pharmaceut Sci & Chinese Med Resourc, Taichung, Taiwan; [Kuo, Yueh-Hsiung; Chiu, Hsi-Lin] Asia Univ, Dept Biotechnol, Taichung, Taiwan; [Pai, Man-Hui] Taipei Med Univ, Dept Anat, Taipei, Taiwan; [Rodriguez, Raymond L.] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Tang, Feng-Yao] China Med Univ, Dept Nutr, Biomed Sci Lab, Taichung, Taiwan	National Chung Hsing University; National Chung Hsing University; National Chung Hsing University; Asia University Taiwan; China Medical University Taiwan; Asia University Taiwan; Taipei Medical University; University of California System; University of California Davis; China Medical University Taiwan	Tang, FY (corresponding author), China Med Univ, Dept Nutr, Biomed Sci Lab, Taichung, Taiwan.	vincenttang@mail.cmu.edu.tw	Chiang, EnPei/K-1694-2013	Chiang, EnPei/0000-0002-0158-0962	National Science Council [NSC-100-2320-B-039-003, 100-2628-B005-002-MY4, 101-2320-B-039-054-MY3, 101-2320-B-005-006-MY3, 102-2911-I-005 -301, 101-2811-B-039-024]; Department of Health [DOH 102-TD-B-111-004, DOH-102-TD-C-111-005]; China Medical University (CMU) [CMU101- Award -10, CMU100-ASIA-11, CMU101-ASIA-3, CMU101-S-25]; Ministry of Education, Taiwan, R.O.C.	National Science Council(Ministry of Science and Technology, Taiwan); Department of Health; China Medical University (CMU)(China Medical University); Ministry of Education, Taiwan, R.O.C.(Ministry of Education, Taiwan)	This material is based upon work supported, in part, by the Ministry of Education, Taiwan, R.O.C. under the ATU plan, National Science Council grant, under Agreements NSC-100-2320-B-039-003, 100-2628-B005-002-MY4, 101-2320-B-039-054-MY3, 101-2320-B-005-006-MY3, 102-2911-I-005 -301, 101-2811-B-039-024, the Department of Health Grant under Agreements DOH 102-TD-B-111-004 and DOH-102-TD-C-111-005 and China Medical University (CMU) grant under Agreements CMU101- Award -10, CMU100-ASIA-11, CMU101-ASIA-3, and CMU101-S-25. Any opinions, findings, conclusions, or recommendations expressed in this publication are those of the author(s) and do not necessarily reflect the view of the Ministry of Education, National Science Council, Department of Health, National Chung Hsing University, Taipei Medical University, Asia University, University of California Davis and China Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algire C, 2010, ENDOCR-RELAT CANCER, V17, P351, DOI 10.1677/ERC-09-0252; Aparicio T, 1999, GASTROEN CLIN BIOL, V23, P330; Baba Y, 2010, BRIT J CANCER, V103, P1025, DOI 10.1038/sj.bjc.6605846; Bates RC, 2001, CANCER RES, V61, P5275; Chen MF, 2004, J RADIAT RES, V45, P253, DOI 10.1269/jrr.45.253; Chuu CP, 2012, CANCER PREV RES, V5, P788, DOI 10.1158/1940-6207.CAPR-12-0004-T; Fogarty S, 2010, BBA-PROTEINS PROTEOM, V1804, P581, DOI 10.1016/j.bbapap.2009.09.012; Gocer H, 2011, INT J FOOD SCI NUTR, V62, P821, DOI 10.3109/09637486.2011.585963; Gulhati P, 2012, CARCINOGENESIS, V33, P1782, DOI 10.1093/carcin/bgs203; Gustin JP, 2009, P NATL ACAD SCI USA, V106, P2835, DOI 10.1073/pnas.0813351106; Halilovic E, 2010, CANCER RES, V70, P6804, DOI 10.1158/0008-5472.CAN-10-0409; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hardie DG, 2003, FEBS LETT, V546, P113, DOI 10.1016/S0014-5793(03)00560-X; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kang SY, 2005, P NATL ACAD SCI USA, V102, P802, DOI 10.1073/pnas.0408864102; Kuchiba A, 2012, JNCI-J NATL CANCER I, V104, P415, DOI 10.1093/jnci/djr542; Kuo YY, 2013, INT J MOL SCI, V14, P8801, DOI 10.3390/ijms14058801; Liao HF, 2003, J AGR FOOD CHEM, V51, P7907, DOI 10.1021/jf034729d; Lin HP, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031286, 10.1371/journal.pone.0035240]; Liu YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047049; Mohan S, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-40; Nardini M, 1998, FREE RADICAL BIO MED, V25, P1098, DOI 10.1016/S0891-5849(98)00180-4; Nardini M, 2001, FREE RADICAL BIO MED, V30, P722, DOI 10.1016/S0891-5849(00)00515-3; Natarajan K, 1996, P NATL ACAD SCI USA, V93, P9090, DOI 10.1073/pnas.93.17.9090; Philp AJ, 2001, CANCER RES, V61, P7426; Piazzon A, 2012, J AGR FOOD CHEM, V60, P12312, DOI 10.1021/jf304076z; Ponnurangam S, 2013, MOL CANCER THER, V12, P598, DOI 10.1158/1535-7163.MCT-12-0907; Porstmann T, 2005, ONCOGENE, V24, P6465, DOI 10.1038/sj.onc.1208802; Pramanik KC, 2013, CARCINOGENESIS, V34, P2061, DOI 10.1093/carcin/bgt154; Ramana KV, 2010, MOL CANCER THER, V9, P813, DOI 10.1158/1535-7163.MCT-09-0795; Ribeiro U, 2007, J CLIN GASTROENTEROL, V41, P871, DOI 10.1097/MCG.0b013e31806b5938; SATO R, 1993, P NATL ACAD SCI USA, V90, P9261, DOI 10.1073/pnas.90.20.9261; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Slattery ML, 2010, CARCINOGENESIS, V31, P1604, DOI 10.1093/carcin/bgq142; Stacey DW, 2003, CURR OPIN CELL BIOL, V15, P158, DOI 10.1016/S0955-0674(03)00008-5; Tang FY, 2008, MOL NUTR FOOD RES, V52, P646, DOI 10.1002/mnfr.200700272; Tang FY, 2008, J NUTR BIOCHEM, V19, P287, DOI 10.1016/j.jnutbio.2007.03.003; Tang FY, 2012, MOL NUTR FOOD RES, V56, P1520, DOI 10.1002/mnfr.201200098; Tang FY, 2012, J NUTR BIOCHEM, V23, P1302, DOI 10.1016/j.jnutbio.2011.07.011; Tang FY, 2011, J AGR FOOD CHEM, V59, P9011, DOI 10.1021/jf2017644; Tolba MF, 2013, IUBMB LIFE, V65, P716, DOI 10.1002/iub.1188; Uwai K, 2008, BIOORGAN MED CHEM, V16, P7795, DOI 10.1016/j.bmc.2008.07.006; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Vogt PK, 2007, TRENDS BIOCHEM SCI, V32, P342, DOI 10.1016/j.tibs.2007.05.005; Wang QS, 1998, CARCINOGENESIS, V19, P2001, DOI 10.1093/carcin/19.11.2001; Wang W, 2009, ACTA PHYSIOL, V196, P55, DOI 10.1111/j.1748-1716.2009.01980.x; Wee S, 2009, CANCER RES, V69, P4286, DOI 10.1158/0008-5472.CAN-08-4765; Weyant MJ, 2000, CLIN CANCER RES, V6, P949; Wolter F, 2001, J NUTR, V131, P2197, DOI 10.1093/jn/131.8.2197; Xiang DB, 2006, ANTI-CANCER DRUG, V17, P753, DOI 10.1097/01.cad.0000224441.01082.bb; Yilmaz HR, 2004, J BIOCHEM MOL TOXIC, V18, P234, DOI 10.1002/jbt.20028; Zakikhani M, 2006, CANCER RES, V66, P10269, DOI 10.1158/0008-5472.CAN-06-1500; Zakikhani M, 2008, CANCER PREV RES, V1, P369, DOI 10.1158/1940-6207.CAPR-08-0081	57	74	74	4	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e99631	10.1371/journal.pone.0099631	http://dx.doi.org/10.1371/journal.pone.0099631			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24960186	Green Published, gold			2022-12-27	WOS:000338633900012
J	Shiloach, T; Berens, C; Danke, C; Waiskopf, O; Perlman, R; Ben-Yehuda, D				Shiloach, Tamar; Berens, Christian; Danke, Christina; Waiskopf, Ortal; Perlman, Riki; Ben-Yehuda, Dina			tLivin Displays Flexibility by Promoting Alternative Cell Death Mechanisms	PLOS ONE			English	Article							APOPTOSIS PROTEIN FAMILY; LUNG-CANCER; POLY(ADP-RIBOSE) POLYMERASE-1; SIGNAL-TRANSDUCTION; IAP PROTEINS; KINASE RIP; ML-IAP; INHIBITOR; LIVIN; EXPRESSION	Livin is a member of the Inhibitor of Apoptosis (IAP) protein family that inhibits apoptosis triggered by a variety of stimuli. We previously demonstrated that while Livin inhibits caspase activity, caspases can cleave Livin to produce a truncated protein, tLivin and that this newly formed tLivin paradoxically induces cell death. However to date, the mechanism of tLivin-induced cell death is not fully understood. In this study, we set out to characterize the form of cell death mediated by tLivin. Here we demonstrate that, unlike most death-promoting proteins, tLivin is a flexible inducer of cell death capable of promoting necrosis or apoptosis in different cell lines. The unusual flexibility of tLivin is displayed by its ability to activate an alternative form of cell death when apoptosis is inhibited. Thus, tLivin can promote more than one form of cell death in the same cell type. Interestingly, in cells where tLivin induces necrosis, deletion of the caspase binding BIR domain results in tLivin-induced apoptosis, suggesting the BIR domain can potentially hamper the ability of tLivin to induce apoptosis. We further elucidate that tLivin activates the JNK pathway and both tLivin-induced apoptosis and necrosis are partially mediated by JNK activity. Acquired resistance to apoptosis, common in many tumors, impinges on the efficiency of conventional anti-cancer agents that function primarily by inducing apoptosis. The ability of tLivin to induce death of apoptosis-compromised cells makes it an attractive candidate for targeted cancer therapy.	[Shiloach, Tamar; Waiskopf, Ortal; Perlman, Riki; Ben-Yehuda, Dina] Hadassah Hebrew Univ Med Ctr, Div Hematol, Jerusalem, Israel; [Berens, Christian; Danke, Christina] Univ Erlangen Nurnberg, Dept Biol Microbiol, D-91054 Erlangen, Germany	Hebrew University of Jerusalem; University of Erlangen Nuremberg	Ben-Yehuda, D (corresponding author), Hadassah Hebrew Univ Med Ctr, Div Hematol, Jerusalem, Israel.	dbyehuda@hadassah.org.il			Israel Science Foundation [524/06]; Public Committee for the Allocation of Estate Funds [3000003130]; Israel Ministry of Justice [3130]; Gabrielle Rich Leukemia Foundation	Israel Science Foundation(Israel Science Foundation); Public Committee for the Allocation of Estate Funds; Israel Ministry of Justice; Gabrielle Rich Leukemia Foundation	This work was supported by the Israel Science Foundation (grant 524/06), the Public Committee for the Allocation of Estate Funds (grant 3000003130), Israel Ministry of Justice (grant 3130) and the Gabrielle Rich Leukemia Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-Elrahman I, 2009, CANCER RES, V69, P5475, DOI 10.1158/0008-5472.CAN-09-0424; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; Ashhab Y, 2001, FEBS LETT, V495, P56, DOI 10.1016/S0014-5793(01)02366-3; Basu A, 2003, FEBS LETT, V538, P41, DOI 10.1016/S0014-5793(03)00131-5; Bode AM, 2007, MOL CARCINOGEN, V46, P591, DOI 10.1002/mc.20348; CAMPOS L, 1993, BLOOD, V81, P3091; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen G, 1997, J EXP MED, V186, P1975, DOI 10.1084/jem.186.12.1975; Chen YS, 2010, MOL BIOL REP, V37, P2241, DOI 10.1007/s11033-009-9711-3; Clem RJ, 2001, J BIOL CHEM, V276, P7602, DOI 10.1074/jbc.M010259200; Crnkovic-Mertens I, 2006, LUNG CANCER, V54, P135, DOI 10.1016/j.lungcan.2006.07.018; Danke C, 2010, J GENE MED, V12, P501, DOI 10.1002/jgm.1461; Deveraux QL, 1999, EMBO J, V18, P5242, DOI 10.1093/emboj/18.19.5242; Dickens M, 1997, SCIENCE, V277, P693, DOI 10.1126/science.277.5326.693; Dunai ZA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041945; Engstrom W, 2010, CELL PROLIFERAT, V43, P56, DOI 10.1111/j.1365-2184.2009.00654.x; Fan MY, 2000, J BIOL CHEM, V275, P29980, DOI 10.1074/jbc.M003776200; Fridman JS, 2003, ONCOGENE, V22, P9030, DOI 10.1038/sj.onc.1207116; Fulda S, 2012, NAT REV DRUG DISCOV, V11, P109, DOI 10.1038/nrd3627; Gong J, 2005, J CLIN PATHOL, V58, P1081, DOI 10.1136/jcp.2005.025817; Guimaraes CA, 2004, EUR J BIOCHEM, V271, P1638, DOI 10.1111/j.1432-1033.2004.04084.x; Hariu H, 2005, CLIN CANCER RES, V11, P1000; Herr R, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-17; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Hsu HL, 1996, IMMUNITY, V4, P387, DOI 10.1016/S1074-7613(00)80252-6; Kasof GM, 2001, J BIOL CHEM, V276, P3238, DOI 10.1074/jbc.M003670200; Kim BJ, 2006, J BIOL CHEM, V281, P21256, DOI 10.1074/jbc.M510644200; Kim DK, 2005, PEDIATR DEVEL PATHOL, V8, P621, DOI 10.1007/s10024-005-4108-3; Kim JY, 2011, APOPTOSIS, V16, P114, DOI 10.1007/s10495-010-0550-4; Kreuzaler P, 2012, NAT REV CANCER, V12, P411, DOI 10.1038/nrc3264; Lazar I, 2012, ONCOLOGY-BASEL, V82, P197, DOI 10.1159/000334234; LEHMANN F, 1995, EUR J IMMUNOL, V25, P340, DOI 10.1002/eji.1830250206; Levy DS, 2009, BLOOD, V113, P1723, DOI 10.1182/blood-2008-02-137737; Lin JH, 2000, BIOCHEM BIOPH RES CO, V279, P820, DOI 10.1006/bbrc.2000.4027; Liu GH, 2013, INT J ONCOL, V42, P2037, DOI 10.3892/ijo.2013.1883; LOWE SW, 1994, SCIENCE, V266, P807, DOI 10.1126/science.7973635; Ma L, 2006, CELL DEATH DIFFER, V13, P2079, DOI 10.1038/sj.cdd.4401959; Mace PD, 2010, CELL DEATH DIFFER, V17, P46, DOI 10.1038/cdd.2009.45; Maueroder C, 2013, AUTOIMMUNITY, V46, P329, DOI 10.3109/08916934.2012.752463; Moubarak RS, 2007, MOL CELL BIOL, V27, P4844, DOI 10.1128/MCB.02141-06; Nachmias B, 2003, CANCER RES, V63, P6340; Okada M, 2004, BLOOD, V103, P2299, DOI 10.1182/blood-2003-05-1605; Ondrouskova E, 2008, LEUKEMIA RES, V32, P599, DOI 10.1016/j.leukres.2007.05.012; Ronen D, 2009, J BIOL CHEM, V284, P24948, DOI 10.1074/jbc.M109.023754; Sakon S, 2003, EMBO J, V22, P3898, DOI 10.1093/emboj/cdg379; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Sanna MG, 2002, MOL CELL BIOL, V22, P1754, DOI 10.1128/MCB.22.6.1754-1766.2002; Shi Y, 2011, HERZ, V36, P296, DOI 10.1007/s00059-011-3470-3; Sugimoto K, 2002, BRIT J HAEMATOL, V118, P229, DOI 10.1046/j.1365-2141.2002.03577.x; Tanabe H, 2004, LUNG CANCER, V46, P299, DOI 10.1016/j.lungcan.2004.05.002; Tang FM, 2002, MOL CELL BIOL, V22, P8571, DOI 10.1128/MCB.22.24.8571-8579.2002; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Vande Velde C, 2000, MOL CELL BIOL, V20, P5454, DOI 10.1128/MCB.20.15.5454-5468.2000; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Ventura JJ, 2004, GENE DEV, V18, P2905, DOI 10.1101/gad.1223004; Ventura JJ, 2006, MOL CELL, V21, P701, DOI 10.1016/j.molcel.2006.01.018; Vucic D, 2000, CURR BIOL, V10, P1359, DOI 10.1016/S0960-9822(00)00781-8; Wagener N, 2007, BRIT J CANCER, V97, P1271, DOI 10.1038/sj.bjc.6604028; Wang SW, 2004, J BIOL CHEM, V279, P25535, DOI 10.1074/jbc.M400944200; Wang TS, 2010, BIOMED PHARMACOTHER, V64, P333, DOI 10.1016/j.biopha.2009.06.002; Xu Y, 2006, J BIOL CHEM, V281, P8788, DOI 10.1074/jbc.M508135200; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221	65	3	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e101075	10.1371/journal.pone.0101075	http://dx.doi.org/10.1371/journal.pone.0101075			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24960127	gold, Green Submitted, Green Published			2022-12-27	WOS:000338633900116
J	Chan, TC; Fu, YC; Wang, DW; Chuang, JH				Chan, Ta-Chien; Fu, Yang-chih; Wang, Da-Wei; Chuang, Jen-Hsiang			Determinants of Receiving the Pandemic (H1N1) 2009 Vaccine and Intention to Receive the Seasonal Influenza Vaccine in Taiwan	PLOS ONE			English	Article							COST-EFFECTIVENESS; SOCIAL NETWORKS; CHILDREN; SPREAD; IMPACT	Objectives: The paper examines the factors associated with both receiving pandemic (H1N1) 2009 vaccines and individuals' intentions to get the next seasonal influenza vaccine in Taiwan. Methods: We conducted a representative nationwide survey with in-person household interviews during April-July 2010. Multivariate logistic regression incorporated socio-demographic background, household characteristics, health status, behaviors, and perceptions of influenza and vaccination. Results: We completed interviews with 1,954 respondents. Among those, 548 (28.0%) received the pandemic (H1N1) 2009 vaccination, and 469 (24.0%) intended to get the next seasonal influenza vaccine. Receipt of the H1N1 vaccine was more prevalent among schoolchildren, the elderly, those who had contact with more people in their daily lives, and those who had received influenza vaccinations in previous years. In comparison, the intention to receive the next seasonal influenza vaccine tended to be stronger among children, the elderly, and those who reported less healthy status or lived with children, who received a seasonal influenza vaccination before, and who worried more about a possible new pandemic. Conclusions: Children, the elderly, and those who had gotten seasonal flu shots before in Taiwan were more likely to both receive a pandemic H1N1 vaccination and intend to receive a seasonal influenza vaccine.	[Chan, Ta-Chien] Acad Sinica, Res Ctr Human & Social Sci, Taipei 115, Taiwan; [Fu, Yang-chih] Acad Sinica, Inst Sociol, Taipei 115, Taiwan; [Wang, Da-Wei] Acad Sinica, Inst Informat Sci, Taipei, Taiwan; [Chuang, Jen-Hsiang] Ctr Dis Control, Deputy Director Gen Off, Taipei, Taiwan; [Chuang, Jen-Hsiang] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; Academia Sinica - Taiwan; Centers For Disease Control - Taiwan; National Yang Ming Chiao Tung University	Chuang, JH (corresponding author), Ctr Dis Control, Deputy Director Gen Off, Taipei, Taiwan.	jhchuang@cdc.gov.tw	Chuang, Jen-Hsiang/G-4356-2010	Chuang, Jen-Hsiang/0000-0002-7114-3418	Centers for Disease Control, Ministry of Health and Welfare, Taiwan, Republic of China [DOH99-DC-1004, DOH101-DC-1011]	Centers for Disease Control, Ministry of Health and Welfare, Taiwan, Republic of China	This work was supported in part by the grants DOH99-DC-1004 and DOH101-DC-1011 from the Centers for Disease Control, Ministry of Health and Welfare, Taiwan, Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashbaugh AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058852; Blank PR, 2009, J INFECTION, V58, P446, DOI 10.1016/j.jinf.2009.04.001; Brien S, 2012, VACCINE, V30, P1255, DOI 10.1016/j.vaccine.2011.12.089; Brunson EK, 2013, PEDIATRICS, V131, pE1397, DOI 10.1542/peds.2012-2452; Carpenter LR, 2007, PEDIATRICS, V120, pE172, DOI 10.1542/peds.2006-2603; Chan TC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011317; Chang YH, 2004, JGSS S 2003 BIRTH JG, P149; Chuang JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036120; Fu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045113; Glass LM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-61; Heikkinen T, 2011, VACCINE, V29, P7529, DOI 10.1016/j.vaccine.2011.08.011; Huang JH, 2012, EUR J PUBLIC HEALTH, V22, P796, DOI 10.1093/eurpub/ckr167; Lemeshow, 2000, APPL LOGISTIC REGRES, P95; Liao Q, 2013, VACCINE, V31, P4084, DOI 10.1016/j.vaccine.2013.07.009; Liao QY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068019; Lugner AK, 2010, HEALTH ECON, V19, P518, DOI 10.1002/hec.1485; Mamelund SE, 2011, VACCINE, V29, P9441, DOI 10.1016/j.vaccine.2011.10.035; Mao L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024706; Marchetti M, 2007, HUM VACCINES, V3, P14, DOI 10.4161/hv.3.1.3657; Mok E, 2006, PUBLIC HEALTH NURS, V23, P506, DOI 10.1111/j.1525-1446.2006.00590.x; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Muller D, 2007, INFECTION, V35, P308, DOI 10.1007/s15010-007-6218-5; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; Nguyen Trang, 2011, Infect Drug Resist, V4, P197, DOI 10.2147/IDR.S23174; Nichol KL, 2007, NEW ENGL J MED, V357, P1373, DOI 10.1056/NEJMoa070844; Painter JE, 2010, HEALTH EDUC RES, V25, P853, DOI 10.1093/her/cyq037; Plans-Rubio P, 2012, PREV MED, V55, P72, DOI 10.1016/j.ypmed.2012.02.015; Read JM, 2012, EPIDEMIOL INFECT, V140, P2117, DOI 10.1017/S0950268812000842; Read JM, 2008, J R SOC INTERFACE, V5, P1001, DOI 10.1098/rsif.2008.0013; Setbon M, 2010, EUR J PUBLIC HEALTH, V20, P490, DOI 10.1093/eurpub/ckq054; Shim E, 2013, MATH BIOSCI ENG, V10, P1615, DOI 10.3934/mbe.2013.10.1615; Sypsa V, 2009, EUROSURVEILLANCE, V14, P2; Szucs TD, 2006, VACCINE, V24, P6776, DOI 10.1016/j.vaccine.2006.06.072; Tarride JE, 2011, VALUE HEALTH, V14, pA119, DOI 10.1016/j.jval.2011.02.665; Tricco AC, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-153; Yang CL., 2013, TAIWAN EPIDEMIOL B, V29, P252	36	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e101083	10.1371/journal.pone.0101083	http://dx.doi.org/10.1371/journal.pone.0101083			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK6BK	24971941	Green Published, Green Submitted, gold			2022-12-27	WOS:000338512200091
J	O'Rourke, BP; Gomez-Ferreria, MA; Berk, RH; Hackl, AMU; Nicholas, MP; O'Rourke, SC; Pelletier, L; Sharp, DJ				O'Rourke, Brian P.; Gomez-Ferreria, Maria Ana; Berk, Robin H.; Hackl, Alexandra M. U.; Nicholas, Matthew P.; O'Rourke, Sean C.; Pelletier, Laurence; Sharp, David J.			Cep192 Controls the Balance of Centrosome and Non-Centrosomal Microtubules during Interphase	PLOS ONE			English	Article							SEVERING ENZYME; GOLGI-COMPLEX; PROTEIN; TUBULIN; ORGANIZATION; NUCLEATION; INTERACTS; DYNAMICS; REVEALS; EB1	Cep192 is a centrosomal protein that contributes to the formation and function of the mitotic spindle in mammalian cells. Cep192's mitotic activities stem largely from its role in the recruitment to the centrosome of numerous additional proteins such as gamma-tubulin and Pericentrin. Here, we examine Cep192's function in interphase cells. Our data indicate that, as in mitosis, Cep192 stimulates the nucleation of centrosomal microtubules thereby regulating the morphology of interphase microtubule arrays. Interestingly, however, cells lacking Cep192 remain capable of generating normal levels of MTs as the loss of centrosomal microtubules is augmented by MT nucleation from other sites, most notably the Golgi apparatus. The depletion of Cep192 results in a significant decrease in the level of centrosome-associated gamma-tubulin, likely explaining its impact on centrosome microtubule nucleation. However, in stark contrast to mitosis, Cep192 appears to maintain an antagonistic relationship with Pericentrin at interphase centrosomes. Interphase cells depleted of Cep192 display significantly higher levels of centrosome-associated Pericentrin while overexpression of Cep192 reduces the levels of centrosomal Pericentrin. Conversely, depletion of Pericentrin results in elevated levels of centrosomal Cep192 and enhances microtubule nucleation at centrosomes, at least during interphase. Finally, we show that depletion of Cep192 negatively impacts cell motility and alters normal cell polarization. Our current working hypothesis is that the microtubule nucleating capacity of the interphase centrosome is determined by an antagonistic balance of Cep192, which promotes nucleation, and Pericentrin, which inhibits nucleation. This in turn determines the relative abundance of centrosomal and non-centrosomal microtubules that tune cell movement and shape.	[O'Rourke, Brian P.; Berk, Robin H.; Hackl, Alexandra M. U.; O'Rourke, Sean C.; Sharp, David J.] Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10467 USA; [Gomez-Ferreria, Maria Ana; Pelletier, Laurence] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Nicholas, Matthew P.] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Yeshiva University; Albert Einstein College of Medicine	Sharp, DJ (corresponding author), Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10467 USA.	david.sharp@einstein.yu.edu	Pelletier, Laurence/F-8858-2013		Telemedicine and Advanced Technology Research Center (TATRC) at the U.S. Army Medical Research and Materiel Command (USAMRMC) [W81XWH1210379]; NIH MSTP [T32-GM007288]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER	Telemedicine and Advanced Technology Research Center (TATRC) at the U.S. Army Medical Research and Materiel Command (USAMRMC)(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); NIH MSTP(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	DJS and the Sharp lab were supported by the Telemedicine and Advanced Technology Research Center (TATRC) at the U.S. Army Medical Research and Materiel Command (USAMRMC) through award W81XWH1210379. MPN was supported by the NIH MSTP Training Grant T32-GM007288. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Applegate KT, 2011, J STRUCT BIOL, V176, P168, DOI 10.1016/j.jsb.2011.07.009; Bartolini F, 2006, J CELL SCI, V119, P4155, DOI 10.1242/jcs.03227; Berrueta L, 1998, P NATL ACAD SCI USA, V95, P10596, DOI 10.1073/pnas.95.18.10596; Bugnard E, 2005, CELL MOTIL CYTOSKEL, V60, P1, DOI 10.1002/cm.20042; Chabin-Brion K, 2001, MOL BIOL CELL, V12, P2047, DOI 10.1091/mbc.12.7.2047; Dammermann A, 2002, J CELL BIOL, V159, P255, DOI 10.1083/jcb.200204023; Efimov A, 2007, DEV CELL, V12, P917, DOI 10.1016/j.devcel.2007.04.002; Fong KW, 2008, MOL BIOL CELL, V19, P115, DOI 10.1091/mbc.E07-04-0371; Gomez-Ferreria MA, 2007, CURR BIOL, V17, P1960, DOI 10.1016/j.cub.2007.10.019; Gomez-Ferreria MA, 2012, CELL CYCLE, V11, P3555, DOI 10.4161/cc.21574; Grimaldi AD, 2013, METHOD CELL BIOL, V118, P401, DOI 10.1016/B978-0-12-417164-0.00024-0; Joukov V, 2010, P NATL ACAD SCI USA, V107, P21022, DOI 10.1073/pnas.1014664107; Kean MJ, 2011, J BIOL CHEM, V286, P25065, DOI 10.1074/jbc.M110.214486; KREIS TE, 1987, EMBO J, V6, P2597, DOI 10.1002/j.1460-2075.1987.tb02550.x; Lawo S, 2012, NAT CELL BIOL, V14, P1148, DOI 10.1038/ncb2591; Lee K, 2011, J CELL BIOL, V195, P1093, DOI 10.1083/jcb.201106093; Lerit DA, 2013, J CELL BIOL, V202, P1013, DOI 10.1083/jcb.201303141; Mennella V, 2012, NAT CELL BIOL, V14, P1159, DOI 10.1038/ncb2597; Miller PM, 2009, NAT CELL BIOL, V11, P1069, DOI 10.1038/ncb1920; Morrison EE, 1998, ONCOGENE, V17, P3471, DOI 10.1038/sj.onc.1202247; Mukherjee S, 2012, CELL CYCLE, V11, P2359, DOI 10.4161/cc.20849; Nishimura Y, 2012, PLOS ONE, V7, P24; PONTEN J, 1967, INT J CANCER, V2, P434, DOI 10.1002/ijc.2910020505; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Sonbuchner TM, 2010, CELL CYCLE, V9, P2403, DOI 10.4161/cc.9.12.11916; Sonnen KF, 2013, J CELL SCI, V126, P3223, DOI 10.1242/jcs.129502; Tran ADA, 2007, J CELL SCI, V120, P1469, DOI 10.1242/jcs.03431; Vinogradova T, 2012, MOL BIOL CELL, V23, P820, DOI 10.1091/mbc.E11-06-0550; Vinopal S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029919; Wang WJ, 2011, J CELL BIOL, V193, P727, DOI 10.1083/jcb.201101109; WEBSTER DR, 1989, J CELL SCI, V92, P57; White RA, 2000, MICROSC RES TECHNIQ, V49, P451, DOI 10.1002/(SICI)1097-0029(20000601)49:5<451::AID-JEMT7>3.0.CO;2-9; Yvon AMC, 2002, MOL BIOL CELL, V13, P1871, DOI 10.1091/mbc.01-11-0539; ZHAI Y, 1994, J CELL SCI, V107, P881; Zhu F, 2008, CURR BIOL, V18, P136, DOI 10.1016/j.cub.2007.12.055	36	28	28	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e101001	10.1371/journal.pone.0101001	http://dx.doi.org/10.1371/journal.pone.0101001			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971877	gold, Green Published			2022-12-27	WOS:000338512200082
J	Beauchet, O; Launay, CP; Merjagnan, C; Kabeshova, A; Annweiler, C				Beauchet, Olivier; Launay, Cyrille P.; Merjagnan, Christine; Kabeshova, Anastasiia; Annweiler, Cedric			Quantified Self and Comprehensive Geriatric Assessment: Older Adults Are Able to Evaluate Their Own Health and Functional Status	PLOS ONE			English	Article							ASSESSMENT SCHEDULE 2.0; ALZHEIMERS-DISEASE; DEMENTIA; INTERVENTION; METAANALYSIS; MULTICENTER; PREVALENCE; INPATIENTS; COMMUNITY; DECLINE	Background: There is an increased interest of individuals in quantifying their own health and functional status. The aim of this study was to examine the concordance of answers to a self-administered questionnaire exploring health and functional status with information collected during a full clinical examination performed by a physician among cognitively healthy adults (CHI) and older patients with mild cognitive impairment (MCI) or mild-to-moderate Alzheimer disease (AD). Methods: Based on cross-sectional design, a total of 60 older adults (20 CHI, 20 patients with MCI, and 20 patients with mildto-moderate AD) were recruited in the memory clinic of Angers, France. All participants completed a self-administered questionnaire in paper format composed of 33 items exploring age, gender, nutrition, place of living, social resources, drugs daily taken, memory complaint, mood and general feeling, fatigue, activities of daily living, physical activity and history of falls. Participants then underwent a full clinical examination by a physician exploring the same domains. Results: High concordance between the self-administered questionnaire and physician's clinical examination was showed. The few divergences were related to cognitive status, answers of AD and MCI patients to the self-administered questionnaire being less reliable than those of CHI. Conclusion: Older adults are able to evaluate their own health and functional status, regardless of their cognitive status. This result needs to be confirmed and opens new perspectives for the quantified self-trend and could be helpful in daily clinical practice of primary care.	[Beauchet, Olivier; Launay, Cyrille P.; Merjagnan, Christine; Kabeshova, Anastasiia; Annweiler, Cedric] Angers Univ Hosp, Dept Neurosci, Angers, France; [Beauchet, Olivier; Merjagnan, Christine] Biomathics, Paris, France; [Annweiler, Cedric] Univ Western Ontario, Dept Med Biophys, London, ON, Canada	Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Western University (University of Western Ontario)	Beauchet, O (corresponding author), Angers Univ Hosp, Dept Neurosci, Angers, France.	olbeauchet@chu-angers.fr	Beauchet, Olivier/AAP-8108-2020	Annweiler, Cedric/0000-0002-7199-8109				Adam S., 2004, EVALUATION TROUBLES; Andrews G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008343; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Beauchet O, 2011, J NUTR HEALTH AGING, V15, P79, DOI 10.1007/s12603-011-0016-6; Berrut G, 2013, J NUTR HEALTH AGING, V17, P688, DOI 10.1007/s12603-013-0039-2; BROWN EC, 1958, J CONSULT PSYCHOL, V22, P469, DOI 10.1037/h0039980; den Braber Maarten, 2013, Ned Tijdschr Geneeskd, V157, pA7028; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GROBER E, 1988, NEUROLOGY, V38, P900, DOI 10.1212/WNL.38.6.900; Hoogerduijn JG, 2007, J CLIN NURS, V16, P46, DOI 10.1111/j.1365-2702.2006.01579.x; KATZ S, 1970, GERONTOLOGIST, V10, P20, DOI 10.1093/geront/10.1_Part_1.20; Kramers PGN, 2003, EUR J PUBLIC HEALTH, V13, P101, DOI 10.1093/eurpub/13.suppl_1.101; Lang PO, 2010, J NUTR HEALTH AGING, V14, P141, DOI 10.1007/s12603-009-0182-y; Li CM, 2010, ARCH GERONTOL GERIAT, V50, pS39, DOI 10.1016/S0167-4943(10)70011-X; Matthews FE, 2013, LANCET, V382, P1405, DOI 10.1016/S0140-6736(13)61570-6; McCusker J, 2001, J AM GERIATR SOC, V49, P1272, DOI 10.1046/j.1532-5415.2001.49254.x; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Peres K, 2006, NEUROLOGY, V67, P461, DOI 10.1212/01.wnl.0000228228.70065.f1; Popa-Wagner A, 2013, J NEURAL TRANSM; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Rockwood K, 2012, CAN GERIATR J, V15, P31, DOI 10.5770/cgj.15.35; ROSEN WG, 1984, AM J PSYCHIAT, V141, P1356; Salomon JA, 2009, AM J EPIDEMIOL, V170, P343, DOI 10.1093/aje/kwp144; Shah A, 1997, AGE AGEING, V26, P217, DOI 10.1093/ageing/26.3.217; Sternberg SA, 2011, J AM GERIATR SOC, V59, P2129, DOI 10.1111/j.1532-5415.2011.03597.x; Ustun TB, 2010, B WORLD HEALTH ORGAN, V88, P815, DOI 10.2471/BLT.09.067231; Van Craen K, 2010, J AM GERIATR SOC, V58, P83, DOI 10.1111/j.1532-5415.2009.02621.x; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x; World Health Organization, 1996, WHO REGIONAL PUBLICA, V58	31	23	23	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100636	10.1371/journal.pone.0100636	http://dx.doi.org/10.1371/journal.pone.0100636			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK2WP	24968016	gold, Green Published, Green Submitted			2022-12-27	WOS:000338280800049
J	Kabbout, M; Dakhlallah, D; Sharma, S; Bronisz, A; Srinivasan, R; Piper, M; Marsh, CB; Ostrowski, MC				Kabbout, Mohamed; Dakhlallah, Duaa; Sharma, Sudarshana; Bronisz, Agnieszka; Srinivasan, Ruchika; Piper, Melissa; Marsh, Clay B.; Ostrowski, Michael C.			MicroRNA 17-92 Cluster Mediates ETS1 and ETS2-Dependent RAS-Oncogenic Transformation	PLOS ONE			English	Article							C-MYC; TRANSCRIPTION FACTORS; GENE-EXPRESSION; CELLULAR-TRANSFORMATION; MIR-17-92 CLUSTER; BREAST-CANCER; CELLS; SURVIVAL; FAMILY; PROLIFERATION	The ETS-family transcription factors Ets1 and Ets2 are evolutionarily conserved effectors of the RAS/ERK signaling pathway, but their function in Ras cellular transformation and biology remains unclear. Taking advantage of Ets1 and Ets2 mouse models to generate Ets1/Ets2 double knockout mouse embryonic fibroblasts, we demonstrate that deletion of both Ets1 and Ets2 was necessary to inhibit Hras(G12V) induced transformation both in vitro and in vivo. Hras(G12V) expression in mouse embryonic fibroblasts increased ETS1 and ETS2 expression and binding to cis-regulatory elements on the c-Myc proximal promoter, and consequently induced a robust increase in MYC expression. The expression of the oncogenic microRNA 17-92 cluster was increased in Hras(G12V) transformed cells, but was significantly reduced when ETS1 and ETS2 were absent. MYC and ETS1 or ETS2 collaborated to increase expression of the oncogenic microRNA 17-92 cluster in Hras(G12V) transformed cells. Enforced expression of exogenous MYC or microRNA 17-92 rescued Hras(G12V) transformation in Ets1/Ets2-null cells, revealing a direct function for MYC and microRNA 17-92 in ETS1/ETS2-dependent Hras(G12V) transformation.	[Kabbout, Mohamed; Sharma, Sudarshana; Bronisz, Agnieszka; Srinivasan, Ruchika; Ostrowski, Michael C.] Ohio State Univ, Coll Med, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Kabbout, Mohamed; Dakhlallah, Duaa; Srinivasan, Ruchika] Ohio State Univ, Grad Program Mol Cellular & Dev Biol, Columbus, OH 43210 USA; [Kabbout, Mohamed; Sharma, Sudarshana; Bronisz, Agnieszka; Srinivasan, Ruchika; Ostrowski, Michael C.] Ohio State Univ, Ctr Comprehens Canc, Solid Tumor Program, Columbus, OH 43210 USA; [Dakhlallah, Duaa; Piper, Melissa; Marsh, Clay B.] Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Piper, Melissa; Marsh, Clay B.] Ohio State Univ, Coll Med, Dept Internal Med, Div Pulm Allergy Crit Care & Sleep Med, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Ostrowski, MC (corresponding author), Ohio State Univ, Coll Med, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA.	michael.ostrowski@osumc.edu	Sharma, Sudarshana Mangalore/AAI-2475-2019; Bronisz, Agnieszka/G-5980-2019; Bronisz, Agnieszka/M-3485-2019; Ostrowski, Michael/H-3108-2011	Bronisz, Agnieszka/0000-0002-5841-1051; Bronisz, Agnieszka/0000-0002-5841-1051; Dakhlallah, Duaa A/0000-0002-6288-4927; Ostrowski, Michael/0000-0003-2948-6297; Sharma, Sudarshana/0000-0002-9745-0061	National Institutes of Health [P01CA097189, R01CA053271]; NATIONAL CANCER INSTITUTE [P01CA097189, P30CA016058] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grants P01CA097189 (M.C.O.) and R01CA053271 (M.C.O.) (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Al-Azawi D, 2008, ONCOGENE, V27, P3021, DOI 10.1038/sj.onc.1210964; Albert T, 2001, J BIOL CHEM, V276, P20482, DOI 10.1074/jbc.M100265200; Angstadt AY, 2012, CANCER GENET-NY, V205, P572, DOI 10.1016/j.cancergen.2012.09.005; Baumhoer D, 2012, CANCER GENET-NY, V205, P212, DOI 10.1016/j.cancergen.2012.03.001; de Nigris F, 2001, CANCER RES, V61, P2267; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Drosten M, 2010, EMBO J, V29, P1091, DOI 10.1038/emboj.2010.7; Eisenman RN, 2001, GENE DEV, V15, P2023, DOI 10.1101/gad928101; Foulds CE, 2004, MOL CELL BIOL, V24, P10954, DOI 10.1128/MCB.24.24.10954-10964.2004; Galang CK, 1996, J BIOL CHEM, V271, P7992, DOI 10.1074/jbc.271.14.7992; Galang CK, 2004, J BIOL CHEM, V279, P11281, DOI 10.1074/jbc.M311887200; Graves BJ, 1998, ADV CANCER RES, V75, P1, DOI 10.1016/S0065-230X(08)60738-1; Hamad NM, 2002, GENE DEV, V16, P2045, DOI 10.1101/gad.993902; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hever A, 2003, EXP CELL RES, V290, P132, DOI 10.1016/S0014-4827(03)00315-X; Hollenhorst PC, 2004, NUCLEIC ACIDS RES, V32, P5693, DOI 10.1093/nar/gkh906; Hong LX, 2010, CANCER RES, V70, P8547, DOI 10.1158/0008-5472.CAN-10-1938; KLAMBT C, 1993, DEVELOPMENT, V117, P163; KRUMM A, 1995, GENE DEV, V9, P559, DOI 10.1101/gad.9.5.559; LANGER SJ, 1992, MOL CELL BIOL, V12, P5355, DOI 10.1128/MCB.12.12.5355; Li RZ, 2000, ONCOGENE, V19, P6514, DOI 10.1038/sj.onc.1204035; Mattingly RR., 2013, ISRN ONCOL, V2013; MUTHUSAMY N, 1995, NATURE, V377, P639, DOI 10.1038/377639a0; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Reichek JL, 2011, CLIN CANCER RES, V17, P1463, DOI 10.1158/1078-0432.CCR-10-0091; Saxena N, 2008, CANCER INVEST, V26, P948, DOI 10.1080/07357900802087275; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang XW, 2013, SCI REP-UK, V3, DOI 10.1038/srep01942; WASYLYK C, 1994, ONCOGENE, V9, P3665; Wei G, 2004, J IMMUNOL, V173, P1374, DOI 10.4049/jimmunol.173.2.1374; Wei G, 2009, BLOOD, V114, P1123, DOI 10.1182/blood-2009-03-211391; WHITE MA, 1995, CELL, V80, P533, DOI 10.1016/0092-8674(95)90507-3; Williamson D, 2005, J CLIN ONCOL, V23, P880, DOI 10.1200/JCO.2005.11.078; Wittinghofer A, 1998, BIOL CHEM, V379, P933; Xu DK, 2008, J BIOL CHEM, V283, P23567, DOI 10.1074/jbc.M800790200; Yang BS, 1996, MOL CELL BIOL, V16, P538	40	13	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100693	10.1371/journal.pone.0100693	http://dx.doi.org/10.1371/journal.pone.0100693			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968297	gold, Green Published, Green Submitted			2022-12-27	WOS:000338280800052
J	Li, RY; Zhang, LL; Jia, LZ; Duan, Y; Li, Y; Bao, LD; Sha, N				Li, Ruiya; Zhang, Lingli; Jia, Lizhou; Duan, Yan; Li, Yan; Bao, Lidao; Sha, Na			Long Non-Coding RNA BANCR Promotes Proliferation in Malignant Melanoma by Regulating MAPK Pathway Activation	PLOS ONE			English	Article							EPIDERMAL NEOPLASIA; INHIBITOR U0126; CANCER; KINASE; DISEASE; GROWTH; TUMOR; METASTASIS; MECHANISMS; CELLS	Long non-coding RNAs (lncRNAs) have been shown to be implicated in the complex network of cancer including malignant melanoma and play important roles in tumorigenesis and progression. However, their functions and downstream mechanisms are largely unknown. This study aimed to investigate whether BRAF-activated non-coding RNA (BANCR), a novel and potential regulator of melanoma cell, participates in the proliferation of malignant melanoma and elucidate the underlying mechanism in this process. We found that BANCR was abnormally overexpressed in human malignant melanoma cell lines and tissues, and increased with tumor stages by quantitative PCR. BANCR knockdown induced by shRNA transfection significantly inhibited proliferation of tumor cells and inactivated MAPK pathway, especially by silencing the ERK1/2 and JNK component. Moreover, combination treatment of BANCR knockdown and suppression ERK1/2 or JNK (induced by specific inhibitors U0126 or SP600125 respectively) produced synergistic inhibitory effects in vitro. And the inhibitory effects induced by ERK1/2 or JNK could be rescued by BANCR overexpression. By tumorigenicity assay in BALB/c nude mice, we further found that BANCR knockdown inhibited tumor growth in vivo. In addition, patients with high expression of BANCR had a lower survival rate. Taken together, we confirmed the abnormal upregulation of a novel lncRNA, BANCR, in human malignant melanoma. BANCR was involved in melanoma cell proliferation both in vitro and in vivo. The linkage between BANCR and MAPK pathway may provide a novel interpretation for the mechanism of proliferation regulation in malignant melanoma.	[Li, Ruiya; Duan, Yan; Sha, Na] Inner Mongolia Peoples Hosp, Dept Dermatol, Hohhot, Inner Mongolia, Peoples R China; [Zhang, Lingli] Inner Mongolia Peoples Hosp, Dept Pathol, Hohhot, Inner Mongolia, Peoples R China; [Jia, Lizhou] Inner Mongolia Med Univ, Affiliated Peoples Hosp, Dept Pathol, Hohhot, Inner Mongolia, Peoples R China; [Li, Yan] Inner Mongolia Med Univ, Affiliated Hosp, Dept Dermatol, Hohhot, Inner Mongolia, Peoples R China; [Bao, Lidao] Inner Mongolia Med Univ, Affiliated Hosp, Dept Pharm, Hohhot, Inner Mongolia, Peoples R China	Inner Mongolia Medical University; Inner Mongolia Medical University; Inner Mongolia Medical University	Sha, N (corresponding author), Inner Mongolia Peoples Hosp, Dept Dermatol, Hohhot, Inner Mongolia, Peoples R China.	drnasha@126.com						Basu S, 2009, P NATL ACAD SCI USA, V106, P7957, DOI 10.1073/pnas.0902857106; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Cheetham SW, 2013, BRIT J CANCER, V108, P2419, DOI 10.1038/bjc.2013.233; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dhomen N, 2009, CANCER CELL, V15, P294, DOI 10.1016/j.ccr.2009.02.022; Ellis B. C, 2013, BIOCH BIOPHYS ACTA; Flockhart RJ, 2012, GENOME RES, V22, P1006, DOI 10.1101/gr.140061.112; Flores LG, 2013, MOL IMAGING BIOL, V15, P175, DOI 10.1007/s11307-012-0588-5; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Han JH, 2007, TRENDS BIOCHEM SCI, V32, P364, DOI 10.1016/j.tibs.2007.06.007; Hombach S, 2013, BIOESSAYS, V35, P1093, DOI 10.1002/bies.201300068; Jiang M, 2013, BIOCH PHARM; Jin JY, 2011, J INVEST DERMATOL, V131, P1149, DOI 10.1038/jid.2011.1; Ke HN, 2013, J INVEST DERMATOL, V133, P221, DOI 10.1038/jid.2012.253; Ke HN, 2010, CANCER RES, V70, P3080, DOI 10.1158/0008-5472.CAN-09-2923; Lasithiotakis KG, J INVEST DERMATOL, V128, P2013; Lee DJ, 2013, CANCER RES, V73, P4744, DOI 10.1158/0008-5472.CAN-12-4226; MacKie RM, 2009, ANN ONCOL, V20, P1, DOI 10.1093/annonc/mdp252; Marampon F, 2009, MOL CANCER THER, V8, P543, DOI 10.1158/1535-7163.MCT-08-0570; Margue C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073473; McCarthy N, 2012, NAT REV CANCER, V12, P454, DOI 10.1038/nrc3302; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; Nagano T, 2011, CELL, V145, P178, DOI 10.1016/j.cell.2011.03.014; Rajagopalan H, 2002, NATURE, V418, P934, DOI 10.1038/418934a; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Shieh JM, 2010, BRIT J PHARMACOL, V160, P1171, DOI 10.1111/j.1476-5381.2010.00746.x; Shields JM, 2000, TRENDS CELL BIOL, V10, P147, DOI 10.1016/S0962-8924(00)01740-2; Solus JF, 2013, ADV ANAT PATHOL, V20, P217, DOI 10.1097/PAP.0b013e3182976c94; Wang WF, 2010, CANCER SCI, V101, P112, DOI 10.1111/j.1349-7006.2009.01370.x; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001; Wu W, 2013, ACTA GEOTECH, V8, P1, DOI 10.1007/s11440-013-0214-y; Yang LQ, 2013, NATURE, V500, P598, DOI 10.1038/nature12451; Yang X, 2013, GUT, V9; Yang Z, 2011, ANN SURG ONCOL, V18, P1243, DOI 10.1245/s10434-011-1581-y	36	132	145	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100893	10.1371/journal.pone.0100893	http://dx.doi.org/10.1371/journal.pone.0100893			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967732	gold, Green Published, Green Submitted			2022-12-27	WOS:000338280800077
J	Lu, ZH; Rynkiewicz, MJ; Madico, G; Li, S; Yang, CY; Perkins, HM; Sompuram, SR; Kodela, V; Liu, T; Morris, T; Wang, D; Roche, MI; Seaton, BA; Sharon, J				Lu, Zhaohua; Rynkiewicz, Michael J.; Madico, Guillermo; Li, Sheng; Yang, Chiou-Ying; Perkins, Hillary M.; Sompuram, Seshi R.; Kodela, Vani; Liu, Tong; Morris, Timothy; Wang, Daphne; Roche, Marly I.; Seaton, Barbara A.; Sharon, Jacqueline			B-Cell Epitopes in GroEL of Francisella tularensis	PLOS ONE			English	Article							LIVE VACCINE STRAIN; OUTER-MEMBRANE PROTEIN; BETA T-CELLS; HEAT-SHOCK PROTEINS; PROTECTIVE IMMUNITY; O-ANTIGEN; MONOCLONAL-ANTIBODIES; SWISS-MODEL; CHLAMYDIA-TRACHOMATIS; MASS-SPECTROMETRY	The chaperonin protein GroEL, also known as heat shock protein 60 (Hsp60), is a prominent antigen in the human and mouse antibody response to the facultative intracellular bacterium Francisella tularensis (Ft), the causative agent of tularemia. In addition to its presumed cytoplasmic location, FtGroEL has been reported to be a potential component of the bacterial surface and to be released from the bacteria. In the current study, 13 IgG2a and one IgG3 mouse monoclonal antibodies (mAbs) specific for FtGroEL were classified into eleven unique groups based on shared VH-VL germline genes, and seven crossblocking profiles revealing at least three non-overlapping epitope areas in competition ELISA. In a mouse model of respiratory tularemia with the highly pathogenic Ft type A strain SchuS4, the Ab64 and N200 IgG2a mAbs, which block each other's binding to and are sensitive to the same two point mutations in FtGroEL, reduced bacterial burden indicating that they target protective GroEL B-cell epitopes. The Ab64 and N200 epitopes, as well as those of three other mAbs with different crossblocking profiles, Ab53, N3, and N30, were mapped by hydrogen/deuterium exchange-mass spectrometry (DXMS) and visualized on a homology model of FtGroEL. This model was further supported by its experimentally-validated computational docking to the X-ray crystal structures of Ab64 and Ab53 Fabs. The structural analysis and DXMS profiles of the Ab64 and N200 mAbs suggest that their protective effects may be due to induction or stabilization of a conformational change in FtGroEL.	[Lu, Zhaohua; Madico, Guillermo; Yang, Chiou-Ying; Perkins, Hillary M.; Roche, Marly I.; Sharon, Jacqueline] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA; [Rynkiewicz, Michael J.; Seaton, Barbara A.] Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA; [Madico, Guillermo] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Li, Sheng; Liu, Tong; Morris, Timothy; Wang, Daphne] Univ Calif San Diego, Dept Med, Sch Med, San Diego, CA 92103 USA; [Yang, Chiou-Ying] Natl Chung Hsing Univ, Inst Mol Biol, Taichung 40227, Taiwan; [Sompuram, Seshi R.; Kodela, Vani] Med Discovery Partners LLC, Boston, MA USA	Boston University; Boston University; Boston University; University of California System; University of California San Diego; National Chung Hsing University	Sharon, J (corresponding author), Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA.	jsharon@bu.edu		Rynkiewicz, Michael/0000-0002-4717-5700; Yang, Chiou-Ying/0000-0001-7130-1781	National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Department of Health and Human Services [HHSN272200900054C]; NIH [1S10RR029388]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029388] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH, http://www.nih.gov/), Department of Health and Human Services, under Contract No. HHSN272200900054C to JS, and NIH grant No. 1S10RR029388 to Virgil L. Woods Jr. (now deceased). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aiyegbo MS, 2014, J VIROL, V88, P469, DOI 10.1128/JVI.01665-13; Andersen PH, 2006, PROTEIN SCI, V15, P2558, DOI 10.1110/ps.062405906; Apicella MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011060; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bae JE, 2002, VET MICROBIOL, V88, P189, DOI 10.1016/S0378-1135(02)00101-3; Bakshi CS, 2008, VACCINE, V26, P5276, DOI 10.1016/j.vaccine.2008.07.051; Bansal A, 2010, MOL CELL BIOCHEM, V337, P213, DOI 10.1007/s11010-009-0301-4; Barbas CF, 1997, SCIENCE, V278, P2085, DOI 10.1126/science.278.5346.2085; Chen DH, 2013, CELL, V153, P1354, DOI 10.1016/j.cell.2013.04.052; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; Comeau SR, 2007, PROTEINS, V69, P781, DOI 10.1002/prot.21795; Conlan JW, 2011, FUTURE MICROBIOL, V6, P391, DOI [10.2217/FMB.11.22, 10.2217/fmb.11.22]; Conlan JW, 2002, VACCINE, V20, P3465, DOI 10.1016/S0264-410X(02)00345-6; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; DRABICK JJ, 1994, AM J MED SCI, V308, P83, DOI 10.1097/00000441-199408000-00003; Elkins KL, 2007, ANN NY ACAD SCI, V1105, P284, DOI 10.1196/annals.1409.014; Elkins KL, 1999, INFECT IMMUN, V67, P6002, DOI 10.1128/IAI.67.11.6002-6007.1999; Elkins KL, 1996, INFECT IMMUN, V64, P3288, DOI 10.1128/IAI.64.8.3288-3293.1996; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ericsson M, 2001, SCAND J INFECT DIS, V33, P145, DOI 10.1080/003655401750065562; ERICSSON M, 1994, INFECT IMMUN, V62, P178, DOI 10.1128/IAI.62.1.178-183.1994; Eyles JE, 2008, MICROB PATHOGENESIS, V44, P164, DOI 10.1016/j.micpath.2007.08.009; Eyles JE, 2007, PROTEOMICS, V7, P2172, DOI 10.1002/pmic.200600985; Fink AL, 1999, PHYSIOL REV, V79, P425, DOI 10.1152/physrev.1999.79.2.425; FORTIER AH, 1991, INFECT IMMUN, V59, P2922, DOI 10.1128/IAI.59.9.2922-2928.1991; Foshay L, 1940, MEDICINE, V19, P1, DOI 10.1097/00005792-194002000-00001; FULOP M, 1995, VACCINE, V13, P1220, DOI 10.1016/0264-410X(95)00062-6; Fulop M, 1996, FEMS IMMUNOL MED MIC, V13, P245, DOI 10.1111/j.1574-695X.1996.tb00245.x; Fulop M, 2001, VACCINE, V19, P4465, DOI 10.1016/S0264-410X(01)00189-X; Grason JP, 2008, P NATL ACAD SCI USA, V105, P17339, DOI 10.1073/pnas.0807418105; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Habich C, 2007, CELL MOL LIFE SCI, V64, P742, DOI 10.1007/s00018-007-6413-7; Hartley MG, 2004, INFECT IMMUN, V72, P4109, DOI 10.1128/IAI.72.7.4109-4113.2004; Havlasova J, 2005, PROTEOMICS, V5, P2090, DOI 10.1002/pmic.200401123; HAVLIR DV, 1991, INFECT IMMUN, V59, P665, DOI 10.1128/IAI.59.2.665-670.1991; Hechard C, 2004, J MED MICROBIOL, V53, P861, DOI 10.1099/jmm.0.05442-0; Henderson B, 2010, CELL BIOCHEM FUNCT, V28, P1, DOI 10.1002/cbf.1609; HERLYN DM, 1980, CANCER RES, V40, P717; Hickey AJ, 2011, VACCINE, V29, P6941, DOI 10.1016/j.vaccine.2011.07.075; Hoffman P S, 1999, Infect Dis Obstet Gynecol, V7, P58, DOI 10.1002/(SICI)1098-0997(1999)7:1/2<58::AID-IDOG12>3.3.CO;2-1; Horwich AL, 2009, FEBS LETT, V583, P2654, DOI 10.1016/j.febslet.2009.06.049; Janovska S, 2007, IMMUNOL LETT, V108, P151, DOI 10.1016/j.imlet.2006.12.004; KHLEBNIKOV VS, 1992, ZH MIKROB EPID IMMUN, P67; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kirimanjeswara GS, 2008, IMMUNOL REV, V225, P244, DOI 10.1111/j.1600-065X.2008.00689.x; Kirimanjeswara GS, 2007, J IMMUNOL, V179, P532, DOI 10.4049/jimmunol.179.1.532; Klimpel GR, 2008, VACCINE, V26, P6874, DOI 10.1016/j.vaccine.2008.09.077; Klimpel GR, 2008, VACCINE; Kozakov D, 2006, PROTEINS, V65, P392, DOI 10.1002/prot.21117; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kulis M, 2013, MOL NUTR FOOD RES, V57, P906, DOI 10.1002/mnfr.201200410; Larsson P, 2005, NAT GENET, V37, P153, DOI 10.1038/ng1499; Leclerq S, 2002, J MED MICROBIOL, V51, P20, DOI 10.1099/0022-1317-51-1-20; Lee BY, 2006, INFECT IMMUN, V74, P4002, DOI 10.1128/IAI.00257-06; LEIBY DA, 1992, INFECT IMMUN, V60, P84, DOI 10.1128/IAI.60.1.84-89.1992; Li J, 2007, MICROBIOL-SGM, V153, P3141, DOI 10.1099/mic.0.2007/006460-0; Lin JS, 1996, INFECT IMMUN, V64, P4396, DOI 10.1128/IAI.64.10.4396-4400.1996; Linhares IM, 2010, CELL STRESS CHAPERON, V15, P467, DOI 10.1007/s12192-010-0171-4; Lu Z, 2007, IMMUNOL LETT, V112, P92, DOI 10.1016/j.imlet.2007.07.006; Lu ZH, 2012, IMMUNOLOGY, V136, P352, DOI 10.1111/j.1365-2567.2012.03589.x; Madej T, 2012, NUCLEIC ACIDS RES, V40, pD461, DOI 10.1093/nar/gkr1162; Madico G, 1998, J CLIN MICROBIOL, V36, P3205, DOI 10.1128/JCM.36.11.3205-3210.1998; Madico G, 2000, J CLIN MICROBIOL, V38, P1085, DOI 10.1128/JCM.38.3.1085-1093.2000; Maguire M, 2002, CELL STRESS CHAPERON, V7, P317, DOI 10.1379/1466-1268(2002)007<0317:CUISOC>2.0.CO;2; Marcatili P, 2008, BIOINFORMATICS, V24, P1953, DOI 10.1093/bioinformatics/btn341; McLendon MK, 2006, ANNU REV MICROBIOL, V60, P167, DOI 10.1146/annurev.micro.60.080805.142126; Melillo A, 2006, FEMS MICROBIOL LETT, V263, P102, DOI 10.1111/j.1574-6968.2006.00413.x; Murphy K. M., 2011, JANEWAYS IMMUNOBIOLO; Noah CE, 2010, INFECT IMMUN, V78, P1797, DOI 10.1128/IAI.01135-09; Noll A, 1996, INFECT IMMUN, V64, P2955, DOI 10.1128/IAI.64.8.2955-2961.1996; NOLL A, 1994, INFECT IMMUN, V62, P2784, DOI 10.1128/IAI.62.7.2784-2791.1994; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Oyston PCF, 2009, VACCINE, V27, pD48, DOI 10.1016/j.vaccine.2009.07.090; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; Pfister G, 2005, J CELL SCI, V118, P1587, DOI 10.1242/jcs.02292; Polewicz M, 2013, VACCINE, V31, P3148, DOI 10.1016/j.vaccine.2013.05.008; Prakken B, 1998, BIOTHERAPY, V10, P205, DOI 10.1007/BF02678298; Quintana FJ, 2011, TRENDS IMMUNOL, V32, P89, DOI 10.1016/j.it.2010.11.001; Ranson NA, 1998, BIOCHEM J, V333, P233, DOI 10.1042/bj3330233; RHINEHARTJONES TR, 1994, INFECT IMMUN, V62, P3129, DOI 10.1128/IAI.62.8.3129-3137.1994; Roche MI, 2011, HYBRIDOMA, V30, P19, DOI 10.1089/hyb.2010.0083; Rye HS, 1999, CELL, V97, P325, DOI 10.1016/S0092-8674(00)80742-4; Rynkiewicz MJ, 2012, BIOCHEMISTRY-US, V51, P5684, DOI 10.1021/bi201711m; Savitt AG, 2009, CLIN VACCINE IMMUNOL, V16, P414, DOI 10.1128/CVI.00362-08; SCHLIMOK G, 1986, HYBRIDOMA, V5, pS163; Sebastian S, 2009, VACCINE, V27, P597, DOI 10.1016/j.vaccine.2008.10.079; Sebastian S, 2007, INFECT IMMUN, V75, P2591, DOI 10.1128/IAI.01789-06; Serriere J, 2011, J MOL BIOL, V405, P33, DOI 10.1016/j.jmb.2010.10.033; Sharon J, 2014, IMMUNOLOGY, V142, P1, DOI 10.1111/imm.12213; Sharon Jacqueline, 2002, Methods Mol Biol, V178, P101; SHULMAN M, 1978, NATURE, V276, P269, DOI 10.1038/276269a0; Sjostedt A, 2007, ANN NY ACAD SCI, V1105, P1, DOI 10.1196/annals.1409.009; Stenmark S, 2003, MICROB PATHOGENESIS, V35, P73, DOI 10.1016/S0882-4010(03)00095-0; Stenmark S, 1999, INFECT IMMUN, V67, P1789; Takahashi I, 1996, J PERIODONTAL RES, V31, P589, DOI 10.1111/j.1600-0765.1996.tb00524.x; Tarnvik A, 2007, ANN NY ACAD SCI, V1105, P378, DOI 10.1196/annals.1409.017; Thomas LD, 2010, INFECT DIS CLIN N AM, V24, P43, DOI 10.1016/j.idc.2009.10.012; Twine SM, 2006, BIOCHEM BIOPH RES CO, V346, P999, DOI 10.1016/j.bbrc.2006.06.008; Twine SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010000; Valentino MD, 2011, IMMUNOLOGY, V132, P348, DOI 10.1111/j.1365-2567.2010.03387.x; van der Zee R, 1998, SEMIN IMMUNOL, V10, P35, DOI 10.1006/smim.1997.0103; van Eden W, 2000, CELL STRESS CHAPERON, V5, P452, DOI 10.1379/1466-1268(2000)005<0452:APRPOS>2.0.CO;2; Vanniasinkam T, 2004, VET IMMUNOL IMMUNOP, V98, P91, DOI 10.1016/j.vetimm.2003.11.001; Wang Q, 2011, BIOCHEMISTRY-US, V50, P10941, DOI 10.1021/bi201450v; Wendling U, 1998, BIOTHERAPY, V10, P223, DOI 10.1007/BF02678300; Wick G, 2000, HERZ, V25, P87, DOI 10.1007/PL00001957; Woods VL, 2001, J CELL BIOCHEM, V84, P89, DOI 10.1002/jcb.10069; Wu TH, 2005, INFECT IMMUN, V73, P2644, DOI 10.1128/IAI.73.5.2644-2654.2005; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; Yamaguchi H, 2000, INFECT IMMUN, V68, P3448, DOI 10.1128/IAI.68.6.3448-3454.2000; ZHANG ZQ, 1993, PROTEIN SCI, V2, P522	113	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e99847	10.1371/journal.pone.0099847	http://dx.doi.org/10.1371/journal.pone.0099847			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968190	Green Published, Green Submitted, gold			2022-12-27	WOS:000338280800021
J	Schiavoni, I; Fedele, G; Quattrini, A; Bianco, M; Schnoeller, C; Openshaw, PJ; Locht, C; Ausiello, CM				Schiavoni, Ilaria; Fedele, Giorgio; Quattrini, Adriano; Bianco, Manuela; Schnoeller, Corinna; Openshaw, Peter J.; Locht, Camille; Ausiello, Clara M.			Live Attenuated B. pertussis BPZE1 Rescues the Immune Functions of Respiratory Syncytial Virus Infected Human Dendritic Cells by Promoting Th1/Th17 Responses	PLOS ONE			English	Article							BORDETELLA-PERTUSSIS; T-CELLS; INTERFERON; VACCINE; MATURATION; LUNG; ACTIVATION; MIGRATION; DISEASE; INNATE	Respiratory Syncytial virus (RSV) is the leading cause of acute lower respiratory tract viral infection in young children and a major cause of winter hospitalization. Bordetella pertussis is a common cause of bacterial lung disease, affecting a similar age group. Although vaccines are available for B. pertussis infection, disease rates have recently increased in many countries. We have therefore developed a novel live attenuated B. pertussis strain (BPZE1), which has recently undergone a successful clinical phase I trial. In mice, BPZE1 provides protection against disease caused by respiratory viral challenge. Here, we analyze the effect of BPZE1 on antiviral T cell responses induced by human monocyte-derived dendritic cells (MDDC). We found that BPZE1 influences antiviral immune responses at several levels, enhancing MDDC maturation, IL-12p70 production, and shifting T cell cytokine profile towards a Th1/Th17 pattern. These data were supported by the intracellular signaling analysis. RSV infection of MDDC caused MyD88-independent STAT1 phosphorylation, whereas BPZE1 activated MyD88-dependent signaling pathways; co-infection caused both pathways to be activated. These findings suggest that BPZE1 given during infancy might improve the course and outcome of viral lung disease in addition to providing specific protection against B. pertussis infection.	[Schiavoni, Ilaria; Fedele, Giorgio; Quattrini, Adriano; Bianco, Manuela; Ausiello, Clara M.] Ist Super Sanita, Dipartimento Malattie Infett Parassitarie & Immun, I-00161 Rome, Italy; [Schnoeller, Corinna; Openshaw, Peter J.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Ctr Resp Infect, London, England; [Locht, Camille] INSERM, U1019, F-59045 Lille, France; [Locht, Camille] Inst Pasteur, Ctr Immunol & Biol Parasitaire, CNRS, UMR8204, F-59019 Lille, France; [Locht, Camille] Inst Pasteur, Ctr Infect & Immun Lille, F-59019 Lille, France; [Locht, Camille] Univ Lille Nord France, Lille, France	Istituto Superiore di Sanita (ISS); Imperial College London; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille	Ausiello, CM (corresponding author), Ist Super Sanita, Dipartimento Malattie Infett Parassitarie & Immun, Viale Regina Elena 299, I-00161 Rome, Italy.	clara.ausiello@iss.it	Locht, Camille/L-3516-2018; FEDELE, GIORGIO/M-4357-2015; fedele, giorgio/N-4681-2015; SCHIAVONI, ILARIA/M-4367-2015; schiavoni, ilaria/N-5524-2015; Ausiello, Clara/G-3232-2011; Openshaw, Peter/AAL-9442-2020	FEDELE, GIORGIO/0000-0003-0017-6711; SCHIAVONI, ILARIA/0000-0003-1870-8907; Openshaw, Peter/0000-0002-7220-2555; Locht, Camille/0000-0001-7295-7336	European Commission [201502]; Italian Ministry of Health [RF-2010-2317709]; Wellcome Trust [087805/Z/08/Z]	European Commission(European CommissionEuropean Commission Joint Research Centre); Italian Ministry of Health(Ministry of Health, Italy); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a grant from the European Commission under the grant agreement # 201502 (ChildINNOVAC), and a grant from the Italian Ministry of Health, RF-2010-2317709. PO is an NIHR Senior Investigator, supported by the Wellcome Trust (Programme 087805/Z/08/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Raya B, 2013, PEDIATR INFECT DIS J, V32, P619, DOI 10.1097/INF.0b013e3182877973; Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; AKIRA S, 1992, IMMUNOL REV, V127, P25, DOI 10.1111/j.1600-065X.1992.tb01407.x; Bartz H, 2003, IMMUNOLOGY, V109, P49, DOI 10.1046/j.1365-2567.2003.01629.x; Beyer M, 2004, J ALLERGY CLIN IMMUN, V113, P127, DOI 10.1016/j.jaci.2003.10.057; Chi B, 2006, J VIROL, V80, P5032, DOI 10.1128/JVI.80.10.5032-5040.2006; Collins PL, 2008, J VIROL, V82, P2040, DOI 10.1128/JVI.01625-07; Culley FJ, 2006, J VIROL, V80, P8151, DOI 10.1128/JVI.00496-06; de Graaff PAA, 2005, J IMMUNOL, V175, P5904, DOI 10.4049/jimmunol.175.9.5904; Faber TE, 2012, J MED VIROL, V84, P1084, DOI 10.1002/jmv.23291; Falsey AR, 2000, CLIN MICROBIOL REV, V13, P371, DOI 10.1128/CMR.13.3.371-384.2000; Fedele G, 2004, EUR J IMMUNOL, V34, P1342, DOI 10.1002/eji.200324728; Fedele G, 2008, J IMMUNOL, V181, P208, DOI 10.4049/jimmunol.181.1.208; Fedele G, 2011, J IMMUNOL, V186, P5388, DOI 10.4049/jimmunol.1003765; Fedele G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008734; Feunou PF, 2010, VACCINE, V28, P7047, DOI 10.1016/j.vaccine.2010.08.017; Fischer JE, 1997, J VIROL, V71, P8672, DOI 10.1128/JVI.71.11.8672-8677.1997; Frasca L, 2006, BLOOD, V107, P2392, DOI 10.1182/blood-2005-07-2913; General Assembly of the World Medical Association, 2014, J Am Coll Dent, V81, P14; GLEZEN WP, 1986, AM J DIS CHILD, V140, P543, DOI 10.1001/archpedi.1986.02140200053026; Gonzalez PA, 2012, REV MED VIROL, V22, P230, DOI 10.1002/rmv.1704; Gonzalez PA, 2008, P NATL ACAD SCI USA, V105, P14999, DOI 10.1073/pnas.0802555105; Groskreutz DJ, 2006, J IMMUNOL, V176, P1733, DOI 10.4049/jimmunol.176.3.1733; Higgins SC, 2003, J IMMUNOL, V171, P3119, DOI 10.4049/jimmunol.171.6.3119; KIM HW, 1969, AM J EPIDEMIOL, V89, P422, DOI 10.1093/oxfordjournals.aje.a120955; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Le Nouen C, 2009, VIROLOGY, V385, P169, DOI 10.1016/j.virol.2008.11.043; Li R, 2010, J VIROL, V84, P7105, DOI 10.1128/JVI.02542-09; Lim DS, 2009, EUR J IMMUNOL, V39, P1334, DOI 10.1002/eji.200838987; Liotta F, 2008, J ALLERGY CLIN IMMUN, V121, P1000, DOI 10.1016/j.jaci.2008.01.004; Liu JG, 2003, J EXP MED, V198, P1265, DOI 10.1084/jem.20030026; Loebbermann J, 2013, P NATL ACAD SCI USA, V110, P2987, DOI 10.1073/pnas.1217580110; Loebbermann J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032371; Lukens MV, 2009, J VIROL, V83, P7235, DOI 10.1128/JVI.00452-09; McDermott DS, 2011, FUTURE VIROL, V6, P963, DOI 10.2217/fvl.11.62; Mielcarek N, 2006, PLOS PATHOG, V2, P662, DOI 10.1371/journal.ppat.0020065; Moreno G, 2013, MICROBES INFECT, V15, P708, DOI 10.1016/j.micinf.2013.06.010; Mukherjee S, 2011, AM J PATHOL, V179, P248, DOI 10.1016/j.ajpath.2011.03.003; Munir S, 2008, J VIROL, V82, P8780, DOI 10.1128/JVI.00630-08; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Nakahara T, 2006, J DERMATOL SCI, V42, P1, DOI 10.1016/j.jdermsci.2005.11.004; Nasso M, 2009, J IMMUNOL, V183, P1892, DOI 10.4049/jimmunol.0901071; Newcomb DC, 2013, THORAX, V68, P717, DOI 10.1136/thoraxjnl-2012-202404; Olson MR, 2008, J IMMUNOL, V181, P7958, DOI 10.4049/jimmunol.181.11.7958; Openshaw PJM, 2004, J ALLERGY CLIN IMMUN, V114, P1275, DOI 10.1016/j.jaci.2004.08.024; Pinto RA, 2006, PEDIATRICS, V117, pE878, DOI 10.1542/peds.2005-2119; Schnoeller C, 2014, AM J RESP CRIT CARE, V189, P194, DOI [10.1164/rccm.201307-1227OC, 10.1164/rccm.201307-227OC]; Sigurs N, 2005, AM J RESP CRIT CARE, V171, P137, DOI 10.1164/rccm.200406-730OC; Skerry CM, 2009, CLIN VACCINE IMMUNOL, V16, P1344, DOI 10.1128/CVI.00082-09; Spensieri F, 2006, INFECT IMMUN, V74, P2831, DOI 10.1128/IAI.74.5.2831-2838.2006; Stein MF, 2013, MOL CELL BIOL, V33, P1331, DOI 10.1128/MCB.01051-12; Steinman RM, 2006, CURR TOP MICROBIOL, V311, P17; Tekkanat KK, 2001, AM J PATHOL, V159, P631, DOI 10.1016/S0002-9440(10)61734-8; Thorstensson R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083449; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Wolfe DN, 2010, J IMMUNOL, V184, P1392, DOI 10.4049/jimmunol.0803045	56	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100166	10.1371/journal.pone.0100166	http://dx.doi.org/10.1371/journal.pone.0100166			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967823	gold, Green Published, Green Submitted			2022-12-27	WOS:000338280800027
J	Zhang, HL; Gu, LB; Liu, T; Chiang, KY; Zhou, MX				Zhang, Hailong; Gu, Lubing; Liu, Tao; Chiang, Kuang-Yueh; Zhou, Muxiang			Inhibition of MDM2 by Nilotinib Contributes to Cytotoxicity in Both Philadelphia-Positive and Negative Acute Lymphoblastic Leukemia	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; TYROSINE KINASE INHIBITORS; WILD-TYPE P53; BCR-ABL; POOR-PROGNOSIS; C-ABL; CYTOGENETIC RESPONSES; CHILDHOOD LEUKEMIAS; HEMATOPOIETIC-CELLS; IMATINIB	Nilotinib is a selective BCR-ABL tyrosine kinase inhibitor related to imatinib that is more potent than imatinib. Nilotinib is widely used to treat chronic myelogenous leukemia (CML) and Philadelphia-positive (Ph+) acute lymphoblastic leukemia (ALL). The present study identifies Mouse double minute 2 homolog (MDM2) as a target of nilotinib. In studying ALL cell lines, we found that the expression of MDM2 in both Philadelphia positive (Ph+) and Philadelphia negative (Ph-) ALL cells was remarkably inhibited by nilotinib, in a dose-and time-dependent manner. Further studies demonstrated that nilotinib inhibited MDM2 at the post-translational level by inducing MDM2 self-ubiquitination and degradation. Nilotinib-mediated MDM2 downregulation did not result in accumulation and activation of p53. Inhibition of MDM2 in nilotinib-treated ALL cells led to downregulation of the anti-apoptotic protein X-linked inhibitor of apoptosis protein (XIAP), a translational target of MDM2, resulting in activation of caspases. Inhibition of XIAP following nilotinib-mediated downregulation of MDM2 resulted in apoptosis of MDM2-expressing ALL; however, similar nilotinib treatment induced stronger apoptosis in Ph+/MDM2+ ALL than in Ph-/MDM2+ or Ph+/MDM2-ALL. The ALL cells that were Ph-/MDM2- were totally resistant to nilotinib. These results suggested that nilotinib can inhibit MDM2 and induce a p53-independent apoptosis pathway by downregulating XIAP; thus, nilotinib can treat not only Ph+, but also Ph-ALL patients whose cancer cells overexpress MDM2.	[Zhou, Muxiang] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30332 USA; Emory Univ, Sch Med, Aflac Canc & Blood Disorders Ctr, Atlanta, GA USA	Emory University; Emory University	Zhou, MX (corresponding author), Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30332 USA.	mzhou@emory.edu			National Institutes of Health [R01 CA123490, R01CA143107]; CURE; NATIONAL CANCER INSTITUTE [R01CA180519, R01CA143107, R01CA123490] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CURE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health (R01 CA123490 and R01CA143107 to MZ) and CURE (to MZ and LG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUESORAMOS CE, 1993, BLOOD, V82, P2617; Camgoz A, 2013, LEUKEMIA LYMPHOMA, V54, P1279, DOI 10.3109/10428194.2012.737919; Carter BZ, 2006, BLOOD, V107, P1555, DOI 10.1182/blood-2004-12-4704; Chow KU, 2007, LEUKEMIA LYMPHOMA, V48, P1379, DOI 10.1080/10428190701385181; Deininger MWN, 2000, BLOOD, V96, P3343, DOI 10.1182/blood.V96.10.3343; Fava C, 2009, BLOOD, V113, P5058, DOI 10.1182/blood-2008-10-184960; Goetz AW, 2001, CANCER RES, V61, P7635; Goldberg Z, 2004, CELL CYCLE, V3, P1188; Gu LB, 2009, CANCER CELL, V15, P363, DOI 10.1016/j.ccr.2009.03.002; Gustafsson B, 1998, PEDIATR HEMAT ONCOL, V15, P519, DOI 10.3109/08880019809018313; Gustafsson B, 2001, PEDIATR HEMAT ONCOL, V18, P497, DOI 10.1080/088800101753328466; Gustafsson B, 2000, MED PEDIATR ONCOL, V34, P117, DOI 10.1002/(SICI)1096-911X(200002)34:2<117::AID-MPO9>3.0.CO;2-8; Hantschel O, 2004, NAT REV MOL CELL BIO, V5, P33, DOI 10.1038/nrm1280; Hazlehurst LA, 2009, CANCER CONTROL, V16, P100, DOI 10.1177/107327480901600202; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Huang M, 2013, MOL CANCER THER, V12, P184, DOI 10.1158/1535-7163.MCT-12-0425; Iacobucci I, 2008, BLOOD, V112, P3847, DOI 10.1182/blood-2007-09-112631; Jing Y, 2007, J BIOCHEM, V141, P621, DOI 10.1093/jb/mvm068; JUVEN T, 1993, ONCOGENE, V8, P3411; Kantarjian H, 2002, NEW ENGL J MED, V346, P645, DOI 10.1056/NEJMoa011573; Kantarjian H, 2006, NEW ENGL J MED, V354, P2542, DOI 10.1056/NEJMoa055104; Klejman A, 2002, EMBO J, V21, P5766, DOI 10.1093/emboj/cdf562; Lee HJ, 2011, CANCER-AM CANCER SOC, V117, P1583, DOI 10.1002/cncr.25690; Levav-Cohen Y, 2005, BIOCHEM BIOPH RES CO, V331, P737, DOI 10.1016/j.bbrc.2005.03.152; Mahon FX, 2008, CANCER RES, V68, P9809, DOI 10.1158/0008-5472.CAN-08-1008; Marks DI, 1997, J CLIN ONCOL, V15, P1158, DOI 10.1200/JCO.1997.15.3.1158; Marks DI, 1996, BLOOD, V87, P1155, DOI 10.1182/blood.V87.3.1155.bloodjournal8731155; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Momand J, 1998, NUCLEIC ACIDS RES, V26, P3453, DOI 10.1093/nar/26.15.3453; Montemurro M, 2009, EUR J CANCER, V45, P2293, DOI 10.1016/j.ejca.2009.04.030; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; NAUMOVSKI L, 1988, CANCER RES, V48, P2876; Nawata R, 2003, ONCOGENE, V22, P7774, DOI 10.1038/sj.onc.1206901; Oetzel C, 2000, CLIN CANCER RES, V6, P1958; Riedl SJ, 2001, CELL, V104, P791, DOI 10.1016/S0092-8674(02)02036-6; Shaker ME, 2013, BBA-MOL CELL RES, V1833, P1992, DOI 10.1016/j.bbamcr.2013.02.033; Sharp DA, 1999, J BIOL CHEM, V274, P38189, DOI 10.1074/jbc.274.53.38189; Shiozaki EN, 2003, MOL CELL, V11, P519, DOI 10.1016/S1097-2765(03)00054-6; Skorski T, 1997, EMBO J, V16, P6151, DOI 10.1093/emboj/16.20.6151; Talpaz M, 2002, BLOOD, V99, P1928, DOI 10.1182/blood.V99.6.1928; Trotta R, 2003, CANCER CELL, V3, P145, DOI 10.1016/S1535-6108(03)00020-5; Waning DL, 2011, J BIOL CHEM, V286, P216, DOI 10.1074/jbc.M110.183012; Zhang Z, 2005, CURR CANCER DRUG TAR, V5, P9, DOI 10.2174/1568009053332618; Zhou M, 2000, LEUKEMIA, V14, P61, DOI 10.1038/sj.leu.2401619; ZHOU MX, 1995, BLOOD, V85, P1608, DOI 10.1182/blood.V85.6.1608.bloodjournal8561608	45	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100960	10.1371/journal.pone.0100960	http://dx.doi.org/10.1371/journal.pone.0100960			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968304	Green Published, gold, Green Submitted			2022-12-27	WOS:000338280800092
J	Bail, M; Meister, LMB; Campagnoli, EB; Jorge, JH; Ban, MDI; Sanchez-Ayala, A; Campanha, NH				Bail, Michele; Brol Meister, Lissandra Matos; Campagnoli, Eduardo Bauml; Jorge, Janaina Habib; Iglesias Ban, Manuella de Cassia; Sanchez-Ayala, Alfonso; Campanha, Nara Hellen			Histopathological Changes by the Use of Soft Reline Materials: A Rat Model Study	PLOS ONE			English	Article							DENTURE BASE; METHYL-METHACRYLATE; RESIDUAL MONOMER; LINING MATERIALS; RESILIENT LINER; ACRYLIC RESINS; L929 CELLS; WATER-BATH; CYTOTOXICITY; OVERDENTURE	Aim: To assess the histopathological changes of rat palatal mucosa exposed to soft reline materials. Methods: Forty-five adult female Wistar rats with controlled living conditions and fed ad libitum were employed. Palatal appliances of heat-polymerized acrylic resin Lucitone 550 were manufactured and worn by forty animals during 14 days. Five animals did not use the appliances (G1) and were used to control the appliance influence. One experimental group (n = 10) used the appliances without any relining material (G2) to control the material effect. Three experimental groups (n = 10) received the following soft reline materials below appliances: Dentusoft (G3), Dentuflex (G4), and Trusoft (G5). Appliances from half of each experimental group(n = 5) was immersed in water bath at 55 degrees C for 10 min before use. Animals were slaughtered and the palates were fixed in 10% buffered formalin. Hematoxylin and eosin stained sections of 5 mu m were analyzed by computerized planimetry. Cellular compartment, keratin and total epithelial thickness, and basement membrane length were measured to histopathological description. Analysis of variance and Tukey post-hoc test were used to data examination(alpha = 0.05). Results: For heat-treatment groups, G4 showed less elongated ridges at the basal layer interface (p = 0.037) than G2. When comparing the conditions with and without heat-treatment, only G2 showed a significant decrease in the cellular compartment, keratin layer and total epithelium thickness (p<0.05). Conclusion: The post-polymerization for Lucitone 550 was an effective method to reduce the changes in the rat palatal mucosa. The soft reline materials tested did not cause significant histopathological changes in the rat palatal mucosa.	[Bail, Michele; Brol Meister, Lissandra Matos; Campagnoli, Eduardo Bauml; Iglesias Ban, Manuella de Cassia; Sanchez-Ayala, Alfonso; Campanha, Nara Hellen] Univ Estadual Ponta Grossa, Dept Dent, Ponta Grossa, Parana, Brazil; [Jorge, Janaina Habib] Univ Estadual Paulista, UNESP, Araraquara Dent Sch, Dept Dent Mat & Prosthodont, Sao Paulo, Brazil	Universidade Estadual de Ponta Grossa; Universidade Estadual Paulista	Jorge, JH (corresponding author), Univ Estadual Paulista, UNESP, Araraquara Dent Sch, Dept Dent Mat & Prosthodont, Sao Paulo, Brazil.	janainahj@bol.com.br	Jorge, Janaina Habib/H-7896-2013; Bombarda, Nara H.C./C-7956-2013; Jorge, Janaina Habib/Q-2197-2019; Sánchez-Ayala, Alfonso/A-9049-2015	Jorge, Janaina Habib/0000-0002-9135-3455; Bombarda, Nara H.C./0000-0002-9915-1591; Jorge, Janaina Habib/0000-0002-9135-3455; Sánchez-Ayala, Alfonso/0000-0003-3426-0997	CAPES, Brazil; Araucaria Foundation, Parana, Brazil [11386]	CAPES, Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Araucaria Foundation, Parana, Brazil(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FA)	This study was performed by MB as partial fulfillment of her PhD degree at the Ponta Grossa State University. This investigation was supported in part by Grants from the CAPES, Brazil (P.I. MB); Araucaria Foundation, Parana, Brazil, 11386 (P.I. JHJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akal U K, 1997, J Marmara Univ Dent Fac, V2, P665; ALI A, 1986, BRIT DENT J, V161, P444, DOI 10.1038/sj.bdj.4806008; ANDERSEN L, 1986, HUMAN ORAL EMBRYOLOG; [Anonymous], 1992, 10993 ISO; [Anonymous], 1996, 7405 ISO; Atay A, 2012, DENT MATER J, V31, P1082, DOI 10.4012/dmj.2012-209; BAKER S, 1988, J DENT RES, V67, P1295, DOI 10.1177/00220345880670101001; Barclay SC, 1997, J DENT, V25, P251, DOI 10.1016/S0300-5712(96)00005-X; BROWNE RM, 1994, J DENT, V22, pS21, DOI 10.1016/0300-5712(94)90035-3; Brozek R, 2011, DENT MATER, V27, P281, DOI 10.1016/j.dental.2010.11.003; BRUNETTE DM, 1984, J CELL SCI, V69, P35; Cain JR, 1998, INT J ORAL MAX IMPL, V13, P857; Campanha NH, 2006, INT J PROSTHODONT, V19, P195; Chatterjee S, 2003, BIOCHEM BIOPH RES CO, V309, P36, DOI 10.1016/S0006-291X(03)01513-4; COOK RJ, 1991, J DENT, V19, P135, DOI 10.1016/0300-5712(91)90001-F; ELsyad MA, 2012, INT J PROSTHODONT, V25, P148; Elsyad MA, 2010, CLIN ORAL IMPLAN RES, V21, P473, DOI 10.1111/j.1600-0501.2009.01879.x; GOLLAMUDI R, 1985, J APPL TOXICOL, V5, P368, DOI 10.1002/jat.2550050606; Goncalves TS, 2006, AM J ORTHOD DENTOFAC, V129, P431, DOI 10.1016/j.ajodo.2005.10.017; GRAHAM BS, 1991, J DENT RES, V70, P870, DOI 10.1177/00220345910700050101; Hara T, 2000, J ORAL PATHOL MED, V29, P33, DOI 10.1034/j.1600-0714.2000.290106.x; Hashimoto Y, 2007, DENT MATER J, V26, P785, DOI 10.4012/dmj.26.785; HENSTENPETTERSEN A, 1991, J PROSTHET DENT, V65, P138, DOI 10.1016/0022-3913(91)90066-6; Hilborn J, 2007, J TISSUE ENG REGEN M, V1, P110, DOI 10.1002/term.4; Inoue T, 2001, Adv Dent Res, V15, P101; ISO, 2020, 800022020 ISO; Jiang JT, 2011, TOXICOLOGY, V290, P322, DOI 10.1016/j.tox.2011.10.008; Jorge JH, 2007, GERODONTOLOGY, V24, P52, DOI 10.1111/j.1741-2358.2007.00146.x; Jorge Janaina Habib, 2009, Quintessence Int, V40, pe93; Jorge Janaina Habib, 2006, J. Appl. Oral Sci., V14, P203, DOI 10.1590/S1678-77572006000300011; Kedjarune U, 1999, AUST DENT J, V44, P25, DOI 10.1111/j.1834-7819.1999.tb00532.x; Kiat-Amnuay S, 1999, J PROSTHET DENT, V81, P568, DOI 10.1016/S0022-3913(99)70211-8; Lai YL, 2004, J ORAL REHABIL, V31, P1165, DOI 10.1111/j.1365-2842.2004.01355.x; LAMB DJ, 1983, J DENT, V11, P80, DOI 10.1016/0300-5712(83)90051-9; LANDBERG G, 1990, EXP CELL RES, V187, P111, DOI 10.1016/0014-4827(90)90124-S; Lee SY, 2002, EUR J ORAL SCI, V110, P179, DOI 10.1034/j.1600-0722.2002.11232.x; Lefebvre Carol A., 1992, International Journal of Prosthodontics, V5, P558; Lunder T, 2000, CONTACT DERMATITIS, V43, P232; MACK PJ, 1989, AUST DENT J, V34, P454, DOI 10.1111/j.1834-7819.1989.tb00704.x; Munksgaard EC, 2005, EUR J ORAL SCI, V113, P166, DOI 10.1111/j.1600-0722.2005.00204.x; Munksgaard EC, 2004, EUR J ORAL SCI, V112, P101, DOI 10.1111/j.0909-8836.2004.00091.x; Murata H, 1996, DENT MATER, V12, P19, DOI 10.1016/S0109-5641(96)80059-5; Murata H, 2010, DENT MATER J, V29, P446, DOI 10.4012/dmj.2009-135; Nakai M, 1999, BIOCHEM BIOPH RES CO, V254, P311, DOI 10.1006/bbrc.1998.9928; Niedermeier W, 1990, Dtsch Zahnarztl Z, V45, P443; Oki K, 2002, J ORAL REHABIL, V29, P594, DOI 10.1046/j.1365-2842.2002.00863.x; Ostlund S, 1958, ACTA ODONTOL SCAND, V16; Ozdemir KG, 2009, J BIOMED MATER RES B, V90B, P82, DOI 10.1002/jbm.b.31256; Pant N, 2011, HUM EXP TOXICOL, V30, P507, DOI 10.1177/0960327110374205; RAZEK MKA, 1978, J PROSTHET DENT, V39, P29; SCHMALZ G, 1994, J DENT, V22, pS6, DOI 10.1016/0300-5712(94)90032-9; Sjogren G, 2000, J PROSTHET DENT, V84, P229, DOI 10.1067/mpr.2000.107227; Sofou A, 2005, ANAL BIOANAL CHEM, V381, P1336, DOI 10.1007/s00216-005-3059-x; Tay LY, 2012, GERODONTOLOGY, V29, pE275, DOI 10.1111/j.1741-2358.2011.00463.x; TSUCHIYA H, 1994, J PROSTHET DENT, V71, P618, DOI 10.1016/0022-3913(94)90448-0; Tsuruoka M, 2008, J ORAL REHABIL, V35, P889, DOI 10.1111/j.1365-2842.2008.01883.x; Urban VM, 2007, DENT MATER, V23, P363, DOI 10.1016/j.dental.2006.01.021; Vallittu PK, 1998, EUR J ORAL SCI, V106, P588, DOI 10.1046/j.0909-8836.1998.eos106109.x; VERHEIJEN R, 1989, J CELL SCI, V92, P531; Yoshii E, 1997, J BIOMED MATER RES, V37, P517, DOI 10.1002/(SICI)1097-4636(19971215)37:4<517::AID-JBM10>3.0.CO;2-5; Zentner A, 2000, EUR J ORTHODONT, V22, P639, DOI 10.1093/ejo/22.6.639	61	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100293	10.1371/journal.pone.0100293	http://dx.doi.org/10.1371/journal.pone.0100293			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963657	Green Published, gold, Green Submitted			2022-12-27	WOS:000338709500037
J	Moseby, KE; Hill, BM; Lavery, TH				Moseby, Katherine E.; Hill, Brydie M.; Lavery, Tyrone H.			Tailoring Release Protocols to Individual Species and Sites: One Size Does Not Fit All	PLOS ONE			English	Article							REINTRODUCTION ATTEMPTS; TRANSLOCATION SUCCESS; MARSUPIALIA; AUSTRALIA; CONSERVATION; REANALYSIS; PREDATION; SURVIVAL; ECOLOGY; RANGE	Reintroduction programs for threatened species often include elaborate release strategies designed to improve success, but their advantages are rarely tested scientifically. We used a set of four experiments to demonstrate that the influence of release strategies on short-term reintroduction outcomes is related to both intrinsic and extrinsic factors. We compared different reintroduction strategies for three mammal species in an arid environment where exotic mammalian predators were removed. Wild greater stick-nest rats selected vegetation shelter sites with greater structural density than captive-bred rats, travelled further from the release site and experienced lower rates of mortality. In comparison, there was no difference in mortality or movement between wild and captive-bred greater bilbies. Burrowing bettongs and greater bilbies were also subjected to immediate and delayed release strategies and whilst no difference was detected in bilbies, bettongs that were subjected to delayed releases lost less weight and took less time to establish burrows than those that were immediately released. Interspecific differences in treatment response were attributed to predation risk, the nature of the release site, and behavioural traits such as shelter investment and sociality. Our varied results highlight the inadequacies of review articles focusing on optimum release protocols due to their attempt to generalise across species and release sites. We provide an example of a predictive model to guide future release strategy experimentation that recognises the range of intrinsic and extrinsic factors influencing reintroduction outcomes. We encourage researchers to treat programs experimentally, identify individual site and species characters that may influence release strategies and record data on movements, mortality, weight dynamics, and settling times and distances. The inherent issues of small sample size and low statistical power that plague most reintroduction experiments suggests there is also a need for increased standardisation and publication of data sets to enable appropriate meta-analyses to occur.	[Moseby, Katherine E.] Univ Adelaide, Adelaide, SA, Australia; [Moseby, Katherine E.; Hill, Brydie M.] Arid Recovery, Roxby Downs, Australia; [Lavery, Tyrone H.] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia	University of Adelaide; University of Queensland	Moseby, KE (corresponding author), Univ Adelaide, Adelaide, SA, Australia.	katherine.moseby@adelaide.edu.au	Moseby, Katherine/AAR-3301-2020; Lavery, Tyrone/C-6038-2016	Moseby, Katherine/0000-0003-0691-1625; Lavery, Tyrone/0000-0001-5397-4974	BHP Billiton; University of Adelaide; South Australian Department of Environment and Natural Resources; Earthwatch Institute; Friends of Arid Recovery; Nature Foundation S.A.	BHP Billiton; University of Adelaide; South Australian Department of Environment and Natural Resources; Earthwatch Institute; Friends of Arid Recovery; Nature Foundation S.A.	This study was undertaken through Arid Recovery, a conservation initiative partly funded by BHP Billiton, The University of Adelaide and the South Australian Department of Environment and Natural Resources. Additional funding was provided by Earthwatch Institute, Friends of Arid Recovery and the Nature Foundation S A. The funders had no role in study design, data collection and analysis. decision to publish, or preparation of the manuscript.	Armstrong DP, 2008, TRENDS ECOL EVOL, V23, P20, DOI 10.1016/j.tree.2007.10.003; Bajomi B, 2010, REINTRODUCTION ENDAN, P10; Beck B. B., 1994, P265; Bester AJ, 2009, AUST MAMMAL, V31, P9, DOI DOI 10.1071/AM08104; Bice Jackie, 2008, Australian Mammalogy, V30, P1; Bolton Julia, 2004, Pacific Conservation Biology, V10, P193; BRIGHT PW, 1994, J APPL ECOL, V31, P699, DOI 10.2307/2404160; Campbell L., 2001, VET CONSERVATION BIO, P173; CHRISTENSEN P, 1995, REINTRODUCTION BIOLOGY OF AUSTRALIAN AND NEW ZEALAND FAUNA, P199; Clayton JA, 2014, MAMMAL REV, V44, P109, DOI 10.1111/mam.12020; Copley P, 1999, WILDLIFE RES, V26, P513, DOI 10.1071/WR97056; CROWLEY PH, 1992, ANNU REV ECOL SYST, V23, P405, DOI 10.1146/annurev.es.23.110192.002201; DAVIS MH, 1983, J WILDLIFE MANAGE, V47, P59, DOI 10.2307/3808052; Finlayson GR, 2004, WILDLIFE RES, V31, P457, DOI 10.1071/WR03035; FINLAYSON H. H., 1961, REC S AUSTRALIAN MUS, V14, P141; Fischer J, 2000, BIOL CONSERV, V96, P1, DOI 10.1016/S0006-3207(00)00048-3; Gedeon CI, 2011, EUR J WILDLIFE RES, V57, P1101, DOI 10.1007/s10344-011-0504-3; GRIFFITH B, 1989, SCIENCE, V245, P477, DOI 10.1126/science.245.4917.477; Hardman B, 2006, BIOL CONSERV, V128, P403, DOI 10.1016/j.biocon.2005.10.006; IUCN, 2012, IUCN SSC GUID REINTR; Johnson CN, 2007, P R SOC B, V274, P341, DOI 10.1098/rspb.2006.3711; Kemper C., 1990, P67; KLEIMAN DG, 1989, BIOSCIENCE, V39, P152, DOI 10.2307/1311025; Letty J, 2000, ANIM CONSERV, V3, P211, DOI 10.1017/S1367943000000925; Mateju J, 2012, EUR J WILDLIFE RES, V58, P473, DOI 10.1007/s10344-011-0597-8; Moro D, 2003, BIOL CONSERV, V111, P305, DOI 10.1016/S0006-3207(02)00296-3; Moro Dorian, 2001, Re-introduction News, V20, P17; Morton S.R., 1990, Proceedings of the Ecological Society of Australia, V16, P201; Moseby KE, 2011, BIOL CONSERV, V144, P2863, DOI 10.1016/j.biocon.2011.08.003; Moseby KE, 2012, ANIM BEHAV, V83, P1011, DOI 10.1016/j.anbehav.2012.01.023; Moseby KE, 2006, BIOL CONSERV, V127, P429, DOI 10.1016/j.biocon.2005.09.002; Moseby KE, 2003, WILDLIFE RES, V30, P15, DOI 10.1071/WR02012; Norrdahl K, 1998, ECOLOGY, V79, P226; Parker Kevin A., 2012, P105; Pople AR, 2001, BIOL CONSERV, V102, P285, DOI 10.1016/S0006-3207(01)00101-X; Read J., 1995, Rangeland Journal, V17, P228, DOI 10.1071/RJ9950228; Richards JD, 2003, BIOL CONSERV, V109, P181, DOI 10.1016/S0006-3207(02)00140-4; Richardson K, 2015, ORYX, V49, P535, DOI 10.1017/S0030605313001014; Sander U, 1997, WILDLIFE RES, V24, P143, DOI 10.1071/WR96021; Sarrazin F, 1996, TRENDS ECOL EVOL, V11, P474, DOI 10.1016/0169-5347(96)20092-8; Sherley E. H., 2010, SUMMARY NATIVE BAT R; Shier DM, 2006, CONSERV BIOL, V20, P1780, DOI 10.1111/j.1523-1739.2006.00512.x; SHORT J, 1992, BIOL CONSERV, V62, P189, DOI 10.1016/0006-3207(92)91047-V; Short J, 2000, BIOL CONSERV, V96, P185, DOI 10.1016/S0006-3207(00)00067-7; Short J, 2009, CHARACTERISTICS SUCC; Soorae PS, 2010, GLOBAL REINTRODUCTIO; Southgate R, 1994, REINTRODUCTION GREAT; Southgate R.I., 1990, P303; SPSS Inc. Released, 2009, PASW STAT WIND VERS; STEEN H, 1994, ANN ZOOL FENN, V31, P271; Teixeira CP, 2007, ANIM BEHAV, V73, P1, DOI 10.1016/j.anbehav.2006.06.002; Thompson JR, 2001, SOUTHWEST NAT, V46, P87, DOI 10.2307/3672378; Wanless RM, 2002, BIOL CONSERV, V107, P203, DOI 10.1016/S0006-3207(02)00067-8; Wimberger K, 2009, S AFR J WILDL RES, V39, P192, DOI 10.3957/056.039.0213; Wolf CM, 1998, BIOL CONSERV, V86, P243; Wolf CM, 1996, CONSERV BIOL, V10, P1142, DOI 10.1046/j.1523-1739.1996.10041142.x	56	42	43	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e99753	10.1371/journal.pone.0099753	http://dx.doi.org/10.1371/journal.pone.0099753			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963633	gold, Green Submitted, Green Published			2022-12-27	WOS:000338709500018
J	Cordeiro, EMG; Correa, AS; Guedes, RNC				Cordeiro, Erick Mauricio G.; Correa, Alberto S.; Guedes, Raul Narciso C.			Insecticide-Mediated Shift in Ecological Dominance between Two Competing Species of Grain Beetles	PLOS ONE			English	Article							INTERMEDIATE DISTURBANCE HYPOTHESIS; LARVAL COMPETITION; PESTICIDES; POPULATIONS; PREDATION; HORMESIS; HISTORY; SUSCEPTIBILITY; DISPLACEMENT; COEXISTENCE	Competition is a driving force regulating communities often considered an intermittent phenomenon, difficult to verify and potentially driven by environmental disturbances. Insecticides are agents of environmental disturbance that can potentially change ecological relationships and competitive outcomes, but this subject has seldom been examined. As the co-existing cereal grain beetle species Sitophilus zeamais Motschulsky and Rhyzopertha dominica F. share a common realized niche, directly competing for the same resources, they were used as models in our study. Intraspecific competition experiments were performed with increasing insect densities and insecticide doses in additive and replacement series using various density combinations of both beetle species maintained on insecticide-free or -sprayed grains. Insecticide-mediated release from competitive stress was not observed in our study of intraspecific competition in grain beetles. The insecticide enhanced the effect of insect density, particularly for the maize weevil S. zeamais, further impairing population growth at high densities. Therefore, insecticide susceptibility increased with intraspecific competition favoring insecticide efficacy. However, the effect of insecticide exposure on competitive interaction extends beyond intraspecific competition, affecting interspecific competition as well. Sitophilus zeamais was the dominant species when in interspecific competition prevailing in natural conditions (without insecticide exposure), but the dominance and species prevalence shifted from S. zeamais to R. dominica under insecticide exposure. Therefore, high conspecific densities favored insecticide efficacy, but the strength of the relationship differs with the species. In addition, the insecticide mediated a shift in species dominance and competition outcome indicating that insecticides are relevant mediators of species interaction, potentially influencing community composition and raising management concerns as potential cause of secondary pest outbreaks.	[Cordeiro, Erick Mauricio G.; Correa, Alberto S.; Guedes, Raul Narciso C.] Univ Fed Vicosa, Dept Entomol, Vicosa, MG, Brazil; [Correa, Alberto S.] Univ Sao Paulo, Escola Super Agr Luiz de Queiroz, Dept Entomol & Acarol Agr, Sao Paulo, Brazil	Universidade Federal de Vicosa; Universidade de Sao Paulo	Guedes, RNC (corresponding author), Univ Fed Vicosa, Dept Entomol, Vicosa, MG, Brazil.	guedes@ufv.br	Guedes, Raul Narciso Carvalho/L-3924-2013; Correa, Alberto S/C-4683-2014; Cordeiro, Erick MG/P-7042-2015	Guedes, Raul Narciso Carvalho/0000-0001-6229-7549; Correa, Alberto S/0000-0002-3788-7480; 	Minas Gerais State Foundation of Research Aid (FAPEMIG); CAPES Foundation (Brazilian Ministry of Education); National Council for Scientific and Technological Development (CNPq); Brazilian Ministry of Science and Technology	Minas Gerais State Foundation of Research Aid (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CAPES Foundation (Brazilian Ministry of Education)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Ministry of Science and Technology	Funding was provided by the following Brazilian agencies: Minas Gerais State Foundation of Research Aid (FAPEMIG; www.fapemig.br), the CAPES Foundation (Brazilian Ministry of Education; www.capes.gov.br), and the National Council for Scientific and Technological Development (CNPq; Brazilian Ministry of Science and Technology; www.cnpq.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AYALA FJ, 1969, NATURE, V224, P1076, DOI 10.1038/2241076a0; Beketov MA, 2006, J APPL ECOL, V43, P1069, DOI 10.1111/j.1365-2664.2006.01226.x; BIRCH LC, 1957, AM NAT, V91, P5, DOI 10.1086/281957; BIRCH LC, 1953, EVOLUTION, V7, P136, DOI 10.2307/2405749; Boone MD, 2002, ECOL APPL, V12, P307, DOI 10.1890/1051-0761(2002)012[0307:IOAIWC]2.0.CO;2; COLEGRAVE N, 1994, OIKOS, V71, P499, DOI 10.2307/3545838; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Cordeiro EMG, 2013, CHEMOSPHERE, V93, P1111, DOI 10.1016/j.chemosphere.2013.06.030; Crombie A. C., 1947, Journal of Animal Ecology, V16, P44; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Foit K, 2012, AQUAT TOXICOL, V106, P25, DOI 10.1016/j.aquatox.2011.09.012; Forbes VE, 1999, ENVIRON TOXICOL CHEM, V18, P1544, DOI 10.1002/etc.5620180729; Fox JW, 2013, TRENDS ECOL EVOL, V28, P86, DOI 10.1016/j.tree.2012.08.014; Gao YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092625; Gause GF, 1935, AM NAT, V69, P596, DOI 10.1086/280628; Guedes, 2011, STEWART POSTHARV REV, V5, P1, DOI DOI 10.2212/SPR.2011.3.5; Guedes NMP, 2010, ANIM BEHAV, V79, P281, DOI 10.1016/j.anbehav.2009.10.022; Guedes RNC, 2009, J ECON ENTOMOL, V102, P170, DOI 10.1603/029.102.0124; Guedes RNC, 2007, AUSTRAL ECOL, V32, P697, DOI 10.1111/j.1442-9993.2007.01769.x; Guedes RNC, 2014, PEST MANAG SCI, V70, P690, DOI 10.1002/ps.3669; HARDIN MR, 1995, CROP PROT, V14, P3, DOI 10.1016/0261-2194(95)91106-P; HAYNES KF, 1988, ANNU REV ENTOMOL, V33, P149, DOI 10.1146/annurev.en.33.010188.001053; Kesavaraju B, 2012, J MED ENTOMOL, V49, P988, DOI 10.1603/ME11245; Knillmann S, 2012, ECOTOXICOLOGY, V21, P1857, DOI 10.1007/s10646-012-0919-y; Liess M, 2005, ENVIRON TOXICOL CHEM, V24, P954, DOI 10.1897/03-652.1; Liess M, 2010, AQUAT TOXICOL, V97, P15, DOI 10.1016/j.aquatox.2009.11.018; Linke-Gamenick I, 1999, MAR ECOL PROG SER, V184, P139, DOI 10.3354/meps184139; Lotka A. J., 1925, ELEMENTS PHYS BIOL, DOI 10.1038/116461b0; LOTKA ALFRED J., 1932, JOUR WASHINGTON ACAD SCI, V22, P461; MAPA, 2014, MAN GAR QUAL AN; Mills NE, 2004, ECOL APPL, V14, P1041, DOI 10.1890/02-5134; Muturi EJ, 2011, J MED ENTOMOL, V48, P429, DOI 10.1603/ME10213; Oliveira EE, 2007, CHEMOSPHERE, V69, P17, DOI 10.1016/j.chemosphere.2007.04.077; PARK T, 1948, ECOL MONOGR, V18, P265, DOI 10.2307/1948641; Pestana JLT, 2009, AQUAT TOXICOL, V93, P138, DOI 10.1016/j.aquatox.2009.04.008; Rees David P., 1996, P1; Reitz SR, 2002, ANNU REV ENTOMOL, V47, P435, DOI 10.1146/annurev.ento.47.091201.145227; RIPPER WE, 1956, ANNU REV ENTOMOL, V1, P403, DOI 10.1146/annurev.en.01.010156.002155; SAS Institute, 2008, SAS STAT US GUID; SCHOENER TW, 1982, AM SCI, V70, P586; Shea K, 2004, ECOL LETT, V7, P491, DOI 10.1111/j.1461-0248.2004.00600.x; Sheil D, 2013, TRENDS ECOL EVOL, V28, P571, DOI 10.1016/j.tree.2013.07.006; Smith R.H., 1985, P423; SMITH RH, 1991, ADV ECOL RES, V21, P63, DOI 10.1016/S0065-2504(08)60097-5; Stark JD, 1997, ECOTOX ENVIRON SAFE, V37, P273, DOI 10.1006/eesa.1997.1552; Stark JD, 2003, ANNU REV ENTOMOL, V48, P505, DOI 10.1146/annurev.ento.48.091801.112621; Sun DB, 2013, B ENTOMOL RES, V103, P344, DOI 10.1017/S0007485312000788; Mallqui KSV, 2013, J STORED PROD RES, V55, P32, DOI 10.1016/j.jspr.2013.07.004; Vonesh JR, 2009, OECOLOGIA, V160, P379, DOI 10.1007/s00442-009-1301-5; Walthall WK, 1997, ENVIRON TOXICOL CHEM, V16, P1068, DOI 10.1002/etc.5620160529; White P.S., 1985, ECOLOGY NATURAL DIST, P3, DOI 10.1016/B978-0-12-554520-4.50006-X; WIENS JA, 1977, AM SCI, V65, P590; WIENS JA, 1986, COMMUNITY ECOLOGY, P154; Wilkinson DM, 1999, OIKOS, V84, P145, DOI 10.2307/3546874; WISSINGER SA, 1989, ECOLOGY, V70, P1017, DOI 10.2307/1941370; WITMAN JD, 1987, ECOL MONOGR, V57, P167, DOI 10.2307/1942623	56	29	30	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100990	10.1371/journal.pone.0100990	http://dx.doi.org/10.1371/journal.pone.0100990			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959673	Green Published, Green Submitted, gold			2022-12-27	WOS:000338633900109
J	Das, I; Basantray, I; Mamidi, P; Nayak, TK; Pratheek, BM; Chattopadhyay, S; Chattopadhyay, S				Das, Indrani; Basantray, Itishree; Mamidi, Prabhudutta; Nayak, Tapas K.; Pratheek, B. M.; Chattopadhyay, Subhasis; Chattopadhyay, Soma			Heat Shock Protein 90 Positively Regulates Chikungunya Virus Replication by Stabilizing Viral Non-Structural Protein nsP2 during Infection	PLOS ONE			English	Article							HSP90 MOLECULAR CHAPERONE; ORIGIN-BINDING PROTEIN; REVERSE-TRANSCRIPTASE; RNA REPLICATION; CROSS-TALK; EXPRESSION; CELLS; INHIBITION; APOPTOSIS; IDENTIFICATION	Background: The high morbidity and socio-economic loss associated with the recent massive global outbreak of Chikungunya virus (CHIKV) emphasize the need to understand the biology of the virus for developing effective antiviral therapies. Methods and Findings: In this study, an attempt was made to understand the molecular mechanism involved in Heat shock protein 90 (Hsp90) mediated regulation of CHIKV infection in mammalian cells using CHIKV prototype strain (S 27) and Indian outbreak strain of 2006 (DRDE-06). Our results showed that Hsp90 is required at a very early stage of viral replication and Hsp90 inhibitor Geldanamycin (GA) can abrogate new virus particle formation more effectively in the case of S 27 than that of DRDE-06. Further analysis revealed that CHIKV nsP2 protein level is specifically reduced by GA treatment as well as HSP90-siRNA transfection; however, viral RNA remains unaltered. Immunoprecipitation analysis showed that nsP2 interacts with Hsp90 during infection; however this interaction is reduced in the presence of GA. In addition, our analysis on Hsp90 associated PI3K/Akt/mTOR signaling pathway demonstrated that CHIKV infection stabilizes Raf1 and activates Hsp90 client protein Akt, which in turn phosphorylates mTOR. Subsequently, this phosphorylation leads to the activation of two important downstream effectors, S6K and 4EBP1, which may facilitate translation of viral as well as cellular mRNAs. Hence, the data suggests that CHIKV infection is regulated by Hsp90 associated Akt phosphorylation and DRDE-06 is more efficient than S 27 in enhancing the activation of host signaling molecules for its efficient replication and virus production. Conclusion: Hsp90 positively regulates Chikungunya virus replication by stabilizing CHIKV-nsP2 through its interaction during infection. The study highlights the possible molecular mechanism of GA mediated inhibition of CHIKV replication and differential effect of this drug on S 27 and DRDE-06, which will be informative for developing effective anti-CHIKV therapies in future.	[Das, Indrani; Basantray, Itishree; Mamidi, Prabhudutta; Chattopadhyay, Soma] Inst Life Sci, Bhubaneswar, Odisha, India; [Nayak, Tapas K.; Pratheek, B. M.; Chattopadhyay, Subhasis] Natl Inst Sci Educ & Res, Sch Biol Sci, Bhubaneswar, Odisha, India	Department of Biotechnology (DBT) India; Institute of Life Sciences India (ILS); National Institute of Science Education & Research (NISER)	Chattopadhyay, S (corresponding author), Inst Life Sci, Bhubaneswar, Odisha, India.	sochat.ils@gmail.com	Mamidi, Prabhudutta/GNM-5436-2022		Department of Biotechnology, Ministry of Science and Technology, Govt. of India [BT/PR13118/GBD/27/186/2009]; Council of Scientific and Industrial Research (CSIR) [37(1542)/12/EMR-II]; Ministry of Science and Technology, Govt. of India [BT/PR15173/GBD/27/356/2011]; Ministry of Science and Technology, Govt. of India	Department of Biotechnology, Ministry of Science and Technology, Govt. of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Ministry of Science and Technology, Govt. of India; Ministry of Science and Technology, Govt. of India	This work was supported by Department of Biotechnology, Ministry of Science and Technology, Govt. of India vide grant no. BT/PR13118/GBD/27/186/2009 and BT/PR15173/GBD/27/356/2011 Ministry of Science and Technology, Govt. of India and by Council of Scientific and Industrial Research (CSIR) ( Project No. 37(1542)/12/EMR-II), Ministry of Science and Technology, Govt. of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arndt V, 2007, CELL MOL LIFE SCI, V64, P2525, DOI 10.1007/s00018-007-7188-6; Basha Walid, 2005, Antiviral Chemistry & Chemotherapy, V16, P135; Basso AD, 2002, ONCOGENE, V21, P1159, DOI 10.1038/sj.onc.1205184; Blagosklonny MV, 2002, LEUKEMIA, V16, P455, DOI 10.1038/sj.leu.2402415; Bourai M, 2012, J VIROL, V86, P3121, DOI 10.1128/JVI.06390-11; Brenner BG, 2001, EXPERT OPIN BIOL TH, V1, P67, DOI 10.1517/14712598.1.1.67; Burch AD, 2005, J VIROL, V79, P10740, DOI 10.1128/JVI.79.16.10740-10749.2005; Campbell SL, 1998, ONCOGENE, V17, P1395, DOI 10.1038/sj.onc.1202174; Chattopadhyay S, 2006, J VIROL, V80, P4491, DOI 10.1128/JVI.80.9.4491-4500.2006; Chattopadhyay S, J VIROL METHODS C, V199C, P86; Chattopadhyay S, 2007, J VIROL, V81, P13659, DOI 10.1128/JVI.01204-07; Clippinger AJ, 2011, J VIROL, V85, P3930, DOI 10.1128/JVI.01913-10; Creagh EM, 2000, LEUKEMIA, V14, P1161, DOI 10.1038/sj.leu.2401841; Das PK, 2014, J BIOL CHEM, V289, P5635, DOI 10.1074/jbc.M113.503433; Dittmar KD, 1998, J BIOL CHEM, V273, P7358, DOI 10.1074/jbc.273.13.7358; Dutta D, 2011, J BIOL CHEM, V286, P20065, DOI 10.1074/jbc.M111.231878; Dutta D, 2009, VIROLOGY, V391, P325, DOI 10.1016/j.virol.2009.06.044; Ehrhardt C, 2007, J VIROL, V81, P3058, DOI 10.1128/JVI.02082-06; Enserink M, 2007, SCIENCE, V318, P1860, DOI 10.1126/science.318.5858.1860; Fros JJ, 2013, J VIROL, V87, P10394, DOI 10.1128/JVI.00884-13; Fujita N, 2002, J BIOL CHEM, V277, P10346, DOI 10.1074/jbc.M106736200; Garmashova N, 2006, J VIROL, V80, P5686, DOI 10.1128/JVI.02739-05; Geller R, 2007, GENE DEV, V21, P195, DOI 10.1101/gad.1505307; GRIFFIN DE, 2007, FIELDS VIROLOGY; Hu JM, 2004, J VIROL, V78, P13122, DOI 10.1128/JVI.78.23.13122-13131.2004; Hu JM, 1996, P NATL ACAD SCI USA, V93, P1060, DOI 10.1073/pnas.93.3.1060; Hu JM, 2000, J VIROL, V74, P11447, DOI 10.1128/JVI.74.24.11447-11455.2000; Hung JJ, 2002, J VIROL, V76, P1379, DOI 10.1128/JVI.76.3.1379-1390.2002; Karpe YA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022336; Khan M, 2011, ANTIVIR RES, V89, P1, DOI 10.1016/j.antiviral.2010.10.009; Kumar A, 2006, PLOS ONE, V9; LAAKKONEN P, 1994, J VIROL, V68, P7418, DOI 10.1128/JVI.68.11.7418-7425.1994; Lewthwaite J, 1998, TRENDS MICROBIOL, V6, P426, DOI 10.1016/S0966-842X(98)01362-6; Li L, 2010, NATURE, V468, P705, DOI 10.1038/nature09546; Ludwig S, 2006, CELL MICROBIOL, V8, P375, DOI 10.1111/j.1462-5822.2005.00678.x; Ma YJ, 2004, J CHEM NEUROANAT, V28, P51, DOI 10.1016/j.jchemneu.2003.08.007; McClellan AJ, 2005, NAT CELL BIOL, V7, P736, DOI 10.1038/ncb0805-736; Momose F, 2002, J BIOL CHEM, V277, P45306, DOI 10.1074/jbc.M206822200; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Naito T, 2007, J VIROL, V81, P1339, DOI 10.1128/JVI.01917-06; Neckers L, 2008, CELL HOST MICROBE, V4, P519, DOI 10.1016/j.chom.2008.10.011; Okamoto T, 2006, EMBO J, V25, P5015, DOI 10.1038/sj.emboj.7601367; Parida MM, 2007, J CLIN MICROBIOL, V45, P351, DOI 10.1128/JCM.01734-06; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Pastorino BAM, 2008, VIRUS RES, V131, P293, DOI 10.1016/j.virusres.2007.09.009; PERANEN J, 1990, J VIROL, V64, P1888; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Rathore AP, 2013, ANTIVIRAL RES C, V103C, P7; Richter K, 2001, J CELL PHYSIOL, V188, P281, DOI 10.1002/jcp.1131; ROBINSON M C, 1955, Trans R Soc Trop Med Hyg, V49, P28, DOI [10.1016/0035-9203(57)90022-6, 10.1016/0035-9203(55)90080-8]; Roe SM, 1999, J MED CHEM, V42, P260, DOI 10.1021/jm980403y; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Schulte TW, 1997, BIOCHEM BIOPH RES CO, V239, P655, DOI 10.1006/bbrc.1997.7527; SEDGER L, 1994, J VIROL, V68, P4685, DOI 10.1128/JVI.68.7.4685-4689.1994; Sharp S, 2006, ADV CANCER RES, V95, P323, DOI 10.1016/S0065-230X(06)95009-X; Stewart S, 1999, MOL CELL BIOL, V19, P5523; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Sullivan CS, 2001, VIROLOGY, V287, P1, DOI 10.1006/viro.2001.1038; Sullivan W, 1997, J BIOL CHEM, V272, P8007, DOI 10.1074/jbc.272.12.8007; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Voss JE, 2010, NATURE, V468, P709, DOI 10.1038/nature09555; Waxman L, 2001, P NATL ACAD SCI USA, V98, P13931, DOI 10.1073/pnas.241510898; WELCH WJ, 1993, SCI AM, V268, P56, DOI 10.1038/scientificamerican0593-56; WELCH WJ, 1982, J BIOL CHEM, V257, P4949; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; XU Y, 1993, P NATL ACAD SCI USA, V90, P7074, DOI 10.1073/pnas.90.15.7074; Yao JQ, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-30; Zheng ZZ, 2010, J GEN VIROL, V91, P1728, DOI 10.1099/vir.0.019323-0	69	50	50	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100531	10.1371/journal.pone.0100531	http://dx.doi.org/10.1371/journal.pone.0100531			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959709	Green Published, gold, Green Submitted			2022-12-27	WOS:000338633900054
J	Fan, L; Feng, Y; Wan, HY; Shi, GC; Niu, WQ				Fan, Liang; Feng, Yun; Wan, Huanying; Shi, Guochao; Niu, Wenquan			Clinicopathological and Demographical Characteristics of Non-Small Cell Lung Cancer Patients with ALK Rearrangements: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							EML4-ALK FUSION GENE; DRIVER MUTATIONS; NEVER-SMOKERS; HISTOLOGIC SUBTYPES; CLINICAL-FEATURES; ADENOCARCINOMA; EGFR; IMMUNOHISTOCHEMISTRY; IDENTIFICATION; TRANSLOCATION	Objective: This meta-analysis aimed to comprehensively examine the relationship between the clinicopathological and demographical characteristics and ALK rearrangements in patients with non-small cell lung cancer (NSCLC). Methods and Main Findings: In total, 62 qualified articles including 1178 ALK rearranged cases from 20541 NSCLC patients were analyzed, and the data were extracted independently by two investigators. NSCLC patients with ALK rearrangements tended to be younger than those without (mean difference: -7.16 years; 95% confidence interval (95% CI): -9.35 to -4.96; P<0.00001), even across subgroups by race. Compared with female NSCLC patients, the odds ratio (OR) of carrying ALK rearrangements was reduced by 28% (95% CI: 0.58-0.90; P = 0.004) in males, and this reduction was potentiated in Asians, yet in opposite direction in Caucasians. Likewise, smokers were less likely to have ALK rearrangements than never-smokers (OR = 0.33; 95% CI: 0.25-0.44; P<0.00001), even in race-stratified subgroups. Moreover, compared with NSCLC patients with tumor stage IV, ALK rearrangements were underrepresented in those with tumor stage I-III (OR = 0.58; 95% CI: 0.44-0.78; P = 0.0002). Patients with lung adenocarcinomas had a significantly higher rate of ALK rearrangements (7.2%) than patients with non-adenocarcinoma (2.0%) (OR = 2.25; 95% CI: 1.54-3.27; P<0.0001). Conclusion: Our findings demonstrate that ALK rearrangements tended to be present in NSCLC patients with no smoking habit, younger age and tumor stage IV. Moreover, race, age, gender, smoking status, tumor stage and histology might be potential sources of heterogeneity.	[Fan, Liang; Feng, Yun; Wan, Huanying; Shi, Guochao] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Resp Med, Shanghai 200030, Peoples R China; [Niu, Wenquan] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, State Key Lab Med Genom, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Jiao Tong University	Wan, HY (corresponding author), Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Resp Med, Shanghai 200030, Peoples R China.	huanyingwanruijin@126.com; shiguochao@hotmail.com; niuwenquan_shcn@163.com			National Natural Science Foundation of China [81201837]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (81201837). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040109; Boland JM, 2009, HUM PATHOL, V40, P1152, DOI 10.1016/j.humpath.2009.01.012; Cardarella S, 2012, J THORAC ONCOL, V7, P1767, DOI 10.1097/JTO.0b013e3182745bcb; Chen Tai-Di, 2012, Chang Gung Med J, V35, P309; Chen Z, 2010, CANCER RES, V70, P9827, DOI 10.1158/0008-5472.CAN-10-1671; Conde E, 2013, HISTOPATHOLOGY, V62, P609, DOI 10.1111/his.12037; Dai Z, 2012, MOL CYTOGENET, V5, P1755; Desai SS, 2013, INDIAN J CANCER, V50, P80, DOI 10.4103/0019-509X.117007; Doebele RC, 2012, CANCER-AM CANCER SOC, V118, P4502, DOI 10.1002/cncr.27409; Ettinger DS, 2012, J NATL COMPR CANC NE, V10, P1236, DOI 10.6004/jnccn.2012.0130; Fukui T, 2012, LUNG CANCER, V77, P319, DOI 10.1016/j.lungcan.2012.03.013; Gainor JF, 2013, CLIN CANCER RES, V19, P4273, DOI 10.1158/1078-0432.CCR-13-0318; Hozo SP., 2005, BMC MED RES METHODOL, V5, P1, DOI [10.1186/1471-2288-5-13, DOI 10.1186/1471-2288-5-13]; Ilie M, 2012, ANN ONCOL, V23, P2907, DOI 10.1093/annonc/mds137; Inamura K, 2009, MODERN PATHOL, V22, P508, DOI 10.1038/modpathol.2009.2; Jin G, 2012, J KOREAN MED SCI, V27, P228, DOI 10.3346/jkms.2012.27.2.228; Jokoji R, 2010, J CLIN PATHOL, V63, P1066, DOI 10.1136/jcp.2010.081166; Just PA, 2012, LUNG CANCER, V76, P309, DOI 10.1016/j.lungcan.2011.11.004; Kanaji N, 2012, LUNG CANCER, V77, P293, DOI 10.1016/j.lungcan.2012.03.018; Kim HR, 2012, CANCER-AM CANCER SOC, V118, P729, DOI 10.1002/cncr.26311; Kobayashi Masashi, 2012, Asian Cardiovasc Thorac Ann, V20, P426, DOI 10.1177/0218492312440700; Koh Y, 2011, J THORAC ONCOL, V6, P905, DOI 10.1097/JTO.0b013e3182111461; Koivunen JP, 2008, CLIN CANCER RES, V14, P4275, DOI 10.1158/1078-0432.CCR-08-0168; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Laszlo A, 2013, CANCER J, V19, P238, DOI 10.1097/PPO.0b013e31829a68eb; Lee HY, 2013, LUNG CANCER, V79, P40, DOI 10.1016/j.lungcan.2012.10.002; Lee JO, 2011, J THORAC ONCOL, V6, P1474, DOI 10.1097/JTO.0b013e3182208fc2; Lee JK, 2012, LUNG CANCER, V77, P460, DOI 10.1016/j.lungcan.2012.04.012; Li C, 2011, PLOS ONE, V6, P30; LI Y, 2013, PLOS ONE, V8, DOI DOI 10.1371/JOURNAL.PONE.0077864; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mano H, 2008, CANCER SCI, V99, P2349, DOI 10.1111/j.1349-7006.2008.00972.x; Martelli MP, 2009, AM J PATHOL, V174, P661, DOI 10.2353/ajpath.2009.080755; Martinez P, 2013, PLOS ONE, V8, P24; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Niu WQ, 2009, HYPERTENS RES, V32, P1060, DOI 10.1038/hr.2009.164; Paik JH, 2012, LUNG CANCER, V76, P403, DOI 10.1016/j.lungcan.2011.11.008; Paik PK, 2012, CANCER-AM CANCER SOC, V118, P5840, DOI 10.1002/cncr.27637; Park HS, 2012, LUNG CANCER, V77, P288, DOI 10.1016/j.lungcan.2012.03.004; Perner S, 2008, NEOPLASIA, V10, P298, DOI 10.1593/NEO.07878; Ren S, 2012, CELL BIOCH BIOPHYS, V17, P17; Ren SX, 2012, CELL BIOCHEM BIOPHYS, V64, P155, DOI 10.1007/s12013-012-9384-8; Rimkunas VM, 2012, CLIN CANCER RES, V18, P4449, DOI 10.1158/1078-0432.CCR-11-3351; Rodig SJ, 2009, CLIN CANCER RES, V15, P5216, DOI 10.1158/1078-0432.CCR-09-0802; Sakai K, 2012, J THORAC ONCOL, V7, P913, DOI 10.1097/JTO.0b013e31824c7f7a; Sakai Y, 2013, INT J SURG PATHOL, V20, P20; Sakairi Y, 2010, CLIN CANCER RES, V16, P4938, DOI 10.1158/1078-0432.CCR-10-0099; Salido M, 2011, J THORAC ONCOL, V6, P21, DOI 10.1097/JTO.0b013e3181fb7cd6; Seo JS, 2012, GENOME RES, V22, P2109, DOI 10.1101/gr.145144.112; Shaw AT, 2013, J CLIN ONCOL, V31, P1105, DOI 10.1200/JCO.2012.44.5353; Shaw AT, 2011, LANCET ONCOL, V12, P1004, DOI 10.1016/S1470-2045(11)70232-7; Shaw AT, 2009, J CLIN ONCOL, V27, P4247, DOI 10.1200/JCO.2009.22.6993; Shen LJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059070, 10.1371/journal.pone.0077077, 10.1371/journal.pone.0077515]; Shinmura K, 2008, LUNG CANCER, V61, P163, DOI 10.1016/j.lungcan.2007.12.013; Soda M, 2012, CLIN CANCER RES, V11, P11; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Soda M, 2012, CLIN CANCER RES, V18, P5682, DOI 10.1158/1078-0432.CCR-11-2947; Sweeting MJ, 2004, STAT MED, V23, P1351, DOI 10.1002/sim.1761; Takahashi T, 2010, ANN SURG ONCOL, V17, P889, DOI 10.1245/s10434-009-0808-7; Takamochi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069794; Takeda M, 2012, ANN ONCOL, V23, P2931, DOI 10.1093/annonc/mds124; Takeuchi K, 2012, NAT MED, V18, P378, DOI 10.1038/nm.2658; To KF, 2013, J THORAC ONCOL, V8, P883, DOI 10.1097/JTO.0b013e3182904e22; Wallander ML, 2012, ARCH PATHOL LAB MED, V136, P796, DOI 10.5858/arpa.2011-0321-OA; Wang R, 2012, J CLIN ONCOL, V30, P4352, DOI 10.1200/JCO.2012.44.1477; Wang ZJ, 2012, ONCOLOGY-BASEL, V83, P248, DOI 10.1159/000341381; Wong DWS, 2009, CANCER-AM CANCER SOC, V115, P1723, DOI 10.1002/cncr.24181; Wu SG, 2012, J THORAC ONCOL, V7, P98, DOI 10.1097/JTO.0b013e3182370e30; Xia N, 2013, EXP LUNG RES, V6, P6; Yamaguchi N, 2013, LUNG CANCER, V7, P013; Yang P, 2012, J THORAC ONCOL, V7, P90, DOI 10.1097/JTO.0b013e31823c5c32; Yoon HJ, 2012, RADIOLOGY, V265, P939, DOI 10.1148/radiol.12112613; Yoshida A, 2011, AM J SURG PATHOL, V35, P1226, DOI 10.1097/PAS.0b013e3182233e06; Zhang X, 2010, MOL CANCER, V9, P1476; Zhang Y, 2012, CLIN CANCER RES, V18, P1947, DOI 10.1158/1078-0432.CCR-11-2511; Zhou JX, 2013, ANN ONCOL, V24, P1319, DOI 10.1093/annonc/mds626; Zhou SZ, 2012, GENE CHROMOSOME CANC, V51, P925, DOI 10.1002/gcc.21976	77	37	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100866	10.1371/journal.pone.0100866	http://dx.doi.org/10.1371/journal.pone.0100866			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959902	Green Submitted, Green Published, gold			2022-12-27	WOS:000338633900098
J	Forde, N; Simintiras, CA; Sturmey, R; Mamo, S; Kelly, AK; Spencer, TE; Bazer, FW; Lonergan, P				Forde, Niamh; Simintiras, Constantine A.; Sturmey, Roger; Mamo, Solomon; Kelly, Alan K.; Spencer, Thomas E.; Bazer, Fuller W.; Lonergan, Pat			Amino Acids in the Uterine Luminal Fluid Reflects the Temporal Changes in Transporter Expression in the Endometrium and Conceptus during Early Pregnancy in Cattle	PLOS ONE			English	Article							SELECT NUTRIENTS; SYSTEMIC PROGESTERONE; BOVINE ENDOMETRIUM; ESTROUS-CYCLE; EMBRYO; LUMEN; ELONGATION; METABOLISM; SECRETIONS; SURVIVAL	In cattle, conceptus-maternal interactions are critical for the establishment and maintenance of pregnancy. A major component of this early interaction involves the transport of nutrients and secretion of key molecules by uterine epithelial cells to help support conceptus development during the peri-implantation period of pregnancy. Objectives were to: 1) analyze temporal changes in the amino acid (AA) content of uterine luminal fluid (ULF) during the bovine estrous cycle; 2) understand conceptus-induced alterations in AA content; 3) determine expression of AA transporters in the endometrium and conceptus; and 4) determine how these transporters are modulated by (Progesterone) P4. Concentrations of aspartic acid, arginine, glutamine, histidine, lysine, isoleucine, leucine, phenylalanine and tyrosine decreased on Day 16 of the estrous cycle but increased on Day 19 in pregnant heifers (P, 0.05). Glutamic acid only increased in pregnant heifers on Day 19 (P, 0.001). Asparagine concentrations were greater in ULF of cyclic compared to pregnant heifers on Day 7 (P, 0.05) while valine concentrations were higher in pregnant heifers on Day 16 (P, 0.05). Temporal changes in expression of the cationic AA transporters SLC7A1 SLC7A4 and SLC7A6 occurred in the endometrium during the estrous cycle/early pregnancy coordinate with changes in conceptus expression of SLC7A4, SLC7A2 and SLC7A1 (P < 0.05). Only one acidic AA transporter (SLC1A5) increased in the endometrium while conceptus expression of SLC1A4 increased (P < 0.05). The neutral AA transporters SLC38A2 and SLC7A5 increased in the endometrium in a temporal manner while conceptus expression of SLC38A7, SLC43A2, SLC38A11 and SLC7A8 also increased (P < 0.05). P4 modified the expression of SLC1A1, -1A4, -1A5, -38A2, 38A4, -38A7, -43A2, -6A14, -7A1, -7A5 and -7A7 in the endometrium. Results demonstrate that temporal changes in AA in the ULF reflect changes in transporter expression in the endometrium and conceptus during early pregnancy in cattle, some of which are modified by P4.	[Forde, Niamh; Mamo, Solomon; Lonergan, Pat] Univ Coll Dublin, Sch Agr & Food Sci, Dublin 2, Ireland; [Simintiras, Constantine A.; Sturmey, Roger; Kelly, Alan K.] Univ Hull, Ctr Cardiovasc & Metab Res, Kingston Upon Hull HU6 7RX, N Humberside, England; [Spencer, Thomas E.] Washington State Univ, Dept Anim Sci, Pullman, WA 99164 USA; [Bazer, Fuller W.] Texas A&M Univ, Dept Anim Sci, College Stn, TX 77843 USA	University College Dublin; University of Hull; Washington State University; Texas A&M University System; Texas A&M University College Station	Forde, N (corresponding author), Univ Coll Dublin, Sch Agr & Food Sci, Dublin 2, Ireland.	niamh.forde@ucd.ie	Simintiras, Constantine A./AAW-7287-2021; Spencer, Thomas/AAD-6434-2020; Bazer, Fuller/AAF-4317-2021	Simintiras, Constantine A./0000-0001-5123-258X; Bazer, Fuller/0000-0002-5823-5086; Sturmey, Roger/0000-0003-4423-5058; Forde, Niamh/0000-0002-3539-9643; Spencer, Thomas/0000-0003-2815-766X	Science Foundation Ireland [10/IN.1/B3011]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by Science Foundation Ireland under grant number 10/IN.1/B3011 to PL. (www.sfi.ie.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulos NI, 2005, REPROD FERT DEVELOP, V17, P799, DOI 10.1071/RD04104; Bauersachs S, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094771; Bazer FW, 2012, J REPROD DEVELOP, V58, P180, DOI 10.1262/jrd.2011-019; Bazer FW, 2010, BIOL REPROD, P75; BAZER FW, 1975, J ANIM SCI, V41, P1376, DOI 10.2527/jas1975.4151376x; Berendt FJ, 2005, PROTEOMICS, V5, P2551, DOI 10.1002/pmic.200401242; BETTERIDGE KJ, 1980, J REPROD FERTIL, V59, P205, DOI 10.1530/jrf.0.0590205; Brandao DO, 2004, BIOL REPROD, V71, P2048, DOI 10.1095/biolreprod.103.025916; Carter F, 2008, REPROD FERT DEVELOP, V20, P368, DOI 10.1071/RD07204; Clemente M, 2009, REPRODUCTION, V138, P507, DOI 10.1530/REP-09-0152; Diskin MG, 2008, REPROD DOMEST ANIM, V43, P260, DOI 10.1111/j.1439-0531.2008.01171.x; Dorniak P, 2012, J ANIM SCI; Dorniak P, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.100487; Dorniak P, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097063; Dorniak P, 2011, BIOL REPROD, V84, P1119, DOI 10.1095/biolreprod.110.089979; Forde N, 2011, BIOL REPROD, V85, P144, DOI 10.1095/biolreprod.110.090019; Forde N, 2011, BIOL REPROD, V84, P266, DOI 10.1095/biolreprod.110.085910; Forde N, 2009, BIOL REPROD, V81, P784, DOI 10.1095/biolreprod.108.074336; Forde N, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-321; Forde N, 2012, J REPROD DEVELOP, V58, P189, DOI 10.1262/jrd.2011-021; Gao HJ, 2009, BIOL REPROD, V80, P1196, DOI 10.1095/biolreprod.108.075440; Gao HJ, 2009, BIOL REPROD, V80, P602, DOI 10.1095/biolreprod.108.073890; Gao HJ, 2009, BIOL REPROD, V80, P86, DOI 10.1095/biolreprod.108.071597; Gray CA, 2002, REPRODUCTION, V124, P289, DOI 10.1530/rep.0.1240289; Groebner AE, 2011, CELL REPROGRAM, V13, P403, DOI 10.1089/cell.2011.0006; Groebner AE, 2011, REPRODUCTION, V141, P685, DOI 10.1530/REP-10-0533; Houghton FD, 2002, HUM REPROD, V17, P999, DOI 10.1093/humrep/17.4.999; Hugentobler SA, 2010, REPROD FERT DEVELOP, V22, P684, DOI 10.1071/RD09129; Hugentobler SA, 2007, MOL REPROD DEV, V74, P445, DOI 10.1002/mrd.20607; Kim J, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105080; Ledgard AM, 2011, REPROD FERT DEVELOP, V23, P737, DOI 10.1071/RD10183; Leese HJ, 2012, REPRODUCTION, V143, P417, DOI 10.1530/REP-11-0484; Mamo S, 2011, BIOL REPROD, V85, P1143, DOI 10.1095/biolreprod.111.092643; Meier S, 2014, J DAIRY SCI, V97, P1364, DOI 10.3168/jds.2013-6954; Meier S, 2011, J DAIRY RES, V78, P263, DOI 10.1017/S0022029911000173; Mullen MP, 2014, REPROD FERT DEVELOP, V26, P282, DOI 10.1071/RD12319; NORTHEY DL, 1980, J ANIM SCI, V50, P298, DOI 10.2527/jas1980.502298x; Satterfield MC, 2010, BIOL REPROD, V82, P224, DOI 10.1095/biolreprod.109.076729; Sturmey RG, 2010, MOL REPROD DEV, V77, P285, DOI 10.1002/mrd.21145; Wale PL, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.100552	40	81	83	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100010	10.1371/journal.pone.0100010	http://dx.doi.org/10.1371/journal.pone.0100010			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24960174	Green Published, gold, Green Submitted			2022-12-27	WOS:000338633900020
J	Leymarie, O; Embury-Hyatt, C; Chevalier, C; Jouneau, L; Moroldo, M; Da Costa, B; Berhane, Y; Delmas, B; Weingartl, HM; Le Goffic, R				Leymarie, Olivier; Embury-Hyatt, Carissa; Chevalier, Christophe; Jouneau, Luc; Moroldo, Marco; Da Costa, Bruno; Berhane, Yohannes; Delmas, Bernard; Weingartl, Hana M.; Le Goffic, Ronan			PB1-F2 Attenuates Virulence of Highly Pathogenic Avian H5N1 Influenza Virus in Chickens	PLOS ONE			English	Article							MITOCHONDRIAL-MEMBRANE; PANDEMIC INFLUENZA; PROTEIN; TRANSMISSION; CELLS; EXPRESSION; DEATH; DUCKS; GENE; HA	Highly pathogenic avian influenza virus (HPAIV) is a permanent threat due to its capacity to cross species barriers and generate severe infections and high mortality in humans. Recent findings have highlighted the potential role of PB1-F2, a small accessory influenza protein, in the pathogenesis process mediated by HPAIV in mammals. In this study, using a recombinant H5N1 HPAIV (wt) and its PB1-F2-deleted mutant (Delta F2), we studied the effects of PB1-F2 in a chicken model. Unexpectedly, when using low inoculation dose we observed that the wt-infected chickens had a higher survival rate than the Delta F2-infected chickens, a feature that contrasts with what is usually observed in mammals. High inoculation dose had similar mortality rate for both viruses, and comparison of the bio-distribution of the two viruses indicated that the expression of PB1-F2 allows a better spreading of the virus within chicken embryos. Transcriptomic profiles of lungs and blood cells were characterized at two days post-infection in chickens inoculated with the wild type (wt) or the Delta F2 mutant viruses. In lungs, the expression of PB1-F2 during the infection induced pathways related to calcium signaling and repressed a large panel of immunological functions. In blood cells, PB1-F2 was associated with a gene signature specific for mitochondrial dysfunction and down-modulated leucocytes activation. Finally we compared the effect of PB1-F2 in lungs of chickens and mice. We identified that gene signature associated to tissue damages is a PB1-F2 feature shared by the two species; by contrast, the early inhibition of immune response mediated by PB1-F2 observed in chickens is not seen in mice. In summary, our data suggest that PB1-F2 expression deeply affect the immune response in chickens in a way that may attenuate pathogenicity at low infection dose, a feature differing from what was previously observed in mammal species.	[Leymarie, Olivier; Chevalier, Christophe; Jouneau, Luc; Da Costa, Bruno; Delmas, Bernard; Le Goffic, Ronan] INRA, Unite Rech UR892, Unite Virol & Immunol Mol, Jouy En Josas, France; [Embury-Hyatt, Carissa; Berhane, Yohannes; Weingartl, Hana M.] Canadian Food Inspect Agcy, Natl Ctr Foreign Anim Dis, Winnipeg, MB, Canada; [Moroldo, Marco] INRA, Ctr Ressources Biol Genom Anim Domest & Interet E, Jouy En Josas, France; [Weingartl, Hana M.] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada	INRAE; UDICE-French Research Universities; Universite Paris Saclay; Canadian Food Inspection Agency; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Manitoba	Weingartl, HM (corresponding author), Canadian Food Inspect Agcy, Natl Ctr Foreign Anim Dis, Winnipeg, MB, Canada.	Hana.Weingartl@inspection.gc.ca; ronan.legoffic@jouy.inra.fr	Chevalier, Christophe/AAW-5560-2020; Jouneau, Luc/AAC-4711-2020; LE GOFFIC, Ronan/M-3099-2019; Chevalier, Christophe/AAK-4461-2020; LE GOFFIC, Ronan/B-7649-2008; Chevalier, Christophe/C-2575-2009	LE GOFFIC, Ronan/0000-0002-2012-0064; LE GOFFIC, Ronan/0000-0002-2012-0064; Chevalier, Christophe/0000-0003-3231-9027; Leymarie, Olivier/0000-0001-8670-3089	Conseil regional d'Ile-de-France through DIM Malinf ("Domaine d'Interet Majeur Maladies Infectieuses, parasitaires et nosocomiales emergentes'') [dim100157]; OECD Co-operative Research Programme [TAD/PROG 67049]; "DIM Malinf'' doctoral fellowships - "Conseil regional d'Ile-de-France''	Conseil regional d'Ile-de-France through DIM Malinf ("Domaine d'Interet Majeur Maladies Infectieuses, parasitaires et nosocomiales emergentes'')(Region Ile-de-France); OECD Co-operative Research Programme; "DIM Malinf'' doctoral fellowships - "Conseil regional d'Ile-de-France''	This work was partially funded by the Conseil regional d'Ile-de-France through DIM Malinf ("Domaine d'Interet Majeur Maladies Infectieuses, parasitaires et nosocomiales emergentes'', Grant#: dim100157) and by the OECD Co-operative Research Programme (Contract No.: TAD/PROG 67049). OL was supported by "DIM Malinf'' doctoral fellowships awarded by the "Conseil regional d'Ile-de-France''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alymova IV, 2011, J VIROL, V85, P12324, DOI 10.1128/JVI.05872-11; Audas TE, 2008, MOL CELL BIOL, V28, P3952, DOI 10.1128/MCB.01439-07; Barber MRW, 2010, P NATL ACAD SCI USA, V107, P5913, DOI 10.1073/pnas.1001755107; Brown IH, 2010, AVIAN DIS, V54, P187, DOI 10.1637/8949-053109-Reg.1; Cardona CJ, 2009, COMP IMMUNOL MICROB, V32, P255, DOI 10.1016/j.cimid.2008.01.001; Chakrabarti AK, 2013, VIROLOGY; Chanturiya AN, 2004, J VIROL, V78, P6304, DOI 10.1128/JVI.78.12.6304-6312.2004; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Chevalier C, 2010, J BIOL CHEM, V285, P13233, DOI 10.1074/jbc.M109.067710; Conenello GM, 2007, PLOS PATHOG, V3, P1414, DOI 10.1371/journal.ppat.0030141; Conenello GM, 2011, J VIROL, V85, P652, DOI 10.1128/JVI.01987-10; DeLuca DS, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S13-S6; Di Leva F, 2008, ARCH BIOCHEM BIOPHYS, V476, P65, DOI 10.1016/j.abb.2008.02.026; Dundon WG, 2012, VIRUS GENES, V44, P363, DOI 10.1007/s11262-012-0714-0; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Gibbs JS, 2003, J VIROL, V77, P7214, DOI 10.1128/JVI.77.13.7214-7224.2003; Gyorgy H, 2006, CELL CALCIUM, V40, P553, DOI 10.1016/j.ceca.2006.08.016; Hajnoczky G, 2003, BIOCHEM BIOPH RES CO, V304, P445, DOI 10.1016/S0006-291X(03)00616-8; Hassan IH, 2012, J BIOL CHEM, V287, P4679, DOI 10.1074/jbc.M111.284695; Henkel M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011112; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Hoffmann E, 2002, VACCINE, V20, P3165, DOI 10.1016/S0264-410X(02)00268-2; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Iverson AR, 2011, J INFECT DIS, V203, P880, DOI 10.1093/infdis/jiq113; Jagger BW, 2012, SCIENCE, V337, P199, DOI 10.1126/science.1222213; KAWAOKA Y, 1989, J VIROL, V63, P4603, DOI 10.1128/JVI.63.11.4603-4608.1989; Kim JK, 2009, INFLUENZA OTHER RESP, V3, P121, DOI 10.1111/j.1750-2659.2009.00084.x; Kuchipudi SV, 2012, IMMUNOL CELL BIOL, V90, P116, DOI 10.1038/icb.2011.17; Le Goffic R, 2006, PLOS PATHOG, V2, P526, DOI 10.1371/journal.ppat.0020053; Le Goffic R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002202; Le Goffic R, 2010, J IMMUNOL, V185, P4812, DOI 10.4049/jimmunol.0903952; Leymarie O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057894; Mazur I, 2008, CELL MICROBIOL; McAuley JL, 2007, CELL HOST MICROBE, V2, P240, DOI 10.1016/j.chom.2007.09.001; McAuley JL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001014; McAuley JL, 2010, J VIROL, V84, P558, DOI 10.1128/JVI.01785-09; OIE-WAHID, 2012, INF VIR NOT AV INFL; Pappas C, 2008, P NATL ACAD SCI USA, V105, P3064, DOI 10.1073/pnas.0711815105; Pasricha G, 2012, INFLUENZA OTHER RESP; Schmolke M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002186; SCHOLTISSEK C, 1978, VIROLOGY, V87, P13, DOI 10.1016/0042-6822(78)90153-8; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Srikanth S, 2012, P NATL ACAD SCI USA, V109, P8682, DOI 10.1073/pnas.1200667109; Tisoncik JR, 2012, MICROBIOL MOL BIOL R, V76, P16, DOI 10.1128/MMBR.05015-11; Ueda M, 2010, J VIROL, V84, P3068, DOI 10.1128/JVI.01923-09; Varga ZT, 2012, J VIROL, V86, P8359, DOI 10.1128/JVI.01122-12; Varga ZT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002067; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Wang TT, 2012, SCIENCE, V335, P1463, DOI 10.1126/science.1218888; Wise HM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002998; Wise HM, 2009, J VIROL, V83, P8021, DOI 10.1128/JVI.00826-09; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Xu H, 2014, ELIFE, V3, DOI 10.7554/eLife.01489; Yamada H, 2004, FEBS LETT, V578, P331, DOI 10.1016/j.febslet.2004.11.017; Yen HL, 2009, CURR TOP MICROBIOL, V333, P3, DOI 10.1007/978-3-540-92165-3_1; Zamarin D, 2006, J VIROL, V80, P7976, DOI 10.1128/JVI.00415-06; Zamarin Dmitriy, 2005, PLoS Pathogens, V1, P40; Zell R, 2007, J GEN VIROL, V88, P536, DOI 10.1099/vir.0.82378-0	58	23	23	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100679	10.1371/journal.pone.0100679	http://dx.doi.org/10.1371/journal.pone.0100679			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959667	Green Submitted, Green Published, gold			2022-12-27	WOS:000338633900069
J	Liu, H; Wang, DX; Li, Y; Li, Z; Zhang, Y; Lei, F; Du, LN; Tang, XD				Liu, Hong; Wang, Dexi; Li, Yun; Li, Zhe; Zhang, Ying; Lei, Fei; Du, Lina; Tang, Xiangdong			Examination of Daytime Sleepiness and Cognitive Performance Testing in Patients with Primary Insomnia	PLOS ONE			English	Article							ATTENTION NETWORK TEST; LATENCY TEST; NEUROPSYCHOLOGICAL PERFORMANCE; IMPAIRMENT; DEPRESSION; VIGILANCE; CHILDREN; RECOVERY; DEFICITS	Objective: While individuals with insomnia consistently complain of cognitive impairment, previous studies on the effect of insomnia on objective measures of cognitive function have obtained ambiguous results. The relationship between daytime sleepiness and cognitive manifestations in insomnia patients is not clear. Methods: Thirty-six primary insomnia patients (PIPs) and 26 good sleep controls (GSCs) with age and gender matched manner were included in the study. Participants underwent an overnight polysomnography followed by a multiple sleep latency test (MSLT) and an examination of the attention network test (ANT). ANT reflected three attentional networks including alerting, orienting and executive control. According to whether accompanied with excessive daytime sleepiness (EDS), the insomnia group were subdivided into PIPs with EDS (n = 12, score on MSLT<10 min) and PIPs without EDS (n = 24, score on MSLT >= 10 min). Results: PIPs only performed worse on executive control function than GSCs in ANT. PIPs with EDS had longer overall reaction time (RT) related to PIPs without EDS. Further analyses with Pearson correlation analysis showed a significant negative correlation between the overall RT and MSLT latency in insomniacs (r = 20.444, p<0.01), whereas no such correlation was found in controls. Conclusions: Results suggest that PIPs do show executive control function deficits compared with GSCs. Daytime sleepiness in terms of MSLT latency was associated with poor cognitive manifestations in patients with insomnia.	[Liu, Hong; Wang, Dexi; Li, Yun; Li, Zhe; Lei, Fei; Du, Lina; Tang, Xiangdong] Sichuan Univ, West China Hosp, Translat Neurosci Ctr, Sleep Med Ctr,Mental Hlth Ctr, Chengdu 610064, Sichuan Provinc, Peoples R China; [Liu, Hong] First Peoples Hosp Yibin, Dept Internal Med, Yibin, Sichuan Provinc, Peoples R China; [Wang, Dexi] First Peoples Hosp Yibin, Dept Neurosurg, Yibin, Sichuan Provinc, Peoples R China; [Zhang, Ying] Dalhousie Univ, Dept Psychol, Halifax, NS, Canada	Sichuan University; Dalhousie University	Tang, XD (corresponding author), Sichuan Univ, West China Hosp, Translat Neurosci Ctr, Sleep Med Ctr,Mental Hlth Ctr, Chengdu 610064, Sichuan Provinc, Peoples R China.	xiangdong.tang@gmail.com		Tang, Xiangdong/0000-0001-6876-3328; Zhang, Ying/0000-0003-4363-5666; Li, Yun/0000-0001-6276-9104	National Natural Science Foundation of China [81170072]; Sino-German Joint Center for Sleep Medicine [GZ538]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sino-German Joint Center for Sleep Medicine	This work was supported by the National Natural Science Foundation of China (81170072) and by the Sino-German Joint Center for Sleep Medicine (GZ538). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolfsdottir S, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-9; Altena E, 2008, SLEEP, V31, P1271; Altena E, 2008, J SLEEP RES, V17, P335, DOI 10.1111/j.1365-2869.2008.00671.x; American Psychiatric Association A, 1994, DIAGN STAT MAN MENT; Bayard S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033525; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Brocki K, 2009, NEUROSCIENCE, V164, P241, DOI 10.1016/j.neuroscience.2009.01.029; BUYSSE DJ, 1991, SLEEP, V14, P331; CARSKADON MA, 1986, SLEEP, V9, P519, DOI 10.1093/sleep/9.4.519; Carter CS, 1999, REV NEUROSCIENCE, V10, P49; Covassin N, 2011, INT J PSYCHOPHYSIOL, V80, P79, DOI 10.1016/j.ijpsycho.2011.02.005; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Drummond SPA, 2005, SLEEP, V28, P1059; Durmer JS, 2005, SEMIN NEUROL, V25, P117, DOI 10.1055/s-0029-1237117; Edinger JD, 2003, J SLEEP RES, V12, P43, DOI 10.1046/j.1365-2869.2003.00335.x; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Fernandez-Mendoza J, 2010, SLEEP, V33, P459, DOI 10.1093/sleep/33.4.459; Finan PH, 2013, SLEEP MED REV, V17, P173, DOI 10.1016/j.smrv.2012.03.003; Fortier-Brochu E, 2012, SLEEP MED REV, V16, P83, DOI 10.1016/j.smrv.2011.03.008; Fossella J, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-14; Fulda S, 2001, SLEEP MED REV, V5, P423, DOI 10.1053/smrv.2001.0157; Gradisar M, 2007, J CLIN SLEEP MED, V3, P722; Huang LL, 2012, J SLEEP RES, V21, P684, DOI 10.1111/j.1365-2869.2012.01028.x; Iber C., 2007, AASM MANUAL SCORING; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Lamond N, 2007, J SLEEP RES, V16, P33, DOI 10.1111/j.1365-2869.2007.00574.x; Li SH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0083037, 10.1371/journal.pone.0067928, 10.1371/journal.pone.0057604]; Littner MR, 2005, SLEEP, V28, P113, DOI 10.1093/sleep/28.1.113; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; MENDELSON WB, 1984, PSYCHIAT RES, V12, P235, DOI 10.1016/0165-1781(84)90029-5; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Neuhaus AH, 2010, INT J PSYCHOPHYSIOL, V76, P72, DOI 10.1016/j.ijpsycho.2010.02.005; O'Brien LM, 2009, CHILD ADOL PSYCH CL, V18, P813, DOI 10.1016/j.chc.2009.04.008; Orff HJ, 2007, SLEEP, V30, P1205, DOI 10.1093/sleep/30.9.1205; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Riedel BW, 2000, SLEEP MED REV, V4, P277, DOI 10.1053/smrv.1999.0074; Riemann D, 2010, SLEEP MED REV, V14, P19, DOI 10.1016/j.smrv.2009.04.002; Sateia MJ, 2004, LANCET, V364, P1959, DOI 10.1016/S0140-6736(04)17480-1; SCHNEIDERHELMERT D, 1987, SLEEP, V10, P452; Shekleton JA, 2010, SLEEP MED REV, V14, P47, DOI 10.1016/j.smrv.2009.06.001; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Van Dam NT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054035; Van Dongen HPA, 2004, SLEEP, V27, P423; Vignola A, 2000, J GERONTOL B-PSYCHOL, V55, pP54; Wang K, 2005, SCHIZOPHR RES, V78, P235, DOI 10.1016/j.schres.2005.01.019; Weaver B, 2009, ACCIDENT ANAL PREV, V41, P76, DOI 10.1016/j.aap.2008.09.006; Westlye LT, 2011, CEREB CORTEX, V21, P345, DOI 10.1093/cercor/bhq101; Yin XT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050590; ZAMMIT GK, 1988, J CLIN PSYCHOL, V44, P123, DOI 10.1002/1097-4679(198803)44:2<123::AID-JCLP2270440206>3.0.CO;2-D	50	25	26	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100965	10.1371/journal.pone.0100965	http://dx.doi.org/10.1371/journal.pone.0100965			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK7UT	24959897	Green Submitted, Green Published, gold			2022-12-27	WOS:000338633900106
J	Odaka, H; Arai, S; Inoue, T; Kitaguchi, T				Odaka, Haruki; Arai, Satoshi; Inoue, Takafumi; Kitaguchi, Tetsuya			Genetically-Encoded Yellow Fluorescent cAMP Indicator with an Expanded Dynamic Range for Dual-Color Imaging	PLOS ONE			English	Article							ADENYLYL-CYCLASE DEFINES; EPAC ACTIVATION; PROTEIN; CA2+; MICRODOMAINS; SECRETION; RECEPTOR; CELLS; PROBE	Cyclic AMP is a ubiquitous second messenger, which mediates many cellular responses mainly initiated by activation of cell surface receptors. Various Forster resonance energy transfer-based ratiometric cAMP indicators have been created for monitoring the spatial and temporal dynamics of cAMP at the single-cell level. However, single fluorescent protein-based cAMP indicators have been poorly developed, with improvement required for dynamic range and brightness. Based on our previous yellow fluorescent protein-based cAMP indicator, Flamindo, we developed an improved yellow fluorescent cAMP indicator named Flamindo2. Flamindo2 has a 2-fold expanded dynamic range and 8-fold increased brightness compared with Flamindo by optimization of linker peptides in the vicinity of the chromophore. We found that fluorescence intensity of Flamindo2 was decreased to 25% in response to cAMP. Live-cell cAMP imaging of the cytosol and nucleus in COS7 cells using Flamindo2 and nlsFlamindo2, respectively, showed that forskolin elevated cAMP levels in each compartment with different kinetics. Furthermore, dual-color imaging of cAMP and Ca2+ with Flamindo2 and a red fluorescent Ca2+ indicator, R-GECO, showed that cAMP and Ca2+ elevation were induced by noradrenaline in single HeLa cells. Our study shows that Flamindo2, which is feasible for multi-color imaging with other intracellular signaling molecules, is useful and is an alternative tool for live-cell imaging of intracellular cAMP dynamics.	[Odaka, Haruki; Arai, Satoshi; Kitaguchi, Tetsuya] Waseda Univ, Waseda Biosci Res Inst Singapore WABIOS, Cell Signaling Grp, Singapore, Singapore; [Odaka, Haruki; Inoue, Takafumi] Waseda Univ, Sch Adv Sci & Engn, Dept Life Sci & Med Biosci, Tokyo, Japan	Waseda University	Kitaguchi, T (corresponding author), Waseda Univ, Waseda Biosci Res Inst Singapore WABIOS, Cell Signaling Grp, Singapore, Singapore.	kitaguct@aoni.waseda.jp	KITAGUCHI, TETSUYA/AAR-1895-2021; Inoue, Takafumi/AAM-9533-2020; Kitaguchi, Tetsuya/F-5260-2017; Odaka, Haruki/AAQ-4448-2020; ARAI, SATOSHI/L-6709-2018	KITAGUCHI, TETSUYA/0000-0001-6701-1933; Inoue, Takafumi/0000-0002-2728-0060; Kitaguchi, Tetsuya/0000-0001-6701-1933; Odaka, Haruki/0000-0001-5632-2680; ARAI, SATOSHI/0000-0003-4807-8248	Waseda University Organization for University Research Initiatives; Ministry of Education, Culture, Sports, Science and Technology of Japan;  [25350970]	Waseda University Organization for University Research Initiatives; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	This research was supported by the Waseda University Organization for University Research Initiatives, a Grant-in aid for Scientific Research to T.K. (grant number 25350970) and the Supporting Project to Form the Strategic Research Platforms for a Private University from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS SR, 1991, NATURE, V349, P694, DOI 10.1038/349694a0; Baillie GS, 2009, FEBS J, V276, P1790, DOI 10.1111/j.1742-4658.2009.06926.x; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; Berg J, 2009, NAT METHODS, V6, P161, DOI [10.1038/NMETH.1288, 10.1038/nmeth.1288]; Buck J, 1999, P NATL ACAD SCI USA, V96, P79, DOI 10.1073/pnas.96.1.79; DiPilato LM, 2004, P NATL ACAD SCI USA, V101, P16513, DOI 10.1073/pnas.0405973101; Ghosh I, 2000, J AM CHEM SOC, V122, P5658, DOI 10.1021/ja994421w; KASAI H, 1994, TRENDS NEUROSCI, V17, P95, DOI 10.1016/0166-2236(94)90112-0; Kawai Y, 2004, ANAL CHEM, V76, P6144, DOI 10.1021/ac040037s; Kitaguchi T, 2013, BIOCHEM J, V450, P365, DOI 10.1042/BJ20121022; Li BY, 1999, ACTA PHARMACOL SIN, V20, P1011; Marvin JS, 2013, NAT METHODS, V10, P162, DOI [10.1038/NMETH.2333, 10.1038/nmeth.2333]; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Nausch LWM, 2008, P NATL ACAD SCI USA, V105, P365, DOI 10.1073/pnas.0710387105; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Ohkura M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051286; Ponsioen B, 2004, EMBO REP, V5, P1176, DOI 10.1038/sj.embor.7400290; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; SCHWINN DA, 1991, MOL PHARMACOL, V40, P619; Sunahara Roger K, 2002, Mol Interv, V2, P168, DOI 10.1124/mi.2.3.168; TALLMAN JF, 1977, P NATL ACAD SCI USA, V74, P873, DOI 10.1073/pnas.74.3.873; Tantama M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3550; Willoughby D, 2008, NAT METHODS, V5, P29, DOI 10.1038/NMETH1135; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592; Zippin JH, 2004, J CELL BIOL, V164, P527, DOI 10.1083/jcb.200311119; Zippin JH, 2002, FASEB J, V16, P82, DOI 10.1096/fj.02-0598fje	30	51	54	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100252	10.1371/journal.pone.0100252	http://dx.doi.org/10.1371/journal.pone.0100252			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959857	Green Submitted, Green Published, gold			2022-12-27	WOS:000338633900032
J	Shao, HJ; Xue, QS; Zhang, FJ; Luo, Y; Zhu, H; Zhang, XQ; Zhang, HH; Ding, WL; Yu, BW				Shao, Haijun; Xue, Qingsheng; Zhang, Fujun; Luo, Yan; Zhu, Hao; Zhang, Xiaoqing; Zhang, Honghai; Ding, Wenlong; Yu, Buwei			Spinal SIRT1 Activation Attenuates Neuropathic Pain in Mice	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; PERIPHERAL-NERVE INJURY; DEACETYLASE SIRT1; IN-VIVO; CIRCADIAN CONTROL; SENSITIVE METHOD; SENSORY NEURONS; RESVERATROL; NICOTINAMIDE; INHIBITORS	Abnormal histone acetylation occurs during neuropathic pain through an epigenetic mechanism. Silent information regulator 1 (sir2 or SIRT1), a NAD-dependent deacetylase, plays complex systemic roles in a variety of processes through deacetylating acetylated histone and other specific substrates. But the role of SIRT1 in neuropathic pain is not well established yet. The present study was intended to detect SIRT1 content and activity, nicotinamide (NAM) and nicotinamide adenine dinucleotide (NAD) in the spinal cord using immunoblotting or mass spectroscopy over time in mice following chronic constriction injury (CCI) or sham surgery. In addition, the effect of intrathecal injection of NAD or resveratrol on thermal hyperalgesia and mechanical allodynia was evaluated in CCI mice. Finally, we investigated whether SIRT1 inhibitor EX-527 could reverse the anti-nociceptive effect of NAD or resveratrol. It was found that spinal SIRT1 expression, deacetylase activity and NAD/NAM decreased significantly 1, 3, 7, 14 and 21 days after CCI surgery as compared with sham group. In addition, daily intrathecal injection of 5 mu l 800 mM NAD 1 h before and 1 day after CCI surgery or single intrathecal injection of 5 mu l 90 mM resveratrol 1 h before CCI surgery produced a transient inhibitory effect on thermal hyperalgesia and mechanical allodynia in CCI mice. Finally, an intrathecal injection of 5 mu l 1.2 mM EX-527 1 h before NAD or resveratrol administration reversed the anti-nociceptive effect of NAD or resveratrol. These data indicate that the reduction in SIRT1 deacetylase activity may be a factor contributing to the development of neuropathic pain in CCI mice. Our findings suggest that the enhancement of spinal NAD/NAM and/or SIRT1 activity may be a potentially promising strategy for the prevention or treatment of neuropathic pain.	[Shao, Haijun; Xue, Qingsheng; Zhang, Fujun; Luo, Yan; Zhang, Xiaoqing; Yu, Buwei] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Anesthesiol, Shanghai 200030, Peoples R China; [Zhu, Hao; Ding, Wenlong] Shanghai Jiao Tong Univ, Sch Med, Dept Anat, Shanghai 200030, Peoples R China; [Zhang, Honghai] Nanjing Med Univ, Hangzhou Peoples Hosp 1, Dept Anesthesiol, Hangzhou, Zhejiang, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Nanjing Medical University	Yu, BW (corresponding author), Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Anesthesiol, Shanghai 200030, Peoples R China.	yubuwei_1958@163.com			Natural Sciences Foundation of China [30400421]	Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Sciences Foundation of China (grant number 30400421). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adilakshmi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039674; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Baron R, 2006, NAT CLIN PRACT NEURO, V2, P95, DOI 10.1038/ncpneuro0113; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Bellamacina CR, 1996, FASEB J, V10, P1257, DOI 10.1096/fasebj.10.11.8836039; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Bermudez-Ocana DY, 2006, PHARMACOL BIOCHEM BE, V84, P535, DOI 10.1016/j.pbb.2006.06.019; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Borrelli E, 2008, NEURON, V60, P961, DOI 10.1016/j.neuron.2008.10.012; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruzzone S, 2001, FASEB J, V15, P10; Chiechio S, 2009, MOL PHARMACOL, V75, P1014, DOI 10.1124/mol.108.054346; Denk F, 2013, PAIN, V154, P1668, DOI 10.1016/j.pain.2013.05.021; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hoane MR, 2008, NEUROSCIENCE, V154, P861, DOI 10.1016/j.neuroscience.2008.04.044; HYLDEN JLK, 1980, EUR J PHARMACOL, V67, P313, DOI 10.1016/0014-2999(80)90515-4; Imai S, 2011, J NEUROSCI, V31, P15294, DOI 10.1523/JNEUROSCI.0921-11.2011; Imai S, 2009, BBA-GEN SUBJECTS, V1790, P997, DOI 10.1016/j.bbagen.2009.03.005; Kiguchi N, 2012, J PHARMACOL EXP THER, V340, P577, DOI 10.1124/jpet.111.187724; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Klaidman LK, 1996, NEUROSCI LETT, V206, P5, DOI 10.1016/0304-3940(96)12446-0; Larrosa M, 2011, EUR J NUTR, V50, P673, DOI 10.1007/s00394-011-0178-3; Lee JC, 2012, BRAIN RES, V1433, P20, DOI 10.1016/j.brainres.2011.11.019; Milne JC, 2008, CURR OPIN CHEM BIOL, V12, P11, DOI 10.1016/j.cbpa.2008.01.019; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Napper AD, 2005, J MED CHEM, V48, P8045, DOI 10.1021/jm050522v; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Peck B, 2010, MOL CANCER THER, V9, P844, DOI 10.1158/1535-7163.MCT-09-0971; Perez-Severiano F, 2008, PHARMACOL BIOCHEM BE, V90, P742, DOI 10.1016/j.pbb.2008.05.024; Qin WP, 2006, J BIOL CHEM, V281, P21745, DOI 10.1074/jbc.M602909200; Renthal W, 2009, NEURON, V62, P335, DOI 10.1016/j.neuron.2009.03.026; Tang BL, 2010, BRAIN RES BULL, V81, P359, DOI 10.1016/j.brainresbull.2009.12.007; Tillu DV, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-5; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Tsai RY, 2012, ANESTH ANALG, V115, P944, DOI 10.1213/ANE.0b013e31825da0fb; Uchida H, 2013, NEUROSCIENCE, V240, P147, DOI 10.1016/j.neuroscience.2013.02.053; Uchida H, 2010, NEUROSCIENCE, V166, P1, DOI 10.1016/j.neuroscience.2009.12.021; Uchida H, 2010, J NEUROSCI, V30, P4806, DOI 10.1523/JNEUROSCI.5541-09.2010; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Wang Y, 2012, GENE THER; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Wuertz K, 2011, SPINE, V36, pE1373, DOI 10.1097/BRS.0b013e318221e655; Yin Q, 2013, REG ANESTH PAIN MED; Zakhary SM, 2010, ANAT REC, V293, P1024, DOI 10.1002/ar.21116	47	58	60	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100938	10.1371/journal.pone.0100938	http://dx.doi.org/10.1371/journal.pone.0100938			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959710	Green Published, Green Submitted, gold			2022-12-27	WOS:000338633900102
J	Suplatov, D; Panin, N; Kirilin, E; Shcherbakova, T; Kudryavtsev, P; Svedas, V				Suplatov, Dmitry; Panin, Nikolay; Kirilin, Evgeny; Shcherbakova, Tatyana; Kudryavtsev, Pavel; Svedas, Vytas			Computational Design of a pH Stable Enzyme: Understanding Molecular Mechanism of Penicillin Acylase's Adaptation to Alkaline Conditions	PLOS ONE			English	Article							PROTEIN STABILITY; DIRECTED EVOLUTION; CATALYTIC EFFICIENCY; TRICHODERMA-REESEI; CRYSTAL-STRUCTURE; GENETIC-ANALYSIS; ALPHA-AMYLASE; DYNAMICS; RESOLUTION; ACYLATION	Protein stability provides advantageous development of novel properties and can be crucial in affording tolerance to mutations that introduce functionally preferential phenotypes. Consequently, understanding the determining factors for protein stability is important for the study of structure-function relationship and design of novel protein functions. Thermal stability has been extensively studied in connection with practical application of biocatalysts. However, little work has been done to explore the mechanism of pH-dependent inactivation. In this study, bioinformatic analysis of the Ntn-hydrolase superfamily was performed to identify functionally important subfamily-specific positions in protein structures. Furthermore, the involvement of these positions in pH-induced inactivation was studied. The conformational mobility of penicillin acylase in Escherichia coli was analyzed through molecular modeling in neutral and alkaline conditions. Two functionally important subfamily-specific residues, Glu beta 482 and Asp beta 484, were found. Ionization of these residues at alkaline pH promoted the collapse of a buried network of stabilizing interactions that consequently disrupted the functional protein conformation. The subfamily-specific position Asp beta 484 was selected as a hotspot for mutation to engineer enzyme variant tolerant to alkaline medium. The corresponding D beta 484N mutant was produced and showed 9-fold increase in stability at alkaline conditions. Bioinformatic analysis of subfamily-specific positions can be further explored to study mechanisms of protein inactivation and to design more stable variants for the engineering of homologous Ntn-hydrolases with improved catalytic properties.	[Svedas, Vytas] Moscow MV Lomonosov State Univ, Belozersky Inst Physicochem Biol, Moscow, Russia; Moscow MV Lomonosov State Univ, Fac Bioengn & Bioinformat, Moscow, Russia	Lomonosov Moscow State University; Lomonosov Moscow State University	Svedas, V (corresponding author), Moscow MV Lomonosov State Univ, Belozersky Inst Physicochem Biol, Moscow, Russia.	vytas@belozersky.msu.ru	panin, nikolay/AAO-1045-2020; Svedas, Vytas/J-6594-2012; Evgeny, Kirilin/AAG-3522-2019; Suplatov, Dmitry/A-4878-2015	Svedas, Vytas/0000-0002-1664-0307; Evgeny, Kirilin/0000-0003-4960-8925; Suplatov, Dmitry/0000-0002-7054-3487	Skolkovo Institute of Science and Technology [182-MRA]; Russian Foundation for Basic Research [14-08-00987]	Skolkovo Institute of Science and Technology; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	Financial support from Skolkovo Institute of Science and Technology (grant 182-MRA) and Russian Foundation for Basic Research (grant 14-08-00987) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni A, 2005, NAT GENET, V37, P73, DOI 10.1038/ng1482; AKKE M, 1990, PROTEINS, V8, P23, DOI 10.1002/prot.340080106; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arroyo M, 2003, APPL MICROBIOL BIOT, V60, P507, DOI 10.1007/s00253-002-1113-6; Azevedo AM, 1999, J CHEM TECHNOL BIOT, V74, P1110, DOI 10.1002/(SICI)1097-4660(199911)74:11<1110::AID-JCTB149>3.0.CO;2-B; Basso A, 2001, J MOL CATAL B-ENZYM, V11, P851, DOI 10.1016/S1381-1177(00)00070-9; Basso A, 2007, ADV SYNTH CATAL, V349, P877, DOI 10.1002/adsc.200600337; Beadle BM, 2002, J MOL BIOL, V321, P285, DOI 10.1016/S0022-2836(02)00599-5; Belien T, 2009, PROTEIN ENG DES SEL, V22, P587, DOI 10.1093/protein/gzp024; Bessler C, 2003, PROTEIN SCI, V12, P2141, DOI 10.1110/ps.0384403; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Bornscheuer UT, 2012, NATURE, V485, P185, DOI 10.1038/nature11117; Bruggink A, 1998, ORG PROCESS RES DEV, V2, P128, DOI 10.1021/op9700643; Chen L, 2005, THESIS U WATERLOO; Chilov GG, 2003, TETRAHEDRON-ASYMMETR, V14, P2613, DOI 10.1016/S0957-4166(03)00523-8; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; CUNNINGHAM BC, 1987, PROTEIN ENG, V1, P319, DOI 10.1093/protein/1.4.319; Day R, 2002, J MOL BIOL, V322, P189, DOI 10.1016/S0022-2836(02)00672-1; Deaguero AL, 2012, PROTEIN ENG DES SEL, V25, P135, DOI 10.1093/protein/gzr065; DELRIO G, 1995, BIOTECHNOL BIOENG, V48, P141, DOI 10.1002/bit.260480208; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; DUGGLEBY HJ, 1995, NATURE, V373, P264, DOI 10.1038/373264a0; Eijsink VGH, 2004, J BIOTECHNOL, V113, P105, DOI 10.1016/j.jbiotec.2004.03.026; Eijsink VGH, 2005, BIOMOL ENG, V22, P21, DOI 10.1016/j.bioeng.2004.12.003; Fersht AR, 2002, CELL, V108, P573, DOI 10.1016/S0092-8674(02)00620-7; Finkelstein A. V, 2002, PROTEIN PHYS, P207; Fischer JD, 2008, BIOINFORMATICS, V24, P613, DOI 10.1093/bioinformatics/btm626; Fushinobu S, 1998, PROTEIN ENG, V11, P1121, DOI 10.1093/protein/11.12.1121; Gardossi L, 2010, TRENDS BIOTECHNOL, V28, P171, DOI 10.1016/j.tibtech.2010.01.001; Giorgino T, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i07; Grinberg VY, 2008, BBA-PROTEINS PROTEOM, V1784, P736, DOI 10.1016/j.bbapap.2008.01.016; Groger H., 2012, ENZYME CATALYSIS ORG, P1; Gulich S, 2002, PROTEIN ENG, V15, P835, DOI 10.1093/protein/15.10.835; Guranda DT, 2010, ACTA NATURAE, V2, P94, DOI 10.32607/20758251-2010-2-1-94-96; Guranda DT, 2004, BIOCHEMISTRY-MOSCOW+, V69, P1386, DOI 10.1007/s10541-005-0085-4; Guranda DT, 2004, TETRAHEDRON-ASYMMETR, V15, P2901, DOI 10.1016/j.tetasy.2004.06.051; Guranda DT, 2001, TETRAHEDRON-ASYMMETR, V12, P1645, DOI 10.1016/S0957-4166(01)00263-4; Hanefeld U, 2009, CHEM SOC REV, V38, P453, DOI 10.1039/b711564b; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ismail H, 2008, GREEN CHEM, V10, P415, DOI 10.1039/b714088f; Iyer PV, 2008, PROCESS BIOCHEM, V43, P1019, DOI 10.1016/j.procbio.2008.06.004; Jasnaya AS, 2008, MOSCOW U CHEM BULL, V49, P127; Kallenberg AI, 2005, ADV SYNTH CATAL, V347, P905, DOI 10.1002/adsc.200505042; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; Katchalski-Katzir E, 2000, J MOL CATAL B-ENZYM, V10, P157, DOI 10.1016/S1381-1177(00)00124-7; Khan S, 2010, HUM MUTAT, V31, P675, DOI 10.1002/humu.21242; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LESK AM, 1980, J MOL BIOL, V136, P225, DOI 10.1016/0022-2836(80)90373-3; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Liu LW, 2009, PROCESS BIOCHEM, V44, P912, DOI 10.1016/j.procbio.2009.02.013; Liu YH, 2012, J APPL MICROBIOL, V113, P541, DOI 10.1111/j.1365-2672.2012.05359.x; Margolin AL, 1996, TRENDS BIOTECHNOL, V14, P223, DOI 10.1016/0167-7799(96)10031-7; MARGOLIN AL, 1982, BIOTECHNOL BIOENG, V24, P237, DOI 10.1002/bit.260240119; Mateo C, 2002, BIOTECHNOL PROGR, V18, P629, DOI 10.1021/bp010171n; MATTHEWS BW, 1993, ANNU REV BIOCHEM, V62, P139, DOI 10.1146/annurev.bi.62.070193.001035; McVey CE, 2001, J MOL BIOL, V313, P139, DOI 10.1006/jmbi.2001.5043; Menke M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040010; Mongan J, 2005, CURR OPIN STRUC BIOL, V15, P157, DOI 10.1016/j.sbi.2005.02.002; Mongan J, 2004, J COMPUT CHEM, V25, P2038, DOI 10.1002/jcc.20139; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Novikov FN, 2013, FEBS J, V280, P115, DOI 10.1111/febs.12054; O'Fagain C, 2011, METHODS MOL BIOL, V681, P103, DOI 10.1007/978-1-60761-913-0_7; Oinonen C, 2000, PROTEIN SCI, V9, P2329, DOI 10.1110/ps.9.12.2329; PAKULA AA, 1989, ANNU REV GENET, V23, P289, DOI 10.1146/annurev.ge.23.120189.001445; Palmer B, 2008, J BIOTECHNOL, V134, P222, DOI 10.1016/j.jbiotec.2007.12.009; Park S, 2005, PROTEINS, V60, P450, DOI 10.1002/prot.20511; Pchelintsev NA, 2009, J MOL CATAL B-ENZYM, V56, P202, DOI 10.1016/j.molcatb.2008.05.006; Phadtare S, 2002, BIOTECHNOL PROGR, V18, P483, DOI 10.1021/bp015504v; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pleiss J, 2012, ENZYME CATALYSIS ORG, P89; Polizzi Karen M., 2006, Biotechnology Journal, V1, P531, DOI 10.1002/biot.200600029; Potapov V, 2009, PROTEIN ENG DES SEL, V22, P553, DOI 10.1093/protein/gzp030; Qin YQ, 2008, J BIOTECHNOL, V135, P190, DOI 10.1016/j.jbiotec.2008.03.016; Rehm S, 2010, PROTEIN SCI, V19, P2122, DOI 10.1002/pro.493; Robinson NE, 2002, P NATL ACAD SCI USA, V99, P5283, DOI 10.1073/pnas.082102799; SALI A, 1994, NATURE, V369, P248, DOI 10.1038/369248a0; SAWYER L, 1982, NATURE, V295, P79, DOI 10.1038/295079a0; Scheraga HA, 2007, ANNU REV PHYS CHEM, V58, P57, DOI 10.1146/annurev.physchem.58.032806.104614; SERRANO L, 1993, J MOL BIOL, V233, P305, DOI 10.1006/jmbi.1993.1508; Shaw A, 1996, CURR OPIN STRUC BIOL, V6, P546, DOI 10.1016/S0959-440X(96)80122-9; Shirai T, 1997, PROTEIN ENG, V10, P627, DOI 10.1093/protein/10.6.627; Shirai T, 2001, J MOL BIOL, V310, P1079, DOI 10.1006/jmbi.2001.4835; SHOICHET BK, 1995, P NATL ACAD SCI USA, V92, P452, DOI 10.1073/pnas.92.2.452; Shumway RH, 2010, TIME SERIES ANAL ITS; Sillitoe I, 2013, NUCLEIC ACIDS RES, V41, pD490, DOI 10.1093/nar/gks1211; SOLODENKO VA, 1993, TETRAHEDRON-ASYMMETR, V4, P1965, DOI 10.1016/S0957-4166(00)82240-5; Soloshonok VA, 1998, J ORG CHEM, V63, P1878, DOI 10.1021/jo971777m; Stephens DE, 2009, FEMS MICROBIOL LETT, V293, P42, DOI 10.1111/j.1574-6968.2009.01519.x; Suplatov DA, 2012, PROTEIN ENG DES SEL, V25, P689, DOI 10.1093/protein/gzs068; Suplatov D, 2014, J BIOMOL STRUCT DYN, V32, P1752, DOI 10.1080/07391102.2013.834514; Suplatov D, 2014, J BIOMOL STRUCT DYN, V32, P75, DOI 10.1080/07391102.2012.750249; Svedas V, 1997, FEBS LETT, V417, P414, DOI 10.1016/S0014-5793(97)01289-1; Svedas VK, 1998, ANN NY ACAD SCI, V864, P524, DOI 10.1111/j.1749-6632.1998.tb10373.x; Svedas VK, 1977, BIOORG KHIM, V3, P546; Taly JF, 2011, NAT PROTOC, V6, P1669, DOI 10.1038/nprot.2011.393; Tokuriki N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000002; Trodler P, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-9; Uversky VN, 2013, BIOPOLYMERS, V99, P870, DOI 10.1002/bip.22298; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; van Rantwijk F, 2004, TETRAHEDRON, V60, P501, DOI 10.1016/j.tet.2003.10.018; Voevodin V.l., 2012, OTKRYTYE SISTEMY, V7, P36; Wagner GP., 2005, ROBUSTNESS EVOLVABIL; Wang T, 2005, BIOMOL ENG, V22, P89, DOI 10.1016/j.bioeng.2004.10.003; Wohlfahrt G, 2003, BIOCHEMISTRY-US, V42, P10095, DOI 10.1021/bi034954o; Xu H, 2013, J BIOSCI BIOENG, V115, P618, DOI 10.1016/j.jbiosc.2012.12.006; YANG AS, 1993, J MOL BIOL, V231, P459, DOI 10.1006/jmbi.1993.1294; Yang HQ, 2013, J BIOTECHNOL, V164, P59, DOI 10.1016/j.jbiotec.2012.12.007; Zeldovich KB, 2007, P NATL ACAD SCI USA, V104, P16152, DOI 10.1073/pnas.0705366104	108	40	43	4	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100643	10.1371/journal.pone.0100643	http://dx.doi.org/10.1371/journal.pone.0100643			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959852	Green Submitted, Green Published, gold			2022-12-27	WOS:000338633900065
J	Zhu, P; Liu, Y; Han, L; Xu, G; Ran, JM				Zhu, Ping; Liu, Yan; Han, Lu; Xu, Gang; Ran, Jian-min			Serum Uric Acid Is Associated with Incident Chronic Kidney Disease in Middle-Aged Populations: A Meta-Analysis of 15 Cohort Studies	PLOS ONE			English	Article							RENAL-FUNCTION DECLINE; CHINESE POPULATION; RISK-FACTORS; HYPERURICEMIA; THERAPY; HEALTH; MEN	Background: Mounting evidence indicates that elevated serum uric acid may increase the incidence of chronic kidney disease (CKD). Our goal was to systematically evaluate longitudinal cohort studies for the association of serum uric acid levels and incident CKD. Methods: We searched electronic databases and the reference lists of relevant articles. The primary outcome was incident CKD, which was defined as an eGFR less than 60 mL/min/1.73 m(2) at the follow-up examination. Study-specific risk estimates were combined using random-effects models. The included studies were stratified into subgroups, and meta-regression analyses were performed. Results: Fifteen unique cohorts with a total of 99,205 individuals and 3,492 incident CKD cases were included. The relative risk of CKD was 1.22 (95% CI 1.16-1.28, I-2 = 65.9%) per 1 mg/dL serum uric level increment. This positive association was consistently observed in subgroups stratified according to most of the study-level characteristics. The observed positive association was more pronounced among group with a mean age <60 years (RR 1.26, 95% CI 1.21-1.31), and low-level heterogeneity was observed in the findings for this age group (I-2 = 46.4%, P = 0.022). However, no association was observed among studies with a mean age >= 60 years (RR 1.04, 95% CI 0.96-1.13), and no evidence of heterogeneity was evident among the studies (I-2 = 0%, P = 0.409). This mean age-related difference in the association between serum uric acid levels and CKD was significant (P = 0.004). The sensitivity analysis results were consistent when the analyses were restricted to studies that controlled for proteinuria and metabolic syndrome. Conclusions: Our meta-analysis demonstrated a positive association between serum uric acid levels and risk of CKD in middle-aged patients independent of established metabolic risk factors. Future randomized, high-quality clinical trials are warranted to determine whether lowering uric acid levels is beneficial in CKD.	[Zhu, Ping; Xu, Gang; Ran, Jian-min] Jinan Univ, Coll Med, Guangzhou Red Cross Hosp, Dept Endocrinol & Metab, Guangzhou, Guangdong, Peoples R China; [Liu, Yan] Jinan Univ, Dept Nephrol, Guangzhou Red Cross Hosp, Coll Med, Guangzhou, Guangdong, Peoples R China; [Han, Lu] Sun Yat Sen Univ, Sch Publ Hlth, Dept Med Stat & Epidemiol, Guangzhou 510275, Guangdong, Peoples R China	Jinan University; Jinan University; Sun Yat Sen University	Ran, JM (corresponding author), Jinan Univ, Coll Med, Guangzhou Red Cross Hosp, Dept Endocrinol & Metab, Guangzhou, Guangdong, Peoples R China.	sumszc@gmail.com			National Natural Science Foundation of China [81200613]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by a grant from the National Natural Science Foundation of China (No. 81200613). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bellomo G, 2010, AM J KIDNEY DIS, V56, P264, DOI 10.1053/j.ajkd.2010.01.019; Ben-Dov IZ, 2011, NEPHROL DIAL TRANSPL, V26, P2558, DOI 10.1093/ndt/gfq740; Bose B, 2014, NEPHROL DIAL TRANSPL, V29, P406, DOI 10.1093/ndt/gft378; Chien KL, 2010, AM J MED, V123, P836, DOI 10.1016/j.amjmed.2010.05.010; Choi HK, 2004, LANCET, V363, P1277, DOI 10.1016/S0140-6736(04)16000-5; Chonchol M, 2007, AM J KIDNEY DIS, V50, P239, DOI 10.1053/j.ajkd.2007.05.013; Corry DB, 2008, J HYPERTENS, V26, P269, DOI 10.1097/HJH.0b013e3282f240bf; Danesh J, 1998, JAMA-J AM MED ASSOC, V279, P1477, DOI 10.1001/jama.279.18.1477; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Domrongkitchaiporn S, 2005, J AM SOC NEPHROL, V16, P791, DOI 10.1681/ASN.2004030208; Dong JY, 2011, AM J CLIN NUTR, V94, P900, DOI 10.3945/ajcn.111.015578; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Girillo P, 2006, J AM SOC NEPHROL, V17, pS165, DOI 10.1681/ASN.2006080909; Hemingway H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000286; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Inker LA, 2014, AM J KIDNEY DIS, V63, P713, DOI 10.1053/j.ajkd.2014.01.416; Jalal DI, 2013, AM J KIDNEY DIS, V61, P134, DOI 10.1053/j.ajkd.2012.07.021; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Johnson RJ, 2013, NEPHROL DIAL TRANSPL, V28, P2221, DOI 10.1093/ndt/gft029; Kawashima M, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-31; KDIGO, 2013, KIDNEY INT S, V3, P19, DOI DOI 10.1038/KISUP.2012.64; Khosla UM, 2005, KIDNEY INT, V67, P1739, DOI 10.1111/j.1523-1755.2005.00273.x; Kodama S, 2009, DIABETES CARE, V32, P1737, DOI 10.2337/dc09-0288; Lecoultre V, 2013, DIABETES CARE, V36, pE149, DOI 10.2337/dc13-0866; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Mok Y, 2012, NEPHROL DIAL TRANSPL, V27, P1831, DOI 10.1093/ndt/gfr530; Obermayr RP, 2008, NEPHROL DIAL TRANSPL, V23, P1265, DOI 10.1093/ndt/gfm790; Obermayr RP, 2008, J AM SOC NEPHROL, V19, P2407, DOI 10.1681/ASN.2008010080; Odden MC, 2006, AM J EPIDEMIOL, V164, P1180, DOI 10.1093/aje/kwj333; Odermatt A, 2011, AM J PHYSIOL-RENAL, V301, pF919, DOI 10.1152/ajprenal.00068.2011; Ryoo JH, 2013, J KOREAN MED SCI, V28, P855, DOI 10.3346/jkms.2013.28.6.855; Ryu ES, 2013, AM J PHYSIOL-RENAL, V304, pF471, DOI 10.1152/ajprenal.00560.2012; Sanchez-Lozada LG, 2005, KIDNEY INT, V67, P237, DOI 10.1111/j.1523-1755.2005.00074.x; Schlesinger N, 2005, CURR PHARM DESIGN, V11, P4133, DOI 10.2174/138161205774913273; Sedaghat S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076827; Selvin E, 2004, ANN INTERN MED, V141, P421, DOI 10.7326/0003-4819-141-6-200409210-00007; Sonoda H, 2011, AM J NEPHROL, V33, P352, DOI 10.1159/000326848; Wang F, 2011, NEPHROL DIAL TRANSPL, V26, P2847, DOI 10.1093/ndt/gfq816; Wang SF, 2011, NEPHROLOGY, V16, P767, DOI 10.1111/j.1440-1797.2011.01513.x; Weiner DE, 2008, J AM SOC NEPHROL, V19, P1204, DOI 10.1681/ASN.2007101075; Yamada T, 2011, AM J MED SCI, V342, P461, DOI 10.1097/MAJ.0b013e318218bd89; Yamagata K, 2007, KIDNEY INT, V71, P159, DOI 10.1038/sj.ki.5002017; Yen CJ, 2009, J FORMOS MED ASSOC, V108, P921, DOI 10.1016/S0929-6646(10)60004-6; Zhang LX, 2012, NEPHROL DIAL TRANSPL, V27, P1836, DOI 10.1093/ndt/gfr597; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6	47	87	92	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100801	10.1371/journal.pone.0100801	http://dx.doi.org/10.1371/journal.pone.0100801			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959886	gold, Green Submitted, Green Published			2022-12-27	WOS:000338633900089
J	Schou, J; Kelstrup, CD; Hayward, DG; Olsen, JV; Nilsson, J				Schou, Julie; Kelstrup, Christian D.; Hayward, Daniel G.; Olsen, Jesper V.; Nilsson, Jakob			Comprehensive Identification of SUMO2/3 Targets and Their Dynamics during Mitosis	PLOS ONE			English	Article							CHROMOSOME SEGREGATION; AURORA-B; TOPOISOMERASE-II; RHO GTPASE; CENP-E; SUMOYLATION; PROTEINS; MODIFIER; REVEALS; SUMO-1	During mitosis large alterations in cellular structures occur rapidly, which to a large extent is regulated by post-translational modification of proteins. Modification of proteins with the small ubiquitin-related protein SUMO2/3 regulates mitotic progression, but few mitotic targets have been identified so far. To deepen our understanding of SUMO2/3 during this window of the cell cycle, we undertook a comprehensive proteomic characterization of SUMO2/3 modified proteins in mitosis and upon mitotic exit. We developed an efficient tandem affinity purification strategy of SUMO2/3 modified proteins from mitotic cells. Combining this purification strategy with cell synchronization procedures and quantitative mass spectrometry allowed for the mapping of numerous novel targets and their dynamics as cells progressed out of mitosis. This identified RhoGDI alpha as a major SUMO2/3 modified protein, specifically during mitosis, mediated by the SUMO ligases PIAS2 and PIAS3. Our data provide a rich resource for further exploring the role of SUMO2/3 modifications in mitosis and cell cycle regulation.	[Schou, Julie; Kelstrup, Christian D.; Hayward, Daniel G.; Olsen, Jesper V.; Nilsson, Jakob] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Prot Res, Copenhagen, Denmark	University of Copenhagen	Nilsson, J (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Prot Res, Copenhagen, Denmark.	jakob.nilsson@cpr.ku.dk	Olsen, Jesper/ABH-4638-2020	Olsen, Jesper/0000-0002-4747-4938; Kelstrup, Christian Dahl/0000-0003-4647-1425; Nilsson, Jakob/0000-0003-4100-1125	Lundbeck Foundation; Novo Nordisk Foundation	Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	Lundbeck Foundation (www.lundbeckfonden.com) supported this work through a Junior Group Leader Fellowship to JN. The Novo Nordisk Foundation (www.novonordiskfonden.dk) supported this through institute funding for JN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinho M, 2008, CANCER RES, V68, P2409, DOI 10.1158/0008-5472.CAN-07-2092; Andersen Jens S., 2009, V497, P19, DOI 10.1007/978-1-59745-566-4_2; Azuma Y, 2003, J CELL BIOL, V163, P477, DOI 10.1083/jcb.200304088; Azuma Y, 2005, EMBO J, V24, P2172, DOI 10.1038/sj.emboj.7600700; Blomster HA, 2009, MOL CELL PROTEOMICS, V8, P1382, DOI 10.1074/mcp.M800551-MCP200; Boulter E, 2010, NAT CELL BIOL, V12, P477, DOI 10.1038/ncb2049; Bruderer R, 2011, EMBO REP, V12, P142, DOI 10.1038/embor.2010.206; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cubenas-Potts C, 2013, DEV CELL, V24, P1, DOI 10.1016/j.devcel.2012.11.020; Desterro JMP, 1997, FEBS LETT, V417, P297, DOI 10.1016/S0014-5793(97)01305-7; Diaz-Martinez LA, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000053; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Flotho A, 2013, ANNU REV BIOCHEM, V82, P357, DOI 10.1146/annurev-biochem-061909-093311; Fujita Y, 2007, DEV CELL, V12, P17, DOI 10.1016/j.devcel.2006.11.002; Galanty Y, 2009, NATURE, V462, P935, DOI 10.1038/nature08657; Galisson F, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004796; Gill G, 2003, CURR OPIN GENET DEV, V13, P108, DOI 10.1016/S0959-437X(03)00021-2; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; Kelstrup CD, 2012, J PROTEOME RES, V11, P3487, DOI 10.1021/pr3000249; Kotaja N, 2002, MOL CELL BIOL, V22, P5222, DOI 10.1128/MCB.22.14.5222-5234.2002; Maddox AS, 2003, J CELL BIOL, V160, P255, DOI 10.1083/jcb.200207130; Maddox PS, 2007, J CELL BIOL, V176, P757, DOI 10.1083/jcb.200701065; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; Matic I, 2010, MOL CELL, V39, P641, DOI 10.1016/j.molcel.2010.07.026; Merbl Y, 2013, CELL, V152, P1160, DOI 10.1016/j.cell.2013.02.007; Mikolajczyk J, 2007, J BIOL CHEM, V282, P26217, DOI 10.1074/jbc.M702444200; Nacerddine K, 2005, DEV CELL, V9, P769, DOI 10.1016/j.devcel.2005.10.007; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Nilsson J, 2011, BIOESSAYS, V33, P903, DOI 10.1002/bies.201100094; Nilsson J, 2008, NAT CELL BIOL, V10, P1411, DOI 10.1038/ncb1799; Ong SE, 2003, METHODS, V29, P124, DOI 10.1016/S1046-2023(02)00303-1; Qian JB, 2011, CURR BIOL, V21, P766, DOI 10.1016/j.cub.2011.03.047; Ren J, 2009, PROTEOMICS, V9, P3409, DOI 10.1002/pmic.200800646; Rytinki MM, 2009, CELL MOL LIFE SCI, V66, P3029, DOI 10.1007/s00018-009-0061-z; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Schimmel J, 2008, MOL CELL PROTEOMICS, V7, P2107, DOI 10.1074/mcp.M800025-MCP200; Schimmel J, 2014, MOL CELL, V53, P1053, DOI 10.1016/j.molcel.2014.02.001; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Silva MCC, 2012, DEV CELL, V22, P52, DOI 10.1016/j.devcel.2011.10.014; Tatham MH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001484; Vertegaal ACO, 2006, MOL CELL PROTEOMICS, V5, P2298, DOI 10.1074/mcp.M600212-MCP200; Westman BJ, 2010, MOL CELL, V39, P618, DOI 10.1016/j.molcel.2010.07.025; Wurzenberger C, 2012, J CELL BIOL, V198, P173, DOI 10.1083/jcb.201112112; Yu JX, 2012, J BIOL CHEM, V287, P13752, DOI 10.1074/jbc.M111.337469; Zhang XD, 2008, MOL CELL, V29, P729, DOI 10.1016/j.molcel.2008.01.013	46	15	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100692	10.1371/journal.pone.0100692	http://dx.doi.org/10.1371/journal.pone.0100692			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971888	Green Submitted, gold, Green Published			2022-12-27	WOS:000338512200051
J	Gipson, IK; Spurr-Michaud, S; Tisdale, A; Menon, BB				Gipson, Ilene K.; Spurr-Michaud, Sandra; Tisdale, Ann; Menon, Balaraj B.			Comparison of the Transmembrane Mucins MUC1 and MUC16 in Epithelial Barrier Function	PLOS ONE			English	Article							FIBRONECTIN-BINDING PROTEIN; OCULAR SURFACE EPITHELIA; MEMBRANE-TETHERED MUCINS; HUMAN CORNEAL-LIMBAL; STREPTOCOCCUS-PNEUMONIAE; CARBOHYDRATE EPITOPE; TIGHT JUNCTIONS; MUCOSAL BARRIER; ERM PROTEINS; CANCER-CELLS	Membrane-anchored mucins are present in the apical surface glycocalyx of mucosal epithelial cells, each mucosal epithelium having at least two of the mucins. The mucins have been ascribed barrier functions, but direct comparisons of their functions within the same epithelium have not been done. In an epithelial cell line that expresses the membrane-anchored mucins, MUC1 and MUC16, the mucins were independently and stably knocked down using shRNA. Barrier functions tested included dye penetrance, bacterial adherence and invasion, transepithelial resistance, tight junction formation, and apical surface size. Knockdown of MUC16 decreased all barrier functions tested, causing increased dye penetrance and bacterial invasion, decreased transepithelial resistance, surprisingly, disruption of tight junctions, and greater apical surface cell area. Knockdown of MUC1 did not decrease barrier function, in fact, barrier to dye penetrance and bacterial invasion increased significantly. These data suggest that barrier functions of membrane-anchored mucins vary in the context of other membrane mucins, and MUC16 provides a major barrier when present.	[Gipson, Ilene K.; Spurr-Michaud, Sandra; Tisdale, Ann; Menon, Balaraj B.] Harvard Univ, Sch Med, Dept Ophthalmol, Schepens Eye Res Inst Massachusetts Eye & Ear, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Gipson, IK (corresponding author), Harvard Univ, Sch Med, Dept Ophthalmol, Schepens Eye Res Inst Massachusetts Eye & Ear, Boston, MA 02115 USA.	Ilene_gipson@meei.harvard.edu			 [NIH NEI EY03306];  [NIH NEI EY018850]; NATIONAL EYE INSTITUTE [R01EY003306, R37EY003306, R01EY018850] Funding Source: NIH RePORTER	; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was funded by NIH NEI EY03306, and NIH NEI EY018850 to IKG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argueso P, 2003, INVEST OPHTH VIS SCI, V44, P2487, DOI 10.1167/iovs.02-0862; Argueso P, 2006, INVEST OPHTH VIS SCI, V47, P113, DOI 10.1167/iovs.05-0735; Argueso P, 2006, GLYCOBIOLOGY, V16, P1219, DOI 10.1093/glycob/cwl041; Argueso P, 2009, J BIOL CHEM, V284, P23037, DOI 10.1074/jbc.M109.033332; Bafna S, 2010, ONCOGENE, V29, P2893, DOI 10.1038/onc.2010.87; Balda MS, 1996, J CELL BIOL, V134, P1031, DOI 10.1083/jcb.134.4.1031; Blalock TD, 2008, INVEST OPHTH VIS SCI, V49, P1864, DOI 10.1167/iovs.07-1081; Blalock TD, 2007, INVEST OPHTH VIS SCI, V48, P4509, DOI 10.1167/iovs.07-0430; Bonilha VL, 1999, J CELL BIOL, V147, P1533, DOI 10.1083/jcb.147.7.1533; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Cheon DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004675; Cheung AL, 1998, INFECT IMMUN, V66, P5988, DOI 10.1128/IAI.66.12.5988-5993.1998; Davies JR, 2007, INT J BIOCHEM CELL B, V39, P1943, DOI 10.1016/j.biocel.2007.05.013; Ellerbroek SM, 2001, J BIOL CHEM, V276, P24833, DOI 10.1074/jbc.M005631200; Fink L, 1998, NAT MED, V4, P1329, DOI 10.1038/3327; Gipson IK, 2005, E SCHERING RES FDN W, V52, P219; Gipson IK, 2003, INVEST OPHTH VIS SCI, V44, P2496, DOI 10.1167/iovs.02-0851; Gipson IK, 2003, INT REV CYTOL, V231, P1, DOI 10.1016/S0074-7696(03)31001-0; Gipson IK, 2008, BIOL REPROD, V78, P134, DOI 10.1095/biolreprod.106.058347; Gniewek P, 2012, BIOPHYS J, V102, P195, DOI 10.1016/j.bpj.2011.11.4010; Govindarajan B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032418; Govindarajan B, 2010, EXP EYE RES, V90, P655, DOI 10.1016/j.exer.2010.02.014; HANNA C, 1960, ARCH OPHTHALMOL-CHIC, V64, P536; Hattrup CL, 2008, ANNU REV PHYSIOL, V70, P431, DOI 10.1146/annurev.physiol.70.113006.100659; Jang JH, 2003, PROTEOMICS, V3, P1947, DOI 10.1002/pmic.200300563; Jett BD, 2002, INFECT IMMUN, V70, P4697, DOI 10.1128/IAI.70.8.4697-4700.2002; Kesimer M, 2013, MUCOSAL IMMUNOL, V6, P379, DOI 10.1038/mi.2012.81; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; Maiers JL, 2013, J CELL SCI, V126, P3904, DOI 10.1242/jcs.126565; McAuley JL, 2007, J CLIN INVEST, V117, P2313, DOI 10.1172/JCI26705; NICHOLS BA, 1985, INVEST OPHTH VIS SCI, V26, P464; Palmai-Pallag T, 2005, FEBS J, V272, P2901, DOI 10.1111/j.1742-4658.2005.04711.x; Papasergi S, 2010, J BIOL CHEM, V285, P7517, DOI 10.1074/jbc.M109.062075; PFISTER RR, 1975, INVEST OPHTH VISUAL, V14, P267; Pracht D, 2005, INFECT IMMUN, V73, P2680, DOI 10.1128/IAI.73.5.2680-2689.2005; PREOBRAZHENSKY AA, 1993, ANAL BIOCHEM, V209, P315, DOI 10.1006/abio.1993.1125; Senapati S, 2010, TRENDS BIOCHEM SCI, V35, P236, DOI 10.1016/j.tibs.2009.10.003; Shen L, 2005, MOL BIOL CELL, V16, P3919, DOI 10.1091/mbc.E04-12-1089; Shen Q, 2008, MOL CANCER RES, V6, P555, DOI 10.1158/1541-7786.MCR-07-2033; Singh PK, 2006, TRENDS CELL BIOL, V16, P467, DOI 10.1016/j.tcb.2006.07.006; SPICER AP, 1995, J BIOL CHEM, V270, P30093; Spurr-Michaud S, 2007, EXP EYE RES, V84, P939, DOI 10.1016/j.exer.2007.01.018; SPURRMICHAUD SJ, 1988, INVEST OPHTH VIS SCI, V29, P379; Stonebraker JR, 2004, J VIROL, V78, P13755, DOI 10.1128/JVI.78.24.13755-13768.2004; Thornton DJ, 2000, METH MOL B, V125, P77; THORNTON DJ, 1995, ANAL BIOCHEM, V227, P162, DOI 10.1006/abio.1995.1266; Tsutsumida H, 2006, CLIN CANCER RES, V12, P2976, DOI 10.1158/1078-0432.CCR-05-1197; Ueno K, 2008, AM J RESP CELL MOL, V38, P263, DOI 10.1165/rcmb.2007-0336RC; Wesseling J, 1996, MOL BIOL CELL, V7, P565, DOI 10.1091/mbc.7.4.565; Yonemura S, 1999, J CELL BIOL, V145, P1497, DOI 10.1083/jcb.145.7.1497	50	91	92	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100393	10.1371/journal.pone.0100393	http://dx.doi.org/10.1371/journal.pone.0100393			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968021	Green Published, Green Submitted, gold			2022-12-27	WOS:000338280800039
J	Kermani, N; Abu Hassan, ZA; Suhaimi, A; Abuzid, I; Ismail, NF; Attia, M; Abd Ghani, I				Kermani, Nadia; Abu Hassan, Zainal-Abidin; Suhaimi, Amalina; Abuzid, Ismail; Ismail, Noor Farehan; Attia, Mansour; Abd Ghani, Idris			Parasitism Performance and Fitness of Cotesia vestalis (Hymenoptera: Braconidae) Infected with Nosema sp (Microsporidia: Nosematidae): Implications in Integrated Pest Management Strategy	PLOS ONE			English	Article							MUSCIDIFURAX-RAPTOR HYMENOPTERA; VAIRIMORPHA SP MICROSPORIDIA; PLUTELLA-XYLOSTELLA LEPIDOPTERA; DIAMONDBACK MOTH; MACROCENTRUS-GRANDII; ENTOMOPATHOGENIC MICROSPORIDIUM; HOST; TRANSMISSION; PTEROMALIDAE; LARVAE	The diamondback moth (DBM) Plutella xylostella (L.) has traditionally been managed using synthetic insecticides. However, the increasing resistance of DBM to insecticides offers an impetus to practice integrated pest management (IPM) strategies by exploiting its natural enemies such as pathogens, parasitoids, and predators. Nevertheless, the interactions between pathogens and parasitoids and/or predators might affect the effectiveness of the parasitoids in regulating the host population. Thus, the parasitism rate of Nosema-infected DBM by Cotesia vestalis (Haliday) (Hym., Braconidae) can be negatively influenced by such interactions. In this study, we investigated the effects of Nosema infection in DBM on the parasitism performance of C. vestalis. The results of no-choice test showed that C. vestalis had a higher parasitism rate on non-infected host larvae than on Nosema-treated host larvae. The C. vestalis individuals that emerged from Nosema-infected DBM (F1) and their progeny (F2) had smaller pupae, a decreased rate of emergence, lowered fecundity, and a prolonged development period compared to those of the control group. DBM infection by Nosema sp. also negatively affected the morphometrics of C. vestalis. The eggs of female C. vestalis that developed in Nosema-infected DBM were larger than those of females that developed in non-infected DBM. These detrimental effects on the F1 and F2 generations of C. vestalis might severely impact the effectiveness of combining pathogens and parasitoids as parts of an IPM strategy for DBM control.	[Kermani, Nadia; Suhaimi, Amalina; Abuzid, Ismail; Ismail, Noor Farehan; Attia, Mansour; Abd Ghani, Idris] Univ Natl Malaysia, Sch Environm & Nat Resource Sci, Bangi, Malaysia; [Abu Hassan, Zainal-Abidin] Univ Technol MARA UITM, Fac Med, Shah Alam, Malaysia	Universiti Teknologi MARA	Abd Ghani, I (corresponding author), Univ Natl Malaysia, Sch Environm & Nat Resource Sci, Bangi, Malaysia.	idrisgh@ukm.edu.my	KERMANI, NADIA/ABH-4897-2020	ABUZID, ISMAIL/0000-0002-2789-1574; KERMANI, NADIA/0000-0003-1914-1068	Ministry of Sciences, Technology and Innovation, Malaysia (MOSTI) [02-01-02-SF0601, 05-01-02-SF1019]; Research University Grant (OUP) [OUP-2012-043, OUP-2013-043]	Ministry of Sciences, Technology and Innovation, Malaysia (MOSTI); Research University Grant (OUP)	This research was funded by grant No. (02-01-02-SF0601) and (05-01-02-SF1019) from the Ministry of Sciences, Technology and Innovation, Malaysia (MOSTI) and Research University Grant (OUP): OUP-2012-043, OUP-2013-043. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew P, 1999, P ROY SOC B-BIOL SCI, V266, P947, DOI 10.1098/rspb.1999.0728; ANDREADIS TG, 1980, J INVERTEBR PATHOL, V35, P229, DOI 10.1016/0022-2011(80)90155-X; Batoto T. C., 2010, Malaysian Applied Biology, V39, P1; BECNEL J, 1999, MICROSPORIDIA MICROS; Becnel James J., 1999, P447; BECNEL JJ, 1994, J EUKARYOT MICROBIOL, V41, P236, DOI 10.1111/j.1550-7408.1994.tb01504.x; Biondi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076548; Biondi A, 2012, CHEMOSPHERE, V87, P803, DOI 10.1016/j.chemosphere.2011.12.082; Boohene CK, 2003, BIOL CONTROL, V26, P1, DOI 10.1016/S1049-9644(02)00106-8; BROOKS W M, 1973, Miscellaneous Publications of the Entomological Society of America, V9, P105; Brooks Wayne M., 1993, P231; Canning EU, 1999, J INVERTEBR PATHOL, V74, P29, DOI 10.1006/jipa.1999.4861; CANTWELL G E, 1970, American Bee Journal, V110, P222; Casas J, 2005, ECOLOGY, V86, P545, DOI 10.1890/04-0812; COSSENTINE JE, 1987, CAN J ZOOL, V65, P2532, DOI 10.1139/z87-382; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Didier ES, 2000, MICROBES INFECT, V2, P709, DOI 10.1016/S1286-4579(00)00354-3; Doury G, 1997, J INSECT PHYSIOL, V43, P69, DOI 10.1016/S0022-1910(96)00053-4; Down RE, 2005, B ENTOMOL RES, V95, P133, DOI 10.1079/BER2004343; Dunn AM, 2001, ADV PARASIT, V48, P57, DOI 10.1016/S0065-308X(01)48005-5; Ellers J, 1996, NETH J ZOOL, V46, P227, DOI 10.1163/156854295X00186; Elzinga JA, 2003, ENTOMOL EXP APPL, V108, P95, DOI 10.1046/j.1570-7458.2003.00072.x; Endersby NM, 2004, P 4 INT WORKSH MAN D; Federici BA, 1996, BIOSCIENCE, V46, P410, DOI 10.2307/1312875; Furlong MJ, 2013, ANNU REV ENTOMOL, V58, P517, DOI 10.1146/annurev-ento-120811-153605; Futerman PH, 2006, PARASITOLOGY, V132, P479, DOI 10.1017/S0031182005009339; Geden CJ, 2003, ENVIRON ENTOMOL, V32, P1139, DOI 10.1603/0046-225X-32.5.1139; GEDEN CJ, 1995, BIOL CONTROL, V5, P607, DOI 10.1006/bcon.1995.1072; Haque MA, 1999, B ENTOMOL RES, V89, P147, DOI 10.1017/S0007485399000231; Henn MW, 2000, J INVERTEBR PATHOL, V76, P263, DOI 10.1006/jipa.2000.4977; Hoch G, 2000, J INVERTEBR PATHOL, V75, P59, DOI 10.1006/jipa.1999.4894; Hoch G, 2002, ARCH INSECT BIOCHEM, V50, P109, DOI 10.1002/arch.10030; Idris A. B., 1997, Malaysian Applied Biology, V26, P105; Idris AB, 2003, INT J PEST MANAGE, V49, P71, DOI 10.1080/713867831; Idris AB, 2001, ONLINE J BIOL SCI, V1, P905; Idris AB, 1999, SAINS MALAYS, V28, P39; Katinka MD, 2001, NATURE, V414, P450, DOI 10.1038/35106579; Keeling PJ, 2003, FUNGAL GENET BIOL, V38, P298, DOI 10.1016/S1087-1845(02)00537-6; Kermani N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062884; Kurtz J, 2000, J INVERTEBR PATHOL, V75, P237, DOI 10.1006/jipa.1999.4909; Lange CE, 2008, J INVERTEBR PATHOL, V99, P357, DOI 10.1016/j.jip.2008.09.002; Lange Carlos E., 2002, Revista de la Sociedad Entomologica Argentina, V61, P1; Lange CE, 2010, BIOCONTROL SCI TECHN, V20, P19, DOI 10.1080/09583150903338746; Linde Andreas, 2000, IOBC-WPRS Bulletin, V23, P285; Maddox JV, 1999, J INVERTEBR PATHOL, V73, P1, DOI 10.1006/jipa.1998.4817; Mewis I, 2003, BIOL CONTROL, V26, P202, DOI 10.1016/S1049-9644(02)00126-3; MITCHELL MJ, 1994, J ECON ENTOMOL, V87, P933, DOI 10.1093/jee/87.4.933; ORR DB, 1994, ENVIRON ENTOMOL, V23, P1020, DOI 10.1093/ee/23.4.1020; Parkinson N, 2002, INSECT BIOCHEM MOLEC, V32, P729, DOI 10.1016/S0965-1748(01)00155-2; Remadevi O. K., 2010, International Journal of Tropical Insect Science, V30, P138, DOI 10.1017/S1742758410000214; Riddick EW, 2006, BIOCONTROL, V51, P603, DOI 10.1007/s10526-005-2939-5; SAJAP AS, 1988, J INVERTEBR PATHOL, V52, P294, DOI 10.1016/0022-2011(88)90138-3; Sarfraz M, 2005, J APPL ENTOMOL, V129, P149, DOI 10.1111/j.1439-0418.2005.00930.x; Sayyed AH, 2004, PEST MANAG SCI, V60, P827, DOI 10.1002/ps.869; Schuld M, 1999, J INVERTEBR PATHOL, V74, P120, DOI 10.1006/jipa.1999.4865; Shelton A.M., 2008, P 5 INT WORKSH MAN D; Simoes RA, 2012, BIOL CONTROL, V63, P164, DOI 10.1016/j.biocontrol.2012.06.012; SOLTER L. F., 2007, FIELD MANUAL TECHNIQ, P199; Solter Leellen F., 2000, P231; Srinivasan R, 2011, P 6 INT WORKSH MAN D, P321; Tabashnik BE, 1990, J ECON ENTOMOL, V83, P1651; TALEKAR NS, 1993, ANNU REV ENTOMOL, V38, P275, DOI 10.1146/annurev.en.38.010193.001423; Tsai SJ, 2003, J INVERTEBR PATHOL, V83, P51, DOI 10.1016/S0022-2011(03)00035-1; Verkerk RHJ, 1996, B ENTOMOL RES, V86, P205, DOI 10.1017/S0007485300052482; Visser B, 2008, J INSECT PHYSIOL, V54, P1315, DOI 10.1016/j.jinsphys.2008.07.014; Visser B, 2012, GENOME BIOL EVOL, V4, P864, DOI 10.1093/gbe/evs065; Visser B, 2010, P NATL ACAD SCI USA, V107, P8677, DOI 10.1073/pnas.1001744107; WITTNER M, 1999, MICROSPORIDIA MICROS, P553; ZCHORIFEIN E, 1992, J INVERTEBR PATHOL, V60, P292, DOI 10.1016/0022-2011(92)90011-R; Zhao JZ, 2002, J ECON ENTOMOL, V95, P430, DOI 10.1603/0022-0493-95.2.430	70	5	5	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100671	10.1371/journal.pone.0100671	http://dx.doi.org/10.1371/journal.pone.0100671			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968125	gold, Green Published, Green Submitted			2022-12-27	WOS:000338280800050
J	Li, Y; Kromer, B; Schukraft, G; Bubenzer, O; Huang, MR; Wang, ZM; Bian, LG; Li, CS				Li, Ying; Kromer, Bernd; Schukraft, Gerd; Bubenzer, Olaf; Huang, Man-Rong; Wang, Ze-Min; Bian, Lin-Gen; Li, Cheng-Sen			Growth Rate of Usnea aurantiacoatra (Jacq.) Bory on Fildes Peninsula, Antarctica and Its Climatic Background	PLOS ONE			English	Article							KING-GEORGE-ISLAND; RHIZOCARPON-GEOGRAPHICUM; LICHEN COLONIZATION; PARMELIACEAE; MORAINES; RANGE	The ages of a fruticose lichen of Usnea aurantiacoatra (Jacq.) Bory, from Fildes Peninsula, King George Island, Southwest Antarctic, were determined by radiocarbon (C-14), and it is 1993-1996 at bottom and 2006-2007 at top of the lichen branch. The growth rates of U. aurantiacoatra calculated are 4.3 to 5.5 mm year(-1) based on its length and ages. The comparisons show that the growth rates of U. aurantiacoatra are higher than those of U. antarctica (0.4 to 1.1 mm year(-1)). The growth rates of fruticose lichens are always higher, usually > 2 mm year(-1), than those of crustose ones, usually < 1 mm year(-1), in polar areas. A warming trend on Fildes Peninsula is recorded in the period from 1969 to 2010 obviously: the mean annual temperature rose from -2.75 to -1.9 degrees C and the average temperature of summer months from 0.95 to 1.4 degrees C, as well as the average temperature of winter months from -6.75 to -5.5 degrees C. The alteration of lichen growth rates in polar areas may respond to the climatic and environmental changes, and the lichens may act as bio-monitor of natural condition.	[Li, Ying; Li, Cheng-Sen] Acad Sinica, Inst Bot, Beijing 100044, Peoples R China; [Li, Ying; Schukraft, Gerd; Bubenzer, Olaf] Heidelberg Univ, Heidelberg, Germany; [Kromer, Bernd] Klaus Tschira Labor Curt Engelhorn Zentrum Archao, Mannheim, Germany; [Huang, Man-Rong] Beijing Museum Nat Hist, Beijing, Peoples R China; [Wang, Ze-Min] Wuhan Univ, Wuhan, Hubei, Peoples R China; [Bian, Lin-Gen] Chinese Acad Meteorol Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Ruprecht Karls University Heidelberg; Wuhan University; Chinese Academy of Meteorological Sciences (CAMS)	Li, CS (corresponding author), Acad Sinica, Inst Bot, Beijing 100044, Peoples R China.	lics@ibcas.ac.cn			International Cooperation Project of Chinese Arctic and Antarctic Administration [IC 201103]; Innovation Key Program of the Chinese Academy of Sciences [KSCX2-EW-J-1]; National Natural Science Foundation of China [41271222]; Curt-Engelhorn-Zentrum Archaometrie gGmbH	International Cooperation Project of Chinese Arctic and Antarctic Administration; Innovation Key Program of the Chinese Academy of Sciences; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Curt-Engelhorn-Zentrum Archaometrie gGmbH	This study was supported by the International Cooperation Project of Chinese Arctic and Antarctic Administration (No. IC 201103), the Innovation Key Program of the Chinese Academy of Sciences (No. KSCX2-EW-J-1) and the National Natural Science Foundation of China (No. 41271222). Curt-Engelhorn-Zentrum Archaometrie gGmbH provided support in the form of a salary for author BK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahti T, 1962, COLOGICAL INVESTIGAT; Andreyev VN, 1954, GEOBOTANIKA, V9, P11; Articus K, 2004, TAXON, V53, P925, DOI 10.2307/4135560; Chen J.Y., 1988, SCI CHINA, V1, P95; Chen JB, 1996, ACTA MYCOLOGICA SINI, V15, P21; Chen JB, 1995, CHINESE BIODIVERSITY, V3, P113; Chen JY, 1984, J GLACIOLOGY GEOCRYO, V6, P85; Chipev N, 2005, P INT C HIGH PREC AT, P12; Comiso JC, 2000, J CLIMATE, V13, P1674, DOI 10.1175/1520-0442(2000)013<1674:VATIAS>2.0.CO;2; DEGELIUS GUNNAR, 1964, ACTA HORTI GOTOBURGENSIS [MEDD GOTEBORGS BOT TRADGARD], V27, P11; Doran PT, 2002, NATURE, V415, P517, DOI 10.1038/nature710; Frey E, 1953, ERGBN WISS UNTERS SC, V2, P361; Galum M, 1988, CRC HDB LICHENOLOGY, VIII; Hale M.E., 1973, LICHENS, P473; Hale ME, 1967, BIOL LICHENS, P78; Hale ME, 1974, BIOL LICHENS; Hale ME, 1957, LICHEN HDB; Helle T., 1983, RANGIFER, V3, P2, DOI DOI 10.7557/2.3.2.471; Herre AC, 1904, BOT GAZ, V38, P0218, DOI 10.1086/328543; Hooker T, 1980, BRIT ANTARCTIC SURVE, V50, P27; INNES JL, 1985, PROG PHYS GEOG, V9, P187, DOI 10.1177/030913338500900202; IPCC, 2001, CLIMATE CHANGE 2001, DOI DOI 10.1017/CBO9781107415379; Kappen L, 2000, ANTARCT SCI, V12, P314, DOI 10.1017/S0954102000000377; Kim JH, 2006, J MICROBIOL, V44, P480; LANGE OL, 1990, ISRAEL J BOT, V39, P383; Lechowicz MJ, 1972, ECOLOGY, V54, P413; Lee JS, 2008, J MICROBIOL BIOTECHN, V18, P1016; Li YL, 1999, CHINESE J POLAR RES, V11, P69; Lindsay DC, 1975, BRIT ANTARCTIC SURVE, V40, P49; Longton E.R., 1988, BIOL POLAR BRYOPHYTE; Lumbsch HT, 2011, LICHENOLOGIST, V43, P553, DOI 10.1017/S0024282911000417; M Galum, 1988, CRC HDB LICHENOLOGY, VI; M Galum, 1988, CRC HDB LICHENOLOGY, VII; Michel R. F. M., 2010, Proceedings of the 19th World Congress of Soil Science: Soil solutions for a changing world, Brisbane, Australia, 1-6 August 2010. Symposium 1.1.1 Soil morphology and climate change, P1; Nash TH, 2008, LICHEN BIOLOGY, 2ND EDITION, P1, DOI 10.1017/CBO9780511790478; Olech M., 2004, LICHENS KING GEORGE; PEGAU RE, 1968, ARCTIC, V21, P255; PORTER SC, 1981, ARCTIC ALPINE RES, V13, P11, DOI 10.2307/1550622; PROCTOR MCF, 1983, LICHENOLOGIST, V15, P249, DOI 10.1017/S0024282983000389; Sancho LG, 2007, FLORA, V202, P667, DOI 10.1016/j.flora.2007.05.005; Sancho LG, 2004, POLAR BIOL, V27, P312, DOI 10.1007/s00300-004-0594-4; SANCHO LG, 1993, POLAR BIOL, V13, P227; Sancho LG, 2001, CATENA, V43, P323, DOI 10.1016/S0341-8162(00)00131-4; Seaward MRD, 2008, LICHEN BIOLOGY, 2ND EDITION, P274, DOI 10.1017/CBO9780511790478.015; Smith RIL, 1995, LICHENOLOGIST, V27, P473, DOI 10.1016/S0024-2829(95)80007-7; SMITH RIL, 1990, ANTARCTIC ECOSYSTEMS, P32; Soper T., 2008, ANTARCTICA GUIDE WIL; Stevenson SK, 1985, IWIFR 26 VICT BC US; Victoria F de C, 2005, CHARACTERIZATION PLA; Wacker L, 2010, RADIOCARBON, V52, P252, DOI 10.1017/S0033822200045288; WALKER FJ, 1985, B BRIT MUS NAT HIST, V13, P1; Xayidin Hurnisa, 2005, Journal of Fungal Research, V3, P51	52	4	4	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100735	10.1371/journal.pone.0100735	http://dx.doi.org/10.1371/journal.pone.0100735			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968131	Green Published, Green Submitted, gold			2022-12-27	WOS:000338280800060
J	Sasaki, H; Sasaki, N; Nishino, T; Nagasaki, K; Kitamura, H; Torigoe, D; Agui, T				Sasaki, Hayato; Sasaki, Nobuya; Nishino, Tomohiro; Nagasaki, Ken-ichi; Kitamura, Hiroshi; Torigoe, Daisuke; Agui, Takashi			Quantitative Trait Loci for Resistance to the Congenital Nephropathy in Tensin 2-Deficient Mice	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GENOME-WIDE ASSOCIATION; CHRONIC KIDNEY-DISEASE; NEPHROTIC SYNDROME; ICGN STRAIN; MESANGIAL SCLEROSIS; GENETIC-ANALYSIS; RENAL-DISEASE; BLOOD-CELL; PODOCYTE	The ICR-derived glomerulonephritis (ICGN) mouse is a chronic kidney disease (CKD) model that is characterized histologically by glomerulosclerosis, vascular sclerosis and tubulointerstitial fibrosis, and clinically by proteinuria and anemia, which are common symptoms and pathological changes associated with a variety of kidney diseases. Previously, we performed a quantitative trait locus (QTL) analysis to identify the causative genes for proteinuria in ICGN mice, and found a deletion mutation of the tensin 2 gene (Tns2(nph), MGI no: 2447990). Interestingly, the congenic strain carrying the Tns2(nph) mutation on a C57BL/6J (B6) genetic background exhibited milder phenotypes than did ICGN mice, indicating the presence of several modifier genes controlling the disease phenotype. In this study, to identify the modifier/resistant loci for CKD progression in Tns2-deficient mice, we performed QTL analysis using backcross progenies from susceptible ICGN and resistant B6 mice. We identified a significant locus on chromosome (Chr) 2 (LOD = 5.36; 31 cM) and two suggestive loci on Chrs 10 (LOD = 2.27; 64 cM) and X (LOD = 2.65; 67 cM) with linkage to the severity of tubulointerstitial injury. One significant locus on Chr 13 (LOD = 3.49; approximately 14 cM) and one suggestive locus on Chr 2 (LOD = 2.41; 51 cM) were identified as QTLs for the severity of glomerulosclerosis. Suggestive locus in BUN was also detected in the same Chr 2 region (LOD = 2.34; 51 cM). A locus on Chr 2 (36 cM) was significantly linked with HGB (LOD = 4.47) and HCT (LOD = 3.58). Four novel epistatic loci controlling either HGB or tubulointerstitial injury were discovered. Further genetic analysis should lead to identification of CKD modifier gene(s), aiding early diagnosis and providing novel approaches to the discovery of drugs for the treatment and possible prevention of kidney disease.	[Sasaki, Hayato; Nishino, Tomohiro; Torigoe, Daisuke; Agui, Takashi] Hokkaido Univ, Grad Sch Vet Med, Dept Dis Control, Lab Anim Sci & Med, Sapporo, Hokkaido, Japan; [Sasaki, Nobuya] Kitasato Univ, Lab Anim Sci & Med, Towada, Aomori, Japan; [Nagasaki, Ken-ichi] Japan Food Res Labs, Chitose Lab, Sect Biol Safety Res, Chitose, Japan; [Kitamura, Hiroshi] Rakuno Gakuen Univ, Sch Vet Med, Dept Vet Physiol, Ebetsu, Hokkaido 069, Japan	Hokkaido University; Kitasato University; Rakuno Gakuen University	Sasaki, N (corresponding author), Kitasato Univ, Lab Anim Sci & Med, Towada, Aomori, Japan.	nobsasa@vmas.kitasato-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT); KAKENHI [20302614]; MEXT	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Glant-in-Aid for Scientific Research, KAKENHI (20302614) to N.S. H.S. was a research assistant of the Program of Leading Graduate School supported by MEXT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews KL, 2002, AM J PATHOL, V160, P721, DOI 10.1016/S0002-9440(10)64892-4; Beltran M, 2008, GENE DEV, V22, P756, DOI 10.1101/gad.455708; Boger CA, 2011, KIDNEY BLOOD PRESS R, V34, P225, DOI 10.1159/000326901; Burghardt T, 2013, J AM SOC NEPHROL, V24, P1830, DOI 10.1681/ASN.2012080788; Cho AR, 2006, MAMM GENOME, V17, P407, DOI 10.1007/s00335-005-0167-z; Davis RC, 2013, MAMM GENOME, V24, P105, DOI 10.1007/s00335-013-9448-0; Doorenbos C, 2008, GENETICS, V179, P693, DOI 10.1534/genetics.107.085142; El-Aouni C, 2006, J AM SOC NEPHROL, V17, P1334, DOI 10.1681/ASN.2005090921; Elliot SJ, 2003, AM J PATHOL, V162, P1441, DOI 10.1016/S0002-9440(10)64277-0; Freedman BI, 2004, J AM SOC NEPHROL, V15, P2719, DOI 10.1097/01.ASN.0000141312.39483.4F; Guo JK, 2002, HUM MOL GENET, V11, P651, DOI 10.1093/hmg/11.6.651; Harendza S, 2009, CELL MOL BIOL LETT, V14, P679, DOI 10.2478/s11658-009-0026-0; Hartner A, 2003, NEPHROL DIAL TRANSPL, V18, P1999, DOI 10.1093/ndt/gfg299; Kanasaki K, 2008, DEV BIOL, V313, P584, DOI 10.1016/j.ydbio.2007.10.047; Kang YS, 2010, KIDNEY INT, V78, P363, DOI 10.1038/ki.2010.137; Kato T, 2008, BIOMED RES-TOKYO, V29, P279, DOI 10.2220/biomedres.29.279; Kelada SNP, 2012, G3-GENES GENOM GENET, V2, P157, DOI 10.1534/g3.111.001776; Kottgen A, 2010, NAT GENET, V42, P376, DOI 10.1038/ng.568; KRUGLYAK L, 1995, GENETICS, V139, P1421; Lo SH, 2004, INT J BIOCHEM CELL B, V36, P31, DOI 10.1016/S1357-2725(03)00171-7; Manly KF, 2001, MAMM GENOME, V12, P930, DOI 10.1007/s00335-001-1016-3; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Mizuno S, 1999, AM J NEPHROL, V19, P73, DOI 10.1159/000013430; Mizuno S, 1997, EXP NEPHROL, V5, P498; Mizuno S, 2000, KIDNEY INT, V57, P937; Mundel P, 2001, Adv Nephrol Necker Hosp, V31, P235; Murea M, 2010, KIDNEY INT, V78, P514, DOI 10.1038/ki.2010.172; Nishino T, 2012, EXP ANIM TOKYO, V61, P525, DOI 10.1538/expanim.61.525; Nishino T, 2012, BIOMED RES-TOKYO, V33, P53, DOI 10.2220/biomedres.33.53; Nishino T, 2010, J VET MED SCI, V72, P1313, DOI 10.1292/jvms.10-0144; OGURA A, 1989, LAB ANIM, V23, P169, DOI 10.1258/002367789780863628; OGURA A, 1995, VET PATHOL, V32, P321, DOI 10.1177/030098589503200317; Papeta N, 2009, J CLIN INVEST, V119, P1178, DOI 10.1172/JCI37131; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Peters LL, 2010, BLOOD, V116, pE139, DOI 10.1182/blood-2010-05-283879; Roselli S, 2004, MOL CELL BIOL, V24, P550, DOI 10.1128/MCB.24.2.550-560.2004; Sheehan S, 2007, AM J PHYSIOL-RENAL, V293, pF1649, DOI 10.1152/ajprenal.00233.2007; Soda K, 2012, J CLIN INVEST, V122, P4401, DOI 10.1172/JCI65289; Stevens LA, 2011, KIDNEY INT, V79, P555, DOI 10.1038/ki.2010.462; Uchio-Yamada K, 2013, NEPHRON EXP NEPHROL, V123, P22, DOI 10.1159/000354058; van der Harst P, 2012, NATURE, V492, P369, DOI 10.1038/nature11677; Warsow G, 2013, KIDNEY INT, V84, P104, DOI 10.1038/ki.2013.64; Wiggins RC, 2007, KIDNEY INT, V71, P1205, DOI 10.1038/sj.ki.5002222	43	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e99602	10.1371/journal.pone.0099602	http://dx.doi.org/10.1371/journal.pone.0099602			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967628	Green Submitted, Green Published, gold			2022-12-27	WOS:000338280800015
J	Yoshihisa, A; Suzuki, S; Takiguchi, M; Shimizu, T; Abe, S; Sato, T; Yamaki, T; Sugimoto, K; Kunii, H; Nakazato, K; Suzuki, H; Saitoh, S; Takeishi, Y				Yoshihisa, Akiomi; Suzuki, Satoshi; Takiguchi, Mai; Shimizu, Takeshi; Abe, Satoshi; Sato, Takamasa; Yamaki, Takayoshi; Sugimoto, Koichi; Kunii, Hiroyuki; Nakazato, Kazuhiko; Suzuki, Hitoshi; Saitoh, Shu-ichi; Takeishi, Yasuchika			Impact of Sleep-Disordered Breathing on Heart Rate Turbulence in Heart Failure Patients	PLOS ONE			English	Article							BLOOD-PRESSURE; VENTRICULAR-ARRHYTHMIAS; NERVE-STIMULATION; RATE-VARIABILITY; SUDDEN-DEATH; APNEA; MORTALITY; MODULATION; DISEASE; ASSOCIATION	Background: Sleep-disordered breathing (SDB) is associated with adverse outcomes in patients with chronic heart failure (CHF). Additionally, heart rate turbulence (HRT) reflects changes in the sinus cycle length of baroreceptor in response to hemodynamic fluctuations after ventricular premature beat. Recent studies have suggested that HRT as a marker of vagal activity has a predictive value of poor prognosis in CHF patients. However, little is known about the relationship between SDB and HRT in CHF patients. Methods and Results: In this study, 75 patients with CHF were enrolled. We simultaneously performed Holter ECG during a 24-hr period and portable sleep monitoring at nighttime, and determined the respiratory disturbance index (RDI), HRT (turbulence onset (TO) and turbulence slope (TS)) during that 24-hr period. These patients were divided into two groups based on the presence of severe SDB: Group A (RDI >= 30, n = 17) and Group B (RDI<30, n = 58). TS was significantly lower in Group A than in Group B across the 24-hr period (nighttime: 3.6 +/- 1.1 vs. 6.9 +/- 1.3; daytime: 3.7 +/- 0.8 vs. 7.0 +/- 1.1; all-day: 3.5 +/- 0.7 vs. 6.7 +/- 0.9% ms/RR, P<0.05, respectively). TO did not differ between the two groups. Furthermore, there was a significant negative correlation between all-day TS and RDI (R = -0.257, P = 0.027). Moreover, in the multiple regression analysis, RDI was an independent factor to determine all-day TS. Conclusions: In patients with severe SDB, blunted TS was observed across 24 hours. These results suggest that SDB induce impairment of vagal activity across a 24-hour period and may be associated with poor prognosis in CHF patients.	[Yoshihisa, Akiomi; Suzuki, Satoshi; Takiguchi, Mai; Shimizu, Takeshi; Abe, Satoshi; Sato, Takamasa; Yamaki, Takayoshi; Sugimoto, Koichi; Kunii, Hiroyuki; Nakazato, Kazuhiko; Suzuki, Hitoshi; Saitoh, Shu-ichi; Takeishi, Yasuchika] Fukushima Med Univ, Dept Cardiol & Hematol, Fukushima, Japan; [Yoshihisa, Akiomi; Suzuki, Satoshi; Takeishi, Yasuchika] Fukushima Med Univ, Dept Adv Cardiac Therapeut, Fukushima, Japan	Fukushima Medical University; Fukushima Medical University	Yoshihisa, A (corresponding author), Fukushima Med Univ, Dept Cardiol & Hematol, Fukushima, Japan.	yoshihis@fmu.ac.jp			Japan Society for the Promotion of Science [25461061]; Japanese Ministry of Health, Labour, and Welfare, Tokyo, Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese Ministry of Health, Labour, and Welfare, Tokyo, Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported in part by a grant-in-aid for Scientific Research (No. 25461061) from the Japan Society for the Promotion of Science, and grants-in-aid from the Japanese Ministry of Health, Labour, and Welfare, Tokyo, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aytemir K, 2007, RESP MED, V101, P1277, DOI 10.1016/j.rmed.2006.10.016; Berry RB, 2012, J CLIN SLEEP MED, V8, P597, DOI 10.5664/jcsm.2172; Bitter T, 2011, EUR HEART J, V32, P61, DOI 10.1093/eurheartj/ehq327; Camm AJ, 1996, CIRCULATION, V93, P1043; Cygankiewicz I, 2008, HEART RHYTHM, V5, P1095, DOI 10.1016/j.hrthm.2008.04.017; Cygankiewicz I, 2006, AM J CARDIOL, V98, P1635, DOI 10.1016/j.amjcard.2006.07.042; Davies LC, 2001, AM J CARDIOL, V87, P737, DOI 10.1016/S0002-9149(00)01493-4; De Ferrari GM, 2011, EUR HEART J, V32, P847, DOI 10.1093/eurheartj/ehq391; Fauchier L, 1997, J AM COLL CARDIOL, V30, P1009, DOI 10.1016/S0735-1097(97)00265-9; Floras JS, 2009, J AM COLL CARDIOL, V54, P375, DOI 10.1016/j.jacc.2009.03.061; Galinier M, 2000, EUR HEART J, V21, P475, DOI 10.1053/euhj.1999.1875; Gottlieb DJ, 2010, CIRCULATION, V122, P352, DOI 10.1161/CIRCULATIONAHA.109.901801; HIRSCH AT, 1987, CIRCULATION, V75, P36; Javaheri S, 2007, J AM COLL CARDIOL, V49, P2028, DOI 10.1016/j.jacc.2007.01.084; Jessup M, 2009, CIRCULATION, V119, P1977, DOI 10.1161/CIRCULATIONAHA.109.192064; Koyama J, 2002, CIRC J, V66, P902, DOI 10.1253/circj.66.902; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Li M, 2004, CIRCULATION, V109, P120, DOI 10.1161/01.CIR.0000105721.71640.DA; Lin LY, 2004, J CARDIOVASC ELECTR, V15, P752, DOI 10.1046/j.1540-8167.2004.03289.x; Manzano-Fernandez S, 2011, J CARD FAIL, V17, P735, DOI 10.1016/j.cardfail.2011.05.007; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Moore RKG, 2006, EUR J HEART FAIL, V8, P585, DOI 10.1016/j.ejheart.2005.11.012; Mortara A, 1997, CIRCULATION, V96, P3450; Narkiewicz K, 1998, CIRCULATION, V98, P1071, DOI 10.1161/01.CIR.98.11.1071; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Schmidt G, 1999, LANCET, V353, P1390, DOI 10.1016/S0140-6736(98)08428-1; Silber MH, 2007, J CLIN SLEEP MED, V3, P121; Somers VK, 2008, J AM COLL CARDIOL, V52, P686, DOI 10.1016/j.jacc.2008.05.002; Ueno LM, 2011, INT J CARDIOL, V148, P53, DOI 10.1016/j.ijcard.2009.10.023; Wang HQ, 2007, J AM COLL CARDIOL, V49, P1625, DOI 10.1016/j.jacc.2006.12.046; Yamada S, 2013, CIRC J, V77, P1466, DOI 10.1253/circj.CJ-12-0836; Yang A, 2005, BASIC RES CARDIOL, V100, P439, DOI 10.1007/s00395-005-0536-5; Yumino D, 2013, AM J RESP CRIT CARE, V187, P433, DOI 10.1164/rccm.201205-0894OC	33	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e101307	10.1371/journal.pone.0101307	http://dx.doi.org/10.1371/journal.pone.0101307			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968229	Green Submitted, Green Published, gold			2022-12-27	WOS:000338280800121
J	Pereyra-Bonnet, F; Gimeno, ML; Argumedo, NR; Ielpi, M; Cardozo, JA; Gimenez, CA; Hyon, SH; Balzaretti, M; Loresi, M; Fainstein-Day, P; Litwak, LE; Argibay, PF				Pereyra-Bonnet, Federico; Gimeno, Maria L.; Argumedo, Nelson R.; Ielpi, Marcelo; Cardozo, Johana A.; Gimenez, Carla A.; Hyon, Sung-Ho; Balzaretti, Marta; Loresi, Monica; Fainstein-Day, Patricia; Litwak, Leon E.; Argibay, Pablo F.			Skin Fibroblasts from Patients with Type 1 Diabetes (T1D) Can Be Chemically Transdifferentiated into Insulin-Expressing Clusters: A Transgene-Free Approach	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; DNA METHYLATION; SMALL-MOLECULE; BISULFITE-PCR; DIFFERENTIATION; BONE; TRANSPLANTATION; INDUCTION; CONVERT; ISLETS	The conversion of differentiated cells into insulin-producing cells is a promising approach for the autologous replacement of pancreatic cells in patients with type 1 diabetes (T1D). At present, cellular reprogramming strategies encompass ethical problems, epigenetic failure or teratoma formation, which has prompted the development of new approaches. Here, we report a novel technique for the conversion of skin fibroblasts from T1D patients into insulin-expressing clusters using only drug-based induction. Our results demonstrate that skin fibroblasts from diabetic patients have pancreatic differentiation capacities and avoid the necessity of using transgenic strategies, stem cell sources or global demethylation steps. These findings open new possibilities for studying diabetes mechanisms, drug screenings and ultimately autologous transgenic-free regenerative medicine therapies in patients with T1D.	[Pereyra-Bonnet, Federico; Gimeno, Maria L.; Argumedo, Nelson R.; Ielpi, Marcelo; Cardozo, Johana A.; Gimenez, Carla A.; Loresi, Monica; Argibay, Pablo F.] HIBA, ICBME, Buenos Aires, DF, Argentina; [Hyon, Sung-Ho] HIBA, Gen Surg Serv, Buenos Aires, DF, Argentina; [Balzaretti, Marta; Fainstein-Day, Patricia; Litwak, Leon E.] HIBA, Endocrinol & Nucl Med Serv, Buenos Aires, DF, Argentina		Pereyra-Bonnet, F (corresponding author), HIBA, ICBME, Buenos Aires, DF, Argentina.	federico.pereyra@hospitalitaliano.org.ar	Hyon, Sung Ho/AAM-6884-2020	Fainstein-Day, Patricia/0000-0002-6402-1690	Hospital Italiano de Buenos Aires; FUCIBA; Fundacion Florencio Fiorini	Hospital Italiano de Buenos Aires; FUCIBA; Fundacion Florencio Fiorini	This work was financially supported by Hospital Italiano de Buenos Aires, FUCIBA and Fundacion Florencio Fiorini. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Bollati V, 2007, CANCER RES, V67, P876, DOI 10.1158/0008-5472.CAN-06-2995; Cappellesso-Fleury S, 2010, J CLIN IMMUNOL, V30, P607, DOI 10.1007/s10875-010-9415-4; Chen S, 2009, NAT CHEM BIOL, V5, P258, DOI 10.1038/nchembio.154; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Daley GQ, 2012, CELL STEM CELL, V10, P740, DOI 10.1016/j.stem.2012.05.010; Drucker DJ, 1998, DIABETES, V47, P159, DOI 10.2337/diabetes.47.2.159; Feldon SE, 2006, AM J PATHOL, V169, P1183, DOI 10.2353/ajpath.2006.060434; Fomina-Yadlin D, 2010, P NATL ACAD SCI USA, V107, P15099, DOI 10.1073/pnas.1010018107; Gregoire FM, 2001, EXP BIOL MED, V226, P997, DOI 10.1177/153537020122601106; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Guo T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022387; Habeck M, 2003, NAT MED, V9, P1228, DOI 10.1038/nm1003-1228a; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Hee CK, 2006, BIOMATERIALS, V27, P875, DOI 10.1016/j.biomaterials.2005.07.004; Hirata K, 2003, BONE, V32, P502, DOI 10.1016/S8756-3282(03)00054-1; Hosokawa M, 2001, BIOCHEM BIOPH RES CO, V289, P1114, DOI 10.1006/bbrc.2001.6145; Hou PP, 2013, SCIENCE, V341, P651, DOI 10.1126/science.1239278; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Hyon SH, 2004, CELL TRANSPLANT, V13, P61, DOI 10.3727/000000004772664905; Jiang MH, 2010, LAB INVEST, V90, P282, DOI 10.1038/labinvest.2009.132; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Kass SU, 1997, TRENDS GENET, V13, P444, DOI 10.1016/S0168-9525(97)01268-7; Krebsbach PH, 2000, HUM GENE THER, V11, P1201, DOI 10.1089/10430340050015248; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Kubo A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024058; Kuroda A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006953; Lau J, 2009, CELL TRANSPLANT, V18, P23, DOI 10.3727/096368909788237131; Lee CS, 2006, DIABETES, V55, P269; Lei T, 2007, CELL RES, V17, P682, DOI 10.1038/cr.2007.61; Li K, 2014, CELL STEM CELL, V14, P228, DOI 10.1016/j.stem.2014.01.006; Li Z, 2000, J ENDOCRINOL, V165, P93, DOI 10.1677/joe.0.1650093; Lisanti S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079044; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Lysy PA, 2007, HEPATOLOGY, V46, P1574, DOI 10.1002/hep.21839; Maehr R, 2009, P NATL ACAD SCI USA, V106, P15768, DOI 10.1073/pnas.0906894106; Masuda S, 2013, J MOL CELL BIOL, V5, P354, DOI 10.1093/jmcb/mjt034; Mizuno S, 1996, EXP CELL RES, V227, P89, DOI 10.1006/excr.1996.0253; Palm F, 2004, DIABETES-METAB RES, V20, P452, DOI 10.1002/dmrr.472; Pennarossa G, 2013, P NATL ACAD SCI USA, V110, P8948, DOI 10.1073/pnas.1220637110; Pinney SE, 2011, DIABETOLOGIA, V54, P2606, DOI 10.1007/s00125-011-2250-1; REDDI AH, 1972, P NATL ACAD SCI USA, V69, P1601, DOI 10.1073/pnas.69.6.1601; Rutherford RB, 2003, CONNECT TISSUE RES, V44, P117, DOI 10.1080/03008200390152197; Rutherford RB, 2002, TISSUE ENG, V8, P441, DOI 10.1089/107632702760184709; Ryan EA, 2002, DIABETES, V51, P2148, DOI 10.2337/diabetes.51.7.2148; Shui CX, 2002, J CELL PHYSIOL, V193, P164, DOI 10.1002/jcp.10157; Siegfried Z, 1997, CURR BIOL, V7, pR305, DOI 10.1016/S0960-9822(06)00144-8; Sumi S, 2004, PANCREAS, V29, pE85, DOI 10.1097/00006676-200410000-00017; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; Wakao S, 2011, P NATL ACAD SCI USA, V108, P9875, DOI 10.1073/pnas.1100816108; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032; Zhang DH, 2009, CELL RES, V19, P429, DOI 10.1038/cr.2009.28; Zhou J, 1999, DIABETES, V48, P2358, DOI 10.2337/diabetes.48.12.2358; Zhou Q, 2008, CELL STEM CELL, V3, P382, DOI 10.1016/j.stem.2008.09.015	57	13	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100369	10.1371/journal.pone.0100369	http://dx.doi.org/10.1371/journal.pone.0100369			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963634	Green Published, gold, Green Submitted			2022-12-27	WOS:000338709500045
J	Zong, JF; Lin, SJ; Chen, YB; Wang, BY; Xiao, YP; Lin, J; Li, R; Pan, JJ				Zong, Jingfeng; Lin, Shaojun; Chen, Yunbin; Wang, Bingyi; Xiao, Youping; Lin, Jin; Li, Rui; Pan, Jianji			Does MRI-Detected Cranial Nerve Involvement Affect the Prognosis of Locally Advanced Nasopharyngeal Carcinoma Treated with Intensity Modulated Radiotherapy?	PLOS ONE			English	Article							CONVENTIONAL 2-DIMENSIONAL RADIOTHERAPY; TRIGEMINAL NERVE; CANCER; CHEMOTHERAPY; EXPERIENCE; OUTCOMES; SPREAD; TRIAL; PALSY; HEAD	Nasopharyngeal carcinoma (NPC) is one of the common cancers in South China. It can easily invade into cranial nerves, especially in patients with local advanced disease. Despite the fact that the magnetic resonance imaging (MRI) findings are not always consistent with the symptoms of CN palsy, MRI is recommended for the detection of CN involvement (CNI). However, the prognostic impact of MRI-detected CNI in NPC patients is still controversial. To investigate the prognostic value of MRI detected CNI, we performed a retrospective analysis on the clinical data of 375 patients with NPC who were initially diagnosed by MRI. All patients had T3-4 disease and received radical intensity modulated radiation therapy (IMRT) as their primary treatment. The incidence of MRI-detected CNI was 60.8%. A higher incidence of MRI-detected CNI was observed in T4 disease compared with T3 disease (96.8% vs. 42.8%, P<0.001), and a higher incidence was also found in patients with Stage IV disease compared with those with Stage III disease (91.5% vs. 42.3%; P<0.001). The local relapse-free survival (LRFS), distant metastasis-free survival (DMFS), and overall survival (OS) of patients with T3 disease, with or without MRI-detected CNI, was superior to that of patients with T4 disease (P<0.05). No significant differences in LRFS, DMFS or OS were observed between T3 patients with or without MRI-detected CNI. The survival of Stage III patients with or without MRI-detected CNI was significantly superior to that of Stage IV patients (P<0.01), but there was no significant difference between Stage III patients with or without MRI-detected CNI for all endpoints. Therefore, when treated with IMRT, MRI-detected CNI in patients with NPC does not appear to affect the prognosis. In patients with clinical T3 disease, the presence of MRI-detected CNI is not sufficient evidence for defining T4 disease.	[Zong, Jingfeng; Lin, Shaojun; Chen, Yunbin; Wang, Bingyi; Xiao, Youping; Lin, Jin; Li, Rui; Pan, Jianji] Fujian Med Univ, Prov Clin Coll, Fuzhou, Fujian Province, Peoples R China; [Zong, Jingfeng; Lin, Shaojun; Wang, Bingyi; Lin, Jin; Li, Rui; Pan, Jianji] Fujian Prov Canc Hosp, Dept Radiat Oncol, Fuzhou, Fujian Province, Peoples R China; [Zong, Jingfeng; Lin, Shaojun; Wang, Bingyi; Lin, Jin; Li, Rui; Pan, Jianji] Fujian Prov Canc Hosp, Fujian Prov Key Lab Translat Canc Med, Fuzhou, Fujian Province, Peoples R China; [Chen, Yunbin; Xiao, Youping] Fujian Prov Canc Hosp, Dept Radiol, Fuzhou, Fujian Province, Peoples R China	Fujian Medical University	Pan, JJ (corresponding author), Fujian Med Univ, Prov Clin Coll, Fuzhou, Fujian Province, Peoples R China.	panjianji@126.com	, 宗井凤/AAH-1938-2020	Pan, Jianji/0000-0002-3211-7874	Clinical Specialty Discipline Construction Program of Fujian, P.R.C	Clinical Specialty Discipline Construction Program of Fujian, P.R.C	Sponsored by key Clinical Specialty Discipline Construction Program of Fujian, P.R.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang JTC, 2005, INT J RADIAT ONCOL, V63, P1354, DOI 10.1016/j.ijrobp.2005.05.042; Chong VFH, 1997, HEAD NECK-J SCI SPEC, V19, P121; Edge SB, 2009, AJCC CANC STAGING MA, V7; Ginsberg LE, 1999, SEMIN ULTRASOUND CT, V20, P175, DOI 10.1016/S0887-2171(99)90018-5; Lai SZ, 2011, INT J RADIAT ONCOL, V80, P661, DOI 10.1016/j.ijrobp.2010.03.024; Lee AWM, 2005, J CLIN ONCOL, V23, P6966, DOI 10.1200/JCO.2004.00.7542; Lee AWM, 1999, INT J CANCER, V84, P179, DOI 10.1002/(SICI)1097-0215(19990420)84:2<179::AID-IJC15>3.0.CO;2-6; Lee N, 2002, INT J RADIAT ONCOL, V53, P12, DOI 10.1016/S0360-3016(02)02724-4; Lin SJ, 2009, INT J RADIAT ONCOL, V75, P1071, DOI 10.1016/j.ijrobp.2008.12.015; Liu LZ, 2009, CANCER-AM CANCER SOC, V115, P1995, DOI 10.1002/cncr.24201; Lu TX, 2001, INT J RADIAT ONCOL, V51, P589, DOI 10.1016/S0360-3016(01)01678-9; Majoie CBLM, 1997, EUR J RADIOL, V24, P191, DOI 10.1016/S0720-048X(96)01122-9; Mo HY, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-149; Nemzek WR, 1998, AM J NEURORADIOL, V19, P701; Pan J, 2013, AM J CLIN ONCOL; Peng G, 2012, RADIOTHER ONCOL, V104, P286, DOI 10.1016/j.radonc.2012.08.013; Razek AAKA, 2012, AM J ROENTGENOL, V198, P11, DOI 10.2214/AJR.11.6954; Su CY, 1996, CANCER, V78, P2063, DOI 10.1002/(SICI)1097-0142(19961115)78:10<2063::AID-CNCR5>3.0.CO;2-P; Tham IWK, 2009, INT J RADIAT ONCOL, V75, P1481, DOI 10.1016/j.ijrobp.2009.01.018; Wee J, 2005, J CLIN ONCOL, V23, P6730, DOI 10.1200/JCO.2005.16.790; Yap ML, 2012, J MED IMAG RADIAT ON, V56, P548, DOI 10.1111/j.1754-9485.2012.02391.x	21	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100571	10.1371/journal.pone.0100571	http://dx.doi.org/10.1371/journal.pone.0100571			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963626	Green Published, Green Submitted, gold			2022-12-27	WOS:000338709500063
J	Dave, S; Nanduri, R; Dkhar, HK; Bhagyaraj, E; Rao, A; Gupta, P				Dave, Sandeep; Nanduri, Ravikanth; Dkhar, Hedwin Kitdorlang; Bhagyaraj, Ella; Rao, Alka; Gupta, Pawan			Nuclear MEK1 Sequesters PPAR gamma and Bisects MEK1/ERK Signaling: A Non-Canonical Pathway of Retinoic Acid Inhibition of Adipocyte Differentiation	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; GENE-EXPRESSION; MAP KINASE; TRANSCRIPTIONAL CONTROL; RETINOYLATION REACTION; COVALENT MODIFICATION; CELL-DIFFERENTIATION; BINDING PROTEIN; RECEPTOR; ADIPOGENESIS	Uncontrolled adipogenesis and adipocyte proliferation have been connected to human comorbidities. Retinoic acid (RA) is known to inhibit adipocyte differentiation, however the underlying mechanisms have not been adequately understood. This study reports that RA acting as a ligand to RA receptors (RARs and RXRs) is not a sine qua non to the inhibition of adipogenesis. Our intriguing observation of a negative correlation between increased retinoylation and adipogenesis led us to explore retinoylated proteins in adipocytes. Exportin (CRM1) was found to be retinoylated, which in turn can affect the spatio-temporal regulation of the important signaling molecule mitogen-activated protein kinase kinase 1 (MEK1), likely by disrupting its export from the nucleus. Nuclear enrichment of MEK1 physically sequesters peroxisome proliferator-activated receptor gamma (PPAR gamma), the master regulator of adipogenesis, from its target genes and thus inhibits adipogenesis while also disrupting the MEK1-extracellular-signal regulated kinase (ERK) signaling cascade. This study is first to report the inhibition of adipocyte differentiation by retinoylation.	[Dave, Sandeep; Nanduri, Ravikanth; Dkhar, Hedwin Kitdorlang; Bhagyaraj, Ella; Rao, Alka; Gupta, Pawan] CSIR, Inst Microbial Technol, Chandigarh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Gupta, P (corresponding author), CSIR, Inst Microbial Technol, Chandigarh, India.	pawan@imtech.res.in	Rao, Alka/F-9826-2010; NANDURI, RAVIKANTH/Q-9729-2018	NANDURI, RAVIKANTH/0000-0002-0031-2333; Ella, Bhagyaraj/0000-0002-5887-9228; Dave, Sandeep/0000-0003-2832-2098	Department of Science & Technology SERC-FAST Track project; Department of Biotechnology-India project [BT/01/IYBA/2009]; CSIR [BSC0210, BSC0120]	Department of Science & Technology SERC-FAST Track project(Department of Science & Technology (DOST), Philippines); Department of Biotechnology-India project; CSIR(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the Department of Science & Technology SERC-FAST Track project to PG, Department of Biotechnology-India project BT/01/IYBA/2009 and CSIR 12th Plan Network project Infectious Disease and Biodiscovery (BSC0210 & BSC0120) to PG and facilities provided by IMTech-CSIR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2006, MOL BIOL CELL, V17, P566, DOI 10.1091/mbc.E05-06-0519; Aguilar V, 2010, ENDOCRINOLOGY, V151, P5247, DOI 10.1210/en.2010-0461; Aubert J, 1999, CELL MOL LIFE SCI, V56, P538, DOI 10.1007/s000180050450; Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; Berry DC, 2010, J BIOL CHEM, V285, P15324, DOI 10.1074/jbc.M110.110635; Bhat AH, 2012, NUCLEIC ACIDS RES, V40, pD388, DOI 10.1093/nar/gkr911; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bost F, 2005, BIOCHIMIE, V87, P51, DOI 10.1016/j.biochi.2004.10.018; BREITMAN TR, 1980, P NATL ACAD SCI-BIOL, V77, P2936, DOI 10.1073/pnas.77.5.2936; Burgermeister E, 2007, CELL CYCLE, V6, P1539, DOI 10.4161/cc.6.13.4453; Burgermeister E, 2007, MOL CELL BIOL, V27, P803, DOI 10.1128/MCB.00601-06; Camp HS, 1997, J BIOL CHEM, V272, P10811; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Cione E, 2005, MOL CELL BIOCHEM, V276, P55, DOI 10.1007/s11010-005-2845-2; Cione E, 2005, J BIOENERG BIOMEMBR, V37, P43, DOI 10.1007/s10863-005-4122-1; Cione E, 2004, J BIOENERG BIOMEMBR, V36, P211, DOI 10.1023/B:JOBB.0000023625.22324.f0; Cione E, 2009, BBA-MOL CELL BIOL L, V1791, P3, DOI 10.1016/j.bbalip.2008.09.004; CONRAD DH, 1973, IMMUNOCHEMISTRY, V10, P273, DOI 10.1016/0019-2791(73)90205-X; Dave S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030831; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fukuda M, 1996, J BIOL CHEM, V271, P20024, DOI 10.1074/jbc.271.33.20024; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Genchi G, 2001, BBA-MOL CELL BIOL L, V1530, P146, DOI 10.1016/S1388-1981(00)00175-X; Gupta P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004363; Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100; Iankova I, 2006, MOL ENDOCRINOL, V20, P1494, DOI 10.1210/me.2005-0222; Jaaro H, 1997, P NATL ACAD SCI USA, V94, P3742, DOI 10.1073/pnas.94.8.3742; KAMEI Y, 1993, BIOCHEM J, V293, P807, DOI 10.1042/bj2930807; KAMEI Y, 1994, LIFE SCI, V55, pPL307, DOI 10.1016/0024-3205(94)90073-6; KEIDEL S, 1993, EUR J BIOCHEM, V212, P13, DOI 10.1111/j.1432-1033.1993.tb17627.x; Kim SW, 2007, MOL CELL BIOL, V27, P6933, DOI 10.1128/MCB.02385-06; Kubo Y, 2005, J BIOCHEM, V138, P493, DOI 10.1093/jb/mvi145; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; LENORMAND P, 1993, J CELL BIOL, V122, P1079, DOI 10.1083/jcb.122.5.1079; Mahajan S, 2012, J IMMUNOL, V188, P5593, DOI 10.4049/jimmunol.1103038; Mangelsdorf David J., 1994, P319; Moon HS, 2007, J NUTR BIOCHEM, V18, P322, DOI 10.1016/j.jnutbio.2006.06.004; Myhre AM, 1996, J LIPID RES, V37, P1971; Napoli JL, 1996, FASEB J, V10, P993, DOI 10.1096/fasebj.10.9.8801182; Persaud SD, 2009, FASEB J, V23; Prusty D, 2002, J BIOL CHEM, V277, P46226, DOI 10.1074/jbc.M207776200; Rangwala SM, 2000, ANNU REV NUTR, V20, P535, DOI 10.1146/annurev.nutr.20.1.535; RENSTROM B, 1989, BIOCHIM BIOPHYS ACTA, V998, P69, DOI 10.1016/0167-4838(89)90120-9; Rosen ED, 2000, GENE DEV, V14, P1293; SALE EM, 1995, EMBO J, V14, P674, DOI 10.1002/j.1460-2075.1995.tb07046.x; SCHALLREUTER KU, 1991, SKIN PHARMACOL, V4, P14, DOI 10.1159/000210919; Schupp M, 2007, MOL PHARMACOL, V71, P1251, DOI 10.1124/mol.106.033662; Schwarz EJ, 1997, MOL CELL BIOL, V17, P1552, DOI 10.1128/MCB.17.3.1552; Senatore V, 2010, J BIOENERG BIOMEMBR, V42, P321, DOI 10.1007/s10863-010-9293-8; SURYAWAN A, 1993, COMP BIOCHEM PHYS A, V105, P485, DOI 10.1016/0300-9629(93)90424-3; TAKAHASHI N, 1992, P NATL ACAD SCI USA, V89, P10807, DOI 10.1073/pnas.89.22.10807; TAKAHASHI N, 1991, ARCH BIOCHEM BIOPHYS, V285, P105, DOI 10.1016/0003-9861(91)90334-F; Takahashi N, 2005, SEIKAGAKU, V77, P527; Takahashi N, 1997, BIOCHEM BIOPH RES CO, V239, P80, DOI 10.1006/bbrc.1997.7434; Takahashi N, 2010, BRIT J DERMATOL, V162, P974, DOI 10.1111/j.1365-2133.2009.09592.x; Takahashi N, 1995, CLIN CANCER RES, V1, P637; Takahashi N, 2002, YAKUGAKU ZASSHI, V122, P547, DOI 10.1248/yakushi.122.547; TAKAHASHI N, 1991, BIOCHEM BIOPH RES CO, V180, P393, DOI 10.1016/S0006-291X(05)81306-3; TAKAHASHI N, 1994, J BIOL CHEM, V269, P5913; TAKAHASHI N, 1989, J BIOL CHEM, V264, P5159; Takahashi N., 1994, Vitamin A in health and disease., P257; TAKAHASHI N, 1990, METHOD ENZYMOL, V189, P233; TAKAHASHI N, 1991, ARCH BIOCHEM BIOPHYS, V290, P293, DOI 10.1016/0003-9861(91)90544-S; Tang XH, 2011, ANNU REV PATHOL-MECH, V6, P345, DOI 10.1146/annurev-pathol-011110-130303; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tucci P, 2008, J BIOENERG BIOMEMBR, V40, P111, DOI 10.1007/s10863-008-9132-3; Villarroya F, 1999, INT J OBESITY, V23, P1, DOI 10.1038/sj.ijo.0800799; Wada M, 2001, J BIOCHEM-TOKYO, V130, P457, DOI 10.1093/oxfordjournals.jbchem.a003006; Wang P, 2009, J CELL SCI, V122, P3772, DOI 10.1242/jcs.057026; Xue JC, 1996, MOL CELL BIOL, V16, P1567; Yael Asscher SP, 2001, LEPTOMYCIN B; Yamamoto Y, 2002, METABOLISM, V51, P1407, DOI 10.1053/meta.2002.35586; Yao Z, 2001, ONCOGENE, V20, P7588, DOI 10.1038/sj.onc.1204963; Zehorai E, 2010, MOL CELL ENDOCRINOL, V314, P213, DOI 10.1016/j.mce.2009.04.008	78	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100862	10.1371/journal.pone.0100862	http://dx.doi.org/10.1371/journal.pone.0100862			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959884	gold, Green Published, Green Submitted			2022-12-27	WOS:000338633900097
J	Diep, TA; Madsen, AN; Krogh-Hansen, S; Al-Shahwani, M; Al-Sabagh, L; Holst, B; Hansen, HS				Diep, Thi Ai; Madsen, Andreas N.; Krogh-Hansen, Sandra; Al-Shahwani, Marwa; Al-Sabagh, Laila; Holst, Birgitte; Hansen, Harald S.			Dietary Non-Esterified Oleic Acid Decreases the Jejunal Levels of Anorectic N-Acylethanolamines	PLOS ONE			English	Article							PHOSPHOLIPASE-D; FATTY-ACIDS; INTESTINAL LEVELS; GUT; ANANDAMIDE; RAT; OLEOYLETHANOLAMIDE; GPR119; ACYLPHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLETHANOLAMINE	Background and Aims: Oleoylethanolamide and several other N-acylethanolamines (NAEs), e.g. linoleoylethanolamide and palmitoylethanolamide, have anorectic properties in rats, and prolonged intake of a high-fat diet decreases the levels of the anorectic NAEs in jejunum. Jejunal anorectic NAEs are thought to add to the control of food intake via activation of PPARalpha and the vagus nerve. The fat-induced decrease may explain part of the hyperphagic effect of high-fat diets. In the present study, we investigated 1) whether the reduced levels of anorectic NAEs were reversible in rats, 2) whether mice respond to dietary fat (olive oil) by reducing levels of anorectic NAEs, and 3) whether dietary non-esterified oleic acid also can decrease levels of anorectic NAEs in mice. We are searching for the fat sensor in the intestine, which mediates the decreased levels of anorectic NAEs. Methods: Male rats and mice were fed diets high (45 energy% fat) in either triacylglycerol or free fatty acids for 7-14 days, and jejunal NAE and N-acylphosphatidylethanolamine (NAPE) levels were determined by liquid-chromatography mass spectrometry. Results: In rats, reduced levels of anorectic NAEs could be reversed after 3 days from changing the diet from high-fat to chow. Corresponding NAPE levels tended to show the same changes. In mice, jejunal levels of anorectic NAEs were also reduced when fed a high-fat diet. In addition, we found that non-esterified oleic acid were also able to reduce levels of anorectic NAEs in mice. Conclusions: These results suggest that the down-regulation of the jejunal level of anorectic NAEs by dietary fat is not restricted to rats, and that the fatty acid component oleic acid, in dietary olive oil may be sufficient to mediate this regulation. Thus, a fatty acid sensor may mediate this effect of dietary fat.	[Diep, Thi Ai; Krogh-Hansen, Sandra; Al-Shahwani, Marwa; Al-Sabagh, Laila; Hansen, Harald S.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, Copenhagen, Denmark; [Madsen, Andreas N.; Holst, Birgitte] Univ Copenhagen, Fac Hlth & Med Sci, Dept Neurosci & Pharmacol, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Hansen, HS (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, Copenhagen, Denmark.	hsh@sund.ku.dk		Hansen, Harald S./0000-0001-7360-7418; Diep, Thi Ai/0000-0003-2681-1090; Holst, Birgitte/0000-0001-7432-097X	Danish Ministry of Science, Technology and Innovation; Augustinus Foundation; Novo Nordisk Foundation; Novo Nordisk Fonden [NNF12OC1016214] Funding Source: researchfish	Danish Ministry of Science, Technology and Innovation; Augustinus Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was carried out as a part of the research programme of the UNIK: Food, Fitness & Pharma for Healt and Disease (see www.foodfitnesspharma.ku.dk). The UNIK programme is supported by the Danish Ministry of Science, Technology and Innovation. This project was also supported by the Augustinus Foundation, and the Novo Nordisk Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artmann A, 2008, BBA-MOL CELL BIOL L, V1781, P200, DOI 10.1016/j.bbalip.2008.01.006; Aviello G, 2008, J MOL MED, V86, P413, DOI 10.1007/s00109-008-0305-7; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Calignano A, 1998, NATURE, V394, P277, DOI 10.1038/28393; de Fonseca FR, 2001, NATURE, V414, P209, DOI 10.1038/35102582; Diep TA, 2011, FASEB J, V25, P765, DOI 10.1096/fj.10-166595; Fu J, 2003, NATURE, V425, P90, DOI 10.1038/nature01921; Fu J, 2008, AM J PHYSIOL-REG I, V295, pR45, DOI 10.1152/ajpregu.00126.2008; Gaetani S, 2003, NEUROPSYCHOPHARMACOL, V28, P1311, DOI 10.1038/sj.npp.1300166; Gillum MP, 2008, CELL, V135, P813, DOI 10.1016/j.cell.2008.10.043; Hansen HS, 2014, PHARMACOL RES, V86, P18, DOI 10.1016/j.phrs.2014.03.006; Hansen HS, 2012, TRENDS PHARMACOL SCI, V33, P374, DOI 10.1016/j.tips.2012.03.014; Hansen HS, 2010, EXP NEUROL, V224, P48, DOI 10.1016/j.expneurol.2010.03.022; Hansen HS, 2009, BIOCHEM PHARMACOL, V78, P553, DOI 10.1016/j.bcp.2009.04.024; Hansen KB, 2011, J CLIN ENDOCR METAB, V96, pE1409, DOI 10.1210/jc.2011-0647; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Iakoubov R, 2011, ENDOCRINOLOGY, V152, P1244, DOI 10.1210/en.2010-1352; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Jaggar SI, 1998, NEUROSCI LETT, V253, P123, DOI 10.1016/S0304-3940(98)00621-1; Judge MK, 2008, AM J PHYSIOL-REG I, V295, pR773, DOI 10.1152/ajpregu.00727.2007; Kleberg K, 2014, BIOFACTORS, V40, P363, DOI 10.1002/biof.1158; Langhans W, 2011, AM J PHYSIOL-REG I, V300, pR554, DOI 10.1152/ajpregu.00610.2010; Liou AP, 2011, GASTROENTEROLOGY, V140, P903, DOI 10.1053/j.gastro.2010.10.012; Madsen AN, 2010, J ENDOCRINOL, V206, P287, DOI 10.1677/JOE-10-0004; Mazzari S, 1996, EUR J PHARMACOL, V300, P227, DOI 10.1016/0014-2999(96)00015-5; Naville D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030686; Nielsen MJ, 2004, J LIPID RES, V45, P1027, DOI 10.1194/jlr.C300008-JLR200; Okamoto Y, 2004, J BIOL CHEM, V279, P5298, DOI 10.1074/jbc.M306642200; Petersen G, 2000, J LIPID RES, V41, P1532; Petersen G, 2006, BBA-MOL CELL BIOL L, V1761, P143, DOI 10.1016/j.bbalip.2005.12.011; Piomelli D, 2013, TRENDS ENDOCRIN MET, V24, P332, DOI 10.1016/j.tem.2013.03.001; Prentice AM, 1998, AM J CLIN NUTR, V67, p535S, DOI 10.1093/ajcn/67.3.535S; Rasmussen BA, 2012, TRENDS ENDOCRIN MET, V23, P49, DOI 10.1016/j.tem.2011.11.001; Rasoamanana R, 2012, P NUTR SOC, V27, P1; Reimann F, 2012, CELL METAB, V15, P421, DOI 10.1016/j.cmet.2011.12.019; ROTHWELL NJ, 1983, INT J OBESITY, V7, P263; SCHMID PC, 1986, CHEM PHYS LIPIDS, V41, P195, DOI 10.1016/0009-3084(86)90022-8; Schwartz GJ, 2008, CELL METAB, V8, P281, DOI 10.1016/j.cmet.2008.08.005; Sclafani A, 2012, AM J PHYSIOL-REG I, V302, pR1119, DOI 10.1152/ajpregu.00038.2012; Skonberg C, 2010, J LIPID RES, V51, P3062, DOI 10.1194/jlr.D004606; Solorzano C, 2009, P NATL ACAD SCI USA, V106, P20966, DOI 10.1073/pnas.0907417106; Syed SK, 2012, AM J PHYSIOL-ENDOC M, V303, pE1469, DOI 10.1152/ajpendo.00269.2012; Tellez LA, 2013, SCIENCE, V341, P800, DOI 10.1126/science.1239275; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Wellner N, 2013, BBA-MOL CELL BIOL L, V1831, P652, DOI 10.1016/j.bbalip.2012.08.019; Wellner N, 2011, BBA-MOL CELL BIOL L, V1811, P508, DOI 10.1016/j.bbalip.2011.06.020	46	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100365	10.1371/journal.pone.0100365	http://dx.doi.org/10.1371/journal.pone.0100365			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959837	Green Published, Green Submitted, gold			2022-12-27	WOS:000338633900040
J	Flores, JA; Balseiro-Gomez, S; Cabeza, JM; Acosta, J; Ramirez-Ponce, P; Ales, E				Flores, Juan A.; Balseiro-Gomez, Santiago; Cabeza, Jose M.; Acosta, Jorge; Ramirez-Ponce, Pilar; Ales, Eva			A New Role for Myosin II in Vesicle Fission	PLOS ONE			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; ADRENAL CHROMAFFIN CELLS; FUSION PORE; MAST-CELLS; COMPENSATORY ENDOCYTOSIS; NEUROENDOCRINE CELLS; ACTIN CYTOSKELETON; SECRETORY VESICLE; COATED PITS; EXOCYTOSIS	An endocytic vesicle is formed from a flat plasma membrane patch by a sequential process of invagination, bud formation and fission. The scission step requires the formation of a tubular membrane neck ( the fission pore) that connects the endocytic vesicle with the plasma membrane. Progress in vesicle fission can be measured by the formation and closure of the fission pore. Live-cell imaging and sensitive biophysical measurements have provided various glimpses into the structure and behaviour of the fission pore. In the present study, the role of non-muscle myosin II (NM-2) in vesicle fission was tested by analyzing the kinetics of the fission pore with perforated-patch clamp capacitance measurements to detect single vesicle endocytosis with millisecond time resolution in peritoneal mast cells. Blebbistatin, a specific inhibitor of NM-2, dramatically increased the duration of the fission pore and also prevented closure during large endocytic events. Using the fluorescent markers FM1-43 and pHrodo Green dextran, we found that NM-2 inhibition greatly arrested vesicle fission in a late phase of the scission event when the pore reached a final diameter of similar to 5 nm. Our results indicate that loss of the ATPase activity of myosin II drastically reduces the efficiency of membrane scission by making vesicle closure incomplete and suggest that NM-2 might be especially relevant in vesicle fission during compound endocytosis.	[Flores, Juan A.; Balseiro-Gomez, Santiago; Cabeza, Jose M.; Acosta, Jorge; Ramirez-Ponce, Pilar; Ales, Eva] Univ Seville, Fac Med, Dpto Fisiol Med & Biofis, Seville, Spain	University of Sevilla	Ales, E (corresponding author), Univ Seville, Fac Med, Dpto Fisiol Med & Biofis, Seville, Spain.	eales@us.es	Ales, Eva/E-6315-2010; Acosta-Lopez, Jorge/H-6271-2015; Ramírez-Ponce, MP/F-1788-2010	Ales, Eva/0000-0002-5536-4616; Acosta-Lopez, Jorge/0000-0003-1349-4495; Ramírez-Ponce, MP/0000-0003-0299-1269; Cabeza Fernandez, Jose Maria/0000-0002-1784-6219	Ministerio de Ciencia e Innovacion ISCIII; Fondos FEDER [PI11/00257]	Ministerio de Ciencia e Innovacion ISCIII(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); Fondos FEDER(European Commission)	This work was supported by the Ministerio de Ciencia e Innovacion ISCIII and Fondos FEDER Grant PI11/00257 (to E. A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez de Toledo G, 1993, NATURE, V363, P554; Angleson JK, 1999, NAT NEUROSCI, V2, P440, DOI 10.1038/8107; Aoki R, 2010, BIOCHEM J, V429, P497, DOI 10.1042/BJ20091839; Artalejo CR, 2002, P NATL ACAD SCI USA, V99, P6358, DOI 10.1073/pnas.082658499; Babich V, 2008, BLOOD, V111, P5282, DOI 10.1182/blood-2007-09-113746; Bananis E, 2004, MOL BIOL CELL, V15, P3688, DOI 10.1091/mbc.E04-04-0278; Benesch S, 2005, J CELL SCI, V118, P3103, DOI 10.1242/jcs.02444; Berberian K, 2009, J NEUROSCI, V29, P863, DOI 10.1523/JNEUROSCI.2818-08.2009; Bhat P, 2009, MOL BIOL CELL, V20, P1795, DOI 10.1091/mbc.E08-10-1048; BRECKENRIDGE LJ, 1987, NATURE, V328, P814, DOI 10.1038/328814a0; Brumback AC, 2004, METHODS, V33, P287, DOI 10.1016/j.ymeth.2004.01.002; Cabeza JM, 2013, J BIOL CHEM, V288, P20293, DOI 10.1074/jbc.M113.459065; Chandrasekar I, 2014, TRAFFIC; Chandrasekar I, 2013, J NEUROSCI, V33, P16131, DOI 10.1523/JNEUROSCI.2229-13.2013; Chen MH, 2013, J NEUROSCI, V33, P2071, DOI 10.1523/JNEUROSCI.3426-12.2013; Cochilla AJ, 1999, ANNU REV NEUROSCI, V22, P1, DOI 10.1146/annurev.neuro.22.1.1; Cochilla AJ, 2000, J CELL BIOL, V150, P839, DOI 10.1083/jcb.150.4.839; Debus K, 2000, BIOPHYS J, V78, P2983, DOI 10.1016/S0006-3495(00)76837-8; DETOLEDO GA, 1990, J GEN PHYSIOL, V95, P397, DOI 10.1085/jgp.95.3.397; Doreian BW, 2008, J NEUROSCI, V28, P4470, DOI 10.1523/JNEUROSCI.0008-08.2008; FAWCETT DW, 1954, J EXP MED, V100, P217, DOI 10.1084/jem.100.2.217; Fulop T, 2005, J NEUROSCI, V25, P7324, DOI 10.1523/JNEUROSCI.2042-05.2005; Galletta BJ, 2010, CURR OPIN BIOTECH, V21, P604, DOI 10.1016/j.copbio.2010.06.006; Gu C, 2010, EMBO J, V29, P3593, DOI 10.1038/emboj.2010.249; Gutierrez LM, 2012, INT REV CEL MOL BIO, V295, P109, DOI 10.1016/B978-0-12-394306-4.00009-5; Henkel AW, 2000, EMBO J, V19, P84, DOI 10.1093/emboj/19.1.84; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; Kobayashi S, 2010, AUTOPHAGY, V6, P36, DOI 10.4161/auto.6.1.10324; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; Krendel M, 2007, FEBS LETT, V581, P644, DOI 10.1016/j.febslet.2007.01.021; LINDAU M, 1988, PFLUG ARCH EUR J PHY, V411, P137, DOI 10.1007/BF00582306; Lollike K, 1999, J IMMUNOL METHODS, V232, P111, DOI 10.1016/S0022-1759(99)00169-6; Cabeza JM, 2010, TRAFFIC, V11, P1579, DOI 10.1111/j.1600-0854.2010.01120.x; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Merrifield CJ, 1999, NAT CELL BIOL, V1, P72, DOI 10.1038/9048; Merrifield CJ, 2005, MICROSC MICROANAL S2, V11, P240; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; Miserey-Lenkei S, 2010, NAT CELL BIOL, V12, P645, DOI 10.1038/ncb2067; MONCK JR, 1990, P NATL ACAD SCI USA, V87, P7804, DOI 10.1073/pnas.87.20.7804; Neco P, 2004, J BIOL CHEM, V279, P27450, DOI 10.1074/jbc.M311462200; Neco P, 2008, J BIOL CHEM, V283, P10949, DOI 10.1074/jbc.M709058200; NEHER E, 1982, P NATL ACAD SCI-BIOL, V79, P6712, DOI 10.1073/pnas.79.21.6712; Perrais D, 2004, J PHYSIOL-LONDON, V560, P413, DOI 10.1113/jphysiol.2004.064410; ROHLICH P, 1971, J CELL BIOL, V51, P465, DOI 10.1083/jcb.51.2.465; ROSENBOOM H, 1994, P NATL ACAD SCI USA, V91, P5267, DOI 10.1073/pnas.91.12.5267; SPRUCE AE, 1990, NEURON, V4, P643, DOI 10.1016/0896-6273(90)90192-I; Spudich G, 2007, NAT CELL BIOL, V9, P176, DOI 10.1038/ncb1531; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Taraska JW, 2003, P NATL ACAD SCI USA, V100, P2070, DOI 10.1073/pnas.0337526100; Taylor MJ, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001302; Wu Y, 2011, BIOCHEMISTRY-US, V50, P7493, DOI 10.1021/bi2006288; Yao LH, 2013, J NEUROSCI, V33, P15793, DOI 10.1523/JNEUROSCI.2171-13.2013; Yarar D, 2005, MOL BIOL CELL, V16, P964, DOI 10.1091/mbc.e04-09-0774; Yu HYE, 2007, MOL BIOL CELL, V18, P4096, DOI 10.1091/mbc.E06-11-0993; Yue HY, 2014, J NEUROSCI, V34, P295, DOI 10.1523/JNEUROSCI.3744-13.2014	55	14	14	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100757	10.1371/journal.pone.0100757	http://dx.doi.org/10.1371/journal.pone.0100757			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959909	gold, Green Published, Green Submitted			2022-12-27	WOS:000338633900082
J	Logez, C; Berger, S; Legros, C; Baneres, JL; Cohen, W; Delagrange, P; Nosjean, O; Boutin, JA; Ferry, G; Simonin, F; Wagner, R				Logez, Christel; Berger, Sylvie; Legros, Celine; Baneres, Jean-Louis; Cohen, William; Delagrange, Philippe; Nosjean, Olivier; Boutin, Jean A.; Ferry, Gilles; Simonin, Frederic; Wagner, Renaud			Recombinant Human Melatonin Receptor MT1 Isolated in Mixed Detergents Shows Pharmacology Similar to That in Mammalian Cell Membranes	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; MOLECULAR PHARMACOLOGY; BINDING-SITE; PURIFICATION; EXPRESSION; SOLUBILIZATION; CHOLESTEROL; STABILIZATION; ACTIVATION; LIGANDS	The human melatonin MT1 receptor-belonging to the large family of G protein-coupled receptors (GPCRs)-plays a key role in circadian rhythm regulation and is notably involved in sleep disorders and depression. Structural and functional information at the molecular level are highly desired for fine characterization of this receptor; however, adequate techniques for isolating soluble MT1 material suitable for biochemical and biophysical studies remain lacking. Here we describe the evaluation of a panel of constructs and host systems for the production of recombinant human MT1 receptors, and the screening of different conditions for their solubilization and purification. Our findings resulted in the establishment of an original strategy using a mixture of Fos14 and CHAPS detergents to extract and purify a recombinant human MT1 from Pichia pastoris membranes. This procedure enabled the recovery of relatively pure, monomeric and ligand-binding active MT1 receptor in the near-milligram range. A comparative study based on extensive ligand-binding characterization highlighted a very close correlation between the pharmacological profiles of MT1 purified from yeast and the same receptor present in mammalian cell membranes. The high quality of the purified MT1 was further confirmed by its ability to activate its cognate G alpha i protein partner when reconstituted in lipid discs, thus opening novel paths to investigate this receptor by biochemical and biophysical approaches.	[Logez, Christel; Simonin, Frederic; Wagner, Renaud] Univ Strasbourg, Inst Rech ESBS, CNRS UMR7242, Lab Excellence MEDALIS, Illkirch Graffenstaden, France; [Logez, Christel; Berger, Sylvie; Legros, Celine; Cohen, William; Nosjean, Olivier; Boutin, Jean A.; Ferry, Gilles] Inst Rech Servier, Croissy Sur Seine, France; [Baneres, Jean-Louis] Univ Montpellier I, Inst Biomol Max Mousseron, CNRS UMR 5247, Montpellier, France; [Baneres, Jean-Louis] Univ Montpellier 2, Fac Pharm, Montpellier, France; [Delagrange, Philippe] Inst Rech Servier, Unite Rech & Decouvertes Neurosci, Croissy Sur Seine, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Servier; Institut de Recherches Internationales Servier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Ecole nationale superieure de chimie de Montpellier; Universite de Montpellier; Universite de Montpellier; Servier; Institut de Recherches Internationales Servier	Boutin, JA (corresponding author), Inst Rech Servier, Croissy Sur Seine, France.	jean.boutin@fr.netgrs.com	Boutin, Jean Albert/W-9103-2019	Boutin, Jean Albert/0000-0003-0068-7204; Baneres, jean-louis/0000-0001-7078-1285; Wagner, Renaud/0000-0002-4249-9853	Servier Laboratories; French government	Servier Laboratories; French government	This work was supported by Servier Laboratories (http://www.servier.fr) and by the French government, managed by the "Agence National de la Recherche" under the "Programme d'investissement d'avenir". The present work has been published within the LABEX ANR-10-LABX-0034_Medalis. The Institut de Recherches SERVIER employed some authors in this study and so played a role in the study design, data collection and analysis, decision to publish and preparation of the manuscript.	Alkhalfioui F, 2011, PRODUCTION OF MEMBRANE PROTEINS: STRATEGIES FOR EXPRESSION AND ISOLATION, P75; Andre N, 2006, PROTEIN SCI, V15, P1115, DOI 10.1110/ps.062098206; ARENDT J, 1988, CLIN ENDOCRINOL, V29, P205, DOI 10.1111/j.1365-2265.1988.tb00263.x; Audinot V, 2003, N-S ARCH PHARMACOL, V367, P553, DOI 10.1007/s00210-003-0751-2; Audinot V, 2008, BIOCHEM PHARMACOL, V75, P2007, DOI 10.1016/j.bcp.2008.02.022; Boutin JA, 2005, TRENDS PHARMACOL SCI, V26, P412, DOI 10.1016/j.tips.2005.06.006; Boutin JA, 2000, J RECEPT SIGNAL TR R, V20, P105, DOI 10.3109/10799890009150040; Carpentieri A, 2012, PHARMACOL RES, V65, P437, DOI 10.1016/j.phrs.2012.01.003; Chattopadhyay A, 2002, MOL MEMBR BIOL, V19, P211, DOI 10.1080/09687680210149586; Chiu ML, 2008, COMB CHEM HIGH T SCR, V11, P439, DOI 10.2174/138620708784911456; Coge F, 2009, BRIT J PHARMACOL, V158, P1248, DOI 10.1111/j.1476-5381.2009.00453.x; Damian M, 2012, J BIOL CHEM, V287, P3630, DOI 10.1074/jbc.M111.288324; de Bodinat C, 2010, NAT REV DRUG DISCOV, V9, P628, DOI 10.1038/nrd3140; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; Devavry S, 2012, J PINEAL RES, V53, P29, DOI 10.1111/j.1600-079X.2011.00968.x; Devavry S, 2012, EUR J PHARMACOL, V677, P15, DOI 10.1016/j.ejphar.2011.12.009; El Moustaine D, 2012, P NATL ACAD SCI USA, V109, P16342, DOI 10.1073/pnas.1205838109; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; Hassaine G, 2006, PROTEIN EXPRES PURIF, V45, P343, DOI 10.1016/j.pep.2005.06.007; Hassaine G, 2013, BBA-BIOMEMBRANES, V1828, P2544, DOI 10.1016/j.bbamem.2013.05.028; Hino T, 2012, NATURE, V482, P237, DOI 10.1038/nature10750; Jockers R, 2008, BRIT J PHARMACOL, V154, P1182, DOI 10.1038/bjp.2008.184; KOBILKA BK, 1995, ANAL BIOCHEM, V231, P269, DOI 10.1006/abio.1995.1533; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Kozasa Tohru, 2003, V237, P21; Kunji ERS, 2008, METHODS, V46, P62, DOI 10.1016/j.ymeth.2008.10.020; Lagane B, 2000, J BIOL CHEM, V275, P33197, DOI 10.1074/jbc.C000576200; Leck KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015027; Legros C, 2014, BRIT J PHARMACOL, V171, P186, DOI 10.1111/bph.12457; Liguori L., 2008, CURR PROTOC PROTEIN, V5, P22; Lundstrom Kenneth, 2006, Journal of Structural and Functional Genomics, V7, P77, DOI 10.1007/s10969-006-9011-2; Mailliet F, 2004, BIOCHEM PHARMACOL, V67, P667, DOI 10.1016/j.bcp.2003.09.037; Marques B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000856; McDevitt CA, 2006, STRUCTURE, V14, P1623, DOI 10.1016/j.str.2006.08.014; Nosjean O, 2000, J BIOL CHEM, V275, P31311, DOI 10.1074/jbc.M005141200; O'Malley MA, 2011, BIOPHYS J, V100, pL11, DOI 10.1016/j.bpj.2010.12.3698; Oates J, 2011, CURR OPIN STRUC BIOL, V21, P802, DOI 10.1016/j.sbi.2011.09.007; Oldham WM, 2007, P NATL ACAD SCI USA, V104, P7927, DOI 10.1073/pnas.0702623104; Oldham WM, 2006, NAT STRUCT MOL BIOL, V13, P772, DOI 10.1038/nsmb1129; Opekarova M, 2003, BBA-BIOMEMBRANES, V1610, P11, DOI 10.1016/S0005-2736(02)00708-3; Pawate S, 1998, J BIOL CHEM, V273, P22753, DOI 10.1074/jbc.273.35.22753; Pozza A, 2006, CELL MOL LIFE SCI, V63, P1912, DOI 10.1007/s00018-006-6159-7; Reiter R J, 1980, Endocr Rev, V1, P109; Shimamura T, 2011, NATURE, V475, P65, DOI 10.1038/nature10236; Steyaert J, 2011, CURR OPIN STRUC BIOL, V21, P567, DOI 10.1016/j.sbi.2011.06.011; Thompson AA, 2011, METHODS, V55, P310, DOI 10.1016/j.ymeth.2011.10.011; Uchiyama M, 2011, SLEEP MED, V12, P119, DOI 10.1016/j.sleep.2010.08.010; Vernier G, 2009, PROTEIN SCI, V18, P1882, DOI 10.1002/pro.199; Vukoti K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046290; Wang XQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023076; Weis WI, 2008, CURR OPIN STRUC BIOL, V18, P734, DOI 10.1016/j.sbi.2008.09.010; Yan JH, 2008, ACTA PHARMACOL SIN, V29, P1515, DOI 10.1111/j.1745-7254.2008.00903.x	52	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100616	10.1371/journal.pone.0100616	http://dx.doi.org/10.1371/journal.pone.0100616			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959712	Green Published, Green Submitted, gold			2022-12-27	WOS:000338633900062
J	Maganga, GD; Bourgarel, M; Vallo, P; Dallo, TD; Ngoagouni, C; Drexler, JF; Drosten, C; Nakoune, ER; Leroy, EM; Morand, S				Maganga, Gael D.; Bourgarel, Mathieu; Vallo, Peter; Dallo, Thierno D.; Ngoagouni, Carine; Drexler, Jan Felix; Drosten, Christian; Nakoune, Emmanuel R.; Leroy, Eric M.; Morand, Serge			Bat Distribution Size or Shape as Determinant of Viral Richness in African Bats	PLOS ONE			English	Article							SPECIES RICHNESS; FRUIT BAT; ROUSETTUS-AEGYPTIACUS; MOLECULAR PHYLOGENY; GEOGRAPHICAL RANGE; NEOTROPICAL BATS; RESERVOIR HOSTS; WILD MAMMALS; VIRUS; CORONAVIRUSES	The rising incidence of emerging infectious diseases (EID) is mostly linked to biodiversity loss, changes in habitat use and increasing habitat fragmentation. Bats are linked to a growing number of EID but few studies have explored the factors of viral richness in bats. These may have implications for role of bats as potential reservoirs. We investigated the determinants of viral richness in 15 species of African bats (8 Pteropodidae and 7 microchiroptera) in Central and West Africa for which we provide new information on virus infection and bat phylogeny. We performed the first comparative analysis testing the correlation of the fragmented geographical distribution (defined as the perimeter to area ratio) with viral richness in bats. Because of their potential effect, sampling effort, host body weight, ecological and behavioural traits such as roosting behaviour, migration and geographical range, were included into the analysis as variables. The results showed that the geographical distribution size, shape and host body weight have significant effects on viral richness in bats. Viral richness was higher in large-bodied bats which had larger and more fragmented distribution areas. Accumulation of viruses may be related to the historical expansion and contraction of bat species distribution range, with potentially strong effects of distribution edges on virus transmission. Two potential explanations may explain these results. A positive distribution edge effect on the abundance or distribution of some bat species could have facilitated host switches. Alternatively, parasitism could play a direct role in shaping the distribution range of hosts through host local extinction by virulent parasites. This study highlights the importance of considering the fragmentation of bat species geographical distribution in order to understand their role in the circulation of viruses in Africa.	[Maganga, Gael D.; Bourgarel, Mathieu; Leroy, Eric M.] Ctr Int Rech Med Franceville, Franceville, Gabon; [Maganga, Gael D.] Inst Natl Super Agron & Biotechnol, Franceville, Gabon; [Bourgarel, Mathieu; Morand, Serge] CIRAD, UPR AGIRs, Montpellier, France; [Bourgarel, Mathieu] CIRAD, UPR AGIRs, Harare, Zimbabwe; [Vallo, Peter] Acad Sci Czech Republ, Inst Vertebrate Biol, Brno, Czech Republic; [Vallo, Peter] Univ Ulm, Inst Expt Ecol, D-89069 Ulm, Germany; [Dallo, Thierno D.; Drexler, Jan Felix; Drosten, Christian] Univ Bonn, Med Ctr, Inst Virol, Bonn, Germany; [Ngoagouni, Carine; Nakoune, Emmanuel R.] Inst Pasteur, Bangui, Cent Afr Republ; [Leroy, Eric M.] Inst Rech Dev, UMR MIVEGEC 224, IRD CNRS UM1, Montpellier, France; [Morand, Serge] Univ Montpellier 2, CNRS UM2, CC065, Inst Sci Evolut, Montpellier, France; [Morand, Serge] Ctr Infectiol Christophe Merieux Laos, Viangchan, Laos	CIRAD; CIRAD; Czech Academy of Sciences; Institute of Vertebrate Biology of the Czech Academy of Sciences; Ulm University; University of Bonn; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Bourgarel, M (corresponding author), Ctr Int Rech Med Franceville, BP 769, Franceville, Gabon.	mathieu.bourgarel@cirad.fr	Vallo, Peter/F-9650-2014; Nakoune, Emmanuel/W-2710-2019; Drexler, Jan Felix/GMW-5098-2022; Morand, Serge/M-5433-2018; LEROY, Eric M/I-4347-2016; Bourgarel, Mathieu/F-1750-2017	Morand, Serge/0000-0003-3986-7659; LEROY, Eric M/0000-0003-0022-0890; Bourgarel, Mathieu/0000-0001-9774-7669; Drexler, Jan Felix/0000-0002-3509-0232	Global Viral Forecasting, a "Fonds de Solidarite Prioritaire" grant from the Ministere des Affaires Etrangeres de la France (FSP); government of Gabon; Total-Fina-Elf Gabon; Ministere des Affaires Etrangeres de la France; BONFOR intramural program at the University of Bonn;  [2002005700]	Global Viral Forecasting, a "Fonds de Solidarite Prioritaire" grant from the Ministere des Affaires Etrangeres de la France (FSP); government of Gabon; Total-Fina-Elf Gabon; Ministere des Affaires Etrangeres de la France; BONFOR intramural program at the University of Bonn; 	This work was supported by Global Viral Forecasting, a "Fonds de Solidarite Prioritaire'' grant from the Ministere des Affaires Etrangeres de la France (FSP no 2002005700). CIRMF is supported by the government of Gabon, Total-Fina-Elf Gabon, and the Ministere des Affaires Etrangeres de la France. T.D. Dallo received a personal scholarship from the BONFOR intramural program at the University of Bonn. This study was also made possible by the generous support of the American people through the United States Agency for International Development (USAID) Emerging Pandemic Threats PREDICT. The contents are the responsibility of the authors and do not necessarily reflect the views of USAID or the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida FC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-281; BICKHAM JW, 1995, J HERED, V86, P140, DOI 10.1093/oxfordjournals.jhered.a111544; Bickham JW, 2004, MOL PHYLOGENET EVOL, V33, P333, DOI 10.1016/j.ympev.2004.06.012; Bordes F, 2008, OECOLOGIA, V158, P109, DOI 10.1007/s00442-008-1115-x; Bordes Frederic, 2011, Infect Ecol Epidemiol, V1, DOI 10.3402/iee.v1i0.7346; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Canuti M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029140; Crochu S, 2004, J GEN VIROL, V85, P1971, DOI 10.1099/vir.0.79850-0; CWYNAR LC, 1987, AM NAT, V129, P463, DOI 10.1086/284651; Luna LKD, 2007, J CLIN MICROBIOL, V45, P1049, DOI 10.1128/JCM.02426-06; Dobson AP, 2005, SCIENCE, V310, P628, DOI 10.1126/science.1120872; Drexler JF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1796; Drexler JF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006367; Dzikwi AA, 2010, J WILDLIFE DIS, V46, P267, DOI 10.7589/0090-3558-46.1.267; Esona MD, 2010, EMERG INFECT DIS, V16, P1844, DOI 10.3201/eid1612.101089; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fortin MJ, 2005, OIKOS, V108, P7, DOI 10.1111/j.0030-1299.2005.13146.x; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503; Gaston KJ, 1998, PHILOS T R SOC B, V353, P219, DOI 10.1098/rstb.1998.0204; Guegan JF, 1996, PARASITOL TODAY, V12, P367, DOI 10.1016/0169-4758(96)10054-5; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hayman DTS, 2012, EPIDEMIOL INFECT, V140, P2163, DOI 10.1017/S0950268812000167; Hayman DTS, 2008, EMERG INFECT DIS, V14, P926, DOI 10.3201/eid1406.071421; Hayman DTS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011978; Hayman DTS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002739; Hochberg ME, 1999, ECOGRAPHY, V22, P268, DOI 10.1111/j.1600-0587.1999.tb00502.x; Holt RD, 2003, EVOL ECOL RES, V5, P159; IRWIN DM, 1991, J MOL EVOL, V32, P128, DOI 10.1007/BF02515385; IUCN, 2012, IUCN RED LIST THREAT; Janoska M, 2011, VET J, V189, P118, DOI 10.1016/j.tvjl.2010.06.020; KALUNDA M, 1986, AM J TROP MED HYG, V35, P387, DOI 10.4269/ajtmh.1986.35.387; Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; KEMP GE, 1988, B SOC PATHOL EXOT, V81, P40; KEMP GE, 1975, B WORLD HEALTH ORGAN, V52, P615; Konstantinov O. K., 2006, Meditsinskaya Parazitologiya i Parazitarnye Bolezni, P34; Kunz T.H., 2009, ECOLOGICAL BEHAV MET; Kuzmin IV, 2008, J CLIN MICROBIOL, V46, P1451, DOI 10.1128/JCM.00016-08; Kuzmin IV, 2010, EMERG INFECT DIS, V16, P352, DOI 10.3201/eid1602.091269; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Lindenfors P, 2007, GLOBAL ECOL BIOGEOGR, V16, P496, DOI 10.1111/j.1466-8238.2006.00301.x; Luis AD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2753; Maganga GD, 2011, J INFECT DIS, V204, pS800, DOI 10.1093/infdis/jir358; Markotter W, 2008, VIRUS RES, V135, P10, DOI 10.1016/j.virusres.2008.02.001; Memish ZA, 2013, EMERG INFECT DIS, V19, P1819, DOI 10.3201/eid1911.131172; Messenger SL, 2003, BAT ECOLOGY, P622; Moureau G, 2007, VECTOR-BORNE ZOONOT, V7, P467, DOI 10.1089/vbz.2007.0206; Muller MA, 2007, EMERG INFECT DIS, V13, P1367, DOI 10.3201/eid1309.070342; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Patterson BD, 2008, PARASITOL RES, V103, P1091, DOI 10.1007/s00436-008-1097-y; Pfefferle S, 2009, EMERG INFECT DIS, V15, P1377, DOI 10.3201/eid1509.090224; Pourrut X, 2007, J INFECT DIS, V196, pS176, DOI 10.1086/520541; Pourrut X, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-159; Quan PL, 2010, MBIO, V1, DOI 10.1128/mBio.00208-10; Razafindratsimandresy R, 2009, J GEN VIROL, V90, P44, DOI 10.1099/vir.0.006825-0; Rector A, 2006, VET MICROBIOL, V117, P267, DOI 10.1016/j.vetmic.2006.06.010; Sakai T, 2003, GENES GENET SYST, V78, P179; Streicker DG, 2010, SCIENCE, V329, P676, DOI 10.1126/science.1188836; Swanepoel R, 2007, EMERG INFECT DIS, V13, P1847, DOI 10.3201/eid1312.071115; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; Tong SX, 2009, EMERG INFECT DIS, V15, P482, DOI 10.3201/eid1503.081013; Torres J, 2006, BIODIVERS CONSERV, V15, P4619, DOI 10.1007/s10531-005-5824-8; Towner JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000764; Towner JS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000536; Turmelle AS, 2009, ECOHEALTH, V6, P522, DOI 10.1007/s10393-009-0263-8; Wang LF, 2006, EMERG INFECT DIS, V12, P1834; Wong S, 2007, REV MED VIROL, V17, P67, DOI 10.1002/rmv.520; Wright E, 2010, VIROLOGY, V408, P183, DOI 10.1016/j.virol.2010.09.014	69	26	27	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100172	10.1371/journal.pone.0100172	http://dx.doi.org/10.1371/journal.pone.0100172			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959855	Green Published, gold			2022-12-27	WOS:000338633900024
J	Lai, WF; Jung, HS				Lai, Wing-Fu; Jung, Han-Sung			Cell Transfection with a beta-Cyclodextrin-PEI-Propane1,2,3-Triol Nanopolymer	PLOS ONE			English	Article							CHITOSAN-GRAFT-POLYETHYLENIMINE; NONVIRAL GENE DELIVERY; NUCLEIC-ACID DELIVERY; LOW-MOLECULAR-WEIGHT; BETA-CYCLODEXTRIN; IN-VITRO; BRANCHED POLYETHYLENIMINE; ABSORPTION ENHANCER; DERIVATIVES; VECTOR	Successful gene therapy necessitates safe and efficient gene transfer. This article describes the use of a cationic polymer, which was synthesized by cross-linking low molecular weight branched poly(ethylenimine) (PEI) with both beta-cyclodextrin and propane-1,2,3-triol, for efficient and safe non-viral gene delivery. Experimentation demonstrated that the polymer had a pH buffering capacity and DNA condensing ability comparable to those of PEI 25 kDa. In B16-F0 cells, the polymer increased the transfection efficiency of naked DNA by 700-fold and yielded better transfection efficiencies than Fugene HD (threefold higher) and PEI 25 kDa (fivefold higher). The high transfection efficiency of the polymer was not affected by the presence of serum during transfection. In addition to B16-F0 cells, the polymer enabled efficient transfection of HepG2 and U87 cells with low cytotoxicity. Our results indicated that our polymer is a safe and efficient transfection reagent that warrants further development for in vitro, in vivo and clinical applications.	[Lai, Wing-Fu; Jung, Han-Sung] Yonsei Univ, PLUS Project BK21, Div Anat & Dev Biol, Dept Oral Biol,Oral Sci Res Ctr,Coll Dent, Seoul 120749, South Korea; [Jung, Han-Sung] Univ Hong Kong, Fac Dent, Hong Kong, Hong Kong, Peoples R China	Yonsei University; Yonsei University Health System; University of Hong Kong	Jung, HS (corresponding author), Yonsei Univ, PLUS Project BK21, Div Anat & Dev Biol, Dept Oral Biol,Oral Sci Res Ctr,Coll Dent, Seoul 120749, South Korea.	hsjung@yuhs.ac	Lai, Wing-Fu/J-3170-2015; Jung, Han-Sung/I-3848-2012	Lai, Wing-Fu/0000-0003-0585-6396; Jung, Han-Sung/0000-0003-2795-531X	National Research Foundation of Korea (NRF) of the Ministry of Education, Science and Technology (MEST), Republic of Korea [2012M3A9B4028738]	National Research Foundation of Korea (NRF) of the Ministry of Education, Science and Technology (MEST), Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea)	This work was supported by a grant for the Bio and Medical Technology Development Program (2012M3A9B4028738) funded by the National Research Foundation of Korea (NRF) of the Ministry of Education, Science and Technology (MEST), Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner A, 2002, GENE THER, V9, P1700, DOI 10.1038/sj.gt.3301839; Bandyopadhyay P, 1999, J BIOL CHEM, V274, P10163, DOI 10.1074/jbc.274.15.10163; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Creusat G, 2008, CHEMBIOCHEM, V9, P2787, DOI 10.1002/cbic.200800540; Diaz-Alvarez AE, 2011, CHEM COMMUN, V47, P6208, DOI 10.1039/c1cc10620a; Dong W, 2006, ACTA BIOCH BIOPH SIN, V38, P780, DOI 10.1111/j.1745-7270.2006.00220.x; Fischer D, 1999, PHARMACEUT RES, V16, P1273, DOI 10.1023/A:1014861900478; FORMOSO C, 1973, BIOCHEM BIOPH RES CO, V50, P999, DOI 10.1016/0006-291X(73)91505-2; Forrest ML, 2005, BIOTECHNOL BIOENG, V89, P416, DOI 10.1002/bit.20356; Godbey WT, 1999, J BIOMED MATER RES, V45, P268, DOI 10.1002/(SICI)1097-4636(19990605)45:3<268::AID-JBM15>3.0.CO;2-Q; Gosselin MA, 2001, BIOCONJUGATE CHEM, V12, P989, DOI 10.1021/bc0100455; Grosse S, 2008, J CONTROL RELEASE, V132, P105, DOI 10.1016/j.jconrel.2008.08.018; Hwang SJ, 2001, BIOCONJUGATE CHEM, V12, P280, DOI 10.1021/bc0001084; Jiang HL, 2007, GENE THER, V14, P1389, DOI 10.1038/sj.gt.3302997; Jiang HL, 2007, J CONTROL RELEASE, V117, P273, DOI 10.1016/j.jconrel.2006.10.025; Lai WF, 2011, RECENT PAT NANOMED, V1, P7; Lai WF, 2010, J MAT SCI ENG, V4, P34; Lai WF, 2014, BIOMATERIALS, V35, P401, DOI 10.1016/j.biomaterials.2013.09.061; Lai WF, 2011, EXPERT REV MED DEVIC, V8, P173, DOI [10.1586/erd.10.83, 10.1586/ERD.10.83]; Lai WF, 2009, J CONTROL RELEASE, V134, P158, DOI 10.1016/j.jconrel.2008.11.021; LEE RJ, 1995, BBA-BIOMEMBRANES, V1233, P134, DOI 10.1016/0005-2736(94)00235-H; Li S, 1999, GENE THER, V6, P585, DOI 10.1038/sj.gt.3300865; Liu Y, 2009, POLYMER, V50, P3895, DOI 10.1016/j.polymer.2009.06.043; Martins PS, 2006, INT J PHARM, V325, P39, DOI 10.1016/j.ijpharm.2006.06.014; Neu M, 2005, J GENE MED, V7, P992, DOI 10.1002/jgm.773; Ng SSM, 2007, J NATL CANCER I, V99, P936, DOI 10.1093/jnci/djm011; Pun SH, 2004, BIOCONJUGATE CHEM, V15, P831, DOI 10.1021/bc049891g; Rashidzadeh H, 1998, ANAL CHEM, V70, P131, DOI 10.1021/ac970568z; Redenti E, 2001, ADV DRUG DELIVER REV, V53, P235, DOI 10.1016/S0169-409X(01)00230-7; SCHIPPER NGM, 1993, BRIT J PHARMACOL, V110, P1335, DOI 10.1111/j.1476-5381.1993.tb13965.x; Yang CA, 2007, BIOMATERIALS, V28, P3245, DOI 10.1016/j.biomaterials.2007.03.033; Yao H, 2009, BIOMATERIALS, V30, P5793, DOI 10.1016/j.biomaterials.2009.06.051; Zou SM, 2000, J GENE MED, V2, P128, DOI 10.1002/(SICI)1521-2254(200003/04)2:2<128::AID-JGM95>3.0.CO;2-W	33	15	16	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100258	10.1371/journal.pone.0100258	http://dx.doi.org/10.1371/journal.pone.0100258			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956480	gold, Green Submitted, Green Published			2022-12-27	WOS:000338917900036
J	Bank, S; Andersen, PS; Burisch, J; Pedersen, N; Roug, S; Galsgaard, J; Turino, SY; Brodersen, JB; Rashid, S; Rasmussen, BK; Avlund, S; Olesen, TB; Hoffmann, HJ; Thomsen, MK; Thomsen, VO; Frydenberg, M; Nexo, BA; Sode, J; Vogel, U; Andersen, V				Bank, Steffen; Andersen, Paal Skytt; Burisch, Johan; Pedersen, Natalia; Roug, Stine; Galsgaard, Julie; Turino, Stine Ydegaard; Brodersen, Jacob Broder; Rashid, Shaista; Rasmussen, Britt Kaiser; Avlund, Sara; Olesen, Thomas Bastholm; Hoffmann, Hans Jurgen; Thomsen, Marianne Kragh; Thomsen, Vibeke Ostergaard; Frydenberg, Morten; Nexo, Bjorn Andersen; Sode, Jacob; Vogel, Ulla; Andersen, Vibeke			Polymorphisms in the Inflammatory Pathway Genes TLR2, TLR4, TLR9, LY96, NFKBIA, NFKB1, TNFA, TNFRSF1A, IL6R, IL10, IL23R, PTPN22, and PPARG Are Associated with Susceptibility of Inflammatory Bowel Disease in a Danish Cohort	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; TOLL-LIKE RECEPTORS; COLITIS RISK LOCI; CROHNS-DISEASE; ULCERATIVE-COLITIS; PROMOTER; EXPRESSION; GAMMA	Background: The inflammatory bowel diseases (IBD), Crohn's disease (CD) and ulcerative colitis (UC), result from the combined effects of susceptibility genes and environmental factors. Polymorphisms in genes regulating inflammation may explain part of the genetic heritage. Methods: Using a candidate gene approach, 39 mainly functional single nucleotide polymorphisms (SNPs) in 26 genes regulating inflammation were assessed in a clinical homogeneous group of severely diseased patients consisting of 624 patients with CD, 411 patients with UC and 795 controls. The results were analysed using logistic regression. Results: Sixteen polymorphisms in 13 genes involved in regulation of inflammation were associated with risk of CD and/or UC (p <= 0.05). The polymorphisms TLR2 (rs1816702), NFKB1 (rs28362491), TNFRSF1A (rs4149570), IL6R (rs4537545), IL23R (rs11209026) and PTPN22 (rs2476601) were associated with risk of CD and the polymorphisms TLR2 (rs1816702), TLR4 (rs1554973 and rs12377632), TLR9 (rs352139), LY96 (rs11465996), NFKBIA (rs696), TNFA (rs1800629), TNFRSF1A (rs4149570), IL10 (rs3024505), IL23R (rs11209026), PTPN22 (rs2476601) and PPARG (rs1801282) were associated with risk of UC. When including all patients (IBD) the polymorphisms TLR2 (rs4696480 and rs1816702), TLR4 (rs1554973 and rs12377632), TLR9 (rs187084), TNFRSF1A (rs4149570), IL6R (rs4537545), IL10 (rs3024505), IL23R (rs11209026) and PTPN22 (rs2476601) were associated with risk. After Bonferroni correction for multiple testing, both the homozygous and the heterozygous variant genotypes of IL23R G>A(rs11209026) (ORCD,adj: 0.38, 95% CI: 0.21-0.67, p = 0.03; ORIBD,adj 0.43, 95% CI: 0.28-0.67, p = 0.007) and PTPN22 1858 G>A(rs2476601) (ORCD,unadj 0.54, 95% CI: 0.41-0.72, p = 7*10(-4); ORIBD,unadj: 0.61, 95% CI: 0.48-0.77, p = 0.001) were associated with reduced risk of CD. Conclusion: The biological effects of the studied polymorphisms suggest that genetically determined high inflammatory response was associated with increased risk of CD. The many SNPs found in TLRs suggest that the host microbial composition or environmental factors in the gut are involved in risk of IBD in genetically susceptible individuals.	[Bank, Steffen; Andersen, Vibeke] Viborg Reg Hosp, Dept Med, Viborg, Denmark; [Bank, Steffen; Nexo, Bjorn Andersen] Univ Aarhus, Aarhus, Denmark; [Andersen, Paal Skytt; Sode, Jacob] Statens Serum Inst, DK-2300 Copenhagen, Denmark; [Burisch, Johan; Pedersen, Natalia] Herlev Hosp, Dept Gastroenterol, DK-2730 Herlev, Denmark; [Roug, Stine] Hvidovre Univ Hosp, Dept Gastroenterol, Hvidovre, Denmark; [Galsgaard, Julie] Koge Hosp, Dept Med, Koge, Denmark; [Turino, Stine Ydegaard] Hillerod Hosp, Dept Med, Hillerod, Denmark; [Brodersen, Jacob Broder] Sydvestjysk Hosp, Dept Med, Esbjerg, Denmark; [Rashid, Shaista] Bispebjerg Hosp, Dept Med, Bispebjerg, Denmark; [Rasmussen, Britt Kaiser] Nykobing Falster Hosp, Dept Med, Nykobing, Denmark; [Avlund, Sara] Aarhus Univ Hosp, Dept Med 5, DK-8000 Aarhus, Denmark; [Olesen, Thomas Bastholm] Slagelse Hosp, Dept Med, Slagelse, Denmark; [Hoffmann, Hans Jurgen] Aarhus Univ Hosp, Inst Clin Med, Dept Resp Dis B, DK-8000 Aarhus, Denmark; [Thomsen, Marianne Kragh] Aarhus Univ Hosp, Dept Clin Microbiol, DK-8000 Aarhus, Denmark; [Thomsen, Vibeke Ostergaard] Statens Serum Inst, Int Reference Lab Mycobacteriol, DK-2300 Copenhagen, Denmark; [Frydenberg, Morten] Aarhus Univ, Dept Publ Hlth, Biostat Sect, Aarhus, Denmark; [Nexo, Bjorn Andersen; Andersen, Vibeke] Univ Southern Denmark, Inst Reg Hlth Res, Odense, Denmark; [Sode, Jacob] Frederiksberg Univ Hosp, Dept Rheumatol, Frederiksberg, Denmark; [Vogel, Ulla] Natl Res Ctr Working Environm, Copenhagen, Denmark; [Andersen, Vibeke] Hosp Southern Jutland Aabenraa, Organ Ctr, Aabenraa, Denmark; [Andersen, Vibeke] Odense Univ Hosp, OPEN Odense Patient data Explorat Network, DK-5000 Odense, Denmark	Aarhus University; Aarhus University; Statens Serum Institut; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; Aarhus University; Aarhus University; Aarhus University; Statens Serum Institut; Aarhus University; University of Southern Denmark; National Research Centre for the Working Environment; University of Southern Denmark; Odense University Hospital	Bank, S (corresponding author), Viborg Reg Hosp, Dept Med, Viborg, Denmark.	stb@mb.au.dk	Sode, Jacob/AAD-9615-2020; Olesen, Thomas/AFS-2588-2022; Vogel, Ulla/ABC-2212-2020; Vogel, Ulla B/I-5048-2012; Thomsen, Vibeke Østergaard/H-9370-2013; Burisch, Johan/AGJ-3893-2022; Andersen, Paal S/H-2087-2015; Hoffman, Hans Jurgen/I-6969-2018; Andersen, Vibeke/I-7932-2012; Thomsen, Marianne Kragh/AAJ-5115-2020	Sode, Jacob/0000-0002-2718-9320; Olesen, Thomas/0000-0003-1464-7342; Vogel, Ulla/0000-0001-6807-1524; Vogel, Ulla B/0000-0001-6807-1524; Burisch, Johan/0000-0002-3312-5139; Andersen, Paal S/0000-0001-5656-0427; Hoffman, Hans Jurgen/0000-0002-6743-7931; Andersen, Vibeke/0000-0002-0127-2863; Brodersen, Jacob Broder/0000-0003-2530-7554; Thomsen, Marianne Kragh/0000-0002-3645-6689; Thomsen, Vibeke Ostergaard/0000-0002-1653-6294	Health Research Fund of Central Denmark Region; Colitis-Crohn Foreningen; University of Aarhus	Health Research Fund of Central Denmark Region; Colitis-Crohn Foreningen; University of Aarhus	The work was funded by Health Research Fund of Central Denmark Region, Colitis-Crohn Foreningen and University of Aarhus (PhD grant). VA receives compensation as a consultant for Merck & Co., Inc. (MSD) and Janssen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahirwar Dinesh K, 2012, J Gastrointest Cancer, V43, P196, DOI 10.1007/s12029-010-9238-9; Andersen V, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-139; Andersen V, 2011, INFLAMM BOWEL DIS, V17, P937, DOI 10.1002/ibd.21440; Andersen V, 2011, WORLD J GASTROENTERO, V17, P197, DOI 10.3748/wjg.v17.i2.197; Andersen V, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-82; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Aoyagi Y, 2010, PEDIATR INT, V52, P729, DOI 10.1111/j.1442-200X.2010.03195.x; Baldini M, 1999, AM J RESP CELL MOL, V20, P976, DOI 10.1165/ajrcmb.20.5.3494; Bank S, 2013, GENET TEST MOL BIOMA, V17, P501, DOI 10.1089/gtmb.2012.0429; Bielinski SJ, 2011, HUM GENET, V129, P655, DOI 10.1007/s00439-011-0962-4; Cario E, 2010, INFLAMM BOWEL DIS, V16, P1583, DOI 10.1002/ibd.21282; Carrol ED, 2011, J IMMUNOL, V186, P2329, DOI 10.4049/jimmunol.1002402; Chen HM, 2006, HUM MOL GENET, V15, P519, DOI 10.1093/hmg/ddi469; Ellinghaus D, 2013, GASTROENTEROLOGY, V145, P339, DOI 10.1053/j.gastro.2013.04.040; Elsby LM, 2010, CLIN EXP RHEUMATOL, V28, P708; Ernst A, 2007, SCAND J GASTROENTERO, V42, P1445, DOI 10.1080/00365520701427102; Ernst A, 2011, EUR J GASTROEN HEPAT, V23, P269, DOI 10.1097/MEG.0b013e3283438a44; Espinoza JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026229; Ferguson LR, 2008, WORLD J GASTROENTERO, V14, P4652, DOI 10.3748/wjg.14.4652; Ferguson LR, 2009, GASTROENT RES PRACT, V2009, DOI 10.1155/2009/591704; Fowler EV, 2008, AM J GASTROENTEROL, V103, P2519, DOI 10.1111/j.1572-0241.2008.02023.x; Franke A, 2008, NAT GENET, V40, P1319, DOI 10.1038/ng.221; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gast A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024370; Gewirtz AT, 2006, AM J PHYSIOL-GASTR L, V290, pG1157, DOI 10.1152/ajpgi.00544.2005; Glas J, 2008, FUNCTIONAL TOLL LIKE, V46, P41; Gu W, 2007, ANN SURG, V246, P151, DOI 10.1097/01.sla.0000262788.67171.3f; Guo DH, 2004, NAT GENET, V36, P837, DOI 10.1038/ng1391; Hawn TR, 2003, J EXP MED, V198, P1563, DOI 10.1084/jem.20031220; Hitomi Y, 2009, J ALLERGY CLIN IMMUN, V124, P779, DOI 10.1016/j.jaci.2009.07.044; Hong JW, 2007, J GASTROEN HEPATOL, V22, P1666, DOI 10.1111/j.1440-1746.2007.05020.x; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kaluza W, 2000, J INVEST DERMATOL, V114, P1180, DOI 10.1046/j.1523-1747.2000.00001.x; Karimi M, 2009, EUR J HUM GENET, V17, P1454, DOI 10.1038/ejhg.2009.80; Kariuki SN, 2008, ARTHRITIS RHEUM, V58, P2818, DOI 10.1002/art.23728; Kim EJ, 2012, J KOREAN MED SCI, V27, P72, DOI [10.3346/jkms.2011.27.1.72, 10.3346/jkms.2012.27.1.72]; Klein W, 2004, INT J COLORECTAL DIS, V19, P153, DOI 10.1007/s00384-003-0531-y; Lind H, 2007, CYTOKINE, V38, P43, DOI 10.1016/j.cyto.2007.05.001; Lv K, 2006, SCAND J IMMUNOL, V64, P164, DOI 10.1111/j.1365-3083.2006.01786.x; Mertens J, 2009, J MOL MED, V87, P815, DOI 10.1007/s00109-009-0479-7; Muise AM, 2011, GASTROENTEROLOGY, V141, P633, DOI 10.1053/j.gastro.2011.04.057; Oosting M, 2011, INFECT IMMUN, V79, P4681, DOI 10.1128/IAI.05242-11; Ostergaard M, 2009, SCAND J GASTROENTERO, V44, P65, DOI 10.1080/00365520802400826; Park JY, 2007, AM J PHYSIOL-HEART C, V293, pH2320, DOI 10.1152/ajpheart.00186.2007; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Poliska S, 2012, INFLAMM BOWEL DIS, V18, P472, DOI 10.1002/ibd.21798; Pravica V, 2000, HUM IMMUNOL, V61, P863, DOI 10.1016/S0198-8859(00)00167-1; Rafiq S, 2007, GENES IMMUN, V8, P552, DOI 10.1038/sj.gene.6364414; Rafiq S, 2007, GENES IMMUN, V8, P344, DOI 10.1038/sj.gene.6364393; Rees LEN, 2002, CELL MOL LIFE SCI, V59, P560, DOI 10.1007/s00018-002-8448-0; Sashio H, 2002, IMMUNOGENETICS, V53, P1020, DOI 10.1007/s00251-001-0423-7; Shah R, 2006, HUM GENET, V120, P461, DOI 10.1007/s00439-006-0194-1; Skieceviciene J, 2013, INFLAMM BOWEL DIS, V19, P2349, DOI 10.1097/MIB.0b013e3182a3eaeb; Smith AJP, 2008, CLIN CHEM, V54, P841, DOI 10.1373/clinchem.2007.098608; Song SX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021726; Szamosi T, 2009, DIGEST DIS SCI, V54, P351, DOI 10.1007/s10620-008-0351-6; Tao K, 2007, ANN RHEUM DIS, V66, P905, DOI 10.1136/ard.2006.065961; Thair SA, 2011, J IMMUNOL, V186, P2321, DOI 10.4049/jimmunol.1002864; Udalova IA, 2000, MOL CELL BIOL, V20, P9113, DOI 10.1128/MCB.20.24.9113-9119.2000; Verstrepen L, 2008, CELL MOL LIFE SCI, V65, P2964, DOI 10.1007/s00018-008-8064-8; Vogel U, 2011, ATHEROSCLEROSIS, V219, P200, DOI 10.1016/j.atherosclerosis.2011.06.018; Wallis SK, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3239; Wang GB, 2011, HUM IMMUNOL, V72, P451, DOI 10.1016/j.humimm.2011.02.004; Wang SY, 2011, LIFE SCI, V88, P792, DOI 10.1016/j.lfs.2011.02.016; Wen AQ, 2010, SHOCK, V33, P576, DOI 10.1097/SHK.0b013e3181cc0a8e; Yoshida M, 2012, SCHIZOPHR RES, V140, P185, DOI 10.1016/j.schres.2012.06.031; Zhang F, 2013, INFECTION, V41, P941, DOI 10.1007/s15010-013-0444-9; Zou YF, 2011, TISSUE ANTIGENS, V77, P9, DOI 10.1111/j.1399-0039.2010.01559.x	68	85	89	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e98815	10.1371/journal.pone.0098815	http://dx.doi.org/10.1371/journal.pone.0098815			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971461	gold, Green Published, Green Submitted			2022-12-27	WOS:000338512200006
J	Bedford, KJA; Sharkey, AB				Bedford, K. Juliet A.; Sharkey, Alyssa B.			Local Barriers and Solutions to Improve Care-Seeking for Childhood Pneumonia, Diarrhoea and Malaria in Kenya, Nigeria and Niger: A Qualitative Study	PLOS ONE			English	Article							HEALTH-CARE; NEWBORN BABIES; SOUTH-AFRICA; BEHAVIOR; ILLNESSES; CHILDREN; INTERVENTIONS; NUTRITION; COMMUNITY; FRAMEWORK	We present qualitative research findings on care-seeking and treatment uptake for pneumonia, diarrhoea and malaria among children under 5 in Kenya, Nigeria and Niger. The study aimed to determine the barriers caregivers face in accessing treatment for these conditions; to identify local solutions that facilitate more timely access to treatment; and to present these findings as a platform from which to develop context-specific strategies to improve care-seeking for childhood illness. Kenya, Nigeria and Niger are three high burden countries with low rates of related treatment coverage, particularly in underserved areas. Data were collected in Homa Bay County in Nyanza Province, Kenya; in Kebbi and Cross River States, Nigeria; and in the Maradi and Tillaberi regions of Niger. Primary caregivers of children under 5 who did not regularly engage with health services or present their child at a health facility during illness episodes were purposively selected for interview. Data underwent rigorous thematic analysis. We organise the identified barriers and related solutions by theme: financial barriers; distance/location of health facilities; socio-cultural barriers and gender dynamics; knowledge and information barriers; and health facility deterrents. The relative importance of each differed by locality. Participant suggested solutions ranged from community-level actions to facility-level and more policy-oriented actions, plus actions to change underlying problems such as social perceptions and practices and gender dynamics. We discuss the feasibility and implications of these suggested solutions. Given the high burden of childhood morbidity and mortality due to pneumonia, diarrhoea and malaria in Kenya, Nigeria and Niger, this study provides important insights relating to demand-side barriers and locally proposed solutions. Significant advancements are possible when communities participate in both problem identification and resolution, and are engaged as important partners in improving child health and survival.	[Bedford, K. Juliet A.] Anthrologica, Oxford, England; [Bedford, K. Juliet A.] Univ Oxford, Sch Anthropol, Oxford, England; [Sharkey, Alyssa B.] Program Div United Nations Childrens Fund UNICEF, Hlth Sect, Knowledge Management & Implementat Res Unit, New York, NY USA	University of Oxford; UNICEF	Sharkey, AB (corresponding author), Program Div United Nations Childrens Fund UNICEF, Hlth Sect, Knowledge Management & Implementat Res Unit, New York, NY USA.	asharkey@unicef.org			Bill and Melinda Gates Foundation; Rockefeller Foundation	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Rockefeller Foundation	This study was supported by a grant from the Bill and Melinda Gates Foundation (website: http://www.gatesfoundation.org/). Additional funding was received from the Rockefeller Foundation to support the publication of this manuscript (website: http://www.rockefellerfoundation.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adimorah Gilbert N, 2011, BMC Res Notes, V4, P228, DOI 10.1186/1756-0500-4-228; Amouzou A, 2012, LANCET, V380, P1169, DOI 10.1016/S0140-6736(12)61376-2; Bedford J, 2012, QUALITATIVE STUDY ID; Bryman A., 2008, SOCIAL RES METHODS, V3rd; Burton DC, 2011, J HEALTH POPUL NUTR, V29, P61, DOI 10.3329/jhpn.v29i1.7567; Carrera C, 2012, LANCET, V380, P1341, DOI 10.1016/S0140-6736(12)61378-6; Charles JO, 2008, HEALTH CARE WOMEN IN, V29, P906, DOI 10.1080/07399330802269626; Chopra M, 2012, LANCET, V380, P1331, DOI 10.1016/S0140-6736(12)61423-8; Colvin CJ, 2013, SOC SCI MED, V86, P66, DOI 10.1016/j.socscimed.2013.02.031; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Edson WN, 2004, DEV JOB AIDS INCREAS; Ekman B, 2008, LANCET, V372, P990, DOI 10.1016/S0140-6736(08)61408-7; Elam G., 2008, QUALITATIVE RES PRAC; Ellis AA, 2013, J BIOSOC SCI, V45, P743, DOI 10.1017/S0021932013000163; Enato EFO, 2006, SCAND J INFECT DIS, V38, P474, DOI 10.1080/00365540500525153; Falade CO, 2005, INT Q COMMUNITY HEAL, V24, P347, DOI 10.2190/GN66-9447-3984-4064; Federal Ministry of Health, 2010, HLTH PLANNING RS, P136; Ferdous F, 2013, SCI J PUBLIC HLTH, V1, P69, DOI DOI 10.11648/J.SJPH.20130102.14; Garg R, 2001, AM J PUBLIC HEALTH, V91, P1611, DOI 10.2105/AJPH.91.10.1611; Guest G, 2012, APPL THEMATIC ANAL, DOI 10.4135/9781483384436; Hahn R. A., 2009, ANTHR PUBLIC HLTH BR; Institut National de la Statistique et Macro International Inc, 2007, ENQ DEM SANT IND MUL; Iwelunmor J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-354; Kenya National Bureau of Statistics (KNBS) and ICF Macro, 2010, KEN DEM HLTH SURV 20; Lock M., 1990, MED ANTHR CONT THEOR, P47; Mbagaya Grace M, 2005, Afr Health Sci, V5, P322; McPake B, 2011, HEALTH POLICY PLANN, V26, pII104, DOI 10.1093/heapol/czr064; Ministere de la Sante Publique Secretariat General Republique du Niger, 2011, PLAN DEV SAN PDS 201; Ministry of Medical Services and Ministry of Public Health & Sanitation Government of Kenya, 2012, ACC ATT HLTH GOALS K; National Population Commission of Nigeria & ICF Macro, 2009, NIG DEM HLTH SURV 20; Nichter M., 2008, GLOBAL HLTH WHY CULT; Page AL, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-389; Perry HB, 2014, ANNU REV PUBL HEALTH, V35, P399, DOI 10.1146/annurev-publhealth-032013-182354; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Pronyk PM, 2006, LANCET, V368, P1973, DOI 10.1016/S0140-6736(06)69744-4; Raquejo J, 2012, COUNTDOWN 2015 MATER; Scott K, 2014, HEALTH POLICY PLANN, V29, P292, DOI 10.1093/heapol/czt016; Tinuade O, 2010, J PAEDIATR CHILD H, V46, P238, DOI 10.1111/j.1440-1754.2009.01677.x; UN Inter-agency Group for Child Mortality Estimation, 2013, LEVELS TRENDS CHILD; UNDP, 2010, ASSESSING PROGR AFRI; Wouters E, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-210	41	50	50	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100038	10.1371/journal.pone.0100038	http://dx.doi.org/10.1371/journal.pone.0100038			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK6BK	24971642	Green Published, Green Submitted, gold			2022-12-27	WOS:000338512200017
J	Huang, F; Mazin, AV				Huang, Fei; Mazin, Alexander V.			A Small Molecule Inhibitor of Human RAD51 Potentiates Breast Cancer Cell Killing by Therapeutic Agents in Mouse Xenografts	PLOS ONE			English	Article							DISRUPTS HOMOLOGOUS RECOMBINATION; DNA-REPAIR; ANTISENSE INHIBITION; OVEREXPRESSION; DAMAGE; ACTIVATION; CHECKPOINT; RESISTANCE; PROTEIN; ATM	The homologous recombination pathway is responsible for the repair of DNA double strand breaks. RAD51, a key homologous recombination protein, promotes the search for homology and DNA strand exchange between homologous DNA molecules. RAD51 is overexpressed in a variety of cancer cells. Downregulation of RAD51 by siRNA increases radio-or chemo-sensitivity of cancer cells. We recently developed a specific RAD51 small molecule inhibitor, B02, which inhibits DNA strand exchange activity of RAD51 in vitro. In this study, we used human breast cancer cells MDA-MB-231 to investigate the ability of B02 to inhibit RAD51 and to potentiate an anti-cancer effect of chemotherapeutic agents including doxorubicin, etoposide, topotecan, and cisplatin. We found that the combination of B02 with cisplatin has the strongest killing effect on the cancer cells. We then tested the effect of B02 and cisplatin on the MDA-MB-231 cell proliferation in mouse xenografts. Our results showed that B02 significantly enhances the therapeutic effect of cisplatin on tumor cells in vivo. Our current data demonstrate that use of RAD51-specific small molecule inhibitor represents a feasible strategy of a combination anticancer therapy.	[Huang, Fei; Mazin, Alexander V.] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19104 USA	Drexel University	Mazin, AV (corresponding author), Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19104 USA.	amazin@drexelmed.edu			NIH [CA100839, DA033981, MH097512]; NATIONAL CANCER INSTITUTE [P30CA056036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH097512] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the NIH grants CA100839, DA033981, MH097512 (to AVM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abengozar MA, 2012, BLOOD, V119, P4565, DOI 10.1182/blood-2011-09-380006; Bartkova J, 2005, CELL CYCLE, V4, P838, DOI 10.4161/cc.4.6.1742; Bhattacharyya A, 2000, J BIOL CHEM, V275, P23899, DOI 10.1074/jbc.C000276200; Bianco P R, 1998, Front Biosci, V3, pD570; Brown ET, 2009, MOL CARCINOGEN, V48, P105, DOI 10.1002/mc.20463; Budke B, 2013, J MED CHEM, V56, P254, DOI 10.1021/jm301565b; Budke B, 2012, NUCLEIC ACIDS RES, V40, P7347, DOI 10.1093/nar/gks353; Choudhury A, 2009, MOL CANCER THER, V8, P203, DOI 10.1158/1535-7163.MCT-08-0959; Curtin NJ, 2012, NAT REV CANCER, V12, P801, DOI 10.1038/nrc3399; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Foltz CJ, 1999, LAB ANIMAL, V28, P28; Gonzalez-Prieto R, 2013, EMBO J, V32, P1307, DOI 10.1038/emboj.2013.73; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Guengerich FP, 2008, CHEM RES TOXICOL, V21, P70, DOI 10.1021/tx700079z; Hannay JAF, 2007, MOL CANCER THER, V6, P1650, DOI 10.1158/1535-7163.MCT-06-0636; Helleday T, 2010, CARCINOGENESIS, V31, P955, DOI 10.1093/carcin/bgq064; Huang F, 2012, J MED CHEM, V55, P3011, DOI 10.1021/jm201173g; Huang F, 2011, ACS CHEM BIOL, V6, P628, DOI 10.1021/cb100428c; Ishida T, 2009, NUCLEIC ACIDS RES, V37, P3367, DOI 10.1093/nar/gkp200; Ito M, 2005, J GENE MED, V7, P1044, DOI 10.1002/jgm.753; Keimling M, 2009, CARCINOGENESIS, V30, P1260, DOI 10.1093/carcin/bgp117; Kiyohara E, 2012, GENE THER, V19, P734, DOI 10.1038/gt.2011.123; Klein HL, 2008, DNA REPAIR, V7, P686, DOI 10.1016/j.dnarep.2007.12.008; Kocher S, 2013, RADIOTHER ONCOL, V108, P409, DOI 10.1016/j.radonc.2013.06.024; Koehn H, 2007, ANTI-CANCER DRUG, V18, P419, DOI 10.1097/CAD.0b013e328012a9a0; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Lord CJ, 2012, NATURE, V481, P287, DOI 10.1038/nature10760; Maacke H, 2000, INT J CANCER, V88, P907, DOI 10.1002/1097-0215(20001215)88:6<907::AID-IJC11>3.0.CO;2-4; Mao ZY, 2009, NEOPLASIA, V11, P683, DOI 10.1593/neo.09312; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Ohnishi T, 1998, BIOCHEM BIOPH RES CO, V245, P319, DOI 10.1006/bbrc.1998.8440; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Powell SN, 2009, DNA REPAIR, V8, P1153, DOI 10.1016/j.dnarep.2009.04.011; Raderschall E, 1999, P NATL ACAD SCI USA, V96, P1921, DOI 10.1073/pnas.96.5.1921; Raderschall E, 2002, CANCER RES, V62, P219; SANDELL LL, 1993, CELL, V75, P729, DOI 10.1016/0092-8674(93)90493-A; Schonn I, 2011, APOPTOSIS, V16, P359, DOI 10.1007/s10495-010-0564-y; Sharom FJ, 1997, J MEMBRANE BIOL, V160, P161, DOI 10.1007/s002329900305; Song H, 2013, MOL CANCER THER, V12, P2043, DOI 10.1158/1535-7163.MCT-13-0108; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Takaku M, 2011, GENES CELLS, V16, P427, DOI 10.1111/j.1365-2443.2011.01494.x; Taki T, 1996, BIOCHEM BIOPH RES CO, V223, P434, DOI 10.1006/bbrc.1996.0911; Tennstedt P, 2013, INT J CANCER, V132, P2118, DOI 10.1002/ijc.27907; Turchi JJ, 2000, NUCLEIC ACIDS RES, V28, P4634, DOI 10.1093/nar/28.23.4634; Wiseman H, 1996, BIOCHEM J, V313, P17, DOI 10.1042/bj3130017; Xia SJJ, 1997, MOL CELL BIOL, V17, P7151, DOI 10.1128/MCB.17.12.7151; Xu ZY, 2005, J PHARMACOL EXP THER, V314, P495, DOI 10.1124/jpet.105.084053	47	83	88	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100993	10.1371/journal.pone.0100993	http://dx.doi.org/10.1371/journal.pone.0100993			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971740	Green Submitted, gold, Green Published			2022-12-27	WOS:000338512200081
J	Probst, AJ; Birarda, G; Holman, HYN; DeSantis, TZ; Wanner, G; Andersen, GL; Perras, AK; Meck, S; Volkel, J; Bechtel, HA; Wirth, R; Moissl-Eichinger, C				Probst, Alexander J.; Birarda, Giovanni; Holman, Hoi-Ying N.; DeSantis, Todd Z.; Wanner, Gerhard; Andersen, Gary L.; Perras, Alexandra K.; Meck, Sandra; Voelkel, Joerg; Bechtel, Hans A.; Wirth, Reinhard; Moissl-Eichinger, Christine			Coupling Genetic and Chemical Microbiome Profiling Reveals Heterogeneity of Archaeome and Bacteriome in Subsurface Biofilms That Are Dominated by the Same Archaeal Species	PLOS ONE			English	Article							PEARLS-LIKE MORPHOLOGY; NATURAL COMMUNITIES; SULFIDIC SPRINGS; SM1 EURYARCHAEON; DIVERSITY; GROWTH; LIPIDS; EPSILONPROTEOBACTERIA; ENVIRONMENTS; POPULATIONS	Earth harbors an enormous portion of subsurface microbial life, whose microbiome flux across geographical locations remains mainly unexplored due to difficult access to samples. Here, we investigated the microbiome relatedness of subsurface biofilms of two sulfidic springs in southeast Germany that have similar physical and chemical parameters and are fed by one deep groundwater current. Due to their unique hydrogeological setting these springs provide accessible windows to subsurface biofilms dominated by the same uncultivated archaeal species, called SM1 Euryarchaeon. Comparative analysis of infrared imaging spectra demonstrated great variations in archaeal membrane composition between biofilms of the two springs, suggesting different SM1 euryarchaeal strains of the same species at both aquifer outlets. This strain variation was supported by ultrastructural and metagenomic analyses of the archaeal biofilms, which included intergenic spacer region sequencing of the rRNA gene operon. At 16S rRNA gene level, PhyloChip G3 DNA microarray detected similar biofilm communities for archaea, but site-specific communities for bacteria. Both biofilms showed an enrichment of different deltaproteobacterial operational taxonomic units, whose families were, however, congruent as were their lipid spectra. Consequently, the function of the major proportion of the bacteriome appeared to be conserved across the geographic locations studied, which was confirmed by dsrB-directed quantitative PCR. Consequently, microbiome differences of these subsurface biofilms exist at subtle nuances for archaea (strain level variation) and at higher taxonomic levels for predominant bacteria without a substantial perturbation in bacteriome function. The results of this communication provide deep insight into the dynamics of subsurface microbial life and warrant its future investigation with regard to metabolic and genomic analyses.	[Probst, Alexander J.; Perras, Alexandra K.; Meck, Sandra; Wirth, Reinhard; Moissl-Eichinger, Christine] Univ Regensburg, Inst Microbiol, D-93053 Regensburg, Germany; [Probst, Alexander J.; Perras, Alexandra K.; Meck, Sandra; Wirth, Reinhard; Moissl-Eichinger, Christine] Univ Regensburg, Archaea Ctr, D-93053 Regensburg, Germany; [Birarda, Giovanni; Holman, Hoi-Ying N.; Andersen, Gary L.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Ctr Environm Biotechnol, Berkeley, CA 94720 USA; [Probst, Alexander J.; DeSantis, Todd Z.] Second Genome Inc, Dept Bioinformat, San Francisco, CA USA; [Wanner, Gerhard] Ludwig Maximilians Univ Munchen, Dept Biol 1, Biozentrum, Planegg Martinsried, Germany; [Voelkel, Joerg] Tech Univ Munich, Dept Geomorphol & Soil Sci, Ctr Life & Food Sci Weihenstephan, Freising Weihenstephan, Germany; [Bechtel, Hans A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Adv Light Source, Berkeley, CA 94720 USA	University of Regensburg; University of Regensburg; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Munich; Technical University of Munich; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Moissl-Eichinger, C (corresponding author), Univ Regensburg, Inst Microbiol, D-93053 Regensburg, Germany.	christine.moissl-eichinger@ur.de	Moissl-Eichinger, Christine/A-6682-2015; Andersen, Gary/G-2792-2015; Probst, Alexander J/K-2813-2016; Holman, Hoi-Ying/N-8451-2014	Moissl-Eichinger, Christine/0000-0001-6755-6263; Andersen, Gary/0000-0002-1618-9827; Holman, Hoi-Ying/0000-0002-7534-2625; Birarda, Giovanni/0000-0003-2418-058X; Probst, Alexander/0000-0002-9392-6544	DFG [MO 1977 3-1]; German National Academic Foundation (Studienstiftung des Deutschen Volkes); Office of Biological and Environmental Research's Structural Biology Program, Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]; Lawrence Berkeley National Laboratory; German Research Foundation (DFG)	DFG(German Research Foundation (DFG)); German National Academic Foundation (Studienstiftung des Deutschen Volkes); Office of Biological and Environmental Research's Structural Biology Program, Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); German Research Foundation (DFG)(German Research Foundation (DFG))	This research was funded by the DFG (grant MO 1977 3-1). AJP was supported by the German National Academic Foundation (Studienstiftung des Deutschen Volkes). The SR-FTIR spectromicroscopy work was conducted through the Berkeley Synchrotron Infrared Structural Biology (BSISB) Program at the Advanced Light Source, which is supported by the Director, Office of Biological and Environmental Research's Structural Biology Program, Office of Science of the U.S. Department of Energy through contract DE-AC02-05CH11231 with Lawrence Berkeley National Laboratory. This work was supported by the German Research Foundation (DFG) within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele G, 1950, GEOLOGICA BAVARICA, V2, P94; AMANN RI, 1990, J BACTERIOL, V172, P762, DOI 10.1128/jb.172.2.762-770.1990; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Andres G., 1981, THERMAL SCHWEFELWASS, V15, P108; Baumann M, 1981, SCHRIFTENREIHE BAYER, V15, P4; Brodie EL, 2007, P NATL ACAD SCI USA, V104, P299, DOI 10.1073/pnas.0608255104; Burggraf S, 1997, INT J SYST BACTERIOL, V47, P657, DOI 10.1099/00207713-47-3-657; BURGGRAF S, 1992, SYST APPL MICROBIOL, V15, P352, DOI 10.1016/S0723-2020(11)80207-9; Castelle CJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3120; Cooper M, 2011, APPL ENVIRON MICROB, V77, P5438, DOI 10.1128/AEM.00192-11; DEROSA M, 1988, PROG LIPID RES, V27, P153, DOI 10.1016/0163-7827(88)90011-2; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; DeSantis TZ, 2007, MICROB ECOL, V53, P371, DOI 10.1007/s00248-006-9134-9; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Engel AS, 2004, FEMS MICROBIOL ECOL, V51, P31, DOI 10.1016/j.femsec.2004.07.004; Engel AS, 2003, APPL ENVIRON MICROB, V69, P5503, DOI 10.1128/AEM.69.9.5503-5511.2003; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; Henneberger R, 2006, APPL ENVIRON MICROB, V72, P192, DOI 10.1128/AEM.72.1.192-199.2006; Holman HYN, 2010, ANAL CHEM, V82, P8757, DOI 10.1021/ac100991d; Kallmeyer J, 2012, P NATL ACAD SCI USA, V109, P16213, DOI 10.1073/pnas.1203849109; Koch M, 2006, FEMS MICROBIOL ECOL, V57, P55, DOI 10.1111/j.1574-6941.2006.00088.x; Kristjansson JK, 1992, THERMOPHILIC BACTERI; La Duc MT, 2009, APPL ENVIRON MICROB, V75, P6559, DOI 10.1128/AEM.01073-09; Lamcke K(, 1976, BUU VER SCHWEIZ PETR, V42, P9; Lane D.J., 1991, 16S 23S RRNA SEQUENC; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; LOVLEY DR, 1995, REV GEOPHYS, V33, P365, DOI 10.1029/95RG01305; Lovley DR, 2000, CURR OPIN MICROBIOL, V3, P252, DOI 10.1016/S1369-5274(00)00085-0; Loy A, 2002, APPL ENVIRON MICROB, V68, P5064, DOI 10.1128/AEM.68.10.5064-5081.2002; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Mantsch H. H., 1996, INFRARED SPECTROSCOP; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Mendes R, 2011, SCIENCE, V332, P1097, DOI 10.1126/science.1203980; Moissl C, 2005, MOL MICROBIOL, V56, P361, DOI 10.1111/j.1365-2958.2005.04294.x; Moissl C, 2003, ARCH MICROBIOL, V180, P211, DOI 10.1007/s00203-003-0580-1; Moissl C, 2002, APPL ENVIRON MICROB, V68, P933, DOI 10.1128/AEM.68.2.933-937.2002; Moissl-Eichinger C, 2011, ISME J, V5, P209, DOI 10.1038/ismej.2010.124; Morris BE, 2013, FEMS MICROBIOL REV, V37, P384, DOI 10.1111/1574-6976.12019; Nielsen H, 1981, SCHRIFTENREIHE BAYER, V15, P99; Ortiz M, 2013, ISME J; PALMER AN, 1991, GEOL SOC AM BULL, V103, P1, DOI 10.1130/0016-7606(1991)103<0001:OAMOLC>2.3.CO;2; Probst AJ, 2014, MICROARRAYS: CURRENT TECHNOLOGY, INNOVATIONS AND APPLICATIONS, P99; Probst AJ, 2013, ISME J, V7, P635, DOI 10.1038/ismej.2012.133; Rudolph C, 2004, FEMS MICROBIOL ECOL, V50, P1, DOI 10.1016/j.femsec.2004.05.006; Rudolph C, 2001, APPL ENVIRON MICROB, V67, P2336, DOI 10.1128/AEM.67.5.2336-2344.2001; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Socrates G., 2010, INFRARED RAMAN CHARA, V3rd; SPROTT GD, 1992, J BIOENERG BIOMEMBR, V24, P555, DOI 10.1007/BF00762348; Summit M, 2001, P NATL ACAD SCI USA, V98, P2158, DOI 10.1073/pnas.051516098; THIRKELL D, 1974, A VAN LEEUW J MICROB, V40, P71, DOI 10.1007/BF00394555; Ulrich GA, 1998, MICROBIAL ECOL, V36, P141, DOI 10.1007/s002489900101; Ulrih NP, 2009, APPL MICROBIOL BIOT, V84, P249, DOI 10.1007/s00253-009-2102-9; Vaishampayan P, 2013, ISME J, V7, P312, DOI 10.1038/ismej.2012.114; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Wrighton KC, 2012, SCIENCE, V337, P1661, DOI 10.1126/science.1224041	57	18	19	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e99801	10.1371/journal.pone.0099801	http://dx.doi.org/10.1371/journal.pone.0099801			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971452	Green Published, Green Submitted, gold			2022-12-27	WOS:000338512200014
J	Chen, KX; Ablimit, A; Ling, FJ; Wu, WW; Shan, WJ; Qin, WB; Keweier, T; Zuo, HL; Zhang, FC; Ma, ZH; Zheng, XF				Chen, Kaixu; Ablimit, Abdurahman; Ling, Fengjun; Wu, Weiwei; Shan, Wenjuan; Qin, Wenbei; Keweier, Tuerhong; Zuo, Hongli; Zhang, Fuchun; Ma, Zhenghai; Zheng, Xiufen			Paternal and Maternal Genetic Analysis of a Desert Keriyan Population: Keriyans Are Not the Descendants of Guge Tibetans	PLOS ONE			English	Article							MITOCHONDRIAL-DNA DIVERSITY; MTDNA VARIATION; PHYLOGEOGRAPHIC ANALYSIS; SEQUENCE POLYMORPHISMS; ETHNIC POPULATIONS; TARIM BASIN; SILK ROAD; ORIGIN; REGION; SOUTH	The Keriyan people live in an isolated village in the Taklimakan Desert in Xinjiang, Western China. The origin and migration of the Keriyans remains unclear. We studied paternal and maternal genetic variance through typing Y-STR loci and sequencing the complete control region of the mtDNA and compared them with other adjacent populations. Data show that the Keriyan have relatively low genetic diversity on both the paternal and maternal lineages and possess both European and Asian specific haplogroups, indicating Keriyan is an admixture population of West and East. There is a gender-bias in the extent of contribution from Europe vs. Asia to the Keriyan gene pool. Keriyans have more genetic affinity to Uyghurs than to Tibetans. The Keriyan are not the descendants of the Guge Tibetans.	[Chen, Kaixu; Ablimit, Abdurahman; Shan, Wenjuan; Qin, Wenbei; Zhang, Fuchun; Ma, Zhenghai; Zheng, Xiufen] Xinjiang Univ, Coll Life Sci & Technol, Xinjiang Key Lab Biol Resources & Genet Engn, Urumqi, Xinjiang, Peoples R China; [Ling, Fengjun] Beijing Entry Exit Inspect & Quarantine Bur, Beijing, Peoples R China; [Wu, Weiwei] Inst Forens Sci Zhejiang, Hangzhou, Peoples R China; [Keweier, Tuerhong; Zuo, Hongli] Blood Ctr Urumqi, Xinjiang, Peoples R China; [Zheng, Xiufen] Univ Western Ontario, Dept Pathol, London, ON, Canada; [Zheng, Xiufen] Lawson Hlth Res Inst, London, ON, Canada	Xinjiang University; Western University (University of Western Ontario); Western University (University of Western Ontario)	Ma, ZH (corresponding author), Xinjiang Univ, Coll Life Sci & Technol, Xinjiang Key Lab Biol Resources & Genet Engn, Urumqi, Xinjiang, Peoples R China.	zhenghai98@gmail.com; xzheng26@uwo.ca		Ma, Zhenghai/0000-0002-0930-7696	Natural Science Foundation of China [31260267]; Heart and Stroke Foundation of Canada; "Tianshan Scholar'' program of Xinjiang University	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); "Tianshan Scholar'' program of Xinjiang University	This work was supported by funds from the Natural Science Foundation of China (31260267), Heart and Stroke Foundation of Canada, and "Tianshan Scholar'' program of Xinjiang University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; BANDELT HJ, 1995, GENETICS, V141, P743; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Cheng BW, 2008, J HUM GENET, V53, P905, DOI 10.1007/s10038-008-0325-8; Comas D, 1998, AM J HUM GENET, V63, P1824, DOI 10.1086/302133; Comas D, 2004, EUR J HUM GENET, V12, P495, DOI 10.1038/sj.ejhg.5201160; Cui YQ, 2010, AM J PHYS ANTHROPOL, V142, P558, DOI 10.1002/ajpa.21257; Derenko M. V., 1997, Molekulyarnaya Biologiya (Moscow), V31, P784; Derenko M, 2007, AM J HUM GENET, V81, P1025, DOI 10.1086/522933; Derenko MV, 2003, ANN HUM GENET, V67, P391, DOI 10.1046/j.1469-1809.2003.00035.x; Forster P, 1996, AM J HUM GENET, V59, P935; Gayden T, 2007, AM J HUM GENET, V80, P884, DOI 10.1086/516757; Gokcumen O, 2008, AM J PHYS ANTHROPOL, V136, P278, DOI 10.1002/ajpa.20802; Hill C, 2007, AM J HUM GENET, V80, P29, DOI 10.1086/510412; Jin HJ, 2006, FORENSIC SCI INT, V158, P125, DOI 10.1016/j.forsciint.2005.03.026; Kivisild T, 2002, MOL BIOL EVOL, V19, P1737, DOI 10.1093/oxfordjournals.molbev.a003996; Kolman CJ, 1996, GENETICS, V142, P1321; Kong QP, 2003, HUM GENET, V113, P391, DOI 10.1007/s00439-003-1004-7; Li CX, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-15; Li H, 2007, AM J PHYS ANTHROPOL, V134, P481, DOI 10.1002/ajpa.20690; Maruyama S, 2003, INT J LEGAL MED, V117, P218, DOI 10.1007/s00414-003-0379-2; Metspalu M, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-26; Nohira C, 2010, INT J LEGAL MED, V124, P7, DOI 10.1007/s00414-008-0308-5; Peng MS, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-46; Roostalu U, 2007, MOL BIOL EVOL, V24, P436, DOI 10.1093/molbev/msl173; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Schonberg A, 2011, EUR J HUM GENET, V19, P988, DOI 10.1038/ejhg.2011.62; Shan W, 2014, INT J LEGAL MED; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Starikovskaya EB, 2005, ANN HUM GENET, V69, P67, DOI 10.1046/j.1529-8817.2003.00127.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TORRONI A, 1993, AM J HUM GENET, V53, P563; Underhill PA, 2010, EUR J HUM GENET, V18, P479, DOI 10.1038/ejhg.2009.194; VIGILANT L, 1989, P NATL ACAD SCI USA, V86, P9350, DOI 10.1073/pnas.86.23.9350; Wen B, 2004, NATURE, V431, P302, DOI 10.1038/nature02878; Yan S, 2011, EUR J HUM GENET, V19, P1013, DOI 10.1038/ejhg.2011.64; Yao YG, 2002, J HUM GENET, V47, P311, DOI 10.1007/s100380200042; Yao YG, 2002, AM J HUM GENET, V70, P635, DOI 10.1086/338999; Yao YG, 2004, MOL BIOL EVOL, V21, P2265, DOI 10.1093/molbev/msh238; Yao YG, 2003, MOL BIOL EVOL, V20, P214, DOI 10.1093/molbev/msg026; Zhao M, 2009, P NATL ACAD SCI USA, V106, P21230, DOI 10.1073/pnas.0907844106	41	0	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100479	10.1371/journal.pone.0100479	http://dx.doi.org/10.1371/journal.pone.0100479			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968299	Green Published, gold, Green Submitted			2022-12-27	WOS:000338280800042
J	Kleynen, M; Braun, SM; Bleijlevens, MH; Lexis, MA; Rasquin, SM; Halfens, J; Wilson, MR; Beurskens, AJ; Masters, RSW				Kleynen, Melanie; Braun, Susy M.; Bleijlevens, Michel H.; Lexis, Monique A.; Rasquin, Sascha M.; Halfens, Jos; Wilson, Mark R.; Beurskens, Anna J.; Masters, Rich S. W.			Using a Delphi Technique to Seek Consensus Regarding Definitions, Descriptions and Classification of Terms Related to Implicit and Explicit Forms of Motor Learning	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; SKILL; PARKINSONS; SPORTS; STROKE; TASK	Background: Motor learning is central to domains such as sports and rehabilitation; however, often terminologies are insufficiently uniform to allow effective sharing of experience or translation of knowledge. A study using a Delphi technique was conducted to ascertain level of agreement between experts from different motor learning domains (i.e., therapists, coaches, researchers) with respect to definitions and descriptions of a fundamental conceptual distinction within motor learning, namely implicit and explicit motor learning. Methods: A Delphi technique was embedded in multiple rounds of a survey designed to collect and aggregate informed opinions of 49 international respondents with expertise related to motor learning. The survey was administered via an online survey program and accompanied by feedback after each round. Consensus was considered to be reached if >= 70% of the experts agreed on a topic. Results: Consensus was reached with respect to definitions of implicit and explicit motor learning, and seven common primary intervention strategies were identified in the context of implicit and explicit motor learning. Consensus was not reached with respect to whether the strategies promote implicit or explicit forms of learning. Discussion: The definitions and descriptions agreed upon may aid translation and transfer of knowledge between domains in the field of motor learning. Empirical and clinical research is required to confirm the accuracy of the definitions and to explore the feasibility of the strategies that were identified in research, everyday practice and education.	[Kleynen, Melanie; Braun, Susy M.; Beurskens, Anna J.] Zuyd Univ Appl Sci, Fac Hlth, Res Ctr Auton & Participat People Chron Illness, Heerlen, Netherlands; [Kleynen, Melanie; Halfens, Jos] Adelante Rehabil Ctr, Dept Brain Injury, Hoensbroek, Netherlands; [Braun, Susy M.; Bleijlevens, Michel H.] Maastricht Univ, Fac Hlth Med & Life Sci, Sch Publ Hlth & Primary Care, Dept Hlth Serv Res,CAPHRI, Maastricht, Netherlands; [Bleijlevens, Michel H.] Sevagram Zorgcentra, Ctr Expertise Geriatr Rehabil & Chron Somat Care, Heerlen, Netherlands; [Lexis, Monique A.] Zuyd Univ Appl Sci, Res Ctr Technol Care, Heerlen, Netherlands; [Rasquin, Sascha M.] Adelante Ctr Expertise Rehabil & Audiol, Hoensbroek, Netherlands; [Rasquin, Sascha M.] Maastricht Univ, Fac Hlth Med & Life Sci, Sch Publ Hlth & Primary Care, Dept Rehabil Med,CAPHRI, Maastricht, Netherlands; [Wilson, Mark R.] Univ Exeter, Dept Sport & Hlth Sci, Exeter, Devon, England; [Beurskens, Anna J.] Maastricht Univ, Fac Hlth Med & Life Sci, Sch Publ Hlth & Primary Care, Dept Family Practice,CAPHRI, Maastricht, Netherlands; [Masters, Rich S. W.] Univ Hong Kong, Inst Human Performance, Hong Kong, Hong Kong, Peoples R China; [Masters, Rich S. W.] Univ Waikato, Dept Sport & Leisure Studies, Hamilton, New Zealand	Maastricht University; Maastricht University; University of Exeter; Maastricht University; University of Hong Kong; University of Waikato	Kleynen, M (corresponding author), Zuyd Univ Appl Sci, Fac Hlth, Res Ctr Auton & Participat People Chron Illness, Heerlen, Netherlands.	melanie.kleynen@zuyd.nl	Masters, Richard/A-3889-2010	Masters, Richard/0000-0003-0707-6107; Wilson, Mark/0000-0001-8145-6971	Stichting Alliantie Innovatie (Innovation Alliance Foundation); RAAK-international [20113-33int]	Stichting Alliantie Innovatie (Innovation Alliance Foundation); RAAK-international	This study was financially supported by Stichting Alliantie Innovatie (Innovation Alliance Foundation), RAAK-international (Registration number: 20113-33int). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbruzzese G, 2009, EUR J PHYS REHAB MED, V45, P209; Boulkedid R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020476; Boyd LA, 2003, PHYS THER, V83, P976, DOI 10.1093/ptj/83.11.976; Capio CM, 2013, J INTELL DISABIL RES, V57, P295, DOI 10.1111/j.1365-2788.2012.01535.x; Dechamps A, 2011, AM J ALZHEIMERS DIS, V26, P273, DOI 10.1177/1533317511404394; Frensch PA, 1998, HDB IMPLICIT LEARNIN; Gobel EW, 2013, NEUROPSYCHOLOGY, V27, P314, DOI 10.1037/a0032305; Halsband U, 2006, J PHYSIOL-PARIS, V99, P414, DOI 10.1016/j.jphysparis.2006.03.007; Hasson F, 2000, J ADV NURS, V32, P1008, DOI 10.1046/j.1365-2648.2000.01567.x; Kitago Tomoko, 2013, Handb Clin Neurol, V110, P93, DOI 10.1016/B978-0-444-52901-5.00008-3; Kleynen M, 2013, JMIR RES PROTOC, V2, DOI 10.2196/resprot.2604; Kwakkel G, 2004, RESTOR NEUROL NEUROS, V22, P281; Lam WK, 2009, J SPORT SCI, V27, P179, DOI 10.1080/02640410802448764; Larin HM, 2006, PHYS THERAPY CHILDRE, P131; Masters RSW, 2008, SURGERY, V143, P140, DOI 10.1016/j.surg.2007.06.018; MASTERS RSW, 1992, BRIT J PSYCHOL, V83, P343, DOI 10.1111/j.2044-8295.1992.tb02446.x; Masters RSW, 2012, SKILL ACQUISITION SP, P59; Maxwell JP, 2003, CONSCIOUS COGN, V12, P376, DOI 10.1016/S1053-8100(03)00005-9; Meehan SK, 2011, HUM BRAIN MAPP, V32, P290, DOI 10.1002/hbm.21019; Mokkink L B, 2006, BMC Med Res Methodol, V6, P2, DOI 10.1186/1471-2288-6-2; Mount J, 2007, NEUROREHABILITATION, V22, P123; Orrell AJ, 2006, PHYS THER, V86, P369, DOI 10.1093/ptj/86.3.369; Pohl PS, 2001, PHYS THER, V81, P1780, DOI 10.1093/ptj/81.11.1780; Poolton JM, 2005, HUM MOVEMENT SCI, V24, P362, DOI 10.1016/j.humov.2005.06.006; Powell C, 2003, J ADV NURS, V41, P376, DOI 10.1046/j.1365-2648.2003.02537.x; Raab M, 2009, INT J SPORT EXERC PS, V7, P413, DOI 10.1080/1612197X.2009.9671917; REBER AS, 1967, J VERB LEARN VERB BE, V6, P855, DOI 10.1016/S0022-5371(67)80149-X; Schneider SA, 2010, MOVEMENT DISORD, V25, P1343, DOI 10.1002/mds.22692; Steenbergen B, 2010, DISABIL REHABIL, V32, P1509, DOI 10.3109/09638288.2010.497035; Turloff M., 1975, DELPHI METHOD TECHNI; van Halteren-van Tilborg IADA, 2007, NEUROPSYCHOL REV, V17, P203, DOI 10.1007/s11065-007-9030-1; van Tilborg IADA, 2011, NEUROREHABILITATION, V29, P295, DOI 10.3233/NRE-2011-0705; van Tilborg IADA, 2010, MOTOR CONTROL, V14, P344, DOI 10.1123/mcj.14.3.344; Waller SM, 2012, GAIT POSTURE, V36, P419, DOI 10.1016/j.gaitpost.2012.03.025; Williams AM, 2008, J SPORT SCI, V26, P401, DOI 10.1080/02640410701765631; Yang Y, 2011, INT J PSYCHOL, V46, P1, DOI 10.1080/00207594.2010.509800; Zafar SY, 2012, LANCET ONCOL, V13, pE77, DOI 10.1016/S1470-2045(11)70215-7	37	83	85	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100227	10.1371/journal.pone.0100227	http://dx.doi.org/10.1371/journal.pone.0100227			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK2WP	24968228	Green Submitted, gold, Green Published			2022-12-27	WOS:000338280800031
J	Lakkam, M; Wager, S; Wise, PH; Wein, LM				Lakkam, Milinda; Wager, Stefan; Wise, Paul H.; Wein, Lawrence M.			Quantifying and Exploiting the Age Dependence in the Effect of Supplementary Food for Child Undernutrition	PLOS ONE			English	Article							USE THERAPEUTIC FOOD; NUTRITIONAL-STATUS; ADULT HEALTH; MORTALITY; GROWTH; MALNUTRITION; METAANALYSIS; PNEUMONIA; COUNTRIES; DIARRHEA	Motivated by the lack of randomized controlled trials with an intervention-free control arm in the area of child undernutrition, we fit a trivariate model of weight-for-age z score (WAZ), height-for-age z score (HAZ) and diarrhea status to data from an observational study of supplementary feeding (100 kCal/day for children with WAZ <-2.5) in 17 Guatemalan communities. Incorporating time lags, intention to treat (i.e., to give supplementary food), seasonality and age interactions, we estimate how the effect of supplementary food on WAZ, HAZ and diarrhea status varies with a child's age. We find that the effect of supplementary food on all 3 metrics decreases linearly with age from 6 to 20 mo and has little effect after 20 mo. We derive 2 food allocation policies that myopically (i.e., looking ahead 2 mo) minimize either the underweight or stunting severity -i.e., the sum of squared WAZ or HAZ scores for all children with WAZ or HAZ <0. A simulation study based on the statistical model predicts that the 2 derived policies reduce the underweight severity (averaged over all ages) by 13.6-14.1% and reduce the stunting severity at age 60 mo by 7.1-8.0% relative to the policy currently in use, where all policies have a budget that feeds approximate to 4% of children. While these findings need to be confirmed on additional data sets, it appears that in a low-dose (100 kCal/day) supplementary feeding setting in Guatemala, allocating food primarily to 6-12 mo infants can reduce the severity of underweight and stunting.	[Lakkam, Milinda] Stanford Univ, Inst Computat & Math Engn, Stanford, CA 94305 USA; [Wager, Stefan] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Wise, Paul H.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Wein, Lawrence M.] Stanford Univ, Grad Sch Business, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Wein, LM (corresponding author), Stanford Univ, Grad Sch Business, Stanford, CA 94305 USA.	lwein@stanford.edu			Graduate School of Business, Stanford University; B.C. and E.J. Eaves Stanford Graduate Fellowship	Graduate School of Business, Stanford University(Stanford University); B.C. and E.J. Eaves Stanford Graduate Fellowship	Graduate School of Business, Stanford University and a B.C. and E.J. Eaves Stanford Graduate Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair LS, 2013, LANCET, V382, P525, DOI 10.1016/S0140-6736(13)60103-8; Bhagowalia P, 2011, ECON HUM BIOL, V9, P66, DOI 10.1016/j.ehb.2010.05.002; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Caulfield LE, 2004, AM J CLIN NUTR, V80, P193; de Onis M, 2007, J NUTR, V137, P144, DOI 10.1093/jn/137.1.144; Dewey KG, 2011, MATERN CHILD NUTR, V7, P129, DOI 10.1111/j.1740-8709.2011.00357.x; Dewey KG, 2009, MATERN CHILD NUTR, V5, P283, DOI 10.1111/j.1740-8709.2009.00190.x; Garenne M, 2006, J NUTR, V136, P2893, DOI 10.1093/jn/136.11.2893; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Imbens GW, 2008, J ECONOMETRICS, V142, P615, DOI 10.1016/j.jeconom.2007.05.001; Isanaka S, 2009, JAMA-J AM MED ASSOC, V301, P277, DOI 10.1001/jama.2008.1018; Maleta K, 2003, ACTA PAEDIATR, V92, P491, DOI 10.1111/j.1651-2227.2003.tb00584.x; McDonald C., 2010, SCALING NUTR WHAT WI; McDonald CM, 2013, AM J CLIN NUTR, V97, P896, DOI 10.3945/ajcn.112.047639; Richard SA, 2012, J NUTR, V142, P1291, DOI 10.3945/jn.111.154922; SCHROEDER DG, 1995, J NUTR, V125, pS1051; Shoham J, 2013, TECHNICAL REPORT; Singh AS, 2010, INDIAN PEDIATR, V47, P679, DOI 10.1007/s13312-010-0100-8; Singhal A, 2004, LANCET, V363, P1642, DOI 10.1016/S0140-6736(04)16210-7; VANDENBROECK J, 1993, LANCET, V341, P1491, DOI 10.1016/0140-6736(93)90632-Q; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Victora CG, 2010, PEDIATRICS, V125, pE473, DOI 10.1542/peds.2009-1519; VICTORA CG, 1992, J NUTR, V122, P1105, DOI 10.1093/jn/122.5.1105; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Yang Y, 2013, P NATL ACAD SCI USA, V110, P4545, DOI 10.1073/pnas.1216075110; Yoon PW, 1997, AM J CLIN NUTR, V65, P1070, DOI 10.1093/ajcn/65.4.1070	27	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e99632	10.1371/journal.pone.0099632	http://dx.doi.org/10.1371/journal.pone.0099632			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967745	Green Submitted, Green Published, gold			2022-12-27	WOS:000338280800017
J	Pishva, E; Drukker, M; Viechtbauer, W; Decoster, J; Collip, D; van Winkel, R; Wichers, M; Jacobs, N; Thiery, E; Derom, C; Geschwind, N; van den Hove, D; Lataster, T; Myin-Germeys, I; van Os, J; Rutten, BPF; Kenis, G				Pishva, Ehsan; Drukker, Marjan; Viechtbauer, Wolfgang; Decoster, Jeroen; Collip, Dina; van Winkel, Ruud; Wichers, Marieke; Jacobs, Nele; Thiery, Evert; Derom, Catherine; Geschwind, Nicole; van den Hove, Daniel; Lataster, Tineke; Myin-Germeys, Inez; van Os, Jim; Rutten, Bart P. F.; Kenis, Gunter			Epigenetic Genes and Emotional Reactivity to Daily Life Events: A Multi-Step Gene-Environment Interaction Study	PLOS ONE			English	Article							DE-NOVO METHYLATION; DNA METHYLATION; GLUCOCORTICOID-RECEPTOR; PSYCHOTIC EXPERIENCES; MAMMALIAN DEVELOPMENT; STRESS; DNMT3A; PSYCHIATRY; CORTISOL; CELLS	Recent human and animal studies suggest that epigenetic mechanisms mediate the impact of environment on development of mental disorders. Therefore, we hypothesized that polymorphisms in epigenetic-regulatory genes impact stress-induced emotional changes. A multi-step, multi-sample gene-environment interaction analysis was conducted to test whether 31 single nucleotide polymorphisms (SNPs) in epigenetic-regulatory genes, i.e. three DNA methyltransferase genes DNMT1, DNMT3A, DNMT3B, and methylenetetrahydrofolate reductase (MTHFR), moderate emotional responses to stressful and pleasant stimuli in daily life as measured by Experience Sampling Methodology (ESM). In the first step, main and interactive effects were tested in a sample of 112 healthy individuals. Significant associations in this discovery sample were then investigated in a population-based sample of 434 individuals for replication. SNPs showing significant effects in both the discovery and replication samples were subsequently tested in three other samples of: (i) 85 unaffected siblings of patients with psychosis, (ii) 110 patients with psychotic disorders, and iii) 126 patients with a history of major depressive disorder. Multilevel linear regression analyses showed no significant association between SNPs and negative affect or positive affect. No SNPs moderated the effect of pleasant stimuli on positive affect. Three SNPs of DNMT3A (rs11683424, rs1465764, rs1465825) and 1 SNP of MTHFR (rs1801131) moderated the effect of stressful events on negative affect. Only rs11683424 of DNMT3A showed consistent directions of effect in the majority of the 5 samples. These data provide the first evidence that emotional responses to daily life stressors may be moderated by genetic variation in the genes involved in the epigenetic machinery.	[Pishva, Ehsan; Drukker, Marjan; Viechtbauer, Wolfgang; Decoster, Jeroen; Collip, Dina; van Winkel, Ruud; Wichers, Marieke; Jacobs, Nele; van den Hove, Daniel; Lataster, Tineke; Myin-Germeys, Inez; van Os, Jim; Rutten, Bart P. F.; Kenis, Gunter] Maastricht Univ, Med Ctr, Dept Psychiat & Neuropsychol, Sch Mental Hlth & Neurosci, Maastricht, Netherlands; [Jacobs, Nele] Open Univ Netherlands, Sch Psychol, Heerlen, Netherlands; [Thiery, Evert] Ghent Univ Hosp, Dept Neurol, Ghent, Belgium; [Derom, Catherine] Univ Hosp Leuven, Ctr Human Genet, Leuven, Belgium; [Derom, Catherine] Katholieke Univ Leuven, Dept Human Genet, Leuven, Belgium; [Geschwind, Nicole] Maastricht Univ, Dept Clin Psychol Sci, Maastricht, Netherlands; [van den Hove, Daniel] Univ Wurzburg, Dept Psychiat & Mol Psychiat, Lab Translat Neurosci, D-97070 Wurzburg, Germany; [van Os, Jim] Kings Coll London, Inst Psychiat, Dept Psychosis Studies, Kings Hlth Partners, London, England	Maastricht University; Open University Netherlands; Ghent University; Ghent University Hospital; KU Leuven; University Hospital Leuven; KU Leuven; Maastricht University; University of Wurzburg; University of London; King's College London	Rutten, BPF (corresponding author), Maastricht Univ, Med Ctr, Dept Psychiat & Neuropsychol, Sch Mental Hlth & Neurosci, Maastricht, Netherlands.	b.rutten@maastrichtuniversity.nl	Wichers, Marieke/N-6667-2014; van Os, Jim/C-2113-2014; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; Myin-Germeys, Inez/L-5106-2014; Viechtbauer, Wolfgang/M-1549-2013; van Os, Jim/V-8884-2019; Geschwind, Nicole/J-4617-2019; Myin Germeys, Inez/HIR-3364-2022	Wichers, Marieke/0000-0001-5024-9064; Viechtbauer, Wolfgang/0000-0003-3463-4063; van Os, Jim/0000-0002-7245-1586; Geschwind, Nicole/0000-0001-7171-6426; Myin Germeys, Inez/0000-0002-3731-4930; Rutten, Bart/0000-0002-9834-6346; Derom, Catherine/0000-0001-5574-796X; van den Hove, Daniel/0000-0003-4047-3198; Pishva, Ehsan/0000-0002-8964-0682	NARSAD Young Investigator; Dutch Organisation for Scientific Research (NWO) (VENI grant) [916.76.147]; Fund of Scientific Research, Flanders and Twins, a non-profit association for Scientific Research in Multiple Births(Belgium); Servier (unrestricted grant)	NARSAD Young Investigator(NARSAD); Dutch Organisation for Scientific Research (NWO) (VENI grant); Fund of Scientific Research, Flanders and Twins, a non-profit association for Scientific Research in Multiple Births(Belgium); Servier (unrestricted grant)	Part of this study was supported by a 2006 NARSAD Young Investigator awarded to Inez Myin-Germeys and by a grant from the Dutch Organisation for Scientific Research (NWO) (VENI grant number: 916.76.147) to M. Wichers. The TWIN population study has been partly supported by grants from the Fund of Scientific Research, Flanders and Twins, a non-profit association for Scientific Research in Multiple Births(Belgium). Data collection was financially supported by Servier (unrestricted grant). The funders had no role in study design, data collection andanalysis, decision to publish, or preparation of the manuscript.	Chen TP, 2002, J BIOL CHEM, V277, P38746, DOI 10.1074/jbc.M205312200; Collip D, 2011, PSYCHOL MED, V41, P2305, DOI 10.1017/S0033291711000602; Delespaul P, 2002, SOC PSYCH PSYCH EPID, V37, P97, DOI 10.1007/s001270200000; Derom CA, 2006, TWIN RES HUM GENET, V9, P733, DOI 10.1375/183242706779462723; Duncan LE, 2011, AM J PSYCHIAT, V168, P1041, DOI 10.1176/appi.ajp.2011.11020191; Edlund CK, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-174; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Friso S, 2002, P NATL ACAD SCI USA, V99, P5606, DOI 10.1073/pnas.062066299; Frissen A, 2014, SOCIAL PSYCHIAT PSYC; Geschwind N, 2011, J CONSULT CLIN PSYCH, V79, P618, DOI 10.1037/a0024595; Gross JJ, 1998, J PERS SOC PSYCHOL, V74, P224, DOI 10.1037/0022-3514.74.1.224; Hunter DJ, 2005, NAT REV GENET, V6, P287, DOI 10.1038/nrg1578; Jacobs N, 2005, LIFE SCI, V76, P2431, DOI 10.1016/j.lfs.2004.10.045; Johns LC, 2001, CLIN PSYCHOL REV, V21, P1125, DOI 10.1016/S0272-7358(01)00103-9; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kember RL, 2012, BRAIN BEHAV, V2, P455, DOI 10.1002/brb3.69; LaPlant Q, 2010, NAT NEUROSCI, V13, P1137, DOI 10.1038/nn.2619; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Lin PI, 2007, AM J HUM GENET, V80, P1002; Lin PI, 2007, AM J HUM GENET, V80, P531, DOI 10.1086/512133; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Ma DKK, 2010, NAT NEUROSCI, V13, P1338, DOI 10.1038/nn.2672; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; MCGUFFIN P, 1991, ARCH GEN PSYCHIAT, V48, P764; Melas PA, 2013, INT J NEUROPSYCHOPH, P1; Mill J, 2006, AM J MED GENET B, V141B, P421, DOI 10.1002/ajmg.b.30316; Moffitt TE, 2005, ARCH GEN PSYCHIAT, V62, P473, DOI 10.1001/archpsyc.62.5.473; Murgatroyd C, 2009, NAT NEUROSCI, V12, P1559, DOI 10.1038/nn.2436; Myin-Germeys I, 2003, ACTA PSYCHIAT SCAND, V107, P124, DOI 10.1034/j.1600-0447.2003.02025.x; Myin-Germeys I, 2001, ARCH GEN PSYCHIAT, V58, P1137, DOI 10.1001/archpsyc.58.12.1137; Myin-Germeys I, 2002, AM J PSYCHIAT, V159, P443, DOI 10.1176/appi.ajp.159.3.443; Myin-Germeys I, 2009, PSYCHOL MED, V39, P1533, DOI 10.1017/S0033291708004947; Ober C, 2011, TRENDS GENET, V27, P107, DOI 10.1016/j.tig.2010.12.004; Oberlander TF, 2008, EPIGENETICS-US, V3, P97, DOI 10.4161/epi.3.2.6034; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ouellet-Morin I, 2012, PSYCHOL MED, P1; Peerbooms O, 2012, ACTA PSYCHIAT SCAND, V125, P247, DOI 10.1111/j.1600-0447.2011.01806.x; Peerbooms OLJ, 2011, BRAIN BEHAV IMMUN, V25, P1530, DOI 10.1016/j.bbi.2010.12.006; Pishva E, 2012, TRANSL NEUROSCI, V3, P196, DOI 10.2478/s13380-012-0024-y; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Souren NYP, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r44; Thewissen V, 2008, J ABNORM PSYCHOL, V117, P143, DOI 10.1037/0021-843X.117.1.143; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Unternaehrer E, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.77; van Os J, 2013, WORLD PSYCHIATRY, V12, P113, DOI 10.1002/wps.20046; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Weisenberger DJ, 2002, GENE, V298, P91, DOI 10.1016/S0378-1119(02)00976-9; Yang XJ, 2012, BIOCHEM BIOPH RES CO, V420, P570, DOI 10.1016/j.bbrc.2012.03.035	49	23	23	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100935	10.1371/journal.pone.0100935	http://dx.doi.org/10.1371/journal.pone.0100935			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967710	gold, Green Published			2022-12-27	WOS:000338280800086
J	Friedlander, AM; Caselle, JE; Ballesteros, E; Brown, EK; Turchik, A; Sala, E				Friedlander, Alan M.; Caselle, Jennifer E.; Ballesteros, Enric; Brown, Eric K.; Turchik, Alan; Sala, Enric			The Real Bounty: Marine Biodiversity in the Pitcairn Islands	PLOS ONE			English	Article							HENDERSON ISLAND; ALGAL FLORA; CLIMATE-CHANGE; CORAL-REEFS; PHAEOPHYCEAE; EXTINCTION; FISHES; IMPACT; LIMITS; ATOLL	In 2012 we conducted an integrated ecological assessment of the marine environment of the Pitcairn Islands, which are four of the most remote islands in the world. The islands and atolls (Ducie, Henderson, Oeno, and Pitcairn) are situated in the central South Pacific, halfway between New Zealand and South America. We surveyed algae, corals, mobile invertebrates, and fishes at 97 sites between 5 and 30 m depth, and found 51 new records for algae, 23 for corals, and 15 for fishes. The structure of the ecological communities was correlated with age, isolation, and geomorphology of the four islands. Coral and algal assemblages were significantly different among islands with Ducie having the highest coral cover (56%) and Pitcairn dominated by erect macroalgae (42%). Fish biomass was dominated by top predators at Ducie (62% of total fish biomass) and at Henderson (35%). Herbivorous fishes dominated at Pitcairn, while Oeno showed a balanced fish trophic structure. We found high levels of regional endemism in the fish assemblages across the islands (45%), with the highest level observed at Ducie (56% by number). We conducted the first surveys of the deep habitats around the Pitcairn Islands using drop-cameras at 21 sites from depths of 78 to 1,585 m. We observed 57 fish species from the drop-cams, including rare species such as the false catshark (Pseudotriakis microdon) and several new undescribed species. In addition, we made observations of typically shallow reef sharks and other reef fishes at depths down to 300 m. Our findings highlight the uniqueness and high biodiversity value of the Pitcairn Islands as one of the least impacted in the Pacific, and suggest the need for immediate protection.	[Friedlander, Alan M.; Turchik, Alan; Sala, Enric] Natl Geog Soc, Washington, DC 20036 USA; [Friedlander, Alan M.] Univ Hawaii, Dept Biol, Fisheries Ecol Res Lab, Honolulu, HI 96822 USA; [Caselle, Jennifer E.] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; [Ballesteros, Enric; Sala, Enric] Ctr Estudis Avancats Blanes, Blanes, Spain; [Brown, Eric K.] Natl Pk Serv, Kalaupapa Natl Hist Pk, Kalaupapa, HI USA	National Geographic Society; University of Hawaii System; University of California System; University of California Santa Barbara; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); United States Department of the Interior	Friedlander, AM (corresponding author), Natl Geog Soc, Washington, DC 20036 USA.	alan.friedlander@hawaii.edu			National Geographic; Blancpain; Davidoff Cool Water	National Geographic(National Geographic Society); Blancpain; Davidoff Cool Water	Funding was provided by National Geographic, Blancpain, and Davidoff Cool Water to ES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLENDER B M, 1983, Brunonia, V6, P73, DOI 10.1071/BRU9830073; Althaus F, 2009, MAR ECOL PROG SER, V397, P279, DOI 10.3354/meps08248; Amoamo M, 2013, TOURISM GEOGR, V15, P107, DOI 10.1080/14616688.2012.699093; Amoamo M, 2011, TOUR PLAN DEV, V8, P1, DOI 10.1080/21568316.2011.554035; Ault JS, 1998, FISH B-NOAA, V96, P395; Behrenfeld MJ, 2006, NATURE, V444, P752, DOI 10.1038/nature05317; Bellwood DR, 2005, ECOL LETT, V8, P643, DOI 10.1111/j.1461-0248.2005.00763.x; Bellwood DR, 2001, SCIENCE, V292, P1532, DOI 10.1126/science.1058635; BENTON TG, 1995, BIOL J LINN SOC, V56, P243, DOI 10.1111/j.1095-8312.1995.tb01088.x; BLAKE SG, 1995, BIOL J LINN SOC, V56, P43, DOI 10.1006/bijl.1995.0053; Brooke Michael, 2010, British Birds, V103, P428; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Chassot E, 2010, ECOL LETT, V13, P495, DOI 10.1111/j.1461-0248.2010.01443.x; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Connolly SR, 2003, ECOLOGY, V84, P2178, DOI 10.1890/02-0254; DeMartini EE, 2008, MAR ECOL PROG SER, V365, P199, DOI 10.3354/meps07501; Denis V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054330; Devine JA, 2006, NATURE, V439, P29, DOI 10.1038/439029a; Friedlander AM, 2013, AQUAT CONSERV, V23, P515, DOI 10.1002/aqc.2333; Friedlander AM, 2010, MAR ECOL PROG SER, V410, P219, DOI 10.3354/meps08634; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Gorley C.K., 2006, GETTING STARTED PRIM; Government of Pitcairn, 2013, IMM POL; Graham Nicholas A.J., 2013, P253; Graham NAJ, 2013, BIOSCIENCE, V63, P397, DOI 10.1525/bio.2013.63.5.13; Green R., 1979, SAMPLING DESIGN STAT; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hendry Ian, 2011, BRIT OVERSEAS TERRIT; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Irving R, 2012, MARINE ENV PITCAIRN; IRVING RA, 1995, BIOL J LINN SOC, V56, P309, DOI 10.1111/j.1095-8312.1995.tb01092.x; Irving Robert, 2013, P299; Jennings S, 1998, ADV MAR BIOL, V34, P201, DOI 10.1016/S0065-2881(08)60212-6; Jerlov N. G., 1976, MARINE OPTICS; Kahng SE, 2010, CORAL REEFS, V29, P255, DOI 10.1007/s00338-010-0593-6; Kingston N, 2009, ENCY ISLANDS, P744; Kirk R. W., 2008, PITCAIRN ISLAND BOUN; Kleypas JA, 1999, AM ZOOL, V39, P146; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; Kulbicki M, 2005, CYBIUM, V29, P235; Letourneur Y, 1998, NAGA, V21, P39; Littler D. S., 2003, S PACIFIC REEF PLANT; LITTLER MM, 1985, SCIENCE, V227, P57, DOI 10.1126/science.227.4682.57; Ludwig J. A., 1988, STAT ECOLOGY; Marten GG, 1982, ICLARM C P, V9, P254; Mattio L, 2008, J PHYCOL, V44, P1541, DOI 10.1111/j.1529-8817.2008.00597.x; McArthur RH, 1967, THEORY ISLAND BIOGEO; McClanahan TR, 2011, P NATL ACAD SCI USA, V108, P17230, DOI 10.1073/pnas.1106861108; N'Yeurt ADR, 2007, CRYPTOGAMIE ALGOL, V28, P3; N'Yeurt ADR, 2006, CRYPTOGAMIE ALGOL, V27, P111; N'Yeurt ADR, 2010, CRYPTOGAMIE ALGOL, V31, P3; Newman MJH, 2006, ECOL LETT, V9, P1216, DOI 10.1111/j.1461-0248.2006.00976.x; Nordhoff CB, 1936, BOUNTY TRILOGY MUTIN; Nunn PD, 2010, GEOMORPHOLOGICAL LANDSCAPES OF THE WORLD, P349, DOI 10.1007/978-90-481-3055-9_36; OKAL EA, 1985, EARTH PLANET SC LETT, V72, P99, DOI 10.1016/0012-821X(85)90120-7; Oldfield S, 1997, J APPL ECOL, V34, P1111, DOI 10.2307/2405225; PANDOLFI JM, 1995, BIOL J LINN SOC, V56, P63, DOI 10.1006/bijl.1995.0054; PAULAY G, 1989, ATOLL RES B, V326, P1, DOI DOI 10.5479/SI.00775630.326.1; Pichon M, 1985, P 5 INT COR REEF C T, V1, P399; Polovina JJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031745; PREECE RC, 1995, BIOL J LINN SOC, V56, P339, DOI 10.1111/j.1095-8312.1995.tb01095.x; Randall John E., 1999, Atoll Research Bulletin, V461, P1; Randall RE, 2005, REEF SHORE FISHES S; Rooney J, 2010, CORAL REEFS, V29, P361, DOI 10.1007/s00338-010-0596-3; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Sivadas M., 2005, J MARINE BIOL ASS IN, V47, P111; Spencer T., 1989, Atoll Research Bulletin, P1; SPENCER T, 1995, BIOL J LINN SOC, V56, P13, DOI 10.1111/j.1095-8312.1995.tb01076.x; STODDART D R, 1992, Pacific Science, V46, P276; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; ter Braak CJF, 1994, ECOSCIENCE, V1, P127, DOI 10.1080/11956860.1994.11682237; Thomson DP, 2010, CORAL REEFS, V29, P923, DOI 10.1007/s00338-010-0650-1; Thrush SF, 2002, ANNU REV ECOL SYST, V33, P449, DOI 10.1146/annurev.ecolsys.33.010802.150515; Tsuda R. T., 1976, REV ALGOLOGIQUE, V11, P325; Vlaams Instituut voor de Zee (Flanders Marine Institute), 2005, MAR BOUND GEOD; WEISLER MI, 1995, BIOL J LINN SOC, V56, P377, DOI 10.1111/j.1095-8312.1995.tb01099.x; WHATLEY R, 1995, BIOL J LINN SOC, V56, P359, DOI 10.1006/bijl.1995.0072; WHITTAKER JE, 1995, BIOL J LINN SOC, V56, P365; WOODHEAD JD, 1993, EARTH PLANET SC LETT, V116, P81, DOI 10.1016/0012-821X(93)90046-C; Young R. A., 1894, MUTINY BOUNTY STORY; Zar JH, 1999, BIOSTATISTICAL ANAL	82	38	40	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100142	10.1371/journal.pone.0100142	http://dx.doi.org/10.1371/journal.pone.0100142			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963808	gold, Green Submitted, Green Published			2022-12-27	WOS:000338709500030
J	Rossato, FA; Zecchin, KG; La Guardia, PG; Ortega, RM; Alberici, LC; Costa, RAP; Catharino, RR; Graner, E; Castilho, RF; Vercesi, AE				Rossato, Franco A.; Zecchin, Karina G.; La Guardia, Paolo G.; Ortega, Rose M.; Alberici, Luciane C.; Costa, Rute A. P.; Catharino, Rodrigo R.; Graner, Edgard; Castilho, Roger F.; Vercesi, Anibal E.			Fatty Acid Synthase Inhibitors Induce Apoptosis in Non-Tumorigenic Melan-A Cells Associated with Inhibition of Mitochondrial Respiration	PLOS ONE			English	Article							BREAST-CANCER CELLS; CYTOCHROME-C RELEASE; REACTIVE OXYGEN; IMMUNOHISTOCHEMICAL EXPRESSION; ELECTRON-TRANSPORT; N-ACETYLCYSTEINE; ANTIOBESITY DRUG; SKELETAL-MUSCLE; ORLISTAT; DEATH	The metabolic enzyme fatty acid synthase (FASN) is responsible for the endogenous synthesis of palmitate, a saturated long-chain fatty acid. In contrast to most normal tissues, a variety of human cancers overexpress FASN. One such cancer is cutaneous melanoma, in which the level of FASN expression is associated with tumor invasion and poor prognosis. We previously reported that two FASN inhibitors, cerulenin and orlistat, induce apoptosis in B16-F10 mouse melanoma cells via the intrinsic apoptosis pathway. Here, we investigated the effects of these inhibitors on non-tumorigenic melan-a cells. Cerulenin-and orlistat treatments were found to induce apoptosis and decrease cell proliferation, in addition to inducing the release of mitochondrial cytochrome c and activating caspases-9 and -3. Transfection with FASN siRNA did not result in apoptosis. Mass spectrometry analysis demonstrated that treatment with the FASN inhibitors did not alter either the mitochondrial free fatty acid content or composition. This result suggests that cerulenin- and orlistat-induced apoptosis events are independent of FASN inhibition. Analysis of the energy-linked functions of melan-a mitochondria demonstrated the inhibition of respiration, followed by a significant decrease in mitochondrial membrane potential (Delta psi m) and the stimulation of superoxide anion generation. The inhibition of NADH-linked substrate oxidation was approximately 40% and 61% for cerulenin and orlistat treatments, respectively, and the inhibition of succinate oxidation was approximately 46% and 52%, respectively. In contrast, no significant inhibition occurred when respiration was supported by the complex IV substrate N,N,N',N' -tetramethyl-p-phenylenediamine (TMPD). The protection conferred by the free radical scavenger acetyl-cysteine indicates that the FASN inhibitors induced apoptosis through an oxidative stress-associated mechanism. In combination, the present results demonstrate that cerulenin and orlistat induce apoptosis in non-tumorigenic cells via mitochondrial dysfunction, independent of FASN inhibition.	[Rossato, Franco A.; Zecchin, Karina G.; La Guardia, Paolo G.; Costa, Rute A. P.; Catharino, Rodrigo R.; Castilho, Roger F.; Vercesi, Anibal E.] Univ Estadual Campinas UNICAMP, Fac Ciencias Med, Dept Patol Clin, Campinas, SP, Brazil; [Zecchin, Karina G.; Ortega, Rose M.; Graner, Edgard] Univ Estadual Campinas UNICAMP, Fac Odontol Piracicaba, Dept Diagnost Oral, Piracicaba, SP, Brazil; [Alberici, Luciane C.] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Dept Quim & Fis, BR-14049 Ribeirao Preto, SP, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade de Sao Paulo	Vercesi, AE (corresponding author), Univ Estadual Campinas UNICAMP, Fac Ciencias Med, Dept Patol Clin, Campinas, SP, Brazil.	anibal@unicamp.br	Alberici, Luciane C/J-3013-2015; Graner, Edgard/K-4411-2012; Catharino, Rodrigo/AAH-4333-2021; Zecchin, Karina G/F-5298-2013; Catharino, Rodrigo/G-1487-2013; Graner, Edgard/P-4651-2019; Castilho, Roger F/G-3906-2012; Vercesi, Aníbal E/C-8767-2012; Rossato, Franco Aparecido/K-7981-2014	Alberici, Luciane C/0000-0002-7464-9385; Graner, Edgard/0000-0002-4737-7935; Catharino, Rodrigo/0000-0001-7219-2644; Catharino, Rodrigo/0000-0001-7219-2644; Castilho, Roger/0000-0003-2338-8717; Rossato, Franco Aparecido/0000-0002-4132-2271; Vercesi, Anibal Eugenio/0000-0001-6671-7125	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [06/59786-0, 07/54639-1, 08/57471- 7, 11/50400-0]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [470539/2008-9]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP -06/59786-0, 07/54639-1, 08/57471- 7, and 11/50400-0), Coordenacao, de Aperfeic,oamento de Pessoal de Nivel Superior (CAPES), and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico ( CNPq - 470539/2008-9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini M, 2004, ORAL ONCOL, V40, P728, DOI 10.1016/j.oraloncology.2004.01.011; Almeida JP, 2005, J PERIODONTOL, V76, P272, DOI 10.1902/jop.2005.76.2.272; Alo PL, 2000, ONCOL REP, V7, P1383; ARUOMA OI, 1989, FREE RADICAL BIO MED, V6, P593, DOI 10.1016/0891-5849(89)90066-X; Balkova P, 2011, PHYSIOL RES, V60, P467, DOI 10.33549/physiolres.932042; Bandyopadhyay S, 2006, CANCER RES, V66, P5934, DOI 10.1158/0008-5472.CAN-05-3197; Baron A, 2004, J CELL BIOCHEM, V91, P47, DOI 10.1002/jcb.10708; BENNETT DC, 1987, INT J CANCER, V39, P414, DOI 10.1002/ijc.2910390324; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Browne CD, 2006, FASEB J, V20, P2027, DOI 10.1096/fj.05-5404com; Campos CBL, 2004, BIOCHEM PHARMACOL, V68, P2197, DOI 10.1016/j.bcp.2004.08.006; Campos CBL, 2006, CYTOM PART A, V69A, P515, DOI 10.1002/cyto.a.20273; Carvalho MA, 2008, INT J CANCER, V123, P2557, DOI 10.1002/ijc.23835; Chajes V, 2006, CANCER RES, V66, P5287, DOI 10.1158/0008-5472.CAN-05-1489; Chirala SS, 2001, P NATL ACAD SCI USA, V98, P3104, DOI 10.1073/pnas.051635998; Chirala SS, 2003, P NATL ACAD SCI USA, V100, P6358, DOI 10.1073/pnas.0931394100; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; da Silva SD, 2009, ORAL ONCOL, V45, pE134, DOI 10.1016/j.oraloncology.2009.02.004; Deepa PR, 2012, BASIC CLIN PHARMACOL, V110, P494, DOI 10.1111/j.1742-7843.2011.00844.x; Dowling S, 2009, LIPIDS, V44, P489, DOI 10.1007/s11745-009-3298-2; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; EPSTEIN JI, 1995, UROLOGY, V45, P81, DOI 10.1016/S0090-4295(95)96904-7; Figueira TR, 2013, ANTIOXID REDOX SIGN, V18, P2029, DOI 10.1089/ars.2012.4729; Figueira TR, 2012, METHODS MOL BIOL, V810, P103, DOI 10.1007/978-1-61779-382-0_7; Gansler TS, 1997, HUM PATHOL, V28, P686, DOI 10.1016/S0046-8177(97)90177-5; Heiligtag SJ, 2002, CELL DEATH DIFFER, V9, P1017, DOI 10.1038/sj.cdd.4401055; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Ho TS, 2007, BIOMED PHARMACOTHER, V61, P578, DOI 10.1016/j.biopha.2007.08.020; HOLDEN MJ, 1989, PLANT PHYSIOL, V91, P1296, DOI 10.1104/pp.91.4.1296; Innocenzi D, 2003, J CUTAN PATHOL, V30, P23, DOI 10.1034/j.1600-0560.2003.300104.x; Kapur P, 2005, MODERN PATHOL, V18, P1107, DOI 10.1038/modpathol.3800395; Knowles LM, 2004, J BIOL CHEM, V279, P30540, DOI 10.1074/jbc.M405061200; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Kothakota S, 1997, SCIENCE, V278, P294, DOI 10.1126/science.278.5336.294; Kridel SJ, 2004, CANCER RES, V64, P2070, DOI 10.1158/0008-5472.can-03-3645; Krontiras H, 1999, HEAD NECK-J SCI SPEC, V21, P325, DOI 10.1002/(SICI)1097-0347(199907)21:4<325::AID-HED6>3.3.CO;2-G; Kuhajda FP, 2000, P NATL ACAD SCI USA, V97, P3450, DOI 10.1073/pnas.050582897; Kuhajda FP, 2000, NUTRITION, V16, P202, DOI 10.1016/S0899-9007(99)00266-X; Kumar-Sinha C, 2003, CANCER RES, V63, P132; Kusakabe T, 2002, HISTOPATHOLOGY, V40, P71, DOI 10.1046/j.1365-2559.2002.01289.x; La Guardia PG, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00103; Li JN, 2001, CANCER RES, V61, P1493; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Liu XS, 2006, MOL CANCER THER, V5, P494, DOI 10.1158/1535-7163.MCT-05-0049; MAYER M, 1994, P NATL ACAD SCI USA, V91, P7496, DOI 10.1073/pnas.91.16.7496; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Menendez JA, 2005, ANN ONCOL, V16, P1253, DOI 10.1093/annonc/mdi239; Menendez JA, 2005, EXP BIOL MED, V230, P151; Milgraum LZ, 1997, CLIN CANCER RES, V3, P2115; Nemoto T, 2001, PATHOBIOLOGY, V69, P297, DOI 10.1159/000064636; Ogino S, 2008, J CLIN ONCOL, V26, P5713, DOI [10.1200/JCO.2008.18.2675, 10.1200/JCO.2009.22.8858]; Oliveira KAP, 2008, J BIOENERG BIOMEMBR, V40, P307, DOI 10.1007/s10863-008-9155-9; Panov A, 2005, J BIOL CHEM, V280, P42026, DOI 10.1074/jbc.M508628200; Payne CM, 2007, CARCINOGENESIS, V28, P215, DOI 10.1093/carcin/bgl139; Piyathilake CJ, 2000, HUM PATHOL, V31, P1068, DOI 10.1053/hupa.2000.9842; Pizer ES, 1996, CANCER RES, V56, P1189; Pizer ES, 2000, CANCER RES, V60, P213; Pizer ES, 1996, CANCER RES, V56, P2745; Pizer ES, 1998, CANCER RES, V58, P4611; Pizer ES, 2000, P AM ASSOC CANC RES, V41, P655; Rangan VS, 2001, BIOCHEMISTRY-US, V40, P10792, DOI 10.1021/bi015535z; Ricci JE, 2004, CELL, V117, P773, DOI 10.1016/j.cell.2004.05.008; Ricci JE, 2003, J CELL BIOL, V160, P65, DOI 10.1083/jcb.200208089; Richardson RD, 2007, MOL CANCER THER, V6, P2120, DOI 10.1158/1535-7163.MCT-07-0187; Rossi S, 2006, J PATHOL, V209, P369, DOI 10.1002/path.1983; Rossi S, 2003, MOL CANCER RES, V1, P707; Rudel T, 1998, J IMMUNOL, V160, P7; Sahara S, 1999, NATURE, V401, P168, DOI 10.1038/43678; Seguin F, 2012, BRIT J CANCER, V107, P977, DOI 10.1038/bjc.2012.355; Silva SD, 2008, VIRCHOWS ARCH, V453, P57, DOI 10.1007/s00428-008-0626-5; Silva SD, 2004, ORAL ONCOL, V40, P688, DOI 10.1016/j.oraloncology.2004.01.004; Sirvent P, 2005, BIOCHEM BIOPH RES CO, V338, P1426, DOI 10.1016/j.bbrc.2005.10.108; STOOPS JK, 1981, J BIOL CHEM, V256, P5128; Swinnen JV, 2002, INT J CANCER, V98, P19, DOI 10.1002/ijc.10127; Takahiro T, 2003, CLIN CANCER RES, V9, P2204; TSUKAMOTO Y, 1983, J BIOL CHEM, V258, P5312; TYMIANSKI M, 1993, J NEUROSCI, V13, P2085; Ueda SM, 2010, J ONCOL, V2010, DOI 10.1155/2010/285191; VERCESI AE, 1991, J BIOL CHEM, V266, P14431; Vercesi AE, 1998, J BIOL CHEM, V273, P31040, DOI 10.1074/jbc.273.47.31040; Visca P, 1999, CLIN CANCER RES, V5, P4111; Visca P, 2003, ANTICANCER RES, V23, P335; Vlad LD, 1999, MODERN PATHOL, V12, P70; Walter K, 2009, CANCER EPIDEM BIOMAR, V18, P2380, DOI 10.1158/1055-9965.EPI-09-0144; WEISS L, 1986, BIOL CHEM H-S, V367, P905, DOI 10.1515/bchm3.1986.367.2.905; Wu CC, 2013, ANTIOXID REDOX SIGN, V19, P546, DOI 10.1089/ars.2012.4905; Xia J, 2009, NUCLEIC ACIDS RES, V40, pW127, DOI DOI 10.1093/NAR/GKS374; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Zecchin KG, 2007, J BIOENERG BIOMEMBR, V39, P186, DOI 10.1007/s10863-007-9076-z; Zecchin KG, 2011, LAB INVEST, V91, P232, DOI 10.1038/labinvest.2010.157; Zecchin KG, 2011, RAPID COMMUN MASS SP, V25, P449, DOI 10.1002/rcm.4875; Zhang JH, 2003, AGEING RES REV, V2, P357, DOI 10.1016/S1568-1637(03)00026-6; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	95	29	33	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e101060	10.1371/journal.pone.0101060	http://dx.doi.org/10.1371/journal.pone.0101060			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964211	Green Published, gold, Green Submitted			2022-12-27	WOS:000338709500116
J	Schilder, AJ; Anema, A; Pai, J; Rich, A; Miller, CL; Chan, K; Strathdee, SA; Moore, D; Montaner, JSG; Hogg, RS				Schilder, Arn J.; Anema, Aranka; Pai, Jay; Rich, Ashleigh; Miller, Cari L.; Chan, Keith; Strathdee, Steffanie A.; Moore, David; Montaner, Julio S. G.; Hogg, Robert S.			Association between Childhood Physical Abuse, Unprotected Receptive Anal Intercourse and HIV Infection among Young Men Who Have Sex with Men in Vancouver, Canada	PLOS ONE			English	Article							TRANSMISSION RISK BEHAVIOR; UNITED-STATES; POSITIVE MEN; ANTIRETROVIRAL THERAPY; DOMESTIC VIOLENCE; SUBSTANCE-ABUSE; HEALTH OUTCOMES; BISEXUAL MEN; HISTORY; ADULTS	Introduction: The association between childhood sexual abuse and HIV risk among men who have sex with men (MSM) is well established. However, no studies have examined the potential impact of other forms of childhood maltreatment on HIV incidence in this population. Methods: We explored the impact of child physical abuse (CPA) on HIV seroconversion in a cohort of gay/bisexual men aged 15 to 30 in Vancouver, Canada. Cox proportional hazard models were used, controlling for confounders. Results: Among 287 participants, 211 (73.5%) reported experiencing CPA before the age of 17, and 42 (14.6%) reporting URAI in the past year. After a median of 6.6 years follow-up, 16 (5.8%) participants HIV-seroconverted. In multivariate analysis, CPA was significantly associated with HIV seroconversion (adjusted hazard ratio [AHR] = 4.89, 95% confidence interval (CI): 1.65-14.48), after controlling for potential confounders. Conclusion: Our study uncovered a link between childhood physical violence and HIV incidence. Results highlight an urgent need for screening of young gay and bisexual men for histories of violence, and social and structural supports to prevent HIV transmission in this population.	[Schilder, Arn J.; Anema, Aranka; Pai, Jay; Rich, Ashleigh; Chan, Keith; Strathdee, Steffanie A.; Moore, David; Montaner, Julio S. G.; Hogg, Robert S.] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Miller, Cari L.; Hogg, Robert S.] Simon Fraser, Fac Hlth Sci, Burnaby, BC, Canada; [Strathdee, Steffanie A.] Univ Calif San Diego, Dept Med, Div Global Publ Hlth, San Diego, CA 92103 USA; [Moore, David; Montaner, Julio S. G.] Univ British Columbia, Fac Med, Vancouver, BC, Canada	B.C. Centre for Excellence in HIV/AIDS; Simon Fraser University; University of California System; University of California San Diego; University of British Columbia	Hogg, RS (corresponding author), British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada.	robert_hogg@sfu.ca	Strathdee, Steffanie A/B-9042-2009; Hogg, Robert S/B-2783-2012	Hogg, Robert S/0000-0003-3463-5488; Rich, Ashleigh/0000-0003-3742-7086; Strathdee, Steffanie/0000-0002-7724-691X	Canadian Institutes for Health Research (CIHR); British Columbia Ministry of Health; National Institute of Drug Abuse (NIDA), at the US National Institutes of Health (NIH) [1DP1DA026182]; Canadian Institutes of Health Research (CIHR); International AIDS Society; United Nations AIDS Program; World Health Organization; National Institutes of Health Research-Office of AIDS Research; National Institute of Allergy & Infectious Diseases; United States President's Emergency Plan for AIDS Relief (PEPfAR); UNICEF; University of British Columbia; Simon Fraser University; Providence Health Care; Vancouver Coastal Health Authority; National Institutes of Health; Canadian Institutes of Health Research National Health Research Development Program; Health Canada; Agouron Pharmaceuticals Inc; Boehringer Ingelheim Pharmaceuticals Inc; Bristol-Myers Squibb; GlaxoSmithKline; Merck Frosst Laboratories; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA031055, R01DA019829, R01DA036307, R37DA019829] Funding Source: NIH RePORTER	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); British Columbia Ministry of Health; National Institute of Drug Abuse (NIDA), at the US National Institutes of Health (NIH); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); International AIDS Society; United Nations AIDS Program; World Health Organization(World Health Organization); National Institutes of Health Research-Office of AIDS Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy & Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); United States President's Emergency Plan for AIDS Relief (PEPfAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); UNICEF; University of British Columbia; Simon Fraser University; Providence Health Care; Vancouver Coastal Health Authority; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research National Health Research Development Program(Canadian Institutes of Health Research (CIHR)); Health Canada; Agouron Pharmaceuticals Inc; Boehringer Ingelheim Pharmaceuticals Inc(Boehringer Ingelheim); Bristol-Myers Squibb(Bristol-Myers Squibb); GlaxoSmithKline(GlaxoSmithKline); Merck Frosst Laboratories; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was funded by the Canadian Institutes for Health Research (CIHR). Dr. Julio Montaner is supported by the British Columbia Ministry of Health; through an Avant-Garde Award (No. 1DP1DA026182) from the National Institute of Drug Abuse (NIDA), at the US National Institutes of Health (NIH); and through a KT Award from the Canadian Institutes of Health Research (CIHR). He has also received financial support from the International AIDS Society, United Nations AIDS Program, World Health Organization, National Institutes of Health Research-Office of AIDS Research, National Institute of Allergy & Infectious Diseases, The United States President's Emergency Plan for AIDS Relief (PEPfAR), UNICEF, the University of British Columbia, Simon Fraser University, Providence Health Care and Vancouver Coastal Health Authority. Dr. Robert Hogg has held grants from the National Institutes of Health, Canadian Institutes of Health Research National Health Research Development Program, and Health Canada. He has also received funding from Agouron Pharmaceuticals Inc, Boehringer Ingelheim Pharmaceuticals Inc, Bristol-Myers Squibb, GlaxoSmithKline, and Merck Frosst Laboratories for participating in continued medical education programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anda RF, 2006, EUR ARCH PSY CLIN N, V256, P174, DOI 10.1007/s00406-005-0624-4; Arreola SG, 2009, AM J PUBLIC HEALTH, V99, pS432, DOI 10.2105/AJPH.2008.138925; Beattie N, 2009, J NERV MENT DIS, V197, P56, DOI 10.1097/NMD.0b013e31819273a8; Bensley LS, 2000, AM J PREV MED, V18, P151, DOI 10.1016/S0749-3797(99)00084-7; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Brennan DJ, 2007, AM J PUBLIC HEALTH, V97, P1107, DOI 10.2105/AJPH.2005.071423; Briere J, 2003, CHILD ABUSE NEGLECT, V27, P1205, DOI 10.1016/j.chiabu.2003.09.008; Buckingham ET, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-012-0342-3; Canada PHA, 2009, EST HIV PREV INC CAN; CARBALLODIEGUEZ A, 1995, CHILD ABUSE NEGLECT, V19, P595, DOI 10.1016/0145-2134(95)00018-4; Catania JA, 2008, CHILD ABUSE NEGLECT, V32, P925, DOI 10.1016/j.chiabu.2007.12.010; Cohen M, 2000, AM J PUBLIC HEALTH, V90, P560, DOI 10.2105/AJPH.90.4.560; Corliss HL, 2002, CHILD ABUSE NEGLECT, V26, P1165, DOI 10.1016/S0145-2134(02)00385-X; CUNNINGHAM RN, 1994, CHILD ABUSE NEGLECT, V18, P233, DOI 10.1016/0145-2134(94)90108-2; Currie J, 2010, CHILD MALTREATMENT, V15, P111, DOI 10.1177/1077559509355316; Diaz RM, 1999, HISPANIC J BEHAV SCI, V21, P480, DOI 10.1177/0739986399214007; Dube SR, 2010, PREV CHRONIC DIS, V7; Epstein Michelle A, 2002, Child Maltreat, V7, P210, DOI 10.1177/1077559502007003004; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; Fuller-Thomson E, 2012, SUICIDE LIFE-THREAT, V42, P279, DOI 10.1111/j.1943-278X.2012.00089.x; Gilbert R, 2009, LANCET, V373, P68, DOI 10.1016/S0140-6736(08)61706-7; Greenfield EA, 2001, CHILD ABUSE NEGL, V34, P161; Greenfield EA, 2009, J AGING HEALTH, V21, P943, DOI 10.1177/0898264309343905; Griffing S, 2006, J INTERPERS VIOLENCE, V21, P936, DOI 10.1177/0886260506288938; Grulich AE, 2010, INT J EPIDEMIOL, V39, P1064, DOI 10.1093/ije/dyq101; Hall HI, 2008, JAIDS-J ACQ IMM DEF, V49, P294, DOI 10.1097/QAI.0b013e3181893f17; Hart GJ, 2010, CURR OPIN INFECT DIS, V23, P39, DOI 10.1097/QCO.0b013e328334feb1; Herida M, 2007, EUROSURVEILLANCE EUR, V12; Herrenkohl RC, 2005, CHILD ABUSE NEGLECT, V29, P413, DOI 10.1016/j.chiabu.2005.04.002; Hogg RS, 2001, AIDS, V15, P1321, DOI 10.1097/00002030-200107060-00020; Jacobs RJ, 2010, AIDS CARE, V22, P1204, DOI 10.1080/09540121003615137; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; Jinich S, 1998, AIDS BEHAV, V2, P41, DOI DOI 10.1023/A:1022307323744; Jong E, 2010, AIDS, V24, P1387, DOI 10.1097/QAD.0b013e328339d004; Joseph HA, 2011, SEX TRANSM INFECT, V87, P442, DOI 10.1136/sextrans-2011-050010; Kalichman Seth C, 2004, J Child Sex Abus, V13, P1, DOI 10.1300/J070v13n01_01; Lampinen TM, 2005, JAIDS-J ACQ IMM DEF, V40, P242, DOI 10.1097/01.qai.0000168182.14523.d4; Lampinen TM, 2005, CAN MED ASSOC J, V172, P479, DOI 10.1503/cmaj.1031785; Leeb RebeccaT., 2008, CHILD MALTREATMENT; Lenderking WR, 1997, J GEN INTERN MED, V12, P250, DOI 10.1046/j.1525-1497.1997.012004250.x; Levitan RD, 1998, AM J PSYCHIAT, V155, P1746, DOI 10.1176/ajp.155.12.1746; Lima VD, 2007, AIDS, V21, P1175, DOI 10.1097/QAD.0b013e32811ebf57; Liu Y, 2013, SOC PSYCH PSYCH EPID, V48, P357, DOI 10.1007/s00127-012-0554-1; Lloyd S, 2012, AIDS EDUC PREV, V24, P228, DOI 10.1521/aeap.2012.24.3.228; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; McLaughlin KA, 2012, CHILD ABUSE NEGLECT, V36, P645, DOI 10.1016/j.chiabu.2012.07.004; Meade CS, 2009, AIDS BEHAV, V13, P207, DOI 10.1007/s10461-007-9326-4; Milloy MJ, 2012, AIDS PATIENT CARE ST, V26, P60, DOI 10.1089/apc.2011.0169; Mimiaga MJ, 2009, JAIDS-J ACQ IMM DEF, V51, P340, DOI 10.1097/QAI.0b013e3181a24b38; Newman PA, 2004, AM J PUBLIC HEALTH, V94, P1998, DOI 10.2105/AJPH.94.11.1998; O'Leary A, 2003, AIDS CARE, V15, P17, DOI 10.1080/0954012021000039725; Paul JP, 2001, CHILD ABUSE NEGLECT, V25, P557, DOI 10.1016/S0145-2134(01)00226-5; Pence BW, 2007, SOUTH MED J, V100, P1114, DOI 10.1097/01.smj.0000286756.54607.9f; Pence BW, 2009, J ANTIMICROB CHEMOTH, V63, P636, DOI 10.1093/jac/dkp006; Purcell DW, 2001, J SUBST ABUSE, V13, P185, DOI 10.1016/S0899-3289(01)00072-4; Roberts AL, 2010, AM J PUBLIC HEALTH, V100, P2433, DOI 10.2105/AJPH.2009.168971; Rocha GM, 2013, AIDS BEHAV      0117, V17; Rodgers CS, 2004, CHILD ABUSE NEGLECT, V28, P575, DOI 10.1016/j.chiabu.2004.01.002; Rosenberg M., 1979, CONCEIVING SELF; Rothman K., 1998, MODERN EPIDEMIOLOGY; Saunders BE, 2003, J INTERPERS VIOLENCE, V18, P356, DOI 10.1177/0886260502250840; Scott KM, 2011, ARCH GEN PSYCHIAT, V68, P838, DOI 10.1001/archgenpsychiatry.2011.77; Seedat S, 2012, CURR HIV-AIDS REP, V9, P344, DOI 10.1007/s11904-012-0139-3; Sikkema KJ, 2007, AIDS BEHAV, V11, P49, DOI 10.1007/s10461-006-9149-8; Strathdee SA, 2000, CAN MED ASSOC J, V162, P21; United States Centres for Disease Control and Prevention (CDC) Adverse Childhood Experiences (ACE) Study, DAT STAT PREV IND AD; Welles SL, 2009, AM J PUBLIC HEALTH, V99, P1079, DOI 10.2105/AJPH.2007.133280; Wolitski RJ, 2011, AIDS BEHAV, V15, pS9, DOI 10.1007/s10461-011-9901-6; Wu NS, 2010, ADDICT BEHAV, V35, P68, DOI 10.1016/j.addbeh.2009.09.003; Zielinski DS, 2009, CHILD ABUSE NEGLECT, V33, P666, DOI 10.1016/j.chiabu.2009.09.001	70	16	17	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100501	10.1371/journal.pone.0100501	http://dx.doi.org/10.1371/journal.pone.0100501			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK8WO	24963804	Green Published, gold, Green Submitted			2022-12-27	WOS:000338709500057
J	Vyrastekova, J; Huisman, J; Mosha, I; Smits, J				Vyrastekova, Jana; Huisman, Janine; Mosha, Idda; Smits, Jeroen			Mothers More Altruistic than Fathers, but Only When Bearing Responsibility Alone: Evidence from Parental Choice Experiments in Tanzania	PLOS ONE			English	Article							PATERNAL INVESTMENT; SEXUAL SELECTION; HUMAN FAMILY; EVOLUTION; BEHAVIOR; RESEMBLANCE; PREFERENCES; FERTILITY; ORIGINS; MODEL	Evolutionary theory predicts humans to be more altruistic towards genetically more closely related kin. Because fathers face uncertainty about the relation to their children, the asymmetric parental altruism hypothesis predicts mothers to provide a higher share of parental care than fathers. We tested this hypothesis using parental choice experiments in rural Tanzania, in which fathers and mothers could choose between an outcome that benefited themselves and an outcome that benefited their children. When a parent was solely responsible for the outcome, mothers chose more altruistic than fathers. However when the choice situation was changed into a coordination game in which responsibility was shared with the partner, the sex difference disappeared. Fathers then chose somewhat more altruistic, but mothers substantially less. Our findings thus partly support the asymmetric parental altruism hypothesis, but they also show that parental altruism is influenced by the context in which choices are taken.	[Vyrastekova, Jana; Smits, Jeroen] Radboud Univ Nijmegen, Nijmegen Ctr Econ, IMR, Nijmegen, Netherlands; [Huisman, Janine] Radboud Univ Nijmegen, Ctr Int Dev Issues Nijmegen CIDIN, Nijmegen, Netherlands; [Mosha, Idda] Muhimbili Univ Hlth & Allied Sci, Sch Publ Hlth & Social Sci, Dar Es Salaam, Tanzania	Radboud University Nijmegen; Radboud University Nijmegen; Muhimbili University of Health & Allied Sciences	Vyrastekova, J (corresponding author), Radboud Univ Nijmegen, Nijmegen Ctr Econ, IMR, Nijmegen, Netherlands.	J.Vyrastekova@fm.ru.nl	smits, jeroen pjm/D-3840-2012; Mosha, Idda H./ABG-4870-2021	smits, jeroen pjm/0000-0002-5802-975X; Mosha, Idda H./0000-0002-5550-1924	The William and Flora Hewlett Foundation; Netherlands Organisation for Scientific Research (NWO); WOTRO Science for Global Development [W07.40.201.00]	The William and Flora Hewlett Foundation; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); WOTRO Science for Global Development	This research was made possible by a grant from The William and Flora Hewlett Foundation and the Netherlands Organisation for Scientific Research (NWO), WOTRO Science for Global Development, project nr. W07.40.201.00. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alger I, 2013, REV ECON HOUSEHOLD, V11, P421, DOI 10.1007/s11150-013-9201-1; Alvergne A, 2009, ANIM BEHAV, V78, P61, DOI 10.1016/j.anbehav.2009.03.019; BARRO RJ, 1989, ECONOMETRICA, V57, P481, DOI 10.2307/1912563; Becker Gary S., 1991, TREATISE FAMILY, DOI DOI 10.4159/9780674020665; Bergstrom TC, 1997, HDB POPULATION FAMIL; Bishop DI, 2009, EVOL PSYCHOL, V7, P66, DOI 10.1177/147470490900700109; Burdette AM, 2007, J FAM ISSUES, V28, P1553, DOI 10.1177/0192513X07304269; Campbell B., 1972, SEXUAL SELECTION DES, DOI DOI 10.1002/AJPA.1330400226; DALY M, 1980, J MARRIAGE FAM, V42, P277, DOI 10.2307/351225; Davis JN, 1997, Q REV BIOL, V72, P407, DOI 10.1086/419953; Doss C, 2006, J AFR ECON, V15, P149, DOI 10.1093/jae/eji025; Eswaran M, 2004, CAN J ECON, V37, P918, DOI 10.1111/j.0008-4085.2004.00254.x; FORSYTHE R, 1994, GAME ECON BEHAV, V6, P347, DOI 10.1006/game.1994.1021; GAULIN SJC, 1980, ETHOL SOCIOBIOL, V1, P301, DOI 10.1016/0162-3095(80)90015-1; Gavrilets S, 2012, P NATL ACAD SCI USA, V109, P9923, DOI 10.1073/pnas.1200717109; Geary DC, 2001, PARENT-SCI PRACT, V1, P5, DOI 10.1207/S15327922PAR011&2_2; Geary DC., 2005, EVOLUTIONARY PSYCHOL, P483; Greig F, 2009, J ECON BEHAV ORGAN, V70, P1, DOI 10.1016/j.jebo.2008.12.006; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hardy MA, 1993, REGRESSION DUMMY VAR, V93; HODDINOTT J, 1995, OXFORD B ECON STAT, V57, P77, DOI 10.1111/j.1468-0084.1995.tb00028.x; Humphrey N., 1976, GROWING POINTS ETHOL, P303; Kaplan HS, 2003, OFFSPRING, P170; Kokko H, 2008, J EVOLUTION BIOL, V21, P919, DOI 10.1111/j.1420-9101.2008.01540.x; Kokko H, 2012, EVOLUTION OF PARENTAL CARE, P101; Kollmann R, 1997, J POPUL ECON, V10, P87, DOI 10.1007/s001480050032; Korn E, 2000, PUBLIC CHOICE, V105, P357, DOI 10.1023/A:1005198714654; Kuijper B, 2012, ANNU REV ECOL EVOL S, V43, P287, DOI 10.1146/annurev-ecolsys-110411-160245; Luce R. D., 1989, GAMES DECISIONS INTR; Madsen EA, 2006, BRIT J PSYCHOL, V98, P1; Quisumbing A. R., 2007, FOOD POLICY DEV COUN; Sear R, 2002, DEMOGRAPHY, V39, P43, DOI 10.1353/dem.2002.0010; Sear R, 2008, EVOL HUM BEHAV, V29, P1, DOI 10.1016/j.evolhumbehav.2007.10.001; Strassmann B I, 1992, Hum Nat, V3, P89, DOI 10.1007/BF02692249; Strassmann BI, 2012, P NATL ACAD SCI USA, V109, P9781, DOI 10.1073/pnas.1110442109; THOMAS D, 1990, J HUM RESOUR, V25, P635, DOI 10.2307/145670; Tomasello M, 2005, BEHAV BRAIN SCI, V28, P675, DOI 10.1017/S0140525X05000129; Welling LLM, 2011, EVOL HUM BEHAV, V32, P118, DOI 10.1016/j.evolhumbehav.2010.11.001	38	4	4	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e99952	10.1371/journal.pone.0099952	http://dx.doi.org/10.1371/journal.pone.0099952			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK8WO	24964142	Green Published, Green Submitted, gold			2022-12-27	WOS:000338709500025
J	Xu, S; Xu, WD; Chen, W; He, XY; Huang, YQ; Wen, H				Xu, Sheng; Xu, Wenduo; Chen, Wei; He, Xingyuan; Huang, Yanqing; Wen, Hua			Leaf Phenological Characters of Main Tree Species in Urban Forest of Shenyang	PLOS ONE			English	Article							CANOPY; PLANTS; PHOTOSYNTHESIS; LONGEVITIES; DYNAMICS; GROWTH; CHINA	Background: Plant leaves, as the main photosynthetic organs and the high energy converters among primary producers in terrestrial ecosystems, have attracted significant research attention. Leaf lifespan is an adaptive characteristic formed by plants to obtain the maximum carbon in the long-term adaption process. It determines important functional and structural characteristics exhibited in the environmental adaptation of plants. However, the leaf lifespan and leaf characteristics of urban forests were not studied up to now. Methods: By using statistic, linear regression methods and correlation analysis, leaf phenological characters of main tree species in urban forest of Shenyang were observed for five years to obtain the leafing phenology (including leafing start time, end time, and duration), defoliating phenology (including defoliation start time, end time, and duration), and the leaf lifespan of the main tree species. Moreover, the relationships between temperature and leafing phenology, defoliating phenology, and leaf lifespan were analyzed. Findings: The timing of leafing differed greatly among species. The early leafing species would have relatively early end of leafing; the longer it took to the end of leafing would have a later time of completed leafing. The timing of defoliation among different species varied significantly, the early defoliation species would have relatively longer duration of defoliation. If the mean temperature rise for 1uC in spring, the time of leafing would experience 5 days earlier in spring. If the mean temperature decline for 1 degrees C, the time of defoliation would experience 3 days delay in autumn. Interpretation: There is significant correlation between leaf longevity and the time of leafing and defoliation. According to correlation analysis and regression analysis, there is significant correlation between temperature and leafing and defoliation phenology. Early leafing species would have a longer life span and consequently have advantage on carbon accumulation compared with later defoliation species.	[Xu, Sheng; Xu, Wenduo; Chen, Wei; He, Xingyuan; Huang, Yanqing; Wen, Hua] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS	He, XY (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China.	hexy1962@126.com	huang, yan/GWM-4747-2022		National Natural Science Foundation of China [31270518, 31170573]; Key Project of NNSFC [90411019]; Key Project in the National Science and Technology Pillar Program [2012BAC05B05]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of NNSFC; Key Project in the National Science and Technology Pillar Program	The study was supported by National Natural Science Foundation of China (31270518, 31170573), and Key Project of NNSFC (90411019), and Key Project in the National Science and Technology Pillar Program (2012BAC05B05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHABOT BF, 1982, ANNU REV ECOL SYST, V13, P229, DOI 10.1146/annurev.es.13.110182.001305; Coley PD, 1996, ANNU REV ECOL SYST, V27, P305, DOI 10.1146/annurev.ecolsys.27.1.305; [段喜华 Duan Xihua], 2003, [植物研究, Bulletin of Botanical Research], V23, P334; GOWER ST, 1993, TREE PHYSIOL, V12, P327, DOI 10.1093/treephys/12.4.327; Hang Yue-yu, 2004, Acta Botanica Yunnanica, V26, P398; HANNINEN H, 1995, CAN J BOT, V73, P183, DOI 10.1139/b95-022; [何兴元 He Xingyuan], 2003, [生态学杂志, Chinese Journal of Ecology], V22, P162; Hu Jianbo, 2006, Shengtaixue Zazhi, V25, P1455; KIKUZAWA K, 1995, CAN J BOT, V73, P158, DOI 10.1139/b95-019; Kikuzawa K, 1995, VEGETATIO, V121, P89, DOI 10.1007/BF00044675; KIKUZAWA K, 1991, AM NAT, V138, P1250, DOI 10.1086/285281; Kitajima K, 1997, AM J BOT, V84, P702, DOI 10.2307/2445906; Kttppers M, 1984, OECOLOGIA, V64, P332; KULL O, 1995, PLANT CELL ENVIRON, V18, P1174, DOI 10.1111/j.1365-3040.1995.tb00627.x; Li DW, 2011, APPL MECH MATER, V71-78, P2891, DOI 10.4028/www.scientific.net/AMM.71-78.2891; Lin XianQing, 2003, Chinese Journal of Rice Science, V17, P281; Liu Chang-fu, 2008, Yingyong Shengtai Xuebao, V19, P1173; Liu CF, 2012, URBAN FOR URBAN GREE, V11, P121, DOI 10.1016/j.ufug.2011.03.002; Liu J., 2007, J CHANGCHUN U TRADIT, V23, P29; MAILLETTE L, 1982, J APPL ECOL, V19, P203, DOI 10.2307/2403005; McDowell SCL, 2002, AM J BOT, V89, P1431, DOI 10.3732/ajb.89.9.1431; REICH PB, 1992, ECOL MONOGR, V62, P365, DOI 10.2307/2937116; Seiwa K, 1998, J ECOL, V86, P219, DOI 10.1046/j.1365-2745.1998.00245.x; Song L, 2007, J LIAONING TECHNICAL, V26, P136; SUN SC, 1998, ACTA PHYTOECOL SIN, V22, P538; Wan M., 1979, METHOD PHENOLOGY OBS; Wang X., 2000, ACTA PHYTOECOL SIN, V24, P625; Wenduo X., 1983, CHIN B BOTANY, V25, P264; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Xu CY, 2007, OECOLOGIA, V154, P11, DOI 10.1007/s00442-007-0807-y; Xu W., 1985, CHINESE J ECOL, V3, P35; Xu WD, 2005, CHIN J APPL ECOL, V16; Xu WD, 2004, CHIN J APPL ECOL, V14, P2095; Xu Wen-duo, 2008, Shengtaixue Zazhi, V27, P1461; Xu Wenduo, 2006, Yingyong Shengtai Xuebao, V17, P1777; Xu Wenduo, 2006, Yingyong Shengtai Xuebao, V17, P1999; [徐雨晴 Xu Yuqing], 2005, [地理研究, Geographical Research], V24, P412; Yang YF, 2003, CHIN J APPL ECOL, V14, P30; Zhang FC, 1995, ACTA GEOGR SIN, V50, P402; Zhang Lin, 2004, Acta Phytoecologica Sinica, V28, P844; Zhang Ya-jie, 2004, Zhiwu Shengli yu Fenzi Shengwuxue Xuebao, V30, P269; Zhao JB, 2013, J TROP ECOL, V29, P161, DOI 10.1017/S0266467413000114; Zhu N, 1990, CHIN J PLANT ECOL, V14, P336; [朱旭斌 ZHU XuBin], 2006, [植物生态学报, Acta Phytoecologica Sinica], V30, P25; 谢寿昌, 1997, 生态学报, V17, P51	45	6	6	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e99277	10.1371/journal.pone.0099277	http://dx.doi.org/10.1371/journal.pone.0099277			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963625	Green Published, gold, Green Submitted			2022-12-27	WOS:000338709500009
J	Jongbloed, F; de Bruin, RWF; Pennings, JLA; Payan-Gomez, C; van den Engel, S; van Oostrom, CT; de Bruin, A; Hoeijmakers, JHJ; van Steeg, H; IJzermans, JNM; Dolle, MET				Jongbloed, Franny; de Bruin, Ron W. F.; Pennings, Jeroen L. A.; Payan-Gomez, Cesar; van den Engel, Sandra; van Oostrom, Conny T.; de Bruin, Alain; Hoeijmakers, Jan H. J.; van Steeg, Harry; IJzermans, Jan N. M.; Dolle, Martijn E. T.			Preoperative Fasting Protects against Renal Ischemia-Reperfusion Injury in Aged and Overweight Mice	PLOS ONE			English	Article							CALORIC RESTRICTION; ISCHEMIA/REPERFUSION INJURY; KIDNEY-TRANSPLANTATION; DIETARY RESTRICTION; OXIDATIVE STRESS; SUSCEPTIBILITY; MECHANISMS; OUTCOMES; OLDER	Ischemia-reperfusion injury (IRI) is inevitable during kidney transplantation leading to oxidative stress and inflammation. We previously reported that preoperative fasting in young-lean male mice protects against IRI. Since patients are generally of older age with morbidities possibly leading to a different response to fasting, we investigated the effects of preoperative fasting on renal IRI in aged-overweight male and female mice. Male and female F1-FVB/C57BL6-hybrid mice, average age 73 weeks weighing 47.2 grams, were randomized to preoperative ad libitum feeding or 3 days fasting, followed by renal IRI. Body weight, kidney function and survival of the animals were monitored until day 28 postoperatively. Kidney histopathology was scored for all animals and gene expression profiles after fasting were analyzed in kidneys of young and aged male mice. Preoperative fasting significantly improved survival after renal IRI in both sexes compared with normal fed mice. Fasted groups had a better kidney function shown by lower serum urea levels after renal IRI. Histopathology showed less acute tubular necrosis and more regeneration in kidneys from fasted mice. A mRNA analysis indicated the involvement of metabolic processes including fatty acid oxidation and retinol metabolism, and the NRF2-mediated stress response. Similar to young-lean, healthy male mice, preoperative fasting protects against renal IRI in aged-overweight mice of both genders. These findings suggest a general protective response of fasting against renal IRI regardless of age, gender, body weight and genetic background. Therefore, fasting could be a non-invasive intervention inducing increased oxidative stress resistance in older and overweight patients as well.	[Jongbloed, Franny; de Bruin, Ron W. F.; van den Engel, Sandra; IJzermans, Jan N. M.] Erasmus Univ, Med Ctr, Dept Surg, Lab Expt Transplantat & Intestinal Surg, Rotterdam, Netherlands; [Jongbloed, Franny; Pennings, Jeroen L. A.; van Oostrom, Conny T.; van Steeg, Harry; Dolle, Martijn E. T.] Natl Inst Publ Hlth & Environm, Lab Hlth Protect Res, NL-3720 BA Bilthoven, Netherlands; [Payan-Gomez, Cesar; Hoeijmakers, Jan H. J.] Erasmus Univ, Med Ctr, Dept Genet, Rotterdam, Netherlands; [Payan-Gomez, Cesar] Univ Rosario, Fac Ciencias Nat & Matemat, Bogota, Colombia; [de Bruin, Alain] Univ Utrecht, Fac Vet Med, Dept Pathobiol, Dutch Mol Pathol Ctr, Utrecht, Netherlands; [van Steeg, Harry] Leiden Univ, Med Ctr, Dept Toxicogenet, Leiden, Netherlands	Erasmus University Rotterdam; Erasmus MC; Netherlands National Institute for Public Health & the Environment; Erasmus University Rotterdam; Erasmus MC; Universidad del Rosario; Utrecht University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Dolle, MET (corresponding author), Natl Inst Publ Hlth & Environm, Lab Hlth Protect Res, NL-3720 BA Bilthoven, Netherlands.	Martijn.Dolle@rivm.nl	de Bruin, Alain/AAL-9195-2020; Payan-Gomez, Cesar/G-8589-2016; Hoeijmakers, Jan/AAX-6972-2021	Payan-Gomez, Cesar/0000-0002-0633-1332; de Bruin, Alain/0000-0001-8579-2649; Pennings, Jeroen L.A./0000-0002-9188-6358	National Institute for Public Health and the Environment; Ministry of Health, Welfare and Sport of The Netherlands [S/340005]	National Institute for Public Health and the Environment; Ministry of Health, Welfare and Sport of The Netherlands	This research was funded by a grant from the National Institute for Public Health and the Environment and the Ministry of Health, Welfare and Sport of The Netherlands (S/340005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akoh JA, 2013, J TRANSPLANT, V2013, DOI 10.1155/2013/475964; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Carrier M, 2012, TRANSPL P, V44, P2227, DOI 10.1016/j.transproceed.2012.07.120; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Cruzen C, 2009, CLIN GERIATR MED, V25, P733, DOI 10.1016/j.cger.2009.07.001; Dolle MET, 2011, PATHOBIOL AGING AGE, V1, DOI 10.3402/pba.v1i0.7219; Edwards MG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-80; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Goldstein JL, 2011, COLD SH Q B, V76, P121, DOI 10.1101/sqb.2011.76.010447; Hu HL, 2009, TOHOKU J EXP MED, V218, P325, DOI 10.1620/tjem.218.325; Jaeschke H, 2012, TRANSPLANT REV-ORLAN, V26, P103, DOI 10.1016/j.trre.2011.10.006; Kosieradzki M, 2008, TRANSPL P, V40, P3279, DOI 10.1016/j.transproceed.2008.10.004; Lim WH, 2013, TRANSPLANTATION, V95, P106, DOI 10.1097/TP.0b013e318277b2be; Liu M, 2013, KIDNEY INT; Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI 10.1007/s00018-003-3216-3; MCCAY CM, 1989, NUTRITION, V5, P155; Mitchell JR, 2010, AGING CELL, V9, P40, DOI 10.1111/j.1474-9726.2009.00532.x; Nakagawa S, 2012, AGING CELL, V11, P401, DOI 10.1111/j.1474-9726.2012.00798.x; Pamplona R, 2006, BBA-BIOENERGETICS, V1757, P496, DOI 10.1016/j.bbabio.2006.01.009; Park KM, 2004, J BIOL CHEM, V279, P52282, DOI 10.1074/jbc.M407629200; Port FK, 2002, TRANSPLANTATION, V74, P1281, DOI 10.1097/00007890-200211150-00014; Rains JL, 2011, FREE RADICAL BIO MED, V50, P567, DOI 10.1016/j.freeradbiomed.2010.12.006; Rao PS, 2007, TRANSPLANTATION, V83, P1069, DOI 10.1097/01.tp.0000259621.56861.31; Saxena R, 2009, INT UROL NEPHROL, V41, P195, DOI 10.1007/s11255-008-9489-6; Sharif A, 2013, AM J KIDNEY DIS, V62, P150, DOI 10.1053/j.ajkd.2012.11.050; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Spindler SR, 2010, AGEING RES REV, V9, P324, DOI 10.1016/j.arr.2009.10.003; Sykiotis GP, 2011, CURR OPIN CLIN NUTR, V14, P41, DOI 10.1097/MCO.0b013e32834136f2; Tonelli M, 2011, AM J TRANSPLANT, V11, P2093, DOI 10.1111/j.1600-6143.2011.03686.x; van Ginhoven TM, 2010, NUTR RES, V30, P865, DOI 10.1016/j.nutres.2010.09.014; van Ginhoven TM, 2010, TRANSPL INT, V23, P1171, DOI 10.1111/j.1432-2277.2010.01116.x; van Ginhoven TM, 2009, LIVER TRANSPLANT, V15, P1183, DOI 10.1002/lt.21871; Verweij M, 2011, LIVER TRANSPLANT, V17, P695, DOI 10.1002/lt.22243; Yamagishi T, 2010, HEART VESSELS, V25, P417, DOI 10.1007/s00380-009-1222-6; Yu ZF, 1999, J NEUROSCI RES, V57, P830, DOI 10.1002/(SICI)1097-4547(19990915)57:6&lt;830::AID-JNR8&gt;3.0.CO;2-2	35	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100853	10.1371/journal.pone.0100853	http://dx.doi.org/10.1371/journal.pone.0100853			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959849	Green Published, Green Submitted, gold			2022-12-27	WOS:000338633900096
J	Kim, HJ; Kim, HJ; Jeong, JE; Baek, JY; Jeong, J; Kim, S; Kim, YM; Kim, Y; Nam, JH; Huh, SH; Seo, J; Jin, BK; Lee, KJ				Kim, Hee-Jung; Kim, Hyun Jung; Jeong, Jae-Eun; Baek, Jeong Yeob; Jeong, Jaeho; Kim, Sun; Kim, Young-Mee; Kim, Youhwa; Nam, Jin Han; Huh, Sue Hee; Seo, Jawon; Jin, Byung Kwan; Lee, Kong-Joo			N-Terminal Truncated UCH-L1 Prevents Parkinson's Disease Associated Damage	PLOS ONE			English	Article							COMPLEX-I DEFICIENCY; NIGROSTRIATAL DOPAMINERGIC-NEURONS; TRANSLATION START SITES; ALPHA-SYNUCLEIN; POSTTRANSLATIONAL MODIFICATIONS; ANTIOXIDATIVE STRESS; OXIDATIVE STRESS; NULL MICE; PGP 9.5; UBIQUITIN	Ubiquitin C-terminal hydrolase-L1 (UCH-L1) has been proposed as one of the Parkinson's disease (PD) related genes, but the possible molecular connection between UCH-L1 and PD is not well understood. In this study, we discovered an N-terminal 11 amino acid truncated variant UCH-L1 that we called NT-UCH-L1, in mouse brain tissue as well as in NCI-H157 lung cancer and SH-SY5Y neuroblastoma cell lines. In vivo experiments and hydrogen-deuterium exchange (HDX) with tandem mass spectrometry (MS) studies showed that NT-UCH-L1 is readily aggregated and degraded, and has more flexible structure than UCH-L1. Post-translational modifications including monoubiquitination and disulfide crosslinking regulate the stability and cellular localization of NT-UCH-L1, as confirmed by mutational and proteomic studies. Stable expression of NT-UCH-L1 decreases cellular ROS levels and protects cells from H2O2, rotenone and CCCP-induced cell death. NT-UCH-L1-expressing transgenic mice are less susceptible to degeneration of nigrostriatal dopaminergic neurons seen in the MPTP mouse model of PD, in comparison to control animals. These results suggest that NT-UCH-L1 may have the potential to prevent neural damage in diseases like PD.	[Kim, Hee-Jung; Kim, Hyun Jung; Jeong, Jae-Eun; Jeong, Jaeho; Kim, Sun; Kim, Young-Mee; Kim, Youhwa; Seo, Jawon; Lee, Kong-Joo] Ewha Womans Univ, Coll Pharm, Grad Sch Pharmaceut Sci, Seoul, South Korea; [Baek, Jeong Yeob; Nam, Jin Han; Huh, Sue Hee; Jin, Byung Kwan] Kyung Hee Univ, Sch Med, Neurodegenerat Control Res Ctr, Dept Biochem & Mol Biol, Seoul, South Korea	Ewha Womans University; Kyung Hee University	Jin, BK (corresponding author), Kyung Hee Univ, Sch Med, Neurodegenerat Control Res Ctr, Dept Biochem & Mol Biol, Seoul, South Korea.	bkjin@khu.ac.kr; kjl@ewha.ac.kr		Lee, Kong-Joo/0000-0001-7972-6020; Nam, Jinhan/0000-0003-4153-3711	Global Research Lab Program [2012K1A1A2045441]; Proteogenomics Research Program of the National Research Foundation of Korea [2012M3A9B90036680]; Brain Korea 21 project; Ewha Womans University; Basic Science Research Program through the NRF - Ministry of Education, Science, and Technology [20090063274]; Ministry of Education [2013R1A1A2061412]	Global Research Lab Program; Proteogenomics Research Program of the National Research Foundation of Korea(National Research Foundation of Korea); Brain Korea 21 project(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); Ewha Womans University; Basic Science Research Program through the NRF - Ministry of Education, Science, and Technology(National Research Foundation of Korea); Ministry of Education	This work was supported by the Global Research Lab Program (No. 2012K1A1A2045441), and the Proteogenomics Research Program (No. 2012M3A9B90036680) of the National Research Foundation of Korea. Kim HJ, Kim HJ, Jeong JE, Kim S, Kim YM, Kim Y, and Seo J were supported by the Brain Korea 21 project. Kim HJ was supported by RP-Grant 2010 of Ewha Womans University. This work was also supported by the Basic Science Research Program through the NRF funded by the Ministry of Education, Science, and Technology (Grant 20090063274) and by the Ministry of Education (No. 2013R1A1A2061412. The funder's had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardley HC, 2003, MOL BIOL CELL, V14, P4541, DOI 10.1091/mbc.E03-02-0078; Bazykin GA, 2011, NUCLEIC ACIDS RES, V39, P567, DOI 10.1093/nar/gkq806; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Callio J, 2005, J BIOL CHEM, V280, P18536, DOI 10.1074/jbc.M413224200; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Casarejos MJ, 2006, J NEUROCHEM, V97, P934, DOI 10.1111/j.1471-4159.2006.03777.x; Chung YC, 2011, NEUROPHARMACOLOGY, V60, P963, DOI 10.1016/j.neuropharm.2011.01.043; Chung YC, 2010, J IMMUNOL, V185, P1230, DOI 10.4049/jimmunol.1000208; Cookson MR, 2008, INT J CLIN EXP PATHO, V1, P217; Das C, 2006, P NATL ACAD SCI USA, V103, P4675, DOI 10.1073/pnas.0510403103; Dauer W, 2002, P NATL ACAD SCI USA, V99, P14524, DOI 10.1073/pnas.172514599; Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034; DAY INM, 1987, FEBS LETT, V210, P157, DOI 10.1016/0014-5793(87)81327-3; Deng HX, 2006, P NATL ACAD SCI USA, V103, P7142, DOI 10.1073/pnas.0602046103; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; FORNO LS, 1969, J AM GERIATR SOC, V17, P557, DOI 10.1111/j.1532-5415.1969.tb01316.x; Gandre S, 2003, MITOCHONDRION, V2, P245, DOI 10.1016/S1567-7249(02)00105-8; Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Goldberg MS, 2000, NAT CELL BIOL, V2, pE115, DOI 10.1038/35017124; Ha NN, 2011, CELL STEM CELL, V8, P267, DOI 10.1016/j.stem.2011.01.013; Hao LY, 2010, P NATL ACAD SCI USA, V107, P9747, DOI 10.1073/pnas.0911175107; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; HEIKKILA R, 1971, SCIENCE, V172, P1257, DOI 10.1126/science.172.3989.1257; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Huh SH, 2011, J IMMUNOL, V187, P960, DOI 10.4049/jimmunol.1100009; Iwata A, 2005, P NATL ACAD SCI USA, V102, P13135, DOI 10.1073/pnas.0505801102; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; Jeong JH, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000513; Kabuta T, 2008, HUM MOL GENET, V17, P1482, DOI 10.1093/hmg/ddn037; Kaipio K, 2005, BIOCHEM BIOPH RES CO, V337, P633, DOI 10.1016/j.bbrc.2005.09.093; Kim HJ, 2009, ONCOGENE, V28, P117, DOI 10.1038/onc.2008.364; Kim MS, 2013, ACTA CRYSTALLOGR D, V69, P669, DOI 10.1107/S0907444913001194; Kochetov AV, 2008, BIOESSAYS, V30, P683, DOI 10.1002/bies.20771; Koharudin LMI, 2010, P NATL ACAD SCI USA, V107, P6835, DOI 10.1073/pnas.1002295107; Lee E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007949; Lee T, 2005, J MOL BIOL, V353, P600, DOI 10.1016/j.jmb.2005.08.029; Leissring MA, 2004, BIOCHEM J, V383, P439, DOI 10.1042/BJ20041081; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Lotharius J, 2000, J BIOL CHEM, V275, P38581, DOI 10.1074/jbc.M005385200; LOWE J, 1990, J PATHOL, V161, P153, DOI 10.1002/path.1711610210; Mazzulli JR, 2011, CELL, V146, P37, DOI 10.1016/j.cell.2011.06.001; Meray RK, 2007, J BIOL CHEM, V282, P10567, DOI 10.1074/jbc.M611153200; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Osaka H, 2003, HUM MOL GENET, V12, P1945, DOI 10.1093/hmg/ddg211; Oueslati A, 2010, PROG BRAIN RES, V183, P115, DOI 10.1016/S0079-6123(10)83007-9; Parker WD, 2008, BRAIN RES, V1189, P215, DOI 10.1016/j.brainres.2007.10.061; PARKER WD, 1989, ANN NEUROL, V26, P719, DOI 10.1002/ana.410260606; Parkkinen L, 2005, NEUROPATHOLOGY, V25, P304, DOI 10.1111/j.1440-1789.2005.00644.x; Perier C, 2003, TRENDS NEUROSCI, V26, P345, DOI 10.1016/S0166-2236(03)00144-9; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Richardson JR, 2005, TOXICOL SCI, V88, P193, DOI 10.1093/toxsci/kfi304; Rosas SLB, 2001, CANCER LETT, V170, P73, DOI 10.1016/S0304-3835(01)00449-9; Saito Y, 2004, J NEUROPATH EXP NEUR, V63, P742, DOI 10.1093/jnen/63.7.742; SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0; SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x; Seo J, 2008, J PROTEOME RES, V7, P587, DOI 10.1021/pr700657y; Shim JH, 2011, MITOCHONDRION; SPECTOR A, 1978, P NATL ACAD SCI USA, V75, P3244, DOI 10.1073/pnas.75.7.3244; Sunderland PA, 2004, BIOCHEM SOC T, V32, P614, DOI 10.1042/BST0320614; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; Takahashi-Niki K, 2004, BIOCHEM BIOPH RES CO, V320, P389, DOI 10.1016/j.bbrc.2004.05.187; Tanaka M, 2004, J BIOL CHEM, V279, P4625, DOI 10.1074/jbc.M310994200; Tompkins MM, 1997, BRAIN RES, V775, P24, DOI 10.1016/S0006-8993(97)00874-3; Tsika E, 2010, J NEUROSCI, V30, P3409, DOI 10.1523/JNEUROSCI.4977-09.2010; Uversky VN, 2007, J NEUROCHEM, V103, P17, DOI 10.1111/j.1471-4159.2007.04764.x; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Vila M, 2003, NAT REV NEUROSCI, V4, P365, DOI 10.1038/nrn1100; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; WILKINSON KD, 1989, SCIENCE, V246, P670, DOI 10.1126/science.2530630; Wilkinson KD, 1999, J MOL BIOL, V291, P1067; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103	73	13	13	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e99654	10.1371/journal.pone.0099654	http://dx.doi.org/10.1371/journal.pone.0099654			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959670	Green Published, Green Submitted, gold			2022-12-27	WOS:000338633900013
J	Li, Y; Thompson, CM; Lipsitch, M				Li, Yuan; Thompson, Claudette M.; Lipsitch, Marc			A Modified Janus Cassette (Sweet Janus) to Improve Allelic Replacement Efficiency by High-Stringency Negative Selection in Streptococcus pneumoniae	PLOS ONE			English	Article							SUCROSE SENSITIVITY; GENE; SACB; TRANSFORMATION; EXPRESSION; VARIANTS	The Janus cassette permits marker-free allelic replacement or knockout in streptomycin-resistant Streptococcus pneumoniae (pneumococcus) through sequential positive and negative selection. Spontaneous revertants of Janus can lead to high level of false-positives during negative selection, which necessitate a time-consuming post-selection screening process. We hypothesized that an additional counter-selectable marker in Janus would decrease the revertant frequency and reduce false-positives, since simultaneous reversion of both counter-selectable makers is much less likely. Here we report a modified cassette, Sweet Janus (SJ), in which the sacB gene from Bacillus subtilis conferring sucrose sensitivity is added to Janus. By using streptomycin and sucrose simultaneously as selective agents, the frequency of SJ double revertants was about 10(5)-fold lower than the frequency of Janus revertants. Accordingly, the frequency of false-positives in the SJ-mediated negative selection was about 100-fold lower than what was seen for Janus. Thus, SJ enhances negative selection stringency and can accelerate allelic replacement in pneumococcus, especially when transformation frequency is low due to strain background or suboptimal transformation conditions. Results also suggested the sacB gene alone can function as a counter-selectable marker in the Gram-positive pneumococcus, which will have the advantage of not requiring a streptomycin-resistant strain for allelic replacement.	[Li, Yuan] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Li, Y (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	liyuan@hsph.harvard.edu			United States National Institute of Allergy and Infectious Diseases [5R01AI048935-12]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048935] Funding Source: NIH RePORTER	United States National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by award 5R01AI048935-12 to ML from the United States National Institute of Allergy and Infectious Diseases (http://www.niaid.nih.gov). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dedonder R, 1966, METHOD ENZYMOL, V8, P6; Evans BA, 2013, ISME J, V7, P791, DOI 10.1038/ismej.2012.170; JAGER W, 1992, J BACTERIOL, V174, P5462; Joloba ML, 2010, INT J ANTIMICROB AG, V36, P124, DOI 10.1016/j.ijantimicag.2010.03.024; Li Y, 2013, INFECT IMMUN, V81, P4519, DOI 10.1128/IAI.00724-13; Li Y, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002989; Pelicic V, 1996, J BACTERIOL, V178, P1197, DOI 10.1128/jb.178.4.1197-1199.1996; Pozzi G, 1996, J BACTERIOL, V178, P6087, DOI 10.1128/jb.178.20.6087-6090.1996; Reyrat JM, 1998, INFECT IMMUN, V66, P4011; STEINMETZ M, 1983, MOL GEN GENET, V191, P138, DOI 10.1007/BF00330901; Sun XY, 2013, APPL MICROBIOL BIOT, V97, P8629, DOI 10.1007/s00253-013-5058-8; Sung CK, 2001, APPL ENVIRON MICROB, V67, P5190, DOI 10.1128/AEM.67.11.5190-5196.2001; Trzcinski K, 2003, APPL ENVIRON MICROB, V69, P7364, DOI 10.1128/AEM.69.12.7364-7370.2003; Trzcinski K, 2008, INFECT IMMUN, V76, P2678, DOI 10.1128/IAI.00141-08	14	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100510	10.1371/journal.pone.0100510	http://dx.doi.org/10.1371/journal.pone.0100510			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959661	Green Published, gold, Green Submitted			2022-12-27	WOS:000338633900053
J	Radiloff, D; Zhao, YL; Boico, A; Blueschke, G; Palmer, G; Fontanella, A; Dewhirst, M; Piantadosi, CA; Noveck, R; Irwin, D; Hamilton, K; Klitzman, B; Schroeder, T				Radiloff, Daniel; Zhao, Yulin; Boico, Alina; Blueschke, Gert; Palmer, Gregory; Fontanella, Andrew; Dewhirst, Mark; Piantadosi, Claude A.; Noveck, Robert; Irwin, David; Hamilton, Karyn; Klitzman, Bruce; Schroeder, Thies			Anti-Hypotensive Treatment and Endothelin Blockade Synergistically Antagonize Exercise Fatigue in Rats under Simulated High Altitude	PLOS ONE			English	Article							HYPOXIC PULMONARY VASOCONSTRICTION; BLOOD-FLOW-VELOCITY; CEREBRAL RESISTANCE ARTERIOLES; LIMITING FACTOR; RECEPTOR ANTAGONISM; EPHEDRINE; CAPACITY; AUTOREGULATION; PERFORMANCE; SILDENAFIL	Rapid ascent to high altitude causes illness and fatigue, and there is a demand for effective acute treatments to alleviate such effects. We hypothesized that increased oxygen delivery to the tissue using a combination of a hypertensive agent and an endothelin receptor A antagonist drugs would limit exercise-induced fatigue at simulated high altitude. Our data showed that the combination of 0.1 mg/kg ambrisentan with either 20 mg/kg ephedrine or 10 mg/kg methylphenidate significantly improved exercise duration in rats at simulated altitude of 4,267 m, whereas the individual compounds did not. In normoxic, anesthetized rats, ephedrine alone and in combination with ambrisentan increased heart rate, peripheral blood flow, carotid and pulmonary arterial pressures, breathing rate, and vastus lateralis muscle oxygenation, but under inspired hypoxia, only the combination treatment significantly enhanced muscle oxygenation. Our results suggest that sympathomimetic agents combined with endothelin-A receptor blockers offset altitude-induced fatigue in rats by synergistically increasing the delivery rate of oxygen to hypoxic muscle by concomitantly augmenting perfusion pressure and improving capillary conductance in the skeletal muscle. Our findings might therefore serve as a basis to develop an effective treatment to prevent high-altitude illness and fatigue in humans.	[Radiloff, Daniel; Zhao, Yulin; Boico, Alina; Palmer, Gregory; Fontanella, Andrew; Dewhirst, Mark] Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC USA; [Blueschke, Gert; Klitzman, Bruce] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Piantadosi, Claude A.] Duke Univ, Med Ctr, Dept Pulm Med, Durham, NC USA; [Noveck, Robert] Duke Univ, Med Ctr, Dept Med Clin Pharmacol, Durham, NC USA; [Irwin, David] Univ Colorado Denver, Dept Cardiol, Aurora, CO USA; [Hamilton, Karyn] Colorado State Univ, Dept Hlth & Exercise Sci, Ft Collins, CO 80523 USA; [Schroeder, Thies] Johannes Gutenberg Univ Mainz, Dept Phys Chem, D-55122 Mainz, Germany	Duke University; Duke University; Duke University; Duke University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado State University; Johannes Gutenberg University of Mainz	Schroeder, T (corresponding author), Johannes Gutenberg Univ Mainz, Dept Phys Chem, D-55122 Mainz, Germany.	tschroeder28@gmail.com	Palmer, Gregory M/C-6910-2008; Dewhirst, Mark/Q-1302-2019; Schroeder, Thies/G-5244-2014	Palmer, Gregory M/0000-0003-2955-8297; Dewhirst, Mark/0000-0003-3459-6546; 	U.S. Defense Advanced Research Projects Agency (DARPA) [N66001-10-C-2134]	U.S. Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	This work was funded by the U.S. Defense Advanced Research Projects Agency (DARPA) Prime Award Number N66001-10-C-2134. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainslie PN, 2007, AM J PHYSIOL-HEART C, V292, pH976, DOI 10.1152/ajpheart.00639.2006; Amann M, 2006, J APPL PHYSIOL, V101, P119, DOI 10.1152/japplphysiol.01596.2005; Anholm JD, 2011, HIGH ALT MED BIOL, V12, P313, DOI 10.1089/ham.2011.1059; Anholm JD, 2011, HIGH ALT MED BIOL, V12, P321, DOI 10.1089/ham.2011.1075; Avois L, 2006, BRIT J SPORT MED, V40, DOI 10.1136/bjsm.2006.027557; Bada AA, 2012, J PHYSIOL-LONDON, V590, P2051, DOI 10.1113/jphysiol.2011.225334; Barst RJ, 2007, VASC HEALTH RISK MAN, V3, P11; Bartsch P, 2005, J APPL PHYSIOL, V98, P1101, DOI 10.1152/japplphysiol.01167.2004; Bartsch P, 2007, CIRCULATION, V116, P2191, DOI 10.1161/CIRCULATIONAHA.106.650796; Bordeleau R, 1999, CAFFEINE EPHEDRINE T; Buehler PW, 2012, AM J PHYSIOL-LUNG C, V303, pL312, DOI 10.1152/ajplung.00074.2012; Casey DP, 2011, J APPL PHYSIOL, V111, P1527, DOI 10.1152/japplphysiol.00895.2011; Cho SC, 2012, J PSYCHOPHARMACOL, V26, P380, DOI 10.1177/0269881111405356; CUNNINGHAM WL, 1965, J APPL PHYSIOL, V20, P607, DOI 10.1152/jappl.1965.20.4.607; DALY PA, 1993, INT J OBESITY, V17, pS73; de Bisschop C, 2012, J APPL PHYSIOL, V112, P20, DOI 10.1152/japplphysiol.00670.2011; Doi Y, 2002, HISTOL HISTOPATHOL, V17, P97, DOI 10.14670/HH-17.97; Dunnick JK, 2007, TOXICOL PATHOL, V35, P657, DOI 10.1080/01926230701459978; Eccles R, 2007, BRIT J CLIN PHARMACO, V63, P10, DOI 10.1111/j.1365-2125.2006.02833.x; Fernandez N, 1998, EUR J PHARMACOL, V348, P199, DOI 10.1016/S0014-2999(98)00144-7; Fulco CS, 1998, AVIAT SPACE ENVIR MD, V69, P793; Ghofrani HA, 2004, ANN INTERN MED, V141, P169, DOI 10.7326/0003-4819-141-3-200408030-00005; Goerge T, 2002, J MEMBRANE BIOL, V187, P203, DOI 10.1007/s00232-001-0164-4; Hamilton N.B., 2010, FRONT NEUROENERGETIC, V2, DOI 10.3389/fnene.2010.00005; Hanna G, 2013, AM J PHYSIOL-LUNG C, V304, pL86, DOI 10.1152/ajplung.00178.2012; HASSOUN PM, 1992, P SOC EXP BIOL MED, V199, P165; Hergenroder S, 1998, VASA-J VASCULAR DIS, V27, P216; HESTER RL, 1993, AM J PHYSIOL, V265, pH146; Hopkins SR, 2007, J APPL PHYSIOL, V103, P2112, DOI 10.1152/japplphysiol.00306.2007; Irwin DC, 2008, AM J PHYSIOL-HEART C, V295, pH1090, DOI 10.1152/ajpheart.00303.2008; Joyner MJ, 2013, J APPL PHYSL; Kelly JJ, 1999, CLIN EXP PHARMACOL P, V26, P158, DOI 10.1046/j.1440-1681.1999.03011.x; Kobayashi S, 2003, ANESTH ANALG, V97, P1239, DOI 10.1213/01.ANE.0000092917.96558.3C; KUWAHIRA I, 1994, RESP PHYSIOL, V97, P309, DOI 10.1016/0034-5687(94)90067-1; Laughlin M H, 1985, Exerc Sport Sci Rev, V13, P95; LAUGHLIN MH, 1988, J APPL PHYSIOL, V64, P2420, DOI 10.1152/jappl.1988.64.6.2420; Levine BD, 1997, CIRCULATION, V96, P1224, DOI 10.1161/01.CIR.96.4.1224; Liles JT, 2006, J PHARMACOL EXP THER, V316, P95, DOI 10.1124/jpet.105.090035; LOUGEE L, 1990, MICROCIRC ENDOTH LYM, V6, P355; Luks AM, 2010, CONGENIT HEART DIS, V5, P220, DOI 10.1111/j.1747-0803.2010.00415.x; Lundby C, 2008, J APPL PHYSIOL, V105, P581, DOI 10.1152/japplphysiol.90484.2008; Lundby C, 2008, J PHYSIOL-LONDON, V586, P123, DOI 10.1113/jphysiol.2007.146035; Maggiorini M, 2010, PROG CARDIOVASC DIS, V52, P500, DOI 10.1016/j.pcad.2010.03.001; Magkos Faidon, 2004, Sports Med, V34, P871, DOI 10.2165/00007256-200434130-00002; McGoon MD, 2009, CHEST, V135, P122, DOI 10.1378/chest.08-1028; McMahon LR, 2003, DRUG ALCOHOL DEPEN, V70, P255, DOI 10.1016/S0376-8716(03)00011-5; Miller DK, 1998, PSYCHOPHARMACOLOGY, V140, P52; Mitchell D, 2002, MICROVASC RES, V64, P179, DOI 10.1006/mvre.2002.2427; Mortensen SP, 2009, HYPERTENSION, V53, P993, DOI 10.1161/HYPERTENSIONAHA.109.130880; Naeije R, 2010, EUR RESPIR J, V36, P1049, DOI 10.1183/09031936.00024410; Naeije R, 2011, HIGH ALT MED BIOL, V12, P319, DOI 10.1089/ham.2011.1074; Naeije R, 2011, HIGH ALT MED BIOL, V12, P309, DOI 10.1089/ham.2011.1060; Naeije R, 2010, PROG CARDIOVASC DIS, V52, P456, DOI 10.1016/j.pcad.2010.03.004; Osmond JM, 2014, AM J PHYSL HEART CIR; PACE N, 1945, SCIENCE, V102, P589, DOI 10.1126/science.102.2658.589; Patel TR, 1996, EUR J PHARMACOL, V307, P41, DOI 10.1016/0014-2999(96)00188-4; PENTEL P, 1984, JAMA-J AM MED ASSOC, V252, P1898, DOI 10.1001/jama.252.14.1898; PING PP, 1992, AM J PHYSIOL, V263, pH1177, DOI 10.1152/ajpheart.1992.263.4.H1177; Pitman JT, 2012, WILD ENVIRON MED, V23, P374, DOI 10.1016/j.wem.2012.06.006; Powers ME, 2001, J ATHL TRAINING, V36, P420; Prommer E, 2012, AM J HOSP PALLIAT ME, V29, P483, DOI 10.1177/1049909111427029; Querido JS, 2013, J APPL PHYSIOL, V114, P1183, DOI 10.1152/japplphysiol.00024.2013; Radiloff DR, 2012, J APPL PHYSL; Richalet JP, 2005, AM J RESP CRIT CARE, V171, P275, DOI 10.1164/rccm.200406-804OC; Roelands B, 2008, MED SCI SPORT EXER, V40, P879, DOI 10.1249/MSS.0b013e3181659c4d; Rubin LJ, 2012, LIFE SCI, V91, P517, DOI 10.1016/j.lfs.2012.07.033; Scherrer U, 2010, PROG CARDIOVASC DIS, V52, P485, DOI 10.1016/j.pcad.2010.02.004; Shekelle P, 2003, Evid Rep Technol Assess (Summ), P1; Siebenmann C, 2011, HIGH ALT MED BIOL, V12, P169, DOI 10.1089/ham.2010.1075; Spence R, 2008, J CLIN PHARMACOL, V48, P1451, DOI 10.1177/0091270008324180; Spilk S, 2013, AM J PHYSIOL-HEART C, V305, pH1639, DOI 10.1152/ajpheart.00073.2013; Spratt JCS, 2001, BRIT J PHARMACOL, V134, P648, DOI 10.1038/sj.bjp.0704304; Thomas KN, 2010, HIGH ALT MED BIOL, V11, P163, DOI 10.1089/ham.2009.1056; Touzani O, 1997, J CEREBR BLOOD F MET, V17, P1157, DOI 10.1097/00004647-199711000-00004; Umbrello M, 2014, J PHYSL; Varsos GV, 2014, NEUROCRIT CARE, V20, P40, DOI 10.1007/s12028-013-9913-3; Wagenaar GT, 2013, AM J PHYSL LUNG CELL; Wellman PJ, 1998, PSYCHOPHARMACOLOGY, V135, P133, DOI 10.1007/s002130050494; WIXSON SK, 1987, LAB ANIM SCI, V37, P736; Young AJ, 1996, J APPL PHYSIOL, V81, P252, DOI 10.1152/jappl.1996.81.1.252; Zheng ZJ, 2012, XENOBIOTICA, V42, P775, DOI 10.3109/00498254.2012.658884	81	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e99309	10.1371/journal.pone.0099309	http://dx.doi.org/10.1371/journal.pone.0099309			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24960187	Green Published, Green Submitted, gold			2022-12-27	WOS:000338633900004
J	Sepako, E; Glennie, SJ; Jambo, KC; Mzinza, D; Iwajomo, OH; Banda, D; van Oosterhout, JJ; Williams, NA; Gordon, SB; Heyderman, RS				Sepako, Enoch; Glennie, Sarah J.; Jambo, Kondwani C.; Mzinza, David; Iwajomo, Oluwadamilola H.; Banda, Dominic; van Oosterhout, Joep J.; Williams, Neil A.; Gordon, Stephen B.; Heyderman, Robert S.			Incomplete Recovery of Pneumococcal CD4 T Cell Immunity after Initiation of Antiretroviral Therapy in HIV-Infected Malawian Adults	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; POLYFUNCTIONAL CD4(+); BRONCHOALVEOLAR LAVAGE; DISEASE; VACCINE; MEMORY; PNEUMOLYSIN; RESPONSES; CHILDREN; PROTECTION	HIV-infected African adults are at a considerably increased risk of life-threatening invasive pneumococcal disease (IPD) which persists despite antiretroviral therapy (ART). Defects in naturally acquired pneumococcal-specific T-cell immunity have been identified in HIV-infected adults. We have therefore determined the extent and nature of pneumococcal antigenspecific immune recovery following ART. HIV-infected adults were followed up at 3, 6 and 12 months after initiating ART. Nasopharyngeal swabs were cultured to determine carriage rates. Pneumococcal-specific CD4 T-cell immunity was assessed by IFN-gamma ELISpot, proliferation assay, CD154 expression and intracellular cytokine assay. S. pneumoniae colonization was detected in 27% (13/48) of HIV-infected patients prior to ART. The rates remained elevated after 12 months ART, 41% (16/39) (p = 0.17) and significantly higher than in HIV-uninfected individuals (HIVneg 14%(4/29); p = 0.0147). CD4(+) T-cell proliferative responses to pneumococcal antigens increased significantly to levels comparable with HIV-negative individuals at 12 months ART (p = 0.0799). However, recovery of the pneumococcal-specific CD154 expression was incomplete (p = 0.0015) as were IFN-gamma ELISpot responses (p = 0.0040) and polyfunctional CD4(+) T-cell responses (TNF-alpha, IL-2 and IFN-gamma expression) (p = 0.0040) to a pneumolysin-deficient mutant strain. Impaired control of pneumococcal colonisation and incomplete restoration of pneumococcal-specific immunity may explain the persistently higher risk of IPD amongst HIV-infected adults on ART. Whether vaccination and prolonged ART can overcome this immunological defect and reduce the high levels of pneumococcal colonisation requires further evaluation.	[Sepako, Enoch; Glennie, Sarah J.; Jambo, Kondwani C.; Mzinza, David; Iwajomo, Oluwadamilola H.; Banda, Dominic; Heyderman, Robert S.] Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust, Clin Res Programme, Blantyre, Malawi; [Sepako, Enoch; Jambo, Kondwani C.; Gordon, Stephen B.] Univ Liverpool, Liverpool Sch Trop Med, Resp Infect Grp, Liverpool L3 5QA, Merseyside, England; [van Oosterhout, Joep J.] Dignitas Int Zomba, Zomba, Malawi; [Iwajomo, Oluwadamilola H.] Univ Toronto, Div Clin Sci, Toronto, ON M5S 1A1, Canada; [Glennie, Sarah J.; Iwajomo, Oluwadamilola H.; Williams, Neil A.] Univ Bristol, Bristol, Avon, England	University of Malawi; Liverpool School of Tropical Medicine; University of Liverpool; University of Toronto; University of Bristol	Sepako, E (corresponding author), Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust, Clin Res Programme, Blantyre, Malawi.	enoch.sepako@mopipi.ub.bw		Heyderman, Robert/0000-0003-4573-449X; Mzinza, David/0000-0002-5999-8616; Jambo, Kondwani/0000-0002-3195-2210; Gordon, Stephen/0000-0001-6576-1116	Wellcome Trust (United Kingdom); Liverpool School of Tropical Medicine	Wellcome Trust (United Kingdom)(Wellcome Trust); Liverpool School of Tropical Medicine	The work was supported by a grant to R. S. H from the Wellcome Trust (United Kingdom). E. S. received a PhD studentship from the Liverpool School of Tropical Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel B, 2010, AM J RESP CRIT CARE, V181, P1407, DOI 10.1164/rccm.200910-1484OC; AHDAHL BM, 1995, AM J RESP CRIT CARE, V152, P2000, DOI 10.1164/ajrccm.152.6.8520768; Basset A, 2007, INFECT IMMUN, V75, P5460, DOI 10.1128/IAI.00773-07; Berry AM, 1999, INFECT IMMUN, V67, P981, DOI 10.1128/IAI.67.2.981-985.1999; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Beveridge NER, 2007, EUR J IMMUNOL, V37, P3089, DOI 10.1002/eji.200737504; Brenchley JM, 2008, MUCOSAL IMMUNOL, V1, P49, DOI 10.1038/mi.2007.5; Cao W, 2009, AIDS RES HUM RETROV, V25, P183, DOI 10.1089/aid.2008.0140; Chattopadhyay PK, 2006, NAT PROTOC, V1, P1, DOI 10.1038/nprot.2006.1; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Dworkin MS, 2001, CLIN INFECT DIS, V32, P794, DOI 10.1086/319218; Forbes EK, 2008, J IMMUNOL, V181, P4955, DOI 10.4049/jimmunol.181.7.4955; French MA, 2007, HIV MED, V8, P148, DOI 10.1111/j.1468-1293.2007.00445.x; French N, 2000, LANCET, V355, P2106, DOI 10.1016/S0140-6736(00)02377-1; French N, 2016, MALAWI MED J, V28, P115, DOI 10.1056/NEJMoa0903029; Gilks CF, 1996, LANCET, V347, P718, DOI 10.1016/S0140-6736(96)90076-8; Glennie SJ, 2013, CLIN INFECT DIS, V56, P291, DOI 10.1093/cid/cis842; Glennie SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025610; Gordon SB, 2002, AIDS, V16, P1409, DOI 10.1097/00002030-200207050-00013; Greenwood B, 1999, PHILOS T R SOC B, V354, P777, DOI 10.1098/rstb.1999.0430; Heffernan RT, 2005, J INFECT DIS, V191, P2038, DOI 10.1086/430356; Iwajomo OH, 2011, J INFECT DIS, V204, P534, DOI 10.1093/infdis/jir316; Jambo KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038628; Jambo KC, 2011, THORAX, V66, P375, DOI 10.1136/thx.2010.153825; Kalsdorf B, 2009, AM J RESP CRIT CARE, V180, P1262, DOI 10.1164/rccm.200907-1011OC; Klugman KP, 2007, CURR OPIN INFECT DIS, V20, P11, DOI 10.1097/QCO.0b013e328012c5f1; Knox KS, 2010, J VIROL, V84, P9010, DOI 10.1128/JVI.01138-10; Lange CG, 2002, CLIN IMMUNOL, V102, P154, DOI 10.1006/clim.2001.5164; Lederman HM, 2003, J INFECT DIS, V188, P1794, DOI 10.1086/379900; Malley R, 2003, P NATL ACAD SCI USA, V100, P1966, DOI 10.1073/pnas.0435928100; McEllistrem MC, 2002, J INFECT DIS, V185, P1364, DOI 10.1086/339882; Mureithi MW, 2009, J INFECT DIS, V200, P783, DOI 10.1086/605023; Nunes MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027929; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; O'Brien KL, 2003, PEDIATR INFECT DIS J, V22, P133, DOI [10.1097/00006454-200302000-00009, 10.1097/00006454-200302000-00010]; Pido-Lopez J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002396; Rapola S, 2000, J INFECT DIS, V182, P1146, DOI 10.1086/315822; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Steg SF, 2002, J INFECT DIS, V185, P1401; Sutherland JS, 2010, J IMMUNOL, V184, P6537, DOI 10.4049/jimmunol.1000399; Van Braeckel E, 2013, VACCINE, V31, P3739, DOI 10.1016/j.vaccine.2013.05.021; WHO, 2008, 23 VAL PNEUM POL VAC; Wilkinson KA, 2009, AM J RESP CRIT CARE, V180, P674, DOI 10.1164/rccm.200904-0568OC; Zhang QB, 2007, J INFECT DIS, V195, P1194, DOI 10.1086/512617	44	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100640	10.1371/journal.pone.0100640	http://dx.doi.org/10.1371/journal.pone.0100640			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959834	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000338633900064
J	Zhu, H; Li, DF; Liu, MY; Copie, V; Lei, BF				Zhu, Hui; Li, Dengfeng; Liu, Mengyao; Copie, Valerie; Lei, Benfang			Non-Heme-Binding Domains and Segments of the Staphylococcus aureus IsdB Protein Critically Contribute to the Kinetics and Equilibrium of Heme Acquisition from Methemoglobin	PLOS ONE			English	Article							CELL-SURFACE PROTEIN; HEMOGLOBIN RECEPTOR ISDB; IRON; STREPTOCOCCUS; HTSA; IDENTIFICATION; SHP; MECHANISM; PATHWAY; SYSTEM	The hemoglobin receptor IsdB rapidly acquires heme from methemoglobin (metHb) in the heme acquisition pathway of Staphylococcus aureus. IsdB consists of N-terminal segment (NS), NEAT1 (N1), middle (MD), and heme binding NEAT2 (N2) domains, and C-terminal segment (CS). This study aims to elucidate the roles of these domains or segments in the metHb/IsdB reaction. Deletion of CS does not alter the kinetics and equilibrium of the reaction. Sequential deletions of NS and N1 in NS-N1-MD-N2 progressively reduce heme transfer rates and change the kinetic pattern from one to two phases, but have no effect on the equilibrium of the heme transfer reaction, whereas further deletion of MD reduces the percentage of transferred metHb heme. MD-N2 has higher affinity for heme than N2. MD in trans reduces rates of heme dissociation from holo-N2 and increases the percentage of metHb heme captured by N2 by 4.5 fold. NS-N1-MD and N2, but not NS-N1, MD, and N2, reconstitute the rapid metHb/IsdB reaction. NS-N1-MD-N-IsdC, a fusion protein of NS-N1-MD and the NEAT domain of IsdC, slowly acquires heme from metHb by itself but together with N2 results in rapid heme loss from metHb. Thus, NS-N1 and MD domains specifically and critically contribute to the kinetics and equilibrium of the metHb/IsdB reaction, respectively. These findings support a mechanism of direct heme acquisition by IsdB in which MD enhances the affinity of N2 for heme to thermodynamically drive heme transfer from metHb to IsdB and in which NS is required for the rapid and single phase kinetics of the metHb/IsdB reaction.	[Zhu, Hui; Li, Dengfeng; Liu, Mengyao; Lei, Benfang] Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59717 USA; [Copie, Valerie] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA; [Zhu, Hui] Harbin Med Univ, Dept Physiol, Harbin, Peoples R China	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman; Harbin Medical University	Zhu, H (corresponding author), Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59717 USA.	dzhuhui@aliyun.com; blei@montana.edu	Copie, Valerie/GPW-9767-2022	Copie, Valerie/0000-0002-2778-1463; Lei, Benfang Lei/0000-0001-8133-6021	National Institutes of Health (NIH) [R01AI095704, AI095704, GM103500-09]; USDA Animal Formula Fund; Montana State University Agricultural Experimental Station; Bureau of Harbin City Science and Technology [2013RFLXJ021]; Heilongjiang Provincial Science and Technology Innovation Team in Higher Education Institutes for Infection and Immunity; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI097703, R01AI095704] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA Animal Formula Fund; Montana State University Agricultural Experimental Station; Bureau of Harbin City Science and Technology; Heilongjiang Provincial Science and Technology Innovation Team in Higher Education Institutes for Infection and Immunity; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was supported in part by National Institutes of Health (NIH) Grants R01AI095704, AI095704, and GM103500-09, USDA Animal Formula Fund, and the Montana State University Agricultural Experimental Station. The work done at Harbin Medical University was supported by grant 2013RFLXJ021 from the Bureau of Harbin City Science and Technology and a grant from Heilongjiang Provincial Science and Technology Innovation Team in Higher Education Institutes for Infection and Immunity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CE, 2009, J BACTERIOL, V191, P2638, DOI 10.1128/JB.01784-08; Andrade MA, 2002, GENOME BIOL, V3; Bates CS, 2003, INFECT IMMUN, V71, P1042, DOI 10.1128/IAI.71.3.1042-1055.2003; Dickson CF, 2014, J BIOL CHEM, V289, P6728, DOI 10.1074/jbc.M113.545566; Eichenbaum Z, 1996, INFECT IMMUN, V64, P5428, DOI 10.1128/IAI.64.12.5428-5429.1996; Fonner BA, 2014, BIOCHEMISTRY; Fonner BA, 2014, BIOMOL NMR ASSIGN, V8, P201, DOI 10.1007/s12104-013-9483-5; Fuhrhop J. H., 1975, PORPHYRINS METALLOPO, P804; Gaudin CFM, 2011, BIOCHEMISTRY-US, V50, P5443, DOI 10.1021/bi200369p; HARGROVE MS, 1994, J BIOL CHEM, V269, P4207; Lei BF, 2003, INFECT IMMUN, V71, P5962, DOI 10.1128/IAI.71.10.5962-5969.2003; Lei BF, 2002, INFECT IMMUN, V70, P4494, DOI 10.1128/IAI.70.8.4494-4500.2002; Liu MY, 2008, J BIOL CHEM, V283, P6668, DOI 10.1074/jbc.M708372200; Liu MY, 2005, INFECT IMMUN, V73, P5086, DOI 10.1128/IAI.73.8.5086-5092.2005; Lu CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037556; Maresso AW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000132; Marraffini LA, 2005, J BIOL CHEM, V280, P16263, DOI 10.1074/jbc.M500071200; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; Muryoi N, 2008, J BIOL CHEM, V283, P28125, DOI 10.1074/jbc.M802171200; Nygaard TK, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-82; Nygaard TK, 2006, J BIOL CHEM, V281, P20761, DOI 10.1074/jbc.M601832200; OTTO BR, 1992, CRIT REV MICROBIOL, V18, P217, DOI 10.3109/10408419209114559; Ouattara M, 2010, MOL MICROBIOL, V78, P739, DOI 10.1111/j.1365-2958.2010.07367.x; Pishchany G, 2014, J INFECT DIS, V209, P1764, DOI 10.1093/infdis/jit817; Ran YC, 2007, J BIOL CHEM, V282, P31380, DOI 10.1074/jbc.M705967200; Ran YC, 2013, BIOCHEMISTRY-US, V52, P6537, DOI 10.1021/bi400965u; Ran YC, 2010, BIOCHEMISTRY-US, V49, P2834, DOI 10.1021/bi901987h; Skaar EP, 2004, SCIENCE, V305, P1626, DOI 10.1126/science.1099930; Spirig T, 2013, J BIOL CHEM, V288, P1065, DOI 10.1074/jbc.M112.419119; Torres VJ, 2006, J BACTERIOL, V188, P8421, DOI 10.1128/JB.01335-06; Zhu H, 2008, J BIOL CHEM, V283, P18450, DOI 10.1074/jbc.M801466200; Zhu H, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-15	32	11	11	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100744	10.1371/journal.pone.0100744	http://dx.doi.org/10.1371/journal.pone.0100744			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959723	gold, Green Submitted, Green Published			2022-12-27	WOS:000338633900078
J	Coince, A; Cordier, T; Lengelle, J; Defossez, E; Vacher, C; Robin, C; Buee, M; Marcais, B				Coince, Aurore; Cordier, Tristan; Lengelle, Juliette; Defossez, Emmanuel; Vacher, Corinne; Robin, Cecile; Buee, Marc; Marcais, Benoit			Leaf and Root-Associated Fungal Assemblages Do Not Follow Similar Elevational Diversity Patterns	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; COMMUNITY STRUCTURE; SPECIES RICHNESS; ALTITUDINAL GRADIENT; FOLIAR ENDOPHYTES; BACTERIAL; FOREST; SOIL; VARIABILITY; REVEAL	The diversity of fungi along environmental gradients has been little explored in contrast to plants and animals. Consequently, environmental factors influencing the composition of fungal assemblages are poorly understood. The aim of this study was to determine whether the diversity and composition of leaf and root-associated fungal assemblages vary with elevation and to investigate potential explanatory variables. High-throughput sequencing of the Internal Transcribed Spacer 1 region was used to explore fungal assemblages along three elevation gradients, located in French mountainous regions. Beech forest was selected as a study system to minimise the host effect. The variation in species richness and specific composition was investigated for ascomycetes and basidiomycetes assemblages with a particular focus on root-associated ectomycorrhizal fungi. The richness of fungal communities associated with leaves or roots did not significantly relate to any of the tested environmental drivers, i.e. elevation, mean temperature, precipitation or edaphic variables such as soil pH or the ratio carbon: nitrogen. Nevertheless, the ascomycete species richness peaked at mid-temperature, illustrating a mid-domain effect model. We found that leaf and root-associated fungal assemblages did not follow similar patterns of composition with elevation. While the composition of the leaf-associated fungal assemblage correlated primarily with the mean annual temperature, the composition of root-associated fungal assemblage was explained equally by soil pH and by temperature. The ectomycorrhizal composition was also related to these variables. Our results therefore suggest that above and below-ground fungal assemblages are not controlled by the same main environmental variables. This may be due to the larger amplitude of climatic variables in the tree foliage compared to the soil environment.	[Coince, Aurore; Lengelle, Juliette; Buee, Marc; Marcais, Benoit] Univ Lorraine Interact Arbres Microorganismes, Labex ARBRE, FR EFABA, UMR INRA 1136, Champenoux, France; [Cordier, Tristan; Vacher, Corinne; Robin, Cecile] INRA, BIOGECO, UMR1202, Cestas, France; [Cordier, Tristan; Vacher, Corinne; Robin, Cecile] Univ Bordeaux, BIOGECO, UMR1202, Talence, France; [Defossez, Emmanuel] Irstea, UR EMGR Ecosyst Montagnards, F-38402 St Martin Dheres, France	INRAE; Universite de Lorraine; INRAE; UDICE-French Research Universities; Universite de Bordeaux; INRAE	Buee, M (corresponding author), Univ Lorraine Interact Arbres Microorganismes, Labex ARBRE, FR EFABA, UMR INRA 1136, Champenoux, France.	marcais@nancy.inra.fr; buee@nancy.inra.fr	Vacher, Corinne/J-1777-2012; Vacher, Corinne/Q-3182-2019; defossez, emmanuel/ABE-9799-2020; Vacher, Corinne/ABG-8163-2020; Cordier, Tristan/B-7836-2018; Marcais, Benoit/O-5049-2019	Vacher, Corinne/0000-0003-3023-6113; defossez, emmanuel/0000-0002-3279-9190; Vacher, Corinne/0000-0003-3023-6113; Cordier, Tristan/0000-0001-7398-4790; Marcais, Benoit/0000-0002-8107-644X; Buee, Marc/0000-0001-8614-3886	European project, Biodiversity And Climate Change, A Risk Analysis (BACCARA) [22000325]; Region Lorraine; French Ministry of Agriculture, Forest Health Department [E17/08, 22000285]; French National Research Agency (ANR) as part of the "Investissements d'Avenir" program (Lab of Excellence ARBRE) [ANR-11-LABX-0002-01];  [42 AP09/10]	European project, Biodiversity And Climate Change, A Risk Analysis (BACCARA); Region Lorraine(Region Grand-Est); French Ministry of Agriculture, Forest Health Department; French National Research Agency (ANR) as part of the "Investissements d'Avenir" program (Lab of Excellence ARBRE)(French National Research Agency (ANR)); 	This study was supported by joint grants from a European project, Biodiversity And Climate Change, A Risk Analysis (BACCARA, no 22000325), the Region Lorraine and the French Ministry of Agriculture, Forest Health Department (Convention E17/08, no 22000285). The UMR IaM is supported by a grant overseen by the French National Research Agency (ANR) as part of the "Investissements d'Avenir" program (ANR-11-LABX-0002-01, Lab of Excellence ARBRE). The Genoscope contributed to the data collection through the 454 pyrosequencing steps (project #42 AP09/10). The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arfi Y, 2012, FEMS MICROBIOL ECOL, V79, P433, DOI 10.1111/j.1574-6941.2011.01236.x; Bahram M, 2012, NEW PHYTOL, V193, P465, DOI 10.1111/j.1469-8137.2011.03927.x; Benichou P., 1987, METEOROLOGIE, V7, P23; Bertrand R, 2011, NATURE, V479, P517, DOI 10.1038/nature10548; Bryant JA, 2008, P NATL ACAD SCI USA, V105, P11505, DOI 10.1073/pnas.0801920105; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Buee M, 2011, FUNGAL ECOL, V4, P22, DOI 10.1016/j.funeco.2010.07.003; Colwell RK, 2000, TRENDS ECOL EVOL, V15, P70, DOI 10.1016/S0169-5347(99)01767-X; Cordier T, 2012, NEW PHYTOL, V196, P510, DOI 10.1111/j.1469-8137.2012.04284.x; Cordier T, 2012, FUNGAL ECOL, V5, P509, DOI 10.1016/j.funeco.2011.12.004; Davey ML, 2013, MOL ECOL, V22, P368, DOI 10.1111/mec.12122; Douhan GW, 2007, MYCOLOGIA, V99, P812, DOI 10.3852/mycologia.99.6.812; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; DUCHAUFOUR P., 1959, Bulletin de l'Association Francaise pour l'Etude du Sol, P193; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fierer Noah, 2008, P95; Fierer N, 2011, ECOLOGY, V92, P797, DOI 10.1890/10-1170.1; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Gorzelak MA, 2012, FUNGAL ECOL, V5, P36, DOI 10.1016/j.funeco.2011.08.008; Green JL, 2004, NATURE, V432, P747, DOI 10.1038/nature03034; Haegeman B, 2013, ISME J, V7, P1092, DOI 10.1038/ismej.2013.10; Ishida TA, 2007, NEW PHYTOL, V174, P430, DOI 10.1111/j.1469-8137.2007.02016.x; Joshee S, 2009, MYCOL RES, V113, P1003, DOI 10.1016/j.mycres.2009.06.004; Jumpponen A, 2009, NEW PHYTOL, V184, P438, DOI 10.1111/j.1469-8137.2009.02990.x; Kennedy PG, 2012, MOL ECOL, V21, P4151, DOI 10.1111/j.1365-294X.2012.05703.x; Kernaghan G, 2003, OIKOS, V102, P497, DOI 10.1034/j.1600-0706.2003.12415.x; Kernaghan G, 2001, ECOGRAPHY, V24, P181, DOI 10.1034/j.1600-0587.2001.240208.x; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Lugo MA, 2008, MICROB ECOL, V55, P705, DOI 10.1007/s00248-007-9313-3; Manter DK, 2010, APPL ENVIRON MICROB, V76, P2086, DOI 10.1128/AEM.03017-09; McCain CM, 2007, ECOLOGY, V88, P76, DOI 10.1890/0012-9658(2007)88[76:AAMED]2.0.CO;2; McCain CM, 2005, ECOLOGY, V86, P366, DOI 10.1890/03-3147; Meier CL, 2010, SOIL BIOL BIOCHEM, V42, P1083, DOI 10.1016/j.soilbio.2010.03.005; Meng H, 2013, APPL MICROBIOL BIOT, V97, P2219, DOI 10.1007/s00253-012-4063-7; Nilsson RH, 2010, FUNGAL ECOL, V3, P284, DOI 10.1016/j.funeco.2010.05.002; Nilsson RH, 2008, EVOL BIOINFORM, V4, P193; Nogues-Bravo D, 2008, NATURE, V453, P216, DOI 10.1038/nature06812; Oksanen J., 2022, VEGAN COMMUNITY ECOL; Pinheiro J, 2012, NLME LINEAR NONLINEA; RAHBEK C, 1995, ECOGRAPHY, V18, P200, DOI 10.1111/j.1600-0587.1995.tb00341.x; Rinaldi AC, 2008, FUNGAL DIVERS, V33, P1; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Tedersoo L, 2012, MOL ECOL, V21, P4160, DOI 10.1111/j.1365-294X.2012.05602.x; Tedersoo L, 2010, NEW PHYTOL, V188, P291, DOI 10.1111/j.1469-8137.2010.03373.x; Tedersoo L, 2010, MYCORRHIZA, V20, P217, DOI 10.1007/s00572-009-0274-x; Tedersoo L, 2010, NEW PHYTOL, V185, P351, DOI 10.1111/j.1469-8137.2009.03134.x; Unterseher M, 2010, FUNGAL ECOL, V3, P366, DOI 10.1016/j.funeco.2010.03.001; Wu BY, 2007, MYCORRHIZA, V17, P495, DOI 10.1007/s00572-007-0114-9; Zimmerman NB, 2012, P NATL ACAD SCI USA, V109, P13022, DOI 10.1073/pnas.1209872109	54	79	81	1	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100668	10.1371/journal.pone.0100668	http://dx.doi.org/10.1371/journal.pone.0100668			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971637	gold, Green Published, Green Submitted			2022-12-27	WOS:000338512200049
J	Joseph, SJ; Li, B; Ghonasgi, T; Haase, CP; Qin, ZHS; Dean, D; Read, TD				Joseph, Sandeep J.; Li, Ben; Ghonasgi, Tanvi; Haase, Chad P.; Qin, Zhaohui S.; Dean, Deborah; Read, Timothy D.			Direct Amplification, Sequencing and Profiling of Chlamydia trachomatis Strains in Single and Mixed Infection Clinical Samples	PLOS ONE			English	Article							OBLIGATE INTRACELLULAR PATHOGEN; POPULATION-STRUCTURE; GENOME SEQUENCES; RECOMBINATION; ALIGNMENT; GENOTYPE; DISEASES; CULTURE; HUMANS	Sequencing bacterial genomes from DNA isolated directly from clinical samples offers the promise of rapid and precise acquisition of informative genetic information. In the case of Chlamydia trachomatis, direct sequencing is particularly desirable because it obviates the requirement for culture in mammalian cells, saving time, cost and the possibility of missing low abundance strains. In this proof of concept study, we developed methodology that would allow genome-scale direct sequencing, using a multiplexed microdroplet PCR enrichment technology to amplify a 100 kb region of the C. trachomatis genome with 500 1.1-1.3 kb overlapping amplicons (5-fold amplicon redundancy). We integrated comparative genomic data into a pipeline to preferentially select conserved sites for amplicon design. The 100 kb target region could be amplified from clinical samples, including remnants from diagnostics tests, originating from the cervix, urethra and urine, For rapid analysis of these data, we developed a framework for whole-genome based genotyping called binstrain. We used binstrain to estimate the proportion of SNPs originating from 14 C. trachomatis reference serotype genomes in each sample. Direct DNA sequencing methods such as the one described here may have an important role in understanding the biology of C. trachomatis mixed infections and the natural genetic variation of the species within clinically relevant ecological niches.	[Joseph, Sandeep J.; Read, Timothy D.] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA 30322 USA; [Li, Ben; Qin, Zhaohui S.] Emory Univ, Rollins Sch Publ Hlth, Dept Biostati & Bioinformat, Atlanta, GA 30322 USA; [Ghonasgi, Tanvi; Dean, Deborah] Childrens Hosp Oakland, Res Inst, Ctr Immunobiol & Vaccine Dev, Oakland, CA 94609 USA; [Haase, Chad P.; Read, Timothy D.] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA USA; [Dean, Deborah] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Dean, Deborah] Univ Calif San Francisco, Joint Grad Program Bioengn, San Francisco, CA 94143 USA; [Dean, Deborah] Univ Calif Berkeley, Berkeley, CA 94720 USA	Emory University; Emory University; Rollins School Public Health; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Emory University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley	Read, TD (corresponding author), Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA 30322 USA.	tread@emory.edu	Qin, Zhaohui/Q-3133-2019	Qin, Zhaohui/0000-0002-1583-146X; Joseph, Sandeep/0000-0003-0697-2487; Read, Timothy/0000-0001-8966-9680	Emory University School of Medicine; National Institutes of Health [R01AI098843]; Georgia Research Alliance; Atlanta Clinical and Translational Sciences Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI098843] Funding Source: NIH RePORTER	Emory University School of Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Research Alliance; Atlanta Clinical and Translational Sciences Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by development funds from Emory University School of Medicine (to TDR), and Public Health Service grant R01AI098843 from the National Institutes of Health (to DD and TDR). This project made use of the Emory Genomics Center, which used equipment funded by the Georgia Research Alliance and Atlanta Clinical and Translational Sciences Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bos KI, 2011, NATURE, V478, P506, DOI 10.1038/nature10549; Brown SDJ, 2012, MOL ECOL RESOUR, V12, P562, DOI 10.1111/j.1755-0998.2011.03108.x; Brunham RC, 1996, J INFECT DIS, V173, P950, DOI 10.1093/infdis/173.4.950; Cook JA, 2008, NEW ENGL J MED, V358, P1777, DOI 10.1056/NEJMp0708546; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Dean D, 1997, J CLIN INVEST, V99, P475, DOI 10.1172/JCI119182; Dean D, 2000, J INFECT DIS, V182, P909, DOI 10.1086/315778; Dean D, 2009, EMERG INFECT DIS, V15, P1385, DOI 10.3201/eid1509.090272; Dean D, 2008, PLOS MED, V5, P57, DOI 10.1371/journal.pmed.0050014; DeMars R, 2008, J BACTERIOL, V190, P1605, DOI 10.1128/JB.01592-07; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Geniez S, 2012, SYMBIOSIS, V58, P201, DOI 10.1007/s13199-012-0215-x; Gomes JP, 2007, GENOME RES, V17, P50, DOI 10.1101/gr.5674706; Harris SR, 2012, NAT GENET, V44, P413, DOI 10.1038/ng.2214; Huang WC, 2012, BIOINFORMATICS, V28, P593, DOI 10.1093/bioinformatics/btr708; Inouye M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-338; Jalal H, 2011, J MED MICROBIOL, V60, P881, DOI 10.1099/jmm.0.028076-0; Jeffrey BM, 2010, INFECT IMMUN, V78, P2544, DOI 10.1128/IAI.01324-09; Joseph SJ, 2012, MOL BIOL EVOL, V29, P3933, DOI 10.1093/molbev/mss198; Joseph SJ, 2012, NAT GENET, V44, P364, DOI 10.1038/ng.2225; Joseph SJ, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-28; Keim PS, 2009, NAT REV MICROBIOL, V7, P813, DOI 10.1038/nrmicro2219; Kiss MM, 2008, ANAL CHEM, V80, P8975, DOI 10.1021/ac801276c; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Melnikov A, 2011, GENOME BIOL, V12, DOI [10.1186/gb-2011-12-8-R73, 10.1186/gb-2011-12-8-r73]; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Molano M, 2005, J INFECT DIS, V191, P907, DOI 10.1086/428287; Nguyen BD, 2012, P NATL ACAD SCI USA, V109, P1263, DOI 10.1073/pnas.1117884109; Pritchard JK, 2000, GENETICS, V155, P945; Putman TE, 2013, MICROBIOL-SGM, V159, P2109, DOI 10.1099/mic.0.070029-0; Read TD, 2000, NUCLEIC ACIDS RES, V28, P1397, DOI 10.1093/nar/28.6.1397; Seth-Smith HMB, 2013, GENOME RES, V23, P855, DOI 10.1101/gr.150037.112; Somboonna N, 2011, MBIO, V2, DOI 10.1128/mBio.00045-11; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Thomson NR, 2008, GENOME RES, V18, P161, DOI 10.1101/gr.7020108; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Wang YB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002258; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	39	19	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e99290	10.1371/journal.pone.0099290	http://dx.doi.org/10.1371/journal.pone.0099290			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971628	Green Submitted, Green Published, gold			2022-12-27	WOS:000338512200008
J	Sidik, SM; Hackett, CG; Tran, F; Westwood, NJ; Lourido, S				Sidik, Saima M.; Hackett, Caroline G.; Tran, Fanny; Westwood, Nicholas J.; Lourido, Sebastian			Efficient Genome Engineering of Toxoplasma gondii Using CRISPR/Cas9	PLOS ONE			English	Article							INVASION; SYSTEMS; MARKER; GENES	Toxoplasma gondii is a parasite of humans and animals, and a model for other apicomplexans including Plasmodium spp., the causative agents of malaria. Despite many advances, manipulating the T. gondii genome remains labor intensive, and is often restricted to lab-adapted strains or lines carrying mutations that enable selection. Here, we use the RNA-guided Cas9 nuclease to efficiently generate knockouts without selection, and to introduce point mutations and epitope tags into the T. gondii genome. These methods will streamline the functional analysis of parasite genes and enable high-throughput engineering of their genomes.	[Sidik, Saima M.; Hackett, Caroline G.; Lourido, Sebastian] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Tran, Fanny; Westwood, Nicholas J.] Univ St Andrews, Sch Chem & Biomed Sci Res Complex, St Andrews, Fife, Scotland; [Tran, Fanny; Westwood, Nicholas J.] EaStCHEM, St Andrews, Fife, Scotland	Massachusetts Institute of Technology (MIT); Whitehead Institute; University of St Andrews; University of St Andrews	Lourido, S (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	lourido@wi.mit.edu		Westwood, Nicholas/0000-0003-0630-0138; Lourido, Sebastian/0000-0002-5237-1095	NIH [1DP5OD017892]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD017892] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by NIH grant 1DP5OD017892 to S.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andenmatten N, 2013, NAT METHODS, V10, P125, DOI 10.1038/NMETH.2301; Bastin P, 1996, MOL BIOCHEM PARASIT, V77, P235, DOI 10.1016/0166-6851(96)02598-4; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Dobrowolski JM, 1997, MOL MICROBIOL, V26, P163, DOI 10.1046/j.1365-2958.1997.5671913.x; DONALD RGK, 1993, P NATL ACAD SCI USA, V90, P11703, DOI 10.1073/pnas.90.24.11703; Donald RGK, 2006, MOL BIOCHEM PARASIT, V149, P86, DOI 10.1016/j.molbiopara.2006.05.003; Fox BA, 2009, EUKARYOT CELL, V8, P520, DOI 10.1128/EC.00357-08; Garrison E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003049; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; KIM K, 1995, EXP PARASITOL, V80, P46, DOI 10.1006/expr.1995.1006; KIM K, 1993, SCIENCE, V262, P911, DOI 10.1126/science.8235614; Lourido S, 2012, EMBO J, V31, P4524, DOI 10.1038/emboj.2012.299; Mccoy JM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003066; NAGEL SD, 1988, MOL BIOCHEM PARASIT, V29, P261, DOI 10.1016/0166-6851(88)90081-3; Tran F, 2013, MOLECULES, V18, P11639, DOI 10.3390/molecules180911639; VANDENHOFF MJB, 1992, NUCLEIC ACIDS RES, V20, P2902, DOI 10.1093/nar/20.11.2902; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981	20	153	158	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100450	10.1371/journal.pone.0100450	http://dx.doi.org/10.1371/journal.pone.0100450			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971596	gold, Green Published, Green Submitted			2022-12-27	WOS:000338512200032
J	Tsai, VWW; Manandhar, R; Jorgensen, SB; Lee-Ng, KKM; Zhang, HP; Marquis, CP; Jiang, L; Husaini, Y; Lin, S; Sainsbury, A; Sawchenko, PE; Brown, DA; Breit, SN				Tsai, Vicky Wang-Wei; Manandhar, Rakesh; Jorgensen, Sebastian Beck; Lee-Ng, Ka Ki Michelle; Zhang, Hong Ping; Marquis, Christopher Peter; Jiang, Lele; Husaini, Yasmin; Lin, Shu; Sainsbury, Amanda; Sawchenko, Paul E.; Brown, David A.; Breit, Samuel N.			The Anorectic Actions of the TGF beta Cytokine MIC-1/GDF15 Require an Intact Brainstem Area Postrema and Nucleus of the Solitary Tract	PLOS ONE			English	Article							MACROPHAGE INHIBITORY CYTOKINE-1; GLUCAGON-LIKE PEPTIDE-1; CENTRAL-NERVOUS-SYSTEM; PARAVENTRICULAR NUCLEUS; FOOD-INTAKE; ARCUATE NUCLEUS; HYPOTHALAMUS; NEURONS; SERUM; RAT	Macrophage inhibitory cytokine-1 (MIC-1/GDF15) modulates food intake and body weight under physiological and pathological conditions by acting on the hypothalamus and brainstem. When overexpressed in disease, such as in advanced cancer, elevated serum MIC-1/GDF15 levels lead to an anorexia/cachexia syndrome. To gain a better understanding of its actions in the brainstem we studied MIC-1/GDF15 induced neuronal activation identified by induction of Fos protein. Intraperitoneal injection of human MIC-1/GDF15 in mice activated brainstem neurons in the area postrema (AP) and the medial (m) portion of the nucleus of the solitary tract (NTS), which did not stain with tyrosine hydroxylase (TH). To determine the importance of these brainstem nuclei in the anorexigenic effect of MIC-1/GDF15, we ablated the AP alone or the AP and the NTS. The latter combined lesion completely reversed the anorexigenic effects of MIC-1/GDF15. Altogether, this study identified neurons in the AP and/or NTS, as being critical for the regulation of food intake and body weight by MIC-1/GDF15.	[Tsai, Vicky Wang-Wei; Manandhar, Rakesh; Lee-Ng, Ka Ki Michelle; Zhang, Hong Ping; Jiang, Lele; Husaini, Yasmin; Brown, David A.; Breit, Samuel N.] St Vincents Hosp, St Vincents Ctr Appl Med Res, Sydney, NSW 2010, Australia; [Tsai, Vicky Wang-Wei; Manandhar, Rakesh; Lee-Ng, Ka Ki Michelle; Zhang, Hong Ping; Jiang, Lele; Husaini, Yasmin; Brown, David A.; Breit, Samuel N.] Univ New S Wales, Sydney, NSW, Australia; [Jorgensen, Sebastian Beck] Novo Nordisk AS, Diabet Res Unit, Malov, Denmark; [Marquis, Christopher Peter] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Lin, Shu; Sainsbury, Amanda] Garvan Inst Med Res, Neurosci Program, Sydney, NSW, Australia; [Sainsbury, Amanda] Univ Sydney, Sydney Med Sch, Boden Inst Obes Nutr Exercise & Eating Disorders, Sydney, NSW 2006, Australia; [Sawchenko, Paul E.] Salk Inst Biol Studies, Neuronal Struct & Funct Lab, La Jolla, CA 92037 USA	St Vincents Hospital Sydney; University of New South Wales Sydney; Novo Nordisk; University of New South Wales Sydney; Garvan Institute of Medical Research; University of Sydney; Salk Institute	Breit, SN (corresponding author), St Vincents Hosp, St Vincents Ctr Appl Med Res, Sydney, NSW 2010, Australia.	s.breit@amr.org.au	Salis, Amanda/A-3187-2011; Marquis, Christopher/E-3847-2013	Salis, Amanda/0000-0001-9176-1574; Marquis, Christopher/0000-0003-1656-7215; lin, shu/0000-0002-4239-2028; Jiang, Lele/0000-0002-1326-5871; Brown, David/0000-0003-1382-9419	National Health and Medical Research Council of Australia (NHMRC); NHMRC; National Institute of Health (NIH) of U.S. [NS-21182]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021182, R37NS021182] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); National Institute of Health (NIH) of U.S.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Health and Medical Research Council of Australia (NHMRC). AS, DAB and SL are recipients of NHMRC Career Development Awards or Fellowships. Professor Paul E. Sawchenko is supported by grants (NS-21182) from the National Institute of Health (NIH) of U.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affleck VS, 2012, NEUROSCIENCE, V219, P48, DOI 10.1016/j.neuroscience.2012.05.070; ARMSTRONG DM, 1982, J COMP NEUROL, V212, P173, DOI 10.1002/cne.902120207; BAKER RA, 1995, J COMP NEUROL, V358, P518, DOI 10.1002/cne.903580405; Bauskin AR, 2005, CANCER RES, V65, P2330, DOI 10.1158/0008-5472.CAN-04-3827; Bauskin AR, 2006, CANCER RES, V66, P4983, DOI 10.1158/0008-5472.CAN-05-4067; Bell ME, 2000, J NEUROSCI, V20, P6707, DOI 10.1523/JNEUROSCI.20-17-06707.2000; Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; Breit SN, 2012, NEPHROL DIAL TRANSPL, V27, P70, DOI 10.1093/ndt/gfr575; Breit SN, 2011, GROWTH FACTORS, V29, P187, DOI 10.3109/08977194.2011.607137; Brown DA, 2006, CLIN CANCER RES, V12, P89, DOI 10.1158/1078-0432.CCR-05-1331; Brown DA, 2003, CLIN CANCER RES, V9, P2642; Brown DA, 2002, BIOTECHNIQUES, V33, P118, DOI 10.2144/02331rr03; Brown DA, 2002, LANCET, V359, P2159, DOI 10.1016/S0140-6736(02)09093-1; Coll AP, 2007, CELL, V129, P251, DOI 10.1016/j.cell.2007.04.001; CUNNINGHAM ET, 1994, NEUROSCIENCE, V58, P635, DOI 10.1016/0306-4522(94)90087-6; EDWARDS GL, 1986, AM J PHYSIOL, V251, pR575, DOI 10.1152/ajpregu.1986.251.3.R575; Ericsson A, 1997, J NEUROSCI, V17, P7166; Fairlie WD, 2001, BIOCHEMISTRY-US, V40, P65, DOI 10.1021/bi001064p; Fuchs T, 2013, AGING CELL; Giza BK, 1996, CHEM SENSES, V21, P147, DOI 10.1093/chemse/21.2.147; Glattfelder KJ, 2008, AREA POSTREMA, P2053; Hosoi T, 2002, ENDOCRINOLOGY, V143, P3498, DOI 10.1210/en.2002-220077; Husaini Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043833; Johnen H, 2007, NAT MED, V13, P1333, DOI 10.1038/nm1677; Johnen H, 2012, CARDIOVASC PATHOL, V21, P499, DOI 10.1016/j.carpath.2012.02.003; Koopmann J, 2006, CLIN CANCER RES, V12, P442, DOI 10.1158/1078-0432.CCR-05-0564; Koopmann J, 2004, CLIN CANCER RES, V10, P2386, DOI 10.1158/1078-0432.CCR-03-0165; Larsen PJ, 1997, NEUROSCIENCE, V77, P257, DOI 10.1016/S0306-4522(96)00434-4; Macia L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034868; Maolood N, 2009, J CHEM NEUROANAT, V37, P182, DOI 10.1016/j.jchemneu.2008.12.007; Matzinger D, 1999, AM J PHYSIOL-REG I, V277, pR1718, DOI 10.1152/ajpregu.1999.277.6.R1718; Moore AG, 2000, J CLIN ENDOCR METAB, V85, P4781, DOI 10.1210/jc.85.12.4781; Moran TH, 2006, OBESITY, V14, P250; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Munzberg H, 2004, ENDOCRINOLOGY, V145, P4880, DOI 10.1210/en.2004-0726; Paul CA, 2008, CSH PROTOC, V2008; Paxinos G, 2001, MOUSE BRAIN STEREOTA, Vxxv; Radley JJ, 2008, J NEUROSCI, V28, P5806, DOI 10.1523/JNEUROSCI.0552-08.2008; Renner E, 2010, EUR J NEUROSCI, V31, P302, DOI 10.1111/j.1460-9568.2009.07053.x; Reyes TM, 2002, J NEUROSCI, V22, P5091, DOI 10.1523/JNEUROSCI.22-12-05091.2002; Rinaman L, 2003, J NEUROSCI, V23, P10084; RINAMAN L, 1995, J COMP NEUROL, V360, P246, DOI 10.1002/cne.903600204; Rinaman L, 2007, FRONT NEUROENDOCRIN, V28, P50, DOI 10.1016/j.yfrne.2007.02.002; Romano A, 2013, AM J PHYSIOL-ENDOC M, V305, pE1266, DOI 10.1152/ajpendo.00411.2013; SAWCHENKO PE, 1981, SCIENCE, V214, P685, DOI 10.1126/science.7292008; SAWCHENKO PE, 1982, J COMP NEUROL, V205, P260, DOI 10.1002/cne.902050306; Schwartz GJ, 2010, FORUM NUTR, V63, P141, DOI 10.1159/000264402; SHAPIRO RE, 1985, J COMP NEUROL, V238, P473, DOI 10.1002/cne.902380411; Treece BR, 2000, BRAIN RES, V872, P37, DOI 10.1016/S0006-8993(00)02432-X; Tsai VWW, 2012, J CACHEXIA SARCOPENI, V3, P239, DOI 10.1007/s13539-012-0082-6; Tsai VWW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055174; Welsh JB, 2003, P NATL ACAD SCI USA, V100, P3410, DOI 10.1073/pnas.0530278100; Wiklund FE, 2010, AGING CELL, V9, P1057, DOI 10.1111/j.1474-9726.2010.00629.x; Wollert KC, 2007, CIRCULATION, V115, P962, DOI 10.1161/CIRCULATIONAHA.106.650846; Yamamoto H, 2003, J NEUROSCI, V23, P2939	55	63	67	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100370	10.1371/journal.pone.0100370	http://dx.doi.org/10.1371/journal.pone.0100370			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971956	Green Published, Green Submitted, gold			2022-12-27	WOS:000338512200028
J	Paukner, R; Staudigl, P; Choosri, W; Sygmund, C; Halada, P; Haltrich, D; Leitner, C				Paukner, Regina; Staudigl, Petra; Choosri, Withu; Sygmund, Christoph; Halada, Petr; Haltrich, Dietmar; Leitner, Christian			Galactose Oxidase from Fusarium oxysporum - Expression in E-coli and P-pastoris and Biochemical Characterization	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; PROTEINS; COFACTOR; PURIFICATION; CLEAVAGE	A gene coding for galactose 6-oxidase from Fusarium oxysporum G12 was cloned together with its native preprosequence and a C-terminal His-tag, and successfully expressed both in Escherichia coli and Pichia pastoris. The enzyme was subsequently purified and characterized. Among all tested substrates, the highest catalytic efficiency (k(cat)/K-m) was found with 1-methyl-beta-D-galactopyranoside (2.2 mM(-1) s(-1)). The Michaelis constant (K-m) for D-galactose was determined to be 47 mM. Optimal pH and temperature for the enzyme activity were 7.0 and 40 degrees C, respectively, and the enzyme was thermoinactivated at temperatures above 50 degrees C. GalOx contains a unique metalloradical complex consisting of a copper atom and a tyrosine residue covalently attached to the sulphur of a cysteine. The correct formation of this thioether bond during the heterologous expression in E. coli and P. pastoris could be unequivocally confirmed by MALDI mass spectrometry, which offers a convenient alternative to prove this Tyr-Cys crosslink, which is essential for the catalytic activity of GalOx.	[Paukner, Regina; Staudigl, Petra; Sygmund, Christoph; Haltrich, Dietmar; Leitner, Christian] BOKU Univ Nat Resources & Life Sci, Dept Food Sci & Technol, Vienna, Austria; [Choosri, Withu] Ramkhamhang Univ, Dept Food Technol, Bangkok, Thailand; [Halada, Petr] Acad Sci Czech Republ, Inst Microbiol Vvi, Prague, Czech Republic	University of Natural Resources & Life Sciences, Vienna; Ramkhamhaeng University; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Leitner, C (corresponding author), BOKU Univ Nat Resources & Life Sci, Dept Food Sci & Technol, Vienna, Austria.	christian.leitner@boku.ac.at	Haltrich, Dietmar/N-2624-2019; Halada, Petr/H-3330-2014	Haltrich, Dietmar/0000-0002-8722-8176; Halada, Petr/0000-0002-7229-3450	Austrian Science Foundation [L 504-B11]; IMIC Institutional Research Project [RVO61388971]	Austrian Science Foundation(Austrian Science Fund (FWF)); IMIC Institutional Research Project	Funding came from the Austrian Science Foundation, http://www.fwf.ac.at Grant: L 504-B11, IMIC Institutional Research Project, Grant: RVO61388971. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AISAKA K, 1984, AGR BIOL CHEM TOKYO, V48, P1425, DOI 10.1080/00021369.1984.10866336; Alberton D, 2007, J BASIC MICROB, V47, P203, DOI 10.1002/jobm.200610290; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; AVIGAD G, 1962, J BIOL CHEM, V237, P2736; Barbosa-Tessmann IP, 2001, J BASIC MICROB, V41, P143, DOI 10.1002/1521-4028(200107)41:3/4<143::AID-JOBM143>3.0.CO;2-G; BARON AJ, 1994, J BIOL CHEM, V269, P25095; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Choosri W, 2011, WORLD J MICROB BIOT, V27, P1349, DOI 10.1007/s11274-010-0585-2; COOPER JAD, 1959, J BIOL CHEM, V234, P445; Cordeiro FA, 2010, J BASIC MICROB, V50, P527, DOI 10.1002/jobm.201000078; Deacon SE, 2011, CHEMBIOCHEM, V12, P593, DOI 10.1002/cbic.201000634; Deacon SE, 2004, CHEMBIOCHEM, V5, P972, DOI 10.1002/cbic.200300810; Dietzsch C, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-85; ETTINGER MJ, 1974, BIOCHEMISTRY-US, V13, P1242, DOI 10.1021/bi00703a029; Firbank SJ, 2003, BIOCHEM SOC T, V31, P506, DOI 10.1042/bst0310506; Gasparotto EPL, 2006, BRAZ ARCH BIOL TECHN, V49, P557, DOI 10.1590/S1516-89132006000500004; ITO N, 1994, J MOL BIOL, V238, P794, DOI 10.1006/jmbi.1994.1335; ITO N, 1991, NATURE, V350, P87, DOI 10.1038/350087a0; ITO N, 1990, BIOCHEM SOC T, V18, P931, DOI 10.1042/bst0180931; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leitner C, 2001, APPL ENVIRON MICROB, V67, P3636, DOI 10.1128/AEM.67.8.3636-3644.2001; Levasseur A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-41; Lis M, 1997, ANTIMICROB AGENTS CH, V41, P999, DOI 10.1128/AAC.41.5.999; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; Martinie RJ, 2012, METALLOMICS, V4, P1037, DOI 10.1039/c2mt20093g; Mazur Adam W, 1991, GALACTOSE OXIDASE EN, P99; MCPHERSON MJ, 1993, BIOCHEM SOC T, V21, P752, DOI 10.1042/bst0210752; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; Rogers MS, 2008, BIOCHEMISTRY-US, V47, P10428, DOI 10.1021/bi8010835; Rogers MS, 2000, J AM CHEM SOC, V122, P990, DOI 10.1021/ja993385y; Saysell CG, 1997, J BIOL INORG CHEM, V2, P702, DOI 10.1007/s007750050186; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Spadiut O, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-68; Sun LH, 2002, CHEMBIOCHEM, V3, P781, DOI 10.1002/1439-7633(20020802)3:8<781::AID-CBIC781>3.0.CO;2-8; Sun LH, 2001, PROTEIN ENG, V14, P699, DOI 10.1093/protein/14.9.699; Whittaker JW, 2005, ARCH BIOCHEM BIOPHYS, V433, P227, DOI 10.1016/j.abb.2004.08.034; Whittaker JW, 2002, ADV PROTEIN CHEM, V60, P1; Whittaker JW, 1997, J INORG BIOCHEM, V67, P39; Whittaker MM, 2000, PROTEIN EXPRES PURIF, V20, P105, DOI 10.1006/prep.2000.1287; WHITTAKER MM, 1988, J BIOL CHEM, V263, P6074; Whittaker MM, 2003, J BIOL CHEM, V278, P22090, DOI 10.1074/jbc.M300112200; Wilkinson D, 2004, PROTEIN ENG DES SEL, V17, P141, DOI 10.1093/protein/gzh018; Xu F, 2000, APPL BIOCHEM BIOTECH, V88, P23, DOI 10.1385/ABAB:88:1-3:023	44	16	15	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100116	10.1371/journal.pone.0100116	http://dx.doi.org/10.1371/journal.pone.0100116			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967652	gold, Green Published, Green Submitted			2022-12-27	WOS:000338280800025
J	Qin, W; Chen, ZL; Zhang, YH; Yan, RB; Yan, GR; Li, S; Zhong, HB; Lin, S				Qin, Wei; Chen, Zelin; Zhang, Yihan; Yan, Ruibin; Yan, Guanrong; Li, Song; Zhong, Hanbing; Lin, Shuo			Nom1 Mediates Pancreas Development by Regulating Ribosome Biogenesis in Zebrafish	PLOS ONE			English	Article							SET ENRICHMENT ANALYSIS; PROTEIN PHOSPHATASE-1; RNA-SEQ; DYSKERATOSIS-CONGENITA; DIGESTIVE ORGANS; GENE; EXPRESSION; NUCLEOLUS; IDENTIFICATION; ABNORMALITIES	Ribosome biogenesis is an important biological process for proper cellular function and development. Defects leading to improper ribosome biogenesis can cause diseases such as Diamond-Blackfan anemia and Shwachman-Bodian-Diamond syndrome. Nucleolar proteins are a large family of proteins and are involved in many cellular processes, including the regulation of ribosome biogenesis. Through a forward genetic screen and positional cloning, we identified and characterized a zebrafish line carrying mutation in nucleolar protein with MIF4G domain 1 (nom1), which encodes a conserved nulceolar protein with a role in pre-rRNA processing. Zebrafish nom1 mutants exhibit major defects in endoderm development, especially in exocrine pancreas. Further studies revealed that impaired proliferation of ptf1a-expressing pancreatic progenitor cells mainly contributed to the phenotype. RNA-seq and molecular analysis showed that ribosome biogenesis and pre-mRNA splicing were both affected in the mutant embryos. Several defects of ribosome assembly have been shown to have a p53-dependent mechanism. In the nom1 mutant, loss of p53 did not rescue the pancreatic defect, suggesting a p53-independent role. Further studies indicate that protein phosphatase 1 alpha, an interacting protein to Nom1, could partially rescue the pancreatic defect in nom1 morphants if a human nucleolar localization signal sequence was artificially added. This suggests that targeting Pp1 alpha into the nucleolus by Nom1 is important for pancreatic proliferation. Altogether, our studies revealed a new mechanism involving Nom1 in controlling vertebrate exocrine pancreas formation.	[Qin, Wei; Chen, Zelin; Zhang, Yihan; Yan, Ruibin; Yan, Guanrong; Li, Song; Lin, Shuo] Peking Univ, Shenzhen Grad Sch, Sch Chem Biol & Biotechnol, Lab Chem Genom, Shenzhen, Peoples R China; [Zhong, Hanbing] South Univ Sci & Technol China, Dept Biol, Shenzhen, Guangdong, Peoples R China; [Lin, Shuo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA USA	Peking University; University Town of Shenzhen; Southern University of Science & Technology; University of California System; University of California Los Angeles	Lin, S (corresponding author), Peking Univ, Shenzhen Grad Sch, Sch Chem Biol & Biotechnol, Lab Chem Genom, Shenzhen, Peoples R China.	shuolin@ucla.edu		Qin, Wei/0000-0003-2158-0553	Shenzhen Science and Technology Program [JC201104220257A, CXC201104210009A]; National Natural Science Foundation of China [31271550]	Shenzhen Science and Technology Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by Shenzhen Science and Technology Program (JC201104220257A, CXC201104210009A) and National Natural Science Foundation of China(31271550). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov A, 2011, GENE DEV, V25, P1078, DOI 10.1101/gad.2045411; Aravind L, 2000, GENOME RES, V10, P1172, DOI 10.1101/gr.10.8.1172; Berghmans S, 2005, P NATL ACAD SCI USA, V102, P407, DOI 10.1073/pnas.0406252102; Boglev Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003279; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Chen J, 2005, GENE DEV, V19, P2900, DOI 10.1101/gad.1366405; Cohen PTW, 2002, J CELL SCI, V115, P241; Danilova N, 2008, BLOOD, V112, P5228, DOI 10.1182/blood-2008-01-132290; Doudna JA, 2002, CELL, V109, P153, DOI 10.1016/S0092-8674(02)00725-0; Duan J, 2011, INT J BIOCHEM CELL B, V43, P1218, DOI 10.1016/j.biocel.2011.04.015; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Geisler R, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-11; Gunawardena SR, 2008, J BIOL CHEM, V283, P398, DOI 10.1074/jbc.M706708200; Heiss NS, 1999, HUM MOL GENET, V8, P2515, DOI 10.1093/hmg/8.13.2515; Hozumi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033675; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Langheinrich U, 2002, CURR BIOL, V12, P2023, DOI 10.1016/S0960-9822(02)01319-2; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Linder P, 2011, NAT REV MOL CELL BIO, V12, P505, DOI 10.1038/nrm3154; Lowery LA, 2007, DEV DYNAM, V236, P1347, DOI 10.1002/dvdy.21132; Marciniak RA, 1998, P NATL ACAD SCI USA, V95, P6887, DOI 10.1073/pnas.95.12.6887; Mayer AN, 2003, DEVELOPMENT, V130, P3917, DOI 10.1242/dev.00600; Pereboom TC, 2011, BLOOD, V118, P5458, DOI 10.1182/blood-2011-04-351460; Provost E, 2013, ZEBRAFISH, V10, P161, DOI 10.1089/zeb.2013.0884; Provost E, 2012, DEVELOPMENT, V139, P3232, DOI 10.1242/dev.077107; Rios Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001271; Sasaki M, 2011, NAT MED, V17, P944, DOI 10.1038/nm.2392; Simmons HM, 2005, GENE, V347, P137, DOI 10.1016/j.gene.2004.12.027; Simmons HM, 2002, LEUKEMIA, V16, P2408, DOI 10.1038/sj.leu.2402773; Skarie JM, 2008, HUM MOL GENET, V17, P2474, DOI 10.1093/hmg/ddn147; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Trede NS, 2007, P NATL ACAD SCI USA, V104, P6608, DOI 10.1073/pnas.0701919104; Trinkle-Mulcahy L, 2001, J CELL SCI, V114, P4219; von Bergh ARM, 2006, GENE CHROMOSOME CANC, V45, P731, DOI 10.1002/gcc.20335; Walker MB, 2007, BIOTECH HISTOCHEM, V82, P23, DOI 10.1080/10520290701333558; Wang DW, 2007, P NATL ACAD SCI USA, V104, P12428, DOI 10.1073/pnas.0705502104; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Woo LL, 2006, EXP CELL RES, V312, P3443, DOI 10.1016/j.yexcr.2006.07.023; Yee NS, 2007, PLOS BIOL, V5, P2484, DOI 10.1371/journal.pbio.0050312; Zhang YP, 2009, CANCER CELL, V16, P369, DOI 10.1016/j.ccr.2009.09.024; Zhang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030188; Zhao CT, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004074	48	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100796	10.1371/journal.pone.0100796	http://dx.doi.org/10.1371/journal.pone.0100796			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967912	Green Published, gold, Green Submitted			2022-12-27	WOS:000338280800069
J	Rudnicki, WR; Mroczek, T; Cudek, P				Rudnicki, Witold R.; Mroczek, Teresa; Cudek, Pawel			Amino Acid Properties Conserved in Molecular Evolution	PLOS ONE			English	Article							STANDARD GENETIC-CODE; SUBSTITUTION MATRICES; MUTATION MATRICES; PROTEIN EVOLUTION; ORIGIN; IDENTIFICATION; MODEL	That amino acid properties are responsible for the way protein molecules evolve is natural and is also reasonably well supported both by the structure of the genetic code and, to a large extent, by the experimental measures of the amino acid similarity. Nevertheless, there remains a significant gap between observed similarity matrices and their reconstructions from amino acid properties. Therefore, we introduce a simple theoretical model of amino acid similarity matrices, which allows splitting the matrix into two parts - one that depends only on mutabilities of amino acids and another that depends on pairwise similarities between them. Then the new synthetic amino acid properties are derived from the pairwise similarities and used to reconstruct similarity matrices covering a wide range of information entropies. Our model allows us to explain up to 94% of the variability in the BLOSUM family of the amino acids similarity matrices in terms of amino acid properties. The new properties derived from amino acid similarity matrices correlate highly with properties known to be important for molecular evolution such as hydrophobicity, size, shape and charge of amino acids. This result closes the gap in our understanding of the influence of amino acids on evolution at the molecular level. The methods were applied to the single family of similarity matrices used often in general sequence homology searches, but it is general and can be used also for more specific matrices. The new synthetic properties can be used in analyzes of protein sequences in various biological applications.	[Rudnicki, Witold R.] Warsaw Univ, Interdisciplinary Ctr Math & Computat Modelling, Warsaw, Poland; [Mroczek, Teresa; Cudek, Pawel] Univ Informat Technol & Management, Chair Expert Syst & Artificial Intelligence, Rzeszow, Poland	University of Warsaw; Interdisciplinary Centre for Mathematical & Computational Modelling; University of Information Technology & Management Rzeszow	Rudnicki, WR (corresponding author), Warsaw Univ, Interdisciplinary Ctr Math & Computat Modelling, Warsaw, Poland.	W.Rudnicki@icm.edu.pl	Rudnicki, Witold R/B-6670-2012	Rudnicki, Witold R/0000-0002-7928-4944; Mroczek, Teresa/0000-0002-6064-9528	Polish Ministry of Science and Higher Education, Faculty of Applied IT, University of Information Technology and Management;  [503-07-04-03]	Polish Ministry of Science and Higher Education, Faculty of Applied IT, University of Information Technology and Management; 	This research was partially funded within project No. 503-07-04-03. The project is subsidized by the Polish Ministry of Science and Higher Education as part of the statutory research of the Faculty of Applied IT, University of Information Technology and Management. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Altschul SF, 1991, J MOL BIOL, V219, P55; Ardell DH, 1998, J MOL EVOL, V47, P1, DOI 10.1007/PL00006356; CLARKE B, 1970, NATURE, V228, P159, DOI 10.1038/228159a0; CRICK FHC, 1968, J MOL BIOL, V38, P367, DOI 10.1016/0022-2836(68)90392-6; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, V5, P345; Dayhoff MO, 1968, ATLAS PROTEIN SEQUEN, P33; Di Giulio M, 2003, ORIGINS LIFE EVOL B, V33, P479, DOI 10.1023/A:1025772828039; Di Giulio M, 2001, J MOL EVOL, V53, P724, DOI 10.1007/s002390010259; EPSTEIN CJ, 1967, NATURE, V215, P355, DOI 10.1038/215355a0; Freeland SJ, 2003, ORIGINS LIFE EVOL B, V33, P457, DOI 10.1023/A:1025771327614; Gambin A, 2006, J COMPUT BIOL, V13, P81, DOI 10.1089/cmb.2006.13.81; GAMOW G, 1954, NATURE, V173, P318, DOI 10.1038/173318a0; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Kinjo AR, 2004, BIOINFORMATICS, V20, P2504, DOI 10.1093/bioinformatics/bth297; Koshi JM, 1997, PROTEINS, V27, P336, DOI 10.1002/(SICI)1097-0134(199703)27:3<336::AID-PROT2>3.0.CO;2-B; KOSHI JM, 1995, PROTEIN ENG, V8, P641; LIM WA, 1992, BIOCHEMISTRY-US, V31, P4324, DOI 10.1021/bi00132a025; Ng PC, 2000, BIOINFORMATICS, V16, P760, DOI 10.1093/bioinformatics/16.9.760; NICHOLSON H, 1988, NATURE, V336, P651, DOI 10.1038/336651a0; Pokarowski P, 2007, PROTEINS, V69, P379, DOI 10.1002/prot.21509; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; SNEATH PHA, 1966, J THEOR BIOL, V12, P157, DOI 10.1016/0022-5193(66)90112-3; SONNEBORN T. M., 1965, P377; Tomii K, 1996, PROTEIN ENG, V9, P27, DOI 10.1093/protein/9.1.27; WOESE CR, 1966, COLD SPRING HARB SYM, V31, P723, DOI 10.1101/SQB.1966.031.01.093; WONG JTF, 1975, P NATL ACAD SCI USA, V72, P1909, DOI 10.1073/pnas.72.5.1909; Xia XH, 1998, J MOL EVOL, V47, P557, DOI 10.1007/PL00006412; Yarus M, 2002, ANNU REV GENET, V36, P125, DOI 10.1146/annurev.genet.36.031902.105056; Zhu W, 2006, J THEOR BIOL, V239, P63, DOI 10.1016/j.jtbi.2005.07.012; Zimmermann K, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-4; ZUCKERKANDL EMILE, 1965, P97	35	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e98983	10.1371/journal.pone.0098983	http://dx.doi.org/10.1371/journal.pone.0098983			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967708	Green Submitted, Green Published, gold			2022-12-27	WOS:000338280800006
J	Arevalo-Herrera, M; Forero-Pena, DA; Rubiano, K; Gomez-Hincapie, J; Martinez, NL; Lopez-Perez, M; Castellanos, A; Cespedes, N; Palacios, R; Onate, JM; Herrera, S				Arevalo-Herrera, Myriam; Forero-Pena, David A.; Rubiano, Kelly; Gomez-Hincapie, Jose; Martinez, Nora L.; Lopez-Perez, Mary; Castellanos, Angelica; Cespedes, Nora; Palacios, Ricardo; Onate, Jose Millan; Herrera, Socrates			Plasmodium vivax Sporozoite Challenge in Malaria-Naive and Semi-Immune Colombian Volunteers	PLOS ONE			English	Article							DUFFY-BINDING-PROTEIN; CIRCUMSPOROZOITE PROTEIN; ANOPHELES-ALBIMANUS; PROTECTIVE EFFICACY; VACCINE CANDIDATE; AOTUS MONKEYS; IMMUNOGENICITY; FALCIPARUM; RESPONSES; RECEPTOR	Background: Significant progress has been recently achieved in the development of Plasmodium vivax challenge infections in humans, which are essential for vaccine and drug testing. With the goal of accelerating clinical development of malaria vaccines, the outcome of infections experimentally induced in naive and semi-immune volunteers by infected mosquito bites was compared. Methods: Seven malaria-naive and nine semi-immune Colombian adults (n = 16) were subjected to the bites of 2-4 P. vivax sporozoite-infected Anopheles mosquitoes. Parasitemia levels, malaria clinical manifestations, and immune responses were assessed and compared. Results: All volunteers developed infections as confirmed by microscopy and RT-qPCR. No significant difference in the prepatent period (mean 12.5 and 12.8 days for malaria-naive and malaria-exposed, respectively) was observed but naive volunteers developed classical malaria signs and symptoms, while semi-immune volunteers displayed minor or no symptoms at the day of diagnosis. A malaria-naive volunteer developed a transient low submicroscopic parasitemia that cured spontaneously. Infection induced an increase in specific antibody levels in both groups. Conclusion: Sporozoite infectious challenge was safe and reproducible in semi-immune and naive volunteers. This model will provide information for simultaneous comparison of the protective efficacy of P. vivax vaccines in naive and semi-immune volunteers under controlled conditions and would accelerate P. vivax vaccine development.	[Arevalo-Herrera, Myriam; Forero-Pena, David A.; Rubiano, Kelly; Gomez-Hincapie, Jose; Martinez, Nora L.; Lopez-Perez, Mary; Castellanos, Angelica; Cespedes, Nora; Herrera, Socrates] Malaria Vaccine & Drug Dev Ctr MVDC, Cali, Colombia; [Arevalo-Herrera, Myriam; Cespedes, Nora] Univ Valle, Sch Hlth, Cali, Colombia; [Forero-Pena, David A.; Rubiano, Kelly; Gomez-Hincapie, Jose; Martinez, Nora L.; Lopez-Perez, Mary; Castellanos, Angelica; Cespedes, Nora; Herrera, Socrates] CSRC, Cali, Colombia; [Palacios, Ricardo] Merid R&D, Sao Paulo, Brazil; [Onate, Jose Millan] Ctr Med Imbanaco, Cali, Colombia	Universidad del Valle	Arevalo-Herrera, M (corresponding author), Malaria Vaccine & Drug Dev Ctr MVDC, Cali, Colombia.	marevalo@inmuno.org	Palacios, Ricardo/AAN-7606-2020; Lopez-Perez, Mary/E-5059-2016; Palacios, Ricardo/B-7248-2018	Palacios, Ricardo/0000-0002-1410-8579; Lopez-Perez, Mary/0000-0002-9876-0248; Palacios, Ricardo/0000-0002-1410-8579; Castellanos Sanchez, Angelica Maria/0000-0002-6602-9696; Rubiano, Kely/0000-0002-4149-4030; Arevalo, Myriam/0000-0002-3434-9425; Onate Gutierrez, Jose Millan/0000-0002-6180-792X; Forero, David/0000-0002-8065-8464	National Heart, Lung and Blood Institute (NHLBI) [5R01HL086488]; Colombian National Research Council, COLCIENCIAS [527-2009, 529-2009, 360-2012, 458-2012]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086488] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Colombian National Research Council, COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by: 1) National Heart, Lung and Blood Institute (NHLBI, grant #5R01HL086488) http://www.nhlbi.nih.gov/. 2) Colombian National Research Council, COLCIENCIAS (contract No. 527-2009,529-2009, 360-2012 and 458-2012) http://www.colciencias.gov.co/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arevalo-Herrera M, 2005, AM J TROP MED HYG, V73, P25; Arevalo-Herrera M, 1998, ANN TROP MED PARASIT, V92, P539, DOI 10.1080/00034989859230; Arevalo-Herrera M, 2012, ACTA TROP, V121, P303, DOI 10.1016/j.actatropica.2011.06.008; Arevalo-Herrera M, 2011, AM J TROP MED HYG, V84, P71, DOI 10.4269/ajtmh.2011.10-0085; Artavanis-Tsakonas K, 2003, CLIN EXP IMMUNOL, V133, P145, DOI 10.1046/j.1365-2249.2003.02174.x; BEIER JC, 1991, MED VET ENTOMOL, V5, P63, DOI 10.1111/j.1365-2915.1991.tb00522.x; Bell BA, 2009, VACCINE, V27, P1448, DOI 10.1016/j.vaccine.2008.12.027; Cespedes N, 2013, VACCINE, V31, P4923, DOI 10.1016/j.vaccine.2013.05.082; Chaparro P, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-330; Chitnis CE, 2008, TRENDS PARASITOL, V24, P29, DOI 10.1016/j.pt.2007.10.004; Erhart LM, 2004, AM J TROP MED HYG, V70, P8, DOI 10.4269/ajtmh.2004.70.8; Food and Drug Administration (FDA), 2007, GUID IND TOX GRAD SC; Genton B, 2010, VACCINE, V28, P6573, DOI 10.1016/j.vaccine.2010.07.067; Grieco JP, 2005, J AM MOSQUITO CONTR, V21, P279, DOI 10.2987/8756-971X(2005)21[279:CSOTSO]2.0.CO;2; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Herrera S, 2005, AM J TROP MED HYG, V73, P3, DOI 10.4269/ajtmh.2005.73.3; Herrera S, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-87; Herrera S, 2011, AM J TROP MED HYG, V84, P4, DOI 10.4269/ajtmh.2011.09-0498; Herrera S, 2011, AM J TROP MED HYG, V84, P12, DOI 10.4269/ajtmh.2011.09-0516; Herrera S, 2009, AM J TROP MED HYG, V81, P740, DOI 10.4269/ajtmh.2009.09-0194; Hurtado S, 1997, ANN TROP MED PARASIT, V91, P49, DOI 10.1080/00034983.1997.11813111; Imwong M, 2007, INT J PARASITOL, V37, P1013, DOI 10.1016/j.ijpara.2007.02.010; International Conference on Harmonization, 1996, INT C HARM TECHN REQ; Karunaweera ND, 2008, GENE, V410, P105, DOI 10.1016/j.gene.2007.11.022; Laurens Matthew B, 2012, Vaccine, V30, P5302, DOI 10.1016/j.vaccine.2012.04.088; Lumsden JM, 2012, VACCINE, V30, P3311, DOI 10.1016/j.vaccine.2012.03.004; Lyke KE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013490; Malkin EM, 2005, VACCINE, V23, P3131, DOI 10.1016/j.vaccine.2004.12.019; McCarthy JS, 2013, J INFECT DIS, V208, P1688, DOI 10.1093/infdis/jit394; MinSalud, 2010, GUIA AT CLIN INT PAC; Molina DM, 2012, AM J TROP MED HYG, V87, P460, DOI 10.4269/ajtmh.2012.12-0222; Moreno A, 2008, VACCINE, V26, P4338, DOI 10.1016/j.vaccine.2008.06.010; Noulin F, 2013, TRENDS PARASITOL, V29, P286, DOI 10.1016/j.pt.2013.03.012; Rodriguez JCP, 2011, MEM I OSWALDO CRUZ, V106, P114, DOI 10.1590/S0074-02762011000900015; Rougemont M, 2004, J CLIN MICROBIOL, V42, P5636, DOI 10.1128/JCM.42.12.5636-5643.2004; Russell B, 2006, TRENDS PARASITOL, V22, P399, DOI 10.1016/j.pt.2006.06.013; Shute P. G., 1963, Archives Roumaines de Pathologie Experimentale et de Microbiologie, V22, P887; Solarte Y, 2011, AM J TROP MED HYG, V84, P28, DOI 10.4269/ajtmh.2011.09-0499; Sousa TN, 2007, VOX SANG, V92, P373, DOI 10.1111/j.1423-0410.2007.00902.x; Stoute JA, 2012, PATHOG GLOB HEALTH, V106, P320, DOI 10.1179/2047772412Z.00000000080; Valderrama-Aguirre A, 2005, AM J TROP MED HYG, V73, P16, DOI 10.4269/ajtmh.2005.73.16; White MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061395; WHO, 1997, GUID EV PLASM FALC A; Wu Yu-Huan, 2008, P3; Zimmerman PA, 2013, ADV PARASIT, V81, P27, DOI 10.1016/B978-0-12-407826-0.00002-3	45	42	43	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e99754	10.1371/journal.pone.0099754	http://dx.doi.org/10.1371/journal.pone.0099754			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963662	Green Submitted, Green Published, gold			2022-12-27	WOS:000338709500019
J	Arribas, M; Kubota, K; Cabanillas, L; Lazaro, E				Arribas, Maria; Kubota, Kirina; Cabanillas, Laura; Lazaro, Ester			Adaptation to Fluctuating Temperatures in an RNA Virus Is Driven by the Most Stringent Selective Pressure	PLOS ONE			English	Article							OF-ALL-TRADES; BENEFICIAL MUTATIONS; LOCAL ADAPTATION; EXPERIMENTAL EVOLUTION; HOST ADAPTATION; FITNESS; COST; ARBOVIRUS; MEMORY; SPECIALIZATION	The frequency of change in the selective pressures is one of the main factors driving evolution. It is generally accepted that constant environments select specialist organisms whereas changing environments favour generalists. The particular outcome achieved in either case also depends on the relative strength of the selective pressures and on the fitness costs of mutations across environments. RNA viruses are characterized by their high genetic diversity, which provides fast adaptation to environmental changes and helps them evade most antiviral treatments. Therefore, the study of the adaptive possibilities of RNA viruses is highly relevant for both basic and applied research. In this study we have evolved an RNA virus, the bacteriophage Q beta, under three different temperatures that either were kept constant or alternated periodically. The populations obtained were analyzed at the phenotypic and the genotypic level to characterize the evolutionary process followed by the virus in each case and the amount of convergent genetic changes attained. Finally, we also investigated the influence of the pre-existent genetic diversity on adaptation to high temperature. The main conclusions that arise from our results are: i) under periodically changing temperature conditions, evolution of bacteriophage Qb is driven by the most stringent selective pressure, ii) there is a high degree of evolutionary convergence between replicated populations and also among populations evolved at different temperatures, iii) there are mutations specific of a particular condition, and iv) adaptation to high temperatures in populations differing in their pre-existent genetic diversity takes place through the selection of a common set of mutations.	[Arribas, Maria; Cabanillas, Laura; Lazaro, Ester] CSIC, Ctr Astrobiol, INTA, Madrid 28850, Spain; [Kubota, Kirina] Univ Autonoma Madrid, Fac Ciencias, E-28049 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA); Autonomous University of Madrid	Lazaro, E (corresponding author), CSIC, Ctr Astrobiol, INTA, Madrid 28850, Spain.	lazarole@cab.inta-csic.es	Lázaro, Ester/L-3398-2017; Arribas, María/L-2934-2014	Lázaro, Ester/0000-0001-7477-7822; Arribas, María/0000-0002-5802-3315	Spanish Ministry of Science and Innovation [FIS2011-27569, BFU2011-25271]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by the Spanish Ministry of Science and Innovation (www.micinn.es) through grants FIS2011-27569 and BFU2011-25271. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudelo-Romero P, 2008, INFECT GENET EVOL, V8, P806, DOI 10.1016/j.meegid.2008.07.010; Alto BW, 2013, EVOLUTION, V67, P969, DOI 10.1111/evo.12034; Arribas M, 2011, VIROLOGY, V417, P343, DOI 10.1016/j.virol.2011.06.016; BARRERA I, 1993, J MOL BIOL, V232, P512, DOI 10.1006/jmbi.1993.1407; Bedhomme S, 2012, MOL BIOL EVOL, V29, P1481, DOI 10.1093/molbev/msr314; Bollback JP, 2009, GENETICS, V181, P225, DOI 10.1534/genetics.107.085225; Briones C, 2008, AIDS REV, V10, P93; Bull JJ, 1997, GENETICS, V147, P1497; Cabanillas L, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-11; Cases-Gonzalez C, 2008, J MOL BIOL, V384, P1120, DOI 10.1016/j.jmb.2008.10.014; Coffey LL, 2008, P NATL ACAD SCI USA, V105, P6970, DOI 10.1073/pnas.0712130105; Coffey LL, 2011, J VIROL, V85, P1025, DOI 10.1128/JVI.01918-10; Cooper LA, 2001, GENETICS, V157, P1403; Deardorff ER, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002335; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; Dessau M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003102; Domingo E, 2003, PROG DRUG RES, V60, P133; Domingo E, 2002, VIRUS RES, V82, P39; Domingo E, 1997, Prog Drug Res, V48, P99; Domingo E, 2012, MICROBIOL MOL BIOL R, V76, P159, DOI 10.1128/MMBR.05023-11; Elena SF, 2010, CHAOS, V20, DOI 10.1063/1.3449300; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; Gandon S, 2004, EVOLUTION, V58, P455, DOI 10.1111/j.0014-3820.2004.tb01669.x; Garcia-Villada L, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130043; Gerrish PJ, 1998, GENETICA, V102-3, P127, DOI 10.1023/A:1017067816551; Greene IP, 2005, J VIROL, V79, P14253, DOI 10.1128/JVI.79.22.14253-14260.2005; Hellgren O, 2009, ECOLOGY, V90, P2840, DOI 10.1890/08-1059.1; Hereford J, 2009, AM NAT, V173, P579, DOI 10.1086/597611; Holder KK, 2001, GENETICS, V159, P1393; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; KAWECKI TJ, 1994, AM NAT, V144, P833, DOI 10.1086/285709; Kidmose RT, 2010, P NATL ACAD SCI USA, V107, P10884, DOI 10.1073/pnas.1003015107; Knies JL, 2009, AM NAT, V173, P419, DOI 10.1086/597224; Krasnov BR, 2004, AM NAT, V164, P506, DOI 10.1086/423716; Lalic J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002378; Lang GI, 2011, GENETICS, V188, P647, DOI 10.1534/genetics.111.128942; Lauring AS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001005; Lee KH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025640; Legros M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-159; LEVINS RICHARD, 1968; LYNCH M, 1983, AM NAT, V122, P745, DOI 10.1086/284169; Magalhaes S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-182; Malpica JM, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000041; Novella IS, 1999, J MOL BIOL, V287, P459, DOI 10.1006/jmbi.1999.2635; Palaima A, 2007, BIOL J LINN SOC, V90, P583, DOI 10.1111/j.1095-8312.2007.00745.x; Poulin R, 1998, ECOL LETT, V1, P118; Remold SK, 2008, MOL BIOL EVOL, V25, P1138, DOI 10.1093/molbev/msn059; Rokyta DR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002075; Ruiz-Jarabo CM, 2000, J VIROL, V74, P3543, DOI 10.1128/JVI.74.8.3543-3547.2000; Rumnieks J, 2011, PROTEIN SCI, V20, P1707, DOI 10.1002/pro.704; Sanjuan R, 2012, FUTURE VIROL, V7, P391, DOI 10.2217/FVL.12.19; Sniegowski PD, 2010, PHILOS T R SOC B, V365, P1255, DOI 10.1098/rstb.2009.0290; Stearns S.C., 1992, pi; Straub CS, 2011, AM NAT, V177, P389, DOI 10.1086/658177; Takeshita D, 2010, P NATL ACAD SCI USA, V107, P15733, DOI 10.1073/pnas.1006559107; Tokuriki N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000002; Turner PE, 2000, GENETICS, V156, P1465; Vasilakis N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000467; VIA S, 1990, ANNU REV ENTOMOL, V35, P421, DOI 10.1146/annurev.en.35.010190.002225; Wallis CM, 2007, J GEN VIROL, V88, P2839, DOI 10.1099/vir.0.82814-0; Wang XJ, 2002, J MOL BIOL, V320, P85, DOI 10.1016/S0022-2836(02)00400-X; Weaver SC, 1999, J VIROL, V73, P4316, DOI 10.1128/JVI.73.5.4316-4326.1999; Weinreich DM, 2005, EVOLUTION, V59, P1165; Whitlock MC, 1996, AM NAT, V148, pS65, DOI 10.1086/285902; Wichman HA, 1999, SCIENCE, V285, P422, DOI 10.1126/science.285.5426.422	65	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100940	10.1371/journal.pone.0100940	http://dx.doi.org/10.1371/journal.pone.0100940			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963780	Green Published, Green Submitted, gold			2022-12-27	WOS:000338709500102
J	Bednarz, M; Halliday, JA; Herman, C; Golding, I				Bednarz, Michael; Halliday, Jennifer A.; Herman, Christophe; Golding, Ido			Revisiting Bistability in the Lysis/Lysogeny Circuit of Bacteriophage Lambda	PLOS ONE			English	Article							STOCHASTIC GENE-EXPRESSION; ESCHERICHIA-COLI; PHAGE-LAMBDA; DECISION-MAKING; IN-VIVO; PROTEIN EXPRESSION; REGULATORY CIRCUIT; SINGLE CELLS; CI REPRESSOR; NOISE	The lysis/lysogeny switch of bacteriophage lambda serves as a paradigm for binary cell fate decision, long-term maintenance of cellular state and stimulus-triggered switching between states. In the literature, the system is often referred to as "bistable.'' However, it remains unclear whether this term provides an accurate description or is instead a misnomer. Here we address this question directly. We first quantify transcriptional regulation governing lysogenic maintenance using a single-cell fluorescence reporter. We then use the single-cell data to derive a stochastic theoretical model for the underlying regulatory network. We use the model to predict the steady states of the system and then validate these predictions experimentally. Specifically, a regime of bistability, and the resulting hysteretic behavior, are observed. Beyond the steady states, the theoretical model successfully predicts the kinetics of switching from lysogeny to lysis. Our results show how the physics-inspired concept of bistability can be reliably used to describe cellular phenotype, and how an experimentally-calibrated theoretical model can have accurate predictive power for cell-state switching.	[Bednarz, Michael; Golding, Ido] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Golding, Ido] Univ Illinois, Ctr Phys Living Cells, Urbana, IL 61801 USA; [Halliday, Jennifer A.; Herman, Christophe; Golding, Ido] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Halliday, Jennifer A.; Herman, Christophe] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Halliday, Jennifer A.; Herman, Christophe] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Golding, I (corresponding author), Univ Illinois, Dept Phys, 1110 W Green St, Urbana, IL 61801 USA.	igolding@illinois.edu			US National Institutes of Health [R01 GM082837]; US National Science Foundation [082265, PHY-1147498]; Welch Foundation [Q-1759]; National Institutes of Health [R01 GM088653]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088653, R01GM082837] Funding Source: NIH RePORTER; Division Of Physics [1147498] Funding Source: National Science Foundation	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); Welch Foundation(The Welch Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work received financial support from the following sources: US National Institutes of Health grant R01 GM082837, US National Science Foundation grants 082265 (CPLC) and PHY-1147498 (CAREER), Welch Foundation grant Q-1759 to IG; and a National Institutes of Health grant R01 GM088653 to CH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 2007, INTRO SYSTEMS BIOL D; Anderson LM, 2008, P NATL ACAD SCI USA, V105, P5827, DOI 10.1073/pnas.0705570105; Angeli D, 2004, P NATL ACAD SCI USA, V101, P1822, DOI 10.1073/pnas.0308265100; Arkin A, 1998, GENETICS, V149, P1633; Aurell E, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.048101; Bakk A, 2004, FEBS LETT, V563, P66, DOI 10.1016/S0014-5793(04)00249-2; Balazsi G, 2011, CELL, V144, P910, DOI 10.1016/j.cell.2011.01.030; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Bialek W, 2001, ADV NEUR IN, V13, P103; Biggar SR, 2001, EMBO J, V20, P3167, DOI 10.1093/emboj/20.12.3167; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Crews ST, 2009, CURR BIOL, V19, pR241, DOI 10.1016/j.cub.2009.01.015; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dodd IB, 2004, GENE DEV, V18, P344, DOI 10.1101/gad.1167904; Dodd IB, 2001, GENE DEV, V15, P3013, DOI 10.1101/gad.937301; Dubnau D, 2006, MOL MICROBIOL, V61, P564, DOI 10.1111/j.1365-2958.2006.05249.x; EISEN H, 1970, P NATL ACAD SCI USA, V66, P855, DOI 10.1073/pnas.66.3.855; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Farewell A, 1998, J BACTERIOL, V180, P4704, DOI 10.1128/JB.180.17.4704-4710.1998; Ferrell JE, 2012, CURR BIOL, V22, pR458, DOI 10.1016/j.cub.2012.03.045; Friedman N, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.168302; GAITANARIS GA, 1994, MOL MICROBIOL, V14, P861, DOI 10.1111/j.1365-2958.1994.tb01322.x; Golding I, 2011, ANNU REV BIOPHYS, V40, P63, DOI 10.1146/annurev-biophys-042910-155227; Gordon AJE, 2009, PLOS BIOL, V7, P364, DOI 10.1371/journal.pbio.1000044; Gurdon JB, 2008, SCIENCE, V322, P1811, DOI 10.1126/science.1160810; HANGGI P, 1990, REV MOD PHYS, V62, P251, DOI 10.1103/RevModPhys.62.251; Hensel Z, 2012, NAT STRUCT MOL BIOL, V19, P797, DOI 10.1038/nsmb.2336; HERENDEEN SL, 1979, J BACTERIOL, V139, P185, DOI 10.1128/JB.139.1.185-194.1979; Hershey A. D., 1971, BACTERIOPHAGE LAMBDA; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; JOHNSON AD, 1981, NATURE, V294, P217, DOI 10.1038/294217a0; Kampen NGv, 1981, STOCHASTIC PROCESSES; Lawrence Peter A, 1993, MAKING FLY GENETICS, V6; LEVINE A, 1979, J MOL BIOL, V131, P655, DOI 10.1016/0022-2836(79)90014-7; Lewis D, 2011, P NATL ACAD SCI USA, V108, P14807, DOI 10.1073/pnas.1111221108; LITTLE JW, 1982, CELL, V29, P11, DOI 10.1016/0092-8674(82)90085-X; Little JW, 1999, EMBO J, V18, P4299, DOI 10.1093/emboj/18.15.4299; Locke JCW, 2009, NAT REV MICROBIOL, V7, P383, DOI 10.1038/nrmicro2056; Mehta P, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/2/026005; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Moler C, 2003, SIAM REV, V45, P3, DOI 10.1137/S00361445024180; Oppenheim AB, 2005, ANNU REV GENET, V39, P409, DOI 10.1146/annurev.genet.39.073003.113656; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; PIRROTTA V, 1970, NATURE, V227, P41, DOI 10.1038/227041a0; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Press W. H., 1992, ART SCI COMPUTING; Ptashne M, 2004, GENETIC SWITCH PHAGE; Ptashne M, 2007, CURR BIOL, V17, pR233, DOI 10.1016/j.cub.2007.02.030; REICHARDT L, 1971, P NATL ACAD SCI USA, V68, P2185, DOI 10.1073/pnas.68.9.2185; REINITZ J, 1990, J THEOR BIOL, V145, P295, DOI 10.1016/S0022-5193(05)80111-0; Santillan M, 2004, BIOPHYS J, V86, P75, DOI 10.1016/S0006-3495(04)74085-0; Schubert RA, 2007, GENE DEV, V21, P2461, DOI 10.1101/gad.1584907; Sha W, 2003, P NATL ACAD SCI USA, V100, P975, DOI 10.1073/pnas.0235349100; Shahrezaei V, 2008, P NATL ACAD SCI USA, V105, P17256, DOI 10.1073/pnas.0803850105; Slack J. M. W., 1991, REGIONAL SPECIFICATI; So LH, 2011, NAT GENET, V43, P554, DOI 10.1038/ng.821; St-Pierre F, 2008, P NATL ACAD SCI USA, V105, P20705, DOI 10.1073/pnas.0808831105; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; Svenningsen SL, 2005, P NATL ACAD SCI USA, V102, P4465, DOI 10.1073/pnas.0409839102; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; To TL, 2010, SCIENCE, V327, P1142, DOI 10.1126/science.1178962; TOMAN Z, 1985, J MOL BIOL, V186, P97, DOI 10.1016/0022-2836(85)90260-8; VILLAVERDE A, 1993, APPL ENVIRON MICROB, V59, P3485, DOI 10.1128/AEM.59.10.3485-3487.1993; Young JW, 2012, NAT PROTOC, V7, P80, DOI 10.1038/nprot.2011.432; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623; Zeng LY, 2010, CELL, V141, P682, DOI 10.1016/j.cell.2010.03.034; Zong CH, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.96	69	31	31	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100876	10.1371/journal.pone.0100876	http://dx.doi.org/10.1371/journal.pone.0100876			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963924	Green Published, gold, Green Submitted			2022-12-27	WOS:000338709500094
J	Hauerslev, S; Vissing, J; Krag, TO				Hauerslev, Simon; Vissing, John; Krag, Thomas O.			Muscle Atrophy Reversed by Growth Factor Activation of Satellite Cells in a Mouse Muscle Atrophy Model	PLOS ONE			English	Article							SKELETAL-MUSCLE; IN-VITRO; MYOBLAST DIFFERENTIATION; TRANSCRIPTION FACTORS; MUSCULAR-DYSTROPHY; UBIQUITIN LIGASES; MYOSTATIN; PROLIFERATION; EXPRESSION; REGENERATION	Muscular dystrophies comprise a large group of inherited disorders that lead to progressive muscle wasting. We wanted to investigate if targeting satellite cells can enhance muscle regeneration and thus increase muscle mass. We treated mice with hepatocyte growth factor and leukemia inhibitory factor under three conditions: normoxia, hypoxia and during myostatin deficiency. We found that hepatocyte growth factor treatment led to activation of the Akt/mTOR/p70S6K protein synthesis pathway, up-regulation of the myognic transcription factors MyoD and myogenin, and subsequently the negative growth control factor, myostatin and atrophy markers MAFbx and MuRF1. Hypoxia-induced atrophy was partially restored by hepatocyte growth factor combined with leukemia inhibitory factor treatment. Dividing satellite cells were three-fold increased in the treatment group compared to control. Finally, we demonstrated that myostatin regulates satellite cell activation and myogenesis in vivo following treatment, consistent with previous findings in vitro. Our results suggest, not only a novel in vivo pharmacological treatment directed specifically at activating the satellite cells, but also a myostatin dependent mechanism that may contribute to the progressive muscle wasting seen in severely affected patients with muscular dystrophy and significant on-going regeneration. This treatment could potentially be applied to many conditions that feature muscle wasting to increase muscle bulk and strength.	[Hauerslev, Simon; Vissing, John; Krag, Thomas O.] Univ Copenhagen, Rigshosp, Dept Neurol, Neuromuscular Res Unit, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen	Krag, TO (corresponding author), Univ Copenhagen, Rigshosp, Dept Neurol, Neuromuscular Res Unit, DK-2100 Copenhagen, Denmark.	thomas.krag@regionh.dk	Krag, Thomas/AAD-3307-2021	Krag, Thomas/0000-0001-9330-668X	Lundbeck Foundation [R9-A783]; Aase og Ejnar Danielsen Fond [106179]; AP MAller Foundations [070126, 080140]; Research Council at Rigshospitalet	Lundbeck Foundation(Lundbeckfonden); Aase og Ejnar Danielsen Fond; AP MAller Foundations; Research Council at Rigshospitalet	This work was supported by the Lundbeck Foundation grant #R9-A783 (http://www.lundbeckfonden.com), Aase og Ejnar Danielsen Fond #106179 (http://www.danielsensfond.dk), AP MAller Foundations #070126,080140 (http://www.apmollerfonde.dk), and The Research Council at Rigshospitalet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN RE, 1995, J CELL PHYSIOL, V165, P307, DOI 10.1002/jcp.1041650211; BARNARD W, 1994, J NEUROL SCI, V123, P108, DOI 10.1016/0022-510X(94)90211-9; Bersanini C, 2012, EUR RESPIR J, V39, P1206, DOI 10.1183/09031936.00087511; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bogdanovich S, 2002, NATURE, V420, P418, DOI 10.1038/nature01154; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Cornelison DDW, 1997, DEV BIOL, V191, P270, DOI 10.1006/dbio.1997.8721; Farkas GA, 2007, MUSCLE NERVE, V36, P708, DOI 10.1002/mus.20858; Gill R, 2010, J CELL SCI, V123, P1873, DOI 10.1242/jcs.061242; Grounds MD, 2002, J HISTOCHEM CYTOCHEM, V50, P589, DOI 10.1177/002215540205000501; Hauerslev S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066929; Hauerslev S, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-43; Koning M, 2011, TISSUE ENG PT A, V17, P1747, DOI 10.1089/ten.tea.2010.0624; Kook SH, 2008, CELL BIOL INT, V32, P871, DOI 10.1016/j.cellbi.2008.03.017; Krag TO, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-31; Langley B, 2002, J BIOL CHEM, V277, P49831, DOI 10.1074/jbc.M204291200; Lokireddy S, 2011, MOL ENDOCRINOL, V25, P1936, DOI 10.1210/me.2011-1124; McCroskery S, 2003, J CELL BIOL, V162, P1135, DOI 10.1083/jcb.200207056; McFarlane C, 2011, AM J PHYSIOL-CELL PH, V301, pC195, DOI 10.1152/ajpcell.00012.2011; Melacini P, 1996, NEUROMUSCULAR DISORD, V6, P367, DOI 10.1016/0960-8966(96)00357-4; Miller KJ, 2000, AM J PHYSIOL-CELL PH, V278, pC174, DOI 10.1152/ajpcell.2000.278.1.C174; Mosqueira M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069567; Mosqueira M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013450; Pistilli EE, 2010, AM J PHYSIOL-REG I, V298, pR96, DOI 10.1152/ajpregu.00138.2009; Sartori R, 2009, AM J PHYSIOL-CELL PH, V296, pC1248, DOI 10.1152/ajpcell.00104.2009; Sheehan SM, 1999, J CELL PHYSIOL, V181, P499, DOI 10.1002/(SICI)1097-4652(199912)181:3<499::AID-JCP14>3.0.CO;2-1; Song YH, 2005, J INVEST MED, V53, P135, DOI 10.2310/6650.2005.00309; Spiller MP, 2002, MOL CELL BIOL, V22, P7066, DOI 10.1128/MCB.22.20.7066-7082.2002; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Tatsumi R, 1998, DEV BIOL, V194, P114, DOI 10.1006/dbio.1997.8803; TOMAS FM, 1992, BIOCHEM J, V282, P91, DOI 10.1042/bj2820091; Trendelenburg AU, 2009, AM J PHYSIOL-CELL PH, V296, pC1258, DOI 10.1152/ajpcell.00105.2009; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Villena J, 2004, J CELL PHYSIOL, V198, P169, DOI 10.1002/jcp.10422; White JD, 2001, MUSCLE NERVE, V24, P695, DOI 10.1002/mus.1057; White JD, 2001, CELL TISSUE RES, V306, P129, DOI 10.1007/s004410100432; Yamada M, 2010, AM J PHYSIOL-CELL PH, V298, pC465, DOI 10.1152/ajpcell.00449.2009	37	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100594	10.1371/journal.pone.0100594	http://dx.doi.org/10.1371/journal.pone.0100594			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963862	Green Submitted, Green Published, gold			2022-12-27	WOS:000338709500067
J	Rose, JP; Todd, BD				Rose, Jonathan P.; Todd, Brian D.			Projecting Invasion Risk of Non-Native Watersnakes (Nerodia fasciata and Nerodia sipedon) in the Western United States	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; SELECTING THRESHOLDS; BIOLOGICAL INVASIONS; RANA-CATESBEIANA; RANDOM FORESTS; PREDICTION; ECOLOGY; HOMOGENIZATION; CLASSIFICATION; HYBRIDIZATION	Species distribution models (SDMs) are increasingly used to project the potential distribution of introduced species outside their native range. Such studies rarely explicitly evaluate potential conflicts with native species should the range of introduced species expand. Two snake species native to eastern North America, Nerodia fasciata and Nerodia sipedon, have been introduced to California where they represent a new stressor to declining native amphibians, fish, and reptiles. To project the potential distributions of these non-native watersnakes in western North America, we built ensemble SDMs using MaxEnt, Boosted Regression Trees, and Random Forests and habitat and climatic variables. We then compared the overlap between the projected distribution of invasive watersnakes and the distributions of imperiled native amphibians, fish, and reptiles that can serve as prey or competitors for the invaders, to estimate the risk to native species posed by non-native watersnakes. Large areas of western North America were projected to be climatically suitable for both species of Nerodia according to our ensemble SDMs, including much of central California. The potential distributions of both N. fasciata and N. sipedon overlap extensively with the federally threatened Giant Gartersnake, Thamnophis gigas, which inhabits a similar ecological niche. N. fasciata also poses risk to the federally threatened California Tiger Salamander, Ambystoma californiense, whereas N. sipedon poses risk to some amphibians of conservation concern, including the Foothill Yellow-legged Frog, Rana boylii. We conclude that non-native watersnakes in California can likely inhabit ranges of several native species of conservation concern that are expected to suffer as prey or competing species for these invaders. Action should be taken now to eradicate or control these invasions before detrimental impacts on native species are widespread. Our methods can be applied broadly to quantify the risk posed by incipient invasions to native biodiversity.	[Rose, Jonathan P.; Todd, Brian D.] Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Davis, CA 95616 USA; [Rose, Jonathan P.] Univ Calif Davis, Grad Grp Ecol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Rose, JP (corresponding author), Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Davis, CA 95616 USA.	jprose@ucdavis.edu		Todd, Brian/0000-0003-3133-791X				Adams MJ, 2003, ECOL LETT, V6, P343, DOI 10.1046/j.1461-0248.2003.00435.x; Alfaro ME, 2001, MOL PHYLOGENET EVOL, V21, P408, DOI 10.1006/mpev.2001.1024; [Anonymous], 1985, REC PLAN SAN FRANC G; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Austin MP, 2002, ECOL MODEL, V157, P101, DOI 10.1016/S0304-3800(02)00205-3; Balfour Peter S., 2002, Herpetological Review, V33, P150; Balfour Peter S., 2007, Herpetological Review, V38, P489; Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x; Barve N, 2011, ECOL MODEL, V222, P1810, DOI 10.1016/j.ecolmodel.2011.02.011; Blair RB, 1996, ECOL APPL, V6, P506, DOI 10.2307/2269387; BLANEY RM, 1979, HERPETOLOGICA, V35, P350; Bomford M, 2009, BIOL INVASIONS, V11, P713, DOI 10.1007/s10530-008-9285-3; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Broennimann O, 2008, BIOL LETTERS, V4, P585, DOI 10.1098/rsbl.2008.0254; BROWN LR, 1994, CALIF FISH GAME, V79, P96; BURY R B, 1976, Biological Conservation, V10, P1; Camper JD, 2010, HERPETOLOGICA, V66, P464, DOI 10.1655/09-029.1; Capinha C, 2011, DIVERS DISTRIB, V17, P13, DOI 10.1111/j.1472-4642.2010.00727.x; Clavero M, 2005, TRENDS ECOL EVOL, V20, P110, DOI 10.1016/j.tree.2005.01.003; CONANT ROGER, 1963, AMER MUS NOVITATES, V2122, P1; Coote T, 2003, ORYX, V37, P91, DOI 10.1017/S0030605303000176; Cord A, 2011, ECOL APPL, V21, P3285, DOI 10.1890/11-0114.1; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Dorcas ME, 2012, P NATL ACAD SCI USA, V109, P2418, DOI 10.1073/pnas.1115226109; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Elith J, 2009, ECOGRAPHY, V32, P66, DOI 10.1111/j.1600-0587.2008.05505.x; Ellstrand NC, 2000, P NATL ACAD SCI USA, V97, P7043, DOI 10.1073/pnas.97.13.7043; Ficetola GF, 2007, DIVERS DISTRIB, V13, P476, DOI 10.1111/j.1472-4642.2007.00377.x; Fisher RN, 1996, CONSERV BIOL, V10, P1387, DOI 10.1046/j.1523-1739.1996.10051387.x; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Fuller Michael M., 2006, Herpetological Review, V37, P363; Fuller TE, 2011, RESTOR ECOL, V19, P204, DOI 10.1111/j.1526-100X.2010.00708.x; Gibbons J.W., 2004, N AM WATERSNAKES NAT; Gurevitch J, 2004, TRENDS ECOL EVOL, V19, P470, DOI 10.1016/j.tree.2004.07.005; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hirzel AH, 2002, ECOLOGY, V83, P2027, DOI 10.1890/0012-9658(2002)083[2027:ENFAHT]2.0.CO;2; HUEY RB, 1979, AM ZOOL, V19, P357; Jimenez-Valverde A, 2011, BIOL INVASIONS, V13, P2785, DOI 10.1007/s10530-011-9963-4; Light T, 2007, CONSERV BIOL, V21, P434, DOI 10.1111/j.1523-1739.2006.00643.x; Liu CR, 2013, J BIOGEOGR, V40, P778, DOI 10.1111/jbi.12058; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Marchetti MP, 2004, FRESHWATER BIOL, V49, P646, DOI 10.1111/j.1365-2427.2004.01202.x; Marchetti MP, 2001, ECOL APPL, V11, P530, DOI 10.2307/3060907; Mebert K, 2008, MOL ECOL, V17, P1918, DOI 10.1111/j.1365-294X.2008.03725.x; Miano Oliver J., 2012, Herpetological Review, V43, P348; MOYLE PB, 1973, COPEIA, P18; Moyle PB, 2011, BIOL CONSERV, V144, P2414, DOI 10.1016/j.biocon.2011.06.002; Pattishall A, 2008, COPEIA, P752, DOI 10.1643/CH-07-228; Peterson AT, 2008, GLOBAL ECOL BIOGEOGR, V17, P135, DOI 10.1111/j.1466-8238.2007.00347.x; Peterson A. T., 2011, ECOLOGICAL NICHES GE; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Phillips BL, 2003, CONSERV BIOL, V17, P1738, DOI 10.1111/j.1523-1739.2003.00353.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Poff NL, 2007, P NATL ACAD SCI USA, V104, P5732, DOI 10.1073/pnas.0609812104; Prasad AM, 2006, ECOSYSTEMS, V9, P181, DOI 10.1007/s10021-005-0054-1; Price SJ, 2011, HERPETOL CONSERV BIO, V6, P287; Rahel FJ, 2000, SCIENCE, V288, P854, DOI 10.1126/science.288.5467.854; Randin CF, 2006, J BIOGEOGR, V33, P1689, DOI 10.1111/j.1365-2699.2006.01466.x; RODDA GH, 1992, J HERPETOL, V26, P166, DOI 10.2307/1564858; Rodda GH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014670; Roe JH, 2004, BIOL CONSERV, V118, P79, DOI 10.1016/j.biocon.2003.07.010; Rodder D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007843; Rogers H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043446; Rose JP, 2013, J HERPETOL, V47, P421, DOI 10.1670/12-119; Rossman DA, 1996, GARTER SNAKES EVOLUT; Roura-Pascual N, 2009, BIOL INVASIONS, V11, P1017, DOI 10.1007/s10530-008-9313-3; SAVIDGE JA, 1987, ECOLOGY, V68, P660, DOI 10.2307/1938471; Schwaner T.D., 1976, Occasional Papers Mus Nat Hist Univ Kans, VNo. 45, P1; Segurado P, 2006, J APPL ECOL, V43, P433, DOI 10.1111/j.1365-2664.2006.01162.x; Seigel RA, 1995, HERPETOLOGICA, V51, P424; Vander Zanden MJ, 1999, NATURE, V401, P464, DOI 10.1038/46762; Veloz SD, 2009, J BIOGEOGR, V36, P2290, DOI 10.1111/j.1365-2699.2009.02174.x; VITOUSEK PM, 1990, OIKOS, V57, P7, DOI 10.2307/3565731; Wenger SJ, 2012, METHODS ECOL EVOL, V3, P260, DOI 10.1111/j.2041-210X.2011.00170.x; Wieczorek J, 2004, INT J GEOGR INF SCI, V18, P745, DOI 10.1080/13658810412331280211; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420	80	12	13	2	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100277	10.1371/journal.pone.0100277	http://dx.doi.org/10.1371/journal.pone.0100277			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964204	Green Submitted, Green Published, gold			2022-12-27	WOS:000338709500035
J	Ryan, VH; Primiani, CT; Rao, JS; Ahn, K; Rapoport, SI; Blanchard, H				Ryan, Veronica H.; Primiani, Christopher T.; Rao, Jagadeesh S.; Ahn, Kwangmi; Rapoport, Stanley I.; Blanchard, Helene			Coordination of Gene Expression of Arachidonic and Docosahexaenoic Acid Cascade Enzymes during Human Brain Development and Aging	PLOS ONE			English	Article							CYTOSOLIC PHOSPHOLIPASE A(2); ALZHEIMERS-DISEASE BRAIN; HUMAN PREFRONTAL CORTEX; MICROARRAY DATA; SYNAPTIC MARKERS; CEREBRAL-CORTEX; STEM-CELLS; RAT-BRAIN; N-3 PUFA; METABOLISM	Background: The polyunsaturated arachidonic and docosahexaenoic acids (AA and DHA) participate in cell membrane synthesis during neurodevelopment, neuroplasticity, and neurotransmission throughout life. Each is metabolized via coupled enzymatic reactions within separate but interacting metabolic cascades. Hypothesis: AA and DHA pathway genes are coordinately expressed and underlie cascade interactions during human brain development and aging. Methods: The BrainCloud database for human non-pathological prefrontal cortex gene expression was used to quantify postnatal age changes in mRNA expression of 34 genes involved in AA and DHA metabolism. Results: Expression patterns were split into Development (0 to 20 years) and Aging (21 to 78 years) intervals. Expression of genes for cytosolic phospholipases A(2) (cPLA(2)), cyclooxygenases (COX)-1 and -2, and other AA cascade enzymes, correlated closely with age during Development, less so during Aging. Expression of DHA cascade enzymes was less inter-correlated in each period, but often changed in the opposite direction to expression of AA cascade genes. Except for the PLA2G4A (cPLA(2) IVA) and PTGS2 (COX-2) genes at 1q25, highly inter-correlated genes were at distant chromosomal loci. Conclusions: Coordinated age-related gene expression during the brain Development and Aging intervals likely underlies coupled changes in enzymes of the AA and DHA cascades and largely occur through distant transcriptional regulation. Healthy brain aging does not show upregulation of PLA2G4 or PTGS2 expression, which was found in Alzheimer's disease.	[Ryan, Veronica H.; Primiani, Christopher T.; Rao, Jagadeesh S.; Rapoport, Stanley I.; Blanchard, Helene] NIA, Brain Physiol & Metab Sect, Lab Neurosci, NIH, Bethesda, MD 20892 USA; [Ahn, Kwangmi] NIMH, Child Psychiat Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Ryan, VH (corresponding author), NIA, Brain Physiol & Metab Sect, Lab Neurosci, NIH, Bethesda, MD 20892 USA.	veronica.ryan@nih.gov	Ahn, Kwangmi/GLV-4077-2022	Ryan, Veronica/0000-0001-5121-4672	Intramural Research Programs of the National Institute on Aging at the National Institutes of Health	Intramural Research Programs of the National Institute on Aging at the National Institutes of Health	This work was supported by the Intramural Research Programs of the National Institute on Aging at the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AZARI NP, 1992, BRAIN RES, V589, P279, DOI 10.1016/0006-8993(92)91288-P; Balsinde J, 1998, P NATL ACAD SCI USA, V95, P7951, DOI 10.1073/pnas.95.14.7951; Basselin M, 2010, J LIPID RES, V51, P3166, DOI 10.1194/jlr.M008334; Bazan NG, 2002, PROSTAG OTH LIPID M, V68-9, P197, DOI 10.1016/S0090-6980(02)00031-X; Bazan NG, 2007, CURR OPIN CLIN NUTR, V10, P136, DOI 10.1097/MCO.0b013e32802b7030; Bazan NG, 2009, J LIPID RES, V50, pS400, DOI 10.1194/jlr.R800068-JLR200; Belkind-Gerson J, 2008, J PEDIATR GASTR NUTR, V47, pS7, DOI 10.1097/MPG.0b013e3181818e3f; Casey BJ, 2000, BIOL PSYCHOL, V54, P241, DOI 10.1016/S0301-0511(00)00058-2; CHUGANI HT, 1987, ANN NEUROL, V22, P487, DOI 10.1002/ana.410220408; Colangelo V, 2002, J NEUROSCI RES, V70, P462, DOI 10.1002/jnr.10351; Colantuoni C, 2002, BIOINFORMATICS, V18, P1540, DOI 10.1093/bioinformatics/18.11.1540; Colantuoni C, 2011, NATURE, V478, P519, DOI 10.1038/nature10524; Cunnane SC, 2013, PROSTAG LEUKOTR ESS, V88, P61, DOI 10.1016/j.plefa.2012.04.006; Dayan J, 2010, J PHYSIOL-PARIS, V104, P279, DOI 10.1016/j.jphysparis.2010.08.007; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Dennis EA, 2011, CHEM REV, V111, P6130, DOI 10.1021/cr200085w; Di Nunzio M, 2009, LIPIDS, V44, P1073, DOI 10.1007/s11745-009-3362-y; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; Duplus E, 2002, BIOCHEM PHARMACOL, V64, P893, DOI 10.1016/S0006-2952(02)01157-7; Eisen M, 1998, CLUSTER 3 0 MANUAL; Esposito G, 2008, J NUCL MED, V49, P1414, DOI 10.2967/jnumed.107.049619; Freo U, 2005, AM J PSYCHIAT, V162, P2061, DOI 10.1176/appi.ajp.162.11.2061; FURTH EE, 1988, J BIOL CHEM, V263, P15951; Giovacchini G, 2004, J NUCL MED, V45, P1471; Gogtay N, 2007, J CHILD PSYCHOL PSYC, V48, P852, DOI 10.1111/j.1469-7610.2007.01747.x; Gogtay N, 2007, ARCH GEN PSYCHIAT, V64, P772, DOI 10.1001/archpsyc.64.7.772; Hatanpaa K, 1999, J NEUROPATH EXP NEUR, V58, P637, DOI 10.1097/00005072-199906000-00008; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Ho L, 2001, ARCH NEUROL-CHICAGO, V58, P487, DOI 10.1001/archneur.58.3.487; Hodzic M, 2013, Z GERONTOL GERIATR, V46, P629, DOI 10.1007/s00391-013-0531-7; HUTTENLOCHER PR, 1990, NEUROPSYCHOLOGIA, V28, P517, DOI 10.1016/0028-3932(90)90031-I; Igarashi M, 2011, J ALZHEIMERS DIS, V24, P507, DOI 10.3233/JAD-2011-101608; Igarashi M, 2010, J PSYCHIATR RES, V44, P177, DOI 10.1016/j.jpsychires.2009.08.001; Ilbanez V, 2004, BRAIN RES BULL, V63, P147, DOI 10.1016/j.brainresbull.2004.02.003; Kam PCA, 2000, ANAESTHESIA, V55, P442, DOI 10.1046/j.1365-2044.2000.01271.x; Kaufmann WE, 1996, P NATL ACAD SCI USA, V93, P2317, DOI 10.1073/pnas.93.6.2317; Keleshian VL, 2013, J NEUROCHEM, V125, P63, DOI 10.1111/jnc.12153; Kim HW, 2011, MOL PSYCHIATR, V16, P419, DOI 10.1038/mp.2009.137; Kim HW, 2011, PROSTAG LEUKOTR ESS, V85, P361, DOI 10.1016/j.plefa.2011.08.002; KOSS E, 1991, DEV NEUROPSYCHOL, V7, P99, DOI 10.1080/87565649109540479; Lands W., 1976, ENZYMES BIOL MEMBRAN, V2, P3; LAPOSATA M, 1987, METHOD ENZYMOL, V141, P350; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; LESLIE JB, 1985, J NEUROSURG, V63, P659, DOI 10.3171/jns.1985.63.5.0659; Loerch PM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003329; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Morrison JH, 2012, NAT REV NEUROSCI, V13, P240, DOI 10.1038/nrn3200; Moses GSD, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-28; Mukherjee PK, 2004, P NATL ACAD SCI USA, V101, P8491, DOI 10.1073/pnas.0402531101; Murakami M, 1999, J BIOL CHEM, V274, P3103, DOI 10.1074/jbc.274.5.3103; Naraba H, 1998, J IMMUNOL, V160, P2974; NEUFELD EJ, 1985, J CELL BIOL, V101, P573, DOI 10.1083/jcb.101.2.573; Numata S, 2012, AM J HUM GENET, V90, P260, DOI 10.1016/j.ajhg.2011.12.020; O'Banion, 1999, Expert Opin Investig Drugs, V8, P1521, DOI 10.1517/13543784.8.10.1521; Ong WY, 2005, J NEUROCYTOL, V34, P447, DOI 10.1007/s11068-006-8730-4; Ong WY, 1999, J BRAIN RES, V39, P391; Pardue S, 2003, MOL BRAIN RES, V116, P106, DOI 10.1016/S0169-328X(03)00262-6; Persengiev S, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00032; Purdon A.D., 2007, HDB NEUROCHEMISTRY M, P401; Purdon AD, 1998, BIOCHEM J, V335, P313, DOI 10.1042/bj3350313; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Rao JS, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.27; Rao JS, 2007, SOC NEUR ABSTR; Rapoport SI, 2008, J NUTR, V138, P2515, DOI 10.1093/jn/138.12.2515; Rapoport SI, 2009, BRAIN RES REV, V61, P185, DOI 10.1016/j.brainresrev.2009.06.003; Rapoport SI, 2008, PROSTAG LEUKOTR ESS, V79, P153, DOI 10.1016/j.plefa.2008.09.010; Rhie BH, 2013, BIOCHEM BIOPH RES CO, V439, P570, DOI 10.1016/j.bbrc.2013.09.017; ROBINSON PJ, 1992, BRAIN RES REV, V17, P187, DOI 10.1016/0165-0173(92)90016-F; Saiz L, 2001, BIOPHYS J, V81, P204, DOI 10.1016/S0006-3495(01)75692-5; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Scott KF, 1999, J LEUKOCYTE BIOL, V66, P535, DOI 10.1002/jlb.66.4.535; Serhan CN, 2005, CURR OPIN CLIN NUTR, V8, P115, DOI 10.1097/00075197-200503000-00003; Shaw P, 2007, P NATL ACAD SCI USA, V104, P19649, DOI 10.1073/pnas.0707741104; SHIMIZU T, 1990, J NEUROCHEM, V55, P1, DOI 10.1111/j.1471-4159.1990.tb08813.x; Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0; SODERBERG M, 1991, LIPIDS, V26, P421, DOI 10.1007/BF02536067; Somel M, 2013, NAT REV NEUROSCI, V14, P112, DOI 10.1038/nrn3372; Somel M, 2010, GENOME RES, V20, P1207, DOI 10.1101/gr.106849.110; Soupene E, 2008, EXP BIOL MED, V233, P507, DOI 10.3181/0710-MR-287; Stephenson DT, 1996, NEUROBIOL DIS, V3, P51, DOI 10.1006/nbdi.1996.0005; SUN GY, 1989, ANN NY ACAD SCI, V559, P37; TAY A, 1995, GENOMICS, V26, P138, DOI 10.1016/0888-7543(95)80093-2; Ueno N, 2001, J BIOL CHEM, V276, P34918, DOI 10.1074/jbc.M100429200; Wang YS, 2013, J CELL BIOCHEM, V114, P2231, DOI 10.1002/jcb.24569; Xu LZ, 1996, J BIOL CHEM, V271, P24711; Yakovlev P. I., 1967, REGIONAL DEV BRAIN E, P3; Yamashita A, 1997, J BIOCHEM-TOKYO, V122, P1; Yu YQ, 2004, PROSTAG LEUKOTR ESS, V71, P405, DOI 10.1016/j.plefa.2004.09.001	88	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100858	10.1371/journal.pone.0100858	http://dx.doi.org/10.1371/journal.pone.0100858			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963629	gold, Green Published, Green Submitted			2022-12-27	WOS:000338709500090
J	Banno, T; Blumenberg, M				Banno, Tomohiro; Blumenberg, Miroslav			Keratinocyte Detachment-Differentiation Connection Revisited, or Anoikis-Pityriasi Nexus Redux	PLOS ONE			English	Article							EPIDERMAL-KERATINOCYTES; TERMINAL DIFFERENTIATION; INTERFERON-GAMMA; STEM-CELLS; ADHESION; EXPRESSION; INTEGRIN; PATHWAY; SKIN; ACTIVATION	Epidermis, a continuously self-renewing and differentiating organ, produces a protective stratum corneum that shields us from external chemical, physical and microbial threats. Epidermal differentiation is a multi-step process regulated by influences, some unknown, others insufficiently explored. Detachment of keratinocytes from the basement membrane is one such pro-differentiation stimulus. Here, we define the transcriptional changes during differentiation, especially those caused by detachment from the substratum. Using comprehensive transcriptional profiling, we revisited the effects of detachment as a differentiation signal to keratinocytes. We identified the genes regulated by detachment, the corresponding ontological categories and, using metaanalysis, compared the genes and categories to those regulated by other pro-differentiating stimuli. We identified 762 genes overexpressed in suspended keratinocyte, including known and novel differentiation markers, and 1427 in attached cells, including basal layer markers. Detachment induced epidermis development, cornification and desmosomal genes, but also innate immunity, proliferation inhibitors, transcription regulators and MAPKs; conversely the attached cells overexpressed cell cycle, anchoring, motility, splicing and mitochondrial genes, and both positive and negative regulators of apoptosis. Metaanalysis identified which detachment-regulated categories overlap with those induced by suprabasal location in vivo, by reaching confluency in vitro, and by inhibition of JUN kinases. Attached and in vivo basal cells shared overexpression of mitochondrial components. Interestingly, melanosome trafficking components were also overexpressed in the attached and in vivo basal keratinocytes. These results suggest that specific pro-differentiation signals induce specific features of the keratinization process, which are in vivo orchestrated into harmonious epidermal homeostasis.	[Banno, Tomohiro; Blumenberg, Miroslav] NYU, Langone Med Ctr, RO Perelman Dept Dermatol, New York, NY 10012 USA; [Blumenberg, Miroslav] NYU, Dept Mol Pharmacol & Biochem, Langone Med Ctr, New York, NY USA; [Blumenberg, Miroslav] NYU, Inst Canc, Langone Med Ctr, New York, NY USA	New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center	Blumenberg, M (corresponding author), NYU, Langone Med Ctr, RO Perelman Dept Dermatol, New York, NY 10012 USA.	Miroslav.Blumenberg@nyumc.org		Blumenberg, Miroslav/0000-0002-8672-7774	R.O. Perelman Department of Dermatology, NYU Langone Medical Center	R.O. Perelman Department of Dermatology, NYU Langone Medical Center	The R.O. Perelman Department of Dermatology, NYU Langone Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JC, 1990, CELL, V63, P425, DOI 10.1016/0092-8674(90)90175-E; ADAMS JC, 1989, NATURE, V340, P307, DOI 10.1038/340307a0; Banno T, 2005, J BIOL CHEM, V280, P18973, DOI 10.1074/jbc.M411758200; Banno T, 2003, ANTIVIR THER, V8, P541; Barrett T, 2005, NUCLEIC ACIDS RES, V33, pD562; Bertrand-Vallery V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010462; Bikle DD, 2012, EXPERT REV ENDOCRINO, V7, P461, DOI 10.1586/EEM.12.34; BLUMENBERG M, 1992, J INVEST DERMATOL, V98, pS42, DOI 10.1111/1523-1747.ep12462194; Campbell ID, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004994; Chiricozzi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090284; Darmon Michel, 1993, P181; Efimova T, 2003, J BIOL CHEM, V278, P34277, DOI 10.1074/jbc.M302759200; Efimova T, 2010, CELL CYCLE, V9, P498, DOI 10.4161/cc.9.3.10541; Feingold KR, 2013, BIOCHIM BIOPHYS ACTA, V18, P00249; Gazel A, 2006, J BIOL CHEM, V28, P28; Hamada T, 2013, EXP DERMATOL, V22, P83, DOI 10.1111/exd.12021; Hamanaka RB, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003638; Han BS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036941; Harmon RM, 2013, J CLIN INVEST, V123, P1556, DOI 10.1172/JCI65220; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jensen MA, 2014, NAT STRUCT MOL BIOL, V21, P189, DOI 10.1038/nsmb.2756; Kretz M, 2013, NATURE, V493, P231, DOI 10.1038/nature11661; Kretz M, 2012, GENE DEV, V26, P338, DOI 10.1101/gad.182121.111; Lee DD, 2009, J CELL PHYSIOL, V220, P427, DOI 10.1002/jcp.21784; Lee JS, 2009, EXP MOL MED, V41, P42, DOI 10.3858/emm.2009.41.1.006; Li DL, 2001, FASEB J, V15, P2533, DOI 10.1096/fj.01-0172fje; Lippens S, 2005, CELL DEATH DIFFER, V12, P1497, DOI 10.1038/sj.cdd.4401722; Lopez-Pajares V, 2013, TRENDS GENET, V29, P31, DOI 10.1016/j.tig.2012.10.005; Lowes MA, 2014, ANNU REV IMMUNOL, V32, P227, DOI 10.1146/annurev-immunol-032713-120225; Mahadevappa M, 1999, NAT BIOTECHNOL, V17, P1134, DOI 10.1038/15124; Marconi A, 2004, J CELL SCI, V117, P5815, DOI 10.1242/jcs.01490; Marconi A, 2007, STEM CELLS, V25, P149, DOI 10.1634/stemcells.2006-0165; Margadant C, 2010, FASEB J, V24, P4133, DOI 10.1096/fj.09-151449; Mimoso C, 2013, METHOD MOL BIOL, V3, P3; MORRIS GM, 1987, CELL TISSUE KINET, V20, P161, DOI 10.1111/j.1365-2184.1987.tb01095.x; Perdigoto CN, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a015263; Pyeon D, 2013, METHOD MOL BIOL, V27, P27; Radoja N, 2006, PHYSIOL GENOMICS, V27, P65, DOI 10.1152/physiolgenomics.00031.2006; Shen B, 2012, CURR OPIN CELL BIOL, V24, P600, DOI 10.1016/j.ceb.2012.08.011; Stojadinovic O, 2007, J BIOL CHEM, V282, P4021, DOI 10.1074/jbc.M606262200; Taddei ML, 2012, J PATHOL, V226, P380, DOI 10.1002/path.3000; Tiberio R, 2002, FEBS LETT, V524, P139, DOI 10.1016/S0014-5793(02)03040-5; Tran QT, 2012, PHYSIOL GENOMICS, V44, P455, DOI 10.1152/physiolgenomics.00176.2011; Tsuruta D, 2011, J DERMATOL SCI, V62, P1, DOI 10.1016/j.jdermsci.2011.01.005; Ura H, 2004, J DERMATOL SCI, V35, P19, DOI 10.1016/j.jdermsci.2004.03.005; Vukelic S, 2010, J BIOL CHEM, V285, P1980, DOI 10.1074/jbc.M109.016741; Walsh R, 2011, J BIOL CHEM, V286, P9419, DOI 10.1074/jbc.M110.197087; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399; Wu N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045761; Yin TF, 2004, SEMIN CELL DEV BIOL, V15, P665, DOI 10.1016/j.semcdb.2004.09.005	50	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100279	10.1371/journal.pone.0100279	http://dx.doi.org/10.1371/journal.pone.0100279			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24960166	Green Submitted, Green Published, gold			2022-12-27	WOS:000338633900036
J	Kapadia, M; Zhao, H; Ma, DL; Hatkar, R; Marchese, M; Sakic, B				Kapadia, Minesh; Zhao, Hui; Ma, Donglai; Hatkar, Rupal; Marchese, Monica; Sakic, Boris			Zoopharmacognosy in Diseased Laboratory Mice: Conflicting Evidence	PLOS ONE			English	Article							MRL-LPR MICE; DIETARY SELF-SELECTION; CHRONIC MILD STRESS; AUTOIMMUNE-DISEASE; SOIL CONSUMPTION; FAS ANTIGEN; LUPUS; SUCROSE; MOUSE; CYCLOPHOSPHAMIDE	Zoopharmacognosy denotes a constellation of learned ingestive responses that promote healing and survival of infected or poisoned animals. A similar self-medication phenomenon was reported in diseased laboratory rodents. In particular, a series of studies revealed that autoimmune MRL/lpr mice readily consume solutions paired or laced with cyclophosphamide (CY), an immunosuppressive drug that prevents inflammatory damage to internal organs. However, due to design limitations, it could not be elucidated whether such a response reflects the learned therapeutic effect of CY, or a deficit in sensory input. We presently assess the behavioural effects of prolonged consumption of CY-laced, 16% sucrose solution in a continuous choice paradigm, with tap water available ad lib. Contrary to overall expectation, MRL/lpr mice did not increase their intake of CY with disease progression. Moreover, they ingested lower doses of CY and preferred less CY-laced sucrose solution than age-matched controls. The results obtained could not confirm zoopharmacognosy in diseased MRL/lpr mice, likely due to impaired responsiveness to palatable stimulation, or attenuated survival mechanisms after prolonged inbreeding in captivity. However, by revealing the effectiveness of unrestricted drinking of drug-laced sucrose solution on behavior and immunity, the current study supports broader use of such an administration route in behavioural studies sensitive to external stressors.	[Kapadia, Minesh; Zhao, Hui; Hatkar, Rupal; Sakic, Boris] McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada; [Ma, Donglai] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Marchese, Monica] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University	Sakic, B (corresponding author), McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada.	sakic@mcmaster.ca		Kapadia, Minesh/0000-0003-1380-7551	Father Sean O'Sullivan Foundation (St. Joseph's hospital, Hamilton, Ontario)	Father Sean O'Sullivan Foundation (St. Joseph's hospital, Hamilton, Ontario)	This project was funded by PhD scholarship from the Father Sean O'Sullivan Foundation (St. Joseph's hospital, Hamilton, Ontario) to Minesh Kapadia. The Father Sean O'Sullivan Foundation had no role in the in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS BS, 1978, J EXP MED, V148, P1198, DOI 10.1084/jem.148.5.1198; Attardo C, 2003, Boll Chim Farm, V142, P54; Ballok DA, 2004, HIPPOCAMPUS, V14, P649, DOI 10.1002/hipo.10205; Ballok DA, 2003, BEHAV BRAIN RES, V140, P119, DOI 10.1016/S0166-4328(02)00276-0; BELLUSH LL, 1986, BRAIN RES BULL, V17, P653, DOI 10.1016/0361-9230(86)90197-8; DAVIES AG, 1988, BIOTROPICA, V20, P252, DOI 10.2307/2388241; Deacon RMJ, 2006, NAT PROTOC, V1, P7, DOI 10.1038/nprot.2006.2; Diamond JM, 1999, NATURE, V400, P120, DOI 10.1038/22014; Dixon F J, 1978, Arthritis Rheum, V21, pS64, DOI 10.1002/art.1780210909; GALEF BG, 1991, PSYCHOL REV, V98, P218, DOI 10.1037/0033-295X.98.2.218; GARCIA J, 1974, SCIENCE, V185, P824, DOI 10.1126/science.185.4154.824; GROTA L J, 1989, Brain Behavior and Immunity, V3, P263, DOI 10.1016/0889-1591(89)90041-X; GROTA L J, 1987, Brain Behavior and Immunity, V1, P238, DOI 10.1016/0889-1591(87)90026-2; GROTA LJ, 1990, PHARMACOL BIOCHEM BE, V37, P527, DOI 10.1016/0091-3057(90)90023-B; Huffman MA, 2003, P NUTR SOC, V62, P371, DOI 10.1079/PNS2003257; Huffman MA, 2001, INT J PRIMATOL, V22, P329, DOI 10.1023/A:1010734310002; JIMENEZ JA, 1994, SCIENCE, V266, P271, DOI 10.1126/science.7939661; Kim A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035588; KREULEN DA, 1985, MAMMAL REV, V15, P107, DOI 10.1111/j.1365-2907.1985.tb00391.x; Loheswaran G, 2010, CLIN EXP NEUROIMMUNO, V1, P141; Loheswaran G, 2013, BRAIN BEHAV IMMUN, V32, P86, DOI 10.1016/j.bbi.2013.02.006; Meagher S, 2000, P NATL ACAD SCI USA, V97, P3324, DOI 10.1073/pnas.060284797; MONLEON S, 1995, PSYCHOPHARMACOLOGY, V117, P453, DOI 10.1007/BF02246218; Mukherjee N, 2011, NEUROSCIENCE, V192, P732, DOI 10.1016/j.neuroscience.2011.07.006; Mukherjee N, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0061607, 10.1371/annotation/5487e265-8175-47cb-b9a4-d85862a4a96f]; MUSCAT R, 1992, NEUROSCI BIOBEHAV R, V16, P507, DOI 10.1016/S0149-7634(05)80192-7; OATES JF, 1978, BIOTROPICA, V10, P241, DOI 10.2307/2387676; Raman R, 2008, RESONANCE, V13, P245, DOI 10.1007/s12045-008-0038-5; SAKIC B, 1994, PHYSIOL BEHAV, V56, P609, DOI 10.1016/0031-9384(94)90309-3; SAKIC B, 1992, BRAIN BEHAV IMMUN, V6, P265; Sakic B, 1996, BRAIN RES BULL, V41, P305, DOI 10.1016/S0361-9230(96)00190-6; SAKIC B, 1995, PHYSIOL BEHAV, V58, P797; Sakic B, 1998, J NEUROIMMUNOL, V87, P162, DOI 10.1016/S0165-5728(98)00085-X; SAKIC B, 1993, BEHAV BRAIN RES, V54, P57, DOI 10.1016/0166-4328(93)90048-U; Sled JG, 2009, ARTHRITIS RHEUM-US, V60, P1764, DOI 10.1002/art.24523; Theofilopoulos AN, 1992, SYSTEMIC LUPUS ERYTH, P121; Villalba JJ, 2012, SMALL RUMINANT RES, V103, P50, DOI 10.1016/j.smallrumres.2011.10.018; WATANABEFUKUNAGA R, 1992, J IMMUNOL, V148, P1274; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; Williams S, 2010, J NEUROIMMUNOL, V218, P73, DOI 10.1016/j.jneuroim.2009.10.008; WILLNER P, 1992, NEUROSCI BIOBEHAV R, V16, P525, DOI 10.1016/S0149-7634(05)80194-0; WRANGHAM RW, 1995, AM J PRIMATOL, V37, P297, DOI 10.1002/ajp.1350370404; ZAHORIK DM, 1974, J COMP PHYSIOL PSYCH, V87, P1083, DOI 10.1037/h0037585	43	4	4	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100684	10.1371/journal.pone.0100684	http://dx.doi.org/10.1371/journal.pone.0100684			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956477	Green Published, gold, Green Submitted			2022-12-27	WOS:000338917900081
J	Jaspard, M; Le Moal, G; Saberan-Roncato, M; Plainchamp, D; Langlois, A; Camps, P; Guigon, A; Hocqueloux, L; Prazuck, T				Jaspard, Marie; Le Moal, Gwenael; Saberan-Roncato, Mariam; Plainchamp, David; Langlois, Aurelie; Camps, Pascale; Guigon, Aurelie; Hocqueloux, Laurent; Prazuck, Thierry			Finger-Stick Whole Blood HIV-1/-2 Home-Use Tests Are More Sensitive than Oral Fluid-Based In-Home HIV Tests	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ANTIRETROVIRAL THERAPY; ANTIBODY TESTS; INFECTION; DIAGNOSIS; PERFORMANCE	Background: Several countries have recently recommended the expansion of anti-human immunodeficiency virus (HIV) antibody testing, including self-testing with rapid tests using oral fluid (OF). Several tests have been proposed for at-home use, but their diagnostic accuracy has not been fully evaluated. Objective: To evaluate the performance of 5 rapid diagnostic tests for the detection of anti-HIV-1/2 antibodies, with 4 testing OF and 1 testing whole blood. Methods: Prospective multi-center study in France. HIV-infected adults and HIV-uninfected controls were systematically screened with 5 at-home HIV tests using either OF or finger-stick blood (FSB) specimens. Four OF tests (OraQuick Advance Rapid HIV-1/2, Chembio DPP HIV 1/2 Assay, test A, and test B) and one FSB test (Chembio Sure Check HIV1/2 Assay) were performed by trained health workers and compared with laboratory tests. Results: In total, 179 HIV-infected patients (M/F sex ratio: 1.3) and 60 controls were included. Among the HIV-infected patients, 67.6% had an undetectable HIV viral load in their plasma due to antiretroviral therapy. Overall, the sensitivities of the OF tests were 87.2%, 88.3%, 58.9%, and 28% (for OraQuick, DPP, test A, and test B, respectively) compared with 100% for the FSB test Sure Check (p < 0.0001 for all comparisons). The OraQuick and DPP OF tests' sensitivities were significantly lower than that of the FSB-based Sure Check (p < 0.05). The sensitivities of the OF tests increased among the patients with a detectable HIV viral load (>50 copies/mL), reaching 94.8%, 96.5%, 90%, and 53.1% (for OraQuick, DPP, test A, and test B, respectively). The specificities of the four OF tests were 98.3%, 100%, 100%, and 87.5%, respectively, compared with 100% for the FSB test. Conclusion: An evaluation of candidates for HIV self-testing revealed unexpected differences in performance of the rapid tests: the FSB test showed a far greater reliability than OF tests.	[Jaspard, Marie; Langlois, Aurelie; Hocqueloux, Laurent; Prazuck, Thierry] CHR, Source Infect & Trop Dis Dept, Orleans, France; [Le Moal, Gwenael; Plainchamp, David] CHU Poitiers, Infect & Trop Dis Dept, Poitiers, France; [Saberan-Roncato, Mariam; Camps, Pascale] CH Rochelle, Dept Infect Dis, La Rochelle, France; [Guigon, Aurelie] CHR, Source Lab Microbiol, Orleans, France	Centre Hospitalier Regional d'Orleans; CHU Poitiers; Universite de Poitiers; Centre Hospitalier Regional d'Orleans	Prazuck, T (corresponding author), CHR, Source Infect & Trop Dis Dept, Orleans, France.	thierry.prazuck@chr-orleans.fr	Camps, Pelayo/D-4421-2014	Camps, Pelayo/0000-0002-9633-3525	Centre Hospitalier Regional d'Orleans	Centre Hospitalier Regional d'Orleans	This study was funded internally from the Centre Hospitalier Regional d'Orleans. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, AV AUT DEP INF VIH; [Anonymous], 2013, PROBL POS COMM AUT D; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Cazein F, 2012, JAIDS-J ACQ IMM DEF, V60, pE114, DOI 10.1097/QAI.0b013e318256b3fd; de la Fuente L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046555; Delaney KP, 2011, CLIN INFECT DIS, V52, P257, DOI 10.1093/cid/ciq068; Delpierre C, 2006, AIDS PATIENT CARE ST, V20, P838, DOI 10.1089/apc.2006.20.838; Donnell-Fink LA, 2012, JAIDS-J ACQ IMM DEF, V61, P588, DOI [10.1097/QAI.0b013e31826a6d67., 10.1097/QAI.0b013e31826a6d67]; Gaydos CA, 2011, ANN EMERG MED, V58, pS74, DOI 10.1016/j.annemergmed.2011.03.029; GRANADE TC, 1995, CLIN DIAGN LAB IMMUN, V2, P395, DOI 10.1128/CDLI.2.4.395-399.1995; Greacen T, 2012, SEX TRANSM INFECT, V88, P368, DOI 10.1136/sextrans-2011-050405; Holguin A, 2009, J CLIN VIROL, V45, P150, DOI 10.1016/j.jcv.2009.04.002; Kigozi IM, 2009, JAIDS-J ACQ IMM DEF, V52, P280, DOI 10.1097/QAI.0b013e3181ab6eab; Ng OT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045168; O'Connell RJ, 2003, J CLIN MICROBIOL, V41, P2153, DOI 10.1128/JCM.41.5.2153-2155.2003; Pascoe SJS, 2009, AIDS PATIENT CARE ST, V23, P571, DOI 10.1089/apc.2008.0225; Pavie J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011581; Prost A, 2009, SEX TRANSM INFECT, V85, P326, DOI 10.1136/sti.2008.033233; TAMASHIRO H, 1994, B WORLD HEALTH ORGAN, V72, P135; Wesolowski LG, 2006, AIDS, V20, P1661, DOI 10.1097/01.aids.0000238413.13442.ed; World Health Organization, 2011, UN ACC SCAL PRIOR HI; Zachary D, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-183	22	26	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e101148	10.1371/journal.pone.0101148	http://dx.doi.org/10.1371/journal.pone.0101148			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971842	Green Submitted, Green Published, gold			2022-12-27	WOS:000338512200098
J	Ma, ZW; Wang, WY; Wu, Y; He, YM; Wu, TH				Ma, Zhanwei; Wang, Wenyan; Wu, Ying; He, Yiming; Wu, Tinghua			Oxidative Degradation of Chitosan to the Low Molecular Water-Soluble Chitosan over Peroxotungstate as Chemical Scissors	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; AQUEOUS-SOLUTIONS; ALLYLIC ALCOHOLS; DINUCLEAR PEROXOTUNGSTATE; HETEROGENEOUS DEGRADATION; CATALYTIC-OXIDATION; EPOXIDATION; OLEFINS; GLUCOSAMINE; DERIVATIVES	Low molecular water-soluble chitosan was prepared by the depolymerization of chitosan in the presence of a series of catalysts with active W(O-2) sites. Both the peroxo species [W2O3(O-2)(4)](2-) and {PO4[WO(O-2)(2)](4)}(3-) showed high efficiency in the degradation of chitosan, indicating that the degradation mechanism did not follow the radical mechanism. That means center dot OH is not the active species, which has been proven by the fluorescence spectra. H2O2 acted as an oxidant to regenerate the active W(O-2) sites in the depolymerization of chitosan. The developed catalyst (TBA)(3){PO4[WO(O-2)(2)](4)} is recoverable.	[Ma, Zhanwei; Wang, Wenyan; Wu, Ying; Wu, Tinghua] Zhejiang Normal Univ, Inst Phys Chem, Minist Educ Adv Catalysis Mat, Key Lab, Jinhua, Peoples R China; [He, Yiming] Zhejiang Normal Univ, Dept Mat Phys, Jinhua, Peoples R China	Zhejiang Normal University; Zhejiang Normal University	Wu, Y (corresponding author), Zhejiang Normal Univ, Inst Phys Chem, Minist Educ Adv Catalysis Mat, Key Lab, Jinhua, Peoples R China.	yingwu@zjnu.cn; thwu@zjnu.cn	He, Yiming/Q-2987-2017	He, Yiming/0000-0002-1919-0719	Nature Science Foundation of China [21373188]	Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is financially supported by grants from Nature Science Foundation of China (21373188). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUBRY C, 1991, INORG CHEM, V30, P4409, DOI 10.1021/ic00023a024; Boddu VM, 2008, SEP SCI TECHNOL, V43, P1365, DOI 10.1080/01496390801940762; Bregeault JM, 2003, DALTON T, P3289, DOI 10.1039/b303073n; Buonomenna MG, 2008, APPL CATAL B-ENVIRON, V79, P35, DOI 10.1016/j.apcatb.2007.10.003; CAMPBELL NJ, 1989, J CHEM SOC DALTON, P1203, DOI 10.1039/dt9890001203; Dai TH, 2011, EXPERT REV ANTI-INFE, V9, P857, DOI [10.1586/ERI.11.59, 10.1586/eri.11.59]; DUNCAN DC, 1995, J AM CHEM SOC, V117, P681, DOI 10.1021/ja00107a012; Fang XW, 1996, ULTRASON SONOCHEM, V3, P57, DOI 10.1016/1350-4177(95)00032-1; Gallezot P, 2012, CHEM SOC REV, V41, P1538, DOI 10.1039/c1cs15147a; HOROWITZ ST, 1957, J AM CHEM SOC, V79, P5046, DOI 10.1021/ja01575a059; Hou SY, 2006, EUR J INORG CHEM, P1670, DOI 10.1002/ejic.200501008; Huang QZ, 2008, CARBOHYD POLYM, V72, P500, DOI 10.1016/j.carbpol.2007.09.022; Huang QZ, 2007, CARBOHYD POLYM, V68, P761, DOI 10.1016/j.carbpol.2006.08.015; Huang QZ, 2010, CARBOHYD RES, V345, P115, DOI 10.1016/j.carres.2009.09.027; Ishibashi K, 2000, J PHOTOCH PHOTOBIO A, V134, P139, DOI 10.1016/S1010-6030(00)00264-1; ISHII Y, 1988, J ORG CHEM, V53, P3587, DOI 10.1021/jo00250a032; Kamata K, 2004, CHEM-EUR J, V10, P4728, DOI 10.1002/chem.200400352; Kamata K, 2009, J AM CHEM SOC, V131, P6997, DOI 10.1021/ja901289r; Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b; KURITA K, 1977, MAKROMOL CHEM, V178, P3197; Lane BS, 2003, CHEM REV, V103, P2457, DOI 10.1021/cr020471z; Makuuchi K, 2010, RADIAT PHYS CHEM, V79, P267, DOI 10.1016/j.radphyschem.2009.10.011; Mizuno N, 2005, COORDIN CHEM REV, V249, P1944, DOI 10.1016/j.ccr.2004.11.019; Ngah WSW, 2006, ADSORPTION, V12, P249, DOI 10.1007/s10450-006-0501-0; Nge KL, 2006, PLANT SCI, V170, P1185, DOI 10.1016/j.plantsci.2006.02.006; Hien NQ, 2012, CARBOHYD POLYM, V87, P935, DOI 10.1016/j.carbpol.2011.08.018; No HK, 2007, J FOOD SCI, V72, pR87, DOI 10.1111/j.1750-3841.2007.00383.x; POSPIESZNY H, 1991, PLANT SCI, V79, P63, DOI 10.1016/0168-9452(91)90070-O; SAITO H, 1987, MACROMOLECULES, V20, P2424, DOI 10.1021/ma00176a017; Schnepp Z, 2013, ANGEW CHEM INT EDIT, V52, P1096, DOI 10.1002/anie.201206943; Swayampakula K, 2009, J HAZARD MATER, V170, P680, DOI 10.1016/j.jhazmat.2009.05.106; Ueno H, 1999, BIOMATERIALS, V20, P1407, DOI 10.1016/S0142-9612(99)00046-0; Wang SM, 2005, CARBOHYD RES, V340, P1143, DOI 10.1016/j.carres.2005.02.009; Yin H, 2009, CURR TOP MED CHEM, V9, P1546, DOI 10.2174/156802609789909795; Zhang BY, 2012, J CATAL, V287, P5, DOI 10.1016/j.jcat.2011.11.003	36	47	49	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100743	10.1371/journal.pone.0100743	http://dx.doi.org/10.1371/journal.pone.0100743			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971631	Green Published, gold, Green Submitted			2022-12-27	WOS:000338512200056
J	Baccelli, I; Lombardi, L; Luti, S; Bernardi, R; Picciarelli, P; Scala, A; Pazzagli, L				Baccelli, Ivan; Lombardi, Lara; Luti, Simone; Bernardi, Rodolfo; Picciarelli, Piero; Scala, Aniello; Pazzagli, Luigia			Cerato-Platanin Induces Resistance in Arabidopsis Leaves through Stomatal Perception, Overexpression of Salicylic Acid- and Ethylene-Signalling Genes and Camalexin Biosynthesis	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; TRANSCRIPTION FACTOR; DEFENSE RESPONSES; PHYTOALEXIN BIOSYNTHESIS; PHYTOTOXIC PROTEIN; INNATE IMMUNITY; FAMILY PROTEIN; EXPRESSION; JASMONATE; STRESS	Microbe-associated molecular patterns (MAMPs) lead to the activation of the first line of plant defence. Few fungal molecules are universally qualified as MAMPs, and proteins belonging to the cerato-platanin protein (CPP) family seem to possess these features. Cerato-platanin (CP) is the name-giving protein of the CPP family and is produced by Ceratocystis platani, the causal agent of the canker stain disease of plane trees (Platanus spp.). On plane tree leaves, the biological activity of CP has been widely studied. Once applied on the leaf surface, CP acts as an elicitor of defence responses. The molecular mechanism by which CP elicits leaves is still unknown, and the protective effect of CP against virulent pathogens has not been clearly demonstrated. In the present study, we tried to address these questions in the model plant Arabidopsis thaliana. Our results suggest that stomata rapidly sense CP since they responded to the treatment with ROS signalling and stomatal closure, and that CP triggers salicylic acid (SA)- and ethylene (ET)-signalling pathways, but not the jasmonic acid (JA)-signalling pathway, as revealed by the expression pattern of 20 marker genes. Among these, EDS1, PAD4, NPR1, GRX480, WRKY70, ACS6, ERF1a/b, COI1, MYC2, PDF1.2a and the pathogenesis-related (PR) genes 1-5. CP rapidly induced MAPK phosphorylation and induced the biosynthesis of camalexin within 12 hours following treatment. The induction of localised resistance was shown by a reduced susceptibility of the leaves to the infection with Botrytis cinerea and Pseudomonas syringae pv. tomato. These results contribute to elucidate the key steps of the signalling process underlying the resistance induction in plants by CP and point out the central role played by the stomata in this process.	[Baccelli, Ivan; Scala, Aniello] Univ Florence, Dept Agri Food Prod & Environm Sci, Florence, Italy; [Lombardi, Lara] Univ Pisa, Dept Biol, Pisa, Italy; [Luti, Simone; Pazzagli, Luigia] Univ Florence, Dept Biomed Expt & Clin Sci, Florence, Italy; [Bernardi, Rodolfo; Picciarelli, Piero] Univ Pisa, Dept Agr Food & Environm, Pisa, Italy	University of Florence; University of Pisa; University of Florence; University of Pisa	Baccelli, I (corresponding author), Univ Florence, Dept Agri Food Prod & Environm Sci, Florence, Italy.	ivan.baccelli@unifi.it	Baccelli, Ivan/GLS-8786-2022; Picciarelli, Piero/F-9698-2014	Baccelli, Ivan/0000-0002-1368-1250; Picciarelli, Piero/0000-0002-2372-0620; Luti, Simone/0000-0001-7050-6590	Ministero Italiano dell'Universita e della Ricerca Scientifica	Ministero Italiano dell'Universita e della Ricerca Scientifica(Ministry of Education, Universities and Research (MIUR))	This work was supported by Ministero Italiano dell'Universita e della Ricerca Scientifica, Progetti di Ricerca di Interesse Nazionale (PRIN) 2009 (http://prin.miur.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja I, 2012, TRENDS PLANT SCI, V17, P73, DOI 10.1016/j.tplants.2011.11.002; Allan AC, 1997, PLANT CELL, V9, P1559, DOI 10.1105/tpc.9.9.1559; Baccelli I, 2013, BIOL PLANTARUM, V57, P571, DOI 10.1007/s10535-013-0308-2; Baccelli I, 2014, APPL MICROBIOL BIOT, V98, P175, DOI 10.1007/s00253-013-4822-0; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Barsottini MRD, 2013, MOL PLANT MICROBE IN, V26, P1281, DOI 10.1094/MPMI-05-13-0148-R; Beckers GJM, 2009, PLANT CELL, V21, P944, DOI 10.1105/tpc.108.062158; Beets C, 2011, ANAL BIOCHEM, V419, P260, DOI 10.1016/j.ab.2011.08.031; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Carresi L, 2006, PROTEIN EXPRES PURIF, V49, P159, DOI 10.1016/j.pep.2006.07.006; Cettul E, 2008, MOL PLANT PATHOL, V9, P675, DOI 10.1111/J.1364-3703.2008.00492.X; Chen HX, 2013, MYCOLOGIA, V105, P1479, DOI 10.3852/13-115; Comparini C, 2009, APPL MICROBIOL BIOT, V84, P309, DOI 10.1007/s00253-009-1998-4; de Oliveira AL, 2011, J BIOL CHEM, V286, P17560, DOI 10.1074/jbc.M111.223644; Djonovic S, 2006, MOL PLANT MICROBE IN, V19, P838, DOI 10.1094/MPMI-19-0838.02006; Ezaki B, 2000, PLANT PHYSIOL, V122, P657, DOI 10.1104/pp.122.3.657; Ferrari S, 2007, PLANT PHYSIOL, V144, P367, DOI 10.1104/pp.107.095596; Fontana F, 2008, J PLANT PATHOL, V90, P295; Frias M, 2013, MOL PLANT P IN PRESS, DOI 10.1111/mpp.12097; Frias M, 2013, MOL PLANT PATHOL, V14, P191, DOI 10.1111/j.1364-3703.2012.00842.x; Frias M, 2011, NEW PHYTOL, V192, P483, DOI 10.1111/j.1469-8137.2011.03802.x; Frischmann A, 2013, J BIOL CHEM, V288, P4278, DOI 10.1074/jbc.M112.427633; Galletti R, 2011, PLANT PHYSIOL, V157, P804, DOI 10.1104/pp.111.174003; Gijzen M, 2006, PHYTOCHEMISTRY, V67, P1800, DOI 10.1016/j.phytochem.2005.12.008; Iriti M, 2009, PLANT SIGNAL BEHAV, V4, P66, DOI 10.4161/psb.4.1.7408; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Katsir L, 2008, P NATL ACAD SCI USA, V105, P7100, DOI 10.1073/pnas.0802332105; Klarzynski O, 2000, PLANT PHYSIOL, V124, P1027, DOI 10.1104/pp.124.3.1027; Kliebenstein DJ, 2005, PLANT J, V44, P25, DOI 10.1111/j.1365-313X.2005.02508.x; Kumar MN, 2013, PLANT PHYSIOL, V161, P942, DOI 10.1104/pp.112.209791; Lake JA, 2002, J EXP BOT, V53, P183, DOI 10.1093/jexbot/53.367.183; Lee S, 1999, PLANT PHYSIOL, V121, P147, DOI 10.1104/pp.121.1.147; Liu YD, 2004, PLANT CELL, V16, P3386, DOI 10.1105/tpc.104.026609; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lombardi L, 2013, PHYSIOL PLANTARUM, V149, P408, DOI 10.1111/ppl.12041; Lorenzo O, 2004, PLANT CELL, V16, P1938, DOI 10.1105/tpc.022319; Mao GH, 2011, PLANT CELL, V23, P1639, DOI 10.1105/tpc.111.084996; Martellini F, 2013, MOL BIOTECHNOL, V55, P27, DOI 10.1007/s12033-012-9618-4; Melotto M, 2006, CELL, V126, P969, DOI 10.1016/j.cell.2006.06.054; Mittler R, 2011, TRENDS PLANT SCI, V16, P300, DOI 10.1016/j.tplants.2011.03.007; Mowla SB, 2006, PLANT J, V48, P743, DOI 10.1111/j.1365-313X.2006.02911.x; Pazzagli L, 1999, J BIOL CHEM, V274, P24959, DOI 10.1074/jbc.274.35.24959; Pazzagli L, 2014, PLANT SCI IN PRESS; Pazzagli L, 2009, BBA-GEN SUBJECTS, V1790, P1334, DOI 10.1016/j.bbagen.2009.07.014; Penninckx IAMA, 1998, PLANT CELL, V10, P2103, DOI 10.1105/tpc.10.12.2103; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; Qiu JL, 2008, EMBO J, V27, P2214, DOI 10.1038/emboj.2008.147; Ren DT, 2008, P NATL ACAD SCI USA, V105, P5638, DOI 10.1073/pnas.0711301105; Robatzek S, 2006, GENE DEV, V20, P537, DOI 10.1101/gad.366506; Sawinski K, 2013, MOL PLANT MICROBE IN, V26, P626, DOI 10.1094/MPMI-12-12-0288-CR; Scala A, 2004, J PLANT PATHOL, V86, P27; Schwessinger B, 2012, ANNU REV PLANT BIOL, V63, P451, DOI 10.1146/annurev-arplant-042811-105518; Thaler JS, 2012, TRENDS PLANT SCI, V17, P260, DOI 10.1016/j.tplants.2012.02.010; Thomma BPHJ, 2011, PLANT CELL, V23, P4, DOI 10.1105/tpc.110.082602; Thomma BPHJ, 2001, CURR OPIN IMMUNOL, V13, P63, DOI 10.1016/S0952-7915(00)00183-7; Torres MA, 2005, CURR OPIN PLANT BIOL, V8, P397, DOI 10.1016/j.pbi.2005.05.014; Vargas WA, 2008, J BIOL CHEM, V283, P19804, DOI 10.1074/jbc.M802724200; Wagner U, 2002, PLANT MOL BIOL, V49, P515, DOI 10.1023/A:1015557300450; Wan JR, 2004, MOL PLANT PATHOL, V5, P125, DOI [10.1111/j.1364-3703.2004.00215.x, 10.1111/J.1364-3703.2004.00215.X]; Wang L, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000301; Wang PT, 2008, NEW PHYTOL, V178, P703, DOI 10.1111/j.1469-8137.2008.02431.x; Yang YY, 2009, PLANT BIOTECHNOL J, V7, P763, DOI 10.1111/j.1467-7652.2009.00442.x	62	33	34	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100959	10.1371/journal.pone.0100959	http://dx.doi.org/10.1371/journal.pone.0100959			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968226	Green Published, gold, Green Submitted			2022-12-27	WOS:000338280800091
J	Mundy, ME; Downing, PE; Honey, RC; Singh, KD; Graham, KS; Dwyer, DM				Mundy, Matthew E.; Downing, Paul E.; Honey, Robert C.; Singh, Krish D.; Graham, Kim S.; Dwyer, Dominic M.			Brain Correlates of Experience-Dependent Changes in Stimulus Discrimination Based on the Amount and Schedule of Exposure	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; NEURAL MECHANISMS; AREAS; ATTENTION; ROBUST; OPTIMIZATION; REGISTRATION; ACTIVATIONS; PREEXPOSURE; SPECIFICITY	One product of simple exposure to similar visual stimuli is that they become easier to distinguish. The early visual cortex and other brain areas (such as the prefrontal cortex) have been implicated in such perceptual learning effects, but the anatomical specificity within visual cortex and the relationship between sensory cortex and other brain areas has yet to be examined. Moreover, while variations in the schedule (rather than merely the amount) of exposure influence experience-dependent improvement in discrimination, the neural sequelae of exposure schedule have not been fully investigated. In an event-related fMRI study, participants were exposed to confusable pairs of faces, scenes and dot patterns, using either intermixed or blocked presentation schedules. Participants then performed same/different judgements with exposed and novel pairs of stimuli. Stimulus independent activation, which was correlated with experience-dependent improvement in discrimination, was seen in frontal areas (e.g. frontal and supplementary eye fields and dorsolateral prefrontal cortex) and in early visual cortex (V1-4). In all regions, the difference in activation between exposed and novel stimuli decreased as a function of the degree of discrimination improvement. Overall levels of BOLD activation differed across regions, consistent with the possibility that, as a consequence of experience, processing shifts from initial engagement of early visual regions to higher order visual areas. Similar relationships were observed when contrasting intermixed with blocked exposure, suggesting that the schedule of exposure primarily influences the degree of, rather than the mechanisms for, discrimination performance.	[Mundy, Matthew E.; Graham, Kim S.] Cardiff Univ, Sch Psychol, WICN, Cardiff CF10 3AX, S Glam, Wales; [Downing, Paul E.] Bangor Univ, Sch Psychol, WICN, Bangor, Gwynedd, Wales; [Honey, Robert C.; Dwyer, Dominic M.] Cardiff Univ, Sch Psychol, Cardiff CF10 3AX, S Glam, Wales; [Singh, Krish D.] Cardiff Univ, Cardiff Univ Brain Imaging Res Ctr CUBRIC, Cardiff CF10 3AX, S Glam, Wales; [Mundy, Matthew E.] Monash Univ, Sch Psychol Sci, Melbourne, Vic 3004, Australia; [Dwyer, Dominic M.] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia	Cardiff University; Bangor University; Cardiff University; Cardiff University; Monash University; University of New South Wales Sydney	Mundy, ME (corresponding author), Cardiff Univ, Sch Psychol, WICN, Cardiff CF10 3AX, S Glam, Wales.	Matthew.Mundy@monash.edu	Singh, Krish/D-1066-2009; Dwyer, Dominic Michael/D-1498-2009	Dwyer, Dominic Michael/0000-0001-8069-5508; Mundy, Matthew/0000-0002-7073-0047; Downing, Paul/0000-0002-5046-2858; Singh, Krishna/0000-0002-3094-2475; Graham, Kim/0000-0002-1512-7667	BBSRC Grant [BB/I007091/1]; Wales Institute of Cognitive Neuroscience via Welsh Government; BBSRC [BB/I007091/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I007091/1] Funding Source: researchfish	BBSRC Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wales Institute of Cognitive Neuroscience via Welsh Government; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was funded by BBSRC Grant (BB/I007091/1) and the Wales Institute of Cognitive Neuroscience, which was established via a grant from the Welsh Government to the Schools of Psychology at Cardiff, Bangor and Swansea Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahissar M, 1996, VISION RES, V36, P3487, DOI 10.1016/0042-6989(96)00036-3; Ahissar M, 1997, NATURE, V387, P401, DOI 10.1038/387401a0; Ahissar M, 2004, TRENDS COGN SCI, V8, P457, DOI 10.1016/j.tics.2004.08.011; Ahissar M, 2002, PERCEPTUAL LEARNING, P253; Beckmann CF, 2003, NEUROIMAGE, V20, P1052, DOI 10.1016/S1053-8119(03)00435-X; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Dubois S, 1999, NEUROIMAGE, V9, P278, DOI 10.1006/nimg.1998.0409; Dwyer DM, 2004, Q J EXP PSYCHOL-B, V57, P245, DOI 10.1080/02724990344000114; Dwyer DM, WILEY BLACK IN PRESS; Dwyer DM, 2011, J EXP PSYCHOL ANIM B, V37, P300, DOI 10.1037/a0023078; Eickhoff SB, 2007, NEUROIMAGE, V36, P511, DOI 10.1016/j.neuroimage.2007.03.060; Fahle M, 2004, J VISION, V4, P879, DOI 10.1167/4.10.4; Furmanski CS, 2004, CURR BIOL, V14, P573, DOI 10.1016/j.cub.2004.03.032; Gaffan D, 1996, COGNITIVE BRAIN RES, V5, P69, DOI 10.1016/S0926-6410(96)00042-0; GIBSON EJ, 1963, ANNU REV PSYCHOL, V14, P29, DOI 10.1146/annurev.ps.14.020163.000333; Gibson Eleanor Jack, 1969, PRINCIPLES PERCEPTUA; Giesbrecht B, 2003, NEUROIMAGE, V19, P496, DOI 10.1016/S1053-8119(03)00162-9; Gilbert CD, 1998, PHYSIOL REV, V78, P467, DOI 10.1152/physrev.1998.78.2.467; Goldstone RL, 1998, ANNU REV PSYCHOL, V49, P585, DOI 10.1146/annurev.psych.49.1.585; Hall G, 2003, Q J EXP PSYCHOL-B, V56, P43, DOI 10.1080/02724990244000151; Hall G., 1991, PERCEPTUAL ASS LEARN; Honey RC, 1996, Q J EXP PSYCHOL-B, V49, P259; HONEY RC, 1994, Q J EXP PSYCHOL-B, V47, P83; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; Ibbotson MR, 2005, FITTING MIND WORLD A; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; Kastner S, 1998, SCIENCE, V282, P108, DOI 10.1126/science.282.5386.108; Lavis Y, 2006, Q J EXP PSYCHOL, V59, P2083, DOI 10.1080/17470210600705198; McGovern DP, 2012, J VISION, V12, DOI 10.1167/12.11.4; McGovern DP, 2012, J NEUROSCI, V32, P13621, DOI 10.1523/JNEUROSCI.1363-12.2012; McLaren I.P.L., 1989, PARALLEL DISTRIBUTED, P102; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mitchell C, 2014, PSYCHOL BULL, V140, P283, DOI 10.1037/a0032765; Mukai I, 2007, J NEUROSCI, V27, P11401, DOI 10.1523/JNEUROSCI.3002-07.2007; Mundy ME, 2007, J EXP PSYCHOL ANIM B, V33, P124, DOI 10.1037/0097-7403.33.2.124; Mundy ME, 2013, J NEUROSCI, V33, P10490, DOI 10.1523/JNEUROSCI.2958-12.2013; Mundy ME, 2009, Q J EXP PSYCHOL, V62, P18, DOI 10.1080/17470210802240614; Mundy ME, 2009, NEUROREPORT, V20, P1397, DOI 10.1097/WNR.0b013e32832f81f4; Mundy ME, 2006, J EXP PSYCHOL ANIM B, V32, P178, DOI 10.1037/0097-7403.32.2.178; Peelen MV, 2005, HUM BRAIN MAPP, V25, P402, DOI 10.1002/hbm.20116; Schiltz C, 1999, NEUROIMAGE, V9, P46, DOI 10.1006/nimg.1998.0394; Schwartz S, 2002, P NATL ACAD SCI USA, V99, P17137, DOI 10.1073/pnas.242414599; SHIU LP, 1992, PERCEPT PSYCHOPHYS, V52, P582, DOI 10.3758/BF03206720; Sigman M, 2005, NEURON, V46, P823, DOI 10.1016/j.neuron.2005.05.014; Singh KD, 2000, NEUROIMAGE, V12, P550, DOI 10.1006/nimg.2000.0642; Smith AT, 1998, J NEUROSCI, V18, P3816; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; SYMONDS M, 1995, LEARN MOTIV, V26, P203, DOI 10.1016/0023-9690(95)90005-5; Talairach J., 1988, COPLANAR STEREOTAXIC; Turk-Browne NB, 2007, CEREB CORTEX, V17, P425, DOI 10.1093/cercor/bhj159; Weinberger NM, 1998, AUDIOL NEURO-OTOL, V3, P145, DOI 10.1159/000013787; Woldorff MG, 2004, J COGNITIVE NEUROSCI, V16, P149, DOI 10.1162/089892904322755638; Woolrich MW, 2004, NEUROIMAGE, V21, P1732, DOI 10.1016/j.neuroimage.2003.12.023; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127; Xiao LQ, 2008, CURR BIOL, V18, P1922, DOI 10.1016/j.cub.2008.10.030; Zhang T, 2010, VISION RES, V50, P368, DOI 10.1016/j.visres.2009.08.024	59	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e101011	10.1371/journal.pone.0101011	http://dx.doi.org/10.1371/journal.pone.0101011			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967903	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000338280800098
J	Woldehawariat, G; Martinez, PE; Hauser, P; Hoover, DM; Drevets, WWC; McMahon, FJ				Woldehawariat, Girma; Martinez, Pedro E.; Hauser, Peter; Hoover, David M.; Drevets, Wayne W. C.; McMahon, Francis J.			Corpus Callosum Size Is Highly Heritable in Humans, and May Reflect Distinct Genetic Influences on Ventral and Rostral Regions	PLOS ONE			English	Article							WHITE-MATTER ABNORMALITIES; BIPOLAR AFFECTIVE-DISORDER; HUMAN BRAIN; MOOD DISORDERS; INTERHEMISPHERIC COMMUNICATION; SCHIZOPHRENIA; TWINS; SPECIALIZATION; PERSPECTIVES; NEUROANATOMY	Anatomical differences in the corpus callosum have been found in various psychiatric disorders, but data on the genetic contributions to these differences have been limited. The current study used morphometric MRI data to assess the heritability of corpus callosum size and the genetic correlations among anatomical sub-regions of the corpus callosum among individuals with and without mood disorders. The corpus callosum (CC) was manually segmented at the mid-sagittal plane in 42 women (healthy, n = 14; major depressive disorder, n = 15; bipolar disorder, n = 13) and their 86 child or adolescent offspring. Four anatomical sub-regions (CC-genu, CC2, CC3 and CC-splenium) and total CC were measured and analyzed. Heritability and genetic correlations were estimated using a variance components method, with adjustment for age, sex, diagnosis, and diagnosis x age, where appropriate. Significant heritability was found for several CC sub-regions (P < 0.01), with estimated values ranging from 48% (splenium) to 67% (total CC). There were strong and significant genetic correlations among most sub regions. Correlations between the genu and mid-body, between the genu and total corpus callosum, and between anterior and mid body were all > 90%, but no significant genetic correlations were detected between ventral and rostral regions in this sample. Genetic factors play an important role in corpus callosum size among individuals. Distinct genetic factors seem to be involved in caudal and rostral regions, consistent with the divergent functional specialization of these brain areas.	[Woldehawariat, Girma; McMahon, Francis J.] NIMH, Genet Basis Mood & Anxiety Disorders Sect, Human Genet Branch, NIH,DHHS, Bethesda, MD 20892 USA; [Martinez, Pedro E.] NIMH, Sect Behav Endocrinol, NIH, DHHS, Bethesda, MD 20892 USA; [Hauser, Peter] VISN 22 Network Off, Long Beach, CA USA; [Hoover, David M.] NIH, Ctr Informat Technol, Bethesda, MD 20892 USA; [Drevets, Wayne W. C.] Laureate Inst Brain Res, Tulsa, OK USA; [Drevets, Wayne W. C.] Univ Oklahoma, Coll Med, Tulsa, OK USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT); Laureate Institute for Brain Research, Inc.; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma - Tulsa	Woldehawariat, G (corresponding author), NIMH, Genet Basis Mood & Anxiety Disorders Sect, Human Genet Branch, NIH,DHHS, Bethesda, MD 20892 USA.	hawariag@mail.nih.gov	McMahon, Francis J/A-7290-2009	McMahon, Francis J/0000-0002-9469-305X	National Institutes of Mental Health (NIMH) of the US government; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002810] Funding Source: NIH RePORTER	National Institutes of Mental Health (NIMH) of the US government; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research is funded by National Institutes of Mental Health (NIMH) of the US government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; ALMASY L, 2009, GENETICS COMPLEX HUM, P37; Anderson ML, 2013, NEUROIMAGE, V73, P50, DOI 10.1016/j.neuroimage.2013.01.071; Baare WFC, 2001, CEREB CORTEX, V11, P816, DOI 10.1093/cercor/11.9.816; Bachmann S, 2003, PSYCHOL MED, V33, P1019, DOI 10.1017/S0033291703008043; Badea A, 2009, NEUROIMAGE, V45, P1067, DOI 10.1016/j.neuroimage.2009.01.021; Bartley AJ, 1997, BRAIN, V120, P257, DOI 10.1093/brain/120.2.257; Brambilla P, 2004, EPIDEMIOL PSICHIAT S, V11, P88; Brambilla Paolo, 2002, Epidemiol Psichiatr Soc, V11, P88; Bruen PD, 2008, BRAIN, V131, P2455, DOI 10.1093/brain/awn151; Carmelli D, 2002, BIOL PSYCHOL, V61, P139, DOI 10.1016/S0301-0511(02)00056-X; CLARKE JM, 1994, BEHAV BRAIN RES, V64, P185, DOI 10.1016/0166-4328(94)90131-7; Comuzzie AG, 1997, ARTERIOSCL THROM VAS, V17, P859, DOI 10.1161/01.ATV.17.5.859; Doron KW, 2008, CORTEX, V44, P1023, DOI 10.1016/j.cortex.2008.03.007; Drevets WC, 2008, BRAIN STRUCT FUNCT, V213, P93, DOI 10.1007/s00429-008-0189-x; Evans AE, 2012, MOL REGULATION STRIA, V2012; Evans SJ, 2003, NEUROBIOL DIS, V14, P240, DOI 10.1016/S0969-9961(03)00126-8; Falconer D. S., 1996, INTRO QUANTITATIVE G; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Fears SC, 2014, JAMA PSYCHIAT, V71, P375, DOI 10.1001/jamapsychiatry.2013.4100; Frazier JA, 2007, BIPOLAR DISORD, V9, P799, DOI 10.1111/j.1399-5618.2007.00482.x; Gazzaniga MS, 2000, BRAIN, V123, P1293, DOI 10.1093/brain/123.7.1293; Geschwind DH, 2002, P NATL ACAD SCI USA, V99, P3176, DOI 10.1073/pnas.052494999; Good CD, 2002, NEUROIMAGE, V17, P29, DOI 10.1006/nimg.2002.1202; Good CD, 2001, REV NEUROL-FRANCE, V157, P797; Hamer RM, 2006, COMPUTE 6 INTERCLASS; HAUSER P, 1989, BIOL PSYCHIAT, V26, P659, DOI 10.1016/0006-3223(89)90100-5; Hofer S, 2006, NEUROIMAGE, V32, P989, DOI 10.1016/j.neuroimage.2006.05.044; Honey CJ, 2010, NEUROIMAGE, V52, P766, DOI 10.1016/j.neuroimage.2010.01.071; Hulshoff-Pol HE, 2006, J NEUROSCI, V26, P10235, DOI 10.1523/JNEUROSCI.1312-06.2006; HYND GW, 1991, J LEARN DISABIL, V24, P141, DOI 10.1177/002221949102400302; Jahanshad N, 2013, NEUROIMAGE, V81, P455, DOI 10.1016/j.neuroimage.2013.04.061; Kochunov P, 2010, NEUROIMAGE, V53, P1116; Kochunov P, 2011, HYPERTENSION, V57, P330, DOI 10.1161/HYPERTENSIONAHA.110.162206; Lacerda ALT, 2005, J PSYCHIATR RES, V39, P347, DOI 10.1016/j.jpsychires.2004.10.004; Lopez-Larson M, 2010, BRAIN IMAGING BEHAV, V4, P220, DOI 10.1007/s11682-010-9101-4; Lyoo IK, 2002, BIOL PSYCHIAT, V52, P1134, DOI 10.1016/S0006-3223(02)01436-1; Martinez P, 2002, SOC NEUROSCI; Martynoga B, 2005, DEV BIOL, V283, P113, DOI 10.1016/j.ydbio.2005.04.005; Pfefferbaum A, 2000, NEUROBIOL AGING, V21, P63, DOI 10.1016/S0197-4580(00)00086-5; Phillips KA, 2012, TWIN RES HUM GENET, V15, P315, DOI 10.1017/thg.2012.10; Price G, 2005, J NEUROL NEUROSUR PS, V76, P585, DOI 10.1136/jnnp.2004.042952; Price JL, 2010, NEUROPSYCHOPHARMACOL, V35, P192, DOI 10.1038/npp.2009.104; RADKEYARROW M, 1992, J AM ACAD CHILD PSY, V31, P68, DOI 10.1097/00004583-199201000-00011; RISSE GL, 1989, ARCH NEUROL-CHICAGO, V46, P437, DOI 10.1001/archneur.1989.00520400097026; Scamvougeras A, 2003, NEUROSCI LETT, V338, P91, DOI 10.1016/S0304-3940(02)01333-2; Schulte T, 2005, CEREB CORTEX, V15, P1384, DOI 10.1093/cercor/bhi020; Schulte T, 2010, NEUROPSYCHOL REV, V20, P174, DOI 10.1007/s11065-010-9130-1; Soares JC, 1997, BIOL PSYCHIAT, V41, P86, DOI 10.1016/S0006-3223(96)00006-6; Soares JC, 1997, J PSYCHIATR RES, V31, P393, DOI 10.1016/S0022-3956(97)00016-2; Storm EE, 2006, DEVELOPMENT, V133, P1831, DOI 10.1242/dev.02324; Strenziok M, 2013, DIFFERENTIAL CONTRIB, V8, P2; Sussmann JE, 2009, BIPOLAR DISORD, V11, P11, DOI 10.1111/j.1399-5618.2008.00646.x; Thompson PM, 2001, NAT NEUROSCI, V4, P1253, DOI 10.1038/nn758; Todd RD, 2002, CHILD ADOL PSYCH CL, V11, P499, DOI 10.1016/S1056-4993(02)00013-5; Vidal CN, 2006, BIOL PSYCHIAT, V60, P218, DOI 10.1016/j.biopsych.2005.11.011; Walterfang M, 2009, AUST NZ J PSYCHIAT, V43, P838, DOI 10.1080/00048670903107534; WITELSON SF, 1989, BRAIN, V112, P799, DOI 10.1093/brain/112.3.799	59	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e99980	10.1371/journal.pone.0099980	http://dx.doi.org/10.1371/journal.pone.0099980			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968245	Green Submitted, gold, Green Published			2022-12-27	WOS:000338280800022
J	Bourgeon, S; Leat, EHK; Magnusdottir, E; Furness, RW; Strom, H; Petersen, A; Gabrielsen, GW; Hanssen, SA; Bustnes, JO				Bourgeon, Sophie; Leat, Eliza H. K.; Magnusdottir, Ellen; Furness, Robert W.; Strom, Hallvard; Petersen, Aevar; Gabrielsen, Geir W.; Hanssen, Sveinn Are; Bustnes, Jan Ove			Feather Corticosterone Levels on Wintering Grounds Have No Carry-Over Effects on Breeding among Three Populations of Great Skuas (Stercorarius skua)	PLOS ONE			English	Article							PERSISTENT ORGANIC POLLUTANTS; BLACK-LEGGED KITTIWAKES; INDIVIDUAL VARIATION; STABLE-ISOTOPES; MIGRATORY BIRD; SEABIRD; QUALITY; GEOLOCATION; SPARROWS; DYNAMICS	Environmental conditions encountered by migratory seabirds in their wintering areas can shape their fitness. However, the underlying physiological mechanisms remain largely unknown as birds are relatively inaccessible during winter. To assess physiological condition during this period, we measured corticosterone concentrations in winter-grown primary feathers of female great skuas (Stercorarius skua) from three breeding colonies (Bjornoya, Iceland, Shetland) with wintering areas identified from characteristic stable isotope signatures. We subsequently compared winter feather corticosterone levels between three wintering areas (Africa, Europe and America). Among females breeding in 2009, we found significant differences in feather corticosterone levels between wintering areas. Surprisingly, levels were significantly higher in Africa despite seemingly better local ecological factors (based on lower foraging effort). Moreover, contrary to our predictions, females sharing the same wintering grounds showed significant differences in feather corticosterone levels depending on their colony of origin suggesting that some skuas could be using suboptimal wintering areas. Among females wintering in Africa, Shetland females showed feather corticosterone levels on average 22% lower than Bjornoya and Iceland females. Finally, the lack of significant relationships between winter feather corticosterone levels and any of the breeding phenology traits does not support the hypothesis of potential carry-over effects of winter feather corticosterone. Yet, the fitness consequences of elevated feather corticosterone levels remain to be determined.	[Bourgeon, Sophie; Hanssen, Sveinn Are; Bustnes, Jan Ove] Norwegian Inst Nat Res, Fram Ctr, Tromso, Norway; [Bourgeon, Sophie; Strom, Hallvard; Gabrielsen, Geir W.] Norwegian Polar Res Inst, Fram Ctr, Tromso, Norway; [Leat, Eliza H. K.; Furness, Robert W.] Univ Glasgow, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Magnusdottir, Ellen; Petersen, Aevar] Iceland Inst Nat Hist, Reykjavik, Iceland	Norwegian Institute Nature Research; Norwegian Polar Institute; University of Glasgow	Bourgeon, S (corresponding author), Norwegian Inst Nat Res, Fram Ctr, Tromso, Norway.	sophie.bourgeon@npolar.no	Hanssen, Sveinn Are/C-9989-2009	Hanssen, Sveinn Are/0000-0003-1792-435X	Research Council of Norway [184830]	Research Council of Norway(Research Council of Norway)	This study was supported by the Research Council of Norway (http://www.forskningsradet.no/en/Home_ page/1177315753906), grant number 184830. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelier F, 2007, HORM BEHAV, V52, P482, DOI 10.1016/j.yhbeh.2007.07.003; Bogdanova MI, 2011, P ROY SOC B-BIOL SCI, V278, P2412, DOI 10.1098/rspb.2010.2601; Bortolotti GR, 2008, FUNCT ECOL, V22, P494, DOI 10.1111/j.1365-2435.2008.01387.x; Bourgeon S, 2013, ENVIRON SCI TECHNOL, V47, P5963, DOI 10.1021/es400442q; Bourgeon S, 2012, ENVIRON RES, V118, P31, DOI 10.1016/j.envres.2012.08.004; Carrete M, 2013, ANIM CONSERV, V16, P353, DOI 10.1111/acv.12001; Costantini D, 2008, J COMP PHYSIOL B, V178, P829, DOI 10.1007/s00360-008-0270-z; Egevang C, 2010, P NATL ACAD SCI USA, V107, P2078, DOI 10.1073/pnas.0909493107; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Furness R. W., 1987, SKUAS; Gaston A.J., 2004, SEABIRDS NATURAL HIS; Gonzalez-Solis J, 2011, MAR ECOL PROG SER, V435, P251, DOI 10.3354/meps09233; Kitaysky AS, 1999, FUNCT ECOL, V13, P577, DOI 10.1046/j.1365-2435.1999.00352.x; Kitaysky AS, 2001, BEHAV ECOL, V12, P619, DOI 10.1093/beheco/12.5.619; Koren L, 2012, P ROY SOC B-BIOL SCI, V279, P1560, DOI 10.1098/rspb.2011.2062; Kouwenberg AL, 2013, IBIS, V155, P413, DOI 10.1111/ibi.12030; Lattin CR, 2011, J AVIAN BIOL, V42, P247, DOI 10.1111/j.1600-048X.2010.05310.x; Leat EHK, 2013, MAR ECOL PROG SER, V491, P277, DOI 10.3354/meps10455; Lok T, 2011, ANIM BEHAV, V82, P837, DOI 10.1016/j.anbehav.2011.07.019; Magnusdottir E, 2012, THESIS U ICELAND; Magnusdottir E, 2012, BIRD STUDY, V59, P1; Marra PP, 1998, OECOLOGIA, V116, P284, DOI 10.1007/s004420050590; Marra PP, 1998, SCIENCE, V282, P1884, DOI 10.1126/science.282.5395.1884; Phillips RA, 2007, MAR ECOL PROG SER, V345, P281, DOI 10.3354/meps06991; Phillips RA, 2009, OECOLOGIA, V160, P795, DOI 10.1007/s00442-009-1342-9; Quillfeldt P, 2012, MAR BIOL, V159, P1809, DOI 10.1007/s00227-012-1971-0; R Core Team, 2012, R LANG ENV STAT COMP; Raberg L, 1998, P ROY SOC B-BIOL SCI, V265, P1637, DOI 10.1098/rspb.1998.0482; Romero LM, 2005, COMP BIOCHEM PHYS A, V142, P65, DOI 10.1016/j.cbpa.2005.07.014; Sedinger JS, 2011, AM NAT, V178, pE110, DOI 10.1086/662165; Sorensen MC, 2009, J ANIM ECOL, V78, P460, DOI 10.1111/j.1365-2656.2008.01492.x; Stenhouse IJ, 2012, IBIS, V154, P42, DOI 10.1111/j.1474-919X.2011.01180.x; Thompson DR, 1998, ENVIRON POLLUT, V101, P193, DOI 10.1016/S0269-7491(98)00078-5; WINGFIELD JC, 1983, AUK, V100, P56, DOI 10.1093/auk/100.1.56; WINGFIELD JC, 1994, PERSPECTIVES IN COMPARATIVE ENDOCRINOLOGY, P520	35	22	23	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100439	10.1371/journal.pone.0100439	http://dx.doi.org/10.1371/journal.pone.0100439			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964085	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000338709500051
J	Shin, YW; Jung, KH; Kim, JM; Cho, YD; Lee, ST; Chu, K; Kim, M; Lee, SK; Han, MH; Roh, JK				Shin, Yong-Won; Jung, Keun-Hwa; Kim, Jeong-Min; Cho, Young Dae; Lee, Soon-Tae; Chu, Kon; Kim, Manho; Lee, Sang Kun; Han, Moon Hee; Roh, Jae-Kyu			Echocardiographic Evidence of Innate Aortopathy in the Human Intracranial Aneurysm	PLOS ONE			English	Article							CERVICOCEPHALIC ARTERIAL DISSECTIONS; GENOME-WIDE ASSOCIATION; NEURAL CREST; RISK-FACTORS; DISEASE; CELLS; COARCTATION; POPULATION; PREVALENCE; VARIANT	Background: Intracranial aneurysm (IA) is significantly more prevalent in patients with coarctation of the aorta or bicuspid aortic valve than in the general population, suggesting a common pathophysiology connecting IA and aortopathy. Here, we analyzed echocardiographic aortic root dimension (ARD) in patients with IA to confirm this possibility. Methods: From January 2008 to December 2010, 260 consecutive patients with IA who were admitted to our institution for coil embolization or for acute stroke management and who also underwent echocardiography were enrolled. We hypothesized that patients with large, ruptured, or multiple IAs are more likely to harbor co-prevalent aortopathy as measured by ARD compared to patients with small, isolated, unruptured IAs. Eccentric group was defined as patients aged, <55 years with at least one ruptured aneurysm, an aneurysm >= 7 mm in size, or multiple aneurysms; the remainder was classified into a non-eccentric group. Clinical, angiographic, and echocardiographic findings of the two groups were compared. Results: ARD was significantly larger in the eccentric group than in the non-eccentric group (P = 0.049), and the difference was confirmed by multivariable analysis (P = 0.02). Subgroup analysis of patients aged <55 years showed similar result for ARD (P = 0.03), whereas hypertension was more associated with the non-eccentric group (P = 0.01). In addition, height was inversely related to aneurysm size after adjustment for age, sex, weight, ARD, smoking status, and number of aneurysms (P = 0.004). Conclusions: A certain group of IA patients share a common intrinsic wall defect with aortopathy. Shared neural crest cell origin may give rise to this phenomenon.	[Shin, Yong-Won; Jung, Keun-Hwa; Lee, Soon-Tae; Chu, Kon; Kim, Manho; Lee, Sang Kun; Roh, Jae-Kyu] Seoul Natl Univ Hosp, Dept Neurol, Biomed Res Inst, Lab Neurotherapeut, Seoul 110744, South Korea; [Jung, Keun-Hwa; Lee, Soon-Tae; Chu, Kon; Kim, Manho; Lee, Sang Kun] Seoul Natl Univ, Coll Med, Program Neurosci, Neurosci Res Inst SNUMRC, Seoul, South Korea; [Kim, Jeong-Min] Chung Ang Univ, Coll Med, Dept Neurol, Med Ctr, Seoul 156756, South Korea; [Cho, Young Dae; Han, Moon Hee] Seoul Natl Univ Hosp, Dept Radiol, Seoul 110744, South Korea; [Roh, Jae-Kyu] Armed Forces Capital Hosp, Dept Neurol, Songnam, Gyeunggido, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Chung Ang University; Chung Ang University Hospital; Seoul National University (SNU); Seoul National University Hospital	Jung, KH (corresponding author), Seoul Natl Univ Hosp, Dept Neurol, Biomed Res Inst, Lab Neurotherapeut, Seoul 110744, South Korea.	jungkh@gmail.com; stemcell.snu@gmail.com		Lee, Soon-Tae/0000-0003-4767-7564; Jung, Keun-Hwa/0000-0003-1433-8005; Chu, Kon/0000-0001-5863-0302; Kim, Jeong-Min/0000-0001-7213-5527	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI12C0421]; Seoul National University Hospital Research Fund [0420131120]	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; Seoul National University Hospital Research Fund	This study was supported by a grant from the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI12C0421). Dr. Keun-Hwa Jung was supported by the Seoul National University Hospital Research Fund (0420131120). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alg VS, 2013, NEUROLOGY, V80, P2154, DOI 10.1212/WNL.0b013e318295d751; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Arima Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2258; Bishop DT, 2009, NAT GENET, V41, P920, DOI 10.1038/ng.411; Campos C, 1998, INTERV NEURORADIOL, V4, P293, DOI 10.1177/159101999800400405; Casimiro MV, 2004, SURG NEUROL, V61, P541; Chalouhi N, 2012, J CEREBR BLOOD F MET, V32, P1659, DOI 10.1038/jcbfm.2012.84; Connolly HM, 2003, MAYO CLIN PROC, V78, P1491, DOI 10.4065/78.12.1491; Cunnington MS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000899; Curtis SL, 2012, AM J NEURORADIOL, V33, P1182, DOI 10.3174/ajnr.A2915; Dupin E, 2012, DEV BIOL, V366, P83, DOI 10.1016/j.ydbio.2012.02.035; Elefteriou F, 2009, AM J MED GENET A, V149A, P2327, DOI 10.1002/ajmg.a.33045; Etchevers HC, 2001, ENDOCRIN DEV, V4, P13; Etchevers HC, 2001, DEVELOPMENT, V128, P1059; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lee BC, 2006, AM J PREV MED, V31, pS243, DOI 10.1016/j.amepre.2006.08.019; Low SK, 2012, HUM MOL GENET, V21, P2102, DOI 10.1093/hmg/dds020; Meng H, 2014, AM J NEURORADIOL, V35, P1254, DOI 10.3174/ajnr.A3558; Morita A, 2012, NEW ENGL J MED, V366, P2474, DOI 10.1056/NEJMoa1113260; MOSTELLER RD, 1987, NEW ENGL J MED, V317, P1098, DOI 10.1056/nejm198710223171717; NEHLS DG, 1985, J NEUROSURG, V63, P342, DOI 10.3171/jns.1985.63.3.0342; Nguyen TV, 2009, J STROKE CEREBROVASC, V18, P374, DOI 10.1016/j.jstrokecerebrovasdis.2008.12.004; NODEN DM, 1995, TRENDS CARDIOVAS MED, V5, P69, DOI 10.1016/S1050-1738(99)80002-4; Pasmant E, 2011, J NATL CANCER I, V103, P1713, DOI 10.1093/jnci/djr416; Pichiecchio A, 2002, NEUROLOGY, V59, P606, DOI 10.1212/WNL.59.4.606; Rinkel GJE, 2011, LANCET NEUROL, V10, P349, DOI 10.1016/S1474-4422(11)70017-5; Rinkel GJE, 1998, STROKE, V29, P251, DOI 10.1161/01.STR.29.1.251; RINNE J, 1994, NEUROSURGERY, V35, P803, DOI 10.1227/00006123-199411000-00001; ROSENQUIST TH, 1990, ANAT RECORD, V226, P347, DOI 10.1002/ar.1092260312; SCHIEVINK WI, 1995, STROKE, V26, P1935, DOI 10.1161/01.STR.26.10.1935; Schievink WI, 2005, AM J MED GENET A, V134A, P45, DOI 10.1002/ajmg.a.30475; Schievink WI, 1996, NEUROSURGERY, V39, P685, DOI 10.1097/00006123-199610000-00006; Schievink WI, 1996, NEUROSURGERY, V38, P1237, DOI 10.1097/00006123-199606000-00038; Schievink WI, 2010, NEUROLOGY, V74, P1430, DOI 10.1212/WNL.0b013e3181dc1acf; Southerland AM, 2013, CURR OPIN NEUROL, V26, P13, DOI 10.1097/WCO.0b013e32835c607f; VASAN RS, 1995, CIRCULATION, V91, P734, DOI 10.1161/01.CIR.91.3.734; Vlak MHM, 2011, LANCET NEUROL, V10, P626, DOI 10.1016/S1474-4422(11)70109-0; Wiebers D, 2003, LANCET, V362, P103, DOI 10.1016/S0140-6736(03)13860-3; Yasuno K, 2011, P NATL ACAD SCI USA, V108, P19707, DOI 10.1073/pnas.1117137108	39	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100569	10.1371/journal.pone.0100569	http://dx.doi.org/10.1371/journal.pone.0100569			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964197	Green Submitted, Green Published, gold			2022-12-27	WOS:000338709500062
J	Sistiaga, A; Mallol, C; Galvan, B; Summons, RE				Sistiaga, Ainara; Mallol, Carolina; Galvan, Bertila; Everett Summons, Roger			The Neanderthal Meal: A New Perspective Using Faecal Biomarkers	PLOS ONE			English	Article							HUMAN GUT; STEROLS; CHOLESTEROL; COPROSTANOL; CONVERSION; POLLUTION; FECES; CAVE; CONTAMINATION; SEDIMENT	Neanderthal dietary reconstructions have, to date, been based on indirect evidence and may underestimate the significance of plants as a food source. While zooarchaeological and stable isotope data have conveyed an image of Neanderthals as largely carnivorous, studies on dental calculus and scattered palaeobotanical evidence suggest some degree of contribution of plants to their diet. However, both views remain plausible and there is no categorical indication of an omnivorous diet. Here we present direct evidence of Neanderthal diet using faecal biomarkers, a valuable analytical tool for identifying dietary provenance. Our gas chromatography-mass spectrometry results from El Salt (Spain), a Middle Palaeolithic site dating to ca. 50,000 yr. BP, represents the oldest positive identification of human faecal matter. We show that Neanderthals, like anatomically modern humans, have a high rate of conversion of cholesterol to coprostanol related to the presence of required bacteria in their guts. Analysis of five sediment samples from different occupation floors suggests that Neanderthals predominantly consumed meat, as indicated by high coprostanol proportions, but also had significant plant intake, as shown by the presence of 5 beta-stigmastanol. This study highlights the applicability of the biomarker approach in Pleistocene contexts as a provider of direct palaeodietary information and supports the opportunity for further research into cholesterol metabolism throughout human evolution.	[Sistiaga, Ainara; Mallol, Carolina; Galvan, Bertila] Univ La Laguna, Dept Geog & Hist, Tenerife, Spain; [Sistiaga, Ainara; Everett Summons, Roger] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA USA; [Sistiaga, Ainara; Mallol, Carolina] Inst Univ Bioorgan Antonio Gonzalez, Tenerife, Spain	Universidad de la Laguna; Massachusetts Institute of Technology (MIT); Universidad de la Laguna	Sistiaga, A (corresponding author), Univ La Laguna, Dept Geog & Hist, Tenerife, Spain.	msistiag@ull.es	Sistiaga, Ainara/AAB-7769-2021; Summons, Roger Everett/AAL-3789-2020	Sistiaga, Ainara/0000-0003-1732-7010; 	Spanish Government I+D project [HAR2012-32703 MEC-FEDER]; Canarian Government predoctoral grant; EAOG travel award; NASA Astrobiology Institute [NNA13AA90A]	Spanish Government I+D project; Canarian Government predoctoral grant; EAOG travel award; NASA Astrobiology Institute	Archaeological research at El Salt is funded by the Spanish Government I+D project (HAR2012-32703 MEC-FEDER), and a Canarian Government predoctoral grant and EAOG travel award to A. S. Research at MIT was supported by a grant (NNA13AA90A) from the NASA Astrobiology Institute to R. E. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BETHELL PH, 1994, J ARCHAEOL SCI, V21, P619, DOI 10.1006/jasc.1994.1061; Bocherens H, 2009, VERTEBR PALEOBIOL PA, P241, DOI 10.1007/978-1-4020-9699-0_19; Bouchet F, 2003, MEM I OSWALDO CRUZ, V98, P95, DOI 10.1590/S0074-02762003000900015; Buck LT, 2013, QUAT SCI REV; Bull ID, 2002, ENVIRON INT, V27, P647, DOI 10.1016/S0160-4120(01)00124-6; Bull ID, 2001, GEOARCHAEOLOGY, V16, P223, DOI 10.1002/1520-6548(200102)16:2<223::AID-GEA1002>3.0.CO;2-7; Chizzolini R, 1999, TRENDS FOOD SCI TECH, V10, P119, DOI 10.1016/S0924-2244(99)00034-5; D'Anjou RM, 2012, P NATL ACAD SCI USA, V109, P20332, DOI 10.1073/pnas.1212730109; Ecker M, 2013, J HUM EVOL, V65, P363, DOI 10.1016/j.jhevol.2013.06.013; Elhmmali MM, 2000, ENVIRON SCI TECHNOL, V34, P39, DOI 10.1021/es990076z; Evershed RP, 1997, J ARCHAEOL SCI, V24, P485, DOI 10.1006/jasc.1996.0132; EYSSEN HJ, 1973, EUR J BIOCHEM, V36, P411, DOI 10.1111/j.1432-1033.1973.tb02926.x; FLOATE M J S, 1970, Soil Biology and Biochemistry, V2, P173, DOI 10.1016/0038-0717(70)90005-2; FREIER TA, 1994, INT J SYST BACTERIOL, V44, P137, DOI 10.1099/00207713-44-1-137; Furtula V, 2012, WATER RES, V46, P1079, DOI 10.1016/j.watres.2011.12.002; Garralda MD, 2014, J HUMAN EVO IN PRESS; GASKELL SJ, 1975, NATURE, V254, P209, DOI 10.1038/254209b0; Gaudzinski-Windheuser S, 2012, QUATERN INT, V252, P1, DOI 10.1016/j.quaint.2011.10.017; Gerard P, 2007, APPL ENVIRON MICROB, V73, P5742, DOI 10.1128/AEM.02806-06; Gerard P, 2014, PATHOGENS, V3, P14, DOI 10.3390/pathogens3010014; GRIMALT JO, 1990, ENVIRON SCI TECHNOL, V24, P357, DOI 10.1021/es00073a011; GULACAR FO, 1990, J ARCHAEOL SCI, V17, P691, DOI 10.1016/0305-4403(90)90050-F; Hardy BL, 2010, QUATERNARY SCI REV, V29, P662, DOI 10.1016/j.quascirev.2009.11.016; Hardy K, 2012, NATURWISSENSCHAFTEN, V99, P617, DOI 10.1007/s00114-012-0942-0; Henry AG, 2011, P NATL ACAD SCI USA, V108, P486, DOI 10.1073/pnas.1016868108; ILLMAN RJ, 1993, J NUTR, V123, P1094; Leeming R, 1996, WATER RES, V30, P2893, DOI 10.1016/S0043-1354(96)00011-5; Lev E, 2005, J ARCHAEOL SCI, V32, P475, DOI 10.1016/j.jas.2004.11.006; LIN DS, 1978, J LIPID RES, V19, P215; MACDONALD IA, 1983, J LIPID RES, V24, P675; Madella M, 2002, J ARCHAEOL SCI, V29, P703, DOI 10.1006/jasc.2001.0743; Mallol C, 2013, J ARCHAEOL SCI, V40, P2515, DOI 10.1016/j.jas.2012.09.017; MIDTVEDT AC, 1993, J PEDIATR GASTR NUTR, V17, P161, DOI 10.1097/00005176-199308000-00006; MIDTVEDT T, 1990, APMIS, V98, P839, DOI 10.1111/j.1699-0463.1990.tb05004.x; MURTAUGH JJ, 1967, J WATER POLLUT CON F, V39, P404; Navder K P, 1992, Indian J Med Sci, V46, P275; Nichols PD, 1996, J CHROMATOGR A, V733, P497, DOI 10.1016/0021-9673(95)00807-1; Normen L, 1999, EUR J NUTR, V38, P84, DOI 10.1007/s003940050048; Peters K.E., 2005, BIOMARKER GUIDE; Poinar H, 2009, SCIENCE, V325, DOI [10.1126/science.1167531, 10.1126/science.1168182]; Pumpin C, 2010, 550 JAHR WISS BEW UN; Ren DW, 1996, STEROIDS, V61, P33, DOI 10.1016/0039-128X(95)00173-N; Richards MP, 2009, P NATL ACAD SCI USA, V106, P16034, DOI 10.1073/pnas.0903821106; Shah VG, 2007, WATER RES, V41, P3691, DOI 10.1016/j.watres.2007.04.006; Sistiaga A, 2014, J ARCHAEOL SCI, V41, P813, DOI 10.1016/j.jas.2013.10.016; Trinkaus E, 2007, P NATL ACAD SCI USA, V104, P7367, DOI 10.1073/pnas.0702214104; Tyagi P, 2008, WATER AIR SOIL POLL, V187, P263, DOI 10.1007/s11270-007-9514-x; Veiga P, 2005, FEMS MICROBIOL LETT, V242, P81, DOI 10.1016/j.femsle.2004.10.042; WILKINS TD, 1974, CANCER RES, V34, P2250	49	83	86	0	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e101045	10.1371/journal.pone.0101045	http://dx.doi.org/10.1371/journal.pone.0101045			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963925	Green Published, gold, Green Submitted			2022-12-27	WOS:000338709500112
J	Visioli, F; Wang, YG; Alam, GN; Ning, Y; Rados, PV; Nor, JE; Polverini, PJ				Visioli, Fernanda; Wang, Yugang; Alam, Goleeta N.; Ning, Yu; Rados, Pantelis V.; Noer, Jacques E.; Polverini, Peter J.			Glucose-Regulated Protein 78 ( Grp78) Confers Chemoresistance to Tumor Endothelial Cells under Acidic Stress	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM-STRESS; DRUG-RESISTANCE; P-GLYCOPROTEIN; NECK-CANCER; ER STRESS; IN-VIVO; APOPTOSIS; ACIDOSIS; ACTIVATION; DEATH	This study was designed to investigate the activation of the unfolded protein response (UPR) tumor associated endothelial cells (TECs) and its association with chemoresistance during acidic pH stress. Materials and Methods: Endothelial cells from human oral squamous cell carcinomas (OSCC) were excised by laser capture microdissection (LCM) followed by analysis of UPR markers (Grp78, ATF4 and CHOP) using quantitative PCR. Grp78 expression was also determined by immunostaining. Acidic stress was induced in primary human dermal microvascular endothelial cells (HDMECs) by treatment with conditioned medium (CM) from tumor cells grown under hypoxic conditions or by adjusting medium pH to 6.4 or 7.0 using lactic acid or hydrochloric acid (HCl). HDMEC resistance to the antiangiogenic drug Sunitinib was assessed with SRB assay. Results: UPR markers, Grp78, ATF4 and CHOP were significantly upregulated in TECs from OSCC compared to HDMECs. HDMECs cultured in acidic CM (pH 6.0-6.4) showed increased expression of the UPR markers. However, severe acidosis led to marked cell death in HDMECs. Alternatively, HDMECs were able to adapt when exposed to chronic acidosis at pH 7.0 for 7 days, with concomittant increase in Grp78 expression. Chronic acidosis also confers drug resistance to HDMECs against Sunitinib. Knockdown of Grp78 using shRNA resensitizes HDMECs to drug treatment. Conclusions: UPR induction in ECs under acidic pH conditions is related to chemoresistance and may contribute to therapeutic failures in response to chemotherapy. Targeting Grp78, the key component of the UPR pathway, may provide a promising approach to overcome ECs resistance in cancer therapy.	[Visioli, Fernanda; Wang, Yugang; Alam, Goleeta N.; Ning, Yu] Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA; [Visioli, Fernanda; Rados, Pantelis V.] Univ Fed Rio Grande do Sul, Sch Dent, Dept Conservat Dent, Porto Alegre, RS, Brazil; [Noer, Jacques E.] Univ Michigan, Sch Dent, Dept Cariol Restorat Sci & Endodont, Ann Arbor, MI 48109 USA; [Polverini, Peter J.] Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Universidade Federal do Rio Grande do Sul; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Visioli, F (corresponding author), Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA.	fernanda.visioli@ufrgs.br	Polverini, Peter/AAJ-8392-2020; Visioli, Fernanda/X-2368-2019; Rados, Pantelis/AAT-7032-2020; Nor, Jacques/AAJ-6139-2021; Rados, Pantelis/AAG-6643-2021; visioli, fernanda/G-4139-2012	Visioli, Fernanda/0000-0002-4033-8431; Nor, Jacques/0000-0002-4056-0235; Rados, Pantelis/0000-0001-9307-1980; visioli, fernanda/0000-0002-4033-8431	CAPES (Brazil); Sharon and Larry Daniels Cancer Biology Fellowship	CAPES (Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Sharon and Larry Daniels Cancer Biology Fellowship	This work was supported by CAPES (Brazil) and by Sharon and Larry Daniels Cancer Biology Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama K, 2005, J CEREBR BLOOD F MET, V25, P358, DOI 10.1038/sj.jcbfm.9600043; Becelli R, 2007, J CRANIOFAC SURG, V18, P1051, DOI 10.1097/scs.0b013e3180de63eb; Bolli R, 2007, AM J PHYSIOL-HEART C, V292, pH19, DOI 10.1152/ajpheart.00712.2006; Brenner JC, 2010, HEAD NECK-J SCI SPEC, V32, P417, DOI 10.1002/hed.21198; Dudley AC, 2009, CLIN CANCER RES, V15, P4787, DOI 10.1158/1078-0432.CCR-09-0902; Gillies RJ, 2002, J MAGN RESON IMAGING, V16, P430, DOI 10.1002/jmri.10181; Healy SJM, 2009, EUR J PHARMACOL, V625, P234, DOI 10.1016/j.ejphar.2009.06.064; Jia LJ, 2009, CANCER RES, V69, P4974, DOI 10.1158/0008-5472.CAN-08-4671; Jiang CC, 2009, CARCINOGENESIS, V30, P197, DOI 10.1093/carcin/bgn220; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kumar S, 2008, J CELL MOL MED, V12, P1584, DOI 10.1111/j.1582-4934.2007.00172.x; Kumar S, 2007, CARDIOVASC RES, V73, P172, DOI 10.1016/j.cardiores.2006.09.018; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee AS, 2007, CANCER RES, V67, P3496, DOI 10.1158/0008-5472.CAN-07-0325; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Misawa K, 2013, TRANSL ONCOL, V6, P338, DOI 10.1593/tlo.13115; Misawa K, 2008, CLIN CANCER RES, V14, P7604, DOI 10.1158/1078-0432.CCR-07-4673; Pamarthy D, 2007, CANCER BIOL THER, V6, P360, DOI 10.4161/cbt.6.3.3703; Pyrko P, 2007, CANCER RES, V67, P9809, DOI 10.1158/0008-5472.CAN-07-0625; Ranganathan AC, 2006, CANCER RES, V66, P1702, DOI 10.1158/0008-5472.CAN-05-3092; Rao RV, 2002, FEBS LETT, V514, P122, DOI 10.1016/S0014-5793(02)02289-5; Reddy RK, 2003, J BIOL CHEM, V278, P20915, DOI 10.1074/jbc.M212328200; Rutkowski DT, 2007, TRENDS BIOCHEM SCI, V32, P469, DOI 10.1016/j.tibs.2007.09.003; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Sauvant C, 2008, INT J CANCER, V123, P2532, DOI 10.1002/ijc.23818; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Singh AK, 2011, CELL MOL LIFE SCI, V68, P1041, DOI 10.1007/s00018-010-0503-7; Suzuki T, 2007, ARCH BIOCHEM BIOPHYS, V468, P1, DOI 10.1016/j.abb.2007.09.004; Thews O, 2006, NEOPLASIA, V8, P143, DOI 10.1593/neo.05697; Virrey JJ, 2008, MOL CANCER RES, V6, P1268, DOI 10.1158/1541-7786.MCR-08-0060; Wang YG, 2012, CANCER RES, V72, P5396, DOI 10.1158/0008-5472.CAN-12-0474; Wolosker H, 1997, BIOCHEM J, V321, P545, DOI 10.1042/bj3210545; Xiong YQ, 2009, CLIN CANCER RES, V15, P4838, DOI 10.1158/1078-0432.CCR-08-2780; Zeitlin BD, 2006, CANCER RES, V66, P8698, DOI 10.1158/0008-5472.CAN-05-3691	35	34	36	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e101053	10.1371/journal.pone.0101053	http://dx.doi.org/10.1371/journal.pone.0101053			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964091	gold, Green Published			2022-12-27	WOS:000338709500114
J	Cohen, A; Sendersky, E; Carmeli, S; Schwarz, R				Cohen, Assaf; Sendersky, Eleonora; Carmeli, Shmuel; Schwarz, Rakefet			Collapsing Aged Culture of the Cyanobacterium Synechococcus elongatus Produces Compound(s) Toxic to Photosynthetic Organisms	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; OXIDATIVE STRESS; NATURAL ALGICIDE; PHOTOSYSTEM-II; PHYTOPLANKTON; COCCOLITHOPHORE; TERRESTRIAL; POPULATION; DYNAMICS; PCC-7942	Phytoplankton mortality allows effective nutrient cycling, and thus plays a pivotal role in driving biogeochemical cycles. A growing body of literature demonstrates the involvement of regulated death programs in the abrupt collapse of phytoplankton populations, and particularly implicates processes that exhibit characteristics of metazoan programmed cell death. Here, we report that the cell-free, extracellular fluid (conditioned medium) of a collapsing aged culture of the cyanobacterium Synechococcus elongatus is toxic to exponentially growing cells of this cyanobacterium, as well as to a large variety of photosynthetic organisms, but not to eubacteria. The toxic effect, which is light-dependent, involves oxidative stress, as suggested by damage alleviation by antioxidants, and the very high sensitivity of a catalase-mutant to the conditioned medium. At relatively high cell densities, S. elongatus cells survived the deleterious effect of conditioned medium in a process that required de novo protein synthesis. Application of conditioned medium from a collapsing culture caused severe pigment bleaching not only in S. elongatus cells, but also resulted in bleaching of pigments in a cell free extract. The latter observation indicates that the elicited damage is a direct effect that does not require an intact cell, and therefore, is mechanistically different from the metazoan-like programmed cell death described for phytoplankton. We suggest that S. elongatus in aged cultures are triggered to produce a toxic compound, and thus, this process may be envisaged as a novel regulated death program.	[Cohen, Assaf; Sendersky, Eleonora; Schwarz, Rakefet] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel; [Carmeli, Shmuel] Tel Aviv Univ, Dept Chem, IL-69978 Tel Aviv, Israel	Bar Ilan University; Tel Aviv University	Schwarz, R (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel.	Rakefet.Schwarz@biu.ac.il	Carmeli, shmuel/N-1273-2018	Carmeli, shmuel/0000-0002-9641-9943	Mina & Everard Goodman Faculty of Life Sciences, Bar-Ilan University	Mina & Everard Goodman Faculty of Life Sciences, Bar-Ilan University	This work was supported by the Mina & Everard Goodman Faculty of Life Sciences, Bar-Ilan University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azam F, 1998, SCIENCE, V280, P694, DOI 10.1126/science.280.5364.694; Balint I, 2006, FEBS LETT, V580, P2117, DOI 10.1016/j.febslet.2006.03.020; Berman-Frank I, 2004, LIMNOL OCEANOGR, V49, P997, DOI 10.4319/lo.2004.49.4.0997; Bidle KD, 2007, P NATL ACAD SCI USA, V104, P6049, DOI 10.1073/pnas.0701240104; Bidle KD, 2004, NAT REV MICROBIOL, V2, P643, DOI 10.1038/nrmicro956; Brussaard CPD, 2004, J EUKARYOT MICROBIOL, V51, P125, DOI 10.1111/j.1550-7408.2004.tb00537.x; Choi CJ, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.21; Engelberg-Kulka H, 2006, PLOS GENET, V2, P1518, DOI 10.1371/journal.pgen.0020135; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Franklin DJ, 2006, EUR J PHYCOL, V41, P1, DOI 10.1080/09670260500505433; Geider RJ, 2001, GLOBAL CHANGE BIOL, V7, P849, DOI 10.1046/j.1365-2486.2001.00448.x; GLEASON FK, 1984, ARCH MICROBIOL, V138, P273, DOI 10.1007/BF00402134; GLEASON FK, 1986, PLANT PHYSIOL, V80, P834, DOI 10.1104/pp.80.4.834; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Jimenez C, 2009, J EXP BOT, V60, P815, DOI 10.1093/jxb/ern330; KALFF J, 1978, ANNU REV ECOL SYST, V9, P475, DOI 10.1146/annurev.es.09.110178.002355; Larom S, 2010, P NATL ACAD SCI USA, V107, P9650, DOI 10.1073/pnas.1000187107; Lewis K, 2000, MICROBIOL MOL BIOL R, V64, P503, DOI 10.1128/MMBR.64.3.503-514.2000; Mayali X, 2004, J EUKARYOT MICROBIOL, V51, P139, DOI 10.1111/j.1550-7408.2004.tb00538.x; Moharikar S, 2006, J PHYCOL, V42, P423, DOI 10.1111/j.1529-8817.2006.00207.x; Murik O, 2009, ENVIRON MICROBIOL, V11, P2301, DOI 10.1111/j.1462-2920.2009.01957.x; Ning SB, 2002, J APPL MICROBIOL, V93, P15, DOI 10.1046/j.1365-2672.2002.01651.x; NIXON PJ, 1991, PLANT CELL, V3, P383, DOI 10.1105/tpc.3.4.383; Paul C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021032; Perelman A, 2003, J BACTERIOL, V185, P3654, DOI 10.1128/JB.185.12.3654-3660.2003; Rice KC, 2008, MICROBIOL MOL BIOL R, V72, P85, DOI 10.1128/MMBR.00030-07; Sakamoto T, 1998, APPL ENVIRON MICROB, V64, P2361; Schatz D, 2013, ENVIRON MICROBIOL, V15, P1786, DOI 10.1111/1462-2920.12070; Schwarz R, 1998, P NATL ACAD SCI USA, V95, P11008, DOI 10.1073/pnas.95.18.11008; Sedmak B, 2008, MICROB ECOL, V56, P201, DOI 10.1007/s00248-007-9336-9; Segovia M, 2003, PLANT PHYSIOL, V132, P99, DOI 10.1104/pp.102.017129; SILVERBERG BA, 1974, NEW PHYTOL, V73, P143, DOI 10.1111/j.1469-8137.1974.tb04615.x; Suginaka K, 1999, BIOSCI BIOTECH BIOCH, V63, P1112, DOI 10.1271/bbb.63.1112; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; Vardi A, 1999, CURR BIOL, V9, P1061, DOI 10.1016/S0960-9822(99)80459-X; Vardi A, 2007, ENVIRON MICROBIOL, V9, P360, DOI 10.1111/j.1462-2920.2006.01146.x; Vardi A, 2012, P NATL ACAD SCI USA, V109, P19327, DOI 10.1073/pnas.1208895109; Vardi A, 2009, SCIENCE, V326, P861, DOI 10.1126/science.1177322; Zito F, 1997, PLANT MOL BIOL, V33, P79, DOI 10.1023/A:1005734809834	39	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100747	10.1371/journal.pone.0100747	http://dx.doi.org/10.1371/journal.pone.0100747			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959874	Green Published, gold, Green Submitted			2022-12-27	WOS:000338633900080
J	Reifenstein, E; Stemmler, M; Herz, AVM; Kempter, R; Schreiber, S				Reifenstein, Eric; Stemmler, Martin; Herz, Andreas V. M.; Kempter, Richard; Schreiber, Susanne			Movement Dependence and Layer Specificity of Entorhinal Phase Precession in Two-Dimensional Environments	PLOS ONE			English	Article							GRID CELLS; SPATIAL REPRESENTATION; STELLATE CELLS; PLACE CELLS; THETA; OSCILLATIONS; POSITION; INTEGRATION; EXPERIENCE; RESONANCE	As a rat moves, grid cells in its entorhinal cortex (EC) discharge at multiple locations of the external world, and the firing fields of each grid cell span a hexagonal lattice. For movements on linear tracks, spikes tend to occur at successively earlier phases of the theta-band filtered local field potential during the traversal of a firing field - a phenomenon termed phase precession. The complex movement patterns observed in two-dimensional (2D) open-field environments may fundamentally alter phase precession. To study this question at the behaviorally relevant single-run level, we analyzed EC spike patterns as a function of the distance traveled by the rat along each trajectory. This analysis revealed that cells across all EC layers fire spikes that phase-precess; indeed, the rate and extent of phase precession were the same, only the correlation between spike phase and path length was weaker in EC layer III. Both slope and correlation of phase precession were surprisingly similar on linear tracks and in 2D open-field environments despite strong differences in the movement statistics, including running speed. While the phase-precession slope did not correlate with the average running speed, it did depend on specific properties of the animal's path. The longer a curving path through a grid-field in a 2D environment, the shallower was the rate of phase precession, while runs that grazed a grid field tangentially led to a steeper phase-precession slope than runs through the field center. Oscillatory interference models for grid cells do not reproduce the observed phenomena.	[Reifenstein, Eric; Kempter, Richard; Schreiber, Susanne] Humboldt Univ, Dept Biol, Inst Theoret Biol, Berlin, Germany; [Reifenstein, Eric; Kempter, Richard; Schreiber, Susanne] Bernstein Ctr Computat Neurosci Berlin, Berlin, Germany; [Stemmler, Martin; Herz, Andreas V. M.] Univ Munich, Dept Biol 2, Planegg Martinsried, Germany; [Stemmler, Martin; Herz, Andreas V. M.] Bernstein Ctr Computat Neurosci Munich, Munich, Germany	Humboldt University of Berlin; University of Munich	Reifenstein, E (corresponding author), Humboldt Univ, Dept Biol, Inst Theoret Biol, Berlin, Germany.	eric.reifenstein@bccn-berlin.de		Reifenstein, Eric/0000-0002-6898-0178	Deutsche Forschungsgemeinschaft [SFB 618 TP B3, GRK 1123]; German Federal Ministry for Education and Research [01GQ0440, 01GQ0901, 01GQ0972, 01GQ1001A]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by the Deutsche Forschungsgemeinschaft Grants SFB 618 TP B3 and GRK 1123, and the German Federal Ministry for Education and Research Grants 01GQ0440, 01GQ0901, 01GQ0972, and 01GQ1001A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONSO A, 1989, NATURE, V342, P175, DOI 10.1038/342175a0; Beed P, 2010, NEURON, V68, P1059, DOI 10.1016/j.neuron.2010.12.009; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; Burgess N, 2008, HIPPOCAMPUS, V18, P1157, DOI 10.1002/hipo.20518; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Canto CB, 2012, HIPPOCAMPUS, V22, P1277, DOI 10.1002/hipo.20993; Chance FS, 2012, J NEUROSCI, V32, P16693, DOI 10.1523/JNEUROSCI.2786-12.2012; Climer JR, 2013, EUR J NEUROSCI, V38, P2526, DOI 10.1111/ejn.12256; Couey JJ, 2013, NAT NEUROSCI, V16, P318, DOI 10.1038/nn.3310; Derdikman D, 2009, NAT NEUROSCI, V12, P1325, DOI 10.1038/nn.2396; Engel TA, 2008, J NEUROPHYSIOL, V100, P1576, DOI 10.1152/jn.01282.2007; Erchova I, 2004, J PHYSIOL-LONDON, V560, P89, DOI 10.1113/jphysiol.2004.069930; Fernandez FR, 2013, J NEUROSCI, V33, P6027, DOI 10.1523/JNEUROSCI.3892-12.2013; Fuhs MC, 2006, J NEUROSCI, V26, P4266, DOI 10.1523/JNEUROSCI.4353-05.2006; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hafting T, 2008, NATURE, V453, P1248, DOI 10.1038/nature06957; Hayman R, 2011, NAT NEUROSCI, V14, P1182, DOI 10.1038/nn.2892; Huxter J, 2003, NATURE, V425, P828, DOI 10.1038/nature02058; Huxter JR, 2008, NAT NEUROSCI, V11, P587, DOI 10.1038/nn.2106; Jaramillo J SR, 2014, J NEUROSCI IN PRESS; Jeewajee A, 2014, PHILOS T ROYAL SOC B, V369; Jensen O, 2000, J NEUROPHYSIOL, V83, P2602, DOI 10.1152/jn.2000.83.5.2602; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; Kayser C, 2009, NEURON, V61, P597, DOI 10.1016/j.neuron.2009.01.008; Kempter R, 2012, J NEUROSCI METH, V207, P113, DOI 10.1016/j.jneumeth.2012.03.007; Klink R, 1997, HIPPOCAMPUS, V7, P571; Langston RF, 2010, SCIENCE, V328, P1576, DOI 10.1126/science.1188210; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Mizuseki K, 2009, NEURON, V64, P267, DOI 10.1016/j.neuron.2009.08.037; Navratilova Z, 2012, HIPPOCAMPUS, V22, P772, DOI 10.1002/hipo.20939; Nitz DA, 2011, J NEUROPHYSIOL, V105, P1815, DOI 10.1152/jn.00573.2010; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Rao JS., 2001, TOPICS CIRCULAR STAT; Reifenstein ET, 2012, P NATL ACAD SCI USA, V109, P6301, DOI 10.1073/pnas.1109599109; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Schmidt R, 2009, J NEUROSCI, V29, P13232, DOI 10.1523/JNEUROSCI.2270-09.2009; Schmidt-Hieber C, 2013, NAT NEUROSCI, V16, P325, DOI 10.1038/nn.3340; Schreiber S, 2004, J NEUROPHYSIOL, V92, P408, DOI 10.1152/jn.01116.2003; Siegel M, 2009, P NATL ACAD SCI USA, V106, P21341, DOI 10.1073/pnas.0908193106; Singer AC, 2010, J NEUROSCI, V30, P11586, DOI 10.1523/JNEUROSCI.0926-10.2010; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Varga C, 2010, NAT NEUROSCI, V13, P822, DOI 10.1038/nn.2570; Zar JH, 1999, BIOSTATISCAL ANAL BI; Zilli EA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000573	46	11	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100638	10.1371/journal.pone.0100638	http://dx.doi.org/10.1371/journal.pone.0100638			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959748	Green Published, gold, Green Submitted			2022-12-27	WOS:000338633900063
J	Kume, S; Araki, S; Ono, N; Shinhara, A; Muramatsu, T; Araki, H; Isshiki, K; Nakamura, K; Miyano, H; Koya, D; Haneda, M; Ugi, S; Kawai, H; Kashiwagi, A; Uzu, T; Maegawa, H				Kume, Shinji; Araki, Shin-ichi; Ono, Nobukazu; Shinhara, Atsuko; Muramatsu, Takahiko; Araki, Hisazumi; Isshiki, Keiji; Nakamura, Kazuki; Miyano, Hiroshi; Koya, Daisuke; Haneda, Masakazu; Ugi, Satoshi; Kawai, Hiromichi; Kashiwagi, Atsunori; Uzu, Takashi; Maegawa, Hiroshi			Predictive Properties of Plasma Amino Acid Profile for Cardiovascular Disease in Patients with Type 2 Diabetes	PLOS ONE			English	Article							METABOLOMIC PROFILES; RENAL-FUNCTION; RISK; MICROALBUMINURIA; ASSOCIATION; REMISSION	Prevention of cardiovascular disease (CVD) is an important therapeutic object of diabetes care. This study assessed whether an index based on plasma free amino acid (PFAA) profiles could predict the onset of CVD in diabetic patients. The baseline concentrations of 31 PFAAs were measured with high-performance liquid chromatography-electrospray ionization-mass spectrometry in 385 Japanese patients with type 2 diabetes registered in 2001 for our prospective observational follow-up study. During 10 years of follow-up, 63 patients developed cardiovascular composite endpoints (myocardial infarction, angina pectoris, worsening of heart failure and stroke). Using the PFAA profiles and clinical information, an index (CVD-AI) consisting of six amino acids to predict the onset of any endpoints was retrospectively constructed. CVD-AI levels were significantly higher in patients who did than did not develop CVD. The area under the receiver-operator characteristic curve of CVD-AI (0.72 [95% confidence interval (CI): 0.64-0.79]) showed equal or slightly better discriminatory capacity than urinary albumin excretion rate (0.69 [95% CI: 0.62-0.77]) on predicting endpoints. A multivariate Cox proportional hazards regression analysis showed that the high level of CVD-AI was identified as an independent risk factor for CVD (adjusted hazard ratio: 2.86 [95% CI: 1.57-5.19]). This predictive effect of CVD-AI was observed even in patients with normoalbuminuria, as well as those with albuminuria. In conclusion, these results suggest that CVD-AI based on PFAA profiles is useful for identifying diabetic patients at risk for CVD regardless of the degree of albuminuria, or for improving the discriminative capability by combining it with albuminuria.	[Kume, Shinji; Araki, Shin-ichi; Araki, Hisazumi; Isshiki, Keiji; Ugi, Satoshi; Kawai, Hiromichi; Kashiwagi, Atsunori; Uzu, Takashi; Maegawa, Hiroshi] Shiga Univ Med Sci, Dept Med, Otsu, Shiga 52021, Japan; [Ono, Nobukazu; Shinhara, Atsuko; Muramatsu, Takahiko; Nakamura, Kazuki; Miyano, Hiroshi] Ajinomoto Co Inc, Inst Innovat, Kawasaki, Kanagawa, Japan; [Koya, Daisuke] Kanazawa Med Univ, Div Diabetol & Endocrinol, Kahoku, Ishikawa 92002, Japan; [Haneda, Masakazu] Asahikawa Med Univ, Dept Med, Div Metab & Biosyst Sci, Asahikawa, Hokkaido, Japan	Shiga University of Medical Science; Ajinomoto Co Inc; Kanazawa Medical University; Asahikawa Medical College	Kume, S (corresponding author), Shiga Univ Med Sci, Dept Med, Otsu, Shiga 52021, Japan.	skume@belle.shiga-med.ac.jp	Kashiwagi, Atsunori/H-8712-2019; Koya, Daisuke/J-3257-2014	Maegawa, Hiroshi/0000-0002-4611-8149	Ajinomoto Co., Inc.; Grants-in-Aid for Scientific Research (KAKENHI) from Japan Society for the Promotion of Science [25713033, 70242980]; Ministry of Health, Labour and Welfare of Japan	Ajinomoto Co., Inc.; Grants-in-Aid for Scientific Research (KAKENHI) from Japan Society for the Promotion of Science; Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was partly funded by Ajinomoto Co., Inc. Some of authors, NO, AS, TM, KN, and H. Miyano, are employees of Ajinomoto, Co., Inc. They contributed to the design of study, analysis of the data and describing the manuscript. However, this does not alter the authors' adherence to all the journal policies on sharing data and materials. This study was also granted by the Grants-in-Aid for Scientific Research (KAKENHI) from Japan Society for the Promotion of Science (No. 25713033 to S. K. and No. 70242980 to DK) and a Grant-in-Aid for Diabetic Nephropathy and Nephrosclerosis Research from Ministry of Health, Labour and Welfare of Japan (SA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Araki S, 2005, DIABETES, V54, P2983, DOI 10.2337/diabetes.54.10.2983; Araki S, 2007, DIABETES, V56, P1727, DOI 10.2337/db06-1646; Araki S, 2013, DIABETES CARE, V36, P1248, DOI 10.2337/dc12-1298; Bain JR, 2009, DIABETES, V58, P2429, DOI 10.2337/db09-0580; Benjamin DI, 2012, CELL METAB, V16, P565, DOI 10.1016/j.cmet.2012.09.013; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Kimura T, 2009, CURR OPIN CLIN NUTR, V12, P49, DOI 10.1097/MCO.0b013e3283169242; Magnusson M, 2013, EUR HEART J, V34, P1982, DOI 10.1093/eurheartj/ehs424; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; McKillop AM, 2011, DIABETES CARE, V34, P2624, DOI 10.2337/dc11-0837; Miyagi Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024143; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Schmieder RE, 2011, J AM SOC NEPHROL, V22, P1353, DOI 10.1681/ASN.2010091001; Seino Y, 2010, J DIABETES INVEST, V1, P212, DOI 10.1111/j.2040-1124.2010.00074.x; Shah SH, 2012, CIRCULATION, V126, P1110, DOI 10.1161/CIRCULATIONAHA.111.060368; Shah SH, 2012, AM HEART J, V163, P844, DOI 10.1016/j.ahj.2012.02.005; Shah SH, 2010, CIRC-CARDIOVASC GENE, V3, P207, DOI 10.1161/CIRCGENETICS.109.852814; Shah SH, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.11; Shimbo K, 2009, ANAL CHEM, V81, P5172, DOI 10.1021/ac900470w; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Yokoyama H, 2012, DIABETOLOGIA, V55, P1911, DOI 10.1007/s00125-012-2536-y; Yokoyama H, 2013, DIABETES CARE, V36, P3227, DOI 10.2337/dc13-0281	23	26	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e101219	10.1371/journal.pone.0101219	http://dx.doi.org/10.1371/journal.pone.0101219			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971671	Green Published, gold, Green Submitted			2022-12-27	WOS:000338512200105
J	Langevin, SA; Bowen, RA; Reisen, WK; Andrade, CC; Ramey, WN; Maharaj, PD; Anishchenko, M; Kenney, JL; Duggal, NK; Romo, H; Bera, AK; Sanders, TA; Bosco-Lauth, A; Smith, JL; Kuhn, R; Brault, AC				Langevin, Stanley A.; Bowen, Richard A.; Reisen, William K.; Andrade, Christy C.; Ramey, Wanichaya N.; Maharaj, Payal D.; Anishchenko, Michael; Kenney, Joan L.; Duggal, Nisha K.; Romo, Hannah; Bera, Aloke Kumar; Sanders, Todd A.; Bosco-Lauth, Angela; Smith, Janet L.; Kuhn, Richard; Brault, Aaron C.			Host Competence and Helicase Activity Differences Exhibited by West Nile Viral Variants Expressing NS3-249 Amino Acid Polymorphisms	PLOS ONE			English	Article							VIRUS LINEAGE 2; PHYLOGENETIC ANALYSIS; MAXIMUM-LIKELIHOOD; AMERICAN CROWS; CENTRAL-EUROPE; NEW-YORK; STRAINS; BIRDS; FLAVIVIRUS; VIRULENCE	A single helicase amino acid substitution, NS3-T249P, has been shown to increase viremia magnitude/mortality in American crows (AMCRs) following West Nile virus (WNV) infection. Lineage/intra-lineage geographic variants exhibit consistent amino acid polymorphisms at this locus; however, the majority of WNV isolates associated with recent outbreaks reported worldwide have a proline at the NS3-249 residue. In order to evaluate the impact of NS3-249 variants on avian and mammalian virulence, multiple amino acid substitutions were engineered into a WNV infectious cDNA (NY99; NS3-249P) and the resulting viruses inoculated into AMCRs, house sparrows (HOSPs) and mice. Differential viremia profiles were observed between mutant viruses in the two bird species; however, the NS3-249P virus produced the highest mean peak viral loads in both avian models. In contrast, this avian modulating virulence determinant had no effect on LD50 or the neurovirulence phenotype in the murine model. Recombinant helicase proteins demonstrated variable helicase and ATPase activities; however, differences did not correlate with avian or murine viremia phenotypes. These in vitro and in vivo data indicate that avian-specific phenotypes are modulated by critical viral-host protein interactions involving the NS3-249 residue that directly influence transmission efficiency and therefore the magnitude of WNV epizootics in nature.	[Langevin, Stanley A.; Reisen, William K.; Andrade, Christy C.; Ramey, Wanichaya N.; Maharaj, Payal D.; Brault, Aaron C.] Univ Calif Davis, Sch Vet Med, Ctr Vectorborne Dis, Davis, CA 95616 USA; [Langevin, Stanley A.; Reisen, William K.; Andrade, Christy C.; Ramey, Wanichaya N.; Maharaj, Payal D.; Brault, Aaron C.] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; [Bowen, Richard A.; Bosco-Lauth, Angela] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA; [Anishchenko, Michael; Kenney, Joan L.; Duggal, Nisha K.; Romo, Hannah; Bosco-Lauth, Angela; Brault, Aaron C.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO USA; [Bera, Aloke Kumar; Kuhn, Richard] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Sanders, Todd A.] US Fish & Wildlife Serv, Portland, OR USA; [Smith, Janet L.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of California System; University of California Davis; University of California System; University of California Davis; Colorado State University; Centers for Disease Control & Prevention - USA; Purdue University System; Purdue University; Purdue University West Lafayette Campus; United States Department of the Interior; US Fish & Wildlife Service; University of Michigan System; University of Michigan	Brault, AC (corresponding author), Univ Calif Davis, Sch Vet Med, Ctr Vectorborne Dis, Davis, CA 95616 USA.	abrault@cdc.gov	Bera, Aloke Kumar/AAD-9541-2022; Kenney, Joan L./AAE-7416-2019; Kuhn, Richard/AAR-2722-2021	Kuhn, Richard/0000-0003-4148-1026; Maharaj, Payal/0000-0002-4157-4479; Kenney, Joanie/0000-0002-6761-4272	NIAID NIH [R01-AI55607, AI061822]; CDC [UO1 CI000235]; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [R01CI000235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061822, R01AI055607] Funding Source: NIH RePORTER	NIAID NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for the described studies were provided by NIAID NIH grants R01-AI55607 and AI061822 and CDC grant UO1 CI000235. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade CC, 2011, J GEN VIROL, V92, P2523, DOI 10.1099/vir.0.032318-0; [Anonymous], VET PATHOL; [Anonymous], 2007, NATURE; [Anonymous], EMBO J; [Anonymous], 1 SEROLOGICAL EVIDEN; [Anonymous], VECTOR BORNE ZOONOTI; Bakonyi T, 2006, EMERG INFECT DIS, V12, P618; Bakonyi T, 2005, EMERG INFECT DIS, V11, P225, DOI 10.3201/eid1102.041028; Barrera R, 2010, J MED ENTOMOL, V47, P1185, DOI 10.1603/ME10038; Beasley DWC, 2002, VIROLOGY, V296, P17, DOI 10.1006/viro.2002.1372; Bera AK, 2007, J BIOL CHEM, V282, P12883, DOI 10.1074/jbc.M611318200; Botha EM, 2008, EMERG INFECT DIS, V14, P222, DOI 10.3201/eid1402.070457; Brault AC, 2007, NAT GENET, V39, P1162, DOI 10.1038/ng2097; Brault AC, 2004, EMERG INFECT DIS, V10, P2161, DOI 10.3201/eid1012.040486; Charrel RN, 2003, VIROLOGY, V315, P381, DOI 10.1016/S0042-6822(03)00536-1; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Davis CT, 2005, VIROLOGY, V342, P252, DOI 10.1016/j.virol.2005.07.022; Deardorff E, 2006, EMERG INFECT DIS, V12, P314, DOI 10.3201/eid1202.050871; Ebel GD, 2004, AM J TROP MED HYG, V71, P493, DOI 10.4269/ajtmh.2004.71.493; Eidson M, 2001, EMERG INFECT DIS, V7, P631, DOI 10.3201/eid0704.010405; Foppa IM, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-43; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Huang CYH, 2000, J VIROL, V74, P3020, DOI 10.1128/JVI.74.7.3020-3028.2000; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jerzak GVS, 2008, VIROLOGY, V374, P256, DOI 10.1016/j.virol.2008.02.032; Khan SA, 2011, EMERG INFECT DIS, V17, P947, DOI 10.3201/eid1705.100479; Kinney R, 2006, J GEN VIROL IN PRESS; Kinney RM, 2006, J GEN VIROL, V87, P3611, DOI 10.1099/vir.0.82299-0; Koo QY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005352; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333; Langevin SA, 2005, AM J TROP MED HYG, V72, P99, DOI 10.4269/ajtmh.2005.72.99; McLean RG, 2001, ANN NY ACAD SCI, V951, P54; Milne I, 2004, BIOINFORMATICS, V20, P1806, DOI 10.1093/bioinformatics/bth155; Misra M, 2007, BIOINFORMATICS, V23, P2645, DOI 10.1093/bioinformatics/btm383; Murata R, 2011, AM J TROP MED HYG, V84, P461, DOI 10.4269/ajtmh.2011.09-0714; Murgue B, 2001, EMERG INFECT DIS, V7, P692; Nemeth NM, 2007, AM J TROP MED HYG, V76, P431, DOI 10.4269/ajtmh.2007.76.431; Papa A, 2011, EMERG INFECT DIS, V17, P920, DOI 10.3201/eid1705.101759; Rossini G, 2011, EMERG INFECT DIS, V17, P903, DOI 10.3201/eid1705.101569; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Steele KE, 2000, VET PATHOL, V37, P208, DOI 10.1354/vp.37-3-208; Van Den Hurk AF, 2010, ANN TROP MED PARASIT, V104, P623, DOI 10.1179/136485910X12851868779984; Venter M, 2010, VECTOR-BORNE ZOONOT, V10, P659, DOI 10.1089/vbz.2009.0230; Wheeler SS, 2009, CONDOR, V111, P1, DOI 10.1525/cond.2009.080013; Wu JH, 2005, J VIROL, V79, P10268, DOI 10.1128/JVI.79.16.10268-10277.2005; Zimmerman E, 2009, HOUSE SPARROW HIST	49	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100802	10.1371/journal.pone.0100802	http://dx.doi.org/10.1371/journal.pone.0100802			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971589	Green Published, Green Submitted, gold			2022-12-27	WOS:000338512200064
J	Heylen, E; Likele, BB; Zeller, M; Stevens, S; De Coster, S; Conceicao-Neto, N; Van Geet, C; Jacobs, J; Ngbonda, D; Van Ranst, M; Matthijnssens, J				Heylen, Elisabeth; Likele, Bibi Batoko; Zeller, Mark; Stevens, Stijn; De Coster, Sarah; Conceicao-Neto, Nadia; Van Geet, Christel; Jacobs, Jan; Ngbonda, Dauly; Van Ranst, Marc; Matthijnssens, Jelle			Rotavirus Surveillance in Kisangani, the Democratic Republic of the Congo, Reveals a High Number of Unusual Genotypes and Gene Segments of Animal Origin in Non-Vaccinated Symptomatic Children	PLOS ONE			English	Article							FULL GENOMIC ANALYSIS; SEQUENCE-INDEPENDENT AMPLIFICATION; INTERSPECIES TRANSMISSION; PROVIDES EVIDENCE; PHYLOGENETIC ANALYSIS; BOVINE ROTAVIRUSES; ACUTE DIARRHEA; VP4 GENOTYPES; STRAINS; PORCINE	Group A rotavirus (RVA) infections form a major public health problem, especially in low-income countries like the Democratic Republic of the Congo (COD). However, limited data on RVA diversity is available from sub-Saharan Africa in general and the COD in particular. Therefore, the first aim of this study was to determine the genetic diversity of 99 RVAs detected during 2007-2010 in Kisangani, COD. The predominant G-type was G1 (39%) and the most predominant P-type was P[6] (53%). A total of eight different G/P-combinations were found: G1P[8] (28%), G8P[6] (26%), G2P[4] (14%), G12P[6] (13%), G1P[6] (11%), G9P[8] (4%), G4P[6] (2%) and G8P[4] (1%). The second aim of this study was to gain insight into the diversity of P[6] RVA strains in the COD. Therefore, we selected five P[6] RVA strains in combination with the G1, G4, G8 (2x) or G12 genotype for complete genome analysis. Complete genome analysis showed that the genetic background of the G1P[6] and G12P[6] strains was entirely composed of genotype 1 (Wa-like), while the segments of the two G8P[6] strains were identified as genotype 2 (DS-1-like). Interestingly, all four strains possessed a NSP4 gene of animal origin. The analyzed G4P[6] RVA strain was found to possess the unusual G4-P[6]-I1-R1-C1-M1-A1-N1-T7-E1-H1 constellation. Although the majority of its genes (if not all), were presumably of porcine origin, this strain was able to cause gastro-enteritis in humans. The high prevalence of unusual RVA strains in the COD highlights the need for continued surveillance of RVA diversity in the COD. These results also underline the importance of complete genetic characterization of RVA strains and indicate that reassortments and interspecies transmission among human and animal RVAs strains occur regularly. Based on these data, RVA vaccines will be challenged with a wide variety of different RVA strain types in the COD.	[Heylen, Elisabeth; Zeller, Mark; Stevens, Stijn; De Coster, Sarah; Conceicao-Neto, Nadia; Van Ranst, Marc; Matthijnssens, Jelle] Univ Leuven, Rega Inst Med Res, Dept Microbiol & Immunol, Lab Clin & Epidemiol Virol, Leuven, Belgium; [Likele, Bibi Batoko; Ngbonda, Dauly] Univ Hosp Kisangani, Dept Pediat, Kisangani, DEM REP CONGO; [Van Geet, Christel] Univ Hosp Leuven, Dept Pediat, Leuven, Belgium; [Jacobs, Jan] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium	KU Leuven; KU Leuven; University Hospital Leuven; Institute of Tropical Medicine (ITM)	Matthijnssens, J (corresponding author), Univ Leuven, Rega Inst Med Res, Dept Microbiol & Immunol, Lab Clin & Epidemiol Virol, Leuven, Belgium.	jelle.matthijnssens@uz.kuleuven.ac.be	Matthijnssens, Jelle/O-7069-2019; Jacobs, Jan/GRX-7316-2022; Matthijnssens, Jelle/B-8634-2016; Matthijnssens, Jelle/A-6770-2015; Conceição-Neto, Nádia/F-9705-2014; Heylen, Elisabeth/AAR-5254-2020; Van Ranst, Marc/P-7522-2017	Matthijnssens, Jelle/0000-0003-1188-9733; Matthijnssens, Jelle/0000-0003-1188-9733; Conceição-Neto, Nádia/0000-0002-9659-6835; Heylen, Elisabeth/0000-0003-4359-7225; Van Ranst, Marc/0000-0002-1674-4157	Flemish Interuniversity Council - University Development Cooperation [ZRRDC2009EI04]; Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT Vlaanderen)	Flemish Interuniversity Council - University Development Cooperation; Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	BBL and the field collections were supported by the Flemish Interuniversity Council - University Development Cooperation - project VLIR-UOS ZRRDC2009EI04. M.Z. was supported by the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT Vlaanderen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkan F, 2010, VET MICROBIOL, V141, P231, DOI 10.1016/j.vetmic.2009.09.016; Aminu M, 2010, J INFECT DIS, V202, pS198, DOI 10.1086/653570; Armah GE, 2010, LANCET, V376, P606, DOI 10.1016/S0140-6736(10)60889-6; Banyai K, 2009, ARCH VIROL, V154, P1823, DOI 10.1007/s00705-009-0499-1; Binka FN, 2003, TROP MED INT HEALTH, V8, P840, DOI 10.1046/j.1365-3156.2003.01097.x; BRIDGER JC, 1975, BRIT VET J, V131, P528, DOI 10.1016/S0007-1935(17)35184-9; Bucardo F, 2012, INFECT GENET EVOL, V12, P1282, DOI 10.1016/j.meegid.2012.03.007; CLARK HF, 1987, J CLIN MICROBIOL, V25, P1757, DOI 10.1128/JCM.25.9.1757-1762.1987; COOK SM, 1990, B WORLD HEALTH ORGAN, V68, P171; Cunliffe NA, 2000, VIROLOGY, V274, P309, DOI 10.1006/viro.2000.0456; Cunliffe NA, 2010, J INFECT DIS, V202, pS168, DOI 10.1086/653577; Degiuseppe JI, 2013, CLIN MICROBIOL INFEC, V19, pE367, DOI 10.1111/1469-0691.12216; Dong HJ, 2013, INFECT GENET EVOL, V20, P155, DOI 10.1016/j.meegid.2013.08.024; Esona MD, 2013, INFECT GENET EVOL, V18, P315, DOI 10.1016/j.meegid.2013.06.005; Esona MD, 2009, J MED VIROL, V81, P937, DOI 10.1002/jmv.21468; Ghosh S, 2011, J MED VIROL, V83, P367, DOI 10.1002/jmv.21974; Gomez MM, 2013, INFECT GENET EVOL, V19, P395, DOI 10.1016/j.meegid.2013.03.028; Heylen E, 2013, INFECT GENET EVOL, V13, P27, DOI 10.1016/j.meegid.2012.08.019; Hu LY, 2012, NATURE, V485, P256, DOI 10.1038/nature10996; Jere KC, 2011, J MED VIROL, V83, P540, DOI 10.1002/jmv.21999; Jere KC, 2012, VET MICROBIOL, V159, P245, DOI 10.1016/j.vetmic.2012.03.040; Jere KC, 2011, INFECT GENET EVOL, V11, P2072, DOI 10.1016/j.meegid.2011.09.023; Jere KC, 2011, J MED VIROL, V83, P2018, DOI 10.1002/jmv.22207; Johns Hopkins Bloomberg School of Public Health International Vaccine Access Center, 2014, VIMS REP GLOB VACC I; Kabue JP, 2010, J INFECT DIS, V202, pS193, DOI 10.1086/653576; Kim HH, 2012, INFECT GENET EVOL, V12, P1427, DOI 10.1016/j.meegid.2012.04.028; Levy K, 2009, INT J EPIDEMIOL, V38, P1487, DOI 10.1093/ije/dyn260; Madhi SA, 2010, NEW ENGL J MED, V362, P289, DOI 10.1056/NEJMoa0904797; Maestri RP, 2012, J MED VIROL, V84, P1993, DOI 10.1002/jmv.23364; Martel-Paradis O, 2013, VET MICROBIOL, V162, P94, DOI 10.1016/j.vetmic.2012.08.028; Martella V, 2006, VIROLOGY, V344, P509, DOI 10.1016/j.virol.2005.08.029; Matthijnssens J, 2006, J VIROL, V80, P3801, DOI 10.1128/JVI.80.8.3801-3810.2006; Matthijnssens J, 2008, J GEN VIROL, V89, P2630, DOI 10.1099/vir.0.2008/003780-0; Matthijnssens J, 2008, J VIROL, V82, P3204, DOI 10.1128/JVI.02257-07; Matthijnssens J, 2006, J CLIN MICROBIOL, V44, P1801, DOI 10.1128/JCM.44.5.1801-1809.2006; Matthijnssens J, 2009, J VIROL, V83, P2917, DOI 10.1128/JVI.02246-08; Midgley SE, 2012, VET MICROBIOL, V156, P238, DOI 10.1016/j.vetmic.2011.10.027; Monini M, 2008, VET MICROBIOL, V129, P384, DOI 10.1016/j.vetmic.2007.11.036; Moon SS, 2013, PEDIAT INFECT DIS J; Mukherjee A, 2011, CLIN MICROBIOL INFEC, V17, P1343, DOI 10.1111/j.1469-0691.2010.03383.x; Nakagomi T, 2013, J GEN VIROL, V94, P1273, DOI 10.1099/vir.0.050625-0; Ndze VN, 2013, J MED VIROL, V85, P1485, DOI 10.1002/jmv.23603; Nielsen NM, 2005, J CLIN VIROL, V34, P13, DOI 10.1016/j.jcv.2004.12.017; Nokes DJ, 2010, J INFECT DIS, V202, pS180, DOI 10.1086/653566; Nordgren J, 2012, INFECT GENET EVOL, V12, P1892, DOI 10.1016/j.meegid.2012.08.014; Nyaga MM, 2013, INFECT GENET EVOL, V16, P62, DOI 10.1016/j.meegid.2013.01.005; Okitsu S, 2013, INFECT GENET EVOL, V18, P74, DOI 10.1016/j.meegid.2013.05.005; Papp H, 2013, INFECT GENET EVOL, V19, P71, DOI 10.1016/j.meegid.2013.06.013; Papp H, 2013, VET MICROBIOL, V165, P190, DOI 10.1016/j.vetmic.2013.03.020; PATH, 2014, ROT VACC ACC DEL COU; Rahman M, 2004, J CLIN MICROBIOL, V42, P1605, DOI 10.1128/JCM.42.4.1605-1608.2004; Rahman M, 2003, J CLIN MICROBIOL, V41, P2088, DOI 10.1128/JCM.41.5.2088-2095.2003; Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434; Seheri M, 2014, PEDIATR INFECT DIS J, V33, pS76, DOI 10.1097/INF.0000000000000053; Serazin Andrew C, 2010, Nat Immunol, V11, P769, DOI 10.1038/ni0910-769; Sow SO, 2012, VACCINE, V30, pA71, DOI 10.1016/j.vaccine.2011.11.094; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664; Wang YH, 2010, J MED VIROL, V82, P1094, DOI 10.1002/jmv.21760; Yassin MA, 2012, PAEDIATR INT CHILD H, V32, P51, DOI 10.1179/1465328111Y.0000000047; Zeller M, 2012, INFECT GENET EVOL, V12, P1492, DOI 10.1016/j.meegid.2012.03.002	62	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100953	10.1371/journal.pone.0100953	http://dx.doi.org/10.1371/journal.pone.0100953			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968018	Green Submitted, gold, Green Published			2022-12-27	WOS:000338280800089
J	Mathur, A; Ware, C; Davis, L; Gazdar, A; Pan, BS; Lutterbach, B				Mathur, Anjili; Ware, Christopher; Davis, Lenora; Gazdar, Adi; Pan, Bo-Sheng; Lutterbach, Bart			FGFR2 Is Amplified in the NCI-H716 Colorectal Cancer Cell Line and Is Required for Growth and Survival	PLOS ONE			English	Article							GENE AMPLIFICATION; LUNG-CANCER; CARCINOMA; MET; RECEPTOR; INHIBITOR; PROTEIN; HER-2; SENSITIVITY; RESISTANCE	Aberrant kinase activation resulting from mutation, amplification, or translocation can drive growth and survival in a subset of human cancer. FGFR2 is amplified in breast and gastric cancer, and we report here the first characterization of FGFR2 gene amplification in colorectal cancer in the NCI-H716 colorectal cancer cell line. FGFR2 is highly expressed and activated in NCI-H716 cells, and FGFR selective small molecule inhibitors or FGFR2 shRNA strongly inhibited cell viability in vitro, indicating "addiction'' of NCI-H716 cells to FGFR2. NCI-H716 growth in a xenograft model was also inhibited by an FGFR small molecule inhibitor. FGFR2 was required for activation of multiple downstream signaling proteins including AKT, ERK, S6RP and NFKB. Inhibition of downstream kinases such as AKT or ERK alone had modest effects on proliferation, whereas combined inhibition of AKT and ERK signaling resulted in a loss of viability similar to FGFR2 inhibition. We identified elevated FGFR2 expression in a small subset of primary colorectal cancer, however FGFR2 amplification was not observed. Although FGFR2 amplification is not common in primary colon cancer or lymph node and liver metastases, other subsets of colorectal cancer such as ascites, from which the NCI-H716 cell line was derived, have yet to be tested. These results suggest that emerging FGFR inhibitor therapeutics may have efficacy in a subset of colon cancer driven by FGFR2 amplification.	[Mathur, Anjili; Ware, Christopher; Davis, Lenora; Pan, Bo-Sheng; Lutterbach, Bart] Merck Res Labs, Boston, MA 02115 USA; [Gazdar, Adi] Univ Texas Southwestern, Hamon Ctr Therapeut Oncol, Dallas, TX USA	Merck & Company; University of Texas System; University of Texas Southwestern Medical Center Dallas	Lutterbach, B (corresponding author), Merck Res Labs, Boston, MA 02115 USA.	lutterba@gmail.com			Merck Research Labs	Merck Research Labs	This work was supported by Merck Research Labs. The funder provided support in the form of salaries for authors (AM, CW, LD, BP, BL), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benedettini E, 2010, AM J PATHOL, V177, P415, DOI 10.2353/ajpath.2010.090863; Dahlberg PS, 2004, ANN THORAC SURG, V78, P1790, DOI 10.1016/j.athoracsur.2004.05.037; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; DEBRUINE AP, 1992, VIRCHOWS ARCH B, V62, P311; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Guagnano V, 2012, CANCER DISCOV, V2, P1118, DOI 10.1158/2159-8290.CD-12-0210; Hattori Y, 1996, CLIN CANCER RES, V2, P1373; ITOH H, 1994, CANCER RES, V54, P3237; Katz JD, 2011, J MED CHEM, V54, P4092, DOI 10.1021/jm200112k; Klokk TI, 2007, MOL CELL BIOL, V27, P1823, DOI 10.1128/MCB.01297-06; Kunii K, 2008, CANCER RES, V68, P2340, DOI 10.1158/0008-5472.CAN-07-5229; Lutterbach B, 2007, CANCER RES, V67, P2081, DOI 10.1158/0008-5472.CAN-06-3495; Moffa AB, 2004, MOL CANCER RES, V2, P643; O'Connell JB, 2004, JNCI-J NATL CANCER I, V96, P1420, DOI 10.1093/jnci/djh275; Ooi A, 2004, MODERN PATHOL, V17, P895, DOI 10.1038/modpathol.3800137; Pan BS, 2010, CANCER RES, V70, P1524, DOI 10.1158/0008-5472.CAN-09-2541; Parada LA, 2002, CURR BIOL, V12, P1692, DOI 10.1016/S0960-9822(02)01166-1; PARK JG, 1987, CANCER RES, V47, P6710; Pavlakis K, 2007, APPL IMMUNOHISTO M M, V15, P441, DOI 10.1097/01.pai.0000213156.94804.b5; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; SEKIGUCHI M, 1978, JPN J EXP MED, V48, P61; Siena S, 2009, JNCI-J NATL CANCER I, V101, P1308, DOI 10.1093/jnci/djp280; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Sorscher SM, 2011, CANCER INVEST, V29, P456, DOI 10.3109/07357907.2011.590569; Tanoue Y, 2009, WORLD J GASTROENTERO, V15, P248, DOI 10.3748/wjg.15.248; Turner N, 2010, ONCOGENE, V29, P2013, DOI 10.1038/onc.2009.489; UNTAWALE S, 1993, CANCER RES, V53, P1630; YOSHIDA T, 1993, SEMIN CANCER BIOL, V4, P33; Zbuk K, 2009, SEMIN ONCOL, V36, P439, DOI 10.1053/j.seminoncol.2009.07.008	31	32	33	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e98515	10.1371/journal.pone.0098515	http://dx.doi.org/10.1371/journal.pone.0098515			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968263	Green Submitted, Green Published, gold			2022-12-27	WOS:000338280800002
J	Stein, AP; Saha, S; Liu, CZ; Hartig, GK; Lambert, PF; Kimple, RJ				Stein, Andrew P.; Saha, Sandeep; Liu, Cheng Z.; Hartig, Gregory K.; Lambert, Paul F.; Kimple, Randall J.			Influence of Handling Conditions on the Establishment and Propagation of Head and Neck Cancer Patient Derived Xenografts	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; HPV-NEGATIVE HEAD; NUDE-MICE; MODELS; GROWTH; LINES; HETEROTRANSPLANTATION; TUMORS; KRAS	Background: Patient derived xenografts (PDXs) for head and neck cancer (HNC) and other cancers represent powerful research platforms. Most groups implant patient tissue into immunodeficient mice immediately although the significance of this time interval is anecdotal. We tested the hypothesis that the time from tumor excision to implantation is crucial for PDX passaging and establishment. Methods: We examined whether time or storage medium affected PDX viability for passaging two established HNC PDXs (UW-SCC34, UW-SCC52). Tumors were harvested, stored in ice-cold media or saline for 0-48 hours, and implanted into new mice. Tumor growth was compared by two-way ANOVA with respect to time and storage condition. Three new HNC PDXs (UW-SCC63-65) were generated by implanting patient tissue into mice immediately (Time 0) and 24 hours after receiving tissue from the operating room. Results: Similar quantities of tumor were implanted into each mouse. At the end of the experiment, no significant difference was seen in mean tumor weight between the media and saline storage conditions for UW-SCC34 or UW-SCC52 (p = 0.650 and p = 0.177, respectively). No difference in tumor formation prevalence was seen on the basis of time from harvest to implantation (>= 13 of 16 tumors grew at every time point). Histological analysis showed strong similarity to the initial tumor across all groups. Tumors developed at both Time 0 and 24 hours for UW-SCC63 and UW-SCC64. Conclusions: We demonstrated that neither storage medium nor time from tumor excision to implantation (up to 48 hours) affected viability or histological differentiation in a subsequent passage for two HNC PDXs. Moreover, we revealed that fresh patient tissue is viable up to 24 hours post-resection. This information is important as it applies to the development and sharing of PDXs.	[Stein, Andrew P.; Kimple, Randall J.] Univ Wisconsin, Dept Human Oncol, Carbone Canc Ctr, Madison, WI 53706 USA; [Saha, Sandeep] Univ Wisconsin, Dept Biostat, Carbone Canc Ctr, Madison, WI USA; [Liu, Cheng Z.] Univ Wisconsin, Dept Pathol, Carbone Canc Ctr, Madison, WI 53706 USA; [Hartig, Gregory K.] Univ Wisconsin, Dept Otolaryngol, Carbone Canc Ctr, Madison, WI USA; [Stein, Andrew P.; Lambert, Paul F.] Univ Wisconsin, McArdle Lab Canc Res, Carbone Canc Ctr, Madison, WI 53706 USA; [Stein, Andrew P.; Lambert, Paul F.] Univ Wisconsin, Dept Oncol, Carbone Canc Ctr, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Kimple, RJ (corresponding author), Univ Wisconsin, Dept Human Oncol, Carbone Canc Ctr, Madison, WI 53706 USA.	rkimple@humonc.wisc.edu	Kimple, Randall/L-6460-2019	Kimple, Randall/0000-0001-8336-8000; Stein, Andrew/0000-0002-2551-1064; Liu, Cheng/0000-0002-2219-1018	UW ICTR-Shapiro fellowship; UWCCC; UWCCC/MIR/WID;  [R00 CA160639]; NATIONAL CANCER INSTITUTE [K99CA160639, R00CA160639, P30CA014520] Funding Source: NIH RePORTER	UW ICTR-Shapiro fellowship; UWCCC; UWCCC/MIR/WID; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by R00 CA160639 (RK), UWCCC and UWCCC/MIR/WID institutional grants (PL), and a UW ICTR-Shapiro fellowship (AS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borrell B, 2010, NATURE, V463, P858, DOI 10.1038/463858a; Boyd MR, 1997, CLIN TRIALS APPROVAL, V20; Brake T, 2005, P NATL ACAD SCI USA, V102, P2490, DOI 10.1073/pnas.0409883102; Chen JC, 1996, ORAL SURG ORAL MED O, V81, P197, DOI 10.1016/S1079-2104(96)80415-X; Choyce A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057798; Collins MA, 2012, J CLIN INVEST, V122, P639, DOI 10.1172/JCI59227; Daniel VC, 2009, CANCER RES, V69, P3364, DOI 10.1158/0008-5472.CAN-08-4210; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; Dong X, 2010, CLIN CANCER RES, V16, P1442, DOI 10.1158/1078-0432.CCR-09-2878; Ertel A, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-55; Garrido-Laguna I, 2011, CLIN CANCER RES, V17, P5793, DOI 10.1158/1078-0432.CCR-11-0341; Gillet JP, 2011, P NATL ACAD SCI USA, V108, P18708, DOI 10.1073/pnas.1111840108; GIOVANELLA BC, 1978, CANCER, V42, P2269, DOI 10.1002/1097-0142(197811)42:5<2269::AID-CNCR2820420527>3.0.CO;2-F; Hidalgo M, 2011, MOL CANCER THER, V10, P1311, DOI 10.1158/1535-7163.MCT-11-0233; Jarzabek MA, 2013, MOL IMAGING, V12, DOI 10.2310/7290.2012.00029; Jimeno A, 2009, MOL CANCER THER, V8, P310, DOI 10.1158/1535-7163.MCT-08-0924; Johnson JI, 2001, BRIT J CANCER, V84, P1424, DOI 10.1054/bjoc.2001.1796; Keysar SB, 2013, MOL ONCOL, V7, P776, DOI 10.1016/j.molonc.2013.03.004; Kimple RJ, 2013, CLIN CANCER RES, V19, P855, DOI 10.1158/1078-0432.CCR-12-2746; Masters JR, 2002, NAT REV CANCER, V2, P315, DOI 10.1038/nrc775; Park JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075056; Qiu CP, 2003, J ORAL MAXIL SURG, V61, P696, DOI 10.1053/joms.2003.50139; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Rubio-Viqueira B, 2006, CLIN CANCER RES, V12, P4652, DOI 10.1158/1078-0432.CCR-06-0113; RYGAARD J, 1969, Acta Pathologica et Microbiologica Scandinavica, V77, P758; Sano D, 2009, HEAD NECK ONCOL, V1, DOI 10.1186/1758-3284-1-32; Sivanand S, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003643; Sorio C, 2001, VIRCHOWS ARCH, V438, P154, DOI 10.1007/s004280000343; Strati K, 2006, P NATL ACAD SCI USA, V103, P14152, DOI 10.1073/pnas.0606698103; Tentler JJ, 2012, NAT REV CLIN ONCOL, V9, P338, DOI 10.1038/nrclinonc.2012.61; Uva P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011742; Wang Huixia, 2006, BMC Genomics, V7, P166; WENNERBERG J, 1983, ACTA OTO-LARYNGOL, V95, P183, DOI 10.3109/00016488309130933; Westphalen CB, 2012, CANCER J, V18, P502, DOI 10.1097/PPO.0b013e31827ab4c4; Xing-Dong Feng, 2007, Genomics Proteomics & Bioinformatics, V5, P15, DOI 10.1016/S1672-0229(07)60010-2; Yoon SS, 2009, INT J RADIAT ONCOL, V74, P1207, DOI 10.1016/j.ijrobp.2009.02.052; ZATTERSTROM UK, 1992, APMIS, V100, P976; Zhou YH, 2010, NAT BIOTECHNOL, V28, P71, DOI 10.1038/nbt.1595	38	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100995	10.1371/journal.pone.0100995	http://dx.doi.org/10.1371/journal.pone.0100995			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967635	Green Submitted, Green Published, gold			2022-12-27	WOS:000338280800095
J	Sun, WM; Xiao, XS; Li, SQ; Guo, XM; Zhang, QJ				Sun, Wenmin; Xiao, Xueshan; Li, Shiqiang; Guo, Xiangming; Zhang, Qingjiong			Exome Sequencing of 18 Chinese Families with Congenital Cataracts: A New Sight of the NHS Gene	PLOS ONE			English	Article							NANCE-HORAN-SYNDROME; CHILDHOOD BLINDNESS; INDIAN FAMILIES; MUTATIONS; CRYSTALLIN; DANISH	Purpose: The aim of this study was to investigate the mutation spectrum and frequency of 34 known genes in 18 Chinese families with congenital cataracts. Methods: Genomic DNA and clinical data was collected from 18 families with congenital cataracts. Variations in 34 cataract-associated genes were screened by whole exome sequencing and then validated by Sanger sequencing. Results: Eleven candidate variants in seven of the 34 genes were detected by exome sequencing and then confirmed by Sanger sequencing, including two variants predicted to be benign and the other pathogenic mutations. The nine mutations were present in 9 of the 18 (50%) families with congenital cataracts. Of the four families with mutations in the X-linked NHS gene, no other abnormalities were recorded except for cataract, in which a pseudo-dominant inheritance form was suggested, as female carriers also had different forms of cataracts. Conclusion: This study expands the mutation spectrum and frequency of genes responsible for congenital cataract. Mutation in NHS is a common cause of nonsyndromic congenital cataract with pseudo-autosomal dominant inheritance. Combined with our previous studies, a genetic basis could be identified in 67.6% of families with congenital cataracts in our case series, in which mutations in genes encoding crystallins, genes encoding connexins, and NHS are responsible for 29.4%, 14.7%, and 11.8% of families, respectively. Our results suggest that mutations in NHS are the common cause of congenital cataract, both syndromic and nonsyndromic.	[Sun, Wenmin; Xiao, Xueshan; Li, Shiqiang; Guo, Xiangming; Zhang, Qingjiong] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Zhang, QJ (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	zhangqji@mail.sysu.edu.cn	Zhang, Qingjiong/AAR-6331-2021	Zhang, Qingjiong/0000-0001-7508-848X	National Natural Science Foundation of China [81170881]; National 973 plan [2010CB529904]; "985 project'' of Sun Yat-sen University; State Key Laboratory of Ophthalmology	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 plan(National Basic Research Program of China); "985 project'' of Sun Yat-sen University; State Key Laboratory of Ophthalmology	Supported by the National Natural Science Foundation of China (81170881), the National 973 plan (2010CB529904), the "985 project'' of Sun Yat-sen University, and the Fundamental Research Funds of the State Key Laboratory of Ophthalmology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Apple DJ, 2000, SURV OPHTHALMOL, V45, pS5; Burdon KP, 2004, BRIT J OPHTHALMOL, V88, P79, DOI 10.1136/bjo.88.1.79; Burdon KP, 2003, AM J HUM GENET, V73, P1120, DOI 10.1086/379381; Coccia M, 2009, HUM MOL GENET, V18, P2643, DOI 10.1093/hmg/ddp206; Dave A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072518; Devi RR, 2008, MOL VIS, V14, P1157; Francis PJ, 2002, J MED GENET, V39, P105, DOI 10.1136/jmg.39.2.105; Gilbert C, 2001, B WORLD HEALTH ORGAN, V79, P227; Haargaard B, 2004, OPHTHALMOLOGY, V111, P2292, DOI 10.1016/j.ophtha.2004.06.024; Hansen L, 2009, INVEST OPHTH VIS SCI, V50, P3291, DOI 10.1167/iovs.08-3149; Hejtmancik JF, 2008, SEMIN CELL DEV BIOL, V19, P134, DOI 10.1016/j.semcdb.2007.10.003; Huang KM, 2007, MOL VIS, V13, P470; Kumar M, 2011, MOL VIS, V17, P693; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Ponnam SPG, 2013, MOL VIS, V19, P1141; RAHI JS, 1995, EYE, V9, P545, DOI 10.1038/eye.1995.137; Ramprasad VL, 2005, INVEST OPHTH VIS SCI, V46, P17, DOI 10.1167/iovs.04-0477; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Shiels A, 2013, CLIN GENET, V84, P120, DOI 10.1111/cge.12182; Shiels A, 2010, MOL VIS, V16, P2007; Sun WM, 2011, MOL VIS, V17, P2197; Sun WM, 2011, MOL VIS, V17, P1508; Tug E, 2013, GENE, V525, P141, DOI 10.1016/j.gene.2013.03.094; Wang KJ, 2011, ARCH OPHTHALMOL-CHIC, V129, P337, DOI 10.1001/archophthalmol.2011.11; Wang Q, 2010, MOL VIS, V16, P303; Xiao Xueshan, 2011, Mol Vis, V17, P2049	27	39	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100455	10.1371/journal.pone.0100455	http://dx.doi.org/10.1371/journal.pone.0100455			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968223	Green Published, Green Submitted, gold			2022-12-27	WOS:000338280800041
J	Buckland, S; Cole, NC; Groombridge, JJ; Kupper, C; Burke, T; Dawson, DA; Gallagher, LE; Harris, S				Buckland, Steeves; Cole, Nik C.; Groombridge, Jim J.; Kuepper, Clemens; Burke, Terry; Dawson, Deborah A.; Gallagher, Laura E.; Harris, Stephen			High Risks of Losing Genetic Diversity in an Endemic Mauritian Gecko: Implications for Conservation	PLOS ONE			English	Article							COMPUTER-PROGRAM; POPULATION-STRUCTURE; INBREEDING DEPRESSION; BAYESIAN-INFERENCE; ASSIGNMENT METHODS; GENOTYPING ERRORS; DNA; MICROSATELLITE; SOFTWARE; TESTS	Genetic structure can be a consequence of recent population fragmentation and isolation, or a remnant of historical localised adaptation. This poses a challenge for conservationists since misinterpreting patterns of genetic structure may lead to inappropriate management. Of 17 species of reptile originally found in Mauritius, only five survive on the main island. One of these, Phelsuma guimbeaui (lowland forest day gecko), is now restricted to 30 small isolated subpopulations following severe forest fragmentation and isolation due to human colonisation. We used 20 microsatellites in ten subpopulations and two mitochondrial DNA (mtDNA) markers in 13 subpopulations to: (i) assess genetic diversity, population structure and genetic differentiation of subpopulations; (ii) estimate effective population sizes and migration rates of subpopulations; and (iii) examine the phylogenetic relationships of haplotypes found in different subpopulations. Microsatellite data revealed significant population structure with high levels of genetic diversity and isolation by distance, substantial genetic differentiation and no migration between most subpopulations. MtDNA, however, showed no evidence of population structure, indicating that there was once a genetically panmictic population. Effective population sizes of ten subpopulations, based on microsatellite markers, were small, ranging from 44 to 167. Simulations suggested that the chance of survival and allelic diversity of some subpopulations will decrease dramatically over the next 50 years if no migration occurs. Our DNA-based evidence reveals an urgent need for a management plan for the conservation of P. guimbeaui. We identified 18 threatened and 12 viable subpopulations and discuss a range of management options that include translocation of threatened subpopulations to retain maximum allelic diversity, and habitat restoration and assisted migration to decrease genetic erosion and inbreeding for the viable subpopulations.	[Buckland, Steeves; Cole, Nik C.; Harris, Stephen] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Buckland, Steeves; Kuepper, Clemens; Burke, Terry; Dawson, Deborah A.] Univ Sheffield, Dept Anim & Plant Sci, NERC Biomol Anal Facil, Sheffield S10 2TN, S Yorkshire, England; [Buckland, Steeves; Gallagher, Laura E.] Natl Pk & Conservat Serv, Reduit, Mauritius; [Cole, Nik C.] Durrell Wildlife Conservat Trust, Jersey, England; [Cole, Nik C.] Mauritian Wildlife Fdn, Vacoas, Mauritius; [Groombridge, Jim J.] Univ Kent, Sch Anthropol & Conservat, Durrell Inst Conservat & Ecol, Canterbury CT2 7NZ, Kent, England	University of Bristol; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); University of Sheffield; University of Kent	Buckland, S (corresponding author), Univ Bristol, Sch Biol Sci, Bristol, Avon, England.	steeves.buckland@bristol.ac.uk	Burke, Terry/B-3196-2011; Küpper, Clemens/D-8116-2011	Burke, Terry/0000-0003-3848-1244; Küpper, Clemens/0000-0002-1507-8033	Natural Environment Research Council (NERC); University of Bristol; Rufford Small Grant; Interessengruppe Phelsuma sponsor; NERC [NBAF010001] Funding Source: UKRI; Natural Environment Research Council [NBAF010001] Funding Source: researchfish	Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); University of Bristol; Rufford Small Grant; Interessengruppe Phelsuma sponsor; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by the Natural Environment Research Council (NERC). SB was supported by the University of Bristol, a Rufford Small Grant and Interessengruppe Phelsuma sponsors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EC, 2008, MOL ECOL RESOUR, V8, P1219, DOI 10.1111/j.1755-0998.2008.02355.x; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Arnold E.N., 2000, BONN ZOOL MONOGR, V46, P309; Austin JJ, 2004, MOL PHYLOGENET EVOL, V31, P109, DOI 10.1016/j.ympev.2003.07.011; Balmer O, 2011, J HERED, V102, P29, DOI 10.1093/jhered/esq096; Beerli P, 2006, BIOINFORMATICS, V22, P341, DOI 10.1093/bioinformatics/bti803; Bijlsma R, 2000, J EVOLUTION BIOL, V13, P502, DOI 10.1046/j.1420-9101.2000.00177.x; Brunner PC, 1998, MOL ECOL, V7, P209, DOI 10.1046/j.1365-294x.1998.00341.x; Buckland S, 2013, CONSERV GENET RESOUR, V5, P1013, DOI 10.1007/s12686-013-9957-x; Busch JD, 2007, MOL ECOL, V16, P2450, DOI 10.1111/j.1365-294X.2007.03283.x; Cheke A., 2008, LOST LAND DODO ECOLO; Chen C, 2007, MOL ECOL NOTES, V7, P747, DOI 10.1111/j.1471-8286.2007.01769.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cornuet JM, 1996, GENETICS, V144, P2001; Da Silva A, 2006, CONSERV GENET, V7, P371, DOI 10.1007/s10592-005-9048-y; Dixo M, 2009, BIOL CONSERV, V142, P1560, DOI 10.1016/j.biocon.2008.11.016; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Falush D, 2003, GENETICS, V164, P1567; Frankham R., 2010, INTRO CONSERVATION G, DOI DOI 10.1017/CBO9780511809002; Franklin IR, 1998, ANIM CONSERV, V1, P69, DOI 10.1111/j.1469-1795.1998.tb00228.x; Fu YX, 1997, GENETICS, V147, P915; Gardner MG, 2000, J EVOLUTION BIOL, V13, P551; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; Hoffman JI, 2005, MOL ECOL, V14, P599, DOI 10.1111/j.1365-294X.2004.02419.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Janecka JE, 2008, CONSERV GENET, V9, P869, DOI 10.1007/s10592-007-9412-1; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kalinowski ST, 2006, MOL ECOL NOTES, V6, P576, DOI 10.1111/j.1471-8286.2006.01256.x; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Kenta T, 2008, MOL ECOL RESOUR, V8, P1230, DOI 10.1111/j.1755-0998.2008.02190.x; Kupper C, 2012, MOL ECOL, V21, P5864, DOI 10.1111/mec.12064; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Landguth EL, 2010, MOL ECOL, V19, P4179, DOI 10.1111/j.1365-294X.2010.04808.x; Levy E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046351; Liberg O, 2005, BIOL LETT-UK, V1, P17, DOI 10.1098/rsbl.2004.0266; Manel S, 2005, TRENDS ECOL EVOL, V20, P136, DOI 10.1016/j.tree.2004.12.004; Meirmans PG, 2012, MOL ECOL, V21, P2839, DOI 10.1111/j.1365-294X.2012.05578.x; Nei M., 1987, MOL EVOLUTIONARY GEN; Nicholls JA, 2000, J AVIAN BIOL, V31, P165, DOI 10.1034/j.1600-048X.2000.310208.x; NyHagen DF, 2001, J TROP ECOL, V17, P755, DOI 10.1017/S0266467401001560; Ovenden JR, 2007, MOL ECOL, V16, P127, DOI 10.1111/j.1365-294X.2006.03132.x; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Page W, 1997, VEGETATION SUR UNPUB; Palsboll PJ, 2013, MOL ECOL, V22, P22, DOI 10.1111/mec.12094; Palstra FP, 2012, ECOL EVOL, V2, P2357, DOI 10.1002/ece3.329; Park SDE, 2002, THESIS U DUBLIN; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Peery MZ, 2012, MOL ECOL, V21, P3403, DOI 10.1111/j.1365-294X.2012.05635.x; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard JK., 2010, DOCUMENTATION STRUCT; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rocha S, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-3; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Rozen S, 2000, Methods Mol Biol, V132, P365; Safford RJ, 1997, BIOL CONSERV, V80, P181, DOI 10.1016/S0006-3207(96)00048-1; Schtickzelle N, 2006, ECOLOGY, V87, P1057, DOI 10.1890/0012-9658(2006)87[1057:DDWHFI]2.0.CO;2; Seddon PJ, 2010, RESTOR ECOL, V18, P796, DOI 10.1111/j.1526-100X.2010.00724.x; Slate J, 2000, P ROY SOC B-BIOL SCI, V267, P1657, DOI 10.1098/rspb.2000.1192; SLATKIN M, 1991, GENETICS, V129, P555; TAJIMA F, 1989, GENETICS, V123, P585; Ujvari B, 2002, BIOL CONSERV, V105, P127, DOI 10.1016/S0006-3207(01)00176-8; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vaughan RE, 1937, J ECOL, V25, P289, DOI 10.2307/2256197; Verhoeven KJF, 2005, OIKOS, V108, P643, DOI 10.1111/j.0030-1299.2005.13727.x; Wang JP, 2004, MOL PHYLOGENET EVOL, V31, P1143, DOI 10.1016/j.ympev.2003.10.001; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Weiser EL, 2012, MOL ECOL RESOUR, V12, P1161, DOI 10.1111/j.1755-0998.2012.03176.x; Wilson GA, 2003, GENETICS, V163, P1177; Wright S, 1943, GENETICS, V28, P114; Wright S., 1969, THEORY GENE FREQUENC, V2, P520	80	3	3	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e93387	10.1371/journal.pone.0093387	http://dx.doi.org/10.1371/journal.pone.0093387			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963708	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000338709500002
J	Eriksen, KT; Halkjaer, J; Sorensen, M; Meliker, JR; McElroy, JA; Tjonneland, A; Raaschou-Nielsen, O				Eriksen, Kirsten T.; Halkjaer, Jytte; Sorensen, Mette; Meliker, Jaymie R.; McElroy, Jane A.; Tjonneland, Anne; Raaschou-Nielsen, Ole			Dietary Cadmium Intake and Risk of Breast, Endometrial and Ovarian Cancer in Danish Postmenopausal Women: A Prospective Cohort Study	PLOS ONE			English	Article							EXPOSURE; ESTROGEN; ACTIVATION; HEALTH; ALPHA; CELL	Purpose: Cadmium is a human lung carcinogen and possesses estrogen-like activity. This combination of carcinogenic and estrogenic activity makes cadmium a contaminant of high concern for hormone-related cancers. Diet and smoking are the main sources of cadmium exposure. The aim of this study was to investigate the association between dietary cadmium intake and risk of breast, endometrial and ovarian cancer in Danish postmenopausal woman. Methods: We estimated dietary cadmium intake in the Diet, Cancer and Health cohort at enrolment 1993-97. The estimates were based on food frequency questionnaires and cadmium contents in all foods. Among 23,815 postmenopausal women we identified 1390 breast, 192 endometrial, and 146 ovarian cancer cases from enrolment through December 31, 2010 using the Danish Cancer Registry. Cox regression was used to analyse the association between dietary cadmium intake and cancer risk. Results: Mean dietary cadmium intake was 14 mu g/day. Cadmium was not associated with breast cancer, incidence rate ratio (IRR) = 0.99, 95% confidence interval (CI): 0.87-1.13 per 10 mu g higher dietary cadmium intake/day; endometrial cancer, IRR = 1.08, 95% CI: 0.76-1.53; or ovarian cancer, IRR = 1.15, 95% CI: 0.78-1.70. We found a positive association between cadmium and endometrial cancer for the women with BMI<25 (IRR = 1.50, 95% CI: 0.94-2.39), whereas an inverse association was seen for the women with BMI >= 25 (IRR = 0.69, 95% CI: 0.42-1.12); p value for interaction = 0.02. Conclusions: Our study does not indicate that our estimated dietary cadmium intake is associated with hormone-related cancers in women.	[Eriksen, Kirsten T.; Halkjaer, Jytte; Sorensen, Mette; Tjonneland, Anne; Raaschou-Nielsen, Ole] Danish Canc Soc, Res Ctr, Copenhagen, Denmark; [Meliker, Jaymie R.] SUNY Stony Brook, Dept Prevent Med, Stony Brook, NY 11794 USA; [Meliker, Jaymie R.] SUNY Stony Brook, Grad Program Publ Hlth, Stony Brook, NY 11794 USA; [McElroy, Jane A.] Univ Missouri, Columbia, MT USA	Danish Cancer Society; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Missouri System; University of Missouri Columbia	Eriksen, KT (corresponding author), Danish Canc Soc, Res Ctr, Copenhagen, Denmark.	kirsthor@cancer.dk	Raaschou-Nielsen, Ole/GOK-0338-2022	Raaschou-Nielsen, Ole/0000-0002-1223-0909; McElroy, Jane/0000-0001-7518-747X; Tjonneland, Anne/0000-0003-4385-2097; Meliker, Jaymie/0000-0002-6408-8596; Sorensen, Mette/0000-0002-7302-4789	National Institutes of Health (NIH) [R01ES019209]; Danish Cancer Society [R20A93010S2]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019209] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish Cancer Society(Danish Cancer Society); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by research grants from the National Institutes of Health (NIH) (grant no.: R01ES019209) and from the Danish Cancer Society (grant no: R20A93010S2). The funders had no role in the design of the study, data collection, interpretation of results, or writing of the manuscript.	Abshire MK, 1996, J TOXICOL ENV HEALTH, V48, P359, DOI 10.1080/009841096161258; Adams SV, 2012, CANCER CAUSE CONTROL, V23, P845, DOI 10.1007/s10552-012-9953-6; Akesson A, 2008, CANCER RES, V68, P6435, DOI 10.1158/0008-5472.CAN-08-0329; Althuis MD, 2004, CANCER EPIDEM BIOMAR, V13, P1558; Barlow WE, 1999, J CLIN EPIDEMIOL, V52, P1165, DOI 10.1016/S0895-4356(99)00102-X; BARON JA, 1990, AM J OBSTET GYNECOL, V162, P502, DOI 10.1016/0002-9378(90)90420-C; Brama M, 2007, MOL CELL ENDOCRINOL, V264, P102, DOI 10.1016/j.mce.2006.10.013; Coyle YM, 2004, BREAST CANCER RES TR, V84, P273, DOI 10.1023/B:BREA.0000019964.33963.09; FISCHERMAN K, 1988, ACTA ONCOL, V27, P593, DOI 10.3109/02841868809091756; FLANAGAN PR, 1978, GASTROENTEROLOGY, V74, P841; Gallagher CM, 2010, AGING-US, V2, P804, DOI 10.18632/aging.100226; GARCIAMORALES P, 1994, J BIOL CHEM, V269, P16896; International Agency for Research on Cancer, IARC MONOGRAPHS EVAL; Itoh H, 2014, INT J HYG ENVIR HEAL, V217, P70, DOI 10.1016/j.ijheh.2013.03.010; Jarup L, 2009, TOXICOL APPL PHARM, V238, P201, DOI 10.1016/j.taap.2009.04.020; Jarup Lars, 1998, Scandinavian Journal of Work Environment and Health, V24, P1; Johnson MD, 2003, NAT MED, V9, P1081, DOI 10.1038/nm902; Joseph P, 2009, TOXICOL APPL PHARM, V238, P272, DOI 10.1016/j.taap.2009.01.011; Julin B, 2011, BRIT J CANCER, V105, P441, DOI 10.1038/bjc.2011.238; Julin B, 2012, CANCER RES, V72, P1459, DOI 10.1158/0008-5472.CAN-11-0735; KAJI T, 1992, TOXICOLOGY, V76, P257, DOI 10.1016/0300-483X(92)90194-J; Larsen EH, 2002, FOOD ADDIT CONTAM, V19, P33, DOI 10.1080/02652030110087447; Lauritsen J., 1998, FOODCALC 1 3; Liu ZW, 2008, TOXICOL APPL PHARM, V228, P286, DOI 10.1016/j.taap.2007.12.017; MADIGAN MP, 1995, J NATL CANCER I, V87, P1681, DOI 10.1093/jnci/87.22.1681; Martinez-Campa C, 2006, J PINEAL RES, V40, P291, DOI 10.1111/j.1600-079X.2006.00315.x; McElroy JA, 2006, JNCI-J NATL CANCER I, V98, P869, DOI 10.1093/jnci/djj233; Sartor F, 1992, IARC Sci Publ, P101; Sawada N, 2012, EPIDEMIOLOGY, V23, P368, DOI 10.1097/EDE.0b013e31824d063c; Schottenfeld D, 2006, CANC EPIDEMIOLOGY PR; Stoica A, 2000, MOL ENDOCRINOL, V14, P545, DOI 10.1210/me.14.4.545; Strumylaite L, 2010, MEDICINA-LITHUANIA, V46, P867, DOI 10.3390/medicina46120121; Tjonneland A, 2007, SCAND J PUBLIC HEALT, V35, P432, DOI 10.1080/14034940601047986; van Wijngaarden E, 2008, PROSTATE, V68, P122, DOI 10.1002/pros.20668; Waalkes MP, 2003, MUTAT RES-FUND MOL M, V533, P107, DOI 10.1016/j.mrfmmm.2003.07.011; Wilson VS, 2004, TOXICOL SCI, V81, P69, DOI 10.1093/toxsci/kfh180; Yu XY, 2010, TOXICOL APPL PHARM, V245, P83, DOI 10.1016/j.taap.2010.02.005	37	43	45	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100815	10.1371/journal.pone.0100815	http://dx.doi.org/10.1371/journal.pone.0100815			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963789	gold, Green Published, Green Submitted			2022-12-27	WOS:000338709500084
J	Papuchon, J; Pinson, P; Guidicelli, GL; Bellecave, P; Thomas, R; LeBlanc, R; Reigadas, S; Taupin, JL; Baril, JG; Routy, JP; Wainberg, M; Fleury, H				Papuchon, Jennifer; Pinson, Patricia; Guidicelli, Gwenda-Line; Bellecave, Pantxika; Thomas, Rejean; LeBlanc, Roger; Reigadas, Sandrine; Taupin, Jean-Luc; Baril, Jean Guy; Routy, Jean Pierre; Wainberg, Mark; Fleury, Herve		Provir Latitude 45 Study Grp	Kinetics of HIV-1 CTL Epitopes Recognized by HLA I Alleles in HIV-Infected Individuals at Times near Primary Infection: The Provir/Latitude45 Study	PLOS ONE			English	Article							T-CELL RESPONSES; ANTIRETROVIRAL THERAPY; IMMUNE-RESPONSES; VACCINE; RESERVOIR; ADAPTATION; LEVEL; AIDS; CURE	In patients responding successfully to ART, the next therapeutic step is viral cure. An interesting strategy is antiviral vaccination, particularly involving CD8 T cell epitopes. However, attempts at vaccination are dependent on the immunogenetic background of individuals. The Provir/Latitude 45 project aims to investigate which CTL epitopes in proviral HIV-1 will be recognized by the immune system when HLA alleles are taken into consideration. A prior study (Papuchon et al, PLoS ONE 2013) showed that chronically-infected patients under successful ART exhibited variations of proviral CTL epitopes compared to a reference viral strain (HXB2) and that a generic vaccine may not be efficient. Here, we investigated viral and/or proviral CTL epitopes at different time points in recently infected individuals of the Canadian primary HIV infection cohort and assessed the affinity of these epitopes for HLA alleles during the study period. An analysis of the results confirms that it is not possible to fully predict which epitopes will be recognized by the HLA alleles of the patients if the reference sequences and epitopes are taken as the basis of simulation. Epitopes may be seen to vary in circulating RNA and proviral DNA. Despite this confirmation, the overall variability of the epitopes was low in these patients who are temporally close to primary infection.	[Papuchon, Jennifer; Pinson, Patricia; Guidicelli, Gwenda-Line; Bellecave, Pantxika; Reigadas, Sandrine; Taupin, Jean-Luc; Fleury, Herve] Univ Hosp Bordeaux, Bordeaux, France; [Papuchon, Jennifer; Pinson, Patricia; Bellecave, Pantxika; Reigadas, Sandrine; Fleury, Herve] CNRS, UMR 5234, Bordeaux, France; [Guidicelli, Gwenda-Line; Taupin, Jean-Luc] CNRS, UMR 5164, Bordeaux, France; [Thomas, Rejean] Clin Med Actuel, Montreal, PQ, Canada; [LeBlanc, Roger] Clin Med Opus, Montreal, PQ, Canada; [Baril, Jean Guy] Clin Med Quartier Latin, Montreal, PQ, Canada; [Routy, Jean Pierre] McGill Univ, Ctr Hlth, Montreal, PQ, Canada; [Wainberg, Mark] McGill AIDS Ctr, Montreal, PQ, Canada	CHU Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; McGill University; McGill University	Fleury, H (corresponding author), Univ Hosp Bordeaux, Bordeaux, France.	herve.fleury@viro.u-bordeaux2.fr			Merck company	Merck company(Merck & Company)	This study has been funded by Merck company. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackard JT, 2012, CURR HIV RES, V10, P133, DOI 10.2174/157016212799937245; Brumme ZL, 2012, CURR OPIN VIROL, V2, P599, DOI 10.1016/j.coviro.2012.08.003; Cale EM, 2011, J VIROL, V85, P3746, DOI 10.1128/JVI.02420-10; Carlson JM, 2012, J VIROL, V86, P5230, DOI 10.1128/JVI.06728-11; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Chun TW, 2010, AIDS, V24, P2803, DOI 10.1097/QAD.0b013e328340a239; Chun TW, 2005, J CLIN INVEST, V115, P3250, DOI 10.1172/JCI26197; Deeks SG, 2012, NAT REV IMMUNOL, V12, P607, DOI 10.1038/nri3262; Eriksson S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003174; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Kawashima Y, 2009, NATURE, V458, P641, DOI 10.1038/nature07746; Launay O, 2013, VACCINE, V31, P4406, DOI 10.1016/j.vaccine.2013.06.102; Liu Y, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0015639, 10.1371/journal.pone.0022241]; McMichael AJ, 2001, NATURE, V410, P980, DOI 10.1038/35073658; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; Mothe B, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-208; Mudd PA, 2012, NATURE, V491, P129, DOI 10.1038/nature11443; Palmer S, 2008, P NATL ACAD SCI USA, V105, P3879, DOI 10.1073/pnas.0800050105; Papuchon J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069029; Pollard RB, 2014, LANCET INFECT DIS, V14, P291, DOI 10.1016/S1473-3099(13)70343-8; Sriwanthana B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041696	21	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100452	10.1371/journal.pone.0100452	http://dx.doi.org/10.1371/journal.pone.0100452			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964202	gold, Green Submitted, Green Published			2022-12-27	WOS:000338709500053
J	Stone, B; Vargo, J; Liu, P; Habeeb, D; DeLucia, A; Trail, M; Hu, YT; Russell, A				Stone, Brian, Jr.; Vargo, Jason; Liu, Peng; Habeeb, Dana; DeLucia, Anthony; Trail, Marcus; Hu, Yongtao; Russell, Armistead			Avoided Heat-Related Mortality through Climate Adaptation Strategies in Three US Cities	PLOS ONE			English	Article							UNITED-STATES; URBAN; TEMPERATURE; WEATHER; CALIFORNIA; IMPACTS; ISLAND; MODEL	Heat-related mortality in US cities is expected to more than double by the mid-to-late 21st century. Rising heat exposure in cities is projected to result from: 1) climate forcings from changing global atmospheric composition; and 2) local land surface characteristics responsible for the urban heat island effect. The extent to which heat management strategies designed to lessen the urban heat island effect could offset future heat-related mortality remains unexplored in the literature. Using coupled global and regional climate models with a human health effects model, we estimate changes in the number of heat-related deaths in 2050 resulting from modifications to vegetative cover and surface albedo across three climatically and demographically diverse US metropolitan areas: Atlanta, Georgia, Philadelphia, Pennsylvania, and Phoenix, Arizona. Employing separate health impact functions for average warm season and heat wave conditions in 2050, we find combinations of vegetation and albedo enhancement to offset projected increases in heat-related mortality by 40 to 99% across the three metropolitan regions. These results demonstrate the potential for extensive land surface changes in cities to provide adaptive benefits to urban populations at risk for rising heat exposure with climate change.	[Stone, Brian, Jr.; Habeeb, Dana] Georgia Inst Technol, Sch City & Reg Planning, Atlanta, GA 30332 USA; [Vargo, Jason] Univ Wisconsin, Ctr Sustainabil & Global Environm, Madison, WI USA; [Liu, Peng; Trail, Marcus; Hu, Yongtao; Russell, Armistead] Georgia Inst Technol, Sch Civil & Environm Engn, Atlanta, GA 30332 USA; [DeLucia, Anthony] E Tennessee State Univ, Quillen Coll Med, Johnson City, TN 37614 USA	University System of Georgia; Georgia Institute of Technology; University of Wisconsin System; University of Wisconsin Madison; University System of Georgia; Georgia Institute of Technology; East Tennessee State University	Stone, B (corresponding author), Georgia Inst Technol, Sch City & Reg Planning, Atlanta, GA 30332 USA.	stone@gatech.edu	Hu, Yongtao/H-7543-2016	Hu, Yongtao/0000-0002-5161-0592	US Centers for Disease Control and Prevention (CDC) [5U01EH000432-02]; NATIONAL CENTER FOR ENVIRONMENTAL HEALTH [U01EH000432] Funding Source: NIH RePORTER	US Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR ENVIRONMENTAL HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This research was made possible by a grant from the US Centers for Disease Control and Prevention (CDC) through project #5U01EH000432-02. Although the research described in the article has been funded wholly or in part by the CDC, it has not been subjected to any CDC review and therefore does not necessarily reflect the views of the Center, and no official endorsement should be inferred. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert D, 2012, ATLANTIC CITIES 0505; Anderson GB, 2011, ENVIRON HEALTH PERSP, V119, P210, DOI 10.1289/ehp.1002313; Convertino M, 2013, SCI REP-UK, V3, DOI 10.1038/srep02922; Fry J, 2009, 1379 US GEOL SURV, V1379; Hajat S, 2002, J EPIDEMIOL COMMUN H, V56, P367, DOI 10.1136/jech.56.5.367; Hajat S, 2006, EPIDEMIOLOGY, V17, P632, DOI 10.1097/01.ede.0000239688.70829.63; Hart M, 2009, THEOR APPL CLIMATOL, V95, P397, DOI 10.1007/s00704-008-0017-5; Hayhoe K, 2004, P NATL ACAD SCI USA, V101, P12422, DOI 10.1073/pnas.0404500101; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; KALKSTEIN LS, 1989, ANN ASSOC AM GEOGR, V79, P44, DOI 10.1111/j.1467-8306.1989.tb00249.x; Knowlton K, 2007, AM J PUBLIC HEALTH, V97, P2028, DOI 10.2105/AJPH.2006.102947; Liu P, 2012, ATMOS CHEM PHYS, V12, P3601, DOI 10.5194/acp-12-3601-2012; Lynn BH, 2010, CLIMATIC CHANGE, V99, P567, DOI 10.1007/s10584-009-9729-5; McCarthy MP, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042845; Medina-Ramon M, 2007, OCCUP ENVIRON MED, V64, P827, DOI 10.1136/oem.2007.033175; Oke T.R., 1987, BOUNDARY LAYER CLIMA, DOI DOI 10.4324/9780203407219; Peng RD, 2011, ENVIRON HEALTH PERSP, V119, P701, DOI 10.1289/ehp.1002430; Racherla PN, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD018091; Schmidt GA, 2006, J CLIMATE, V19, P153, DOI 10.1175/JCLI3612.1; Sheridan SC, 2012, CLIMATIC CHANGE, V115, P291, DOI 10.1007/s10584-012-0436-2; Skamarock WC, 2008, J COMPUT PHYS, V227, P3465, DOI 10.1016/j.jcp.2007.01.037; Spronken-Smith RA, 1998, INT J REMOTE SENS, V19, P2085, DOI 10.1080/014311698214884; Stone B, 2007, INT J CLIMATOL, V27, P1801, DOI 10.1002/joc.1555; TAHA H, 1991, THEOR APPL CLIMATOL, V44, P123, DOI 10.1007/BF00867999; Trail M, 2013, GEOSCI MODEL DEV, V6, P1429, DOI 10.5194/gmd-6-1429-2013; Vargo J, 2013, J ENVIRON MANAGE, V114, P243, DOI 10.1016/j.jenvman.2012.10.007; Voorhees AS, 2011, ENVIRON SCI TECHNOL, V45, P1450, DOI 10.1021/es102820y; Zanobetti A, 2008, EPIDEMIOLOGY, V19, P563, DOI 10.1097/EDE.0b013e31816d652d; Zhou LM, 2004, P NATL ACAD SCI USA, V101, P9540, DOI 10.1073/pnas.0400357101; Zhou Y, 2010, NAT HAZARDS, V52, P639, DOI 10.1007/s11069-009-9406-z	30	96	97	7	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100852	10.1371/journal.pone.0100852	http://dx.doi.org/10.1371/journal.pone.0100852			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964213	Green Published, gold			2022-12-27	WOS:000338709500089
J	Stratoulias, V; Heino, TI; Michon, F				Stratoulias, Vassilis; Heino, Tapio I.; Michon, Frederic			Lin-28 Regulates Oogenesis and Muscle Formation in Drosophila melanogaster	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; LET-7 MICRORNA; RNA; EXPRESSION; DIFFERENTIATION; PROTEIN; LIN28; TRANSCRIPTOME; TRANSLATION; ACTIVATION	Understanding the control of stem cell (SC) differentiation is important to comprehend developmental processes as well as to develop clinical applications. Lin28 is a conserved molecule that is involved in SC maintenance and differentiation by regulating let-7 miRNA maturation. However, little is known about the in vivo function of Lin28. Here, we report critical roles for lin-28 during oogenesis. We found that let-7 maturation was increased in lin-28 null mutant fly ovaries. We showed that lin-28 null mutant female flies displayed reduced fecundity, due to defects in egg chamber formation. More specifically, we demonstrated that in mutant ovaries, the egg chambers fuse during early oogenesis resulting in abnormal late egg chambers. We also showed that this phenotype is the combined result of impaired germline SC differentiation and follicle SC differentiation. We suggest a model in which these multiple oogenesis defects result from a misregulation of the ecdysone signaling network, through the fine-tuning of Abrupt and Fasciclin2 expression. Our results give a better understanding of the evolutionarily conserved role of lin-28 on GSC maintenance and differentiation.	[Stratoulias, Vassilis; Heino, Tapio I.] Univ Helsinki, Dept Biosci, Helsinki, Finland; [Michon, Frederic] Univ Helsinki, Inst Biotechnol, Dev Biol Program, Helsinki, Finland	University of Helsinki; University of Helsinki	Heino, TI (corresponding author), Univ Helsinki, Dept Biosci, Helsinki, Finland.	Tapio.Heino@helsinki.fi; Frederic.Michon@helsinki.fi	Stratoulias, Vassilis/P-6724-2018; Stratoulias, Vassilis/M-7074-2019; MICHON, Frédéric/ABH-6712-2020	Stratoulias, Vassilis/0000-0002-9724-6589; Stratoulias, Vassilis/0000-0002-9724-6589; Michon, Frederic/0000-0003-4305-305X	Finnish Cultural Foundation; University of Helsinki Funds; Academy of Finland	Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); University of Helsinki Funds; Academy of Finland(Academy of Finland)	This work was supported by the Finnish Cultural Foundation (V.S., www. skr.fi/en), University of Helsinki Funds (T.H.), and the Academy of Finland (F.M., www.aka.fi/en-GB/A/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HW, 2010, MOL HUM REPROD, V16, P463, DOI 10.1093/molehr/gaq017; AMBROS V, 1984, SCIENCE, V226, P409, DOI 10.1126/science.6494891; Bhartiya D, 2012, J OVARIAN RES, V5, DOI 10.1186/1757-2215-5-32; Caygill EE, 2008, CURR BIOL, V18, P943, DOI 10.1016/j.cub.2008.06.020; Chawla G, 2012, DEVELOPMENT, V139, P1788, DOI 10.1242/dev.077743; Childs AJ, 2012, STEM CELLS DEV, V21, P2343, DOI 10.1089/scd.2011.0730; Coulom H, 2004, J NEUROSCI, V24, P10993, DOI 10.1523/JNEUROSCI.2993-04.2004; deCuevas M, 1996, DEVELOPMENT, V122, P3959; Djagaeva I, 2005, DEV BIOL, V284, P143, DOI 10.1016/j.ydbio.2005.05.012; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Foley K, 1998, DEVELOPMENT, V125, P1075; Hopf C, 2011, DEV GENES EVOL, V221, P209, DOI 10.1007/s00427-011-0373-5; Jang ACC, 2009, NAT CELL BIOL, V11, P569, DOI 10.1038/ncb1863; Jin JY, 2011, NUCLEIC ACIDS RES, V39, P3724, DOI 10.1093/nar/gkq1350; Konig A, 2011, EMBO J, V30, P1549, DOI 10.1038/emboj.2011.73; Kucherenko MM, 2012, EMBO J, V31, P4511, DOI 10.1038/emboj.2012.298; LANTZ V, 1994, GENE DEV, V8, P598, DOI 10.1101/gad.8.5.598; Li J, 2010, P NATL ACAD SCI USA, V107, P10280, DOI 10.1073/pnas.1001198107; Li X, 2012, CELL DEATH DIFFER, V19, P378, DOI 10.1038/cdd.2011.127; Li Y, 2012, DEVELOPMENT, V139, P1547, DOI 10.1242/dev.077412; Loughlin FE, 2012, NAT STRUCT MOL BIOL, V19, P84, DOI 10.1038/nsmb.2202; Michon F, 2010, DEV BIOL, V340, P355, DOI 10.1016/j.ydbio.2010.01.019; Nam Y, 2011, CELL, V147, P1080, DOI 10.1016/j.cell.2011.10.020; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; O'Reilly AM, 2006, DEVELOPMENT, V133, P2627, DOI 10.1242/dev.02423; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039; Polesskaya A, 2007, GENE DEV, V21, P1125, DOI 10.1101/gad.415007; Pritchett TL, 2009, APOPTOSIS, V14, P969, DOI 10.1007/s10495-009-0369-z; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Richards M, 2004, STEM CELLS, V22, P51, DOI 10.1634/stemcells.22-1-51; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Rybak A, 2009, NAT CELL BIOL, V11, P1411, DOI 10.1038/ncb1987; Sato K, 2011, GENE DEV, V25, P2361, DOI 10.1101/gad.174110.111; SCHWARTZ MB, 1989, INSECT BIOCHEM, V19, P243, DOI 10.1016/0020-1790(89)90068-1; Sempere LF, 2002, DEV BIOL, V244, P170, DOI 10.1006/dbio.2002.0594; Sokol NS, 2008, GENE DEV, V22, P1591, DOI 10.1101/gad.1671708; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Szafranski P, 2004, DEVELOPMENT, V131, P2023, DOI 10.1242/dev.01097; Virant-Klun I, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/381928; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; West JA, 2009, NATURE, V460, P909, DOI 10.1038/nature08210; WHITE RAH, 1984, J EMBRYOL EXP MORPH, V84, P275; White YAR, 2012, NAT MED, V18, P413, DOI 10.1038/nm.2669; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; Wong LC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024355; Wulczyn FG, 2007, FASEB J, V21, P415, DOI 10.1096/fj.06-6130com; Yang DH, 2003, GENE EXPR PATTERNS, V3, P719, DOI 10.1016/S1567-133X(03)00140-6; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhong XM, 2010, J BIOL CHEM, V285, P41961, DOI 10.1074/jbc.M110.169607	51	17	18	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e101141	10.1371/journal.pone.0101141	http://dx.doi.org/10.1371/journal.pone.0101141			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963666	gold, Green Published, Green Submitted			2022-12-27	WOS:000338709500118
J	Goodman, CA; Bennie, JA; Leikis, MJ; McKenna, MJ				Goodman, Craig A.; Bennie, Jason A.; Leikis, Murray J.; McKenna, Michael J.			Unaccustomed Eccentric Contractions Impair Plasma K+ Regulation in the Absence of Changes in Muscle Na+, K+- ATPase Content	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; MESSENGER-RNA EXPRESSION; POTASSIUM KINETICS; INTENSE EXERCISE; NA+,K+-ATPASE ACTIVITY; MOUSE MUSCLE; FATIGUE; HUMANS; DAMAGE; ACTIVATION	The Na+, K+-ATPase (NKA) plays a fundamental role in the regulation of skeletal muscle membrane Na+ and K+ gradients, excitability and fatigue during repeated intense contractions. Many studies have investigated the effects of acute concentric exercise on K+ regulation and skeletal muscle NKA, but almost nothing is known about the effects of repeated eccentric contractions. We therefore investigated the effects of unaccustomed maximal eccentric knee extensor contractions on K+ regulation during exercise, peak knee extensor muscle torque, and vastus lateralis muscle NKA content and 3-O-MFPase activity. Torque measurements, muscle biopsies, and venous blood samples were taken before, during and up to 7 days following the contractions in six healthy adults. Eccentric contractions reduced peak isometric muscle torque immediately post-exercise by 26 +/- 11% and serum creatine kinase concentration peaked 24 h post-exercise at 339 +/- 90 IU/L. During eccentric contractions, plasma [K+] rose during Set 1 and remained elevated at similar to 4.9 mM during sets 4-10; this was despite a decline in work output by Set 4, which fell by 18.9% at set 10. The rise in plasma [K+].work(-1) ratio was elevated over Set 2 from Set 4- Set 10. Eccentric contractions had no effect on muscle NKA content or maximal in-vitro 3-O-MFPase activity immediately post- or up to 7 d post-exercise. The sustained elevation in plasma [K+] despite a decrease in work performed by the knee extensor muscles suggests an impairment in K+ regulation during maximal eccentric contractions, possibly due to increased plasma membrane permeability or to excitation-contraction uncoupling.	[Goodman, Craig A.; Bennie, Jason A.; Leikis, Murray J.; McKenna, Michael J.] Victoria Univ, Muscle Ions & Exercise Grp, Inst Sport Exercise & Act Living, Melbourne, Vic 8001, Australia; [Goodman, Craig A.] Univ Wisconsin, Sch Vet Med, Dept Comparat Biosci, Madison, WI 53706 USA; [Leikis, Murray J.] Univ Melbourne, Royal Melbourne Hosp, Dept Nephrol, Dept Med, Melbourne, Vic 3050, Australia	Victoria University; University of Wisconsin System; University of Wisconsin Madison; Royal Melbourne Hospital; University of Melbourne	McKenna, MJ (corresponding author), Victoria Univ, Muscle Ions & Exercise Grp, Inst Sport Exercise & Act Living, Melbourne, Vic 8001, Australia.	michael.mckenna@vu.edu.au	Goodman, Craig/H-8085-2019; McKenna, Michael/AAH-3697-2021; Bennie, Jason/AAY-2915-2020	Goodman, Craig/0000-0002-5874-7743; Bennie, Jason/0000-0002-8668-8998; McKenna, Michael/0000-0001-9998-0093				ASP S, 1995, J APPL PHYSIOL, V79, P1338, DOI 10.1152/jappl.1995.79.4.1338; ASP S, 1995, J PHYSIOL-LONDON, V482, P705, DOI 10.1113/jphysiol.1995.sp020553; Beaton LJ, 2002, J PHYSIOL-LONDON, V544, P849, DOI 10.1113/jphysiol.2002.022350; Benziane B, 2012, J BIOL CHEM, V287, P23451, DOI 10.1074/jbc.M111.331926; Bloch RJ, 2002, CLIN ORTHOP RELAT R, pS203, DOI 10.1097/01.blo.0000031982.92980.da; BONDEPETERSEN F, 1972, J APPL PHYSIOL, V33, P792, DOI 10.1152/jappl.1972.33.6.792; Cairns SP, 2008, J PHYSIOL-LONDON, V586, P4039, DOI 10.1113/jphysiol.2008.155424; Chen ZP, 2003, DIABETES, V52, P2205, DOI 10.2337/diabetes.52.9.2205; Clarkson PM, 2002, AM J PHYS MED REHAB, V81, pS52, DOI [10.1097/00002060-200211001-00007, 10.1097/01.PHM.0000029772.45258.43]; Clarkson PM, 1999, CAN J APPL PHYSIOL, V24, P234, DOI 10.1139/h99-020; Clausen T, 2008, ACTA PHYSIOL, V192, P339, DOI 10.1111/j.1748-1716.2007.01798.x; Clausen T, 2003, PHYSIOL REV, V83, P1269, DOI 10.1152/physrev.00011.2003; Enoka RM, 1996, J APPL PHYSIOL, V81, P2339, DOI 10.1152/jappl.1996.81.6.2339; Fraser SF, 2002, J APPL PHYSIOL, V93, P1650, DOI 10.1152/japplphysiol.01247.2001; Fraser SF, 1998, ANAL BIOCHEM, V258, P63, DOI 10.1006/abio.1998.2572; Green HJ, 2001, MUSCLE NERVE, V24, P69, DOI 10.1002/1097-4598(200101)24:1<69::AID-MUS8>3.0.CO;2-O; Hargreaves M, 1998, J APPL PHYSIOL, V84, P1687, DOI 10.1152/jappl.1998.84.5.1687; Ingalls CP, 1998, J APPL PHYSIOL, V85, P58, DOI 10.1152/jappl.1998.85.1.58; Ingwersen MS, 2011, J MEMBRANE BIOL, V242, P1, DOI 10.1007/s00232-011-9365-7; Juel C, 2000, AM J PHYSIOL-REG I, V278, pR400, DOI 10.1152/ajpregu.2000.278.2.R400; Juel C, 2013, AM J PHYSIOL-REG I, V304, pR1161, DOI 10.1152/ajpregu.00591.2012; Lovering RM, 2004, AM J PHYSIOL-CELL PH, V286, pC230, DOI 10.1152/ajpcell.00199.2003; MacIntyre DL, 2001, EUR J APPL PHYSIOL, V84, P180, DOI 10.1007/s004210170002; McKenna MJ, 2008, J APPL PHYSIOL, V104, P288, DOI 10.1152/japplphysiol.01037.2007; McKenna MJ, 2006, J PHYSIOL-LONDON, V576, P279, DOI 10.1113/jphysiol.2006.115352; McKenna MJ, 2003, J PHYSIOL-LONDON, V547, P567, DOI 10.1113/jphysiol.2003.034512; MCKENNA MJ, 1993, J APPL PHYSIOL, V75, P173, DOI 10.1152/jappl.1993.75.1.173; McKenna MJ, 1997, J PHYSIOL-LONDON, V501, P687, DOI 10.1111/j.1469-7793.1997.687bm.x; MEDBO JI, 1990, J PHYSIOL-LONDON, V421, P105, DOI 10.1113/jphysiol.1990.sp017935; Mohr M, 2004, PFLUG ARCH EUR J PHY, V448, P452, DOI 10.1007/s00424-004-1257-6; Murphy KT, 2007, ACTA PHYSIOL, V189, P259, DOI 10.1111/j.1748-1716.2006.01635.x; Murphy RM, 2007, J APPL PHYSIOL, V103, P926, DOI 10.1152/japplphysiol.01422.2006; Nielsen JS, 2007, ACTA PHYSIOL, V191, P217, DOI 10.1111/j.1748-1716.2007.01732.x; Nielsen JJ, 2004, J PHYSIOL-LONDON, V554, P857, DOI 10.1113/jphysiol.2003.050658; Nordsborg N, 2005, J PHYSIOL-LONDON, V567, P583, DOI 10.1113/jphysiol.2005.087031; Nordsborg N, 2003, AM J PHYSIOL-REG I, V285, pR143, DOI 10.1152/ajpregu.00029.2003; NORGAARD A, 1984, SCAND J CLIN LAB INV, V44, P509, DOI 10.3109/00365518409083604; NORGAARD A, 1986, ACTA PHARMACOL TOX, V58, P1; Pedersen TH, 2004, SCIENCE, V305, P1144, DOI 10.1126/science.1101141; Petersen AC, 2005, AM J PHYSIOL-REG I, V289, pR266, DOI 10.1152/ajpregu.00378.2004; Pilegaard H, 1998, AM J PHYSIOL-ENDOC M, V274, pE554, DOI 10.1152/ajpendo.1998.274.3.E554; Ryschon TW, 1997, J APPL PHYSIOL, V83, P867, DOI 10.1152/jappl.1997.83.3.867; Sejersted OM, 2000, PHYSIOL REV, V80, P1411, DOI 10.1152/physrev.2000.80.4.1411; Street D, 2005, J PHYSIOL-LONDON, V566, P481, DOI 10.1113/jphysiol.2005.086801; Takekura H, 2001, J PHYSIOL-LONDON, V533, P571, DOI 10.1111/j.1469-7793.2001.0571a.x; VOLLESTAD NK, 1994, J PHYSIOL-LONDON, V475, P359, DOI 10.1113/jphysiol.1994.sp020077; Warren G L, 2001, Exerc Sport Sci Rev, V29, P82; Warren GL, 1999, J PHYSIOL-LONDON, V515, P609, DOI 10.1111/j.1469-7793.1999.609ac.x; Williams MW, 2001, J CELL SCI, V114, P751; Yeung EW, 2002, J PHYSIOL-LONDON, V540, P581, DOI 10.1113/jphysiol.2001.013839; Zheng D, 2008, AM J PHYSIOL-CELL PH, V294, pC126, DOI 10.1152/ajpcell.00464.2007	51	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e101039	10.1371/journal.pone.0101039	http://dx.doi.org/10.1371/journal.pone.0101039			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959836	Green Accepted, gold, Green Published			2022-12-27	WOS:000338633900112
J	Li, MV; Shukla, D; Rhodes, BH; Lall, A; Shu, JM; Moriarity, BS; Largaespada, DA				Li, Ming V.; Shukla, Dip; Rhodes, Brian H.; Lall, Anjali; Shu, Jingmin; Moriarity, Branden S.; Largaespada, David A.			HomeRun Vector Assembly System: A Flexible and Standardized Cloning System for Assembly of Multi-Modular DNA Constructs	PLOS ONE			English	Article							IN-VITRO; HOMING ENDONUCLEASES; RECOMBINATION; EXPRESSION; CRE; EFFICIENCY; EXCHANGE	Advances in molecular and synthetic biology call for efficient assembly of multi-modular DNA constructs. We hereby present a novel modular cloning method that obviates the need for restriction endonucleases and significantly improves the efficiency in the design and construction of complex DNA molecules by standardizing all DNA elements and cloning reactions. Our system, named HomeRun Vector Assembly System (HVAS), employs a three-tiered vector series that utilizes both multisite gateway cloning and homing endonucleases, with the former building individual functional modules and the latter linking modules into the final construct. As a proof-of-principle, we first built a two-module construct that supported doxycycline-induced expression of green fluorescent protein (GFP). Further, with a three-module construct we showed quantitatively that there was minimal promoter leakage between neighbouring modules. Finally, we developed a method, in vitro Cre recombinase-mediated cassette exchange (RMCE) cloning, to regenerate a gateway destination vector from a previous multisite gateway cloning reaction, allowing access to existing DNA element libraries in conventional gateway entry clones, and simple creation of constructs ready for in vivo RMCE. We believe these methods constitute a useful addition to the standard molecular cloning techniques that could potentially support industrial scale synthesis of DNA constructs.	[Li, Ming V.; Shu, Jingmin] Univ Minnesota, Dept Med, Div Endocrinol & Diabet, Minneapolis, MN 55455 USA; [Shukla, Dip; Lall, Anjali; Shu, Jingmin; Moriarity, Branden S.; Largaespada, David A.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Rhodes, Brian H.] Univ Minnesota, Dept Agron & Plant Genet, St Paul, MN USA; [Shu, Jingmin; Moriarity, Branden S.; Largaespada, David A.] Univ Minnesota, Ctr Genome Engn, Minneapolis, MN 55455 USA; [Shu, Jingmin; Moriarity, Branden S.; Largaespada, David A.] Univ Minnesota, Inst Human Genet, Minneapolis, MN 55455 USA; [Shu, Jingmin; Moriarity, Branden S.; Largaespada, David A.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Li, MV (corresponding author), Univ Minnesota, Dept Med, Div Endocrinol & Diabet, Box 736 UMHC, Minneapolis, MN 55455 USA.	lixx1138@umn.edu		Shukla, Dip/0000-0002-1636-7830	National Institutes of Health [5 T32 DK007203-35]; Margaret Harvey Schering Land Grant Chair in Cancer Genetics; National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007203] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Margaret Harvey Schering Land Grant Chair in Cancer Genetics; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health T32 training grant [5 T32 DK007203-35 to MVL and JS] and Margaret Harvey Schering Land Grant Chair in Cancer Genetics [to DAL]. Funding for open access charge: National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azaro MA, 1997, EMBO J, V16, P3744, DOI 10.1093/emboj/16.12.3744; Bechtel S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-399; Belfort M, 1997, NUCLEIC ACIDS RES, V25, P3379, DOI 10.1093/nar/25.17.3379; Burgess-Beusse B, 2002, P NATL ACAD SCI USA, V99, P16433, DOI 10.1073/pnas.162342499; BUSHMAN W, 1985, SCIENCE, V230, P906, DOI 10.1126/science.2932798; Casini A, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt915; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Feng YQ, 1999, J MOL BIOL, V292, P779, DOI 10.1006/jmbi.1999.3113; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Guye P, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt605; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; Heinz N, 2011, HUM GENE THER, V22, P166, DOI 10.1089/hum.2010.099; Knight T., 2003, IDEMPOTENT VECTOR DE; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Li MA, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr764; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marcaida MJ, 2010, CELL MOL LIFE SCI, V67, P727, DOI 10.1007/s00018-009-0188-y; Moriarity BS, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt115; Petersen LK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024531; Quan JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006441; Sarrion-Perdigones A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021622; Sasaki Y, 2004, J BIOTECHNOL, V107, P233, DOI 10.1016/j.jbiotec.2003.10.001; Sauer B, 2004, NUCLEIC ACIDS RES, V32, P6086, DOI 10.1093/nar/gkh941; SCHLAKE T, 1994, BIOCHEMISTRY-US, V33, P12746, DOI 10.1021/bi00209a003; Slusarczyk AL, 2012, NAT REV GENET, V13, P406, DOI 10.1038/nrg3227; Takata Y, 2011, GENES CELLS, V16, P765, DOI 10.1111/j.1365-2443.2011.01526.x; Temple G, 2009, GENOME RES, V19, P2324, DOI 10.1101/gr.095976.109; Yahata K, 2007, J MOL BIOL, V374, P580, DOI 10.1016/j.jmb.2007.09.054; Zeevi V, 2012, PLANT PHYSIOL, V158, P132, DOI 10.1104/pp.111.184374; Zhang YW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1288	34	9	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100948	10.1371/journal.pone.0100948	http://dx.doi.org/10.1371/journal.pone.0100948			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959875	Green Published, gold, Green Submitted			2022-12-27	WOS:000338633900105
J	Song, S; Hwang, S; Lee, S; Ha, NC; Lee, K				Song, Saemee; Hwang, Soonhye; Lee, Seunghwa; Ha, Nam-Chul; Lee, Kangseok			Interaction Mediated by the Putative Tip Regions of MdsA and MdsC in the Formation of a Salmonella-Specific Tripartite Efflux Pump	PLOS ONE			English	Article							ALPHA-BARREL TIP; MULTIDRUG EFFLUX; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; PERIPLASMIC COMPONENT; TOLC HOMOLOGS; PROTEIN; TRANSPORTER; ACRAB; RESISTANCE	To survive in the presence of a wide range of toxic compounds, gram-negative bacteria expel such compounds via tripartite efflux pumps that span both the inner and outer membranes. The Salmonella-specific MdsAB pump consists of MdsB, a resistance-nodulation-division (RND)-type inner membrane transporter (IMT) that requires the membrane fusion protein (MFP) MdsA, and an outer membrane protein (OMP; MdsC or TolC) to form a tripartite efflux complex. In this study, we investigated the role of the putative tip regions of MdsA and its OMPs, MdsC and TolC, in the formation of a functional MdsAB-mediated efflux pump. Comparative analysis indicated that although sequence homologies of MdsA and MdsC with other MFPs and OMPs, respectively, are extremely low, key residues in the putative tip regions of these proteins are well conserved. Mutagenesis studies on these conserved sites demonstrated their importance for the physical and functional interactions required to form an MdsAB-mediated pump. Our studies suggest that, despite differences in the primary amino acid sequences and functions of various OMPs and MFPs, interactions mediated by the conserved tip regions of OMP and MFP are required for the formation of functional tripartite efflux pumps in gram-negative bacteria.	[Song, Saemee; Hwang, Soonhye; Lee, Seunghwa; Lee, Kangseok] Chung Ang Univ, Dept Life Sci, Seoul 156756, South Korea; [Ha, Nam-Chul] Seoul Natl Univ, Res Inst Agr & Life Sci, Dept Agr Biotechnol, Dept Food & Anim Biotechnol, Seoul, South Korea	Chung Ang University; Seoul National University (SNU)	Ha, NC (corresponding author), Seoul Natl Univ, Res Inst Agr & Life Sci, Dept Agr Biotechnol, Dept Food & Anim Biotechnol, Seoul, South Korea.	hanc210@snu.ac.kr; kangseok@cau.ac.kr			Next-Generation BioGreen 21 Program (SSAC) [PJ009025]; Rural Development Administration; Korean Healthcare Technology R&D Project, Korean Ministry of Health and Welfare, Republic of Korea [H12C0947]	Next-Generation BioGreen 21 Program (SSAC)(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration(Rural Development Administration (RDA), Republic of Korea); Korean Healthcare Technology R&D Project, Korean Ministry of Health and Welfare, Republic of Korea	This work was supported by the Next-Generation BioGreen 21 Program (SSAC, Grant no. PJ009025), Rural Development Administration and a grant from the Korean Healthcare Technology R&D Project, Korean Ministry of Health and Welfare (Grant no. H12C0947), Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akama H, 2004, J BIOL CHEM, V279, P25939, DOI 10.1074/jbc.C400164200; Bavro VN, 2008, MOL CELL, V30, P114, DOI 10.1016/j.molcel.2008.02.015; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DuPont HL, 2007, CLIN INFECT DIS, V45, P1353, DOI 10.1086/522662; FIELDS PI, 1986, P NATL ACAD SCI USA, V83, P5189, DOI 10.1073/pnas.83.14.5189; Fralick JA, 1996, J BACTERIOL, V178, P5803, DOI 10.1128/jb.178.19.5803-5805.1996; Higgins MK, 2004, P NATL ACAD SCI USA, V101, P9994, DOI 10.1073/pnas.0400375101; Kim HM, 2010, J BACTERIOL, V192, P4498, DOI 10.1128/JB.00334-10; Koronakis V, 2004, ANNU REV BIOCHEM, V73, P467, DOI 10.1146/annurev.biochem.73.011303.074104; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Lee M, 2013, J MICROBIOL, V51, P154, DOI 10.1007/s12275-013-2699-3; Lee M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040460; Lee S, 2014, J MICROBIOL, V52, P148, DOI 10.1007/s12275-014-3578-2; Mikolosko J, 2006, STRUCTURE, V14, P577, DOI 10.1016/j.str.2005.11.015; Misra R, 2009, BBA-PROTEINS PROTEOM, V1794, P817, DOI 10.1016/j.bbapap.2009.02.017; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Nikaido H, 1999, CURR OPIN INFECT DIS, V12, P529, DOI 10.1097/00001432-199912000-00001; Nikaido H, 2001, J MOL MICROB BIOTECH, V3, P215; Nishino K, 2001, J BACTERIOL, V183, P5803, DOI 10.1128/JB.183.20.5803-5812.2001; Nishino K, 2006, MOL MICROBIOL, V59, P126, DOI 10.1111/j.1365-2958.2005.04940.x; Nishino K, 2003, ANTIMICROB AGENTS CH, V47, P3030, DOI 10.1128/AAC.47.9.3030-3033.2003; Pei XY, 2011, P NATL ACAD SCI USA, V108, P2112, DOI 10.1073/pnas.1012588108; Reffay M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005035; Su CC, 2011, NATURE, V470, P558, DOI 10.1038/nature09743; Symmons MF, 2009, P NATL ACAD SCI USA, V106, P7173, DOI 10.1073/pnas.0900693106; Thanabalu T, 1998, EMBO J, V17, P6487, DOI 10.1093/emboj/17.22.6487; Weeks JW, 2014, MOL MICROBIOL, V91, P965, DOI 10.1111/mmi.12508; Weybridge UK, 2003, REP SALM POULTR, P83; Xu Y, 2012, J BIOL CHEM, V287, P11240; Xu Y, 2011, J BIOL CHEM, V286, P17910, DOI 10.1074/jbc.M111.238535; Xu Y, 2011, J BIOL CHEM, V286, P13541, DOI 10.1074/jbc.M110.202598; Xu YB, 2010, BIOCHEM BIOPH RES CO, V394, P962, DOI 10.1016/j.bbrc.2010.03.097; Yeom JH, 2006, BIOCHEM BIOPH RES CO, V345, P1372, DOI 10.1016/j.bbrc.2006.05.018; Yum SW, 2009, J MOL BIOL, V387, P1286, DOI 10.1016/j.jmb.2009.02.048; Zgurskaya HI, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00189	36	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100881	10.1371/journal.pone.0100881	http://dx.doi.org/10.1371/journal.pone.0100881			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24960027	Green Submitted, Green Published, gold			2022-12-27	WOS:000338633900099
J	Nakamura, T; Sakata, Y; Otsuka-Kanazawa, S; Ichii, O; Chihara, M; Nagasaki, K; Namiki, Y; Kon, Y				Nakamura, Teppei; Sakata, Yuko; Otsuka-Kanazawa, Saori; Ichii, Osamu; Chihara, Masataka; Nagasaki, Ken-ichi; Namiki, Yuka; Kon, Yasuhiro			Genomic Analysis of the Appearance of Ovarian Mast Cells in Neonatal MRL/MpJ Mice	PLOS ONE			English	Article							CCL17; DIFFERENTIATION; SPERMATOCYTES; REGENERATION; RESISTANCE; MIGRATION; TISSUE	In MRL/MpJ mice, ovarian mast cells (OMCs) are more abundant than in other mouse strains, and tend to distribute beneath the ovarian surface epithelium at birth. This study investigated the factors regulating the appearance of neonatal OMCs in progeny of the cross between MRL/MpJ and C57BL/6N strains. F1 neonates had less than half the number of OMCs than MRL/MpJ. Interestingly, MRLB6F1 had more neonatal OMCs than B6MRLF1, although they were distributed over comparable areas. Furthermore, in MRL/MpJ fetuses for which parturition was delayed until embryonic day 21.5, the number of OMCs was significantly higher than in age-matched controls at postnatal day 2. These results suggest that the number of OMCs was influenced by the environmental factors during pregnancy. Quantitative trait locus analysis using N2 backcross progeny revealed two significant loci on chromosome 8: D8Mit343-D8Mit312 for the number of OMCs and D8Mit86-D8Mit89 for their distribution, designated as mast cell in the ovary of MRL/MpJ 1 (mcom1) and mcom2, respectively. Among MC migration-associated genes, ovarian expression of chemokine (C-C motif) ligand 17 at mcom1 locus was significantly higher in MRL/MpJ than in C57BL/6N, and positively correlated with the expression of OMC marker genes. These results indicate that the appearance of neonatal OMCs in MRL/MpJ is controlled by environmental factors and filial genetic factors, and that the abundance and distribution of OMCs are regulated by independent filial genetic elements.	[Nakamura, Teppei; Otsuka-Kanazawa, Saori; Ichii, Osamu; Chihara, Masataka; Kon, Yasuhiro] Hokkaido Univ, Grad Sch Vet Med, Dept Biomed Sci, Anat Lab, Sapporo, Hokkaido, Japan; [Nakamura, Teppei; Sakata, Yuko; Nagasaki, Ken-ichi] Japan Food Res Labs, Chitose Lab, Sect Biol Safety Res, Chitose, Hokkaido, Japan; [Namiki, Yuka] Hokkaido Univ, Grad Sch Vet Med, Off Fac Dev & Teaching Enriched Vet Med, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University	Kon, Y (corresponding author), Hokkaido Univ, Grad Sch Vet Med, Dept Biomed Sci, Anat Lab, Sapporo, Hokkaido, Japan.	y-kon@vetmed.hokudai.ac.jp		Kon, Yasuhiro/0000-0002-8859-6122; NAKAMURA, Teppei/0000-0003-3204-0245	Ministry of Education, Culture, Sports and Technology of Japan [24380156]; Japan Society for the Promotion of Science [24002135]	Ministry of Education, Culture, Sports and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Scientific Research B from the Ministry of Education, Culture, Sports and Technology of Japan (No. 24380156), and a Research fellowship from the Japan Society for the Promotion of Science (No. 24002135). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRANNSTROM M, 1993, BIOL REPROD, V48, P277, DOI 10.1095/biolreprod48.2.277; Clark LD, 1998, CLIN IMMUNOL IMMUNOP, V88, P35, DOI 10.1006/clin.1998.4519; Coussens LM, 1999, GENE DEV, V13, P1382, DOI 10.1101/gad.13.11.1382; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; Gersch C, 2002, HISTOCHEM CELL BIOL, V118, P41, DOI 10.1007/s00418-002-0425-z; Jackson NE, 2005, EUR J IMMUNOL, V35, P2376, DOI 10.1002/eji.200526154; Juremalm M, 2005, CLIN EXP ALLERGY, V35, P708, DOI 10.1111/j.1365-2222.2005.02203.x; Kezele PR, 2005, BIOL REPROD, V72, P241, DOI 10.1095/biolreprod.104.032060; Kokubu K, 2005, J REPROD DEVELOP, V51, P773, DOI 10.1262/jrd.17033; Kon Y, 1999, CELL TISSUE RES, V296, P359, DOI 10.1007/s004410051296; Kon Y, 2007, ANAT HISTOL EMBRYOL, V36, P172, DOI 10.1111/j.1439-0264.2006.00728.x; Kon Y, 2001, MOL REPROD DEV, V58, P216, DOI 10.1002/1098-2795(200102)58:2&lt;216::AID-MRD11&gt;3.0.CO;2-C; Lee S, 2010, MAMM GENOME, V21, P162, DOI 10.1007/s00335-010-9254-x; Lee YM, 2003, J KOREAN MED SCI, V18, P97; Leferovich JM, 2001, P NATL ACAD SCI USA, V98, P9830, DOI 10.1073/pnas.181329398; Liu J, 2009, NAT MED, V15, P940, DOI 10.1038/nm.1994; Manly KF, 2001, MAMM GENOME, V12, P930, DOI 10.1007/s00335-001-1016-3; Nakamura T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077246; Namiki Y, 2005, MAMM GENOME, V16, P96, DOI 10.1007/s00335-004-2424-y; Namiki Y, 2003, MOL REPROD DEV, V64, P179, DOI 10.1002/mrd.10208; Nose M, 2000, INT J CARDIOL, V75, pS53, DOI 10.1016/S0167-5273(00)00191-1; Otsuka S, 2008, BIOL REPROD, V79, P9, DOI 10.1095/biolreprod.107.064519; Otsuka S, 2012, MAMM GENOME, V23, P741, DOI 10.1007/s00335-012-9405-3; Papadopoulos EJ, 2000, EUR J IMMUNOL, V30, P2355, DOI 10.1002/1521-4141(2000)30:8<2355::AID-IMMU2355>3.0.CO;2-#; QUAIFE CJ, 1994, BIOCHEMISTRY-US, V33, P7250, DOI 10.1021/bi00189a029; Robbie-Ryan M, 2002, CURR OPIN IMMUNOL, V14, P728, DOI 10.1016/S0952-7915(02)00394-1; SKALKO RG, 1968, ANAT REC, V161, P459, DOI 10.1002/ar.1091610407; Stutte S, 2010, P NATL ACAD SCI USA, V107, P8736, DOI 10.1073/pnas.0906126107; THEOFILOPOULOS AN, 1985, ADV IMMUNOL, V37, P269, DOI 10.1016/S0065-2776(08)60342-9; Tsunemi Y, 2006, EUR J IMMUNOL, V36, P2116, DOI 10.1002/eji.200535564; Woldacki K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.214; Yin X., 2005, BMC IMMUNOL, V2005, P6, DOI 10.1186%2F1471-2172-6-21; Yu HR, 2005, MAMM GENOME, V16, P918, DOI 10.1007/s00335-005-0077-0; Zierau O, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00169	34	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100617	10.1371/journal.pone.0100617	http://dx.doi.org/10.1371/journal.pone.0100617			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956472	gold, Green Published			2022-12-27	WOS:000338917900072
J	von Rintelen, T; Stelbrink, B; Marwoto, RM; Glaubrecht, M				von Rintelen, Thomas; Stelbrink, Bjoern; Marwoto, Ristiyanti M.; Glaubrecht, Matthias			A Snail Perspective on the Biogeography of Sulawesi, Indonesia: Origin and Intra-Island Dispersal of the Viviparous Freshwater Gastropod Tylomelania	PLOS ONE			English	Article							ADAPTIVE RADIATION; ANCIENT LAKES; PACHYCHILIDAE; MITOCHONDRIAL; CERITHIOIDEA; PHYLOGENY; EVOLUTION; DIVERSIFICATION; MODELS; ASIA	The complex geological history of the Indonesian island Sulawesi has shaped the origin and subsequent diversification of its taxa. For the endemic freshwater snail Tylomelania a vicariant origin from the Australian margin has been hypothesized. Divergence time estimates from a mtDNA phylogeny based on a comprehensive island-wide sampling of Tylomelania fit regional tectonic constraints and support the 'out-of-Australia' vicariance hypothesis. The Banggai-Sula region of the Sula Spur, the Australian promontory colliding with West Sulawesi during the Miocene, is identified as a possible source area for the colonization of Sulawesi by the ancestor of Tylomelania. The molecular phylogeny also shows a rapid diversification of Tylomelania into eight major lineages with very little overlap in their distribution on the island. Haplotype networks provide further evidence for a strong spatial structure of genetic diversity in Tylomelania. Distribution boundaries of the major lineages do at best partially coincide with previously identified contact zones for other endemic species groups on Sulawesi. This pattern has likely been influenced by the poor dispersal capabilities and altitudinal distribution limits of this strict freshwater inhabitant. We suggest that late Miocene and Pliocene orogeny in large parts of Sulawesi has been the vicariant event driving primary diversification in Tylomelania.	[von Rintelen, Thomas; Stelbrink, Bjoern; Glaubrecht, Matthias] Leibniz Inst Evolut & Biodivers Sci, Museum Nat Kunde, Berlin, Germany; [Marwoto, Ristiyanti M.] LIPI, Biol Res Ctr, Museum Zoologicum Bogoriense, Div Zool, Bogor, Indonesia	Leibniz Institut fur Evolutions und Biodiversitatsforschung; Bogor Zoology Museum; Indonesian Institute of Sciences	von Rintelen, T (corresponding author), Leibniz Inst Evolut & Biodivers Sci, Museum Nat Kunde, Berlin, Germany.	thomas.rintelen@mfn-berlin.de	Stelbrink, Björn/Y-5023-2019	Stelbrink, Björn/0000-0002-7471-4992; Marwoto, Ristiyanti/0000-0003-1724-8152	German Research Council (DFG) [GL 1738/1-1, GL 1738/7-1, GL 1738/7-2, GL 1738/7-3, RI 1738/4-1]	German Research Council (DFG)(German Research Foundation (DFG))	This study was financed by German Research Council (DFG, www.dfg.de) grants GL 1738/1-1, 7-1, 7-2, -3, and RI 1738/4-1 to MG and TvR, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbogast BS, 2001, J BIOGEOGR, V28, P819, DOI 10.1046/j.1365-2699.2001.00594.x; Avise J, 2004, MOL MARKERS NATURAL; Bridle JR, 2004, EVOLUTION, V58, P1394; Bridle JR, 2001, BIOL J LINN SOC, V72, P373, DOI 10.1111/j.1095-8312.2001.tb01324.x; BURRETT C, 1991, Australian Systematic Botany, V4, P13, DOI 10.1071/SB9910013; Butlin RK, 1998, BIOGEOGRAPHY GEOLOGI, P355; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Clouse RM, 2010, J BIOGEOGR, V37, P1114, DOI 10.1111/j.1365-2699.2010.02274.x; COHEN A S, 1987, Palaios, V2, P426, DOI 10.2307/3514614; Cox CB, 2001, J BIOGEOGR, V28, P511; De Bruyn Mark, 2012, Systematics Association Special Volume Series, V82, P316; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Evans BJ, 2008, BIOL LETTERS, V4, P430, DOI 10.1098/rsbl.2008.0166; Evans BJ, 1999, BIOL J LINN SOC, V66, P539, DOI 10.1006/bijl.1998.0292; Evans BJ, 2003, EVOLUTION, V57, P1931; Evans BJ, 2003, EVOLUTION, V57, P1436; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Garrard R.A., 1988, P IND PETR ASS 17 AN, P23; Glaubrecht M, 2003, ZOOL SCR, V32, P415, DOI 10.1046/j.1463-6409.2003.00127.x; Glaubrecht M., 1996, EVOLUTIONSOKOLOGIE S; Glaubrecht M, 2008, HYDROBIOLOGIA, V615, P181, DOI 10.1007/s10750-008-9568-9; Hall R, 2009, BLUMEA, V54, P148, DOI 10.3767/000651909X475941; Hall R., 2012, BIOTIC EVOLUTION ENV, P32, DOI DOI 10.1017/CBO9780511735882.005; Hall R, 2011, GEOL SOC SPEC PUBL, V355, P75, DOI 10.1144/SP355.5; Keast A, 2001, FAUNAL AND FLORAL MIGRATIONS AND EVOLUTION IN SE ASIA-AUSTRALASIA, P287; Kohler F, 2010, BIOL J LINN SOC, V99, P867, DOI 10.1111/j.1095-8312.2009.01390.x; Kohler F, 2009, ZOOL J LINN SOC-LOND, V157, P679, DOI 10.1111/j.1096-3642.2009.00541.x; Kohler F, 2004, EVOLUTION, V58, P2215; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Linkem CW, 2013, J BIOGEOGR, V40, P507, DOI 10.1111/jbi.12022; Lohman DJ, 2011, ANNU REV ECOL EVOL S, V42, P205, DOI 10.1146/annurev-ecolsys-102710-145001; Mayr E, 1944, Q REV BIOL, V19, P1, DOI 10.1086/394684; Merker S, 2009, P NATL ACAD SCI USA, V106, P8459, DOI 10.1073/pnas.0900319106; Metcalfe I, 2011, GEOL SOC SPEC PUBL, V355, P7, DOI 10.1144/SP355.2; Michaux B, 2010, BIOL J LINN SOC, V101, P193, DOI 10.1111/j.1095-8312.2010.01473.x; Morley R.J., 2000, ORIGIN EVOLUTION TRO; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruedas LA, 2005, J MAMMAL, V86, P353, DOI 10.1644/BER-117.1; SATHIAMURTHY E., 2006, NATURAL HIST J CHULA, V2, P1; Setiadi MI, 2011, AM NAT, V178, P221, DOI 10.1086/660830; SIMPSON GG, 1977, P AM PHILOS SOC, V121, P107; Spakman W, 2010, NAT GEOSCI, V3, P562, DOI [10.1038/ngeo917, 10.1038/NGEO917]; Sparks JS, 2004, MOL PHYLOGENET EVOL, V33, P719, DOI 10.1016/j.ympev.2004.07.002; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stelbrink B, 2012, EVOLUTION, V66, P2252, DOI 10.1111/j.1558-5646.2012.01588.x; Swofford D., 2002, PAUP VERSION 4 0 PHY; Taylor EH, 1928, DISTRIBUTION LIFE PH, V21, P214; Von Rintelen T, 2005, BIOL J LINN SOC, V85, P513, DOI 10.1111/j.1095-8312.2005.00515.x; von Rintelen T, 2004, P ROY SOC B-BIOL SCI, V271, P2541, DOI 10.1098/rspb.2004.2842; von Rintelen T., 2012, BIOTIC EVOLUTION ENV, P290, DOI DOI 10.1017/CBO9780511735882.014; Von Rintelen T, 2008, ZOOTAXA, P37; von Rintelen T, 2007, HYDROBIOLOGIA, V592, P11, DOI 10.1007/s10750-007-0765-8; von Rintelen T, 2010, EVOLUTION IN ACTION: CASE STUDIES IN ADAPTIVE RADIATION, SPECIATION AND THE ORIGIN OF BIODIVERSITY, P485, DOI 10.1007/978-3-642-12425-9_23; Wallace A. R., 1860, J LINN SOC LOND, V4, P172, DOI DOI 10.1111/J.1096-3642.1860.TB00090.X; Whittaker R. J., 2007, ISLAND BIOGEOGRAPHY; Whitten AJ, 2002, ECOLOGY SULAWESI; Wilke T, 2009, AM MALACOL BULL, V27, P25, DOI 10.4003/006.027.0203; Wilson MEJ, 1999, PALAEOGEOGR PALAEOCL, V145, P303, DOI 10.1016/S0031-0182(98)00127-8; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3	63	27	27	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e98917	10.1371/journal.pone.0098917	http://dx.doi.org/10.1371/journal.pone.0098917			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971564	Green Published, gold, Green Submitted			2022-12-27	WOS:000338512200007
J	La Paz, JL; Pla, M; Centeno, E; Vicient, CM; Puigdomenech, P				Luis La Paz, Jose; Pla, Maria; Centeno, Emilio; Vicient, Carlos M.; Puigdomenech, Pere			The Use of Massive Sequencing to Detect Differences between Immature Embryos of MON810 and a Comparable Non-GM Maize Variety	PLOS ONE			English	Article							E3 UBIQUITIN LIGASES; GENE-EXPRESSION; RNA-SEQ; TRANSCRIPTOME; DISCOVERY; PATTERNS; DORMANCY; RICE; TOOL; PCR	The insect resistant maize YieldGard MON810 was studied to assess the extent to which introduction of a transgene may putatively alter the expression of endogenous genes by comparison of various GM lines vs. their non-transgenic counterparts. To assess the extent to which introduction of a transgene may putatively alter the expression of endogenous genes, GM lines of the insect resistant maize YieldGard MON810 were compared with non-transgenic counterparts. For a more in-depth study, high-throughput deep sequencing together with microarrays were used to compare the transcriptomes of immature embryos of the MON810 variety DKC6575, with a cryIA(b) transgene, and its near-isogenic variety Tietar, grown under controlled environmental conditions. This technique also allows characterisation of the transgenic mRNAs produced. 39UTR-anchored mRNA-seq produced 1,802,571 sequences from DKC6575 and 1,170,973 from Tietar, which mapped to 14,712 and 14,854 unigenes, respectively. Up to 32 reads from the transgenic embryos matched to the synthetic cry1A(b) sequence, similar to medium-abundant mRNAs. Gene expression analysis, using the R-bioconductor packages EdgeR and DEseq, revealed 140 differentially expressed genes mainly involved in carbohydrate metabolism, protein metabolism and chromatin organisation. Comparison of the expression of 30 selected genes in two additional MON810 and near-isogenic variety pairs showed that most of them were differentially expressed in the three pairs of varieties analysed. Analysis of functional annotation and the precise moment of expression of the differentially expressed genes and physiological data obtained suggest a slight but significant delay in seed and plant maturation of MON810 plants. However, these transcriptomic changes were not associated to undesirable changes in the global phenotype or plant behaviour. Moreover, while most expression changes in MON810 immature embryos were maintained in other transgenic varieties, some gene expression was found to be modulated by the genetic background in which the transgene was introduced through conventional breeding programs.	[Luis La Paz, Jose; Pla, Maria; Centeno, Emilio; Vicient, Carlos M.; Puigdomenech, Pere] CSIC IRTA UAB UB, Consejo Super Invest Cient, Ctr Res Agrigen, Dept Mol Genet, Barcelona, Spain; [Pla, Maria] Univ Girona, Inst Food & Agr Technol INTEA, EPS I, Girona, Spain	Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); IRTA; University of Barcelona; Universitat de Girona	Puigdomenech, P (corresponding author), CSIC IRTA UAB UB, Consejo Super Invest Cient, Ctr Res Agrigen, Dept Mol Genet, Barcelona, Spain.	pere.puigdomenech@cragenomica.es	Vicient, Carlos M M/K-3878-2012; Centeno, Emilio/Q-4784-2019; Pla, Maria/K-5170-2017; Schulman, Alan/A-9322-2011	Vicient, Carlos M M/0000-0002-6897-9046; Centeno, Emilio/0000-0003-2798-978X; Pla, Maria/0000-0003-4382-5494; Schulman, Alan/0000-0002-4126-6177	Spanish MEC project [AGL2007-65903/AGR]; CONSOLIDER project; Xarxa de Referencia en Biotecnologia of the Generalitat de Catalunya	Spanish MEC project(Spanish Government); CONSOLIDER project(Spanish Government); Xarxa de Referencia en Biotecnologia of the Generalitat de Catalunya	This work was funded by the Spanish MEC project ref. AGL2007-65903/AGR, the CONSOLIDER project and the Xarxa de Referencia en Biotecnologia of the Generalitat de Catalunya. The authors thank the Massive Sequencing Service of CRAG for their help. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andersson HC, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2561; Asmann YW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-531; Barros E, 2010, PLANT BIOTECHNOL J, V8, P436, DOI 10.1111/j.1467-7652.2009.00487.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; BOCHICCHIO A, 1988, AGRONOMIE, V8, P29, DOI 10.1051/agro:19880104; Bourgon R, 2010, P NATL ACAD SCI USA, V107, P9546, DOI 10.1073/pnas.0914005107; Che P, 2006, PLANT MOL BIOL, V62, P1, DOI 10.1007/s11103-006-9013-2; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Coetzer N, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-31; Coll A, 2008, PLANT MOL BIOL, V68, P105, DOI 10.1007/s11103-008-9355-z; Coll A, 2010, PLANT MOL BIOL, V73, P349, DOI 10.1007/s11103-010-9624-5; Craig A, 2009, J EXP BOT, V60, P1123, DOI 10.1093/jxb/erp059; DALESSIO JM, 1988, NUCLEIC ACIDS RES, V16, P1999; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Emrich SJ, 2007, GENOME RES, V17, P69, DOI 10.1101/gr.5145806; Eveland AL, 2008, PLANT PHYSIOL, V146, P32, DOI 10.1104/pp.107.108597; He H, 2009, ACTA PHYSIOL PLANT, V31, P749, DOI 10.1007/s11738-009-0287-2; Hernandez M, 2003, TRANSGENIC RES, V12, P179, DOI 10.1023/A:1022979624333; Holck A, 2002, EUR FOOD RES TECHNOL, V214, P449, DOI 10.1007/s00217-001-0473-y; Kogel KH, 2010, P NATL ACAD SCI USA, V107, P6198, DOI 10.1073/pnas.1001945107; Leida C, 2010, TREE PHYSIOL, V30, P655, DOI 10.1093/treephys/tpq008; Lohse M, 2012, NUCL ACIDS RES, V40; Lopez A, 2009, DOSSIER TECNIC N35 G; La Paz JL, 2010, ANAL BIOANAL CHEM, V396, P2125, DOI 10.1007/s00216-009-3176-z; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Meuer S, 2001, RAPID CYCLE REAL TIM, P21, DOI 10.1007/978-3-642-59524-0; Montero M, 2011, PLANT BIOTECHNOL J, V9, P693, DOI 10.1111/j.1467-7652.2010.00572.x; Nemhauser JL, 2006, CELL, V126, P467, DOI 10.1016/j.cell.2006.05.050; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rosati A, 2008, PLANT MOL BIOL, V67, P271, DOI 10.1007/s11103-008-9315-7; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schrader J, 2004, PLANT J, V40, P173, DOI 10.1111/j.1365-313X.2004.02199.x; Sekhon RS, 2014, PLANT PHYSIOL, V165, P658, DOI 10.1104/pp.114.235424; Sekhon RS, 2011, PLANT J, V66, P553, DOI 10.1111/j.1365-313X.2011.04527.x; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Teoh KT, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-19; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; van Dijk JP, 2010, REGUL TOXICOL PHARM, V58, pS21, DOI 10.1016/j.yrtph.2010.06.012; van Haver E, 2008, FOOD CHEM TOXICOL, V46, pS2, DOI 10.1016/j.fct.2008.02.008; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484	45	6	6	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100895	10.1371/journal.pone.0100895	http://dx.doi.org/10.1371/journal.pone.0100895			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967839	Green Published, gold, Green Submitted			2022-12-27	WOS:000338280800078
J	Pellon-Maison, M; Montanaro, MA; Lacunza, E; Garcia-Fabiani, MB; Soler-Gerino, MC; Cattaneo, ER; Quiroga, IY; Abba, MC; Coleman, RA; Gonzalez-Baro, MR				Pellon-Maison, Magali; Montanaro, Mauro A.; Lacunza, Ezequiel; Garcia-Fabiani, Maria B.; Soler-Gerino, Mercedes C.; Cattaneo, Elizabeth R.; Quiroga, Ivana Y.; Abba, Martin C.; Coleman, Rosalind A.; Gonzalez-Baro, Maria R.			Glycerol-3-Phosphate Acyltranferase-2 Behaves as a Cancer Testis Gene and Promotes Growth and Tumorigenicity of the Breast Cancer MDA-MB-231 Cell Line	PLOS ONE			English	Article							STEM-CELLS; CANCER/TESTIS ANTIGENS; GENOME-WIDE; EXPRESSION; OVEREXPRESSION; COEXPRESSION; GPAT2; PIRNA	The de novo synthesis of glycerolipids in mammalian cells begins with the acylation of glycerol-3-phosphate, catalyzed by glycerol-3-phosphate acyltransferase (GPAT). GPAT2 is a mitochondrial isoform primarily expressed in testis under physiological conditions. Because it is aberrantly expressed in multiple myeloma, it has been proposed as a novel cancer testis gene. Using a bioinformatics approach, we found that GPAT2 is highly expressed in melanoma, lung, prostate and breast cancer, and we validated GPAT2 expression at the protein level in breast cancer by immunohistochemistry. In this case GPAT2 expression correlated with a higher histological grade. 5-Aza-2' deoxycytidine treatment of human cells lines induced GPAT2 expression suggesting epigenetic regulation of gene expression. In order to evaluate the contribution of GPAT2 to the tumor phenotype, we silenced its expression in MDA-MB-231 cells. GPAT2 knockdown diminished cell proliferation, anchorage independent growth, migration and tumorigenicity, and increased staurosporine-induced apoptosis. In contrast, GPAT2 over-expression increased cell proliferation rate and resistance to staurosporine-induced apoptosis. To understand the functional role of GPAT2, we performed a co-expression analysis in mouse and human testis and found a significant association with semantic terms involved in cell cycle, DNA integrity maintenance, piRNA biogenesis and epigenetic regulation. Overall, these results indicate the GPAT2 would be directly associated with the control of cell proliferation. In conclusion, we confirm GPAT2 as a cancer testis gene and that its expression contributes to the tumor phenotype of MDA-MB-231 cells.	[Pellon-Maison, Magali; Montanaro, Mauro A.; Garcia-Fabiani, Maria B.; Soler-Gerino, Mercedes C.; Cattaneo, Elizabeth R.; Quiroga, Ivana Y.; Gonzalez-Baro, Maria R.] Univ Nacl La Plata, Inst Invest Bioquim La Plata, Consejo Nacl Invest Cient & Tecn, Fac Ciencias Med, La Plata, Buenos Aires, Argentina; [Lacunza, Ezequiel; Abba, Martin C.] Univ Nacl La Plata, Ctr Invest Inmunol Basicas & Aplicadas, Fac Ciencias Med, La Plata, Buenos Aires, Argentina; [Coleman, Rosalind A.] Univ N Carolina, Dept Nutr, Chapel Hill, NC USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; National University of La Plata; University of North Carolina; University of North Carolina Chapel Hill	Gonzalez-Baro, MR (corresponding author), Univ Nacl La Plata, Inst Invest Bioquim La Plata, Consejo Nacl Invest Cient & Tecn, Fac Ciencias Med, La Plata, Buenos Aires, Argentina.	mgbaro@med.unlp.edu.ar		Abba, Martin/0000-0002-9206-2369; Quiroga-Barber, Ivana/0000-0002-6799-0059; Pellon-Maison, Magali/0000-0002-7981-5258	NIH, USA [1R03TW008698, R01DK56598]; PICT [2246 ANPCyT]; UNLP, Argentina [M168]; FOGARTY INTERNATIONAL CENTER [R03TW008698] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056598] Funding Source: NIH RePORTER	NIH, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PICT(ANPCyT); UNLP, Argentina(National University of La Plata); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH Grants 1R03TW008698 (MRGB) and R01DK56598 (RAC), USA, PICT 2246 ANPCyT and UNLP M168 (MRGB), Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r139; BELL RM, 1980, ANNU REV BIOCHEM, V49, P459, DOI 10.1146/annurev.bi.49.070180.002331; BRINKLEY BR, 1980, CANCER RES, V40, P3118; Cattaneo ER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042986; Cheng J, 2011, CLIN CHIM ACTA, V412, P1621, DOI 10.1016/j.cca.2011.05.015; Cheng Yan-Ho, 2011, Spermatogenesis, V1, P209, DOI 10.4161/spmg.1.3.17990; Chuma S, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0338; Coletta A, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r104; Condomines M, 2009, J IMMUNOL, V183, P832, DOI 10.4049/jimmunol.0803298; Costa FF, 2007, STEM CELLS, V25, P707, DOI 10.1634/stemcells.2006-0469; Dougherty CJ, 2008, BIOCHEM BIOPH RES CO, V370, P109, DOI 10.1016/j.bbrc.2008.03.040; Duan ZF, 2003, CLIN CANCER RES, V9, P2778; Fratta E, 2011, MOL ONCOL, V5, P164, DOI 10.1016/j.molonc.2011.02.001; Hofmann O, 2008, P NATL ACAD SCI USA, V105, P20422, DOI 10.1073/pnas.0810777105; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Janic A, 2010, SCIENCE, V330, P1824, DOI 10.1126/science.1195481; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Lee JH, 2010, CANCER RES, V70, P4569, DOI 10.1158/0008-5472.CAN-09-2670; Lin ML, 2009, CANCER SCI, V100, P1443, DOI 10.1111/j.1349-7006.2009.01185.x; Low J, 2010, J BIOMOL SCREEN, V15, P830, DOI 10.1177/1087057110374983; McCall MN, 2010, BIOSTATISTICS, V11, P242, DOI 10.1093/biostatistics/kxp059; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Pek JW, 2011, CELL DIV, V6, DOI 10.1186/1747-1028-6-6; Scanlan Matthew J, 2004, Cancer Immun, V4, P1; Scanlan MJ, 2002, IMMUNOL REV, V188, P22, DOI 10.1034/j.1600-065X.2002.18803.x; Shiromoto Y, 2013, RNA, V19, P803, DOI 10.1261/rna.038521.113; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Wang S, 2007, ARCH BIOCHEM BIOPHYS, V465, P347, DOI 10.1016/j.abb.2007.06.033; Wendel AA, 2009, BBA-MOL CELL BIOL L, V1791, P501, DOI 10.1016/j.bbalip.2008.10.010	29	28	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100896	10.1371/journal.pone.0100896	http://dx.doi.org/10.1371/journal.pone.0100896			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967918	Green Published, Green Submitted, gold			2022-12-27	WOS:000338280800079
J	Butterworth, MB; Zhang, L; Liu, XN; Shanks, RM; Thibodeau, PH				Butterworth, Michael B.; Zhang, Liang; Liu, Xiaoning; Shanks, Robert M.; Thibodeau, Patrick H.			Modulation of the Epithelial Sodium Channel (ENaC) by Bacterial Metalloproteases and Protease Inhibitors	PLOS ONE			English	Article							AERUGINOSA ALKALINE PROTEASE; SURFACE LIQUID VOLUME; PSEUDOMONAS-AERUGINOSA; CYSTIC-FIBROSIS; CRYSTAL-STRUCTURE; SERRATIA-MARCESCENS; VIRULENCE FACTORS; ESCHERICHIA-COLI; AIRWAY EPITHELIA; EXOTOXIN-A	The serralysin family of metalloproteases is associated with the virulence of multiple gram-negative human pathogens, including Pseudomonas aeruginosa and Serratia marcescens. The serralysin proteases share highly conserved catalytic domains and show evolutionary similarity to the mammalian matrix metalloproteases. Our previous studies demonstrated that alkaline protease (AP) from Pseudomonas aeruginosa is capable of activating the epithelial sodium channel (ENaC), leading to an increase in sodium absorption in airway epithelia. The serralysin proteases are often co-expressed with endogenous, intracellular or periplasmic inhibitors, which putatively protect the bacterium from unwanted or unregulated protease activities. To evaluate the potential use of these small protein inhibitors in regulating the serralysin induced activation of ENaC, proteases from Pseudomonas aeruginosa and Serratia marcescens were purified for characterization along with a high affinity inhibitor from Pseudomonas. Both proteases showed activity against in vitro substrates and could be blocked by near stoichiometric concentrations of the inhibitor. In addition, both proteases were capable of activating ENaC when added to the apical surfaces of multiple epithelial cells with similar slow activation kinetics. The high-affinity periplasmic inhibitor from Pseudomonas effectively blocked this activation. These data suggest that multiple metalloproteases are capable of activating ENaC. Further, the endogenous, periplasmic bacterial inhibitors may be useful for modulating the downstream effects of the serralysin virulence factors under physiological conditions.	[Butterworth, Michael B.; Zhang, Liang; Liu, Xiaoning; Thibodeau, Patrick H.] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15260 USA; [Shanks, Robert M.] Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Thibodeau, PH (corresponding author), Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15260 USA.	thibodea@pitt.edu	Shanks, Robert M. Q./AFO-0831-2022; Zhang, Liang/D-9446-2015	Shanks, Robert M. Q./0000-0002-7699-5396; Zhang, Liang/0000-0003-4268-6939	NIH [DK083284, AI085570, DK078917, DK072506]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085570] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083284, R00DK078917, K99DK078917, R56DK083284, P30DK072506] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported, in part, by NIH grants DK083284 to PHT, AI085570 to RMS, DK078917 and a Gilead CF Scholars grant to MBB. The University of Pittsburgh Cystic Fibrosis Center Cell Core facility is supported, in part, by NIH grant DK072506. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelos JA, 2003, VET MICROBIOL, V92, P363, DOI 10.1016/S0378-1135(02)00410-8; Bardoel BW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002206; BAUMANN U, 1993, EMBO J, V12, P3357, DOI 10.1002/j.1460-2075.1993.tb06009.x; BAUMANN U, 1994, J MOL BIOL, V242, P244, DOI 10.1006/jmbi.1994.1576; BAUMANN U, 1995, J MOL BIOL, V248, P653, DOI 10.1006/jmbi.1995.0249; Bens M, 1999, J AM SOC NEPHROL, V10, P923; BURKE V, 1991, PATHOLOGY, V23, P145, DOI 10.3109/00313029109060814; Butterworth MB, 2012, J BIOL CHEM, V287, P32556, DOI 10.1074/jbc.M112.369520; Butterworth MB, 2012, AM J PHYSIOL-RENAL, V302, pF581, DOI 10.1152/ajprenal.00304.2011; Chenal A, 2009, J BIOL CHEM, V284, P1781, DOI 10.1074/jbc.M807312200; Coote K, 2009, J PHARMACOL EXP THER, V329, P764, DOI 10.1124/jpet.108.148155; DUONG F, 1992, GENE, V121, P47, DOI 10.1016/0378-1119(92)90160-Q; Edinger RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046593; Emody L, 2003, INT J ANTIMICROB AG, V22, pS29, DOI 10.1016/S0924-8579(03)00236-X; Feltzer RE, 2000, J BIOL CHEM, V275, P21002, DOI 10.1074/jbc.M002088200; GUZZO J, 1990, J BACTERIOL, V172, P942, DOI 10.1128/jb.172.2.942-948.1990; Hege T, 2001, J BIOL CHEM, V276, P35087, DOI 10.1074/jbc.M104020200; Hejazi A, 1997, J MED MICROBIOL, V46, P903, DOI 10.1099/00222615-46-11-903; HORVAT RT, 1988, INFECT IMMUN, V56, P2925, DOI 10.1128/IAI.56.11.2925-2932.1988; JAFFARBANDJEE MC, 1995, J CLIN MICROBIOL, V33, P924, DOI 10.1128/JCM.33.4.924-929.1995; JAGGER KN, 1983, J CLIN MICROBIOL, V17, P55, DOI 10.1128/JCM.17.1.55-59.1983; JAGGER KS, 1982, J CLIN MICROBIOL, V15, P1054, DOI 10.1128/JCM.15.6.1054-1058.1982; Jaswal SS, 2002, NATURE, V415, P343, DOI 10.1038/415343a; Kachlany SC, 2000, INFECT IMMUN, V68, P6094, DOI 10.1128/IAI.68.11.6094-6100.2000; Kashlan OB, 2010, J BIOL CHEM, V285, P35216, DOI 10.1074/jbc.M110.167064; KLINGER JD, 1984, J CLIN INVEST, V74, P1669, DOI 10.1172/JCI111583; KOSMIDIS J, 1986, SCAND J INFECT DIS, P135; Leidal KG, 2003, J INTERF CYTOK RES, V23, P307, DOI 10.1089/107999003766628151; Lilie H, 2000, FEBS LETT, V470, P173, DOI 10.1016/S0014-5793(00)01308-9; Linhartova I, 2010, FEMS MICROBIOL REV, V34, P1076, DOI 10.1111/j.1574-6976.2010.00231.x; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; Maekawa A, 2009, J HYPERTENS, V27, P181, DOI 10.1097/HJH.0b013e328317a762; Mall MA, 2010, J BIOL CHEM, V285, P26945, DOI 10.1074/jbc.M110.151803; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Myerburg MM, 2010, AM J RESP CELL MOL, V43, P712, DOI 10.1165/rcmb.2009-0348OC; Myerburg MM, 2008, AM J PHYSIOL-LUNG C, V294, pL932, DOI 10.1152/ajplung.00437.2007; Myerburg MM, 2006, J BIOL CHEM, V281, P27942, DOI 10.1074/jbc.M606449200; Pinna A, 2011, ACTA OPHTHALMOL, V89, P382, DOI 10.1111/j.1755-3768.2009.01689.x; Sarkisova S, 2005, J BACTERIOL, V187, P4327, DOI 10.1128/JB.187.13.4327-4337.2005; SEBO P, 1993, MOL MICROBIOL, V9, P999, DOI 10.1111/j.1365-2958.1993.tb01229.x; Sisirak Maida, 2013, Acta Med Acad, V42, P25, DOI 10.5644/ama2006-124.67; Song YL, 2009, AM J PHYSIOL-LUNG C, V297, pL1131, DOI 10.1152/ajplung.00085.2009; SUTER S, 1994, AM J RESP CRIT CARE, V150, pS118, DOI 10.1164/ajrccm/150.6_Pt_2.S118; Tarran R, 2006, J GEN PHYSIOL, V127, P591, DOI 10.1085/jgp.200509468; Thanassi DG, 2000, CURR OPIN CELL BIOL, V12, P420, DOI 10.1016/S0955-0674(00)00111-3; Tingpej P, 2007, J CLIN MICROBIOL, V45, P1697, DOI 10.1128/JCM.02364-06; Zhang L, 2012, J BIOL CHEM, V287, P4311, DOI 10.1074/jbc.M111.310300	47	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100313	10.1371/journal.pone.0100313	http://dx.doi.org/10.1371/journal.pone.0100313			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963801	Green Accepted, Green Published, gold			2022-12-27	WOS:000338709500039
J	Caggiano, V; Sur, M; Bizzi, E				Caggiano, Vittorio; Sur, Mirganka; Bizzi, Emilio			Rostro-Caudal Inhibition of Hindlimb Movements in the Spinal Cord of Mice	PLOS ONE			English	Article							LOCOMOTOR-LIKE ACTIVITY; MODULAR ORGANIZATION; MUSCLE AFFERENTS; MOTOR CONTROL; NEONATAL-RAT; NEURONS; MOUSE; GABA; LUMBAR; CAT	Inhibitory neurons in the adult mammalian spinal cord are known to locally modulate afferent feedback - from muscle proprioceptors and from skin receptors - to pattern motor activity for locomotion and postural control. Here, using optogenetic tools, we explored how the same population of inhibitory interneurons globally affects hindlimb movements in the spinal cord of both anesthetized and freely moving mice. Activation of inhibitory interneurons up to the middle/lower spinal cord i.e. T8-T9, were able to completely and globally suppress all ipsilateral hindlimb movements. Furthermore, the same population of interneurons - which inhibited movements - did not significantly change the sensory and proprioceptive information from the affected limbs to the cortex. These results suggest a rostro-caudal organization of inhibition in the spinal cord motor output without modulation of ascending sensory pathways.	[Caggiano, Vittorio; Bizzi, Emilio] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Sur, Mirganka] MIT, Picower Inst Learning & Memory, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Northwell Health	Caggiano, V (corresponding author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	caggiano@mit.edu; ebizzi@mit.edu		/0000-0002-7644-4498; Caggiano, Vittorio/0000-0002-2186-1550	Human Frontier Science Program fellowship [LT001234/2011-L]; NSF [IIS-0904594]	Human Frontier Science Program fellowship(Human Frontier Science Program); NSF(National Science Foundation (NSF))	V.C. is supported by the Human Frontier Science Program fellowship (LT001234/2011-L). Contributing grants include NSF IIS-0904594. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alilain WJ, 2008, J NEUROSCI, V28, P11862, DOI 10.1523/JNEUROSCI.3378-08.2008; Allain AE, 2006, J COMP NEUROL, V496, P832, DOI 10.1002/cne.20967; Arber S, 2012, NEURON, V74, P975, DOI 10.1016/j.neuron.2012.05.011; Berg RW, 2007, SCIENCE, V315, P390, DOI 10.1126/science.1134960; Bertrand S, 1999, EUR J NEUROSCI, V11, P583, DOI 10.1046/j.1460-9568.1999.00473.x; Bertrand S, 2002, EUR J NEUROSCI, V16, P1741, DOI 10.1046/j.1460-9568.2002.02233.x; Betley JN, 2009, CELL, V139, P161, DOI 10.1016/j.cell.2009.08.027; Bizzi E, 2002, NEUROSCIENTIST, V8, P437, DOI 10.1177/107385802236969; Bonnot A, 2002, BRAIN RES REV, V40, P141, DOI 10.1016/S0165-0173(02)00197-2; Bonnot AS, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-03-j0001.2002; Chaudhry FA, 1998, J NEUROSCI, V18, P9733; Cowley KC, 1997, J NEUROPHYSIOL, V77, P247, DOI 10.1152/jn.1997.77.1.247; Cowley KC, 2010, ANN NY ACAD SCI, V1198, P42, DOI 10.1111/j.1749-6632.2009.05421.x; Delivet-Mongrain H, 2008, J NEUROPHYSIOL, V100, P907, DOI 10.1152/jn.90454.2008; Farrar MJ, 2012, NAT METHODS, V9, P297, DOI [10.1038/NMETH.1856, 10.1038/nmeth.1856]; Frigon A, 2012, EXP NEUROL, V235, P588, DOI 10.1016/j.expneurol.2012.03.013; Ghosh A, 2009, J NEUROSCI, V29, P12210, DOI 10.1523/JNEUROSCI.1828-09.2009; Gosgnach S, 2006, NATURE, V440, P215, DOI 10.1038/nature04545; Grillner S, 2009, CURR OPIN NEUROBIOL, V19, P572, DOI 10.1016/j.conb.2009.10.011; Guan Y, 2006, J NEUROSCI, V26, P4298, DOI 10.1523/JNEUROSCI.0960-06.2006; HOLSTEGE JC, 1991, J NEUROSCI, V11, P159; JANKOWSKA E, 1992, PROG NEUROBIOL, V38, P335, DOI 10.1016/0301-0082(92)90024-9; Jankowska E, 2008, J NEUROSCI, V28, P3615, DOI 10.1523/JNEUROSCI.0466-08.2008; Jasmin L, 2004, CNS NEUROL DISORD-DR, V3, P487, DOI 10.2174/1568007043336716; Jean A, 2001, PHYSIOL REV, V81, P929, DOI 10.1152/physrev.2001.81.2.929; Kiehn O, 1998, ANN NY ACAD SCI, V860, P110, DOI 10.1111/j.1749-6632.1998.tb09043.x; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; Krenzer M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024998; Levine AJ, 2014, NAT NEUROSCI, V17, P586, DOI 10.1038/nn.3675; Lu J, 2006, NATURE, V441, P589, DOI 10.1038/nature04767; MCHANWELL S, 1981, PHILOS T ROY SOC B, V293, P477, DOI 10.1098/rstb.1981.0082; Miller KE, 1998, BRAIN RES BULL, V47, P43, DOI 10.1016/S0361-9230(98)00065-3; Nadeau S, 2010, NEUROREHAB NEURAL RE, V24, P377, DOI 10.1177/1545968309349945; Ovsepian SV, 2004, NEUROSCIENCE, V129, P639, DOI 10.1016/j.neuroscience.2004.07.050; Pearson KG, 1998, ANN NY ACAD SCI, V860, P203, DOI 10.1111/j.1749-6632.1998.tb09050.x; Quinlan KA, 2007, J NEUROSCI, V27, P6521, DOI 10.1523/JNEUROSCI.1618-07.2007; Saltiel P, 2001, J NEUROPHYSIOL, V85, P605, DOI 10.1152/jn.2001.85.2.605; Saltiel P, 1998, J NEUROPHYSIOL, V80, P2323, DOI 10.1152/jn.1998.80.5.2323; TAAL W, 1994, NEUROREPORT, V5, P2225, DOI 10.1097/00001756-199411000-00005; Taepavarapruk N, 2008, J NEUROPHYSIOL, V100, P598, DOI 10.1152/jn.01231.2007; Talpalar AE, 2011, NEURON, V71, P1071, DOI 10.1016/j.neuron.2011.07.011; Tripodi M, 2011, NATURE, V479, P61, DOI 10.1038/nature10538; Wang Y, 2009, NEUROSCIENCE, V164, P1031, DOI 10.1016/j.neuroscience.2009.09.010; Windhorst U, 1996, PROG NEUROBIOL, V49, P517, DOI 10.1016/0301-0082(96)00023-8; Zhang JM, 2014, NEURON, V82, P138, DOI 10.1016/j.neuron.2014.02.013; Zhao SL, 2011, NAT METHODS, V8, P745, DOI 10.1038/nmeth.1668	46	22	23	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100865	10.1371/journal.pone.0100865	http://dx.doi.org/10.1371/journal.pone.0100865			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963653	Green Published, gold			2022-12-27	WOS:000338709500091
J	Havermann, S; Chovolou, Y; Humpf, HU; Watjen, W				Havermann, Susannah; Chovolou, Yvonni; Humpf, Hans-Ulrich; Waetjen, Wim			Caffeic Acid Phenethylester Increases Stress Resistance and Enhances Lifespan in Caenorhabditis elegans by Modulation of the Insulin-Like DAF-16 Signalling Pathway	PLOS ONE			English	Article							NF-KAPPA-B; OXIDATIVE STRESS; CANCER CELLS; FOXO FAMILY; ESTER CAPE; C-ELEGANS; ANTIOXIDANT; LONGEVITY; PROPOLIS; GENE	CAPE is an active constituent of propolis which is widely used in traditional medicine. This hydroxycinnamic acid derivate is a known activator of the redox-active Nrf2 signalling pathway in mammalian cells. We used C. elegans to investigate the effects of this compound on accumulation of reactive oxygen species and the modulation of the pivotal redox-active pathways SKN-1 and DAF-16 (homologues of Nrf2 and FoxO, respectively) in this model organism; these results were compared to the effects in Hct116 human colon carcinoma cells. CAPE exerts a strong antioxidative effect in C. elegans: The increase of reactive oxygen species induced by thermal stress was diminished by about 50%. CAPE caused a nuclear translocation of DAF-16, but not SKN-1. CAPE increased stress resistance of the nematode against thermal stress and finally a prolongation of the median and maximum lifespan by 9 and 17%, respectively. This increase in stress resistance and lifespan was dependent on DAF-16 as shown in experiments using a DAF-16 loss of function mutant strain. Life prolongation was retained under SKN-1 RNAi conditions showing that the effect is SKN-1 independent. The results of CAPE obtained in C. elegans differed from the results obtained in Hct116 colon carcinoma cells: CAPE also caused strong antioxidative effects in the mammalian cells, but no activation of the FoxO4 signalling pathway was detectable. Instead, an activation of the Nrf2 signalling pathway was shown by luciferase assay and western blots. CONCLUSION: CAPE activates the insulin-like DAF-16, but not the SKN-1 signalling pathway in C. elegans and therefore enhances the stress resistance and lifespan of this organism. Since modulation of the DAF-16 pathway was found to be a pivotal effect of CAPE in C. elegans, this has to be taken into account for the investigation of the molecular mechanisms of the traditional use of propolis.	[Havermann, Susannah; Chovolou, Yvonni; Waetjen, Wim] Univ Dusseldorf, Inst Toxicol, Dusseldorf, Germany; [Havermann, Susannah; Humpf, Hans-Ulrich] Univ Munster, Inst Food Chem, D-48149 Munster, Germany; [Havermann, Susannah; Waetjen, Wim] Univ Halle Wittenberg, Inst Agr & Nutr Sci, D-06108 Halle, Germany	Heinrich Heine University Dusseldorf; University of Munster; Martin Luther University Halle Wittenberg	Watjen, W (corresponding author), Univ Dusseldorf, Inst Toxicol, Dusseldorf, Germany.	wim.waetjen@landw.uni-halle.de	Wätjen, Wim/AAE-9018-2021; Humpf, Hans-Ulrich/AAV-4845-2020; Wätjen, Wim/G-8339-2015	Humpf, Hans-Ulrich/0000-0003-3296-3058	"Deutsche Forschungsgemeinschaft" (DFG) [1427]	"Deutsche Forschungsgemeinschaft" (DFG)(German Research Foundation (DFG))	Funding provided by the "Deutsche Forschungsgemeinschaft" (DFG - research training group 1427 "Food constituents as triggers of nuclear receptor mediated intestinal signalling"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Back P, 2010, EXP GERONTOL, V45, P603, DOI 10.1016/j.exger.2010.01.014; Balogun E, 2003, BIOCHEM J, V371, P887, DOI 10.1042/BJ20021619; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; Chen YJ, 2001, ANTI-CANCER DRUG, V12, P143, DOI 10.1097/00001813-200102000-00008; Choe KP, 2012, DRUG METAB REV, V44, P209, DOI 10.3109/03602532.2012.684799; Dubtsova E A, 2008, Adv Gerontol, V21, P252; Esrefoglu M, 2012, ULTRASTRUCT PATHOL, V36, P244, DOI 10.3109/01913123.2012.679351; Esrefoglu M, 2011, FUND CLIN PHARMACOL, V25, P580, DOI 10.1111/j.1472-8206.2010.00876.x; Farooqui Tahira, 2012, Front Biosci (Elite Ed), V4, P779; GRUNBERGER D, 1988, EXPERIENTIA, V44, P230, DOI 10.1007/BF01941717; Havermann S, 2013, J AGR FOOD CHEM, V61, P2158, DOI 10.1021/jf304553g; He XQ, 2009, MOL PHARMACOL, V76, P1265, DOI 10.1124/mol.109.058453; Huang MT, 1996, CARCINOGENESIS, V17, P761, DOI 10.1093/carcin/17.4.761; Irazoqui JE, 2010, NAT REV IMMUNOL, V10, P47, DOI 10.1038/nri2689; Kampkotter A, 2008, COMP BIOCHEM PHYS B, V149, P314, DOI 10.1016/j.cbpb.2007.10.004; Khalil Mahmoud Lotfy, 2006, Asian Pac J Cancer Prev, V7, P22; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Kuo YY, 2013, INT J MOL SCI, V14, P8801, DOI 10.3390/ijms14058801; Lee KJ, 2008, FOOD CHEM TOXICOL, V46, P2445, DOI 10.1016/j.fct.2008.03.032; Lee Y, 2010, EUR J PHARMACOL, V643, P21, DOI 10.1016/j.ejphar.2010.06.016; LEWIS JA, 1995, CAENORHABDITIS ELEGA, P4; Matsuzaki H, 2005, J BIOCHEM, V138, P485, DOI 10.1093/jb/mvi146; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Natarajan K, 1996, P NATL ACAD SCI USA, V93, P9090, DOI 10.1073/pnas.93.17.9090; Oh SW, 2006, NAT GENET, V38, P251, DOI 10.1038/ng1723; Ozturk G, 2012, EUR REV MED PHARMACO, V16, P2064; Pramanik KC, 2013, CARCINOGENESIS, V34, P2061, DOI 10.1093/carcin/bgt154; Pun PBL, 2010, BIOGERONTOLOGY, V11, P17, DOI 10.1007/s10522-009-9223-5; Russo A, 2002, FITOTERAPIA, V73, pS21, DOI 10.1016/S0367-326X(02)00187-9; Salatino A, 2011, NAT PROD REP, V28, P925, DOI 10.1039/c0np00072h; Sawicka D, 2012, FOLIA HISTOCHEM CYTO, V50, P25, DOI [10.5603/FHC.2012.0004, 10.2478/18693]; Scapagnini G, 2002, MOL PHARMACOL, V61, P554, DOI 10.1124/mol.61.3.554; Schaffitzel E, 2006, EXP GERONTOL, V41, P557, DOI 10.1016/j.exger.2006.02.008; Sforcin JM, 2011, J ETHNOPHARMACOL, V133, P253, DOI 10.1016/j.jep.2010.10.032; Surh YJ, 2005, J NUTR, V135, p2993S, DOI 10.1093/jn/135.12.2993S; Sykiotis GP, 2011, CURR OPIN CLIN NUTR, V14, P41, DOI 10.1097/MCO.0b013e32834136f2; Tolba MF, 2013, IUBMB LIFE, V65, P716, DOI 10.1002/iub.1188; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; Viuda-Martos M, 2008, J FOOD SCI, V73, pR117, DOI 10.1111/j.1750-3841.2008.00966.x; Wasserman WW, 1997, P NATL ACAD SCI USA, V94, P5361, DOI 10.1073/pnas.94.10.5361; Wilson MA, 2006, AGING CELL, V5, P59, DOI 10.1111/j.1474-9726.2006.00192.x; Yeh CT, 2009, J NUTR BIOCHEM, V20, P163, DOI 10.1016/j.jnutbio.2008.01.005; Zhao Y, 2011, J MOL CELL BIOL, V3, P276, DOI 10.1093/jmcb/mjr013	44	30	30	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100256	10.1371/journal.pone.0100256	http://dx.doi.org/10.1371/journal.pone.0100256			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964141	gold, Green Published, Green Submitted			2022-12-27	WOS:000338709500034
J	Hu, ZY; Yang, JL; Wu, YP; Xiong, GL; Wang, YL; Yang, J; Deng, L				Hu, Zhangyong; Yang, Jinliang; Wu, Yangping; Xiong, Guolian; Wang, Yali; Yang, Jun; Deng, Lan			Polymorphisms in CISH Gene Are Associated with Persistent Hepatitis B Virus Infection in Han Chinese Population	PLOS ONE			English	Article							REGULATORY T-CELLS; IMMUNE-RESPONSE; PROTEIN; SUSCEPTIBILITY; SH2	Background and Aim: Cytokine-inducible SRC homology 2 domain protein (CISH) is the first member of the suppressors of cytokine signaling (SOCS) protein family. An association between multiple CISH polymorphisms and susceptibility to infectious diseases has been reported. This study aimed to investigate the possible association of these single nucleotide polymorphisms (SNPs) in CISH gene with different outcomes of Hepatitis B virus (HBV) infection. Methods: 1019 unrelated Chinese Han subjects, including 240 persistent asymptomatic HBV carriers, 217 chronic hepatitis B patients, 137 HBV-related liver cirrhosis patients, and 425 cases of spontaneously recovered HBV as controls, were studied. Four SNPs (rs622502, rs2239751, rs414171 and rs6768300) in CISH gene were genotyped with the snapshot technique. Transcriptional activity of the CISH promoter was assayed in vitro using the dual-luciferase reporter assay system. Results: At position rs414171, A allele and AA genotype frequencies were significantly higher in the HBV-resolved group as compared to the persistent HBV infection group. At position rs2239751, TT genotype was further observed in the HBV-resolved group. Using asymptomatic HBV carriers as controls, our results indicated that the rs414171 and rs2239751 polymorphisms were unrelated to HBV progression. The other two SNPs (rs622502 and rs6768300) showed no association with persistent HBV infection. Haplotype analysis revealed that the GGCA haplotype was associated with spontaneous clearance of HBV in this population. Moreover, luciferase activity was significantly higher in the PGL3-Basic-rs414171T construct as compared to the PGL3-Basic-rs414171A construct (p<0.001). Conclusion: Two SNPs (rs414171 and rs2239751) in the CISH gene were associated with persistent HBV infection in Han Chinese population, but not with HBV progression.	[Hu, Zhangyong; Yang, Jinliang; Wu, Yangping] Sichuan Univ, West China Med Sch, West China Hosp, State Key Lab Biotherapy, Chengdu 610064, Peoples R China; [Hu, Zhangyong; Yang, Jinliang; Wu, Yangping] Sichuan Univ, West China Med Sch, West China Hosp, Ctr Canc, Chengdu 610064, Peoples R China; [Hu, Zhangyong; Xiong, Guolian; Wang, Yali; Yang, Jun; Deng, Lan] Chengdu Med Coll, Affiliated Hosp 1, Dept Infect Dis, Chengdu, Sichuan Provinc, Peoples R China	Sichuan University; Sichuan University; Chengdu Medical College	Yang, JL (corresponding author), Sichuan Univ, West China Med Sch, West China Hosp, State Key Lab Biotherapy, Chengdu 610064, Peoples R China.	jlyang011@163.com		Wu, Yangping/0000-0002-8937-4417	First Affiliated Hospital of Chengdu Medical College; Health Department of Sichuan Province	First Affiliated Hospital of Chengdu Medical College; Health Department of Sichuan Province	This work was financially supported by the First Affiliated Hospital of Chengdu Medical College and the Health Department of Sichuan Province. The funders had no role role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barboza L, 2007, VIROLOGY, V368, P41, DOI 10.1016/j.virol.2007.06.030; Borges S, 2008, ADV EXP MED BIOL, V617, P321, DOI 10.1007/978-0-387-69080-3_30; Chen S, 2003, INT IMMUNOL, V15, P403, DOI 10.1093/intimm/dxg039; de Andres MC, 2011, BIOCHEM BIOPH RES CO, V407, P54, DOI 10.1016/j.bbrc.2011.02.101; Deng GH, 2004, HEPATOLOGY, V40, P318, DOI 10.1002/hep.20318; Di Cristofaro J, 2010, J MOL DIAGN, V12, P453, DOI 10.2353/jmoldx.2010.090222; Gupta S, 2008, MOL IMMUNOL, V46, P213, DOI 10.1016/j.molimm.2008.08.275; Jung MC, 2002, LANCET INFECT DIS, V2, P43, DOI 10.1016/S1473-3099(01)00172-4; Khor CC, 2010, NEW ENGL J MED, V362, P2092, DOI 10.1056/NEJMoa0905606; Li SL, 2000, J EXP MED, V191, P985, DOI 10.1084/jem.191.6.985; Liang TJ, 2009, HEPATOLOGY, V49, pS13, DOI 10.1002/hep.22881; Maini MK, 2000, J EXP MED, V191, P1269, DOI 10.1084/jem.191.8.1269; Maini MK, 1999, GASTROENTEROLOGY, V117, P1386, DOI 10.1016/S0016-5085(99)70289-1; Maini MK, 2000, J VIRAL HEPATITIS, V7, P321; Mbarek H, 2011, HUM MOL GENET, V20, P3884, DOI 10.1093/hmg/ddr301; Miah MA, 2012, EUR J IMMUNOL, V42, P58, DOI 10.1002/eji.201141846; Nishida N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039175; Palmer DC, 2009, TRENDS IMMUNOL, V30, P592, DOI 10.1016/j.it.2009.09.009; Peng GP, 2008, IMMUNOLOGY, V123, P57, DOI 10.1111/j.1365-2567.2007.02691.x; Periasamy S, 2011, J INFECT DIS, V203, P1256, DOI 10.1093/infdis/jir011; Sprengers D, 2006, J HEPATOL, V45, P182, DOI 10.1016/j.jhep.2005.12.022; Stoop JN, 2005, HEPATOLOGY, V41, P771, DOI 10.1002/hep.20649; Tong HV, 2012, IMMUNOGENETICS, V64, P261, DOI 10.1007/s00251-011-0584-y; Trengove MC, 2013, AM J CLIN EXP IMMUNO, V2, P1; Tsai SL, 2003, J BIOMED SCI, V10, P120, DOI [10.1159/000068091, 10.1007/BF02256004]; Tsao JT, 2008, CLIN EXP MED, V8, P179, DOI 10.1007/s10238-008-0006-0; Yang XXO, 2013, NAT IMMUNOL, V14, P732, DOI 10.1038/ni.2633; Yoshimura A, 2004, J LEUKOCYTE BIOL, V75, P422, DOI 10.1189/jlb.0403194; Yoshimura A, 2005, ARTHRITIS RES THER, V7, P100, DOI 10.1186/ar1741	29	6	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100826	10.1371/journal.pone.0100826	http://dx.doi.org/10.1371/journal.pone.0100826			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964072	Green Published, gold, Green Submitted			2022-12-27	WOS:000338709500087
J	Kato, A; Okura, T; Hamada, C; Miyoshi, S; Katayama, H; Higaki, J; Ito, R				Kato, Aki; Okura, Takafumi; Hamada, Chizuru; Miyoshi, Seigo; Katayama, Hitoshi; Higaki, Jitsuo; Ito, Ryoji			Cell Stress Induces Upregulation of Osteopontin via the ERK Pathway in Type II Alveolar Epithelial Cells	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; ACTIVATED PROTEIN-KINASE; ENDOPLASMIC-RETICULUM STRESS; GENE-EXPRESSION; DNA-DAMAGE; INHIBITOR; APOPTOSIS; INTERLEUKIN-1-BETA; PATHOGENESIS; INDUCTION	Osteopontin (OPN) is a multifunctional protein that plays important roles in cell growth, differentiation, migration and tissue fibrosis. In human idiopathic pulmonary fibrosis and murine bleomycin-induced lung fibrosis, OPN is upregulated in type II alveolar epithelial cells (AEC II). However, the mechanism of OPN induction in AEC II is not fully understood. In this study, we demonstrate the molecular mechanism of OPN induction in AEC II and elucidate the functions of OPN in AEC II and lung fibroblasts. Human lung adenocarcinoma cells (A549) and mouse alveolar epithelial cells (MLE12), used as type II alveolar epithelial cell lines for in vitro assays, and human pulmonary alveolar epithelial cells (HPAEpiC) were treated with either bleomycin, doxorubicin or tunicamycin. The mechanism of OPN induction in these cells and its function as a pro-fibrotic cytokine on A549 and lung fibroblasts were analyzed. The DNA damaging reagents bleomycin and doxorubicin were found to induce OPN expression in A549, MLE12 and HPAEpiC. OPN expression was induced via activation of the extracellular signal-regulated protein kinase (ERK)-dependent signaling pathway in A549 and MLE12. The endoplasmic reticulum (ER) stress-inducing reagent tunicamycin induced OPN mRNA expression in A549, MLE12 and HPAEpiC, and OPN mRNA expression was induced via activation of the ERK-dependent signaling pathway in A549 and MLE12. Another ER stress-inducing reagent thapsigargin induced the expression of OPN mRNA as well as the subsequent production of OPN in A549 and MLE12. Furthermore, OPN promoted the proliferation of A549 and the migration of normal human lung fibroblasts. Inhibition of OPN by small interference RNA or neutralizing antibody suppressed both of these responses. The results of this study suggest that cell stress induces the upregulation of OPN in AEC II by signaling through the ERK pathway, and that upregulated OPN may play a role in fibrogenesis of the lung.	[Kato, Aki; Okura, Takafumi; Hamada, Chizuru; Miyoshi, Seigo; Katayama, Hitoshi; Higaki, Jitsuo; Ito, Ryoji] Ehime Univ, Grad Sch Med, Dept Cardiol Pulmonol Hypertens & Nephrol, Toon, Ehime, Japan	Ehime University	Okura, T (corresponding author), Ehime Univ, Grad Sch Med, Dept Cardiol Pulmonol Hypertens & Nephrol, Toon, Ehime, Japan.	okura@m.ehime-u.ac.jp						ADAMSON IYR, 1988, AM J PATHOL, V130, P377; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Barbas-Filho JV, 2001, J CLIN PATHOL, V54, P132, DOI 10.1136/jcp.54.2.132; Berman JS, 2004, AM J PHYSIOL-LUNG C, V286, pL1311, DOI 10.1152/ajplung.00394.2003; BJORKMAN U, 1982, EUR J BIOCHEM, V125, P585, DOI 10.1111/j.1432-1033.1982.tb06723.x; Buckley S, 1999, AM J PHYSIOL-LUNG C, V277, pL159, DOI 10.1152/ajplung.1999.277.1.L159; Day RM, 2001, AM J RESP CELL MOL, V25, P613, DOI 10.1165/ajrcmb.25.5.4521; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Hodgson U, 2002, THORAX, V57, P338, DOI 10.1136/thorax.57.4.338; Hong SY, 2010, MOL CELL BIOCHEM, V335, P263, DOI 10.1007/s11010-009-0276-1; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kelly MM, 2006, AM J RESP CRIT CARE, V174, P557, DOI 10.1164/rccm.200510-1648OC; KUHN C, 1991, AM J PATHOL, V138, P1257; Lawson WE, 2011, P NATL ACAD SCI USA, V108, P10562, DOI 10.1073/pnas.1107559108; Lee VY, 2005, AM J PHYSIOL-LUNG C, V289, pL521, DOI 10.1152/ajplung.00340.2004; Leleu X, 2009, BLOOD, V113, P626, DOI 10.1182/blood-2007-10-116848; Maitra M, 2012, P NATL ACAD SCI USA, V109, P21064, DOI 10.1073/pnas.1217069110; Matsuoka H, 2002, AM J PHYSIOL-LUNG C, V283, pL103, DOI 10.1152/ajplung.00187.2001; Mishra A, 2000, AM J RESP CELL MOL, V22, P543, DOI 10.1165/ajrcmb.22.5.3851; MIYAZAKI Y, 1995, ANN NY ACAD SCI, V760, P334, DOI 10.1111/j.1749-6632.1995.tb44651.x; Nogee LM, 2001, NEW ENGL J MED, V344, P573, DOI 10.1056/NEJM200102223440805; Pardo A, 2005, PLOS MED, V2, P891, DOI 10.1371/journal.pmed.0020251; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Selman Moises, 2006, Proc Am Thorac Soc, V3, P364, DOI 10.1513/pats.200601-003TK; Serlin DM, 2006, J CELL BIOCHEM, V97, P519, DOI 10.1002/jcb.20661; Takahashi F, 2001, AM J RESP CELL MOL, V24, P264, DOI 10.1165/ajrcmb.24.3.4293; TEWEY KM, 1984, SCIENCE, V226, P466, DOI 10.1126/science.6093249; Wang XK, 1996, ARTERIOSCL THROM VAS, V16, P1365, DOI 10.1161/01.ATV.16.11.1365; WICTOME M, 1992, BIOCHEM J, V283, P525, DOI 10.1042/bj2830525; Xie ZL, 2004, J CELL PHYSIOL, V198, P399, DOI 10.1002/jcp.10419; Yoshida K, 2002, J PATHOL, V198, P388, DOI 10.1002/path.1208	31	28	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100106	10.1371/journal.pone.0100106	http://dx.doi.org/10.1371/journal.pone.0100106			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963635	Green Published, Green Submitted, gold			2022-12-27	WOS:000338709500027
J	Martin-Merino, E; Fortuny, J; Rivero-Ferrer, E; Garcia-Rodriguez, LA				Martin-Merino, Elisa; Fortuny, Joan; Rivero-Ferrer, Elena; Alberto Garcia-Rodriguez, Luis			Incidence of Retinal Complications in a Cohort of Newly Diagnosed Diabetic Patients	PLOS ONE			English	Article							SIGHT-THREATENING RETINOPATHY; NIDDM; PROGRESSION; POPULATION; PREVALENCE; MELLITUS; WALES; EYE	Purpose: We aimed at estimating the incidence of diabetic retinopathy (DR) and maculopathy (DMP) among newly diagnosed type 1 (t1DM) and type 2 diabetic patients (t2DM) in the United Kingdom primary care system. The incidence of DMP among patients with DR was also estimated. Method: We conducted a cohort study using The Health Improvement Network database. The cohort included 64,983 incident diabetic patients (97.3% were t2DM) aged 1-84 years diagnosed between 2000 and 2007. This cohort was followed from the date of diabetes diagnosis until recording of DR or DMP in two separate follow-ups. Follow-up was censored at 85 years of age, death, or end of 2008. An additional follow-up was conducted from DR to DMP diagnosis using similar censoring reasons. DR and DMP cumulative incidences were calculated as well as incidence rates (IR; cases per 1,000 person-years) per calendar period (2000-2001 and 2006-2007). Results: Follow-up for DR: 9 years after diabetes diagnosis, 28% of t2DM and 24% of t1DM patients had developed DR (7,899 incident DR cases). During the first 2 years with diabetes, the IR was almost 2 times higher in patients diagnosed with diabetes in 2006-2007 (47.7) than among those diagnosed in 2000-2001 (24.5). Follow-up for DMP: 9 years after diabetes diagnosis, 3.6% of t2DM and 4.4% of t2DM patients had developed DMP (912 incident DMP cases). During the first 2 years with diabetes, the IR was three times higher in patients diagnosed with diabetes in 2006-2007 (5.8) than among those diagnosed in 2000-2001 (1.8). Macular oedema occurred in 0.8% of patients. Conclusions: In a cohort of incident diabetes, 28% of patients developed retinopathy and 4% maculopathy within the first 9 years. The 2-year IRs of DR and DMP were higher in patients diagnosed with diabetes during the period 2006-2007 than in those diagnosed during the 2000-2001 period.	[Martin-Merino, Elisa; Alberto Garcia-Rodriguez, Luis] Ctr Espanol Invest Farmacoepidemiol, Madrid, Spain; [Fortuny, Joan; Rivero-Ferrer, Elena] Novartis Farmaceut SA, DS&E Global Clin Epidemiol, Barcelona, Spain		Martin-Merino, E (corresponding author), Ctr Espanol Invest Farmacoepidemiol, Madrid, Spain.	elisaceife@gmail.com	rodriguez, luis a garcia/B-1980-2010; Rivero, Elena/ABC-3314-2021	RIVERO FERRER, MARIA ELENA/0000-0001-5093-2445; Fortuny, Joan/0000-0001-9401-5243; Martin Merino, Elisa/0000-0002-3576-8605	Novartis Farmaceutica	Novartis Farmaceutica	This study was funded by Novartis Farmaceutica S.A. The funder also provided support in the form of salaries for the authors JF and ERF but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the Author Contributions section.	[Anonymous], 2008, ANN REP 1 APR 2007 3; Blak Betina T, 2011, Inform Prim Care, V19, P251; Bunce C, 2008, EYE, V22, P905, DOI 10.1038/sj.eye.6702767; Cegedim Strategic Data Medical Research UK, THIN DAT STAT; Evans JMM, 2007, DIABETOLOGIA, V50, P729, DOI 10.1007/s00125-006-0585-9; HARDING SP, 1995, BMJ-BRIT MED J, V311, P1131, DOI 10.1136/bmj.311.7013.1131; HARRIS MI, 1993, DIABETES CARE, V16, P642, DOI 10.2337/diacare.16.4.642; HARRIS MI, 1992, DIABETES CARE, V15, P815, DOI 10.2337/diacare.15.7.815; Jones CD, 2012, DIABETES CARE, V35, P592, DOI 10.2337/dc11-0943; KLEIN R, 1995, OPHTHALMOLOGY, V102, P7; KLEIN R, 1984, ARCH OPHTHALMOL-CHIC, V102, P520, DOI 10.1001/archopht.1984.01040030398010; Kohner EM, 2001, DIABETIC MED, V18, P178; Martin-Merino E, 2012, DIABETES CARE, V35, P762, DOI 10.2337/dc11-2069; Gonzalez ELM, 2009, J EPIDEMIOL COMMUN H, V63, P332, DOI 10.1136/jech.2008.080382; Multilex. First DataBank Europe Ltd, 2010, MULT; ONEIL M, 1995, METHOD INFORM MED, V34, P187; Rosner B, 2011, FUNDAMENTALS BIOSTAT, P71; Rosner B, 2011, FUNDAMENTALS BIOSTAT, P760; Ruigomez A, 1998, EUR J EPIDEMIOL, V14, P439, DOI 10.1023/A:1007484920656; Semeraro F, 2011, J DIABETES COMPLICAT, V25, P292, DOI 10.1016/j.jdiacomp.2010.12.002; StataCorp, 2009, STAT STAT SOFTW REL; Stuart-Buttle C D, 1996, Proc AMIA Annu Fall Symp, P75; Thomas RL, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e874; Younis N, 2003, DIABETIC MED, V20, P758, DOI 10.1046/j.1464-5491.2003.01035.x; Younis N, 2003, LANCET, V361, P195, DOI 10.1016/S0140-6736(03)12267-2	25	30	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100283	10.1371/journal.pone.0100283	http://dx.doi.org/10.1371/journal.pone.0100283			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963628	Green Published, gold, Green Submitted			2022-12-27	WOS:000338709500036
J	Wan, NF; Ji, XY; Jiang, JX				Wan, Nian-Feng; Ji, Xiang-Yun; Jiang, Jie-Xian			Testing the Enemies Hypothesis in Peach Orchards in Two Different Geographic Areas in Eastern China: The Role of Ground Cover Vegetation	PLOS ONE			English	Article							NATURAL ENEMIES; BENEFICIAL ARTHROPODS; APPLE ORCHARD; DIVERSITY; COMMUNITIES; POPULATIONS; ABUNDANCE; PESTS; CROP; MANAGEMENT	Many studies have supported the enemies hypothesis, which suggests that natural enemies are more efficient at controlling arthropod pests in polyculture than in monoculture agro-ecosystems. However, we do not yet have evidence as to whether this hypothesis holds true in peach orchards over several geographic locations. In the two different geographic areas in eastern China (Xinchang a town in the Shanghai municipality, and Hudai, a town in Jiangsu Province) during a continuous three-year (2010-2012) investigation, we sampled arthropod pests and predators in Trifolium repens L. and in tree canopies of peach orchards with and without the ground cover plant T. repens. No significant differences were found in the abundances of the main groups of arthropod pests and predators in T. repens between Hudai and Xinchang. The abundance, richness, Simpson's index, Shannon-Wiener index, and Pielou evenness index of canopy predators in ground cover areas increased by 85.5, 27.5, 3.5, 16.7, and 7.9% in Xinchang, and by 87.0, 27.6, 3.5, 17.0 and 8.0% in Hudai compared to those in the controls, respectively. The average abundance of Lepidoptera, Coleoptera, Homoptera, true bugs and Acarina canopy pests in ground cover areas decreased by 9.2, 10.2, 17.2, 19.5 and 14.1% in Xinchang, and decreased by 9.5, 8.2, 16.8, 20.1 and 16.6% in Hudai compared to that in control areas, respectively. Our study also found a higher density of arthropod species resources in T. repens, as some omnivorous pests and predators residing in T. repens could move between the ground cover and the orchard canopy. In conclusion, ground cover in peach orchards supported the enemies hypothesis, as indicated by the fact that ground cover T. repens promoted the abundance and diversity of predators and reduced the number of arthropod pests in tree canopies in both geographical areas.	[Wan, Nian-Feng; Ji, Xiang-Yun; Jiang, Jie-Xian] Shanghai Acad Agr Sci, Shanghai Key Lab Protected Hort Technol, Ecoenvironm Protect Res Inst, Shanghai, Peoples R China	Shanghai Academy of Agricultural Sciences	Jiang, JX (corresponding author), Shanghai Acad Agr Sci, Shanghai Key Lab Protected Hort Technol, Ecoenvironm Protect Res Inst, Shanghai, Peoples R China.	jiangjiexian@163.com			Shanghai Agriculture Committee for young-talent growth [2014.1-22]; Shanghai Municipal Science and Technology Commission [12ZR1449100, 08dz1900401, 123919N0400]	Shanghai Agriculture Committee for young-talent growth; Shanghai Municipal Science and Technology Commission(Science & Technology Commission of Shanghai Municipality (STCSM))	This study was funded by the grants from Shanghai Agriculture Committee for young-talent growth ( No. 2014.1-22), and from Shanghai Municipal Science and Technology Commission (12ZR1449100, 08dz1900401, 123919N0400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDOW DA, 1991, ANNU REV ENTOMOL, V36, P561, DOI 10.1146/annurev.en.36.010191.003021; [毕守东 Bi Shoudong], 2003, [生态学杂志, Chinese Journal of Ecology], V22, P113; Bjorkman M, 2010, AGR FOREST ENTOMOL, V12, P123, DOI 10.1111/j.1461-9563.2009.00452.x; Bone NJ, 2009, CROP PROT, V28, P675, DOI 10.1016/j.cropro.2009.03.021; Carvalheiro LG, 2011, ECOL LETT, V14, P251, DOI 10.1111/j.1461-0248.2010.01579.x; Castagneyrol B, 2014, J APPL ECOL, V51, P134, DOI 10.1111/1365-2664.12175; Chen LL, 2011, BIOL CONTROL, V59, P326, DOI 10.1016/j.biocontrol.2011.09.007; Costello MJ, 1998, ECOL ENTOMOL, V23, P33, DOI 10.1046/j.1365-2311.1998.00108.x; Dong Jie, 2005, Great Lakes Entomologist, V38, P186; Downey RV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041672; Frechette B, 2008, EUR J ENTOMOL, V105, P521, DOI 10.14411/eje.2008.069; Giffard B, 2012, OECOLOGIA, V168, P415, DOI 10.1007/s00442-011-2089-7; Gray DM, 2012, APPL SOIL ECOL, V60, P41, DOI 10.1016/j.apsoil.2012.06.007; GRUYS P, 1982, ENTOMOL EXP APPL, V31, P70, DOI 10.1111/j.1570-7458.1982.tb03120.x; Hossain Z, 2000, AUST J ENTOMOL, V39, P39, DOI 10.1046/j.1440-6055.2000.00132.x; Hughes AR, 2012, ECOLOGY, V93, P1411, DOI 10.1890/11-1555.1; Jiang Jie-xian, 2011, Yingyong Shengtai Xuebao, V22, P2303; Landis DA, 2000, ANNU REV ENTOMOL, V45, P175, DOI 10.1146/annurev.ento.45.1.175; Letourneau DK, 2011, ECOL APPL, V21, P9, DOI 10.1890/09-2026.1; LETOURNEAU DK, 1987, ECOLOGY, V68, P1616, DOI 10.2307/1939853; Lundgren JG, 2010, ENVIRON ENTOMOL, V39, P1816, DOI 10.1603/EN10041; Mailloux Julie, 2010, Experimental and Applied Acarology, V52, P275, DOI 10.1007/s10493-010-9367-7; Norris RF, 2005, ANNU REV ENTOMOL, V50, P479, DOI 10.1146/annurev.ento.49.061802.123218; Penvern S, 2010, CROP PROT, V29, P1148, DOI 10.1016/j.cropro.2010.06.010; Podgaiski LR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060207; Riihimaki J, 2005, OECOLOGIA, V142, P90, DOI 10.1007/s00442-004-1696-y; RISCH SJ, 1981, ECOLOGY, V62, P1325, DOI 10.2307/1937296; ROOT RB, 1973, ECOL MONOGR, V43, P95, DOI 10.2307/1942161; Schuldt A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022905; Schut AGT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082778; Silva EB, 2010, B ENTOMOL RES, V100, P489, DOI 10.1017/S0007485309990526; Simon S, 2007, AGR ECOSYST ENVIRON, V122, P340, DOI 10.1016/j.agee.2007.01.020; Smith MW, 1996, BIOL CONTROL, V6, P164, DOI 10.1006/bcon.1996.0021; Song BZ, 2010, BIOCONTROL, V55, P741, DOI 10.1007/s10526-010-9301-2; TEDDERS WL, 1984, J GEORGIA ENTOMOL SO, V19, P498; Uliarte EM, 2013, AGR FOREST METEOROL, V181, P1, DOI 10.1016/j.agrformet.2013.06.019; Wan NF, 2014, ECOL ENG, V64, P62, DOI 10.1016/j.ecoleng.2013.12.033; Wan Nian-feng, 2011, Shengtaixue Zazhi, V30, P30; Wasser L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054776; Wilson AR, 2010, EUR J HORTIC SCI, V75, P269; Wyss E, 1996, AGR ECOSYST ENVIRON, V60, P47, DOI 10.1016/S0167-8809(96)01060-2; Zou Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082792	42	15	16	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e99850	10.1371/journal.pone.0099850	http://dx.doi.org/10.1371/journal.pone.0099850			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963719	gold, Green Published, Green Submitted			2022-12-27	WOS:000338709500020
J	Wang, XW; Liu, F; Wei, F; Ren, H; Hu, HD				Wang, Xiwei; Liu, Fen; Wei, Fang; Ren, Hong; Hu, Huaidong			Efficacy and Safety of Pegylated Interferon Plus Ribavirin Therapy for Chronic Hepatitis C Genotype 6: A Meta-Analysis	PLOS ONE			English	Article							VIRUS-INFECTION; VIROLOGICAL RESPONSE; COMBINATION THERAPY; HCV GENOTYPE-2; EPIDEMIOLOGY; STRATEGIES; MANAGEMENT; INHIBITORS; UPDATE; TRIAL	Background: Hepatitis C genotype 6 (HCV-6) is prevalent in Southeast Asia. Data on the efficacy of direct-acting antiviral agents in chronic HCV-6 patients is limited and pegylated interferon (Peg-IFN) plus ribavirin (RBV) combination therapy remains standard therapy for those patients. Aim: Meta-analysis was performed to assess the efficacy and safety of Peg-IFN plus RBV combination therapy for chronic HCV-6 patients. Methods: Relevant studies were found by database search through Medline, Embase, Web of Science and The Cochrane Library. All published clinical trials assessing the efficacy of Peg-IFN plus RBV combination therapy for chronic HCV-6 patients were included. Sustained virological response rate (SVR) was pooled. We performed additional meta-analyses to compare the SVR outcomes of 24 versus 48 weeks of treatment in four head-to-head trials. Another second meta-analysis was also conducted to compare the efficacy of combination Peg-IFN plus RBV therapy in HCV-6 versus HCV-1 patients. Results: Thirteen studies met the inclusion criteria. The pooled SVR of all single arms was 75% (95% CI: 0.68-0.81). The SVR of 24 weeks treatment was significantly lower than that at 48 weeks, with a risk difference of 214% (95% CI: 20.25 to 20.02, p = 0.02). However, when restricted to the patients with rapid virological response (RVR), there was no significant effect on SVR between these two treatment groups, with a risk difference of 21% (95% CI: 20.1 to 0.07, p = 0.67). The SVR in HCV-6 patients was significantly higher than that in HCV-1 patients, with a relative risk of 1.35 (95% CI: 1.16-1.57, p < 0.001). Side effects were common, but rarely caused treatment discontinuation. Conclusions: The results of this meta-analysis suggest that Peg-IFN plus RBV is effective and safe for HCV-6 patients. Shortening treatment seems to be feasible in HCV-6 patients with RVR when tolerance to treatment is poor. However, this decision should be made cautiously.	[Wang, Xiwei; Liu, Fen; Wei, Fang; Ren, Hong; Hu, Huaidong] Chongqing Med Univ, Affiliated Hosp 2, Dept Infect Dis, Inst Viral Hepatitis,Key Lab Mol Biol Infect Dis, Chongqing, Peoples R China	Chongqing Medical University	Hu, HD (corresponding author), Chongqing Med Univ, Affiliated Hosp 2, Dept Infect Dis, Inst Viral Hepatitis,Key Lab Mol Biol Infect Dis, Chongqing, Peoples R China.	huaidong.hu@gmail.com			Natural Science Foundation of China [81171560, 30930082, 81171561, 30972584]; National Science and Technology Major Project of China [2008ZX10002-006, 2012ZX10002007001, 2011ZX09302005, 2012ZX09303001-001, 2012ZX10002003]; Key Project of Chongqing Science and Technology [cstc2012gg-yyjsB10007]; Chongqing Natural Science Commission Foundation [cstc2011jjA10025]; Medical Research Fund by Chongqing Municipal Health Bureau [2009-1-71]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project of China; Key Project of Chongqing Science and Technology; Chongqing Natural Science Commission Foundation; Medical Research Fund by Chongqing Municipal Health Bureau	This research was supported by the Natural Science Foundation of China (81171560, 30930082, 81171561, 30972584), the National Science and Technology Major Project of China (2008ZX10002-006, 2012ZX10002007001, 2011ZX09302005, 2012ZX09303001-001, 2012ZX10002003), the Key Project of Chongqing Science and Technology (cstc2012gg-yyjsB10007), the Chongqing Natural Science Commission Foundation (cstc2011jjA10025), the Medical Research Fund by Chongqing Municipal Health Bureau (2009-1-71). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriulli A, 2008, ALIMENT PHARM THER, V28, P397, DOI 10.1111/j.1365-2036.2008.03763.x; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bunchorntavakul C, 2013, WORLD J HEPATOL, V5, P496, DOI 10.4254/wjh.v5.i9.496; Cai QX, 2013, HEPATOLOGY, V58, p1098A; Cai QX, 2011, HEPATOLOGY, V54, p829A; Chao DT, 2011, ALIMENT PHARM THER, V34, P286, DOI 10.1111/j.1365-2036.2011.04714.x; Clark VC, 2013, LIVER INT, V33, P80, DOI 10.1111/liv.12061; Craxi A, 2011, J HEPATOL, V55, P245, DOI 10.1016/j.jhep.2011.02.023; DAVIDSON F, 1995, J GEN VIROL, V76, P1197, DOI 10.1099/0022-1317-76-5-1197; Davies A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055373; Davis GL, 1997, HEPATOLOGY, V26, pS122, DOI 10.1002/hep.510260721; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Druyts E, 2012, CLIN EXP GASTROENTER, V5, P11, DOI 10.2147/CEG.S28253; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; FREEMAN MF, 1950, ANN MATH STAT, V21, P607, DOI 10.1214/aoms/1177729756; Fung J, 2008, J INFECT DIS, V198, P808, DOI 10.1086/591252; Gerber L, 2013, LIVER INT, V33, P85, DOI 10.1111/liv.12068; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Hsu CS, 2013, NEW ENGL J MED, V369, P678, DOI 10.1056/NEJMc1307641; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Lam KD, 2010, HEPATOLOGY, V52, P1573, DOI 10.1002/hep.23889; Lenz O, 2013, J HEPATOL, V58, P445, DOI 10.1016/j.jhep.2012.10.028; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Mauss S, 2012, Z GASTROENTEROL, V50, P441, DOI 10.1055/s-0031-1282072; MCOMISH F, 1994, J CLIN MICROBIOL, V32, P884, DOI 10.1128/JCM.32.4.884-892.1994; Mellor J, 1996, J CLIN MICROBIOL, V34, P417, DOI 10.1128/JCM.34.2.417-423.1996; Nguyen MH, 2008, AM J GASTROENTEROL, V103, P1131, DOI 10.1111/j.1572-0241.2008.01793.x; Nguyen Mindie H, 2005, Clin Gastroenterol Hepatol, V3, pS97, DOI 10.1016/S1542-3565(05)00711-1; Nguyen NH, 2010, J VIRAL HEPATITIS, V17, P691, DOI 10.1111/j.1365-2893.2009.01226.x; Pham TTT, 2012, J HEPATOL, V56, P1012, DOI 10.1016/j.jhep.2011.12.020; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Seto WK, 2013, J VIRAL HEPATITIS, V20, P470, DOI 10.1111/jvh.12047; Shao X, 2012, J HEPATOL, V56, pS66, DOI 10.1016/S0168-8278(12)60166-4; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Tangkijvanich P, 2012, J VIRAL HEPATITIS, V19, P423, DOI 10.1111/j.1365-2893.2011.01566.x; Tsang OT, 2008, HEPATOLOGY, V48, p884A; Tsang OTY, 2010, J GASTROEN HEPATOL, V25, P766, DOI 10.1111/j.1440-1746.2009.06163.x; Welsch C, 2012, GUT, V61, P36, DOI 10.1136/gutjnl-2012-302144; Zeuzem S, 2004, J HEPATOL, V40, P993, DOI [10.1016/S0168-8278(04)00060-1, 10.1016/j.jhep.2004.02.007]; Zeuzem S, 2011, GASTROENTEROLOGY, V141, P2047, DOI 10.1053/j.gastro.2011.08.051; Zhou YQ, 2011, J VIRAL HEPATITIS, V18, P595, DOI 10.1111/j.1365-2893.2010.01373.x	42	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100128	10.1371/journal.pone.0100128	http://dx.doi.org/10.1371/journal.pone.0100128			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963667	Green Published, Green Submitted, gold			2022-12-27	WOS:000338709500028
J	Bis, JC; DeStefano, A; Liu, XM; Brody, JA; Choi, SH; Verhaaren, BFJ; Debette, S; Ikram, MA; Shahar, E; Butler, KR; Gottesman, RF; Muzny, D; Kovar, CL; Psaty, BM; Hofman, A; Lumley, T; Gupta, M; Wolf, PA; van Duijn, C; Gibbs, RA; Mosley, TH; Longstreth, WT; Boerwinkle, E; Seshadri, S; Fornage, M				Bis, Joshua C.; DeStefano, Anita; Liu, Xiaoming; Brody, Jennifer A.; Choi, Seung Hoan; Verhaaren, Benjamin F. J.; Debette, Stephanie; Ikram, M. Arfan; Shahar, Eyal; Butler, Kenneth R., Jr.; Gottesman, Rebecca F.; Muzny, Donna; Kovar, Christie L.; Psaty, Bruce M.; Hofman, Albert; Lumley, Thomas; Gupta, Mayetri; Wolf, Philip A.; van Duijn, Cornelia; Gibbs, Richard A.; Mosley, Thomas H.; Longstreth, W. T., Jr.; Boerwinkle, Eric; Seshadri, Sudha; Fornage, Myriam			Associations of NINJ2 Sequence Variants with Incident Ischemic Stroke in the Cohorts for Heart and Aging in Genomic Epidemiology (CHARGE) Consortium	PLOS ONE			English	Article							FOLLOW-UP; GENOMEWIDE ASSOCIATION; CHROMOSOME 12P13; LIFETIME RISK; DISEASE; METAANALYSIS; FRAMINGHAM; SUBTYPES; HISTORY; SNPS	Background: Stroke, the leading neurologic cause of death and disability, has a substantial genetic component. We previously conducted a genome-wide association study (GWAS) in four prospective studies from the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium and demonstrated that sequence variants near the NINJ2 gene are associated with incident ischemic stroke. Here, we sought to fine-map functional variants in the region and evaluate the contribution of rare variants to ischemic stroke risk. Methods and Results: We sequenced 196 kb around NINJ2 on chromosome 12p13 among 3,986 European ancestry participants, including 475 ischemic stroke cases, from the Atherosclerosis Risk in Communities Study, Cardiovascular Health Study, and Framingham Heart Study. Meta-analyses of single-variant tests for 425 common variants (minor allele frequency [MAF] >= 1%) confirmed the original GWAS results and identified an independent intronic variant, rs34166160 (MAF = 0.012), most significantly associated with incident ischemic stroke (HR = 1.80, p = 0.0003). Aggregating 278 putatively-functional variants with MAF <= 1% using count statistics, we observed a nominally statistically significant association, with the burden of rare NINJ2 variants contributing to decreased ischemic stroke incidence (HR = 0.81; p = 0.026). Conclusion: Common and rare variants in the NINJ2 region were nominally associated with incident ischemic stroke among a subset of CHARGE participants. Allelic heterogeneity at this locus, caused by multiple rare, low frequency, and common variants with disparate effects on risk, may explain the difficulties in replicating the original GWAS results. Additional studies that take into account the complex allelic architecture at this locus are needed to confirm these findings.	[Bis, Joshua C.; Brody, Jennifer A.; Psaty, Bruce M.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA USA; [DeStefano, Anita; Choi, Seung Hoan; Gupta, Mayetri] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Liu, Xiaoming; Boerwinkle, Eric; Fornage, Myriam] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX 77030 USA; [Verhaaren, Benjamin F. J.; Ikram, M. Arfan] Erasmus MC, Dept Radiol, Rotterdam, Netherlands; [Verhaaren, Benjamin F. J.; Ikram, M. Arfan; Hofman, Albert; van Duijn, Cornelia] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Debette, Stephanie] INSERM, U708, Paris, France; [Debette, Stephanie] Univ Versailles St Quentin en Yvelines, Dept Epidemiol, Paris, France; [Ikram, M. Arfan] Erasmus MC, Dept Neurol, Rotterdam, Netherlands; [Ikram, M. Arfan] Consortium Hlth Aging, Leiden, Netherlands; [Shahar, Eyal] Univ Arizona, Mel & Enid Zuckerman Coll Publ Hlth, Tucson, AZ USA; [Butler, Kenneth R., Jr.; Mosley, Thomas H.] Univ Mississippi, Med Ctr, Dept Geriatr Med, Jackson, MS 39216 USA; [Gottesman, Rebecca F.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Muzny, Donna; Kovar, Christie L.; Gibbs, Richard A.; Boerwinkle, Eric] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Psaty, Bruce M.; Longstreth, W. T., Jr.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Psaty, Bruce M.] Grp Hlth, Grp Hlth Res Inst, Seattle, WA USA; [Lumley, Thomas] Univ Auckland, Dept Stat, Auckland 1, New Zealand; [Wolf, Philip A.; Seshadri, Sudha] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Longstreth, W. T., Jr.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Boerwinkle, Eric; Fornage, Myriam] Univ Texas Hlth Sci Ctr Houston, Brown Fdn, Inst Mol Med, Houston, TX 77030 USA	University of Washington; University of Washington Seattle; Boston University; University of Texas System; University of Texas Health Science Center Houston; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Erasmus University Rotterdam; Erasmus MC; University of Arizona; University of Mississippi; University of Mississippi Medical Center; Johns Hopkins University; Baylor College of Medicine; University of Washington; University of Washington Seattle; University of Auckland; Boston University; University of Washington; University of Washington Seattle; University of Texas System; University of Texas Health Science Center Houston	Fornage, M (corresponding author), Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX 77030 USA.	myriam.fornage@uth.tmc.edu	Ikram, M. Arfan/AAM-5225-2021; Liu, Xiaoming/C-2743-2008; Gottesman, Rebecca/ABA-8468-2020; Verhaaren, Benjamin F.J./R-1450-2016; Butler, Kenneth Ray/S-3328-2019; Debette, Stephanie/T-4946-2019	Liu, Xiaoming/0000-0001-8285-5528; Debette, Stephanie/0000-0001-8675-7968; Verhaaren, Benjamin/0000-0003-3477-9350; Seshadri, Sudha/0000-0001-6135-2622; Van Duijn, Cornelia/0000-0002-2374-9204	NIH through the American Recovery and Reinvestment Act of (ARRA) [5RC2HL102419]; National Heart, Lung, and Blood Institute (NHLBI) [HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C]; NHLBI [HHSN268201200036C, HHSN268200800007C, N01HC55222, N01HC85079, N01HC85080, N01HC85081, N01HC85082, N01HC85083, N01HC85086, HL080295, HL087652, HL105756, HL103612, HL120393]; Boston University [N01-HC-25195]; Affymetrix, Inc. [N02-HL-6-4278]; Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine and Boston Medical Center; NIA [AG023629, AG15928, AG20098, AG027058]; Erasmus Medical Center; Erasmus University, Rotterdam; Netherlands Organization for Health Research and Development; Research Institute for Diseases in the Elderly; Ministry of Education, Culture and Science; Ministry for Health, Welfare and Sports; European Commission; Municipality of Rotterdam; Research Institute for Diseases in the Elderly (RIDE2) [014-93-015]; Netherlands Genomics InitiativeNetherlands Organization for Scientific Research (Center for Medical Systems Biology and the Netherlands Consortium for Healthy Aging); Netherlands Heart Foundation (Nederlandse Hartstichting) [2009B102]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC085079, N01HC025195, N01HC085081, N01HC085082, N01HC085086, N01HC055222, N01HC085080, N01HC085083] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080295, R01HL103612, R01HL120393, R01HL087652, R01HL064278, U01HL120393, U01HL080295, R01HL105756, RC2HL102419] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020098, R01AG015928, R56AG020098, R56AG023629, R01AG027058, R01AG023629] Funding Source: NIH RePORTER	NIH through the American Recovery and Reinvestment Act of (ARRA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Boston University; Affymetrix, Inc.; Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine and Boston Medical Center; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Erasmus Medical Center; Erasmus University, Rotterdam; Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Research Institute for Diseases in the Elderly; Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry for Health, Welfare and Sports; European Commission(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam; Research Institute for Diseases in the Elderly (RIDE2); Netherlands Genomics InitiativeNetherlands Organization for Scientific Research (Center for Medical Systems Biology and the Netherlands Consortium for Healthy Aging); Netherlands Heart Foundation (Nederlandse Hartstichting)(Netherlands Heart Foundation); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding support for "Building on GWAS for NHLBI-diseases: the U.S. CHARGE Consortium'' was provided by the NIH through the American Recovery and Reinvestment Act of 2009 (ARRA) (5RC2HL102419). Data for "Building on GWAS for NHLBI-diseases: the U. S. CHARGE Consortium'' was provided by Eric Boerwinkle on behalf of the Atherosclerosis Risk in Communities (ARIC) Study, L. Adrienne Cupples, principal investigator for the Framingham Heart Study, and Bruce Psaty, principal investigator for the Cardiovascular Health Study. Sequencing was carried out at the Baylor Genome Center (U54 HG003273). The ARIC Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute (NHLBI) contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C). The Framingham Heart Study is conducted and supported by the NHLBI in collaboration with Boston University (Contract No. N01-HC-25195), and its contract with Affymetrix, Inc., for genome-wide genotyping services (Contract No. N02-HL-6-4278), for quality control by Framingham Heart Study investigators using genotypes in the SNP Health Association Resource (SHARe) project. A portion of this research was conducted using the Linux Cluster for Genetic Analysis (LinGA-II) funded by the Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine and Boston Medical Center. This CHS research was supported by NHLBI contracts HHSN268201200036C, HHSN268200800007C, N01HC55222, N01HC85079, N01HC85080, N01HC85081, N01HC85082, N01HC85083, N01HC85086; and NHLBI grants HL080295, HL087652, HL105756, HL103612, and HL120393 with additional contribution from the National Institute of Neurological Disorders and Stroke (NINDS). Additional support was provided through AG023629, AG15928, AG20098, and AG027058 from the NIA. A full list of principal CHS investigators and institutions can be found at CHS-NHLBI.org. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The Rotterdam Study was funded by Erasmus Medical Center and Erasmus University, Rotterdam; the Netherlands Organization for Health Research and Development; the Research Institute for Diseases in the Elderly; the Ministry of Education, Culture and Science; the Ministry for Health, Welfare and Sports; the European Commission; and the Municipality of Rotterdam; by grants from the Research Institute for Diseases in the Elderly (014-93-015; RIDE2), the Netherlands Genomics InitiativeNetherlands Organization for Scientific Research (Center for Medical Systems Biology and the Netherlands Consortium for Healthy Aging), and the Netherlands Heart Foundation (Nederlandse Hartstichting 2009B102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Reinvestment Act of 2009 (ARRA) (5RC2HL102419). Data for "Building on GWAS for NHLBI-diseases: the U. S. CHARGE Consortium'' was provided by Eric Boerwinkle on	Bak S, 2002, STROKE, V33, P769, DOI 10.1161/hs0302.103619; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Carandang R, 2006, JAMA-J AM MED ASSOC, V296, P2939, DOI 10.1001/jama.296.24.2939; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Dimou L, 2006, J NEUROSCI, V26, P5591, DOI 10.1523/JNEUROSCI.1103-06.2006; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Hollander M, 2002, CIRCULATION, V105, P2872, DOI 10.1161/01.CIR.0000018650.58984.75; Homer N, 2009, PLOS ONE, V4, pA95, DOI 10.1371/journal.pone.0007767; Hsieh YC, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-1; Ikram MA, 2009, NEW ENGL J MED, V360, P1718, DOI 10.1056/NEJMoa0900094; Jousilahti P, 1997, STROKE, V28, P1361, DOI 10.1161/01.STR.28.7.1361; Kim Dong-Eog, 2012, BMC Res Notes, V5, P155, DOI 10.1186/1756-0500-5-155; Li BH, 2012, J NEUROL SCI, V316, P116, DOI 10.1016/j.jns.2012.01.010; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liao DP, 1997, STROKE, V28, P1908, DOI 10.1161/01.STR.28.10.1908; Liu XM, 2011, HUM MUTAT, V32, P894, DOI 10.1002/humu.21517; Longstreth WT, 2001, NEUROLOGY, V56, P368, DOI 10.1212/WNL.56.3.368; Matsushita T, 2010, J HUM GENET, V55, P473, DOI 10.1038/jhg.2010.45; Olsson S, 2011, STROKE, V42, P214, DOI 10.1161/STROKEAHA.110.594010; Price T R, 1993, Ann Epidemiol, V3, P504; Psaty BM, 2009, CIRC-CARDIOVASC GENE, V2, P73, DOI 10.1161/CIRCGENETICS.108.829747; Rosamond WD, 1999, STROKE, V30, P736, DOI 10.1161/01.STR.30.4.736; Rosand J, 2010, NEW ENGL J MED, V362, P1547, DOI 10.1056/NEJMc0910050; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Seshadri S, 2006, STROKE, V37, P345, DOI 10.1161/01.STR.0000199613.38911.b2; Traylor M, 2012, LANCET NEUROL, V11, P951, DOI 10.1016/S1474-4422(12)70234-X; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wolf P A, 1978, Adv Neurol, V19, P107; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Zuk O, 2014, P NATL ACAD SCI USA, V111, pE455, DOI 10.1073/pnas.1322563111	33	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e99798	10.1371/journal.pone.0099798	http://dx.doi.org/10.1371/journal.pone.0099798			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959832	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000338633900015
J	Chen, R; Wu, X; Shen, LJ; Wang, B; Ma, MM; Yang, Y; Zhao, BW				Chen, Ran; Wu, Xia; Shen, Li-Jun; Wang, Bei; Ma, Ming-Ming; Yang, Yuan; Zhao, Bo-Wen			Left Ventricular Myocardial Function in Hemodialysis and Nondialysis Uremia Patients: A Three-Dimensional Speckle-Tracking Echocardiography Study	PLOS ONE			English	Article							2-DIMENSIONAL STRAIN; KIDNEY-DISEASE; QUANTIFICATION; CARDIOMYOPATHY; ASSOCIATION; TORSION	Background: Several studies have demonstrated that uremic patients who have preserved left ventricular ejection fraction (LVEF) could still have the potential for systolic dysfunction. The aim of this study was to assess the differences between the left ventricular (LV) myocardial function in hemodialysis and nondialysis uremic patients based on three-dimensional speckle-tracking echocardiography. Methods: The study population consisted of 35 maintenance hemodialysis patients (the hemodialysis group), 30 uremic patients who were hospitalized for the creation of a primary arteriovenous fistula (the nondialysis group), and 32 healthy volunteers. All of the patients had normal left ventricular ejection fractions (i.e., 55% or greater). Three-dimensional speckle tracking echocardiography was performed to assess the left ventricle's global three-dimensional strain, regional longitudinal strain, circumferential strain, and radial strain. Results: The left ventricular regional longitudinal strain, radial strain, circumferential strain, and global three-dimensional strain were significantly decreased in the nondialysis patients compared with the other two groups (all, P<0.001). However, the three-dimensional strain and the regional longitudinal strain were lower in the hemodialysis patients than in the controls (P<0.01). In the hemodialysis patients and the control group, the longitudinal strain, circumferential strain, and radial strain were higher at the apical level than they were at the basal level and midlevels. A multivariate linear regression analysis showed that the blood urea nitrogen and creatinine levels were independently associated with the values of the global three-dimensional strain (beta = -0.217, P = 0.000; beta = -0.243, P = 0.011, respectively) and the longitudinal strain (beta = -0.154, P = 0.032; beta = -0.188, P = 0.029, respectively). Conclusions: Three-dimensional speckle-tracking echocardiography may detect myocardial dysfunction in patients with uremia who have preserved LVEF. The global three-dimensional strain and the regional longitudinal strain appear to be superior in hemodialysis patients compared with nondialysis patients.	[Chen, Ran; Wang, Bei; Ma, Ming-Ming; Yang, Yuan; Zhao, Bo-Wen] Zhejiang Univ, Dept Diagnost Ultrasound & Echocardiog, Sir Run Run Shaw Hosp, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Ran; Wu, Xia; Wang, Bei; Ma, Ming-Ming; Yang, Yuan; Zhao, Bo-Wen] Zhejiang Univ, Sir Run Run Shaw Inst Clin Med, Hangzhou 310003, Zhejiang, Peoples R China; [Wu, Xia] Zhejiang Univ, Dept Radiol, Sir Run Run Shaw Hosp, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China; [Shen, Li-Jun] First Peoples Hosp, Dept Ultrasound, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Zhao, BW (corresponding author), Zhejiang Univ, Dept Diagnost Ultrasound & Echocardiog, Sir Run Run Shaw Hosp, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China.	zbwcjp@163.com			Specialized Research Fund for the Doctoral Program of Higher Education [20110101120136]	Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	The research is supported by Specialized Research Fund for the Doctoral Program of Higher Education (20110101120136). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AURIGEMMA GP, 1995, CURR PROB CARDIOLOGY, V20, P367; Bogaert J, 2001, AM J PHYSIOL-HEART C, V280, pH610; Buckberg G D, 2001, Semin Thorac Cardiovasc Surg, V13, P402; Fagugli RM, 2001, AM J KIDNEY DIS, V38, P371, DOI 10.1053/ajkd.2001.26103; Fleiss JL, 1986, DESIGN ANAL CLIN EXP, Vxiv; Foley RN, 1998, J AM SOC NEPHROL, V9, P267; Gotte MJW, 2006, J AM COLL CARDIOL, V48, P2002, DOI 10.1016/j.jacc.2006.07.048; Hayashi SY, 2004, NEPHROL DIAL TRANSPL, V19, P1497, DOI 10.1093/ndt/gfh205; Kang Y, 2012, ACTA CARDIOL, V67, P423, DOI 10.1080/AC.67.4.2170683; Kim HK, 2007, J AM SOC ECHOCARDIOG, V20, P45, DOI 10.1016/j.echo.2006.07.007; Kleijn SA, 2012, EUR HEART J-CARD IMG, V13, P834, DOI 10.1093/ehjci/jes030; Lekawanvijit S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041281; Liu YW, 2011, AM J NEPHROL, V33, P84, DOI 10.1159/000322709; Maizel J, 2009, CIRCULATION, V119, P306, DOI 10.1161/CIRCULATIONAHA.108.797407; Marks AR, 1997, AM J PHYSIOL-HEART C, V272, pH597, DOI 10.1152/ajpheart.1997.272.2.H597; Mendes Ligia, 2008, Rev Port Cardiol, V27, P1011; Ng ACT, 2008, AM J CARDIOL, V102, P784, DOI 10.1016/j.amjcard.2008.05.027; Perk G, 2007, J AM SOC ECHOCARDIOG, V20, P234, DOI 10.1016/j.echo.2006.08.023; Popovic ZB, 2008, J AM SOC ECHOCARDIOG, V21, P1299, DOI 10.1016/j.echo.2008.09.011; Rakhit DJ, 2007, AM HEART J, V153, P656, DOI 10.1016/j.ahj.2007.01.028; Saito K, 2009, J AM SOC ECHOCARDIOG, V22, P1025, DOI 10.1016/j.echo.2009.05.021; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Semple D, 2011, J AM SOC NEPHROL, V22, P207, DOI 10.1681/ASN.2009090900; Serri K, 2006, J AM COLL CARDIOL, V47, P1175, DOI 10.1016/j.jacc.2005.10.061; Smith GL, 2006, ARCH INTERN MED, V166, P1134, DOI 10.1001/archinte.166.10.1134; Yan P, 2011, NEPHRON CLIN PRACT, V118, pC232, DOI 10.1159/000321383	26	20	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100265	10.1371/journal.pone.0100265	http://dx.doi.org/10.1371/journal.pone.0100265			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959903	Green Published, Green Submitted, gold			2022-12-27	WOS:000338633900034
J	Greensite, F				Greensite, Fred			Special Relativity Derived from Spacetime Magma	PLOS ONE			English	Article							ALGEBRA; TIME	We present a derivation of relativistic spacetime largely untethered from specific physical considerations, in constrast to the many physically-based derivations that have appeared in the last few decades. The argument proceeds from the inherent magma (groupoid) existing on the union of spacetime frame components R and Euclidean R-3 which is consistent with an "inversion symmetry'' constraint from which the Minkowski norm results. In this context, the latter is also characterized as one member of a class of "inverse norms'' which play major roles with respect to various unital*-algebras more generally.	Univ Calif Irvine, Dept Radiol Sci, Irvine, CA 92717 USA	University of California System; University of California Irvine	Greensite, F (corresponding author), Univ Calif Irvine, Dept Radiol Sci, Irvine, CA 92717 USA.	fredg@uci.edu						BAYLIS WE, 1989, J PHYS A-MATH GEN, V22, P1, DOI [10.1088/0305-4470/22/1/008, 10.1016/0920-5632(89)90417-9]; Bourbaki N, 1974, ALGEBRA, P1; CARLINI A, 1994, PHYS REV D, V49, P866, DOI 10.1103/PhysRevD.49.866; Chappell JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051756; Hestenes D, 2003, AM J PHYS, V71, P691, DOI 10.1119/1.1571836; Itin Y, 2004, ANN PHYS-NEW YORK, V312, P60, DOI 10.1016/j.aop.2004.01.009; McCrimmon K, 2004, TASTE JORDAN ALGEBRA, P79; PAGE DN, 1983, PHYS REV D, V27, P2885, DOI 10.1103/PhysRevD.27.2885; SCHUTZ JW, 1989, J MATH PHYS, V30, P635, DOI 10.1063/1.528431; Tegmark M., 2014, OUR MATH UNIVERSE; van Dam H, 2001, PHYS LETT B, V520, P159, DOI 10.1016/S0370-2693(01)01140-6; Yahalom A, 2008, FOUND PHYS, V38, P489, DOI 10.1007/s10701-008-9215-3; Yau S-T, 2013, EXPLAINS EVERYTHING, P34	13	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100583	10.1371/journal.pone.0100583	http://dx.doi.org/10.1371/journal.pone.0100583			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959889	Green Published, gold, Green Submitted			2022-12-27	WOS:000338633900059
J	Sydow, JF; Lipsmeier, F; Larraillet, V; Hilger, M; Mautz, B; Molhoj, M; Kuentzer, J; Klostermann, S; Schoch, J; Voelger, HR; Regula, JT; Cramer, P; Papadimitriou, A; Kettenberger, H				Sydow, Jasmin F.; Lipsmeier, Florian; Larraillet, Vincent; Hilger, Maximiliane; Mautz, Bjoern; Molhoj, Michael; Kuentzer, Jan; Klostermann, Stefan; Schoch, Juergen; Voelger, Hans R.; Regula, Joerg T.; Cramer, Patrick; Papadimitriou, Apollon; Kettenberger, Hubert			Structure-Based Prediction of Asparagine and Aspartate Degradation Sites in Antibody Variable Regions	PLOS ONE			English	Article							RECOMBINANT MONOCLONAL-ANTIBODY; COMPLEMENTARITY-DETERMINING REGIONS; X-L DEAMIDATION; PROTEIN DEAMIDATION; PEPTIDE DEGRADATION; CHEMICAL PATHWAYS; SUCCINIMIDE FORMATION; NONENZYMATIC DEAMIDATION; CHARGE HETEROGENEITY; MODEL HEXAPEPTIDES	Monoclonal antibodies (mAbs) and proteins containing antibody domains are the most prevalent class of biotherapeutics in diverse indication areas. Today, established techniques such as immunization or phage display allow for an efficient generation of new mAbs. Besides functional properties, the stability of future therapeutic mAbs is a key selection criterion which is essential for the development of a drug candidate into a marketed product. Therapeutic proteins may degrade via asparagine (Asn) deamidation and aspartate (Asp) isomerization, but the factors responsible for such degradation remain poorly understood. We studied the structural properties of a large, uniform dataset of Asn and Asp residues in the variable domains of antibodies. Their structural parameters were correlated with the degradation propensities measured by mass spectrometry. We show that degradation hotspots can be characterized by their conformational flexibility, the size of the C-terminally flanking amino acid residue, and secondary structural parameters. From these results we derive an accurate in silico prediction method for the degradation propensity of both Asn and Asp residues in the complementarity-determining regions (CDRs) of mAbs.	[Sydow, Jasmin F.; Larraillet, Vincent; Hilger, Maximiliane; Mautz, Bjoern; Molhoj, Michael; Voelger, Hans R.; Regula, Joerg T.; Kettenberger, Hubert] Roche Pharmaceut Res & Early Dev, Large Mol Res, Penzberg, Germany; [Kuentzer, Jan] Roche Pharmaceut Res & Early Dev, Dis & Translat Informat, Penzberg, Germany; [Lipsmeier, Florian; Klostermann, Stefan; Schoch, Juergen] Roche Pharmaceut Res & Early Dev, Therapeut Modal Informat, Penzberg, Germany; [Papadimitriou, Apollon] Roche Pharmaceut Res & Early Dev, Pharmaceut Sci, Penzberg, Germany; [Cramer, Patrick] Univ Munich, Gene Ctr Munich, Munich, Germany; [Cramer, Patrick] Univ Munich, Ctr Integrated Prot Sci CIPSM, Dept Biochem, Munich, Germany	University of Munich; University of Munich	Kettenberger, H (corresponding author), Roche Pharmaceut Res & Early Dev, Large Mol Res, Penzberg, Germany.	hubert.kettenberger@roche.com		Regula, Joerg Thomas/0000-0002-7343-1077	Roche PostDoc Fellowship programme	Roche PostDoc Fellowship programme	J.F.S. was funded by the Roche PostDoc Fellowship programme. All other authors, except P.C., are current employees of Roche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accelrys Software Inc, 2012, DISC STUD MOD ENV VE; AlLazikani B, 1997, J MOL BIOL, V273, P927, DOI 10.1006/jmbi.1997.1354; Athiner L, 2002, J BIOL CHEM, V277, P30502, DOI 10.1074/jbc.M205314200; Beck A, 2013, ANAL CHEM, V85, P715, DOI 10.1021/ac3032355; BISCHOFF R, 1994, J CHROMATOGR B, V662, P261, DOI 10.1016/0378-4347(94)00203-7; Bohme L, 2008, BIOL CHEM, V389, P1043, DOI 10.1515/BC.2008.123; Bohme L, 2008, BIOL CHEM, V389, P1055, DOI 10.1515/BC.2008.125; BRENNAN TV, 1995, INT J PEPT PROT RES, V45, P547; BRENNAN TV, 1993, PROTEIN SCI, V2, P331; Cacia J, 1996, BIOCHEMISTRY-US, V35, P1897, DOI 10.1021/bi951526c; Capasso S, 2000, J PEPT RES, V55, P224, DOI 10.1034/j.1399-3011.2000.00172.x; CAPASSO S, 1992, PEPTIDE RES, V5, P325; Catak S, 2009, J PHYS CHEM A, V113, P1111, DOI 10.1021/jp808597v; Chelius D, 2005, ANAL CHEM, V77, P6004, DOI 10.1021/ac050672d; Chennamsetty N, 2009, P NATL ACAD SCI USA, V106, P11937, DOI 10.1073/pnas.0904191106; CHOTHIA C, 1989, NATURE, V342, P877, DOI 10.1038/342877a0; Chu GC, 2007, PHARM RES-DORDR, V24, P1145, DOI 10.1007/s11095-007-9241-4; CLARKE S, 1987, INT J PEPT PROT RES, V30, P808, DOI 10.1111/j.1399-3011.1987.tb03390.x; Deverman BE, 2002, CELL, V111, P51, DOI 10.1016/S0092-8674(02)00972-8; Diepold K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030295; Dimitriadou E, 2011, MISC FUNCTIONS DEP S; GEIGER T, 1987, J BIOL CHEM, V262, P785; Haberger M, 2014, MABS-AUSTIN, V6, P327, DOI 10.4161/mabs.27876; Hambly DM, 2009, ANAL CHEM, V81, P7454, DOI 10.1021/ac901258g; HARDING JJ, 1989, MECH AGEING DEV, V50, P7, DOI 10.1016/0047-6374(89)90054-7; Harris RJ, 2001, J CHROMATOGR B, V752, P233, DOI 10.1016/S0378-4347(00)00548-X; Huang LH, 2005, ANAL CHEM, V77, P1432, DOI 10.1021/ac0494174; Joshi AB, 2005, J PHARM SCI-US, V94, P1912, DOI 10.1002/jps.20405; Karatzoglou A, 2004, J STAT SOFTW, V11, P1, DOI [10.18637/jss.v011.i09, DOI 10.18637/JSS.V011.I09]; Kosky AA, 1999, PROTEIN SCI, V8, P2519; Kosky AA, 2009, PHARM RES-DORDR, V26, P2417, DOI 10.1007/s11095-009-9953-8; KOSSIAKOFF AA, 1988, SCIENCE, V240, P191, DOI 10.1126/science.3353715; Kosugi S, 2008, BIOCHEM BIOPH RES CO, V371, P22, DOI 10.1016/j.bbrc.2008.03.109; KROON DJ, 1992, PHARMACEUT RES, V9, P1386, DOI 10.1023/A:1015894409623; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Liu HC, 2006, J CHROMATOGR B, V837, P35, DOI 10.1016/j.jchromb.2006.03.053; Liu HJ, 2008, J CHROMATOGR A, V1210, P76, DOI 10.1016/j.chroma.2008.09.059; MANNING MC, 1989, PHARM RES-DORDR, V6, P903, DOI 10.1023/A:1015929109894; Martin ACR, 1996, J MOL BIOL, V263, P800, DOI 10.1006/jmbi.1996.0617; Morea V, 1998, J MOL BIOL, V275, P269, DOI 10.1006/jmbi.1997.1442; Neergaard MS, 2014, J PHARM SCI-US, V103, P115, DOI 10.1002/jps.23788; OLIYAI C, 1994, PHARMACEUT RES, V11, P751, DOI 10.1023/A:1018944800691; OLIYAI C, 1994, PHARM RES-DORDR, V11, P901, DOI 10.1023/A:1018998312503; OLIYAI C, 1993, PHARMACEUT RES, V10, P95, DOI 10.1023/A:1018981231468; PATEL K, 1990, PHARMACEUT RES, V7, P703, DOI 10.1023/A:1015807303766; Perkins M, 2000, PHARMACEUT RES, V17, P1110, DOI 10.1023/A:1026461830617; Pilot Pipeline, 2012, PIP PIL VERS 8 5 0 2; Rehder DS, 2008, BIOCHEMISTRY-US, V47, P2518, DOI 10.1021/bi7018223; Reichert JM, 2005, NAT BIOTECHNOL, V23, P1073, DOI 10.1038/nbt0905-1073; Ripley B, 2011, TREE CLASSIFICATION; ROBINSON AB, 1970, P NATL ACAD SCI USA, V66, P753, DOI 10.1073/pnas.66.3.753; Robinson NE, 2002, P NATL ACAD SCI USA, V99, P5283, DOI 10.1073/pnas.082102799; Robinson NE, 2001, P NATL ACAD SCI USA, V98, P4367, DOI 10.1073/pnas.071066498; Robinson NE, 2001, P NATL ACAD SCI USA, V98, P12409, DOI 10.1073/pnas.221463198; Robinson NE, 2001, P NATL ACAD SCI USA, V98, P944, DOI 10.1073/pnas.98.3.944; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schrodinger, SCHRODINGERTHE PYMOL; SHAO J, 1993, J AM STAT ASSOC, V88, P486, DOI 10.2307/2290328; Shimizu T, 2005, BIOL PHARM BULL, V28, P1590, DOI 10.1248/bpb.28.1590; Simpson R.J., 2010, COLD SPRING HARB PRO, V2010; Sinha S, 2009, PROTEIN SCI, V18, P1573, DOI 10.1002/pro.173; Spassov VZ, 2008, PROTEIN ENG DES SEL, V21, P91, DOI 10.1093/protein/gzm083; Sreedhara A, 2012, PHARM RES-DORDR, V29, P187, DOI 10.1007/s11095-011-0534-2; STEPHENSON RC, 1989, J BIOL CHEM, V264, P6164; Swann PG, 2008, CURR OPIN IMMUNOL, V20, P493, DOI 10.1016/j.coi.2008.05.013; Takata T, 2008, PROTEIN SCI, V17, P1565, DOI 10.1110/ps.035410.108; Takata T, 2007, BIOCHEMISTRY-US, V46, P8861, DOI 10.1021/bi700487q; Therneau RM, 2010, RPART RECURSIVE PART; Timm V, 2010, J CHROMATOGR B, V878, P777, DOI 10.1016/j.jchromb.2010.01.036; TOMIZAWA H, 1994, BIOCHEMISTRY-US, V33, P8770, DOI 10.1021/bi00195a019; TYLERCROSS R, 1991, J BIOL CHEM, V266, P22549; Valliere-Douglass J, 2008, ANAL CHEM, V80, P3168, DOI 10.1021/ac702245c; Venables WN., 2002, MODERN APPL STAT S 4; Vlasak J, 2008, CURR PHARM BIOTECHNO, V9, P468, DOI 10.2174/138920108786786402; Vlasak J, 2009, ANAL BIOCHEM, V392, P145, DOI 10.1016/j.ab.2009.05.043; Wakankar AA, 2007, J PHARM SCI-US, V96, P1708, DOI 10.1002/jps.20823; Wakankar AA, 2007, BIOCHEMISTRY-US, V46, P1534, DOI 10.1021/bi061500t; Wakankar AA, 2006, J PHARM SCI-US, V95, P2321, DOI 10.1002/jps.20740; Weihs C, 2005, ST CLASS DAT ANAL, P335; Weintraub SJ, 2004, MECH AGEING DEV, V125, P255, DOI 10.1016/j.mad.2004.03.002; Weintraub Steven J, 2007, Sci STKE, V2007, pre7, DOI 10.1126/stke.4092007re7; Whitelegg Nicholas, 2004, Methods Mol Biol, V248, P51; WRIGHT HT, 1991, PROTEIN ENG, V4, P283, DOI 10.1093/protein/4.3.283; WRIGHT HT, 1991, CRIT REV BIOCHEM MOL, V26, P1, DOI 10.1080/10409230490440532; Xiao G, 2008, J PHARMACEUT BIOMED, V47, P23, DOI 10.1016/j.jpba.2007.11.050; Xiao G, 2007, ANAL CHEM, V79, P2714, DOI 10.1021/ac0617870; Xie M, 2000, J PEPT RES, V56, P165, DOI 10.1034/j.1399-3011.2000.00764.x; Xie ML, 1999, J PHARM SCI, V88, P8, DOI 10.1021/js9802493; Xu QS, 2001, CHEMOMETR INTELL LAB, V56, P1, DOI 10.1016/S0169-7439(00)00122-2; Yan BX, 2009, J PHARM SCI-US, V98, P3509, DOI 10.1002/jps.21655; Yang HQ, 2010, ELECTROPHORESIS, V31, P1764, DOI 10.1002/elps.201000027; Yang XY, 2013, MABS-AUSTIN, V5, P787, DOI 10.4161/mabs.25269; Yi L, 2013, J PHARM SCI-US, V102, P947, DOI 10.1002/jps.23423; Yu XC, 2011, ANAL CHEM, V83, P5912, DOI 10.1021/ac200750u; Zabrouskov V, 2006, BIOCHEMISTRY-US, V45, P987, DOI 10.1021/bi0517584; Zhang J, 2011, ANAL BIOCHEM, V410, P234, DOI 10.1016/j.ab.2010.11.040; Zhang W, 2003, J PHARMACEUT BIOMED, V30, P1479, DOI 10.1016/S0731-7085(02)00479-X; Zhao R, 2004, CANCER CELL, V5, P37, DOI 10.1016/S1535-6108(03)00333-7; Zhao R, 2007, PLOS BIOL, V5, P39, DOI 10.1371/journal.pbio.0050001; Zheng JY, 2006, INT J PHARM, V308, P46, DOI 10.1016/j.ijpharm.2005.10.024	100	88	98	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100736	10.1371/journal.pone.0100736	http://dx.doi.org/10.1371/journal.pone.0100736			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959685	Green Published, Green Submitted, gold			2022-12-27	WOS:000338633900077
J	Jimenez, R; Hidalgo, M				Jimenez, Raul; Hidalgo, Manuel			Forensic Analysis of Venezuelan Elections during the Chavez Presidency	PLOS ONE			English	Article							RECALL REFERENDUM; BENFORDS LAW; DEMOCRACY; BEHAVIOR	Hugo Chavez dominated the Venezuelan electoral landscape since his first presidential victory in 1998 until his death in 2013. Nobody doubts that he always received considerable voter support in the numerous elections held during his mandate. However, the integrity of the electoral system has come into question since the 2004 Presidential Recall Referendum. From then on, different sectors of society have systematically alleged electoral irregularities or biases in favor of the incumbent party. We have carried out a thorough forensic analysis of the national-level Venezuelan electoral processes held during the 1998-2012 period to assess these complaints. The second-digit Benford's law and two statistical models of vote distributions, recently introduced in the literature, are reviewed and used in our case study. In addition, we discuss a new method to detect irregular variations in the electoral roll. The outputs obtained from these election forensic tools are examined taking into account the substantive context of the elections and referenda under study. Thus, we reach two main conclusions. Firstly, all the tools uncover anomalous statistical patterns, which are consistent with election fraud from 2004 onwards. Although our results are not a concluding proof of fraud, they signal the Recall Referendum as a turning point in the integrity of the Venezuelan elections. Secondly, our analysis calls into question the reliability of the electoral register since 2004. In particular, we found irregular variations in the electoral roll that were decisive in winning the 50% majority in the 2004 Referendum and in the 2012 Presidential Elections.	[Jimenez, Raul] Univ Carlos III Madrid, Dept Stat, Madrid, Spain; [Hidalgo, Manuel] Univ Carlos III Madrid, Dept Social Sci, Madrid, Spain	Universidad Carlos III de Madrid; Universidad Carlos III de Madrid	Jimenez, R (corresponding author), Univ Carlos III Madrid, Dept Stat, Madrid, Spain.	rauljose.jimenez@uc3m.es	Jimenez, Raul/K-6438-2014	Jimenez, Raul/0000-0002-8125-1586; HIDALGO, MANUEL/0000-0001-6352-2576	Spanish Ministry of Economy and Competitiveness [ECO2011-25706, CSO2012-35852]	Spanish Ministry of Economy and Competitiveness(Spanish Government)	This work was supported by the Spanish Ministry of Economy and Competitiveness (Projects ECO2011-25706 and CSO2012-35852). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez AE, 2009, AM LAT HOY, V51, P61; Araujo NAM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012446; Asociacion Civil Ojo Electoral, 2009, INF FIN OBS REF PROP; Ball P, 2012, NATURE NEWS, DOI [10.1038/nature.2012.9925, DOI 10.1038/NATURE.2012.9925]; Beber B, 2012, POLIT ANAL, V20, P211, DOI 10.1093/pan/mps003; Cantu F, 2011, POLIT ANAL, V19, P409, DOI 10.1093/pan/mpr033; Carriquiry AL, 2011, STAT SCI, V26, P471, DOI 10.1214/11-STS379; Corrales Javier, 2005, REV EUROPEA ESTUDIOS, V79, P105; Costa RN, 1999, PHYS REV E, V60, P1067, DOI 10.1103/PhysRevE.60.1067; Deckert J, 2011, POLIT ANAL, V19, P245, DOI 10.1093/pan/mpr014; Delfino G, 2012, ESDATA; Drake P. D., 2000, J ACCOUNTING ED, V18, P127, DOI DOI 10.1016/S0748-5751(00)00008-7; Ehremberg R, 2012, SCIENCENEWS, V181, P16; European Union Election Observation Mission, 2007, FIN REP PRES EL VEN; Fortunato S, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.138701; Gomez E, 2012, CAPRILES AQUI GANO G, V1, P4; Hausmann R, 2011, STAT SCI, V26, P543, DOI 10.1214/11-STS373; Heath O, 2009, ELECT STUD, V28, P467, DOI 10.1016/j.electstud.2009.06.001; Hidalgo M, 2011, ELECT STUD, V30, P872, DOI 10.1016/j.electstud.2011.10.002; Hidalgo M, 2009, J DEMOCR, V20, P78; Jimenez R, 2012, KEEP EYE VENEZUELAN; Jimenez R, 2011, STAT SCI, V26, P564, DOI 10.1214/11-STS375; Klimek P, 2012, P NATL ACAD SCI USA, V109, P16469, DOI 10.1073/pnas.1210722109; Kornblith M, 2005, J DEMOCR, V16, P124, DOI 10.1353/jod.2005.0011; Kornblith M, 2001, VENEZUELA TRANSICION; Levin I, 2009, EVT WOTE09 P 2009 C; Levin I, 2013, INTRO VIRTUAL ISSUE; Levine D, 2012, AM LAT HOY, V62, P157; Lohr S, 2004, SAMPLING DESIGN ANAL; Lopez-Pintor R, 2010, IFES ELECT FRAUD WHI; Lupu N, 2010, LAT AM RES REV, V45, P7; Martin I, 2011, STAT SCI, V26, P528, DOI 10.1214/10-STS350; McCoy JL, 1999, J DEMOCR, V10, P64, DOI 10.1353/jod.1999.0049; Mebane Walter., 2008, ELECTION FRAUD DETEC, P162; Mebane WR, 2011, POLIT ANAL, V19, P269, DOI 10.1093/pan/mpr024; Molina JE, 2004, LAT AM POLIT SOC, V46, P103, DOI 10.1353/lap.2004.0008; Monitor Electoral Presidencial 2012, 2012, INF CONS DEM REG EL; Mosquera G, 2012, INFORME UCAB CONSIST; Myakgov M, 2009, FORENSICS ELECTION F; Organizacion de Estados Americanos, 2008, INF FIN MIS OBS EL O; Pantin M, 2012, RED OBSERVACION ELEC; Pereira V, 2011, QUALITY DEMOCRACY; Pericchi L, 2011, STAT SCI, V26, P502, DOI 10.1214/09-STS296; Prado R, 2011, STAT SCI, V26, P517, DOI 10.1214/09-STS295; Robertson E, 2012, VENEZUELAN ELECTORAL; Sumate, 2008, INF SUM REF PROYECT; The Carter Center, 2012, STUD MISS OCT 7 PRES; The Carter Center, 1999, OBS 1998 VEN EL; The Carter Center, 2001, OBS POL CHANG VEN BO; Wallace W.A., 2002, J GOVE FINANC MANAG, V51, P16	50	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100884	10.1371/journal.pone.0100884	http://dx.doi.org/10.1371/journal.pone.0100884			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK6BK	24971462	Green Published, gold, Green Submitted			2022-12-27	WOS:000338512200070
J	Souverein, D; Boers, SA; Veenendaal, D; Euser, SM; Kluytmans, J; Den Boer, JW				Souverein, Dennis; Boers, Stefan A.; Veenendaal, Dick; Euser, Sjoerd M.; Kluytmans, Jan; Den Boer, Jeroen W.			Polyclonal Spread and Outbreaks with ESBL Positive Gentamicin Resistant Klebsiella spp. in the Region Kennemerland, The Netherlands	PLOS ONE			English	Article							LACTAMASE-PRODUCING ENTEROBACTERIACEAE; ESCHERICHIA-COLI; CHICKEN MEAT; PNEUMONIAE; MICROORGANISMS; HUMANS; GENES	Objective: The objective of this study was to analyze the transmission dynamics of ESBL positive Klebsiella spp. with an additional resistance towards gentamicin (ESBL-G) in a Dutch region of 650,000 inhabitants in 2012. Methods: All patient related ESBL-G isolates isolated in 2012 were genotyped using both Amplification Fragment Length Polymorphism (AFLP) and High-throughput MultiLocus Sequence Typing (HiMLST). HiMLST was used to analyze the presence of (unidentified) clusters of ESBL-G positive patients. Furthermore, all consecutive ESBL-G isolates within patients were studied in order to evaluate the intra-patient variation of antibiotic phenotypes. Results: There were 38 ESBL-G isolates, which were classified into 18 different sequence types (STs) and into 21 different AFLP types. Within the STs, four clusters were detected from which two were unknown resulting in a transmission index of 0.27. An analysis of consecutive ESBL-G isolates (with similar STs) within patients showed that for 68.8% of the patients at least one isolate had a different consecutive antibiotic phenotype. Conclusion: The transmission of ESBL-G in the region Kennemerland in 2012 was polyclonal with several outbreaks (with a high level of epidemiological linkage). Furthermore, clustering by antibiotic phenotype characterization seems to be an inadequate approach in this setting. The routine practice of molecular typing of collected ESBL-G isolates may help to detect transmission in an early stage, which opens the possibility of a rapid response.	[Souverein, Dennis; Boers, Stefan A.; Veenendaal, Dick; Euser, Sjoerd M.; Den Boer, Jeroen W.] Reg Publ Hlth Lab Kennemerland, Dept Epidemiol & Infect Prevent, Haarlem, Netherlands; [Kluytmans, Jan] Amphia Hosp, Lab Microbiol & Infect Control, Breda, Netherlands; [Kluytmans, Jan] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands	Amphia Hospital; Vrije Universiteit Amsterdam	Souverein, D (corresponding author), Reg Publ Hlth Lab Kennemerland, Dept Epidemiol & Infect Prevent, Haarlem, Netherlands.	d.souverein@streeklabhaarlem.nl		Boers, Stefan/0000-0002-1560-6799				Boers SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039630; Bonten MJM, 2011, NED TIJDSCHR GENEES, V155, pA3992; Cosgrove SE, 2006, CLIN INFECT DIS, V42, pS82, DOI 10.1086/499406; Diancourt L, 2005, J CLIN MICROBIOL, V43, P4178, DOI 10.1128/JCM.43.8.4178-4182.2005; ECDC, 2012, SUMM LAT DAT ANT RES; European Centre for Disease Prevention and Control (ECDC), 2012, ANT RES SURV EUR 201; Falagas ME, 2009, J HOSP INFECT, V73, P345, DOI 10.1016/j.jhin.2009.02.021; Kluytmans JAJW, 2013, CLIN INFECT DIS, V56, P478, DOI 10.1093/cid/cis929; Livermore DM, 2012, KOREAN J INTERN MED, V27, P128, DOI 10.3904/kjim.2012.27.2.128; Morris D, 2012, J ANTIMICROB CHEMOTH, V67, P2367, DOI 10.1093/jac/dks239; Nielsen JB, 2011, EUR J CLIN MICROBIOL, V30, P773, DOI 10.1007/s10096-011-1153-x; NVMM, 2013, GUID LAB DET HIGHL R; Overdevest I, 2011, EMERG INFECT DIS, V17, P1216, DOI 10.3201/eid1707.110209; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Rakotonirina HC, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-85; Rottier WC, 2012, J ANTIMICROB CHEMOTH, V67, P1311, DOI 10.1093/jac/dks065; Tumbarello M, 2007, ANTIMICROB AGENTS CH, V51, P1987, DOI 10.1128/AAC.01509-06; van Belkum A, 2007, CLIN MICROBIOL INFEC, V13, P1, DOI 10.1111/j.1469-0691.2007.01786.x; van der Zee A, 2003, J CLIN MICROBIOL, V41, P798, DOI [10.1128/JCM.41.2.798-802.2003, 10.1128/JCm.41.2.798-802.2003]; van der Zwet WC, 1999, J HOSP INFECT, V42, P295, DOI 10.1053/jhin.1998.0611; van't Veen A, 2005, J CLIN MICROBIOL, V43, P4961, DOI 10.1128/JCM.43.10.4961-4967.2005; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Willemsen I, 2011, INFECT CONT HOSP EP, V32, P333, DOI 10.1086/658941; Willemsen I, 2008, INFECT CONT HOSP EP, V29, P1110, DOI 10.1086/592408; Woodford N, 2011, FEMS MICROBIOL REV, V35, P736, DOI 10.1111/j.1574-6976.2011.00268.x	25	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e101212	10.1371/journal.pone.0101212	http://dx.doi.org/10.1371/journal.pone.0101212			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971598	gold, Green Published, Green Submitted			2022-12-27	WOS:000338512200104
J	Wang, B				Wang, Bo			Effect of Time Delay on Recognition Memory for Pictures: The Modulatory Role of Emotion	PLOS ONE			English	Article							COGNITIVE COSTS; NEUTRAL WORDS; RESPONSE BIAS; RECOLLECTION; FAMILIARITY; NEUROSCIENCE; AROUSAL; PERSPECTIVE; EXPERIENCE; RETENTION	This study investigated the modulatory role of emotion in the effect of time delay on recognition memory for pictures. Participants viewed neutral, positive and negative pictures, and took a recognition memory test 5 minutes, 24 hours, or 1 week after learning. The findings are: 1) For neutral, positive and negative pictures, overall recognition accuracy in the 5-min delay did not significantly differ from that in the 24-h delay. For neutral and positive pictures, overall recognition accuracy in the 1-week delay was lower than in the 24-h delay; for negative pictures, overall recognition in the 24-h and 1-week delay did not significantly differ. Therefore negative emotion modulates the effect of time delay on recognition memory, maintaining retention of overall recognition accuracy only within a certain frame of time. 2) For the three types of pictures, recollection and familiarity in the 5-min delay did not significantly differ from that in the 24-h and the 1-week delay. Thus emotion does not appear to modulate the effect of time delay on recollection and familiarity. However, recollection in the 24-h delay was higher than in the 1-week delay, whereas familiarity in the 24-h delay was lower than in the 1-week delay.	Cent Univ Finance & Econ, Sch Social Dev, Dept Psychol, Inst Econ Psychol, Beijing, Peoples R China	Central University of Finance & Economics	Wang, B (corresponding author), Cent Univ Finance & Econ, Sch Social Dev, Dept Psychol, Inst Econ Psychol, Beijing, Peoples R China.	709534442@qq.com			National Natural Science Foundation of China [31100736]; Program for Innovation Research in Central University of Finance and Economics; "project 211(Phase III)'' of Central University of Finance and Economics	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Innovation Research in Central University of Finance and Economics; "project 211(Phase III)'' of Central University of Finance and Economics	This study was supported by a Grant from the National Natural Science Foundation of China (No. 31100736), a Program for Innovation Research in Central University of Finance and Economics, and a Grant from the "project 211(Phase III)'' of Central University of Finance and Economics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahola A, 2012, PSYCHOL CRIME LAW, V18, P491, DOI 10.1080/1068316X.2010.509316; Atienza M, 2008, J SLEEP RES, V17, P285, DOI 10.1111/j.1365-2869.2008.00661.x; Aube W, 2013, MEMORY, V21, P981, DOI 10.1080/09658211.2013.770871; Bartsch T, 2011, P NATL ACAD SCI USA, V108, P17562, DOI 10.1073/pnas.1110266108; Baumeister RF, 1998, J PERS SOC PSYCHOL, V74, P1252, DOI 10.1037/0022-3514.74.5.1252; Bouton ME, 2004, LEARN MEMORY, V11, P485, DOI 10.1101/lm.78804; BRADLEY MM, 1992, J EXP PSYCHOL LEARN, V18, P379, DOI 10.1037/0278-7393.18.2.379; Brandt KR, 2009, NEUROCASE, V15, P60, DOI 10.1080/13554790802613025; BROWN MW, 1987, BRAIN RES, V409, P158, DOI 10.1016/0006-8993(87)90753-0; Brubaker MS, 2014, AGING NEUROPSYCHOL C, V21, P1, DOI 10.1080/13825585.2013.772558; Comblain C, 2004, MEMORY, V12, P673, DOI 10.1080/09658210344000477; COREN S, 1990, B PSYCHONOMIC SOC, V28, P551; DANION JM, 1995, J AFFECT DISORDERS, V34, P227, DOI 10.1016/0165-0327(95)00021-E; Davidson RJ, 2000, PSYCHOL BULL, V126, P890, DOI 10.1037/0033-2909.126.6.890; Delamater AR, 2004, Q J EXP PSYCHOL-B, V57, P97, DOI 10.1080/02724990344000097; Doerksen S, 2001, EMOTION, V1, P5, DOI 10.1037/1528-3542.1.1.5; Dolcos F, 2005, P NATL ACAD SCI USA, V102, P2626, DOI 10.1073/pnas.0409848102; Dougal S, 2007, PSYCHON B REV, V14, P423, DOI 10.3758/BF03194083; Duarte A, 2004, COGNITIVE BRAIN RES, V18, P255, DOI 10.1016/j.cogbrainres.2003.10.010; Ebbinghaus H., 1964, MEMORY CONTRIBUTION; EICHENBAUM H, 1994, BEHAV BRAIN SCI, V17, P449, DOI 10.1017/S0140525X00035391; Erdelyi MH, 2010, AM PSYCHOL, V65, P623, DOI 10.1037/a0020440; Fredrickson BL, 2005, COGNITION EMOTION, V19, P313, DOI 10.1080/02699930441000238; Garavan H, 2000, AM J PSYCHIAT, V157, P1789, DOI 10.1176/appi.ajp.157.11.1789; Geraci L, 2006, PSYCHON B REV, V13, P466, DOI 10.3758/BF03193871; Greder RC, 2008, MEM COGNITION, V36, P933, DOI 10.3758/MC.36.5.933; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Gross JJ, 1998, J PERS SOC PSYCHOL, V74, P224, DOI 10.1037/0022-3514.74.1.224; Guy SC, 1999, CONSCIOUS COGN, V8, P114, DOI 10.1006/ccog.1998.0379; Hamann SB, 2002, PSYCHOL SCI, V13, P135, DOI 10.1111/1467-9280.00425; Itier RJ, 2004, NEUROREPORT, V15, P1261, DOI 10.1097/01.wnr.0000127827.73576.d8; Kapucu A, 2008, J EXP PSYCHOL LEARN, V34, P703, DOI 10.1037/0278-7393.34.3.703; Keng SL, 2013, BEHAV RES THER, V51, P899, DOI 10.1016/j.brat.2013.10.006; Kensinger EA, 2003, MEM COGNITION, V31, P1169, DOI 10.3758/BF03195800; Kensinger EA, 2009, EMOT REV, V1, P120, DOI 10.1177/1754073908100436; KLEINSMITH LJ, 1963, J EXP PSYCHOL, V65, P190, DOI 10.1037/h0040288; Lane RD, 1997, NEUROPSYCHOLOGIA, V35, P1437, DOI 10.1016/S0028-3932(97)00070-5; Lang PJ, 2008, A7 U FLORIDA; Maratos EJ, 2000, NEUROPSYCHOLOGIA, V38, P1452, DOI 10.1016/S0028-3932(00)00061-0; McGaugh JL, 2002, TRENDS NEUROSCI, V25, P456, DOI 10.1016/S0166-2236(02)02211-7; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Mickley Steinmetz KR, 2013, COGNITION EMOTION; Nielson KA, 2009, CONSCIOUS COGN, V18, P786, DOI 10.1016/j.concog.2009.06.001; Ochsner KN, 2000, J EXP PSYCHOL GEN, V129, P242, DOI 10.1037//0096-3445.129.2.242; Rescorla RA, 2004, LEARN MEMORY, V11, P501, DOI 10.1101/lm.77504; Richards JM, 2000, J PERS SOC PSYCHOL, V79, P410, DOI 10.1037//0022-3514.79.3.410; Rimmele U, 2011, EMOTION, V11, P553, DOI 10.1037/a0024246; Rossion B, 2000, NEUROREPORT, V11, P69, DOI 10.1097/00001756-200001170-00014; Rugg MD, 2003, TRENDS COGN SCI, V7, P313, DOI 10.1016/S1364-6613(03)00131-1; Sharot T, 2008, COGNITION, V106, P538, DOI 10.1016/j.cognition.2007.03.002; Sharot T, 2004, COGN AFFECT BEHAV NE, V4, P294, DOI 10.3758/CABN.4.3.294; Skinner EI, 2007, NEUROPSYCHOLOGIA, V45, P2163, DOI 10.1016/j.neuropsychologia.2007.03.007; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704; Thoma P, 2006, NEUROPSYCHOLOGIA, V44, P430, DOI 10.1016/j.neuropsychologia.2005.05.017; TULVING E, 1985, CAN PSYCHOL, V26, P1, DOI 10.1037/h0080017; van den Hout M, 2003, BEHAV RES THER, V41, P369, DOI 10.1016/S0005-7967(02)00097-9; Weiermann B, 2010, INT J NEUROSCI, V120, P211, DOI 10.3109/00207450903506510; Weymar M, 2011, HUM BRAIN MAPP, V32, P632, DOI 10.1002/hbm.21051; Woodworth R.S., 1954, EXP PSYCHOL; Yonelinas AP, 2002, PSYCHON B REV, V9, P575, DOI 10.3758/BF03196315; Yonelinas AP, 2005, J NEUROSCI, V25, P3002, DOI 10.1523/JNEUROSCI.5295-04.2005	62	10	10	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100238	10.1371/journal.pone.0100238	http://dx.doi.org/10.1371/journal.pone.0100238			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK6BK	24971457	gold, Green Published, Green Submitted			2022-12-27	WOS:000338512200022
J	Bilousov, O; Koval, A; Keshelava, A; Katanaev, VL				Bilousov, Oleksii; Koval, Alexey; Keshelava, Amiran; Katanaev, Vladimir L.			Identification of Novel Elements of the Drosophila Blisterome Sheds Light on Potential Pathological Mechanisms of Several Human Diseases	PLOS ONE			English	Article							WING MORPHOGENESIS; CELL-ADHESION; PS INTEGRINS; EPIDERMOLYSIS-BULLOSA; EXTRACELLULAR-MATRIX; SIGNALING PATHWAY; LAMININ-A; PROTEIN; GENES; MELANOGASTER	Main developmental programs are highly conserved among species of the animal kingdom. Improper execution of these programs often leads to progression of various diseases and disorders. Here we focused on Drosophila wing tissue morphogenesis, a fairly complex developmental program, one of the steps of which - apposition of the dorsal and ventral wing sheets during metamorphosis - is mediated by integrins. Disruption of this apposition leads to wing blistering which serves as an easily screenable phenotype for components regulating this process. By means of RNAi-silencing technique and the blister phenotype as readout, we identify numerous novel proteins potentially involved in wing sheet adhesion. Remarkably, our results reveal not only participants of the integrin-mediated machinery, but also components of other cellular processes, e.g. cell cycle, RNA splicing, and vesicular trafficking. With the use of bioinformatics tools, these data are assembled into a large blisterome network. Analysis of human orthologues of the Drosophila blisterome components shows that many disease-related genes may contribute to cell adhesion implementation, providing hints on possible mechanisms of these human pathologies.	[Bilousov, Oleksii; Koval, Alexey; Keshelava, Amiran; Katanaev, Vladimir L.] Univ Lausanne, Fac Biol & Med, Dept Pharmacol & Toxicol, Lausanne, Switzerland	University of Lausanne	Katanaev, VL (corresponding author), Univ Lausanne, Fac Biol & Med, Dept Pharmacol & Toxicol, Lausanne, Switzerland.	vladimir.katanaev@unil.ch	Koval, Alexey/AAU-4766-2020; Katanaev, Vladimir/F-9480-2014	Katanaev, Vladimir/0000-0002-7909-5617; Bilousov, Oleksii/0000-0001-5783-6325	Swiss National Science Foundation [31003A_138350]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The work was supported by the Swiss National Science Foundation (grant #31003A_138350) to V.L.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhuin T, 2011, INT J DEV BIOL, V55, P269, DOI 10.1387/ijdb.103149tb; Bokel C, 2002, DEV CELL, V3, P311, DOI 10.1016/S1534-5807(02)00265-4; Brabant MC, 1998, ANN NY ACAD SCI, V857, P99, DOI 10.1111/j.1749-6632.1998.tb10110.x; BRABANT MC, 1993, DEV BIOL, V157, P49, DOI 10.1006/dbio.1993.1111; Brabant MC, 1996, DEVELOPMENT, V122, P3307; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Brooke MA, 2012, J PATHOL, V226, P158, DOI 10.1002/path.3027; BROWER DL, 1985, DEV BIOL, V108, P120, DOI 10.1016/0012-1606(85)90014-4; BROWER DL, 1989, NATURE, V342, P285, DOI 10.1038/342285a0; Brown NH, 2002, DEV CELL, V3, P569, DOI 10.1016/S1534-5807(02)00290-3; CAPDEVILA J, 1994, EMBO J, V13, P4459, DOI 10.1002/j.1460-2075.1994.tb06768.x; Clark KA, 2003, DEVELOPMENT, V130, P2611, DOI 10.1242/dev.00492; D'Avino PP, 2000, DEV BIOL, V220, P211, DOI 10.1006/dbio.2000.9650; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Egoz-Matia N, 2011, DEV BIOL, V351, P99, DOI 10.1016/j.ydbio.2010.12.039; Fine JD, 2007, ANN NY ACAD SCI, V1112, P396, DOI 10.1196/annals.1415.017; Fine JD, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-12; FOGERTY FJ, 1994, DEVELOPMENT, V120, P1747; Fraichard S, 2010, DEV BIOL, V340, P504, DOI 10.1016/j.ydbio.2010.02.008; FRISTROM D, 1993, DEVELOPMENT, V117, P509; FRISTROM D, 1994, DEVELOPMENT, V120, P2661; Godenschwege TA, 2000, EUR J CELL BIOL, V79, P495, DOI 10.1078/0171-9335-00072; GOTWALS PJ, 1994, CURR OPIN CELL BIOL, V6, P734, DOI 10.1016/0955-0674(94)90101-5; Graner MW, 1998, J BIOL CHEM, V273, P18235, DOI 10.1074/jbc.273.29.18235; Gregory SL, 1998, J CELL BIOL, V143, P1271, DOI 10.1083/jcb.143.5.1271; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; HENCHCLIFFE C, 1993, DEVELOPMENT, V118, P325; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; Inoue Y, 2007, DEV BIOL, V304, P90, DOI 10.1016/j.ydbio.2006.12.022; Jonsson PF, 2006, BIOINFORMATICS, V22, P2291, DOI 10.1093/bioinformatics/btl390; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Katanaev VL, 2011, BIOCHEMISTRY-MOSCOW+, V76, P1556, DOI 10.1134/S0006297911130116; Katanayeva N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012331; Lee SB, 2003, DEVELOPMENT, V130, P4001, DOI 10.1242/dev.00595; Loer B, 2008, NAT CELL BIOL, V10, P422, DOI 10.1038/ncb1704; Martin D, 1999, J CELL BIOL, V145, P191, DOI 10.1083/jcb.145.1.191; McQuilton P, 2012, NUCLEIC ACIDS RES, V40, pD706, DOI 10.1093/nar/gkr1030; Milenkovic T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-70; Narasimha M, 2000, INTEGRINS ASS PROTEI; Nikolaidou KK, 2004, CURR BIOL, V14, P1822, DOI 10.1016/j.cub.2004.09.080; Pandey UB, 2011, PHARMACOL REV, V63, P411, DOI 10.1124/pr.110.003293; Pesquita C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000443; Prout M, 1997, GENETICS, V146, P275; Raghavan S, 2000, J CELL BIOL, V150, P1149, DOI 10.1083/jcb.150.5.1149; Rebhan M, 1997, TRENDS GENET, V13, P163, DOI 10.1016/S0168-9525(97)01103-7; Reiter LT, 2001, GENOME RES, V11, P1114, DOI 10.1101/gr.169101; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Said MR, 2004, P NATL ACAD SCI USA, V101, P18006, DOI 10.1073/pnas.0405996101; SCHUBIGER M, 1987, DEV BIOL, V123, P145, DOI 10.1016/0012-1606(87)90436-2; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; STURTEVANT MA, 1995, DEVELOPMENT, V121, P785; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Torgler CN, 2004, DEV CELL, V6, P357, DOI 10.1016/S1534-5807(04)00055-3; Vakaloglou KM, 2012, J CELL SCI, V125, P3221, DOI 10.1242/jcs.102384; Van Dongen S, 2008, SIAM J MATRIX ANAL A, V30, P121, DOI 10.1137/040608635; Wachi S, 2005, BIOINFORMATICS, V21, P4205, DOI 10.1093/bioinformatics/bti688; Walsh EP, 1998, GENETICS, V150, P791; Waterhouse RM, 2013, NUCLEIC ACIDS RES, V41, pD358, DOI 10.1093/nar/gks1116; Watt F. M., 2011, COLD SPRING HARBOR P, V3; WILCOX M, 1989, DEVELOPMENT, V107, P891; WILCOX M, 1981, CELL, V25, P159, DOI 10.1016/0092-8674(81)90240-3; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zaidel-Bar R, 2010, J CELL SCI, V123, P1385, DOI 10.1242/jcs.066183; Zervas CG, 2001, J CELL BIOL, V152, P1007, DOI 10.1083/jcb.152.5.1007; Zhang LP, 2008, J BIOL CHEM, V283, P34076, DOI 10.1074/jbc.M804267200; Zhang YJ, 2002, J CELL SCI, V115, P4777, DOI 10.1242/jcs.00166; ZUSMAN S, 1990, DEVELOPMENT, V108, P391	68	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e101133	10.1371/journal.pone.0101133	http://dx.doi.org/10.1371/journal.pone.0101133			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968325	Green Published, Green Submitted, gold			2022-12-27	WOS:000338280800113
J	Hanieh, S; Ha, TT; Simpson, JA; Thuy, TT; Khuong, NC; Thoang, DD; Tran, TD; Tuan, T; Fisher, J; Biggs, BA				Hanieh, Sarah; Ha, Tran T.; Simpson, Julie A.; Thuy, Tran T.; Khuong, Nguyen C.; Thoang, Dang D.; Tran, Thach D.; Tran Tuan; Fisher, Jane; Biggs, Beverley-Ann			Maternal Vitamin D Status and Infant Outcomes in Rural Vietnam: A Prospective Cohort Study	PLOS ONE			English	Article							D DEFICIENCY; HIGH PREVALENCE; PREGNANCY; HEALTH; SUPPLEMENTATION; RISK; 25-HYDROXYVITAMIN-D; ASSOCIATION; CHILDREN; GROWTH	Objective: Vitamin D deficiency affects 1 billion people globally. It has an important role in bone homeostasis, brain development and modulation of the immune system and yet the impact of antenatal vitamin D deficiency on infant outcomes is poorly understood. We assessed the association of 25- hydroxyvitamin D levels (25-OHD) in late pregnancy and early infant growth and developmental outcomes in rural Vietnam. Design and Methods: A prospective cohort study of 960 women who had previously participated in a double-blind cluster randomized controlled trial of antenatal micronutrient supplementation in rural Vietnam was undertaken. Maternal 25-OHD concentration was measured at 32 weeks gestation, and infants were followed until 6 months of age. Main outcome measures were cognitive, motor, socio-emotional and language scores using the Bayley Scales of Infant Development, 3rd edition, and infant length-for-age z scores at 6 months of age. Results: 60% (582/960) of women had 25-OHD levels < 75 nmol/L at 32 weeks gestation. Infants born to women with 25-OHD deficiency (< 37.5 nmol/L) had reduced developmental language scores compared to those born to women who were vitamin D replete (>= 75 nmol/L) (Mean Difference (MD) -3.48, 95% Confidence Interval (CI) -5.67 to -1.28). For every 25 nmol increase in 25-OHD concentration in late pregnancy, infant length-for-age z scores at 6 months of age decreased by 0.08 (95% CI -0.15 to -0.02). Conclusions: Low maternal 25- hydroxyvitamin D levels during late pregnancy are of concern in rural Vietnam, and are associated with reduced language developmental outcomes at 6 months of age. Our findings strengthen the evidence for giving vitamin D supplementation during pregnancy.	[Hanieh, Sarah; Biggs, Beverley-Ann] Univ Melbourne, Dept Med, Melbourne Acad Ctr, Doherty Inst, Parkville, Vic 3052, Australia; [Ha, Tran T.; Thuy, Tran T.; Tran, Thach D.; Tran Tuan] RTCCD, Hanoi, Vietnam; [Simpson, Julie A.] Univ Melbourne, Ctr Biostat & Epidemiol, Melbourne Sch Populat & Global Hlth, Parkville, Vic 3052, Australia; [Khuong, Nguyen C.; Thoang, Dang D.] Prov Ctr Prevent Med, Hanam, Hanam Province, Vietnam; [Tran, Thach D.; Fisher, Jane] Monash Univ, Jean Hailes Res Unit, Sch Publ Hlth & Prevent Med, Clayton, Vic, Australia; [Biggs, Beverley-Ann] Royal Melbourne Hosp, Victorian Infect Dis Serv, Parkville, Vic 3050, Australia	University of Melbourne; University of Melbourne; Monash University; Royal Melbourne Hospital	Biggs, BA (corresponding author), Univ Melbourne, Dept Med, Melbourne Acad Ctr, Doherty Inst, Parkville, Vic 3052, Australia.	babiggs@unimelb.edu.au	TRAN, THACH DUC/H-7734-2014; Simpson, Julie A/P-7299-2014; Fisher, Jane/I-1569-2014	TRAN, THACH DUC/0000-0002-4686-8601; Biggs, Beverley-Ann/0000-0002-2961-9793; Simpson, Julie/0000-0002-2660-2013; Tran, Tuan/0000-0002-4947-9169; Fisher, Jane/0000-0002-1959-6807	National Health and Medical Research Council of Australia [628751]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	The original randomised trial was funded through a grant from the National Health and Medical Research Council of Australia. ( Grant Number 628751). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghajafari F, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1169; Bayley N, 1993, BAYLEY SCALES INFANT; Bodnar LM, 2007, J CLIN ENDOCR METAB, V92, P3517, DOI 10.1210/jc.2007-0718; Bodnar LM, 2009, J NUTR, V139, P1157, DOI 10.3945/jn.108.103168; Camargo CA, 2011, PEDIATRICS, V127, pE180, DOI 10.1542/peds.2010-0442; Davis LM, 2010, J PEDIATR ADOL GYNEC, V23, P45, DOI 10.1016/j.jpag.2009.05.005; Dawodu A, 2011, PEDIATR INT, V53, P207, DOI 10.1111/j.1442-200X.2010.03209.x; De-Regil LM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008873.pub2; Dror DK, 2011, CURR OPIN OBSTET GYN, V23, P422, DOI 10.1097/GCO.0b013e32834cb791; Dror DK, 2010, NUTR REV, V68, P465, DOI 10.1111/j.1753-4887.2010.00306.x; Gale CR, 2008, EUR J CLIN NUTR, V62, P68, DOI 10.1038/sj.ejcn.1602680; General Statistics Office of Vietnam, 2011, STAT YB VIETN; Grant WB, 2013, DERM-ENDOCRINOL, V5, DOI 10.4161/derm.22942; Greer FR, 2008, AM J CLIN NUTR, V88, p529S, DOI 10.1093/ajcn/88.2.529S; Hanieh S, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001470; Hensel KJ, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.08.013; Ho-Pham LT, 2011, OSTEOPOROSIS INT, V22, P241, DOI 10.1007/s00198-010-1207-4; Holick MF, 2011, CURR DRUG TARGETS, V12, P4; Hollis BW, 2011, CURR OPIN ENDOCRINOL, V18, P371, DOI 10.1097/MED.0b013e32834b0040; Hollis BW, 2011, J BONE MINER RES, V26, P2341, DOI 10.1002/jbmr.463; Institute of Medicine, 2010, DIETARY REFERENCE IN; Javaid MK, 2006, LANCET, V367, P36, DOI 10.1016/S0140-6736(06)67922-1; Kocovska E, 2012, RES DEV DISABIL, V33, P1541, DOI 10.1016/j.ridd.2012.02.015; Leffelaar ER, 2010, BRIT J NUTR, V104, P108, DOI 10.1017/S000711451000022X; Lips P, 2010, J STEROID BIOCHEM, V121, P297, DOI 10.1016/j.jsbmb.2010.02.021; Merewood A, 2009, J CLIN ENDOCR METAB, V94, P940, DOI 10.1210/jc.2008-1217; Mithal A, 2009, OSTEOPOROSIS INT, V20, P1807, DOI 10.1007/s00198-009-0954-6; Morley R, 2006, J CLIN ENDOCR METAB, V91, P906, DOI 10.1210/jc.2005-1479; Mostafa GA, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-201; Mullins RJ, 2011, CLIN EXP ALLERGY, V41, P766, DOI 10.1111/j.1365-2222.2011.03742.x; Nguyen HTT, 2012, BONE, V51, P1029, DOI 10.1016/j.bone.2012.07.023; Pawley N, 2004, AM J CLIN NUTR, V80, p1748S, DOI 10.1093/ajcn/80.6.1748S; Prentice A, 2009, ACTA PAEDIATR, V98, P1360, DOI 10.1111/j.1651-2227.2009.01352.x; Shibata M, 2011, J BONE MINER METAB, V29, P615, DOI 10.1007/s00774-011-0264-x; Soheilykhah S, 2010, NUTR CLIN PRACT, V25, P524, DOI 10.1177/0884533610379851; Thorne-Lyman A, 2012, PAEDIATR PERINAT EP, V26, P75, DOI 10.1111/j.1365-3016.2012.01283.x; UNICEF/WHO/UNU, 1999, UNICEF WHO UNU WORKS; Viet Nam Academy of Social Science, 2006, VIETN POV UPD POV PO; Vu TTH, 2012, MATERN CHILD NUTR, V8, P533, DOI 10.1111/j.1740-8709.2011.00327.x; Wagner CL, 2012, NUTRIENTS, V4, P208, DOI 10.3390/nu4030208; Webster RI, 2004, J CHILD NEUROL, V19, P471, DOI 10.1177/08830738040190070101; Whitehouse AJO, 2012, PEDIATRICS, V129, P485, DOI 10.1542/peds.2011-2644; WHO, 2012, VIT D SUPPL PREGN PR; WHO (World Health Organization), 2011, WHO ANTHR VERS 3 2 2; World Health Organization, 2012, WHO CHILD GROWTH STA; Yu CKH, 2009, CLIN ENDOCRINOL, V70, P685, DOI 10.1111/j.1365-2265.2008.03403.x	46	46	46	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e99005	10.1371/journal.pone.0099005	http://dx.doi.org/10.1371/journal.pone.0099005			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967813	Green Published, gold, Green Submitted			2022-12-27	WOS:000338280800007
J	Yang, CY; Lu, RH; Lin, CH; Jen, CH; Tung, CY; Yang, SH; Lin, JK; Jiang, JK; Lin, CH				Yang, Chih-Yung; Lu, Ruey-Hwa; Lin, Chien-Hsing; Jen, Chih-Hung; Tung, Chien-Yi; Yang, Shung-Haur; Lin, Jen-Kou; Jiang, Jeng-Kai; Lin, Chi-Hung			Single Nucleotide Polymorphisms Associated with Colorectal Cancer Susceptibility and Loss of Heterozygosity in a Taiwanese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; TRANSCRIPTION FACTOR MOK2; HOMEOBOX GENE-EXPRESSION; BARRETTS-ESOPHAGUS; TUMOR PROGRESSION; RISK; ALLELOTYPE; SUPPRESSOR; PITX1; LOCI	Given the significant racial and ethnic diversity in genetic variation, we are intrigued to find out whether the single nucleotide polymorphisms (SNPs) identified in genome-wide association studies of colorectal cancer (CRC) susceptibility in East Asian populations are also relevant to the population of Taiwan. Moreover, loss of heterozygosity (LOH) may provide insight into how variants alter CRC risk and how regulatory elements control gene expression. To investigate the racial and ethnic diversity of CRC-susceptibility genetic variants and their relevance to the Taiwanese population, we genotyped 705 CRC cases and 1,802 healthy controls (Taiwan Biobank) for fifteen previously reported East Asian CRC-susceptibility SNPs and four novel genetic variants identified by whole-exome sequencing. We found that rs10795668 in FLJ3802842 and rs4631962 in CCND2 were significantly associated with CRC risk in the Taiwanese population. The previously unreported rs1338565 was associated with a significant increased risk of CRC. In addition, we also genotyped tumor tissue and paired adjacent normal tissues of these 705 CRC cases to search for LOH, as well as risk-associated and protective alleles. LOH analysis revealed preferential retention of three SNPs, rs12657484, rs3802842, and rs4444235, in tumor tissues. rs4444235 has been recently reported to be a cis-acting regulator of BMP4 gene; in this study, the C allele was preferentially retained in tumor tissues (p = 0.0023). rs4631962 and rs10795668 contribute to CRC risk in the Taiwanese and East Asian populations, and the newly identified rs1338565 was specifically associated with CRC, supporting the ethnic diversity of CRC-susceptibility SNPs. LOH analysis suggested that the three CRC risk variants, rs12657484, rs3802842, and rs4444235, exhibited somatic allele-specific imbalance and might be critical during neoplastic progression.	[Yang, Chih-Yung; Lin, Chi-Hung] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan; [Yang, Chih-Yung; Lin, Chi-Hung] Taipei City Hosp, Dept Educ & Res, Taipei, Taiwan; [Lu, Ruey-Hwa] Taipei City Hosp, Dept Surg, Taipei, Taiwan; [Lin, Chien-Hsing] Natl Hlth Res Inst, Div Mol & Genom Med, Zhunan, Taiwan; [Jen, Chih-Hung; Tung, Chien-Yi; Lin, Chi-Hung] Natl Yang Ming Univ, VYM Genome Res Ctr, Taipei 112, Taiwan; [Yang, Shung-Haur; Lin, Jen-Kou; Jiang, Jeng-Kai] Taipei Vet Gen Hosp, Dept Surg, Taipei, Taiwan; [Yang, Shung-Haur; Lin, Jen-Kou; Jiang, Jeng-Kai] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; Taipei City Hospital; Taipei City Hospital; National Health Research Institutes - Taiwan; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Jiang, JK (corresponding author), Taipei Vet Gen Hosp, Dept Surg, Taipei, Taiwan.	jkjiang@vghtpe.gov.tw; linch@ym.edu.tw			National Science Council [NSC101-2321-B-075-001, NSC 102-2325-B-010-013, NSC102-2319-B-010-001]; Ministry of Education, Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan(Ministry of Education, Taiwan)	This work was supported by research grants NSC101-2321-B-075-001, NSC 102-2325-B-010-013 and NSC102-2319-B-010-001, National Science Council and Aim for the Top University Plan from Ministry of Education, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltonen L, 2007, CLIN CANCER RES, V13, P356, DOI 10.1158/1078-0432.CCR-06-1256; Abuli A, 2013, CARCINOGENESIS, V34, P2286, DOI 10.1093/carcin/bgt179; Anand P, 2008, PHARM RES-DORDR, V25, P2097, DOI 10.1007/s11095-008-9661-9; [Anonymous], 2012, CANC REG ANN REP TAI; Arranz V, 2001, J BIOL CHEM, V276, P11963, DOI 10.1074/jbc.M011036200; Broderick P, 2007, NAT GENET, V39, P1315, DOI 10.1038/ng.2007.18; Brown MA, 1997, ADV GENET, V36, P45, DOI 10.1016/S0065-2660(08)60307-7; Byeon JS, 2007, GASTROINTEST ENDOSC, V65, P1015, DOI 10.1016/j.gie.2006.12.065; Chen YN, 2008, WORLD J GASTROENTERO, V14, P292, DOI 10.3748/wjg.14.292; Chen Y, 2007, LUNG CANCER, V55, P287, DOI 10.1016/j.lungcan.2006.11.001; Cui R, 2011, GUT, V60, P799, DOI 10.1136/gut.2010.215947; Deng HY, 2007, EXP CELL RES, V313, P1033, DOI 10.1016/j.yexcr.2006.12.020; Dong LM, 2008, JAMA-J AM MED ASSOC, V299, P2423, DOI 10.1001/jama.299.20.2423; Dreuillet C, 2002, NUCLEIC ACIDS RES, V30, P4634, DOI 10.1093/nar/gkf587; Dreuillet C, 2008, BIOL CELL, V100, P51, DOI 10.1042/BC20070053; Ferlay J, 2010, IARC CANCERBASE, V2; Fletcher O, 2010, NAT REV CANCER, V10, P353, DOI 10.1038/nrc2840; FULTS D, 1990, CANCER RES, V50, P5784; Gerber MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037672; Gundem G, 2010, NAT METHODS, V7, P92, DOI 10.1038/nmeth0210-92; HANSEN MF, 1987, CANCER RES, V47, P5518; He J, 2011, CANCER EPIDEM BIOMAR, V20, P70, DOI 10.1158/1055-9965.EPI-10-0892; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Ho JW, 2011, BRIT J CANCER, V104, P369, DOI 10.1038/sj.bjc.6605977; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jia WH, 2013, NAT GENET, V45, P191, DOI 10.1038/ng.2505; Knosel T, 2012, INT J COLORECTAL DIS, V27, P1391, DOI 10.1007/s00384-012-1460-4; KNUDSON AG, 1985, CANCER RES, V45, P1437; Koboldt DC, VARSCAN VARIANT DETE; Kolfschoten IGM, 2005, CELL, V121, P849, DOI 10.1016/j.cell.2005.04.017; Kosinski C, 2007, P NATL ACAD SCI USA, V104, P15418, DOI 10.1073/pnas.0707210104; Kupfer SS, 2010, GASTROENTEROLOGY, V139, P1677, DOI 10.1053/j.gastro.2010.07.038; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Liu DX, 2007, CELL DEATH DIFFER, V14, P1893, DOI 10.1038/sj.cdd.4402209; Loo LWM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030477; Lord RVN, 2005, SURGERY, V138, P924, DOI 10.1016/j.surg.2005.05.007; Mates IN, 2012, J GASTROINTEST LIVER, V21, P45; Matsuo K, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-379; Mermelshtein A, 2005, BRIT J CANCER, V93, P338, DOI 10.1038/sj.bjc.6602709; Middeldorp A, 2009, CANCER EPIDEM BIOMAR, V18, P3062, DOI 10.1158/1055-9965.EPI-09-0601; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Nakanishi H, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000660; Niittymaki I, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-23; Peters U, 2012, HUM GENET, V131, P217, DOI 10.1007/s00439-011-1055-0; Pittman AM, 2008, HUM MOL GENET, V17, P3720, DOI 10.1093/hmg/ddn267; Pittman AM, 2009, GENOME RES, V19, P987, DOI 10.1101/gr.092668.109; Polakis P, 2000, GENE DEV, V14, P1837; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; Qi DL, 2011, MOL CELL BIOL, V31, P1624, DOI 10.1128/MCB.00470-10; Reid BJ, 1996, EUR J CANCER PREV, V5, P57, DOI 10.1097/00008469-199612002-00009; Sanchez JJ, 2006, ELECTROPHORESIS, V27, P1713, DOI 10.1002/elps.200500671; Sarkar R, 2010, COLORECTAL DIS, V12, P316, DOI 10.1111/j.1463-1318.2009.01829.x; SATO T, 1990, CANCER RES, V50, P7184; STANBRIDGE EJ, 1990, ANNU REV GENET, V24, P615; Sung JJY, 2008, GUT, V57, P1166, DOI 10.1136/gut.2007.146316; Talseth-Palmer BA, 2011, J MED GENET, V48, P279, DOI 10.1136/jmg.2010.079962; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Tenesa A, 2009, NAT REV GENET, V10, P353, DOI 10.1038/nrg2574; Thean LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042407; THRASHBINGHAM CA, 1995, P NATL ACAD SCI USA, V92, P2854, DOI 10.1073/pnas.92.7.2854; Tomlinson IPM, 2010, BRIT J CANCER, V102, P447, DOI 10.1038/sj.bjc.6605338; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Tomlinson IPM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002105; TSUCHIYA E, 1992, CANCER RES, V52, P2478; VOGELSTEIN B, 1989, SCIENCE, V244, P207, DOI 10.1126/science.2565047; von Holst S, 2010, BRIT J CANCER, V103, P575, DOI 10.1038/sj.bjc.6605774; Watanabe T, 2011, EUR J CANCER, V47, P1946, DOI 10.1016/j.ejca.2011.03.029; Weir BS, 2005, GENOME RES, V15, P1468, DOI 10.1101/gr.4398405; Wijnen JT, 2009, GASTROENTEROLOGY, V136, P131, DOI 10.1053/j.gastro.2008.09.033; Xiong F, 2010, CANCER EPIDEM BIOMAR, V19, P1855, DOI 10.1158/1055-9965.EPI-10-0210; YAMAGUCHI T, 1992, CANCER RES, V52, P2419; Yang H, 2009, CANCER EPIDEM BIOMAR, V18, P2522, DOI 10.1158/1055-9965.EPI-09-0398; Zou L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045461	78	8	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100060	10.1371/journal.pone.0100060	http://dx.doi.org/10.1371/journal.pone.0100060			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968322	Green Submitted, Green Published, gold			2022-12-27	WOS:000338280800023
J	Zappasodi, F; Olejarczyk, E; Marzetti, L; Assenza, G; Pizzella, V; Tecchio, F				Zappasodi, Filippo; Olejarczyk, Elzbieta; Marzetti, Laura; Assenza, Giovanni; Pizzella, Vittorio; Tecchio, Franca			Fractal Dimension of EEG Activity Senses Neuronal Impairment in Acute Stroke	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; MOTOR CORTICAL DISINHIBITION; ALZHEIMERS-DISEASE; QUANTITATIVE EEG; HEMISPHERIC STROKE; TIME-SERIES; RECOVERY; SYNCHRONIZATION; VARIABILITY; RECORDINGS	The brain is a self-organizing system which displays self-similarities at different spatial and temporal scales. Thus, the complexity of its dynamics, associated to efficient processing and functional advantages, is expected to be captured by a measure of its scale-free (fractal) properties. Under the hypothesis that the fractal dimension (FD) of the electroencephalographic signal (EEG) is optimally sensitive to the neuronal dysfunction secondary to a brain lesion, we tested the FD's ability in assessing two key processes in acute stroke: the clinical impairment and the recovery prognosis. Resting EEG was collected in 36 patients 4-10 days after a unilateral ischemic stroke in the middle cerebral artery territory and 19 healthy controls. National Health Institute Stroke Scale (NIHss) was collected at T0 and 6 months later. Highuchi FD, its inter-hemispheric asymmetry (FDasy) and spectral band powers were calculated for EEG signals. FD was smaller in patients than in controls (1.447 +/- 0.092 vs 1.525 +/- 0.105) and its reduction was paired to a worse acute clinical status. FD decrease was associated to alpha increase and beta decrease of oscillatory activity power. Larger FDasy in acute phase was paired to a worse clinical recovery at six months. FD in our patients captured the loss of complexity reflecting the global system dysfunction resulting from the structural damage. This decrease seems to reveal the intimate nature of structure-function unity, where the regional neural multi-scale self-similar activity is impaired by the anatomical lesion. This picture is coherent with neuronal activity complexity decrease paired to a reduced repertoire of functional abilities. FDasy result highlights the functional relevance of the balance between homologous brain structures' activities in stroke recovery.	[Zappasodi, Filippo; Marzetti, Laura; Pizzella, Vittorio] Univ G DAnnunzio, Dept Neurosci Imaging & Clin Sci, Chieti, Italy; [Zappasodi, Filippo; Olejarczyk, Elzbieta; Marzetti, Laura; Pizzella, Vittorio] Univ G DAnnunzio, Inst Adv Biomed Technol, Chieti, Italy; [Olejarczyk, Elzbieta] Polish Acad Sci, Nalecz Inst Biocybernet & Biomed Engn, Warsaw, Poland; [Assenza, Giovanni] Campus Biomed Univ Rome, Inst Neurol, Rome, Italy; [Tecchio, Franca] Fatebenefratelli Hosp Isola Tiberina, CNR, ISTC, Lab Electrophysiol Translat NeuroScience LETS, Rome, Italy; [Tecchio, Franca] IRCCS San Raffale Pisana, Dept Imaging, Rome, Italy	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; Polish Academy of Sciences; Nalecz Institute of Biocybernetics & Biomedical Engineering of the Polish Academy of Sciences; University Campus Bio-Medico - Rome Italy; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR); IRCCS San Raffaele Pisana	Zappasodi, F (corresponding author), Univ G DAnnunzio, Dept Neurosci Imaging & Clin Sci, Chieti, Italy.	f.zappasodi@unich.it	Assenza, Giovanni/K-6877-2018; Zappasodi, Filippo/AAL-4717-2020; Olejarczyk, Elzbieta/ABG-5529-2020; Zappasodi, Filippo/AAC-2414-2022; Marzetti, Laura/ABC-9763-2021; tecchio, franca/AAX-2770-2020; Marzetti, Laura/Q-2909-2016; Marzetti, Laura/AAA-4231-2020	Assenza, Giovanni/0000-0003-3129-1982; Marzetti, Laura/0000-0002-6481-3743; tecchio, franca/0000-0002-1325-5059; Marzetti, Laura/0000-0002-6481-3743; Pizzella, Vittorio/0000-0002-0452-1108; Olejarczyk, Elzbieta/0000-0002-6821-350X; Assenza, Giovanni/0000-0002-6160-4348	Italian Ministry of Health [Cod. GR-2008-1138642]; MIUR [Prot. 2010SH7H3F ConnAge]; PNR-CNR Aging Program	Italian Ministry of Health(Ministry of Health, Italy); MIUR(Ministry of Education, Universities and Research (MIUR)); PNR-CNR Aging Program	The research leading to these results has received funding from: 1. The Italian Ministry of Health, Cod. GR-2008-1138642; 2. MIUR Prot. 2010SH7H3F ConnAge; 3. PNR-CNR Aging Program 2012-2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accardo A, 1997, BIOL CYBERN, V77, P339, DOI 10.1007/s004220050394; AHMED I, 1988, CLIN ELECTROENCEPHAL, V19, P205, DOI 10.1177/155005948801900406; Assenza G, 2013, RESTOR NEUROL NEUROS, V31, P177, DOI 10.3233/RNN-120244; Assenza G, 2009, NEUROIMAGE, V44, P1267, DOI 10.1016/j.neuroimage.2008.09.049; Barbati G, 2004, CLIN NEUROPHYSIOL, V115, P1220, DOI 10.1016/j.clinph.2003.12.015; Bullmore ET, 2001, HUM BRAIN MAPP, V12, P61, DOI 10.1002/1097-0193(200102)12:2<61::AID-HBM1004>3.0.CO;2-W; Butz M, 2004, NEUROSCI LETT, V355, P93, DOI 10.1016/j.neulet.2003.10.065; Cannon WB, 1929, PHYSIOL REV, V9, P399, DOI 10.1152/physrev.1929.9.3.399; Capotosto P, 2009, J NEUROSCI, V29, P5863, DOI 10.1523/JNEUROSCI.0539-09.2009; Carmichael ST, 2002, J NEUROSCI, V22, P6062; Carter AR, 2010, ANN NEUROL, V67, P365, DOI 10.1002/ana.21905; Cuspineda E, 2007, CLIN EEG NEUROSCI, V38, P155, DOI 10.1177/155005940703800312; Cuspineda E, 2003, CLIN ELECTROENCEPHAL, V34, P1; DASILVA FL, 1991, ELECTROEN CLIN NEURO, V79, P81, DOI 10.1016/0013-4694(91)90044-5; Deco G, 2012, J NEUROSCI, V32, P3366, DOI 10.1523/JNEUROSCI.2523-11.2012; Deco G, 2011, NAT REV NEUROSCI, V12, P43, DOI 10.1038/nrn2961; Di Ieva A, 2013, NEUROSCIENTIST; DUNCAN PW, 1992, STROKE, V23, P1084, DOI 10.1161/01.STR.23.8.1084; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Escudero J, 2006, PHYSIOL MEAS, V27, P1091, DOI 10.1088/0967-3334/27/11/004; Fadel PJ, 2004, J APPL PHYSIOL, V97, P2056, DOI 10.1152/japplphysiol.00657.2004; Ferenets R, 2006, IEEE T BIO-MED ENG, V53, P1067, DOI 10.1109/TBME.2006.873543; Fernandez-Bouzas A, 2000, CLIN ELECTROENCEPHAL, V31, P165, DOI 10.1177/155005940003100403; Finnigan S, 2013, CLIN NEUROPHYSIOL, V124, P10, DOI 10.1016/j.clinph.2012.07.003; Finnigan SP, 2007, CLIN NEUROPHYSIOL, V118, P2525, DOI 10.1016/j.clinph.2007.07.021; Freeman WJ, 2009, COGN NEURODYNAMICS, V3, P97, DOI 10.1007/s11571-008-9064-y; Garrett DD, 2013, NEUROSCI BIOBEHAV R, V37, P610, DOI 10.1016/j.neubiorev.2013.02.015; Garrett DD, 2013, CEREB CORTEX, V23, P684, DOI 10.1093/cercor/bhs055; GIAQUINTO S, 1994, STROKE, V25, P2204, DOI 10.1161/01.STR.25.11.2204; GLOOR P, 1977, NEUROLOGY, V27, P326, DOI 10.1212/WNL.27.4.326; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; Graziadio S, 2012, EXP NEUROL, V238, P168, DOI 10.1016/j.expneurol.2012.08.031; Grefkes C, 2014, NEUROSCIENTIST, V20, P56, DOI 10.1177/1073858413491147; Hausdorff JM, 2001, PHYSICA A, V302, P138, DOI 10.1016/S0378-4371(01)00460-5; He BYJ, 2011, J NEUROSCI, V31, P13786, DOI 10.1523/JNEUROSCI.2111-11.2011; He BYJ, 2010, NEURON, V66, P353, DOI 10.1016/j.neuron.2010.04.020; HIGUCHI T, 1988, PHYSICA D, V31, P277, DOI 10.1016/0167-2789(88)90081-4; INOUYE T, 1991, ELECTROEN CLIN NEURO, V79, P204, DOI 10.1016/0013-4694(91)90138-T; JACKEL R A, 1989, Neurophysiologie Clinique, V19, P185, DOI 10.1016/S0987-7053(89)80036-X; Jensen O, 2012, TRENDS COGN SCI, V16, P200, DOI 10.1016/j.tics.2012.03.002; Jiang T, 2012, NEUROSCIENCE, V226, P421, DOI 10.1016/j.neuroscience.2012.09.035; Juhasz C, 1997, ACTA NEUROL SCAND, V96, P397; Khedr EM, 2009, EUR J NEUROL, V16, P1323, DOI 10.1111/j.1468-1331.2009.02746.x; Le van Quyen M, 2003, EPILEPSIA S12, P30; Leao RN, 2005, P ROY SOC B-BIOL SCI, V272, P2551, DOI 10.1098/rspb.2005.3258; Linkenkaer-Hansen K, 2001, J NEUROSCI, V21, P1370; Makela JP, 1998, ELECTROEN CLIN NEURO, V106, P433, DOI 10.1016/S0013-4694(98)00005-4; Manganotti P, 2008, NEUROREHAB NEURAL RE, V22, P396, DOI 10.1177/1545968307313505; Mansoori BK, 2014, EXP NEUROL; Marzetti L, 2007, NEUROIMAGE, V36, P48, DOI 10.1016/j.neuroimage.2007.02.034; Meyer M, 2003, EUR J APPL PHYSIOL, V90, P305, DOI 10.1007/s00421-003-0915-2; Milstein J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004338; Mizuno T, 2010, CLIN NEUROPHYSIOL, V121, P1438, DOI 10.1016/j.clinph.2010.03.025; Murri L, 1998, NEUROPHYSIOL CLIN, V28, P249, DOI 10.1016/S0987-7053(98)80115-9; NAGATA K, 1982, J CEREBR BLOOD F MET, V2, P79, DOI 10.1038/jcbfm.1982.9; Niedermeyer E., 2005, ELECTROEN CLIN NEURO; NIESTROJ E, 1995, NEUROPSYCHOBIOLOGY, V31, P166, DOI 10.1159/000119187; Nowak DA, 2008, ARCH NEUROL-CHICAGO, V65, P741, DOI 10.1001/archneur.65.6.741; Oliviero A, 2004, NEUROIMAGE, V23, P542, DOI 10.1016/j.neuroimage.2004.06.040; Peruzzotti-Jametti L, 2013, STROKE, V44, P3166, DOI 10.1161/STROKEAHA.113.001687; PFURTSCHELLER G, 1986, American Journal of EEG Technology, V26, P19; Pfurtscheller G, 1996, ELECTROEN CLIN NEURO, V98, P281, DOI 10.1016/0013-4694(95)00258-8; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Pomeroy VM, 2007, NEUROREHAB NEURAL RE, V21, P509, DOI 10.1177/1545968307300418; Pritchard W.S., 1991, DEMENTIA, V2, P102, DOI DOI 10.1159/000107183; Rossini PM, 2004, BRAIN, V127, P99, DOI 10.1093/brain/awh012; SAINIO K, 1983, ELECTROEN CLIN NEURO, V56, P117, DOI 10.1016/0013-4694(83)90066-4; Sauseng P, 2013, NEUROIMAGE, V65, P52, DOI 10.1016/j.neuroimage.2012.09.048; Scafetta N, 2009, CHAOS, V19, DOI 10.1063/1.3143035; Serletis D, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/5/056008; Shimizu T, 2002, BRAIN, V125, P1896, DOI 10.1093/brain/awf183; Stam CJ, 2005, CLIN NEUROPHYSIOL, V116, P2266, DOI 10.1016/j.clinph.2005.06.011; Stam CJ, 2002, J CLIN NEUROPHYSIOL, V19, P562, DOI 10.1097/00004691-200212000-00010; Stam CJ, 1999, CLIN NEUROPHYSIOL, V110, P1801, DOI 10.1016/S1388-2457(99)00099-1; STAM CJ, 1995, ELECTROEN CLIN NEURO, V95, P309, DOI 10.1016/0013-4694(95)00147-Q; Swie Y W, 2005, Electromyogr Clin Neurophysiol, V45, P329; Tecchio F, 2005, NEUROIMAGE, V28, P72, DOI 10.1016/j.neuroimage.2005.05.051; Tecchio F, 2007, J NEUROL, V254, P296, DOI 10.1007/s00415-006-0355-0; Thut G, 2006, J NEUROSCI, V26, P9494, DOI 10.1523/JNEUROSCI.0875-06.2006; Truong QDK, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/461426; Van der Drift JHA, 1972, HDB ELECTROENCEPHALO, V14a, p[12, 47]; van Meer MPA, 2010, J NEUROSCI, V30, P3964, DOI 10.1523/JNEUROSCI.5709-09.2010; Vernieri F, 1999, STROKE, V30, P593, DOI 10.1161/01.STR.30.3.593; Volz L.J., 2014, BRAIN STRUCT FUNCT; Voss RF, 1988, SCI FRACTAL IMAGES, P21, DOI DOI 10.1007/978-1-4612-3784-6_1; Yao DZ, 2001, PHYSIOL MEAS, V22, P693, DOI 10.1088/0967-3334/22/4/305; Zappasodi F, 2007, NEUROSCI LETT, V416, P310, DOI 10.1016/j.neulet.2007.02.017	87	89	93	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100199	10.1371/journal.pone.0100199	http://dx.doi.org/10.1371/journal.pone.0100199			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967904	Green Published, gold, Green Submitted			2022-12-27	WOS:000338280800028
J	Amor, MD; Norman, MD; Cameron, HE; Strugnell, JM				Amor, Michael D.; Norman, Mark D.; Cameron, Hayley E.; Strugnell, Jan M.			Allopatric Speciation within a Cryptic Species Complex of Australasian Octopuses	PLOS ONE			English	Article							TETRICUS MOLLUSCA-CEPHALOPODA; MOLECULAR PHYLOGENY; MITOCHONDRIAL-DNA; LIFE-HISTORY; OCTOPODIDAE; NEMADACTYLUS; VULGARIS; CHEILODACTYLIDAE; BIOGEOGRAPHY; SUBDIVISION	Despite extensive revisions over recent decades, the taxonomy of benthic octopuses (Family Octopodidae) remains in a considerable flux. Among groups of unresolved status is a species complex of morphologically similar shallow- water octopods from subtropical Australasia, including: Allopatric populations of Octopus tetricus on the eastern and western coasts of Australia, of which the Western Australian form is speculated to be a distinct or sub- species; and Octopus gibbsi from New Zealand, a proposed synonym of Australian forms. This study employed a combination of molecular and morphological techniques to resolve the taxonomic status of the ` tetricus complex'. Phylogenetic analyses (based on five mitochondrial genes: 12S rRNA, 16S rRNA, COI, COIII and Cytb) and Generalised Mixed Yule Coalescent (GMYC) analysis (based on COI, COIII and Cytb) distinguished eastern and Western Australian O. tetricus as distinct species, while O. gibbsi was found to be synonymous with the east Australian form (BS = >97, PP = 1; GMYC p = 0.01). Discrete morphological differences in mature male octopuses (based on sixteen morphological traits) provided further evidence of cryptic speciation between east (including New Zealand) and west coast populations; although females proved less useful in morphological distinction among members of the tetricus complex. In addition, phylogenetic analyses suggested populations of octopuses currently treated under the name Octopus vulgaris are paraphyletic; providing evidence of cryptic speciation among global populations of O. vulgaris, the most commercially valuable octopus species worldwide.	[Amor, Michael D.; Strugnell, Jan M.] La Trobe Univ, Dept Genet, La Trobe Inst Mol Sci, Bundoora, Vic, Australia; [Amor, Michael D.; Norman, Mark D.] Museum Victoria, Dept Sci, Carlton, Vic, Australia; [Cameron, Hayley E.] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia	La Trobe University; Museum Victoria; Monash University	Amor, MD (corresponding author), La Trobe Univ, Dept Genet, La Trobe Inst Mol Sci, Bundoora, Vic, Australia.	mdamor@students.latrobe.edu.au	Strugnell, Jan M/P-9921-2016	Strugnell, Jan/0000-0003-2994-637X; Amor, Michael/0000-0001-9015-860X	A La Trobe University Faculty of Science, Technology and Engineering grant	A La Trobe University Faculty of Science, Technology and Engineering grant	A La Trobe University Faculty of Science, Technology and Engineering grant supported this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Allcock AL, 2007, POLAR BIOL, V30, P883, DOI 10.1007/s00300-006-0248-9; Allcock AL, 2008, BIOL J LINN SOC, V95, P205, DOI 10.1111/j.1095-8312.2008.01031.x; Anderson TJ, 1997, MAR ECOL PROG SER, V150, P137, DOI 10.3354/meps150137; Berner D, 2011, OECOLOGIA, V166, P961, DOI 10.1007/s00442-011-1934-z; Booth JD, 2000, MAR ECOL PROG SER, V200, P241, DOI 10.3354/meps200241; BOOTH JD, 1994, CRUSTACEANA, V66, P271, DOI 10.1163/156854094X00035; BRASHER DJ, 1992, NEW ZEAL J MAR FRESH, V26, P53, DOI 10.1080/00288330.1992.9516499; Burridge CP, 1999, MOL PHYLOGENET EVOL, V13, P93, DOI 10.1006/mpev.1999.0622; Burridge CP, 2003, NEW ZEAL J MAR FRESH, V37, P223, DOI 10.1080/00288330.2003.9517160; Burridge CP, 2000, BIOL J LINN SOC, V70, P435, DOI 10.1006/bijl.1999.0413; Carlini DB, 2001, MOL PHYLOGENET EVOL, V21, P388, DOI 10.1006/mpev.2001.1022; Chiswell SM, 2003, MAR ECOL PROG SER, V247, P173, DOI 10.3354/meps247173; Dartnall A, 1974, BIOGEOGRAPHY ECOLOGY; Donnan Laboratories, 2001, EXTR DNA TISS HIGH S; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Edgar G, 2000, AUSTR MARINE LIFE PL; Ezard T, 2009, PACKAGE SPLITS SPECI; FAO, 2009, GLOB PROD STAT 2007; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Frakes LA, 1987, FAUNA AUSTR A, P1; GREWE PM, 1994, CAN J FISH AQUAT SCI, V51, P1101, DOI 10.1139/f94-109; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guzik MT, 2005, MOL PHYLOGENET EVOL, V37, P235, DOI 10.1016/j.ympev.2005.05.009; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; IRIBARNE OO, 1991, J ZOOL, V223, P549, DOI 10.1111/j.1469-7998.1991.tb04387.x; JOLL LM, 1977, AUST J MAR FRESH RES, V28, P45, DOI 10.1071/MF9770045; JOLL LM, 1978, AUST J MAR FRESH RES, V29, P19; JOLL LM, 1976, MAR BIOL, V36, P327, DOI 10.1007/BF00389194; Joll LM, 1983, OCTOPUS TETRICUS, P325; Kaneko N, 2011, MALACOLOGIA, V54, P97, DOI 10.4002/040.054.0102; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Ling SD, 2009, P NATL ACAD SCI; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; MOORE WS, 1995, EVOLUTION, V49, P718, DOI 10.1111/j.1558-5646.1995.tb02308.x; Norman M.D., 2005, Phuket Marine Biological Center Research Bulletin, V66, P127; Norman Mark D., 2006, National Science Museum Monographs, V34, P171; Norman MD, 1997, INVERTEBR TAXON, V11, P89, DOI 10.1071/IT95026; Norman MD, 2014, FAO SPECIES CATALOGU, V3, P36; Norman MD, 2000, CEPHALOPODS WORLD GU; Nottage JD, 2007, REV FISH BIOL FISHER, V17, P271, DOI 10.1007/s11160-006-9032-8; O'Hara TD, 2000, J BIOGEOGR, V27, P1321, DOI 10.1046/j.1365-2699.2000.00499.x; O'Loughlin P. Mark, 2003, Memoirs of Museum Victoria, V60, P181; O'Shea S, 1999, NIWA BIODIVERSITY ME; OVENDEN JR, 1992, MAR BIOL, V112, P319, DOI 10.1007/BF00702478; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Quinn G, 2002, EXPT DESIGN ANAL BIO; R Core Team, 2021, R LANGUAGE ENV STAT; Rambaut A, 2003, TRACER 1 3; Ridgway KR, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030392; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roper C. F. E., 1984, FAO FISH SYNOP, V125, P1; ROY SN, 1958, ANN MATH STAT, V29, P491, DOI 10.1214/aoms/1177706624; SIMON C, 1990, UCLA SYM BI, V122, P235; SMALE MJ, 1981, MAR BIOL, V65, P1, DOI 10.1007/BF00397061; Acosta-Jofre MS, 2012, SCI MAR, V76, P311, DOI 10.3989/scimar.03365.03B; Strugnell J, 2004, CURR BIOL, V14, pR300, DOI 10.1016/j.cub.2004.03.048; Strugnell JM, 2008, ANTARCT SCI, V20, P245, DOI 10.1017/S0954102008001132; Strugnell JM, 2012, MOL ECOL, V21, P2775, DOI 10.1111/j.1365-294X.2012.05572.x; Systat Software Inc, 2009, STST VERS 13; Talavera G, 2013, METHODS ECOLOGY EVOL; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, P28; Teske PR, 2007, MAR BIOL, V151, P2119, DOI 10.1007/s00227-007-0644-x; Thiel M, 2005, OCEANOGR MAR BIOL, V43, P279; TOLL RB, 1988, AM MALACOL BULL, V6, P207; Undheim EAB, 2010, CR BIOL, V333, P395, DOI 10.1016/j.crvi.2010.02.002; VALENTINE JW, 1984, GEOLOGY, V12, P647, DOI 10.1130/0091-7613(1984)12<647:NMCTIF>2.0.CO;2; Villanueva R, 1995, CAN J FISH AQUAT SCI, V52, P2639, DOI 10.1139/f95-853; Villanueva R, 2008, OCEANOGR MAR BIOL, V46, P105; VOIGHT JR, 1995, BIOL BULL, V189, P113, DOI 10.2307/1542461; VOIGHT JR, 1991, B MAR SCI, V49, P98; VOIGHT JR, 1991, MALACOLOGIA, V33, P241; Waters JM, 2005, MOL ECOL, V14, P2789, DOI 10.1111/j.1365-294X.2005.02635.x; WHITE BN, 1986, SYST ZOOL, V35, P176, DOI 10.2307/2413429; Wilson B.R., 1987, P43	78	39	45	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e98982	10.1371/journal.pone.0098982	http://dx.doi.org/10.1371/journal.pone.0098982			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964133	Green Accepted, Green Published, gold			2022-12-27	WOS:000338709500007
J	Deng, HZ; Deng, H; Cen, CQ; Chen, KY; Du, ML				Deng, Hong-Zhu; Deng, Hong; Cen, Chao-Qun; Chen, Kai-Yun; Du, Min-Lian			Post-Receptor Crosstalk between Growth Hormone and Insulin Signal in Rats Born Small for Gestational Age with Catch-Up Growth	PLOS ONE			English	Article							SKELETAL-MUSCLE; ADIPOSE-TISSUE; YOUNG-ADULTS; RESISTANCE; GLUCOSE; SENSITIVITY; WEIGHT; MODEL; RESTRICTION; METABOLISM	Objective: Insulin resistance has been observed in individuals born small for gestational age (SGA) with catch-up growth (CUG), yet the mechanisms involved remain unclear. This study examined the role of GH and insulin signaling crosstalk in insulin resistance of SGA rats with CUG. Design and Methods: SGA rats were developed by dietary restriction in pregnant rats. GH receptor inhibition was performed on four-week old CUG-SGA and AGA rats. Phosphorylation of IRS-1, AKT, and ERK, and expression of SOCS3 in the skeletal muscle were determined via immunoblot analysis at baseline and after insulin stimulation in CUG-SGA, NCUG-SGA and AGA groups. Results: Compared to AGA controls, phosphorylation of IRS-1 and AKT in response to insulin stimulation in CUG-SGA rats was significantly blunted (P<0.05), and phosphorylation of ERK at baseline was dramatically activated (P<0.05). SOCS3 expression was significantly increased in CUG-SGA compared to AGA (P = 0.001) and NCUG-SGA (P = 0.006) rats, and was significantly suppressed following GHR inhibition (P<0.05). Furthermore, phosphorylation of IRS-1 and AKT in response to insulin stimulation increased after GHR inhibition (P<0.05). Conclusions: Insulin resistance in CUG-SGA rats is associated with impairment of IRS-1-PI3K-AKT signaling, which may result from GH signaling-induced up-regulation of SOCS3.	[Deng, Hong-Zhu; Cen, Chao-Qun; Chen, Kai-Yun] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Pediat, Guangzhou 510275, Guangdong, Peoples R China; [Deng, Hong] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Infect Dis, Guangzhou 510275, Guangdong, Peoples R China; [Deng, Hong-Zhu; Du, Min-Lian] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Pediat, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Deng, H (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Infect Dis, Guangzhou 510275, Guangdong, Peoples R China.	denghong2@foxmail.com			Natural Science Foundation of China [81100571]; Natural Science Foundation of Guangdong Province [S2011020005224]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	The study was supported by the Natural Science Foundation of China (grant number 81100571) and the Natural Science Foundation of Guangdong Province (grant number S2011020005224). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Croker BA, 2008, SEMIN CELL DEV BIOL, V19, P414, DOI 10.1016/j.semcdb.2008.07.010; De Blasio MJ, 2012, ENDOCRINOLOGY, V153, P2142, DOI 10.1210/en.2011-1955; Deng HZ, 2011, EUR J PEDIATR, V170, P75, DOI 10.1007/s00431-010-1274-8; [邓红珠 DENG Hongzhu], 2011, [中国病理生理杂志, Chinese Journal of Pathophysiology], V27, P1360; Dominici FP, 2005, GROWTH HORM IGF RES, V15, P324, DOI 10.1016/j.ghir.2005.07.001; Dulloo AG, 2002, INT J OBESITY, V26, pS46, DOI 10.1038/sj.ijo.0802127; Emanuelli B, 2001, J BIOL CHEM, V276, P47944, DOI 10.1074/jbc.M104602200; Fasshauer M, 2004, J ENDOCRINOL, V181, P129, DOI 10.1677/joe.0.1810129; Hofman PL, 2004, NEW ENGL J MED, V351, P2179, DOI 10.1056/NEJMoa042275; Hovi P, 2007, NEW ENGL J MED, V356, P2053, DOI 10.1056/NEJMoa067187; Huang TT, 2008, HORM RES, V70, P29, DOI 10.1159/000129675; Irving RJ, 2000, LANCET, V355, P2135, DOI 10.1016/S0140-6736(00)02384-9; Jorgensen JOL, 2006, AM J PHYSIOL-ENDOC M, V291, pE899, DOI 10.1152/ajpendo.00024.2006; Jorgensen SB, 2013, DIABETES, V62, P56, DOI 10.2337/db12-0443; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Moller N, 2009, ENDOCR REV, V30, P152, DOI 10.1210/er.2008-0027; Peraldi P, 2001, J BIOL CHEM, V276, P24614, DOI 10.1074/jbc.M102209200; Rotteveel J, 2008, PEDIATRICS, V122, P313, DOI 10.1542/peds.2007-2012; Shirakami A, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740309; Varvarigou AA, 2010, J PEDIATR ENDOCR MET, V23, P215, DOI 10.1515/JPEM.2010.23.3.215; Vijayakumar A, 2012, DIABETES, V61, P94, DOI 10.2337/db11-0814; Vuguin P, 2004, DIABETES, V53, P2617, DOI 10.2337/diabetes.53.10.2617; Xu J, 2009, VITAM HORM, V80, P125, DOI 10.1016/S0083-6729(08)00606-7; Ye J, 2012, PEDIATR RES, V72, P550, DOI 10.1038/pr.2012.123	24	6	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100459	10.1371/journal.pone.0100459	http://dx.doi.org/10.1371/journal.pone.0100459			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963636	gold, Green Published, Green Submitted			2022-12-27	WOS:000338709500054
J	Elmariah, SB; Reddy, VB; Lerner, EA				Elmariah, Sarina B.; Reddy, Vemuri B.; Lerner, Ethan A.			Cathepsin S Signals via PAR2 and Generates a Novel Tethered Ligand Receptor Agonist	PLOS ONE			English	Article							PROTEINASE-ACTIVATED RECEPTOR-2; MHC CLASS-II; THROMBIN-RECEPTOR; CYSTEINE CATHEPSINS; HUMAN KERATINOCYTES; NETHERTON SYNDROME; INVARIANT CHAIN; EXPRESSION; IDENTIFICATION; SPECIFICITY	Protease-activated receptor-2 is widely expressed in mammalian epithelial, immune and neural tissues. Cleavage of PAR2 by serine proteases leads to self-activation of the receptor by the tethered ligand SLIGRL. The contribution of other classes of proteases to PAR activation has not been studied in detail. Cathepsin S is a widely expressed cysteine protease that is upregulated in inflammatory conditions. It has been suggested that cathepsin S activates PAR2. However, cathepsin S activation of PAR2 has not been demonstrated directly nor has the potential mechanism of activation been identified. We show that cathepsin S cleaves near the N-terminus of PAR2 to expose a novel tethered ligand, KVDGTS. The hexapeptide KVDGTS generates downstream signaling events specific to PAR2 but is weaker than SLIGRL. Mutation of the cathepsin S cleavage site prevents receptor activation by the protease while KVDGTS retains activity. In conclusion, the range of actions previously ascribed to cysteine cathepsins in general, and cathepsin S in particular, should be expanded to include molecular signaling. Such signaling may link together observations that had been attributed previously to PAR2 or cathepsin S individually. These interactions may contribute to inflammation.	[Lerner, Ethan A.] Massachusetts Gen Hosp, Dept Dermatol, Cutaneous Biol Res Ctr, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Lerner, EA (corresponding author), Massachusetts Gen Hosp, Dept Dermatol, Cutaneous Biol Res Ctr, Boston, MA 02114 USA.	elerner@partners.org			NIAMS/NIH [1R01AR057744]; Dermatology Foundation; Women's Dermatologic Society; LaRoche-Posay; NIH training [5T32AR007098]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007098] Funding Source: NIH RePORTER	NIAMS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Dermatology Foundation; Women's Dermatologic Society; LaRoche-Posay; NIH training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grant number 1R01AR057744 from NIAMS/NIH to EAL and its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIAMS or NIH. In addition, SBE was supported by the Dermatology Foundation, the Women's Dermatologic Society, an award from LaRoche-Posay and by NIH training grant 5T32AR007098. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa E, 2009, CIRCULATION, V119, P1785, DOI 10.1161/CIRCULATIONAHA.108.827972; Biniossek ML, 2011, J PROTEOME RES, V10, P5363, DOI 10.1021/pr200621z; Briot A, 2010, J INVEST DERMATOL, V130, P2736, DOI 10.1038/jid.2010.233; Briot A, 2009, J EXP MED, V206, P1135, DOI 10.1084/jem.20082242; Buddenkotte J, 2005, J INVEST DERMATOL, V124, P38, DOI 10.1111/j.0022-202X.2004.23539.x; Cattaruzza F, 2011, GASTROENTEROLOGY, V141, P1864, DOI 10.1053/j.gastro.2011.07.035; CHEN YH, 1994, J BIOL CHEM, V269, P27372; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Hwang HS, 2002, PROTEIN EXPRES PURIF, V25, P541, DOI 10.1016/S1046-5928(02)00033-5; Jeon SK, 2008, J INVEST DERMATOL, V128, P1930, DOI 10.1038/jid.2008.13; Lerner DJ, 1996, J BIOL CHEM, V271, P13943, DOI 10.1074/jbc.271.24.13943; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Liu Q, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001925; Lourbakos A, 1998, FEBS LETT, V435, P45, DOI 10.1016/S0014-5793(98)01036-9; Moormann C, 2006, J INVEST DERMATOL, V126, P746, DOI 10.1038/sj.jid.5700169; Oikonomopoulou K, 2006, J BIOL CHEM, V281, P32095, DOI 10.1074/jbc.M513138200; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Oldham WM, 2007, P NATL ACAD SCI USA, V104, P7927, DOI 10.1073/pnas.0702623104; Ramachandran R, 2007, AM J PHYSIOL-LUNG C, V292, pL788, DOI 10.1152/ajplung.00226.2006; Ramachandran R, 2012, BIOL CHEM, V393, P421, DOI 10.1515/hsz-2011-0251; Ramachandran R, 2012, NAT REV DRUG DISCOV, V11, P69, DOI 10.1038/nrd3615; Ramachandran R, 2009, MOL PHARMACOL, V76, P791, DOI 10.1124/mol.109.055509; Reddy VB, 2010, BRIT J DERMATOL, V163, P532, DOI 10.1111/j.1365-2133.2010.09862.x; Reddy VB, 2010, J INVEST DERMATOL, V130, P1468, DOI 10.1038/jid.2009.430; Reiser J, 2010, J CLIN INVEST, V120, P3421, DOI 10.1172/JCI42918; Riese RJ, 1996, IMMUNITY, V4, P357, DOI 10.1016/S1074-7613(00)80249-6; Ruckrich T, 2006, BIOL CHEM, V387, P1503, DOI 10.1515/BC.2006.188; Russo A, 2009, MOL INTERV, V9, P87, DOI 10.1124/mi.9.2.8; SCARBOROUGH RM, 1992, J BIOL CHEM, V267, P13146; Schwarz G, 2002, J INVEST DERMATOL, V119, P44, DOI 10.1046/j.1523-1747.2002.01800.x; Steinhoff M, 1999, EXP DERMATOL, V8, P282; Tobbell DA, 2002, PROTEIN EXPRES PURIF, V24, P242, DOI 10.1006/prep.2001.1573; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; van's Gravesande KS, 2002, J IMMUNOL, V168, P4488, DOI 10.4049/jimmunol.168.9.4488; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; VU TKH, 1991, NATURE, V353, P674, DOI 10.1038/353674a0; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; XIN XQ, 1992, ARCH BIOCHEM BIOPHYS, V299, P334, DOI 10.1016/0003-9861(92)90283-3	38	43	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e99702	10.1371/journal.pone.0099702	http://dx.doi.org/10.1371/journal.pone.0099702			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964046	Green Published, gold, Green Submitted			2022-12-27	WOS:000338709500014
J	Bulir, DC; Waltho, DA; Stone, CB; Mwawasi, KA; Nelson, JC; Mahony, JB				Bulir, David C.; Waltho, Daniel A.; Stone, Christopher B.; Mwawasi, Kenneth A.; Nelson, Jordan C.; Mahony, James B.			Chlamydia pneumoniae CopD Translocator Protein Plays a Critical Role in Type III Secretion (T3S) and Infection	PLOS ONE			English	Article							ENTEROPATHOGENIC ESCHERICHIA-COLI; COILED-COIL DOMAIN; CHLAMYDOPHILA-PNEUMONIAE; SYSTEMS; IPAB; INJECTISOME; CHAPERONES; BINDING; DELIVERY; INSIGHTS	Pathogenic Gram-negative bacteria use type III secretion (T3S) to inject effector proteins into the host cell to create appropriate conditions for infection and intracellular replication. Chlamydia spp. are believed to use T3S to infect their host cell, and the translocator proteins are an essential component of this system. Chlamydia pneumoniae contains genes encoding two sets of translocator proteins; CopB and CopD, and CopB2 and CopD2. In this study, we identified novel interactions between CopD and three type III secretion proteins; namely, CopN, CdsN, and CdsF. We identified a CopD putative chaperone binding motif, PxLxxP, within the N-terminal region (CopD amino acids 120-125), which was necessary for interaction with its putative chaperone LcrH_1. Using size exclusion chromatography, we showed that CopD and LcrH_1 formed higher order structures in solution with CopD and LcrH_1 binding in a ratio of 1:1, which is unique for T3SS translocator proteins. Lastly, we showed that antibodies to CopD reduced C. pneumoniae infectivity by >95%. Collectively, this data suggests that CopD plays a critical role in pathogenesis and likely functions as a hydrophobic translocator of the type III secretion system in Chlamydia pneumoniae.	[Mahony, James B.] McMaster Univ, Fac Hlth Sci, MG DeGroote Inst Infect Dis Res, Hamilton, ON, Canada; McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; St Josephs Healthcare, Father Sean OSullivan Res Ctr, Hamilton, ON, Canada	McMaster University; McMaster University	Mahony, JB (corresponding author), McMaster Univ, Fac Hlth Sci, MG DeGroote Inst Infect Dis Res, Hamilton, ON, Canada.	mahonyj@mcmaster.ca						Adam PR, 2012, BIOCHEMISTRY-US, V51, P4062, DOI 10.1021/bi300243z; Beeckman DSA, 2010, CURR ISSUES MOL BIOL, V12, P17; Betts-Hampikian HJ, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00114; Blaylock B, 2006, J BACTERIOL, V188, P3525, DOI 10.1128/JB.188.10.3525-3534.2006; Chellas-Gery B, 2011, INFECT IMMUN, V79, P3036, DOI 10.1128/IAI.00159-11; Cordes FS, 2005, J MOL BIOL, V354, P206, DOI 10.1016/j.jmb.2005.09.062; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Cornelis GR, 2010, BIOL CHEM, V391, P745, DOI 10.1515/BC.2010.079; Daniell SJ, 2001, INFECT IMMUN, V69, P4055, DOI 10.1128/IAI.69.6.4055-4064.2001; Dautry-Varsat A, 2005, CELL MICROBIOL, V7, P1714, DOI 10.1111/j.1462-5822.2005.00627.x; Delahay RM, 2002, MOL MICROBIOL, V45, P905, DOI 10.1046/j.1365-2958.2002.03083.x; Delahay RM, 1999, J BIOL CHEM, V274, P35969, DOI 10.1074/jbc.274.50.35969; Dickenson NE, 2013, PROTEIN SCI, V22, P614, DOI 10.1002/pro.2245; Diepold A, 2010, EMBO J, V29, P1928, DOI 10.1038/emboj.2010.84; Edqvist PJ, 2006, MOL MICROBIOL, V59, P31, DOI 10.1111/j.1365-2958.2005.04923.x; Espina M, 2007, PROTEIN SCI, V16, P704, DOI 10.1110/ps.062645007; Fields KA, 2005, J BACTERIOL, V187, P6466, DOI 10.1128/JB.187.18.6466-6478.2005; Gazi AD, 2009, CELL MICROBIOL, V11, P719, DOI 10.1111/j.1462-5822.2009.01297.x; Heine SJ, 2014, J IMMUNOL, V192, P1630, DOI 10.4049/jimmunol.1302743; Iriarte M, 1998, EMBO J, V17, P1907, DOI 10.1093/emboj/17.7.1907; Ivanov MI, 2008, INFECT IMMUN, V76, P5181, DOI 10.1128/IAI.00189-08; Johnson DL, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-218; Lunelli M, 2009, P NATL ACAD SCI USA, V106, P9661, DOI 10.1073/pnas.0812900106; Martinez-Becerra FJ, 2013, INFECT IMMUN, V81, P4470, DOI 10.1128/IAI.00859-13; Mattei PJ, 2011, FEBS J, V278, P414, DOI 10.1111/j.1742-4658.2010.07974.x; Ouellette SP, 2005, J BACTERIOL, V187, P7853, DOI 10.1128/JB.187.22.7853-7856.2005; Pallen MJ, 2005, FEMS MICROBIOL REV, V29, P201, DOI 10.1016/j.femsre.2005.01.001; Pallen MJ, 1997, MOL MICROBIOL, V25, P423, DOI 10.1046/j.1365-2958.1997.4901850.x; Pallen MJ, 2003, FEMS MICROBIOL LETT, V223, P53, DOI 10.1016/S0378-1097(03)00344-6; Parsot C, 2003, CURR OPIN MICROBIOL, V6, P7, DOI 10.1016/S1369-5274(02)00002-4; Shen DK, 2010, INFECT IMMUN, V78, P4999, DOI 10.1128/IAI.00470-10; Stone CB, 2008, J BACTERIOL, V190, P6580, DOI 10.1128/JB.00761-08; Stone CB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030220; Veenendaal AKJ, 2007, MOL MICROBIOL, V63, P1719, DOI 10.1111/j.1365-2958.2007.05620.x	34	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e99315	10.1371/journal.pone.0099315	http://dx.doi.org/10.1371/journal.pone.0099315			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959658	Green Published, gold, Green Submitted			2022-12-27	WOS:000338633900005
J	Zhou, C; Ma, Q; Li, GJ				Zhou, Chuan; Ma, Qin; Li, Guojun			Elucidation of Operon Structures across Closely Related Bacterial Genomes	PLOS ONE			English	Article							SEQUENCE; PREDICTION; DATABASE; IDENTIFICATION; CONSERVATION; AGENT; ODB	About half of the protein-coding genes in prokaryotic genomes are organized into operons to facilitate co-regulation during transcription. With the evolution of genomes, operon structures are undergoing changes which could coordinate diverse gene expression patterns in response to various stimuli during the life cycle of a bacterial cell. Here we developed a graph-based model to elucidate the diversity of operon structures across a set of closely related bacterial genomes. In the constructed graph, each node represents one orthologous gene group (OGG) and a pair of nodes will be connected if any two genes, from the corresponding two OGGs respectively, are located in the same operon as immediate neighbors in any of the considered genomes. Through identifying the connected components in the above graph, we found that genes in a connected component are likely to be functionally related and these identified components tend to form treelike topology, such as paths and stars, corresponding to different biological mechanisms in transcriptional regulation as follows. Specifically, (i) a path-structure component integrates genes encoding a protein complex, such as ribosome; and (ii) a star-structure component not only groups related genes together, but also reflects the key functional roles of the central node of this component, such as the ABC transporter with a transporter permease and substrate-binding proteins surrounding it. Most interestingly, the genes from organisms with highly diverse living environments, i.e., biomass degraders and animal pathogens of clostridia in our study, can be clearly classified into different topological groups on some connected components.	[Zhou, Chuan; Li, Guojun] Shandong Univ, Sch Math, Jinan 250100, Peoples R China; [Ma, Qin] Univ Georgia, Dept Biochem & Mol Biol, Computat Syst Biol Lab, Athens, GA 30602 USA; [Ma, Qin] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA	Shandong University; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Li, GJ (corresponding author), Shandong Univ, Sch Math, Jinan 250100, Peoples R China.	guojunsdu@gmail.com	Ma, Qin/O-1525-2013; Ma, Qin/V-7920-2019	Ma, Qin/0000-0002-3264-8392; Ma, Qin/0000-0002-3264-8392	 [61272016]		This work was supported by 61272016 (http://www.nsfc.gov.cn/). GL received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bang-Jensen J, 2007, SPRINGER MONOGR MATH; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bettegowda C, 2006, NAT BIOTECHNOL, V24, P1573, DOI 10.1038/nbt1256; Brazier JS, 2002, J MED MICROBIOL, V51, P985, DOI 10.1099/0022-1317-51-11-985; Brouwer RWW, 2008, BRIEF BIOINFORM, V9, P367, DOI 10.1093/bib/bbn019; Bruggemann H, 2003, P NATL ACAD SCI USA, V100, P1316, DOI 10.1073/pnas.0335853100; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dam P, 2007, NUCLEIC ACIDS RES, V35, P288, DOI 10.1093/nar/gkl1018; Dandekar T, 1998, TRENDS BIOCHEM SCI, V23, P324, DOI 10.1016/S0968-0004(98)01274-2; de Daruvar A, 2002, J MOL EVOL, V55, P211, DOI 10.1007/s00239-002-2317-1; Ermolaeva MD, 2001, NUCLEIC ACIDS RES, V29, P1216, DOI 10.1093/nar/29.5.1216; Feinberg L, 2011, J BACTERIOL, V193, P2906, DOI 10.1128/JB.00322-11; Hemme CL, 2010, J BACTERIOL, V192, P6494, DOI 10.1128/JB.01064-10; Hill KK, 2007, J BACTERIOL, V189, P818, DOI 10.1128/JB.01180-06; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Itoh T, 1999, MOL BIOL EVOL, V16, P332, DOI 10.1093/oxfordjournals.molbev.a026114; JACOB F, 1961, COLD SPRING HARB SYM, V26, P193, DOI 10.1101/SQB.1961.026.01.024; Kopke M, 2010, P NATL ACAD SCI USA, V107, P13087, DOI 10.1073/pnas.1004716107; Li GJ, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr766; Li GJ, 2011, NUCLEIC ACIDS RES, V39, pE42, DOI 10.1093/nar/gkq948; Li Guojun, 2009, Journal of Bioinformatics and Computational Biology, V7, P19, DOI 10.1142/S0219720009003984; Ma Q, 2013, BIOINFORMATICS, V29, P2261, DOI 10.1093/bioinformatics/btt397; Mao FL, 2009, NUCLEIC ACIDS RES, V37, pD459, DOI 10.1093/nar/gkn757; Mao XZ, 2014, NUCLEIC ACIDS RES, V42, pD654, DOI 10.1093/nar/gkt1048; Miller DA, 2011, J BACTERIOL, V193, P2357, DOI 10.1128/JB.00239-11; Moran NA, 2002, CELL, V108, P583, DOI 10.1016/S0092-8674(02)00665-7; Myers GSA, 2006, GENOME RES, V16, P1031, DOI 10.1101/gr.5238106; Nolling J, 2001, J BACTERIOL, V183, P4823, DOI 10.1128/JB.183.16.4823-4838.2001; Okuda S, 2006, NUCLEIC ACIDS RES, V34, pD358, DOI 10.1093/nar/gkj037; Okuda S, 2011, NUCLEIC ACIDS RES, V39, pD552, DOI 10.1093/nar/gkq1090; Omelchenko MV, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r55; Pagani I, 2012, NUCLEIC ACIDS RES, V40, pD571, DOI 10.1093/nar/gkr1100; Pertea M, 2009, NUCLEIC ACIDS RES, V37, pD479, DOI 10.1093/nar/gkn784; Price MN, 2006, PLOS GENET, V2, P859, DOI 10.1371/journal.pgen.0020096; Qin M, 2014, NUCL ACIDS IN PRESS; Rocha EPC, 2006, MOL BIOL EVOL, V23, P513, DOI 10.1093/molbev/msj052; Salgado H, 2013, NUCLEIC ACIDS RES, V41, pD203, DOI 10.1093/nar/gks1201; Seedorf H, 2008, P NATL ACAD SCI USA, V105, P2128, DOI 10.1073/pnas.0711093105; Skarin H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-185; Taboada B, 2012, NUCLEIC ACIDS RES, V40, pD627, DOI 10.1093/nar/gkr1020; Taboada B, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq254; Van Dongen SM, 2001, GRAPH CLUSTERING FLO; Wang Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-479; Wolf YI, 2001, GENOME RES, V11, P356, DOI 10.1101/gr.GR-1619R; Yokoyama S, 2011, J BACTERIOL, V193, P5568, DOI 10.1128/JB.05637-11; Zheng Y, 2002, GENOME RES, V12, P1221, DOI 10.1101/gr.200602; Zhou C, 2014, BIOENERG RES, V7, P1481, DOI 10.1007/s12155-014-9486-9	47	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100999	10.1371/journal.pone.0100999	http://dx.doi.org/10.1371/journal.pone.0100999			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959722	Green Published, Green Submitted, gold			2022-12-27	WOS:000338633900110
J	Giebeler, A; Streetz, KL; Soehnlein, O; Neumann, U; Wang, JM; Brandenburg, LO				Giebeler, Arne; Streetz, Konrad L.; Soehnlein, Oliver; Neumann, Ulf; Wang, Ji Ming; Brandenburg, Lars-Ove			Deficiency of Formyl Peptide Receptor 1 and 2 Is Associated with Increased Inflammation and Enhanced Liver Injury after LPS-Stimulation	PLOS ONE			English	Article							N-FORMYLPEPTIDE RECEPTOR; BILE-DUCT LIGATION; 1-42-INDUCED SIGNAL-TRANSDUCTION; HEPATIC-FIBROSIS; GLIAL-CELLS; TRANSCRIPTIONAL REGULATION; HUMAN NEUTROPHILS; GENE-CLUSTER; C-MET; EXPRESSION	Introduction: Formyl peptide-receptor 1 and 2 (FPR1 and FPR2) in mice were identified as receptors with contrary affinity for the PAMP fMLF. Formyl-methionyl-leucyl-phenylalanine is either part of the bacterial membrane and is secreted by the mitochondria of eukaryotic ceslls during apoptosis. Furthermore FPR1 and 2 are described as highly relevant factors for the chemotaxis of immune cells. Their role during the acute liver injury has not been investigated yet. Materials and Methods: Constitutive knockout mice for FPR1 (mFPR1(-/-)), FPR2 (mFPR2(-/-)) and wild type (WT) mice were challenged with LPS i.p. for 3 h and 6 h. Liver and serum were sampled for further analysis. Results: Liver transaminases were elevated in all mice 3 h and 6 h post LPS stimulation. Gene expression analysis displayed a reduced expression of the pro-inflammatory cytokines IL-6 and CXCL1 after 3 h in the mFPR1(-/-) compared to wild type and mFPR2(-/-) mice. After 6 h, IL-6, TNF-alpha and CXCL1 were significantly higher in mice lacking mFPR1 or 2. Consistent to these findings the numbers of CD11b(+) and Ly6G(+) immune cells were altered in the livers. The analysis of TLR2 and TLR4 revealed time and genotype specific changes in theirs gene expression. Additionally, the liver in mFPR1- and mFPR2-deficient mice seem to be more susceptible to apoptosis by showing a significant higher number of TUNEL+-cells in the liver than WT-mice and displayed less Ki67-positive nuclei in the liver. Conclusion: The results suggest a prominent role of FPRs in the regulation of the hepatic inflammatory response after LPS induced liver injury. Deletion of mFPR1 or mFPR2 leads to deregulation of the inflammatory response compared to WT mice, associated with more severe liver injury represented by higher levels of transaminases, apoptotic cells and a reduced regenerative capacity.	[Giebeler, Arne; Neumann, Ulf] Rhein Westfal TH Aachen, Dept Surg, Univ Hosp, Aachen, Germany; [Brandenburg, Lars-Ove] Rhein Westfal TH Aachen, Dept Anat & Cell Biol, Aachen, Germany; [Streetz, Konrad L.] Rhein Westfal TH Aachen, Dept Med 3, Univ Hosp, Aachen, Germany; [Soehnlein, Oliver] Ludwig Maximilians Univ Munchen, Inst Cardiovasc Prevent IPEK, Munich, Germany; [Wang, Ji Ming] NCI, Mol Immunoregulat Lab, Canc & Inflammat Program, Ctr Canc Res, Frederick, MD 21701 USA	RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University; RWTH Aachen University Hospital; University of Munich; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Giebeler, A (corresponding author), Rhein Westfal TH Aachen, Dept Surg, Univ Hosp, Aachen, Germany.	agiebeler@ukaachen.de			Department of Surgery, University Hospital Aachen, RWTH Aachen	Department of Surgery, University Hospital Aachen, RWTH Aachen	This work was supported by the Department of Surgery, University Hospital Aachen, RWTH Aachen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliberti J, 2002, MOL IMMUNOL, V38, P891, DOI 10.1016/S0161-5890(02)00015-9; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Becker EL, 1998, CELL TISSUE RES, V292, P129, DOI 10.1007/s004410051042; Best J, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00258; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Brandenburg LO, 2007, J NEUROCHEM, V101, P718, DOI 10.1111/j.1471-4159.2006.04351.x; Brandenburg LO, 2010, J NEUROCHEM, V113, P749, DOI 10.1111/j.1471-4159.2010.06637.x; Brenner David A, 2009, Trans Am Clin Climatol Assoc, V120, P361; CARP H, 1982, J EXP MED, V155, P264, DOI 10.1084/jem.155.1.264; Cattaneo F, 2010, NEUROCHEM RES, V35, P2018, DOI 10.1007/s11064-010-0301-5; Chen KQ, 2010, J IMMUNOL, V184, P3331, DOI 10.4049/jimmunol.0903022; Christenson K, 2008, J LEUKOCYTE BIOL, V83, P139, DOI 10.1189/jlb.0507276; CRAIG PM, 1992, GUT, V33, P1020, DOI 10.1136/gut.33.8.1020; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; Czapiga M, 2005, EXP HEMATOL, V33, P73, DOI 10.1016/j.exphem.2004.09.010; DURSTIN M, 1994, BIOCHEM BIOPH RES CO, V201, P174, DOI 10.1006/bbrc.1994.1685; Friedman SL, 2010, NAT REV GASTRO HEPAT, V7, P425, DOI 10.1038/nrgastro.2010.97; Friedman SL, 2008, TOXICOLOGY, V254, P120, DOI 10.1016/j.tox.2008.06.013; Gao JL, 1998, GENOMICS, V51, P270, DOI 10.1006/geno.1998.5376; Gao JL, 1999, J EXP MED, V189, P657, DOI 10.1084/jem.189.4.657; Georgiev P, 2008, BRIT J SURG, V95, P646, DOI 10.1002/bjs.6050; Giebeler A, 2012, LAB INVEST, V92, P1726, DOI 10.1038/labinvest.2012.122; Giebeler A, 2009, GASTROENTEROLOGY, V137, P297, DOI 10.1053/j.gastro.2009.01.068; Grommes J, 2013, J INNATE IMMUN; He HQ, 2013, MOL PHARMACOL, V83, P389, DOI 10.1124/mol.112.081315; Kim SD, 2009, J IMMUNOL, V183, P5511, DOI 10.4049/jimmunol.0802986; Klein C, 2005, J CLIN INVEST, V115, P860, DOI 10.1172/JCI200523640; Kovalovich K, 2001, J BIOL CHEM, V276, P26605, DOI 10.1074/jbc.M100740200; Le YY, 2002, INT IMMUNOPHARMACOL, V2, P1, DOI 10.1016/S1567-5769(01)00150-3; Lee RJ, 1997, BIOCHEM BIOPH RES CO, V235, P812, DOI 10.1006/bbrc.1997.6874; Leoni G, 2013, J CLIN INVEST, V123, P443, DOI 10.1172/JCI65831; Liang TS, 2000, BIOCHEM BIOPH RES CO, V270, P331, DOI 10.1006/bbrc.2000.2416; Liberles SD, 2009, P NATL ACAD SCI USA, V106, P9842, DOI 10.1073/pnas.0904464106; MCCOY R, 1995, J EXP MED, V182, P207, DOI 10.1084/jem.182.1.207; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; McLeish KR, 1998, J LEUKOCYTE BIOL, V64, P537, DOI 10.1002/jlb.64.4.537; Michalopoulos GK, 2010, AM J PATHOL, V176, P2, DOI 10.2353/ajpath.2010.090675; Mukhopadhyay B, 2011, P NATL ACAD SCI USA, V108, P6323, DOI 10.1073/pnas.1017689108; Mukhopadhyay B, 2010, J BIOL CHEM, V285, P19002, DOI 10.1074/jbc.M109.068460; Nagaoka I, 2006, J IMMUNOL, V176, P3044, DOI 10.4049/jimmunol.176.5.3044; Norling LV, 2013, J INNATE IMMUN, V5, P367, DOI 10.1159/000350612; SCHIFFMANN E, 1975, J IMMUNOL, V114, P1831; SCHIFFMANN E, 1975, P NATL ACAD SCI USA, V72, P1059, DOI 10.1073/pnas.72.3.1059; Schuppan D, 2013, J CLIN INVEST, V123, P1887, DOI 10.1172/JCI66028; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Selzner M, 1999, HEPATOLOGY, V30, P469, DOI 10.1002/hep.510300215; Shin MK, 2011, J BIOL CHEM, V286, P17133, DOI 10.1074/jbc.M110.197772; Slowik A, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-55; Stefanovic L, 2005, EXP BIOL MED, V230, P573, DOI 10.1177/153537020523000809; Waechter V, 2012, J IMMUNOL, V188, P1856, DOI 10.4049/jimmunol.1101788; Wantha S, 2013, CIRC RES, V112, P792, DOI 10.1161/CIRCRESAHA.112.300666; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zhao Y, 2007, J CELL PHYSIOL, V213, P556, DOI 10.1002/jcp.21136	53	24	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100522	10.1371/journal.pone.0100522	http://dx.doi.org/10.1371/journal.pone.0100522			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956481	Green Published, Green Submitted, gold			2022-12-27	WOS:000338917900063
J	Kingsley, LJ; Lill, MA				Kingsley, Laura J.; Lill, Markus A.			Ensemble Generation and the Influence of Protein Flexibility on Geometric Tunnel Prediction in Cytochrome P450 Enzymes	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; LIGAND-BINDING; ACCESS TUNNELS; P450S; CHANNELS; SUBSTRATE; IDENTIFICATION; MECHANISM; KINETICS	Computational prediction of ligand entry and egress paths in proteins has become an emerging topic in computational biology and has proven useful in fields such as protein engineering and drug design. Geometric tunnel prediction programs, such as Caver3.0 and MolAxis, are computationally efficient methods to identify potential ligand entry and egress routes in proteins. Although many geometric tunnel programs are designed to accommodate a single input structure, the increasingly recognized importance of protein flexibility in tunnel formation and behavior has led to the more widespread use of protein ensembles in tunnel prediction. However, there has not yet been an attempt to directly investigate the influence of ensemble size and composition on geometric tunnel prediction. In this study, we compared tunnels found in a single crystal structure to ensembles of various sizes generated using different methods on both the apo and holo forms of cytochrome P450 enzymes CYP119, CYP2C9, and CYP3A4. Several protein structure clustering methods were tested in an attempt to generate smaller ensembles that were capable of reproducing the data from larger ensembles. Ultimately, we found that by including members from both the apo and holo data sets, we could produce ensembles containing less than 15 members that were comparable to apo or holo ensembles containing over 100 members. Furthermore, we found that, in the absence of either apo or holo crystal structure data, pseudo-apo or -holo ensembles (e.g. adding ligand to apo protein throughout MD simulations) could be used to resemble the structural ensembles of the corresponding apo and holo ensembles, respectively. Our findings not only further highlight the importance of including protein flexibility in geometric tunnel prediction, but also suggest that smaller ensembles can be as capable as larger ensembles at capturing many of the protein motions important for tunnel prediction at a lower computational cost.	[Kingsley, Laura J.; Lill, Markus A.] Purdue Univ, Coll Pharm, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Lill, MA (corresponding author), Purdue Univ, Coll Pharm, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA.	mlill@purdue.edu	Lill, Markus A/E-5118-2017	Lill, Markus A/0000-0003-3023-5188; Kingsley, Laura/0000-0002-5566-3974	NIH, Department of Education Graduate Assistantship for Areas of National Need (GAANN) Fellowship [GM092855]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092855] Funding Source: NIH RePORTER	NIH, Department of Education Graduate Assistantship for Areas of National Need (GAANN) Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NIH GM092855, Department of Education Graduate Assistantship for Areas of National Need (GAANN) Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Berka K, 2013, J PHYS CHEM B, V117, P11556, DOI 10.1021/jp4059559; Berka K, 2012, NUCLEIC ACIDS RES, V40, pW222, DOI 10.1093/nar/gks363; Biedermannova L, 2012, J BIOL CHEM, V287, P29062, DOI 10.1074/jbc.M112.377853; Brezovsky J, 2013, BIOTECHNOL ADV, V31, P38, DOI 10.1016/j.biotechadv.2012.02.002; Brouk M, 2010, J MOL CATAL B-ENZYM, V66, P72, DOI 10.1016/j.molcatb.2010.03.006; Buch I, 2011, P NATL ACAD SCI USA, V108, P10184, DOI 10.1073/pnas.1103547108; Caillat C, 2008, P NATL ACAD SCI USA, V105, P16900, DOI 10.1073/pnas.0804525105; Case D, 2012, AMBER 12; Cheng LS, 2008, J MED CHEM, V51, P3878, DOI 10.1021/jm8001197; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; Cojocaru V, 2007, BBA-GEN SUBJECTS, V1770, P390, DOI 10.1016/j.bbagen.2006.07.005; Cojocaru V, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002152; Copeland RA, 2006, NAT REV DRUG DISCOV, V5, P730, DOI 10.1038/nrd2082; Cui Y-L, 2013, J CHEM INF MODEL; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Haines DC, 2001, BIOCHEMISTRY-US, V40, P13456, DOI 10.1021/bi011197q; Hendrychova T, 2012, CURR DRUG METAB, V13, P177, DOI 10.2174/138920012798918408; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Korb O, 2012, J CHEM INF MODEL, V52, P1262, DOI 10.1021/ci2005934; Najmanovich R, 2000, PROTEINS, V39, P261, DOI 10.1002/(SICI)1097-0134(20000515)39:3<261::AID-PROT90>3.0.CO;2-4; Oda A, 2005, J COMPUT CHEM, V26, P818, DOI 10.1002/jcc.20221; Otyepka M, 2007, BBA-GEN SUBJECTS, V1770, P376, DOI 10.1016/j.bbagen.2006.09.013; Pavlova M, 2009, NAT CHEM BIOL, V5, P727, DOI 10.1038/nchembio.205; Schleinkofer K, 2005, EMBO REP, V6, P584, DOI 10.1038/sj.embor.7400420; Seifert A, 2006, PROTEINS, V64, P147, DOI 10.1002/prot.20951; Setny P, 2013, P NATL ACAD SCI USA, V110, P1197, DOI 10.1073/pnas.1221231110; Skopalik J, 2008, J PHYS CHEM B, V112, P8165, DOI 10.1021/jp800311c; Stepankova V, 2013, CHEMBIOCHEM, V14, P890, DOI 10.1002/cbic.201200733; Totrov M, 2008, CURR OPIN STRUC BIOL, V18, P178, DOI 10.1016/j.sbi.2008.01.004; Ulmschneider MB, 2013, P NATL ACAD SCI USA, V110, P6364, DOI 10.1073/pnas.1214667110; Vargiu AV, 2012, P NATL ACAD SCI USA, V109, P20637, DOI 10.1073/pnas.1218348109; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Winn PJ, 2002, P NATL ACAD SCI USA, V99, P5361, DOI 10.1073/pnas.082522999; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401; Yaffe E, 2008, PROTEINS, V73, P72, DOI 10.1002/prot.22052; Yu XF, 2013, BIOTECHNOL APPL BIOC, V60, P134, DOI 10.1002/bab.1074	38	16	16	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e99408	10.1371/journal.pone.0099408	http://dx.doi.org/10.1371/journal.pone.0099408			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956479	Green Published, Green Submitted, gold			2022-12-27	WOS:000338917900009
J	Chen, FC; Liao, YC; Huang, JM; Lin, CH; Chen, YY; Dou, HY; Hsiung, CA				Chen, Feng-Chi; Liao, Yu-Chieh; Huang, Jie-Mao; Lin, Chieh-Hua; Chen, Yih-Yuan; Dou, Horng-Yunn; Hsiung, Chao Agnes			Pros and Cons of the Tuberculosis Drugome Approach - An Empirical Analysis	PLOS ONE			English	Article							PLASMA-LEVELS; PHARMACOKINETICS; TAMOXIFEN; SERUM; PHARMACOLOGY; INHIBITION; RESISTANCE; REGIMENS; BLOOD; FLUID	Drug-resistant Mycobacterium tuberculosis (MTB), the causative pathogen of tuberculosis (TB), has become a serious threat to global public health. Yet the development of novel drugs against MTB has been lagging. One potentially powerful approach to drug development is computation-aided repositioning of current drugs. However, the effectiveness of this approach has rarely been examined. Here we select the "TB drugome" approach - a protein structure-based method for drug repositioning for tuberculosis treatment - to (1) experimentally validate the efficacy of the identified drug candidates for inhibiting MTB growth, and (2) computationally examine how consistently drug candidates are prioritized, considering changes in input data. Twenty three drugs in the TB drugome were tested. Of them, only two drugs (tamoxifen and 4-hydroxytamoxifen) effectively suppressed MTB growth at relatively high concentrations. Both drugs significantly enhanced the inhibitory effects of three first-line anti-TB drugs (rifampin, isoniazid, and ethambutol). However, tamoxifen is not a top-listed drug in the TB drugome, and 4-hydroxytamoxifen is not approved for use in humans. Computational re-examination of the TB drugome indicated that the rankings were subject to technical and data-related biases. Thus, although our results support the effectiveness of the TB drugome approach for identifying drugs that can potentially be repositioned for stand-alone applications or for combination treatments for TB, the approach requires further refinements via incorporation of additional biological information. Our findings can also be extended to other structure-based drug repositioning methods.	[Chen, Feng-Chi; Liao, Yu-Chieh; Huang, Jie-Mao; Lin, Chieh-Hua; Hsiung, Chao Agnes] Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Biostat & Bioinformat, Zhunan, Miaoli County, Taiwan; [Chen, Feng-Chi] Natl Chiao Tung Univ, Dept Life Sci, Hsinchu, Taiwan; [Chen, Feng-Chi] China Med Univ, Dept Dent, Taichung, Taiwan; [Lin, Chieh-Hua] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan; [Chen, Yih-Yuan; Dou, Horng-Yunn] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan, Miaoli County, Taiwan	National Health Research Institutes - Taiwan; National Yang Ming Chiao Tung University; China Medical University Taiwan; National Tsing Hua University; National Health Research Institutes - Taiwan	Chen, FC (corresponding author), Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Biostat & Bioinformat, Zhunan, Miaoli County, Taiwan.	fcchen@nhri.org.tw; hsiung@nhri.org.tw	Dou, horng-yunn/F-1966-2015; Liao, Yu-Chieh/E-5031-2011; Chen, Feng-Chi/E-3841-2010; Liao, Yu-Chieh/L-5113-2019; Hsiung, Chao Agnes/E-3994-2010; Dou, Horng-Yunn/B-2652-2010	Liao, Yu-Chieh/0000-0002-4360-7932; 	National Health Research Institutes [PH-101-SP05, PH-102-SP04]	National Health Research Institutes(National Health Research Institutes, Japan)	This study was supported by the National Health Research Institutes intramural funding (PH-101-SP05 and PH-102-SP04: www.nhri.org.tw). The computational facilities for this work were partly supported by the Ministry of Science and Technology, Taiwan (Taiwan Bioinformatics Institute Core Facility (NSC102-2319-B-400-001): www.most.gov.tw). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakar I, 2013, LANCET INFECT DIS, V13, P529, DOI 10.1016/S1473-3099(13)70030-6; Da Silva PEA, 2011, J ANTIMICROB CHEMOTH, V66, P1417, DOI 10.1093/jac/dkr173; Almond-Roesler B, 1998, DERMATOLOGY, V196, P176, DOI 10.1159/000017856; Castelnuovo B, 2010, AFR HEALTH SCI, V10, P320; Cioffi M, 2001, J PEDIATR ENDOCR MET, V14, P1635; Czock D, 2005, BRIT J CLIN PHARMACO, V59, P479, DOI 10.1111/j.1365-2125.2004.02326.x; Dheda K, 2008, NEW ENGL J MED, V359, P2390, DOI 10.1056/NEJMc081884; Diacon AH, 2012, LANCET, V380, P986, DOI 10.1016/S0140-6736(12)61080-0; DONEHOWER RC, 1986, CANCER TREAT REP, V70, P1059; Ekins S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063240; Elbireer S, 2011, TROP MED INT HEALTH, V16, P981, DOI 10.1111/j.1365-3156.2011.02800.x; EMORI HW, 1976, ANN RHEUM DIS, V35, P333, DOI 10.1136/ard.35.4.333; Farhat MR, 2013, NAT GENET, V45, P1183, DOI 10.1038/ng.2747; Garcia-Sosa AT, 2012, CURR MED CHEM, V19, P1646; Garijo D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080278; Gatti G, 1999, AIDS, V13, P2083, DOI 10.1097/00002030-199910220-00011; Harmsen S, 2010, CANCER CHEMOTH PHARM, V66, P765, DOI 10.1007/s00280-009-1221-4; Hempen C, 2012, ANN CLIN BIOCHEM, V49, P170, DOI 10.1258/acb.2011.011004; HOWELL SK, 1980, CLIN CHEM, V26, P734; Issa NT, 2013, CURR TOP MED CHEM, V13, P2328, DOI 10.2174/15680266113136660163; Jekarl DW, 2012, J CLIN LAB ANAL, V26, P412, DOI 10.1002/jcla.21535; JOYCE DA, 1990, BRIT J CLIN PHARMACO, V30, P511, DOI 10.1111/j.1365-2125.1990.tb03808.x; Keshavjee S, 2012, NEW ENGL J MED, V367, P931, DOI 10.1056/NEJMra1205429; Kinnings SL, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000976; Kisanga ER, 2004, CLIN CANCER RES, V10, P2336, DOI 10.1158/1078-0432.CCR-03-0538; Letendre SL, 2000, ANTIMICROB AGENTS CH, V44, P2173, DOI 10.1128/AAC.44.8.2173-2175.2000; Liu K, 2014, DRUG METAB PHARMACOK, V29, P219, DOI 10.2133/dmpk.DMPK-13-NT-089; Macingwana L, 2012, J ANTIMICROB CHEMOTH, V67, P2908, DOI 10.1093/jac/dks306; Macquaire V, 2002, ACTA ANAESTH SCAND, V46, P1010, DOI 10.1034/j.1399-6576.2002.460814.x; Magnet S, 2010, TUBERCULOSIS, V90, P354, DOI 10.1016/j.tube.2010.09.001; Marzolini C, 2001, THER DRUG MONIT, V23, P394, DOI 10.1097/00007691-200108000-00012; Myers JA, 2013, BMC BIOPHYS, V6, DOI 10.1186/2046-1682-6-4; Nencini C, 2008, EUR REV MED PHARMACO, V12, P293; Nichols K C, 1984, Obstet Gynecol Surv, V39, P230, DOI 10.1097/00006254-198404000-00022; Nishikawa N, 2009, PARKINSONISM RELAT D, V15, P351, DOI 10.1016/j.parkreldis.2008.08.005; OVERDIEK HWPM, 1985, CLIN PHARMACOL THER, V38, P469, DOI 10.1038/clpt.1985.206; Palomino JC, 2013, J ANTIMICROB CHEMOTH, V68, P275, DOI 10.1093/jac/dks405; Penuelas-Urquides K, 2013, BRAZ J MICROBIOL, V44, P287, DOI 10.1590/S1517-83822013000100042; Reynolds RC, 2012, TUBERCULOSIS, V92, P72, DOI 10.1016/j.tube.2011.05.005; ROBINSON SP, 1991, DRUG METAB DISPOS, V19, P36; Ruslami R, 2006, ANTIMICROB AGENTS CH, V50, P822, DOI 10.1128/AAC.50.2.822-823.2006; RYLANCE GW, 1985, ARCH DIS CHILD, V60, P29, DOI 10.1136/adc.60.1.29; Seminari E, 2005, J ANTIMICROB CHEMOTH, V56, P790, DOI 10.1093/jac/dki314; Sliwoski G, 2014, PHARMACOL REV, V66, P334, DOI 10.1124/pr.112.007336; Stricker R, 2006, CLIN CHEM LAB MED, V44, P883, DOI 10.1515/CCLM.2006.160; WELLBY M, 1966, BRIT MED J, V2, P668, DOI 10.1136/bmj.2.5515.668; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067; Xie L, 2009, BIOINFORMATICS, V25, pI305, DOI 10.1093/bioinformatics/btp220; Yilmaz A, 2009, AIDS RES HUM RETROV, V25, P457, DOI 10.1089/aid.2008.0216; Zhao XJ, 2002, XENOBIOTICA, V32, P863, DOI 10.1080/00498250210158230	50	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100829	10.1371/journal.pone.0100829	http://dx.doi.org/10.1371/journal.pone.0100829			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971632	Green Published, Green Submitted, gold			2022-12-27	WOS:000338512200065
J	Cheng, T; Adepeju, M				Cheng, Tao; Adepeju, Monsuru			Modifiable Temporal Unit Problem (MTUP) and Its Effect on Space-Time Cluster Detection	PLOS ONE			English	Article							AGGREGATION; SERIES	Background: When analytical techniques are used to understand and analyse geographical events, adjustments to the datasets (e.g. aggregation, zoning, segmentation etc.) in both the spatial and temporal dimensions are often carried out for various reasons. The 'Modifiable Areal Unit Problem' (MAUP), which is a consequence of adjustments in the spatial dimension, has been widely researched. However, its temporal counterpart is generally ignored, especially in space-time analysis. Methods: In analogy to MAUP, the Modifiable Temporal Unit Problem (MTUP) is defined as consisting of three temporal effects (aggregation, segmentation and boundary). The effects of MTUP on the detection of space-time clusters of crime datasets of Central London are examined using Space-Time Scan Statistics (STSS). Results and Conclusion: The case study reveals that MTUP has significant effects on the space-time clusters detected. The attributes of the clusters, i.e. temporal duration, spatial extent (size) and significance value (p-value), vary as the aggregation, segmentation and boundaries of the datasets change. Aggregation could be used to find the significant clusters much more quickly than at lower scales; segmentation could be used to understand the cyclic patterns of crime types. The consistencies of the clusters appearing at different temporal scales could help in identifying strong or 'true' clusters.	[Cheng, Tao; Adepeju, Monsuru] UCL, SpaceTimeLab, Dept Civil Environm & Geomat Engn, London WC1E 6BT, England	University of London; University College London	Cheng, T (corresponding author), UCL, SpaceTimeLab, Dept Civil Environm & Geomat Engn, Gower St, London WC1E 6BT, England.	tao.cheng@ucl.ac.uk		Cheng, Tao/0000-0002-5503-9813; Adepeju, Monsuru/0000-0002-9006-4934	UK Engineering and Physical Sciences Research Council [EP/J004197/1]; UCL; EPSRC [EP/J004197/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/J004197/1] Funding Source: researchfish	UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); UCL; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work is part of the project - Crime, Policing and Citizenship (CPC): Space-Time Interactions of Dynamic Networks (www.ucl.ac.uk/cpc), supported by the UK Engineering and Physical Sciences Research Council (EP/J004197/1). The second author would like to acknowledge the Dean's scholarship received from UCL for his PhD research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALT JE, 2000, POLITICAL ANAL, V0009; Amendola A, 2010, STUD CLASS DATA ANAL, P435, DOI 10.1007/978-3-642-03739-9_49; AMRHEIN CG, 1995, ENVIRON PLANN A, V27, P105, DOI 10.1068/a270105; Andrienko G, 2008, IEEE S VIS ANAL, P51, DOI 10.1109/VAST.2008.4677356; Bohlen MH, 2008, LECT NOTES COMPUT SC, V5071, P257, DOI 10.1007/978-3-540-70504-8_27; Coltekin A., 2011, ISPRS ICA WORKSH PER; Cook AJ, 2010, BIOMETRICS, V66, P783, DOI 10.1111/j.1541-0420.2009.01323.x; Dark SJ, 2007, PROG PHYS GEOG, V31, P471, DOI 10.1177/0309133307083294; de Jong R, 2012, BIOGEOSCIENCES, V9, P71, DOI 10.5194/bg-9-71-2012; Engestru┬m Y., 2009, LEARNING EXPANDING A, P303, DOI DOI 10.1017/CBO9780511809989.020; Fotheringham A.S., 2002, GEOGRAPHICALLY WEIGH; FOTHERINGHAM AS, 1993, INT J GEOGR INF SYST, V7, P3, DOI 10.1080/02693799308901936; FREEMAN JR, 1989, POLITICAL ANAL, V0001; Gangopadhyay S, 2004, J HYDROMETEOROL, V5, P1192, DOI 10.1175/JHM-391.1; GRIFFITH DA, 1983, J REGIONAL SCI, V23, P377, DOI 10.1111/j.1467-9787.1983.tb00996.x; Jeffery C, 2009, J AM MED INFORM ASSN, V16, P847, DOI 10.1197/jamia.M2788; Jones SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048036; Kechadi M-Tahar, 2009, Data Mining and Knowledge Discovery in Real Life Applications, P215; KIRSHEN PH, 1980, WATER RESOUR RES, V16, P457, DOI 10.1029/WR016i003p00457; Kulldorff, 2010, SATSCAN SOFTWARE SPA; Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Kwan MP, 2012, ANN ASSOC AM GEOGR, V102, P958, DOI 10.1080/00045608.2012.687349; Marcellino M, 1999, J BUS ECON STAT, V17, P129, DOI 10.2307/1392244; MARTIN RJ, 1987, GEOGR ANAL, V19, P272; Neill DB., 2007, ADV DIS SURVEILLANCE, V4, P13; OPENSHAW S, 1984, ENVIRON PLANN A, V16, P17, DOI 10.1068/a160017; Openshaw S, 1987, INT J GEOGR INF SYST, V1, P335, DOI DOI 10.1080/02693798708927821; Openshaw S., 1981, QUANTITATIVE GEOGRAP, P60; Ozonoff A, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-52; PINEDA J, 1993, DEEP-SEA RES PT I, V40, P2179, DOI 10.1016/0967-0637(93)90097-M; ROSSANA RJ, 1995, J BUS ECON STAT, V13, P441, DOI 10.2307/1392389; Shellman SM, 2004, POLIT ANAL, V12, P97, DOI 10.1093/pan/mpg017; Thomas GD, 2002, FLOR POL SCI ASS M S; Tuia D, 2008, COMMUN NONLINEAR SCI, V13, P1689, DOI 10.1016/j.cnsns.2007.03.004; Uittenbogaard A., 2012, REV EUR STUD, V4, P148, DOI [10.5539/RES.V4N5P148, DOI 10.5539/RES.V4N5P148]; WEI WWS, 1982, J AM STAT ASSOC, V77, P316, DOI 10.2307/2287241; Zhang L S., 2012, STRUCTUREDESIGNAND F, P1	38	68	72	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100465	10.1371/journal.pone.0100465	http://dx.doi.org/10.1371/journal.pone.0100465			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971885	Green Published, gold, Green Submitted			2022-12-27	WOS:000338512200035
J	Choleva, L; Musilova, Z; Kohoutova-Sediva, A; Paces, J; Rab, P; Janko, K				Choleva, Lukas; Musilova, Zuzana; Kohoutova-Sediva, Alena; Paces, Jan; Rab, Petr; Janko, Karel			Distinguishing between Incomplete Lineage Sorting and Genomic Introgressions: Complete Fixation of Allospecific Mitochondrial DNA in a Sexually Reproducing Fish (Cobitis; Teleostei), despite Clonal Reproduction of Hybrids	PLOS ONE			English	Article							LOACHES GENUS COBITIS; SPINED LOACHES; ANCIENT HYBRIDIZATION; RETICULATE EVOLUTION; NUCLEAR DISCORDANCE; POPULATION SIZES; MIGRATION RATES; SPECIES TREES; DIVERGENCE; HISTORY	Distinguishing between hybrid introgression and incomplete lineage sorting causing incongruence among gene trees in that they exhibit topological differences requires application of statistical approaches that are based on biologically relevant models. Such study is especially challenging in hybrid systems, where usual vectors mediating interspecific gene transfers hybrids with Mendelian heredity - are absent or unknown. Here we study a complex of hybridizing species, which are known to produce clonal hybrids, to discover how one of the species, Cobitis tanaitica, has achieved a pattern of mito-nuclear mosaic genome over the whole geographic range. We appplied three distinct methods, including the method using solely the information on gene tree topologies, and found that the contrasting mito-nuclear signal might not have resulted from the retention of ancestral polymorphism. Instead, we found two signs of hybridization events related to C. tanaitica; one concerning nuclear gene flow and the other suggested mitochondrial capture. Interestingly, clonal inheritance ( gynogenesis) of contemporary hybrids prevents genomic introgressions and non-clonal hybrids are either absent or too rare to be detected among European Cobitis. Our analyses therefore suggest that introgressive hybridizations are rather old episodes, mediated by previously existing hybrids whose inheritance was not entirely clonal. Cobitis complex thus supports the view that the type of resulting hybrids depends on a level of genomic divergence between sexual species.	[Choleva, Lukas; Musilova, Zuzana; Kohoutova-Sediva, Alena; Paces, Jan; Rab, Petr; Janko, Karel] AS CR, Vvi, Inst Anim Physiol & Genet, Lab Fish Genet, Libechov, Czech Republic; [Choleva, Lukas] Univ Helsinki, Dept Biosci, Ecol Genet Res Unit, Helsinki, Finland; [Musilova, Zuzana] Univ Basel, Inst Zool, CH-4051 Basel, Switzerland; [Musilova, Zuzana] Charles Univ Prague, Fac Sci, Dept Zool, Prague, Czech Republic; [Kohoutova-Sediva, Alena] Slovak Acad Sci, Inst Zool, Bratislava, Slovakia; [Paces, Jan] Inst Mol Genet ASCR, Vvi, Lab Genom & Bioinformat, Prague, Czech Republic; [Janko, Karel] Univ Ostrava, Fac Nat Sci, Dept Biol & Ecol, Life Sci Res Ctr, CZ-70103 Ostrava, Czech Republic	Czech Academy of Sciences; Institute of Animal Physiology & Genetics of the Czech Academy of Sciences; University of Helsinki; University of Basel; Charles University Prague; Slovak Academy of Sciences; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; University of Ostrava	Choleva, L (corresponding author), AS CR, Vvi, Inst Anim Physiol & Genet, Lab Fish Genet, Libechov, Czech Republic.	choleva@iapg.cas.cz	Janko, Karel/G-7183-2014; Sediva, Alena/G-7204-2014; Musilova, Zuzana/S-2899-2017; Ráb, Petr/G-7176-2014; Pačes, Jan/C-8851-2009	Musilova, Zuzana/0000-0001-8759-8663; Pačes, Jan/0000-0003-3059-6127	Czech Science Foundation [P506/10/1155, P506/12/P857]; Academy of Sciences of the Czech Republic (ASCR); Program for internal support of projects of international cooperation ASCR [M200451271]; European Community under Synthesys [ES-TAF-169];  [RVO 67985904]	Czech Science Foundation(Grant Agency of the Czech Republic); Academy of Sciences of the Czech Republic (ASCR)(Czech Academy of Sciences); Program for internal support of projects of international cooperation ASCR; European Community under Synthesys; 	The authors gratefully acknowledge the grant support no. P506/10/1155 to LC, PR and KJ provided by the Czech Science Foundation (www.gacr.cz). Further support was provided by the Academy of Sciences of the Czech Republic (ASCR) (www.cas.cz) by the Grant No. RVO 67985904 and by the Project No. M200451271 to LC within the Program for internal support of projects of international cooperation ASCR. LC is also profoundly grateful for the financial support (No. ES-TAF-169) from the European Community's Programme "Structuring the European Research Area'' under Synthesys (www.synthesys.info), hosted by I. Doadrio at the Museo Nacional de Ciencias Naturales CSIC and to the Czech Science Foundation (www.gacr.cz) by grant no. P506/12/P857. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison JA, 2009, MOL ECOL, V18, P1239, DOI 10.1111/j.1365-294X.2009.04094.x; Allendorf FW, 2001, TRENDS ECOL EVOL, V16, P613, DOI 10.1016/S0169-5347(01)02290-X; Alves MJ, 2001, GENETICA, V111, P375, DOI 10.1023/A:1013783029921; Alves MJ, 1998, MOL BIOL EVOL, V15, P1233, DOI 10.1093/oxfordjournals.molbev.a025852; Arnold M. L., 2006, EVOLUTION GENETIC EX; Axelsson E, 2004, MOL BIOL EVOL, V21, P1538, DOI 10.1093/molbev/msh157; Bachtrog D, 2006, EVOLUTION, V60, P292, DOI 10.1111/j.0014-3820.2006.tb01107.x; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Binet MC, 2005, J FISH BIOL, V67, P1169, DOI 10.1111/j.1095-8649.2005.00802.x; Bogart JP, 2013, CYTOGENET GENOME RES, V140, P117, DOI 10.1159/000351593; Bogart JP, 2007, GENOME, V50, P119, DOI 10.1139/G06-152; Buckley TR, 2006, SYST BIOL, V55, P411, DOI 10.1080/10635150600697283; Buj I, 2008, FOLIA ZOOL, V57, P71; Carson EW, 2006, MOL ECOL, V15, P667, DOI 10.1111/j.1365-294X.2005.02763.x; Choleva L, 2008, PHILOS T R SOC B, V363, P2911, DOI 10.1098/rstb.2008.0059; Choleva L, 2012, EVOLUTION, V66, P2191, DOI 10.1111/j.1558-5646.2012.01589.x; Christiansen DG, 2009, EVOLUTION, V63, P1754, DOI 10.1111/j.1558-5646.2009.00673.x; CLARK AG, 1990, MOL BIOL EVOL, V7, P111; Cui RF, 2013, EVOLUTION, V67, P2166, DOI 10.1111/evo.12099; Currat M, 2008, EVOLUTION, V62, P1908, DOI 10.1111/j.1558-5646.2008.00413.x; De Gelas K, 2008, MOL ECOL RESOUR, V8, P1001, DOI 10.1111/j.1755-0998.2008.02135.x; Di Candia MR, 2007, MOL PHYLOGENET EVOL, V45, P564, DOI 10.1016/j.ympev.2007.06.014; Dowling TE, 1997, ANNU REV ECOL SYST, V28, P593, DOI 10.1146/annurev.ecolsys.28.1.593; Felsenstein J, 2004, INFERRING PHYLOGENIE; Gaggiotti OE, 2011, MOL ECOL, V20, P2229, DOI 10.1111/j.1365-294X.2011.05104.x; Gerard D, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-291; GODDARD KA, 1993, COPEIA, P650; Gompert Z, 2006, SCIENCE, V314, P1923, DOI 10.1126/science.1135875; Gompert Z, 2008, MOL ECOL, V17, P5231, DOI 10.1111/j.1365-294X.2008.03988.x; Good JM, 2008, MOL ECOL, V17, P1313, DOI 10.1111/j.1365-294X.2007.03640.x; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Hey J, 2006, CURR OPIN GENET DEV, V16, P592, DOI 10.1016/j.gde.2006.10.005; Hey J, 2010, MOL BIOL EVOL, V27, P921, DOI 10.1093/molbev/msp298; Hey J, 2010, MOL BIOL EVOL, V27, P905, DOI 10.1093/molbev/msp296; HOTZ H, 1992, MOL BIOL EVOL, V9, P610; Hudson RR, 2003, EVOLUTION, V57, P182; HUDSON RR, 1987, GENETICS, V116, P153; HUDSON RR, 1985, GENETICS, V111, P147; Janko K, 2007, J FISH BIOL, V71, P387, DOI 10.1111/j.1095-8649.2007.01663.x; Janko K, 2005, MOL ECOL, V14, P2991, DOI 10.1111/j.1365-294X.2005.02583.x; Janko K, 2003, J EVOLUTION BIOL, V16, P1280, DOI 10.1046/j.1420-9101.2003.00627.x; Janko K, 2007, GENETICA, V131, P185, DOI 10.1007/s10709-006-9130-5; Janko K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045384; Jennings WB, 2005, EVOLUTION, V59, P2033; Joly S, 2009, AM NAT, V174, pE54, DOI 10.1086/600082; Jones JC, 2012, MOL ECOL, V21, P2692, DOI 10.1111/j.1365-294X.2012.05571.x; Kuhner MK, 2009, TRENDS ECOL EVOL, V24, P86, DOI 10.1016/j.tree.2008.09.007; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu L, 2008, BIOINFORMATICS, V24, P2542, DOI 10.1093/bioinformatics/btn484; Liu L, 2007, SYST BIOL, V56, P504, DOI 10.1080/10635150701429982; Maddison WP, 2019, MESQUITE MODULAR SYS; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; Matos I, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-101; Mee JA, 2012, CAN J ZOOL, V90, P577, DOI 10.1139/Z2012-023; Meyer A, 2006, MOL ECOL, V15, P721, DOI 10.1111/j.1365-294X.2006.02810.x; Morishima K, 2008, HEREDITY, V100, P581, DOI 10.1038/hdy.2008.17; Moritz C. C., 1989, EVOLUTION ECOLOGY UN, P87; Nadachowska K, 2009, MOL BIOL EVOL, V26, P829, DOI 10.1093/molbev/msp004; Nei M., 1987, MOL EVOLUTIONARY GEN; Nevado B, 2009, MOL ECOL, V18, P4240, DOI 10.1111/j.1365-294X.2009.04348.x; Nielsen R, 2001, GENETICS, V158, P885; Niemiller ML, 2010, MOL ECOL, V19, P1513, DOI 10.1111/j.1365-294X.2010.04564.x; Peters JL, 2007, EVOLUTION, V61, P1992, DOI 10.1111/j.1558-5646.2007.00149.x; Petit RJ, 2009, TRENDS ECOL EVOL, V24, P386, DOI 10.1016/j.tree.2009.02.011; Plotner J, 2008, J EVOLUTION BIOL, V21, P668, DOI 10.1111/j.1420-9101.2008.01527.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Presgraves DC, 2005, CURR BIOL, V15, P1651, DOI 10.1016/j.cub.2005.07.065; Rannala B, 2003, GENETICS, V164, P1645; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ropiquet A, 2006, MOL PHYLOGENET EVOL, V41, P395, DOI 10.1016/j.ympev.2006.05.033; Rosenberg NA, 2002, THEOR POPUL BIOL, V61, P225, DOI 10.1006/tpbi.2001.1568; Saat TV, 1991, SOVIET J DEV BIOL, V22, P332; Saitoh K, 2004, ZOOL SCI, V21, P795, DOI 10.2108/zsj.21.795; Sang T, 2000, SYST BIOL, V49, P422, DOI 10.1080/10635159950127321; SCHARTL M, 1995, NATURE, V373, P68, DOI 10.1038/373068a0; SCHULTZ RJ, 1969, AM NAT, V103, P605, DOI 10.1086/282629; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Senn HV, 2009, MOL ECOL, V18, P862, DOI 10.1111/j.1365-294X.2008.04051.x; Sequeira F, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-264; Slatkin M, 2005, MOL ECOL, V14, P67, DOI 10.1111/j.1365-294X.2004.02393.x; SLOWINSKI JB, 1989, AM NAT, V134, P907, DOI 10.1086/285021; Sousa VC, 2011, MOL ECOL, V20, P3956, DOI 10.1111/j.1365-294X.2011.05247.x; SPOLSKY C, 1984, P NATL ACAD SCI-BIOL, V81, P5802, DOI 10.1073/pnas.81.18.5802; Stenberg P, 2013, CYTOGENET GENOME RES, V140, P185, DOI 10.1159/000351731; Stock M, 2002, NAT GENET, V30, P325, DOI 10.1038/ng839; Stock M, 2012, P ROY SOC B-BIOL SCI, V279, P1293, DOI 10.1098/rspb.2011.1738; Strasburg JL, 2011, MOL ECOL, V20, P2353, DOI 10.1111/j.1365-294X.2011.05048.x; Tachida H, 2000, GENE, V261, P3, DOI 10.1016/S0378-1119(00)00475-3; TAJIMA F, 1993, GENETICS, V135, P599; TAKAHATA N, 1989, GENETICS, V122, P957; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang QY, 2008, HYDROBIOLOGIA, V605, P17, DOI 10.1007/s10750-008-9296-1; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toews DPL, 2012, MOL ECOL, V21, P3907, DOI 10.1111/j.1365-294X.2012.05664.x; Vasil'ev VP, 2003, FOLIA BIOL-KRAKOW, V51, P67; Vergilino R, 2011, MOL ECOL, V20, P1191, DOI 10.1111/j.1365-294X.2011.05004.x; VRIJENHOEK RC, 1994, ANNU REV ECOL SYST, V25, P71, DOI 10.1146/annurev.es.25.110194.000443; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wilson CC, 1998, MOL ECOL, V7, P127, DOI 10.1046/j.1365-294x.1998.00302.x; Won YJ, 2005, MOL BIOL EVOL, V22, P297, DOI 10.1093/molbev/msi017; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107	103	49	50	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e80641	10.1371/journal.pone.0080641	http://dx.doi.org/10.1371/journal.pone.0080641			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971792	Green Submitted, Green Published, gold			2022-12-27	WOS:000338512200001
J	Kulkarni, R; Acharya, J; Ghaskadbi, S; Goel, P				Kulkarni, Rashmi; Acharya, Jhankar; Ghaskadbi, Saroj; Goel, Pranay			Thresholds of Oxidative Stress in Newly Diagnosed Diabetic Patients on Intensive Glucose-Control Therapy	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; INSULIN-RESISTANCE; REDOX STATE; MITOCHONDRIAL H2O2; GLUTATHIONE; TOLERANCE; CATALASE	Cellular and animal studies suggest that oxidative stress could be the central defect underlying both beta-cell dysfunction and insulin resistance in type 2 diabetes mellitus. A reduction of glycemic stress in diabetic patients on therapy alleviates systemic oxidative stress and improves insulin resistance and beta-cell secretion. Monitoring oxidative stress systematically with glucose can potentially identify an individual's recovery trajectory. To determine a quantitative model of serial changes in oxidative stress, as measured via the antioxidant glutathione, we followed patients newly diagnosed with diabetes over 8 weeks of starting anti-diabetic treatment. We developed a mathematical model which shows recovery is marked with a quantal response. For each individual the model predicts three theoretical quantities: an estimate of maximal glutathione at low stress, a glucose threshold for half-maximal glutathione, and a rate at which recovery progresses. Individual patients are seen to vary considerably in their response to glucose control. Thus, model estimates can potentially be used to determine whether an individual patient's response is better or worse than average in terms of each of these indices; they can therefore be useful in reassessing treatment strategy. We hypothesize that this method can aid the personalization of effective targets of glucose control in anti-diabetic therapy.	[Kulkarni, Rashmi] Indian Inst Sci Educ & Res, Dept Biol, Pune, Maharashtra, India; [Acharya, Jhankar; Ghaskadbi, Saroj] Univ Pune, Dept Zool, Pune, Maharashtra, India; [Goel, Pranay] Indian Inst Sci Educ & Res, Pune, Maharashtra, India	Indian Institute of Science Education & Research (IISER) Pune; Savitribai Phule Pune University; Indian Institute of Science Education & Research (IISER) Pune	Goel, P (corresponding author), Indian Inst Sci Educ & Res, Pune, Maharashtra, India.	pgoel@iiserpune.ac.in		Acharya, Jhankar/0000-0003-2371-2230; Goel, Pranay/0000-0002-2249-0288	Department of Biotechnology, Government of India; University Grants Commission; Council for Scientific and Industrial Research, India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); University Grants Commission(University Grants Commission, India); Council for Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was financially supported by Department of Biotechnology, Government of India. JA was supported by University Grants Commission and RK by Council for Scientific and Industrial Research, India. The study sponsor(s) had no role in study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.	Abdul-Ghani MA, 2007, DIABETES METAB SYND, V1, P105, DOI 10.1016/j.dsx.2007.02.004; Acharya JD, 2014, DIABETES ME IN PRESS; Akerboom T P, 1981, Methods Enzymol, V77, P373; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Bensellam M, 2012, MOL CELL ENDOCRINOL, V364, P1, DOI 10.1016/j.mce.2012.08.003; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Chen LJ, 2008, AGING CELL, V7, P866, DOI 10.1111/j.1474-9726.2008.00432.x; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Evans JL, 2002, ENDOCR REV, V23, P599, DOI 10.1210/er.2001-0039; Evans JL, 2005, ANTIOXID REDOX SIGN, V7, P1040, DOI 10.1089/ars.2005.7.1040; Hoehn KL, 2009, P NATL ACAD SCI USA, V106, P17787, DOI 10.1073/pnas.0902380106; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Jones DP, 2000, FREE RADICAL BIO MED, V28, P625, DOI 10.1016/S0891-5849(99)00275-0; Lee HY, 2010, CELL METAB, V12, P668, DOI 10.1016/j.cmet.2010.11.004; Lortz S, 2003, FREE RADICAL BIO MED, V34, P683, DOI 10.1016/S0891-5849(02)01371-0; Meigs JB, 2007, DIABETES CARE, V30, P2529, DOI 10.2337/dc07-0817; MEISTER A, 1995, METHOD ENZYMOL, V251, P3, DOI 10.1016/0076-6879(95)51106-7; PAOLISSO G, 1992, AM J PHYSIOL, V263, pE435, DOI 10.1152/ajpendo.1992.263.3.E435; PAOLISSO G, 1992, DIABETES CARE, V15, P1, DOI 10.2337/diacare.15.1.1; Raz I, 2013, DIABETES CARE, V36, P1779, DOI 10.2337/dc13-0512; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Tajiri Y, 2000, Int J Exp Diabetes Res, V1, P111, DOI 10.1155/EDR.2000.111; Tanaka Y, 2002, P NATL ACAD SCI USA, V99, P12363, DOI 10.1073/pnas.192445199; The Oxford Centre for Diabetes, HOMA CALC 0315; Wolf G, 2010, J ENDOCRINOL, V207, P163, DOI 10.1677/JOE-09-0455	26	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100897	10.1371/journal.pone.0100897	http://dx.doi.org/10.1371/journal.pone.0100897			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971653	Green Published, Green Submitted, gold			2022-12-27	WOS:000338512200073
J	Lozano-Santos, C; Martinez-Velasquez, J; Fernandez-Cuevas, B; Polo, N; Navarro, B; Millan, I; Garcia, JM; Collado, R; Sanchez-Godoy, P; Carbonell, F; Garcia-Vela, JA; Garcia-Marco, JA; Gomez-Lozano, N				Lozano-Santos, Carol; Martinez-Velasquez, Jimena; Fernandez-Cuevas, Belen; Polo, Natividad; Navarro, Belen; Millan, Isabel; Miguel Garcia, Jose; Collado, Rosa; Sanchez-Godoy, Pedro; Carbonell, Felix; Antonio Garcia-Vela, Jose; Antonio Garcia-Marco, Jose; Gomez-Lozano, Natalia			Vascular Endothelial Growth Factor A (VEGFA) Gene Polymorphisms Have an Impact on Survival in a Subgroup of Indolent Patients with Chronic Lymphocytic Leukemia	PLOS ONE			English	Article							SEQUENCE VARIATION; AUTOCRINE VEGF; CLL; ANGIOGENESIS; EXPRESSION; PREDICT; RECEPTORS; PROMOTER; REGION; CELLS	Vascular endothelial growth factor (VEGF)-mediated angiogenesis contributes to the pathogenesis of B-cell chronic lymphocytic leukaemia (CLL). We investigated the impact of VEGFA gene diversity on the clinical outcome of patients with this disease. A VEGFA haplotype conformed by positions rs699947 (-1540C>A), rs833061 (-460T>C) and rs2010963 (405C>G) and two additional single-nucleotide polymorphisms (SNPs), rs3025039 (936C>T) and rs25648 (1032C>T), were analysed in 239 patients at the time of their CLL diagnosis. Here, we showed that homozygosity for rs699947/rs833061/rs2010963 ACG haplotype (ACG(+/+) genotype) correlated with a reduced survival in CLL patients (ACG(+/+) vs other genotypes: HR = 2.3, p = 0.002; recessive model). In multivariate analysis, the ACG(+/+) genotype was identified as a novel independent prognostic factor (HR = 2.1, p = 0.005). Moreover, ACG homozygosity subdivided patients with CLL with otherwise indolent parameters into prognostic subgroups with different outcomes. Specifically, patients carrying the ACG(+/+) genotype with mutated IgV(H), very low and low-risk cytogenetics, initial clinical stage, CD38 negative status or early age at diagnosis showed a shorter survival (ACG(+/+) vs other genotypes: HR = 3.5, p = 0.035; HR = 3.4, p = 0.001; HR = 2.2, p = 0.035; HR = 3.4, p = 0.0001 and HR = 3.1, p = 0.009, respectively). In conclusion, VEGFA ACG(+/+) genotype confers an adverse effect in overall survival in CLL patients with an indolent course of the disease. These observations support the biological and prognostic implications of VEGFA genetics in CLL.	[Lozano-Santos, Carol; Fernandez-Cuevas, Belen; Polo, Natividad; Navarro, Belen; Antonio Garcia-Marco, Jose] Hosp Univ Puerta Hierro Majadahonda, Dept Hematol, Madrid, Spain; [Lozano-Santos, Carol; Martinez-Velasquez, Jimena; Fernandez-Cuevas, Belen; Polo, Natividad; Navarro, Belen; Millan, Isabel; Miguel Garcia, Jose; Antonio Garcia-Marco, Jose; Gomez-Lozano, Natalia] Inst Invest Puerta Hierro Majadahonda IDIPHIM, Madrid, Spain; [Millan, Isabel] Hosp Univ Puerta Hierro Majadahonda, Dept Stat, Madrid, Spain; [Martinez-Velasquez, Jimena; Gomez-Lozano, Natalia] Hosp Univ Puerta Hierro Majadahonda, Grp Immunogenet, Madrid, Spain; [Miguel Garcia, Jose] Hosp Univ Puerta Hierro Majadahonda, Oncol Grp, Madrid, Spain; [Collado, Rosa; Carbonell, Felix] Univ Valencia, Consorcio Hosp, Dept Hematol, Valencia, Spain; [Sanchez-Godoy, Pedro] Hosp Severo Ochoa Madrid, Dept Hematol, Madrid, Spain; [Antonio Garcia-Vela, Jose] Hosp Univ Ramon & Cajal Madrid, Dept Hematol, Madrid, Spain	Hospital Puerta de Hierro-Majadahonda; Hospital Puerta de Hierro-Majadahonda; Hospital Puerta de Hierro-Majadahonda; Hospital Puerta de Hierro-Majadahonda; University of Valencia; Severo Ochoa University Hospital	Gomez-Lozano, N (corresponding author), Hosp Univ Puerta Hierro Majadahonda, Grp Immunogenet, Madrid, Spain.	ngomez@idiphim.org	Collado Nieto, Rosa María/GZK-9557-2022; Gomez-Lozano, Natalia/K-6488-2014; Garcia Marco, Jose/H-2554-2015	Gomez-Lozano, Natalia/0000-0003-3959-9519; Garcia Marco, Jose/0000-0002-8993-5982; Carbonell, Felix/0000-0001-9617-6171; Collado, Rosa/0000-0002-8205-6192	Fundacion para la Investigacion Biomedica; Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III [FIS CP09-182]; programa Miguel Servet, Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III; Roche Pharma; Fundacion para la Investigacion Biomedica Puerta de Hierro	Fundacion para la Investigacion Biomedica; Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III(Instituto de Salud Carlos III); programa Miguel Servet, Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III; Roche Pharma; Fundacion para la Investigacion Biomedica Puerta de Hierro	This work was supported by Fundacion para la Investigacion Biomedica and Fondo de Investigacion Sanitaria (FIS CP09-182), Instituto de Salud Carlos III. The authors were funded by the following institutions: NGL by a grant from programa Miguel Servet, Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III; CLS by a research grant from Roche Pharma and JMV by Fundacion para la Investigacion Biomedica Puerta de Hierro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguayo A, 2000, BLOOD, V96, P2240, DOI 10.1182/blood.V96.6.2240.h8002240_2240_2245; Awata T, 2002, DIABETES, V51, P1635, DOI 10.2337/diabetes.51.5.1635; Bairey O, 2004, LEUKEMIA RES, V28, P243, DOI 10.1016/S0145-2126(03)00256-X; Brogan IJ, 1999, HUM IMMUNOL, V60, P1245, DOI 10.1016/S0198-8859(99)00132-9; Cheson BD, 1996, BLOOD, V87, P4990, DOI 10.1182/blood.V87.12.4990.bloodjournal87124990; Diao LP, 2009, J CANCER RES CLIN, V135, P1473, DOI 10.1007/s00432-009-0650-0; Edelmann J, 2008, LEUKEMIA RES, V32, P1565, DOI 10.1016/j.leukres.2008.03.003; Farahani M, 2005, LEUKEMIA, V19, P524, DOI 10.1038/sj.leu.2403631; Ferrajoli A, 2001, CLIN CANCER RES, V7, P795; Freathy RM, 2006, J PANCREAS, V7, P295; Gehrke I, 2011, MOL MED, V17, P619, DOI 10.2119/molmed.2010.00210; Ghia P, 2007, LEUKEMIA, V21, P1, DOI 10.1038/sj.leu.2404457; Ghosh AK, 2010, BLOOD, V115, P1755, DOI 10.1182/blood-2009-09-242719; Girnita DM, 2006, TRANSPLANTATION, V82, P1774, DOI 10.1097/01.tp.0000250656.33731.08; Gora-Tybor J, 2005, EUR CYTOKINE NETW, V16, P41; Hansen TF, 2010, J CANCER RES CLIN, V136, P751, DOI 10.1007/s00432-009-0714-1; Hussong JW, 2000, BLOOD, V95, P309; Jain L, 2009, MOL CANCER THER, V8, P2496, DOI 10.1158/1535-7163.MCT-09-0302; Kim DH, 2010, ANN ONCOL, V21, P1179, DOI 10.1093/annonc/mdp452; Kim DH, 2008, BRIT J HAEMATOL, V140, P71, DOI 10.1111/j.1365-2141.2007.06887.x; Kini AR, 2000, LEUKEMIA, V14, P1414, DOI 10.1038/sj.leu.2401825; Koukourakis MI, 2004, LUNG CANCER, V46, P293, DOI 10.1016/j.lungcan.2004.04.037; Lee YK, 2004, BLOOD, V104, P788, DOI 10.1182/blood-2003-08-2763; Maffei R, 2010, LEUKEMIA RES, V34, P312, DOI 10.1016/j.leukres.2009.06.023; Molica S, 1999, BRIT J HAEMATOL, V107, P605, DOI 10.1046/j.1365-2141.1999.01752.x; Pepper C, 2007, LEUKEMIA, V21, P687, DOI 10.1038/sj.leu.2404587; Prior SJ, 2006, AM J PHYSIOL-HEART C, V290, pH1848, DOI 10.1152/ajpheart.01033.2005; Renner W, 2000, J VASC RES, V37, P443, DOI 10.1159/000054076; Rossi D, 2013, BLOOD, V121, P1403, DOI 10.1182/blood-2012-09-458265; Shanafelt T, 2010, LEUKEMIA LYMPHOMA, V51, P2222, DOI 10.3109/10428194.2010.524327; Shanafelt TD, 2009, BRIT J HAEMATOL, V146, P660, DOI 10.1111/j.1365-2141.2009.07811.x; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Stevens A, 2003, CANCER RES, V63, P812; Till KJ, 2005, BLOOD, V105, P4813, DOI 10.1182/blood-2004-10-4054; Ugarte-Berzal E, 2010, BLOOD, V115, P846, DOI 10.1182/blood-2009-08-239426; Watson CJ, 2000, CYTOKINE, V12, P1232, DOI 10.1006/cyto.2000.0692; Wrobel T, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/159813; Wrobel T, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0456-4	39	8	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e101063	10.1371/journal.pone.0101063	http://dx.doi.org/10.1371/journal.pone.0101063			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971577	Green Published, Green Submitted, gold			2022-12-27	WOS:000338512200087
J	Teixeira, FB; Santana, LND; Bezerra, FR; De Carvalho, S; Fontes, EA; Prediger, RD; Crespo-Lopez, ME; Maia, CSF; Lima, RR				Teixeira, Francisco Bruno; da Silva Santana, Luana Nazare; Bezerra, Fernando Romualdo; De Carvalho, Sabrina; Fontes-Junior, Eneas Andrade; Prediger, Rui Daniel; Crespo-Lopez, Maria Elena; Ferraz Maia, Cristiane Socorro; Lima, Rafael Rodrigues			Chronic Ethanol Exposure during Adolescence in Rats Induces Motor Impairments and Cerebral Cortex Damage Associated with Oxidative Stress	PLOS ONE			English	Article							NF-KAPPA-B; ALCOHOL EXPOSURE; INFLAMMATORY MEDIATORS; COGNITIVE DEFICITS; PROTECT NEURONS; CELL-DEATH; ADULT RATS; BRAIN; MICROGLIA; HIPPOCAMPUS	Binge drinking is common among adolescents, and this type of ethanol exposure may lead to long-term nervous system damage. In the current study, we evaluated motor performance and tissue alterations in the cerebral cortex of rats subjected to intermittent intoxication with ethanol from adolescence to adulthood. Adolescent male Wistar rats (35 days old) were treated with distilled water or ethanol (6.5 g/kg/day, 22.5%w/v) during 55 days by gavage to complete 90 days of age. The open field, inclined plane and the rotarod tests were used to assess the spontaneous locomotor activity and motor coordination performance in adult animals. Following completion of behavioral tests, half of animals were submitted to immunohistochemical evaluation of NeuN (marker of neuronal bodies), GFAP (a marker of astrocytes) and Iba1 (microglia marker) in the cerebral cortex while the other half of the animals were subjected to analysis of oxidative stress markers by biochemical assays. Chronic ethanol intoxication in rats from adolescence to adulthood induced significant motor deficits including impaired spontaneous locomotion, coordination and muscle strength. These behavioral impairments were accompanied by marked changes in all cellular populations evaluated as well as increased levels of nitrite and lipid peroxidation in the cerebral cortex. These findings indicate that continuous ethanol intoxication from adolescence to adulthood is able to provide neurobehavioral and neurodegenerative damage to cerebral cortex.	[Teixeira, Francisco Bruno; da Silva Santana, Luana Nazare; Lima, Rafael Rodrigues] Fed Univ Para, Inst Biol Sci, Lab Funct & Struct Biol, BR-66059 Belem, Para, Brazil; [Bezerra, Fernando Romualdo; De Carvalho, Sabrina; Fontes-Junior, Eneas Andrade; Ferraz Maia, Cristiane Socorro] Fed Univ Para, Inst Hlth Sci, Lab Pharmacol Inflammat & Behav, BR-66059 Belem, Para, Brazil; [Fontes-Junior, Eneas Andrade; Crespo-Lopez, Maria Elena] Fed Univ Para, Inst Biol Sci, Mol Pharmacol Lab, BR-66059 Belem, Para, Brazil; [Prediger, Rui Daniel] Univ Fed Santa Catarina, Ctr Biol Sci, Dept Pharmacol, Florianopolis, SC, Brazil	Universidade Federal do Para; Universidade Federal do Para; Universidade Federal do Para; Universidade Federal de Santa Catarina (UFSC)	Maia, CSF (corresponding author), Fed Univ Para, Inst Hlth Sci, Lab Pharmacol Inflammat & Behav, BR-66059 Belem, Para, Brazil.	crismaia@ufpa.br	Crespo-Lopez, Maria Elena/X-7912-2018; Fontes-Júnior, Enéas Andrade/ABF-8064-2020; Prediger, Rui D/C-4036-2013; Fontes-Júnior, Enéas Andrade/R-6372-2018; Prediger, Rui/CAG-4328-2022; DE CARVALHO CARTÁGENES, SABRINA/AAU-3102-2021; Teixeira, Francisco/N-6442-2014; Lima, Rafael Rodrigues/M-7726-2019; Prediger, Rui Daniel/AAV-3419-2020; Maia, Cristiane/E-7217-2016	Crespo-Lopez, Maria Elena/0000-0002-1335-6853; Prediger, Rui D/0000-0002-7547-6463; Fontes-Júnior, Enéas Andrade/0000-0002-6186-9581; Prediger, Rui/0000-0001-5102-0296; Teixeira, Francisco/0000-0001-8596-3727; Lima, Rafael Rodrigues/0000-0003-1486-4013; Prediger, Rui Daniel/0000-0002-7547-6463; Maia, Cristiane/0000-0003-4493-7375	Brazilian Government/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) fellowship; Brazilian Government/Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) fellowship; CNPq; PROPESP - UFPA	Brazilian Government/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) fellowship(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Government/Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) fellowship(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PROPESP - UFPA	Francisco Bruno Teixeira was supported by a Brazilian Government/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) fellowship. Fernando Romualdo Bezerra was supported by a Brazilian Government/Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) fellowship. R.D.P. is supported by a research fellowship from CNPq. The authors would like to thank the PROPESP - UFPA for providing financial support (PAPQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASANUMA H, 1973, Physiologist, V16, P143; Bell RL, 2003, ALCOHOL, V29, P137, DOI 10.1016/S0741-8329(03)00022-3; Blanco AM, 2005, J IMMUNOL, V175, P6893, DOI 10.4049/jimmunol.175.10.6893; Brocardo PS, 2011, BRAIN RES REV, V67, P209, DOI 10.1016/j.brainresrev.2011.02.001; Collins MA, 2012, NEUROTOX RES, V21, P70, DOI 10.1007/s12640-011-9276-5; Crews FT, 2006, NEUROSCIENCE, V137, P437, DOI 10.1016/j.neuroscience.2005.08.090; Crews FT, 2009, ALCOHOL ALCOHOLISM, V44, P115, DOI 10.1093/alcalc/agn079; Maia CDF, 2009, NEUROTOXICOLOGY, V30, P23, DOI 10.1016/j.neuro.2008.11.008; Doremus F, 2010, BRAIN COGNITION, V72, P114; Doremus-Fitzwater TL, 2007, ALCOHOL CLIN EXP RES, V31, P1516, DOI 10.1111/j.1530-0277.2007.00457.x; ESTERBAUER H, 1990, METHOD ENZYMOL, V186, P407; EVARTS EV, 1983, J NEUROPHYSIOL, V49, P1199, DOI 10.1152/jn.1983.49.5.1199; Franke H, 1997, ALCOHOL, V14, P445, DOI 10.1016/S0741-8329(96)00209-1; FRANKE H, 1995, ACTA HISTOCHEM, V97, P263, DOI 10.1016/S0065-1281(11)80187-X; Gomes-Leal W, 2004, EXP NEUROL, V190, P456, DOI 10.1016/j.expneurol.2004.06.028; Gonzalez A, 2007, BRAIN RES, V1178, P28, DOI 10.1016/j.brainres.2007.08.040; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Harding AJ, 1996, NEUROSCIENCE, V72, P699, DOI 10.1016/0306-4522(95)00577-3; HARPER CG, 1982, J NEUROL NEUROSUR PS, V45, P838, DOI 10.1136/jnnp.45.9.838; Harper C, 2009, ALCOHOL ALCOHOLISM, V44, P136, DOI 10.1093/alcalc/agn102; He J, 2008, EXP NEUROL, V210, P349, DOI 10.1016/j.expneurol.2007.11.017; Helfer JL, 2009, J COMP NEUROL, V514, P259, DOI 10.1002/cne.22018; Instituto Nacional de Ciencia e Tecnologia para Politicas Publicas do Alcool e Outras Drogas, 2013, LEV NAC ALC DROG LEN; Koss WA, 2012, BRAIN RES, V1466, P24, DOI 10.1016/j.brainres.2012.05.023; Lalancette-Hebert M, 2007, J NEUROSCI, V27, P2596, DOI 10.1523/JNEUROSCI.5360-06.2007; Little PJ, 1996, ALCOHOL CLIN EXP RES, V20, P1346, DOI 10.1111/j.1530-0277.1996.tb01133.x; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Lopez-Caneda E, 2014, ALCOHOL ALCOHOLISM, V49, P173, DOI 10.1093/alcalc/agt168; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maier SE, 2001, ALCOHOL, V23, P49, DOI 10.1016/S0741-8329(00)00133-6; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; McClain JA, 2011, J COMP NEUROL, V519, P2697, DOI 10.1002/cne.22647; MURPHY MP, 1995, NEUROBIOL LEARN MEM, V64, P181, DOI 10.1006/nlme.1995.1057; Neumann J, 2008, J NEUROSCI, V28, P5965, DOI 10.1523/JNEUROSCI.0060-08.2008; Neumann J, 2006, FASEB J, V20, P714, DOI 10.1096/fj.05-4882fje; Obernier JA, 2002, ALCOHOL CLIN EXP RES, V26, P547, DOI 10.1097/00000374-200204000-00016; Oliveira GB, 2014, BRAIN RES, V1561, P23, DOI 10.1016/j.brainres.2014.03.005; ONeill LAJ, 1997, TRENDS NEUROSCI, V20, P252, DOI 10.1016/S0166-2236(96)01035-1; Pascual M, 2007, EUR J NEUROSCI, V25, P541, DOI 10.1111/j.1460-9568.2006.05298.x; Pascual M, 2014, ALCOHOL ALCOHOLISM, V49, P187, DOI 10.1093/alcalc/agt164; Qin LY, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-5; Reddy VD, 2013, MOL CELL BIOCHEM, V375, P39, DOI 10.1007/s11010-012-1526-1; Ros-Simo C, 2013, J NEUROCHEM, V125, P736, DOI 10.1111/jnc.12247; Sanes JN, 2000, ANNU REV NEUROSCI, V23, P393, DOI 10.1146/annurev.neuro.23.1.393; Schramm-Sapyta NL, 2014, PSYCHOPHARMACOLOGY, V231, P1831, DOI 10.1007/s00213-013-3319-y; Selemon LD, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.7; Skala K, 2013, NEUROPSYCHIATRIE, V27, P202, DOI 10.1007/s40211-013-0066-6; Stigger F, 2013, INT J DEV NEUROSCI, V31, P820, DOI 10.1016/j.ijdevneu.2013.10.003; Tiwari V, 2013, NEUROSCIENCE, V244, P147, DOI 10.1016/j.neuroscience.2013.03.042; Toga AW, 2006, TRENDS NEUROSCI, V29, P148, DOI 10.1016/j.tins.2006.01.007; Toumbourou JW, 2014, ADDICTION, V109, P417, DOI 10.1111/add.12401; Valles SL, 2004, BRAIN PATHOL, V14, P365; Varlinskaya EI, 2004, ALCOHOL CLIN EXP RES, V28, P40, DOI 10.1097/01.ALC.0000108655.51087.DF; Ward RJ, 2009, J NEUROCHEM, V111, P1119, DOI 10.1111/j.1471-4159.2009.06389.x; Watts LT, 2005, J NEUROSCI RES, V80, P655, DOI 10.1002/jnr.20502; White AM, 2002, PHARMACOL BIOCHEM BE, V73, P673, DOI 10.1016/S0091-3057(02)00860-2; White AM, 2002, ALCOHOL CLIN EXP RES, V26, P960, DOI 10.1097/01.ALC.0000021334.47130.F9; World Health Organization, 2011, GLOB STAT REP ALC HL; Zhao YN, 2013, BEHAV BRAIN RES, V236, P270, DOI 10.1016/j.bbr.2012.08.052; Zou JY, 2005, BRAIN RES, V1034, P11, DOI 10.1016/j.brainres.2004.11.014	60	49	50	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e101074	10.1371/journal.pone.0101074	http://dx.doi.org/10.1371/journal.pone.0101074			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967633	gold, Green Published, Green Submitted			2022-12-27	WOS:000338280800105
J	Odland, ML; Rasmussen, H; Jacobsen, GW; Kafulafula, UK; Chamanga, P; Odland, JO				Odland, Maria L.; Rasmussen, Hanne; Jacobsen, Geir W.; Kafulafula, Ursula K.; Chamanga, Piaroza; Odland, Jon O.			Decrease in Use of Manual Vacuum Aspiration in Postabortion Care in Malawi: A Cross-Sectional Study from Three Public Hospitals, 2008-2012	PLOS ONE			English	Article							UNSAFE ABORTION; MISOPROSTOL	Objectives: To investigate the use of manual vacuum aspiration in postabortion care in Malawi between 2008-2012. Methods: A retrospective cross-sectional study was done at the referral hospital Queen Elisabeth Central Hospital, and the two district hospitals of Chiradzulu and Mangochi. The data were collected simultaneously at the three sites from Feb-March 2013. All records available for women admitted to the gynaecological ward from 2008-2012 were reviewed. Women who had undergone surgical uterine evacuation after incomplete abortion were included and the use of manual vacuum aspiration versus sharp curettage was analysed. Results: Altogether, 5121 women were included. One third (34.2%) of first trimester abortions were treated with manual vacuum aspiration, while all others were treated with sharp curettage. There were significant differences between the hospitals and between years. Overall there was an increase in the use of manual vacuum aspiration from 2008 (19.7%) to 2009 (31.0%), with a rapid decline after 2010 (28.5%) ending at only 4.9% in 2012. Conversely there was an increase in use of sharp curettage in all hospitals from 2010 to 2012. Conclusion: Use of manual vacuum aspiration as part of the postabortion care in Malawi is rather low, and decreased from 2010 to 2012, while the use of sharp curettage became more frequent. This is in contrast with current international guidelines.	[Odland, Maria L.] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway; [Rasmussen, Hanne; Jacobsen, Geir W.] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, N-7034 Trondheim, Norway; [Kafulafula, Ursula K.; Chamanga, Piaroza; Odland, Jon O.] Kamuzu Coll Nursing, Blantyre, Malawi; [Odland, Jon O.] Univ Tromso, Dept Community Med, Tromso, Norway; [Odland, Jon O.] Univ Pretoria, Sch Hlth Syst & Publ Hlth, ZA-0002 Pretoria, South Africa	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); UiT The Arctic University of Tromso; University of Pretoria	Odland, ML (corresponding author), Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway.	odland@stud.ntnu.no	Odland, Jon Oyvind/L-5096-2017	Odland, Jon Oyvind/0000-0002-2756-0732	Norwegian Agency for Development Cooperation (Norad); Kamuzu College of Nursing	Norwegian Agency for Development Cooperation (Norad)(CGIAR); Kamuzu College of Nursing	The study was partly funded by the Norwegian Agency for Development Cooperation (Norad) and the Kamuzu College of Nursing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahman E, 2011, INT J GYNECOL OBSTET, V115, P121, DOI 10.1016/j.ijgo.2011.05.027; Banerjee SK, 2012, INT J GYNECOL OBSTET, V118, pS113, DOI 10.1016/S0020-7292(12)60009-5; Benson J, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-39; Bique C, 2007, INT J GYNECOL OBSTET, V98, P222, DOI 10.1016/j.ijgo.2007.05.003; Corbett MR, 2003, INT FAM PLAN PERSPEC, V29, P106, DOI 10.2307/3181075; Dao B, 2007, BJOG-INT J OBSTET GY, V114, P1368, DOI 10.1111/j.1471-0528.2007.01468.x; FORNA F, 2001, COCHRANE DB SYST REV; Graff Maura, 2009, Afr J Reprod Health, V13, P73; Grimes DA, 2006, LANCET, V368, P1908, DOI 10.1016/S0140-6736(06)69481-6; Hord Charlotte, 2004, Afr J Reprod Health, V8, P29, DOI 10.2307/3583302; Jackson E, 2011, REPROD HEALTH MATTER, V19, P133, DOI 10.1016/S0968-8080(11)37563-5; Levandowski BA, 2013, INT PERSPECT SEX R H, V39, P88, DOI 10.1363/3908813; Leyandowski BA, 2012, INT J GYNECOL OBSTET, V118, pS167, DOI 10.1016/S0020-7292(12)60017-4; Malawi Ministry of Health, 2009, STAND EQ LIST TYP DI; Malawi Ministry of Health, 2011, AB MAL RES STUD INC; NSO and ICF Macro, 2011, MAL DEM HLTH SURV 20; Rasch V, 2011, ACTA OBSTET GYN SCAN, V90, P692, DOI 10.1111/j.1600-0412.2011.01165.x; Schenck-Yglesias C, 2004, EVALUATION POSTABORT; Shah I, 2010, REPROD HEALTH MATTER, V18, P90, DOI 10.1016/S0968-8080(10)36537-2; Sharan M, 2010, QUALITY MATERNAL HLT; WHO, 2010, TRENDS MAT MORT 1990; World Health Organization, 2011, GLOB REG EST INC ASS; World Health Organization, 2012, SAF AB TECHN POL GUI, V2nd ed.; World Health Organization, 1992, PREV MAN UNS AB REP; World Health Organization, 2013, WHO WORLD COOP STRAT	25	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100728	10.1371/journal.pone.0100728	http://dx.doi.org/10.1371/journal.pone.0100728			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963882	Green Published, gold, Green Submitted			2022-12-27	WOS:000338709500076
J	Shao, YT; Wang, FY; Fu, WC; Yan, HY; Anraku, K; Chen, IS; Borg, B				Shao, Yi Ta; Wang, Feng-Yu; Fu, Wen-Chun; Yan, Hong Young; Anraku, Kazuhiko; Chen, I-Shiung; Borg, Bertil			Androgens Increase Iws Opsin Expression and Red Sensitivity in Male Three-Spined Sticklebacks	PLOS ONE			English	Article							SALMON ONCORHYNCHUS-KISUTCH; SPECTRAL SENSITIVITY; GENE-EXPRESSION; THYROID-HORMONE; GASTEROSTEUS-ACULEATUS; ONTOGENIC CHANGES; RAINBOW-TROUT; BLACK BREAM; EVOLUTION; RETINA	Optomotor studies have shown that three-spined sticklebacks (Gasterosteus aculeatus) are more sensitive to red during summer than winter, which may be related to the need to detect the red breeding colour of males. This study aimed to determine whether this change of red light sensitivity is specifically related to reproductive physiology. The mRNA levels of opsin genes were examined in the retinae of sexually mature and immature fish, as well as in sham-operated males, castrated control males, or castrated males implanted with androgen 11-ketoandrostenedione (11 KA), maintained under stimulatory (L16:D8) or inhibitory (L8:D16) photoperiods. In both sexes, red-sensitive opsin gene (Iws) mRNA levels were higher in sexually mature than in immature fish. Under L16:D8, lws mRNA levels were higher in intact than in castrated males, and were up-regulated by 11 KA treatment in castrated males. Moreover, electroretinogram data confirmed that sexual maturation resulted in higher relative red spectral sensitivity. Mature males under L16:D8 were more sensitive to red light than males under L8:D16. Red light sensitivity under L16:D8 was diminished by castration, but increased by 11 KA treatment. Thus, in sexually mature male sticklebacks, androgen is a key factor in enhancing sensitivity to red light via regulation of opsin gene expression. This is the first study to demonstrate that sex hormones can regulate spectral vision sensitivity.	[Shao, Yi Ta; Borg, Bertil] Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden; [Wang, Feng-Yu] Taiwan Ocean Res Inst, Natl Appl Res Labs, Kaohsiung, Taiwan; [Shao, Yi Ta; Fu, Wen-Chun; Yan, Hong Young] Acad Sinica, Marine Res Stn, Sensory Physiol Lab, I Iain, Taiwan; [Yan, Hong Young] Hanse Wissenschaftskolleg Inst Adv Study, Delmenhorst, Germany; [Anraku, Kazuhiko] Kagoshima Univ, Fac Fisheries, Kagoshima 890, Japan; [Chen, I-Shiung] Natl Taiwan Ocean Univ, Inst Marine Biol, Keelung, Taiwan	Stockholm University; National Applied Research Laboratories - Taiwan; Kagoshima University; National Taiwan Ocean University	Yan, HY (corresponding author), Acad Sinica, Marine Res Stn, Sensory Physiol Lab, I Iain, Taiwan.	hyyan@gate.sinica.edu.tw; bertil.borg@zoologi.su.se		Anraku, Kazuhiko/0000-0001-8173-8741	Swedish Research Council Formas; Academia Sinica; Hanse Wissenschaftskolleg Institute for Advanced Study, Delmenhorst, Germany	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Academia Sinica(Academia Sinica - Taiwan); Hanse Wissenschaftskolleg Institute for Advanced Study, Delmenhorst, Germany	This study was supported by the Swedish Research Council Formas to B.Borg, and intramural research grants from Academia Sinica to H. Y. Yan.During the course of the manuscript preparation, H. Y. Yan was supported by a fellowship from Hanse Wissenschaftskolleg Institute for Advanced Study, Delmenhorst, Germany. Y. T. Shao was supported in part by a postdoctoral fellowship from Academia Sinica. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekseyenko OV, 2006, NEUROSCIENCE, V140, P1349, DOI 10.1016/j.neuroscience.2006.03.001; Allison WT, 2003, J COMP NEUROL, V461, P294, DOI 10.1002/cne.10682; Amano M, 1997, ZOOL SCI, V14, P1, DOI 10.2108/zsj.14.1; Andersson E, 1992, THESIS STOCKHOLM U S; Andersson Malte, 1994; BORG B, 1994, COMP BIOCHEM PHYS C, V109, P219, DOI 10.1016/0742-8413(94)00063-G; BORG B, 1993, CAN J ZOOL, V71, P2327, DOI 10.1139/z93-326; Borg B, 1995, BEHAVIOUR, V132, P1025, DOI 10.1163/156853995X00432; BORG B, 1985, BEHAVIOUR, V93, P153, DOI 10.1163/156853986X00810; Borg Bertil, 2010, P371; Boulcott P, 2007, EVOL ECOL, V21, P601, DOI 10.1007/s10682-006-9138-4; Bowmaker JK, 2008, SENSES COMPREHENSIVE, V1, P53; CARDWELL JR, 1995, J COMP PHYSIOL A, V176, P55; Carleton KL, 2001, MOL BIOL EVOL, V18, P1540, DOI 10.1093/oxfordjournals.molbev.a003940; Cheng CL, 2009, INVEST OPHTH VIS SCI, V50, P3024, DOI 10.1167/iovs.08-2713; CLARK L, 1990, J EXP ZOOL, V255, P22, DOI 10.1002/jez.1402550105; CRONLYDILLON J, 1968, J EXP BIOL, V49, P679; Cyr DG, 1996, REV FISH BIOL FISHER, V6, P165, DOI 10.1007/BF00182342; Darwin C, 1871, DESCENT MAN SELECTIO, P387; Dedden I, 2011, THESIS QUEENS U CANA; ENDLER JA, 1993, PHILOS T R SOC B, V340, P215, DOI 10.1098/rstb.1993.0060; Engstrom-Ost J, 2007, BEHAV ECOL, V18, P393, DOI 10.1093/beheco/arl097; Fisher RA, 1915, EUGEN REV, V7, P184; Flamarique IN, 2005, J COMP PHYSIOL A, V191, P37, DOI 10.1007/s00359-004-0573-9; Flamarique IN, 2013, J EXP BIOL, V216, P656, DOI 10.1242/jeb.078840; Fuller RC, 2004, J COMP PHYSIOL A, V190, P147, DOI 10.1007/s00359-003-0478-z; Habibi HR, 2012, GEN COMP ENDOCR, V175, P19, DOI 10.1016/j.ygcen.2011.11.003; Harbott LK, 2007, J COMP NEUROL, V504, P57, DOI 10.1002/cne.21435; Hellqvist A, 2006, GEN COMP ENDOCR, V145, P263, DOI 10.1016/j.ygcen.2005.09.012; Hoffmann E, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-23; Hofmann CM, 2010, MOL ECOL, V19, P2064, DOI 10.1111/j.1365-294X.2010.04621.x; Jakobsson S, 1999, FISH PHYSIOL BIOCHEM, V20, P79, DOI 10.1023/A:1007776016610; KIRKPATRICK M, 1982, EVOLUTION, V36, P1, DOI 10.1111/j.1558-5646.1982.tb05003.x; Kunzler R, 2001, BEHAV ECOL, V12, P681, DOI 10.1093/beheco/12.6.681; Largiader CR, 2001, HEREDITY, V86, P459, DOI 10.1046/j.1365-2540.2001.00850.x; Li P, 2005, J EXP BIOL, V208, P497, DOI 10.1242/jeb.01424; Lisney TJ, 2010, J EXP BIOL, V213, P1453, DOI 10.1242/jeb.036897; Maximov VV, 2000, PHILOS T ROY SOC B, V355, P1239, DOI 10.1098/rstb.2000.0675; MOORE A, 1991, PHILOS T ROY SOC B, V332, P241, DOI 10.1098/rstb.1991.0052; Morita Y, 1997, PHYSIOL BEHAV, V61, P159, DOI 10.1016/S0031-9384(96)00354-X; Rowland William J., 1994, P297; ROWLAND WJ, 1995, ANIM BEHAV, V49, P1559, DOI 10.1016/0003-3472(95)90077-2; Seeliger Mathias W., 2002, Documenta Ophthalmologica, V104, P57, DOI 10.1023/A:1014454927931; Shand J, 1999, J COMP NEUROL, V412, P203, DOI 10.1002/(SICI)1096-9861(19990920)412:2<203::AID-CNE2>3.0.CO;2-3; Shand J, 2008, J EXP BIOL, V211, P1495, DOI 10.1242/jeb.012047; Shao YT, 2013, GEN COMP ENDOCR, V182, P16, DOI 10.1016/j.ygcen.2012.10.017; Shao YT, 2012, ZOOL STUD, V51, P1282; Spady TC, 2006, MOL BIOL EVOL, V23, P1538, DOI 10.1093/molbev/msl014; Suliman T, 2014, J COMP NEUROL, V522, P98, DOI 10.1002/cne.23391; Tchoudakova A, 1999, GEN COMP ENDOCR, V113, P388, DOI 10.1006/gcen.1998.7217; Temple SE, 2008, J EXP BIOL, V211, P3879, DOI 10.1242/jeb.020289; Temple SE, 2006, J COMP PHYSIOL A, V192, P301, DOI 10.1007/s00359-005-0068-3; van der Assem J, 1967, BEHAVIOUR S, V16; WAI EVELYN HUI, 1963, CANADIAN JOUR ZOOL, V41, P611, DOI 10.1139/z63-034; WILLIAMS DD, 1989, ENVIRON BIOL FISH, V24, P33, DOI 10.1007/BF00001608; WOOD P, 1993, P ROY SOC B-BIOL SCI, V254, P227, DOI 10.1098/rspb.1993.0150; Wu DM, 2001, INVEST OPHTH VIS SCI, V42, P2115; Yokoyama S, 2008, GENETICS, V179, P2037, DOI 10.1534/genetics.108.090449; YOUNG G, 1989, GEN COMP ENDOCR, V74, P335, DOI 10.1016/S0016-6480(89)80029-2	59	29	31	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100330	10.1371/journal.pone.0100330	http://dx.doi.org/10.1371/journal.pone.0100330			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963891	gold, Green Submitted, Green Published			2022-12-27	WOS:000338709500040
J	Wu, CC; Huang, PH; Lai, CL; Leu, HB; Chen, JW; Lin, SJ				Wu, Chih-Cheng; Huang, Po-Hsun; Lai, Chao-Lun; Leu, Hsin-Bang; Chen, Jaw-Wen; Lin, Shing-Jong			The Impact of Endothelial Progenitor Cells on Restenosis after Percutaneous Angioplasty of Hemodialysis Vascular Access	PLOS ONE			English	Article							IN-STENT RESTENOSIS; CORONARY INTERVENTION; NEOINTIMAL FORMATION; DYSFUNCTION; FISTULAS; NUMBER; MOBILIZATION; INFLAMMATION; GRAFTS; RISK	Objective: We prospectively investigate the relation between baseline circulating endothelial progenitor cells and the subsequent development of restenosis after angioplasty of hemodialysis vascular access. Background: Effect of angioplasty for hemodialysis vascular access is greatly attenuated by early and frequent restenosis. Circulating endothelial progenitor cells (EPCs) play a key role in vascular repair but are deficient in hemodialysis patients. Method: After excluding 14 patients due to arterial stenosis, central vein stenosis, and failed angioplasty, 130 patients undergoing angioplasty for dysfunctional vascular access were prospectively enrolled. Flow cytometry with quantification of EPC markers (defined as CD34+, CD34+ KDR+, CD34+ KDR+ CD133+) in peripheral blood immediately before angioplasty procedures was used to assess circulating EPC numbers. Patients were followed clinically for up to one year after angioplasty. Results: During the one-year follow-up, 95 patients (73%) received interventions for recurrent access dysfunction. Patients in the lower tertile of CD34+ KDR+ cell count had the highest restenosis rates (46%) at three month (early restenosis), compared with patients in the medium and upper tertiles of CD34+ KDR+ cell count (27% and 12% respectively, p = 0.002). Patients in the lower tertile of CD34+ KDR+ cell count received more re-interventions during one year. Patients with early restenosis had impaired EPC adhesive function and increased senescence and apoptosis. In multivariate analysis, the CD34+ KDR+ and CD34+ KDR+ CD133+ cell counts were independent predictors of target-lesion early restenosis. Conclusion: Our results suggest that the deficiency of circulating EPCs is associated with early and frequent restenosis after angioplasty of hemodialysis vascular access.	[Wu, Chih-Cheng; Lai, Chao-Lun; Leu, Hsin-Bang] Natl Taiwan Univ Hosp, Cardiovasc Ctr, Hsinchu Branch, Hsinchu, Taiwan; [Huang, Po-Hsun; Chen, Jaw-Wen; Lin, Shing-Jong] Taipei Vet Gen Hosp, Div Cardiol, Taipei, Taiwan; [Chen, Jaw-Wen; Lin, Shing-Jong] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Leu, Hsin-Bang] Taipei Vet Gen Hosp, Healthcare & Management Ctr, Taipei, Taiwan; [Wu, Chih-Cheng; Lai, Chao-Lun] Natl Taiwan Univ, Sch Med, Taipei 10764, Taiwan; [Huang, Po-Hsun; Lin, Shing-Jong] Natl Yang Ming Univ, Dept Med, Taipei 112, Taiwan; [Huang, Po-Hsun; Lin, Shing-Jong] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Wu, Chih-Cheng; Huang, Po-Hsun; Lin, Shing-Jong] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Huang, Po-Hsun; Leu, Hsin-Bang; Chen, Jaw-Wen; Lin, Shing-Jong] Natl Yang Ming Univ, Cardiovasc Res Ctr, Taipei 112, Taiwan; [Chen, Jaw-Wen] Natl Yang Ming Univ, Inst & Dept Pharmacol, Taipei 112, Taiwan	National Taiwan University; National Taiwan University Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Taiwan University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Huang, PH (corresponding author), Taipei Vet Gen Hosp, Div Cardiol, Taipei, Taiwan.	huangbs@vghtpe.gov.tw		WU, CHIH-CHENG/0000-0002-9690-6573; Lai, Chao-Lun/0000-0002-0362-245X	National Taiwan University Hospital, Hsinchu Branch [HCH100-4, HCH101-13]; UST-UCSD International Centre of Excellence in Advanced Bio-engineering [NSC-100-2911-I-009-101-A2]	National Taiwan University Hospital, Hsinchu Branch; UST-UCSD International Centre of Excellence in Advanced Bio-engineering	This study was supported by grants from the National Taiwan University Hospital, Hsinchu Branch (HCH100-4, HCH101-13), and the UST-UCSD International Centre of Excellence in Advanced Bio-engineering NSC-100-2911-I-009-101-A2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Banerjee S, 2006, ATHEROSCLEROSIS, V189, P70, DOI 10.1016/j.atherosclerosis.2006.04.026; Bittl JA, 2010, JACC-CARDIOVASC INTE, V3, P1, DOI 10.1016/j.jcin.2009.10.021; Chiang CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089942; Chiang CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031799; de Groot K, 2004, KIDNEY INT, V66, P641, DOI 10.1111/j.1523-1755.2004.00784.x; Fadini GP, 2008, ATHEROSCLEROSIS, V197, P496, DOI 10.1016/j.atherosclerosis.2007.12.039; George J, 2003, ARTERIOSCL THROM VAS, V23, pE57, DOI 10.1161/01.ATV.0000107029.65274.db; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Huang PH, 2010, ARTERIOSCL THROM VAS, V30, P869, DOI 10.1161/ATVBAHA.109.200618; Inoue T, 2011, JACC-CARDIOVASC INTE, V4, P1057, DOI 10.1016/j.jcin.2011.05.025; Kipshidze N, 2004, J AM COLL CARDIOL, V44, P733, DOI 10.1016/j.jacc.2004.04.048; Kraan J, 2012, J THROMB HAEMOST, V10, P931, DOI 10.1111/j.1538-7836.2012.04681.x; Kraan J, 2012, DRUG DISCOV TODAY, V17, P710, DOI 10.1016/j.drudis.2012.01.011; Lanuti P, 2012, J IMMUNOL METHODS, V380, P16, DOI 10.1016/j.jim.2012.03.007; Marboeuf P, 2008, J THROMB HAEMOST, V6, P195; Maruyama S, 2008, KIDNEY INT, V74, P1603, DOI 10.1038/ki.2008.495; Matsuo Y, 2006, INTERNAL MED, V45, P581, DOI 10.2169/internalmedicine.45.1663; Mills NL, 2009, HEART, V95, P2003, DOI 10.1136/hrt.2008.163162; Nakazawa G, 2010, JACC-CARDIOVASC INTE, V3, P68, DOI 10.1016/j.jcin.2009.09.015; Otsuka F, 2012, NAT REV CARDIOL, V9, P439, DOI 10.1038/nrcardio.2012.64; Padfield GJ, 2010, J AM COLL CARDIOL, V55, P1553, DOI 10.1016/j.jacc.2009.10.070; Pelliccia F, 2010, JACC-CARDIOVASC INTE, V3, P78, DOI 10.1016/j.jcin.2009.10.020; Rajan DK, 2004, RADIOLOGY, V232, P508, DOI 10.1148/radiol.2322030714; Rotmans JI, 2005, CIRCULATION, V112, P12, DOI 10.1161/CIRCULATIONAHA.104.504407; Roy-Chaudhury P, 2006, J AM SOC NEPHROL, V17, P1112, DOI 10.1681/ASN.2005050615; Stam F, 2006, J AM SOC NEPHROL, V17, P537, DOI 10.1681/ASN.2005080834; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Werner N, 2002, ARTERIOSCL THROM VAS, V22, P1567, DOI 10.1161/01.ATV.0000036417.43987.D8; Wu CC, 2010, ATHEROSCLEROSIS, V209, P598, DOI 10.1016/j.atherosclerosis.2009.10.021; Wu CC, 2009, J AM SOC NEPHROL, V20, P213, DOI 10.1681/ASN.2008050476; Yoder MC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006692	32	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e101058	10.1371/journal.pone.0101058	http://dx.doi.org/10.1371/journal.pone.0101058			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964143	gold, Green Published, Green Submitted			2022-12-27	WOS:000338709500115
J	Fernandes, J; Vieira, M; Carreto, L; Santos, MAS; Duarte, CB; Carvalho, AL; Santos, AE				Fernandes, Joana; Vieira, Marta; Carreto, Laura; Santos, Manuel A. S.; Duarte, Carlos B.; Carvalho, Ana Luisa; Santos, Armanda E.			In Vitro Ischemia Triggers a Transcriptional Response to Down-Regulate Synaptic Proteins in Hippocampal Neurons	PLOS ONE			English	Article							GLUTAMATE-RECEPTOR SUBUNIT; D-ASPARTATE RECEPTOR; OXYGEN-GLUCOSE DEPRIVATION; GENE-EXPRESSION; AMPA RECEPTORS; GLOBAL-ISCHEMIA; OXYGEN/GLUCOSE DEPRIVATION; MICROARRAY ANALYSIS; SURFACE EXPRESSION; NR1 SUBUNIT	Transient global cerebral ischemia induces profound changes in the transcriptome of brain cells, which is partially associated with the induction or repression of genes that influence the ischemic response. However, the mechanisms responsible for the selective vulnerability of hippocampal neurons to global ischemia remain to be clarified. To identify molecular changes elicited by ischemic insults, we subjected hippocampal primary cultures to oxygen-glucose deprivation (OGD), an in vitro model for global ischemia that resulted in delayed neuronal death with an excitotoxic component. To investigate changes in the transcriptome of hippocampal neurons submitted to OGD, total RNA was extracted at early (7 h) and delayed (24 h) time points after OGD and used in a whole-genome RNA microarray. We observed that at 7 h after OGD there was a general repression of genes, whereas at 24 h there was a general induction of gene expression. Genes related with functions such as transcription and RNA biosynthesis were highly regulated at both periods of incubation after OGD, confirming that the response to ischemia is a dynamic and coordinated process. Our analysis showed that genes for synaptic proteins, such as those encoding for PICK1, GRIP1, TARP gamma 3, calsyntenin-2/3, SAPAP2 and SNAP-25, were down-regulated after OGD. Additionally, OGD decreased the mRNA and protein expression levels of the GluA1 AMPA receptor subunit as well as the GluN2A and GluN2B subunits of NMDA receptors, but increased the mRNA expression of the GluN3A subunit, thus altering the composition of ionotropic glutamate receptors in hippocampal neurons. Together, our results present the expression profile elicited by in vitro ischemia in hippocampal neurons, and indicate that OGD activates a transcriptional program leading to down-regulation in the expression of genes coding for synaptic proteins, suggesting that the synaptic proteome may change after ischemia.	[Fernandes, Joana; Vieira, Marta; Duarte, Carlos B.; Carvalho, Ana Luisa; Santos, Armanda E.] Univ Coimbra, CNC Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Fernandes, Joana; Vieira, Marta; Santos, Armanda E.] Univ Coimbra, Fac Pharm, Coimbra, Portugal; [Carreto, Laura; Santos, Manuel A. S.] Univ Aveiro, Dept Biol, RNA Biol Lab, P-3800 Aveiro, Portugal; [Carreto, Laura; Santos, Manuel A. S.] Univ Aveiro, CESAM, P-3800 Aveiro, Portugal; [Duarte, Carlos B.; Carvalho, Ana Luisa] Univ Coimbra, Fac Sci & Technol, Dept Life Sci, Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra; Universidade de Aveiro; Universidade de Aveiro; Universidade de Coimbra	Carvalho, AL (corresponding author), Univ Coimbra, CNC Ctr Neurosci & Cell Biol, Coimbra, Portugal.	alc@cnc.uc.pt	Santos, Armanda E/AAV-1242-2020; Fernandes, Joana/L-9384-2014; Duarte, Carlos B/K-6358-2013; Carvalho, Ana Luisa/K-6367-2013; Vieira, M/G-3703-2012	Fernandes, Joana/0000-0002-4505-4809; Duarte, Carlos B/0000-0002-1474-0208; Carvalho, Ana Luisa/0000-0001-8368-6666; Vieira, M/0000-0001-7332-6181; Santos, Manuel/0000-0002-0437-1146	FEDER funding via Programa Operacional Factores de Competitividade -COMPETE; Fundacao para a Ciencia e Tecnologia (FCT) [PTDC/SAU-NEU/099440/2008, PTDC/NEU-NMC/ 0750/2012, PTDC/SAU-NMC/12144/2010, PTDC/NEU-SCC/1351/2012, PEst-C/SAU/LA0001/2013-2014]; FCT [SFRH/BD/ 62600/2009, SFRH/BD/47739/2008]; Fundação para a Ciência e a Tecnologia [PTDC/NEU-SCC/1351/2012, PTDC/SAU-GMG/098850/2008, PTDC/SAU-NEU/099440/2008, PTDC/NEU-NMC/0750/2012] Funding Source: FCT	FEDER funding via Programa Operacional Factores de Competitividade -COMPETE; Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundação para a Ciência e a Tecnologia	This work was supported by FEDER funding via Programa Operacional Factores de Competitividade -COMPETE and Portuguese national funding by Fundacao para a Ciencia e Tecnologia (FCT) in the scope of the following grants: PTDC/SAU-GMG/098850/2008, PTDC/SAU-NEU/099440/2008, PTDC/NEU-NMC/ 0750/2012, PTDC/SAU-NMC/12144/2010, PTDC/NEU-SCC/1351/2012 and PEst-C/SAU/LA0001/2013-2014. J. F. and M. V. received PhD grants from FCT (SFRH/BD/ 62600/2009 and SFRH/BD/47739/2008, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benardete EA, 2009, BRAIN RES, V1292, P107, DOI 10.1016/j.brainres.2009.07.027; Bevers MB, 2008, J CEREBR BLOOD F MET, V28, P655, DOI 10.1038/sj.jcbfm.9600595; Bonde C, 2005, NEUROSCIENCE, V136, P779, DOI 10.1016/j.neuroscience.2005.07.020; Bonfoco Emanuela, 1997, V29, P237; Bottiger BW, 1998, J CEREBR BLOOD F MET, V18, P1077; Buttner F, 2009, BRAIN RES, V1252, P1, DOI 10.1016/j.brainres.2008.10.045; Calderone A, 2003, J NEUROSCI, V23, P2112; Chatterton JE, 2002, NATURE, V415, P793, DOI 10.1038/nature715; Clinkinbeard T, 2013, BRAIN RES, V1499, P129, DOI 10.1016/j.brainres.2012.12.039; Das S, 1998, NATURE, V393, P377, DOI 10.1038/30748; Dennis SH, 2011, J NEUROSCI, V31, P11941, DOI 10.1523/JNEUROSCI.1183-11.2011; Dixon RM, 2009, J BIOL CHEM, V284, P14230, DOI 10.1074/jbc.M901203200; Dos-Anjos S, 2009, NEUROSCIENCE, V164, P1119, DOI 10.1016/j.neuroscience.2009.09.019; Dos-Anjos S, 2009, NEUROCHEM INT, V54, P180, DOI 10.1016/j.neuint.2008.09.016; Formisano L, 2007, P NATL ACAD SCI USA, V104, P4170, DOI 10.1073/pnas.0611704104; Formisano L, 2013, NEUROBIOL DIS, V50, P76, DOI 10.1016/j.nbd.2012.10.010; Friedman LK, 2001, MOL BRAIN RES, V86, P34, DOI 10.1016/S0169-328X(00)00252-7; Garcia-Bonilla L, 2006, NEUROCHEM RES, V31, P1433, DOI 10.1007/s11064-006-9195-7; Gascon S, 2005, J BIOL CHEM, V280, P35018, DOI 10.1074/jbc.M504108200; Gorter JA, 1997, J NEUROSCI, V17, P6179; Hanley JG, 2005, EMBO J, V24, P3266, DOI 10.1038/sj.emboj.7600801; Henson MA, 2010, PROG NEUROBIOL, V91, P23, DOI 10.1016/j.pneurobio.2010.01.004; Hofmeijer J, 2012, STROKE, V43, P607, DOI 10.1161/STROKEAHA.111.632943; Hsu JC, 1998, J CEREBR BLOOD F MET, V18, P768, DOI 10.1097/00004647-199807000-00008; Jayanthi S, 2014, BIOL PSYCHIAT, V76, P47, DOI 10.1016/j.biopsych.2013.09.034; Jin KL, 2001, ANN NEUROL, V50, P93, DOI 10.1002/ana.1073; Jung YJ, 2012, KOREAN J PHYSIOL PHA, V16, P423, DOI 10.4196/kjpp.2012.16.6.423; Kaneko N, 2014, J NEUROSCI, V34, P6030, DOI 10.1523/JNEUROSCI.4045-13.2014; Kawahara N, 2004, J CEREBR BLOOD F MET, V24, P212, DOI 10.1097/01.WCB.0000106012.33322.A2; Kim E, 1997, J CELL BIOL, V136, P669, DOI 10.1083/jcb.136.3.669; Kim YD, 2002, BRAIN RES BULL, V58, P491, DOI 10.1016/S0361-9230(02)00823-7; Kovalenko T, 2006, HIPPOCAMPUS, V16, P814, DOI 10.1002/hipo.20211; Kwak S, 2006, CURR OPIN NEUROBIOL, V16, P281, DOI 10.1016/j.conb.2006.05.004; Lai TW, 2013, PROG NEUROBIOL; Lau A, 2010, PFLUG ARCH EUR J PHY, V460, P525, DOI 10.1007/s00424-010-0809-1; Lau CG, 2010, J NEUROSCI, V30, P242, DOI 10.1523/JNEUROSCI.4933-08.2010; Liu BS, 2006, J NEUROSCI, V26, P5309, DOI 10.1523/JNEUROSCI.0567-06.2006; Liu SJ, 2007, TRENDS NEUROSCI, V30, P126, DOI 10.1016/j.tins.2007.01.006; Liu SQJ, 2005, NAT NEUROSCI, V8, P768, DOI 10.1038/nn1468; Lobo AC, 2011, NEUROBIOL DIS, V44, P292, DOI 10.1016/j.nbd.2011.07.010; Low CM, 2010, MOL PHARMACOL, V78, P1, DOI 10.1124/mol.110.064006; Lu T, 2014, NATURE, V507, P448, DOI 10.1038/nature13163; Lu XCM, 2004, J NEUROSCI RES, V77, P843, DOI 10.1002/jnr.20218; Lunyak VV, 2005, CELL, V121, P499, DOI 10.1016/j.cell.2005.05.003; Manadas B, 2009, J PROTEOME RES, V8, P4536, DOI 10.1021/pr900366x; Matsuda K, 2002, MOL BRAIN RES, V100, P43, DOI 10.1016/S0169-328X(02)00173-0; McIlhinney RAJ, 1998, NEUROPHARMACOLOGY, V37, P1355, DOI 10.1016/S0028-3908(98)00121-X; Mele M, 2014, NEUROBIOL DIS, V65, P220, DOI 10.1016/j.nbd.2014.01.019; Naisbitt S, 1997, J NEUROSCI, V17, P5687; Nakanishi N, 2009, J NEUROSCI, V29, P5260, DOI 10.1523/JNEUROSCI.1067-09.2009; Newcomb-Fernandez JK, 2001, J CEREBR BLOOD F MET, V21, P1281, DOI 10.1097/00004647-200111000-00004; Nishi M, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-23-j0003.2001; Noh KM, 2005, P NATL ACAD SCI USA, V102, P12230, DOI 10.1073/pnas.0505408102; Noh KM, 2012, P NATL ACAD SCI USA, V109, pE962, DOI 10.1073/pnas.1121568109; Optiz T, 2000, P NATL ACAD SCI USA, V97, P13360; Otto SJ, 2007, J NEUROSCI, V27, P6729, DOI 10.1523/JNEUROSCI.0091-07.2007; Pachernegg S, 2012, TRENDS NEUROSCI, V35, P240, DOI 10.1016/j.tins.2011.11.010; Palm K, 1998, J NEUROSCI, V18, P1280; Papadopoulos MC, 2000, BRIT J NEUROSURG, V14, P305; PELLEGRINIGIAMPIETRO DE, 1992, P NATL ACAD SCI USA, V89, P10499, DOI 10.1073/pnas.89.21.10499; Perez-Otano I, 2001, J NEUROSCI, V21, P1228; PETITO CK, 1987, NEUROLOGY, V37, P1281, DOI 10.1212/WNL.37.8.1281; Pettem KL, 2013, NEURON, V80, P113, DOI 10.1016/j.neuron.2013.07.016; Pina-Crespo JC, 2010, J NEUROSCI, V30, P11501, DOI 10.1523/JNEUROSCI.1593-10.2010; Prasad SS, 2012, J MOL NEUROSCI, V47, P322, DOI 10.1007/s12031-012-9751-3; Ramos-Cejudo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052121; Schutt J, 2009, J BIOL CHEM, V284, P25479, DOI 10.1074/jbc.M109.042663; Takeuchi M, 1997, J BIOL CHEM, V272, P11943, DOI 10.1074/jbc.272.18.11943; Tang Y, 2002, EUR J NEUROSCI, V15, P1937, DOI 10.1046/j.1460-9568.2002.02030.x; Tomita S, 2007, P NATL ACAD SCI USA, V104, P18784, DOI 10.1073/pnas.0708970104; Wang H, 2013, ASN NEURO, V5, P231, DOI 10.1042/AN20130009; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Wee KSL, 2008, J COMP NEUROL, V509, P118, DOI 10.1002/cne.21747; Wong HK, 2002, J COMP NEUROL, V450, P303, DOI 10.1002/cne.10314; Zhou M, 2006, J NEUROSCI, V26, P2956, DOI 10.1523/JNEUROSCI.4299-05.2006; Zhu MX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051552; Zukin R.S., 2004, STROKE, Vfourth, P829	77	16	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e99958	10.1371/journal.pone.0099958	http://dx.doi.org/10.1371/journal.pone.0099958			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24960035	Green Published, gold, Green Submitted			2022-12-27	WOS:000338633900019
J	Rodamilans, B; Leon, DS; Muhlberger, L; Candresse, T; Neumuller, M; Oliveros, JC; Garcia, JA				Rodamilans, Bernardo; San Leon, David; Muehlberger, Louisa; Candresse, Thierry; Neumueller, Michael; Carlos Oliveros, Juan; Antonio Garcia, Juan			Transcriptomic Analysis of Prunus domestica Undergoing Hypersensitive Response to Plum Pox Virus Infection	PLOS ONE			English	Article							TOBACCO-MOSAIC-VIRUS; RESISTANCE GENE; RNA-SEQ; EXPRESSION ANALYSIS; SHARKA DISEASE; PROTEIN; QUANTIFICATION; BOTTLENECKS; POPULATIONS; DISCOVERY	Plum pox virus (PPV) infects Prunus trees around the globe, posing serious fruit production problems and causing severe economic losses. One variety of Prunus domestica, named 'Jojo', develops a hypersensitive response to viral infection. Here we compared infected and non-infected samples using next-generation RNA sequencing to characterize the genetic complexity of the viral population in infected samples and to identify genes involved in development of the resistance response. Analysis of viral reads from the infected samples allowed reconstruction of a PPV-D consensus sequence. De novo reconstruction showed a second viral isolate of the PPV-Rec strain. RNA-seq analysis of PPV-infected 'Jojo' trees identified 2,234 and 786 unigenes that were significantly up-or downregulated, respectively (false discovery rate; FDR <= 0.01). Expression of genes associated with defense was generally enhanced, while expression of those related to photosynthesis was repressed. Of the total of 3,020 differentially expressed unigenes, 154 were characterized as potential resistance genes, 10 of which were included in the NBS-LRR type. Given their possible role in plant defense, we selected 75 additional unigenes as candidates for further study. The combination of next-generation sequencing and a Prunus variety that develops a hypersensitive response to PPV infection provided an opportunity to study the factors involved in this plant defense mechanism. Transcriptomic analysis presented an overview of the changes that occur during PPV infection as a whole, and identified candidates suitable for further functional characterization.	[Rodamilans, Bernardo; San Leon, David; Carlos Oliveros, Juan; Antonio Garcia, Juan] CSIC, Ctr Nacl Biotecnol, Madrid, Spain; [Muehlberger, Louisa; Neumueller, Michael] Tech Univ Munich, Unit Fruit Sci, Ctr Life & Food Sci Weihenstephan, Freising Weihenstephan, Germany; [Candresse, Thierry] UMR 1332 Biol Fruit & Pathol, Villenave Dornon, France	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Technical University of Munich; UDICE-French Research Universities; Universite de Bordeaux	Rodamilans, B (corresponding author), CSIC, Ctr Nacl Biotecnol, Campus Univ Autonoma Madrid, Madrid, Spain.	brodamilans@cnb.csic.es	Garcia, Juan Antonio/N-3723-2014; Rodamilans, Bernardo/ABA-9093-2021	Garcia, Juan Antonio/0000-0002-4861-9609; Rodamilans, Bernardo/0000-0002-6541-2589; Candresse, Thierry/0000-0001-9757-1835; San Leon Granado, David/0000-0001-8138-500X; Oliveros, Juan Carlos/0000-0002-4520-0853	EU; Spanish MCI [BIO2010-18541]	EU(European Commission); Spanish MCI(Spanish Government)	The authors acknowledge support of the EU in the frame of the FP7 KBBE-204429 SharCo project. Research is also supported by grants BIO2010-18541 from the Spanish MCI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Adams M.J., 2012, VIRUS TAXONOMY, P1069; Garcia JA, 2014, MOL PLANT PATHOL, V15, P226, DOI 10.1111/mpp.12083; Babraham Bioinformatics, FASTQC QUAL TOOL HIG; Babu M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-325; Boyes DC, 1998, P NATL ACAD SCI USA, V95, P15849, DOI 10.1073/pnas.95.26.15849; Cambra M., 2006, Bulletin OEPP, V36, P202; Candresse T., 2006, Bulletin OEPP, V36, P239; Carrier G, 2011, AM J BOT, V98, pE13, DOI 10.3732/ajb.1000371; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cox, 2008, PLUM POX DIS STONE F; Dardick C, 2007, MOL PLANT MICROBE IN, V20, P1004, DOI 10.1094/MPMI-20-8-1004; Decroocq V, 2005, MOL GENET GENOMICS, V272, P680, DOI 10.1007/s00438-004-1099-0; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Diaz-Vivancos P, 2008, J EXP BOT, V59, P2147, DOI 10.1093/jxb/ern082; Dietrich C, 2003, J GEN VIROL, V84, P2871, DOI 10.1099/vir.0.19245-0; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Gahlan P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-126; Gildow F, 2004, PHYTOPATHOLOGY, V94, P868, DOI 10.1094/PHYTO.2004.94.8.868; Glasa M, 2013, PHYTOPATHOLOGY, V103, P972, DOI 10.1094/PHYTO-11-12-0285-R; Gururani MA, 2012, PHYSIOL MOL PLANT P, V78, P51, DOI 10.1016/j.pmpp.2012.01.002; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Ivanov KI, 2014, J GEN VIROL, DOI 10.10999/vir.0.064220-0; Jridi C, 2006, J VIROL, V80, P2349, DOI 10.1128/JVI.80.5.2349-2357.2006; Kawahara-Miki R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026043; Kim MJ, 2005, PLANT MOL BIOL, V59, P981, DOI 10.1007/s11103-005-2619-y; Kreuze JF, 2009, VIROLOGY, V388, P1, DOI 10.1016/j.virol.2009.03.024; Kuss SK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000082; Kwok H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036939; Kwon SJ, 2009, PLANT J, V58, P235, DOI 10.1111/j.1365-313X.2008.03772.x; Labonne G, 1995, ACTA HORTIC, P207, DOI 10.17660/ActaHortic.1995.386.27; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Levy M, 2004, PLANT PHYSIOL, V135, P2392, DOI 10.1104/pp.104.044859; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li HY, 2004, J VIROL, V78, P10582, DOI 10.1128/JVI.78.19.10582-10587.2004; Li L, 2002, PLANTA, V215, P239, DOI 10.1007/s00425-002-0750-4; Lichtenegger L., 2010, Julius-Kuhn-Archiv, P327; Llacer G., 2006, Bulletin OEPP, V36, P219; Lopez-Moya J. J., 2008, ENCY VIROLOGY, P313; Lopez-Moya JJ, 2000, J BIOTECHNOL, V76, P121, DOI 10.1016/S0168-1656(99)00196-0; Ma KW, 2011, PLANT PHYSIOL, V157, P535, DOI 10.1104/pp.111.182295; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Mazorra-Manzano MA, 2010, PHYTOCHEMISTRY, V71, P515, DOI 10.1016/j.phytochem.2009.12.005; Mes JJ, 2000, PLANT J, V23, P183, DOI 10.1046/j.1365-313x.2000.00765.x; Moffett P, 2009, ADV VIRUS RES, V75, P1, DOI 10.1016/S0065-3527(09)07501-0; Mohr TJ, 2010, MOL PLANT MICROBE IN, V23, P1303, DOI 10.1094/MPMI-01-10-0022; Neumuller M, 2008, HORTIC SCI, V35, P50, DOI 10.17221/639-HORTSCI; Neumuller M., 2005, PHYTOPATHOL POL, V36, P77; Oliveros JC., 2007, FIESTA BIOINFOGP INT; Pacheco R, 2012, MOL PLANT MICROBE IN, V25, P709, DOI 10.1094/MPMI-11-11-0305; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Predajna L, 2012, VIRUS RES, V167, P112, DOI 10.1016/j.virusres.2012.04.002; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rodrigo G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040526; Rozen S, 2000, Methods Mol Biol, V132, P365; Sacristan S, 2003, J VIROL, V77, P9906, DOI 10.1128/JVI.77.18.9906-9911.2003; Sanseverino W, 2010, NUCLEIC ACIDS RES, V38, pD814, DOI 10.1093/nar/gkp978; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Serce CU, 2009, VIRUS RES, V142, P121, DOI 10.1016/j.virusres.2009.01.022; Sochor J, 2012, VIRUSES-BASEL, V4, P2853, DOI 10.3390/v4112853; Soriano JM, 2005, THEOR APPL GENET, V110, P980, DOI 10.1007/s00122-005-1920-0; Subr Z, 2013, ACTA VIROL, V57, P217, DOI 10.4149/av_2013_02_217; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan XP, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-56; Topfer A, 2013, J COMPUT BIOL, V20, P113, DOI 10.1089/cmb.2012.0232; Tong ZG, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-71; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wright CF, 2011, J VIROL, V85, P2266, DOI 10.1128/JVI.01396-10; Wu QF, 2010, P NATL ACAD SCI USA, V107, P1606, DOI 10.1073/pnas.0911353107; Xu DL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-133; Yoshimura S, 1998, P NATL ACAD SCI USA, V95, P1663, DOI 10.1073/pnas.95.4.1663; Zagordi O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047046; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	78	29	32	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100477	10.1371/journal.pone.0100477	http://dx.doi.org/10.1371/journal.pone.0100477			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959894	Green Published, gold, Green Submitted			2022-12-27	WOS:000338633900049
J	Shpigler, H; Amsalem, E; Huang, ZY; Cohen, M; Siegel, AJ; Hefetz, A; Bloch, G				Shpigler, Hagai; Amsalem, Etya; Huang, Zachary Y.; Cohen, Mira; Siegel, Adam J.; Hefetz, Abraham; Bloch, Guy			Gonadotropic and Physiological Functions of Juvenile Hormone in Bumblebee (Bombus terrestris) Workers	PLOS ONE			English	Article							DIVISION-OF-LABOR; HONEYBEE APIS-MELLIFERA; DUFOURS GLAND SECRETION; FORAGING BEHAVIOR; SOCIAL-ORGANIZATION; OVARIAN DEVELOPMENT; DOMINANCE BEHAVIOR; GENE-EXPRESSION; BEE; PHEROMONE	The evolution of advanced sociality in bees is associated with apparent modifications in juvenile hormone (JH) signaling. By contrast to most insects in which JH is a gonadotropin regulating female fertility, in the highly eusocial honey bee (Apis mellifera) JH has lost its gonadotrophic function in adult females, and instead regulates age-related division of labor among worker bees. In order to shed light on the evolution of JH signaling in bees we performed allatectomy and replacement therapies to manipulate JH levels in workers of the "primitively eusocial" bumblebee Bombus terrestris. Allatectomized worker bees showed remarkable reduction in ovarian development, egg laying, Vitellogenin and Kruppel homolog 1 fat body transcript levels, hemolymph Vitellogenin protein abundance, wax secretion, and egg-cell construction. These effects were reverted, at least partially, by treating allatectomized bees with JH-III, the natural JH of bees. Allatectomy also affected the amount of ester component in Dufour's gland secretion, which is thought to convey a social signal relating to worker fertility. These findings provide a strong support for the hypothesis that in contrast to honey bees, JH is a gonadotropin in bumblebees and lend credence to the hypothesis that the evolution of advanced eusociality in honey bees was associated with major modifications in JH signaling.	[Shpigler, Hagai; Cohen, Mira; Siegel, Adam J.; Bloch, Guy] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Ecol Evolut & Behav, Jerusalem, Israel; [Amsalem, Etya; Hefetz, Abraham] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Zool, IL-69978 Tel Aviv, Israel; [Huang, Zachary Y.] Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA	Hebrew University of Jerusalem; Tel Aviv University; Michigan State University	Shpigler, H (corresponding author), Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Ecol Evolut & Behav, Jerusalem, Israel.	hagai.shpigler@mail.huji.ac.il	Bloch, Guy/I-5861-2019; Huang, Zachary/D-5485-2011; Hefetz, Abraham/I-3853-2015	Bloch, Guy/0000-0003-1624-4926; Huang, Zachary/0000-0001-5354-5547; 	United States - Israel Binational Agricultural Research and Development Fund [IS-4418-11]; US-Israel Binational Science Foundation - BSF [2007465]; "Hoffman Leadership and Responsibility" doctoral scholarship; Vaadia-BARD Postdoctoral Fellowship Award from BARD [FI-462-2012]	United States - Israel Binational Agricultural Research and Development Fund(US-Israel Binational Science Foundation); US-Israel Binational Science Foundation - BSF(US-Israel Binational Science Foundation); "Hoffman Leadership and Responsibility" doctoral scholarship; Vaadia-BARD Postdoctoral Fellowship Award from BARD	This work was supported by United States - Israel Binational Agricultural Research and Development Fund, #IS-4418-11, http://www.bard-isus.com to GB; US-Israel Binational Science Foundation - BSF #2007465, http://www.bsf.org.il/BSFPublic/Default.aspx to GB and GVA; the "Hoffman Leadership and Responsibility" doctoral scholarship to HS; and the Vaadia-BARD Postdoctoral Fellowship Award No. FI-462-2012 from BARD to HS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amdam GV, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-1; Amdam GV, 2003, J THEOR BIOL, V223, P451, DOI 10.1016/S0022-5193(03)00121-8; Amdam GV, 2003, P NATL ACAD SCI USA, V100, P1799, DOI 10.1073/pnas.0333979100; Amsalem E, 2013, J INSECT PHYSIOL, V59, P1250, DOI 10.1016/j.jinsphys.2013.09.007; Amsalem E, 2010, BEHAV ECOL SOCIOBIOL, V64, P1685, DOI 10.1007/s00265-010-0982-4; Amsalem E, 2009, P R SOC B, V276, P1295, DOI 10.1098/rspb.2008.1688; [Anonymous], 1971, INSECT SOC; [Anonymous], 1974, SOCIAL BEHAV BEES; BELL WJ, 1973, INSECT SOC, V20, P253, DOI 10.1007/BF02223194; Bloch G, 2009, HORMONES, BRAIN AND BEHAVIOR, VOLS 1-5, 2ND EDITION, P1027; Bloch G, 2001, J BIOL RHYTHM, V16, P444, DOI 10.1177/074873001129002123; Bloch G, 1999, BEHAV ECOL SOCIOBIOL, V45, P125, DOI 10.1007/s002650050546; Bloch G, 1996, PHYSIOL ENTOMOL, V21, P257, DOI 10.1111/j.1365-3032.1996.tb00863.x; Bloch G, 2000, J INSECT PHYSIOL, V46, P47, DOI 10.1016/S0022-1910(99)00101-8; Bloch Guy, 2002, P195; Bortolotti L., 2000, Insect Social Life, V3, P85; CAMERON SA, 1990, ANN ENTOMOL SOC AM, V83, P626, DOI 10.1093/aesa/83.3.626; Corona M, 2007, P NATL ACAD SCI USA, V104, P7128, DOI 10.1073/pnas.0701909104; De Loof A, 2001, ARCH INSECT BIOCHEM, V47, P129, DOI 10.1002/arch.1044; Dor R, 2005, BEHAV ECOL SOCIOBIOL, V58, P270, DOI 10.1007/s00265-005-0923-9; DUCHATEAU MJ, 1989, ENTOMOL EXP APPL, V51, P199, DOI 10.1007/BF00347883; ENGELS W, 1976, J INSECT PHYSIOL, V22, P1427, DOI 10.1016/0022-1910(76)90167-0; Fussnecker B, 2008, INSECT MOL BIOL, V17, P515, DOI 10.1111/j.1365-2583.2008.00819.x; Geva S, 2005, J INSECT PHYSIOL, V51, P811, DOI 10.1016/j.jinsphys.2005.03.009; GILBERT LI, 1980, ANNU REV PHYSIOL, V42, P493, DOI 10.1146/annurev.ph.42.030180.002425; Grozinger CM, 2007, J COMP PHYSIOL A, V193, P461, DOI 10.1007/s00359-006-0202-x; Grozinger CM, 2002, INTEGR COMP BIOL, V42, P1237; Guidugli KR, 2005, FEBS LETT, V579, P4961, DOI 10.1016/j.febslet.2005.07.085; Hagai T, 2007, INSECT BIOCHEM MOLEC, V37, P689, DOI 10.1016/j.ibmb.2007.04.002; Hartfelder K, 2000, BRAZ J MED BIOL RES, V33, P157, DOI 10.1590/S0100-879X2000000200003; Hartfelder K, 1998, CURR TOP DEV BIOL, V40, P45, DOI 10.1016/S0070-2153(08)60364-6; HUANG ZY, 1992, P NATL ACAD SCI USA, V89, P11726, DOI 10.1073/pnas.89.24.11726; HUANG ZY, 1991, J INSECT PHYSIOL, V37, P733, DOI 10.1016/0022-1910(91)90107-B; KAATZ HH, 1992, J COMP PHYSIOL B, V162, P588, DOI 10.1007/BF00296638; Katzav-Gozansky T, 2003, INSECT SOC, V50, P20, DOI 10.1007/s000400300003; Katzav-Gozansky T, 2001, BEHAV ECOL SOCIOBIOL, V51, P76, DOI 10.1007/s002650100406; Katzav-Gozansky T, 2000, J INSECT PHYSIOL, V46, P993, DOI 10.1016/S0022-1910(99)00209-7; Kayukawa T, 2013, SCI REP, V3, P1; Kayukawa T, 2012, P NATL ACAD SCI USA, V109, P11729, DOI 10.1073/pnas.1204951109; Malka O, 2008, AGGRESSIVE REPROD CO; MEDLER JOHN T., 1962, ANN ENTOMOL SOC AMER, V55, P212; Minakuchi C, 2009, DEV BIOL, V325, P341, DOI 10.1016/j.ydbio.2008.10.016; MULLER WJ, 1994, J INSECT PHYSIOL, V40, P873, DOI 10.1016/0022-1910(94)90021-3; Nelson CM, 2007, PLOS BIOL, V5, P673, DOI 10.1371/journal.pbio.0050062; Pankiw T, 1998, J INSECT PHYSIOL, V44, P685, DOI 10.1016/S0022-1910(98)00040-7; Pinto LZ, 2000, J INSECT PHYSIOL, V46, P153, DOI 10.1016/S0022-1910(99)00111-0; RAIKHEL AS, 1992, ANNU REV ENTOMOL, V37, P217, DOI 10.1146/annurev.en.37.010192.001245; Riddiford LM, 2008, J INSECT PHYSIOL, V54, P895, DOI 10.1016/j.jinsphys.2008.01.014; Riddiford LM, 2012, INTEGR COMP BIOL, V52, pE146; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; ROBINSON GE, 1987, BEHAV ECOL SOCIOBIOL, V20, P329, DOI 10.1007/BF00300679; ROBINSON GE, 1992, GEN COMP ENDOCR, V87, P471, DOI 10.1016/0016-6480(92)90055-O; Robinson GE, 1997, ARCH INSECT BIOCHEM, V35, P559, DOI 10.1002/(SICI)1520-6327(1997)35:4<559::AID-ARCH13>3.0.CO;2-9; ROBINSON GE, 1985, J INSECT PHYSIOL, V31, P277, DOI 10.1016/0022-1910(85)90003-4; ROSELER PF, 1978, J INSECT PHYSIOL, V24, P707, DOI 10.1016/0022-1910(78)90068-9; ROSELER PF, 1974, INSECT SOC, V21, P249, DOI 10.1007/BF02226917; ROSELER PF, 1981, EXPERIENTIA, V37, P348, DOI 10.1007/BF01959856; ROSELER PF, 1977, J INSECT PHYSIOL, V23, P985, DOI 10.1016/0022-1910(77)90126-3; ROSELER PF, 1988, INSECT BIOCHEM, V18, P557, DOI 10.1016/0020-1790(88)90007-8; Shpigler H, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-120; Smith AR, 2013, HORM BEHAV, V63, P1, DOI 10.1016/j.yhbeh.2012.08.012; Sullivan JP, 2000, HORM BEHAV, V37, P1, DOI 10.1006/hbeh.1999.1552; VANDOORN A, 1989, PHYSIOL ENTOMOL, V14, P211, DOI 10.1111/j.1365-3032.1989.tb00954.x; VANDOORN A, 1987, NETH J ZOOL, V37, P255, DOI 10.1163/002829687X00080; Wasielewski O, 2011, J INSECT PHYSIOL, V57, P1682, DOI 10.1016/j.jinsphys.2011.09.002; West-Eberhard Mary Jane, 1996, P290; West-Eberhard Mary Jane, 2003, pi; Wyatt GR, 1996, ADV INSECT PHYSIOL, V26, P1, DOI 10.1016/S0065-2806(08)60030-2; Yerushalmi S, 2006, J EXP BIOL, V209, P1044, DOI 10.1242/jeb.02125	69	50	51	5	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100650	10.1371/journal.pone.0100650	http://dx.doi.org/10.1371/journal.pone.0100650			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959888	Green Submitted, Green Published, gold			2022-12-27	WOS:000338633900066
J	Taylor, A; Herrmann, A; Moss, D; See, V; Davies, K; Williams, SR; Murray, P				Taylor, Arthur; Herrmann, Anne; Moss, Diana; See, Violaine; Davies, Karen; Williams, Steve R.; Murray, Patricia			Assessing the Efficacy of Nano- and Micro-Sized Magnetic Particles as Contrast Agents for MRI Cell Tracking	PLOS ONE			English	Article							IRON-OXIDE NANOPARTICLES; STEM-CELLS; FEASIBILITY; MODEL; T1; T2	Iron-oxide based contrast agents play an important role in magnetic resonance imaging (MRI) of labelled cells in vivo. Currently, a wide range of such contrast agents is available with sizes varying from several nanometers up to a few micrometers and consisting of single or multiple magnetic cores. Here, we evaluate the effectiveness of these different particles for labelling and imaging stem cells, using a mouse mesenchymal stem cell line to investigate intracellular uptake, retention and processing of nano- and microsized contrast agents. The effect of intracellular confinement on transverse relaxivity was measured by MRI at 7 T and in compliance with the principles of the '3Rs', the suitability of the contrast agents for MR-based cell tracking in vivo was tested using a chick embryo model. We show that for all particles tested, relaxivity was markedly reduced following cellular internalisation, indicating that contrast agent relaxivity in colloidal suspension does not accurately predict performance in MR-based cell tracking studies. Using a bimodal imaging approach comprising fluorescence and MRI, we demonstrate that labelled MSC remain viable following in vivo transplantation and can be tracked effectively using MRI. Importantly, our data suggest that larger particles might confer advantages for longer-term imaging.	[Taylor, Arthur; Moss, Diana; Murray, Patricia] Univ Liverpool, Inst Translat Med, Liverpool L69 3BX, Merseyside, England; [Herrmann, Anne; See, Violaine] Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England; [Davies, Karen] Univ Manchester, Ctr Imaging Sci, Manchester, Lancs, England	University of Liverpool; University of Liverpool; University of Manchester	Taylor, A (corresponding author), Univ Liverpool, Inst Translat Med, Liverpool L69 3BX, Merseyside, England.	taylora@liv.ac.uk	Taylor, Arthur W/F-4393-2012; Williams, Steve C/D-6979-2011; Williams, Steve R/C-8945-2011	Taylor, Arthur W/0000-0003-2028-6694; Williams, Steve C/0000-0003-4299-1941; Williams, Steve R/0000-0001-5940-1675; Murray, Patricia/0000-0003-1316-148X; Herrmann, Anne/0000-0002-0858-419X	United Kingdom EPSRC [EP/H046143]; European Union [PERG08-GA-2010-276909]; Alder Hey Children's NHS Foundation Trust; EPSRC [EP/H046143/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H046143/1] Funding Source: researchfish	United Kingdom EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Union(European Commission); Alder Hey Children's NHS Foundation Trust; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported in part by the United Kingdom EPSRC (http://www.epsrc.ac.uk/, Grant EP/H046143) and by the European Union (http://ec.europa.eu/research/mariecurieactions/, grant PERG08-GA-2010-276909). AH is funded by Alder Hey Children's NHS Foundation Trust (http://www.alderhey.nhs.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanese A, 2012, ANNU REV BIOMED ENG, V14, P1, DOI [10.1146/annurev-bioeng-071811-150124, 10.1146/annurev.bioeng-071811-150124]; Billotey C, 2003, MAGN RESON MED, V49, P646, DOI 10.1002/mrm.10418; Boss A, 2008, J MAGN RESON IMAGING, V28, P1510, DOI 10.1002/jmri.21601; Brader P, 2013, J NUCL MED, V54, P167, DOI 10.2967/jnumed.111.099788; Bulte JWM, 2009, AM J ROENTGENOL, V193, P314, DOI 10.2214/AJR.09.3107; Carroll MRJ, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/3/035103; Cengelli F, 2006, J PHARMACOL EXP THER, V318, P108, DOI 10.1124/jpet.106.101915; de Vries IJM, 2005, NAT BIOTECHNOL, V23, P1407, DOI 10.1038/nbt1154; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; Frank JA, 2003, RADIOLOGY, V228, P480, DOI 10.1148/radiol.2281020638; Geraldes CFGC, 2009, CONTRAST MEDIA MOL I, V4, P1, DOI 10.1002/cmmi.265; Grainger DW, 2009, ADV DRUG DELIVER REV, V61, P419, DOI 10.1016/j.addr.2009.04.003; JUNG CW, 1995, MAGN RESON IMAGING, V13, P661, DOI 10.1016/0730-725X(95)00024-B; Kalva S.P., 2006, APPL RADIOL, V35, P18; Kircher MF, 2011, NAT REV CLIN ONCOL, V8, P677, DOI 10.1038/nrclinonc.2011.141; Klug G, 2010, MAGN RESON MED, V64, P1607, DOI 10.1002/mrm.22557; Laurent S, 2008, CHEM REV, V108, P2064, DOI 10.1021/cr068445e; Laurent S, 2012, PLOS ONE, V7, P306, DOI 10.1371/journal.pone.0029997; Levy M, 2012, CONTRAST MEDIA MOL I, V7, P373, DOI 10.1002/cmmi.504; Levy M, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/39/395103; Matuszewski L, 2005, RADIOLOGY, V235, P155, DOI 10.1148/radiol.2351040094; Monopoli MP, 2012, NAT NANOTECHNOL, V7, P779, DOI [10.1038/NNANO.2012.207, 10.1038/nnano.2012.207]; Rashidi H, 2009, BIOESSAYS, V31, P459, DOI 10.1002/bies.200800168; Ren GW, 2012, STEM CELL TRANSL MED, V1, P51, DOI 10.5966/sctm.2011-0019; Rezwan K, 2005, J PHYS CHEM B, V109, P14469, DOI 10.1021/jp050528w; Richards JMJ, 2012, CIRC-CARDIOVASC IMAG, V5, P509, DOI 10.1161/CIRCIMAGING.112.972596; Shapiro EM, 2004, P NATL ACAD SCI USA, V101, P10901, DOI 10.1073/pnas.0403918101; Shapiro EM, 2005, MAGNET RESON MED, V53, P329, DOI 10.1002/mrm.20342; Shapiro EM, 2008, FUND BIOMED TECHNOL, V3, P141; Simon GH, 2006, EUR RADIOL, V16, P738, DOI 10.1007/s00330-005-0031-2; Skotland T, 2002, J PHARMACEUT BIOMED, V28, P323, DOI 10.1016/S0731-7085(01)00592-1; Soenen SJH, 2010, SMALL, V6, P2136, DOI 10.1002/smll.201000763; Sun C, 2008, ADV DRUG DELIVER REV, V60, P1252, DOI 10.1016/j.addr.2008.03.018; Taylor A, 2012, CHEM SOC REV, V41, P2707, DOI 10.1039/c2cs35031a; Toso C, 2008, AM J TRANSPLANT, V8, P701, DOI 10.1111/j.1600-6143.2007.02120.x; Zhu JH, 2006, NEW ENGL J MED, V355, P2376, DOI 10.1056/NEJMc055304	36	31	32	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100259	10.1371/journal.pone.0100259	http://dx.doi.org/10.1371/journal.pone.0100259			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959883	gold, Green Published, Green Submitted			2022-12-27	WOS:000338633900033
J	Theunissen, M; Peters, ML; Schouten, EGW; Fiddelers, AAA; Willemsen, MGA; Pinto, PR; Gramke, HF; Marcus, MAE				Theunissen, Maurice; Peters, Madelon L.; Schouten, Erik G. W.; Fiddelers, Audrey A. A.; Willemsen, Mark G. A.; Pinto, Patricia R.; Gramke, Hans-Fritz; Marcus, Marco A. E.			Validation of the Surgical Fear Questionnaire in Adult Patients Waiting for Elective Surgery	PLOS ONE			English	Article							AMSTERDAM PREOPERATIVE ANXIETY; PAIN CATASTROPHIZING SCALE; RISK-FACTORS; POSTOPERATIVE PAIN; HOSPITAL ANXIETY; DISC SURGERY; PREDICTORS; DEPRESSION; RECOVERY; WOMEN	Objectives: Because existing instruments for assessing surgical fear seem either too general or too limited, the Surgical Fear Questionnaire (SFQ) was developed. The aim of this study is to assess the validity and reliability of the SFQ. Methods: Based on existing literature and expert consultation the ten-item SFQ was composed. Data on the SFQ were obtained from 5 prospective studies (N = 3233) in inpatient or day surgery patients. These data were used for exploratory factor analysis (EFA), confirmatory factor analysis (CFA), reliability analysis and validity analysis. Results: EFA in Study 1 and 2 revealed a two-factor structure with one factor associated with fear of the short-term consequences of surgery (SFQ-s, item 1-4) and the other factor with fear of the long-term consequences of surgery (SFQ-l, item 5-10). However, in both studies two items of the SFQ-l had low factor loadings. Therefore in Study 3 and 4 the 2-factor structure was tested and confirmed by CFA in an eight-item version of the SFQ. Across all studies significant correlations of the SFQ with pain catastrophizing, state anxiety, and preoperative pain intensity indicated good convergent validity. Internal consistency (Cronbach's alpha) was between 0.765-0.920 (SFQ-total), 0.766-0.877 (SFQ-s), and 0.628-0.899 (SFQ-l). The SFQ proved to be sensitive to detect differences based on age, sex, education level, employment status and preoperative pain intensity. Discussion: The SFQ is a valid and reliable eight-item index of surgical fear consisting of two subscales: fear of the short-term consequences of surgery and fear of the long-term consequences.	[Theunissen, Maurice; Fiddelers, Audrey A. A.; Willemsen, Mark G. A.; Gramke, Hans-Fritz; Marcus, Marco A. E.] Maastricht Univ, Med Ctr, Dept Anesthesiol & Pain Management, Maastricht, Netherlands; [Peters, Madelon L.; Schouten, Erik G. W.] Maastricht Univ, Dept Clin Psychol Sci, Maastricht, Netherlands; [Pinto, Patricia R.] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal; [Pinto, Patricia R.] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal; [Marcus, Marco A. E.] Hamad Med Corp, ICU Pain & Palliat Care, Dept Anesthesia, Doha, Qatar	Maastricht University; Maastricht University; Universidade do Minho; Hamad Medical Corporation	Theunissen, M (corresponding author), Maastricht Univ, Med Ctr, Dept Anesthesiol & Pain Management, Maastricht, Netherlands.	maurice.theunissen@mumc.nl	Pinto, Patrícia J R/AAA-6721-2020	Pinto, Patrícia J R/0000-0003-3428-5801; peters, madelon/0000-0003-2969-6286	Netherlands Organisation for Scientific Research (Zon-MW) [110000007]	Netherlands Organisation for Scientific Research (Zon-MW)(Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Health Research and Development)	This study was conducted with departmental funding and supported by a grant from The Netherlands Organisation for Scientific Research (Zon-MW, http://www.zonmw.nl/en/), grant no. 110000007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1980, HANDLEIDING BIJ ZELF; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Boker A, 2002, CAN J ANAESTH, V49, P792, DOI 10.1007/BF03017410; Carr E, 2006, J CLIN NURS, V15, P341, DOI 10.1111/j.1365-2702.2006.01285.x; Caumo W, 2001, ACTA ANAESTH SCAND, V45, P298, DOI 10.1034/j.1399-6576.2001.045003298.x; deGroot KI, 1997, BRIT J HEALTH PSYCH, V2, P229; Dihle A, 2006, CLIN J PAIN, V22, P617, DOI 10.1097/01.ajp.0000210905.57546.c1; Ene KW, 2006, BMC NURS, V5, DOI 10.1186/1472-6955-5-8; Ferreira-Valente MA, 2011, PAIN MED, V12, P1470, DOI 10.1111/j.1526-4637.2011.01208.x; Fiddelers A, 2012, EUR J ANAESTH, P198; GRAHAM LE, 1971, NURS RES, V20, P113; Gramke HF, 2009, CLIN J PAIN, V25, P455, DOI 10.1097/AJP.0b013e31819a6e34; GRAVER V, 1995, J PSYCHOSOM RES, V39, P465, DOI 10.1016/0022-3999(94)00148-X; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; JOHNSTON M, 1982, BRIT J CLIN PSYCHOL, V21, P255, DOI 10.1111/j.2044-8260.1982.tb00563.x; JOHNSTON M, 1980, PSYCHOL MED, V10, P145, DOI 10.1017/S0033291700039684; Kleinbeck SVM, 2000, RES NURS HEALTH, V23, P461, DOI 10.1002/1098-240X(200012)23:6<461::AID-NUR5>3.0.CO;2-S; Koivula M, 2002, INT J NURS STUD, V39, P415, DOI 10.1016/S0020-7489(01)00044-X; Koivula M, 2002, INT J NURS STUD, V39, P811, DOI 10.1016/S0020-7489(02)00022-6; MILLAR K, 1995, BRIT J ANAESTH, V74, P180, DOI 10.1093/bja/74.2.180; Moerman N, 1996, ANESTH ANALG, V82, P445, DOI 10.1097/00000539-199603000-00002; Munafo MR, 2001, J PSYCHOSOM RES, V51, P589, DOI 10.1016/S0022-3999(01)00258-6; Pais-Ribeiro J, 2007, Psychol Health Med, V12, P225, DOI 10.1080/13548500500524088; Peters ML, 2010, BRIT J SURG, V97, P1518, DOI 10.1002/bjs.7152; Peters ML, 2007, ANN SURG, V245, P487, DOI 10.1097/01.sla.0000245495.79781.65; Peters ML, 2011, RECOVERY HYSTERECTOM; Pinto PR, 2012, J PAIN, V13, P1045, DOI 10.1016/j.jpain.2012.07.014; Pinto PR, 2012, PAIN, V153, P218, DOI 10.1016/j.pain.2011.10.020; Pinto PR, 2012, EUR J PAIN, V14; Poleshuck EL, 2006, J PAIN, V7, P626, DOI 10.1016/j.jpain.2006.02.007; Riley JL, 1997, CLIN J PAIN, V13, P156, DOI 10.1097/00002508-199706000-00010; Rosenberger PH, 2009, ANN BEHAV MED, V37, P70, DOI 10.1007/s12160-008-9078-z; Shafer A, 1996, ANESTH ANALG, V83, P1285, DOI 10.1097/00000539-199612000-00027; Sommer M, 2010, CLIN J PAIN, V26, P87, DOI 10.1097/AJP.0b013e3181b43d68; Sommer M, 2009, ARCH OTOLARYNGOL, V135, P124, DOI 10.1001/archoto.2009.3; Spielberger CD, 1985, SO PSYCHOL, V2, P6; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Theunissen M, 2012, CLIN J PAIN, V28, P819, DOI 10.1097/AJP.0b013e31824549d6; Van Damme S, 2002, PAIN, V96, P319, DOI 10.1016/S0304-3959(01)00463-8; Zieger M, 2010, CENT EUR NEUROSURG, V71, P26, DOI 10.1055/s-0029-1225325; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	41	52	52	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100225	10.1371/journal.pone.0100225	http://dx.doi.org/10.1371/journal.pone.0100225			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK7UT	24960025	Green Published, gold			2022-12-27	WOS:000338633900027
J	Geng, S; Zhang, XJ; Chen, J; Liu, X; Zhang, HP; Xu, XY; Ma, Y; Li, BX; Zhang, YQ; Bi, ZG; Yang, CL				Geng, Shuo; Zhang, Xiaojun; Chen, Jie; Liu, Xing; Zhang, Hepeng; Xu, Xiaoyan; Ma, Yan; Li, Baoxin; Zhang, Yunqi; Bi, Zhenggang; Yang, Chenglin			The Tumor Suppressor Role of miR-124 in Osteosarcoma	PLOS ONE			English	Article							DOWN-REGULATION; CANCER; EXPRESSION; METASTASIS; PROLIFERATION; MICRORNAS; INVASION; GROWTH; RAC1; P53	MicroRNAs have crucial roles in development and progression of human cancers, including osteosarcoma. Recent studies have shown that miR-124 was down-regulated in many cancers; however, the role of miR-124 in osteosarcoma development is unkonwn. In this study, we demonstrate that expression of miR-124 is significantly downregulated in osteosarcoma tissues and cell lines, compared to the adjacent tissues. The expression of miR-124 in the metastases osteosarcoma tissues was lower than that in non-metastases tissues. We identified and confirmed Rac1 as a novel, direct target of miR-124 using prdiction algorithms and luciferase reporter gene assays. Overexpression of miR-124 suppressed Rac1 protein expression and attenuated cell proliferation, migration, and invasion and induced apotosis in MG-63 and U2OS in vitro. Moreover, overexpression of Rac1 in miR-124-transfected osteosarcoma cells effectively rescued the inhibition of cell invasion caused by miR-124. Therefore, our results demonstrate that miR-124 is a tumor suppressor miRNA and suggest that this miRNA could be a potential target for the treatment of osteosarcoma in future.	[Geng, Shuo; Zhang, Xiaojun; Liu, Xing; Zhang, Hepeng; Xu, Xiaoyan; Ma, Yan; Zhang, Yunqi; Bi, Zhenggang; Yang, Chenglin] Harbin Med Univ, Affiliated Hosp 1, Dept Orthoped Surg, Harbin, Heilongjiang Pr, Peoples R China; [Chen, Jie] Harbin Med Univ, Affiliated Hosp 1, Dept Obstet & Gynaecol, Harbin, Heilongjiang Pr, Peoples R China; [Li, Baoxin] Harbin Med Univ, Dept Pharmacol, Harbin, Heilongjiang Pr, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University	Yang, CL (corresponding author), Harbin Med Univ, Affiliated Hosp 1, Dept Orthoped Surg, Harbin, Heilongjiang Pr, Peoples R China.	chenglinyang@163.com	zhang, jin/GXV-9154-2022		National Natural Science Foundation of China [81271984]; Research Fund for the Doctoral Program of Higher Education of China [20122307120036]; Natural Science Foundation for Returness of Heilongjiang Province of China [LC2012C11]; Research Fund of the First Affiliated Hospital of Harbin Medical University [2013LX01]; Heilongjiang Postdoctoral Financial Assistance [LBH-Z13143]; China Postdoctoral Science Foundation [2014M551275]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Natural Science Foundation for Returness of Heilongjiang Province of China; Research Fund of the First Affiliated Hospital of Harbin Medical University; Heilongjiang Postdoctoral Financial Assistance; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This study is supported by National Natural Science Foundation of China (81271984) and Research Fund for the Doctoral Program of Higher Education of China (20122307120036) and Natural Science Foundation for Returness of Heilongjiang Province of China (LC2012C11), Research Fund of the First Affiliated Hospital of Harbin Medical University (2013LX01), Heilongjiang Postdoctoral Financial Assistance (Grant Number: LBH-Z13143), and China Postdoctoral Science Foundation (Grant Number: 2014M551275). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baglio SR, 2013, GENE, V527, P321, DOI 10.1016/j.gene.2013.06.021; Baugher PJ, 2005, BREAST CANCER RES, V7, pR965, DOI 10.1186/bcr1329; Bi Y, 2005, AM J PHYSIOL-CELL PH, V289, pC22, DOI 10.1152/ajpcell.00395.2004; Chan AY, 2005, ONCOGENE, V24, P7821, DOI 10.1038/sj.onc.1208909; Chandrasekar V, 2009, MOL CELL NEUROSCI, V42, P350, DOI 10.1016/j.mcn.2009.08.009; Chou J, 2013, CELL CYCLE, V12, P3262, DOI 10.4161/cc.26087; Dassow H, 2013, CURR PHARM DESIGN, V19, P1242; Duong Linh M, 2013, J Registry Manag, V40, P59; Engers R, 2001, J BIOL CHEM, V276, P41889, DOI 10.1074/jbc.M105049200; Furuta M, 2010, CARCINOGENESIS, V31, P766, DOI 10.1093/carcin/bgp250; Gadea G, 2007, J CELL BIOL, V178, P23, DOI 10.1083/jcb.200701120; Gougelet A, 2011, INT J CANCER, V129, P680, DOI 10.1002/ijc.25715; Han ZB, 2013, CELL PHYSIOL BIOCHEM, V31, P823, DOI 10.1159/000350100; Hunt S, 2011, FEBS LETT, V585, P187, DOI 10.1016/j.febslet.2010.11.038; Kobayashi Eisuke, 2012, Sarcoma, V2012, P359739, DOI 10.1155/2012/359739; Koukos G, 2013, GASTROENTEROLOGY; Li KKW, 2009, HUM PATHOL, V40, P1234, DOI 10.1016/j.humpath.2009.02.003; Liang YJ, 2013, CARCINOGENESIS, V34, P713, DOI 10.1093/carcin/bgs383; Liu KJ, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/867537; Lv ZH, 2013, MOL MED REP, V8, P345, DOI 10.3892/mmr.2013.1561; Matsuoka T, 2011, CLIN EXP METASTAS, V28, P627, DOI 10.1007/s10585-011-9396-6; O'Connor K, 2013, SMALL GTPASES, V4; Osaki M, 2011, MOL THER, V19, P1123, DOI 10.1038/mt.2011.53; Ottaviani G, 2009, CANCER TREAT RES, V152, P3, DOI 10.1007/978-1-4419-0284-9_1; Pan YL, 2004, BIOCHEM BIOPH RES CO, V315, P686, DOI 10.1016/j.bbrc.2004.01.108; Shi XB, 2013, ONCOGENE, V32, P4130, DOI 10.1038/onc.2012.425; van der Deen M, 2013, J BIOL CHEM, V288, P21307, DOI 10.1074/jbc.M112.445890; Wu ZY, 2011, MED ONCOL, V28, P1469, DOI 10.1007/s12032-010-9563-7; Xia JT, 2012, J PATHOL, V227, P470, DOI 10.1002/path.4030; Yang JL, 2013, CURR OPIN ONCOL, V25, P398, DOI 10.1097/CCO.0b013e3283622c1b; Yang Q, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0689-2; Yates LA, 2013, CELL, V153, P516, DOI 10.1016/j.cell.2013.04.003; Zavarella S, 2009, J NEUROSURG-PEDIATR, V4, P97, DOI 10.3171/2009.4.PEDS08322; Zhang JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070300; Zheng F, 2012, GUT, V61, P278, DOI 10.1136/gut.2011.239145	35	50	51	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e91566	10.1371/journal.pone.0091566	http://dx.doi.org/10.1371/journal.pone.0091566			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971902	Green Published, gold			2022-12-27	WOS:000338512200002
J	Gupta, GD; Dey, G; Swetha, MG; Ramalingam, B; Shameer, K; Thottacherry, JJ; Kalappurakkal, JM; Howes, MT; Chandran, R; Das, A; Menon, S; Parton, RG; Sowdhamini, R; Thattai, M; Mayor, S				Gupta, Gagan D.; Dey, Gautam; Swetha, M. G.; Ramalingam, Balaji; Shameer, Khader; Thottacherry, Joseph Jose; Kalappurakkal, Joseph Mathew; Howes, Mark T.; Chandran, Ruma; Das, Anupam; Menon, Sindhu; Parton, Robert G.; Sowdhamini, R.; Thattai, Mukund; Mayor, Satyajit			Population Distribution Analyses Reveal a Hierarchy of Molecular Players Underlying Parallel Endocytic Pathways	PLOS ONE			English	Article							GENOME-WIDE RNAI; SNARE COMPLEX; NETWORK INTEGRATION; ESCRT MACHINERY; GENE-EXPRESSION; DEEP-ORANGE; PROTEIN; MUTATIONS; SCREEN; INTERNALIZATION	Single-cell-resolved measurements reveal heterogeneous distributions of clathrin-dependent (CD) and - independent (CLIC/GEEC: CG) endocytic activity in Drosophila cell populations. dsRNA-mediated knockdown of core versus peripheral endocytic machinery induces strong changes in the mean, or subtle changes in the shapes of these distributions, respectively. By quantifying these subtle shape changes for 27 single-cell features which report on endocytic activity and cell morphology, we organize 1072 Drosophila genes into a tree-like hierarchy. We find that tree nodes contain gene sets enriched in functional classes and protein complexes, providing a portrait of core and peripheral control of CD and CG endocytosis. For 470 genes we obtain additional features from separate assays and classify them into early-or late-acting genes of the endocytic pathways. Detailed analyses of specific genes at intermediate levels of the tree suggest that Vacuolar ATPase and lysosomal genes involved in vacuolar biogenesis play an evolutionarily conserved role in CG endocytosis.	[Gupta, Gagan D.; Dey, Gautam; Swetha, M. G.; Ramalingam, Balaji; Shameer, Khader; Thottacherry, Joseph Jose; Kalappurakkal, Joseph Mathew; Chandran, Ruma; Das, Anupam; Menon, Sindhu; Sowdhamini, R.; Thattai, Mukund; Mayor, Satyajit] Natl Ctr Biol Sci, Tata Inst Fundamental Res, Bangalore, Karnataka, India; [Howes, Mark T.; Parton, Robert G.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); University of Queensland	Thattai, M (corresponding author), Natl Ctr Biol Sci, Tata Inst Fundamental Res, UAS GKVK Campus, Bangalore, Karnataka, India.	thattai@ncbs.res.in; mayor@ncbs.res.in	Dey, Gautam/GON-6083-2022; Khader, Shameer/J-2564-2016; Dey, Gautam/AAQ-8917-2020; Parton, Robert/C-5673-2009	Dey, Gautam/0000-0003-1416-6223; Dey, Gautam/0000-0003-1416-6223; Kalappurakkal, Joseph Mathew/0000-0001-9265-6821; Thottacherry, Joseph/0000-0001-6881-8819; Gupta, Gagan/0000-0002-1089-965X; Menon, Sindhu/0000-0001-6066-5520; Howes, Mark/0000-0002-9666-3364; Parton, Robert/0000-0002-7494-5248	Council for Scientific and Industrial Research; University Grants Commission; Wellcome Trust-DBT India Alliance; Natural Sciences and Engineering Research Council of Canada; JC Bose Fellowship of the DST; National Health and Medical Research Council of Australia [569542, 1045092]; DST (Nanotech Council, India);  [56954]	Council for Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission(University Grants Commission, India); Wellcome Trust-DBT India Alliance(Wellcome TrustWellcome Trust DBT India Alliance); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); JC Bose Fellowship of the DST; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); DST (Nanotech Council, India); 	The authors acknowledge support from the Council for Scientific and Industrial Research (JJT), University Grants Commission (JMK), Wellcome Trust-DBT India Alliance (MT), Natural Sciences and Engineering Research Council of Canada (GDG), and Project Grant 56954 (GDG), JC Bose Fellowship of the DST(SM) and the National Health and Medical Research Council of Australia (Australia Fellowship 569542, RGP, and Project Grant 1045092, RGP and MTH) and for support from the DST (Nanotech Council, India) to develop the cell array and HCS system, from the DBT (CoE, and RNAi) for help in establishing the NCBS Screening facility. RGP and MTH acknowledge the facilities, and the scientific and technical assistance, of the Australian Microscopy & Microanalysis Research Facility at the Centre for Microscopy and Microanalysis, The University of Queensland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar MA, 2009, MOL BIOL CELL, V20, P1705, DOI 10.1091/mbc.E08-03-0282; Altschuler SJ, 2010, CELL, V141, P559, DOI 10.1016/j.cell.2010.04.033; Arunachalam L, 2008, MOL BIOL CELL, V19, P722, DOI 10.1091/mbc.E07-07-0662; Beller M, 2008, PLOS BIOL, V6, P2530, DOI 10.1371/journal.pbio.0060292; Bottcher RT, 2009, CURR OPIN CELL BIOL, V21, P670, DOI 10.1016/j.ceb.2009.05.008; Bowman BJ, 2006, J BIOL CHEM, V281, P31885, DOI 10.1074/jbc.M605532200; Brideau C, 2003, J BIOMOL SCREEN, V8, P634, DOI 10.1177/1087057103258285; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Chadda R, 2007, TRAFFIC, V8, P702, DOI 10.1111/j.1600-0854.2007.00565.x; Chan KT, 2011, TRENDS CELL BIOL; Collinet C, 2010, NATURE, V464, P243, DOI 10.1038/nature08779; Dai JW, 1999, BIOPHYS J, V77, P3363, DOI 10.1016/S0006-3495(99)77168-7; DasGupta R, 2005, SCIENCE, V308, P826, DOI 10.1126/science.1109374; Defilippi P, 2006, TRENDS CELL BIOL, V16, P257, DOI 10.1016/j.tcb.2006.03.003; Dey G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090540; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Donaldson JG, 2009, CELL SIGNAL, V21, P1, DOI 10.1016/j.cellsig.2008.06.020; Eyster CA, 2009, TRAFFIC, V10, P590, DOI 10.1111/j.1600-0854.2009.00894.x; Felsenstein J, 1997, SYST BIOL, V46, P101, DOI 10.2307/2413638; Foley E, 2004, PLOS BIOL, V2, P1091, DOI 10.1371/journal.pbio.0020203; Fuchs F, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.25; Gasman S, 2003, NAT CELL BIOL, V5, P195, DOI 10.1038/ncb935; Guha A, 2003, J CELL SCI, V116, P3373, DOI 10.1242/jcs.00637; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Gupta GD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006768; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; Haft CR, 2000, MOL BIOL CELL, V11, P4105, DOI 10.1091/mbc.11.12.4105; Hecht S, 1942, J GEN PHYSIOL, V25, P819, DOI 10.1085/jgp.25.6.819; Horn T, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r61; Howes MT, 2010, J CELL BIOL, V190, P675, DOI 10.1083/jcb.201002119; Howes MT, 2010, CURR OPIN CELL BIOL, V22, P519, DOI 10.1016/j.ceb.2010.04.001; Huang TY, 2006, CURR OPIN CELL BIOL, V18, P26, DOI 10.1016/j.ceb.2005.11.005; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; Jani K, 2007, J CELL BIOL, V179, P1583, DOI 10.1083/jcb.200707045; Kalia M, 2006, MOL BIOL CELL, V17, P3689, DOI 10.1091/mbc.E05-10-0980; Kirkham M, 2005, J CELL BIOL, V168, P465, DOI 10.1083/jcb.200407078; Krag C, 2010, J CELL SCI, V123, P4240, DOI 10.1242/jcs.071712; Kulkarni MM, 2006, NAT METHODS, V3, P833, DOI 10.1038/nmeth935; Kumari S, 2008, NAT CELL BIOL, V10, P30, DOI 10.1038/ncb1666; Kumari S, 2010, CELL RES, V20, P256, DOI 10.1038/cr.2010.19; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Levsky JM, 2003, TRENDS CELL BIOL, V13, P4, DOI 10.1016/S0962-8924(02)00002-8; Lloyd V, 1998, TRENDS CELL BIOL, V8, P257, DOI 10.1016/S0962-8924(98)01270-7; Lundmark R, 2008, CURR BIOL, V18, P1802, DOI 10.1016/j.cub.2008.10.044; Luria SE, 1943, GENETICS, V28, P491; Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; Misselwitz B, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.7; MOLLENHAUER HH, 1990, BIOCHIM BIOPHYS ACTA, V1031, P225, DOI 10.1016/0304-4157(90)90008-Z; Moseley JB, 2006, J CELL SCI, V119, P1547, DOI 10.1242/jcs.02860; Mostafavi S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s4; Nevins AK, 2005, J BIOL CHEM, V280, P1944, DOI 10.1074/jbc.M409528200; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866; Price A, 2000, J CELL BIOL, V148, P1231, DOI 10.1083/jcb.148.6.1231; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Raucher D, 2000, J CELL BIOL, V148, P127, DOI 10.1083/jcb.148.1.127; Rizo J, 2002, NAT REV NEUROSCI, V3, P641, DOI 10.1038/nrn898; Rohn, 2011, JCB, V194, P789; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Sathyanarayanan S, 2008, GENE DEV, V22, P1522, DOI 10.1101/gad.1652308; Sevrioukov EA, 1999, MOL CELL, V4, P479, DOI 10.1016/S1097-2765(00)80199-9; Sims D, 2006, NUCLEIC ACIDS RES, V34, pD479, DOI 10.1093/nar/gkj038; Slack M, 2009, CURR OPIN DRUG DISC, V12, P351; Snijder B, 2013, NAT METHODS, V10, P1089, DOI [10.1038/NMETH.2655, 10.1038/nmeth.2655]; Snijder B, 2009, NATURE, V461, P520, DOI 10.1038/nature08282; Sriram V, 2003, J CELL BIOL, V161, P593, DOI 10.1083/jcb.200210166; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Sun KLW, 2011, DEVELOPMENT, V138, P2153, DOI 10.1242/dev.044529; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tai GH, 2004, MOL BIOL CELL, V15, P4011, DOI 10.1091/mbc.e03-12-0876; Tilghman RW, 2008, SEMIN CANCER BIOL, V18, P45, DOI 10.1016/j.semcancer.2007.08.002; Toonen RFG, 2005, J NEUROCHEM, V93, P1393, DOI 10.1111/j.1471-4159.2005.03128.x; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Wang X, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002566; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Witke W, 1998, EMBO J, V17, P967, DOI 10.1093/emboj/17.4.967; Xu L, 2007, J CELL BIOL, V178, P981, DOI 10.1083/jcb.200703106	84	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100554	10.1371/journal.pone.0100554	http://dx.doi.org/10.1371/journal.pone.0100554			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971745	Green Submitted, Green Published, gold			2022-12-27	WOS:000338512200041
J	Schacter, JL; Henson, ES; Gibson, SB				Schacter, Jennifer L.; Henson, Elizabeth S.; Gibson, Spencer B.			Estrogen Regulation of Anti-Apoptotic Bcl-2 Family Member Mcl-1 Expression in Breast Cancer Cells	PLOS ONE			English	Article							TRAIL-INDUCED APOPTOSIS; TARGETING MCL-1; GENE-EXPRESSION; CROSS-TALK; ER-ALPHA; PATHWAY; GROWTH; BETA; ACTIVATION; RESISTANCE	Estrogen is implicated as an important factor in stimulating breast cancer cell proliferation, and presence of estrogen receptor (ER) is an indication of a good prognosis in breast cancer patients. Mcl-1 is an anti-apoptotic Bcl-2 family member that is often over expressed in breast tumors, correlating with poor survival. In breast cancer, it was been previously shown that epidermal growth factor receptors up-regulate Mcl-1 but the role of estrogen in increasing Mcl-1 expression was unknown. In ER alpha positive cell lines MCF-7 and ZR-75, estrogen treatment increased Mcl-1 expression at both the protein and mRNA level. In two ER alpha negative cell lines, SK-BR-3 and MDA-MB-231, estrogen failed to increase in Mcl-1 protein expression. We found that ER alpha antagonists decreased estrogen mediated Mcl-1 expression at both the protein and mRNA level. Upon knockdown of ER alpha, Mcl-1 mRNA expression after estrogen treatment was also decreased. We also found that ER alpha binds to the Mcl-1 promoter at a region upstream of the translation start site containing a half ERE site. Streptavidin-pull down assay showed that both ER alpha and transcription factor Sp1 bind to this region. These results suggest that estrogen is involved in regulating Mcl-1 expression specifically through a mechanism involving ER alpha.	[Schacter, Jennifer L.; Henson, Elizabeth S.; Gibson, Spencer B.] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB, Canada; [Schacter, Jennifer L.; Henson, Elizabeth S.; Gibson, Spencer B.] CancerCare Manitoba, Manitoba Inst Cell Biol, Winnipeg, MB, Canada	University of Manitoba; CancerCare Manitoba Foundation	Gibson, SB (corresponding author), Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB, Canada.	gibsonsb@cc.umanitoba.ca		Gibson, Spencer/0000-0003-0119-732X	Canadian Breast Cancer Foundation, Prairie/NWT chapter operating grant; Manitoba Health Research Council (MHRC)	Canadian Breast Cancer Foundation, Prairie/NWT chapter operating grant; Manitoba Health Research Council (MHRC)	This project was supported by the Canadian Breast Cancer Foundation, Prairie/NWT chapter operating grant. Dr. Gibson is also Manitoba Chair supported by the Manitoba Health Research Council (MHRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acoca S, 2011, PROTEINS, V79, P2624, DOI 10.1002/prot.23083; Akgul C, 2009, CELL MOL LIFE SCI, V66, P1326, DOI 10.1007/s00018-008-8637-6; Atanaskova N, 2002, ONCOGENE, V21, P4000, DOI 10.1038/sj.onc.1205506; Azijli K, 2013, APOPTOSIS, V18, P851, DOI 10.1007/s10495-013-0829-3; Bae J, 2000, J BIOL CHEM, V275, P25255, DOI 10.1074/jbc.M909826199; Becker TM, 2013, ONCOGENE; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bhattacharya S, 2005, BIOCHEM J, V392, P335, DOI 10.1042/BJ20050465; Booy EP, 2011, ONCOGENE, V30, P2367, DOI 10.1038/onc.2010.616; Boucher MJ, 2000, J CELL BIOCHEM, V79, P355, DOI 10.1002/1097-4644(20001201)79:3<355::AID-JCB20>3.3.CO;2-S; Britton DJ, 2006, BREAST CANCER RES TR, V96, P131, DOI 10.1007/s10549-005-9070-2; Burow ME, 2001, J STEROID BIOCHEM, V78, P409, DOI 10.1016/S0960-0760(01)00117-0; Ding QQ, 2007, CANCER RES, V67, P4564, DOI 10.1158/0008-5472.CAN-06-1788; Doi K, 2012, J BIOL CHEM, V287, P10224, DOI 10.1074/jbc.M111.334532; Dowsett M, 2005, BREAST CANCER RES TR, V93, pS11, DOI 10.1007/s10549-005-9037-3; DUBIK D, 1992, ONCOGENE, V7, P1587; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; Fox EM, 2008, STEROIDS, V73, P1039, DOI 10.1016/j.steroids.2008.04.006; Goncharenko-Khaider N, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-84; Henson ES, 2006, CLIN CANCER RES, V12, P845, DOI 10.1158/1078-0432.CCR-05-0754; Kanczuga-Koda L, 2010, ONCOL LETT, V1, P1067, DOI 10.3892/ol.2010.178; Kazi A, 2011, J BIOL CHEM, V286, P9382, DOI 10.1074/jbc.M110.203638; Kelly MJ, 2001, TRENDS ENDOCRIN MET, V12, P152, DOI 10.1016/S1043-2760(01)00377-0; Leu CM, 2000, ONCOGENE, V19, P1665, DOI 10.1038/sj.onc.1203452; Lewis-Wambi JS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2255; Liu WS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029466; Murphy LC, 2012, SEMIN REPROD MED, V30, P5, DOI 10.1055/s-0031-1299592; Orlando L, 2010, CANCER TREAT REV, V36, pS67, DOI 10.1016/S0305-7372(10)70023-2; Pike CJ, 1999, J NEUROCHEM, V72, P1552, DOI 10.1046/j.1471-4159.1999.721552.x; Porter W, 1996, MOL ENDOCRINOL, V10, P1371, DOI 10.1210/me.10.11.1371; Quinn BA, 2011, EXPERT OPIN INV DRUG, V20, P1397, DOI 10.1517/13543784.2011.609167; Safe S, 2001, VITAM HORM, V62, P231, DOI 10.1016/S0083-6729(01)62006-5; Stoica GE, 2003, ONCOGENE, V22, P7998, DOI 10.1038/sj.onc.1206769; Warr MR, 2008, CURR MOL MED, V8, P138; Witters LM, 2007, ONCOL REP, V17, P465; WUPENG XS, 1992, MOL ENDOCRINOL, V6, P231, DOI 10.1210/me.6.2.231; Yang QF, 1999, PATHOL INT, V49, P775, DOI 10.1046/j.1440-1827.1999.00942.x	37	20	22	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100364	10.1371/journal.pone.0100364	http://dx.doi.org/10.1371/journal.pone.0100364			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971890	gold, Green Published, Green Submitted			2022-12-27	WOS:000338512200027
J	Alam, MK; Hamza, MA; Khafiz, MA; Rahman, SA; Shaari, R; Hassan, A				Alam, Mohammad Khursheed; Hamza, Muhammad Asyraf; Khafiz, Muhammad Aizuddin; Rahman, Shaifulizan Abdul; Shaari, Ramizu; Hassan, Akram			Multivariate Analysis of Factors Affecting Presence and/or Agenesis of Third Molar Tooth	PLOS ONE			English	Article							ORTHODONTIC PATIENTS; HYPODONTIA; POPULATION; GERMS; AGE	To investigate the presence and/or agenesis of third molar (M3) tooth germs in orthodontics patients in Malaysian Malay and Chinese population and evaluate the relationship between presence and/or agenesis of M3 with different skeletal malocclusion patterns and sagittal maxillomandibular jaw dimensions. Pretreatment records of 300 orthodontic patients (140 males and 160 females, 219 Malaysian Malay and 81 Chinese, average age was 16.27 +/- 4.59) were used. Third-molar agenesis was calculated with respect to race, genders, number of missing teeth, jaws, skeletal malocclusion patterns and sagittal maxillomandibular jaw dimensions. The Pearson chi-square test and ANOVA was performed to determine potential differences. Associations between various factors and M3 presence/agenesis groups were assessed using logistic regression analysis. The percentages of subjects with 1 or more M3 agenesis were 30%, 33% and 31% in the Malaysian Malay, Chinese and total population, respectively. Overall prevalence of M3 agenesis in male and female was equal (P>0.05). The frequency of the agenesis of M3s is greater in maxilla as well in the right side (P>0.05). The prevalence of M3 agenesis in those with a Class III and Class II malocclusion was relatively higher in Malaysian Malay and Malaysian Chinese population respectively. Using stepwise regression analyses, significant associations were found between Mx (P<0.05) and ANB (P<0.05) and M3 agenesis. This multivariate analysis suggested that Mx and ANB were significantly correlated with the M3 presence/agenesis.	[Alam, Mohammad Khursheed; Hamza, Muhammad Asyraf; Khafiz, Muhammad Aizuddin] Univ Sains Malaysia, Sch Dent Sci, Orthodont Unit, Kota Baharu, Kelantan, Malaysia; [Rahman, Shaifulizan Abdul; Shaari, Ramizu] Univ Sains Malaysia, Sch Dent Sci, Oral & Maxillofacial Surg Unit, Kota Baharu, Kelantan, Malaysia; [Hassan, Akram] Univ Sains Malaysia, Sch Dent Sci, Periodontol Unit, Kota Baharu, Kelantan, Malaysia	Universiti Sains Malaysia; Universiti Sains Malaysia; Universiti Sains Malaysia	Alam, MK (corresponding author), Univ Sains Malaysia, Sch Dent Sci, Orthodont Unit, Kota Baharu, Kelantan, Malaysia.	dralam@gmail.com	alam, mohammed/GXH-3645-2022; Alam, Mohammad Khursheed/D-3062-2012; Alam, Mohammad/GQR-2648-2022; Hamza, Muhammad/GQH-0690-2022	Alam, Mohammad Khursheed/0000-0001-7131-1752; Hamza, Muhammad/0000-0001-7800-689X				Barka G, 2012, INT J GEN MED, V5, P441, DOI 10.2147/IJGM.S31200; Bishara SE, 1999, AM J ORTHOD DENTOFAC, V115, P628, DOI 10.1016/S0889-5406(99)70287-8; BREDY E, 1991, Deutsche Zahn- Mund- und Kieferheilkunde, V79, P357; Cameron J, 1996, AUST DENT J, V41, P1, DOI 10.1111/j.1834-7819.1996.tb05645.x; Celikoglu M, 2012, ANGLE ORTHOD, V82, P165, DOI 10.2319/041911-274.1; ELOMAA M, 1973, Proceedings of the Finnish Dental Society, V69, P141; Garcia-Hernandez F, 2008, INT J MORPHOL, V26, P825, DOI 10.4067/S0717-95022008000400008; GARN SM, 1962, J DENT RES, V41, P717, DOI 10.1177/00220345620410033001; Goren S, 2005, Refuat Hapeh Vehashinayim (1993), V22, P49; Gravely J F, 1965, Br Dent J, V119, P397; Harris EF, 2008, AM J ORTHOD DENTOFAC, V134, P761, DOI 10.1016/j.ajodo.2006.12.019; HATTAB FN, 1995, ORAL SURG ORAL MED O, V79, P24, DOI 10.1016/S1079-2104(05)80068-X; Hellman M., 1936, DENT COSM, V78, P750; HOUSTON WJB, 1983, AM J ORTHOD DENTOFAC, V83, P382, DOI 10.1016/0002-9416(83)90322-6; John J, 2012, J DENT SCI, V7, P211, DOI 10.1016/j.jds.2012.05.002; Sanchez MJ, 2009, ANGLE ORTHOD, V79, P473, DOI 10.2319/052008-276.1; Kajii T, 2001, AM J ORTHOD DENTOFAC, V119, P245, DOI 10.1067/mod.2001.111222; Kajii TS, 2004, ANGLE ORTHOD, V74, P337; Keene H J, 1965, Angle Orthod, V35, P289; Kleinbaum DG, 1994, LOGISTIC REGRESSION; Kruger E, 2001, ORAL SURG ORAL MED O, V92, P150, DOI 10.1067/moe.2001.115461; Lee SH, 2009, FORENSIC SCI INT, V188, P107, DOI 10.1016/j.forsciint.2009.03.033; LEVESQUE GY, 1981, J DENT RES, V60, P1735, DOI 10.1177/00220345810600100201; Llarena del Rosario M E, 1990, Rev ADM, V47, P112; LYNHAM A, 1990, AUST DENT J, V35, P19, DOI 10.1111/j.1834-7819.1990.tb03021.x; Mok Y. Y., 1996, Annals Academy of Medicine Singapore, V25, P828; NANDA RS, 1954, AM J ORTHOD DENTOFAC, V40, P698, DOI 10.1016/0002-9416(54)90058-5; Rozkovcova E, 2004, Prague Med Rep, V105, P35; Sandhu S, 2005, J ORAL MAXIL SURG, V63, P640, DOI 10.1016/j.joms.2004.12.014; Shinn D L, 1976, J Dent, V4, P42, DOI 10.1016/0300-5712(76)90069-5; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]	31	14	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e101157	10.1371/journal.pone.0101157	http://dx.doi.org/10.1371/journal.pone.0101157			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967595	gold, Green Published, Green Submitted			2022-12-27	WOS:000338280800114
J	Du, CYQ; Choi, RCY; Dong, TTX; Lau, DTW; Tsim, KWK				Du, Crystal Y. Q.; Choi, Roy C. Y.; Dong, Tina T. X.; Lau, David T. W.; Tsim, Karl W. K.			Yu Ping Feng San, an Ancient Chinese Herbal Decoction, Regulates the Expression of Inducible Nitric Oxide Synthase and Cyclooxygenase-2 and the Activity of Intestinal Alkaline Phosphatase in Cultures	PLOS ONE			English	Article							KAPPA-B ACTIVATION; DANGGUI BUXUE TANG; URSOLIC ACID; RADIX ASTRAGALI; MUCOSAL DEFENSE; MACROPHAGES; MEDICINE; ALPHA; MODEL; COX-2	Yu Ping Feng San (YPFS), a Chinese herbal decoction comprising Astragali Radix (AR; Huangqi), Atractylodis Macrocephalae Rhizoma (AMR; Baizhu), and Saposhnikoviae Radix (SR; Fangfeng), has been used clinically to treat inflammatory bowel diseases (IBD). Previously, we demonstrated a dual role of YPFS in regulating cytokine release in cultured macrophages. In this study, we elucidated the anti-inflammatory effect of YPFS that is mediated through modulating the expression of three key enzymes involved in IBD: inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), and intestinal alkaline phosphatase (IALP). In a lipopolysaccharide (LPS)-induced chronic-inflammation model of cultured murine macrophages, YPFS treatment suppressed the activation of iNOS and COX-2 expression in a dose-dependent manner. Conversely, application of YPFS in cultured small intestinal enterocytes markedly induced the expression of IALP in a time-dependent manner, which might strengthen the intestinal detoxification system. A duality of YPFS in modulating the expression of iNOS and COX-2 was determined here. The expression of iNOS and COX-2 in macrophages was induced by YPFS, and this activation was partially blocked by the NF-kappa B-specific inhibitor BAY 11-7082, indicating a role of NF-kappa B signaling. These YPFS-induced changes in gene regulation strongly suggest that the anti-inflammatory effects of YPFS are mediated through the regulation of inflammatory enzymes.	[Tsim, Karl W. K.] Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China; Hong Kong Univ Sci & Technol, Ctr Chinese Med, Hong Kong, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Tsim, KWK (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China.	botsim@ust.hk	Du, Crystal Yingqing/AAH-5824-2020	Du, Crystal Yingqing/0000-0003-1353-4477; Lau, Tai Wai David/0000-0002-3443-1808; Tsim, Karl/0000-0003-4808-1674	Hong Kong Research Grants Council [T13-607/12R]; GRF [662911, 663012, 662713, N_HKUST629/13]; Hong Kong Jockey Club Charities Trust and Foundation of The Awareness of Nature [TAON12SC01]; ITC [GHP/059/12SZ]	Hong Kong Research Grants Council(Hong Kong Research Grants Council); GRF; Hong Kong Jockey Club Charities Trust and Foundation of The Awareness of Nature; ITC	This research was supported by Hong Kong Research Grants Council Theme-based Research Scheme (T13-607/12R), GRF (662911, 663012, 662713, N_HKUST629/13), The Hong Kong Jockey Club Charities Trust and Foundation of The Awareness of Nature (TAON12SC01) and ITC (GHP/059/12SZ) to Karl Tsim. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bi CWC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051670; Chen X, 2000, J Tradit Chin Med, V20, P302; Chiu SC, 2009, PHYTOTHER RES, V23, P363, DOI 10.1002/ptr.2633; Choi KW, 2003, ANN INTERN MED, V139, P715, DOI 10.7326/0003-4819-139-9-200311040-00005; Du CYQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078622; Fang SP, 2005, BIOL PHARM BULL, V28, P829, DOI 10.1248/bpb.28.829; Gilroy DW, 1998, INFLAMMATION, V22, P509, DOI 10.1023/A:1022350111213; Goldberg RF, 2008, P NATL ACAD SCI USA, V105, P3551, DOI 10.1073/pnas.0712140105; Hoo RLC, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-67; Ikeda Y, 2007, J IMMUNOL, V178, P4854, DOI 10.4049/jimmunol.178.8.4854; Kankuri E, 1999, INFLAMMATION, V23, P141, DOI 10.1023/A:1020241028723; Khan S, 2011, J CELL BIOCHEM, V112, P2179, DOI 10.1002/jcb.23137; Lanas A, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2465; Lee JC, 2007, PHYTOMEDICINE, V14, P390, DOI 10.1016/j.phymed.2006.09.012; Li CQ, 2007, PHYTOTHER RES, V21, P347, DOI 10.1002/ptr.2040; LICHTENBERGER LM, 1983, SCIENCE, V219, P1327, DOI 10.1126/science.6828859; Liu Q, 2013, J ETHNOPHARMACOL, V150, P521, DOI 10.1016/j.jep.2013.08.056; Makino T, 2005, BIOL PHARM BULL, V28, P110, DOI 10.1248/bpb.28.110; Makino T, 2004, BIOL PHARM BULL, V27, P554, DOI 10.1248/bpb.27.554; McCafferty DM, 1997, GASTROENTEROLOGY, V112, P1022, DOI 10.1053/gast.1997.v112.pm9041266; MILLER TA, 1983, AM J PHYSIOL, V245, pG601, DOI 10.1152/ajpgi.1983.245.5.G601; Mizuno H, 1997, GASTROENTEROLOGY, V112, P387, DOI 10.1053/gast.1997.v112.pm9024292; Molnar K, 2012, WORLD J GASTROENTERO, V18, P3254, DOI 10.3748/wjg.v18.i25.3254; Morin MJ, 2001, AM J PHYSIOL-GASTR L, V281, pG552, DOI 10.1152/ajpgi.2001.281.2.G552; NAJID A, 1992, FEBS LETT, V299, P213, DOI 10.1016/0014-5793(92)80117-Y; Newberry RD, 1999, NAT MED, V5, P900, DOI 10.1038/11341; Poon PMK, 2006, AM J CHINESE MED, V34, P13, DOI 10.1142/S0192415X0600359X; Sakamoto C, 1998, J GASTROENTEROL, V33, P618, DOI 10.1007/s005350050147; Shishodia S, 2003, CANCER RES, V63, P4375; Suh N, 1998, CANCER RES, V58, P717; Tuin A, 2009, GUT, V58, P379, DOI 10.1136/gut.2007.128868; Wallace JL, 1997, GASTROENTEROLOGY, V112, P1000, DOI 10.1053/gast.1997.v112.pm9041264; WALLACE JL, 1995, ALIMENT PHARM THERAP, V9, P227; Wallace JL, 2000, GASTROENTEROLOGY, V119, P512, DOI 10.1053/gast.2000.9304; Wang CC, 1999, CANCER LETT, V145, P151, DOI 10.1016/S0304-3835(99)00248-7; Willoughby DA, 2000, LANCET, V355, P646, DOI 10.1016/S0140-6736(99)12031-2; You HJ, 2001, FEBS LETT, V509, P156, DOI 10.1016/S0014-5793(01)03161-1; Zheng KYZ, 2010, J ETHNOPHARMACOL, V132, P259, DOI 10.1016/j.jep.2010.08.029; Zheng YZ, 2010, PLANTA MED, V76, P439, DOI 10.1055/s-0029-1186222; Zhu KY, 2010, J SEP SCI, V33, P3666, DOI 10.1002/jssc.201000498	40	15	16	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100382	10.1371/journal.pone.0100382	http://dx.doi.org/10.1371/journal.pone.0100382			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967898	Green Submitted, Green Published, gold			2022-12-27	WOS:000338280800038
J	Martorana, AM; Motta, S; Di Silvestre, D; Falchi, F; Deho, G; Mauri, P; Sperandeo, P; Polissi, A				Martorana, Alessandra M.; Motta, Sara; Di Silvestre, Dario; Falchi, Federica; Deho, Gianni; Mauri, Pierluigi; Sperandeo, Paola; Polissi, Alessandra			Dissecting Escherichia coli Outer Membrane Biogenesis Using Differential Proteomics	PLOS ONE			English	Article							ENVELOPE STRESS-RESPONSE; BARREL ASSEMBLY MACHINE; ABC FAMILY TRANSPORTER; GRAM-NEGATIVE BACTERIA; AAA PROTEASE FTSH; CELL-DIVISION; LIPOPOLYSACCHARIDE TRANSPORT; PEPTIDOGLYCAN SYNTHESIS; SALMONELLA-TYPHIMURIUM; SHOCK-PROTEIN	The cell envelope of Gram-negative bacteria is a complex multi-layered structure comprising an inner cytoplasmic membrane and an additional asymmetric lipid bilayer, the outer membrane, which functions as a selective permeability barrier and is essential for viability. Lipopolysaccharide, an essential glycolipid located in the outer leaflet of the outer membrane, greatly contributes to the peculiar properties exhibited by the outer membrane. This complex molecule is transported to the cell surface by a molecular machine composed of seven essential proteins LptABCDEFG that form a transenvelope complex and function as a single device. While advances in understanding the mechanisms that govern the biogenesis of the cell envelope have been recently made, only few studies are available on how bacterial cells respond to severe envelope biogenesis defects on a global scale. Here we report the use of differential proteomics based on Multidimensional Protein Identification Technology (MudPIT) to investigate how Escherichia coli cells respond to a block of lipopolysaccharide transport to the outer membrane. We analysed the envelope proteome of a lptC conditional mutant grown under permissive and non permissive conditions and identified 123 proteins whose level is modulated upon LptC depletion. Most such proteins belong to pathways implicated in cell envelope biogenesis, peptidoglycan remodelling, cell division and protein folding. Overall these data contribute to our understanding on how E. coli cells respond to LPS transport defects to restore outer membrane functionality.	[Martorana, Alessandra M.; Sperandeo, Paola; Polissi, Alessandra] Univ Milano Bicocca, Dipartimento Biotecnol & Biosci, Milan, Italy; [Motta, Sara; Di Silvestre, Dario; Mauri, Pierluigi] CNR, ITB, I-20133 Milan, Italy; [Falchi, Federica; Deho, Gianni] Univ Milan, Dipartimento Biosci, Milan, Italy	University of Milano-Bicocca; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Milan	Sperandeo, P (corresponding author), Univ Milano Bicocca, Dipartimento Biotecnol & Biosci, Milan, Italy.	paola.sperandeo@unimib.it; alessandra.polissi@unimib.it	Martorana, Alessandra M./AAB-2017-2021; di silvestre, dario/AAB-5037-2022; Mauri, Pietro Luigi/AAC-3095-2019; MOTTA, SARA/P-9635-2018; Sperandeo, Paola/AAF-2755-2019	Martorana, Alessandra M./0000-0003-3996-4141; di silvestre, dario/0000-0002-7143-6229; Mauri, Pietro Luigi/0000-0003-4364-0393; MOTTA, SARA/0000-0001-8421-6287; POLISSI, ALESSANDRA/0000-0003-0903-8024; DEHO', GIOVANNI/0000-0001-5492-7766; FALCHI, FEDERICA ANNA/0000-0002-1692-8167	Fondazione Cariplo [2010-0653]; MIUR-Regione Lombardia [ID 30190679]; Regione Lombardia "Cooperazione scientifica e tecnologica internazionale' [16876 SAL-18]; Fondazione Banca del Monte di Lombardia; MIUR-PRIN [2012WJSX8K]	Fondazione Cariplo(Fondazione Cariplo); MIUR-Regione Lombardia(Regione Lombardia); Regione Lombardia "Cooperazione scientifica e tecnologica internazionale'(Regione Lombardia); Fondazione Banca del Monte di Lombardia; MIUR-PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This work was supported by Fondazione Cariplo (Grant no. 2010-0653) to P. S., MIUR-Regione Lombardia (ID 30190679) to A. P. and G. D., Regione Lombardia "Cooperazione scientifica e tecnologica internazionale'' (Grant 16876 SAL-18), Fondazione Banca del Monte di Lombardia and MIUR-PRIN 2012 (2012WJSX8K) to A. P. P. L. M. thanks the Italian Ministry of Economy and Finance, in particular the Project of CNR "FaReBio di Qualita.'' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah J, 2007, J BACTERIOL, V189, P9140, DOI 10.1128/JB.01208-07; Ades SE, 2008, CURR OPIN MICROBIOL, V11, P535, DOI 10.1016/j.mib.2008.10.004; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bury-Mone S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000651; Chimalakonda G, 2011, P NATL ACAD SCI USA, V108, P2492, DOI 10.1073/pnas.1019089108; Chng SS, 2010, P NATL ACAD SCI USA, V107, P5363, DOI 10.1073/pnas.0912872107; Comunian C, 2011, PROTEOMICS, V11, P2320, DOI 10.1002/pmic.201000479; Cox AD, 2003, J BACTERIOL, V185, P3270, DOI 10.1128/JB.185.11.3270-3277.2003; Cronan JE, 2003, ANNU REV MICROBIOL, V57, P203, DOI 10.1146/annurev.micro.57.030502.090851; Cronan JE, 1996, ESCHERICHIA COLI SAL, V1, P612; Cullen TW, 2010, P NATL ACAD SCI USA, V107, P5160, DOI 10.1073/pnas.0913451107; Dartigalongue C, 2001, J BIOL CHEM, V276, P20866, DOI 10.1074/jbc.M100464200; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deng M, 1996, MOL MICROBIOL, V21, P605, DOI 10.1111/j.1365-2958.1996.tb02568.x; Egan AJF, 2013, ANN NY ACAD SCI, V1277, P8, DOI 10.1111/j.1749-6632.2012.06818.x; Freinkman E, 2012, BIOCHEMISTRY; Freinkman E, 2011, P NATL ACAD SCI USA, V108, P2486, DOI 10.1073/pnas.1015617108; Gerding MA, 2007, MOL MICROBIOL, V63, P1008, DOI 10.1111/j.1365-2958.2006.05571.x; Hernandez SB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002459; HSU L, 1991, J BIOL CHEM, V266, P13783; Huerta AM, 2003, J MOL BIOL, V333, P261, DOI 10.1016/j.jmb.2003.07.017; Joly N, 2010, FEMS MICROBIOL REV, V34, P797, DOI 10.1111/j.1574-6976.2010.00240.x; Klein G, 2014, J BIOL CHEM, V289, P14829, DOI 10.1074/jbc.M113.539494; Langklotz S, 2012, BBA-MOL CELL RES, V1823, P40, DOI 10.1016/j.bbamcr.2011.08.015; Leblanc SKD, 2011, J BACTERIOL, V193, P3367, DOI 10.1128/JB.01534-10; Lin DA A.J., 2001, MULTIDIMENSIONAL PRO; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Ma D, 1996, MOL MICROBIOL, V19, P101, DOI 10.1046/j.1365-2958.1996.357881.x; Mahalakshmi S, 2014, MOL MICROBIOL, V91, P145, DOI 10.1111/mmi.12452; Majdalani N, 2005, ANNU REV MICROBIOL, V59, P379, DOI 10.1146/annurev.micro.59.050405.101230; Malinverni JC, 2009, P NATL ACAD SCI USA, V106, P8009, DOI 10.1073/pnas.0903229106; Marolda CL, 2004, MICROBIOL-SGM, V150, P4095, DOI 10.1099/mic.0.27456-0; Martorana AM, 2011, RES MICROBIOL, V162, P470, DOI 10.1016/j.resmic.2011.03.007; Mauri P, 2005, FASEB J, V19, P1125, DOI 10.1096/fj.04-3000fje; Mauri P, 2008, METHOD ENZYMOL, V447, P99, DOI 10.1016/S0076-6879(08)02206-4; MISRA R, 1995, MOL MICROBIOL, V16, P779, DOI 10.1111/j.1365-2958.1995.tb02439.x; MOHAN S, 1994, J BIOL CHEM, V269, P32896; Narita S, 2013, P NATL ACAD SCI USA, V110, pE3612, DOI 10.1073/pnas.1312012110; Narita S, 2009, FEBS LETT, V583, P2160, DOI 10.1016/j.febslet.2009.05.051; Nicolaes V, 2014, J BACTERIOL, V196, P300, DOI 10.1128/JB.00921-13; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Ogura T, 1999, MOL MICROBIOL, V31, P833, DOI 10.1046/j.1365-2958.1999.01221.x; Okuda S, 2012, SCIENCE, V338, P1214, DOI 10.1126/science.1228984; OSBORN MJ, 1972, J BIOL CHEM, V247, P3962; Paradis-Bleau C, 2010, CELL, V143, P1110, DOI 10.1016/j.cell.2010.11.037; Polissi A, 1996, MOL MICROBIOL, V20, P1221, DOI 10.1111/j.1365-2958.1996.tb02642.x; Polissi A, 2014, MAR DRUGS, V12, P1023, DOI 10.3390/md12021023; Potluri LP, 2012, J BACTERIOL, V194, P5334, DOI 10.1128/JB.00859-12; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2009, J LIPID RES, V50, pS103, DOI 10.1194/jlr.R800060-JLR200; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Raivio TL, 2005, MOL MICROBIOL, V56, P1119, DOI 10.1111/j.1365-2958.2005.04625.x; Rhodius VA, 2006, PLOS BIOL, V4, P43, DOI 10.1371/journal.pbio.0040002; Ricci DP, 2012, P NATL ACAD SCI USA, V109, P3487, DOI 10.1073/pnas.1201362109; Ricci DP, 2012, BBA-BIOMEMBRANES, V1818, P1067, DOI 10.1016/j.bbamem.2011.08.020; Rigel NW, 2013, P NATL ACAD SCI USA, V110, P5151, DOI 10.1073/pnas.1302662110; Rowley G, 2006, NAT REV MICROBIOL, V4, P383, DOI 10.1038/nrmicro1394; Rubires X, 1997, J BACTERIOL, V179, P7581, DOI 10.1128/jb.179.23.7581-7586.1997; Ruiz N, 2005, CURR OPIN MICROBIOL, V8, P122, DOI 10.1016/j.mib.2005.02.013; Ruiz N, 2008, P NATL ACAD SCI USA, V105, P5537, DOI 10.1073/pnas.0801196105; SABBATTINI P, 1995, J BACTERIOL, V177, P1425, DOI 10.1128/jb.177.6.1425-1434.1995; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Sperandeo P, 2008, J BACTERIOL, V190, P4460, DOI 10.1128/JB.00270-08; Sperandeo P, 2007, J BACTERIOL, V189, P244, DOI 10.1128/JB.01126-06; Sperandeo P, 2006, RES MICROBIOL, V157, P547, DOI 10.1016/j.resmic.2005.11.014; Sperandeo P, 2011, J BACTERIOL, V193, P1042, DOI 10.1128/JB.01037-10; Sperandeo P, 2009, BBA-MOL CELL BIOL L, V1791, P594, DOI 10.1016/j.bbalip.2009.01.011; Stevenson G, 1996, J BACTERIOL, V178, P4885, DOI 10.1128/jb.178.16.4885-4893.1996; Stout V, 1996, J BACTERIOL, V178, P4273, DOI 10.1128/jb.178.14.4273-4280.1996; Tachikawa T, 2011, BIOSCI BIOTECH BIOCH, V75, P162, DOI 10.1271/bbb.100612; Tran AX, 2006, J BACTERIOL, V188, P4531, DOI 10.1128/JB.00146-06; Typas A, 2012, NAT REV MICROBIOL, V10, P123, DOI 10.1038/nrmicro2677; Typas A, 2010, CELL, V143, P1097, DOI 10.1016/j.cell.2010.11.038; Villa R, 2013, J BACTERIOL, V195, P1100, DOI 10.1128/JB.02057-12; Vollmer W, 2008, BBA-BIOMEMBRANES, V1778, P1714, DOI 10.1016/j.bbamem.2007.06.007; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Whitfield C, 1999, MOL MICROBIOL, V31, P1307, DOI 10.1046/j.1365-2958.1999.01276.x; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015; Wu T, 2006, P NATL ACAD SCI USA, V103, P11754, DOI 10.1073/pnas.0604744103; Xiong XL, 1996, J BACTERIOL, V178, P1213, DOI 10.1128/jb.178.4.1213-1215.1996; Young K, 1995, J BIOL CHEM, V270, P30384, DOI 10.1074/jbc.270.51.30384; Zgurskaya HI, 2009, BBA-PROTEINS PROTEOM, V1794, P794, DOI 10.1016/j.bbapap.2008.10.010; Zhou ZM, 1999, J BIOL CHEM, V274, P18503, DOI 10.1074/jbc.274.26.18503; Zhou ZM, 1998, J BIOL CHEM, V273, P12466, DOI 10.1074/jbc.273.20.12466	85	24	24	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100941	10.1371/journal.pone.0100941	http://dx.doi.org/10.1371/journal.pone.0100941			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967819	gold, Green Published, Green Submitted			2022-12-27	WOS:000338280800087
J	Muwonge, A; Malama, S; Bronsvoort, BMD; Biffa, D; Ssengooba, W; Skjerve, E				Muwonge, Adrian; Malama, Sydney; Bronsvoort, Barend M. de C.; Biffa, Demelash; Ssengooba, Willy; Skjerve, Eystein			A Comparison of Tools Used for Tuberculosis Diagnosis in Resource-Limited Settings: A Case Study at Mubende Referral Hospital, Uganda	PLOS ONE			English	Article							FLUORESCENCE MICROSCOPY; SMEAR MICROSCOPY; HIV; PULMONARY; ADULTS	Background: This study compared TB diagnostic tools and estimated levels of misdiagnosis in a resource-limited setting. Furthermore, we estimated the diagnostic utility of three-TB-associated predictors in an algorithm with and without Direct Ziehl-Neelsen (DZM). Materials and Methods: Data was obtained from a cross-sectional study in 2011 conducted at Mubende regional referral hospital in Uganda. An individual was included if they presented with a two weeks persistent cough and or lymphadenitis/abscess. 344 samples were analyzed on DZM in Mubende and compared to duplicates analyzed on direct fluorescent microscopy (DFM), growth on solid and liquid media at Makerere University. Clinical variables from a questionnaire and DZM were used to predict TB status in multivariable logistic and Cox proportional hazard models, while optimization and visualization was done with receiver operating characteristics curve and algorithm-charts in Stata, R and Lucid-Charts respectively. Results: DZM had a sensitivity and specificity of 36.4% (95% CI = 24.9-49.1) and 97.1%(95% CI = 94.4-98.7) compared to DFM which had a sensitivity and specificity of 80.3%(95% CI = 68.7-89.1) and 97.1%(95% CI = 94.4-98.7) respectively. DZM false negative results were associated with patient's HIV status, tobacco smoking and extra-pulmonary tuberculosis. One of the false negative cases was infected with multi drug resistant TB (MDR). The three-predictor screening algorithm with and without DZM classified 50% and 33% of the true cases respectively, while the adjusted algorithm with DZM classified 78% of the true cases. Conclusion: The study supports the concern that using DZM alone risks missing majority of TB cases, in this case we found nearly 60%, of who one was an MDR case. Although adopting DFM would reduce this proportion to 19%, the use of a three-predictor screening algorithm together with DZM was almost as good as DFM alone. It's utility is whoever subject to HIV screening all TB suspects.	[Muwonge, Adrian; Skjerve, Eystein] Norwegian Univ Life Sci, Ctr Epidemiol & Biostat, Dept Food Safety & Infect Biol, Oslo, Norway; [Muwonge, Adrian; Bronsvoort, Barend M. de C.] Univ Edinburgh, Coll Med & Vet Med, Roslin Inst, Edinburgh, Midlothian, Scotland; [Malama, Sydney] Univ Zambia, Inst Econ & Social Res, Lusaka, Zambia; [Biffa, Demelash] Univ Arizona, Coll Med, Tucson, AZ USA; [Ssengooba, Willy] Makerere Univ, Coll Hlth Sci, Dept Med Microbiol, Mycobacteriol Lab, Kampala, Uganda	Norwegian University of Life Sciences; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Zambia; University of Arizona; Makerere University	Muwonge, A (corresponding author), Norwegian Univ Life Sci, Ctr Epidemiol & Biostat, Dept Food Safety & Infect Biol, Oslo, Norway.	adrian.muwonge@roslin.ed.ac.uk	Ssengooba, Willy/AAG-1202-2020; Skjerve, Eystein/D-7491-2014; Ssengooba, Willy/ABE-2168-2020	Ssengooba, Willy/0000-0002-1643-110X; Skjerve, Eystein/0000-0001-9652-6952; Ssengooba, Willy/0000-0002-1643-110X; ADRIAN, MUWONGE/0000-0002-8579-0384; Bronsvoort, Mark/0000-0002-3271-8485	Norwegian quota scholarship scheme; centre of epidemiology and biostatistics at the Norwegian university of Life sciences; BBSRC [BBS/E/D/05191133] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/05191133] Funding Source: researchfish	Norwegian quota scholarship scheme; centre of epidemiology and biostatistics at the Norwegian university of Life sciences; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded through the Norwegian quota scholarship scheme and core funding from the centre of epidemiology and biostatistics at the Norwegian university of Life sciences. This was purely research work, therefore the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abal AT, 2005, RESP MED, V99, P415, DOI 10.1016/j.rmed.2004.08.016; Bemer P, 2002, J CLIN MICROBIOL, V40, P150, DOI 10.1128/JCM.40.1.150-154.2002; Burman WJ, 1997, AM J RESP CRIT CARE, V155, P321, DOI 10.1164/ajrccm.155.1.9001331; Chihota VN, 2010, INT J TUBERC LUNG D, V14, P1024; Corbett EL, 2010, B WORLD HEALTH ORGAN, V88, P13, DOI 10.2471/BLT.08.055467; David H, 1976, BACTERIOLOGY MYCOBAC; DECOCK KM, 1995, LANCET, V346, P675, DOI 10.1016/S0140-6736(95)92284-9; Foulds J, 1998, INT J TUBERC LUNG D, V2, P778; Globalgiving, 2010, ADV 8000 TB AFF PERS; Harries AD, 1998, B WORLD HEALTH ORGAN, V76, P651; Huerga H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051336; Kankya C, 2011, ADV TROP MED PUB HLT, V1, P111; Kivihya-Ndugga LEA, 2003, INT J TUBERC LUNG D, V7, P1163; Kumari A, 2005, EFFICACY FLUOROCHROM, P179; Laurence B, TOBACCO SMOKING SPEC, pA4758; Marais BJ, 2008, CLIN INFECT DIS, V47, P203, DOI 10.1086/589248; Muwonge A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064745; Muwonge A, 2013, INFECT GENET EVOL, V17, P16, DOI 10.1016/j.meegid.2013.03.039; Piot M, 1967, SIMULATION MODEL CAS; Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3; Ratzinger F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049658; Reichman L, 2012, INT J LUNG TUBERCLE; Reid MJA, 2009, LANCET INFECT DIS, V9, P173, DOI 10.1016/S1473-3099(09)70043-X; Rwabwogo M.O., 2007, UGANDA DISTRICT INFO; Samb B, 1997, INT J TUBERC LUNG D, V1, P25; SAUNDERSON PR, 1995, SOC SCI MED, V40, P1203, DOI 10.1016/0277-9536(94)00240-T; Shah S, 2009, JAIDS-J ACQ IMM DEF, V50, P537, DOI 10.1097/QAI.0b013e318196761c; SIDDIQUI SH, 2007, MYCOBACTERIA GROWTH; Steingart KR, 2006, LANCET INFECT DIS, V6, P664, DOI 10.1016/S1473-3099(06)70602-8; Swai Hedwiga F, 2011, BMC Res Notes, V4, P475, DOI 10.1186/1756-0500-4-475; TOMAN K, 2004, TOMANS TUBERCULOSIS, P31; Toman K, 2004, CASE DETECTION TREAT, P11; Union TDI, 2005, INT J TUBERC LUNG D, V9, P355; Walker D, 2001, INT J TUBERC LUNG D, V5, P1099; Were W, 2009, INT J TUBERC LUNG D, V13, P47; Whitehorn J, 2010, INT J TUBERC LUNG D, V14, P741; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2011, POL STAT FLUOR LIGHT; WHO, 1997, GLOB TUB PROGR TREAT, P220; WHO, 2007, IMPR DIAGN TREATM SM; Wilkinson D, 1997, T ROY SOC TROP MED H, V91, P422, DOI 10.1016/S0035-9203(97)90264-9; Wilson D, 2006, INT J TUBERC LUNG D, V10, P31; World Health Organization, 1998, LAB SERV TB CONTR 2	43	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100720	10.1371/journal.pone.0100720	http://dx.doi.org/10.1371/journal.pone.0100720			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967713	Green Submitted, Green Published, gold			2022-12-27	WOS:000338280800056
J	El Albani, A; Bengtson, S; Canfield, DE; Riboulleau, A; Bard, CR; Macchiarelli, R; Pemba, LN; Hammarlund, E; Meunier, A; Mouele, IM; Benzerara, K; Bernard, S; Boulvais, P; Chaussidon, M; Cesari, C; Fontaine, C; Chi-Fru, E; Ruiz, JMG; Gauthier-Lafaye, F; Mazurier, A; Pierson-Wickmann, AC; Rouxel, O; Trentesaux, A; Vecoli, M; Versteegh, GJM; White, L; Whitehouse, M; Bekker, A				El Albani, Abderrazak; Bengtson, Stefan; Canfield, Donald E.; Riboulleau, Armelle; Bard, Claire Rollion; Macchiarelli, Roberto; Pemba, Lauriss Ngombi; Hammarlund, Emma; Meunier, Alain; Mouele, Idalina Moubiya; Benzerara, Karim; Bernard, Sylvain; Boulvais, Philippe; Chaussidon, Marc; Cesari, Christian; Fontaine, Claude; Chi-Fru, Ernest; Garcia Ruiz, Juan Manuel; Gauthier-Lafaye, Francois; Mazurier, Arnaud; Pierson-Wickmann, Anne Catherine; Rouxel, Olivier; Trentesaux, Alain; Vecoli, Marco; Versteegh, Gerard J. M.; White, Lee; Whitehouse, Martin; Bekker, Andrey			The 2.1 Ga Old Francevillian Biota: Biogenicity, Taphonomy and Biodiversity	PLOS ONE			English	Article							ORGANIC-WALLED MICROFOSSILS; NATURAL FISSION REACTORS; DEVONIAN HUNSRUCK SLATE; ISOTOPE FRACTIONATION; ATMOSPHERIC OXYGEN; GREAT OXIDATION; SULFUR ISOTOPES; BLACK SHALES; BASIN; PRESERVATION	The Paleoproterozoic Era witnessed crucial steps in the evolution of Earth's surface environments following the first appreciable rise of free atmospheric oxygen concentrations similar to 2.3 to 2.1 Ga ago, and concomitant shallow ocean oxygenation. While most sedimentary successions deposited during this time interval have experienced thermal overprinting from burial diagenesis and metamorphism, the ca. 2.1 Ga black shales of the Francevillian B Formation (FB2) cropping out in southeastern Gabon have not. The Francevillian Formation contains centimeter-sized structures interpreted as organized and spatially discrete populations of colonial organisms living in an oxygenated marine ecosystem. Here, new material from the FB2 black shales is presented and analyzed to further explore its biogenicity and taphonomy. Our extended record comprises variably sized, shaped, and structured pyritized macrofossils of lobate, elongated, and rodshaped morphologies as well as abundant non-pyritized disk-shaped macrofossils and organic-walled acritarchs. Combined microtomography, geochemistry, and sedimentary analysis suggest a biota fossilized during early diagenesis. The emergence of this biota follows a rise in atmospheric oxygen, which is consistent with the idea that surface oxygenation allowed the evolution and ecological expansion of complex megascopic life.	[El Albani, Abderrazak; Pemba, Lauriss Ngombi; Meunier, Alain; Mouele, Idalina Moubiya; Fontaine, Claude] Univ Poitiers, CNRS INSU, UMR 7285, Inst IC2MP, Poitiers, France; [Bengtson, Stefan; Hammarlund, Emma] Swedish Museum Nat Hist, Dept Palaeozool, S-10405 Stockholm, Sweden; [Bengtson, Stefan; Hammarlund, Emma] Swedish Museum Nat Hist, Nord Ctr Earth Evolut, S-10405 Stockholm, Sweden; [Canfield, Donald E.; Hammarlund, Emma] Nord Ctr Earth Evolut, Odense M, Denmark; [Riboulleau, Armelle; Cesari, Christian; Trentesaux, Alain; Vecoli, Marco] Univ Lille 1, CNRS, UMR 8217, Lab Geosyst, F-59655 Villeneuve Dascq, France; [Bard, Claire Rollion; Chaussidon, Marc] CNRS, UMR 7358, Ctr Rech Petrog & Geochim, Vandoeuvre Les Nancy, France; [Macchiarelli, Roberto] Univ Poitiers, Dept Geosci, Poitiers, France; [Macchiarelli, Roberto] Museum Natl Hist Nat, CNRS, UMR 7194, Dept Prehist, Paris, France; [Benzerara, Karim; Bernard, Sylvain] Univ Paris 04, IMPMC, UMR 7590, MNHN,UPMC,IRD UMR 206, Paris, France; [Boulvais, Philippe; Pierson-Wickmann, Anne Catherine] Univ Rennes, UMR 6118, Dept Geosci, Rennes, France; [Chi-Fru, Ernest] Stockholm Univ, Dept Geol Sci, SE-10691 Stockholm, Sweden; [Garcia Ruiz, Juan Manuel] Univ Granada, CSIC, Inst Andaluz Ciencias Tierra, Granada 18100, Spain; [Gauthier-Lafaye, Francois] CNRS, UMR 7517, Lab Hydrol & Geochim Strasbourg, Strasbourg, France; [Mazurier, Arnaud] CRI Biopole, Soc Etud Rech Mat, Poitiers, France; [Rouxel, Olivier] IFREMER, Dept Phys Resources & Deep Sea Ecosyst Technopole, Plouzane, France; [Versteegh, Gerard J. M.] Marum Ctr Marine Environm Sci, Bremen, Germany; [White, Lee] Agence Natl Parcs Nationaux, Libreville, Gabon; [Whitehouse, Martin] Swedish Museum Nat Hist, Lab Isotope Geol, S-10405 Stockholm, Sweden; [Whitehouse, Martin] Swedish Museum Nat Hist, Nord Ctr Earth Evolut, S-10405 Stockholm, Sweden; [Bekker, Andrey] Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Poitiers; Swedish Museum of Natural History; Swedish Museum of Natural History; Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Lorraine; Universite de Poitiers; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Rennes; Stockholm University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Andaluz de Ciencias de la Tierra (IACT); University of Granada; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Poitiers; Ifremer; University of Bremen; Swedish Museum of Natural History; Swedish Museum of Natural History; University of California System; University of California Riverside	El Albani, A (corresponding author), Univ Poitiers, CNRS INSU, UMR 7285, Inst IC2MP, Poitiers, France.	abder.albani@univ-poitiers.fr	Arnaud, Mazurier/Q-3199-2017; García-Ruiz, Juan Manuel/U-1085-2019; Versteegh, Gerardus/H-2119-2011; Arnaud, Mazurier/R-4577-2019; Pierson-Wickmann, Anne-Catherine/J-3383-2012; Garcia-Ruiz, Juan Manuel/C-4389-2015; Trentesaux, Alain P. G./A-5607-2010; Bernard, Sylvain/B-6756-2013; Chaussidon, Marc/E-7067-2017; Whitehouse, Martin J/E-1425-2013; Rouxel, Olivier J/F-3954-2014; Canfield, Don/C-1735-2012; IMPMC, ROCKS @/U-8478-2017; Vecoli, Marco/AAK-5473-2020; Benzerara, Karim/J-1532-2016	Arnaud, Mazurier/0000-0003-1894-0554; García-Ruiz, Juan Manuel/0000-0002-4743-8718; Versteegh, Gerardus/0000-0002-9320-3776; Arnaud, Mazurier/0000-0003-1894-0554; Pierson-Wickmann, Anne-Catherine/0000-0002-7715-3772; Garcia-Ruiz, Juan Manuel/0000-0002-4743-8718; Trentesaux, Alain P. G./0000-0001-6186-1005; Whitehouse, Martin J/0000-0003-2227-577X; Rouxel, Olivier J/0000-0002-1431-222X; Canfield, Don/0000-0001-7602-8366; Vecoli, Marco/0000-0001-9203-7625; Bekker, Andrey/0000-0002-1154-0585; Bengtson, Stefan/0000-0003-0206-5791; Hammarlund, Emma/0000-0001-7625-4793; Riboulleau, Armelle/0000-0002-2717-8330; Benzerara, Karim/0000-0002-0553-0137; Chi Fru, Ernest/0000-0003-2673-0565	University of Poitiers, Centre National pour la Recherche Scientifique	University of Poitiers, Centre National pour la Recherche Scientifique	Funding of this study was provided by University of Poitiers, Centre National pour la Recherche Scientifique and Fond Europeen pour le Developpement Regional. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bekker A, 2012, EARTH PLANET SC LETT, V317, P295, DOI 10.1016/j.epsl.2011.12.012; Bengtson S, 2007, PALEOBIOLOGY, V33, P351, DOI 10.1666/04040.1; Bengtson Stefan, 2002, Paleontological Society Papers, V8, P289; BERTRANDSARFATI J, 1994, PRECAMBRIAN RES, V65, P341, DOI 10.1016/0301-9268(94)90112-0; Blumenberg M, 2012, PRECAMBRIAN RES, V196, P113, DOI 10.1016/j.precamres.2011.11.010; BONHOMME MG, 1982, PRECAMBRIAN RES, V18, P87, DOI 10.1016/0301-9268(82)90038-9; Bonner JT., 2000, 1 SIGNALS EVOLUTION; Borkow PS, 2003, SED REC, V1, P4, DOI DOI 10.2110/SEDRED.2003.3.4; Briggs DEG, 1996, AM J SCI, V296, P633, DOI 10.2475/ajs.296.6.633; BROS R, 1992, EARTH PLANET SC LETT, V113, P207, DOI 10.1016/0012-821X(92)90220-P; Bryant C, 1991, METAZOAN LIFE OXYGEN; Butterfield NJ, 2009, GEOBIOLOGY, V7, P1, DOI 10.1111/j.1472-4669.2009.00188.x; Butterfield NJ, 2007, PALAEONTOLOGY, V50, P41, DOI 10.1111/j.1475-4983.2006.00613.x; Butterfield NJ, 2009, PRECAMBRIAN RES, V173, P201, DOI 10.1016/j.precamres.2009.01.008; Canfield DE, 2005, ANNU REV EARTH PL SC, V33, P1, DOI 10.1146/annurev.earth.33.092203.122711; Canfield DE, 2001, GEOCHIM COSMOCHIM AC, V65, P1117, DOI 10.1016/S0016-7037(00)00584-6; Canfield DE, 1991, TAPHONOMY RELEASING, P338; Canfield DE, 2013, P NATL ACAD SCI USA, V110, P16736, DOI 10.1073/pnas.1315570110; Chang Z, 2008, GEOLOGY, V36, P971, DOI 10.1130/G25001A.1; CRIMES TP, 1985, J PALEONTOL, V59, P310; DILL H, 1990, SEDIMENTOLOGY, V37, P427, DOI 10.1111/j.1365-3091.1990.tb00145.x; Douzery EJP, 2004, P NATL ACAD SCI USA, V101, P15386, DOI 10.1073/pnas.0403984101; El Albani A, 2010, NATURE, V466, P100, DOI 10.1038/nature09166; Ferrini V, 2010, J GEOL SOC LONDON, V167, P1009, DOI 10.1144/0016-76492009-161; Fisher ISJ, 1987, GEOLOGICAL SOC LONDO, V26, P69, DOI DOI 10.1144/GSL.SP.1987.026.01.04; Gabbott SE, 2004, GEOLOGY, V32, P901, DOI 10.1130/G20640.1; GARCIARUIZ JM, 1993, NATO ADV SCI INST SE, V304, P183; Gauthier-Lafaye F, 2006, GEOL SOC AM MEM, V198, P157, DOI 10.1130/2006.1198(09); GAUTHIERLAFAYE F, 1989, ECON GEOL, V84, P2286, DOI 10.2113/gsecongeo.84.8.2286; GauthierLafaye F, 1996, GEOCHIM COSMOCHIM AC, V60, P4831, DOI 10.1016/S0016-7037(96)00245-1; Grimes ST, 2002, J GEOL SOC LONDON, V159, P493, DOI 10.1144/0016-764901-176; Grosberg RK, 2007, ANNU REV ECOL EVOL S, V38, P621, DOI 10.1146/annurev.ecolsys.36.102403.114735; Hagadorn JW, 2011, ATL GEOL, V47, P66, DOI 10.4138/atlgeol.2011.002; Horie K, 2005, GEOCHIM COSMOCHIM AC, V69, pA11; Javaux EJ, 2010, NATURE, V463, P934, DOI 10.1038/nature08793; Jensen S., 2006, 22 JORN SOC ESP PAL, P132; Johnston DT, 2012, EARTH PLANET SC LETT, V335, P25, DOI 10.1016/j.epsl.2012.05.010; Kakegawa T, 1998, GEOCHIM COSMOCHIM AC, V62, P3205, DOI 10.1016/S0016-7037(98)00229-4; Knoll AH, 2006, PHILOS T R SOC B, V361, P1023, DOI 10.1098/rstb.2006.1843; KNOLL A. H., 1996, PALEONTOLOGY PRINCIP, V1, P51; Knoll AH, 2011, ANNU REV EARTH PL SC, V39, P217, DOI 10.1146/annurev.earth.031208.100209; Kump LR, 2011, SCIENCE, V334, P1694, DOI 10.1126/science.1213999; Lamb DM, 2009, PRECAMBRIAN RES, V173, P93, DOI 10.1016/j.precamres.2009.05.005; Leonov MV, 2007, GEOL SOC SPEC PUBL, V286, P259, DOI 10.1144/SP286.18; MacGabhann BA, 2007, GEOL SOC SPEC PUBL, V286, P297, DOI 10.1144/SP286.21; MANGUM C, 1991, J EXP ZOOL, V260, P33, DOI 10.1002/jez.1402600105; Marshall CP, 2005, PRECAMBRIAN RES, V138, P208, DOI 10.1016/j.precamres.2005.05.006; Ossa FO, 2013, CHEM GEOL, V362, P181, DOI 10.1016/j.chemgeo.2013.08.011; Parfrey LW, 2013, BIOESSAYS, V35, P339, DOI 10.1002/bies.201200143; Partin CA, 2013, EARTH PLANET SC LETT, V369, P284, DOI 10.1016/j.epsl.2013.03.031; Payne JL, 2011, PHOTOSYNTH RES, V107, P37, DOI 10.1007/s11120-010-9593-1; Peng YB, 2009, PRECAMBRIAN RES, V168, P223, DOI 10.1016/j.precamres.2008.10.005; Planavsky NJ, 2012, P NATL ACAD SCI USA, V109, P18300, DOI 10.1073/pnas.1120387109; RAISWELL R, 1993, AM J SCI, V293, P569, DOI 10.2475/ajs.293.6.569; Raiswell R, 1997, J GEOL SOC LONDON, V154, P343, DOI 10.1144/gsjgs.154.2.0343; RONA PA, 1978, B MAR SCI, V28, P371; Rona PA, 2009, DEEP-SEA RES PT II, V56, P1700, DOI 10.1016/j.dsr2.2009.05.015; Schiffbauer JD, 2012, GEOBIOLOGY, V10, P402, DOI 10.1111/j.1472-4669.2012.00332.x; Scott C, 2014, EARTH PLANET SC LETT, V389, P95, DOI 10.1016/j.epsl.2013.12.010; Seilacher A, 2001, SEDIMENT GEOL, V143, P41, DOI 10.1016/S0037-0738(01)00092-6; Talyzina NM, 2000, PRECAMBRIAN RES, V102, P123, DOI 10.1016/S0301-9268(00)00062-0; Thomassot E, 2009, EARTH PLANET SC LETT, V282, P79, DOI 10.1016/j.epsl.2009.03.001; UNDERWOOS CJ, 1994, GEOL MAG, V131, P315, DOI 10.1017/S0016756800011080; Wacey D., 2009, EARLY LIFE EARTH PRA; Wagner T, 2006, AM J SCI, V306, P525, DOI 10.2475/07.2006.02; Wang QW, 1996, MAR CHEM, V52, P99, DOI 10.1016/0304-4203(95)00082-8; Weber F., 1968, SERIE PRECAMBRIENNE; Whitehouse MJ, 2005, CHEM GEOL, V222, P112, DOI 10.1016/j.chemgeo.2005.06.004; Wilkins MR, 1995, EXPERIENTIA, V51, P1189, DOI 10.1007/BF01944736	69	42	42	2	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e99438	10.1371/journal.pone.0099438	http://dx.doi.org/10.1371/journal.pone.0099438			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963687	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000338709500010
J	Chien, CC; Wu, MS; Shen, SC; Ko, CH; Chen, CH; Yang, LL; Chen, YC				Chien, Chih-Chiang; Wu, Ming-Shun; Shen, Shing-Chuan; Ko, Ching-Huai; Chen, Chih-Hung; Yang, Ling-Ling; Chen, Yen-Chou			Activation of JNK Contributes to Evodiamine-Induced Apoptosis and G(2)/M Arrest in Human Colorectal Carcinoma Cells: A Structure-Activity Study of Evodiamine	PLOS ONE			English	Article							BREAST-CANCER CELLS; INDEPENDENT APOPTOSIS; ROS; INHIBITION; PHOSPHORYLATION; TELOMERASE; PATHWAY; GROWTH; BINDS	Evodiamine (EVO; 8,13,13b,14-tetrahydro-14-methylindolo[2'3'-3,4]pyrido[2,1-b]quinazolin-5-[7H]-one derived from the traditional herbal medicine Evodia rutaecarpa was reported to possess anticancer activity; however, the anticancer mechanism is still unclear. In this study, we investigated the anticancer effects of EVO on human colon COLO205 and HT-29 cells and their potential mechanisms. MTT and lactate dehydrogenase (LDH) release assays showed that the viability of COLOL205 and HT-29 cells was inhibited by EVO at various concentrations in accordance with increases in the percentage of apoptotic cells and cleavage of caspase-3 and poly(ADP ribose) polymerase (PARP) proteins. Disruption of the mitochondrial membrane potential by EVO was accompanied by increased Bax, caspase-9 protein cleavage, and cytochrome (Cyt) c protein translocation in COLO205 and HT-29 cells. Application of the antioxidant N-acetyl-L-cysteine (NAC) inhibited H2O2-induced reactive oxygen species (ROS) production and apoptosis, but did not affect EVO-induced apoptosis of COLO205 or HT-29 cells. Significant increases in the G(2)/M ratio and cyclinB1/cdc25c protein expression by EVO were respectively identified in colon carcinoma cells via a flow cytometric analysis and Western blotting. Induction of extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) protein phosphorylation was detected in EVO-treated cells, and the JNK inhibitor, SP600125, but not the ERK inhibitor, U0126, inhibited EVO-induced phosphorylated JNK protein expression, apoptosis, and G(2)/M arrest of colon carcinoma cells. Data of the structure-activity analysis showed that EVO-related chemicals containing an alkyl group at position 14 were able to induce apoptosis, G(2)/M arrest associated with increased DNA ladder formation, cleavage of caspase-3 and PARP, and elevated cycB1 and cdc25c protein expressions in COLO205 and HT-29 cells. Evidence supporting JNK activation leading to EVO-induced apoptosis and G(2)/M arrest in colon carcinoma cells is provided, and alkylation at position 14 of EVO is a critical substitution for treatment of colonic cancer.	[Chien, Chih-Chiang] Chi Mei Med Ctr, Dept Nephrol, Tainan, Taiwan; [Chien, Chih-Chiang] Chung Hwa Univ Med Technol, Dept Food Nutr, Tainan, Taiwan; [Wu, Ming-Shun] Taipei Med Univ, Wan Fang Hosp, Dept Internal Med, Div Gastroenterol, Taipei, Taiwan; [Shen, Shing-Chuan; Chen, Yen-Chou] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan; [Ko, Ching-Huai; Chen, Chih-Hung] Ind Technol Res Inst, Strateg Business & Innovat Technol Dev Div, Hsinchu, Taiwan; [Ko, Ching-Huai; Chen, Chih-Hung] Ind Technol Res Inst, Biomed Technol & Device Res Labs, Hsinchu, Taiwan; [Yang, Ling-Ling] Fo Guang Univ, Coll LOHAS, Yilan, Taiwan; [Chen, Yen-Chou] Taipei Med Univ Hosp, Canc Res Ctr, Taipei, Taiwan; [Chen, Yen-Chou] Taipei Med Univ Hosp, Orthoped Res Ctr, Taipei, Taiwan	Chi Mei Hospital; Chung Hua University; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Industrial Technology Research Institute - Taiwan; Industrial Technology Research Institute - Taiwan; Fo Guang University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital	Chen, YC (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan.	yc3270@tmu.edu.tw			National Science Council of Taiwan [NSC 101-2320-B-038-025-MY3, NSC 102-2320-B-038-050]; Taipei Medical University-Wan Fang Hospital [103TMU-WFH-01-2]; Taipei Medical University-Chi Mei Hospital [103CM-TMU-04]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Taipei Medical University-Wan Fang Hospital; Taipei Medical University-Chi Mei Hospital	This study was supported by the National Science Council of Taiwan (NSC 101-2320-B-038-025-MY3 and NSC 102-2320-B-038-050), Taipei Medical University-Wan Fang Hospital (103TMU-WFH-01-2), and Taipei Medical University-Chi Mei Hospital (103CM-TMU-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carnesecchi S, 2002, J PHARMACOL EXP THER, V301, P625, DOI 10.1124/jpet.301.2.625; Chae HD, 2011, BMB REP, V44, P553, DOI 10.5483/BMBRep.2011.44.8.553; Chen YC, 2005, BBA-MOL CELL RES, V1743, P291, DOI 10.1016/j.bbamcr.2004.10.016; Chien CC, 2012, J CELL PHYSIOL, V227, P3128, DOI 10.1002/jcp.23067; Chien CC, 2009, J CELL PHYSIOL, V218, P405, DOI 10.1002/jcp.21613; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; De Chiara G, 2006, J BIOL CHEM, V281, P21353, DOI 10.1074/jbc.M511052200; Du J, 2013, ONCOL REP, V30, P685, DOI 10.3892/or.2013.2498; Fei XF, 2003, CANCER SCI, V94, P92, DOI 10.1111/j.1349-7006.2003.tb01358.x; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Huang YC, 2004, LIFE SCI, V75, P35, DOI 10.1016/j.lfs.2003.11.025; Jang BC, 2004, BIOCHEM PHARMACOL, V68, P263, DOI 10.1016/j.bcp.2004.03.007; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Johansson M, 2008, ANTI-CANCER AGENT ME, V8, P723, DOI 10.2174/187152008785914833; Kan SF, 2007, J CELL BIOCHEM, V101, P44, DOI 10.1002/jcb.21036; Ko CH, 2005, BIOCHEM PHARMACOL, V69, P913, DOI 10.1016/j.bcp.2004.12.005; Ko CH, 2007, INT J CANCER, V121, P1670, DOI 10.1002/ijc.22910; Kobayashi Y, 2003, PLANTA MED, V69, P425, DOI 10.1055/s-2003-39701; Lee TJ, 2006, MOL CANCER THER, V5, P2398, DOI 10.1158/1535-7163.MCT-06-0167; Line-Edwige M, 2009, AFR J TRADIT COMPLEM, V6, P112; Mahindroo N, 2006, EXPERT OPIN THER PAT, V16, P647, DOI 10.1517/13543776.16.5.647; Maryanovich M, 2013, TRENDS CELL BIOL, V23, P129, DOI 10.1016/j.tcb.2012.09.007; Muller GA, 2012, NUCLEIC ACIDS RES, V40, P1561, DOI 10.1093/nar/gkr793; Muller GA, 2010, FEBS J, V277, P877, DOI 10.1111/j.1742-4658.2009.07508.x; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Ogasawara M, 2004, BIOL PHARM BULL, V27, P578, DOI 10.1248/bpb.27.578; Seo HR, 2008, J BIOL CHEM, V283, P15601, DOI 10.1074/jbc.M800987200; Shen SC, 2008, TOXICOL APPL PHARM, V229, P239, DOI 10.1016/j.taap.2008.01.018; Sun QR, 2010, J CELL PHYSIOL, V222, P421, DOI 10.1002/jcp.21982; Wang KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067297; Wang T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083264; Yang J, 2010, FREE RADICAL RES, V44, P792, DOI 10.3109/10715762.2010.481302; Yang JC, 2011, FREE RADICAL BIO MED, V51, P641, DOI 10.1016/j.freeradbiomed.2011.05.012; Zhang C, 2010, ANTI-CANCER DRUG, V21, P766, DOI 10.1097/CAD.0b013e32833d26a9; Zhou Jun, 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P65, DOI 10.2174/1568011053352569	35	56	59	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e99729	10.1371/journal.pone.0099729	http://dx.doi.org/10.1371/journal.pone.0099729			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959718	gold, Green Submitted, Green Published			2022-12-27	WOS:000338633900014
J	Fukumasu, H; Rochetti, AL; Pires, PRL; Silva, ER; Mesquita, LG; Strefezzi, RF; De Carvalho, DD; Dagli, ML				Fukumasu, Heidge; Rochetti, Arina L.; Pires, Pedro R. L.; Silva, Edson R.; Mesquita, Ligia G.; Strefezzi, Ricardo F.; De Carvalho, Daniel D.; Dagli, Maria L.			Constitutive Androstane Receptor Ligands Modulate the Anti-Tumor Efficacy of Paclitaxel in Non-Small Cell Lung Cancer Cells	PLOS ONE			English	Article							NUCLEAR RECEPTOR; ACTIVE/ANDROSTANE RECEPTOR; XENOBIOTIC RECEPTOR; GENE-EXPRESSION; CAR; PXR; METABOLISM; ACTIVATION; RESISTANCE; THERAPY	Background: Lung tumors are the leading cause of cancer deaths worldwide and paclitaxel has proven to be useful for patients with lung cancer, however, acquired resistance is a major problem. To overcome this problem, one promising option is the use of Constitutive Androstane Receptor (CAR) ligands in combination with chemotherapeutics against cancer cells. Therefore, we wish to elucidate the effects of CAR ligands on the antineoplastic efficacy of paclitaxel in lung cancer cells. Methodology/Principal Findings: Our results from cell viability assays exposing CAR agonist or inverse-agonist to mouse and human lung cancer cells modulated the antineoplastic effect of paclitaxel. The CAR agonists increased the effect of Paclitaxel in 6 of 7 lung cancer cell lines, whereas the inverse-agonist had no effect on paclitaxel cytotoxicity. Interestingly, the mCAR agonist TCPOBOP enhanced the expression of two tumor suppressor genes, namely WT1 and MGMT, which were additively enhanced in cells treated with CAR agonist in combination with paclitaxel. Also, in silico analysis showed that both paclitaxel and CAR agonist TCPOBOP docked into the mCAR structure but not the inverse agonist androstenol. Paclitaxel per se increases the expression of CAR in cancer cells. At last, we analyzed the expression of CAR in two public independent studies from The Cancer Genome Atlas (TCGA) of Non Small Cell Lung Cancer (NSCLC). CAR is expressed in variable levels in NSCLC samples and no association with overall survival was noted. Conclusions/Significance: Taken together, our results demonstrated that CAR agonists modulate the antineoplastic efficacy of paclitaxel in mouse and human cancer cell lines. This effect was probably related by the enhanced expression of two tumor suppressor genes, viz. WT1 and MGMT. Most of NSCLC cases present CAR gene expression turning it possible to speculate the use of CAR modulation by ligands along with Paclitaxel in NSCLC therapy.	[Fukumasu, Heidge; Rochetti, Arina L.; Pires, Pedro R. L.; Silva, Edson R.; Mesquita, Ligia G.; Strefezzi, Ricardo F.] Univ Sao Paulo, Sch Anim Sci & Food Engn, Dept Vet Med, Lab Comparat & Translat Oncol, Pirassununga, Brazil; [De Carvalho, Daniel D.] Univ Hlth Network, Princess Margaret Canc Ctr, Ontario Canc Inst, Campbell Family Canc Res Inst, Toronto, ON, Canada; [De Carvalho, Daniel D.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Dagli, Maria L.] Univ Sao Paulo, Sch Vet Med & Anim Sci, Dept Pathol, Lab Expt & Comparat Oncol, Sao Paulo, Brazil	Universidade de Sao Paulo; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; Universidade de Sao Paulo	Fukumasu, H (corresponding author), Univ Sao Paulo, Sch Anim Sci & Food Engn, Dept Vet Med, Lab Comparat & Translat Oncol, Pirassununga, Brazil.	fukumasu@usp.br	Fukumasu, Heidge/B-3866-2013; Strefezzi, Ricardo F/B-8754-2010; Mesquita, Ligia/C-4935-2012; De Carvalho, Daniel D/J-5503-2014; Pires, Pedro R L/N-4864-2016; Dagli, Maria/C-5809-2012; da Silva, Edson Roberto/G-3913-2012; De Carvalho, Daniel/J-5503-2014	Fukumasu, Heidge/0000-0002-3265-5090; Strefezzi, Ricardo F/0000-0002-8810-2815; De Carvalho, Daniel D/0000-0002-8572-5259; Pires, Pedro R L/0000-0003-0827-7445; Dagli, Maria/0000-0001-7031-6711; da Silva, Edson Roberto/0000-0002-6246-4404; Rochetti, Arina/0000-0002-1225-1953; De Carvalho, Daniel/0000-0003-0771-2265; Garcia Mesquita, Ligia/0000-0001-9938-4275	Fundacao de Apoio a Pesquisa do Estado de Sao Paulo (FAPESP) [2008/56584-2, 2009/11081-6, 2010/00535-3, 2010/05650-5, 2011/05690-0]	Fundacao de Apoio a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The authors thanks Fundacao de Apoio a Pesquisa do Estado de Sao Paulo (FAPESP) for financial support (process. numbers: 2008/56584-2; 2009/11081-6; 2010/00535-3; 2010/05650-5; 2011/05690-0. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Berhoune M, 2008, ANN PHARMACOTHER, V42, P1640, DOI 10.1345/aph.1L200; Bertilsson G, 1998, P NATL ACAD SCI USA, V95, P12208, DOI 10.1073/pnas.95.21.12208; Cancer multidrug resistance, 2000, NAT BIOTECHNOL S, V18, pIT18; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chakraborty S, 2011, BRIT J CANCER, V104, P448, DOI 10.1038/sj.bjc.6606064; Chen YK, 2012, BIOCHEM PHARMACOL, V83, P1112, DOI 10.1016/j.bcp.2012.01.030; Chu Q, 2005, LUNG CANCER, V50, P355, DOI 10.1016/j.lungcan.2005.06.010; Ekim M, 2011, GENET TEST MOL BIOMA, V15, P357, DOI 10.1089/gtmb.2010.0211; Esteller M, 2000, NEW ENGL J MED, V343, P1350, DOI 10.1056/NEJM200011093431901; Fukumasu H, 2013, MOL CARCINOGEN, V52, P497, DOI 10.1002/mc.21884; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Goodwin B, 2002, MOL PHARMACOL, V62, P359, DOI 10.1124/mol.62.2.359; Gu CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072633; Harmsen S, 2010, CANCER CHEMOTH PHARM, V66, P765, DOI 10.1007/s00280-009-1221-4; Hayashi S, 2012, CANCER INVEST, V30, P165, DOI 10.3109/07357907.2011.633291; Huang WD, 2005, MOL ENDOCRINOL, V19, P1646, DOI 10.1210/me.2004-0520; Kreso A, 2013, SCIENCE, V339, P543, DOI 10.1126/science.1227670; KUNTZ ID, 1982, J MOL BIOL, V161, P269, DOI 10.1016/0022-2836(82)90153-X; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malkinson AM, 1997, TOXICOLOGY, V123, P53, DOI 10.1016/S0300-483X(97)00108-X; Mennecier G, 2012, MOL CARCINOG; Moore LB, 2000, J BIOL CHEM, V275, P15122, DOI 10.1074/jbc.M001215200; Moreau A, 2014, MOL PHARM, V5, P35; Moustakas DT, 2014, J COMPUT AID MOL DES, V20, P601; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pondugula SR, 2013, CANCER LETT, V328, P1, DOI 10.1016/j.canlet.2012.08.030; Qiao EQ, 2013, ONCOL LETT, V5, P1093, DOI 10.3892/ol.2013.1149; RICHARDS FM, 1977, ANNU REV BIOPHYS BIO, V6, P151, DOI 10.1146/annurev.bb.06.060177.001055; Rozen S, 2000, Methods Mol Biol, V132, P365; Scripture CD, 2006, NAT REV CANCER, V6, P546, DOI 10.1038/nrc1887; Shan L, 2004, MOL CELL, V16, P907, DOI 10.1016/S1097-2765(04)00728-2; Shiao YH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007505; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sithanandam G, 2005, AM J RESP CELL MOL, V33, P490, DOI 10.1165/rcmb.2005-0049OC; Suino K, 2004, MOL CELL, V16, P893, DOI 10.1016/j.molcel.2004.11.036; Takizawa D, 2011, CARCINOGENESIS, V32, P576, DOI 10.1093/carcin/bgq277; Thomas CR, 1998, J CLIN ONCOL, V16, P1631, DOI 10.1200/JCO.1998.16.4.1631; Wada T, 2009, TRENDS ENDOCRIN MET, V20, P273, DOI 10.1016/j.tem.2009.03.003; Wang D, 2013, BLOOD, V121, P329, DOI 10.1182/blood-2012-06-436691; Willson TM, 2002, NAT REV DRUG DISCOV, V1, P259, DOI 10.1038/nrd753; Wu C, 2013, J THORAC ONCOL, V8, P1163, DOI 10.1097/JTO.0b013e31829f6a5f; Xu CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068837; Yamamoto Y, 2004, CANCER RES, V64, P7197, DOI 10.1158/0008-5472.CAN-04-1459	44	12	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e99484	10.1371/journal.pone.0099484	http://dx.doi.org/10.1371/journal.pone.0099484			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959746	Green Published, gold, Green Submitted			2022-12-27	WOS:000338633900006
J	Knapp, DJHF; McGovern, RA; Poon, AFY; Zhong, XY; Chan, D; Swenson, LC; Dong, WN; Harrigan, PR				Knapp, David J. H. F.; McGovern, Rachel A.; Poon, Art F. Y.; Zhong, Xiaoyin; Chan, Dennison; Swenson, Luke C.; Dong, Winnie; Harrigan, P. Richard			"Deep'' Sequencing Accuracy and Reproducibility Using Roche/454 Technology for Inferring Co-Receptor Usage in HIV-1	PLOS ONE			English	Article							MARAVIROC; MUTATIONS; CANCER; TRIAL; RNA	Next generation, "deep'', sequencing has increasing applications both clinically and in disparate fields of research. This study investigates the accuracy and reproducibility of "deep'' sequencing as applied to co-receptor prediction using the V3 loop of Human Immunodeficiency Virus-1. Despite increasing use in HIV co-receptor prediction, the accuracy and reproducibility of deep sequencing technology, and the factors which can affect it, have received only a limited level of investigation. To accomplish this, repeated deep sequencing results were generated using the Roche GS-FLX (454) from a number of sources including a non-homogeneous clinical sample (N = 47 replicates over 18 deep sequencing runs), and a large clinical cohort from the MOTIVATE and A400129 studies (N = 1521). For repeated measurements of a non-homogeneous clinical sample, increasing input copy number both decreased variance in the measured proportion of non-R5 using virus (p << 0.001 and 0.02 for single replicates and triplicates respectively) and increased measured viral diversity (p < 0.001; multiple measures). Detection of sequences with a mean abundance less than 1% abundance showed a 2 fold increase in median coefficient of variation (CV) in repeated measurements of a non-homogeneous clinical sample, and a 2.7 fold increase in CV in the MOTIVATE/A400129 dataset compared to sequences with >= 1% abundance. An unexpected source of error included read position, with low accuracy reads occurring more frequently towards the edge of sequencing regions (p << 0.001). Overall, the primary source of variability was sampling error caused by low input copy number/minority species prevalence, though other sources of error including sequence intrinsic, temporal, and read-position related errors were detected.	[Knapp, David J. H. F.; McGovern, Rachel A.; Poon, Art F. Y.; Zhong, Xiaoyin; Chan, Dennison; Swenson, Luke C.; Dong, Winnie; Harrigan, P. Richard] BC Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Harrigan, P. Richard] Univ British Columbia, Fac Med, Vancouver, BC, Canada	B.C. Centre for Excellence in HIV/AIDS; University of British Columbia	Harrigan, PR (corresponding author), BC Ctr Excellence HIV AIDS, Vancouver, BC, Canada.	prharrigan@cfenet.ubc.ca	Poon, Art/W-9811-2019	Poon, Art/0000-0003-3779-154X; Knapp, David JHF/0000-0002-2161-9959	Canadian Institutes of Health Research (CIHR) [200802HFE]; CIHR/GSK; Pfizer; Glaxo-Smith Kline; Abbott; Merck; Virco; Monogram	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR/GSK(Canadian Institutes of Health Research (CIHR)); Pfizer(Pfizer); Glaxo-Smith Kline(GlaxoSmithKline); Abbott(Abbott Laboratories); Merck(Merck & Company); Virco; Monogram	Funding for this paper was provided by CIHR and by Pfizer/ViiV healthcare. Art F.Y. Poon is funded by a Canadian Institutes of Health Research (CIHR) Fellowships Award in HIV/AIDS Research (200802HFE). PRH is funded by a CIHR/GSK Research Chair in Clinical Virology and has received grants from, served as an ad hoc advisor to, or spoke at various events sponsored by: Pfizer, Glaxo-Smith Kline, Abbott, Merck, Virco and Monogram. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer J, 2009, AIDS, V23, P1209, DOI 10.1097/QAD.0b013e32832b4399; Balwierz PJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r79; Beerenwinkel N, 2011, CURR OPIN VIROL, V1, P413, DOI 10.1016/j.coviro.2011.07.008; Berger EA, 1998, NATURE, V391, P240, DOI 10.1038/34571; Bunnik EM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002106; Campbell PJ, 2008, P NATL ACAD SCI USA, V105, P13081, DOI 10.1073/pnas.0801523105; Cornils K, 2013, EXP HEMATOL, V41, P28, DOI 10.1016/j.exphem.2012.09.003; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; Este JA, 2007, LANCET, V370, P81, DOI 10.1016/S0140-6736(07)61052-6; Gulick RM, 2008, NEW ENGL J MED, V359, P1429, DOI 10.1056/NEJMoa0803152; Jabara CB, 2011, P NATL ACAD SCI USA, V108, P20166, DOI 10.1073/pnas.1110064108; Jensen MA, 2003, J VIROL, V77, P13376, DOI 10.1128/JVI.77.24.13376-13388.2003; Knapp DJ, 2012, J CLIN MICROBIOL; Kohlmann A, 2011, LEUKEMIA, V25, P1840, DOI 10.1038/leu.2011.155; Lu R, 2011, NAT BIOTECHNOL, V29, P928, DOI 10.1038/nbt.1977; Ma QLC, 2012, CURR OPIN GENET DEV, V22, P3, DOI 10.1016/j.gde.2012.01.008; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mild M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022741; Minoche AE, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r112; Saag M, 2009, J INFECT DIS, V199, P1638, DOI 10.1086/598965; Swenson LC, 2009, EUR AIDS CLIN SOC CO; Swenson LC, 2011, CLIN INFECT DIS, V53, P732, DOI 10.1093/cid/cir493; Swenson LC, 2011, J INFECT DIS, V203, P237, DOI 10.1093/infdis/jiq030; Swenson LC, 2010, JAIDS-J ACQ IMM DEF, V54, P506, DOI 10.1097/QAI.0b013e3181d0558f	25	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e99508	10.1371/journal.pone.0099508	http://dx.doi.org/10.1371/journal.pone.0099508			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959876	Green Published, gold, Green Submitted			2022-12-27	WOS:000338633900008
J	Kogiso, T; Nagahara, H; Hashimoto, E; Ariizumi, S; Yamamoto, M; Shiratori, K				Kogiso, Tomomi; Nagahara, Hikaru; Hashimoto, Etsuko; Ariizumi, Shunichi; Yamamoto, Masakazu; Shiratori, Keiko			Efficient Induction of Apoptosis by Wee1 Kinase Inhibition in Hepatocellular Carcinoma Cells	PLOS ONE			English	Article							PHOSPHORYLATION SITES; THERAPEUTIC TARGET; ACTIVATING KINASE; PROTEIN-KINASE; P34CDC2 KINASE; CYCLE ARREST; CANCER; CHECKPOINT; IDENTIFICATION; RADIOSENSITIZATION	Transforming growth factor-beta 1 (TGF-beta 1) potently inhibits human hepatocellular carcinoma (HCC) cell growth. Here we demonstrated that TGF-beta 1-induced apoptosis is mediated by decreased phosphorylation of cdc2 at Tyr15 accompanied by down-regulation of Wee1 kinase expression. As expected from these results, a Wee1 kinase inhibitor efficiently induced apoptosis in HCC cells in the absence of TGF-beta 1 treatment. In surgically resected samples, Wee1 kinase was expressed in moderately to poorly differentiated HCC, whereas no Wee1 kinase expression was observed in non-cancerous tissue, including cirrhotic tissue. Our results suggest that Wee1 kinase inhibitors may be a practical novel therapeutic option against advanced HCC.	[Kogiso, Tomomi; Hashimoto, Etsuko; Shiratori, Keiko] Tokyo Womens Med Univ, Dept Internal Med, Inst Gastroenterol, Tokyo, Japan; [Nagahara, Hikaru] Tokyo Womens Med Univ, Aoyama Hosp, Tokyo, Japan; [Ariizumi, Shunichi; Yamamoto, Masakazu] Tokyo Womens Med Univ, Inst Gastroenterol, Dept Surg, Tokyo, Japan	Tokyo Women's Medical University; Tokyo Women's Medical University; Tokyo Women's Medical University	Kogiso, T (corresponding author), Tokyo Womens Med Univ, Dept Internal Med, Inst Gastroenterol, Tokyo, Japan.	kogiso@ige.twmu.ac.jp	Ariizumi, Shunichi/AAG-3829-2020		Ministry of Education, Culture, Sports, Science, and Technology, Japan [26461024-0001]; Nakayama Cancer Research Institute Scholarship; Itoe Okamoto Scholarship Grant; Hisako Yamakawa Award; Takako Satake Award at Tokyo Women's Medical University	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nakayama Cancer Research Institute Scholarship; Itoe Okamoto Scholarship Grant; Hisako Yamakawa Award; Takako Satake Award at Tokyo Women's Medical University	Support for this study was received from Grants-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (#26461024-0001), a Nakayama Cancer Research Institute Scholarship, an Itoe Okamoto Scholarship Grant, the Hisako Yamakawa Award and the Takako Satake Award at Tokyo Women's Medical University to T.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Block TM, 2003, ONCOGENE, V22, P5093, DOI 10.1038/sj.onc.1206557; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Chang CC, 2004, P NATL ACAD SCI USA, V101, P13239, DOI 10.1073/pnas.0405407101; Choi KS, 1999, J BIOL CHEM, V274, P31775, DOI 10.1074/jbc.274.45.31775; Claassen GF, 2000, P NATL ACAD SCI USA, V97, P9498, DOI 10.1073/pnas.150006697; Gauthier A, 2012, HEPATOL RES; Hamer PCD, 2011, CLIN CANCER RES, V17, P4200, DOI 10.1158/1078-0432.CCR-10-2537; Harris PS, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-72; Jang CW, 2002, NAT CELL BIOL, V4, P51, DOI 10.1038/ncb731; Janssen A, 2011, ONCOGENE, V30, P2799, DOI 10.1038/onc.2011.30; KREK W, 1992, NEW BIOL, V4, P323; KREK W, 1991, EMBO J, V10, P3331, DOI 10.1002/j.1460-2075.1991.tb04897.x; KREK W, 1991, EMBO J, V10, P305, DOI 10.1002/j.1460-2075.1991.tb07951.x; Leijen S, 2010, CURR CLIN PHARMACOL, V5, P186, DOI 10.2174/157488410791498824; Li J, 2002, RADIAT RES, V157, P322, DOI 10.1667/0033-7587(2002)157[0322:WTTIGP]2.0.CO;2; Liu L, 2006, CANCER RES, V66, P11851, DOI 10.1158/0008-5472.CAN-06-1377; Llovet JM, 2003, HEPATOLOGY, V37, P429, DOI 10.1053/jhep.2003.50047; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Nagahara H, 1999, P NATL ACAD SCI USA, V96, P14961, DOI 10.1073/pnas.96.26.14961; NORBURY C, 1991, EMBO J, V10, P3321, DOI 10.1002/j.1460-2075.1991.tb04896.x; O'Connor DS, 2002, CANCER CELL, V2, P43, DOI 10.1016/S1535-6108(02)00084-3; Perlman R, 2001, NAT CELL BIOL, V3, P708, DOI 10.1038/35087019; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Porter CC, 2012, LEUKEMIA, V26, P1266, DOI 10.1038/leu.2011.392; RUSSELL P, 1987, CELL, V49, P559, DOI 10.1016/0092-8674(87)90458-2; SOLOMON MJ, 1992, MOL BIOL CELL, V3, P13, DOI 10.1091/mbc.3.1.13; Wang YL, 2001, CANCER RES, V61, P8211; Yilmaz M, 2011, EMBO J, V30, P4489, DOI 10.1038/emboj.2011.319	30	23	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100495	10.1371/journal.pone.0100495	http://dx.doi.org/10.1371/journal.pone.0100495			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24960176	Green Published, Green Submitted, gold			2022-12-27	WOS:000338633900052
J	Liu, YB; Pan, JY; Jin, KK; Liu, CL; Wang, J; Chen, L; Chen, L; Yuan, JD				Liu, Yangbo; Pan, Jingye; Jin, Keke; Liu, Cailong; Wang, Jing; Chen, Li; Chen, Lei; Yuan, Jiandong			Analysis of 30 Patients with Acupuncture-Induced Primary Inoculation Tuberculosis	PLOS ONE			English	Article							CUTANEOUS TUBERCULOSIS	Primary inoculation tuberculosis is a skin condition that develops at the site of inoculation of Mycobacterium tuberculosis in tuberculosis-free individuals. This report describes the diagnosis, treatment and >1 year follow-up of 30 patients presenting with acupuncture-induced primary inoculation tuberculosis. Our data provide a deeper insight into this rare route of infection of tuberculosis. We also review effective treatment options.	[Liu, Yangbo; Liu, Cailong; Wang, Jing; Chen, Lei; Yuan, Jiandong] Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China; [Pan, Jingye] Wenzhou Med Univ, Affiliated Hosp 1, Intens Care Unit, Wenzhou, Zhejiang, Peoples R China; [Jin, Keke] Wenzhou Med Univ, Wenzhou, Zhejiang, Peoples R China; [Chen, Li] Univ Melbourne, Melbourne, Vic, Australia	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; University of Melbourne	Yuan, JD (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China.	chenlei@wzhospital.cn; liuybwz@me.com		yangbo, liu/0000-0002-1180-4974; CHEN, LI/0000-0002-6717-5708				American Thoracic Society C and Infectious Diseases Society of America, 2003, MMWR RECOMMENDATIONS; [Anonymous], 2011, GLOB TUB CONTR 2011; BLOCH AB, 1989, CLIN CHEST MED, V10, P297; Centers for Disease Control and Prevention, MANT TB SKINT FAC GU; Jardin OD, 2010, ENFERM INFEC MICR CL, V28, P596, DOI 10.1016/j.eimc.2009.08.003; GOETTE DK, 1978, ARCH DERMATOL, V114, P567, DOI 10.1001/archderm.114.4.567; HAIM S, 1978, CUTIS, V21, P643; Ho C. K., 2006, Hong Kong Medical Journal, V12, P272; Lee JJ, 2003, INT J TUBERC LUNG D, V7, P569; Lu Hong-qing, 2012, Zhongguo Zhen Jiu, V32, P570; Luca Simona, 2013, Maedica (Bucur), V8, P53; Otu J, 2008, J INFECT DEV COUNTR, V2, P200; Rook G, 2000, ANN NY ACAD SCI, V917, P913; Rook GAW, 1997, PSYCHONEUROENDOCRINO, V22, pS109, DOI 10.1016/S0306-4530(97)00014-0; Saitoh H, 2000, Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi, V11, P19; Tappeiner G, 2008, FITZPATRICKS DERMATO; Tigoulet F, 2003, Bull Soc Pathol Exot, V96, P362; Walker LA, 2002, COMPLEMENT THER MED, V10, P8, DOI 10.1054/ctim.2002.0522; Wong Hoong-Wai, 2005, Australas J Dermatol, V46, P84, DOI 10.1111/j.1440-0960.2005.00147.x; Zhao Xiu-Ping, 2009, Zhongguo Zhen Jiu, V29, P10	20	3	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100377	10.1371/journal.pone.0100377	http://dx.doi.org/10.1371/journal.pone.0100377			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959854	Green Submitted, Green Published, gold			2022-12-27	WOS:000338633900041
J	Xie, X; Wu, QH; Hao, YH; Yin, H; Fu, WQ; Ning, N; Xu, L; Liu, CJ; Li, Y; Kang, Z; He, CZ; Liu, GX				Xie, Xin; Wu, Qunhong; Hao, Yanhua; Yin, Hui; Fu, Wenqi; Ning, Ning; Xu, Ling; Liu, Chaojie; Li, Ye; Kang, Zheng; He, Changzhi; Liu, Guoxiang			Identifying Determinants of Socioeconomic Inequality in Health Service Utilization among Patients with Chronic Non-Communicable Diseases in China	PLOS ONE			English	Article							CARE UTILIZATION; RURAL CHINA; HORIZONTAL INEQUITY; EQUITY; ACCESS; POLICY	Background: People with chronic non-communicable diseases (NCD) are particularly vulnerable to socioeconomic inequality due to their long-term expensive health needs. This study aimed to assess socioeconomic-related inequality in health service utilization among NCD patients in China and to analyze factors associated with this disparity. Methods: Data were taken from the 2008 Chinese National Health Survey, in which a multiple stage stratified random sampling method was employed to survey 56,456 households. We analyzed the distribution of actual use, need-expected use, and need-standardized usage of outpatient services (over a two-week period) and inpatient services (over one-year) across different income groups in 27,233 adult respondents who reported as having a NCD. We used a concentration index to measure inequality in the distribution of health services, which was expressed as HI (Horizontal Inequity Index) for need-standardized use of services. A non-linear probit regression model was employed to detect inequality across socioeconomic groups. Results: Pro-rich inequity in health services among NCD patients was more substantial than the average population. A higher degree of pro-rich inequity (HI = 0.253) was found in inpatient services compared to outpatient services (HI = 0.089). Despite a greater need for health services amongst those of lower socio-economic status, their actual use is much less than their more affluent counterparts. Health service underuse by the poor and overuse by the affluent are evident. Household income disparity was the greatest inequality factor in NCD service use for both outpatients (71.3%) and inpatients (108%), more so than health insurance policies. Some medical insurance schemes, such as the MIUE, actually made a pro-rich contribution to health service inequality (16.1% for outpatient and 12.1% for inpatient). Conclusions: Inequality in health services amongst NCD patients in China remains largely determined by patient financial capability. The current insurance schemes are insufficient to address this inequity. A comprehensive social policy that encompasses a more progressive taxation package and redistribution of social capital as well as pro-poor welfare is needed.	[Xie, Xin; Wu, Qunhong; Hao, Yanhua; Yin, Hui; Fu, Wenqi; Ning, Ning; Li, Ye; Kang, Zheng; He, Changzhi; Liu, Guoxiang] Harbin Med Univ, Sch Hlth Management, Dept Social Med, Harbin, Heilongjiang, Peoples R China; [Xie, Xin] Harbin Med Univ Daqing, Dept Humanities & Social Sci, Daqing, Heilongjiang, Peoples R China; [Xu, Ling] Minist Hlth, Ctr Hlth Stat & Informat, Beijing, Peoples R China; [Xie, Xin; Wu, Qunhong; Hao, Yanhua; Yin, Hui; Fu, Wenqi; Ning, Ning; Li, Ye; Kang, Zheng; Liu, Guoxiang] Harbin Med Univ, Modern Hlth Management Tech Dev & Applicat Lab, Harbin, Heilongjiang, Peoples R China; [Liu, Chaojie] La Trobe Univ, Sch Publ Hlth, Melbourne, Vic, Australia	Harbin Medical University; Harbin Medical University; Harbin Medical University; La Trobe University	Wu, QH (corresponding author), Harbin Med Univ, Sch Hlth Management, Dept Social Med, Harbin, Heilongjiang, Peoples R China.	wuqunhong@163.com; hyhyjw@126.com	Liu, Chaojie/Q-6915-2018; hao, yan/HGB-0465-2022	Liu, Chaojie/0000-0003-0877-0424; 	Key National Natural Science Fund [71333003]; China Medical Board [09-979]	Key National Natural Science Fund; China Medical Board	This work was supported by the Key National Natural Science Fund (71333003) and the China Medical Board (09-979). Website of Key National Natural Science Fund (71333003): http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list. Website of China Medical Board (09-979):http://chinamedicalboard.org/grants/evaluation_and_capacity_building_chinas_hospital_reform_pilots-09_979. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Zaineh M, 2011, SOC SCI MED, V72, P133, DOI 10.1016/j.socscimed.2010.10.018; Anson O, 2004, HEALTH PLACE, V10, P75, DOI 10.1016/S1353-8292(03)00048-0; Center for Health Statistics and Information of MOH, 2009, AN REP 2008 NAT HLTH; Chinese Diabetes Society, 2012, CHINESE J DIABETES, V20, P1; Chinese National Center for Cardiovascular Diseases, 2011, REP CARD DIS CHIN 20; Chou WL, 2009, HEALTH ECON, V18, pS137, DOI 10.1002/hec.1511; d'Uva TB, 2009, J HEALTH ECON, V28, P280, DOI 10.1016/j.jhealeco.2008.09.008; Fang PQ, 2010, HEALTH POLICY, V94, P14, DOI 10.1016/j.healthpol.2009.08.002; Feng XL, 2012, B WORLD HEALTH ORGAN, V90, P30, DOI 10.2471/BLT.11.090399; Feng XL, 2011, B WORLD HEALTH ORGAN, V89, P432, DOI 10.2471/BLT.10.085274; Feng Xing Lin, 2011, Environmental Health and Preventive Medicine, V16, P209, DOI 10.1007/s12199-010-0187-5; Gao J, 2001, HEALTH POLICY PLANN, V16, P302, DOI 10.1093/heapol/16.3.302; Hajizadeh M, 2012, APPL ECON LETT, V19, P1765, DOI 10.1080/13504851.2012.659337; Hosseinpoor AR, 2006, INT J EPIDEMIOL, V35, P1211, DOI 10.1093/ije/dyl164; Hu J, 2007, CHIN J PREVCONTRCHRO, V15, P189; Hu SL, 2008, LANCET, V372, P1846, DOI 10.1016/S0140-6736(08)61368-9; Hu Z., 2011, CHINA EC Q, V10, P1423; Jian W, 2009, HEALTH AFFAIR, V29, P2189; Jing SS, 2010, CHINESE HLTH EC, V29, P35; Li Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093253; Lisheng L, 2011, ZHONGHUA XIN XUE GUA, P701; Liu C, 2003, CLOSING GAP POLICY R; Liu GG, 2002, SOC SCI MED, V55, P1779, DOI 10.1016/S0277-9536(01)00306-9; Liu S, 2011, PUBLIC HEALTH, V125, P669, DOI 10.1016/j.puhe.2011.08.004; Liu YL, 1999, SOC SCI MED, V49, P1349, DOI 10.1016/S0277-9536(99)00207-5; Lu JFR, 2007, SOC SCI MED, V64, P199, DOI 10.1016/j.socscimed.2006.08.033; Luo JH, 2009, HEALTH POLICY, V93, P111, DOI 10.1016/j.healthpol.2009.06.003; Ma X, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-44; McGrail KM, 2009, AM J PUBLIC HEALTH, V99, P1856, DOI 10.2105/AJPH.2007.129361; Meng Q, 2012, LANCET, V379, P805, DOI 10.1016/S0140-6736(12)60278-5; Ministry of Health, 2005, CHIN HLTH STAT DIG 2; Ministry of Health-People's Republic of China, 2010, CHIN HLTH STAT YB 20; Ramesh M, 2008, POLICY SOC, V27, P129, DOI DOI 10.1016/J.POLSOC.2008.09.004; Shi WX, 2010, INT J EQUITY HEALTH, V9, DOI 10.1186/1475-9276-9-7; Shin H, 2010, INT J EQUITY HEALTH, V9, DOI 10.1186/1475-9276-9-17; Somkotra T, 2011, ASIA-PAC J PUBLIC HE, V23, P980, DOI 10.1177/1010539509360674; Song L, 2010, CHINESE MED J-PEKING, V123, P664, DOI 10.3760/cma.j.issn.0366-6999.2010.06.005; State Council, 2012, PLANS DEEP REF HEALT; Sun P, 2012, SOC SCI MED, V74, P84, DOI 10.1016/j.socscimed.2011.10.010; Sun Q, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-42; Sun XJ, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-2; van Doorslaer E, 2004, HEALTH ECON, V13, P629, DOI 10.1002/hec.919; van Doorslaer E, 2003, J HEALTH ECON, V22, P61, DOI 10.1016/S0167-6296(02)00080-2; Van Doorslaer E, 2004, INCOME RELATED INEQU, P109; WAGSTAFF A, 1991, SOC SCI MED, V33, P545, DOI 10.1016/0277-9536(91)90212-U; WAGSTAFF A, 1991, J HEALTH ECON, V10, P169, DOI 10.1016/0167-6296(91)90003-6; Wagstaff A, 2003, J ECONOMETRICS, V112, P207, DOI 10.1016/S0304-4076(02)00161-6; Wang LD, 2005, LANCET, V366, P1821, DOI 10.1016/S0140-6736(05)67344-8; Wang X, 2010, HUMAN RESOURCES, V8, P51; World Bank, 2006, MEAS IN HLTH SERV DE; World Health Organization, WHO HLTH SYST; Wu ZC, 2012, MATERN CHILD HLTH J, V16, P501, DOI 10.1007/s10995-011-0773-1; Xu J, 2010, J HUAZHONG U SCI-MED, V30, P141, DOI 10.1007/s11596-010-0201-6; Yip W, 2009, SOC SCI MED, V68, P201, DOI 10.1016/j.socscimed.2008.09.066; Yu BR, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-116; Zhang LY, 2010, TROP MED INT HEALTH, V15, P468, DOI 10.1111/j.1365-3156.2010.02469.x; Zhou ZL, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-201	57	40	42	7	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100231	10.1371/journal.pone.0100231	http://dx.doi.org/10.1371/journal.pone.0100231			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK7UT	24960168	Green Submitted, Green Published, gold			2022-12-27	WOS:000338633900028
J	Zeng, J; Zhao, DY; Yu, ZB; Huang, R; Wu, QLL				Zeng, Jin; Zhao, Dayong; Yu, Zhongbo; Huang, Rui; Wu, Qinglong L.			Temperature Responses of Ammonia-Oxidizing Prokaryotes in Freshwater Sediment Microcosms	PLOS ONE			English	Article							COMMUNITY STRUCTURE; LAKE TAIHU; ARCHAEA; BACTERIA; DIVERSITY; NITRIFICATION; ABUNDANCE; SOIL; GROWTH; CULTIVATION	In order to investigate the effects of temperature on the abundances and community compositions of ammonia-oxidizing archaea (AOA) and bacteria (AOB), lake microcosms were constructed and incubated at 15 degrees C, 25 degrees C and 35 degrees C for 40 days, respectively. Temperature exhibited different effects on the abundance and diversity of archaeal and bacterial amoA gene. The elevated temperature increased the abundance of archaeal amoA gene, whereas the abundance of bacterial amoA gene decreased. The highest diversity of bacterial amoA gene was found in the 25 degrees C treatment sample. However, the 25 degrees C treatment sample maintained the lowest diversity of archaeal amoA gene. Most of the archaeal amoA sequences obtained in this study affiliated with the Nitrosopumilus cluster. Two sequences obtained from the 15 degrees C treatment samples were affiliated with the Nitrosotalea cluster. N. oligotropha lineage was the most dominant bacterial amoA gene group. Several sequences affiliated to Nitrosospira and undefined N. europaea/NC. mobilis like lineage were found in the pre-incubation and 25 degrees C treatment groups.	[Zeng, Jin; Wu, Qinglong L.] Chinese Acad Sci, Nanjing Inst Geog & Limnol, State Key Lab Lake Sci & Environm, Nanjing, Jiangsu, Peoples R China; [Zhao, Dayong; Yu, Zhongbo] Hohai Univ, State Key Lab Hydrol Water Resources & Hydraul En, Nanjing, Jiangsu, Peoples R China; [Zhao, Dayong; Yu, Zhongbo; Huang, Rui] Hohai Univ, Coll Hydrol & Water Resources, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Sciences; Nanjing Institute of Geography & Limnology, CAS; Hohai University; Hohai University	Zeng, J (corresponding author), Chinese Acad Sci, Nanjing Inst Geog & Limnol, State Key Lab Lake Sci & Environm, Nanjing, Jiangsu, Peoples R China.	jzeng@niglas.ac.cn	Zeng, Jin/AAQ-7810-2020		National Natural Science Foundation of China [41101052, 31225004, 41371098, U1202231]; Natural Science Foundation of Jiangsu Province, China [BK2011876]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province)	This work was supported by the National Natural Science Foundation of China (41101052, 31225004, 41371098, U1202231) and Natural Science Foundation of Jiangsu Province, China (BK2011876). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Avrahami S, 2003, ENVIRON MICROBIOL, V5, P691, DOI 10.1046/j.1462-2920.2003.00457.x; Beman JM, 2006, APPL ENVIRON MICROB, V72, P7767, DOI 10.1128/AEM.00946-06; Cao HL, 2011, ANTON LEEUW INT J G, V100, P545, DOI 10.1007/s10482-011-9610-1; Chen GY, 2009, RES MICROBIOL, V160, P173, DOI 10.1016/j.resmic.2009.01.003; Dang HY, 2010, APPL ENVIRON MICROB, V76, P4691, DOI 10.1128/AEM.02563-09; de Bie MJM, 2001, AQUAT MICROB ECOL, V23, P225, DOI 10.3354/ame023225; de la Torre JR, 2008, ENVIRON MICROBIOL, V10, P810, DOI 10.1111/j.1462-2920.2007.01506.x; Fierer N, 2009, MICROB ECOL, V58, P435, DOI 10.1007/s00248-009-9517-9; Francis CA, 2005, P NATL ACAD SCI USA, V102, P14683, DOI 10.1073/pnas.0506625102; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; Hatzenpichler R, 2008, P NATL ACAD SCI USA, V105, P2134, DOI 10.1073/pnas.0708857105; Hatzenpichler R, 2012, APPL ENVIRON MICROB, V78, P7501, DOI 10.1128/AEM.01960-12; He J, 2007, ENVIRON MICROBIOL, V9, P2364, DOI 10.1111/j.1462-2920.2007.01358.x; Horz HP, 2004, P NATL ACAD SCI USA, V101, P15136, DOI 10.1073/pnas.0406616101; Hou J, 2013, WATER RES, V47, P2285, DOI 10.1016/j.watres.2013.01.042; Jantti H, 2011, AQUAT MICROB ECOL, V63, P171, DOI 10.3354/ame01492; Jia ZJ, 2009, ENVIRON MICROBIOL, V11, P1658, DOI 10.1111/j.1462-2920.2009.01891.x; Jin X., 1990, SURVEY SPECIFICATION, P208; Koops HP, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 5, THIRD EDITION, P778, DOI 10.1007/0-387-30745-1_36; Kowalchuk GA, 2001, ANNU REV MICROBIOL, V55, P485, DOI 10.1146/annurev.micro.55.1.485; Lehtovirta-Morley LE, 2011, P NATL ACAD SCI USA, V108, P15892, DOI 10.1073/pnas.1107196108; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Offre P, 2009, FEMS MICROBIOL ECOL, V70, P99, DOI 10.1111/j.1574-6941.2009.00725.x; Park HD, 2004, WATER RES, V38, P3275, DOI 10.1016/j.watres.2004.04.047; Pester M, 2012, ENVIRON MICROBIOL, V14, P525, DOI 10.1111/j.1462-2920.2011.02666.x; Racz L, 2010, BIORESOURCE TECHNOL, V101, P6454, DOI 10.1016/j.biortech.2010.03.058; Reigstad LJ, 2008, FEMS MICROBIOL ECOL, V64, P167, DOI 10.1111/j.1574-6941.2008.00466.x; Rotthauwe JH, 1997, APPL ENVIRON MICROB, V63, P4704, DOI 10.1128/AEM.63.12.4704-4712.1997; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Seitzinger SP, 1990, DENITRIFICATION AQUA; Spang A, 2010, TRENDS MICROBIOL, V18, P331, DOI 10.1016/j.tim.2010.06.003; Stark JM, 1996, BIOGEOCHEMISTRY, V35, P433, DOI 10.1007/BF02183035; Starry OS, 2005, J N AM BENTHOL SOC, V24, P753, DOI 10.1899/05-015.1; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thamdrup B, 1998, AQUAT MICROB ECOL, V15, P191, DOI 10.3354/ame015191; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tourna M, 2008, ENVIRON MICROBIOL, V10, P1357, DOI 10.1111/j.1462-2920.2007.01563.x; Tourna M, 2011, P NATL ACAD SCI USA, V108, P8420, DOI 10.1073/pnas.1013488108; Treusch AH, 2005, ENVIRON MICROBIOL, V7, P1985, DOI 10.1111/j.1462-2920.2005.00906.x; Urakawa H, 2008, APPL ENVIRON MICROB, V74, P894, DOI 10.1128/AEM.01529-07; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Wu YC, 2013, APPL ENVIRON MICROB, V79, P3076, DOI 10.1128/AEM.00061-13; Wu YC, 2010, ENV MICROBIOL REP, V2, P569, DOI 10.1111/j.1758-2229.2010.00146.x; Zeng J, 2009, WORLD J MICROB BIOT, V25, P225, DOI 10.1007/s11274-008-9883-3; Zeng J, 2012, CAN J MICROBIOL, V58, P1018, DOI [10.1139/w2012-078, 10.1139/W2012-078]; Zhao WD, 2011, GEOMICROBIOL J, V28, P149, DOI 10.1080/01490451003753076	47	26	31	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100653	10.1371/journal.pone.0100653	http://dx.doi.org/10.1371/journal.pone.0100653			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959960	Green Submitted, gold, Green Published			2022-12-27	WOS:000338633900067
J	Huang, YY; Meng, T; Wang, SZ; Zhang, H; Mues, G; Qin, CL; Feng, JQ; D'Souza, RN; Lu, YB				Huang, Yanyu; Meng, Tian; Wang, Suzhen; Zhang, Hua; Mues, Gabriele; Qin, Chunlin; Feng, Jian Q.; D'Souza, Rena N.; Lu, Yongbo			Twist1-and Twist2-Haploinsufficiency Results in Reduced Bone Formation	PLOS ONE			English	Article							SAETHRE-CHOTZEN-SYNDROME; OSTEOBLAST DIFFERENTIATION; DORSOVENTRAL PATTERN; GENE-EXPRESSION; ZYGOTIC GENE; GROWTH; FGF; TRANSCRIPTION; ROLES; MOUSE	Background: Twist1 and Twist2 are highly homologous bHLH transcription factors that exhibit extensive highly overlapping expression profiles during development. While both proteins have been shown to inhibit osteogenesis, only Twist1 haploinsufficiency is associated with the premature synostosis of cranial sutures in mice and humans. On the other hand, biallelic Twist2 deficiency causes only a focal facial dermal dysplasia syndrome or additional cachexia and perinatal lethality in certain mouse strains. It is unclear how these proteins cooperate to synergistically regulate bone formation. Methods: Twist1 floxed mice (Twist1(f/f)) were bred with Twist2-Cre knock-in mice (Twist2(Cre/+)) to generate Twist1 and Twist2 haploinsufficient mice (Twist1(f/+); Twist2(Cre/+)). X-radiography, micro-CT scans, alcian blue/alizarin red staining, trap staining, BrdU labeling, immunohistochemistry, in situ hybridizations, real-time PCR and dual luciferase assay were employed to investigate the overall skeletal defects and the bone-associated molecular and cellular changes of Twist1(f/+); Twist2(Cre/+) mice. Results: Twist1 and Twist2 haploinsufficient mice did not present with premature ossification and craniosynostosis; instead they displayed reduced bone formation, impaired proliferation and differentiation of osteoprogenitors. These mice exhibited decreased expressions of Fgf2 and Fgfr1-4 in bone, resulting in a down-regulation of FGF signaling. Furthermore, in vitro studies indicated that both Twist1 and Twist2 stimulated 4.9 kb Fgfr2 promoter activity in the presence of E12, a Twist binding partner. Conclusion: These data demonstrated that Twist1-and Twist2-haploinsufficiency caused reduced bone formation due to compromised FGF signaling.	[Huang, Yanyu; Meng, Tian; Wang, Suzhen; Zhang, Hua; Mues, Gabriele; Qin, Chunlin; Feng, Jian Q.; D'Souza, Rena N.; Lu, Yongbo] Texas A&M Univ, Baylor Coll Dent, Dept Biomed Sci, Dallas, TX 75252 USA; [Huang, Yanyu; Meng, Tian; Wang, Suzhen; Zhang, Hua; Mues, Gabriele; Qin, Chunlin; Feng, Jian Q.; D'Souza, Rena N.; Lu, Yongbo] Texas A&M Univ, Baylor Coll Dent, Ctr Craniofacial Res & Diag, Dallas, TX USA; [Huang, Yanyu] Wuhan Univ, Sch & Hosp Stomatol, Minist Educ, State Key Lab Breeding Base Basic Sci Stomatol Hu, Wuhan 430072, Peoples R China; [Huang, Yanyu] Wuhan Univ, Sch & Hosp Stomatol, Minist Educ, Key Lab Oral Biomed, Wuhan 430072, Peoples R China; [D'Souza, Rena N.] Univ Utah, Sch Dent, Salt Lake City, UT USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Wuhan University; Wuhan University; Utah System of Higher Education; University of Utah	Lu, YB (corresponding author), Texas A&M Univ, Baylor Coll Dent, Dept Biomed Sci, Dallas, TX 75252 USA.	ylu@bcd.tamhsc.edu		Zhang, Hua/0000-0002-6789-9343; Lu, Yongbo/0000-0003-3692-1736; D'Souza, Rena/0000-0002-1505-5173	National Institute of Dental and Craniofacial Research/National Institutes of Health [DE021773, DE013368, DE005092]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R03DE021773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013368] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institute of Dental and Craniofacial Research/National Institutes of Health grants DE021773 to YL, DE013368 to RD, and DE005092 to CQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bialek P, 2004, DEV CELL, V6, P423, DOI 10.1016/S1534-5807(04)00058-9; Bottcher RT, 2005, ENDOCR REV, V26, P63, DOI 10.1210/er.2003-0040; Bourgeois P, 1998, HUM MOL GENET, V7, P945, DOI 10.1093/hmg/7.6.945; Cao ZG, 2012, J BONE MINER RES, V27, P1080, DOI 10.1002/jbmr.1552; Carver EA, 2002, ANAT REC, V268, P90, DOI 10.1002/ar.10124; Chen YT, 2007, GENESIS, V45, P588, DOI 10.1002/dvg.20332; Connerney J, 2008, DEV BIOL, V318, P323, DOI 10.1016/j.ydbio.2008.03.037; Connerney J, 2006, DEV DYNAM, V235, P1345, DOI 10.1002/dvdy.20717; ElGhouzzi V, 1997, NAT GENET, V15, P42; Feng JQ, 2003, J DENT RES, V82, P776, DOI 10.1177/154405910308201003; Franco HL, 2011, NUCLEIC ACIDS RES, V39, P1177, DOI 10.1093/nar/gkq890; Gibson MP, 2013, J BIOL CHEM, V288, P7204, DOI 10.1074/jbc.M112.445775; Gitelman I, 1997, DEV BIOL, V189, P205, DOI 10.1006/dbio.1997.8614; Guenou H, 2005, HUM MOL GENET, V14, P1429, DOI 10.1093/hmg/ddi152; Hayashi M, 2007, J CELL SCI, V120, P1350, DOI 10.1242/jcs.000067; Isenmann S, 2009, STEM CELLS, V27, P2457, DOI 10.1002/stem.181; Lee MS, 1999, J CELL BIOCHEM, V75, P566, DOI 10.1002/(SICI)1097-4644(19991215)75:4<566::AID-JCB3>3.0.CO;2-0; Li CL, 1999, HUM MOL GENET, V8, P35, DOI 10.1093/hmg/8.1.35; LI L, 1995, DEV BIOL, V172, P280, DOI 10.1006/dbio.1995.0023; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu YB, 2012, DEV DYNAM, V241, P1708, DOI 10.1002/dvdy.23858; Marie PJ, 2003, GENE, V316, P23, DOI 10.1016/S0378-1119(03)00748-0; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Miraoui H, 2010, J CELL BIOCHEM, V110, P1147, DOI 10.1002/jcb.22628; Qin Q, 2012, CELL RES, V22, P90, DOI 10.1038/cr.2011.144; Rangiani A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042329; Rice DPC, 2000, DEVELOPMENT, V127, P1845; SIMPSON P, 1983, GENETICS, V105, P615; Siyam A, 2012, BIOCHEM BIOPH RES CO, V424, P641, DOI 10.1016/j.bbrc.2012.07.037; Sosic D, 2003, CELL, V112, P169, DOI 10.1016/S0092-8674(03)00002-3; THISSE B, 1987, NUCLEIC ACIDS RES, V15, P3439, DOI 10.1093/nar/15.8.3439; Tukel T, 2010, AM J HUM GENET, V87, P289, DOI 10.1016/j.ajhg.2010.07.009; WOLF C, 1991, DEV BIOL, V143, P363, DOI 10.1016/0012-1606(91)90086-I; Yousfi M, 2002, HUM MOL GENET, V11, P359, DOI 10.1093/hmg/11.4.359; Yu K, 2003, DEVELOPMENT, V130, P3063, DOI 10.1242/dev.00491; Zhang R, 2011, J BONE MINER RES, V26, P1047, DOI 10.1002/jbmr.294	36	15	20	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e99331	10.1371/journal.pone.0099331	http://dx.doi.org/10.1371/journal.pone.0099331			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971743	Green Submitted, Green Published, gold			2022-12-27	WOS:000338512200009
J	Khosravi, R; Sodek, KL; Xu, WP; Bais, MV; Saxena, D; Faibish, M; Trackman, PC				Khosravi, Roozbeh; Sodek, Katharine L.; Xu, Wan-Peng; Bais, Manish V.; Saxena, Debashree; Faibish, Michael; Trackman, Philip C.			A Novel Function for Lysyl Oxidase in Pluripotent Mesenchymal Cell Proliferation and Relevance to Inflammation-Associated Osteopenia	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; FORKHEAD-BOX-O; OXIDATIVE STRESS; BETA-CATENIN; CROSS-LINKS; GROWTH-FACTOR; BONE-DISEASE; APOPTOSIS; OSTEOPOROSIS; OSTEOBLASTS	Lysyl oxidase is a multifunctional enzyme required for collagen biosynthesis. Various growth factors regulate lysyl oxidase during osteoblast differentiation, subject to modulation by cytokines such as TNF-alpha in inflammatory osteopenic disorders including diabetic bone disease. Canonical Wnt signaling promotes osteoblast development. Here we investigated the effect of Wnt3a and TNF-alpha on lysyl oxidase expression in pluripotent C3H10T1/2 cells, bone marrow stromal cells, and committed osteoblasts. Lysyl oxidase was up-regulated by a transcriptional mechanism 3-fold in C3H10T1/2 cells, and 2.5-fold in bone marrow stromal cells. A putative functional TCF/LEF element was identified in the lysyl oxidase promoter. Interestingly, lysyl oxidase was not up-regulated in committed primary rat calvarial-or MC3T3-E1 osteoblasts. TNF-alpha down-regulated lysyl oxidase both in Wnt3a-treated and in non-treated C3H10T1/2 cells by a post-transcriptional mechanism mediated by miR203. Non-differentiated cells do not produce a collagen matrix; thus, a novel biological role for lysyl oxidase in pluripotent cells was investigated. Lysyl oxidase shRNAs effectively silenced lysyl oxidase expression, and suppressed the growth of C3H10T1/2 cells by 50%, and blocked osteoblast differentiation. We propose that interference with lysyl oxidase expression under excess inflammatory conditions such as those that occur in diabetes, osteoporosis, or rheumatoid arthritis can result in a diminished pool of pluripotent cells which ultimately contributes to osteopenia.	[Khosravi, Roozbeh; Sodek, Katharine L.; Xu, Wan-Peng; Bais, Manish V.; Saxena, Debashree; Faibish, Michael; Trackman, Philip C.] Boston Univ, Henry M Goldman Sch Dent Med, Dept Mol & Cell Biol, Boston, MA 02215 USA	Boston University	Trackman, PC (corresponding author), Boston Univ, Henry M Goldman Sch Dent Med, Dept Mol & Cell Biol, Boston, MA 02215 USA.	trackman@bu.edu	Xu, Wanpeng/M-4664-2019; Trackman, Philip C/AAX-9280-2021	Trackman, Philip C/0000-0001-5064-614X; Khosravi, Roozbeh/0000-0002-9070-0339; Bais, Manish/0000-0003-4198-7377	NIH/NIDCR [R01 DE014066, DE 011004]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014066] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE011004, R29DE011004] Funding Source: NIH RePORTER	NIH/NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by NIH/NIDCR R01 DE014066 and DE 011004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alikhani M, 2005, J BIOL CHEM, V280, P12096, DOI 10.1074/jbc.M412171200; Almeida M, 2007, J BIOL CHEM, V282, P27298, DOI 10.1074/jbc.M702811200; [Anonymous], AM J PHYSIOL CELL PH; Atsawasuwan P, 2008, J BIOL CHEM, V283, P34229, DOI 10.1074/jbc.M803142200; Bais MV, 2014, ONCOGENE IN PRESS; Baker AM, 2013, ONCOGENE, V32, P1863, DOI 10.1038/onc.2012.202; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; BOUILLON R, 1991, CALCIFIED TISSUE INT, V49, P155, DOI 10.1007/BF02556109; Brannon M, 1997, GENE DEV, V11, P2359, DOI 10.1101/gad.11.18.2359; Cagnetta V, 2012, CLIN CASES MINER BON, V9, P85; Choi SS, 2009, LIFE SCI, V84, P908, DOI 10.1016/j.lfs.2009.04.001; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Goetz R, 2013, NAT REV MOL CELL BIO, V14, P166, DOI 10.1038/nrm3528; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Graves DT, 2006, J DENT RES, V85, P15, DOI 10.1177/154405910608500103; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Huang HY, 2009, P NATL ACAD SCI USA, V106, P12670, DOI 10.1073/pnas.0906266106; Jackson A, 2005, BONE, V36, P585, DOI 10.1016/j.bone.2005.01.007; KAGAN HM, 1991, AM J RESP CELL MOL, V5, P206, DOI 10.1165/ajrcmb/5.3.206; Khosla S, 2008, J CLIN INVEST, V118, P421, DOI 10.1172/JCI33612; Khosravi R, 2014, BONE, V58, P33, DOI 10.1016/j.bone.2013.10.001; Li WD, 2003, J CELL BIOCHEM, V88, P152, DOI 10.1002/jcb.10304; Liu RK, 2006, AM J PATHOL, V168, P757, DOI 10.2353/ajpath.2006.050907; Lucero HA, 2008, J BIOL CHEM, V283, P24103, DOI 10.1074/jbc.M709897200; Manolagas SC, 2007, MOL ENDOCRINOL, V21, P2605, DOI 10.1210/me.2007-0259; Merlotti D, 2010, NUTR METAB CARDIOVAS, V20, P683, DOI 10.1016/j.numecd.2010.07.008; Monroe DG, 2012, GENE, V492, P1, DOI 10.1016/j.gene.2011.10.044; Nakerakanti Sashidhar, 2012, Open Rheumatol J, V6, P156, DOI 10.2174/1874312901206010156; Nusse R, 2012, EMBO J, V31, P2670, DOI 10.1038/emboj.2012.146; Oxlund H, 1996, BONE, V19, P479, DOI 10.1016/S8756-3282(96)00283-9; OXLUND H, 1995, BONE, V17, pS365, DOI 10.1016/8756-3282(95)00328-B; Payne SL, 2005, CANCER RES, V65, P11429, DOI 10.1158/0008-5472.CAN-05-1274; Pischon N, 2009, CALCIFIED TISSUE INT, V85, P119, DOI 10.1007/s00223-009-9252-8; Rauner M, 2013, INT ARCH ALLERGY IMM, V160, P114, DOI 10.1159/000342426; Reynaud C, 1999, CELL MOL BIOL, V45, P1237; Saito M, 2006, OSTEOPOROSIS INT, V17, P1514, DOI 10.1007/s00198-006-0155-5; Saito Mitsuru, 2013, Front Endocrinol (Lausanne), V4, P72, DOI 10.3389/fendo.2013.00072; Saux CJ, 1997, J CELL BIOCHEM, V64, P328, DOI 10.1002/(SICI)1097-4644(199702)64:2<328::AID-JCB14>3.0.CO;2-E; Semenov M, 2005, J BIOL CHEM, V280, P26770, DOI 10.1074/jbc.M504308200; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Vora SR, 2010, J BIOL CHEM, V285, P7384, DOI 10.1074/jbc.M109.033597; Yeh LCC, 2010, GROWTH FACTORS, V28, P117, DOI 10.3109/08977190903512586	42	17	17	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100669	10.1371/journal.pone.0100669	http://dx.doi.org/10.1371/journal.pone.0100669			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971753	Green Published, Green Submitted, gold			2022-12-27	WOS:000338512200050
J	Vilanova, C; Marin, M; Baixeras, J; Latorre, A; Porcar, M				Vilanova, Cristina; Marin, Maria; Baixeras, Joaquin; Latorre, Amparo; Porcar, Manuel			Selecting Microbial Strains from Pine Tree Resin: Biotechnological Applications from a Terpene World	PLOS ONE			English	Article							ACID-DEGRADING BACTERIA; PSEUDOMONAS-AERUGINOSA; PULP; BIODEGRADATION; BIOSYNTHESIS; DEGRADATION; DIVERSITY; CHEMICALS; SEQUENCE	Resin is a chemical and physical defensive barrier secreted by many plants, especially coniferous trees, with insecticidal and antimicrobial properties. The degradation of terpenes, the main components accounting for the toxicity of resin, is highly relevant for a vast range of biotechnological processes, including bioremediation. In the present work, we used a resin-based selective medium in order to study the resin-tolerant microbial communities associated with the galls formed by the moth Retinia resinella; as well as resin from Pinus sylvestris forests, one of the largest ecosystems on Earth and a yet-unexplored source of terpene-degrading microorganisms. The taxonomic and functional diversity of the cultivated, resin-tolerant fraction of the whole microbiota were unveiled by high-throughput sequencing, which resulted in the detection of more than 40 bacterial genera among the terpene-degrading microorganisms, and a range of genes involved in the degradation of different terpene families. We further characterized through culture-based approaches and transcriptome sequencing selected microbial strains, including Pseudomonas sp., the most abundant species in both environmental resin and R. resinella resin-rich galls, and three fungal species, and experimentally confirmed their ability to degrade resin and also other terpene-based compounds and, thus, their potential use in biotechnological applications involving terpene catabolism.	[Vilanova, Cristina; Marin, Maria; Baixeras, Joaquin; Latorre, Amparo; Porcar, Manuel] Univ Valencia, Cavanilles Inst Biodivers & Evolut Biol, Valencia, Spain; [Latorre, Amparo] CSISP, Unidad Mixta Invest Genom & Salud, Valencia, Spain; [Porcar, Manuel] Univ Valencia, Fundacio Gen, Valencia, Spain	University of Valencia; University of Valencia	Porcar, M (corresponding author), Univ Valencia, Cavanilles Inst Biodivers & Evolut Biol, Valencia, Spain.	manuel.porcar@uv.es	Porcar, Manuel/D-2503-2010; Almela, Joaquin Baixeras/L-1734-2014; Latorre, Amparo/E-4997-2015	Porcar, Manuel/0000-0002-7916-9479; Almela, Joaquin Baixeras/0000-0002-6092-0496; Latorre, Amparo/0000-0002-9146-7284	Ministerio de Ciencia e Innovacion, Spain [BFU2012-39816-C02-01]; FEDER funds; Ministerio de Ciencia e Innovacion [CGL2008-00605]; FPU fellowship from Ministerio de Educacion (Spain)	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FEDER funds(European Commission); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); FPU fellowship from Ministerio de Educacion (Spain)	Financial support was provided by grant BFU2012-39816-C02-01 (Ministerio de Ciencia e Innovacion, Spain) co-financed by FEDER funds to Amparo Latorre and CGL2008-00605 (Ministerio de Ciencia e Innovacion) to Joaquin Baixeras. Cristina Vilanova is a recipient of a FPU fellowship from the Ministerio de Educacion (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AS, 2013, APPL ENVIRON MICROB, V79, P3468, DOI 10.1128/AEM.00068-13; BICHO PA, 1995, APPL ENVIRON MICROB, V61, P3245, DOI 10.1128/AEM.61.9.3245-3250.1995; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; BUIJTENE.JP, 1972, CAN ENTOMOL, V104, P215, DOI 10.4039/Ent104215-2; COX CD, 1985, INFECT IMMUN, V48, P130, DOI 10.1128/IAI.48.1.130-138.1985; DAGLEY S, 1975, AM SCI, V63, P681; de Carvalho CCCR, 2006, BIOTECHNOL ADV, V24, P134, DOI 10.1016/j.biotechadv.2005.08.004; Douglas AE, 2013, J CHEM ECOL, V39, P952, DOI 10.1007/s10886-013-0308-x; Gershenzon J, 2007, NAT CHEM BIOL, V3, P408, DOI 10.1038/nchembio.2007.5; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; GRAYER RJ, 1994, PHYTOCHEMISTRY, V37, P19, DOI 10.1016/0031-9422(94)85005-4; HANOVER JW, 1975, ANNU REV ENTOMOL, V20, P75, DOI 10.1146/annurev.en.20.010175.000451; HELIOVAARA K, 1988, ENTOMOL GEN, V14, P37; HIMEJIMA M, 1992, J CHEM ECOL, V18, P1809, DOI 10.1007/BF02751105; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; LEUENBERGER C, 1985, WATER RES, V19, P885, DOI 10.1016/0043-1354(85)90147-2; de Araujo DAM, 2011, LIFE SCI, V89, P540, DOI 10.1016/j.lfs.2011.04.020; Marpeau A, 1989, TREES-STRUCT FUNCT, V3, P220, DOI 10.1007/BF00225355; Martin VJJ, 1999, ARCH MICROBIOL, V172, P131, DOI 10.1007/s002030050752; Martin VJJ, 2000, J BACTERIOL, V182, P3784, DOI 10.1128/JB.182.13.3784-3793.2000; Mathee K, 2008, P NATL ACAD SCI USA, V105, P3100, DOI 10.1073/pnas.0711982105; Mela F, 2011, ISME J, V5, P1494, DOI 10.1038/ismej.2011.29; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Mohn WW, 1999, SYST APPL MICROBIOL, V22, P68, DOI 10.1016/S0723-2020(99)80029-0; Noguchi H, 2008, DNA RES, V15, P387, DOI 10.1093/dnares/dsn027; Ochsner UA, 2002, MOL MICROBIOL, V45, P1277, DOI 10.1046/j.1365-2958.2002.03084.x; Pearce RB, 1996, NEW PHYTOL, V132, P203, DOI 10.1111/j.1469-8137.1996.tb01842.x; Redondo-Nieto M, 2012, J BACTERIOL, V194, P1273, DOI 10.1128/JB.06601-11; Savluchinske-Feio S, 2006, APPL MICROBIOL BIOT, V72, P430, DOI 10.1007/s00253-006-0517-0; Smith DJ, 2007, J BACTERIOL, V189, P6195, DOI 10.1128/JB.00179-07; SUNTIO LR, 1988, CHEMOSPHERE, V17, P1249, DOI 10.1016/0045-6535(88)90080-X; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tomlin ES, 2000, TREE PHYSIOL, V20, P1087; Trapp S, 2001, ANNU REV PLANT PHYS, V52, P689, DOI 10.1146/annurev.arplant.52.1.689; Wang JF, 2012, CHEM COMMUN, V48, P916, DOI 10.1039/c1cc16432e; Wilson AEJ, 1996, APPL ENVIRON MICROB, V62, P3146, DOI 10.1128/AEM.62.9.3146-3151.1996; Xu MF, 2011, J ASIAN NAT PROD RES, V13, P260, DOI 10.1080/10286020.2010.550882; Yermakova TG, 1997, CHEM SUSTAINABLE DEV, V5, P149; Yu Z, 1999, MICROB ECOL, V38, P114, DOI 10.1007/s002489900163; Zhang B.C., 1994, INDEX EC IMPORTANT L; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3	41	13	13	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100740	10.1371/journal.pone.0100740	http://dx.doi.org/10.1371/journal.pone.0100740			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971580	Green Submitted, gold, Green Published			2022-12-27	WOS:000338512200055
J	Guo, WX; Tsujimura, K; Otsuka, IM; Irie, K; Igarashi, K; Nakashima, K; Zhao, XY				Guo, Weixiang; Tsujimura, Keita; Otsuka, Maky, I; Irie, Koichiro; Igarashi, Katsuhide; Nakashima, Kinichi; Zhao, Xinyu			VPA Alleviates Neurological Deficits and Restores Gene Expression in a Mouse Model of Rett Syndrome	PLOS ONE			English	Article							CPG-BINDING PROTEIN-2; VALPROIC ACID; DNA METHYLATION; MECP2; DISORDERS; NEURONS; MICE; MUTATIONS; EPILEPSY; DISEASE	Rett syndrome (RTT) is a devastating neurodevelopmental disorder that occurs once in every 10,000-15,000 live female births. Despite intensive research, no effective cure is yet available. Valproic acid (VPA) has been used widely to treat mood disorder, epilepsy, and a growing number of other disorders. In limited clinical studies, VPA has also been used to control seizure in RTT patients with promising albeit somewhat unclear efficacy. In this study we tested the effect of VPA on the neurological symptoms of RTT and discovered that short-term VPA treatment during the symptomatic period could reduce neurological symptoms in RTT mice. We found that VPA restores the expression of a subset of genes in RTT mouse brains, and these genes clustered in neurological disease and developmental disorder networks. Our data suggest that VPA could be used as a drug to alleviate RTT symptoms.	[Guo, Weixiang; Zhao, Xinyu] Univ Wisconsin, Sch Med & Publ Hlth, Dept Neurosci, Madison, WI USA; [Guo, Weixiang; Zhao, Xinyu] Univ Wisconsin, Sch Med & Publ Hlth, Waisman Ctr, Madison, WI USA; [Tsujimura, Keita; Irie, Koichiro; Nakashima, Kinichi] Kyushu Univ, Grad Sch Med Sci, Dept Stem Cell Biol & Med, Fukuoka 812, Japan; [Otsuka, Maky, I; Igarashi, Katsuhide] Hoshi Univ, Sch Pharm & Pharmaceut Sci, Life Sci Tokyo Adv Res Ctr L StaR, Tokyo 142, Japan	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Kyushu University; Hoshi University	Igarashi, K (corresponding author), Hoshi Univ, Sch Pharm & Pharmaceut Sci, Life Sci Tokyo Adv Res Ctr L StaR, Tokyo 142, Japan.	k-igarashi@hoshi.ac.jp; kin1@scb.med.kyushu-u.ac.jp; xzhao69@wisc.edu		Tsujimura, Keita/0000-0002-7464-6133	National Institutes of Health (NIH) [R01MH080434, R01MH078972]; International Rett Syndrome Foundation (IRSF) [2755]; NIH [P30HD03352]; University of Wisconsin Center for Stem Cells and Regenerative Medicine; Ministry of Education, Culture, Sports, Science and Technology of Japan; Neurological and Psychiatric Disorders of NCNP [24-12]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078972, R01MH080434] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [25281028] Funding Source: KAKEN	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Rett Syndrome Foundation (IRSF); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Wisconsin Center for Stem Cells and Regenerative Medicine; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Neurological and Psychiatric Disorders of NCNP; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the National Institutes of Health (NIH) (R01MH080434 and R01MH078972 to X. Zhao), the International Rett Syndrome Foundation (IRSF, 2755 to X. Zhao), and a Center grant from the NIH to the Waisman Center (P30HD03352 to X. Zhao). W. Guo was funded by a postdoctoral fellowship from University of Wisconsin Center for Stem Cells and Regenerative Medicine. This work was also supported in part by a Grant-in-Aid for Scientific Research (A) (to K. Nakashima), a Grant-in-Aid for Scientific Research on Innovative Areas: Foundation of Synapse and Neurocircuit Pathology (to K. Nakashima), all from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by an Intramural Research Grant (24-12) for Neurological and Psychiatric Disorders of NCNP (to K. Nakashima). This work was also supported in part by a Grant-in-Aid for Challenging Exploratory Research and a Grant-in-Aid for Scientific Research (B) (to K. Igarashi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Keilani MA, 2011, ACTA NEUROL BELG, V111, P328; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Ben-Shachar S, 2009, HUM MOL GENET, V18, P2431, DOI 10.1093/hmg/ddp181; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chateauvieux S, 2010, J BIOMEDICINE BIOTEC, V2010; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Chien WH, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-23; Chiu CT, 2013, PHARMACOL REV, V65, P105, DOI 10.1124/pr.111.005512; Compton AG, 2008, AM J HUM GENET, V83, P714, DOI 10.1016/j.ajhg.2008.10.022; Faulkner MA, 2013, PHARMACOTHERAPY, V33, P330, DOI 10.1002/phar.1201; Gottlicher M, 2004, Ann Hematol, V83 Suppl 1, pS91; Grozinger CM, 2002, CHEM BIOL, V9, P3, DOI 10.1016/S1074-5521(02)00092-3; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Huppke P, 2007, EUR J PAEDIATR NEURO, V11, P10, DOI 10.1016/j.ejpn.2006.09.003; Kim H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025174; KOCHWESER J, 1980, NEW ENGL J MED, V302, P661, DOI 10.1056/NEJM198003203021204; Krajnc N, 2011, J CHILD NEUROL, V26, P1429, DOI 10.1177/0883073811408422; Kriaucionis S, 2003, HUM MOL GENET, V12, pR221, DOI 10.1093/hmg/ddg286; Leonard H, 2010, ARCH DIS CHILD, V95, P444, DOI 10.1136/adc.2008.148932; Maunakea AK, 2013, CELL RES; Neul Jeffrey Lorenz, 2012, Dialogues Clin Neurosci, V14, P253; Palumbo O, 2013, GENE, V516, P107, DOI 10.1016/j.gene.2012.12.073; Shahbazian MD, 2002, NEURON, V35, P243, DOI 10.1016/S0896-6273(02)00768-7; Smrt RD, 2007, NEUROBIOL DIS, V27, P77, DOI 10.1016/j.nbd.2007.04.005; Smrt RD, 2011, HUM MOL GENET, V20, P1834, DOI 10.1093/hmg/ddr066; Szulwach KE, 2010, J CELL BIOL, V189, P127, DOI 10.1083/jcb.200908151; Trapp S, 2011, EXP PHYSIOL, V96, P451, DOI 10.1113/expphysiol.2010.055848; Vecsler M, 2010, EPIGENETICS-US, V5, P61, DOI 10.4161/epi.5.1.10630; Yazdani M, 2012, STEM CELLS, V30, P2128, DOI 10.1002/stem.1180; Young JI, 2005, P NATL ACAD SCI USA, V102, P17551, DOI 10.1073/pnas.0507856102; Zhao YT, 2013, NEUROBIOL DIS, V59, P257, DOI 10.1016/j.nbd.2013.08.001	33	11	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100215	10.1371/journal.pone.0100215	http://dx.doi.org/10.1371/journal.pone.0100215			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968028	Green Submitted, Green Published, gold			2022-12-27	WOS:000338280800029
J	Hung, SF; Hsieh, CM; Chen, YC; Wang, YC; Ho, HO; Sheu, MT				Hung, Sheng-Feng; Hsieh, Chien-Ming; Chen, Ying-Chen; Wang, Yu-Chun; Ho, Hsiu-O; Sheu, Ming-Thau			Characterizations of Plasticized Polymeric Film Coatings for Preparing Multiple-Unit Floating Drug Delivery Systems (muFDDSs) with Controlled-Release Characteristics	PLOS ONE			English	Article							GASTRORETENTIVE DOSAGE FORMS; IN-VITRO EVALUATION; HELICOBACTER-PYLORI; GASTROINTESTINAL-TRACT; MECHANICAL-PROPERTIES; MICROSPHERES; DESIGN; MICROBALLOONS; DENSITY; INVITRO	Effervescent multiple-unit floating drug delivery systems (muFDDSs) consisting of drug (lorsartan)- and effervescent (sodium bicarbonate)-containing pellets were characterized in this study. The mechanical properties (stress and strain at rupture, Young's modulus, and toughness) of these plasticized polymeric films of acrylic (Eudragit RS, RL, and NE) and cellulosic materials (ethyl cellulose (EC), and Surelease) were examined by a dynamic mechanical analyzer. Results demonstrated that polymeric films prepared from Surelease and EC were brittle with less elongation compared to acrylic films. Eudragit NE films were very flexible in both the dry and wet states. Because plasticizer leached from polymeric films during exposure to the aqueous medium, plasticization of wet Eudragit RS and RL films with 15% triethyl citrate (TEC) or diethyl phthalate (DEP) resulted in less elongation. DEP might be the plasticizer of choice among the plasticizers examined in this study for Eudragit RL to provide muFDDSs with a short time for all pellets to float (TPF) and a longer period of floating. Eudragit RL and RS at a 1:1 ratio plasticized with 15% DEP were optimally selected as the coating membrane for the floating system. Although the release of losartan from the pellets was still too fast as a result of losartan being freely soluble in water, muFDDSs coated with Eudragit RL and RS at a 1:1 ratio might have potential use for the sustained release of water-insoluble or the un-ionized form of drugs from gastroretentive drug delivery systems.	[Hung, Sheng-Feng; Hsieh, Chien-Ming; Chen, Ying-Chen; Wang, Yu-Chun; Ho, Hsiu-O; Sheu, Ming-Thau] Taipei Med Univ, Coll Pharm, Sch Pharm, Taipei, Taiwan; [Sheu, Ming-Thau] Taipei Med Univ Hosp, Clin Res Ctr, Taipei, Taiwan; [Sheu, Ming-Thau] Taipei Med Univ Hosp, Tradit Herbal Med Res Ctr, Taipei, Taiwan; [Hsieh, Chien-Ming] Providence Univ, Dept Cosmet Sci, Taichung, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; Providence University - Taiwan	Ho, HO (corresponding author), Taipei Med Univ, Coll Pharm, Sch Pharm, Taipei, Taiwan.	hsiuoho@tmu.edu.tw; mingsheu@tmu.edu.tw		Hsieh, Chien-Ming/0000-0002-7204-4681				Bardonnet PL, 2006, J CONTROL RELEASE, V111, P1, DOI 10.1016/j.jconrel.2005.10.031; BECHGAARD H, 1978, J PHARM PHARMACOL, V30, P690, DOI 10.1111/j.2042-7158.1978.tb13366.x; Bi YX, 1996, CHEM PHARM BULL, V44, P2121; BODMEIER R, 1994, PHARMACEUT RES, V11, P882, DOI 10.1023/A:1018942127524; Chen YC, 2012, J PHARM SCI-US, V101, P3811, DOI 10.1002/jps.23279; Dixit N, 2011, J CURR PHARM RES, V7, P6; Hamdani J, 2006, INT J PHARM, V322, P96, DOI 10.1016/j.ijpharm.2006.05.052; Iannuccelli V, 1998, INT J PHARM, V174, P47, DOI 10.1016/S0378-5173(98)00229-4; ICHIKAWA M, 1991, J PHARM SCI, V80, P1062, DOI 10.1002/jps.2600801113; Jain SK, 2005, J CONTROL RELEASE, V107, P300, DOI 10.1016/j.jconrel.2005.06.007; Kawano Yoshio, 2002, Polímeros, V12, P96, DOI 10.1590/S0104-14282002000200008; KAWASHIMA Y, 1991, J CONTROL RELEASE, V16, P279, DOI 10.1016/0168-3659(91)90004-W; Krogel I, 1999, INT J PHARM, V187, P175, DOI 10.1016/S0378-5173(99)00189-1; Munday DL, 2003, DRUG DEV IND PHARM, V29, P575, DOI 10.1081/DDC-120018646; Pawar VK, 2011, DRUG DELIV, V18, P97, DOI 10.3109/10717544.2010.520354; Prajapati VD, 2013, J CONTROL RELEASE, V168, P151, DOI 10.1016/j.jconrel.2013.02.028; Rouge N, 1996, INT J PHARMACEUT, V136, P117, DOI 10.1016/0378-5173(96)85200-8; Sato Y, 2004, INT J PHARM, V275, P97, DOI 10.1016/j.ijpharm.2004.01.036; SETA Y, 1988, INT J PHARM, V41, P245, DOI 10.1016/0378-5173(88)90201-3; Sica DA, 2005, CLIN PHARMACOKINET, V44, P797, DOI 10.2165/00003088-200544080-00003; Singh BN, 2000, J CONTROL RELEASE, V63, P235, DOI 10.1016/S0168-3659(99)00204-7; Streubel A, 2003, J MICROENCAPSUL, V20, P329, DOI 10.1080/0265204021000058384; Sungthonjeen S, 2008, EUR J PHARM BIOPHARM, V69, P255, DOI 10.1016/j.ejpb.2007.09.013; Talukder R, 2004, DRUG DEV IND PHARM, V30, P405, DOI 10.1081/DDC-120030935; Umamaheshwari RB, 2003, J PHARM PHARMACOL, V55, P1607, DOI 10.1211/0022357022223; Waterman KC, 2007, PHARM DEV TECHNOL, V12, P1, DOI 10.1080/10837450601168680; Wu JS, 2001, EUR J PHARM SCI, V12, P417, DOI 10.1016/S0928-0987(00)00196-2; Wurster DE, 2003, J PHARM SCI-US, V92, P2008, DOI 10.1002/jps.10454; Yang LB, 1999, J CONTROL RELEASE, V57, P215, DOI 10.1016/S0168-3659(98)00066-2	29	12	12	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100321	10.1371/journal.pone.0100321	http://dx.doi.org/10.1371/journal.pone.0100321			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967594	Green Submitted, Green Published, gold			2022-12-27	WOS:000338280800034
J	Miller, MA; Wright, H; Ji, C; Cappuccio, FP				Miller, Michelle A.; Wright, Hayley; Ji, Chen; Cappuccio, Francesco P.			Cross-Sectional Study of Sleep Quantity and Quality and Amnestic and Non-Amnestic Cognitive Function in an Ageing Population: The English Longitudinal Study of Ageing (ELSA)	PLOS ONE			English	Article							OLDER-ADULTS; DAYTIME SLEEPINESS; MEMORY IMPAIRMENT; UNITED-STATES; WHITEHALL II; LATER LIFE; DEMENTIA; DURATION; COHORT; ASSOCIATION	Background: The aim was to investigate the association between sleep disturbances and cognitive function in younger and older individuals from an ageing population. Methods: 3,968 male and 4,821 female white participants, aged 50 years and over, from the English Longitudinal Study of Ageing (ELSA) were studied. Information on sleep quality and quantity as well as both amnestic (memory, ACF) and non-amnestic (non-memory, nACF) function was available at Wave 4 (2008). Analysis of covariance was used to evaluate the relationship between sleep and cognitive function. Results: After adjustment for multiple confounders in the younger group (50-64 years) duration of sleep explained 15.2% of the variance in ACF (p = 0.003) and 20.6% of nACF (p = 0.010). In the older group (65+ years) the estimates were 21.3% (p<0.001) and 25.6% (p<0.001), respectively. For sleep quality, there was a statistically significant association between sleep quality and both ACF (p<0.001) and nACF (p<0.001) in the older age group, but not in the younger age group (p = 0.586 and p = 0.373, respectively; interaction between age and sleep quality in the study sample including both age groups: p<0.001 for ACF and p = 0.018 for nACF). Sleep quality explained between 15.1% and 25.5% of the variance in cognition. The interaction with age was independent of duration of sleep. At any level of sleep duration there was a steeper association between sleep quality and ACF in the older than the younger group. Conclusions: The associations between sleep disturbances and cognitive function vary between younger and older adults. Prospective studies will determine the temporal relationships between sleep disturbances and changes in cognition in different age groups.	[Miller, Michelle A.; Wright, Hayley; Ji, Chen; Cappuccio, Francesco P.] Univ Warwick, Warwick Med Sch, Div Mental Hlth & Wellbeing, Coventry CV4 7AL, W Midlands, England	University of Warwick	Miller, MA (corresponding author), Univ Warwick, Warwick Med Sch, Div Mental Hlth & Wellbeing, Coventry CV4 7AL, W Midlands, England.	Michelle.miller@warwick.ac.uk	Miller, Michelle A/D-1840-2009	Miller, Michelle A/0000-0002-6696-0923; Wright, Hayley/0000-0003-2199-8255; Ji, Chen/0000-0003-4919-3299	Economic and Social Research Council (ESRC) [ES/K002910/1]; ESRC [ES/K002910/1] Funding Source: UKRI; Economic and Social Research Council [ES/K002910/1] Funding Source: researchfish	Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	MAM and FPC received funding from the The Economic and Social Research Council (ESRC) grant number ES/K002910/1(www.esrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The study is part of the Sleep, Health and Society Research Programme of The University of Warwick.	Activity and Health Research, 1992, ALL DUNB NAT FITN SU; Banks J, 2011, EC J LONDON, V120, pF381; Behncke S, 2012, HEALTH ECON, V21, P282, DOI 10.1002/hec.1712; Bierman EJM, 2005, AM J GERIAT PSYCHIAT, V13, P686, DOI 10.1176/appi.ajgp.13.8.686; Blackwell T, 2014, SLEEP IN PRESS; Blackwell T, 2011, SLEEP, V34, P1347, DOI 10.5665/SLEEP.1276; Bliwise DL., 2005, PRINCIPLES PRACTICE, V4th ed., P24; Boeve BF, 1998, NEUROLOGY, V51, P363, DOI 10.1212/WNL.51.2.363; Busse A, 2003, ACTA NEUROL SCAND, V108, P71, DOI 10.1034/j.1600-0404.2003.00118.x; Cappuccio FP, 2010, SLEEP HLTH SOC AETIO, DOI 10.1093/acprof: oso/9780199566594.001.0001/acprof-9780199566594; Cricco M, 2001, J AM GERIATR SOC, V49, P1185, DOI 10.1046/j.1532-5415.2001.49235.x; Elwood PC, 2011, J EPIDEMIOL COMMUN H, V65, P820, DOI 10.1136/jech.2009.100503; Faubel R, 2009, J SLEEP RES, V18, P427, DOI 10.1111/j.1365-2869.2009.00759.x; Ferrie JE, 2011, SLEEP, V34, P565, DOI 10.1093/sleep/34.5.565; Fischer P, 2007, NEUROLOGY, V68, P288, DOI 10.1212/01.wnl.0000252358.03285.9d; Foley D, 2001, J AM GERIATR SOC, V49, P1628, DOI 10.1111/j.1532-5415.2001.49271.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Hayes TL, 2014, ALZ DIS ASSOC DIS, V28, P145, DOI 10.1097/WAD.0000000000000010; Huppert F.A., 2006, RETIREMENT HLTH RELA, P217; Huppert FA, 2000, APPL COGNITIVE PSYCH, V14, pS63, DOI 10.1002/acp.771; Hussey D, 2010, FINANCIAL CIRCUMSTAN, P386; Hyde M, 2003, AGING MENT HEALTH, V7, P186, DOI 10.1080/1360786031000101157; Jelicic M, 2002, INT J GERIATR PSYCH, V17, P73, DOI 10.1002/gps.529; Karlamangla AS, 2009, AM J EPIDEMIOL, V170, P331, DOI 10.1093/aje/kwp154; Keage HAD, 2012, SLEEP MED, V13, P886, DOI 10.1016/j.sleep.2012.02.003; Kronholm E, 2009, J SLEEP RES, V18, P436, DOI 10.1111/j.1365-2869.2009.00765.x; Kumari M, 2010, FINANCIAL CIRCUMSTAN, P178; Lang I, 2007, AGE AGEING, V36, P256, DOI 10.1093/ageing/afm001; Lang IA, 2008, J AM GERIATR SOC, V56, P191, DOI 10.1111/j.1532-5415.2007.01557.x; Lim ASP, 2013, SLEEP, V36, P1027, DOI 10.5665/sleep.2802; Llewellyn DJ, 2008, AGE AGEING, V37, P685, DOI 10.1093/ageing/afn194; Loerbroks A, 2010, INT J GERIATR PSYCH, V25, P100, DOI 10.1002/gps.2305; Lou PA, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004436; Marmot M, 2003, HLTH WEALTH LIFESTYL; Ofstedal M.B., 2005, DOCUMENTATION COGNIT, V10; Palmer K, 2008, AM J GERIAT PSYCHIAT, V16, P603, DOI 10.1097/JGP.0b013e3181753a64; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Potvin O, 2012, SLEEP, V35, P491, DOI 10.5665/sleep.1732; Rabbitt P, 2001, NEUROPSYCHOLOGIA, V39, P532, DOI 10.1016/S0028-3932(00)00099-3; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Ramos AR, 2013, J CLIN SLEEP MED, V9, P669, DOI 10.5664/jcsm.2834; Rauchs G, 2008, NEUROREPORT, V19, P1159, DOI 10.1097/WNR.0b013e32830867c4; Richards M, 1999, NEUROLOGY, V53, P308, DOI 10.1212/WNL.53.2.308; Sachdev PS, 2012, J AM GERIATR SOC, V60, P24, DOI 10.1111/j.1532-5415.2011.03774.x; Spiegel R, 1999, BIOL PSYCHIAT, V45, P435, DOI 10.1016/S0006-3223(98)00042-0; Steffick DE., 2000, DOCUMENTATION AFFECT; Steptoe A, 2013, INT J EPIDEMIOL, V42, P1640, DOI 10.1093/ije/dys168; Stranges S, 2008, AM J EPIDEMIOL, V168, P1353, DOI 10.1093/aje/kwn337; Tworoger SS, 2006, ALZ DIS ASSOC DIS, V20, P41, DOI 10.1097/01.wad.0000201850.52707.80; Vahtera J, 2009, SLEEP, V32, P1459, DOI 10.1093/sleep/32.11.1459; Xu L, 2011, SLEEP, V34, P575, DOI 10.1093/sleep/34.5.575; Yaffe K, 2011, JAMA-J AM MED ASSOC, V306, P613, DOI 10.1001/jama.2011.1115; Zhang J, 2014, J NEUROSCI, V34, P4418, DOI 10.1523/JNEUROSCI.5025-12.2014	53	33	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100991	10.1371/journal.pone.0100991	http://dx.doi.org/10.1371/journal.pone.0100991			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK2WP	24968354	Green Submitted, Green Published, gold			2022-12-27	WOS:000338280800093
J	Touchon, JC; Wojdak, JM				Touchon, Justin C.; Wojdak, Jeremy M.			Plastic Hatching Timing by Red-Eyed Treefrog Embryos Interacts with Larval Predator Identity and Sublethal Predation to Affect Prey Morphology but Not Performance	PLOS ONE			English	Article							BEHAVIORAL PLASTICITY; SWIMMING PERFORMANCE; HABITAT COMPLEXITY; MULTIPLE PREDATORS; NONLETHAL INJURY; OPPOSITE SHIFTS; TAIL SHAPE; TRADE-OFFS; TADPOLES; METAMORPHOSIS	Many animals respond to predation risk by altering their morphology, behavior, or life-history. We know a great deal about the cues prey respond to and the changes to prey that can be induced by predation risk, but less is known about how plastic responses to predators may be affected by separate plastic responses occurring earlier in life, particularly during the embryonic period. Embryos of a broad array of taxa can respond to egg- or larval-stage risks by altering hatching timing, which may alter the way organisms respond to future predators. Using the red-eyed treefrog (Agalychnis callidryas), a model for understanding the effects of plasticity across life-stages, we assessed how the combined effects of induced variation in the timing of embryo hatching and variation in the larval predator community impacted tadpole morphology, pigmentation and swimming performance. We found that A. callidryas tadpoles developed deeper tail muscles and fins and darker pigmentation in response to fish predators, either when alone or in diverse community with other predators. Tadpoles altered morphology much less so to dragonfly naiads or water bugs. Interestingly, morphological responses to predators were also affected by induced differences in hatching age, with early and late-hatched tadpoles exhibiting different allometric relationships between tail height and body length in different predator environments. Beyond induced morphological changes, fish predators often damaged tadpoles' tails without killing them (i.e., sublethal predation), but these tadpoles swam equally quickly to those with fully intact tails. This was due to the fact that tadpoles with more damaged tails increased tail beats to achieve equal swimming speed. This study demonstrates that plastic phenotypic responses to predation risk can be influenced by a complex combination of responses to both the embryo and larval environments, but also that prey performance can be highly resilient to sublethal predation.	[Touchon, Justin C.] Boston Univ, Dept Biol, Boston, MA 02215 USA; [Touchon, Justin C.] Smithsonian Trop Res Inst, Balboa, Panama; [Wojdak, Jeremy M.] Radford Univ, Dept Biol, Radford, VA 24142 USA	Boston University; Smithsonian Institution; Smithsonian Tropical Research Institute; Radford University	Touchon, JC (corresponding author), Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA.	justintouchon@gmail.com			Research Opportunity Award from the National Science Foundation; NSF [DEB-0717220, DEB-0716923]; Radford University; Smithsonian Tropical Research Institute;  [IIA-1064566]	Research Opportunity Award from the National Science Foundation; NSF(National Science Foundation (NSF)); Radford University; Smithsonian Tropical Research Institute(Smithsonian InstitutionSmithsonian Tropical Research Institute); 	JMW was supported by a Research Opportunity Award from the National Science Foundation, stemming from NSF grant DEB-0717220 to James Vonesh. JCT was partially supported by NSF grant DEB-0716923 to Karen Warkentin and by IIA-1064566 to JCT. Radford University and the Smithsonian Tropical Research Institute also provided funding or support.	[Anonymous], DEV PLASTICITY EVOLU; Arnold E.N., 1988, Biology of Reptilia, V16, P235; Baber MJ, 2004, COPEIA, P173, DOI 10.1643/CE-03-056R1; Bateman PW, 2009, J ZOOL, V277, P1, DOI 10.1111/j.1469-7998.2008.00484.x; Bates D.M., 2009, LME4 LINEAR MIXED EF, VR package Ver. 0.999375-28; Benard MF, 2004, ANNU REV ECOL EVOL S, V35, P651, DOI 10.1146/annurev.ecolsys.35.021004.112426; Berner D, 2011, OECOLOGIA, V166, P961, DOI 10.1007/s00442-011-1934-z; Bowerman J, 2010, ECOLOGY, V91, P242, DOI 10.1890/08-1687.1; Capellan E, 2007, EVOL ECOL, V21, P445, DOI 10.1007/s10682-006-9133-9; Crawley M.J., 2007, R BOOK; Dayton GH, 2005, OIKOS, V111, P582, DOI 10.1111/j.1600-0706.2005.14340.x; DeWitt TJ, 2003, J SEA RES, V49, P143, DOI 10.1016/S1385-1101(02)00220-4; Ferrari MCO, 2005, ANIM BEHAV, V70, P777, DOI 10.1016/j.anbehav.2005.01.009; FIGIEL CR, 1991, CAN J ZOOL, V69, P830, DOI 10.1139/z91-125; Gelman A., 2006, DATA ANAL USING REGR, DOI DOI 10.1017/CBO9780511790942.005; Gibbons ME, 2013, OECOLOGIA, V171, P831, DOI 10.1007/s00442-012-2443-4; Hoff KV, 2000, AM ZOOL, V40, P62, DOI 10.1668/0003-1569(2000)040[0062:TLAMAT]2.0.CO;2; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Johansson F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011680; Karban R., 1997, INDUCED RESPONSES HE, DOI 10.7208/chicago/9780226424972.001.0001; Komak S, 2000, WILDLIFE RES, V27, P185, DOI 10.1071/WR99028; Mandrillon AL, 2007, CHEMOECOLOGY, V17, P169, DOI 10.1007/s00049-007-0376-x; Mccoy MW, 2006, OECOLOGIA, V148, P547, DOI 10.1007/s00442-006-0403-6; Mccoy MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047495; Meyer JJ, 2005, ECOL LETT, V8, P160, DOI 10.1111/j.1461-0248.2004.00700.x; Miner BG, 2005, TRENDS ECOL EVOL, V20, P685, DOI 10.1016/j.tree.2005.08.002; Mirza RS, 2006, BEHAVIOUR, V143, P877, DOI 10.1163/156853906778017926; Nunes AL, 2010, BASIC APPL ECOL, V11, P645, DOI 10.1016/j.baae.2010.09.003; Orizaola G, 2005, FRESHWATER BIOL, V50, P438, DOI 10.1111/j.1365-2427.2005.01332.x; Pechenik JA, 2006, INTEGR COMP BIOL, V46, P323, DOI 10.1093/icb/icj028; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rasband WS, 1997, IMAGEJ; Relyea RA, 2004, ECOLOGY, V85, P172, DOI 10.1890/03-0169; Relyea RA, 2003, ECOLOGY, V84, P1827, DOI 10.1890/0012-9658(2003)084[1827:HPRTCP]2.0.CO;2; Relyea RA, 2001, ECOLOGY, V82, P523, DOI 10.1890/0012-9658(2001)082[0523:MABPOL]2.0.CO;2; Schmitz OJ, 2007, ECOLOGY, V88, P2415, DOI 10.1890/06-0937.1; Shah AA, 2010, J HERPETOL, V44, P185, DOI 10.1670/09-025.1; SHERRATT TN, 1989, OIKOS, V56, P170, DOI 10.2307/3565332; Sih A, 1998, TRENDS ECOL EVOL, V13, P350, DOI 10.1016/S0169-5347(98)01437-2; Sinclair ELE, 2011, J ZOOL, V283, P243, DOI 10.1111/j.1469-7998.2010.00776.x; Tejedo M, 2010, CLIM RES, V43, P31, DOI 10.3354/cr00878; TOLLRIAN R, 1999, ECOLOGY EVOLUTION IN; Touchon JC, 2008, OIKOS, V117, P634, DOI 10.1111/j.0030-1299.2008.16354.x; Touchon JC, 2013, OECOLOGIA, V173, P801, DOI 10.1007/s00442-013-2714-8; Touchon JC, 2013, ECOLOGY, V94, P850, DOI 10.1890/12-0194.1; Van Buskirk J, 2000, J EXP BIOL, V203, P2149; Van Buskirk J, 2004, COPEIA, P599, DOI 10.1643/CE-03-283R; Van Buskirk J, 2000, J EVOLUTION BIOL, V13, P336; Van Buskirk J, 2003, J HERPETOL, V37, P420, DOI 10.1670/0022-1511(2003)037[0420:TLETTS]2.0.CO;2; Van Buskirk J, 2001, J EVOLUTION BIOL, V14, P482, DOI 10.1046/j.1420-9101.2001.00282.x; Vonesh JR, 2006, ECOLOGY, V87, P556, DOI 10.1890/05-0930; Walsh PT, 2008, FUNCT ECOL, V22, P699, DOI 10.1111/j.1365-2435.2008.01429.x; Warkentin KM, 2011, INTEGR COMP BIOL, V51, P14, DOI 10.1093/icb/icr017; Warkentin KM, 1999, BIOL J LINN SOC, V68, P443, DOI 10.1006/bijl.1999.0325; Warkentin KM, 2000, ANIM BEHAV, V60, P503, DOI 10.1006/anbe.2000.1508; WARKENTIN KM, 1995, P NATL ACAD SCI USA, V92, P3507, DOI 10.1073/pnas.92.8.3507; Warkentin KM, 2002, PHYSIOL BIOCHEM ZOOL, V75, P155, DOI 10.1086/339214; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; Willink B, 2013, EVOL ECOL, V28, P1; Wilson RS, 2005, FUNCT ECOL, V19, P238, DOI 10.1111/j.1365-2435.2005.00958.x; Wojdak JM, 2014, OECOLOGIA IN PRESS	61	12	13	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100623	10.1371/journal.pone.0100623	http://dx.doi.org/10.1371/journal.pone.0100623			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967896	Green Submitted, Green Published, gold			2022-12-27	WOS:000338280800048
J	Buonfrate, D; Gobbi, F; Angheben, A; Marocco, S; Farina, C; Van den Ende, J; Bisoffi, Z				Buonfrate, Dora; Gobbi, Federico; Angheben, Andrea; Marocco, Stefania; Farina, Claudio; Van den Ende, Jef; Bisoffi, Zeno			Autochthonous Cases of Mycetoma in Europe: Report of Two Cases and Review of Literature	PLOS ONE			English	Article							SCEDOSPORIUM-APIOSPERMUM INFECTION; MADURA FOOT; IMMUNOCOMPROMISED PATIENT; PSEUDALLESCHERIA-BOYDII; ACTINOMADURA-MADURAE; VORICONAZOLE; ITRACONAZOLE	Background: Mycetoma is a chronic granulomatous infection involving cutaneous and subcutaneous tissues. It is endemic in tropical and subtropical areas, but sporadic cases have been reported also in countries of temperate climate. The purpose of this paper is to review the cases of mycetoma in European subjects (and presumably acquired in Europe), to give an insight in the main factors associated with this condition, and to describe two previously unpublished cases observed at our Centre. Methods and Findings: PubMed was systematically searched for case reports and case series of mycetoma in Europeans reported between 1980 and 2014, using specific search strategies. Two further cases diagnosed by the authors are described. Forty-two cases were collected. Eleven cases were caused by Scedosporium apiospermium, mainly in immunosuppressed patients from Bulgaria, Germany, the Netherlands, Portugal, Slovenia, Spain and the United Kingdom. Excluding all patients with immunosuppression, 29 cases remain. Most of them were reported from Bulgaria and in Albanian patients (all diagnosed outside Albania). In the Bulgarian case series many different micro-organisms, both bacteria and fungi, were isolated, while all the 5 cases from Albania were caused by Actinomadura spp. Other countries reporting cases were Greece, Italy and Turkey. In general, Actinomadura spp is the most frequent causative agent isolated, followed by Nocardia spp and Madurella mycetomatis. The foot was the most reported site involved. Most patients were medically treated, but unfortunately a long-term follow up (at least one year) was available only in a few cases. Conclusions: Our review and our own cases suggest that Europeans without travel history can be affected by Madura foot. The lack of a surveillance system is likely to cause an underreporting of cases. Moreover, the unfamiliarity of Western doctors with this peculiar infection may cause a mismanagement, including unnecessary amputations.	[Buonfrate, Dora; Gobbi, Federico; Angheben, Andrea; Marocco, Stefania; Bisoffi, Zeno] Sacro Cuore Hosp, CTD, Verona, Italy; [Farina, Claudio] AO Papa Giovanni XXIII, Inst Microbiol, Bergamo, Italy; [Van den Ende, Jef] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium	IRCCS Sacro Cuore Don Calabria; ASST Papa Giovanni XXIII; Institute of Tropical Medicine (ITM)	Buonfrate, D (corresponding author), Sacro Cuore Hosp, CTD, Verona, Italy.	dora.buonfrate@sacrocuore.it	Marocco, Stefania/AAB-2167-2021; Angheben, Andrea/H-6248-2019; Buonfrate, Dora/ABG-7386-2020; Bisoffi, Zeno/B-6438-2013; Buonfrate, Dora/N-2965-2016; Angheben, Andrea/C-9167-2013; Gobbi, Federico/ABG-7554-2020; Farina, Claudio/U-7175-2017	Buonfrate, Dora/0000-0003-0108-6822; Bisoffi, Zeno/0000-0001-9530-8742; Buonfrate, Dora/0000-0003-0108-6822; Angheben, Andrea/0000-0003-4545-8034; Gobbi, Federico/0000-0002-6899-4545; Farina, Claudio/0000-0003-2298-4293				Ahmed AAO, 2007, CURR OPIN INFECT DIS, V20, P146, DOI 10.1097/QCO.0b013e32803d38fe; AJELLO L, 1985, European Journal of Epidemiology, V1, P5, DOI 10.1007/BF00162306; BALABANOFF VA, 1980, ANN PARASIT HUM COMP, V55, P605; Beier F, 2010, TRANSPL INFECT DIS, V12, P538, DOI 10.1111/j.1399-3062.2010.00537.x; BINAZZI M, 1983, MYKOSEN, V26, P298; Bosma F, 2003, CLIN MICROBIOL INFEC, V9, P750, DOI 10.1046/j.1469-0691.2003.00596.x; Bower CPR, 1999, J CLIN PATHOL, V52, P846, DOI 10.1136/jcp.52.11.846; Cardoso Jose Carlos, 2009, Dermatol Online J, V15, P8; Chaveiro MA, 2003, J EUR ACAD DERMATOL, V17, P47, DOI 10.1046/j.1468-3083.2003.00640.x; De Palma L, 2006, JOINT BONE SPINE, V73, P321, DOI 10.1016/j.jbspin.2005.10.018; Degavre B, 1997, J AM ACAD DERMATOL, V37, P318, DOI 10.1016/S0190-9622(97)70016-1; Douwes KE, 2003, J AM ACAD DERMATOL, V49, pS170, DOI 10.1067/mjd.2003.302; Gunduz K, 2006, MYCOSES, V49, P436, DOI 10.1111/j.1439-0507.2006.01260.x; HAY RJ, 1983, CLIN EXP DERMATOL, V8, P553, DOI 10.1111/j.1365-2230.1983.tb01823.x; Horre R, 2002, MED MYCOL, V40, P525, DOI 10.1080/mmy.40.5.525.527; Ispoglou SS, 2003, CLIN IMAG, V27, P233, DOI 10.1016/S0899-7071(02)00502-8; Lainscak M, 2007, CLIN RHEUMATOL, V26, P1023, DOI 10.1007/s10067-006-0263-9; Lichon V, 2006, AM J CLIN DERMATOL, V7, P315, DOI 10.2165/00128071-200607050-00005; Montero LA, 2004, ENFERM INFEC MICR CL, V22, P551, DOI 10.1157/13067623; NEUMEISTER B, 1995, MYCOSES, V38, P271, DOI 10.1111/j.1439-0507.1995.tb00406.x; Papaioannides D, 2001, WESTERN J MED, V174, P96, DOI 10.1136/ewjm.174.2.96; Pelzer K, 2000, BRIT J DERMATOL, V143, P1311, DOI 10.1046/j.1365-2133.2000.03908.x; Reimann D, 2004, NEPHROL DIAL TRANSPL, V19, P245, DOI 10.1093/ndt/gfg433; Rigopoulos D, 2000, INT J DERMATOL, V39, P557, DOI 10.1046/j.1365-4362.2000.00819-5.x; Tammer I, 2007, J TRAUMA, V62, P1295, DOI 10.1097/01.ta.0000195444.54418.9a; Usai F, 2005, MICROBIOLOGIA MED, V20, P161; van de Sande WWJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002550; Welsh O, 1995, Curr Top Med Mycol, V6, P47	28	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100590	10.1371/journal.pone.0100590	http://dx.doi.org/10.1371/journal.pone.0100590			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963778	Green Published, Green Submitted, gold			2022-12-27	WOS:000338709500066
J	Li, LL; Wang, QF; Li, HL; Yuan, MW; Yuan, ML				Li, Lili; Wang, Qifeng; Li, Hongli; Yuan, Mingwei; Yuan, Minglong			Preparation, Characterization, In Vitro Release and Degradation of Cathelicidin-BF-30-PLGA Microspheres	PLOS ONE			English	Article							AMINO-ACID; PROTEIN; STABILITY; NANOPARTICLES; CYTOTOXICITY; CARRIERS; PLA	Cathelicidin-BF-30 (BF-30), a water-soluble peptide isolated from the snake venom of Bungarus fasciatus containing 30 amino acid residues, was incorporated in poly(D,L-lactide-co-glycolide) (PLGA) 75:25 microspheres (MS) prepared by a water in oil in water W/O/W emulsification solvent extraction method. The aim of this work was to investigate the stability of BF-30 after encapsulation. D-trehalose was used as an excipient to stabilize the peptide. The MS obtained were mostly under 2 mu m in size and the encapsulation efficiency was 88.50 +/- 1.29%. The secondary structure of the peptide released in vitro was determined to be nearly the same as the native peptide using Circular Dichroism (CD). The ability of BF-30 to inhibit the growth of Escherichia coli was also maintained. The cellular relative growth and hemolysis rates were 92.16 +/- 3.55% and 3.52 +/- 0.45% respectively.	[Li, Lili; Li, Hongli; Yuan, Mingwei; Yuan, Minglong] Yunnan Univ Nationalities, Engn Res Ctr Biopolymer Funct Mat Yunnan, Kunming, Yunnan, Peoples R China; [Wang, Qifeng] Sichuan Canc Hosp, Dept Radiat Oncol, Chengdu, Sichuan, Peoples R China	Yunnan Minzu University	Yuan, ML (corresponding author), Yunnan Univ Nationalities, Engn Res Ctr Biopolymer Funct Mat Yunnan, Kunming, Yunnan, Peoples R China.	yml@188.com	Wang, Qifeng/AAX-7678-2021	Wang, Qifeng/0000-0001-8544-9007	National Natural Science Foundation of China [31160198, 31360417]; Applied Basic Research Key Project of Yunnan [2013FA039]; Applied Basic Research Project of Yunnan [2011FB084]; High-End Technology Professionals Introduction Plan in Yunnan province [2010CI119]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Applied Basic Research Key Project of Yunnan; Applied Basic Research Project of Yunnan; High-End Technology Professionals Introduction Plan in Yunnan province	This work was supported by the National Natural Science Foundation of China (31160198, 31360417), the Applied Basic Research Key Project of Yunnan (2013FA039), the Applied Basic Research Project of Yunnan (2011FB084), the High-End Technology Professionals Introduction Plan in Yunnan province (2010CI119). The funders had role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Crotts G, 1998, J MICROENCAPSUL, V15, P699, DOI 10.3109/02652049809008253; Cui F, 2005, J CONTROL RELEASE, V107, P310, DOI 10.1016/j.jconrel.2005.07.001; Das TK, 2012, AAPS PHARMSCITECH, V13, P732, DOI 10.1208/s12249-012-9793-4; Fischer D, 2003, BIOMATERIALS, V24, P1121, DOI 10.1016/S0142-9612(02)00445-3; Ghassemi AH, 2012, PHARM RES-DORDR, V29, P110, DOI 10.1007/s11095-011-0517-3; Hamamoto K, 2002, MICROBIOL IMMUNOL, V46, P741, DOI 10.1111/j.1348-0421.2002.tb02759.x; He ZQ, 2011, J MACROMOL SCI B, V50, P1154, DOI 10.1080/00222348.2010.503106; Jain RA, 2000, BIOMATERIALS, V21, P2475, DOI 10.1016/S0142-9612(00)00115-0; Kim K, 2004, J CONTROL RELEASE, V98, P47, DOI 10.1016/j.jconrel.2004.04.009; Kim TH, 2002, BIOMATERIALS, V23, P2311, DOI 10.1016/S0142-9612(01)00365-9; Kostanski JW, 2000, PHARM DEV TECHNOL, V5, P585, DOI 10.1081/PDT-100102043; Li XH, 2000, J CONTROL RELEASE, V68, P41, DOI 10.1016/S0168-3659(00)00235-2; MAGENHEIM B, 1993, INT J PHARMACEUT, V94, P115, DOI 10.1016/0378-5173(93)90015-8; Mohamed F, 2008, J PHARM SCI-US, V97, P71, DOI 10.1002/jps.21082; Monkarsh SP, 1997, ANAL BIOCHEM, V247, P434, DOI 10.1006/abio.1997.2128; Montalvo-Ortiz BL, 2012, AAPS PHARMSCITECH, P1; OGAWA Y, 1988, CHEM PHARM BULL, V36, P1095; Pan H, 2011, WIRES NANOMED NANOBI, V3, P318, DOI 10.1002/wnan.126; Panyam J, 2003, J CONTROL RELEASE, V92, P173, DOI 10.1016/S0168-3659(03)00328-6; Regnier-Delplace C, 2013, J CONTROL RELEASE, V166, P256, DOI 10.1016/j.jconrel.2012.12.024; Samadi N, 2013, BIOMACROMOLECULES, V14, P1044, DOI 10.1021/bm301900t; Shen JM, 2012, BIOCONJUGATE CHEM, V23, P1010, DOI 10.1021/bc300008k; Sun HL, 2011, BIOMACROMOLECULES, V12, P1937, DOI 10.1021/bm200043u; Trindade RA, 2012, INT J PHARMACEUT, V423, P124, DOI 10.1016/j.ijpharm.2011.02.027; Wang YP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003217; Wei Y, 2011, J MATER CHEM, V21, P12691, DOI 10.1039/c1jm12643a; YEH MK, 1995, J CONTROL RELEASE, V33, P437, DOI 10.1016/0168-3659(94)00123-C; Zetterberg MM, 2011, J CONTROL RELEASE, V156, P323, DOI 10.1016/j.jconrel.2011.08.029; Zhang ZX, 2008, J HUAZHONG U SCI-MED, V28, P604, DOI 10.1007/s11596-008-0526-6; Zhou HM, 2011, PEPTIDES, V32, P1131, DOI 10.1016/j.peptides.2011.04.002	30	12	12	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100809	10.1371/journal.pone.0100809	http://dx.doi.org/10.1371/journal.pone.0100809			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963652	gold, Green Published, Green Submitted			2022-12-27	WOS:000338709500082
J	Liu, SC; Kuang, HQ; Lai, ZX				Liu, Shengcai; Kuang, Huaqin; Lai, Zhongxiong			Transcriptome Analysis by Illumina High-Throughout Paired-End Sequencing Reveals the Complexity of Differential Gene Expression during In Vitro Plantlet Growth and Flowering in Amaranthus tricolor L.	PLOS ONE			English	Article							GERMIN-LIKE PROTEIN; CIRCADIAN CLOCK; GLOBAL TRANSCRIPTOME; ROOT TRANSCRIPTOME; MESSENGER-RNA; LEAVES; TIME; TUBERCULATUS; TRANSITION; GENERATION	Amaranthus tricolor L. is a C-4 plant, which is consumed as a major leafy vegetable in some tropical countries. Under conditions of high temperature and short daylight, Am. tricolor readily bolts and blooms, degrading leaf quality. A preliminary in vitro flowering study demonstrated that the flowering control pathway in Am. tricolor may differ from that of Arabidopsis. Nevertheless, no transcriptome analysis of the flowering process in Amaranthus has been conducted. To study Am. tricolor floral regulatory mechanisms, we conducted a large-scale transcriptome analysis-based on Illumina HiSeq sequencing of cDNA libraries generated from Am. tricolor at young seedling (YSS), adult seedling (ASS), flower bud (FBS), and flowering (FS) stages. A total of 99,312 unigenes were obtained. Using BLASTX, 43,088 unigenes (43.39%) were found to have significant similarity with accessions in Nr, Nt, and Swiss-Prot databases. Of these unigenes, 11,291 were mapped to 266 KEGG pathways. Further analysis of the four digital transcriptomes revealed that 735, 17,184, 274, and 206 unigenes were specifically expressed during YSS, ASS, FBS, and FS, respectively, with 59,517 unigenes expressed throughout the four stages. These unigenes were involved in many metabolic pathways related to in vitro flowering. Among these pathways, 259 unigenes were associated with ubiquitin-mediated proteolysis, indicating its importance for in vitro flowering in Am. tricolor. Other pathways, such as circadian rhythm and cell cycle, also had important roles. Finally, 26 unigenes were validated by qRT-PCR in samples from Am. tricolor at YSS, ASS, FBS, and FS; their differential expressions at the various stages indicate their possible roles in Am. tricolor growth and development, but the results were somewhat similar to Arabidopsis. Because unigenes involved in many metabolic pathways or of unknown function were revealed to regulate in vitro plantlet growth and flowering in Am. tricolor, the process appears to be highly complex in this species.	[Liu, Shengcai; Kuang, Huaqin; Lai, Zhongxiong] Fujian Agr & Forestry Univ, Inst Hort Biotechnol, Fuzhou, Fujian, Peoples R China	Fujian Agriculture & Forestry University	Lai, ZX (corresponding author), Fujian Agr & Forestry Univ, Inst Hort Biotechnol, Fuzhou, Fujian, Peoples R China.	laizx01@163.com			Research Fund for the Doctoral Program of Higher Education of the Chinese Ministry of Education [20123515120009]; Science Foundation of Fujian Province, China [2013J05045]; Research Fund of the Education Department of Fujian Province [JA12098]; Fujian Agriculture and Forestry University [132300102]; Special Foundation for Young Scientists of the Horticultural College of Fujian Agriculture and Forestry University [FAFU2012 YYPY10]	Research Fund for the Doctoral Program of Higher Education of the Chinese Ministry of Education; Science Foundation of Fujian Province, China; Research Fund of the Education Department of Fujian Province; Fujian Agriculture and Forestry University; Special Foundation for Young Scientists of the Horticultural College of Fujian Agriculture and Forestry University	This study was supported by the Research Fund for the Doctoral Program of Higher Education of the Chinese Ministry of Education (20123515120009), the Science Foundation of Fujian Province, China (2013J05045), the Research Fund of the Education Department of Fujian Province (JA12098), Horticulture Postdoctoral Funding from Fujian Agriculture and Forestry University (132300102), and the Special Foundation for Young Scientists of the Horticultural College of Fujian Agriculture and Forestry University (FAFU2012 YYPY10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andini R, 2013, AGRONOMY-BASEL, V3, P391, DOI 10.3390/agronomy3020391; Andres F, 2012, NAT REV GENET, V13, P627, DOI 10.1038/nrg3291; Armour CD, 2009, NAT METHODS, V6, P647, DOI [10.1038/NMETH.1360, 10.1038/nmeth.1360]; Bai S, 2013, PLANT CELL PHYSL; BERNIER G, 1993, PLANT CELL, V5, P1147, DOI 10.1105/tpc.5.10.1147; Biswas M, 2013, FOOD SCI BIOTECHNOL, V22, P1, DOI 10.1007/s10068-013-0041-9; Borner R, 2000, PLANT J, V24, P591, DOI 10.1046/j.1365-313x.2000.00906.x; Chu TingTing, 2010, China Biotechnology, V30, P98; Cong HQ, 2013, PLANT GROWTH REGUL, V69, P247, DOI 10.1007/s10725-012-9767-2; Cruz-Garcia GS, 2012, ACTA SOC BOT POL, V81, P397, DOI 10.5586/asbp.2012.047; Cui X, 2013, PLANT PHYSIOL, V162, P897, DOI 10.1104/pp.112.213009; de Montaigu A, 2010, TRENDS GENET, V26, P296, DOI 10.1016/j.tig.2010.04.003; Delano-Frier JP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-363; Dunwell JM, 2008, CRIT REV PLANT SCI, V27, P342, DOI 10.1080/07352680802333938; Fan ZM, 2005, BIOCHEM BIOPH RES CO, V331, P1257, DOI 10.1016/j.bbrc.2005.04.045; Fullwood MJ, 2009, GENOME RES, V19, P521, DOI 10.1101/gr.074906.107; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hao DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021220; Hao DC, 2012, SCI CHINA LIFE SCI, V55, P452, DOI 10.1007/s11427-012-4319-6; He CY, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-119; HEINTZEN C, 1994, PLANT PHYSIOL, V106, P905, DOI 10.1104/pp.106.3.905; Hicks KA, 1996, SCIENCE, V274, P790, DOI 10.1126/science.274.5288.790; Hicks KA, 2001, PLANT CELL, V13, P1281, DOI 10.1105/tpc.13.6.1281; Horvath D, 2010, CURR GENOMICS, V11, P47, DOI 10.2174/138920210790217972; Hsiao YY, 2013, GENE, V518, P91, DOI 10.1016/j.gene.2012.11.069; Huang YJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-691; Hyodo H, 2003, PLANT MOL BIOL, V52, P473, DOI 10.1023/A:1023904217641; Imaizumi T, 2010, CURR OPIN PLANT BIOL, V13, P83, DOI 10.1016/j.pbi.2009.09.007; Jarillo JA, 2011, PLANT SCI, V181, P364, DOI 10.1016/j.plantsci.2011.06.011; Kim J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-657; Kobayashi M, 2012, MOL BIOL REP, V39, P4367, DOI 10.1007/s11033-011-1224-1; Kobayashi M, 2010, J PLANT PHYSIOL, V167, P812, DOI 10.1016/j.jplph.2009.12.005; Kumar SV, 2010, CELL, V140, P136, DOI 10.1016/j.cell.2009.11.006; Lai ZX, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-561; Lau OS, 2011, MOL CELL, V43, P703, DOI 10.1016/j.molcel.2011.07.013; Lee JR, 2008, CONSERV GENET, V9, P243, DOI 10.1007/s10592-007-9323-1; Lee RM, 2009, WEED SCI, V57, P463, DOI 10.1614/WS-09-021.1; [李铁柱 Li Tiezhu], 2012, [中南林业科技大学学报, Journal of Central South University of Forestry & Technology], V32, P9; Li W, 2012, PLANT PHYSIOL, V159, P239, DOI 10.1104/pp.111.192617; Li ZQ, 2004, LIFE SCI RES, V8, P76; [刘生财 LIU Shengcai], 2011, [热带作物学报, Chinese Journal of Tropical Crops], V32, P1296; Logacheva MD, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-30; Lu SX, 2012, PLANT PHYSIOL, V158, P1079, DOI 10.1104/pp.111.189670; LULIN H, 2012, PLOS ONE, V0007; Mallory MA, 2008, CROP SCI, V48, P1098, DOI 10.2135/cropsci2007.08.0457; Sanz-Penella JM, 2012, PLANT FOOD HUM NUTR, V67, P50, DOI 10.1007/s11130-011-0269-6; Maroyi A, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-60; Maughan PJ, 2008, CROP SCI, V48, pS85, DOI 10.2135/cropsci2007.08.0434tpg; Maughan PJ, 2009, PLANT GENOME-US, V2, P260, DOI 10.3835/plantgenome2009.08.0022; Meng XQ, 2013, CURRENT BIOTECHNOLOG, P1; Misra S, 2013, INT J AGR FOOD SCI, V3, P131; Mizoguchi T, 2002, DEV CELL, V2, P629, DOI 10.1016/S1534-5807(02)00170-3; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mosyakin SL, 2003, AMARANTHUS, V4, P410; Natale DA, 2000, GENOME BIOL, V1; Natarajan P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-191; Ono M, 1996, PLANT CELL PHYSIOL, V37, P855, DOI 10.1093/oxfordjournals.pcp.a029022; Pacin M, 2014, PLANT PHYSIOL; Pal A, 2013, IN VITRO CELL DEV-PL, V49, P114, DOI 10.1007/s11627-013-9489-9; Pineiro M, 2013, PLANT SCI, V198, P98, DOI [10.1016/j.plantsci.2012.10.005, 10.1016/j.pla]; Rastogi A, 2013, CRIT REV FOOD SCI, V53, P109, DOI 10.1080/10408398.2010.517876; Riggins CW, 2010, PEST MANAG SCI, V66, P1042, DOI 10.1002/ps.2006; Rowland LJ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-46; Samach A, 2012, PLANT BIOTECHNOLOGY AND AGRICULTURE: PROSPECTS FOR THE 21ST CENTURY, P387, DOI 10.1016/B978-0-12-381466-1.00025-0; Shi CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-131; Singh VK, 2013, PLANT BIOTECHNOL J, V11, P691, DOI 10.1111/pbi.12059; Sinha R, 2007, INDIAN J TRADIT KNOW, V6, P217; Song YL, 2012, SCI CHINA LIFE SCI, V55, P241, DOI 10.1007/s11427-012-4300-4; Sun Chang-Hui, 2007, Yichuan, V29, P1182, DOI 10.1360/yc-007-1182; Takayama S, 1999, J BIOL CHEM, V274, P781, DOI 10.1074/jbc.274.2.781; Tanaka N, 2011, PLANT CELL, V23, P2143, DOI 10.1105/tpc.111.083436; Wang QQ, 2010, GENOMICS, V96, P369, DOI 10.1016/j.ygeno.2010.08.009; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Wei WL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-451; Wilczek AM, 2009, SCIENCE, V323, P930, DOI 10.1126/science.1165826; Xiong YQ, 2011, PLANT MOL BIOL REP, V29, P835, DOI 10.1007/s11105-011-0291-8; Yaacob J, 2011, 1 INT S SUST VEG PRO, V958, P171; Yang N, 2012, J BEIJING FORESTR S1, P104; Yang WenWen, 2011, Journal of Fujian Agriculture and Forestry University (Natural Science Edition), V40, P360; Zhang GJ, 2010, GENOME RES, V20, P646, DOI 10.1101/gr.100677.109	81	15	17	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100919	10.1371/journal.pone.0100919	http://dx.doi.org/10.1371/journal.pone.0100919			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963660	Green Submitted, Green Published, gold			2022-12-27	WOS:000338709500100
J	Mu, XT; Nie, BB; Wang, H; Duan, SF; Zhang, Z; Dai, GH; Ma, QZ; Shan, BC; Ma, L				Mu, Xuetao; Nie, Binbin; Wang, Hong; Duan, Shaofeng; Zhang, Zan; Dai, Guanghui; Ma, Qiaozhi; Shan, Baoci; Ma, Lin			Spatial Patterns of Whole Brain Grey and White Matter Injury in Patients with Occult Spastic Diplegic Cerebral Palsy	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; PERIVENTRICULAR LEUKOMALACIA; GRAY-MATTER; PREMATURE-INFANT; DIFFUSION; CHILDREN; MOTOR; TERM; MRI; SURVIVORS	Spastic diplegic cerebral palsy(SDCP) is a common type of cerebral palsy (CP), which presents as a group of motor-impairment syndromes. Previous conventional MRI studies have reported abnormal structural changes in SDCP, such as periventricular leucomalacia. However, there are roughly 27.8% SDCP patients presenting normal appearance in conventional MRI, which were considered as occult SDCP. In this study, sixteen patients with occult SDCP and 16 age-and sex-matched healthy control subjects were collected and the data were acquired on a 3T MR system. We applied voxel-based morphometry (VBM) and tract-based spatial statistics (TBSS) analysis to investigate whole brain grey and white matter injury in occult SDCP. By using VBM method, the grey matter volume reduction was revealed in the bilateral basal ganglia regions, thalamus, insula, and left cerebral peduncle, whereas the white matter atrophy was found to be located in the posterior part of corpus callosum and right posterior corona radiata in the occult SDCP patients. By using TBSS, reduced fractional anisotropy (FA) values were detected in multiple white matter regions, including bilateral white matter tracts in prefrontal lobe, temporal lobe, internal and external capsule, corpus callosum, cingulum, thalamus, brainstem and cerebellum. Additionally, several regions of white matter tracts injury were found to be significantly correlated with motor dysfunction. These results collectively revealed the spatial patterns of whole brain grey and white matter injury in occult SDCP.	[Mu, Xuetao; Ma, Lin] Chinese Peoples Liberat Army Gen Hosp, Dept Radiol, Beijing, Peoples R China; [Mu, Xuetao; Wang, Hong; Ma, Qiaozhi] Chinese Peoples Armed Police Forces, Gen Hosp, Dept MRI, Beijing, Peoples R China; [Nie, Binbin; Duan, Shaofeng; Shan, Baoci] Chinese Acad Sci, Inst High Energy Phys, Key Lab Nucl Anal Tech, Beijing Engn Res Ctr Radiog Tech & Equipment, Beijing, Peoples R China; [Zhang, Zan; Dai, Guanghui] Chinese Peoples Armed Police Forces, Gen Hosp, Inst Neurosurg, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese Academy of Sciences; Institute of High Energy Physics, CAS	Wang, H (corresponding author), Chinese Peoples Armed Police Forces, Gen Hosp, Dept MRI, Beijing, Peoples R China.	wanghongmri@sina.com; cjr.malin@vip.163.com	Ma, Lin/AAF-8728-2019	Duan, Shaofeng/0000-0002-2695-5898; Nie, Binbin/0000-0002-8038-7772; Shan, Baoci/0000-0001-7417-5063	Beijing Natural Science Foundation [7143186]; Scientific Foundation of General Hospital of Armed Police [WZ2010006]	Beijing Natural Science Foundation(Beijing Natural Science Foundation); Scientific Foundation of General Hospital of Armed Police	This work was supported by Beijing Natural Science Foundation (Grant No. 7143186) and the Scientific Foundation of General Hospital of Armed Police (Grant No. WZ2010006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson J.L.R., 2007, TR07JA1 FMRIB; Andersson J.L.R, 2007, TR07JA2 FMRIB; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Bax M, 2006, JAMA-J AM MED ASSOC, V296, P1602, DOI 10.1001/jama.296.13.1602; Benini R, 2013, J PEDIATR-US, V162, P369, DOI 10.1016/j.jpeds.2012.07.044; Carducci F, 2013, FUNCT NEUROL, V28, P19, DOI 10.11138/FNeur/2013.28.1.019; Fan GG, 2006, CLIN RADIOL, V61, P358, DOI 10.1016/j.crad.2006.01.001; Friston K., 2007, STAT PARAMETRIC MAPP, DOI [10.1016/B978-0-12-372560-8.X5000-1, DOI 10.1016/B978-0-12-372560-8.X5000-1]; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Good CD, 2001, REV NEUROL-FRANCE, V157, P797; Hoon AH, 2009, DEV MED CHILD NEUROL, V51, P697, DOI 10.1111/j.1469-8749.2009.03306.x; Inder TE, 1999, ANN NEUROL, V46, P755, DOI 10.1002/1531-8249(199911)46:5<755::AID-ANA11>3.0.CO;2-0; Inder TE, 2005, PEDIATRICS, V115, P286, DOI 10.1542/peds.2004-0326; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Lee JD, 2011, BRAIN, V134, P1199, DOI 10.1093/brain/awr021; Leviton A, 2007, TRENDS NEUROSCI, V30, P473, DOI 10.1016/j.tins.2007.05.009; Ligam P, 2009, PEDIATR RES, V65, P524, DOI 10.1203/PDR.0b013e3181998baf; Nagae LM, 2007, AM J NEURORADIOL, V28, P1213, DOI 10.3174/ajnr.A0534; Nagasunder AC, 2011, AM J NEURORADIOL, V32, P185, DOI 10.3174/ajnr.A2243; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Northington FJ, 2005, BRAIN RES REV, V50, P244, DOI 10.1016/j.brainresrev.2005.07.003; Padovani A, 2006, J NEUROL NEUROSUR PS, V77, P457, DOI 10.1136/jnnp.2005.075713; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Pierson CR, 2007, ACTA NEUROPATHOL, V114, P619, DOI 10.1007/s00401-007-0295-5; Rai Y, 2013, EUR J PAEDIATR NEURO, V17, P294, DOI 10.1016/j.ejpn.2012.11.005; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Scheck SM, 2012, DEV MED CHILD NEUROL, V54, P684, DOI 10.1111/j.1469-8749.2012.04332.x; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Stone BS, 2008, ANN NEUROL, V64, P535, DOI 10.1002/ana.21517; Tan L, 2013, NEUROSCI BULL, V29, P642, DOI 10.1007/s12264-013-1370-7; Thomas B, 2005, BRAIN, V128, P2562, DOI 10.1093/brain/awh600; Thompson DK, 2007, BRAIN, V130, P667, DOI 10.1093/brain/awl277; Towsley K, 2011, EUR J PAEDIATR NEURO, V15, P29, DOI 10.1016/j.ejpn.2010.07.005; Wang ZQ, 2010, EUR J RADIOL, V75, P129, DOI 10.1016/j.ejrad.2009.04.041; Woodward LJ, 2006, NEW ENGL J MED, V355, P685, DOI 10.1056/NEJMoa053792; Yoshida S, 2013, J MAGN RESON IMAGING, V38, P288, DOI 10.1002/jmri.23931; Yoshida S, 2010, DEV MED CHILD NEUROL, V52, P935, DOI 10.1111/j.1469-8749.2010.03669.x	40	6	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100451	10.1371/journal.pone.0100451	http://dx.doi.org/10.1371/journal.pone.0100451			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964139	gold, Green Published, Green Submitted			2022-12-27	WOS:000338709500052
J	Sohoni, SV; Fazio, A; Workman, CT; Mijakovic, I; Lantz, E				Sohoni, Sujata Vijay; Fazio, Alessandro; Workman, Christopher T.; Mijakovic, Ivan; Lantz, Eliasson			Synthetic Promoter Library for Modulation of Actinorhodin Production in Streptomyces coelicolor A3(2)	PLOS ONE			English	Article							ANTIBIOTIC PRODUCTION; SECONDARY METABOLISM; TRANSCRIPTIONAL ACTIVATION; BIOSYNTHETIC GENES; REGULATOR; EXPRESSION; STRESS; SYSTEM; RESISTANCE; GROWTH	The objective of this study was the application of the synthetic promoter library (SPL) technology for modulation of actinorhodin production in Streptomyces coelicolor A3(2). The SPL technology was used to optimize the expression of a pathway specific positive transcriptional regulator Actll orf4, which activates the transcription of the S. coelicolor actinorhodin biosynthetic gene cluster. The native actll orf4 promoter was replaced with synthetic promoters, generating a S. coelicolor library with a broad range of expression levels of actll orf4. The resulting library was screened based on the yield of actinorhodin. Selected strains were further physiologically characterized. One of the strains from the library, ScoSPL20, showed considerably higher yield of actinorhodin and final actinorhodin titer, compared to S. coelicolor wild type and S. coelicolor with actll orf4 expressed from a strong constitutive promoter. ScoSPL20 demonstrated exceptional productivity despite having a comparatively weak expression from the promoter. Interestingly, the ScoSPL20 promoter was activated at a much earlier stage of growth compared to the wild type, demonstrating the advantage of fine-tuning and temporal tuning of gene expression in metabolic engineering. Transcriptome studies were performed in exponential and actinorhodin-producing phase of growth to compare gene expression between ScoSPL20 and the wild type. To our knowledge, this is the first successful application of the SPL technology for secondary metabolite production in filamentous bacteria.	[Sohoni, Sujata Vijay; Fazio, Alessandro; Workman, Christopher T.; Lantz, Eliasson] Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Mijakovic, Ivan] Chalmers Univ Technol, Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden	Technical University of Denmark; Chalmers University of Technology	Lantz, E (corresponding author), Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark.	ael@bio.dtu.dk	Lantz, Anna Eliasson/G-8569-2012; Workman, Christopher T/K-1066-2015; Mijakovic, Ivan/Q-5583-2016	Lantz, Anna Eliasson/0000-0003-1547-9299; Workman, Christopher T/0000-0002-2210-3743; Mijakovic, Ivan/0000-0002-8860-6853	Denmark Technical University; Danish Biotechnology Research School; European Commission [IP005224]	Denmark Technical University; Danish Biotechnology Research School; European Commission(European CommissionEuropean Commission Joint Research Centre)	Denmark Technical University, the Danish Biotechnology Research School and the European Commission (IP005224 ActinoGEN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AFF, 2000, AFF GENECHIP EXPR AN; Alper H, 2006, P NATL ACAD SCI USA, V103, P3006, DOI 10.1073/pnas.0511314103; Andersen HW, 2001, J BACTERIOL, V183, P3458, DOI 10.1128/JB.183.11.3458-3467.2001; Arias P, 1999, J BACTERIOL, V181, P6958, DOI 10.1128/JB.181.22.6958-6968.1999; BAILEY JE, 1991, SCIENCE, V252, P1668, DOI 10.1126/science.2047876; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bibb MJ, 2005, CURR OPIN MICROBIOL, V8, P208, DOI 10.1016/j.mib.2005.02.016; Blank LM, 2004, MICROBIOL-SGM, V150, P1085, DOI 10.1099/mic.0.26845-0; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Borodina I, 2008, J BIOL CHEM, V283, P25186, DOI 10.1074/jbc.M803105200; Bruheim P, 2002, J IND MICROBIOL BIOT, V28, P103, DOI 10.1038/sj/jim/7000219; Bruheim P, 2002, APPL MICROBIOL BIOT, V58, P735, DOI 10.1007/s00253-002-0969-9; CHATER KF, 1985, EMBO J, V4, P1893, DOI 10.1002/j.1460-2075.1985.tb03866.x; Chong PP, 1998, MICROBIOL-UK, V144, P193, DOI 10.1099/00221287-144-1-193; Craney A, 2012, CHEM BIOL, V19, P1020, DOI 10.1016/j.chembiol.2012.06.013; DOULL JL, 1990, APPL MICROBIOL BIOT, V32, P449, DOI 10.1007/BF00903781; Gao CH, 2012, ADV DIFFER EQU-NY, P1, DOI 10.1186/1687-1847-2012-3; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Huang J, 2005, MOL MICROBIOL, V58, P1276, DOI 10.1111/j.1365-2958.2005.04879.x; Jensen PR, 1998, BIOTECHNOL BIOENG, V58, P191, DOI 10.1002/(SICI)1097-0290(19980420)58:2/3<191::AID-BIT11>3.0.CO;2-G; Jensen PR, 1998, APPL ENVIRON MICROB, V64, P82; Kisser T, 2000, PRACTICAL STREPTOMYC; Lian W, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-56; Ludwig H, 2001, MOL MICROBIOL, V41, P409, DOI 10.1046/j.1365-2958.2001.02523.x; Mijakovic I, 2005, CURR OPIN BIOTECH, V16, P329, DOI 10.1016/j.copbio.2005.04.003; Miksch G, 2005, J BIOTECHNOL, V120, P25, DOI 10.1016/j.jbiotec.2005.04.027; MUTH G, 1989, MOL GEN GENET, V219, P341, DOI 10.1007/BF00259605; Rigali S, 2008, EMBO REP, V9, P670, DOI 10.1038/embor.2008.83; Rud I, 2006, MICROBIOL-SGM, V152, P1011, DOI 10.1099/mic.0.28599-0; RUDD BAM, 1980, J GEN MICROBIOL, V119, P333; Sambrook J., 2001, MOL CLONING LAB MANU; Santos CNS, 2008, CURR OPIN CHEM BIOL, V12, P168, DOI 10.1016/j.cbpa.2008.01.017; Scotti C, 1996, J BACTERIOL, V178, P7316, DOI 10.1128/jb.178.24.7316-7321.1996; Seghezzi N, 2011, APPL MICROBIOL BIOT, V90, P615, DOI 10.1007/s00253-010-3018-0; Shu D, 2009, APPL MICROBIOL BIOT, V81, P1149, DOI 10.1007/s00253-008-1738-1; Sianidis G, 2006, J BIOTECHNOL, V121, P498, DOI 10.1016/j.jbiotec.2005.08.002; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sohoni SV, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-9; Sola-Landa A, 2003, P NATL ACAD SCI USA, V100, P6133, DOI 10.1073/pnas.0931429100; Solem C, 2002, APPL ENVIRON MICROB, V68, P2397, DOI 10.1128/AEM.68.5.2397-2403.2002; Tanaka A, 2007, J MOL BIOL, V369, P322, DOI 10.1016/j.jmb.2007.02.096; Uguru GC, 2005, MOL MICROBIOL, V58, P131, DOI 10.1111/j.1365-2958.2005.04817.x; VOGTLI M, 1994, MOL MICROBIOL, V14, P643, DOI 10.1111/j.1365-2958.1994.tb01303.x; Wang GJ, 2008, APPL ENVIRON MICROB, V74, P2834, DOI 10.1128/AEM.02800-07; WRIGHT LF, 1976, J GEN MICROBIOL, V96, P289, DOI 10.1099/00221287-96-2-289	46	28	30	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e99701	10.1371/journal.pone.0099701	http://dx.doi.org/10.1371/journal.pone.0099701			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963940	Green Submitted, Green Published, gold			2022-12-27	WOS:000338709500013
J	Kuwayama, H; Gotoh, H; Konishi, Y; Nishikawa, H; Yaginuma, T; Niimi, T				Kuwayama, Hisashi; Gotoh, Hiroki; Konishi, Yusuke; Nishikawa, Hideto; Yaginuma, Toshinobu; Niimi, Teruyuki			Establishment of Transgenic Lines for Jumpstarter Method Using a Composite Transposon Vector in the Ladybrid Beetle, Harmonia axyridis	PLOS ONE			English	Article							INSERTIONAL MUTAGENESIS; DROSOPHILA-MELANOGASTER; INSECT TRANSGENESIS; REGULATORY ELEMENTS; ENHANCER DETECTION; LADYBIRD BEETLE; GENE-EXPRESSION; PIGGYBAC; TRANSFORMATION; GERMLINE	In this post-genomic era, genome-wide functional analysis is indispensable. The recent development of RNA interference techniques has enabled researchers to easily analyze gene function even in non-model organisms. On the other hand, little progress has been made in the identification and functional analyses of cis-regulatory elements in non-model organisms. In order to develop experimental platform for identification and analyses of cis-regulatory elements in a non-model organism, in this case, the ladybird beetle, Harmonia axyridis, we established transgenic transposon-tagged lines using a novel composite vector. This vector enables the generation of two types of insertion products (jumpstarter and mutator). The jumpstarter portion carries a transposase gene, while the mutator segment carries a reporter gene for detecting enhancers. The full-composite element is flanked by functional termini (required for movement); however, the mutator region has an extra terminus making it possible for the mutator to remobilize on its own, thus leaving an immobile jumpstarter element behind. Each insertion type is stable on its own, but once crossed, jumpstarters can remobilize mutators. After crossing a jumpstarter and mutator line, all tested G(2) females gave rise to at least one new insertion line in the next generation. This jumping rate is equivalent to the P-element-mediated jumpstarter method in Drosophila. These established transgenic lines will offer us the ideal experimental materials for the effective screening and identification of enhancers in this species. In addition, this jumpstarter method has the potential to be as effective in other non-model insect species and thus applicable to any organism.	[Kuwayama, Hisashi; Gotoh, Hiroki; Konishi, Yusuke; Nishikawa, Hideto; Yaginuma, Toshinobu; Niimi, Teruyuki] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Gotoh, Hiroki] Washington State Univ, Dept Entomol, Pullman, WA 99164 USA	Nagoya University; Washington State University	Niimi, T (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan.	niimi@agr.nagoya-u.ac.jp	Gotoh, Hiroki/B-7568-2017	Niimi, Teruyuki/0000-0003-3981-0177	Formation and Recognition; PRESTO; Japan Science and Technology Agency; Ministry of Education, Science, Sports and Culture of Japan; Japan Society for the Promotion of Science Research; Ministry of Agriculture, Forestry and Fisheries	Formation and Recognition; PRESTO; Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Agriculture, Forestry and Fisheries(Ministry of Agriculture Forestry & Fisheries - Japan)	This research was supported in part by Formation and Recognition, PRESTO, Japan Science and Technology Agency, Grants-in-Aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan, the Japan Society for the Promotion of Science Research for the Future and Grant-in- Aid (BDP) from the Ministry of Agriculture, Forestry and Fisheries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERG CA, 1991, GENETICS, V127, P515; Berghammer AJ, 1999, NATURE, V402, P370, DOI 10.1038/46463; Brown SD, 1999, J CHEMOMETR, V13, P1; COOLEY L, 1988, SCIENCE, V239, P1121, DOI 10.1126/science.2830671; Dupuy AJ, 2001, GENESIS, V30, P82, DOI 10.1002/gene.1037; Gerlitz O, 2002, INT J DEV BIOL, V46, P173; Handler AM, 1999, INSECT MOL BIOL, V8, P449, DOI 10.1046/j.1365-2583.1999.00139.x; Handler AM, 2004, NAT BIOTECHNOL, V22, P1150, DOI 10.1038/nbt1002; Hara Kimiko, 2008, Journal of Insect Biotechnology and Sericology, V77, P159; Hayashi S, 2002, GENESIS, V34, P58, DOI 10.1002/gene.10137; Hediger M, 2001, INSECT MOL BIOL, V10, P113, DOI 10.1046/j.1365-2583.2001.00243.x; Horie K, 2001, P NATL ACAD SCI USA, V98, P9191, DOI 10.1073/pnas.161071798; Horn C, 2003, GENETICS, V163, P647; Horn C, 2002, INSECT BIOCHEM MOLEC, V32, P1221, DOI 10.1016/S0965-1748(02)00085-1; Horn C, 2000, DEV GENES EVOL, V210, P630, DOI 10.1007/s004270000110; Koch R L, 2003, J Insect Sci, V3, P32; KOMAI T, 1956, ADV GENET, V8, P155, DOI 10.1016/S0065-2660(08)60502-7; Kuwayama H, 2006, INSECT MOL BIOL, V15, P507, DOI 10.1111/j.1365-2583.2006.00665.x; Lewis DL, 1999, CURR BIOL, V9, P1279, DOI 10.1016/S0960-9822(00)80049-4; LONG D, 1993, P NATL ACAD SCI USA, V90, P10370, DOI 10.1073/pnas.90.21.10370; Lorenzen MD, 2007, INSECT MOL BIOL, V16, P265, DOI 10.1111/j.1365-2583.2007.00727.x; Masumoto M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049323; Muller GB, 2007, NAT REV GENET, V8, P943, DOI 10.1038/nrg2219; Niimi Teruyuki, 2005, Journal of Insect Biotechnology and Sericology, V74, P95; OKANE CJ, 1987, P NATL ACAD SCI USA, V84, P9123, DOI 10.1073/pnas.84.24.9123; Osawa N, 2000, POPUL ECOL, V42, P115, DOI 10.1007/PL00011990; ROBERTSON HM, 1988, GENETICS, V118, P461; Sasakura Y, 2008, DEV DYNAM, V237, P39, DOI 10.1002/dvdy.21333; Uchino Keiro, 2006, Journal of Insect Biotechnology and Sericology, V75, P89; Uchino K, 2008, INSECT BIOCHEM MOLEC, V38, P1165, DOI 10.1016/j.ibmb.2008.09.009; Wimmer EA, 2003, NAT REV GENET, V4, P225, DOI 10.1038/nrg1021; Wittkopp PJ, 2012, NAT REV GENET, V13, P59, DOI 10.1038/nrg3095; Zagoraiou L, 2001, P NATL ACAD SCI USA, V98, P11474, DOI 10.1073/pnas.201392398	33	6	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100804	10.1371/journal.pone.0100804	http://dx.doi.org/10.1371/journal.pone.0100804			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959904	Green Published, Green Submitted, gold			2022-12-27	WOS:000338633900090
J	Rouhier, MF; Raphemot, R; Denton, JS; Piermarini, PM				Rouhier, Matthew F.; Raphemot, Rene; Denton, Jerod S.; Piermarini, Peter M.			Pharmacological Validation of an Inward- Rectifier Potassium (Kir) Channel as an Insecticide Target in the Yellow Fever Mosquito Aedes aegypti	PLOS ONE			English	Article							CHIKUNGUNYA VIRUS; RENAL TUBULES; EXCHANGER	Mosquitoes are important disease vectors that transmit a wide variety of pathogens to humans, including those that cause malaria and dengue fever. Insecticides have traditionally been deployed to control populations of disease-causing mosquitoes, but the emergence of insecticide resistance has severely limited the number of active compounds that are used against mosquitoes. Thus, to improve the control of resistant mosquitoes there is a need to identify new insecticide targets and active compounds for insecticide development. Recently we demonstrated that inward rectifier potassium (Kir) channels and small molecule inhibitors of Kir channels offer promising new molecular targets and active compounds, respectively, for insecticide development. Here we provide pharmacological validation of a specific mosquito Kir channel (AeKir1) in the yellow fever mosquito Aedes aegypti. We show that VU590, a small-molecule inhibitor of mammalian Kir1.1 and Kir7.1 channels, potently inhibits AeKir1 but not another mosquito Kir channel (AeKir2B) in vitro. Moreover, we show that a previously identified inhibitor of AeKir1 (VU573) elicits an unexpected agonistic effect on AeKir2B in vitro. Injection of VU590 into the hemolymph of adult female mosquitoes significantly inhibits their capacity to excrete urine and kills them within 24 h, suggesting a mechanism of action on the excretory system. Importantly, a structurally-related VU590 analog (VU608), which weakly blocks AeKir1 in vitro, has no significant effects on their excretory capacity and does not kill mosquitoes. These observations suggest that the toxic effects of VU590 are associated with its inhibition of AeKir1.	[Rouhier, Matthew F.; Piermarini, Peter M.] Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Entomol, Wooster, OH 44691 USA; [Raphemot, Rene; Denton, Jerod S.] Vanderbilt Univ, Sch Med, Dept Anesthesiol, Nashville, TN 37212 USA; [Raphemot, Rene; Denton, Jerod S.] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; [Denton, Jerod S.] Vanderbilt Univ, Sch Med, Inst Chem Biol, Nashville, TN 37212 USA; [Denton, Jerod S.] Vanderbilt Univ, Sch Med, Inst Global Hlth, Nashville, TN 37212 USA	University System of Ohio; Ohio State University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Denton, JS (corresponding author), Vanderbilt Univ, Sch Med, Dept Anesthesiol, Nashville, TN 37212 USA.	jerod.s.denton@vanderbilt.edu; piermarini.1@osu.edu	Piermarini, Peter/AAO-5666-2021	Piermarini, Peter/0000-0003-1020-5774	Foundation for the National Institutes of Health through the Vector-Based Transmission of Control: Discovery Research (VCTR) program of the Grand Challenges in Global Health initiative; National Institute of Diabetes and Digestive and Kidney Diseases [1R01DK082884]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082884] Funding Source: NIH RePORTER	Foundation for the National Institutes of Health through the Vector-Based Transmission of Control: Discovery Research (VCTR) program of the Grand Challenges in Global Health initiative; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funded by a grant from the Foundation for the National Institutes of Health through the Vector-Based Transmission of Control: Discovery Research (VCTR) program of the Grand Challenges in Global Health initiative. This work was also supported in part by a grant from the National Institute of Diabetes and Digestive and Kidney Diseases (1R01DK082884; JSD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asidi A, 2012, EMERG INFECT DIS, V18, P1101, DOI 10.3201/eid1807.120218; Bhatt S, 2013, NATURE; Bhave G, 2010, FUTURE MED CHEM, V2, P757, DOI 10.4155/FMC.10.179; Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873; Greenwood B, 2012, SCIENCE, V338, P49, DOI 10.1126/science.1229177; Hemingway J, 2006, TRENDS PARASITOL, V22, P308, DOI 10.1016/j.pt.2006.05.003; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Lewis LM, 2009, MOL PHARMACOL, V76, P1094, DOI 10.1124/mol.109.059840; MAHARAJ R, 2011, OPEN ACCESS INSECT P, V3, P27, DOI DOI 10.2147/OAIP.S8620; Piermarini PM, 2013, INSECT BIOCHEM MOLEC, V43, P75, DOI 10.1016/j.ibmb.2012.09.009; Piermarini PM, 2010, AM J PHYSIOL-REG I, V298, pR642, DOI 10.1152/ajpregu.00729.2009; Piermarini PM, 2009, AM J PHYSIOL-RENAL, V296, pF730, DOI 10.1152/ajprenal.90564.2008; Raphemot R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064905; Raphemot R, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00075; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; Rouhier MF, 2014, INSECT BIOCHEM MOLEC, V48, P91, DOI 10.1016/j.ibmb.2014.03.003; WHO, 2013, WORLD MALARIA REPORT 2013, P1	17	30	32	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100700	10.1371/journal.pone.0100700	http://dx.doi.org/10.1371/journal.pone.0100700			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959745	Green Published, Green Submitted, gold			2022-12-27	WOS:000338633900071
J	Stocks, M; Siol, M; Lascoux, M; De Mita, S				Stocks, Michael; Siol, Mathieu; Lascoux, Martin; De Mita, Stephane			Amount of Information Needed for Model Choice in Approximate Bayesian Computation	PLOS ONE			English	Article							DEMOGRAPHIC HISTORY; POPULATION-SIZE; NUCLEOTIDE DIVERSITY; STATISTICS; BOTTLENECK; INFERENCE; SELECTION; PATTERNS; GENETICS	Approximate Bayesian Computation (ABC) has become a popular technique in evolutionary genetics for elucidating population structure and history due to its flexibility. The statistical inference framework has benefited from significant progress in recent years. In population genetics, however, its outcome depends heavily on the amount of information in the dataset, whether that be the level of genetic variation or the number of samples and loci. Here we look at the power to reject a simple constant population size coalescent model in favor of a bottleneck model in datasets of varying quality. Not only is this power dependent on the number of samples and loci, but it also depends strongly on the level of nucleotide diversity in the observed dataset. Whilst overall model choice in an ABC setting is fairly powerful and quite conservative with regard to false positives, detecting weaker bottlenecks is problematic in smaller or less genetically diverse datasets and limits the inferences possible in non-model organism where the amount of information regarding the two models is often limited. Our results show it is important to consider these limitations when performing an ABC analysis and that studies should perform simulations based on the size and nature of the dataset in order to fully assess the power of the study.	[Stocks, Michael; Lascoux, Martin] Uppsala Univ, Evolutionary Biol Ctr, Program Plant Ecol & Evolut, Dept Ecol & Genet, Uppsala, Sweden; [Siol, Mathieu] INRA, UMR Agroecol, F-21034 Dijon, France; [De Mita, Stephane] INRA, UMR Interact Arbres Microorganismes IAM, Nancy, France; [De Mita, Stephane] Inst Rech Dev, UMR Divers & Adaptat Plantes Cultivees, Montpellier, France	Uppsala University; INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; INRAE; Universite de Lorraine; Institut de Recherche pour le Developpement (IRD)	Stocks, M (corresponding author), Uppsala Univ, Evolutionary Biol Ctr, Program Plant Ecol & Evolut, Dept Ecol & Genet, Uppsala, Sweden.	mspopgen@gmail.com	Stocks, Michael/P-5417-2014	Stocks, Michael/0000-0003-3344-6036; Lascoux, Martin/0000-0003-1699-9042	European Community's Seventh Framework Programme (FP7) [211868]; Eranet Biodiversa LINKTREE project; Eranet Biodiversa TIPTREE project; Agropolis Fondation; EBC graduate school on Genomes and Phenotypes at Uppsala University	European Community's Seventh Framework Programme (FP7); Eranet Biodiversa LINKTREE project; Eranet Biodiversa TIPTREE project; Agropolis Fondation; EBC graduate school on Genomes and Phenotypes at Uppsala University	This work was supported by the European Community's Seventh Framework Programme (FP7/20072013), under grant agreement 211868 (Project Noveltree) and the Eranet Biodiversa LINKTREE and TIPTREE projects. M. Siol and S. De Mita were funded by Agropolis Fondation. The research trip of M. Stocks to IRD was funded by the EBC graduate school on Genomes and Phenotypes at Uppsala University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeschbacher S, 2012, GENETICS, V192, P1027, DOI 10.1534/genetics.112.143164; Beaumont MA, 2002, GENETICS, V162, P2025; Beaumont MA, 2010, ANNU REV ECOL EVOL S, V41, P379, DOI 10.1146/annurev-ecolsys-102209-144621; Blum MGB, 2013, STAT SCI, V28, P189, DOI 10.1214/12-STS406; Bodare S, 2013, ECOL EVOL, V3, P3320, DOI 10.1002/ece3.698; Burr T, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/210646; Caicedo AL, 2007, PLOS GENET, V3, P1745, DOI 10.1371/journal.pgen.0030163; Chan YL, 2006, PLOS GENET, V2, P451, DOI 10.1371/journal.pgen.0020059; Chikhi L, 2010, GENETICS, V186, P983, DOI 10.1534/genetics.110.118661; Clotault J, 2012, MOL BIOL EVOL, V29, P1199, DOI 10.1093/molbev/msr287; De Mita S, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-27; Estoup A, 2012, MOL ECOL RESOUR, V12, P846, DOI 10.1111/j.1755-0998.2012.03153.x; Fay JC, 2000, GENETICS, V155, P1405; Fearnhead P, 2012, J R STAT SOC B, V74, P419, DOI 10.1111/j.1467-9868.2011.01010.x; Gattepaille LM, 2013, HEREDITY, V110, P409, DOI 10.1038/hdy.2012.120; Hamilton G, 2005, GENETICS, V170, P409, DOI 10.1534/genetics.104.034199; Heuertz M, 2006, GENETICS, V174, P2095, DOI 10.1534/genetics.106.065102; Hickerson MJ, 2006, MOL ECOL, V15, P209, DOI 10.1111/j.1365-294X.2005.02718.x; Huang W, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-1; Jeffreys H., 1948, INT SERIES MONOGRAPH, V2a; Joyce P, 2008, STAT APPL GENET MOL, V7; Li JR, 2012, MOL ECOL, V21, P28, DOI 10.1111/j.1365-294X.2011.05308.x; Li S, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-22; Marin JM, 2013, J ROYAL STAT SOC B; Nei M., 1987, MOL EVOLUTIONARY GEN; Ness RW, 2010, GENETICS, V184, P381, DOI 10.1534/genetics.109.110130; Nunes MA, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1576; Peter BM, 2010, MOL ECOL, V19, P4648, DOI 10.1111/j.1365-294X.2010.04783.x; Prangle D, 2014, STAT APPL GENET MOL, V13, P67, DOI 10.1515/sagmb-2013-0012; Robert CP, 2011, P NATL ACAD SCI USA, V108, P15112, DOI 10.1073/pnas.1102900108; Siol M, 2010, NEW PHYTOL, V188, P313, DOI 10.1111/j.1469-8137.2010.03401.x; TAJIMA F, 1989, GENETICS, V123, P597; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; Thornton K, 2006, GENETICS, V172, P1607, DOI 10.1534/genetics.105.048223; Wakeley J., 2009, COALESCENT THEORY IN, V1; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wegmann D, 2009, GENETICS, V182, P1207, DOI 10.1534/genetics.109.102509	38	7	7	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e99581	10.1371/journal.pone.0099581	http://dx.doi.org/10.1371/journal.pone.0099581			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959900	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000338633900009
J	Poblador-Plou, B; van den Akker, M; Vos, R; Calderon-Larranaga, A; Metsemakers, J; Prados-Torres, A				Poblador-Plou, Beatriz; van den Akker, Marjan; Vos, Rein; Calderon-Larranaga, Amaia; Metsemakers, Job; Prados-Torres, Alexandra			Similar Multimorbidity Patterns in Primary Care Patients from Two European Regions: Results of a Factor Analysis	PLOS ONE			English	Article							HEALTH-CARE; COMORBIDITY; DISORDERS; MORBIDITY	Objective: To compare the similarities among the multimorbidity patterns identified in primary care patients from two European regions (Spain and the Netherlands) with similar organisational features of their primary care systems, using validated methodologies. Methodology: This observational, retrospective, multicentre study analysed information from primary care electronic medical records. Multimorbidity patterns were assessed using exploratory factor analysis of the diagnostic information of patients over 14 years of age. The analysis was stratified by age groups and sex. Results: The analysis of Dutch data revealed a higher prevalence of multimorbidity which corresponds with the clustering of a higher number of diseases in each of the patterns. Relevant clinical similarities were found between both countries for three multimorbidity patterns that were previously identified in the original Spanish study: cardiometabolic, mechanical and psychiatric-substance abuse. In addition, the clinical evolution towards complexity of the cardiometabolic pattern with advancing age -already demonstrated in the original study-was corroborated in the Dutch context. A clear association between mechanical and psychosocial disorders was unique to the Dutch population, as well as the recurrent presentation of the psychiatric-substance abuse pattern in all age and sex groups. Conclusions: The similarities found for the cardiometabolic, mechanical and psychiatric-substance abuse patterns in primary care patients from two different European countries could offer initial clues for the elaboration of clinical practice guidelines, if further evidenced in other contexts. This study also endorses the use of primary care electronic medical records for the epidemiologic characterization of multimorbidity.	[Poblador-Plou, Beatriz; Calderon-Larranaga, Amaia; Prados-Torres, Alexandra] Miguel Servet Univ Hosp, IIS Aragon, Aragon Hlth Sci Inst IACS, EpiChron Res Grp Chron Dis, Zaragoza, Spain; [Poblador-Plou, Beatriz; Calderon-Larranaga, Amaia; Prados-Torres, Alexandra] Carlos III Hlth Inst, Red Invest Serv Salud Enfermedades Cron REDISSEC, Madrid, Spain; [Poblador-Plou, Beatriz; Calderon-Larranaga, Amaia; Prados-Torres, Alexandra] IIS Aragon, Aragon Hlth Sci Inst IACS, Teaching Unit Prevent Med & Publ Hlth, Zaragoza, Spain; [van den Akker, Marjan; Vos, Rein; Metsemakers, Job] Maastricht Univ, Dept Family Med, CAPHRI Sch Publ Hlth & Primary Care, Maastricht, Netherlands; [van den Akker, Marjan] Katholieke Univ Leuven, Dept Gen Practice, Leuven, Belgium; [Calderon-Larranaga, Amaia; Prados-Torres, Alexandra] Univ Zaragoza, Dept Microbiol Prevent Med & Publ Hlth, Zaragoza, Spain	Miguel Servet University Hospital; Maastricht University; KU Leuven; University of Zaragoza	Poblador-Plou, B (corresponding author), Miguel Servet Univ Hosp, IIS Aragon, Aragon Hlth Sci Inst IACS, EpiChron Res Grp Chron Dis, Zaragoza, Spain.	bpoblador.iacs@aragon.es	Poblador-Plou, Beatriz/ABC-7915-2020; Calderón-Larrañaga, Amaia/ABC-6828-2021; Prados-Torres, Alexandra/P-5818-2017	Poblador-Plou, Beatriz/0000-0002-5119-5093; Calderón-Larrañaga, Amaia/0000-0001-9064-9222; Prados-Torres, Alexandra/0000-0002-5704-6056; van den Akker, Marjan/0000-0002-1022-8637	Carlos III Health Institute [PI11/01126]; Europe XXI Programme for Research Fellowships (Caja Inmaculada grant-making foundation)	Carlos III Health Institute(Instituto de Salud Carlos III); Europe XXI Programme for Research Fellowships (Caja Inmaculada grant-making foundation)	This study was funded by grant PI11/01126 from the Carlos III Health Institute. BPP received a Grant from the Europe XXI Programme for Research Fellowships (Caja Inmaculada grant-making foundation, 2012) to carry out this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Caughey Gillian E, 2011, J Comorb, V1, P8; Chevreul K., 2010, HLTH SYST TRANSIT, V12, P1, DOI DOI 10.1038/KI.2015.25; Cornell JE, 2007, APPL MULTIVARIATE RE, V2007, P163, DOI [10.22329/amr.v12i3.658, DOI 10.22329/AMR.V12I3.658]; Fortin M, 2006, QUAL LIFE RES, V15, P83, DOI 10.1007/s11136-005-8661-z; France EF, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X636146; Garin N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084794; Gijsen R, 2001, J CLIN EPIDEMIOL, V54, P661, DOI 10.1016/S0895-4356(00)00363-2; Goodman RA, 2012, ANN FAM MED, V10, P100, DOI 10.1370/afm.1391; Hughes LD, 2013, AGE AGEING, V42, P62, DOI 10.1093/ageing/afs100; Islam MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083783; Kraatz S, 2013, INT ARCH OCC ENV HEA, V86, P375, DOI 10.1007/s00420-013-0848-y; Kubinger K., 2003, PSYCHOL SCI, V45, P106, DOI DOI 10.1177/014662169101500105; Lamberts H., 1987, ICPC INT CLASSIFICAT; Mangin D, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3526; Mercer Stewart W, 2011, J Comorb, V1, P4; METSEMAKERS JFM, 1992, BRIT J GEN PRACT, V42, P102; NICE website, NICE SHOULD PROD GUI; Olaya-Contreras P, 2013, SCAND J PUBLIC HEALT, V41, P247, DOI 10.1177/1403494812473380; Prados-Torres A, 2014, J CLIN EPIDEMIOL, V67, P254, DOI 10.1016/j.jclinepi.2013.09.021; Prados-Torres A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032190; Salisbury C, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X548929; Schafer A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014060; Stewart M, 2013, FAM PRACT, V30, P473, DOI 10.1093/fampra/cmt012; Tabchnic B, 2006, USING MULTIVARIATE S; The Johns Hopkins ACG&REG;System, 2008, REF MAN VERS 8 2; van den Bussche H, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-101; van den Dungen C, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-887; Wang PS, 2007, LANCET, V370, P841, DOI 10.1016/S0140-6736(07)61414-7; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269	30	30	30	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100375	10.1371/journal.pone.0100375	http://dx.doi.org/10.1371/journal.pone.0100375			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956475	gold, Green Published, Green Submitted			2022-12-27	WOS:000338917900045
J	Chung, SD; Liu, SP; Lin, HC; Wang, LH				Chung, Shiu-Dong; Liu, Shih-Ping; Lin, Herng-Ching; Wang, Li-Hsuan			Increased Risk of Pneumonia in Patients Receiving Gonadotropin-Releasing Hormone Agonists for Prostate Cancer	PLOS ONE			English	Article							ANDROGEN; INFECTION	Background: This study aimed to investigate the relationship between the use of gonadotropin-releasing hormone (GnRH) agonists and subsequent risk of pneumonia in patients with prostate cancer (PC) using a population-based dataset. Methods: We obtained the data from Taiwan's Longitudinal Health Insurance Database 2000. We included 2064 PC in this study. Of the sampled PC patients, 1207 received treatment with GnRH agonists. We individually traced each PC patient for a 1-year period to identify those who were hospitalized with pneumonia. We performed a Cox proportional hazard regression to explore the association between the use of GnRH agonists and the risk of pneumonia during the 1-year follow-up period. Results: Incidence rates of pneumonia during the 1-year follow-up period were 4.35 (95% confidence interval (CI): 1.89 similar to 9.64) per 100 person-years and 2.14 (95% CI: 1.31 similar to 3.32) per 100 person-years for PC patients who did and those who did not receive treatment with GnRH agonists, respectively. The log-rank test suggested that there was a significant difference in the 1-year pneumonia-free survival rate between PC patients who did and those who did not receive treatment with GnRH agonists (p < 0.002). After adjusting for age, monthly income, and the Charlson Comorbidities Index score, PC patients who received treatment with GnRH agonists were more likely to have been hospitalized for pneumonia during the 1-year follow-up period than PC patients who did not receive treatment with GnRH agonists (hazard ratio: 1.92, 95% CI: 1.10 similar to 3.36). Conclusions: PC patients who received treatment with GnRH agonists had an increased risk of pneumonia.	[Chung, Shiu-Dong] Far Eastern Mem Hosp, Dept Surg, Div Urol, New Taipei City, Taiwan; [Chung, Shiu-Dong] Fu Jen Catholic Univ, Sch Med, New Taipei City, Taiwan; [Chung, Shiu-Dong; Lin, Herng-Ching] Taipei Med Univ Hosp, Sleep Res Ctr, Taipei, Taiwan; [Liu, Shih-Ping] Natl Taiwan Univ Hosp, Dept Urol, Taipei, Taiwan; [Liu, Shih-Ping] Coll Med, Taipei, Taiwan; [Lin, Herng-Ching] Taipei Med Univ, Sch Hlth Care Adm, Taipei, Taiwan; [Wang, Li-Hsuan] Taipei Med Univ, Sch Pharm, Taipei, Taiwan; [Wang, Li-Hsuan] Taipei Med Univ Hosp, Dept Pharm, Taipei, Taiwan	Far Eastern Memorial Hospital; Fu Jen Catholic University; Taipei Medical University; Taipei Medical University Hospital; National Taiwan University; National Taiwan University Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital	Wang, LH (corresponding author), Taipei Med Univ, Sch Pharm, Taipei, Taiwan.	shiuan@tmu.edu.tw	Wang, Li-Hsuan/AAU-3257-2021	LIU, SHIH-PING/0000-0002-8015-0695				Chen YC, 2011, SCIENTOMETRICS, V86, P365, DOI 10.1007/s11192-010-0289-2; Chuang KH, 2009, J EXP MED, V206, P1181, DOI 10.1084/jem.20082521; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Garcia-Gomez E, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/928290; Klein SL, 2000, NEUROSCI BIOBEHAV R, V24, P627, DOI 10.1016/S0149-7634(00)00027-0; Kosyreva AM, 2013, B EXP BIOL MED+, V154, P480, DOI 10.1007/s10517-013-1982-y; Labrie F, 2005, ENDOCR REV, V26, P361, DOI 10.1210/er.2004-0017; Nelson WG, 2003, NEW ENGL J MED, V349, P366, DOI 10.1056/NEJMra021562; Ojeda MS, 1997, LIPIDS, V32, P57, DOI 10.1007/s11745-997-0009-0; Ojeda MS, 2000, BRAZ J MED BIOL RES, V33, P279, DOI 10.1590/S0100-879X2000000300004; Plotkin BJ, 2003, CURR MICROBIOL, V47, P514, DOI 10.1007/s00284-003-4080-y; Quintar AA, 2012, INT J ANDROL, V35, P845, DOI 10.1111/j.1365-2605.2012.01288.x; Schroder F, 2012, BJU INT, V109, P1, DOI 10.1111/j.1464-410X.2012.11215.x; van den Bergh RCN, 2009, CANCER-AM CANCER SOC, V115, P3868, DOI 10.1002/cncr.24446	14	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e101254	10.1371/journal.pone.0101254	http://dx.doi.org/10.1371/journal.pone.0101254			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971988	Green Published, gold, Green Submitted			2022-12-27	WOS:000338512200108
J	Cui, X; Geffers, L; Eichele, G; Yan, J				Cui, Xiao; Geffers, Lars; Eichele, Gregor; Yan, Jun			A Computational Approach to Estimate Interorgan Metabolic Transport in a Mammal	PLOS ONE			English	Article							AMINO-ACID-TRANSPORT; MEMBRANE-TRANSPORT; RENAL METABOLISM; GENOME; RECONSTRUCTION; NETWORK; LIVER; PHYSIOLOGY; KIDNEY; INSUFFICIENCY	In multicellular organisms metabolism is distributed across different organs, each of which has specific requirements to perform its own specialized task. But different organs also have to support the metabolic homeostasis of the organism as a whole by interorgan metabolite transport. Recent studies have successfully reconstructed global metabolic networks in tissues and cell types and attempts have been made to connect organs with interorgan metabolite transport. Instead of these complicated approaches to reconstruct global metabolic networks, we proposed in this study a novel approach to study interorgan metabolite transport focusing on transport processes mediated by solute carrier (Slc) transporters and their couplings to cognate enzymatic reactions. We developed a computational approach to identify and score potential interorgan metabolite transports based on the integration of metabolism and transports in different organs in the adult mouse from quantitative gene expression data. This allowed us to computationally estimate the connectivity between 17 mouse organs via metabolite transport. Finally, by applying our method to circadian metabolism, we showed that our approach can shed new light on the current understanding of interorgan metabolite transport at a whole-body level in mammals.	[Cui, Xiao; Yan, Jun] CAS MPG Partner Inst Computat Biol, Funct Genom Grp, Shanghai, Peoples R China; [Geffers, Lars; Eichele, Gregor] Max Planck Inst Biophys Chem, Dept Genes & Behav, D-37077 Gottingen, Germany	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Max Planck Society	Yan, J (corresponding author), CAS MPG Partner Inst Computat Biol, Funct Genom Grp, Shanghai, Peoples R China.	junyan@picb.ac.cn		Geffers, Lars/0000-0001-6800-4305	Chinese Academy of Sciences; German Max-Planck Society	Chinese Academy of Sciences(Chinese Academy of Sciences); German Max-Planck Society(Max Planck Society)	This research was supported by Chinese Academy of Sciences and German Max-Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Bean GJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r123; Becker SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000082; BIOLO G, 1995, METABOLISM, V44, P719, DOI 10.1016/0026-0495(95)90183-3; Bordbar A, 2012, J INTERN MED, V271, P131, DOI 10.1111/j.1365-2796.2011.02494.x; Bordbar A, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-180; Bordbar A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.68; Brosnan JT, 2003, J NUTR, V133, p2068S, DOI 10.1093/jn/133.6.2068S; BROSNAN JT, 1987, CAN J PHYSIOL PHARM, V65, P2355, DOI 10.1139/y87-373; Capel F, 2009, DIABETES, V58, P1558, DOI 10.2337/db09-0033; CHRISTENSEN HN, 1982, PHYSIOL REV, V62, P1193, DOI 10.1152/physrev.1982.62.4.1193; Cori C F, 1981, Curr Top Cell Regul, V18, P377; DANTZLER WH, 1988, AM J PHYSIOL, V255, pF397, DOI 10.1152/ajprenal.1988.255.3.F397; DEJONG CHC, 1993, HEPATOLOGY, V18, P890, DOI 10.1002/hep.1840180422; Dejong CHC, 1998, CLIN SCI, V95, P409, DOI 10.1042/CS19980002; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Ferreira GK, 2013, NEUROTOX RES, V23, P327, DOI 10.1007/s12640-012-9345-4; Folger O, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.35; Gerich JE, 2010, DIABETIC MED, V27, P136, DOI 10.1111/j.1464-5491.2009.02894.x; Gille C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.62; Ideker T, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2011.99; Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233; Jerby L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.56; Joyce AR, 2006, NAT REV MOL CELL BIO, V7, P198, DOI 10.1038/nrm1857; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; KNELL AJ, 1974, BMJ-BRIT MED J, V1, P549, DOI 10.1136/bmj.1.5907.549; Lewis NE, 2010, NAT BIOTECHNOL, V28, P1279, DOI 10.1038/nbt.1711; Minami Y, 2009, P NATL ACAD SCI USA, V106, P9890, DOI 10.1073/pnas.0900617106; Moraes TF, 2012, BBA-BIOMEMBRANES, V1818, P2687, DOI 10.1016/j.bbamem.2012.06.007; Najman L, 2004, P SOC PHOTO-OPT INS, V5300, P98, DOI 10.1117/12.526592; Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77; Oster H, 2006, CELL METAB, V4, P163, DOI 10.1016/j.cmet.2006.07.002; Schellenberger J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-213; Schilling CH, 2000, J THEOR BIOL, V203, P229, DOI 10.1006/jtbi.2000.1073; Shlomi T, 2008, NAT BIOTECHNOL, V26, P1003, DOI 10.1038/nbt.1487; Sigurdsson MI, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-140; SILBERNAGL S, 1988, PHYSIOL REV, V68, P911, DOI 10.1152/physrev.1988.68.3.911; SNELL K, 1986, BIOCHEM J, V233, P617, DOI 10.1042/bj2330617; Thiele I, 2013, NAT BIOTECHNOL; TIZIANELLO A, 1980, J CLIN INVEST, V65, P1162, DOI 10.1172/JCI109771; van de Poll MCG, 2007, AM J CLIN NUTR, V85, P167, DOI 10.1093/ajcn/85.1.167; van de Poll MCG, 2004, AM J CLIN NUTR, V79, P185; Wang YL, 2012, BMC SYST BIOL, V6, DOI [10.1186/1752-0509-6-153, 10.1186/1752-0509-6-S3-S21]; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; Yan J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000193	45	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100963	10.1371/journal.pone.0100963	http://dx.doi.org/10.1371/journal.pone.0100963			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971892	Green Published, gold, Green Submitted			2022-12-27	WOS:000338512200075
J	Guo, ZQ; Wang, HQ; Liu, Q; Yang, J				Guo, Zhiqiang; Wang, Huaiqing; Liu, Quan; Yang, Jie			A Feature Fusion Based Forecasting Model for Financial Time Series	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; SUPPORT VECTOR MACHINES; DIMENSIONALITY REDUCTION; MARKET; ICA; RECOGNITION; REGRESSION	Predicting the stock market has become an increasingly interesting research area for both researchers and investors, and many prediction models have been proposed. In these models, feature selection techniques are used to pre-process the raw data and remove noise. In this paper, a prediction model is constructed to forecast stock market behavior with the aid of independent component analysis, canonical correlation analysis, and a support vector machine. First, two types of features are extracted from the historical closing prices and 39 technical variables obtained by independent component analysis. Second, a canonical correlation analysis method is utilized to combine the two types of features and extract intrinsic features to improve the performance of the prediction model. Finally, a support vector machine is applied to forecast the next day's closing price. The proposed model is applied to the Shanghai stock market index and the Dow Jones index, and experimental results show that the proposed model performs better in the area of prediction than other two similar models.	[Guo, Zhiqiang; Liu, Quan; Yang, Jie] Wuhan Univ Technol, Sch Informat Engn, Key Lab Fiber Opt Sensing Technol & Informat Proc, Wuhan 430070, Peoples R China; [Wang, Huaiqing] South Univ Sci & Technol China, Dept Financial Math & Financial Engn, Shenzhen, Peoples R China	Wuhan University of Technology; Southern University of Science & Technology	Guo, ZQ (corresponding author), Wuhan Univ Technol, Sch Informat Engn, Key Lab Fiber Opt Sensing Technol & Informat Proc, Wuhan 430070, Peoples R China.	guozhiqiang@whut.edu.cn			National Natural Science Foundation of China [51175389]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by National Natural Science Foundation of China (Grant no. 51175389). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achelis S. B., 2013, TECHNICAL ANAL A Z; Ahn H, 2007, EXPERT SYST APPL, V33, P181, DOI 10.1016/j.eswa.2006.04.016; Amari S, 1996, ADV NEUR IN, V8, P757; Ang KK, 2006, IEEE T NEURAL NETWOR, V17, P1301, DOI 10.1109/TNN.2006.875996; Atsalakis GS, 2009, EXPERT SYST APPL, V36, P5932, DOI 10.1016/j.eswa.2008.07.006; Bartlett MS, 2002, IEEE T NEURAL NETWOR, V13, P1450, DOI 10.1109/TNN.2002.804287; Batal I, 2009, EIGHTH INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND APPLICATIONS, PROCEEDINGS, P735, DOI 10.1109/ICMLA.2009.13; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Bunau P., 2009, PHYS REV LETT, V103; Cao LJ, 2003, NEUROCOMPUTING, V55, P321, DOI 10.1016/S0925-2312(03)00433-8; Cao LJ, 2003, NEUROCOMPUTING, V51, P321, DOI 10.1016/S0925-2312(02)00577-5; Cao LJ, 2003, IEEE T NEURAL NETWOR, V14, P1506, DOI 10.1109/TNN.2003.820556; Cardoso J, 1993, RADAR SIGNAL PROCESS, V140, P771; Chen AS, 2003, COMPUT OPER RES, V30, P901, DOI 10.1016/S0305-0548(02)00037-0; Cowles A, 1937, ECONOMETRICA, V5, P280, DOI 10.2307/1905515; Cui B., 2010, P 2010 ACM SIGMOD IN, P435; Das S.P., 2012, INT J COMPUTER APPL, V41, P22, DOI DOI 10.5120/5522-7555; Dong Y, 2006, J TIANJIN U TECHNOLO, V22, P24; Ettes D., 2000, Proceedings of the IEEE/IAFE/INFORMS 2000 Conference on Computational Intelligence for Financial Engineering (CIFEr) (Cat. No.00TH8520), P22, DOI 10.1109/CIFER.2000.844591; FELSEN J, 1975, IEEE T SYST MAN CYB, V5, P583, DOI 10.1109/TSMC.1975.4309399; Fu T., 2001, P KDD 2001 WORKSH TE, P27; Guo C, 2001, SYSTEMS ENG THEORY P, V31, P1921; Hall DL, 1997, P IEEE, V85, P6, DOI 10.1109/5.554205; He WW, 2008, NEUROCOMPUTING, V72, P600, DOI 10.1016/j.neucom.2007.11.010; Hong ZQ, 1999, PATTERN RECOGN, V24, P317; Hotelling H, 1936, BIOMETRIKA, V28, P321, DOI 10.2307/2333955; Hsieh TJ, 2011, APPL SOFT COMPUT, V11, P2510, DOI 10.1016/j.asoc.2010.09.007; Huang SC, 2010, SMART INNOV SYST TEC, V4, P163; Huang W, 2005, COMPUT OPER RES, V32, P2513, DOI 10.1016/j.cor.2004.03.016; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Hyvarinen A, 1996, PROGR NEURAL INFORMA, V2, P1201; Ince H, 2007, IIE TRANS, V39, P629, DOI 10.1080/07408170600897486; Keogh E., 2001, Knowledge and Information Systems, V3, P263, DOI 10.1007/PL00011669; Kim KJ, 2003, NEUROCOMPUTING, V55, P307, DOI 10.1016/S0925-2312(03)00372-2; Kwak N, 2008, NEUROCOMPUTING, V71, P2596, DOI 10.1016/j.neucom.2007.11.036; Laloux L, 1999, PHYS REV LETT, V83, P1467, DOI 10.1103/PhysRevLett.83.1467; Lendasse A., 2001, European Journal of Economic and Social Systems, V15, P31, DOI 10.1051/ejess:2001114; Liang J, 2011, ADV ARTIFICIAL NEURA, DOI [10.1155/2011/814769, DOI 10.1155/2011/814769]; Lizieri C, 2007, REAL ESTATE ECON, V35, P569, DOI 10.1111/j.1540-6229.2007.00201.x; Lu CJ, 2010, INT J PROD ECON, V128, P603, DOI 10.1016/j.ijpe.2010.07.004; Lu CJ, 2010, EXPERT SYST APPL, V37, P7056, DOI 10.1016/j.eswa.2010.03.012; Lu CJ, 2009, DECIS SUPPORT SYST, V47, P115, DOI 10.1016/j.dss.2009.02.001; LUO FQ, 2010, P 8 WORLD C INT CONT, P5048; Matteson DS, 2011, J AM STAT ASSOC, V106, P1450, DOI 10.1198/jasa.2011.tm10616; Mok PY, 2004, IEEE IJCNN, P2135; Padhiary PK, 2011, INT J ENG SCI, V3, P1576; Parras-Gutierrez E, 2012, SOFT COMPUT, V16, P919, DOI 10.1007/s00500-011-0784-2; Perng C.-S., 2000, Proceedings of 16th International Conference on Data Engineering (Cat. No.00CB37073), P33, DOI 10.1109/ICDE.2000.839385; Pinquier J, 2012, INT C PATT RECOG, P3192; Plerou V, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.066126; Saigal S., 2012, ADV INF MIN, V4, P57; Samsudin R., 2010, Journal of Applied Sciences, V10, P950, DOI 10.3923/jas.2010.950.958; Su SZ, 2013, ABSTR APPL ANAL, DOI 10.1155/2013/436062; Sui XS, 2007, PROCEEDINGS OF 2007 INTERNATIONAL CONFERENCE ON MANAGEMENT SCIENCE & ENGINEERING (14TH) VOLS 1-3, P1654; Sun QS, 2005, PATTERN RECOGN, V38, P2437, DOI 10.1016/j.patcog.2004.12.013; Sutheebanjard Phaisarn, 2010, Proceedings of the 2010 Second International Conference on Computer and Network Technology (ICCNT 2010), P377, DOI 10.1109/ICCNT.2010.21; Tay FEH, 2002, NEUROCOMPUTING, V48, P847, DOI 10.1016/S0925-2312(01)00676-2; Teixeira LA, 2010, EXPERT SYST APPL, V37, P6885, DOI 10.1016/j.eswa.2010.03.033; Vapnik V., 2013, NATURE STAT LAERNING; Verleysen M, 2005, LECT NOTES COMPUT SC, V3512, P758; White H., 1988, IEEE International Conference on Neural Networks (IEEE Cat. No.88CH2632-8), P451, DOI 10.1109/ICNN.1988.23959; Wu E, 2005, LECT NOTES COMPUTER, V3578, P179; [吴建星 WU Jianxing], 2007, [火工品, Initiators & Pyrotechnics], P18; Yeh CC, 2009, 29 ANN INT S FOR HON, P21; Yu L, 2009, IEEE T EVOLUT COMPUT, V13, P87, DOI 10.1109/TEVC.2008.928176; Zhao YC, 2006, IEEE T KNOWL DATA EN, V18, P231, DOI 10.1109/TKDE.2006.30; Zorin A, 2002, MODELLING RIGA STOCK	68	18	18	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e101113	10.1371/journal.pone.0101113	http://dx.doi.org/10.1371/journal.pone.0101113			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971455	gold, Green Published, Green Submitted			2022-12-27	WOS:000338512200094
J	Flibotte, JJ; Jablonski, AM; Kalb, RG				Flibotte, John J.; Jablonski, Angela M.; Kalb, Robert G.			Oxygen Sensing Neurons and Neuropeptides Regulate Survival after Anoxia in Developing C-elegans	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; SUSPENDED ANIMATION; GUANYLATE CYCLASES; CELL-CYCLE; PROTEINS	Hypoxic brain injury remains a major source of neurodevelopmental impairment for both term and preterm infants. The perinatal period is a time of rapid transition in oxygen environments and developmental resetting of oxygen sensing. The relationship between neural oxygen sensing ability and hypoxic injury has not been studied. The oxygen sensing circuitry in the model organism C. elegans is well understood. We leveraged this information to investigate the effects of impairments in oxygen sensing on survival after anoxia. There was a significant survival advantage in developing worms specifically unable to sense oxygen shifts below their preferred physiologic range via genetic ablation of BAG neurons, which appear important for conferring sensitivity to anoxia. Oxygen sensing that is mediated through guanylate cyclases (gcy-31, 33, 35) is unlikely to be involved in conferring this sensitivity. Additionally, animals unable to process or elaborate neuropeptides displayed a survival advantage after anoxia. Based on these data, we hypothesized that elaboration of neuropeptides by BAG neurons sensitized animals to anoxia, but further experiments indicate that this is unlikely to be true. Instead, it seems that neuropeptides and signaling from oxygen sensing neurons operate through independent mechanisms, each conferring sensitivity to anoxia in wild type animals.	[Flibotte, John J.] Childrens Hosp Philadelphia, Dept Pediat, Div Neonatol, Philadelphia, PA 19104 USA; [Jablonski, Angela M.] Univ Penn, Perelman Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA; [Kalb, Robert G.] Childrens Hosp Philadelphia, Dept Pediat, Res Inst, Div Neurol, Philadelphia, PA 19104 USA; [Kalb, Robert G.] Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Kalb, RG (corresponding author), Childrens Hosp Philadelphia, Dept Pediat, Res Inst, Div Neurol, Philadelphia, PA 19104 USA.	kalb@email.chop.edu			NIH Office of Research Infrastructure Programs [P40 OD010440]; NIH [T32 HD060556-02]; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Children's Hospital of Philadelphia Neonatology Fellows' Research Fund; L. Morton Morley Fund of the Philadelphia Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD060556] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	NIH Office of Research Infrastructure Programs; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Children's Hospital of Philadelphia Neonatology Fellows' Research Fund; L. Morton Morley Fund of the Philadelphia Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Some strains used in this work were provided by the CGC, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440). The authors gratefully acknowledge the following additional funding sources, which supported this work: NIH T32 HD060556-02, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (JJF), the Children's Hospital of Philadelphia Neonatology Fellows' Research Fund (JJF), and the L. Morton Morley Fund of the Philadelphia Foundation (JJF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRENNER S, 1974, GENETICS, V77, P71; Busch KE, 2012, NAT NEUROSCI, V15, P581, DOI 10.1038/nn.3061; Carrillo MA, 2013, J NEUROSCI, V33, P9675, DOI 10.1523/JNEUROSCI.4541-12.2013; Chang AJ, 2006, PLOS BIOL, V4, P1588, DOI 10.1371/journal.pbio.0040274; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; Higgins RD, 2011, EARLY HUM DEV, V87, pS17, DOI 10.1016/j.earlhumdev.2011.01.004; Hung WL, 2014, DEVELOPMENT, V141, P1767, DOI 10.1242/dev.103846; Hung WL, 2013, EMBO J, V32, P1745, DOI 10.1038/emboj.2013.91; Husson SJ, 2006, J NEUROCHEM, V98, P1999, DOI 10.1111/j.1471-4159.2006.04014.x; Jacobs SE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub3; Kass J, 2001, J NEUROSCI, V21, P9265, DOI 10.1523/JNEUROSCI.21-23-09265.2001; LI C, 2008, NEUROPEPTIDES, DOI DOI 10.1895/WORMBOOK.1.142.1; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Liu TW, 2013, EMBO J, V32, P1529, DOI 10.1038/emboj.2013.75; Mendenhall AR, 2006, GENETICS, V174, P1173, DOI 10.1534/genetics.106.061390; Padilla PA, 2002, MOL BIOL CELL, V13, P1473, DOI 10.1091/mbc.01-12-0594; Padilla PA, 2012, CELL CYCLE, V11, P1672, DOI 10.4161/cc.19444; Prahlad V, 2008, SCIENCE, V320, P811, DOI 10.1126/science.1156093; Prahlad V, 2011, P NATL ACAD SCI USA, V108, P14204, DOI 10.1073/pnas.1106557108; Ringstad N, 2008, NAT NEUROSCI, V11, P1168, DOI 10.1038/nn.2186; Salio C, 2006, CELL TISSUE RES, V326, P583, DOI 10.1007/s00441-006-0268-3; Schmidt J. W., 2010, J NEONATAL PERINAT M, V3, P277, DOI DOI 10.3233/NPM-2010-0126; Speese S, 2007, J NEUROSCI, V27, P6150, DOI 10.1523/JNEUROSCI.1466-07.2007; Tymianski M, 2011, NAT NEUROSCI, V14, P1369, DOI 10.1038/nn.2951; Zimmer M, 2009, NEURON, V61, P865, DOI 10.1016/j.neuron.2009.02.013	25	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e101102	10.1371/journal.pone.0101102	http://dx.doi.org/10.1371/journal.pone.0101102			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967811	gold, Green Submitted, Green Published			2022-12-27	WOS:000338280800107
J	Miller, RR; Field, JC; Santora, JA; Schroeder, ID; Huff, DD; Key, M; Pearson, DE; MacCall, AD				Miller, Rebecca R.; Field, John C.; Santora, Jarrod A.; Schroeder, Isaac D.; Huff, David D.; Key, Meisha; Pearson, Don E.; MacCall, Alec D.			A Spatially Distinct History of the Development of California Groundfish Fisheries	PLOS ONE			English	Article							ONSLOW BAY; CONSERVATION; SEBASTES; COAST; MANAGEMENT; PATTERNS; CATCH; COLLAPSE; BEHAVIOR; DECLINE	During the past century, commercial fisheries have expanded from small vessels fishing in shallow, coastal habitats to a broad suite of vessels and gears that fish virtually every marine habitat on the globe. Understanding how fisheries have developed in space and time is critical for interpreting and managing the response of ecosystems to the effects of fishing, however time series of spatially explicit data are typically rare. Recently, the 1933-1968 portion of the commercial catch dataset from the California Department of Fish and Wildlife was recovered and digitized, completing the full historical series for both commercial and recreational datasets from 1933-2010. These unique datasets include landing estimates at a coarse 10 by 10 minute "grid-block'' spatial resolution and extends the entire length of coastal California up to 180 kilometers from shore. In this study, we focus on the catch history of groundfish which were mapped for each grid-block using the year at 50% cumulative catch and total historical catch per habitat area. We then constructed generalized linear models to quantify the relationship between spatiotemporal trends in groundfish catches, distance from ports, depth, percentage of days with wind speed over 15 knots, SST and ocean productivity. Our results indicate that over the history of these fisheries, catches have taken place in increasingly deeper habitat, at a greater distance from ports, and in increasingly inclement weather conditions. Understanding spatial development of groundfish fisheries and catches in California are critical for improving population models and for evaluating whether implicit stock assessment model assumptions of relative homogeneity of fisheries removals over time and space are reasonable. This newly reconstructed catch dataset and analysis provides a comprehensive appreciation for the development of groundfish fisheries with respect to commonly assumed trends of global fisheries patterns that are typically constrained by a lack of long-term spatial datasets.	[Miller, Rebecca R.; Huff, David D.] Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA; [Miller, Rebecca R.; Field, John C.; Pearson, Don E.; MacCall, Alec D.] NOAA, Fisheries Ecol Div, SW Fisheries Sci Ctr, Natl Marine Fisheries Serv, Santa Cruz, CA USA; [Santora, Jarrod A.] Univ Calif Santa Cruz, Ctr Stock Assessment Res, Santa Cruz, CA 95064 USA; [Schroeder, Isaac D.] NOAA, Div Environm Res, SW Fisheries Sci Ctr, Natl Marine Fisheries Serv, Pacific Grove, CA USA; [Key, Meisha] Natl Marine Fisheries Serv, Calif Dept Fish & Wildlife, SW Fisheries Sci Ctr, Santa Cruz, CA USA	University of California System; University of California Santa Cruz; National Oceanic Atmospheric Admin (NOAA) - USA; University of California System; University of California Santa Cruz; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA	Miller, RR (corresponding author), Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA.	Rebecca.Miller@noaa.gov	MacCall, Alec/AAT-6323-2020; Huff, David/A-8166-2008	MacCall, Alec/0000-0002-0805-7787; Huff, David/0000-0001-9061-7685	NOAA Climate Data Modernization Project (CDMP); NMFS Stock Assessment Improvement Plan; SWFSC California Current Integrated Ecosystem Assessment (IEA)	NOAA Climate Data Modernization Project (CDMP); NMFS Stock Assessment Improvement Plan; SWFSC California Current Integrated Ecosystem Assessment (IEA)	NOAA Climate Data Modernization Project (CDMP), the NMFS Stock Assessment Improvement Plan, and the SWFSC California Current Integrated Ecosystem Assessment (IEA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Anderson S, 2001, FISH FISH, V12, P317; [Anonymous], STATUS DOVER SOLE MI; [Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], 2013, STOCK ASSESSMENT SHO; Barsky K, 1990, FISH B, V174, P174; BARTON K, 2011, MUML PACKAGE MULTIMO; Bellman MA, 2005, CAN J FISH AQUAT SCI, V62, P2886, DOI 10.1139/F05-180; Berkeley SA, 2004, FISHERIES, V29, P23, DOI 10.1577/1548-8446(2004)29[23:FSVPOA]2.0.CO;2; Berkes F, 2006, SCIENCE, V311, P1557, DOI 10.1126/science.1122804; Cadigan S.T., 2001, RES MARITIME HIST, V21, P31; California Department of Fish and Game, 1935, FISH B, V44; California Department of Fish and Game, 1952, FISH B, V86; Cardinale M, 2011, FISH RES, V108, P106, DOI 10.1016/j.fishres.2010.12.007; Cardinale M, 2011, FISH FISH, V12, P289, DOI 10.1111/j.1467-2979.2010.00393.x; Cardinale M, 2009, MAR ECOL PROG SER, V386, P197, DOI 10.3354/meps08076; Christensen AS, 2006, FISH RES, V81, P258, DOI 10.1016/j.fishres.2006.06.018; Clark M, 1999, OCEANOL ACTA, V22, P593, DOI 10.1016/S0399-1784(00)88950-1; Cope JM, 2011, FISH RES, V107, P22, DOI 10.1016/j.fishres.2010.10.002; Dick E.J., 2007, STATUS COWCOD SEBAST; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Dreyfus-Leon MJ, 1999, ECOL MODEL, V120, P287; EPPERLY SP, 1995, B MAR SCI, V56, P450; ESRI, 2010, ARCGIS 10 0 ENV SYST; Field J. C., 2011, STATUS BLACKGILL ROC; Field JC, 2006, FISH FISH, V7, P284, DOI 10.1111/j.1467-2979.2006.00226.x; Gunderson D, 1984, N AM J FISH MANAGE, V4, P465; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2009, CONSERV LETT, V2, P138, DOI 10.1111/j.1755-263X.2009.00058.x; Haltuch M.A., 2013, STATUS US PETRALE SO; Hilborn R, 2012, CONSERV BIOL, V26, DOI 10.1111/j.1523-1739.2011.01800.x; Hill K.T., 1999, SIO REFERENCE SERIES, V99; Hooker SB, 2000, PROG OCEANOGR, V45, P427, DOI 10.1016/S0079-6611(00)00012-4; Huitric M, 2005, ECOL SOC, V10; HUYER A, 1983, PROG OCEANOGR, V12, P259, DOI 10.1016/0079-6611(83)90010-1; IHAKA R., 1996, J COMPUTATIONAL GRAP, V5, P239; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Karpov K, 1995, FISH B, V176; Karpov K., 2000, SERIAL DEPLETION COL; Kasperski S, 2013, P NATL ACAD SCI USA, V110, P2076, DOI 10.1073/pnas.1212278110; Keller AA, 2012, FISH B-NOAA, V110, P205; Kilpatrick KA, 2001, J GEOPHYS RES-OCEANS, V106, P9179, DOI 10.1029/1999JC000065; Kirby MX, 2004, P NATL ACAD SCI USA, V101, P13096, DOI 10.1073/pnas.0405150101; Koslow JA, 2000, ICES J MAR SCI, V57, P548, DOI 10.1006/jmsc.2000.0722; Kronman M, 1999, SANTA BARBARA HOOK L; Leipzig P, 2001, PACIFIC GROUNDFISH B; Love MS, 2006, ECOLOGY OF MARINE FISHES: CALIFORNIA AND ADJACENT WATERS, P567; Love MS, 1998, CAL COOP OCEAN FISH, V39, P180; Magnuson W. G., 1968, PUBLICATIONS FISHERI, V4, P7; Mansfield B, 2001, PROF GEOGR, V53, P384, DOI 10.1111/0033-0124.00292; Mason J, 1998, MAR FISH REV, V60, P15; Mason J, 2012, MAR POLICY, V36, P1054, DOI 10.1016/j.marpol.2012.03.002; McEvoy Arthur, 1986, FISHERMANS PROBLEM E; Morato T, 2006, FISH FISH, V7, P24, DOI 10.1111/j.1467-2979.2006.00205.x; NOAA National Geophysical Data Center, 2011, COAST REL MOD; Orensanz JML, 1998, REV FISH BIOL FISHER, V8, P117, DOI 10.1023/A:1008891412756; Pacific Fishery Management Council, 2011, PAC COAST GROUNDF; Parker SJ, 2000, FISHERIES, V25, P22, DOI 10.1577/1548-8446(2000)025<0022:MOPR>2.0.CO;2; Pearson D, 1997, NOAATMNMFSSWFSC240; Pickett MH, 2003, J ATMOS OCEAN TECH, V20, P1869, DOI 10.1175/1520-0426(2003)020<1869:QSCWNB>2.0.CO;2; Punt AE, 2004, AM FISH S S, V42, P133; Ralston S, 2002, N AM J FISH MANAGE, V22, P249, DOI 10.1577/1548-8675(2002)022<0249:WCGHP>2.0.CO;2; Ralston S, 2010, NOAATMNMFSSWFSC461; Ralston S, 2008, CAN J FISH AQUAT SCI, V65, P588, DOI 10.1139/F07-174; Ralston S, 2010, CAN J FISH AQUAT SCI, V67, P1005, DOI 10.1139/F10-039; Roberts JJ, 2010, ENVIRON MODELL SOFTW, V25, P1197, DOI 10.1016/j.envsoft.2010.03.029; Rogers J, 2003, NMFSNWFSC57NOAA; Rudershausen PJ, 2008, T AM FISH SOC, V137, P1389, DOI 10.1577/T07-159.1; Schroeder DM, 2002, CAL COOP OCEAN FISH, V43, P182; Scofield W, 1954, FISH B, V96; Scofield W. L., 1948, FISH B, V72; Sethi SA, 2010, P NATL ACAD SCI USA, V107, P12163, DOI 10.1073/pnas.1003236107; Skinner J, 1962, HIST REV FISH GAME; Stewart I, 2007, UPUPDATED US ENGLISH; Stewart I. J., 2011, STATUS US SABLEFISH; Stewart K, 2010, CHARACTERIZING FISHI; Swartz W, 2010, SPATIAL EXPANSION EC; Thomas AC, 2013, J GEOPHYS RES-OCEANS, V118, P5296, DOI 10.1002/jgrc.20365; Vetter RD, 1997, MAR ECOL PROG SER, V155, P173, DOI 10.3354/meps155173; Watson RA, 2013, FISH RES, V140, P63, DOI 10.1016/j.fishres.2012.12.004; Wilen JE, 2002, B MAR SCI, V70, P553; Wilson J, 2012, SMALL SCALE SPATIAL; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146; Yoklavich MM, 2007, CAN J FISH AQUAT SCI, V64, P1795, DOI 10.1139/F07-145	84	26	27	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e99758	10.1371/journal.pone.0099758	http://dx.doi.org/10.1371/journal.pone.0099758			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967973	Green Submitted, Green Published, gold			2022-12-27	WOS:000338280800019
J	Tian, XS; Guo, XJ; Ruan, Z; Lei, Y; Chen, YT; Zhang, HY				Tian, Xue Song; Guo, Xian Jun; Ruan, Zhi; Lei, Yun; Chen, Yu Ting; Zhang, Hai Yan			Long-Term Vision and Non-Vision Dominant Behavioral Deficits in the 2-VO Rats Are Accompanied by Time and Regional Glial Activation in the White Matter	PLOS ONE			English	Article							CHRONIC CEREBRAL HYPOPERFUSION; COMMON CAROTID-ARTERY; BRAIN-DAMAGE; COGNITIVE FUNCTION; PERMANENT OCCLUSION; WORKING-MEMORY; MESSENGER-RNA; BLOOD-FLOW; IMPAIRMENT; ISCHEMIA	The permanent occlusion of common carotid arteries (2-VO) in rats has been shown to induce progressive and long-lasting deficits in cognitive performance, however, whether these aberrant behaviors are attributed to visual dysfunction or cognitive impairment and what are the underlying mechanisms, remain controversial. In the present study, vision dominant (Morris water maze) and non-vision dominant (voice-cued fear conditioning) behavioral tests were assigned to comprehensively evaluate the influence of 2-VO lesion on cognitive behaviors. In the Morris water maze test, escape latencies of 2-VO rats were markedly increased in both hidden and unfixed visible platform tasks, which were accompanied by severe retinal damage. In the voice-cued fear conditioning test, significant reduction in the percentage of freezing behavior was observed at 60 days after 2-VO lesion. Chronic lesion by 2-VO failed to cause noticeable changes in the grey matter, as indicated by intact hippocampal and prefrontal cortical structures, sustained synaptic protein levels and glial cell numbers. In contrast, aberrant arrangement of myelinated axons was observed in the optic tract, but not in the corpus callosum and inner capsule of 2-VO rats. Concurrently, marked astrocyte proliferation and microglia activation in the optic tract occurred at 3 days after 2-VO lesion, and continued for up to 60 days. Differently, robust glial activation was observed in the corpus callosum at 3 days after 2-VO surgery, and then gradually returned to the baseline level at 14 and 60 days. Our study reported for the first time about the effect of 2-VO on the long-term cognitive impairment in the non-vision dominant fear conditioning test, which may be more applicable than the Morris water maze test for assessing 2-VO associated cognitive function. The time and region specific glial activation in the white matter may relate to retinal impairment, even behavioral deficits, in the setting of chronic cerebral hypoperfusion.	[Tian, Xue Song; Guo, Xian Jun; Ruan, Zhi; Lei, Yun; Chen, Yu Ting; Zhang, Hai Yan] Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Shanghai 200031, Peoples R China; [Zhang, Hai Yan] Chinese Acad Sci, Shanghai Inst Mat Med, Dept Pharmacol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Zhang, HY (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Shanghai 200031, Peoples R China.	hzhang@simm.ac.cn	Ruan, Zhi/P-7829-2016; Chen, Yuting/GSI-9211-2022; ruan, zhi/AAC-5421-2019	Ruan, Zhi/0000-0003-3587-9425; Tian, Xuesong/0000-0001-6162-2856; Lei, Yun/0000-0003-4572-6078	National Natural Science Foundation of China [81173034, 81072646]; National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program'' of China [2012ZX09301001-004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program'' of China	This work is supported by the National Natural Science Foundation of China (No. 81173034, 81072646); National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program'' of China (No. 2012ZX09301001-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai J, 2013, J NEUROSCI, V33, P3989, DOI 10.1523/JNEUROSCI.1997-12.2013; Anguera MC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002248; Baldi E, 2004, NEUROBIOL LEARN MEM, V81, P162, DOI 10.1016/j.nlm.2004.02.004; Bennett SAL, 1998, NEUROREPORT, V9, P161; Bhattacharjee AK, 2012, NEUROCHEM RES, V37, P1490, DOI 10.1007/s11064-012-0740-2; Cai QY, 2011, NEUROSCI LETT, V497, P22, DOI 10.1016/j.neulet.2011.04.013; Cechetti F, 2012, LIFE SCI, V91, P29, DOI 10.1016/j.lfs.2012.05.013; Davidson CM, 2000, BRAIN RES, V859, P96, DOI 10.1016/S0006-8993(00)01937-5; De Jong GI, 1999, NEUROSCIENCE, V91, P203, DOI 10.1016/S0306-4522(98)00659-9; Farkas E, 2004, BRAIN RES, V1008, P252, DOI 10.1016/j.brainres.2004.02.037; Farkas E, 2004, ACTA NEUROPATHOL, V108, P57, DOI 10.1007/s00401-004-0864-9; Farkas E, 2007, BRAIN RES REV, V54, P162, DOI 10.1016/j.brainresrev.2007.01.003; Feng ZB, 2012, J ETHNOPHARMACOL, V144, P313, DOI 10.1016/j.jep.2012.09.014; He XL, 2012, EUR J PHARMACOL, V680, P41, DOI 10.1016/j.ejphar.2012.01.025; Henrich-Noack P, 2011, BRAIN RES BULL, V85, P346, DOI 10.1016/j.brainresbull.2011.04.001; Holman MC, 2010, INVEST OPHTH VIS SCI, V51, P2197, DOI 10.1167/iovs.09-4191; Ihara M, 2001, J CEREBR BLOOD F MET, V21, P828, DOI 10.1097/00004647-200107000-00008; Kim SK, 2008, KOREAN J PHYSIOL PHA, V12, P89, DOI 10.4196/kjpp.2008.12.3.89; Kwak PA, 2012, J CLIN NEUROL, V8, P284, DOI 10.3988/jcn.2012.8.4.284; Lavinsky D, 2006, GRAEF ARCH CLIN EXP, V244, P199, DOI 10.1007/s00417-005-0006-7; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; Mumby DG, 2001, BEHAV BRAIN RES, V127, P159, DOI 10.1016/S0166-4328(01)00367-9; Murakami Y, 1997, JPN J PHARMACOL, V75, P443, DOI 10.1254/jjp.75.443; NI JW, 1995, BRAIN RES, V673, P290, DOI 10.1016/0006-8993(94)01436-L; Ohta H, 1997, NEUROSCIENCE, V79, P1039, DOI 10.1016/S0306-4522(97)00037-7; Ohtaki H, 2006, ACTA NEUROCHIR SUPPL, V96, P283; Osawa A, 2004, DISABIL REHABIL, V26, P739, DOI 10.1080/09638280410001704331; Osborne NN, 2004, PROG RETIN EYE RES, V23, P91, DOI 10.1016/j.preteyeres.2003.12.001; Pappas BA, 1996, BRAIN RES, V708, P50, DOI 10.1016/0006-8993(95)01267-2; Paul RH., 2005, VASCULAR DEMENTIA CE; Peng Y, 2007, J PHARMACOL EXP THER, V321, P902, DOI 10.1124/jpet.106.118760; Rathnasamy G, 2014, NEUROPHARMACOLOGY, V77, P428, DOI 10.1016/j.neuropharm.2013.10.024; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; Saar-Ashkenazy R, 2014, J TRAUMA STRESS, V27, P18, DOI 10.1002/jts.21887; Sarti C, 2002, BEHAV BRAIN RES, V136, P13, DOI 10.1016/S0166-4328(02)00090-6; Schmid H, 2014, INVEST OPHTH VIS SCI, V55, P2777, DOI 10.1167/iovs.13-13372; Schmidt-Kastner R, 2005, BRAIN RES, V1052, P28, DOI 10.1016/j.brainres.2005.06.018; Schmidt-Kastner R, 2001, MOL BRAIN RES, V92, P157, DOI 10.1016/S0169-328X(01)00157-7; Shibata M, 2004, STROKE, V35, P2598, DOI 10.1161/01.STR.0000143725.19053.60; Spencer SJ, 2008, STROKE, V39, P975, DOI 10.1161/STROKEAHA.107.497016; Stevens WD, 2002, STROKE, V33, P1107, DOI 10.1161/01.STR.0000014204.05597.0C; Tian XS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069252; Tohda M, 2004, BIOL PHARM BULL, V27, P2021, DOI 10.1248/bpb.27.2021; TSUCHIYA M, 1993, EXP BRAIN RES, V95, P1; WAKITA H, 1994, ACTA NEUROPATHOL, V87, P484; WAKITA H, 1995, STROKE, V26, P1415, DOI 10.1161/01.STR.26.8.1415; Wang J, 2010, J NEUROSCI RES, V88, P807, DOI 10.1002/jnr.22237; Wang ZF, 2007, FEBS LETT, V581, P596, DOI 10.1016/j.febslet.2007.01.016; Winocur G, 2013, BEHAV BRAIN RES, V252, P144, DOI 10.1016/j.bbr.2013.05.052; Yaldizli O, 2014, MULT SCLER J, V20, P356, DOI 10.1177/1352458513496880; Yamamoto H, 2006, EXP EYE RES, V82, P767, DOI 10.1016/j.exer.2005.09.019	53	8	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e101120	10.1371/journal.pone.0101120	http://dx.doi.org/10.1371/journal.pone.0101120			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968196	Green Published, gold, Green Submitted			2022-12-27	WOS:000338280800111
J	de Araujo, MA; Marques, TEBS; Taniele-Silva, J; Souza, FMD; de Andrade, TG; Garcia-Cairasco, N; Paco-Larson, ML; Gitai, DLG				de Araujo, Mykaella Andrade; Batista Sales Marques, Thalita Ewellyn; Taniele-Silva, Jamile; de Araujo Souza, Fernanda Maria; de Andrade, Tiago Gomes; Garcia-Cairasco, Norberto; Paco-Larson, Maria Luisa; Goes Gitai, Daniel Leite			Identification of Endogenous Reference Genes for the Analysis of microRNA Expression in the Hippocampus of the Pilocarpine-Induced Model of Mesial Temporal Lobe Epilepsy	PLOS ONE			English	Article							TIME QUANTITATIVE PCR; IMMATURE RAT MODEL; MESSENGER-RNA; RT-PCR; UP-REGULATION; EPILEPTOGENESIS; QUANTIFICATION; NORMALIZATION; BIOGENESIS; SEIZURE	Real-time quantitative RT-PCR (qPCR) is one of the most powerful techniques for analyzing miRNA expression because of its sensitivity and specificity. However, in this type of analysis, a suitable normalizer is required to ensure that gene expression is unaffected by the experimental condition. To the best of our knowledge, there are no reported studies that performed a detailed identification and validation of suitable reference genes for miRNA qPCR during the epileptogenic process. Here, using a pilocarpine (PILO) model of mesial temporal lobe epilepsy (MTLE), we investigated five potential reference genes, performing a stability expression analysis using geNorm and NormFinder softwares. As a validation strategy, we used each one of the candidate reference genes to measure PILO-induced changes in microRNA-146a levels, a gene whose expression pattern variation in the PILO injected model is known. Our results indicated U6SnRNA and SnoRNA as the most stable candidate reference genes. By geNorm analysis, the normalization factor should preferably contain at least two of the best candidate reference genes (snoRNA and U6SnRNA). In fact, when normalized using the best combination of reference genes, microRNA-146a transcripts were found to be significantly increased in chronic stage, which is consistent with the pattern reported in different models. Conversely, when reference genes were individually employed for normalization, we failed to detect up-regulation of the microRNA-146a gene in the hippocampus of epileptic rats. The data presented here support that the combination of snoRNA and U6SnRNA was the minimum necessary for an accurate normalization of gene expression at the different stages of epileptogenesis that we tested.	[de Araujo, Mykaella Andrade; Batista Sales Marques, Thalita Ewellyn; Taniele-Silva, Jamile; de Araujo Souza, Fernanda Maria; Goes Gitai, Daniel Leite] Univ Fed Alagoas, Inst Biol Sci & Hlth, Dept Cell, Maceio, Alagoas, Brazil; [de Andrade, Tiago Gomes] Univ Fed Alagoas, Maceio, Alagoas, Brazil; [Garcia-Cairasco, Norberto] Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Physiol, Sao Paulo, Brazil; [Paco-Larson, Maria Luisa] Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Cellular & Mol Biol, Sao Paulo, Brazil	Universidade Federal de Alagoas; Universidade Federal de Alagoas; Universidade de Sao Paulo; Universidade de Sao Paulo	Gitai, DLG (corresponding author), Univ Fed Alagoas, Inst Biol Sci & Hlth, Dept Cell, Maceio, Alagoas, Brazil.	danielgitai@gmail.com	de Araújo, Mykaella Andrade/X-3778-2018; Cairasco, Norberto Garcia/E-3250-2015; de Andrade, Tiago/I-3522-2013; Gitai, Daniel LG/A-7982-2019; Paço-Larson, Maria L/I-8613-2012; De Andrade, Tiago G/I-5572-2015	Cairasco, Norberto Garcia/0000-0001-8857-3775; Gitai, Daniel LG/0000-0001-7056-2373; De Andrade, Tiago G/0000-0003-0948-6329; Araujo, Mykaella/0000-0002-6425-2595; Souza, Fernanda/0000-0002-9514-3092	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); FAPEAL (Fundacao de Amparo a Pesquisa do Estado de Alagoas); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo); FAEPA-HCRP (Fundacao de Apoio ao Ensino Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo)	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEAL (Fundacao de Amparo a Pesquisa do Estado de Alagoas)(Fundacao de Amparo a Pesquisa do Estado de Alagoas (FAPEAL)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAEPA-HCRP (Fundacao de Apoio ao Ensino Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo)	This work was supported by the CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico), FAPEAL (Fundacao de Amparo a Pesquisa do Estado de Alagoas), CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior), FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) and FAEPA-HCRP (Fundacao de Apoio ao Ensino Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Aronica E, 2010, EUR J NEUROSCI, V31, P1100, DOI 10.1111/j.1460-9568.2010.07122.x; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Marques TEBS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071892; Becker AJ, 2003, EUR J NEUROSCI, V18, P2792, DOI 10.1111/j.1460-9568.2003.02993.x; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Chugh P, 2012, WIRES RNA, V3, P601, DOI 10.1002/wrna.1120; Cikos S, 2009, ANAL BIOCHEM, V384, P1, DOI 10.1016/j.ab.2008.08.031; Cui JG, 2010, J BIOL CHEM, V285, P38951, DOI 10.1074/jbc.M110.178848; Djuranovic S, 2011, SCIENCE, V331, P550, DOI 10.1126/science.1191138; Elliott RC, 2003, J NEUROSCI, V23, P2218; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Gorter JA, 2006, J NEUROSCI, V26, P11083, DOI 10.1523/JNEUROSCI.2766-06.2006; Gorter JA, 2014, NEUROBIOL DIS, V62, P508, DOI 10.1016/j.nbd.2013.10.026; Hebert SS, 2009, TRENDS NEUROSCI, V32, P199, DOI 10.1016/j.tins.2008.12.003; Hill JM, 2009, NEUROREPORT, V20, P1500, DOI 10.1097/WNR.0b013e3283329c05; Hu K, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-115; Hunsberger JG, 2005, MOL BRAIN RES, V141, P95, DOI 10.1016/j.molbrainres.2005.08.005; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Iyer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044789; Jimenez-Mateos EM, 2012, NAT MED, V18, P1087, DOI 10.1038/nm.2834; Jimenez-Mateos EM, 2011, AM J PATHOL, V179, P2519, DOI 10.1016/j.ajpath.2011.07.036; Junker A, 2009, BRAIN, V132, P3342, DOI 10.1093/brain/awp300; Kang K, 2012, J ANIM SCI BIOTECHNO, V3, DOI 10.1186/2049-1891-3-4; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Lin YL, 2013, PLANT PHYSIOL BIOCH, V66, P20, DOI 10.1016/j.plaphy.2013.02.002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lukasiuk K, 2003, EUR J NEUROSCI, V17, P271, DOI 10.1046/j.1460-9568.2003.02461.x; Lukiw WJ, 2011, J TOXICOL ENV HEAL A, V74, P1460, DOI 10.1080/15287394.2011.618973; Lukiw WJ, 2007, J INORG BIOCHEM, V101, P1265, DOI 10.1016/j.jinorgbio.2007.06.004; Lukiw WJ, 2012, MOL NEUROBIOL, V46, P11, DOI 10.1007/s12035-012-8234-4; Mathern GW, 2002, PROG BRAIN RES, V135, P237; Matos G, 2014, PROG NEURO-PSYCHOPH, V51, P159, DOI 10.1016/j.pnpbp.2014.02.001; Okamoto OK, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-230; Omran A, 2012, EPILEPSIA, V53, P1215, DOI 10.1111/j.1528-1167.2012.03540.x; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Peng J, 2013, J MOL NEUROSCI, V50, P291, DOI 10.1007/s12031-013-9953-3; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Pitkanen A, 2009, EPILEPSY BEHAV, V14, P16, DOI 10.1016/j.yebeh.2008.09.023; Pritchard CC, 2012, NAT REV GENET, V13, P358, DOI 10.1038/nrg3198; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Redell JB, 2011, J NEUROSCI RES, V89, P212, DOI 10.1002/jnr.22539; Redell JB, 2009, J NEUROSCI RES, V87, P1435, DOI 10.1002/jnr.21945; Risbud RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053464; Risbud RM, 2011, BRAIN RES, V1424, P53, DOI 10.1016/j.brainres.2011.09.039; Saba R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030832; Sano T, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.23; Song YJ, 2011, BRAIN RES, V1387, P134, DOI 10.1016/j.brainres.2011.02.073; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wiebe S, 2001, NEW ENGL J MED, V345, P311, DOI 10.1056/NEJM200108023450501	56	9	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100529	10.1371/journal.pone.0100529	http://dx.doi.org/10.1371/journal.pone.0100529			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964029	gold, Green Submitted, Green Published			2022-12-27	WOS:000338709500059
J	Gese, EM; Thompson, CM				Gese, Eric M.; Thompson, Craig M.			Does Habitat Heterogeneity in a Multi-Use Landscape Influence Survival Rates and Density of a Native Mesocarnivore?	PLOS ONE			English	Article							FOXES VULPES-VELOX; SWIFT FOXES; NORTHWESTERN TEXAS; SOUTHEASTERN COLORADO; EASTERN COLORADO; OCCUPANCY RATES; WESTERN KANSAS; HOME-RANGE; COMMUNITY; GRASSLAND	The relationships between predators, prey, and habitat have long been of interest to applied and basic ecologists. As a native Great Plains mesocarnivore of North America, swift foxes (Vulpes velox) depended on the historic disturbance regime to maintain open grassland habitat. With a decline in native grasslands and subsequent impacts to prairie specialists, notably the swift fox, understanding the influence of habitat on native predators is paramount to future management efforts. From 2001 to 2004, we investigated the influence of vegetation structure on swift fox population ecology (survival and density) on and around the Pinon Canyon Maneuver Site, southeastern Colorado, USA. We monitored 109 foxes on 6 study sites exposed to 3 different disturbance regimes (military training, grazing, unused). On each site we evaluated vegetation structure based on shrub density, basal coverage, vegetation height, and litter. Across all sites, annual fox survival rates ranged from 0.50 to 0.92 for adults and 0.27 to 0.78 for juveniles. Among sites, population estimates ranged from 1 to 7 foxes per 10 km transect. Fox density or survival was not related to the relative abundance of prey. A robust model estimating fox population size and incorporating both shrub density and percent basal cover as explanatory variables far outperformed all other models. Our results supported the idea that, in our region, swift foxes were shortgrass prairie specialists and also indicated a relationship between habitat quality and landscape heterogeneity. We suggest the regulation of swift fox populations may be based on habitat quality through landscape-mediated survival, and managers may effectively use disturbance regimes to create or maintain habitat for this native mesocarnivore.	[Gese, Eric M.] Utah State Univ, USDA, Wildlife Serv, Natl Wildlife Res Ctr,Dept Wildland Resources, Logan, UT 84322 USA; [Thompson, Craig M.] Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA	United States Department of Agriculture (USDA); Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University	Gese, EM (corresponding author), Utah State Univ, USDA, Wildlife Serv, Natl Wildlife Res Ctr,Dept Wildland Resources, Logan, UT 84322 USA.	eric.gese@usu.edu	Gese, Eric M/B-4578-2011		United States Army, Directorate of Environmental Compliance and Management, Fort Carson, Colorado, through United States Fish and Wildlife Service, Colorado Assistance Office, Golden, Colorado; Utah Cooperative Fish and Wildlife Research Unit at Utah State University; United States Department of Agriculture, Wildlife Services, National Wildlife Research Center at Utah State University, Logan, Utah	United States Army, Directorate of Environmental Compliance and Management, Fort Carson, Colorado, through United States Fish and Wildlife Service, Colorado Assistance Office, Golden, Colorado; Utah Cooperative Fish and Wildlife Research Unit at Utah State University; United States Department of Agriculture, Wildlife Services, National Wildlife Research Center at Utah State University, Logan, Utah	Funding and logistical assistance was provided by the United States Army, Directorate of Environmental Compliance and Management, Fort Carson, Colorado, through the United States Fish and Wildlife Service, Colorado Assistance Office, Golden, Colorado, and the Utah Cooperative Fish and Wildlife Research Unit at Utah State University. Additional support was provided by the United States Department of Agriculture, Wildlife Services, National Wildlife Research Center at Utah State University, Logan, Utah. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1971, P 2 INT S INF THEOR, P267, DOI DOI 10.2307/2334537; Allington GRH, 2013, ECOL LETT, V16, P158, DOI 10.1111/ele.12023; BARBOUR M., 1999, TERRESTRIAL PLANT EC, V3rd; Brown JR, 1999, ECOLOGY, V80, P2385, DOI 10.1890/0012-9658(1999)080[2385:SIOGRI]2.0.CO;2; Dale M.R.T., 1999, SPATIAL PATTERN ANAL; Disney M, 1992, J WILDLIFE MANAGE, V64, P388; Finley DJ, 2005, J WILDLIFE MANAGE, V69, P861, DOI 10.2193/0022-541X(2005)069[0861:EOSFPS]2.0.CO;2; Fitzgerald J, 1996, POPULATION DYNAMICS; GERMANO DJ, 1983, J RANGE MANAGE, V36, P309, DOI 10.2307/3898476; Guthery Fred S., 1996, P59; Hartnett DC, 1996, J RANGE MANAGE, V49, P413, DOI 10.2307/4002922; Jackson VL, 2000, SOUTHWEST NAT, V45, P212, DOI 10.2307/3672463; Kamler JF, 2003, J MAMMAL, V84, P989, DOI 10.1644/BJK-033; Kamler JF, 2003, J WILDLIFE MANAGE, V67, P317, DOI 10.2307/3802773; Kamler JF, 2003, CAN J ZOOL, V81, P168, DOI 10.1139/Z02-222; Karki SM, 2007, J WILDLIFE MANAGE, V71, P2707, DOI 10.2193/2006-275; Kitchen AM, 1999, CAN J ZOOL, V77, P1645, DOI 10.1139/cjz-77-10-1645; Kozlowski AJ, 2003, WILDLIFE SOC B, V31, P630; List R, 2003, J ZOOL, V259, P1, DOI 10.1017/S0952836902002959; Lyon LJ, 2000, WILDLAND FIRE ECOSYS, P43; Martin DJ, 2007, SOUTHWEST NAT, V52, P541, DOI 10.1894/0038-4909(2007)52[541:ORBSFV]2.0.CO;2; Matlack RS, 2000, SOUTHWEST NAT, V45, P221, DOI 10.2307/3672464; Milchunas DG, 1999, J ENVIRON QUAL, V28, P1533, DOI 10.2134/jeq1999.00472425002800050019x; Moehrenschlager A, 2004, BIOLOGY AND CONSERVATION OF WILD CANIDS, P185; Morin P., 1999, COMMUNITY ECOL; Nicholson KL, 2007, WEST N AM NATURALIST, V67, P102, DOI 10.3398/1527-0904(2007)67[102:DAEMOS]2.0.CO;2; Nicholson KL, 2006, J WILDLIFE MANAGE, V70, P1659, DOI 10.2193/0022-541X(2006)70[1659:SFUOBP]2.0.CO;2; Olson TL, 2002, J MAMMAL, V83, P199, DOI 10.1644/1545-1542(2002)083<0199:SFSAPI>2.0.CO;2; RONGSTAD OJ, 1989, ECOLOGY SWIFT FOX PI; Schauster ER, 2002, WILDLIFE SOC B, V30, P464; Schauster ER, 2002, CAN J ZOOL, V80, P307, DOI 10.1139/Z02-009; SCOTTBROWN JM, 1987, WILD FURBEARER MANAG, P433; SHAW RB, 1990, J ENVIRON QUAL, V19, P234, DOI 10.2134/jeq1990.00472425001900020007x; Shaw RB, 1989, COLORADO STATE U SCI, V37; Sovada MA, 1998, J WILDLIFE MANAGE, V62, P1300, DOI 10.2307/3801994; Sovada MA, 2003, ECOLOGY CONSERVATION; Sovada MA, 2009, CAN FIELD NAT, V123, P346, DOI 10.22621/cfn.v123i4.1004; SWIHART RK, 1985, J WILDLIFE MANAGE, V49, P1019, DOI 10.2307/3801388; Thibault KM, 2010, OIKOS, V119, P1719, DOI 10.1111/j.1600-0706.2010.18378.x; Thompson CM, 2007, ECOLOGY, V88, P334, DOI 10.1890/0012-9658(2007)88[334:FWAIPC]2.0.CO;2; Thompson CM, 2013, ACTA THERIOL, V58, P55, DOI 10.1007/s13364-012-0098-5; Valone TJ, 2002, SOUTHWEST NAT, V47, P557, DOI 10.2307/3672659; Valone TJ, 1999, J ARID ENVIRON, V42, P15, DOI 10.1006/jare.1999.0500; White EP, 2004, AM NAT, V164, P670, DOI 10.1086/424766; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Wright HA, 1980, INT85 US FOR SERV	46	4	4	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100500	10.1371/journal.pone.0100500	http://dx.doi.org/10.1371/journal.pone.0100500			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963713	Green Published, gold			2022-12-27	WOS:000338709500056
J	Rosenstierne, MW; McLoughlin, KS; Olesen, ML; Papa, A; Gardner, SN; Engler, O; Plumet, S; Mirazimi, A; Weidmann, M; Niedrig, M; Fomsgaard, A; Erlandsson, L				Rosenstierne, Maiken W.; McLoughlin, Kevin S.; Olesen, Majken Lindholm; Papa, Anna; Gardner, Shea N.; Engler, Olivier; Plumet, Sebastien; Mirazimi, Ali; Weidmann, Manfred; Niedrig, Matthias; Fomsgaard, Anders; Erlandsson, Lena			The Microbial Detection Array for Detection of Emerging Viruses in Clinical Samples - A Useful Panmicrobial Diagnostic Tool	PLOS ONE			English	Article							REAL-TIME PCR; RESPIRATORY-TRACT INFECTIONS; HEMORRHAGIC-FEVER VIRUS; WEST-NILE-VIRUS; LABORATORY DETECTION; IDENTIFICATION; RNA; DNA; AMPLIFICATION; ASSAY	Emerging viruses are usually endemic to tropical and sub-tropical regions of the world, but increased global travel, climate change and changes in lifestyle are believed to contribute to the spread of these viruses into new regions. Many of these viruses cause similar disease symptoms as other emerging viruses or common infections, making these unexpected pathogens difficult to diagnose. Broad-spectrum pathogen detection microarrays containing probes for all sequenced viruses and bacteria can provide rapid identification of viruses, guiding decisions about treatment and appropriate case management. We report a modified Whole Transcriptome Amplification (WTA) method that increases unbiased amplification, particular of RNA viruses. Using this modified WTA method, we tested the specificity and sensitivity of the Lawrence Livermore Microbial Detection Array (LLMDA) against a wide range of emerging viruses present in both non-clinical and clinical samples using two different microarray data analysis methods.	[Rosenstierne, Maiken W.; Olesen, Majken Lindholm; Fomsgaard, Anders; Erlandsson, Lena] Statens Serum Inst, Dept Microbiol Diagnost & Virol, DK-2300 Copenhagen, Denmark; [McLoughlin, Kevin S.; Gardner, Shea N.] Lawrence Livermore Natl Lab, Livermore, CA USA; [Papa, Anna] Aristotle Univ Thessaloniki, Dept Microbiol, GR-54006 Thessaloniki, Greece; [Engler, Olivier] Fed Off Civil Protect, Spiez Lab, Spiez, Switzerland; [Plumet, Sebastien] French Army Forces Biomed Inst IRBA, Dept Virol, Marseille, France; [Mirazimi, Ali] Swedish Inst Communicable Dis Control, Solna, Sweden; [Mirazimi, Ali] Natl Vet Inst SVA, Uppsala, Sweden; [Mirazimi, Ali] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Weidmann, Manfred] Univ Stirling, Inst Aquaculture, Stirling FK9 4LA, Scotland; [Niedrig, Matthias] Robert Koch Inst, Ctr Biosafety, Berlin, Germany; [Fomsgaard, Anders] Univ Southern Denmark, Inst Clin Res, Odense, Denmark	Statens Serum Institut; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Aristotle University of Thessaloniki; Swedish Institute for Infectious Disease Control; National Veterinary Institute SVA; Linkoping University; University of Stirling; Robert Koch Institute; University of Southern Denmark	Rosenstierne, MW (corresponding author), Statens Serum Inst, Dept Microbiol Diagnost & Virol, DK-2300 Copenhagen, Denmark.	MWR@ssi.dk	Weidmann, Manfred/G-1817-2015	Weidmann, Manfred/0000-0002-7063-7491; Lindholm, Majken/0000-0002-1766-8678; Fomsgaard, Anders/0000-0003-4304-0603; , Ali/0000-0003-2371-6055; Erlandsson, Lena/0000-0003-4350-5909	European Commission under the Health Cooperation Work Program of the 7th Framework Program for contributing with CCHFV-positive clinical samples [260427]; Lawrence Livermore National Laboratory [DE-AC52-07NA27344]	European Commission under the Health Cooperation Work Program of the 7th Framework Program for contributing with CCHFV-positive clinical samples; Lawrence Livermore National Laboratory(United States Department of Energy (DOE))	We thank Solvej Jensen, Birgit Knudsen, Bente Ostergaard and Britt Christensen for expert technical help. We thank the CCH Fever Network supported by the European Commission under the Health Cooperation Work Program of the 7th Framework Program (no. 260427) for contributing with CCHFV-positive clinical samples. This work was performed in part under the auspices of the U.S. Department of Energy by Lawrence Livermore National Laboratory under Contract DE-AC52-07NA27344.	Ausubel F.M., 1994, CURRENT PROTOCOLS MO, V27, DOI [10.1002/mrd.1080010210, DOI 10.1002/MRD.1080010210]; Berthet N, 2013, J CLIN VIROL, V56, P238, DOI 10.1016/j.jcv.2012.10.022; Berthet N, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-77; Bexfield N, 2011, VET J, V190, P191, DOI 10.1016/j.tvjl.2010.10.014; Blow JA, 2004, J VIROL METHODS, V119, P195, DOI 10.1016/j.jviromet.2004.03.015; Calzolari M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038058; Cavrini F, 2009, EUROSURVEILLANCE, V14, P17; Chiu CY, 2008, J PEDIATR-US, V153, P76, DOI 10.1016/j.jpeds.2007.12.035; Devault AM, 2014, SCI REP-UK, V4, DOI 10.1038/srep04245; Drosten C, 2002, J CLIN MICROBIOL, V40, P2323, DOI 10.1128/JCM.40.7.2323-2330.2002; Erlandsson L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022631; Filippone C, 2013, CLIN MICROBIOL INFEC, V19, pE118, DOI 10.1111/1469-0691.12075; Gardner SN, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-668; Grubaugh ND, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002349; Grubaugh ND, 2013, AM J TROP MED HYG, V88, P245, DOI 10.4269/ajtmh.2012.12-0048; Heyman P, 2011, EUROSURVEILLANCE, V16, P15; Heyman P, 2010, EXPERT REV ANTI-INFE, V8, P33, DOI 10.1586/ERI.09.118; Karimi-Busheri F, 1998, NUCLEIC ACIDS RES, V26, P4395, DOI 10.1093/nar/26.19.4395; Kistler A, 2007, J INFECT DIS, V196, P817, DOI 10.1086/520816; Kramski M, 2007, CLIN CHEM, V53, P1899, DOI 10.1373/clinchem.2007.093245; Lambert AJ, 2003, J CLIN MICROBIOL, V41, P379, DOI 10.1128/JCM.41.1.379-385.2003; Maltezou HC, 2010, TRAVEL MED INFECT DI, V8, P139, DOI 10.1016/j.tmaid.2010.04.008; McLoughlin KS, 2011, BRIEF FUNCT GENOMICS, V10, P342, DOI 10.1093/bfgp/elr027; Nichol ST, 2000, P NATL ACAD SCI USA, V97, P12411, DOI 10.1073/pnas.210382297; Okamoto H, 2009, CURR TOP MICROBIOL, V331, P1, DOI 10.1007/978-3-540-70972-5_1; Papa A, 2012, EXPERT REV ANTI-INFE, V10, P743, DOI [10.1586/ERI.12.59, 10.1586/eri.12.59]; Pastorino B, 2005, J VIROL METHODS, V124, P65, DOI 10.1016/j.jviromet.2004.11.002; Pecorari M, 2009, EURO SURVEILL B EUR, V14, P9; Ruzek D, 2010, LANCET, V376, P2104, DOI 10.1016/S0140-6736(10)61120-8; Ryschkewitsch C, 2004, J VIROL METHODS, V121, P217, DOI 10.1016/j.jviromet.2004.06.021; Schwaiger M, 2003, J CLIN VIROL, V27, P136, DOI 10.1016/S1386-6532(02)00168-3; Shchelkunov SN, 2011, J VIROL METHODS, V175, P163, DOI 10.1016/j.jviromet.2011.05.002; Shirato K, 2005, J VIROL METHODS, V126, P119, DOI 10.1016/j.jviromet.2005.02.001; Thissen JB, 2014, J VIROL METHODS, V201, P73, DOI 10.1016/j.jviromet.2014.01.024; Tomashek KM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001614; van der Poel WHM, 2006, VECTOR-BORNE ZOONOT, V6, P315, DOI 10.1089/vbz.2006.6.315; Victoria JG, 2010, J VIROL, V84, P6033, DOI 10.1128/JVI.02690-09; Wang D, 2002, P NATL ACAD SCI USA, V99, P15687, DOI 10.1073/pnas.242579699; Wang Yun-peng, 2011, Virologica Sinica, V26, P73, DOI 10.1007/s12250-011-3186-9; Weidmann M, 2005, J CLIN MICROBIOL, V43, P808, DOI 10.1128/JCM.43.2.808-812.2005; Weidmann M, 2008, J CLIN VIROL, V42, P326, DOI 10.1016/j.jcv.2008.03.005; Weidmann M, 2007, J CLIN VIROL, V39, P65, DOI 10.1016/j.jcv.2006.12.023; Weidmann M, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-81; Whitehouse CA, 2004, ANTIVIR RES, V64, P145, DOI 10.1016/j.antiviral.2004.08.001; Wood DJ, 1999, J MED VIROL, V58, P188, DOI 10.1002/(SICI)1096-9071(199906)58:2<188::AID-JMV15>3.3.CO;2-8; Yozwiak NL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001485	46	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100813	10.1371/journal.pone.0100813	http://dx.doi.org/10.1371/journal.pone.0100813			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963710	gold, Green Published			2022-12-27	WOS:000338709500083
J	Wilson, R; Bourne, C; Chaudhuri, RR; Gregory, R; Kenny, J; Cossins, A				Wilson, Robert; Bourne, Christian; Chaudhuri, Roy R.; Gregory, Richard; Kenny, John; Cossins, Andrew			Single-Step Selection of Bivalent Aptamers Validated by Comparison with SELEX Using High-Throughput Sequencing	PLOS ONE			English	Article							DNA APTAMERS; STRANDED-DNA; AFFINITY; THROMBIN; BINDING	The identification of nucleic acid aptamers would be advanced if they could be obtained after fewer rounds of selection and amplification. In this paper the identification of bivalent aptamers for thrombin by SELEX and single-step selection are compared using next generation sequencing and motif finding informatics. Results show that similar aptamers are identified by both methods. This is significant because it shows that next generation sequencing and motif finding informatics have the potential to simplify the selection of aptamers by avoiding multiple rounds of enzymatic transcription and amplification.	[Wilson, Robert; Bourne, Christian; Chaudhuri, Roy R.; Gregory, Richard; Kenny, John; Cossins, Andrew] Univ Liverpool, Inst Integrat Biol, Ctr Genom Res, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Wilson, R (corresponding author), Univ Liverpool, Inst Integrat Biol, Ctr Genom Res, Liverpool L69 3BX, Merseyside, England.	R.Wilson@liv.ac.uk	Kenny, John/HCI-1952-2022; Chaudhuri, Roy/E-3774-2014	Kenny, John/0000-0003-2994-6169; Chaudhuri, Roy/0000-0001-5037-2695; Cossins, Andrew/0000-0002-0813-5212	United Kingdom's Biotechnology and Biological Sciences Research Council (BBSRC) [BB/1013245/1]; Biotechnology and Biological Sciences Research Council [BB/I013245/1, BB/I012729/2] Funding Source: researchfish; BBSRC [BB/I012729/2, BB/I013245/1] Funding Source: UKRI	United Kingdom's Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Financial support for this work was provided by the United Kingdom's Biotechnology and Biological Sciences Research Council (BBSRC) Grant Number BB/1013245/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad KM, 2012, NUCLEIC ACIDS RES, V40, P11777, DOI 10.1093/nar/gks899; Arnold S, 2012, BIOL CHEM, V393, P343, DOI 10.1515/hsz-2011-0253; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Berezovski M, 2006, J AM CHEM SOC, V128, P1410, DOI 10.1021/ja056943j; BOCK LC, 1992, NATURE, V355, P564, DOI 10.1038/355564a0; Bode W, 2006, BLOOD CELL MOL DIS, V36, P122, DOI 10.1016/j.bcmd.2005.12.027; Cho M, 2010, P NATL ACAD SCI USA, V107, P15373, DOI 10.1073/pnas.1009331107; Davies DR, 2012, P NATL ACAD SCI USA, V109, P19971, DOI 10.1073/pnas.1213933109; Doessing H, 2012, MOLECULES, V17, P13087, DOI 10.3390/molecules171113087; Famulok M, 2007, CHEM REV, V107, P3715, DOI 10.1021/cr0306743; Fitter S, 2005, J BIOL CHEM, V280, P34193, DOI 10.1074/jbc.M504772200; Gold L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015004; Hasegawa H, 2008, SENSORS-BASEL, V8, P1090, DOI 10.3390/s8021090; Kuwahara M, 2006, NUCLEIC ACIDS RES, V34, P5383, DOI 10.1093/nar/gkl637; Lauridsen LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041702; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Mayer G, 2009, ANGEW CHEM INT EDIT, V48, P2672, DOI 10.1002/anie.200804643; Meyer S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071798; Muller J, 2008, J THROMB HAEMOST, V6, P2105, DOI 10.1111/j.1538-7836.2008.03162.x; Muller J, 2007, CHEMBIOCHEM, V8, P2223, DOI 10.1002/cbic.200700535; Nitsche A, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-48; Pinto A, 2012, THESIS U ROVIRA VIRG, P44; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Stoltenburg R, 2007, BIOMOL ENG, V24, P381, DOI 10.1016/j.bioeng.2007.06.001; STUBBS MT, 1993, THROMB RES, V69, P1, DOI 10.1016/0049-3848(93)90002-6; Szeto K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082667; Tasset DM, 1997, J MOL BIOL, V272, P688, DOI 10.1006/jmbi.1997.1275; Vaught JD, 2010, J AM CHEM SOC, V132, P4141, DOI 10.1021/ja908035g; Wilson R, 2013, NUCLEIC ACID THER, V23, P88, DOI 10.1089/nat.2012.0386; Wilson R, 2011, NUCLEIC ACID THER, V21, P437, DOI 10.1089/nat.2011.0322; Wilson Robert, 2011, J Proteomics, V74, P1852; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	32	22	25	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100572	10.1371/journal.pone.0100572	http://dx.doi.org/10.1371/journal.pone.0100572			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963654	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000338709500064
J	Kwon, M; Lu, ZL; Miller, A; Kazlas, M; Hunter, DG; Bex, PJ				Kwon, MiYoung; Lu, Zhong-Lin; Miller, Alexandra; Kazlas, Melanie; Hunter, David G.; Bex, Peter J.			Assessing Binocular Interaction in Amblyopia and Its Clinical Feasibility	PLOS ONE			English	Article							ANISOMETROPIC AMBLYOPIA; INTEROCULAR SUPPRESSION; STRABISMIC AMBLYOPIA; GLOBAL MOTION; QUANTITATIVE MEASUREMENT; CONTRAST SENSITIVITY; VISUOMOTOR BEHAVIOR; VISUAL DEFICITS; CHILDREN; ACUITY	Purpose: To measure binocular interaction in amblyopes using a rapid and patient-friendly computer-based method, and to test the feasibility of the assessment in the clinic. Methods: Binocular interaction was assessed in subjects with strabismic amblyopia (n = 7), anisometropic amblyopia (n = 6), strabismus without amblyopia (n = 15) and normal vision (n = 40). Binocular interaction was measured with a dichoptic phase matching task in which subjects matched the position of a binocular probe to the cyclopean perceived phase of a dichoptic pair of gratings whose contrast ratios were systematically varied. The resulting effective contrast ratio of the weak eye was taken as an indicator of interocular imbalance. Testing was performed in an ophthalmology clinic under 8 mins. We examined the relationships between our binocular interaction measure and standard clinical measures indicating abnormal binocularity such as interocular acuity difference and stereoacuity. The test-retest reliability of the testing method was also evaluated. Results: Compared to normally-sighted controls, amblyopes exhibited significantly reduced effective contrast (similar to 20%) of the weak eye, suggesting a higher contrast requirement for the amblyopic eye compared to the fellow eye. We found that the effective contrast ratio of the weak eye covaried with standard clincal measures of binocular vision. Our results showed that there was a high correlation between the 1(st) and 2(nd) measurements (r = 0.94, p<0.001) but without any significant bias between the two. Conclusions: Our findings demonstrate that abnormal binocular interaction can be reliably captured by measuring the effective contrast ratio of the weak eye and quantitative assessment of binocular interaction is a quick and simple test that can be performed in the clinic. We believe that reliable and timely assessment of deficits in a binocular interaction may improve detection and treatment of amblyopia.	[Kwon, MiYoung; Miller, Alexandra; Bex, Peter J.] Massachusetts Eye & Ear Infirm, Schepens Eye Res Inst, Boston, MA 02114 USA; [Kwon, MiYoung; Miller, Alexandra; Kazlas, Melanie; Hunter, David G.; Bex, Peter J.] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA USA; [Lu, Zhong-Lin] Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA; [Kazlas, Melanie; Hunter, David G.] Boston Childrens Hosp, Dept Ophthalmol, Boston, MA USA	Harvard University; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute; Harvard University; Harvard Medical School; University System of Ohio; Ohio State University; Harvard University; Boston Children's Hospital	Kwon, M (corresponding author), Massachusetts Eye & Ear Infirm, Schepens Eye Res Inst, Boston, MA 02114 USA.	miyoungkwon02@gmail.com		Hunter, David/0000-0002-4587-4794; Lu, Zhong-Lin/0000-0002-7295-727X	NIH [R01 EY021553]; NATIONAL EYE INSTITUTE [R01EY021553] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NIH grant R01 EY021553. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaen-Stockdale C, 2008, VISION RES, V48, P1965, DOI 10.1016/j.visres.2008.06.012; Baker DH, 2008, VISION RES, V48, P1625, DOI 10.1016/j.visres.2008.04.017; Baker DH, 2007, VISION RES, V47, P3096, DOI 10.1016/j.visres.2007.08.013; Baker DH, 2007, INVEST OPHTH VIS SCI, V48, P5332, DOI 10.1167/iovs.07-0194; Barrett BT, 2003, INVEST OPHTH VIS SCI, V44, P1555, DOI 10.1167/iovs.02-0515; Birch EE, 2007, INVEST OPHTH VIS SCI, V48, pe1108; Birch EE, 2013, PROG RETIN EYE RES, V33, P67, DOI 10.1016/j.preteyeres.2012.11.001; Black JM, 2011, OPTOMETRY VISION SCI, V88, pE334, DOI 10.1097/OPX.0b013e318205a162; BLAKEMORE C, 1976, J PHYSIOL-LONDON, V261, P423, DOI 10.1113/jphysiol.1976.sp011566; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bosworth RG., 2003, INVEST, V44, pE3183; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Cameron AC, 1997, J ECONOMETRICS, V77, P329; Ding J, 2006, P NATL ACAD SCI USA, V103, P1141, DOI 10.1073/pnas.0509629103; Ding J, 2013, J VISION, V13, DOI 10.1167/13.2.14; Efron B, 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; Gonzalez EG, 2012, INVEST OPHTH VIS SCI, V53, P5386, DOI 10.1167/iovs.12-9941; GOODWIN RT, 1985, INVEST OPHTH VIS SCI, V26, P917; Hess RF, 2007, VISION RES, V47, P1682, DOI 10.1016/j.visres.2007.02.005; Hess RF, 2012, OPTOMETRY, V83, P87; Hess RF, 2010, RESTOR NEUROL NEUROS, V28, P793, DOI 10.3233/RNN-2010-0550; HESS RF, 1977, VISION RES, V17, P1049, DOI 10.1016/0042-6989(77)90009-8; HESS RF, 1983, PROC R SOC SER B-BIO, V217, P309, DOI 10.1098/rspb.1983.0012; HESS RF, 1978, PFLUG ARCH EUR J PHY, V377, P201, DOI 10.1007/BF00584273; Hess RF, 1997, VISION RES, V37, P3145, DOI 10.1016/S0042-6989(96)00281-7; HESS RF, 1980, NATURE, V287, P463, DOI 10.1038/287463a0; Howard IP, 1995, BINOCULAR VISION STE; Huang CB, 2009, J VISION, V9, DOI 10.1167/9.3.17; Huang CB, 2011, J VISION, V11, DOI 10.1167/11.6.4; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P1041, DOI 10.1152/jn.1965.28.6.1041; JONES RK, 1981, J EXP PSYCHOL HUMAN, V7, P30, DOI 10.1037/0096-1523.7.1.30; Knox PJ, 2012, INVEST OPHTH VIS SCI, V53, P817, DOI 10.1167/iovs.11-8219; Kwon M, 2014, VIS SCI SOC 13 ANN M; Lagarias JC, 1998, SIAM J OPTIMIZ, V9, P112, DOI 10.1137/S1052623496303470; LAWDEN MC, 1982, VISION RES, V22, P1005, DOI 10.1016/0042-6989(82)90037-2; Levi DM, 2011, VISION RES, V51, P48, DOI 10.1016/j.visres.2010.09.029; LEVI DM, 1977, INVEST OPHTH VIS SCI, V16, P90; LEVI DM, 1985, VISION RES, V25, P979, DOI 10.1016/0042-6989(85)90208-1; LEVI DM, 1980, DOC OPHTHALMOL, V49, P303, DOI 10.1007/BF01886623; Li JR, 2011, INVEST OPHTH VIS SCI, V52, P4169, DOI 10.1167/iovs.11-7233; Li JR, 2013, OPHTHALMOLOGY, V120, P1672, DOI 10.1016/j.ophtha.2013.01.048; Mansouri B, 2008, VISION RES, V48, P2775, DOI 10.1016/j.visres.2008.09.002; McKee SP, 2003, J VISION, V3, P380, DOI 10.1167/3.5.5; Mitchell DE, 1998, CURR BIOL, V8, P1179, DOI 10.1016/S0960-9822(07)00489-7; Mitchell DE, 2009, PHILOS T R SOC B, V364, P383, DOI 10.1098/rstb.2008.0192; Narasimhan S, 2012, VISION RES, V66, P1, DOI 10.1016/j.visres.2012.06.007; Niechwiej-Szwedo E, 2012, INVEST OPHTH VIS SCI, V53, P7458, DOI 10.1167/iovs.12-10550; Niechwiej-Szwedo E, 2011, INVEST OPHTH VIS SCI, V52, P795, DOI 10.1167/iovs.10-6092; Niechwiej-Szwedo E, 2010, INVEST OPHTH VIS SCI, V51, P6348, DOI 10.1167/iovs.10-5882; O'Connor AR, 2010, OPTOMETRY VISION SCI, V87, P942, DOI 10.1097/OPX.0b013e3181fd132e; Ooi T L, 2001, Optometry, V72, P168; PARDHAN S, 1992, DOC OPHTHALMOL, V82, P239, DOI 10.1007/BF00160771; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Sengpiel F, 2006, CEREB CORTEX, V16, P1750, DOI 10.1093/cercor/bhj110; SHEEDY JE, 1986, AM J OPTOM PHYS OPT, V63, P839; Simmers AJ, 2003, VISION RES, V43, P729, DOI 10.1016/S0042-6989(02)00684-3; Simmons DR, 2005, PERCEPTION, V34, P1035, DOI 10.1068/p5279; SJOSTRAND J, 1981, ACTA OPHTHALMOL, V59, P25; To L, 2011, IEEE T NEUR SYS REH, V19, P280, DOI 10.1109/TNSRE.2011.2115255; Vedamurthy I, 2008, VISION RES, V48, P1522, DOI 10.1016/j.visres.2008.04.004; Vedamurthy I, 2007, VISION RES, V47, P179, DOI 10.1016/j.visres.2006.08.017; Weakley DR, 2001, OPHTHALMOLOGY, V108, P163, DOI 10.1016/S0161-6420(00)00425-5	62	24	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100156	10.1371/journal.pone.0100156	http://dx.doi.org/10.1371/journal.pone.0100156			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959842	Green Published, gold, Green Submitted			2022-12-27	WOS:000338633900023
J	Garikipati, VNS; Jadhav, S; Pal, L; Prakash, P; Dikshit, M; Nityanand, S				Garikipati, Venkata Naga Srikanth; Jadhav, Sachin; Pal, Lily; Prakash, Prem; Dikshit, Madhu; Nityanand, Soniya			Mesenchymal Stem Cells from Fetal Heart Attenuate Myocardial Injury after Infarction: An In Vivo Serial Pinhole Gated SPECT-CT Study in Rats	PLOS ONE			English	Article							LEFT-VENTRICULAR FUNCTION; CARDIAC PROGENITOR CELLS; BONE-MARROW-CELLS; ISCHEMIC CARDIOMYOPATHY; MODEL; TRANSPLANTATION; DIFFERENTIATE; INJECTION; PERFUSION; THERAPY	Mesenchymal stem cells (MSC) have emerged as a potential stem cell type for cardiac regeneration after myocardial infarction (MI). Recently, we isolated and characterized mesenchymal stem cells derived from rat fetal heart (fC-MSC), which exhibited potential to differentiate into cardiomyocytes, endothelial cells and smooth muscle cells in vitro. In the present study, we investigated the therapeutic efficacy of intravenously injected fC-MSC in a rat model of MI using multi-pinhole gated SPECT-CT system. fC-MSC were isolated from the hearts of Sprague Dawley (SD) rat fetuses at gestation day 16 and expanded ex vivo. One week after induction of MI, 2610 6 fC-MSC labeled with PKH26 dye (n = 6) or saline alone (n = 6) were injected through the tail vein of the rats. Initial in vivo tracking of 99mTc-labeled fC-MSC revealed a focal uptake of cells in the anterior mid-ventricular region of the heart. At 4 weeks of fC-MSC administration, the cells labeled with PKH26 were located in abundance in infarct/peri-infarct region and the fC-MSC treated hearts showed a significant increase in left ventricular ejection fraction and a significant decrease in the end diastolic volume, end systolic volume and left ventricular myo-mass in comparison to the saline treated group. In addition, fC-MSC treated hearts had a significantly better myocardial perfusion and attenuation in the infarct size, in comparison to the saline treated hearts. The engrafted PKH26-fC-MSC expressed cardiac troponin T, endothelial CD31 and smooth muscle sm-MHC, suggesting their differentiation into all major cells of cardiovascular lineage. The fC-MSC treated hearts demonstrated an up-regulation of cardio-protective growth factors, anti-fibrotic and anti-apoptotic molecules, highlighting that the observed left ventricular functional recovery may be due to secretion of paracrine factors by fC-MSC. Taken together, our results suggest that fC-MSC therapy may be a new therapeutic strategy for MI and multi-pinhole gated SPECT-CT system may be a useful tool to evaluate cardiac perfusion, function and cell tracking after stem cell therapy in acute myocardial injury setting.	[Garikipati, Venkata Naga Srikanth; Jadhav, Sachin; Nityanand, Soniya] Sanjay Gandhi Postgrad Inst Med Sci, Dept Hematol, Stem Cell Res Facil, Lucknow, Uttar Pradesh, India; [Pal, Lily] Sanjay Gandhi Postgrad Inst Med Sci, Dept Pathol, Lucknow, Uttar Pradesh, India; [Prakash, Prem; Dikshit, Madhu] Cent Drug Res Inst, Div Pharmacol, Cardiovasc Unit, Lucknow 226001, Uttar Pradesh, India	Sanjay Gandhi Postgraduate Institute of Medical Sciences; Sanjay Gandhi Postgraduate Institute of Medical Sciences; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Nityanand, S (corresponding author), Sanjay Gandhi Postgrad Inst Med Sci, Dept Hematol, Stem Cell Res Facil, Lucknow, Uttar Pradesh, India.	soniya@sgpgi.ac.in	Prakash, Prem/AAI-1672-2020	Prakash, Prem/0000-0001-9501-0065; Jadhav, S H/0000-0002-4752-4202	Department of Biotechnology, Government of India [BT/PR6519/MED/14/826/2005]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by an extramural grant sanctioned by Department of Biotechnology, Government of India, to Dr. S. Nityanand (BT/PR6519/MED/14/826/2005). http://dbtindia.nic.in/index.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbash IM, 2003, CIRCULATION, V108, P863, DOI 10.1161/01.CIR.0000084828.50310.6A; Beeres SLMA, 2007, J AM COLL CARDIOL, V49, P1137, DOI 10.1016/j.jacc.2006.10.072; Berry MF, 2006, AM J PHYSIOL-HEART C, V290, pH2196, DOI 10.1152/ajpheart.01017.2005; Chen PM, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-49; Christoforou N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011536; Dawn B, 2005, P NATL ACAD SCI USA, V102, P3766, DOI 10.1073/pnas.0405957102; Dussault AA, 2006, BIOL PROCED ONLINE, V8, P1, DOI 10.1251/bpo114; Eisen HJ, 2008, NAT CLIN PRACT CARD, V5, P520, DOI 10.1038/ncpcardio1299; Fehlberg S, 2003, BRIT J PHARMACOL, V139, P495, DOI 10.1038/sj.bjp.0705275; Garikipati Venkata Naga Srikanth NKT, 2012, INT J REGENERATIVE M, V1, P1; Hagege AA, 2003, LANCET, V361, P491, DOI 10.1016/S0140-6736(03)12458-0; Halkos ME, 2008, BASIC RES CARDIOL, V103, P525, DOI 10.1007/s00395-008-0741-0; Hare JM, 2009, J AM COLL CARDIOL, V54, P2277, DOI 10.1016/j.jacc.2009.06.055; Huikuri HV, 2008, EUR HEART J, V29, P2723, DOI 10.1093/eurheartj/ehn436; Iso Y, 2007, BIOCHEM BIOPH RES CO, V354, P700, DOI 10.1016/j.bbrc.2007.01.045; Kajstura J, 2005, CIRC RES, V96, P127, DOI 10.1161/01.RES.0000151843.79801.60; Krishnamurthy P, 2011, CIRC RES, V109, P1280, DOI 10.1161/CIRCRESAHA.111.248369; Martin-Rendon E, 2008, EUR HEART J, V29, P1807, DOI 10.1093/eurheartj/ehn220; Meyer GP, 2006, CIRCULATION, V113, P1287, DOI 10.1161/CIRCULATIONAHA.105.575118; Mias C, 2009, STEM CELLS, V27, P2734, DOI 10.1002/stem.169; Morrison AR, 2009, CARDIOL CLIN, V27, P329, DOI 10.1016/j.ccl.2008.12.008; Oskouei BN, 2012, STEM CELL TRANSL MED, V1, P116, DOI 10.5966/sctm.2011-0015; Pelekanos RA, 2012, STEM CELL RES, V8, P58, DOI 10.1016/j.scr.2011.08.003; Ramkisoensing AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024164; Rota M, 2008, CIRC RES, V103, P107, DOI 10.1161/CIRCRESAHA.108.178525; Schuh A, 2008, BASIC RES CARDIOL, V103, P69, DOI 10.1007/s00395-007-0685-9; Schuleri KH, 2008, AM J PHYSIOL-HEART C, V294, pH2002, DOI 10.1152/ajpheart.00762.2007; Silva GV, 2005, CIRCULATION, V111, P150, DOI 10.1161/01.CIR.0000151812.86142.45; Srikanth GVN, 2009, J STEM CELLS REGEN, V5, P30; Srikanth Garikipati Venkata Naga, 2013, World J Stem Cells, V5, P26, DOI 10.4252/wjsc.v5.i1.26; Tang XL, 2010, CIRC J, V74, P390, DOI 10.1253/circj.CJ-09-0923; Tran N, 2006, CELL TRANSPLANT, V15, P351, DOI 10.3727/000000006783981918; Tsui BMW, 2009, J NUCL MED, V50, P667, DOI 10.2967/jnumed.108.058479; Williams AR, 2013, CIRCULATION, V127, P213, DOI 10.1161/CIRCULATIONAHA.112.131110; Wu JC, 2010, J NUCL MED, V51, p128S, DOI 10.2967/jnumed.109.068239; Yoon YS, 2005, J CLIN INVEST, V115, P326, DOI 10.1172/JCI200522326	36	22	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100982	10.1371/journal.pone.0100982	http://dx.doi.org/10.1371/journal.pone.0100982			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971627	Green Published, gold, Green Submitted			2022-12-27	WOS:000338512200080
J	Lee, JJ; Lin, MY; Chang, JS; Hung, CC; Chang, JM; Chen, HC; Yu, ML; Hwang, SJ				Lee, Jia-Jung; Lin, Ming-Yen; Chang, Jung-San; Hung, Chi-Chih; Chang, Jer-Ming; Chen, Hung-Chun; Yu, Ming-Lung; Hwang, Shang-Jyh			Hepatitis C Virus Infection Increases Risk of Developing End-Stage Renal Disease Using Competing Risk Analysis	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CARDIOVASCULAR-DISEASE; ASSOCIATION; POPULATION; SURVIVAL; DEATH; REPLACEMENT; PREVALENCE; MORTALITY; OUTCOMES	Background: Chronic kidney disease (CKD) and hepatitis C virus (HCV) infection are closely linked and both increase patient mortality. The association of HCV and risk of developing end-stage renal disease (ESRD) has not been analyzed with competing risk model. Method: We enrolled a prospective cohort of 4,185 patients (mean age, 62 years; 41% female) registered in the CKD integrated care program at two affiliated hospitals of Kaohsiung Medical University in Taiwan between November 11, 2002 and May 31, 2009. With competing risk model, we analyzed the association of HCV infection, defined by seropositive of anti-HCV antibody, and hepatitis B virus (HBV) infection, defined by seropositive of HBV surface antigen, with the risk of entering ESRD. Results: The prevalence of HCV infection was 7.6% and it increased with the CKD stages (trend test, P < 0.001), while the prevalence of HBV infection was 7.4% and no specific trend among CKD stages (tend test, P = 0.1). During the 9,101 person-year follow-up period, there were 446 death and 1,205 patients entering ESRD. After adjusting death as the competing risk, the estimated 5-year cumulative incidence rate of ESRD among patients with and without HCV infection were 52.6% and 38.4%, respectively (modified log-rank, P < 0.001). Multivariable analysis showed that HCV infection, but not HBV infection, had higher risk of developing ESRD compared with cases without infection (HCV, HR: 1.32, 95% CI: 1.07-1.62; HBV, HR: 1.10, 95% CI: 0.89-1.35). Subgroup analyses showed consistent results. Conclusions: With death-adjusted competing risk analysis, HCV infection is associated with an increased risk of developing ESRD in CKD cohort.	[Lee, Jia-Jung; Lin, Ming-Yen; Hung, Chi-Chih; Chang, Jer-Ming; Chen, Hung-Chun; Hwang, Shang-Jyh] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Nephrol, Kaohsiung, Taiwan; [Chang, Jung-San] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Gastroenterol, Kaohsiung, Taiwan; [Yu, Ming-Lung] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Hepatobiliary, Kaohsiung, Taiwan; [Lee, Jia-Jung; Hung, Chi-Chih; Chang, Jer-Ming; Chen, Hung-Chun; Yu, Ming-Lung; Hwang, Shang-Jyh] Kaohsiung Med Univ, Coll Med, Fac Med, Kaohsiung, Taiwan; [Lee, Jia-Jung; Chang, Jung-San; Hung, Chi-Chih; Chang, Jer-Ming; Chen, Hung-Chun; Hwang, Shang-Jyh] Kaohsiung Med Univ, Coll Med, Fac Renal Care, Kaohsiung, Taiwan; [Lin, Ming-Yen] Instrument Technol Res Ctr, Natl Appl Res Labs, Hsinchu, Taiwan; [Chang, Jer-Ming] Kaohsiung Med Univ, Municipal Hsiao Kang Hosp, Dept Internal Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; National Applied Research Laboratories - Taiwan; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital	Hwang, SJ (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Nephrol, Kaohsiung, Taiwan.	sjhwang@kmu.edu.tw	Lin, Ming Yen/A-8637-2010	Lin, Ming Yen/0000-0002-8194-4833; Lee, Jia-Jung/0000-0002-7951-9571	National Science Council of Taiwan, R.O.C. [NSC: 99-2314-B-037-003-MY3, NSC 102-3114-Y-492-076-023]; Kaohsiung Medical University Hospital [1R09]	National Science Council of Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan); Kaohsiung Medical University Hospital	The authors are grateful for the research support from the National Science Council of Taiwan, R.O.C. under grant number NSC: 99-2314-B-037-003-MY3, NSC 102-3114-Y-492-076-023, and from Kaohsiung Medical University Hospital under grant number 1R09. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barsoum RS, 2007, NEPHROL DIAL TRANSPL, V22, P1840, DOI 10.1093/ndt/gfm205; Chen YC, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-187; Chuang WL, 2013, J GASTROENTEROL, V48, P22, DOI 10.1007/s00535-012-0669-x; Conway B, 2009, NEPHROL DIAL TRANSPL, V24, P1930, DOI 10.1093/ndt/gfn772; Crook ED, 2005, DIABETES CARE, V28, P2187, DOI 10.2337/diacare.28.9.2187; Dai CY, 2015, J GASTROEN HEPATOL, V30, P879, DOI 10.1111/jgh.12313; Dalrymple LS, 2011, J GEN INTERN MED, V26, P379, DOI 10.1007/s11606-010-1511-x; De Nicola L, 2011, CLIN J AM SOC NEPHRO, V6, P2421, DOI 10.2215/CJN.01180211; Fabrizi F, 2013, AM J KIDNEY DIS, V61, P623, DOI 10.1053/j.ajkd.2012.08.040; Fabrizi F, 2012, CLIN J AM SOC NEPHRO, V7, P549, DOI 10.2215/CJN.06920711; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Foley RN, 2005, J AM SOC NEPHROL, V16, P489, DOI 10.1681/ASN.2004030203; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Grams ME, 2012, CLIN J AM SOC NEPHRO, V7, P1606, DOI 10.2215/CJN.03460412; Gray B, 2013, CMPRSK SUBDISTRIBUTI; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Hsu YC, 2014, HEPATOLOGY, V59, P1293, DOI 10.1002/hep.26892; Keith DS, 2004, ARCH INTERN MED, V164, P659, DOI 10.1001/archinte.164.6.659; Lee JJ, 2010, AM J KIDNEY DIS, V56, P23, DOI 10.1053/j.ajkd.2010.01.015; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Liu JY, 2008, CLIN INFECT DIS, V46, P1761, DOI 10.1086/587992; Liu WC, 2012, CLIN J AM SOC NEPHRO, V7, P541, DOI 10.2215/CJN.09420911; Meyers CM, 2003, AM J KIDNEY DIS, V42, P631, DOI 10.1016/S0272-6386(03)00828-X; Noordzij M, 2013, NEPHROL DIAL TRANSPL, V28, P2670, DOI 10.1093/ndt/gft355; Perico N, 2009, CLIN J AM SOC NEPHRO, V4, P207, DOI 10.2215/CJN.03710708; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Satapathy SK, 2012, HEPATOL INT, V6, P369, DOI 10.1007/s12072-011-9284-9; Sheikh MY, 2008, HEPATOLOGY, V47, P2127, DOI 10.1002/hep.22269; Su FH, 2012, AM J KIDNEY DIS, V60, P553, DOI 10.1053/j.ajkd.2012.04.003; Tsai YC, 2014, AM J KIDNEY DIS, V63, P68, DOI 10.1053/j.ajkd.2013.06.011; Tsui JI, 2007, ARCH INTERN MED, V167, P1271, DOI 10.1001/archinte.167.12.1271; Wen CP, 2008, LANCET, V371, P2173, DOI 10.1016/S0140-6736(08)60952-6; Wornle M, 2006, AM J PATHOL, V168, P370, DOI 10.2353/ajpath.2006.050491; Yang JF, 2011, KAOHSIUNG J MED SCI, V27, P258, DOI 10.1016/j.kjms.2010.11.007; Yu ML, 2014, J HEPATOL, V60, P253, DOI 10.1016/j.jhep.2013.09.023; Yu ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052048; Zhu NL, 1998, J VIROL, V72, P3691, DOI 10.1128/JVI.72.5.3691-3697.1998	38	93	96	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100790	10.1371/journal.pone.0100790	http://dx.doi.org/10.1371/journal.pone.0100790			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971499	gold, Green Published, Green Submitted			2022-12-27	WOS:000338512200063
J	Paquette, MA; Atlas, E; Wade, MG; Yauk, CL				Paquette, Martin A.; Atlas, Ella; Wade, Mike G.; Yauk, Carole L.			Thyroid Hormone Response Element Half-Site Organization and Its Effect on Thyroid Hormone Mediated Transcription	PLOS ONE			English	Article							X-RECEPTOR RXR; RETINOIC ACID; ENVIRONMENTAL CHEMICALS; GENE; HETERODIMER; EXPRESSION; PROMOTER; DEFICIENCY; INDUCTION; PARTNER	Thyroid hormone (TH) exerts its effects by binding to the thyroid hormone receptor (TR), which binds to TH response elements (TREs) to regulate target gene expression. We investigated the relative ability of liganded homodimers TR and retinoid X receptor (RXR), and the heterodimer TR/RXR, to regulate gene expression for the TRE half-site organizations: direct repeat 4 (DR4), inverted repeat 0 (IR0) and everted repeat 6 (ER6). Luciferase reporter assays using a DR4 TRE suggest that both the TR homodimer and TR/RXR heterodimer regulate luciferase expression in the presence of their respective ligands. However, in the presence of the IR0 TRE, transfection with TR/RXR and RXR alone increased luciferase activity and there was no effect of TR alone. The presence of 9-cis-retinoic acid was necessary for luciferase expression, whereas TH treatment alone was insufficient. For the ER6 TRE, transfection with TR/RXR, TR alone and RXR alone (in the presence of their respective ligands) all caused a significant increase in luciferase activity. When both ligands were present, transfection with both TR/RXR caused more activation. Finally, we investigated the efficacy of the TR-antagonist 1-850 in inhibiting transcription by TR or TR/RXR at DR4 and ER6 TREs. We found that 1-850 did not suppress luciferase activation in the presence of TR/RXR for the ER6 TRE, suggesting conformational changes of the ligand binding domain of the TR when bound to different TRE half-site organizations. Collectively, the findings indicate that there are fundamental differences between TRE configurations that affect nuclear receptor interactions with the response element and ability to bind ligands and antagonists.	[Paquette, Martin A.; Atlas, Ella; Wade, Mike G.; Yauk, Carole L.] Hlth Canada, Hlth Environm & Consumer Safety Branch, Environm Hlth Sci & Res Bur, Ottawa, ON K1A 0L2, Canada; [Paquette, Martin A.; Yauk, Carole L.] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada	Health Canada; Carleton University	Yauk, CL (corresponding author), Hlth Canada, Hlth Environm & Consumer Safety Branch, Environm Hlth Sci & Res Bur, Ottawa, ON K1A 0L2, Canada.	carole.yauk@hc-sc.gc.ca		Yauk, Carole/0000-0003-4919-876X; Wade, Michael/0000-0002-7331-3839; Yauk, Carole/0000-0002-6725-3454	Health Canada Genomics RD Initiative; Canadian Regulatory System for Biotechnology	Health Canada Genomics RD Initiative; Canadian Regulatory System for Biotechnology	This work was funded by the Health Canada Genomics R&D Initiative and the Canadian Regulatory System for Biotechnology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUFLIEGNER M, 1993, MOL CELL BIOL, V13, P5725, DOI 10.1128/MCB.13.9.5725; Bansal R, 2008, ENDOCRINOLOGY, V149, P4001, DOI 10.1210/en.2007-1774; Boas M, 2006, EUR J ENDOCRINOL, V154, P599, DOI 10.1530/eje.1.02128; BRENT GA, 1989, J BIOL CHEM, V264, P178; BRENT GA, 1989, MOL ENDOCRINOL, V3, P1996, DOI 10.1210/mend-3-12-1996; Brent GA, 2012, J CLIN INVEST, V122, P3035, DOI 10.1172/JCI60047; Brucker-Davis F, 1998, THYROID, V8, P827, DOI 10.1089/thy.1998.8.827; BUGGE TH, 1992, EMBO J, V11, P1409, DOI 10.1002/j.1460-2075.1992.tb05186.x; CARR FE, 1994, J BIOL CHEM, V269, P4175; Castillo AI, 2004, MOL CELL BIOL, V24, P502, DOI 10.1128/MCB.24.2.502-513.2004; Chin S, 1998, ENDOCRINOLOGY, V139, P3423, DOI 10.1210/en.139.8.3423; Decherf S, 2010, P NATL ACAD SCI USA, V107, P4471, DOI 10.1073/pnas.0905190107; Denver RJ, 2009, ENDOCRINOLOGY, V150, P3935, DOI 10.1210/en.2009-0050; Dong H, 2007, ENDOCRINOLOGY, V148, P3932, DOI 10.1210/en.2007-0452; Echchgadda I, 2004, MOL PHARMACOL, V65, P720, DOI 10.1124/mol.65.3.720; Farsetti A, 1997, ENDOCRINOLOGY, V138, P4705, DOI 10.1210/en.138.11.4705; Giera S, 2011, ENDOCRINOLOGY, V152, P2909, DOI 10.1210/en.2010-1490; Haddow JE, 1999, NEW ENGL J MED, V341, P549, DOI 10.1056/NEJM199908193410801; Harbers M, 1996, NUCLEIC ACIDS RES, V24, P2252, DOI 10.1093/nar/24.12.2252; Jugan ML, 2010, BIOCHEM PHARMACOL, V79, P939, DOI 10.1016/j.bcp.2009.11.006; Lee CH, 1999, BIOCHEMISTRY-US, V38, P8820, DOI 10.1021/bi9903547; LEID M, 1992, CELL, V68, P377, DOI 10.1016/0092-8674(92)90478-U; Li DS, 2004, J BIOL CHEM, V279, P7427, DOI 10.1074/jbc.M311596200; Li DS, 2002, MOL CELL BIOL, V22, P5782, DOI 10.1128/MCB.22.16.5782-5792.2002; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; MANGELSDORF DJ, 1992, GENE DEV, V6, P329, DOI 10.1101/gad.6.3.329; MANGELSDORF DJ, 1990, NATURE, V345, P224, DOI 10.1038/345224a0; Schapira M, 2003, P NATL ACAD SCI USA, V100, P7354, DOI 10.1073/pnas.1131854100; Velasco LFR, 2007, J BIOL CHEM, V282, P12458, DOI 10.1074/jbc.M610700200; Zimmermann MB, 2009, ENDOCR REV, V30, P376, DOI 10.1210/er.2009-0011; Zoeller TR, 2010, HORM-INT J ENDOCRINO, V9, P28, DOI 10.14310/horm.2002.1250	31	16	17	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e101155	10.1371/journal.pone.0101155	http://dx.doi.org/10.1371/journal.pone.0101155			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971931	Green Published, gold, Green Submitted			2022-12-27	WOS:000338512200099
J	Duquette, JF; Belant, JL; Svoboda, NJ; Beyer, DE; Lederle, PE				Duquette, Jared F.; Belant, Jerrold L.; Svoboda, Nathan J.; Beyer, Dean E., Jr.; Lederle, Patrick E.			Effects of Maternal Nutrition, Resource Use and Multi-Predator Risk on Neonatal White-Tailed Deer Survival	PLOS ONE			English	Article							CAUSE-SPECIFIC MORTALITY; ELK CALF SURVIVAL; HABITAT SELECTION; ANTIPREDATOR RESPONSE; POPULATION-DYNAMICS; TEMPORAL VARIATION; FAWN SURVIVAL; CANIS-LUPUS; WOLVES; WOLF	Growth of ungulate populations is typically most sensitive to survival of neonates, which in turn is influenced by maternal nutritional condition and trade-offs in resource selection and avoidance of predators. We assessed whether resource use, multi-predator risk, maternal nutritional effects, hiding cover, or interactions among these variables best explained variation in daily survival of free-ranging neonatal white-tailed deer (Odocoileus virginianus) during their post-partum period (14 May-31 Aug) in Michigan, USA. We used Cox proportional hazards mixed-effects models to assess survival related to covariates of resource use, composite predation risk of 4 mammalian predators, fawn body mass at birth, winter weather, and vegetation growth phenology. Predation, particularly from coyotes (Canis latrans), was the leading cause of mortality; however, an additive model of non-ideal resource use and maternal nutritional effects explained 71% of the variation in survival. This relationship suggested that dams selected areas where fawns had poor resources, while greater predation in these areas led to additive mortalities beyond those related to resource use alone. Also, maternal nutritional effects suggested that severe winters resulted in dams producing smaller fawns, which decreased their likelihood of survival. Fawn resource use appeared to reflect dam avoidance of lowland forests with poor forage and greater use by wolves (C. lupus), their primary predator. While this strategy led to greater fawn mortality, particularly by coyotes, it likely promoted the life-long reproductive success of dams because many reached late-age (>10 years old) and could have produced multiple generations of fawns. Studies often link resource selection and survival of ungulates, but our results suggested that multiple factors can mediate that relationship, including multi-predator risk. We emphasize the importance of identifying interactions among biological and environmental factors when assessing survival of ungulates.	[Duquette, Jared F.; Belant, Jerrold L.; Svoboda, Nathan J.] Mississippi State Univ, Forest & Wildlife Res Ctr, Carnivore Ecol Lab, Mississippi State, MS 39762 USA; [Beyer, Dean E., Jr.] Michigan Dept Nat Resources, Wildlife Div, Marquette, MI USA; [Lederle, Patrick E.] Michigan Dept Nat Resources, Wildlife Div, Lansing, MI USA	Mississippi State University	Duquette, JF (corresponding author), Mississippi State Univ, Forest & Wildlife Res Ctr, Carnivore Ecol Lab, Mississippi State, MS 39762 USA.	jduquette@cfr.msstate.edu	Belant, Jerrold/HDM-7749-2022		Michigan Department of Natural Resources [W-147-R]; Safari Club International; Safari Club International Michigan Involvement Committee	Michigan Department of Natural Resources; Safari Club International; Safari Club International Michigan Involvement Committee	This study was funded by the Michigan Department of Natural Resources through the Federal Aid in Wildlife Restoration Act under Pittman-Robertson project W-147-R, Safari Club International, and Safari Club International Michigan Involvement Committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlt D, 2007, ECOLOGY, V88, P792, DOI 10.1890/06-0574; Atwood TC, 2007, J WILDLIFE MANAGE, V71, P1098, DOI 10.2193/2006-102; Ballard WB, 1999, J WILDLIFE MANAGE, V63, P574, DOI 10.2307/3802645; Barber-Meyer SM, 2008, WILDLIFE MONOGR, P1, DOI 10.2193/2008-004; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Battin J, 2004, CONSERV BIOL, V18, P1482, DOI 10.1111/j.1523-1739.2004.00417.x; Beauchamp G, 2011, AM NAT, V177, P143, DOI 10.1086/657437; Berger KM, 2008, ECOLOGY, V89, P818, DOI 10.1890/07-0193.1; Berger KM, 2007, J ANIM ECOL, V76, P1075, DOI 10.1111/j.1365-2656.2007.01287.x; BERGERUD AT, 1987, CAN J ZOOL, V65, P1597, DOI 10.1139/z87-249; Beyer H. L, 2012, GEOSPATIAL MODELLING; Bongi P, 2008, J ZOOL, V276, P242, DOI 10.1111/j.1469-7998.2008.00481.x; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Broekhuis F, 2013, J ANIM ECOL, V82, P1097, DOI 10.1111/1365-2656.12077; Carstensen M, 2003, WILDLIFE SOC B, V31, P634; Carstensen M, 2009, J WILDLIFE MANAGE, V73, P175, DOI 10.2193/2006-107; CAUGHLEY G, 1966, ECOLOGY, V47, P906, DOI 10.2307/1935638; Christianson D, 2010, ECOLOGY, V91, P1184, DOI 10.1890/09-0221.1; Ciuti S, 2004, BEHAV ECOL SOCIOBIOL, V56, P552, DOI 10.1007/s00265-004-0819-0; COOK RS, 1971, J WILDLIFE MANAGE, V35, P47, DOI 10.2307/3799870; Creel S, 2005, ECOLOGY, V86, P3387, DOI 10.1890/05-0032; Creel S, 2008, ANIM BEHAV, V76, P1139, DOI 10.1016/j.anbehav.2008.07.006; DeCesare NJ, 2014, J ANIM ECOL, V83, P343, DOI 10.1111/1365-2656.12144; DelGiudice GD, 2002, J WILDLIFE MANAGE, V66, P698, DOI 10.2307/3803136; Delgiudice GD, 2006, J WILDLIFE MANAGE, V70, P1556, DOI 10.2193/0022-541X(2006)70[1556:ALASAO]2.0.CO;2; Demma DJ, 2009, CAN FIELD NAT, V123, P299, DOI 10.22621/cfn.v123i4.997; Duquette JF, 2012, WILDLIFE SOC B, V36, P115, DOI 10.1002/wsb.115; Duquette JF, 2014, POPUL ECOL, V56, P481, DOI 10.1007/s10144-014-0432-7; Dussault C, 2012, P ROY SOC B-BIOL SCI, V279, P4481, DOI 10.1098/rspb.2012.1700; Environmental Systems Research Institute Inc, 2010, ARCGIS 10 0; Farmer CJ, 2006, J WILDLIFE MANAGE, V70, P1403, DOI 10.2193/0022-541X(2006)70[1403:RFAMOB]2.0.CO;2; Ferrari MCO, 2007, P ROY SOC B-BIOL SCI, V274, P1853, DOI 10.1098/rspb.2007.0297; Fox J., 2002, R S PLUS COMPANION A; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Frid A, 2002, CONSERV ECOL, V6; Gaillard JM, 1998, TRENDS ECOL EVOL, V13, P58, DOI 10.1016/S0169-5347(97)01237-8; Gaillard JM, 2000, ANNU REV ECOL SYST, V31, P367, DOI 10.1146/annurev.ecolsys.31.1.367; Gillies CS, 2006, J ANIM ECOL, V75, P887, DOI 10.1111/j.1365-2656.2006.01106.x; Griffin KA, 2011, J ANIM ECOL, V80, P1246, DOI 10.1111/j.1365-2656.2011.01856.x; Grovenburg TW, 2012, ANIM BEHAV, V84, P59, DOI 10.1016/j.anbehav.2012.04.005; Grovenburg TW, 2010, J WILDLIFE MANAGE, V74, P1250, DOI 10.2193/2009-399; Gurarie E, 2011, OECOLOGIA, V165, P891, DOI 10.1007/s00442-010-1883-y; Gustine DD, 2006, WILDLIFE MONOGR, P1, DOI 10.2193/0084-0173(2006)165[1:CSOWCI]2.0.CO;2; Jackson AM, 2011, THESIS AUBURN U AUBU; Johnson CJ, 2004, J APPL ECOL, V41, P238, DOI 10.1111/j.0021-8901.2004.00899.x; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Kilgo JC, 2012, J WILDLIFE MANAGE, V76, P1420, DOI 10.1002/jwmg.393; Kittle AM, 2008, OECOLOGIA, V157, P163, DOI 10.1007/s00442-008-1051-9; Kjellander P, 2004, P ROY SOC LOND B BIO, V271, P338; KUNKEL KE, 1994, CAN J ZOOL, V72, P1557, DOI 10.1139/z94-207; Liley S, 2008, BEHAV ECOL, V19, P245, DOI 10.1093/beheco/arm116; Lomas LA, 2007, J WILDLIFE MANAGE, V71, P884, DOI 10.2193/2006-203; Manly B.F.J., 2002, RESOURCE SELECTION A; MESSIER F, 1994, ECOLOGY, V75, P478, DOI 10.2307/1939551; Millspaugh JJ., 2001, RADIO TRACKING ANIMA; Monteith KL, 2009, J MAMMAL, V90, P651, DOI 10.1644/08-MAMM-A-191R1.1; Muhly TB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017050; Nelson ME, 1981, WILDLIFE MONOGR, V77, P3; NELSON TA, 1987, J WILDLIFE MANAGE, V51, P326, DOI 10.2307/3801010; OZOGA JJ, 1982, J WILDLIFE MANAGE, V46, P281, DOI 10.2307/3808640; OZOGA JJ, 1982, J WILDLIFE MANAGE, V46, P1, DOI 10.2307/3808402; Panzacchi M, 2010, BEHAV ECOL SOCIOBIOL, V64, P1267, DOI 10.1007/s00265-010-0941-0; Parker KL, 2009, FUNCT ECOL, V23, P57, DOI 10.1111/j.1365-2435.2009.01528.x; Petroelje TR, 2013, WILDLIFE BIOL, V19, P41, DOI 10.2981/12-022; Pettorelli N, 2005, J ANIM ECOL, V74, P972, DOI 10.1111/j.1365-2656.2005.00988.x; Pierce BM, 2004, J WILDLIFE MANAGE, V68, P533, DOI 10.2193/0022-541X(2004)068[0533:HSBMDF]2.0.CO;2; Quinn GP, 2003, EXPT DESIGN DATA ANA; Relyea Rick A., 2005, P189; Rohm JH, 2007, J WILDLIFE MANAGE, V71, P851, DOI 10.2193/2006-027; Sams MG, 1996, J MAMMAL, V77, P179, DOI 10.2307/1382719; Sih Andrew, 2005, P240; Sih A, 2012, ECOL LETT, V15, P278, DOI 10.1111/j.1461-0248.2011.01731.x; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Sirot E, 2010, ANIM BEHAV, V80, P737, DOI 10.1016/j.anbehav.2010.07.014; Sivertsen TR, 2012, EUR J WILDLIFE RES, V58, P863, DOI 10.1007/s10344-012-0626-2; Stricker HK, 2012, WILDLIFE SOC B, V36, P257, DOI 10.1002/wsb.137; SUTHERLAND WJ, 1983, J ANIM ECOL, V52, P821, DOI 10.2307/4456; Therneau T. M, 2015, SURVIVAL SURVIVAL AN; Therrien JF, 2008, ANIM BEHAV, V75, P235, DOI 10.1016/j.anbehav.2007.04.030; Theuerkauf J, 2008, FOREST ECOL MANAG, V256, P1325, DOI 10.1016/j.foreco.2008.06.030; Thomas DL, 2006, J WILDLIFE MANAGE, V70, P324, DOI 10.2193/0022-541X(2006)70[324:SDATFC]2.0.CO;2; Tollefson TN, 2011, J WILDLIFE MANAGE, V75, P919, DOI 10.1002/jwmg.113; United State Geological Survey, 2013, 250 M MODIS NORM DIF; van Beest FM, 2013, OECOLOGIA, V173, P409, DOI 10.1007/s00442-013-2647-2; Van Moorter B, 2009, OECOLOGIA, V159, P669, DOI 10.1007/s00442-008-1245-1; VERME LJ, 1977, J WILDLIFE MANAGE, V41, P700, DOI 10.2307/3799992; VERME LJ, 1985, J WILDLIFE MANAGE, V49, P962, DOI 10.2307/3801379; VERME LJ, 1989, J MAMMAL, V70, P438, DOI 10.2307/1381538; Vreeland JK, 2004, WILDLIFE SOC B, V32, P542, DOI 10.2193/0091-7648(2004)32[542:SRMCAH]2.0.CO;2; White CG, 2010, J WILDLIFE MANAGE, V74, P355, DOI 10.2193/2007-506; WHITE M, 1973, J MAMMAL, V54, P291, DOI 10.2307/1378900; Zar JH, 1999, BIOSTATISTICAL ANAL	92	24	24	1	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100841	10.1371/journal.pone.0100841	http://dx.doi.org/10.1371/journal.pone.0100841			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968318	gold, Green Submitted, Green Published			2022-12-27	WOS:000338280800073
J	Espinosa, F; Garrido, I; Ortega, A; Casimiro, I; Alvarez-Tinaut, MC				Espinosa, Francisco; Garrido, Inmaculada; Ortega, Alfonso; Casimiro, Ilda; Carmen Alvarez-Tinaut, Ma			Redox Activities and ROS, NO and Phenylpropanoids Production by Axenically Cultured Intact Olive Seedling Roots after Interaction with a Mycorrhizal or a Pathogenic Fungus	PLOS ONE			English	Article							NITRIC-OXIDE ACCUMULATION; ARBUSCULAR MYCORRHIZA; PLANT DEFENSE; VERTICILLIUM-DAHLIAE; GLOMUS-INTRARADICES; HYDROGEN-PEROXIDE; OXIDATIVE BURST; JASMONATE; RESPONSES; CELL	Roots of intact olive seedlings, axenically cultured, were alternatively placed in contact with Rhizophagus irregularis (mycorrhizal) or Verticillim dahliae (pathogenic) fungi. MeJA treatments were also included. In vivo redox activities in the apoplast of the intact roots (anion superoxide generation, superoxide dismutase and peroxidase activities) were measured. All our results showed that apoplastic redox activities of intact seedling roots in contact with the compatible mycorrhizal fungus were clearly attenuated in comparison with the pathogenic fungus or treated with MeJA, even at the early stages of treatment used. Total phenolics, flavonoids and phenylpropanoid glycosides were also quantified. Roots in contact with the mycorrhizal fungus did not enhance the biosynthesis of phenolic compounds with respect to controls, while those in contact with the pathogenic one significantly enhanced the biosynthesis of all phenolic fractions measured. Reactive oxygen species and nitric oxid accumulation in roots were examined by fluorescence microscopy. All of them presented much higher accumulation in roots in contact with the pathogenic than with the mycorrhizal fungus. Altogether these results indicate that intact olive seedling roots clearly differentiated between mycorrhizal and pathogenic fungi, attenuating defense reactions against the first to facilitate its establishment, while inducing a strong and sustained defense reaction against the second. Both reactive oxygen and nitrogen species seemed to be involved in these responses from the first moments of contact. However, further investigations are required to clarify the proposed crosstalk between them and their respective roles in these responses since fluorescence images of roots revealed that reactive oxygen species were mainly accumulated in the apoplast (congruently with the measured redox activities in this compartment) while nitric oxid was mainly stored in the cytosol.	[Espinosa, Francisco; Garrido, Inmaculada; Ortega, Alfonso; Carmen Alvarez-Tinaut, Ma] Univ Extremadura, Dept Biol Vegetal Ecol & Ciencias Tierra, Badajoz, Spain; [Casimiro, Ilda] Univ Extremadura, Dept Anat Biol Celular & Zool, Badajoz, Spain	Universidad de Extremadura; Universidad de Extremadura	Espinosa, F (corresponding author), Univ Extremadura, Dept Biol Vegetal Ecol & Ciencias Tierra, Ave Elvas S-N, Badajoz, Spain.	espinosa@unex.es	Casimiro, Ilda/R-3506-2019; Espinosa, Francisco/I-8205-2018	Espinosa, Francisco/0000-0002-6467-0359; GARRIDO CARBALLO, INMACULADA/0000-0002-2367-0985	Ministerio de Ciencia e Innovacion, Spain [CGL2009-12406]; regional government of Extremadura [PRI09A023]	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); regional government of Extremadura	This research was supported by the Ministerio de Ciencia e Innovacion, Spain (grant number CGL2009-12406) and the regional government of Extremadura (PRI09A023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Lateif K, 2012, PLANT SIGNAL BEHAV, V7, P636, DOI 10.4161/psb.20039; Apel K, 2004, ANNU REV PLANT BIOL, V109, P1247; Baptista P, 2007, MYCORRHIZA, V17, P185, DOI 10.1007/s00572-006-0091-4; BECARD G, 1988, NEW PHYTOL, V108, P211, DOI 10.1111/j.1469-8137.1988.tb03698.x; Blilou I, 2000, J EXP BOT, V51, P1969, DOI 10.1093/jexbot/51.353.1969; Bolwell GP, 2002, J EXP BOT, V53, P1367, DOI 10.1093/jexbot/53.372.1367; Bolwell PP, 2001, PROTOPLASMA, V217, P20, DOI 10.1007/BF01289409; Calcagno C, 2012, MYCORRHIZA, V22, P259, DOI 10.1007/s00572-011-0400-4; CANAS LA, 1987, PLANT SCI, V50, P85, DOI 10.1016/0168-9452(87)90034-3; Catanzariti AM, 2006, PLANT CELL, V18, P243, DOI 10.1105/tpc.105.035980; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Correa-Aragunde N, 2008, NEW PHYTOL, V179, P386, DOI 10.1111/j.1469-8137.2008.02466.x; Dixon RA, 2002, MOL PLANT PATHOL, V3, P371, DOI 10.1046/j.1364-3703.2002.00131.x; Dotan Y, 2004, PROG LIPID RES, V43, P200, DOI 10.1016/j.plipres.2003.10.001; Dumas-Gaudot E, 2000, ARBUSCULAR MYCORRHIZ, P173; Egan MJ, 2007, P NATL ACAD SCI USA, V104, P11772, DOI 10.1073/pnas.0700574104; Estaun V, 2003, J AM SOC HORTIC SCI, V128, P767, DOI 10.21273/JASHS.128.5.0767; Fester T, 2005, MYCORRHIZA, V15, P373, DOI 10.1007/s00572-005-0363-4; Foissner I, 2000, PLANT J, V23, P817, DOI 10.1046/j.1365-313X.2000.00835.x; Galvez M, 2005, J AGR FOOD CHEM, V53, P1927, DOI 10.1021/jf048076s; Garcia-Garrido JM, 2002, J EXP BOT, V53, P1377, DOI 10.1093/jexbot/53.373.1377; Garrido I, 2012, PLANT GROWTH REGUL, V68, P203, DOI 10.1007/s10725-012-9708-0; Garrido I, 2003, PROTOPLASMA, V221, P79, DOI 10.1007/s00709-002-0073-0; Garrido I, 2009, PROTOPLASMA, V237, P27, DOI 10.1007/s00709-009-0069-0; Gayoso C, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-232; Gianinazzi-Pearson V, 2008, ADV BOT RES, V46, P181, DOI DOI 10.1016/S0065-2296(07)46005-0; Gupta KJ, 2011, TRENDS PLANT SCI, V16, P160, DOI 10.1016/j.tplants.2010.11.007; Harborne JB, 2000, PHYTOCHEMISTRY, V55, P481, DOI 10.1016/S0031-9422(00)00235-1; Hause B, 2005, PLANTA, V221, P184, DOI 10.1007/s00425-004-1436-x; Heller J, 2011, ANNU REV PHYTOPATHOL, V49, P369, DOI 10.1146/annurev-phyto-072910-095355; Jimenez-Diaz RM, 1998, COMPENDIUM VERTICILL, P13; Kapulnik Y, 1996, NEW PHYTOL, V133, P59, DOI 10.1111/j.1469-8137.1996.tb04341.x; Kim DO, 2003, FOOD CHEM, V81, P321, DOI 10.1016/S0308-8146(02)00423-5; Kruger M, 2012, NEW PHYTOL, V193, P970, DOI 10.1111/j.1469-8137.2011.03962.x; Lambais MR, 2003, NEW PHYTOL, V160, P421, DOI 10.1046/j.1469-8137.2003.00881.x; Liszkay A, 2004, PLANT PHYSIOL, V136, P3114, DOI 10.1104/pp.104.044784; Liu JY, 2003, PLANT CELL, V15, P2106, DOI 10.1105/tpc.014183; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; MISRA HP, 1972, J BIOL CHEM, V247, P188; Nanda AK, 2010, J INTEGR PLANT BIOL, V52, P195, DOI 10.1111/j.1744-7909.2010.00933.x; Neill SJ, 2002, J EXP BOT, V53, P1237, DOI 10.1093/jexbot/53.372.1237; NGO TT, 1980, ANAL BIOCHEM, V105, P389, DOI 10.1016/0003-2697(80)90475-3; O'Brien JA, 2012, PLANTA, V236, P765, DOI 10.1007/s00425-012-1696-9; O'Connell RJ, 2006, NEW PHYTOL, V171, P699, DOI 10.1111/j.1469-8137.2006.01829.x; Passardi F, 2005, PLANT CELL REP, V24, P255, DOI 10.1007/s00299-005-0972-6; Peipp H, 1997, PHYTOCHEMISTRY, V44, P581, DOI 10.1016/S0031-9422(96)00561-4; Rodriguez-Serrano M, 2006, PLANT CELL ENVIRON, V29, P1532, DOI 10.1111/j.1365-3040.2006.01531.x; Ruiz-Lozano JM, 2001, J EXP BOT, V52, P2241, DOI 10.1093/jexbot/52.364.2241; Salzer P, 1999, PLANTA, V208, P319, DOI 10.1007/s004250050565; Samalova M, 2013, NEW PHYTOL, V197, P207, DOI 10.1111/j.1469-8137.2012.04368.x; Scheler C, 2013, CURR OPIN PLANT BIOL, V16, P534, DOI 10.1016/j.pbi.2013.06.020; Seo HS, 2001, P NATL ACAD SCI USA, V98, P4788, DOI 10.1073/pnas.081557298; Shi FM, 2008, BMB REP, V41, P79, DOI 10.5483/BMBRep.2008.41.1.079; Siciliano V, 2007, PLANT PHYSIOL, V144, P1455, DOI 10.1104/pp.107.097980; SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144; SPANU P, 1989, PLANTA, V177, P447, DOI 10.1007/BF00392612; StArnaud M, 1996, MYCOL RES, V100, P328, DOI 10.1016/S0953-7562(96)80164-X; STASWICK PE, 1992, PLANT PHYSIOL, V99, P804, DOI 10.1104/pp.99.3.804; Torres MA, 2006, PLANT PHYSIOL, V141, P373, DOI 10.1104/pp.106.079467; TSAI SM, 1991, APPL ENVIRON MICROB, V57, P1485, DOI 10.1128/AEM.57.5.1485-1488.1991; van Baarlen P, 2007, MOL PLANT PATHOL, V8, P41, DOI 10.1111/j.1364-3703.2006.00367.x; Vierheilig H, 2002, ADV EXP MED BIOL, V505, P23; Wendehenne D, 2004, CURR OPIN PLANT BIOL, V7, P449, DOI 10.1016/j.pbi.2004.04.002; Wojtaszek P, 1997, BIOCHEM J, V322, P681, DOI 10.1042/bj3220681; Wrzaczek M, 2013, CURR OPIN PLANT BIOL, V16, P575, DOI 10.1016/j.pbi.2013.07.002; Zeidler D, 2004, P NATL ACAD SCI USA, V101, P15811, DOI 10.1073/pnas.0404536101	66	31	35	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100132	10.1371/journal.pone.0100132	http://dx.doi.org/10.1371/journal.pone.0100132			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967716	Green Published, gold, Green Submitted			2022-12-27	WOS:000338280800026
J	Qin, HX; Ma, J; Wang, CN; Wu, Y				Qin, Huixin; Ma, Jun; Wang, Chunni; Wu, Ying			Autapse-Induced Spiral Wave in Network of Neurons under Noise	PLOS ONE			English	Article							SPATIAL COHERENCE RESONANCES; SMALL-WORLD NETWORKS; SYNAPTIC-TRANSMISSION; TRANSITION; EMERGENCE; DYNAMICS; PHASE; MODEL	Autapse plays an important role in regulating the electric activity of neuron by feedbacking time-delayed current on the membrane of neuron. Autapses are considered in a local area of regular network of neurons to investigate the development of spatiotemporal pattern, and emergence of spiral wave is observed while it fails to grow up and occupy the network completely. It is found that spiral wave can be induced to occupy more area in the network under optimized noise on the network with periodical or no-flux boundary condition being used. The developed spiral wave with self-sustained property can regulate the collective behaviors of neurons as a pacemaker. To detect the collective behaviors, a statistical factor of synchronization is calculated to investigate the emergence of ordered state in the network. The network keeps ordered state when self-sustained spiral wave is formed under noise and autapse in local area of network, and it independent of the selection of periodical or no-flux boundary condition. The developed stable spiral wave could be helpful for memory due to the distinct self-sustained property.	[Qin, Huixin; Ma, Jun; Wang, Chunni] Lanzhou Univ Technol, Dept Phys, Lanzhou, Peoples R China; [Wu, Ying] Xi An Jiao Tong Univ, Sch Aerosp, Xian 710049, Peoples R China	Lanzhou University of Technology; Xi'an Jiaotong University	Ma, J (corresponding author), Lanzhou Univ Technol, Dept Phys, Lanzhou, Peoples R China.	hyperchaos@163.com	Wang, Chunni/J-2666-2012; Ma, Jun/G-2376-2010	Wang, Chunni/0000-0002-4688-7888; Ma, Jun/0000-0002-6127-000X; Wu, Ying/0000-0002-3778-8183	National Nature Science Foundation of China [11265008, 11372122, 11365014]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is partially supported by the National Nature Science Foundation of China under the Grant No. 11265008, and is partially supported by the National Nature Science Foundation of China under the Grant No. 11372122, and it is also partially supported by the National Nature Science Foundation of China under the Grant No. 11365014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao X, 2013, MATH BIOSCI, V245, P49, DOI 10.1016/j.mbs.2013.02.007; Bacci A, 2006, NEURON, V49, P119, DOI 10.1016/j.neuron.2005.12.014; Bekkers JM, 2003, CURR BIOL, V13, pR433, DOI 10.1016/S0960-9822(03)00363-4; Bekkers JM, 2002, CURR BIOL, V12, pR648, DOI 10.1016/S0960-9822(02)01157-0; Bekkers JM, 2009, CURR BIOL, V19, pR296, DOI 10.1016/j.cub.2009.02.010; Erichsen R, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.061917; Gu HG, 2013, PHYSICA A, V392, P1361, DOI 10.1016/j.physa.2012.11.049; He DH, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.055204; Herrmann CS, 2004, INT J BIFURCAT CHAOS, V14, P623, DOI 10.1142/S0218127404009338; HINDMARSH JL, 1984, PROC R SOC SER B-BIO, V221, P87, DOI 10.1098/rspb.1984.0024; HODGKIN AL, 1949, J PHYSIOL-LONDON, V109, P240, DOI 10.1113/jphysiol.1949.sp004388; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hou ZH, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.280601; Hu BL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069251; Huang XY, 2010, NEURON, V68, P978, DOI 10.1016/j.neuron.2010.11.007; Huang XY, 2004, J NEUROSCI, V24, P9897, DOI 10.1523/JNEUROSCI.2705-04.2004; Izhikevich EM, 2004, IEEE T NEURAL NETWOR, V15, P1063, DOI 10.1109/TNN.2004.832719; Li F, 2013, INT J MOD PHYS B, V27, DOI 10.1142/S0217979213501154; Li YY, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.061907; Liao XH, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.056204; Lou Q, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.026213; Ma J, 2013, NONLINEAR DYNAM, V73, P73, DOI 10.1007/s11071-013-0767-1; Ma J, 2013, SCI CHINA PHYS MECH, V56, P1126, DOI 10.1007/s11433-013-5096-3; Ma J, 2013, COMMUN NONLINEAR SCI, V18, P1665, DOI 10.1016/j.cnsns.2012.11.016; Ma J, 2012, CHINESE SCI BULL, V57, P2094, DOI 10.1007/s11434-012-5114-2; Ma J, 2011, CHINESE SCI BULL, V56, P151, DOI 10.1007/s11434-010-4281-2; Ma J, 2010, COMMUN THEOR PHYS, V54, P583, DOI 10.1088/0253-6102/54/3/38; Ma J, 2009, CHINESE PHYS B, V18, P98, DOI 10.1088/1674-1056/18/1/017; MORRIS C, 1981, BIOPHYS J, V35, P193, DOI 10.1016/S0006-3495(81)84782-0; Perc M, 2007, CHAOS SOLITON FRACT, V31, P280, DOI 10.1016/j.chaos.2005.10.018; Qin HX, 2014, SCI CHINA TECHNOL SC, V57, P936, DOI 10.1007/s11431-014-5534-0; Rinzel J., 1989, METHODS NEURONAL MOD, P251; Roxin A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.198101; Schiff SJ, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.178102; Schmid G, 2004, PHYS BIOL, V1, P61, DOI 10.1088/1478-3967/1/2/002; Sinha S, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.015101; Storace M, 2008, CHAOS, V18, DOI 10.1063/1.2975967; Tamas G, 1997, J NEUROSCI, V17, P6352; Tang J, 2013, PHYSICA A, V392, P5764, DOI 10.1016/j.physa.2013.07.043; Tang Z, 2012, COMMUN THEOR PHYS, V57, P61, DOI 10.1088/0253-6102/57/1/10; Wang CN, 2010, COMMUN THEOR PHYS, V53, P382, DOI 10.1088/0253-6102/53/2/32; Wang HT, 2014, COMMUN NONLINEAR SCI, V19, P3242, DOI 10.1016/j.cnsns.2014.02.018; Wang QY, 2010, PHYSICA A, V389, P3299, DOI 10.1016/j.physa.2010.03.031; Wang QY, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026206; Weber S, 2008, EPL-EUROPHYS LETT, V82, DOI 10.1209/0295-5075/82/28003; Wu XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055403; Zhao YH, 2013, CHAOS, V23, DOI 10.1063/1.4822417	47	46	47	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100849	10.1371/journal.pone.0100849	http://dx.doi.org/10.1371/journal.pone.0100849			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967577	Green Published, Green Submitted, gold			2022-12-27	WOS:000338280800074
J	Rain-Franco, A; Munoz, C; Fernandez, C				Rain-Franco, Angel; Munoz, Claudia; Fernandez, Camila			Ammonium Production off Central Chile (36 degrees S) by Photodegradation of Phytoplankton-Derived and Marine Dissolved Organic Matter	PLOS ONE			English	Article							BIOLOGICALLY AVAILABLE NITROGEN; COASTAL UPWELLING AREA; SOLAR-RADIATION; PHOTOCHEMICAL PRODUCTION; SYSTEM; BACTERIOPLANKTON; TRANSFORMATIONS; VARIABILITY; METABOLISM; PACIFIC	We investigated the production of ammonium by the photodegradation of dissolved organic matter (DOM) in the coastal upwelling system off central Chile (36 degrees S). The mean penetration of solar radiation (Z1%) between April 2011 and February 2012 was 9.4 m, 4.4 m and 3.2 m for Photosynthetically Active Radiation (PAR; 400-700 nm), UV-A (320-400 nm) and UV-B (280-320 nm), respectively. Ammonium photoproduction experiments were carried out using exudates of DOM obtained from cultured diatom species (Chaetoceros muelleri and Thalassiosira minuscule) as well as natural marine DOM. Diatom exudates showed net photoproduction of ammonium under exposure to UVR with a mean rate of 0.56 +/- 0.4 mu mol L-1 h(-1) and a maximum rate of 1.49 mu mol L-1 h(-1). Results from natural marine DOM showed net photoproduction of ammonium under exposure to PAR+UVR ranging between 0.06 and 0.2 mu mol L-1 h(-1). We estimated the potential contribution of photochemical ammonium production for phytoplankton ammonium demand. Photoammonification of diatom exudates could support between 117 and 453% of spring-summer NH4+ assimilation, while rates obtained from natural samples could contribute to 50-178% of spring-summer phytoplankton NH4+ requirements. These results have implications for local N budgets, as photochemical ammonium production can occur year-round in the first meters of the euphotic zone that are impacted by full sunlight.	[Rain-Franco, Angel] Univ Concepcion, Dept Oceanog, Grad Program Oceanog, Concepcion, Chile; [Munoz, Claudia; Fernandez, Camila] Univ Concepcion, Dept Oceanog, COPAS SURAUSTRAL Program, Concepcion, Chile; [Munoz, Claudia; Fernandez, Camila] Univ Concepcion, Interdisciplinary Ctr Aquaculture Res INCAR, Concepcion, Chile; [Fernandez, Camila] Univ Paris 06, Univ Sorbonne, UMR 7621, Lab Oceanog Microbienne, Banyuls Sur Mer, France; [Fernandez, Camila] CNRS, UMR 7621, Lab Oceanog Microbienne, Observ Oceanol, Banyuls Sur Mer, France	Universidad de Concepcion; Universidad de Concepcion; Universidad de Concepcion; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite	Fernandez, C (corresponding author), Univ Concepcion, Dept Oceanog, COPAS SURAUSTRAL Program, Concepcion, Chile.	fernandez@obs-banyuls.fr		Rain, Angel/0000-0002-0389-7154	FONDECYT [1100358]; AMMONITE (CNRS-LEFE CIBER); ECOS-CONICYT [C09B02]	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); AMMONITE (CNRS-LEFE CIBER); ECOS-CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This study was funded by projects FONDECYT 1100358, AMMONITE (CNRS-LEFE CIBER) and ECOS-CONICYT C09B02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboudi M, 2008, MICROB ECOL, V55, P344, DOI 10.1007/s00248-007-9280-8; Arrigo KR, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC001226; Berman T, 1999, AQUAT MICROB ECOL, V16, P295, DOI 10.3354/ame016295; Bertilsson S, 1999, AQUAT MICROB ECOL, V19, P47, DOI 10.3354/ame019047; Bouchard JN, 2008, J EXP MAR BIOL ECOL, V359, P67, DOI 10.1016/j.jembe.2008.02.022; Buffam I, 2003, LIMNOL OCEANOGR, V48, P723, DOI 10.4319/lo.2003.48.2.0723; Bushaw KL, 1996, NATURE, V381, P404, DOI 10.1038/381404a0; Bushaw-Newton KL, 1999, AQUAT MICROB ECOL, V18, P285, DOI 10.3354/ame018285; CABRERA S, 1995, J PHOTOCH PHOTOBIO B, V28, P137, DOI 10.1016/1011-1344(94)07103-U; Daneri G, 2000, MAR ECOL PROG SER, V197, P41, DOI 10.3354/meps197041; de Boyer Montegut C, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2004JC002378; De Lange HJ, 2003, J PLANKTON RES, V25, P111, DOI 10.1093/plankt/25.1.111; DUGDALE RC, 1967, LIMNOL OCEANOGR, V12, P196, DOI 10.4319/lo.1967.12.2.0196; Escribano R, 2007, PROG OCEANOGR, V75, P343, DOI 10.1016/j.pocean.2007.08.020; Farias L, 2009, BIOGEOSCIENCES, V6, P3053, DOI 10.5194/bg-6-3053-2009; Fernandez C, 2012, MAR ECOL PROG SER, V451, P1, DOI 10.3354/meps09683; Fernandez C, 2009, PROG OCEANOGR, V83, P159, DOI 10.1016/j.pocean.2009.07.010; Gao HZ, 1998, ENVIRON SCI TECHNOL, V32, P2940, DOI 10.1021/es9803660; Gao KS, 2007, PHOTOCHEM PHOTOBIOL, V83, P802, DOI 10.1111/j.1751-1097.2007.00154.x; Gardner WS, 1998, LIMNOL OCEANOGR, V43, P1814; Godoy N, 2012, BIOGEOSCIENCES, V9, P1267, DOI 10.5194/bg-9-1267-2012; Hader DP, 2007, PHOTOCH PHOTOBIO SCI, V6, P267, DOI 10.1039/b700020k; Helbling EW, 2001, MAR ECOL PROG SER, V211, P43, DOI 10.3354/meps211043; Hernandez K, 2012, PROG OCEANOGR, V92-95, P18, DOI 10.1016/j.pocean.2011.07.011; Hernandez KL, 2006, MAR ECOL PROG SER, V315, P19, DOI 10.3354/meps315019; Holm-Hansen Osmund, 1997, P375; Holmes RM, 1999, CAN J FISH AQUAT SCI, V56, P1801, DOI 10.1139/cjfas-56-10-1801; Huovinen P, 2011, CONT SHELF RES, V31, P254, DOI 10.1016/j.csr.2010.09.004; Kieber RJ, 1999, ENVIRON SCI TECHNOL, V33, P993, DOI 10.1021/es980188a; Kitidis V, 2006, BIOGEOSCIENCES, V3, P439, DOI 10.5194/bg-3-439-2006; Koopmans DJ, 2002, AQUAT MICROB ECOL, V26, P295, DOI 10.3354/ame026295; Manney GL, 2011, NATURE, V478, P469, DOI 10.1038/nature10556; Marie D., 2000, SPRING LAB MAN, P421, DOI 10.1007/978-3-642-57049-0_34; Montero P, 2007, PROG OCEANOGR, V75, P518, DOI 10.1016/j.pocean.2007.08.013; Mopper K., 2002, BIOGEOCHEMISTRY DISS, P455, DOI [10.1016/b978-012323841-2/50011-7, DOI 10.1016/B978-012323841-2/50011-7]; Morell JM, 2001, J GEOPHYS RES-OCEANS, V106, P16807, DOI 10.1029/1999JC000268; Obernosterer I, 1999, LIMNOL OCEANOGR, V44, P1645, DOI 10.4319/lo.1999.44.7.1645; Pakulski JD, 2007, AQUAT MICROB ECOL, V47, P153, DOI 10.3354/ame047153; Sobarzo M, 2004, J GEOPHYS RES-OCEANS, P109; Sobarzo M, 2007, PROG OCEANOGR, V75, P363, DOI 10.1016/j.pocean.2007.08.022; Tedetti M, 2006, PHOTOCHEM PHOTOBIOL, V82, P389, DOI 10.1562/2005-11-09-IR-733; Vahatalo AV, 2007, LIMNOL OCEANOGR, V52, P132; Wang WW, 2000, AQUAT GEOCHEM, V6, P275, DOI 10.1023/A:1009679730079; Whitehead RF, 2000, EFFECTS UV RAD MARIN, P1; WMO, 2011, 52 WMO; Xie H., 2012, BIOGEOSCIENCES DISCU, V9, P4441, DOI [DOI 10.5194/BGD-9-4441-2012, 10.5194/bgd-9-4441-2012]	46	10	11	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100224	10.1371/journal.pone.0100224	http://dx.doi.org/10.1371/journal.pone.0100224			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968138	Green Submitted, gold, Green Published			2022-12-27	WOS:000338280800030
J	SidAhmed-Mezi, M; Kurcewicz, I; Rose, C; Louvel, J; Sokoloff, P; Pumain, R; Laschet, JJ				SidAhmed-Mezi, Mounia; Kurcewicz, Irene; Rose, Christiane; Louvel, Jacques; Sokoloff, Pierre; Pumain, Rene; Laschet, Jacques J.			Mass Spectrometric Detection and Characterization of Atypical Membrane-Bound Zinc-Sensitive Phosphatases Modulating GABAA Receptors	PLOS ONE			English	Article							PROTEIN SERINE/THREONINE PHOSPHATASES; GAMMA-AMINOBUTYRIC-ACID; GATED ION CHANNELS; SUBUNIT COMPOSITION; TYROSINE-PHOSPHATASE; DEPENDENT MODULATION; ALPHA-SUBUNIT; KINASE-C; PHOSPHORYLATION; PURIFICATION	Background: GABA(A) receptor (GABA(A)R) function is maintained by an endogenous phosphorylation mechanism for which the glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is the kinase. This phosphorylation is specific to the long intracellular loop I-2 of the alpha 1 subunit at two identified serine and threonine residues. The phosphorylation state is opposed by an unknown membrane-bound phosphatase, which inhibition favors the phosphorylated state of the receptor and contributes to the maintenance of its function. In cortical nervous tissue from epileptogenic areas in patients with drug-resistant epilepsies, both the endogenous phosphorylation and the functional state of the GABA(A)R are deficient. Methodology/Principal Findings: The aim of this study is to characterize the membrane-bound phosphatases counteracting the endogenous phosphorylation of GABA(A)R. We have developed a new analytical tool for in vitro detection of the phosphatase activities in cortical washed membranes by liquid chromatography coupled to mass spectrometry. The substrates are two synthetic phosphopeptides, each including one of the identified endogenous phosphorylation sites of the I2 loop of GABA(A)R alpha 1 subunit. We have shown the presence of multiple and atypical phosphatases sensitive to zinc ions. Patch-clamp studies of the rundown of the GABA(A)R currents on acutely isolated rat pyramidal cells using the phosphatase inhibitor okadaic acid revealed a clear heterogeneity of the phosphatases counteracting the function of the GABA(A)R. Conclusion/Significance: Our results provide new insights on the regulation of GABA(A)R endogenous phosphorylation and function by several and atypical membrane-bound phosphatases specific to the alpha 1 subunit of the receptor. By identifying specific inhibitors of these enzymes, novel development of antiepileptic drugs in patients with drug-resistant epilepsies may be proposed.	[SidAhmed-Mezi, Mounia; Pumain, Rene; Laschet, Jacques J.] INSERM, Infantile Epilepsies & Brain Plast U1129, Paris, France; [SidAhmed-Mezi, Mounia; Kurcewicz, Irene; Rose, Christiane; Louvel, Jacques; Pumain, Rene; Laschet, Jacques J.] Univ Paris 05, Paris, France; [SidAhmed-Mezi, Mounia; Pumain, Rene; Laschet, Jacques J.] CEA, Gif Sur Yvette, France; [Kurcewicz, Irene; Rose, Christiane; Louvel, Jacques] INSERM, Ctr Psychiat & Neurosci, U894, Paris, France; [Sokoloff, Pierre] Inst Rech Pierre Fabre Neurol & Psychiat, Castres, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; CEA; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	SidAhmed-Mezi, M (corresponding author), INSERM, Infantile Epilepsies & Brain Plast U1129, Paris, France.	mounia.sid-ahmed@inserm.fr; jacques.laschet@inserm.fr			Fondation Francaise pour la Recherche sur l'Epilepsie (FFRE)	Fondation Francaise pour la Recherche sur l'Epilepsie (FFRE)	This work was supported by the Fondation Francaise pour la Recherche sur l'Epilepsie (FFRE). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreeva AV, 2001, MOL BIOL EVOL, V18, P448, DOI 10.1093/oxfordjournals.molbev.a003823; Barford D, 1998, ANNU REV BIOPH BIOM, V27, P133, DOI 10.1146/annurev.biophys.27.1.133; BOIVIN P, 1987, INT J BIOCHEM, V19, P613, DOI 10.1016/0020-711X(87)90227-8; Brandon NJ, 2001, NEUROPHARMACOLOGY, V41, P745, DOI 10.1016/S0028-3908(01)00121-6; Bryan PM, 2002, J BIOL CHEM, V277, P16041, DOI 10.1074/jbc.M110626200; CHEN QX, 1990, J PHYSIOL-LONDON, V420, P207, DOI 10.1113/jphysiol.1990.sp017908; Chen ZW, 2007, J NEUROCHEM, V100, P279, DOI 10.1111/j.1471-4159.2006.04206.x; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; Cohen PTW, 1997, TRENDS BIOCHEM SCI, V22, P245, DOI 10.1016/S0968-0004(97)01060-8; Connolly CN, 1999, J BIOL CHEM, V274, P36565, DOI 10.1074/jbc.274.51.36565; Dawson GR, 2005, CNS SPECTRUMS, V10, P21, DOI 10.1017/S1092852900009871; de Seve JE, 1819, NOUVEAU DICT HIST NA, V36, P387; DEANA AD, 1990, BIOCHIM BIOPHYS ACTA, V1051, P199, DOI 10.1016/0167-4889(90)90194-I; Dounay AB, 2002, CURR MED CHEM, V9, P1939, DOI 10.2174/0929867023368791; Filippova N, 2000, MOL PHARMACOL, V57, P847; Fritschy JM, 2003, PHARMACOL THERAPEUT, V98, P299, DOI 10.1016/S0163-7258(03)00037-8; Gee CE, 2005, CELL MOL LIFE SCI, V62, P1120, DOI 10.1007/s00018-005-5008-4; Herzig S, 2000, PHYSIOL REV, V80, P173, DOI 10.1152/physrev.2000.80.1.173; Honkanen RE, 2002, CURR MED CHEM, V9, P2055, DOI 10.2174/0929867023368836; John H, 2005, ANAL BIOANAL CHEM, V381, P51, DOI 10.1007/s00216-004-2868-7; Korpi ER, 2002, PROG NEUROBIOL, V67, P113, DOI 10.1016/S0301-0082(02)00013-8; Kostiainen R, 2009, J CHROMATOGR A, V1216, P685, DOI 10.1016/j.chroma.2008.08.095; Krezel A, 2006, J BIOL INORG CHEM, V11, P1049, DOI 10.1007/s00775-006-0150-5; Kumar S, 2005, PSYCHOPHARMACOLOGY, V183, P241, DOI 10.1007/s00213-005-0161-x; Laschet J, 1999, EPILEPSY RES, V35, P161, DOI 10.1016/S0920-1211(99)00009-1; Laschet JJ, 2007, P NATL ACAD SCI USA, V104, P3472, DOI 10.1073/pnas.0606451104; Laschet JJ, 2004, J NEUROSCI, V24, P7614, DOI 10.1523/JNEUROSCI.0868-04.2004; Le Novere N, 2008, CELL MOL LIFE SCI, V65, P2125, DOI 10.1007/s00018-008-8150-y; Levitan IB, 2006, NAT NEUROSCI, V9, P305, DOI 10.1038/nn1647; Luo JX, 2000, AM J PHYSIOL-CELL PH, V279, pC108, DOI 10.1152/ajpcell.2000.279.1.C108; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.neuro.17.1.569; Mansuy IM, 2006, TRENDS NEUROSCI, V29, P679, DOI 10.1016/j.tins.2006.10.004; Maret W, 2011, J BIOL INORG CHEM, V16, P1079, DOI 10.1007/s00775-011-0800-0; McConnell JL, 2009, MOL PHARMACOL, V75, P1249, DOI 10.1124/mol.108.053140; Minier F, 2000, NEUROCHEM INT, V36, P499, DOI 10.1016/S0197-0186(99)00158-8; Mirza SP, 2007, PHYSIOL GENOMICS, V30, P89, DOI 10.1152/physiolgenomics.00279.2006; Moss SJ, 2001, NAT REV NEUROSCI, V2, P240, DOI 10.1038/35067500; Moss SJ, 1996, INT REV NEUROBIOL, V39, P1, DOI 10.1016/S0074-7742(08)60662-5; Ogris W, 2006, J NEUROCHEM, V96, P136, DOI 10.1111/j.1471-4159.2005.03509.x; Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505; PATO MD, 1991, MOL CELL BIOCHEM, V101, P31; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; STELZER A, 1988, SCIENCE, V241, P339, DOI 10.1126/science.2455347; SWEETNAM PM, 1988, J NEUROCHEM, V51, P1274, DOI 10.1111/j.1471-4159.1988.tb03097.x; Terunuma M, 2004, J NEUROSCI, V24, P7074, DOI 10.1523/JNEUROSCI.1323-04.2004; Thissen M, 2009, RES LETT BIOCH; TONKS NK, 1990, J BIOL CHEM, V265, P10674; TONKS NK, 1988, J BIOL CHEM, V263, P6731; UNWIN N, 1993, CELL, V72, P31, DOI 10.1016/S0092-8674(05)80026-1; WANG RA, 1995, J NEUROPHYSIOL, V73, P2099, DOI 10.1152/jn.1995.73.5.2099; WANG YX, 1995, J BIOL CHEM, V270, P25607, DOI 10.1074/jbc.270.43.25607; YANG Q, 1993, J BIOL CHEM, V268, P17650; ZHAO ZZ, 1993, J BIOL CHEM, V268, P2816	54	3	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100612	10.1371/journal.pone.0100612	http://dx.doi.org/10.1371/journal.pone.0100612			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967814	Green Published, gold, Green Submitted			2022-12-27	WOS:000338280800047
J	Tian, CR; Qian, L; Shen, XZ; Li, JJ; Wen, JT				Tian, Chang-Rong; Qian, Li; Shen, Xiao-Zhu; Li, Jia-Jing; Wen, Jiang-Tao			Distribution of Serum Total Protein in Elderly Chinese	PLOS ONE			English	Article							LABORATORY TESTS; HEPATIC-INJURY; HEART-FAILURE; ALBUMIN; RISK; RECOMMENDATIONS; COMPLICATIONS; DIAGNOSIS; DIETARY	The serum total protein levels of the elderly possibly decrease gradually with aging. However, serum total protein levels are not suitable as a uniform reference standard for the elderly at different ages and genders. Thus, we investigated the total serum protein distribution in different gender and age groups of 11,453 elderly individuals aged >= 60 years and without liver or renal disease from Lianyungang, Jiangsu, China. The total protein levels (TPL) of these individuals exhibited normal distribution (Z = 1.206, P = 0.109), whereas the reference range (95% CI) was 54.1 g/L to 82.3 g/L. TPL was higher in females than in males for those aged between 60 and 75 years, whereas no significant difference was observed for those aged between 80 and 95 years. TPL was negatively correlated with age in males (r = -0.1342, P < 0.05), females (r = -0.304, P < 0.05), and the total group (r = -0.2136, P < 0.05). TPL also decreased with aging and showed a faster rate in women than in men. These results indicated that an appropriate range of serum total protein based on age and gender differences should be used for clinical applications.	[Tian, Chang-Rong; Shen, Xiao-Zhu] Second Peoples Hosp Lianyungang, Dept Geriatr, Xinpu, Peoples R China; [Qian, Li] Second Peoples Hosp Lianyungang, Dept Microbiol Lab, Xinpu, Peoples R China; [Li, Jia-Jing] Second Peoples Hosp Lianyungang, Dept Elect & Informat Engn Ctr, Xinpu, Peoples R China; [Wen, Jiang-Tao] Second Peoples Hosp Lianyungang, Dept Clin Sci Expt Ctr, Xinpu, Peoples R China		Tian, CR (corresponding author), Second Peoples Hosp Lianyungang, Dept Geriatr, Xinpu, Peoples R China.	tinasxz@yahoo.com.cn; qianlilyg@163.com			Foundation for Scientific research project of Lianyungang Health Bureau [2010-1014]	Foundation for Scientific research project of Lianyungang Health Bureau	This study was supported by Foundation for Scientific research project of Lianyungang Health Bureau (No. 2010-1014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arques S, 2011, ARCH CARDIOVASC DIS, V104, P502, DOI 10.1016/j.acvd.2011.06.003; Brennan DS, 2012, J NUTR HEALTH AGING, V16, P437, DOI 10.1007/s12603-012-0006-3; BURKHARDT RT, 1978, AM J CLIN PATHOL, V70, P508; Chow E, 2008, BRIT J BIOMED SCI, V65, P128, DOI 10.1080/09674845.2008.11732815; DAWNAY ABSJ, 1991, ANN CLIN BIOCHEM, V28, P556, DOI 10.1177/000456329102800604; DECSI T, 1990, Acta Paediatrica Hungarica, V30, P373; Dequanter D, 2011, B-ENT, V7, P181; DOUMAS BT, 1975, CLIN CHEM, V21, P1159; DOUMAS BT, 1981, CLIN CHEM, V27, P1642; Doumas BT, 1981, CLIN CHEM, V27, P1641; Dufour DR, 2000, CLIN CHEM, V46, P2027; Dufour DR, 2000, CLIN CHEM, V46, P2050; Dzoga-Litwinowicz M, 1976, Wiad Lek, V29, P1411; Friedman R B, 1980, Clin Chem, V26, p1D; GORNALL AG, 1949, J BIOL CHEM, V177, P751; Haynes GR, 2003, EUR J ANAESTH, V20, P771, DOI 10.1097/00003643-200310000-00003; He ML, 2011, CLIN CHEM LAB MED, V49, P989, DOI 10.1515/CCLM.2011.153; Ibrahim K, 1989, J Pak Med Assoc, V39, P12; Kaplan A., 1979, CLIN CHEM INTERPRETA; Krohn Randall I, 2011, Curr Protoc Cell Biol, VAppendix 3, p3H, DOI 10.1002/0471143030.cba03hs52; Lai KS, 1973, MED J MALAYSIA, V28, P115; LAKHANI S, 1984, E AFR MED J, V61, P606; Li J, 2011, CLIN LAB MED, V8, P2110; Li M, 2010, PR PREV MED, V17, P994; Liu M, 2012, EUR J HEART FAIL, V14, P39, DOI 10.1093/eurjhf/hfr154; Mahkovic-Hergouth K, 2011, J CLIN ANESTH, V23, P42, DOI 10.1016/j.jclinane.2010.06.007; Malik SI, 2011, J PAK MED ASSOC, V61, P23; Neel DR, 2011, BEST PRACT RES-CLIN, V25, P395, DOI 10.1016/j.bpa.2011.07.006; Orsitto G, 2012, J NUTR HEALTH AGING, V16, P468, DOI 10.1007/s12603-012-0024-1; PETRAS G, 1978, ACTA MED HUNG, V35, P249; Prajapati KD, 2011, REV NEUROSCIENCE, V22, P355, DOI 10.1515/RNS.2011.028; Quinlan GJ, 2005, HEPATOLOGY, V41, P1211, DOI 10.1002/hep.20720; Rahman M Z, 2005, Mymensingh Med J, V14, P38; SINTON TJ, 1986, CLIN CHEM, V32, P76; Tietz NW., 1983, CLIN GUIDE LAB TESTS; Tsutsumi R, 2012, ASIA PAC J CLIN NUTR, V21, P44; Wengreen HJ, 2004, J BONE MINER RES, V19, P537, DOI 10.1359/JBMR.040208; YOUNG DS, 1975, CLIN CHEM, V21, pD1; Zhou Bai-yu, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P1068	39	6	7	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e101242	10.1371/journal.pone.0101242	http://dx.doi.org/10.1371/journal.pone.0101242			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967900	Green Published, gold, Green Submitted			2022-12-27	WOS:000338280800118
J	Valko, PO; Hauser, S; Sommerauer, M; Werth, E; Baumann, CR				Valko, Philipp O.; Hauser, Sabrina; Sommerauer, Michael; Werth, Esther; Baumann, Christian R.			Observations on Sleep-Disordered Breathing in Idiopathic Parkinson's Disease	PLOS ONE			English	Article							REM-SLEEP; DAYTIME SLEEPINESS; APNEA; PRAMIPEXOLE; LEVODOPA; EPISODES; SCALE; NREM	Background: This study has two main goals: 1.) to determine the potential influence of dopaminergic drugs on sleep-disordered breathing (SDB) in Parkinson's disease (PD) and 2.) to elucidate whether NREM and REM sleep differentially impact SDB severity in PD. Methods: Retrospective clinical and polysomnographic study of 119 consecutive PD patients and comparison with age-, sex- and apnea-hypopnea-index-matched controls. Results: SDB was diagnosed in 57 PD patients (48%). Apnea-hypopnea index was significantly higher in PD patients with central SDB predominance (n = 7; 39.3 +/- 16.7/h) than obstructive SDB predominance (n = 50; 20.9 +/- 16.8/h; p = 0.003). All PD patients with central SDB predominance appeared to be treated with both levodopa and dopamine agonists, whereas only 56% of those with obstructive SDB predominance were on this combined treatment (p = 0.03). In the whole PD group with SDB (n = 57), we observed a significant decrease of apnea-hypopnea index from NREM to REM sleep (p = 0.02), while controls revealed the opposite tendency. However, only the PD subgroup with SDB and treatment with dopamine agonists showed this phenomenon, while those without dopamine agonists had a similar NREM/REM pattern as controls. Conclusions: Our findings suggest an ambiguous impact of dopamine agonists on SDB. Medication with dopamine agonists seems to enhance the risk of central SDB predominance. Loss of normal muscle atonia may be responsible for decreased SDB severity during REM sleep in PD patients with dopamine agonists.	[Valko, Philipp O.; Hauser, Sabrina; Sommerauer, Michael; Werth, Esther; Baumann, Christian R.] Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital	Valko, PO (corresponding author), Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland.	philipp.valko@usz.ch	Werth, E/AAN-7955-2021	Baumann, Christian/0000-0003-3417-1978; Werth, Esther/0000-0002-5099-3122				Arnulf I, 2002, NEUROLOGY, V58, P1019, DOI 10.1212/WNL.58.7.1019; Bachmann CG, 2006, MOVEMENT DISORD, V21, P1824, DOI 10.1002/mds.21068; Bloch KE, 1999, RESPIRATION, V66, P440, DOI 10.1159/000029408; Chervin RD, 1998, CHEST, V113, P980, DOI 10.1378/chest.113.4.980; De Cock VC, 2010, SLEEP MED, V11, P247, DOI 10.1016/j.sleep.2009.05.008; DEKEYSER J, 1985, NEUROLOGY, V35, P235; Dhawan V, 2006, AGE AGEING, V35, P220, DOI 10.1093/ageing/afj087; Diederich NJ, 2005, MOVEMENT DISORD, V20, P1413, DOI 10.1002/mds.20624; Fahn S., 1987, RECENT DEV PARKINSON, VVol. 2, P153; FINDLEY LJ, 1985, CHEST, V87, P432, DOI 10.1378/chest.87.4.432; Frucht S, 1999, NEUROLOGY, V52, P1908, DOI 10.1212/WNL.52.9.1908; Gagnon JF, 2002, NEUROLOGY, V59, P585, DOI 10.1212/WNL.59.4.585; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; Haba-Rubio J, 2005, CHEST, V128, P3350, DOI 10.1378/chest.128.5.3350; Hauser RA, 2000, MOVEMENT DISORD, V15, P658, DOI 10.1002/1531-8257(200007)15:4<658::AID-MDS1009>3.0.CO;2-N; Herer B, 2001, CHEST, V119, P387, DOI 10.1378/chest.119.2.387; Hobson DE, 2002, JAMA-J AM MED ASSOC, V287, P455, DOI 10.1001/jama.287.4.455; Hogl B, 2010, SLEEP MED, V11, P233, DOI 10.1016/j.sleep.2009.11.008; Iber C., 2007, AASM MANUAL SCORING; Koo BB, 2008, CHEST, V134, P1156, DOI 10.1378/chest.08-1311; Maria B, 2003, RESP MED, V97, P1151, DOI 10.1016/S0954-6111(03)00188-4; Monaca C, 2006, SLEEP MED, V7, P448, DOI 10.1016/j.sleep.2005.12.002; Norlinah MI, 2009, PARKINSONISM RELAT D, V15, P670, DOI 10.1016/j.parkreldis.2009.02.012; Punjabi NM, 2002, SLEEP, V25, P307; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Schafer D, 2001, SOMNOLOGIE, V5, P103; Schapira AHV, 2000, LANCET, V355, P1332, DOI 10.1016/S0140-6736(00)02118-8; SERIES F, 1990, AM REV RESPIR DIS, V141, P1522, DOI 10.1164/ajrccm/141.6.1522; Siddiqui F, 2006, SLEEP MED, V7, P281, DOI 10.1016/j.sleep.2005.10.006; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Trotti LM, 2010, MOVEMENT DISORD, V25, P2246, DOI 10.1002/mds.23231; Weatherwax KJ, 2003, SLEEP MED, V4, P517, DOI 10.1016/j.sleep.2003.07.004; Wetter TC, 2000, SLEEP, V23, P361; Yong MH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022511; Young T, 2002, ARCH INTERN MED, V162, P893, DOI 10.1001/archinte.162.8.893	35	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100828	10.1371/journal.pone.0100828	http://dx.doi.org/10.1371/journal.pone.0100828			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968233	gold, Green Accepted, Green Published			2022-12-27	WOS:000338280800072
J	Carver, AR; Andrikopoulou, M; Lei, J; Tamayo, E; Gamble, P; Hou, ZP; Zhang, JY; Mori, S; Saade, GR; Costantine, MM; Burd, I				Carver, Alissa R.; Andrikopoulou, Maria; Lei, Jun; Tamayo, Esther; Gamble, Phyllis; Hou, Zhipeng; Zhang, Jiangyang; Mori, Susumu; Saade, George R.; Costantine, Maged M.; Burd, Irina			Maternal Pravastatin Prevents Altered Fetal Brain Development in a Preeclamptic CD-1 Mouse Model	PLOS ONE			English	Article							COA REDUCTASE INHIBITORS; AUTISM SPECTRUM DISORDER; SEX-DIFFERENCES; IN-UTERO; CARDIOVASCULAR FUNCTION; PRENATAL EXPOSURE; HYPOXIA-ISCHEMIA; GENE-TRANSFER; BIRTH-WEIGHT; STATIN USE	Objective: Using an animal model, we have previously shown that preeclampsia results in long-term adverse neuromotor outcomes in the offspring, and this phenotype was prevented by antenatal treatment with pravastatin. This study aims to localize the altered neuromotor programming in this animal model and to evaluate the role of pravastatin in its prevention. Materials and Methods: For the preeclampsia model, pregnant CD-1 mice were randomly allocated to injection of adenovirus carrying sFlt-1 or its control virus carrying mFc into the tail vein. Thereafter they received pravastatin (sFlt-1-pra "experimental group'') or water (sFlt-1 "positive control'') until weaning. The mFc group ("negative control'') received water. Offspring at 6 months of age were sacrificed, and whole brains underwent magnetic resonance imaging (MRI). MRIs were performed using an 11.7 Tesla vertical bore MRI scanner. T2 weighted images were acquired to evaluate the volumes of 28 regions of interest, including areas involved in adaptation and motor, spatial and sensory function. Cytochemistry and cell quantification was performed using neuron-specific Nissl stain. One-way ANOVA with multiple comparison testing was used for statistical analysis. Results: Compared with control offspring, male sFlt-1 offspring have decreased volumes in the fimbria, periaquaductal gray, stria medullaris, and ventricles and increased volumes in the lateral globus pallidus and neocortex; however, female sFlt-1 offspring showed increased volumes in the ventricles, stria medullaris, and fasciculus retroflexus and decreased volumes in the inferior colliculus, thalamus, and lateral globus pallidus. Neuronal quantification via Nissl staining exhibited decreased cell counts in sFlt-1 offspring neocortex, more pronounced in males. Prenatal pravastatin treatment prevented these changes. Conclusion: Preeclampsia alters brain development in sex-specific patterns, and prenatal pravastatin therapy prevents altered neuroanatomic programming in this animal model.	[Carver, Alissa R.; Tamayo, Esther; Gamble, Phyllis; Saade, George R.; Costantine, Maged M.] Univ Texas Med Branch, Dept Obstet & Gynecol, Div Maternal Fetal Med, Galveston, TX 77555 USA; [Andrikopoulou, Maria; Lei, Jun; Burd, Irina] Johns Hopkins Univ, Dept Gynecol & Obstet, Integrated Res Ctr Fetal Med, Div Maternal Fetal Med, Baltimore, MD USA; [Hou, Zhipeng; Zhang, Jiangyang; Mori, Susumu] Johns Hopkins Univ, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD USA	University of Texas System; University of Texas Medical Branch Galveston; Johns Hopkins University; Johns Hopkins University	Carver, AR (corresponding author), Univ Texas Med Branch, Dept Obstet & Gynecol, Div Maternal Fetal Med, Galveston, TX 77555 USA.	arcarver@utmb.edu	Andrikopoulou, Maria/GYD-9003-2022	Zhang, Jiangyang/0000-0003-0740-2662; Burd, Irina/0000-0001-7256-7784; Zhang, Jiangyang/0000-0003-4146-8163	NICHD [K08 HD073315]; NIH [RO1 EB003543]; Brain Science Institute, Johns Hopkins; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K08HD073315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB003543] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brain Science Institute, Johns Hopkins; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by NICHD K08 HD073315 (www.nichd.nih.gov), NIH RO1 EB003543 (www.nih.gov) and grant support from Brain Science Institute, Johns Hopkins (www.brainscienceinstitute.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOG, 2002, OBSTET GYNECOL, V99, P869; Bajo VM, 2013, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00114; Beckmann H, 1999, EUR ARCH PSY CLIN N, V249, P44; Brosda J, 2011, NEUROBIOL DIS, V44, P239, DOI 10.1016/j.nbd.2011.07.008; Bushnell CD, 2006, STROKE, V37, P1427, DOI 10.1161/01.STR.0000221315.60282.ca; Bytautiene E, 2010, AM J PHYSIOL-HEART C, V298, pH189, DOI 10.1152/ajpheart.00792.2009; Carver AR, 2014, INT J DEV NEUROSCI, V33, P33, DOI 10.1016/j.ijdevneu.2013.11.004; Cassel JC, 1997, PROG NEUROBIOL, V51, P663, DOI 10.1016/S0301-0082(97)00009-9; Chagraoui H, 2001, EUR CYTOKINE NETW, V12, P561; Chau V, 2013, NEUROLOGY, V81, P2082, DOI 10.1212/01.wnl.0000437298.43688.b9; Costantine M, 2008, AM J OBSTET GYNECOL, V199, pS40, DOI 10.1016/j.ajog.2008.09.117; Costantine MM, 2013, OBSTET GYNECOL, V121, P349, DOI 10.1097/AOG.0b013e31827d8ad5; Costantine MM, 2010, OBSTET GYNECOL, V116, P114, DOI 10.1097/AOG.0b013e3181e10ebd; Dada T, 2014, BRAIN BEHAV IMMUN, V38, P142, DOI 10.1016/j.bbi.2014.01.014; Davies LA, 2008, MOL THER, V16, P812, DOI 10.1038/mt.2008.25; Edison RJ, 2004, AM J MED GENET A, V131A, P287, DOI 10.1002/ajmg.a.30386; Ehrenstein V, 2009, AM J EPIDEMIOL, V170, P1025, DOI 10.1093/aje/kwp223; Elahi MM, 2008, HYPERTENSION, V51, P939, DOI 10.1161/HYPERTENSIONAHA.107.100982; ELLISON G, 1994, BRAIN RES REV, V19, P223, DOI 10.1016/0165-0173(94)90012-4; Folsom TD, 2013, NEUROPHARMACOLOGY, V68, P122, DOI 10.1016/j.neuropharm.2012.08.015; Fox KA, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.083; Gabory A, 2013, BIOL SEX DIFFER, V4, DOI 10.1186/2042-6410-4-5; Gebhart GF, 2004, NEUROSCI BIOBEHAV R, V27, P729, DOI 10.1016/j.neubiorev.2003.11.008; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Golan MH, 2009, NEUROPHARMACOLOGY, V57, P511, DOI 10.1016/j.neuropharm.2009.07.028; Gutierrez J, 2012, ARCH INTERN MED, V172, P909, DOI 10.1001/archinternmed.2012.2145; Hatanaka T, 2000, CLIN PHARMACOKINET, V39, P397, DOI 10.2165/00003088-200039060-00002; Herson PS, 2013, TRANSL STROKE RES, V4, P413, DOI 10.1007/s12975-012-0238-x; Hill CA, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/867531; Hoglund K, 2007, CNS DRUGS, V21, P449; Huang H, 2013, CEREB CORTE IN PRESS; Infante SK, 2013, INT J DEV NEUROSCI, V31, P398, DOI 10.1016/j.ijdevneu.2013.02.003; Ingalhalikar M, 2014, P NATL ACAD SCI USA, V111, P823, DOI 10.1073/pnas.1316909110; Kazmin A, 2007, J OBSTET GYNAECOL CA, V29, P906, DOI 10.1016/S1701-2163(16)32656-1; Kikuchi N, 2002, GENE THER, V9, P1529, DOI 10.1038/sj.gt.3301818; Kikuchi R, 2004, J PHARMACOL EXP THER, V311, P1147, DOI 10.1124/jpet.104.071621; KLOOSTER J, 1995, BRAIN RES, V688, P34, DOI 10.1016/0006-8993(95)00497-E; Kumar A, 2012, BRAIN RES, V1471, P13, DOI 10.1016/j.brainres.2012.06.050; Kumasawa K, 2011, P NATL ACAD SCI USA, V108, P1451, DOI 10.1073/pnas.1011293108; Leung KK, 2013, NEUROLOGY, V80, P648, DOI 10.1212/WNL.0b013e318281ccd3; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Li AP, 2010, NEUROL RES, V32, P945, DOI 10.1179/016164110X12670144737774; Li H, 2005, ANN NEUROL, V58, P317, DOI 10.1002/ana.20538; Liao JK, 2005, AM J CARDIOL, V96, p24F, DOI 10.1016/j.amjcard.2005.06.009; Lu F, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.06.064; Lu FX, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.12.024; Machon RA, 1997, ARCH GEN PSYCHIAT, V54, P322; Mahmood A, 2009, NEUROSURGERY, V65, P187, DOI 10.1227/01.NEU.0000343540.24780.D6; Mann JR, 2011, J ATTEN DISORD, V15, P667, DOI 10.1177/1087054710370566; Mann JR, 2010, J AUTISM DEV DISORD, V40, P548, DOI 10.1007/s10803-009-0903-4; Many A, 2003, HYPERTENS PREGNANCY, V22, P25, DOI 10.1081/PRG-120016791; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; McCarthy MM, 2009, J NEUROSCI, V29, P12815, DOI 10.1523/JNEUROSCI.3331-09.2009; McDonnold M, 2014, AM J OBSTET GYNECOL, V210; McDonnold M, 2013, AM J OBSTET GYNECOL, V208, pS28, DOI 10.1016/j.ajog.2012.10.220; Mooradian AD, 2005, DIABETES, V54, P2977, DOI 10.2337/diabetes.54.10.2977; Movsas TZ, 2013, J PEDIATR-US, V163, P73, DOI 10.1016/j.jpeds.2012.12.084; Nanovskaya TN, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.05.038; Ofori B, 2007, BRIT J CLIN PHARMACO, V64, P496, DOI 10.1111/j.1365-2125.2007.02905.x; Paintlia AS, 2009, GLIA, V57, P182, DOI 10.1002/glia.20745; Paul MJ, 2011, EUR J NEUROSCI, V34, P478, DOI 10.1111/j.1460-9568.2011.07762.x; Paxino G, 2001, MOUSE BRAIN STEREOTA; Peacock JL, 2012, PEDIATR RES, V71, P305, DOI 10.1038/pr.2011.50; Petersen EE, 2008, AM J MED GENET A, V146A, P2701, DOI 10.1002/ajmg.a.32493; Prevosto V, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00056; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Saad AF, 2014, REPROD SCI, V21, P138, DOI 10.1177/1933719113492207; Sacco RL, 2005, NAT CLIN PRACT CARD, V2, P576, DOI 10.1038/ncpcardio0348; Senoo M, 2000, MOL GENET METAB, V69, P269, DOI 10.1006/mgme.2000.2984; Sierra S, 2011, J ALZHEIMERS DIS, V23, P307, DOI 10.3233/JAD-2010-101179; Singh J, 2011, HYPERTENSION, V58, P716, DOI 10.1161/HYPERTENSIONAHA.111.175919; Stephenson-Jones M, 2013, P NATL ACAD SCI USA, V110, pE3670, DOI 10.1073/pnas.1314815110; Suren P, 2012, PEDIATRICS, V130, pE152, DOI 10.1542/peds.2011-3217; Taguchi N, 2008, REPROD TOXICOL, V26, P175, DOI 10.1016/j.reprotox.2008.06.009; van Wassenaer AG, 2011, AM J OBSTET GYNECOL, V204; Wagner AK, 2005, CRIT CARE MED, V33, P407, DOI 10.1097/01.CCM.0000153931.23488.DD; Wei KV, 2008, J MOL MED, V86, P161, DOI 10.1007/s00109-007-0261-7; Whitehouse AJO, 2012, PAEDIATR PERINAT EP, V26, P101, DOI 10.1111/j.1365-3016.2011.01257.x; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Winterfeld U, 2013, BJOG-INT J OBSTET GY, V120, P463, DOI 10.1111/1471-0528.12066; Zarek J, 2013, PLACENTA, V34, P719, DOI 10.1016/j.placenta.2013.05.002; Zhan Y, 2014, NAT NEUROSCI, V17, P400, DOI 10.1038/nn.3641; Zhang JY, 2010, NEUROIMAGE, V49, P2340, DOI 10.1016/j.neuroimage.2009.10.027; Zhu CL, 2006, J NEUROCHEM, V96, P1016, DOI 10.1111/j.1471-4159.2005.03639.x	84	27	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100873	10.1371/journal.pone.0100873	http://dx.doi.org/10.1371/journal.pone.0100873			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963809	gold, Green Submitted, Green Published			2022-12-27	WOS:000338709500093
J	Feng, DJ; Ji, LQ; Xu, LZ				Feng, Danjun; Ji, Linqin; Xu, Lingzhong			Mediating Effect of Social Support on the Association between Functional Disability and Psychological Distress in Older Adults in Rural China: Does Age Make a Difference?	PLOS ONE			English	Article							DEPRESSIVE SYMPTOMS; AFRICAN-AMERICAN; MENTAL-ILLNESS; LIFE; PREVALENCE; ANXIETY; STRESS	This study aimed to determine the prevalence of psychological distress among elderly people in rural China. Moreover, the mediating effect of social support on the association between functional disability and psychological distress and whether this effect varies with age would be examined. A total of 741 elderly people aged 60-89 years from a rural area of Shandong Province, China participated in a cross-sectional survey. Their psychological distress, perceived social support, enacted social support, and functional disability were assessed through questionnaires. A total of 217 (29.3%) rural elderly people had psychological distress. The functional disability of people >= 75 years old had smaller total effects (0.18) on their psychological distress than in people <75 years old (0.30). Moreover, most of the effects of functional disability on psychological distress among the people >= 75 years old were indirect (0.12; 66.67% of total effects) through the mediating effect of social support especially perceived support, while the direct effect of functional disability was insignificant. In contrast, most of the effects of functional disability on psychological distress among the people <75 years old were direct (0.29; 96.67% of total effects), while the mediating effect of social support was insignificant. In conclusion, the total effect of functional disability, especially the direct effect, on psychological distress decreases sharply with age. The mediating effect of social support on the association between functional disability and psychological distress varies with age and is only found in people >= 75 years.	[Feng, Danjun] Shandong Univ, Sch Nursing, Jinan 250100, Peoples R China; [Ji, Linqin] Shandong Normal Univ, Sch Psychol, Jinan, Peoples R China; [Xu, Lingzhong] Shandong Univ, Dept Hlth Serv Management & Maternal & Child Heal, Jinan 250100, Peoples R China	Shandong University; Shandong Normal University; Shandong University	Xu, LZ (corresponding author), Shandong Univ, Dept Hlth Serv Management & Maternal & Child Heal, Jinan 250100, Peoples R China.	lzxu@sdu.edu.cn			Ministry of Education in China [10YJCXLX007]; Project of Humanities and Social Sciences	Ministry of Education in China(Ministry of Education, China); Project of Humanities and Social Sciences	This study was supported by the Ministry of Education in China, Project of Humanities and Social Sciences (grant No. 10YJCXLX007). The URL of its website is http://www.sinoss.net/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRERA M, 1986, AM J COMMUN PSYCHOL, V14, P413, DOI 10.1007/BF00922627; Bierman A, 2010, J GERONTOL B-PSYCHOL, V65, P631, DOI 10.1093/geronb/gbp128; Briere J, 2010, J TRAUMA STRESS, V23, P767, DOI 10.1002/jts.20578; Chen RL, 2005, ARCH INTERN MED, V165, P2019, DOI 10.1001/archinte.165.17.2019; Department of Human Services, 2008, VICT POP HLTH SURV 2; Elder GH, 2003, HDB LIFE COURSE, P3, DOI DOI 10.1007/978-0-306-48247-2_1; ENSEL WM, 1991, J HEALTH SOC BEHAV, V32, P321, DOI 10.2307/2137101; Hamano T, 2011, STRESS HEALTH, V27, P163, DOI 10.1002/smi.1324; He W.-M., 2007, INT J OPHTHALMOL-CHI, V7, P854; Hooper D., 2008, EJBRM, V6, P53, DOI DOI 10.21427/D7CF7R; Huang JP, 2009, AUST NZ J PSYCHIAT, V43, P674, DOI 10.1080/00048670902970817; Hudson CG, 2005, AM J ORTHOPSYCHIAT, V75, P3, DOI 10.1037/0002-9432.75.1.3; Jang Y, 2005, J GERONTOL B-PSYCHOL, V60, pP313, DOI 10.1093/geronb/60.6.P313; Jang YR, 2004, INT J AGING HUM DEV, V59, P125, DOI 10.2190/RT1W-2HD7-KG5X-K1FB; Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184; Kuriyama S, 2009, J EPIDEMIOL, V19, P294, DOI 10.2188/jea.JE20080076; Liu JF, 2009, GERIATR GERONTOL INT, V9, P253, DOI 10.1111/j.1447-0594.2009.00529.x; Miller NB, 1998, J FAM ISSUES, V19, P181, DOI 10.1177/019251398019002004; Prelow HM, 2006, J BLACK PSYCHOL, V32, P442, DOI 10.1177/0095798406292677; Prina AM, 2011, BRIT J PSYCHIAT, V199, P485, DOI 10.1192/bjp.bp.110.083915; Ross CE, 2008, J AGING HEALTH, V20, P273, DOI 10.1177/0898264308315428; Schieman S, 1998, J HEALTH SOC BEHAV, V39, P169, DOI 10.2307/2676310; Schnittker J, 2005, SOC SCI MED, V60, P13, DOI 10.1016/j.socscimed.2004.04.020; Sicular T, 2007, REV INCOME WEALTH, V53, P93, DOI 10.1111/j.1475-4991.2007.00219.x; Suttajit S, 2010, PSYCHOL MED, V40, P1711, DOI 10.1017/S003329170999208X; Vaeroy H, 2005, NORD J PSYCHIAT, V59, P109, DOI 10.1080/08039480510022945; Yang Y, 2006, J HEALTH SOC BEHAV, V47, P355, DOI 10.1177/002214650604700404; [周成超 ZHOU Chengchao], 2008, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V16, P627	28	12	13	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100945	10.1371/journal.pone.0100945	http://dx.doi.org/10.1371/journal.pone.0100945			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK8WO	24963867	Green Published, gold, Green Submitted			2022-12-27	WOS:000338709500103
J	Fina, BL; Lombarte, M; Rigalli, JP; Rigalli, A				Lorena Fina, Brenda; Lombarte, Mercedes; Pablo Rigalli, Juan; Rigalli, Alfredo			Fluoride Increases Superoxide Production and Impairs the Respiratory Chain in ROS 17/2.8 Osteoblastic Cells	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; SODIUM MONOFLUOROPHOSPHATE; OXIDATIVE STRESS; MITOCHONDRIA; GLUTATHIONE; OXYGEN; INFLAMMATION; INHIBITION; GENERATION; REDUCTASE	It is known that fluoride produces oxidative stress. Inflammation in bone tissue and an impairment of the respiratory chain of liver have been described in treatments with fluoride. Whether the impairment of the respiratory chain and oxidative stress are related is not known. The aim of this work was to study the effects of fluoride on the production of superoxide radical, the function of the respiratory chain and the increase in oxidative stress in ROS 17/2.8 osteoblastic cells. We measured the effect of fluoride (100 mu M) on superoxide production, oxygen consumption, lipid peroxidation and antioxidant enzymes activities of cultured cells following the treatment with fluoride. Fluoride decreased oxygen consumption and increased superoxide production immediately after its addition. Furthermore, chronic treatment with fluoride increased oxidative stress status in osteoblastic cells. These results indicate that fluoride could damage bone tissue by inhibiting the respiratory chain, increasing the production of superoxide radicals and thus of the others reactive oxygen species.	[Lorena Fina, Brenda; Lombarte, Mercedes; Rigalli, Alfredo] Rosario Natl Univ, Sch Med, Bone Biol Lab, Rosario, Santa Fe, Argentina; [Pablo Rigalli, Juan] Consejo Nacl Invest Cient & Tecn, Inst Expt Physiol, Rosario, Santa Fe, Argentina	National University of Rosario; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Fina, BL (corresponding author), Rosario Natl Univ, Sch Med, Bone Biol Lab, Rosario, Santa Fe, Argentina.	brendafina@conicet.gov.ar	Lombarte, Mercedes/M-2774-2016; Fina, Brenda/M-2971-2016; Rigalli, Juan Pablo/E-2099-2018; Rigalli, Alfredo/M-2591-2016	Lombarte, Mercedes/0000-0003-1114-319X; Fina, Brenda/0000-0003-3708-0756; Rigalli, Juan Pablo/0000-0003-4168-9396; Rigalli, Alfredo/0000-0002-3953-278X	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [112-200801-00462]	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This paper was funded by Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) Grant 112-200801-00462 (http://www.conicet.gov.ar). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Antunes F, 2004, P NATL ACAD SCI USA, V101, P16774, DOI 10.1073/pnas.0405368101; Anuradha CD, 2001, FREE RADICAL BIO MED, V31, P367, DOI 10.1016/S0891-5849(01)00591-3; Bergandi L, 2010, CHEM-BIOL INTERACT, V183, P405, DOI 10.1016/j.cbi.2009.11.021; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; BOVERIS A, 1976, BIOCHEM J, V156, P435, DOI 10.1042/bj1560435; Boveris A, 1999, METHOD ENZYMOL, V301, P188; BOVERIS A, 1984, METHOD ENZYMOL, V105, P429; BRIANCON D, 1981, ORTHOP CLIN N AM, V12, P629; Brun LR, 2012, ACTUAL OSTEOL, V8, P19; CADENAS E, 1977, ARCH BIOCHEM BIOPHYS, V180, P248, DOI 10.1016/0003-9861(77)90035-2; Caverzasio J, 1998, BONE, V22, P585, DOI 10.1016/S8756-3282(98)00058-1; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Chen ACH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022453; de Mendiburu F, 2012, AGRICOLAE STAT PROCE; Eberlein M, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-20; EISENBERG AD, 1981, ANTIMICROB AGENTS CH, V19, P807, DOI 10.1128/AAC.19.5.807; EKSTRAND J, 1978, CARIES RES, V12, P123; FATT I, 1968, ANN NY ACAD SCI, V148, P81, DOI 10.1111/j.1749-6632.1968.tb20342.x; Fina BL, 2012, FLUORIDE, V45, P325; Forman HJ, 1997, FASEB J, V11, P374, DOI 10.1096/fasebj.11.5.9141504; Gazzano E, 2010, CURR MED CHEM, V17, P2431, DOI 10.2174/092986710791698503; GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6; LAWRENCE RA, 1976, BIOCHEM BIOPH RES CO, V71, P952, DOI 10.1016/0006-291X(76)90747-6; MAJESKA RJ, 1980, ENDOCRINOLOGY, V107, P1494, DOI 10.1210/endo-107-5-1494; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nathan AT, 1999, BRIT MED BULL, V55, P96, DOI 10.1258/0007142991902312; Navarro A, 2010, J BIOENERG BIOMEMBR, V42, P405, DOI 10.1007/s10863-010-9309-4; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Quinlan CL, 2013, REDOX BIOL, V1, P304, DOI 10.1016/j.redox.2013.04.005; R Core Team, 2021, R LANGUAGE ENV STAT; RIGALLI A, 1994, ARZNEIMITTEL-FORSCH, V44-1, P762; RIGALLI A, 1995, ARZNEIMITTEL-FORSCH, V45-1, P289; Sies H, 1999, FREE RADICAL BIO MED, V27, P916, DOI 10.1016/S0891-5849(99)00177-X; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; TOWLER DA, 1994, MOL ENDOCRINOL, V8, P614, DOI 10.1210/me.8.5.614; TRAUTNER K, 1988, ARCH ORAL BIOL, V33, P543, DOI 10.1016/0003-9969(88)90127-6; Wang YX, 2009, J AM SOC NEPHROL, V20, P1544, DOI 10.1681/ASN.2008080843; Wang Z, 2011, ARCH TOXICOL, V85, P1407, DOI 10.1007/s00204-011-0697-y; WATANABE N, 1986, CLIN CHEM, V32, P1551; Xu H, 2008, BIOL TRACE ELEM RES, V123, P109, DOI 10.1007/s12011-007-8082-7	42	32	32	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100768	10.1371/journal.pone.0100768	http://dx.doi.org/10.1371/journal.pone.0100768			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964137	gold, Green Submitted, Green Published			2022-12-27	WOS:000338709500079
J	Mittendorfer-Rutz, E; Harkanen, T; Tiihonen, J; Haukka, J				Mittendorfer-Rutz, Ellenor; Harkanen, Tommi; Tiihonen, Jari; Haukka, Jari			Association of Socio-Demographic Factors, Sick-Leave and Health Care Patterns with the Risk of Being Granted a Disability Pension among Psychiatric Outpatients with Depression	PLOS ONE			English	Article							WORK; PREDICTORS; DISORDERS; REGISTER; BURDEN	Background: Depression ranges among the leading causes of early exit from the labor market worldwide. We aimed to investigate the associations of socio-demographic factors, sickness absence, health care and prescription patterns with the risk of being granted a disability pension in psychiatric outpatients with depression. Methods: All non-retired patients aged 18-60 years and living in Sweden 31.12.2005 with at least one psychiatric outpatient care visit due to a depressive episode during 2006 (N = 18034): were followed from 01.01.2007 to 31.12.2010 with regard to granting of all-cause and diagnosis-specific disability pension. Uni- and multivariate Rate Ratios (RR) and 95% Confidence Intervals (CI) were estimated for the various risk markers by Poisson Regression. Results: During the four years of follow-up, 3044 patients (16.8%) were granted a disability pension, the majority due to mental disorders (2558, 84%). In the multivariate analyses, being female, below 25 or above 45 years of age, with low educational level, living alone, residing outside big cities and being born outside Europe were predictive of a granted disability pension. Frequent in-and outpatient care due to mental disorders, prescription of antidepressants and long sickness absence spells were also associated with an increased risk of disability pension (range of RRs 1.10 to 5.26). Somatic health care was only predictive of disability pension due to somatic disorders. The risk of being granted a disability pension remained at the same level as at the start of follow-up for about 1.5 years, when it started to decrease and to level off at about 20% of the risk at the end of follow-up. Conclusions: Identified risk markers should be considered when monitoring individuals with depression and when designing intervention programs.	[Mittendorfer-Rutz, Ellenor] Karolinska Inst, Div Insurance Med, Dept Clin Neurosci, Stockholm, Sweden; [Harkanen, Tommi] Natl Inst Hlth & Welf, Helsinki, Finland; [Tiihonen, Jari] Karolinska Inst, Ctr Psychiat Res, Dept Clin Neurosci, Stockholm, Sweden; [Tiihonen, Jari] Univ Eastern Finland, Dept Forens Psychiat, Kuopio, Finland; [Haukka, Jari] Univ Helsinki, Dept Publ Hlth, Fac Med, Helsinki, Finland	Karolinska Institutet; Finland National Institute for Health & Welfare; Karolinska Institutet; University of Eastern Finland; University of Helsinki	Mittendorfer-Rutz, E (corresponding author), Karolinska Inst, Div Insurance Med, Dept Clin Neurosci, Stockholm, Sweden.	Ellenor.mittendorfer-rutz@ki.se	Haukka, Jari/G-1484-2014; Härkänen, Tommi/G-4866-2019; Tiihonen, Jari/G-3078-2012	Haukka, Jari/0000-0003-1450-6208; Härkänen, Tommi/0000-0002-4577-1808; Tiihonen, Jari/0000-0002-0400-6798	Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	The study was funded by the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler DA, 2006, AM J PSYCHIAT, V163, P1569, DOI 10.1176/appi.ajp.163.9.1569; Allebeck P, 2004, SCAND J PUBLIC HEALT, V32, P49, DOI 10.1080/14034950410021853; Arnett JJ, 2001, J ADULT DEV, V8, P133, DOI 10.1023/A:1026450103225; Britain, 2006, IS WORK GOOD YOUR HL, P1; Carstensen B, 2012, EPI PACKAGE STAT ANA; Claussen B, 2009, SCAND J PUBLIC HEALT, V37, P395, DOI 10.1177/1403494809104220; Forsakringskassan, 2012, 10 AR MED AKT; Forsakringskassan, 2007, AN NYA SKUK OCH AKT; Forsakringskassan, 2012, SOC INS FIG 2012; Holma IAK, 2012, ACTA PSYCHIAT SCAND, V125, P325, DOI 10.1111/j.1600-0447.2011.01785.x; JARVISALO J., 2005, MENTAL DISORDERS MAJ; Johansson B, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-845; Karlsson NE, 2008, EUR J PUBLIC HEALTH, V18, P224, DOI 10.1093/eurpub/ckm128; Kessler RC, 2009, EPIDEMIOL PSICHIAT S, V18, P23, DOI 10.1017/S1121189X00001421; Kupfer DJ, 2012, LANCET, V379, P1045, DOI 10.1016/S0140-6736(11)60602-8; LJUNGDAHL LO, 1991, SCAND J SOC MED, V19, P148, DOI 10.1177/140349489101900302; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Meershoek A, 2011, SOC SCI MED, V72, P15, DOI 10.1016/j.socscimed.2010.10.022; OECD, 1996, HIST STAT; OECD, 2005, BEST PRACT RED SICKN; Preston DL, 2005, ENCY BIOSTATISTICS, P4124, DOI DOI 10.1002/0470011815.B2A03094; R Core Team, 2012, LANG ENV STAT COMP; ROHOLD A, 1989, Ugeskrift for Laeger, V151, P2672; Rytsala HJ, 2007, ACTA PSYCHIAT SCAND, V115, P206, DOI 10.1111/j.1600-0447.2006.00878.x; SCB, 2006, LONG INT SJUKF OCH A, V4, P4; SCB, 2003, REG IND SVER 1 JAN 1; Simon GE, 2001, J OCCUP ENVIRON MED, V43, P2, DOI 10.1097/00043764-200101000-00002; Socialstyrelsen, 1997, KLASS SJUKD HALS 199; Socialstyrelsen, 2009, CAUS DEATH REG; Socialstyrelsen, 2008, BESKRIVNING VARDUTNY; Sorvaniemi M, 2003, J AFFECT DISORDERS, V75, P43, DOI 10.1016/S0165-0327(02)00034-4	32	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e99869	10.1371/journal.pone.0099869	http://dx.doi.org/10.1371/journal.pone.0099869			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK8WO	24963812	Green Submitted, gold, Green Published			2022-12-27	WOS:000338709500021
J	Rothenstein, AL; Tsotsos, JK				Rothenstein, Albert L.; Tsotsos, John K.			Attentional Modulation and Selection - An Integrated Approach	PLOS ONE			English	Article							WINNER-TAKE-ALL; VISUAL-ATTENTION; NORMALIZATION MODEL; NEURAL MECHANISMS; AREA MT; CORTEX; RECOGNITION; RESPONSES; PERCEPTION; STIMULI	Various models of the neural mechanisms of attentional modulation in the visual cortex have been proposed. In general, these models assume that an 'attention' parameter is provided separately. Its value as well as the selection of neuron(s) to which it applies are assumed, but its source and the selection mechanism are unspecified. Here we show how the Selective Tuning model of visual attention can account for the modulation of the firing rate at the single neuron level, and for the temporal pattern of attentional modulations in the visual cortex, in a self-contained formulation that simultaneously determines the stimulus elements to be attended while modulating the relevant neural processes.	[Rothenstein, Albert L.] York Univ, Dept Elect Engn & Comp Sci, Toronto, ON M3J 2R7, Canada; York Univ, Ctr Vision Res, Toronto, ON M3J 2R7, Canada	York University - Canada; York University - Canada	Rothenstein, AL (corresponding author), York Univ, Dept Elect Engn & Comp Sci, Toronto, ON M3J 2R7, Canada.	albertlr@cse.yorku.ca	Tsotsos, John/N-1131-2019	Tsotsos, John/0000-0002-8621-9147	Canada Research Chairs Program through a Tier I Chair award; Natural Sciences and Engineering Research Council of Canada	Canada Research Chairs Program through a Tier I Chair award(Canada Research Chairs); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This research was funded by the Canada Research Chairs Program through a Tier I Chair award to the second author (http://www.chairs-chaires.gc.ca), and by the Natural Sciences and Engineering Research Council of Canada via a grant to the second author (http://www.nserc-crsng.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahissar M, 1997, NATURE, V387, P401, DOI 10.1038/387401a0; Ardid S, 2007, J NEUROSCI, V27, P8486, DOI 10.1523/JNEUROSCI.1145-07.2007; Boehler CN, 2009, CEREB CORTEX, V19, P982, DOI 10.1093/cercor/bhn139; Boynton GM, 2005, CURR OPIN NEUROBIOL, V15, P465, DOI 10.1016/j.conb.2005.06.009; Broadbent E. Donald, 1958, PERCEPTION COMMUNICA; Buffalo EA, 2010, P NATL ACAD SCI USA, V107, P361, DOI 10.1073/pnas.0907658106; Buia CI, 2008, J NEUROPHYSIOL, V99, P2158, DOI 10.1152/jn.01004.2007; Bundesen C, 2011, NEUROPSYCHOLOGIA, V49, P1446, DOI 10.1016/j.neuropsychologia.2010.12.006; Busse L, 2009, NEURON, V64, P931, DOI 10.1016/j.neuron.2009.11.004; Carandini M, 2012, NAT REV NEUROSCI, V13, P51, DOI 10.1038/nrn3136; CULHANE SM, 1992, LECT NOTES COMPUT SC, V588, P551; Cutzu F, 2003, VISION RES, V43, P205, DOI 10.1016/S0042-6989(02)00491-1; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; DUNCAN J, 1980, PSYCHOL REV, V87, P272, DOI 10.1037/0033-295X.87.3.272; DUNCAN J, 1984, J EXP PSYCHOL GEN, V113, P501, DOI 10.1037/0096-3445.113.4.501; FUKUSHIMA K, 1986, BIOL CYBERN, V55, P5, DOI 10.1007/BF00363973; FUSTER JM, 1990, J NEUROPHYSIOL, V64, P681, DOI 10.1152/jn.1990.64.3.681; Hamker FH, 2005, CEREB CORTEX, V15, P431, DOI 10.1093/cercor/bhh146; Hochstein S, 2002, NEURON, V36, P791, DOI 10.1016/S0896-6273(02)01091-7; Itti L, 1998, IEEE T PATTERN ANAL, V20, P1254, DOI 10.1109/34.730558; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Itti L., 2005, NEUROBIOLOGY ATTENTI; Khayat PS, 2010, J NEUROSCI, V30, P2188, DOI 10.1523/JNEUROSCI.5314-09.2010; Lauritzen TZ, 2009, J VISION, V9, DOI 10.1167/9.13.18; LAWLER EL, 1966, OPER RES, V14, P699, DOI 10.1287/opre.14.4.699; Lee DK, 1999, NAT NEUROSCI, V2, P375, DOI 10.1038/7286; Lee J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004651; Maass W, 2000, NEURAL COMPUT, V12, P2519, DOI 10.1162/089976600300014827; Martinez-Trujillo JC, 2004, CURR BIOL, V14, P744, DOI 10.1016/j.cub.2004.04.028; Mehta SD, 2000, CEREB CORTEX, V10, P343, DOI 10.1093/cercor/10.4.343; MILNER PM, 1974, PSYCHOL REV, V81, P521, DOI 10.1037/h0037149; Neisser U., 1967, COGNITIVE PSYCHOL; NOWLAN SJ, 1995, J NEUROSCI, V15, P1195; O'Connor DH, 2002, NAT NEUROSCI, V5, P1203, DOI 10.1038/nn957; Pashler HE, 1998, PSYCHOL ATTENTION; Pashler HE, 1998, ATTENTION; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Reynolds JH, 1999, NEURON, V24, P19, DOI 10.1016/S0896-6273(00)80819-3; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; Roelfsema PR, 2007, NEURON, V56, P785, DOI 10.1016/j.neuron.2007.10.006; Rolls ET, 2002, COMPUTATIONAL NEUROS; Rothenstein AL, 2008, IMAGE VISION COMPUT, V26, P114, DOI 10.1016/j.imavis.2005.08.011; SCHNEIDER W, 1977, PSYCHOL REV, V84, P1, DOI 10.1037/0033-295X.84.1.1; Spratling MW, 2008, VISION RES, V48, P1391, DOI 10.1016/j.visres.2008.03.009; Spratling MW, 2008, FRONT COMPUT NEUROSC, V2, P1, DOI 10.3389/neuro.10.004.2008; Spratling MW, 2004, J COGNITIVE NEUROSCI, V16, P219, DOI 10.1162/089892904322984526; TREISMAN A, 1982, COGNITIVE PSYCHOL, V14, P107, DOI 10.1016/0010-0285(82)90006-8; TREISMAN AM, 1969, PSYCHOL REV, V76, P282, DOI 10.1037/h0027242; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Tsotsos J. K., 1989, IJCAI-89 Proceedings of the Eleventh International Joint Conference on Artificial Intelligence, P1571; Tsotsos J. K., 2011, COMPUTATIONAL PERSPE, DOI DOI 10.7551/MITPRESS/9780262015417.001.0001; TSOTSOS JK, 1995, ARTIF INTELL, V78, P507, DOI 10.1016/0004-3702(95)00025-9; TSOTSOS JK, 1990, BEHAV BRAIN SCI, V13, P423, DOI 10.1017/S0140525X00079577; TSOTSOS JK, 1993, SPATIAL VISION IN HUMANS AND ROBOTS, P313; TSOTSOS JK, 1992, INT J COMPUT VISION, V7, P127, DOI 10.1007/BF00128132; Tsotsos JK, 2011, SCHOLARPEDIA, V6, P6201, DOI DOI 10.4249/SCH0LARPEDIA.6201; Tsotsos JK, 1991, RBCVTR9137 U TOR DEP; Tsotsos JK, 1987, INT C COMP VIS HUM M; VanRullen R, 2013, CURRENT BIOL, V23; Walther D, 2006, NEURAL NETWORKS, V19, P1395, DOI 10.1016/j.neunet.2006.10.001	62	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e99681	10.1371/journal.pone.0099681	http://dx.doi.org/10.1371/journal.pone.0099681			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963827	gold, Green Published, Green Submitted			2022-12-27	WOS:000338709500012
J	Bertaggia, E; Scabia, G; Dalise, S; Lo Verso, F; Santini, F; Vitti, P; Chisari, C; Sandri, M; Maffei, M				Bertaggia, Enrico; Scabia, Gaia; Dalise, Stefania; Lo Verso, Francesca; Santini, Ferruccio; Vitti, Paolo; Chisari, Carmelo; Sandri, Marco; Maffei, Margherita			Haptoglobin Is Required to Prevent Oxidative Stress and Muscle Atrophy	PLOS ONE			English	Article							FOXO TRANSCRIPTION FACTORS; SKELETAL-MUSCLE; PROTEIN-DEGRADATION; IN-VIVO; AUTOPHAGY; DISEASE; PATHWAY; HYPERTROPHY; MECHANISMS; EXPRESSION	Background: Oxidative stress (OS) plays a major role on tissue function. Several catabolic or stress conditions exacerbate OS, inducing organ deterioration. Haptoglobin (Hp) is a circulating acute phase protein, produced by liver and adipose tissue, and has an important anti-oxidant function. Hp is induced in pro-oxidative conditions such as systemic inflammation or obesity. The role of systemic factors that modulate oxidative stress inside muscle cells is still poorly investigated. Results: We used Hp knockout mice (Hp(-/-)) to determine the role of this protein and therefore, of systemic OS in maintenance of muscle mass and function. Absence of Hp caused muscle atrophy and weakness due to activation of an atrophy program. When animals were stressed by acute exercise or by high fat diet (HFD), OS, muscle atrophy and force drop were exacerbated in Hp(-/-), Depending from the stress condition, autophagy-lysosome and ubiquitin-proteasome systems were differently induced. Conclusions: Hp is required to prevent OS and the activation of pathways leading to muscle atrophy and weakness in normal condition and upon metabolic challenges.	[Bertaggia, Enrico; Lo Verso, Francesca; Sandri, Marco] Univ Padua, Dept Biomed Sci, Padua, Italy; [Bertaggia, Enrico; Lo Verso, Francesca; Sandri, Marco] Venetian Inst Mol Med, Dulbecco Telethon Inst, Padua, Italy; [Scabia, Gaia; Santini, Ferruccio; Vitti, Paolo; Maffei, Margherita] Univ Pisa, Dept Clin & Expt Med, Pisa, Italy; [Dalise, Stefania; Chisari, Carmelo] Univ Hosp Pisa, Dept Neurosci, Unit Neurorehabil, Pisa, Italy; [Sandri, Marco] CNR, Inst Neurosci, Padua, Italy; [Sandri, Marco] Telethon Inst Genet & Med TIGEM, Naples, Italy; [Maffei, Margherita] CNR, Inst Clin Physiol, I-56100 Pisa, Italy	University of Padua; Fondazione Telethon; Dulbecco Telethon Institute (DTI); Veneto Institute Molecular Medicine; University of Pisa; University of Pisa; Azienda Ospedaliero Universitaria Pisana; Consiglio Nazionale delle Ricerche (CNR); Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR)	Chisari, C (corresponding author), Univ Hosp Pisa, Dept Neurosci, Unit Neurorehabil, Pisa, Italy.	c.chisari@ao-pisa.toscana.it; marco.sandri@unipd.it; maffeim@immr.med.unipi.it	Maffei, Margherita/I-2454-2018; Dalise, Stefania/K-8940-2016; Santini, Ferruccio/J-9272-2018	Maffei, Margherita/0000-0002-8534-2450; Santini, Ferruccio/0000-0002-1706-0822	Telethon fellowship; Telethon-Italy [TCP99016, TCP04009]; European Union (MYOAGE) [223576]; ERC [282310-MyoPHAGY]; Italian Ministry of Education (MiUR) [PRIN 2010/2011]; Foundation Leducq; CARIPARO [PRIN 2009/2011]	Telethon fellowship(Fondazione Telethon); Telethon-Italy(Fondazione Telethon); European Union (MYOAGE)(European Commission); ERC(European Research Council (ERC)European Commission); Italian Ministry of Education (MiUR)(Ministry of Education, Universities and Research (MIUR)); Foundation Leducq(Leducq Foundation); CARIPARO(Fondazione Cariparo)	EB and GS were supported by a Telethon fellowship. This work was supported from Telethon-Italy (TCP99016 to MM and TCP04009 to MS), from the European Union (MYOAGE, contract: 223576 of FP7 to MS), ERC (282310-MyoPHAGY to MS), Italian Ministry of Education (MiUR) (PRIN 2010/2011 to MS), Foundation Leducq and CARIPARO to MS and (MiUR) (PRIN 2009/2011 to CC as coinvestigator). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bonaldo P, 2013, DIS MODEL MECH, V6, P25, DOI 10.1242/dmm.010389; Bryan HK, 2013, BIOCHEM PHARMACOL, V85, P705, DOI 10.1016/j.bcp.2012.11.016; Chiellini C, 2004, J CLIN ENDOCR METAB, V89, P2678, DOI 10.1210/jc.2003-031965; Chiellini C, 2002, J CELL PHYSIOL, V190, P251, DOI 10.1002/JCP.10061; Correale Michele, 2012, Cardiovascular & Hematological Agents in Medicinal Chemistry, V10, P352; Della Gatta PA, 2014, BRAIN BEHAV IMMUN; Dobrowolny G, 2008, CELL METAB, V8, P425, DOI 10.1016/j.cmet.2008.09.002; Dobryszycka W, 1997, EUR J CLIN CHEM CLIN, V35, P647; Farbstein D, 2011, ATHEROSCLEROSIS, V219, P240, DOI 10.1016/j.atherosclerosis.2011.06.005; FRIEDRICHS WE, 1995, BIOCHEM BIOPH RES CO, V209, P250, DOI 10.1006/bbrc.1995.1496; Gamucci O, 2012, ADIPOCYTE, V1, P142, DOI 10.4161/adip.20041; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Grumati P, 2011, AUTOPHAGY, V7, P1415, DOI 10.4161/auto.7.12.17877; Grumati P, 2010, NAT MED, V16, P1313, DOI 10.1038/nm.2247; Jang YC, 2010, FASEB J, V24, P1376, DOI 10.1096/fj.09-146308; Klionsky DJ, 2010, AUTOPHAGY, P6; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lim SK, 1998, BLOOD, V92, P1870, DOI 10.1182/blood.V92.6.1870.418k38_1870_1877; Lisi S, 2011, DIABETES, V60, P2496, DOI 10.2337/db10-1536; Maffei M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-87; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Mikel U. V., 1994, ADV LAB METHODS HIST; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Moylan JS, 2007, MUSCLE NERVE, V35, P411, DOI 10.1002/mus.20743; Nakhoul FM, 2007, NAT CLIN PRACT NEPHR, V3, P339, DOI 10.1038/ncpneph0467; Nielsen MJ, 2009, BLOOD, V114, P764, DOI 10.1182/blood-2009-01-198309; Pinkston-Gosse J, 2007, NAT GENET, V39, P1403, DOI 10.1038/ng.2007.1; Raffaello A, 2010, J CELL BIOL, V191, P101, DOI 10.1083/jcb.201001136; Reid MB, 2011, J PHYSIOL-LONDON, V589, P2171, DOI 10.1113/jphysiol.2010.203356; Romanello V, 2010, EMBO J, V29, P1774, DOI 10.1038/emboj.2010.60; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sandri M, 2013, INT J BIOCH CELL BIO; Sparks LM, 2005, DIABETES, V54, P1926, DOI 10.2337/diabetes.54.7.1926; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Styskal J, 2012, FREE RADICAL BIO MED, V52, P46, DOI 10.1016/j.freeradbiomed.2011.10.441; Tracy K, 2007, AUTOPHAGY, V3, P616, DOI 10.4161/auto.4892; Tufekci K. U., 2011, PARKINSONS DIS, V2011; Vazquez-Medina JP, 2011, J EXP BIOL, V214, P2903, DOI 10.1242/jeb.057935; Wang YP, 2001, REDOX REP, V6, P379, DOI 10.1179/135100001101536580; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	45	35	36	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100745	10.1371/journal.pone.0100745	http://dx.doi.org/10.1371/journal.pone.0100745			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959824	Green Published, Green Submitted, gold			2022-12-27	WOS:000338633900079
J	Gully, N; Bright, R; Marino, V; Marchant, C; Cantley, M; Haynes, D; Butler, C; Dashper, S; Reynolds, E; Bartold, M				Gully, Neville; Bright, Richard; Marino, Victor; Marchant, Ceilidh; Cantley, Melissa; Haynes, David; Butler, Catherine; Dashper, Stuart; Reynolds, Eric; Bartold, Mark			Porphyromonas gingivalis Peptidylarginine Deiminase, a Key Contributor in the Pathogenesis of Experimental Periodontal Disease and Experimental Arthritis	PLOS ONE			English	Article							PROTEINASE-ADHESIN COMPLEXES; ANTIBODY-INDUCED ARTHRITIS; RHEUMATOID-ARTHRITIS; CITRULLINATED PROTEINS; TREPONEMA-DENTICOLA; BONE LOSS; ANTIFILAGGRIN AUTOANTIBODIES; IMMUNE-RESPONSE; MURINE MODEL; VIRULENCE	Objectives: To investigate the suggested role of Porphyromonas gingivalis peptidylarginine deiminase (PAD) in the relationship between the aetiology of periodontal disease and experimentally induced arthritis and the possible association between these two conditions. Methods: A genetically modified PAD-deficient strain of P. gingivalis W50 was produced. The effect of this strain, compared to the wild type, in an established murine model for experimental periodontitis and experimental arthritis was assessed. Experimental periodontitis was induced following oral inoculation with the PAD-deficient and wild type strains of P. gingivalis. Experimental arthritis was induced via the collagen antibody induction process and was monitored by assessment of paw swelling and micro-CT analysis of the radio-carpal joints. Experimental periodontitis was monitored by micro CT scans of the mandible and histological assessment of the periodontal tissues around the mandibular molars. Serum levels of anti-citrullinated protein antibodies (ACPA) and P. gingivalis were assessed by ELISA. Results: The development of experimental periodontitis was significantly reduced in the presence of the PAD-deficient P. gingivalis strain. When experimental arthritis was induced in the presence of the PAD-deficient strain there was less paw swelling, less erosive bone damage to the joints and reduced serum ACPA levels when compared to the wild type P. gingivalis inoculated group. Conclusion: This study has demonstrated that a PAD-deficient strain of P. gingivalis was associated with significantly reduced periodontal inflammation. In addition the extent of experimental arthritis was significantly reduced in animals exposed to prior induction of periodontal disease through oral inoculation of the PAD-deficient strain versus the wild type. This adds further evidence to the potential role for P. gingivalis and its PAD in the pathogenesis of periodontitis and exacerbation of arthritis. Further studies are now needed to elucidate the mechanisms which drive these processes.	[Gully, Neville; Bright, Richard; Marino, Victor; Marchant, Ceilidh; Bartold, Mark] Univ Adelaide, Colgate Australian Clin Dent Res, Sch Dent, Adelaide, SA, Australia; [Cantley, Melissa; Haynes, David] Univ Adelaide, Sch Med Sci, Discipline Anat & Pathol, Adelaide, SA, Australia; [Butler, Catherine; Dashper, Stuart; Reynolds, Eric] Univ Melbourne, Melbourne Dent Sch, Oral Hlth Collaborat Res Ctr, Melbourne, Vic, Australia	University of Adelaide; University of Adelaide; University of Melbourne	Bartold, M (corresponding author), Univ Adelaide, Colgate Australian Clin Dent Res, Sch Dent, Adelaide, SA, Australia.	mark.bartold@adelaide.edu.au	Cantley, Melissa/V-4674-2019; Bartold, Mark/H-8122-2019; Bright, Richard J/S-5447-2017	Bright, Richard J/0000-0003-1988-0725; Dashper, Stuart/0000-0003-0106-8691; Bartold, Peter/0000-0002-5695-3877; Marchant, Ceilidh/0000-0001-6615-8669; Cantley, Melissa/0000-0002-7188-0928; Butler, Catherine/0000-0001-6371-3954; Reynolds, Eric/0000-0002-6618-4856	Australian Dental Research Fund [ADRF 56/2010]; National Health & Medical Council of Australia [NHMRC 1023747]	Australian Dental Research Fund; National Health & Medical Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported in part by research grants from the Australian Dental Research Fund (ADRF 56/2010) and the National Health & Medical Council of Australia (NHMRC 1023747). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asquith DL, 2009, EUR J IMMUNOL, V39, P2040, DOI 10.1002/eji.200939578; Bartold PM, 2005, J PERIODONTOL, V76, P2066, DOI 10.1902/jop.2005.76.11-S.2066; BIRD PS, 1995, J PERIODONTOL, V66, P351, DOI 10.1902/jop.1995.66.5.351; Byrne SJ, 2009, ORAL MICROBIOL IMMUN, V24, P469, DOI 10.1111/j.1399-302X.2009.00544.x; Cantley MD, 2011, J CLIN PERIODONTOL, V38, P532, DOI 10.1111/j.1600-051X.2011.01714.x; Dashper S, 2014, ANTIMICROB AGENTS CH, V58, P378, DOI 10.1128/AAC.01375-13; de Pablo P, 2009, NAT REV RHEUMATOL, V5, P218, DOI 10.1038/nrrheum.2009.28; Dehal PS, 2010, NUCLEIC ACIDS RES, V38, pD396, DOI 10.1093/nar/gkp919; Demoruelle MK, 2014, CURR OPIN RHEUMATOL, V26, P64, DOI 10.1097/BOR.0000000000000017; Doyle HA, 2002, CURR OPIN RHEUMATOL, V14, P244, DOI 10.1097/00002281-200205000-00009; FLETCHER HM, 1995, INFECT IMMUN, V63, P1521, DOI 10.1128/IAI.63.4.1521-1528.1995; Girbal-Neuhauser E, 1999, J IMMUNOL, V162, P585; Harvey GP, 2013, J PERIODONTAL RES, V48, P252, DOI 10.1111/jre.12002; Holers VM, 2013, CURR OPIN IMMUNOL, V25, P728, DOI 10.1016/j.coi.2013.09.018; HORTON RM, 1995, MOL BIOTECHNOL, V3, P93, DOI 10.1007/BF02789105; Jeong E, 2012, J PERIODONTAL RES, V47, P811, DOI 10.1111/j.1600-0765.2012.01501.x; Kesavalu L, 1998, ORAL MICROBIOL IMMUN, V13, P373, DOI 10.1111/j.1399-302X.1998.tb00694.x; Klareskog L, 2008, ANNU REV IMMUNOL, V26, P651, DOI 10.1146/annurev.immunol.26.021607.090244; Knipp M, 2000, ANAL BIOCHEM, V286, P257, DOI 10.1006/abio.2000.4805; Kornman KS, 2009, J PERIODONTOL, V80, P1019, DOI 10.1902/jop.2009.097002; Kuhn KA, 2006, J CLIN INVEST, V116, P961, DOI 10.1172/JCI25422; Linden GJ, 2013, J CLIN PERIODONTOL, V40, pS8, DOI [10.1902/jop.2013.1340010, 10.1111/jcpe.12064]; Lundberg K, 2010, NAT REV RHEUMATOL, V6, P727, DOI 10.1038/nrrheum.2010.139; Maresz KJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003627; Masson-Bessiere C, 2001, J IMMUNOL, V166, P4177, DOI 10.4049/jimmunol.166.6.4177; McGraw WT, 1999, INFECT IMMUN, V67, P3248, DOI 10.1128/IAI.67.7.3248-3256.1999; Nandakumar KS, 2003, AM J PATHOL, V163, P1827, DOI 10.1016/S0002-9440(10)63542-0; Nandakumar KS, 2003, EUR J IMMUNOL, V33, P2269, DOI 10.1002/eji.200323810; Nandakumar KS, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2089; Nesse W, 2012, J CLIN PERIODONTOL, V39, P599, DOI 10.1111/j.1600-051X.2012.01885.x; O'Brien-Simpson NM, 2005, J IMMUNOL, V175, P3980, DOI 10.4049/jimmunol.175.6.3980; O'Brien-Simpson NM, 2001, INFECT IMMUN, V69, P7527, DOI 10.1128/IAI.69.12.7527-7534.2001; Orth RKH, 2011, MOL ORAL MICROBIOL, V26, P229, DOI 10.1111/j.2041-1014.2011.00612.x; Page RC, 1997, PERIODONTOL 2000, V14, P216, DOI 10.1111/j.1600-0757.1997.tb00199.x; Park CH, 2007, J PERIODONTOL, V78, P273, DOI 10.1902/jop.2007.060252; Pathirana RD, 2006, MICROBIOL-SGM, V152, P2381, DOI 10.1099/mic.0.28787-0; Potikuri D, 2012, ANN RHEUM DIS, V71, P1541, DOI 10.1136/annrheumdis-2011-200380; Quirke AM, 2014, ANN RHEUM DIS, V73, P263, DOI 10.1136/annrheumdis-2012-202726; Rajapakse PS, 2002, INFECT IMMUN, V70, P2480, DOI 10.1128/IAI.70.5.2480-2486.2002; Rosenstein ED, 2004, INFLAMMATION, V28, P311, DOI 10.1007/s10753-004-6641-z; Schellekens GA, 1998, J CLIN INVEST, V101, P273, DOI 10.1172/JCI1316; Shiloah J, 2000, J PERIODONTOL, V71, P562, DOI 10.1902/jop.2000.71.4.562; Thiele GM, 2012, INT IMMUNOPHARMACOL, V13, P424, DOI 10.1016/j.intimp.2012.05.007; van Winkelhoff AJ, 2002, J CLIN PERIODONTOL, V29, P1023, DOI 10.1034/j.1600-051X.2002.291107.x; Wegner N, 2010, ARTHRITIS RHEUM-US, V62, P2662, DOI 10.1002/art.27552; Wegner N, 2010, IMMUNOL REV, V233, P34, DOI 10.1111/j.0105-2896.2009.00850.x; Wegner N, 2009, INT J BIOCHEM CELL B, V41, P390, DOI 10.1016/j.biocel.2008.09.012; Willis V, 2011, J IMMUNOL, V186, P4396, DOI 10.4049/jimmunol.1001620	48	71	72	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100838	10.1371/journal.pone.0100838	http://dx.doi.org/10.1371/journal.pone.0100838			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959715	Green Published, gold			2022-12-27	WOS:000338633900094
J	Pisapia, C; Pratchett, MS				Pisapia, Chiara; Pratchett, Morgan S.			Spatial Variation in Background Mortality among Dominant Coral Taxa on Australia's Great Barrier Reef	PLOS ONE			English	Article							SCLERACTINIAN CORALS; BUILDING CORALS; POCILLOPORA-DAMICORNIS; ARTIFICIAL INJURIES; ACROPORA-HYACINTHUS; POPULATION-DYNAMICS; LOCAL VARIABILITY; FRENCH-POLYNESIA; CLIMATE-CHANGE; SIZE STRUCTURE	Even in the absence of major disturbances (e.g., cyclones, bleaching), corals are consistently subject to high levels of background mortality, which undermines individual fitness and resilience of coral colonies. Partial mortality may impact coral response to climate change by reducing colony ability to recover between major acute stressors. This study quantified proportion of injured versus uninjured colonies (the prevalence of injuries) and instantaneous measures of areal extent of injuries across individual colonies (the severity of injuries), in four common coral species along the Great Barrier Reef in Australia: massive Porites, encrusting Montipora, Acropora hyacinthus and Pocillopora damicornis. A total of 2,276 adult colonies were surveyed three latitudinal sectors, nine reefs and 27 sites along 1000 km(2) on the Great Barrier Reef. The prevalence of injuries was very high, especially for Porites spp (91%) and Montipora encrusting (85%) and varied significantly, but most lay at small spatial scales (e.g., among colonies positioned <10-m apart). Similarly, severity of background partial mortality was surprisingly high (between 5% and 21%) but varied greatly among colonies within the same site and habitat. This study suggests that intraspecific variation in partial mortality between adjacent colonies may be more important than variation between colonies in different latitudinal sectors or reefs. Differences in the prevalence and severity of background partial mortality have significant ramifications for coral capacity to cope with increasing acute disturbances, such as climate-induced coral bleaching. These data are important for understanding coral responses to increasing stressors, and in particular for predicting their capacity to recover between subsequent disturbances.	[Pisapia, Chiara; Pratchett, Morgan S.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Pisapia, Chiara] James Cook Univ, Sch Marine Biol, Australian Inst Marine Sci, AIMS JCU, Townsville, Qld 4811, Australia	James Cook University; Australian Institute of Marine Science; James Cook University	Pisapia, C (corresponding author), James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	chiara.pisapia@my.jcu.edu.au	Pratchett, Morgan/AAW-5179-2020; Pratchett, Morgan S/A-9256-2010	Pratchett, Morgan/0000-0002-1862-8459; Pratchett, Morgan S/0000-0002-1862-8459	ARC Centre of Excellence for Coral Reef Studies, Townsville; AIMS@JCU, Townsville	ARC Centre of Excellence for Coral Reef Studies, Townsville(Australian Research Council); AIMS@JCU, Townsville	This project was supported by the ARC Centre of Excellence for Coral Reef Studies, Townsville, and AIMS@JCU, Townsville. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjeroud M, 2007, HYDROBIOLOGIA, V589, P117, DOI 10.1007/s10750-007-0726-2; BABCOCK RC, 1991, ECOL MONOGR, V61, P225, DOI 10.2307/2937107; BAK RPM, 1983, MAR BIOL, V77, P221, DOI 10.1007/BF00395810; Bak RPM, 1998, MAR ECOL PROG SER, V162, P301, DOI 10.3354/meps162301; BAK RPM, 1980, B MAR SCI, V30, P883; BAK RPM, 1980, OECOLOGIA, V47, P145, DOI 10.1007/BF00346812; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bonaldo RM, 2011, CORAL REEFS, V30, P259, DOI 10.1007/s00338-010-0669-3; BROWN BE, 1985, ADV MAR BIOL, V22, P1, DOI 10.1016/S0065-2881(08)60049-8; Bruckner A. W, 2006, Rev. biol. trop, V54, P45; Bruckner AW, 2012, REV BIOL TROP, V60, P39; Bruckner AW, 2009, DIS AQUAT ORGAN, V87, P19, DOI 10.3354/dao02120; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Bythell JC, 2000, MAR ECOL PROG SER, V204, P93, DOI 10.3354/meps204093; BYTHELL JC, 1993, CORAL REEFS, V12, P143, DOI 10.1007/BF00334474; Connell J.H., 1973, P205; Connell JH, 1997, CORAL REEFS, V16, pS101, DOI 10.1007/s003380050246; Connell JH, 1997, ECOL MONOGR, V67, P461, DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; Cumming RL, 2002, MAR ECOL PROG SER, V242, P131, DOI 10.3354/meps242131; D'Croz L, 2004, CORAL REEFS, V23, P473, DOI 10.1007/s00338-004-0397-7; Darling ES, 2012, ECOL LETT, V15, P1378, DOI 10.1111/j.1461-0248.2012.01861.x; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; Denis V, 2011, MAR ECOL PROG SER, V428, P105, DOI 10.3354/meps09060; Dikou A, 2006, MAR POLLUT BULL, V52, P269, DOI 10.1016/j.marpolbul.2005.08.021; DONE TJ, 1988, MAR BIOL, V100, P51, DOI 10.1007/BF00392954; DONE TJ, 1991, CORAL REEFS, V9, P183, DOI 10.1007/BF00290420; Fisher EM, 2007, MAR ECOL PROG SER, V339, P61, DOI 10.3354/meps339061; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Gilmour JP, 2013, SCIENCE, V340, P69, DOI 10.1126/science.1232310; Ginsburg RN, 2001, B MAR SCI, V69, P1149; Halford A, 2004, ECOLOGY, V85, P1892, DOI 10.1890/03-4017; Hall VR, 1997, J EXP MAR BIOL ECOL, V212, P9, DOI 10.1016/S0022-0981(96)02760-8; Hall VR, 1996, ECOLOGY, V77, P950, DOI 10.2307/2265514; HARRIOTT VJ, 1985, MAR ECOL PROG SER, V21, P81, DOI 10.3354/meps021081; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Henry LA, 2005, INT REV HYDROBIOL, V90, P125, DOI 10.1002/iroh.200410759; HIGHSMITH RC, 1980, OECOLOGIA, V46, P322, DOI 10.1007/BF00346259; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1989, ECOLOGY, V70, P275, DOI 10.2307/1938434; Hughes TP, 1999, NATURE, V397, P59, DOI 10.1038/16237; HUGHES TP, 1985, ECOL MONOGR, V55, P141, DOI 10.2307/1942555; HUGHES TP, 1984, AM NAT, V123, P778, DOI 10.1086/284239; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; HUGHES TP, 1980, SCIENCE, V209, P713, DOI 10.1126/science.209.4457.713; HUTCHINGS PA, 1986, CORAL REEFS, V4, P239, DOI 10.1007/BF00298083; Jackson J.B.C., 1979, Systematics Association Special Volume Series, P499; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; JOKIEL PL, 1990, CORAL REEFS, V8, P155, DOI 10.1007/BF00265006; KARLSON RH, 1993, CORAL REEFS, V12, P117, DOI 10.1007/BF00334469; Knowlton N, 1990, CASE STUDY NATURAL P; Linares C, 2011, MAR ECOL PROG SER, V438, P97, DOI 10.3354/meps09272; Lirman D, 2013, ECOL INDIC, DOI [10.1016/2013/10021, DOI 10.1016/2013/10021]; LOYA Y, 1976, NATURE, V261, P490, DOI 10.1038/261490a0; Meesters E.H., 1992, P 7 INT COR REEF S, V2, P681; MEESTERS EH, 1994, MAR ECOL PROG SER, V112, P119, DOI 10.3354/meps112119; Meesters EH, 1997, J SEA RES, V37, P131, DOI 10.1016/S1385-1101(96)00004-4; Meesters EH, 1996, B MAR SCI, V58, P838; Nugues MM, 2003, MAR POLLUT BULL, V46, P314, DOI 10.1016/S0025-326X(02)00402-2; Nystrom M, 2001, ECOSYSTEMS, V4, P406, DOI 10.1007/s10021-001-0019-y; Oliver J, 1985, P 5 INT COR REEF C, V4, P201; Osborne K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017516; Pisapia C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091529; Pratchett MS, 2013, MAR ENVIRON RES, V86, P29, DOI 10.1016/j.marenvres.2013.02.007; Rinkevich B., 1989, ENV QUAL ECOSYSTEM S, V4, P257; ROBERTS HH, 1982, J SEDIMENT PETROL, V52, P145; STIMSON J, 1985, ECOLOGY, V66, P40, DOI 10.2307/1941305; Sweatman H, 2011, CORAL REEFS, V30, P521, DOI 10.1007/s00338-010-0715-1; TANNER JE, 1994, ECOLOGY, V75, P2204, DOI 10.2307/1940877; Titlyanov EA, 2005, J EXP MAR BIOL ECOL, V323, P27, DOI 10.1016/j.jembe.2005.02.015; Toh TC, 2013, B MAR SCI, V89, P583, DOI 10.5343/bms.2012.1089; Trapon ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057788; Trapon Melanie L., 2011, Journal of Marine Biology, V2011, P1, DOI 10.1155/2011/807625; VANVEGHEL MLJ, 1994, MAR ECOL PROG SER, V109, P229, DOI 10.3354/meps109229; Veron J, 1984, AUST I MAR SCI MONOG, V6, P485; Wakeford M, 2008, CORAL REEFS, V27, P1, DOI 10.1007/s00338-007-0284-0; Wesseling I, 2001, INT REV HYDROBIOL, V86, P77, DOI 10.1002/1522-2632(200101)86:1<77::AID-IROH77>3.0.CO;2-7; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; YAP HT, 1992, MAR ECOL PROG SER, V83, P91, DOI 10.3354/meps083091	80	6	6	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100969	10.1371/journal.pone.0100969	http://dx.doi.org/10.1371/journal.pone.0100969			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959921	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000338633900107
J	Sangalli, JR; Chiaratti, MR; De Bem, THC; de Araujo, RR; Bressan, FF; Sampaio, RV; Perecin, F; Smith, LC; King, WA; Meirelles, FV				Sangalli, Juliano Rodrigues; Chiaratti, Marcos Roberto; Camara De Bem, Tiago Henrique; de Araujo, Reno Roldi; Bressan, Fabiana Fernandes; Sampaio, Rafael Vilar; Perecin, Felipe; Smith, Lawrence Charles; King, Willian Allan; Meirelles, Flavio Vieira			Development to Term of Cloned Cattle Derived from Donor Cells Treated with Valproic Acid	PLOS ONE			English	Article							NUCLEAR TRANSFER EMBRYOS; IN-VITRO DEVELOPMENT; HISTONE DEACETYLASE; STEM-CELLS; GENE-EXPRESSION; BOVINE EMBRYOS; SIGNIFICANT IMPROVEMENT; ACETYLATION PATTERNS; PERINATAL LETHALITY; CLONING EFFICIENCY	Cloning of mammals by somatic cell nuclear transfer (SCNT) is still plagued by low efficiency. The epigenetic modifications established during cellular differentiation are a major factor determining this low efficiency as they act as epigenetic barriers restricting reprogramming of somatic nuclei. In this regard, most factors that promote chromatin decondensation, including histone deacetylase inhibitors (HDACis), have been found to increase nuclear reprogramming efficiency, making their use common to improve SCNT rates. Herein we used valproic acid (VPA) in SCNT to test whether the treatment of nuclear donor cells with this HDACi improves pre- and post-implantation development of cloned cattle. We found that the treatment of fibroblasts with VPA increased histone acetylation without affecting DNA methylation. Moreover, the treatment with VPA resulted in increased expression of IGF2R and PPARGC1A, but not of POU5F1. However, when treated cells were used as nuclear donors no difference of histone acetylation was found after oocyte reconstruction compared to the use of untreated cells. Moreover, shortly after artificial activation the histone acetylation levels were decreased in the embryos produced with VPA-treated cells. With respect to developmental rates, the use of treated cells as donors resulted in no difference during pre-and post-implantation development. In total, five clones developed to term; three produced with untreated cells and two with VPA-treated cells. Among the calves from treated group, one stillborn calf was delivered at day 270 of gestation whereas the other one was delivered at term but died shortly after birth. Among the calves from the control group, one died seven days after birth whereas the other two are still alive and healthy. Altogether, these results show that in spite of the alterations in fibroblasts resulting from the treatment with VPA, their use as donor cells in SCNT did not improve pre- and post-implantation development of cloned cattle.	[Sangalli, Juliano Rodrigues; Camara De Bem, Tiago Henrique; de Araujo, Reno Roldi; Bressan, Fabiana Fernandes; Sampaio, Rafael Vilar; Perecin, Felipe; Meirelles, Flavio Vieira] Univ Sao Paulo, Fac Zootecnia & Engn Alimentos, Dept Vet Med, Sao Paulo, Brazil; [Sangalli, Juliano Rodrigues; Chiaratti, Marcos Roberto; de Araujo, Reno Roldi; Sampaio, Rafael Vilar] Univ Sao Paulo, Fac Med Vet & Zootecnia, Dept Cirurgia, Sao Paulo, Brazil; [Sangalli, Juliano Rodrigues; Sampaio, Rafael Vilar; King, Willian Allan] Univ Guelph, Ontario Vet Coll, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada; [Chiaratti, Marcos Roberto] Univ Fed Sao Carlos, Ctr Ciencias Biol & Saude, Dept Genet & Evolucao, BR-13560 Sao Carlos, SP, Brazil; [Camara De Bem, Tiago Henrique] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Genet, Sao Paulo, Brazil; [Smith, Lawrence Charles] Univ Montreal, Fac Med Vet, Ctr Rech Reprod Anim, St Hyacinthe, PQ J2S 7C6, Canada	Universidade de Sao Paulo; Universidade de Sao Paulo; University of Guelph; Universidade Federal de Sao Carlos; Universidade de Sao Paulo; Universite de Montreal	Sangalli, JR (corresponding author), Univ Sao Paulo, Fac Zootecnia & Engn Alimentos, Dept Vet Med, Sao Paulo, Brazil.	jrsh5n1@yahoo.com.br	De Bem, Tiago Henrique Camara/K-4780-2016; Sangalli, Juliano Rodrigues/C-1834-2013; Smith, Lawrence C/K-4658-2012; Smith, Lawrence/AAP-4321-2021; Sampaio, Rafael RVS/B-5354-2013; Bressan, Fabiana F./C-6679-2012; Meirelles, Flavio V/B-5048-2010; Perecin, Felipe/C-7268-2012; Chiaratti, Marcos R/C-2727-2012; CTC USP, CEPID 13 18/J-8951-2014	Smith, Lawrence/0000-0001-8766-0148; Sampaio, Rafael RVS/0000-0002-8227-8510; Bressan, Fabiana F./0000-0001-9862-5874; Meirelles, Flavio V/0000-0003-0372-4920; Perecin, Felipe/0000-0003-2009-5863; Chiaratti, Marcos R/0000-0001-8805-9469; Henrique Camara De Bem, Tiago/0000-0001-5969-6514; CTC USP, CEPID 13 18/0000-0002-7123-9524	Sao Paulo Research Foundation (FAPESP) [2013/06673-7, 2011/51126-9, 2010/13384-3, 2010/19768-8]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	JRS is supported by Sao Paulo Research Foundation (FAPESP), grant number 2013/06673-7, and previously by Coordination for the Improvement of Higher Level Personnel (CAPES/DFAIT). This work was granted by Sao Paulo Research Foundation (FAPESP; grant numbers 2011/51126-9, 2010/13384-3, 2010/19768-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi S, 2013, ANIM SCI J, V84, P191, DOI 10.1111/asj.12035; Amold DR, 2008, PLACENTA, V29, pS108, DOI 10.1016/j.placenta.2007.11.010; Aouali N, 2009, BRIT J HAEMATOL, V147, P662, DOI 10.1111/j.1365-2141.2009.07902.x; Austin S, 2012, J CELL SCI, V125, P4963, DOI 10.1242/jcs.113662; Baqir S, 2006, CLONING STEM CELLS, V8, P200, DOI 10.1089/clo.2006.8.200; Boiani M, 2002, GENE DEV, V16, P1209, DOI 10.1101/gad.966002; Bortvin A, 2003, DEVELOPMENT, V130, P1673, DOI 10.1242/dev.00366; Campbell K H, 1999, Cloning, V1, P3, DOI 10.1089/15204559950020058; Chavatte-Palmer P, 2012, PLACENTA, V33, pS99, DOI 10.1016/j.placenta.2011.09.012; Chiang MC, 2013, NEUROSCIENCE, V229, P118, DOI 10.1016/j.neuroscience.2012.11.003; Costa-Borges N, 2010, CELL REPROGRAM, V12, P437, DOI 10.1089/cell.2009.0108; Das ZC, 2010, CELL REPROGRAM, V12, P95, DOI 10.1089/cell.2009.0068; Dean W, 2001, P NATL ACAD SCI USA, V98, P13734, DOI 10.1073/pnas.241522698; Detich N, 2003, J BIOL CHEM, V278, P27586, DOI 10.1074/jbc.M303740200; Ding X, 2008, THERIOGENOLOGY, V70, P622, DOI 10.1016/j.theriogenology.2008.04.042; Enright BP, 2005, BIOL REPROD, V72, P944, DOI 10.1095/biolreprod.104.033225; Enright BP, 2003, BIOL REPROD, V69, P896, DOI 10.1095/biolreprod.103.017954; Feil R, 1998, MAMM GENOME, V9, P831, DOI 10.1007/s003359900876; Felisbino MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029144; Galli C, 2014, THERIOGENOLOGY, V81, P138, DOI 10.1016/j.theriogenology.2013.09.008; Gao TL, 2007, CELL RES, V17, P135, DOI 10.1038/cr.2007.2; Gaspar-Maia A, 2011, NAT REV MOL CELL BIO, V12, P36, DOI 10.1038/nrm3036; Giraldo AM, 2007, MOL REPROD DEV, V74, P1514, DOI 10.1002/mrd.20740; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Gurdon JB, 2008, SCIENCE, V322, P1811, DOI 10.1126/science.1160810; Gurdon JB, 2011, COLD SPRING HARB PER, V3; Hagemann LJ, 1998, MOL REPROD DEV, V50, P154, DOI 10.1002/(SICI)1098-2795(199806)50:2&lt;154::AID-MRD5&gt;3.0.CO;2-J; Hezroni H, 2011, J BIOL CHEM, V286, P35977, DOI 10.1074/jbc.M111.266254; Hill JR, 2000, BIOL REPROD, V63, P1787, DOI 10.1095/biolreprod63.6.1787; Hu JF, 2000, ENDOCRINOLOGY, V141, P4428, DOI 10.1210/en.141.12.4428; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Johnson AK, 2010, JAVMA-J AM VET MED A, V236, P983, DOI 10.2460/javma.236.9.983; Jullien J, 2011, NAT REV MOL CELL BIO, V12, P453, DOI 10.1038/nrm3140; Kang JD, 2013, THERIOGENOLOGY, V79, P306, DOI 10.1016/j.theriogenology.2012.08.021; Kim YJ, 2011, IN VITRO CELL DEV-AN, V47, P283, DOI 10.1007/s11626-011-9394-7; Kishigami S, 2006, BIOCHEM BIOPH RES CO, V340, P183, DOI 10.1016/j.bbrc.2005.11.164; LAU MMH, 1994, GENE DEV, V8, P2953, DOI 10.1101/gad.8.24.2953; Lee MJ, 2011, J REPROD DEVELOP, V57, P34, DOI 10.1262/jrd.10-012A; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ludwig T, 1996, DEV BIOL, V177, P517, DOI 10.1006/dbio.1996.0182; Marchion DC, 2005, CANCER RES, V65, P3815, DOI 10.1158/0008-5472.CAN-04-2478; Martinez-Diaz MA, 2010, CELL REPROGRAM, V12, P85, DOI 10.1089/cell.2009.0047; Meirelles FV, 2010, REPROD FERT DEVELOP, V22, P88, DOI 10.1071/RD09229; Miranda MD, 2009, CLONING STEM CELLS, V11, P565, DOI 10.1089/clo.2009.0028; Miyoshi K, 2010, CELL REPROGRAM, V12, P67, DOI 10.1089/cell.2009.0032; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nasser LF, 2004, THERIOGENOLOGY, V62, P1577, DOI 10.1016/j.theriogenology.2004.03.013; Ogura A, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0329; Ono T, 2010, BIOL REPROD, V83, P929, DOI 10.1095/biolreprod.110.085282; Pasque V, 2011, TRENDS GENET, V27, P516, DOI 10.1016/j.tig.2011.08.002; Perecin F, 2009, GENET MOL RES, V8, P76, DOI 10.4238/vol8-1gmr541; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Sangalli JR, 2012, CELL REPROGRAM, V14, P235, DOI 10.1089/cell.2011.0079; Santos F, 2003, CURR BIOL, V13, P1116, DOI 10.1016/S0960-9822(03)00419-6; Selokar NL, 2013, CELL REPROGRAM, V15, P531, DOI 10.1089/cell.2013.0018; Shi W, 2003, BIOL REPROD, V69, P301, DOI 10.1095/biolreprod.102.012112; Simonsson S, 2004, NAT CELL BIOL, V6, P984, DOI 10.1038/ncb1176; Smith LC, 2012, REPROD DOMEST ANIM, V47, P107, DOI 10.1111/j.1439-0531.2012.02063.x; Suzuki J, 2011, BIOL REPROD, V84, P947, DOI 10.1095/biolreprod.110.087833; Teng HF, 2010, J CELL BIOCHEM, V110, P995, DOI 10.1002/jcb.22613; Turner BM, 2007, NAT CELL BIOL, V9, P2, DOI 10.1038/ncb0107-2; VerMilyea MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006086; Wee G, 2006, J BIOL CHEM, V281, P6048, DOI 10.1074/jbc.M511340200; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Wilmut I, 2002, NATURE, V419, P583, DOI 10.1038/nature01079; Xu WB, 2012, CELL REPROGRAM, V14, P138, DOI 10.1089/cell.2011.0084; Yang FK, 2007, REPRODUCTION, V133, P219, DOI 10.1530/rep.1.01206; Yang XZ, 2007, NAT GENET, V39, P295, DOI 10.1038/ng1973; Young LE, 2003, MECH DEVELOP, V120, P1433, DOI 10.1016/j.mod.2003.09.006; Young LE, 2001, NAT GENET, V27, P153, DOI 10.1038/84769; Zhao JG, 2010, CELL REPROGRAM, V12, P75, DOI 10.1089/cell.2009.0038; Zhao JG, 2009, BIOL REPROD, V81, P525, DOI 10.1095/biolreprod.109.077016; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	75	33	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e101022	10.1371/journal.pone.0101022	http://dx.doi.org/10.1371/journal.pone.0101022			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959750	gold, Green Published, Green Submitted			2022-12-27	WOS:000338633900111
J	Kokkinopoulou, M; Guler, MA; Lieb, B; Barbeck, M; Ghanaati, S; Markl, J				Kokkinopoulou, Maria; Gueler, M. Alptekin; Lieb, Bernhard; Barbeck, Mike; Ghanaati, Shahram; Markl, Jurgen			3D-Ultrastructure, Functions and Stress Responses of Gastropod (Biomphalaria glabrata) Rhogocytes	PLOS ONE			English	Article							KEYHOLE LIMPET HEMOCYANIN; PORE CELLS; CONNECTIVE-TISSUE; SALIVARY-GLANDS; NEPHRIN; PROTEIN; ACTIN; HEMOGLOBIN; MOLECULES; EVOLUTION	Rhogocytes are pore cells scattered among the connective tissue of different body parts of gastropods and other molluscs, with great variation in their number, shape and size. They are enveloped by a lamina of extracellular matrix. Their most characteristic feature is the "slit apparatus", local invaginations of the plasma membrane bridged by cytoplasmic bars, forming slits of ca. 20 nm width. A slit diaphragm creates a molecular sieve with permeation holes of 20620 nm. In blue-blooded gastropods, rhogocytes synthesize and secrete the respiratory protein hemocyanin, and it has been proposed-though not proven-that in the rare red-blooded snail species they might synthesize and secrete the hemoglobin. However, the cellular secretion pathway for respiratory proteins, and the functional role(s) of the enigmatic rhogocyte slit apparatus are still unclear. Additional functions for rhogocytes have been proposed, notably a role in protein uptake and degradation, and in heavy metal detoxification. Here we provide new structural and functional information on the rhogocytes of the red-blooded freshwater snail Biomphalaria glabrata. By in situ hybridization of mantle tissues, we prove that rhogocytes indeed synthesize hemoglobin. By electron tomography, the first three dimensional (3D) reconstructions of the slit apparatus are provided, showing detail of highly dense material in the cytoplasmic bars close to the slits. By immunogold labelling, we collected evidence that a major component of this material is actin. By genome databank mining, the complete sequence of a B. glabrata nephrin was obtained, and localized to the rhogocytes by immunofluorescence microscopy. The presence of both proteins fit the ultrastructure-based hypothesis that rhogocytes are related to mammalian podocytes and insect nephrocytes. Reactions of the rhogocytes to deprivation of food and cadmium toxification are also documented, and a possible secretion pathway of newly synthesized respiratory proteins through the slit apparatus is discussed.	[Kokkinopoulou, Maria; Gueler, M. Alptekin; Lieb, Bernhard; Markl, Jurgen] Johannes Gutenberg Univ Mainz, Inst Zool, Mainz, Germany; [Barbeck, Mike; Ghanaati, Shahram] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Pathol, D-55122 Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Markl, J (corresponding author), Johannes Gutenberg Univ Mainz, Inst Zool, Saarstr 21, Mainz, Germany.	markl@uni-mainz.de	Lieb, Bernhard/AFT-2157-2022; Barbeck, Mike/U-4340-2018	Barbeck, Mike/0000-0002-3001-1347; Ghanaati, Shahram/0000-0002-7897-0854; Guler, Alptekin/0000-0001-7073-2125	Max Planck Graduate Center (MPGC) of the Johannes Gutenberg University, Mainz, Germany; Electron Microscopy Center Mainz (EMZM) of the Johannes Gutenberg University	Max Planck Graduate Center (MPGC) of the Johannes Gutenberg University, Mainz, Germany; Electron Microscopy Center Mainz (EMZM) of the Johannes Gutenberg University	This work was funded in part by the Max Planck Graduate Center (MPGC) of the Johannes Gutenberg University, Mainz, Germany (MK: grant; JM: consumables, instruments) and the Electron Microscopy Center Mainz (EMZM) of the Johannes Gutenberg University (JM: instruments). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht T, 2001, CELL TISSUE RES, V304, P455, DOI 10.1007/s004410100368; BANI G, 1990, Z MIKROSK ANAT FORSC, V104, P856; Baumeister W, 1999, TRENDS CELL BIOL, V9, P81, DOI 10.1016/S0962-8924(98)01423-8; BOER HH, 1976, CELL TISSUE RES, V170, P221; Brugge J, 1999, AM J PHYSIOL-REG I, V276, pR347, DOI 10.1152/ajpregu.1999.276.2.R347; BRUMMENDORF T, 1994, PROTEIN PROFILE, V1, P951; Dallinger R, 2005, AM J PHYSIOL-REG I, V289, pR1185, DOI 10.1152/ajpregu.00052.2005; DANSCHER G, 1981, HISTOCHEMISTRY, V71, P1, DOI 10.1007/BF00592566; De Carlo S, 2011, MICRON, V42, P117, DOI 10.1016/j.micron.2010.06.003; Decker H, 2000, TRENDS BIOCHEM SCI, V25, P392, DOI 10.1016/S0968-0004(00)01602-9; FIORONI P, 1984, ZOOL ANZ, V212, P193; FOURNIE J, 1982, MALACOLOGIA, V22, P265; Garg P, 2007, MOL CELL BIOL, V27, P8698, DOI 10.1128/MCB.00948-07; Gatsogiannis C, 2009, J MOL BIOL, V385, P963, DOI 10.1016/j.jmb.2008.10.080; Ghanaati S, 2011, ACTA BIOMATER, V7, P4018, DOI 10.1016/j.actbio.2011.07.003; Ghanaati S, 2010, ACTA BIOMATER, V6, P4476, DOI 10.1016/j.actbio.2010.07.006; Ghanaati S, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/3/035005; HANAICHI T, 1986, J ELECTRON MICROSC, V35, P304; Handke B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067208; Harris JR, 2002, MICRON, V33, P461, DOI 10.1016/S0968-4328(01)00039-7; Haszprunar G, 1996, J MOLLUS STUD, V62, P185, DOI 10.1093/mollus/62.2.185; HELMY S, 1986, CELL, V44, P497, DOI 10.1016/0092-8674(86)90471-X; Ichimura K, 2003, J HISTOCHEM CYTOCHEM, V51, P1589, DOI 10.1177/002215540305101203; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; LESSARD JL, 1988, CELL MOTIL CYTOSKEL, V10, P349, DOI 10.1002/cm.970100302; Lieb B, 2004, J MOL EVOL, V59, P536, DOI 10.1007/s00239-004-2646-3; Lieb B, 2006, P NATL ACAD SCI USA, V103, P12011, DOI 10.1073/pnas.0601861103; Marigomez I, 2002, MICROSC RES TECHNIQ, V56, P358, DOI 10.1002/jemt.10040; MARIGOMEZ JA, 1990, HISTOCHEMISTRY, V94, P191, DOI 10.1007/BF02440187; Markl J, 2013, BBA-PROTEINS PROTEOM, V1834, P1840, DOI 10.1016/j.bbapap.2013.02.020; Martin AM, 2011, INVERTEBR BIOL, V130, P302, DOI 10.1111/j.1744-7410.2011.00249.x; McIntosh R, 2005, TRENDS CELL BIOL, V15, P43, DOI 10.1016/j.tcb.2004.11.009; Meister G., 1977, Zoologische Jb (Anat), V97, P54; Moeller V, 2011, IUBMB LIFE, V63, P323, DOI 10.1002/iub.453; Nott JA, 1993, J MAR BIOL ASSOC UK, V13, P396; Patrakka J, 2007, TRENDS MOL MED, V13, P396, DOI 10.1016/j.molmed.2007.06.006; Raghavan N, 2006, TRENDS PARASITOL, V22, P148, DOI 10.1016/j.pt.2006.02.008; RUPPERT EE, 1994, AM ZOOL, V34, P542; Sato T, 1968, J Electron Microsc (Tokyo), V17, P158; Saur M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043685; Schaffeld M, 2004, METHOD CELL BIOL, V78, P627; Schneider SW, 2001, J MEMBRANE BIOL, V181, P67; Segawa A, 1998, CELL TISSUE RES, V291, P325, DOI 10.1007/s004410051002; SKELDING JM, 1975, CELL TISSUE RES, V156, P381; SMINIA T, 1972, Z ZELLFORSCH MIK ANA, V130, P497, DOI 10.1007/BF00307004; SMINIA T, 1972, Z ZELLFORSCH MIK ANA, V135, P563, DOI 10.1007/BF00583437; SMINIA T, 1973, Z ZELLFORSCH MIK ANA, V145, P443, DOI 10.1007/BF00307166; SMINIA T, 1977, CELL TISSUE RES, V183, P299; Stewart H, 2014, INVERTEBR BIOL, V133, P47, DOI 10.1111/ivb.12041; Streit K, 2005, DIFFERENTIATION, V73, P341, DOI 10.1111/j.1432-0436.2005.00035.x; Sudhof T. C., 2011, CSH PERSPECT BIOL, V3, P3, DOI DOI 10.1101/CSHPERSPECT.A005637; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Wartiovaara J, 2004, J CLIN INVEST, V114, P1475, DOI 10.1172/JCI200422562; Weavers H, 2009, NATURE, V457, P322, DOI 10.1038/nature07526; Wolfrum U, 2000, CELL MOTIL CYTOSKEL, V46, P95, DOI 10.1002/1097-0169(200006)46:2<95::AID-CM2>3.0.CO;2-Q; WOOD EJ, 1981, COMP BIOCHEM PHYS B, V69, P877, DOI 10.1016/0305-0491(81)90398-9; Yan K, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000013297.11876.5B; Zampighi GA, 1999, J GEN PHYSIOL, V113, P507, DOI 10.1085/jgp.113.4.507; Zhuang SF, 2009, DEVELOPMENT, V136, P2335, DOI 10.1242/dev.031609	61	18	18	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e101078	10.1371/journal.pone.0101078	http://dx.doi.org/10.1371/journal.pone.0101078			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971744	Green Published, gold, Green Submitted			2022-12-27	WOS:000338512200089
J	Shi, Y; Ivannikov, MV; Walsh, ME; Liu, YH; Zhang, YQ; Jaramillo, CA; Macleod, GT; Van Remmen, H				Shi, Yun; Ivannikov, Maxim V.; Walsh, Michael E.; Liu, Yuhong; Zhang, Yiqiang; Jaramillo, Carlos A.; Macleod, Gregory T.; Van Remmen, Holly			The Lack of CuZnSOD Leads to Impaired Neurotransmitter Release, Neuromuscular Junction Destabilization and Reduced Muscle Strength in Mice	PLOS ONE			English	Article							SPINAL MUSCULAR-ATROPHY; SKELETAL-MUSCLE; SUPEROXIDE-DISMUTASE; MOUSE MODEL; OXIDATIVE STRESS; KNOCKOUT MICE; MOTOR-NEURONS; ION CHANNELS; SYNAPSE; TRANSMISSION	Elevated reactive oxygen species (ROS) production and ROS-dependent protein damage is a common observation in the pathogenesis of many muscle wasting disorders, including sarcopenia. However, the contribution of elevated ROS levels to -a breakdown in neuromuscular communication and muscle atrophy remains unknown. In this study, we examined a copper zinc superoxide dismutase [CuZnSOD (Sod1)] knockout mouse (Sod1(-/-)), a mouse model of elevated oxidative stress that exhibits accelerated loss of muscle mass, which recapitulates many phenotypes of sarcopenia as early as 5 months of age. We found that young adult Sod1(-/-) mice display a considerable reduction in hind limb skeletal muscle mass and strength when compared to age-matched wild-type mice. These changes are accompanied by gross alterations in neuromuscular junction (NMJ) morphology, including reduced occupancy of the motor endplates by axons, terminal sprouting and axon thinning and irregular swelling. Surprisingly however, the average density of acetylcholine receptors in endplates is preserved. Using in vivo electromyography and ex vivo electrophysiological studies of hind limb muscles in Sod1(-/-) mice, we found that motor axons innervating the extensor digitorum longus (EDL) and gastrocnemius muscles release fewer synaptic vesicles upon nerve stimulation. Recordings from individually identified EDL NMJs show that reductions in neurotransmitter release are apparent in the Sod1(-/-) mice even when endplates are close to fully innervated. However, electrophysiological properties, such as input resistance, resting membrane potential and spontaneous neurotransmitter release kinetics (but not frequency) are similar between EDL muscles of Sod1(-/-) and wild-type mice. Administration of the potassium channel blocker 3,4-diaminopyridine, which broadens the presynaptic action potential, improves both neurotransmitter release and muscle strength. Together, these results suggest that ROS-associated motor nerve terminal dysfunction is a contributor to the observed muscle changes in Sod1(-/-) mice.	[Shi, Yun; Ivannikov, Maxim V.; Walsh, Michael E.; Liu, Yuhong; Zhang, Yiqiang; Van Remmen, Holly] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA; [Shi, Yun; Walsh, Michael E.; Liu, Yuhong; Van Remmen, Holly] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Shi, Yun; Liu, Yuhong; Jaramillo, Carlos A.] South Texas Vet Hlth Care Syst, Geriatr Res Educ & Clin Ctr, San Antonio, TX USA; [Ivannikov, Maxim V.; Zhang, Yiqiang; Macleod, Gregory T.] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA; [Jaramillo, Carlos A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Rehabil Med, San Antonio, TX 78229 USA; [Van Remmen, Holly] Oklahoma City VA Med Ctr, Oklahoma City, OK USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Oklahoma System; University of Oklahoma Health Sciences Center	Van Remmen, H (corresponding author), Florida Atlantic Univ, Dept Biol Sci, Jupiter, FL 33458 USA.	holly-vanremmen@omrf.org	Zhang, Yiqiang/AAA-3143-2019	Macleod, Gregory/0000-0003-3782-6968	NIH [AG020591, NS061914, T32-AG021890]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061914] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG020591, T32AG021890] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002595] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	This study was supported by NIH grants AG020591 to HVR, NS061914 to GTM and T32-AG021890 to MVI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekseenko AV, 2008, BRAIN RES, V1241, P193, DOI 10.1016/j.brainres.2008.09.012; BORODIC GE, 1994, MOVEMENT DISORD, V9, P31, DOI 10.1002/mds.870090106; Buck M, 1996, EMBO J, V15, P1753, DOI 10.1002/j.1460-2075.1996.tb00524.x; Cai SQ, 2009, NAT NEUROSCI, V12, P611, DOI 10.1038/nn.2291; Chen J, 2012, J COMP NEUROL, V520, P434, DOI 10.1002/cne.22764; Chiarugi P, 2001, J BIOL CHEM, V276, P33478, DOI 10.1074/jbc.M102302200; Crawley JN, 1999, BRAIN RES, V835, P18, DOI 10.1016/S0006-8993(98)01258-X; Dachs E, 2011, J NEUROPATH EXP NEUR, V70, P444, DOI 10.1097/NEN.0b013e31821cbd8b; DUVAL A, 1985, PFLUG ARCH EUR J PHY, V403, P407, DOI 10.1007/BF00589254; Elchuri S, 2005, ONCOGENE, V24, P367, DOI 10.1038/sj.onc.1208207; Fischer LR, 2011, BRAIN, V134, P196, DOI 10.1093/brain/awq314; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Flood DG, 1999, AM J PATHOL, V155, P663, DOI 10.1016/S0002-9440(10)65162-0; Frey D, 2000, J NEUROSCI, V20, P2534; Fulle S, 2004, EXP GERONTOL, V39, P17, DOI 10.1016/j.exger.2003.09.012; Giniatullin AR, 2006, J NEUROCHEM, V98, P1789, DOI 10.1111/j.1471-4159.2006.03997.x; Gordon T, 2004, NEUROL RES, V26, P174, DOI 10.1179/016164104225013806; Gould TW, 2006, J NEUROSCI, V26, P8774, DOI 10.1523/JNEUROSCI.2315-06.2006; Guo XF, 2005, NEURON, V47, P379, DOI 10.1016/j.neuron.2005.06.027; Ivannikov MV, 2013, J MOL NEUROSCI, V49, P223, DOI 10.1007/s12031-012-9848-8; Jang YC, 2012, AGING CELL, V11, P770, DOI 10.1111/j.1474-9726.2012.00843.x; Jang YC, 2010, FASEB J, V24, P1376, DOI 10.1096/fj.09-146308; Kaja S, 2007, EUR J NEUROSCI, V25, P2009, DOI 10.1111/j.1460-9568.2007.05438.x; Kassmann M, 2008, PFLUG ARCH EUR J PHY, V456, P1085, DOI 10.1007/s00424-008-0477-6; Kong LL, 2009, J NEUROSCI, V29, P842, DOI 10.1523/JNEUROSCI.4434-08.2009; Kostrominova TY, 2010, FREE RADICAL BIO MED, V49, P1582, DOI 10.1016/j.freeradbiomed.2010.08.022; Larkin LM, 2011, AM J PHYSIOL-REG I, V301, pR1400, DOI 10.1152/ajpregu.00093.2011; Li YP, 2003, AM J PHYSIOL-CELL PH, V285, pC806, DOI 10.1152/ajpcell.00129.2003; Li Y, 2011, J NEUROSCI, V31, P14910, DOI 10.1523/JNEUROSCI.3590-11.2011; Ly CV, 2006, NEUROSCIENTIST, V12, P291, DOI 10.1177/1073858406287661; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Mansouri A, 2006, MECH AGEING DEV, V127, P298, DOI 10.1016/j.mad.2005.11.004; McClung JM, 2009, AM J PHYSIOL-CELL PH, V296, pC363, DOI 10.1152/ajpcell.00497.2008; MCLACHLAN EM, 1981, J PHYSIOL-LONDON, V311, P307, DOI 10.1113/jphysiol.1981.sp013586; Mori S, 2012, J NEUROIMMUNOL, V245, P75, DOI 10.1016/j.jneuroim.2012.02.010; Morsch M, 2013, J PHYSIOL-LONDON, V591, P2747, DOI 10.1113/jphysiol.2013.251827; Muller FL, 2006, FREE RADICAL BIO MED, V40, P1993, DOI 10.1016/j.freeradbiomed.2006.01.036; Murray LM, 2008, HUM MOL GENET, V17, P949, DOI 10.1093/hmg/ddm367; Naumenko N, 2011, FRONT CELL NEUROSCI, V5, DOI 10.3389/fncel.2011.00026; Oh SS, 2010, NEUROSCI LETT, V483, P127, DOI 10.1016/j.neulet.2010.07.076; Rozas JL, 2011, J NEUROSCI, V31, P1106, DOI 10.1523/JNEUROSCI.2011-10.2011; Sakellariou GK, 2014, FASEB J, V28, P1666, DOI 10.1096/fj.13-240390; Sasaki T, 2008, AGING CELL, V7, P459, DOI 10.1111/j.1474-9726.2008.00394.x; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SPECTOR SA, 1985, J NEUROSCI, V5, P2189; Tsentsevitsky A, 2011, NEUROSCIENCE, V189, P93, DOI 10.1016/j.neuroscience.2011.05.033; Urbano FJ, 2014, AM J PHYSIOL-CELL PH, V306, pC396, DOI 10.1152/ajpcell.00301.2013; Valdez G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034640; Valdez G, 2010, P NATL ACAD SCI USA, V107, P14863, DOI 10.1073/pnas.1002220107; vanLunteren E, 1996, J APPL PHYSIOL, V81, P2214, DOI 10.1152/jappl.1996.81.5.2214; Vasilaki A, 2010, AGING CELL, V9, P979, DOI 10.1111/j.1474-9726.2010.00635.x; Zhang YQ, 2013, FASEB J, V27, P3536, DOI 10.1096/fj.13-228130	52	38	38	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100834	10.1371/journal.pone.0100834	http://dx.doi.org/10.1371/journal.pone.0100834			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971750	Green Published, Green Submitted, gold			2022-12-27	WOS:000338512200066
J	Wang, HY; Zhao, GH; Chen, GY; Jian, FC; Zhang, SM; Feng, C; Wang, RJ; Zhu, JF; Dong, HJ; Hua, J; Wang, M; Zhang, LX				Wang, Haiyan; Zhao, Guanghui; Chen, Gongyi; Jian, Fuchun; Zhang, Sumei; Feng, Chao; Wang, Rongjun; Zhu, Jinfeng; Dong, Haiju; Hua, Jun; Wang, Ming; Zhang, Longxian			Multilocus Genotyping of Giardia duodenalis in Dairy Cattle in Henan, China	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; CRYPTOSPORIDIUM SPP.; GENETIC CHARACTERIZATIONS; ENTEROCYTOZOON-BIENEUSI; ZOONOTIC TRANSMISSION; PREVALENCE; INFECTIONS; CALVES; IDENTIFICATION; EPIDEMIOLOGY	Giardia duodenalis is a common and widespread intestinal protozoan parasite of both humans and animals. Previous epidemiological and molecular studies have identified Giardia infections in different animals and humans, but only limited information is available about the occurrence and genotypes of Giardia in cattle in China. In this study, we determined the occurrence of giardiasis and genetically characterized G. duodenalis in dairy cattle in Henan Province, central China. The overall prevalence of G. duodenalis was 7.2% (128/1777) on microscopic analysis, with the highest infection rate (22.7%) in calves aged less than 1 month. G. duodenalis assemblages and subtypes were identified with multilocus genotyping based on the SSU rRNA, beta-giardin (bg), glutamate dehydrogenase (gdh), and triosephosphate isomerase (tpi) genes. Two assemblages were detected in the successfully sequenced samples: assemblage A (n = 58), assemblage E (n = 21), with a mixed E and A assemblage (n = 2). Four novel subtypes of the gdh gene and seven of the bg gene were found among the G. duodenalis assemblage E isolates. Using the nomenclature for the multilocus genotype (MLG) model, nine novel multilocus genotypes E (MLGs E1-E9) and three MLGs A (a novel subtype AI, previously detected subtype AII-1, and a combination of both) were identified. MLG AII-1 identified in this study may be an important zoonotic subtype. The dairy cattle in Henan are a potential public health concern.	[Wang, Haiyan; Jian, Fuchun; Zhang, Sumei; Feng, Chao; Wang, Rongjun; Dong, Haiju; Zhang, Longxian] Henan Agr Univ, Coll Anim Sci & Vet Med, Zhengzhou, Henan Province, Peoples R China; [Wang, Haiyan; Chen, Gongyi; Zhu, Jinfeng; Hua, Jun] Henan Vocat Coll Agr, Dept Anim Sci, Zhongmu, Henan Province, Peoples R China; [Wang, Haiyan; Wang, Ming] China Agr Univ, Coll Vet Med, Beijing 100094, Peoples R China; [Zhao, Guanghui] Northwest A&F Univ, Coll Vet Med, Yangling, Shanxi Province, Peoples R China	Henan Agricultural University; China Agricultural University; Northwest A&F University - China	Zhang, LX (corresponding author), Henan Agr Univ, Coll Anim Sci & Vet Med, Zhengzhou, Henan Province, Peoples R China.	zhanglx8999@gmail.com	Zhang, Longxian/R-7799-2019; Zhang, Longxian/I-9223-2019; Zhang, Longxian/HGE-1918-2022	Zhang, Longxian/0000-0002-5706-131X; 	State Key Program of National Natural Science Foundation of China [31330079]; funds for the International Cooperation and Exchange of the National Natural Science Foundation of China [31110103901]; Program for Science&Technology Innovation Talents in Universities of Henan Province [134200510012]; Key National Science and Technology Specific Projects [2012ZX10004220-001]	State Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); funds for the International Cooperation and Exchange of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Science&Technology Innovation Talents in Universities of Henan Province; Key National Science and Technology Specific Projects	This study was supported in part by the State Key Program of National Natural Science Foundation of China (31330079), http://www.nsfc.gov.cn/publish/portal0/default.htm; the funds for the International Cooperation and Exchange of the National Natural Science Foundation of China (No. 31110103901), http://www.nsfc.gov.cn/nsfc/cen/gjhzj/index.html; the Program for Science&Technology Innovation Talents in Universities of Henan Province (134200510012), http://www.hnkjt.gov.cn/new/; and the Key National Science and Technology Specific Projects (No. 2012ZX10004220-001), http://www.nmp.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appelbee AJ, 2003, VET PARASITOL, V112, P289, DOI 10.1016/S0304-4017(02)00422-3; Becher KA, 2004, VET PARASITOL, V123, P1, DOI 10.1016/j.vetpar.2004.05.020; Caccio SM, 2008, INT J PARASITOL, V38, P1523, DOI 10.1016/j.ijpara.2008.04.008; Caccio SA, 2002, INT J PARASITOL, V32, P1023, DOI 10.1016/S0020-7519(02)00068-1; Castro-Hermida JA, 2006, J VET MED B, V53, P244, DOI 10.1111/j.1439-0450.2006.00946.x; Coklin T, 2007, VET PARASITOL, V150, P297, DOI 10.1016/j.vetpar.2007.09.014; Geurden T, 2008, VET PARASITOL, V153, P384, DOI 10.1016/j.vetpar.2008.01.031; Geurden T, 2008, INT J PARASITOL, V38, P259, DOI 10.1016/j.ijpara.2007.07.016; Geurden T, 2010, EXP PARASITOL, V124, P98, DOI 10.1016/j.exppara.2009.03.001; Huetink REC, 2001, VET PARASITOL, V102, P53, DOI 10.1016/S0304-4017(01)00514-3; Lalle M, 2005, INT J PARASITOL, V35, P207, DOI 10.1016/j.ijpara.2004.10.022; Langkjaer RB, 2007, PARASITOLOGY, V134, P339, DOI 10.1017/S0031182006001533; Lasek-Nesselquist E, 2010, INT J PARASITOL, V40, P1063, DOI 10.1016/j.ijpara.2010.02.015; Lebbad M, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001262; Lebbad M, 2010, VET PARASITOL, V168, P231, DOI 10.1016/j.vetpar.2009.11.003; Li J, 2012, VET PARASITOL, V188, P368, DOI 10.1016/j.vetpar.2012.04.004; Li W, 2013, EXP PARASITOL, V135, P223, DOI 10.1016/j.exppara.2013.07.009; Liu AQ, 2012, PARASITOL RES, V111, P655, DOI 10.1007/s00436-012-2883-0; Mark-Carew MP, 2012, VET PARASITOL, V185, P151, DOI 10.1016/j.vetpar.2011.09.030; MAYRHOFER G, 1995, PARASITOLOGY, V111, P11, DOI 10.1017/S0031182000064556; Mendonca C, 2007, VET PARASITOL, V147, P47, DOI 10.1016/j.vetpar.2007.03.019; Monis PT, 2003, INFECT GENET EVOL, V3, P29, DOI 10.1016/S1567-1348(02)00149-1; O'Handley RM, 1999, J AM VET MED ASSOC, V214, P391; Quilez J, 1996, VET PARASITOL, V66, P139, DOI 10.1016/S0304-4017(96)01015-1; Read CM, 2004, INFECT GENET EVOL, V4, P125, DOI 10.1016/j.meegid.2004.02.001; Santin M, 2004, VET PARASITOL, V122, P103, DOI 10.1016/j.vetpar.2004.03.020; Santin M, 2009, VET PARASITOL, V162, P40, DOI 10.1016/j.vetpar.2009.02.008; Smith HV, 2006, TRENDS PARASITOL, V22, P160, DOI 10.1016/j.pt.2006.02.009; Sprong H, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000558; Sulaiman IM, 2003, EMERG INFECT DIS, V9, P1444, DOI 10.3201/eid0911.030084; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Gomez-Munoz MT, 2012, RES VET SCI, V93, P836, DOI 10.1016/j.rvsc.2011.12.012; Thompson RCA, 2004, VET PARASITOL, V126, P15, DOI 10.1016/j.vetpar.2004.09.008; Trout JM, 2004, VET PARASITOL, V124, P179, DOI 10.1016/j.vetpar.2004.07.010; Trout JM, 2005, VET PARASITOL, V130, P177, DOI 10.1016/j.vetpar.2005.03.032; Wade SE, 2000, VET PARASITOL, V93, P1, DOI 10.1016/S0304-4017(00)00337-X; Wade SE, 2000, VET PARASITOL, V89, P11, DOI 10.1016/S0304-4017(99)00228-9; Wang L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002437; Wang RJ, 2011, EXP PARASITOL, V127, P42, DOI 10.1016/j.exppara.2010.06.034; Winkworth CL, 2008, NEW ZEAL VET J, V56, P15, DOI 10.1080/00480169.2008.36799; Winkworth CL, 2008, APPL ENVIRON MICROB, V74, P5100, DOI 10.1128/AEM.00232-08; Xiao LH, 2008, INT J PARASITOL, V38, P1239, DOI 10.1016/j.ijpara.2008.03.006; Ye JB, 2014, PARASITOL INT, V63, P132, DOI 10.1016/j.parint.2013.10.007; Ye JB, 2012, EMERG INFECT DIS, V18, P1640, DOI 10.3201/eid1810.120653; Zhang WZ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001826; Zhang WZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031262	47	54	62	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100453	10.1371/journal.pone.0100453	http://dx.doi.org/10.1371/journal.pone.0100453			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971639	gold, Green Published, Green Submitted			2022-12-27	WOS:000338512200033
J	Wu, HY; Chen, CY; Lai, EM				Wu, Hung-Yi; Chen, Chao-Ying; Lai, Erh-Min			Expression and Functional Characterization of the Agrobacterium VirB2 Amino Acid Substitution Variants in T-pilus Biogenesis, Virulence, and Transient Transformation Efficiency	PLOS ONE			English	Article							IV SECRETION SYSTEM; TUMEFACIENS; PROTEINS; PILIN; CONJUGATION; DIVERSITY	Agrobacterium tumefaciens is a phytopathogenic bacterium that causes crown gall disease by transferring transferred DNA (T-DNA) into the plant genome. The translocation process is mediated by the type IV secretion system (T4SS) consisting of the VirD4 coupling protein and 11 VirB proteins (VirB1 to VirB11). All VirB proteins are required for the production of T-pilus, which consists of processed VirB2 (T-pilin) and VirB5 as major and minor subunits, respectively. VirB2 is an essential component of T4SS, but the roles of VirB2 and the assembled T-pilus in Agrobacterium virulence and the T-DNA transfer process remain unknown. Here, we generated 34 VirB2 amino acid substitution variants to study the functions of VirB2 involved in VirB2 stability, extracellular VirB2/T-pilus production and virulence of A. tumefaciens. From the capacity for extracellular VirB2 production (ExB2(+) or ExB2(-)) and tumorigenesis on tomato stems (Vir(+) or Vir(-)), the mutants could be classified into three groups: ExB2(-)/Vir(-), ExB2(-)/Vir(+), and ExB2(+)/Vir(+). We also confirmed by electron microscopy that five ExB2(-)/Vir(+) mutants exhibited a wild-type level of virulence with their deficiency in T-pilus formation. Interestingly, although the five T-pilus(-)/Vir(+) uncoupling mutants retained a wild-type level of tumorigenesis efficiency on tomato stems and/or potato tuber discs, their transient transformation efficiency in Arabidopsis seedlings was highly attenuated. In conclusion, we have provided evidence for a role of T-pilus in Agrobacterium transformation process and have identified the domains and amino acid residues critical for VirB2 stability, T-pilus biogenesis, tumorigenesis, and transient transformation efficiency.	[Wu, Hung-Yi; Lai, Erh-Min] Acad Sinica, Inst Plant & Microbial Biol, Taipei 115, Taiwan; [Wu, Hung-Yi; Chen, Chao-Ying; Lai, Erh-Min] Natl Taiwan Univ, Dept Plant Pathol & Microbiol, Taipei 10764, Taiwan	Academia Sinica - Taiwan; National Taiwan University	Lai, EM (corresponding author), Acad Sinica, Inst Plant & Microbial Biol, Taipei 115, Taiwan.	emlai@gate.sinica.edu.tw	Lai, Erh-Min/ABG-9558-2020; Wu, Hung-Yi/HGF-2679-2022	Lai, Erh-Min/0000-0003-3630-8683; CHEN, CHAO-YING/0000-0003-0455-832X	National Science Council [NSC 101-2321-B-001 -033 -]; Academia Sinica	National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica(Academia Sinica - Taiwan)	This work was supported by a research grant from the National Science Council (NSC 101-2321-B-001 -033 -) and a grant from Academia Sinica to EML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar J, 2011, MBIO, V2, DOI 10.1128/mBio.00218-11; Aguilar J, 2010, P NATL ACAD SCI USA, V107, P3758, DOI 10.1073/pnas.0914940107; Alvarez-Martinez CE, 2009, MICROBIOL MOL BIOL R, V73, P775, DOI 10.1128/MMBR.00023-09; Aly KA, 2007, MICROBIOL-SGM, V153, P3766, DOI 10.1099/mic.0.2007/010462-0; Babic A, 2008, SCIENCE, V319, P1533, DOI 10.1126/science.1153498; Backert S, 2008, TRENDS MICROBIOL, V16, P409, DOI 10.1016/j.tim.2008.07.001; Banta LM, 2011, J BACTERIOL, V193, P2566, DOI 10.1128/JB.00038-11; Baron C, 2006, BIOCHEM CELL BIOL, V84, P890, DOI 10.1139/O06-148; BERGER BR, 1994, J BACTERIOL, V176, P3646, DOI 10.1128/JB.176.12.3646-3660.1994; Bogdanov M, 2009, J BIOL CHEM, V284, P9637, DOI 10.1074/jbc.R800081200; Cameron TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042219; Cascales E, 2004, SCIENCE, V304, P1170, DOI 10.1126/science.1095211; Cascales E, 2013, J BACTERIOL, V195, P2691, DOI 10.1128/JB.00114-13; Chandran V, 2009, NATURE, V462, P1011, DOI 10.1038/nature08588; Christie PJ, 2001, MOL MICROBIOL, V40, P294, DOI 10.1046/j.1365-2958.2001.02302.x; Eisenbrandt R, 1999, J BIOL CHEM, V274, P22548, DOI 10.1074/jbc.274.32.22548; Fronzes R, 2009, SCIENCE, V323, P266, DOI 10.1126/science.1166101; Garza I, 2013, J BACTERIOL, V195, P3022, DOI 10.1128/JB.00287-13; Gelvin SB, 2010, ANNU REV PHYTOPATHOL, V48, P45, DOI 10.1146/annurev-phyto-080508-081852; Hayes CS, 2010, ANNU REV GENET, V44, P71, DOI 10.1146/annurev.genet.42.110807.091449; Jakubowski SJ, 2009, MOL MICROBIOL, V71, P779, DOI 10.1111/j.1365-2958.2008.06565.x; Jakubowski SJ, 2005, J BACTERIOL, V187, P3486, DOI 10.1128/JB.187.10.3486-3495.2005; Jakubowski SJ, 2003, J BACTERIOL, V185, P2867, DOI 10.1128/JB.185.9.2867-2878.2003; Julio Salinas JJS-S, 2006, METHODS MOL BIOL; KADO CI, 1970, PHYTOPATHOLOGY, V60, P969, DOI 10.1094/Phyto-60-969; Kalkum M, 2004, CURR PROTEIN PEPT SC, V5, P417, DOI 10.2174/1389203043379639; Kerr JE, 2010, J BACTERIOL, V192, P4923, DOI 10.1128/JB.00557-10; Kwok T, 2007, NATURE, V449, P862, DOI 10.1038/nature06187; Lacroix B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025578; Lai EM, 2000, J BACTERIOL, V182, P3705, DOI 10.1128/JB.182.13.3705-3716.2000; Lai EM, 2000, TRENDS MICROBIOL, V8, P361, DOI 10.1016/S0966-842X(00)01802-3; Lai EM, 1998, J BACTERIOL, V180, P2711, DOI 10.1128/JB.180.10.2711-2717.1998; Lai EM, 2002, FEMS MICROBIOL LETT, V210, P111, DOI 10.1111/j.1574-6968.2002.tb11168.x; Lai EM, 2002, J BACTERIOL, V184, P327, DOI 10.1128/JB.184.1.327-330.2002; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lawley TD, 2003, FEMS MICROBIOL LETT, V224, P1, DOI 10.1016/S0378-1097(03)00430-0; Li GL, 2012, MOL MICROBIOL, V83, P41, DOI 10.1111/j.1365-2958.2011.07909.x; Lin JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067647; Low HH, 2014, NATURE, V508, P550, DOI 10.1038/nature13081; McCullen CA, 2006, ANNU REV CELL DEV BI, V22, P101, DOI 10.1146/annurev.cellbio.22.011105.102022; Narasimhulu SB, 1996, PLANT CELL, V8, P873, DOI 10.1105/tpc.8.5.873; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schmidt-Eisenlohr H, 1999, J BACTERIOL, V181, P7485, DOI 10.1128/JB.181.24.7485-7492.1999; SHIRASU K, 1993, FEMS MICROBIOL LETT, V111, P287, DOI 10.1111/j.1574-6968.1993.tb06400.x; Shu AC, 2008, LANGMUIR, V24, P6796, DOI 10.1021/la703384n; Thanassi DG, 2012, FEMS MICROBIOL REV, V36, P1046, DOI 10.1111/j.1574-6976.2012.00342.x; Wang YA, 2009, J MOL BIOL, V385, P22, DOI 10.1016/j.jmb.2008.10.054; Wu HY, 2008, J BACTERIOL, V190, P2841, DOI 10.1128/JB.01775-07; Wu HY, 2014, PLANT METHO IN PRESS	50	6	6	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e101142	10.1371/journal.pone.0101142	http://dx.doi.org/10.1371/journal.pone.0101142			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971727	Green Published, gold, Green Submitted			2022-12-27	WOS:000338512200097
J	Zaafar, DK; Zaitone, SA; Moustafa, YM				Zaafar, Dalia K.; Zaitone, Sawsan A.; Moustafa, Yasser M.			Role of Metformin in Suppressing 1,2-Dimethylhydrazine-Induced Colon Cancer in Diabetic and Non-Diabetic Mice: Effect on Tumor Angiogenesis and Cell Proliferation	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; IN-VITRO; 1ST-LINE TREATMENT; COLORECTAL-CANCER; RAT-LIVER; MELLITUS; INSULIN; RISK; OXALIPLATIN; CARCINOMA	Several studies indicated that type 2 diabetes mellitus and insulin resistance are associated with increased colon cancer risk. Recently, studies suggest that metformin can reduce cancer risk in diabetic or non-diabetic patients with unclear mechanisms. This work aimed to determine the effect of metformin on chemically-induced colon cancer in mice. Colon cancer was induced using 1,2-dimethylhydrazine (DMH, 20 mg/kg/week, s.c.) for fifteen weeks. Experiment I: healthy mice were fed with basal diet for four weeks and then allocated into seven groups, (i) saline, (ii) DMH, (iii) oxaliplatin, (iv-v): metformin (100 or 200 mg/kg) and (vi-vii): oxaliplatin+metformin (100 or 200 mg/kg), respectively. Experiment II: type 2 diabetes mellitus was induced by injection of STZ (30 mg/kg) after four weeks of high-fat feeding and then mice were allocated into seven groups similar to those reported in experiment I. Examination of the colonic tissue at the end of the experiment highlighted an increase in angiogenic markers and cell proliferation and showed a greater immunostaining for insulin growth factor I receptors and CD34 in the colon of diabetic mice compared to non-diabetics. In general, metformin downregulated tumor angiogenesis and augmented the antitumor effect of oxaliplatin. Overall, the current results showed that metformin protected against DMH-induced colon cancer in non-diabetic and diabetic mice. This therapeutic effect was, at least in part, attributed to its anti-angiogenic and anti-proliferative mechanisms.	[Zaafar, Dalia K.] Directorate Hlth & Populat, Ismailia, Egypt; [Zaitone, Sawsan A.; Moustafa, Yasser M.] Suez Canal Univ, Fac Pharm, Dept Pharmacol & Toxicol, Ismailia, Egypt	Egyptian Knowledge Bank (EKB); Suez Canal University	Zaitone, SA (corresponding author), Directorate Hlth & Populat, Ismailia, Egypt.	Sawsan_zaytoon@pharm.suez.edu.eg	Zaitone, Sawsan A/G-8930-2017; Moustafa, Yasser/AAS-1212-2021; Zaafar, Dalia/T-2301-2019	Zaitone, Sawsan A/0000-0002-9688-7683; Moustafa, Yasser/0000-0001-5394-5559; Zaafar, Dalia/0000-0002-7201-3658				Anisimov VN, 2005, EXP GERONTOL, V40, P685, DOI 10.1016/j.exger.2005.07.007; Arcaro A, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00030; Awata T, 2002, DIABETES, V51, P1635, DOI 10.2337/diabetes.51.5.1635; Banchroft J.D., 1996, THEORY PRACTICE HIST; Barone BB, 2008, JAMA-J AM MED ASSOC, V300, P2754, DOI 10.1001/jama.2008.824; Bhattacharyya S, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.005967; Bowker SL, 2006, DIABETES CARE, V29, P254, DOI 10.2337/diacare.29.02.06.dc05-1558; Boyd D Barry, 2003, Integr Cancer Ther, V2, P315, DOI 10.1177/1534735403259152; Castleden, 1979, J CANC, V39, P731; Chiarelli F, 2000, DIABETIC MED, V17, P650, DOI 10.1046/j.1464-5491.2000.00350.x; Colussi C, 2001, J NATL CANCER I, V93, P1534, DOI 10.1093/jnci/93.20.1534; Coughlin SS, 2004, AM J EPIDEMIOL, V159, P1160, DOI 10.1093/aje/kwh161; de Gramont A, 2000, J CLIN ONCOL, V18, P2938, DOI 10.1200/JCO.2000.18.16.2938; El-Serag HB, 2006, CLIN GASTROENTEROL H, V4, P369, DOI 10.1016/j.cgh.2005.12.007; Engel S, 2003, NEW ENGL J MED, V348, P2294; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; EVERHART J, 1995, JAMA-J AM MED ASSOC, V273, P1605, DOI 10.1001/jama.273.20.1605; Ferguson RD, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3089; FERRARA N, 1992, ENDOCR REV, V13, P18, DOI 10.1210/er.13.1.18; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Friberg E, 2007, DIABETOLOGIA, V50, P1365, DOI 10.1007/s00125-007-0681-5; Gerstein HC, 2010, JAMA-J AM MED ASSOC, V303, P446, DOI 10.1001/jama.2010.60; Giacchetti S, 2000, J CLIN ONCOL, V18, P136, DOI 10.1200/JCO.2000.18.1.136; Haisa M, 2013, J INT MED RES, V41, P253, DOI 10.1177/0300060513476585; Hanahan D, 1998, NAT MED, V4, P13, DOI 10.1038/nm0198-013; HAYES MA, 1987, CARCINOGENESIS, V8, P1155, DOI 10.1093/carcin/8.8.1155; Hirsch HA, 2009, CANCER RES, V69, P7507, DOI 10.1158/0008-5472.CAN-09-2994; Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3; Hosono K, 2010, MOL CARCINOGEN, V49, P662, DOI 10.1002/mc.20637; Hvid H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079710; Ikemura M, 2013, J CONTROL RELEASE, V170, P191, DOI 10.1016/j.jconrel.2013.05.028; Inoue M, 2006, ARCH INTERN MED, V166, P1871, DOI 10.1001/archinte.166.17.1871; Ito K, 2013, CANCER SCI, V104, P835, DOI 10.1111/cas.12162; Jackson PE, 1999, CARCINOGENESIS, V20, P509, DOI 10.1093/carcin/20.3.509; Janjetovic K, 2011, EUR J PHARMACOL, V668, P373, DOI 10.1016/j.ejphar.2011.07.004; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jiralerspong S, 2009, J CLIN ONCOL, V27, P3297, DOI 10.1200/JCO.2009.19.6410; Kisfalvi K, 2009, CANCER RES, V69, P6539, DOI 10.1158/0008-5472.CAN-09-0418; Larsson SC, 2005, JNCI-J NATL CANCER I, V97, P1679, DOI 10.1093/jnci/dji375; LEWIS JG, 1982, CANCER RES, V42, P89; Libby G, 2009, DIABETES CARE, V32, P1620, DOI 10.2337/dc08-2175; Liu J, 2013, UROL ONCOL-SEMIN ORI, V31, P264, DOI 10.1016/j.urolonc.2011.01.003; Martin A, 2003, MED RES REV, V23, P117, DOI 10.1002/med.10024; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McFarland MS, 2010, PHARMACOTHERAPY, V30, P1159, DOI 10.1592/phco.30.11.1159; Memmott RM, 2010, CANCER PREV RES, V3, P1066, DOI 10.1158/1940-6207.CAPR-10-0055; Michels KB, 2003, DIABETES CARE, V26, P1752, DOI 10.2337/diacare.26.6.1752; Micic D, 2011, HORM-INT J ENDOCRINO, V10, P5, DOI 10.14310/horm.2002.1288; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Oh JS, 2002, NEOPLASIA, V4, P204, DOI 10.1038/sj.neo.7900229; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Rattan R, 2011, NEOPLASIA, V13, P483, DOI 10.1593/neo.11148; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Renehan AG, 2004, LANCET, V363, P1346, DOI 10.1016/S0140-6736(04)16044-3; Rothenberg ML, 2000, ONCOLOGY-NY, V14, P9; Saito T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070010; Shank JJ, 2012, GYNECOL ONCOL, V127, P390, DOI 10.1016/j.ygyno.2012.07.115; Srinivasan K, 2005, PHARMACOL RES, V52, P313, DOI 10.1016/j.phrs.2005.05.004; Stenina OI, 2005, CURR PHARM DESIGN, V11, P2367, DOI 10.2174/1381612054367283; Vigneri P, 2009, ENDOCR-RELAT CANCER, V16, P1103, DOI 10.1677/ERC-09-0087; Will JC, 1998, AM J EPIDEMIOL, V147, P816, DOI 10.1093/oxfordjournals.aje.a009534; Yabe Y, 2001, J PHARMACOL EXP THER, V298, P894; Yilmaz A, 1999, J ANIM SCI, V77, P835; YING TS, 1979, CHEM-BIOL INTERACT, V28, P363, DOI 10.1016/0009-2797(79)90176-5	64	55	57	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100562	10.1371/journal.pone.0100562	http://dx.doi.org/10.1371/journal.pone.0100562			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971882	gold, Green Published, Green Submitted			2022-12-27	WOS:000338512200042
J	Bianchini, P; Cardarelli, F; Di Luca, M; Diaspro, A; Bizzarri, R				Bianchini, Paolo; Cardarelli, Francesco; Di Luca, Mariagrazia; Diaspro, Alberto; Bizzarri, Ranieri			Nanoscale Protein Diffusion by STED-Based Pair Correlation Analysis	PLOS ONE			English	Article							ARGININE-RICH MOTIF; CORRELATION SPECTROSCOPY; CROSS-CORRELATION; NUCLEAR-ENVELOPE; PARTICLES CLPS; IN-VITRO; MICROSCOPY; DYNAMICS; DISPLAY; VIVO	We describe for the first time the combination between cross-pair correlation function analysis (pair correlation analysis or pCF) and stimulated emission depletion (STED) to obtain diffusion maps at spatial resolution below the optical diffraction limit (super-resolution). Our approach was tested in systems characterized by high and low signal to noise ratio, i.e. Capsid Like Particles (CLPs) bearing several (>100) active fluorescent proteins and monomeric fluorescent proteins transiently expressed in living Chinese Hamster Ovary cells, respectively. The latter system represents the usual condition encountered in living cell studies on fluorescent protein chimeras. Spatial resolution of STED-pCF was found to be about 110 nm, with a more than twofold improvement over conventional confocal acquisition. We successfully applied our method to highlight how the proximity to nuclear envelope affects the mobility features of proteins actively imported into the nucleus in living cells. Remarkably, STED-pCF unveiled the existence of local barriers to diffusion as well as the presence of a slow component at distances up to 500-700 nm from either sides of nuclear envelope. The mobility of this component is similar to that previously described for transport complexes. Remarkably, all these features were invisible in conventional confocal mode.	[Bianchini, Paolo; Diaspro, Alberto; Bizzarri, Ranieri] Italian Inst Technol, Genoa, Italy; [Cardarelli, Francesco] Ist Italiano Tecnol, Ctr Nanotechnol Innovat NEST, Pisa, Italy; [Di Luca, Mariagrazia; Bizzarri, Ranieri] Scuola Normale Super Pisa, NEST, Pisa, Italy; [Di Luca, Mariagrazia; Bizzarri, Ranieri] CNR, Ist Nanosci, I-56100 Pisa, Italy; [Bizzarri, Ranieri] CNR, Ist Biofis, I-56100 Pisa, Italy	Istituto Italiano di Tecnologia - IIT; Istituto Italiano di Tecnologia - IIT; Scuola Normale Superiore di Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto Nanoscienze (NANO-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR)	Diaspro, A (corresponding author), Italian Inst Technol, Genoa, Italy.	alberto.diaspro@iit.it; r.bizzarri@sns.it	Diaspro, Alberto/E-7833-2010; Bizzarri, Ranieri/ABH-8343-2020; Bianchini, Paolo/A-9500-2008; Bizzarri, Ranieri/H-1779-2011	Diaspro, Alberto/0000-0002-4916-5928; Bianchini, Paolo/0000-0001-6457-751X; Bizzarri, Ranieri/0000-0002-8222-2672; Di Luca, Mariagrazia/0000-0002-0688-034X	Regione Toscana; Bando Salute; PRIN [2010BJ23MN_004]	Regione Toscana(Regione Toscana); Bando Salute; PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This work was supported by the Regione Toscana under the framework of the project "New diagnostic strategies from nano-engineered viral capsid proteins'', Bando Salute 2009 and by the PRIN project 2010BJ23MN_004 "Nanostructured Soft Matter: from Fundamental Research to Novel Applications''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bizzarri R, 2012, ANAL BIOANAL CHEM, V403, P2339, DOI 10.1007/s00216-012-6025-4; Brinkmeier M, 1999, ANAL CHEM, V71, P609, DOI 10.1021/ac980820i; Cardarelli F, 2008, TRAFFIC, V9, P528, DOI 10.1111/j.1600-0854.2007.00696.x; Cardarelli F, 2007, MOL THER, V15, P1313, DOI 10.1038/sj.mt.6300172; Cardarelli F, 2012, P NATL ACAD SCI USA, V109, P9863, DOI 10.1073/pnas.1200486109; Cardarelli F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010475; Cardarelli F, 2009, J BIOL CHEM, V284, P36638, DOI 10.1074/jbc.M109.036699; Digman MA, 2005, BIOPHYS J, V89, P1317, DOI 10.1529/biophysj.105.062836; Digman MA, 2008, BIOPHYS J, V94, P2819, DOI 10.1529/biophysj.107.104984; Digman MA, 2011, ANNU REV PHYS CHEM, V62, P645, DOI 10.1146/annurev-physchem-032210-103424; Digman MA, 2009, WIRES SYST BIOL MED, V1, P273, DOI 10.1002/wsbm.5; Digman MA, 2009, BIOPHYS J, V97, P665, DOI 10.1016/j.bpj.2009.04.048; Donnert G, 2006, P NATL ACAD SCI USA, V103, P11440, DOI 10.1073/pnas.0604965103; Eggeling C, 2009, NATURE, V457, P1159, DOI 10.1038/nature07596; Hedde PN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3093; Hell SW, 2009, NAT METHODS, V6, P24, DOI [10.1038/NMETH.1291, 10.1038/nmeth.1291]; Hess ST, 2002, BIOCHEMISTRY-US, V41, P697, DOI 10.1021/bi0118512; Hinde E, 2011, BIOPHYS J, V100, P67; Hinde E, 2010, P NATL ACAD SCI USA, V107, P16560, DOI 10.1073/pnas.1006731107; Hotta JI, 2010, J AM CHEM SOC, V132, P5021, DOI 10.1021/ja100079w; Kratz PA, 1999, P NATL ACAD SCI USA, V96, P1915, DOI 10.1073/pnas.96.5.1915; Leutenegger M, 2010, OPT EXPRESS, V18, P26417, DOI 10.1364/OE.18.026417; Linkert M, 2010, J CELL BIOL, V189, P777, DOI 10.1083/jcb.201004104; Moneron G, 2010, OPT EXPRESS, V18, P1302, DOI 10.1364/OE.18.001302; Mueller V, 2011, BIOPHYS J, V101, P1651, DOI 10.1016/j.bpj.2011.09.006; Rankin BR, 2011, BIOPHYS J, V100, pL63, DOI 10.1016/j.bpj.2011.05.020; Ries J, 2006, BIOPHYS J, V91, P1915, DOI 10.1529/biophysj.106.082297; Ringemann C, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/10/103054; Stewart CL, 2007, SCIENCE, V318, P1408, DOI 10.1126/science.1142034; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; Vicidomini G, 2011, NAT METHODS, V8, P571, DOI [10.1038/NMETH.1624, 10.1038/nmeth.1624]; Vogel M, 2005, FEBS LETT, V579, P5211, DOI 10.1016/j.febslet.2005.08.044; Vogel M, 2005, PROTEINS, V58, P478, DOI 10.1002/prot.20312; Weidemann T, 2002, SINGLE MOL, V3, P49, DOI 10.1002/1438-5171(200204)3:1<49::AID-SIMO49>3.3.CO;2-K; Wessels JT, 2010, CYTOM PART A, V77A, P667, DOI 10.1002/cyto.a.20931	35	29	29	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e99619	10.1371/journal.pone.0099619	http://dx.doi.org/10.1371/journal.pone.0099619			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967681	Green Published, gold			2022-12-27	WOS:000338280800016
J	Lin, FH; Ahveninen, J; Raij, T; Witzel, T; Chu, YH; Jaaskelainen, IP; Tsai, KWK; Kuo, WJ; Belliveau, JW				Lin, Fa-Hsuan; Ahveninen, Jyrki; Raij, Tommi; Witzel, Thomas; Chu, Ying-Hua; Jaaskelainen, Iiro P.; Tsai, Kevin Wen-Kai; Kuo, Wen-Jui; Belliveau, John W.			Increasing fMRI Sampling Rate Improves Granger Causality Estimates	PLOS ONE			English	Article							DIRECTED TRANSFER-FUNCTION; SURFACE-BASED ANALYSIS; EFFECTIVE CONNECTIVITY; STATISTICAL ASSESSMENT; CORTICAL INTERACTIONS; NONLINEAR CAUSALITY; VISUAL PATHWAYS; FUNCTIONAL MRI; BRAIN ACTIVITY; NETWORK	Estimation of causal interactions between brain areas is necessary for elucidating large-scale functional brain networks underlying behavior and cognition. Granger causality analysis of time series data can quantitatively estimate directional information flow between brain regions. Here, we show that such estimates are significantly improved when the temporal sampling rate of functional magnetic resonance imaging (fMRI) is increased 20-fold. Specifically, healthy volunteers performed a simple visuomotor task during blood oxygenation level dependent (BOLD) contrast based whole-head inverse imaging (InI). Granger causality analysis based on raw InI BOLD data sampled at 100-ms resolution detected the expected causal relations, whereas when the data were downsampled to the temporal resolution of 2 s typically used in echo-planar fMRI, the causality could not be detected. An additional control analysis, in which we SINC interpolated additional data points to the downsampled time series at 0.1-s intervals, confirmed that the improvements achieved with the real InI data were not explainable by the increased time-series length alone. We therefore conclude that the high-temporal resolution of InI improves the Granger causality connectivity analysis of the human brain.	[Lin, Fa-Hsuan; Chu, Ying-Hua; Tsai, Kevin Wen-Kai] Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan; [Lin, Fa-Hsuan; Jaaskelainen, Iiro P.; Tsai, Kevin Wen-Kai] Aalto Univ, Dept Biomed Engn & Computat Sci, Espoo, Finland; [Ahveninen, Jyrki; Raij, Tommi; Witzel, Thomas; Belliveau, John W.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Athinoula A Martinos Ctr Biomed Imaging, Boston, MA USA; [Kuo, Wen-Jui] Natl Yang Ming Univ, Inst Neurosci, Taipei 112, Taiwan	National Taiwan University; Aalto University; Harvard University; Harvard Medical School; Massachusetts General Hospital; National Yang Ming Chiao Tung University	Lin, FH (corresponding author), Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan.	fhlin@ntu.edu.tw	Lin, Fa-Hsuan/G-6988-2012; Jaaskelainen, Iiro P/C-7392-2012; Tsai, Kevin/GQR-1990-2022; Witzel, Thomas/P-1402-2014; Witzel, Thomas/E-7276-2019	Lin, Fa-Hsuan/0000-0002-9539-1731; Jaaskelainen, Iiro P/0000-0001-6001-6950; Witzel, Thomas/0000-0002-5806-4897; Raij, Tommi/0000-0001-7439-7491	National Institutes of Health [R01MH083744, R01HD040712, R01NS037462, R01NS048279]; National Science Council, Taiwan [NSC 101-2628-B-002-005-MY3, NSC 100-2325-B-002-046]; Ministry of Economic Affairs, Taiwan [100-EC-17-A-19-S1-175]; National Health Research Institute, Taiwan [NHRI-EX102-10247EI]; Academy of Finland (the FiDiPro program); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD040712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048279] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Economic Affairs, Taiwan(Ministry of Economic Affairs, Taiwan); National Health Research Institute, Taiwan(National Health Research Institutes - Taiwan); Academy of Finland (the FiDiPro program)(Academy of Finland); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by R01MH083744, R01HD040712, R01NS037462, R01NS048279 (National Institutes of Health), NSC 101-2628-B-002-005-MY3, NSC 100-2325-B-002-046 (National Science Council, Taiwan), 100-EC-17-A-19-S1-175 (Ministry of Economic Affairs, Taiwan), NHRI-EX102-10247EI (National Health Research Institute, Taiwan), and Academy of Finland (the FiDiPro program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abler B, 2006, MAGN RESON IMAGING, V24, P181, DOI 10.1016/j.mri.2005.10.022; Astolfi L, 2004, MAGN RESON IMAGING, V22, P1457, DOI 10.1016/j.mri.2004.10.006; BELLIVEAU JW, 1991, SCIENCE, V254, P716, DOI 10.1126/science.1948051; Blinowska KJ, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.050902; Boyacioglu R, 2012, MAGN RESON MED; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bressler SL, 2011, NEUROIMAGE, V58, P323, DOI 10.1016/j.neuroimage.2010.02.059; Brovelli A, 2004, P NATL ACAD SCI USA, V101, P9849, DOI 10.1073/pnas.0308538101; Buchel C, 1999, SCIENCE, V283, P1538, DOI 10.1126/science.283.5407.1538; Buchel C, 1997, CEREB CORTEX, V7, P768, DOI 10.1093/cercor/7.8.768; Cabeza R, 1997, NEUROREPORT, V8, P3479, DOI 10.1097/00001756-199711100-00013; Chavez M, 2003, J NEUROSCI METH, V124, P113, DOI 10.1016/S0165-0270(02)00367-9; Chen YH, 2006, J NEUROSCI METH, V150, P228, DOI 10.1016/j.jneumeth.2005.06.011; Dale AM, 2000, NEURON, V26, P55, DOI 10.1016/S0896-6273(00)81138-1; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; David O, 2008, PLOS BIOL, V6, P2683, DOI 10.1371/journal.pbio.0060315; Deshpande G, 2009, NEUROIMAGE; Deshpande G, 2010, NEUROIMAGE, V52, P884, DOI 10.1016/j.neuroimage.2009.11.060; Eichler M, 2005, PHILOS T R SOC B, V360, P953, DOI 10.1098/rstb.2005.1641; Feinberg DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015710; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Friston KJ, 2000, P NATL ACAD SCI USA, V97, P7591, DOI 10.1073/pnas.97.13.7591; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Friston KJ, 2007, STAT PARAMETRIC MAPP, Vvii; GEWEKE J, 1982, J AM STAT ASSOC, V77, P304, DOI 10.2307/2287238; Glover GH, 1999, NEUROIMAGE, V9, P416, DOI 10.1006/nimg.1998.0419; Goebel R, 2003, MAGN RESON IMAGING, V21, P1251, DOI 10.1016/j.mri.2003.08.026; Gourevitch B, 2006, BIOL CYBERN, V95, P349, DOI 10.1007/s00422-006-0098-0; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Hennig J, 2007, NEUROIMAGE, V34, P212, DOI 10.1016/j.neuroimage.2006.08.036; Hesse W, 2003, J NEUROSCI METH, V124, P27, DOI 10.1016/S0165-0270(02)00366-7; Kaminski M, 2001, BIOL CYBERN, V85, P145, DOI 10.1007/s004220000235; Kayser AS, 2009, HUM BRAIN MAPP, V30, P3475, DOI 10.1002/hbm.20771; Kus R, 2004, IEEE T BIO-MED ENG, V51, P1501, DOI 10.1109/TBME.2004.827929; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; LEE AT, 1995, MAGNET RESON MED, V33, P745, DOI 10.1002/mrm.1910330602; Liao W, 2010, BIOL CYBERN, V102, P57, DOI 10.1007/s00422-009-0350-5; Lin F, NEUOIMAGE IN PRESS; Lin FH, 2008, NEUROIMAGE, V43, P297, DOI 10.1016/j.neuroimage.2008.06.038; Lin FH, 2008, NEUROIMAGE, V42, P230, DOI 10.1016/j.neuroimage.2008.04.179; Lin FH, 2006, MAGN RESON MED, V56, P787, DOI 10.1002/mrm.20997; Lin FH, 2013, NEUROIMAGE, V78, P372, DOI 10.1016/j.neuroimage.2013.04.017; Lin FH, 2009, HUM BRAIN MAPP, V30, P1877, DOI 10.1002/hbm.20772; Lin FH, 2009, RECONSTRUCTION MAGNE, P4594; Lin FH, 2009, NEUROIMAGE; Lin FH, 2013, NEUROIMAGE; Lindquist MA, 2008, STAT SINICA, V18, P1395; LIU GY, 1993, MAGNET RESON MED, V30, P764, DOI 10.1002/mrm.1910300617; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Londei Alessandro, 2006, Cogn Process, V7, P42, DOI 10.1007/s10339-005-0019-5; MCARDLE JJ, 1984, BRIT J MATH STAT PSY, V37, P234, DOI 10.1111/j.2044-8317.1984.tb00802.x; McIntosh AR, 1996, CEREB CORTEX, V6, P571, DOI 10.1093/cercor/6.4.571; MCINTOSH AR, 1994, J NEUROSCI, V14, P655; Miezin FM, 2000, NEUROIMAGE, V11, P735, DOI 10.1006/nimg.2000.0568; MILLER MW, 1984, J COMP NEUROL, V226, P184, DOI 10.1002/cne.902260204; Neumaier A, 2001, ACM T MATH SOFTWARE, V27, P27, DOI 10.1145/382043.382304; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; Ohliger MA, 2003, MAGNET RESON MED, V50, P1018, DOI 10.1002/mrm.10597; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Penny WD, 2004, NEUROIMAGE, V22, P1157, DOI 10.1016/j.neuroimage.2004.03.026; Roebroeck A, 2005, NEUROIMAGE, V25, P230, DOI 10.1016/j.neuroimage.2004.11.017; Roebroeck A, 2011, NEUROIMAGE, V58, P296, DOI 10.1016/j.neuroimage.2009.09.036; Rosen BR, 1998, P NATL ACAD SCI USA, V95, P773, DOI 10.1073/pnas.95.3.773; Sato JR, 2006, NEUROIMAGE, V31, P187, DOI 10.1016/j.neuroimage.2005.11.039; Schneider T, 2001, ACM T MATH SOFTWARE, V27, P58, DOI 10.1145/382043.382316; Seth AK, 2013, NEUROIMAGE, V65, P540, DOI 10.1016/j.neuroimage.2012.09.049; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; Valdes-Sosa PA, 2004, NEUROINFORMATICS, V2, P239, DOI 10.1385/NI:2:2:239; Valdes-Sosa PA, 2011, NEUROIMAGE, V58, P339, DOI 10.1016/j.neuroimage.2011.03.058; Wen XT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067428; Wiesinger F, 2004, MAGNET RESON MED, V52, P376, DOI 10.1002/mrm.20183; Witt ST, 2009, BRAIN IMAGING BEHAV, V3, P220, DOI 10.1007/s11682-009-9064-5; Zhou ZY, 2009, HUM BRAIN MAPP, V30, P2197, DOI 10.1002/hbm.20661	78	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100319	10.1371/journal.pone.0100319	http://dx.doi.org/10.1371/journal.pone.0100319			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968356	Green Published, Green Submitted, gold			2022-12-27	WOS:000338280800033
J	Lindblom, P; Wilhelmsson, P; Fryland, L; Matussek, A; Haglund, M; Sjowall, J; Vene, S; Nyman, D; Forsberg, P; Lindgren, PE				Lindblom, Pontus; Wilhelmsson, Peter; Fryland, Linda; Matussek, Andreas; Haglund, Mats; Sjowall, Johanna; Vene, Sirkka; Nyman, Dag; Forsberg, Pia; Lindgren, Per-Eric			Factors Determining Immunological Response to Vaccination against Tick-Borne Encephalitis Virus in Older Individuals	PLOS ONE			English	Article							NEUTRALIZING ANTIBODIES; FOLLOW-UP; SEROLOGICAL RESPONSE; TBE VACCINATION; FAR-EASTERN; VACCINES; HUMANS; PERSISTENCE; IMMUNITY; DISEASE	We performed a cross-sectional study including 533 individuals (median age 61) from the highly TBE endemic A land Islands in the archipelago between Sweden and Finland. Blood samples, questionnaires and vaccination records were obtained from all study participants. The aim was to investigate if there was any association between TBEV antibody titer and 12 health-related factors. Measurement of TBEV IgG antibodies was performed using two commercial ELISA assays (Enzygnost and Immunozym), and a third in-house rapid fluorescent focus inhibition test was used to measure TBEV neutralizing antibodies. The age of the individual and the number of vaccine doses were the two most important factors determining the immunological response to vaccination. The response to each vaccine dose declined linearly with increased age. A 35 year age difference corresponds to a vaccine dose increment from 3 to 4 to achieve the same immunological response. Participants previously vaccinated against other flaviviruses had lower odds of being seropositive for neutralizing TBEV antibodies on average, while participants with self-reported asthma had higher odds of being seropositive. By comparing the 3 serological assays we show that the Enzygnost and Immunozym assay differ due to choice of cutoffs, but not in overall accuracy.	[Lindblom, Pontus; Wilhelmsson, Peter; Lindgren, Per-Eric] Linkoping Univ, Dept Clin & Expt Med, Div Med Microbiol, Linkoping, Sweden; [Fryland, Linda; Forsberg, Pia] Linkoping Univ, Dept Clin & Expt Med, Div Infect Dis, Linkoping, Sweden; [Matussek, Andreas; Lindgren, Per-Eric] Cty Hosp Ryhov, Dept Microbiol, Div Med Serv, Jonkoping, Sweden; [Haglund, Mats] Cty Hosp Kalmar, Dept Infect Dis, Kalmar, Sweden; [Sjowall, Johanna; Forsberg, Pia] Linkoping Univ, Clin Infect Dis, Linkoping, Sweden; [Vene, Sirkka] Publ Hlth Agcy Sweden, Stockholm, Sweden; [Nyman, Dag] Aland Cent Hosp, Mariehamn, Aland, Finland	Linkoping University; Linkoping University; Linkoping University; Public Health Agency of Sweden	Lindblom, P (corresponding author), Linkoping Univ, Dept Clin & Expt Med, Div Med Microbiol, Linkoping, Sweden.	pontus.lindblom@liu.se	Matussek, Andreas/AAB-3629-2021	Sjowall, Johanna/0000-0001-5622-866X; Wilhelmsson, Peter/0000-0002-9200-2964	Swedish Research Council branch of Medicine; Medical Research Council of South-East Sweden; County Council of Ostergotland; Wilhelm and Else Stockmann Foundation; Foundation for A land Medical Research of the A land Culture Foundation; ScandTick	Swedish Research Council branch of Medicine(Swedish Research Council); Medical Research Council of South-East Sweden; County Council of Ostergotland; Wilhelm and Else Stockmann Foundation; Foundation for A land Medical Research of the A land Culture Foundation; ScandTick	This study was supported by grants from The Swedish Research Council branch of Medicine, The Medical Research Council of South-East Sweden, Grants from the County Council of Ostergotland, the Wilhelm and Else Stockmann Foundation and the Foundation for A land Medical Research of the A land Culture Foundation, and the EU Interreg IV A supported project ScandTick. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle JH, 2013, AGE, V35, P371, DOI 10.1007/s11357-011-9371-9; Andersson CR, 2010, VACCINE, V28, P2827, DOI 10.1016/j.vaccine.2010.02.001; Arnson Y, 2010, J AUTOIMMUN, V34, pJ258, DOI 10.1016/j.jaut.2009.12.003; Aspinall Richard, 2007, Immun Ageing, V4, P9, DOI 10.1186/1742-4933-4-9; Baldovin T, 2012, J MED VIROL, V84, P1274, DOI 10.1002/jmv.23313; Bender A, 2004, J NEUROL, V251, P353, DOI 10.1007/s00415-004-0329-z; Brossard M, 2004, PARASITOLOGY, V129, pS161, DOI 10.1017/S0031182004004834; Ecker M, 1999, J GEN VIROL, V80, P179, DOI 10.1099/0022-1317-80-1-179; Enmarker I, 2012, SCAND J PUBLIC HEALT, V40, P718, DOI 10.1177/1403494812465031; European Centre for Disease Prevention and Control, 2012, EP SIT TICK BORN ENC; Fritz R, 2012, VACCINE, V30, P1165, DOI 10.1016/j.vaccine.2011.12.013; Fryland L, 2011, INT J INFECT DIS, V15, pE174, DOI 10.1016/j.ijid.2010.10.006; Gritsun TS, 2003, ANTIVIR RES, V57, P129, DOI 10.1016/S0166-3542(02)00206-1; Haglund M, 2003, J MED VIROL, V71, P610, DOI 10.1002/jmv.10497; Haglund M, 1996, SCAND J INFECT DIS, V28, P217, DOI 10.3109/00365549609027160; Hainz U, 2005, VACCINE, V23, P3232, DOI 10.1016/j.vaccine.2005.01.085; Heinz FX, 2013, EMERG INFECT DIS, V19, P69, DOI 10.3201/eid1901.120458; Holgate ST, 2012, NAT MED, V18, P673, DOI 10.1038/nm.2731; Ishikawa T, 2014, VACCINE, V32, P1326, DOI 10.1016/j.vaccine.2014.01.040; Itariu BK, 2014, GERONTOLOGY, V60, P189, DOI 10.1159/000356747; Jaaskelainen A., 2011, EpiNorth - Journal of the Network for Communicable Disease Control in Northern and Eastern Europe, V12, P40; Jilkova E, 2009, EXPERT OPIN BIOL TH, V9, P797, DOI 10.1517/14712590903066711; Kaiser R, 1999, BRAIN, V122, P2067, DOI 10.1093/brain/122.11.2067; Kaiser R, 2002, INT J MED MICROBIOL, V291, P58, DOI 10.1016/S1438-4221(02)80012-1; Kriz B, 2004, INT J MED MICROBIOL, V293, P63, DOI 10.1016/S1433-1128(04)80010-X; Kunz C, 2003, VACCINE, V21, pS50, DOI 10.1016/S0264-410X(02)00813-7; Lambrecht BN, 2013, EUR J IMMUNOL, V43, P3125, DOI 10.1002/eji.201343730; Leonova GN, 2009, VACCINE, V27, P2899, DOI 10.1016/j.vaccine.2009.02.069; Lindblom P, 2014, TICKS TICK-BORNE DIS, V5, P21, DOI 10.1016/j.ttbdis.2013.07.009; Mickiene A, 2002, CLIN INFECT DIS, V35, P650, DOI 10.1086/342059; OKERBLOM N, 1962, BIOLOGY VIRUSES TICK, P423; Orlinger KK, 2011, J INFECT DIS, V203, P1556, DOI 10.1093/infdis/jir122; Paulke-Korinek M, 2013, VACCINE; Paulke-Korinek M, 2009, VACCINE, V27, P7027, DOI 10.1016/j.vaccine.2009.09.068; Rendi-Wagner P, 2007, VACCINE, V25, P5097, DOI 10.1016/j.vaccine.2007.01.116; Rendi-Wagner P, 2006, INT J MED MICROBIOL, V296, P202, DOI 10.1016/j.ijmm.2006.01.030; Stiasny K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034145; Stiasny K, 2009, VACCINE, V27, P7021, DOI 10.1016/j.vaccine.2009.09.069; Studahl M, 2013, DRUGS, V73, P131, DOI 10.1007/s40265-013-0007-5; Suss J, 2011, TICKS TICK-BORNE DIS, V2, P2, DOI 10.1016/j.ttbdis.2010.10.007; van Ree R, 2014, CLIN TRANSL ALLERGY, V4, DOI 10.1186/2045-7022-4-12; Vene S, 1998, J VIROL METHODS, V73, P71, DOI 10.1016/S0166-0934(98)00041-X; Vene S, 2007, VACCINE, V25, P366, DOI 10.1016/j.vaccine.2006.07.026; Wahlberg P, 2006, SCAND J INFECT DIS, V38, P1057, DOI 10.1080/00365540600868297; Weinberger B, 2012, CLIN MICROBIOL INFEC, V18, P100, DOI 10.1111/j.1469-0691.2012.03944.x; Weinberger B, 2010, VACCINE, V28, P3511, DOI 10.1016/j.vaccine.2010.03.024; Who Publication, 2011, Vaccine, V29, P8769, DOI 10.1016/j.vaccine.2011.07.024; Wilhelmsson P, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-362; Wilhelmsson P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081433; Wilhelmsson P, 2010, J CLIN MICROBIOL, V48, P4169, DOI 10.1128/JCM.01061-10	51	22	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100860	10.1371/journal.pone.0100860	http://dx.doi.org/10.1371/journal.pone.0100860			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967619	Green Submitted, Green Published, gold			2022-12-27	WOS:000338280800075
J	Sedeno, L; Couto, B; Melloni, M; Canales-Johnson, A; Yoris, A; Baez, S; Esteves, S; Velasquez, M; Barttfeld, P; Sigman, M; Kichic, R; Chialvo, D; Manes, F; Bekinschtein, TA; Ibanez, A				Sedeno, Lucas; Couto, Blas; Melloni, Margherita; Canales-Johnson, Andres; Yoris, Adrian; Baez, Sandra; Esteves, Sol; Velasquez, Marcela; Barttfeld, Pablo; Sigman, Mariano; Kichic, Rafael; Chialvo, Dante; Manes, Facundo; Bekinschtein, Tristan A.; Ibanez, Agustin			How Do You Feel when You Can't Feel Your Body? Interoception, Functional Connectivity and Emotional Processing in Depersonalization-Derealization Disorder	PLOS ONE			English	Article							RESTING-STATE NETWORKS; HUMAN BRAIN; PHYSIOLOGICAL CONDITION; BEHAVIORAL VARIANT; EMBODIED EMPATHY; SOCIAL COGNITION; PANIC DISORDER; SMALL-WORLD; TEST SCORE; EXPERIENCE	Depersonalization-Derealization Disorder (DD) typically manifests as a disruption of body self-awareness. Interoception defined as the cognitive processing of body signals-has been extensively considered as a key processing for body self-awareness. In consequence, the purpose of this study was to investigate whether there are systematic differences in interoception between a patient with DD and controls that might explain the disembodiment symptoms suffered in this disease. To assess interoception, we utilized a heartbeat detection task and measures of functional connectivity derived from fMRI networks in interoceptive/exteroceptivo/mind-wandering states. Additionally, we evaluated empathic abilities to test the association between interoception and emotional experience. The results showed patient's impaired performance in the heartbeat detection task when compared to controls. Furthermore, regarding functional connectivity, we found a lower global brain connectivity of the patient relative to controls only in the interoceptive state. He also presented a particular pattern of impairments in affective empathy. To our knowledge, this is the first experimental research that assesses the relationship between interoception and DD combining behavioral and neurobiological measures. Our results suggest that altered neural mechanisms and cognitive processes regarding body signaling might be engaged in DD phenomenology. Moreover, our study contributes experimental data to the comprehension of brain-body interactions and the emergence of self-awareness and emotional feelings.	[Sedeno, Lucas; Couto, Blas; Melloni, Margherita; Yoris, Adrian; Baez, Sandra; Esteves, Sol; Velasquez, Marcela; Manes, Facundo; Bekinschtein, Tristan A.; Ibanez, Agustin] Favaloro Univ, LPEN, INECO Inst Cognit Neurol, Buenos Aires, DF, Argentina; [Sedeno, Lucas; Couto, Blas; Melloni, Margherita; Yoris, Adrian; Baez, Sandra; Esteves, Sol; Velasquez, Marcela; Manes, Facundo; Bekinschtein, Tristan A.; Ibanez, Agustin] Favaloro Univ, Inst Neurosci, Buenos Aires, DF, Argentina; [Sedeno, Lucas; Couto, Blas; Melloni, Margherita; Canales-Johnson, Andres; Baez, Sandra; Manes, Facundo; Ibanez, Agustin] Diego Port Univ, UDP INECO Fdn Core Neurosci UIFCoN, Santiago, Chile; [Canales-Johnson, Andres; Bekinschtein, Tristan A.] MRC, Cognit & Brain Sci Unit, Cambridge, England; [Barttfeld, Pablo; Sigman, Mariano] FCEyN UBA, Lab Integrat Neurosci, Dept Phys, Buenos Aires, DF, Argentina; [Barttfeld, Pablo; Sigman, Mariano] IFIBA, Buenos Aires, DF, Argentina; [Kichic, Rafael] INECO Inst Cognit Neurol, Anxiety Clin, Buenos Aires, DF, Argentina; [Sedeno, Lucas; Couto, Blas; Melloni, Margherita; Baez, Sandra; Sigman, Mariano; Chialvo, Dante; Manes, Facundo] Consejo Nacl Invest Cient & Tecn, Natl Sci & Tech Res Council, RA-1033 Buenos Aires, DF, Argentina; [Barttfeld, Pablo] INSERM, Cognit Neuroimaging Unit, Paris, France; [Sigman, Mariano] Univ Torcuato Di Tella, Buenos Aires, DF, Argentina; [Chialvo, Dante] Univ San Andres, Dept Matemat & Ciencias, Buenos Aires, DF, Argentina; [Chialvo, Dante] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Ibanez, Agustin] Univ Autonoma Caribe, Barranquilla, Colombia; [Manes, Facundo; Ibanez, Agustin] Macquarie Univ, Australian Res Council ACR Ctr Excellence Cognit, Sydney, NSW 2109, Australia	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Universidad Torcuato Di Tella; Universidad de San Andres Argentina; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Macquarie University	Ibanez, A (corresponding author), Favaloro Univ, LPEN, INECO Inst Cognit Neurol, Buenos Aires, DF, Argentina.	aibanez@ineco.org.ar	Ibanez, Agustin/H-7976-2015; Chialvo, Dante R/A-4658-2009; Chialvo, Dante R./P-5279-2019	Ibanez, Agustin/0000-0001-6758-5101; Chialvo, Dante R/0000-0002-1038-3637; Chialvo, Dante R./0000-0002-1038-3637; Baez, Sandra/0000-0003-0875-1709; Bekinschtein, Tristan/0000-0001-5501-8628; melloni, margherita/0000-0003-0931-8640	CONICYT/FONDECYT [1130920, 1140114]; Foncyt-PICT [2012-0412, 2012-1309]; CONICET; INECO Foundation	CONICYT/FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Foncyt-PICT(ANPCyTFONCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); INECO Foundation	This research was partially supported by grants CONICYT/FONDECYT Regular (1130920 and 1140114), Foncyt-PICT 2012-0412, Foncyt-PICT 2012-1309, CONICET and INECO Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2000, J NEUROSCI, V20, P2683; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th, DOI [DOI 10.1176/APPI.BOOKS.9780890425596, DOI 10.1016/B978-0-12-809324-5.05530-9]; Association A.P., 1994, DIAGN STAT MAN MENT, V4th; Avenanti A, 2005, NAT NEUROSCI, V8, P955, DOI 10.1038/nn1481; Avenanti A, 2007, CURR BIOL, V17, P2129, DOI 10.1016/j.cub.2007.11.045; Avenanti A, 2009, NEUROIMAGE, V44, P275, DOI 10.1016/j.neuroimage.2008.08.001; Baez S, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00080; Baez S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057664; Baier B, 2008, STROKE, V39, P486, DOI 10.1161/STROKEAHA.107.495606; Baker D, 2003, BRIT J PSYCHIAT, V182, P428, DOI 10.1192/bjp.182.5.428; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Barrett LF, 2004, J PERS SOC PSYCHOL, V87, P684, DOI 10.1037/0022-3514.87.5.684; Barttfeld P, J NEURODEVELOPMENTAL; Barttfeld P, 2014, NEUROPSYCHOBIOLOGY, V69, P65, DOI 10.1159/000356964; Barttfeld P, 2013, J NEURODEV DISORD, V5, DOI 10.1186/1866-1955-5-16; Barttfeld P, 2012, NEUROPSYCHOLOGIA, V50, P3653, DOI 10.1016/j.neuropsychologia.2012.09.047; Bechara A, 2004, NAT NEUROSCI, V7, P102, DOI 10.1038/nn0204-102; Beck AT, 1996, MANUAL HE BECK DEPRE; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Bolognini N, 2013, J NEUROSCI, V33, P4201, DOI 10.1523/JNEUROSCI.4498-12.2013; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2007, NEUROIMAGE, V37, P1091, DOI 10.1016/j.neuroimage.2007.01.010; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cheng Y, 2008, NEUROIMAGE, V40, P1833, DOI 10.1016/j.neuroimage.2008.01.064; Couto B, 2012, CORTEX; Couto B, 2014, SOC COGN AFFECT NEUR, V9, P1253, DOI 10.1093/scan/nst108; Couto B, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00467; Couto B, 2013, CORTEX, V49, P1420, DOI 10.1016/j.cortex.2012.08.006; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Craig AD, 2004, TRENDS COGN SCI, V8, P239, DOI 10.1016/j.tics.2004.04.004; Crawford JR, 2011, CORTEX, V47, P1166, DOI 10.1016/j.cortex.2011.02.017; Crawford JR, 2009, NEUROPSYCHOLOGIA, V47, P2690, DOI 10.1016/j.neuropsychologia.2009.04.011; Crawford JR, 2002, NEUROPSYCHOLOGIA, V40, P1196, DOI 10.1016/S0028-3932(01)00224-X; Crawford JR, 1998, CLIN NEUROPSYCHOL, V12, P482, DOI 10.1076/clin.12.4.482.7241; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Critchley HD, 2001, NAT NEUROSCI, V4, P207, DOI 10.1038/84048; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Davis M., 1996, EMPATHY SOCIAL PSYCH; Davis M. H., 1980, JSAS CATALOG SELECTE, V10, P1, DOI DOI 10.1037/0022-3514.44.1.113; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Decety J, 2006, BRAIN RES, V1079, P4, DOI 10.1016/j.brainres.2005.12.115; Decety Jean, 2004, Behav Cogn Neurosci Rev, V3, P71, DOI 10.1177/1534582304267187; Decety J, 2012, CEREB CORTEX, V22, P209, DOI 10.1093/cercor/bhr111; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Dunn BD, 2010, PSYCHOL SCI, V21, P1835, DOI 10.1177/0956797610389191; Ernst J, 2012, HUM BRAIN MAPP; Farrer C, 2003, NEUROIMAGE, V18, P324, DOI 10.1016/S1053-8119(02)00041-1; First MB, 2002, STRUCTURED CLIN INTE; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fukushima H, 2011, INT J PSYCHOPHYSIOL, V79, P259, DOI 10.1016/j.ijpsycho.2010.10.015; Gallagher S., 2005, BODY SHAPES MIND; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; HANTAS M, 1982, PSYCHOPHYSIOLOGY, V19, P563; Harrison NA, 2010, J NEUROSCI, V30, P12878, DOI 10.1523/JNEUROSCI.1725-10.2010; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Hunter ECM, 2004, SOC PSYCH PSYCH EPID, V39, P9, DOI 10.1007/s00127-004-0701-4; Hunter ECM, 2003, BEHAV RES THER, V41, P1451, DOI 10.1016/S0005-7967(03)00066-4; Iacoboni M., 2005, PERSPECTIVES IMITATI; Iacoboni M, 2009, ANNU REV PSYCHOL, V60, P653, DOI 10.1146/annurev.psych.60.110707.163604; IBANEZ A, 2013, SOC COGN AFFECT NEUR; Ibanez A, 2013, PERS INDIV DIFFER, V54, P616, DOI 10.1016/j.paid.2012.11.022; Ibanez A, 2012, NEUROLOGY, V78, P1354, DOI 10.1212/WNL.0b013e3182518375; Ibanez A, 2010, BRAIN STRUCT FUNCT, V214, P397, DOI 10.1007/s00429-010-0256-y; Karnath HO, 2005, J NEUROSCI, V25, P7134, DOI 10.1523/JNEUROSCI.1590-05.2005; Keysers C, 2004, NEURON, V42, P335, DOI 10.1016/S0896-6273(04)00156-4; Keysers C, 2010, NAT REV NEUROSCI, V11, P417, DOI 10.1038/nrn2833; Khalsa SS, 2009, NAT NEUROSCI, V12, P1494, DOI 10.1038/nn.2411; Lamm C, 2011, NEUROIMAGE, V54, P2492, DOI 10.1016/j.neuroimage.2010.10.014; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Lavin Claudio, 2013, Front Neurosci, V7, P64, DOI 10.3389/fnins.2013.00064; Lawrence EJ, 2004, PSYCHOL MED, V34, P911, DOI 10.1017/S0033291703001624; Lawrence EJ, 2007, SOC NEUROSCI-UK, V2, P292, DOI 10.1080/17470910701391794; Lee WE, 2012, SOC PSYCH PSYCH EPID, V47, P253, DOI 10.1007/s00127-010-0327-7; Lemche E, 2008, BRIT J PSYCHIAT, V193, P222, DOI 10.1192/bjp.bp.107.044263; Lemche E, 2007, NEUROREPORT, V18, P473, DOI 10.1097/WNR.0b013e328057deb3; Lemche E, 2013, PSYCHIAT RES-NEUROIM, V214, P66, DOI 10.1016/j.pscychresns.2013.05.006; Medford N, 2006, PSYCHIAT RES-NEUROIM, V148, P93, DOI 10.1016/j.pscychresns.2006.05.007; Melloni M, 2013, EMPATHY CONTEXTUAL S; Melloni M, 2013, BEHAV BRAIN FUNCT, V9, DOI 10.1186/1744-9081-9-47; Michal M, 2005, J NERV MENT DIS, V193, P629, DOI 10.1097/01.nmd.0000178038.87332.ec; Castillo JJM, 2006, ACTAS ESP PSIQUIATRI, V34, P185; Novembre G, 2014, SOC COGN AFFECT NEUR; NOYES R, 1992, J NERV MENT DIS, V180, P369, DOI 10.1097/00005053-199206000-00006; Ovadia-Caro S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037238; Pennebaker J.W., 1982, PSYCHOL PHYS SYMPTOM; Phillips ML, 2003, STRESS, V6, P157, DOI 10.1080/1025389031000138538; Phillips ML, 2001, PSYCHIAT RES-NEUROIM, V108, P145, DOI 10.1016/S0925-4927(01)00119-6; Pitcher D, 2008, J NEUROSCI, V28, P8929, DOI 10.1523/JNEUROSCI.1450-08.2008; Pollatos O, 2005, COGNITIVE BRAIN RES, V25, P948, DOI 10.1016/j.cogbrainres.2005.09.019; Pollatos O, 2007, HUM BRAIN MAPP, V28, P9, DOI 10.1002/hbm.20258; Pollatos O, 2007, INT J PSYCHOPHYSIOL, V63, P117, DOI 10.1016/j.ijpsycho.2006.09.003; Raichle ME, 2009, J NEUROSCI, V29, P12729, DOI 10.1523/JNEUROSCI.4366-09.2009; Rizzolatti G, 2006, SCI AM, V295, P54, DOI 10.1038/scientificamerican1106-54; ROUSE CH, 1988, PSYCHOPHYSIOLOGY, V25, P400, DOI 10.1111/j.1469-8986.1988.tb01876.x; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Schaefer M, 2012, NEUROIMAGE, V60, P952, DOI 10.1016/j.neuroimage.2012.01.112; SCHANDRY R, 1981, PSYCHOPHYSIOLOGY, V18, P483, DOI 10.1111/j.1469-8986.1981.tb02486.x; Sethi AK, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2011.00395; Sierra M, 1998, BIOL PSYCHIAT, V44, P898, DOI 10.1016/S0006-3223(98)00015-8; Sierra M, 2002, ARCH GEN PSYCHIAT, V59, P833, DOI 10.1001/archpsyc.59.9.833; Sierra M, 2005, PSYCHOL MED, V35, P1523, DOI 10.1017/S0033291705005325; Sierra M, 2002, J NEUROL NEUROSUR PS, V72, P530; Sierra M, 2012, PSYCHIAT RES, V197, P123, DOI 10.1016/j.psychres.2011.12.017; Sierra M, 2011, CONSCIOUS COGN, V20, P99, DOI 10.1016/j.concog.2010.10.018; Singer T, 2009, ANN NY ACAD SCI, V1156, P81, DOI 10.1111/j.1749-6632.2009.04418.x; Spielberg C.D., 1970, MANUAL STATE TRAIT I; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Sporns O, 2006, P NATL ACAD SCI USA, V103, P19219, DOI 10.1073/pnas.0609523103; Straube T, 2010, NEUROPSYCHOLOGIA, V48, P1735, DOI 10.1016/j.neuropsychologia.2010.02.022; Supekar K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002374; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Terasawa Y, 2011, HUM BRAIN MAPP; Toni C, 1996, COMPR PSYCHIAT, V37, P125, DOI 10.1016/S0010-440X(96)90573-8; Torralva T, 2009, J INT NEUROPSYCH SOC, V15, P777, DOI 10.1017/S1355617709990415; Tsakiris M, 2010, NEUROPSYCHOLOGIA, V48, P703, DOI 10.1016/j.neuropsychologia.2009.09.034; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002001; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WHITEHEAD WE, 1977, BIOFEEDBACK SELF-REG, V2, P371, DOI 10.1007/BF00998623; Wicker B, 2003, NEURON, V40, P655, DOI 10.1016/S0896-6273(03)00679-2; Wiens S, 2000, COGNITION EMOTION, V14, P417, DOI 10.1080/026999300378905	129	79	79	4	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e98769	10.1371/journal.pone.0098769	http://dx.doi.org/10.1371/journal.pone.0098769			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK2WP	24967634	Green Published, gold, Green Submitted			2022-12-27	WOS:000338280800005
J	Sun, TQ; Zhang, Y; Shan, P; Zhang, ZC; Chen, SL; Kong, YF; Xu, JJ				Sun, Tongqing; Zhang, Yu; Shan, Pai; Zhang, Zichang; Chen, Shaolin; Kong, Yongfa; Xu, Jingjun			Growth, Structure, Thermal Properties and Spectroscopic Characteristics of Nd3+-Doped KGdP4O12 Crystal	PLOS ONE			English	Article							SPECTRAL PROPERTIES; LASER OPERATION; OPTICAL-PROPERTIES; PERFORMANCE; INTENSITIES; MORPHOLOGY	A single crystal of Nd3+-doped KGdP4O12 was successfully grown with the top-seeded solution growth and slow cooling (TSSG-SC) technique. It crystallizes in space group C2/c with cell parameters a = 7.812(2) angstrom, b = 12.307(3) angstrom, c = 10.474(2) angstrom, beta = 110.84(3)degrees and Z = 4. The IR and Raman spectra also indicated that the phosphoric polyhedra of Nd:KGdP4O12 has a cyclic symmetry. The chemical composition of the crystal was analyzed and the distribution coefficient of Nd3+ was calculated. The crystal morphology of KGdP4O12 was identified using X-ray diffraction. The compound has good thermal stability to 920 degrees C. Its specific heat and thermal conductivity were determined for potential applications. The spectral properties of Nd: KGdP4O12 indicates that it exhibits broad absorption and emission bands, which are attributed to low symmetry of the crystal. The broad absorption band around 798 nm has a full-width at half-maximum (FWHM) of 14.8 nm and is suitable for AlGaAs laser diode pumping. Moreover, 5 at% Nd3+-doped KGdP4O12 crystal has a long luminescence lifetime of 300 mu s and a high quantum efficiency of 96%.	[Sun, Tongqing; Chen, Shaolin; Kong, Yongfa; Xu, Jingjun] Nankai Univ, MOE Key Lab Weak Light Nonlinear Photon, Tianjin 300071, Peoples R China; [Sun, Tongqing; Zhang, Yu; Shan, Pai; Zhang, Zichang; Kong, Yongfa; Xu, Jingjun] Nankai Univ, Sch Phys, Tianjin 300071, Peoples R China; [Chen, Shaolin; Kong, Yongfa; Xu, Jingjun] Nankai Univ, TEDA Appl Phys Inst, Tianjin 300071, Peoples R China	Nankai University; Nankai University; Nankai University	Sun, TQ (corresponding author), Nankai Univ, MOE Key Lab Weak Light Nonlinear Photon, Tianjin 300071, Peoples R China.	suntq@nankai.edu.cn	Jingjun, Xu/A-1282-2010; xu, jing/GRR-8698-2022		National Natural Science Foundation of China [21271109]; Fundamental Research Funds for the Central Universities of China [65122011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work is supported by the National Natural Science Foundation of China (Grant No. 21271109) and the Fundamental Research Funds for the Central Universities of China (65122011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boulon G, 2003, OPT MATER, V22, P85, DOI 10.1016/S0925-3467(02)00350-6; BROWN ID, 1985, ACTA CRYSTALLOGR B, V41, P244, DOI 10.1107/S0108768185002063; Cheng Y, 2009, LASER PHYS LETT, V6, P740, DOI 10.1002/lapl.200910065; Cheng ZX, 2001, JPN J APPL PHYS 1, V40, P4038, DOI 10.1143/JJAP.40.4038; Ettis H, 2003, CRYST GROWTH DES, V3, P599, DOI 10.1021/cg0200659; Faure N, 1996, APPL PHYS B-LASERS O, V63, P593; Horchani K, 2002, MATER RES BULL, V37, P1259, DOI 10.1016/S0025-5408(02)00772-9; JUDD BR, 1962, PHYS REV, V127, P750, DOI 10.1103/PhysRev.127.750; JUNGOWSKA W, 1990, J THERM ANAL, V36, P2095, DOI 10.1007/BF01914131; Kaminskii AA, 2007, LASER PHOTONICS REV, V1, P93, DOI 10.1002/lpor.200710008; Kaminsky W, 2007, J APPL CRYSTALLOGR, V40, P382, DOI 10.1107/S0021889807003986; Koechner W., 2006, SOLID STATE LASER EN, V6th, P54; Li DZ, 2011, LASER PHYS LETT, V8, P647, DOI 10.1002/lapl.201110040; Li DZ, 2011, APPL PHYS B-LASERS O, V104, P53, DOI 10.1007/s00340-010-4302-5; Li DZ, 2010, LASER PHYS LETT, V7, P798, DOI 10.1002/lapl.201010069; Li H, 2010, CRYSTENGCOMM, V12, P1307, DOI 10.1039/b914641e; Li H, 2009, J ALLOY COMPD, V478, P484, DOI 10.1016/j.jallcom.2008.11.079; Maksimova SI, 1981, IAN SSSR NEORG MATER, V17, P116; Meng XM, 2011, CRYSTENGCOMM, V13, P4069, DOI 10.1039/c0ce00922a; OFELT GS, 1962, J CHEM PHYS, V37, P511, DOI 10.1063/1.1701366; Pan ZB, 2013, OPT EXPRESS, V21, P6091, DOI 10.1364/OE.21.006091; Parreu I, 2003, CHEM MATER, V15, P5059, DOI 10.1021/cm034812g; Parreu I, 2005, CHEM MATER, V17, P822, DOI 10.1021/cm048442n; Parreu I, 2007, CHEM MATER, V19, P2868, DOI 10.1021/cm0621242; Parreu I, 2007, OPT EXPRESS, V15, P2360, DOI 10.1364/OE.15.002360; Parreu I, 2007, CRYST GROWTH DES, V7, P557, DOI 10.1021/cg060400j; Parreu I, 2006, CHEM MATER, V18, P221, DOI 10.1021/cm052114l; Parreu I, 2006, CRYSTAL GROWTH CHARA, P114; Rekik W, 2004, ACTA CRYSTALLOGR C, V60, pI50, DOI 10.1107/S0108270104004603; Sato Y, 2005, IEEE J SEL TOP QUANT, V11, P613, DOI 10.1109/JSTQE.2005.850569; Sole R, 2009, J CRYST GROWTH, V311, P3656, DOI 10.1016/j.jcrysgro.2009.05.005; Song MJ, 2007, J CRYST GROWTH, V308, P208, DOI 10.1016/j.jcrysgro.2007.07.049; Song MJ, 2011, J ALLOY COMPD, V509, P2164, DOI 10.1016/j.jallcom.2010.10.175; Song MJ, 2009, J ALLOY COMPD, V480, P839, DOI 10.1016/j.jallcom.2009.02.082; Wang GF, 1999, PHYS REV B, V60, P15469, DOI 10.1103/PhysRevB.60.15469; WEBER HP, 1975, OPT QUANT ELECTRON, V7, P431, DOI 10.1007/BF00619318; Xiao B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040229; Xiao B, 2012, OPTOELECTRON ADV MAT, V6, P404; Xu XD, 2010, OPT EXPRESS, V18, P21370, DOI 10.1364/OE.18.021370; Zhang JJ, 2011, CHEM MATER, V23, P3752, DOI 10.1021/cm2015143; Zhang YY, 2011, IEEE J QUANTUM ELECT, V47, P1506, DOI 10.1109/JQE.2011.2172975	41	7	7	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100922	10.1371/journal.pone.0100922	http://dx.doi.org/10.1371/journal.pone.0100922			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968165	Green Published, gold, Green Submitted			2022-12-27	WOS:000338280800081
J	Vaz, S; Falkmer, M; Parsons, R; Passmore, AE; Parkin, T; Falkmer, T				Vaz, Sharmila; Falkmer, Marita; Parsons, Richard; Passmore, Anne Elizabeth; Parkin, Timothy; Falkmer, Torbjoern			School Belongingness and Mental Health Functioning across the Primary-Secondary Transition in a Mainstream Sample: Multi-Group Cross-Lagged Analyses	PLOS ONE			English	Article							GOODNESS-OF-FIT; DIFFICULTIES-QUESTIONNAIRE; MIDDLE-SCHOOL; YOUNG-PEOPLE; COMMUNITY SAMPLE; ADOLESCENTS; DISORDERS; FAMILY; CHILD; CONNECTEDNESS	The relationship between school belongingness and mental health functioning before and after the primary-secondary school transition has not been previously investigated in students with and without disabilities. This study used a prospective longitudinal design to test the bi-directional relationships between these constructs, by surveying 266 students with and without disabilities and their parents, 6-months before and after the transition to secondary school. Cross-lagged multi-group analyses found student perception of belongingness in the final year of primary school to contribute to change in their mental health functioning a year later. The beneficial longitudinal effects of school belongingness on subsequent mental health functioning were evident in all student subgroups; even after accounting for prior mental health scores and the cross-time stability in mental health functioning and school belongingness scores. Findings of the current study substantiate the role of school contextual influences on early adolescent mental health functioning. They highlight the importance for primary and secondary schools to assess students' school belongingness and mental health functioning and transfer these records as part of the transition process, so that appropriate scaffolds are in place to support those in need. Longer term longitudinal studies are needed to increase the understanding of the temporal sequencing between school belongingness and mental health functioning of all mainstream students.	[Vaz, Sharmila] Curtin Univ, Sch Occupat Therapy & Social Work, Ctr Res Disabil & Soc, Curtin Hlth Innovat Res Inst, Perth, WA 6845, Australia; [Falkmer, Marita; Passmore, Anne Elizabeth; Parkin, Timothy; Falkmer, Torbjoern] Curtin Univ, Sch Occupat Therapy & Social Work, Curtin Hlth Innovat Res Inst, Perth, WA 6845, Australia; [Falkmer, Marita] Jonkoping Univ, Inst Disabil Res, CHILD Programme, Sch Educ & Commun, Jonkoping, Sweden; [Parsons, Richard] Curtin Univ, Sch Occupat Therapy & Social Work, Perth, WA 6845, Australia; [Parsons, Richard] Curtin Univ, Sch Pharm, Curtin Hlth Innovat Res Inst, Perth, WA 6845, Australia; [Falkmer, Torbjoern] La Trobe Univ, Sch Occupat Therapy, Melbourne, Vic, Australia; [Falkmer, Torbjoern] Linkoping Univ, Fac Hlth Sci, Dept Med & Hlth Sci IMH, Linkoping, Sweden; [Falkmer, Torbjoern] Cty Council, UHL, Pain & Rehabil Ctr, Linkoping, Sweden	Curtin University; Curtin University; Jonkoping University; Curtin University; Curtin University; La Trobe University; Linkoping University	Vaz, S (corresponding author), Curtin Univ, Sch Occupat Therapy & Social Work, Ctr Res Disabil & Soc, Curtin Hlth Innovat Res Inst, Perth, WA 6845, Australia.	s.vaz@curtin.edu.au		Vaz, Sharmila/0000-0003-1003-9593	Centre for Research into Disability and Society; School of Occupational Therapy and Social Work, Curtin University, Perth, Australia	Centre for Research into Disability and Society; School of Occupational Therapy and Social Work, Curtin University, Perth, Australia	This project was funded by a Doctoral scholarship provided by the Centre for Research into Disability and Society and the School of Occupational Therapy and Social Work, Curtin University, Perth, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach T. M., 1991, MANUAL SELF REPORT 1; Anderman EM, 2002, J EDUC PSYCHOL, V94, P795, DOI 10.1037//0022-0663.94.4.795; Anderman L., 2004, ADV MOTIVATION ACHIE, V13, P27, DOI DOI 10.1016/S0749-7423(03)13002-6; Anderman LH, 2003, J EXP EDUC, V72, P5, DOI 10.1080/00220970309600877; Australian Bureau of Statistics [ABS], 2001, ABS 2001 CENS DICT; Australian Institute of Health and Welfare (AIHW), 2003, AUSTR YOUNG PEOPL TH; Battistich V, 1997, EDUC PSYCHOL-US, V32, P137, DOI 10.1207/s15326985ep3203_1; Bell M, 2001, SPECIAL ED PERSPECTI, V10, P3; BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037/0033-2909.107.2.238; Berkman L., 2000, SOCIAL EPIDEMIOLOGY; Birch SH, 1998, DEV PSYCHOL, V34, P934, DOI 10.1037/0012-1649.34.5.934; Blum RW, 2005, EDUC LEADERSHIP, V62, P16; Bond L, 2007, J ADOLESCENT HEALTH, V40, DOI DOI 10.1016/J.JADOHEALTH.2006.10.013; Burton E, 2004, J CONSULT CLIN PSYCH, V72, P689, DOI 10.1037/0022-006X.72.4.689; Catalano RF, 2004, J SCHOOL HEALTH, V74, P252, DOI 10.1111/j.1746-1561.2004.tb08281.x; CERNKOVICH SA, 1992, CRIMINOLOGY, V30, P261, DOI 10.1111/j.1745-9125.1992.tb01105.x; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; Cicchetti D, 1999, J CLIN CHILD PSYCHOL, V28, P355, DOI 10.1207/S15374424jccp280308; Davis C, 2000, EARLY INTERVENTION M; DISHION TJ, 1991, DEV PSYCHOL, V27, P172, DOI 10.1037/0012-1649.27.1.172; Eccles J. S., 1989, RES MOTIVATION ED, V3, P139, DOI DOI 10.1037/0003-066X.48.2.90; ECCLES JS, 1991, AM J EDUC, V99, P521, DOI 10.1086/443996; Erikson E.H., 1968, IDENTITY YOUTH CRISI; Fordwood SR, 2007, J CLIN CHILD ADOLESC, V36, P392, DOI 10.1080/15374410701444355; Geller B, 2001, J AM ACAD CHILD PSY, V40, P673, DOI 10.1097/00004583-200106000-00012; Geller B, 2001, AM J PSYCHIAT, V158, P125, DOI 10.1176/appi.ajp.158.1.125; GOODENOW C, 1993, PSYCHOL SCHOOLS, V30, P79, DOI 10.1002/1520-6807(199301)30:1<79::AID-PITS2310300113>3.0.CO;2-X; Goodman R, 1999, J CHILD PSYCHOL PSYC, V40, P791, DOI 10.1017/S0021963099004096; Goodman R, 2003, INT REV PSYCHIATR, V15, P166, DOI 10.1080/0954026021000046128; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Goodman R, 1999, J ABNORMAL CHILD PSY, V1; HAGBORG WJ, 1994, J PSYCHOEDUC ASSESS, V12, P312, DOI 10.1177/073428299401200401; Hargreaves A, 1996, SCH CHANGE REINVENTI; Hawton K, 2002, BMJ-BRIT MED J, V325, P1207, DOI 10.1136/bmj.325.7374.1207; Herd P, 2007, J HEALTH SOC BEHAV, V48, P223, DOI 10.1177/002214650704800302; Hickie I, 2004, INVESTING AUSTR FUTU; Hirschi T., 1969, CAUSE OF DELINQUENCY; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jacobson KC, 1999, DEV PSYCHOL, V35, P926, DOI 10.1037/0012-1649.35.4.926; Johnson MK, 2006, SOC PSYCHOL QUART, V69, P284, DOI 10.1177/019027250606900305; Kieling C, 2011, LANCET, V378, P1515, DOI 10.1016/S0140-6736(11)60827-1; Kline RB, 2005, PRINCIPLES PRACTICE; Kuperminc GP, 2001, J SCHOOL PSYCHOL, V39, P141, DOI 10.1016/S0022-4405(01)00059-0; Larson RW, 1999, PSYCHOL BULL, V125, P701, DOI 10.1037/0033-2909.125.6.701; Loukas A, 2010, J RES ADOLESCENCE, V20, P13, DOI 10.1111/j.1532-7795.2009.00632.x; Loukas A, 2009, J YOUTH ADOLESCENCE, V38, P804, DOI 10.1007/s10964-008-9312-9; Ma X, 2003, J EDUC RES, V96, P340, DOI 10.1080/00220670309596617; McKnight P. E., 2007, MISSING DATA GENTLE; McLennan W, 1997, MENTAL HLTH WELLBEIN; McMahon SD, 2008, PSYCHOL SCH, V45, P26; Mellor D, 2005, AUST PSYCHOL, V40, P215, DOI 10.1080/00050060500243475; Meyers L. S., 2006, APPL MULTIVARIATE RE; Moffitt TE, 1996, DEV PSYCHOPATHOL, V8, P399, DOI 10.1017/S0954579400007161; Monahan K.C., 2010, PREVENTION RES, V17, P3, DOI [DOI 10.1037/E597072010-002, DOI 10.1037/E5970720]; Morrison GM, 2003, CALIFORNIA SCH PSYCH, V8; Oakes JM, 2003, SOC SCI MED, V56, P769, DOI 10.1016/S0277-9536(02)00073-4; ORVASCHEL H, 1995, J AM ACAD CHILD PSY, V34, P1525, DOI 10.1097/00004583-199511000-00020; Parker G, 2001, AUST NZ J PSYCHIAT, V35, P572, DOI 10.1046/j.1440-1614.2001.00934.x; Patel V, 2007, LANCET, V369, P1302, DOI 10.1016/S0140-6736(07)60368-7; Petticrew M, 2005, PROMOTING MENTAL HLT; Resnick MD, 1997, JAMA-J AM MED ASSOC, V278, P823, DOI 10.1001/jama.278.10.823; RUTTER M, 1995, ACTA PSYCHIAT SCAND, V91, P73, DOI 10.1111/j.1600-0447.1995.tb09745.x; Sawyer MG, 2001, AUST NZ J PSYCHIAT, V35, P806, DOI 10.1046/j.1440-1614.2001.00964.x; Sawyer MG, 2000, MENTAL HLTH YOUNG PE; Sawyer MG, 2009, J AFFECT DISORDERS, V117, P48, DOI 10.1016/j.jad.2008.12.013; Scott S, 1998, BRIT MED J, V316, P202; SDQ, 2007, INF RES PROF STRENGT; Shochet IM, 2006, J CLIN CHILD ADOLESC, V35, P170, DOI 10.1207/s15374424jccp3502_1; Stone LL, 2010, CLIN CHILD FAM PSYCH, V13, P254, DOI 10.1007/s10567-010-0071-2; Sturgeon L, 2007, MENTAL HLTH INTELLEC; Svetaz MV, 2000, J ADOLESCENT HEALTH, V27, P340, DOI 10.1016/S1054-139X(00)00170-1; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; Vaz S, 2010, FACTORS AFFECTING ST; Vaz S, 2014, PLOS ONE; Verhulst F. C., 1995, EPIDEMIOLOGY CHILD A; Wade TJ, 1998, CAN J SOCIOL, V23, P1, DOI 10.2307/3341659; Weiss R. S, 1973, LONELINESS EXPERIENC; Weisz JR, 2006, PSYCHOL BULL, V132, P132, DOI 10.1037/0033-2909.132.1.132; West SG, 1995, STRUCTURAL EQUATION; Whitlock J.L., 2006, APPL DEV SCI, V10, P13, DOI [DOI 10.1207/S1532480XADS1001_2, 10.1207/s1532480xads1001_2]; Wickrama KAS, 2008, J HEALTH SOC BEHAV, V49, P468, DOI 10.1177/002214650804900407; World Health Organization, 1996, PROM HLTH SCH WHO GL; Zalsman G, 2006, CHILD ADOL PSYCH CL, V15, P827, DOI 10.1016/j.chc.2006.05.002; Zubrick S, 2000, INDICATORS SOCIAL FA; Zubrick S. R., 1997, W AUSTR CHILD HLTH S; Zubrick SR, 2000, AUST NZ J PSYCHIAT, V34, P570, DOI 10.1080/j.1440-1614.2000.00703.x	86	13	13	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e99576	10.1371/journal.pone.0099576	http://dx.doi.org/10.1371/journal.pone.0099576			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK2WP	24967580	Green Published, gold, Green Submitted			2022-12-27	WOS:000338280800014
J	Bond, DS; Thomas, JG; Raynor, HA; Moon, J; Sieling, J; Trautvetter, J; Leblond, T; Wing, RR				Bond, Dale S.; Thomas, J. Graham; Raynor, Hollie A.; Moon, Jon; Sieling, Jared; Trautvetter, Jennifer; Leblond, Tiffany; Wing, Rena R.			B-MOBILE - A Smartphone-Based Intervention to Reduce Sedentary Time in Overweight/Obese Individuals: A Within-Subjects Experimental Trial	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; ENERGY-EXPENDITURE; LEISURE-TIME; SITTING TIME; ADULTS; ASSOCIATIONS; BEHAVIOR; BREAKING; MORTALITY; MONITORS	Purpose: Excessive sedentary time (SED) has been linked to obesity and other adverse health outcomes. However, few sedentary-reducing interventions exist and none have utilized smartphones to automate behavioral strategies to decrease SED. We tested a smartphone-based intervention to monitor and decrease SED in overweight/obese individuals, and compared 3 approaches to prompting physical activity (PA) breaks and delivering feedback on SED. Design and Methods: Participants [N = 30; Age = 47.5(13.5) years; 83% female; Body Mass Index (BMI) = 36.2(7.5) kg/m(2)] wore the SenseWear Mini Armband (SWA) to objectively measure SED for 7 days at baseline. Participants were then presented with 3 smartphone-based PA break conditions in counterbalanced order: (1) 3-min break after 30 SED min; (2) 6-min break after 60 SED min; and (3) 12-min break after 120 SED min. Participants followed each condition for 7 days and wore the SWA throughout. Results: All PA break conditions yielded significant decreases in SED and increases in light (LPA) and moderate-to-vigorous PA (MVPA) (p<0.005). Average % SED at baseline (72.2%) decreased by 5.9%, 5.6%, and 3.3% [i.e. by mean (95% CI) -47.2(-66.3, -28.2), -44.5(-65.2, -23.8), and -26.2(-40.7, -11.6) min/d] in the 3-, 6-, and 12-min conditions, respectively. Conversely, % LPA increased from 22.8% to 26.7%, 26.7%, and 24.7% [i.e. by 31.0(15.8, 46.2), 31.0(13.6, 48.4), and 15.3(3.9, 26.8) min/d], and % MVPA increased from 5.0% to 7.0%, 6.7%, and 6.3% (i.e. by 16.2(8.5, 24.0), 13.5(6.3, 20.6), and 10.8(4.2, 17.5) min/d] in the 3-, 6-, and 12-min conditions, respectively. Planned pairwise comparisons revealed the 3-min condition was superior to the 12-min condition in decreasing SED and increasing LPA (p<0.05). Conclusion: The smartphone-based intervention significantly reduced SED. Prompting frequent short activity breaks may be the most effective way to decrease SED and increase PA in overweight/obese individuals. Future investigations should determine whether these SED reductions can be maintained long-term.	[Bond, Dale S.; Thomas, J. Graham; Trautvetter, Jennifer; Leblond, Tiffany; Wing, Rena R.] Brown Univ, Dept Psychiat & Human Behav, Alpert Med Sch, Miriam Hosp,Weight Control & Diabet Res Ctr, Providence, RI 02912 USA; [Raynor, Hollie A.] Univ Tennessee, Dept Nutr, Knoxville, TN 37996 USA; [Moon, Jon; Sieling, Jared] MEI Res Ltd, Edina, MN USA	Brown University; Lifespan Health Rhode Island; Miriam Hospital; University of Tennessee System; University of Tennessee Knoxville	Bond, DS (corresponding author), Brown Univ, Dept Psychiat & Human Behav, Alpert Med Sch, Miriam Hosp,Weight Control & Diabet Res Ctr, Providence, RI 02912 USA.	dbond@lifespan.org		Moon, Jon/0000-0002-2339-7130; Raynor, Hollie/0000-0002-3782-9504	National Institutes of Health; NIDDK [DK095740]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK095740] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by a grant from the National Institutes of Health, NIDDK DK095740 (PI: Bond) (http://www.niddk.nih.gov/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bankoski A, 2011, DIABETES CARE, V34, P497, DOI 10.2337/dc10-0987; Barnes J, 2012, APPL PHYSIOL NUTR ME, V37, P540, DOI [10.1139/H2012-024, 10.1139/h2012-024]; Bond DS, 2013, SURG OBES RELAT DIS, V9, P123, DOI 10.1016/j.soard.2012.09.008; Burke LE, 2012, AM J PREV MED, V43, P20, DOI 10.1016/j.amepre.2012.03.016; Carr LJ, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003261; Chau JY, 2012, PREV MED, V54, P195, DOI 10.1016/j.ypmed.2011.12.020; Consolvo S, 2008, CHI 2008: 26TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS VOLS 1 AND 2, CONFERENCE PROCEEDINGS, P1797; Consolvo S, 2009, COMPUTER, V42, P86, DOI 10.1109/MC.2009.185; Du HD, 2013, AM J CLIN NUTR, V97, P487, DOI 10.3945/ajcn.112.046854; Dunstan DW, 2012, DIABETES CARE, V35, P976, DOI 10.2337/dc11-1931; Fujiki Y, 2010, P ACM C HUM FACT COM, P4315; Gardiner PA, 2011, AM J PREV MED, V41, P174, DOI 10.1016/j.amepre.2011.03.020; Global System for Mobile Communications Association, 2013, MOB EC 2013; Greaves CJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-119; Healy GN, 2008, DIABETES CARE, V31, P661, DOI 10.2337/dc07-2046; Healy GN, 2013, PREV MED, V57, P43, DOI 10.1016/j.ypmed.2013.04.004; Healy GN, 2011, EUR HEART J, V32, P590, DOI 10.1093/eurheartj/ehq451; Henson J, 2013, DIABETOLOGIA, V56, P1012, DOI 10.1007/s00125-013-2845-9; Jakicic JM, 2004, MED SCI SPORT EXER, V36, P897, DOI 10.1249/01.MSS.0000126805.32659.43; Johannsen DL, 2010, MED SCI SPORT EXER, V42, P2134, DOI 10.1249/MSS.0b013e3181e0b3ff; Klasnja Predrag, 2009, AMIA Annu Symp Proc, V2009, P338; Kozey-Keadle S, 2013, J PHYS ACT HLTH; Latouche C, 2013, J APPL PHYSIOL, V114, P453, DOI 10.1152/japplphysiol.00978.2012; Leon-Munoz LM, 2013, MED SCI SPORT EXER, V45, P1501, DOI 10.1249/MSS.0b013e3182897e87; Matthews CE, 2012, AM J CLIN NUTR, V95, P437, DOI 10.3945/ajcn.111.019620; Newton RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063171; Otten JJ, 2009, ARCH INTERN MED, V169, P2109, DOI 10.1001/archinternmed.2009.430; Peddie MC, 2013, AM J CLIN NUTR, V98, P358, DOI 10.3945/ajcn.112.051763; Rutten GM, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-1; Scheers T, 2013, MED SCI SPORT EXER, V45, P481, DOI 10.1249/MSS.0b013e31827563ba; Smith A., 2013, SMARTPHONE OWNERSHIP; Swartz AM, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-69; Unick JL, 2012, OBES SURG, V22, P347, DOI 10.1007/s11695-011-0491-1; van Dijk JW, 2013, DIABETES CARE, V36, P3448, DOI 10.2337/dc12-2620; Wetten AA, 2014, J PHYS ACT HEALTH, V11, P638, DOI 10.1123/jpah.2011-0167	35	115	120	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100821	10.1371/journal.pone.0100821	http://dx.doi.org/10.1371/journal.pone.0100821			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964010	gold, Green Published, Green Submitted			2022-12-27	WOS:000338709500086
J	Galateanu, G; Hermes, R; Saragusty, J; Goritz, F; Potier, R; Mulot, B; Maillot, A; Etienne, P; Bernardino, R; Fernandes, T; Mews, J; Hildebrandt, TB				Galateanu, Gabriela; Hermes, Robert; Saragusty, Joseph; Goeritz, Frank; Potier, Romain; Mulot, Baptiste; Maillot, Alexis; Etienne, Pascal; Bernardino, Rui; Fernandes, Teresa; Mews, Jurgen; Hildebrandt, Thomas Bernd			Rhinoceros Feet Step Out of a Rule-of-Thumb: A Wildlife Imaging Pioneering Approach of Synchronized Computed Tomography-Digital Radiography	PLOS ONE			English	Article							DORSOPROXIMAL-DORSODISTAL PROJECTION; FOOT; FRACTURES; CLOSURE; HORSES; BONE	Currently, radiography is the only imaging technique used to diagnose bone pathology in wild animals situated under "field conditions". Nevertheless, while chronic foot disease in captive mega-herbivores is widely reported, foot radiographic imaging is confronted with scarcity of studies. Numerous hindrances lead to such limited numbers and it became very clear that the traditional perspective on bone imaging in domestic animals based on extensive studies and elaborated statistical evaluations cannot be extrapolated to their non-domestic relatives. For these reasons, the authors initiated a multi-modality imaging study and established a pioneering approach of synchronized computed tomography (CT) and digital radiography (DR), based on X-ray projections derived from three-dimensional CT reconstructed images. Whereas this approach can be applied in any clinical field, as a case of outstanding importance and great concern for zoological institutions, we selected foot bone pathologies in captive rhinoceroses to demonstrate the manifold applications of the method. Several advances were achieved, endowing the wildlife clinician with all-important tools: prototype DR exposure protocols and a modus operandi for foot positioning, advancing both traditional projections and, for the first-time, species-related radiographic views; assessment of radiographic diagnostic value for the whole foot and, in premiere, for each autopodial bone; together with additional insights into radiographic appearance of bone anatomy and pathology with a unique, simultaneous CT-DR correlation. Based on its main advantages in availing a wide range of keystone data in wildlife imaging from a limited number of examined subjects and combining advantages of CT as the golden standard method for bone diseases' diagnostic with DR's clinical feasibility under field conditions, synchronized CT-DR presents a new perspective on wildlife's health management. With this we hope to provide veterinary clinicians with concrete imaging techniques and substantial diagnostic tools, which facilitate straightforward attainment and interpretation of field radiography images taken worldwide.	[Galateanu, Gabriela; Hermes, Robert; Saragusty, Joseph; Goeritz, Frank; Hildebrandt, Thomas Bernd] Leibniz Inst Zoo & Wildlife Res, Dept Reprod Management, Berlin, Germany; [Potier, Romain; Mulot, Baptiste] ZooParc Beauval, St Aignan, France; [Maillot, Alexis] Parc Zool Amneville, Amneville Les Thermes, France; [Etienne, Pascal] Parc Zool La Barben Pelissane, La Barben, France; [Bernardino, Rui; Fernandes, Teresa] Jardim Zool Lisboa, Hosp Vet, Lisbon, Portugal; [Mews, Jurgen] Toshiba Med Syst Europe, Clin Applicat Res Ctr, Zoetermeer, Netherlands	Leibniz Institut fur Zoo und Wildtierforschung; Toshiba Corporation	Galateanu, G (corresponding author), Leibniz Inst Zoo & Wildlife Res, Dept Reprod Management, Berlin, Germany.	galateanu@izw-berlin.de	Saragusty, Joseph/M-5030-2016; Mews, Jürgen/AAE-2494-2020	Saragusty, Joseph/0000-0002-9274-7800; Mews, Jürgen/0000-0001-9745-5818				Adelman JS, 2009, INTEGR COMP BIOL, V49, P202, DOI 10.1093/icb/icp028; [Anonymous], 1998, RHINOCEROS CAPTIVITY; Atkinson Mark W., 2006, P89; Bergman H. J., 2011, Veterinary computed tomography, P457; Biddle R, 2012, E BLACK RHINO EEP DI; Ebedes Hym, 1999, P575; Eksell P, 1999, VET RADIOL ULTRASOUN, V40, P228, DOI 10.1111/j.1740-8261.1999.tb00353.x; Emslie R., 2012, IUCN 2012 IUCN RED L; Farrow CS, 2009, VET DIAGNOSTIC IMAGI, P346; Flach EJ, 2003, TREATMENT OSTEOMYELI, P1; Fowler ME, 2010, RESTRAINT HANDLING W, P343; Fowler Murray E., 2006, P271, DOI 10.1002/9780470344484.ch20; Fowler Murray E., 2006, P75, DOI 10.1002/9780470344484.ch8; Gage Laurie, 2006, P192; Gage Laurie J., 1999, P517; Gage LJ, 1997, J ZOO WILDLIFE MED, V28, P208; Galateanu G, 2013, EXTENSIVE STUDY DIAG, P26; Galateanu G, 2013, NEW CLIN TOOLS RHINO, P128; Galateanu G, 2012, RHINOCEROS FOOT SETP, P40; Galateanu G, 2013, DIAGNOSTIC IMAGING N, P127; Galateanu G, 2012, RHINOCEROS FEET MAKE, P142; Galateanu G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068493; Greer M, 1977, Proceedings of the Oklahoma Academy of Science, V57, P39; Hampson B, 2013, AUST VET J, V91, P23, DOI 10.1111/avj.12017; Harrison TM, 2011, J ZOO WILDLIFE MED, V42, P317, DOI 10.1638/2010-0149.1; Hart BL, 2011, PHILOS T R SOC B, V366, P3406, DOI 10.1098/rstb.2011.0092; Hittmair KM, 2000, VET RADIOL ULTRASOUN, V41, P511, DOI 10.1111/j.1740-8261.2000.tb01879.x; HONNAS CM, 1988, VET RADIOLOGY, V29, P98, DOI 10.1111/j.1740-8261.1988.tb01758.x; Houwald FF, 2001, THESIS U ZURICH ZURI; Hutchinson JR, 2008, ANATOMICAL IMAGING: TOWARDS A NEW MORPHOLOGY, P23, DOI 10.1007/978-4-431-76933-0_3; Hutchinson JR, 2011, SCIENCE, V334, P1699, DOI 10.1126/science.1211437; KASERHOTZ B, 1992, VET RADIOL ULTRASOUN, V33, P9, DOI 10.1111/j.1740-8261.1992.tb01949.x; Kaulfers C, 2010, J ZOO WILDLIFE MED, V41, P697, DOI 10.1638/2009-0168.1; Kirberger RM, 1999, VET RADIOL ULTRASOUN, V40, P220, DOI 10.1111/j.1740-8261.1999.tb00352.x; KOCK RA, 1993, RHINOCEROS BIOLOGY AND CONSERVATION, P325; Liem KF., 2001, FUNCTIONAL ANATOMY V; Miller R.E., 2003, FOWLERS ZOO WILD ANI, P559; Mumby C, 2013, VET RECORD IN PRESS; PETERSON PR, 1988, VET RADIOLOGY, V29, P147, DOI 10.1111/j.1740-8261.1988.tb01767.x; Raath J.P., 1999, P556; Roocroft A, 2001, ELEPHANT'S FOOT, P21; Rose PL, 1997, VET RADIOL ULTRASOUN, V38, P424, DOI 10.1111/j.1740-8261.1997.tb00865.x; Ruohoniemi M, 1999, VET RADIOL ULTRASOUN, V40, P275, DOI 10.1111/j.1740-8261.1999.tb00362.x; Schmitt D.L., 2003, ZOO WILD ANIMAL MED, P541; Seeram E, 2009, CLIN APPL QUALITY CO, P536; SHIVELY MJ, 1988, VET RADIOLOGY, V29, P282; Siegal-Willott J, 2008, J ZOO WILDLIFE MED, V39, P320, DOI 10.1638/2007-0031.1; Siegal-Willott Jessica L., 2012, P515; SMALLWOOD JE, 1985, VET RADIOLOGY, V26, P2, DOI 10.1111/j.1740-8261.1985.tb01105.x; Starrak GS, 1996, VET RADIOL ULTRASOUN, V37, P116, DOI 10.1111/j.1740-8261.1996.tb01207.x; Strauss G, 1982, INT S ERKR ZOOT 24, V24, P177; Talukdar BK, 2008, IUCN 2012 IUCN RED L; Uhlhorn H, 1999, VET RADIOL ULTRASOUN, V40, P480, DOI 10.1111/j.1740-8261.1999.tb00379.x; Uhlhorn H, 1998, VET RADIOL ULTRASOUN, V39, P412, DOI 10.1111/j.1740-8261.1998.tb01626.x; van Strien NJ, 2008, IUCN 2012 IUCN RED L; Versteege L, 2012, 2011 EUROPEAN STUDBO; von Houwald F, 2012, INT STUDBOOK 2011; WALLACH JD, 1967, J AM VET MED ASSOC, V151, P887; West Gary, 2006, P263, DOI 10.1002/9780470344484.ch19; Wobeser G.A., 1994, INVESTIGATION MANAGE; Zuba Jeffery R., 2012, P619	61	3	3	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100415	10.1371/journal.pone.0100415	http://dx.doi.org/10.1371/journal.pone.0100415			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963807	Green Published, gold			2022-12-27	WOS:000338709500048
J	Ge, XY; Yang, LQ; Jiang, Y; Yang, WW; Fu, J; Li, SL				Ge, Xi-Yuan; Yang, Lin-Qian; Jiang, Yang; Yang, Wen-Wen; Fu, Jia; Li, Sheng-Lin			Reactive Oxygen Species and Autophagy Associated Apoptosis and Limitation of Clonogenic Survival Induced by Zoledronic Acid in Salivary Adenoid Cystic Carcinoma Cell Line SACC-83	PLOS ONE			English	Article							HUMAN FIBROSARCOMA CELLS; S-PHASE ARREST; IN-VITRO; POSTMENOPAUSAL OSTEOPOROSIS; PANCREATIC-CANCER; MULTIPLE-MYELOMA; PROSTATE-CANCER; BISPHOSPHONATES; METASTASES; GROWTH	Salivary adenoid cystic carcinoma is an epithelial tumor in the head and neck region. Despite its slow growth, patients with salivary adenoid cystic carcinoma exhibit poor long term survival because of a high rate of distant metastasis. Lung and bone are common distant metastasis sites. Zoledronic acid, a third generation bisphosphonate, has been used for tumor-induced osteolysis due to bone metastasis and has direct antitumor activity in several human neoplasms. Here, we observed that zoledronic acid inhibited salivary adenoid cystic carcinoma cell line SACC-83 xenograft tumor growth in nude mice. In vitro, zoledronic acid induced apoptosis and reduced clonogenic survival in SACC-83. Flow cytometry and western blotting indicated that the cell cycle was arrested at G0/G1. Zoledronic acid treatment upregulated reactive oxygen species as well as the autophagy marker protein LC-3B. Reactive oxygen species scavenger N-acetylcysteine and autophagy antagonist 3-methyladenine decreased zoledronic acid-induced apoptosis and increased clonogenic survival. Silencing of the autophagy related gene Beclin-1 also decreased zoledronic acid-induced apoptosis and inhibition of clonogenic formation. In addition, isobolographic analysis revealed synergistic effects on apoptosis when zoledronic acid and paclitaxel/cisplatin were combined. Taken together, our results suggest that zoledronic acid induced apoptosis and reduced clonogenic survival via upregulation of reactive oxygen species and autophagy in the SACC-83 cell line. Thus, zoledronic acid should be considered a promising drug for the treatment of salivary adenoid cystic carcinoma.	[Ge, Xi-Yuan; Fu, Jia; Li, Sheng-Lin] Peking Univ, Cent Lab, Sch & Hosp Stomatol, Beijing 100871, Peoples R China; [Yang, Lin-Qian; Jiang, Yang; Yang, Wen-Wen; Li, Sheng-Lin] Peking Univ, Dept Oral & Maxillofacial Surg, Sch & Hosp Stomatol, Beijing 100871, Peoples R China	Peking University; Peking University	Li, SL (corresponding author), Peking Univ, Cent Lab, Sch & Hosp Stomatol, Beijing 100871, Peoples R China.	kqshlli@bjmu.edu.cn			National Natural Science Foundation of China [81272966, 81272967]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (Nos. 81272966 and 81272967). URL: http://www.nsfc.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almubarak Hussain, 2011, J Carcinog, V10, P2, DOI 10.4103/1477-3163.75723; [Anonymous], ZHONGHUA KOU QIANG Y; BERENBAUM MC, 1989, PHARMACOL REV, V41, P93; Berenson JR, 2005, ONCOLOGIST, V10, P52, DOI 10.1634/theoncologist.10-1-52; Black DM, 2007, NEW ENGL J MED, V356, P1809, DOI 10.1056/NEJMoa067312; Bruzzese F, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.406; Budman DR, 2006, ONCOLOGY-BASEL, V70, P147, DOI 10.1159/000093006; Chang J, 2012, ONCOL LETT, V4, P299, DOI 10.3892/ol.2012.723; Coleman RE, 2004, ONCOLOGIST, V9, P14, DOI 10.1634/theoncologist.9-90004-14; Corey E, 2003, CLIN CANCER RES, V9, P295; Di Salvatore M, 2011, CELL PROLIFERAT, V44, P139, DOI 10.1111/j.1365-2184.2011.00745.x; Dong L, 2011, J DENT RES, V90, P804, DOI 10.1177/0022034511401407; Dong L, 2013, ORAL ONCOL, V49, P1051, DOI 10.1016/j.oraloncology.2013.07.012; Fordice J, 1999, ARCH OTOLARYNGOL, V125, P149, DOI 10.1001/archotol.125.2.149; GRECO WR, 1995, PHARMACOL REV, V47, P331; Green JR, 2003, CANCER, V97, P840, DOI 10.1002/cncr.11128; Grimm M, 2012, INT ENDOD J, V45, P1156, DOI 10.1111/j.1365-2591.2012.02079.x; Han NL, 2000, PAIN, V85, P465, DOI 10.1016/S0304-3959(99)00294-8; Heymann D, 2004, TRENDS MOL MED, V10, P337, DOI 10.1016/j.molmed.2004.05.007; Hiraga T, 2004, CLIN CANCER RES, V10, P4559, DOI 10.1158/1078-0432.CCR-03-0325; Hitre E, 2013, BR J CANC; Ibrahim T, 2013, INT J ONCOL, V42, P1263, DOI 10.3892/ijo.2013.1809; Ibrahim T, 2012, CANCER CELL INT, V12, DOI 10.1186/1475-2867-12-48; Jagdev SP, 2001, BRIT J CANCER, V84, P1126, DOI 10.1054/bjoc.2001.1727; Jaso J, 2011, ARCH PATHOL LAB MED, V135, P511, DOI 10.1043/2009-0527-RS.1; Koto K, 2013, INT J ONCOL, V42, P525, DOI 10.3892/ijo.2012.1735; Koto K, 2010, ONCOL REP, V24, P233, DOI 10.3892/or_00000851; Li YY, 2008, LUNG CANCER, V59, P180, DOI 10.1016/j.lungcan.2007.08.026; Lin JF, 2011, J UROLOGY, V185, P1490, DOI 10.1016/j.juro.2010.11.045; Liu Q, 2013, CHINESE MED J-PEKING, V126, P1486, DOI 10.3760/cma.j.issn.0366-6999.20122385; MATSUBA HM, 1986, CANCER, V57, P519, DOI 10.1002/1097-0142(19860201)57:3<519::AID-CNCR2820570319>3.0.CO;2-V; Ohnuki H, 2012, ARCH ORAL BIOL, V57, P906, DOI 10.1016/j.archoralbio.2011.11.015; Ozturk OH, 2007, CELL BIOL INT, V31, P1069, DOI 10.1016/j.cellbi.2007.02.004; Polascik Thomas J, 2008, Ther Clin Risk Manag, V4, P261; Recknor C, 2011, EXPERT OPIN PHARMACO, V12, P807, DOI 10.1517/14656566.2011.562201; Richhariya Akshara, 2012, Cancer Manag Res, V4, P55, DOI 10.2147/CMAR.S27693; Romani AA, 2009, BIOCHEM PHARMACOL, V78, P133, DOI 10.1016/j.bcp.2009.04.004; Sewing L, 2008, APOPTOSIS, V13, P782, DOI 10.1007/s10495-008-0211-z; Sieber P, 2013, CLIN DRUG INVEST, V33, P117, DOI 10.1007/s40261-012-0041-1; Silverman SL, 2008, JCR-J CLIN RHEUMATOL, V14, P299, DOI 10.1097/RHU.0b013e318188b1f3; Sung MW, 2003, ARCH OTOLARYNGOL, V129, P1193, DOI 10.1001/archotol.129.11.1193; Tallarida RJ, 2001, J PHARMACOL EXP THER, V298, P865; TALLARIDA RJ, 1992, PAIN, V49, P93, DOI 10.1016/0304-3959(92)90193-F; TALLARIDA RJ, 1992, PAIN, V51, P382, DOI 10.1016/0304-3959(92)90225-Z; Tallarida Ronald J, 2011, Genes Cancer, V2, P1003, DOI 10.1177/1947601912440575; Tassone P, 2003, BRIT J CANCER, V88, P1971, DOI 10.1038/sj.bjc.6600986; van der Wal JE, 2002, HEAD NECK-J SCI SPEC, V24, P779, DOI 10.1002/hed.10126; van Weert S, 2013, ORAL ONCOL, V49, P824, DOI 10.1016/j.oraloncology.2013.05.004; Wang J, 2008, CANCER BIOL THER, V7, P1875, DOI 10.4161/cbt.7.12.7067; XY Li, 2012, MED ONCOL; Zhao M, 2012, CANCER SCI, V103, P58, DOI 10.1111/j.1349-7006.2011.02113.x; Zwolak P, 2010, J BONE JOINT SURG AM, V92A, P162, DOI 10.2106/JBJS.H.01679	52	23	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e101207	10.1371/journal.pone.0101207	http://dx.doi.org/10.1371/journal.pone.0101207			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963720	Green Published, Green Submitted			2022-12-27	WOS:000338709500119
J	Svensson, B; Hansson, L				Svensson, Bengt; Hansson, Lars			Effectiveness of Mental Health First Aid Training in Sweden. A Randomized Controlled Trial with a Six-Month and Two-Year Follow-Up	PLOS ONE			English	Article							STIGMATIZING ATTITUDES; DISORDERS; KNOWLEDGE; ILLNESS; PEOPLE; EXPERIENCES; DEPRESSION; AUSTRALIA; LITERACY; BEHAVIOR	Background: According to a recent report from the European Brain Council and the European Colleague of Neuropsychopharmacology the one year prevalence of some kind of mental disorder is around 27% among the adult population in Europe. Research has shown a lack of mental health literacy in the population in general and it is thus important to find ways to improve the public's knowledge and skills to provide first hand support to people with mental disorders. Mental Health First Aid (MHFA) is a training program that has shown positive changes in knowledge and helping behavior. This study investigates if MHFA training in a Swedish context provides a sustained improvement in knowledge about mental disorders, a better ability to be helpful in contacts with people who are ill and if it changes attitudes in a positive direction. Methods and Findings: The introduction of the training program was made in accordance with the constructor's instructions. Participants were mainly public sector employees from a county in the west of Sweden. The study was a randomized controlled trial with an experiment group (n = 199) and a control group (n = 207) placed on a waiting list during a 6-month follow-up. A two-year follow-up was conducted for participants (n = 155) from both the intervention and waiting list group who had completed the training and during the follow-up been in contact with persons with mental disorders. The intervention group improved in knowledge as well as in confidence in providing help for someone in need. The two-year follow-up showed that the improvements were to a great extent maintained. Conclusions: Mental Health First Aid might raise the level of awareness of mental disorders and have an influence on the number of people who can receive professional treatment for their problems.	[Svensson, Bengt; Hansson, Lars] Lund Univ, Dept Hlth Sci, Lund, Sweden	Lund University	Svensson, B (corresponding author), Lund Univ, Dept Hlth Sci, Lund, Sweden.	Bengt.svensson@med.lu.se			Swedish Board of Health and Welfare	Swedish Board of Health and Welfare	The study was funded by the Swedish Board of Health and Welfare, (www.socialstyrelsen.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angermeyer MC, 2013, BRIT J PSYCHIAT, V203, P146, DOI 10.1192/bjp.bp.112.122978; Eekhout I, 2013, J CLIN EPIDEMIOL; Griffiths KM, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-25; Griffiths KM, 2004, BRIT J PSYCHIAT, V185, P342, DOI 10.1192/bjp.185.4.342; Hossain D, 2010, RURAL REMOTE HEALTH, V10; Hossain D., 2009, AUSTRALAS PSYCHIATRY, V17, P116, DOI [DOI 10.1080/10398560902948365, 10.1080/10398560902948365]; Jorm AF, 2005, BMC PSYCHIATRY, V5, DOI 10.1186/1471-244X-5-43; Jorm AF, 2007, INT J CLIN HLTH PSYC, V7, P141; Jorm AF, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-33; Jorm AF, 2010, AUST NZ J PSYCHIAT, V44, P1072, DOI 10.3109/00048674.2010.516426; Jorm AF, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-51; Kanowski Len G, 2009, Int J Ment Health Syst, V3, P10, DOI 10.1186/1752-4458-3-10; Kelly CM, 2011, INT J MENT HEALTH SY, V5, DOI 10.1186/1752-4458-5-4; Kitchener BA, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-23; Kitchener BA, 2002, BMC PSYCHIATRY, V2, DOI 10.1186/1471-244X-2-10; Lam AYK, 2010, INT J MENT HEALTH SY, V4, DOI 10.1186/1752-4458-4-18; Link BG, 1999, AM J PUBLIC HEALTH, V89, P1328, DOI 10.2105/AJPH.89.9.1328; Minas Harry, 2009, Int J Ment Health Syst, V3, P19, DOI 10.1186/1752-4458-3-19; O'Reilly CL, 2011, AUST NZ J PSYCHIAT, V45, P549, DOI 10.3109/00048674.2011.585454; Pierce D, 2010, INT J MENT HEALTH SY, V4, DOI 10.1186/1752-4458-4-10; Reavley NJ, 2012, BRIT J PSYCHIAT, V200, P419, DOI 10.1192/bjp.bp.111.104208; Reavley NJ, 2011, AUST NZ J PSYCHIAT, V45, P1086, DOI 10.3109/00048674.2011.621061; Sartore GM, 2008, AUST J RURAL HEALTH, V16, P313, DOI 10.1111/j.1440-1584.2008.01005.x; Schomerus G, 2012, ACTA PSYCHIAT SCAND, V125, P440, DOI 10.1111/j.1600-0447.2012.01826.x; Terry J, 2010, J PSYCHIATR MENT HLT, V17, P594, DOI 10.1111/j.1365-2850.2010.01557.x; Wang PS, 2007, WORLD PSYCHIATRY, V6, P177; Wittchen HU, 2011, EUR NEUROPSYCHOPHARM, V21, P655, DOI 10.1016/j.euroneuro.2011.07.018; Wittchen HU, 2005, EUR NEUROPSYCHOPHARM, V15, P357, DOI 10.1016/j.euroneuro.2005.04.012	28	47	47	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100911	10.1371/journal.pone.0100911	http://dx.doi.org/10.1371/journal.pone.0100911			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK8WO	24964164	gold, Green Published			2022-12-27	WOS:000338709500097
J	Tong, K; Skibbens, RV				Tong, Kevin; Skibbens, Robert V.			Cohesin without Cohesion: A Novel Role for Pds5 in Saccharomyces cerevisiae	PLOS ONE			English	Article							SISTER-CHROMATID COHESION; DNA-DAMAGE; NIPPED-B; FISSION YEAST; WAPL CONTROLS; S-PHASE; ESTABLISHMENT; ACETYLATION; COMPLEX; ECO1	High fidelity chromosome segregation during mitosis requires that cells identify the products of DNA replication during S-phase and then maintain that identity until anaphase onset. Sister chromatid identity is achieved through cohesin complexes (Smc1, Smc3, and Mcd1 and Irr1/Scc3), but the structure through which cohesins perform this task remains enigmatic. In the absence of unambiguous data, a popular model is that a subset of cohesin subunits form a huge ring-like structure that embraces both sister chromatids. This 'one-ring two-sister chromatid embrace' model makes clear predictions - including that premature cohesion loss in mitotic cells must occur through a substantial reduction in cohesin-DNA associations. We used chromatin immunoprecipitation to directly test for cohesin dissociation from well-established cohesin binding sites in mitotic cells inactivated for Pds5 - a key cohesin regulatory protein. The results reveal little if any chromatin dissociation from cohesins, despite a regimen that produces both massive loss of sister chromatid tethering and cell inviability. We further excluded models that cohesion loss in mitotic cells inactivated for Pds5 arises through either cohesin subunit degradation, premature Hos1-dependent Smc3 de-acetylation or Rad61/WAPL-dependent regulation of cohesin dynamics. In combination, our findings support a model that cohesin complexes associate with each sister and that sister chromatid cohesion likely results from cohesin-cohesin interactions. We further assessed the role that Pds5 plays in cohesion establishment during S-phase. The results show that Pds5 inactivation can result in establishment defects despite normal cohesion loading and Smc3 acetylation, revealing a novel establishment role for Pds5 that is independent of these processes. The combination of findings provides important new insights that significantly impact current models of both cohesion establishment reactions and maintenance.	[Tong, Kevin; Skibbens, Robert V.] Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA	Lehigh University	Skibbens, RV (corresponding author), Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA.	rvs3@lehigh.edu		Skibbens, Robert/0000-0003-4216-8306	National Institute of General Medical Sciences [GM083269]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM083269, R15GM110631] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Skibbens lab is funded by the National Institute of General Medical Sciences (grant number GM083269). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniacci LM, 2006, CURR BIOL, V16, P902, DOI 10.1016/j.cub.2006.03.060; Beckouet F, 2010, MOL CELL, V39, P689, DOI 10.1016/j.molcel.2010.08.008; Bellows AM, 2003, NUCLEIC ACIDS RES, V31, P6334, DOI 10.1093/nar/gkg811; Ben-Shahar TR, 2008, SCIENCE, V321, P563, DOI 10.1126/science.1157774; Borges V, 2010, MOL CELL, V39, P677, DOI 10.1016/j.molcel.2010.08.009; Braunholz D, 2012, EUR J HUM GENET, V20, P271, DOI 10.1038/ejhg.2011.175; Chan KL, 2013, P NATL ACAD SCI USA, V110, P13020, DOI 10.1073/pnas.1306900110; Chang CR, 2005, GENE DEV, V19, P3031, DOI 10.1101/gad.1356305; Ciosk R, 2000, MOL CELL, V5, P243, DOI 10.1016/S1097-2765(00)80420-7; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; D'Ambrosio LM, 2014, CURR BIOL, V24, P361, DOI 10.1016/j.cub.2013.12.038; Deardorff MA, 2012, NATURE, V489, P313, DOI 10.1038/nature11316; Denes V, 2010, ONCOGENE, V29, P3446, DOI 10.1038/onc.2010.100; Dorsett D, 2011, CURR OPIN GENET DEV, V21, P199, DOI 10.1016/j.gde.2011.01.018; Gandhi R, 2006, CURR BIOL, V16, P2406, DOI 10.1016/j.cub.2006.10.061; Gartenberg M, 2009, CHROMOSOME RES, V17, P229, DOI 10.1007/s10577-008-9012-z; Gause M, 2010, MOL CELL BIOL, V30, P4940, DOI 10.1128/MCB.00642-10; Glynn EF, 2004, PLOS BIOL, V2, P1325, DOI 10.1371/journal.pbio.0020259; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; Guacci V, 2012, MOL BIOL CELL, V23, P729, DOI 10.1091/mbc.E11-08-0696; Heidinger-Pauli JM, 2009, MOL CELL, V34, P311, DOI 10.1016/j.molcel.2009.04.008; Kogut I, 2009, GENE DEV, V23, P2345, DOI 10.1101/gad.1819409; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; Kulemzina I, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002856; Laloraya S, 2000, J CELL BIOL, V151, P1047, DOI 10.1083/jcb.151.5.1047; Lengronne A, 2006, MOL CELL, V23, P787, DOI 10.1016/j.molcel.2006.08.018; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lopez-Serra L, 2013, CURR BIOL, V23, P64, DOI 10.1016/j.cub.2012.11.030; Losada A, 2005, J CELL SCI, V118, P2133, DOI 10.1242/jcs.02355; Lyons NA, 2013, NAT STRUCT MOL BIOL, V20, P194, DOI 10.1038/nsmb.2478; Lyons NA, 2011, MOL CELL, V42, P378, DOI 10.1016/j.molcel.2011.03.023; Machin F, 2005, J CELL BIOL, V168, P209, DOI 10.1083/jcb.200408087; Maffini M, 2008, J STEROID BIOCHEM, V108, P32, DOI 10.1016/j.jsbmb.2007.05.034; Maradeo ME, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015381; Maradeo ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004707; Mayer ML, 2001, MOL CELL, V7, P959, DOI 10.1016/S1097-2765(01)00254-4; Milutinovich M, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030012; Misulovin Z, 2008, CHROMOSOMA, V117, P89, DOI 10.1007/s00412-007-0129-1; Mockel C, 2012, NUCLEIC ACIDS RES, V40, P914, DOI 10.1093/nar/gkr749; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Noble D, 2006, CELL CYCLE, V5, P2528, DOI 10.4161/cc.5.21.3405; Panizza S, 2000, CURR BIOL, V10, P1557, DOI 10.1016/S0960-9822(00)00854-X; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rowland BD, 2009, MOL CELL, V33, P763, DOI 10.1016/j.molcel.2009.02.028; Rudra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075435; Rudra S, 2013, J CELL SCI, V126, P31, DOI 10.1242/jcs.116566; Rudra S, 2012, CELL CYCLE, V11, P2114, DOI 10.4161/cc.20547; Schiller CB, 2012, NAT STRUCT MOL BIOL, V19, P693, DOI 10.1038/nsmb.2323; Sharma U, 2013, MOL CELL BIOL, V33, P3473, DOI 10.1128/MCB.00162-12; Shintomi K, 2009, GENE DEV, V23, P2224, DOI 10.1101/gad.1844309; Skibbens RV, 2007, J CELL SCI, V120, P2471, DOI 10.1242/jcs.011999; Skibbens RV, 2000, GENOME RES, V10, P1664, DOI 10.1101/gr.153600; Skibbens RV, 1999, GENE DEV, V13, P307, DOI 10.1101/gad.13.3.307; Skibbens RV, 2005, J CELL BIOL, V169, P841, DOI 10.1083/jcb.200503129; Stead K, 2003, J CELL BIOL, V163, P729, DOI 10.1083/jcb.200305080; Sutani T, 2009, CURR BIOL, V19, P492, DOI 10.1016/j.cub.2009.01.062; Tanaka K, 2001, EMBO J, V20, P5779, DOI 10.1093/emboj/20.20.5779; Tonkin ET, 2004, NAT GENET, V36, P636, DOI 10.1038/ng1363; Unal E, 2007, SCIENCE, V317, P245, DOI 10.1126/science.1140637; Unal E, 2004, MOL CELL, V16, P991, DOI 10.1016/j.molcel.2004.11.027; Unal E, 2008, SCIENCE, V321, P566, DOI 10.1126/science.1157880; Vega H, 2005, NAT GENET, V37, P468, DOI 10.1038/ng1548; Wang SW, 2002, J CELL SCI, V115, P587; Xiong B, 2010, CURR BIOL, V20, P1660, DOI 10.1016/j.cub.2010.08.019; Zhang B, 2007, DEVELOPMENT, V134, P3191, DOI 10.1242/dev.005884; Zhang B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005232; Zhang JL, 2008, MOL CELL, V31, P143, DOI 10.1016/j.molcel.2008.06.006; Zhang NG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069458; Zhang ZJ, 2005, MOL MICROBIOL, V56, P670, DOI 10.1111/j.1365-2958.2005.04582.x	73	22	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100470	10.1371/journal.pone.0100470	http://dx.doi.org/10.1371/journal.pone.0100470			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963665	Green Published, gold			2022-12-27	WOS:000338709500055
J	Brien, ML; Webb, GJ; McGuinness, K; Christian, KA				Brien, Matthew L.; Webb, Grahame J.; McGuinness, Keith; Christian, Keith A.			The Relationship between Early Growth and Survival of Hatchling Saltwater Crocodiles (Crocodylus porosus) in Captivity	PLOS ONE			English	Article							EGG SIZE VARIATION; BODY-SIZE; EVOLUTIONARY ECOLOGY; OFFSPRING FITNESS; CLUTCH SIZE; PATTERNS; TEMPERATURE; POPULATION; SEX; SURVIVORSHIP	Hatchling fitness in crocodilians is affected by "runtism'' or failure to thrive syndrome (FTT) in captivity. In this study, 300 hatchling C. porosus, artificially incubated at 32 degrees C for most of their embryonic development, were raised in semi-controlled conditions, with growth criteria derived for the early detection of FTT (within 24 days). Body mass, four days after hatching (BM4d), was correlated with egg size and was highly clutch specific, while snout-vent length (SVL4d) was much more variable within and between clutches. For the majority of hatchlings growth trajectories within the first 24 days continued to 90 days and could be used to predict FTT affliction up to 300 days, highlighting the importance of early growth. Growth and survival of hatchling C. porosus in captivity was not influenced by initial size (BM4d), with a slight tendency for smaller hatchlings to grow faster in the immediate post-hatching period. Strong clutch effects (12 clutches) on affliction with FTT were apparent, but could not be explained by measured clutch variables or other factors. Among individuals not afflicted by FTT (N = 245), mean growth was highly clutch specific, and the variation could be explained by an interaction between clutch and season. FTT affliction was 2.5 times higher among clutches (N = 7) that hatched later in the year when mean minimum air temperatures were lower, compared with those clutches (N = 5) that hatched early in the year. The results of this study highlight the importance of early growth in hatchling C. porosus, which has implications for the captive management of this species.	[Brien, Matthew L.; Webb, Grahame J.; McGuinness, Keith; Christian, Keith A.] Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT 0909, Australia; [Brien, Matthew L.; Webb, Grahame J.] Wildlife Management Int Pty Ltd, Karama, NT, Australia	Charles Darwin University	Brien, ML (corresponding author), Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT 0909, Australia.	matthew_brien@hotmail.com		Christian, Keith/0000-0001-6135-1670	Holsworth Wildlife Research Endowment (ANZ Trustees Foundation); Northern Territory Research and Innovation Board student grant; Charles Darwin University; Wildlife Management International Pty. Limited	Holsworth Wildlife Research Endowment (ANZ Trustees Foundation); Northern Territory Research and Innovation Board student grant; Charles Darwin University; Wildlife Management International Pty. Limited	This work was supported by a Holsworth Wildlife Research Endowment (ANZ Trustees Foundation), Northern Territory Research and Innovation Board student grant, and Charles Darwin University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Wildlife Management International Pty. Limited provided funding through the Rural Industries Research and Development Corporation. Wildlife Management International Pty. Limited also provided support in the form of salary for authors Matthew L. Brien and Grahame J. Webb, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ALLSTEADT J, 1995, PHYSIOL ZOOL, V68, P76, DOI 10.1086/physzool.68.1.30163919; Anderson M.J., 2008, PERMANOVA PRIMER GUI; [Anonymous], [No title captured]; Berger L, 1977, Zoologica pol, V26, P291; Birkhead TR, 1999, P ROY SOC B-BIOL SCI, V266, P385, DOI 10.1098/rspb.1999.0649; BOBYN ML, 1994, J ZOOL, V233, P233, DOI 10.1111/j.1469-7998.1994.tb08586.x; Brien ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080872; Brien ML, 2013, AUST J ZOOL, V61, P196, DOI 10.1071/ZO13035; Brien ML, 2013, BEHAVIOUR, V150, P737, DOI 10.1163/1568539X-00003078; Bronikowski AM, 1999, ECOLOGY, V80, P2314, DOI 10.1890/0012-9658(1999)080[2314:TEEOLH]2.0.CO;2; Bronikowski AM, 2000, EVOLUTION, V54, P1760; BUENVIAJE GN, 1994, AUST VET J, V71, P165, DOI 10.1111/j.1751-0813.1994.tb03381.x; Carpenter C.C., 1977, P335; Chalfoun AD, 2007, J APPL ECOL, V44, P983, DOI 10.1111/j.1365-2664.2007.01352.x; CHAMOVE AS, 1988, ZOO BIOL, V7, P359, DOI 10.1002/zoo.1430070407; CHARLAND MB, 1989, CAN J ZOOL, V67, P1620, DOI 10.1139/z89-231; Congdon JD, 1999, OECOLOGIA, V121, P224, DOI 10.1007/s004420050924; Connor RC, 2000, CETACEAN SOCIETIES, P91; Couquiaud L, 2005, AQUAT MAMM, V31, P288; Davis BM, 2001, 01123 RUR IND RES DE; DeKogel CH, 1997, J ANIM ECOL, V66, P167; DUNHAM AE, 1985, AM NAT, V126, P231, DOI 10.1086/284411; Fox CW, 2000, ANNU REV ENTOMOL, V45, P341, DOI 10.1146/annurev.ento.45.1.341; GALATTI U, 1992, J HERPETOL, V26, P23, DOI 10.2307/1565017; GARNETT ST, 1986, J ZOOL, V208, P493; GARNETT ST, 1986, AUST J ZOOL, V34, P211, DOI 10.1071/ZO9860211; GITTLEMAN JL, 1986, AM NAT, V127, P744, DOI 10.1086/284523; GOETZ BGR, 1994, NEW ZEAL J ZOOL, V21, P473, DOI 10.1080/03014223.1994.9518017; Grant P. R., 1986, ECOLOGY EVOLUTION DA; HENRICH S, 1988, OIKOS, V51, P13, DOI 10.2307/3565801; Henry C. K. Jeya, 1996, LONG TERM CONSEQUENC; Huchzermeyer F.W., 2003, CROCODILES BIOL HUSB; HUTCHINGS JA, 1991, EVOLUTION, V45, P1162, DOI 10.1111/j.1558-5646.1991.tb04382.x; HUTCHINGS JA, 1985, OIKOS, V45, P118, DOI 10.2307/3565229; Hutton J.M., 1992, P1; HUTTON JM, 1987, J ZOOL, V211, P143, DOI 10.1111/j.1469-7998.1987.tb07458.x; Isberg S., 2009, IMPROVING AUSTR CROC, P4; Jamerlan ML, 2002, THESIS U QUEENSLAND; Janzen FJ, 2000, J EVOLUTION BIOL, V13, P947, DOI 10.1046/j.1420-9101.2000.00234.x; JAYNE BC, 1990, EVOLUTION, V44, P1204, DOI 10.1111/j.1558-5646.1990.tb05226.x; Joanen T., 1976, Proceedings a Meet Wld Maricult Soc, V7, P201; Joanen T., 1987, P533; JORGENSEN SE, 1992, ECOL MODEL, V62, P195, DOI 10.1016/0304-3800(92)90091-R; KAPLAN RH, 1980, EVOLUTION, V34, P51, DOI 10.1111/j.1558-5646.1980.tb04788.x; KARLSSON B, 1985, ECOL ENTOMOL, V10, P205, DOI 10.1111/j.1365-2311.1985.tb00549.x; KENWARD RE, 1974, J WILDLIFE MANAGE, V38, P751, DOI 10.2307/3800041; Kissner KJ, 2005, J ANIM ECOL, V74, P259, DOI 10.1111/j.1365-2656.2005.00919.x; Lang J.W., 1987, P273; Lindburg D.G., 1984, P162; Maddox JD, 2008, AM NAT, V171, P358, DOI 10.1086/527500; Madsen T, 2000, J ANIM ECOL, V69, P952, DOI 10.1046/j.1365-2656.2000.00477.x; MARSH E, 1986, COPEIA, P18; Mason GJ, 2010, TRENDS ECOL EVOL, V25, P713, DOI 10.1016/j.tree.2010.08.011; Mayer R, 1998, CROCODILE FARMING RE; MAZZOTTI FJ, 1986, HERPETOLOGICA, V42, P191; MCGEHEE MA, 1990, HERPETOLOGICA, V46, P251; MCGINLEY MA, 1989, EVOL ECOL, V3, P150, DOI 10.1007/BF02270917; Messel H, 1981, SURVEYS TIDAL RIVER, V1; Packard G.C., 1988, BIOL REPTILIA, V16, P523; Peter J.-J., 1975, P187; PHILLIPS JA, 1993, PHYSIOL BEHAV, V53, P81, DOI 10.1016/0031-9384(93)90014-7; Riese G, 1991, THESIS U QUEENSLAND; Ross J. P., 1998, CROCODILES STATUS SU; SAS Institute, 2010, JMP STAT GRAPH GUID; Seibert LM, 2006, MANUAL OF PARROT BEHAVIOR, P255, DOI 10.1002/9780470344651.ch23; SINERVO B, 1990, EVOLUTION, V44, P279, DOI 10.1111/j.1558-5646.1990.tb05198.x; SMITH CC, 1974, AM NAT, V108, P499, DOI 10.1086/282929; Stamps JA, 1998, AM NAT, V152, P470, DOI 10.1086/286183; STEARNS SC, 1983, OIKOS, V41, P173, DOI 10.2307/3544261; STEINWASCHER K, 1984, AM MIDL NAT, V112, P76, DOI 10.2307/2425459; Turton JA, 1997, AUST VET J, V75, P114, DOI 10.1111/j.1751-0813.1997.tb14170.x; van Zeeland YRA, 2009, APPL ANIM BEHAV SCI, V121, P75, DOI 10.1016/j.applanim.2009.09.006; Webb G., 1989, CROCODILES AUSTR; Webb G.J.W., 1987, P423; Webb G.J.W., 1987, P417; Webb G.J.W., 1994, P 12 WORK M CROC SPE, P176; WEBB GJW, 1987, COPEIA, P252; WEBB GJW, 1977, J WILDLIFE MANAGE, V41, P572, DOI 10.2307/3800531; WEBB GJW, 1989, AM ZOOL, V29, P953; WEBB GJW, 1977, COPEIA, P238; WEBB GJW, 1983, AUST WILDLIFE RES, V10, P563; Webb GJW, 1987, WILDLIFE MANAGEMENT, P189; WIGGINS DA, 1991, EVOLUTION, V45, P1169, DOI 10.1111/j.1558-5646.1991.tb04383.x; WILSON PN, 1960, BIOL REV, V35, P324, DOI 10.1111/j.1469-185X.1960.tb01327.x; Worner LLB, 2009, THESIS VICTORIA U	85	8	12	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100276	10.1371/journal.pone.0100276	http://dx.doi.org/10.1371/journal.pone.0100276			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24960026	Green Published, gold, Green Submitted			2022-12-27	WOS:000338633900035
J	Tian, ZW; Wang, CH; Hu, CJ; Tian, YH; Liu, JB; Wang, XJ				Tian, Zongwen; Wang, Changhua; Hu, Chengjun; Tian, Yihao; Liu, Jinbao; Wang, Xuejun			Autophagic-Lysosomal Inhibition Compromises Ubiquitin-Proteasome System Performance in a p62 Dependent Manner in Cardiomyocytes	PLOS ONE			English	Article							MOUSE MODEL; HEART; DEGRADATION; MATURATION; AGGREGATION; IMPAIRMENT; STARVATION; RECEPTORS; VACUOLES; PATHWAY	Intracellular protein degradation is primarily performed by the ubiquitin-proteasome system (UPS) and the autophagic-lysosomal pathway (ALP). The interplay between these two pathways has been rarely examined in intact animals and the mechanism underlying the interplay remains unclear. Hence, we sought to test in vivo and in vitro the impact of inhibition of the ALP on UPS proteolytic performance in cardiomyocytes and to explore the underlying mechanism. Transgenic mice ubiquitously expressing a surrogate UPS substrate (GFPdgn) were treated with bafilomycin-A1 (BFA) to inhibit the ALP. Myocardial and renal GFPdgn protein levels but not mRNA levels were increased at 24 hours but not 3 hours after the first injection of BFA. Myocardial protein abundance of key proteasome subunits and the activities of proteasomal peptidases were not discernibly altered by the treatment. In cultured neonatal rat ventricular myocytes (NRVMs), the surrogate UPS substrate GFPu and a control red fluorescence protein (RFP) were co-expressed to probe UPS performance. At 12 hours or 24 hours after ALP inhibition by 3-methyladenine (3-MA) or BFA, GFPu/RFP protein ratios and the protein half-life of GFPu were significantly increased, which is accompanied by increases in p62 proteins. Similar findings were obtained when ALP was inhibited genetically via silencing Atg7 or Rab7. ALP inhibition-induced increases in GFPu and p62 are co-localized in NRVMs. siRNA-mediated p62 knockdown prevented ALP inhibition from inducing GFPu accumulation in NRVMs. We conclude that in a p62-dependent fashion, ALP inhibition impairs cardiac UPS proteolytic performance in cardiomyocytes in vitro and in vivo.	[Tian, Zongwen; Wang, Changhua; Hu, Chengjun; Tian, Yihao; Wang, Xuejun] Univ S Dakota, Sanford Sch Med, Div Basic Biomed Sci, Vermillion, SD 57069 USA; [Liu, Jinbao] Guangzhou Med Univ, Dept Pathophysiol, Prot Modificat & Degradat Lab, Guangzhou, Guangdong, Peoples R China; [Liu, Jinbao] Guangzhou Med Univ, Dept Biochem, Prot Modificat & Degradat Lab, Guangzhou, Guangdong, Peoples R China	University of South Dakota; Guangzhou Medical University; Guangzhou Medical University	Wang, XJ (corresponding author), Univ S Dakota, Sanford Sch Med, Div Basic Biomed Sci, Vermillion, SD 57069 USA.	xuejun.wang@usd.edu	Wang, Xuejun/AAT-9490-2021; Wang, Xuejun/K-8874-2013	Wang, Xuejun/0000-0001-9267-1343; Wang, Xuejun/0000-0001-9267-1343; Hu, Chengjun/0000-0002-7491-3756	US National Institutes of Health [R01HL085629, R01HL072166]; American Heart Association Established Investigator Award [0740025N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072166, R01HL085629] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Established Investigator Award(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by US National Institutes of Health grants R01HL085629 and R01HL072166 and an American Heart Association Established Investigator Award (0740025N) (to X. W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao X, 2014, CELL DEATH DIFFER, V21, P348, DOI 10.1038/cdd.2013.187; Appelqvist H, 2013, J MOL CELL BIOL, V5, P214, DOI 10.1093/jmcb/mjt022; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Birgisdottir AB, 2013, J CELL SCI, V126, P3237, DOI 10.1242/jcs.126128; Day SM, 2013, AM J PHYSIOL-HEART C, V304, pH1283, DOI 10.1152/ajpheart.00249.2012; Dong X, 2004, AM J PHYSIOL-HEART C, V287, pH1417, DOI 10.1152/ajpheart.01233.2003; Eskelinen EL, 2005, AUTOPHAGY, V1, P1, DOI 10.4161/auto.1.1.1270; Giricz Z, 2012, J CARDIOVASC PHARM, V60, P125, DOI 10.1097/FJC.0b013e318256ce10; Guo R, 2012, CARDIOVASC RES, V94, P480, DOI 10.1093/cvr/cvs127; Gustafsson AB, 2009, CIRC RES, V104, P150, DOI 10.1161/CIRCRESAHA.108.187427; Ichimura Y, 2008, AUTOPHAGY, V4, P1063, DOI 10.4161/auto.6826; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Kaushik S, 2012, TRENDS CELL BIOL, V22, P407, DOI 10.1016/j.tcb.2012.05.006; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Korolchuk VI, 2010, FEBS LETT, V584, P1393, DOI 10.1016/j.febslet.2009.12.047; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Kostin S, 2003, CIRC RES, V92, P715, DOI 10.1161/01.RES.0000067471.95890.5C; Kubli DA, 2012, CIRC RES, V111, P1208, DOI 10.1161/CIRCRESAHA.112.265819; Kumarapeli ARK, 2005, FASEB J, V19, P2051, DOI 10.1096/fj.05-3973fje; Lei DX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067793; Lindsten K, 2003, NAT BIOTECHNOL, V21, P897, DOI 10.1038/nbt851; Morales CR, 2014, ANTIOXID REDOX SIGN, V20, P507, DOI 10.1089/ars.2013.5359; Qiao LY, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-17; Ranek MJ, 2014, J MOL CELL CARDIOL, V69, P43, DOI 10.1016/j.yjmcc.2014.01.017; Ranek MJ, 2013, CIRCULATION, V128, P365, DOI 10.1161/CIRCULATIONAHA.113.001971; Schlossarek S, 2012, BASIC RES CARDIOL, V107, DOI [10.1007/s00395-00011-00235-00393, DOI 10.1007/S00395-00011-00235-00393]; Schlossarek S, 2011, CURR OPIN CARDIOL, V26, P190, DOI 10.1097/HCO.0b013e32834598fe; Sciarretta S, 2012, J CARDIOVASC PHARM, V60, P235, DOI 10.1097/FJC.0b013e3182575f61; Su HB, 2011, TRENDS CARDIOVAS MED, V21, P224, DOI 10.1016/j.tcm.2012.05.015; Su HB, 2011, CIRCULATION, V124, P2117, DOI 10.1161/CIRCULATIONAHA.111.048934; Taherbhoy AM, 2011, MOL CELL, V44, P451, DOI 10.1016/j.molcel.2011.08.034; Tang MX, 2010, CARDIOVASC RES, V88, P424, DOI 10.1093/cvr/cvq217; Tannous P, 2008, CIRCULATION, V117, P3070, DOI 10.1161/CIRCULATIONAHA.107.763870; Tian ZW, 2012, CIRC RES, V111, P532, DOI 10.1161/CIRCRESAHA.112.270983; Tydlacka S, 2008, J NEUROSCI, V28, P13285, DOI 10.1523/JNEUROSCI.4393-08.2008; Wang XJ, 2013, AUTOPHAGY, V9, P1500, DOI 10.4161/auto.25573; Wang XJ, 2001, CIRCULATION, V103, P2402, DOI 10.1161/01.cir.103.19.2402; Wang XJ, 2014, J MOL CELL CARDIOL, V71, P16, DOI 10.1016/j.yjmcc.2013.11.006; Wang XJ, 2013, J MOL CELL CARDIOL, V55, P73, DOI 10.1016/j.yjmcc.2012.09.012; Wang XJ, 2013, CIRC RES, V112, P367, DOI 10.1161/CIRCRESAHA.112.268706; Xie M, 2014, CIRCULATION, V129, P1139, DOI 10.1161/CIRCULATIONAHA.113.002416; Xu XH, 2013, CARDIOVASC RES, V99, P412, DOI 10.1093/cvr/cvt116; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Young GW, 2008, TRENDS CARDIOVAS MED, V18, P93, DOI 10.1016/j.tcm.2008.01.004; Zheng QW, 2011, AM J CARDIOVASC DIS, V1, P214; Zheng QW, 2011, CIRC RES, V109, P296, DOI 10.1161/CIRCRESAHA.111.244707	48	29	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100715	10.1371/journal.pone.0100715	http://dx.doi.org/10.1371/journal.pone.0100715			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959866	gold, Green Published, Green Submitted			2022-12-27	WOS:000338633900074
J	Roy, S; Shrinivas, K; Bagchi, B				Roy, Susmita; Shrinivas, Krishna; Bagchi, Biman			A Stochastic Chemical Dynamic Approach to Correlate Autoimmunity and Optimal Vitamin-D Range	PLOS ONE			English	Article							REGULATORY T-CELLS; D ENDOCRINE SYSTEM; DENDRITIC CELLS; D-RECEPTOR; 25-HYDROXYVITAMIN D-3; IMMUNE-SYSTEM; DIFFERENTIATION; ACTIVATION; EXPRESSION; SUBPOPULATIONS	Motivated by several recent experimental observations that vitamin-D could interact with antigen presenting cells (APCs) and T-lymphocyte cells (T-cells) to promote and to regulate different stages of immune response, we developed a coarse grained but general kinetic model in an attempt to capture the role of vitamin-D in immunomodulatory responses. Our kinetic model, developed using the ideas of chemical network theory, leads to a system of nine coupled equations that we solve both by direct and by stochastic (Gillespie) methods. Both the analyses consistently provide detail information on the dependence of immune response to the variation of critical rate parameters. We find that although vitamin-D plays a negligible role in the initial immune response, it exerts a profound influence in the long term, especially in helping the system to achieve a new, stable steady state. The study explores the role of vitamin-D in preserving an observed bistability in the phase diagram (spanned by system parameters) of immune regulation, thus allowing the response to tolerate a wide range of pathogenic stimulation which could help in resisting autoimmune diseases. We also study how vitamin-D affects the time dependent population of dendritic cells that connect between innate and adaptive immune responses. Variations in dose dependent response of anti-inflammatory and pro-inflammatory T-cell populations to vitamin-D correlate well with recent experimental results. Our kinetic model allows for an estimation of the range of optimum level of vitamin-D required for smooth functioning of the immune system and for control of both hyper-regulation and inflammation. Most importantly, the present study reveals that an overdose or toxic level of vitamin-D or any steroid analogue could give rise to too large a tolerant response, leading to an inefficacy in adaptive immune function.	[Roy, Susmita; Shrinivas, Krishna; Bagchi, Biman] Indian Inst Sci, SSCU, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Bagchi, B (corresponding author), Indian Inst Sci, SSCU, Bangalore 560012, Karnataka, India.	profbiman@gmail.com	Shrinivas, Krishna/ABF-1250-2020	Shrinivas, Krishna/0000-0002-4167-9385; BAGCHI, BIMAN/0000-0002-7146-5994	Department of Science and Technology (DST), India; Sir J.C. Bose Fellowship (DST)	Department of Science and Technology (DST), India(Department of Science & Technology (India)); Sir J.C. Bose Fellowship (DST)	This work was supported in parts by grants from Department of Science and Technology (DST), India and Sir J.C. Bose Fellowship (DST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adorini L, 2005, CELL IMMUNOL, V233, P115, DOI 10.1016/j.cellimm.2005.04.013; Adorini L, 2003, ANN NY ACAD SCI, V987, P258, DOI 10.1111/j.1749-6632.2003.tb06057.x; Autier P, 2007, ARCH INTERN MED, V167, P1730, DOI 10.1001/archinte.167.16.1730; Bates MF, 2014, PEDIATRICS, V133, pE39, DOI 10.1542/peds.2013-2418; Bikle D, 2009, J CLIN ENDOCR METAB, V94, P26, DOI 10.1210/jc.2008-1454; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Chaudhury S, 2013, J PHYS CHEM B, V117, P503, DOI 10.1021/jp3096659; Christen U, 2004, CURR OPIN IMMUNOL, V16, P759, DOI 10.1016/j.coi.2004.09.002; Correale J, 2009, BRAIN, V132, P1146, DOI 10.1093/brain/awp033; Cutolo M, 2011, AUTOIMMUN REV, V11, P84, DOI 10.1016/j.autrev.2011.08.003; Cutolo M, 2011, VITAM HORM, V86, P327, DOI 10.1016/B978-0-12-386960-9.00014-9; Das J, 2009, CELL, V136, P337, DOI 10.1016/j.cell.2008.11.051; de Pillis L, 2013, DISCRETE CONT DYN-B, V18, P915, DOI 10.3934/dcdsb.2013.18.915; Dimeloe S, 2010, J STEROID BIOCHEM, V120, P86, DOI 10.1016/j.jsbmb.2010.02.029; Fearnley DB, 1999, BLOOD, V93, P728, DOI 10.1182/blood.V93.2.728.402k03_728_736; Finsen NR, 1903, COUNT KAH MORN RECT; Fleet JC, 2004, J NUTR, V134, P3215, DOI 10.1093/jn/134.12.3215; Fouchet D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002306; Ghosh S, 2012, EUR PHYS J E, V35, DOI 10.1140/epje/i2012-12011-4; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Gregori S, 2001, J IMMUNOL, V167, P1945, DOI 10.4049/jimmunol.167.4.1945; Harris SS, 2005, J NUTR, V135, P323, DOI 10.1093/jn/135.2.323; Hewison M, 2012, CLIN ENDOCRINOL, V76, P315, DOI 10.1111/j.1365-2265.2011.04261.x; Hewison M, 2011, VITAM HORM, V86, P23, DOI 10.1016/B978-0-12-386960-9.00002-2; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hong T, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-66; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; Hypponen E, 2009, ALLERGY, V64, P613, DOI 10.1111/j.1398-9995.2008.01865.x; Jeffery LE, 2012, IMMUNOLOGY, V137, P125; JERNE NK, 1974, ANN INST PASTEUR IMM, VC125, P373; Jones G, 2012, ARCH BIOCHEM BIOPHYS, V523, P9, DOI 10.1016/j.abb.2011.11.003; Jonuleit H, 2000, J EXP MED, V192, P1213, DOI 10.1084/jem.192.9.1213; Jonuleit H, 2001, TRENDS IMMUNOL, V22, P394, DOI 10.1016/S1471-4906(01)01952-4; Kamen D, 2008, CURR OPIN RHEUMATOL, V20, P532, DOI 10.1097/BOR.0b013e32830a991b; Kamen DL, 2010, J MOL MED, V88, P441, DOI 10.1007/s00109-010-0590-9; Leon K, 2000, J THEOR BIOL, V207, P231, DOI 10.1006/jtbi.2000.2169; LIGTHART GJ, 1985, IMMUNOLOGY, V55, P15; Ling EM, 2004, LANCET, V363, P608, DOI 10.1016/S0140-6736(04)15592-X; Lo WC, 2013, B MATH BIOL, V75, P1417, DOI 10.1007/s11538-013-9853-2; Lutz MB, 2002, TRENDS IMMUNOL, V23, P445, DOI 10.1016/S1471-4906(02)02281-0; Mandlik V, 2012, INTEGR BIOL-UK, V4, P1130, DOI 10.1039/c2ib20037f; Martinez-Pasamar S, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-34; Min W, 2008, J PHYS CHEM B, V112, P454, DOI 10.1021/jp076533c; Min W, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3207274; Moller KI, 2005, PHOTODERMATOL PHOTO, V21, P118, DOI 10.1111/j.1600-0781.2005.00159.x; Moyad MA, 2009, DERMATOLOGY NURSING, V21, P1; Opferman JT, 1999, SCIENCE, V283, P1745, DOI 10.1126/science.283.5408.1745; Peelen E, 2011, AUTOIMMUN REV, V10, P733, DOI 10.1016/j.autrev.2011.05.002; Penna G, 2005, BLOOD, V106, P3490, DOI 10.1182/blood-2005-05-2044; Piemonti L, 2000, J IMMUNOL, V164, P4443, DOI 10.4049/jimmunol.164.9.4443; Pike JW, 2012, REV ENDOCR METAB DIS, V13, P45, DOI 10.1007/s11154-011-9198-9; Powrie F, 2003, SCIENCE, V299, P1030, DOI 10.1126/science.1082031; Qian H, 2003, BIOPHYS CHEM, V105, P585, DOI 10.1016/S0301-4622(03)00068-1; Qian H, 2009, PHYS CHEM CHEM PHYS, V11, P4861, DOI 10.1039/b900335p; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Ross AC, 2011, Dietary Reference Intakes for Calcium and Vitamin D, P1; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sanders KM, 2013, CALCIFIED TISSUE INT, V92, P191, DOI 10.1007/s00223-012-9679-1; Santra M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066112; Santra M, 2012, J PHYS CHEM B, V116, P11809, DOI 10.1021/jp305045w; Sasmal DK, 2013, LANGMUIR, V29, P2289, DOI 10.1021/la3043473; Schuster I, 2006, ANTICANCER RES, V26, P2653; Stolzenberg-Solomon RZ, 2010, AM J EPIDEMIOL, V172, P81, DOI 10.1093/aje/kwq120; Takeyama K, 1997, SCIENCE, V277, P1827, DOI 10.1126/science.277.5333.1827; Turner TE, 2004, COMPUT BIOL CHEM, V28, P165, DOI 10.1016/j.compbiolchem.2004.05.001; von Essen MR, 2010, NAT IMMUNOL, V11, P344, DOI 10.1038/ni.1851; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; Whitmire JK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000041; Wilhelm T, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-90; Williams CJ, 1849, LOND J MED, V1, P1, DOI DOI 10.1136/BMJ.S2-1.1.1; Wu ZH, 2012, BIOPHYS J, V103, P1052, DOI 10.1016/j.bpj.2012.08.008	71	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100635	10.1371/journal.pone.0100635	http://dx.doi.org/10.1371/journal.pone.0100635			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971516	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000338512200047
J	Wu, AC; Ral, JP; Morell, MK; Gilbert, RG				Wu, Alex Chi; Ral, Jean-Philippe; Morell, Matthew K.; Gilbert, Robert G.			New Perspectives on the Role of alpha- and beta-Amylases in Transient Starch Synthesis	PLOS ONE			English	Article							GRANULE BIOSYNTHESIS; ARABIDOPSIS LEAVES; LEAF STARCH; DISPROPORTIONATING ENZYME; CHLAMYDOMONAS-REINHARDTII; DEBRANCHING ENZYMES; BRANCHING ENZYMES; DOWN-REGULATION; RICE ENDOSPERM; WATER DIKINASE	Transient starch in leaves is synthesized by various biosynthetic enzymes in the chloroplasts during the light period. This paper presents the first mathematical model for the (bio) synthesis of the chain-length distribution (CLD) of transient starch to aid the understanding of this synthesis. The model expresses the rate of change of the CLD in terms of the actions of the enzymes involved. Using this to simulate the experimental CLD with different enzyme combinations is a new means to test for enzymes that are significant to the rate of change of the CLD during synthesis. Comparison between the simulated CLD from different enzyme combinations and the experimental CLD in the leaves of the model plant Arabidopsis thaliana indicate alpha-amylase, in addition to the core starch biosynthetic enzymes, is also involved in the modification of glucans for the synthesis of insoluble starch granules. The simulations suggest involvement of beta-amylase, in the absence of alpha-amylase in mutants, slows the rate of attaining a crystalline-competent CLD for crystallization of glucans to form insoluble starch. This suggests a minor role of beta-amylase in shaping normal starch synthesis. The model simulation predicts that debranching of glucans is an efficient mechanism for the attainment of crystalline-competent CLD; however, attaining this is still possible, albeit slower, through combinations of alpha- and beta-amylase in the absence of isoamylase-type debranching enzyme. In Arabidopsis defective in one of the isoamylase-type debranching enzymes, the impact of alpha-amylase in starch synthesis is reduced, while beta-amylase becomes significantly involved, slowing the rate of synthesis in this mutant. Modeling of transient starch CLD brings to light previously unrecognized but significant effects of alpha- and beta-amylase on the rate of transient starch synthesis.	[Wu, Alex Chi; Gilbert, Robert G.] Huazhong Univ Sci & Technol, Tongji Sch Pharm, Wuhan 430074, Hubei Province, Peoples R China; [Wu, Alex Chi; Gilbert, Robert G.] Univ Queensland, Ctr Nutr & Food Sci, Queensland Alliance Agr & Food Innovat, Brisbane, Qld, Australia; [Ral, Jean-Philippe; Morell, Matthew K.] CSIRO, Food Futures Natl Res Flagship, Canberra, ACT, Australia; [Ral, Jean-Philippe; Morell, Matthew K.] CSIRO, Canberra, ACT, Australia	Huazhong University of Science & Technology; University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Gilbert, RG (corresponding author), Huazhong Univ Sci & Technol, Tongji Sch Pharm, Wuhan 430074, Hubei Province, Peoples R China.	b.gilbert@uq.edu.au	Morell, Matthew/AAQ-5368-2021; Gilbert, Robert G/C-5660-2009; Wu, Alex/C-3513-2017; Ral, Jean-Philippe/H-5632-2012; Ral, Jean-Philippe/Q-1711-2019	Morell, Matthew/0000-0003-4467-1626; Gilbert, Robert G/0000-0001-6988-114X; Wu, Alex/0000-0002-6612-7691; Ral, Jean-Philippe/0000-0002-3226-6204	Australian Postgraduate Award; CSIRO Food Future Flagship Postgraduate (top-up) Scholarship	Australian Postgraduate Award(Australian Government); CSIRO Food Future Flagship Postgraduate (top-up) Scholarship	This work is supported by an Australian Postgraduate Award (http://www.innovation.gov.au/research/researchblockgrants/pages/australianpostgraduateawards.aspx) and CSIRO Food Future Flagship Postgraduate (top-up) Scholarship (http://www.csiro.au/Portals/Careers/Work-experience-and-scholarships/Postgraduate-scholarships/Flagship-Postgrad-Scholarships.aspx#food). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball SG, 2003, ANNU REV PLANT BIOL, V54, P207, DOI 10.1146/annurev.arplant.54.031902.134927; Butardo VM, 2011, J EXP BOT, V62, P4927, DOI 10.1093/jxb/err188; Colleoni C, 1999, PLANT PHYSIOL, V120, P993, DOI 10.1104/pp.120.4.993; Critchley JH, 2001, PLANT J, V26, P89, DOI 10.1046/j.1365-313x.2001.01012.x; Dauvillee D, 2006, PLANT J, V48, P274, DOI 10.1111/j.1365-313X.2006.02870.x; Delatte T, 2005, PLANT J, V41, P815, DOI 10.1111/j.1365-313X.2005.02348.x; Fujita N, 2003, PLANT CELL PHYSIOL, V44, P607, DOI 10.1093/pcp/pcg079; Fulton DC, 2008, PLANT CELL, V20, P1040, DOI 10.1105/tpc.107.056507; Kotting O, 2005, PLANT PHYSIOL, V137, P242, DOI 10.1104/pp.104.055954; Lloyd JR, 2005, TRENDS PLANT SCI, V10, P130, DOI 10.1016/j.tplants.2005.01.001; Mikkelsen R, 2005, P NATL ACAD SCI USA, V102, P1785, DOI 10.1073/pnas.0406674102; Myers AM, 2000, PLANT PHYSIOL, V122, P989, DOI 10.1104/pp.122.4.989; Nakamura Y, 2012, PLANT CELL PHYSIOL, V53, P869, DOI 10.1093/pcp/pcs030; Nakamura Y, 2010, PLANT CELL PHYSIOL, V51, P776, DOI 10.1093/pcp/pcq035; Nielsen TH, 2002, J BIOL CHEM, V277, P20249, DOI 10.1074/jbc.M201866200; Rathore RS, 2009, CRIT REV BIOTECHNOL, V29, P214, DOI 10.1080/07388550902926063; Ritte G, 2006, FEBS LETT, V580, P4872, DOI 10.1016/j.febslet.2006.07.085; Roldan I, 2007, PLANT J, V49, P492, DOI 10.1111/j.1365-313X.2006.02968.x; Scheidig A, 2002, PLANT J, V30, P581, DOI 10.1046/j.1365-313X.2002.01317.x; Seung D, 2013, J BIOL CHEM, V288, P33620, DOI 10.1074/jbc.M113.514794; Smith AM, 2012, STARCH-STARKE, V64, P421, DOI 10.1002/star.201100163; Smith AM, 2005, ANNU REV PLANT BIOL, V56, P73, DOI 10.1146/annurev.arplant.56.032604.144257; Streb S, 2012, J BIOL CHEM, V287, P41745, DOI 10.1074/jbc.M112.395244; Streb S, 2008, PLANT CELL, V20, P3448, DOI 10.1105/tpc.108.063487; Szydlowski N, 2011, J EXP BOT, V62, P4547, DOI 10.1093/jxb/err172; TABATA S, 1978, CARBOHYD RES, V67, P189, DOI 10.1016/S0008-6215(00)83741-6; TAKEDA Y, 1981, CARBOHYD RES, V89, P174, DOI 10.1016/S0008-6215(00)85242-8; Wattebled F, 2005, PLANT PHYSIOL, V138, P184, DOI 10.1104/pp.105.059295; Wattebled F, 2003, PLANT PHYSIOL, V132, P137, DOI 10.1104/pp.102.016527; Wattebled F, 2008, PLANT PHYSIOL, V148, P1309, DOI 10.1104/pp.108.129379; Wu AC, 2013, AUST J CHEM, V66, P1550, DOI 10.1071/CH13397; Wu AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065768; Wu AC, 2010, BIOMACROMOLECULES, V11, P3539, DOI 10.1021/bm1010189; Yu TS, 2005, J BIOL CHEM, V280, P9773, DOI 10.1074/jbc.M413638200; Yu TS, 2001, PLANT CELL, V13, P1907, DOI 10.1105/tpc.13.8.1907; Zeeman SC, 2007, BIOCHEM J, V401, P13, DOI 10.1042/BJ20061393	36	23	24	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100498	10.1371/journal.pone.0100498	http://dx.doi.org/10.1371/journal.pone.0100498			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971464	Green Published, Green Submitted, gold			2022-12-27	WOS:000338512200038
J	Howison, M; Zapata, F; Edwards, EJ; Dunn, CW				Howison, Mark; Zapata, Felipe; Edwards, Erika J.; Dunn, Casey W.			Bayesian Genome Assembly and Assessment by Markov Chain Monte Carlo Sampling	PLOS ONE			English	Article								Most genome assemblers construct point estimates, choosing only a single genome sequence from among many alternative hypotheses that are supported by the data. We present a Markov chain Monte Carlo approach to sequence assembly that instead generates distributions of assembly hypotheses with posterior probabilities, providing an explicit statistical framework for evaluating alternative hypotheses and assessing assembly uncertainty. We implement this approach in a prototype assembler, called Genome Assembly by Bayesian Inference (GABI), and illustrate its application to the bacteriophage Phi X174. Our sampling strategy achieves both good mixing and convergence on Illumina test data for Phi X174, demonstrating the feasibility of our approach. We summarize the posterior distribution of assembly hypotheses generated by GABI as a majority-rule consensus assembly. Then we compare the posterior distribution to external assemblies of the same test data, and annotate those assemblies by assigning posterior probabilities to features that are in common with GABI's assembly graph. GABI is freely available under a GPL license from https://bitbucket.org/mhowison/gabi.	[Howison, Mark] Brown Univ, Ctr Computat & Visualizat, Providence, RI 02912 USA; [Zapata, Felipe; Edwards, Erika J.; Dunn, Casey W.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA	Brown University; Brown University	Howison, M (corresponding author), Brown Univ, Ctr Computat & Visualizat, Providence, RI 02912 USA.	mhowison@brown.edu		Howison, Mark/0000-0002-0764-4090; Zapata, Felipe/0000-0002-9386-0573; Dunn, Casey/0000-0003-0628-5150	National Science Foundation through the Alan T. Waterman Award; Brown Division of Biology and Medicine;  [DEB-1026611]	National Science Foundation through the Alan T. Waterman Award; Brown Division of Biology and Medicine; 	This work was supported by the National Science Foundation (http://www.nsf.gov) through the Alan T. Waterman Award to CWD and award DEB-1026611 to EJE, and through additional support from the Brown Division of Biology and Medicine (http://biomed.brown.edu) to EJE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bostock M, 2011, IEEE T VIS COMPUT GR, V17, P2301, DOI 10.1109/TVCG.2011.185; Clark SC, 2013, BIOINFORMATICS, V29, P435, DOI 10.1093/bioinformatics/bts723; Gelman A, 1997, ANN APPL PROBAB, V7, P110, DOI [10.1214/aoap/1034625254, DOI 10.1214/AOAP/1034625254]; GEYER CJ, 1991, COMP SCI STAT, V23, P156, DOI DOI 10.1080/01621459.1995.10476590; Ghodsi Mohammadreza, 2013, BMC Res Notes, V6, P334, DOI 10.1186/1756-0500-6-334; Gilks W. R., 1995, MARKOV CHAIN MONTE C, DOI 10.1201/b14835; Holder M, 2003, NAT REV GENET, V4, P275, DOI 10.1038/nrg1044; Howison M, 2012, P 4 USENIX WORKSH TH; Howison M, 2014, GENOME ASSEMBLY BAYE, DOI DOI 10.7301/Z0H41PB7; Howison M, 2013, BIOINFORMATICS, V29, P2959, DOI 10.1093/bioinformatics/btt525; Lam ET, 2012, NAT BIOTECHNOL, V30, P771, DOI 10.1038/nbt.2303; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Lin D, 2012, P 15 INT C ART INT S, P694; Matropolis N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Medvedev P, 2009, J COMPUT BIOL, V16, P1101, DOI 10.1089/cmb.2009.0047; Myers E W, 1995, J Comput Biol, V2, P275, DOI 10.1089/cmb.1995.2.275; Myers EW, 2005, BIOINFORMATICS, V21, P79, DOI 10.1093/bioinformatics/bti1114; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Rahman A, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-r8; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Simpson JT, 2012, GENOME RES, V22, P549, DOI 10.1101/gr.126953.111; Varma A, 2011, P 1 IEEE INT C COMP, P165, DOI 10.1109/ICCABS.2011.5729873.; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	23	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e99497	10.1371/journal.pone.0099497	http://dx.doi.org/10.1371/journal.pone.0099497			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968249	gold, Green Submitted, Green Published			2022-12-27	WOS:000338280800012
J	Levin, A; Wang, SA; Levin, C; Tsu, V; Hutubessy, R				Levin, Ann; Wang, Susan A.; Levin, Carol; Tsu, Vivien; Hutubessy, Raymond			Costs of Introducing and Delivering HPV Vaccines in Low and Lower Middle Income Countries: Inputs for GAVI Policy on Introduction Grant Support to Countries	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS VACCINATION	Background: In November 2011, the GAVI Alliance made the decision to add HPV vaccine as one of the new vaccines for which countries eligible for its funding (less than $1520 per capita income) could apply to receive support for national HPV vaccination, provided they could demonstrate the ability to deliver HPV vaccines. This paper describes the data and analysis shared with GAVI policymakers for this decision regarding GAVI HPV vaccine support. The paper reviews why strategies and costs for HPV vaccine delivery are different from other vaccines and what is known about the cost components from available data that originated primarily from HPV vaccine delivery costing studies in low and middle income-countries. Methods: Financial costs of HPV vaccine delivery were compared across three sources of data: 1) vaccine delivery costing of pilot projects in five low and lower-middle income countries; 2) cost estimates of national HPV vaccination in two low income countries; and 3) actual expenditure data from national HPV vaccine introduction in a low income country. Both costs of resources required to introduce the vaccine (or initial one-time investment, such as cold chain equipment purchases) and recurrent (ongoing costs that repeat every year) costs, such as transport and health personnel time, were analyzed. The cost per dose, cost per fully immunized girl (FIG) and cost per eligible girl were compared across studies. Results: Costs varied among pilot projects and estimates of national programs due to differences in scale and service delivery strategy. The average introduction costs per fully immunized girl ranged from $1.49 to $18.94 while recurrent costs per girl ranged from $1.00 to $15.69, with both types of costs varying by delivery strategy and country. Evaluating delivery costs along programme characteristics as well as country characteristics (population density, income/cost level, existing service delivery infrastructure) are likely the most informative and useful for anticipating costs for HPV vaccine delivery. Conclusions: This paper demonstrates the importance of country level cost data to inform global donor policies for vaccine introduction support. Such data are also valuable for informing national decisions on HPV vaccine introduction.	[Levin, Ann] WHO, Washington, DC USA; [Wang, Susan A.; Hutubessy, Raymond] WHO, Dept Immunizat Vaccines & Biol, CH-1211 Geneva, Switzerland; [Levin, Carol] Univ Washington, Seattle, WA 98195 USA; [Tsu, Vivien] PATH, Seattle, WA USA	World Health Organization; World Health Organization; University of Washington; University of Washington Seattle	Hutubessy, R (corresponding author), WHO, Dept Immunizat Vaccines & Biol, CH-1211 Geneva, Switzerland.	hutubessyr@who.int			GAVI Alliance in Geneva, Switzerland	GAVI Alliance in Geneva, Switzerland	The external body who funded this research was the GAVI Alliance in Geneva, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhutan Ministry of Health, 2012, COMMUNICATION; Brownson R C, 1999, J Public Health Manag Pract, V5, P86; Fesenfeld M, 2013, VACCINE, V31, P3786, DOI 10.1016/j.vaccine.2013.06.060; Hutubessy R, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-136; Jit M, 2014, LANCET GLOB IN PRESS; Jit M, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-23; LaMontagne DS, 2011, B WORLD HEALTH ORGAN, V89, P821, DOI [10.2471/BLT.11.089862, 10.2471/BLT.11.08986]; Levin A, 2013, COSTS INTRO 3 UNPUB; Levin CE, 2013, B WORLD HEALTH ORGAN, V91, P585, DOI 10.2471/BLT.12.113837; MONATH TP, 1993, AM J TROP MED HYG, V48, P274, DOI 10.4269/ajtmh.1993.48.274; PATH, 2011, HPV VACC MONTHL IMM; Quentin W, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-137; WHO | World Health Organization, 2009, PER INT ROUT IMM LES; World Health Organization, 2009, WKLY EPIDEMIOL REC, V84, P118	14	44	48	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e101114	10.1371/journal.pone.0101114	http://dx.doi.org/10.1371/journal.pone.0101114			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968002	Green Published, gold, Green Submitted			2022-12-27	WOS:000338280800109
J	Rohrbeck, A; Schroder, A; Hagemann, S; Pich, A; Holtje, M; Ahnert-Hilger, G; Just, I				Rohrbeck, Astrid; Schroeder, Anke; Hagemann, Sandra; Pich, Andreas; Hoeltje, Markus; Ahnert-Hilger, Gudrun; Just, Ingo			Vimentin Mediates Uptake of C3 Exoenzyme	PLOS ONE			English	Article							JAPANESE ENCEPHALITIS-VIRUS; INTERMEDIATE-FILAMENTS; CLOSTRIDIUM-BOTULINUM; ADP-RIBOSYLTRANSFERASE; PROTEIN TOXINS; HIPPOCAMPAL-NEURONS; GUANINE-NUCLEOTIDE; CRYSTAL-STRUCTURE; CELL-SURFACE; RHO PROTEINS	Clostridium botulinum C3 exoenzyme (C3) selectively inactivates RhoA/B/C GTPases by ADP-ribosylation. Based on this substrate specificity C3 is a well-established tool in cell biology. C3 is taken up by eukaryotic cells although lacking an uptake and translocation domain. Based on different approaches vimentin was identified as membranous C3-interaction partner by mass spectrometry. Vimentin in fact was partly localized at the outer surface of hippocampal HT22 cells and J744A.1 macrophages. Domain analysis identified the rod domain as binding partner of C3. Vimentin was also involved in uptake of C3 as shown by knock down of vimentin in HT22 and J774A.1 cells. The involvement of vimentin in uptake of C3 was further supported by the findings that the vimentin disruptor acrylamide blocked uptake of C3. Vimentin is not only a major organizing element of the intermediate filament network but is also involved in both binding and uptake of C3 exoenzyme.	[Rohrbeck, Astrid; Schroeder, Anke; Hagemann, Sandra; Pich, Andreas; Just, Ingo] Charite, Hannover Med Sch, Inst Toxicol, D-13353 Berlin, Germany; [Hoeltje, Markus; Ahnert-Hilger, Gudrun] Charite, Ctr Anat, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Hannover Medical School; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Rohrbeck, A (corresponding author), Charite, Hannover Med Sch, Inst Toxicol, D-13353 Berlin, Germany.	rohrbeck.astrid@mh-hannover.de		Holtje, Markus/0000-0003-3193-4140	Deutsche Forschungsgemeinschaft (DFG) [JU231/5]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft (DFG project JU231/5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnert-Hilger G, 2004, J NEUROCHEM, V90, P9, DOI 10.1111/j.1471-4159.2004.02475.x; Aktories K, 2005, CURR TOP MICROBIOL, V291, P113; AKTORIES K, 1987, BIOCHEM J, V247, P363, DOI 10.1042/bj2470363; Auer M, 2013, J PERIPHER NERV SYST, V18, P30, DOI 10.1111/jns5.12004; Auer M, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00043; Bhattacharya B, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-7; Bhattacharya R, 2009, J CELL SCI, V122, P1390, DOI 10.1242/jcs.043042; Boato F, 2010, J CELL SCI, V123, P1652, DOI 10.1242/jcs.066050; Boilard E, 2003, BLOOD, V102, P2901, DOI 10.1182/blood-2002-12-3702; Bryant AE, 2006, J INFECT DIS, V193, P1685, DOI 10.1086/504261; Chernyatina AA, 2012, P NATL ACAD SCI USA, V109, P13620, DOI 10.1073/pnas.1206836109; Chou YH, 2000, J CELL BIOL, V150, pF101, DOI 10.1083/jcb.150.3.F101; Chou YH, 2003, MOL BIOL CELL, V14, P1468, DOI 10.1091/mbc.E02-08-0545; Das S, 2011, VIRUS RES, V160, P404, DOI 10.1016/j.virusres.2011.06.001; ECKERT BS, 1985, EUR J CELL BIOL, V37, P169; Eckes B, 1998, J CELL SCI, V111, P1897; Fahrer J, 2010, CELL MICROBIOL, V12, P233, DOI 10.1111/j.1462-5822.2009.01393.x; Faigle W, 2000, MOL BIOL CELL, V11, P3485, DOI 10.1091/mbc.11.10.3485; FISHMAN PH, 1982, J MEMBRANE BIOL, V69, P85, DOI 10.1007/BF01872268; Galou M, 1997, BIOL CELL, V89, P85, DOI 10.1016/S0248-4900(99)80068-9; Genth H, 2003, J BIOL CHEM, V278, P28523, DOI 10.1074/jbc.M301915200; Genth H, 2008, INT J BIOCHEM CELL B, V40, P592, DOI 10.1016/j.biocel.2007.12.014; Geny B, 2006, BIOL CELL, V98, P633, DOI 10.1042/BC20060038; Goldman RD, 1996, J CELL BIOL, V134, P971, DOI 10.1083/jcb.134.4.971; Han SI, 2001, J MOL BIOL, V305, P95, DOI 10.1006/jmbi.2000.4292; Haudenschild DR, 2011, J ORTHOP RES, V29, P20, DOI 10.1002/jor.21198; Ho TTG, 2008, J BIOL CHEM, V283, P21588, DOI 10.1074/jbc.M710033200; Holtje M, 2011, ANN ANAT, V193, P314, DOI 10.1016/j.aanat.2011.01.008; Hoffmann A, 2008, GLIA, V56, P1162, DOI 10.1002/glia.20687; HOLMGREN J, 1974, MED BIOL, V52, P229; Holtje M, 2005, J NEUROCHEM, V95, P1237, DOI 10.1111/j.1471-4159.2005.03443.x; Huelsenbeck J, 2007, BIOCHEMISTRY-US, V46, P4923, DOI 10.1021/bi602465z; Huelsenbeck SC, 2012, NEUROTHERAPEUTICS, V9, P185, DOI 10.1007/s13311-011-0072-y; Huet D, 2006, J IMMUNOL, V176, P652, DOI 10.4049/jimmunol.176.1.652; Ise H, 2012, GLYCOBIOLOGY, V22, P788, DOI 10.1093/glycob/cws052; Ise H, 2010, GLYCOBIOLOGY, V20, P843, DOI 10.1093/glycob/cwq039; Ivaska J, 2007, EXP CELL RES, V313, P2050, DOI 10.1016/j.yexcr.2007.03.040; Izmiryan A, 2009, EXP CELL RES, V315, P769, DOI 10.1016/j.yexcr.2008.12.009; JUST I, 1995, BIOCHEMISTRY-US, V34, P334, DOI 10.1021/bi00001a041; Just I, 2000, CURR TOP MICROBIOL, V250, P97; Just I, 2011, N-S ARCH PHARMACOL, V383, P247, DOI 10.1007/s00210-010-0589-3; Kim JK, 2006, J VIROL, V80, P689, DOI 10.1128/JVI.80.2.689-696.2006; KITAMURA M, 1980, BIOCHIM BIOPHYS ACTA, V628, P328, DOI 10.1016/0304-4165(80)90382-7; Koudelka KJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000417; Lahat G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010105; Levin EC, 2009, BRAIN RES, V1298, P194, DOI 10.1016/j.brainres.2009.08.072; Liang JJ, 2011, CELL MICROBIOL, V13, P1358, DOI 10.1111/j.1462-5822.2011.01624.x; LILIENBAUM A, 1990, J VIROL, V64, P256, DOI 10.1128/JVI.64.1.256-263.1990; Luecke N, 2010, RAPID COMMUN MASS SP, V24, P561, DOI 10.1002/rcm.4412; Mendez MG, 2010, FASEB J, V24, P1838, DOI 10.1096/fj.09-151639; Merritt EA, 2002, J AM CHEM SOC, V124, P8818, DOI 10.1021/ja0202560; Mitchell BS, 1997, HISTOCHEM J, V29, P393, DOI 10.1023/A:1026490901926; Moisan E, 2006, J LEUKOCYTE BIOL, V79, P489, DOI 10.1189/jlb.0405190; Mor-Vaknin N, 2003, NAT CELL BIOL, V5, P59, DOI 10.1038/ncb898; Murli S, 2001, CELL MICROBIOL, V3, P795, DOI 10.1046/j.1462-5822.2001.00158.x; Nieminen M, 2006, NAT CELL BIOL, V8, P156, DOI 10.1038/ncb1355; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; PATERSON HF, 1990, J CELL BIOL, V111, P1001, DOI 10.1083/jcb.111.3.1001; PERIDES G, 1987, J BIOL CHEM, V262, P13742; Perlson E, 2005, NEURON, V45, P715, DOI 10.1016/j.neuron.2005.01.023; Perlson E, 2006, J MOL BIOL, V364, P938, DOI 10.1016/j.jmb.2006.09.056; PIEPER FR, 1992, EUR J BIOCHEM, V210, P509, DOI 10.1111/j.1432-1033.1992.tb17449.x; Podor TJ, 2002, J BIOL CHEM, V277, P7529, DOI 10.1074/jbc.M109675200; Risco C, 2002, J VIROL, V76, P1839, DOI 10.1128/JVI.76.4.1839-1855.2002; RITTLING SR, 1989, NUCLEIC ACIDS RES, V17, P1619, DOI 10.1093/nar/17.4.1619; Rohrbeck A, 2012, FEBS J, V279, P2657, DOI 10.1111/j.1742-4658.2012.08645.x; Rotsch J, 2012, N-S ARCH PHARMACOL, V385, P883, DOI 10.1007/s00210-012-0764-9; Sandvig K, 2013, HISTOCHEM CELL BIOL, V140, P317, DOI 10.1007/s00418-013-1111-z; Sehr P, 1998, BIOCHEMISTRY-US, V37, P5296, DOI 10.1021/bi972592c; Shime H, 2002, INFECT IMMUN, V70, P6460, DOI 10.1128/IAI.70.11.6460-6463.2002; Steinmetz Nicole F, 2011, Cancers (Basel), V3, P2870, DOI 10.3390/cancers3032870; Styers ML, 2004, MOL BIOL CELL, V15, P5369, DOI 10.1091/mbc.E04-03-0272; Teshigawara K, 2013, BRIT J PHARMACOL, V168, P903, DOI 10.1111/j.1476-5381.2012.02211.x; Thomas EK, 1996, VIRAL IMMUNOL, V9, P73, DOI 10.1089/vim.1996.9.73; Tobaben S, 2011, CELL DEATH DIFFER, V18, P282, DOI 10.1038/cdd.2010.92; Walter M, 2009, BIOL CELL, V101, P141, DOI 10.1042/BC20070171; WIEGERS W, 1991, EUR J CELL BIOL, V54, P237; Wilde C, 2001, J BIOL CHEM, V276, P9537, DOI 10.1074/jbc.M011035200; Xu B, 2004, MOL CELL BIOL, V24, P9198, DOI 10.1128/MCB.24.20.9198-9206.2004; Zou YM, 2006, BIOCHEM BIOPH RES CO, V351, P625, DOI 10.1016/j.bbrc.2006.10.091	80	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e101071	10.1371/journal.pone.0101071	http://dx.doi.org/10.1371/journal.pone.0101071			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967582	Green Published, Green Submitted, gold			2022-12-27	WOS:000338280800104
J	Sode, J; Vogel, U; Bank, S; Andersen, PS; Thomsen, MK; Hetland, ML; Locht, H; Heegaard, NHH; Andersen, V				Sode, Jacob; Vogel, Ulla; Bank, Steffen; Andersen, Paal Skytt; Thomsen, Marianne Kragh; Hetland, Merete Lund; Locht, Henning; Heegaard, Niels H. H.; Andersen, Vibeke			Anti-TNF Treatment Response in Rheumatoid Arthritis Patients Is Associated with Genetic Variation in the NLRP3-Inflammasome	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; DANISH DANBIO REGISTRY; THERAPY; ADHERENCE; PATHWAYS; DISEASE; RISK	Objective: Many patients with rheumatoid arthritis (RA) benefit from tumor necrosis factor-alpha blocking treatment (anti-TNF), but about one third do not respond. The objective of this study was to replicate and extend previously found associations between anti-TNF treatment response and genetic variation in the TNF-, NF-kappa B-and pattern recognition receptor signalling pathways. Methods: Forty-one single nucleotide polymorphisms (SNPs), including 34 functional, in 28 genes involved in inflammatory pathways were assessed in 538 anti-TNF naive Danish RA patients with clinical data. Multivariable logistic regression analyses were performed to test associations between genotypes and treatment response at 3-6 months using the European League Against Rheumatism (EULAR) response criterion. American College of Rheumatology treatment response (ACR50) and relative change in 28-joint disease activity score (relDAS28) were used as secondary outcomes. Subgroup analyses were stratified according to smoking status, type of anti-TNF drug and IgM-Rheumatoid Factor (IgM-RF) status. False discovery rate (FDR) controlling was used to adjust for multiple testing. Results: Statistically significant associations with EULAR response were found for two SNPs in NLRP3(rs4612666) (OR (odds ratio) for good/moderate response = 0.64 (95% confidence interval: 0.44-0.95), p = 0.025, q = 0.95) and INFG(rs2430561) (OR = 0.40 (0.21-0.76), p = 0.005, q = 0.18) and among IgM-RF positive patients for TNFRS1A(rs4149570) (0.59 (0.36-0.98), p = 0.040, q = 0.76). Current smokers who carried the NLRP3(rs4612666) variant allele were less likely to benefit from anti-TNF treatment (OR = 0.24 (0.10-0.56), p = 0.001, q = 0.04). Conclusions: In a population of Danish RA patients, we confirm the NLRP3 gene as associated with EULAR anti-TNF response as previously reported. The NLRP3 variant (T) allele is associated with lower treatment response, in particular among current smokers. Furthermore, we find that a functional polymorphism in the interferon-gamma gene is associated with anti-TNF response. All findings should be tested by replication in independent validation cohorts and augmented by assessing cytokine levels and activities of the relevant gene products.	[Sode, Jacob; Heegaard, Niels H. H.] Statens Serum Inst, DK-2300 Copenhagen, Denmark; [Sode, Jacob; Locht, Henning] Frederiksberg Univ Hosp, Dept Rheumatol, Frederiksberg, Denmark; [Sode, Jacob; Andersen, Vibeke] Univ Southern Denmark, Inst Reg Hlth Res, Odense, Denmark; [Vogel, Ulla] Natl Res Ctr Working Environm, Copenhagen, Denmark; [Bank, Steffen; Andersen, Vibeke] Viborg Reg Hosp, Dept Med, Viborg, Denmark; [Bank, Steffen] Univ Aarhus, Aarhus, Denmark; [Andersen, Paal Skytt] Statens Serum Inst, Dept Microbiol & Infect Control, DK-2300 Copenhagen, Denmark; [Thomsen, Marianne Kragh] Aarhus Univ Hosp, Dept Clin Microbiol, DK-8000 Aarhus, Denmark; [Hetland, Merete Lund] Glostrup Cty Hosp, Ctr Rheumatol & Spine Dis, Copenhagen Ctr Arthrit Res, DANBIO Registry, Glostrup, Denmark; [Hetland, Merete Lund] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark; [Hetland, Merete Lund] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark; [Andersen, Vibeke] Hosp Southern Jutland, Organ Ctr, Aabenraa, Denmark; [Andersen, Vibeke] Odense Univ Hosp, OPEN, DK-5000 Odense, Denmark	Statens Serum Institut; University of Southern Denmark; National Research Centre for the Working Environment; Aarhus University; Aarhus University; Statens Serum Institut; Aarhus University; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Southern Denmark; Odense University Hospital	Sode, J (corresponding author), Statens Serum Inst, DK-2300 Copenhagen, Denmark.	jaso@ssi.dk	Vogel, Ulla B/I-5048-2012; Hetland, Merete L/AAE-5297-2019; Thomsen, Marianne Kragh/AAJ-5115-2020; Andersen, Vibeke/I-7932-2012; Vogel, Ulla/ABC-2212-2020; Andersen, Paal S/H-2087-2015; Sode, Jacob/AAD-9615-2020	Vogel, Ulla B/0000-0001-6807-1524; Hetland, Merete L/0000-0003-4229-6818; Andersen, Vibeke/0000-0002-0127-2863; Vogel, Ulla/0000-0001-6807-1524; Andersen, Paal S/0000-0001-5656-0427; Sode, Jacob/0000-0002-2718-9320; Thomsen, Marianne Kragh/0000-0002-3645-6689	Danish Rheumatism Association; Region of Southern Denmark's PhD Fund; Department of Rheumatology, Frederiksberg Hospital	Danish Rheumatism Association; Region of Southern Denmark's PhD Fund; Department of Rheumatology, Frederiksberg Hospital	This study was supported by the Danish Rheumatism Association (www.gigtforeningen.dk), Region of Southern Denmark's PhD Fund (www.regionsyddanmark.dk) and the Department of Rheumatology, Frederiksberg Hospital (www.frederiksberghospital.dk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bank S, 2014, PHARMACOGENOMICS J, V14, P526, DOI 10.1038/tpj.2014.19; Bank S, 2014, PLOS ONE IN PRESS; Bank S, 2013, GENET TEST MOL BIOMA, V17, P501, DOI 10.1089/gtmb.2012.0429; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blomgran R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031326; Chen HM, 2006, HUM MOL GENET, V15, P519, DOI 10.1093/hmg/ddi469; Coenen MJH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014326; Cui J, 2010, ARTHRITIS RHEUM-US, V62, P1849, DOI 10.1002/art.27457; Emery P, 2011, ANN RHEUM DIS, V70, P2063, DOI 10.1136/ard.2010.148015; Espinoza JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026229; Fransen J, 2005, CLIN EXP RHEUMATOL, V23, pS93; Goh FG, 2012, RHEUMATOLOGY, V51, P7, DOI 10.1093/rheumatology/ker257; Gu W, 2007, ANN SURG, V246, P151, DOI 10.1097/01.sla.0000262788.67171.3f; Hetland ML, 2008, ANN RHEUM DIS, V67, P1023, DOI 10.1136/ard.2007.087262; Hetland ML, 2011, RHEUMATOLOGY, V50, P69, DOI 10.1093/rheumatology/keq309; Hetland ML, 2010, ARTHRITIS RHEUM-US, V62, P22, DOI 10.1002/art.27227; Hitomi Y, 2009, J ALLERGY CLIN IMMUN, V124, P779, DOI 10.1016/j.jaci.2009.07.044; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Klareskog L, 2009, LANCET, V373, P659, DOI 10.1016/S0140-6736(09)60008-8; Krintel SB, 2012, PHARMACOGENET GENOM, V22, P577, DOI 10.1097/FPC.0b013e3283544043; Mathews RJ, 2014, ANN RHEUM DIS, V73, P1202, DOI 10.1136/annrheumdis-2013-203276; Mirkov MU, 2013, ANN RHEUM DIS, V72, P1375, DOI 10.1136/annrheumdis-2012-202405; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Plant D, 2012, ARTHRITIS RHEUM-US, V64, P665, DOI 10.1002/art.33381; Plenge RM, 2011, ARTHRITIS RHEUM-US, V63, P2839, DOI 10.1002/art.30509; Potter C, 2010, ANN RHEUM DIS, V69, P1315, DOI 10.1136/ard.2009.117309; Pravica V, 2000, HUM IMMUNOL, V61, P863, DOI 10.1016/S0198-8859(00)00167-1; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Rosenblum H, 2011, AUTOIMMUN REV, V10, P563, DOI 10.1016/j.autrev.2011.04.010; Rosengren S, 2005, ANN RHEUM DIS, V64, P708, DOI 10.1136/ard.2004.025577; Simard JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072138; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Toonen EJM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033199; Valavanidis A, 2009, INT J ENV RES PUB HE, V6, P445, DOI 10.3390/ijerph6020445; van Loo G, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3324; Wang GB, 2011, HUM IMMUNOL, V72, P451, DOI 10.1016/j.humimm.2011.02.004	36	47	52	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100361	10.1371/journal.pone.0100361	http://dx.doi.org/10.1371/journal.pone.0100361			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967817	Green Published, gold, Green Submitted			2022-12-27	WOS:000338280800037
J	Saab, S; Buteau, B; Leclere, L; Bron, AM; Creuzot-Garcher, CP; Bretillon, L; Acar, N				Saab, Sarah; Buteau, Benedicte; Leclere, Laurent; Bron, Alain M.; Creuzot-Garcher, Catherine P.; Bretillon, Lionel; Acar, Niyazi			Involvement of Plasmalogens in Post-Natal Retinal Vascular Development	PLOS ONE			English	Article							FIBROBLAST GROWTH FACTOR-2; BLOOD-VESSEL FORMATION; MACULAR DEGENERATION; TUMOR ANGIOGENESIS; FATTY-ACIDS; INTEGRIN; VASCULOGENESIS; ACTIVATION; EXPRESSION; STRESS	Objective: Proper development of retinal blood vessels is essential to ensure sufficient oxygen and nutrient supplies to the retina. It was shown that polyunsaturated fatty acids (PUFAs) could modulate factors involved in tissue vascularization. A congenital deficiency in ether-phospholipids, also termed "plasmalogens'', was shown to lead to abnormal ocular vascularization. Because plasmalogens are considered to be reservoirs of PUFAs, we wished to improve our understanding of the mechanisms by which plasmalogens regulate retinal vascular development and whether the release of PUFAs by calcium-independent phospholipase A2 (iPLA2) could be involved. Methods and Results: By characterizing the cellular and molecular steps of retinal vascular development in a mouse model of plasmalogen deficiency, we demonstrated that plasmalogens modulate angiogenic processes during the early phases of retinal vascularization. They influence glial activity and primary astrocyte template formation, endothelial cell proliferation and retinal vessel outgrowth, and impact the expression of the genes involved in angiogenesis in the retina. These early defects led to a disorganized and dysfunctional retinal vascular network at adult age. By comparing these data to those obtained on a mouse model of retinal iPLA2 inhibition, we suggest that these processes may be mediated by PUFAs released from plasmalogens and further signalling through the angiopoietin/tie pathways. Conclusions: These data suggest that plasmalogens play a crucial role in retinal vascularization processes.	[Saab, Sarah; Buteau, Benedicte; Leclere, Laurent; Bron, Alain M.; Creuzot-Garcher, Catherine P.; Bretillon, Lionel; Acar, Niyazi] CNRS, Ctr Sci Gout & Alimentat, UMR6265, Dijon, France; [Saab, Sarah; Buteau, Benedicte; Leclere, Laurent; Bron, Alain M.; Creuzot-Garcher, Catherine P.; Bretillon, Lionel; Acar, Niyazi] INRA, Ctr Sci Gout & Alimentat, UMR1324, F-21034 Dijon, France; [Saab, Sarah; Buteau, Benedicte; Leclere, Laurent; Bron, Alain M.; Creuzot-Garcher, Catherine P.; Bretillon, Lionel; Acar, Niyazi] Univ Bourgogne, UMR Ctr Sci Gout & Alimentat, Dijon, France; [Bron, Alain M.; Creuzot-Garcher, Catherine P.] Univ Hosp, Dept Ophthalmol, Dijon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut Agro; AgroSup Dijon; Universite de Bourgogne; INRAE; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; CHU Dijon Bourgogne	Acar, N (corresponding author), CNRS, Ctr Sci Gout & Alimentat, UMR6265, Dijon, France.	niyazi.acar@dijon.inra.fr	Bron, Alain/AAP-8010-2020	Bron, Alain/0000-0002-7265-931X; Bretillon, Lionel/0000-0002-6957-100X	French National Institute for Agricultural Research (INRA, France); Regional Council of Burgundy (France); French Government [ANR-11-LABEX-0021]; Abbott Laboratories (Dijon, France); FEDER (European Funding for Regional Economic Development)	French National Institute for Agricultural Research (INRA, France); Regional Council of Burgundy (France)(Region Bourgogne-Franche-Comte); French Government; Abbott Laboratories (Dijon, France); FEDER (European Funding for Regional Economic Development)	A PhD fellowship to Sarah Saab-Aoude was funded by a grant from the French National Institute for Agricultural Research (INRA, France) and the Regional Council of Burgundy (France). This work was supported by a French Government grant managed by the French National Research Agency (ANR) under the program "Investissements d'Avenir'' with reference ANR-11-LABEX-0021, and by grants from Abbott Laboratories (Dijon, France), the Regional Council of Burgundy (France), and the FEDER (European Funding for Regional Economic Development). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar N, 2007, EXP EYE RES, V84, P143, DOI 10.1016/j.exer.2006.09.009; Ambati J, 2012, NEURON, V75, P26, DOI 10.1016/j.neuron.2012.06.018; Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Boudard DL, 2011, INVEST OPHTH VIS SCI, V52, P8686, DOI 10.1167/iovs.11-8162; Calviello G, 2004, CARCINOGENESIS, V25, P2303, DOI 10.1093/carcin/bgh265; Chen-Konak L, 2003, FASEB J, V17, P2121, DOI 10.1096/fj.02-1151fje; Chong EWT, 2009, ARCH OPHTHALMOL-CHIC, V127, P674, DOI 10.1001/archophthalmol.2009.60; Chong EWT, 2008, ARCH OPHTHALMOL-CHIC, V126, P826, DOI 10.1001/archopht.126.6.826; Connor KM, 2007, NAT MED, V13, P868, DOI 10.1038/nm1591; DIAZARAYA CM, 1995, J COMP NEUROL, V363, P53, DOI 10.1002/cne.903630106; Dorrell MI, 2002, INVEST OPHTH VIS SCI, V43, P3500; Ehlken C, 2011, ACTA OPHTHALMOL, V89, P82, DOI 10.1111/j.1755-3768.2009.01609.x; Fagiani E, 2013, CANCER LETT, V328, P18, DOI 10.1016/j.canlet.2012.08.018; Farooqui A. A., 2008, METABOLISM FUNCTIONS, P85; Farooqui AA, 2010, MOL NEUROBIOL, V41, P267, DOI 10.1007/s12035-009-8091-y; FLIESLER SJ, 1983, PROG LIPID RES, V22, P79; Fruttiger M, 2002, INVEST OPHTH VIS SCI, V43, P522; Fujikawa K, 1999, J VASC RES, V36, P272, DOI 10.1159/000025655; GARIANO RF, 1994, INVEST OPHTH VIS SCI, V35, P3442; Hartnett ME, 2012, NEW ENGL J MED, V367, P2515, DOI 10.1056/NEJMra1208129; HAZEN SL, 1991, J BIOL CHEM, V266, P5629; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; Hennig T, 2011, J VASC RES, V48, P453, DOI 10.1159/000327009; Hoffmann J, 2005, FASEB J, V19, P2035, DOI 10.1096/fj.04-2109fje; Ito M, 1999, ANAT EMBRYOL, V200, P403, DOI 10.1007/s004290050289; JIANG B, 1994, J CELL SCI, V107, P2499; Kermorvant-Duchemin E, 2005, NAT MED, V11, P1339, DOI 10.1038/nm1336; Kishan AU, 2011, SURV OPHTHALMOL, V56, P195, DOI 10.1016/j.survophthal.2010.08.008; Kopatz K, 2000, J NEUROCYTOL, V29, P157, DOI 10.1023/A:1026594721760; Li LX, 2010, GLIA, V58, P1157, DOI 10.1002/glia.20995; Lorger M, 2009, P NATL ACAD SCI USA, V106, P10666, DOI 10.1073/pnas.0903035106; Luhmann UFO, 2005, GENESIS, V42, P253, DOI 10.1002/gene.20141; Luu CD, 2012, INVEST OPHTH VIS SCI, V53, P2218, DOI 10.1167/iovs.11-8490; Meitinger D, 2001, EXP EYE RES, V73, P681, DOI 10.1006/exer.2001.1079; Mitchell K, 2009, J CELL SCI, V122, P1778, DOI 10.1242/jcs.040956; Pickering JG, 1997, CIRC RES, V80, P627, DOI 10.1161/01.RES.80.5.627; RENNIE D, 1975, ARCH OPHTHALMOL-CHIC, V93, P395; Risau W, 1995, ANNU REV CELL DEV BI, V11, P73, DOI 10.1146/annurev.cb.11.110195.000445; Robinson SD, 2011, CURR OPIN CELL BIOL, V23, P630, DOI 10.1016/j.ceb.2011.03.014; Rodemer C, 2003, HUM MOL GENET, V12, P1881, DOI 10.1093/hmg/ddg191; Roy S, 1996, INVEST OPHTH VIS SCI, V37, P258; Ruegg C, 2010, RECENT RESULTS CANC, V180, P83, DOI 10.1007/978-3-540-78281-0_6; Saab-Aoude S, 2013, BIOCHIMIE, V95, P903, DOI 10.1016/j.biochi.2012.12.008; Sato T, 2011, AM J OPHTHALMOL, V151, P353, DOI 10.1016/j.ajo.2010.08.037; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; SCHUSCHEREBA ST, 1994, INVEST OPHTH VIS SCI, V35, P945; Seddon JM, 2006, ARCH OPHTHALMOL-CHIC, V124, P995, DOI 10.1001/archopht.124.7.995; Seeliger MW, 2005, VISION RES, V45, P3512, DOI 10.1016/j.visres.2005.08.014; Sinha D, 2012, TRANSGENIC RES, V21, P1033, DOI 10.1007/s11248-012-9608-0; Somanath PR, 2009, CELL BIOCHEM BIOPHYS, V53, P53, DOI 10.1007/s12013-008-9040-5; Szymczak M, 2008, BLOOD, V111, P3514, DOI 10.1182/blood-2007-08-109934; Tourtas T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031340; Uemura A, 2006, J CLIN INVEST, V116, P369, DOI 10.1172/JCI25964; Vardar-Sengul S, 2008, J PERIODONTOL, V79, P1934, DOI [10.1902/jop.2008.080001, 10.1902/jop.2008.080001 ]; Wilson SH, 2003, INVEST OPHTH VIS SCI, V44, P1704, DOI 10.1167/iovs.02-0773; Zhu MD, 2000, EXP EYE RES, V70, P767, DOI 10.1006/exer.2000.0844; Zhuang W, 2013, J CARDIOVASC TRANSL, V6, P287, DOI 10.1007/s12265-012-9409-0	57	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e101076	10.1371/journal.pone.0101076	http://dx.doi.org/10.1371/journal.pone.0101076			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963632	Green Published, gold, Green Submitted			2022-12-27	WOS:000338709500117
J	Dong, QS; Cai, N; Tao, T; Zhang, R; Yan, W; Li, R; Zhang, JX; Luo, H; Shi, Y; Luan, WK; Zhang, YX; You, YP; Wang, YY; Liu, N				Dong, Qingsheng; Cai, Ning; Tao, Tao; Zhang, Rui; Yan, Wei; Li, Rui; Zhang, Junxia; Luo, Hui; Shi, Yan; Luan, Wenkang; Zhang, Yaxuan; You, Yongping; Wang, Yingyi; Liu, Ning			An Axis Involving SNAI1, microRNA-128 and SP1 Modulates Glioma Progression	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; COLORECTAL-CANCER; MALIGNANT GLIOMAS; EPITHELIAL-CELLS; EXPRESSION; METASTASIS; INVOLVEMENT; BIOGENESIS; RESISTANCE; MECHANISM	Background: Glioblastoma is an extraordinarily aggressive disease that requires more effective therapeutic options. Snail zinc finger 1, dysregulated in many neoplasms, has been reported to be involved in gliomas. However, the biological mechanisms underlying SNAI1 function in gliomas need further investigation. Methods: Quantitative real-time PCR was used to measure microRNA-128 (miR-128) expression level and western blot was performed to detect protein expression in U87 and U251 cells and human brain tissues. Cell cycle, CCK-8, transwell and wound-healing assays were performed. Dual-luciferase reporter assay was used for identifying the mechanism of SNAI1 and miR-128b regulation. The mechanism of miR-128 targeting SP1 was also tested by luciferase reporter assay. Immunohistochemistry and in situ hybridisation staining were used for quantifying SNAI1, SP1 and miR-128 expression levels in human glioma samples. Results: The Chinese Glioma Genome Atlas (CGGA) data revealed that SNAI1 was up-regulated in glioma and we confirmed the findings in normal and glioma tissues. SNAI1 depletion by shRNA retarded the cell cycle and suppressed proliferation and invasion in glioma cell lines. The CGGA data showed that the Pearson correlation index between SNAI1 and miR-128 was negatively correlated. SNAI1 suppressed miR-128b expression by binding to the miR-128b specific promoter motif, and miR-128 targeted SP1 via binding to the 3'-untranslated region of SP1. Moreover, introduction of miR-128 anti-sense oligonucleotide alleviated the cell cycle retardation, proliferation and invasion inhibition induced by SNAI1 shRNA. Immunohistochemistry and in situ hybridisation analysis of SNAI1, SP1 and miR-128 unraveled their expression levels and correlations in glioma samples. Conclusions: We propose that the SNAI1/miR-128/SP1 axis, which plays a vital role in glioma progression, may come to be a clinically relevant therapeutic target.	[Dong, Qingsheng; Cai, Ning; Zhang, Rui; Yan, Wei; Li, Rui; Zhang, Junxia; Luo, Hui; Shi, Yan; Luan, Wenkang; Zhang, Yaxuan; You, Yongping; Wang, Yingyi; Liu, Ning] Nanjing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China; [Tao, Tao] Southeast Univ, Affiliated Zhongda Hosp, Dept Urol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Southeast University - China	Wang, YY (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China.	Lindsay_wang3431@126.com; Liuning0853@126.com		Liu, Ning/0000-0001-7895-1285	National High Technology Research and Development Program of China (863) [2012AA02A508]; International Cooperation Program [2012DFA30470]; National Natural Science Foundation of China [91229121, 81272792, 81172389, 81372709, 81302185, 81101901, 81302184]; Jiangsu Province's Key Provincial Talents Program [RC2011051]; Jiangsu Province's Key Discipline of Medicine [XK201117]; Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Jiangsu Provincial Special Program of Medical Science [BL2012028]	National High Technology Research and Development Program of China (863)(National High Technology Research and Development Program of China); International Cooperation Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province's Key Provincial Talents Program; Jiangsu Province's Key Discipline of Medicine; Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Jiangsu Provincial Special Program of Medical Science	This work was supported by grants from the National High Technology Research and Development Program of China (863) (2012AA02A508), International Cooperation Program (2012DFA30470), National Natural Science Foundation of China (91229121, 81272792, 81172389, 81372709, 81302185, 81101901, 81302184), Jiangsu Province's Key Provincial Talents Program (RC2011051), Jiangsu Province's Key Discipline of Medicine (XK201117), Jiangsu Provincial Special Program of Medical Science (BL2012028), and Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU, and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlakha YK, 2011, CELL MOL LIFE SCI, V68, P1415, DOI 10.1007/s00018-010-0528-y; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bruyere F, 2013, UROL ONCOL, V28, P591; Cieply B, 2013, CANC RES IN PRESS; Evangelisti C, 2009, FASEB J, V23, P4276, DOI 10.1096/fj.09-134965; Giese A, 2003, J CLIN ONCOL, V21, P1624, DOI 10.1200/JCO.2003.05.063; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; Grinstein E, 2002, ONCOGENE, V21, P1485, DOI 10.1038/sj.onc.1205211; Gupta K, 2012, J CANCER RES CLIN, V138, P1971, DOI 10.1007/s00432-012-1323-y; Haar CP, 2012, NEUROCHEM RES, V37, P1192, DOI 10.1007/s11064-011-0701-1; Han SP, 2011, CELL MOL NEUROBIOL, V31, P489, DOI 10.1007/s10571-010-9643-4; He J, 2011, ONCOL REP, V26, P1305, DOI 10.3892/or.2011.1393; Jackstadt R, 2013, J EXP MED, V210, P1331, DOI 10.1084/jem.20120812; Khan AP, 2010, MOL CELL PROTEOMICS, V9, P298, DOI 10.1074/mcp.M900159-MCP200; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Kudo-Saito C, 2009, CANCER CELL, V15, P195, DOI 10.1016/j.ccr.2009.01.023; Laneve P, 2010, NUCLEIC ACIDS RES, V38, P6895, DOI 10.1093/nar/gkq604; Lim SO, 2010, FEBS LETT, V584, P2231, DOI 10.1016/j.febslet.2010.04.006; Lin YH, 2013, ONCOGENE, V32, P4509, DOI 10.1038/onc.2013.309; Liu L, 2013, HEPATOLOGY IN PRESS; Lou Z, 2005, CANCER RES, V65, P1007; Mestdagh P, 2010, ONCOGENE, V29, P1394, DOI 10.1038/onc.2009.429; Murray SA, 2007, DEVELOPMENT, V134, P1789, DOI 10.1242/dev.02837; Nicoloso MS, 2008, BRAIN PATHOL, V18, P122, DOI 10.1111/j.1750-3639.2007.00119.x; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Nuovo GJ, 2009, NAT PROTOC, V4, P107, DOI 10.1038/nprot.2008.215; Olmeda D, 2007, ONCOGENE, V26, P1862, DOI 10.1038/sj.onc.1209997; Olson RA, 2011, J NEURO-ONCOL, V105, P325, DOI 10.1007/s11060-011-0594-5; Peinado H, 2004, MOL CELL BIOL, V24, P306, DOI 10.1128/MCB.24.1.306-319.2004; Qian PX, 2012, CANCER RES, V72, P6036, DOI 10.1158/0008-5472.CAN-12-1507; Safe S, 2005, EUR J CANCER, V41, P2438, DOI 10.1016/j.ejca.2005.08.006; Shi ZM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032709; Singh A, 2013, J CLIN INVEST, V123, P2921, DOI 10.1172/JCI66353; Smirnova L, 2005, EUR J NEUROSCI, V21, P1469, DOI 10.1111/j.1460-9568.2005.03978.x; Tao T, 2013, EUR J CANCER, V49, P3055, DOI 10.1016/j.ejca.2013.05.010; Wang YZ, 2013, CANCER LETT, V331, P139, DOI 10.1016/j.canlet.2012.12.024; Wu YD, 2010, CELL ADHES MIGR, V4, P199, DOI 10.4161/cam.4.2.10943; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yeh Chi-Tai, 2013, CARCINOGENE IN PRESS; Zannetti A, 2005, BIOCHEM PHARMACOL, V70, P1277, DOI 10.1016/j.bcp.2005.07.024; Zhang CH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-184; Zhang Y, 2009, J MOL MED, V87, P43, DOI 10.1007/s00109-008-0403-6	42	45	45	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e98651	10.1371/journal.pone.0098651	http://dx.doi.org/10.1371/journal.pone.0098651			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959930	gold, Green Published, Green Submitted			2022-12-27	WOS:000338633900002
J	Pauwels, L; Swinnen, SP; Beets, IAM				Pauwels, Lisa; Swinnen, Stephan P.; Beets, Iseult A. M.			Contextual Interference in Complex Bimanual Skill Learning Leads to Better Skill Persistence	PLOS ONE			English	Article							MOTOR-SKILL; ACQUISITION; RETENTION; TASK; CONSOLIDATION; PERFORMANCE; PRINCIPLES; SCHEDULE	The contextual interference (CI) effect is a robust phenomenon in the (motor) skill learning literature. However, CI has yielded mixed results in complex task learning. The current study addressed whether the CI effect is generalizable to bimanual skill learning, with a focus on the temporal evolution of memory processes. In contrast to previous studies, an extensive training schedule, distributed across multiple days of practice, was provided. Participants practiced three frequency ratios across three practice days following either a blocked or random practice schedule. During the acquisition phase, better overall performance for the blocked practice group was observed, but this difference diminished as practice progressed. At immediate and delayed retention, the random practice group outperformed the blocked practice group, except for the most difficult frequency ratio. Our main finding is that the random practice group showed superior performance persistence over a one week time interval in all three frequency ratios compared to the blocked practice group. This study contributes to our understanding of learning, consolidation and memory of complex motor skills, which helps optimizing training protocols in future studies and rehabilitation settings.	[Pauwels, Lisa; Swinnen, Stephan P.; Beets, Iseult A. M.] Katholieke Univ Leuven, Dept Kinesiol, Movement Control & Neuroplast Res Grp, Grp Biomed Sci, Leuven, Belgium; [Swinnen, Stephan P.] Katholieke Univ Leuven, Leuven Res Inst Neurosci & Dis LIND, Leuven, Belgium	KU Leuven; KU Leuven	Pauwels, L (corresponding author), Katholieke Univ Leuven, Dept Kinesiol, Movement Control & Neuroplast Res Grp, Grp Biomed Sci, Leuven, Belgium.	Lisa.pauwels@faber.kuleuven.be		Pauwels, Lisa/0000-0002-2033-8274	Research Program of the Research Foundation; Flanders (Fonds Wetenschappelijk Onderzoek; FWO; Research Fund of KU Leuven, Belgium [G0483.10, G0721.12]; Interuniversity Attraction Poles program of the Belgian federal government [OT/11/071, Grant P7/11]; Research Foundation - Flanders (FWO)	Research Program of the Research Foundation; Flanders (Fonds Wetenschappelijk Onderzoek; FWO(FWO); Research Fund of KU Leuven, Belgium; Interuniversity Attraction Poles program of the Belgian federal government(Belgian Federal Science Policy Office); Research Foundation - Flanders (FWO)(FWO)	This work was supported by a grant from the Research Program of the Research Foundation - Flanders (Fonds Wetenschappelijk Onderzoek - FWO; http://www.fwo.be/) (G0483.10, G0721.12), from the Research Fund of KU Leuven, Belgium (OT/11/071), and Grant P7/11 from the Interuniversity Attraction Poles program of the Belgian federal government. LP is funded by an aspirant fellowship of the Research Foundation - Flanders (FWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JA, 1971, J MOTOR BEHAV, V3, P111; Albaret JM, 1998, ACTA PSYCHOL, V100, P9, DOI 10.1016/S0001-6918(98)00022-5; Barnett M L, 1973, Res Q, V44, P440; Battig W.F., 1979, LEVELS PROCESSING HU, P23; Boutin A, 2010, HUM MOVEMENT SCI, V29, P910, DOI 10.1016/j.humov.2010.07.011; Brady F, 1998, QUEST, V50, P266, DOI 10.1080/00336297.1998.10484285; Guadagnoli MA, 2004, J MOTOR BEHAV, V36, P212, DOI 10.3200/JMBR.36.2.212-224; Hebert EP, 1996, RES Q EXERCISE SPORT, V67, P52, DOI 10.1080/02701367.1996.10607925; Jarus T, 2001, Can J Occup Ther, V68, P280; Kantak SS, 2012, BEHAV BRAIN RES, V228, P219, DOI 10.1016/j.bbr.2011.11.028; Kantak SS, 2010, NAT NEUROSCI, V13, P923, DOI 10.1038/nn.2596; Kay H., 1970, MECH MOTOR SKILL DEV; Kovacs AJ, 2011, ACTA PSYCHOL, V136, P311, DOI 10.1016/j.actpsy.2010.12.004; Lee T.D., 2004, SKILL ACQUISITION SP, P29; Lee T.D., 1985, DIFFERING PERSPECTIV, P3, DOI DOI 10.1016/S0166-4115(08)62528-5; LEE TD, 1983, J EXP PSYCHOL LEARN, V9, P730, DOI 10.1037/0278-7393.9.4.730; Lin CH, 2008, J MOTOR BEHAV, V40, P578, DOI 10.3200/JMBR.40.6.578-586; Lin CH, 2010, J MOTOR BEHAV, V42, P223, DOI 10.1080/00222895.2010.492720; Magill R.A, 2020, MOTOR LEARNING CONTR, V12th; MAGILL RA, 1990, HUM MOVEMENT SCI, V9, P241, DOI 10.1016/0167-9457(90)90005-X; Marteniuk R.G., 1976, INFORM PROCESSING MO; Maslovat D, 2004, MOTOR CONTROL, V8, P213, DOI 10.1123/mcj.8.2.213; Robertson EM, 2004, NAT REV NEUROSCI, V5, P576, DOI 10.1038/nrn1426; Schmidt R.A., 2011, HUMAN KINETICS; SCHMIDT RA, 1992, PSYCHOL SCI, V3, P207, DOI 10.1111/j.1467-9280.1992.tb00029.x; SHEA CH, 1990, ACTA PSYCHOL, V73, P145, DOI 10.1016/0001-6918(90)90076-R; Shea J.B., 1983, MEMORY CONTROL ACTIO, P345, DOI DOI 10.1016/S0166-4115(08)61998-6; SHEA JB, 1979, J EXP PSYCHOL-HUM L, V5, P179, DOI 10.1037/0278-7393.5.2.179; Sisti HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023619; Smith PJK, 1995, J SPORT SCI, V13, P455, DOI 10.1080/02640419508732262; Swinnen SP, 2004, TRENDS COGN SCI, V8, P18, DOI 10.1016/j.tics.2003.10.017; Tanaka S, 2010, CEREB CORTEX, V20, P2114, DOI 10.1093/cercor/bhp276; Tsutsui S, 1998, J MOTOR BEHAV, V30, P151, DOI 10.1080/00222899809601332; WINSTEIN CJ, 1990, J EXP PSYCHOL LEARN, V16, P677, DOI 10.1037/0278-7393.16.4.677; WRISBERG CA, 1991, RES Q EXERCISE SPORT, V62, P406, DOI 10.1080/02701367.1991.10607541; Wulf G, 2002, PSYCHON B REV, V9, P185, DOI 10.3758/BF03196276; YOUNG DE, 1993, HUM MOVEMENT SCI, V12, P577, DOI 10.1016/0167-9457(93)90005-A	37	29	29	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100906	10.1371/journal.pone.0100906	http://dx.doi.org/10.1371/journal.pone.0100906			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK7UT	24960171	Green Published, Green Submitted, gold			2022-12-27	WOS:000338633900100
J	Xu, K; Xu, P				Xu, Ke; Xu, Ping			Betaine and Beet Molasses Enhance L-Lactic Acid Production by Bacillus coagulans	PLOS ONE			English	Article							GLYCINE BETAINE; OSMOTIC-STRESS; FERMENTATION; TOLERANCE; STRATEGY; GLUCOSE; BATCH; ACCUMULATION; SUBTILIS	Lactic acid is an important chemical with various industrial applications, and it can be efficiently produced by fermentation, in which Bacillus coagulans strains present excellent performance. Betaine can promote lactic acid fermentation as an effective osmoprotectant. Here, positive effect of betaine on fermentation by B. coagulans is revealed. Betaine could enhance lactic acid production by protecting L-LDH activity and cell growth from osmotic inhibition, especially under high glucose concentrations and with poor organic nitrogen nutrients. The fermentation with 0.05 g/L betaine could produce 17.9% more lactic acid compared to the fermentation without betaine. Beet molasses, which is rich in sucrose and betaine, was utilized in a co-feeding fermentation and raised the productivity by 22%. The efficient lactic acid fermentation by B. coagulans is thus developed by using betaine and beet molasses.	[Xu, Ke; Xu, Ping] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Xu, Ke; Xu, Ping] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Xu, P (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China.	pingxu@sjtu.edu.cn		Xu, Ping/0000-0002-4418-9680	National Basic Research Program of China from Ministry of Science and Technology of China [2013CB733901]; National Natural Science Foundation of China [31121064]; Chinese National Program for High Technology Research and Development [2011AA02A202]	National Basic Research Program of China from Ministry of Science and Technology of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese National Program for High Technology Research and Development(National High Technology Research and Development Program of China)	The authors acknowledge the National Basic Research Program of China (2013CB733901) from Ministry of Science and Technology of China, and the grant from National Natural Science Foundation of China (31121064). This work was partially supported by the Chinese National Program for High Technology Research and Development (2011AA02A202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rahman MA, 2013, BIOTECHNOL ADV, V31, P877, DOI 10.1016/j.biotechadv.2013.04.002; Akerberg C, 1998, APPL MICROBIOL BIOT, V49, P682, DOI 10.1007/s002530051232; Boniolo FS, 2009, CURR MICROBIOL, V59, P593, DOI 10.1007/s00284-009-9479-7; Calik P, 2009, APPL MICROBIOL BIOT, V85, P65, DOI 10.1007/s00253-009-2060-2; Chojnacka A, 2011, BIORESOURCE TECHNOL, V102, P10057, DOI 10.1016/j.biortech.2011.08.063; Ding SF, 2006, PROCESS BIOCHEM, V41, P1451, DOI 10.1016/j.procbio.2006.01.014; Gao C, 2011, BIOTECHNOL ADV, V29, P930, DOI 10.1016/j.biotechadv.2011.07.022; Ge XY, 2011, APPL MICROBIOL BIOT, V89, P73, DOI 10.1007/s00253-010-2868-9; Goksungur Y, 1997, J CHEM TECHNOL BIOT, V69, P399, DOI [10.1002/(SICI)1097-4660(199708)69:4&lt;399::AID-JCTB728&gt;3.0.CO;2-Q, 10.1002/(SICI)1097-4660(199708)69:4<399::AID-JCTB728>3.0.CO;2-Q]; Hatano K, 2009, BIORESOURCE TECHNOL, V100, P4697, DOI 10.1016/j.biortech.2009.04.063; Hoffmann T, 2013, J BACTERIOL, V195, P510, DOI 10.1128/JB.01505-12; Lotfy WA, 2007, BIORESOURCE TECHNOL, V98, P3491, DOI 10.1016/j.biortech.2006.11.035; Maqueda M, 2011, J IND MICROBIOL BIOT, V38, P459, DOI 10.1007/s10295-010-0790-x; Obis D, 2001, FEMS MICROBIOL LETT, V202, P39, DOI [10.1111/j.1574-6968.2001.tb10777.x, 10.1016/S0378-1097(01)00293-2]; Ou MS, 2011, J IND MICROBIOL BIOT, V38, P599, DOI 10.1007/s10295-010-0796-4; Robert H, 2000, APPL ENVIRON MICROB, V66, P509, DOI 10.1128/AEM.66.2.509-517.2000; Romero-Garcia S, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-23; Ronsch H, 2003, J BIOTECHNOL, V104, P87, DOI 10.1016/S0168-1656(03)00166-4; Roukas T, 1999, APPL BIOCHEM BIOTECH, V80, P77, DOI 10.1385/ABAB:80:1:77; Sashihara T, 2001, APPL MICROBIOL BIOT, V56, P496, DOI 10.1007/s002530100669; Selmer-Olsen E, 1999, J APPL MICROBIOL, V87, P429, DOI 10.1046/j.1365-2672.1999.00839.x; SUTHERLAND L, 1986, J BACTERIOL, V168, P805, DOI 10.1128/jb.168.2.805-814.1986; THOMAS KC, 1994, APPL ENVIRON MICROB, V60, P1519, DOI 10.1128/AEM.60.5.1519-1524.1994; Wang XL, 2012, BIORESOURCE TECHNOL, V125, P165, DOI 10.1016/j.biortech.2012.08.125; Xi YL, 2013, BIORESOURCE TECHNOL, V136, P775, DOI 10.1016/j.biortech.2013.03.107; Xu K, 2013, GENOME ANNOUNC, V1; Xu K, 2014, BIORESOURCE TECHNOL, V153, P23, DOI 10.1016/j.biortech.2013.11.057; Yang LB, 2014, BIORESOURCE TECHNOL, V151, P120, DOI 10.1016/j.biortech.2013.10.031; Yu L, 2008, J BIOTECHNOL, V134, P154, DOI 10.1016/j.jbiotec.2008.01.008; Zheng ZJ, 2012, APPL ENVIRON MICROB, V78, P3480, DOI 10.1128/AEM.00058-12; Zhou S, 2006, BIOTECHNOL LETT, V28, P671, DOI 10.1007/s10529-006-0033-4; Zhou XD, 2013, APPL MICROBIOL BIOT, V97, P4309, DOI 10.1007/s00253-013-4710-7; Zou HB, 2013, BIORESOURCE TECHNOL, V148, P591, DOI 10.1016/j.biortech.2013.08.105	33	19	19	4	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100731	10.1371/journal.pone.0100731	http://dx.doi.org/10.1371/journal.pone.0100731			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956474	Green Published, Green Submitted, gold			2022-12-27	WOS:000338917900090
J	Cousins, MM; Konikoff, J; Sabin, D; Khaki, L; Longosz, AF; Laeyendecker, O; Celum, C; Buchbinder, SP; Seage, GR; Kirk, GD; Moore, RD; Mehta, SH; Margolick, JB; Brown, J; Mayer, KH; Kobin, BA; Wheeler, D; Justman, JE; Hodder, SL; Quinn, TC; Brookmeyer, R; Eshleman, SH				Cousins, Matthew M.; Konikoff, Jacob; Sabin, Devin; Khaki, Leila; Longosz, Andrew F.; Laeyendecker, Oliver; Celum, Connie; Buchbinder, Susan P.; Seage, George R., III; Kirk, Gregory D.; Moore, Richard D.; Mehta, Shruti H.; Margolick, Joseph B.; Brown, Joelle; Mayer, Kenneth H.; Kobin, Beryl A.; Wheeler, Darrell; Justman, Jessica E.; Hodder, Sally L.; Quinn, Thomas C.; Brookmeyer, Ron; Eshleman, Susan H.			A Comparison of Two Measures of HIV Diversity in Multi-Assay Algorithms for HIV Incidence Estimation	PLOS ONE			English	Article							RESOLUTION MELTING ASSAY; UNITED-STATES; GENETIC DIVERSITY; INFECTION; VACCINE; TRIALS; COHORT; PERFORMANCE; NETWORK; PLASMA	Background: Multi-assay algorithms (MAAs) can be used to estimate HIV incidence in cross-sectional surveys. We compared the performance of two MAAs that use HIV diversity as one of four biomarkers for analysis of HIV incidence. Methods: Both MAAs included two serologic assays (LAg-Avidity assay and BioRad-Avidity assay), HIV viral load, and an HIV diversity assay. HIV diversity was quantified using either a high resolution melting (HRM) diversity assay that does not require HIV sequencing (HRM score for a 239 base pair env region) or sequence ambiguity (the percentage of ambiguous bases in a 1,302 base pair pol region). Samples were classified as MAA positive (likely from individuals with recent HIV infection) if they met the criteria for all of the assays in the MAA. The following performance characteristics were assessed: (1) the proportion of samples classified as MAA positive as a function of duration of infection, (2) the mean window period, (3) the shadow (the time period before sample collection that is being assessed by the MAA), and (4) the accuracy of cross-sectional incidence estimates for three cohort studies. Results: The proportion of samples classified as MAA positive as a function of duration of infection was nearly identical for the two MAAs. The mean window period was 141 days for the HRM-based MAA and 131 days for the sequence ambiguity-based MAA. The shadows for both MAAs were,1 year. Both MAAs provided cross-sectional HIV incidence estimates that were very similar to longitudinal incidence estimates based on HIV seroconversion. Conclusions: MAAs that include the LAg-Avidity assay, the BioRad-Avidity assay, HIV viral load, and HIV diversity can provide accurate HIV incidence estimates. Sequence ambiguity measures obtained using a commercially-available HIV genotyping system can be used as an alternative to HRM scores in MAAs for cross-sectional HIV incidence estimation.	[Cousins, Matthew M.; Sabin, Devin; Khaki, Leila; Eshleman, Susan H.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Konikoff, Jacob; Brookmeyer, Ron] Univ Calif Los Angeles, Sch Publ Hlth, Dept Biostat, Los Angeles, CA 90024 USA; [Longosz, Andrew F.; Laeyendecker, Oliver; Quinn, Thomas C.] NIAID, NIH, Bethesda, MD 20892 USA; [Laeyendecker, Oliver; Moore, Richard D.; Quinn, Thomas C.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Celum, Connie] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Celum, Connie] Univ Washington, Dept Med, Seattle, WA USA; [Buchbinder, Susan P.] San Francisco Dept Hlth, Bridge HIV, San Francisco, CA USA; [Buchbinder, Susan P.] Univ Calif San Francisco, Dept Epidemiol, San Francisco, CA 94143 USA; [Buchbinder, Susan P.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Seage, George R., III] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Kirk, Gregory D.; Mehta, Shruti H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Margolick, Joseph B.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Brown, Joelle] Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA; [Brown, Joelle] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Mayer, Kenneth H.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Fenway Inst, Boston, MA 02215 USA; [Kobin, Beryl A.] New York Blood Ctr, Lab Infect Dis Prevent, New York, NY 10021 USA; [Wheeler, Darrell] Loyola Univ Chicago, Grad Sch Social Work, Chicago, IL USA; [Justman, Jessica E.] Columbia Univ, Dept Epidemiol, New York, NY USA; [Justman, Jessica E.] Columbia Univ, Dept Med, New York, NY USA; [Hodder, Sally L.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Med, Div Infect Dis, Newark, NJ 07103 USA	Johns Hopkins University; University of California System; University of California Los Angeles; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johns Hopkins University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Harvard T.H. Chan School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of California System; University of California Los Angeles; University of California System; University of California San Francisco; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; New York Blood Center; Loyola University Chicago; Columbia University; Columbia University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Eshleman, SH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA.	seshlem@jhmi.edu	Justman, Jessica/AAA-3572-2020	Laeyendecker, Oliver/0000-0002-6429-4760; Cousins, Matthew/0000-0003-0067-9087	HIV Prevention Trials Network (HPTN) - National Institute of Allergy and Infectious Diseases (NIAID), National Institute on Drug Abuse (NIDA) [UM1-AI068613]; Division of Intramural Research, NIAID, NIH; National Institute of Mental Health (NIMH), and the Office of AIDS Research of the National Institutes of Health (NIH), Department of Health and Human Services;  [R01-AI095068]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R25HD045810] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069496, U01AI035042, U01AI035041, N01AI045200, U01AI035043, ZIAAI000361, U01AI035039, R01AI095068, UM1AI069470, UM1AI068613, N01AI035176, UM1AI068619, UM1AI035043, U01AI035040, UM1AI068617] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA016893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U01DA036935, R01DA012568, R01DA011602, U01DA036297, R01DA004334] Funding Source: NIH RePORTER	HIV Prevention Trials Network (HPTN) - National Institute of Allergy and Infectious Diseases (NIAID), National Institute on Drug Abuse (NIDA); Division of Intramural Research, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Mental Health (NIMH), and the Office of AIDS Research of the National Institutes of Health (NIH), Department of Health and Human Services; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by: (1) the HIV Prevention Trials Network (HPTN) sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), National Institute on Drug Abuse (NIDA), National Institute of Mental Health (NIMH), and the Office of AIDS Research of the National Institutes of Health (NIH), Department of Health and Human Services (UM1-AI068613 to SE); (2) R01-AI095068 (to SE and RB); and (3) the Division of Intramural Research, NIAID, NIH. Support for the studies that provided samples for this project was as follows: HIVNET 001/001.1: N01-AI35176, N01-AI-45200, and AI-45202; ALIVE: R01-DA-04334 and R01-DA12568; MACS: U01-AI35042, U01-AI35043, U01-AI35039, U01-AI35040, U01-AI35041, and UL1-RR025005; JHHCC: R01-DA011602 to RDM and R01-AA016893 to RDM; HPTN 061 and HPTN 064: UM1-AI068619, UM1-AI068617, and UM1-AI068613. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson E, 2013, INFECT GENET EVOL, V18, P125, DOI 10.1016/j.meegid.2013.03.050; Bar KJ, 2010, J VIROL, V84, P6241, DOI 10.1128/JVI.00077-10; Brookmeyer R, 1997, J ROY STAT SOC A STA, V160, P127, DOI 10.1111/1467-985X.00049; Brookmeyer R, 2013, JAIDS-J ACQ IMM DEF, V63, pS233, DOI 10.1097/QAI.0b013e3182986fdf; Brookmeyer R, 2013, AM J EPIDEMIOL, V177, P264, DOI 10.1093/aje/kws436; Brookmeyer R, 2010, EPIDEMIOL REV, V32, P26, DOI 10.1093/epirev/mxq002; Celum CL, 2001, J INFECT DIS, V183, P23, DOI 10.1086/317658; Chen I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081213; Cousins MM, 2014, J CLIN MICROBIOL, V52, P115, DOI 10.1128/JCM.02040-13; Cousins MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051359; Cousins MM, 2013, J MOL DIAGN, V15, P130, DOI 10.1016/j.jmoldx.2012.08.008; Cousins MM, 2012, J CLIN MICROBIOL, V50, P3054, DOI 10.1128/JCM.01460-12; Cousins MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027211; Dobbs T, 2004, J CLIN MICROBIOL, V42, P2623, DOI 10.1128/JCM.42.6.2623-2628.2004; Duong YT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033328; Eshleman SH, 2004, J CLIN MICROBIOL, V42, P2711, DOI 10.1128/JCM.42.6.2711-2717.2004; Eshleman SH, 2013, J INFECT DIS, V207, P223, DOI 10.1093/infdis/jis658; Galli Rick, 2002, Am Clin Lab, V21, P13; Herrmann MG, 2007, CLIN CHEM, V53, P1544, DOI 10.1373/clinchem.2007.088120; Hodder SL, 2013, ANN INTERN MED, V158, P10, DOI 10.7326/0003-4819-158-1-201301010-00004; Huang DD, 2005, J CLIN MICROBIOL, V43, P3963, DOI 10.1128/JCM.43.8.3963-3970.2005; Huang DD, 2003, J CLIN MICROBIOL, V41, P3265, DOI 10.1128/JCM.41.7.3265-3272.2003; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; James MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057350; James MM, 2012, PEDIATR INFECT DIS J, V31, pE222, DOI 10.1097/INF.0b013e3182678c3f; James MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018642; Kaplan EH, 1999, OPER RES, V47, P29, DOI 10.1287/opre.47.1.29; KASLOW RA, 1987, AM J EPIDEMIOL, V126, P310, DOI 10.1093/aje/126.2.310; Koblin BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070413; Konikoff J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082772; Kouyos RD, 2011, CLIN INFECT DIS, V52, P532, DOI 10.1093/cid/ciq164; Laeyendecker O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078818; Laeyendecker O, 2013, J INFECT DIS, V207, P232, DOI 10.1093/infdis/jis659; Li H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000890; Longosz AF, 2014, AIDS; Longosz AF, 2014, AIDS RES HUM RETROV, V30, P339, DOI [10.1089/aid.2013.0169, 10.1089/AID.2013.0169]; Masciotra S, 2010, 17 C RETR OPP INF SA; Mellquist JL, 1999, AIDS RES HUM RETROV, V15, P217, DOI 10.1089/088922299311637; Moore RD, 1998, J ACQ IMMUN DEF SYND, V17, pS38, DOI 10.1097/00042560-199801001-00011; Parekh BS, 2011, AIDS RES HUM RETROV, V27, P265, DOI 10.1089/aid.2010.0159; Park SY, 2014, J VIROL, V88, P2977, DOI 10.1128/JVI.03128-13; Ragonnet-Cronin M, 2012, J INFECT DIS, V206, P756, DOI 10.1093/infdis/jis411; Seage GR, 2001, AM J EPIDEMIOL, V153, P619, DOI 10.1093/aje/153.7.619; Shafer RW, 2001, J CLIN MICROBIOL, V39, P1522, DOI 10.1128/JCM.39.4.1522-1529.2001; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; Vlahov D, 1991, NIDA Res Monogr, V109, P75; Wendel SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055525; Yang J, 2012, SCI CHINA LIFE SCI, V55, P328, DOI 10.1007/s11427-012-4312-0; Yang OO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007388	49	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e101043	10.1371/journal.pone.0101043	http://dx.doi.org/10.1371/journal.pone.0101043			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968135	Green Published, Green Submitted, gold			2022-12-27	WOS:000338280800100
J	Mathys, L; Francois, KO; Quandte, M; Braakman, I; Balzarini, J				Mathys, Leen; Francois, Katrien O.; Quandte, Matthias; Braakman, Ineke; Balzarini, Jan			Deletion of the Highly Conserved N-Glycan at Asn260 of HIV-1 gp120 Affects Folding and Lysosomal Degradation of gp120, and Results in Loss of Viral Infectivity	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NEUTRALIZING ANTIBODY-RESPONSES; ENVELOPE GLYCOPROTEIN; GLYCOSYLATION SITES; DISULFIDE BONDS; TYPE-1 GP120; CLEAVAGE; EVOLUTION; DOMAINS; COMPLEX	N-linked glycans covering the surface of the HIV-1 glycoprotein gp120 are of major importance for the correct folding of this glycoprotein. Of the, on average, 24 N-linked glycans present on gp120, the glycan at Asn260 was reported to be essential for the correct expression of gp120 and gp41 in the virus particle and deletion of the N260 glycan in gp120 heavily compromised virus infectivity. We show here that gp160 containing the N260Q mutation reaches the Golgi apparatus during biosynthesis. Using pulse-chase experiments with [S-35] methionine/cysteine, we show that oxidative folding was slightly delayed in case of mutant N260Q gp160 and that CD4 binding was markedly compromised compared to wild-type gp160. In the search of compensatory mutations, we found a mutation in the V1/V2 loop of gp120 (S128N) that could partially restore the infectivity of mutant N260Q gp120 virus. However, the mutation S128N did not enhance any of the above-mentioned processes so its underlying compensatory mechanism must be a conformational effect that does not affect CD4 binding per se. Finally, we show that mutant N260Q gp160 was cleaved to gp120 and gp41 to a much lower extent than wild-type gp160, and that it was subject of lysosomal degradation to a higher extent than wild-type gp160 showing a prominent role of this process in the breakdown of N260-glycan-deleted gp160, which could not be counteracted by the S128N mutation. Moreover, at least part of the wild-type or mutant gp160 that is normally targeted for lysosomal degradation reached a conformation that enabled CD4 binding.	[Mathys, Leen; Francois, Katrien O.; Balzarini, Jan] Katholieke Univ Leuven, Rega Inst Med Res, Leuven, Belgium; [Quandte, Matthias; Braakman, Ineke] Univ Utrecht, Fac Sci, Bijvoet Ctr Biomol Res, Utrecht, Netherlands	KU Leuven; Utrecht University	Balzarini, J (corresponding author), Katholieke Univ Leuven, Rega Inst Med Res, Leuven, Belgium.	jan.balzarini@rega.kuleuven.be		Braakman, Ineke/0000-0003-1592-4364	KU Leuven Centers of Excellence [PF-10/018]; KU Leuven Geconcerteerde Onderzoeksacties (GOA) [10/014]; Fonds voor Wetenschappelijk Onderzoek (FWO) [G. 0485.08]; CHAARM Network Project of the European Commission; Leen Mathys is supported by a fellowship from L'Oreal-UNESCO; Belgian FWO (Aspirant); European Union	KU Leuven Centers of Excellence; KU Leuven Geconcerteerde Onderzoeksacties (GOA); Fonds voor Wetenschappelijk Onderzoek (FWO)(FWO); CHAARM Network Project of the European Commission; Leen Mathys is supported by a fellowship from L'Oreal-UNESCO; Belgian FWO (Aspirant); European Union(European Commission)	This work was supported by grants from the KU Leuven Centers of Excellence (PF-10/018), the KU Leuven Geconcerteerde Onderzoeksacties (GOA) (no. 10/014), the Fonds voor Wetenschappelijk Onderzoek (FWO) (G. 0485.08) and the CHAARM Network Project of the European Commission. Leen Mathys is supported by a fellowship from L'Oreal-UNESCO, in collaboration with the Belgian FWO (Aspirant). Matthias Quandte was supported by the European Union 7th framework program, ITN "Virus entry''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balzarini J, 2011, J BIOL CHEM, V286, P42900; Bergeron JJ, 1996, P NATL ACAD SCI US, V93, P9606; Bonifacino JS, 1988, P NATL ACAD SCI US, V85, P9580; Bonomelli C, 2010, P NATL ACAD SCI US, V107, P13800; Busser E, 2004, AIDS RES HUM RETROVI, V20, P742; Cherepanov P, 2002, ANTIMICROB AGENTS CH, V46, P3954; Dankers MM, 2004, RETROVIROLOGY, V1, P3; Dekeersmaeker N, 2009, CLIN MICROBIOL, V47, P2232; Desai K, 2005, PLOS MED, V2, pe142; Doores KJ, 2011, PLOS ONE, V6; Francois KO, 2008, VIROLOGY, V382, P10; Gennero L, 2001, J CLIN VIROL, V20, P131; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Holschbach C, 1988, J BIOL CHEM, V263, P11760; Hsu ST, 2008, MOL BIOL CELL, V19, P4707; Hu QX, 2007, VIROLOGY, V368, P145, DOI 10.1016/j.virol.2007.06.029; Jitsuhara Y, 2002, J BIOCHEM, V132, P803, DOI 10.1093/oxfordjournals.jbchem.a003290; Laethem K, 2005, J VIROL METHODS, V123, P25; Land A, 2009, J VIROL, V83, P368; Lao S, 2012, J VIROL, V86, P2153; Li Y, 2008, J VIROL, V82, P638, DOI 10.1128/JVI.01691-07; Macovei A, 2012, PLOS ONE, V7; Molbert E, 1970, J MOL BIOL, V49, P99; Nie J, 2013, RETROVIROLOGY, V10, P14; Parodi AJ, 2003, ANN REV CELL DEV BIO, V19, P649; Reitter JN, 1998, NAT MED, V4, P679, DOI 10.1038/nm0698-679; Ross EK, 1989, J VIROL, V63, P3595; Sassaroli M, 1996, CLIN THER, V18, P1080; Smith DH, 1988, J VIROL, V62, P139; Spellman MW, 1990, J BIOL CHEM, V265, P10373; Syu WJ, 1992, P NATL ACAD SCI US, V89, P2213; Thayer RM, 1991, NUCL ACIDS RES, V19, P3979; Weberova J, 2006, J VIROL METHODS, V136, P102; Willey RL, 1994, J VIROL, V68, P6836; Wyatt R, 1998, NATURE, V393, P648; Zonneveld D, 2003, FASEB J, V17, P1058	36	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e101181	10.1371/journal.pone.0101181	http://dx.doi.org/10.1371/journal.pone.0101181			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967714	Green Published, gold, Green Submitted			2022-12-27	WOS:000338280800116
J	Mumah, JN; Jackson-Smith, D				Mumah, Joyce N.; Jackson-Smith, Douglas			Why Are the Benefits of Increased Resources Not Impacting the Risk of HIV Infection for High SES Women in Cameroon?	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; SOCIOECONOMIC-STATUS; SEXUAL-BEHAVIOR; HEALTH SURVEY; SOUTH-AFRICA; ADULT-POPULATION; POVERTY; COUNTRIES; TANZANIA; GENDER	Background: Despite evidence of a positive SES-HIV gradient in some SSA countries, researchers and policy-makers frequently assume that a range of protective interventions - increasing awareness of mechanisms of HIV transmission, techniques for prevention, greater access to health care facilities, and greater availability of condoms - will reduce the likelihood of contracting HIV, even among higher SES populations. We therefore explore the relationships between SES and these intervening behaviors to illuminate the complex factors that link SES and HIV among women in Cameroon. Methods: We use bivariate and multivariate statistical analysis to examine patterns among the 5, 155 women aged 15-49 who participated in the 2004 CDHS. Results: The results show a strong pattern where higher SES women have greater access to and use of health care facilities, higher levels of condom use, more HIV knowledge, and command higher power within their relationships, yet also have higher rates of HIV. These traditionally protective factors appear to be offset by riskier sexual behaviors on the part of women with increased resources, most notably longer years of premarital sexual experience, multiple partners in last 12 months, and sexual encounters outside of relationship. Multivariate analyses suggests net of the effect of other factors, women who command higher decision-making power, have greater access to health care, more negative attitudes toward wife beating, longer years of premarital sexual exposure, and partners with professional/white collar jobs (characteristics associated with rising SES) had higher odds of testing positive for HIV. Conclusion: Results show that higher riskier sexual practices on part of high SES women offset benefits that may have accrued from their increased access to resources. The results suggest that traditional approaches to HIV prevention which rely on poverty reduction, improving access to health care, improving HIV knowledge, and boosting women's social and economic power may be insufficient to address other drivers of HIV infection among women in SSA.	[Mumah, Joyce N.] African Populat & Hlth Res Ctr, Populat Dynam & Reprod Hlth Program, Nairobi, Kenya; [Jackson-Smith, Douglas] Utah State Univ, Dept Sociol Social Work & Anthropol, Logan, UT 84322 USA	African Population & Health Research Centre; Utah System of Higher Education; Utah State University	Mumah, JN (corresponding author), African Populat & Hlth Res Ctr, Populat Dynam & Reprod Hlth Program, Nairobi, Kenya.	nduehice@gmail.com	Jackson-Smith, Douglas/AAQ-8400-2021	Jackson-Smith, Douglas/0000-0002-0671-5862; Mumah, Joyce/0000-0001-6181-6837				Abimanyi-Ochom J, 2011, AIDS CARE, V23, P1545, DOI 10.1080/09540121.2011.582477; Adair T, 2008, J BIOSOC SCI, V40, P743, DOI 10.1017/S0021932007002556; Biesma RG, 2009, HEALTH POLICY PLANN, V24, P239, DOI 10.1093/heapol/czp025; Bingenheimer JB, 2007, INT FAM PLAN PERSPEC, V33, P83, DOI 10.1363/3308307; Bongaarts J, 2007, POP STUD-J DEMOG, V61, P73, DOI 10.1080/00324720601048343; Buve A, 2001, AIDS, V15, pS117, DOI 10.1097/00002030-200108004-00013; Coovadia HM, 2005, GLOBALIZATION HEALTH, V1, DOI 10.1186/1744-8603-1-13; Defo BK, 1997, SOC SCI MED, V44, P1023, DOI 10.1016/S0277-9536(96)00228-6; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; Fenton L, 2004, LANCET, V364, P1186, DOI 10.1016/S0140-6736(04)17109-2; Fortson JG, 2008, DEMOGRAPHY, V45, P303, DOI 10.1353/dem.0.0006; Fox AM, 2010, PUBLIC HEALTH REP, V125, P16, DOI 10.1177/00333549101250S405; Gargano JW, 2012, AIDS, V26, P1545, DOI 10.1097/QAD.0b013e328353b7b9; Gillespie S, 2007, AIDS, V21, pS5, DOI 10.1097/01.aids.0000300531.74730.72; Glynn JR, 2004, TROP MED INT HEALTH, V9, P4, DOI 10.1046/j.1365-3156.2003.01168.x; Glynn JR, 2001, AIDS, V15, P2025, DOI 10.1097/00002030-200110190-00016; Hargreaves JR, 2002, TROP MED INT HEALTH, V7, P489, DOI 10.1046/j.1365-3156.2002.00889.x; Institut National de la Statistique (INS) et ORC Macro, 2004, ENQ DEM SANT CAM 200 ENQ DEM SANT CAM 200; Johnson K, 2006, JAIDS-J ACQ IMM DEF, V42, P627, DOI 10.1097/01.qai.0000225870.87456.ae; Kapiga SH, 2002, AIDS CARE, V14, P455, DOI [10.1080/09540120208629665, 10.1080/09540120220132991]; Kathewera-Banda M, 2005, INT SOC SCI J, V57, P649, DOI 10.1111/j.1468-2451.2005.00582.x; Kongnyuy E., 2006, BMC INT HEALTH HUM R, V6, P1; Leclerc-Madlala S, 2003, SOC DYNAMICS, V29, P213, DOI 10.1080/02533950308628681; Lurie MN, 2003, AIDS, V17, P2245, DOI 10.1097/00002030-200310170-00013; Macro ORC, 2005, DEM HLTH SURV INT MA; Measure DHS:, 2004, HIV FACT SHEET; MISHRA V, 2007, STUDY ASS HIV INFECT; Mishra V., 2009, LEVELS SPREAD HIV SE; Mishra V, 2007, HIV AIDS IMPL M MEAS; Mishra V, 2007, AIDS, V21, pS17, DOI 10.1097/01.aids.0000300532.51860.2a; Msisha WM, 2008, INT J EPIDEMIOL, V37, P1297, DOI 10.1093/ije/dyn186; Mumah J, 2011, THESIS UTAH STATE U; Mumah JN, 2014, J BIOSOC SCI, V46, P431, DOI 10.1017/S0021932013000631; Muthengi E, 2009, AFRICAN POPULATION S, V23, P161; Nattrass N, 2012, AJAR-AFR J AIDS RES, V11, P307, DOI 10.2989/16085906.2012.754830; O'Farrell N, 2001, LANCET, V357, P636, DOI 10.1016/S0140-6736(05)71428-8; Obermeyer CM, 2013, TROP MED INT HEALTH, V18, P1110, DOI 10.1111/tmi.12155; Parkhurst JO, 2010, B WORLD HEALTH ORGAN, V88, P519, DOI 10.2471/BLT.09.070185; Pisani E, 2008, WISDOM WHORES BUREAU, P372; Reither EN, 2009, J AFRI POP STUD, V23, P127; Sa ZH, 2008, J BIOSOC SCI, V40, P505, DOI 10.1017/S002193200700257X; Wojcicki JM, 2005, J BIOSOC SCI, V37, P1, DOI 10.1017/S0021932004006534; Zaba B, 2002, P ANN M POP ASS AM A	43	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100507	10.1371/journal.pone.0100507	http://dx.doi.org/10.1371/journal.pone.0100507			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK2WP	24968350	Green Published, gold, Green Submitted			2022-12-27	WOS:000338280800043
J	Sabatino, R; Antonelli, A; Battistelli, S; Schwendener, R; Magnani, M; Rossi, L				Sabatino, Raffaella; Antonelli, Antonella; Battistelli, Serafina; Schwendener, Reto; Magnani, Mauro; Rossi, Luigia			Macrophage Depletion by Free Bisphosphonates and Zoledronate-Loaded Red Blood Cells	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; IN-VITRO; DRUG-DELIVERY; MOUSE MODEL; CLODRONATE; ACID; ERYTHROCYTES; APOPTOSIS; CARRIERS; VIVO	Bisphosphonates, besides being important drugs for the treatment of various bone diseases, could also be used to induce apoptosis in macrophage-like and cancer cells. However, their activity in vivo is limited by a short plasma half-life and rapid uptake within bone. Therefore, several delivery systems have been proposed to modify their pharmacokinetic profile and biodistribution. Among these, red blood cells (RBCs) represent one of the most promising biological carriers. The aim of this study was to select the best performing compound among Clodronate, Pamidronate, Ibandronate and Zoledronate in killing macrophages and to investigate RBCs as innovative carrier system to selectively target bisphosphonates to macrophages. To this end, the encapsulation of the selected bisphosphonates in autologous RBCs as well as the effect on macrophages, both in vitro and in vivo were studied. This work shows that, among the tested bisphosphonates, Zoledronate has proven to be the most active molecule. Human and murine RBCs have been successfully loaded with Zoledronate by a procedure of hypotonic dialysis and isotonic resealing, obtaining a dose-dependent drug entrapment with a maximal loading of 7.96 +/- 2.03, 6.95 +/- 3.9 and 7.0 +/- 1.89 mu moles of Zoledronate/ml of packed RBCs for human, Swiss and Balb/C murine RBCs, respectively. Engineered RBCs were able to detach human and murine macrophages in vitro, leading to a detachment of 66 +/- 8%, 67 +/- 8% and 60.5 +/- 3.5% for human, Swiss and Balb/C RBCs, respectively. The in vivo efficacy of loaded RBCs was tested in Balb/C mice administering 59 mu g/mouse of RBC-encapsulated Zoledronate. By a single administration, depletion of 29.0 +/- 16.38% hepatic macrophages and of 67.84 +/- 5.48% spleen macrophages was obtained, confirming the ability of encapsulated Zoledronate to deplete macrophages in vivo. In conclusion, RBCs loaded with Zoledronate should be considered a suitable system for targeted delivery to macrophages, both in vitro and in vivo.	[Sabatino, Raffaella; Antonelli, Antonella; Battistelli, Serafina; Magnani, Mauro; Rossi, Luigia] Univ Urbino Carlo Bo, Dept Biomol Sci, Urbino, PU, Italy; [Schwendener, Reto] Univ Zurich, Inst Mol Canc Res, Zurich, Switzerland; [Magnani, Mauro; Rossi, Luigia] EryDel SpA, Urbino, PU, Italy	University of Urbino; University of Zurich	Rossi, L (corresponding author), Univ Urbino Carlo Bo, Dept Biomol Sci, Urbino, PU, Italy.	luigia.rossi@uniurb.it	ANTONELLI, ANTONELLA/C-6238-2011; Schwendener, Reto A/F-6373-2011; Magnani, Mauro/A-1919-2008	Magnani, Mauro/0000-0001-6456-6626; Sabatino, Raffaella/0000-0003-0093-7808	FIRB project [RBFR1299K0_003]; Ministry of Education; University and Research; EryDel	FIRB project; Ministry of Education; University and Research; EryDel	This work was partially supported by: FIRB project n. RBFR1299K0_003, Ministry of Education, University and Research (MIUR,www.istruzione.it) to RS, AA, MM and LR.; and EryDel S.p.A. (www.erydel.com) to MM LR. The funder did not provide support in the form of salaries and did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen B, 2010, CALCIFIED TISSUE INT, V86, P421, DOI 10.1007/s00223-010-9364-1; Akbarzadeh A, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-102; Alves-Rosa F, 2000, BLOOD, V96, P2834, DOI 10.1182/blood.V96.8.2834.h8002834_2834_2840; Barros ER, 2012, J PEDIATR ENDOCR MET, V25, P485, DOI 10.1515/jpem-2012-0016; Black DM, 2007, NEW ENGL J MED, V356, P1809, DOI 10.1056/NEJMoa067312; Bonabello A, 2003, BONE, V33, P567, DOI 10.1016/S8756-3282(03)00229-1; Bottino R, 1997, TRANSPL P, V29, P2057, DOI 10.1016/S0041-1345(97)00228-5; CECCHINI MG, 1987, J BONE MINER RES, V2, P135; Chapurlat RD, 2013, OSTEOPOROSIS INT, V24, P311, DOI 10.1007/s00198-012-1947-4; Coscia M, 2010, J CELL MOL MED, V14, P2803, DOI 10.1111/j.1582-4934.2009.00926.x; Crowley R, 2013, CLIN MED, V13, P287, DOI 10.7861/clinmedicine.13-3-287; Cummings SR, 2007, NEW ENGL J MED, V356, P1895, DOI 10.1056/NEJMc076132; Fan T, 2013, CLINICOECONOMIC OUTC, V5, P589, DOI 10.2147/CEOR.S39076; Frith JC, 2003, J BONE MINER RES, V18, P204, DOI 10.1359/jbmr.2003.18.2.204; Giraudo E, 2004, J CLIN INVEST, V114, P623, DOI 10.1172/JCI200422087; Hafeman S, 2010, CANCER IMMUNOL IMMUN, V59, P441, DOI 10.1007/s00262-009-0763-y; Hamidi M, 2007, J CONTROL RELEASE, V118, P145, DOI 10.1016/j.jconrel.2006.06.032; Jedynak M, 2012, ANAESTH INTENSIVE TH, V44, P221; Jordan MB, 2003, BLOOD, V101, P594, DOI 10.1182/blood-2001-11-0061; Katzav A, 2013, IMMUNOL RES, V56, P334, DOI 10.1007/s12026-013-8406-y; Kolesnikova TA, 2013, EXPERT OPIN DRUG DEL, V10, P47, DOI 10.1517/17425247.2013.730516; Lutz HU, 2012, ADV EXP MED BIOL, V750, P76, DOI 10.1007/978-1-4614-3461-0_6; Lyles KW, 2007, NEW ENGL J MED, V357, P1799, DOI 10.1056/NEJMoa074941; MAGNANI M, 1992, P NATL ACAD SCI USA, V89, P6477, DOI 10.1073/pnas.89.14.6477; MAGNANI M, 1992, BIOTECHNOL APPL BIOC, V16, P188; Magnani M, 2011, ENCY NANOSCIENCE NAN, V22, P309; Magnani M, 2012, THER DELIV, V3, P405, DOI 10.4155/TDE.12.6; Mantovani A, 2007, BREAST, V16, pS27, DOI 10.1016/j.breast.2007.07.013; Matsuo A, 2003, J RHEUMATOL, V30, P1280; MEBIUS RE, 1991, IMMUNOBIOLOGY, V182, P277, DOI 10.1016/S0171-2985(11)80663-7; Melani C, 2007, CANCER RES, V67, P11438, DOI 10.1158/0008-5472.CAN-07-1882; MELTZER MS, 1990, ANNU REV IMMUNOL, V8, P169, DOI 10.1146/annurev.iy.08.040190.001125; Millan CG, 2004, J CONTROL RELEASE, V95, P27, DOI 10.1016/j.jconrel.2003.11.018; Monkkonen H, 2001, PHARMACEUT RES, V18, P1550, DOI 10.1023/A:1013026313647; Moreau MF, 2007, BIOCHEM PHARMACOL, V73, P718, DOI 10.1016/j.bcp.2006.09.031; Mukthavaram R, 2014, J CONTROL RELEASE, V183, P146, DOI 10.1016/j.jconrel.2014.03.038; Muzykantov VR, 2010, EXPERT OPIN DRUG DEL, V7, P403, DOI 10.1517/17425241003610633; Oldenborg PA, 2004, LEUKEMIA LYMPHOMA, V45, P1319, DOI 10.1080/1042819042000201989; Reid Ian R, 2012, Expert Opin Pharmacother, V13, P637, DOI 10.1517/14656566.2012.662486; Reid IR, 2009, BONE, V44, P4, DOI 10.1016/j.bone.2008.09.012; Rodan Gideon A., 2002, Current Molecular Medicine (Hilversum), V2, P571, DOI 10.2174/1566524023362104; Rogers MJ, 1996, J BONE MINER RES, V11, P1482; Rossi L, 2005, J DRUG TARGET, V13, P99, DOI 10.1080/10611860500064123; Rossi L, 2008, TRANSPLANTATION, V85, P648, DOI 10.1097/TP.0b013e31816360f3; Ruiz P, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/210506; Selander KS, 1996, MOL PHARMACOL, V50, P1127; Serafini S, 2009, ANTIVIR RES, V81, P93, DOI 10.1016/j.antiviral.2008.09.006; Shi GX, 2014, ADV HEALTHC MATER, V3, P142, DOI 10.1002/adhm.201300084; Shih JY, 2006, J CANC MOL, V2, P101; Shmeeda H, 2013, J CONTROL RELEASE, V167, P265, DOI 10.1016/j.jconrel.2013.02.003; Solinas G, 2009, J LEUKOCYTE BIOL, V86, P1065, DOI 10.1189/jlb.0609385; Spencer Andrew, 2008, BMC Clin Pharmacol, V8, P2, DOI 10.1186/1472-6904-8-2; Stasi R, 2012, SEMIN THROMB HEMOST, V38, P454, DOI 10.1055/s-0032-1305780; Strobach D, 2003, BIOCHEM BIOPH RES CO, V307, P23, DOI 10.1016/S0006-291X(03)01127-6; Takayama J, 2000, TRANSPLANT P, V32, P1016, DOI 10.1016/S0041-1345(00)01090-3; Valleala H, 2003, LIFE SCI, V73, P2413, DOI 10.1016/S0024-3205(03)00657-X; van Nieuwenhuijze A, 2013, MOL IMMUNOL, V56, P675, DOI 10.1016/j.molimm.2013.05.002; van Rooijen N, 2002, J LIPOSOME RES, V12, P81, DOI 10.1081/LPR-120004780; VANROOIJEN N, 1992, RES IMMUNOL, V143, P215; Veldboer K, 2011, J CHROMATOGR B, V879, P2073, DOI 10.1016/j.jchromb.2011.05.037; Veltman JD, 2010, BRIT J CANCER, V103, P629, DOI 10.1038/sj.bjc.6605814; WU LX, 1994, MICROB PATHOGENESIS, V16, P387, DOI 10.1006/mpat.1994.1039; Ylitalo R, 2002, PHARMACOL TOXICOL, V90, P139, DOI 10.1034/j.1600-0773.2002.900305.x; Young RJ, 2013, FUTURE ONCOL, V9, P633, DOI [10.2217/fon.13.28, 10.2217/FON.13.28]; Zeisberger SM, 2006, BRIT J CANCER, V95, P272, DOI 10.1038/sj.bjc.6603240; Zhang W, 2010, CLIN CANCER RES, V16, P3420, DOI 10.1158/1078-0432.CCR-09-2904	66	27	29	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e101260	10.1371/journal.pone.0101260	http://dx.doi.org/10.1371/journal.pone.0101260			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968029	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000338280800119
J	Ancel, A; Cristofari, R; Fretwell, PT; Trathan, PN; Wienecke, B; Boureau, M; Morinay, J; Blanc, S; Le Maho, Y; Le Bohec, C				Ancel, Andre; Cristofari, Robin; Fretwell, Peter T.; Trathan, Phil N.; Wienecke, Barbara; Boureau, Matthieu; Morinay, Jennifer; Blanc, Stephane; Le Maho, Yvon; Le Bohec, Celine			Emperors in Hiding: When Ice-Breakers and Satellites Complement Each Other in Antarctic Exploration	PLOS ONE			English	Article							PENGUIN COLONIES; BEHAVIOR; SEA	Evaluating the demographic trends of marine top predators is critical to understanding the processes involved in the ongoing rapid changes in Antarctic ecosystems. However, the remoteness and logistical complexity of operating in Antarctica, especially during winter, make such an assessment difficult. Satellite imaging is increasingly recognised as a valuable method for remote animal population monitoring, yet its accuracy and reliability are still to be fully evaluated. We report here the first ground visit of an emperor penguin colony first discovered by satellite, but also the discovery of a second one not indicated by satellite survey at that time. Several successive remote surveys in this coastal region of East Antarctica, both before and after sudden local changes, had indeed only identified one colony. These two colonies (with a total of ca. 7,400 breeding pairs) are located near the Mertz Glacier in an area that underwent tremendous habitat change after the glacier tongue broke off in February 2010. Our findings therefore suggest that a satellite survey, although offering a major advance since it allows a global imaging of emperor penguin colonies, may miss certain colony locations when challenged by certain features of polar ecosystems, such as snow cover, evolving ice topology, and rapidly changing habitat. Moreover our survey shows that this large seabird has considerable potential for rapid adaptation to sudden habitat loss, as the colony detected in 2009 may have moved and settled on new breeding grounds. Overall, the ability of emperor penguin colonies to relocate following habitat modification underlines the continued need for a mix of remote sensing and field surveys (aerial photography and ground counts), especially in the less-frequented parts of Antarctica, to gain reliable knowledge about the population demography and dynamics of this flagship species of the Antarctic ecosystem.	[Ancel, Andre; Cristofari, Robin; Boureau, Matthieu; Morinay, Jennifer; Blanc, Stephane; Le Maho, Yvon; Le Bohec, Celine] Univ Strasbourg, Inst Pluridisciplinaire Hubert Curien, Strasbourg, France; [Ancel, Andre; Cristofari, Robin; Boureau, Matthieu; Morinay, Jennifer; Blanc, Stephane; Le Maho, Yvon; Le Bohec, Celine] CNRS, UMR 7178, Strasbourg, France; [Cristofari, Robin; Le Maho, Yvon; Le Bohec, Celine] Ctr Sci Monaco, LEA BioSensib 647, Monaco, Monaco; [Fretwell, Peter T.; Trathan, Phil N.] British Antarctic Survey, Cambridge CB3 0ET, England; [Wienecke, Barbara] Australian Antarctic Div, Kingston, Tas, Australia	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Australian Antarctic Division	Ancel, A (corresponding author), Univ Strasbourg, Inst Pluridisciplinaire Hubert Curien, Strasbourg, France.	andre.ancel@iphc.cnrs.fr	LE BOHEC, CELINE/AAD-3589-2022; Cristofari, Robin/AAO-8097-2021; Morinay, Jennifer/R-4535-2019	Morinay, Jennifer/0000-0002-7905-9691; LE BOHEC, Celine/0000-0003-0149-6477	Institut Polaire Francais Paul-Emile Victor (IPEV Programme) [137]; Centre National de la Recherche Scientifique (CNRS); NERC [bas0100025, bas010011] Funding Source: UKRI; Natural Environment Research Council [bas0100025, bas010011] Funding Source: researchfish	Institut Polaire Francais Paul-Emile Victor (IPEV Programme); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was supported by the Institut Polaire Francais Paul-Emile Victor (IPEV Programme 137) and the Centre National de la Recherche Scientifique (CNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancel A, 1999, RAPPORT ACTIVITE IFR, P40; Ancel A, 2013, CR BIOL, V336, P1, DOI 10.1016/j.crvi.2013.02.002; Ancel A, 2009, P ROY SOC B-BIOL SCI, V276, P2163, DOI 10.1098/rspb.2009.0140; Barber-Meyer SM, 2007, POLAR BIOL, V30, P1565, DOI 10.1007/s00300-007-0317-8; BUDD G. M., 1961, EMU, V61, P171; Budd GM, 1962, P ZOOL SOC LOND, V139, P365; Coria Nestor R., 2000, Marine Ornithology, V28, P119; Fretwell PT, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085285, 10.1371/journal.pone.0088655]; Fretwell PT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033751; Fretwell PT, 2009, GLOBAL ECOL BIOGEOGR, V18, P543, DOI 10.1111/j.1466-8238.2009.00467.x; Gilbert C, 2008, POLAR BIOL, V31, P163, DOI 10.1007/s00300-007-0343-6; Isenmann P, 1970, Oiseau, V40, P136; Isenmann P, 1971, OISEAU RFO, V40, P136; JOUVENTIN P, 1972, Alauda, V40, P56; JOUVENTIN P, 1972, Behaviour, V43, P176; JOUVENTIN P, 1971, Terre et la Vie, V25, P510; Jouventin P., 1971, Revue Comport Anim, V5, P189; Jouventin P., 1975, P435; KOOYMAN GL, 1993, ANTARCT SCI, V5, P143, DOI 10.1017/S0954102093000203; Lea Mary-Anne, 2005, Marine Ornithology, V33, P59; LEMAHO Y, 1977, AM SCI, V65, P680; Lynch HJ, 2012, ECOLOGY, V93, P1367; Massom RA, 2009, MAR ECOL PROG SER, V374, P243, DOI 10.3354/meps07734; Melick D., 1995, POLAR REC, V31, P426; Peter H.-U., 2008, FED ENV AGENCY TEXTE, V20, P508; Prevost J, 1961, ECOLOGIE MANCHOT EMP; STONEHOUSE B, 1952, NATURE, V169, P760, DOI 10.1038/169760a0; Todd Frank S., 2004, Marine Ornithology, V32, P193; Wienecke B, 2012, POLAR BIOL, V35, P1289, DOI 10.1007/s00300-012-1172-9; Wienecke B, 2010, POLAR REC, V46, P271, DOI 10.1017/S0032247409990283; Wienecke B, 2009, POLAR REC, V45, P304, DOI 10.1017/S0032247409008341; Wilson GJ, 1983, BIOMASS SCI SER, V4, P1; Wilson PR, 2001, MAR ECOL PROG SER, V213, P301, DOI 10.3354/meps213301; Woehler E. J., 1997, Marine Ornithology, V25, P43; Woehler EJ, 1993, DISTRIBUTION ABUNDAN	35	14	15	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100404	10.1371/journal.pone.0100404	http://dx.doi.org/10.1371/journal.pone.0100404			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963661	Green Accepted, Green Published, gold			2022-12-27	WOS:000338709500046
J	Kristjansson, A; Johannesson, OI; Thornton, IM				Kristjansson, Arni; Johannesson, Omar I.; Thornton, Ian M.			Common Attentional Constraints in Visual Foraging	PLOS ONE			English	Article							COLOR POLYMORPHISM; LIMITED ATTENTION; SEARCH IMAGE; PREY; EVOLUTION; SELECTION; SHIFTS	Predators are known to select food of the same type in non-random sequences or "runs'' that are longer than would be expected by chance. If prey are conspicuous, predators will switch between available sources, interleaving runs of different prey types. However, when prey are cryptic, predators tend to focus on one food type at a time, effectively ignoring equally available sources. This latter finding is regarded as a key indicator that animal foraging is strongly constrained by attention. It is unknown whether human foraging is equally constrained. Here, using a novel iPad task, we demonstrate for the first time that it is. Participants were required to locate and touch 40 targets from 2 different categories embedded within a dense field of distractors. When individual target items "popped-out'' search was organized into multiple runs, with frequent switching between target categories. In contrast, as soon as focused attention was required to identify individual targets, participants typically exhausted one entire category before beginning to search for the other. This commonality in animal and human foraging is compelling given the additional cognitive tools available to humans, and suggests that attention constrains search behavior in a similar way across a broad range of species.	[Kristjansson, Arni; Johannesson, Omar I.] Univ Iceland, Sch Hlth Sci, Fac Psychol, Reykjavik, Iceland; [Thornton, Ian M.] Univ Malta, Fac Media & Knowledge Sci, Dept Cognit Sci, Msida, Malta	University of Iceland; University of Malta	Kristjansson, A (corresponding author), Univ Iceland, Sch Hlth Sci, Fac Psychol, Reykjavik, Iceland.	ak@hi.is; ian.thornton@um.edu.mt		Thornton, Ian/0000-0001-6328-3536				BOND AB, 1982, HUM FACTORS, V24, P101, DOI 10.1177/001872088202400110; Bond AB, 2006, P NATL ACAD SCI USA, V103, P3214, DOI 10.1073/pnas.0509963103; BOND AB, 1983, J EXP PSYCHOL ANIM B, V9, P292, DOI 10.1037/0097-7403.9.3.292; Bond AB, 1999, ANIM LEARN BEHAV, V27, P461, DOI 10.3758/BF03209981; Bond AB, 2007, ANNU REV ECOL EVOL S, V38, P489, DOI 10.1146/annurev.ecolsys.38.091206.095728; Brascamp JW, 2011, J EXP PSYCHOL HUMAN, V37, P1700, DOI 10.1037/a0025636; Cain MS, 2012, PSYCHOL SCI, V23, P1047, DOI 10.1177/0956797612440460; CHARNOV EL, 1976, AM NAT, V110, P141, DOI 10.1086/283054; COOPER JM, 1994, BIOL J LINN SOC, V51, P433, DOI 10.1006/bijl.1994.1033; DAWKINS M, 1971, ANIM BEHAV, V19, P575, DOI 10.1016/S0003-3472(71)80114-8; Dukas R, 2000, BEHAV ECOL, V11, P502, DOI 10.1093/beheco/11.5.502; DUKAS R, 1993, ECOLOGY, V74, P1337, DOI 10.2307/1940064; Dukas R, 2002, PHILOS T R SOC B, V357, P1539, DOI 10.1098/rstb.2002.1063; Dukas R, 2001, BEHAV ECOL, V12, P192, DOI 10.1093/beheco/12.2.192; Gibbons J.D., 2003, NONPARAMETRIC STAT I; Gilchrist ID, 2001, PERCEPTION, V30, P1459, DOI 10.1068/p3249; Hills T. T., 2012, COGNITIVE SEARCH EVO, P11; Hills TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060488; Hills TT, 2012, PSYCHOL REV, V119, P431, DOI 10.1037/a0027373; Hills TT, 2006, COGNITIVE SCI, V30, P3, DOI 10.1207/s15516709cog0000_50; Kalff C, 2010, P 32 ANN C COGN SCI, P1; Kamil Alan C., 2006, P106; Karpestam E, 2014, BIOL J LINN IN PRESS; Karpestam E, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-17; Klein RM, 1999, PSYCHOL SCI, V10, P346, DOI 10.1111/1467-9280.00166; Kono H, 1998, ANIM BEHAV, V56, P963, DOI 10.1006/anbe.1998.0847; Kristjansson A, 2006, VIS COGN, V13, P324, DOI 10.1080/13506280544000039; Kristjansson A, 2010, ATTEN PERCEPT PSYCHO, V72, P5, DOI 10.3758/APP.72.1.5; Langley CM, 1996, J EXP PSYCHOL ANIM B, V22, P139, DOI 10.1037/0097-7403.22.2.139; Nakayama K, 2011, VISION RES, V51, P1526, DOI 10.1016/j.visres.2010.09.003; Pellicano E, 2011, P NATL ACAD SCI USA, V108, P421, DOI 10.1073/pnas.1014076108; PIETREWICZ AT, 1979, SCIENCE, V204, P1332, DOI 10.1126/science.204.4399.1332; Punzalan D, 2005, EVOL ECOL, V19, P303, DOI 10.1007/s10682-005-2777-z; PYKE GH, 1977, Q REV BIOL, V52, P137, DOI 10.1086/409852; REID PJ, 1992, J EXP PSYCHOL ANIM B, V18, P273, DOI 10.1037/0097-7403.18.3.273; Stephens D.W., 1986, pi; TINBERGEN L., 1960, ARCH NEERLAND ZOOL, V13, P265; TREISMAN A, 1988, Q J EXP PSYCHOL-A, V40, P201, DOI 10.1080/02724988843000104; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Vogel EK, 2008, CURR DIR PSYCHOL SCI, V17, P171, DOI 10.1111/j.1467-8721.2008.00569.x; Watson JM, 2010, PSYCHON B REV, V17, P479, DOI 10.3758/PBR.17.4.479; Wilmer JB, 2012, COGN NEUROPSYCHOL, V29, P360, DOI 10.1080/02643294.2012.753433; Wolfe JM, 2013, J VISION, V13, DOI 10.1167/13.3.10; Wolfe JM, 2004, NAT REV NEUROSCI, V5, P495, DOI 10.1038/nrn1411	44	58	59	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100752	10.1371/journal.pone.0100752	http://dx.doi.org/10.1371/journal.pone.0100752			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK8WO	24964082	gold, Green Published			2022-12-27	WOS:000338709500078
J	Liu, XN; Erasmus, V; Wu, Q; Richardus, JH				Liu, Xiaona; Erasmus, Vicki; Wu, Qing; Richardus, Jan Hendrik			Behavioral and Psychosocial Interventions for HIV Prevention in Floating Populations in China over the Past Decade: A Systematic Literature Review and Meta-Analysis	PLOS ONE			English	Article							TO-URBAN MIGRANTS; SEXUAL-BEHAVIOR; DETERMINANTS; SHANGHAI; STIGMA; RISKS	Background: Floating populations have been repeatedly characterized as "the tipping point'' for the HIV epidemic in China. This study aims to systematically summarize and assess the effectiveness of HIV prevention interventions in floating populations in China over the past decade. Methods: We conducted a systematic search in three international databases for literature published between 2005 and 2012 with condom use as the primary outcome, and knowledge about HIV transmission and prevention and stigma towards HIV-infected individuals as secondary outcomes. The impact of interventions on changing the primary and secondary outcomes was calculated by risk difference (RD). We also performed subgroup analyses and meta-regression based on different study characteristics, using Stata 12.0, for the primary outcome. Results: Sixteen studies (out of 149) involved 19 different programs and a total of 10,864 participants at entry from 11 provinces in China. The pooled effect estimate of all studies indicated that people participating in HIV-related interventions were 13% more likely to use condoms (95% CI: 0.07, 0.18), however, the effects on increasing condom use exhibited significant heterogeneity across programs (P<0.01, I-2 = 0.93). The meta-regression results suggest that interventions have been significantly less successful in changing condom use in more recent studies (beta, 0.14; 95% CI: 0.01, 0.27), adjusted for sexual relationship, study design and follow-up period. Regarding the secondary outcomes, HIV-related interventions were successful at improving knowledge about HIV transmission and prevention (RD, 20.26; 95% CI: 20.36, 20.16 and RD, 20.25; 95% CI: 20.33, 20.16, respectively), and decreasing stigma (RD, 0.18; 95% CI: 0.09, 0.27). Conclusions: The included studies between 2005 and 2012 indicate that HIV prevention interventions among Chinese floating populations in the past decade were only marginally effective at increasing condom use, but relatively successful at increasing HIV knowledge and decreasing stigma. To avert new infections, novel sexual risk-reduction interventions taking into account the changing socio-economic and cultural situation of Chinese floating populations are urgently needed.	[Liu, Xiaona; Erasmus, Vicki; Wu, Qing; Richardus, Jan Hendrik] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Richardus, JH (corresponding author), Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands.	j.richardus@erasmusmc.nl	Liu, Xiaona/AAE-3907-2021; Richardus, Jan Hendrik/AAE-1278-2021	Richardus, Jan Hendrik/0000-0003-0564-6313; Liu, Xiaona/0000-0002-0183-8011	Chinese Scholarship Council (CSC) PhD studentship; Netherlands Institutes for Health Science (NIHES)	Chinese Scholarship Council (CSC) PhD studentship; Netherlands Institutes for Health Science (NIHES)	XL is supported by a Chinese Scholarship Council (CSC) PhD studentship. QW is supported by Netherlands Institutes for Health Science (NIHES). VE and JR are members of infectious diseases control research, Erasmus MC, University Medical Center Rotterdam, The Netherlands. There are no other funding sources to report. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AF, 2003, AIDS CARE, V15, P177, DOI 10.1080/0954012031000068326; Barker DH, 2011, AIDS BEHAV; Bartholomew LK, 2011, PLANNING HLTH PROMOT; Beijing Civiel Society Development Research Center, 2013, CHINA DEV BRIEF; Berg R, 2009, EURO SURVEILL, V14; Brown L, 2003, AIDS EDUC PREV, V15, P49, DOI 10.1521/aeap.15.1.49.23844; China National Knowledge Infrastructure, 2010, FREQ ASK QUEST; Dick B, 2006, WHO TECH REP SER, V938, P1; Donovan B, 2000, LANCET, V355, P1897, DOI 10.1016/S0140-6736(00)02302-3; Du JiaXiao, 2011, Chongqing Medicine, V40, P2859; Earnshaw VA, 2009, AIDS BEHAV, V13, P1160, DOI 10.1007/s10461-009-9593-3; Flay BR, 2005, PREV SCI, V6, P151, DOI 10.1007/s11121-005-5553-y; Fu S, 2009, CHINESE J HLTH ED, V25, P116; Gorbach PM, 2002, AIDS, V16, pS35, DOI 10.1097/00002030-200216004-00006; He N, 2006, AIDS EDUC PREV, V18, P176, DOI 10.1521/aeap.2006.18.2.176; He N, 2007, AIDS, V21, pS73, DOI 10.1097/01.aids.0000304700.85379.f3; He N, 2007, BIOSCI TRENDS, V1, P72; Hong Y, 2009, AIDS BEHAV, V13, P603, DOI 10.1007/s10461-008-9483-0; [侯丽艳 Hou Liyan], 2011, [中国公共卫生, China Public Health], V27, P116; Huang Fen, 2009, Wei Sheng Yan Jiu, V38, P72; Johnson BT, 2010, AIDS BEHAV, V14, pS204, DOI 10.1007/s10461-010-9803-z; JPT H., 2011, COCHRANE HDB SYSTEMA; Kapiga SH, 1996, E AFR MED J, V73, P435; Kirby D, 2006, WHO TECH REP SER, V938, P103; Li LanDi, 2011, Occupation and Health, V27, P46; Li X, 2010, CHINESE NURSING RES, V24, P2275; Li Y, 2006, GUANGXI MED J, V28, P816; Lin DH, 2010, AIDS EDUC PREV, V22, P344, DOI 10.1521/aeap.2010.22.4.344; Liu P, 2010, MED SOC, V23, P39; Mahajan AP, 2008, AIDS, V22, pS67, DOI 10.1097/01.aids.0000327438.13291.62; Maticka-Tyndale E, 2006, WHO TECH REP SER, V938, P243; Ministry of Health of the People's Republic of China, 2011, 2010 HLTH STAT YB CH; Ministry of Health of the People's Republic of China, 2012, 2012 CHIN AIDS RESP; Naning Wenming Website, 2013, CAR MIGR WORK CONSTR; National Center for AIDS/STD Control and Prevention C, 2013, MONTHL REP HIV AIDS, P212; National Center for AIDS/STD Control and Prevention C, 2008, MONTHL REP HIV AIDS, P16; National Center for AIDS/STD Control and Prevention C, 2012, MONTHL REP HIV AIDS, P67; Ning Y, 2010, CHINESE J HLTH ED, V26, P258; Ning Zhang, 2011, J NW POLYTECHNICAL U, V31, P53; Owiredu WKBA, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-70; Peng X. Z., 2000, CHANGING POPULATION; Qian ZH, 2005, SEX TRANSM INFECT, V81, P442, DOI 10.1136/sti.2004.014258; Rou KM, 2010, INT J EPIDEMIOL, V39, pII38, DOI 10.1093/ije/dyq211; Sackett D., 2000, EVIDENCE BASED MED P, DOI DOI 10.1136/BMJ.H3089; Sheng M, 2010, CHINESE RURAL HLTH S, V30, P1060; Shi X, 2011, CHINESE PRIMARY HLTH, V25, P67; The Ministry of Health of the People's Republic of China Joint United Nations Programme on HIV/AIDS and World Health Organization, 2006, 2005 UPD HIV AIDS EP; UNAIDS, 2012, GLOBAL REPORT UNAIDS; Wang HongWei, 2011, Journal of Environmental & Occupational Medicine, V28, P730; Wasti SA, 2002, J PERS SOC PSYCHOL, V83, P394, DOI 10.1037/0022-3514.83.2.394; Xu X, 2006, CHINESE J HLTH ED, V22, P208; Xu Y, 2010, CHINESE J HLTH ED, V26, P292; Yu C, 2008, CHINESE J EVIDENCE B, V8, P323; Zhang Kong-lai, 2004, Sex Health, V1, P39, DOI 10.1071/SH03015; Zhang L, 2013, SEX TRANSM DIS, V40, P136, DOI 10.1097/OLQ.0b013e318281134f; Zhang QiWen, 2009, Journal of Tropical Medicine (Guangzhou), V9, P1326; Zhang Y., 2008, CHINESE J POPULATION, V2, P80; Zheng Q, 2006, CHINESE J PUBLIC HLT, V22, P515; Zhou J, 2009, CHINESE J DIS CONTRO, V13, P139; Zhuang X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031986	60	15	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e101006	10.1371/journal.pone.0101006	http://dx.doi.org/10.1371/journal.pone.0101006			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK8WO	24963669	Green Submitted, Green Published, gold			2022-12-27	WOS:000338709500109
J	Simeonov, KP; Uppal, H				Simeonov, Kamen P.; Uppal, Hirdesh			Direct Reprogramming of Human Fibroblasts to Hepatocyte-Like Cells by Synthetic Modified mRNAs	PLOS ONE			English	Article							DIRECT CONVERSION; STEM-CELLS; LIVER; TRANSPLANTATION; FOXA	Direct reprogramming by overexpression of defined transcription factors is a promising new method of deriving useful but rare cell types from readily available ones. While the method presents numerous advantages over induced pluripotent stem (iPS) cell approaches, a focus on murine conversions and a reliance on retroviral vectors limit potential human applications. Here we address these concerns by demonstrating direct conversion of human fibroblasts to hepatocyte-like cells via repeated transfection with synthetic modified mRNAs. Hepatic induction was achieved with as little as three transcription factor mRNAs encoding HNF1A plus any two of the factors, FOXA1, FOXA3, or HNF4A in the presence of an optimized hepatic growth medium. We show that the absolute necessity of exogenous HNF1A mRNA delivery is explained both by the factor's inability to be activated by any other factors screened and its simultaneous ability to strongly induce expression of other master hepatic transcription factors. Further analysis of factor interaction showed that a series of robust cross-activations exist between factors that induce a hepatocyte-like state. Transcriptome and small RNA sequencing during conversion toward hepatocyte-like cells revealed global preferential activation of liver genes and miRNAs over those associated with other endodermal tissues, as well as downregulation of fibroblast-associated genes. Induced hepatocytelike cells also exhibited hepatic morphology and protein expression. Our data provide insight into the process by which direct hepatic reprogramming occurs in human cells. More importantly, by demonstrating that it is possible to achieve direct reprogramming without the use of retroviral gene delivery, our results supply a crucial step toward realizing the potential of direct reprogramming in regenerative medicine.	[Simeonov, Kamen P.; Uppal, Hirdesh] Genentech Inc, Dept Invest Toxicol, San Francisco, CA 94080 USA	Roche Holding; Genentech	Simeonov, KP (corresponding author), Genentech Inc, Dept Invest Toxicol, San Francisco, CA 94080 USA.	kamen.simeonov@gmail.com	Simeonov, Kamen/B-9230-2013	Simeonov, Kamen/0000-0003-2194-3668	Genentech	Genentech(Roche HoldingGenentech)	The work was funded by Genentech, performed internally at Genentech, and all authors are employed by Genentech. Two patent applications are filed related to this work: 1. Simeonov KP, Uppal H. Methods and Compositions for Producing Induced Hepatocytes. US20140087416 A1, March 27, 2014 (https://www.google.com/patents/US20140087416); 2. Simeonov KP, Uppal H. Methods and Compositions for Producing Induced Hepatocytes. WO2014039768 A1, March 13, 2014. (http://www.google.com/patents/WO2014039768A1?cl=en). The authors are the inventors listed on the patent applications but have no financial stake in either application. Both patent applications are wholly owned by the funder. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Ben-David U, 2011, NAT REV CANCER, V11, P268, DOI 10.1038/nrc3034; Bushman F, 2005, NAT REV MICROBIOL, V3, P848, DOI 10.1038/nrmicro1263; Chambers SM, 2011, CELL, V145, P827, DOI 10.1016/j.cell.2011.05.036; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Dhawan A, 2010, NAT REV GASTRO HEPAT, V7, P288, DOI 10.1038/nrgastro.2010.44; Du YY, 2014, CELL STEM CELL, V14, P394, DOI 10.1016/j.stem.2014.01.008; Girard M, 2008, J HEPATOL, V48, P648, DOI 10.1016/j.jhep.2008.01.019; Huang PY, 2014, CELL STEM CELL, V14, P370, DOI 10.1016/j.stem.2014.01.003; Huang PY, 2011, NATURE, V475, P386, DOI 10.1038/nature10116; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Jang YY, 2004, NAT CELL BIOL, V6, P532, DOI 10.1038/ncb1132; Kaplowitz N, 2005, NAT REV DRUG DISCOV, V4, P489, DOI 10.1038/nrd1750; Le PP, 2005, PLOS GENET, V1, P159, DOI 10.1371/journal.pgen.0010016; Lee CS, 2005, NATURE, V435, P944, DOI 10.1038/nature03649; Lee J, 2012, CELL, V151, P547, DOI 10.1016/j.cell.2012.09.034; Liu X, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-271; Odom DT, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100059; Ohtake Y, 2008, CELL BIOCHEM FUNCT, V26, P359, DOI 10.1002/cbf.1451; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; Sekiya S, 2011, NATURE, V475, P390, DOI 10.1038/nature10263; Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139; Stainier DYR, 2002, GENE DEV, V16, P893, DOI 10.1101/gad.974902; Theise ND, 2000, HEPATOLOGY, V32, P11, DOI 10.1053/jhep.2000.9124; Thuluvath PJ, 2010, AM J TRANSPLANT, V10, P1003, DOI 10.1111/j.1600-6143.2010.03037.x; Vierbuchen T, 2011, NAT BIOTECHNOL, V29, P892, DOI 10.1038/nbt.1946; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Wasmuth HE, 2009, GASTROENTEROLOGY, V137, P309, DOI 10.1053/j.gastro.2009.03.053; Yu B, 2013, CELL STEM CELL, V13, P328, DOI 10.1016/j.stem.2013.06.017	30	61	65	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100134	10.1371/journal.pone.0100134	http://dx.doi.org/10.1371/journal.pone.0100134			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963715	Green Published, Green Submitted, gold			2022-12-27	WOS:000338709500029
J	Tianpei, XZ; Zhu, YG; Li, SQ				Tianpei, Xiuzi; Zhu, Yingguo; Li, Shaoqing			Optimized Scorpion Polypeptide LMX: A Pest Control Protein Effective against Rice Leaf Folder	PLOS ONE			English	Article							INSECT RESISTANCE; DEPRESSANT TOXIN; BT CROPS; BACULOVIRUS; EXPRESSION; NEUROTOXIN; CHANNELS; COTTON; INHIBITORS; POTASSIUM	Lepidopteran insect pests are the main class of pests causing significant damage to crop plant yields. Insecticidal scorpion peptides exhibit toxicity specific for insects. Here, we report that a peptide LMX, optimized from the insect-specific scorpion neurotoxin LqhIT2, showed high levels of activity against rice leaf folder in vitro and in planta. Oral ingestion of LMX protein led to a significant decrease in feeding on rice leaves, repression of larval growth and development, delay in molting, and increase in larval lethality. Compared with LqhIT2 protein, the stability and insecticidal efficacy of LMX was better. Meanwhile, biochemical analysis showed that LMX protein ingestion dramatically decreased ecdysone content in rice leaf folder larvae, and down-regulated enzymatic activities of the detoxification system (a-naphthyl acetate esterase and glutathione S-transferase), the digestive system (tryptase and chymotrypsin), and the antioxidant system (catalase). These changes were tightly correlated with the dosage of LMX protein. Transgene analysis showed that the rate of leaf damage, and the number of damaged tillers and leaves in the transgenic line were greatly reduced relative to wild type plants and empty vector plants. Based on these observations, we propose that the insect-specific scorpion neurotoxin peptide LMX is an attractive and effective alternative molecule for the protection of rice from rice leaf folder.	[Tianpei, Xiuzi; Zhu, Yingguo; Li, Shaoqing] Wuhan Univ, State Key Lab Hybrid Rice,Coll Life Sci,Minist Ed, Key Lab Res & Utilizat Heterosis Indica Rice, Minist Agr,Engn Res Ctr Plant Biotechol & Germpla, Wuhan 430072, Peoples R China	Ministry of Agriculture & Rural Affairs; Wuhan University	Li, SQ (corresponding author), Wuhan Univ, State Key Lab Hybrid Rice,Coll Life Sci,Minist Ed, Key Lab Res & Utilizat Heterosis Indica Rice, Minist Agr,Engn Res Ctr Plant Biotechol & Germpla, Wuhan 430072, Peoples R China.	shaoqingli@whu.edu.cn			National High Technology Program [2012AA10A304]; Transgenic Research and Development Program [2011ZX08001004]	National High Technology Program; Transgenic Research and Development Program	This work was supported by the National High Technology Program (2012AA10A304), Transgenic Research and Development Program (2011ZX08001004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Alfageme F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020278; Alvi Shah Muhammad, 2003, International Journal of Agriculture and Biology, V5, P615; Benedict JH, 2001, GENETIC IMPROVEMENT OF COTTON, P137; Benkhalifa R, 1997, LIFE SCI, V61, P819, DOI 10.1016/S0024-3205(97)00564-X; Bergeron ZL, 2012, TOXINS, V4, P1082, DOI 10.3390/toxins4111082; Christian P, 1994, P S BIOP OPP AUSTR I, P40; Christou P, 2006, TRENDS PLANT SCI, V11, P302, DOI 10.1016/j.tplants.2006.04.001; de la Vega RCR, 2005, TOXICON, V46, P831, DOI 10.1016/j.toxicon.2005.09.006; DEDIANOUS S, 1987, TOXICON, V25, P411, DOI 10.1016/0041-0101(87)90074-2; Deka S, 2010, BIOTECHNOL ADV, V28, P70, DOI 10.1016/j.biotechadv.2009.09.003; Dunse KM, 2010, P NATL ACAD SCI USA, V107, P15011, DOI 10.1073/pnas.1009241107; Fan XJ, 2008, CHINESE SCI BULL, V53, P1855, DOI 10.1007/s11434-008-0242-4; Fass D, 2012, ANNU REV BIOPHYS, V41, P63, DOI 10.1146/annurev-biophys-050511-102321; Ferre J, 2002, ANNU REV ENTOMOL, V47, P501, DOI 10.1146/annurev.ento.47.091201.145234; Fitches E, 2002, INSECT BIOCHEM MOLEC, V32, P1653, DOI 10.1016/S0965-1748(02)00105-4; Food and Agriculture Organization of the United Nations (FAO), 2004, STAT FOOD SEC WORLD, P30; Froy O, 1999, J MOL EVOL, V48, P187, DOI 10.1007/PL00006457; Gurevitz M, 2007, TOXICON, V49, P473, DOI 10.1016/j.toxicon.2006.11.015; Hagele BF, 2004, J INSECT PHYSIOL, V50, P621, DOI 10.1016/j.jinsphys.2004.04.008; HERRMANN R, 1995, TOXICON, V33, P1099, DOI 10.1016/0041-0101(95)98053-X; Ho NH, 2006, CROP SCI, V46, P781, DOI 10.2135/cropsci2005.06-0111; Hu J, 2011, PLANT PHYSIOL, V156, P856, DOI 10.1104/pp.111.174334; Karbat I, 2007, J MOL BIOL, V366, P586, DOI 10.1016/j.jmb.2006.10.085; Khan SA, 2006, TRANSGENIC RES, V15, P349, DOI 10.1007/s11248-006-0007-2; Khush GS, 2002, P 20 SESS INT RIC CO; King GF, 2013, ANNU REV ENTOMOL, V58, P475, DOI 10.1146/annurev-ento-120811-153650; Koundal K. R., 2003, Indian Journal of Biotechnology, V2, P110; Kumar S, 2008, J ENVIRON BIOL, V29, P641; Li SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047401; Luo ShouJin, 2010, Plant Diseases and Pests, V1, P13; MURRAY EE, 1989, NUCLEIC ACIDS RES, V17, P477, DOI 10.1093/nar/17.2.477; Pava-Ripoll M, 2008, J INVERTEBR PATHOL, V99, P220, DOI 10.1016/j.jip.2008.05.004; Peng XJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-125; Perlak FJ, 2001, PLANT J, V27, P489, DOI 10.1046/j.1365-313X.2001.01120.x; Rajendra W, 2006, BBA-GEN SUBJECTS, V1760, P158, DOI 10.1016/j.bbagen.2005.11.008; RAMACHANDRAN R, 1991, J CHEM ECOL, V17, P41, DOI 10.1007/BF00994421; Regev A, 2003, FEBS LETT, V537, P106, DOI 10.1016/S0014-5793(03)00104-2; Schluter U, 2010, J EXP BOT, V61, P4169, DOI 10.1093/jxb/erq166; Shelton AM, 2002, ANNU REV ENTOMOL, V47, P845, DOI 10.1146/annurev.ento.47.091201.145309; Smigocki AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057303; Strugatsky D, 2005, BIOCHEMISTRY-US, V44, P9179, DOI 10.1021/bi050235t; Sun XL, 2009, BIOL CONTROL, V49, P77, DOI 10.1016/j.biocontrol.2008.12.011; Tabashnik BE, 2003, J ECON ENTOMOL, V96, P1031, DOI 10.1603/0022-0493-96.4.1031; Tabashnik BE, 2013, NAT BIOTECHNOL, V31, P510, DOI 10.1038/nbt.2597; Tawfik AI, 1999, ARCH INSECT BIOCHEM, V41, P134, DOI 10.1002/(SICI)1520-6327(1999)41:3&lt;134::AID-ARCH4&gt;3.0.CO;2-6; Trung NP, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-18; van Beek N, 2003, BIOL CONTROL, V27, P53, DOI 10.1016/S1049-9644(02)00172-X; Wang CS, 2007, NAT BIOTECHNOL, V25, P1455, DOI 10.1038/nbt1357; Wang JX, 2005, PLANT CELL REP, V24, P549, DOI 10.1007/s00299-005-0967-3; Wu JH, 2008, BIOTECHNOL LETT, V30, P547, DOI 10.1007/s10529-007-9555-7; Wudayagiri R, 2001, BMC BIOCHEM, V2, DOI 10.1186/1472-2091-2-16; ZLOTKIN E, 1991, BIOCHEMISTRY-US, V30, P4814, DOI 10.1021/bi00233a025	52	3	5	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100232	10.1371/journal.pone.0100232	http://dx.doi.org/10.1371/journal.pone.0100232			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964088	Green Published, Green Submitted, gold			2022-12-27	WOS:000338709500033
J	Wei, LJ; Liu, CP; Kang, L; Liu, YF; Shi, SL; Wu, Q; Li, Y				Wei, Lijun; Liu, Chuanpeng; Kang, Li; Liu, Yufeng; Shi, Shuliang; Wu, Qiong; Li, Yu			Experimental Study on Effect of Simulated Microgravity on Structural Chromosome Instability of Human Peripheral Blood Lymphocytes	PLOS ONE			English	Article							COMMON FRAGILE SITES; CANCER; TISSUES; STRESS	Experimental study was made by keeping human peripheral blood lymphocytes under simulated microgravity in a Rotary Cell Culture System bioreactor to investigate the changes that occur in the number of chromosomes, the expression rate of chromosome fragile site, and the expressions of DNA replication- and repair-related genes. Experimental results indicate simulated microgravity has no effect on the numerical chromosome instability of human peripheral blood lymphocytes, but it enhances the structural chromosome instability of human peripheral blood lymphocytes through the inhibition of DNA replication and the reduction of DNA repair. So, the mechanism of chromosome fragile site induced by simulated microgravity can be explained using the changes that occur in the chromosome structure of human peripheral blood lymphocytes, the DNA replication and repair under the effect of simulated microgravity.	[Wei, Lijun; Liu, Chuanpeng; Kang, Li; Liu, Yufeng; Shi, Shuliang; Wu, Qiong; Li, Yu] Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150006, Peoples R China; [Wei, Lijun; Li, Yu] Chinese Astronaut Res & Training Ctr, State Key Lab Space Med Fundamentals & Applicat, Beijing, Peoples R China	Harbin Institute of Technology	Li, Y (corresponding author), Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150006, Peoples R China.	liyugene@hit.edu.cn	黎, 伟/GXM-4040-2022; wei, li/GSD-3630-2022; wu, qiong/GRY-4672-2022		National Science Foundation of China [30970686, 31271507]; Opening Foundation of the State Key Laboratory for Space Medicine Fundamentals and Application [SMFA14K01]; Natural Science Foundation of Heilongjiang Province [D200879]; Natural Scientific Research Innovation Foundation of Harbin Institute of Technology [HIT.NSRIF.2008.14]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Opening Foundation of the State Key Laboratory for Space Medicine Fundamentals and Application; Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province); Natural Scientific Research Innovation Foundation of Harbin Institute of Technology(Harbin Institute of Technology)	This work is funded by National Science Foundation of China (30970686 and 31271507), Opening Foundation of the State Key Laboratory for Space Medicine Fundamentals and Application (SMFA14K01), Natural Science Foundation of Heilongjiang Province (D200879), and Natural Scientific Research Innovation Foundation of Harbin Institute of Technology (HIT.NSRIF.2008.14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burrell RA, 2013, NATURE, V494, P492, DOI 10.1038/nature11935; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; Cha RS, 2002, SCIENCE, V297, P602, DOI 10.1126/science.1071398; Ducray C, 1998, ADV SPACE RES, V22, P597, DOI 10.1016/S0273-1177(98)00082-9; Durkin SG, 2007, ANNU REV GENET, V41, P169, DOI 10.1146/annurev.genet.41.042007.165900; Glover TW, 2006, CANCER LETT, V232, P4, DOI 10.1016/j.canlet.2005.08.032; GLOVER TW, 1984, HUM GENET, V67, P136, DOI 10.1007/BF00272988; Gollin SM, 2005, SEMIN CANCER BIOL, V15, P33, DOI 10.1016/j.semcancer.2004.09.004; GOODWIN TJ, 1993, J CELL BIOCHEM, V51, P301, DOI 10.1002/jcb.240510309; Gutala RV, 2004, J NEUROSCI METH, V132, P101, DOI 10.1016/j.jneumeth.2003.09.005; HECHT F, 1984, CANCER GENET CYTOGEN, V13, P185, DOI 10.1016/0165-4608(84)90060-8; Ingram M, 1997, IN VITRO CELL DEV-AN, V33, P459; Liu QZ, 1999, GENETIC COUNSELING K, P13; MONDELLO C, 1995, CANCER GENET CYTOGEN, V79, P41, DOI 10.1016/0165-4608(94)00085-P; O'Keefe LV, 2006, CANCER LETT, V232, P37, DOI 10.1016/j.canlet.2005.07.041; Ricke RM, 2008, TRENDS GENET, V24, P457, DOI 10.1016/j.tig.2008.07.002; Schwarz R P, 1992, J Tissue Cult Methods, V14, P51, DOI 10.1007/BF01404744; Unsworth BR, 1998, NAT MED, V4, P901, DOI 10.1038/nm0898-901; Wei L, 2013, PLOS ONE, V8, P1; Wei LJ, 2012, MICROGRAVITY SCI TEC, V24, P335, DOI 10.1007/s12217-012-9324-7	21	2	3	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100595	10.1371/journal.pone.0100595	http://dx.doi.org/10.1371/journal.pone.0100595			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963972	Green Published, Green Submitted, gold			2022-12-27	WOS:000338709500068
J	Yamaguchi, M; Ando, M; Yamamoto, R; Akiyama, S; Kato, S; Katsuno, T; Kosugi, T; Sato, W; Tsuboi, N; Yasuda, Y; Mizuno, M; Ito, Y; Matsuo, S; Maruyama, S				Yamaguchi, Makoto; Ando, Masahiko; Yamamoto, Ryohei; Akiyama, Shinichi; Kato, Sawako; Katsuno, Takayuki; Kosugi, Tomoki; Sato, Waichi; Tsuboi, Naotake; Yasuda, Yoshinari; Mizuno, Masashi; Ito, Yasuhiko; Matsuo, Seiichi; Maruyama, Shoichi			Smoking Is a Risk Factor for the Progression of Idiopathic Membranous Nephropathy	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; COMMUNITY-BASED POPULATION; CHRONIC-RENAL-FAILURE; NEPHROTIC SYNDROME; CIGARETTE-SMOKING; OXIDATIVE STRESS; CYCLOSPORINE; ASSOCIATION; GLOMERULONEPHRITIS; OBESITY	Background: Multiple studies have shown cigarette smoking to be a risk factor for chronic kidney disease. However, it is unknown whether smoking similarly increases the risk for progression of membranous nephropathy. Methods: This study used the Nagoya Nephrotic Syndrome Cohort Study (N-NSCS), including 171 patients with idiopathic membranous nephropathy (IMN) from 10 nephrology centers in Japan. The dose-response relationships between cigarette smoking and the outcomes were assessed by using multivariate Cox proportional hazards models adjusted for clinically relevant factors. The primary outcome was a 30% decline in the estimated glomerular filtration rate (eGFR). The secondary outcome was first complete remission (CR) of proteinuria. Results: During the observation period (median, 37 months; interquartile range, 16-71 months), 37 (21.6%) patients developed a 30% decline in eGFR and 2 (1.2%) progressed to ESRD. CR occurred in 103 (60.2%) patients. Multivariate Cox proportional hazards models revealed current smoking (adjusted hazard ratio [HR], 7.81 [95% confidence interval (CI), 3.17-19.7]), female sex (adjusted HR, 3.58 [95% CI, 1.87-8.00]), older age (adjusted HR, 1.71 [95% CI, 1.13-2.62] per 10 years), the number of cigarettes smoked daily (adjusted HR, 1.61 [95% CI, 1.23-2.09] per 10 cigarettes daily), and cumulative smoking of >= 40 pack-years (adjusted HR, 5.56 [95% CI, 2.17-14.6]) to be associated with a 30% decline in eGFR. However, smoking was not associated with CR. Conclusion: Smoking is a significant and dose-dependent risk factor for IMN progression. All patients with IMN who smoke should be encouraged to quit.	[Yamaguchi, Makoto; Akiyama, Shinichi; Kato, Sawako; Katsuno, Takayuki; Kosugi, Tomoki; Sato, Waichi; Tsuboi, Naotake; Yasuda, Yoshinari; Mizuno, Masashi; Ito, Yasuhiko; Matsuo, Seiichi; Maruyama, Shoichi] Nagoya Univ, Grad Sch Med, Dept Nephrol, Nagoya, Aichi 4648601, Japan; [Ando, Masahiko] Nagoya Univ Hosp, Ctr Adv Med & Clin Res, Nagoya, Aichi, Japan; [Yamamoto, Ryohei] Osaka Univ, Grad Sch Med, Dept Geriatr Med & Nephrol, Suita, Osaka, Japan	Nagoya University; Nagoya University; Osaka University	Maruyama, S (corresponding author), Nagoya Univ, Grad Sch Med, Dept Nephrol, Nagoya, Aichi 4648601, Japan.	marus@med.nagoya-u.ac.jp	Mizuno, Masashi/I-7347-2014; YAMAMOTO, Ryohei/AAU-3059-2021	YAMAMOTO, Ryohei/0000-0003-2610-9824; Tsuboi, Naotake/0000-0003-0760-845X	Ministry of Health, Labour, and Welfare of Japan; Grants-in-Aid for Scientific Research [25461215, 25670408, 26461220] Funding Source: KAKEN	Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-Aid for Progressive Renal Diseases Research, Research on Rare and Intractable Disease, from the Ministry of Health, Labour, and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulos E, 2006, NEPHROL DIAL TRANSPL, V21, P3127, DOI 10.1093/ndt/gfl360; Alves SA, 2012, AM J NEPHROL, V36, P334, DOI 10.1159/000342337; Amaral S, 2008, CURR DIABETES REV, V4, P46, DOI 10.2174/157339908783502398; [Anonymous], 2012, Kidney Int Suppl (2011), V2, P186; Baggio B, 2005, NEPHROL DIAL TRANSPL, V20, P114, DOI 10.1093/ndt/gfh553; Bleyer AJ, 2000, KIDNEY INT, V57, P2072, DOI 10.1046/j.1523-1755.2000.00056.x; CATTRAN DC, 1995, KIDNEY INT, V47, P1130, DOI 10.1038/ki.1995.161; Cattran DC, 2001, KIDNEY INT, V59, P1983, DOI 10.1046/j.1523-1755.2001.0590051983.x; Cattran DC, 2001, KIDNEY INT, V59, P1484, DOI 10.1046/j.1523-1755.2001.0590041484.x; Cattran DC, 1997, KIDNEY INT, V51, P901, DOI 10.1038/ki.1997.127; du Buf-Vereijken PWG, 2005, AM J KIDNEY DIS, V46, P1012, DOI 10.1053/j.ajkd.2005.08.020; Ejerblad E, 2004, J AM SOC NEPHROL, V15, P2178, DOI 10.1097/01.ASN.0000135048.35659.10; Fatehi-Hassanabad Z, 2010, EUR J PHARMACOL, V636, P8, DOI 10.1016/j.ejphar.2010.03.048; Fervenza FC, 2008, CLIN J AM SOC NEPHRO, V3, P905, DOI 10.2215/CJN.04321007; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P844, DOI 10.1001/jama.291.7.844; Gambaro G, 1998, J AM SOC NEPHROL, V9, P562; HAAK T, 1994, METABOLISM, V43, P267, DOI 10.1016/0026-0495(94)90091-4; Hallan S, 2006, AM J KIDNEY DIS, V47, P396, DOI 10.1053/j.ajkd.2005.11.027; Hallan SI, 2011, KIDNEY INT, V80, P516, DOI 10.1038/ki.2011.157; Haroun MK, 2003, J AM SOC NEPHROL, V14, P2934, DOI 10.1097/01.ASN.0000095249.99803.85; Hofstra JM, 2012, NEPHROL DIAL TRANSPL, V27, P6, DOI 10.1093/ndt/gfr371; Hua P, 2010, AM J PHYSIOL-RENAL, V299, pF732, DOI 10.1152/ajprenal.00293.2010; Ishani A, 2006, J AM SOC NEPHROL, V17, P1444, DOI 10.1681/ASN.2005091012; Jaimes EA, 2007, AM J PHYSIOL-HEART C, V292, pH76, DOI 10.1152/ajpheart.00693.2006; Maiese K, 2007, CURR MED CHEM, V14, P1729; Marx BE, 1999, KIDNEY INT, V56, P666, DOI 10.1046/j.1523-1755.1999.00598.x; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Nagasawa Y, 2012, HYPERTENS RES, V35, P261, DOI 10.1038/hr.2011.205; NOEL LH, 1979, AM J MED, V66, P82, DOI 10.1016/0002-9343(79)90486-8; PEI Y, 1992, KIDNEY INT, V42, P960, DOI 10.1038/ki.1992.374; Reichert LJM, 1998, AM J KIDNEY DIS, V31, P1, DOI 10.1053/ajkd.1998.v31.pm9428445; Sellers EM, 1998, JAMA-J AM MED ASSOC, V280, P179, DOI 10.1001/jama.280.2.179; Shankar A, 2006, AM J EPIDEMIOL, V164, P263, DOI 10.1093/aje/kwj173; Sherman BW, 2014, PATIENT PREFER ADHER, V8, P477, DOI 10.2147/PPA.S60927; Shiiki H, 2004, KIDNEY INT, V65, P1400, DOI 10.1111/j.1523-1755.2004.00518.x; Soyoral YU, 2011, ATHEROSCLEROSIS, V218, P243, DOI 10.1016/j.atherosclerosis.2011.05.037; Stengel B, 2000, KIDNEY INT, V57, P2519, DOI 10.1016/S0085-2538(15)47011-5; Stengel B, 2003, EPIDEMIOLOGY, V14, P479, DOI 10.1097/01.EDE.0000071413.55296.c4; Tozawa M, 2002, KIDNEY INT, V62, P956, DOI 10.1046/j.1523-1755.2002.00506.x; Troyanov S, 2004, KIDNEY INT, V66, P1199, DOI 10.1111/j.1523-1755.2004.00873.x; van den Brand JAJG, 2011, CLIN J AM SOC NEPHRO, V6, P2846, DOI 10.2215/CJN.04020411; Yamagata K, 2007, KIDNEY INT, V71, P159, DOI 10.1038/sj.ki.5002017; Yamamoto R, 2010, AM J KIDNEY DIS, V56, P313, DOI 10.1053/j.ajkd.2010.02.351; Yu M, 2010, NEPHROL DIAL TRANSPL, V25, P469, DOI 10.1093/ndt/gfp483; Zucchelli P, 1987, Nephrol Dial Transplant, V2, P73	45	10	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100835	10.1371/journal.pone.0100835	http://dx.doi.org/10.1371/journal.pone.0100835			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964146	gold, Green Submitted, Green Published			2022-12-27	WOS:000338709500088
J	Yanez-Arenas, C; Peterson, AT; Mokondoko, P; Rojas-Soto, O; Martinez-Meyer, E				Yanez-Arenas, Carlos; Peterson, A. Townsend; Mokondoko, Pierre; Rojas-Soto, Octavio; Martinez-Meyer, Enrique			The Use of Ecological Niche Modeling to Infer Potential Risk Areas of Snakebite in the Mexican State of Veracruz	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; SUB-SAHARAN AFRICA; SAMPLE-SIZE; ABSENCE DATA; BITE; DISEASE; DISTRIBUTIONS; PERFORMANCE; POPULATION; EPIDEMIOLOGY	Background: Many authors have claimed that snakebite risk is associated with human population density, human activities, and snake behavior. Here we analyzed whether environmental suitability of vipers can be used as an indicator of snakebite risk. We tested several hypotheses to explain snakebite incidence, through the construction of models incorporating both environmental suitability and socioeconomic variables in Veracruz, Mexico. Methodology/Principal Findings: Ecological niche modeling (ENM) was used to estimate potential geographic and ecological distributions of nine viper species' in Veracruz. We calculated the distance to the species' niche centroid (DNC); this distance may be associated with a prediction of abundance. We found significant inverse relationships between snakebites and DNCs of common vipers (Crotalus simus and Bothrops asper), explaining respectively 15% and almost 35% of variation in snakebite incidence. Additionally, DNCs for these two vipers, in combination with marginalization of human populations, accounted for 76% of variation in incidence. Conclusions/Significance: Our results suggest that niche modeling and niche-centroid distance approaches can be used to mapping distributions of environmental suitability for venomous snakes; combining this ecological information with socioeconomic factors may help with inferring potential risk areas for snakebites, since hospital data are often biased (especially when incidences are low).	[Yanez-Arenas, Carlos; Peterson, A. Townsend] Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA; [Mokondoko, Pierre] Inst Ecol AC, Div Posgrado, Xalapa, Veracruz, Mexico; [Rojas-Soto, Octavio] Inst Ecol AC, Red Biol Evolut, Xalapa, Veracruz, Mexico; [Martinez-Meyer, Enrique] Univ Nacl Autonoma Mexico, Inst Biol, Mexico City 04510, DF, Mexico	University of Kansas; Instituto de Ecologia - Mexico; Instituto de Ecologia - Mexico; Universidad Nacional Autonoma de Mexico	Yanez-Arenas, C (corresponding author), Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA.	lichoso@gmail.com	Yañez-Arenas, Carlos/X-6091-2018; Rojas-Soto, Octavio/Q-6252-2018; Peterson, A. Townsend/I-5697-2013	Yañez-Arenas, Carlos/0000-0002-6299-275X; Rojas-Soto, Octavio/0000-0002-0201-1454; Martinez-Meyer, Enrique/0000-0003-1184-9264; Peterson, A. Townsend/0000-0003-0243-2379	CONACYT	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	CONACYT support the postdoctoral stay of Carlos Yanez-Arenas at the University of Kansas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alirol E, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000603; Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; [Anonymous], 2011, ECOLOGICAL NICHES GE; Balde MC, 2002, B SOC PATHOL EXOT, V95, P157; Barve N, 2008, TOOL PARTIAL ROC; Barve N, 2011, ECOL MODEL, V222, P1810, DOI 10.1016/j.ecolmodel.2011.02.011; Campbell J. A., 2004, VENOMOUS REPTILES W; Chiappy-Jhones C.J., 2002, U CIENCIA, V18, P87; Chippaux JP, 2012, TOXICON, V59, P86, DOI 10.1016/j.toxicon.2011.10.008; Chippaux JP, 2011, TOXICON, V57, P586, DOI 10.1016/j.toxicon.2010.12.022; Chippaux JP, 2002, PERSPECTIVES IN MOLECULAR TOXINOLOGY, P457; CHIPPAUX JP, 1981, B SOC PATHOL EXOT, V74, P458; Chippaux JP, 2002, B SOC PATHOL EXOT, V95, P151; Coombs MD, 1997, T ROY SOC TROP MED H, V91, P319, DOI 10.1016/S0035-9203(97)90091-2; ESRI, 2011, ARCMAP 10; Faizma HM., 1995, J BANGLADESH COLL PH, V13, P3; Fayomi B, 2002, B SOC PATHOL EXOT, V95, P178; Lopez-Arevalo HF, 2011, BIOL CONSERV, V144, P1451, DOI 10.1016/j.biocon.2011.01.014; Flores-Villela O., 1994, BIODIVERSIDAD CONSER, V2nd, P439; Gormley AM, 2011, J APPL ECOL, V48, P25, DOI 10.1111/j.1365-2664.2010.01911.x; Guzman GS, 1990, 1 REUN HERP VILL TAB; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Hansson E, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000896; Harrison RA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000569; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Kasturiratne A, 2008, PLOS MED, V5, P1591, DOI 10.1371/journal.pmed.0050218; Lee J.C., 1996, AMPHIBIANS REPTILES; Leynaud GC, 2009, REV PANAM SALUD PUBL, V26, P64, DOI 10.1590/S1020-49892009000700010; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Luna-Bauza E. M., 2004, REV FACULTAD MED UNA, V47, P149; Mak S, 2010, J MED ENTOMOL, V47, P99, DOI 10.1603/033.047.0114; Gutierrez JM, 2010, TOXICON, V56, P1223, DOI 10.1016/j.toxicon.2009.11.020; Martinez-Meyer E, 2006, ORYX, V40, P411, DOI 10.1017/S0030605306001360; Martinez-Meyer E, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0637; Miller RH, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001678; Morrone J.J., 2001, BIOGEOGRAFIA AM LATI; Newman WJ, 1997, ANN TROP MED PARASIT, V91, P967, DOI 10.1080/00034989760392; PEREZ-HIGAREdA G., 1991, OFIDIOFAUNA VERACRUZ; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson AT, 2006, EMERG INFECT DIS, V12, P1822; Peterson AT, 2005, T ROY SOC TROP MED H, V99, P647, DOI 10.1016/j.trstmh.2005.02.004; Peterson AT, 2002, EMERG INFECT DIS, V8, P662, DOI 10.3201/eid0807.010454; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; PUGH RNH, 1980, LANCET, V2, P1181; R Development Core Team, 2012, R LANG ENV STAT COMP; Rahman R, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000860; Raxworthy CJ, 2003, NATURE, V426, P837, DOI 10.1038/nature02205; Sasa M, 2003, TOXICON, V41, P19, DOI 10.1016/S0041-0101(02)00172-1; SNOW RW, 1994, ANN TROP MED PARASIT, V88, P665, DOI 10.1080/00034983.1994.11812919; Soberon J, 2009, P NATL ACAD SCI USA, V106, P19644, DOI 10.1073/pnas.0901637106; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Soto M., 1989, ATLAS CLIMATICO ESTA; Stock RP, 2007, NAT BIOTECHNOL, V25, P173, DOI 10.1038/nbt0207-173; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; Stockwell DRB, 2002, ECOL MODEL, V148, P1, DOI 10.1016/S0304-3800(01)00388-X; Tay-Zavala J., 2002, REV FACULTAD MED UNA, V145, P212; Torres NM, 2012, DIVERS DISTRIB, V18, P615, DOI 10.1111/j.1472-4642.2012.00892.x; VanDerWal J, 2009, AM NAT, V174, P282, DOI 10.1086/600087; Warrell DA, 2010, LANCET, V375, P77, DOI 10.1016/S0140-6736(09)61754-2; White J, 2000, THER DRUG MONIT, V22, P65, DOI 10.1097/00007691-200002000-00014; WHO, 2009, NEGL TROP DIS SNAK; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood SN, 2010, MGCV MIXED GAM COMPU; Yanez-Arenas C, 2012, OIKOS, V121, P2081, DOI 10.1111/j.1600-0706.2012.20350.x	67	35	37	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100957	10.1371/journal.pone.0100957	http://dx.doi.org/10.1371/journal.pone.0100957			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963989	Green Published, gold, Green Submitted			2022-12-27	WOS:000338709500104
J	Cespedes, N; Habel, C; Lopez-Perez, M; Castellanos, A; Kajava, AV; Servis, C; Felger, I; Moret, R; Arevalo-Herrera, M; Corradin, G; Herrera, S				Cespedes, Nora; Habel, Catherine; Lopez-Perez, Mary; Castellanos, Angelica; Kajava, Andrey V.; Servis, Catherine; Felger, Ingrid; Moret, Remy; Arevalo-Herrera, Myriam; Corradin, Giampietro; Herrera, Socrates			Plasmodium vivax Antigen Discovery Based on Alpha-Helical Coiled Coil Protein Motif	PLOS ONE			English	Article							RECEPTOR-BINDING DOMAIN; PAPUA-NEW-GUINEA; MALARIA VACCINE; CIRCUMSPOROZOITE PROTEIN; AOTUS MONKEYS; FALCIPARUM; IMMUNOGENICITY; SEQUENCE; PREDICTION; ANTIBODIES	Protein alpha-helical coiled coil structures that elicit antibody responses, which block critical functions of medically important microorganisms, represent a means for vaccine development. By using bioinformatics algorithms, a total of 50 antigens with alpha-helical coiled coil motifs orthologous to Plasmodium falciparum were identified in the P. vivax genome. The peptides identified in silico were chemically synthesized; circular dichroism studies indicated partial or high alpha-helical content. Antigenicity was evaluated using human sera samples from malaria-endemic areas of Colombia and Papua New Guinea. Eight of these fragments were selected and used to assess immunogenicity in BALB/c mice. ELISA assays indicated strong reactivity of serum samples from individuals residing in malaria-endemic regions and sera of immunized mice, with the alpha-helical coiled coil structures. In addition, ex vivo production of IFN-gamma by murine mononuclear cells confirmed the immunogenicity of these structures and the presence of T-cell epitopes in the peptide sequences. Moreover, sera of mice immunized with four of the eight antigens recognized native proteins on blood-stage P. vivax parasites, and antigenic cross-reactivity with three of the peptides was observed when reacted with both the P. falciparum orthologous fragments and whole parasites. Results here point to the alpha-helical coiled coil peptides as possible P. vivax malaria vaccine candidates as were observed for P. falciparum. Fragments selected here warrant further study in humans and non-human primate models to assess their protective efficacy as single components or assembled as hybrid linear epitopes.	[Cespedes, Nora; Castellanos, Angelica; Arevalo-Herrera, Myriam; Herrera, Socrates] Malaria Vaccine & Drug Dev Ctr MVDC, Cali, Colombia; [Cespedes, Nora; Arevalo-Herrera, Myriam] Univ Valle, Sch Hlth, Cali, Colombia; [Habel, Catherine; Servis, Catherine; Corradin, Giampietro] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Lopez-Perez, Mary; Herrera, Socrates] Caucaseco Sci Res Ctr, Cali, Colombia; [Castellanos, Angelica] Fdn Ctr Primates, Cali, Colombia; [Kajava, Andrey V.] Univ Montpellier, Ctr Rech Biochim Macromol, F-34059 Montpellier, France; [Kajava, Andrey V.] Univ Montpellier, Inst Biol Computat, CNRS, F-34059 Montpellier, France; [Kajava, Andrey V.] Univ ITMO, St Petersburg, Russia; [Felger, Ingrid] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Moret, Remy] Hop St Camille, Ouagadougou, Burkina Faso	Universidad del Valle; University of Lausanne; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; ITMO University; University of Basel; Swiss Tropical & Public Health Institute	Herrera, S (corresponding author), Malaria Vaccine & Drug Dev Ctr MVDC, Cali, Colombia.	sherrera@inmuno.org	Kajava, Andrey V/E-1107-2014; Lopez-Perez, Mary/E-5059-2016	Kajava, Andrey V/0000-0002-2342-6886; Lopez-Perez, Mary/0000-0002-9876-0248; Felger, Ingrid/0000-0003-1255-2606; Arevalo, Myriam/0000-0002-3434-9425; Castellanos Sanchez, Angelica Maria/0000-0002-6602-9696	Colciencias [278-2008, 360-2011, 458-2012, 719-2013]; NIH [5U19AI089702]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089702] Funding Source: NIH RePORTER	Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by Colciencias (Contract 278-2008, Contract 360-2011, Contract 458-2012 and Contract 719-2013) and NIH (Grant number 5U19AI089702. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALPERS MP, 1992, PAPUA NEW GUINEA MED, V35, P285; Arevalo-Herrera M, 2005, AM J TROP MED HYG, V73, P25; Arevalo-Herrera M, 1998, ANN TROP MED PARASIT, V92, P539, DOI 10.1080/00034989859230; Arevalo-Herrera M, 2012, ACTA TROP, V121, P303, DOI 10.1016/j.actatropica.2011.06.008; Bell BA, 2009, VACCINE, V27, P1448, DOI 10.1016/j.vaccine.2008.12.027; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; Cespedes N, 2013, VACCINE, V31, P4923, DOI 10.1016/j.vaccine.2013.05.082; Corradin Giarnpietro, 2007, Endocrine Metabolic & Immune Disorders-Drug Targets, V7, P259, DOI 10.2174/187153007782794371; Doolan DL, 2003, P NATL ACAD SCI USA, V100, P9952, DOI 10.1073/pnas.1633254100; Eisenhaber B, 1999, J MOL BIOL, V292, P741, DOI 10.1006/jmbi.1999.3069; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Greenwood BM, 2011, CLIN MICROBIOL INFEC, V17, P1600, DOI 10.1111/j.1469-0691.2011.03612.x; Guda C, 2005, BIOINFORMATICS, V21, P3963, DOI 10.1093/bioinformatics/bti650; Herrera S, 2005, AM J TROP MED HYG, V73, P3, DOI 10.4269/ajtmh.2005.73.3; Herrera S, 2011, AM J TROP MED HYG, V84, P12, DOI 10.4269/ajtmh.2011.09-0516; Valencia SH, 2011, MEM I OSWALDO CRUZ, V106, P179, DOI 10.1590/S0074-02762011000900023; Hill AVS, 2011, PHILOS T R SOC B, V366, P2806, DOI 10.1098/rstb.2011.0091; Jafarshad A, 2007, J IMMUNOL, V178, P3099, DOI 10.4049/jimmunol.178.5.3099; Kim Y, 2012, NUCLEIC ACIDS RES, V40, pW525, DOI 10.1093/nar/gks438; Koepfli C, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001424; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kulangara C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046112; Kulangara C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005419; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; Moreno A, 2008, VACCINE, V26, P4338, DOI 10.1016/j.vaccine.2008.06.010; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; Olugbile S, 2009, INFECT IMMUN, V77, P5701, DOI 10.1128/IAI.00652-09; Olugbile S, 2011, VACCINE, V29, P7090, DOI 10.1016/j.vaccine.2011.06.122; Peters B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-132; Salvador A, 2012, EXPERT REV VACCINES, V11, P1071, DOI [10.1586/ERV.12.87, 10.1586/erv.12.87]; Schwartz L, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-11; Sidney John, 2008, Immunome Res, V4, P2, DOI 10.1186/1745-7580-4-2; Singh S, 2005, INFECT IMMUN, V73, P1235, DOI 10.1128/IAI.73.2.1235-1238.2005; Teixeira LH, 2014, INFECT IMMUN, V82, P793, DOI 10.1128/IAI.01410-13; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Tripet B, 2006, J STRUCT BIOL, V155, P176, DOI 10.1016/j.jsb.2006.03.019; Vicentin EC, 2014, INFECT IMMUN, V82, P1296, DOI 10.1128/IAI.01169-13; Villard V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000645; Wang P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-568; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Wu Yu-Huan, 2008, P3	46	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100440	10.1371/journal.pone.0100440	http://dx.doi.org/10.1371/journal.pone.0100440			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959747	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000338633900047
J	Perucho, L; Artero-Castro, A; Guerrero, S; Cajal, SRY; LLeonart, ME; Wang, ZQ				Perucho, Laura; Artero-Castro, Ana; Guerrero, Sergi; Ramon y Cajal, Santiago; LLeonart, Matilde E.; Wang, Zhao-Qi			RPLP1, a Crucial Ribosomal Protein for Embryonic Development of the Nervous System	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; SACCHAROMYCES-CEREVISIAE; P53-DEPENDENT CHECKPOINT; ACIDIC PHOSPHOPROTEINS; ESCHERICHIA-COLI; STEM-CELLS; RAT-LIVER; ACTIVATION; MINUTE; STRESS	Ribosomal proteins are pivotal to development and tissue homeostasis. RP Large P1 (Rplp1) overexpression is associated with tumorigenesis. However, the physiological function of Rplp1 in mammalian development remains unknown. In this study, we disrupted Rplp1 in the mouse germline and central nervous system (Rplp1(CNS Delta)). Rplp1 heterozygosity caused body size reductions, male infertility, systemic abnormalities in various tissues and a high frequency of early postnatal death. Rplp1(CNS Delta) newborn mice exhibited perinatal lethality and brain atrophy with size reductions of the neocortex, midbrain and ganglionic eminence. The Rplp1 knockout neocortex exhibited progenitor cell proliferation arrest and apoptosis due to the dysregulation of key cell cycle and apoptosis regulators (cyclin A, cyclin E, p21(CIP1), p27(KIP1), p53). Similarly, Rplp1 deletion in pMEFs led to proliferation arrest and premature senescence. Importantly, Rplp1 deletion in primary mouse embryonic fibroblasts did not alter global protein synthesis, but did change the expression patterns of specific protein subsets involved in protein folding and the unfolded protein response, cell death, protein transport and signal transduction, among others. Altogether, we demonstrated that the translation "fine- tuning'' exerted by Rplp1 is essential for embryonic and brain development and for proper cell proliferation.	[Perucho, Laura; Wang, Zhao-Qi] Leibniz Inst Age Res, Fritz Lipmann Inst, Jena, Germany; [Artero-Castro, Ana; Guerrero, Sergi; Ramon y Cajal, Santiago; LLeonart, Matilde E.] Hosp Valle De Hebron, Inst Recerca, Oncol & Pathol Grp, Barcelona, Spain; [Wang, Zhao-Qi] Univ Jena, Fac Biol & Pharm, Jena, Germany	Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Friedrich Schiller University of Jena	LLeonart, ME (corresponding author), Hosp Valle De Hebron, Inst Recerca, Oncol & Pathol Grp, Barcelona, Spain.	melleona@ir.vhebron.net	Artero, Ana/AAD-2247-2022; LLeonart, Matilde E./Q-2662-2019; Ramon y Cajal, Santiago/H-4955-2016	LLeonart, Matilde E./0000-0002-6196-7405; Ramon y Cajal, Santiago/0000-0002-3867-1390; Perucho Aznar, Laura/0000-0002-0915-0633	Marato project [TV3/052130]; FIS project [PI12/01104]; MELL is a FIS investigator (Miguel Servet) [CP03/00101]; La Caixa and the Deutscher Akademischer Austauschdienst	Marato project; FIS project; MELL is a FIS investigator (Miguel Servet); La Caixa and the Deutscher Akademischer Austauschdienst	This work was supported by the Marato project TV3/052130 and the FIS project PI12/01104. MELL is a FIS investigator (Miguel Servet stabilized contract CP03/00101). Laura Perucho was supported by a fellowship from La Caixa and the Deutscher Akademischer Austauschdienst. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SJ, 2007, IMMUNITY, V26, P759, DOI 10.1016/j.immuni.2007.04.012; Artero-Castro A, 2009, EXP CELL RES, V315, P1372, DOI 10.1016/j.yexcr.2009.02.007; Artero-Castro A, 2011, HUM PATHOL, V42, P194, DOI 10.1016/j.humpath.2010.04.020; Bargis-Surgey P, 1999, EUR J BIOCHEM, V262, P606, DOI 10.1046/j.1432-1327.1999.00434.x; Chakraborty A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004152; Challagundla KB, 2011, MOL CELL BIOL, V31, P4007, DOI 10.1128/MCB.05810-11; Chen A, 2002, CANCER RES, V62, P1036; Chen QM, 1998, BIOCHEM J, V332, P43, DOI 10.1042/bj3320043; Colome N, 2010, J PROTEOME RES, V9, P2600, DOI 10.1021/pr100044d; Danilova N, 2008, BLOOD, V112, P5228, DOI 10.1182/blood-2008-01-132290; de las Heras-Rubio A, 2014, CANCER METAST REV, V33, P115, DOI 10.1007/s10555-013-9460-6; Denoyelle C, 2006, NAT CELL BIOL, V8, P1053, DOI 10.1038/ncb1471; Draptchinskaia N, 1999, NAT GENET, V21, P169, DOI 10.1038/5951; EGEBJERG J, 1990, J MOL BIOL, V213, P275, DOI 10.1016/S0022-2836(05)80190-1; Eymin B, 1999, ONCOGENE, V18, P1411, DOI 10.1038/sj.onc.1202437; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Frippiat C, 2000, EXP GERONTOL, V35, P733, DOI 10.1016/S0531-5565(00)00167-4; FURUKAWA T, 1992, ARCH BIOCHEM BIOPHYS, V298, P182, DOI 10.1016/0003-9861(92)90110-I; Gomez-Lorenzo MG, 2000, EMBO J, V19, P2710, DOI 10.1093/emboj/19.11.2710; Huang CH, 2010, J MOL BIOL, V399, P145, DOI 10.1016/j.jmb.2010.04.009; Hustert E, 1996, MAMM GENOME, V7, P881, DOI 10.1007/s003359900261; Iadevaia V, 2010, ONCOGENE, V29, P5490, DOI 10.1038/onc.2010.279; Ishii K, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-37; Jin A, 2004, MOL CELL BIOL, V24, P7669, DOI 10.1128/MCB.24.17.7669-7680.2004; Kirn-Safran CB, 2007, DEV DYNAM, V236, P447, DOI 10.1002/dvdy.21046; Kondrashov N, 2011, CELL, V145, P383, DOI 10.1016/j.cell.2011.03.028; KONGSUWAN K, 1985, NATURE, V317, P555, DOI 10.1038/317555a0; Lambertsson A, 1998, ADV GENET, V38, P69, DOI 10.1016/S0065-2660(08)60142-X; Lindstrom MS, 2010, PLOS ONE, V5, pA116, DOI 10.1371/journal.pone.0009578; Loging WT, 1999, CANCER EPIDEM BIOMAR, V8, P1011; Lopez-Contreras AJ, 2013, CELL REP, V3, P1105, DOI 10.1016/j.celrep.2013.03.009; Mansergh FC, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-5; Marone M, 2002, LEUKEMIA LYMPHOMA, V43, P51, DOI 10.1080/10428190210195; Martinez-Azorin F, 2008, FEBS LETT, V582, P3029, DOI 10.1016/j.febslet.2008.07.039; Martinez-Azorin F, 2008, BIOCHEM J, V413, P527, DOI 10.1042/BJ20080049; Marygold SJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r216; Matsson H, 2004, MOL CELL BIOL, V24, P4032, DOI 10.1128/MCB.24.9.4032-4037.2004; McAllister SS, 2003, MOL CELL BIOL, V23, P216, DOI 10.1128/MCB.23.1.216-228.2003; MITSUI K, 1988, J BIOCHEM-TOKYO, V104, P908, DOI 10.1093/oxfordjournals.jbchem.a122581; MOAZED D, 1988, NATURE, V334, P362, DOI 10.1038/334362a0; Morgado-Palacin L, 2012, CELL CYCLE, V11, P503, DOI 10.4161/cc.11.3.19002; MORGAN WC, 1950, J HERED, V41, P208, DOI 10.1093/oxfordjournals.jhered.a106131; Nakayashiki T, 2013, J BACTERIOL, V195, P1226, DOI 10.1128/JB.02145-12; Nguyen L, 2006, GENE DEV, V20, P1511, DOI 10.1101/gad.377106; Nusspaumer G, 2000, EMBO J, V19, P6075, DOI 10.1093/emboj/19.22.6075; Oliver ER, 2004, DEVELOPMENT, V131, P3907, DOI 10.1242/dev.01268; Panic L, 2006, MOL CELL BIOL, V26, P8880, DOI 10.1128/MCB.00751-06; REMACHA M, 1995, MOL CELL BIOL, V15, P4754; Ribeiro-Neto F, 2002, P NATL ACAD SCI USA, V99, P5418, DOI 10.1073/pnas.082122499; Robledo S, 2008, RNA, V14, P1918, DOI 10.1261/rna.1132008; SAENZROBLES MT, 1990, BIOCHIM BIOPHYS ACTA, V1050, P51, DOI 10.1016/0167-4781(90)90140-W; Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028; SANTOS C, 1995, J BIOL CHEM, V270, P20608, DOI 10.1074/jbc.270.35.20608; Stoneley M, 2004, ONCOGENE, V23, P3200, DOI 10.1038/sj.onc.1207551; Sulic S, 2005, GENE DEV, V19, P3070, DOI 10.1101/gad.359305; Sun L, 2008, J AM SOC NEPHROL, V19, P2293, DOI 10.1681/ASN.2008030336; Suzuki A, 1999, MOL CELL BIOL, V19, P3842; TSURUGI K, 1985, J BIOCHEM-TOKYO, V98, P1427, DOI 10.1093/oxfordjournals.jbchem.a135410; UCHIUMI T, 1990, J BIOL CHEM, V265, P89; Uchiumi T, 2002, J BIOL CHEM, V277, P3857, DOI 10.1074/jbc.M107730200; VANAGTHOVEN A, 1978, EUR J BIOCHEM, V91, P553; YOSHIDA Y, 1992, MOL CELL BIOL, V12, P3407, DOI 10.1128/MCB.12.8.3407; Yoshihama M, 2002, GENOME RES, V12, P379, DOI 10.1101/gr.214202; Zhang L, 1997, SCIENCE, V276, P1268, DOI 10.1126/science.276.5316.1268; ZINKER S, 1976, J BIOL CHEM, V251, P1799	65	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e99956	10.1371/journal.pone.0099956	http://dx.doi.org/10.1371/journal.pone.0099956			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959908	Green Published, gold, Green Submitted			2022-12-27	WOS:000338633900018
J	Thompson, P; Urayama, K; Zheng, J; Yang, P; Ford, M; Buffler, P; Chokkalingam, A; Lightfoot, T; Taylor, M				Thompson, Pamela; Urayama, Kevin; Zheng, Jie; Yang, Peng; Ford, Matt; Buffler, Patricia; Chokkalingam, Anand; Lightfoot, Tracy; Taylor, Malcolm			Differences in Meiotic Recombination Rates in Childhood Acute Lymphoblastic Leukemia at an MHC Class II Hotspot Close to Disease Associated Haplotypes	PLOS ONE			English	Article							B-CELL PRECURSOR; HUMAN GENOME; SEQUENCE POLYMORPHISMS; RISK; SUSCEPTIBILITY; GENE; VARIANTS; CHILDREN; CANCER; LEUKEMOGENESIS	Childhood Acute Lymphoblastic Leukemia (ALL) is a malignant lymphoid disease of which B-cell precursor- (BCP) and T-cell-(T) ALL are subtypes. The role of alleles encoded by major histocompatibility loci (MHC) have been examined in a number of previous studies and results indicating weak, multi-allele associations between the HLA-DPB1 locus and BCP-ALL suggested a role for immunosusceptibility and possibly infection. Two independent SNP association studies of ALL identified loci approximately 37 kb from one another and flanking a strong meiotic recombination hotspot (DNA3), adjacent to HLA-DOA and centromeric of HLA-DPB1. To determine the relationship between this observation and HLA-DPB1 associations, we constructed high density SNP haplotypes of the 316 kb region from HLA-DMB to COL11A2 in childhood ALL and controls using a UK GWAS data subset and the software PHASE. Of four haplotype blocks identified, predicted haplotypes in Block 1 (centromeric of DNA3) differed significantly between BCP-ALL and controls (P = 0.002) and in Block 4 (including HLA-DPB1) between T-ALL and controls (P = 0.049). Of specific common (>5%) haplotypes in Block 1, two were less frequent in BCP-ALL, and in Block 4 a single haplotype was more frequent in T-ALL, compared to controls. Unexpectedly, we also observed apparent differences in ancestral meiotic recombination rates at DNA3, with BCP-ALL showing increased and T-ALL decreased levels compared to controls. In silico analysis using LDsplit sotware indicated that recombination rates at DNA3 are influenced by flanking loci, including SNPs identified in childhood ALL association studies. The observed differences in rates of meiotic recombination at this hotspot, and potentially others, may be a characteristic of childhood leukemia and contribute to disease susceptibility, alternatively they may reflect interactions between ALL-associated haplotypes in this region.	[Thompson, Pamela] Univ Manchester, St Marys Hosp, Inst Canc Sci, Paediat & Familial Canc Res Grp, Manchester M13 0JH, Lancs, England; [Urayama, Kevin; Buffler, Patricia; Chokkalingam, Anand] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Urayama, Kevin] Tokyo Med & Dent Univ, Dept Human Genet & Dis Div, Tokyo, Japan; [Zheng, Jie] Nanyang Technol Univ, Sch Comp Engn, Singapore 639798, Singapore; [Zheng, Jie] Biopolis, A STAR Agcy Sci Technol & Res, Genome Inst Singapore, Singapore, Singapore; [Yang, Peng] ASTAR, Inst Infocomm Res, Data Analyt Dept, Singapore, Singapore; [Ford, Matt] Univ Manchester, Fac Med & Human Sci, Res Comp Serv, Manchester, Lancs, England; [Lightfoot, Tracy] Univ York, York YO10 5DD, N Yorkshire, England	University of Manchester; University of California System; University of California Berkeley; Tokyo Medical & Dental University (TMDU); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Agency for Science Technology & Research (A*STAR); A*STAR - Institute for Infocomm Research (I2R); University of Manchester; University of York - UK	Thompson, P (corresponding author), Univ Manchester, St Marys Hosp, Inst Canc Sci, Paediat & Familial Canc Res Grp, Manchester M13 0JH, Lancs, England.	pamela.thompson@manchester.ac.uk	Zheng, Jie/C-1356-2011; Zheng, Jie/AAX-1454-2021	Zheng, Jie/0000-0001-6774-9786; Thompson, Pamela/0000-0002-2660-6348	Children With Cancer, UK	Children With Cancer, UK	PT is supported by funds from Children With Cancer, UK (http://www.childrenwithcancer.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akasaka T, 2007, BLOOD, V109, P3451, DOI 10.1182/blood-2006-08-041012; Berg IL, 2011, P NATL ACAD SCI USA, V108, P12378, DOI 10.1073/pnas.1109531108; Boulton A, 2000, BRIT J CANCER, V82, P1073; Coebergh JWW, 2006, EUR J CANCER, V42, P2019, DOI 10.1016/j.ejca.2006.06.005; Crawford DC, 2004, NAT GENET, V36, P700, DOI 10.1038/ng1376; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Dorak MT, 2002, LEUKEMIA RES, V26, P651, DOI 10.1016/S0145-2126(01)00189-8; Eden T, 2010, CANCER TREAT REV, V36, P286, DOI 10.1016/j.ctrv.2010.02.004; Georgopoulos K, 1997, ANNU REV IMMUNOL, V15, P155, DOI 10.1146/annurev.immunol.15.1.155; Greaves M, 2006, NAT REV CANCER, V6, P193, DOI 10.1038/nrc1816; Guce AI, 2013, NAT STRUCT MOL BIOL, V20, P90, DOI 10.1038/nsmb.2460; GURNEY JG, 1995, CANCER, V75, P2186, DOI 10.1002/1097-0142(19950415)75:8<2186::AID-CNCR2820750825>3.0.CO;2-F; Hinch AG, 2011, NATURE, V476, P170, DOI 10.1038/nature10336; Hosking FJ, 2011, BLOOD, V117, P1633, DOI 10.1182/blood-2010-08-301598; Hussin J, 2013, GENOME RES, V23, P419, DOI 10.1101/gr.144188.112; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Jeffreys AJ, 2002, NAT GENET, V31, P267, DOI 10.1038/ng910; KARLSSON L, 1991, NATURE, V351, P485, DOI 10.1038/351485a0; Kauppi L, 2004, NAT REV GENET, V5, P413, DOI 10.1038/nrg1346; Khor CC, 2012, TRENDS GENET, V28, P233, DOI 10.1016/j.tig.2012.02.001; Kong A, 2010, NATURE, V467, P1099, DOI 10.1038/nature09525; Lahoud MH, 2001, GENOME RES, V11, P1327, DOI 10.1101/gr.168801; Li N, 2003, GENETICS, V165, P2213; LILLY F, 1964, LANCET, V2, P1207; Migliorini G, 2013, BLOOD, V122, P3298, DOI 10.1182/blood-2013-03-491316; Mullighan CG, 2009, LEUKEMIA, V23, P1209, DOI 10.1038/leu.2009.18; Ng SK, 2010, PLOS ONE, V5, pA18, DOI 10.1371/journal.pone.0009547; Papaemmanuil E, 2009, NAT GENET, V41, P1006, DOI 10.1038/ng.430; Shang EY, 2011, J CELL BIOCHEM, V112, P2784, DOI 10.1002/jcb.23192; Sherborne AL, 2010, NAT GENET, V42, P492, DOI 10.1038/ng.585; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tan IKL, 2010, GENOME RES, V20, P1629, DOI 10.1101/gr.101881.109; Taylor GM, 2008, BRIT J CANCER, V98, P1125, DOI 10.1038/sj.bjc.6604257; Taylor GM, 2009, LEUKEMIA, V23, P863, DOI 10.1038/leu.2008.374; Taylor GM, 2002, HUM MOL GENET, V11, P1585; Taylor M, 2011, HUM IMMUNOL, V72, P897, DOI 10.1016/j.humimm.2011.05.011; Taylor M, 2009, BLOOD CELL MOL DIS, V42, P129, DOI 10.1016/j.bcmd.2008.10.009; Trevino LR, 2009, NAT GENET, V41, P1001, DOI 10.1038/ng.432; Urayama KY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072557; Urayama KY, 2012, BLOOD, V120, P3039, DOI 10.1182/blood-2012-01-404723; Yang P, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-48; Zheng J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r103	43	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100480	10.1371/journal.pone.0100480	http://dx.doi.org/10.1371/journal.pone.0100480			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959916	Green Published, gold			2022-12-27	WOS:000338633900050
J	Xu, J; Wu, F; Tian, DY; Wang, JJ; Zheng, ZZ; Xia, NS				Xu, Jian; Wu, Fan; Tian, Deying; Wang, Jingjing; Zheng, Zizheng; Xia, Ningshao			Open Reading Frame 3 of Genotype 1 Hepatitis E Virus Inhibits Nuclear Factor-kappa appa B Signaling Induced by Tumor Necrosis Factor-alpha in Human A549 Lung Epithelial Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; HEV INFECTION; ACTIVATION; A20; UBIQUITINATION; INFLAMMATION; TRANSMISSION; PATHOGENESIS; SUPERFAMILY	Hepatitis E virus (HEV) is one of the primary causative agents of acute hepatitis, and represents a major cause of severe public health problems in developing countries. The pathogenesis of HEV is not well characterized, however, primarily due to the lack of well-defined cell and animal models. Here, we investigated the effects of genotype 1 HEV open reading frame 3 (ORF3) on TNF-alpha-induced nucleus factor-kappa appa B (NF-kappa B) signaling. Human lung epithelial cells (A549) were transiently transfected with ORF3 containing plasmids. These cells were then stimulated with TNF-alpha and the nucleus translocation of the p65 NF-kappa B subunit was assessed using western blot and laser confocal microscopy. DNA-binding activity of p65 was also examined using electrophoretic mobility shift assay (EMSA), and the suppression of NF-kappa B target genes were detected using real-time RT-PCR and ELISA. These results enabled us to identify the decreased phosphorylation levels of IKB alpha. We focused on the gene of negative regulation of NF-kappa B, represented by TNF-alpha-induced protein 3 (TNFAIP3, also known as A20). Reducing the levels of A20 with siRNAs significantly enhances luciferase activation of NF-kappa B. Furthermore, HEV ORF3 regulated A20 primarily via activating transcription factor 6 (ATF6), involved in unfolded protein response (UPR), resulting in the degradation or inactivation of the receptor interacting protein 1 (RIP1), a major upstream activator of IKB kinase compounds (IKKs). Consequently, the phosphorylation of IKBa and the nucleus translocation of p65 are blocked, which contributes to diminished NF-kappa B DNA-binding activation and NF-kappa B-dependent gene expression. The findings suggest that genotype 1 HEV, through ORF3, may transiently activate NF-kappa B through UPR in early stage, and subsequently inhibit TNF-alpha-induced NF-kappa B signaling in late phase so as to create a favorable virus replication environment.	[Xu, Jian; Wu, Fan; Tian, Deying] Huazhong Univ Sci & Technol, Dept Infect Dis, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China; [Wang, Jingjing] Huazhong Univ Sci & Technol, Dept Anesthesiol, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China; [Zheng, Zizheng; Xia, Ningshao] Xiamen Univ, Sch Publ Hlth, Natl Inst Diagnost & Vaccine Dev Infect Dis, Xiamen, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Xiamen University	Tian, DY (corresponding author), Huazhong Univ Sci & Technol, Dept Infect Dis, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China.	dytian@tjh.tjmu.edu.cn	Tian, Deying/AAB-3667-2019; WANG, JINGYI/GSJ-1241-2022; wang, jing/GRS-7509-2022					Abmayr Susan M, 2006, Curr Protoc Pharmacol, VChapter 12, DOI [10.1002/0471142727.mb1201s75, 10.1002/0471141755.ph1203s35]; Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Aggarwal R, 2011, HEPATOLOGY, V54, P2218, DOI 10.1002/hep.24674; Carrara M, 2013, INT J MOL SCI, V14, P6454, DOI 10.3390/ijms14036454; Chandra V, 2008, J BIOSCIENCES, V33, P451, DOI 10.1007/s12038-008-0064-1; Chandra V, 2008, J VIROL, V82, P7100, DOI 10.1128/JVI.00403-08; Dalton HR, 2008, LANCET INFECT DIS, V8, P698, DOI 10.1016/S1473-3099(08)70255-X; Devhare PB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063793; DiPerna G, 2004, J BIOL CHEM, V279, P36570, DOI 10.1074/jbc.M400567200; Dong C, 2012, HEPATOLOGY, V55, P1324, DOI 10.1002/hep.25530; Elsharkawy AM, 2007, HEPATOLOGY, V46, P590, DOI 10.1002/hep.21802; Emerson SU, 2001, P NATL ACAD SCI USA, V98, P15270, DOI 10.1073/pnas.251555098; Fauquet CM, 2005, VIRUS TAXONOMY 8 REP; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Tallon AIG, 2011, GASTROENT HEPAT-BARC, V34, P398, DOI 10.1016/j.gastrohep.2011.02.011; Harhaj EW, 2012, IMMUNOL REV, V246, P107, DOI 10.1111/j.1600-065X.2012.01100.x; Holla RP, 2013, SEMIN LIVER DIS, V33, P3, DOI 10.1055/s-0033-1338110; Hosoi T, 2007, BRAIN RES, V1152, P27, DOI 10.1016/j.brainres.2007.03.052; Kaneko M, 2003, BIOL PHARM BULL, V26, P931, DOI 10.1248/bpb.26.931; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Khuroo MS, 2009, J VIRAL HEPATITIS, V16, P519, DOI 10.1111/j.1365-2893.2009.01101.x; Kumar A, 2004, INT J GYNECOL OBSTET, V85, P240, DOI 10.1016/j.ijgo.2003.11.018; Li QT, 2000, GENE DEV, V14, P1729; Lu L, 2006, REV MED VIROL, V16, P5, DOI 10.1002/rmv.482; Mitsui T, 2004, J MED VIROL, V74, P563, DOI 10.1002/jmv.20215; Mori K, 2009, J BIOCHEM, V146, P743, DOI 10.1093/jb/mvp166; Motte A, 2012, J CLIN VIROL, V53, P162, DOI 10.1016/j.jcv.2011.11.012; Nagasaki F, 2005, HEPATOL RES, V32, P134, DOI 10.1016/j.hepres.2005.03.017; Nakajima S, 2010, BIOCHEM BIOPH RES CO, V397, P176, DOI 10.1016/j.bbrc.2010.05.069; Okada T, 2003, J BIOL CHEM, V278, P31024, DOI 10.1074/jbc.M300923200; Parmar VM, 2012, ADV EXP MED BIOL, V738, P153, DOI 10.1007/978-1-4614-1680-7_10; Pelzer C, 2013, NAT IMMUNOL, V14, P337, DOI 10.1038/ni.2540; Rehman S, 2008, VIROLOGY, V370, P77, DOI 10.1016/j.virol.2007.07.036; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; ROULSTON A, 1995, MICROBIOL REV, V59, P481, DOI 10.1128/MMBR.59.3.481-505.1995; Roy AK, 2004, J BIOL CHEM, V279, P28345, DOI 10.1074/jbc.M400457200; Schlosser B, 2012, J HEPATOL, V56, P500, DOI 10.1016/j.jhep.2011.06.021; Scobie L, 2013, J VIRAL HEPATITIS, V20, P1, DOI 10.1111/jvh.12024; Shembade N, 2012, CELL MOL IMMUNOL, V9, P123, DOI 10.1038/cmi.2011.59; Tai DI, 2000, HEPATOLOGY, V31, P656, DOI 10.1002/hep.510310316; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tanaka T, 2007, J GEN VIROL, V88, P903, DOI 10.1099/vir.0.82535-0; Perez-Gracia MT, 2014, INFECT GENET EVOL, V22, P40, DOI 10.1016/j.meegid.2014.01.002; Teshale EH, 2010, CLIN INFECT DIS, V51, P328, DOI 10.1086/653943; Teshale EH, 2010, CLIN INFECT DIS, V50, P1006, DOI 10.1086/651077; Verhelst K, 2012, EMBO J, V31, P3845, DOI 10.1038/emboj.2012.240; Wagner S, 2008, ONCOGENE, V27, P3739, DOI 10.1038/sj.onc.1211042; Wang Y, 2000, J BIOL CHEM, V275, P27013; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Yugo DM, 2013, INT J ENV RES PUB HE, V10, P4507, DOI 10.3390/ijerph10104507; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zhu FC, 2010, LANCET, V376, P895, DOI 10.1016/S0140-6736(10)61030-6	53	31	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100787	10.1371/journal.pone.0100787	http://dx.doi.org/10.1371/journal.pone.0100787			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959724	Green Published, gold, Green Submitted			2022-12-27	WOS:000338633900086
J	Zampighi, GA; Serrano, R; Vergara, JL				Zampighi, Guido A.; Serrano, Raul; Vergara, Julio L.			A Novel Synaptic Vesicle Fusion Path in the Rat Cerebral Cortex: The "Saddle'' Point Hypothesis	PLOS ONE			English	Article							CONICAL ELECTRON TOMOGRAPHY; ACTIVE ZONE; PRESYNAPTIC MEMBRANES; CHEMICAL SYNAPSE; FINE-STRUCTURE; MICROSCOPY; PROTEINS; SNARE; ORGANIZATION; EXOCYTOSIS	We improved freeze-fracture electron microscopy to study synapses in the neuropil of the rat cerebral cortex at similar to 2 nm resolution and in three-dimensions. In the pre-synaptic axon, we found that "rods'' assembled from short filaments protruding from the vesicle and the plasma membrane connects synaptic vesicles to the membrane of the active zone. We equated these "connector rods'' to protein complexes involved in "docking'' and "priming'' vesicles to the active zone. Depending on their orientation, the "rods'' define two synaptic vesicle-fusion paths: When parallel to the plasma membrane, the vesicles hemi-fuse anywhere ("randomly'') in the active zone following the conventional path anticipated by the SNARE hypothesis. When perpendicular to the plasma membrane, the vesicles hemi-fuse at the base of sharp crooks, called "indentations,'' that are spaced 75-85 nm center-to-center, arranged in files and contained within gutters. They result from primary and secondary membrane curvatures that intersect at stationary inflection ("saddle'') points. Computer simulations indicate that this novel vesicle-fusion path evokes neurotransmitter concentration domains on the postsynaptic spine that are wider, shallower, and that reach higher average concentrations than the more conventional vesicle fusion path. In the post-synaptic spine, large (similar to 9x similar to 15 nm) rectangular particles at densities of 72 +/- 10/mu m(2) (170-240/spine) match the envelopes of the homotetrameric GluR2 AMPA-sensitive receptor. While these putative receptors join clusters, called the "post-synaptic domains,'' the overwhelming majority of the rectangular particles formed bands in the "non-synaptic'' plasma membrane of the spine. In conclusion, in the neuropil of the rat cerebral cortex, curvatures of the plasma membrane define a novel vesicle-fusion path that preconditions specific regions of the active zone for neurotransmitter release. We hypothesize that a change in the hybridization of the R-SNARE synaptobrevin from parallel to antiparallel swings the synapse into this novel vesicle-fusion path.	[Zampighi, Guido A.] Univ Calif Los Angeles, UCLA Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Serrano, Raul; Vergara, Julio L.] Univ Calif Los Angeles, UCLA Sch Med, Dept Physiol, Los Angeles, CA USA; [Zampighi, Guido A.] Univ Calif Los Angeles, UCLA Sch Med, Jules Stein Eye Res Inst, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Zampighi, GA (corresponding author), Univ Calif Los Angeles, UCLA Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA.	gzampighi@mednet.ucla.edu			National Institutes of Health (NIH) [EY-04110]; NIH/NIAMS [AR047664, AR54816, AR041802]; Muscular Dystrophy Association; NATIONAL EYE INSTITUTE [R01EY004110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041802, R56AR047664, R01AR047664] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institutes of Health (NIH) EY-04110 (GAZ) and NIH/NIAMS AR047664, AR54816, and AR041802 and a Grant in Aid from the Muscular Dystrophy Association (JLV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akert K., 1972, P67; BLOOM FE, 1966, SCIENCE, V154, P1575, DOI 10.1126/science.154.3756.1575; Boyken J, 2013, NEURON, V78, P285, DOI 10.1016/j.neuron.2013.02.027; BRANTON D, 1971, PHILOS T ROY SOC B, V261, P133, DOI 10.1098/rstb.1971.0043; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Chernomordik LV, 2005, CELL, V123, P375, DOI 10.1016/j.cell.2005.10.015; COUTEAUX R, 1970, Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences Serie D Sciences Naturelles, V271, P2346; Degtyar V, 2013, J NEUROSCI, V33, P5507, DOI 10.1523/JNEUROSCI.2337-12.2013; Delgado R, 2000, NEURON, V28, P941, DOI 10.1016/S0896-6273(00)00165-3; Eskandari S, 1998, P NATL ACAD SCI USA, V95, P11235, DOI 10.1073/pnas.95.19.11235; Fernandez-Busnadiego R, 2010, J CELL BIOL, V188, P145, DOI 10.1083/jcb.200908082; GRAY EG, 1963, J ANAT, V97, P101; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; Harris KM, 2003, PHILOS T R SOC B, V358, P745, DOI 10.1098/rstb.2002.1254; Jahn R, 2012, NATURE, V490, P201, DOI 10.1038/nature11320; KATZ B, 1971, SCIENCE, V173, P123, DOI 10.1126/science.173.3992.123; Lanzavecchia S, 2005, J STRUCT BIOL, V149, P87, DOI 10.1016/j.jsb.2004.09.004; MANDEL LJ, 1993, NATURE, V361, P552, DOI 10.1038/361552a0; O'Brien J, 2006, P NATL ACAD SCI USA, V103, P1575, DOI 10.1073/pnas.0507884103; PALAY SL, 1955, J BIOPHYS BIOCHEM CY, V1, P69, DOI 10.1083/jcb.1.1.69; PALAY SL, 1975, COLD SPRING HARB SYM, V40, P1; PFENNINGER K, 1971, PHILOS T R SOC B, V261, P387, DOI 10.1098/rstb.1971.0071; PFENNINGER K, 1972, J NEUROCYTOL, V1, P129, DOI 10.1007/BF01099180; Pinto da Silva P, 1972, CHEM PHYS LIPIDS, V8, P265; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Sabatini BL, 1996, NATURE, V384, P170, DOI 10.1038/384170a0; Schikorski T, 2001, NAT NEUROSCI, V4, P391, DOI 10.1038/86042; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Weninger K, 2003, P NATL ACAD SCI USA, V100, P14800, DOI 10.1073/pnas.2036428100; Zampighi GA, 2006, BIOPHYS J, V91, P2910, DOI 10.1529/biophysj.106.084814; Zampighi GA, 1999, J GEN PHYSIOL, V113, P507, DOI 10.1085/jgp.113.4.507; ZAMPIGHI GA, 1989, J CELL BIOL, V108, P2255, DOI 10.1083/jcb.108.6.2255; Zampighi GA, 2003, J MOL BIOL, V325, P201, DOI 10.1016/S0022-2836(02)01200-7; Zampighi GA, 1997, J STRUCT BIOL, V119, P347, DOI 10.1006/jsbi.1997.3882; Zampighi GA, 2008, J NEUROSCI, V28, P4151, DOI 10.1523/JNEUROSCI.4639-07.2008; Zampighi GA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016944; Zampighi LM, 2004, J STRUCT BIOL, V146, P368, DOI 10.1016/j.jsb.2004.01.008	40	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100710	10.1371/journal.pone.0100710	http://dx.doi.org/10.1371/journal.pone.0100710			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959848	Green Published, gold			2022-12-27	WOS:000338633900073
J	Alexandre, F; Heraud, N; Oliver, N; Varray, A				Alexandre, Francois; Heraud, Nelly; Oliver, Nicolas; Varray, Alain			Cortical Implication in Lower Voluntary Muscle Force Production in Non-Hypoxemic COPD Patients	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; OXYGENATION CHANGES; PREFRONTAL CORTEX; PHYSICAL-ACTIVITY; MOTOR CONTROL; QUADRICEPS; ACTIVATION; EXERCISE; WEAKNESS; SPECTROSCOPY	Recent studies have shown that muscle alterations cannot totally explain peripheral muscle weakness in COPD. Cerebral abnormalities in COPD are well documented but have never been implicated in muscle torque production. The purpose of this study was to assess the neural correlates of quadriceps torque control in COPD patients. Fifteen patients (FEV1 54.1 +/- 3.6% predicted) and 15 age- and sex-matched healthy controls performed maximal (MVCs) and submaximal (SVCs) voluntary contractions at 10, 30 and 50% of the maximal voluntary torque of the knee extensors. Neural activity was quantified with changes in functional near-infrared spectroscopy oxyhemoglobin (fNIRS-HbO) over the contralateral primary motor (M1), primary somatosensory (S1), premotor (PMC) and prefrontal (PFC) cortical areas. In parallel to the lower muscle torque, the COPD patients showed lower increase in HbO than healthy controls over the M1 (p < 0.05), PMC (p < 0.05) and PFC areas (p < 0.01) during MVCs. In addition, they exhibited lower HbO changes over the M1 (p < 0.01), S1 (p < 0.05) and PMC (p < 0.01) areas during SVCs at 50% of maximal torque and altered motor control characterized by higher torque fluctuations around the target. The results show that low muscle force production is found in a context of reduced motor cortex activity, which is consistent with central nervous system involvement in COPD muscle weakness.	[Alexandre, Francois; Varray, Alain] Univ Montpellier I, Euromov, Movement Hlth Lab, Montpellier, France; [Alexandre, Francois; Heraud, Nelly; Oliver, Nicolas] Clin Souffle Vallonie, Fontalvie, Lodeve, France	Universite de Montpellier	Alexandre, F (corresponding author), Univ Montpellier I, Euromov, Movement Hlth Lab, Montpellier, France.	francois.alexandre@fontalvie.fr	Varray, Alain/P-6730-2019	Varray, Alain/0000-0003-3876-1211	French Ministry through the Association Nationale de la Recherche et de la Technology (National Agency for Research and Technology)	French Ministry through the Association Nationale de la Recherche et de la Technology (National Agency for Research and Technology)	FA was partially supported by a grant in aid from the French Ministry through the Association Nationale de la Recherche et de la Technology (National Agency for Research and Technology). The authors did not receive other specific funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albayrak R, 2006, RESP MED, V100, P1826, DOI 10.1016/j.rmed.2006.01.015; [Anonymous], 1994, J Clin Neurophysiol, V11, P111; Bernard S, 1998, AM J RESP CRIT CARE, V158, P629, DOI 10.1164/ajrccm.158.2.9711023; Chow JW, 2011, J APPL PHYSIOL, V111, P1290, DOI 10.1152/japplphysiol.00462.2011; Clark BC, 2008, J GERONTOL A-BIOL, V63, P829, DOI 10.1093/gerona/63.8.829; Colier WNJM, 1999, EXP BRAIN RES, V129, P457, DOI 10.1007/s002210050913; Decramer M, 1997, EUR RESPIR J, V10, P417, DOI 10.1183/09031936.97.10020417; Derosiere G, 2012, ADV EXP MED BIOL, V737, P269, DOI 10.1007/978-1-4614-1566-4_40; Dodd JW, 2010, EUR RESPIR J, V35, P913, DOI 10.1183/09031936.00125109; Dodd JW, 2012, AM J RESP CRIT CARE, V186, P240, DOI 10.1164/rccm.201202-0355OC; Duncan A, 1996, PEDIATR RES, V39, P889, DOI 10.1203/00006450-199605000-00025; Ekkekakis P, 2009, J SPORT EXERCISE PSY, V31, P505, DOI 10.1123/jsep.31.4.505; FOX PT, 1988, SCIENCE, V241, P462, DOI 10.1126/science.3260686; Gosselink R, 1996, AM J RESP CRIT CARE, V153, P976, DOI 10.1164/ajrccm.153.3.8630582; Herbert RD, 1999, J NEUROPHYSIOL, V82, P2271, DOI 10.1152/jn.1999.82.5.2271; Higashimoto Y, 2011, RESPIRATION, V82, P492, DOI 10.1159/000324571; Hopkinson NS, 2004, RESP PHYSIOL NEUROBI, V141, P1, DOI 10.1016/j.resp.2004.04.003; Kirkil G, 2007, CLIN NEUROL NEUROSUR, V109, P553, DOI 10.1016/j.clineuro.2007.03.013; Kramer AF, 2007, TRENDS COGN SCI, V11, P342, DOI 10.1016/j.tics.2007.06.009; Lahousse L, 2013, AM J RESP CRIT CARE, V188, P783, DOI 10.1164/rccm.201303-0455OC; Lin PY, 2013, HUM BRAIN MAPP, V34, P2381, DOI 10.1002/hbm.22072; Mador MJ, 2003, AM J RESP CRIT CARE, V168, P102, DOI 10.1164/rccm.200202-080OC; Mador MJ, 2001, RESP RES, V2, P216; Manto M, 2012, CEREBELLUM, V11, P457, DOI 10.1007/s12311-011-0331-9; Mehagnoul-Schipper DJ, 2002, HUM BRAIN MAPP, V16, P14, DOI 10.1002/hbm.10026; Mehta RK, 2013, EUR J APPL PHYSL; Menon MK, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-119; Minagawa-Kawai Y, 2011, CEREB CORTEX, V21, P254, DOI 10.1093/cercor/bhq082; Missenard O, 2008, NEUROSCI LETT, V437, P154, DOI 10.1016/j.neulet.2008.03.090; Nishimura Y, 2007, NEUROSCI RES, V59, P243, DOI 10.1016/j.neures.2007.07.003; Oncel C, 2010, COPD, V7, P11, DOI 10.3109/15412550903499480; PAULIN MG, 1993, BRAIN BEHAV EVOLUT, V41, P39, DOI 10.1159/000113822; Perrey S, 2008, METHODS, V45, P289, DOI 10.1016/j.ymeth.2008.04.005; Sato H, 2013, NEUROIMAGE, V83, P158, DOI 10.1016/j.neuroimage.2013.06.043; Seymour JM, 2012, MUSCLE NERVE, V46, P548, DOI 10.1002/mus.23353; Shim TS, 2001, CHEST, V120, P1506, DOI 10.1378/chest.120.5.1506; Shrikrishna D, 2012, EUR RESPIR J, V40, P1115, DOI 10.1183/09031936.00170111; Strangman G, 2002, NEUROIMAGE, V17, P719, DOI 10.1006/nimg.2002.1227; Swallow EB, 2007, THORAX, V62, P115, DOI 10.1136/thx.2006.062026; van Duinen H, 2008, HUM BRAIN MAPP, V29, P281, DOI 10.1002/hbm.20388; Vivodtzev I, 2008, MUSCLE NERVE, V37, P27, DOI 10.1002/mus.20867; VOORRIPS LE, 1991, MED SCI SPORT EXER, V23, P974, DOI 10.1249/00005768-199108000-00015; Yildiz S, 2012, CLIN IMAG, V36, P185, DOI 10.1016/j.clinimag.2011.08.021; Zhang H, 2013, AM J NEURORADIOL, V34, P334, DOI 10.3174/ajnr.A3235	44	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100961	10.1371/journal.pone.0100961	http://dx.doi.org/10.1371/journal.pone.0100961			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971775	Green Published, Green Submitted, gold			2022-12-27	WOS:000338512200074
J	Kurita, M; Nishino, S; Numata, Y; Okubo, Y; Sato, T				Kurita, Masatake; Nishino, Satoshi; Numata, Yukio; Okubo, Yoshiro; Sato, Tadahiro			The Noradrenaline Metabolite MHPG Is a Candidate Biomarker from the Manic to the Remission State in Bipolar Disorder I: A Clinical Naturalistic Study	PLOS ONE			English	Article							PLASMA-CATECHOLAMINE METABOLITES; NEUROTROPHIC FACTOR; BRAIN; DEPRESSION; ANTIPSYCHOTICS; 3-METHOXY-4-HYDROXYPHENYLGLYCOL; RISPERIDONE; LIQUID; PHASE; SCALE	Remission is the primary goal of treatment for bipolar disorder I (BDI). Metabolites of noradrenaline and dopamine, 3-methoxy-4-hydroxyphenylglycol (MHPG) and homovanillic acid (HVA), respectively, are reduced by treatment with antipsychotics, but whether these phenomena are caused by antipsychotics or by the pathophysiology of BDI is not known. Interactions between brain-derived neurotrophic factor (BDNF) and mood disorders have also been suggested. We conducted a multifaceted study in BDI patients to ascertain if biological markers are associated with the manic state. Patients with Young Mania Rating Scale (YMRS) scores >20 participated in the study. Final analyses involved 24 BDI patients (13 men and 11 women). We used YMRS scores to identify mania stages in individual BDI patients (i.e., manic syndrome, response and remission stages). Statistical analyses were done using one-way repeated-measures analyses of variance (rep-ANOVA) throughout manic syndrome, response and remission stages. Plasma concentrations of MHPG and HVA were analyzed by high-performance liquid chromatography with electrochemical detection. Plasma levels of BDNF were measured by sandwich enzyme-linked immunosorbent assay. BDI patients had significantly reduced plasma levels of MHPG throughout manic syndrome, response and remission stages (rep-ANOVA, p = 0.002). Without a case of response state, there was a significant positive correlation between YMRS scores and plasma levels of MHPG (rho = 0.33, p = 0.033, n = 48). Plasma levels of HVA and BDNF were not significantly altered throughout manic syndrome, response and remission stages. These data suggest that the peripheral level of MHPG (which is associated with noradrenaline levels in the brain) could be used as a biomarker for the manic state in BDI. The MHPG level is likely to reflect the clinical characteristics of the manic syndrome in BDI, and noradrenaline may reflect the pathophysiology from manic to remission states.	[Kurita, Masatake; Nishino, Satoshi; Numata, Yukio; Sato, Tadahiro] Sato Hosp, Nanyo, Yamagata, Japan; [Kurita, Masatake; Nishino, Satoshi] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Cellular Signaling, Aoba Ku, Sendai, Miyagi 980, Japan; [Kurita, Masatake; Okubo, Yoshiro] Nippon Med Sch, Grad Sch Med, Dept Psychiat & Behav Sci, Bunkyo Ku, Tokyo 113, Japan	Tohoku University; Nippon Medical School	Kurita, M (corresponding author), Sato Hosp, 948-1 Kunugizuka, Nanyo, Yamagata, Japan.	kurita@koutoku.or.jp			Koutokukai, Sato Hospital	Koutokukai, Sato Hospital	This study was supported by funding from Koutokukai, Sato Hospital. The study did not receive funding from any pharmaceutical corporations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen NC, 2010, BIOL PSYCHIAT, V67, P255, DOI 10.1016/j.biopsych.2009.08.040; AZORIN JM, 1990, ACTA PSYCHIAT SCAND, V81, P14, DOI 10.1111/j.1600-0447.1990.tb06442.x; BOWERS MB, 1989, BIOL PSYCHIAT, V25, P734, DOI 10.1016/0006-3223(89)90245-X; Calabrese JR, 2005, AM J PSYCHIAT, V162, P2152, DOI 10.1176/appi.ajp.162.11.2152; Choi SW, 2011, PSYCHIAT RES, V186, P427, DOI 10.1016/j.psychres.2010.07.028; Fernandes BS, 2011, J PSYCHIATR RES, V45, P995, DOI 10.1016/j.jpsychires.2011.03.002; GWIRTSMAN HE, 1989, AM J PSYCHIAT, V146, P1427; Kane JM, 2002, AM J PSYCHIAT, V159, P1, DOI 10.1176/appi.ajp.159.1.1; Kapczinski F, 2011, J PSYCHIATR RES, V45, P156, DOI 10.1016/j.jpsychires.2010.05.015; Kastrup MC, 2007, DAN MED BULL, V54, P42; Koenigsberg HW, 2004, J PSYCHIATR RES, V38, P503, DOI 10.1016/j.jpsychires.2004.03.006; KUKOPULOS A, 1980, PHARMAKOPSYCH NEURO, V13, P156; Kurita M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039212; Macrithie K, 2003, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD004052; Monteleone P, 2008, BIPOLAR DISORD, V10, P95, DOI 10.1111/j.1399-5618.2008.00459.x; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Piccinni A, 2008, CHRONOBIOL INT, V25, P819, DOI 10.1080/07420520802387773; Rosa AR, 2008, PSYCHOTHER PSYCHOSOM, V77, P390, DOI 10.1159/000151520; Rush AJ, 2003, J CLIN PSYCHIAT, V64, P4; SCHANBER.SM, 1968, BIOCHEM PHARMACOL, V17, P2006, DOI 10.1016/0006-2952(68)90119-6; Tauscher J, 2002, MOL PSYCHIATR, V7, P317, DOI 10.1038/sj.mp.4001009; Tohen M, 1999, AM J PSYCHIAT, V156, P702; Vieta E, 2005, BIPOLAR DISORD, V7, P21, DOI 10.1111/j.1399-5618.2005.00212.x; WHITE E, 1993, INT CLIN PSYCHOPHARM, V8, P119, DOI 10.1097/00004850-199300820-00007; Yatham LN, 2009, BIPOLAR DISORD, V11, P225, DOI 10.1111/j.1399-5618.2009.00672.x; Yeung PKF, 1996, J PHARM SCI, V85, P451, DOI 10.1021/js950361q; Yildiz A, 2011, NEUROPSYCHOPHARMACOL, V36, P375, DOI 10.1038/npp.2010.192; Yoshimura R, 2005, HUM PSYCHOPHARM CLIN, V20, P243, DOI 10.1002/hup.685; Yoshimura R, 2006, HUM PSYCHOPHARM CLIN, V21, P433, DOI 10.1002/hup.804; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429	30	12	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100634	10.1371/journal.pone.0100634	http://dx.doi.org/10.1371/journal.pone.0100634			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971450	gold, Green Published, Green Submitted			2022-12-27	WOS:000338512200046
J	Osland, MJ; Day, RH; Larriviere, JC; From, AS				Osland, Michael J.; Day, Richard H.; Larriviere, Jack C.; From, Andrew S.			Aboveground Allometric Models for Freeze-Affected Black Mangroves (Avicennia germinans): Equations for a Climate Sensitive Mangrove-Marsh Ecotone	PLOS ONE			English	Article							GULF-OF-MEXICO; NITROGEN-CONTENT; PUERTO-RICO; FORESTS; BIOMASS; CARBON; EXPANSION; PRODUCTIVITY; VEGETATION; IMPACTS	Across the globe, species distributions are changing in response to climate change and land use change. In parts of the southeastern United States, climate change is expected to result in the poleward range expansion of black mangroves (Avicennia germinans) at the expense of some salt marsh vegetation. The morphology of A. germinans at its northern range limit is more shrub-like than in tropical climes in part due to the aboveground structural damage and vigorous multi-stem regrowth triggered by extreme winter temperatures. In this study, we developed aboveground allometric equations for freeze-affected black mangroves which can be used to quantify: (1) total aboveground biomass; (2) leaf biomass; (3) stem plus branch biomass; and (4) leaf area. Plant volume (i.e., a combination of crown area and plant height) was selected as the optimal predictor of the four response variables. We expect that our simple measurements and equations can be adapted for use in other mangrove ecosystems located in abiotic settings that result in mangrove individuals with dwarf or shrub-like morphologies including oligotrophic and arid environments. Many important ecological functions and services are affected by changes in coastal wetland plant community structure and productivity including carbon storage, nutrient cycling, coastal protection, recreation, fish and avian habitat, and ecosystem response to sea level rise and extreme climatic events. Coastal scientists in the southeastern United States can use the identified allometric equations, in combination with easily obtained and non-destructive plant volume measurements, to better quantify and monitor ecological change within the dynamic, climate sensitive, and highly-productive mangrove-marsh ecotone.	[Osland, Michael J.; Day, Richard H.] US Geol Survey, Natl Wetlands Res Ctr, Lafayette, LA 70506 USA; [Larriviere, Jack C.; From, Andrew S.] US Geol Survey, Rivers Serv LLC 5, Natl Wetlands Res Ctr, Lafayette, LA USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey	Osland, MJ (corresponding author), US Geol Survey, Natl Wetlands Res Ctr, Lafayette, LA 70506 USA.	mosland@usgs.gov	Osland, Michael J./D-1814-2014	Osland, Michael J./0000-0001-9902-8692; Day, Richard/0000-0002-5959-7054; From, Andrew/0000-0002-6543-2627	Department of Interior Southeast Climate Science Center	Department of Interior Southeast Climate Science Center	This project was supported by the Department of Interior Southeast Climate Science Center (doi.gov/csc/southeast/index.cfm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam P., 1990, SALTMARSH ECOLOGY; Alleman LK, 2011, WETL ECOL MANAG, V19, P47, DOI 10.1007/s11273-010-9199-6; Allen CD, 1998, P NATL ACAD SCI USA, V95, P14839, DOI 10.1073/pnas.95.25.14839; Alongi DM, 2009, ENERGETICS MANGROVE; Angelini C, 2011, BIOSCIENCE, V61, P782, DOI 10.1525/bio.2011.61.10.8; [Anonymous], 2012, GLOBAL CHANGE FUNCTI, DOI DOI 10.1007/978-94-007-4494-3_2; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; BEAUCHAMP JJ, 1973, ECOLOGY, V54, P1403, DOI 10.2307/1934208; Bianchi TS, 2013, ESTUAR COAST SHELF S, V119, P7, DOI 10.1016/j.ecss.2012.12.007; Bruno JF, 2001, MARINE COMMUNITY ECOLOGY, P201; Castaneda-Moya E, 2013, FOREST ECOL MANAG, V307, P226, DOI 10.1016/j.foreco.2013.07.011; Caudill M.C., 2005, THESIS LOUISIANA STA; Cavanaugh KC, 2014, P NATL ACAD SCI USA, V111, P723, DOI 10.1073/pnas.1315800111; Chavez-Ramirez F, 2012, WETLANDS, V32, P11, DOI 10.1007/s13157-011-0250-z; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; CINTRON G, 1978, BIOTROPICA, V10, P110, DOI 10.2307/2388013; Cintron G., 1984, MANGROVE ECOSYSTEM R, P91; Cleary MB, 2008, J ARID ENVIRON, V72, P285, DOI 10.1016/j.jaridenv.2007.07.013; Clough B. F., 1989, Forest Ecology and Management, V27, P117, DOI 10.1016/0378-1127(89)90034-0; Clough BF, 1997, AUST J BOT, V45, P1023, DOI 10.1071/BT96075; Comeaux RS, 2012, ESTUAR COAST SHELF S, V96, P81, DOI 10.1016/j.ecss.2011.10.003; Coronado-Molina C., 2004, Wetlands Ecology and Management, V12, P157, DOI 10.1023/B:WETL.0000034071.17156.c0; DAY JW, 1987, AQUAT BOT, V27, P267, DOI 10.1016/0304-3770(87)90046-5; Dayton P.K., 1972, P C CONSERVATION PRO, P81; Doyle TW, 2010, FOREST ECOL MANAG, V259, P770, DOI 10.1016/j.foreco.2009.10.023; Duarte CM, 2013, NAT CLIM CHANGE, V3, P961, DOI [10.1038/nclimate1970, 10.1038/NCLIMATE1970]; Ellison AM, 2005, FRONT ECOL ENVIRON, V3, P479, DOI 10.1890/1540-9295(2005)003[0479:LOFSCF]2.0.CO;2; Feagin RA, 2009, P NATL ACAD SCI USA, V106, P10109, DOI 10.1073/pnas.0901297106; Feller IC, 2003, BIOGEOCHEMISTRY, V62, P145, DOI 10.1023/A:1021166010892; Fromard F, 1998, OECOLOGIA, V115, P39, DOI 10.1007/s004420050489; Gedan KB, 2011, CLIMATIC CHANGE, V106, P7, DOI 10.1007/s10584-010-0003-7; Giri C, 2011, J COASTAL RES, V27, P1059, DOI 10.2112/JCOASTRES-D-11-00028.1; Henry KM, 2013, J COASTAL RES, V29, P1273, DOI 10.2112/JCOASTRES-D-12-00184.1; Jiang J, 2012, THEOR POPUL BIOL, V82, P29, DOI 10.1016/j.tpb.2012.02.007; Kirwan ML, 2013, NATURE, V504, P53, DOI 10.1038/nature12856; Komiyama A, 2008, AQUAT BOT, V89, P128, DOI 10.1016/j.aquabot.2007.12.006; Krauss KW, 2014, NEW PHYTOL, V202, P19, DOI 10.1111/nph.12605; Krauss KW, 2014, ECOHYDROLOGY, V7, P354, DOI 10.1002/eco.1353; Lewis DB, 2014, ESTUAR COAST SHELF S, V139, P11, DOI 10.1016/j.ecss.2013.12.032; Lovelock CE, 2006, PLANT CELL ENVIRON, V29, P793, DOI 10.1111/j.1365-3040.2005.01446.x; Lugo A. E., 1974, Annual Review of Ecology and Systematics, V5, P39, DOI 10.1146/annurev.es.05.110174.000351; Marani M, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001600; McClaran MP, 2013, J ARID ENVIRON, V88, P39, DOI 10.1016/j.jaridenv.2012.08.015; Mckee KL, 2008, GLOBAL CHANGE BIOL, V14, P971, DOI 10.1111/j.1365-2486.2008.01547.x; Mcleod E, 2011, FRONT ECOL ENVIRON, V9, P552, DOI 10.1890/110004; Michot T.C., 2010, NEWSLETTER LOUSIANA, P4; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING SY; Morris JT, 2002, ECOLOGY, V83, P2869, DOI 10.1890/0012-9658(2002)083[2869:ROCWTR]2.0.CO;2; NEILSON RP, 1993, ECOL APPL, V3, P385, DOI 10.2307/1941907; Northup BK, 2005, J ARID ENVIRON, V62, P23, DOI 10.1016/j.jaridenv.2004.09.019; Odum W.E., 1982, ECOLOGY MANGROVES S; Osland MJ, 2013, GLOBAL CHANGE BIOL, V19, P1482, DOI 10.1111/gcb.12126; Osland MJ, 2012, ECOSYSTEMS, V15, P848, DOI 10.1007/s10021-012-9551-1; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parvaresh H., 2012, J BASIC APPL SCI RES, V2, P1763; Patterson CS., 1997, MANGROVES SALT MARSH, V1, P103, DOI 10.1023/A:1009923917812; Pennings SC, 2001, MARINE COMMUNITY ECOLOGY, P289; Perry CL, 2009, WETLANDS, V29, P396, DOI 10.1672/08-100.1; Pickens CN, 2011, ESTUAR COAST, V34, P824, DOI 10.1007/s12237-010-9358-2; POOL DJ, 1977, BIOTROPICA, V9, P195, DOI 10.2307/2387881; RISSER PG, 1995, BIOSCIENCE, V45, P318, DOI 10.2307/1312492; Ross Michael S., 2001, Wetlands Ecology and Management, V9, P27, DOI 10.1023/A:1008411103288; Ross MS, 2009, GLOBAL CHANGE BIOL, V15, P1817, DOI 10.1111/j.1365-2486.2009.01900.x; Saintilan N, 2014, GLOBAL CHANGE BIOL, V20, P147, DOI 10.1111/gcb.12341; Smith Thomas J. III, 2006, Wetlands Ecology and Management, V14, P409, DOI 10.1007/s11273-005-6243-z; SPRUGEL DG, 1983, ECOLOGY, V64, P209, DOI 10.2307/1937343; Stagg CL, 2011, ECOL APPL, V21, P1731, DOI 10.1890/09-2128.1; Tomlinson P.B., 2016, BOT MANGROVES, DOI [10.1017/CBO9781139946575, DOI 10.1017/CBO9781139946575]; URESK DW, 1977, J RANGE MANAGE, V30, P311, DOI 10.2307/3897313; West R. C., 1977, Wet coastal ecosystems., P193; WOODROFFE CD, 1985, ESTUAR COAST SHELF S, V20, P265, DOI 10.1016/0272-7714(85)90042-3; WOODROFFE CD, 1991, J BIOGEOGR, V18, P479, DOI 10.2307/2845685	72	37	37	7	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e99604	10.1371/journal.pone.0099604	http://dx.doi.org/10.1371/journal.pone.0099604			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971938	Green Published, gold, Green Submitted			2022-12-27	WOS:000338512200011
J	Reece, P; Gauvreau, GM; Sehmi, R; Denburg, JA				Reece, Pia; Gauvreau, Gail M.; Sehmi, Roma; Denburg, Judah A.			IL-4 and IL-13 Differentially Regulate TLR-Induced Eosinophil-Basophil Differentiation of Cord Blood CD34(+) Progenitor Cells	PLOS ONE			English	Article							CYTOKINE PRODUCTION; ALLERGEN CHALLENGE; PERIPHERAL-BLOOD; MATERNAL ALLERGY; PROTEIN-KINASE; ASTHMA; EXPRESSION; CHILDREN; INTERLEUKIN-13; RECEPTORS	Intrauterine environmental exposures have been shown to influence neonatal immunity and subsequent allergic disease development. We have previously shown that fewer lipopolysaccharide (LPS)-stimulated eosinophil-basophil (Eo/B) colonies grow from cord blood (CB) of high-atopic risk infants, compared to low-atopic risk infants. In the present study, we investigated whether a surrogate ex vivo T(H)2 milieu (i.e., either IL-4 or IL-13) could represent an underlying mechanism to explain our previous findings. CB CD34(+) cells from healthy donors were cultured with IL-4 or IL-13 (in combination with LPS) and assessed for Eo/B differentiation using methylcellulose cultures and flow cytometry for related intracellular signalling pathways. Pharmacological inhibitors were added to the methylcellulose cultures to determine the effect of blocking intracellular signalling in CB CD34(+) cells in relation to Eo/B colony forming unit (CFU) formation. Stimulation of CD34(+) cells with IL-4, but not IL-13, reduced Eo/B CFU formation in the presence of LPS; this was found to be dependent on IL-4R alpha and not IL-13R alpha 1. Additionally, IL-4 reduced the expression of ERK 1/2 after LPS stimulation, which was recovered by inhibition of IL-4R alpha. While IL-13 did not have an inhibitory effect on ERK 1/2 expression, inhibition of ERK 1/2 significantly reduced Eo/B CFU formation. Thus, the responsiveness of CB CD34(+) progenitor cells to LPS is differentially regulated by the T(H)2 cytokines, IL-4 and IL-13. This may have implications for in utero interactions between placental-derived pro-allergic cytokines and neonatal progenitor cells influencing Eo/B-mediated inflammatory responses in early life.	[Reece, Pia; Gauvreau, Gail M.; Denburg, Judah A.] McMaster Univ, Div Clin Immunol & Allergy, Hamilton, ON, Canada; [Sehmi, Roma] McMaster Univ, Firestone Inst Resp Hlth, Asthma Res Grp, Hamilton, ON, Canada	McMaster University; McMaster University	Denburg, JA (corresponding author), McMaster Univ, Div Clin Immunol & Allergy, Hamilton, ON, Canada.	denburg@mcmaster.ca			CIHR [MOP 111029]	CIHR(Canadian Institutes of Health Research (CIHR))	This work is supported by a grant from CIHR [MOP 111029]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2000, J IMMUNOL, V165, P2198, DOI 10.4049/jimmunol.165.4.2198; Amoudruz P, 2005, J ALLERGY CLIN IMMUN, V115, P1304, DOI 10.1016/j.jaci.2005.02.036; Amoudruz P, 2009, CLIN EXP IMMUNOL, V155, P387, DOI 10.1111/j.1365-2249.2008.03792.x; BJORKSTEN B, 1995, INT ARCH ALLERGY IMM, V107, P34, DOI 10.1159/000236922; Brown M, 2004, HUM IMMUNOL, V65, P1336, DOI 10.1016/j.humimm.2004.08.176; Chatila TA, 2004, TRENDS MOL MED, V10, P493, DOI 10.1016/j.molmed.2004.08.004; Denburg JA, 2005, PEDIATR RES, V57, P276, DOI 10.1203/01.PDR.0000148279.72611.1D; Ege MJ, 2006, J ALLERGY CLIN IMMUN, V117, P817, DOI 10.1016/j.jaci.2005.12.1307; Fernandes R, 2008, PEDIATR ALLERGY IMMU, V19, P239, DOI 10.1111/j.1399-3038.2007.00615.x; Gauvreau GM, 2011, AM J RESP CRIT CARE, V183, P1007, DOI 10.1164/rccm.201008-1210OC; Geest CR, 2009, STEM CELLS, V27, P2271, DOI 10.1002/stem.152; HAMID Q, 1994, J CLIN INVEST, V94, P870, DOI 10.1172/JCI117408; Hinz D, 2012, ALLERGY, V67, P380, DOI 10.1111/j.1398-9995.2011.02767.x; Hinz D, 2010, CLIN EXP ALLERGY, V40, P419, DOI 10.1111/j.1365-2222.2009.03434.x; HUANG SK, 1995, J IMMUNOL, V155, P2688; Kajitani H, 1989, GROWTH FACTORS, V1, DOI 10.3109/08977198909000252; Krutzik PO, 2005, J IMMUNOL, V175, P2366, DOI 10.4049/jimmunol.175.4.2366; OCHIAI K, 1995, CLIN EXP IMMUNOL, V99, P124; Okoye IS, 2011, IMMUNOLOGY, V134, P368, DOI 10.1111/j.1365-2567.2011.03497.x; Oymar K, 2000, PEDIATR ALLERGY IMMU, V11, P220, DOI 10.1034/j.1399-3038.2000.00094.x; Prefontaine D, 2010, CLIN EXP ALLERGY, V40, P1648, DOI 10.1111/j.1365-2222.2010.03570.x; Prescott SL, 2010, P NUTR SOC, V69, P366, DOI 10.1017/S0029665110001874; Punia N, 2012, CLIN EXP ALLERGY, V42, P255, DOI 10.1111/j.1365-2222.2011.03889.x; Queto T, 2010, J LEUKOCYTE BIOL, V87, P885, DOI 10.1189/jlb.1108709; Radinger M, 2009, PHARMACOL THERAPEUT, V121, P174, DOI 10.1016/j.pharmthera.2008.10.008; Reece P, 2013, IMMUNOLOGY, V139, P256, DOI 10.1111/imm.12078; Reece P, 2011, J ALLERGY CLIN IMMUN, V127, P447, DOI 10.1016/j.jaci.2010.11.006; Robinson DS, 1999, AM J RESP CELL MOL, V20, P9, DOI 10.1165/ajrcmb.20.1.3449; Roduit C, 2011, J ALLERGY CLIN IMMUN, V127, P179, DOI 10.1016/j.jaci.2010.10.010; Saghafian-Hedengren S, 2008, CLIN EXP ALLERGY, V38, P449, DOI 10.1111/j.1365-2222.2007.02917.x; Schaub B, 2009, J ALLERGY CLIN IMMUN, V123, P774; Upham JW, 1999, J ALLERGY CLIN IMMUN, V104, P370, DOI 10.1016/S0091-6749(99)70381-7; von Mutius E, 2010, NAT REV IMMUNOL, V10, P861, DOI 10.1038/nri2871; WALKER C, 1992, AM REV RESPIR DIS, V146, P109, DOI 10.1164/ajrccm/146.1.109; Wedi B, 1998, J ALLERGY CLIN IMMUN, V102, P1013, DOI 10.1016/S0091-6749(98)70340-9; Wenzel S, 2007, LANCET, V370, P1422, DOI 10.1016/S0140-6736(07)61600-6; Wenzel S, 2013, NEW ENGL J MED, V368, P2455, DOI 10.1056/NEJMoa1304048	37	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100734	10.1371/journal.pone.0100734	http://dx.doi.org/10.1371/journal.pone.0100734			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971469	gold, Green Submitted, Green Published			2022-12-27	WOS:000338512200054
J	Wang, Q; Yuan, XZ; Willison, JHM; Zhang, YW; Liu, H				Wang, Qiang; Yuan, Xingzhong; Willison, J. H. Martin; Zhang, Yuewei; Liu, Hong			Diversity and Above-Ground Biomass Patterns of Vascular Flora Induced by Flooding in the Drawdown Area of China's Three Gorges Reservoir	PLOS ONE			English	Article							RIVER-MARGIN VEGETATION; RIPARIAN VEGETATION; DAM; CONSERVATION; TOLERANCE; RESPONSES; SURVIVAL; IMPACTS; TIME	Hydrological alternation can dramatically influence riparian environments and shape riparian vegetation zonation. However, it was difficult to predict the status in the drawdown area of the Three Gorges Reservoir (TGR), because the hydrological regime created by the dam involves both short periods of summer flooding and long-term winter impoundment for half a year. In order to examine the effects of hydrological alternation on plant diversity and biomass in the drawdown area of TGR, twelve sites distributed along the length of the drawdown area of TGR were chosen to explore the lateral pattern of plant diversity and above-ground biomass at the ends of growing seasons in 2009 and 2010. We recorded 175 vascular plant species in 2009 and 127 in 2010, indicating that a significant loss of vascular flora in the drawdown area of TGR resulted from the new hydrological regimes. Cynodon dactylon and Cyperus rotundus had high tolerance to short periods of summer flooding and long-term winter flooding. Almost half of the remnant species were annuals. Species richness, Shannon-Wiener Index and above-ground biomass of vegetation exhibited an increasing pattern along the elevation gradient, being greater at higher elevations subjected to lower submergence stress. Plant diversity, above-ground biomass and species distribution were significantly influenced by the duration of submergence relative to elevation in both summer and previous winter. Several million tonnes of vegetation would be accumulated on the drawdown area of TGR in every summer and some adverse environmental problems may be introduced when it was submerged in winter. We conclude that vascular flora biodiversity in the drawdown area of TGR has dramatically declined after the impoundment to full capacity. The new hydrological condition, characterized by long-term winter flooding and short periods of summer flooding, determined vegetation biodiversity and above-ground biomass patterns along the elevation gradient in the drawdown area.	[Wang, Qiang] Southwest Univ, Key Lab Aquat Sci Chongqing, Key Lab Freshwater Fish Reprod & Dev, Minist Educ,Sch Life Sci, Chongqing, Peoples R China; [Wang, Qiang; Yuan, Xingzhong; Zhang, Yuewei; Liu, Hong] Chongqing Univ, State Key Lab Coal Mine Disaster Dynam & Control, Chongqing 630044, Peoples R China; [Yuan, Xingzhong; Zhang, Yuewei; Liu, Hong] Chongqing Univ, Coll Resources & Environm Sci, Chongqing 630044, Peoples R China; [Yuan, Xingzhong] Chongqing Univ, Coll Architecture & Urban Planning, Chongqing 630044, Peoples R China; [Willison, J. H. Martin] Dalhousie Univ, Sch Resource & Environm Studies, Halifax, NS, Canada	Southwest University - China; Chongqing University; Chongqing University; Chongqing University; Dalhousie University	Wang, Q (corresponding author), Southwest Univ, Key Lab Aquat Sci Chongqing, Key Lab Freshwater Fish Reprod & Dev, Minist Educ,Sch Life Sci, Chongqing, Peoples R China.	wang1984china@gmail.com; 1072000659@qq.com		Willison, J.H. Martin/0000-0003-3024-296X	National Natural Science Foundation of China [51179214]; China Postdoctoral Science Foundation [2014M552296]; National Science & Technology Major Project [2013ZX07104-004-05]; Natural Science Foundation Project of China SWU [SWU112049]; Fundamental Research Funds for the Central Universities [XDJK2013C127]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Science & Technology Major Project; Natural Science Foundation Project of China SWU(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was financed by the National Natural Science Foundation of China (51179214), China Postdoctoral Science Foundation (2014M552296), National Science & Technology Major Project (2013ZX07104-004-05), the Natural Science Foundation Project of China SWU (SWU112049) and the Fundamental Research Funds for the Central Universities (XDJK2013C127). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts HC, 2004, SYST RES BEHAV SCI, V21, P585, DOI 10.1002/sres.604; Ali MM, 2003, LIMNOLOGICA, V33, P305, DOI 10.1016/S0075-9511(03)80025-7; [Anonymous], ILLUSTRATED SPECIES; Auble GT, 2007, ENVIRON MANAGE, V39, P806, DOI 10.1007/s00267-006-0018-z; [白宝伟 BAI Baowei], 2005, [西南农业大学学报, Journal of Southwest Agricultural University], V27, P684; Banach K, 2009, ANN BOT-LONDON, V103, P341, DOI 10.1093/aob/mcn183; Bao Da-Chuan, 2010, Wuhan Zhiwuxue Yanjiu, V28, P711, DOI 10.3724/SP.J.1142.2010.60711; Batalha MA, 2002, FLORA, V197, P452, DOI 10.1078/0367-2530-00062; BAXTER RM, 1977, ANNU REV ECOL SYST, V8, P255, DOI 10.1146/annurev.es.08.110177.001351; Changming Zhao, 2007, Shengwu Duoyangxing, V15, P510, DOI 10.1360/biodiv.070084; [程瑞梅 CHENG Rui-mei], 2009, [水土保持学报, Journal of Soil and Water Conservation], V23, P156; Cheng WL, 2008, PLANTS VEGETATION VA; Ellender ER, 2009, THESIS RHODES U LAKE; Elstad S, 2001, CHEM PHYSICAL PROPER; Fearnside PM, 2001, ENVIRON MANAGE, V27, P377, DOI 10.1007/s002670010156; Guo QuanShui, 2013, Scientia Silvae Sinicae, V49, P1; Jansson R, 2000, ECOL APPL, V10, P203; [贾中民 JIA Zhong-min], 2009, [西南大学学报. 自然科学版, Journal of Southwest University. Natural Science Edition], V31, P124; Koutecky Petr, 2005, Ecohydrology & Hydrobiology, V5, P33; Li Y, 2010, ACTA ECOLOGICA SINIC, V28, P1923; [梁福庆 LIANG FuQing], 2008, [湿地科学, Wetland Science], V6, P326; [刘维暐 Liu Weiwei], 2012, [生态学报, Acta Ecologica Sinica], V32, P5454; Liu X, 2008, RESOURCES ENV YANGTZ, V17, P60; [罗芳丽 LUO FangLi], 2008, [生态学报, Acta Ecologica Sinica], V28, P1964; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; New T, 2008, BIODIVERS CONSERV, V17, P3149, DOI 10.1007/s10531-008-9416-2; NILSSON C, 1988, CAN J FISH AQUAT SCI, V45, P1896, DOI 10.1139/f88-221; Nilsson C, 1997, SCIENCE, V276, P798, DOI 10.1126/science.276.5313.798; Nilsson C, 2000, BIOSCIENCE, V50, P783, DOI 10.1641/0006-3568(2000)050[0783:AORECB]2.0.CO;2; Sophocleous Marios., 2004, NAT RESOUR RES, V13, P61, DOI [DOI 10.1007/978-0-387-21706-2, 10.1023/B:NARR.0000032644.16734.f5]; Stokes KE, 2008, PLANT ECOL, V197, P91, DOI 10.1007/s11258-007-9363-0; Strom L, 2011, GLOBAL CHANGE BIOL, V17, P254, DOI 10.1111/j.1365-2486.2010.02230.x; Stromberg JC, 2007, FRESHWATER BIOL, V52, P651, DOI 10.1111/j.1365-2427.2006.01713.x; Tan Shu-Duan, 2009, Wuhan Zhiwuxue Yanjiu, V27, P391; ter Braak C.J.F., 2012, CANOCO REFERENCE MAN; Thomaz SM, 2006, HYDROBIOLOGIA, V570, P53, DOI 10.1007/s10750-006-0161-9; Tian ZQ, 2007, ACTA ECOLOGICA SINIC, V28, P3110; USDI-U.S. Departmentof the Interior, 2013, LAK MEAD HOOV DAM EL; van Eck WHJM, 2006, HYDROBIOLOGIA, V565, P59, DOI 10.1007/s10750-005-1905-7; van Eck WHJM, 2004, OIKOS, V107, P393, DOI 10.1111/j.0030-1299.2004.13083.x; Vervuren PJA, 2003, J ECOL, V91, P135, DOI 10.1046/j.1365-2745.2003.00749.x; [王建超 WANG Jianchao], 2011, [长江流域资源与环境, Resources and Environment in the Yangtze Basin], V20, P603; Wang Q, 2012, POL J ECOL, V60, P95; [王晓荣 Wang Xiaorong], 2010, [生态学报, Acta Ecologica Sinica], V30, P5821; Wang Yong, 2006, Wuhan Zhiwuxue Yanjiu, V24, P574; Wantzen KM, 2008, HYDROBIOLOGIA, V613, P1, DOI 10.1007/s10750-008-9466-1; Water-data Web, 2013, LAK POW WAT DAIL WAT; Wu JG, 2003, SCIENCE, V300, P1239, DOI 10.1126/science.1083312; Yang F., 2012, ACTA ECOLOGICA SINIC, V32, P89, DOI [10.1016/j.chnaes.2012.02.004, DOI 10.1016/J.CHNAES.2012.02.004]; YING JS, 2001, BIODIVERSITY SCI, V9, P393, DOI DOI 10.17520/BI0DS.2001058; [张虹 ZHANG Hong], 2008, [水土保持通报, Bulletin of Soil and Water Conservation], V28, P46; Zhang JianJun, 2012, Scientia Silvae Sinicae, V48, P154; Zhenli H., 2001, BIODIVERS SCI, V9, P472, DOI [DOI 10.3321/J.ISSN:1005-0094.2001.04.021, 10.17520/biods.2001068, DOI 10.17520/BIODS.2001068]	53	23	30	5	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100889	10.1371/journal.pone.0100889	http://dx.doi.org/10.1371/journal.pone.0100889			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971514	Green Submitted, Green Published, gold			2022-12-27	WOS:000338512200071
J	Alcalde, M; Campuzano, O; Berne, P; Garcia-Pavia, P; Doltra, A; Arbelo, E; Sarquella-Brugada, G; Iglesias, A; Alonso-Pulpon, L; Brugada, J; Brugada, R				Alcalde, Mireia; Campuzano, Oscar; Berne, Paola; Garcia-Pavia, Pablo; Doltra, Ada; Arbelo, Elena; Sarquella-Brugada, Georgia; Iglesias, Anna; Alonso-Pulpon, Luis; Brugada, Josep; Brugada, Ramon			Stop-Gain Mutations in PKP2 Are Associated with a Later Age of Onset of Arrhythmogenic Right Ventricular Cardiomyopathy	PLOS ONE			English	Article							DYSPLASIA/CARDIOMYOPATHY; PLAKOPHILIN-2; DISEASE; PHENOTYPE; DESMOSOME; FAMILY; DIAGNOSIS; INSIGHTS; TITIN; GENE	Background: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a cardiac disease characterized by the presence of fibrofatty replacement of the right ventricular myocardium, which may cause ventricular arrhythmias and sudden cardiac death. Pathogenic mutations in several genes encoding mainly desmosomal proteins have been reported. Our aim is to perform genotype-phenotype correlations to establish the diagnostic value of genetics and to assess the role of mutation type in age-related penetrance in ARVC. Methods and Results: Thirty unrelated Spanish patients underwent a complete clinical evaluation. They all were screened for PKP2, DSG2, DSC2, DSP, JUP and TMEM43 genes. A total of 70 relatives of four families were also studied. The 30 patients fulfilled definite disease diagnostic criteria. Genetic analysis revealed a pathogenic mutation in 19 patients ( 13 in PKP2, 3 in DSG2, 2 in DSP, and 1 in DSC2). Nine of these mutations created a truncated protein due to the generation of a stop codon. Familial assessment revealed 28 genetic carriers among family members. Stop-gain mutations were associated to a later age of onset of ARVC, without differences in the severity of the pathology. Conclusions: Familial genetic analysis helps to identify the cause responsible for the pathology. In discrepancy with previous studies, the presence of a truncating protein does not confer a worse severity. This information could suggest that truncating proteins may be compensated by the normal allele and that missense mutations may act as poison peptides.	[Alcalde, Mireia; Campuzano, Oscar; Iglesias, Anna; Brugada, Ramon] Univ Girona IDIBGI, Cardiovasc Genet Ctr, Girona, Spain; [Berne, Paola; Doltra, Ada; Arbelo, Elena; Brugada, Josep] Hosp Clin Barcelona, Thorax Inst, Arrhythmia Sect, Barcelona, Spain; [Garcia-Pavia, Pablo; Alonso-Pulpon, Luis] Hosp Univ Puerta Hierro, Dept Cardiol, Heart Failure & Heart Transplant Sect, Cardiomyopathy Unit, Madrid, Spain; [Sarquella-Brugada, Georgia] Hosp St Joan de Deu, Arrhythmia Sect, Barcelona, Spain	Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); University of Barcelona; Hospital Clinic de Barcelona; Hospital Puerta de Hierro-Majadahonda; University of Barcelona	Brugada, R (corresponding author), Univ Girona IDIBGI, Cardiovasc Genet Ctr, Girona, Spain.	rbrugada@gencardio.com	Alcalde, Mireia/AAB-1499-2019; Arbelo, Elena/GRS-2793-2022; Arbelo, Elena/GMX-0351-2022; Garcia-Pavia, Pablo/T-9100-2019; campuzano, oscar/J-1968-2014; Berne, Paola/HHM-4858-2022; Sarquella-Brugada, Georgia/W-9278-2018	Alcalde, Mireia/0000-0002-7222-0913; campuzano, oscar/0000-0001-5298-5276; Sarquella-Brugada, Georgia/0000-0002-6857-8904; Berne, Paola/0000-0003-1160-4064; ARBELO, ELENA/0000-0003-0424-6393; BRUGADA, JOSEP/0000-0002-5662-8302	CNIC [CNIC-03-2008]; Obra Social "la Caixa,''Fondo de Investigacion Sanitaria [PI11/00019]; RETICS (Red Investigacion Cardiovascular. Instituto de Salud Carlos III)	CNIC; Obra Social "la Caixa,''Fondo de Investigacion Sanitaria; RETICS (Red Investigacion Cardiovascular. Instituto de Salud Carlos III)	This work was supported by CNIC-Translational 2008 (CNIC-03-2008), Obra Social "la Caixa,''Fondo de Investigacion Sanitaria (PI11/00019), and RETICS (Red Investigacion Cardiovascular. Instituto de Salud Carlos III). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aad G, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.272002; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Andreasen C, 2013, EUR J HUM GENET; Asimaki A, 2009, NEW ENGL J MED, V360, P1075, DOI 10.1056/NEJMoa0808138; Awad MM, 2006, AM J HUM GENET, V79, P136, DOI 10.1086/504393; Barahona-Dussault C, CLIN GENET, V77, P37; Campuzano O, 2013, J MED GENET, V50, P280, DOI 10.1136/jmedgenet-2013-101523; Christensen AH, 2010, CARDIOLOGY, V115, P148, DOI 10.1159/000263456; Corrado D, 2000, CIRCULATION, V101, pE101, DOI 10.1161/01.CIR.101.11.e101; Cox MGPJ, 2011, CIRCULATION, V123, P2690, DOI 10.1161/CIRCULATIONAHA.110.988287; Dalal D, 2006, CIRCULATION, V113, P1641, DOI 10.1161/CIRCULATIONAHA.105.568642; Dalal D, 2006, J AM COLL CARDIOL, V48, P1416, DOI 10.1016/j.jacc.2006.06.045; ExomeVariantServer. NHLBI Exome Sequencing Project (ESP) S WA, 2012, EX VARIANTSERVER; Garcia-Gras E, 2006, J CLIN INVEST, V116, P2012, DOI 10.1172/JCI27751; Gerull B, 2004, NAT GENET, V36, P1162, DOI 10.1038/ng1461; Gonzalez-Perez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004; Herman DS, 2012, NEW ENGL J MED, V366, P619, DOI 10.1056/NEJMoa1110186; Herren T, 2009, CLIN RES CARDIOL, V98, P141, DOI 10.1007/s00392-009-0751-4; Joshi-Mukherjee R, 2008, HEART RHYTHM, V5, P1715, DOI 10.1016/j.hrthm.2008.09.009; Kannankeril PJ, 2006, HEART RHYTHM, V3, P939, DOI 10.1016/j.hrthm.2006.04.028; Li Mura IE, 2013, EUR J HUM GENET; Lombardi R, 2010, CURR OPIN CARDIOL, V25, P222, DOI 10.1097/HCO.0b013e3283376daf; Marcus FI, 2010, EUR HEART J, V31, P806, DOI [10.1093/eurheartj/ehq025, 10.1161/CIRCULATIONAHA.108.840827]; Marcus FI, 2009, HEART RHYTHM, V6, P984, DOI 10.1016/j.hrthm.2009.03.013; Nakajima T, 2012, CIRC J, V76, P737, DOI 10.1253/circj.CJ-11-0927; Pedra SRFF, 2005, PEDIATR CARDIOL, V26, P543, DOI 10.1007/s00246-004-0688-3; Rampazzo A, 2002, AM J HUM GENET, V71, P1200, DOI 10.1086/344208; RAMPAZZO A, 1994, HUM MOL GENET, V3, P959, DOI 10.1093/hmg/3.6.959; Rampazzo A, 2006, HEART INT, V2, P17, DOI 10.4081/hi.2006.17; Rasmussen TB, 2013, HUM MUTAT, V34, P697, DOI 10.1002/humu.22289; Roberts JD, 2013, CLIN GENET, V83, P452, DOI 10.1111/j.1399-0004.2012.01950.x; Saffitz JE, 2009, J INVEST MED, V57, P861, DOI 10.2310/JIM.0b013e3181c5e631; Sato T, 2011, LEGAL MED-TOKYO, V13, P298, DOI 10.1016/j.legalmed.2011.08.004; Sen-Chowdhry S, 2007, J AM COLL CARDIOL, V50, P1813, DOI 10.1016/j.jacc.2007.08.008; Sen-Chowdhry S, 2007, CIRCULATION, V115, P1710, DOI 10.1161/CIRCULATIONAHA.106.660241; Taylor M, 2011, CIRCULATION, V124, P876, DOI 10.1161/CIRCULATIONAHA.110.005405; Yang Z, 2006, CIRC RES, V99, P646, DOI 10.1161/01.RES.0000241482.19382.c6	37	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100560	10.1371/journal.pone.0100560	http://dx.doi.org/10.1371/journal.pone.0100560			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967631	Green Submitted, Green Published, gold			2022-12-27	WOS:000338280800045
J	Camilli, R; Spencer, BL; Moschioni, M; Pinto, V; Berti, F; Nahm, MH; Pantosti, A				Camilli, Romina; Spencer, Brady L.; Moschioni, Monica; Pinto, Vittoria; Berti, Francesco; Nahm, Moon H.; Pantosti, Annalisa			Identification of Streptococcus pneumoniae Serotype 11E, Serovariant 11Av and Mixed Populations by High-Resolution Magic Angle Spinning Nuclear Magnetic Resonance (HR-MAS NMR) Spectroscopy and Flow Cytometric Serotyping Assay (FCSA)	PLOS ONE			English	Article							CAPSULAR POLYSACCHARIDE; DISCOVERY; CARRIAGE; STRAINS	Background: Recent studies have identified Streptococcus pneumoniae serotype 11E and serovariant 11Av among isolates previously typed as 11A by classical serotyping methods. Serotype 11E and serovariant 11Av differ from serotype 11A by having totally or partially inactive wcjE, a gene in cps locus coding for an O-acetyl transferase. Serotype 11E is rare among carriage isolates but common among invasive isolates suggesting that it survives better during invasion. Aim of this work was to investigate the epidemiology of serotype 11A in a pneumococcal collection using a new serotyping approach based on High-Resolution Magic Angle Spinning Nuclear Magnetic Resonance (HR-MAS NMR) spectroscopy to distinguish serotypes 11A and 11E. Methods: A collection of 48 (34 invasive and 14 carriage) S. pneumoniae isolates from Italy, previously identified as serotype 11A by the Quellung reaction, were investigated by wcjE sequencing, HR-MAS NMR spectroscopy and the reference flow cytometric serotyping assay (FCSA) based on monoclonal antibodies. Results: HR-MAS NMR spectra from serotypes 11A and 11E showed different NMR peaks indicating that HR-MAS NMR could be used to distinguish these serotypes, although HR-MAS NMR could not distinguish serotype 11Av from serotype 11E unambiguously. Thirty-eight isolates were confirmed to be serotype 11A, 8 isolates with a mutated wcjE were serotype 11E, 1 isolate belonged to serovariant 11Av, and 1 isolate was a mixed population 11A/11Av. All 11E isolates were identified among invasive isolates. Conclusions: We proved that HR-MAS NMR can be of potential use for pneumococcal serotyping. The detection of serotype 11E among invasive isolates in our collection, supports previous epidemiological studies suggesting that mutations in wcjE can represent a mechanism promoting pneumococcal survival during invasion. The discovery of a spectrum of immunochemical diversity within established serotypes should stimulate efforts to develop new serotyping approaches.	[Camilli, Romina; Pantosti, Annalisa] Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, I-00161 Rome, Italy; [Spencer, Brady L.; Nahm, Moon H.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Moschioni, Monica; Pinto, Vittoria; Berti, Francesco] Novartis Vaccines & Diagnost, Siena, Italy; [Nahm, Moon H.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); Istituto Superiore di Sanita (ISS); University of Alabama System; University of Alabama Birmingham; Novartis; University of Alabama System; University of Alabama Birmingham	Pantosti, A (corresponding author), Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, Viale Regina Elena 299, I-00161 Rome, Italy.	annalisa.pantosti@iss.it	CAMILLI, ROMINA/C-8811-2016; Pantosti, Annalisa/A-7291-2013	CAMILLI, ROMINA/0000-0003-1309-5670; Pantosti, Annalisa/0000-0002-8409-4731; Spencer, Brady/0000-0003-4374-6403; Nahm, Moon/0000-0002-6922-1042	Italian Ministry of Health, CCM	Italian Ministry of Health, CCM(Ministry of Health, Italy)	This study was funded in part by a grant from the Italian Ministry of Health, CCM 2009, project "Surveillance of invasive bacterial diseases due to Neisseria meningitidis, Streptococcus pneumoniae and Haemophilus influenzae'' (www.ccm-network.it/home.html) given to Istituto Superiore di Sanita' (ISS) that only supported the experiments performed at ISS, while experiments performed at the University of Alabama at Birmingham (UAB) or Novartis were funded by their respective Institution or Company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeygunawardana C, 2000, ANAL BIOCHEM, V279, P226, DOI 10.1006/abio.1999.4470; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; Berry DS, 2002, INFECT IMMUN, V70, P3707, DOI 10.1128/IAI.70.7.3707-3713.2002; Brady AM, 2014, J INFECT DIS, V210, P1155, DOI 10.1093/infdis/jiu195; Calix JJ, 2014, J CLIN MICROBIOL, V52, P758, DOI 10.1128/JCM.02695-13; Calix JJ, 2012, J BIOL CHEM, V287, P27885, DOI 10.1074/jbc.M112.380451; Calix JJ, 2012, CLIN INFECT DIS, V54, P794, DOI 10.1093/cid/cir953; Calix JJ, 2011, J BACTERIOL, V193, P5271, DOI 10.1128/JB.05034-11; Calix JJ, 2010, J INFECT DIS, V202, P29, DOI 10.1086/653123; Camilli R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076309; Camilli R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-25; Hiller NL, 2007, J BACTERIOL, V189, P8186, DOI 10.1128/JB.00690-07; Hyams C, 2010, INFECT IMMUN, V78, P704, DOI 10.1128/IAI.00881-09; LUND E, 1960, Bull World Health Organ, V23, P5; Mavroidi A, 2007, J BACTERIOL, V189, P7841, DOI 10.1128/JB.00836-07; Melchiorre S, 2012, MICROBIOL-SGM, V158, P338, DOI 10.1099/mic.0.054270-0; Oliver MB, 2013, J BIOL CHEM, V288, P25976, DOI 10.1074/jbc.M113.480152; Oliver MB, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.488528; Park IH, 2007, J CLIN MICROBIOL, V45, P1225, DOI 10.1128/JCM.02199-06; Richter SS, 2009, CLIN INFECT DIS, V48, pE23, DOI 10.1086/595857; Tocheva AS, 2010, EMERG INFECT DIS, V16, P154, DOI 10.3201/eid1601.090650; VANN WF, 1983, INFECT IMMUN, V39, P623, DOI 10.1128/IAI.39.2.623-629.1983; Wroe PC, 2012, PEDIATR INFECT DIS J, V31, P249, DOI 10.1097/INF.0b013e31824214ac; Yu J, 2008, J MED MICROBIOL, V57, P171, DOI 10.1099/jmm.0.47549-0; Zartler ER, 2009, J BIOL CHEM, V284, P7318, DOI 10.1074/jbc.M807952200	25	8	9	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100722	10.1371/journal.pone.0100722	http://dx.doi.org/10.1371/journal.pone.0100722			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967818	Green Published, Green Submitted, gold			2022-12-27	WOS:000338280800057
J	Zhang, JB; Zhuang, PW; Wang, Y; Song, LL; Zhang, MX; Lu, ZQ; Zhang, L; Wang, J; Alemu, PN; Zhang, YJ; Wei, HJ; Li, HY				Zhang, Jinbao; Zhuang, Pengwei; Wang, Yan; Song, Lili; Zhang, Mixia; Lu, Zhiqiang; Zhang, Lu; Wang, Jing; Alemu, Paulos N.; Zhang, Yanjun; Wei, Hongjun; Li, Hongyan			Reversal of Muscle Atrophy by Zhimu-Huangbai Herb-Pair via Akt/mTOR/FoxO3 Signal Pathway in Streptozotocin-Induced Diabetic Mice	PLOS ONE			English	Article							FOXO TRANSCRIPTION FACTORS; SKELETAL-MUSCLE; INSULIN-RESISTANCE; PROTEIN-DEGRADATION; UBIQUITIN LIGASES; KINASE-B; HYPERTROPHY; ACTIVATION; EXPRESSION; ABLATION	Skeletal muscle atrophy is one of the serious complications of diabetes. Zhimu-Huangbai herb-pair (ZB) is widely used in Chinese traditional medicine formulas for treating Xiaoke (known as diabetes) and its complications. However, the effect of ZB on reversal of muscle atrophy and the underlying mechanisms remain unknown. In this research, we investigated the effect and possible mechanisms of ZB on skeletal muscle atrophy in diabetic mice. Animal model of diabetic muscle atrophy was developed by high fat diet (HFD) feeding plus streptozotocin (STZ) injection. After oral adminstration of ZB for 6 weeks, the effects of ZB on reversal of muscle atrophy and the underlying mechanisms were evaluated by biochemical, histological and western blot methods. The skeletal muscle weight, strength, and cross-sectional area of diabetic mice were significantly increased by ZB treatment. Biochemical results showed that ZB treatment reduced the serum glucose level, and elevated the serum insulin-like growth factor 1 (IGF-1) and insulin levels significantly compared with untreated diabetic group. The western blot results showed that ZB activated the mTOR signal pathway, shown as increased phosphorylations (p-) of Akt, mTOR, Raptor, S6K1 and reduced Foxo3 expression compared with the model group. ZB could reverse muscle atrophy in diabetic mice. This may be through activation of mTOR signaling pathway that promotes protein synthesis, and inactivation foxo3 protein that inhibits protein degradation. These findings suggested that ZB may be considered as a potential candidate drug in treatment of diabetic muscle atrophy.	[Zhang, Jinbao; Zhuang, Pengwei; Wang, Yan; Song, Lili; Zhang, Mixia; Lu, Zhiqiang; Zhang, Lu; Wang, Jing; Alemu, Paulos N.; Zhang, Yanjun] Tianjin Univ Tradit Chinese Med, Chinese Mat Med Coll, Tianjin, Peoples R China; [Zhuang, Pengwei; Wang, Yan; Song, Lili; Zhang, Mixia; Zhang, Yanjun] Tianjin Univ Tradit Chinese Med, Tianjin State Key Lab Modern Chinese Med, Tianjin, Peoples R China; [Zhuang, Pengwei; Wei, Hongjun; Li, Hongyan] Tianjin JF Pharmaland Technol Dev Co Ltd, Tianjin, Peoples R China	Tianjin University of Traditional Chinese Medicine; Tianjin University of Traditional Chinese Medicine	Zhang, YJ (corresponding author), Tianjin Univ Tradit Chinese Med, Chinese Mat Med Coll, Tianjin, Peoples R China.	zyjsunye@163.com	Zhang, Lu/GLU-9890-2022		National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program'' [2012ZX09101202]	National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program''	This work was supported by the National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program'' (2012ZX09101202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegoke OAJ, 2012, APPL PHYSIOL NUTR ME, V37, P395, DOI [10.1139/h2012-009, 10.1139/H2012-009]; Bassil MS, 2013, CURR OPIN CLIN NUTR, V16, P83, DOI 10.1097/MCO.0b013e32835a88ee; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Bhutada P, 2011, BEHAV BRAIN RES, V220, P30, DOI 10.1016/j.bbr.2011.01.022; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Chambon C, 2010, P NATL ACAD SCI USA, V107, P14327, DOI 10.1073/pnas.1009536107; Clavel S, 2010, MOL CELL BIOL, V30, P470, DOI 10.1128/MCB.00666-09; Deblon N, 2012, BRIT J PHARMACOL, V165, P2325, DOI 10.1111/j.1476-5381.2011.01716.x; Dogra C, 2007, FASEB J, V21, P1857, DOI 10.1096/fj.06-7537com; Drummond MJ, 2009, J APPL PHYSIOL, V106, P1374, DOI 10.1152/japplphysiol.91397.2008; Glass DJ, 2003, NAT CELL BIOL, V5, P87, DOI 10.1038/ncb0203-87; Glass DJ, 2005, INT J BIOCHEM CELL B, V37, P1974, DOI 10.1016/j.biocel.2005.04.018; Goodman CA, 2010, MOL BIOL CELL, V21, P3258, DOI 10.1091/mbc.E10-05-0454; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; He K, 2011, J ETHNOPHARMACOL, V137, P1135, DOI 10.1016/j.jep.2011.07.033; Hill AJ, 2012, BRIT J PHARMACOL, V167, P1629, DOI 10.1111/j.1476-5381.2012.02207.x; Hulmi JJ, 2012, AM J PHYSIOL-ENDOC M, V302, pE307, DOI 10.1152/ajpendo.00398.2011; Ito N, 2013, NAT MED, V19, P101, DOI 10.1038/nm.3019; Jia W, 2003, PHYTOTHER RES, V17, P1127, DOI 10.1002/ptr.1398; Kusakabe T, 2009, DIABETOLOGIA, V52, P675, DOI 10.1007/s00125-009-1258-2; Lambertucci AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050390; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Latres E, 2005, J BIOL CHEM, V280, P2737, DOI 10.1074/jbc.M407517200; Liu YW, 2012, J ETHNOPHARMACOL, V139, P194, DOI 10.1016/j.jep.2011.11.004; Ma CH, 2008, BIOMED CHROMATOGR, V22, P835, DOI 10.1002/bmc.1000; Mammucari C, 2008, AUTOPHAGY, V4, P524, DOI 10.4161/auto.5905; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Miyazaki M, 2009, J APPL PHYSIOL, V106, P1367, DOI 10.1152/japplphysiol.91355.2008; Mu J, 2006, DIABETES, V55, P1695, DOI 10.2337/db05-1602; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; Newsholme P, 2011, FRONT BIOSCI-LANDMRK, V16, P315, DOI 10.2741/3690; Ohanna M, 2005, NAT CELL BIOL, V7, P286, DOI 10.1038/ncb1231; Pandey SN, 2012, BIOL OPEN, V1, P629, DOI 10.1242/bio.20121305; Paul PK, 2010, J CELL BIOL, V191, P1395, DOI 10.1083/jcb.201006098; Pereira S, 2008, DIABETES, V57, P56, DOI 10.2337/db07-0887; Ravenscroft G, 2011, BRAIN, V134, P1101, DOI 10.1093/brain/awr004; Risson V, 2009, J CELL BIOL, V187, P859, DOI 10.1083/jcb.200903131; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Schiaffino S, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-4; Sishi B, 2011, EXP PHYSIOL, V96, P179, DOI 10.1113/expphysiol.2010.054189; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Sugita H, 2005, AM J PHYSIOL-ENDOC M, V288, pE585, DOI 10.1152/ajpendo.00321.2004; Tang YH, 2012, PLANTA MED, V78, P18, DOI 10.1055/s-0031-1280268; Tong XL, 2012, AM J CHINESE MED, V40, P877, DOI 10.1142/S0192415X12500656; Wang XN, 2006, ENDOCRINOLOGY, V147, P4160, DOI 10.1210/en.2006-0251; Workeneh B, 2013, INT J BIOCHEM CELL B, V45, P2239, DOI 10.1016/j.biocel.2013.06.028; Wu MZ, 2011, J CELL PHYSIOL, V226, P29, DOI 10.1002/jcp.22353; Wu Y, 2012, BRIT J PHARMACOL, V165, P1319, DOI 10.1111/j.1476-5381.2011.01572.x; Xie WD, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/726723; Zhang X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042529; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004; Zheng B, 2010, FASEB J, V24, P2660, DOI 10.1096/fj.09-151480; Zhuang PW, 2013, CNS NEUROSCI THER, V19, P154, DOI 10.1111/cns.12050; Zhuang PW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035636	58	27	31	4	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100918	10.1371/journal.pone.0100918	http://dx.doi.org/10.1371/journal.pone.0100918			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968071	Green Published, gold, Green Submitted			2022-12-27	WOS:000338280800080
J	Chen, T; Lu, YH; Wang, WJ; Bian, CY; Cheng, XY; Su, Y; Zhou, PM				Chen, Tao; Lu, Yong-hong; Wang, Wen-ju; Bian, Cai-yun; Cheng, Xiao-yun; Su, Yu; Zhou, Pei-mei			Elevated Urinary Levels of Cystatin C and Neutrophil Gelatinase-Associated Lipocalin in Henoch-Schonlein Purpura Patients with Renal Involvement	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; BIOMARKERS; DURATION; CHILDREN	Henoch-Schonlein purpura (HSP) is a commonest systemic vasculitis in childhood. The long-term prognosis of HSP is determined by the degree of renal involvement. The aim of this study is to search novel clinically applicable biomarkers to evaluate renal involvement in HSP patients. 20 bio-indexes in urine samples were simultaneously screened by antibody array assay. We indicated that urinary levels of cystatin C (Cys C) and neutrophil gelatinase-associated lipocalin (NGAL) in HSP patients with renal involvement were significantly higher than those without renal involvement and healthy controls. Furthermore, ELISA was used to analyze urinary Cys C and NGAL levels in HSP patients with or without renal involvement, atopic dermatitis (AD) patients and healthy controls. Our results demonstrated that urinary Cys C and NGAL levels in HSP patients with renal involvement were significantly elevated, when compared with those without renal involvement, AD patients and control subjects. In addition, by receiver operating characteristic (ROC) curve analysis, we demonstrated that the area under the ROC curve of NGAL (0.789) was larger than that of Cys C (0.692). Taken together, we show firstly that urinary Cys C and NGAL levels is abnormally elevated in HSP patients with renal involvement. We suggest that urinary Cys C and NGAL are novel useful biomarkers of renal involvement in HSP patients.	[Chen, Tao; Lu, Yong-hong; Wang, Wen-ju; Bian, Cai-yun; Zhou, Pei-mei] Chengdu Second Peoples Hosp, Dept Dermatovenereol, Chengdu, Peoples R China; [Cheng, Xiao-yun; Su, Yu] Chengdu Second Peoples Hosp, Dept Nephrol, Chengdu, Peoples R China; [Cheng, Xiao-yun] Chengdu Second Peoples Hosp, Dept Rheumatol, Chengdu, Peoples R China		Lu, YH (corresponding author), Chengdu Second Peoples Hosp, Dept Dermatovenereol, Chengdu, Peoples R China.	1255395583@qq.com	Cheng, Xiaoyun/HDM-5535-2022		Natural Science Foundation of China [81101198]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Natural Science Foundation of China (NO. 81101198) to TC. URL: http://www.nsfc.gov.cn/Portal0/default152.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Endre ZH, 2011, KIDNEY INT, V79, P1119, DOI 10.1038/ki.2010.555; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Mishra Jaya, 2005, Lancet, V365, P1231, DOI 10.1016/S0140-6736(05)74811-X; Narchi H, 2005, ARCH DIS CHILD, V90, P916, DOI 10.1136/adc.2005.074641; Ozen S, 2010, ANN RHEUM DIS, V69, P798, DOI 10.1136/ard.2009.116657; Roos JF, 2007, CLIN BIOCHEM, V40, P383, DOI 10.1016/j.clinbiochem.2006.10.026; Scharer K, 1999, PEDIATR NEPHROL, V13, P816, DOI 10.1007/s004670050707; Vaidya VS, 2008, ANNU REV PHARMACOL, V48, P463, DOI 10.1146/annurev.pharmtox.48.113006.094615; XU SY, 1995, SCAND J CLIN LAB INV, V55, P125, DOI 10.3109/00365519509089604; Yin XL, 2013, J NEPHROL, V26, P699, DOI 10.5301/jn.5000267	10	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e101026	10.1371/journal.pone.0101026	http://dx.doi.org/10.1371/journal.pone.0101026			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963810	Green Submitted, gold, Green Published			2022-12-27	WOS:000338709500111
J	Drummond, C; Deluca, P; Coulton, S; Bland, M; Cassidy, P; Crawford, M; Dale, V; Gilvarry, E; Godfrey, C; Heather, N; McGovern, R; Myles, J; Newbury-Birch, D; Oyefeso, A; Parrott, S; Patton, R; Perryman, K; Phillips, T; Shepherd, J; Touquet, R; Kaner, E				Drummond, Colin; Deluca, Paolo; Coulton, Simon; Bland, Martin; Cassidy, Paul; Crawford, Mike; Dale, Veronica; Gilvarry, Eilish; Godfrey, Christine; Heather, Nick; McGovern, Ruth; Myles, Judy; Newbury-Birch, Dorothy; Oyefeso, Adenekan; Parrott, Steve; Patton, Robert; Perryman, Katherine; Phillips, Tom; Shepherd, Jonathan; Touquet, Robin; Kaner, Eileen			The Effectiveness of Alcohol Screening and Brief Intervention in Emergency Departments: A Multicentre Pragmatic Cluster Randomized Controlled Trial	PLOS ONE			English	Article							MISUSING PATIENTS; CARE; DRINKING; ACCIDENT	Background: Alcohol misuse is common in people attending emergency departments (EDs) and there is some evidence of efficacy of alcohol screening and brief interventions (SBI). This study investigated the effectiveness of SBI approaches of different intensities delivered by ED staff in nine typical EDs in England: the SIPS ED trial. Methods and Findings: Pragmatic multicentre cluster randomized controlled trial of SBI for hazardous and harmful drinkers presenting to ED. Nine EDs were randomized to three conditions: a patient information leaflet (PIL), 5 minutes of brief advice (BA), and referral to an alcohol health worker who provided 20 minutes of brief lifestyle counseling (BLC). The primary outcome measure was the Alcohol Use Disorders Identification Test ( AUDIT) status at 6 months. Of 5899 patients aged 18 or more presenting to EDs, 3737 (63.3%) were eligible to participate and 1497 (40.1%) screened positive for hazardous or harmful drinking, of whom 1204 (80.4%) gave consent to participate in the trial. Follow up rates were 72% (n = 863) at six, and 67% (n = 810) at 12 months. There was no evidence of any differences between intervention conditions for AUDIT status or any other outcome measures at months 6 or 12 in an intention to treat analysis. At month 6, compared to the PIL group, the odds ratio of being AUDIT negative for brief advice was 1.103 (95% CI 0.328 to 3.715). The odds ratio comparing BLC to PIL was 1.247 (95% CI 0.315 to 4.939). A per protocol analysis confirmed these findings. Conclusions: SBI is difficult to implement in typical EDs. The results do not support widespread implementation of alcohol SBI in ED beyond screening followed by simple clinical feedback and alcohol information, which is likely to be easier and less expensive to implement than more complex interventions.	[Drummond, Colin; Deluca, Paolo; Myles, Judy; Patton, Robert; Perryman, Katherine; Phillips, Tom] Kings Coll London, Inst Psychiat, Addict Dept, London WC2R 2LS, England; [Coulton, Simon] Univ Kent, Ctr Hlth Serv Studies, Canterbury, Kent, England; [Bland, Martin; Dale, Veronica; Godfrey, Christine; Parrott, Steve] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; [Crawford, Mike] Univ London Imperial Coll Sci Technol & Med, Dept Psychol Med, London, England; [Gilvarry, Eilish; McGovern, Ruth; Newbury-Birch, Dorothy; Kaner, Eileen] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Gilvarry, Eilish] Northern Reg Drug & Alcohol Serv, Newcastle Upon Tyne, Tyne & Wear, England; [Heather, Nick] Northumbria Univ, Fac Hlth & Life Sci, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England; [Oyefeso, Adenekan] Univ London, Div Populat Hlth Sci & Educ, London, England; [Oyefeso, Adenekan] Jeesal Cawston Pk Hosp, Norwich, Norfolk, England; [Phillips, Tom] Humber NHS Fdn Trust, Willerby, England; [Shepherd, Jonathan] Cardiff Univ, Violence Res Grp, Cardiff CF10 3AX, S Glam, Wales; [Touquet, Robin] Kingston Hosp, Emergency Dept, London, England	University of London; King's College London; University of Kent; University of York - UK; Imperial College London; Newcastle University - UK; Northumbria University; University of London; Cardiff University	Deluca, P (corresponding author), Kings Coll London, Inst Psychiat, Addict Dept, London WC2R 2LS, England.	Paolo.Deluca@kcl.ac.uk	Kaner, Eileen/ABF-2444-2020; Deluca, Paolo/X-2580-2019; Patton, Robert/E-8354-2012; Drummond, Colin/O-9141-2019	Patton, Robert/0000-0002-0468-3406; Drummond, Colin/0000-0001-9379-5452; Deluca, Paolo/0000-0002-9511-7230; Kaner, Eileen/0000-0002-7169-9344; Parrott, Steven James/0000-0002-0165-1150; Shepherd, Jonathan/0000-0001-6466-2298; Phillips, Tom/0000-0001-8020-4510; Coulton, Simon/0000-0002-7704-3274; Newbury-Birch, Dorothy/0000-0003-0065-8649; Crawford, Mike/0000-0003-3137-5772; Perryman, Katherine/0000-0003-1275-6991; McGovern, Ruth/0000-0002-4119-4353	UK Department of Health; Medical Research Council [G0701681, MR/K023195/1, MR/K02325X/1, MR/K023195/1B, G0701818] Funding Source: researchfish; National Institute for Health Research [13/86/03, RP-PG-0609-10162] Funding Source: researchfish; MRC [G0701818, G0701681] Funding Source: UKRI	UK Department of Health; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded by the UK Department of Health. The Department of Health, proposed the general study design, but the details of the methodology were determined by the study team. The sponsor had no role in data collection, data analysis, interpretation of the results or writing the report. The corresponding author had full access to the data and had final responsibility for the decision to submit for publication. The views expressed herein do not necessarily reflect those of the Department of Health or the National Health Service in England and Wales.	Bazargan-Hejazi S, 2005, ANN EMERG MED, V46, P67, DOI 10.1016/j.annemergmed.2004.10.014; Bernstein JA, 2010, DRUG ALCOHOL REV, V29, P498, DOI 10.1111/j.1465-3362.2010.00174.x; Blow FC, 2009, ALCOHOL ALCOHOLISM, V44, P486, DOI 10.1093/alcalc/agp031; Cherpitel CJ, 2010, ALCOHOL CLIN EXP RES, V34, P1922, DOI 10.1111/j.1530-0277.2010.01281.x; Coulton S, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-114; Crawford M, 2004, LANCET, V364, P1334, DOI 10.1016/S0140-6736(04)17190-0; Cunningham RM, 2010, ANN EMERG MED, V55, P556, DOI 10.1016/j.annemergmed.2010.03.004; Cunningham RM, 2009, ACAD EMERG MED, V16, P1078, DOI 10.1111/j.1553-2712.2009.00552.x; D'Onofrio G, 2002, ACAD EMERG MED, V9, P627, DOI 10.1197/aemj.9.6.627; D'Onofrio G, 2008, ANN EMERG MED, V51, P742, DOI 10.1016/j.annemergmed.2007.11.028; D'Onofrio G, 2012, ANN EMERG MED, V60, P181, DOI 10.1016/j.annemergmed.2012.02.006; Daeppen JB, 2007, ADDICTION, V102, P1224, DOI 10.1111/j.1360-0443.2007.01869.x; Dent AW, 2008, EMERG MED AUSTRALAS, V20, P121, DOI 10.1111/j.1742-6723.2008.01067.x; Drummond C, 2005, ALCOHOL CLIN EXP R S, V29, p36A; Drummond DC, 1997, ADDICTION, V92, P375; Field CA, 2010, ALCOHOL CLIN EXP RES, V34, P2004, DOI 10.1111/j.1530-0277.2010.01297.x; French MT, 2008, SUBST USE MISUSE, V43, P2074, DOI 10.1080/10826080802344849; Kaner E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e8501; Kaner EFS, 2009, DRUG ALCOHOL REV, V28, P301, DOI 10.1111/j.1465-3362.2009.00071.x; Moyer A, 2002, ADDICTION, V97, P279, DOI 10.1046/j.1360-0443.2002.00018.x; Newbury-Birch D, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-418; Patton R, 2013, EMERG MED J, V30, P492, DOI 10.1136/emermed-2012-201527; Peters J, 1998, ADDICTION, V93, P589, DOI 10.1046/j.1360-0443.1998.93458914.x; Prime Minister's Strategy Unit, 2004, ALC HARM RED STRAT; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Rollnick S., 1999, HLTH BEHAV CHANGE GU, V1st; Trinks A, 2013, INT EMERG NURS, V21, P3, DOI 10.1016/j.ienj.2011.11.004; Waller S, 1998, ALCOHOL ALCOHOLISM, V33, P354; Walton MA, 2008, J STUD ALCOHOL DRUGS, V69, P550, DOI 10.15288/jsad.2008.69.550; Williams S, 2005, DRUG ALCOHOL DEPEN, V77, P205, DOI 10.1016/j.drugalcdep.2004.07.011; Wittes J, 2002, EPIDEMIOL REV, V24, P39, DOI 10.1093/epirev/24.1.39	31	68	69	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e99463	10.1371/journal.pone.0099463	http://dx.doi.org/10.1371/journal.pone.0099463			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK8WO	24963731	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000338709500011
J	Zhang, HF; An, D; Liu, W; Mao, QY; Jin, J; Xu, L; Sun, SY; Jiang, LP; Li, XJ; Shao, J; Ma, HX; Huang, XY; Guo, SJ; Chen, HY; Cheng, T; Yang, LS; Su, WH; Kong, W; Liang, ZL; Jiang, CL				Zhang, Huafei; An, Dong; Liu, Wei; Mao, Qunying; Jin, Jun; Xu, Lin; Sun, Shiyang; Jiang, Liping; Li, Xiaojun; Shao, Jie; Ma, Hongxia; Huang, Xueyong; Guo, Shijie; Chen, Haiying; Cheng, Tong; Yang, Lisheng; Su, Weiheng; Kong, Wei; Liang, Zhenglun; Jiang, Chunlai			Analysis of Cross-Reactive Neutralizing Antibodies in Human HFMD Serum with an EV71 Pseudovirus-Based Assay	PLOS ONE			English	Article							HUMAN ENTEROVIRUS 71; ASIA-PACIFIC REGION; COXSACKIEVIRUS A16; MOUTH-DISEASE; MOLECULAR EPIDEMIOLOGY; GENETIC-CHARACTERISTICS; DOUBLE-BLIND; VACCINE; STRAINS; HAND	Hand, foot and mouth disease, associated with enterovirus 71 (EV71) infections, has recently become an important public health issue throughout the world. Serum neutralizing antibodies are major indicators of EV71 infection and protective immunity. However, the potential for cross-reactivity of neutralizing antibodies for different EV71 genotypes and subgenotypes is unclear. Here we measured the cross-reactive neutralizing antibody titers against EV71 of different genotypes or subgenotypes in sera collected from EV71-infected children and vaccine-inoculated children in a phase III clinical trial (ClinicalTrials.gov Identifier: NCT01636245) using a new pseudovirus-based neutralization assay. Antibodies induced by EV71-C4a were cross-reactive for different EV71 genotypes, demonstrating that C4a is a good candidate strain for an EV71 vaccine. Our study also demonstrated that this new assay is practical for analyses of clinical samples from epidemiological and vaccine studies.	[Zhang, Huafei; An, Dong; Liu, Wei; Jin, Jun; Xu, Lin; Sun, Shiyang; Jiang, Liping; Li, Xiaojun; Su, Weiheng; Kong, Wei; Jiang, Chunlai] Jilin Univ, Sch Life Sci, Changchun 130023, Peoples R China; [Zhang, Huafei; An, Dong; Liu, Wei; Jin, Jun; Xu, Lin; Sun, Shiyang; Jiang, Liping; Li, Xiaojun; Su, Weiheng; Kong, Wei; Jiang, Chunlai] Jilin Univ, Natl Engn Lab AIDS Vaccine, Changchun 130023, Peoples R China; [Mao, Qunying; Shao, Jie; Liang, Zhenglun] Natl Inst Food & Drug Control, Beijing, Peoples R China; [Ma, Hongxia; Huang, Xueyong] Henan Prov Ctr Dis Control & Prevent, Zhengzhou, Peoples R China; [Guo, Shijie; Chen, Haiying] Jilin Univ, Dept Pediat, Hosp 1, Changchun 130023, Peoples R China; [Cheng, Tong; Yang, Lisheng] Xiamen Univ, Natl Inst Diagnost & Vaccine Dev Infect Dis, Sch Life Sci, Xiamen, Peoples R China; [Su, Weiheng; Kong, Wei; Jiang, Chunlai] Jilin Univ, Minist Educ, Key Lab Mol Enzymol & Engn, Changchun 130023, Peoples R China	Jilin University; Jilin University; National Institute of Food & Drug Control - China; Jilin University; Xiamen University; Jilin University	Liang, ZL (corresponding author), Natl Inst Food & Drug Control, Beijing, Peoples R China.	lzhenglun@126.com; jiangcl@jlu.edu.cn	An, Dong/ABB-6635-2021	An, Dong/0000-0002-7770-2284; Cheng, Tong/0000-0002-1638-6214	Ministry of Science and Technology of the People's Republic of China [2012ZX10001009]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China)	The current study was sponsored by the National 12th Five Major Special Projects Funding Program (No. 2012ZX10001009) from the Ministry of Science and Technology of the People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arita M, 2007, J VIROL, V81, P9386, DOI 10.1128/JVI.02856-06; Brown BA, 1999, J VIROL, V73, P9969, DOI 10.1128/JVI.73.12.9969-9975.1999; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Cardosa MJ, 2003, EMERG INFECT DIS, V9, P461; Chen YX, 2013, VACCINE, V31, P425, DOI 10.1016/j.vaccine.2012.10.032; Chou AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079783; CHUMAKOV M, 1979, ARCH VIROL, V60, P329, DOI 10.1007/BF01317504; DiazGranados CA, 2012, VACCINE, V31, P49, DOI 10.1016/j.vaccine.2012.10.084; Hancil J, 1985, Cesk Pediatr, V40, P731; Hu YM, 2013, CLIN VACCINE IMMUNOL, V20, P1805, DOI 10.1128/CVI.00491-13; Huang ML, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002067; Huang YP, 2008, VIRUS RES, V137, P206, DOI 10.1016/j.virusres.2008.07.015; Huang YP, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-277; Iwai M, 2009, JPN J INFECT DIS, V62, P254; Jin J, 2013, J VIROL METHODS, V187, P362, DOI 10.1016/j.jviromet.2012.11.014; Jun Jin LX, 2012, CHEM RES CHINESE U, V28, P91; Korber B, 2001, BRIT MED BULL, V58, P19, DOI 10.1093/bmb/58.1.19; Li LL, 2005, J CLIN MICROBIOL, V43, P3835, DOI 10.1128/JCM.43.8.3835-3839.2005; Li XJ, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-250; Li YP, 2012, VACCINE, V30, P3295, DOI 10.1016/j.vaccine.2012.03.010; Mao QY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079599; Mao QY, 2012, J VIROL, V86, P11967, DOI 10.1128/JVI.00902-12; Mao QY, 2012, ARCH VIROL, V157, P37, DOI 10.1007/s00705-011-1136-3; McCutchan FE, 2000, AIDS RES HUM RETROV, V16, P801, DOI 10.1089/088922200308792; McMinn P, 2001, J VIROL, V75, P7732, DOI 10.1128/JVI.75.16.7732-7738.2001; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; MIWA C, 1980, JPN J MED SCI BIOL, V33, P167, DOI 10.7883/yoken1952.33.167; Mizuta K, 2009, VACCINE, V27, P3153, DOI 10.1016/j.vaccine.2009.03.060; Nie JH, 2012, J VIROL METHODS, V185, P267, DOI 10.1016/j.jviromet.2012.07.011; Sanders SA, 2006, ARCH VIROL, V151, P1003, DOI 10.1007/s00705-005-0684-9; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tan XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025662; Teng Zheng, 2010, Chinese Journal of Virology, V26, P437; Van Tu P, 2007, EMERG INFECT DIS, V13, P1733, DOI 10.3201/eid1311.070632; Vicat JM, 1998, NAT BIOTECHNOL, V16, P702, DOI 10.1038/nbt0898-702b; Wang XG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0051667, 10.1371/journal.pone.0029469, 10.1371/journal.pone.0047703, 10.1371/journal.pone.0036274, 10.1371/journal.pone.0048069, 10.1371/journal.pone.0032405]; Wu JS, 2013, J VIROL METHODS, V193, P713, DOI 10.1016/j.jviromet.2013.07.051; Wu X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064116; Yi LN, 2011, CRIT REV MICROBIOL, V37, P313, DOI 10.3109/1040841X.2011.580723; Yu HY, 2010, VIRUS GENES, V41, P1, DOI 10.1007/s11262-010-0472-9; Zhang Y, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059086, 10.1371/journal.pone.0056341]; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027895; Zhang Y, 2010, J CLIN MICROBIOL, V48, P619, DOI 10.1128/JCM.02338-09; Zhao K, 2011, EMERG INFECT DIS, V17, P1537, DOI 10.3201/eid1708.101719; Zhu FC, 2013, LANCET, V381, P2024, DOI 10.1016/S0140-6736(13)61049-1; Zhu Z, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-300	49	24	35	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100545	10.1371/journal.pone.0100545	http://dx.doi.org/10.1371/journal.pone.0100545			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964084	Green Published, gold, Green Submitted			2022-12-27	WOS:000338709500060
J	Tala, A; Delle Side, D; Buccolieri, G; Tredici, SM; Velardi, L; Paladini, F; De Stefano, M; Nassisi, V; Alifano, P				Tala, Adelfia; Delle Side, Domenico; Buccolieri, Giovanni; Tredici, Salvatore Maurizio; Velardi, Luciano; Paladini, Fabio; De Stefano, Mario; Nassisi, Vincenzo; Alifano, Pietro			Exposure to Static Magnetic Field Stimulates Quorum Sensing Circuit in Luminescent Vibrio Strains of the Harveyi Clade	PLOS ONE			English	Article							S-RIBOSYLHOMOCYSTEINASE LUXS; GENE-EXPRESSION; III SECRETION; LUMINOUS BACTERIA; SENSOR KINASE; REAL-TIME; BIOLUMINESCENCE; VIRULENCE; SYSTEMS; SIGNAL	In this study, the evidence of electron-dense magnetic inclusions with polyhedral shape in the cytoplasm of Harveyi clade Vibrio strain PS1, a bioluminescent bacterium living in symbiosis with marine organisms, led us to investigate the behavior of this bacterium under exposure to static magnetic fields ranging between 20 and 2000 Gauss. When compared to sham-exposed, the light emission of magnetic field-exposed bacteria growing on solid medium at 18 degrees C +/- 0.1 degrees C was increased up to two-fold as a function of dose and growth phase. Stimulation of bioluminescence by magnetic field was more pronounced during the post-exponential growth and stationary phase, and was lost when bacteria were grown in the presence of the iron chelator deferoxamine, which caused disassembly of the magnetic inclusions suggesting their involvement in magnetic response. As in luminescent Vibrio spp. bioluminescence is regulated by quorum sensing, possible effects of magnetic field exposure on quorum sensing were investigated. Measurement of mRNA levels by reverse transcriptase real time-PCR demonstrated that luxR regulatory gene and luxCDABE operon coding for luciferase and fatty acid reductase complex were significantly up-regulated in magnetic field-exposed bacteria. In contrast, genes coding for a type III secretion system, whose expression was negatively affected by LuxR, were down-regulated. Up-regulation of luxR paralleled with down-regulation of small RNAs that mediate destabilization of luxR mRNA in quorum sensing signaling pathways. The results of experiments with the well-studied Vibrio campbellii strain BB120 (originally classified as Vibrio harveyi) and derivative mutants unable to synthesize autoinducers suggest that the effects of magnetic fields on quorum sensing may be mediated by AI-2, the interspecies quorum sensing signal molecule.	[Tala, Adelfia; Tredici, Salvatore Maurizio; Alifano, Pietro] Univ Salento, Dipartimento Sci & Tecnol Biol & Ambientali, Lecce, Italy; [Delle Side, Domenico; Buccolieri, Giovanni; Velardi, Luciano; Paladini, Fabio; Nassisi, Vincenzo] Univ Salento INFN Lecce, Dipartimento Matemat & Fis Ennio De Giorgi, Lecce, Italy; [De Stefano, Mario] Univ Naples 2, Dipartimento Sci Ambientali, Caserta, Italy	University of Salento; University of Salento; Universita della Campania Vanvitelli	Alifano, P (corresponding author), Univ Salento, Dipartimento Sci & Tecnol Biol & Ambientali, Lecce, Italy.	pietro.alifano@unisalento.it	Velardi, Luciano/D-4699-2016; Delle Side, Domenico/E-9245-2014	Velardi, Luciano/0000-0003-4518-9217; Delle Side, Domenico/0000-0003-3417-8803; BUCCOLIERI, Giovanni/0000-0001-8672-9238; Alifano, Pietro/0000-0003-3768-7275	Italian Ministero dell'Istruzione, dell' Universita e della Ricerca (MIUR)	Italian Ministero dell'Istruzione, dell' Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR))	This study was supported by grants from Italian Ministero dell'Istruzione, dell' Universita e della Ricerca (MIUR) to Vincenzo Nassisi and Pietro Alifano (PRIN projects). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin B, 2006, LETT APPL MICROBIOL, V43, P119, DOI 10.1111/j.1472-765X.2006.01989.x; Barros MP, 1998, FREE RADICAL BIO MED, V24, P767, DOI 10.1016/S0891-5849(97)00335-3; BASSLER BL, 1993, MOL MICROBIOL, V9, P773, DOI 10.1111/j.1365-2958.1993.tb01737.x; BASSLER BL, 1994, MOL MICROBIOL, V13, P273, DOI 10.1111/j.1365-2958.1994.tb00422.x; Bassler BL, 1997, J BACTERIOL, V179, P4043, DOI 10.1128/jb.179.12.4043-4045.1997; Bazylinski DA, 1996, CHEM GEOL, V132, P191, DOI 10.1016/S0009-2541(96)00055-1; Bazylinski DA, 2000, CHEM GEOL, V169, P319, DOI 10.1016/S0009-2541(00)00211-4; Carrano CJ, 2009, MAR BIOTECHNOL, V11, P431, DOI 10.1007/s10126-009-9191-4; Chen X, 2002, NATURE, V415, P545, DOI 10.1038/415545a; Coburn B, 2007, CLIN MICROBIOL REV, V20, P535, DOI 10.1128/CMR.00013-07; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; DEARAUJO FFT, 1986, BIOPHYS J, V50, P375, DOI 10.1016/S0006-3495(86)83471-3; DEBARROS HGPL, 1990, SCI PROG, V74, P347; Defoirdt T, 2008, ISME J, V2, P19, DOI 10.1038/ismej.2007.92; Defoirdt T, 2012, ISME J, V6, P2314, DOI 10.1038/ismej.2012.58; Freeman JA, 1999, MOL MICROBIOL, V31, P665, DOI 10.1046/j.1365-2958.1999.01208.x; Freeman JA, 2000, MOL MICROBIOL, V35, P139, DOI 10.1046/j.1365-2958.2000.01684.x; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; Gao WM, 2005, BIOELECTROMAGNETICS, V26, P558, DOI 10.1002/bem.20133; Glasauer S, 2002, SCIENCE, V295, P117, DOI 10.1126/science.1066577; Gopishetty B, 2009, J AM CHEM SOC, V131, P1243, DOI 10.1021/ja808206w; Gravili C, 2012, J MAR BIOL ASSOC UK, V92, P1317, DOI 10.1017/S0025315411001408; GRISSOM CB, 1995, CHEM REV, V95, P3, DOI 10.1021/cr00033a001; Haddock SHD, 2010, ANNU REV MAR SCI, V2, P443, DOI 10.1146/annurev-marine-120308-081028; Hellinger J, 2012, J COMP PHYSIOL A, V198, P593, DOI 10.1007/s00359-012-0732-3; Henke JM, 2004, J BACTERIOL, V186, P6902, DOI 10.1128/JB.186.20.6902-6914.2004; Henke JM, 2004, J BACTERIOL, V186, P3794, DOI 10.1128/JB.186.12.3794-3805.2004; Higgins DA, 2007, NATURE, V450, P883, DOI 10.1038/nature06284; HONG FT, 1995, BIOSYSTEMS, V36, P187, DOI 10.1016/0303-2647(95)01555-Y; Iwasaka M, 1998, J APPL PHYS, V83, P6456, DOI 10.1063/1.367736; Ji WJ, 2009, MICRON, V40, P894, DOI 10.1016/j.micron.2009.05.010; Kalirai SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053368; Klumpp S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033562; Kohno, 2000, Pathophysiology, V7, P143, DOI 10.1016/S0928-4680(00)00042-0; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; Lesser MP, 2006, ANNU REV PHYSIOL, V68, P253, DOI 10.1146/annurev.physiol.68.040104.110001; Lilley BN, 2000, MOL MICROBIOL, V36, P940, DOI 10.1046/j.1365-2958.2000.01913.x; Lin BC, 2010, ENV MICROBIOL REP, V2, P81, DOI 10.1111/j.1758-2229.2009.00100.x; Liu D, 2013, ENVIRON SCI POLLUT R, V20, P60, DOI 10.1007/s11356-012-1052-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manefield M, 2000, APPL ENVIRON MICROB, V66, P2079, DOI 10.1128/AEM.66.5.2079-2084.2000; McKenzie KM, 2005, CHEM COMMUN, P4863, DOI 10.1039/b509396a; Miller MB, 2002, CELL, V110, P303, DOI 10.1016/S0092-8674(02)00829-2; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Mok KC, 2003, EMBO J, V22, P870, DOI 10.1093/emboj/cdg085; Moore A, 2009, J FISH BIOL, V74, P1629, DOI 10.1111/j.1095-8649.2009.02197.x; Morrow AC, 2007, BIOELECTROMAGNETICS, V28, P439, DOI 10.1002/bem.20332; Mouchka ME, 2010, INTEGR COMP BIOL, V50, P662, DOI 10.1093/icb/icq061; Muscatine L., 1990, P75; Neiditch MB, 2006, CELL, V126, P1095, DOI 10.1016/j.cell.2006.07.032; Neiditch MB, 2005, MOL CELL, V18, P507, DOI 10.1016/j.molcel.2005.04.020; Nodwell LM, 2001, LIMNOL OCEANOGR, V46, P765, DOI 10.4319/lo.2001.46.4.0765; Perez-Gonzalez T, 2010, GEOCHIM COSMOCHIM AC, V74, P967, DOI 10.1016/j.gca.2009.10.035; PETUSHKOV VN, 1985, BIOFIZIKA+, V30, P349; Potenza L, 2004, MUTAT RES-GEN TOX EN, V561, P53, DOI 10.1016/j.mrgentox.2004.03.009; Rees JF, 1998, J EXP BIOL, V201, P1211; Rodgers CT, 2009, PURE APPL CHEM, V81, P19, DOI 10.1351/PAC-CON-08-10-18; Rosen AD, 2003, CELL BIOCHEM BIOPHYS, V39, P163, DOI 10.1385/CBB:39:2:163; Rosen AD, 2003, BIOELECTROMAGNETICS, V24, P517, DOI 10.1002/bem.10124; Ruwandeepika HAD, 2012, REV AQUACULT, V4, P59, DOI 10.1111/j.1753-5131.2012.01061.x; SAKURAI I, 1980, P NATL ACAD SCI-BIOL, V77, P7232, DOI 10.1073/pnas.77.12.7232; Schauder S, 2001, MOL MICROBIOL, V41, P463, DOI 10.1046/j.1365-2958.2001.02532.x; SCHOLZ F, 1984, BIOPHYS J, V45, P589, DOI 10.1016/S0006-3495(84)84196-X; Stabili L, 2008, MICROB ECOL, V56, P625, DOI 10.1007/s00248-008-9382-y; Stabili L, 2006, MICROB ECOL, V52, P603, DOI 10.1007/s00248-006-9010-7; Stabili L, 2011, J EXP MAR BIOL ECOL, V396, P77, DOI 10.1016/j.jembe.2010.10.004; Stabili L, 2010, MICROB ECOL, V59, P555, DOI 10.1007/s00248-009-9605-x; STEINER UE, 1989, CHEM REV, V89, P51, DOI 10.1021/cr00091a003; STUBBE J, 1988, BIOCHEMISTRY-US, V27, P3893, DOI 10.1021/bi00411a001; Surette MG, 1999, P NATL ACAD SCI USA, V96, P1639, DOI 10.1073/pnas.96.4.1639; Triampo W, 2004, J BIOSCI BIOENG, V98, P182; VILCHESTROYA J, 1984, J COMP NEUROL, V226, P489, DOI 10.1002/cne.902260404; WALKER MM, 1984, SCIENCE, V224, P751, DOI 10.1126/science.224.4650.751; WALKER MM, 1988, J EXP BIOL, V140, P51; Weil E, 2006, DIS AQUAT ORGAN, V69, P1, DOI 10.3354/dao069001; Wooldridge SA, 2010, BIOESSAYS, V32, P615, DOI 10.1002/bies.200900182; Woutersen M, 2011, ANAL BIOANAL CHEM, V400, P915, DOI 10.1007/s00216-010-4372-6; Zhu JG, 2003, BIOCHEMISTRY-US, V42, P4717, DOI 10.1021/bi034289j	78	20	20	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100825	10.1371/journal.pone.0100825	http://dx.doi.org/10.1371/journal.pone.0100825			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24960170	gold, Green Submitted, Green Published			2022-12-27	WOS:000338633900092
J	Vos, SJB; Visser, PJ; Verhey, F; Aalten, P; Knol, D; Ramakers, I; Scheltens, P; Rikkert, MGMO; Verbeek, MM; Teunissen, CE				Vos, Stephanie J. B.; Visser, Pieter Jelle; Verhey, Frans; Aalten, Pauline; Knol, Dirk; Ramakers, Inez; Scheltens, Philip; Rikkert, Marcel G. M. Olde; Verbeek, Marcel M.; Teunissen, Charlotte E.			Variability of CSF Alzheimer's Disease Biomarkers: Implications for Clinical Practice	PLOS ONE			English	Article							CEREBROSPINAL-FLUID BIOMARKERS; DIAGNOSIS; RECOMMENDATIONS; GUIDELINES; TAU	Background: Cerebrospinal fluid (CSF) biomarkers are increasingly being used for diagnosis of Alzheimer's disease (AD). Objective: We investigated the influence of CSF intralaboratory and interlaboratory variability on diagnostic CSF-based AD classification of subjects and identified causes of this variation. Methods: We measured CSF amyloid-beta (A beta) 1-42, total tau (t-tau), and phosphorylated tau (p-tau) by INNOTEST enzyme-linked-immunosorbent assays (ELISA) in a memory clinic population (n = 126). Samples were measured twice in a single or two laboratories that served as reference labs for CSF analyses in the Netherlands. Predefined cut-offs were used to classify CSF biomarkers as normal or abnormal/AD pattern. Results: CSF intralaboratory variability was higher for A beta 1-42 than for t-tau and p-tau. Reanalysis led to a change in biomarker classification (normal vs. abnormal) of 26% of the subjects based on A beta 1-42, 10% based on t-tau, and 29% based on p-tau. The changes in absolute biomarker concentrations were paralleled by a similar change in levels of internal control samples between different assay lots. CSF interlaboratory variability was higher for p-tau than for Ab1-42 and t-tau, and reanalysis led to a change in biomarker classification of 12% of the subjects based on A beta 1-42, 1% based on t-tau, and 22% based on p-tau. Conclusions: Intralaboratory and interlaboratory CSF variability frequently led to change in diagnostic CSF-based AD classification for A beta 1-42 and p-tau. Lot-to-lot variation was a major cause of intralaboratory variability. This will have implications for the use of these biomarkers in clinical practice.	[Vos, Stephanie J. B.; Visser, Pieter Jelle; Verhey, Frans; Aalten, Pauline; Ramakers, Inez] Maastricht Univ, Sch Mental Hlth & Neurosci, Alzheimer Ctr Limburg, Dept Psychiat & Neuropsychol, Maastricht, Netherlands; [Visser, Pieter Jelle; Scheltens, Philip] Vrije Univ Amsterdam, Med Ctr, Alzheimer Ctr, Amsterdam, Netherlands; [Visser, Pieter Jelle; Scheltens, Philip] Vrije Univ Amsterdam, Med Ctr, Dept Neurol, Amsterdam, Netherlands; [Knol, Dirk] Vrije Univ Amsterdam, Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Rikkert, Marcel G. M. Olde] Radboud Univ Nijmegen, Med Ctr, Dept Geriatr Med, NL-6525 ED Nijmegen, Netherlands; [Rikkert, Marcel G. M. Olde; Verbeek, Marcel M.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Rikkert, Marcel G. M. Olde; Verbeek, Marcel M.] Radboud Alzheimer Ctr, Nijmegen, Netherlands; [Verbeek, Marcel M.] Radboud Univ Nijmegen, Dept Neurol, NL-6525 ED Nijmegen, Netherlands; [Verbeek, Marcel M.] Radboud Univ Nijmegen, Dept Lab Med, NL-6525 ED Nijmegen, Netherlands; [Teunissen, Charlotte E.] Vrije Univ Amsterdam, Med Ctr, Neurol Lab, Dept Clin Chem, Amsterdam, Netherlands	Maastricht University; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Vrije Universiteit Amsterdam	Vos, SJB (corresponding author), Maastricht Univ, Sch Mental Hlth & Neurosci, Alzheimer Ctr Limburg, Dept Psychiat & Neuropsychol, Maastricht, Netherlands.	s.vos@maastrichtuniversity.nl	Visser, Pieter Jelle/S-5242-2019; Visser, Pieter J/C-8541-2015; Rikkert, M.G.M. Olde/H-8078-2014; Scheltens, Philip/AAL-9631-2020; Verbeek, Marcel M/D-1971-2010	Visser, Pieter Jelle/0000-0001-8008-9727; Visser, Pieter J/0000-0001-8008-9727; Rikkert, M.G.M. Olde/0000-0003-1397-1677; Scheltens, Philip/0000-0002-1046-6408; Verbeek, Marcel M/0000-0003-4635-7876	Center for Translational Molecular Medicine [02N-01]; Zon-Mw	Center for Translational Molecular Medicine; Zon-Mw(Netherlands Organization for Health Research and Development)	This study was funded by the Center for Translational Molecular Medicine (www.ctmm.nl) project LeARN (grant 02N-01) and in part by Zon-Mw as part of the BIOMARKAPD project of the European Joint Programming Initiative on Neurodegenerative Disorders (JPND). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Blennow K, 2003, LANCET NEUROL, V2, P605, DOI 10.1016/S1474-4422(03)00530-1; de Jong D, 2007, CLIN CHEM LAB MED, V45, P1421, DOI 10.1515/CCLM.2007.320; del Campo M, 2012, BIOMARK MED, V6, P419, DOI [10.2217/bmm.12.46, 10.2217/BMM.12.46]; Dumurgier J, 2013, ALZHEIMERS DEMENT, V9, P406, DOI 10.1016/j.jalz.2012.06.006; Dunn G, 2007, J BIOPHARM STAT, V17, P739, DOI 10.1080/10543400701329513; Fagan AM, 2010, BIOMARK MED, V4, P51, DOI 10.2217/BMM.09.83; Handels RLH, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-72; Hort J, 2010, EUR J NEUROL, V17, P1236, DOI 10.1111/j.1468-1331.2010.03040.x; Jack CR, 2011, ALZHEIMERS DEMENT, V7, P257, DOI 10.1016/j.jalz.2011.03.004; Lewczuk P, 2006, NEUROSCI LETT, V409, P1, DOI 10.1016/j.neulet.2006.07.009; Mattsson N, 2011, ALZHEIMERS DEMENT, V7, P386, DOI 10.1016/j.jalz.2011.05.2243; Mulder C, 2010, CLIN CHEM, V56, P248, DOI 10.1373/clinchem.2009.130518; Schoonenboom NSM, 2005, CLIN CHEM, V51, P189, DOI 10.1373/clinchem.2004.039735; Shrout P E, 1998, Stat Methods Med Res, V7, P301, DOI 10.1191/096228098672090967; Spies PE, 2013, ALZHEIMERS DEMENT, V9, P262, DOI 10.1016/j.jalz.2012.01.010; Teunissen Charlotte E, 2010, Int J Alzheimers Dis, V2010, DOI 10.4061/2010/635053; Vanderstichele H, 2012, ALZHEIMERS DEMENT, V8, P65, DOI 10.1016/j.jalz.2011.07.004; Verwey NA, 2009, ANN CLIN BIOCHEM, V46, P235, DOI 10.1258/acb.2009.008232; Vos SJB, 2013, NEUROLOGY, V80, P1124, DOI 10.1212/WNL.0b013e318288690c	20	59	60	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100784	10.1371/journal.pone.0100784	http://dx.doi.org/10.1371/journal.pone.0100784			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959687	Green Published, Green Submitted, gold			2022-12-27	WOS:000338633900085
J	Bruno, AE; Ruby, AM; Luft, JR; Grant, TD; Seetharaman, J; Montelione, GT; Hunt, JF; Snell, EH				Bruno, Andrew E.; Ruby, Amanda M.; Luft, Joseph R.; Grant, Thomas D.; Seetharaman, Jayaraman; Montelione, Gaetano T.; Hunt, John F.; Snell, Edward H.			Comparing Chemistry to Outcome: The Development of a Chemical Distance Metric, Coupled with Clustering and Hierarchal Visualization Applied to Macromolecular Crystallography	PLOS ONE			English	Article							CRYSTALLIZATION CONDITIONS; PROTEIN; SIMILARITY; SALT	Many bioscience fields employ high-throughput methods to screen multiple biochemical conditions. The analysis of these becomes tedious without a degree of automation. Crystallization, a rate limiting step in biological X-ray crystallography, is one of these fields. Screening of multiple potential crystallization conditions (cocktails) is the most effective method of probing a proteins phase diagram and guiding crystallization but the interpretation of results can be time-consuming. To aid this empirical approach a cocktail distance coefficient was developed to quantitatively compare macromolecule crystallization conditions and outcome. These coefficients were evaluated against an existing similarity metric developed for crystallization, the C6 metric, using both virtual crystallization screens and by comparison of two related 1,536-cocktail high-throughput crystallization screens. Hierarchical clustering was employed to visualize one of these screens and the crystallization results from an exopolyphosphatase-related protein from Bacteroides fragilis, (BfR192) overlaid on this clustering. This demonstrated a strong correlation between certain chemically related clusters and crystal lead conditions. While this analysis was not used to guide the initial crystallization optimization, it led to the re-evaluation of unexplained peaks in the electron density map of the protein and to the insertion and correct placement of sodium, potassium and phosphate atoms in the structure. With these in place, the resulting structure of the putative active site demonstrated features consistent with active sites of other phosphatases which are involved in binding the phosphoryl moieties of nucleotide triphosphates. The new distance coefficient, CDcoeff, appears to be robust in this application, and coupled with hierarchical clustering and the overlay of crystallization outcome, reveals information of biological relevance. While tested with a single example the potential applications related to crystallography appear promising and the distance coefficient, clustering, and hierarchal visualization of results undoubtedly have applications in wider fields.	[Bruno, Andrew E.; Ruby, Amanda M.] SUNY Buffalo, Ctr Computat Res, Buffalo, NY 14260 USA; [Luft, Joseph R.; Grant, Thomas D.; Snell, Edward H.] Hauptman Woodward Med Res Inst, Buffalo, NY 14203 USA; [Luft, Joseph R.; Snell, Edward H.] SUNY Buffalo, Dept Biol Struct, Buffalo, NY 14260 USA; [Seetharaman, Jayaraman; Hunt, John F.] Columbia Univ, Northeast Struct Genom Consortium, Dept Biol Sci, New York, NY USA; [Montelione, Gaetano T.] Rutgers State Univ, Ctr Adv Biotechnol & Med, Dept Mol Biol & Biochem, Northeast Struct Genom Consortium,Robert Wood Joh, Piscataway, NJ 08854 USA; [Montelione, Gaetano T.] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Hauptman Woodward Medical Research Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Columbia University; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center	Snell, EH (corresponding author), Hauptman Woodward Med Res Inst, Buffalo, NY 14203 USA.	esnell@hwi.buffalo.edu	Snell, Edward/G-2055-2018; Grant, Thomas/GXH-9990-2022; Grant, Thomas/T-2921-2019	Snell, Edward/0000-0001-8714-3191; Grant, Thomas/0000-0002-8583-3700; Grant, Thomas/0000-0002-8583-3700; Montelione, Gaetano/0000-0002-9440-3059	DTRA; NIH [R01GM088396, R01GM100494]; NSF [1231306]; Protein Structure Initiative of the National Institutes of Health, NIGMS [R01GM100494, U54 GM094597]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094597, R01GM088396, R01GM100494] Funding Source: NIH RePORTER	DTRA(United States Department of DefenseDefense Threat Reduction Agency); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Protein Structure Initiative of the National Institutes of Health, NIGMS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The research is supported by DTRA, NIH R01GM088396, R01GM100494 and NSF 1231306. The protein samples used in this work were provided in part by the Protein Structure Initiative of the National Institutes of Health, NIGMS grant U54 GM094597 and R01GM100494. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acton TB, 2011, METHOD ENZYMOL, V493, P21, DOI 10.1016/B978-0-12-381274-2.00002-9; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P17, DOI 10.1016/S0968-0004(97)01162-6; Bergfors T, 2003, J STRUCT BIOL, V142, P66, DOI 10.1016/S1047-8477(03)00039-X; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Cacace MG, 1997, Q REV BIOPHYS, V30, P241, DOI 10.1017/S0033583597003363; CHAYEN NE, 1992, J CRYST GROWTH, V122, P176, DOI 10.1016/0022-0248(92)90241-A; Collins KD, 2006, BIOPHYS CHEM, V119, P271, DOI 10.1016/j.bpc.2005.08.010; Cormier Catherine Y., 2011, Journal of Structural and Functional Genomics, V12, P55, DOI 10.1007/s10969-011-9100-8; Dumetz AC, 2007, PROTEIN SCI, V16, P1867, DOI 10.1110/ps.072957907; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Hofmeister F., 1888, ARCH EXP PATHOL PH, V24, P247, DOI [DOI 10.1007/BF01918191, 10.1007/BF01918191]; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430; Jones E., 2001, SCIPY OPEN SOURCE SC; Kantardjieff KA, 2004, BIOINFORMATICS, V20, P2162, DOI 10.1093/bioinformatics/bth066; Krause EF., 1987, TAXICAB GEOMETRY ADV; LANCE GN, 1967, COMPUT J, V10, P271, DOI 10.1093/comjnl/10.3.271; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Luft JR, 2007, PROTEIN SCI, V16, P715, DOI 10.1110/ps.062699707; Luft JR, 2011, EXPERT OPIN DRUG DIS, V6, P465, DOI 10.1517/17460441.2011.566857; Luft JR, 2011, CRYST GROWTH DES, V11, P651, DOI 10.1021/cg1013945; Luft JR, 2003, J STRUCT BIOL, V142, P170, DOI 10.1016/S1047-8477(03)00048-0; Matte A, 1998, STRUCT FOLD DES, V6, P413, DOI 10.1016/S0969-2126(98)00043-4; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagel RM, 2008, J APPL CRYSTALLOGR, V41, P1173, DOI 10.1107/S0021889808028938; Newman J, 2012, ACTA CRYSTALLOGR F, V68, P253, DOI 10.1107/S1744309112002618; Newman J, 2010, CRYST GROWTH DES, V10, P2785, DOI 10.1021/cg1004209; Nikolova N, 2004, QSAR COMB SCI, V22, P1006, DOI 10.1002/qsar.200330831; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rogers D, 2010, J CHEM INF MODEL, V50, P742, DOI 10.1021/ci100050t; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Skokal R, 1926, TAXON, V11, P33; Snell EH, 2008, ACTA CRYSTALLOGR D, V64, P1240, DOI 10.1107/S0907444908032411; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Willett P, 1998, J CHEM INF COMP SCI, V38, P983, DOI 10.1021/ci9800211; Xiao R, 2010, J STRUCT BIOL, V172, P21, DOI 10.1016/j.jsb.2010.07.011; Zhang YJ, 2006, CURR OPIN CHEM BIOL, V10, P658, DOI 10.1016/j.cbpa.2006.09.020	38	11	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100782	10.1371/journal.pone.0100782	http://dx.doi.org/10.1371/journal.pone.0100782			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971458	Green Submitted, gold, Green Published			2022-12-27	WOS:000338512200062
J	Yang, J; d'Esterre, CD; Amtul, Z; Cechetto, DF; Lee, TY				Yang, Jun; d'Esterre, Christopher D.; Amtul, Zareen; Cechetto, David F.; Lee, Ting Yim			Hemodynamic Effects of Combined Focal Cerebral Ischemia and Amyloid Protein Toxicity in a Rat Model: A Functional CT Study	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; BLOOD-FLOW; ALZHEIMERS-DISEASE; A-BETA; EMISSION-TOMOGRAPHY; TRANSGENIC MICE; PERFUSION CT; FDG-PET; BRAIN; DEMENTIA	Background/Objective: Clinical evidence indicates that cerebral ischemia (CI) and a pathological factor of Alzheimer's disease, the beta-amyloid (A beta) protein, can increase the rate of cognitive impairment in the ageing population. Using the CT Perfusion (CTP) functional imaging, we sought to investigate the interaction between CI and the A beta protein on cerebral hemodynamics. Methods: A previously established rat model of CI and A beta was used for the CTP study. Iodinated contrast was given intravenously, while serial CT images of sixteen axial slices were acquired. Cerebral blood flow (CBF) and blood volume (CBV) parametric maps were co-registered to a rat brain atlas and regions of interest were drawn on the maps. Microvascular alteration was investigated with histopathology. Results: CTP results revealed that ipsilateral striatum of A beta+CI and CI groups showed significantly lower CBF and CBV than control at the acute phase. Striatal CBF and CBV increased significantly at week 1 in the CI and A beta+CI groups, but not in the A beta alone or control group. Histopathology showed that average density of dilated microvessels in the ipsilateral striatum in CI and A beta+CI groups was significantly higher than control at week 1, indicating this could be associated with hyperperfusion and hypervolemia observed from CTP results. Conclusion: These results demonstrate that CTP can quantitatively measure the hemodynamic disturbance on CBF and CBV functional maps in a rat model of CI interacting with A beta.	[Yang, Jun; Lee, Ting Yim] Univ Western Ontario, Robarts Res Inst, Dept Med Biophys, Imaging Labs, London, ON, Canada; [d'Esterre, Christopher D.] Univ Calgary, Foothills Med Ctr, Dept Radiol, Calgary, AB, Canada; [Amtul, Zareen; Cechetto, David F.] Univ Western Ontario, Dept Anat & Cell Biol, London, ON, Canada; [Lee, Ting Yim] Lawson Hlth Res Inst, Imaging Div, London, ON, Canada	Western University (University of Western Ontario); University of Calgary; Western University (University of Western Ontario); Western University (University of Western Ontario)	Lee, TY (corresponding author), Univ Western Ontario, Robarts Res Inst, Dept Med Biophys, Imaging Labs, London, ON, Canada.	tlee@robarts.ca	AMTUL, ZAREEN/Y-6364-2019; Lee, Ting-Yim/M-1721-2013		Canadian Institutes of Health Research (CIHR); Canadian Foundation of Innovation; Ontario Research Fund	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Foundation of Innovation(Canada Foundation for Innovation); Ontario Research Fund	This study is funded by Canadian Institutes of Health Research (CIHR), Canadian Foundation of Innovation and Ontario Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsop DC, 2008, NEUROIMAGE, V42, P1267, DOI 10.1016/j.neuroimage.2008.06.006; Alsop DC, 2010, J ALZHEIMERS DIS, V20, P871, DOI 10.3233/JAD-2010-091699; Austin BP, 2011, J ALZHEIMERS DIS, V26, P123, DOI 10.3233/JAD-2011-0010; BELL MA, 1981, ACTA NEUROPATHOL, V53, P299, DOI 10.1007/BF00690372; Bisdas S, 2006, EUR RADIOL, V16, P2220, DOI 10.1007/s00330-006-0209-2; Breteler MMB, 2000, ANN NY ACAD SCI, V903, P457, DOI 10.1111/j.1749-6632.2000.tb06399.x; Brown WR, 2011, NEUROPATH APPL NEURO, V37, P56, DOI 10.1111/j.1365-2990.2010.01139.x; Cenic A, 1999, AM J NEURORADIOL, V20, P63; Clifford PM, 2007, BRAIN RES, V1142, P223, DOI 10.1016/j.brainres.2007.01.070; d'Esterre CD, 2012, TRANSL STROKE RES, V3, P205, DOI 10.1007/s12975-012-0178-5; Dai WY, 2009, RADIOLOGY, V250, P856, DOI 10.1148/radiol.2503080751; de la Torre JC, 2008, NEURODEGENER DIS, V5, P126, DOI 10.1159/000113681; de la Torre JC, 2002, STROKE, V33, P1152, DOI 10.1161/01.STR.0000014421.15948.67; Dietrich HH, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-15; Helzner EP, 2009, ARCH NEUROL-CHICAGO, V66, P343, DOI 10.1001/archneur.66.3.343; Heyman A, 1998, NEUROLOGY, V51, P159, DOI 10.1212/WNL.51.1.159; Hiltunen M, 2009, NEUROBIOL DIS, V35, P103, DOI 10.1016/j.nbd.2009.04.009; Hirao K, 2005, NEUROIMAGE, V28, P1014, DOI 10.1016/j.neuroimage.2005.06.066; Jantaratnotai N, 2011, INT J ALZHEIMERS DIS, V2011, P1; Johnson NA, 2005, RADIOLOGY, V234, P851, DOI 10.1148/radiol.2343040197; Kogure D, 2000, J NUCL MED, V41, P1155; Koistinaho M, 2002, P NATL ACAD SCI USA, V99, P1610, DOI 10.1073/pnas.032670899; Kudo K, 2003, AM J NEURORADIOL, V24, P419; Lewis H, 2006, NEUROPATH APPL NEURO, V32, P103, DOI 10.1111/j.1365-2990.2006.00696.x; Luckhaus C, 2008, NEUROIMAGE, V40, P495, DOI 10.1016/j.neuroimage.2007.11.053; Miles KA, 2010, CLIN RADIOL, V65, P549, DOI 10.1016/j.crad.2010.04.007; Mosconi L, 2005, EUR J NUCL MED MOL I, V32, P486, DOI [10.1007/s00259-008-1039-z, 10.1007/s00259-005-1762-7]; Mosconi L, 2010, J ALZHEIMERS DIS, V20, P843, DOI 10.3233/JAD-2010-091504; NARIAI T, 1995, AM J NEURORADIOL, V16, P563; Nordberg A, 2010, NAT REV NEUROL, V6, P78, DOI 10.1038/nrneurol.2009.217; O'Brien JT, 2003, LANCET NEUROL, V2, P89, DOI 10.1016/S1474-4422(03)00305-3; O'Connor JPB, 2011, BRIT J RADIOL, V84, pS112, DOI 10.1259/bjr/55166688; Pakrasi S, 2005, NUCL MED COMMUN, V26, P189, DOI 10.1097/00006231-200503000-00003; Paris D, 2003, NEUROL RES, V25, P642, DOI 10.1179/016164103101201940; Pike KE, 2007, BRAIN, V130, P2837, DOI 10.1093/brain/awm238; Pluta Ryszard, 2008, Neuropsychiatr Dis Treat, V4, P855; Riekse RG, 2004, J AM GERIATR SOC, V52, P1442, DOI 10.1111/j.1532-5415.2004.52405.x; Schuff N, 2009, ALZHEIMERS DEMENT, V5, P454, DOI 10.1016/j.jalz.2009.04.1233; Seshadri S, 2006, STROKE, V37, P345, DOI 10.1161/01.STR.0000199613.38911.b2; Shi J, 2000, BRAIN RES, V853, P1, DOI 10.1016/S0006-8993(99)02113-7; Snowdon DA, 1997, JAMA-J AM MED ASSOC, V277, P813, DOI 10.1001/jama.277.10.813; Song IU, 2007, COGN BEHAV NEUROL, V20, P93, DOI 10.1097/WNN.0b013e31805d859e; Suo ZM, 1998, NEUROSCI LETT, V257, P77, DOI 10.1016/S0304-3940(98)00814-3; Townsend KP, 2002, ANN NY ACAD SCI, V977, P65, DOI 10.1111/j.1749-6632.2002.tb04799.x; Vermeer SE, 2003, NEW ENGL J MED, V348, P1215, DOI 10.1056/NEJMoa022066; Villemagne VL, 2011, INT PSYCHOGERIATR, V23, pS41, DOI 10.1017/S1041610211000895; White L, 2009, J ALZHEIMERS DIS, V18, P713, DOI 10.3233/JAD-2009-1178; Whitehead SN, 2007, STROKE, V38, P3245, DOI 10.1161/STROKEAHA.107.492660; Whitehead SN, 2005, STROKE, V36, P107, DOI 10.1161/01.STR.0000149627.30763.f9; Wintermark M, 2005, STROKE, V36, pE83, DOI 10.1161/01.STR.0000177884.72657.8b; Wolk DA, 2009, CURR NEUROL NEUROSCI, V9, P345, DOI 10.1007/s11910-009-0051-4; Zaknun JJ, 2008, NUCL MED COMMUN, V29, P260, DOI 10.1097/MNM.0b013e3282f38f8f; Zhang FY, 1997, J NEUROSCI, V17, P7655, DOI 10.1523/jneurosci.17-20-07655.1997	53	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100575	10.1371/journal.pone.0100575	http://dx.doi.org/10.1371/journal.pone.0100575			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971942	Green Published, gold, Green Submitted			2022-12-27	WOS:000338512200043
J	Garbaisz, D; Turoczi, Z; Aranyi, P; Fulop, A; Rosero, O; Hermesz, E; Ferencz, A; Lotz, G; Harsanyi, L; Szijarto, A				Garbaisz, David; Turoczi, Zsolt; Aranyi, Peter; Fulop, Andras; Rosero, Oliver; Hermesz, Edit; Ferencz, Agnes; Lotz, Gabor; Harsanyi, Laszlo; Szijarto, Attila			Attenuation of Skeletal Muscle and Renal Injury to the Lower Limb following Ischemia-Reperfusion Using mPTP Inhibitor NIM-811	PLOS ONE			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; CYCLOSPORINE-A; CELL-DEATH; VASCULAR-SURGERY; NITRIC-OXIDE; PEROXYNITRITE; LIVER; PORE; MECHANISM; RAT	Introduction: Operation on the infrarenal aorta and large arteries of the lower extremities may cause rhabdomyolysis of the skeletal muscle, which in turn may induce remote kidney injury. NIM-811 (N-metyl-4-isoleucine-cyclosporine) is a mitochondria specific drug, which can prevent ischemic-reperfusion (IR) injury, by inhibiting mitochondrial permeability transition pores (mPTP). Objectives: Our aim was to reduce damages in the skeletal muscle and the kidney after IR of the lower limb with NIM-811. Materials and methods: Wistar rats underwent 180 minutes of bilateral lower limb ischemia and 240 minutes of reperfusion. Four animal groups were formed called Sham (receiving vehicle and sham surgery), NIM-Sham (receiving NIM811 and sham surgery), IR (receiving vehicle and surgery), and NIM-IR (receiving NIM-811 and surgery). Serum, urine and histological samples were taken at the end of reperfusion. NADH-tetrazolium staining, muscle Wet/Dry (W/D) ratio calculations, laser Doppler-flowmetry (LDF) and mean arterial pressure (MAP) monitoring were performed. Renal peroxynitrite concentration, serum TNF-alpha and IL-6 levels were measured. Results: Less significant histopathological changes were observable in the NIM-IR group as compared with the IR group. Serum K+ and necroenzyme levels were significantly lower in the NIM-IR group than in the IR group (LDH: p<0.001; CK: p< 0.001; K+: p = 0.017). Muscle mitochondrial viability proved to be significantly higher (p = 0.001) and renal function parameters were significantly better (creatinine: p = 0.016; FENa: p<0.001) in the NIM-IR group in comparison to the IR group. Serum TNF-alpha and IL-6 levels were significantly lower (TNF-alpha: p = 0.003, IL-6: p = 0.040) as well as W/D ratio and peroxynitrite concentration were significantly lower (p = 0.014; p<0.001) in the NIM-IR group than in the IR group. Conclusion: NIM-811 could have the potential of reducing rhabdomyolysis and impairment of the kidney after lower limb IR injury.	[Garbaisz, David; Turoczi, Zsolt; Aranyi, Peter; Fulop, Andras; Rosero, Oliver; Harsanyi, Laszlo; Szijarto, Attila] Semmelweis Univ, Dept Surg 1, H-1085 Budapest, Hungary; [Hermesz, Edit; Ferencz, Agnes] Univ Szeged, Dept Biochem & Mol Biol, Szeged, Hungary; [Lotz, Gabor] Semmelweis Univ, Dept Pathol 2, H-1085 Budapest, Hungary	Semmelweis University; Szeged University; Semmelweis University	Garbaisz, D (corresponding author), Semmelweis Univ, Dept Surg 1, H-1085 Budapest, Hungary.	garbaiszdavid@t-online.hu	Hermesz, Edit/M-7661-2018; Edit, Hermesz/AAH-5969-2020	Hermesz, Edit/0000-0002-0543-6693; Edit, Hermesz/0000-0002-0543-6693				Abdulhannan P, 2012, BRIT MED BULL, V104, P21, DOI 10.1093/bmb/lds027; Aranyi P TZ, 2011, HYPERTONIA NEPHROLOG, V15, P117; Argaud L, 2005, CIRCULATION, V111, P194, DOI 10.1161/01.CIR.0000151290.04952.3B; Argaud Laurent, 2005, J Mol Cell Cardiol, V38, P367, DOI 10.1016/j.yjmcc.2004.12.001; Carroll CMA, 1997, PLAST RECONSTR SURG, V100, P58, DOI 10.1097/00006534-199707000-00010; Cheng CH, 2013, TRANSPLANTATION, V95, P559, DOI 10.1097/TP.0b013e31827e6b02; Cour M, 2011, EUR HEART J, V32, P226, DOI 10.1093/eurheartj/ehq112; Duina AA, 1996, SCIENCE, V274, P1713, DOI 10.1126/science.274.5293.1713; FOURNIER N, 1987, J BIOENERG BIOMEMBR, V19, P297, DOI 10.1007/BF00762419; FREEMAN R, 1972, J CLIN PATHOL, V25, P912, DOI 10.1136/jcp.25.10.912; Garbaisz D, 2013, J SURG RES, V185, P469, DOI 10.1016/j.jss.2013.05.022; Gill RS, 2012, SHOCK, V37, P341, DOI 10.1097/SHK.0b013e31824bc9ab; Goksin I, 2011, ANN VASC SURG, V25, P1118, DOI 10.1016/j.avsg.2011.07.007; Gomez L, 2009, CARDIOVASC RES, V83, P226, DOI 10.1093/cvr/cvp063; GRIFFITHS EJ, 1995, BIOCHEM J, V307, P93, DOI 10.1042/bj3070093; Groeneveld ABJ, 1997, EUR J VASC ENDOVASC, V14, P351, DOI 10.1016/S1078-5884(97)80284-5; Gyurkovics E, 2010, INTERV MED APPL SCI, V2, P169, DOI 10.1556/IMAS.2.2010.4.5; Gyurkovics E, 2011, J SURG RES, V169, P139, DOI 10.1016/j.jss.2009.10.014; HALESTRAP AP, 1990, BIOCHEM J, V268, P153, DOI 10.1042/bj2680153; Halloran PF, 1996, CLIN TRANSPLANT, V10, P118; Holt SG, 2001, INTENS CARE MED, V27, P803, DOI 10.1007/s001340100878; Homer-Vanniasinkam S, 2001, EUR J VASC ENDOVASC, V22, P523, DOI 10.1053/ejvs.2001.1467; HUIE RE, 1993, FREE RADICAL RES COM, V18, P195, DOI 10.3109/10715769309145868; Javadov S, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00076; Klebl BM, 1998, FEBS LETT, V422, P381, DOI 10.1016/S0014-5793(98)00053-2; Lemasters JJ, 1998, BBA-BIOENERGETICS, V1366, P177, DOI 10.1016/S0005-2728(98)00112-1; Li W, 2013, STEM CELL RES, V10, P405, DOI 10.1016/j.scr.2013.01.005; Lim SY, 2007, CARDIOVASC RES, V75, P530, DOI 10.1016/j.cardiores.2007.04.022; Lin HC, 2012, TRANSPLANTATION, V93, P265, DOI 10.1097/TP.0b013e31823ef335; LUCAS CE, 1976, SURG CLIN N AM, V56, P953; Matsumoto S, 1999, J CEREBR BLOOD F MET, V19, P736, DOI 10.1097/00004647-199907000-00002; McAllister SE, 2008, AM J PHYSIOL-REG I, V295, pR681, DOI 10.1152/ajpregu.90303.2008; MENGER MD, 1988, RES EXP MED, V188, P151, DOI 10.1007/BF01852316; Miller CC, 2008, EUR J CARDIO-THORAC, V33, P691, DOI 10.1016/j.ejcts.2008.01.006; Mowlavi A, 2001, ANN PLAS SURG, V46, P426, DOI 10.1097/00000637-200104000-00013; Muriel P, 2000, NITRIC OXIDE-BIOL CH, V4, P333, DOI 10.1006/niox.2000.0285; Naparus A, 2012, EUR J PHARMACOL, V686, P90, DOI 10.1016/j.ejphar.2012.04.045; Norwood MGA, 2004, EUR J VASC ENDOVASC, V28, P234, DOI 10.1016/j.ejvs.2004.03.026; ODEH M, 1991, NEW ENGL J MED, V324, P1417; Olivas TP, 2001, PLAST RECONSTR SURG, V107, P785, DOI 10.1097/00006534-200103000-00020; PACKER MA, 1994, FEBS LETT, V345, P237, DOI 10.1016/0014-5793(94)00461-7; PATERSON IS, 1989, ANN SURG, V209, P231, DOI 10.1097/00000658-198902000-00015; Piot C, 2008, NEW ENGL J MED, V359, P473, DOI 10.1056/NEJMoa071142; Pottecher J, 2013, J VASC SURG, V57, P1100, DOI 10.1016/j.jvs.2012.09.020; Puglisi RN, 1996, J SURG RES, V65, P115, DOI 10.1006/jsre.1996.0352; Rajan DK, 2009, J VASC INTERV RADIOL, V20, pS208, DOI 10.1016/j.jvir.2009.04.010; Ravikumar R, 2007, J NEUROTRAUM, V24, P1618, DOI 10.1089/neu.2007.0329; Rieber J, 1998, TRANSPLANT P, V30, P1098, DOI 10.1016/S0041-1345(98)00168-7; ROSENTHAL SM, 1945, ARCH SURG-CHICAGO, V51, P244, DOI 10.1001/archsurg.1945.01230040253004; ROUMEN RMH, 1993, ANN SURG, V218, P769, DOI 10.1097/00000658-199312000-00011; RUBBO H, 1994, J BIOL CHEM, V269, P26066; Squadrito F, 1999, EUR J PHARMACOL, V364, P159, DOI 10.1016/S0014-2999(98)00823-1; Szabo C, 2003, TOXICOL LETT, V140, P105, DOI 10.1016/S0378-4274(02)00507-6; Szabo C, 1997, NITRIC OXIDE-BIOL CH, V1, P373, DOI 10.1006/niox.1997.0143; Szijarto A, 2006, J SURG RES, V131, P150, DOI 10.1016/j.jss.2005.09.002; Troitzsch D, 2013, SHOCK, V39, P220, DOI 10.1097/SHK.0b013e31828044f6; Turoczi Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084783; Wang WZ, 2011, J SURG RES, V171, P175, DOI 10.1016/j.jss.2011.07.015; Zhong Z, 2007, AM J TRANSPLANT, V7, P1103, DOI 10.1111/j.1600-6143.2007.01770.x; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A; Zorov DB, 2009, CARDIOVASC RES, V83, P213, DOI 10.1093/cvr/cvp151	61	26	29	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e101067	10.1371/journal.pone.0101067	http://dx.doi.org/10.1371/journal.pone.0101067			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968303	gold, Green Submitted, Green Published			2022-12-27	WOS:000338280800102
J	Thavamanikumar, S; Southerton, S; Thumma, B				Thavamanikumar, Saravanan; Southerton, Simon; Thumma, Bala			RNA-Seq Using Two Populations Reveals Genes and Alleles Controlling Wood Traits and Growth in Eucalyptus nitens	PLOS ONE			English	Article							KRAFT PULP YIELD; TRANSCRIPTOME ANALYSIS; BASIC DENSITY; GENOME-WIDE; EXPRESSION; IDENTIFICATION; RESISTANCE; EVOLUTION; SELECTION; GLOBULUS	Eucalyptus nitens is a perennial forest tree species grown mainly for kraft pulp production in many parts of the world. Kraft pulp yield (KPY) is a key determinant of plantation profitability and increasing the KPY of trees grown in plantations is a major breeding objective. To speed up the breeding process, molecular markers that can predict KPY are desirable. To achieve this goal, we carried out RNA-Seq studies on trees at extremes of KPY in two different trials to identify genes and alleles whose expression correlated with KPY. KPY is positively correlated with growth measured as diameter at breast height (DBH) in both trials. In total, six RNA bulks from two treatments were sequenced on an Illumina HiSeq platform. At 5% false discovery rate level, 3953 transcripts showed differential expression in the same direction in both trials; 2551 (65%) were down-regulated and 1402 (35%) were up-regulated in low KPY samples. The genes up-regulated in low KPY trees were largely involved in biotic and abiotic stress response reflecting the low growth among low KPY trees. Genes down-regulated in low KPY trees mainly belonged to gene categories involved in wood formation and growth. Differential allelic expression was observed in 2103 SNPs (in 1068 genes) and of these 640 SNPs (30%) occurred in 313 unique genes that were also differentially expressed. These SNPs may represent the cis-acting regulatory variants that influence total gene expression. In addition we also identified 196 genes which had Ka/Ks ratios greater than 1.5, suggesting that these genes are under positive selection. Candidate genes and alleles identified in this study will provide a valuable resource for future association studies aimed at identifying molecular markers for KPY and growth.	[Thavamanikumar, Saravanan] Univ Melbourne, Dept Forest & Ecosyst Sci, Creswick, Vic, Australia; [Southerton, Simon; Thumma, Bala] CSIRO Plant Ind, Acton, ACT, Australia	University of Melbourne; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Thumma, B (corresponding author), CSIRO Plant Ind, Acton, ACT, Australia.	reddy.thumma@csiro.au	Thavamanikumar, Saravanan/J-3804-2014; Thumma, Bala/AAF-6143-2020	Thumma, Bala/0000-0002-1749-0611	University of Melbourne	University of Melbourne(University of Melbourne)	ST received an Early Career Researcher grant from the University of Melbourne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett IJ, 2013, GENET EPIDEMIOL, V37, P142, DOI 10.1002/gepi.21699; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bishop JG, 2000, P NATL ACAD SCI USA, V97, P5322, DOI 10.1073/pnas.97.10.5322; Bystrykh L, 2005, NAT GENET, V37, P225, DOI 10.1038/ng1497; Capon F, 2004, HUM MOL GENET, V13, P2361, DOI 10.1093/hmg/ddh273; Chen G, 2011, SCI CHINA LIFE SCI, V54, P1121, DOI 10.1007/s11427-011-4255-x; Cheung VG, 2009, NAT REV GENET, V10, P595, DOI 10.1038/nrg2630; da Fonseca RR, 2010, FEBS LETT, V584, P469, DOI 10.1016/j.febslet.2009.12.022; Downes Geoff, 2006, New Zealand Journal of Forestry, V51, P13; Edwards NC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038864; EINSPAHR DEAN W., 1967, SILVAE GENET, V16, P106; Elissetche J, 2011, BMC P, V5, pP108; Emond MJ, 2012, NAT GENET, V44, P886, DOI 10.1038/ng.2344; Foucart C, 2006, NEW PHYTOL, V170, P739, DOI 10.1111/j.1469-8137.2006.01705.x; GODDARD ME, 2007, J ANIM BREED GENET, V124, P323; Grattapaglia D, 1996, GENETICS, V144, P1205; Greaves BL, 1997, SILVAE GENET, V46, P264; Greenberg JT, 1996, P NATL ACAD SCI USA, V93, P12094, DOI 10.1073/pnas.93.22.12094; Gurwitz D, 2013, PHARMACOGENOMICS, V14, P337, DOI [10.2217/PGS.13.35, 10.2217/pgs.13.35]; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Jung KH, 2013, RICE, V6, DOI 10.1186/1939-8433-6-19; Khaitovich P, 2005, SCIENCE, V309, P1850, DOI 10.1126/science.1108296; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Kofler R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015925; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Le Provost G, 2007, BIOL RES, V40, P291, DOI [10.4067/S0716-97602007000400003, /S0716-97602007000400003]; Li J, 2005, HUM MOL GENET, V14, pR163, DOI 10.1093/hmg/ddi267; Liu JJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-884; Masclaux FG, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-227; Mizrachi E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-681; Montoya-Burgos JI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024800; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Paux E, 2004, PLANT MOL BIOL, V55, P263, DOI 10.1007/s11103-004-0621-4; Plomion C, 2001, PLANT PHYSIOL, V127, P1513, DOI 10.1104/pp.010816; Prassinos C, 2005, PLANT CELL PHYSIOL, V46, P1213, DOI 10.1093/pcp/pci130; Qiu D, 2008, NEW PHYTOL, V179, P94, DOI 10.1111/j.1469-8137.2008.02439.x; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schimleck L, 2005, CAN J FOREST RES, V35, P2797, DOI 10.1139/X05-193; Stackpole DJ, 2011, G3-GENES GENOM GENET, V1, P151, DOI 10.1534/g3.111.000372; Thavamanikumar S, 2013, TREE GENET GENOMES, V9, P627, DOI 10.1007/s11295-013-0594-z; Thumma BR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-364; Thumma BR, 2009, GENETICS, V183, P1153, DOI 10.1534/genetics.109.106591; Tibbits WN, 1997, 24 SO FOR TREE IMPR, P81; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tuch BB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009317; van Bakel H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000371; Villar E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-538; Williams RBH, 2007, GENOME RES, V17, P1707, DOI 10.1101/gr.6981507; Yahiaoui N, 2006, PLANT J, V47, P85, DOI 10.1111/j.1365-313X.2006.02772.x; Yang X, 2013, PRINCIPLES, METHODOLOGIES, AND SERVICE-ORIENTED APPROACHES FOR CLOUD COMPUTING, P1, DOI 10.4018/978-1-4666-2854-0; Zeeberg BR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-168	54	21	22	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e101104	10.1371/journal.pone.0101104	http://dx.doi.org/10.1371/journal.pone.0101104			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967893	gold, Green Published			2022-12-27	WOS:000338280800108
J	Vasu, S; Moffett, RC; Thorens, B; Flatt, PR				Vasu, Srividya; Moffett, R. Charlotte; Thorens, Bernard; Flatt, Peter R.			Role of Endogenous GLP-1 and GIP in Beta Cell Compensatory Responses to Insulin Resistance and Cellular Stress	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; FAT-FED MICE; PANCREATIC ALPHA-CELLS; GLUCOSE-HOMEOSTASIS; RECEPTOR ACTIVATION; ENTEROINSULAR AXIS; HORMONE MIMETICS; SECRETION; INCRETINS; POLYPEPTIDE	Role of GLP-1 and GIP in beta cell compensatory responses to beta cell attack and insulin resistance were examined in C57BL/6 mice lacking functional receptors for GLP-1 and GIP. Mice were treated with multiple low dose streptozotocin or hydrocortisone. Islet parameters were assessed by immunohistochemistry and hormone measurements were determined by specific enzyme linked immunoassays. Wild-type streptozotocin controls exhibited severe diabetes, irregularly shaped islets with lymphocytic infiltration, decreased Ki67/TUNEL ratio with decreased beta cell and increased alpha cell areas. GLP-1 and GIP were co-expressed with glucagon and numbers of alpha cells mainly expressing GLP-1 were increased. In contrast, hydrocortisone treatment and induction of insulin resistance increased islet numbers and area, with enhanced beta cell replication, elevated mass of beta and alpha cells, together with co-expression of GLP-1 and GIP with glucagon in islets. The metabolic responses to streptozotocin in GLP-1RKO and GIPRKO mice were broadly similar to C57BL/6 controls, although decreases in islet numbers and size were more severe. In contrast, both groups of mice lacking functional incretin receptors displayed substantially impaired islet adaptations to insulin resistance induced by hydrocortisone, including marked curtailment of expansion of islet area, beta cell mass and islet number. Our observations cannot be explained by simple changes in circulating incretin concentrations, suggesting that intra-islet GLP-1 and GIP make a significant contribution to islet adaptation, particularly expansion of beta cell mass and compensatory islet compensation to hydrocortisone and insulin resistance.	[Vasu, Srividya; Moffett, R. Charlotte; Flatt, Peter R.] Univ Ulster, SAAD Ctr Pharm & Diabet, Coleraine BT52 1SA, Londonderry, North Ireland; [Thorens, Bernard] Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland	Ulster University; University of Lausanne	Vasu, S (corresponding author), Univ Ulster, SAAD Ctr Pharm & Diabet, Coleraine BT52 1SA, Londonderry, North Ireland.	s.vasu@ulster.ac.uk		Moffett, R Charlotte/0000-0002-7196-7863; Flatt, Peter/0000-0001-8548-7943	EFSD/Boehringer Ingelheim Grant; Department of Education and Learning, Northern Ireland	EFSD/Boehringer Ingelheim Grant; Department of Education and Learning, Northern Ireland	The study was supported in part by an EFSD/Boehringer Ingelheim Grant and a research scholarship to RCM from Department of Education and Learning, Northern Ireland. Professor DJ Drucker is thanked for provision of GLP-1RKO mice. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; BAILEY CJ, 1982, METABOLISM, V31, P238, DOI 10.1016/0026-0495(82)90059-2; Barnett AH, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4382; Calcinaro F, 2005, DIABETOLOGIA, V48, P1565, DOI 10.1007/s00125-005-1831-2; Campbell JE, 2013, CELL METAB, V17, P819, DOI 10.1016/j.cmet.2013.04.008; Creutzfeldt W, 2001, EXP CLIN ENDOCR DIAB, V109, pS288, DOI 10.1055/s-2001-18589; Drucker DJ, 2007, J CLIN INVEST, V117, P24, DOI 10.1172/JCI30076; EISSELE R, 1992, EUR J CLIN INVEST, V22, P283, DOI 10.1111/j.1365-2362.1992.tb01464.x; Ellingsgaard H, 2011, NAT MED, V17, P1481, DOI 10.1038/nm.2513; Flatt PR, 2009, CURR DRUG METAB, V10, P125, DOI 10.2174/138920009787522124; Flatt PR, 2008, FRONT BIOSCI-LANDMRK, V13, P3648, DOI 10.2741/2956; FLATT PR, 1981, DIABETOLOGIA, V20, P573; Fujita Y, 2010, GASTROENTEROLOGY, V138, P1966, DOI 10.1053/j.gastro.2010.01.049; Gault VA, 2011, J ENDOCRINOL, V208, P265, DOI 10.1530/JOE-10-0419; Green BD, 2007, BEST PRACT RES CL EN, V21, P497, DOI 10.1016/j.beem.2007.09.003; Hansen AMK, 2011, DIABETOLOGIA, V54, P1379, DOI 10.1007/s00125-011-2080-1; Hansotia T, 2005, REGUL PEPTIDES, V128, P125, DOI 10.1016/j.regpep.2004.07.019; Heller RS, 1995, AM J PHYSIOL-GASTR L, V269, pG852, DOI 10.1152/ajpgi.1995.269.6.G852; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Irwin N, 2009, DIABETES OBES METAB, V11, P603, DOI 10.1111/j.1463-1326.2009.01036.x; Irwin N, 2013, CURR OPIN PHARMACOL, V13, P989, DOI 10.1016/j.coph.2013.09.009; Irwin N, 2013, BIOCHEM PHARMACOL, V85, P81, DOI 10.1016/j.bcp.2012.10.008; Irwin N, 2010, EXPERT OPIN INV DRUG, V19, P1039, DOI 10.1517/13543784.2010.513381; Irwin N, 2009, BEST PRACT RES CL EN, V23, P499, DOI 10.1016/j.beem.2009.03.001; Kaiser D, 2014, BR J PHARM; Kelly C, 2011, ISLETS, V3, P41, DOI 10.4161/isl.3.2.14805; Kilimnik G, 2010, ISLETS, V2, P149, DOI 10.4161/isl.2.3.11396; Marchetti P, 2012, DIABETOLOGIA, V55, P3262, DOI 10.1007/s00125-012-2716-9; Masur K, 2005, MOL ENDOCRINOL, V19, P1373, DOI 10.1210/me.2004-0350; McIntosh CHS, 2009, VITAM HORM, V80, P409, DOI 10.1016/S0083-6729(08)00615-8; MOJSOV S, 1990, J BIOL CHEM, V265, P8001; Nadal A, 2009, J PHYSIOL-LONDON, V587, P5031, DOI 10.1113/jphysiol.2009.177188; Nauck MA, 2013, DIABETOLOGIA, V56, P1878, DOI 10.1007/s00125-013-2953-6; Nie Y, 2000, J CLIN INVEST, V105, P955, DOI 10.1172/JCI7456; OBrien BA, 1996, J PATHOL, V178, P176; Preitner F, 2004, J CLIN INVEST, V113, P635, DOI 10.1172/JCI200420518; Salehi M, 2010, DIABETES, V59, P1330, DOI 10.2337/db09-1253; Scrocchi LA, 1996, NAT MED, V2, P1254, DOI 10.1038/nm1196-1254; Swali A, 2008, DIABETOLOGIA, V51, P2003, DOI 10.1007/s00125-008-1137-2; Takeda Y, 2012, DIABETOLOGIA, V55, P404, DOI 10.1007/s00125-011-2365-4; Thorens B, 2013, J INTERN MED, V274, P203, DOI 10.1111/joim.12096; Thyssen S, 2006, ENDOCRINOLOGY, V147, P2346, DOI 10.1210/en.2005-0396; Ugleholdt R, 2006, J BIOL CHEM, V281, P11050, DOI 10.1074/jbc.M601203200; Whalley NM, 2011, J ENDOCRINOL, V211, P99, DOI 10.1530/JOE-11-0094; Wideman RD, 2007, DIABETES, V56, P2744, DOI 10.2337/db07-0563	45	61	61	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e101005	10.1371/journal.pone.0101005	http://dx.doi.org/10.1371/journal.pone.0101005			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967820	Green Submitted, Green Published, gold			2022-12-27	WOS:000338280800097
J	Yue, J; Li, C; Liu, YW; Yu, JJ				Yue, Jing; Li, Cong; Liu, Yuwei; Yu, Jingjuan			A Remorin Gene SiREM6, the Target Gene of SiARDP, from Foxtail Millet (Setaria italica) Promotes High Salt Tolerance in Transgenic Arabidopsis	PLOS ONE			English	Article							PLASMA-MEMBRANE; LOW-TEMPERATURE; TRANSCRIPTIONAL ACTIVATOR; MEDICAGO-TRUNCATULA; RESPONSIVE GENES; ABIOTIC-STRESS; WATER-DEFICIT; PROTEINS; EXPRESSION; DROUGHT	Remorin proteins (REMs) form a plant-specific protein family, with some REMs being responsive to abiotic stress. However, the precise functions of REMs in abiotic stress tolerance are not clear. In this study, we identified 11 remorin genes from foxtail millet (Setaria italica) and cloned a remorin gene, SiREM6, for further investigation. The transcript level of SiREM6 was increased by high salt stress, low temperature stress and abscisic acid (ABA) treatment, but not by drought stress. The potential oligomerization of SiREM6 was examined by negative staining electron microscopy. The overexpression of SiREM6 improved high salt stress tolerance in transgenic Arabidopsis at the germination and seedling stages as revealed by germination rate, survival rate, relative electrolyte leakage and proline content. The SiREM6 promoter contains two dehydration responsive elements (DRE) and one ABA responsive element (ABRE). An ABA responsive DRE-binding transcription factor, SiARDP, and an ABRE-binding transcription factor, SiAREB1, were cloned from foxtail millet. SiARDP could physically bind to the DREs, but SiAREB1 could not. These results revealed that SiREM6 is a target gene of SiARDP and plays a critical role in high salt stress tolerance.	[Yue, Jing; Li, Cong; Liu, Yuwei; Yu, Jingjuan] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China	China Agricultural University	Yu, JJ (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	yujj@cau.edu.cn			National Basic Research Program of China [2012CB215301]	National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the National Basic Research Program of China (2012CB215301). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bariola PA, 2004, PLANT MOL BIOL, V55, P579, DOI 10.1007/s11103-004-1520-4; Barton L, 2009, P NATL ACAD SCI USA, V106, P5523, DOI 10.1073/pnas.0809960106; Bechtold N, 1998, METH MOL B, V82, P259; Bettinger RL, 2010, EVOL ANTHROPOL, V19, P9, DOI 10.1002/evan.20236; Bray EA, 2002, ANN BOT-LONDON, V89, P803, DOI 10.1093/aob/mcf104; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Busk PK, 1998, PLANT MOL BIOL, V37, P425, DOI 10.1023/A:1006058700720; Checker VG, 2013, PLANT CELL REP, V32, P1729, DOI 10.1007/s00299-013-1483-5; Chen LG, 2012, BBA-GENE REGUL MECH, V1819, P120, DOI 10.1016/j.bbagrm.2011.09.002; Chen L, 2010, MOL BIOL REP, V37, P737, DOI 10.1007/s11033-009-9582-7; Coaker GL, 2004, MOL PLANT MICROBE IN, V17, P1019, DOI 10.1094/MPMI.2004.17.9.1019; Dubouzet JG, 2003, PLANT J, V33, P751, DOI 10.1046/j.1365-313X.2003.01661.x; El Yahyaoui F, 2004, PLANT PHYSIOL, V136, P3159, DOI 10.1104/pp.104.043612; FARMER EE, 1991, J BIOL CHEM, V266, P3140; FARMER EE, 1989, P NATL ACAD SCI USA, V86, P1539, DOI 10.1073/pnas.86.5.1539; Fedorova M, 2002, PLANT PHYSIOL, V130, P519, DOI 10.1104/pp.006833; Gilmour SJ, 2000, PLANT PHYSIOL, V124, P1854, DOI 10.1104/pp.124.4.1854; JACINTO T, 1993, PLANT PHYSIOL, V103, P1393, DOI 10.1104/pp.103.4.1393; Kaplan B, 2006, PLANT CELL, V18, P2733, DOI 10.1105/tpc.106.042713; Kistner C, 2005, PLANT CELL, V17, P2217, DOI 10.1105/tpc.105.032714; Kizis D, 2002, PLANT J, V30, P679, DOI 10.1046/j.1365-313X.2002.01325.x; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; Lefebvre B, 2010, P NATL ACAD SCI USA, V107, P2343, DOI 10.1073/pnas.0913320107; Lin F, 2003, CELL RES, V13, P59, DOI 10.1038/sj.cr.7290151; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Malakshah SN, 2007, BIOSCI BIOTECH BIOCH, V71, P2144, DOI 10.1271/bbb.70027; Marin M, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00086; Ofosu-Anim J., 2006, International Journal of Agriculture and Biology, V8, P576; Qin F, 2007, PLANT J, V50, P54, DOI 10.1111/j.1365-313X.2007.03034.x; Raffaele S, 2007, PLANT PHYSIOL, V145, P593, DOI 10.1104/pp.107.108639; Reymond P, 1996, PLANT CELL, V8, P2265, DOI 10.1105/tpc.8.12.2265; Rock CD, 2000, NEW PHYTOL, V148, P357, DOI 10.1046/j.1469-8137.2000.00769.x; Sanchez-Moran E, 2005, CYTOGENET GENOME RES, V109, P181, DOI 10.1159/000082398; Stockinger EJ, 1997, P NATL ACAD SCI USA, V94, P1035, DOI 10.1073/pnas.94.3.1035; Toth K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030817; Tuteja N, 2007, METHOD ENZYMOL, V428, P419, DOI 10.1016/S0076-6879(07)28024-3; Waditee R, 2005, P NATL ACAD SCI USA, V102, P1318, DOI 10.1073/pnas.0409017102; Wang QY, 2008, PLANT MOL BIOL, V67, P589, DOI 10.1007/s11103-008-9340-6; Widjaja I, 2009, PROTEOMICS, V9, P138, DOI 10.1002/pmic.200800293; Wienkoop S, 2003, PLANT PHYSIOL, V131, P1080, DOI 10.1104/pp.102.015362; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Xue GP, 2003, PLANT J, V33, P373, DOI 10.1046/j.1365-313X.2003.01630.x; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; YEO AR, 1984, PLANT PHYSIOL, V75, P298, DOI 10.1104/pp.75.2.298; Zhao L, 2009, PLANT BIOTECHNOL J, V7, P550, DOI 10.1111/j.1467-7652.2009.00423.x	45	23	27	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100772	10.1371/journal.pone.0100772	http://dx.doi.org/10.1371/journal.pone.0100772			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967625	Green Published, Green Submitted, gold			2022-12-27	WOS:000338280800065
J	Zaccaria, E; van Baarlen, P; de Greeff, A; Morrison, DA; Smith, H; Wells, JM				Zaccaria, Edoardo; van Baarlen, Peter; de Greeff, Astrid; Morrison, Donald A.; Smith, Hilde; Wells, Jerry M.			Control of Competence for DNA Transformation in Streptococcus suis by Genetically Transferable Pherotypes	PLOS ONE			English	Article							GENE-TRANSFER; PEPTIDE; PNEUMONIAE; ACTIVATION; EXPRESSION; SYSTEM; IDENTIFICATION; MECHANISMS; REGULATOR; EVOLUTION	Here we show that S. suis, a major bacterial pathogen of pigs and emerging pathogen in humans responds to a peptide pheromone by developing competence for DNA transformation. This species does not fall within any of the phylogenetic clusters of streptococci previously shown to regulate competence via peptide pheromones suggesting that more species of streptococci may be naturally competent. Induction of competence was dependent on ComX, a sigma factor that controls the streptococcal late competence regulon, extracellular addition of a comX-inducing peptide (XIP), and ComR, a regulator of comX. XIP was identified as an N-terminally truncated variant of ComS. Different comS alleles are present among strains of S. suis. These comS alleles are not functionally equivalent and appear to operate in conjuction with a cognate ComR to regulate comX through a conserved comR-box promoter. We demonstrate that these 'pherotypes' can be genetically transferred between strains, suggesting that similar approaches might be used to control competence induction in other lactic acid bacteria that lack ComR/ComS homologues but possess comX and the late competence regulon. The approaches described in this paper to identify and optimize peptide-induced competence may also assist other researchers wishing to identify natural competence in other bacteria. Harnessing natural competence is expected to accelerate genetic research on this and other important streptococcal pathogens and to allow high-throughput mutation approaches to be implemented, opening up new avenues for research.	[Zaccaria, Edoardo; van Baarlen, Peter; Wells, Jerry M.] Wageningen Univ, NL-6700 AP Wageningen, Netherlands; [de Greeff, Astrid; Smith, Hilde] Wageningen Univ, Cent Vet Inst, Lelystad, Netherlands; [Morrison, Donald A.] Univ Illinois, Chicago, IL USA	Wageningen University & Research; Wageningen University & Research; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Wells, JM (corresponding author), Wageningen Univ, NL-6700 AP Wageningen, Netherlands.	jerry.wells@wur.nl	Zaccaria, Edoardo/AAP-9740-2020	van Baarlen, Peter/0000-0003-3530-5472	National Science Foundation [MCB-1020863]	National Science Foundation(National Science Foundation (NSF))	J.W. and E.Z. gratefully acknowledge their financial support. D. M. acknowledges support from the National Science Foundation (MCB-1020863). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLOING G, 1990, MOL MICROBIOL, V4, P633, DOI 10.1111/j.1365-2958.1990.tb00632.x; Blomqvist T, 2006, ARCH MICROBIOL, V186, P465, DOI 10.1007/s00203-006-0162-0; Booijink CCGM, 2007, FUTURE MICROBIOL, V2, P285, DOI 10.2217/17460913.2.3.285; Booijink CCGM, 2010, ENVIRON MICROBIOL, V12, P3213, DOI 10.1111/j.1462-2920.2010.02294.x; Bouillaut L, 2008, NUCLEIC ACIDS RES, V36, P3791, DOI 10.1093/nar/gkn149; Chen I, 2004, NAT REV MICROBIOL, V2, P241, DOI 10.1038/nrmicro844; Dagkessamanskaia A, 2004, MOL MICROBIOL, V51, P1071, DOI 10.1111/j.1365-2958.2003.03892.x; Dehal PS, 2010, NUCLEIC ACIDS RES, V38, pD396, DOI 10.1093/nar/gkp919; Desai K, 2012, J BACTERIOL, V194, P3774, DOI 10.1128/JB.00337-12; FACKLAM RR, 1977, J CLIN MICROBIOL, V5, P184; Ferrando ML, 2010, MICROBIOL-SGM, V156, P2818, DOI 10.1099/mic.0.037960-0; Fleuchot B, 2011, MOL MICROBIOL, V80, P1102, DOI 10.1111/j.1365-2958.2011.07633.x; Fleuchot B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066042; Fontaine L, 2013, MOL MICROBIOL, V87, P1113, DOI 10.1111/mmi.12157; Fontaine L, 2010, J BACTERIOL, V192, P1444, DOI 10.1128/JB.01251-09; Gardan R, 2013, J BACTERIOL, V195, P1845, DOI 10.1128/JB.02196-12; Gardan R, 2009, J BACTERIOL, V191, P4647, DOI 10.1128/JB.00257-09; Goodstadt L, 2001, BIOINFORMATICS, V17, P845, DOI 10.1093/bioinformatics/17.9.845; Gottschalk M, 2010, FUTURE MICROBIOL, V5, P371, DOI [10.2217/fmb.10.2, 10.2217/FMB.10.2]; HAVARSTEIN LS, 1995, P NATL ACAD SCI USA, V92, P11140, DOI 10.1073/pnas.92.24.11140; Johnsborg O, 2007, RES MICROBIOL, V158, P767, DOI 10.1016/j.resmic.2007.09.004; Johnston C, 2014, NAT REV MICROBIOL, V12, P181, DOI 10.1038/nrmicro3199; Kleerebezem M, 1997, APPL ENVIRON MICROB, V63, P4581, DOI 10.1128/AEM.63.11.4581-4584.1997; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lau PCY, 2002, J MICROBIOL METH, V49, P193, DOI 10.1016/S0167-7012(01)00369-4; Lee MS, 1999, J BACTERIOL, V181, P5004, DOI 10.1128/JB.181.16.5004-5016.1999; LORENZ MG, 1994, MICROBIOL REV, V58, P563, DOI 10.1128/MMBR.58.3.563-602.1994; Martin B, 2006, TRENDS MICROBIOL, V14, P339, DOI 10.1016/j.tim.2006.06.007; Mashburn-Warren L, 2012, J BACTERIOL, V194, P4589, DOI 10.1128/JB.00830-12; Mashburn-Warren L, 2010, MOL MICROBIOL, V78, P589, DOI 10.1111/j.1365-2958.2010.07361.x; Maughan H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005854; Morrison DA, 2013, J BACTERIOL, V195, P2612, DOI 10.1128/JB.00230-13; NAKAYAMA J, 1994, J BACTERIOL, V176, P7405, DOI 10.1128/JB.176.23.7405-7408.1994; Nguyen THM, 2008, CLIN INFECT DIS, V46, P659, DOI 10.1086/527385; Okinaga T, 2010, J BACTERIOL, V192, P1844, DOI 10.1128/JB.01667-09; Peterson SN, 2004, MOL MICROBIOL, V51, P1051, DOI 10.1046/j.1365-2958.2003.03907.x; Redfield RJ, 2005, J MOL BIOL, V347, P735, DOI 10.1016/j.jmb.2005.01.012; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Slamti L, 2002, EMBO J, V21, P4550, DOI 10.1093/emboj/cdf450; Solomon JM, 1996, GENE DEV, V10, P2014, DOI 10.1101/gad.10.16.2014; Sung CK, 2005, J BACTERIOL, V187, P3052, DOI 10.1128/JB.187.9.3052-3061.2005; Syvanen M, 2012, ANNU REV GENET, V46, P341, DOI 10.1146/annurev-genet-110711-155529; Takeuchi N, 2014, G3-GENES GENOM GENET, V4, P325, DOI 10.1534/g3.113.009845; VONHEIJNE G, 1984, EMBO J, V3, P2315, DOI 10.1002/j.1460-2075.1984.tb02132.x; Zoetendal EG, 2012, ISME J, V6, P1415, DOI 10.1038/ismej.2011.212	45	46	50	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e99394	10.1371/journal.pone.0099394	http://dx.doi.org/10.1371/journal.pone.0099394			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968201	Green Submitted, Green Published, gold			2022-12-27	WOS:000338280800011
J	Zhou, X; Du, YP; Huang, ZB; Xu, J; Qiu, TZ; Wang, J; Wang, TS; Zhu, W; Liu, P				Zhou, Xin; Du, Yiping; Huang, Zebo; Xu, Jun; Qiu, Tianzhu; Wang, Jian; Wang, Tongshan; Zhu, Wei; Liu, Ping			Prognostic Value of PLR in Various Cancers: A Meta-Analysis	PLOS ONE			English	Article							PLATELET-LYMPHOCYTE RATIO; SYSTEMIC INFLAMMATORY RESPONSE; SERUM CA19-9 LEVELS; CELL LUNG-CANCER; NEUTROPHIL-LYMPHOCYTE; POOR-PROGNOSIS; PREDICT SURVIVAL; TO-LYMPHOCYTE; TUMOR; NEUTROPHIL/LYMPHOCYTE	Background: Recently, more and more studies investigated the association of inflammation parameters such as the Platelet Lymphocyte Ratio (PLR) and the prognosis of various cancers. However, the prognostic role of PLR in cancer remains controversial. Methods: We conducted a meta-analysis of published studies to evaluate the prognostic value of PLR in various cancers. In order to investigate the association between PLR and overall survival (OS), the hazard ratio (HR) and its 95% confidence interval (CI) were calculated. Results: A total of 13964 patients from 26 studies were included in the analysis. The summary results showed that elevated PLR was a negative predictor for OS with HR of 1.60 (95%CI: 1.35-1.90; P-heterogeneity<0.001). Subgroup analysis revealed that increased PLR was a negative prognostic marker in patients with gastric cancer (HR = 1.35, 95%CI: 0.80-2.25, P-heterogeneity = 0.011), colorectal cancer (HR = 1.65, 95%CI: 1.33-2.05, P-heterogeneity = 0.995), hepatocellular carcinoma (HR = 3.07, 95%CI: 2.04-4.62, P-heterogeneity = 0.133), ovarian cancer (HR = 1.57, 95%CI: 1.07-2.31, P-heterogeneity = 0.641) and non-small cell lung cancer (NSCLC) (HR = 1.85, 95%CI: 1.42-2.41, P-heterogeneity = 0.451) except for pancreatic cancer (HR = 1.00, 95%CI: 0.92-1.09, P-heterogeneity = 0.388). Conclusion: The meta-analysis demonstrated that PLR could act as a significant biomarker in the prognosis of various cancers.	[Zhou, Xin; Du, Yiping; Huang, Zebo; Xu, Jun; Qiu, Tianzhu; Wang, Jian; Wang, Tongshan; Zhu, Wei; Liu, Ping] Nanjing Med Univ, Affiliated Hosp 1, Dept Oncol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Zhu, W (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Oncol, Nanjing, Jiangsu, Peoples R China.	zhuwei1983213@163.com; liu-ping@csco.org.cn						Alexandrakis MG, 2003, AM J CLIN ONCOL-CANC, V26, P135, DOI 10.1097/00000421-200304000-00007; Aliustaoglu M, 2010, MED ONCOL, V27, P1060, DOI 10.1007/s12032-009-9335-4; Asher V, 2011, CLIN TRANSL ONCOL, V13, P499, DOI 10.1007/s12094-011-0687-9; Azab B, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0432-4; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Bambace NM, 2011, J THROMB HAEMOST, V9, P237, DOI 10.1111/j.1538-7836.2010.04131.x; Bhatti I, 2010, AM J SURG, V200, P197, DOI 10.1016/j.amjsurg.2009.08.041; Brown KM, 2005, AM J SURG, V189, P278, DOI 10.1016/j.amjsurg.2004.11.014; Carruthers R, 2012, COLORECTAL DIS, V14, pE701, DOI 10.1111/j.1463-1318.2012.03147.x; Cedres S, 2012, CLIN TRANSL ONCOL, V14, P864, DOI 10.1007/s12094-012-0872-5; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Feng JF, 2013, SCI WORLD J, DOI 10.1155/2013/504365; Fogar P, 2006, PANCREAS, V32, P22, DOI 10.1097/01.mpa.0000188305.90290.50; Fox P, 2013, BRIT J CANCER, V109, P147, DOI 10.1038/bjc.2013.300; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He WZ, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0439-x; Ikeda M, 2002, ANN SURG ONCOL, V9, P287, DOI 10.1245/aso.2002.9.3.287; Kinoshita A, 2012, BRIT J CANCER, V107, P988, DOI 10.1038/bjc.2012.354; Klinger MHF, 2002, J INTERF CYTOK RES, V22, P913, DOI 10.1089/10799900260286623; Kwon HC, 2012, BIOMARKERS, V17, P216, DOI 10.3109/1354750X.2012.656705; Laird BJ, 2013, CLIN CANCER RES, V19, P5456, DOI 10.1158/1078-0432.CCR-13-1066; Lee S, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-350; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Liu HB, 2013, J THORAC DIS, V5, P783, DOI 10.3978/j.issn.2072-1439.2013.12.34; Mahmoud SMA, 2011, J CLIN ONCOL, V29, P1949, DOI 10.1200/JCO.2010.30.5037; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mantovani A, 2008, LANCET, V371, P771, DOI 10.1016/S0140-6736(08)60241-X; McMillan DC, 2009, CURR OPIN CLIN NUTR, V12, P223, DOI 10.1097/MCO.0b013e32832a7902; Mohamed Z, 2013, BR J CANC; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Paul D, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/783131; Pinato DJ, 2012, J HEPATOL, V57, P1013, DOI 10.1016/j.jhep.2012.06.022; Pinato DJ, 2012, J THORAC ONCOL, V7, P587, DOI 10.1097/JTO.0b013e31823f45c1; Proctor MJ, 2011, EUR J CANCER, V47, P2633, DOI 10.1016/j.ejca.2011.03.028; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Raungkaewmanee S, 2012, J GYNECOL ONCOL, V23, P265, DOI 10.3802/jgo.2012.23.4.265; Romano F, 2004, J EXP CLIN CANC RES, V23, P195; Sanchez-Lara K, 2012, NUTR CANCER, V64, P526, DOI 10.1080/01635581.2012.668744; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sierko E, 2004, SEMIN THROMB HEMOST, V30, P95; Smith RA, 2008, J GASTROINTEST SURG, V12, P1422, DOI 10.1007/s11605-008-0554-3; Smith RA, 2008, SURGERY, V143, P658, DOI 10.1016/j.surg.2007.12.014; Son HJ, 2013, ANN SURG ONCOL, V20, P2908, DOI 10.1245/s10434-013-2968-8; Stotz M, 2013, BRIT J CANCER, V109, P416, DOI 10.1038/bjc.2013.332; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Szkandera J, 2014, AM J SURG; Unal D, 2013, ASIAN PAC J CANCER P, V14, P5237, DOI 10.7314/APJCP.2013.14.9.5237; Wang D, 2013, CHINESE MED J-PEKING, V126, P1464, DOI 10.3760/cma.j.issn.0366-6999.20122672; Wang DS, 2012, MED ONCOL, V29, P3092, DOI 10.1007/s12032-012-0226-8; Wang DS, 2012, TUMOR BIOL, V33, P749, DOI 10.1007/s13277-011-0285-z; Wiesner T, 2010, CLIN EXP METASTAS, V27, P141, DOI 10.1007/s10585-010-9311-6	57	194	201	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e101119	10.1371/journal.pone.0101119	http://dx.doi.org/10.1371/journal.pone.0101119			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968121	Green Submitted, Green Published, gold			2022-12-27	WOS:000338280800110
J	Brom, L; Pasman, HRW; Widdershoven, GAM; van der Vorst, MJDL; Reijneveld, JC; Postma, TJ; Onwuteaka-Philipsen, BD				Brom, Linda; Pasman, H. Roeline W.; Widdershoven, Guy A. M.; van der Vorst, Maurice J. D. L.; Reijneveld, Jaap C.; Postma, Tjeerd J.; Onwuteaka-Philipsen, Bregje D.			Patients' Preferences for Participation in Treatment Decision-Making at the End of Life: Qualitative Interviews with Advanced Cancer Patients	PLOS ONE			English	Article							RECURRENT OVARIAN-CANCER; BREAST-CANCER; OF-LIFE; COLORECTAL-CANCER; PROSTATE-CANCER; INFORMATION NEEDS; INVOLVEMENT; WOMEN; CARE; PERCEPTIONS	Purpose: Patients are often encouraged to participate in treatment decision-making. Most studies on this subject focus on choosing between different curative treatment types. In the last phase of life treatment decisions differ as they often put more emphasis on weighing quantity against quality of life, such as whether or not to start treatment aimed at life prolongation but with the possibility of side effects. This study aimed to obtain insight into cancer patients' preferences and the reasons for patients' preferred role in treatment decision-making at the end of life. Methods: 28 advanced cancer patients were included at the start of their first line treatment. In-depth interviews were held prior to upcoming treatment decisions whether or not to start a life prolonging treatment. The Control Preference Scale was used to start discussing the extent and type of influence patients wanted to have concerning upcoming treatment decision-making. Interviews were audio taped and transcribed. Results: All patients wanted their physician to participate in the treatment decision-making process. The extent to which patients themselves preferred to participate seemed to depend on how patients saw their own role or assessed their own capabilities for participating in treatment decision-making. Patients foresaw a shift in the preferred level of participation to a more active role depending in the later phase of illness when life prolongation would become more limited and quality of life would become more important. Conclusion: Patients vary in how much involvement they would like to have in upcoming treatment decision-making. Individual patients' preferences may change in the course of the illness, with a shift to more active participation in the later phases. Communication about patients' expectations, wishes and preferences for participation in upcoming treatment decisions is of great importance. An approach in which these topics are openly discussed would be beneficial.	[Brom, Linda; Pasman, H. Roeline W.; Onwuteaka-Philipsen, Bregje D.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Dept Publ & Occupat Hlth,Expertise Ctr Palliat Ca, Amsterdam, Netherlands; [Widdershoven, Guy A. M.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Dept Med Humanities, Amsterdam, Netherlands; [van der Vorst, Maurice J. D. L.] Vrije Univ Amsterdam, Med Ctr, Dept Med Oncol, Amsterdam, Netherlands; [Reijneveld, Jaap C.; Postma, Tjeerd J.] Vrije Univ Amsterdam, Med Ctr, Dept Neurol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Brom, L (corresponding author), Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Dept Publ & Occupat Hlth,Expertise Ctr Palliat Ca, Amsterdam, Netherlands.	eol@vumc.nl		Onwuteaka-Philipsen, Bregje/0000-0002-9440-1248	Innovational Research Incentives Scheme VICI from the Netherlands Organisation for Scientific Research (NWO)	Innovational Research Incentives Scheme VICI from the Netherlands Organisation for Scientific Research (NWO)	This study was funded by the Innovational Research Incentives Scheme VICI 2008 from the Netherlands Organisation for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora NK, 2000, MED CARE, V38, P335, DOI 10.1097/00005650-200003000-00010; Beaver K, 2005, HEALTH EXPECT, V8, P103, DOI 10.1111/j.1369-7625.2005.00320.x; Beaver K, 2007, EUR J ONCOL NURS, V11, P409, DOI 10.1016/j.ejon.2007.04.004; Berendsen AJ, 2010, PATIENT EDUC COUNS, V79, P100, DOI 10.1016/j.pec.2009.07.032; BLANCHARD CG, 1988, SOC SCI MED, V27, P1139, DOI 10.1016/0277-9536(88)90343-7; BRITTEN N, 1995, BRIT MED J, V311, P251, DOI 10.1136/bmj.311.6999.251; Brown R, 2012, J CLIN ONCOL, V30, P857, DOI 10.1200/JCO.2011.37.7952; Brundage Michael D., 2000, Health Expect, V3, P55, DOI 10.1046/j.1369-6513.2000.00083.x; Buiting HM, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1933; Caress AL, 2005, THORAX, V60, P199, DOI 10.1136/thx.2004.029041; Carey M, 2012, PATIENT EDUC COUNS, V88, P87, DOI 10.1016/j.pec.2011.12.014; Chu E, 2012, CLIN COLORECTAL CANC, V11, P1, DOI 10.1016/j.clcc.2011.05.005; Clark JA, 2003, J CLIN ONCOL, V21, P3777, DOI 10.1200/JCO.2003.02.115; Clark JA, 2001, J CLIN ONCOL, V19, P72, DOI 10.1200/JCO.2001.19.1.72; Cohen H, 2003, FAM PRACT, V20, P724, DOI 10.1093/fampra/cmg617; Colorectal Canc Collaborative Grp, 2000, BMJ-BRIT MED J, V321, P531; Deber RB, 2007, HEALTH EXPECT, V10, P248, DOI 10.1111/j.1369-7625.2007.00441.x; Degner L F, 1997, Can J Nurs Res, V29, P21; Degner LF, 1997, JAMA-J AM MED ASSOC, V277, P1485, DOI 10.1001/jama.277.18.1485; Donovan KA, 2002, GYNECOL ONCOL, V86, P200, DOI 10.1006/gyno.2002.6748; Elit L, 2010, PSYCHO-ONCOLOGY, V19, P318, DOI 10.1002/pon.1562; Elkin EB, 2007, J CLIN ONCOL, V25, P5275, DOI 10.1200/JCO.2007.11.1922; Fiset Valerie, 2000, Health Expect, V3, P125, DOI 10.1046/j.1369-6513.2000.00067.x; Fried Terri R, 2003, J Palliat Med, V6, P237, DOI 10.1089/109662103764978489; Gattellari M, 2001, SOC SCI MED, V52, P1865, DOI 10.1016/S0277-9536(00)00303-8; Glaser B.G., 1968, DISCOV GROUNDED THEO; Hack TF, 2006, PSYCHO-ONCOL, V15, P9, DOI 10.1002/pon.907; HACK TF, 1994, SOC SCI MED, V39, P279, DOI 10.1016/0277-9536(94)90336-0; Hubbard G, 2008, EUR J ONCOL NURS, V12, P299, DOI 10.1016/j.ejon.2008.03.004; Kremer H, 2007, MED DECIS MAKING, V27, P522, DOI 10.1177/0272989x07306782; Labianca R, 2010, CRIT REV ONCOL HEMAT, V74, P106, DOI 10.1016/j.critrevonc.2010.01.010; Lantz PM, 2005, HEALTH SERV RES, V40, P745, DOI 10.1111/j.1475-6773.2005.00383.x; Lanz NK, 2004, J CLIN ONCOL, V22, P3091, DOI 10.1200/JCO.2004.09.069; LEVY SM, 1989, J CLIN ONCOL, V7, P367, DOI 10.1200/JCO.1989.7.3.367; Mack JW, 2010, J CLIN ONCOL, V28, P1203, DOI 10.1200/JCO.2009.25.4672; MCQUELLON RP, 1995, J CLIN ONCOL, V13, P858, DOI 10.1200/JCO.1995.13.4.858; Payne DK, 2000, ANN SURG ONCOL, V7, P150, DOI 10.1007/s10434-000-0150-6; Pentz RD, 2012, ONCOLOGIST, V17, P881, DOI 10.1634/theoncologist.2011-0446; POZO C, 1992, J CLIN ONCOL, V10, P1292, DOI 10.1200/JCO.1992.10.8.1292; Purbrick RMJ, 2006, EYE, V20, P1034, DOI 10.1038/sj.eye.6702074; Rothenbacher D, 1997, EUR J CANCER, V33, P1184, DOI 10.1016/S0959-8049(97)00034-8; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Sepucha KR, 2009, MED DECIS MAKING, V29, P475, DOI 10.1177/0272989X09333124; SLEVIN ML, 1990, BRIT MED J, V300, P1458, DOI 10.1136/bmj.300.6737.1458; Strauss A., 1990, BASICS QUALITATIVE R; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Sulmasy DP, 2007, J AM GERIATR SOC, V55, P1981, DOI 10.1111/j.1532-5415.2007.01473.x; Taphoorn MJB, 2005, LANCET ONCOL, V6, P937, DOI 10.1016/S1470-2045(05)70432-0; Tariman JD, 2010, ANN ONCOL, V21, P1145, DOI 10.1093/annonc/mdp534; The AM, 2000, BRIT MED J, V321, P1376, DOI 10.1136/bmj.321.7273.1376; Weeks JC, 2012, NEW ENGL J MED, V367, P1616, DOI 10.1056/NEJMoa1204410; Wright AA, 2010, CANCER-AM CANCER SOC, V116, P4656, DOI 10.1002/cncr.25217	52	62	62	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100435	10.1371/journal.pone.0100435	http://dx.doi.org/10.1371/journal.pone.0100435			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK8WO	24964036	Green Published, gold, Green Submitted			2022-12-27	WOS:000338709500050
J	Damiano, M; Gautier, CA; Bulteau, AL; Ferrando-Miguel, R; Gouarne, C; Paoli, MG; Pruss, R; Auchere, F; L'Hermitte-Stead, C; Bouillaud, F; Brice, A; Corti, O; Lombes, A				Damiano, Maria; Gautier, Clement A.; Bulteau, Anne-Laure; Ferrando-Miguel, Rosa; Gouarne, Caroline; Paoli, Marc Giraudon; Pruss, Rebecca; Auchere, Francoise; L'Hermitte-Stead, Caroline; Bouillaud, Frederic; Brice, Alexis; Corti, Olga; Lombes, Anne			Tissue- and Cell-Specific Mitochondrial Defect in Parkin-Deficient Mice	PLOS ONE			English	Article							COMPLEX I DEFICIENCY; OXIDATIVE STRESS; ENERGY-METABOLISM; SYNAPTIC FUNCTION; YEAST MODEL; MOUSE MODEL; DISEASE; PINK1; DYSFUNCTION; MUTATIONS	Loss of Parkin, encoded by PARK2 gene, is a major cause of autosomal recessive Parkinson's disease. In Drosophila and mammalian cell models Parkin has been shown in to play a role in various processes essential to maintenance of mitochondrial quality, including mitochondrial dynamics, biogenesis and degradation. However, the relevance of altered mitochondrial quality control mechanisms to neuronal survival in vivo is still under debate. We addressed this issue in the brain of PARK2(-/-) mice using an integrated mitochondrial evaluation, including analysis of respiration by polarography or by fluorescence, respiratory complexes activity by spectrophotometric assays, mitochondrial membrane potential by rhodamine 123 fluorescence, mitochondrial DNA content by real time PCR, and oxidative stress by total glutathione measurement, proteasome activity, SOD2 expression and proteins oxidative damage. Respiration rates were lowered in PARK2(-/-) brain with high resolution but not standard respirometry. This defect was specific to the striatum, where it was prominent in neurons but less severe in astrocytes. It was present in primary embryonic cells and did not worsen in vivo from 9 to 24 months of age. It was not associated with any respiratory complex defect, including complex I. Mitochondrial inner membrane potential in PARK2(-/-) mice was similar to that of wild-type mice but showed increased sensitivity to uncoupling with ageing in striatum. The presence of oxidative stress was suggested in the striatum by increased mitochondrial glutathione content and oxidative adducts but normal proteasome activity showed efficient compensation. SOD2 expression was increased only in the striatum of PARK2(-/-) mice at 24 months of age. Altogether our results show a tissue-specific mitochondrial defect, present early in life of PARK2(-/-) mice, mildly affecting respiration, without prominent impact on mitochondrial membrane potential, whose underlying mechanisms remain to be elucidated, as complex I defect and prominent oxidative damage were ruled out.	[Damiano, Maria; Gautier, Clement A.; Ferrando-Miguel, Rosa; Brice, Alexis; Corti, Olga] Hop La Pitie Salpetriere, CRICM, INSERM, U975, Paris, France; [Damiano, Maria; Gautier, Clement A.; Ferrando-Miguel, Rosa; Brice, Alexis; Corti, Olga] Univ Paris 06, UMR S975, Paris, France; [Damiano, Maria; Gautier, Clement A.; Ferrando-Miguel, Rosa; Brice, Alexis; Corti, Olga] CNRS, UMR 7225, Paris, France; [Bulteau, Anne-Laure; L'Hermitte-Stead, Caroline; Bouillaud, Frederic; Lombes, Anne] Inst Cochin, Inserm U1016, Paris, France; [Bulteau, Anne-Laure; L'Hermitte-Stead, Caroline; Bouillaud, Frederic; Lombes, Anne] CNRS, UMR 8104, Paris, France; [Bulteau, Anne-Laure; L'Hermitte-Stead, Caroline; Bouillaud, Frederic; Lombes, Anne] Univ Paris 05, UMR S1016, Paris, France; [Gouarne, Caroline; Paoli, Marc Giraudon; Pruss, Rebecca] Trophos SA, Marseille, France; [Auchere, Francoise] Univ Paris Diderot CNRS, Inst Jacques Monod, Dept Pathol Mol & Cellulaire, Lab Mitochondries Met & Stress Oxydatif, Paris, France; [Brice, Alexis] Hop La Pitie Salpetriere, AP HP, Dept Genet & Cytogenet, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Lombes, A (corresponding author), Inst Cochin, Inserm U1016, Paris, France.	anne.lombes@inserm.fr	Bouillaud, Frédéric R/L-3238-2017; Corti, Olga/AAC-3160-2019; Lombes, Anne/G-4684-2014; Brice, Alexis/A-2170-2009; Corti, Olga/I-4981-2016; bulteau, anne-laure/AAN-4004-2020; brice, alexis/AAE-8275-2019	Bouillaud, Frédéric R/0000-0002-7518-9237; Lombes, Anne/0000-0002-9064-0399; Corti, Olga/0000-0003-2093-7389; brice, alexis/0000-0002-0941-3990	Institut national de la sante et de la recherche medicale; Association France Parkinson; Fondation de France; Agence Nationale de la Recherche; MEFOPA - EU 7th Framework Programme [HEALTH-2009-241791]; Fondation ICM, "Investissements d'avenir'' [ANR-10-IAIHU-06]; Fondation pour la Recherche Medicale	Institut national de la sante et de la recherche medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Association France Parkinson; Fondation de France(Fondation de France); Agence Nationale de la Recherche(French National Research Agency (ANR)); MEFOPA - EU 7th Framework Programme; Fondation ICM, "Investissements d'avenir''(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by Institut national de la sante et de la recherche medicale, Association France Parkinson, Fondation de France, Agence Nationale de la Recherche, MEFOPA (funded by the EU 7th Framework Programme, Grant Agreement HEALTH-2009-241791), Fondation ICM, "Investissements d'avenir'' ANR-10-IAIHU-06. CG was supported by a fellowship from the Fondation pour la Recherche Medicale. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auchere F, 2008, HUM MOL GENET, V17, P2790, DOI 10.1093/hmg/ddn178; Bulteau AL, 2007, FREE RADICAL BIO MED, V42, P1561, DOI 10.1016/j.freeradbiomed.2007.02.014; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Cardoso SM, 2011, CURR PHARM DESIGN, V17, P3390; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Chinopoulos C, 2011, METHODS MOL BIOL, V793, P311, DOI 10.1007/978-1-61779-328-8_20; Corti O, 2013, CURR OPIN NEUROBIOL, V23, P100, DOI 10.1016/j.conb.2012.11.002; Corti O, 2011, PHYSIOL REV, V91, P1161, DOI 10.1152/physrev.00022.2010; Couplan E, 2002, J BIOL CHEM, V277, P43079, DOI 10.1074/jbc.M206726200; Dagda RK, 2011, CELL DEATH DIFFER, V18, P1914, DOI 10.1038/cdd.2011.74; Darios F, 2003, HUM MOL GENET, V12, P517, DOI 10.1093/hmg/ddg044; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007; Flinn L, 2009, BRAIN, V132, P1613, DOI 10.1093/brain/awp108; Fournier M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006629; FRIEDMAN WJ, 1993, EXP NEUROL, V119, P72, DOI 10.1006/exnr.1993.1007; Gandhi S, 2009, MOL CELL, V33, P627, DOI 10.1016/j.molcel.2009.02.013; Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105; Geisler S, 2010, AUTOPHAGY, V6, P871, DOI 10.4161/auto.6.7.13286; Gimenez-Cassina A, 2012, NEURON, V74, P719, DOI 10.1016/j.neuron.2012.03.032; Gispert S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005777; Goldberg MS, 2003, J BIOL CHEM, V278, P43628, DOI 10.1074/jbc.M308947200; Grunewald A, 2009, EXP NEUROL, V219, P266, DOI 10.1016/j.expneurol.2009.05.027; Grunewald A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012962; HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x; Hauser DN, 2013, NEUROBIOL DIS, V51, P35, DOI 10.1016/j.nbd.2012.10.011; Itier JM, 2003, HUM MOL GENET, V12, P2277, DOI 10.1093/hmg/ddg239; Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X; Kubli Dieter A, 2013, Commun Integr Biol, V6, pe24511, DOI 10.4161/cib.24511; Kubli DA, 2013, J BIOL CHEM, V288, P915, DOI 10.1074/jbc.M112.411363; Larsen NJ, 2011, NEUROSCIENCE, V196, P251, DOI 10.1016/j.neuroscience.2011.08.016; Liu S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002537; MacMillan-Crow LA, 2001, FREE RADICAL RES, V34, P325, DOI 10.1080/10715760100300281; Magistretti PJ, 1996, ANN NY ACAD SCI, V777, P380, DOI 10.1111/j.1749-6632.1996.tb34449.x; Mann VM, 1992, BRAIN, V115; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Medja F, 2009, MITOCHONDRION, V9, P331, DOI 10.1016/j.mito.2009.05.001; Moisoi N, 2014, NEUROPHARMACOLOGY, V77, P350, DOI 10.1016/j.neuropharm.2013.10.009; Morais VA, 2009, EMBO MOL MED, V1, P99, DOI 10.1002/emmm.200900006; MORGANTI MC, 1990, EXP NEUROL, V109, P98, DOI 10.1016/S0014-4886(05)80012-3; Mortiboys H, 2008, ANN NEUROL, V64, P555, DOI 10.1002/ana.21492; Muftuoglu M, 2004, MOVEMENT DISORD, V19, P544, DOI 10.1002/mds.10695; Narendra D, 2012, COLD SPRING HARB PER, V4; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Pacelli C, 2011, BBA-MOL BASIS DIS, V1812, P1041, DOI 10.1016/j.bbadis.2010.12.022; Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200; Perez FA, 2005, P NATL ACAD SCI USA, V102, P2174, DOI 10.1073/pnas.0409598102; Periquet M, 2005, J NEUROCHEM, V95, P1259, DOI 10.1111/j.1471-4159.2005.03442.x; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Schagger H, 2001, J BIOL CHEM, V276, P37861; SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0; Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010; Sterky FH, 2011, P NATL ACAD SCI USA, V108, P12937, DOI 10.1073/pnas.1103295108; Stichel CC, 2007, HUM MOL GENET, V16, P2377, DOI 10.1093/hmg/ddm083; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Van Laar VS, 2011, HUM MOL GENET, V20, P927, DOI 10.1093/hmg/ddq531; Viengchareun S, 2007, ANTIVIR THER, V12, P919; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; von Coelln R, 2004, P NATL ACAD SCI USA, V101, P10744, DOI 10.1073/pnas.0401297101; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Zhang C, 2011, P NATL ACAD SCI USA, V108, P16259, DOI 10.1073/pnas.1113884108	64	32	33	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e99898	10.1371/journal.pone.0099898	http://dx.doi.org/10.1371/journal.pone.0099898			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959870	Green Submitted, Green Published, gold			2022-12-27	WOS:000338633900017
J	Garcia-Arevalo, M; Alonso-Magdalena, P; Dos Santos, JR; Quesada, I; Carneiro, EM; Nadal, A				Garcia-Arevalo, Marta; Alonso-Magdalena, Paloma; Rebelo Dos Santos, Junia; Quesada, Ivan; Carneiro, Everardo M.; Nadal, Angel			Exposure to Bisphenol-A during Pregnancy Partially Mimics the Effects of a High-Fat Diet Altering Glucose Homeostasis and Gene Expression in Adult Male Mice	PLOS ONE			English	Article							PERINATAL EXPOSURE; ENDOCRINE DISRUPTORS; BODY-WEIGHT; MOLECULAR-MECHANISMS; INSULIN-RESISTANCE; METABOLIC SYNDROME; HEPATIC STEATOSIS; RECEPTOR-ALPHA; FOOD-INTAKE; OBESITY	Bisphenol-A (BPA) is one of the most widespread EDCs used as a base compound in the manufacture of polycarbonate plastics. The aim of our research has been to study how the exposure to BPA during pregnancy affects weight, glucose homeostasis, pancreatic beta-cell function and gene expression in the major peripheral organs that control energy flux: white adipose tissue (WAT), the liver and skeletal muscle, in male offspring 17 and 28 weeks old. Pregnant mice were treated with a subcutaneous injection of 10 mu g/kg/day of BPA or a vehicle from day 9 to 16 of pregnancy. One month old offspring were divided into four different groups: vehicle treated mice that ate a normal chow diet (Control group); BPA treated mice that also ate a normal chow diet (BPA); vehicle treated animals that had a high fat diet (HFD) and BPA treated animals that were fed HFD (HFD-BPA). The BPA group started to gain weight at 18 weeks old and caught up to the HFD group before week 28. The BPA group as well as the HFD and HFD-BPA ones presented fasting hyperglycemia, glucose intolerance and high levels of non-esterified fatty acids (NEFA) in plasma compared with the Control one. Glucose stimulated insulin release was disrupted, particularly in the HFD-BPA group. In WAT, the mRNA expression of the genes involved in fatty acid metabolism, Srebpc1, Ppar alpha and Cpt1 beta was decreased by BPA to the same extent as with the HFD treatment. BPA treatment upregulated Pparc and Prkaa1 genes in the liver; yet it diminished the expression of Cd36. Hepatic triglyceride levels were increased in all groups compared to control. In conclusion, male offspring from BPA-treated mothers presented symptoms of diabesity. This term refers to a form of diabetes which typically develops in later life and is associated with obesity.	[Garcia-Arevalo, Marta; Rebelo Dos Santos, Junia; Quesada, Ivan; Nadal, Angel] Univ Miguel Hernandez Elche, Inst Bioingn, Elche, Spain; [Alonso-Magdalena, Paloma; Quesada, Ivan] Univ Miguel Hernandez Elche, Dept Biol Aplicada, Elche, Spain; [Garcia-Arevalo, Marta; Alonso-Magdalena, Paloma; Quesada, Ivan; Nadal, Angel] Univ Miguel Hernandez Elche, CIBERDEM, Ctr Invest Biomed Red Diabet & Enfermedades Metab, Elche, Spain; [Rebelo Dos Santos, Junia; Carneiro, Everardo M.] Univ Estadual Campinas, UNICAMP, Inst Biol, Dept Biol Estruct & Func, Campinas, SP, Brazil	Universidad Miguel Hernandez de Elche; Universidad Miguel Hernandez de Elche; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Universidad Miguel Hernandez de Elche; Universidade de Sao Paulo; Universidade Estadual de Campinas	Nadal, A (corresponding author), Univ Miguel Hernandez Elche, Inst Bioingn, Elche, Spain.	nadal@umh.es	García-Arévalo, Marta/C-9440-2014; Ivan, Quesada/P-6541-2014; Carneiro, Everardo/D-4758-2012; Alonso-Magdalena, Paloma/AAH-2076-2021; Silva, Junia C Santos/E-5052-2015; Nadal, Angel/G-6721-2014	Ivan, Quesada/0000-0002-9808-514X; Silva, Junia C Santos/0000-0002-8667-8140; Nadal, Angel/0000-0003-4178-2152; ALONSO MAGDALENA, PALOMA/0000-0003-1065-5388; Garcia-Arevalo Provencio, Marta/0000-0001-7238-9498	Ministerio de Economia y Competitividad [BFU2011-28358, BFU2010-21773]; Generalitat Valenciana [Prometeo/2011/080, ACOMP/2010/113]	Ministerio de Economia y Competitividad(Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission)	This research was supported by grants from Ministerio de Economia y Competitividad grants, BFU2011-28358 and BFU2010-21773, and Generalitat Valenciana grants Prometeo/2011/080 and ACOMP/2010/113. The "Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas'' is an initiative of the Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Magdalena P, 2006, ENVIRON HEALTH PERSP, V114, P106, DOI [10.1289/ehp.8451, 10.1289/ehp.8062]; Alonso-Magdalena P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002069; Alonso-Magdalena P, 2012, MOL CELL ENDOCRINOL, V355, P201, DOI 10.1016/j.mce.2011.12.012; Alonso-Magdalena P, 2011, NAT REV ENDOCRINOL, V7, P346, DOI 10.1038/nrendo.2011.56; Alonso-Magdalena P, 2010, ENVIRON HEALTH PERSP, V118, P1243, DOI 10.1289/ehp.1001993; Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; Angle BM, 2013, REPROD TOXICOL, V42, P256, DOI 10.1016/j.reprotox.2013.07.017; Batista TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033814; Boslem E, 2013, J BIOL CHEM, V288, P26569, DOI 10.1074/jbc.M113.489310; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bryzgalova G, 2008, AM J PHYSIOL-ENDOC M, V295, pE904, DOI 10.1152/ajpendo.90248.2008; Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P39, DOI 10.1289/ehp.10753; Casals-Casas C, 2011, ANNU REV PHYSIOL, V73, P135, DOI 10.1146/annurev-physiol-012110-142200; Chamorro-Garcia R, 2013, ENVIRON HEALTH PERSP, V121, P359, DOI 10.1289/ehp.1205701; Collins SC, 2010, DIABETES, V59, P1192, DOI 10.2337/db09-0791; Fradin D, 2011, J NUTR METAB, V2011, DOI 10.1155/2011/647514; Gavrilova O, 2003, J BIOL CHEM, V278, P34268, DOI 10.1074/jbc.M300043200; Goudriaan JR, 2003, J LIPID RES, V44, P2270, DOI 10.1194/jlr.M300143-JLR200; Grasselli E, 2013, CHEMOSPHERE, V91, P1123, DOI 10.1016/j.chemosphere.2013.01.016; Guerre-Millo M, 2001, DIABETES, V50, P2809, DOI 10.2337/diabetes.50.12.2809; Hajszan T, 2010, FRONT NEUROENDOCRIN, V31, P519, DOI 10.1016/j.yfrne.2010.06.004; Hectors TLM, 2011, DIABETOLOGIA, V54, P1273, DOI 10.1007/s00125-011-2109-5; Howdeshell KL, 1999, NATURE, V401, P763, DOI 10.1038/44517; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Koonen DPY, 2007, DIABETES, V56, P2863, DOI 10.2337/db07-0907; Kubista Mikael, 2006, Molecular Aspects of Medicine, V27, P95, DOI 10.1016/j.mam.2005.12.007; Lakind JS, 2008, J EXPO SCI ENV EPID, V18, P608, DOI 10.1038/jes.2008.20; Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303; Li DS, 2009, NAT PROTOC, V4, P1649, DOI 10.1038/nprot.2009.150; Li X, 2012, ENVIRON HEALTH PERSP, V120, P1720, DOI 10.1289/ehp.1205383; Lin Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.206; Liu JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064143; MacKay H, 2013, ENDOCRINOLOGY, V154, P1465, DOI 10.1210/en.2012-2044; Maffini MV, 2006, MOL CELL ENDOCRINOL, V254, P179, DOI 10.1016/j.mce.2006.04.033; Marchetti P, 2013, ADV EXP MED BIOL, V771, P288; Marmugi A, 2012, HEPATOLOGY, V55, P395, DOI 10.1002/hep.24685; Marroqui L, 2011, DIABETOLOGIA, V54, P843, DOI 10.1007/s00125-010-2024-1; Muoio DM, 2006, ANNU REV BIOCHEM, V75, P367, DOI 10.1146/annurev.biochem.75.103004.142512; Nadal A, 2000, P NATL ACAD SCI USA, V97, P11603, DOI 10.1073/pnas.97.21.11603; Nadal A, 2013, NAT REV ENDOCRINOL, V9, P9, DOI 10.1038/nrendo.2012.205; Nadal A, 2009, MOL CELL ENDOCRINOL, V304, P63, DOI 10.1016/j.mce.2009.02.016; Neel BA, 2011, DIABETES, V60, P1838, DOI 10.2337/db11-0153; Newbold Retha R, 2008, Fertil Steril, V89, pe55, DOI 10.1016/j.fertnstert.2008.01.062; Newbold RR, 2009, MOL CELL ENDOCRINOL, V304, P84, DOI 10.1016/j.mce.2009.02.024; Quesada I, 2002, FASEB J, V16, P1671, DOI 10.1096/fj.02-0313fje; Rubin BS, 2009, MOL CELL ENDOCRINOL, V304, P55, DOI 10.1016/j.mce.2009.02.023; Rubin BS, 2001, ENVIRON HEALTH PERSP, V109, P675, DOI 10.2307/3454783; Ryan KK, 2010, ENDOCRINOLOGY, V151, P2603, DOI 10.1210/en.2009-1218; Saal FSV, 2012, MOL CELL ENDOCRINOL, V354, P74, DOI 10.1016/j.mce.2012.01.001; Sachdeva MM, 2009, MOL ENDOCRINOL, V23, P747, DOI 10.1210/me.2008-0400; Shankar A, 2011, J CLIN ENDOCR METAB, V96, P3822, DOI 10.1210/jc.2011-1682; Sharpe RM, 2013, OBESITY, V21, P1081, DOI 10.1002/oby.20373; Silva E, 2011, TOXICOL SCI, V122, P383, DOI 10.1093/toxsci/kfr103; Somm E, 2009, ENVIRON HEALTH PERSP, V117, P1549, DOI 10.1289/ehp.11342; Soriano S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031109; Supale S, 2012, TRENDS ENDOCRIN MET, V23, P477, DOI 10.1016/j.tem.2012.06.002; Talsness CE, 2009, PHILOS T R SOC B, V364, P2079, DOI 10.1098/rstb.2008.0281; Taylor JA, 2011, ENVIRON HEALTH PERSP, V119, P422, DOI 10.1289/ehp.1002514; Taylor M, 2013, J TOXICOL ENV HEAL A, V76, P1333, DOI 10.1080/15287394.2013.854715; Toth JI, 2004, MOL CELL BIOL, V24, P8288, DOI 10.1128/MCB.24.18.8288-8300.2004; Trasande L, 2012, JAMA-J AM MED ASSOC, V308, P1113, DOI 10.1001/2012.jama.11461; Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010; Vandenberg LN, 2012, ENDOCR REV, V33, P378, DOI 10.1210/er.2011-1050; Vandenberg LN, 2009, ENDOCR REV, V30, P75, DOI 10.1210/er.2008-0021; Viollet B, 2006, J PHYSIOL-LONDON, V574, P41, DOI 10.1113/jphysiol.2006.108506; vom Saal FS, 2007, REPROD TOXICOL, V24, P131, DOI 10.1016/j.reprotox.2007.07.005; Wang TG, 2012, J CLIN ENDOCR METAB, V97, pE223, DOI 10.1210/jc.2011-1989; Wei J, 2011, ENDOCRINOLOGY, V152, P3049, DOI 10.1210/en.2011-0045; Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16; Welshons WV, 2006, ENDOCRINOLOGY, V147, pS56, DOI 10.1210/en.2005-1159; Wetherill YB, 2007, REPROD TOXICOL, V24, P178, DOI 10.1016/j.reprotox.2007.05.010	72	114	116	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100214	10.1371/journal.pone.0100214	http://dx.doi.org/10.1371/journal.pone.0100214			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959901	Green Published, gold, Green Submitted			2022-12-27	WOS:000338633900026
J	Gotz, R; Sendtner, M				Goetz, Rudolf; Sendtner, Michael			Cooperation of Tyrosine Kinase Receptor TrkB and Epidermal Growth Factor Receptor Signaling Enhances Migration and Dispersal of Lung Tumor Cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; NEUROTROPHIC FACTOR; ANOIKIS RESISTANCE; BETA-CATENIN; E-CADHERIN; CANCER CELLS; IN-VITRO; METASTASIS; EXPRESSION; BDNF	TrkB mediates the effects of brain-derived neurotrophic factor (BDNF) in neuronal and nonnneuronal cells. Based on recent reports that TrkB can also be transactivated through epidermal growth-factor receptor (EGFR) signaling and thus regulates migration of early neurons, we investigated the role of TrkB in migration of lung tumor cells. Early metastasis remains a major challenge in the clinical management of non-small cell lung cancer (NSCLC). TrkB receptor signaling is associated with metastasis and poor patient prognosis in NSCLC. Expression of this receptor in A549 cells and in another adenocarcinoma cell line, NCI-H441, promoted enhanced migratory capacity in wound healing assays in the presence of the TrkB ligand BDNF. Furthermore, TrkB expression in A549 cells potentiated the stimulatory effect of EGF in wound healing and in Boyden chamber migration experiments. Consistent with a potential loss of cell polarity upon TrkB expression, cell dispersal and de-clustering was induced in A549 cells independently of exogeneous BDNF. Morphological transformation involved extensive cytoskeletal changes, reduced E-cadherin expression and suppression of E-cadherin expression on the cell surface in TrkB expressing tumor cells. This function depended on MEK and Akt kinase activity but was independent of Src. These data indicate that TrkB expression in lung adenoma cells is an early step in tumor cell dissemination, and thus could represent a target for therapy development.	[Goetz, Rudolf; Sendtner, Michael] Univ Hosp Wurzburg, Inst Clin Neurobiol, Wurzburg, Germany	University of Wurzburg	Gotz, R (corresponding author), Univ Hosp Wurzburg, Inst Clin Neurobiol, Wurzburg, Germany.	Goetz_R1@ukw.de	Sendtner, Michael/J-1542-2012; Sendtner, Michael/M-8137-2014	Sendtner, Michael/0000-0002-4737-2974; Sendtner, Michael/0000-0002-4737-2974	Wilhelm Sander-Stiftung [2011.059.1]	Wilhelm Sander-Stiftung	This work was supported by Wilhelm Sander-Stiftung (grant number 2011.059.1). Url of the funder: http://www.sanst.de/cms/front_content.php?idcat = 1&lang = 1 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardelli A, 2003, SCIENCE, V300, P949, DOI 10.1126/science.1082596; Bartkowska K, 2007, DEVELOPMENT, V134, P4369, DOI 10.1242/dev.008227; Beckles MA, 2003, CHEST, V123, p97S, DOI 10.1378/chest.123.1_suppl.97S; Brodeur GM, 2009, CLIN CANCER RES, V15, P3244, DOI 10.1158/1078-0432.CCR-08-1815; BROWER M, 1986, CANCER RES, V46, P798; Buckley ST, 2010, CELL TISSUE RES, V342, P39, DOI 10.1007/s00441-010-1029-x; Camarero G, 2006, MOL CELL BIOL, V26, P7103, DOI 10.1128/MCB.00424-06; Ceteci F, 2007, CANCER CELL, V12, P145, DOI 10.1016/j.ccr.2007.06.014; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Christofori G, 2006, NATURE, V441, P444, DOI 10.1038/nature04872; Derksen PWB, 2006, CANCER CELL, V10, P437, DOI 10.1016/j.ccr.2006.09.013; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Douma S, 2004, NATURE, V430, P1034, DOI 10.1038/nature02765; Eide FF, 1996, J NEUROSCI, V16, P3123; Geiger TR, 2007, CANCER RES, V67, P6221, DOI 10.1158/0008-5472.CAN-07-0121; Geiger TR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016871; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Harada T, 2011, CLIN CANCER RES, V17, P2638, DOI 10.1158/1078-0432.CCR-10-3034; Harel L, 2009, NEURON, V63, P585, DOI 10.1016/j.neuron.2009.08.020; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Kim H, 2004, J BIOL CHEM, V279, P33538, DOI 10.1074/jbc.M404115200; Kim Y, 2009, J CELL BIOL, V184, P309, DOI 10.1083/jcb.200806067; Larsen JE, 2011, CLIN CHEST MED, V32, P703, DOI 10.1016/j.ccm.2011.08.003; Liebmann C, 2011, MOL CELL ENDOCRINOL, V331, P222, DOI 10.1016/j.mce.2010.04.008; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; Marchetti A, 2008, HUM MUTAT, V29, P609, DOI 10.1002/humu.20707; Marques FR, 2004, GYNECOL ONCOL, V94, P16, DOI 10.1016/j.ygyno.2004.03.037; MATSUMOTO K, 1995, CANCER RES, V55, P1798; Medina DL, 2004, EMBO J, V23, P3803, DOI 10.1038/sj.emboj.7600399; Nikoletopoulou V, 2010, NATURE, V467, P59, DOI 10.1038/nature09336; Okamura K, 2012, LUNG CANCER, V78, P100, DOI 10.1016/j.lungcan.2012.07.011; Pearse RN, 2005, BLOOD, V105, P4429, DOI 10.1182/blood-2004-08-3096; Puehringer D, 2013, NAT NEUROSCI, V16, P407, DOI 10.1038/nn.3333; Ramos C, 2010, AM J PHYSIOL-LUNG C, V299, pL222, DOI 10.1152/ajplung.00070.2010; Ricci A, 2001, AM J RESP CELL MOL, V25, P439, DOI 10.1165/ajrcmb.25.4.4470; Rinker-Schaeffer CW, 2006, CLIN CANCER RES, V12, P3882, DOI 10.1158/1078-0432.CCR-06-1014; Sclabas GM, 2005, CLIN CANCER RES, V11, P440; Shintani Y, 2008, AM J RESP CELL MOL, V38, P95, DOI 10.1165/rcmb.2007-0071OC; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Smit MA, 2011, ONCOGENE, V30, P3735, DOI 10.1038/onc.2011.96; Smit MA, 2009, MOL CELL BIOL, V29, P3722, DOI 10.1128/MCB.01164-08; Swartz MA, 2012, CANCER RES, V72, P2473, DOI 10.1158/0008-5472.CAN-12-0122; Thiele CJ, 2009, CLIN CANCER RES, V15, P5962, DOI 10.1158/1078-0432.CCR-08-0651; Travis WD, 2013, J CLIN ONCOL, V31, P992, DOI 10.1200/JCO.2012.46.9270; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Wells A, 2013, CANCER RES, V73, P3811, DOI 10.1158/0008-5472.CAN-13-0356; YAMAMOTO H, 1990, J NEUROSCI, V10, P3469; Yu YJ, 2010, APMIS, V118, P188, DOI 10.1111/j.1600-0463.2009.02577.x; Zhang SY, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-43; Zhang Y, 2008, ONCOLOGY-BASEL, V75, P17, DOI 10.1159/000151615	51	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100944	10.1371/journal.pone.0100944	http://dx.doi.org/10.1371/journal.pone.0100944			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959744	gold, Green Published, Green Submitted			2022-12-27	WOS:000338633900103
J	Jin, L; Lim, SW; Doh, KC; Piao, SG; Jin, J; Heo, SB; Chung, BH; Yang, CW				Jin, Long; Lim, Sun Woo; Doh, Kyoung Chan; Piao, Shang Guo; Jin, Jian; Heo, Seong Beom; Chung, Byung Ha; Yang, Chul Woo			Dipeptidyl Peptidase IV Inhibitor MK-0626 Attenuates Pancreatic Islet Injury in Tacrolimus-Induced Diabetic Rats	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; EXENDIN-4 ANALOG; BETA-CELLS; CYCLOSPORINE; SITAGLIPTIN; KIDNEY; MODEL; FK506; NEPHROTOXICITY; NEPHROPATHY	Background: Tacrolimus (TAC)-induced pancreatic islet injury is one of the important causes of new-onset diabetes in transplant recipients. This study was performed to evaluate whether a dipeptidyl peptidase IV (DPP IV) inhibitor is effective in improving TAC-induced diabetes mellitus by reducing pancreatic islet injury. Methods: Rats were treated with TAC (1.5 mg/kg, subcutaneously) and the DPP IV inhibitor MK-0626 (10 or 20 mg/kg, oral gavage) for 4 weeks. The effect of MK-0626 on TAC-induced diabetes was evaluated by assessing pancreatic islet function, histopathology. TAC-induced incretin dysfunction was also examined based on active glucagon-like peptide-1 (GLP-1) levels in the serum after glucose loading. The protective effect of MK-0626 was evaluated by measuring markers of oxidative stress, oxidative resistance, and apoptosis. To determine whether enhanced GLP-1 signaling is associated with these protective effects, we measured the expression of the GLP-1 receptor (GLP-1R) and the effect of the GLP-1 analog exendin-4 on cell viability and oxidative stress in isolated islets. Results: MK-0626 treatment attenuated TAC-induced pancreatic islet dysfunction and islet morphology. TAC treatment led to a defect in active GLP-1 secretion; however, MK-0626 reversed these effects. TAC treatment increased the level of 8-hydroxy-2'-deoxyguanosine (8-OHdG), the number of apoptotic death, and the level of active caspase-3, and decreased the level of manganese superoxide dismutase and heme oxygenase-1; MK-0626 treatment reversed these changes. MK-0626 treatment restored the expression of GLP-1R, and direct administration of exendin-4 to isolated islets reduced TAC-induced cell death and 8-OHdG expression. Conclusions: The DPP IV inhibitor MK-0626wasan effective antidiabetic agent that exerted antioxidative and antiapoptotic effects via enhanced GLP-1 signaling in TAC-induced diabetics.	[Jin, Long; Lim, Sun Woo; Doh, Kyoung Chan; Piao, Shang Guo; Jin, Jian; Heo, Seong Beom; Chung, Byung Ha; Yang, Chul Woo] Catholic Univ Korea, Seoul St Marys Hosp, Convergent Res Consortium Immunol Dis, Seoul, South Korea; [Jin, Long; Lim, Sun Woo; Doh, Kyoung Chan; Piao, Shang Guo; Jin, Jian; Heo, Seong Beom; Chung, Byung Ha; Yang, Chul Woo] Catholic Univ Korea, Transplant Res Ctr, Seoul, South Korea; [Chung, Byung Ha; Yang, Chul Woo] Catholic Univ Korea, Div Nephrol, Dept Internal Med, Seoul St Marys Hosp, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital	Yang, CW (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Convergent Res Consortium Immunol Dis, Seoul, South Korea.	yangch@catholic.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2012R1A1A30-01890]; Korean Health Technology R & D Project, Ministry for Health & Welfare, Republic of Korea [HI09C1555]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning; Korean Health Technology R & D Project, Ministry for Health & Welfare, Republic of Korea	This work was supported by a Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2012R1A1A30-01890) and the Korean Health Technology R & D Project, Ministry for Health & Welfare, Republic of Korea (HI09C1555). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANK HL, 1987, DIABETOLOGIA, V30, P812; BANK HL, 1988, IN VITRO CELL DEV B, V24, P266; Chang GL, 2013, EUR J PHARMACOL, V718, P105, DOI 10.1016/j.ejphar.2013.09.007; Edmondson SD, 2006, J MED CHEM, V49, P3614, DOI 10.1021/jm060015t; GHIANI BU, 1995, COMP BIOCHEM PHYS A, V111, P439; Glorie LLF, 2012, AM J PHYSIOL-RENAL, V303, pF681, DOI 10.1152/ajprenal.00075.2012; Haidinger M, 2013, AM J TRANSPLANT; Hirata K, 2009, BIOCHEM BIOPH RES CO, V380, P44, DOI 10.1016/j.bbrc.2009.01.003; Hwang H, 2012, IMMUNOPHARM IMMUNOT, V34, P434, DOI 10.3109/08923973.2011.618135; ISHIZUKA J, 1993, TRANSPLANTATION, V56, P1486, DOI 10.1097/00007890-199312000-00039; Iwasaki K, 2007, DRUG METAB PHARMACOK, V22, P328, DOI 10.2133/dmpk.22.328; Joo KW, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-98; Kan M, 2012, J NEUROPATH EXP NEUR, V71, P494, DOI 10.1097/NEN.0b013e3182580673; Katagiri D, 2013, J AM SOC NEPHROL, V24, P2034, DOI 10.1681/ASN.2013020134; Kim D, 2005, J MED CHEM, V48, P141, DOI 10.1021/jm0493156; Krishna R, 2007, J CLIN PHARMACOL, V47, P165, DOI 10.1177/0091270006296523; Lane JT, 2011, TRANSPLANTATION, V92, pE56, DOI 10.1097/TP.0b013e3182347ea4; Lee BW, 2011, TOXICOL APPL PHARM, V252, P47, DOI 10.1016/j.taap.2011.01.018; Lee E, 2011, BIOCHEM BIOPH RES CO, V414, P397, DOI 10.1016/j.bbrc.2011.09.087; Lee YE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050412; Lim S, 2013, PLOS ONE, V8; Lim SW, 2012, TRANSPLANTATION, V94, P218, DOI 10.1097/TP.0b013e31825ace5c; Liu WJ, 2012, J PHARMACOL EXP THER, V340, P248, DOI 10.1124/jpet.111.186866; Mu J, 2009, EUR J PHARMACOL, V623, P148, DOI 10.1016/j.ejphar.2009.09.027; Park CW, 2007, J AM SOC NEPHROL, V18, P1227, DOI 10.1681/ASN.2006070778; Piao SG, 2012, TRANSPLANTATION, V93, P383, DOI 10.1097/TP.0b013e3182421604; Sharif A, 2012, TRANSPLANTATION, V94, pE23, DOI 10.1097/TP.0b013e318260b1e9; Shih CM, 2013, CURR MED CHEM; Shihab FS, 1997, TRANSPLANTATION, V64, P1829, DOI 10.1097/00007890-199712270-00034; Song HK, 2009, AM J TRANSPLANT, V9, P2024, DOI 10.1111/j.1600-6143.2009.02751.x; Song YM, 2013, ENDOCRINOLOGY, V154, P2626, DOI 10.1210/en.2013-1031; Stillman IE, 1995, LAB INVEST, V73, P794; Strom Halden TA, 2014, NEPHROL DIAL TRANSPL; Valderhaug TG, 2011, DIABETOLOGIA, V54, P1341, DOI 10.1007/s00125-011-2105-9; Yoon HE, 2012, NEPHRON EXP NEPHROL, V120, pE123, DOI 10.1159/000342117; Yuan L, 2010, J ENDOCRINOL INVEST, V33, P13, DOI 10.1007/BF03346544; Yuan L, 2013, ACTA DIABETOL, V50, P479, DOI 10.1007/s00592-010-0210-8; Zhang Y, 2011, INVEST OPHTH VIS SCI, V52, P278, DOI 10.1167/iovs.09-4727; Zhang Y, 2009, GRAEF ARCH CLIN EXP, V247, P699, DOI 10.1007/s00417-008-1004-3	39	17	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100798	10.1371/journal.pone.0100798	http://dx.doi.org/10.1371/journal.pone.0100798			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959755	Green Published, Green Submitted, gold			2022-12-27	WOS:000338633900087
J	Krohn, A; Ahrens, T; Yalcin, A; Plones, T; Wehrle, J; Taromi, S; Wollner, S; Follo, M; Brabletz, T; Mani, SA; Claus, R; Hackanson, B; Burger, M				Krohn, Alexander; Ahrens, Theresa; Yalcin, Arzu; Ploenes, Till; Wehrle, Julius; Taromi, Sanaz; Wollner, Stefan; Follo, Marie; Brabletz, Thomas; Mani, Sendurai A.; Claus, Rainer; Hackanson, Bjoern; Burger, Meike			Tumor Cell Heterogeneity in Small Cell Lung Cancer (SCLC): Phenotypical and Functional Differences Associated with Epithelial-Mesenchymal Transition (EMT) and DNA Methylation Changes	PLOS ONE			English	Article							CLINICAL-SIGNIFICANCE; ABERRANT EXPRESSION; STEM-CELLS; CARCINOMAS; ADHESION; DIFFERENTIATION; CHEMORESISTANCE; IDENTIFICATION; CHEMOTHERAPY; METASTASIS	Small Cell Lung Cancer (SCLC) is a specific subtype of lung cancer presenting as highly metastatic disease with extremely poor prognosis. Despite responding initially well to chemo- or radiotherapy, SCLC almost invariably relapses and develops resistance to chemotherapy. This is suspected to be related to tumor cell subpopulations with different characteristics resembling stem cells. Epithelial-Mesenchymal Transition (EMT) is known to play a key role in metastatic processes and in developing drug resistance. This is also true for NSCLC, but there is very little information on EMT processes in SCLC so far. SCLC, in contrast to NSCLC cell lines, grow mainly in floating cell clusters and a minor part as adherent cells. We compared these morphologically different subpopulations of SCLC cell lines for EMT and epigenetic features, detecting significant differences in the adherent subpopulations with high levels of mesenchymal markers such as Vimentin and Fibronectin and very low levels of epithelial markers like E-cadherin and Zona Occludens 1. In addition, expression of EMT-related transcription factors such as Snail/Snai1, Slug/Snai2, and Zeb1, DNA methylation patterns of the EMT hallmark genes, functional responses like migration, invasion, matrix metalloproteases secretion, and resistance to chemotherapeutic drug treatment all differed significantly between the sublines. This phenotypic variability might reflect tumor cell heterogeneity and EMT during metastasis in vivo, accompanied by the development of refractory disease in relapse. We propose that epigenetic regulation plays a key role during phenotypical and functional changes in tumor cells and might therefore provide new treatment options for SCLC patients.	[Krohn, Alexander; Yalcin, Arzu; Wehrle, Julius; Taromi, Sanaz; Wollner, Stefan; Follo, Marie; Claus, Rainer; Hackanson, Bjoern; Burger, Meike] Univ Med Ctr, Dept Hematol Oncol & Stem Cell Transplantat, Freiburg, Germany; [Ahrens, Theresa] Univ Med Ctr, Dept Pathol, Freiburg, Germany; [Ahrens, Theresa] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Ploenes, Till] Univ Med Ctr Witten Herdecke, Dept Thorac Surg, Cologne, Germany; [Brabletz, Thomas] Univ Med Ctr, Dept Visceral Surg, Freiburg, Germany; [Mani, Sendurai A.] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA; [Burger, Meike] Univ Furtwangen, Fac Med & Life Sci, Villingen Schwenningen, Germany	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; University of Texas System; UTMD Anderson Cancer Center	Burger, M (corresponding author), Univ Med Ctr, Dept Hematol Oncol & Stem Cell Transplantat, Freiburg, Germany.	meike.burger@uniklinik-freiburg.de	Claus, Rainer/AAZ-5606-2020; Plönes, Till/AAK-8208-2021; Mani, Sendurai A./A-7244-2009	Claus, Rainer/0000-0003-2617-8766; Plönes, Till/0000-0003-4839-2130; Mani, Sendurai A./0000-0002-5918-4276; Follo, Marie/0000-0002-3090-7442; Ahrens, Theresa/0000-0003-0667-9248	Deutsche Forschungsgemeinschaft (DFG) [CRC 850, C3]; Deutsche Krebshilfe [110213]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe)	This work was supported by the Deutsche Forschungsgemeinschaft (DFG), project C3, CRC 850 (to MB), and the Deutsche Krebshilfe (110213 to BH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Brabletz T, 2012, NAT REV CANCER, V12, P425, DOI 10.1038/nrc3265; BRAMBILLA E, 1991, J CLIN ONCOL, V9, P50, DOI 10.1200/JCO.1991.9.1.50; Brooks PC, 1996, CELL, V85, P683, DOI 10.1016/S0092-8674(00)81235-0; Calbo J, 2011, CANCER CELL, V19, P244, DOI 10.1016/j.ccr.2010.12.021; CARNEY DN, 1985, CANCER RES, V45, P2913; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Govindan R, 2006, J CLIN ONCOL, V24, P4539, DOI 10.1200/JCO.2005.04.4859; Grady WM, 2000, NAT GENET, V26, P16, DOI 10.1038/79120; GRAFF JR, 1995, CANCER RES, V55, P5195; Gunasinghe NP, 2012, CANC METASTASIS REV; Haberland J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-52; Haddadin S, 2011, CLIN LUNG CANCER, V12, P87, DOI 10.1016/j.cllc.2011.03.002; Hara J, 2014, ONCOL REP, V31, P589, DOI 10.3892/or.2013.2876; Hartmann TN, 2005, ONCOGENE, V24, P4462, DOI 10.1038/sj.onc.1208621; Iniesta P, 2007, ONCOL REP, V17, P217; Islam S, 2000, J CELL BIOCHEM, V78, P141, DOI 10.1002/(SICI)1097-4644(20000701)78:1<141::AID-JCB13>3.0.CO;2-R; Iwatsuki M, 2010, CANCER SCI, V101, P293, DOI 10.1111/j.1349-7006.2009.01419.x; Jing J, 2004, EUR J CANCER, V40, P2143, DOI 10.1016/j.ejca.2004.05.018; Justilien V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035040; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; KHAN MZ, 1991, ANTICANCER RES, V11, P1687; Kobayashi S, 1999, TOHOKU J EXP MED, V189, P37, DOI 10.1620/tjem.189.37; Kraus AC, 2002, ONCOGENE, V21, P8683, DOI 10.1038/sj.onc.1205939; Liu LK, 2010, MODERN PATHOL, V23, P213, DOI 10.1038/modpathol.2009.160; Lovly CM, 2011, NAT REV CLIN ONCOL, V8, P68, DOI 10.1038/nrclinonc.2010.224; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; MIRSKI SEL, 1987, CANCER RES, V47, P2594; Pirozzi G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021548; Ploenes Till, 2012, Asian Cardiovasc Thorac Ann, V20, P694, DOI 10.1177/0218492312453348; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Radisky DC, 2008, CELL STEM CELL, V2, P511, DOI 10.1016/j.stem.2008.05.007; Rekhtman N, 2010, ARCH PATHOL LAB MED, V134, P1628, DOI 10.1043/2009-0583-RAR.1; Riaz SP, 2011, LUNG CANC; Sanchez-Tillo E, 2012, CELL MOL LIFE SCI, V69, P3429, DOI 10.1007/s00018-012-1122-2; Satelli A, 2011, CELL MOL LIFE SCI, V68, P3033, DOI 10.1007/s00018-011-0735-1; Scheel C., 2012, SEMINARS CANC BIOL; SEHESTED M, 1986, CANCER, V57, P804, DOI 10.1002/1097-0142(19860215)57:4<804::AID-CNCR2820570420>3.0.CO;2-E; Shibue T, 2011, SEMIN CANCER BIOL, V21, P99, DOI 10.1016/j.semcancer.2010.12.003; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tiwari N, 2012, SEMIN CANCER BIOL, V22, P194, DOI 10.1016/j.semcancer.2012.02.013; Travis WD., 2004, TRAVIS WB WHO CLASSI; van Meerbeeck JP, 2011, LANCET, V378, P1741, DOI 10.1016/S0140-6736(11)60165-7	47	38	39	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100249	10.1371/journal.pone.0100249	http://dx.doi.org/10.1371/journal.pone.0100249			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959847	Green Published, gold, Green Submitted			2022-12-27	WOS:000338633900031
J	Meireles, DD; Alegria, TGP; Alves, SV; Arantes, CRR; Netto, LES				Meireles, Diogo de Abreu; Pires Alegria, Thiago Geronimo; Alves, Simone Vidigal; Rocha Arantes, Carla Rani; Soares Netto, Luis Eduardo			A 14.7 kDa Protein from Francisella tularensis subsp novicida (Named FTN_1133), Involved in the Response to Oxidative Stress Induced by Organic Peroxides, Is Not Endowed with Thiol-Dependent Peroxidase Activity	PLOS ONE			English	Article							HYDROPEROXIDE RESISTANCE PROTEIN; SUCCINATE-DEHYDROGENASE; SECONDARY STRUCTURE; ESCHERICHIA-COLI; REACTIVE OXYGEN; PEROXYNITRITE; GENE; EXPRESSION; VIRULENCE; REDUCTION	Francisella genus comprises Gram-negative facultative intracellular bacteria that are among the most infectious human pathogens. A protein of 14.7 KDa named as FTN_1133 was previously described as a novel hydroperoxide resistance protein in F. tularensis subsp. novicida, implicated in organic peroxide detoxification and virulence. Here, we describe a structural and biochemical characterization of FTN_1133. Contrary to previous assumptions, multiple amino acid sequence alignment analyses revealed that FTN_1133 does not share significant similarity with proteins of the Ohr/OsmC family or any other Cys-based, thiol dependent peroxidase, including conserved motifs around reactive cysteine residues. Circular dichroism analyses were consistent with the in silico prediction of an all-a-helix secondary structure. The pK(a) of its single cysteine residue, determined by a monobromobimane alkylation method, was shown to be 8.0=0.1, value that is elevated when compared with other Cys-based peroxidases, such as peroxiredoxins and Ohr/OsmC proteins. Attempts to determine a thiol peroxidase activity for FTN_1133 failed, using both dithiols (DTT, thioredoxin and lipoamide) and monothiols (glutathione or 2-mercaptoethanol) as reducing agents. Heterologous expression of FTN_1133 gene in ahpC and oxyR mutants of E. coli showed no complementation. Furthermore, analysis of FTN_1133 protein by non-reducing SDS-PAGE showed that an intermolecular disulfide bond (not detected in Ohr proteins) can be generated under hydroperoxide treatment, but the observed rates were not comparable to those observed for other thiol-dependent peroxidases. All the biochemical and structural data taken together indicated that FTN_1133 displayed distinct characteristics from other thiol dependent peroxidases and, therefore, suggested that FTN_1133 is not directly involved in hydroperoxide detoxification.	[Meireles, Diogo de Abreu; Pires Alegria, Thiago Geronimo; Alves, Simone Vidigal; Rocha Arantes, Carla Rani; Soares Netto, Luis Eduardo] Univ Sao Paulo, Inst Biociencias, Dept Genet & Biol Evolut, Sao Paulo, Brazil	Universidade de Sao Paulo	Netto, LES (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Genet & Biol Evolut, Sao Paulo, Brazil.	nettoles@ib.usp.br	de Abreu Meireles, Diogo/AAP-7591-2020; Meireles, Diogo/C-4427-2014; Netto, Luis/A-3783-2008	de Abreu Meireles, Diogo/0000-0002-8451-2083; Meireles, Diogo/0000-0002-8451-2083; Netto, Luis/0000-0002-4250-9177; Alegria, Thiago Geronimo Pires/0000-0002-3086-4059	Fundacao de Amparo a Pesquisado Estado de Sao Paulo (FAPESP) [2007/58147-6, 2013/07937-8]; FAPESP [2012/21722-1]	Fundacao de Amparo a Pesquisado Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by grants 2007/58147-6 and 2013/07937-8 from the Fundacao de Amparo a Pesquisado Estado de Sao Paulo (FAPESP) and by a post-doctoral fellowship from FAPESP, process number 2012/21722-1, to Diogo de Abreu Meireles. The funder (FAPESP) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk M, 2006, MICROBIOL-SGM, V152, P1621, DOI 10.1099/mic.0.28495-0; Allen RG, 2012, INFECT IMMUN, V80, P3429, DOI 10.1128/IAI.00714-12; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Atichartpongkul S, 2001, MICROBIOL-SGM, V147, P1775, DOI 10.1099/00221287-147-7-1775; Bakshi CS, 2006, J BACTERIOL, V188, P6443, DOI 10.1128/JB.00266-06; Bryk R, 2000, NATURE, V407, P211, DOI 10.1038/35025109; Bryk R, 2002, SCIENCE, V295, P1073, DOI 10.1126/science.1067798; Caina JA, 2014, J PROTEOMICS, V97, P265, DOI 10.1016/j.jprot.2013.08.012; Chauhan R, 2002, BIOCHEM J, V367, P255, DOI 10.1042/BJ20020545; Clarke TE, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-27; Cuff JA, 1998, BIOINFORMATICS, V14, P892, DOI 10.1093/bioinformatics/14.10.892; Cussiol JRR, 2010, J BIOL CHEM, V285, P21943, DOI 10.1074/jbc.M110.117283; Discola KF, 2009, J MOL BIOL, V385, P889, DOI 10.1016/j.jmb.2008.10.055; Fang FC, 2004, NAT REV MICROBIOL, V2, P820, DOI 10.1038/nrmicro1004; Ferrer-Sueta G, 2011, CHEM RES TOXICOL, V24, P434, DOI 10.1021/tx100413v; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Hall A, 2011, ANTIOXID REDOX SIGN, V15, P795, DOI 10.1089/ars.2010.3624; Hansen RE, 2009, ANAL BIOCHEM, V394, P147, DOI 10.1016/j.ab.2009.07.051; Hao HX, 2009, SCIENCE, V325, P1139, DOI 10.1126/science.1175689; HOLLIS DG, 1989, J CLIN MICROBIOL, V27, P1601, DOI 10.1128/JCM.27.7.1601-1608.1989; Horta BB, 2010, J BIOL CHEM, V285, P16051, DOI 10.1074/jbc.M109.094839; Hugo M, 2009, BIOCHEMISTRY-US, V48, P9416, DOI 10.1021/bi901221s; IYER KS, 1973, J BIOL CHEM, V248, P707; JIANG ZY, 1992, ANAL BIOCHEM, V202, P384, DOI 10.1016/0003-2697(92)90122-N; Kadzhaev K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005463; Lassmann T, 2006, NUCLEIC ACIDS RES, V34, pW596, DOI 10.1093/nar/gkl191; Lesniak J, 2003, PROTEIN SCI, V12, P2838, DOI 10.1110/ps.03375603; Llewellyn AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024201; Lu J, 2014, FREE RADICAL BIO MED, V66, P75, DOI 10.1016/j.freeradbiomed.2013.07.036; Mailman Timothy L, 2005, Can J Infect Dis Med Microbiol, V16, P245; Malle E, 2007, BRIT J PHARMACOL, V152, P838, DOI 10.1038/sj.bjp.0707358; Manta B, 2009, ARCH BIOCHEM BIOPHYS, V484, P146, DOI 10.1016/j.abb.2008.11.017; McCaffrey RL, 2010, J LEUKOCYTE BIOL, V88, P791, DOI 10.1189/jlb.1209811; McLean S, 2010, J BIOL CHEM, V285, P20724, DOI 10.1074/jbc.M109.085506; Mcneil MB, 2012, J BIOL CHEM, V287, P18418, DOI 10.1074/jbc.M111.293803; Melillo AA, 2010, J BIOL CHEM, V285, P27553, DOI 10.1074/jbc.M110.144394; Melillo AA, 2009, J BACTERIOL, V191, P6447, DOI 10.1128/JB.00534-09; Nelson KJ, 2011, PROTEINS, V79, P947, DOI 10.1002/prot.22936; Nelson KJ, 2008, BIOCHEMISTRY-US, V47, P12860, DOI 10.1021/bi801718d; Ogusucu R, 2007, FREE RADICAL BIO MED, V42, P326, DOI 10.1016/j.freeradbiomed.2006.10.042; Oliveira MA, 2006, J MOL BIOL, V359, P433, DOI 10.1016/j.jmb.2006.03.054; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; Peskin AV, 2007, J BIOL CHEM, V282, P11885, DOI 10.1074/jbc.M700339200; Porollo AA, 2004, BIOINFORMATICS, V20, P2460, DOI 10.1093/bioinformatics/bth248; Renato J, 2003, J BIOL CHEM, V278, P11570, DOI 10.1074/jbc.M300252200; Sardi F, 2013, ANAL BIOCHEM, V435, P74, DOI 10.1016/j.ab.2012.12.017; Shin DH, 2004, ACTA CRYSTALLOGR D, V60, P903, DOI 10.1107/S0907444904005013; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sugano Y, 2007, J BIOL CHEM, V282, P36652, DOI 10.1074/jbc.M706996200; Tairum CA, 2012, J MOL BIOL, V424, P28, DOI 10.1016/j.jmb.2012.09.008; Trujillo M, 2007, ARCH BIOCHEM BIOPHYS, V467, P95, DOI 10.1016/j.abb.2007.08.008; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wehrly TD, 2009, CELL MICROBIOL, V11, P1128, DOI 10.1111/j.1462-5822.2009.01316.x	54	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e99492	10.1371/journal.pone.0099492	http://dx.doi.org/10.1371/journal.pone.0099492			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959833	Green Published, gold, Green Submitted			2022-12-27	WOS:000338633900007
J	Qi, LS; Li, BL; Dong, Y; Xu, H; Chen, LB; Wang, HW; Li, PF; Zhao, WY; Gu, YY; Wang, CG; Guo, Z				Qi, Lishuang; Li, Bailiang; Dong, Yu; Xu, Hui; Chen, Libin; Wang, Hongwei; Li, Pengfei; Zhao, Wenyuan; Gu, Yunyan; Wang, Chenguang; Guo, Zheng			Deconvolution of the Gene Expression Profiles of Valuable Banked Blood Specimens for Studying the Prognostic Values of Altered Peripheral Immune Cell Proportions in Cancer Patients	PLOS ONE			English	Article							LUNG-CANCER; COLORECTAL-CANCER; DENDRITIC CELLS; ADJUVANT CHEMOTHERAPY; MONONUCLEAR-CELLS; LYMPHOCYTE RATIO; FLOW-CYTOMETRY; OVARIAN-CANCER; BREAST-CANCER; SURVIVAL	Background: The altered composition of immune cells in peripheral blood has been reported to be associated with cancer patient survival. However, analysis of the composition of peripheral immune cells are often limited in retrospective survival studies employing banked blood specimens with long-term follow-up because the application of flow cytometry to such specimens is problematic. The aim of this study was to demonstrate the feasibility of deconvolving blood-based gene expression profiles (GEPs) to estimate the proportions of immune cells and determine their prognostic values for cancer patients. Methods and Results: Here, using GEPs from peripheral blood mononuclear cells (PBMC) of 108 non-small cell lung cancer (NSCLC) patients, we deconvolved the immune cell proportions and analyzed their association with patient survival. Univariate Kaplan-Meier analysis showed that a low proportion of T cells was significantly associated with poor patient survival, as was the proportion of T helper cells; however, only the proportion of T cells was independently prognostic for patients by a multivariate Cox regression analysis (hazard ratio = 2.23; 95% CI, 1.01-4.92; p = .048). Considering that altered peripheral blood compositions can reflect altered immune responses within the tumor microenvironment, based on a tissue-based GEPs of NSCLC patients, we demonstrated a significant association between poor patient survival and the low level of antigen presentation, which play a critical role in T cell proliferation. Conclusions: These results demonstrate that it is feasible to deconvolve GEPs from banked blood specimens for retrospective survival analysis of alterations of immune cell composition, and suggest the proportion of T cells in PBMC which might reflect the antigen presentation level within the tumor microenvironment can be a prognostic marker for NSCLC patients.	[Qi, Lishuang; Dong, Yu; Xu, Hui; Chen, Libin; Wang, Hongwei; Li, Pengfei; Zhao, Wenyuan; Gu, Yunyan; Guo, Zheng] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China; [Li, Bailiang; Wang, Chenguang] Harbin Med Univ, Coll Pharm, Harbin, Peoples R China; [Guo, Zheng] Fujian Med Univ, Sch Basic Med Sci, Dept Bioinformat, Fuzhou, Peoples R China	Harbin Medical University; Harbin Medical University; Fujian Medical University	Wang, CG (corresponding author), Harbin Med Univ, Coll Pharm, Harbin, Peoples R China.	cgwang1231@hotmail.com; guoz@ems.hrbmu.edu.cn	Wang, Hongwei/E-5448-2016; Li, Bailiang/AAL-5871-2020	Li, Bailiang/0000-0001-6729-219X; Gu, Yunyan/0000-0001-5693-4126; Wang, Hongwei/0000-0003-3581-8892	National Natural Science Foundation of China [91029717, 81071646, 81372213, 81201822]; Research Fund for the Doctoral Program of Higher Education of China [20112307110011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the National Natural Science Foundation of China (Grant Nos. 91029717, 81071646, 81372213 and 81201822), and Research Fund for the Doctoral Program of Higher Education of China (Grant No. 20112307110011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006098; Abbas AR, 2005, GENES IMMUN, V6, P319, DOI 10.1038/sj.gene.6364173; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; BONADONNA G, 1981, NEW ENGL J MED, V304, P10, DOI 10.1056/NEJM198101013040103; Burczynski ME, 2005, CLIN CANCER RES, V11, P1181; Cedres S, 2012, CLIN TRANSL ONCOL, V14, P864, DOI 10.1007/s12094-012-0872-5; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Croci DO, 2007, CANCER IMMUNOL IMMUN, V56, P1687, DOI 10.1007/s00262-007-0343-y; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; DEVAUX BC, 1993, J NEUROSURG, V78, P767, DOI 10.3171/jns.1993.78.5.0767; Dieu-Nosjean MC, 2008, J CLIN ONCOL, V26, P4410, DOI 10.1200/JCO.2007.15.0284; Eisenthal A, 2001, HUM PATHOL, V32, P803, DOI 10.1053/hupa.2001.26455; Fan HT, 2005, CURR MOL MED, V5, P3, DOI 10.2174/1566524053152861; Fox J., 2002, R S PLUS COMPANION A; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Gaujoux R, 2013, BIOINFORMATICS, V29, P2211, DOI 10.1093/bioinformatics/btt351; Gaujoux R, 2012, INFECT GENET EVOL, V12, P913, DOI 10.1016/j.meegid.2011.08.014; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; HARRINGTON DP, 1982, BIOMETRIKA, V69, P553, DOI 10.2307/2335991; Hirashima M, 1998, J CANCER RES CLIN, V124, P329, DOI 10.1007/s004320050178; Hirschowitz EA, 2004, J CLIN ONCOL, V22, P2808, DOI 10.1200/JCO.2004.01.074; Jaye DL, 2012, J IMMUNOL, V188, P4715, DOI 10.4049/jimmunol.1290017; Johnson SK, 2000, LUNG CANCER-J IASLC, V27, P27, DOI 10.1016/S0169-5002(99)00095-1; Kikuchi E, 2007, CANCER SCI, V98, P1424, DOI 10.1111/j.1349-7006.2007.00558.x; Kossenkov AV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034392; Leffers N, 2009, CANCER IMMUNOL IMMUN, V58, P449, DOI 10.1007/s00262-008-0583-5; Li YX, 2012, J CANC THERAPY, V03, P412; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mohr S, 2007, TRENDS MOL MED, V13, P422, DOI 10.1016/j.molmed.2007.08.003; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Pautu Jeremy L, 2003, Natl Med J India, V16, P150; Pinzon-Charry A, 2005, IMMUNOL CELL BIOL, V83, P451, DOI 10.1111/j.1440-1711.2005.01371.x; Ribic CM, 2003, NEW ENGL J MED, V349, P247, DOI 10.1056/NEJMoa022289; Ruffini E, 2009, ANN THORAC SURG, V87, P365, DOI 10.1016/j.athoracsur.2008.10.067; Sandel MH, 2005, CLIN CANCER RES, V11, P2576, DOI 10.1158/1078-0432.CCR-04-1448; Sarraf KM, 2009, J THORAC CARDIOV SUR, V137, P425, DOI 10.1016/j.jtcvs.2008.05.046; SATOMI A, 1995, ACTA ONCOL, V34, P69, DOI 10.3109/02841869509093641; Showe MK, 2012, ONCOIMMUNOLOGY, V1, P1414, DOI 10.4161/onci.21096; Showe MK, 2009, CANCER RES, V69, P9202, DOI 10.1158/0008-5472.CAN-09-1378; Solsona E, 2001, J UROLOGY, V165, P1506, DOI 10.1016/S0022-5347(05)66337-9; Suzuki K, 2011, CLIN CANCER RES, V17, P5247, DOI 10.1158/1078-0432.CCR-10-2805; Takeuchi T, 2006, J CLIN ONCOL, V24, P1679, DOI 10.1200/JCO.2005.03.8224; TOLLERUD DJ, 1991, J CLIN LAB ANAL, V5, P255; Tosolini M, 2011, CANCER RES, V71, P1263, DOI 10.1158/0008-5472.CAN-10-2907; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324; Walsh Sr, 2005, J SURG ONCOL, V91, P181, DOI 10.1002/jso.20329; Watkins NA, 2009, BLOOD, V113, pE1, DOI 10.1182/blood-2008-06-162958; Wei SH, 2006, CLIN CANCER RES, V12, P2788, DOI 10.1158/1078-0432.CCR-05-1551; WRONSKI M, 1995, J NEUROSURG, V83, P605, DOI 10.3171/jns.1995.83.4.0605	51	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100934	10.1371/journal.pone.0100934	http://dx.doi.org/10.1371/journal.pone.0100934			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959668	Green Submitted, Green Published, gold			2022-12-27	WOS:000338633900101
J	Sohn, MJ; Yoo, SJ; Oh, DB; Kwon, O; Lee, SY; Sibirny, AA; Kang, HA				Sohn, Min Jeong; Yoo, Su Jin; Oh, Doo-Byoung; Kwon, Ohsuk; Lee, Sang Yup; Sibirny, Andriy A.; Kang, Hyun Ah			Novel Cysteine-Centered Sulfur Metabolic Pathway in the Thermotolerant Methylotrophic Yeast Hansenula polymorpha	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; SCHIZOSACCHAROMYCES-POMBE; GENE ENCODES; N-GLYCAN; GLUTATHIONE; PROTEIN; TRANSCRIPTION; BIOSYNTHESIS; ASSIMILATION; AUXOTROPHY	In yeast and filamentous fungi, sulfide can be condensed either with O-acetylhomoserine to generate homocysteine, the precursor of methionine, or with O-acetylserine to directly generate cysteine. The resulting homocysteine and cysteine can be interconverted through transsulfuration pathway. Here, we systematically analyzed the sulfur metabolic pathway of the thermotolerant methylotrophic yeast Hansenula polymorpha, which has attracted much attention as an industrial yeast strain for various biotechnological applications. Quite interestingly, the detailed sulfur metabolic pathway of H. polymorpha, which was reconstructed based on combined analyses of the genome sequences and validation by systematic gene deletion experiments, revealed the absence of de novo synthesis of homocysteine from inorganic sulfur in this yeast. Thus, the direct biosynthesis of cysteine from sulfide is the only pathway of synthesizing sulfur amino acids from inorganic sulfur in H. polymorpha, despite the presence of both directions of transsulfuration pathway Moreover, only cysteine, but no other sulfur amino acid, was able to repress the expression of a subset of sulfur genes, suggesting its central and exclusive role in the control of H. polymorpha sulfur metabolism. S-35-Cys was more efficiently incorporated into intracellular sulfur compounds such as glutathione than S-35-Met in H. polymorpha, further supporting the cysteine-centered sulfur pathway. This is the first report on the novel features of H. polymorpha sulfur metabolic pathway, which are noticeably distinct from those of other yeast and filamentous fungal species.	[Sohn, Min Jeong; Yoo, Su Jin; Kang, Hyun Ah] Chung Ang Univ, Dept Life Sci, Seoul 156756, South Korea; [Sohn, Min Jeong; Lee, Sang Yup] Korea Adv Inst Sci & Technol, Dept Biomol & Chem Engn, Program BK21, Taejon 305701, South Korea; [Oh, Doo-Byoung; Kwon, Ohsuk] Korea Res Inst Biosci & Biotechnol, Biochem & Synthet Biol Res Ctr, Taejon, South Korea; [Sibirny, Andriy A.] Natl Acad Sci Ukraine, Inst Cell Biol, Lvov, Ukraine	Chung Ang University; Korea Advanced Institute of Science & Technology (KAIST); Korea Research Institute of Bioscience & Biotechnology (KRIBB); National Academy of Sciences Ukraine; Institute of Cell Biology of NASU	Kang, HA (corresponding author), Chung Ang Univ, Dept Life Sci, Seoul 156756, South Korea.	hyunkang@cau.ac.kr	Lee, Sang Yup/C-1526-2011	Lee, Sang Yup/0000-0003-0599-3091; Sibirny, Andriy/0000-0001-8579-1566; Yoo, Su Jin/0000-0001-5023-5164; Oh, Doo-Byoung/0000-0002-4432-0941	National Research Foundation of Korea (NRF) [NRF-2012-0001150, NRF-2013M3A6A8073554]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	Funding provided by the National Research Foundation of Korea (NRF) grant No. NRF-2012-0001150, http://www.nrf.re.kr/nrf_eng_cms/ and the National Research Foundation of Korea (NRF) grant No. NRF-2013M3A6A8073554, http://www.nrf.re.kr/nrf_eng_cms/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blazhenko Oleksandra V, 2006, Biometals, V19, P593, DOI 10.1007/s10534-006-0005-0; Brzywczy J, 2002, YEAST, V19, P29, DOI 10.1002/yea.798; Cheon SA, 2012, J MICROBIOL, V50, P341, DOI 10.1007/s12275-012-2097-2; Cheon SA, 2009, YEAST, V26, P507, DOI 10.1002/yea.1701; CHEREST H, 1992, GENETICS, V130, P51; Fujita Y, 2004, BIOSCI BIOTECH BIOCH, V68, P306, DOI 10.1271/bbb.68.306; Gellissen G, 2002, HANSENULA POLYMORPHA; Gidijala L, 2007, FEMS YEAST RES, V7, P1160, DOI 10.1111/j.1567-1364.2007.00228.x; Grynberg M, 2000, MICROBIOL-UK, V146, P2695, DOI 10.1099/00221287-146-10-2695; Hebert A, 2011, APPL MICROBIOL BIOT, V91, P1409, DOI 10.1007/s00253-011-3481-2; Hebert A, 2011, FEMS YEAST RES, V11, P366, DOI 10.1111/j.1567-1364.2011.00725.x; Isnard AD, 1996, J MOL BIOL, V262, P473, DOI 10.1006/jmbi.1996.0529; Kaur J, 2007, GENETICS, V176, P877, DOI 10.1534/genetics.107.070342; KUMARI K, 1994, ANAL BIOCHEM, V220, P374, DOI 10.1006/abio.1994.1352; Lafaye A, 2005, J BIOL CHEM, V280, P24723, DOI 10.1074/JBC.M502285200; Lee B, 2002, MICROBIOL-SGM, V148, P2697, DOI 10.1099/00221287-148-9-2697; Marzluf GA, 1997, ANNU REV MICROBIOL, V51, P73, DOI 10.1146/annurev.micro.51.1.73; Menant A, 2006, J BIOL CHEM, V281, P11744, DOI 10.1074/jbc.M600037200; Mendoza-Cozatl D, 2005, FEMS MICROBIOL REV, V29, P653, DOI 10.1016/j.femsre.2004.09.004; Natorff R, 2003, MOL MICROBIOL, V49, P1081, DOI 10.1046/j.1365-2958.2003.03617.x; Oh Doo-Byoung, 2008, Biotechnology Journal, V3, P659, DOI 10.1002/biot.200700252; Penninckx MJ, 2002, FEMS YEAST RES, V2, P295, DOI 10.1111/j.1567-1364.2002.tb00098.x; Saito K, 2004, PLANT PHYSIOL, V136, P2443, DOI 10.1104/pp.104.046755; Spector D, 2001, J BIOL CHEM, V276, P7011, DOI 10.1074/jbc.M009814200; Thomas D, 1997, MICROBIOL MOL BIOL R, V61, P503, DOI 10.1128/.61.4.503-532.1997; THOMAS D, 1992, MOL CELL BIOL, V12, P1719, DOI 10.1128/MCB.12.4.1719; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ubiyvovk VM, 2006, CELL BIOL INT, V30, P665, DOI 10.1016/j.cellbi.2006.04.006; Ubiyvovk VM, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-8; van der Klei IJ, 2002, HANSENULA POLYMORPHA: BIOLOGY AND APPLICATIONS, P76; Vido K, 2001, J BIOL CHEM, V276, P8469, DOI 10.1074/jbc.M008708200; Yurimoto H, 2011, INT J MICROBIOL, V2011, DOI DOI 10.1155/2011/101298	32	18	19	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100725	10.1371/journal.pone.0100725	http://dx.doi.org/10.1371/journal.pone.0100725			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959887	Green Submitted, Green Published, gold			2022-12-27	WOS:000338633900075
J	Xu, Y; Lin, ZW; Zhao, N; Zhou, LP; Liu, F; Cichacz, Z; Zhang, L; Zhan, QM; Zhao, XH				Xu, Yang; Lin, Zhengwei; Zhao, Nan; Zhou, Lanping; Liu, Fang; Cichacz, Zbigniew; Zhang, Lin; Zhan, Qimin; Zhao, Xiaohang			Receptor Interactive Protein Kinase 3 Promotes Cisplatin-Triggered Necrosis in Apoptosis-Resistant Esophageal Squamous Cell Carcinoma Cells	PLOS ONE			English	Article							MIXED LINEAGE KINASE; DOMAIN-LIKE; C-FOS; MOLECULAR-MECHANISMS; INDUCED CYTOTOXICITY; PROGRAMMED NECROSIS; INDUCED NECROPTOSIS; RIP KINASES; L929 CELLS; DEATH	Cisplatin-based chemotherapy is currently the standard treatment for locally advanced esophageal cancer. Cisplatin has been shown to induce both apoptosis and necrosis in cancer cells, but the mechanism by which programmed necrosis is induced remains unknown. In this study, we provide evidence that cisplatin induces necrotic cell death in apoptosis-resistant esophageal cancer cells. This cell death is dependent on RIPK3 and on necrosome formation via autocrine production of TNF alpha. More importantly, we demonstrate that RIPK3 is necessary for cisplatin-induced killing of esophageal cancer cells because inhibition of RIPK1 activity by necrostatin or knockdown of RIPK3 significantly attenuates necrosis and leads to cisplatin resistance. Moreover, microarray analysis confirmed an anti-apoptotic molecular expression pattern in esophageal cancer cells in response to cisplatin. Taken together, our data indicate that RIPK3 and autocrine production of TNFa contribute to cisplatin sensitivity by initiating necrosis when the apoptotic pathway is suppressed or absent in esophageal cancer cells. These data provide new insight into the molecular mechanisms underlying cisplatin-induced necrosis and suggest that RIPK3 is a potential marker for predicting cisplatin sensitivity in apoptosis-resistant and advanced esophageal cancer.	[Xu, Yang; Lin, Zhengwei; Zhao, Nan; Zhou, Lanping; Liu, Fang; Zhan, Qimin; Zhao, Xiaohang] Chinese Acad Med Sci, Canc Inst & Hosp, State Key Lab Mol Oncol, Beijing 100730, Peoples R China; [Zhang, Lin] Univ Pittsburgh, Inst Canc, Dept Pharmacol, Pittsburgh, PA USA; [Zhang, Lin] Univ Pittsburgh, Inst Canc, Dept Biol Chem, Pittsburgh, PA USA; [Cichacz, Zbigniew] Arizona State Univ, Biodesign Inst, Tempe, AZ USA; [Zhao, Xiaohang] Navy Gen Hosp, Ctr Basic Med Sci, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Arizona State University; Arizona State University-Tempe; Sixth Medical Center of Chinese PLA General Hospital	Zhao, XH (corresponding author), Chinese Acad Med Sci, Canc Inst & Hosp, State Key Lab Mol Oncol, Beijing 100730, Peoples R China.	zhaoxh@cicams.ac.cn	Zhang, Lin/A-7389-2009	Zhang, Lin/0000-0003-0018-3903	NSFC [81071811, 91029725, 81321091, 81372591, 81372385]; National High-tech R D Program [2012AA020206, 2012AA02A503]; State Key Projects for Basic Research of China [2011CB910703]	NSFC(National Natural Science Foundation of China (NSFC)); National High-tech R D Program(National High Technology Research and Development Program of China); State Key Projects for Basic Research of China	This work was supported by grants from the NSFC (No. 81071811, 91029725, 81321091, 81372591, 81372385), the National High-tech R & D Program (No. 2012AA020206, 2012AA02A503), and the State Key Projects for Basic Research (No. 2011CB910703) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajpai J, 2011, PEDIATR RADIOL, V41, P441, DOI 10.1007/s00247-010-1876-3; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Chen WZ, 2013, J BIOL CHEM, V288, P16247, DOI 10.1074/jbc.M112.435545; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Cui Q, 2011, PATHOL ONCOL RES, V17, P587, DOI 10.1007/s12253-010-9354-7; Declercq W, 2009, CELL, V138, P229, DOI 10.1016/j.cell.2009.07.006; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Eilber FC, 2001, J CLIN ONCOL, V19, P3203, DOI 10.1200/JCO.2001.19.13.3203; Eschenburg G, 2012, CANCER RES, V72, P2645, DOI 10.1158/0008-5472.CAN-11-4072; Festjens N, 2007, CELL DEATH DIFFER, V14, P400, DOI 10.1038/sj.cdd.4402085; Fortes GB, 2012, BLOOD, V119, P2368, DOI 10.1182/blood-2011-08-375303; Fuertes MA, 2003, CURR MED CHEM, V10, P257, DOI 10.2174/0929867033368484; Galluzzi L, 2009, J MOL CELL BIOL, V1, P8, DOI 10.1093/jmcb/mjp007; Gonzalez VM, 2001, MOL PHARMACOL, V59, P657, DOI 10.1124/mol.59.4.657; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hughes MA, 2013, METHODS, V61, P98, DOI 10.1016/j.ymeth.2013.02.006; Ilson David H, 2008, Gastrointest Cancer Res, V2, P85; Irizarry RA, 2003, STAT APPL GENET MOL, V2, DOI DOI 10.2202/1544-6115.1002; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jin ZY, 2005, CANCER BIOL THER, V4, P139, DOI 10.4161/cbt.4.2.1508; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kravchenko-Balasha N, 2009, J BIOL CHEM, V284, P11717, DOI 10.1074/jbc.M900217200; Lash LH, 2003, J PHARMACOL EXP THER, V305, P1163, DOI 10.1124/jpet.102.046185; Li DD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045058; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Lin J, 2013, CELL REP, V3, P200, DOI 10.1016/j.celrep.2012.12.012; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loder S, 2012, LEUKEMIA, V26, P1020, DOI 10.1038/leu.2011.353; Miller CR, 2006, J CLIN ONCOL, V24, P5419, DOI 10.1200/JCO.2006.08.1497; Muscella A, 2009, BRIT J PHARMACOL, V156, P751, DOI 10.1111/j.1476-5381.2008.00049.x; Ogawa Y, 1997, CLIN CANCER RES, V3, P2301; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Ramesh G, 2003, AM J PHYSIOL-RENAL, V285, pF610, DOI 10.1152/ajprenal.00101.2003; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Roychowdhury S, 2013, HEPATOLOGY, V57, P1773, DOI 10.1002/hep.26200; Sancho-Martinez SM, 2011, TOXICOL SCI, V122, P73, DOI 10.1093/toxsci/kfr098; Sharma A, 2009, DNA CELL BIOL, V28, P311, DOI 10.1089/dna.2009.0851; SHIMADA Y, 1992, CANCER, V69, P277, DOI 10.1002/1097-0142(19920115)69:2<277::AID-CNCR2820690202>3.0.CO;2-C; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vanlangenakker N, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.111; Wainford RD, 2009, TOXICOL IN VITRO, V23, P780, DOI 10.1016/j.tiv.2009.04.004; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Welz PS, 2011, NATURE, V477, P330, DOI 10.1038/nature10273; Wu YT, 2011, CELL DEATH DIFFER, V18, P26, DOI 10.1038/cdd.2010.72; Xia Y, 2013, J BIOL CHEM; Xu Y, 2011, CLIN CANCER RES, V17, P5412, DOI 10.1158/1078-0432.CCR-11-0426; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhang LJ, 2008, ANTI-CANCER DRUG, V19, P159, DOI 10.1097/CAD.0b013e3282f30d05; Zhao J, 2012, P NATL ACAD SCI USA, V109, P5322, DOI 10.1073/pnas.1200012109	53	32	35	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100127	10.1371/journal.pone.0100127	http://dx.doi.org/10.1371/journal.pone.0100127			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959694	Green Published, gold, Green Accepted			2022-12-27	WOS:000338633900021
J	Bazil, JN; Stamm, KD; Li, X; Thiagarajan, R; Nelson, TJ; Tomita-Mitchell, A; Beard, DA				Bazil, Jason N.; Stamm, Karl D.; Li, Xing; Thiagarajan, Raghuram; Nelson, Timothy J.; Tomita-Mitchell, Aoy; Beard, Daniel A.			The Inferred Cardiogenic Gene Regulatory Network in the Mammalian Heart	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; EXPRESSION PROFILES; STEM-CELLS; INFERENCE; GATA4; ONTOLOGY; BIOLOGY; IDENTIFICATION; MORPHOGENESIS; SIMILARITY	Cardiac development is a complex, multiscale process encompassing cell fate adoption, differentiation and morphogenesis. To elucidate pathways underlying this process, a recently developed algorithm to reverse engineer gene regulatory networks was applied to time-course microarray data obtained from the developing mouse heart. Approximately 200 genes of interest were input into the algorithm to generate putative network topologies that are capable of explaining the experimental data via model simulation. To cull specious network interactions, thousands of putative networks are merged and filtered to generate scale-free, hierarchical networks that are statistically significant and biologically relevant. The networks are validated with known gene interactions and used to predict regulatory pathways important for the developing mammalian heart. Area under the precision-recall curve and receiver operator characteristic curve are 9% and 58%, respectively. Of the top 10 ranked predicted interactions, 4 have already been validated. The algorithm is further tested using a network enriched with known interactions and another depleted of them. The inferred networks contained more interactions for the enriched network versus the depleted network. In all test cases, maximum performance of the algorithm was achieved when the purely data-driven method of network inference was combined with a data-independent, functional-based association method. Lastly, the network generated from the list of approximately 200 genes of interest was expanded using gene-profile uniqueness metrics to include approximately 900 additional known mouse genes and to form the most likely cardiogenic gene regulatory network. The resultant network supports known regulatory interactions and contains several novel cardiogenic regulatory interactions. The method outlined herein provides an informative approach to network inference and leads to clear testable hypotheses related to gene regulation.	[Bazil, Jason N.; Thiagarajan, Raghuram; Beard, Daniel A.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Stamm, Karl D.; Tomita-Mitchell, Aoy] Med Coll Wisconsin, Biotechnol & Bioengn Ctr, Milwaukee, WI 53226 USA; [Li, Xing] Mayo Clin, Dept Hlth Sci Res, Div Biomed Stat & Informat, Rochester, MN USA; [Nelson, Timothy J.] Dept Med, Rochester, MN USA; [Nelson, Timothy J.] Dept Mol Pharmacol, Rochester, MN USA; [Nelson, Timothy J.] Dept Expt Therapeut, Rochester, MN USA; [Nelson, Timothy J.] Mayo Clin, Ctr Regenerat Med, Rochester, MN USA	University of Michigan System; University of Michigan; Medical College of Wisconsin; Mayo Clinic; Mayo Clinic	Beard, DA (corresponding author), Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.	beardda@umich.edu		Stamm, Karl/0000-0002-7844-7326	National Institutes of Health [P50-GM09450]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM094503] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grant P50-GM09450 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altay G, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-132; Bansal M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100120; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bazil JN, 2012, B MATH BIOL, V74, P688, DOI 10.1007/s11538-011-9686-9; Bazil JN, 2011, INTEGR BIOL-UK, V3, P1215, DOI 10.1039/c1ib00117e; Behfar A, 2007, J EXP MED, V204, P405, DOI 10.1084/jem.20061916; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Booth HAF, 2004, GENOMICS, V84, P229, DOI 10.1016/j.ygeno.2004.02.014; Bounova G, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.016117; Bozdag S, 2010, BIOINFORMATICS, V26, P1792, DOI 10.1093/bioinformatics/btq275; Briegel KJ, 2001, DEV BIOL, V233, P291, DOI 10.1006/dbio.2001.0225; Butte AJ, 2000, P NATL ACAD SCI USA, V97, P12182, DOI 10.1073/pnas.220392197; Cermenati S, 2008, BLOOD, V111, P2657, DOI 10.1182/blood-2007-07-100412; Chang B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055635; Chiriac A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009943; Civelek M, 2010, AM J PHYSIOL-HEART C, V298, pH163, DOI 10.1152/ajpheart.00652.2009; D'haeseleer P, 2000, BIOINFORMATICS, V16, P707, DOI 10.1093/bioinformatics/16.8.707; Davis J., 2006, P 23 INT C MACH LEAR, P233, DOI [10.1145/1143844.1143874, DOI 10.1145/1143844.1143874]; di Bernardo D, 2005, NAT BIOTECHNOL, V23, P377, DOI 10.1038/nbt1075; Donahue MM, 2010, IET SYST BIOL, V4, P249, DOI 10.1049/iet-syb.2009.0031; Durocher D, 1997, EMBO J, V16, P5687, DOI 10.1093/emboj/16.18.5687; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Franco D, 1998, CARDIOVASC RES, V38, P25, DOI 10.1016/S0008-6363(97)00321-0; Gaborit N, 2007, J PHYSIOL-LONDON, V582, P675, DOI 10.1113/jphysiol.2006.126714; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Gardner TS, 2005, PHYS LIFE REV, V2, P65, DOI 10.1016/j.plrev.2005.01.001; Greulich F, 2011, CARDIOVASC RES, V91, P212, DOI 10.1093/cvr/cvr112; Groh WJ, 2012, HEART RHYTHM, V9, P1890, DOI 10.1016/j.hrthm.2012.06.038; Haller ST, 2012, AM J HYPERTENS, V25, P690, DOI 10.1038/ajh.2012.17; Hartemink Alexander J, 2002, Pac Symp Biocomput, P437; Hasty J, 2001, NAT REV GENET, V2, P268, DOI 10.1038/35066056; Haury AC, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-145; Holtzinger A, 2005, DEVELOPMENT, V132, P4005, DOI 10.1242/dev.01978; Johannessen M, 2006, CELL MOL LIFE SCI, V63, P268, DOI 10.1007/s00018-005-5438-z; Kangas J A, 1990, IEEE Trans Neural Netw, V1, P93, DOI 10.1109/72.80208; Kapoor N, 2013, NAT BIOTECHNOL, V31, P54, DOI 10.1038/nbt.2465; Karlebach G, 2008, NAT REV MOL CELL BIO, V9, P770, DOI 10.1038/nrm2503; KOHONEN T, 1990, NATURE, V346, P24, DOI 10.1038/346024b0; Langfelder P, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-54; Lee WP, 2009, BRIEF BIOINFORM, V10, P408, DOI 10.1093/bib/bbp028; Li RZ, 2000, ONCOGENE, V19, P6514, DOI 10.1038/sj.onc.1204035; Li X, 2014, PHYSL GENOMICS; Liao J, 2008, DEV BIOL, V316, P524, DOI 10.1016/j.ydbio.2008.01.037; Lu JR, 1999, MOL CELL BIOL, V19, P4495; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Marbach D, 2010, P NATL ACAD SCI USA, V107, P6286, DOI 10.1073/pnas.0913357107; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Markowetz F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S5; Meyer PE, 2007, EURASIP J BIOINFORM, DOI 10.1155/2007/79879; Mistry M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-327; Morin RD, 2008, BIOTECHNIQUES, V45, P81, DOI 10.2144/000112900; Nazri A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028713; Oka T, 2006, CIRC RES, V98, P837, DOI 10.1161/01.RES.0000215985.18538.c4; Okuda Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000936; Perdomo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050637; Popescu M, 2006, IEEE ACM T COMPUT BI, V3, P263, DOI 10.1109/TCBB.2006.37; Prall OWJ, 2002, ANN MED, V34, P148; Riazi AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005698; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/nmeth.2212, 10.1038/NMETH.2212]; Schachterle W, 2012, DEV BIOL, V361, P439, DOI 10.1016/j.ydbio.2011.10.023; Schmitt WA, 2004, GENOME RES, V14, P1654, DOI 10.1101/gr.2439804; Schmittgen Thomas D., 2008, V429, P89, DOI 10.1007/978-1-60327-040-3_7; Shaw OJ, 2004, BIOINFORMATICS, V20, P3638, DOI 10.1093/bioinformatics/bth395; Shimada K, 2009, CANCER RES, V69, P3157, DOI 10.1158/0008-5472.CAN-08-3530; Srivastava D, 2006, CELL, V126, P1037, DOI 10.1016/j.cell.2006.09.003; Stennard FA, 2003, DEV BIOL, V262, P206, DOI 10.1016/S0012-1606(03)00385-3; Stolovitzky G, 2007, ANN NY ACAD SCI, V1115, P1, DOI 10.1196/annals.1407.021; Tomita-Mitchell A, 2012, PHYSIOL GENOMICS, V44, P518, DOI 10.1152/physiolgenomics.00013.2012; Verger A, 2002, BIOESSAYS, V24, P362, DOI 10.1002/bies.10068; Vohradsky J, 2001, FASEB J, V15, P2054, DOI 10.1096/fj.00-0889fje; Wahde M, 2000, BIOSYSTEMS, V55, P129, DOI 10.1016/S0303-2647(99)00090-8; Zeisberg EM, 2005, J CLIN INVEST, V115, P1522, DOI 10.1172/JCI23769; Zhang C, 2005, DEV DYNAM, V234, P878, DOI 10.1002/dvdy.20565; Zoubarev A, 2012, BIOINFORMATICS, V28, P2272, DOI 10.1093/bioinformatics/bts430	78	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100842	10.1371/journal.pone.0100842	http://dx.doi.org/10.1371/journal.pone.0100842			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971943	Green Published, Green Submitted, gold			2022-12-27	WOS:000338512200068
J	Tan, X; Zhao, SS; Lei, Q; Lu, XP; He, GY; Ostrikov, K				Tan, Xiao; Zhao, Shasha; Lei, Qian; Lu, Xinpei; He, Guangyuan; Ostrikov, Kostya			Single-Cell-Precision Microplasma-Induced Cancer Cell Apoptosis	PLOS ONE			English	Article							NANOSCALE CORONA DISCHARGE; LEVEL; MEMBRANE; PLASMAS	The issue of single-cell control has recently attracted enormous interest. However, in spite of the presently achievable intracellular-level physiological probing through bio-photonics, nano-probe-based, and some other techniques, the issue of inducing selective, single-cell-precision apoptosis, without affecting neighbouring cells remains essentially open. Here we resolve this issue and report on the effective single-cell-precision cancer cell treatment using the reactive chemistry of the localized corona-type plasma discharge around a needle-like electrode with the spot size similar to 1 mu m. When the electrode is positioned with the micrometer precision against a selected cell, a focused and highly-localized micro-plasma discharge induces apoptosis in the selected individual HepG2 and HeLa cancer cells only, without affecting any surrounding cells, even in small cell clusters. This is confirmed by the real-time monitoring of the morphological and structural changes at the cellular and cell nucleus levels after the plasma exposure.	[Tan, Xiao; Lu, Xinpei] Huazhong Univ Sci & Technol, State Key Lab Adv Electromagnet Engn & Technol, Wuhan 430074, Hubei, Peoples R China; [Zhao, Shasha; Lei, Qian; He, Guangyuan] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Key Lab Mol Biophys, Chinese Minist Sci & Technol,Chinese Minist Educ, Wuhan 430074, Peoples R China; [Ostrikov, Kostya] CSIRO, Mat Sci & Engn, Lindfield, NSW, Australia; [Ostrikov, Kostya] Queensland Univ Technol, Sch Chem Phys & Mech Engn, Brisbane, Qld 4001, Australia	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Queensland University of Technology (QUT)	Lu, XP (corresponding author), Huazhong Univ Sci & Technol, State Key Lab Adv Electromagnet Engn & Technol, Wuhan 430074, Hubei, Peoples R China.	luxinpei@hotmail.com	Lu, Xinpei/D-9540-2015; Lu, XinPei/M-5570-2013	Lu, XinPei/0000-0003-0676-9585; Ostrikov, Kostya (Ken)/0000-0001-8672-9297	National Science Foundation of China [51077063, 51277087]; ARC; CSIRO OCE Science Leadership Scheme	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); ARC(Australian Research Council); CSIRO OCE Science Leadership Scheme	XL acknowledges support from the National Science Foundation of China (Grant No. 51077063, 51277087). KO acknowledges support from the ARC and the CSIRO OCE Science Leadership Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharyya S, 2009, ADV MATER, V21, P4039, DOI 10.1002/adma.200900673; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Dumont EA, 2001, NAT MED, V7, P1352, DOI 10.1038/nm1201-1352; Ishaq M, 2014, MOL BIOL CELL, V25, P1523, DOI 10.1091/mbc.E13-10-0590; Ishaq M, 2014, INT J CANCER, V134, P1517, DOI 10.1002/ijc.28323; Keidar M, 2011, BRIT J CANCER, V105, P1295, DOI 10.1038/bjc.2011.386; Keidar M, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4801516; Kim JY, 2011, SMALL, V7, P2291, DOI 10.1002/smll.201100456; Kim JY, 2010, SMALL, V6, P1474, DOI 10.1002/smll.201000480; Kim M, 2002, CLIN CANCER RES, V8, P22; Kim SH, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3605508; KONG MG, 2009, NEW J PHYS, V11, DOI DOI 10.1088/1367-2630/11/11/115012; Laroussi M, 2005, PLASMA PROCESS POLYM, V2, P391, DOI 10.1002/ppap.200400078; Li GW, 2011, NATURE, V475, P308, DOI 10.1038/nature10315; Lin ZY, 2009, ANGEW CHEM INT EDIT, V48, P2044, DOI 10.1002/anie.200805743; Meziane M, 2011, EUR PHYS J-APPL PHYS, V56, DOI 10.1051/epjap/2011110154; Orynbayeva Z, 2012, NANOMED-NANOTECHNOL, V8, P590, DOI 10.1016/j.nano.2011.08.008; Ostrikov K, 2013, ADV PHYS, V62, P113, DOI 10.1080/00018732.2013.808047; Schulte A, 2007, ANGEW CHEM INT EDIT, V46, P8760, DOI 10.1002/anie.200604851; Shapiro AB, 1997, EUR J BIOCHEM, V250, P122, DOI 10.1111/j.1432-1033.1997.00122.x; Spencer SL, 2011, CELL, V144, P926, DOI 10.1016/j.cell.2011.03.002; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Spiller DG, 2010, NATURE, V465, P736, DOI 10.1038/nature09232; Staack D, 2008, ANGEW CHEM INT EDIT, V47, P8020, DOI 10.1002/anie.200802891; Steinmeyer JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035603; Tian BZ, 2012, NAT MATER, V11, P986, DOI [10.1038/NMAT3404, 10.1038/nmat3404]; Van Cruchten S, 2002, ANAT HISTOL EMBRYOL, V31, P214, DOI 10.1046/j.1439-0264.2002.00398.x; VERHOVEN B, 1995, J EXP MED, V182, P1597, DOI 10.1084/jem.182.5.1597; Vermesh U, 2011, ANGEW CHEM INT EDIT, V50, P7378, DOI 10.1002/anie.201102249; Vernier PT, 2004, BIOPHYS J, V86, P4040, DOI 10.1529/biophysj.103.037945; Yan RX, 2012, NAT NANOTECHNOL, V7, P191, DOI [10.1038/nnano.2011.226, 10.1038/NNANO.2011.226]; Yan X, 2012, PLASMA PROCESS POLYM, V9, P59, DOI 10.1002/ppap.201100031; Zhao SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073665	33	31	32	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e101299	10.1371/journal.pone.0101299	http://dx.doi.org/10.1371/journal.pone.0101299			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971517	Green Published, Green Submitted, gold			2022-12-27	WOS:000338512200111
J	Xu, KN; Zhang, YF; Wang, Y; Ling, P; Xie, X; Jiang, CY; Zhang, ZZ; Lian, XY				Xu, Kangning; Zhang, Yufen; Wang, Yan; Ling, Peng; Xie, Xin; Jiang, Chenyao; Zhang, Zhizhen; Lian, Xiao-Yuan			Ginseng Rb Fraction Protects Glia, Neurons and Cognitive Function in a Rat Model of Neurodegeneration	PLOS ONE			English	Article							GABAERGIC NEURONS; CORTICAL ASTROCYTES; STATUS EPILEPTICUS; CELL-DEATH; HIPPOCAMPAL; INTERNEURONS; PARVALBUMIN; ACTIVATION; MEMORY; OSCILLATIONS	The loss and injury of neurons play an important role in the onset of various neurodegenerative diseases, while both microgliosis and astrocyte loss or dysfunction are significant causes of neuronal degeneration. Previous studies have suggested that an extract enriched panaxadiol saponins from ginseng has more neuroprotective potential than the total saponins of ginseng. The present study investigated whether a fraction of highly purified panaxadiol saponins (termed as Rb fraction) was protective for both glia and neurons, especially GABAergic interneurons, against kainic acid (KA)-induced excitotoxicity in rats. Rats received Rb fraction at 30 mg/kg (ip), 40 mg/kg (ip or saline followed 40 min later by an intracerebroventricular injection of KA. Acute hippocampal injury was determined at 48 h after KA, and impairment of hippocampus-dependent learning and memory as well as delayed neuronal injury was determined 16 to 21 days later. KA injection produced significant acute hippocampal injuries, including GAD67-positive GABAergic interneuron loss in CA1, paralbumin (PV)-positive GABAergic interneuron loss, pyramidal neuron degeneration and astrocyte damage accompanied with reactive microglia in both CA1 and CA3 regions of the hippocampus. There was also a delayed loss of GAD67-positive interneurons in CA1, CA3, hilus and dentate gyrus. Microgliosis also became more severe 21 days later. Accordingly, KA injection resulted in hippocampus-dependent spatial memory impairment. Interestingly, the pretreatment with Rb fraction at 30 or 40 mg/kg significantly protected the pyramidal neurons and GABAergic interneurons against KA-induced acute excitotoxicity and delayed injury. Rb fraction also prevented memory impairments and protected astrocytes from KA-induced acute excitotoxicity. Additionally, microglial activation, especially the delayed microgliosis, was inhibited by Rb fraction. Overall, this study demonstrated that Rb fraction protected both astrocytes and neurons, especially GABAergic interneurons, and maintained microglial homeostasis against KA-induced excitotoxicity. Therefore, Rb fraction has the potential to prevent and treat neurodegenerative diseases.	[Xu, Kangning; Wang, Yan; Xie, Xin; Jiang, Chenyao; Lian, Xiao-Yuan] Zhejiang Univ, Coll Pharmaceut Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Zhizhen] Zhejiang Univ, Ocean Coll, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Yufen; Ling, Peng] Anhui Univ Chinese Med, Hefei, Peoples R China	Zhejiang University; Zhejiang University; Anhui University of Chinese Medicine	Zhang, ZZ (corresponding author), Zhejiang Univ, Ocean Coll, Hangzhou 310003, Zhejiang, Peoples R China.	zzhang88@zju.edu.cn; xylian@zju.edu.cn	ZHANG, ZHIZHEN/GYA-3230-2022		National Basic Research Program of China (973 program) [2011CB504403]; Major Project of the Modernization of Traditional Chines Medicine, the Science and Technology Commission of Shanghai Municipality [08DZ1972000]	National Basic Research Program of China (973 program)(National Basic Research Program of China); Major Project of the Modernization of Traditional Chines Medicine, the Science and Technology Commission of Shanghai Municipality	This study was financially supported by grants from the National Basic Research Program of China (973 program, No 2011CB504403) and the Major Project of the Modernization of Traditional Chines Medicine, the Science and Technology Commission of Shanghai Municipality (No. 08DZ1972000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews-Zwilling Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040555; Andrews-Zwilling Y, 2010, J NEUROSCI, V30, P13707, DOI 10.1523/JNEUROSCI.4040-10.2010; Attele AS, 1999, BIOCHEM PHARMACOL, V58, P1685, DOI 10.1016/S0006-2952(99)00212-9; Bechstein M, 2012, EXP NEUROL, V236, P141, DOI 10.1016/j.expneurol.2012.04.009; BENARI Y, 1980, BRAIN RES, V191, P79, DOI 10.1016/0006-8993(80)90316-9; BENARI Y, 1979, BRAIN RES, V163, P176, DOI 10.1016/0006-8993(79)90163-X; Bissonette GB, 2014, BEHAV BRAIN RES, V259, P143, DOI 10.1016/j.bbr.2013.10.051; Budd SL, 1998, NAT NEUROSCI, V1, P431, DOI 10.1038/2147; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Cho IH, 2008, BRAIN, V131, P3019, DOI 10.1093/brain/awn230; Cho IH, 2006, J NEUROSCI RES, V84, P1505, DOI 10.1002/jnr.21052; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Colangelo AM, 2012, BIOTECHNOL ADV, V30, P261, DOI 10.1016/j.biotechadv.2011.06.016; Cui YJ, 2008, CELL, V135, P549, DOI 10.1016/j.cell.2008.09.060; Doble A, 1999, PHARMACOL THERAPEUT, V81, P163, DOI 10.1016/S0163-7258(98)00042-4; Fuchs EC, 2007, NEURON, V53, P591, DOI 10.1016/j.neuron.2007.01.031; Gouder N, 2004, J NEUROSCI, V24, P692, DOI 10.1523/JNEUROSCI.4781-03.2004; Goutagny R, 2013, EUR J NEUROSCI, V37, P1896, DOI 10.1111/ejn.12233; Gulyas AI, 2010, J NEUROSCI, V30, P15134, DOI 10.1523/JNEUROSCI.4104-10.2010; Hong J, 2010, J BIOL CHEM, V285, P39447, DOI 10.1074/jbc.M110.132522; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Klausberger T, 2005, J NEUROSCI, V25, P9782, DOI 10.1523/JNEUROSCI.3269-05.2005; Klausberger T, 2004, NAT NEUROSCI, V7, P41, DOI 10.1038/nn1159; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Kullmann DM, 2011, CURR OPIN NEUROBIOL, V21, P709, DOI 10.1016/j.conb.2011.05.006; Kuruba R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024493; Lazarus MS, 2013, CEREB CORTEX, DOI [10.1093/cercor/bht1322, DOI 10.1093/CERCOR/BHT1322]; Lee JK, 2008, NEUROSCI LETT, V440, P260, DOI 10.1016/j.neulet.2008.05.112; Leung L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053569; Li TF, 2012, GLIA, V60, P83, DOI 10.1002/glia.21250; Lian XY, 2006, EPILEPSY RES, V70, P244, DOI 10.1016/j.eplepsyres.2006.05.010; Lian XY, 2005, ANN NEUROL, V57, P642, DOI 10.1002/ana.20450; Lian XY, 2005, EPILEPSIA, V46, P15, DOI 10.1111/j.0013-9580.2005.40904.x; Liu B, 2013, NEUROSCI RES, V75, P160, DOI 10.1016/j.neures.2012.12.002; Liu Z, 2013, NEUROL SCI, V34, P1189, DOI 10.1007/s10072-012-1220-9; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; MITCHELL J, 1993, EXP NEUROL, V121, P224, DOI 10.1006/exnr.1993.1089; Montgomery SM, 2007, P NATL ACAD SCI USA, V104, P14495, DOI 10.1073/pnas.0701826104; Murray AJ, 2011, NAT NEUROSCI, V14, P297, DOI 10.1038/nn.2751; Nakazawa K, 2012, NEUROPHARMACOLOGY, V62, P1574, DOI 10.1016/j.neuropharm.2011.01.022; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Park D, 2012, CELL TRANSPLANT, V21, P365, DOI 10.3727/096368911X586765; Ratte Stephanie, 2006, Adv Neurol, V97, P69; Rizzi M, 2003, NEUROBIOL DIS, V14, P494, DOI 10.1016/j.nbd.2003.08.001; Shetty AK, 2001, EXP NEUROL, V169, P276, DOI 10.1006/exnr.2001.7668; Shetty AK, 2009, J CELL MOL MED, V13, P2408, DOI 10.1111/j.1582-4934.2009.00675.x; SINGER W, 1993, ANNU REV PHYSIOL, V55, P349, DOI 10.1146/annurev.physiol.55.1.349; SPERK G, 1985, BRAIN RES, V338, P289, DOI 10.1016/0006-8993(85)90159-3; StubleyWeatherly L, 1996, BRAIN RES, V716, P29, DOI 10.1016/0006-8993(95)01589-2; Verkhratsky A, 2012, ASN NEURO, V4, DOI 10.1042/AN20120010; Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046; Volman V, 2011, J NEUROSCI, V31, P18137, DOI 10.1523/JNEUROSCI.3041-11.2011; Wang Q, 2005, MOL NEUROBIOL, V31, P3, DOI 10.1385/MN:31:1-3:003; Watson C, 2006, RAT BRAIN STEREOTAXI; Wenk G.L., 2004, CURRENT PROTOCOLS NE; WILLIAMS SM, 1992, J COMP NEUROL, V320, P353, DOI 10.1002/cne.903200307; Zhang Z, 2011, PHARM CROPS, V2, P65; Zheng HH, 2010, NEUROIMMUNOMODULAT, V17, P31, DOI 10.1159/000243083; Zheng XY, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/457079	59	10	10	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e101077	10.1371/journal.pone.0101077	http://dx.doi.org/10.1371/journal.pone.0101077			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971630	Green Submitted, Green Published, gold			2022-12-27	WOS:000338512200088
J	Menne-Lothmann, C; Viechtbauer, W; Hohn, P; Kasanova, Z; Haller, SP; Drukker, M; van Os, J; Wichers, M; Lau, JYF				Menne-Lothmann, Claudia; Viechtbauer, Wolfgang; Hohn, Petra; Kasanova, Zuzana; Haller, Simone P.; Drukker, Marjan; van Os, Jim; Wichers, Marieke; Lau, Jennifer Y. F.			How to Boost Positive Interpretations? A Meta-Analysis of the Effectiveness of Cognitive Bias Modification for Interpretation	PLOS ONE			English	Article							MODIFYING INTERPRETATION; MENTAL-IMAGERY; EFFECT SIZE; ANXIETY; DEPRESSION; THREAT; VALIDITY; THINKING; SERIES	The current meta-analysis explores the strength of effects of cognitive bias modification training for interpretation bias (CBM-I) on positive (i.e., adaptive) interpretations and mood as well as the training and sample characteristics influencing these effects. Data-bases were searched with the key words "interpret* bias AND training'' and "interpret* bias AND modif*''. Reference lists of identified articles were checked and authors of identified articles were contacted for further relevant articles and unpublished data. Studies were reviewed for inclusion with eligibility criteria being that the study (a) aimed to target interpretation biases through any kind of training, (b) assessed mood and/or interpretation bias as outcome measures, (c) allocated individuals to training conditions at random, and (d) recruited adult samples. A meta-analytic multilevel mixed-effects model was employed to assess standardized mean changes in interpretation bias, negative mood, and emotional reactivity. In addition, several training and sample characteristics were explored for their potential to enhance benign training effectiveness. On average, benign CBM-I resulted in an increase in positive interpretation bias (p<.01) and a decrease in negative mood state (p<.001), but did not affect emotional reactivity. These effects were not consistently different from control conditions with no or neutral training. However, within benign training conditions imagery instructions and more training sessions were related to larger cognitive and mood effects, whereas feedback about training performance and inclusion of non-benign training items (instead of including benign items only) boosted cognitive effects only. Finally, training was more effective in women (cognitive and mood effects) and presumably samples with symptomatic emotional dysregulation (cognitive effects). Although the effects of emotional dysregulation and number of training sessions could not well be distinguished, there is an indication that when used with imagery instructions and more training sessions, benign CBM-I can be employed as a useful complementary treatment to usual psychotherapies.	[Menne-Lothmann, Claudia; Viechtbauer, Wolfgang; Hohn, Petra; Kasanova, Zuzana; Drukker, Marjan; van Os, Jim; Wichers, Marieke] Maastricht Univ, South Limburg Mental Hlth Res & Teaching Network, Dept Psychiat & Psychol, EURON, Maastricht, Netherlands; [Haller, Simone P.] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; [Lau, Jennifer Y. F.] Kings Coll London, Inst Psychiat, Dept Psychol, London, England	Maastricht University; University of Oxford; University of London; King's College London	Menne-Lothmann, C (corresponding author), Maastricht Univ, South Limburg Mental Hlth Res & Teaching Network, Dept Psychiat & Psychol, EURON, Maastricht, Netherlands.	c.lothmann@maastrichtuniversity.nl	Wichers, Marieke/N-6667-2014; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; Viechtbauer, Wolfgang/M-1549-2013; van Os, Jim/V-8884-2019; van Os, Jim/C-2113-2014	Wichers, Marieke/0000-0001-5024-9064; Viechtbauer, Wolfgang/0000-0003-3463-4063; van Os, Jim/0000-0002-7245-1586; Kasanova, Zuzana/0000-0002-8795-5373; Lau, Jennifer/0000-0001-8220-3618	Maastricht University; Medical Research Council [1242237] Funding Source: researchfish	Maastricht University; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was conducted within the frame of a PhD project at Maastricht University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, QUICK REF DIAGN CRIT; Amir N, 2012, J CONSULT CLIN PSYCH, V80, P497, DOI 10.1037/a0026928; Amir N, 2010, J ANXIETY DISORD, V24, P178, DOI 10.1016/j.janxdis.2009.10.005; Beard C, 2011, DEPRESS ANXIETY, P1; Beard C, 2008, BEHAV RES THER, V46, P1135, DOI 10.1016/j.brat.2008.05.012; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Blackhart GC, 2009, PERS SOC PSYCHOL REV, V13, P269, DOI 10.1177/1088868309346065; Blackwell SE, 2010, APPL COGNITIVE PSYCH, V24, P338, DOI 10.1002/acp.1680; Bowler JO, 2012, J CONSULT CLIN PSYCH, V80, P1021, DOI 10.1037/a0029932; Brosan L, 2011, J BEHAV THER EXP PSY, V42, P258, DOI 10.1016/j.jbtep.2010.12.006; Clerkin EM, 2011, J BEHAV THER EXP PSY, V42, P337, DOI 10.1016/j.jbtep.2011.01.003; Cooper, 2017, RES SYNTHESIS META A; CSIKSZENTMIHALYI M, 1987, J NERV MENT DIS, V175, P526, DOI 10.1097/00005053-198709000-00004; Csikszentmihalyi M, 2003, J HAPPINESS STUDIES, V4; EYSENCK MW, 1991, J ABNORM PSYCHOL, V100, P144, DOI 10.1037/0021-843X.100.2.144; Furmark T, 2002, ARCH GEN PSYCHIAT, V59, P425, DOI 10.1001/archpsyc.59.5.425; GIBBONS RD, 1993, J EDUC STAT, V18, P271, DOI 10.3102/10769986018003271; Gleitman H, 2004, PSYCHOLOGY; Gopinath S, 2007, J AFFECT DISORDERS, V101, P57, DOI 10.1016/j.jad.2006.10.023; Grey S, 2000, Q J EXP PSYCHOL-A, V53, P1143, DOI 10.1080/02724980050156335; Grey SJ, 2009, J BEHAV THER EXP PSY, V40, P338, DOI 10.1016/j.jbtep.2009.01.003; Hallion LS, 2011, PSYCHOL BULL, V137, P940, DOI 10.1037/a0024355; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hayes S, 2010, BEHAV RES THER, V48, P171, DOI 10.1016/j.brat.2009.10.006; Hertel PT, 2011, J ABNORM PSYCHOL, V120, P902, DOI 10.1037/a0023974; Hertel PT, 2003, APPL COGNITIVE PSYCH, V17, P775, DOI 10.1002/acp.905; Hirsch CR, 2007, BEHAV RES THER, V45, P2173, DOI 10.1016/j.brat.2006.11.001; Hirsch CR, 2009, J ABNORM PSYCHOL, V118, P44, DOI 10.1037/a0013473; Holmes EA, 2006, BEHAV THER, V37, P237, DOI 10.1016/j.beth.2006.02.002; Holmes EA, 2009, J ABNORM PSYCHOL, V118, P76, DOI 10.1037/a0012590; Hoppitt L, 2010, APPL COGNITIVE PSYCH, V24, P312, DOI 10.1002/acp.1678; Hoppitt L, 2010, BEHAV THER, V41, P73, DOI 10.1016/j.beth.2009.01.002; Husky MM, 2009, COGNITIVE THER RES, V33, P264, DOI 10.1007/s10608-008-9212-z; Koster EHW, 2009, J ABNORM PSYCHOL, V118, P1, DOI 10.1037/a0014379; Lang TJ, 2012, EUR J PERSONALITY, V26, P145, DOI 10.1002/per.855; Lang TJ, 2009, BEHAV RES THER, V47, P139, DOI 10.1016/j.brat.2008.11.002; Lange WG, 2010, APPL COGNITIVE PSYCH, V24, P326, DOI 10.1002/acp.1679; Lewinsohn PM, 1993, J ABNORMAL PSYCHOL, V102; Lothmann C, 2011, J CHILD PSYCHOL PSYC, V52, P24, DOI 10.1111/j.1469-7610.2010.02286.x; MacDonald EM, 2013, COGNITIVE THER RES, V37, P860, DOI 10.1007/s10608-012-9519-7; Mackintosh B, 2006, BEHAV THER, V37, P209, DOI 10.1016/j.beth.2006.03.001; Mathews A, 2004, BEHAV RES THER, V42, P1019, DOI 10.1016/j.brat.2004.04.003; Mathews A, 2000, J ABNORM PSYCHOL, V109, P602, DOI 10.1037//0021-843X.109.4.602; Mathews A, 2007, J BEHAV THER EXP PSY, V38, P225, DOI 10.1016/j.jbtep.2006.10.011; Mogg K, 2005, COGNITIVE THER RES, V29, P29, DOI 10.1007/s10608-005-1646-y; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Morris SB, 2002, PSYCHOL METHODS, V7, P105, DOI 10.1037//1082-989X.7.1.105; Muris P, 2008, CHILD PSYCHIAT HUM D, V39, P455, DOI 10.1007/s10578-008-0101-1; Murphy R, 2007, BEHAV RES THER, V45, P1517, DOI 10.1016/j.brat.2007.01.007; Neshat-Doost HT, 1998, J ABNORMAL PSYCHOL, V107; Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676; Pinheiro J, 2000, MIXED EFFECTS MODELS; Salanti G, 2008, STAT METHODS MED RES, V17, P279, DOI 10.1177/0962280207080643; Salemink E, 2007, J BEHAV THER EXP PSY, V38, P212, DOI 10.1016/j.jbtep.2006.10.010; Salemink E, 2007, BEHAV RES THER, V45, P329, DOI 10.1016/j.brat.2006.03.011; Salemink E, 2012, BEHAV RES THER, V50, P40, DOI 10.1016/j.brat.2011.10.006; Salemink E, 2010, J BEHAV THER EXP PSY, V41, P310, DOI 10.1016/j.jbtep.2010.02.010; Salemink E, 2010, COGNITION EMOTION, V24, P453, DOI 10.1080/02699930802692053; Salemink E, 2010, J BEHAV THER EXP PSY, V41, P140, DOI 10.1016/j.jbtep.2009.11.006; Salemink E, 2009, J ANXIETY DISORD, V23, P676, DOI 10.1016/j.janxdis.2009.02.006; Standage H, 2010, BEHAV RES THER, V48, P4, DOI 10.1016/j.brat.2009.08.005; Standage H, 2009, J BEHAV THER EXP PSY, V40, P558, DOI 10.1016/j.jbtep.2009.07.006; Steel C, 2010, PSYCHIAT RES, V178, P451, DOI 10.1016/j.psychres.2010.04.042; Steinman SA, 2010, J ANXIETY DISORD, V24, P71, DOI 10.1016/j.janxdis.2009.08.008; Teachman BA, 2008, COGNITIVE THER RES, V32, P448, DOI 10.1007/s10608-006-9084-z; Tran TB, 2011, EMOTION, V11, P145, DOI 10.1037/a0021754; Tran TB, 2011, COGNITION EMOTION, V25, P546, DOI 10.1080/02699931.2010.532393; Turner R, 2011, BEHAV COGN PSYCHOTH, V39, P341, DOI 10.1017/S1352465810000706; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Wichers M, 2011, ACTA PSYCHIAT SCAND, V124, P262, DOI 10.1111/j.1600-0447.2011.01749.x; Williams AD, 2013, J CONSULTING CLIN PS; Wilson EJ, 2006, J ABNORM PSYCHOL, V115, P103, DOI 10.1037/0021-843X.115.1.103; Yiend J, 2005, BEHAV RES THER, V43, P779, DOI 10.1016/j.brat.2004.06.007	73	126	130	1	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100925	10.1371/journal.pone.0100925	http://dx.doi.org/10.1371/journal.pone.0100925			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK2WP	24968234	Green Published, gold, Green Submitted			2022-12-27	WOS:000338280800082
J	Rustgi, S; Matanguihan, J; Mejias, JH; Gemini, R; Brew-Appiah, RAT; Wen, N; Osorio, C; Ankrah, N; Murphy, KM; von Wettstein, D				Rustgi, Sachin; Matanguihan, Janet; Mejias, Jaime H.; Gemini, Richa; Brew-Appiah, Rhoda A. T.; Wen, Nuan; Osorio, Claudia; Ankrah, Nii; Murphy, Kevin M.; von Wettstein, Diter			Assessment of Genetic Diversity among Barley Cultivars and Breeding Lines Adapted to the US Pacific Northwest, and Its Implications in Breeding Barley for Imidazolinone-Resistance	PLOS ONE			English	Article							PLANT ACETOHYDROXYACID SYNTHASE; LENGTH POLYMORPHISMS; COMPARATIVE GENOMICS; WHEAT; HERBICIDE; MAP	Extensive application of imidazolinone (IMI) herbicides had a significant impact on barley productivity contributing to a continuous decline in its acreage over the last two decades. A possible solution to this problem is to transfer IMI-resistance from a recently characterized mutation in the 'Bob' barley AHAS (acetohydroxy acid synthase) gene to other food, feed and malting barley cultivars. We focused our efforts on transferring IMI-resistance to barley varieties adapted to the US Pacific Northwest (PNW), since it comprises similar to 23% (335,000 ha) of the US agricultural land under barley production. To effectively breed for IMI-resistance, we studied the genetic diversity among 13 two-rowed spring barley cultivars/breeding-lines from the PNW using 61 microsatellite markers, and selected six barley genotypes that showed medium to high genetic dissimilarity with the 'Bob' AHAS mutant. The six selected genotypes were used to make 29-53 crosses with the AHAS mutant and a range of 358-471 F-1 seeds were obtained. To make informed selection for the recovery of the recipient parent genome, the genetic location of the AHAS gene was determined and its genetic nature assessed. Large F-2 populations ranging in size from 2158-2846 individuals were evaluated for herbicide resistance and seedling vigor. Based on the results, F-3 lines from the six most vigorous F-2 genotypes per cross combination were evaluated for their genetic background. A range of 20%-90% recovery of the recipient parent genome for the carrier chromosome was observed. An effort was made to determine the critical dose of herbicide to distinguish between heterozygotes and homozygotes for the mutant allele. Results suggested that the mutant can survive up to the 10x field recommended dose of herbicide, and the 86x and 10x herbicide doses can distinguish between the two AHAS mutant genotypes. Finally, implications of this research in sustaining barley productivity in the PNW are discussed.	[Rustgi, Sachin; Matanguihan, Janet; Mejias, Jaime H.; Gemini, Richa; Brew-Appiah, Rhoda A. T.; Wen, Nuan; Osorio, Claudia; Ankrah, Nii; Murphy, Kevin M.; von Wettstein, Diter] Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA; [Mejias, Jaime H.] Inst Invest Agr INIA, Vilcun, Chile; [von Wettstein, Diter] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA; [von Wettstein, Diter] Washington State Univ, Ctr Reprod Biol, Pullman, WA 99164 USA	Washington State University; Washington State University; Washington State University	Rustgi, S (corresponding author), Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA.	rustgi@wsu.edu; diter@wsu.edu	Rustgi, Sachin/AAF-5590-2020; Bassaletti, Jaime H Mejias/V-8967-2019; Brew-Appiah, Rhoda Araba Tawiah/N-9817-2019	Bassaletti, Jaime H Mejias/0000-0002-5510-1955; Brew-Appiah, Rhoda Araba Tawiah/0000-0003-2123-0828; Osorio, Claudia E./0000-0001-6205-0730; Rustgi, Sachin/0000-0002-6881-9501	Washington Grain Commission [13C-3019-3590]	Washington Grain Commission	This work was supported by the Washington Grain Commission Grant # 13C-3019-3590. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhunov ED, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-702; Anderson JA, 2004, WEED SCI, V52, P83, DOI 10.1614/WS-03-055R; Baik B.-K., 2011, BARLEY PRODUCTION IM; Bandopadhyay R, 2011, J GENET GENOMICS, V38, P315, DOI 10.1016/j.jgg.2011.06.003; Black AL, 1986, P HANDS ON WORKSH IM; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Brester G, 2012, BARLEY PROFILE; Cuadrado A, 2008, CYTOGENET GENOME RES, V120, P210, DOI 10.1159/000121069; Duggleby RG, 2000, J BIOCHEM MOL BIOL, V33, P1; Duggleby RG, 2008, PLANT PHYSIOL BIOCH, V46, P309, DOI 10.1016/j.plaphy.2007.12.004; Garstang J.R., 2011, BARLEY PRODUCTION IM, P221, DOI DOI 10.1002/9780470958636.CH1; Hufford MB, 2012, NAT GENET, V44, P808, DOI 10.1038/ng.2309; JANOSKY J, 2002, PACIFIC NW CONSERVAT, V16, pCH10; Kasha KJ, 2001, EUPHYTICA, V120, P379, DOI 10.1023/A:1017564100823; Lee H, 2011, P NATL ACAD SCI USA, V108, P8909, DOI 10.1073/pnas.1105612108; Lee YT, 2001, BIOCHEMISTRY-US, V40, P6836, DOI 10.1021/bi002775q; Mayer KFX, 2011, PLANT CELL, V23, P1249, DOI 10.1105/tpc.110.082537; McCourt JA, 2006, P NATL ACAD SCI USA, V103, P569, DOI 10.1073/pnas.0508701103; Molnar I, 2011, ANN BOT-LONDON, V107, P65, DOI 10.1093/aob/mcq215; Newman RK, 2008, BARLEY FOOD HLTH SCI; Perrier X., 2003, GENETIC DIVERSITY CU, P43; Randhawa HS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005752; Rustgi S, 2013, MED AROMATIC PLANTS, V2, pe148; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sambrook J., 2002, MOL CLONING LAB MANU; Schillinger WF, 2006, PLANT DIS, V90, P302, DOI 10.1094/PD-90-0302; Shaner DL., 1997, HERBICIDE ACTIVITY T, P69; SINGH BK, 1988, ANAL BIOCHEM, V171, P173, DOI 10.1016/0003-2697(88)90139-X; SMILEY RW, 1992, PLANT DIS, V76, P937, DOI 10.1094/PD-76-0937; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; Tan SY, 2005, PEST MANAG SCI, V61, P246, DOI 10.1002/ps.993; Tegelstrom Hakan, 1992, P89; Turner W. J., 2001, CROP PROFILE BARLEY; Varshney RK, 2007, THEOR APPL GENET, V114, P1091, DOI 10.1007/s00122-007-0503-7	35	3	3	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100998	10.1371/journal.pone.0100998	http://dx.doi.org/10.1371/journal.pone.0100998			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967712	gold, Green Published, Green Submitted			2022-12-27	WOS:000338280800096
J	Liang, YR; Wang, P; Liu, DH; Shen, ZG; Liu, H; Jia, ZX; Zhou, ZQ				Liang, Yiran; Wang, Peng; Liu, Donghui; Shen, Zhigang; Liu, Hui; Jia, Zhixin; Zhou, Zhiqiang			Enantioselective Metabolism of Quizalofop-Ethyl in Rat	PLOS ONE			English	Article								The pharmacokinetic and distribution of the enantiomers of quizalofop-ethyl and its metabolite quizalofop-acid were studied in Sprague-Dawley male rats. The two pairs of enantiomers were determined using a validated chiral high-performance liquid chromatography method. Animals were administered quizalofop-ethyl at 10 mg kg(-1) orally and intravenously. It was found high concentration of quizalofop-acid in the blood and tissues by both intragastric and intravenous administration, and quizalofop-ethyl could not be detected through the whole study which indicated a quick metabolism of quizalofop-ethyl to quizalofop-acid in vivo. In almost all the samples, the concentrations of (+)-quizalofopacid exceeded those of (2)-quizalofop-acid. Quizalofop-acid could still be detected in the samples even at 120 h except in brain due to the function of blood-brain barrier. Based on a rough calculation, about 8.77% and 2.16% of quizalofop-acid were excreted through urine and feces after intragastric administration. The oral bioavailability of (+)-quizalofop-acid and (-2)-quizalofop-acid were 72.8% and 83.6%.	[Liang, Yiran; Wang, Peng; Liu, Donghui; Shen, Zhigang; Liu, Hui; Zhou, Zhiqiang] China Agr Univ, Dept Appl Chem, Beijing 100094, Peoples R China; [Jia, Zhixin] Chinese Acad Med Sci, Inst Mat Med, Beijing 100050, Peoples R China; [Jia, Zhixin] Peking Union Med Coll, Beijing 100021, Peoples R China	China Agricultural University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Zhou, ZQ (corresponding author), China Agr Univ, Dept Appl Chem, Beijing 100094, Peoples R China.	zqzhou@cau.edu.cn	Jia, Zhixin/GNP-4427-2022	Jia, Zhixin/0000-0003-3849-2234; wang, peng/0000-0001-7854-1163	National Excellent Doctoral Dissertation of PR China, Program for New Century Excellent Talents in University [NCET09-0738]; National Natural Science Foundation of China [21277171, 21307155]; New-Star of Science and Technology; Beijing Metropolis, Program for New Century Excellent Talents in University; Program for Changjiang Scholars and Innovative Research Team in University	National Excellent Doctoral Dissertation of PR China, Program for New Century Excellent Talents in University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New-Star of Science and Technology; Beijing Metropolis, Program for New Century Excellent Talents in University; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	Supported by A Foundation for the Author of National Excellent Doctoral Dissertation of PR China, Program for New Century Excellent Talents in University (NCET09-0738), the National Natural Science Foundation of China (21277171, 21307155), the New-Star of Science and Technology supported by Beijing Metropolis, Program for New Century Excellent Talents in University and Program for Changjiang Scholars and Innovative Research Team in University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Abhilash PC, 2009, J HAZARD MATER, V165, P1, DOI 10.1016/j.jhazmat.2008.10.061; BANIJAMALI AR, 1993, J AGR FOOD CHEM, V41, P1122, DOI 10.1021/jf00031a022; Costa LG, 2008, FRONT BIOSCI-LANDMRK, V13, P1240, DOI 10.2741/2758; Covaci A, 2004, CHEMOSPHERE, V56, P757, DOI 10.1016/j.chemosphere.2004.02.014; Hoekstra PF, 2001, TOXICOL LETT, V125, P75, DOI 10.1016/S0378-4274(01)00410-6; James d, 1999, EVIDENCE DEV REPROD; KOEPPE MK, 1990, J AGR FOOD CHEM, V38, P1085, DOI 10.1021/jf00094a039; Kurihara N, 1997, PURE APPL CHEM, V69, pR7; Liu WP, 2009, J AGR FOOD CHEM, V57, P2087, DOI 10.1021/jf900079y; Liu WP, 2005, P NATL ACAD SCI USA, V102, P701, DOI 10.1073/pnas.0408847102; Lv JG, 2010, B ENVIRON CONTAM TOX, V85, P137, DOI 10.1007/s00128-010-0048-3; Marucchini C, 2002, CHIRALITY, V14, P32, DOI 10.1002/chir.10032; Ogwok P, 2009, B ENVIRON CONTAM TOX, V82, P529, DOI 10.1007/s00128-009-9668-x; Sahoo SK, 2013, ENVIRON MONIT ASSESS, V185, P1711, DOI 10.1007/s10661-012-2662-5; Sun J, 2005, OCCUPATION HLTH, V11; Ulrich EM, 2001, ENVIRON SCI TECHNOL, V35, P1604, DOI 10.1021/es001754g; Williams A, 1996, PESTIC SCI, V46, P3, DOI 10.1002/(SICI)1096-9063(199601)46:1&lt;3::AID-PS337&gt;3.0.CO;2-J; Wu T, 2011, J AGR FOOD CHEM, V59, P4315, DOI 10.1021/jf200213z	19	4	4	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e101052	10.1371/journal.pone.0101052	http://dx.doi.org/10.1371/journal.pone.0101052			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964043	Green Submitted, gold, Green Published			2022-12-27	WOS:000338709500113
J	Shah, S; Van den Bergh, R; Van Bellinghen, B; Severy, N; Sadiq, S; Afridi, SA; Akhtar, A; Maikere, J; Van Overloop, C; Saeed-ur-Rehman; Khilji, TBUD; Saleem-ur-Rehman; van Griensven, J; Schneider, S; Bosman, P; Guillergan, ELD; Dazzi, F; Zachariah, R				Shah, Safieh; Van den Bergh, Rafael; Van Bellinghen, Benedicte; Severy, Nathalie; Sadiq, Sana; Afridi, Sher Ali; Akhtar, Asma; Maikere, Jacob; Van Overloop, Catherine; Saeed-ur-Rehman; Khilji, Tahir Bashir-ud-Din; Saleem-ur-Rehman; van Griensven, Johan; Schneider, Serge; Bosman, Philippe; Guillergan, Erwin Lloyd D.; Dazzi, Francesca; Zachariah, Rony			Offering Mental Health Services in a Conflict Affected Region of Pakistan: Who Comes, and Why?	PLOS ONE			English	Article							PRIMARY-CARE; LOW-INCOME; DISORDERS; ASSOCIATION; DEPRESSION; PREVALENCE; BARRIERS; STRESS; INDIA	Background: North West Pakistan is an area ravaged by conflict and population displacement for over three decades. Recently, drone attacks and military operations have aggravated underlying mental disorders, while access to care is limited. Among patients attending a mental health clinic integrated in district hospital conducted by psychologists; we describe service utilization, patient characteristics, presenting complaints, morbidity patterns, and follow-up details. Methodology/Principal Findings: A retrospective study using routinely collected programme data was conducted from February to December 2012. A total of 1545 consultations were conducted for 928 patients (86% females). There were 71(8%) children and adolescents. An increase was observed from February to July, followed by a decline. 163 new patients (18%) were on psychotropic medication at presentation. The most common morbidity in females (36%) were symptoms of adjustment disorders and acute reactions. Depression and anxiety were common in both genders while post traumatic disorder was frequent in males (21%). Out of the 928 new patients, 639(69%) had a follow up visit planned with their psychologist, but only 220(34%) new patients returned for a follow up visit. Conclusion: In a district hospital, mental health services managed by psychologists were well attended. There is a need to consider widening the current package of care to cater to the diversity of mental health disorders, gender difference, children and adolescents. Standardized diagnostic and monitoring tools would also need to be adapted accordingly and to assess patient progress. Innovative approaches to tackle the problem of the low return rate are needed.	[Shah, Safieh; Van Bellinghen, Benedicte; Severy, Nathalie; Maikere, Jacob; Van Overloop, Catherine; Bosman, Philippe; Guillergan, Erwin Lloyd D.; Dazzi, Francesca] Med Sans Frontieres Operat Ctr Brussels, Dept Med, Islamabad, Punjab, Pakistan; [Van den Bergh, Rafael; Zachariah, Rony] Med Sans Frontieres Operat Ctr Brussels, Operat Res Unit LuxOR, Luxembourg, Luxembourg; [Sadiq, Sana; Afridi, Sher Ali; Akhtar, Asma] Med Sans Frontieres Operat Ctr Brussels, Mental Hlth Clin, Timurgara, Khyber Pakhtunk, Pakistan; [Saeed-ur-Rehman; Khilji, Tahir Bashir-ud-Din; Saleem-ur-Rehman] Dist Headquarter Hosp, Pakistan Minist Hlth MoH, Timurgara, Khyber Pakhtunk, Pakistan; [van Griensven, Johan] Inst Trop Med, B-2000 Antwerp, Belgium; [Schneider, Serge] Med Sans Frontieres Operat Ctr Luxembourg, Luxembourg, Luxembourg	Institute of Tropical Medicine (ITM)	Shah, S (corresponding author), Med Sans Frontieres Operat Ctr Brussels, Dept Med, Islamabad, Punjab, Pakistan.	msfocb-islamabad-med@brussels.msf.org	Shah, Safieh/AAK-3257-2020; Shah, Safieh/Z-2078-2018	Shah, Safieh/0000-0001-5358-9240; Shah, Safieh/0000-0001-5358-9240; Schneider, Serge/0000-0003-0485-8269; zachariah, rony/0000-0002-2915-9328; Van den Bergh, Rafael/0000-0001-6277-8713	operational research course	operational research course	This research was supported through an operational research course, which was jointly developed and run by the Operational Research Unit, Medecins Sans Frontieres, Brussels Operational Centre, Luxembourg (LUXOR); the Centre for Operational Research, International Union Against Tuberculosis and Lung Disease (The Union), Paris, France and The Union South-East Asia Regional Office, Delhi, India. Additional support for running the course was provided by the Institute for Tropical Medicine, Antwerp, Belgium; the Center for International Health, University of Bergen; the University of Nairobi, Kenya and Partners In Health, Rwanda. This course is under the umbrella of the World Health Organization's special Programme for Research and Training in Tropical Diseases (WHO-TDR) SORTIT program me (Structured Operational Research and Training Initiative) for capacity building in low-and middle-income countries. Funding for the course was provided by Medecins Sans Frontieres Luxembourg, Brussels Operational Centre, Luxembourg, the Bloomberg Philanthropies and the Department for International Development (DFID), UK. There are no commercial funders and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afridi Muhammad Iqbal, 2008, J Pak Med Assoc, V58, P225; Ahmed S H, 1991, J Pak Med Assoc, V41, P10; Ahmed SH, 2007, MULT C 2007 INMIC 20, P1; Ali FA, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-77; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; BAINGANA F, 2005, MENTAL HLTH CONFLICT; Bolton P, 2013, LANCET, V381, P879, DOI 10.1016/S0140-6736(13)60637-6; Chisholm D, 2000, BRIT J PSYCHIAT, V176, P581, DOI 10.1192/bjp.176.6.581; Coldiron Matthew E, 2013, Confl Health, V7, P23, DOI 10.1186/1752-1505-7-23; Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581, DOI 10.1001/jama.291.21.2581; Gaddit AAM, 2007, J MED BIOL SCI, V1, P1; Gadit A, 2004, CULTURE MENTAL HLTH; Gadit AA, 1999, J COLL PHYS SURG PAK, V9, P362; Gadit Amin, 2006, J Pak Med Assoc, V56, P49; Gadit Amin A Muhammad, 2007, J Pak Med Assoc, V57, P453; Husain N, 2007, BRIT J PSYCHIAT, V190, P36, DOI 10.1192/bjp.bp.106.022913; James S, 2002, INT J SOC PSYCHIATR, V48, P163, DOI 10.1177/002076402128783217; Kakuma R, 2011, LANCET, V378, P1654, DOI 10.1016/S0140-6736(11)61093-3; Kessler RC, 2009, EPIDEMIOL PSICHIAT S, V18, P23, DOI 10.1017/S1121189X00001421; Khalily M. T., 2011, AUSTRALASIAN J DISAS, V2011; Khalily MT, 2011, INT J INTEGR CARE, V11; Khan MM, 2006, PSYCHIATR BULL, V30, P85, DOI 10.1192/pb.30.3.85; Knapp M, 2006, HEALTH POLICY PLANN, V21, P157, DOI 10.1093/heapol/czl003; Llosa Augusto E, 2012, Confl Health, V6, P8, DOI 10.1186/1752-1505-6-8; Mirza I, 2004, BMJ-BRIT MED J, V328, P794, DOI 10.1136/bmj.328.7443.794; Mubbashar Malik Hussain, 2003, Int Psychiatry, V1, P11; Muhammad Irfan, 2011, Journal of Postgraduate Medical Institute, V25, P118; Mumford DB, 1996, BRIT J PSYCHIAT, V168, P299, DOI 10.1192/bjp.168.3.299; Paul KE, 2013, INTERVENTION, V11, P8, DOI 10.1097/WTF.0b013e32835f7d1a; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Saraceno B, 2007, LANCET, V370, P1164, DOI 10.1016/S0140-6736(07)61263-X; Shanks Leslie, 2013, Confl Health, V7, P19, DOI 10.1186/1752-1505-7-19; Siddiqi K, 2007, T ROY SOC TROP MED H, V101, P957, DOI 10.1016/j.trstmh.2007.04.006; Steel Z, 2009, JAMA-J AM MED ASSOC, V302, P537, DOI 10.1001/jama.2009.1132; U.S. Department of Health and Human Services, 1999, MULT PLAN HYDR R D P, P32; WHO, 2020, MENT HLTH ATL 2011; WHO, 2012, GLOB BURD MENT HLTH; World Bank, 2011, NCDS POL BRIEF; World Health Organization, 2003, INV MENT HLTH; World Health Organization, 2013, MENT HLTH ACT PLAN 2; World Health Organization (WHO) Ministry of Health-Brazil, 2007, WHO AIMS REPORT MENT	41	15	15	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e97939	10.1371/journal.pone.0097939	http://dx.doi.org/10.1371/journal.pone.0097939			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK8WO	24963793	Green Published, Green Submitted, gold			2022-12-27	WOS:000338709500003
J	Shin, SS; Choi, YM; Han, JY; Lee, K				Shin, Sangsu; Choi, Young Min; Han, Jae Yong; Lee, Kichoon			Inhibition of Lipolysis in the Novel Transgenic Quail Model Overexpressing G(0)/G(1) Switch Gene 2 in the Adipose Tissue during Feed Restriction	PLOS ONE			English	Article							HORMONE-SENSITIVE LIPASE; LIPID DROPLET BINDING; TRIGLYCERIDE LIPASE; NUTRITIONAL REGULATION; MEDIATED LIPOLYSIS; TERMINAL REGION; JAPANESE-QUAIL; CLONING; FAT; CHICKEN	In addition to the issue of obesity in humans, the production of low-fat meat from domestic animals is important in the agricultural industry to satisfy consumer demand. Understanding the regulation of lipolysis in adipose tissue could advance our knowledge to potentially solve both issues. Although the G(0)/G(1) switch gene 2 (G0S2) was recently identified as an inhibitor of adipose triglyceride lipase (ATGL) in vitro, its role in vivo has not been fully clarified. This study was conducted to investigate the role of G0S2 gene in vivo by using two independent transgenic quail lines during different energy conditions. Unexpectedly, G0S2 overexpression had a negligible effect on plasma NEFA concentration, fat cell size and fat pad weight under ad libitum feeding condition when adipose lipolytic activity is minimal. A two-week feed restriction in non-transgenic quail expectedly caused increased plasma NEFA concentration and dramatically reduced fat cell size and fat pad weight. Contrary, G0S2 overexpression under a feed restriction resulted in a significantly less elevation of plasma NEFA concentration and smaller reductions in fat pad weights and fat cell size compared to non-transgenic quail, demonstrating inhibition of lipolysis and resistance to loss of fat by G0S2. Excessive G0S2 inhibits lipolysis in vivo during active lipolytic conditions, such as food restriction and fasting, suggesting G0S2 as a potential target for treatment of obesity. In addition, transgenic quail are novel models for studying lipid metabolism and mechanisms of obesity.	[Shin, Sangsu; Choi, Young Min; Lee, Kichoon] Ohio State Univ, Dept Anim Sci, Columbus, OH 43210 USA; [Han, Jae Yong] Seoul Natl Univ, Coll Agr & Life Sci, Res Inst Agr & Life Sci, World Class Univ Biomodulat Major,Dept Agr Biotec, Seoul, South Korea	University System of Ohio; Ohio State University; Seoul National University (SNU)	Lee, K (corresponding author), Ohio State Univ, Dept Anim Sci, Columbus, OH 43210 USA.	lee.2626@osu.edu	Choi, Young Min/J-6027-2014; Lee, Kichoon/G-2234-2012	Choi, Young Min/0000-0003-3015-6316; , Young Min Choi/0000-0003-2376-7784	Korea Research Foundation [KRF-2009-220-F00006]; Next-Generation BioGreen 21 Program [PJ008142012013]; Rural Development Administration of Republic of Korea; Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture [2010-65206-20716]	Korea Research Foundation(National Research Foundation of Korea); Next-Generation BioGreen 21 Program(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration of Republic of Korea(Rural Development Administration (RDA), Republic of Korea); Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture	This work was supported by Korea Research Foundation (KRF-2009-220-F00006), Next-Generation BioGreen 21 Program (No. PJ008142012013) funded by Rural Development Administration of Republic of Korea and by Agriculture and Food Research Initiative Competitive Grant no. 2010-65206-20716 from the USDA National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2013, LIPIDS, V48, P209, DOI 10.1007/s11745-013-3756-8; Ball GF, 2010, ILAR J, V51, P310, DOI 10.1093/ilar.51.4.310; Bezaire V, 2009, J BIOL CHEM, V284, P18282, DOI 10.1074/jbc.M109.008631; Chen P, 2014, POULT SCI, DOI org/10.3382/ps.2013-03816.; Duncan RE, 2010, J LIPID RES, V51, P309, DOI 10.1194/jlr.M000729; Gruber A, 2010, J BIOL CHEM, V285, P12289, DOI 10.1074/jbc.M109.064469; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Han JY, 2009, COMP IMMUNOL MICROB, V32, P61, DOI 10.1016/j.cimid.2007.11.010; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Kobayashi K, 2008, J CLIN ENDOCR METAB, V93, P2877, DOI 10.1210/jc.2007-2247; Koksal F, 2004, BEHAV RES THER, V42, P1421, DOI 10.1016/j.brat.2003.10.001; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Lee K, 2003, J CLIN INVEST, V111, P453, DOI 10.1172/JCI15924; Lee K, 2009, POULTRY SCI, V88, P620, DOI 10.3382/ps.2008-00265; Nielsen TS, 2011, J CLIN ENDOCR METAB, V96, pE1293, DOI 10.1210/jc.2011-0149; Ogawa A, 1997, CHROMOSOME RES, V5, P93, DOI 10.1023/A:1018461906913; Oh SA, 2011, J ANIM SCI, V89, P367, DOI 10.2527/jas.2010-3339; Ottinger MA, 2004, EXP GERONTOL, V39, P1679, DOI 10.1016/j.exger.2004.06.021; Poynter G, 2009, COLD SPRING HARB PRO, V2009; SANG H, 1994, TRENDS BIOTECHNOL, V12, P415, DOI 10.1016/0167-7799(94)90030-2; Schweiger M, 2008, J BIOL CHEM, V283, P17211, DOI 10.1074/jbc.M710566200; Schweiger M, 2012, J LIPID RES, V53, P2307, DOI 10.1194/jlr.M027409; Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200; Scott BB, 2010, ILAR J, V51, P353, DOI 10.1093/ilar.51.4.353; Seidl AH, 2013, J COMP NEUROL, V521, P5, DOI 10.1002/cne.23187; Serr J, 2011, J ANIM SCI, V89, P3490, DOI 10.2527/jas.2011-3897; Serr J, 2009, POULTRY SCI, V88, P2585, DOI 10.3382/ps.2009-00265; Shin J, 2009, J ANIM SCI, V87, P3923, DOI 10.2527/jas.2009-2124; Shin SS, 2008, FASEB J, V22, P2435, DOI 10.1096/fj.07-101485; Tan GH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni124; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Wueest S, 2012, AM J PHYSIOL-ENDOC M, V302, pE153, DOI 10.1152/ajpendo.00338.2011; Yang SJ, 2013, LIPIDS, V48, P13, DOI 10.1007/s11745-012-3742-6; Yang XY, 2010, CELL METAB, V11, P194, DOI 10.1016/j.cmet.2010.02.003; Zandbergen F, 2005, BIOCHEM J, V392, P313, DOI 10.1042/BJ20050636; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	36	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100905	10.1371/journal.pone.0100905	http://dx.doi.org/10.1371/journal.pone.0100905			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964090	gold, Green Published, Green Submitted			2022-12-27	WOS:000338709500096
J	Tietz, SM; Hofmann, R; Thomas, T; Tackenberg, B; Gaestel, M; Berghoff, M				Tietz, Silvia M.; Hofmann, Regina; Thomas, Tobias; Tackenberg, Bjoern; Gaestel, Matthias; Berghoff, Martin			MK2 and Fas Receptor Contribute to the Severity of CNS Demyelination	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; ACTIVATED PROTEIN-KINASE; CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS; T-CELLS; PERIPHERAL-BLOOD; CEREBROSPINAL-FLUID; MESSENGER-RNA	Models of inflammatory or degenerative diseases demonstrated that the protein-kinase MK2 is a key player in inflammation. In this study we examined the role of MK2 in MOG(35-55)-induced experimental autoimmune encephalomyelitis (EAE), the animal model for multiple sclerosis. In MK2-deficient (MK2(-/-)) mice we found a delayed onset of the disease and MK2(-/-) mice did not recover until day 24 after EAE induction. At this day a higher number of leukocytes in the CNS of MK2(-/-) mice was found. TNF alpha was not detectable in serum of MK2(-/-) mice in any stage of EAE, while high TNF alpha levels were found at day 16 in wild-type mice. Further investigation revealed an increased expression of FasR mRNA in leukocytes isolated from CNS of wild-type mice but not in MK2(-/-) mice, however in vitro stimulation of MK2(-/-) splenocytes with rmTNF alpha induced the expression of FasR. In addition, immunocomplexes between the apoptosis inhibitor cFlip and the FasR adapter molecule FADD were only detected in splenocytes of MK2(-/-) mice at day 24 after EAE induction. Moreover, the investigation of blood samples from relapsing-remitting multiple sclerosis patients revealed reduced FasR mRNA expression compared to healthy controls. Taken together, our data suggest that MK2 is a key regulatory inflammatory cytokines in EAE and multiple sclerosis. MK2(-/-) mice showed a lack of TNFa and thus might not undergo TNF alpha-induced up-regulation of FasR. This may prevent autoreactive leukocytes from apoptosis and may led to prolonged disease activity. The findings indicate a key role of MK2 and FasR in the regulation and limitation of the immune response in the CNS.	[Tietz, Silvia M.; Thomas, Tobias; Berghoff, Martin] Univ Giessen, Dept Neurol, D-35390 Giessen, Germany; [Tietz, Silvia M.] Univ Bern, Theodor Kocher Inst, Bern, Switzerland; [Hofmann, Regina] Univ Giessen, Dept Child Neurol, D-35390 Giessen, Germany; [Tackenberg, Bjoern] Univ Marburg, Dept Neurol, Clin Neuroimmunol Grp, Marburg, Germany; [Gaestel, Matthias] Hannover Med Sch, Inst Biochem, Hannover, Germany	Justus Liebig University Giessen; University of Bern; Justus Liebig University Giessen; Philipps University Marburg; Hannover Medical School	Tietz, SM (corresponding author), Univ Giessen, Dept Neurol, D-35390 Giessen, Germany.	Silvia.Tietz@neuro.med.uni-giessen.de	Gaestel, Matthias/A-6560-2013	Gaestel, Matthias/0000-0002-4944-4652; Tietz, Silvia/0000-0002-9154-0912	Biogen Idec GmbH; Deutsche Forschungsgemeinschaft (DFG) [SFB566]	Biogen Idec GmbH(Biogen); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The study was funded by Biogen Idec GmbH (www.biogenidec.de). Matthias Gaestel was funded by a grant of SFB566 of the Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnason BGW, 1999, NEUROLOGY, V53, P457, DOI 10.1212/wnl.53.3.457; Barone FC, 1997, STROKE, V28, P1233, DOI 10.1161/01.STR.28.6.1233; Di Pauli F, 2010, J NEUROL SCI, V288, P147, DOI 10.1016/j.jns.2009.09.016; Ewald F, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.138; Gary DS, 1998, J CEREBR BLOOD F MET, V18, P1283, DOI 10.1097/00004647-199812000-00001; Ghasemlou N, 2010, J NEUROSCI, V30, P13750, DOI 10.1523/JNEUROSCI.2998-10.2010; Gomes AC, 2003, J NEUROIMMUNOL, V135, P126, DOI 10.1016/S0165-5728(02)00437-X; Gorska MM, 2007, J EXP MED, V204, P1637, DOI 10.1084/jem.20062621; Hofstetter HH, 2006, NEUROSCI LETT, V391, P127, DOI 10.1016/j.neulet.2005.08.042; Julia E, 2006, J NEUROIMMUNOL, V180, P147, DOI 10.1016/j.jneuroim.2006.07.001; Kassiotis G, 2001, J EXP MED, V193, P427, DOI 10.1084/jem.193.4.427; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; Krammer PH, 2007, NAT REV IMMUNOL, V7, P532, DOI 10.1038/nri2115; Kruglov AA, 2011, J IMMUNOL, V187, P5660, DOI 10.4049/jimmunol.1100663; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lange C, 2011, BRAIN BEHAV IMMUN, V25, P120, DOI 10.1016/j.bbi.2010.09.004; Li J, 2008, ONCOGENE, V27, P6194, DOI 10.1038/onc.2008.297; Liu JL, 1998, NAT MED, V4, P78, DOI 10.1038/nm0198-078; Lopatinskaya L, 2003, J NEUROIMMUNOL, V138, P123, DOI 10.1016/S0165-5728(03)00089-4; Macchi B, 1999, NEUROREPORT, V10, P399, DOI 10.1097/00001756-199902050-00034; NAGAFUJI K, 1995, BLOOD, V86, P883, DOI 10.1182/blood.V86.3.883.bloodjournal863883; Namiki K, 2012, J BIOL CHEM, V287, P24228, DOI 10.1074/jbc.M111.338541; Noubade R, 2011, BLOOD, V118, P3290, DOI 10.1182/blood-2011-02-336552; Okuda Y, 2006, J NEUROIMMUNOL, V171, P163, DOI 10.1016/j.jneuroim.2005.09.020; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Probert L, 2000, BRAIN, V123, P2005, DOI 10.1093/brain/123.10.2005; Rafei M, 2009, J IMMUNOL, V182, P2620, DOI 10.4049/jimmunol.0803495; Sabelko KA, 1997, J IMMUNOL, V159, P3096; Saresella M, 2005, J NEUROIMMUNOL, V166, P173, DOI 10.1016/j.jneuroim.2005.05.010; Schutze S, 2008, NAT REV MOL CELL BIO, V9, P655, DOI 10.1038/nrm2430; Shi N, 2009, MULT SCLER J, V15, P120, DOI 10.1177/1352458508096871; Starace D, 2004, FASEB J, V18, P473, DOI 10.1096/fj.04-2726fje; Suvannavejh GC, 2000, J CLIN INVEST, V105, P223, DOI 10.1172/JCI8561; Targoni OS, 2001, J IMMUNOL, V166, P4757, DOI 10.4049/jimmunol.166.7.4757; Thomas T, 2008, J NEUROCHEM, V105, P2039, DOI 10.1111/j.1471-4159.2008.05310.x; Waldner H, 1997, J IMMUNOL, V159, P3100; Wang XK, 2002, J BIOL CHEM, V277, P43968, DOI 10.1074/jbc.M206837200; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; Zhang J, 2000, J EXP MED, V191, P1017, DOI 10.1084/jem.191.6.1017; ZHENG LX, 1995, NATURE, V377, P348, DOI 10.1038/377348a0; Zhu B, 2002, J IMMUNOL, V169, P1561, DOI 10.4049/jimmunol.169.3.1561; Ziaber J, 2000, J INVEST ALLERG CLIN, V10, P98	42	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100363	10.1371/journal.pone.0100363	http://dx.doi.org/10.1371/journal.pone.0100363			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964076	Green Published, gold, Green Submitted			2022-12-27	WOS:000338709500042
J	Di Loreto, C; La Marra, F; Mazzon, G; Belgrano, E; Trombetta, C; Cauci, S				Di Loreto, Carla; La Marra, Francesco; Mazzon, Giorgio; Belgrano, Emanuele; Trombetta, Carlo; Cauci, Sabina			Immunohistochemical Evaluation of Androgen Receptor and Nerve Structure Density in Human Prepuce from Patients with Persistent Sexual Side Effects after Finasteride Use for Androgenetic Alopecia	PLOS ONE			English	Article							MALE-PATTERN BALDNESS; PROSTATE-CANCER; HAIR LOSS; 5-ALPHA-REDUCTASE INHIBITOR; STEROID-HORMONES; TESTOSTERONE; EXPRESSION; HYPERPLASIA; DUTASTERIDE; EXPERIENCE	Finasteride is an inhibitor of 5-alpha-reductase used against male androgenetic alopecia (AGA). Reported side effects of finasteride comprise sexual dysfunction including erectile dysfunction, male infertility, and loss of libido. Recently these effects were described as persistent in some subjects. Molecular events inducing persistent adverse sexual symptoms are unexplored. This study was designed as a retrospective case-control study to assess if androgen receptor (AR) and nerve density in foreskin prepuce specimens were associated with persistent sexual side effects including loss of sensitivity in the genital area due to former finasteride use against AGA. Cases were 8 males (aged 29-43 years) reporting sexual side effects including loss of penis sensitivity over 6 months after discontinuation of finasteride who were interviewed and clinically visited. After informed consent they were invited to undergo a small excision of skin from prepuce. Controls were 11 otherwise healthy matched men (aged 23-49 years) who undergone circumcision for phimosis, and who never took finasteride or analogues. Differences in AR expression and nerve density in different portions of dermal prepuce were evaluated in the 2 groups. Density of nuclear AR in stromal and epithelial cells was higher in cases (mean 40.0%, and 80.6% of positive cells, respectively) than controls (mean 23.4%, and 65.0% of positive cells, respectively), P = 0.023 and P = 0.043, respectively. Conversely, percentage of vessel smooth muscle cells positive for AR and density of nerves were similar in the 2 groups. The ratio of AR positive stromal cells % to serum testosterone concentrations was 2-fold higher in cases than in controls (P = 0.001). Our findings revealed that modulation of local AR levels might be implicated in long-term side effects of finasteride use. This provides the first evidence of a molecular objective difference between patients with long-term adverse sexual effects after finasteride use versus drug untreated healthy controls in certain tissues.	[Di Loreto, Carla; La Marra, Francesco; Cauci, Sabina] Univ Udine, Sch Med, Dept Med & Biol Sci, I-33100 Udine, Italy; [Mazzon, Giorgio; Belgrano, Emanuele; Trombetta, Carlo] Univ Trieste, Dept Med Surg & Hlth Sci, Urol Hosp Dept, Trieste, Italy	University of Udine; University of Trieste	Cauci, S (corresponding author), Univ Udine, Sch Med, Dept Med & Biol Sci, I-33100 Udine, Italy.	sabina.cauci@uniud.it	Mazzon, Giorgio/AHE-5020-2022	Cauci, Sabina/0000-0001-7443-1899; carlo, trombetta/0000-0003-0237-544X; Mazzon, Giorgio/0000-0002-7890-2018	University of Udine funds	University of Udine funds	Support was provided by University of Udine funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anitha B, 2009, J Cutan Aesthet Surg, V2, P12, DOI 10.4103/0974-2077.53093; Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; Banerjee PP, 2001, ENDOCRINOLOGY, V142, P4066, DOI 10.1210/en.142.9.4066; Bolton EC, 2007, GENE DEV, V21, P2005, DOI 10.1101/gad.1564207; Brand LJ, 2013, CURR DRUG TARGETS, V14, P441; Budd D, 2000, EUR J DERMATOL, V10, P122; Cecchin E, 2014, INT J BIOL MARKERS; Chang CS, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.109132; Chhipa RR, 2013, PROSTATE, V73, P1483, DOI 10.1002/pros.22696; Cobb JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005081; Duskova M, 2010, Endocr Regul, V44, P3; Finasteride, 2014, DRUG INFORM LEXI COM; Friedman AE, 2012, PROSTATE, V72, P703, DOI 10.1002/pros.21480; GELLER J, 1990, J CLIN ENDOCR METAB, V71, P1552, DOI 10.1210/jcem-71-6-1552; GRINO PB, 1990, ENDOCRINOLOGY, V126, P1165, DOI 10.1210/endo-126-2-1165; Hsieh JT, 2011, PROSTATE, V71, P1115, DOI 10.1002/pros.21325; Huang PX, 2010, ANNU REV PHYSIOL, V72, P247, DOI 10.1146/annurev-physiol-021909-135917; Iacono F, 2012, BMC SURG, V12, DOI [10.1186/1471-2482-12-S1-S24, 10.1186/1471-2482-12-S1-S21]; Ing NH, 2005, BIOL REPROD, V72, P1290, DOI 10.1095/biolreprod.105.040014; Irwig MS, 2012, J SEX MED, V9, P2927, DOI 10.1111/j.1743-6109.2012.02846.x; Irwig MS, 2011, J SEX MED, V8, P1747, DOI 10.1111/j.1743-6109.2011.02255.x; Isidori AM, 2013, EUR UROL, V2838, P876; Kato S, 2011, TRENDS BIOCHEM SCI, V36, P272, DOI 10.1016/j.tibs.2011.01.001; Kaufman KD, 2002, MOL CELL ENDOCRINOL, V198, P89, DOI 10.1016/S0303-7207(02)00372-6; Kaufman KD, 2002, EUR J DERMATOL, V12, P38; La Marra F, 2012, AM J PATHOL, V181, pS8; Leader JE, 2006, BIOCHEM PHARMACOL, V72, P1589, DOI 10.1016/j.bcp.2006.05.024; Lee HJ, 2003, CELL MOL LIFE SCI, V60, P1613, DOI 10.1007/s00018-003-2309-3; Li J, 2009, MATURITAS, V63, P142, DOI 10.1016/j.maturitas.2009.03.008; Lim AC, 2013, CURR DRUG TARGETS, V14, P408; LIN MC, 1993, J STEROID BIOCHEM, V45, P333; Marron TU, 2005, J NEUROCHEM, V92, P10, DOI 10.1111/j.1471-4159.2004.02836.x; McDonough PH, 2011, CUTIS, V88, P165; McGahuey CA, 2000, J SEX MARITAL THER, V26, P25, DOI 10.1080/009262300278623; Melcangi RC, 2013, J SEX MED, V10, P2598, DOI 10.1111/jsm.12269; Nickel JC, 1996, CAN MED ASSOC J, V155, P1251; NORWOOD OT, 1975, SOUTHERN MED J, V68, P1359, DOI 10.1097/00007611-197511000-00009; Nyquist MD, 2013, HORM CANCER-US, V4, P61, DOI 10.1007/s12672-013-0131-4; Otberg N, 2007, ENDOCRIN METAB CLIN, V36, P379, DOI 10.1016/j.ecl.2007.03.004; Patrao MTCC, 2009, ARQ BRAS ENDOCRINOL, V53, P934, DOI 10.1590/S0004-27302009000800006; Perobelli JE, 2013, REPROD TOXICOL, V38, P65, DOI 10.1016/j.reprotox.2013.03.004; Pinsky MR, 2011, J SEX MED, V8, P3066, DOI 10.1111/j.1743-6109.2011.02425.x; Pozzi P, 2003, J NEUROENDOCRINOL, V15, P882, DOI 10.1046/j.1365-2826.2003.01074.x; Randhawa HK, 2013, JAMA DERMATOL, V149, P732, DOI 10.1001/jamadermatol.2013.2874; Rathnayake D, 2010, EXPERT OPIN PHARMACO, V11, P1295, DOI 10.1517/14656561003752730; Rhodes T, 1998, DERMATOL SURG, V24, P1330, DOI 10.1111/j.1524-4725.1998.tb00009.x; RITTMASTER RS, 1994, NEW ENGL J MED, V330, P120; Ryu HK, 2006, BRIT J DERMATOL, V154, P730, DOI 10.1111/j.1365-2133.2005.07072.x; Schmidt LJ, 2013, CURR DRUG TARGETS, V14, P401; Traish AM, 2012, ENDOCR PRACT, V18, P965, DOI 10.4158/12108.RA; Traish AM, 2011, J SEX MED, V8, P872, DOI 10.1111/j.1743-6109.2010.02157.x; Traish AM, 2009, J ANDROL, V30, P363, DOI 10.2164/jandrol.108.006007; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; Vierhapper H, 2001, J CLIN ENDOCR METAB, V86, P5762, DOI 10.1210/jc.86.12.5762; Waltering KK, 2009, CANCER RES, V69, P8141, DOI 10.1158/0008-5472.CAN-09-0919; Winiarska A, 2006, SKIN PHARMACOL PHYS, V19, P311, DOI 10.1159/000095251; Yip L, 2011, AUSTRALAS J DERMATOL, V52, P81, DOI 10.1111/j.1440-0960.2011.00745.x; Zhang MG, 2013, UROLOGY, V82, DOI 10.1016/j.urology.2013.02.045; Zhang MG, 2012, J SEX MED, V9, P1328, DOI 10.1111/j.1743-6109.2012.02661.x	59	27	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100237	10.1371/journal.pone.0100237	http://dx.doi.org/10.1371/journal.pone.0100237			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959691	Green Submitted, Green Published, gold			2022-12-27	WOS:000338633900029
J	Gomez-Segui, I; Sanchez-Izquierdo, D; Barragan, E; Such, E; Luna, I; Lopez-Pavia, M; Ibanez, M; Villamon, E; Alonso, C; Martin, I; Llop, M; Dolz, S; Fuster, O; Montesinos, P; Canigral, C; Boluda, B; Salazar, C; Cervera, J; Sanz, MA				Gomez-Segui, Ines; Sanchez-Izquierdo, Dolors; Barragan, Eva; Such, Esperanza; Luna, Irene; Lopez-Pavia, Maria; Ibanez, Mariam; Villamon, Eva; Alonso, Carmen; Martin, Ivan; Llop, Marta; Dolz, Sandra; Fuster, Oscar; Montesinos, Pau; Canigral, Carolina; Boluda, Blanca; Salazar, Claudia; Cervera, Jose; Sanz, Miguel A.			Single-Nucleotide Polymorphism Array-Based Karyotyping of Acute Promyelocytic Leukemia	PLOS ONE			English	Article							TRANS-RETINOIC ACID; RISK-ADAPTED TREATMENT; ANTHRACYCLINE MONOCHEMOTHERAPY; COPY; GENE; ADULT; ISOCHROMOSOME; MALIGNANCIES; PETHEMA; PATIENT	Acute promyelocytic leukemia (APL) is characterized by the t(15; 17)(q22; q21), but additional chromosomal abnormalities (ACA) and other rearrangements can contribute in the development of the whole leukemic phenotype. We hypothesized that some ACA not detected by conventional techniques may be informative of the onset of APL. We performed the high-resolution SNP array (SNP-A) 6.0 (Affymetrix) in 48 patients diagnosed with APL on matched diagnosis and remission sample. Forty-six abnormalities were found as an acquired event in 23 patients (48%): 22 duplications, 23 deletions and 1 Copy-Neutral Loss of Heterozygocity (CN-LOH), being a duplication of 8(q24) (23%) and a deletion of 7(q33-qter) (6%) the most frequent copy-number abnormalities (CNA). Four patients (8%) showed CNAs adjacent to the breakpoints of the translocation. We compared our results with other APL series and found that, except for dup(8q24) and del(7q33-qter), ACA were infrequent (<= 3%) but most of them recurrent (70%). Interestingly, having CNA or FLT3 mutation were mutually exclusive events. Neither the number of CNA, nor any specific CNA was associated significantly with prognosis. This study has delineated recurrent abnormalities in addition to t(15; 17) that may act as secondary events and could explain leukemogenesis in up to 40% of APL cases with no ACA by conventional cytogenetics.	[Gomez-Segui, Ines; Such, Esperanza; Luna, Irene; Lopez-Pavia, Maria; Ibanez, Mariam; Villamon, Eva; Alonso, Carmen; Martin, Ivan; Montesinos, Pau; Canigral, Carolina; Boluda, Blanca; Salazar, Claudia; Cervera, Jose; Sanz, Miguel A.] Hosp Univ & Politecn La Fe, Dept Hematol, Valencia, Spain; [Sanchez-Izquierdo, Dolors] Inst Invest Sanitaria Fdn La Fe, Arrays Unit, Valencia, Spain; [Barragan, Eva; Llop, Marta; Dolz, Sandra; Fuster, Oscar] Univ Hosp La Fe, Dept Clin Chem, Mol Biol Lab, Valencia, Spain; [Cervera, Jose] Hosp Univ & Politecn La Fe, Genet Unit, Valencia, Spain; [Sanz, Miguel A.] Univ Valencia, Dept Med, Valencia, Spain	Hospital Universitari i Politecnic La Fe; Hospital Universitari i Politecnic La Fe; University of Valencia	Cervera, J (corresponding author), Hosp Univ & Politecn La Fe, Dept Hematol, Valencia, Spain.	gomez_ine@gva.es; sanz_mig@gva.es	Martin, Ivan/K-9286-2016; Luna del Valle, Irene/GZL-0421-2022; Martín, Iván/AAL-7783-2021; Sanz, Miguel A./F-7485-2018; Seguí, Inés Gómez/ABH-5290-2020; IBAÑEZ COMPANY, MARIAM/AAW-9082-2021; Villamon, Eva/A-6574-2016; Cervera, Jose/ABF-2143-2020	Sanz, Miguel A./0000-0003-1489-1177; IBAÑEZ COMPANY, MARIAM/0000-0002-7486-4659; Cervera, Jose/0000-0001-8252-1106; Fuster, Oscar/0000-0001-9011-2062; Such, Esperanza/0000-0001-6892-403X; Llop, Marta/0000-0002-0106-7296; Lopez Pavia, Maria/0000-0002-8529-4372; Montesinos, Pau/0000-0002-3275-5593; Villamon, Eva/0000-0003-0636-3358	Rio Hortega [CM10/00321, CM11/00343]; Health Research Program [PI12/01047]; program "Red Tematica de Investigacion Cooperativa en Cancer'' [RD12/0036/0014]; "Red Cooperativa de Biobancos Hospitalarios'' from "Instituto de Salud Carlos III'', Ministry of Science and Innovation, Spain [RD09/0076/00021]; "Instituto Investigacion Sanitaria Hospital La Fe'' [2013/0327]; Generalitat Valenciana [PROMETEO/2011/025]	Rio Hortega; Health Research Program; program "Red Tematica de Investigacion Cooperativa en Cancer''; "Red Cooperativa de Biobancos Hospitalarios'' from "Instituto de Salud Carlos III'', Ministry of Science and Innovation, Spain; "Instituto Investigacion Sanitaria Hospital La Fe''; Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission)	This work was supported by the Grant "Rio Hortega'' (CM10/00321, CM11/00343), the Health Research Program (PI12/01047), the program "Red Tematica de Investigacion Cooperativa en Cancer'' (RD12/0036/0014) and the "Red Cooperativa de Biobancos Hospitalarios'' (RD09/0076/00021) from "Instituto de Salud Carlos III'', Ministry of Science and Innovation, Spain, (www.isciii.es); the research grant 2013/0327 from the "Instituto Investigacion Sanitaria Hospital La Fe'', (www.iislafe.es); and the Excellence Research Project (PROMETEO/2011/025) granted by Generalitat Valenciana, (www.cece.gva.es). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi T, 2009, BLOOD, V113, P1741, DOI 10.1182/blood-2007-12-130260; Barbouti A, 2004, AM J HUM GENET, V74, P1, DOI 10.1086/380648; Barragan E, 2011, HAEMATOL-HEMATOL J, V96, P1470, DOI 10.3324/haematol.2011.044933; Cervera J, 2010, HAEMATOL-HEMATOL J, V95, P424, DOI 10.3324/haematol.2009.013243; Chen KS, 1997, NAT GENET, V17, P154, DOI 10.1038/ng1097-154; Delgado MD, 2013, CLIN TRANSL ONCOL, V15, P87, DOI 10.1007/s12094-012-0926-8; Garcia-Casado Z, 2006, CANCER GENET CYTOGEN, V168, P73, DOI 10.1016/j.cancergencyto.2005.12.014; Goldschmidt N, 2010, HEMATOLOGY, V15, P332, DOI 10.1179/102453310X12647083621083; Greenberg PL, 2012, BLOOD, V120, P2454, DOI 10.1182/blood-2012-03-420489; Haraguchi K, 2009, LEUKEMIA RES, V33, P1552, DOI 10.1016/j.leukres.2009.04.033; Heinrichs S, 2010, BLOOD, V115, P4157, DOI 10.1182/blood-2009-11-203182; Hernandez JM, 2001, HAEMATOLOGICA, V86, P807; Huh J, 2011, ANN HEMATOL, V90, P1255, DOI 10.1007/s00277-011-1195-2; Koshy J, 2012, CANCER GENET-NY, V205, P537, DOI 10.1016/j.cancergen.2012.07.017; Kuhn MWM, 2012, BLOOD, V119, pE67, DOI 10.1182/blood-2011-09-380444; Manola KN, 2010, ACTA HAEMATOL-BASEL, V123, P162, DOI 10.1159/000294959; Nowak D, 2012, GENE CHROMOSOME CANC, V51, P756, DOI 10.1002/gcc.21961; O'Keefe C, 2010, BLOOD, V115, P2731, DOI 10.1182/blood-2009-10-201848; Parkin B, 2010, BLOOD, V116, P4958, DOI 10.1182/blood-2010-01-266999; Sanz MA, 2004, BLOOD, V103, P1237, DOI 10.1182/blood-2003-07-2462; Sanz MA, 2010, BLOOD, V115, P5137, DOI 10.1182/blood-2010-01-266007; Schweighofer CD, 2013, J MOL DIAGN, V15, P196, DOI 10.1016/j.jmoldx.2012.09.006; Slack GW, 2011, ADV ANAT PATHOL, V18, P219, DOI 10.1097/PAP.0b013e3182169948; Such E, 2011, HAEMATOL-HEMATOL J, V96, P375, DOI 10.3324/haematol.2010.030957; Tiu RV, 2009, J CLIN ONCOL, V27, P5219, DOI 10.1200/JCO.2009.21.9840; Walter MJ, 2009, P NATL ACAD SCI USA, V106, P12950, DOI 10.1073/pnas.0903091106	26	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100245	10.1371/journal.pone.0100245	http://dx.doi.org/10.1371/journal.pone.0100245			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959826	Green Published, gold, Green Submitted			2022-12-27	WOS:000338633900030
J	Kim, JM; Lee, ST; Chu, K; Jung, KH; Kim, JH; Yu, JS; Kim, S; Kim, SH; Park, DK; Moon, J; Ban, J; Kim, M; Lee, SK; Roh, JK				Kim, Jeong-Min; Lee, Soon-Tae; Chu, Kon; Jung, Keun-Hwa; Kim, Jin Hee; Yu, Jung-Suk; Kim, Soyun; Kim, So Hee; Park, Dong-Kyu; Moon, Jangsup; Ban, Jaejun; Kim, Manho; Lee, Sang Kun; Roh, Jae-Kyu			Inhibition of Let7c MicroRNA Is Neuroprotective in a Rat Intracerebral Hemorrhage Model	PLOS ONE			English	Article							GROWTH-FACTOR-I; INTRANASAL DELIVERY; INSULIN; STROKE	Intracerebral hemorrhage (ICH) is a devastating neurological disease with a grave prognosis. We evaluated microRNA (miRNA) expression after ICH and evaluated Let7c as a therapeutic target. We harvested hemorrhagic brain 24 hours after collagenase induced ICH in the rat. Microarray analysis was performed to compare the miRNAs expression pattern between hemorrhagic hemisphere and contralateral hemisphere. An in vitro thrombin toxicity model and blood injection ICH model were also used to evaluate miRNA expression. We selected miRNA for the therapeutic target study after reviewing target gene databases and their expression. The antagonistic sequence of the selected miRNA (antagomir) was used to evaluate its therapeutic potential in the in vitro thrombin toxicity and in vivo ICH models. Among 1,088 miRNAs analyzed, let7c was induced in the thrombin and ICH models. Let7c antagomir treatment increased cell survival in the in vitro thrombin injury model and improved neurological function at 4 weeks after ICH. Let7c antagomir decreased perihematoma edema, apoptotic cell death and inflammation around hematoma. Let7c antagomir also induced insulin like growth factor receptor 1 (IGF1R) protein and phosphorylated serine threonine kinase after ICH. This study shows a distinct miRNA expression pattern after ICH. The let7c antagomir reduced cell death and edema and enhanced neurological recovery at least in part by activating the IGF1R pro-survival pathway. This suggests blocking let7c might be a potential therapeutic target in ICH.	[Kim, Jeong-Min; Lee, Soon-Tae; Chu, Kon; Jung, Keun-Hwa; Kim, Jin Hee; Yu, Jung-Suk; Kim, Soyun; Kim, So Hee; Park, Dong-Kyu; Moon, Jangsup; Ban, Jaejun; Kim, Manho; Lee, Sang Kun; Roh, Jae-Kyu] Seoul Natl Univ Hosp, Biomed Res Inst, Lab Neurotherapeut, Seoul 110744, South Korea; [Kim, Jeong-Min] Chung Ang Univ, Med Ctr, Dept Neurol, Seoul 156756, South Korea; [Lee, Soon-Tae; Chu, Kon; Jung, Keun-Hwa; Moon, Jangsup; Kim, Manho; Lee, Sang Kun; Roh, Jae-Kyu] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Neurol, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Chung Ang University; Chung Ang University Hospital; Seoul National University (SNU); Seoul National University Hospital	Chu, K (corresponding author), Seoul Natl Univ Hosp, Biomed Res Inst, Lab Neurotherapeut, Seoul 110744, South Korea.	stemcell.snu@gmail.com; rohjk777@gmail.com		Chu, Kon/0000-0001-5863-0302; Kim, Jeong-Min/0000-0001-7213-5527; Kim, Jin Hee/0000-0003-4980-6331; Moon, Jangsup/0000-0003-1282-4528; Lee, Soon-Tae/0000-0003-4767-7564; Jung, Keun-Hwa/0000-0003-1433-8005	Korea Health Technology R & D Project, Ministry of Health & Welfare, Republic of Korea [HI11C1347]; Brain Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2009-0080355]	Korea Health Technology R & D Project, Ministry of Health & Welfare, Republic of Korea; Brain Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning	This study was supported by a grant from the Korea Health Technology R & D Project, Ministry of Health & Welfare, Republic of Korea (HI11C1347). Dr. Roh was supported by the Brain Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2009-0080355). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dhuria SV, 2010, J PHARM SCI-US, V99, P1654, DOI 10.1002/jps.21924; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Fletcher L, 2009, J NEUROSURG, V111, P164, DOI 10.3171/2009.2.JNS081199; Jimenez-Mateos EM, 2012, NAT MED, V18, P1087, DOI 10.1038/nm.2834; Jung KH, 2004, STROKE, V35, P1744, DOI 10.1161/01.STR.0000131270.45822.85; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Lee ST, 2008, BRAIN, V131, P616, DOI 10.1093/brain/awm306; Lee ST, 2012, ANN NEUROL, V72, P269, DOI 10.1002/ana.23588; Lee ST, 2011, J NEURO-ONCOL, V102, P19, DOI 10.1007/s11060-010-0286-6; Lee ST, 2010, STROKE, V41, P1646, DOI 10.1161/STROKEAHA.110.579649; Lee ST, 2006, J NEUROCHEM, V96, P1728, DOI 10.1111/j.1471-4159.2006.03697.x; Lehmann SM, 2012, NAT NEUROSCI, V15, P827, DOI 10.1038/nn.3113; Levi M, 2010, NEW ENGL J MED, V363, P1791, DOI 10.1056/NEJMoa1006221; Liu DZ, 2010, J CEREBR BLOOD F MET, V30, P92, DOI 10.1038/jcbfm.2009.186; Lu AG, 2006, J CEREBR BLOOD F MET, V26, P230, DOI 10.1038/sj.jcbfm.9600183; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Qureshi AI, 2009, LANCET, V373, P1632, DOI 10.1016/S0140-6736(09)60371-8; Rosell A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016750; Selvamani A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032662; Shingaki T, 2010, MOL PHARMACEUT, V7, P1561, DOI 10.1021/mp900275s; Smith TJ, 2010, PHARMACOL REV, V62, P199, DOI 10.1124/pr.109.002469; Sukhanov S, 2007, ARTERIOSCL THROM VAS, V27, P2684, DOI 10.1161/ATVBAHA.107.156257; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Wolf DA, 2012, MOL GENET METAB, V106, P131, DOI 10.1016/j.ymgme.2012.02.006; Zheng HW, 2012, CNS NEUROSCI THER, V18, P1003, DOI 10.1111/cns.12019	25	14	15	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e97946	10.1371/journal.pone.0097946	http://dx.doi.org/10.1371/journal.pone.0097946			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959881	Green Published, Green Submitted, gold			2022-12-27	WOS:000338633900001
J	Logan, D; Kiemel, T; Jeka, JJ				Logan, David; Kiemel, Tim; Jeka, John J.			Asymmetric Sensory Reweighting in Human Upright Stance	PLOS ONE			English	Article							POSTURAL CONTROL; SENSORIMOTOR INTEGRATION; SUPPORT; IDENTIFICATION; BOOTSTRAP; IDENTIFY	To investigate sensory reweighting as a fundamental property of sensor fusion during standing, we probed postural control with simultaneous rotations of the visual scene and surface of support. Nineteen subjects were presented with pseudo-random pitch rotations of visual scene and platform at the ankle to test for amplitude dependencies in the following conditions: low amplitude vision: high amplitude platform, low amplitude vision: low amplitude platform, and high amplitude vision: low amplitude platform. Gain and phase of frequency response functions (FRFs) to each stimulus were computed for two body sway angles and a single weighted EMG signal recorded from seven muscles. When platform stimulus amplitude was increased while visual stimulus amplitude remained constant, gain to vision increased, providing strong evidence for inter-modal reweighting between vision and somatosensation during standing. Intra-modal reweighting of vision was also observed as gains to vision decreased as visual stimulus amplitude increased. Such intra-modal and inter-modal amplitude dependent changes in gain were also observed in muscular activity. Gains of leg segment angle and muscular activity relative to the platform, on the other hand, showed only intra-modal reweighting. That is, changing platform motion amplitude altered the responses to both visual and support surface motion whereas changing visual scene motion amplitude did not significantly affect responses to support surface motion, indicating that the sensory integration scheme between somatosensation (at the support surface) and vision is asymmetric.	[Logan, David; Kiemel, Tim; Jeka, John J.] Univ Maryland, Dept Kinesiol, College Pk, MD 20742 USA; [Logan, David; Jeka, John J.] Univ Maryland, Neurosci & Cognit Sci Program, College Pk, MD 20742 USA; [Jeka, John J.] Univ Maryland, Biomed Engn Grad Program, College Pk, MD 20742 USA; [Jeka, John J.] Temple Univ, Dept Kinesiol, Philadelphia, PA 19122 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Jeka, JJ (corresponding author), Univ Maryland, Dept Kinesiol, College Pk, MD 20742 USA.	jjeka@temple.edu		Jeka, John/0000-0001-5942-3209	National Institute of Neurological Disorders and Stroke [R01 NS-35070]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035070] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding for this research was provided by National Institute of Neurological Disorders and Stroke grant R01 NS-35070 (PI: J. Jeka). NIH Reporter: http://projectreporter.nih.gov/project_info_description.cfm?aid=6911493&icde=15217597&ddparam=&ddvalue=&ddsub=&cr=3&csb=default&cs=ASC. Funding ders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendat J.S., 2000, RANDOM DATA ANAL MEA; Cenciarini M, 2006, J NEUROPHYSIOL, V95, P2733, DOI 10.1152/jn.00856.2004; DIETZ V, 1992, PHYSIOL REV, V72, P33, DOI 10.1152/physrev.1992.72.1.33; DIJKSTRA TMH, 1994, BIOL CYBERN, V71, P489, DOI 10.1007/BF00198467; Fitzpatrick R, 1996, J NEUROPHYSIOL, V76, P3994, DOI 10.1152/jn.1996.76.6.3994; HALL P, 1988, ANN STAT, V16, P927, DOI 10.1214/aos/1176350933; Horak F, 1996, HDB PHYSIOL 12, V12, P255; Hwang S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088132; Kiemel T, 2011, J NEUROSCI, V31, P15144, DOI 10.1523/JNEUROSCI.1013-11.2011; Kiemel T, 2011, J MOTOR BEHAV, V43, P237, DOI 10.1080/00222895.2011.568991; Kiemel T, 2008, J NEUROPHYSIOL, V100, P3394, DOI 10.1152/jn.01272.2007; Loram ID, 2007, J PHYSIOL-LONDON, V584, P661, DOI 10.1113/jphysiol.2007.140046; Mahboobin A, 2005, EXP BRAIN RES, V167, P260, DOI 10.1007/s00221-005-0053-7; MAKI BE, 1986, IEEE T BIO-MED ENG, V33, P775, DOI 10.1109/TBME.1986.325901; Maurer C, 2006, EXP BRAIN RES, V171, P231, DOI 10.1007/s00221-005-0256-y; McIlroy WE, 1997, CLIN BIOMECH, V12, P66, DOI 10.1016/S0268-0033(96)00040-X; Mergner T, 2005, EXP BRAIN RES, V167, P535, DOI 10.1007/s00221-005-0065-3; NASHNER LM, 1982, J NEUROSCI, V2, P536; Nashner LM, 1982, HDB BEHAV NEUROBIOLO, P527; Oie KS, 2002, COGNITIVE BRAIN RES, V14, P164, DOI 10.1016/S0926-6410(02)00071-X; Peterka RJ, 2004, J NEUROPHYSIOL, V91, P410, DOI 10.1152/jn.00516.2003; PETERKA RJ, 1995, EXP BRAIN RES, V105, P101; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Shumway-Cook A, 2000, J GERONTOL A-BIOL, V55, pM10; TEASDALE N, 1991, J GERONTOL, V46, pB238, DOI 10.1093/geronj/46.6.B238; van der Kooij H, 2005, J NEUROSCI METH, V145, P175, DOI 10.1016/j.jneumeth.2005.01.003; van der Kooij H, 2011, J COMPUT NEUROSCI, V30, P759, DOI 10.1007/s10827-010-0291-y; WOOLLACOTT MH, 1986, INT J AGING HUM DEV, V23, P97, DOI 10.2190/VXN3-N3RT-54JB-X16X; Zoubir AM, 1998, IEEE SIGNAL PROC MAG, V15, P56, DOI 10.1109/79.647043	29	20	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100418	10.1371/journal.pone.0100418	http://dx.doi.org/10.1371/journal.pone.0100418			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959665	Green Published, gold			2022-12-27	WOS:000338633900045
J	Schibbye, P; Ghaderi, A; Ljotsson, B; Hedman, E; Lindefors, N; Ruck, C; Kaldo, V				Schibbye, Peter; Ghaderi, Ata; Ljotsson, Brjann; Hedman, Erik; Lindefors, Nils; Ruck, Christian; Kaldo, Viktor			Using Early Change to Predict Outcome in Cognitive Behaviour Therapy: Exploring Timeframe, Calculation Method, and Differences of Disorder-Specific versus General Measures	PLOS ONE			English	Article							DEPRESSION RATING-SCALE; SOCIAL ANXIETY SCALE; SELF-REPORT VERSION; PANIC DISORDER; BULIMIA-NERVOSA; DSM-IV; INTERNET; PSYCHOTHERAPY; RELIABILITY; CLINICIAN	Early change can predict outcome of psychological treatment, especially in cognitive behavior therapy. However, the optimal operationalization of "early change'' for maximizing its predictive ability, and differences in predictive ability of disorder-specific versus general mental health measures has yet to be clarified. This study aimed to investigate how well early change predicted outcome depending on the week it was measured, the calculation method (regression slope or simple subtraction), the type of measures used, and the target disorder. During 10-15 weeks of internet-based cognitive behavior therapy for depression, social anxiety disorder, or panic disorder, weekly ratings were collected through both disorder-specific measures and general measures (Outcome Questionnaire-45 (OQ-45) and Clinical Outcomes in Routine Evaluation-10 (CORE-10)). With outcome defined as the disorder-specific measure, change at week four was the optimal predictor. Slope and subtraction methods performed equally well. The OQ-45 explained 18% of outcome for depression, 14% for social anxiety disorder, and 0% for panic disorder. Corresponding values for CORE-10 were 23%, 29%, and 25%. Specific measures explained 41%, 43%, and 34% respectively: this exceeded the ability of general measures also when they predicted themselves. We conclude that a simple calculation method with a disorder-specific measure at week four seems to provide a good choice for predicting outcome in time-limited cognitive behavior therapy.	[Schibbye, Peter; Lindefors, Nils; Ruck, Christian; Kaldo, Viktor] Karolinska Inst, Dept Clin Neurosci, Div Psychiat, Stockholm, Sweden; [Schibbye, Peter] Sundsvall Harnosand Cty Hosp, Vasternorrland Cty Council, Sect Psychiat, Sundsvall, Sweden; [Ghaderi, Ata; Ljotsson, Brjann; Hedman, Erik] Karolinska Inst, Dept Clin Neurosci, Div Psychol, Stockholm, Sweden; [Hedman, Erik] Karolinska Inst, Dept Clin Neurosci, Osher Ctr Integrat Med, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	Kaldo, V (corresponding author), Karolinska Inst, Dept Clin Neurosci, Div Psychiat, Stockholm, Sweden.	viktor.kaldo@ki.se		Kaldo, Viktor/0000-0002-6443-5279; Ruck, Christian/0000-0002-8742-0168; Hedman-Lagerlof, Erik/0000-0002-7939-9848; Ljotsson, Brjann/0000-0001-8086-1668; Ghaderi, Ata/0000-0001-8483-7964	Karolinska Institutet; Stockholm County Council	Karolinska Institutet(Karolinska Institutet); Stockholm County Council(Stockholm County Council)	This study was funded by Karolinska Institutet and by Stockholm County Council. Role of the Sponsor: The main funding organizations (Karolinska Institutet and Stockholm County Council) are public institutions and neither of the funding organizations had any role in the design and conduct of the study; in the collection or interpretation of the data; nor in the writing of the report or in the decision to submit it.	Agras WS, 2000, AM J PSYCHIAT, V157, P1302, DOI 10.1176/appi.ajp.157.8.1302; Andersson G, 2005, BRIT J PSYCHIAT, V187, P456, DOI 10.1192/bjp.187.5.456; Andersson G, 2008, COMPUT HUM BEHAV, V24, P1790, DOI 10.1016/j.chb.2008.02.003; Andersson G, 2009, BEHAV RES THER, V47, P175, DOI 10.1016/j.brat.2009.01.010; Baker SL, 2002, BEHAV RES THER, V40, P701, DOI 10.1016/S0005-7967(01)00060-2; Barlow DH, 2000, JAMA-J AM MED ASSOC, V283, P2529, DOI 10.1001/jama.283.19.2529; Barlow DH, 2000, MASTERY YOUR ANXIETY; Beck A, 1979, COGNITIVE THERAPY DE; Bergstrom J, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-54; Clark DM, 2003, COGNITIVE THERAPY VE; Clark DM, 1999, BRIEF COGNITIVE THER; Connell J, 2007, CORE 10 USER MANUAL; Cuijpers P, 2008, J CONSULT CLIN PSYCH, V76, P909, DOI 10.1037/a0013075; Dimidjian S, 2006, J CONSULT CLIN PSYCH, V74, P658, DOI 10.1037/0022-006X.74.4.658; Eskildsen A, 2010, NORD J PSYCHIAT, V64, P94, DOI 10.3109/08039480903426929; Fantino B, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-26; Fresco DM, 2001, PSYCHOL MED, V31, P1025, DOI 10.1017/S0033291701004056; Haby MM, 2006, AUST NZ J PSYCHIAT, V40, P9, DOI 10.1080/j.1440-1614.2006.01736.x; Hannan C, 2005, J CLIN PSYCHOL, V61, P155, DOI 10.1002/jclp.20108; Hansen NB, 2002, CLIN PSYCHOL-SCI PR, V9, P329, DOI 10.1093/clipsy/9.3.329; Harmon SC, 2007, PSYCHOTHER RES, V17, P379, DOI 10.1080/10503300600702331; Hawkins EJ, 2004, PSYCHOTHER RES, V14, P308, DOI 10.1093/ptr/kph027; Hedman E., 2013, ACTA PSYCHIAT SCAND; Hedman E, 2012, ACTA PSYCHIAT SCAND, P1; Hedman E, 2014, J AFFECT DISORDERS, V155, P49, DOI 10.1016/j.jad.2013.10.023; Hedman E, 2012, EXPERT REV PHARM OUT, V12, P745, DOI [10.1586/erp.12.67, 10.1586/ERP.12.67]; Hedman E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018001; Houck PR, 2002, DEPRESS ANXIETY, V15, P183, DOI 10.1002/da.10049; Kaldo-Sandstrom Viktor, 2004, Am J Audiol, V13, P185, DOI 10.1044/1059-0889(2004/023); Lambert M.J., 2004, BERGIN GARFIELDS HDB, P139; Lambert M.J., 2010, PREVENTION TREATMENT; Lambert M, 2007, PSYCHOTHER RES, V17, P1, DOI 10.1080/10503300601032506; Lambert MJ, 2003, CLIN PSYCHOL-SCI PR, V10, P288, DOI 10.1093/clipsy/bpg025; Lambert MJ, 2010, PREVENTION TREATMENT, P135; Lambert MJ, 2011, ADM SCORING MANUAL O; Lee Eun-Ho, 2009, Depress Anxiety, V26, pE120, DOI 10.1002/da.20461; Margison FR, 2000, BRIT J PSYCHIAT, V177, P123, DOI 10.1192/bjp.177.2.123; Martell C. R., 2001, DEPRESSION CONTEXT S; Monkul ES, 2004, DEPRESS ANXIETY, V20, P8, DOI 10.1002/da.20011; Ost LG, 2008, NORD J PSYCHIAT, V62, P5, DOI 10.1080/08039480802315590; Percevic R, 2006, PSYCHOTHER RES, V16, P364, DOI 10.1080/10503300500485524; Renaud J, 1998, RAPID RESPONSE PSYCH; Rytwinski NK, 2009, DEPRESS ANXIETY, V26, P34, DOI 10.1002/da.20503; Sapyta J, 2005, J CLIN PSYCHOL, V61, P145, DOI 10.1002/jclp.20107; Shear MK, 1997, MULTICENTER COLLABOR; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Spek V, 2008, J AFFECT DISORDERS, V105, P137, DOI 10.1016/j.jad.2007.05.001; Spielmans GI, 2006, CLIN PSYCHOL PSYCHOT, V13, P202, DOI 10.1002/cpp.491; Svanborg P, 2003, NORD J PSYCHIAT, V57, P291, DOI 10.1080/08039480307281; Svanborg P, 2001, J AFFECT DISORDERS, V64, P203, DOI 10.1016/S0165-0327(00)00242-1; Tang TZ, 1999, CLIN PSYCHOL-SCI PR, V6, P283, DOI 10.1093/clipsy/6.3.283; Wennberg P, 2010, PSYCHOL PSYCHOTHER-T, V83, P325, DOI 10.1348/147608309X478715; Wilson GT, 1996, BEHAV RES THER, V34, P197, DOI 10.1016/0005-7967(95)00068-2; Wilson GT, 1996, BEHAV RES THER, V34, P295, DOI 10.1016/0005-7967(95)00084-4; Wilson GT, 1999, CLIN PSYCHOL-SCI PR, V6, P289; Zaider TI, 2003, ACTA PSYCHIAT SCAND, V108, P72, DOI 10.1034/j.1600-0447.108.s417.8.x	56	30	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100614	10.1371/journal.pone.0100614	http://dx.doi.org/10.1371/journal.pone.0100614			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK7UT	24959666	gold, Green Published, Green Submitted			2022-12-27	WOS:000338633900061
J	Goswami, P; Murty, US; Mutheneni, SR; Krishnan, ST				Goswami, Prashant; Murty, Upadhayula Suryanarayana; Mutheneni, Srinivasa Rao; Krishnan, Swathi Trithala			Relative Roles of Weather Variables and Change in Human Population in Malaria: Comparison over Different States of India	PLOS ONE			English	Article							VECTOR ANOPHELES-GAMBIAE; GLOBAL CLIMATE-CHANGE; PLASMODIUM-FALCIPARUM; TEMPERATURE-VARIATION; TRANSMISSION; RISK; AFRICA; MICROCLIMATE; STEPHENSI; SETTINGS	Background: Pro-active and effective control as well as quantitative assessment of impact of climate change on malaria requires identification of the major drivers of the epidemic. Malaria depends on vector abundance which, in turn, depends on a combination of weather variables. However, there remain several gaps in our understanding and assessment of malaria in a changing climate. Most of the studies have considered weekly or even monthly mean values of weather variables, while the malaria vector is sensitive to daily variations. Secondly, rarely all the relevant meteorological variables have been considered together. An important question is the relative roles of weather variables (vector abundance) and change in host (human) population, in the change in disease load. Method: We consider the 28 states of India, characterized by diverse climatic zones and changing population as well as complex variability in malaria, as a natural test bed. An annual vector load for each of the 28 states is defined based on the number of vector genesis days computed using daily values of temperature, rainfall and humidity from NCEP daily Reanalysis; a prediction of potential malaria load is defined by taking into consideration changes in the human population and compared with the reported number of malaria cases. Results: For most states, the number of malaria cases is very well correlated with the vector load calculated with the combined conditions of daily values of temperature, rainfall and humidity; no single weather variable has any significant association with the observed disease prevalence. Conclusion: The association between vector-load and daily values of weather variables is robust and holds for different climatic regions (states of India). Thus use of all the three weather variables provides a reliable means of pro-active and efficient vector sanitation and control as well as assessment of impact of climate change on malaria.	[Goswami, Prashant; Krishnan, Swathi Trithala] CSIR Fourth Paradigm Inst, Bengaluru, India; [Murty, Upadhayula Suryanarayana; Mutheneni, Srinivasa Rao] CSIR Indian Inst Chem Technol, Hyderabad, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Fourth Paradigm Institute (CSIR 4PI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT)	Goswami, P (corresponding author), CSIR Fourth Paradigm Inst, Bengaluru, India.	goswami@cmmacs.ernet.in	Mutheneni, Srinivasa Rao/AAI-2262-2020	Mutheneni, Srinivasa Rao/0000-0003-3263-3905	project Integrated Analysis for Impact, Mitigation and Sustainability - CSIR, India	project Integrated Analysis for Impact, Mitigation and Sustainability - CSIR, India	This work was supported by the project Integrated Analysis for Impact, Mitigation and Sustainability funded by CSIR, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanford JI, 2013, SCI REP-UK, V3, DOI 10.1038/srep01300; Caminade C, 2011, ATMOS SCI LETT, V12, P96, DOI 10.1002/asl.296; Craig MH, 1999, PARASITOL TODAY, V15, P105, DOI 10.1016/S0169-4758(99)01396-4; DAVIDSON G, 1973, B WORLD HEALTH ORGAN, V49, P475; Dhiman R. C., 2008, Regional Health Forum, V12, P27; Epstein PR, 1998, B AM METEOROL SOC, V79, P409, DOI 10.1175/1520-0477(1998)079<0409:BAPSOC>2.0.CO;2; Ermert V, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-35; Gaudart J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-61; GILL C. A., 1921, Indian Journal of Medical Research, V8, P633; GILL CA, 1920, INDIAN J MED RES, V37, P618; Gillett JD, 1974, S BRIT SOC PARASITOL, V12, P79; Githeko AK, 2000, B WORLD HEALTH ORGAN, V78, P9; Goswami P, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027594; Goswami P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049713; Hoshen MB, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-32; Hunter PR, 2003, J APPL MICROBIOL, V94, p37S, DOI 10.1046/j.1365-2672.94.s1.5.x; Imbahale SS, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-81; Kistler R, 2001, B AM METEOROL SOC, V82, P247, DOI 10.1175/1520-0477(2001)082<0247:TNNYRM>2.3.CO;2; Kiszewski AE, 2004, AM J TROP MED HYG, V71, P128, DOI 10.4269/ajtmh.2004.71.128; Koenraadt CJM, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-20; KUMAR A, 1994, J AM MOSQUITO CONTR, V10, P534; LEAF A, 1989, NEW ENGL J MED, V321, P1577, DOI 10.1056/NEJM198912073212305; Leeson H., 1939, B ENTOMOL RES, V30, P103; Lindsay SW, 1998, B WORLD HEALTH ORGAN, V76, P33; LOEVINSOHN ME, 1994, LANCET, V343, P714, DOI 10.1016/S0140-6736(94)91586-5; Macdonald G, 1958, P ROY SOC MED, V51, P223; MARTENS WJM, 1995, ENVIRON HEALTH PERSP, V103, P458, DOI 10.2307/3432584; Matsuoka Y, 1994, J GLOBAL ENV ENG, V1, P1; Mo KC, 1996, J CLIMATE, V9, P1531, DOI 10.1175/1520-0442(1996)009<1531:LSAMTA>2.0.CO;2; Mohapatra PK, 2001, NATL MED J INDIA, V14, P139; Paaijmans KP, 2009, PNAS, V106, P33; Paaijmans KP, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-183; Paaijmans KP, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-196; Paaijmans KP, 2010, P NATL ACAD SCI USA, V107, P15135, DOI 10.1073/pnas.1006422107; Paaijmans KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001146; Parham PE, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-271; Parham PE, 2010, ENVIRON HEALTH PERSP, V118, P620, DOI 10.1289/ehp.0901256; Patz JA, 2000, INT J PARASITOL, V30, P1395, DOI 10.1016/S0020-7519(00)00141-7; Patz JA, 1996, JAMA-J AM MED ASSOC, V275, P217, DOI 10.1001/jama.275.3.217; Sharma SK, 2004, ANN TROP MED PARASIT, V98, P459, DOI 10.1179/000349804225003569; Singh N, 2004, TROP MED INT HEALTH, V9, P364, DOI 10.1046/j.1365-3156.2003.01181.x; Snow RW, 1999, PARASITOL TODAY, V15, P99, DOI 10.1016/S0169-4758(99)01395-2; Tanser FC, 2003, LANCET, V362, P1792, DOI 10.1016/S0140-6736(03)14898-2; Tiwari S, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-179; Vinayak S, 2003, ACTA TROP, V87, P287, DOI 10.1016/S0001-706X(03)00021-4; Yang GJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000385	46	8	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e99867	10.1371/journal.pone.0099867	http://dx.doi.org/10.1371/journal.pone.0099867			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971510	gold, Green Published, Green Submitted			2022-12-27	WOS:000338512200015
J	Janssens, L; Stoks, R				Janssens, Lizanne; Stoks, Robby			Chronic Predation Risk Reduces Escape Speed by Increasing Oxidative Damage: A Deadly Cost of an Adaptive Antipredator Response	PLOS ONE			English	Article							LIFE-HISTORY; SURVIVAL SELECTION; CHRONIC STRESS; TRADE-OFF; PERFORMANCE; BEHAVIOR; GROWTH; SHAPE; PROTEINS; DEFENSES	Prey organisms evolved a multitude of plastic responses to avoid being eaten by predators. Besides the evolution of plastic morphological responses to escape predation, prey also evolved a set of physiological stress responses to avoid dying because of chronic predator stress per se due to disruption of cellular homeostasis. As physiological stress theory predicts increased energy consumption and the inhibition of essential nonemergency body functions, we tested whether chronic predation risk may increase oxidative damage thereby generating negative effects on escape performance. Specifically, we evaluated whether predation risk reduces escape swimming speed in damselfly larvae and whether this operates through stress-associated increases in oxidative damage. Counterintuitively and in contrast with many empirical studies, chronic predation risk decreased escape performance. This is however entirely consistent with the expectation of it being a long-term cost of responding to predation risk (e.g. by increasing respiration or upregulating the stress protein levels). The decreased swimming speed could be explained by an increased oxidative damage to proteins, thereby providing one of the poorly studied ecological links between oxidative damage and whole-animal performance. This likely widespread, understudied cost of chronic predation risk may provide an important pathway of non-consumptive predator effects on prey population dynamics. Moreover, it could play an evolutionary role by acting as a selective force causing prey organisms to adjust the magnitude of the physiological stress response and should be considered when evaluating life history trade-offs thought to be mediated by oxidative damage.	[Janssens, Lizanne; Stoks, Robby] Univ Leuven, Lab Aquat Ecol Evolut & Conservat, Leuven, Belgium	KU Leuven	Janssens, L (corresponding author), Univ Leuven, Lab Aquat Ecol Evolut & Conservat, Leuven, Belgium.	lizanne.janssens@bio.kuleuven.be	Stoks, Robby/AAK-1227-2020	Stoks, Robby/0000-0003-4130-0459	KU Leuven research fund; Fund for Scientific Research (FWO) Flanders	KU Leuven research fund(KU Leuven); Fund for Scientific Research (FWO) Flanders(FWO)	RS received funding from the KU Leuven research fund and the Fund for Scientific Research (FWO) Flanders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo SA, 2011, HORM BEHAV, V60, P478, DOI 10.1016/j.yhbeh.2011.07.015; Archer CR, 2013, EVOLUTION, V67, P620, DOI 10.1111/j.1558-5646.2012.01805.x; Arnold KE, 2010, BEHAV ECOL SOCIOBIOL, V64, P1857, DOI 10.1007/s00265-010-0997-x; Beckerman AP, 2007, OECOLOGIA, V152, P335, DOI 10.1007/s00442-006-0642-6; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boonstra R, 2013, FUNCT ECOL, V27, P11, DOI 10.1111/1365-2435.12008; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Dayton GH, 2005, OIKOS, V111, P582, DOI 10.1111/j.1600-0706.2005.14340.x; De Block M, 2004, OIKOS, V106, P587; Domenici P, 2008, P ROY SOC B-BIOL SCI, V275, P195, DOI 10.1098/rspb.2007.1088; Guerra C, 2013, COMP BIOCHEM PHYS A, V165, P89, DOI 10.1016/j.cbpa.2013.02.006; Halliwell B., 2007, FREE RADICAL BIO MED, P260; Hawlena D, 2011, FUNCT ECOL, V25, P279, DOI 10.1111/j.1365-2435.2010.01767.x; Hawlena D, 2010, AM NAT, V176, P537, DOI 10.1086/656495; Hettyey A, 2011, J EVOLUTION BIOL, V24, P1007, DOI 10.1111/j.1420-9101.2011.02233.x; Iserbyt A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032648; Janssens L, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0350; Karatas F, 2002, ANAL BIOCHEM, V311, P76, DOI 10.1016/S0003-2697(02)00387-1; Lee WS, 2010, J EXP BIOL, V213, P3289, DOI 10.1242/jeb.043083; McCauley SJ, 2011, ECOLOGY, V92, P2043, DOI 10.1890/11-0455.1; McGraw KJ, 2010, FUNCT ECOL, V24, P947, DOI 10.1111/j.1365-2435.2010.01772.x; McPeek MA, 2001, ECOLOGY, V82, P1535, DOI 10.1890/0012-9658(2001)082[1535:PABRTP]2.0.CO;2; McPeek MA, 1997, EVOLUTION, V51, P459, DOI 10.1111/j.1558-5646.1997.tb02433.x; Metcalfe NB, 2010, FUNCT ECOL, V24, P984, DOI 10.1111/j.1365-2435.2010.01750.x; Miyamoto S, 2012, OXIDATIVE STRESS IN AQUATIC ECOSYSTEMS, P440; Monaghan P, 2009, ECOL LETT, V12, P75, DOI 10.1111/j.1461-0248.2008.01258.x; Nussey DH, 2009, FUNCT ECOL, V23, P809, DOI 10.1111/j.1365-2435.2009.01555.x; Pauwels K, 2005, J EVOLUTION BIOL, V18, P867, DOI 10.1111/j.1420-9101.2005.00890.x; Peacor SD, 2006, HYDROBIOLOGIA, V573, P39, DOI 10.1007/s10750-006-0256-3; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; Relyea Rick A., 2005, P189; Sapolsky R.M., 2004, WHY ZEBRAS DONT GET, V3rd ed.; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Selman C, 2012, TRENDS ECOL EVOL, V27, P570, DOI 10.1016/j.tree.2012.06.006; Slos S, 2008, FUNCT ECOL, V22, P637, DOI 10.1111/j.1365-2435.2008.01424.x; Stoks R, 2005, ECOL LETT, V8, P1307, DOI 10.1111/j.1461-0248.2005.00840.x; Stoks R, 2003, ECOLOGY, V84, P3327, DOI 10.1890/02-0696; Stoks R, 2005, J ANIM ECOL, V74, P708, DOI 10.1111/j.1365-2656.2005.00969.x; Stoks R, 2001, OECOLOGIA, V127, P222, DOI 10.1007/s004420000595; Stoks R, 2006, AM NAT, V168, pS50, DOI 10.1086/509045; Strobbe F, 2009, J EVOLUTION BIOL, V22, P1172, DOI 10.1111/j.1420-9101.2009.01733.x; Strobbe F, 2010, FUNCT ECOL, V24, P1306, DOI 10.1111/j.1365-2435.2010.01752.x; Teplitsky C, 2005, J EVOLUTION BIOL, V18, P180, DOI 10.1111/j.1420-9101.2004.00790.x; Travers M, 2010, ECOL LETT, V13, P980, DOI 10.1111/j.1461-0248.2010.01488.x	44	10	10	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e101273	10.1371/journal.pone.0101273	http://dx.doi.org/10.1371/journal.pone.0101273			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968142	Green Published, gold, Green Submitted			2022-12-27	WOS:000338280800120
J	Schneider, EM; Iglesias, JR; Hallberg, K; Kuperman, MN				Schneider, Eder Milton; Iglesias, Jose Roberto; Hallberg, Karen; Nestor Kuperman, Marcelo			Crimes against Humanity: The Role of International Courts	PLOS ONE			English	Article							COMPLEX NETWORKS; EMERGENCE; DYNAMICS; PUNISH; MODEL	We study the role of international tribunals, like the International Criminal Court (ICC), as an effective way of reducing the number and/or gravity of crimes against humanity. The action of the ICC is directed against leaders that promote or tolerate these kinds of crimes, that is, political authorities, army commanders, civil leaders, etc. In order to simulate the action of the ICC we build a hierarchical society where the most important leaders have the highest connectivity and can spread their points of view, or their orders, through a chain of less but still highly connected deputy chiefs or opinion chieftains. In this way, if they practice misconduct, corruption, or any kind of discriminatory or criminal actions against individuals or groups, it would very difficult and improbable that they will be prosecuted by the courts of their own country. It is to alleviate this situation that the ICC was created. Its mission is to process and condemn crimes against humanity though a supranational organism that can act on criminal leaders in any country. In this study, the action of the ICC is simulated by removing the corrupt leader and replacing it by a "decent'' one. However, as the action of the corrupt leader could have spread among the population by the time the ICC acts, we try to determine if a unique action of the ICC is sufficient or if further actions are required, depending on the degree of deterioration of the human rights in the hypothetical country. The results evidence the positive effect of the ICC action with a relatively low number of interventions. The effect of the ICC is also compared with the action of the local national judiciary system.	[Schneider, Eder Milton; Iglesias, Jose Roberto] Univ Fed Rio Grande do Sul, Inst Fis, Porto Alegre, RS, Brazil; [Iglesias, Jose Roberto] Univ Vale Rio dos Sinos, Escola Gestao & Negocios, Programa Posgrad Econ, Sao Leopoldo, RS, Brazil; [Iglesias, Jose Roberto] Inst Nacl Ciencia & Tecnol Sistemas Complexos, Rio De Janeiro, RJ, Brazil; [Hallberg, Karen; Nestor Kuperman, Marcelo] Consejo Nacl Invest Cient & Tecn, Ctr Atom Bariloche, RA-8400 San Carlos De Bariloche, Argentina; [Hallberg, Karen; Nestor Kuperman, Marcelo] Consejo Nacl Invest Cient & Tecn, Inst Balseiro CNEA, RA-8400 San Carlos De Bariloche, Argentina	Universidade Federal do Rio Grande do Sul; Universidade do Vale do Rio dos Sinos (Unisinos); Comision Nacional de Energia Atomica (CNEA); Centro Atomico Bariloche; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Comision Nacional de Energia Atomica (CNEA); University Nacional Cuyo Mendoza; Instituto Balseiro; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Iglesias, JR (corresponding author), Univ Fed Rio Grande do Sul, Inst Fis, Porto Alegre, RS, Brazil.	joseroberto.iglesias@gmail.com	Kuperman, Marcelo N/N-3783-2019; Kuperman, Marcelo N/N-1446-2015; Iglesias, Jose Roberto/D-7011-2014	Kuperman, Marcelo N/0000-0003-0935-7949; Kuperman, Marcelo N/0000-0003-0935-7949; Iglesias, Jose Roberto/0000-0002-0232-299X				Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Boguna M., 2003, CONDMAT0309263 ARXIV; Castellano C., 2009, REV MODERN PHYS, V81; Coles N, 2001, BRIT J CRIMINOL, V41, P580, DOI 10.1093/bjc/41.4.580; Copelli M, 2002, INT J MOD PHYS C, V13, P783, DOI 10.1142/S0129183102003528; Dietz T, 2003, SCIENCE, V302, P1907, DOI 10.1126/science.1091015; Dreber A, 2008, NATURE, V452, P348, DOI 10.1038/nature06723; Gambra MB, 2011, EUR PHYS J B, V83, P507, DOI 10.1140/epjb/e2011-10359-0; Helbing D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000758; Iglesias JR, 2012, PHYSICA A, V391, P3942, DOI 10.1016/j.physa.2012.03.001; Kuperman M, 2001, PHYS REV LETT, V86, P2909, DOI 10.1103/PhysRevLett.86.2909; Laguna MF, 2005, PHYSICA A, V351, P580, DOI 10.1016/j.physa.2004.11.064; Mullins CW, 2010, INT CRIM LAW REV, V10, P771, DOI 10.1163/157181210X528414; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Perc M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076063; Schabas W A, 2007, INTRO INT CRIMINAL C, V3; Wikipedia, 2013, NUR TRIALS; Wikipedia, 2013, INT CRIM TRIB FORM Y; Wikipedia, 2013, INT MIL TRIB FAR E	21	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e99064	10.1371/journal.pone.0099064	http://dx.doi.org/10.1371/journal.pone.0099064			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967894	Green Submitted, Green Published, gold			2022-12-27	WOS:000338280800008
J	Sinunu, MA; Schouten, EJ; Wadonda-Kabondo, N; Kajawo, E; Eliya, M; Moyo, K; Chimbwandira, F; Strunin, L; Kellerman, SE				Sinunu, Michele A.; Schouten, Erik J.; Wadonda-Kabondo, Nellie; Kajawo, Enock; Eliya, Michael; Moyo, Kundai; Chimbwandira, Frank; Strunin, Lee; Kellerman, Scott E.			Evaluating the Impact of Prevention of Mother-to-Child Transmission of HIV in Malawi through Immunization Clinic-Based Surveillance	PLOS ONE			English	Article							PROGRAMS; DIAGNOSIS; INFANTS; OPPORTUNITIES; MORTALITY; LILONGWE; SERVICES; WOMEN; COST; CARE	Background: Prevention of mother-to-child transmission of HIV (PMTCT) programs can greatly reduce the vertical transmission rate (VTR) of HIV, and Malawi is expanding PMTCT access by offering HIV-infected pregnant women life-long antiretroviral therapy (Option B+). There is currently no empirical data on the effectiveness of Malawian PMTCT programs. This study describes a surveillance approach to obtain population-based estimates of the VTR of infants < 3 months of age in Malawi immediately after the adoption of Option B+. Methods and Findings: A sample of caregivers and infants < 3 months from 53 randomly chosen immunization clinics in 4 districts were enrolled. Infant dried blood spot (DBS) samples were tested for HIV exposure with an antibody test to determine maternal seropositivity. Positive samples were further tested using DNA PCR to determine infant infection status and VTR. Caregivers were surveyed about maternal receipt of PMTCT services. Of the 5,068 DBS samples, 764 were ELISA positive indicating 15.1% (14.1-16.1%) of mothers were HIV-infected and passed antibodies to their infant. Sixty-five of the ELISA-positive samples tested positive by DNA PCR, indicating a vertical transmission rate of 8.5% (6.6-10.7%). Survey data indicates 64.8% of HIV-infected mothers and 46.9% of HIV-exposed infants received some form of antiretroviral prophylaxis. Results do not include the entire breastfeeding period which extends to almost 2 years in Malawi. Conclusions: The observed VTR was lower than expected given earlier modeled estimates, suggesting that Malawi's PMTCT program has been successful at averting perinatal HIV transmission. Challenges to full implementation of PMTCT remain, particularly around low reported antiretroviral prophylaxis. This approach is a useful surveillance tool to assess changes in PMTCT effectiveness as Option B+ is scaled-up, and can be expanded to track programming effectiveness for young infants over time in Malawi and elsewhere.	[Sinunu, Michele A.; Strunin, Lee] Boston Univ, Sch Publ Hlth, Boston, MA 02215 USA; [Schouten, Erik J.; Kajawo, Enock; Kellerman, Scott E.] Management Sci Hlth, Lilongwe, Malawi; [Wadonda-Kabondo, Nellie; Eliya, Michael; Moyo, Kundai; Chimbwandira, Frank] Minist Hlth, Lilongwe, Malawi	Boston University	Sinunu, MA (corresponding author), Boston Univ, Sch Publ Hlth, Boston, MA 02215 USA.	msinunu@bu.edu			USAID	USAID(United States Agency for International Development (USAID))	This study was conducted with funding from USAID (http://www.usaid.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chetty T, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-146; Chimbwandira F, 2013, MMWR-MORBID MORTAL W, V62, P148; Ciaranello AL, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-59; Fasawe O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057778; Ferguson L, 2012, TROP MED INT HEALTH, V17, P564, DOI 10.1111/j.1365-3156.2012.02958.x; Government of Malawi, 2010, Q HIV PROGR REP Q2 2; Government of Malawi, 2010, MAL HIV AIDS MON EV; Government of Malawi, 2012, INT HIV PROGR REP OC; Government of Malawi, 2011, INT HIV PROGR REP JU; Government of Malawi, 2012, 2012 GLOB AIDS RESP; Government of Malawi, 2012, INT HIV PROGR REP JU; Homsy J, 2007, 2007 HIV AIDS IMPL M; Levy JM, 2009, REPROD HEALTH MATTER, V17, P152, DOI 10.1016/S0968-8080(09)33436-9; Mandala J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-405; Mandala J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-314; Mate KS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005483; National Statistical Office ICF Macro, 2010, MAL DEM HLTH SURV 20; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Rollins N, 2007, AIDS, V21, P1341, DOI 10.1097/QAD.0b013e32814db7d4; Rollins N, 2009, AIDS, V23, P1851, DOI 10.1097/QAD.0b013e32832d84fd; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; SAS Institute Inc, 2011, BAS SAS 9 3 PROC GUI; Schouten EJ, 2011, LANCET, V378, P282, DOI 10.1016/S0140-6736(10)62303-3; Stringer EM, 2008, B WORLD HEALTH ORGAN, V86, P57, DOI 10.2471/BLT.07.043117; Stringer EM, 2010, JAMA-J AM MED ASSOC, V304, P293, DOI 10.1001/jama.2010.990; Stringer JSA, 2003, LANCET, V362, P667, DOI 10.1016/S0140-6736(03)14172-4; UNAIDS, 2012, GLOBAL REPORT UNAIDS; Weigel R, 2012, TROP MED INT HEALTH, V17, P751, DOI 10.1111/j.1365-3156.2012.02980.x; Wettstein C, 2012, AIDS, V26, P2361, DOI 10.1097/QAD.0b013e328359ab0c; WHO, 2012, IMM PROF MAL; World Health Organization (WHO), 2007, GUID GLOB SCAL UP PR; Zachariah R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000121	32	19	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100741	10.1371/journal.pone.0100741	http://dx.doi.org/10.1371/journal.pone.0100741			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968298	gold, Green Submitted, Green Published			2022-12-27	WOS:000338280800062
J	Tam, A; Wadsworth, S; Dorscheid, D; Man, SFP; Sin, DD				Tam, Anthony; Wadsworth, Samuel; Dorscheid, Delbert; Man, Shu-Fan Paul; Sin, Don D.			Estradiol Increases Mucus Synthesis in Bronchial Epithelial Cells	PLOS ONE			English	Article							CYSTIC-FIBROSIS; MENSTRUAL-CYCLE; REGULATES MUCIN; MESSENGER-RNA; GOBLET CELLS; MUC5AC MUCIN; EXPRESSION; IDENTIFICATION; RECEPTOR; ALPHA	Airway epithelial mucus hypersecretion and mucus plugging are prominent pathologic features of chronic inflammatory conditions of the airway (e.g. asthma and cystic fibrosis) and in most of these conditions, women have worse prognosis compared with male patients. We thus investigated the effects of estradiol on mucus expression in primary normal human bronchial epithelial cells from female donors grown at an air liquid interface (ALI). Treatment with estradiol in physiological ranges for 2 weeks caused a concentration-dependent increase in the number of PAS-positive cells (confirmed to be goblet cells by MUC5AC immunostaining) in ALI cultures, and this action was attenuated by estrogen receptor beta (ER-beta) antagonist. Protein microarray data showed that nuclear factor of activated T-cell (NFAT) in the nuclear fraction of NHBE cells was increased with estradiol treatment. Estradiol increased NFATc1 mRNA and protein in ALI cultures. In a human airway epithelial (1HAE(0)) cell line, NFATc1 was required for the regulation of MUC5AC mRNA and protein. Estradiol also induced post-translational modification of mucins by increasing total fucose residues and fucosyltransferase (FUT-4, -5, -6) mRNA expression. Together, these data indicate a novel mechanism by which estradiol increases mucus synthesis in the human bronchial epithelium.	[Sin, Don D.] Univ British Columbia, Providence Heart Lung Ctr, UBC James Hogg Res Ctr, Vancouver, BC V5Z 1M9, Canada; Univ British Columbia, Dept Med, Vancouver, BC, Canada	University of British Columbia; University of British Columbia	Sin, DD (corresponding author), Univ British Columbia, Providence Heart Lung Ctr, UBC James Hogg Res Ctr, Vancouver, BC V5Z 1M9, Canada.	Don.Sin@hli.ubc.ca	Sin, Don/AAC-2219-2021		Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Funding was provided by the Canadian Institutes of Health Research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker DJ, 2003, GLYCOBIOLOGY, V13, p41R, DOI 10.1093/glycob/cwg054; Chen Y, 2003, J BIOL CHEM, V278, P17036, DOI 10.1074/jbc.M210429200; Compton DR, 2004, J MED CHEM, V47, P5872, DOI 10.1021/jm049631k; Danahay H, 2002, AM J PHYSIOL-LUNG C, V282, pL226, DOI 10.1152/ajplung.00311.2001; Dave V, 2004, J BIOL CHEM, V279, P34578, DOI 10.1074/jbc.M404296200; Dave V, 2006, J CLIN INVEST, V116, P2597, DOI 10.1172/JCI27331; Dougherty SM, 2006, ENDOCR-RELAT CANCER, V13, P113, DOI 10.1677/erc.1.01118; Farha S, 2009, AM J RESP CRIT CARE, V180, P304, DOI 10.1164/rccm.200904-0497OC; GRUENERT DC, 1988, P NATL ACAD SCI USA, V85, P5951, DOI 10.1073/pnas.85.16.5951; Hogg JC, 2007, AM J RESP CRIT CARE, V176, P454, DOI 10.1164/rccm.200612-1772OC; Hovenberg HW, 1996, BIOCHEM J, V318, P319, DOI 10.1042/bj3180319; Johannesson M, 2000, RESP MED, V94, P1043, DOI 10.1053/rmed.2000.0891; Kohri K, 2002, EUR RESPIR J, V20, P1263, DOI 10.1183/09031936.02.00001402; Lamblin G, 2001, GLYCOCONJUGATE J, V18, P661, DOI 10.1023/A:1020867221861; Shao MXG, 2004, AM J PHYSIOL-LUNG C, V287, pL420, DOI 10.1152/ajplung.00019.2004; Sheehan JK, 2004, J BIOL CHEM, V279, P15698, DOI 10.1074/jbc.M313241200; Smirnova MG, 2003, CELL IMMUNOL, V221, P42, DOI 10.1016/S0008-8749(03)00059-5; Smith PL, 2002, J CELL BIOL, V158, P801, DOI 10.1083/jcb.200203125; Sun J, 2002, ENDOCRINOLOGY, V143, P941, DOI 10.1210/en.143.3.941; Takeyama K, 1999, P NATL ACAD SCI USA, V96, P3081, DOI 10.1073/pnas.96.6.3081; Thornton DJ, 2008, ANNU REV PHYSIOL, V70, P459, DOI 10.1146/annurev.physiol.70.113006.100702; Voynow JA, 1999, AM J PHYSIOL-LUNG C, V276, pL835; Voynow JA, 2009, CHEST, V135, P505, DOI 10.1378/chest.08-0412; Wickstrom C, 1998, BIOCHEM J, V334, P685, DOI 10.1042/bj3340685; Yoon JH, 1999, ACTA OTO-LARYNGOL, V119, P905	25	50	50	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100633	10.1371/journal.pone.0100633	http://dx.doi.org/10.1371/journal.pone.0100633			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964096	Green Published, gold, Green Submitted			2022-12-27	WOS:000338709500070
J	Liu, RZ; Ma, MH; Cui, MY; Dong, Z; Wang, XL; Zhang, W; Yang, MH; Yu, SY				Liu, Ruozhuo; Ma, Minghui; Cui, Mingyu; Dong, Zhao; Wang, Xiaolin; Zhang, Wei; Yang, Minghui; Yu, Shengyuan			Effects of Tumor Necrosis Factor-beta (TNF-beta) 252A > G Polymorphism on the Development of Migraine: A Meta-Analysis	PLOS ONE			English	Article							GENE POLYMORPHISM; LYMPHOTOXIN ALPHA; ASSOCIATION; SUSCEPTIBILITY; PREVALENCE; VARIANTS; DISEASE; AURA	Background and Objective: Genetic factors including TNF-beta have been considered as important components in the aetiology of migraine. Many studies have investigated the association between TNF-beta 252A>G polymorphism and migraine risk, with debatable results. This study was designed to examine whether the TNF-beta 252A>G polymorphism confers genetic susceptibility to migraine in diverse populations. Method: Studies eligible for this meta-analysis were searched in the PubMed, Embase, and CNKI by using the keywords "tumor necrosis factor'', "TNF'', "252A>G'', "rs909253'', "polymorphism'', "polymorphisms'', "variant'', "SNP'', combined with "migraine'' or "migraine with aura (MA)'' or "migraine without aura (MO)''. Pooled ORs and 95% CI were appropriately calculated using the fixed-effect model. Results: We finally included a total of seven studies, providing 5 557 migraineurs and 20 543 unrelated healthy controls. Meta-analysis results showed no statistical evidence of a significant association between TNF-beta 252A>G polymorphism and overall migraine risk. Stratified analyses by type of migraine and gender revealed similar results. Interestingly, an OR with 95% CI representing an increased migraine risk was indicated in Asians under the recessive model (GG vs. AG + AA: OR, 1.38; 95%CI, 1.04-1.84; P for heterogeneity, 0.665). Conclusions: Our findings appear to support the hypothesis that genetic variability of 252A>G polymorphism in TNF region may modulate risk of migraine in the population of Asian ancestry.	[Liu, Ruozhuo; Cui, Mingyu; Dong, Zhao; Wang, Xiaolin; Zhang, Wei; Yu, Shengyuan] Chinese Peoples Liberat Army Gen Hosp, Dept Neurol, Beijing, Peoples R China; [Ma, Minghui] Acad Mil Med Sci, Med Lib Chinese PLA, Minist Resource Construct, Beijing, Peoples R China; [Yang, Minghui] Chinese Peoples Liberat Army Gen Hosp, Dept Tradit Chinese Med, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Academy of Military Medical Sciences - China; Chinese People's Liberation Army General Hospital	Yang, MH (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Tradit Chinese Med, Beijing, Peoples R China.	ymh9651@sina.com; yusy1963@126.com			Postdoctoral Science Sustentation Fund, China: Study on the mechanism of Ligusticumchuanxiong the treatment of migraine [2012M521880]	Postdoctoral Science Sustentation Fund, China: Study on the mechanism of Ligusticumchuanxiong the treatment of migraine	This study was supported by the Postdoctoral Science Sustentation Fund, China: Study on the mechanism of Ligusticumchuanxiong the treatment of migraine (Grant No. 2012M521880). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asuni C, 2009, J NEUROL, V256, P194, DOI 10.1007/s00415-009-0961-8; Aurora SK, 2000, CURR OPIN NEUROL, V13, P273, DOI 10.1097/00019052-200006000-00007; Bouma G, 1996, SCAND J IMMUNOL, V43, P456, DOI 10.1046/j.1365-3083.1996.d01-65.x; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; Colson NJ, 2006, MOL GENET METAB, V88, P107, DOI 10.1016/j.ymgme.2005.11.013; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Estevez M, 2004, HUM GENET, V114, P225, DOI 10.1007/s00439-003-1055-9; Ferrari MD, 1998, LANCET, V351, P1043, DOI 10.1016/S0140-6736(97)11370-8; Ghosh J, 2010, J NEUROL, V257, P898, DOI 10.1007/s00415-009-5430-x; Haut SR, 2006, LANCET NEUROL, V5, P148, DOI 10.1016/S1474-4422(06)70348-9; Ishii M, 2012, J CLIN NEUROL, V8, P301, DOI 10.3988/jcn.2012.8.4.301; Ishii M, 2012, MOL CELL BIOCHEM, V363, P357, DOI 10.1007/s11010-011-1188-4; Kraig RP, 2010, DOSE-RESPONSE, V8, P389, DOI 10.2203/dose-response.09-056.Kraig; Lee Jee-Young, 2005, J Clin Neurol, V1, P8, DOI 10.3988/jcn.2005.1.1.8; Lee KA, 2007, HEADACHE, V47, P1056, DOI 10.1111/j.1526-4610.2007.00847.x; Leonardi Matilde, 2005, J Headache Pain, V6, P429, DOI 10.1007/s10194-005-0252-4; Lipton RB, 1997, NEUROL CLIN, V15, P1, DOI 10.1016/S0733-8619(05)70291-7; Maher BH, 2011, MOL GENET GENOMICS, V285, P433, DOI 10.1007/s00438-011-0622-3; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mulder EJ, 2003, TWIN RES, V6, P422, DOI 10.1375/twin.6.5.422; Oikari LE, 2013, GENE, V512, P527, DOI 10.1016/j.gene.2012.09.116; Pappa S, 2010, ARCH MED SCI, V6, P430, DOI 10.5114/aoms.2010.14267; Perini F, 2005, HEADACHE, V45, P926, DOI 10.1111/j.1526-4610.2005.05135.x; Rainero I, 2004, NEUROLOGY, V62, P141, DOI 10.1212/01.WNL.0000101717.16799.8F; ROSE FC, 1983, CEPHALALGIA, V34, P225; Russell MB, 1996, CEPHALALGIA, V16, P431, DOI 10.1046/j.1468-2982.1996.1606431.x; Sakai F, 1997, CEPHALALGIA, V17, P15, DOI 10.1046/j.1468-2982.1997.1701015.x; Schurks M, 2011, CEPHALALGIA, V31, P1381, DOI 10.1177/0333102411419022; Schurks M, 2009, J PAIN, V10, P759, DOI 10.1016/j.jpain.2009.01.326; Smirnova AS, 2008, MOL IMMUNOL, V45, P295, DOI 10.1016/j.molimm.2007.04.012; Stuart S, 2013, TWIN RES HUM GENET, V16, P1079, DOI 10.1017/thg.2013.63; Svensson DA, 2003, HEADACHE, V43, P235, DOI 10.1046/j.1526-4610.2003.03047.x; Trabace S, 2002, HEADACHE, V42, P341, DOI 10.1046/j.1526-4610.2002.02104.x; WILSON AG, 1995, J INFLAMM, V45, P1	35	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100189	10.1371/journal.pone.0100189	http://dx.doi.org/10.1371/journal.pone.0100189			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959879	Green Published, Green Submitted, gold			2022-12-27	WOS:000338633900025
J	Bengtsson, D; Avril, A; Gunnarsson, G; Elmberg, J; Soderquist, P; Norevik, G; Tolf, C; Safi, K; Fiedler, W; Wikelski, M; Olsen, B; Waldenstrom, J				Bengtsson, Daniel; Avril, Alexis; Gunnarsson, Gunnar; Elmberg, Johan; Soderquist, Par; Norevik, Gabriel; Tolf, Conny; Safi, Kamran; Fiedler, Wolfgang; Wikelski, Martin; Olsen, Bjorn; Waldenstrom, Jonas			Movements, Home-Range Size and Habitat Selection of Mallards during Autumn Migration	PLOS ONE			English	Article							TEAL ANAS-CRECCA; GREEN-WINGED TEAL; DABBLING DUCKS; STOPOVER ECOLOGY; FEEDING ECOLOGY; PROTECTED AREAS; KERNEL METHODS; TRADE-OFF; WATERFOWL; STRATEGIES	The mallard (Anas platyrhynchos) is a focal species in game management, epidemiology and ornithology, but comparably little research has focused on the ecology of the migration seasons. We studied habitat use, time-budgets, home-range sizes, habitat selection, and movements based on spatial data collected with GPS devices attached to wild mallards trapped at an autumn stopover site in the Northwest European flyway. Sixteen individuals (13 males, 3 females) were followed for 15-38 days in October to December 2010. Forty-nine percent (SD = 8.4%) of the ducks' total time, and 85% of the day-time (SD = 28.3%), was spent at sheltered reefs and bays on the coast. Two ducks used ponds, rather than coast, as day-roosts instead. Mallards spent most of the night (76% of total time, SD = 15.8%) on wetlands, mainly on alvar steppe, or in various flooded areas (e.g. coastal meadows). Crop fields with maize were also selectively utilized. Movements between roosting and foraging areas mainly took place at dawn and dusk, and the home-ranges observed in our study are among the largest ever documented for mallards (mean = 6,859 ha; SD = 5,872 ha). This study provides insights into relatively unknown aspects of mallard ecology. The fact that autumn-staging migratory mallards have a well-developed diel activity pattern tightly linked to the use of specific habitats has implications for wetland management, hunting and conservation, as well as for the epidemiology of diseases shared between wildlife and domestic animals.	[Bengtsson, Daniel; Avril, Alexis; Tolf, Conny; Waldenstrom, Jonas] Linnaeus Univ, Ctr Ecol & Evolut Microbial Model Syst, Kalmar, Sweden; [Gunnarsson, Gunnar; Elmberg, Johan; Soderquist, Par] Kristianstad Univ, Div Nat Sci, Kristianstad, Sweden; [Norevik, Gabriel] Ottenby Bird Observ, Degerhamn, Sweden; [Safi, Kamran; Fiedler, Wolfgang; Wikelski, Martin] Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Radolfzell am Bodensee, Germany; [Safi, Kamran; Fiedler, Wolfgang; Wikelski, Martin] Univ Konstanz, Dept Biol, Constance, Germany; [Olsen, Bjorn] Uppsala Univ, Dept Med Sci, Infect Dis Sect, Uppsala, Sweden	Linnaeus University; Kristianstad University; Max Planck Society; University of Konstanz; Uppsala University	Waldenstrom, J (corresponding author), Linnaeus Univ, Ctr Ecol & Evolut Microbial Model Syst, Kalmar, Sweden.	Jonas.Waldenstrom@lnu.se	Safi, Kamran/B-2079-2008; Fiedler, Wolfgang/AAG-4510-2021; Waldenström, Jonas/E-4460-2013	Safi, Kamran/0000-0002-8418-6759; Fiedler, Wolfgang/0000-0003-1082-4161; Waldenström, Jonas/0000-0002-1152-4235; Olsen, Bjorn/0000-0002-4646-691X	Swedish Research Council VR [2010-3067, 2011-3568]; Swedish Research Council FORMAS [2009-1220]	Swedish Research Council VR(Swedish Research Council); Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas)	Funding for this project was provided by the Swedish Research Councils VR (2010-3067, 2011-3568) and FORMAS (2009-1220). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alerstam T, 1998, J AVIAN BIOL, V29, P343, DOI 10.2307/3677155; Alerstam T, 1990, BIRD MIGRATION PHYSL, P331, DOI [DOI 10.1007/978-3-642-74542-3_22., 10.1007/978-3-642-74542-3_22]; Arzel C, 2007, CAN J ZOOL, V85, P81, DOI 10.1139/Z06-201; Arzel C, 2006, J ORNITHOL, V147, P167, DOI 10.1007/s10336-006-0054-8; Arzel C, 2009, J ORNITHOL, V150, P61, DOI 10.1007/s10336-008-0318-6; Bergstrom U., 1938, Fauna och Flora Uppsala, V1938, P1; Brochet AL, 2012, WATERBIRDS, V35, P555, DOI 10.1675/063.035.0406; Brochet AL, 2009, ECOGRAPHY, V32, P919, DOI 10.1111/j.1600-0587.2009.05757.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Calenge C, 2007, J STAT SOFTW, V22, P1; Callicutt JT, 2011, J FISH WILDL MANAG, V2, P29, DOI 10.3996/102010-JFWM-038; Cox RR, 1996, CONDOR, V98, P810, DOI 10.2307/1369861; Cramp S., 1980, HDB BIRDS EUROPE MID, V1st; CURIO E, 1983, EXPERIENTIA, V39, P25, DOI 10.1007/BF01960617; DWYER TJ, 1979, J WILDLIFE MANAGE, V43, P526, DOI 10.2307/3800366; Edelstam C, 1972, VISIBLE MIGRATION S7; Forsyth B., 1965, Proceedings of the Arkansas Academy of Science, V19, P74; Foster MA, 2010, J WILDLIFE MANAGE, V74, P489, DOI 10.2193/2008-588; Fretwell S.D., 1970, ACTA BIOTHEOR, V19, P16, DOI DOI 10.1007/BF01601953; Getz WM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000207; GILMER DS, 1975, J WILDLIFE MANAGE, V39, P781, DOI 10.2307/3800242; Glutz von Blotzheim UN, 1990, HDB VOGEL MITTELEURO, V2; Green AJ, 2002, ACTA OECOL, V23, P177, DOI 10.1016/S1146-609X(02)01149-9; Green AJ, 2014, BIOL REV, V89, P105, DOI 10.1111/brv.12045; Guillemain M, 2005, IBIS, V147, P688, DOI 10.1111/j.1474-919X.2005.00446.x; Guillemain M, 2002, BIODIVERS CONSERV, V11, P1721, DOI 10.1023/A:1020322032114; Guillemain M, 2002, BIOL CONSERV, V103, P183, DOI 10.1016/S0006-3207(01)00120-3; Guillemain M, 2010, WILDLIFE BIOL, V16, P215, DOI 10.2981/09-042; Gunnarsson G, 2012, IBIS, P1; Gunnarsson G, 2006, OECOLOGIA, V149, P203, DOI 10.1007/s00442-006-0446-8; Helseth A, 2005, ARDEA, V93, P213; Hereu B, 2005, MAR ECOL-EVOL PERSP, V26, P54, DOI 10.1111/j.1439-0485.2005.00038.x; Hirsch BT, 2011, BEHAV ECOL, V22, P648, DOI 10.1093/beheco/arr026; HOUSTON AI, 1993, PHILOS T ROY SOC B, V341, P375, DOI 10.1098/rstb.1993.0123; Johnson WP, 2000, WETLANDS, V20, P184, DOI 10.1672/0277-5212(2000)020[0184:FBOGWT]2.0.CO;2; Jones J, 2001, AUK, V118, P557, DOI 10.1642/0004-8038(2001)118[0557:HSSIAE]2.0.CO;2; JORDE DG, 1983, J WILDLIFE MANAGE, V47, P1044, DOI 10.2307/3808163; JORDE DG, 1984, CONDOR, V86, P258, DOI 10.2307/1366993; Jourdain E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008935; Kery M, 2006, J ANIM ECOL, V75, P1172, DOI 10.1111/j.1365-2656.2006.01140.x; King J.R., 1974, Publications Nuttall Orn Club, VNo. 15, P4; KIRBY RE, 1985, WILSON BULL, V97, P215; Kozulin Alexander, 1995, Acta Ornithologica (Warsaw), V30, P125; Krapu Gary L., 1992, P1; Latorre-Margalef N, 2009, P ROY SOC B-BIOL SCI, V276, P1029, DOI 10.1098/rspb.2008.1501; Legagneux P, 2009, J ORNITHOL, V150, P183, DOI 10.1007/s10336-008-0333-7; LINDSTROM A, 1995, ISR J ZOOL, V41, P407; Mack GG, 2006, AUK, V123, P467, DOI 10.1642/0004-8038(2006)123[467:HCABSA]2.0.CO;2; Manly BFJ, 2003, RESOURCE SELECTION A; Martin AC, 1939, TECHNICAL B, V634; MCNEIL R, 1992, BIOL REV, V67, P381, DOI 10.1111/j.1469-185X.1992.tb01188.x; MOHR CO, 1947, AM MIDL NAT, V37, P223, DOI 10.2307/2421652; Nichols JD, 2007, J ORNITHOL, V148, pS343, DOI 10.1007/s10336-007-0256-8; Nilsson Leif, 2013, Ornis Svecica, V23, P46; Paracuellos M, 2004, WATERBIRDS, V27, P446, DOI 10.1675/1524-4695(2004)027[0446:FATDOA]2.0.CO;2; Paracuellos M, 2006, BIODIVERS CONSERV, V15, P4569, DOI 10.1007/s10531-005-5820-z; PAULUS S L, 1988, P135; POYSA H, 1987, BEHAVIOUR, V103, P108, DOI 10.1163/156853987X00297; Poysa H, 2001, OIKOS, V94, P365, DOI 10.1034/j.1600-0706.2001.940218.x; Ripple WJ, 2001, BIOL CONSERV, V102, P227, DOI 10.1016/S0006-3207(01)00107-0; Roshier DA, 2008, OECOLOGIA, V156, P465, DOI 10.1007/s00442-008-0987-0; Roshier DA, 2009, MAR FRESHWATER RES, V60, P299, DOI 10.1071/MF08152; SAKIA RM, 1992, J ROY STAT SOC D-STA, V41, P169, DOI 10.2307/2348250; Sauter A, 2012, J ORNITHOL, V153, P713, DOI 10.1007/s10336-011-0788-9; SCHOENER TW, 1983, AM NAT, V121, P608, DOI 10.1086/284090; Tamisier A., 1981, Verhandlungen der Ornithologischen Gesellschaft in Bayern, V23, P229; Tamisier A., 1999, CAMARGUE CANARDS FOU; THOMAS GJ, 1982, J ZOOL, V197, P131, DOI 10.1111/jzo.1982.197.1.131; Tidwell PR, 2013, J FISH WILDL MANAG, V4, P63, DOI 10.3996/072012-JFWM-062; van Eerden R. E., 1984, COASTAL WADERS WILDF, P84; Wallensten A, 2007, EMERG INFECT DIS, V13, P404, DOI 10.3201/eid1303.061130; Weber TP, 1997, J ANIM ECOL, V66, P297, DOI 10.2307/5976; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423	73	37	42	2	119	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100764	10.1371/journal.pone.0100764	http://dx.doi.org/10.1371/journal.pone.0100764			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971887	Green Published, gold, Green Submitted			2022-12-27	WOS:000338512200058
J	Dujardin, S; Begard, S; Caillierez, R; Lachaud, C; Delattre, L; Carrier, S; Loyens, A; Galas, MC; Bousset, L; Melki, R; Auregan, G; Hantraye, P; Brouillet, E; Buee, L; Colin, M				Dujardin, Simon; Begard, Severine; Caillierez, Raphaelle; Lachaud, Cedrick; Delattre, Lucie; Carrier, Sebastien; Loyens, Anne; Galas, Marie-Christine; Bousset, Luc; Melki, Ronald; Auregan, Gwennaelle; Hantraye, Philippe; Brouillet, Emmanuel; Buee, Luc; Colin, Morvane			Ectosomes: A New Mechanism for Non-Exosomal Secretion of Tau Protein	PLOS ONE			English	Article							PROGRESSIVE SUPRANUCLEAR PALSY; CELL-DERIVED MICROPARTICLES; PAIRED HELICAL FILAMENTS; ALZHEIMERS-DISEASE; EXTRACELLULAR VESICLES; NEUROFIBRILLARY TANGLES; NEUROBLASTOMA-CELLS; CEREBROSPINAL-FLUID; MEMBRANE-VESICLES; PLASMA-MEMBRANE	Tau is a microtubule-associated protein that aggregates in neurodegenerative disorders known as tauopathies. Recently, studies have suggested that Tau may be secreted and play a role in neural network signalling. However, once deregulated, secreted Tau may also participate in the spreading of Tau pathology in hierarchical pathways of neurodegeneration. The mechanisms underlying neuron-to-neuron Tau transfer are still unknown; given the known role of extra-cellular vesicles in cell-to-cell communication, we wondered whether these vesicles could carry secreted Tau. We found, among vesicles, that Tau is predominately secreted in ectosomes, which are plasma membrane-originating vesicles, and when it accumulates, the exosomal pathway is activated.	[Dujardin, Simon; Begard, Severine; Caillierez, Raphaelle; Lachaud, Cedrick; Delattre, Lucie; Carrier, Sebastien; Loyens, Anne; Galas, Marie-Christine; Buee, Luc; Colin, Morvane] INSERM, UMR837, F-59045 Lille, France; [Dujardin, Simon; Begard, Severine; Caillierez, Raphaelle; Lachaud, Cedrick; Delattre, Lucie; Carrier, Sebastien; Loyens, Anne; Galas, Marie-Christine; Buee, Luc; Colin, Morvane] Univ Lille, Fac Med, IMPRT, JPARC, Lille, France; [Galas, Marie-Christine; Buee, Luc; Colin, Morvane] Hop A Calmette, CHR, CMRR, Lille, France; [Bousset, Luc; Melki, Ronald] CNRS, Lab Enzymol & Biochim Struct, UPR 3082, Gif Sur Yvette, France; [Auregan, Gwennaelle; Hantraye, Philippe; Brouillet, Emmanuel] Atom Energy Commiss CEA, Inst Biomed Imaging I2BM, Mol Imaging Res Ctr MIRCen, Fontenay Aux Roses, France; [Auregan, Gwennaelle; Hantraye, Philippe; Brouillet, Emmanuel] CNRS, Mol Imaging Res Ctr MIRCen, URA2210, Fontenay Aux Roses, France	Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS)	Buee, L (corresponding author), INSERM, UMR837, F-59045 Lille, France.	luc.buee@inserm.fr; morvane.colin@inserm.fr	Dujardin, Simon/ABA-1796-2020; BUEE, Luc/B-3126-2010; Galas, Marie-Christine/AAL-9812-2020; Brouillet, Emmanuel/B-4784-2014	BUEE, Luc/0000-0002-6261-4230; bousset, luc/0000-0002-0433-4337; Colin, Morvane/0000-0003-0611-4167; Dujardin, Simon/0000-0002-5614-341X; Brouillet, Emmanuel/0000-0001-6322-7403; Galas, Marie-Christine/0000-0002-3766-7103	LabEx DISTALZ (an excellent laboratory-Development of Innovative Strategies for a Transdisciplinary Approach to Alzheimer's disease); FUI MEDIALZ; CPER DN2M (VICTAUR); Inserm; CNRS; University of Lille 2; Lille Metropole Communaute Urbaine (LMCU); Region Nord/Pas-de-Calais; FEDER; 'Fondation Plan Alzheimer' (PRIMATAU)	LabEx DISTALZ (an excellent laboratory-Development of Innovative Strategies for a Transdisciplinary Approach to Alzheimer's disease); FUI MEDIALZ; CPER DN2M (VICTAUR); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Lille 2; Lille Metropole Communaute Urbaine (LMCU); Region Nord/Pas-de-Calais(Region Hauts-de-FranceEuropean Commission); FEDER(European Commission); 'Fondation Plan Alzheimer' (PRIMATAU)	This work was supported through the LabEx DISTALZ (an excellent laboratory-Development of Innovative Strategies for a Transdisciplinary Approach to Alzheimer's disease), the FUI MEDIALZ and CPER DN2M (VICTAUR), Inserm, CNRS, University of Lille 2, Lille Metropole Communaute Urbaine (LMCU), Region Nord/Pas-de-Calais, FEDER and the 'Fondation Plan Alzheimer' (PRIMATAU). We thank the IMPRT (Lille) for access to core facilities (animal housing, D. Taillieu; EM, C. Allet). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrei C, 1999, MOL BIOL CELL, V10, P1463, DOI 10.1091/mbc.10.5.1463; [Anonymous], NEUROBIOL AGING33; Baron M, 2012, J CELL MOL MED, V16, P1365, DOI 10.1111/j.1582-4934.2011.01486.x; Borroni B, 2009, NEUROBIOL AGING, V30, P34, DOI 10.1016/j.neurobiolaging.2007.05.009; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2011, ACTA NEUROPATHOL, V121, P171, DOI 10.1007/s00401-010-0789-4; BRANDT R, 1995, J CELL BIOL, V131, P1327, DOI 10.1083/jcb.131.5.1327; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Caillierez R, 2013, MOL THER, V21, P1358, DOI 10.1038/mt.2013.66; Castillo-Carranza DL, 2014, J NEUROSCI, V34, P4260, DOI 10.1523/JNEUROSCI.3192-13.2014; Chai XY, 2012, NEUROBIOL DIS, V48, P356, DOI 10.1016/j.nbd.2012.05.021; Choi DS, 2013, MOL DIAGN THER, V17, P265, DOI 10.1007/s40291-013-0042-7; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Cuervo AM, 2010, MOVEMENT DISORD, V25, pS49, DOI 10.1002/mds.22718; Davizon P, 2010, SEMIN THROMB HEMOST, V36, P857, DOI 10.1055/s-0030-1267039; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; de Calignon A, 2010, NATURE, V464, P1201, DOI 10.1038/nature08890; de Gassart A, 2003, BLOOD, V102, P4336, DOI 10.1182/blood-2003-03-0871; Delacourte A, 1999, NEUROLOGY, V52, P1158, DOI 10.1212/WNL.52.6.1158; Diaz-Hernandez M, 2010, J BIOL CHEM, V285, P32539, DOI 10.1074/jbc.M110.145003; Doeuvre L, 2009, J NEUROCHEM, V110, P457, DOI 10.1111/j.1471-4159.2009.06163.x; Dujardin S, 2014, ACTA NEUROPATHOLOGIC; Ekinci FJ, 2000, CELL MOL NEUROBIOL, V20, P497, DOI 10.1023/A:1007075115574; EL Andaloussi S, 2013, NAT REV DRUG DISCOV, V12, P348, DOI 10.1038/nrd3978; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Galas MC, 2006, J BIOL CHEM, V281, P19296, DOI 10.1074/jbc.M601849200; Gamblin TC, 2003, P NATL ACAD SCI USA, V100, P10032, DOI 10.1073/pnas.1630428100; Gerson JE, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00093; Gomez-Ramos A, 2006, FEBS LETT, V580, P4842, DOI 10.1016/j.febslet.2006.07.078; Hanisch K, 2010, J PROTEOME RES, V9, P1476, DOI 10.1021/pr901002t; Horowitz PM, 2004, J NEUROSCI, V24, P7895, DOI 10.1523/JNEUROSCI.1988-04.2004; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Kalra H, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001450; Karch CM, 2012, J BIOL CHEM, V287, P42751, DOI 10.1074/jbc.M112.380642; Kaufman SK, 2013, NEUROTHERAPEUTICS, V10, P371, DOI 10.1007/s13311-013-0196-3; Kempf M, 1996, J NEUROSCI, V16, P5583; Kfoury N, 2012, J BIOL CHEM, V287, P19440, DOI 10.1074/jbc.M112.346072; Kim W, 2010, FEBS LETT, V584, P3085, DOI 10.1016/j.febslet.2010.05.042; Kim W, 2010, J ALZHEIMERS DIS, V19, P647, DOI 10.3233/JAD-2010-1273; Lecolle K, 2013, GENE THER, V20, P283, DOI 10.1038/gt.2012.39; Lee Sangmook, 2012, Int J Alzheimers Dis, V2012, P172837, DOI 10.1155/2012/172837; Liu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084849; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Maas T, 2000, J BIOL CHEM, V275, P15733, DOI 10.1074/jbc.M000389200; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Piccin A, 2007, BLOOD REV, V21, P157, DOI 10.1016/j.blre.2006.09.001; Plouffe V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036873; Pooler AM, 2013, EMBO REP, V14, P389, DOI 10.1038/embor.2013.15; Ramcharitar J, 2013, J NEUROPATH EXP NEUR, V72, P824, DOI 10.1097/NEN.0b013e3182a0a39f; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Saito Y, 2004, J NEUROPATH EXP NEUR, V63, P911, DOI 10.1093/jnen/63.9.911; Saman S, 2012, J BIOL CHEM, V287, P3842, DOI 10.1074/jbc.M111.277061; Santa-Maria I, 2012, J BIOL CHEM, V287, P20522, DOI 10.1074/jbc.M111.323279; SAUTIERE PE, 1994, NEURODEGENERATION, V3, P53; Schraen-Maschke S, 2008, BIOMARK MED, V2, P363, DOI 10.2217/17520363.2.4.363; Sergeant N, 2001, HUM MOL GENET, V10, P2143, DOI 10.1093/hmg/10.19.2143; Shea TB, 1996, J NEUROCHEM, V66, P1539; Simon D, 2012, FEBS LETT, V586, P47, DOI 10.1016/j.febslet.2011.11.022; Sultan A, 2011, J BIOL CHEM, V286, P4566, DOI 10.1074/jbc.M110.199976; Thery C, 2001, J IMMUNOL, V166, P7309, DOI 10.4049/jimmunol.166.12.7309; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Troquier L, 2012, CURR ALZHEIMER RES, V9, P397, DOI 10.2174/156720512800492503; Usardi A, 2011, FEBS J, V278, P2927, DOI 10.1111/j.1742-4658.2011.08218.x; Verny M, 1996, BRAIN, V119, P1123, DOI 10.1093/brain/119.4.1123; Wang YP, 2007, P NATL ACAD SCI USA, V104, P10252, DOI 10.1073/pnas.0703676104; Wang YP, 2010, AUTOPHAGY, V6, P182, DOI 10.4161/auto.6.1.10815; Yamada K, 2011, J NEUROSCI, V31, P13110, DOI 10.1523/JNEUROSCI.2569-11.2011	69	135	139	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100760	10.1371/journal.pone.0100760	http://dx.doi.org/10.1371/journal.pone.0100760			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971751	Green Published, Green Submitted, gold			2022-12-27	WOS:000338512200057
J	Hu, ZY; Wang, YZ; Im, WT; Wang, SY; Zhao, GP; Zheng, HJ; Quan, ZX				Hu, Zi-Ye; Wang, Yue-Zhu; Im, Wan-Taek; Wang, Sheng-Yue; Zhao, Guo-Ping; Zheng, Hua-Jun; Quan, Zhe-Xue			The First Complete Genome Sequence of the Class Fimbriimonadia in the Phylum Armatimonadetes	PLOS ONE			English	Article							BACTERIAL; IDENTIFICATION; GENE; PROTECTION; CANDIDATE; EVOLUTION; PROTEIN; STRESS; SYSTEM; REGION	In this study, we present the complete genome of Fimbriimonas ginsengisoli Gsoil 348(T) belonging to the class Fimbriimonadia of the phylum Armatimonadetes, formerly called as candidate phylum OP10. The complete genome contains a single circular chromosome of 5.23 Mb including a 45.5 kb prophage. Of the 4820 open reading frames (ORFs), 3,000 (62.2%) genes could be classified into Clusters of Orthologous Groups (COG) families. With the split of rRNA genes, strain Gsoil 348(T) had no typical 16S-23S-5S ribosomal RNA operon. In this genome, the GC skew inversion which was usually observed in archaea was found. The predicted gene functions suggest that the organism lacks the ability to synthesize histidine, and the TCA cycle is incomplete. Phylogenetic analyses based on ribosomal proteins indicated that strain Gsoil 348(T) represents a deeply branching lineage of sufficient divergence with other phyla, but also strongly involved in superphylum Terrabacteria.	[Hu, Zi-Ye; Zhao, Guo-Ping; Quan, Zhe-Xue] Fudan Univ, Sch Life Sci, Dept Microbiol & Microbial Engn, Shanghai 200433, Peoples R China; [Wang, Yue-Zhu; Wang, Sheng-Yue; Zhao, Guo-Ping; Zheng, Hua-Jun] Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai, Peoples R China; [Im, Wan-Taek] Hankyoung Natl Univ, Dept Biotechnol, Kyonggi Do, South Korea; [Zheng, Hua-Jun] Shanghai Inst Planned Parenthood Res, Lab Med Foods, Shanghai, Peoples R China	Fudan University	Zheng, HJ (corresponding author), Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai, Peoples R China.	quanzx@fudan.edu.cn; zhenghj@chgc.sh.cn	Quan, Zhexue/B-8046-2013; Zheng, Huajun/AAN-4973-2020	Quan, Zhexue/0000-0002-7561-8572; Zhao, Guo-Ping/0000-0002-7621-6620	Program for New Century Excellent Talents in University, Ministry of Education, China [NCET-13010]	Program for New Century Excellent Talents in University, Ministry of Education, China(Program for New Century Excellent Talents in University (NCET))	This work was supported by Program for New Century Excellent Talents in University (NCET-13010), Ministry of Education, China (http://www.moe.edu.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertsen M, 2013, NAT BIOTECHNOL, V31, P533, DOI 10.1038/nbt.2579; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Boyer SL, 2001, MOL BIOL EVOL, V18, P1057, DOI 10.1093/oxfordjournals.molbev.a003877; Bruno-Barcena JM, 2004, APPL ENVIRON MICROB, V70, P4702, DOI 10.1128/AEM.70.8.4702-4710.2004; Cabreiro F, 2006, ANN NY ACAD SCI, V1067, P37, DOI 10.1196/annals.1354.006; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Dunfield PF, 2012, ENVIRON MICROBIOL, V14, P3069, DOI 10.1111/j.1462-2920.2012.02742.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Grigoriev A, 1998, NUCLEIC ACIDS RES, V26, P2286, DOI 10.1093/nar/26.10.2286; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guo FB, 2003, NUCLEIC ACIDS RES, V31, P1780, DOI 10.1093/nar/gkg254; Hugenholtz P, 1998, J BACTERIOL, V180, P366, DOI 10.1128/JB.180.2.366-376.1998; Hwang RY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030090; Im WT, 2012, ANTON LEEUW INT J G, V102, P307, DOI 10.1007/s10482-012-9739-6; Janczarek M, 2011, INT J MOL SCI, V12, P7898, DOI 10.3390/ijms12117898; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kohler R, 2004, MOL MICROBIOL, V54, P647, DOI 10.1111/j.1365-2958.2004.04307.x; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Lee KCY, 2011, INT J SYST EVOL MICR, V61, P2482, DOI 10.1099/ijs.0.027235-0; Lee KCY, 2014, ISME J, V8, P1522, DOI 10.1038/ismej.2013.251; Letoffe S, 2006, P NATL ACAD SCI USA, V103, P12891, DOI 10.1073/pnas.0605440103; Mackiewicz P, 2004, NUCLEIC ACIDS RES, V32, P3781, DOI 10.1093/nar/gkh699; Merhej V, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-13; OLSON ER, 1991, J BACTERIOL, V173, P234, DOI 10.1128/jb.173.1.234-244.1991; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; Portillo MC, 2009, WORLD J MICROB BIOT, V25, P347, DOI 10.1007/s11274-008-9895-z; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Salzberg SL, 1998, NUCLEIC ACIDS RES, V26, P544, DOI 10.1093/nar/26.2.544; Sauer FG, 2000, CURR OPIN MICROBIOL, V3, P65, DOI 10.1016/S1369-5274(99)00053-3; Stathopoulos C, 2000, MICROBES INFECT, V2, P1061, DOI 10.1016/S1286-4579(00)01260-0; Strous M, 2006, NATURE, V440, P790, DOI 10.1038/nature04647; Tamaki H, 2011, INT J SYST EVOL MICR, V61, P1442, DOI 10.1099/ijs.0.025643-0; Thibessard A, 2004, APPL ENVIRON MICROB, V70, P2220, DOI 10.1128/AEM.70.4.2220-2229.2004; Urich T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002527; Yutin N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036972	36	11	12	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100794	10.1371/journal.pone.0100794	http://dx.doi.org/10.1371/journal.pone.0100794			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24967843	Green Published, Green Submitted, gold			2022-12-27	WOS:000338280800068
J	Mayfield, JA; Liang, Z; Agrahari, G; Lee, SW; Donahue, DL; Ploplis, VA; Castellino, FJ				Mayfield, Jeffrey A.; Liang, Zhong; Agrahari, Garima; Lee, Shaun W.; Donahue, Deborah L.; Ploplis, Victoria A.; Castellino, Francis J.			Mutations in the Control of Virulence Sensor Gene from Streptococcus pyogenes after Infection in Mice Lead to Clonal Bacterial Variants with Altered Gene Regulatory Activity and Virulence	PLOS ONE			English	Article							GROUP-A STREPTOCOCCUS; DISSEMINATED M1T1 CLONE; IN-VIVO; CYSTEINE PROTEASE; EXPRESSION; STRAIN; SEQUENCE; BINDING; GROWTH; DEGRADATION	The cluster of virulence sensor (CovS)/responder (CovR) two-component operon (CovRS) regulates similar to 15% of the genes of the Group A Streptococcal pyogenes (GAS) genome. Bacterial clones containing inactivating mutations in the covS gene have been isolated from patients with virulent invasive diseases. We report herein an assessment of the nature and types of covS mutations that can occur in both virulent and nonvirulent GAS strains, and assess whether a nonvirulent GAS can attain enhanced virulence through this mechanism. A group of mice were infected with a globally-disseminated clonal M1T1 GAS (isolate 5448), containing wild-type (WT) CovRS (5448/CovR(+)S(+)), or less virulent engineered GAS strains, AP53/CovR(+)S(+) and Manfredo M5/CovR(+)S(+). SpeB negative GAS clones from wound sites and/or from bacteria disseminated to the spleen were isolated and the covS gene was subjected to DNA sequence analysis. Numerous examples of inactivating mutations were found in CovS in all regions of the gene. The mutations found included frame-shift insertions and deletions, and in-frame small and large deletions in the gene. Many of the mutations found resulted in early translation termination of CovS. Thus, the covS gene is a genomic mutagenic target that gives GAS enhanced virulence. In cases wherein CovS-was discovered, these clonal variants exhibited high lethality, further suggesting that randomly mutated covS genes occur during the course of infection, and lead to the development of a more invasive infection.	[Mayfield, Jeffrey A.; Liang, Zhong; Agrahari, Garima; Lee, Shaun W.; Donahue, Deborah L.; Ploplis, Victoria A.; Castellino, Francis J.] Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA; [Liang, Zhong; Agrahari, Garima; Ploplis, Victoria A.; Castellino, Francis J.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Lee, Shaun W.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA	University of Notre Dame; University of Notre Dame; University of Notre Dame	Castellino, FJ (corresponding author), Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA.	fcastell@nd.edu			 [HL013423]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL013423, R37HL013423] Funding Source: NIH RePORTER	; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding provided by HL013423. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrahari G, 2013, J BIOL CHEM, V288, P27494, DOI 10.1074/jbc.M113.494864; Aziz RK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009798; Aziz RK, 2005, J BACTERIOL, V187, P3311, DOI 10.1128/JB.187.10.3311-3318.2005; Aziz RK, 2004, MOL MICROBIOL, V51, P123, DOI 10.1046/j.1365-2958.2003.03797.x; Barnett TC, 2013, CELL HOST MICROBE, V14, P675, DOI 10.1016/j.chom.2013.11.003; BROCKWAY WJ, 1972, ARCH BIOCHEM BIOPHYS, V151, P194, DOI 10.1016/0003-9861(72)90488-2; Carroll RK, 2011, J CLIN INVEST, V121, P1956, DOI 10.1172/JCI45169; Chatellier S, 2000, INFECT IMMUN, V68, P3523, DOI 10.1128/IAI.68.6.3523-3534.2000; Churchward G, 2007, MOL MICROBIOL, V64, P34, DOI 10.1111/j.1365-2958.2007.05649.x; Cole JN, 2011, NAT REV MICROBIOL, V9, P724, DOI 10.1038/nrmicro2648; Cole JN, 2010, MBIO, V1, DOI 10.1128/mBio.00191-10; Dalton TL, 2004, J BACTERIOL, V186, P3928, DOI 10.1128/JB.186.12.3928-3937.2004; Engleberg NC, 2001, J INFECT DIS, V183, P1043, DOI 10.1086/319291; Federle MJ, 1999, J BACTERIOL, V181, P3649, DOI 10.1128/JB.181.12.3649-3657.1999; Flores AR, 2013, INFECT IMMUN, V81, P4128, DOI 10.1128/IAI.00405-13; Gao R, 2009, ANNU REV MICROBIOL, V63, P133, DOI 10.1146/annurev.micro.091208.073214; Garcia AF, 2010, MICROBIOL-SGM, V156, P3085, DOI 10.1099/mic.0.042614-0; Graham MR, 2002, P NATL ACAD SCI USA, V99, P13855, DOI 10.1073/pnas.202353699; Hollands A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004102; Honda-Ogawa M, 2013, J BIOL CHEM, V288, P15854, DOI 10.1074/jbc.M113.469106; Horstmann N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002311; Ikebe T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000832; Kansal RG, 2010, J INFECT DIS, V201, P855, DOI 10.1086/651019; Kappeler KV, 2009, INFECT IMMUN, V77, P5411, DOI 10.1128/IAI.00373-09; Le Breton Y, 2013, INFECT IMMUN, V81, P862, DOI 10.1128/IAI.00837-12; Liang Z, 2013, J BIOL CHEM, V288, P6561, DOI 10.1074/jbc.M112.442657; Maamary PG, 2012, FASEB J, V26, P4675, DOI 10.1096/fj.12-212142; Maamary PG, 2010, J INNATE IMMUN, V2, P596, DOI 10.1159/000317640; McIver KS, 1997, J BACTERIOL, V179, P5178, DOI 10.1128/jb.179.16.5178-5187.1997; MILLER L, 1988, J BIOL CHEM, V263, P5668; Moxon R, 2006, ANNU REV GENET, V40, P307, DOI 10.1146/annurev.genet.40.110405.090442; MUSSER JM, 1991, P NATL ACAD SCI USA, V88, P2668, DOI 10.1073/pnas.88.7.2668; Nomizu M, 2001, J BIOL CHEM, V276, P44551, DOI 10.1074/jbc.M106306200; Raeder R, 1998, RES MICROBIOL, V149, P539, DOI 10.1016/S0923-2508(99)80001-1; Rezcallah MS, 2004, MICROBIOL-SGM, V150, P365, DOI 10.1099/mic.0.26826-0; SCOTT JR, 1986, J EXP MED, V164, P1641, DOI 10.1084/jem.164.5.1641; Smoot JC, 2002, P NATL ACAD SCI USA, V99, P4668, DOI 10.1073/pnas.062526099; Smoot LM, 2001, P NATL ACAD SCI USA, V98, P10416, DOI 10.1073/pnas.191267598; Sumby P, 2006, PLOS PATHOG, V2, P41, DOI 10.1371/journal.ppat.0020005; Sumitomo T, 2013, J BIOL CHEM, V288, P13317, DOI 10.1074/jbc.M113.459875; Sun HM, 2004, SCIENCE, V305, P1283, DOI 10.1126/science.1101245; Tatsuno Ichiro, 2013, BMC Res Notes, V6, P126, DOI 10.1186/1756-0500-6-126; Tran-Winkler HJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002361; Trevino J, 2009, INFECT IMMUN, V77, P3141, DOI 10.1128/IAI.01560-08; Vachon P, 2002, CONTEMP TOP LAB ANIM, V41, P15; Venturini C, 2013, INFECT IMMUN, V81, P2062, DOI 10.1128/IAI.00192-13; Walker JS, 2003, ADV EXP MED BIOL, V521, P148; Walker JS, 1996, INFLAMM RES, V45, P557, DOI 10.1007/BF02342227; Walker MJ, 2007, NAT MED, V13, P981, DOI 10.1038/nm1612; WANNAMAKER LW, 1983, REV INFECT DIS, V5, pS723; Zhang YL, 2012, J BIOL CHEM, V287, P42093, DOI 10.1074/jbc.M112.417808	51	22	22	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100698	10.1371/journal.pone.0100698	http://dx.doi.org/10.1371/journal.pone.0100698			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968349	Green Published, gold, Green Submitted			2022-12-27	WOS:000338280800053
J	Moore, HC; Jacoby, P; Hogan, AB; Blyth, CC; Mercer, GN				Moore, Hannah C.; Jacoby, Peter; Hogan, Alexandra B.; Blyth, Christopher C.; Mercer, Geoffry N.			Modelling the Seasonal Epidemics of Respiratory Syncytial Virus in Young Children	PLOS ONE			English	Article							INFECTIONS; POPULATION; VACCINATION; BURDEN; HEALTH; AGE	Background: Respiratory syncytial virus (RSV) is a major cause of paediatric morbidity. Mathematical models can be used to characterise annual RSV seasonal epidemics and are a valuable tool to assess the impact of future vaccines. Objectives: Construct a mathematical model of seasonal epidemics of RSV and by fitting to a population-level RSV dataset, obtain a better understanding of RSV transmission dynamics. Methods: We obtained an extensive dataset of weekly RSV testing data in children aged less than 2 years, 2000-2005, for a birth cohort of 245,249 children through linkage of laboratory and birth record datasets. We constructed a seasonally forced compartmental age-structured Susceptible-Exposed-Infectious-Recovered-Susceptible (SEIRS) mathematical model to fit to the seasonal curves of positive RSV detections using the Nelder-Mead method. Results: From 15,830 specimens, 3,394 were positive for RSV. RSV detections exhibited a distinct biennial seasonal pattern with alternating sized peaks in winter months. Our SEIRS model accurately mimicked the observed data with alternating sized peaks using disease parameter values that remained constant across the 6 years of data. Variations in the duration of immunity and recovery periods were explored. The best fit to the data minimising the residual sum of errors was a model using estimates based on previous models in the literature for the infectious period and a slightly lower estimate for the immunity period. Conclusions: Our age-structured model based on routinely collected population laboratory data accurately captures the observed seasonal epidemic curves. The compartmental SEIRS model, based on several assumptions, now provides a validated base model. Ranges for the disease parameters in the model that could replicate the patterns in the data were identified. Areas for future model developments include fitting climatic variables to the seasonal parameter, allowing parameters to vary according to age and implementing a newborn vaccination program to predict the effect on RSV incidence.	[Moore, Hannah C.; Jacoby, Peter] Univ Western Australia, Telethon Kids Inst, Perth, WA 6009, Australia; [Hogan, Alexandra B.; Mercer, Geoffry N.] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia; [Blyth, Christopher C.] Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA 6009, Australia; [Blyth, Christopher C.] Princess Margaret Hosp Children, Dept Paediat & Adolescent Med, Perth, WA, Australia	Telethon Kids Institute; University of Western Australia; Australian National University; University of Western Australia; University of Western Australia	Moore, HC (corresponding author), Univ Western Australia, Telethon Kids Inst, Perth, WA 6009, Australia.	hannah.moore@telethonkids.org.au	Moore, Hannah/AHH-1092-2022; Blyth, Christopher/ABG-8231-2020; Moore, Hannah C/W-4727-2018; Moore, Hannah/AAA-4107-2019	Moore, Hannah/0000-0001-6434-8290; Blyth, Christopher/0000-0003-2017-0683; Moore, Hannah C/0000-0001-6434-8290; Moore, Hannah/0000-0001-6434-8290; Hogan, Alexandra/0000-0002-6271-9921	National Health and Medical Research Council Fellowship [1034254]	National Health and Medical Research Council Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	HCM is funded by National Health and Medical Research Council Fellowship #1034254. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acedo L, 2010, EPIDEMIOL INFECT, V138, P853, DOI 10.1017/S0950268809991373; Australian Bureau of Statistics, 2011, 3101 0 AUSTR DEM STA; Bihorel S, 2012, NELDERMEAD R PORT SC; Bolisetty Srinivas, 2005, Aust J Rural Health, V13, P265, DOI 10.1111/j.1440-1584.2005.00715.x; Bradley JS, 2011, CLIN INFECT DIS, V53, pE25, DOI [10.1093/cid/cir531, 10.1093/cid/cir625]; Carville KS, 2007, PEDIATR INFECT DIS J, V26, P210, DOI 10.1097/01.inf.0000254148.09831.7f; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Hall C. B., 1981, TXB PEDIATRIC INFECT, VII, P1247; HALL CB, 1976, J PEDIATR-US, V89, P11, DOI 10.1016/S0022-3476(76)80918-3; HALL CB, 1976, NEW ENGL J MED, V294, P414, DOI 10.1056/NEJM197602192940803; Hardelid P, 2013, INFLUENZA OTHER RESP, V7, P35, DOI 10.1111/j.1750-2659.2012.00345.x; HENDERSON FW, 1979, NEW ENGL J MED, V300, P530, DOI 10.1056/NEJM197903083001004; Keeling MJ., 2007, MODELING INFECT DIS, VIllustrated edition; Kelman CW, 2002, AUST NZ J PUBL HEAL, V26, P251, DOI 10.1111/j.1467-842X.2002.tb00682.x; Leecaster M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-105; Malkin E, 2013, SAFETY SHEDDING IMMU; Meijboom MJ, 2012, VACCINE, V30, P4691, DOI 10.1016/j.vaccine.2012.04.072; Milne GJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004005; Moore H, 2007, J PAEDIATR CHILD H, V43, P451, DOI 10.1111/j.1440-1754.2007.01110.x; Moore HC, 2012, J PAEDIATR CHILD H, V48, P520, DOI 10.1111/j.1440-1754.2011.02229.x; Moore HC, 2012, J EPIDEMIOL COMMUN H, V66, P489, DOI 10.1136/jech.2010.122762; Moore HC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-757; Moore HC, 2009, PEDIATR INFECT DIS J, V28, P598, DOI 10.1097/INF.0b013e318199cefd; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Okiro EA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-15; R Core Team, 2021, R LANGUAGE ENV STAT; Ranmuthugala G, 2011, COMMUN DIS INTELL, V35, P177; Stensballe LG, 2003, PEDIATR INFECT DIS J, V22, pS21, DOI 10.1097/00006454-200302001-00004; Vicente D, 2003, EPIDEMIOL INFECT, V131, P867, DOI 10.1017/S0950268803008926; Viegas M, 2004, J INFECTION, V49, P222, DOI 10.1016/j.jinf.2003.10.006; Walton NA, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-68; Weber A, 2001, MATH BIOSCI, V172, P95, DOI 10.1016/S0025-5564(01)00066-9; Yang CF, 2013, VACCINE, V31, P2822, DOI 10.1016/j.vaccine.2013.04.006	33	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100422	10.1371/journal.pone.0100422	http://dx.doi.org/10.1371/journal.pone.0100422			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968133	gold, Green Published			2022-12-27	WOS:000338280800040
J	Ray, PS; Fox, PL				Ray, Partho Sarothi; Fox, Paul L.			Origin and Evolution of Glutamyl-prolyl tRNA Synthetase WHEP Domains Reveal Evolutionary Relationships within Holozoa	PLOS ONE			English	Article							NONCANONICAL FUNCTION; MAXIMUM-LIKELIHOOD; ANIMAL EVOLUTION; GENOME; PHYLOGENY; GENE; EXPRESSION; RELATIVES; CLADE	Repeated domains in proteins that have undergone duplication or loss, and sequence divergence, are especially informative about phylogenetic relationships. We have exploited divergent repeats of the highly structured, 50-amino acid WHEP domains that join the catalytic subunits of bifunctional glutamyl-prolyl tRNA synthetase (EPRS) as a sequence-informed repeat (SIR) to trace the origin and evolution of EPRS in holozoa. EPRS is the only fused tRNA synthetase, with two distinct aminoacylation activities, and a non-canonical translation regulatory function mediated by the WHEP domains in the linker. Investigating the duplications, deletions and divergence of WHEP domains, we traced the bifunctional EPRS to choanozoans and identified the fusion event leading to its origin at the divergence of ichthyosporea and emergence of filozoa nearly a billion years ago. Distribution of WHEP domains from a single species in two or more distinct clades suggested common descent, allowing the identification of linking organisms. The discrete assortment of choanoflagellate WHEP domains with choanozoan domains as well as with those in metazoans supported the phylogenetic position of choanoflagellates as the closest sister group to metazoans. Analysis of clustering and assortment of WHEP domains provided unexpected insights into phylogenetic relationships amongst holozoan taxa. Furthermore, observed gaps in the transition between WHEP domain groupings in distant taxa allowed the prediction of undiscovered or extinct evolutionary intermediates. Analysis based on SIR domains can provide a phylogenetic counterpart to palaentological approaches of discovering "missing links'' in the tree of life.	[Ray, Partho Sarothi; Fox, Paul L.] Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44106 USA; [Ray, Partho Sarothi] Indian Inst Sci Educ & Res, Dept Biol Sci, Kolkata, India	Cleveland Clinic Foundation; Indian Institute of Science Education & Research (IISER) - Kolkata	Fox, PL (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44106 USA.	foxp@ccf.org	Ray, Partho Sarothi/H-3020-2019	Ray, Partho Sarothi/0000-0002-8795-3060	Wellcome Trust/DBT India Alliance Fellow Award; National Institutes of Health [P01 HL029582, P01 HL076491, R01 GM086430]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL076491, P01HL029582] Funding Source: NIH RePORTER	Wellcome Trust/DBT India Alliance Fellow Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a Wellcome Trust/DBT India Alliance Fellow Award (to P.S.R.) and by National Institutes of Health grants P01 HL029582, P01 HL076491, and R01 GM086430 (to P.L.F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; Baldauf SL, 2000, SCIENCE, V290, P972, DOI 10.1126/science.290.5493.972; Berthonneau E, 2000, FEBS LETT, V470, P300, DOI 10.1016/S0014-5793(00)01343-0; Blair JE, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-7; Boore JL, 2006, TRENDS ECOL EVOL, V21, P439, DOI 10.1016/j.tree.2006.05.009; Bourlat SJ, 2006, NATURE, V444, P85, DOI 10.1038/nature05241; Brady SG, 2006, P NATL ACAD SCI USA, V103, P18172, DOI 10.1073/pnas.0605858103; Cahuzac B, 2000, EMBO J, V19, P445, DOI 10.1093/emboj/19.3.445; Cerini C, 1997, EUR J BIOCHEM, V244, P176, DOI 10.1111/j.1432-1033.1997.00176.x; de Pouplana LR, 2001, J MOL EVOL, V53, P261, DOI 10.1007/s002390010216; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Douzery EJP, 2004, P NATL ACAD SCI USA, V101, P15386, DOI 10.1073/pnas.0403984101; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Gerardo NM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r21; Guo M, 2010, NAT REV MOL CELL BIO, V11, P668, DOI 10.1038/nrm2956; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; IWABE N, 1989, P NATL ACAD SCI USA, V86, P9355, DOI 10.1073/pnas.86.23.9355; Jermiin LS, 2005, SCIENCE, V310, P1910, DOI 10.1126/science.1122440; Jia J, 2008, MOL CELL, V29, P679, DOI 10.1016/j.molcel.2008.01.010; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Nikaido M, 1999, P NATL ACAD SCI USA, V96, P10261, DOI 10.1073/pnas.96.18.10261; PUSTELL J, 1982, NUCLEIC ACIDS RES, V10, P4765, DOI 10.1093/nar/10.15.4765; Ray PS, 2007, EMBO J, V26, P3360, DOI 10.1038/sj.emboj.7601774; Ray PS, 2011, MOL BIOL EVOL, V28, P437, DOI 10.1093/molbev/msq246; Rho SB, 1996, P NATL ACAD SCI USA, V93, P10128, DOI 10.1073/pnas.93.19.10128; Rogozin IB, 2007, MOL BIOL EVOL, V24, P1080, DOI 10.1093/molbev/msm029; Rokas A, 2005, SCIENCE, V310, P1933, DOI 10.1126/science.1116759; Rokas A, 2000, TRENDS ECOL EVOL, V15, P454, DOI 10.1016/S0169-5347(00)01967-4; Rokas A, 2003, EVOL DEV, V5, P346, DOI 10.1046/j.1525-142X.2003.03042.x; Salichos L, 2013, NATURE, V497, P327, DOI 10.1038/nature12130; Sampath P, 2004, CELL, V119, P195, DOI 10.1016/j.cell.2004.09.030; Shalchian-Tabrizi K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002098; Shiba K, 2002, J MOL EVOL, V55, P727, DOI 10.1007/s00239-002-2368-3; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Warren WC, 2008, NATURE, V453, P175, DOI 10.1038/nature06936; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Wolf YI, 2004, GENOME RES, V14, P29, DOI 10.1101/gr.1347404	38	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e98493	10.1371/journal.pone.0098493	http://dx.doi.org/10.1371/journal.pone.0098493			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968216	Green Published, Green Submitted, gold			2022-12-27	WOS:000338280800001
J	Frohbergh, M; Ge, Y; Meng, FL; Karabul, N; Solyom, A; Lai, A; Iatridis, J; Schuchman, EH; Simonaro, CM				Frohbergh, Michael; Ge, Yi; Meng, Fanli; Karabul, Nesrin; Solyom, Alexander; Lai, Alon; Iatridis, James; Schuchman, Edward H.; Simonaro, Calogera M.			Dose Responsive Effects of Subcutaneous Pentosan Polysulfate Injection in Mucopolysaccharidosis Type VI Rats and Comparison to Oral Treatment	PLOS ONE			English	Article							ENZYME REPLACEMENT THERAPY; SYNOVIAL-FLUID; OSTEOARTHRITIS; JOINT; IDENTIFICATION; PROTEINS; DISEASE; HORSES	Background: We previously demonstrated the benefits of daily, oral pentosan polysulfate (PPS) treatment in a rat model of mucopolysaccharidosis (MPS) type VI. Herein we compare these effects to once weekly, subcutaneous (sc) injection. The bioavailability of injected PPS is greater than oral, suggesting better delivery to difficult tissues such as bone and cartilage. Injected PPS also effectively treats osteoarthritis in animals, and has shown success in osteoarthritis patients. Methodology/Principal Findings: One-month-old MPS VI rats were given once weekly sc injections of PPS (1, 2 and 4 mg/kg, human equivalent dose (HED)), or daily oral PPS (4 mg/kg HED) for 6 months. Serum inflammatory markers and total glycosaminoglycans (GAGs) were measured, as were several histological, morphological and functional endpoints. Overall, weekly sc PPS injections led to similar or greater therapeutic effects as daily oral administration. Common findings between the two treatment approaches included reduced serum inflammatory markers, improved dentition and skull lengths, reduced tracheal deformities, and improved mobility. Enhanced effects of sc treatment included GAG reduction in urine and tissues, greater endurance on a rotarod, and better improvements in articular cartilage and bone in some dose groups. Optimal therapeutic effects were observed at 2 mg/kg, sc. No drug-related increases in liver enzymes, coagulation factor abnormalities or other adverse effects were identified following 6 months of sc PPS administration. Conclusions: Once weekly sc administration of PPS in MPS VI rats led to equal or better therapeutic effects than daily oral administration, including a surprising reduction in urine and tissue GAGs. No adverse effects from sc PPS administration were observed over the 6-month study period.	[Frohbergh, Michael; Ge, Yi; Meng, Fanli; Lai, Alon; Iatridis, James; Schuchman, Edward H.; Simonaro, Calogera M.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Karabul, Nesrin; Solyom, Alexander] Johannes Gutenberg Univ Mainz, Dept Pediat, Mainz, Germany; [Solyom, Alexander] Univ Pecs, Dept Pediat, Pecs, Hungary	Icahn School of Medicine at Mount Sinai; Johannes Gutenberg University of Mainz; University of Pecs	Simonaro, CM (corresponding author), Icahn Sch Med Mt Sinai, New York, NY 10029 USA.	calogera.simonaro@mssm.edu		Iatridis, James/0000-0002-2186-0590; Lai, Alon/0000-0002-0163-4588	National Institutes of Health [1R01DK087185, 5R21DK096182, 1R01AR057397]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057397] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087185, R21DK096182] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institutes of Health grant numbers 1R01DK087185, 5R21DK096182 and 1R01AR057397 received by CMS and EHS (www.nih.gov). The MPS 1 Research Foundation, CMS (helpmps1.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algahim MF, 2013, THER CLIN RISK MANAG, V9, P45, DOI 10.2147/TCRM.S24771; Anger JT, 2011, INT UROGYNECOL J, V22, P395, DOI 10.1007/s00192-010-1252-8; Archer LD, 2014, J INHERIT METAB DIS, V37, P1, DOI 10.1007/s10545-013-9613-3; Beck M, 2010, J PEDIATR REHAB MED, V3, P39, DOI 10.3233/PRM-2010-0100; Clarke LA, 2009, PEDIATRICS, V123, P229, DOI 10.1542/peds.2007-3847; Ghosh P, 1999, SEMIN ARTHRITIS RHEU, V28, P211, DOI 10.1016/S0049-0172(99)80021-3; Giugliani R, 2010, GENET MOL BIOL, V33, P589, DOI 10.1590/S1415-47572010005000093; Grevers LC, 2011, ARTHRITIS RHEUM-US, V63, P1365, DOI 10.1002/art.30290; Hanno PM, 2011, J UROLOGY, V185, P2162, DOI 10.1016/j.juro.2011.03.064; JOFFE S, 1976, ARCH SURG-CHICAGO, V111, P37; KUNIEDA T, 1995, GENOMICS, V29, P582, DOI 10.1006/geno.1995.9962; Kwan C, 2012, AUST VET J, V90, P315, DOI 10.1111/j.1751-0813.2012.00959.x; Lampe C, 2013, RHEUM DIS CLIN N AM, V39, P431, DOI 10.1016/j.rdc.2013.03.004; Langereis EJ, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-155; McIlwraith CW, 2012, AM J VET RES, V73, P628, DOI 10.2460/ajvr.73.5.628; Muenzer J, 2011, RHEUMATOLOGY, V50, pV4, DOI 10.1093/rheumatology/ker394; Newman PK, 2014, J NEUROL NEUROSUR PS, V85, P919, DOI 10.1136/jnnp-2013-305590; Noh H, 2014, J CLIN PHARM THER, V39, P215, DOI 10.1111/jcpt.12136; Ohashi Toya, 2012, Pediatr Endocrinol Rev, V10 Suppl 1, P26; Polgreen LE, 2014, J CLIN DENSITOM, V17, P200, DOI 10.1016/j.jocd.2013.03.004; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Schelbergen RFP, 2012, ARTHRITIS RHEUM-US, V64, P1477, DOI 10.1002/art.33495; Schuchman EH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054459; Sillence D, 2012, JIMD REP, V2, P103, DOI 10.1007/8904_2011_56; Simonaro CM, 2010, P NATL ACAD SCI USA, V107, P222, DOI 10.1073/pnas.0912937107; Simonaro CM, 2005, PEDIATR RES, V57, P701, DOI 10.1203/01.PDR.0000156510.96253.5A; Simonaro CM, 2001, LAB INVEST, V81, P1319, DOI 10.1038/labinvest.3780345; Valayannopoulos V, 2011, RHEUMATOLOGY, V50, pV49, DOI 10.1093/rheumatology/ker396; Valcamonica E, 2014, CLIN EXP RHEUMATOL, V32, P243; van Lent PLEM, 2008, ANN RHEUM DIS, V67, P1750, DOI 10.1136/ard.2007.077800; VandeBerg JR, 2004, ARCH ORAL BIOL, V49, P477, DOI 10.1016/j.archoralbio.2003.12.007; Vera M, 2013, PEDIATR RES, V74, P712, DOI 10.1038/pr.2013.158; Vinazzer H, 1989, Folia Haematol Int Mag Klin Morphol Blutforsch, V116, P927; White KK, 2011, RHEUMATOLOGY, V50, pV26, DOI 10.1093/rheumatology/ker393; YAN SD, 1994, J BIOL CHEM, V269, P9889	35	34	35	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100882	10.1371/journal.pone.0100882	http://dx.doi.org/10.1371/journal.pone.0100882			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964042	Green Published, Green Submitted, gold			2022-12-27	WOS:000338709500095
J	Khademi, A; Braithwaite, RS; Saure, D; Schaefer, AJ; Nucifora, K; Roberts, MS				Khademi, Amin; Braithwaite, R. Scott; Saure, Denis; Schaefer, Andrew J.; Nucifora, Kimberly; Roberts, Mark S.			Should Expectations about the Rate of New Antiretroviral Drug Development Impact the Timing of HIV Treatment Initiation and Expectations about Treatment Benefits?	PLOS ONE			English	Article							THERAPY; INFECTION; MODEL	Background: Many analyses of HIV treatment decisions assume a fixed formulary of HIV drugs. However, new drugs are approved nearly twice a year, and the rate of availability of new drugs may affect treatment decisions, particularly when to initiate antiretroviral therapy (ART). Objectives: To determine the impact of considering the availability of new drugs on the optimal initiation criteria for ART and outcomes in patients with HIV/AIDS. Methods: We enhanced a previously described simulation model of the optimal time to initiate ART to incorporate the rate of availability of new antiviral drugs. We assumed that the future rate of availability of new drugs would be similar to the past rate of availability of new drugs, and we estimated the past rate by fitting a statistical model to actual HIV drug approval data from 1982-2010. We then tested whether or not the future availability of new drugs affected the model-predicted optimal time to initiate ART based on clinical outcomes, considering treatment initiation thresholds of 200, 350, and 500 cells/mm(3). We also quantified the impact of the future availability of new drugs on life expectancy (LE) and quality-adjusted life expectancy (QALE). Results: In base case analysis, considering the availability of new drugs raised the optimal starting CD4 threshold for most patients to 500 cells/mm(3). The predicted gains in outcomes due to availability of pipeline drugs were generally small (less than 1%), but for young patients with a high viral load could add as much as a 4.9% (1.73 years) increase in LE and a 8% (2.43 QALY) increase in QALE, because these patients were particularly likely to exhaust currently available ART regimens before they died. In sensitivity analysis, increasing the rate of availability of new drugs did not substantially alter the results. Lowering the toxicity of future ART drugs had greater potential to increase benefit for many patient groups, increasing QALE by as much as 10%. Conclusions: The future availability of new ART drugs without lower toxicity raises optimal treatment initiation for most patients, and improves clinical outcomes, especially for younger patients with higher viral loads. Reductions in toxicity of future ART drugs could impact optimal treatment initiation and improve clinical outcomes for all HIV patients.	[Khademi, Amin] Clemson Univ, Dept Ind Engn, Clemson, SC USA; [Braithwaite, R. Scott] NYU, Dept Med, New York, NY 10016 USA; [Braithwaite, R. Scott; Nucifora, Kimberly] NYU, Sch Med, Dept Populat Hlth, Div Comparat Effectiveness & Decis Sci, New York, NY USA; [Saure, Denis] Univ Chile, Dept Ind Engn, Santiago, RM, Chile; [Schaefer, Andrew J.; Roberts, Mark S.] Univ Pittsburgh, Dept Ind Engn, Pittsburgh, PA 15261 USA; [Roberts, Mark S.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Hlth Policy & Management, Pittsburgh, PA USA; [Roberts, Mark S.] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15213 USA	Clemson University; New York University; New York University; Universidad de Chile; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Roberts, MS (corresponding author), Univ Pittsburgh, Dept Ind Engn, Pittsburgh, PA 15261 USA.	mroberts@Pitt.edu	Sauré, Denis/F-5598-2016	Sauré, Denis/0000-0002-8123-5009; Braithwaite, Ronald Scott/0000-0001-7067-3655	A computer simulation of the Sub-Saharan HIV pandemic that can estimate benefit and value from alcohol interventions [R01AA017385-01]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017385, U24AA022007] Funding Source: NIH RePORTER	A computer simulation of the Sub-Saharan HIV pandemic that can estimate benefit and value from alcohol interventions; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was partially supported by: R01AA017385-01 "A computer simulation of the Sub-Saharan HIV pandemic that can estimate benefit and value from alcohol interventions" - PI: Braithwaite (http://www.niaaa.nih.gov/), and U24AA022007-01 "The Operations Research Collaboration for Alcohol Abuse and Aids - ORCAAA" - PI: Braithwaite (http://www.niaaa.nih.gov/) and NS grant (NS F CMMI-0546960). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braithwaite RS, 2006, J ANTIMICROB CHEMOTH, V58, P1036, DOI 10.1093/jac/dkl386; Braithwaite RS, 2008, ANN INTERN MED, V148, P178, DOI 10.7326/0003-4819-148-3-200802050-00004; Braithwaite RS, 2007, VALUE HEALTH, V10, P204, DOI 10.1111/j.1524-4733.2007.00170.x; Braithwaite RS, 2005, AM J MED, V118, P890, DOI 10.1016/j.amjmed.2004.12.034; Food and Drug Administration, 2013, ANT DRUGS US TREATM; Harrington M, 2000, LANCET, V355, P2147, DOI 10.1016/S0140-6736(00)02388-6; Holmberg SD, 2004, CLIN INFECT DIS, V39, P1699, DOI 10.1086/425743; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Johnson Victoria A, 2010, Top HIV Med, V18, P156; Lane HC, 2003, ANN INTERN MED, V138, P680, DOI 10.7326/0003-4819-138-8-200304150-00018; Maida A, 2009, APPRAISAL REPORT FEA; MONTGOMERY DC, 2003, ENG STAT; Negoescu DM, 2012, CLIN INFECT DIS, V55, P1392, DOI 10.1093/cid/cis731; Nelson R., 1995, PROBABILITY STOCHAST; Phillips AN, 2008, LANCET, V371, P1443, DOI 10.1016/S0140-6736(08)60624-8; Phillips AN, 2007, BRIT MED J, V334, P76, DOI 10.1136/bmj.39064.406389.94; Shechter SM, 2008, OPER RES, V56, P20, DOI 10.1287/opre.1070.0480; Sloan CE, 2012, AIDS, V26, P45, DOI 10.1097/QAD.0b013e32834dce6e; WHO, 2013, WHO ISS NEW HIV REC	19	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e98354	10.1371/journal.pone.0098354	http://dx.doi.org/10.1371/journal.pone.0098354			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963883	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000338709500004
J	Kolahdooz, F; Simeon, D; Ferguson, G; Sharma, S				Kolahdooz, Fariba; Simeon, Desiree; Ferguson, Gary; Sharma, Sangita			Development of a Quantitative Food Frequency Questionnaire for Use among the Yup'ik People of Western Alaska	PLOS ONE			English	Article							DIETARY-INTAKE; RAPID TRANSITION; LIFE-STYLE; POPULATION; OBESITY; ESKIMOS; INUIT; COMMUNITIES; VALIDATION; NUNAVUT	Alaska Native populations are experiencing a nutrition transition and a resulting decrease in diet quality. The present study aimed to develop a quantitative food frequency questionnaire to assess the diet of the Yup'ik people of Western Alaska. A cross-sectional survey was conducted using 24-hour recalls and the information collected served as a basis for developing a quantitative food frequency questionnaire. A total of 177 males and females, aged 13-88, in six western Alaska communities, completed up to three 24-hour recalls as part of the Alaska Native Dietary and Subsistence Food Assessment Project. The frequency of the foods reported in the 24-hour recalls was tabulated and used to create a draft quantitative food frequency questionnaire, which was pilot tested and finalized with input from community members. Store-bought foods high in fat and sugar were reported more frequently than traditional foods. Seven of the top 26 foods most frequently reported were traditional foods. A 150-item quantitative food frequency questionnaire was developed that included 14 breads and crackers; 3 cereals; 11 dairy products; 69 meats, poultry and fish; 13 fruit; 22 vegetables; 9 desserts and snacks; and 9 beverages. The quantitative food frequency questionnaire contains 39 traditional food items. This quantitative food frequency questionnaire can be used to assess the unique diet of the Alaska Native people of Western Alaska. This tool will allow for monitoring of dietary changes over time as well as the identification of foods and nutrients that could be promoted in a nutrition intervention program intended to reduce chronic disease.	[Kolahdooz, Fariba; Sharma, Sangita] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Simeon, Desiree; Ferguson, Gary] Alaska Native Tribal Hlth Consortium, Community Hlth Serv Div, Wellness & Prevent Dept, Anchorage, AK USA	University of Alberta; Alaska Native Tribal Health Consortium	Sharma, S (corresponding author), Univ Alberta, Dept Med, Edmonton, AB, Canada.	gita.sharma@ualberta.ca		Sharma, Sangita/0000-0002-4995-0010	National Research Initiative from the USDA Cooperative State Research and Extension Service [2007-55215-17923]	National Research Initiative from the USDA Cooperative State Research and Extension Service	This project was supported by the National Research Initiative Grant 2007-55215-17923 from the USDA Cooperative State Research and Extension Service (http://www.usda.gov/wps/portal/usda/usdahome?navid = COOPRES_EXTSERVS&navtype = RT&parentnav = EDUCATION_OUTREACH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaska Native Medical Area Center, 2006, DIAB PREV MAPS; [Anonymous], 2004, AL TRAD DIET PROJ FI; Ballew C, 2006, ECOL FOOD NUTR, V45, P1, DOI 10.1080/03670240500408302; Behavioral Risk Factor Surveillance Survey, 2007, ANN REPORT; Bersamin A, 2007, INT J CIRCUMPOL HEAL, V66, P62, DOI 10.3402/ijch.v66i1.18228; Bersamin A, 2006, J AM DIET ASSOC, V106, P1055, DOI 10.1016/j.jada.2006.04.026; Cade J, 2002, PUBLIC HEALTH NUTR, V5, P567, DOI 10.1079/PHN2001318; DRAPER HH, 1977, AM ANTHROPOL, V79, P309, DOI 10.1525/aa.1977.79.2.02a00070; Ebbesson S O, 1999, Int J Circumpolar Health, V58, P108; Ebbesson Sven O E, 2005, Int J Circumpolar Health, V64, P409; Ebbesson Sven O E, 2005, Int J Circumpolar Health, V64, P396; Eilat-Adar S, 2009, J NUTR, V139, P2322, DOI 10.3945/jn.109.110387; Gibson R, 2005, PRINCIPLES NUTR ASSE; GILBERT TJ, 1992, AM J DIS CHILD, V146, P289, DOI 10.1001/archpedi.1992.02160150029015; Heller CA, 1967, PHS PUBLICATION; Howard Barbara V, 2005, Int J Circumpolar Health, V64, P206; Johnson JS, 2009, INT J CIRCUMPOL HEAL, V68, P109, DOI 10.3402/ijch.v68i2.18320; KINLOCH D, 1992, SCI TOTAL ENVIRON, V122, P247, DOI 10.1016/0048-9697(92)90249-R; Lanier Anne P, 2008, Alaska Med, V49, P120; Lanier AP, 2006, CANC ALASKA NATIVES; MURPHY NJ, 1995, J AM DIET ASSOC, V95, P676, DOI 10.1016/S0002-8223(95)00184-0; Naylor J L, 2003, Int J Circumpolar Health, V62, P363; Nobmann E D, 1999, Int J Circumpolar Health, V58, P254; Nobmann ED, 2005, J NUTR, V135, P856, DOI 10.1093/jn/135.4.856; Pakseresht M, 2010, J HUM NUTR DIET, V23, P67, DOI 10.1111/j.1365-277X.2010.01104.x; Risica PM, 2000, INT J OBESITY, V24, P939, DOI 10.1038/sj.ijo.0801259; Schraer C, 1993, DIABETES DIS CIVILIZ, P169; Schumacher Catherine, 2003, Int J Circumpolar Health, V62, P343; SCOTT EM, 1957, METABOLISM, V6, P320; Sharma S, 2010, BRIT J NUTR, V103, P749, DOI 10.1017/S0007114509992224; Sharma S, 2009, CAN J PUBLIC HEALTH, V100, P442, DOI 10.1007/BF03404341; Stark A, 2002, ECOL FOOD NUTR, V41, P35, DOI 10.1080/03670240212531; State of Alaska Division of Commerce, COMM DAT ONL; Teufel NI, 1997, AM J CLIN NUTR, V65, P1173; United States Department of Agriculture, FOOD DISTR PROGR IND; Willett W., 2012, NUTR EPIDEMIOLOGY	36	8	9	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100412	10.1371/journal.pone.0100412	http://dx.doi.org/10.1371/journal.pone.0100412			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963718	gold, Green Published			2022-12-27	WOS:000338709500047
J	Nickerson, A; Huang, T; Lin, LJ; Nan, XL				Nickerson, Andrew; Huang, Tao; Lin, Li-Jung; Nan, Xiaolin			Photoactivated Localization Microscopy with Bimolecular Fluorescence Complementation (BiFC-PALM) for Nanoscale Imaging of Protein-Protein Interactions in Cells	PLOS ONE			English	Article							RAS; VISUALIZATION; MECHANISM; MCHERRY; GFP	Bimolecular fluorescence complementation (BiFC) has been widely used to visualize protein-protein interactions (PPIs) in cells. Until now, however, the resolution of BiFC has been limited by the diffraction of light to similar to 250 nm, much larger than the nanometer scale at which PPIs occur or are regulated. Cellular imaging at the nanometer scale has recently been realized with single molecule superresolution imaging techniques such as photoactivated localization microscopy (PALM). Here we have combined BiFC with PALM to visualize PPIs inside cells with nanometer spatial resolution and single molecule sensitivity. We demonstrated that PAmCherry1, a photoactivatable fluorescent protein commonly used for PALM, can be used as a BiFC probe when split between residues 159 and 160 into two fragments. PAmCherry1 BiFC exhibits high specificity and high efficiency even at 37 degrees C in detecting PPIs with virtually no background from spontaneous reconstitution. Moreover, the reconstituted protein maintains the fast photoconversion, high contrast ratio, and single molecule brightness of the parent PAmCherry1, which enables selective PALM localization of PPIs with similar to 18 nm spatial precision. With BiFC-PALM, we studied the interactions between the small GTPase Ras and its downstream effector Raf, and clearly observed nanoscale clustering and diffusion of individual KRas G12D/CRaf RBD (Ras-binding domain) complexes on the cell membrane. These observations provided novel insights into the regulation of Ras/Raf interaction at the molecular scale, which would be difficult with other techniques such as conventional BiFC, fluorescence co-localization or FRET.	[Nan, Xiaolin] Oregon Hlth & Sci Univ, Dept Biomed Engn, Knight Canc Inst, Portland, OR 97201 USA; Oregon Hlth & Sci Univ, OHSU Ctr Spatial Syst Biomed, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University	Nan, XL (corresponding author), Oregon Hlth & Sci Univ, Dept Biomed Engn, Knight Canc Inst, Portland, OR 97201 USA.	nan@ohsu.edu		Nan, Xiaolin/0000-0002-0597-0255	OHSU; NIH [5U54CA143836-05]; Damon Runyon Cancer Research Foundation; M. J. Murdock Charitable Trust; FEI company; NATIONAL CANCER INSTITUTE [U54CA143836] Funding Source: NIH RePORTER	OHSU; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation; M. J. Murdock Charitable Trust; FEI company; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by startup funds to X.N. from OHSU. Research in the Nan laboratory is also supported by NIH 5U54CA143836-05 (PI: J. Liphardt), the Damon Runyon Cancer Research Foundation, the M. J. Murdock Charitable Trust, and the FEI company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B, 2008, MOL BIOL CELL, Vxxxiii, P1601; Allen JR, 2013, J OPTICS-UK, V15, DOI 10.1088/2040-8978/15/9/094001; Annibale P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022678; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Bonetta L, 2010, NATURE, V468, P851, DOI [10.1038/468851a, 10.1038/468854a, 10.1038/468852a]; Chen XY, 2013, ADV DRUG DELIVER REV, V65, P1357, DOI 10.1016/j.addr.2012.09.039; Edelstein A., 2010, COMPUTER CONTROL MIC; FABIAN JR, 1994, P NATL ACAD SCI USA, V91, P5982, DOI 10.1073/pnas.91.13.5982; Fan JY, 2008, BIOCHEM BIOPH RES CO, V367, P47, DOI 10.1016/j.bbrc.2007.12.101; Habuchi S, 2005, P NATL ACAD SCI USA, V102, P9511, DOI 10.1073/pnas.0500489102; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Kenworthy AK, 2001, METHODS, V24, P289, DOI 10.1006/meth.2001.1189; Kerppola Tom K, 2013, Cold Spring Harb Protoc, V2013, P727, DOI 10.1101/pdb.prot076497; Kodama Y, 2012, BIOTECHNIQUES, V53, P285, DOI [10.2144/0000113943, 10.2144/000113943]; Lee YR, 2010, MOL IMAGING BIOL, V12, P468, DOI 10.1007/s11307-010-0312-2; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Manley S, 2008, NAT METHODS, V5, P155, DOI 10.1038/NMETH.1176; Nan XL, 2013, P NATL ACAD SCI USA, V110, P18519, DOI 10.1073/pnas.1318188110; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Persson F, 2013, NAT METHODS, V10, P265, DOI [10.1038/NMETH.2367, 10.1038/nmeth.2367]; Plowman SJ, 2005, P NATL ACAD SCI USA, V102, P15500, DOI 10.1073/pnas.0504114102; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Rajakulendran T, 2009, NATURE, V461, P542, DOI 10.1038/nature08314; RIPLEY BD, 1977, J ROY STAT SOC B MET, V39, P172; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Subach FV, 2009, P NATL ACAD SCI USA, V106, P21097, DOI 10.1073/pnas.0909204106; Subach FV, 2009, NAT METHODS, V6, P153, DOI [10.1038/nmeth.1298, 10.1038/NMETH.1298]; Tian TH, 2007, NAT CELL BIOL, V9, P905, DOI 10.1038/ncb1615; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Zhang MS, 2012, NAT METHODS, V9, P727, DOI [10.1038/NMETH.2021, 10.1038/nmeth.2021]	33	52	56	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100589	10.1371/journal.pone.0100589	http://dx.doi.org/10.1371/journal.pone.0100589			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963703	Green Published, Green Submitted, gold			2022-12-27	WOS:000338709500065
J	Wang, C; Cai, YY; Zhang, Y; Xiong, ZY; Li, GZ; Cui, L				Wang, Chen; Cai, Yuanyuan; Zhang, Yun; Xiong, Zhuyou; Li, Guangzao; Cui, Lei			Local Injection of Deferoxamine Improves Neovascularization in Ischemic Diabetic Random Flap by Increasing HIF-1 alpha and VEGF Expression	PLOS ONE			English	Article							MARROW-DERIVED CELLS; SKIN FLAP; MOLECULAR-BASIS; STEM-CELLS; HYPOXIA; ANGIOGENESIS; GROWTH; RECRUITMENT; DYSFUNCTION; SURVIVAL	Background: Although the systemic administration of deferoxamine (DFO) is protective in experimental models of normal ischemic flap and diabetic wound, its effect on diabetic flap ischemia using a local injection remains unknown. Objective: To explore the feasibility of local injection of DFO to improve the survival of ischemic random skin flaps in streptozotocin (STZ)-induced diabetic mice. Methods: Ischemic random skin flaps were made in 125 mice. Animals were divided into the DFO-treated (n = 20), PBS-treated (n = 16) and untreated (n = 16) groups. Surviving area, vessel density, and expression of vascular endothelial growth factor (VEGF) and hypoxia-inducible factor-1 alpha (HIF-1 alpha) were evaluated on the seventh day after local injection. Results: The viability of DFO-treated flap was significantly enhanced, with increased regional blood perfusion and capillary density compared with those in the two control groups. Fluorescence-activated cell sorting (FACS)analysis demonstrated a marked increase in systemic Flk-1(+)/CD11b(-) endothelial progenitor cells (EPCs) in DFO-treated mice. Furthermore, the expression of VEGF and HIF-1 alpha was increased not only in diabetic flap tissue, but also in dermal fibroblasts cultured under hyperglycemic and hypoxic conditions. Conclusions: Local injection of DFO could exert preventive effects against skin flap necrosis in STZ-induced diabetic mice by elevating the expression of HIF-1 alpha and VEGF, increased EPC mobilization, which all contributed to promote ischemic diabetic flap survival.	[Wang, Chen; Zhang, Yun; Cui, Lei] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Plast & Reconstruct Surg, Shanghai 200030, Peoples R China; [Cai, Yuanyuan] Changzhou 2 Peoples Hosp, Dept Plast & Aesthet Surg, Changzhou, Peoples R China; [Xiong, Zhuyou; Li, Guangzao] Bengbu Med Coll, Affiliated Hosp 1, Dept Plast Surg, Bengbu, Anhui, Peoples R China	Shanghai Jiao Tong University; Bengbu Medical College	Li, GZ (corresponding author), Bengbu Med Coll, Affiliated Hosp 1, Dept Plast Surg, Bengbu, Anhui, Peoples R China.	liguangzhaoby_jy@163.com; cuileijy@163.com		Cui, Lei/0000-0002-4339-6629	Natural Science Foundation of China [81201204]; Natural Science Foundation of Shanghai [11ZR1420300]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai)	This work was supported by the Natural Science Foundation of China (Grant No: 81201204) and the Natural Science Foundation of Shanghai (Grant No: 11ZR1420300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGEL MF, 1986, BRIT J PLAST SURG, V39, P469, DOI 10.1016/0007-1226(86)90115-3; Botusan IR, 2008, P NATL ACAD SCI USA, V105, P19426, DOI 10.1073/pnas.0805230105; Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169; Catrina SB, 2004, DIABETES, V53, P3226, DOI 10.2337/diabetes.53.12.3226; Ceradini DJ, 2008, J BIOL CHEM, V283, P10930, DOI 10.1074/jbc.M707451200; Chang EI, 2007, CIRCULATION, V116, P2818, DOI 10.1161/CIRCULATIONAHA.107.715847; Chekanov VS, 2002, CIRCULATION, V105, pE35; Dobryansky M, 2004, ANN PLAS SURG, V52, P512, DOI 10.1097/01.sap.0000123022.98361.c5; Emerit J, 2001, BIOMED PHARMACOTHER, V55, P333, DOI 10.1016/S0753-3322(01)00068-3; Epstein SE, 2001, CIRCULATION, V104, P115, DOI 10.1161/01.CIR.104.1.115; Galiano RD, 2004, WOUND REPAIR REGEN, V12, P485, DOI 10.1111/j.1067-1927.2004.12404.x; Galiano RD, 2004, AM J PATHOL, V164, P1935, DOI 10.1016/S0002-9440(10)63754-6; Gallagher KA, 2007, J CLIN INVEST, V117, P1249, DOI 10.1172/JCI29710; Gao WC, 2011, J CELL MOL MED, V15, P2575, DOI 10.1111/j.1582-4934.2011.01313.x; Green R, 1985, Bibl Haematol, P25; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; Gurunluoglu R, 2005, MICROSURG, V25, P433, DOI 10.1002/micr.20142; Haimovici R, 2002, OPHTHALMOLOGY, V109, P164, DOI 10.1016/S0161-6420(01)00947-2; Haws MJ, 2001, J RECONSTR MICROSURG, V17, P39, DOI 10.1055/s-2001-12687; Kang LN, 2009, CLIN EXP PHARMACOL P, V36, pe47, DOI 10.1111/j.1440-1681.2009.05219.x; Lerman OZ, 2003, AM J PATHOL, V162, P303, DOI 10.1016/S0002-9440(10)63821-7; Lu F, 2008, PLAST RECONSTR SURG, V121, P50, DOI 10.1097/01.prs.0000293876.10700.b8; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Okauchi M, 2010, STROKE, V41, P375, DOI 10.1161/STROKEAHA.109.569830; Potier E, 2008, J TISSUE ENG REGEN M, V2, P272, DOI 10.1002/term.92; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; STREMMEL W, 1988, ANN NY ACAD SCI, V526, P209; Tanaka R, 2008, PLAST RECONSTR SURG, V121, P1929, DOI 10.1097/PRS.0b013e3181715218; Tepper OM, 2005, BLOOD, V105, P1068, DOI 10.1182/blood-2004-03-1051; Thangarajah H, 2009, P NATL ACAD SCI USA, V106, P13505, DOI 10.1073/pnas.0906670106; Vija L, 2009, DIABETES METAB, V35, P85, DOI 10.1016/j.diabet.2008.10.003; WEINSTEIN GS, 1989, OTOLARYNG HEAD NECK, V101, P559, DOI 10.1177/019459988910100508; Weng R, 2010, J PLAST RECONSTR AES, V63, P2152, DOI 10.1016/j.bjps.2010.02.001; Westermann D, 2006, DIABETOLOGIA, V49, P2507, DOI 10.1007/s00125-006-0385-2; Westerweel PE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060357; Zhang T, 2007, UNDERSEA HYPERBAR M, V34, P335	36	32	33	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100818	10.1371/journal.pone.0100818	http://dx.doi.org/10.1371/journal.pone.0100818			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963878	Green Published, gold, Green Submitted			2022-12-27	WOS:000338709500085
J	Barashkov, NA; Teryutin, FM; Pshennikova, VG; Solovyev, AV; Klarov, LA; Solovyeva, NA; Kozhevnikov, AA; Vasilyeva, LM; Fedotova, EE; Pak, MV; Lekhanova, SN; Zakharova, EV; Savvinova, KE; Gotovtsev, NN; Rafailo, AM; Luginov, NV; Alexeev, AN; Posukh, OL; Dzhemileva, LU; Khusnutdinova, EK; Fedorova, SA				Barashkov, Nikolay A.; Teryutin, Fedor M.; Pshennikova, Vera G.; Solovyev, Aisen V.; Klarov, Leonid A.; Solovyeva, Natalya A.; Kozhevnikov, Andrei A.; Vasilyeva, Lena M.; Fedotova, Elvira E.; Pak, Maria V.; Lekhanova, Sargylana N.; Zakharova, Elena V.; Savvinova, Kyunney E.; Gotovtsev, Nyurgun N.; Rafailo, Adyum M.; Luginov, Nikolay V.; Alexeev, Anatoliy N.; Posukh, Olga L.; Dzhemileva, Lilya U.; Khusnutdinova, Elza K.; Fedorova, Sardana A.			Age-Related Hearing Impairment (ARHI) Associated with GJB2 Single Mutation IVS1+1G > A in the Yakut Population Isolate in Eastern Siberia	PLOS ONE			English	Article							STEM EVOKED-POTENTIALS; 26 GENE GJB2; OTOACOUSTIC EMISSIONS; CONNEXIN-26; CARRIERS; DEAFNESS; DFNB1; NOISE	Age-Related Hearing Impairment (ARHI) is one of the frequent sensory disorders registered in 50% of individuals over 80 years. ARHI is a multifactorial disorder due to environmental and poor-known genetic components. In this study, we present the data on age-related hearing impairment of 48 heterozygous carriers of mutation IVS1+ 1G. A (GJB2 gene) and 97 subjects with GJB2 genotype wt/wt in the Republic of Sakha/Yakutia (Eastern Siberia, Russia). This subarctic territory was found as the region with the most extensive accumulation of mutation IVS1+ 1G>A in the world as a result of founder effect in the unique Yakut population isolate. The GJB2 gene resequencing and detailed audiological analysis in the frequency range 0.25, 0.5, 1.0, 2.0, 4.0, 8.0 kHz were performed in all examined subjects that allowed to investigate genotypephenotype correlations between the presence of single mutation IVS1+ 1G>A and hearing of subjects from examined groups. We revealed the linear correlation between increase of average hearing thresholds at speech frequencies (PTA0.5,1.0,2.0,4.0 kHz) and age of individuals with GJB2 genotype IVS1+ 1G>A/wt (rs = 0.499, p = 0.006860 for males and rs = 0.427, p = 0.000277 for females). Moreover, the average hearing thresholds on high frequency (8.0 kHz) in individuals with genotype IVS1+ 1G>A/wt (both sexes) were significantly worse than in individuals with genotype wt/wt (p, 0.05). Age of hearing loss manifestation in individuals with genotype IVS1+ 1G>A/wt was estimated to be,40 years (rs = 0.504, p = 0.003). These findings demonstrate that the single IVS1+ 1G. A mutation (GJB2) is associated with age-related hearing impairment (ARHI) of the IVS1+ 1G>A carriers in the Yakuts.	[Barashkov, Nikolay A.; Teryutin, Fedor M.; Pshennikova, Vera G.; Solovyeva, Natalya A.; Fedorova, Sardana A.] Russian Acad Med Sci, Siberian Branch, Yakut Sci Ctr Complex Med Problems, Dept Mol Genet, Yakutsk, Russia; [Barashkov, Nikolay A.; Teryutin, Fedor M.; Solovyev, Aisen V.; Savvinova, Kyunney E.; Gotovtsev, Nyurgun N.; Fedorova, Sardana A.] MK Ammosov North Eastern Fed Univ, Inst Nat Sci, Mol Biol Lab, Yakutsk, Russia; [Klarov, Leonid A.; Luginov, Nikolay V.] Minist Publ Hlth Sakha Republ, Ctr Emergency Med, Republican Hosp 2, Dept Radiol, Yakutsk, Russia; [Kozhevnikov, Andrei A.] Minist Publ Hlth Sakha Republ, Ctr Emergency Med, Republican Hosp 2, Republican Ctr Profess Pathol, Yakutsk, Russia; [Vasilyeva, Lena M.; Fedotova, Elvira E.] Minist Publ Hlth Sakha Republ, Natl Med Ctr, Republican Hosp 1, Audiology Logopaed Ctr, Yakutsk, Russia; [Pak, Maria V.] MK Ammosov North Eastern Fed Univ, Inst Med, Dept Pediat, Yakutsk, Russia; [Lekhanova, Sargylana N.] MK Ammosov North Eastern Fed Univ, Inst Med, Dept Normal & Abnormal Anat, Yakutsk, Russia; [Zakharova, Elena V.] MK Ammosov North Eastern Fed Univ, Inst Foreign Philol & Reg Studies, Yakutsk, Russia; [Savvinova, Kyunney E.; Gotovtsev, Nyurgun N.; Rafailo, Adyum M.] MK Ammosov North Eastern Fed Univ, Inst Nat Sci, Yakutsk, Russia; [Alexeev, Anatoliy N.] Russian Acad Sci, Inst Humanitarian Res & Indigenous Peoples North, Siberian Branch, Yakutsk, Russia; [Posukh, Olga L.] Russian Acad Sci, Inst Cytol & Genet, Siberian Branch, Novosibirsk 630090, Russia; [Posukh, Olga L.] Novosibirsk State Univ, Novosibirsk 630090, Russia; [Dzhemileva, Lilya U.; Khusnutdinova, Elza K.] Russian Acad Sci, Ufa Sci Ctr, Dept Genom, Inst Biochem & Genet, Ufa 450001, Russia; [Khusnutdinova, Elza K.] Bashkir State Univ, Dept Genet & Fundamental Med, Ufa 450074, Russia	Russian Academy of Medical Sciences; Yakut Science Centre of Complex Medical Problems; North-Eastern Federal University in Yakutsk; North-Eastern Federal University in Yakutsk; North-Eastern Federal University in Yakutsk; North-Eastern Federal University in Yakutsk; North-Eastern Federal University in Yakutsk; Institute for Humanities Research & Indigenous Studies of the North; Russian Academy of Sciences; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Novosibirsk State University; Institute of Biochemistry & Genetics of Ufa Science Centre of the RAS; Russian Academy of Sciences; Bashkir State University	Barashkov, NA (corresponding author), Russian Acad Med Sci, Siberian Branch, Yakut Sci Ctr Complex Med Problems, Dept Mol Genet, Yakutsk, Russia.	barashkov2004@mail.ru	Solovyeva, Natalya/L-4470-2017; Solovyev, Aisen/F-4012-2017; Posukh, Olga L/Q-6065-2016; Dzhemileva, Lilya U/K-8636-2013; Klarov, Leonid/L-4463-2017; Alekseev, Anatoliy Nickolaevich/O-1096-2015; Barashkov, Nikolay/F-1499-2017; Fedorova, Sardana/K-5445-2017; Khusnutdinova, Elza Kamilevna/A-4810-2013; Teryutin, Fedor/K-5104-2017; Lekhanova, Sargylana/AAZ-4597-2021; Dzhemilev, Usein M./O-5155-2015; Pshennikova, Vera/F-4031-2017; Готовцев, Ньургун/K-8020-2017; Solovyeva, Natalya/Q-9965-2018	Posukh, Olga L/0000-0003-1352-3591; Dzhemileva, Lilya U/0000-0003-3315-4746; Klarov, Leonid/0000-0003-1588-0971; Alekseev, Anatoliy Nickolaevich/0000-0002-9488-573X; Barashkov, Nikolay/0000-0002-6984-7934; Khusnutdinova, Elza Kamilevna/0000-0003-2987-3334; Teryutin, Fedor/0000-0002-8659-0886; Dzhemilev, Usein M./0000-0002-7992-6337; Pshennikova, Vera/0000-0001-6866-9462; Готовцев, Ньургун/0000-0002-4710-1592; Solovyeva, Natalya/0000-0002-3570-2585; Fedorova, Sardana/0000-0002-6952-3868	Russian Foundation for Basic Research [12-04-00342_a, 12-04-98520_r_vostok_a, 12-04-97004_r_povolzhye_a, 12-04-31230_mol_a, 14-04-01741_A]; Federal Program Scientific and educational staff for innovative Russia [16.740.11.0190, 16.740.11.0346]; Integration project of SB RAS [92]; Sakha Republic President [80]; Scientific and Educational Foundation for Young Scientists of Republic of Sakha (Yakutia) of Ministry of Education and Science of Russia [656]; RAS Program Fundamental Sciences for Medicine [30(2013-2015)]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Federal Program Scientific and educational staff for innovative Russia; Integration project of SB RAS; Sakha Republic President; Scientific and Educational Foundation for Young Scientists of Republic of Sakha (Yakutia) of Ministry of Education and Science of Russia; RAS Program Fundamental Sciences for Medicine	The authors thank all patients and blood sample donors who have contributed to this study. This study was supported by the Russian Foundation for Basic Research (12-04-00342_a, 12-04-98520_r_vostok_a, 12-04-97004_r_povolzhye_a, 12-04-31230_mol_a, 14-04-01741_A), Federal Program Scientific and educational staff for innovative Russia (#16.740.11.0190, #16.740.11.0346), Integration project of SB RAS #92 Ethnogeny of indigenous peoples in Siberia and North Asia: comparative, historical, ethno-social and genomic analysis, the Sakha Republic President Grant# 80 for Young Researchers for 2014 year, Scientific and Educational Foundation for Young Scientists of Republic of Sakha (Yakutia) for 2014 year, Project # 656 of Ministry of Education and Science of Russia, by grant # 30(2013-2015) of RAS Program Fundamental Sciences for Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALLANA E, CONNEXINS DEAFNESS; Barashkov NA, 2011, J HUM GENET, V56, P631, DOI 10.1038/jhg.2011.72; Engel-Yeger B, 2003, HEARING RES, V175, P140, DOI 10.1016/S0378-5955(02)00719-0; Engel-Yeger B, 2002, HEARING RES, V163, P93, DOI 10.1016/S0378-5955(01)00386-0; Fedorova SA, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-127; Fransen E, 2008, JARO-J ASSOC RES OTO, V9, P264, DOI 10.1007/s10162-008-0123-1; Franze A, 2005, EUR ARCH OTO-RHINO-L, V262, P921, DOI 10.1007/s00405-005-0918-1; Friedman RA, 2009, HUM MOL GENET, V18, P785, DOI 10.1093/hmg/ddn402; Groh D, 2013, PHYSIOL RES, V62, P323, DOI 10.33549/physiolres.932475; Hall A, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001238; Huyghe JR, 2008, AM J HUM GENET, V83, P401, DOI 10.1016/j.ajhg.2008.08.002; Kelley PM, 1998, AM J HUM GENET, V62, P792, DOI 10.1086/301807; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; Kharkov VN, 2008, MOL BIOL+, V42, P198, DOI 10.1134/S0026893308020040; Lefebvre PP, 2000, BRAIN RES REV, V32, P159; Li Qi, 2011, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V46, P543; Morell RJ, 1998, NEW ENGL J MED, V339, P1500, DOI 10.1056/NEJM199811193392103; MORTON NE, 1991, ANN NY ACAD SCI, V630, P16, DOI 10.1111/j.1749-6632.1991.tb19572.x; Pakendorf B, 2006, HUM GENET, V120, P334, DOI 10.1007/s00439-006-0213-2; Sirmaci A, 2006, J GENET, V85, P213, DOI 10.1007/BF02935334; Smith RJH, 2005, LANCET, V365, P879, DOI 10.1016/S0140-6736(05)71047-3; Van Eyken E, 2007, OTOL NEUROTOL, V28, P970; Van Laer L, 2008, HUM MOL GENET, V17, P159, DOI 10.1093/hmg/ddm292; Van Laer L, 2010, EUR J HUM GENET, V18, P685, DOI 10.1038/ejhg.2009.234; Yamasoba T, 2013, HEARING RES, V303, P30, DOI 10.1016/j.heares.2013.01.021; Zelante L, 1997, HUM MOL GENET, V6, P1605, DOI 10.1093/hmg/6.9.1605; Zerjal T, 1997, AM J HUM GENET, V60, P1174	27	4	4	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100848	10.1371/journal.pone.0100848	http://dx.doi.org/10.1371/journal.pone.0100848			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959830	Green Published, gold, Green Submitted			2022-12-27	WOS:000338633900095
J	Ding, Y; Ruan, DK; Luk, KDK; He, Q; Wang, CF				Ding, Yu; Ruan, Dike; Luk, Keith D. K.; He, Qing; Wang, Chaofeng			The Effect of Gamma Irradiation on the Biological Properties of Intervertebral Disc Allografts: In Vitro and In Vivo Studies in a Beagle Model	PLOS ONE			English	Article							ADJACENT-SEGMENT DEGENERATION; BONE; TRANSPLANTATION; STERILIZATION; ARTHROPLASTY; REGENERATION; RADIATION; FUSION; CELLS	Study Design: An animal experiment about intervertebral disc allograft. Objective: To explore the feasibility to decellularize disc allografts treated by Co-60 Gamma Irradiation, and simultaneously, to assess the possibility to make use of the decellularized natural disc scaffold for disc degeneration biotherapy. Summary of Background Data: Studies of both animal and human disc allograft transplantation indicated that the disc allograft may serve as a scaffold to undertake the physiological responsibility of the segment. Methods: Experiment in vitro: 48 discs of beagles were harvested and divided randomly into four groups including a control group and three irradiated groups. Immediate cell viability and biomechanical properties of the discs were checked and comparisons were made among these groups. Experiment in vivo: 24 beagles accepted single-level allografted disc treated with different doses of gamma irradiation. Plain X-rays and MRIs were taken before and after surgery. Then, the spinal columns were harvested en bloc from the sacrificed beagles and were examined morphologically. Results: There were significant differences of both the annulus fibrosus and nucleus pulposus immediate cell viabilities among the various groups. There were no obvious differences of the biomechanical properties among the four groups. The disc height and range of motion decreased significantly in all groups as time went on. The observed indexes in irradiated groups were much smaller than those in the control group, but the indexes in 18-kGy group were larger than those in 25-kGy and 50-kGy groups. Both MRI and macroscopic findings showed that the segmental degeneration in the control and 18-kGy group was less severe than that in 25-kGy and 50-kGy groups. Conclusion: Gamma Irradiation can decellularize disc allograft successfully to provide natural scaffold for the study of degenerative disc disease therapy, and also can be used as an effective method to produce adjustable animal models.	[Ding, Yu] Navy Gen Hosp, Dept Rehabil Med, Beijing, Peoples R China; [Ding, Yu] Navy Gen Hosp, Pain Management Ctr, Beijing, Peoples R China; [Ruan, Dike; He, Qing; Wang, Chaofeng] Navy Gen Hosp, Dept Orthopaed, Beijing, Peoples R China; [Luk, Keith D. K.] Univ Hong Kong, Dept Orthopaed & Traumatol, Hong Kong, Hong Kong, Peoples R China	Sixth Medical Center of Chinese PLA General Hospital; Sixth Medical Center of Chinese PLA General Hospital; Sixth Medical Center of Chinese PLA General Hospital; University of Hong Kong	Ruan, DK (corresponding author), Navy Gen Hosp, Dept Orthopaed, Beijing, Peoples R China.	ruyi_2013@yeah.net			National Natural Science Foundation of China [30730095]; Beijing Municipal Science and Technology Commission [Z131107002213058]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission)	This work was supported by: 1. No. 30730095, the National Natural Science Foundation of China (www.nsfc.gov.cn); and 2. No. Z131107002213058, supported by the Beijing Municipal Science and Technology Commission (www.bjkw.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED SA, 1994, J IMMUNOL METHODS, V170, P211, DOI 10.1016/0022-1759(94)90396-4; Akkus O, 2005, J ORTHOP RES, V23, P1054, DOI 10.1016/j.orthres.2005.03.003; Aslan H, 2009, REGEN MED, V4, P99, DOI 10.2217/17460751.4.1.99; Balsly CR, 2008, CELL TISSUE BANK, V9, P289, DOI 10.1007/s10561-008-9069-0; Bertagnoli R, 2006, J NEUROSURG-SPINE, V4, P91, DOI 10.3171/spi.2006.4.2.91; Gamero EC, 2009, CELL TISSUE BANK, V10, P167, DOI 10.1007/s10561-008-9093-0; Chiang CJ, 2011, SPINE, V36, P761, DOI 10.1097/BRS.0b013e3181e08f01; Cho H, 2011, EXP MOL MED, V43, P334, DOI 10.3858/emm.2011.43.6.036; Fassett DR, 2009, J SPINAL DISORD TECH, V22, P297, DOI 10.1097/BSD.0b013e31816d5f64; Ghiselli G, 2004, J BONE JOINT SURG AM, V86A, P1497, DOI 10.2106/00004623-200407000-00020; GIBBONS MJ, 1991, J ORTHOPAED RES, V9, P209, DOI 10.1002/jor.1100090209; Grieb TA, 2006, J ORTHOP RES, V24, P1011, DOI 10.1002/jor.20079; Hamer AJ, 1999, J BONE JOINT SURG BR, V81B, P342, DOI 10.1302/0301-620X.81B2.9083; Henriksson HB, 2009, SPINE, V34, P141, DOI 10.1097/BRS.0b013e31818f8c20; Hoogendoorn RJ, 2007, SPINE, V32, P1816, DOI 10.1097/BRS.0b013e31811ebac5; Kim KT, 2009, SPINE, V34, P2674, DOI 10.1097/BRS.0b013e3181b4aaac; Kroeber MW, 2002, SPINE, V27, P2684, DOI 10.1097/00007632-200212010-00007; Kunnev D, 2010, ONCOGENE, V29, P3630, DOI 10.1038/onc.2010.125; Luk KDK, 1997, CLIN ORTHOP RELAT R, P13; Matsuzaki H, 1996, SPINE, V21, P178, DOI 10.1097/00007632-199601150-00004; Murrell W, 2009, SPINE J, V9, P585, DOI 10.1016/j.spinee.2009.02.011; Nguyen Huynh, 2007, Cell and Tissue Banking, V8, P81, DOI 10.1007/s10561-006-9019-7; Qi A. Q., 2000, CHIN J CELL BIOL, V22, P50, DOI [10.3969/j.issn.1674-7666.2000.01.013, DOI 10.3969/J.ISSN.1674-7666.2000.01.013]; Rohl K, 2009, SPINAL CORD, V47, P705, DOI 10.1038/sc.2009.31; Ruan DK, 2010, TISSUE ENG PT A, V16, P2381, DOI [10.1089/ten.tea.2009.0770, 10.1089/ten.TEA.2009.0770]; Ruan DK, 2007, LANCET, V369, P993, DOI 10.1016/S0140-6736(07)60496-6; Sakai D, 2008, EUR SPINE J, V17, pS452, DOI 10.1007/s00586-008-0743-5; Singh VA, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-48; Taher F, 2012, ADV ORTHOP, V2012, DOI 10.1155/2012/970752; Xia XP, 2013, SPINE, V38, P597, DOI 10.1097/BRS.0b013e318273a2ea; Yang YC, 2009, INT ORTHOP, V33, P1037, DOI 10.1007/s00264-008-0571-6; Zeiter S, 2005, EUR SPINE J, V14, P874, DOI 10.1007/s00586-005-0957-8	32	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100304	10.1371/journal.pone.0100304	http://dx.doi.org/10.1371/journal.pone.0100304			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959720	gold, Green Submitted, Green Published			2022-12-27	WOS:000338633900038
J	Tang, LD; Wang, XM; Jin, FL; Qiu, BL; Wu, JH; Ren, SX				Tang, Liang-De; Wang, Xing-Min; Jin, Feng-Liang; Qiu, Bao-Li; Wu, Jian-Hui; Ren, Shun-Xiang			De Novo Sequencing-Based Transcriptome and Digital Gene Expression Analysis Reveals Insecticide ResistanceRelevant Genes in Propylaea japonica (Thunberg) (Coleoptea: Coccinellidae)	PLOS ONE			English	Article							APHIS-GOSSYPII; BEETLE; REPRODUCTION; HEMIPTERA; APHIDIDAE; GENOME	The ladybird Propylaea japonica (Thunberg) is one of most important natural enemies of aphids in China. This species is threatened by the extensive use of insecticides but genomics-based information on the molecular mechanisms underlying insecticide resistance is limited. Hence, we analyzed the transcriptome and expression profile data of P. japonica in order to gain a deeper understanding of insecticide resistance in ladybirds. We performed de novo assembly of a transcriptome using Illumina's Solexa sequencing technology and short reads. A total of 27,243,552 reads were generated. These were assembled into 81,458 contigs and 33,647 unigenes (6,862 clusters and 26,785 singletons). Of the unigenes, 23,965 (71.22%) have putative homologues in the non-redundant (nr) protein database from NCBI, using BLASTX, with a cut-off E-value of 10(-5). We examined COG , GO and KEGG annotations to better understand the functions of these unigenes. Digital gene expression (DGE) libraries showed differences in gene expression profiles between two insecticide resistant strains. When compared with an insecticide susceptible profile, a total of 4,692 genes were significantly up-or down-regulated in a moderately resistant strain. Among these genes, 125 putative insecticide resistance genes were identified. To confirm the DGE results, 16 selected genes were validated using quantitative real time PCR (qRT-PCR). This study is the first to report genetic information on P. japonica and has greatly enriched the sequence data for ladybirds. The large number of gene sequences produced from the transcriptome and DGE sequencing will greatly improve our understanding of this important insect, at the molecular level, and could contribute to the in-depth research into insecticide resistance mechanisms.	[Tang, Liang-De; Wang, Xing-Min; Jin, Feng-Liang; Qiu, Bao-Li; Wu, Jian-Hui; Ren, Shun-Xiang] South China Agr Univ, Coll Nat Resource & Environm, Minist Educ, Engn Res Ctr Biol Control, Guangzhou, Guangdong, Peoples R China; [Tang, Liang-De] Chinese Acad Trop Agr, Environm & Plant Protect Inst, Haikou, Peoples R China	South China Agricultural University	Ren, SX (corresponding author), South China Agr Univ, Coll Nat Resource & Environm, Minist Educ, Engn Res Ctr Biol Control, Guangzhou, Guangdong, Peoples R China.	rensxcn@aliyun.com		Wang, Xingmin/0000-0001-9327-9159	National Basic Research Program of China (973 program) [2013CB127600]	National Basic Research Program of China (973 program)(National Basic Research Program of China)	This work was supported by National Basic Research Program of China (973 program, Grant No. 2013CB127600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alias Z, 2010, PESTIC BIOCHEM PHYS, V98, P94, DOI 10.1016/j.pestbp.2010.05.005; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bozsik A, 2006, PEST MANAG SCI, V62, P651, DOI 10.1002/ps.1221; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Galvan TL, 2005, BIOL CONTROL, V34, P108, DOI 10.1016/j.biocontrol.2005.04.005; Gao F, 2010, ENTOMOL EXP APPL, V136, P72, DOI 10.1111/j.1570-7458.2010.01005.x; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hanriot L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-418; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; KAWAUCHI S-E, 1985, Kontyu, V53, P536; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; MULLINS JW, 1993, ACS SYM SER, V524, P183; Nauen R, 2003, B ENTOMOL RES, V93, P47, DOI 10.1079/BER2002215; Papachristos DP, 2008, BIOL CONTROL, V47, P77, DOI 10.1016/j.biocontrol.2008.06.009; Rahmani S, 2013, CROP PROT, V54, P168, DOI 10.1016/j.cropro.2013.08.002; Ranson H, 2001, BIOCHEM J, V359, P295, DOI 10.1042/0264-6021:3590295; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Rodrigues ARS, 2013, ECOTOX ENVIRON SAFE, V96, P53, DOI 10.1016/j.ecoenv.2013.06.014; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Shun Ei K., 1992, Shokubutsu Boeki, V46, P495; Singh SR, 2004, BIOL CONTROL, V30, P127, DOI 10.1016/j.biocontrol.2004.01.003; TAYLOR P, 1994, ANNU REV PHARMACOL, V34, P281, DOI 10.1146/annurev.pa.34.040194.001433; Tijet N, 2001, GENE, V262, P189, DOI 10.1016/S0378-1119(00)00533-3; Weichel L, 2003, PEST MANAG SCI, V59, P991, DOI 10.1002/ps.711; Yamamoto K, 2009, PESTIC BIOCHEM PHYS, V94, P30, DOI 10.1016/j.pestbp.2009.02.008; Youn YN, 2003, BIOL CONTROL, V28, P164, DOI 10.1016/S1049-9644(03)00098-7; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang SZ, 2012, BIOL CONTROL, V62, DOI 10.1016/j.biocontrol.2012.05.002; [张世泽 Zhang Shize], 2004, [干旱地区农业研究, Agricultural Research in the Arid Areas], V22, P206; Zhang SY, 2006, J APPL ENTOMOL, V130, P206, DOI 10.1111/j.1439-0418.2006.01049.x; Zhang YH, 2012, GENOMICS, V100, P35, DOI 10.1016/j.ygeno.2012.05.002	33	25	27	1	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100946	10.1371/journal.pone.0100946	http://dx.doi.org/10.1371/journal.pone.0100946			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959827	Green Submitted, Green Published, gold			2022-12-27	WOS:000338633900104
J	Winter, C; Garcia, JAL; Weinbauer, MG; DuBow, MS; Herndl, GJ				Winter, Christian; Garcia, Juan A. L.; Weinbauer, Markus G.; DuBow, Michael S.; Herndl, Gerhard J.			Comparison of Deep-Water Viromes from the Atlantic Ocean and the Mediterranean Sea	PLOS ONE			English	Article							REFERENCE SEQUENCES REFSEQ; MARINE VIRUSES; BACTERIAL; COMMUNITIES; DIVERSITY	The aim of this study was to compare the composition of two deep-sea viral communities obtained from the Romanche Fracture Zone in the Atlantic Ocean (collected at 5200 m depth) and the southwest Mediterranean Sea (from 2400 m depth) using a pyro-sequencing approach. The results are based on 18.7% and 6.9% of the sequences obtained from the Atlantic Ocean and the Mediterranean Sea, respectively, with hits to genomes in the non-redundant viral RefSeq database. The identifiable richness and relative abundance in both viromes were dominated by archaeal and bacterial viruses accounting for 92.3% of the relative abundance in the Atlantic Ocean and for 83.6% in the Mediterranean Sea. Despite characteristic differences in hydrographic features between the sampling sites in the Atlantic Ocean and the Mediterranean Sea, 440 virus genomes were found in both viromes. An additional 431 virus genomes were identified in the Atlantic Ocean and 75 virus genomes were only found in the Mediterranean Sea. The results indicate that the rather contrasting deep-sea environments of the Atlantic Ocean and the Mediterranean Sea share a common core set of virus types constituting the majority of both virus communities in terms of relative abundance (Atlantic Ocean: 81.4%; Mediterranean Sea: 88.7%).	[Winter, Christian; Garcia, Juan A. L.] Univ Vienna, Dept Limnol & Oceanog, Vienna, Austria; [Weinbauer, Markus G.] Univ Sorbonne, Observ Oceanol, Villefranche Sur Mer, France; [Weinbauer, Markus G.] CNRS, UMR 7093, Observ Oceanol, Villefranche Sur Mer, France; [DuBow, Michael S.] Univ Paris 11, Inst Genet & Microbiol, F-91405 Orsay, France; [Herndl, Gerhard J.] Royal Netherlands Inst Sea Res, Dept Biol Oceanog, Den Burg, Netherlands	University of Vienna; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Saclay; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Winter, C (corresponding author), Univ Vienna, Dept Limnol & Oceanog, Vienna, Austria.	christian.winter@univie.ac.at	Herndl, Gerhard J./B-1513-2013; Herndl, Gerhard J./S-3011-2019; Weinbauer, Markus/ABC-7017-2020; Garcia, Juan Antonio/J-9242-2012	Herndl, Gerhard J./0000-0002-2223-2852; Herndl, Gerhard J./0000-0002-2223-2852; Weinbauer, Markus/0000-0002-7697-5571; Garcia, Juan Antonio/0000-0003-4564-7281; Winter, Christian/0000-0001-6327-0209	Gordon and Betty Moore Foundation [GBMF1799]; European Research Council Advanced Grant (MEDEA) [268595]; Austrian Science Fund (FWF) [P24413-B21]; Austrian Science Fund (FWF) [P 24413] Funding Source: researchfish	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); European Research Council Advanced Grant (MEDEA); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This research was funded in part by the Gordon and Betty Moore Foundation through grant GBMF1799 to the Broad Institute. Samples G2361 and G2362 were sequenced at the Broad Institute. Additional financial support was provided by an European Research Council Advanced Grant (MEDEA, grant number 268595) to GJH and the Austrian Science Fund (FWF): (P24413-B21) to CW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agogue H, 2011, MOL ECOL, V20, P258, DOI 10.1111/j.1365-294X.2010.04932.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Angly FE, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000593; Aristegui J, 2009, LIMNOL OCEANOGR, V54, P1501, DOI 10.4319/lo.2009.54.5.1501; BETHOUX JP, 1990, NATURE, V347, P660, DOI 10.1038/347660a0; Breitbart M, 2005, TRENDS MICROBIOL, V13, P278, DOI 10.1016/j.tim.2005.04.003; Brussaard CPD, 2004, APPL ENVIRON MICROB, V70, P1506, DOI 10.1128/AEM.70.3.1506-1513.2004; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Fouts DE, 2006, NUCLEIC ACIDS RES, V34, P5839, DOI 10.1093/nar/gkl732; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; Guo L, 2007, ENV COLLOIDS PARTICL, V10, P159, DOI DOI 10.1002/9780470024539.CH4; Herndl GJ, 2013, NAT GEOSCI, V6, P718, DOI [10.1038/ngeo1921, 10.1038/NGEO1921]; Lerat E, 2005, PLOS BIOL, V3, P807, DOI 10.1371/journal.pbio.0030130; Marie D, 1999, CURRENT PROTOCOLS CY; Monier A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r106; Ondov BD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-385; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Rodriguez-Brito B, 2010, ISME J, V4, P739, DOI 10.1038/ismej.2010.1; Rodriguez-Valera F, 2009, NAT REV MICROBIOL, V7, P828, DOI 10.1038/nrmicro2235; Romero P, 2004, VIROLOGY, V322, P239, DOI 10.1016/j.virol.2004.01.029; Roux S, 2011, BIOINFORMATICS, V27, P3074, DOI 10.1093/bioinformatics/btr519; Schmieder R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017288; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Tanaka T, 2002, DEEP-SEA RES PT II, V49, P2093, DOI 10.1016/S0967-0645(02)00029-2; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Thingstad TF, 2000, LIMNOL OCEANOGR, V45, P1320, DOI 10.4319/lo.2000.45.6.1320; Wilhelm SW, 1999, BIOSCIENCE, V49, P781, DOI 10.2307/1313569; Winter C, 2010, APPL ENVIRON MICROB, V76, P6724, DOI 10.1128/AEM.00531-10; Winter C, 2010, MICROBIOL MOL BIOL R, V74, P42, DOI 10.1128/MMBR.00034-09; Winter C, 2009, DEEP-SEA RES PT I, V56, P1972, DOI 10.1016/j.dsr.2009.07.003; Winter C, 2009, LIMNOL OCEANOGR, V54, P160, DOI 10.4319/lo.2009.54.1.0160; Yin YB, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-63	36	25	27	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100600	10.1371/journal.pone.0100600	http://dx.doi.org/10.1371/journal.pone.0100600			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959907	Green Published, Green Submitted, gold			2022-12-27	WOS:000338633900060
J	Yang, L; Wang, J; Huang, YH; Hui, DF; Wen, ML				Yang, Long; Wang, Jun; Huang, Yuhui; Hui, Dafeng; Wen, Meili			Effects of the Interception of Litterfall by the Understory on Carbon Cycling in Eucalyptus Plantations of South China	PLOS ONE			English	Article							SOIL CO2 EFFLUX; RESPIRATION; FOREST; BIOMASS; VEGETATION; DECOMPOSITION; ROOT; ECOSYSTEMS; EXCLUSION; DRIVER	For the purposes of forest restoration, carbon (C) fixation, and economic improvement, eucalyptus (Eucalyptus urophylla) has been widely planted in South China. The understory of eucalyptus plantations is often occupied by a dense community of the fern Dicranopteris dichotoma, which intercepts tree canopy leaf litter before it reaches the ground. To understand the effects of this interception of litterfall on C cycling in eucalyptus plantations, we quantified the mass of intercepted litter and the influences of litterfall interception on litter decomposition and soil respiration. The total mass of E. urophylla litterfall collected on the understory was similar to that collected by the traditional litter trap method. All of the eucalyptus litterfall is intercepted by the D. dichotoma canopy. Of the litterfall that was intercepted by D. dichotoma, 20-40% and 60-80% was intercepted by the top (50-100 cm) and bottom (0-50 cm) of the understory canopy, respectively. Intercepted litterfall decomposed faster at the bottom of understory canopy (at the base of the plants) than at the top, and decomposition was slower on the soil surface in the absence of understory than on any location in the understory canopy. Soil respiration was highest when both the understory and litter were present and was lowest when both the understory and litter were absent. These results indicate that litterfall interception changed carbon flow between aboveground and belowground through litter decomposition and soil respiration, which changed carbon cycling in eucalyptus plantations. The effects of the understory on litter decomposition and soil respiration should be considered in ecosystem carbon models.	[Yang, Long; Wen, Meili] Guangzhou Inst Geog, Ctr Resource & Environm, Guangzhou, Guangdong, Peoples R China; [Yang, Long; Wang, Jun] Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China; [Huang, Yuhui] Guangdong Acad Forestry, Guangzhou, Guangdong, Peoples R China; [Hui, Dafeng] Tennessee State Univ, Dept Biol Sci, Nashville, TN 37203 USA	Guangdong Academy of Sciences; Guangzhou Institute of Geography, Guangdong Academy of Sciences; Chinese Academy of Sciences; South China Botanical Garden, CAS; Tennessee State University	Yang, L (corresponding author), Guangzhou Inst Geog, Ctr Resource & Environm, Guangzhou, Guangdong, Peoples R China.	yanglong@scib.ac.cn		Wang, Jun/0000-0003-4492-4953; Hui, Dafeng/0000-0002-5284-2897	National Natural Science Foundation of China [31000212]; Special Foundation for Young Scientists of Guangdong Academy of Sciences [2009-46]; Key Laboratory of Vegetation Restoration and Management of Degraded Ecosystems, Chinese Academy of Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Foundation for Young Scientists of Guangdong Academy of Sciences; Key Laboratory of Vegetation Restoration and Management of Degraded Ecosystems, Chinese Academy of Sciences	This research was funded by the National Natural Science Foundation of China (No. 31000212), the Special Foundation for Young Scientists of Guangdong Academy of Sciences (2009-46), and the Key Laboratory of Vegetation Restoration and Management of Degraded Ecosystems, Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Sanchez J, 1999, BIOTROPICA, V31, P89; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Cadisch G, 1996, DRIVEN NATURE PLANT; Chen DM, 2009, FOREST ECOL MANAG, V257, P2088, DOI 10.1016/j.foreco.2009.02.018; *CHIN STAT FOR BUR, 2005, 6 NAT FOR INV 1999 2; Dearden FM, 2008, OIKOS, V117, P83, DOI 10.1111/j.2007.0030-1299.16136.x; [邓琦 DENG Qi], 2007, [地球科学进展, Advance in Earth Sciences], V22, P976; Dirks I, 2010, GLOBAL CHANGE BIOL, V16, P2799, DOI 10.1111/j.1365-2486.2010.02172.x; Ehrenfeld JG, 2001, ECOL APPL, V11, P1287, DOI 10.2307/3060920; Fang CM, 2005, NATURE, V433, P57, DOI 10.1038/nature03138; Fang JY, 2001, SCIENCE, V292, P2320, DOI 10.1126/science.1058629; Fang JY, 2001, ACTA BOT SIN, V43, P967; Flora of China Editorial Committee, 1999, FLORA CHINA; George LO, 1999, ECOLOGY, V80, P833, DOI 10.1890/0012-9658(1999)080[0833:TFUAAE]2.0.CO;2; Gough CM, 2004, FOREST ECOL MANAG, V191, P353, DOI 10.1016/j.foreco.2004.01.011; He XB, 2013, PLANT SOIL, V372, P207, DOI 10.1007/s11104-013-1734-9; Huang YH, 2011, ENVIRON MANAGE, V48, P1189, DOI 10.1007/s00267-011-9758-5; Hui DF, 2009, PLANT SOIL, V314, P263, DOI 10.1007/s11104-008-9726-x; Kauffman JB, 2009, ECOL APPL, V19, P1211, DOI 10.1890/08-1696.1; Li YQ, 2004, SOIL BIOL BIOCHEM, V36, P2111, DOI 10.1016/j.soilbio.2004.06.003; Lin X.X., 2004, FUJIAN SOIL WATER CO, V16, P60; Liu Wen-fei, 2009, Shengtaixue Zazhi, V28, P1928; Liu Ying-chun, 2008, Shengtaixue Zazhi, V27, P705; Luo YQ, 2001, NATURE, V413, P622, DOI 10.1038/35098065; Nilsson MC, 2005, FRONT ECOL ENVIRON, V3, P421, DOI 10.2307/3868658; OCONNELL AM, 1986, PLANT SOIL, V92, P235, DOI 10.1007/BF02372637; Peng SL, 2009, RESTOR ECOL, V17, P487, DOI 10.1111/j.1526-100X.2008.00399.x; Piao SL, 2005, J GEOPHYS RES-BIOGEO, V110, DOI 10.1029/2005JG000014; RAICH JW, 1992, TELLUS B, V44, P81, DOI 10.1034/j.1600-0889.1992.t01-1-00001.x; Schimel JP, 1999, SOIL BIOL BIOCHEM, V31, P831, DOI 10.1016/S0038-0717(98)00182-5; Swift M.J., 1979, DECOMPOSITION TERRES, V5; Tang XL, 2006, GLOBAL CHANGE BIOL, V12, P546, DOI 10.1111/j.1365-2486.2006.01109.x; Wang Guang-Jun, 2009, Chinese Journal of Plant Ecology, V33, P739, DOI 10.3773/j.issn.1005-264x.2009.04.012; Wang J, 2009, FOREST ECOL MANAG, V258, P1293, DOI 10.1016/j.foreco.2009.06.022; Wang XL, 2011, FOREST ECOL MANAG, V261, P1053, DOI 10.1016/j.foreco.2010.12.027; Wang YD, 2009, ASIA-PAC J ATMOS SCI, V45, P137; Wu ChuanSheng, 2012, Journal of Northeast Forestry University, V40, P37; Wu JP, 2011, SOIL BIOL BIOCHEM, V43, P2355, DOI 10.1016/j.soilbio.2011.07.011; Wu JP, 2011, FUNCT ECOL, V25, P921, DOI 10.1111/j.1365-2435.2011.01845.x; Xu M, 2001, GLOBAL CHANGE BIOL, V7, P667, DOI 10.1046/j.1354-1013.2001.00435.x; Xue Li, 2005, Acta Phytoecologica Sinica, V29, P415; YARIE J, 1980, ECOLOGY, V61, P1498, DOI 10.2307/1939057; Yashiro Y, 2012, ECOL RES, V27, P577, DOI 10.1007/s11284-012-0925-9; YE JX, 1987, ACTA PHYTOECLOGICA G, V11, P203; [袁宜如 YUAN Yiru], 2007, [安徽农业科学, Journal of Anhui Agricultural Sciences], V35, P5047; [张继光 ZHANG Ji-guang], 2009, [热带亚热带植物学报, Journal of Tropical and Subtropical Botany], V17, P395; Zhu HG, 2010, J ANHUI AGR SCI, V38; Zimmermann M, 2009, SOIL BIOL BIOCHEM, V41, P1338, DOI 10.1016/j.soilbio.2009.02.023	48	14	17	4	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100464	10.1371/journal.pone.0100464	http://dx.doi.org/10.1371/journal.pone.0100464			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959853	gold, Green Submitted, Green Published			2022-12-27	WOS:000338633900048
J	Zhang, L; Lei, Y; Liu, X; Wang, X; Liu, Z; Li, D; Zheng, P; Zhang, LJ; Chen, SG; Xie, P				Zhang, Liang; Lei, Yang; Liu, Xia; Wang, Xiao; Liu, Zhao; Li, Dan; Zheng, Peng; Zhang, Lujun; Chen, Shigang; Xie, Peng			Glutamate and Lipid Metabolic Perturbation in the Hippocampi of Asymptomatic Borna Disease Virus-Infected Horses	PLOS ONE			English	Article							PSYCHIATRIC-PATIENTS; MOOD DISORDERS; RAT MODEL; ANTIBODIES; ANIMALS; NEUROPATHOLOGY; EPIDEMIOLOGY; CELLS; SERUM; RNA	Borna disease virus (BDV) is a neurotropic, enveloped, non-segmented, negative-stranded RNA virus that infects a wide variety of vertebrate species from birds to humans across a broad global geographic distribution. Animal symptomatology range from asymptomatic infection to behavioral abnormalities to acute meningoencephalitis. Asymptomatic BDV infection has been shown to be more frequent than conventionally estimated. However, the molecular mechanism(s) underyling asymptomatic BDV infection remain largely unknown. Here, based on real-time quantitative PCR and Western blotting, a total of 18 horse hippocampi were divided into BDV-infected (n = 8) and non-infected control (n = 10) groups. A gas chromatography coupled with mass spectrometry (GC-MS) metabolomic approach, in conjunction with multivariate statistical analysis, was used to characterize the hippocampal metabolic changes associated with asymptomatic BDV infection. Multivariate statistical analysis showed a significant discrimination between the BDV-infected and control groups. BDV-infected hippocampi were characterized by lower levels of D-myo-inositol-1-phosphate, glutamate, phosphoethanolamine, heptadecanoic acid, and linoleic acid in combination with a higher level of ammonia. These differential metabolites are primarily involved in glutamate and lipid metabolism. These finding provide an improved understanding of hippocampal changes associated with asymptomatic BDV infection.	[Zhang, Liang; Liu, Xia; Zheng, Peng; Xie, Peng] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing, Peoples R China; [Zhang, Liang; Lei, Yang; Liu, Xia; Wang, Xiao; Liu, Zhao; Li, Dan; Zheng, Peng; Zhang, Lujun; Chen, Shigang; Xie, Peng] Chongqing Med Univ, Inst Neurosci, Chongqing, Peoples R China; [Zhang, Liang; Lei, Yang; Liu, Xia; Wang, Xiao; Liu, Zhao; Li, Dan; Zheng, Peng; Zhang, Lujun; Chen, Shigang; Xie, Peng] Chongqing Med Univ, Chongqing Key Lab Neurobiol, Chongqing, Peoples R China; [Li, Dan] Chongqing Med Univ, Dept Pathol, Fac Basic Med, Chongqing, Peoples R China; [Lei, Yang] Chongqing Med Univ, Dept Neurol, Univ Town Hosp, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University	Xie, P (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing, Peoples R China.	xiepeng@cqmu.edu.cn			National Basic Research Program of China (973 Program) [2009CB918300]	National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by the National Basic Research Program of China (973 Program) (Grant No. 2009CB918300) (http://www.973.gov.cn/Default_3.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahmani MK, 1996, VIRUS RES, V45, P1, DOI 10.1016/0168-1702(96)01355-X; Beaver BV, 2001, J AM VET MED ASSOC, V218, P669, DOI 10.2460/javma.2001.218.669; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI [10.1056/NEJMra073096, 10.1038/nrdp.2016.65]; Bilzer T, 1993, Arch Virol Suppl, V7, P153; Bode L, 2003, CLIN MICROBIOL REV, V16, P534, DOI 10.1128/CMR.16.3.534-545.2003; BODE L, 1995, NAT MED, V1, P232, DOI 10.1038/nm0395-232; Bode L, 1996, MOL PSYCHIATR, V1, P200; Bode L, 2001, MOL PSYCHIATR, V6, P481, DOI 10.1038/sj.mp.4000909; Cloarec O, 2005, ANAL CHEM, V77, P517, DOI 10.1021/ac048803i; de la Torre JC, 2000, VIRUS TAXONOMY, V10, P531; Eisenman LM, 1999, J NEUROVIROL, V5, P181, DOI 10.3109/13550289909022000; GOSZTONYI G, 1995, CURR TOP MICROBIOL, V190, P39; GOSZTONYI G, 1984, ACTA NEUROPATHOL, V64, P213, DOI 10.1007/BF00688111; Gosztonyi G, 2001, CURR TOP MICROBIOL, V253, P121; Gosztonyi G, 2008, APMIS, V116, P53, DOI 10.1111/j.1600-0463.2008.000m8.x; Hagiwara K, 2001, VET MICROBIOL, V80, P383, DOI 10.1016/S0378-1135(01)00324-8; HERZOG S, 1994, WIEN TIERARZTL MONAT, V81, P374; Hornig M, 1999, P NATL ACAD SCI USA, V96, P12102, DOI 10.1073/pnas.96.21.12102; Huang RZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044665; Joest E, 1911, J NEUROL, V42, P293; KANOSUEOKA T, 1979, P NATL ACAD SCI USA, V76, P5741, DOI 10.1073/pnas.76.11.5741; Kinnunen PM, 2007, J CLIN VIROL, V38, P64, DOI 10.1016/j.jcv.2006.10.003; Kinnunen PM, 2013, J GEN VIROL, V94, P247, DOI 10.1099/vir.0.046961-0; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Lei Y, 2014, METABOLOMICS, V10, P484, DOI 10.1007/s11306-013-0593-y; LUDWIG H, 1977, MED MICROBIOL IMMUN, V163, P215, DOI 10.1007/BF02125505; Ludwig H, 1985, Tierarztl Prax, V13, P421; Ludwig H, 2000, REV SCI TECH OIE, V19, P259, DOI 10.20506/rst.19.1.1217; Luedemann A, 2008, BIOINFORMATICS, V24, P732, DOI 10.1093/bioinformatics/btn023; Munger J, 2006, PLOS PATHOG, V2, P1165, DOI 10.1371/journal.ppat.0020132; NAKAMURA Y, 1995, VACCINE, V13, P1076, DOI 10.1016/0264-410X(95)00050-B; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; PLANZ O, 1995, J VIROL, V69, P896, DOI 10.1128/JVI.69.2.896-903.1995; Priestnall SL, 2011, VET REC, V168, P380, DOI 10.1136/vr.c6405; Resources IoLA, 1996, GUIDE CARE USE LAB A; Richt JA, 2001, VET J, V161, P24, DOI 10.1053/tvjl.2000.0533; ROTT R, 1985, SCIENCE, V228, P755, DOI 10.1126/science.3922055; ROTT R, 1995, CURR TOP MICROBIOL, V190, P17; Sauder C, 1996, J VIROL, V70, P7713, DOI 10.1128/JVI.70.11.7713-7724.1996; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Schindler AR, 2007, MOL CELL PROBE, V21, P47, DOI 10.1016/j.mcp.2006.08.001; Shao WH, 2013, METABOLOMICS, V9, P433, DOI 10.1007/s11306-012-0460-2; Siger M, 2009, ALZ DIS ASSOC DIS, V23, P57, DOI 10.1097/WAD.0b013e3181875434; Sitole LJ, 2013, MOL BIOSYST, V9, P18, DOI 10.1039/c2mb25318f; Sripadi P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012590; Thakur R, 2009, INDIAN J MED MICROBI, V27, P191, DOI 10.4103/0255-0857.53200; Zhang L, 2014, ARCH VIROL, V159, P1941, DOI 10.1007/s00705-013-1971-5; Zhou B, 2012, MOL BIOSYST, V8, P470, DOI 10.1039/c1mb05350g	49	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e99752	10.1371/journal.pone.0099752	http://dx.doi.org/10.1371/journal.pone.0099752			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956478	gold, Green Submitted, Green Published			2022-12-27	WOS:000338917900018
J	Cupi, ML; Sarra, M; De Nitto, D; Franze, E; Marafini, I; Monteleone, I; Blanco, GDV; Paoluzi, OA; Di Fusco, D; Gentileschi, P; Ortenzi, A; Colantoni, A; Pallone, F; Monteleone, G				Cupi, Maria Laura; Sarra, Massimiliano; De Nitto, Daniela; Franze, Eleonora; Marafini, Irene; Monteleone, Ivan; Blanco, Giovanna Del Vecchio; Paoluzi, Omero Alessandro; Di Fusco, Davide; Gentileschi, Paolo; Ortenzi, Angela; Colantoni, Alfredo; Pallone, Francesco; Monteleone, Giovanni			Defective Expression of Scavenger Receptors in Celiac Disease Mucosa	PLOS ONE			English	Article							IMMUNE-RESPONSES; T-CELLS; RECOGNITION; MACROPHAGES; APOPTOSIS; PHAGOCYTOSIS; NEUTROPHILS; MECHANISMS; IL-21	Celiac disease (CD) is a gluten sensitive enteropathy characterized by a marked infiltration of the mucosa with immune cells, over-production of inflammatory cytokines and epithelial cell damage. The factors/mechanisms that sustain and amplify the ongoing mucosal inflammation in CD are not however fully understood. Here, we have examined whether in CD there is a defective clearance of apoptotic cells/bodies, a phenomenon that helps promote tolerogenic signals thus liming pathogenic responses. Accumulation of apoptotic cells and bodies was more pronounced in the epithelial and lamina propria compartments of active CD patients as compared to inactive CD patients and normal controls. Expression of scavenger receptors, which are involved in the clearance of apoptotic cells/bodies, namely thrombospondin (TSP)-1, CD36 and CD61, was significantly reduced in active CD as compared to inactive CD and normal mucosal samples. Consistently, lamina propria mononuclear cells (LPMC) of active CD patients had diminished ability to phagocyte apoptotic cells. Interleukin (IL)-15, IL-21 and interferon-gamma, cytokines over-produced in active CD, inhibited the expression of TSP-1, CD36, and CD61 in normal intestinal LPMC. These results indicate that CD-related inflammation is marked by diminished clearance of apoptotic cells/bodies, thus suggesting a role for such a defect in the ongoing mucosal inflammation in this disorder.	[Cupi, Maria Laura; Sarra, Massimiliano; De Nitto, Daniela; Franze, Eleonora; Marafini, Irene; Monteleone, Ivan; Blanco, Giovanna Del Vecchio; Paoluzi, Omero Alessandro; Di Fusco, Davide; Gentileschi, Paolo; Ortenzi, Angela; Colantoni, Alfredo; Pallone, Francesco; Monteleone, Giovanni] Univ Tor Vergata, Dipartimento Med Sistemi, Rome, Italy	University of Rome Tor Vergata	Monteleone, G (corresponding author), Univ Tor Vergata, Dipartimento Med Sistemi, Rome, Italy.	Gi.Monteleone@Med.uniroma2.it	marafini, irene/AHD-5205-2022; Monteleone, Ivan/AEW-2892-2022; Monteleone, Giovanni/AAE-1418-2021	DEL VECCHIO BLANCO, Giovanna/0000-0002-6327-563X; paoluzi, omero alessandro/0000-0002-5393-5796; Franze, Eleonora/0000-0003-4343-221X; Monteleone, Ivan/0000-0002-3212-832X; Di Fusco, Davide/0000-0002-8908-9237	Giuliani SpA, Milan, Italy; Fondazione Umberto Di Mario, Rome, Italy	Giuliani SpA, Milan, Italy; Fondazione Umberto Di Mario, Rome, Italy	The authors received support for this study by Giuliani SpA, Milan, Italy, and Fondazione Umberto Di Mario, Rome, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Bodd M, 2010, MUCOSAL IMMUNOL, V3, P594, DOI 10.1038/mi.2010.36; Canton J, 2013, NAT REV IMMUNOL, V13, P621, DOI 10.1038/nri3515; Ciccocioppo R, 2001, AM J CLIN PATHOL, V115, P494; Di Sabatino A, 2001, GUT, V49, P380, DOI 10.1136/gut.49.3.380; Di Sabatino A, 2001, IMMUNOLOGY, V103, P435, DOI 10.1046/j.1365-2567.2001.01245.x; Erwig LP, 1999, BLOOD, V93, P1406, DOI 10.1182/blood.V93.4.1406.404k10_1406_1412; FADOK VA, 1993, J IMMUNOL, V151, P4274; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Fina D, 2008, GUT, V57, P887, DOI 10.1136/gut.2007.129882; Gianfrani C, 2005, IMMUNOL LETT, V99, P141, DOI 10.1016/j.imlet.2005.02.017; Green PHR, 2007, NEW ENGL J MED, V357, P1731, DOI 10.1056/NEJMra071600; Jabri B, 2009, NAT REV IMMUNOL, V9, P858, DOI 10.1038/nri2670; Maiuri L, 2000, GASTROENTEROLOGY, V119, P996, DOI 10.1053/gast.2000.18149; Maiuri L, 2003, LANCET, V362, P30, DOI 10.1016/S0140-6736(03)13803-2; Monks J, 2005, CELL DEATH DIFFER, V12, P107, DOI 10.1038/sj.cdd.4401517; Monteleone I, 2010, J IMMUNOL, V184, P2211, DOI 10.4049/jimmunol.0901919; Nilsen EM, 1998, GASTROENTEROLOGY, V115, P551, DOI 10.1016/S0016-5085(98)70134-9; Pluddemann A, 2007, METHODS, V43, P207, DOI 10.1016/j.ymeth.2007.06.004; Sarra M, 2013, MUCOSAL IMMUNOL, V6, P244, DOI 10.1038/mi.2012.65; SAVILL J, 1992, J CLIN INVEST, V90, P1513, DOI 10.1172/JCI116019; SAVILL J, 1993, IMMUNOL TODAY, V14, P131, DOI 10.1016/0167-5699(93)90215-7; Silva MT, 2008, APOPTOSIS, V13, P463, DOI 10.1007/s10495-008-0187-8; Silva MT, 2010, FEBS LETT, V584, P4491, DOI 10.1016/j.febslet.2010.10.046; Taylor AE, 2010, EUR RESPIR J, V35, P1039, DOI 10.1183/09031936.00036709	25	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100980	10.1371/journal.pone.0100980	http://dx.doi.org/10.1371/journal.pone.0100980			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971453	gold, Green Published, Green Submitted			2022-12-27	WOS:000338512200078
J	Duraisingham, SS; Buckland, M; Dempster, J; Lorenzo, L; Grigoriadou, S; Longhurst, HJ				Duraisingham, Sai S.; Buckland, Matthew; Dempster, John; Lorenzo, Lorena; Grigoriadou, Sofia; Longhurst, Hilary J.			Primary vs. Secondary Antibody Deficiency: Clinical Features and Infection Outcomes of Immunoglobulin Replacement	PLOS ONE			English	Article							COMMON VARIABLE IMMUNODEFICIENCY; INTRAVENOUS IMMUNOGLOBULIN; IMMUNE-DEFICIENCY; HYPOGAMMAGLOBULINEMIA; RITUXIMAB; MANAGEMENT; CLASSIFICATION; DIAGNOSIS; PROPHYLAXIS; DISORDERS	Secondary antibody deficiency can occur as a result of haematological malignancies or certain medications, but not much is known about the clinical and immunological features of this group of patients as a whole. Here we describe a cohort of 167 patients with primary or secondary antibody deficiencies on immunoglobulin (Ig)-replacement treatment. The demographics, causes of immunodeficiency, diagnostic delay, clinical and laboratory features, and infection frequency were analysed retrospectively. Chemotherapy for B cell lymphoma and the use of Rituximab, corticosteroids or immunosuppressive medications were the most common causes of secondary antibody deficiency in this cohort. There was no difference in diagnostic delay or bronchiectasis between primary and secondary antibody deficiency patients, and both groups experienced disorders associated with immune dysregulation. Secondary antibody deficiency patients had similar baseline levels of serum IgG, but higher IgM and IgA, and a higher frequency of switched memory B cells than primary antibody deficiency patients. Serious and non-serious infections before and after Ig-replacement were also compared in both groups. Although secondary antibody deficiency patients had more serious infections before initiation of Ig-replacement, treatment resulted in a significant reduction of serious and non-serious infections in both primary and secondary antibody deficiency patients. Patients with secondary antibody deficiency experience similar delays in diagnosis as primary antibody deficiency patients and can also benefit from immunoglobulin-replacement treatment.	[Duraisingham, Sai S.; Buckland, Matthew; Dempster, John; Lorenzo, Lorena; Grigoriadou, Sofia; Longhurst, Hilary J.] Barts Hlth NHS Trust, Dept Immunol, London, England	Barts Health NHS Trust	Longhurst, HJ (corresponding author), Barts Hlth NHS Trust, Dept Immunol, London, England.	hilary.longhurst@bartshealth.nhs.uk	Buckland, Matthew/H-7049-2019	Buckland, Matthew/0000-0002-5646-4707	CSL Behring	CSL Behring	SD's salary was funded by CSL Behring. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Herz W, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00054; Bousfiha AA, 2013, J CLIN IMMUNOL, V33, P1078, DOI 10.1007/s10875-013-9901-6; Baris S, 2011, J INVEST ALLERG CLIN, V21, P514; Becerra E, 2012, INT J CLIN RHEUMATOL, V7, P383, DOI [DOI 10.2217/IJR.12.31, 10.2217/ijr.12.31]; Bernatsky S, 2007, RHEUMATOLOGY, V46, P1157, DOI 10.1093/rheumatology/kem076; BLORE J, 1989, BRIT MED J, V298, P516, DOI 10.1136/bmj.298.6672.516; Bonilla FA, 2005, ANN ALLERG ASTHMA IM, V94, pS1, DOI 10.1016/S1081-1206(10)61142-8; Boumans MJH, 2011, ARTHRITIS RHEUM-US, V63, P3187, DOI 10.1002/art.30567; Bright P, 2013, CLIN EXP IMMUNOL, V171, P195, DOI 10.1111/cei.12010; BUNCH C, 1988, NEW ENGL J MED, V319, P902; Castigli E, 2006, J ALLERGY CLIN IMMUN, V117, P740, DOI 10.1016/j.jaci.2006.01.038; Casulo C, 2013, CL LYMPH MYELOM LEUK, V13, P106, DOI 10.1016/j.clml.2012.11.011; Chapel H, 2008, BLOOD, V112, P277, DOI 10.1182/blood-2007-11-124545; Chapel H, 2009, BRIT J HAEMATOL, V145, P709, DOI 10.1111/j.1365-2141.2009.07669.x; CHAPEL HM, 1994, LANCET, V343, P1059, DOI 10.1016/S0140-6736(94)90180-5; Conley ME, 1999, CLIN IMMUNOL, V93, P190, DOI 10.1006/clim.1999.4799; De La Torre I, 2012, RHEUMATOLOGY, V51, P833, DOI 10.1093/rheumatology/ker417; Duraisingham SS, 2014, EXPERT REV CLIN IMMU, V10, P583, DOI 10.1586/1744666X.2014.902314; Edgar JDM, 2014, CLIN EXP IMMUNOL, V175, P68, DOI 10.1111/cei.12172; Florescu DF, 2013, AM J TRANSPLANT, V13, P2601, DOI 10.1111/ajt.12401; Freeman JA, 2013, LEUKEMIA LYMPHOMA, V54, P99, DOI 10.3109/10428194.2012.706285; Gathmann B, 2009, CLIN EXP IMMUNOL, V157, P3, DOI 10.1111/j.1365-2249.2009.03954.x; Gathmann B, 2014, J ALLERGY C IN PRESS; GRIFFITHS H, 1992, CLIN EXP IMMUNOL, V89, P374; Gunther G, 2013, MICROBIOL IMMUNOL, V57, P527, DOI 10.1111/1348-0421.12060; Herriot R, 2008, J CLIN PATHOL, V61, P994, DOI 10.1136/jcp.2007.051177; Kawano T, 2002, INT ARCH ALLERGY IMM, V128, P240, DOI 10.1159/000064258; Lucas M, 2010, J ALLERGY CLIN IMMUN, V125, P1354, DOI 10.1016/j.jaci.2010.02.040; Makatsori M, 2014, QJM IN PRESS; McLaughlin P, 1998, J CLIN ONCOL, V16, P2825, DOI 10.1200/JCO.1998.16.8.2825; Molica S, 1996, HAEMATOLOGICA, V81, P121; Mouthon L, 2013, CURR OPIN ALLERGY CL, V13, pS56, DOI 10.1097/01.all.0000433132.16436.b5; Orange JS, 2012, J ALLERGY CLIN IMMUN, V130, pS1, DOI 10.1016/j.jaci.2012.07.002; Orange JS, 2010, CLIN IMMUNOL, V137, P21, DOI 10.1016/j.clim.2010.06.012; Ozaras N, 2012, SEIZURE-EUR J EPILEP, V21, P229, DOI 10.1016/j.seizure.2011.12.013; Piqueras B, 2003, J CLIN IMMUNOL, V23, P385, DOI 10.1023/A:1025373601374; Quinti I, 2011, J CLIN IMMUNOL, V31, P315, DOI 10.1007/s10875-011-9511-0; Resnick ES, 2012, BLOOD, V119, P1650, DOI 10.1182/blood-2011-09-377945; Rose ME, 2006, CLEV CLIN J MED, V73, P133, DOI 10.3949/ccjm.73.2.133; Salzer U, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4032; Seymour B, 2005, J CLIN PATHOL, V58, P546, DOI 10.1136/jcp.2004.016204; Shortt J, 2006, BONE MARROW TRANSPL, V38, P433, DOI 10.1038/sj.bmt.1705463; STROBER W, 1967, J CLIN INVEST, V46, P1643, DOI 10.1172/JCI105656; Venhoff N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037626; Warnatz K, 2006, BLOOD, V107, P3045, DOI 10.1182/blood-2005-07-2955; Warnatz K, 2002, BLOOD, V99, P1544, DOI 10.1182/blood.V99.5.1544; Wehr C, 2008, BLOOD, V111, P77, DOI 10.1182/blood-2007-06-091744; Wood P, 2007, CLIN EXP IMMUNOL, V149, P410, DOI 10.1111/j.1365-2249.2007.03432.x; Yip NH, 2006, AM J RESP CRIT CARE, V173, P917, DOI 10.1164/rccm.200510-1609OC; Yomota M, 2012, INTERNAL MED, V51, P2715, DOI 10.2169/internalmedicine.51.7775	50	43	44	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100324	10.1371/journal.pone.0100324	http://dx.doi.org/10.1371/journal.pone.0100324			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971644	Green Published, Green Submitted, gold			2022-12-27	WOS:000338512200025
J	Suzuki, S; Suzuki, C; Hinokio, Y; Ishigaki, Y; Katagiri, H; Kanzaki, M; Azev, VN; Chakraborty, N; d'Alarcao, M				Suzuki, Susumu; Suzuki, Chitose; Hinokio, Yoshinori; Ishigaki, Yasushi; Katagiri, Hideki; Kanzaki, Makoto; Azev, Viatcheslav N.; Chakraborty, Nilanjana; d'Alarcao, Marc			Insulin-Mimicking Bioactivities of Acylated Inositol Glycans in Several Mouse Models of Diabetes with or without Obesity	PLOS ONE			English	Article							PHOSPHOLIPASE-D; RAT ADIPOCYTES; GLYCOSYL-PHOSPHATIDYLINOSITOL; SIGNAL-TRANSDUCTION; SERUM-LEVELS; GENERATION; RESISTANCE; HYDROLYSIS; DIACYLGLYCEROL; EXPRESSION	Insulin-mimetic species of low molecular weight are speculated to mediate some intracellular insulin actions. These inositol glycans, which are generated upon insulin stimulation from glycosylphosphatidylinositols, might control the activity of a multitude of insulin effector enzymes. Acylated inositol glycans (AIGs) are generated by cleavage of protein-free GPI precursors through the action of GPI-specific phospholipase C (GPI-PLC) and D (GPI-PLD). We synthesized AIGs (IG-1, IG-2, IG-13, IG-14, and IG-15) and then evaluated their insulin-mimicking bioactivities. IG-1 significantly stimulated glycogen synthesis and lipogenesis in 3T3-L1 adipocytes and rat isolated adipocytes dose-dependently. IG-2 significantly stimulated lipogenesis in rat isolated adipocytes dose-dependently. IG-15 also enhanced glycogen synthesis and lipogenesis in 3T3-L1 adipocytes. The administration of IG-1 decreased plasma glucose, increased glycogen content in liver and skeletal muscles and improved glucose tolerance in C57B6N mice with normal diets. The administration of IG-1 decreased plasma glucose in STZ-diabetic C57B6N mice. The treatment of IG-1 decreased plasma glucose, increased glycogen content in liver and skeletal muscles and improved glucose tolerance in C57B6N mice with high fat-diets and db/db mice. The long-term treatment of IG-1 decreased plasma glucose and reduced food intake and body weight in C57B6N mice with high fat-diets and ob/ob mice. Thus, IG-1 has insulin-mimicking bioactivities and improves glucose tolerance in mice models of diabetes with or without obesity.	[Suzuki, Susumu; Suzuki, Chitose; Hinokio, Yoshinori; Ishigaki, Yasushi; Katagiri, Hideki] Tohoku Univ Hosp, Dept Diabet & Metab, Sendai, Miyagi, Japan; [Suzuki, Susumu] Ohta Nishinouchi Hosp, Ctr Diabet, Koriyama, Fukushima, Japan; [Kanzaki, Makoto] Tohoku Univ, Grad Sch Biomed Engn, Sendai, Miyagi 980, Japan; [Azev, Viatcheslav N.; Chakraborty, Nilanjana; d'Alarcao, Marc] Tufts Univ, Dept Chem, Medford, MA 02155 USA; [d'Alarcao, Marc] San Jose State Univ, Dept Chem, San Jose, CA 95192 USA	Tohoku University; Tohoku University; Tufts University; California State University System; San Jose State University	Suzuki, S (corresponding author), Tohoku Univ Hosp, Dept Diabet & Metab, Sendai, Miyagi, Japan.	ssuzuki@med.tohoku.ac.jp	Kanzaki, Makoto/H-6680-2017; Azev, Viatcheslav/AAQ-9663-2021	Kanzaki, Makoto/0000-0002-6884-2955; Azev, Viatcheslav/0000-0003-3275-4811; d'Alarcao, Marc/0000-0003-2057-4557	Ministry of Education, Culture, Sports, Science and Technology in Japan [21570122]; NIH [GM084819, DK082974]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R15DK082974] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	S. Suzuki received financial support from the Ministry of Education, Culture, Sports, Science and Technology in Japan (#21570122). M d'Alarcao received financial support from the NIH (GM084819 and DK082974) for support of a portion of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZ JF, 1991, BIOCHEM J, V274, P369, DOI 10.1042/bj2740369; Armesto J, 1996, EUR J BIOCHEM, V238, P259, DOI 10.1111/j.1432-1033.1996.0259q.x; Boudot C, 2002, CELL SIGNAL, V14, P869, DOI 10.1016/S0898-6568(02)00036-0; Boura-Halfon S, 2009, AM J PHYSIOL-ENDOC M, V296, pE581, DOI 10.1152/ajpendo.90437.2008; Bowen RF, 2001, METABOLISM, V50, P1489, DOI 10.1053/meta.2001.28087; BREWIS IA, 1995, J BIOL CHEM, V270, P22946, DOI 10.1074/jbc.270.39.22946; Chakraborty N, 2005, BIOORGAN MED CHEM, V13, P6732, DOI 10.1016/j.bmc.2005.07.020; Chalasani N, 2006, J CLIN ENDOCR METAB, V91, P2279, DOI 10.1210/jc.2006-0075; Deborde S, 2003, J REPROD IMMUNOL, V59, P277, DOI 10.1016/S0165-0378(03)00054-8; Deeg MA, 2001, AM J PHYSIOL-ENDOC M, V281, pE147, DOI 10.1152/ajpendo.2001.281.1.E147; Deeg MA, 2001, J LIPID RES, V42, P442; Deeg MA, 1997, ENDOCRINOLOGY, V138, P819, DOI 10.1210/en.138.2.819; DEEG MA, 1994, BRAZ J MED BIOL RES, V27, P375; Deeg MA, 2007, TRANSL RES, V150, P153, DOI 10.1016/j.trsl.2007.03.008; Ferguson MAJ, 1999, J CELL SCI, V112, P2799; Frick W, 1998, BIOCHEMISTRY-US, V37, P13421, DOI 10.1021/bi9806201; Gray DL, 2008, METABOLISM, V57, P473, DOI 10.1016/j.metabol.2007.11.007; Hecht ML, 2010, ACS CHEM BIOL, V5, P1075, DOI 10.1021/cb1002152; Jaworek CH, 1999, TETRAHEDRON LETT, V40, P667, DOI 10.1016/S0040-4039(98)02530-1; Jones DR, 1997, BIOCHEM BIOPH RES CO, V233, P432, DOI 10.1006/bbrc.1997.6475; Jones DR, 1998, INT J BIOCHEM CELL B, V30, P313, DOI 10.1016/S1357-2725(97)00144-1; Jones DR, 1999, MOL MED, V5, P505, DOI 10.1007/BF03401978; Kessler A, 1998, BIOCHEM J, V330, P277, DOI 10.1042/bj3300277; Kunjara S, 1999, MOL GENET METAB, V68, P488, DOI 10.1006/mgme.1999.2936; Kurtz TA, 2004, METABOLISM, V53, P138, DOI 10.1016/j.metabol.2003.09.004; LARNER J, 1979, SCIENCE, V206, P1408, DOI 10.1126/science.228395; Larner J, 2003, J MED CHEM, V46, P3283, DOI 10.1021/jm030071j; Larner J, 1999, DIABETES REV, V7, P217; MERIDA I, 1990, P NATL ACAD SCI USA, V87, P9421, DOI 10.1073/pnas.87.23.9421; METZ CN, 1991, J BIOL CHEM, V266, P17733; MISEK DE, 1992, J BIOL CHEM, V267, P16266; Muller G, 1997, ENDOCRINOLOGY, V138, P3459, DOI 10.1210/en.138.8.3459; Muller G, 2005, BIOCHEM PHARMACOL, V69, P761, DOI 10.1016/j.bcp.2004.11.014; Muller G, 2002, ARCH BIOCHEM BIOPHYS, V408, P7, DOI 10.1016/S0003-9861(02)00450-2; Muller G, 1999, CELL MOL LIFE SCI, V56, P945, DOI 10.1007/s000180050485; Paneda C, 2001, MOL MED, V7, P454, DOI 10.1007/BF03401850; Raikwar NS, 2006, AM J PHYSIOL-ENDOC M, V290, P463, DOI 10.1152/ajpendo.00593.2004; Rhode H, 1999, CLIN CHIM ACTA, V281, P127, DOI 10.1016/S0009-8981(98)00218-6; ROBERTS WL, 1988, J BIOL CHEM, V263, P18766; RuizAlbusac JM, 1997, J NEUROCHEM, V68, P10; SALTIEL AR, 1986, SCIENCE, V233, P967, DOI 10.1126/science.3016898; Schofield JN, 2002, MOL GENET METAB, V75, P154, DOI 10.1006/mgme.2001.3287; Schofield JN, 2000, BBA-GENE STRUCT EXPR, V1494, P189, DOI 10.1016/S0167-4781(00)00194-9; Shashkin PN, 1997, DIABETOLOGIA, V40, P557, DOI 10.1007/s001250050715; Shashkin PN, 2001, DIABETES-METAB RES, V17, P273, DOI 10.1002/dmrr.218; Sleight S, 2002, G Q 11 IS INVOLVED I; SUZUKI S, 1991, J BIOL CHEM, V266, P8115; SUZUKI S, 1993, DIABETES, V42, P988, DOI 10.2337/diabetes.42.7.988; SUZUKI S, 1992, DIABETES, V41, P1373, DOI 10.2337/diabetes.41.11.1373; Turner DI, 2005, BIOORG MED CHEM LETT, V15, P2023, DOI 10.1016/j.bmcl.2005.02.061; Yamada T, 2008, PHARMACOL THERAPEUT, V117, P188, DOI 10.1016/j.pharmthera.2007.09.006	51	7	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e100466	10.1371/journal.pone.0100466	http://dx.doi.org/10.1371/journal.pone.0100466			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971987	gold, Green Published, Green Submitted			2022-12-27	WOS:000338512200036
J	Warhurst, S; McCabe, P; Heard, R; Yiu, E; Wang, GW; Madill, C				Warhurst, Samantha; McCabe, Patricia; Heard, Rob; Yiu, Edwin; Wang, Gaowu; Madill, Catherine			Quantitative Measurement of Vocal Fold Vibration in Male Radio Performers and Healthy Controls Using High-Speed Videoendoscopy	PLOS ONE			English	Article							GLOTTAL AIR-FLOW; TERM AVERAGE SPECTRUM; OPEN QUOTIENT; SUBGLOTTAL PRESSURE; VOICE; LARYNGEAL; SPEAKERS; WAVE; SINGERS; FORM	Purpose: Acoustic and perceptual studies show a number of differences between the voices of radio performers and controls. Despite this, the vocal fold kinematics underlying these differences are largely unknown. Using high-speed videoendoscopy, this study sought to determine whether the vocal vibration features of radio performers differed from those of non-performing controls. Method: Using high-speed videoendoscopy, recordings of a mid-phonatory/i/in 16 male radio performers (aged 25-52 years) and 16 age-matched controls (aged 25-52 years) were collected. Videos were extracted and analysed semiautomatically using High-Speed Video Program, obtaining measures of fundamental frequency (f0), open quotient and speed quotient. Post-hoc analyses of sound pressure level (SPL) were also performed (n = 19). Pearson's correlations were calculated between SPL and both speed and open quotients. Results: Male radio performers had a significantly higher speed quotient than their matched controls (t = 3.308, p = 0.005). No significant differences were found for f0 or open quotient. No significant correlation was found between either open or speed quotient with SPL. Discussion: A higher speed quotient in male radio performers suggests that their vocal fold vibration was characterised by a higher ratio of glottal opening to closing times than controls. This result may explain findings of better voice quality, higher equivalent sound level and greater spectral tilt seen in previous research. Open quotient was not significantly different between groups, indicating that the durations of complete vocal fold closure were not different between the radio performers and controls. Further validation of these results is required to determine the aetiology of the higher speed quotient result and its implications for voice training and clinical management in performers.	[Warhurst, Samantha; McCabe, Patricia; Heard, Rob; Madill, Catherine] Univ Sydney, Fac Hlth Sci, Lidcombe, NSW, Australia; [Yiu, Edwin; Wang, Gaowu] Univ Hong Kong, Div Speech & Hearing Sci, Hong Kong, Hong Kong, Peoples R China	University of Sydney; University of Hong Kong	Warhurst, S (corresponding author), Univ Sydney, Fac Hlth Sci, Lidcombe, NSW, Australia.	swar0066@uni.sydney.edu.au	Madill, Cate/J-6156-2017; Yiu, Edwin Man Lai/A-3201-2010; McCabe, Patricia/E-9435-2010	Madill, Cate/0000-0001-8114-1427; McCabe, Patricia/0000-0002-5182-1007	Australian Postgraduate Award; Speech Pathology Australia Postgraduate Research Grant; Deirdre Russell Memorial Scholarship	Australian Postgraduate Award(Australian Government); Speech Pathology Australia Postgraduate Research Grant; Deirdre Russell Memorial Scholarship	The first author was supported by an Australian Postgraduate Award, a Speech Pathology Australia Postgraduate Research Grant and the Deirdre Russell Memorial Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKEN RJ, 1992, J VOICE, V6, P98, DOI 10.1016/S0892-1997(05)80123-7; Baken RJ, 2000, CLIN MEASUREMENT SPE; Barrichelo VMO, 2001, J VOICE, V15, P344, DOI 10.1016/S0892-1997(01)00036-4; Bele IV, 2007, J VOICE, V21, P257, DOI 10.1016/J.JVOICE.2005.12.001; Bele IV, 2006, J VOICE, V20, P555, DOI 10.1016/j.jvoice.2005.07.001; Bonilha HS, 2008, AM J SPEECH-LANG PAT, V17, P367, DOI 10.1044/1058-0360(2008/07-0059); Bonilha HS, 2009, LOGOP PHONIATR VOCO, V34, P128, DOI 10.1080/14015430903150210; Deliyski DD, 2008, FOLIA PHONIATR LOGO, V60, P33, DOI 10.1159/000111802; DROMEY C, 1992, J VOICE, V6, P44, DOI 10.1016/S0892-1997(05)80008-6; Echternach M, 2013, J ACOUST SOC AM, V133, pEL82, DOI 10.1121/1.4773200; Echternach M, 2010, J VOICE, V24, P644, DOI 10.1016/j.jvoice.2009.05.003; GAUFFIN J, 1989, J SPEECH HEAR RES, V32, P556, DOI 10.1044/jshr.3203.556; HANSON DG, 1990, J SPEECH HEAR RES, V33, P45, DOI 10.1044/jshr.3301.45; Henrich N, 2004, J ACOUST SOC AM, V115, P1321, DOI 10.1121/1.1646401; Hitech, 2008, SOUNDSW; HOLMBERG EB, 1988, J ACOUST SOC AM, V84, P511, DOI 10.1121/1.396829; Inwald EC, 2011, J VOICE, V25, P576, DOI 10.1016/j.jvoice.2010.04.004; Jiang J, 2000, OTOLARYNG CLIN N AM, V33, P699, DOI 10.1016/S0030-6665(05)70238-3; Kong JP, 2011, HDB VOICE ASSESSMENT; Kunduk M, 2010, LARYNGOSCOPE, V120, P981, DOI 10.1002/lary.20832; Leino T, 2009, J VOICE, V23, P671, DOI 10.1016/j.jvoice.2008.03.008; Lohscheller J, 2007, MED IMAGE ANAL, V11, P400, DOI 10.1016/j.media.2007.04.005; Lohscheller J, 2013, LOGOP PHONIATR VOCO, V38, P182, DOI 10.3109/14015439.2012.731083; Marquardt TP, 2011, COMMUNICATION SCI DI; Master S, 2008, J VOICE, V22, P146, DOI 10.1016/j.jvoice.2006.09.006; Master S, 2013, J VOICE, V27, P187, DOI 10.1016/j.jvoice.2012.10.010; Mecke AC, 2012, J ACOUST SOC AM, V131, P435, DOI 10.1121/1.3662061; Medrado R, 2005, J VOICE, V19, P340, DOI 10.1016/j.jvoice.2004.04.008; Mehta DD, 2011, J ACOUST SOC AM, V130, P3999, DOI 10.1121/1.3658441; Mehta DD, 2010, ANN OTO RHINOL LARYN, V119, P1; Murdoch BE, 1997, CLIN LINGUIST PHONET, V11, P245, DOI 10.3109/02699209708985194; Neil E., 2003, ADV SPEECH LANG PATH, V5, P1, DOI [DOI 10.1080/14417040510001669001, 10.1080/14417040510001669001]; Noh H, 2012, CLIN EXP OTORHINOLAR, V5, P68, DOI 10.3342/ceo.2012.5.2.68; Noordzij JP, 2000, ANN OTO RHINOL LARYN, V109, P441, DOI 10.1177/000348940010900501; Orlikoff RF, 2012, J VOICE, V26, DOI 10.1016/j.jvoice.2012.04.009; Qiu QJ, 2003, FOLIA PHONIATR LOGO, V55, P128, DOI 10.1159/000070724; Sapienza CM, 1998, J VOICE, V12, P31, DOI 10.1016/S0892-1997(98)80073-8; SLAVIT DH, 1990, OTOLARYNG HEAD NECK, V103, P947, DOI 10.1177/019459989010300611; SUNDBERG J, 1974, J ACOUST SOC AM, V55, P838, DOI 10.1121/1.1914609; SUNDBERG J, 1995, FOLIA PHONIATR LOGO, V47, P218, DOI 10.1159/000266353; Sundberg J, 1999, J ACOUST SOC AM, V105, P1965, DOI 10.1121/1.426731; Sundberg J, 2004, J VOICE, V18, P56, DOI 10.1016/j.jvoice.2003.05.006; Sundberg J, 1999, J VOICE, V13, P168, DOI 10.1016/S0892-1997(99)80021-6; SUNDBERG J, 1993, J VOICE, V7, P15, DOI 10.1016/S0892-1997(05)80108-0; Sundberg J., 1987, SCI SINGING VOICE; Svec JG, 1996, J VOICE, V10, P201, DOI 10.1016/S0892-1997(96)80047-6; TIMCKE R, 1959, ARCHIV OTOLARYNGOL, V69, P438; Titze I. R., 2000, PRINCIPLES VOICE PRO; Warhurst S, 2013, VOIC FDN 42 ANN S PH; Warhurst S, 2013, J VOICE, V27, P217, DOI 10.1016/j.jvoice.2012.08.010; Yamauchi A, 2013, J VOICE, V27, P39, DOI 10.1016/j.jvoice.2012.08.002; Yamauchi A, 2012, J VOICE, V26, P742, DOI 10.1016/j.jvoice.2011.12.010; Yan YL, 2005, J VOICE, V19, P161, DOI 10.1016/j.jvoice.2004.04.006; Yiu EML, 2013, J VOICE, V27, P753, DOI 10.1016/j.jvoice.2013.06.010; Yiu EML, 2010, INT J SPEECH-LANG PA, V12, P520, DOI 10.3109/17549501003759221; Zhang Y, 2010, J VOICE, V24, P21, DOI 10.1016/j.jvoice.2008.03.003	56	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2014	9	6							e101128	10.1371/journal.pone.0101128	http://dx.doi.org/10.1371/journal.pone.0101128			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6BK	24971625	Green Submitted, Green Published, gold			2022-12-27	WOS:000338512200096
J	Lynam-Lennon, N; Maher, SG; Maguire, A; Phelan, J; Muldoon, C; Reynolds, JV; O'Sullivan, J				Lynam-Lennon, Niamh; Maher, Stephen G.; Maguire, Aoife; Phelan, James; Muldoon, Cian; Reynolds, John V.; O'Sullivan, Jacintha			Altered Mitochondrial Function and Energy Metabolism Is Associated with a Radioresistant Phenotype in Oesophageal Adenocarcinoma	PLOS ONE			English	Article							HUMAN-TUMOR XENOGRAFTS; COLON-CANCER-CELLS; NEOADJUVANT CHEMORADIOTHERAPY; OXIDATIVE STRESS; PREOPERATIVE CHEMORADIOTHERAPY; GENOMIC INSTABILITY; IONIZING-RADIATION; DNA-REPAIR; EXPRESSION; EXPOSURE	Neoadjuvant chemoradiation therapy (CRT) is increasingly the standard of care for locally advanced oesophageal cancer. A complete pathological response to CRT is associated with a favourable outcome. Radiation therapy is important for local tumour control, however, radioresistance remains a substantial clinical problem. We hypothesise that alterations in mitochondrial function and energy metabolism are involved in the radioresistance of oesophageal adenocarcinoma (OAC). To investigate this, we used an established isogenic cell line model of radioresistant OAC. Radioresistant cells (OE33 R) demonstrated significantly increased levels of random mitochondrial mutations, which were coupled with alterations in mitochondrial function, size, morphology and gene expression, supporting a role for mitochondrial dysfunction in the radioresistance of this model. OE33 R cells also demonstrated altered bioenergetics, demonstrating significantly increased intracellular ATP levels, which was attributed to enhanced mitochondrial respiration. Radioresistant cells also demonstrated metabolic plasticity, efficiently switching between the glycolysis and oxidative phosphorylation energy metabolism pathways, which were accompanied by enhanced clonogenic survival. This data was supported in vivo, in pre-treatment OAC tumour tissue. Tumour ATP5B expression, a marker of oxidative phosphorylation, was significantly increased in patients who subsequently had a poor pathological response to neoadjuvant CRT. This suggests for the first time, a role for specific mitochondrial alterations and metabolic remodelling in the radioresistance of OAC.	[Lynam-Lennon, Niamh; Maher, Stephen G.; Phelan, James; Reynolds, John V.; O'Sullivan, Jacintha] Univ Dublin Trinity Coll, Dept Surg, Dublin 2, Ireland; [Maher, Stephen G.] Univ Hull, Sch Biol Biomed & Environm Sci, Canc Biol & Therapeut Lab, Kingston Upon Hull HU6 7RX, N Humberside, England; [Maguire, Aoife; Muldoon, Cian] St James Hosp, Dept Pathol, Dublin 8, Ireland	Trinity College Dublin; University of Hull; Trinity College Dublin	O'Sullivan, J (corresponding author), Univ Dublin Trinity Coll, Dept Surg, Dublin 2, Ireland.	osullij4@tcd.ie	Maher, Stephen/HHM-9099-2022	Reynolds, John V/0000-0002-5501-9521; Lynam-Lennon, Niamh/0000-0001-8659-4943; Phelan, James J./0000-0001-9431-2002; Maher, Stephen/0000-0003-0126-7906; O'Sullivan, Jacintha/0000-0001-8622-9858; Maguire, Aoife/0000-0002-9120-6383	Health Research Board [HRA_POR/2011/63]	Health Research Board	This work was supported by the Health Research Board (http://www.hrb.ie), HRA_POR/2011/63 to S. G. M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold RS, 2009, PROSTATE, V69, P1, DOI 10.1002/pros.20854; Bellance N, 2009, INT J BIOCHEM CELL B, V41, P2566, DOI 10.1016/j.biocel.2009.08.012; Devesa SS, 1998, CANCER, V83, P2049, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.0.CO;2-2; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; GAUTHIER T, 1990, INT J BIOCHEM, V22, P411, DOI 10.1016/0020-711X(90)90145-S; Geh JI, 2001, BRIT J SURG, V88, P338, DOI 10.1046/j.1365-2168.2001.01670.x; Goetze K, 2013, STRAHLENTHER ONKOL, V189, P782, DOI 10.1007/s00066-013-0371-9; Gorman S, 2010, J MOL MED, V88, P701, DOI 10.1007/s00109-010-0616-3; Grishko VI, 2005, J BIOL CHEM, V280, P8901, DOI 10.1074/jbc.M413022200; Gupta A, 1999, CARCINOGENESIS, V20, P2063, DOI 10.1093/carcin/20.11.2063; Herst PM, 2007, BBA-BIOENERGETICS, V1767, P170, DOI 10.1016/j.bbabio.2006.11.018; Hunt CR, 1998, CANCER RES, V58, P3986; Ilson D H, 1997, Surg Oncol Clin N Am, V6, P723; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Ito A, 2006, RADIAT RES, V165, P703, DOI 10.1667/RR3557.1; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; KALLINOWSKI F, 1989, INT J CANCER, V44, P266, DOI 10.1002/ijc.2910440214; Kim GJ, 2006, CANCER RES, V66, P10377, DOI 10.1158/0008-5472.CAN-05-3036; Limoli CL, 2003, CANCER RES, V63, P3107; Loeb LA, 2008, CANCER RES, V68, P3551, DOI 10.1158/0008-5472.CAN-07-5835; Luu TD, 2008, ANN THORAC SURG, V85, P1217, DOI 10.1016/j.athoracsur.2007.11.070; Lynam-Lennon N, 2012, J MOL MED, V90, P1449, DOI 10.1007/s00109-012-0924-x; Lynam-Lennon N, 2010, RADIAT RES, V174, P703, DOI 10.1667/RR2295.1; Mader S. S., 2004, BIOLOGY; Maher SG, 2009, ANN SURG, V250, P729, DOI 10.1097/SLA.0b013e3181bce7e1; Malakhova L, 2005, CELL MOL BIOL LETT, V10, P721; MANDARD AM, 1994, CANCER, V73, P2680, DOI 10.1002/1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO;2-C; Mason PA, 2003, NUCLEIC ACIDS RES, V31, P1052, DOI 10.1093/nar/gkg167; Murphy TJ, 2008, EXPERT OPIN PHARMACO, V9, P3197, DOI 10.1517/14656560802560237 ; Nugent SME, 2007, RADIAT RES, V168, P134, DOI 10.1667/RR0769.1; Pera M, 2005, J SURG ONCOL, V92, P151, DOI 10.1002/jso.20357; Petkau A, 1987, BR J CANC S, V8, P87; Reynolds JV, 2007, ANN SURG, V245, P707, DOI 10.1097/01.sla.0000254367.15810.38; Rohrdanz E, 1998, FREE RADICAL BIO MED, V24, P27, DOI 10.1016/S0891-5849(97)00159-7; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; Swennen ELR, 2008, BIOCHEM BIOPH RES CO, V367, P383, DOI 10.1016/j.bbrc.2007.12.125; van Hagen P, 2012, NEW ENGL J MED, V366, P2074, DOI 10.1056/NEJMoa1112088; Vlashi E, 2011, P NATL ACAD SCI USA, V108, P16062, DOI 10.1073/pnas.1106704108; Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365; Walsh TN, 1996, NEW ENGL J MED, V335, P462, DOI 10.1056/NEJM199608153350702; WARBURG O, 1956, Oncologia, V9, P75; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Wilson GD, 2004, CANCER METAST REV, V23, P209, DOI 10.1023/B:CANC.0000031762.91306.b4; Yamamori T, 2012, FREE RADICAL BIO MED, V53, P260, DOI 10.1016/j.freeradbiomed.2012.04.033; Yin E, 2003, INT J RADIAT BIOL, V79, P759, DOI 10.1080/09553000310001610961; Zastawny TH, 1998, FREE RADICAL BIO MED, V24, P722, DOI 10.1016/S0891-5849(97)00331-6; Zhou YF, 2012, CANCER RES, V72, P304, DOI 10.1158/0008-5472.CAN-11-1674	47	56	57	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2014	9	6							e100738	10.1371/journal.pone.0100738	http://dx.doi.org/10.1371/journal.pone.0100738			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2WP	24968221	Green Published, gold, Green Submitted			2022-12-27	WOS:000338280800061
J	Aggarwal, R; Subramanyam, S; Zhao, CY; Chen, MS; Harris, MO; Stuart, JJ				Aggarwal, Rajat; Subramanyam, Subhashree; Zhao, Chaoyang; Chen, Ming-Shun; Harris, Marion O.; Stuart, Jeff J.			Avirulence Effector Discovery in a Plant Galling and Plant Parasitic Arthropod, the Hessian Fly (Mayetiola destructor)	PLOS ONE			English	Article							RESISTANCE GENE H13; NEMATODE RESISTANCE; DISEASE RESISTANCE; ADAPTIVE RADIATION; SALIVARY-GLANDS; PROTEINS; APHID; DEFENSE; TOMATO; MIDGES	Highly specialized obligate plant-parasites exist within several groups of arthropods (insects and mites). Many of these are important pests, but the molecular basis of their parasitism and its evolution are poorly understood. One hypothesis is that plant parasitic arthropods use effector proteins to defeat basal plant immunity and modulate plant growth. Because avirulence (Avr) gene discovery is a reliable method of effector identification, we tested this hypothesis using high-resolution molecular genetic mapping of an Avr gene (vH13) in the Hessian fly (HF, Mayetiola destructor), an important gall midge pest of wheat (Triticum spp.). Chromosome walking resolved the position of vH13, and revealed alleles that determine whether HF larvae are virulent (survive) or avirulent (die) on wheat seedlings carrying the wheat H13 resistance gene. Association mapping found three independent insertions in vH13 that appear to be responsible for H13-virulence in field populations. We observed vH13 transcription in H13-avirulent larvae and the salivary glands of H13-avirulent larvae, but not in H13-virulent larvae. RNA-interference-knockdown of vH13 transcripts allowed some H13-avirulent larvae to escape H13-directed resistance. vH13 is the first Avr gene identified in an arthropod. It encodes a small modular protein with no sequence similarities to other proteins in GenBank. These data clearly support the hypothesis that an effector-based strategy has evolved in multiple lineages of plant parasites, including arthropods.	[Aggarwal, Rajat; Zhao, Chaoyang; Stuart, Jeff J.] Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA; [Subramanyam, Subhashree] Purdue Univ, Dept Agron, W Lafayette, IN 47907 USA; [Chen, Ming-Shun] Kansas State Univ, USDA ARS, Manhattan, KS 66506 USA; [Chen, Ming-Shun] Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA; [Harris, Marion O.] N Dakota State Univ, Dept Entomol, Fargo, ND 58105 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Kansas State University; United States Department of Agriculture (USDA); Kansas State University; North Dakota State University Fargo	Stuart, JJ (corresponding author), Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA.	stuartjj@purdue.edu		Zhao, Chaoyang/0000-0003-3378-3163; Harris, Marion/0000-0002-1123-8079	Agriculture and Food Research Initiative of USDA's National Institute of Food and Agriculture [09-35302-05262]	Agriculture and Food Research Initiative of USDA's National Institute of Food and Agriculture	This work was supported by grant No. 09-35302-05262 from the Agriculture and Food Research Initiative of USDA's National Institute of Food and Agriculture (to J.J.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-293; Allen RL, 2004, SCIENCE, V306, P1957, DOI 10.1126/science.1104022; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bansal R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023170; Behura SK, 2004, GENETICS, V167, P343, DOI 10.1534/genetics.167.1.343; Belkhadir Y, 2004, CURR OPIN PLANT BIOL, V7, P391, DOI 10.1016/j.pbi.2004.05.009; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bent AF, 2007, ANNU REV PHYTOPATHOL, V45, P399, DOI 10.1146/annurev.phyto.45.062806.094427; Biradar SK, 2004, THEOR APPL GENET, V109, P1468, DOI 10.1007/s00122-004-1763-0; Bos JIB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001216; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Chen MS, 2008, J INSECT PHYSIOL, V54, P1, DOI 10.1016/j.jinsphys.2007.07.007; Chen MS, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-296; Chen MS, 2004, INSECT MOL BIOL, V13, P101, DOI 10.1111/j.1365-2583.2004.00465.x; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Ellis JG, 2009, CURR OPIN PLANT BIOL, V12, P399, DOI 10.1016/j.pbi.2009.05.004; Gagne RJ, 1994, GALL MIDGES NEOTROPI; GILL BS, 1987, J HERED, V78, P97, DOI 10.1093/oxfordjournals.jhered.a110344; Giraldo MC, 2013, NAT REV MICROBIOL, V11, P800, DOI 10.1038/nrmicro3119; Gleason CA, 2008, MOL PLANT MICROBE IN, V21, P576, DOI 10.1094/MPMI-21-5-0576; Harris MO, 2010, PHYTOPATHOLOGY, V100, P279, DOI 10.1094/PHYTO-100-3-0279; Harris MO, 2006, ANN ENTOMOL SOC AM, V99, P305, DOI 10.1603/0013-8746(2006)099[0305:VHFDCL]2.0.CO;2; Harris MO, 2003, ANNU REV ENTOMOL, V48, P549, DOI 10.1146/annurev.ento.48.091801.112559; Hogenhout SA, 2011, CURR OPIN PLANT BIOL, V14, P422, DOI 10.1016/j.pbi.2011.05.003; Hogenhout SA, 2009, MOL PLANT MICROBE IN, V22, P115, DOI 10.1094/MPMI-22-2-0115; Howe GA, 2008, ANNU REV PLANT BIOL, V59, P41, DOI 10.1146/annurev.arplant.59.032607.092825; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Joy JB, 2007, EVOLUTION, V61, P784, DOI 10.1111/j.1558-5646.2007.00069.x; Kaloshian I, 2004, J CHEM ECOL, V30, P2419, DOI 10.1007/s10886-004-7943-1; Kamoun S, 2006, ANNU REV PHYTOPATHOL, V44, P41, DOI 10.1146/annurev.phyto.44.070505.143436; Klingler J, 2005, PLANT PHYSIOL, V137, P1445, DOI 10.1104/pp.104.051243; Liu XM, 2005, THEOR APPL GENET, V111, P1308, DOI 10.1007/s00122-005-0059-3; Liu XM, 2005, THEOR APPL GENET, V111, P243, DOI 10.1007/s00122-005-2009-5; Lobo NF, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-7; Mutti NS, 2008, P NATL ACAD SCI USA, V105, P9965, DOI 10.1073/pnas.0708958105; Nombela G, 2003, MOL PLANT MICROBE IN, V16, P645, DOI 10.1094/MPMI.2003.16.7.645; PATTERSON FL, 1994, CROP SCI, V34, P315, DOI 10.2135/cropsci1994.0011183X003400010084x; Pitino M, 2013, MOL PLANT MICROBE IN, V26, P130, DOI 10.1094/MPMI-07-12-0172-FI; Price PW, 2005, BASIC APPL ECOL, V6, P413, DOI 10.1016/j.baae.2005.07.002; Richards S, 2011, HESSIAN FLY BASE; Rider SD, 2002, GENOME, V45, P812, DOI [10.1139/G02-047, 10.1139/g02-047]; Rodriguez PA, 2013, MOL PLANT MICROBE IN, V26, P25, DOI 10.1094/MPMI-05-12-0119-FI; Rohfritsch O, 2008, ENTOMOL EXP APPL, V128, P208, DOI 10.1111/j.1570-7458.2008.00726.x; Roskam HC, 2005, BIOL ECOLOGY EVOLUTI, P307; Rossi M, 1998, P NATL ACAD SCI USA, V95, P9750, DOI 10.1073/pnas.95.17.9750; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Soderlund C, 1997, COMPUT APPL BIOSCI, V13, P523; Solovyev V, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s10; STASKAWICZ BJ, 1984, P NATL ACAD SCI-BIOL, V81, P6024, DOI 10.1073/pnas.81.19.6024; Stergiopoulos I, 2009, ANNU REV PHYTOPATHOL, V47, P233, DOI 10.1146/annurev.phyto.112408.132637; Stuart JJ, 2012, ANNU REV PHYTOPATHOL, V50, P339, DOI 10.1146/annurev-phyto-072910-095255; Stuart Jeffrey J., 2008, V1, P93, DOI 10.1007/978-3-540-73833-6_7; Subramanyam S, 2006, PLANT SCI, V170, P90, DOI 10.1016/j.plantsci.2005.08.006; Will T, 2007, P NATL ACAD SCI USA, V104, P10536, DOI 10.1073/pnas.0703535104; Williamson VM, 2006, TRENDS GENET, V22, P396, DOI 10.1016/j.tig.2006.05.003; Win J., 2012, COLD SPRING HARB SYM, V77, P235, DOI [10.1101/sqb.2012.77.015933, DOI 10.1101/SQB.2012.77.015933]; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	58	48	49	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100958	10.1371/journal.pone.0100958	http://dx.doi.org/10.1371/journal.pone.0100958			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964065	Green Published, Green Submitted, gold			2022-12-27	WOS:000338709500105
J	Anton, L; Brown, AG; Bartolomei, MS; Elovitz, MA				Anton, Lauren; Brown, Amy G.; Bartolomei, Marisa S.; Elovitz, Michal A.			Differential Methylation of Genes Associated with Cell Adhesion in Preeclamptic Placentas	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; GLOBAL DNA METHYLATION; EARLY-ONSET PREECLAMPSIA; ESTROGEN-RECEPTOR GENE; GROWTH-FACTOR-BETA; CPG ISLAND; EPIGENETIC ALTERATIONS; TROPHOBLAST INVASION; REGULATED EXPRESSION; PROMOTER METHYLATION	Preeclampsia (PE), a hypertensive disorder of pregnancy, is hypothesized to be associated with, if not mechanistically related to abnormal placental function. However, the exact mechanisms regulating the pathogenesis of PE remain unclear. While many studies have investigated changes in gene expression in the PE placenta, the role of epigenetics in PE associated placental dysfunction remains unclear. Using the genome-wide Illumina Infinium Methylation 450 BeadChip array, we analyzed gene-specific alterations in DNA methylation in placental biopsies collected from normal pregnant women delivering at term (n = 14), with term PE (>= 37 weeks; n = 19) or with preterm PE (<37 weeks, n = 12). Of the 485,582 gene loci on the array, compared to controls, 229 loci were differentially methylated in PE placentas and 3411 loci were differentially methylated in preterm PE (step up p-value <0.05 and >5% methylation difference). Functional annotation of the differentially methylated genes in preterm PE placentas revealed a 32 gene cluster in the cadherin and cell adhesion functional groups (Benjamini p < 0.00001). Hypermethylation of CDH11 (p = 0.0143), COL5A1 (p = 0.0127) and TNF (p = 0.0098) and hypomethylation of NCAM1 (p = 0.0158) was associated with altered mRNA expression in preterm PE placentas. Demethylation of first trimester extravillous trophoblast cells resulted in altered CDH11 (p = 0.0087), COL5A1 (p = 0.0043), NCAM1 (p = 0.0260) and TNF (p = 0.0022) mRNA expression. These studies demonstrate aberrant methylation, correlating with disease severity, in PE placentas. Furthermore, we provide evidence that disruption of gene-specific methylation in preterm PE placentas and first trimester trophoblasts is significantly associated with altered gene expression demonstrating that epigenetic modifications early in pregnancy can have effects on trophoblast function contributing to PE.	[Anton, Lauren; Brown, Amy G.; Elovitz, Michal A.] Univ Penn, Dept Obstet & Gynecol, Perelman Sch Med, Maternal & Child Hlth Res Program, Philadelphia, PA 19104 USA; [Bartolomei, Marisa S.] Univ Penn, Dept Cell & Dev Biol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Anton, L (corresponding author), Univ Penn, Dept Obstet & Gynecol, Perelman Sch Med, Maternal & Child Hlth Res Program, Philadelphia, PA 19104 USA.	lanton@mail.med.upenn.edu		Elovitz, Michal/0000-0001-7554-7180; Bartolomei, Marisa/0000-0001-9410-5222	Vision Grant from the Preeclampsia Foundation; Maternal and Child Health Research Fund at the University of Pennsylvania (MAE)	Vision Grant from the Preeclampsia Foundation; Maternal and Child Health Research Fund at the University of Pennsylvania (MAE)	This work was supported by a 2010 Vision Grant from the Preeclampsia Foundation (www.preeclampsia.org) (LA) and the Maternal and Child Health Research Fund at the University of Pennsylvania (MAE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, 913029 US DEP HLTH H; Anton L, 2013, AM J PATHOL, V183, P1437, DOI 10.1016/j.ajpath.2013.07.021; Anton L, 2012, HUM REPROD, V27, P61, DOI 10.1093/humrep/der362; Bauer S, 2004, J CLIN ENDOCR METAB, V89, P812, DOI 10.1210/jc.2003-031351; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Blair JD, 2013, MOL HUM REPROD, V19, P697, DOI 10.1093/molehr/gat044; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Chang Jeani, 2003, MMWR Surveill Summ, V52, P1; Chavan-Gautam P, 2011, MOL REPROD DEV, V78, P150, DOI 10.1002/mrd.21296; Chelbi ST, 2008, MOL CELL ENDOCRINOL, V282, P120, DOI 10.1016/j.mce.2007.11.022; Chelbi ST, 2007, HYPERTENSION, V49, P76, DOI 10.1161/01.HYP.0000250831.52876.cb; Chelbi ST, 2012, HUM MOL GENET, V21, P1968, DOI 10.1093/hmg/dds006; Clarke MA, 2012, CANC EPIDEMIOLOGY BI; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Enquobahrie DA, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.04.020; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; FALETTE NS, 1990, CANCER RES, V50, P3974; Founds SA, 2009, PLACENTA, V30, P15, DOI 10.1016/j.placenta.2008.09.015; Gao WL, 2011, HYPERTENS RES, V34, P655, DOI 10.1038/hr.2011.9; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Getsios S, 2003, DEV BIOL, V257, P41, DOI 10.1016/S0012-1606(03)00041-1; Getsios S, 1998, J REPROD FERTIL, V114, P357; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Gomez LM, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.10.872; Gonzalgo ML, 1998, CANCER RES, V58, P1245; GRAHAM CH, 1992, BIOL REPROD, V46, P561, DOI 10.1095/biolreprod46.4.561; Hamai Y, 1997, AM J REPROD IMMUNOL, V38, P89; Hiltunen M, 2002, VASC MED, V7, P5, DOI 10.1191/1358863x02vm418oa; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huber AV, 2006, PLACENTA, V27, P127, DOI 10.1016/j.placenta.2005.02.012; Issa JPJ, 1996, P NATL ACAD SCI USA, V93, P11757, DOI 10.1073/pnas.93.21.11757; Iwahashi M, 1997, MOL HUM REPROD, V3, P725, DOI 10.1093/molehr/3.8.725; Jia RZ, 2012, INT J MOL MED, V30, P133, DOI 10.3892/ijmm.2012.983; Jones PA, 1999, TRENDS GENET, V15, P34, DOI 10.1016/S0168-9525(98)01636-9; Koi H, 2002, BIOL REPROD, V67, P1572, DOI 10.1095/biolreprod.102.004325; Koonin L M, 1988, MMWR CDC Surveill Summ, V37, P19; Kulkarni A, 2011, DNA CELL BIOL, V30, P79, DOI 10.1089/dna.2010.1084; LARSEN F, 1993, HUM MOL GENET, V2, P775, DOI 10.1093/hmg/2.6.775; Levine M, 2010, CURR BIOL, V20, pR754, DOI 10.1016/j.cub.2010.06.070; Lim KH, 1997, AM J PATHOL, V151, P1809; Lockwood CJ, 2008, BIOL REPROD, V78, P1064, DOI 10.1095/biolreprod.107.063743; Louwen F, 2012, LESSON CANC RES PLAC; MacCalman CD, 1996, DEV DYNAM, V206, P201; MEEKINS JW, 1994, CLIN EXP IMMUNOL, V98, P110; Meissner A, 1999, MOL HUM REPROD, V5, P252, DOI 10.1093/molehr/5.3.252; Nelissen ECM, 2011, HUM REPROD UPDATE, V17, P397, DOI 10.1093/humupd/dmq052; Neudeck H, 1997, HISTOCHEM J, V29, P419, DOI 10.1023/A:1026499203743; Novakovic B, 2009, J BIOL CHEM; Novakovic B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-529; Ozkan S, 2008, J MATERN-FETAL NEO M, V21, P831, DOI 10.1080/14767050802251024; Petrykowska HM, 2008, GENOME RES, V18, P1238, DOI 10.1101/gr.073817.107; Pilsner JR, 2010, MOL ECOL, V19, P307, DOI 10.1111/j.1365-294X.2009.04452.x; Post WS, 1999, CARDIOVASC RES, V43, P985, DOI 10.1016/S0008-6363(99)00153-4; Proll J, 1996, Early Pregnancy, V2, P271; Renaud SJ, 2005, BIOL REPROD, V73, P237, DOI 10.1095/biolreprod.104.038000; Ruebner M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056145; Sharma P, 2008, DNA CELL BIOL, V27, P357, DOI 10.1089/dna.2007.0694; Sitras V, 2009, PLACENTA, V30, P424, DOI 10.1016/j.placenta.2009.01.012; Sriram K, 2007, J NEUROIMMUNE PHARM, V2, P140, DOI 10.1007/s11481-007-9070-6; TAKAGI H, 1995, EUR J BIOCHEM, V231, P282, DOI 10.1111/j.1432-1033.1995.tb20698.x; van Dijk M, 2010, EPIGENETICS-US, V5, P736, DOI 10.4161/epi.5.8.13084; Wang ZQ, 2010, GYNECOL ENDOCRINOL, V26, P96, DOI 10.3109/09513590903184100; Wutz A, 1997, NATURE, V389, P745, DOI 10.1038/39631; Xue WC, 2003, INT J GYNECOL CANCER, V13, P879, DOI 10.1136/ijgc-00009577-200311000-00022; Yuen RKC, 2010, EUR J HUM GENET, V18, P1006, DOI 10.1038/ejhg.2010.63; Zhou Y, 1997, J CLIN INVEST, V99, P2139, DOI 10.1172/JCI119387; ZHOU Y, 1993, J CLIN INVEST, V91, P950, DOI 10.1172/JCI116316; ZION M, 1994, P NATL ACAD SCI USA, V91, P10722, DOI 10.1073/pnas.91.22.10722	70	64	68	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100148	10.1371/journal.pone.0100148	http://dx.doi.org/10.1371/journal.pone.0100148			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963923	Green Published, gold, Green Submitted			2022-12-27	WOS:000338709500031
J	Avey, MT; Bloomfield, LL; Elie, JE; Freeberg, TM; Guillette, LM; Hoeschele, M; Lee, H; Moscicki, MK; Owens, JL; Sturdy, CB				Avey, Marc T.; Bloomfield, Laurie L.; Elie, Julie E.; Freeberg, Todd M.; Guillette, Lauren M.; Hoeschele, Marisa; Lee, Homan; Moscicki, Michele K.; Owens, Jessica L.; Sturdy, Christopher B.			ZENK Activation in the Nidopallium of Black-Capped Chickadees in Response to Both Conspecific and Heterospecific Calls	PLOS ONE			English	Article							A-DEE CALLS; FEMALE ZEBRA FINCH; POECILE-ATRICAPILLUS; GENE-EXPRESSION; AUDITORY FOREBRAIN; SONGBIRD FOREBRAIN; CAUDOMEDIAL NEOSTRIATUM; ALLOPATRIC CHICKADEES; PARID VOCALIZATIONS; CAROLINA CHICKADEES	Neuronal populations in the songbird nidopallium increase in activity the most to conspecific vocalizations relative to heterospecific songbird vocalizations or artificial stimuli such as tones. Here, we tested whether the difference in neural activity between conspecific and heterospecific vocalizations is due to acoustic differences or to the degree of phylogenetic relatedness of the species producing the vocalizations. To compare differences in neural responses of black-capped chickadees, Poecile atricapillus, to playback conditions we used a known marker for neural activity, ZENK, in the caudal medial nidopallium and caudomedial mesopallium. We used the acoustically complex 'dee' notes from chick-a-dee calls, and vocalizations from other heterospecific species similar in duration and spectral features. We tested the vocalizations from three heterospecific species (chestnut-backed chickadees, tufted titmice, and zebra finches), the vocalizations from conspecific individuals (black-capped chickadees), and reversed versions of the latter. There were no significant differences in the amount of expression between any of the groups except in the control condition, which resulted in significantly less neuronal activation. Our results suggest that, in certain cases, neuronal activity is not higher in response to conspecific than in response to heterospecific vocalizations for songbirds, but rather is sensitive to the acoustic features of the signal. Both acoustic features of the calls and the phylogenetic relationship between of the signaler and the receiver interact in the response of the nidopallium.	[Avey, Marc T.; Guillette, Lauren M.; Hoeschele, Marisa; Lee, Homan; Moscicki, Michele K.; Sturdy, Christopher B.] Univ Alberta, Dept Psychol, Edmonton, AB, Canada; [Bloomfield, Laurie L.] Algoma Univ, Dept Psychol, Sault Ste Marie, ON, Canada; [Elie, Julie E.] Univ Calif Berkeley, Dept Psychol, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Freeberg, Todd M.; Owens, Jessica L.] Univ Tennessee, Dept Psychol, Knoxville, TN 37996 USA; [Freeberg, Todd M.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN USA	University of Alberta; Algoma University; University of California System; University of California Berkeley; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville	Sturdy, CB (corresponding author), Univ Alberta, Dept Psychol, Edmonton, AB, Canada.	csturdy@ualberta.ca	Guillette, Lauren/K-8154-2013; Hoeschele, Marisa/R-2176-2019; Sturdy, Christopher B/A-4407-2009; Hoeschele, Marisa/R-6198-2018	Guillette, Lauren/0000-0002-8777-6543; Hoeschele, Marisa/0000-0002-2102-0882; Hoeschele, Marisa/0000-0002-2102-0882; Sturdy, Christopher/0000-0003-2721-3770; Elie, Julie/0000-0002-7993-0264; Avey, Marc/0000-0002-8696-3232; Freeberg, Todd/0000-0003-3807-4147	Natural Sciences and Engineering Research Council of Canada; Alberta Ingenuity Fund New Faculty Grant; Canada Foundation for Innovation New Opportunities Fund Award; Infrastructure Operating Grants (IOF); University of Alberta; Alberta Ingenuity Fund; Newton Fellowship from The Royal Society and British Academy; European Research Council [230604 "SOMACCA"]; Fondation Fyssen; University of Tennessee	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Ingenuity Fund New Faculty Grant; Canada Foundation for Innovation New Opportunities Fund Award; Infrastructure Operating Grants (IOF); University of Alberta(University of Alberta); Alberta Ingenuity Fund; Newton Fellowship from The Royal Society and British Academy; European Research Council(European Research Council (ERC)European Commission); Fondation Fyssen; University of Tennessee	C.B.S. was supported by a Natural Sciences and Engineering Research Council of Canada Discovery Grant and a Discovery Accelerator Supplement, an Alberta Ingenuity Fund New Faculty Grant, Canada Foundation for Innovation New Opportunities Fund Award and Infrastructure Operating Grants (IOF), as well as start-up and partner funding from the University of Alberta. M.T.A., M.H., M.K.M., and L.L.B. were supported by the Natural Sciences and Engineering Research Council of Canada and Alberta Ingenuity Fund. L.M.G. and M.H. were supported by Izaak Walton Killiam Memorial Scholarships. L.M.G. was supported by a Newton Fellowship from The Royal Society and British Academy. M.H. is currently funded by a European Research Council advanced grant [No. 230604 "SOMACCA"] awarded to W. Tecumseh Fitch at the University of Vienna. J.E.E. was supported by a post-doctoral study grant from the Fondation Fyssen. T.M.F. and J.L.O. acknowledge the funding from the University of Tennessee for portions of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avey MT, 2008, BEHAV BRAIN RES, V188, P201, DOI 10.1016/j.bbr.2007.10.034; Avey MT, 2008, BEHAV PROCESS, V77, P149, DOI 10.1016/j.beproc.2007.12.004; Avey MT, 2011, BEHAV PROCESS, V88, P177, DOI 10.1016/j.beproc.2011.09.005; Avey MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023844; Avey MT, 2005, BEHAV BRAIN RES, V165, P247, DOI 10.1016/j.bbr.2005.07.002; Bailey DJ, 2006, NEUROSCI LETT, V401, P86, DOI 10.1016/j.neulet.2006.02.076; Bailey DJ, 2005, BEHAV BRAIN RES, V162, P108, DOI 10.1016/j.bbr.2005.03.016; Bailey DJ, 2002, J NEUROBIOL, V52, P43, DOI 10.1002/neu.10070; Bailey DJ, 2003, MOL BRAIN RES, V116, P147, DOI 10.1016/S0169-328X(03)00288-2; Bentley GE, 2000, HORM BEHAV, V37, P179, DOI 10.1006/hbeh.2000.1573; Bloomfield LL, 2008, BEHAV PROCESS, V77, P87, DOI 10.1016/j.beproc.2007.06.008; Bloomfield LL, 2008, BEHAV PROCESS, V77, P166, DOI 10.1016/j.beproc.2007.08.003; Bloomfield LL, 2008, BEHAV PROCESS, V77, P73, DOI 10.1016/j.beproc.2007.06.011; BRENOWITZ EA, 1991, SCIENCE, V251, P303, DOI 10.1126/science.1987645; Charrier I, 2005, BEHAV PROCESS, V70, P271, DOI 10.1016/j.beproc.2005.07.007; Charrier I, 2004, CAN J ZOOL, V82, P769, DOI 10.1139/Z04-045; CHEW SJ, 1995, P NATL ACAD SCI USA, V92, P3406, DOI 10.1073/pnas.92.8.3406; Chew SJ, 1996, P NATL ACAD SCI USA, V93, P1950, DOI 10.1073/pnas.93.5.1950; Courter JR, 2010, BEHAV ECOL, V21, P936, DOI 10.1093/beheco/arq086; CYNX J, 1992, P NATL ACAD SCI USA, V89, P1372, DOI 10.1073/pnas.89.4.1372; De Groof G, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00196; Gee JM, 2009, BRAIN BEHAV EVOLUT, V74, P258, DOI 10.1159/000264661; Gentner TQ, 2001, J NEUROBIOL, V46, P48, DOI 10.1002/1097-4695(200101)46:1<48::AID-NEU5>3.0.CO;2-3; George I, 2004, BEHAV NEUROSCI, V118, P597, DOI 10.1037/0735-7044.118.3.597; Gill FB, 2005, AUK, V122, P121, DOI 10.1642/0004-8038(2005)122[0121:POTPIS]2.0.CO;2; Guillette LM, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00229; Hailman Jack P., 1996, P136; HAILMAN JP, 1989, WILSON BULL, V101, P305; Hernandez AM, 2004, J NEUROBIOL, V59, P247, DOI 10.1002/neu.10312; Hoeschele M, 2009, J ACOUST SOC AM, V126, P2088, DOI 10.1121/1.3203736; Huchzermeyer C, 2006, BEHAV BRAIN RES, V171, P154, DOI 10.1016/j.bbr.2006.03.034; Johnson FR, 2003, AUST J ZOOL, V51, P577, DOI 10.1071/ZO03031; Krams I, 2012, PHILOS T R SOC B, V367, P1879, DOI 10.1098/rstb.2011.0222; Long KD, 2002, J COMP PHYSIOL A, V188, P25, DOI 10.1007/s00359-001-0276-4; Lynch KS, 2008, BRAIN BEHAV EVOLUT, V72, P207, DOI 10.1159/000157357; MacDougall-Shackleton SA, 1998, NEUROREPORT, V9, P3047, DOI 10.1097/00001756-199809140-00024; Mahurin EJ, 2009, BEHAV ECOL, V20, P111, DOI 10.1093/beheco/arn121; McLean MJ, 2013, EVOL BIOL, V40, P141, DOI 10.1007/s11692-012-9197-0; Mello CV, 2002, J COMP PHYSIOL A, V188, P943, DOI 10.1007/s00359-002-0347-1; MELLO CV, 1994, J NEUROSCI, V14, P6652; Mello CV, 2004, ANN NY ACAD SCI, V1016, P263, DOI 10.1196/annals.1298.021; MELLO CV, 1995, J NEUROBIOL, V26, P145, DOI 10.1002/neu.480260112; MELLO CV, 1992, P NATL ACAD SCI USA, V89, P6818, DOI 10.1073/pnas.89.15.6818; Mooney R, 2001, P NATL ACAD SCI USA, V98, P12778, DOI 10.1073/pnas.221453298; Nolen MT, 2009, ANIM BEHAV, V77, P1137, DOI 10.1016/j.anbehav.2009.01.023; Ord TJ, 2002, BIOL J LINN SOC, V77, P127, DOI 10.1046/j.1095-8312.2002.00100.x; Ord TJ, 2001, P ROY SOC B-BIOL SCI, V268, P737, DOI 10.1098/rspb.2000.1417; Owens JL, 2007, J ACOUST SOC AM, V122, P1216, DOI 10.1121/1.2749459; Park KHJ, 2002, BEHAV BRAIN RES, V136, P185, DOI 10.1016/S0166-4328(02)00129-8; Phelps SM, 2000, P ROY SOC B-BIOL SCI, V267, P1633, DOI 10.1098/rspb.2000.1189; Phillmore LS, 2011, BEHAV BRAIN RES, V225, P464, DOI 10.1016/j.bbr.2011.08.004; Phillmore LS, 2003, BEHAV BRAIN RES, V147, P125, DOI 10.1016/S0166-4328(03)00155-4; Pinaud R, 2008, J BIOSCIENCES, V33, P145, DOI 10.1007/s12038-008-0030-y; Poirier C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020131; Poirier C, 2009, J NEUROSCI, V29, P2252, DOI 10.1523/JNEUROSCI.4650-08.2009; Ramsier MA, 2012, PHILOS T R SOC B, V367, P1860, DOI 10.1098/rstb.2011.0219; Robillard T, 2011, BEHAVIOUR, V148, P627, DOI 10.1163/000579511X572044; Rosen MJ, 2000, J NEUROSCI, V20, P5437, DOI 10.1523/JNEUROSCI.20-14-05437.2000; Ryan MJ, 1999, ANIM BEHAV, V57, P945, DOI 10.1006/anbe.1998.1057; Scharff C, 1998, J NEUROBIOL, V36, P81, DOI 10.1002/(SICI)1097-4695(199807)36:1<81::AID-NEU7>3.3.CO;2-8; Soard CM, 2009, ANIM BEHAV, V78, P1447, DOI 10.1016/j.anbehav.2009.09.026; Stripling R, 1997, J NEUROSCI, V17, P3883; Stripling R, 2001, J NEUROBIOL, V48, P163, DOI 10.1002/neu.1049; Templeton CN, 2005, SCIENCE, V308, P1934, DOI 10.1126/science.1108841; Terpstra NJ, 2005, J COMP NEUROL, V488, P342, DOI 10.1002/cne.20592; Theunissen FE, 2004, ANN NY ACAD SCI, V1016, P222, DOI 10.1196/annals.1298.023; Tobias ML, 2011, BEHAVIOUR, V148, P519, DOI 10.1163/000579511X569435; Tucker MA, 2012, P ROY SOC B-BIOL SCI, V279, P1583, DOI 10.1098/rspb.2011.1968; Velho TAF, 2005, EUR J NEUROSCI, V22, P1667, DOI 10.1111/j.1460-9568.2005.04369.x; WILLIAMS H, 1985, SCIENCE, V229, P279, DOI 10.1126/science.4012321; Wilson DR, 2011, BEHAV ECOL, V22, P784, DOI 10.1093/beheco/arr051; Yoder KM, 2012, NEUROREPORT, V23, P922, DOI 10.1097/WNR.0b013e3283588b61; Zann RA., 1996, ZEBRA FINCH SYNTHESI	73	18	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100927	10.1371/journal.pone.0100927	http://dx.doi.org/10.1371/journal.pone.0100927			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963707	gold, Green Published			2022-12-27	WOS:000338709500101
J	Ban, L; West, J; Gibson, JE; Fiaschi, L; Sokal, R; Doyle, P; Hubbard, R; Smeeth, L; Tata, LJ				Ban, Lu; West, Joe; Gibson, Jack E.; Fiaschi, Linda; Sokal, Rachel; Doyle, Pat; Hubbard, Richard; Smeeth, Liam; Tata, Laila J.			First Trimester Exposure to Anxiolytic and Hypnotic Drugs and the Risks of Major Congenital Anomalies: A United Kingdom Population-Based Cohort Study	PLOS ONE			English	Article							PRACTICE RESEARCH DATABASE; BENZODIAZEPINE-RECEPTOR AGONISTS; ORAL CLEFTS; PRENATAL EXPOSURE; MEDICAL-RECORDS; HEART-DEFECTS; PREGNANCY; MALFORMATIONS; DIAZEPAM; VALIDATION	Background: Despite their widespread use the effects of taking benzodiazepines and non-benzodiazepine hypnotics during pregnancy on the risk of major congenital anomaly (MCA) are uncertain. The objectives were to estimate absolute and relative risks of MCAs in children exposed to specific anxiolytic and hypnotic drugs taken in the first trimester of pregnancy, compared with children of mothers with depression and/or anxiety but not treated with medication and children of mothers without diagnosed mental illness during pregnancy. Methods: We identified singleton children born to women aged 15-45 years between 1990 and 2010 from a large United Kingdom primary care database. We calculated absolute risks of MCAs for children with first trimester exposures of different anxiolytic and hypnotic drugs and used logistic regression with a generalised estimating equation to compare risks adjusted for year of childbirth, maternal age, smoking, body mass index, and socioeconomic status. Results: Overall MCA prevalence was 2.7% in 1,159 children of mothers prescribed diazepam, 2.9% in 379 children with temazepam, 2.5% in 406 children with zopiclone, and 2.7% in 19,193 children whose mothers had diagnosed depression and/or anxiety but no first trimester drug exposures. When compared with 2.7% in 351,785 children with no diagnosed depression/anxiety nor medication use, the adjusted odds ratios were 1.02 (99% confidence interval 0.63-1.64) for diazepam, 1.07 (0.49-2.37) for temazepam, 0.96 (0.42-2.20) for zopiclone and 1.27 (0.43-3.75) for other anxiolytic/hypnotic drugs and 1.01 (0.90-1.14) for un-medicated depression/anxiety. Risks of system-specific MCAs were generally similar in children exposed and not exposed to such medications. Conclusions: We found no evidence for an increase in MCAs in children exposed to benzodiazepines and non-benzodiazepine hypnotics in the first trimester of pregnancy. These findings suggest that prescription of these drugs during early pregnancy may be safe in terms of MCA risk, but findings from other studies are required before safety can be confirmed.	[Ban, Lu; West, Joe; Gibson, Jack E.; Fiaschi, Linda; Sokal, Rachel; Hubbard, Richard; Tata, Laila J.] Univ Nottingham, City Hosp Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG7 2RD, England; [Doyle, Pat; Smeeth, Liam] London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1, England	Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Nottingham; University of London; London School of Hygiene & Tropical Medicine	Ban, L (corresponding author), Univ Nottingham, City Hosp Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG7 2RD, England.	lu.ban@nottingham.ac.uk; laila.tata@nottingham.ac.uk	West, Joe/M-3867-2019; Fiaschi, Linda/AAB-4905-2022; West, Joe/I-6637-2012; Gibson, Jack E/A-5746-2009; Smeeth, Liam/X-5862-2018; Tata, Laila/J-5227-2012	West, Joe/0000-0002-1135-9356; Fiaschi, Linda/0000-0002-3780-5895; West, Joe/0000-0002-1135-9356; Gibson, Jack E/0000-0003-1717-0252; Ban, Lu/0000-0001-9388-9141; Smeeth, Liam/0000-0002-9168-6022; Tata, Laila/0000-0002-6404-8658	Wellcome Trust; Medical Research Council [MR/K006584/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10090] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This study is funded by a grant from Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ban L, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X656801; Ban L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043462; Bellantuono C, 2013, GEN HOSP PSYCHIAT, V35, P3, DOI 10.1016/j.genhosppsych.2012.09.003; Boden R, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7085; Boden R, 2012, ARCH GEN PSYCHIAT, V69, P715, DOI 10.1001/archgenpsychiatry.2011.1870; Borthen I, 2012, CURR OPIN OBSTET GYN, V24, P78, DOI 10.1097/GCO.0b013e32834feb6a; Bukowski R, 2011, JAMA-J AM MED ASSOC, V306, P2459, DOI 10.1001/jama.2011.1823; Cates C, 1999, BRIT MED J, V319, P918; Charlton RA, 2008, DRUG SAFETY, V31, P39, DOI 10.2165/00002018-200831010-00004; Charlton RA, 2011, DRUG SAFETY, V34, P157, DOI 10.2165/11584970-000000000-00000; Charlton RA, 2010, DRUG SAFETY, V33, P741, DOI 10.2165/11536820-000000000-00000; Confidential Enquiry into Maternal and Child Health (CEMACH), PER MORT 2007 UK; CORREAVILLASENOR A, 1994, TERATOLOGY, V50, P137, DOI 10.1002/tera.1420500208; Czeizel A, 1987, Reprod Toxicol, V1, P183; Czeizel AE, 2004, NEUROTOXICOL TERATOL, V26, P593, DOI 10.1016/j.ntt.2004.03.009; Czeizel AE, 2003, CLIN DRUG INVEST, V23, P451, DOI 10.2165/00044011-200323070-00004; DAMATO RJ, 1994, P NATL ACAD SCI USA, V91, P4082, DOI 10.1073/pnas.91.9.4082; Devine S, 2008, PHARMACOEPIDEM DR S, V17, P434, DOI 10.1002/pds.1573; Dhalwani NN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072218; Dolk H, 2005, ARCH DIS CHILD-FETAL, V90, pF355, DOI 10.1136/adc.2004.062810; Enato E, 2011, J OBSTET GYNAECOL CA, V33, P46, DOI 10.1016/S1701-2163(16)34772-7; Joint Formulary Committee, 2012, BRIT NAT FORM BNF 63, V63; Jueckstock JK, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-46; Kjaer D, 2007, PHARMACOEPIDEM DR S, V16, P181, DOI 10.1002/pds.1288; Lewis JD, 2007, PHARMACOEPIDEM DR S, V16, P393, DOI 10.1002/pds.1335; MARCHETTI F, 1993, EUR J CLIN PHARMACOL, V45, P495, DOI 10.1007/BF00315304; Murray C. J. L., 2013, LANCET; National Institute for Health and Clinical Excellence, 2007, ANT POSTN MENT HLTH; Oberlander TF, 2008, BIRTH DEFECTS RES B, V83, P68, DOI 10.1002/bdrb.20144; Oyebode F, 2012, PHARMACOL THERAPEUT, V135, P71, DOI 10.1016/j.pharmthera.2012.03.008; Prajapati B, 2010, OPTOM TODAY; ROSENBERG L, 1983, NEW ENGL J MED, V309, P1282, DOI 10.1056/NEJM198311243092103; SAFRA MJ, 1975, LANCET, V2, P478; SAXEN I, 1975, INT J EPIDEMIOL, V4, P37, DOI 10.1093/ije/4.1.37; Say Lale, 2006, Reprod Health, V3, P1, DOI 10.1186/1742-4755-3-1; Sokal R, 2013, BIRTH DEFECTS RES A, V97, P546, DOI 10.1002/bdra.23150; StataCorp, GEN EST EQ XTG; Szatkowski L, 2012, J EPIDEMIOL COMMUN H, V66, P791, DOI 10.1136/jech.2010.120154; TIKKANEN J, 1992, TERATOLOGY, V46, P447, DOI 10.1002/tera.1420460509; Townsend PP., 1988, HLTH DEPRIVATION INE; Wikner BN, 2007, PHARMACOEPIDEM DR S, V16, P1203, DOI 10.1002/pds.1457; Wikner BN, 2011, J CLIN PSYCHOPHARM, V31, P356, DOI 10.1097/JCP.0b013e3182197055; World Health Organization(WHO), BMI CLASS; World Health Organization  (WHO), 2001, GEND DISP MENT HLTH; Wurst KE, 2007, PHARMACOEPIDEM DR S, V16, P867, DOI 10.1002/pds.1431; Wurst KE, 2007, BIRTH DEFECTS RES A, V79, P309, DOI 10.1002/bdra.20356	46	40	41	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100996	10.1371/journal.pone.0100996	http://dx.doi.org/10.1371/journal.pone.0100996			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963627	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000338709500108
J	Fremier, AK; Girvetz, EH; Greco, SE; Larsen, EW				Fremier, Alexander K.; Girvetz, Evan H.; Greco, Steven E.; Larsen, Eric W.			Quantifying Process-Based Mitigation Strategies in Historical Context: Separating Multiple Cumulative Effects on River Meander Migration	PLOS ONE			English	Article							SACRAMENTO RIVER; RIPARIAN FOREST; BANK EROSION; CALIFORNIA; USA; ECOSYSTEMS; IMPACTS; CONSERVATION; RESTORATION; COMMUNITIES	Environmental legislation in the US (i.e. NEPA) requires defining baseline conditions on current rather than historical ecosystem conditions. For ecosystems with long histories of multiple environmental impacts, this baseline method can subsequently lead to a significantly altered environment; this has been termed a 'sliding baseline'. In river systems, cumulative effects caused by flow regulation, channel revetment and riparian vegetation removal significantly impact floodplain ecosystems by altering channel dynamics and precluding subsequent ecosystem processes, such as primary succession. To quantify these impacts on floodplain development processes, we used a model of river channel meander migration to illustrate the degree to which flow regulation and riprap impact migration rates, independently and synergistically, on the Sacramento River in California, USA. From pre-dam conditions, the cumulative effect of flow regulation alone on channel migration is a reduction by 38%, and 42-44% with four proposed water diversion project scenarios. In terms of depositional area, the proposed water project would reduce channel migration 51-71 ha in 130 years without current riprap in place, and 17-25 ha with riprap. Our results illustrate the utility of a modeling approach for quantifying cumulative impacts. Model-based quantification of environmental impacts allow scientists to separate cumulative and synergistic effects to analytically define mitigation measures. Additionally, by selecting an ecosystem process that is affected by multiple impacts, it is possible to consider process-based mitigation scenarios, such as the removal of riprap, to allow meander migration and create new floodplains and allow for riparian vegetation recruitment.	[Fremier, Alexander K.] Washington State Univ, Sch Environm, Pullman, WA 99164 USA; [Girvetz, Evan H.] Ctr Int Agr Trop, Nairobi, Kenya; [Girvetz, Evan H.] Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA; [Greco, Steven E.; Larsen, Eric W.] Univ Calif Davis, Dept Human Ecol, Davis, CA 95616 USA	Washington State University; Alliance; International Center for Tropical Agriculture - CIAT; University of Washington; University of Washington Seattle; University of California System; University of California Davis	Fremier, AK (corresponding author), Washington State Univ, Sch Environm, Pullman, WA 99164 USA.	alex.fremier@wsu.edu	, Steve/AAT-4120-2020; Fremier, Alexander/AAC-7706-2019	Fremier, Alexander/0000-0002-4104-6633	California Department of Water Resources (CDWR); Northern District, Red Bluff, California; CDWR Planning and Local Assistance Office, Sacramento, California [4600001950, 4600000736]	California Department of Water Resources (CDWR); Northern District, Red Bluff, California; CDWR Planning and Local Assistance Office, Sacramento, California	The authors are grateful for funding for this research that was provided by the California Department of Water Resources (CDWR), Northern District, Red Bluff, California, and the CDWR Planning and Local Assistance Office, Sacramento, California, under Interagency Agreements #4600001950 and #4600000736. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER WL, 1995, ANN ASSOC AM GEOGR, V85, P320, DOI 10.1111/j.1467-8306.1995.tb01797.x; BEDFORD BL, 1988, ENVIRON MANAGE, V12, P751, DOI 10.1007/BF01867550; Brice J. C., 1977, LATERAL MIGRATION MI, P77; *CALFED, 2000, FIN PROGR ENV IMP ST; *CDWR, 2005, MEM REP BANK SURV RE; CDWR, 1995, 155 CDWR RES AG; CEQ (Council on Enviromental Quality), 1997, HDB NATL; CEQ (Council on Enviromental Quality), 2019, NEPA NAT ENV POL ACT; CHURCH M, 1995, REGUL RIVER, V11, P3, DOI 10.1002/rrr.3450110103; Constantine JA, 2008, GEOLOGY, V36, P23, DOI 10.1130/G24130A.1; Dayton PK, 1998, ECOL APPL, V8, P309, DOI 10.1890/1051-0761(1998)008[0309:SBGARE]2.0.CO;2; Duinker PN, 2007, ENVIRON IMPACT ASSES, V27, P206, DOI 10.1016/j.eiar.2006.11.001; Florsheim JL, 2008, BIOSCIENCE, V58, P519, DOI 10.1641/B580608; GOSSELINK JG, 1990, BIOSCIENCE, V40, P588, DOI 10.2307/1311299; Greco DE, 2003, LANDSCAPE RES, V28, P405; Greco SE, 2013, RIVER RES APPL, V29, P707, DOI 10.1002/rra.2568; Greco SE, 2007, LANDSCAPE URBAN PLAN, V81, P354, DOI 10.1016/j.landurbplan.2007.01.002; Hughes FMR, 2001, REGUL RIVER, V17, P325, DOI 10.1002/rrr.656; HUNSAKER CT, 1993, ENVIRONMENTAL ANALYSIS, P480; Johanesson H, 1989, RIVER MEANDERING; Katibah E.F., 1984, CALIFORNIA RIPARIAN, P23; Larsen EW, 2007, LANDSCAPE URBAN PLAN, V79, P338, DOI 10.1016/j.landurbplan.2006.04.003; Larsen EW, 2006, J AM WATER RESOUR AS, V42, P1077, DOI 10.1111/j.1752-1688.2006.tb04515.x; Larsen EW, 2006, J AM WATER RESOUR AS, V42, P1063, DOI 10.1111/j.1752-1688.2006.tb04514.x; Larsen EW, 2006, ENVIRON MANAGE, V37, P880, DOI 10.1007/s00267-004-0220-9; Larsen EW, 2002, ENVIRON MANAGE, V30, P209, DOI 10.1007/s00267-002-2663-1; MacDonald LH, 2000, ENVIRON MANAGE, V26, P299, DOI 10.1007/s002670010088; Mahoney JM, 1998, WETLANDS, V18, P634, DOI 10.1007/BF03161678; McCold LN, 1996, ENVIRON MANAGE, V20, P767, DOI 10.1007/BF01204147; Michalkova M, 2011, EARTH SURF PROC LAND, V36, P257, DOI 10.1002/esp.2106; Micheli ER, 2011, RIVER RES APPL, V27, P328, DOI 10.1002/rra.1360; Micheli ER, 2004, RIVER RES APPL, V20, P537, DOI 10.1002/rra.756; Nilsson C, 2002, ENVIRON MANAGE, V30, P468, DOI 10.1007/s00267-002-2735-2; Nilsson C, 2000, BIOSCIENCE, V50, P783, DOI 10.1641/0006-3568(2000)050[0783:AORECB]2.0.CO;2; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Perucca E, 2007, WATER RESOUR RES, V43, DOI 10.1029/2006WR005234; Pickett STA, 1997, WILDLIFE AND LANDSCAPE ECOLOGY, P101; Shields FD, 2000, ENVIRON CONSERV, V27, P54, DOI 10.1017/S0376892900000072; Shin N, 2005, PLANT ECOL, V178, P15, DOI 10.1007/s11258-004-2484-9; Stella J, 2011, ECOSYSTEMS, V14, P776, DOI 10.1007/s10021-011-9446-6; United States Army Corps of Engineers (USACE), 2002, SACR SAN JOAQ RIV BA	41	9	9	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e99736	10.1371/journal.pone.0099736	http://dx.doi.org/10.1371/journal.pone.0099736			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964145	Green Published, Green Submitted, gold			2022-12-27	WOS:000338709500016
J	Fu, SH; Sun, YQ; Luo, LM; Ye, P				Fu, Shihui; Sun, Yuqing; Luo, Leiming; Ye, Ping			Relationship of Arterial Compliance and Blood Pressure with Microalbuminuria and Mildly Decreased Glomerular Filtration Rate: A Chinese Community-Based Analysis	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; RENAL-FUNCTION; ENDOTHELIAL FUNCTION; AORTIC STIFFNESS; HYPERTENSION; INDEX	Objective: This analysis is designed to determine the prevalence of microalbuminuria (MAU) and mildly decreased glomerular filtration rate (GFR); to investigate the association of augmentation index (AIx), central blood pressure (cBP) and peripheral blood pressure (pBP) with MAU and mildly decreased GFR; and to compare the association strength of cBP and pBP with MAU and mildly decreased GFR. Methods: This community-based analysis included 2071 Chinese residents. Urine albumin-to-creatinine ratio (UACR), GFR, and pulse wave measurements were performed. UACR of 30-299 mg/g and GFR of 60-89 ml/min/1.73 m(2) were identified as MAU and mildly decreased GFR. Results: The prevalence of MAU and mildly decreased GFR was 21.3% and 33.2%. The AIx, cBP and pBP were significantly higher in participants with MAU compared with those without MAU, and in participants with mildly decreased GFR compared with those without mildly decreased GFR (all P<0.001). After participants were categorized into four subgroups based on the presence or absence of MAU and mildly decreased GFR, Aix, cBP and pBP progressively increased from the subgroup without both of MAU and mildly decreased GFR to the subgroups with either one of them, and arrived at top in the subgroup with both of them (all P<0.001). Compared with the reference category without MAU and mildly decreased GFR, the odd ratio values significantly increased from the category with either one of MAU and mildly decreased GFR to the category with both of them (all P<0.001). The AIx, cBP and pBP were all independently associated with MAU and mildly decreased GFR after full adjustment (all P<0.05), and the association strength of MAU and mildly decreased GFR with cBP was similar to those with pBP. Conclusions: In Chinese community-dwelling population, there was a high prevalence of MAU and mildly decreased GFR. The AIx, cBP and pBP were all independently associated with MAU and mildly decreased GFR; meanwhile, cBP did not exhibit stronger association with MAU and mildly decreased GFR compared with pBP.	[Fu, Shihui] Chinese Peoples Liberat Army Gen Hosp, Dept Cardiol, Beijing, Peoples R China; [Fu, Shihui] Chinese Peoples Liberat Army Gen Hosp, Hainan Branch, Beijing, Peoples R China; [Sun, Yuqing; Luo, Leiming; Ye, Ping] Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Cardiol, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	Luo, LM (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Cardiol, Beijing, Peoples R China.	lleim@sina.com	Luo, Leiming/AAD-5533-2019	Fu, Shihui/0000-0001-6707-9049	National Key Basic Research Project [2012CB517503, 2013CB530804]; Health Special Scientific Research Subject of Chinese People's Liberation Army [12BLZ34]; Clinical Scientific Research Project of Chinese People's Liberation Army General Hospital [2012FC-TSYS1021]	National Key Basic Research Project(National Basic Research Program of China); Health Special Scientific Research Subject of Chinese People's Liberation Army; Clinical Scientific Research Project of Chinese People's Liberation Army General Hospital	This study was supported by grants from the National Key Basic Research Project (2012CB517503 and 2013CB530804), the Health Special Scientific Research Subject of Chinese People's Liberation Army (12BLZ34), and the Clinical Scientific Research Project of Chinese People's Liberation Army General Hospital (2012FC-TSYS1021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN K, 1995, AM J HYPERTENS, V8, P409, DOI 10.1016/0895-7061(94)00248-A; Benetos A, 2002, CIRCULATION, V105, P1202, DOI 10.1161/hc1002.105135; Cherney DZI, 2010, DIABETES CARE, V33, P1344, DOI 10.2337/dc09-2340; Chue CD, 2011, NEPHROL DIAL TRANSPL, V26, P2576, DOI 10.1093/ndt/gfq787; Cottone S, 2009, NEPHROL DIAL TRANSPL, V24, P497, DOI 10.1093/ndt/gfn489; Eddington H, 2009, NEPHRON CLIN PRACT, V112, pC190, DOI 10.1159/000218108; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Hashimoto J, 2011, HYPERTENSION, V58, P839, DOI 10.1161/HYPERTENSIONAHA.111.177469; Hermans MMH, 2007, J AM SOC NEPHROL, V18, P1942, DOI 10.1681/ASN.2006111217; HOEGHOLM A, 1994, HYPERTENSION, V24, P101, DOI 10.1161/01.HYP.24.1.101; Kanaoka T, 2012, CLIN EXP HYPERTENS, V34, P264, DOI 10.3109/10641963.2012.681082; Khoshdel Ali Reza, 2008, Urol J, V5, P3; LONDON G, 1992, HYPERTENSION, V20, P10, DOI 10.1161/01.HYP.20.1.10; London GM, 1998, J HYPERTENS, V16, P1931, DOI 10.1097/00004872-199816121-00012; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Matsui Y, 2011, ATHEROSCLEROSIS, V219, P637, DOI 10.1016/j.atherosclerosis.2011.09.027; McEniery CM, 2006, HYPERTENSION, V48, P602, DOI 10.1161/01.HYP.0000239206.64270.5f; Mule G, 2010, INT J CARDIOL, V145, P372, DOI 10.1016/j.ijcard.2010.02.047; Neisius U, 2012, J HYPERTENS, V30, P67, DOI 10.1097/HJH.0b013e32834e12d8; Oliveras A, 2013, J HYPERTENS, V31, P103, DOI 10.1097/HJH.0b013e32835ac7b5; Olsen BS, 1999, DIABETIC MED, V16, P79, DOI 10.1046/j.1464-5491.1999.00024.x; Prince CT, 2010, DIABETES VASC DIS RE, V7, P216, DOI 10.1177/1479164110375297; Safar ME, 2004, HYPERTENSION, V43, P163, DOI 10.1161/01.HYP.0000114571.75762.b0; Safar ME, 2000, CARDIOVASC RES, V46, P269, DOI 10.1016/S0008-6363(99)00426-5; Tryfonopoulos D, 2005, J ENDOCRINOL INVEST, V28, P616, DOI 10.1007/BF03347260; Tsioufis C, 2003, NEPHRON CLIN PRACT, V93, pC106, DOI 10.1159/000069546; Upadhyay A, 2009, J AM SOC NEPHROL, V20, P2044, DOI 10.1681/ASN.2009010074; Wang KL, 2009, J HYPERTENS, V27, P461, DOI 10.1097/HJH.0b013e3283220ea4; Weir MR, 2011, CLIN J AM SOC NEPHRO, V6, P2403, DOI 10.2215/CJN.01670211	29	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e101013	10.1371/journal.pone.0101013	http://dx.doi.org/10.1371/journal.pone.0101013			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963717	Green Published, gold, Green Submitted			2022-12-27	WOS:000338709500110
J	Guzman-Moreno, J; Flores-Martinez, A; Brieba, LG; Herrera-Estrella, A				Guzman-Moreno, Jesus; Flores-Martinez, Alberto; Brieba, Luis G.; Herrera-Estrella, Alfredo			The Trichoderma reesei Cry1 Protein Is a Member of the Cryptochrome/Photolyase Family with 6-4 Photoproduct Repair Activity	PLOS ONE			English	Article							BLUE-LIGHT PHOTORECEPTORS; DNA-REPAIR; CRYSTAL-STRUCTURE; PHOTOLYASE/CRYPTOCHROME FAMILY; PHOTOLYASE; GENE; DASH; TRANSCRIPTION; ATROVIRIDE; HISTIDINES	DNA-photolyases use UV-visible light to repair DNA damage caused by UV radiation. The two major types of DNA damage are cyclobutane pyrimidine dimers (CPD) and 6-4 photoproducts (6-4PP), which are repaired under illumination by CPD and 6-4 photolyases, respectively. Cryptochromes are proteins related to DNA photolyases with strongly reduced or lost DNA repair activity, and have been shown to function as blue-light photoreceptors and to play important roles in circadian rhythms in plants and animals. Both photolyases and cryptochromes belong to the cryptochrome/photolyase family, and are widely distributed in all organisms. Here we describe the characterization of cry1, a member of the cryptochrome/photolyase protein family of the filamentous fungus Trichoderma reesei. We determined that cry1 transcript accumulates when the fungus is exposed to light, and that such accumulation depends on the photoreceptor Blr1 and is modulated by Envoy. Conidia of cry1 mutants show decreased photorepair capacity of DNA damage caused by UV light. In contrast, strains over-expressing Cry1 show increased repair, as compared to the parental strain even in the dark. These observations suggest that Cry1 may be stimulating other systems involved in DNA repair, such as the nucleotide excision repair system. We show that Cry1, heterologously expressed and purified from E. coli, is capable of binding to undamaged and 6-4PP damaged DNA. Photorepair assays in vitro clearly show that Cry1 repairs 6-4PP, but not CPD and Dewar DNA lesions.	[Guzman-Moreno, Jesus; Flores-Martinez, Alberto] Univ Guanajuato, Dept Biol, Div Ciencias Nat & Exactas, Guanajuato, Mexico; [Brieba, Luis G.; Herrera-Estrella, Alfredo] Cinvestav Irapuato, Lab Nacl Genom Biodiversidad, Guanajuato, Mexico	Universidad de Guanajuato; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Herrera-Estrella, A (corresponding author), Cinvestav Irapuato, Lab Nacl Genom Biodiversidad, Guanajuato, Mexico.	aherrera@langebio.cinvestav.mx	Brieba, Luis/I-8447-2016; Herrera-Estrella, Alfredo/F-3185-2011; Herrera-Estrella, Alfredo/J-8210-2019	Brieba, Luis/0000-0002-6073-5207; Herrera-Estrella, Alfredo/0000-0002-4589-6870; Herrera-Estrella, Alfredo/0000-0002-4589-6870; Guzman-Moreno, Jesus/0000-0003-0237-6493	Consejo Nacional de Ciencia y Tecnologia [83798, I0110/193/10 FON.INST.-30-10]	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Funder of this work, Consejo Nacional de Ciencia y Tecnologia (www.conacyt.mx) grant 83798 and I0110/193/10 FON.INST.-30-10 to AH-E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD M, 1993, NATURE, V366, P162, DOI 10.1038/366162a0; Baek JM, 1998, FUNGAL GENET BIOL, V23, P34, DOI 10.1006/fgbi.1997.1025; Bayram O, 2008, MOL BIOL CELL, V19, P3254, DOI 10.1091/mbc.E08-01-0061; Berrocal-Tito G, 1999, J BIOL CHEM, V274, P14288, DOI 10.1074/jbc.274.20.14288; Berrocal-Tito GM, 2007, EUKARYOT CELL, V6, P1682, DOI 10.1128/EC.00208-06; Bluhm BH, 2008, FUNGAL GENET BIOL, V45, P1364, DOI 10.1016/j.fgb.2008.07.005; Casas-Flores S, 2006, EUKARYOT CELL, V5, P499, DOI 10.1128/EC.5.3.499-506.2006; Casas-Flores S, 2004, MICROBIOL-SGM, V150, P3561, DOI 10.1099/mic.0.27346-0; Casas-Flores S, 2013, TRICHODERMA: BIOLOGY AND APPLICATIONS, P43, DOI 10.1079/9781780642475.0043; Castellanos F, 2010, FUNGAL GENET BIOL, V47, P468, DOI 10.1016/j.fgb.2010.02.001; Castrillo M, 2013, APPL ENVIRON MICROB, V79, P2777, DOI 10.1128/AEM.03110-12; Chaves I, 2011, ANNU REV PLANT BIOL, V62, P335, DOI 10.1146/annurev-arplant-042110-103759; Coesel S, 2009, EMBO REP, V10, P655, DOI 10.1038/embor.2009.59; Corrochano LM, 2007, PHOTOCH PHOTOBIO SCI, V6, P725, DOI 10.1039/b702155k; Daiyasu H, 2004, GENES CELLS, V9, P479, DOI 10.1111/j.1356-9597.2004.00738.x; Esquivel-Naranjo EU, 2007, MICROBIOL-SGM, V153, P3909, DOI 10.1099/mic.0.2007/007302-0; Froehlich AC, 2010, EUKARYOT CELL, V9, P738, DOI 10.1128/EC.00380-09; Geisselbrecht Y, 2012, EMBO REP, V13, P223, DOI 10.1038/embor.2012.2; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Heijde M, 2010, PLANT CELL ENVIRON, V33, P1614, DOI 10.1111/j.1365-3040.2010.02168.x; Heintzen C, 2001, CELL, V104, P453, DOI 10.1016/S0092-8674(01)00232-X; Herrera-Estrella A, 2007, MOL MICROBIOL, V64, P5, DOI 10.1111/j.1365-2958.2007.05632.x; Hitomi K, 2001, J BIOL CHEM, V276, P10103, DOI 10.1074/jbc.M008828200; Hitomi K, 1997, J BIOL CHEM, V272, P32591, DOI 10.1074/jbc.272.51.32591; Hitomi K, 2009, P NATL ACAD SCI USA, V106, P6962, DOI 10.1073/pnas.0809180106; JONES JDG, 1985, EMBO J, V4, P2411, DOI 10.1002/j.1460-2075.1985.tb03949.x; Kobayashi Y, 2000, GENES CELLS, V5, P725, DOI 10.1046/j.1365-2443.2000.00364.x; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Li QH, 2007, PHOTOCHEM PHOTOBIOL, V83, P94, DOI 10.1562/2006-02-28-IR-826; Lin CT, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-220; Maul MJ, 2008, ANGEW CHEM INT EDIT, V47, P10076, DOI 10.1002/anie.200804268; Nakajima S, 1998, NUCLEIC ACIDS RES, V26, P638, DOI 10.1093/nar/26.2.638; RAEDER U, 1985, LETT APPL MICROBIOL, V1, P17, DOI 10.1111/j.1472-765X.1985.tb01479.x; Rosales-Saavedra T, 2006, MICROBIOL-SGM, V152, P3305, DOI 10.1099/mic.0.29000-0; Rosato E, 2001, CURR BIOL, V11, P909, DOI 10.1016/S0960-9822(01)00259-7; Sambrook J., 2001, MOL CLONING LAB MANU; Sancar A, 2003, CHEM REV, V103, P2203, DOI 10.1021/cr0204348; Sancar A, 2008, J BIOL CHEM, V283, P32153, DOI 10.1074/jbc.R800052200; SANCAR GB, 1989, MOL CELL BIOL, V9, P4767, DOI 10.1128/MCB.9.11.4767; Schleicher E, 2007, J BIOL CHEM, V282, P4738, DOI 10.1074/jbc.M604734200; Schmoll M, 2005, EUKARYOT CELL, V4, P1998, DOI 10.1128/EC.4.12.1998-2007.2005; Schmoll M, 2010, FUNGAL GENET BIOL, V47, P909, DOI 10.1016/j.fgb.2010.04.010; Schwerdtfeger C, 2003, EMBO J, V22, P4846, DOI 10.1093/emboj/cdg451; Selby CP, 2006, P NATL ACAD SCI USA, V103, P17696, DOI 10.1073/pnas.0607993103; Somers DE, 1998, SCIENCE, V282, P1488, DOI 10.1126/science.282.5393.1488; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tisch D, 2010, APPL MICROBIOL BIOT, V85, P1259, DOI 10.1007/s00253-009-2320-1; Veluchamy S, 2008, FUNGAL GENET BIOL, V45, P1265, DOI 10.1016/j.fgb.2008.06.004; Weber S, 2005, BBA-BIOENERGETICS, V1707, P1, DOI 10.1016/j.bbabio.2004.02.010; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001; Zhang F, 2013, P NATL ACAD SCI USA, V110, P7217, DOI 10.1073/pnas.1302377110; Zhang FW, 2011, CURR MICROBIOL, V62, P146, DOI 10.1007/s00284-010-9687-1; Zoltowski BD, 2011, BIOCHEMISTRY-US, V50, P4, DOI 10.1021/bi101665s	54	15	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100625	10.1371/journal.pone.0100625	http://dx.doi.org/10.1371/journal.pone.0100625			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24964051	Green Published, gold, Green Submitted			2022-12-27	WOS:000338709500069
J	Niu, YD; McAllister, TA; Nash, JHE; Kropinski, AM; Stanford, K				Niu, Yan D.; McAllister, Tim A.; Nash, John H. E.; Kropinski, Andrew M.; Stanford, Kim			Four Escherichia coli O157:H7 Phages: A New Bacteriophage Genus and Taxonomic Classification of T1-Like Phages	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; TRANSFER-RNA GENES; LYTIC BACTERIOPHAGES; GENERATION; SALMONELLA; THERAPY; POPULATIONS; INFECTION; PROTEOME; VIRULENT	The T1-like bacteriophages vB_EcoS_AHP24, AHS24, AHP42 and AKS96 of the family Siphoviridae were shown to lyse common phage types of Shiga toxin-producing Escherichia coli O157:H7 (STEC O157: H7), but not non-O157 E. coli. All contained circularly permuted genomes of 45.7-46.8 kb (43.8-44 mol% G+C) encoding 74-81 open reading frames and 1 arginyl-tRNA. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis revealed that the structural proteins were identical among the four phages. Further proteomic analysis identified seven structural proteins responsible for tail fiber, tail tape measure protein, major capsid, portal protein as well as major and minor tail proteins. Bioinformatic analyses on the proteins revealed that genomes of AHP24, AHS24, AHP42 and AKS96 did not encode for bacterial virulence factors, integration-related proteins or antibiotic resistance determinants. All four phages were highly lytic to STEC O157:H7 with considerable potential as biocontrol agents. Comparative genomic, proteomic and phylogenetic analysis suggested that the four phages along with 17 T1-like phage genomes from database of National Center for Biotechnology Information (NCBI) can be assigned into a proposed subfamily "Tunavirinae" with further classification into five genera, namely "Tlslikevirus" (TLS, FSL SP-126), "Kp36likevirus" (KP36, F20), Tunalikevirus (T1, ADB-2 and Shf1), "Rtplikevirus" (RTP, vB_EcoS_ACG-M12) and "Jk06likevirus" (JK06, vB_EcoS_Rogue1, AHP24, AHS24, AHP42, AKS96, phiJLA23, phiKP26, phiEB49). The fact that the viruses related to JK06 have been isolated independently in Israel (JK06) (GenBank Assession #, NC_007291), Canada (vB_EcoS_Rogue1, AHP24, AHS24, AHP42, AKS96) and Mexico (phiKP26, phiJLA23) (between 2005 and 2011) indicates that these similar phages are widely distributed, and that horizontal gene transfer does not always prevent the characterization of bacteriophage evolution. With this new scheme, any new discovered phages with same type can be more properly identified. Genomic- and proteomic-based taxonomic classification of phages would facilitate better understanding phages diversity and genetic traits involved in phage evolution.	[Niu, Yan D.; Stanford, Kim] Alberta Agr & Rural Dev, Ctr Agr, Lethbridge, AB, Canada; [McAllister, Tim A.] Agr & Agri Food Canada, Lethbridge Res Ctr, Lethbridge, AB, Canada; [Nash, John H. E.; Kropinski, Andrew M.] Publ Hlth Agcy Canada, Lab Foodborne Zoonoses, Guelph, ON, Canada; [Nash, John H. E.] Univ Guelph, Ontario Vet Coll, Dept Pathobiol, Guelph, ON N1G 2W1, Canada; [Kropinski, Andrew M.] Univ Guelph, Dept Cellular & Mol Biol, Guelph, ON N1G 2W1, Canada	Agriculture & Agri Food Canada; Public Health Agency of Canada; University of Guelph; University of Guelph	Niu, YD (corresponding author), Alberta Agr & Rural Dev, Ctr Agr, Lethbridge, AB, Canada.	dongyan.niu@gov.ab.ca; kim.stanford@gov.ab.ca	Kropinski, Andrew M/H-7130-2016; Nash, John HE/P-2384-2017; McAllister, Tim A./R-9201-2017	Kropinski, Andrew M/0000-0002-6871-6799; Nash, John HE/0000-0003-2925-8710; McAllister, Tim A./0000-0002-8266-6513	Alberta Livestock and Meat Agency, Agriculture and Agri-Food Canada	Alberta Livestock and Meat Agency, Agriculture and Agri-Food Canada	This work was supported by the Alberta Livestock and Meat Agency, Agriculture and Agri-Food Canada Peer-Reviewed Project Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann Hans-W., 2009, V501, P127, DOI 10.1007/978-1-60327-164-6_13; Alonso C, 2013, PREV VET MED, V112, P109, DOI 10.1016/j.prevetmed.2013.06.001; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amarillas L, 2013, GENOME ANNOUNC, V1; Amarillas L, 2013, ARCH VIROL, V158, P2395, DOI 10.1007/s00705-013-1725-4; Atterbury RJ, 2009, MICROB BIOTECHNOL, V2, P601, DOI 10.1111/j.1751-7915.2009.00089.x; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Balogh B, 2010, CURR PHARM BIOTECHNO, V11, P48, DOI 10.2174/138920110790725302; Battaglioli EJ, 2011, APPL ENVIRON MICROB, V77, P6630, DOI 10.1128/AEM.05307-11; Bhensdadia DV, 2013, GENOME ANNOUNC, V1; Callaway TR, 2011, FOODBORNE PATHOG DIS, V8, P261, DOI 10.1089/fpd.2010.0671; Carvalho CM, 2012, BACTERIOPHAGES; Chibeu A, 2012, VIRUSES-BASEL, V4, P471, DOI 10.3390/v4040471; Comeau AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040102; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; German GJ., 2006, R, P211; Havlis J, 2003, ANAL CHEM, V75, P1300, DOI 10.1021/ac026136s; Johnson R. P., 2008, Animal Health Research Reviews, V9, P201, DOI 10.1017/S1466252308001576; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jun JW, 2013, RES MICROBIOL, V164, P979, DOI 10.1016/j.resmic.2013.08.007; Juretic D, 2002, J CHEM INF COMP SCI, V42, P620, DOI 10.1021/ci010263s; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kesik-Szeloch A, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-100; King A.M., 2012, VIRUS TAXONOMY, V9; Kingsford CL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r22; Kropinski AM, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-207; Krumsiek J, 2007, BIOINFORMATICS, V23, P1026, DOI 10.1093/bioinformatics/btm039; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Lavigne R, 2008, RES MICROBIOL, V159, P406, DOI 10.1016/j.resmic.2008.03.005; Lee YD, 2012, ARCH VIROL, V157, P199, DOI 10.1007/s00705-011-1147-0; Li KB, 2003, BIOINFORMATICS, V19, P1585, DOI 10.1093/bioinformatics/btg192; Liu H, 2013, JOINT CAN SOC AN SCI; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Mahadevan P, 2010, ADV EXP MED BIOL, V680, P379, DOI 10.1007/978-1-4419-5913-3_43; Mahadevan Padmanabhan, 2009, International Journal of Computational Biology and Drug Design, V2, P100; Mahadevan Padmanabhan, 2009, BMC Res Notes, V2, P168, DOI 10.1186/1756-0500-2-168; MARTIN DTM, 1976, J GEN VIROL, V33, P309, DOI 10.1099/0022-1317-33-2-309; Maura D, 2011, APPL MICROBIOL BIOT, V90, P851, DOI 10.1007/s00253-011-3227-1; Mishra CK, 2012, J GEN VIROL, V93, P2310, DOI 10.1099/vir.0.043562-0; Mitra A, 2011, NUCLEIC ACIDS RES, V39, pD129, DOI 10.1093/nar/gkq971; Mollov D, 2013, ARCH VIROL, V158, P1917, DOI 10.1007/s00705-013-1686-7; Niu YD, 2009, J APPL MICROBIOL, V107, P646, DOI 10.1111/j.1365-2672.2009.04231.x; Niu YD, 2009, APPL ENVIRON MICROB, V75, P1271, DOI 10.1128/AEM.02100-08; Niu YD, 2012, CAN J MICROBIOL, V58, P923, DOI [10.1139/w2012-063, 10.1139/W2012-063]; Nyachuba DG, 2010, NUTR REV, V68, P257, DOI 10.1111/j.1753-4887.2010.00286.x; OCHMAN H, 1984, J BACTERIOL, V157, P690, DOI 10.1128/JB.157.2.690-693.1984; Olson Sue A, 2002, Brief Bioinform, V3, P87, DOI 10.1093/bib/3.1.87; Public Health Agency of Canada, 2011, NAT ENT SURV PROGR N; RAMSAY N, 1984, VIROLOGY, V132, P239, DOI 10.1016/0042-6822(84)90031-X; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Reyes A, 2012, NAT REV MICROBIOL, V10, P607, DOI 10.1038/nrmicro2853; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Roberts MD, 2004, VIROLOGY, V318, P245, DOI 10.1016/j.virol.2003.09.020; Rozema EA, 2009, J FOOD PROTECT, V72, P241, DOI 10.4315/0362-028X-72.2.241; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sambrook J., 2001, MOL CLONING LAB MANU; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Stanford K, 2010, J FOOD PROTECT, V73, P1304, DOI 10.4315/0362-028X-73.7.1304; Switt AIM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-481; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Westover KM, 2013, MOL PHYLOGENET EVOL, V69, P1, DOI 10.1016/j.ympev.2013.05.010; Wietzorrek A, 2006, J BACTERIOL, V188, P1419, DOI 10.1128/JB.188.4.1419-1436.2006	66	40	41	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100426	10.1371/journal.pone.0100426	http://dx.doi.org/10.1371/journal.pone.0100426			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963920	Green Submitted, Green Published, gold			2022-12-27	WOS:000338709500049
J	Real, A; Comino, I; Moreno, MD; Lopez-Casado, MA; Lorite, P; Torres, MI; Cebolla, A; Sousa, C				Real, Ana; Comino, Isabel; de Lourdes Moreno, Ma; Angel Lopez-Casado, Miguel; Lorite, Pedro; Isabel Torres, Ma; Cebolla, Angel; Sousa, Carolina			Identification and In Vitro Reactivity of Celiac Immunoactive Peptides in an Apparent Gluten-Free Beer	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; DISEASE; INTOLERANCE; TOXICITY; GUT	Gluten content from barley, rye, wheat and in certain oat varieties, must be avoid in individuals with celiac disease. In most of the Western countries, the level of gluten content in food to be considered as gluten-free products is below 20 parts per million measured by ELISA based on specific anti-gluten peptide antibody. However, in beverages or food suffering complex hydrolytic processes as beers, the relative proportion of reactive peptides for celiac patients and the analytical techniques may differ, because of the diversity of the resulting peptide populations after fermentations. A beer below 20 parts per million of gluten but yet detectable levels of gluten peptides by anti-gliadin 33-mer antibodies (G12 and A1) was analyzed. We identified and characterized the relevant peptides for either antibody recognition or immunoactivity in celiac patients. The beer was fractionated by HPLC. The relative reactivity of the different HPLC fractions to the G12/A1 antibodies correlated to the reactivity of peripheral blood mononuclear cells isolated from 14 celiac individuals. Peptides from representative fractions classified according to the relative reactivity to G12/A1 antibodies were identified by mass spectrometry. The beer peptides containing sequences with similarity to those of previously described G12 and A1 epitopes were synthesized and confirmed significant reactivity for the antibodies. The most reactive peptides for G12/A1 also confirmed the highest immunogenicity by peripheral blood mononuclear cell activation and interferon c production from celiac patients. We concluded that preparative HPLC combined with anti-gliadin 33-mer G12/A1 antibodies were very sensitive and specific methods to analyze the relevant immunogenic peptides in hydrolyzed gluten.	[Real, Ana; Comino, Isabel; de Lourdes Moreno, Ma; Sousa, Carolina] Univ Seville, Fac Farm, Dept Microbiol & Parasitol, Seville, Spain; [Angel Lopez-Casado, Miguel] Hosp Virgen de las Nieves, Dept Gastroenterol Pediat, Granada, Spain; [Lorite, Pedro; Isabel Torres, Ma] Campus Univ Las Lagunillas, Dept Biol Expt, Jaen, Spain; [Cebolla, Angel] Biomedal SL, Seville, Spain	University of Sevilla; Hospital Universitario Virgen de las Nieves	Sousa, C (corresponding author), Univ Seville, Fac Farm, Dept Microbiol & Parasitol, Seville, Spain.	csoumar@us.es	de Lourdes Moreno Amador, María/H-5836-2012; Torres, Maria/GVU-3391-2022; Martínez, Pedro Lorite/K-6806-2012; MI, Torres/G-8789-2015	de Lourdes Moreno Amador, María/0000-0002-7490-2037; Martínez, Pedro Lorite/0000-0002-9692-5870; MI, Torres/0000-0002-9309-3837; Sousa Martin, Carolina/0000-0002-9235-9496	Ministerio de Ciencia e Innovacion [IPT-010-2010-26]; Corporacion Tecnologica de Andalucia [12/610]; Agencia IDEA [860203]; Junta de Andalucia (Proyectos de Investigacion de Excelencia) [AGR-4783];  [AGR2009-4966M]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Corporacion Tecnologica de Andalucia; Agencia IDEA; Junta de Andalucia (Proyectos de Investigacion de Excelencia)(Junta de Andalucia); 	This study was supported by a grant (no IPT-010-2010-26, subprograma INNPACTO) from de Ministerio de Ciencia e Innovacion (Fondos Tecnologicos 2007-2013, FEDER). Biomedal thanks Corporacion Tecnologica de Andalucia (Ref. 12/610) and Agencia IDEA (Ref. 860203) for co-funding this study. Ana Real was supported by a fellowship from Junta de Andalucia (Proyectos de Investigacion de Excelencia, AGR-4783). This work was also supported by AGR2009-4966M to M a Isabel Torres (Proyectos de Excelencia, Junta de Andalucia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton SH, 2008, GASTROENTEROL CLIN N, V37, P411, DOI 10.1016/j.gtc.2008.02.001; Bernardo D, 2012, EUR J INTERN MED, V23, P6, DOI 10.1016/j.ejim.2011.09.016; Chen TS, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-16; Comino I, 2013, J SCI FOOD AGR, V93, P933, DOI 10.1002/jsfa.5830; Comino I, 2012, MOL NUTR FOOD RES, V56, P1697, DOI 10.1002/mnfr.201200358; Comino I, 2011, GUT, V60, P915, DOI 10.1136/gut.2010.225268; Ehren J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006313; Green PHR, 2007, NEW ENGL J MED, V357, P1731, DOI 10.1056/NEJMra071600; Hadjivassiliou M, 2010, LANCET NEUROL, V9, P318, DOI 10.1016/S1474-4422(09)70290-X; Koning F, 2003, SCIENCE, V299, P513, DOI 10.1126/science.299.5606.513; MARSH MN, 1995, BAILLIERE CLIN GASTR, V9, P273, DOI 10.1016/0950-3528(95)90032-2; McFarland B, 2009, WORLDS BEST BEERS 10; Moron B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002294; Moron B, 2008, AM J CLIN NUTR, V87, P405, DOI 10.1093/ajcn/87.2.405; Piastowska-Ciesielska AW, 2013, ARCH MED SCI, V9, P739, DOI 10.5114/aoms.2012.30955; Picariello G, 2011, FOOD CHEM, V124, P1718, DOI 10.1016/j.foodchem.2010.07.111; Real A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048365; Shan L, 2002, SCIENCE, V297, P2275, DOI 10.1126/science.1074129; Sheehan MC, 1997, J I BREWING, V103, P297, DOI 10.1002/j.2050-0416.1997.tb00960.x; Shewry PR, 2002, J EXP BOT, V53, P947, DOI 10.1093/jexbot/53.370.947; Shoghi KI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074188; Silano M, 2014, EUR J NUTR, V53, P1177, DOI 10.1007/s00394-013-0617-4; Tye-Din JA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001012; Vader LW, 2002, J EXP MED, V195, P643, DOI 10.1084/jem.20012028; Vader W, 2002, GASTROENTEROLOGY, V122, P1729, DOI 10.1053/gast.2002.33606	25	30	31	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100917	10.1371/journal.pone.0100917	http://dx.doi.org/10.1371/journal.pone.0100917			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963630	Green Published, gold, Green Submitted			2022-12-27	WOS:000338709500099
J	Wen, D; Du, X; Nie, SP; Dong, JZ; Ma, CS				Wen, Dan; Du, Xin; Nie, Shao-Ping; Dong, Jian-Zeng; Ma, Chang-Sheng			Association between RANTES Gene Polymorphisms and Asthma: A Meta-Analysis	PLOS ONE			English	Article							PROMOTER POLYMORPHISMS; CHINESE CHILDREN; ATOPIC ASTHMA; RISK; POPULATION; SEVERITY; MCP-1; CCL5	Background: A few recent studies have suggested that regulated on activation, normal T cell expressed and secreted (RANTES) polymorphisms (2403 G/A, 228C/G) are associated with asthma. However, there still existed studies which did not confirm these correlations. Objective: The objective of this study was to evaluate the relationship of RANTES and asthma using a meta-analysis. Methods: Pubmed, Embase, and Cochrane library databases were systemically searched. Data were extracted by two independent reviewers and pooled odds ratio (OR) with 95% confidence interval (CI) were calculated. Results: Eighteen studies were enrolled, including a total of 2558 cases and 2630 controls of -403 G/A, as well as 3311 cases and -031 controls of -28C/G in this meta-analysis. The overall ORs and 95% CIs of -403 G/A were 1.19, 1.06-1.33 (P<0.001) and 1.25, 1.03-1.51 (P = 0.933) in dominant and recessive models, respectively. The overall ORs and 95% CIs of -28G were 1.23, 1.09-1.39 (P = 0.221) and 1.76, 1.32-2.34 (P = 0.356) in dominant and recessive models, respectively. No publication bias among studies was showed. Conclusions: This meta-analysis showed that RANTES -403 G/A polymorphism was a risk factor for asthma, while -28C/G polymorphism were not associated with asthma.	[Wen, Dan; Du, Xin; Nie, Shao-Ping; Dong, Jian-Zeng; Ma, Chang-Sheng] Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiol, Beijing, Peoples R China	Capital Medical University	Ma, CS (corresponding author), Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiol, Beijing, Peoples R China.	azcmuwd@gmail.com	Nie, S/K-1124-2019		International S&T Cooperation Program of China [2013DFB30310]	International S&T Cooperation Program of China	This work was supported by the International S&T Cooperation Program of China (No. 2013DFB30310). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Abdulhadi SA, 2005, GENES IMMUN, V6, P24, DOI 10.1038/sj.gene.6364151; Alam R, 1997, J ALLERGY CLIN IMMUN, V99, P273, DOI 10.1016/S0091-6749(97)70042-3; Bessa SSED, 2012, ARCH MED RES, V43, P36, DOI 10.1016/j.arcmed.2012.01.009; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Elsaadany HM, 2011, EGYPT RHEUMATOL, V33, P85, DOI 10.1016/j.ejr.2011.03.003; Fang Qiaoqiao, 2010, Int J Med Sci, V7, P55; Fryer AA, 2000, GENES IMMUN, V1, P509, DOI 10.1038/sj.gene.6363717; Giuffrida MJ, 2014, INFLUENZA OTHER RESP, V8, P116, DOI 10.1111/irv.12155; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hizawa N, 2002, AM J RESP CRIT CARE, V166, P686, DOI 10.1164/rccm.200202-090OC; Huang Jing-Long, 2005, Journal of Microbiology Immunology and Infection, V38, P158; Isgro M, 2013, MUCOSAL IMMUNOL, V6, P718, DOI 10.1038/mi.2012.109; KAMEYOSHI Y, 1992, J EXP MED, V176, P587, DOI 10.1084/jem.176.2.587; Kaneko Y, 2013, ALLERGOL INT, V62, P113, DOI 10.2332/allergolint.12-OA-0467; Keskin O, 2012, ANN ALLERG ASTHMA IM, V109, P303, DOI 10.1016/j.anai.2012.08.009; Lachheb J, 2007, HUM IMMUNOL, V68, P675, DOI 10.1016/j.humimm.2007.04.004; Leung TF, 2005, RESP MED, V99, P216, DOI 10.1016/j.rmed.2004.06.004; Lewis TC, 2012, CLIN EXP ALLERGY, V42, P1734, DOI 10.1111/cea.12005; Li XB, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-129; Liu CH, 2009, ZHONGHUA ER KE ZA ZH, V43, P462; Liu HL, 1999, P NATL ACAD SCI USA, V96, P4581, DOI 10.1073/pnas.96.8.4581; Liu M, 2005, ZHONG GUO YOU SHENG, V13, P20; Liu QH, 2013, ASIAN PAC J ALLERGY, V31, P247, DOI [10.12932/AP0298.31.3.2013, 10.12932/ap0298.31.3.2013]; Lu YM, 2012, EXP THER MED, V4, P918, DOI 10.3892/etm.2012.684; Moissidis I, 2005, GENET MED, V7, P406, DOI 10.1097/01.GIM.0000170994.24960.48; Murk W, 2011, HUM HERED, V71, P97, DOI 10.1159/000319536; Muro M, 2008, INT J IMMUNOGENET, V35, P19, DOI 10.1111/j.1744-313X.2007.00724.x; Nahas R, 2012, ANN THORAC MED, V7, P16, DOI [10.4103/1817-1737.91558, 10.4103/1817-1737.98844]; Richter M, 2003, AM J PHYSIOL-LUNG C, V285, pL719, DOI 10.1152/ajplung.00406.2002; Seidel P, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/875403; Sohn MH, 2008, LUNG, V186, P37, DOI 10.1007/s00408-007-9049-3; Szalai C, 2001, J ALLERGY CLIN IMMUN, V108, P375, DOI 10.1067/mai.2001.117930; Tolgyesi G, 2006, PEDIATR RES, V60, P543, DOI 10.1203/01.pdr.0000242298.24089.52; Wang Li-Jun, 2004, Zhonghua Jiehe He Huxi Zazhi, V27, P394; Weiss ST, 2009, CURR OPIN GENET DEV, V19, P279, DOI 10.1016/j.gde.2009.05.001; Yao TC, 2003, J ALLERGY CLIN IMMUN, V111, P1285, DOI 10.1067/mai.2003.1506; Zhang J, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-4; Zhang YG, 2010, ARCH MED RES, V41, P50, DOI 10.1016/j.arcmed.2010.01.002	38	19	21	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e90460	10.1371/journal.pone.0090460	http://dx.doi.org/10.1371/journal.pone.0090460			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8WO	24963658	Green Published, gold, Green Submitted			2022-12-27	WOS:000338709500001
J	Aterido, A; Palacio, C; Marsal, S; Avila, G; Julia, A				Aterido, Adria; Palacio, Carlos; Marsal, Sara; Avila, Gabriela; Julia, Antonio			Novel Insights into the Regulatory Architecture of CD4+T Cells in Rheumatoid Arthritis	PLOS ONE			English	Article							NF-KAPPA-B; QUANTITATIVE TRAIT LOCI; T-CELL; DISEASE-ACTIVITY; GENE-EXPRESSION; NONCODING RNAS; SURVIVIN; INFLAMMATION; ASSOCIATION; HYPOMETHYLATION	Rheumatoid arthritis (RA) is the most frequent autoimmune chronic inflammatory disease of the joints and it is characterized by the inflammation of the synovial membrane and the subsequent destruction of the joints. In RA, CD4+ T cells are the main drivers of disease initiation and the perpetuation of the damaging inflammatory process. To date, however, the genetic regulatory mechanisms of CD4+ T cells associated with RA etiology are poorly understood. The genome-wide analysis of expression quantitative trait loci (eQTL) in disease-relevant cell types is a recent genomic integration approach that is providing significant insights into the genetic regulatory mechanisms of many human pathologies. The objective of the present study was to analyze, for the first time, the genome-wide genetic regulatory mechanisms associated with the gene expression of CD4+ T cells in RA. Whole genome gene expression profiling of CD4+ T cells and the genome-wide genotyping (598,258 SNPs) of 29 RA patients with an active disease were performed. In order to avoid the excessive burden of multiple testing associated with genome-wide trans-eQTL analysis, we developed and implemented a novel systems genetics approach. Finally, we compared the genomic regulation pattern of CD4+ T cells in RA with the genomic regulation observed in reference lymphoblastoid cell lines (LCLs). We identified a genome-wide significant cis-eQTL associated with the expression of FAM66C gene (P = 6.51e-9). Using our new systems genetics approach we identified six statistically significant trans-eQTLs associated with the expression of KIAA0101 (P<7.4e-8) and BIRC5 (P = 5.35e-8) genes. Finally, comparing the genomic regulation profiles between RA CD4+ T cells and control LCLs we found 20 genes showing differential regulatory patterns between both cell types. The present genome-wide eQTL analysis has identified new genetic regulatory elements that are key to the activity of CD4+ T cells in RA.	[Aterido, Adria; Marsal, Sara; Avila, Gabriela; Julia, Antonio] Vall dHebron Hosp Res Inst, Rheumatol Res Grp, Barcelona, Spain; [Palacio, Carlos] Hosp Univ Vall dHebron, Dept Hematol, Barcelona, Spain	Hospital Universitari Vall d'Hebron; Hospital Universitari Vall d'Hebron	Marsal, S (corresponding author), Vall dHebron Hosp Res Inst, Rheumatol Res Grp, Barcelona, Spain.	sara.marsal@vhir.org; toni.julia@vhir.org		marsal, sara/0000-0001-5515-3854; Avila-Pedretti, Gabriela/0000-0002-6526-6278; Julia Cano, Antonio/0000-0001-6064-3620; Palacio-Garcia, Carles/0000-0002-9085-3327	Spanish Ministry of Economy and Competitiveness [PSE-010000-2006-6, IPT-010000-2010-36]; Fondo de Investigacion Sanitaria [PI040720]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III)	This work was supported by the Spanish Ministry of Economy and Competitiveness grants [PSE-010000-2006-6 and IPT-010000-2010-36] and the Fondo de Investigacion Sanitaria grant [PI040720]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003514; Ahn JK, 2010, INFLAMMATION, V33, P381, DOI 10.1007/s10753-010-9196-1; Andersson SEM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047668; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bokarewa M, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4474; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Burkovics P, 2009, NUCLEIC ACIDS RES, V37, P4247, DOI 10.1093/nar/gkp357; Choy EHS, 2001, NEW ENGL J MED, V344, P907, DOI 10.1056/NEJM200103223441207; Civelek M, 2013, NAT REV GENET, V3; Contassot E, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13590; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; Deshpande P, 2013, J IMMUNOL, V190, P1416, DOI 10.4049/jimmunol.1201620; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Doss S, 2005, GENOME RES, V15, P681, DOI 10.1101/gr.3216905; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eisenstein EM, 2009, PEDIATR RES, V65, p26R, DOI 10.1203/PDR.0b013e31819e76c7; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Fehrmann RSN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002197; Feldmann M, 2002, ANN RHEUM DIS, V61, P13; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Fu LH, 2011, ACTA PHARMACOL SIN, V32, P1373, DOI 10.1038/aps.2011.98; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Grundberg E, 2009, GENOME RES, V19, P1942, DOI 10.1101/gr.095224.109; Hahn MW, 2005, MOL BIOL EVOL, V22, P803, DOI 10.1093/molbev/msi072; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Heinzen EL, 2008, PLOS BIOL, V6, P2869, DOI 10.1371/journal.pbio.1000001; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Joy MP, 2005, J BIOMED BIOTECHNOL, P96, DOI 10.1155/JBB.2005.96; Julia A, 2013, CURR TOP MED CHEM, V13, P720, DOI 10.2174/1568026611313060005; Kais Z, 2011, MOL CANCER RES, V9, P1091, DOI 10.1158/1541-7786.MCR-10-0503; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karouzakis E, 2009, ARTHRITIS RHEUM-US, V60, P3613, DOI 10.1002/art.25018; Kolev M, 2013, SEMIN IMMUNOL, V25, P12, DOI 10.1016/j.smim.2013.04.012; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Liu HT, 2003, CURR OPIN PHARMACOL, V3, P317, DOI 10.1016/S1471-4892(03)00037-7; Majewski J, 2011, TRENDS GENET, V27, P72, DOI 10.1016/j.tig.2010.10.006; Makarov SS, 2001, ARTHRITIS RES, V3, P200, DOI 10.1186/ar300; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; Maxwell L, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007277.pub2; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Montgomery SB, 2011, NAT REV GENET, V12, P277, DOI 10.1038/nrg2969; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Nica AC, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0362; Noack M, 2014, AUTOIMMUN REV, V11, P00008; Oh H, 2013, IMMUNOL REV, V252, P41, DOI 10.1111/imr.12033; Page CE, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2960; Pieper J, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-34; Pope RM, 2013, NAT REV RHEUMATOL, V9, P252, DOI 10.1038/nrrheum.2012.170; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Salmon M, 1997, J CLIN INVEST, V99, P439, DOI 10.1172/JCI119178; Shabalin AA, 2012, BIOINFORMATICS, V28, P1353, DOI 10.1093/bioinformatics/bts163; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Simmonds RE, 2008, RHEUMATOLOGY, V47, P584, DOI 10.1093/rheumatology/kem298; Skapenko A, 2005, ARTHRITIS RES THER, V7, pS4, DOI 10.1186/ar1703; Small KS, 2011, NAT GENET, V43, P561, DOI 10.1038/ng.833; Smolen JS, 2012, NAT REV RHEUMATOL, V8, P235, DOI 10.1038/nrrheum.2012.23; Song JX, 2007, NAT IMMUNOL, V8, P64, DOI 10.1038/ni1413; Song JX, 2005, IMMUNITY, V22, P621, DOI 10.1016/j.immuni.2005.03.012; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Strainic MG, 2013, NAT IMMUNOL, V14, P162, DOI 10.1038/ni.2499; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Svensson B, 2010, ANN MED, V42, P45, DOI 10.3109/07853890903376280; Vallabhajosyula RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005344; van Nas A, 2010, GENETICS, V185, P1059, DOI 10.1534/genetics.110.116087; Vasanthi P, ROLE TUMOR NECROSIS; Wang WH, 2012, RHEUMATOL INT, V32, P887, DOI 10.1007/s00296-010-1710-0; Zhu M, 2009, J DRUG TARGET, V17, P524, DOI 10.1080/10611860903046610	78	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100690	10.1371/journal.pone.0100690	http://dx.doi.org/10.1371/journal.pone.0100690			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959711	gold, Green Published, Green Submitted			2022-12-27	WOS:000338633900070
J	Delotterie, D; Mathis, C; Cassel, JC; Dorner-Ciossek, C; Marti, A				Delotterie, David; Mathis, Chantal; Cassel, Jean-Christophe; Dorner-Ciossek, Cornelia; Marti, Anelise			Optimization of Touchscreen-Based Behavioral Paradigms in Mice: Implications for Building a Battery of Tasks Taxing Learning and Memory Functions	PLOS ONE			English	Article							EARLY ALZHEIMERS-DISEASE; VISUAL-DISCRIMINATION; HIPPOCAMPAL-LESIONS; MOUSE MODEL; NEURODEGENERATIVE DISEASES; AMYLOID PLAQUES; DRUG DISCOVERY; TESTING METHOD; ANIMAL-MODELS; PERFORMANCE	Although many clinical pathological states are now detectable using imaging and biochemical analyses, neuropsychological tests are often considered as valuable complementary approaches to confirm diagnosis, especially for disorders like Alzheimer's or Parkinson's disease, and schizophrenia. The touchscreen-based automated test battery, which was introduced two decades ago in humans to assess cognitive functions, has recently been successfully back-translated in monkeys and rodents. We focused on optimizing the protocol of three distinct behavioral paradigms in mice: two variants of the Paired Associates Learning (PAL) and the Visuo-Motor Conditional Learning (VMCL) tasks. Acquisition of these tasks was assessed in naive versus pre-trained mice. In naive mice, we managed to define testing conditions allowing significant improvements of learning performances over time in the three aforementioned tasks. In pre-trained mice, we observed differential acquisition rates after specific task combinations. Particularly, we identified that animals previously trained in the VMCL paradigm subsequently poorly learned the sPAL rule. Together with previous findings, these data confirm the feasibility of using such behavioral assays to evaluate the power of different models of cognitive dysfunction in mice. They also highlight the risk of interactions between tasks when rodents are run through a battery of different cognitive touchscreen paradigms.	[Delotterie, David; Mathis, Chantal; Cassel, Jean-Christophe] Univ Strasbourg, UMR 7364, Lab Neurosci Cognit & Adaptat, CNRS,Fac Psychol, Strasbourg, France; [Delotterie, David; Dorner-Ciossek, Cornelia; Marti, Anelise] Boehringer Ingelheim Pharma GmbH & Co KG, Dept CNS Dis Res, Biberach, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Boehringer Ingelheim	Delotterie, D (corresponding author), Univ Strasbourg, UMR 7364, Lab Neurosci Cognit & Adaptat, CNRS,Fac Psychol, Strasbourg, France.	david.delotterie@boehringer-ingelheim.com	MATHIS, CHANTAL mb/B-6399-2013; Delotterie, David F./AAX-9574-2021	MATHIS, CHANTAL mb/0000-0002-6663-5282; Delotterie, David F./0000-0001-9125-6746	Boehringer Ingelheim Pharma GmbH Co KG; CNRS; University of Strasbourg	Boehringer Ingelheim Pharma GmbH Co KG(Boehringer Ingelheim); CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Strasbourg	The authors' work was supported by Boehringer Ingelheim Pharma GmbH & Co KG, as well as CNRS and University of Strasbourg. Despite the affiliation of some authors to Boehringer Ingelheim Pharma GmbH & Co KG (DD, CDC, AM), all authors could collegially design the study, analyze and interprete the data, write the manuscript and decide to publish their work without any pressure or constraint, whatever the origin.	Barkus C, 2012, NEUROPHARMACOLOGY, V62, P1263, DOI 10.1016/j.neuropharm.2011.06.005; Barnett JH, 2010, NEUROSCI BIOBEHAV R, V34, P1161, DOI 10.1016/j.neubiorev.2010.01.012; Barnett JH, 2005, PSYCHOL MED, V35, P1031, DOI 10.1017/S0033291704004301; Bartko SJ, 2011, PSYCHOPHARMACOLOGY, V214, P537, DOI 10.1007/s00213-010-2050-1; Biagioni MC, 2011, NEURODEGENER DIS MAN, V1, P127, DOI 10.2217/NMT.11.11; Blackwell AD, 2004, DEMENT GERIATR COGN, V17, P42, DOI 10.1159/000074081; Bossers WJR, 2012, DEMENT GER COGN D EX, V2, P589, DOI 10.1159/000345038; Brunner D, 2012, BEHAV PROCESS, V89, P187, DOI 10.1016/j.beproc.2011.10.011; Bussey TJ, 2012, NEUROPHARMACOLOGY, V62, P1191, DOI 10.1016/j.neuropharm.2011.04.011; Bussey TJ, 2008, LEARN MEMORY, V15, P516, DOI 10.1101/lm.987808; Bussey TJ, 2000, BEHAV BRAIN RES, V111, P187, DOI 10.1016/S0166-4328(00)00155-8; Bussey TJ, 1997, BEHAV NEUROSCI, V111, P920, DOI 10.1037/0735-7044.111.5.920; Bussey TJ, 2001, BEHAV NEUROSCI, V115, P957, DOI 10.1037/0735-7044.115.4.957; Chen GQ, 2000, NATURE, V408, P975, DOI 10.1038/35050103; Chudasama Y, 2001, EUR J NEUROSCI, V14, P1009, DOI 10.1046/j.0953-816x.2001.01607.x; Cummings J, 2012, DEMENT GERIATR COGN, V33, P341, DOI 10.1159/000340056; de Rover M, 2011, NEUROPSYCHOLOGIA, V49, P2060, DOI 10.1016/j.neuropsychologia.2011.03.037; Doody RS, 2013, NEW ENGL J MED, V369, P341, DOI 10.1056/NEJMoa1210951; EVERITT BJ, 1983, NEUROSCIENCE, V10, P397, DOI 10.1016/0306-4522(83)90142-2; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frolich L, 2011, J ALZHEIMERS DIS, V24, P363, DOI [10.3233/JAD-2011-101554, 10.3233/JAD-2010-101554]; Gilbert PE, 2002, BEHAV NEUROSCI, V116, P63, DOI 10.1037//0735-7044.116.1.63; Harrison J, 2013, MED CLIN N AM, V97, P425, DOI 10.1016/j.mcna.2012.12.014; HIGGINS LS, 1995, NEURODEGENERATION, V4, P117, DOI 10.1006/neur.1995.0015; Horner AE, 2013, NAT PROTOC, V8, P1961, DOI 10.1038/nprot.2013.122; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Keeler JF, 2011, BIOCHEM PHARMACOL, V81, P1356, DOI 10.1016/j.bcp.2010.12.028; Knopman DS, 2008, COGN BEHAV NEUROL, V21, P197, DOI 10.1097/WNN.0b013e318190cf75; Langston RF, 2010, HIPPOCAMPUS, V20, P1139, DOI 10.1002/hipo.20714; Lee I, 2008, LEARN MEMORY, V15, P357, DOI 10.1101/lm.902708; Markou A, 2009, NEUROPSYCHOPHARMACOL, V34, P74, DOI 10.1038/npp.2008.173; MARSTON HM, 1993, NEUROPSYCHOLOGIA, V31, P1099, DOI 10.1016/0028-3932(93)90035-X; McCarthy AD, 2011, PHARMACOL BIOCHEM BE, V98, P76, DOI 10.1016/j.pbb.2010.11.019; McIlwain KL, 2001, PHYSIOL BEHAV, V73, P705, DOI 10.1016/S0031-9384(01)00528-5; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McTighe SM, 2009, NEUROREPORT, V20, P881, DOI 10.1097/WNR.0b013e32832c5eb2; Middei S, 2004, LEARN MEMORY, V11, P447, DOI 10.1101/lm.80604; Nagahara AH, 2010, NEUROBIOL AGING, V31, P1020, DOI 10.1016/j.neurobiolaging.2008.07.007; NETTO CA, 1985, BEHAV NEURAL BIOL, V44, P515, DOI 10.1016/S0163-1047(85)91048-9; O'Connell H, 2004, INT J GERIATR PSYCH, V19, P1207, DOI 10.1002/gps.1180; Palmer AM, 2012, DRUG DISCOV TODAY, V17, P1068, DOI 10.1016/j.drudis.2012.05.001; READING PJ, 1991, BEHAV BRAIN RES, V45, P147, DOI 10.1016/S0166-4328(05)80080-4; ROBBINS TW, 1990, BEHAV BRAIN RES, V38, P243, DOI 10.1016/0166-4328(90)90179-I; Robbins TW, 1997, PSYCHOPHARMACOLOGY, V134, P95, DOI 10.1007/s002130050430; Romberg C, 2013, BRAIN RES BULL, V92, P49, DOI 10.1016/j.brainresbull.2012.02.007; Romberg C, 2011, J NEUROSCI, V31, P3500, DOI 10.1523/JNEUROSCI.5242-10.2011; SAHAKIAN BJ, 1992, J ROY SOC MED, V85, P399; SAHAKIAN BJ, 1988, BRAIN, V111, P695, DOI 10.1093/brain/111.3.695; SAHAKIAN BJ, 1993, ACTA NEUROL SCAND, V88, P29; Savonenko AV, 2012, NEUROPSYCHOPHARMACOL, V37, P261, DOI 10.1038/npp.2011.211; Sperling R, 2011, NEUROBIOL AGING, V32, pS37, DOI 10.1016/j.neurobiolaging.2011.09.009; Spinelli S, 2006, NEUROPHARMACOLOGY, V51, P238, DOI 10.1016/j.neuropharm.2006.03.012; Swainson R, 2001, DEMENT GERIATR COGN, V12, P265, DOI 10.1159/000051269; Taffe MA, 1999, COGNITIVE BRAIN RES, V8, P203, DOI 10.1016/S0926-6410(99)00021-X; Talpos JC, 2008, BEHAV BRAIN RES, V192, P216, DOI 10.1016/j.bbr.2008.04.008; Talpos JC, 2010, NEUROBIOL LEARN MEM, V94, P341, DOI 10.1016/j.nlm.2010.07.006; Talpos JC, 2009, PSYCHOPHARMACOLOGY, V205, P157, DOI 10.1007/s00213-009-1526-3; Theuring F, 1997, TRENDS BIOTECHNOL, V15, P320, DOI 10.1016/S0167-7799(97)01066-4; Voikar V, 2004, GENES BRAIN BEHAV, V3, P27, DOI 10.1046/j.1601-183X.2003.0044.x; Weed MR, 1999, COGNITIVE BRAIN RES, V8, P185, DOI 10.1016/S0926-6410(99)00020-8; Weintraub S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006171; Winters BD, 2010, NEUROBIOL LEARN MEM, V93, P221, DOI 10.1016/j.nlm.2009.10.002; Young JW, 2013, NEUROSCI BIOBEHAV R, V37, P2181, DOI 10.1016/j.neubiorev.2012.10.002	63	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100817	10.1371/journal.pone.0100817	http://dx.doi.org/10.1371/journal.pone.0100817			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24960028	gold, Green Published, Green Submitted			2022-12-27	WOS:000338633900091
J	Vilaplana, C; Prats, C; Marzo, E; Barril, C; Vegue, M; Diaz, J; Valls, J; Lopez, D; Cardona, PJ				Vilaplana, Cristina; Prats, Clara; Marzo, Elena; Barril, Carles; Vegue, Marina; Diaz, Jorge; Valls, Joaquim; Lopez, Daniel; Cardona, Pere-Joan			To Achieve an Earlier IFN-gamma Response Is Not Sufficient to Control Mycobacterium tuberculosis Infection in Mice	PLOS ONE			English	Article							INITIATION; HISTOLOGY	The temporo-spatial relationship between the three organs (lung, spleen and lymph node) involved during the initial stages of Mycobacterium tuberculosis infection has been poorly studied. As such, we performed an experimental study to evaluate the bacillary load in each organ after aerosol or intravenous infection and developed a mathematical approach using the data obtained in order to extract conclusions. The results showed that higher bacillary doses result in an earlier IFN-gamma response, that a certain bacillary load (BL) needs to be reached to trigger the IFN-gamma response, and that control of the BL is not immediate after onset of the IFN-gamma response, which might be a consequence of the spatial dimension. This study may have an important impact when it comes to designing new vaccine candidates as it suggests that triggering an earlier IFN-gamma response might not guarantee good infection control, and therefore that additional properties should be considered for these candidates.	[Vilaplana, Cristina; Marzo, Elena; Diaz, Jorge; Cardona, Pere-Joan] Univ Autonoma Barcelona, CIBERES, Unitat TB Expt, Fundacio Inst Invest Ciencies Salut German Trias, Badalona, Catalonia, Spain; [Prats, Clara; Barril, Carles; Vegue, Marina; Valls, Joaquim; Lopez, Daniel] Univ Politecn Cataluna, Escola Super Agr Barcelona, Dept Fis & Engn Nucl, Castelldefels, Catalonia, Spain	Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Fundacio Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP); Universitat Politecnica de Catalunya	Cardona, PJ (corresponding author), Univ Autonoma Barcelona, CIBERES, Unitat TB Expt, Fundacio Inst Invest Ciencies Salut German Trias, Badalona, Catalonia, Spain.	pjcardona@igtp.cat	Marzo, Elena/AAG-7662-2020; Valls, Joaquim/L-7135-2014; Codina, Daniel Lopez/Q-5959-2019; Barril, Carles/AGH-0271-2022; Prats, Clara/L-4797-2014; Codina, Daniel Lopez/L-5309-2014; Cardona, Pere-Joan/A-5258-2011; Vilaplana, Cristina/K-7216-2012	Valls, Joaquim/0000-0002-2346-5041; Codina, Daniel Lopez/0000-0002-0408-4526; Prats, Clara/0000-0002-1398-7559; Codina, Daniel Lopez/0000-0002-0408-4526; Cardona, Pere-Joan/0000-0001-5623-7873; Vilaplana, Cristina/0000-0002-2808-7270; Barril, Carles/0000-0002-4612-5533	Spanish Government through the Ministerio de Ciencia e Innovacion [CGL2010-20160]; FIS [11/01702];  [CP13/00174]	Spanish Government through the Ministerio de Ciencia e Innovacion; FIS(Instituto de Salud Carlos III); 	This study was financially supported by the Spanish Government through the Plan Nacional I+D+i of the Ministerio de Ciencia e Innovacion CGL2010-20160, the FIS 11/01702 and Dr Vilaplana's Miguel Servet Contract CP13/00174. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baena A, 2009, TISSUE ANTIGENS, V74, P189, DOI 10.1111/j.1399-0039.2009.01301.x; Briken V, 2013, ADV EXP MED BIOL, V783, P93, DOI 10.1007/978-1-4614-6111-1_5; Bru A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012985; Cardona PJ, 2009, INFECTION, V37, P80, DOI 10.1007/s15010-008-8087-y; Cardona PJ, 2011, ENFERM INFEC MICR CL, V29, P14, DOI 10.1016/S0213-005X(11)70013-1; Cesta MF, 2006, TOXICOL PATHOL, V34, P455, DOI 10.1080/01926230600867743; Chackerian AA, 2002, INFECT IMMUN, V70, P4501, DOI 10.1128/IAI.70.8.4501-4509.2002; Gill WP, 2009, NAT MED, V15, P211, DOI 10.1038/nm.1915; Hernandez-Pando R, 2000, LANCET, V356, P2133, DOI 10.1016/S0140-6736(00)03493-0; Jung YJ, 2005, J EXP MED, V201, P1915, DOI 10.1084/jem.20050265; Khader SA, 2009, J IMMUNOL, V183, P8004, DOI 10.4049/jimmunol.0901937; Marzo E, 2014, TUBERCULOSIS, V94, P55, DOI 10.1016/j.tube.2013.09.004; McCullagh P, 1989, NAT MED; Mehra A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003734; Ramachandra L, 2005, INFECT IMMUN, V73, P1097, DOI 10.1128/IAI.73.2.1097-1105.2005; Ramachandra L, 2001, J EXP MED, V194, P1421, DOI 10.1084/jem.194.10.1421; Rubin EJ, 2009, NEW ENGL J MED, V360, P2471, DOI 10.1056/NEJMcibr0902539; Treuting PM, 2012, COMP ANATOMY HISTOLO, pxii; Vilaplana C, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00055; Wang CY, 1916, LANCET, V2, P417; Willard-Mack CL, 2006, TOXICOL PATHOL, V34, P409, DOI 10.1080/01926230600867727; Wolf AJ, 2008, J EXP MED, V205, P105, DOI 10.1084/jem.20071367	22	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100830	10.1371/journal.pone.0100830	http://dx.doi.org/10.1371/journal.pone.0100830			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959669	Green Published, gold, Green Submitted			2022-12-27	WOS:000338633900093
J	Wu, G; Jia, HB; Huang, YW; Gan, L; Fu, CH; Zhang, LB; Yu, LJ; Li, MT				Wu, Geng; Jia, Haibo; Huang, Yongwei; Gan, Lu; Fu, Chunhua; Zhang, Libin; Yu, Longjiang; Li, Maoteng			Characterization and Molecular Interpretation of the Photosynthetic Traits of Lonicera confusa in Karst Environment	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION; SEEDLING GROWTH; CALCIUM; PROTEIN; SALT; RESPONSES; DROUGHT; LEAVES; PLANT; CHLOROPLASTS	Lonicera confusa was a medical plant which could adapt to the Ca-rich environment in the karst area of China. The photosynthesis, relative chlorophyll content, differentially expressed genes (DEGs) and differentially expressed proteins (DEPs) of L. confusa that cultivated in calcareous and sandstone soils were investigated. The results showed that the relative chlorophyll content and net photosynthesis rate of L. confusa in calcareous soil are much higher than that planted in sandstone soil, the higher content of calcium might play a role in keeping the chloroplast from harm and showed higher photosynthesis rate. The transpiration and stomata conductance were decreased in calcareous soil, which might result from the closure of stomata. The GeneFishing and proteomic results showed that the expression of DEGs and DEPs were critical for photosynthesis and stomata closure, such as RuBisCO, photosynthetic electron transfer c and malate dehydrogenase varied in the leaves of L. confusa that cultivated in different soils. These DEGs or DEPs were further found to be directly or indirectly regulated by calcium sensor proteins. This study enriched our knowledge of the molecular mechanism of high net photosynthesis rate and lower transpiration of L. confusa that cultivated in the calcareous soil in some degree.	[Wu, Geng; Jia, Haibo; Huang, Yongwei; Gan, Lu; Fu, Chunhua; Zhang, Libin; Yu, Longjiang; Li, Maoteng] Huazhong Univ Sci & Technol, Sch Life Sci & Technol, Wuhan 430074, Hubei, Peoples R China; [Wu, Geng] China Univ Geosci, State Key Lab Biogeol & Environm Geol, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology; China University of Geosciences	Li, MT (corresponding author), Huazhong Univ Sci & Technol, Sch Life Sci & Technol, Wuhan 430074, Hubei, Peoples R China.	limaoteng426@mail.hust.edu.cn	Wu, Geng/G-9740-2018; WU, Geng/F-8840-2010	WU, Geng/0000-0002-7259-1044	National Science Foundation of China [31270373]; Natural Science Funds for Distinguished Young Scholars of Hubei Province of China [2010CDA097]; Ministry of Education of China [NCET110172]; Hubei Key Laboratory of Economic Forest Germplasm Improvement and Resources Comprehensive Utilization [2011BLKF247]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Funds for Distinguished Young Scholars of Hubei Province of China; Ministry of Education of China(Ministry of Education, China); Hubei Key Laboratory of Economic Forest Germplasm Improvement and Resources Comprehensive Utilization	The research was supported by the National Science Foundation of China (31270373), Natural Science Funds for Distinguished Young Scholars of Hubei Province of China (2010CDA097), New Century Talents Support Program by the Ministry of Education of China (NCET110172) and Hubei Key Laboratory of Economic Forest Germplasm Improvement and Resources Comprehensive Utilization (2011BLKF247). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, PLANT PHYSL 5 EDITIO; Bertsch U, 1995, PLANT MOL BIOL, V29, P1039, DOI 10.1007/BF00014976; BRAND JJ, 1984, J BIOENERG BIOMEMBR, V16, P239, DOI 10.1007/BF00744278; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; [曹建华 Cao Jian hua], 2003, [地球科学进展, Advance in Earth Sciences], V18, P37; Chaerle L, 2006, PLANT CELL PHYSIOL, V47, P1323, DOI 10.1093/pcp/pcj102; Cheng SH, 2002, PLANT PHYSIOL, V129, P469, DOI 10.1104/pp.005645; Coria NA, 1998, J AGR FOOD CHEM, V46, P4524, DOI 10.1021/jf980151+; Crafts-Brandner SJ, 2002, PLANT PHYSIOL, V129, P1773, DOI 10.1104/pp.002170; DAMERVAL C, 1988, PLANT PHYSIOL, V86, P1304, DOI 10.1104/pp.86.4.1304; Davis PA, 2011, PLANT CELL ENVIRON, V34, P2047, DOI 10.1111/j.1365-3040.2011.02402.x; Deng YM, 2012, PLANT PHYSIOL BIOCH, V55, P93, DOI 10.1016/j.plaphy.2012.03.006; Dodd AN, 2010, ANNU REV PLANT BIOL, V61, P593, DOI 10.1146/annurev-arplant-070109-104628; FARQUHAR GD, 1982, ANNU REV PLANT PHYS, V33, P317, DOI 10.1146/annurev.pp.33.060182.001533; Gabara B, 2003, PLANT SCI, V164, P507, DOI 10.1016/S0168-9452(02)00447-8; Garty J, 2001, J ENVIRON QUAL, V30, P884, DOI 10.2134/jeq2001.303884x; He ChengXin, 2007, Guangxi Zhiwu / Guihaia, V27, P53; Hrabak EM, 2003, PLANT PHYSIOL, V132, P666, DOI 10.1104/pp.102.011999; Hu HH, 2006, P NATL ACAD SCI USA, V103, P12987, DOI 10.1073/pnas.0604882103; [黄玉清 HUANG Yuqing], 2006, [广西植物, Guihaia], V26, P171; Hughes NM, 2007, NEW PHYTOL, V175, P675, DOI 10.1111/j.1469-8137.2007.02133.x; Kasahara M, 2002, NATURE, V420, P829, DOI 10.1038/nature01213; Khayyat M, 2009, FRUITS, V64, P53, DOI 10.1051/fruits/2008050; Kiegle E, 2000, PLANT J, V23, P267, DOI 10.1046/j.1365-313x.2000.00786.x; Kobe RK, 2002, CAN J FOREST RES, V32, P954, DOI [10.1139/x02-018, 10.1139/X02-018]; KRETSINGER RH, 1976, INT REV CYTOL, V46, P323, DOI 10.1016/S0074-7696(08)60994-8; Kudla J, 2010, PLANT CELL, V22, P541, DOI 10.1105/tpc.109.072686; Lasserre Jean Paul, 2012, Methods Mol Biol, V869, P317, DOI 10.1007/978-1-61779-821-4_27; [李强 LI Qiang], 2006, [水科学进展, Advances in Water Science], V17, P733; Li XH, 2006, J PROTEOME RES, V5, P2809, DOI 10.1021/pr0603093; Liu HT, 2003, PLANT PHYSIOL, V132, P1186, DOI 10.1104/pp.102.018564; Liu TW, 2011, TREE PHYSIOL, V31, P402, DOI 10.1093/treephys/tpr019; Liu ZH, 2004, GROUND WATER, V42, P491, DOI 10.1111/j.1745-6584.2004.tb02617.x; Luan S, 2002, PLANT CELL, V14, pS389, DOI 10.1105/tpc.001115; Ludlow M. M., 1989, Current Topics in Plant Biochemistry and Physiology, V8, P81; Mall TK, 2011, PLANT MOL BIOL, V75, P467, DOI 10.1007/s11103-011-9741-9; Miller A, 2000, PHOTOSYNTH RES, V63, P1, DOI 10.1023/A:1006367719639; Ng CKY, 2001, NATURE, V410, P596, DOI 10.1038/35069092; Nunes-Nesi A, 2005, PLANT PHYSIOL, V137, P611, DOI 10.1104/pp.104.055566; Ouyang B, 2007, J EXP BOT, V58, P507, DOI 10.1093/jxb/erl258; [彭涛 PENG Tao], 2006, [植物生理学通讯, Plant Physiology Communications], V42, P83; Petroutsos D, 2011, PLANT CELL, V23, P2950, DOI 10.1105/tpc.111.087973; Qiu QS, 2007, PLANT PHYSIOL, V144, P468, DOI 10.1104/pp.106.095182; Rocha AG, 2012, PROTOPLASMA, V249, P957, DOI 10.1007/s00709-011-0373-3; Roxas VP, 1997, NAT BIOTECHNOL, V15, P988, DOI 10.1038/nbt1097-988; Roy A, 2013, PLANT CELL ENVIRON, V36, P2120, DOI 10.1111/pce.12099; Selth LA, 2005, PLANT CELL, V17, P311, DOI 10.1105/tpc.104.027235; Sun Xian-zhi, 2008, Yingyong Shengtai Xuebao, V19, P1983; Tan W, 2011, J PLANT PHYSIOL, V168, P2063, DOI 10.1016/j.jplph.2011.06.009; TANAKA A, 1980, PLANT PHYSIOL, V65, P1211, DOI 10.1104/pp.65.6.1211; Terashima M, 2012, P NATL ACAD SCI USA, V109, P17717, DOI 10.1073/pnas.1207118109; Tian HQ, 1997, PLANTA, V202, P93, DOI 10.1007/s004250050107; Wang WH, 2012, J EXP BOT, V63, P177, DOI 10.1093/jxb/err259; [吴耿 Wu Geng], 2011, [植物学报, Chinese Bulletin of Botany], V46, P658; Wu G, 2011, PLANT SOIL, V338, P343, DOI 10.1007/s11104-010-0549-1; Xu D.Q., 1997, PLANT PHYSL COMMUN, V33, P241, DOI [10.13592/j.cnki.ppj.1997.04.001, DOI 10.13592/J.CNKI.PPJ.1997.04.001]; Yang Y, 2012, PLANT CELL PHYSIOL, V53, P1083, DOI 10.1093/pcp/pcs055; Yao X, 2006, BIOMED CHROMATOGR, V20, P1192, DOI 10.1002/bmc.684; [由继红 You Jihong], 2002, [作物学报, Acta Agronomica Sinica], V28, P693; Yuan DX, 2001, ACTA GEOL SIN-ENGL, V75, P336; Yue YM, 2010, ENVIRON MONIT ASSESS, V160, P157, DOI 10.1007/s10661-008-0665-z; Zhu S, 2013, PLANT MOL BIOL REP, V31, P1193, DOI 10.1007/s11105-013-0631-y	62	1	1	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2014	9	6							e100703	10.1371/journal.pone.0100703	http://dx.doi.org/10.1371/journal.pone.0100703			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7UT	24959829	gold, Green Published, Green Submitted			2022-12-27	WOS:000338633900072
J	Chen, JQ; Shi, Y; Regan, J; Karuppaiah, K; Ornitz, DM; Long, FX				Chen, Jianquan; Shi, Yu; Regan, Jenna; Karuppaiah, Kannan; Ornitz, David M.; Long, Fanxin			Osx-Cre Targets Multiple Cell Types besides Osteoblast Lineage in Postnatal Mice	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; BONE-FORMATION; OSTERIX; MOUSE; DIFFERENTIATION; MAINTENANCE; ACTIVATION; HEDGEHOG; ROLES	Osterix (Osx or Sp7) is a zinc-finger-family transcriptional factor essential for osteoblast differentiation in mammals. The Osx-Cre mouse line (also known as Osx1-GFP:: Cre) expresses GFP:: Cre fusion protein from a BAC transgene containing the Osx regulatory sequence. The mouse strain was initially characterized during embryogenesis, and found to target mainly osteoblast-lineage cells. Because the strain has been increasingly used in postnatal studies, it is important to evaluate its targeting specificity in mice after birth. By crossing the Osx-Cre mouse with the R26-mT/mG reporter line and analyzing the progenies at two months of age, we find that Osx-Cre targets not only osteoblasts, osteocytes and hypertrophic chondrocytes as expected, but also stromal cells, adipocytes and perivascular cells in the bone marrow. The targeting of adipocytes and perivascular cells appears to be specific to those residing within the bone marrow, as the same cell types elsewhere are not targeted. Beyond the skeleton, Osx-Cre also targets the olfactory glomerular cells, and a subset of the gastric and intestinal epithelium. Thus, potential contributions from the non-osteoblast-lineage cells should be considered when Osx-Cre is used to study gene functions in postnatal mice.	[Chen, Jianquan; Shi, Yu; Regan, Jenna; Long, Fanxin] Washington Univ, Sch Med, Dept Orthopaed Surg, St Louis, MO 63130 USA; [Karuppaiah, Kannan; Ornitz, David M.; Long, Fanxin] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO USA; [Long, Fanxin] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Long, FX (corresponding author), Washington Univ, Sch Med, Dept Orthopaed Surg, St Louis, MO 63130 USA.	longf@wudosis.wustl.edu	Shi, Yu/J-5370-2018	Ornitz, David/0000-0003-1592-7629; Chen, Jianping/0000-0001-5685-8581; Regan, Jenna/0000-0002-6698-3340	National Institutes of Health [DK065789, AR055923]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD049808] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065789] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work is funded by National Institutes of Health grants DK065789 and AR055923 to FL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Canalis E, 2013, ENDOCRINOLOGY, V154, P623, DOI 10.1210/en.2012-1732; Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008; Chen JQ, 2013, J BONE MINER RES, V28, P1160, DOI 10.1002/jbmr.1834; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Davey RA, 2012, TRANSGENIC RES, V21, P885, DOI 10.1007/s11248-011-9581-z; Fazeli PK, 2013, J CLIN ENDOCR METAB, V98, P935, DOI 10.1210/jc.2012-3634; Heffner CS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2186; Hilton MJ, 2005, DEVELOPMENT, V132, P4339, DOI 10.1242/dev.02025; Hirschi KK, 1996, CARDIOVASC RES, V32, P687, DOI 10.1016/S0008-6363(96)00063-6; Hu HL, 2005, DEVELOPMENT, V132, P49, DOI 10.1242/dev.01564; Joeng KS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055134; Liu YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071318; Long FX, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008334; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Maes C, DEV CELL, V19, P329; Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Park D, 2012, CELL STEM CELL, V10, P259, DOI 10.1016/j.stem.2012.02.003; Park JS, 2011, BIOCHEM BIOPH RES CO, V407, P842, DOI 10.1016/j.bbrc.2011.03.129; Razidlo DF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011492; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Xian LL, 2012, NAT MED, V18, P1095, DOI 10.1038/nm.2793; Zhou X, 2010, P NATL ACAD SCI USA, V107, P12919, DOI 10.1073/pnas.0912855107	26	255	264	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85161	10.1371/journal.pone.0085161	http://dx.doi.org/10.1371/journal.pone.0085161			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454809	Green Published, gold, Green Submitted			2022-12-27	WOS:000330235100058
J	Feng, Q; Zhang, QL; Du, Y; Ye, YL; He, QQ				Feng, Qi; Zhang, Qing-le; Du, Yue; Ye, Yong-ling; He, Qi-qiang			Associations of Physical Activity, Screen Time with Depression, Anxiety and Sleep Quality among Chinese College Freshmen	PLOS ONE			English	Article							MENTAL-HEALTH; SEDENTARY BEHAVIOR; EXERCISE; ADOLESCENTS; CHILDREN; STUDENTS; TELEVISION; INSTRUMENT; DISORDERS; AVENA	Objectives: To investigate the independent and interactive associations of physical activity (PA) and screen time (ST) with depression, anxiety and sleep quality among Chinese college students. Methods: A cross-sectional study was conducted in Wuhan University, China from November to December 2011. The students reported their PA, ST and socio-economic characteristics using self-administered questionnaires. Sleep quality was measured by the Pittsburgh Sleep Quality Index (PSQI). Depression and anxiety were assessed using the Self-rating Depression Scale (SDS) and Self-rating Anxiety Scale (SAS), respectively. Multivariate logistic regression models were used to estimate the odds ratios (ORs) and 95% confidence intervals (CIs) of the independent and interactive relationships of PA and ST with depression, anxiety and sleep quality. Results: A total of 1106 freshmen (471 females and 635 males) aged 18.9 +/- 0.9 years were included in the study. After adjustment for potential confounders, high PA and low ST were independently associated with significantly lower risks for poor sleep quality (OR: 0.48, 95% CI: 0.30-0.78) and depression (OR: 0.67, 95% CI: 0.44-0.89), respectively. An interactive inverse association was observed for combined effects of PA and low ST on depression (OR: 0.62, 95% CI: 0.40-0.92) and sleep quality (OR: 0.51, 95% CI: 0.27-0.91). No statistically significant associations were found between PA, ST and anxiety among the participants. Conclusions: These findings suggest an independent and interactive relationship of high PA and low ST with significantly reduced prevalence of depressive problems and favorable sleep quality among Chinese college freshmen.	[Feng, Qi; Zhang, Qing-le; Du, Yue; Ye, Yong-ling; He, Qi-qiang] Wuhan Univ, Sch Publ Hlth, Wuhan 430072, Peoples R China; [He, Qi-qiang] Wuhan Univ, Global Hlth Inst, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University	He, QQ (corresponding author), Wuhan Univ, Sch Publ Hlth, Wuhan 430072, Peoples R China.	heqiqiang@gmail.com	He, Qiqiang/A-7990-2012	FENG, QI/0000-0001-9323-9421	Fundamental Research Funds for the Central Universities [2012GSP101]; National Undergraduate Innovative Research Training Program of Wuhan University [201310486083]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Undergraduate Innovative Research Training Program of Wuhan University	This study is a social science research project at Wuhan University, supported by the Fundamental Research Funds for the Central Universities (No. 2012GSP101) and National Undergraduate Innovative Research Training Program of Wuhan University (No. 201310486083). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-on ME, 2001, PEDIATRICS, V107, P423, DOI 10.1542/peds.107.2.423; Bayram N, 2008, SOC PSYCH PSYCH EPID, V43, P667, DOI 10.1007/s00127-008-0345-x; Brand S, 2010, J ADOLESCENT HEALTH, V46, P133, DOI 10.1016/j.jadohealth.2009.06.018; Buckworth J, 2004, J AM COLL HEALTH, V53, P28, DOI 10.3200/JACH.53.1.28-34; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cao H, 2011, PREV MED, V53, P316, DOI 10.1016/j.ypmed.2011.09.002; Carney CE, 2006, CHRONOBIOL INT, V23, P623, DOI 10.1080/07420520600650695; Chung KF, 2008, SLEEP, V31, P185, DOI 10.1093/sleep/31.2.185; De Moor MHM, 2008, ARCH GEN PSYCHIAT, V65, P897, DOI 10.1001/archpsyc.65.8.897; Drake C, 2013, J CLIN SLEEP MED, V9, P1195, DOI 10.5664/jcsm.3170; Driver HS, 2000, SLEEP MED REV, V4, P387, DOI 10.1053/smrv.2000.0110; Dworak M, 2008, SLEEP MED, V9, P266, DOI 10.1016/j.sleep.2007.04.017; Fletcher GF, 1996, CIRCULATION, V94, P857, DOI 10.1161/01.CIR.94.4.857; Halson SL, 2014, SPORTS MED, V44, P13, DOI 10.1007/s40279-014-0147-0; Kalak N, 2012, J ADOLESCENT HEALTH, V51, P615, DOI 10.1016/j.jadohealth.2012.02.020; Larun L, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004691.pub2; Lemma S, 2012, SLEEP DISORD, V2012; Li XZ, 2005, ZHONGGUO LINCHUANG K, V8, P20; Liu XC, 1995, CHINESE J PSYCHIAT, p[2, 102]; Martinez-Gomez D, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-274; Oginska H, 2006, CHRONOBIOL INT, V23, P1317, DOI 10.1080/07420520601089349; Pearsall R, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-117; Peng H, 2013, SHANGHAI MED PHARM J, V14, P20, DOI [10.3969/j.issn.1006-1533.2013.14.011, DOI 10.3969/J.ISSN.1006-1533.2013.14.011]; Sharif I, 2006, PEDIATRICS, V118, pE1061, DOI 10.1542/peds.2005-2854; Sloan RA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-885; Stein C, 2007, J ADOLESCENT HEALTH, V40; Strohle A, 2009, J NEURAL TRANSM, V116, P777, DOI 10.1007/s00702-008-0092-x; Tao M., 1994, CHIN J NERV MENT DIS, V5, P301; Torsheim T, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-324; van Berkel J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-558; Velez Juan Carlos, 2013, Sleep Disord, V2013, P910104, DOI 10.1155/2013/910104; Vicente-Rodriguez G, 2008, NUTRITION, V24, P654, DOI 10.1016/j.nut.2008.03.011; Xie CJ, 2007, CHINESE J PUBLIC HLT, V5, P42; Xu JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079045; Youngstedt SD, 2003, PHYSIOL BEHAV, V78, P395, DOI 10.1016/S0031-9384(03)00004-0; Youngstedt SD, 1997, SLEEP, V20, P203, DOI 10.1093/sleep/20.3.203; Zivin K, 2009, J AFFECT DISORDERS, V117, P180, DOI 10.1016/j.jad.2009.01.001; ZUNG WWK, 1971, PSYCHOSOMATICS, V12, P371; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V13, P508, DOI 10.1001/archpsyc.1965.01730060026004	39	121	128	10	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2014	9	6							e100914	10.1371/journal.pone.0100914	http://dx.doi.org/10.1371/journal.pone.0100914			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK8WO	25093337	gold, Green Published, Green Submitted			2022-12-27	WOS:000338709500098
